data_5jto_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5jto _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.3 m . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.098 -0.704 . . . . 74.14 109.098 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.531 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -138.47 132.28 31.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.199 1.0 . . . . 75.25 109.76 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -153.56 109.11 3.23 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.153 0.581 . . . . 71.41 109.764 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.584 HG12 ' HD2' ' A' ' 84' ' ' PHE . 45.5 mt -75.06 122.92 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.294 -0.632 . . . . 73.13 109.294 177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -93.57 -35.34 12.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.598 0.561 . . . . 72.42 110.677 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -169.23 140.29 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.658 -0.246 . . . . 75.23 110.356 -170.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.577 HD13 ' HG3' ' C' ' 130' ' ' PRO . 0.2 OUTLIER -125.95 141.54 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.175 -1.046 . . . . 75.22 108.175 173.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.6 p90 -174.16 155.7 2.49 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.926 0.49 . . . . 73.13 111.365 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -78.36 121.29 24.29 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.808 -0.633 . . . . 72.51 109.569 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.5 mtpt -87.02 -25.2 24.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.625 0.37 . . . . 75.44 110.187 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.2 t70 -151.27 139.31 20.07 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.462 -0.79 . . . . 75.21 109.623 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.3 mt -131.38 139.47 50.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 106.77 -1.567 . . . . 75.41 106.77 176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -147.59 127.4 13.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.235 -1.024 . . . . 74.31 108.235 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.2 t80 -135.63 113.12 10.73 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.227 -1.397 . . . . 74.03 107.227 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.82 130.03 55.55 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.797 -0.816 . . . . 72.25 108.797 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.1 78.52 33.38 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.222 -1.399 . . . . 62.23 107.222 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.05 -46.77 23.56 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 123.641 2.894 . . . . 71.34 113.272 -164.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.16 41.68 3.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.759 -0.83 . . . . 74.03 108.759 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.65 -53.5 19.41 Favored Pre-proline 0 CA--C 1.561 1.379 0 O-C-N 124.199 0.937 . . . . 74.12 112.322 175.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -63.96 -23.84 67.71 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 121.951 1.767 . . . . 72.41 113.173 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -95.35 -21.95 18.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.728 0.811 . . . . 65.41 111.342 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.2 t -80.79 -32.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.002 0.921 . . . . 72.22 112.424 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.08 -1.47 20.27 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.453 0.701 . . . . 74.51 112.863 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -105.71 -11.3 16.35 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.003 0.921 . . . . 64.24 112.236 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.17 170.96 15.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.567 0.951 . . . . 73.44 113.567 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.01 134.36 57.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.766 1.226 . . . . 75.54 110.013 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -85.44 62.29 7.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 73.34 111.604 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -146.59 76.73 11.73 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.153 0.981 . . . . 73.15 109.906 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.88 149.14 32.85 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.525 2.15 . . . . 73.03 112.428 163.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.49 102.12 13.81 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.707 -1.219 . . . . 75.42 107.707 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 t -84.92 95.44 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.746 -0.464 . . . . 72.41 109.746 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -85.32 119.74 26.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.087 -0.961 . . . . 74.01 109.605 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -97.58 146.18 25.54 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.382 0.61 . . . . 74.43 109.423 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.674 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.9 m-20 -136.84 146.8 46.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.41 1.084 . . . . 75.31 108.531 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 tt -141.32 125.34 17.22 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.715 -1.217 . . . . 71.32 107.715 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.627 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.9 m-20 -116.32 131.95 56.8 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.102 -1.073 . . . . 71.42 108.102 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -106.06 125.02 50.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.812 -1.085 . . . . 72.53 109.085 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.05 126.05 9.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.257 0.623 . . . . 74.34 109.352 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 p -110.57 162.67 14.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.638 0.775 . . . . 74.1 109.21 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 44.4 t -148.44 153.61 38.75 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.502 0.721 . . . . 71.35 109.665 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -104.96 116.44 31.96 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.151 -1.055 . . . . 75.31 108.151 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.5 mt -96.36 -35.78 11.09 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.07 0.462 . . . . 73.14 109.96 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.87 -179.03 7.47 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.164 -0.925 . . . . 73.0 109.653 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.29 121.94 16.37 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.585 -0.895 . . . . 71.42 108.585 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 67.3 8.22 6.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.57 1.148 . . . . 74.22 112.515 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -113.51 106.2 20.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 107.929 -1.137 . . . . 74.04 107.929 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.98 125.27 50.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.772 -1.104 . . . . 71.12 108.593 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 34.9 tt0 -91.98 148.95 21.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.346 -0.843 . . . . 62.32 109.315 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.585 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 41.2 t -127.13 130.11 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.58 -1.267 . . . . 74.13 107.58 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.55 131.1 72.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.432 -0.951 . . . . 75.1 108.432 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 103' ' ' PRO . 2.7 mm? -119.52 114.9 22.97 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.842 -1.17 . . . . 74.44 107.842 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 21.5 ttp180 -85.18 100.35 11.69 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' A' ' 114' ' ' ILE . 10.1 t -93.99 110.1 23.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.522 -1.288 . . . . 71.11 107.522 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -109.12 126.91 53.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.962 -0.755 . . . . 72.54 108.962 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.6 t -116.03 124.17 72.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 106.906 -1.516 . . . . 70.24 106.906 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 2.6 m -127.16 129.65 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.351 -0.611 . . . . 73.11 109.351 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.65 124.16 37.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.814 -0.81 . . . . 74.25 108.814 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.9 m -134.03 127.42 32.23 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.298 0.639 . . . . 73.13 109.938 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 31' ' ' VAL . 5.2 mp -87.4 80.66 8.08 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.559 -1.275 . . . . 72.04 107.559 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.44 -83.49 1.32 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.232 -1.349 . . . . 64.22 111.286 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.34 -21.73 10.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 72.43 111.586 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.73 119.32 38.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.53 0.332 . . . . 75.13 111.207 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 25.0 m -70.47 133.24 46.64 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.75 0.648 . . . . 73.22 112.75 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -81.12 -63.62 1.36 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.885 1.274 . . . . 74.54 109.99 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -153.35 168.82 24.78 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 114.694 -1.139 . . . . 75.44 110.931 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -143.89 107.29 4.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.599 -1.637 . . . . 64.21 107.352 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.9 m -105.8 97.91 7.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.102 0.561 . . . . 73.55 110.525 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.99 115.48 29.0 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.859 0.863 . . . . 73.41 108.796 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.83 109.89 17.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.656 0.783 . . . . 72.11 109.317 -173.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.0 mt-30 -85.38 86.44 7.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.753 -0.832 . . . . 74.31 108.753 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.49 104.6 9.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.806 -1.088 . . . . 72.44 108.876 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.73 160.11 28.6 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.797 -0.638 . . . . 62.22 112.106 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.02 123.33 1.23 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.115 -0.794 . . . . 45.43 111.115 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.364 0.666 . . . . 75.23 109.463 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.585 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 33.7 m-85 -134.44 118.89 17.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.445 -0.946 . . . . 72.41 108.445 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -83.48 100.69 10.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.77 -0.826 . . . . 72.41 108.77 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.39 140.53 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.328 0.651 . . . . 72.14 110.697 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.16 165.87 30.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.461 1.104 . . . . 63.22 109.534 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.89 86.61 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.086 0.395 . . . . 64.44 114.086 176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -110.1 134.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.236 0.615 . . . . 73.21 109.522 -172.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -146.56 171.68 14.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.581 1.152 . . . . 74.34 108.6 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.44 -129.02 24.53 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 115.404 0.922 . . . . 61.43 115.404 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 8.9 t -76.44 -15.18 59.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.454 0.702 . . . . 72.24 111.922 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -67.64 -45.21 76.02 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.618 -0.512 . . . . 71.43 109.618 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -27.96 49.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.683 0.393 . . . . 63.3 110.625 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 92' ' ' THR . . . -68.65 -32.01 71.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.293 0.637 . . . . 63.22 111.718 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -87.31 -33.91 19.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.206 0.603 . . . . 74.33 110.209 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -61.65 -45.91 92.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.95 0.5 . . . . 71.4 110.355 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.02 -30.21 18.9 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.487 -0.779 . . . . 71.24 111.176 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.65 -3.27 81.0 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 114.846 0.698 . . . . 71.13 114.846 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.96 -60.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.937 0.868 . . . . 71.34 112.208 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 71.0 t80 -68.89 -70.68 0.26 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 113.101 0.778 . . . . 74.13 113.101 -168.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 79.3 m -63.71 -33.11 9.17 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.889 1.44 . . . . 64.33 114.889 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.528 ' HA ' HD22 ' A' ' 60' ' ' LEU . 30.0 Cg_endo -62.64 -33.46 77.39 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 121.768 1.645 . . . . 75.41 112.98 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -74.54 -15.92 60.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.185 0.594 . . . . 73.43 111.097 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.72 -40.97 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.46 0.648 . . . . 54.43 109.527 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.97 -17.89 27.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.15 -0.932 . . . . 73.5 112.346 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.32 -45.37 99.09 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.243 -0.884 . . . . 73.22 113.156 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.99 -31.25 76.94 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.202 1.934 . . . . 73.42 113.509 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -76.64 -36.48 57.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.365 0.666 . . . . 72.53 111.911 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.77 77.91 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 109.133 -0.692 . . . . 75.42 109.133 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -52.62 -52.01 57.43 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.742 1.276 . . . . 74.32 109.932 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.81 -48.68 78.05 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.394 1.059 . . . . 75.15 110.601 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.429 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.2 t -57.59 -43.22 84.46 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.77 0.669 . . . . 70.43 111.252 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 118' ' ' VAL . 76.9 mt -62.78 -56.9 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.164 -0.925 . . . . 74.5 109.785 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.7 m -50.55 -43.72 56.29 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.595 1.184 . . . . 74.1 111.667 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -62.72 -48.4 79.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.539 -1.209 . . . . 75.34 109.945 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.457 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 36.6 mtm -64.4 -40.41 95.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.163 0.585 . . . . 73.33 111.296 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.5 t -56.46 -48.18 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 123.906 0.754 . . . . 72.14 109.807 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.3 t -73.38 -26.87 61.18 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 114.955 -1.02 . . . . 73.42 111.438 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -73.06 -27.93 62.02 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.619 0.768 . . . . 73.12 110.59 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.86 3.6 74.62 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.779 0.674 . . . . 62.25 112.896 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.3 m 62.1 44.16 8.18 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.077 1.351 . . . . 70.11 110.272 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -116.97 145.42 35.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.201 -1.363 . . . . 75.02 108.068 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.54 131.82 0.39 Allowed 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 124.196 3.264 . . . . 71.43 114.263 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.95 133.6 56.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.033 0.833 . . . . 71.13 110.969 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.06 110.67 21.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.254 -0.647 . . . . 75.33 109.254 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -99.57 108.69 21.16 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.284 -1.376 . . . . 75.54 107.284 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.31 117.43 7.85 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.647 -0.871 . . . . 72.53 108.647 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.95 98.14 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.314 0.646 . . . . 71.35 111.08 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.426 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 76.4 Cg_exo -54.78 109.42 0.4 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.119 2.546 . . . . 73.2 113.484 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.95 112.8 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.035 -1.469 . . . . 75.12 107.035 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -81.39 95.03 6.91 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.768 -0.827 . . . . 72.33 108.768 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -57.8 -32.48 67.6 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.735 -1.121 . . . . 72.23 111.45 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.473 0.702 0 O-C-N 124.309 1.005 . . . . 71.23 110.741 177.225 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.243 0.719 0 N-CA-C 107.047 -1.464 . . . . 74.14 107.047 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.502 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 77.2 t80 -140.88 132.34 26.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.01 -0.737 . . . . 73.03 109.01 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.435 HE21 ' HB2' ' B' ' 85' ' ' SER . 8.6 tt0 -144.07 131.61 21.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.306 -0.998 . . . . 74.44 108.306 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' D' ' 129' ' ' ALA . 13.3 tt -82.02 126.73 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.044 -0.724 . . . . 74.3 109.044 174.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.12 -42.44 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.25 0.62 . . . . 71.2 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -165.01 151.02 10.0 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.466 0.174 . . . . 75.31 110.764 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.71 135.16 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.244 -1.762 . . . . 63.35 106.244 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.441 ' HE1' HG13 ' B' ' 83' ' ' ILE . 7.3 p90 -168.24 146.29 4.29 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.166 0.586 . . . . 75.23 109.962 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.5 m -76.97 122.55 25.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.511 -0.768 . . . . 73.23 108.982 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -98.08 -27.22 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 74.03 111.379 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.7 t70 -158.35 139.69 13.39 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.527 0.517 . . . . 72.41 111.261 -172.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.558 HD13 ' SG ' ' B' ' 113' ' ' CYS . 48.2 mm -140.88 141.86 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.423 1.489 . . . . 74.04 108.001 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -145.78 131.58 19.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.211 -1.403 . . . . 64.41 107.211 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.5 t80 -145.76 110.28 5.06 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.73 -1.211 . . . . 75.14 107.73 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.42 134.3 54.99 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.803 -0.814 . . . . 74.33 108.803 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.6 81.22 60.5 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 106.419 -1.696 . . . . 62.23 106.419 171.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.69 -32.62 37.5 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.371 2.714 . . . . 74.15 112.469 -171.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.45 31.56 6.66 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.605 1.162 . . . . 72.21 109.855 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.07 -48.4 14.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 115.818 1.784 . . . . 73.44 115.818 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.74 -25.02 4.6 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 121.843 1.696 . . . . 74.33 112.789 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.422 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 72.0 m80 -94.74 -16.19 23.25 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.024 0.75 . . . . 72.11 113.024 -171.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' B' ' 73' ' ' ALA . 12.0 p -64.23 -12.75 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.803 0.841 . . . . 75.15 111.96 175.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -56.37 -25.74 50.55 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.013 0.925 . . . . 73.15 112.637 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 24.8 pt20 -71.44 -29.13 64.52 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 73.44 111.108 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.652 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 32.2 mmtp -107.52 80.3 1.39 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.342 1.057 . . . . 74.33 108.691 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.71 109.19 18.54 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.408 -0.815 . . . . 62.44 110.283 -174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.43 ' O ' HD22 ' B' ' 68' ' ' LEU . 0.0 OUTLIER 161.69 -158.91 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.965 2.506 . . . . 74.33 109.262 157.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -49.44 106.99 0.69 Allowed Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 124.679 1.192 . . . . 72.42 111.621 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.22 153.07 14.12 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.479 2.119 . . . . 73.23 110.944 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -71.1 102.33 2.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.269 -1.011 . . . . 74.1 108.269 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -88.9 140.61 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.481 -0.933 . . . . 74.43 108.481 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -134.56 125.61 27.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.35 1.06 . . . . 75.31 109.211 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.2 148.0 23.52 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.131 0.972 . . . . 75.04 109.17 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -158.69 112.5 2.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.903 -0.777 . . . . 72.34 108.903 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.18 134.04 43.68 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.127 -0.694 . . . . 75.15 109.127 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.06 142.06 51.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.13 0.972 . . . . 55.31 108.882 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -109.19 117.5 34.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.538 0.735 . . . . 72.41 110.427 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.474 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -124.68 140.25 53.1 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.248 1.019 . . . . 75.21 109.036 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.5 p -145.12 162.89 35.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.848 0.459 . . . . 72.04 111.102 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -158.89 145.81 17.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.301 1.04 . . . . 64.54 109.238 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -96.49 112.05 23.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.527 -0.916 . . . . 74.14 108.527 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.24 -45.12 50.02 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.424 0.69 . . . . 75.43 110.681 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.4 -174.1 4.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.669 -1.151 . . . . 72.32 109.584 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.59 116.92 11.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.353 -0.84 . . . . 73.43 109.065 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 70.6 -2.29 2.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.541 1.536 . . . . 71.14 112.978 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.9 t -104.52 113.52 41.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -117.63 169.16 9.78 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.745 . . . . 73.23 109.31 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.409 ' HG2' HG12 ' B' ' 83' ' ' ILE . 4.7 tm-20 -142.47 105.92 4.64 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.721 -1.214 . . . . 74.43 107.721 -174.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.08 121.15 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.515 1.126 . . . . 54.0 109.434 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.3 t -106.02 121.74 58.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 124.24 1.016 . . . . 72.31 108.694 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 2.2 tm? -108.51 114.36 28.13 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.795 -1.187 . . . . 73.41 107.795 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -93.38 129.92 39.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.306 -0.861 . . . . 74.43 109.442 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.21 104.27 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.707 -1.22 . . . . 73.42 107.707 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -98.99 131.09 45.3 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.578 -0.527 . . . . 74.03 109.578 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 91.4 t -122.53 122.12 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.41 1.084 . . . . 73.24 108.922 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -115.05 143.71 44.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.625 -0.88 . . . . 72.14 108.625 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.81 142.87 38.7 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.766 -0.827 . . . . 71.31 108.766 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.5 p -161.37 148.02 14.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.826 0.704 . . . . 62.42 111.041 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.652 ' HB2' ' HB3' ' B' ' 34' ' ' LYS . 2.7 mp -123.73 130.78 53.16 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.636 -0.875 . . . . 74.43 108.636 173.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.17 -119.02 7.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.723 -0.951 . . . . 71.01 110.723 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.41 4.93 14.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.046 0.538 . . . . 75.22 110.967 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.23 161.95 18.65 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.572 0.349 . . . . 74.13 110.259 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.8 m -78.53 152.35 32.01 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.112 0.965 . . . . 73.35 111.538 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.643 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -97.49 -62.21 1.28 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.859 -1.164 . . . . 65.42 107.859 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.97 153.29 22.15 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.439 -1.255 . . . . 73.44 109.657 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.1 mt -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.608 -1.256 . . . . 71.5 107.608 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.45 152.2 33.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.993 0.517 . . . . 70.13 109.811 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -163.39 132.14 3.89 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.384 -0.969 . . . . 73.5 108.384 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.411 HG21 HD12 ' B' ' 21' ' ' ILE . 88.5 t -124.94 146.63 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.558 -0.904 . . . . 74.13 108.558 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.527 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.9 mt-30 -124.08 95.39 4.54 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.545 -1.28 . . . . 75.32 107.545 170.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.61 102.57 14.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.827 -1.175 . . . . 75.53 107.827 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.57 159.48 29.5 Favored Glycine 0 C--O 1.242 0.64 0 N-CA-C 110.958 -0.857 . . . . 50.41 110.958 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 125.69 1.55 Allowed Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.025 -0.83 . . . . 73.3 111.025 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.441 HG13 ' HE1' ' B' ' 17' ' ' TYR . 52.3 mt -85.71 131.36 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.89 -1.152 . . . . 74.22 107.89 175.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -139.05 132.84 30.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.43 -0.952 . . . . 74.54 108.43 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.435 ' HB2' HE21 ' B' ' 12' ' ' GLN . 66.1 m -89.8 101.91 14.61 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.422 HG21 ' HA ' ' B' ' 11' ' ' PHE . 15.1 pt -125.69 138.45 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.014 0.926 . . . . 72.21 109.605 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.65 166.54 33.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.566 1.146 . . . . 74.43 108.941 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 -28.16 2.64 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-N 117.569 0.168 . . . . 62.1 113.438 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 40.6 pt -54.35 135.31 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.322 1.449 . . . . 74.22 111.249 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -151.7 140.65 21.07 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.94 -0.573 . . . . 75.2 110.41 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.96 -110.78 2.11 Favored Glycine 0 C--N 1.355 1.611 0 O-C-N 124.738 1.274 . . . . 71.44 113.402 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 63.4 m -66.48 -42.93 86.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.113 0.965 . . . . 63.41 111.196 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -68.88 -31.93 71.22 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.62 0.768 . . . . 71.4 111.137 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.596 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 24.6 ttt -67.28 -57.32 6.89 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 123.512 0.507 . . . . 73.2 110.026 173.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.58 72.77 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.438 1.086 . . . . 74.52 111.95 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.85 -31.73 59.46 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.421 0.688 . . . . 65.45 111.188 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.97 -67.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.654 0.264 . . . . 63.53 110.593 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.471 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -83.62 -13.14 54.98 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.831 0.678 . . . . 74.44 112.831 -174.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.16 0.09 41.04 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.178 0.431 . . . . 74.51 114.178 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.24 -54.04 0.34 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 117.244 0.522 . . . . 74.02 110.954 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -71.33 -52.43 18.79 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.688 0.795 . . . . 75.43 111.181 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.502 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 33.4 m -67.03 -45.93 52.89 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 123.872 0.869 . . . . 71.52 112.538 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 84.9 Cg_exo -55.45 -38.25 94.13 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.544 2.163 . . . . 62.21 113.649 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -69.67 -22.41 63.44 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.874 0.734 . . . . 74.41 111.276 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.14 -46.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.172 0.589 . . . . 73.5 109.864 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.83 -26.64 60.7 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.484 -0.78 . . . . 73.54 111.586 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.4 -50.32 88.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.223 1.194 . . . . 73.34 114.223 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.43 -38.48 74.14 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.6 2.2 . . . . 75.53 114.138 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' D' ' 115' ' ' THR . 52.5 m-85 -70.79 -45.08 65.32 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.812 0.845 . . . . 73.04 110.562 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.38 85.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.39 -0.823 . . . . 71.53 110.901 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -63.62 -51.42 65.29 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.269 1.428 . . . . 73.04 110.207 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -68.24 -29.82 68.72 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.75 0.656 . . . . 72.14 110.301 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.558 ' SG ' HD13 ' B' ' 21' ' ' ILE . 3.2 t -67.82 -42.12 82.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.533 0.333 . . . . 74.14 110.427 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.21 -48.18 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.42 0.688 . . . . 65.01 109.623 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 89.3 m -56.67 -34.71 67.64 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.369 1.068 . . . . 65.43 111.599 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.9 t -69.42 -48.19 61.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.289 0.636 . . . . 73.23 110.066 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -70.47 -33.51 71.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.031 0.532 . . . . 74.4 111.545 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.46 -39.06 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.446 0.698 . . . . 74.22 109.855 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.483 ' OG ' HG21 ' C' ' 115' ' ' THR . 11.9 t -69.93 -27.2 64.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.456 -0.793 . . . . 73.11 111.824 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.5 mtt-85 -76.61 -32.1 57.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.304 0.642 . . . . 72.54 109.84 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.73 0.2 82.71 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.547 0.529 . . . . 73.0 112.259 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 61.4 p 61.38 33.88 18.58 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.675 1.99 . . . . 63.24 112.518 171.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -94.68 155.85 38.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.237 -0.892 . . . . 74.21 109.801 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -55.62 167.02 2.31 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.54 2.827 . . . . 72.12 114.422 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 5.7 tp60 -59.56 134.03 56.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.835 -1.075 . . . . 74.21 113.413 -172.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.77 96.13 4.9 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.42 -1.263 . . . . 65.23 107.867 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.408 HD21 ' HG3' ' B' ' 125' ' ' GLN . 4.0 p30 -108.28 112.79 25.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.574 -0.899 . . . . 75.03 108.574 172.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.414 HD13 ' H ' ' B' ' 129' ' ' ALA . 20.5 tp -75.18 139.76 42.87 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.001 -0.545 . . . . 74.21 109.828 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.414 ' H ' HD13 ' B' ' 128' ' ' LEU . . . -63.05 148.05 93.33 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.48 1.112 . . . . 71.12 111.619 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.494 ' HG3' HD11 ' D' ' 16' ' ' ILE . 5.5 Cg_exo -71.09 110.41 2.81 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.24 1.96 . . . . 75.13 110.21 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.4 t -99.39 121.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.55 -1.278 . . . . 63.11 107.55 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -74.21 88.69 1.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.357 -0.979 . . . . 72.03 108.357 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 123.479 0.712 . . . . 72.51 111.137 -177.459 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' C' ' 97' ' ' CYS . 54.3 ttp . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 121.259 0.552 . . . . 73.3 111.081 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -109.0 99.69 8.98 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.593 -1.262 . . . . 74.32 107.593 173.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -105.76 130.27 53.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.027 -0.988 . . . . 74.3 109.533 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -151.14 139.17 20.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.902 0.881 . . . . 75.4 109.575 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -86.94 142.5 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.661 0.784 . . . . 74.15 110.004 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 75.9 mt-30 -101.56 -49.89 3.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.596 0.358 . . . . 71.31 110.584 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -167.79 127.04 1.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.466 0.306 . . . . 74.43 110.824 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -107.89 143.63 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.108 -1.071 . . . . 75.43 108.108 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -172.03 164.07 6.14 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.535 0.683 . . . . 72.41 111.139 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.4 p -85.33 109.69 18.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.382 -0.969 . . . . 75.22 108.382 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -33.12 74.9 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.177 0.513 . . . . 75.23 109.875 173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -155.41 150.29 26.54 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.577 -1.192 . . . . 72.3 109.572 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 60.2 mt -138.63 149.09 23.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.506 -1.665 . . . . 71.13 106.506 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 21.2 t -160.67 152.08 19.33 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.332 0.587 . . . . 65.22 110.789 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -147.02 141.86 26.85 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.691 -1.226 . . . . 73.54 107.691 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 50.2 mt-10 -132.92 150.89 52.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.707 0.803 . . . . 75.42 109.189 170.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.73 80.7 7.38 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 106.957 -1.497 . . . . 72.32 106.957 170.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.07 -35.04 20.99 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.488 2.125 . . . . 75.44 111.741 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.39 32.03 3.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.266 1.027 . . . . 74.01 109.489 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.43 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -59.67 -51.2 82.68 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 114.512 1.301 . . . . 72.31 114.512 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 15.4 Cg_exo -71.46 -35.55 7.99 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 121.627 1.617 . . . . 71.33 111.073 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -62.68 -23.41 67.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.131 1.772 . . . . 75.24 112.85 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.437 HG22 ' HD2' ' C' ' 34' ' ' LYS . 4.0 p -61.28 -20.33 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.03 0.752 . . . . 72.31 113.03 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.52 -40.3 96.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.436 0.695 . . . . 75.44 110.826 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -97.48 23.19 7.92 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.864 0.866 . . . . 74.41 110.461 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 4.2 ttmp? -109.06 150.28 28.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.071 . . . . 75.45 109.913 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.75 125.96 30.07 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.889 -0.782 . . . . 70.3 108.889 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -84.74 75.59 10.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.331 0.586 . . . . 74.51 109.958 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -162.8 80.05 1.73 Allowed Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 107.895 -1.15 . . . . 73.01 107.895 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -87.65 154.2 7.57 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.901 2.4 . . . . 65.23 112.477 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.87 89.31 7.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 106.3 -1.741 . . . . 64.33 106.3 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.97 120.67 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.999 -1.001 . . . . 75.03 109.062 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -109.98 130.8 55.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.77 1.228 . . . . 71.43 109.592 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.487 HD23 HD23 ' C' ' 128' ' ' LEU . 16.9 mt -87.32 122.89 31.68 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.025 -0.731 . . . . 74.24 109.025 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.39 103.19 8.57 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.467 1.107 . . . . 73.23 108.167 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -111.71 146.51 37.4 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.483 0.713 . . . . 64.23 109.518 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 21.4 t70 -138.8 135.32 34.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.283 -1.377 . . . . 71.23 107.283 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 22.0 p -127.13 126.94 43.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.456 0.302 . . . . 72.41 111.05 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.47 164.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.915 0.886 . . . . 71.42 110.058 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -144.46 148.36 34.48 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.984 0.914 . . . . 75.02 108.974 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 16.0 p -147.64 129.02 14.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.12 0.568 . . . . 74.01 109.964 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -75.4 125.38 28.87 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 109.295 -0.632 . . . . 72.13 109.295 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.406 HD13 HD13 ' C' ' 83' ' ' ILE . 73.5 mt -99.65 -31.4 11.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.696 0.798 . . . . 74.42 110.547 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 -177.79 6.22 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.269 1.028 . . . . 73.53 109.644 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.84 121.85 13.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.603 -0.726 . . . . 64.33 109.506 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 69.0 -3.0 1.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.85 1.26 . . . . 54.33 112.791 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -100.38 112.66 33.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.844 -0.799 . . . . 63.43 108.844 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -126.89 124.47 39.64 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.201 -1.037 . . . . 74.44 108.201 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.63 119.48 23.87 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.969 -1.014 . . . . 75.13 108.434 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.8 t -96.16 124.55 48.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.119 -1.067 . . . . 73.45 108.119 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.35 129.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.057 -1.09 . . . . 75.3 108.057 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -122.68 95.67 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.931 -1.137 . . . . 75.45 107.931 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.514 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.7 tmt_? -86.05 114.12 22.67 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.822 -1.177 . . . . 74.42 107.822 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.9 t -113.28 132.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.107 -1.071 . . . . 72.51 108.107 175.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -128.81 124.2 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.493 -0.928 . . . . 74.42 108.493 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.625 HG23 HG21 ' C' ' 114' ' ' ILE . 39.0 t -106.55 110.48 31.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.928 -1.138 . . . . 62.33 107.928 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.0 m -106.71 127.03 53.04 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.113 -0.699 . . . . 71.52 109.113 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.9 20.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.065 -1.087 . . . . 71.21 108.065 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.7 m -148.15 126.7 12.44 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.966 0.506 . . . . 74.42 109.782 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.425 HD21 ' H ' ' C' ' 68' ' ' LEU . 0.2 OUTLIER -87.44 58.6 5.05 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.727 0.811 . . . . 74.01 109.473 177.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 -119.18 5.86 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.877 -1.289 . . . . 64.43 109.877 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.71 -24.02 21.67 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.616 0.766 . . . . 74.55 109.512 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.606 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 14.7 tp10 -68.2 96.1 0.62 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.192 0.997 . . . . 71.24 110.553 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.2 m -83.12 126.52 32.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.738 0.78 . . . . 74.24 111.259 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.661 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -82.78 -53.67 5.71 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.174 1.39 . . . . 61.52 110.19 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.88 170.46 16.75 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.022 0.826 . . . . 74.21 110.379 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.8 tm? -136.99 137.9 39.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 106.507 -1.664 . . . . 74.33 106.507 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -146.8 143.04 28.34 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.284 -1.006 . . . . 74.05 108.284 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -155.32 135.53 13.09 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.061 0.544 . . . . 72.05 109.887 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -138.3 135.23 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.235 1.014 . . . . 74.14 108.355 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -105.92 89.15 2.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.944 -1.132 . . . . 75.12 107.944 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -81.21 107.73 14.25 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.045 -0.979 . . . . 74.24 109.749 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.62 145.67 16.23 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.98 -0.448 . . . . 74.31 111.98 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.5 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.05 127.71 3.34 Favored Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 110.416 -1.074 . . . . 61.32 110.416 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 10.2 mm -81.28 114.64 22.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.842 -1.17 . . . . 75.53 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -121.55 137.11 54.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.037 -0.727 . . . . 74.3 109.037 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 m -109.96 105.59 14.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.425 -0.954 . . . . 74.24 108.425 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.617 ' HB ' ' HE2' ' C' ' 94' ' ' MET . 2.2 mp -114.7 111.88 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.648 -1.612 . . . . 73.53 106.648 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.64 157.94 31.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.994 0.518 . . . . 74.35 111.726 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.07 -60.51 0.97 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.016 -0.993 . . . . 71.42 112.384 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.68 178.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.833 0.453 . . . . 72.33 111.726 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.32 -171.07 3.74 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.631 -0.713 . . . . 72.43 110.419 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.45 -128.8 44.34 Favored Glycine 0 C--N 1.355 1.634 0 O-C-N 123.856 0.723 . . . . 61.13 114.166 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -68.18 -31.92 71.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.065 0.946 . . . . 71.42 111.743 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.88 -46.32 82.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.658 0.783 . . . . 74.14 110.117 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.725 ' HG2' HD23 ' C' ' 98' ' ' LEU . 27.9 ttt -78.32 -25.69 46.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.342 -0.845 . . . . 74.14 110.987 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -32.73 74.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.999 0.52 . . . . 72.14 111.003 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.432 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 38.9 t-80 -65.49 -36.75 84.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.644 -0.707 . . . . 71.45 111.073 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.419 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 53.9 t -76.17 -61.35 1.97 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.627 0.371 . . . . 64.52 111.143 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' C' ' 94' ' ' MET . 3.4 pp -70.71 -34.04 71.51 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.186 0.594 . . . . 74.24 110.989 -175.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.65 -2.47 75.84 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.65 0.62 . . . . 71.53 114.65 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -137.24 -57.86 0.7 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.349 0.575 . . . . 74.44 111.193 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 68.0 t80 -72.59 -48.95 35.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 122.897 0.479 . . . . 74.13 111.586 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.593 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 81.2 m -58.21 -45.03 99.76 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.383 0.883 . . . . 72.44 113.383 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' C' ' 98' ' ' LEU . 50.3 Cg_exo -56.92 -36.5 99.1 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 122.548 2.165 . . . . 75.3 113.209 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.417 HD22 ' HD2' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -68.7 -22.53 64.35 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.714 0.805 . . . . 73.21 111.734 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.3 mm -83.33 -36.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.803 0.441 . . . . 73.23 110.052 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.5 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.4 mt -82.34 -24.89 34.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.75 0.82 . . . . 74.44 112.131 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.77 -48.84 96.08 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 113.571 0.952 . . . . 72.41 113.571 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.96 -40.03 75.26 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.066 1.844 . . . . 74.21 113.184 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -70.51 -42.91 70.69 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.405 -0.816 . . . . 74.44 111.519 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.88 -46.47 87.75 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.357 0.663 . . . . 73.41 109.215 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -55.93 -51.64 66.92 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.483 1.513 . . . . 75.25 111.827 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.68 -33.2 70.65 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.503 0.321 . . . . 75.43 110.163 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.2 t -70.59 -31.02 67.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.637 0.375 . . . . 64.21 111.013 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.625 HG21 HG23 ' C' ' 64' ' ' VAL . 77.1 mt -72.05 -51.17 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.676 0.79 . . . . 74.54 109.76 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.483 HG21 ' OG ' ' B' ' 119' ' ' SER . 88.4 m -59.23 -41.27 88.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.626 0.77 . . . . 75.42 111.071 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 26.2 t -60.3 -44.38 95.45 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.064 0.853 . . . . 61.35 109.653 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.92 -39.95 91.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.312 0.645 . . . . 74.4 111.824 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.403 HG21 ' O ' ' C' ' 114' ' ' ILE . 72.6 t -62.16 -40.66 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.022 0.529 . . . . 64.22 110.116 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.411 ' HB2' ' NE2' ' B' ' 125' ' ' GLN . 84.1 p -76.17 -26.41 56.21 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.568 -0.742 . . . . 71.45 111.742 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.9 mtt-85 -71.52 -34.58 70.21 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.758 0.823 . . . . 75.24 110.168 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.62 6.06 59.25 Favored Glycine 0 C--N 1.355 1.593 0 O-C-N 123.576 0.548 . . . . 73.52 112.384 170.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p 61.67 19.49 10.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.168 2.187 . . . . 75.2 113.314 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.406 ' HE1' HG13 ' C' ' 31' ' ' VAL . 52.2 m-85 -85.88 156.27 58.18 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.136 0.974 . . . . 73.32 109.688 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.68 120.58 7.24 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.033 2.489 . . . . 72.54 111.958 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' B' ' 125' ' ' GLN . 96.2 mt-30 -57.08 143.99 36.31 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.309 1.006 . . . . 73.11 112.477 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.513 HD11 HG12 ' C' ' 64' ' ' VAL . 5.9 tt -119.28 109.18 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.178 -1.045 . . . . 75.0 108.178 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.95 119.0 31.29 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.43 -0.952 . . . . 73.41 108.43 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.487 HD23 HD23 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -73.13 136.75 44.87 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.083 -0.71 . . . . 75.41 109.083 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.9 151.75 94.56 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.288 1.035 . . . . 74.42 111.574 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.577 ' HG3' HD13 ' A' ' 16' ' ' ILE . 15.0 Cg_exo -66.39 98.54 0.4 Allowed 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.486 2.124 . . . . 62.32 111.325 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.92 108.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.908 -1.145 . . . . 74.31 107.908 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -95.04 99.05 11.12 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.762 -0.829 . . . . 74.2 108.762 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.417 ' HD2' HD22 ' C' ' 104' ' ' ASN . 78.1 m-85 -68.71 -37.0 79.16 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 72.45 109.949 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 31.3 t70 . . . . . 0 N--CA 1.477 0.907 0 C-N-CA 124.474 1.11 . . . . 75.44 112.265 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 30.1 m . . . . . 0 C--O 1.243 0.759 0 N-CA-C 108.094 -1.076 . . . . 70.44 108.094 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' D' ' 85' ' ' SER . 51.0 t80 -161.63 99.39 1.14 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.39 -0.967 . . . . 73.22 108.39 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -136.42 131.26 33.88 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.544 -0.91 . . . . 63.45 108.544 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mt -82.34 122.12 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.206 -0.665 . . . . 63.33 109.206 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.63 -31.78 19.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.819 0.448 . . . . 73.43 110.826 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -167.3 144.66 4.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 110.48 -0.193 . . . . 75.13 110.48 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.494 HD11 ' HG3' ' B' ' 130' ' ' PRO . 0.1 OUTLIER -133.56 133.15 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 106.357 -1.72 . . . . 74.52 106.357 173.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 21.6 p90 -168.31 166.79 12.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.793 0.806 . . . . 75.32 111.12 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -93.09 121.63 34.63 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.371 -1.286 . . . . 74.13 108.769 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -88.77 -31.26 18.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.884 0.474 . . . . 75.23 110.069 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.01 139.44 18.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.946 -1.024 . . . . 51.12 109.012 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.576 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.2 mt -139.59 151.3 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.771 -1.196 . . . . 72.11 107.771 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -158.68 121.67 3.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.663 0.785 . . . . 74.12 110.264 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.9 t80 -113.65 121.22 43.5 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 106.657 -1.609 . . . . 72.22 106.657 165.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.4 mt-10 -121.88 117.63 26.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.708 -0.478 . . . . 72.53 109.708 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.68 87.66 2.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.13 -36.77 5.35 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.739 2.293 . . . . 72.21 112.727 -170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -113.0 40.1 2.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.27 1.028 . . . . 64.25 108.623 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.98 -65.09 1.1 Allowed Pre-proline 0 CA--C 1.563 1.468 0 CA-C-O 117.916 -1.04 . . . . 63.1 113.799 -166.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.92 -9.81 11.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 122.6 1.964 . . . . 73.4 112.91 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -74.07 -42.44 60.18 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.688 1.195 . . . . 75.35 110.377 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.28 -33.69 14.29 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 115.951 -0.568 . . . . 75.42 109.909 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -56.16 -22.55 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 74.04 113.699 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -70.6 -36.16 73.37 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.015 0.526 . . . . 72.11 110.436 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 63.32 1.63 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.778 0.831 . . . . 72.21 111.381 171.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -107.47 97.93 7.61 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.529 0.732 . . . . 74.5 109.714 -175.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.448 ' O ' HD22 ' D' ' 68' ' ' LEU . 13.2 m95 -121.87 -155.12 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.037 -1.097 . . . . 74.14 108.037 -169.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -54.45 109.04 1.32 Allowed Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.082 0.771 . . . . 72.11 113.082 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 9.8 Cg_exo -72.03 139.45 32.87 Favored 'Trans proline' 0 C--N 1.386 2.525 0 C-N-CA 123.102 2.535 . . . . 72.31 112.968 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.0 116.48 29.0 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.561 -1.274 . . . . 74.04 107.561 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.32 149.85 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.923 0.889 . . . . 74.45 112.21 -170.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -127.83 139.35 52.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.72 1.608 . . . . 73.44 108.473 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -120.84 114.7 21.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.944 -0.762 . . . . 70.31 108.944 -179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -109.08 141.98 40.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.209 1.004 . . . . 74.34 108.501 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.04 145.03 48.54 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.335 -0.617 . . . . 73.52 109.335 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.04 159.55 44.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.177 0.991 . . . . 73.04 108.47 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -136.6 168.78 18.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.13 0.572 . . . . 74.1 110.501 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.32 154.31 36.48 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.603 1.161 . . . . 72.34 108.347 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 58.6 p -149.44 150.67 32.75 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.31 0.244 . . . . 74.32 111.117 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -174.18 127.73 0.36 Allowed 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.34 1.056 . . . . 73.13 108.93 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.89 127.31 32.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.898 -0.779 . . . . 74.34 108.898 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' D' ' 57' ' ' GLU . 57.6 mt -92.55 -36.01 13.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.886 0.474 . . . . 74.33 111.147 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.61 -171.1 1.99 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.433 0.693 . . . . 65.42 111.115 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -58.13 114.31 2.32 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.869 -1.06 . . . . 65.44 110.785 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 62.29 13.01 5.61 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.591 1.156 . . . . 74.33 112.501 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 80.6 t -115.52 118.48 58.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.512 -0.921 . . . . 71.31 108.512 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -131.25 132.54 44.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.657 1.183 . . . . 74.52 108.144 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.484 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.5 tt0 -99.77 126.0 45.77 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.375 0.422 . . . . 72.34 110.596 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -107.36 117.75 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 107.248 -1.389 . . . . 73.5 107.248 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.545 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.0 t -100.27 132.25 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.649 -1.241 . . . . 72.3 107.649 172.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -124.26 110.81 15.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.555 -0.906 . . . . 73.45 108.555 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.07 118.4 29.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.272 1.029 . . . . 74.12 109.694 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 65.3 t -102.42 130.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.867 -1.161 . . . . 72.31 107.867 166.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.3 m -121.4 131.2 54.04 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.449 0.642 . . . . 74.35 109.887 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.403 HG22 HG22 ' D' ' 114' ' ' ILE . 88.5 t -122.42 105.89 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.473 1.509 . . . . 65.0 108.938 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -107.45 108.84 20.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.847 0.859 . . . . 73.22 109.258 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.59 137.0 37.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.451 -0.574 . . . . 74.14 109.451 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -139.21 123.08 17.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.309 -0.996 . . . . 61.02 108.309 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.702 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.4 pp -129.1 137.55 51.3 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.711 -0.478 . . . . 74.03 109.711 174.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.38 -113.09 3.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.683 -0.689 . . . . 73.34 112.119 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -116.37 3.14 13.29 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.723 0.809 . . . . 72.23 111.21 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.78 176.05 13.12 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.071 0.462 . . . . 74.51 111.497 -168.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 78.1 m -66.78 138.13 57.13 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.918 -1.037 . . . . 74.22 111.015 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.4 -65.79 0.97 Allowed 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.06 -1.089 . . . . 65.25 108.06 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -156.52 164.72 37.89 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.787 -1.551 . . . . 74.24 109.231 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.6 mt -126.26 144.31 50.84 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.665 1.186 . . . . 71.22 107.842 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.408 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 0.7 OUTLIER -145.7 139.24 26.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.204 1.002 . . . . 72.1 108.348 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -157.79 130.1 7.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.52 -0.548 . . . . 74.12 109.52 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 55.3 t -137.6 119.52 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.4 0.68 . . . . 74.35 109.682 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -89.29 91.24 8.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.539 0.735 . . . . 64.11 109.083 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.59 94.66 6.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.259 0.624 . . . . 72.01 109.491 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.7 141.73 18.11 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.524 -0.63 . . . . 64.14 111.524 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.23 129.83 5.05 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 110.953 -0.859 . . . . 63.43 110.953 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.416 HG23 HD13 ' D' ' 51' ' ' LEU . 45.8 mt -89.41 119.42 36.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.793 -1.188 . . . . 65.34 107.793 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -121.47 147.52 45.66 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.04 0.936 . . . . 73.11 109.199 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 19.5 m -99.57 93.3 5.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.173 -1.418 . . . . 74.2 107.173 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.425 HG22 ' HE1' ' D' ' 94' ' ' MET . 71.9 mt -106.78 118.35 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.107 -0.701 . . . . 64.01 109.107 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -151.94 160.74 43.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.114 0.966 . . . . 73.22 109.447 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.44 -23.16 4.91 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 115.696 1.038 . . . . 53.14 115.696 170.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.419 HG13 ' HG2' ' D' ' 94' ' ' MET . 26.2 pt -96.11 135.7 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.597 -0.89 . . . . 75.05 108.597 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.05 172.93 15.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.518 -0.765 . . . . 74.43 110.153 -169.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.69 -137.28 44.39 Favored Glycine 0 C--N 1.35 1.309 0 O-C-N 123.492 0.495 . . . . 73.23 112.595 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -77.58 -20.41 54.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.861 0.864 . . . . 75.42 111.511 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -62.38 -47.38 84.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.77 0.828 . . . . 74.2 110.318 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.529 ' SD ' HD11 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -64.69 -46.96 80.15 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.246 -0.888 . . . . 74.33 109.681 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.17 67.41 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.341 1.026 . . . . 71.3 112.182 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -67.25 -50.55 60.11 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.247 -0.888 . . . . 65.43 111.159 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.84 -35.54 78.55 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.058 0.543 . . . . 75.14 111.462 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.529 HD11 ' SD ' ' D' ' 94' ' ' MET . 4.1 tt -70.27 -45.64 65.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.94 1.296 . . . . 63.21 109.226 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.74 -22.39 72.31 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 75.15 113.831 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.33 -66.82 1.04 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.405 0.52 . . . . 74.34 112.405 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -72.92 -48.19 39.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.551 0.741 . . . . 74.51 112.51 -166.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -60.1 -48.71 93.77 Favored Pre-proline 0 CA--C 1.571 1.781 0 C-N-CA 123.89 0.876 . . . . 71.21 112.784 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.64 -21.72 18.86 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.964 1.776 . . . . 73.31 112.906 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.09 -31.58 72.15 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.226 0.61 . . . . 64.5 110.577 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.8 mm -68.0 -42.82 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.674 0.79 . . . . 74.01 110.332 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.1 mt -73.73 -29.9 62.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.235 -0.893 . . . . 75.42 111.716 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -59.98 -44.11 96.0 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.338 1.236 . . . . 74.33 114.338 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.48 -41.09 80.15 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.445 2.097 . . . . 74.11 114.03 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -74.29 -37.36 63.7 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.258 0.623 . . . . 74.11 111.371 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . 0.406 ' O ' HG13 ' D' ' 114' ' ' ILE . . . -63.71 -47.45 81.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.086 0.554 . . . . 73.32 109.975 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -53.9 -53.51 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.772 1.295 . . . . 63.32 110.562 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.56 -46.98 85.74 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 124.523 1.139 . . . . 74.53 110.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.3 t -59.44 -32.88 70.62 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.579 0.549 . . . . 75.45 111.708 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.541 ' HA ' ' HE3' ' D' ' 117' ' ' MET . 73.3 mt -73.24 -49.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.157 0.583 . . . . 74.43 109.916 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' B' ' 109' ' ' TYR . 21.8 m -55.07 -40.99 70.95 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.719 1.208 . . . . 72.13 111.577 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -71.65 -37.51 70.81 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.335 -0.848 . . . . 72.11 110.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 71.3 mtm -63.37 -45.34 91.56 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 122.742 0.417 . . . . 75.03 111.287 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.428 HG22 ' O ' ' D' ' 114' ' ' ILE . 57.6 t -63.05 -41.87 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.142 -0.936 . . . . 71.24 110.451 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.2 p -68.16 -31.86 71.72 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.207 0.603 . . . . 71.15 111.754 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -71.93 -30.1 64.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.74 0.816 . . . . 72.42 110.931 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.62 8.63 64.7 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.965 -0.561 . . . . 71.11 112.569 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.6 p 60.73 24.97 14.8 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.018 2.127 . . . . 72.4 113.036 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.23 161.17 27.02 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.836 1.255 . . . . 74.12 109.499 172.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 120.04 7.16 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.475 2.117 . . . . 73.44 111.102 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.87 139.68 50.66 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.689 0.618 . . . . 74.5 110.093 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tt -109.19 117.75 34.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.401 -0.592 . . . . 75.21 109.401 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -99.98 95.39 6.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.969 -1.014 . . . . 72.54 108.362 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.12 121.19 12.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.433 0.693 . . . . 74.02 110.08 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' B' ' 13' ' ' ILE . . . -66.95 140.7 96.25 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.38 0.672 . . . . 63.55 110.577 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.0 108.65 2.77 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.549 2.166 . . . . 74.41 110.777 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.94 138.88 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.443 0.697 . . . . 75.13 109.199 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -74.17 112.37 10.26 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 123.97 0.794 . . . . 74.25 110.428 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 123.56 0.744 . . . . 72.53 110.988 177.794 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.932 -0.395 . . . . 72.24 109.932 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.448 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 21.7 t80 -137.08 131.69 33.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.784 0.834 . . . . 71.12 109.442 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -154.96 108.09 2.81 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.688 0.618 . . . . 72.44 109.904 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.683 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.4 mt -70.84 119.56 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 110.015 -0.365 . . . . 74.14 110.015 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.68 -33.01 27.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.646 0.778 . . . . 73.13 110.674 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -173.37 136.77 0.62 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.011 0.524 . . . . 75.43 110.182 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 pp -122.59 139.39 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.058 -0.719 . . . . 74.32 109.058 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' B' ' 122' ' ' THR . 12.4 p90 -173.91 172.28 3.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.422 0.63 . . . . 73.42 111.189 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -94.93 123.45 38.41 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.386 -0.825 . . . . 61.53 108.849 171.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.8 mtpt -83.24 -34.89 25.74 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 110.003 -0.369 . . . . 74.12 110.003 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -152.99 140.66 19.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.524 -0.762 . . . . 72.32 109.127 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.5 mt -129.96 143.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.268 1.027 . . . . 64.15 108.5 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.64 122.53 10.65 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.313 0.383 . . . . 75.33 110.41 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 91.6 t80 -123.58 140.72 52.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 107.721 -1.214 . . . . 72.34 107.721 166.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.36 133.93 31.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.828 0.451 . . . . 75.41 110.438 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -150.34 72.61 9.19 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.606 1.562 . . . . 75.24 107.414 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.42 -42.57 3.63 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.791 2.327 . . . . 73.31 111.465 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.94 27.7 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.631 -1.168 . . . . 70.22 110.803 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.563 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -49.24 -53.2 41.76 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 118.216 -0.897 . . . . 74.33 112.211 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.93 -30.41 83.61 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.945 1.763 . . . . 74.01 113.036 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -74.42 -50.03 20.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.58 0.705 . . . . 71.53 110.139 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.4 p -70.42 -22.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 114.49 -1.232 . . . . 73.21 112.168 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -64.74 -27.94 69.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.105 0.409 . . . . 71.41 112.105 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -100.94 -10.81 20.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.653 0.612 . . . . 74.42 112.653 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmtp -72.0 172.67 9.61 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.744 0.646 . . . . 74.54 112.744 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -50.79 117.56 2.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.599 1.16 . . . . 74.02 110.997 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -69.61 65.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.063 1.745 . . . . 75.11 110.691 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -148.63 68.96 10.13 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.603 1.161 . . . . 71.45 109.491 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -85.94 120.3 1.95 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.791 2.327 . . . . 73.03 112.706 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.93 105.16 17.19 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.651 -1.24 . . . . 74.41 107.651 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.1 p -85.09 124.98 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.487 -0.779 . . . . 72.01 109.932 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 67.0 tttm -102.82 117.77 35.35 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.552 1.141 . . . . 73.24 108.737 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tt -96.82 129.02 44.32 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.045 -1.094 . . . . 74.42 108.045 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.735 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.0 m-20 -134.51 140.01 45.87 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.669 0.788 . . . . 74.42 109.951 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.48 119.06 31.89 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.219 -1.03 . . . . 74.14 108.219 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 32.3 t70 -121.42 141.56 50.87 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.18 -1.415 . . . . 73.1 107.18 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -149.07 159.18 44.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.881 0.309 . . . . 74.0 111.518 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.44 116.12 1.08 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.697 0.623 . . . . 72.34 110.917 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.2 p -89.91 153.45 20.61 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.809 -0.811 . . . . 75.51 108.809 168.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -159.02 159.65 35.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.327 -0.99 . . . . 64.34 108.327 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.29 129.78 56.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.432 -0.581 . . . . 74.02 109.432 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.754 HD12 ' HB2' ' A' ' 57' ' ' GLU . 77.4 mt -99.1 -39.43 8.5 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.947 0.899 . . . . 65.43 110.965 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.7 178.43 8.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.627 0.771 . . . . 72.24 109.556 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -62.07 117.64 6.26 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.952 -0.758 . . . . 70.42 108.952 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 71.51 0.72 3.58 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.275 1.43 . . . . 64.34 112.835 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.51 119.02 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.567 -0.901 . . . . 74.44 108.567 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -130.14 141.1 50.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.952 0.501 . . . . 75.52 110.108 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.754 ' HB2' HD12 ' A' ' 51' ' ' LEU . 39.9 tt0 -104.03 142.49 34.36 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.419 0.688 . . . . 74.23 109.899 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.83 128.28 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.423 -0.954 . . . . 72.13 108.423 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.88 131.13 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.137 -0.69 . . . . 75.42 109.137 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.51 HD23 HD11 ' A' ' 106' ' ' LEU . 4.1 mm? -110.94 100.8 9.44 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.767 -1.197 . . . . 74.41 107.767 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 37.6 ttp85 -84.01 100.52 11.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.423 -0.954 . . . . 71.43 108.423 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 114' ' ' ILE . 35.7 t -95.08 121.62 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.414 -0.958 . . . . 73.31 108.414 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.735 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.4 m -108.52 131.38 54.89 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.66 -0.496 . . . . 73.23 109.66 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 114' ' ' ILE . 67.0 t -128.86 109.27 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.824 1.249 . . . . 74.55 107.805 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.8 m -108.1 151.49 25.81 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.062 -1.088 . . . . 74.41 108.062 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.28 128.14 23.49 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.149 -1.056 . . . . 71.13 108.149 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.7 m -137.54 127.61 25.94 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.202 0.456 . . . . 72.12 111.594 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.75 80.45 6.55 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.837 1.255 . . . . 74.4 108.354 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.53 -84.04 0.88 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.22 -1.152 . . . . 63.45 110.22 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.95 -12.94 5.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.132 0.973 . . . . 72.41 111.387 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.639 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.5 tp10 -90.17 99.77 12.73 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.634 . . . . 72.34 110.553 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 87.4 m -67.58 129.58 40.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.206 0.526 . . . . 64.51 111.985 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -76.12 -64.07 1.18 Allowed 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.394 0.678 . . . . 62.53 110.077 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.11 158.92 41.16 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.179 -0.919 . . . . 72.42 111.854 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.29 107.54 9.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.622 -1.172 . . . . 73.44 107.882 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.471 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -108.98 110.53 21.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.327 1.051 . . . . 74.41 109.191 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -130.29 117.37 19.71 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 63.5 108.603 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.423 HG11 ' SG ' ' A' ' 113' ' ' CYS . 66.1 t -123.63 120.55 60.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.745 0.818 . . . . 75.24 110.241 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -90.68 82.49 5.76 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 124.217 1.007 . . . . 73.42 108.358 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.36 100.32 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.909 -1.041 . . . . 75.21 109.571 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.96 145.32 17.54 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.796 -0.521 . . . . 74.11 111.796 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.02 120.31 1.88 Allowed Glycine 0 CA--C 1.504 -0.624 0 N-CA-C 110.388 -1.085 . . . . 64.3 110.388 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.551 HG22 HD11 ' A' ' 51' ' ' LEU . 55.7 mt -87.45 127.72 40.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.555 -0.905 . . . . 74.35 108.555 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.683 ' HD2' HG12 ' A' ' 13' ' ' ILE . 1.4 m-85 -133.54 162.78 30.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 74.13 108.959 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.4 t -119.73 113.47 20.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 63.22 108.494 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 ' SG ' ' A' ' 97' ' ' CYS . 11.5 tt -126.71 148.71 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 122.964 0.506 . . . . 75.11 110.529 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 165.83 22.93 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.02 0.928 . . . . 75.44 109.308 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.49 11.78 65.84 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.883 -0.954 . . . . 71.31 114.693 171.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.61 161.77 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.92 0.86 . . . . 75.41 112.24 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.8 tt0 -160.59 -175.59 5.08 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 124.951 1.3 . . . . 74.41 107.689 167.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.43 -140.04 31.5 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 118.04 0.382 . . . . 75.13 113.348 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -72.6 -29.94 63.93 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.386 0.674 . . . . 75.33 111.116 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -61.64 -45.69 92.97 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.604 0.762 . . . . 73.31 111.027 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.502 ' SD ' HD21 ' A' ' 98' ' ' LEU . 9.0 tmm? -66.64 -51.22 58.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.452 -0.795 . . . . 71.2 110.116 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.7 -22.74 64.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.021 0.928 . . . . 72.33 112.528 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -77.23 -32.16 55.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.548 0.739 . . . . 72.42 110.846 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' A' ' 86' ' ' ILE . 49.4 t -69.65 -64.52 0.86 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.375 0.27 . . . . 74.03 110.886 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.502 HD21 ' SD ' ' A' ' 94' ' ' MET . 1.2 pt? -67.97 -27.14 66.34 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 119.09 -0.481 . . . . 72.22 110.671 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -8.99 71.02 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 114.913 0.725 . . . . 73.33 114.913 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.399 1.099 . . . . 75.32 111.821 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.448 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.0 t80 -63.33 -62.51 1.64 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.202 1.001 . . . . 75.12 112.442 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.9 m -65.53 -33.29 7.32 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 114.114 1.153 . . . . 73.21 114.114 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.17 -50.79 12.42 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.451 2.1 . . . . 75.32 112.405 161.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -64.92 -22.63 67.03 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.606 0.762 . . . . 64.21 112.069 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.16 -50.34 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.385 -0.598 . . . . 72.2 109.385 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.51 HD11 HD23 ' A' ' 60' ' ' LEU . 77.7 mt -82.87 -19.54 37.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.736 -0.666 . . . . 63.34 112.749 -171.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -62.3 -42.97 83.79 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.09 0.956 . . . . 72.13 112.785 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -37.73 91.75 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.106 1.871 . . . . 73.12 113.713 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -71.21 -39.72 71.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.218 0.607 . . . . 73.53 111.487 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.402 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -65.76 -47.83 73.91 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.459 -0.571 . . . . 72.14 109.459 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.42 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.4 ttm105 -51.61 -48.56 63.21 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.728 1.267 . . . . 71.31 110.891 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.95 -48.91 72.37 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.609 0.764 . . . . 72.03 110.906 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.423 ' SG ' HG11 ' A' ' 78' ' ' VAL . 48.8 t -62.16 -30.06 70.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.953 0.501 . . . . 74.22 111.958 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.4 mt -72.17 -59.16 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.375 -0.602 . . . . 72.33 109.375 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.7 m -51.48 -40.32 59.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.882 1.273 . . . . 74.04 112.676 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -66.4 -41.83 88.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.473 -0.785 . . . . 75.33 110.368 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 30.5 mtm -69.21 -35.62 76.4 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.468 0.307 . . . . 73.44 110.832 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.7 t -59.67 -44.27 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 O-C-N 123.848 0.717 . . . . 73.33 109.948 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -75.29 -32.25 60.94 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 116.059 -0.519 . . . . 72.52 111.411 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -68.84 -31.75 70.95 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.434 0.694 . . . . 72.13 110.528 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.3 7.15 68.91 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.531 0.519 . . . . 74.25 112.613 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 p 56.17 49.71 14.91 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 126.493 1.917 . . . . 74.35 112.483 175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.42 161.61 23.89 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 113.028 -1.896 . . . . 73.34 108.329 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -59.98 162.11 17.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.157 2.571 . . . . 74.0 111.982 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.55 137.7 46.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.535 0.684 . . . . 72.31 110.71 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.699 -1.137 . . . . 73.02 108.611 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -135.12 127.14 29.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.763 -0.828 . . . . 73.0 108.763 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.44 125.77 27.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.229 -0.656 . . . . 74.1 109.229 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.78 150.51 93.14 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 122.844 0.458 . . . . 72.14 111.382 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.488 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.2 Cg_exo -60.29 105.12 0.27 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.764 2.309 . . . . 74.41 111.931 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.36 116.16 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.132 -1.432 . . . . 70.21 107.132 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -77.86 83.05 4.21 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.691 0.62 . . . . 55.31 109.506 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -62.55 -33.39 74.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.088 -0.96 . . . . 73.55 110.555 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.474 0.762 0 O-C-N 124.405 1.066 . . . . 74.3 110.41 177.003 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.429 ' HB ' ' HB1' ' B' ' 87' ' ' ALA . 52.1 m . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 108.348 -0.982 . . . . 54.23 108.348 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -137.91 128.9 27.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.514 0.725 . . . . 74.52 109.824 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 3.1 pm0 -147.25 129.35 15.52 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.657 0.783 . . . . 75.31 109.568 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.32 143.19 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.01 108.987 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -105.48 -50.78 3.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.505 0.322 . . . . 63.45 110.136 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -159.39 135.6 8.96 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.802 -167.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.14 129.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 75.01 109.162 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.428 ' HE1' HG13 ' B' ' 83' ' ' ILE . 17.5 p90 -157.81 151.26 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.525 0.679 . . . . 74.43 111.366 -173.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.6 m -76.26 122.13 23.94 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.672 -1.149 . . . . 73.23 109.099 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.93 -17.64 19.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.961 0.504 . . . . 70.32 112.082 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -167.97 139.16 2.85 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.104 0.252 . . . . 73.02 111.031 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.566 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -134.35 141.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.713 1.205 . . . . 71.31 109.414 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.6 t -139.15 137.14 35.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.779 1.232 . . . . 74.51 107.811 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.465 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -143.76 119.61 10.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.904 -1.517 . . . . 73.43 106.904 169.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 31.6 mt-10 -120.61 117.87 28.68 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -121.92 83.45 43.7 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.012 -0.736 . . . . 65.04 109.012 170.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.11 -24.77 32.27 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.879 2.386 . . . . 75.34 111.215 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -114.91 24.5 11.69 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.502 1.121 . . . . 75.05 109.785 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -44.08 -55.48 9.38 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.014 1.325 . . . . 74.02 114.047 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -77.61 -33.74 2.22 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.235 1.957 . . . . 75.41 111.89 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.517 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 70.5 m80 -96.0 4.3 52.76 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 124.245 1.018 . . . . 73.04 112.83 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.14 -25.78 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.886 0.875 . . . . 71.15 111.889 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -66.29 -26.5 67.35 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.594 1.158 . . . . 72.44 112.281 -174.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 24.4 pt20 -67.83 -33.58 75.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 110.047 -0.353 . . . . 74.52 110.047 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.529 ' HB2' HD12 ' B' ' 68' ' ' LEU . 80.1 mttt -108.27 65.48 0.63 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.584 -0.895 . . . . 73.3 108.584 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.39 108.32 14.9 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.698 -0.482 . . . . 65.41 109.698 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.432 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 161.5 -171.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.842 2.457 . . . . 75.41 109.605 157.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -58.56 128.36 83.16 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 122.635 0.374 . . . . 74.33 111.758 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -88.19 161.55 7.08 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.069 2.513 . . . . 75.23 112.099 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -75.49 107.53 7.68 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.92 -0.77 . . . . 72.04 108.92 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 142.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.198 -0.91 . . . . 64.11 110.693 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.7 tttm -139.39 144.1 38.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 75.12 109.528 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 84.7 mt -105.24 156.09 18.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.215 0.606 . . . . 71.4 110.702 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.8 t70 -152.04 109.97 3.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.967 -1.015 . . . . 64.24 108.409 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.36 128.89 55.46 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.607 -0.886 . . . . 75.32 108.607 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -131.45 145.19 51.67 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.78 0.832 . . . . 74.44 109.331 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 75.3 p -116.0 119.45 35.93 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.308 0.643 . . . . 72.12 110.308 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.93 139.79 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.765 -0.828 . . . . 53.33 108.765 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 p -143.32 162.85 34.61 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 111.763 0.283 . . . . 73.14 111.763 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 63.7 p -165.55 153.6 11.15 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.018 0.824 . . . . 72.43 110.024 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.0 126.51 31.48 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.098 -0.704 . . . . 74.41 109.098 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.564 HD13 ' HB2' ' B' ' 57' ' ' GLU . 34.5 mt -93.66 -49.37 5.9 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.37 0.668 . . . . 74.14 109.495 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.57 -166.21 2.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.536 -0.756 . . . . 71.14 110.845 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.84 108.95 1.11 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.669 1.188 . . . . 73.0 111.062 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 66.35 6.75 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.273 1.429 . . . . 54.2 112.107 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.98 115.05 46.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.752 -0.832 . . . . 75.41 108.752 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.83 144.82 50.09 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.563 -0.903 . . . . 73.51 108.563 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.564 ' HB2' HD13 ' B' ' 51' ' ' LEU . 38.4 tt0 -99.53 127.61 45.61 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.489 0.715 . . . . 71.51 109.539 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.0 116.95 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 48.4 t -103.64 128.82 56.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 107.379 -1.341 . . . . 75.44 107.379 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.01 100.15 7.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.063 -1.458 . . . . 75.14 107.063 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -85.7 108.28 17.96 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.0 -1.0 . . . . 71.0 109.159 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 102.88 14.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.567 -1.272 . . . . 75.21 107.567 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.1 m -101.68 130.35 48.03 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.341 -0.845 . . . . 75.24 108.757 177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.14 133.47 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 124.166 0.986 . . . . 70.45 108.594 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.5 m -118.88 144.45 46.39 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.927 0.891 . . . . 74.11 109.037 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.96 21.27 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.606 -1.257 . . . . 71.34 107.606 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.0 p -139.89 128.43 22.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.949 0.5 . . . . 70.45 111.825 -174.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' B' ' 34' ' ' LYS . 28.6 mt -95.48 100.96 12.64 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.563 1.145 . . . . 73.13 109.017 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.77 -125.44 10.02 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 112.007 -0.437 . . . . 74.13 112.007 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -99.06 18.69 16.74 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.763 0.825 . . . . 74.22 110.283 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.41 ' HB3' ' HZ3' ' B' ' 34' ' ' LYS . 10.8 tp10 -126.45 147.23 49.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.94 0.896 . . . . 71.01 109.888 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.9 m -70.12 133.13 46.83 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.568 0.747 . . . . 75.43 110.717 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.473 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -86.66 -62.19 1.56 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.054 -0.721 . . . . 75.01 109.054 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -162.95 154.93 18.16 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.45 -1.25 . . . . 72.42 108.737 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 87.6 mt -130.92 144.91 51.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 70.01 108.386 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.1 t -147.55 152.56 38.19 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.746 -0.835 . . . . 73.24 108.746 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.4 tt0 -159.53 132.16 6.71 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.606 -0.887 . . . . 73.51 108.606 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.403 HG21 HD12 ' B' ' 21' ' ' ILE . 75.5 t -128.59 144.41 38.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.427 -0.953 . . . . 75.05 108.427 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.64 91.87 3.59 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.938 -1.134 . . . . 73.22 107.938 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.95 101.85 12.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.738 -0.838 . . . . 74.41 108.738 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.77 142.83 16.8 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 111.124 -0.79 . . . . 74.15 111.124 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 126.31 3.21 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.741 -0.944 . . . . 71.14 110.741 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.428 HG13 ' HE1' ' B' ' 17' ' ' TYR . 65.2 mt -84.25 123.2 38.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 108.431 -0.951 . . . . 73.4 108.431 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.75 134.74 45.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.321 1.048 . . . . 72.33 108.309 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 16.4 m -103.85 99.81 9.59 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.564 -1.273 . . . . 53.55 107.564 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' B' ' 89' ' ' ILE . 34.2 pt -107.03 139.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.368 0.667 . . . . 71.22 110.521 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.429 ' HB1' ' HB ' ' B' ' 10' ' ' THR . . . -156.52 161.49 40.0 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.11 0.964 . . . . 72.34 109.55 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.78 -59.17 4.94 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.259 -0.428 . . . . 74.42 113.298 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.52 HD12 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.19 125.87 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.355 0.598 . . . . 73.24 110.691 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.73 167.86 29.19 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.672 -0.695 . . . . 73.42 110.877 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -118.04 12.97 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.18 -0.918 . . . . 73.23 113.191 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.2 m -71.72 -35.01 70.06 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.343 0.657 . . . . 72.13 110.945 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -66.58 -36.89 83.73 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.184 -0.916 . . . . 72.2 111.093 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.534 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 16.9 ptp -60.28 -43.32 96.32 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 123.576 0.547 . . . . 71.34 110.008 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.4 69.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.492 0.717 . . . . 74.1 111.383 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -75.4 -40.66 57.57 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.888 0.475 . . . . 74.4 110.65 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -68.32 -67.48 0.46 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.011 0.524 . . . . 61.42 110.945 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' B' ' 94' ' ' MET . 4.0 pp -75.81 -12.62 60.21 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.917 0.487 . . . . 74.53 112.185 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -23.01 24.93 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.945 -0.364 . . . . 74.22 113.986 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.69 -58.7 1.16 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.2 0.5 . . . . 75.23 110.717 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.14 -50.78 72.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.489 1.115 . . . . 72.31 112.181 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.4 m -69.03 -47.27 30.12 Favored Pre-proline 0 CA--C 1.569 1.691 0 C-N-CA 123.481 0.712 . . . . 61.44 112.048 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.8 Cg_exo -53.71 -35.23 77.49 Favored 'Trans proline' 0 C--N 1.397 3.121 0 C-N-CA 122.721 2.28 . . . . 73.34 114.098 170.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . 0.542 HD22 ' HD1' ' B' ' 133' ' ' PHE . 0.9 OUTLIER -67.68 -24.57 65.43 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.399 0.68 . . . . 74.55 111.856 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.41 -45.24 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.997 0.519 . . . . 63.43 110.213 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.08 -21.92 49.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.732 -0.667 . . . . 72.53 112.066 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.451 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 75.5 t80 -56.67 -51.74 78.97 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 117.997 -1.001 . . . . 73.5 113.098 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.8 Cg_exo -58.25 -38.92 88.86 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.437 2.091 . . . . 74.51 113.584 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -67.5 -41.73 83.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.411 0.684 . . . . 74.4 111.191 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.24 88.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.018 0.527 . . . . 73.13 110.573 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.415 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.5 ttt180 -59.56 -60.27 4.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.69 1.596 . . . . 74.51 111.062 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.77 -31.12 70.49 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.38 1.072 . . . . 74.24 111.135 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.566 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.7 t -70.96 -36.65 72.66 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 122.483 -0.136 . . . . 60.11 111.022 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.18 -45.92 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.167 0.587 . . . . 73.25 109.448 173.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.3 m -56.92 -38.68 73.21 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.749 -1.114 . . . . 75.22 111.164 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.9 t -63.97 -47.79 79.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.582 0.753 . . . . 71.41 110.667 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.1 mmt -72.14 -34.73 68.75 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.972 0.509 . . . . 74.02 111.573 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.7 t -67.64 -38.46 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.186 0.594 . . . . 72.11 110.15 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -67.97 -30.92 70.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.913 0.885 . . . . 72.42 111.013 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -72.62 -34.18 67.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.624 0.77 . . . . 75.51 110.504 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.32 3.39 53.54 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.626 0.579 . . . . 74.05 112.3 170.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 17' ' ' TYR . 49.8 p 58.21 54.56 5.7 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.445 1.898 . . . . 73.21 111.357 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -119.44 154.1 54.08 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.139 -1.391 . . . . 54.53 110.265 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -60.22 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.319 2.679 . . . . 75.33 114.776 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -64.98 129.89 41.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.167 -0.924 . . . . 63.1 112.814 -159.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.9 84.78 2.24 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.439 -1.689 . . . . 74.35 106.439 170.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -115.73 127.55 55.21 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.352 -0.981 . . . . 70.15 108.352 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.415 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 4.3 mm? -72.07 147.86 46.35 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.871 0.732 . . . . 75.41 110.311 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.67 150.79 73.42 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 115.464 -0.789 . . . . 71.22 109.205 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.03 102.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.63 2.22 . . . . 64.23 110.938 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.23 110.23 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 109.284 -0.635 . . . . 74.34 109.284 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -85.75 88.32 7.53 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 73.34 108.8 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.542 ' HD1' HD22 ' B' ' 104' ' ' ASN . 98.7 m-85 . . . . . 0 N--CA 1.481 1.093 0 CA-C-N 115.438 -0.801 . . . . 73.22 111.378 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.56 ' HB2' HG22 ' C' ' 89' ' ' ILE . 50.2 ttp . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.304 0.573 . . . . 74.21 111.878 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -86.02 78.01 9.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.286 -1.005 . . . . 72.34 108.286 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 35.0 t80 -112.42 133.96 54.22 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.035 -0.984 . . . . 73.25 109.096 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -154.76 142.15 19.61 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.201 0.6 . . . . 65.04 109.646 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -77.21 97.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.317 -0.856 . . . . 73.34 109.308 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.7 mm-40 -75.06 -42.11 57.66 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.603 -0.517 . . . . 75.03 109.603 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -174.25 147.42 1.2 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.274 0.984 . . . . 73.43 109.561 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.1 mt -129.1 142.03 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 107.62 -1.252 . . . . 74.32 107.62 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -172.64 158.29 4.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.468 0.651 . . . . 74.4 111.418 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -83.22 106.35 14.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.804 -1.089 . . . . 70.21 108.387 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -65.93 -47.47 74.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.554 0.692 . . . . 75.34 109.268 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -135.51 140.42 44.76 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.611 -1.177 . . . . 74.13 109.204 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.44 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 69.9 mt -134.22 138.32 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.325 -1.361 . . . . 73.34 107.325 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -154.79 150.53 27.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.964 0.411 . . . . 72.03 110.034 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.14 108.59 3.62 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.912 -1.144 . . . . 73.3 107.912 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.77 108.82 16.83 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.148 0.579 . . . . 73.24 109.546 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.14 85.45 18.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.398 -0.964 . . . . 70.32 108.398 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -36.22 31.69 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.009 2.473 . . . . 73.13 112.368 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -107.6 34.29 3.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.516 0.726 . . . . 73.22 109.413 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.48 -50.76 63.72 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.223 1.194 . . . . 72.41 114.223 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.97 -32.96 8.2 Favored 'Trans proline' 0 C--N 1.388 2.625 0 CA-C-N 121.036 1.406 . . . . 74.33 112.78 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.18 -37.13 75.08 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.836 0.854 . . . . 75.24 112.642 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.36 -21.09 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.165 0.586 . . . . 75.3 110.608 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.47 -2.26 27.96 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.268 0.627 . . . . 74.11 111.095 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -124.12 26.28 7.54 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.417 1.087 . . . . 74.25 109.837 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.633 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -111.98 147.44 35.93 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.248 1.019 . . . . 75.55 109.947 -178.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.44 131.13 49.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 73.42 111.114 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -71.61 93.57 1.24 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.148 0.979 . . . . 73.41 112.011 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -154.91 74.49 5.64 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.738 0.815 . . . . 70.34 108.991 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -84.44 127.95 3.97 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.563 2.175 . . . . 74.21 112.357 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.56 97.22 10.4 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 106.502 -1.666 . . . . 74.13 106.502 166.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.96 117.05 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.57 -1.196 . . . . 73.3 109.8 -169.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -97.36 109.0 21.85 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.053 -1.091 . . . . 72.54 108.053 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tt -86.81 123.8 32.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.264 -1.754 . . . . 75.52 106.264 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.581 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.9 t70 -120.02 147.91 44.21 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.642 0.777 . . . . 75.21 109.462 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -134.54 131.85 38.44 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.396 1.078 . . . . 72.15 108.129 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.3 t70 -133.52 135.26 44.3 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.511 -0.551 . . . . 75.52 109.511 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -113.41 111.2 21.56 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.754 0.822 . . . . 72.21 109.559 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.79 157.62 35.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.204 1.002 . . . . 74.52 109.851 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 67.5 p -155.15 167.25 30.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.817 0.447 . . . . 75.15 110.95 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -164.86 127.34 2.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.661 0.785 . . . . 73.15 109.839 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.31 135.96 33.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.264 0.483 . . . . 75.42 109.784 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.539 HD13 HD13 ' C' ' 83' ' ' ILE . 41.2 mt -106.11 -47.01 3.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.03 0.932 . . . . 74.45 109.993 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.7 -178.01 5.45 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.138 0.975 . . . . 70.31 108.973 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.64 110.91 1.24 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.6 0.76 . . . . 71.31 111.019 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' C' ' 87' ' ' ALA . 19.1 m-20 62.85 30.75 16.6 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.493 1.117 . . . . 73.42 111.768 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -118.98 111.59 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.619 -1.252 . . . . 75.42 107.619 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.51 125.85 45.65 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.772 0.829 . . . . 52.24 109.81 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.78 120.3 24.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 74.43 108.917 168.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -96.78 117.33 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.585 -1.265 . . . . 75.25 107.585 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.08 131.61 52.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.006 -1.109 . . . . 71.22 108.006 173.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.62 105.85 9.0 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.191 -1.04 . . . . 75.21 108.191 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 59.3 mtt180 -83.3 134.61 34.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.646 -0.502 . . . . 71.52 109.646 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.0 123.77 69.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.798 -1.556 . . . . 73.04 106.798 162.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.8 m -121.17 112.33 18.53 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.446 0.641 . . . . 72.54 109.321 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.591 HG23 HG21 ' C' ' 114' ' ' ILE . 51.5 t -101.13 117.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 73.13 108.586 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.426 HG21 HD21 ' C' ' 75' ' ' LEU . 4.4 m -115.13 141.89 47.4 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.667 -0.864 . . . . 71.54 108.667 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.07 123.0 22.54 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.941 -1.133 . . . . 73.23 107.941 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 127.07 16.97 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 122.852 0.461 . . . . 73.13 110.548 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.514 ' H ' HD12 ' C' ' 68' ' ' LEU . 1.5 mp -90.63 49.25 1.64 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.045 1.338 . . . . 54.44 109.121 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.01 -106.58 2.81 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.212 -0.903 . . . . 73.05 110.901 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -90.35 -30.88 17.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.962 0.905 . . . . 70.03 110.162 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -66.32 115.47 6.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.308 1.043 . . . . 74.43 109.891 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.2 m -89.82 125.6 35.38 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.714 0.688 . . . . 75.53 109.653 168.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.482 ' HB3' HD13 ' C' ' 68' ' ' LEU . . . -72.23 -64.02 1.03 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.79 -1.095 . . . . 65.1 109.502 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.59 170.16 23.02 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.564 -1.198 . . . . 73.32 110.814 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.426 HD21 HG21 ' C' ' 65' ' ' THR . 3.0 tm? -133.69 146.61 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.562 -2.014 . . . . 72.24 105.562 172.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.414 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -151.47 145.26 25.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.394 -0.965 . . . . 63.3 108.394 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . 0.447 ' HB2' HG22 ' C' ' 63' ' ' THR . 34.3 tt0 -157.56 136.37 11.5 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.294 -0.632 . . . . 73.42 109.294 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.58 123.7 49.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.114 -0.948 . . . . 74.32 108.927 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 29.1 mt-30 -92.33 87.56 6.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.656 -1.239 . . . . 75.41 107.656 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -79.08 96.88 5.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.317 -0.624 . . . . 73.12 109.317 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.07 149.05 24.88 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 115.26 -0.882 . . . . 50.33 111.577 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.92 117.23 0.81 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 110.825 -0.91 . . . . 73.13 110.825 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' D' ' 29' ' ' PRO . 14.5 mm -80.98 121.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.398 -0.964 . . . . 75.33 108.398 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.97 126.73 29.16 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.596 -0.89 . . . . 73.1 108.596 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -69.61 119.26 13.58 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.344 -0.984 . . . . 73.14 108.344 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.6 HG21 HD13 ' C' ' 89' ' ' ILE . 59.1 mt -116.3 100.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.066 -0.716 . . . . 73.23 109.066 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' C' ' 54' ' ' ASP . . . -148.71 164.47 34.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.648 1.179 . . . . 73.31 109.031 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.34 32.5 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 123.13 0.269 . . . . 70.55 112.988 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.6 HD13 HG21 ' C' ' 86' ' ' ILE . 11.9 pt -114.45 156.18 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.598 1.159 . . . . 73.25 110.37 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -164.96 156.21 14.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.945 -1.025 . . . . 71.21 109.264 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 63.08 -110.37 3.32 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.423 0.452 . . . . 73.45 114.006 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -83.1 -27.19 30.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.664 0.386 . . . . 74.03 111.797 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -42.07 75.25 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.46 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.2 ptt? -63.57 -35.78 81.62 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.67 -0.696 . . . . 73.33 110.004 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.64 93.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.708 0.803 . . . . 60.11 112.024 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 47.7 t-80 -78.76 -20.92 48.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.304 -0.407 . . . . 73.41 111.265 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.5 t -82.56 -63.25 1.41 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.154 -0.342 . . . . 64.55 111.27 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.575 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 4.6 pp -77.51 -32.16 53.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.847 0.459 . . . . 70.52 111.387 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.34 8.77 64.7 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.727 -0.485 . . . . 73.44 113.702 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -148.64 -56.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.246 0.523 . . . . 75.3 111.838 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -74.49 -40.27 61.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.193 0.442 . . . . 75.43 112.193 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 85.4 m -64.84 -47.24 75.14 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.723 -0.656 . . . . 63.31 111.176 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 55.3 Cg_exo -57.34 -37.24 98.21 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.123 1.882 . . . . 72.24 113.023 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.09 -37.97 81.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.787 0.835 . . . . 74.33 111.348 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.42 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.2 mm -73.23 -46.78 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.242 0.617 . . . . 75.31 110.92 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.92 -20.56 49.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.552 -0.749 . . . . 73.34 112.298 -172.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -58.56 -51.86 78.77 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.747 -1.121 . . . . 72.45 113.192 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.71 -38.57 95.37 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.036 1.824 . . . . 74.21 113.518 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -69.16 -42.64 75.63 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.322 0.649 . . . . 75.52 111.517 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.72 99.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.255 0.622 . . . . 74.33 109.637 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.447 ' NH2' ' HB3' ' C' ' 127' ' ' ASN . 41.1 ttt180 -58.43 -53.88 53.34 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.924 1.69 . . . . 75.24 111.469 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.57 -34.77 78.64 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.579 0.549 . . . . 73.21 110.321 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.56 -32.91 73.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.034 0.534 . . . . 70.33 111.128 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' C' ' 62' ' ' VAL . 78.6 mt -71.52 -53.64 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.777 -0.647 . . . . 74.32 109.869 174.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.2 m -63.05 -28.87 70.38 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.258 0.623 . . . . 72.12 111.693 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.5 t -64.42 -51.51 62.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.498 0.719 . . . . 72.02 109.424 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.21 -38.9 81.05 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.325 1.05 . . . . 74.24 112.213 178.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -60.7 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.561 0.744 . . . . 73.1 109.749 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 41.1 t -67.08 -35.36 79.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.671 0.789 . . . . 73.31 112.083 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 116' ' ' SER . 82.0 mtt-85 -69.3 -31.84 70.6 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.432 0.693 . . . . 75.34 110.551 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.61 12.18 70.08 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.559 0.537 . . . . 71.41 113.073 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.479 HG21 ' HB3' ' D' ' 17' ' ' TYR . 6.9 p 64.84 20.88 12.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.652 1.981 . . . . 74.31 113.423 173.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -89.1 151.1 46.38 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.267 -0.642 . . . . 75.53 109.267 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.78 144.28 96.87 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.205 2.603 . . . . 75.42 113.282 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.457 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -51.08 111.07 0.5 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 71.51 111.415 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.11 85.71 2.16 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.332 -0.988 . . . . 74.14 108.332 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.447 ' HB3' ' NH2' ' C' ' 111' ' ' ARG . 17.5 m120 -91.6 109.32 20.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.47 -1.241 . . . . 73.45 108.427 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.65 135.08 57.29 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.263 0.977 . . . . 74.13 111.929 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.24 157.85 88.93 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.281 1.032 . . . . 65.12 110.345 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.54 105.49 0.76 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.389 2.059 . . . . 74.45 112.171 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.59 107.85 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.488 -1.301 . . . . 74.31 107.488 171.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -105.72 93.91 4.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.432 -0.803 . . . . 73.21 110.004 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -63.7 -41.84 98.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.117 -0.697 . . . . 73.22 109.117 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.416 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.9 p-10 . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 124.959 1.304 . . . . 74.44 111.822 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 95.1 m . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.113 0.483 . . . . 75.0 110.381 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.8 t80 -138.98 122.56 17.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.053 -1.462 . . . . 72.05 107.053 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.5 130.52 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.446 -0.576 . . . . 64.22 109.446 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.88 125.79 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.67 -1.233 . . . . 74.43 107.67 168.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -99.06 -43.6 6.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.766 0.426 . . . . 71.4 110.259 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -179.69 141.0 0.15 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.827 0.851 . . . . 72.35 110.627 179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.95 141.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.15 -1.055 . . . . 74.01 108.15 171.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.479 ' HB3' HG21 ' C' ' 122' ' ' THR . 27.1 p90 -156.55 173.39 16.99 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.847 0.832 . . . . 74.31 111.2 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -104.81 119.62 39.45 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.437 -1.256 . . . . 74.01 109.111 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -90.52 -26.87 19.54 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.279 -0.419 . . . . 72.33 110.42 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -159.71 110.72 1.97 Allowed 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.792 0.682 . . . . 72.24 109.278 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE1' ' C' ' 117' ' ' MET . 69.0 mt -111.27 149.44 14.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.708 -0.849 . . . . 74.04 108.708 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -148.82 142.29 25.3 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.955 0.902 . . . . 74.42 109.82 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.0 t80 -152.55 120.08 6.01 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 106.406 -1.702 . . . . 52.35 106.406 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.32 120.28 26.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.499 0.72 . . . . 73.02 109.269 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.97 85.01 4.75 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.01 -1.107 . . . . 74.13 108.01 171.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.29 -28.68 8.49 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.114 2.543 . . . . 75.53 113.502 -167.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 14.5 m-80 -115.05 28.61 8.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.206 -0.664 . . . . 74.34 109.206 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.85 -66.1 0.47 Allowed Pre-proline 0 CA--C 1.566 1.569 0 N-CA-C 114.992 1.478 . . . . 73.13 114.992 -165.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' C' ' 83' ' ' ILE . 78.7 Cg_endo -77.22 -15.22 16.22 Favored 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.566 1.952 . . . . 75.42 113.199 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.432 ' HA ' HE21 ' D' ' 33' ' ' GLN . 19.5 t-160 -70.23 -38.87 75.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 74.12 109.609 174.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.61 -39.82 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.266 1.026 . . . . 75.22 110.66 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -75.85 -3.77 37.01 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.754 -1.112 . . . . 73.12 113.764 -168.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' D' ' 30' ' ' HIS . 43.4 mt-30 -85.33 -6.88 59.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.774 0.83 . . . . 75.42 111.305 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -121.92 115.21 22.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.386 1.474 . . . . 73.23 108.093 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.83 93.94 8.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.556 0.743 . . . . 71.14 112.381 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -165.22 -179.19 5.47 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.951 0.9 . . . . 73.31 111.848 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.86 140.58 26.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.603 0.761 . . . . 74.42 111.935 -176.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.68 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 58.6 Cg_endo -75.03 156.13 42.83 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.019 2.479 . . . . 73.33 114.152 168.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -89.17 140.68 29.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.354 -1.294 . . . . 73.22 108.058 164.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -119.78 119.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.337 0.655 . . . . 74.43 110.778 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.43 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 61.7 tttt -98.74 137.15 37.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.93 0.892 . . . . 71.0 109.339 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.61 123.51 44.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.589 0.756 . . . . 64.22 109.789 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.618 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.2 m-20 -118.84 127.49 53.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.15 0.98 . . . . 75.04 108.541 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mp -109.06 138.17 45.83 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.251 -0.648 . . . . 73.33 109.251 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.1 t70 -150.49 152.94 34.98 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.536 0.735 . . . . 73.23 109.082 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 20.6 p -140.94 160.88 39.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.008 0.923 . . . . 74.45 110.393 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.95 167.82 29.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.006 0.922 . . . . 73.33 109.593 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 42.2 p -159.07 153.01 23.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.176 0.59 . . . . 75.14 109.799 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 92.6 p -151.9 149.08 28.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.281 -0.637 . . . . 74.42 109.281 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -89.01 118.35 28.68 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.35 -0.611 . . . . 70.51 109.35 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.6 mt -92.02 -36.7 13.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.021 0.529 . . . . 74.32 110.152 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.33 -179.75 8.22 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.294 -0.867 . . . . 71.43 109.955 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.41 125.85 28.83 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.987 -0.746 . . . . 63.54 108.987 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 65.82 14.84 9.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.374 1.07 . . . . 74.34 111.773 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 41.9 t -129.57 124.74 60.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 124.125 0.97 . . . . 75.31 109.145 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.61 ' HB2' HD13 ' D' ' 86' ' ' ILE . 62.7 m-85 -136.1 141.18 44.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.342 0.591 . . . . 73.55 109.805 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.583 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.6 tt0 -91.83 132.66 36.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.471 -1.24 . . . . 74.32 109.792 173.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.57 125.85 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 107.541 -1.281 . . . . 72.33 107.541 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 34.1 t -110.15 129.58 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.039 -0.726 . . . . 74.41 109.039 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.489 HD21 HD11 ' D' ' 106' ' ' LEU . 1.8 mm? -118.65 106.21 12.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.529 0.731 . . . . 73.51 109.599 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.7 ttm180 -88.39 102.03 14.47 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.622 -0.717 . . . . 74.42 109.443 177.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -91.74 121.18 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.786 -1.19 . . . . 74.23 107.786 170.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.4 m -127.0 146.07 50.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.602 0.761 . . . . 61.4 109.298 -175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.481 HG12 HD22 ' D' ' 126' ' ' LEU . 54.0 t -139.5 111.74 5.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.997 1.319 . . . . 65.02 109.038 -172.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.2 m -96.75 95.63 8.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.768 -0.827 . . . . 60.2 108.768 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.82 44.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.35 -0.611 . . . . 73.4 109.35 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.0 m -142.33 141.1 32.32 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.361 0.665 . . . . 74.15 110.778 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.68 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 0.3 OUTLIER -132.17 135.64 46.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.912 1.285 . . . . 64.05 110.17 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 -114.51 5.57 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.902 -0.879 . . . . 74.15 110.902 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.61 4.69 12.36 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.039 0.535 . . . . 73.52 110.418 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -127.36 161.84 27.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.074 0.55 . . . . 73.02 110.946 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -80.75 131.55 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.964 0.505 . . . . 73.35 111.469 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.49 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -72.68 -71.62 0.28 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.754 1.222 . . . . 74.14 108.379 173.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -153.93 140.32 18.68 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.746 -0.661 . . . . 73.25 111.033 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.37 110.2 22.17 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.272 -1.381 . . . . 65.25 107.272 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 48.2 t -119.0 132.89 56.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.478 -0.564 . . . . 74.51 109.478 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -152.08 132.13 13.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.14 0.576 . . . . 61.23 110.249 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.71 117.35 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.356 0.663 . . . . 73.1 109.669 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -87.28 87.33 7.4 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.852 -1.166 . . . . 73.51 107.852 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.33 91.17 5.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.289 -0.869 . . . . 71.42 108.796 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.94 143.61 17.61 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.071 -0.811 . . . . 53.14 111.071 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.92 132.13 5.08 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 111.209 -0.756 . . . . 72.12 111.209 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.509 HG22 HD13 ' D' ' 51' ' ' LEU . 49.1 mt -88.19 124.37 41.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 108.407 -0.96 . . . . 73.23 108.407 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -129.48 160.77 32.13 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.26 0.552 . . . . 74.1 110.112 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 35.5 m -104.9 117.19 33.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.992 -1.114 . . . . 74.51 107.992 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.4 mp -118.15 108.76 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.197 -0.668 . . . . 75.35 109.197 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.32 160.82 41.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.037 0.935 . . . . 74.01 110.014 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.01 -4.13 62.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.728 -0.669 . . . . 73.41 113.904 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.439 HD12 HG21 ' D' ' 86' ' ' ILE . 15.0 pt -126.65 142.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.123 0.969 . . . . 73.14 109.696 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.8 167.21 22.68 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.43 0.692 . . . . 74.34 110.114 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.17 -122.7 27.1 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 124.605 1.191 . . . . 72.05 114.606 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 m -66.27 -44.38 83.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.162 0.985 . . . . 72.44 112.128 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.69 -38.33 88.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.027 0.531 . . . . 70.43 110.873 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.67 -0.695 . . . . 72.44 110.199 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -28.7 67.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.748 0.819 . . . . 71.32 111.767 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -78.69 -30.64 46.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.745 . . . . 74.12 110.513 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -76.61 -50.86 12.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.295 0.569 . . . . 72.23 110.071 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.591 HD11 HG12 ' D' ' 86' ' ' ILE . 6.3 tt -81.96 -23.28 36.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.654 -0.703 . . . . 65.24 111.124 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.18 57.09 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.447 -0.641 . . . . 61.1 114.145 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.01 -53.96 0.48 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.868 0.834 . . . . 73.55 111.782 -177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -73.89 -54.32 8.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 72.51 110.978 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 61.2 m -59.25 -44.95 99.14 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 113.895 1.072 . . . . 74.22 113.895 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.72 -35.49 94.51 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 121.915 1.743 . . . . 71.12 112.794 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -80.78 -7.57 59.43 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.518 0.727 . . . . 70.23 111.415 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.71 -37.38 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.491 0.662 . . . . 74.44 109.747 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.489 HD11 HD21 ' D' ' 60' ' ' LEU . 50.9 mt -81.79 -32.02 31.55 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.129 -0.941 . . . . 74.25 111.409 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.54 -44.21 98.84 Favored Pre-proline 0 CA--C 1.572 1.805 0 N-CA-C 114.195 1.183 . . . . 63.41 114.195 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.56 -39.99 78.09 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.317 2.011 . . . . 72.11 113.421 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -74.9 -33.61 62.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.295 0.638 . . . . 72.44 110.97 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.35 88.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.217 0.607 . . . . 72.35 109.994 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.4 ttp180 -59.42 -52.19 66.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 114.412 -1.267 . . . . 73.33 110.754 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.72 -45.34 94.39 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.176 0.923 . . . . 74.23 110.925 -175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.3 -41.47 84.51 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.761 0.663 . . . . 75.43 110.953 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.568 HG22 ' SG ' ' D' ' 76' ' ' CYS . 47.6 mt -63.29 -55.66 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.612 -0.722 . . . . 74.52 110.39 174.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -53.49 -39.68 64.76 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.337 1.055 . . . . 64.43 111.47 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 20.6 t -65.95 -45.91 80.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.987 -1.006 . . . . 74.22 110.501 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.583 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.9 mtm -67.39 -35.89 80.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.967 0.507 . . . . 74.11 111.776 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.7 t -64.04 -43.59 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 123.838 0.711 . . . . 75.14 109.399 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.0 p -71.62 -29.32 64.53 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.007 0.523 . . . . 73.51 111.87 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' D' ' 116' ' ' SER . 86.3 mtt-85 -72.86 -34.28 66.64 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.574 0.75 . . . . 74.21 110.473 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 9.01 63.96 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.759 0.662 . . . . 74.44 112.202 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.4 p 62.14 18.7 10.29 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.935 2.094 . . . . 64.35 113.544 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -83.34 165.46 40.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 107.557 -1.275 . . . . 75.05 107.557 162.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -84.05 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.284 1.989 . . . . 74.15 113.549 -165.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -74.44 120.57 20.18 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 122.442 0.297 . . . . 74.1 110.891 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.481 HD22 HG12 ' D' ' 64' ' ' VAL . 63.1 tp -116.51 95.0 4.85 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 72.15 108.184 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.27 104.26 13.61 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.508 -0.923 . . . . 71.23 108.508 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.485 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.5 mm? -62.99 113.87 3.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.607 0.763 . . . . 75.12 109.372 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.16 137.12 97.02 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 122.946 0.499 . . . . 74.32 110.477 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.3 131.63 28.92 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.939 2.426 . . . . 72.45 112.273 -173.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 65.1 t -109.28 130.92 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.23 0.612 . . . . 73.34 109.788 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -86.6 85.51 7.3 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.428 -0.953 . . . . 71.54 108.428 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 . . . . . 0 N--CA 1.484 1.272 0 CA-C-N 115.377 -0.829 . . . . 72.43 111.185 177.27 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.442 -0.577 . . . . 71.42 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.456 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 27.2 t80 -137.81 126.13 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.214 1.005 . . . . 71.24 108.712 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -151.06 128.51 11.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.307 0.643 . . . . 72.03 109.502 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.482 ' CD1' HG21 ' A' ' 105' ' ' ILE . 56.4 mt -85.12 129.03 38.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 120.921 0.391 . . . . 73.15 109.955 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -88.6 -42.71 11.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.108 -0.951 . . . . 74.41 110.255 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.422 ' HB3' HD13 ' A' ' 83' ' ' ILE . 60.1 ttt180 -169.83 140.75 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.314 -0.403 . . . . 74.2 110.714 -170.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.81 137.95 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.221 -1.029 . . . . 74.34 108.221 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.526 ' HB3' HG23 ' B' ' 122' ' ' THR . 7.2 p90 -168.23 143.58 3.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.388 0.675 . . . . 73.44 110.463 -171.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -76.59 111.01 11.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.735 -0.839 . . . . 75.32 108.735 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 40.4 mtpt -77.27 -25.28 51.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.969 0.508 . . . . 74.03 110.565 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.24 146.71 24.94 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.941 -1.027 . . . . 72.42 109.895 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' B' ' 117' ' ' MET . 47.4 mt -140.24 145.2 26.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 125.06 1.344 . . . . 62.34 107.498 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 36.5 t -154.7 138.39 16.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.634 0.774 . . . . 72.13 109.103 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -143.58 131.63 21.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.565 -1.643 . . . . 75.42 106.565 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -134.51 128.81 34.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.006 -0.739 . . . . 74.14 109.006 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 78.65 72.94 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 107.33 -1.359 . . . . 73.44 107.33 171.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.73 -26.07 19.75 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.68 2.253 . . . . 70.24 112.055 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -109.39 24.22 13.38 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.773 0.829 . . . . 62.35 109.019 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.21 -61.17 2.48 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 117.879 -1.057 . . . . 70.22 112.595 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.7 Cg_exo -63.21 -24.3 72.5 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 122.28 1.987 . . . . 73.15 113.008 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -77.95 -47.37 18.75 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.673 0.789 . . . . 73.24 110.442 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -73.9 -20.02 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 CA-C-N 115.16 -0.927 . . . . 75.12 110.949 -163.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.9 -19.22 62.62 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.354 1.062 . . . . 75.41 112.765 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -102.53 -10.28 19.47 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.696 0.398 . . . . 71.13 111.979 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HZ2' ' HG2' ' A' ' 71' ' ' GLU . 36.6 mtpt -82.12 167.63 18.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.875 0.47 . . . . 74.44 112.248 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -61.53 141.33 57.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.457 1.103 . . . . 71.34 111.933 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -91.87 64.08 4.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.07 0.548 . . . . 74.12 110.68 -172.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -127.07 73.68 76.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.393 0.677 . . . . 75.54 110.054 175.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -89.72 118.44 0.78 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.619 2.213 . . . . 74.45 112.187 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.73 101.1 12.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.901 -1.518 . . . . 74.54 106.901 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.3 t -76.46 114.89 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.355 -0.839 . . . . 72.21 110.133 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.35 134.41 35.57 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.355 0.662 . . . . 74.21 109.565 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.2 mt -103.28 108.61 19.9 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.527 -0.916 . . . . 74.34 108.527 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -104.26 113.9 27.77 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.004 0.922 . . . . 71.32 108.735 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.48 135.87 39.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.312 0.645 . . . . 73.2 109.586 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.57 134.44 30.56 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.397 -0.964 . . . . 75.03 108.397 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.477 HG23 HD23 ' A' ' 60' ' ' LEU . 11.5 m -148.63 140.57 23.84 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.64 0.376 . . . . 74.32 110.092 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.06 135.07 13.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.369 0.668 . . . . 74.31 110.644 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -96.45 164.09 12.77 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.859 0.864 . . . . 64.42 111.013 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -162.09 119.99 2.2 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.45 1.1 . . . . 73.32 108.752 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.39 118.69 18.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.958 -0.386 . . . . 74.33 109.958 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -89.25 -33.1 17.1 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.487 0.715 . . . . 75.13 111.137 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.53 -174.07 4.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.414 0.686 . . . . 72.35 110.765 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.24 116.66 5.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.425 0.69 . . . . 72.12 110.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 66.16 -0.14 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.403 1.481 . . . . 72.12 113.091 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.91 106.57 19.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.334 -0.987 . . . . 74.35 108.334 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -119.57 124.04 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.801 -1.185 . . . . 74.2 107.801 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -88.77 136.16 33.15 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.563 1.145 . . . . 71.42 108.532 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.478 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 99.0 t -122.76 125.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.644 -1.243 . . . . 74.02 107.644 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.517 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.6 t -104.97 128.02 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.023 0.529 . . . . 74.12 109.875 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.707 HD22 HD11 ' A' ' 106' ' ' LEU . 3.9 mm? -106.28 98.17 7.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 73.42 108.906 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 17.2 ttp180 -87.18 100.88 12.99 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.651 -0.87 . . . . 73.14 108.651 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.554 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.5 t -93.64 122.66 45.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.999 -1.482 . . . . 72.33 106.999 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.3 m -116.35 121.38 41.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.531 0.681 . . . . 74.45 109.281 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 t -111.18 109.84 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.95 1.3 . . . . 74.23 108.672 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.7 m -103.56 140.07 38.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 108.31 -0.996 . . . . 73.2 108.31 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.16 121.22 37.33 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.182 -0.673 . . . . 71.2 109.182 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -122.73 124.82 44.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.245 0.545 . . . . 60.51 110.768 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 5.1 mp -88.81 77.08 7.87 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.351 1.46 . . . . 71.43 107.578 173.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.01 -86.78 0.88 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.865 -1.061 . . . . 74.11 111.15 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -113.9 -27.89 7.58 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.882 0.873 . . . . 55.55 110.65 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' HZ2' ' A' ' 34' ' ' LYS . 8.0 tp10 -86.07 133.71 33.87 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.351 0.66 . . . . 75.32 111.042 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.4 m -78.26 147.24 34.43 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.127 0.421 . . . . 74.32 110.526 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -96.8 -63.25 1.15 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.971 0.908 . . . . 71.44 108.964 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -151.6 163.86 38.15 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.154 -1.384 . . . . 74.4 110.548 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.7 tp -132.89 121.26 22.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.498 1.119 . . . . 74.13 108.461 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.2 m -105.79 141.03 37.92 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.603 1.161 . . . . 55.21 108.719 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.4 tt0 -146.66 115.35 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.091 -1.077 . . . . 74.33 108.091 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 113' ' ' CYS . 46.4 t -131.32 109.96 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.102 -0.703 . . . . 75.31 109.102 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.453 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 64.5 mt-30 -87.7 81.79 7.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.3 -0.864 . . . . 74.13 109.086 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -75.87 93.11 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.108 -0.951 . . . . 74.14 108.633 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.55 145.4 21.92 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.317 -0.713 . . . . 70.15 111.317 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.07 142.82 12.15 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.539 -1.024 . . . . 64.15 110.539 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' A' ' 15' ' ' ARG . 54.8 mt -106.9 126.41 62.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.578 -0.897 . . . . 74.43 108.578 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.478 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 14.5 m-85 -131.45 117.43 18.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.393 0.677 . . . . 73.33 109.199 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 t -78.55 90.63 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.889 0.876 . . . . 52.23 108.661 168.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.5 pt -106.44 143.94 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.654 0.782 . . . . 70.01 110.286 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.22 154.88 28.0 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.809 0.844 . . . . 62.31 109.544 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.66 5.37 88.27 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 115.155 0.822 . . . . 74.24 115.155 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.494 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.6 134.51 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.392 -0.966 . . . . 74.35 108.392 174.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -142.47 171.93 13.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.227 1.011 . . . . 70.23 108.946 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.06 -120.18 14.27 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.459 0.543 . . . . 61.3 114.459 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -80.21 -24.17 40.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.01 0.924 . . . . 74.31 111.593 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -36.91 75.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.348 0.659 . . . . 74.24 109.949 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 52.1 ttp -65.98 -43.06 88.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.915 0.886 . . . . 74.53 110.193 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.93 82.39 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.347 -0.842 . . . . 73.15 111.426 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.731 0.813 . . . . 72.41 110.763 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.46 -49.56 68.67 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.01 0.524 . . . . 55.43 110.836 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 mt -85.03 -32.2 23.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.037 -0.529 . . . . 74.22 111.512 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.58 -1.88 63.69 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 114.823 0.689 . . . . 74.25 114.823 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.75 -54.65 0.19 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.998 0.899 . . . . 62.52 112.445 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -71.31 -64.4 0.92 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.318 1.047 . . . . 72.04 112.629 -167.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.462 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.9 m -70.37 -34.25 3.84 Favored Pre-proline 0 CA--C 1.574 1.87 0 N-CA-C 113.933 1.086 . . . . 65.33 113.933 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.592 ' HB3' HD21 ' A' ' 60' ' ' LEU . 26.2 Cg_endo -64.03 -31.53 65.8 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.249 1.966 . . . . 71.32 113.319 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -62.05 -34.93 77.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.246 0.618 . . . . 73.3 109.666 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.482 HG21 ' CD1' ' A' ' 13' ' ' ILE . 45.6 mm -60.03 -47.3 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.855 0.862 . . . . 73.44 110.603 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.707 HD11 HD22 ' A' ' 60' ' ' LEU . 98.4 mt -76.27 -25.62 55.1 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.454 -0.793 . . . . 71.13 112.091 -171.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.16 -44.58 98.74 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.003 1.112 . . . . 62.33 114.003 -170.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.92 -33.98 95.48 Favored 'Trans proline' 0 C--N 1.392 2.818 0 C-N-CA 122.117 1.878 . . . . 64.54 113.7 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.16 -35.27 56.12 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 75.51 110.98 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.27 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.504 -0.554 . . . . 73.03 109.504 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.475 ' NH1' HG21 ' C' ' 105' ' ' ILE . 38.1 ttm180 -54.28 -53.91 47.35 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 124.663 1.227 . . . . 74.54 110.116 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.48 -43.4 98.92 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.542 1.151 . . . . 75.42 110.98 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.503 ' HB3' HG12 ' A' ' 78' ' ' VAL . 48.0 t -60.15 -40.51 90.11 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.581 0.551 . . . . 61.33 111.002 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.576 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 94.7 mt -65.49 -54.76 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.901 0.751 . . . . 75.32 109.669 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.5 m -53.17 -39.06 63.31 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.936 1.397 . . . . 74.31 111.343 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.8 t -65.94 -47.63 74.05 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.546 -1.206 . . . . 64.42 109.257 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.576 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 44.4 mtm -61.85 -42.94 99.65 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.194 0.598 . . . . 73.31 111.066 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.9 t -56.21 -50.48 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 124.388 1.055 . . . . 75.04 109.957 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -72.0 -32.29 67.06 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.222 -0.899 . . . . 74.25 111.588 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 61.6 mtt-85 -72.16 -27.43 62.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.5 0.72 . . . . 75.03 110.036 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.67 12.36 56.67 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.749 -0.659 . . . . 73.52 113.182 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.5 p 57.99 17.77 4.63 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.808 2.043 . . . . 62.22 113.393 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.28 145.75 49.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.245 -1.391 . . . . 73.43 107.245 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 141.74 80.89 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.494 2.129 . . . . 74.45 111.149 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -48.03 123.16 5.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.619 1.199 . . . . 72.32 111.336 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.47 118.94 38.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.256 0.622 . . . . 73.41 109.387 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -115.48 114.85 25.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.153 -0.684 . . . . 71.31 109.153 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.63 122.09 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.644 0.778 . . . . 74.05 109.939 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.12 132.28 95.25 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 109.276 -0.639 . . . . 64.13 109.276 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.642 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 4.3 Cg_endo -76.72 113.49 3.66 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.119 1.879 . . . . 74.33 110.569 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -98.99 123.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.713 -1.217 . . . . 62.43 107.713 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -76.72 89.98 3.41 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.425 -0.954 . . . . 75.31 108.425 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -62.66 -31.91 72.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.881 0.873 . . . . 73.21 110.902 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 N--CA 1.472 0.656 0 C-N-CA 123.672 0.789 . . . . 64.03 110.566 175.564 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.8 m . . . . . 0 C--O 1.233 0.212 0 N-CA-C 108.295 -1.002 . . . . 74.1 108.295 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.424 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 56.6 t80 -127.68 112.61 15.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.736 -1.209 . . . . 74.33 107.736 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.423 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -131.83 135.29 46.61 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.008 -1.108 . . . . 75.15 108.008 -178.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.421 HD13 ' O ' ' B' ' 13' ' ' ILE . 2.4 pp -94.99 130.52 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.397 0.679 . . . . 74.31 110.277 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -99.12 -50.83 4.02 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.807 -0.558 . . . . 63.34 110.06 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.464 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 41.8 ttt180 -162.59 134.23 5.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.998 -0.546 . . . . 74.3 110.452 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -113.91 142.55 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.71 -1.589 . . . . 72.13 106.71 172.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -168.9 149.35 4.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.615 0.643 . . . . 73.04 112.733 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 37.9 m -79.71 120.1 23.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.345 -0.843 . . . . 72.53 109.529 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.558 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 9.3 mtpt -89.14 -28.88 19.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.4 0.68 . . . . 74.45 110.835 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.7 136.92 14.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.846 -0.616 . . . . 72.24 110.406 -169.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.696 HD11 ' SG ' ' B' ' 113' ' ' CYS . 31.2 mm -124.99 148.88 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.398 1.079 . . . . 75.25 108.155 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.7 t -154.15 141.37 19.51 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.789 -0.641 . . . . 71.51 109.576 170.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -152.71 109.0 3.39 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.26 -1.385 . . . . 72.12 107.26 171.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -118.08 111.53 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.456 -1.313 . . . . 74.53 107.456 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.79 88.23 6.42 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 108.313 -0.995 . . . . 54.42 108.313 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.74 -24.33 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.095 2.53 . . . . 61.34 111.938 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -121.6 24.14 9.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.936 0.895 . . . . 73.25 110.391 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.468 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.69 -54.41 6.74 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 124.788 1.235 . . . . 74.31 114.16 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.9 Cg_endo -66.17 -32.93 41.74 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.317 2.011 . . . . 74.3 113.157 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -94.42 -15.5 24.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.877 0.695 . . . . 75.22 112.877 -169.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.64 -23.25 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.743 1.217 . . . . 71.42 113.682 -169.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -66.57 -21.72 66.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.122 0.969 . . . . 73.23 112.149 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.403 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.6 pt20 -61.98 -29.06 70.0 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.879 0.472 . . . . 63.23 110.619 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.403 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 32.8 mmtp -105.1 67.65 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.536 -1.283 . . . . 74.04 107.536 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.02 79.5 6.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.546 0.738 . . . . 73.0 111.93 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 164.79 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.899 2.079 . . . . 71.33 110.647 160.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.2 126.25 67.2 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.553 1.141 . . . . 72.21 112.335 -170.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.71 176.15 9.33 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.752 2.301 . . . . 75.31 111.597 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.04 104.22 7.4 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.11 -1.441 . . . . 74.24 107.11 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.46 154.91 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.503 0.721 . . . . 70.02 109.197 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -147.18 138.7 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.813 0.845 . . . . 75.35 109.801 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.643 HD22 HD12 ' B' ' 128' ' ' LEU . 5.5 mp -85.4 141.11 30.21 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.052 -1.092 . . . . 75.14 108.052 165.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.8 t70 -141.18 109.99 6.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.35 -1.352 . . . . 72.13 107.35 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.33 131.6 48.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.846 0.458 . . . . 75.33 109.886 -173.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.3 135.41 54.73 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.968 1.307 . . . . 72.54 107.895 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -109.97 145.87 36.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.385 0.674 . . . . 73.1 110.195 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.4 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -154.83 148.3 25.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 71.14 109.282 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.2 m -144.69 167.89 21.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.365 0.666 . . . . 73.55 110.784 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -157.63 154.17 27.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.161 0.985 . . . . 74.53 109.599 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -102.85 130.5 49.89 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.974 -0.75 . . . . 74.43 108.974 171.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 67.2 mt -97.74 -38.05 9.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.194 0.597 . . . . 71.4 110.459 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.7 -171.95 2.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.437 0.695 . . . . 73.52 110.808 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.7 114.48 4.47 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.631 -1.168 . . . . 71.42 110.123 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 72.08 -3.81 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.691 1.597 . . . . 73.22 112.589 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.08 110.74 31.22 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 N-CA-C 107.859 -1.163 . . . . 75.41 107.859 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -122.11 173.24 7.69 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.038 -0.727 . . . . 74.25 109.038 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -142.87 109.98 5.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.022 -1.103 . . . . 71.43 108.022 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -101.65 134.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.331 1.052 . . . . 73.45 109.965 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 22.9 t -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.532 1.133 . . . . 74.32 109.059 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.44 112.32 17.39 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.931 -0.766 . . . . 74.15 108.931 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.756 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 28.0 ttm180 -89.92 124.93 35.14 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.607 0.763 . . . . 72.53 109.62 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -111.61 126.56 69.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.76 -1.2 . . . . 73.44 107.76 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.4 m -121.11 122.1 39.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.775 0.798 . . . . 70.25 109.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.636 HG13 HD23 ' B' ' 126' ' ' LEU . 87.8 t -102.05 95.99 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.29 1.436 . . . . 63.3 108.331 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 24.7 m -85.48 137.06 33.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.749 -0.834 . . . . 75.53 108.749 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.99 127.3 13.04 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.652 -0.499 . . . . 73.0 109.652 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 64.3 p -145.89 144.72 30.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.203 0.601 . . . . 63.24 110.809 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.583 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -133.54 102.31 5.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 72.32 109.406 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.73 -132.97 11.43 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.949 -0.569 . . . . 53.23 112.594 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.81 8.77 24.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.172 0.589 . . . . 63.14 110.744 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.19 154.68 49.13 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.522 0.729 . . . . 74.52 110.675 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' THR . . . . . 0.4 HG21 ' HG ' ' B' ' 75' ' ' LEU . 66.4 m -83.79 138.67 33.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.301 0.64 . . . . 62.23 110.273 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -76.61 -60.24 2.43 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.894 0.878 . . . . 70.0 108.974 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -165.69 153.01 10.36 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 113.656 -1.611 . . . . 73.03 109.054 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.4 ' HG ' HG21 ' B' ' 72' ' ' THR . 94.8 mt -124.1 112.78 17.52 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.562 -1.273 . . . . 75.21 107.562 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.425 ' SG ' HG22 ' B' ' 114' ' ' ILE . 35.8 t -115.98 143.43 45.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.776 -1.194 . . . . 72.32 107.776 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.4 tt0 -157.26 124.2 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 -173.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.481 HG12 HD12 ' B' ' 21' ' ' ILE . 95.4 t -129.78 142.02 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.215 0.606 . . . . 74.44 109.574 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.756 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 42.1 mt-30 -108.1 114.58 28.58 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.739 -1.208 . . . . 74.43 107.739 166.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' B' ' 106' ' ' LEU . 8.4 tp-100 -103.11 110.86 22.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.297 -1.001 . . . . 70.14 108.297 172.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.558 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.96 166.9 19.32 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.682 0.613 . . . . 65.22 111.719 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.84 127.56 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.446 -0.661 . . . . 72.24 111.446 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.17 125.05 40.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.605 0.762 . . . . 71.1 109.066 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.69 132.56 42.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.227 1.011 . . . . 74.33 108.959 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 49.6 m -96.59 97.98 9.83 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.732 0.813 . . . . 62.31 108.908 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.416 HG22 ' SG ' ' B' ' 97' ' ' CYS . 30.1 pt -116.06 132.9 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.398 0.679 . . . . 65.35 110.09 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.24 172.86 16.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.004 0.922 . . . . 63.35 110.605 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -62.46 1.04 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.045 -0.525 . . . . 54.02 112.346 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -90.48 170.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.915 0.886 . . . . 74.34 111.126 -179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.58 171.91 16.36 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.19 0.596 . . . . 72.54 111.089 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.28 42.91 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.121 -0.945 . . . . 74.1 113.286 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -70.73 -28.06 64.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.139 0.976 . . . . 75.5 111.689 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.82 -37.93 89.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.221 0.608 . . . . 75.44 109.822 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.462 ' HG2' HD22 ' B' ' 98' ' ' LEU . 22.9 ttt -80.32 -33.99 37.09 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 73.43 110.133 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -28.07 69.51 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.922 0.889 . . . . 62.53 111.814 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -62.0 -43.31 99.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.602 0.761 . . . . 72.51 110.247 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . 0.416 ' SG ' HG22 ' B' ' 86' ' ' ILE . 53.4 t -70.72 -64.04 0.98 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.577 -0.738 . . . . 72.03 110.81 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.462 HD22 ' HG2' ' B' ' 94' ' ' MET . 4.5 pp -71.04 -30.84 67.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.569 0.747 . . . . 72.43 112.496 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -33.67 11.13 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.575 0.547 . . . . 74.41 113.264 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.88 -67.17 1.02 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.887 0.475 . . . . 63.14 111.33 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -60.18 -46.76 88.61 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.586 0.754 . . . . 73.23 112.898 -172.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.476 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.7 m -63.86 -51.41 64.63 Favored Pre-proline 0 CA--C 1.569 1.678 0 C-N-CA 123.932 0.893 . . . . 75.15 112.292 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.3 Cg_exo -58.94 -30.12 92.33 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.659 2.239 . . . . 75.24 113.733 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -27.98 62.78 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.301 0.64 . . . . 71.1 111.437 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.48 -40.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.543 0.737 . . . . 73.13 109.902 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' B' ' 80' ' ' GLN . 86.4 mt -75.39 -29.34 59.81 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.943 -1.026 . . . . 73.22 111.709 -173.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -55.52 -47.55 98.39 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-O 117.66 -1.162 . . . . 73.43 113.782 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.58 -43.36 33.74 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.131 2.554 . . . . 74.44 114.622 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' D' ' 115' ' ' THR . 81.4 m-85 -70.6 -42.58 70.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.382 0.673 . . . . 72.2 110.325 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.54 -32.17 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.702 -0.681 . . . . 72.41 110.888 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.76 -58.09 10.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.292 1.037 . . . . 73.25 110.482 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.533 0.52 . . . . 75.21 109.878 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.696 ' SG ' HD11 ' B' ' 21' ' ' ILE . 0.0 OUTLIER -67.4 -40.13 85.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.232 0.613 . . . . 74.52 110.776 177.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.587 HG21 HG22 ' B' ' 64' ' ' VAL . 78.5 mt -67.37 -54.3 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 75.24 109.868 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -60.15 -33.0 71.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.222 1.009 . . . . 71.13 111.55 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -60.69 -49.79 76.11 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.47 0.708 . . . . 64.12 110.124 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.7 mmt -71.26 -34.89 71.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.57 0.748 . . . . 75.25 111.584 -172.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.502 HG22 HD21 ' B' ' 126' ' ' LEU . 97.0 t -66.33 -40.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 75.33 110.153 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.6 t -68.67 -28.13 66.6 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.288 -0.869 . . . . 74.31 111.024 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 88.9 mtt-85 -72.64 -25.11 61.17 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.187 0.595 . . . . 74.43 110.753 176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.23 13.8 43.2 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 123.346 0.404 . . . . 74.11 112.557 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.6 p 61.45 31.48 19.05 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 126.903 2.081 . . . . 74.22 112.227 176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -95.79 148.36 34.44 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 115.575 -0.739 . . . . 75.23 110.175 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.76 -171.23 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.597 2.865 . . . . 73.33 114.252 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 17.7 tp60 -59.13 113.44 2.12 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.385 -1.279 . . . . 72.23 112.011 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.636 HD23 HG13 ' B' ' 64' ' ' VAL . 66.5 tp -111.09 100.58 9.23 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.614 -0.884 . . . . 63.2 108.614 171.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.21 123.26 41.82 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.95 0.9 . . . . 75.22 109.875 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.643 HD12 HD22 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -87.28 144.33 26.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.789 0.836 . . . . 73.43 109.011 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . 0.4 ' N ' HD13 ' B' ' 128' ' ' LEU . . . -64.61 143.36 98.63 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.34 1.056 . . . . 72.1 111.568 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.05 90.53 1.08 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.797 2.331 . . . . 75.33 111.311 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.7 t -91.33 111.33 23.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.983 -0.747 . . . . 64.44 108.983 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -93.01 91.97 7.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.568 -0.901 . . . . 73.12 108.568 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 123.764 0.826 . . . . 74.13 111.319 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 121.461 0.648 . . . . 72.43 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 63.6 m -103.76 92.8 4.58 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.826 -1.175 . . . . 75.54 107.826 166.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.481 ' CE1' ' SG ' ' C' ' 102' ' ' CYS . 87.8 t80 -112.43 132.66 54.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.248 -1.019 . . . . 74.21 108.248 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -147.35 144.59 28.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.034 0.445 . . . . 75.02 111.209 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.432 HG23 ' HE2' ' C' ' 84' ' ' PHE . 2.3 pp -93.7 139.76 17.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.09 -0.959 . . . . 74.25 108.451 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -110.55 -51.09 2.9 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.863 -0.421 . . . . 72.41 109.863 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -166.79 128.86 1.75 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.777 -0.647 . . . . 72.12 110.312 -170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.55 143.05 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 106.838 -1.541 . . . . 75.54 106.838 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.422 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.2 p90 -174.34 158.67 2.95 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.575 0.625 . . . . 74.44 111.291 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -81.29 119.26 23.43 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.09 -0.708 . . . . 74.23 109.09 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 11.7 mmmm -73.39 -42.0 62.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 169.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 32.3 t70 -143.95 142.33 30.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.777 -1.101 . . . . 61.44 110.526 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -139.74 143.65 30.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.521 1.528 . . . . 75.4 107.2 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 30.8 t -158.76 151.38 21.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.275 0.559 . . . . 73.44 110.283 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -150.41 125.66 10.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.767 -1.198 . . . . 74.42 107.767 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 45.0 mt-10 -118.26 140.53 49.67 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.291 0.636 . . . . 60.31 110.215 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.59 77.65 22.61 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.787 -1.56 . . . . 75.33 106.787 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.94 -32.78 65.3 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.064 2.51 . . . . 74.45 112.467 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.692 ' HB2' ' HB3' ' C' ' 30' ' ' HIS . 9.2 p30 -112.22 45.49 1.27 Allowed 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.815 0.846 . . . . 74.54 109.677 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' D' ' 19' ' ' LYS . . . -53.31 -41.34 85.94 Favored Pre-proline 0 CA--C 1.577 1.995 0 N-CA-C 114.697 1.369 . . . . 65.34 114.697 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.7 -37.9 1.1 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 121.744 1.63 . . . . 70.32 112.97 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.692 ' HB3' ' HB2' ' C' ' 27' ' ' ASN . 75.5 t60 -69.19 -21.9 63.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.317 1.047 . . . . 74.14 112.338 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.69 -13.84 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.667 0.787 . . . . 74.43 112.566 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.55 -15.45 60.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.563 -0.71 . . . . 71.15 112.301 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -109.1 21.67 16.88 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.578 0.751 . . . . 71.33 110.355 172.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.603 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -82.69 136.96 34.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.223 1.009 . . . . 75.15 109.028 175.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.17 123.56 19.41 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.058 -0.719 . . . . 71.11 109.058 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -85.16 58.94 5.32 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.55 0.34 . . . . 73.51 111.04 -173.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -156.51 53.91 0.81 Allowed Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 124.367 1.067 . . . . 71.13 109.448 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.08 153.3 36.68 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.927 1.751 . . . . 71.11 112.208 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -84.29 115.59 22.56 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.362 -1.347 . . . . 75.53 107.362 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.24 133.82 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.505 -0.554 . . . . 74.52 109.505 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -123.57 112.13 17.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.205 1.002 . . . . 74.01 108.416 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.406 HD23 HD22 ' C' ' 128' ' ' LEU . 8.4 mp -86.06 133.93 33.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.241 -1.392 . . . . 75.44 107.241 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.45 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.5 t70 -117.36 103.11 9.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.176 -1.416 . . . . 62.1 107.176 172.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.34 112.63 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.876 -1.528 . . . . 73.52 106.876 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.3 t70 -127.8 135.1 49.63 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.157 -0.683 . . . . 73.34 109.157 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -114.94 123.62 49.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.84 0.856 . . . . 74.42 109.952 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.11 34.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.32 0.648 . . . . 73.52 110.168 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.9 p -163.38 152.4 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.185 0.594 . . . . 53.11 110.438 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.2 p -151.25 159.35 44.41 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.81 0.844 . . . . 74.52 109.406 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -75.21 120.61 20.94 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.612 -0.722 . . . . 74.44 110.479 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' C' ' 57' ' ' GLU . 83.3 mt -84.95 -46.32 11.36 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.87 -0.789 . . . . 64.21 108.87 169.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.33 178.27 9.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.532 -1.213 . . . . 73.24 108.88 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -66.05 122.37 17.26 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.34 -0.391 . . . . 73.3 110.052 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 74.55 -5.6 2.08 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.813 1.645 . . . . 73.23 112.599 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.536 HG21 ' HG ' ' C' ' 85' ' ' SER . 92.0 t -104.9 116.62 49.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 124.035 0.934 . . . . 75.22 109.475 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 135.58 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.411 -0.959 . . . . 73.22 108.411 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.436 ' CD ' ' HZ1' ' C' ' 19' ' ' LYS . 43.2 tt0 -87.52 120.24 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.799 -0.815 . . . . 61.14 108.799 173.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.31 111.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.399 -0.963 . . . . 74.4 108.399 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.8 t -106.57 127.26 62.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.838 -1.171 . . . . 75.41 107.838 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -130.4 105.48 7.9 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.758 -1.201 . . . . 72.23 107.758 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 24.0 ttm180 -82.65 125.12 30.84 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.855 -0.611 . . . . 71.45 109.614 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -116.71 106.97 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.791 -1.559 . . . . 73.21 106.791 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.4 m -116.29 114.05 23.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.521 0.677 . . . . 74.41 109.618 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.93 111.36 35.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 114.619 -1.173 . . . . 73.51 108.486 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 13.8 m -111.33 125.86 54.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.471 0.708 . . . . 72.44 110.238 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.86 116.83 31.92 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.338 -1.356 . . . . 73.53 107.338 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.5 m -148.39 152.65 37.36 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.827 0.451 . . . . 70.2 110.78 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.476 HD21 ' HD2' ' C' ' 34' ' ' LYS . 4.1 mm? -95.37 26.98 3.53 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.63 1.172 . . . . 74.43 110.203 172.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.85 -104.95 0.95 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.36 -25.47 21.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.359 0.664 . . . . 72.51 110.261 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.54 113.62 21.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.056 0.942 . . . . 71.04 109.679 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.3 m -88.88 129.65 35.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.944 0.497 . . . . 74.31 111.525 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 -57.83 4.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.961 . . . . 74.31 109.728 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.73 155.04 29.21 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.503 -0.771 . . . . 72.02 109.941 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.423 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -117.02 145.28 43.78 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.367 -1.345 . . . . 73.43 107.367 171.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.423 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.9 t -150.07 131.86 15.05 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 173.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -139.79 132.88 29.6 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.526 0.73 . . . . 75.3 110.24 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.62 138.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.867 0.867 . . . . 73.4 109.07 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -113.21 96.65 6.03 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.983 -1.488 . . . . 74.34 106.983 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.45 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.7 tp-100 -83.52 107.36 15.94 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.044 -0.526 . . . . 71.0 109.631 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 145.94 18.27 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.788 -0.642 . . . . 71.13 111.68 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.76 117.44 0.91 Allowed Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.518 -1.033 . . . . 74.22 110.518 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 15.9 mm -81.56 119.73 31.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.627 -0.879 . . . . 74.33 108.627 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.432 ' HE2' HG23 ' C' ' 13' ' ' ILE . 97.3 m-85 -132.52 145.29 51.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.837 0.855 . . . . 63.34 109.552 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.536 ' HG ' HG21 ' C' ' 55' ' ' VAL . 65.9 m -110.69 112.43 24.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.781 0.833 . . . . 53.54 109.287 173.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.511 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.5 mp -116.11 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.895 -1.15 . . . . 72.12 107.895 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.41 162.75 34.95 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.357 1.063 . . . . 73.51 109.843 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.08 -58.51 4.25 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.944 -0.571 . . . . 65.04 112.258 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.51 168.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.622 0.769 . . . . 64.32 111.536 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.28 -177.22 5.88 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.867 1.267 . . . . 64.42 109.012 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.79 -124.45 36.16 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.772 0.67 . . . . 73.33 113.683 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 49.0 p -70.22 -36.57 74.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.491 1.116 . . . . 75.43 111.953 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -66.16 -36.23 82.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.097 0.559 . . . . 73.53 110.858 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.511 ' HG2' HG21 ' C' ' 86' ' ' ILE . 0.1 OUTLIER -83.14 -33.83 26.18 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.426 0.69 . . . . 75.43 109.971 178.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.41 -44.46 95.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.075 0.95 . . . . 74.43 111.263 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -76.8 -26.44 54.42 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.642 -0.708 . . . . 71.22 111.079 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' C' ' 101' ' ' TYR . 47.2 t -73.86 -61.84 1.7 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.739 0.416 . . . . 73.54 110.491 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.667 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 8.4 tt -79.89 -25.5 40.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.404 0.282 . . . . 74.2 110.791 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.75 -7.16 78.86 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 115.083 0.793 . . . . 51.32 115.083 -174.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -55.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.491 0.646 . . . . 75.12 111.369 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.642 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 82.8 t80 -65.89 -39.11 90.35 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.998 0.919 . . . . 75.01 111.734 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 38.3 m -76.37 -47.19 3.39 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.474 -0.774 . . . . 64.34 112.288 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.7 Cg_exo -53.14 -40.36 77.27 Favored 'Trans proline' 0 C--N 1.399 3.206 0 C-N-CA 122.761 2.307 . . . . 75.13 112.891 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.27 -29.34 67.5 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.692 0.797 . . . . 71.23 112.52 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.475 HG21 ' NH1' ' A' ' 111' ' ' ARG . 29.4 mm -75.6 -43.66 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.096 0.558 . . . . 75.25 110.943 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 pp -93.29 -11.07 33.35 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 112.738 0.644 . . . . 74.31 112.738 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -57.44 -49.47 93.66 Favored Pre-proline 0 N--CA 1.491 1.604 0 CA-C-O 117.968 -1.015 . . . . 75.41 112.776 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.99 -31.29 89.5 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 121.94 1.76 . . . . 72.33 112.755 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -68.37 -48.5 64.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.951 0.9 . . . . 74.11 111.147 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -58.72 -41.22 85.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 63.31 110.539 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -69.57 -47.73 62.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.954 -1.476 . . . . 74.33 111.252 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.06 -31.92 72.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.161 0.584 . . . . 74.14 109.95 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.417 ' O ' ' SD ' ' C' ' 117' ' ' MET . 43.0 t -63.99 -40.96 97.54 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.551 0.532 . . . . 73.34 110.589 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 86.6 mt -68.02 -41.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.329 0.651 . . . . 75.44 110.823 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.473 HG22 ' HB3' ' C' ' 125' ' ' GLN . 30.8 m -62.98 -30.16 71.37 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.432 0.693 . . . . 62.55 110.684 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -74.16 -46.23 43.59 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.922 0.889 . . . . 73.1 109.973 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.608 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.69 -42.71 84.21 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.923 0.889 . . . . 74.15 111.642 177.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.9 t -70.91 -33.99 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.86 0.864 . . . . 74.35 110.185 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.487 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 38.5 t -65.59 -33.02 74.94 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.389 0.676 . . . . 72.01 111.464 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 73.4 mtt-85 -81.66 -31.89 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.07 0.948 . . . . 74.53 110.618 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 -1.56 86.45 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.791 -0.641 . . . . 73.2 112.29 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 49.6 p 61.88 31.72 18.16 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 126.075 1.75 . . . . 64.55 112.262 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.0 150.06 37.88 Favored Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 114.495 -1.23 . . . . 71.34 109.385 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -40.3 109.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 124.365 3.377 . . . . 71.35 113.908 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.473 ' HB3' HG22 ' C' ' 115' ' ' THR . 50.6 mt-30 -60.54 142.54 55.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.755 1.222 . . . . 73.45 111.99 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp -121.2 106.5 11.57 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.306 0.642 . . . . 74.23 109.553 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.34 108.44 20.48 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.458 -1.312 . . . . 71.22 107.458 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.406 HD22 HD23 ' C' ' 42' ' ' LEU . 85.2 mt -63.24 144.69 56.71 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.687 0.795 . . . . 75.35 111.868 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.54 159.57 77.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.838 1.255 . . . . 74.31 111.475 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.8 104.22 0.45 Allowed 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.528 2.152 . . . . 74.23 111.76 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.97 109.35 23.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.445 -0.946 . . . . 72.15 108.445 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -104.04 88.62 3.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.818 -1.083 . . . . 75.21 109.576 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.62 -37.98 83.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.099 -0.955 . . . . 72.53 108.763 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 . . . . . 0 CA--C 1.541 0.623 0 CA-C-N 114.895 -1.048 . . . . 65.25 111.83 -178.471 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.243 0.736 0 N-CA-C 108.83 -0.804 . . . . 74.31 108.83 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -174.07 97.1 0.1 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.848 -1.538 . . . . 74.44 106.848 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -133.13 119.81 20.43 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.198 -0.91 . . . . 74.04 108.658 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mt -70.55 107.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 114.711 -1.132 . . . . 74.35 109.482 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.87 -37.64 62.12 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.203 -0.295 . . . . 75.22 110.203 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -170.5 143.89 2.33 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.963 0.79 . . . . 73.54 109.95 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.498 HD11 ' H ' ' D' ' 16' ' ' ILE . 0.1 OUTLIER -120.29 108.36 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.468 1.107 . . . . 72.4 108.205 175.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -138.25 158.69 43.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.447 1.118 . . . . 71.1 111.195 -170.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -92.56 110.31 21.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.768 -1.56 . . . . 74.51 108.873 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 41.3 mtpt -74.05 -31.69 62.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.149 0.5 . . . . 73.14 110.124 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -150.61 141.66 23.03 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.781 -1.1 . . . . 74.33 109.367 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.608 HG23 ' HE1' ' C' ' 117' ' ' MET . 28.8 mt -136.55 141.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.825 1.25 . . . . 74.41 107.802 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.2 t -146.55 137.5 24.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.988 0.915 . . . . 72.12 109.656 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -149.32 121.06 8.09 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 106.127 -1.805 . . . . 64.43 106.127 167.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -131.1 124.78 31.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.48 82.45 68.23 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.106 -1.072 . . . . 73.13 108.106 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.58 -34.34 5.76 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.866 2.377 . . . . 73.55 112.327 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 64.7 m-20 -106.98 23.55 14.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.403 1.081 . . . . 75.14 109.573 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.52 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -45.57 -59.77 4.14 Favored Pre-proline 0 CA--C 1.571 1.751 0 C-N-CA 125.194 1.398 . . . . 73.43 114.492 -168.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.19 -16.73 15.45 Favored 'Trans proline' 0 C--N 1.392 2.86 0 CA-C-N 121.886 1.709 . . . . 74.34 113.133 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -68.52 -43.55 76.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.082 0.953 . . . . 75.23 109.972 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' D' ' 73' ' ' ALA . 99.0 t -65.62 -34.82 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.857 0.863 . . . . 73.22 110.533 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.28 -7.98 46.67 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.871 1.063 . . . . 70.31 113.871 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -84.81 -29.33 25.46 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.102 0.561 . . . . 73.54 111.274 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -109.9 114.26 27.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.76 1.224 . . . . 75.34 108.7 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -91.11 95.09 9.9 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.312 0.577 . . . . 73.41 112.081 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.86 171.29 15.43 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.639 0.776 . . . . 74.24 112.333 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -84.22 134.34 43.46 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.094 1.358 . . . . 64.43 111.388 -169.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.449 ' HB3' HD13 ' D' ' 68' ' ' LEU . 16.6 Cg_exo -68.23 117.55 5.02 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 73.44 114.301 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.91 114.37 10.98 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.19 -1.411 . . . . 72.24 107.19 163.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.85 123.24 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.65 0.738 . . . . 74.23 110.216 -170.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 51.7 tttp -93.44 125.59 38.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.841 1.256 . . . . 73.42 109.132 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -97.66 114.62 26.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.662 -1.607 . . . . 75.13 106.662 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 15.8 t70 -127.89 129.85 47.55 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.665 -0.865 . . . . 73.22 108.665 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 64.0 tp -122.71 135.61 54.63 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.558 0.743 . . . . 72.04 110.118 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -134.51 148.88 50.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.682 1.193 . . . . 75.54 108.165 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -124.08 149.07 46.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.295 0.638 . . . . 55.44 110.674 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.39 152.09 35.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.971 0.908 . . . . 74.12 109.266 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.6 p -174.8 154.17 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.319 0.648 . . . . 73.22 111.373 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 55.2 p -171.46 158.57 5.26 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.369 1.068 . . . . 63.44 109.81 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -87.5 125.61 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.397 -0.594 . . . . 71.33 109.397 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' D' ' 57' ' ' GLU . 50.4 mt -91.36 -42.23 10.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.363 0.665 . . . . 74.41 110.456 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.15 -172.36 4.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.431 -0.804 . . . . 64.11 110.31 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.73 118.2 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.022 -0.99 . . . . 72.11 109.895 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 66.65 0.81 1.96 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.772 1.629 . . . . 75.21 112.661 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -108.49 124.82 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.048 0.539 . . . . 75.21 109.988 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -127.15 159.88 32.93 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.317 1.047 . . . . 75.24 109.403 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.575 ' HB2' HD12 ' D' ' 51' ' ' LEU . 39.6 tt0 -118.27 137.29 53.15 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.889 0.876 . . . . 72.43 108.715 174.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.473 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 69.3 t -121.11 121.43 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.509 -1.293 . . . . 74.42 107.509 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 31.2 t -117.89 129.77 73.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.965 -0.754 . . . . 74.1 108.965 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.33 110.93 20.11 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.636 -0.875 . . . . 73.05 108.636 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 13.7 ttm180 -84.16 99.71 10.69 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.717 -0.846 . . . . 74.24 108.717 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.27 122.38 45.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.116 -0.947 . . . . 75.44 108.487 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.1 m -129.28 130.29 46.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.367 -0.833 . . . . 75.14 109.908 -171.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 82.2 t -124.01 126.43 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.665 1.586 . . . . 74.13 108.146 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 89.2 m -126.42 110.63 13.54 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.76 -0.459 . . . . 74.31 109.76 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.84 124.19 49.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.068 0.547 . . . . 71.3 109.948 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' D' ' 72' ' ' THR . 58.8 m -135.91 119.61 17.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.571 -1.27 . . . . 61.54 107.571 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' D' ' 73' ' ' ALA . 6.8 mp -123.35 133.78 54.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.838 0.855 . . . . 74.21 109.734 -170.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.6 -116.87 5.9 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -112.26 3.76 17.32 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.201 0.6 . . . . 73.34 110.52 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 9.7 pm0 -127.54 164.57 21.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.681 0.792 . . . . 71.13 110.814 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 67' ' ' SER . 53.4 m -86.46 129.98 34.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.147 0.579 . . . . 73.31 110.278 169.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -72.39 -68.61 0.46 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.325 0.65 . . . . 73.24 109.47 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.8 152.03 31.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.906 -1.043 . . . . 72.1 111.947 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -119.63 116.64 26.43 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.572 1.549 . . . . 75.31 107.574 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.588 ' SG ' HG21 ' D' ' 114' ' ' ILE . 17.1 t -127.83 134.94 49.45 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.784 -0.451 . . . . 72.21 109.784 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.7 133.71 13.22 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.189 0.596 . . . . 75.4 109.941 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.63 119.78 22.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.656 0.782 . . . . 74.05 109.324 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 64.6 mt-30 -90.53 88.52 7.18 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 174.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -79.33 97.95 6.51 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.451 -0.795 . . . . 75.13 109.118 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 143.88 16.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.183 -0.767 . . . . 75.11 111.183 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.79 130.96 3.8 Favored Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.224 -1.15 . . . . 70.31 110.224 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.429 HG22 HD11 ' D' ' 51' ' ' LEU . 46.3 mt -90.02 131.82 36.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.94 -0.763 . . . . 74.41 108.94 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.473 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 30.0 m-85 -134.02 125.31 27.85 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.889 -0.782 . . . . 74.41 108.889 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -76.14 103.42 6.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.878 -1.156 . . . . 72.55 107.878 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.522 HG22 HD12 ' D' ' 89' ' ' ILE . 75.0 mt -107.8 132.18 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.358 1.063 . . . . 72.25 109.475 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.66 164.86 19.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.431 0.692 . . . . 62.45 110.948 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.81 47.75 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 115.262 0.865 . . . . 73.14 115.262 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.522 HD12 HG22 ' D' ' 86' ' ' ILE . 15.9 pt -123.97 128.43 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.628 1.171 . . . . 73.42 108.036 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -137.29 159.7 41.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.115 0.566 . . . . 73.1 111.352 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -123.42 31.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 115.46 -0.791 . . . . 73.05 113.201 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -69.19 -25.74 64.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 74.21 111.685 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -72.9 -39.74 66.1 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.385 0.674 . . . . 75.2 110.133 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -31.83 56.18 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.528 -0.545 . . . . 73.43 109.528 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.44 90.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.901 0.88 . . . . 74.32 111.89 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -61.53 -48.13 82.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.582 -0.736 . . . . 74.02 110.34 172.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.17 -29.36 62.79 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.927 -0.579 . . . . 74.15 112.128 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 29.7 tp -95.52 -51.21 4.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.217 1.007 . . . . 71.34 110.834 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.77 5.18 66.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.702 -0.681 . . . . 44.53 114.057 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.86 -55.96 0.73 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.064 0.432 . . . . 74.22 110.696 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -75.61 -41.24 54.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.809 0.67 . . . . 73.3 112.809 -173.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.24 -46.98 90.85 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.834 -0.603 . . . . 74.22 111.026 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.63 -40.0 87.85 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 122.299 1.999 . . . . 72.44 113.061 165.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -60.98 -28.08 68.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.406 0.682 . . . . 74.11 111.4 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -79.42 -50.54 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.842 0.857 . . . . 74.25 110.921 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.11 -28.63 32.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.057 0.762 . . . . 72.34 113.057 -167.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -65.83 -42.57 54.48 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.21 1.004 . . . . 71.11 112.873 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.19 -37.41 94.26 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 121.922 1.748 . . . . 75.44 113.087 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -77.2 -31.04 55.03 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 71.43 111.887 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.55 -51.91 63.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.299 0.64 . . . . 71.44 109.67 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.501 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.3 ttp180 -55.83 -54.32 45.96 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.074 -1.421 . . . . 74.53 110.396 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.8 -39.22 84.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 75.31 111.58 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -62.21 -47.54 83.99 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.029 0.532 . . . . 64.22 111.02 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.588 HG21 ' SG ' ' D' ' 76' ' ' CYS . 85.5 mt -60.11 -51.73 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.099 0.96 . . . . 73.24 110.225 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' B' ' 109' ' ' TYR . 87.0 m -54.71 -43.66 72.78 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.881 1.672 . . . . 73.31 112.452 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.1 t -66.65 -38.49 86.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.486 0.714 . . . . 71.54 110.718 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.582 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.1 mtm -72.1 -29.78 64.44 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.771 0.428 . . . . 74.25 111.842 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.441 HG21 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -64.49 -44.32 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.376 0.67 . . . . 73.12 109.73 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.1 p -72.27 -29.95 64.37 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.07 0.548 . . . . 74.32 111.417 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -69.69 -32.39 70.96 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.583 0.753 . . . . 73.12 110.574 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.76 81.44 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 115.908 -0.587 . . . . 73.34 112.818 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 60.09 21.38 10.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 126.819 2.048 . . . . 65.42 113.311 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -86.74 163.06 42.73 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.957 1.303 . . . . 75.11 109.627 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.71 133.69 20.73 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.114 1.876 . . . . 75.04 110.68 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.8 135.51 56.82 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.752 0.658 . . . . 75.41 111.455 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.65 107.75 18.86 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.134 -1.432 . . . . 73.44 107.134 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 75.8 m-20 -97.81 93.27 6.27 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.069 -1.456 . . . . 74.23 107.069 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -74.18 120.08 19.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.24 -0.891 . . . . 73.34 109.507 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.65 123.22 78.45 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.618 0.767 . . . . 73.53 111.781 -173.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.501 ' HB3' HH12 ' D' ' 111' ' ' ARG . 18.7 Cg_endo -86.86 115.31 1.21 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.082 2.521 . . . . 75.22 111.58 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.8 110.13 30.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.668 -1.234 . . . . 74.11 107.668 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -79.03 87.99 4.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.021 0.528 . . . . 74.33 110.208 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 . . . . . 0 N--CA 1.476 0.827 0 CA-C-N 115.658 -0.701 . . . . 73.3 111.06 174.063 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.3 m . . . . . 0 C--O 1.237 0.402 0 N-CA-C 107.731 -1.211 . . . . 75.04 107.731 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.733 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.4 t80 -135.63 132.82 37.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.725 0.41 . . . . 74.24 110.028 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -152.9 114.31 4.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.824 . . . . 73.52 108.794 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.634 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -83.13 119.79 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.797 -0.446 . . . . 74.32 109.797 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -87.19 -31.05 20.55 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.463 0.705 . . . . 74.0 109.651 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -163.43 142.17 8.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.757 -0.201 . . . . 74.2 110.999 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.94 140.27 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 124.553 1.141 . . . . 75.41 108.166 170.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.514 ' HB3' HG23 ' B' ' 122' ' ' THR . 40.3 p90 -172.76 167.95 5.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.662 0.744 . . . . 72.14 111.023 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -95.88 119.04 33.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.961 -1.018 . . . . 75.45 108.729 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' B' ' 28' ' ' ALA . 29.7 mtpt -81.87 -23.46 36.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.111 0.481 . . . . 74.0 110.464 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.2 t70 -154.58 144.15 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.97 -1.014 . . . . 72.45 110.026 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.7 mt -137.26 144.36 32.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.887 1.675 . . . . 74.21 106.987 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -153.71 125.99 7.99 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.258 0.551 . . . . 63.11 110.033 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 90.1 t80 -124.1 120.85 33.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.939 -1.874 . . . . 74.2 105.939 168.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 35.4 mt-10 -126.95 108.41 10.94 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.715 0.689 . . . . 74.41 110.702 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.18 79.02 2.64 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 106.424 -1.695 . . . . 73.24 106.424 168.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.4 -46.12 3.1 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.388 2.058 . . . . 72.13 111.192 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.8 m-20 -100.81 28.38 5.24 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.914 -1.039 . . . . 75.2 108.874 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.437 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -41.47 -56.77 4.28 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.038 -0.982 . . . . 72.15 113.093 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.517 ' HG2' ' HD2' ' A' ' 30' ' ' HIS . 36.3 Cg_endo -63.19 -30.32 74.49 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 121.794 1.663 . . . . 73.54 112.878 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.517 ' HD2' ' HG2' ' A' ' 29' ' ' PRO . 9.3 m-70 -79.53 -30.2 41.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.748 0.819 . . . . 74.11 111.279 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -82.25 -18.39 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.55 0.34 . . . . 74.2 110.939 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -75.96 -31.07 58.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.203 0.601 . . . . 73.11 110.498 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -82.19 -18.96 40.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.768 0.427 . . . . 75.2 110.595 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -68.82 142.09 54.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.873 0.469 . . . . 71.41 110.166 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.47 139.46 58.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.156 0.582 . . . . 65.42 109.847 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -66.66 90.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.078 0.861 . . . . 71.41 109.889 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -133.81 63.11 61.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.365 1.066 . . . . 74.51 108.389 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.47 133.29 8.35 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.212 1.941 . . . . 64.32 112.063 -172.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.47 91.96 6.05 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.523 -1.288 . . . . 75.12 107.523 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.5 t -78.38 107.56 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -94.27 156.78 16.36 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.317 1.047 . . . . 73.22 109.69 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.431 HD11 HD13 ' A' ' 128' ' ' LEU . 3.5 tt -137.82 109.01 6.81 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.363 -0.977 . . . . 75.13 108.363 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.559 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.4 m-20 -125.46 141.88 51.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.178 0.991 . . . . 73.22 109.252 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.24 126.67 37.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 63.52 109.245 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -118.82 129.08 55.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.675 1.19 . . . . 75.05 108.622 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.8 p -110.38 144.9 38.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.859 0.864 . . . . 75.21 110.339 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.22 131.78 12.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.166 0.586 . . . . 74.15 110.55 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -133.81 151.92 51.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.235 0.614 . . . . 70.41 109.994 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.3 t -154.71 162.19 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.652 0.781 . . . . 72.11 109.672 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -109.22 113.17 25.78 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.762 0.825 . . . . 72.01 108.784 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.5 mt -82.79 -33.63 27.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.259 0.624 . . . . 75.21 110.301 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -170.91 -174.42 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.337 1.055 . . . . 73.04 109.989 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.98 123.2 19.18 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.084 0.554 . . . . 65.45 109.738 173.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 67.52 -4.43 0.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.455 1.502 . . . . 74.22 112.943 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 59.3 t -112.1 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.241 -1.022 . . . . 74.03 108.241 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.82 167.14 16.2 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.103 0.961 . . . . 64.2 108.611 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -129.58 138.8 51.49 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.427 0.691 . . . . 74.51 109.326 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -126.66 129.07 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.415 -1.328 . . . . 73.34 107.415 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.65 131.6 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.118 0.967 . . . . 75.32 109.068 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.6 103.45 9.71 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.987 -1.116 . . . . 75.13 107.987 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 9.8 ttp180 -84.74 110.51 18.84 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.453 -0.573 . . . . 72.51 109.453 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' A' ' 114' ' ' ILE . 12.4 t -92.92 128.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.394 -1.336 . . . . 73.23 107.394 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 16.8 m -123.9 126.83 47.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.471 -0.566 . . . . 62.15 109.471 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.487 HG12 HD21 ' A' ' 126' ' ' LEU . 47.2 t -125.0 131.72 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.767 1.227 . . . . 74.34 107.823 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.6 m -116.38 151.64 35.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.702 -0.851 . . . . 75.43 108.702 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.54 115.69 11.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.926 -1.509 . . . . 71.42 106.926 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.8 t -130.02 128.21 41.52 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.99 0.424 . . . . 75.2 110.228 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.482 HD12 ' HB1' ' A' ' 73' ' ' ALA . 8.2 mp -90.3 85.74 6.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.687 1.195 . . . . 74.34 107.984 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.43 -98.28 2.08 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 114.822 -1.081 . . . . 72.52 110.534 -172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.68 -5.03 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.4 0.68 . . . . 74.41 110.01 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -85.83 100.8 12.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.005 -1.109 . . . . 75.21 108.005 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 59.8 m -71.21 129.66 39.46 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.269 0.556 . . . . 72.23 111.671 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -77.24 -59.74 2.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.06 -1.427 . . . . 74.22 109.897 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.562 ' HE2' HD23 ' A' ' 126' ' ' LEU . 43.1 p90 -159.57 136.9 9.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.322 -0.854 . . . . 72.4 111.4 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 tp -112.54 107.85 16.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.054 1.342 . . . . 74.52 107.495 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.534 ' HB3' HG23 ' A' ' 114' ' ' ILE . 72.6 m -107.93 106.05 16.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.809 0.844 . . . . 74.0 111.156 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 63' ' ' THR . 40.8 tt0 -127.64 125.04 39.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.928 1.291 . . . . 75.11 109.186 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.43 115.32 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.872 0.869 . . . . 75.2 109.752 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.636 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 73.4 mt-30 -83.36 89.33 7.01 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.378 -0.971 . . . . 63.52 108.378 168.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -83.12 106.4 14.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.444 -0.947 . . . . 75.11 108.444 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.2 -177.38 19.13 Favored Glycine 0 N--CA 1.465 0.614 0 O-C-N 123.528 0.518 . . . . 53.44 112.422 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.3 155.71 15.65 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 112.443 -0.263 . . . . 73.25 112.443 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -90.34 115.84 30.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.873 -0.788 . . . . 75.42 108.873 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.733 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -121.1 119.67 33.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.946 0.899 . . . . 75.42 109.564 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 t -83.33 97.94 9.19 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.685 -0.858 . . . . 64.45 108.685 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 89' ' ' ILE . 25.6 pt -112.53 142.9 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.603 0.761 . . . . 71.05 110.386 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -154.81 164.33 38.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.098 0.959 . . . . 55.44 110.184 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.36 -5.89 83.33 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.86 -0.609 . . . . 71.22 113.925 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.431 HD12 ' HG3' ' A' ' 94' ' ' MET . 18.8 pt -114.57 144.79 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.008 0.923 . . . . 75.13 111.118 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -163.18 172.18 15.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.754 0.822 . . . . 72.33 108.783 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.47 -124.6 11.9 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.692 0.637 . . . . 75.11 114.692 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -74.8 -23.62 58.52 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.867 0.867 . . . . 72.45 111.399 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -68.04 -36.98 80.81 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 73.32 109.411 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.431 ' HG3' HD12 ' A' ' 89' ' ' ILE . 24.8 ttt -81.55 -24.68 36.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.715 -0.675 . . . . 72.53 110.822 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.05 85.48 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.852 0.461 . . . . 72.32 111.115 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -68.25 -37.17 80.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.404 -0.816 . . . . 70.41 110.781 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.3 t -73.82 -42.33 61.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 74.14 111.647 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.38 -47.3 20.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.365 0.666 . . . . 71.42 110.264 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.4 -2.69 88.99 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 115.077 0.791 . . . . 70.04 115.077 -170.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.11 -56.75 0.23 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 117.91 0.855 . . . . 74.3 112.279 -175.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.8 t80 -64.78 -47.76 76.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.731 1.213 . . . . 72.14 113.065 -168.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.32 -35.5 1.17 Allowed Pre-proline 0 CA--C 1.57 1.727 0 CA-C-O 118.851 -0.595 . . . . 62.43 112.502 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.85 -39.68 48.64 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.77 2.314 . . . . 60.41 113.295 161.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -61.1 -25.93 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.42 0.688 . . . . 71.1 111.419 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.1 mm -78.95 -55.42 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.695 0.798 . . . . 73.34 110.227 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.95 -24.46 33.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.75 1.018 . . . . 72.45 113.75 -165.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -64.13 -41.57 62.49 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.382 -0.818 . . . . 74.32 112.68 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.34 -43.17 61.15 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 122.095 1.863 . . . . 74.35 113.225 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -67.95 -38.62 83.03 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.441 0.696 . . . . 74.33 112.092 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 -45.96 76.3 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.684 -0.487 . . . . 64.22 109.684 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -53.71 -46.49 70.79 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.576 1.173 . . . . 75.34 110.755 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.23 -49.37 72.2 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.43 1.081 . . . . 73.42 111.148 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.7 t -58.22 -41.47 84.13 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.834 0.709 . . . . 70.25 110.735 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.534 HG23 ' HB3' ' A' ' 76' ' ' CYS . 78.7 mt -64.94 -48.49 83.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 O-C-N 124.097 0.873 . . . . 74.41 109.958 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.623 HG21 ' HG3' ' A' ' 125' ' ' GLN . 91.0 m -51.76 -49.98 61.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.133 0.973 . . . . 74.43 111.768 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -64.02 -42.94 96.94 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.088 0.867 . . . . 64.32 110.409 -175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.43 ' SD ' HG22 ' A' ' 21' ' ' ILE . 5.7 mtp -56.38 -46.76 79.95 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.835 0.854 . . . . 72.02 111.442 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.454 HG22 ' SG ' ' A' ' 76' ' ' CYS . 77.5 t -65.69 -44.2 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.195 0.998 . . . . 74.23 111.68 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.7 p -67.66 -31.35 71.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.981 0.513 . . . . 72.21 111.346 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 88.3 mtt-85 -68.02 -29.6 68.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.602 0.761 . . . . 74.15 110.858 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.47 3.04 80.2 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.177 -0.465 . . . . 63.53 113.547 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.8 m 63.74 35.75 11.09 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.808 1.243 . . . . 75.34 110.045 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -105.58 151.66 39.86 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 114.547 -1.206 . . . . 72.12 108.386 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.05 147.87 91.38 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.431 2.087 . . . . 70.35 111.94 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.623 ' HG3' HG21 ' A' ' 115' ' ' THR . 24.2 tt0 -52.9 128.67 27.83 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.772 0.829 . . . . 63.35 112.472 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.562 HD23 ' HE2' ' A' ' 74' ' ' PHE . 38.4 tp -108.48 118.44 36.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.256 0.623 . . . . 74.54 109.419 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -140.05 109.05 6.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.162 0.985 . . . . 72.21 108.939 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.431 HD13 HD11 ' A' ' 42' ' ' LEU . 17.9 tp -67.48 135.74 53.54 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.198 0.599 . . . . 63.42 110.544 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.408 ' H ' HD12 ' A' ' 128' ' ' LEU . . . -53.52 133.29 54.2 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.647 1.179 . . . . 64.14 112.293 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.407 ' HD3' HD13 ' C' ' 13' ' ' ILE . 6.0 Cg_exo -78.3 92.88 1.11 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.039 2.493 . . . . 75.01 110.864 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 66.9 t -100.54 126.85 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.222 -1.029 . . . . 75.2 108.222 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 40.9 t-20 -73.28 98.69 2.72 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.357 0.663 . . . . 71.4 110.143 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.08 -27.15 62.48 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.928 0.891 . . . . 75.31 110.756 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.448 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 7.1 t70 . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 123.904 0.881 . . . . 74.31 110.587 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 94.0 m . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 107.334 -1.358 . . . . 73.51 107.334 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -116.59 114.71 24.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.0 -1.111 . . . . 72.52 108.0 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -134.75 141.0 46.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.235 0.614 . . . . 74.23 110.344 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -86.2 102.18 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.884 -1.053 . . . . 74.2 110.656 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -77.38 -32.02 54.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 122.019 -0.425 . . . . 74.51 110.055 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -173.75 134.13 0.47 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.19 -0.67 . . . . 73.44 109.19 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.7 mt -113.8 134.62 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 106.915 -1.513 . . . . 74.44 106.915 171.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -166.17 151.24 8.29 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.679 0.752 . . . . 73.52 112.163 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.7 m -77.45 122.12 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.905 -1.043 . . . . 63.31 109.027 170.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -89.71 -39.33 13.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.141 0.576 . . . . 72.42 111.105 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.3 t70 -150.09 136.04 18.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.57 -0.286 . . . . 74.21 110.632 -169.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.504 HG22 ' HE1' ' B' ' 117' ' ' MET . 47.9 mm -128.59 139.13 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.477 1.111 . . . . 75.1 108.687 173.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -141.56 121.55 13.68 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.719 -1.215 . . . . 61.45 107.719 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.503 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.2 t80 -136.19 137.33 40.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.664 -0.865 . . . . 75.14 108.664 172.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.4 mt-10 -136.42 153.35 51.1 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.862 1.265 . . . . 74.03 108.833 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 82.49 7.15 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.833 -1.543 . . . . 74.55 106.833 172.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.62 -46.44 7.01 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.882 2.388 . . . . 73.1 111.712 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 53.8 m-20 -96.89 28.21 3.61 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.928 0.891 . . . . 75.23 109.641 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.522 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . . . -46.86 -51.71 37.26 Favored Pre-proline 0 CA--C 1.568 1.655 0 N-CA-C 114.22 1.193 . . . . 64.24 114.22 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.56 -24.21 6.49 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.715 1.61 . . . . 73.44 112.538 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.4 m80 -97.09 2.18 50.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.225 1.01 . . . . 74.5 112.81 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.475 HG22 HD11 ' B' ' 68' ' ' LEU . 11.1 p -71.51 -19.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.053 0.941 . . . . 75.21 111.334 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -67.08 -23.12 65.82 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.516 1.127 . . . . 75.33 111.938 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.596 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 28.4 pt20 -69.91 -34.04 72.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.373 0.669 . . . . 71.13 110.44 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.601 ' HB2' HD12 ' B' ' 68' ' ' LEU . 31.9 mmtp -107.67 63.71 0.62 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.329 -0.989 . . . . 73.11 108.329 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.05 105.21 14.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.147 -0.686 . . . . 74.13 109.147 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 162.65 -165.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 127.39 2.276 . . . . 74.24 109.216 159.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -61.08 127.35 87.74 Favored Pre-proline 0 C--N 1.363 1.159 0 O-C-N 123.248 0.342 . . . . 75.1 111.18 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.11 160.86 15.55 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.542 2.161 . . . . 73.03 112.112 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.19 106.25 3.23 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.999 -1.112 . . . . 71.25 107.999 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.95 158.33 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.346 0.659 . . . . 75.54 111.705 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.0 tttm -143.64 108.84 5.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.377 1.071 . . . . 72.05 109.058 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 tt -86.59 135.47 33.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 106.772 -1.566 . . . . 73.3 106.772 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.592 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 16.9 t70 -144.51 147.45 33.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.944 -0.761 . . . . 74.23 108.944 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.4 140.01 53.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.294 -0.632 . . . . 74.04 109.294 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 8.7 t70 -123.49 140.95 52.48 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.403 1.081 . . . . 73.22 108.615 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.0 p -108.81 115.53 30.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.281 -0.872 . . . . 74.45 109.977 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -136.22 133.68 37.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.743 0.817 . . . . 72.3 108.892 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.5 p -144.7 167.68 21.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.326 0.65 . . . . 73.42 110.032 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -150.56 137.38 19.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.19 0.596 . . . . 75.11 110.089 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -90.81 94.73 9.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.455 0.702 . . . . 61.14 109.401 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.5 mt -69.87 -39.41 76.35 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.38 0.609 . . . . 71.05 110.102 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.44 -179.59 8.32 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.648 -1.16 . . . . 75.51 109.413 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -67.08 120.43 13.67 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.357 -0.609 . . . . 75.25 109.357 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 73.9 -4.79 2.18 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.375 1.47 . . . . 75.21 112.394 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -104.51 111.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 N-CA-C 108.05 -1.093 . . . . 74.1 108.05 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -126.51 137.6 53.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.602 . . . . 75.33 109.706 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -101.64 102.01 12.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.738 -1.579 . . . . 75.21 106.738 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.7 t -95.54 121.92 46.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.67 1.188 . . . . 74.33 110.219 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.1 t -104.95 120.79 56.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 124.731 1.213 . . . . 64.45 109.633 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' B' ' 103' ' ' PRO . 61.7 tp -104.39 104.66 14.57 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.811 -0.811 . . . . 73.32 108.811 172.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 38.5 ttm180 -88.67 114.09 24.92 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.356 -0.609 . . . . 73.22 109.356 173.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.4 t -106.43 112.03 37.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.084 -1.08 . . . . 73.45 108.084 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.9 m -98.2 138.36 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.992 0.917 . . . . 64.34 110.038 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.621 HG22 HG21 ' B' ' 114' ' ' ILE . 55.5 t -127.34 124.3 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.822 1.249 . . . . 72.15 108.355 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 85.0 m -119.18 145.61 45.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.008 -1.108 . . . . 74.33 108.008 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.1 131.72 17.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.673 -0.862 . . . . 73.54 108.673 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.6 p -152.98 126.91 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.088 0.555 . . . . 74.2 110.433 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 0.1 OUTLIER -104.65 123.75 48.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.816 0.847 . . . . 75.0 109.188 -176.095 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -111.49 3.26 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.14 -1.184 . . . . 73.03 110.14 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.46 6.25 6.93 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 72.25 109.798 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 10.8 pt-20 -113.52 143.4 44.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.531 . . . . 74.43 109.745 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 54.4 m -70.0 133.71 47.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.104 0.562 . . . . 72.31 111.932 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.619 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -88.55 -59.46 2.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.303 1.041 . . . . 72.12 109.426 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.02 150.4 9.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.896 -1.502 . . . . 75.21 109.242 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.32 123.66 39.89 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 124.819 1.248 . . . . 75.32 107.695 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.7 t -129.85 149.91 51.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.257 -0.645 . . . . 73.42 109.257 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -162.78 132.53 4.39 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.026 -0.731 . . . . 65.01 109.026 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD12 ' B' ' 21' ' ' ILE . 85.3 t -126.83 145.62 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.612 0.765 . . . . 72.53 109.505 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -118.01 103.24 9.71 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.288 -1.375 . . . . 72.51 107.288 167.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 5.8 tp-100 -93.21 99.48 12.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.378 -1.341 . . . . 63.14 107.378 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 171.62 38.79 Favored Glycine 0 C--O 1.248 1.024 0 N-CA-C 110.724 -0.95 . . . . 75.43 110.724 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.18 126.66 1.16 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.915 -0.659 . . . . 52.41 112.022 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 28.4 mt -84.73 129.0 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.042 -1.096 . . . . 74.34 108.042 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -133.74 150.59 51.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.602 1.161 . . . . 74.01 108.222 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -114.46 114.8 26.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.074 -1.084 . . . . 74.33 108.074 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' B' ' 10' ' ' THR . 46.3 pt -121.02 130.69 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.348 0.659 . . . . 75.03 110.712 -174.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.66 171.11 19.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.311 1.045 . . . . 71.25 109.79 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.7 -47.08 3.79 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.091 0.377 . . . . 64.52 112.391 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 1.8 pp -70.18 152.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.691 0.797 . . . . 73.33 111.154 169.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -150.41 143.28 24.71 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 111.726 0.269 . . . . 73.22 111.726 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.55 -111.1 2.95 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.99 0.805 . . . . 63.02 113.934 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.97 0.908 . . . . 73.15 110.144 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -76.02 -25.82 56.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.049 0.939 . . . . 75.05 110.327 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 43.7 ttp -73.32 -34.8 65.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.913 0.885 . . . . 73.44 110.307 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.38 68.75 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.604 -0.726 . . . . 72.22 110.814 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 57.1 t-80 -73.56 -24.12 60.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.419 0.687 . . . . 74.43 111.198 173.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -73.59 -63.54 1.18 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.672 0.389 . . . . 71.05 111.024 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.717 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -87.02 -19.23 28.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.577 0.584 . . . . 75.52 112.577 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.71 2.8 52.81 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.83 -0.428 . . . . 63.11 113.972 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -146.39 -46.8 0.19 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.034 0.417 . . . . 74.13 111.43 -177.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -83.23 -38.39 22.31 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 111.577 0.214 . . . . 73.43 111.577 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.717 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.7 m -62.1 -46.54 91.43 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.47 -0.776 . . . . 74.33 111.077 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.651 ' HA ' HD23 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -49.26 -42.2 40.7 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 122.547 2.165 . . . . 62.22 113.878 166.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -58.01 -36.86 73.29 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.547 0.739 . . . . 72.42 111.68 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.401 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 47.3 mt -80.49 -48.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.591 0.756 . . . . 73.35 111.484 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.38 -21.13 53.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.258 0.623 . . . . 75.53 112.167 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.5 -47.73 67.77 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 117.665 -1.159 . . . . 73.32 113.064 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 97.2 Cg_exo -49.98 -45.89 30.57 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.741 2.294 . . . . 74.34 113.917 172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.482 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.8 m-85 -65.61 -43.45 89.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.3 0.64 . . . . 71.25 110.893 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.417 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -66.4 -34.41 77.9 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 115.877 -0.602 . . . . 75.33 110.623 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -59.42 -57.27 13.72 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.152 0.981 . . . . 73.43 110.466 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.18 -33.05 74.64 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.807 0.692 . . . . 71.01 110.307 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.6 t -74.03 -36.44 64.43 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.193 -0.458 . . . . 74.42 111.427 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.621 HG21 HG22 ' B' ' 64' ' ' VAL . 81.6 mt -67.83 -51.77 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 74.54 109.05 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.643 HG23 ' HB2' ' B' ' 125' ' ' GLN . 66.6 m -62.19 -28.33 69.59 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 114.359 -1.292 . . . . 64.23 111.194 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -65.3 -46.34 80.77 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.344 0.658 . . . . 71.1 109.7 174.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.79 -33.02 68.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.999 0.52 . . . . 73.21 111.249 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.41 -41.61 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.407 0.683 . . . . 73.44 109.909 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.1 t -68.68 -31.07 69.92 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.321 -0.854 . . . . 71.42 111.515 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -74.53 -32.27 62.41 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.319 0.648 . . . . 75.41 110.227 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.73 -3.32 83.49 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.443 0.464 . . . . 72.24 112.432 170.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' TYR . 43.2 p 59.45 51.17 6.8 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 126.424 1.89 . . . . 75.45 111.819 175.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.85 145.76 40.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.013 -1.449 . . . . 75.05 109.01 170.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.16 130.05 27.11 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.31 2.673 . . . . 73.25 112.432 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.643 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.7 pt20 -65.43 156.94 30.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.849 -1.069 . . . . 72.13 113.148 -171.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.46 114.05 25.29 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.503 -1.295 . . . . 75.13 107.503 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -91.47 108.65 20.04 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.959 -1.126 . . . . 53.54 107.959 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.87 150.2 45.4 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.821 0.849 . . . . 71.04 112.326 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.22 138.46 71.96 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.849 -1.069 . . . . 65.3 109.789 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.601 ' HG3' HD13 ' D' ' 16' ' ' ILE . 60.5 Cg_endo -71.48 97.22 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.499 2.133 . . . . 75.53 110.811 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.73 109.34 20.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.261 -1.014 . . . . 73.34 108.261 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -76.29 87.34 3.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.705 0.802 . . . . 75.34 109.871 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.467 -0.568 . . . . 61.33 109.467 171.174 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.505 ' HG3' HD13 ' C' ' 89' ' ' ILE . 26.9 ttt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.188 0.518 . . . . 70.4 111.512 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.1 m -92.35 88.74 6.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.573 0.749 . . . . 71.41 109.116 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -119.61 126.55 51.45 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.711 -0.848 . . . . 63.21 108.711 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -150.75 131.04 13.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.872 0.869 . . . . 72.4 108.995 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.407 HD13 ' HD3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -78.52 132.02 33.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.768 -0.827 . . . . 75.22 108.768 174.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 85.6 mm-40 -93.57 -46.04 7.47 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.077 0.551 . . . . 74.25 109.553 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -176.31 126.0 0.19 Allowed 'General case' 0 C--N 1.356 0.891 0 O-C-N 124.168 0.917 . . . . 75.23 110.192 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.01 142.99 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.636 -1.246 . . . . 75.2 107.636 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.419 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -176.79 156.01 1.34 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.617 0.644 . . . . 74.54 111.806 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -75.94 121.79 23.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.786 0.834 . . . . 74.32 109.061 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 12.6 mmmm -76.15 -47.99 22.23 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.305 1.05 . . . . 73.32 108.875 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -140.59 146.0 37.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 113.772 -1.558 . . . . 62.1 109.198 -173.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.7 mt -140.91 144.84 26.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.096 1.358 . . . . 72.12 107.482 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -156.22 151.14 26.2 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.573 0.702 . . . . 73.44 110.433 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -148.89 127.58 12.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.531 -1.285 . . . . 75.42 107.531 171.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.1 mt-10 -120.84 133.89 55.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.789 0.835 . . . . 75.43 109.411 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.53 79.36 24.76 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.335 -0.987 . . . . 74.23 108.335 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.87 -25.13 12.45 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.679 2.253 . . . . 73.22 112.112 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 96.9 m-20 -106.87 34.96 3.18 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.444 1.098 . . . . 73.02 109.504 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.559 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -60.38 -55.6 43.58 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.388 -0.815 . . . . 73.32 112.997 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 26.0 Cg_exo -65.53 -30.09 52.3 Favored 'Trans proline' 0 C--N 1.394 2.932 0 CA-C-N 121.421 1.543 . . . . 72.45 112.204 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.1 t60 -62.76 -23.51 67.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.784 1.234 . . . . 75.34 112.001 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' C' ' 34' ' ' LYS . 8.8 p -52.67 -25.34 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 N-CA-C 112.828 0.677 . . . . 75.33 112.828 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -79.7 -24.56 41.62 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.583 -0.698 . . . . 74.2 112.305 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -102.24 17.63 22.92 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.274 0.559 . . . . 74.12 110.503 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.705 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.07 138.26 33.15 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.085 0.954 . . . . 74.32 110.333 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -77.04 129.17 35.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 72.51 108.927 170.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -80.2 77.55 6.92 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.334 0.588 . . . . 75.14 110.667 -174.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.437 ' O ' ' HB3' ' C' ' 68' ' ' LEU . 36.6 tt0 -160.45 63.64 1.98 Allowed Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 115.048 -0.978 . . . . 73.04 109.293 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.72 126.67 6.01 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.216 1.944 . . . . 74.34 111.416 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -85.88 99.11 11.17 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.609 -1.626 . . . . 75.22 106.609 169.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.435 HG12 HD13 ' C' ' 126' ' ' LEU . 43.2 t -73.19 122.93 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.794 -1.094 . . . . 71.1 109.038 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -124.62 112.34 16.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.345 1.058 . . . . 72.34 109.254 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 145.66 26.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.839 0.856 . . . . 73.03 109.156 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.5 t70 -132.95 143.63 49.59 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.909 -1.145 . . . . 73.44 107.909 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -135.08 115.01 12.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.247 -0.649 . . . . 74.41 109.247 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.0 t70 -111.44 143.39 42.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.104 -1.072 . . . . 73.1 108.104 175.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -115.05 117.39 30.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.728 0.811 . . . . 75.55 110.224 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -112.74 141.98 45.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 72.4 108.824 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -151.32 158.1 43.36 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.134 0.574 . . . . 73.32 110.518 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -167.62 131.88 1.81 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.858 0.863 . . . . 72.21 109.434 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.63 117.91 24.81 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.82 -0.807 . . . . 73.44 108.82 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.409 HD13 HD13 ' C' ' 83' ' ' ILE . 56.6 mt -86.33 -38.97 16.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.022 0.929 . . . . 74.04 111.354 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -171.19 3.08 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.669 -0.696 . . . . 73.53 110.572 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -57.5 110.39 0.86 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.983 -1.008 . . . . 75.31 110.104 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 70.26 -2.19 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.927 1.291 . . . . 63.11 112.781 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.42 HG23 ' HG ' ' C' ' 85' ' ' SER . 91.1 t -94.28 103.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 71.34 108.859 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -115.48 126.15 53.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.084 0.954 . . . . 60.51 109.534 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -84.43 119.26 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.44 -0.578 . . . . 73.41 109.44 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -98.23 128.43 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.495 1.118 . . . . 74.35 108.244 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 70.2 t -131.7 137.38 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.441 0.696 . . . . 72.21 109.413 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' C' ' 103' ' ' PRO . 92.9 mt -125.51 112.42 16.2 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.741 0.816 . . . . 75.13 109.917 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 27.4 ttm180 -82.61 105.79 13.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.024 -0.732 . . . . 75.33 109.024 168.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.62 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.3 t -101.19 125.36 55.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.968 -1.123 . . . . 71.53 107.968 171.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 15.5 m -124.41 113.29 17.97 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.795 -0.817 . . . . 73.11 108.795 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.629 HG23 HG21 ' C' ' 114' ' ' ILE . 60.2 t -102.19 114.22 40.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.681 0.792 . . . . 73.03 109.065 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -102.41 150.71 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.535 -0.913 . . . . 72.14 108.535 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.5 106.09 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.48 -1.674 . . . . 73.31 106.48 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -148.39 146.22 28.38 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.913 0.485 . . . . 62.45 110.544 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.705 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.3 OUTLIER -110.78 55.79 0.64 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.095 0.958 . . . . 72.52 108.544 174.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.95 -113.72 4.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.48 -1.237 . . . . 72.24 111.131 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.36 -17.78 29.83 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.457 0.703 . . . . 74.13 110.301 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -88.96 99.35 12.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.072 0.949 . . . . 74.54 109.529 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -85.57 132.78 34.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.94 0.496 . . . . 73.1 111.096 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -77.47 -64.25 1.19 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.146 0.979 . . . . 63.41 109.591 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -163.58 175.67 10.43 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.416 -0.811 . . . . 73.43 110.324 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -139.27 144.21 38.29 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 107.901 -1.148 . . . . 74.51 107.901 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.405 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.5 t -143.87 149.13 36.46 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.27 -1.011 . . . . 70.33 108.27 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.25 136.46 11.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.922 0.489 . . . . 75.02 110.056 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -138.08 134.79 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.237 1.015 . . . . 75.02 108.456 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 63.3 mt-30 -110.57 91.22 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.951 -1.129 . . . . 72.15 107.951 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.05 117.43 20.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.626 -0.715 . . . . 73.21 110.55 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.37 162.52 20.75 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 123.517 0.51 . . . . 63.14 112.556 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.5 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -166.94 118.19 0.78 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.306 -0.718 . . . . 62.44 111.306 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 13.6 mm -83.21 122.73 37.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.764 -0.828 . . . . 75.41 108.764 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -132.78 132.25 42.03 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.65 0.78 . . . . 74.52 109.417 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.42 ' HG ' HG23 ' C' ' 55' ' ' VAL . 47.8 m -94.18 114.36 26.46 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.594 -0.891 . . . . 72.04 108.594 169.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 50.8 mt -115.08 119.26 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.554 1.142 . . . . 75.11 107.994 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.55 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.246 1.019 . . . . 75.45 109.923 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.78 -34.3 4.59 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.271 -0.422 . . . . 70.25 112.772 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.505 HD13 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -121.9 165.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 75.44 110.176 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -156.46 -179.9 8.61 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.41 0.684 . . . . 61.03 110.42 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' C' ' 94' ' ' MET . . . 68.81 -130.35 25.16 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.384 -0.371 . . . . 73.01 113.052 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -78.95 -20.72 48.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.254 0.622 . . . . 72.43 111.272 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.21 -44.52 95.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.392 0.677 . . . . 75.15 110.184 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' C' ' 91' ' ' GLY . 0.0 OUTLIER -76.58 -26.32 54.93 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 116.029 -0.532 . . . . 70.43 110.785 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.66 -32.13 70.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.892 0.477 . . . . 75.41 111.087 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 60.1 t-80 -73.73 -24.3 59.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.288 0.635 . . . . 54.45 110.73 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -81.67 -58.57 2.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.205 0.602 . . . . 64.21 110.324 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.33 -48.37 42.52 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.19 1.396 . . . . 72.23 110.826 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.83 11.46 72.05 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.547 -0.585 . . . . 64.31 114.111 -171.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -148.61 -59.3 0.23 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.554 0.677 . . . . 71.04 112.217 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -74.85 -38.88 61.86 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.981 0.512 . . . . 75.33 112.243 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.9 -45.46 74.41 Favored Pre-proline 0 CA--C 1.557 1.249 0 CA-C-O 118.833 -0.603 . . . . 63.24 111.277 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.502 ' HA ' HD11 ' C' ' 60' ' ' LEU . 69.9 Cg_exo -48.8 -42.8 36.45 Favored 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.647 2.232 . . . . 73.2 114.457 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -60.7 -40.21 91.39 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.784 0.833 . . . . 74.44 110.798 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.11 -48.21 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.919 0.488 . . . . 75.02 110.72 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.5 HD22 ' HA3' ' C' ' 82' ' ' GLY . 80.3 mt -80.11 -19.57 47.05 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.76 -0.655 . . . . 74.2 112.53 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -58.64 -48.42 96.92 Favored Pre-proline 0 CA--C 1.566 1.593 0 CA-C-O 118.061 -0.971 . . . . 74.43 113.29 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.94 -36.64 96.52 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.358 2.039 . . . . 73.45 113.463 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -66.69 -45.18 79.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.425 0.69 . . . . 75.42 111.146 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.77 88.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.282 0.633 . . . . 74.12 109.64 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -53.7 -49.23 68.49 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.639 1.576 . . . . 73.45 112.091 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.94 -39.01 72.88 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.81 0.694 . . . . 74.21 110.163 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.49 -33.6 74.44 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.994 0.517 . . . . 73.0 111.274 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.629 HG21 HG23 ' C' ' 64' ' ' VAL . 81.3 mt -66.27 -52.29 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.597 0.759 . . . . 75.21 109.53 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 29.1 m -65.28 -29.08 69.82 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.049 -0.978 . . . . 74.52 110.75 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -66.84 -43.75 82.85 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.694 0.798 . . . . 51.21 109.925 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.51 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.44 -37.64 85.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.524 0.73 . . . . 74.03 111.646 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.03 -37.78 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.253 0.621 . . . . 71.21 109.811 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.0 t -66.24 -35.9 81.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.229 1.012 . . . . 74.12 111.829 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.4 mtt-85 -74.35 -35.76 63.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.614 0.766 . . . . 74.44 110.332 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.17 1.14 76.85 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.622 0.576 . . . . 74.32 112.592 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.3 p 61.36 24.05 14.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.035 1.734 . . . . 72.34 112.656 172.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -90.42 155.24 46.46 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.127 0.971 . . . . 73.03 110.03 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.08 122.43 11.8 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.058 2.505 . . . . 71.52 112.38 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.13 153.59 25.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.311 1.045 . . . . 72.33 112.881 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.435 HD13 HG12 ' C' ' 40' ' ' VAL . 5.1 tt -141.52 114.01 8.27 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 106.68 -1.6 . . . . 75.12 106.68 171.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -90.9 131.73 36.35 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.799 0.84 . . . . 72.44 109.749 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.43 141.69 56.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.444 0.698 . . . . 70.24 110.964 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.76 148.89 55.65 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.025 0.93 . . . . 75.22 110.907 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.432 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.9 Cg_exo -64.52 94.69 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.144 2.563 . . . . 72.41 112.465 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.38 106.71 19.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.938 -1.134 . . . . 71.23 107.938 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.89 102.42 11.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.609 -1.256 . . . . 63.35 107.609 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -63.06 -42.3 99.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.454 0.645 . . . . 74.01 109.308 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 N--CA 1.474 0.725 0 C-N-CA 125.195 1.398 . . . . 73.2 112.382 179.117 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 121.14 0.495 . . . . 64.55 110.299 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -159.88 90.62 0.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.629 -1.619 . . . . 73.22 106.629 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.85 114.97 28.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.066 -1.087 . . . . 74.5 108.066 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mt -77.13 104.5 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 108.203 -1.036 . . . . 72.21 108.203 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.96 -45.48 60.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.769 -0.456 . . . . 75.43 109.769 -170.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' D' ' 15' ' ' ARG . 3.4 mmp_? -157.66 147.75 20.54 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.374 1.07 . . . . 73.41 110.138 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.601 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.7 mp -120.04 113.38 40.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 106.496 -1.668 . . . . 75.15 106.496 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.53 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 42.0 p90 -145.93 150.73 36.62 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.759 0.79 . . . . 71.14 111.282 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -81.38 115.28 20.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.897 -1.047 . . . . 75.24 109.549 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.53 -33.14 28.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.424 0.631 . . . . 74.22 109.885 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -144.26 137.2 27.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.483 -1.235 . . . . 51.24 109.524 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.51 HG23 ' HE1' ' C' ' 117' ' ' MET . 93.3 mt -132.05 140.52 47.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.68 1.192 . . . . 73.23 107.885 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 38.6 t -142.34 133.74 26.44 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.562 1.145 . . . . 73.32 108.053 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.578 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -147.91 124.7 11.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.754 -1.573 . . . . 73.21 106.754 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -129.19 137.09 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.488 1.115 . . . . 74.01 108.898 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.11 85.36 59.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.703 -1.591 . . . . 53.22 106.703 172.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.39 -61.59 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.901 2.401 . . . . 74.02 112.547 -172.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.76 41.83 1.09 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.0 -1.111 . . . . 72.32 108.0 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.503 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -49.07 -59.72 5.93 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 114.389 1.255 . . . . 53.4 114.389 -167.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.414 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.5 Cg_endo -78.54 -12.86 15.13 Favored 'Trans proline' 0 C--N 1.385 2.462 0 CA-C-N 121.727 1.652 . . . . 61.43 112.772 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.2 -41.4 57.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.122 1.369 . . . . 74.21 109.597 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.06 -40.69 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.746 -1.116 . . . . 64.44 110.471 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.68 -18.37 64.91 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.146 -0.933 . . . . 71.22 113.064 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -78.79 -14.65 59.15 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.386 0.674 . . . . 71.35 112.222 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -109.04 114.51 28.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.06 0.944 . . . . 72.44 108.593 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -88.14 96.17 10.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.627 0.603 . . . . 64.4 112.627 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.451 ' CZ3' HD21 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -169.42 -174.26 1.89 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.097 0.777 . . . . 73.04 113.097 171.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -92.1 126.5 52.9 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 125.05 1.34 . . . . 75.4 111.509 -173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 56.0 Cg_endo -75.31 150.59 37.09 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.928 2.419 . . . . 74.2 113.783 172.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -83.21 135.59 34.72 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.504 1.122 . . . . 74.22 108.392 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 67.8 t -118.82 138.82 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.381 0.672 . . . . 74.42 109.262 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 47.9 tttm -125.81 121.26 32.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.186 0.994 . . . . 73.43 108.653 -172.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.499 HD13 HD13 ' D' ' 128' ' ' LEU . 0.4 OUTLIER -97.62 112.68 24.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.586 0.754 . . . . 74.12 109.062 -172.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.586 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.9 m-20 -111.75 127.8 55.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.277 1.031 . . . . 74.23 108.848 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.17 140.02 49.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.376 0.67 . . . . 75.32 109.431 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.6 t70 -142.0 136.47 30.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.107 0.963 . . . . 74.31 108.723 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -105.47 143.9 32.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.461 0.704 . . . . 72.31 110.193 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.69 159.02 44.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.694 0.798 . . . . 74.41 109.772 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.2 p -168.27 166.68 12.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.119 0.568 . . . . 73.32 111.166 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -158.84 145.56 17.17 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.368 1.067 . . . . 62.35 109.107 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.0 117.71 25.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.942 -0.762 . . . . 71.23 108.942 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.491 HD13 HG22 ' D' ' 83' ' ' ILE . 31.5 mt -92.85 -24.78 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.598 0.359 . . . . 55.34 110.281 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.87 -178.84 3.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.125 0.97 . . . . 74.35 110.608 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.56 118.92 9.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.914 -1.039 . . . . 75.11 108.937 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 70.07 5.17 5.16 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.696 1.198 . . . . 73.31 112.088 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.26 114.91 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.767 -0.827 . . . . 74.14 108.767 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.59 129.8 39.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.356 1.062 . . . . 70.12 108.883 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.458 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.4 tt0 -88.42 124.79 34.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.428 -0.953 . . . . 74.03 108.428 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.488 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 47.4 t -108.77 122.99 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.039 -1.467 . . . . 75.23 107.039 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 23.3 t -106.28 128.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.724 -0.843 . . . . 73.32 108.724 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.634 HD23 HD13 ' D' ' 106' ' ' LEU . 4.1 mm? -112.06 114.21 26.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.677 -0.49 . . . . 74.3 109.677 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -86.93 106.08 17.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.633 -0.712 . . . . 75.12 109.152 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.95 127.73 48.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.895 -1.15 . . . . 70.51 107.895 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 39.6 m -125.66 130.13 50.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.382 -0.826 . . . . 72.31 108.793 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -120.42 121.27 65.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.785 1.234 . . . . 75.35 108.474 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 87.6 m -120.63 100.43 7.12 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.054 0.942 . . . . 74.34 109.099 -170.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.15 137.47 37.63 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.187 -0.46 . . . . 65.22 110.098 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 53.4 p -150.47 140.12 21.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.603 0.761 . . . . 71.14 109.598 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.681 ' HG ' ' HB1' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -136.22 136.4 39.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.501 1.12 . . . . 75.12 110.135 -174.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.67 3.78 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.337 -0.705 . . . . 73.54 111.337 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.52 4.2 8.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.703 0.801 . . . . 74.12 110.346 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.63 166.85 13.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.15 0.58 . . . . 73.03 110.821 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 87.1 m -80.97 139.14 35.99 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.821 -0.627 . . . . 71.11 110.483 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.681 ' HB1' ' HG ' ' D' ' 68' ' ' LEU . . . -80.56 -72.02 0.43 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.027 -1.101 . . . . 75.44 108.027 172.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.45 146.46 25.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.17 -0.923 . . . . 63.21 108.928 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -110.34 130.06 55.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.57 -1.271 . . . . 74.11 107.57 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.4 t -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 72.31 108.871 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 41.9 tt0 -154.59 121.8 5.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.085 0.554 . . . . 63.33 110.065 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -130.21 118.11 42.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.068 -0.715 . . . . 75.14 109.068 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -87.8 86.78 7.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.612 -1.255 . . . . 74.01 107.612 169.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.98 97.38 6.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.184 -1.371 . . . . 71.22 108.565 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.52 144.0 18.82 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.453 -0.659 . . . . 72.23 111.453 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.28 4.58 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 109.826 -1.31 . . . . 71.44 109.826 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.491 HG22 HD13 ' D' ' 51' ' ' LEU . 63.7 mt -88.75 130.23 38.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.173 . . . . 63.3 107.834 176.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.488 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 42.3 m-85 -129.0 136.16 49.94 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.483 0.49 . . . . 73.41 109.98 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.9 m -86.52 93.32 9.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.924 -1.139 . . . . 74.02 107.924 167.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.46 HG23 ' HE1' ' D' ' 94' ' ' MET . 14.9 mt -106.58 114.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 109.437 -0.579 . . . . 75.01 109.437 -172.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.4 163.0 35.06 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.915 0.886 . . . . 64.21 109.679 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -6.3 83.76 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.508 -0.607 . . . . 64.03 114.568 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 pt -129.11 147.97 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.639 0.719 . . . . 73.51 111.716 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 173.57 13.18 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.823 1.249 . . . . 74.3 109.426 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.24 -127.28 43.08 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 115.258 0.863 . . . . 74.42 115.258 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 90.1 m -66.23 -38.46 87.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.68 1.192 . . . . 75.2 111.642 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -69.2 -36.77 77.63 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.881 0.873 . . . . 75.13 110.75 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.676 ' SD ' HD21 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -72.12 -42.52 65.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.508 -0.553 . . . . 75.34 109.508 176.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.82 88.46 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.588 0.755 . . . . 70.52 110.805 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -64.91 -36.55 84.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.158 -0.928 . . . . 74.05 110.669 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -68.03 -50.53 54.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.513 0.325 . . . . 74.44 111.236 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.676 HD21 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -71.18 -30.3 66.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.9 0.48 . . . . 74.31 111.305 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.24 7.5 56.66 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.61 -0.55 . . . . 75.0 114.06 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.05 -57.82 0.24 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.465 0.633 . . . . 73.41 111.762 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -70.62 -52.94 18.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.211 0.604 . . . . 75.21 111.238 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.423 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 34.0 m -60.58 -45.7 97.2 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.873 0.869 . . . . 74.24 112.127 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.447 ' HA ' ' HG ' ' D' ' 60' ' ' LEU . 75.0 Cg_exo -53.93 -45.59 39.9 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.747 2.298 . . . . 75.33 113.156 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.03 -26.31 68.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.559 0.743 . . . . 71.12 111.725 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.0 mm -73.51 -49.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.373 0.669 . . . . 64.35 110.962 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.634 HD13 HD23 ' D' ' 60' ' ' LEU . 83.2 mt -87.13 -13.95 42.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.13 0.572 . . . . 73.41 112.46 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -67.51 -45.69 47.29 Favored Pre-proline 0 CA--C 1.559 1.326 0 CA-C-O 118.188 -0.91 . . . . 73.2 112.328 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.79 -33.43 96.87 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.21 1.94 . . . . 72.35 113.408 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -78.96 -34.96 43.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.533 0.733 . . . . 73.33 112.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.56 -50.05 68.81 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.933 -0.766 . . . . 74.12 108.933 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -54.18 -48.01 71.4 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.991 1.432 . . . . 74.15 110.574 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.34 -50.1 74.29 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.169 0.918 . . . . 74.13 110.911 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.422 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.6 t -55.32 -43.29 74.76 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.973 0.795 . . . . 73.51 110.913 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.542 HG12 ' SG ' ' D' ' 76' ' ' CYS . 86.1 mt -65.8 -51.91 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 124.355 1.034 . . . . 75.13 110.624 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.402 HG22 ' HB2' ' D' ' 125' ' ' GLN . 68.9 m -51.03 -44.45 61.04 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.986 1.315 . . . . 72.54 111.658 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -69.41 -45.61 68.8 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.849 -1.069 . . . . 72.44 110.812 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.425 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 77.1 mtm -62.98 -36.96 85.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.741 0.416 . . . . 74.44 111.981 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.2 t -66.79 -44.33 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.097 -0.956 . . . . 71.54 109.998 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -69.73 -27.31 64.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.817 0.447 . . . . 73.15 111.414 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -73.21 -29.72 63.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 74.32 110.205 175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.89 11.48 66.69 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.69 -0.686 . . . . 62.12 112.438 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.9 p 57.87 14.11 2.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.725 2.01 . . . . 74.23 113.518 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.02 162.91 55.55 Favored Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.482 1.113 . . . . 74.3 108.342 169.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.32 127.02 10.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.212 1.941 . . . . 74.43 111.41 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.402 ' HB2' HG22 ' D' ' 115' ' ' THR . 0.0 OUTLIER -54.12 142.8 24.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.319 0.648 . . . . 75.11 111.291 -176.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.89 103.79 13.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.021 -0.733 . . . . 73.33 109.021 -161.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -97.05 91.92 5.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.98 -1.118 . . . . 74.41 107.98 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.499 HD13 HD13 ' D' ' 42' ' ' LEU . 0.1 OUTLIER -73.82 126.81 31.23 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.453 -0.943 . . . . 74.14 108.453 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.17 141.52 95.95 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.6 0.76 . . . . 65.33 111.374 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.31 122.8 11.65 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.408 2.072 . . . . 74.31 111.261 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.17 117.9 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.217 -1.031 . . . . 74.24 108.217 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -72.09 84.29 1.0 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.448 0.699 . . . . 72.5 109.686 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 N--CA 1.478 0.968 0 C-N-CA 123.654 0.782 . . . . 74.52 110.903 179.52 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 C--O 1.238 0.476 0 N-CA-C 108.384 -0.969 . . . . 74.23 108.384 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.721 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.2 t80 -123.83 117.69 25.44 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.527 -0.916 . . . . 73.01 108.527 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -141.62 112.67 7.37 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.832 -0.803 . . . . 74.5 108.832 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.624 HG12 ' HD2' ' A' ' 84' ' ' PHE . 66.5 mt -69.91 130.64 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 122.844 0.458 . . . . 73.35 109.986 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.415 ' HB3' HG21 ' A' ' 83' ' ' ILE . 63.9 tt0 -96.47 -38.29 10.08 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.954 -0.546 . . . . 74.5 110.567 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -173.01 123.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.196 0.907 . . . . 74.25 112.686 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.83 133.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.582 -0.896 . . . . 73.23 108.582 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' B' ' 122' ' ' THR . 16.6 p90 -167.88 158.5 10.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.243 1.017 . . . . 73.1 110.653 -172.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -91.73 115.24 27.89 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.347 -0.842 . . . . 72.05 109.425 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -85.56 -18.87 32.12 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.381 -0.372 . . . . 75.25 110.405 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.5 t70 -155.9 140.84 17.25 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.906 0.882 . . . . 75.14 109.735 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -140.73 135.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.447 1.499 . . . . 72.22 107.301 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.6 t -141.45 125.77 17.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.423 -0.955 . . . . 61.44 108.423 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -136.42 110.13 8.08 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.639 -1.245 . . . . 75.21 107.639 171.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.13 120.14 35.35 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.813 0.445 . . . . 61.22 109.945 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.78 80.79 14.45 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 107.633 -1.247 . . . . 54.23 107.633 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.75 -24.74 29.36 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.825 2.35 . . . . 73.53 113.061 -170.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.02 12.98 28.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.395 0.678 . . . . 54.23 111.269 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.08 4.24 Favored Pre-proline 0 CA--C 1.565 1.53 0 N-CA-C 114.964 1.468 . . . . 72.42 114.964 -165.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.509 ' HB3' HD23 ' B' ' 51' ' ' LEU . 26.1 Cg_exo -56.74 -46.51 29.1 Favored 'Trans proline' 0 C--N 1.396 3.037 0 CA-C-N 122.107 1.788 . . . . 64.11 113.045 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -98.7 -6.99 28.54 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.94 0.896 . . . . 72.11 112.911 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.5 p -79.88 -20.18 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.615 -0.678 . . . . 52.41 111.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -86.52 -3.86 59.08 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.446 0.698 . . . . 74.14 112.016 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -100.64 -7.73 23.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.653 0.781 . . . . 74.41 111.0 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -70.29 163.92 25.52 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.738 0.815 . . . . 72.21 112.469 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.39 144.22 51.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.216 1.006 . . . . 64.24 110.049 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -87.24 73.98 9.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.703 0.764 . . . . 74.23 111.404 -169.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -143.41 84.1 10.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 114.614 -1.175 . . . . 74.4 108.066 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.26 136.28 11.29 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.335 2.023 . . . . 61.35 112.131 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -95.13 93.88 7.6 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.765 -1.569 . . . . 62.22 106.765 170.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' THR . 34.0 t -92.46 96.51 6.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.983 -1.008 . . . . 64.52 111.061 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.9 tttm -80.47 111.53 16.97 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.1 -0.955 . . . . 73.52 108.938 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 tt -98.74 121.9 41.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.343 -0.984 . . . . 74.42 108.343 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.548 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 24.0 m-20 -116.72 150.32 38.4 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.356 1.062 . . . . 61.54 108.849 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -130.52 133.47 46.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.946 -0.761 . . . . 71.43 108.946 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -132.97 144.14 49.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.076 0.95 . . . . 73.51 108.769 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 p -136.36 136.38 39.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.778 0.831 . . . . 63.32 109.466 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.6 111.03 5.59 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.977 0.511 . . . . 71.24 110.079 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -92.05 152.07 20.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.501 -0.555 . . . . 74.1 109.501 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -151.96 154.98 37.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.435 -1.32 . . . . 73.41 107.435 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -117.46 130.97 56.8 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.962 -0.755 . . . . 73.33 108.962 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -93.45 -40.48 10.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.513 0.725 . . . . 73.45 110.539 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.26 -177.23 6.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.904 0.882 . . . . 71.4 110.077 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.25 123.61 20.41 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.386 -0.598 . . . . 73.42 109.386 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 69.0 -8.1 0.71 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.809 1.643 . . . . 73.11 112.963 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.36 109.77 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.032 -0.729 . . . . 73.32 109.032 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.73 153.53 32.22 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.947 0.899 . . . . 72.13 108.67 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -129.73 118.95 22.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.337 1.055 . . . . 73.54 108.852 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.77 118.92 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.205 -1.035 . . . . 71.45 108.205 174.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 95.3 t -98.28 128.22 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 108.848 -0.797 . . . . 73.42 108.848 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.24 97.92 6.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.401 -1.703 . . . . 73.44 106.401 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 16.8 ttp180 -88.41 109.13 19.76 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.375 -0.602 . . . . 73.55 109.375 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 11.1 t -93.87 130.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.266 -1.383 . . . . 73.51 107.266 171.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -120.87 128.57 52.94 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.73 -0.841 . . . . 75.44 108.73 176.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.643 HG12 HD23 ' A' ' 126' ' ' LEU . 52.9 t -130.73 107.72 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.349 0.66 . . . . 75.3 109.874 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 13.5 m -102.81 141.23 35.97 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.465 -0.939 . . . . 71.41 108.465 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.53 46.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.004 -1.109 . . . . 74.33 108.004 173.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -142.76 127.46 18.1 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.858 0.463 . . . . 74.2 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' A' ' 73' ' ' ALA . 9.2 mp -95.17 84.93 4.17 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.471 -1.307 . . . . 73.43 107.471 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -127.13 8.29 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.268 -1.333 . . . . 54.34 111.281 -171.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.28 -25.09 22.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 75.24 110.028 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.21 117.53 20.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.277 1.031 . . . . 73.53 110.296 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -66.79 128.4 36.16 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.122 0.889 . . . . 74.43 110.749 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.633 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -70.89 -62.91 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.393 -0.966 . . . . 74.32 108.393 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.22 166.07 33.29 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.713 -1.13 . . . . 73.03 110.183 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -132.41 135.8 46.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.163 -1.421 . . . . 71.12 107.163 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.1 m -134.96 101.05 4.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.562 0.745 . . . . 73.12 109.829 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 34.7 tt0 -125.81 116.01 20.91 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.207 -0.664 . . . . 73.4 109.207 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -128.88 111.63 23.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.088 0.955 . . . . 71.13 108.94 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.6 mt-30 -84.39 84.28 7.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.316 -0.994 . . . . 73.24 108.316 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.78 93.33 3.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.784 -1.098 . . . . 71.4 108.391 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.49 145.29 21.06 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.379 -0.828 . . . . 74.13 111.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.5 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -146.74 121.46 1.43 Allowed Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 111.188 -0.765 . . . . 63.41 111.188 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 14' ' ' GLN . 40.2 mt -82.09 116.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.624 -0.88 . . . . 72.33 108.624 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.3 m-85 -121.83 121.55 37.44 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.335 1.054 . . . . 65.44 108.32 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -79.72 99.84 7.62 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.603 -0.888 . . . . 73.34 108.603 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.94 121.04 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.061 0.944 . . . . 73.42 109.375 -174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.27 161.53 42.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.387 0.675 . . . . 61.45 110.063 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.33 -29.81 8.47 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.69 0.636 . . . . 64.44 114.69 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.67 170.19 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.423 0.689 . . . . 71.14 109.976 178.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -152.74 172.29 16.92 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 123.553 0.533 . . . . 74.43 110.225 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.41 -116.31 3.49 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.422 1.487 . . . . 62.32 115.544 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 t -57.07 -31.74 65.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.31 1.444 . . . . 72.44 112.445 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -75.42 -39.15 59.28 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.482 0.713 . . . . 73.21 110.437 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mtp -77.4 -21.18 53.54 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.266 0.354 . . . . 75.53 110.617 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.28 -33.45 67.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.124 0.57 . . . . 73.22 109.708 172.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -76.16 -35.15 59.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.199 -0.91 . . . . 65.33 110.204 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -70.25 -47.52 60.95 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 122.234 -0.291 . . . . 74.53 110.226 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.16 -40.48 62.54 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.878 -0.601 . . . . 75.44 110.942 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.69 4.25 59.49 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.239 -0.756 . . . . 51.11 114.781 -168.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -146.41 -68.51 0.27 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.178 0.989 . . . . 61.4 112.434 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.477 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 92.1 t80 -68.84 -51.37 41.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.87 0.868 . . . . 75.12 113.065 -167.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.8 m -73.57 -31.74 1.44 Allowed Pre-proline 0 CA--C 1.563 1.48 0 CA-C-O 118.402 -0.808 . . . . 74.42 113.081 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.4 -42.64 34.24 Favored 'Trans proline' 0 C--N 1.395 3.01 0 C-N-CA 122.594 2.196 . . . . 72.11 112.799 159.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 91.9 m-20 -64.63 -19.51 65.74 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.646 0.778 . . . . 71.23 112.093 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.404 HD13 ' ND2' ' C' ' 132' ' ' ASN . 39.1 mm -81.6 -46.43 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.307 -0.627 . . . . 74.55 109.307 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.5 HD22 ' HA3' ' A' ' 82' ' ' GLY . 94.3 mt -78.67 -30.56 46.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.049 0.94 . . . . 71.41 113.073 -171.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -69.78 -38.36 9.47 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.005 -0.997 . . . . 72.11 112.6 -169.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -41.93 71.07 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 122.277 1.984 . . . . 64.32 113.543 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -76.53 -32.37 58.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.146 0.578 . . . . 72.52 111.848 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.23 68.44 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.296 -0.631 . . . . 75.12 109.296 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -54.86 -47.19 74.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.651 1.18 . . . . 74.14 110.623 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.38 -47.14 74.33 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.161 0.913 . . . . 73.11 110.809 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -57.6 -43.79 84.95 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.382 0.673 . . . . 75.41 110.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 76' ' ' CYS . 87.0 mt -64.69 -46.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 O-C-N 124.255 0.972 . . . . 74.32 110.142 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.511 HG21 ' HG3' ' A' ' 125' ' ' GLN . 95.7 m -52.89 -45.75 67.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.651 0.78 . . . . 72.42 111.28 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -69.37 -44.92 70.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.887 -1.051 . . . . 75.42 110.511 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -55.86 -44.59 78.19 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.654 0.781 . . . . 74.24 111.362 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 123' ' ' PHE . 41.0 t -61.9 -48.25 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.971 1.308 . . . . 74.21 110.59 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 77.9 p -68.02 -32.26 72.52 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.001 0.52 . . . . 75.5 111.628 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.29 -33.82 75.04 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.688 0.795 . . . . 74.04 110.366 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 9.53 66.54 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.462 -0.79 . . . . 64.13 113.308 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.797 HG23 ' HD2' ' B' ' 15' ' ' ARG . 17.9 m 73.2 9.13 5.28 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.388 1.075 . . . . 64.25 112.782 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.436 ' HB2' HG13 ' A' ' 118' ' ' VAL . 96.1 m-85 -85.47 138.5 36.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 107.762 -1.199 . . . . 74.32 107.762 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.24 160.2 31.87 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.702 2.268 . . . . 75.51 112.622 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.511 ' HG3' HG21 ' A' ' 115' ' ' THR . 31.1 tt0 -45.44 121.95 3.27 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 124.795 1.31 . . . . 71.43 112.507 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.643 HD23 HG12 ' A' ' 64' ' ' VAL . 48.8 tp -108.4 115.49 30.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.885 -1.052 . . . . 75.13 108.374 174.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -129.28 124.15 33.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.641 -1.163 . . . . 62.21 107.977 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.77 138.86 46.72 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.318 -0.623 . . . . 75.35 109.318 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.22 145.61 96.76 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 122.774 0.429 . . . . 64.11 110.359 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.601 ' HD3' HG21 ' C' ' 13' ' ' ILE . 23.8 Cg_exo -64.6 104.74 0.56 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.967 2.445 . . . . 75.14 112.455 -173.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 t -100.12 112.46 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.881 -1.155 . . . . 72.31 107.881 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -85.82 86.23 7.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.207 -1.405 . . . . 75.15 107.207 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -60.71 -29.18 69.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.523 -0.762 . . . . 74.1 110.659 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HB2' ' ND2' ' A' ' 104' ' ' ASN . 6.8 t70 . . . . . 0 C--N 1.356 0.87 0 C-N-CA 123.762 0.825 . . . . 74.22 109.377 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 25.3 m . . . . . 0 C--O 1.24 0.578 0 N-CA-C 106.935 -1.505 . . . . 74.04 106.935 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -139.74 130.69 26.22 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.25 -0.648 . . . . 75.12 109.25 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 2.6 pm0 -148.47 129.82 14.73 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.573 -0.528 . . . . 75.32 109.573 172.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.17 144.33 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 115.565 -0.743 . . . . 71.32 109.16 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -108.49 -47.49 3.49 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.456 -0.572 . . . . 74.43 109.456 169.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.797 ' HD2' HG23 ' A' ' 122' ' ' THR . 34.8 ttp180 -165.79 152.95 10.14 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.784 -0.644 . . . . 74.52 110.98 -170.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -131.73 139.25 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 107.343 -1.355 . . . . 64.41 107.343 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.585 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.6 p90 -161.46 168.69 23.27 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.785 0.803 . . . . 73.02 112.256 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.2 m -93.25 121.21 34.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.473 -1.239 . . . . 73.5 108.763 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.591 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 24.6 mtpp -87.66 -30.46 20.39 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.428 0.691 . . . . 75.25 110.614 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.86 145.6 18.58 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.739 HD12 ' SG ' ' B' ' 113' ' ' CYS . 28.3 mm -138.81 141.94 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.031 1.732 . . . . 71.25 109.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -150.45 117.4 5.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.181 -1.044 . . . . 71.31 108.181 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -131.81 116.18 16.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.259 -1.385 . . . . 74.11 107.259 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 157.56 27.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.405 0.682 . . . . 74.1 109.694 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.88 79.2 8.62 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.333 -1.358 . . . . 75.45 107.333 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.58 -9.81 20.09 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.006 2.471 . . . . 74.2 112.602 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.402 ' OD1' ' HB ' ' B' ' 72' ' ' THR . 3.0 m120 -116.63 11.25 14.64 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.214 1.006 . . . . 74.4 109.043 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.66 -54.51 26.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.779 1.232 . . . . 64.21 114.216 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.71 -23.27 14.63 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 121.696 1.597 . . . . 73.21 112.436 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.469 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 3.4 m-70 -90.33 -0.36 57.6 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.833 0.853 . . . . 63.14 112.044 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.95 -28.39 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.66 0.784 . . . . 72.31 111.857 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.0 -23.15 64.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.083 0.953 . . . . 75.42 112.146 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.574 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -70.0 -40.01 75.53 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.746 -0.465 . . . . 71.33 109.746 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.574 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 78.5 mttt -109.73 64.52 0.61 Allowed 'General case' 0 C--N 1.359 1.02 0 N-CA-C 108.434 -0.95 . . . . 73.24 108.434 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 9.4 p-10 -78.61 94.06 4.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.921 -0.581 . . . . 64.32 110.388 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' B' ' 35' ' ' ASP . 0.4 OUTLIER 173.93 -173.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.945 1.298 . . . . 75.13 111.024 159.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -55.08 117.99 16.22 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.037 1.335 . . . . 55.04 112.503 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.49 169.31 22.12 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.742 2.295 . . . . 74.31 111.166 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.55 102.01 3.73 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 106.882 -1.525 . . . . 74.53 106.882 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 m -89.95 140.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.807 -1.088 . . . . 74.12 108.976 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -119.1 130.57 55.66 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.239 -0.652 . . . . 75.43 109.239 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.615 HD22 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -86.04 136.91 33.05 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.032 -1.47 . . . . 74.03 107.032 168.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 18.4 t0 -142.88 128.36 19.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.77 -1.196 . . . . 75.43 107.77 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.447 HD23 ' HE1' ' B' ' 133' ' ' PHE . 1.4 mp -131.38 126.49 35.34 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.093 -1.077 . . . . 73.21 108.093 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.3 t70 -123.3 142.61 50.76 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.49 1.116 . . . . 75.3 108.371 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -117.39 119.26 34.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.088 0.555 . . . . 72.53 110.411 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.32 135.29 33.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.9 0.88 . . . . 64.34 108.912 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -134.62 169.91 16.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.318 0.647 . . . . 74.04 110.054 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -151.97 163.86 38.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.561 0.744 . . . . 70.33 110.232 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -108.58 120.08 41.39 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.812 -0.811 . . . . 75.45 108.812 170.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.57 HD13 ' HB2' ' B' ' 57' ' ' GLU . 17.6 mt -92.06 -46.03 8.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.847 0.859 . . . . 74.32 109.336 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.93 -178.86 6.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.3 -1.318 . . . . 74.52 108.803 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.52 122.39 18.94 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.956 -1.02 . . . . 73.22 108.825 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 71.59 -4.3 1.92 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.644 1.577 . . . . 73.11 112.699 -173.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.6 t -106.16 107.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.925 -0.769 . . . . 75.03 108.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.43 140.71 50.97 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.182 0.993 . . . . 75.12 109.586 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.57 ' HB2' HD13 ' B' ' 51' ' ' LEU . 40.2 tt0 -102.72 138.48 39.57 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.916 0.886 . . . . 55.11 109.369 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -115.08 122.94 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.309 1.044 . . . . 75.01 108.301 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.94 116.21 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.539 0.736 . . . . 73.13 109.479 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.59 108.44 19.96 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.907 -0.775 . . . . 74.23 108.907 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.526 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 55.0 ttt180 -86.89 106.19 17.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.828 0.851 . . . . 72.14 108.834 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.02 115.72 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.948 -0.76 . . . . 64.11 108.948 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 16.8 m -116.12 136.12 53.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.211 1.004 . . . . 73.1 109.302 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.427 HG23 HD12 ' B' ' 114' ' ' ILE . 54.1 t -120.0 125.03 73.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.811 1.245 . . . . 75.41 109.086 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -124.89 125.9 44.68 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.689 -0.486 . . . . 74.52 109.689 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.88 146.48 48.39 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.309 1.044 . . . . 74.43 109.335 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.2 p -149.16 128.93 13.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.443 0.535 . . . . 72.02 112.443 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' B' ' 34' ' ' LYS . 82.7 mt -97.32 108.4 21.12 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.396 1.079 . . . . 74.12 109.299 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.57 -124.2 7.96 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.002 -0.545 . . . . 73.0 111.784 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.9 1.96 46.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.378 0.671 . . . . 60.24 110.857 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -127.71 177.18 6.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.942 -0.474 . . . . 74.03 110.651 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' THR . . . . . 0.402 ' HB ' ' OD1' ' B' ' 27' ' ' ASN . 11.9 m -68.49 157.46 35.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.534 1.133 . . . . 74.12 110.709 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.59 -58.68 2.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.018 -0.734 . . . . 75.1 109.018 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -162.73 158.45 22.98 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.237 -1.347 . . . . 63.21 108.266 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -124.08 138.71 54.4 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.724 1.209 . . . . 74.31 108.589 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -146.88 149.47 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.274 -0.639 . . . . 72.04 109.274 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -165.34 133.76 3.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.535 0.734 . . . . 73.21 109.036 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' B' ' 110' ' ' ALA . 96.6 t -127.02 145.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.526 1.13 . . . . 73.33 108.704 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.526 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.1 mt-30 -126.03 96.89 4.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.258 -1.015 . . . . 71.33 108.258 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -94.42 107.17 19.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.634 -0.712 . . . . 75.42 109.127 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.591 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -109.35 141.59 16.06 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.237 -0.745 . . . . 55.43 111.237 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.71 132.4 5.89 Favored Glycine 0 CA--C 1.503 -0.682 0 N-CA-C 110.35 -1.1 . . . . 73.45 110.35 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.439 HG23 HD12 ' B' ' 51' ' ' LEU . 80.5 mt -85.73 125.95 40.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 123.509 0.724 . . . . 75.44 109.164 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -133.06 160.93 35.75 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.421 1.088 . . . . 74.34 108.629 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.517 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 50.9 m -129.41 112.96 14.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.29 -1.004 . . . . 74.24 108.29 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.662 ' HB ' HD13 ' B' ' 89' ' ' ILE . 40.1 pt -119.31 144.45 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.228 1.011 . . . . 74.04 110.314 -173.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.57 156.65 33.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 73.33 109.092 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.72 -61.11 3.5 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.304 0.377 . . . . 73.2 112.542 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.662 HD13 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 133.59 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.524 0.73 . . . . 74.21 111.676 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -152.02 147.51 26.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.073 0.549 . . . . 74.14 110.433 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.42 -104.41 0.98 Allowed Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.468 -0.787 . . . . 53.35 112.506 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -78.58 -35.04 46.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 75.43 110.465 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -64.99 -41.71 95.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.329 0.652 . . . . 72.44 110.021 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 58.4 ttp -70.13 -37.43 75.3 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.813 -0.631 . . . . 73.4 110.66 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.19 75.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.066 0.547 . . . . 73.3 111.258 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.82 -41.8 59.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.504 0.722 . . . . 73.41 110.628 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.83 -65.53 0.73 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.85 -0.614 . . . . 63.04 110.235 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -34.42 78.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.277 1.031 . . . . 71.35 111.305 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.79 54.73 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.568 -0.573 . . . . 53.51 114.509 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.41 -57.84 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 117.824 0.812 . . . . 74.44 112.012 -173.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -61.88 -56.83 15.26 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.991 0.916 . . . . 72.51 112.036 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.499 ' HA ' HD13 ' B' ' 105' ' ' ILE . 61.9 m -62.39 -43.24 84.28 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 124.124 0.969 . . . . 72.53 112.808 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.38 -46.38 33.88 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.536 2.157 . . . . 74.43 112.757 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -20.44 63.58 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 123.719 0.808 . . . . 74.43 112.743 -177.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' B' ' 102' ' ' CYS . 73.3 mt -71.58 -52.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.022 0.529 . . . . 74.41 110.311 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 pp -91.41 -6.18 53.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.554 -0.748 . . . . 74.45 112.166 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.22 -44.36 88.46 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.58 1.152 . . . . 75.35 112.684 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -53.21 -34.82 71.11 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.674 2.25 . . . . 74.44 113.802 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -73.46 -42.57 61.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.16 0.584 . . . . 74.15 110.515 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.464 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -60.97 -42.31 98.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.132 0.573 . . . . 52.41 110.558 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -57.27 -57.66 11.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.903 1.281 . . . . 73.13 111.089 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.03 -28.07 68.59 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.225 1.01 . . . . 75.45 110.876 -172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' B' ' 21' ' ' ILE . 8.1 t -74.0 -41.51 61.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.623 0.369 . . . . 73.41 110.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.562 HG22 HD21 ' B' ' 126' ' ' LEU . 63.1 mt -62.09 -41.68 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.375 -0.602 . . . . 74.35 109.375 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.569 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.5 m -62.28 -35.99 80.7 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.714 1.206 . . . . 64.52 111.449 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -70.01 -52.77 21.42 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.12 0.568 . . . . 73.21 109.875 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -65.43 -36.97 85.53 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.713 0.633 . . . . 74.14 112.028 -170.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.63 -34.12 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 122.481 0.312 . . . . 73.51 110.651 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -77.05 -21.73 54.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.341 0.656 . . . . 70.23 111.066 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -73.54 -34.65 65.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.13 0.572 . . . . 75.23 109.822 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.71 5.65 45.14 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.706 0.629 . . . . 62.24 112.549 169.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 17' ' ' TYR . 49.4 p 59.43 46.83 11.87 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.614 1.965 . . . . 73.54 111.679 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -119.48 157.05 52.64 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 113.898 -1.501 . . . . 75.01 109.781 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.57 143.89 76.73 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.902 2.401 . . . . 74.24 112.178 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.569 ' HB2' HG23 ' B' ' 115' ' ' THR . 3.4 pt20 -63.44 156.68 25.39 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.064 0.852 . . . . 71.35 111.993 -174.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.562 HD21 HG22 ' B' ' 114' ' ' ILE . 9.7 tt -125.23 105.01 8.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.353 -1.351 . . . . 75.32 107.353 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -91.44 115.72 28.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.997 -0.742 . . . . 70.44 108.997 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.615 HD13 HD22 ' B' ' 42' ' ' LEU . 1.1 mm? -67.16 107.56 2.37 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.197 -1.038 . . . . 74.24 108.197 166.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 158.05 54.68 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.127 0.971 . . . . 74.33 111.154 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -61.43 85.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 122.261 1.974 . . . . 74.12 112.153 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.07 110.79 22.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.269 -0.641 . . . . 75.45 109.269 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -82.3 104.22 12.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.256 -1.016 . . . . 73.15 108.256 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . 0.447 ' HE1' HD23 ' B' ' 44' ' ' LEU . 87.1 m-85 . . . . . 0 N--CA 1.481 1.11 0 C-N-CA 123.429 0.692 . . . . 74.41 111.306 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.62 ' HA ' HD12 ' C' ' 89' ' ' ILE . 58.0 ttp . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 113.133 0.79 . . . . 74.03 113.133 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.6 m -93.77 80.52 4.21 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.588 -0.893 . . . . 72.2 108.588 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -104.45 126.91 51.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.597 -0.729 . . . . 70.12 109.669 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.662 ' HG2' ' HB3' ' C' ' 85' ' ' SER . 1.6 pm0 -143.23 132.85 23.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.855 0.862 . . . . 72.33 109.808 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.601 HG21 ' HD3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -79.56 130.28 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.516 0.726 . . . . 72.31 109.213 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.6 mm100 -92.58 -54.2 3.88 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.398 -0.364 . . . . 72.52 110.104 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -169.02 126.84 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.825 0.45 . . . . 72.15 109.961 -173.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.556 HG13 HD12 ' C' ' 13' ' ' ILE . 80.0 mt -106.13 145.0 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.428 -1.323 . . . . 74.2 107.428 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -174.38 143.74 0.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.045 -0.724 . . . . 75.53 109.045 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -69.84 111.35 5.52 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.644 -0.873 . . . . 65.51 108.644 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -65.36 -42.18 93.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.594 0.711 . . . . 73.41 109.506 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -149.06 141.87 24.63 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.433 -1.258 . . . . 73.24 108.951 -176.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.1 mt -130.46 143.43 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.092 -1.447 . . . . 73.22 107.092 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -152.87 151.29 30.22 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.41 0.624 . . . . 72.24 110.897 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 73.1 t80 -152.41 121.19 6.51 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 107.101 -1.444 . . . . 73.45 107.101 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.3 mt-10 -122.85 112.08 17.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.23 80.96 67.18 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.032 -1.099 . . . . 64.12 108.032 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.2 -36.65 16.08 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.169 1.912 . . . . 75.44 111.135 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.45 ' O ' HG21 ' C' ' 31' ' ' VAL . 1.7 m-20 -85.07 14.25 5.24 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.465 1.106 . . . . 73.34 111.174 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.3 -56.99 4.88 Favored Pre-proline 0 N--CA 1.497 1.88 0 C-N-CA 125.773 1.629 . . . . 75.23 114.599 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.4 -29.43 13.74 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.754 1.636 . . . . 74.11 111.997 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -69.76 -24.92 63.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.211 1.004 . . . . 74.53 112.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.453 HG22 ' HZ2' ' C' ' 34' ' ' LYS . 58.4 t -64.4 -26.87 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.246 0.218 . . . . 75.03 111.226 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.02 0.0 12.61 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.875 0.695 . . . . 75.34 112.875 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -127.97 9.17 6.28 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.393 0.677 . . . . 73.04 110.959 170.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.684 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 3.4 ttmp? -87.9 151.92 22.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.335 1.054 . . . . 74.2 111.229 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.36 125.82 26.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.805 1.242 . . . . 73.15 109.617 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -82.78 70.84 9.85 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.277 0.631 . . . . 74.31 110.181 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -163.08 71.38 1.97 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.154 0.581 . . . . 73.23 109.924 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.04 154.14 8.37 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.86 2.374 . . . . 72.24 110.629 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.14 88.08 7.61 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.522 -1.288 . . . . 73.43 107.522 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -59.04 137.34 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 114.4 -1.273 . . . . 73.43 109.948 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 8.8 tmtt? -135.99 115.77 13.04 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.026 0.531 . . . . 70.43 109.771 -166.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.58 130.37 34.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.024 0.929 . . . . 75.21 108.591 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.442 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.2 t70 -142.78 106.34 4.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.827 0.451 . . . . 62.4 109.933 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.42 123.02 49.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.463 0.705 . . . . 74.31 110.315 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.663 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 2.5 m-20 -111.71 154.29 25.2 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.426 -0.953 . . . . 75.1 108.426 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -113.35 111.69 22.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.672 0.789 . . . . 74.13 109.379 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.21 136.49 53.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.159 0.984 . . . . 74.15 108.914 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.5 p -134.85 156.68 48.48 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.999 0.52 . . . . 73.33 110.283 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.28 126.82 15.08 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.257 1.023 . . . . 63.43 108.376 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -88.25 117.25 27.02 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.105 -1.072 . . . . 73.0 108.105 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.52 HD13 HD13 ' C' ' 83' ' ' ILE . 58.3 mt -87.71 -40.47 14.09 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.502 -0.772 . . . . 72.24 109.521 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.75 -173.01 3.07 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.718 -1.128 . . . . 73.54 110.101 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.56 120.56 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.719 -1.128 . . . . 61.23 109.049 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.64 1.13 3.25 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.978 1.311 . . . . 74.4 112.831 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -112.01 95.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 107.757 -1.201 . . . . 72.34 107.757 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -119.64 125.59 49.1 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.759 0.824 . . . . 74.4 109.615 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.2 119.43 24.54 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.022 -0.99 . . . . 62.45 109.531 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.11 123.02 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.854 -1.165 . . . . 74.31 107.854 172.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.84 132.76 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.875 0.87 . . . . 73.54 108.699 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.78 112.23 23.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.38 -0.97 . . . . 73.24 108.38 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.663 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 1.6 tmm_? -82.53 104.18 12.61 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.847 -1.538 . . . . 72.44 106.847 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.22 133.22 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.264 -1.013 . . . . 62.44 108.264 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 94.3 m -128.77 133.88 48.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 175.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 39.1 t -121.43 112.2 34.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.751 -0.833 . . . . 71.53 108.751 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.484 HG21 HD23 ' C' ' 75' ' ' LEU . 2.2 m -99.74 148.72 24.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.704 -0.85 . . . . 75.14 108.704 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.96 108.43 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.342 -1.355 . . . . 75.3 107.342 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.0 m -146.67 139.85 25.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.06 -0.718 . . . . 73.33 109.06 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.92 45.99 0.94 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.131 0.972 . . . . 73.43 109.228 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.88 -116.61 4.05 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 114.795 -1.093 . . . . 74.41 111.043 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 -19.85 26.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.318 0.647 . . . . 73.31 110.024 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.684 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 12.4 tp10 -81.31 99.84 8.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.178 0.991 . . . . 73.44 109.252 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -87.96 131.25 34.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.984 0.421 . . . . 75.1 110.602 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.672 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -79.0 -64.0 1.29 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.616 1.166 . . . . 71.5 110.385 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -163.34 176.57 9.74 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.586 0.708 . . . . 71.23 110.149 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.9 tm? -141.56 139.13 33.1 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.603 -1.628 . . . . 74.34 106.603 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 50.0 t -143.87 116.25 8.54 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.029 -0.73 . . . . 73.25 109.029 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -124.77 131.96 53.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.515 0.726 . . . . 72.21 109.414 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -132.99 115.73 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.233 1.013 . . . . 75.31 109.386 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.649 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 40.4 mt-30 -89.45 91.25 8.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.319 1.048 . . . . 71.32 108.209 172.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -88.79 119.04 28.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.321 -0.854 . . . . 75.2 110.122 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.39 159.3 15.04 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 123.588 0.555 . . . . 64.2 112.26 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.04 119.13 0.88 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.567 -1.013 . . . . 74.12 110.567 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.52 HD13 HD13 ' C' ' 51' ' ' LEU . 18.2 mm -79.78 122.08 34.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.607 -1.257 . . . . 75.11 107.607 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.72 124.79 36.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.548 0.739 . . . . 73.25 109.233 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.662 ' HB3' ' HG2' ' C' ' 12' ' ' GLN . 10.5 t -87.46 109.84 19.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.091 -1.077 . . . . 60.24 108.091 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.407 HD12 ' SD ' ' C' ' 94' ' ' MET . 22.6 pt -115.32 123.24 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.801 1.24 . . . . 73.44 109.205 -175.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.75 170.42 19.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.816 0.446 . . . . 72.34 111.726 -171.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.34 -48.34 1.92 Allowed Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.372 -0.831 . . . . 33.12 113.149 170.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.74 176.32 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.401 0.681 . . . . 62.54 110.929 -174.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.48 -171.23 3.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.028 0.931 . . . . 72.32 109.196 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.08 -147.98 47.02 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.527 0.517 . . . . 73.3 113.193 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 73.7 p -67.9 -18.69 64.86 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.007 0.923 . . . . 73.35 111.733 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -66.25 -43.95 85.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.684 0.794 . . . . 75.1 110.278 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.407 ' SD ' HD12 ' C' ' 86' ' ' ILE . 3.5 tmm? -81.32 -44.56 17.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.518 -0.765 . . . . 73.51 109.189 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.8 -25.67 67.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.237 1.015 . . . . 64.04 112.117 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -58.56 -47.16 85.17 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.701 0.8 . . . . 71.14 110.334 171.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.86 -55.07 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.352 -0.386 . . . . 73.21 111.292 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tt -62.09 -35.83 79.87 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.014 0.525 . . . . 74.34 111.462 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.0 -4.86 62.91 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.045 -0.864 . . . . 73.21 114.437 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.35 -53.07 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 118.558 1.179 . . . . 74.52 112.681 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.76 -48.18 60.26 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.973 0.509 . . . . 74.35 112.121 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.28 -43.76 94.29 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.449 0.7 . . . . 75.22 111.988 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.94 -47.37 21.69 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.78 2.32 . . . . 65.43 113.909 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -62.37 -29.12 70.25 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.392 0.677 . . . . 64.35 112.178 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -75.1 -50.84 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.926 0.491 . . . . 72.03 110.252 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.14 -18.41 53.23 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.909 -0.587 . . . . 73.44 112.225 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.52 -54.6 53.27 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.677 -1.154 . . . . 71.31 112.702 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.79 -32.2 92.63 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.939 1.759 . . . . 75.1 112.843 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -66.45 -47.32 73.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.541 0.737 . . . . 73.3 110.962 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.91 84.62 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.122 0.569 . . . . 72.15 110.524 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.583 ' HG3' HD22 ' C' ' 128' ' ' LEU . 56.2 ttt180 -61.1 -49.17 78.4 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.907 1.283 . . . . 75.13 110.943 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.34 -29.99 69.69 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.619 0.574 . . . . 73.14 110.082 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.493 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.0 t -73.91 -36.56 64.73 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.182 0.593 . . . . 74.22 111.42 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.585 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 91.7 mt -68.63 -47.85 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.486 0.714 . . . . 75.22 109.754 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 98.7 m -60.45 -35.78 76.67 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.077 1.351 . . . . 71.34 111.306 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -41.68 80.67 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.51 0.724 . . . . 74.45 109.844 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.59 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.37 -35.09 78.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.334 0.654 . . . . 75.44 111.796 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.445 HG22 ' O ' ' C' ' 114' ' ' ILE . 96.7 t -62.56 -44.11 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.407 0.683 . . . . 73.31 109.896 173.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.7 p -75.03 -25.78 58.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.549 -0.75 . . . . 75.14 112.223 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.513 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.2 mtt-85 -74.58 -40.17 61.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.69 0.796 . . . . 74.43 110.391 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 3.1 66.13 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.736 0.647 . . . . 72.03 112.56 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.424 HG22 ' O ' ' D' ' 16' ' ' ILE . 43.0 p 61.31 24.32 14.44 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.154 1.781 . . . . 72.31 112.533 170.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -83.88 154.65 64.6 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.739 -1.119 . . . . 74.12 110.118 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -47.71 137.16 21.27 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.483 2.789 . . . . 75.12 113.154 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' B' ' 125' ' ' GLN . 23.7 mm-40 -60.95 147.26 43.91 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.205 1.187 . . . . 63.21 114.205 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 68.3 tp -125.14 96.1 4.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.483 -1.235 . . . . 75.35 108.693 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.8 105.1 16.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.489 -0.93 . . . . 74.42 108.489 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.583 HD22 ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -71.15 151.26 44.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.699 0.8 . . . . 74.42 111.935 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.09 155.61 72.35 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 115.151 -0.931 . . . . 74.21 109.946 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.611 ' HG2' HG21 ' A' ' 13' ' ' ILE . 34.4 Cg_exo -60.54 102.63 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.375 2.05 . . . . 65.33 111.95 171.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.18 106.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 106.7 -1.592 . . . . 74.42 106.7 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.404 ' ND2' HD13 ' A' ' 105' ' ' ILE . 78.7 m-20 -113.03 91.63 3.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.109 -0.951 . . . . 74.51 109.767 -169.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -64.35 -43.91 93.1 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 74.11 110.878 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t70 . . . . . 0 N--CA 1.47 0.548 0 CA-C-N 115.245 -0.889 . . . . 74.24 111.419 -176.642 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.11 -0.7 . . . . 72.42 109.11 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' D' ' 85' ' ' SER . 29.1 t80 -157.79 98.62 1.65 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.057 -1.46 . . . . 74.24 107.057 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -130.18 128.1 41.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.652 -1.24 . . . . 74.43 107.652 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 17.5 mt -70.87 136.28 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 123.685 0.616 . . . . 72.12 110.329 -174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -94.71 -47.54 6.45 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.682 -0.69 . . . . 74.44 110.29 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.04 145.88 22.48 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.3 0.64 . . . . 71.32 110.558 -166.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.424 ' O ' HG22 ' C' ' 122' ' ' THR . 1.1 mp -133.23 137.02 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 105.033 -2.21 . . . . 75.24 105.033 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -169.22 153.3 5.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.634 0.73 . . . . 74.41 110.691 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -84.4 118.43 24.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.688 -0.856 . . . . 74.2 108.688 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -80.2 -37.61 32.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 74.21 110.228 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 22.3 t70 -151.1 140.87 21.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.914 -1.039 . . . . 72.43 109.129 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.59 HG23 ' HE1' ' C' ' 117' ' ' MET . 67.1 mt -135.98 145.65 30.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 124.252 1.021 . . . . 73.44 108.25 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 22' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 45.2 t -147.88 133.52 18.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 62.11 108.244 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.4 t80 -144.68 117.58 8.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.849 -1.908 . . . . 71.11 105.849 170.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.14 129.0 51.93 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.294 -0.632 . . . . 71.31 109.294 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.21 79.67 27.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.205 -1.035 . . . . 73.04 108.205 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.86 -28.28 20.15 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.66 2.24 . . . . 72.25 112.743 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -113.71 40.69 2.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.501 -0.925 . . . . 74.12 108.501 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.433 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -58.97 -65.08 2.22 Favored Pre-proline 0 CA--C 1.568 1.666 0 N-CA-C 114.139 1.163 . . . . 72.43 114.139 -167.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.498 ' HB3' HD11 ' C' ' 83' ' ' ILE . 61.6 Cg_endo -81.82 -11.0 11.53 Favored 'Trans proline' 0 C--N 1.393 2.901 0 CA-C-N 122.624 1.973 . . . . 74.34 112.067 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -71.4 -42.9 67.78 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.931 1.292 . . . . 75.14 110.107 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.23 -35.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 N-CA-C 109.504 -0.554 . . . . 74.51 109.504 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -58.05 -12.13 3.12 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.395 1.078 . . . . 74.11 113.55 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.64 -36.55 51.42 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.181 0.593 . . . . 75.45 110.685 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 60.97 1.67 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.861 0.464 . . . . 75.21 111.399 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -98.6 101.23 12.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.675 . . . . 73.11 111.044 -169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -122.59 -158.98 0.81 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.195 0.998 . . . . 75.13 108.671 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -58.24 106.52 0.71 Allowed Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.539 0.736 . . . . 74.3 110.589 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.35 122.21 5.06 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.819 2.346 . . . . 71.52 110.515 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.96 111.28 6.22 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.902 -1.148 . . . . 72.41 107.902 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 29.3 m -100.9 144.86 12.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.318 0.647 . . . . 73.31 110.081 -177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -120.05 129.22 54.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 74.35 108.468 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.01 112.11 24.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.506 -0.553 . . . . 75.23 109.506 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.753 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 12.9 m-20 -108.07 132.05 53.96 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.994 0.918 . . . . 75.21 109.912 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -110.8 131.41 55.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.262 0.625 . . . . 73.12 109.434 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.8 t70 -133.55 131.46 39.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.487 -1.301 . . . . 52.41 107.487 172.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -105.52 141.81 36.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.98 0.512 . . . . 74.41 109.883 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.64 164.04 37.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.787 0.835 . . . . 70.32 109.071 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.1 p -174.92 161.04 2.94 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.376 0.67 . . . . 74.32 110.896 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 86.6 p -152.17 145.71 24.91 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.76 0.824 . . . . 73.43 109.474 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -81.92 130.93 35.22 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.284 -0.636 . . . . 73.51 109.284 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' D' ' 57' ' ' GLU . 54.6 mt -104.38 -34.93 8.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.134 0.573 . . . . 75.4 109.511 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . 0.449 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -162.51 -174.88 4.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.159 0.584 . . . . 71.24 111.082 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.34 116.14 7.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.535 -1.211 . . . . 71.42 109.189 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 68.05 7.25 5.7 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.465 1.106 . . . . 64.14 112.126 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 88.1 t -113.51 119.06 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.322 1.049 . . . . 71.33 108.533 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.49 134.2 31.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.705 0.402 . . . . 75.12 110.055 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.464 ' HB2' HD11 ' D' ' 51' ' ' LEU . 11.0 tt0 -88.22 114.5 24.9 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.857 -1.164 . . . . 73.43 107.857 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.09 120.11 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.617 -1.253 . . . . 75.55 107.617 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.9 t -105.61 131.93 53.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.668 0.787 . . . . 73.31 109.064 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.24 108.15 13.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.497 -1.297 . . . . 75.0 107.497 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.529 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.3 ttm-85 -84.11 106.24 15.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.991 -0.744 . . . . 74.22 108.991 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.26 130.49 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.267 -1.012 . . . . 73.22 108.267 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 54.2 m -124.73 147.47 48.62 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.429 0.691 . . . . 75.15 109.15 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -135.95 115.74 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.666 1.186 . . . . 74.24 109.07 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.5 m -106.29 103.63 13.15 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 74.11 109.446 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.18 125.06 41.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.456 0.302 . . . . 70.21 110.386 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 52.2 p -125.55 125.47 43.27 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.001 0.92 . . . . 73.11 109.359 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' D' ' 73' ' ' ALA . 3.2 tm? -104.47 114.05 28.02 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.455 -0.943 . . . . 75.13 108.455 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -111.22 3.84 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.621 0.575 . . . . 34.52 111.998 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 8.38 19.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.12 0.968 . . . . 74.42 110.97 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 175.26 9.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.492 0.717 . . . . 73.34 110.119 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -80.28 137.06 36.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.495 0.718 . . . . 74.42 111.07 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' D' ' 68' ' ' LEU . . . -84.89 -63.97 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.718 -0.845 . . . . 71.51 108.718 170.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.46 168.67 24.75 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.423 -1.262 . . . . 73.21 109.994 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 97.7 mt -132.7 151.62 51.93 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.89 -1.152 . . . . 74.24 107.89 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.598 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -154.9 141.29 18.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.155 0.582 . . . . 74.34 109.939 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 33.3 tt0 -158.14 134.68 9.59 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 71.13 109.995 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.94 126.23 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.746 0.818 . . . . 74.42 109.302 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -97.22 87.22 4.12 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.678 -1.23 . . . . 72.01 107.678 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.89 98.76 8.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.847 -0.615 . . . . 70.12 109.562 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.49 144.36 17.13 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.596 -0.729 . . . . 60.42 111.698 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.49 131.05 3.74 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.314 -0.715 . . . . 73.05 111.314 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -90.33 126.98 43.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.376 -0.972 . . . . 70.12 108.376 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -126.96 144.39 51.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.01 0.924 . . . . 64.2 110.075 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 4.4 m -96.81 94.51 7.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.51 -0.922 . . . . 74.25 108.51 174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.49 HG23 ' HE3' ' D' ' 94' ' ' MET . 15.1 mt -108.78 101.06 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.361 -0.607 . . . . 74.5 109.361 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.42 1.088 . . . . 61.34 109.838 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.81 -11.33 59.97 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 114.343 0.497 . . . . 64.14 114.343 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.21 154.46 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.021 0.928 . . . . 74.31 110.781 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 -174.52 4.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.283 1.033 . . . . 75.33 110.043 172.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.54 -140.51 39.01 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 114.282 0.473 . . . . 71.0 114.282 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.9 p -70.84 -32.6 69.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.315 1.046 . . . . 75.12 112.037 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.19 -43.45 78.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.715 0.806 . . . . 72.34 110.649 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.49 ' HE3' HG23 ' D' ' 86' ' ' ILE . 1.3 tmt? -74.06 -32.81 63.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.811 -0.631 . . . . 72.33 110.506 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.37 96.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.943 0.497 . . . . 65.31 110.461 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.09 -36.05 76.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.715 0.806 . . . . 74.4 110.884 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.54 -50.43 67.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.864 0.465 . . . . 75.43 111.498 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.488 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 2.9 pp -75.63 -23.35 56.35 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 111.974 0.361 . . . . 74.45 111.974 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.33 -0.98 56.84 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.53 -0.595 . . . . 72.4 114.361 -172.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.6 -60.69 0.51 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.241 0.52 . . . . 53.2 111.068 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -68.18 -45.71 72.71 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.577 0.751 . . . . 73.45 111.51 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 63.5 m -65.66 -45.76 67.06 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-O 118.695 -0.669 . . . . 74.32 112.018 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -54.25 -34.93 81.62 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.665 2.243 . . . . 70.32 113.908 168.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -66.85 -26.43 66.9 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.85 0.46 . . . . 75.3 111.775 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 32.6 mm -75.71 -47.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.165 0.586 . . . . 74.55 109.775 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.02 -32.23 59.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.154 -0.93 . . . . 70.34 112.609 -169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -62.71 -44.57 86.75 Favored Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 118.177 -0.916 . . . . 65.22 113.042 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.98 -39.02 80.48 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.552 2.168 . . . . 63.33 113.996 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -79.87 -28.31 39.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.156 0.582 . . . . 75.53 111.906 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.21 66.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.798 -0.815 . . . . 65.43 108.798 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -60.84 -35.08 75.63 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.003 1.321 . . . . 73.14 111.396 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.513 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.0 tt0 -56.05 -53.54 55.74 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.021 0.928 . . . . 75.23 110.424 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -67.25 -42.3 84.14 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.806 -1.088 . . . . 71.42 111.306 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.598 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.7 mt -58.57 -60.05 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.822 0.849 . . . . 54.1 110.486 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.431 HG23 ' HB3' ' D' ' 125' ' ' GLN . 97.6 m -52.51 -43.56 65.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.512 1.125 . . . . 72.31 112.1 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.9 t -68.15 -36.96 80.49 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.501 -0.772 . . . . 73.02 111.014 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.517 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 77.7 mtm -67.87 -37.77 82.22 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.662 0.385 . . . . 55.34 111.315 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.9 t -65.41 -41.6 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.324 -0.853 . . . . 73.33 110.337 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 78.3 p -72.28 -30.47 64.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.162 0.585 . . . . 73.14 111.388 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.51 -29.95 65.38 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.927 0.491 . . . . 74.33 110.56 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 6.67 73.66 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.591 0.557 . . . . 75.15 112.456 174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 60.5 25.45 15.08 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 126.591 1.956 . . . . 74.33 113.342 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.18 159.68 31.57 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.575 1.15 . . . . 72.24 108.441 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.76 135.01 29.36 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.473 2.116 . . . . 73.3 111.021 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.431 ' HB3' HG23 ' D' ' 115' ' ' THR . 26.7 mt-30 -49.19 120.03 3.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.381 1.051 . . . . 74.15 110.842 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.02 94.05 5.03 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.501 -0.925 . . . . 75.35 108.501 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -100.65 104.23 15.54 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.207 -1.361 . . . . 73.32 107.946 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.37 143.76 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.863 -0.608 . . . . 73.31 111.459 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.46 133.3 95.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 114.968 -1.014 . . . . 63.45 110.757 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.39 124.61 5.37 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.643 2.229 . . . . 73.02 111.119 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.72 109.36 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.628 -0.879 . . . . 72.44 108.628 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -72.63 96.37 1.98 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.043 -1.095 . . . . 73.44 108.043 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 N--CA 1.478 0.953 0 C-N-CA 123.302 0.641 . . . . 72.34 112.023 -174.418 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.702 -0.851 . . . . 75.35 108.702 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.489 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.1 t80 -137.7 134.42 35.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 73.51 110.139 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -154.54 136.0 14.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.101 -1.409 . . . . 74.3 107.396 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.559 HD12 HD22 ' C' ' 132' ' ' ASN . 32.0 mt -92.44 130.84 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.322 -0.622 . . . . 75.4 109.322 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -98.1 -41.33 7.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.779 -0.629 . . . . 71.31 110.537 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -177.89 123.5 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 112.926 0.713 . . . . 64.32 112.926 -170.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.596 HD11 ' HG3' ' C' ' 130' ' ' PRO . 4.0 mp -104.61 134.74 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.836 -1.172 . . . . 71.45 107.836 168.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.502 ' HB3' HG23 ' B' ' 122' ' ' THR . 22.9 p90 -166.16 152.42 9.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.484 1.113 . . . . 71.31 109.416 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -75.51 118.28 18.2 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.871 -0.788 . . . . 74.01 108.871 172.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -80.56 -24.33 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.65 -0.5 . . . . 72.43 109.65 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -158.91 143.3 15.62 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.1 -0.954 . . . . 75.21 109.8 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.0 mt -132.33 146.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.914 1.286 . . . . 71.51 107.972 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.89 135.13 15.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.491 0.717 . . . . 73.21 109.516 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.9 t80 -138.06 131.21 30.26 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.686 -1.598 . . . . 74.21 106.686 171.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -133.6 114.21 13.28 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.276 0.63 . . . . 64.24 109.556 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.39 83.03 1.37 Allowed Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.496 -1.668 . . . . 70.22 106.496 162.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.58 -31.94 16.04 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 122.605 2.203 . . . . 73.44 112.155 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -113.88 22.9 13.52 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.278 1.031 . . . . 75.0 109.053 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.54 -63.11 1.11 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-O 117.997 -1.002 . . . . 74.13 113.384 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.51 -17.42 59.92 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.024 1.816 . . . . 73.43 113.354 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -85.9 -52.4 5.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.929 0.871 . . . . 72.23 109.995 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -70.52 -21.7 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.034 -1.439 . . . . 71.01 111.941 -160.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -64.42 -30.1 71.15 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.534 0.734 . . . . 74.44 112.22 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.83 -11.58 20.64 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.217 0.607 . . . . 75.34 112.423 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -78.64 171.74 14.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.01 0.524 . . . . 71.44 111.086 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.37 118.22 6.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.052 0.941 . . . . 75.44 110.741 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -79.84 82.37 5.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.573 0.702 . . . . 74.2 110.097 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -126.12 70.28 68.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.419 1.087 . . . . 74.03 108.948 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.74 127.67 8.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.609 2.206 . . . . 74.31 112.045 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -97.97 93.95 6.6 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.854 -1.536 . . . . 64.25 106.854 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.5 m -76.73 106.11 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.617 -1.174 . . . . 75.02 110.578 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 16.7 mtpp -81.73 134.96 35.5 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.959 -1.019 . . . . 74.43 110.402 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tt -110.74 106.45 15.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 106.154 -1.795 . . . . 75.13 106.154 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.683 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.3 m-20 -114.16 142.33 46.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.228 -1.397 . . . . 64.42 107.228 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.708 HD22 HD11 ' A' ' 60' ' ' LEU . 5.7 tt -141.46 128.64 20.93 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.948 -1.13 . . . . 74.12 107.948 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -117.15 134.28 54.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.581 1.153 . . . . 74.44 108.678 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.4 p -110.57 123.1 49.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.906 -1.043 . . . . 74.41 110.589 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.93 131.69 37.55 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.683 0.793 . . . . 71.23 110.477 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.55 152.56 51.92 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.035 0.445 . . . . 64.22 110.325 171.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 163.64 39.01 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.952 1.301 . . . . 71.1 108.233 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -112.54 146.56 38.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.206 0.602 . . . . 73.0 109.515 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 83' ' ' ILE . 57.8 mt -117.62 -43.75 2.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.878 0.871 . . . . 71.34 110.361 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.58 -168.52 3.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.204 0.601 . . . . 73.32 110.819 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.43 112.33 3.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.781 0.832 . . . . 71.55 110.346 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.4 0.39 2.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.516 1.527 . . . . 63.23 112.364 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.509 HG21 ' HG ' ' A' ' 85' ' ' SER . 97.2 t -96.81 107.09 19.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.475 -1.306 . . . . 75.12 107.475 -174.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.471 -0.937 . . . . 74.34 108.471 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -92.07 112.83 24.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.938 0.895 . . . . 74.25 109.396 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.14 111.32 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.619 -1.252 . . . . 71.13 107.619 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 32.1 t -106.7 129.54 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.621 0.768 . . . . 74.04 110.001 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.708 HD11 HD22 ' A' ' 44' ' ' LEU . 4.2 mm? -117.89 110.04 17.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.643 -0.873 . . . . 71.13 108.643 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.526 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 11.0 ttp180 -84.82 107.44 16.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.58 -0.896 . . . . 74.24 108.58 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 16.4 t -92.45 125.34 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 107.807 -1.183 . . . . 75.32 107.807 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.683 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.9 m -118.79 136.89 53.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.019 -0.734 . . . . 64.22 109.019 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.542 HG12 HD23 ' A' ' 126' ' ' LEU . 45.4 t -136.78 115.88 15.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 124.44 1.096 . . . . 75.31 108.068 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 7.1 m -105.25 148.02 27.43 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.912 -0.773 . . . . 74.42 108.912 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.23 106.65 7.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.086 -1.45 . . . . 73.21 107.086 168.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 17.9 t -116.8 126.97 53.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.682 -0.488 . . . . 73.22 109.682 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.514 HD22 HG22 ' A' ' 31' ' ' VAL . 7.7 mp -87.56 82.49 7.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 74.01 107.914 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.28 -84.72 0.83 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 114.976 -1.011 . . . . 70.22 111.881 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -111.92 -27.88 8.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.294 1.037 . . . . 71.13 111.686 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.7 125.15 54.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.564 0.346 . . . . 73.44 111.005 -169.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 63.7 m -73.7 129.3 37.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.573 0.749 . . . . 74.45 112.441 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -69.75 -65.64 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.868 -1.06 . . . . 73.01 109.911 169.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.13 167.77 27.46 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.289 -0.869 . . . . 74.22 111.607 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 tp -141.36 116.09 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.354 1.461 . . . . 71.31 107.728 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.6 m -105.66 131.79 52.6 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.332 0.653 . . . . 64.2 109.559 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 32.6 tt0 -146.59 115.38 6.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.58 -0.526 . . . . 74.32 109.58 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.74 114.27 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.97 0.908 . . . . 74.43 109.231 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 48.5 mt-30 -83.88 84.39 7.59 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.265 -1.013 . . . . 75.43 108.265 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.86 98.26 6.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.322 -0.992 . . . . 74.24 108.322 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.89 145.88 21.04 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.202 -0.759 . . . . 72.03 111.202 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.675 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -150.14 121.79 1.31 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 111.047 -0.821 . . . . 64.54 111.047 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.474 HG22 HD12 ' A' ' 51' ' ' LEU . 34.6 mt -87.78 123.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 123.87 0.868 . . . . 54.44 108.736 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.528 ' HD2' HG12 ' A' ' 13' ' ' ILE . 46.9 m-85 -131.71 120.26 22.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.509 ' HG ' HG21 ' A' ' 55' ' ' VAL . 25.2 m -77.78 90.91 4.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.551 0.74 . . . . 73.31 109.333 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.496 HG22 ' SG ' ' A' ' 97' ' ' CYS . 1.6 pp -118.69 133.26 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.806 0.842 . . . . 75.12 110.509 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.4 177.15 11.48 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.695 0.798 . . . . 75.0 111.125 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.52 86.68 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.758 0.662 . . . . 74.4 112.298 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.76 136.12 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.497 1.119 . . . . 75.13 109.936 -171.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -131.41 172.07 12.62 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.136 0.974 . . . . 74.51 108.863 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.42 4.59 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 115.001 0.761 . . . . 65.4 115.001 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.2 -18.74 58.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.953 0.901 . . . . 70.23 112.041 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -67.87 -48.88 64.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.176 0.591 . . . . 74.35 110.236 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.2 ttm -80.63 -18.56 47.77 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.592 -0.276 . . . . 72.52 110.454 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.425 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -66.38 -33.87 76.69 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.037 0.446 . . . . 73.12 110.428 169.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -68.66 -41.74 78.92 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.874 -0.603 . . . . 75.14 110.26 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG22 ' A' ' 86' ' ' ILE . 47.3 t -64.26 -54.21 36.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.984 0.514 . . . . 72.41 111.959 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 mt -76.26 -35.94 58.69 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.409 0.443 . . . . 71.11 111.719 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.09 4.59 38.58 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 114.858 0.703 . . . . 70.4 114.858 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -146.6 -52.23 0.23 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.85 0.825 . . . . 72.33 112.436 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 134' ' ' ASP . 66.4 t80 -79.81 -68.92 0.62 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.52 0.728 . . . . 74.1 111.939 -168.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.3 m -68.86 -32.36 3.45 Favored Pre-proline 0 CA--C 1.572 1.826 0 N-CA-C 114.844 1.424 . . . . 74.35 114.844 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 28.8 Cg_endo -61.45 -21.87 73.03 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 122.556 2.17 . . . . 72.13 113.458 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -68.12 -26.12 65.64 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.203 0.601 . . . . 75.23 110.034 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -71.2 -36.01 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.477 0.711 . . . . 74.53 109.858 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.675 HD23 ' HA3' ' A' ' 82' ' ' GLY . 97.0 mt -83.48 -30.68 26.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.936 0.894 . . . . 73.54 112.883 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -62.9 -39.79 56.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 113.818 1.044 . . . . 65.22 113.818 -170.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.01 -37.67 51.58 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.387 2.058 . . . . 71.04 113.281 172.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -71.76 -38.62 70.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.14 0.576 . . . . 73.35 111.625 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -45.18 83.42 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.572 -0.529 . . . . 74.33 109.572 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.436 HH22 ' HB3' ' A' ' 130' ' ' PRO . 40.1 ttm180 -53.75 -50.45 65.97 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 124.646 1.216 . . . . 73.54 110.905 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.65 -41.6 75.36 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.204 0.94 . . . . 75.24 111.303 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 44.0 t -56.17 -42.21 76.69 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.576 0.547 . . . . 74.23 110.169 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 118' ' ' VAL . 92.8 mt -66.13 -50.33 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.593 -1.185 . . . . 75.13 110.296 175.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 63.0 m -52.8 -41.93 64.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.301 1.041 . . . . 64.53 111.375 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -69.17 -51.22 40.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.647 -1.161 . . . . 75.24 110.616 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.1 mtp -51.05 -42.91 60.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.026 0.931 . . . . 74.14 111.725 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -64.82 -50.96 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-N 114.376 -1.284 . . . . 74.11 110.718 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 93.2 p -70.38 -22.71 62.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.029 0.532 . . . . 60.31 111.947 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.603 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -75.19 -31.19 60.88 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.796 0.838 . . . . 74.33 110.048 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 -3.26 86.13 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 116.124 -0.489 . . . . 74.34 112.604 171.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.553 ' HB ' HH21 ' B' ' 15' ' ' ARG . 23.3 m 60.05 43.73 14.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.318 1.532 . . . . 73.12 110.133 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -99.53 163.9 17.65 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 113.029 -1.896 . . . . 74.44 108.888 169.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.12 136.46 37.76 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.766 2.311 . . . . 75.44 111.795 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.0 tt0 -48.31 124.37 7.82 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.584 1.177 . . . . 72.44 111.521 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.542 HD23 HG12 ' A' ' 64' ' ' VAL . 12.4 tp -108.13 100.54 9.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.695 0.798 . . . . 73.43 110.484 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.84 97.75 7.22 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.891 -1.152 . . . . 73.14 107.891 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.67 120.89 18.92 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.239 -0.437 . . . . 75.13 110.314 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 133.04 88.87 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.118 0.967 . . . . 72.34 111.934 -173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HB3' HH22 ' A' ' 111' ' ' ARG . 18.0 Cg_endo -87.22 166.49 8.08 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.646 2.231 . . . . 74.43 113.351 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.58 142.51 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 106.779 -1.563 . . . . 72.54 106.779 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.45 75.46 6.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.907 -1.146 . . . . 72.54 107.907 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.5 -43.73 89.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.475 1.11 . . . . 75.1 111.843 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 101' ' ' TYR . 5.3 p-10 . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 123.994 0.917 . . . . 74.42 111.806 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 63.1 m . . . . . 0 C--O 1.237 0.422 0 N-CA-C 107.765 -1.198 . . . . 72.13 107.765 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.574 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 19.4 t80 -141.86 118.59 11.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.556 0.742 . . . . 72.02 109.312 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.451 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 7.3 pt20 -154.88 130.38 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.743 0.817 . . . . 75.22 109.155 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -81.31 132.53 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.142 0.577 . . . . 72.4 109.825 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -89.24 -48.54 7.31 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.884 -0.413 . . . . 74.24 109.884 168.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.553 HH21 ' HB ' ' A' ' 122' ' ' THR . 58.9 ttt180 -162.95 154.85 18.07 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 111.395 0.146 . . . . 74.22 111.395 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 87.3 mt -137.39 111.37 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.403 1.081 . . . . 75.22 108.083 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.416 ' HE1' HG13 ' B' ' 83' ' ' ILE . 24.9 p90 -137.2 147.92 46.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.853 0.461 . . . . 75.44 110.379 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -75.3 119.05 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.742 -0.663 . . . . 74.13 109.744 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -89.92 -23.15 21.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.68 0.792 . . . . 75.14 111.121 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.37 141.64 4.54 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.217 0.323 . . . . 74.35 111.789 -173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.805 HD12 ' SG ' ' B' ' 113' ' ' CYS . 45.5 mm -133.12 146.41 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.195 1.398 . . . . 74.54 109.084 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.0 t -149.08 151.94 35.32 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.881 0.872 . . . . 74.42 109.009 172.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -156.01 122.7 5.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.2 mt-10 -125.12 113.05 17.2 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.031 -0.729 . . . . 71.13 109.031 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.494 ' HB1' ' CB ' ' B' ' 28' ' ' ALA . . . -114.42 84.03 9.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.874 -1.158 . . . . 74.24 107.874 170.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.7 -22.96 17.31 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.661 2.241 . . . . 73.45 111.638 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -113.37 15.31 19.22 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.538 1.135 . . . . 73.1 110.576 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.494 ' CB ' ' HB1' ' B' ' 25' ' ' ALA . . . -48.68 -58.1 9.29 Favored Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 125.335 1.454 . . . . 62.52 114.607 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.475 ' HG2' ' HD1' ' B' ' 30' ' ' HIS . 33.7 Cg_endo -67.76 -25.63 39.52 Favored 'Trans proline' 0 C--N 1.398 3.154 0 C-N-CA 121.903 1.735 . . . . 70.34 112.712 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 75.2 m80 -97.99 1.21 47.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.485 0.714 . . . . 73.3 112.876 -174.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.91 -22.66 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.227 0.611 . . . . 73.35 112.521 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -64.95 -30.77 71.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.941 0.897 . . . . 75.01 112.175 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.7 pt20 -65.49 -36.08 82.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 110.101 -0.333 . . . . 71.34 110.101 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.639 ' HB2' HD13 ' B' ' 68' ' ' LEU . 83.3 mttt -108.89 65.63 0.62 Allowed 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.616 0.722 . . . . 74.25 109.169 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -75.28 108.29 7.95 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.116 -0.947 . . . . 64.12 109.643 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 162.13 -171.69 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 127.61 2.364 . . . . 74.13 108.985 159.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.3 128.8 88.38 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 122.963 0.164 . . . . 72.42 110.838 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.52 -176.22 3.0 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.673 2.249 . . . . 75.43 111.05 168.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -76.04 106.78 7.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.796 -1.187 . . . . 72.0 107.796 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.13 136.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.079 -1.082 . . . . 74.35 108.079 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -150.98 142.41 23.43 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.279 0.631 . . . . 72.33 109.653 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -85.97 159.72 19.55 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.976 0.893 . . . . 74.42 110.505 171.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 33.7 t70 -140.09 110.46 6.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.448 -2.056 . . . . 64.42 105.448 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.87 134.63 47.66 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.885 -0.783 . . . . 73.44 108.885 -167.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.619 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.8 t70 -131.36 139.97 49.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.844 -0.799 . . . . 73.52 108.844 172.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -109.71 124.94 52.09 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.124 0.969 . . . . 73.35 109.605 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.61 43.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.699 0.8 . . . . 75.31 108.893 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -143.19 161.33 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.674 0.389 . . . . 73.14 110.198 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 84.9 p -153.06 150.76 29.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.786 0.834 . . . . 64.22 109.514 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.99 114.91 29.26 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.862 -0.792 . . . . 75.03 108.862 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 77.5 mt -77.75 -42.83 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.807 0.443 . . . . 74.12 110.343 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.11 -171.07 2.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.63 -0.714 . . . . 64.53 111.118 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.33 118.53 9.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.438 -1.256 . . . . 72.42 110.091 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.75 -3.94 1.3 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.296 1.438 . . . . 75.41 112.488 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.96 107.11 21.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.462 -0.94 . . . . 74.03 108.462 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.22 156.63 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.401 -0.818 . . . . 72.41 109.136 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.402 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 7.4 tm-20 -133.12 97.26 3.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.214 -1.402 . . . . 75.1 107.214 -167.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.4 128.83 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.341 1.056 . . . . 74.14 109.238 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.33 143.65 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.917 0.887 . . . . 75.22 109.401 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' B' ' 103' ' ' PRO . 58.6 mt -129.32 122.8 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.419 0.687 . . . . 74.12 109.406 170.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.619 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.8 ttm180 -92.19 108.57 20.04 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.469 -0.937 . . . . 71.31 108.469 172.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.12 103.14 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.197 -1.408 . . . . 75.12 107.197 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 10.8 m -104.53 124.43 49.28 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.228 -0.656 . . . . 74.25 109.228 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.596 HG22 HG21 ' B' ' 114' ' ' ILE . 90.8 t -103.09 104.72 17.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.626 0.77 . . . . 65.11 109.124 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.4 m -94.96 136.89 34.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.341 -0.845 . . . . 73.2 109.415 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.62 136.05 24.1 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.586 -0.894 . . . . 73.53 108.586 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.9 p -142.05 130.59 22.58 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.531 0.519 . . . . 55.04 111.532 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' B' ' 34' ' ' LYS . 46.5 mt -92.29 99.34 12.13 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -109.82 2.96 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.473 -0.785 . . . . 75.23 111.742 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.8 4.3 18.3 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.453 1.101 . . . . 75.22 111.564 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.66 170.88 9.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.609 0.764 . . . . 74.24 109.726 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -76.49 152.53 36.07 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.876 0.47 . . . . 73.33 110.903 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.529 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -104.98 -63.28 1.24 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.271 -1.011 . . . . 62.25 108.271 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.94 156.67 22.69 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.13 -1.396 . . . . 74.54 108.253 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 80.0 mt -132.77 148.82 52.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.532 1.133 . . . . 74.34 108.3 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.92 159.63 44.02 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.333 -0.988 . . . . 64.33 108.333 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.4 tt0 -163.34 137.78 6.14 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.671 0.388 . . . . 75.23 110.004 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' B' ' 110' ' ' ALA . 78.5 t -135.97 144.63 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.154 0.981 . . . . 64.45 109.202 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -122.56 105.43 10.11 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.5 -1.296 . . . . 73.03 107.5 169.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -99.59 108.75 21.23 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 149.94 20.55 Favored Glycine 0 C--O 1.242 0.605 0 N-CA-C 110.914 -0.874 . . . . 61.14 110.914 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.44 123.66 2.03 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.015 -0.834 . . . . 74.12 111.015 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.416 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.3 mt -88.11 126.78 41.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.691 -0.855 . . . . 64.5 108.691 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -135.36 134.38 39.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.483 1.113 . . . . 75.21 108.819 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.451 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 32.7 m -93.92 96.65 9.85 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.75 -0.833 . . . . 72.13 108.75 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -110.7 135.4 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.018 0.927 . . . . 70.02 110.668 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -152.16 164.47 37.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 74.51 109.296 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.67 -39.02 2.8 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 123.003 0.335 . . . . 70.42 113.776 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 28.9 pt -60.85 145.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.326 1.05 . . . . 75.14 111.587 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -166.28 163.1 17.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.663 0.785 . . . . 75.22 109.891 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.8 -123.19 32.65 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.87 0.732 . . . . 73.33 113.391 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -67.98 -36.21 79.66 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.407 1.083 . . . . 64.53 110.936 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.64 -29.97 67.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.794 -1.094 . . . . 74.31 110.674 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.4 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 0.6 OUTLIER -67.98 -49.66 60.33 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.358 -0.837 . . . . 75.43 109.632 175.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.3 73.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.123 0.969 . . . . 72.43 111.85 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -69.7 -34.22 73.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.89 0.876 . . . . 70.15 110.709 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -70.35 -66.88 0.54 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.043 -0.526 . . . . 73.41 111.112 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.564 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.0 OUTLIER -87.9 -14.47 39.27 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.339 0.496 . . . . 73.21 112.339 -169.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.23 -4.22 53.66 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.896 -0.391 . . . . 63.01 113.379 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.82 -58.79 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 117.149 0.475 . . . . 63.34 111.66 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -73.41 -44.93 57.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 73.04 111.999 -172.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.574 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 35.2 m -68.01 -43.8 37.46 Favored Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 118.752 -0.642 . . . . 73.53 111.64 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.44 ' HB3' HD13 ' B' ' 60' ' ' LEU . 29.1 Cg_exo -44.94 -53.03 5.61 Favored 'Trans proline' 0 C--N 1.4 3.241 0 C-N-CA 123.038 2.492 . . . . 63.51 113.354 167.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -56.62 -23.65 42.52 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.219 1.008 . . . . 73.03 113.467 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.7 mt -78.81 -52.57 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.06 0.544 . . . . 72.44 110.929 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -87.38 -7.99 57.1 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -65.28 -45.02 70.61 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.669 1.188 . . . . 71.32 113.186 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.87 -37.66 66.79 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.627 2.218 . . . . 73.45 113.531 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.508 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 44.0 m-85 -68.96 -39.84 79.25 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.243 -0.89 . . . . 74.43 110.393 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -66.37 -45.49 79.93 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.669 0.388 . . . . 72.5 110.669 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -54.66 -56.13 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.329 1.452 . . . . 74.32 111.699 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.856 0.863 . . . . 75.14 110.791 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.805 ' SG ' HD12 ' B' ' 21' ' ' ILE . 6.0 t -66.86 -31.75 72.56 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.0 -0.545 . . . . 74.13 111.385 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.596 HG21 HG22 ' B' ' 64' ' ' VAL . 70.8 mt -67.53 -50.31 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.561 0.744 . . . . 73.04 110.314 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.5 m -61.84 -27.68 68.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 123.945 0.778 . . . . 73.35 111.245 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.14 -50.31 68.71 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.746 0.818 . . . . 64.34 110.295 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -72.49 -34.36 67.61 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.188 0.595 . . . . 73.43 111.653 -171.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.73 -38.55 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.469 0.708 . . . . 75.3 110.029 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t -72.94 -26.19 61.3 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.064 -0.971 . . . . 65.23 111.344 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.4 mtt-85 -73.81 -25.07 59.92 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.143 0.577 . . . . 75.34 110.5 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.24 14.71 32.33 Favored Glycine 0 C--N 1.357 1.697 0 O-C-N 123.541 0.525 . . . . 74.4 112.342 168.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.502 HG23 ' HB3' ' A' ' 17' ' ' TYR . 51.7 p 56.43 47.67 18.41 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.756 2.022 . . . . 63.24 112.612 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.08 151.96 46.17 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.205 -1.361 . . . . 74.12 109.658 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.26 -160.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.957 2.438 . . . . 74.12 113.33 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.621 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.43 125.69 25.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.347 1.059 . . . . 71.4 113.115 -170.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 59.5 tp -136.93 95.38 3.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.438 -0.949 . . . . 74.22 108.438 171.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -103.74 135.97 44.3 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.032 0.933 . . . . 73.41 110.547 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.3 tp -83.35 137.33 34.0 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.681 0.792 . . . . 73.31 109.709 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.51 152.82 95.34 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.278 1.031 . . . . 73.53 112.054 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.4 111.28 1.42 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.492 2.795 . . . . 71.45 112.863 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 t -106.6 110.28 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 61.41 109.341 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -97.25 100.25 11.71 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.355 -0.98 . . . . 74.03 108.355 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 123.464 0.706 . . . . 73.14 110.701 -178.782 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.493 ' HA ' HG13 ' C' ' 89' ' ' ILE . 59.6 ttp . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 113.573 0.953 . . . . 73.54 113.573 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 26.6 m -120.5 94.19 4.29 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.689 -1.226 . . . . 74.34 107.689 167.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -97.13 157.25 16.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.133 -0.939 . . . . 74.41 108.902 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -170.92 129.28 0.77 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.533 0.733 . . . . 75.52 110.155 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.576 ' H ' HD12 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -90.88 107.88 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.7 0.8 . . . . 73.42 109.594 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.422 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 79.7 mm-40 -76.52 -52.83 9.02 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.079 -0.388 . . . . 63.54 110.609 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -166.21 128.58 1.92 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.987 -0.375 . . . . 72.4 109.987 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -108.07 146.36 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.849 -1.167 . . . . 74.34 107.849 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.416 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -176.93 163.39 2.2 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.565 0.698 . . . . 75.4 110.912 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -85.08 117.44 24.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.108 -0.951 . . . . 75.24 108.892 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -68.82 -42.93 76.57 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.844 0.831 . . . . 72.13 108.772 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.27 141.18 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.092 -1.413 . . . . 74.12 109.155 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.9 mt -129.21 140.7 48.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.769 -1.567 . . . . 75.13 106.769 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -157.61 145.84 19.1 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.259 0.552 . . . . 72.22 110.611 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -146.45 105.65 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.236 -1.764 . . . . 74.41 106.236 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -114.73 110.19 19.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.069 -1.086 . . . . 74.21 108.069 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.55 80.06 61.38 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.342 1.057 . . . . 74.33 108.827 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.92 -4.18 13.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.491 2.127 . . . . 74.32 111.731 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -117.7 18.65 14.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.1 . . . . 72.25 109.617 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.07 -52.3 75.5 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 114.177 1.177 . . . . 75.13 114.177 -170.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.498 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 73.8 Cg_endo -75.92 -31.61 4.97 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.47 1.561 . . . . 71.44 112.009 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.61 -23.69 62.6 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.968 1.307 . . . . 64.34 112.734 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.437 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 9.5 p -79.51 -16.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.837 -0.54 . . . . 70.42 111.576 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -67.39 -8.37 32.37 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.054 0.542 . . . . 64.33 112.251 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -116.09 25.18 10.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.784 0.834 . . . . 73.32 111.105 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.519 ' HG2' HD13 ' C' ' 68' ' ' LEU . 3.9 tppt? -91.83 172.69 8.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.002 0.521 . . . . 74.13 111.252 -173.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.64 130.31 35.32 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.729 -0.841 . . . . 72.14 108.729 168.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -70.18 85.15 0.55 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.642 1.177 . . . . 74.3 110.334 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -157.44 66.37 3.7 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.91 0.884 . . . . 63.4 108.967 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.34 109.16 2.84 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.667 2.244 . . . . 74.01 112.33 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -85.86 88.76 7.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.753 -1.573 . . . . 74.51 106.753 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.81 134.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.842 -1.072 . . . . 75.41 109.269 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.617 ' HE3' ' HB2' ' C' ' 43' ' ' ASP . 29.2 ttpt -114.97 129.18 56.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.141 -1.059 . . . . 75.35 108.141 169.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.442 HD22 HD13 ' C' ' 128' ' ' LEU . 49.4 tp -88.03 141.49 28.53 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.463 -1.31 . . . . 64.13 107.463 166.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.617 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 20.8 t70 -140.54 109.7 6.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.008 0.523 . . . . 64.23 109.692 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -105.64 145.73 30.63 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.245 -0.65 . . . . 71.14 109.245 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -143.29 149.76 38.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.519 1.127 . . . . 73.23 108.993 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.1 p -115.23 140.78 48.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.895 0.878 . . . . 72.11 110.257 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -143.11 151.31 40.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 73.24 109.527 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 24.3 m -141.29 155.96 45.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.937 0.495 . . . . 73.14 111.289 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -149.08 126.6 11.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.332 -0.988 . . . . 61.51 108.332 168.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -81.63 117.48 22.03 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 107.828 -1.175 . . . . 70.21 107.828 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' C' ' 57' ' ' GLU . 37.9 mt -97.07 -25.76 15.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.892 0.477 . . . . 75.44 110.549 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.44 -179.72 6.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.773 0.829 . . . . 74.03 110.119 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -62.67 122.35 15.64 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.937 -0.764 . . . . 75.51 108.937 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.8 21.19 12.64 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 124.447 1.092 . . . . 75.05 111.44 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.69 117.34 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 124.01 0.924 . . . . 71.21 108.63 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.66 130.42 43.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.931 0.892 . . . . 75.04 110.19 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD12 ' C' ' 51' ' ' LEU . 34.8 tt0 -82.02 109.28 16.2 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.527 -1.286 . . . . 72.42 107.527 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -96.39 114.12 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.031 -1.47 . . . . 71.13 107.031 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 48.9 t -111.88 131.28 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.455 0.702 . . . . 72.34 109.321 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.545 HD23 HD11 ' C' ' 106' ' ' LEU . 3.6 mm? -117.22 111.31 19.26 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.334 1.054 . . . . 75.2 108.312 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.4 ttm180 -81.99 114.76 20.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.912 -0.773 . . . . 74.12 108.912 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' C' ' 114' ' ' ILE . 33.9 t -105.28 117.03 50.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.854 -1.165 . . . . 74.1 107.854 173.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.0 m -123.74 139.83 53.59 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.417 1.087 . . . . 54.43 108.075 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.7 113.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.136 0.974 . . . . 75.22 108.971 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 45.8 m -98.24 137.09 37.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.278 -0.874 . . . . 74.54 108.658 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.29 112.9 10.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.878 -1.527 . . . . 72.51 106.878 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 48.7 m -145.35 127.6 15.77 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.052 -0.721 . . . . 71.21 109.052 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.519 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.8 mp -90.47 48.78 1.59 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.301 0.572 . . . . 64.2 110.543 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 -117.82 3.21 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.179 -1.168 . . . . 74.12 110.179 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.72 -33.19 16.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.134 0.974 . . . . 63.22 109.267 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.71 121.3 25.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.592 1.157 . . . . 73.3 110.851 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 91.7 m -78.77 137.84 37.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.081 0.952 . . . . 62.42 111.584 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.63 -66.11 0.74 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.106 0.963 . . . . 74.43 109.241 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -159.32 175.87 12.84 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.702 0.763 . . . . 72.4 110.858 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.4 143.36 51.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.982 -1.488 . . . . 73.25 106.982 171.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.44 140.21 41.13 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.659 -1.237 . . . . 74.3 107.659 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -151.46 119.74 6.36 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.373 0.533 . . . . 62.15 110.875 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -117.24 114.14 44.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.512 -0.922 . . . . 74.54 108.512 170.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.498 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 25.9 mt-30 -90.25 97.53 11.24 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.615 -1.254 . . . . 74.35 107.615 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -87.14 119.67 27.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.754 0.822 . . . . 65.34 109.806 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.23 148.95 18.28 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 123.188 0.305 . . . . 72.53 112.593 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.7 2.82 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 110.902 -0.879 . . . . 71.41 110.902 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.502 HD13 HD12 ' C' ' 51' ' ' LEU . 16.2 mm -81.26 119.85 31.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -129.41 142.89 50.69 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.418 -0.956 . . . . 72.03 108.418 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -105.98 123.31 47.78 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.124 -1.065 . . . . 74.3 108.124 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.538 HG23 ' HE3' ' C' ' 94' ' ' MET . 71.9 mt -112.87 100.66 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.914 0.886 . . . . 74.22 108.757 -173.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 169.34 14.22 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.871 1.269 . . . . 75.23 108.818 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.18 -40.94 3.03 Favored Glycine 0 N--CA 1.466 0.7 0 CA-C-N 116.567 -0.288 . . . . 71.02 112.966 174.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.493 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.9 pp -124.86 165.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.041 0.937 . . . . 63.43 110.489 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' C' ' 91' ' ' GLY . 28.4 tt0 -152.97 166.0 33.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.417 0.687 . . . . 74.12 109.985 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' C' ' 90' ' ' GLU . . . 70.59 -118.44 7.74 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.565 -0.289 . . . . 75.2 113.71 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -77.96 -24.48 48.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.503 0.721 . . . . 55.21 111.194 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -41.01 69.23 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.567 -0.531 . . . . 73.41 109.567 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.538 ' HE3' HG23 ' C' ' 86' ' ' ILE . 20.0 ptm -76.98 -28.34 55.08 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.755 176.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.2 69.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.149 0.58 . . . . 75.13 110.836 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -70.92 -36.07 72.51 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.656 0.782 . . . . 74.35 110.496 171.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -67.8 -62.13 1.56 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 63.12 110.568 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.57 -12.42 60.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.628 0.603 . . . . 75.11 112.628 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.48 -4.41 57.22 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.58 -0.567 . . . . 72.33 113.917 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.49 -50.87 0.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.761 0.781 . . . . 71.14 111.726 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -75.98 -54.2 7.23 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.293 0.637 . . . . 74.11 111.677 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.61 -42.32 71.78 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 123.766 0.827 . . . . 75.33 113.167 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.59 -30.84 79.66 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 122.209 1.94 . . . . 72.44 112.68 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.14 -33.77 73.97 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.232 0.613 . . . . 75.03 110.743 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -65.87 -50.49 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.055 0.542 . . . . 74.04 110.091 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.545 HD11 HD23 ' C' ' 60' ' ' LEU . 82.3 mt -79.52 -15.55 57.54 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.831 -0.622 . . . . 74.13 112.409 -172.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.437 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 87.8 t80 -56.41 -55.6 40.69 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.284 1.034 . . . . 72.5 113.131 -175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 21.0 Cg_exo -66.24 -29.87 46.43 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.914 1.743 . . . . 74.23 112.828 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.409 ' HE2' HG22 ' A' ' 115' ' ' THR . 86.1 m-85 -65.64 -45.78 81.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.364 0.666 . . . . 73.33 110.881 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.63 91.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.437 0.695 . . . . 75.23 110.651 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -60.92 -57.1 14.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.749 1.22 . . . . 75.24 111.484 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -33.38 75.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.415 0.447 . . . . 75.33 110.008 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' C' ' 21' ' ' ILE . 26.1 t -61.2 -43.87 98.19 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.978 0.511 . . . . 71.54 110.565 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.426 ' CD1' HG13 ' C' ' 62' ' ' VAL . 66.4 mt -65.15 -43.98 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.177 0.591 . . . . 72.24 110.542 173.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -63.19 -33.15 74.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.441 0.697 . . . . 71.41 111.471 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.2 p -76.78 -41.61 43.95 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.84 -0.8 . . . . 73.12 108.84 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.598 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -54.95 -46.4 75.0 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.89 0.876 . . . . 70.03 112.111 178.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.81 -26.89 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.736 0.414 . . . . 72.12 111.126 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -70.88 -29.89 66.11 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.537 0.735 . . . . 72.55 111.416 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 50.6 mtt-85 -78.68 -33.17 47.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.744 0.818 . . . . 75.04 109.39 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.69 1.53 61.82 Favored Glycine 0 C--N 1.361 1.937 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.881 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 61.74 25.2 15.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.381 1.873 . . . . 60.21 113.069 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -103.4 156.44 35.46 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.35 1.06 . . . . 72.24 110.421 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -40.66 118.9 0.67 Allowed 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 124.238 3.292 . . . . 73.43 113.779 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.16 139.55 57.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.54 -0.754 . . . . 72.31 111.743 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.18 105.7 15.86 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.029 -1.1 . . . . 75.44 108.029 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.18 112.66 22.98 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.211 -1.403 . . . . 72.44 107.211 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.442 HD13 HD22 ' C' ' 42' ' ' LEU . 20.4 tp -84.6 141.86 30.37 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 123.597 0.561 . . . . 75.21 110.039 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.35 145.29 63.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.686 -0.688 . . . . 71.24 112.095 -170.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.596 ' HG3' HD11 ' A' ' 16' ' ' ILE . 5.3 Cg_endo -46.8 102.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.977 3.118 . . . . 73.2 112.762 169.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -96.25 106.71 18.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.042 -1.466 . . . . 65.51 107.042 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.559 HD22 HD12 ' A' ' 13' ' ' ILE . 77.6 m-20 -98.77 85.68 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.541 -1.281 . . . . 72.01 107.541 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -51.22 -38.3 51.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.342 1.057 . . . . 71.34 111.9 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 124.211 1.004 . . . . 71.55 111.811 -179.597 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 25.7 m . . . . . 0 C--O 1.238 0.486 0 N-CA-C 109.726 -0.472 . . . . 70.41 109.726 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -157.68 116.4 3.19 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.537 -1.283 . . . . 71.34 107.537 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.59 140.52 44.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.876 -1.157 . . . . 60.22 107.876 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.494 HD12 HG21 ' D' ' 105' ' ' ILE . 8.7 mt -97.46 124.77 50.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.017 -0.735 . . . . 73.54 109.017 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.82 -37.54 12.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.485 0.714 . . . . 64.24 110.344 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -161.12 148.34 15.17 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 75.54 110.675 -173.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.46 HD12 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -135.34 114.66 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.302 -2.11 . . . . 75.32 105.302 166.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -151.72 151.53 31.55 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.576 0.703 . . . . 72.21 111.081 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -77.32 109.89 11.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.761 -1.108 . . . . 72.53 109.134 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.498 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 34.9 mtpt -79.28 -33.16 43.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.46 . . . . 75.45 110.041 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -141.33 142.2 33.82 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.371 -0.974 . . . . 72.42 108.371 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.598 HG23 ' HE1' ' C' ' 117' ' ' MET . 98.0 mt -133.06 140.91 46.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.574 -1.639 . . . . 75.31 106.574 173.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -146.7 136.47 23.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.605 0.762 . . . . 51.43 109.116 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 57.2 t80 -148.72 123.68 10.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.764 -1.939 . . . . 73.22 105.764 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.12 142.12 51.69 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.431 0.692 . . . . 75.21 109.298 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.66 80.36 66.55 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.913 -1.143 . . . . 64.45 107.913 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.79 -29.97 27.96 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.733 2.289 . . . . 74.01 111.784 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -114.47 40.74 2.47 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.959 1.304 . . . . 73.53 108.775 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.475 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -55.11 -66.41 1.0 Allowed Pre-proline 0 CA--C 1.563 1.453 0 N-CA-C 114.315 1.228 . . . . 74.44 114.315 -166.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' D' ' 28' ' ' ALA . 24.9 Cg_endo -86.21 -3.92 8.66 Favored 'Trans proline' 0 C--N 1.387 2.578 0 CA-C-N 123.074 2.134 . . . . 74.44 112.123 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.25 -39.86 68.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.933 1.293 . . . . 74.33 109.901 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.29 -28.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.337 -0.392 . . . . 75.25 110.1 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.98 -2.33 3.89 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.235 1.198 . . . . 64.04 114.235 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -76.83 -38.18 54.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.145 0.578 . . . . 64.12 109.672 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.478 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -136.3 96.69 3.42 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.373 0.669 . . . . 74.42 112.303 173.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -107.13 98.03 7.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 164.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.543 ' H ' HD12 ' D' ' 68' ' ' LEU . 5.6 m-90 -122.31 -162.85 1.03 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.231 -1.766 . . . . 71.15 106.231 169.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -52.52 104.23 0.42 Allowed Pre-proline 0 N--CA 1.486 1.367 0 CA-C-N 118.66 0.664 . . . . 75.02 112.521 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.7 105.07 2.01 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.662 2.241 . . . . 53.51 109.892 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -61.23 111.0 1.56 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.701 -1.222 . . . . 74.44 107.701 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.533 HG11 HD13 ' D' ' 126' ' ' LEU . 2.2 m -104.61 149.42 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.797 -1.092 . . . . 74.22 110.876 -165.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.574 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.7 mmtt -109.17 133.05 53.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.069 0.947 . . . . 75.24 108.511 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -96.9 111.97 23.93 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.568 -1.271 . . . . 75.21 107.568 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.621 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -124.29 141.47 52.04 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.873 0.869 . . . . 72.22 108.79 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.74 167.14 22.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.22 0.533 . . . . 73.25 110.762 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.508 ' HB3' ' HD2' ' D' ' 61' ' ' ARG . 4.3 t70 -156.31 145.83 20.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.825 -1.176 . . . . 73.43 107.825 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.5 p -106.59 141.79 37.3 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.019 -0.734 . . . . 70.5 109.019 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -153.5 159.39 42.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.528 -0.915 . . . . 72.42 108.528 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 20.4 p -170.89 162.08 7.3 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.576 0.35 . . . . 63.43 110.931 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -152.0 152.24 32.2 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.212 0.605 . . . . 63.24 110.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -90.75 117.56 29.48 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.604 -0.887 . . . . 74.04 108.604 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.6 mt -93.21 -27.98 16.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.393 0.677 . . . . 72.41 109.434 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.94 177.11 6.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.319 1.048 . . . . 74.12 110.218 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.28 127.06 31.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.998 -1.112 . . . . 72.04 107.998 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 70.85 5.92 5.64 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.445 1.098 . . . . 74.42 111.856 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.3 t -125.51 115.22 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.252 1.021 . . . . 75.35 108.277 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -135.92 130.84 34.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.12 0.568 . . . . 72.23 109.553 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' D' ' 51' ' ' LEU . 25.9 tt0 -90.26 136.12 33.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 73.0 109.881 178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.12 114.55 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.654 1.182 . . . . 74.12 108.26 175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -101.85 108.89 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.553 0.741 . . . . 75.0 109.339 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.86 111.25 23.57 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.25 -1.019 . . . . 74.02 108.25 175.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' D' ' 45' ' ' ASP . 14.7 ttm180 -83.91 114.34 21.6 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.324 0.65 . . . . 72.41 109.489 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.4 123.69 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.202 -1.036 . . . . 75.21 108.202 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -129.65 135.32 48.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.324 0.65 . . . . 74.02 109.817 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.9 109.27 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.974 0.91 . . . . 74.55 109.574 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 31.3 m -102.46 102.37 12.66 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.08 -0.711 . . . . 73.3 109.08 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.77 129.35 43.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 110.059 -0.348 . . . . 73.53 110.059 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -124.27 124.11 41.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 64.14 109.152 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.543 HD12 ' H ' ' D' ' 36' ' ' TRP . 0.1 OUTLIER -90.9 96.57 10.7 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.512 -1.292 . . . . 75.33 107.512 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.14 -112.99 4.68 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.477 0.485 . . . . 74.33 112.548 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.95 6.43 48.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.306 1.042 . . . . 72.22 111.908 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -146.75 157.2 43.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.667 0.787 . . . . 73.23 109.336 -171.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -66.66 132.47 48.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.973 0.909 . . . . 70.02 111.909 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.08 -64.51 1.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.925 -0.769 . . . . 74.34 108.925 169.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.58 159.26 38.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.432 -1.258 . . . . 74.11 110.004 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.79 146.59 34.75 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 73.12 108.6 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.8 t -152.29 140.84 20.75 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.999 0.52 . . . . 72.32 110.171 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . 0.443 ' HG3' ' HG1' ' D' ' 63' ' ' THR . 33.5 tt0 -157.95 145.79 18.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.712 0.805 . . . . 74.03 109.872 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.8 116.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.322 1.049 . . . . 73.25 109.018 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.75 90.58 8.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.847 -0.797 . . . . 75.13 108.847 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -82.4 98.23 8.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.353 -0.84 . . . . 73.13 109.819 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.63 144.68 17.52 Favored Glycine 0 C--N 1.342 0.917 0 N-CA-C 111.602 -0.599 . . . . 53.51 111.602 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.31 130.92 4.15 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 111.142 -0.783 . . . . 71.31 111.142 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.7 123.23 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.525 -0.917 . . . . 72.22 108.525 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.68 126.66 37.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.814 0.846 . . . . 74.31 110.024 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.3 m -76.26 98.01 4.34 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.82 -0.807 . . . . 74.25 108.82 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 63.6 mt -107.81 109.94 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.376 -0.972 . . . . 74.53 108.376 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.549 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -151.16 168.33 25.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.108 0.963 . . . . 74.02 110.133 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.52 -20.2 19.63 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.04 -0.527 . . . . 44.01 114.008 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 pt -124.22 162.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.938 0.895 . . . . 73.41 111.178 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 173.67 13.83 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.368 -0.833 . . . . 70.01 111.054 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.83 -118.62 12.39 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 124.156 0.91 . . . . 70.32 114.042 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.7 m -74.54 -31.05 61.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 74.25 111.684 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.52 -43.76 89.06 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.994 0.518 . . . . 75.51 110.987 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -34.91 60.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.012 -0.54 . . . . 64.43 110.363 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.36 -29.35 68.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.136 0.574 . . . . 74.11 111.504 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -71.49 -49.74 38.3 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.614 0.766 . . . . 70.43 109.492 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.73 -39.06 93.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.753 -0.658 . . . . 71.1 111.155 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -78.78 -37.08 41.87 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.499 1.12 . . . . 75.32 111.013 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.33 -23.28 24.79 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.089 -0.505 . . . . 55.0 113.901 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.86 -58.43 2.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.395 0.598 . . . . 71.34 111.635 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.63 -46.29 47.69 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.251 0.463 . . . . 71.31 112.251 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 76.1 m -64.91 -47.27 74.65 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.297 -0.858 . . . . 61.22 112.279 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.2 -34.27 97.49 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.444 2.096 . . . . 74.03 112.998 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.2 -30.11 69.96 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.093 0.957 . . . . 71.54 111.24 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.494 HG21 HD12 ' D' ' 13' ' ' ILE . 49.2 mm -72.41 -43.58 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.267 0.627 . . . . 73.31 110.266 175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.93 -34.57 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.301 -0.863 . . . . 74.41 112.214 -170.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.71 -42.6 92.24 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 114.372 1.249 . . . . 74.22 114.372 -168.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.65 -42.84 54.44 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.464 2.109 . . . . 74.4 113.858 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -76.5 -27.99 56.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.458 0.703 . . . . 75.33 111.493 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.01 -54.29 36.58 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.983 0.42 . . . . 70.02 109.955 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -62.51 -34.22 76.44 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.622 -1.172 . . . . 75.13 111.285 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.64 -52.87 58.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.357 1.063 . . . . 53.41 110.84 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 50.9 t -65.44 -43.68 89.7 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 114.841 -1.072 . . . . 73.42 111.377 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.3 mt -60.58 -56.7 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.752 0.821 . . . . 74.3 110.86 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 97.7 m -51.83 -42.71 62.75 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.32 1.048 . . . . 71.44 111.825 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.6 t -71.05 -28.4 64.35 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.399 -0.819 . . . . 75.23 111.645 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.459 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 77.0 mtm -77.99 -36.65 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.832 0.453 . . . . 75.3 111.391 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.7 t -64.5 -36.6 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.614 0.766 . . . . 75.51 110.752 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 84.9 p -69.71 -31.07 68.88 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.437 0.695 . . . . 65.52 111.322 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' D' ' 116' ' ' SER . 68.8 mtt-85 -74.79 -26.06 59.48 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.559 0.743 . . . . 74.25 110.821 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.32 10.07 62.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.572 0.545 . . . . 72.21 112.538 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p 63.7 23.14 13.39 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.386 1.874 . . . . 74.53 113.287 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.44 163.83 18.94 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.487 1.115 . . . . 71.42 109.438 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.64 155.48 44.68 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.221 1.947 . . . . 75.21 110.555 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -55.57 147.27 18.36 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.513 0.725 . . . . 72.13 111.694 -174.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.533 HD13 HG11 ' D' ' 40' ' ' VAL . 3.0 tt -126.39 106.19 9.32 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.059 -0.719 . . . . 74.35 109.059 -175.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -112.52 110.38 20.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.233 1.013 . . . . 70.43 110.577 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.76 125.39 28.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.639 0.776 . . . . 73.53 108.993 171.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 145.54 99.01 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 122.395 0.278 . . . . 73.33 110.719 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.75 134.41 25.83 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.317 2.011 . . . . 73.5 111.378 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -108.89 120.23 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.152 -0.684 . . . . 52.54 109.152 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -86.41 82.42 7.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.395 0.678 . . . . 73.44 109.656 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.483 1.2 0 C-N-CA 124.174 0.99 . . . . 73.12 111.14 177.012 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 107.675 -1.231 . . . . 72.5 107.675 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.558 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.7 t80 -137.59 124.6 21.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.982 0.513 . . . . 73.02 109.984 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -153.38 112.02 3.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.731 -0.84 . . . . 73.13 108.731 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.579 HG12 ' HD2' ' A' ' 84' ' ' PHE . 67.8 mt -73.96 130.31 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.986 0.514 . . . . 75.03 110.418 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -91.55 -32.13 15.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.478 1.111 . . . . 72.33 111.068 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -164.69 140.71 5.86 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.752 0.421 . . . . 74.23 110.764 -172.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.78 123.73 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.935 -1.506 . . . . 74.32 106.935 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.591 ' HB3' HG21 ' B' ' 122' ' ' THR . 3.2 p90 -163.52 149.22 11.38 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.534 0.683 . . . . 74.55 112.703 -173.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.474 HG22 ' SG ' ' A' ' 113' ' ' CYS . 76.7 p -77.61 112.68 14.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.116 -0.947 . . . . 53.44 109.075 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -77.94 -25.97 48.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.362 -0.381 . . . . 73.45 110.522 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.4 t70 -152.42 144.12 23.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.245 0.966 . . . . 75.24 110.301 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -138.08 141.85 37.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 125.635 1.574 . . . . 73.25 107.055 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.32 119.01 4.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.594 0.559 . . . . 74.42 109.807 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 81.2 t80 -111.31 127.18 55.56 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 106.381 -1.711 . . . . 73.35 106.381 167.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.61 108.9 9.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.533 -0.544 . . . . 73.33 109.533 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.92 82.99 1.97 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.841 -1.17 . . . . 71.14 107.841 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.77 -35.84 26.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.006 2.471 . . . . 74.41 112.347 -169.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -116.4 33.8 5.36 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.142 -0.935 . . . . 60.25 108.867 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.66 -61.04 3.95 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.279 -0.867 . . . . 74.42 113.021 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 -0.2 8.18 Favored 'Trans proline' 0 C--N 1.386 2.522 0 CA-C-N 121.765 1.666 . . . . 72.43 113.812 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -99.59 -42.61 6.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.139 0.976 . . . . 75.32 110.916 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.519 HG22 ' HA ' ' A' ' 73' ' ' ALA . 9.4 p -77.1 -21.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.309 -0.859 . . . . 72.1 111.876 -163.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -76.8 0.57 20.17 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.126 0.57 . . . . 74.2 111.259 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -100.95 -22.57 14.75 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.631 1.173 . . . . 74.2 111.513 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.69 172.73 13.3 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.971 0.908 . . . . 75.22 113.24 -168.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 136.9 51.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.11 0.964 . . . . 71.14 111.249 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -82.17 75.71 9.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.718 0.807 . . . . 75.52 110.478 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.96 69.37 9.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.961 -1.018 . . . . 75.1 110.043 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.06 118.12 5.41 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.029 1.819 . . . . 65.54 111.107 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.72 118.66 31.7 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.601 -1.629 . . . . 74.51 106.601 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.504 ' HA ' ' O ' ' A' ' 65' ' ' THR . 43.9 t -104.9 116.45 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 122.855 0.462 . . . . 75.32 110.115 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 27.8 ttpp -100.19 123.52 44.52 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.217 1.007 . . . . 74.53 109.694 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.463 1.105 . . . . 75.3 108.204 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.708 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -111.65 115.39 29.04 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.466 -0.939 . . . . 71.5 108.466 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 tt -97.9 117.95 33.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.176 -1.416 . . . . 71.13 107.176 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.63 136.24 28.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.624 0.77 . . . . 75.1 109.197 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 m -149.3 150.91 33.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.793 0.437 . . . . 74.33 110.5 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.57 154.7 41.82 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.92 0.888 . . . . 60.35 110.142 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.8 p -120.48 161.59 21.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.848 0.459 . . . . 64.34 110.702 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -156.58 119.17 4.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 63.12 108.249 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -80.95 104.79 11.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.672 -0.862 . . . . 72.21 108.672 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 57' ' ' GLU . 60.1 mt -79.33 -41.95 26.79 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.682 0.793 . . . . 73.25 111.127 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -147.17 -172.65 4.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.777 0.831 . . . . 74.32 109.978 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -73.62 125.06 27.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.021 -0.733 . . . . 64.41 109.021 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 66.56 5.56 3.91 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.731 1.212 . . . . 61.23 113.15 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 84.2 t -121.94 120.59 61.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.678 0.791 . . . . 74.22 108.904 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CE2' HG12 ' A' ' 86' ' ' ILE . 2.0 p90 -133.91 171.04 14.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.499 0.666 . . . . 72.41 110.061 172.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.729 ' HB2' HD12 ' A' ' 51' ' ' LEU . 34.4 tt0 -121.44 140.42 52.17 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.821 -1.536 . . . . 73.43 108.653 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -123.26 126.7 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 107.154 -1.424 . . . . 74.12 107.154 165.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.9 t -106.65 115.45 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.24 -0.652 . . . . 74.35 109.24 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 100.48 12.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.457 -1.312 . . . . 64.23 107.457 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 12.4 ttp180 -85.82 106.38 17.01 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.878 -0.786 . . . . 72.42 108.878 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.61 131.46 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.142 -1.429 . . . . 72.14 107.142 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.708 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.5 m -127.81 125.58 40.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.575 -0.898 . . . . 72.14 108.575 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG12 HD21 ' A' ' 126' ' ' LEU . 44.7 t -119.35 115.22 47.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.055 -0.975 . . . . 74.32 108.81 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.8 m -102.14 146.21 28.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.64 -0.874 . . . . 75.11 108.64 172.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.08 132.08 26.15 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.868 -1.16 . . . . 74.45 107.868 172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 m -142.78 128.01 18.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.52 0.513 . . . . 72.33 110.619 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 73' ' ' ALA . 10.3 mp -87.05 84.29 7.33 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.561 -1.274 . . . . 73.01 107.561 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.6 -116.4 4.88 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 114.708 -1.133 . . . . 64.24 111.757 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.26 -16.05 34.21 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.053 0.941 . . . . 72.43 110.823 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -95.27 116.29 28.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.279 1.032 . . . . 73.41 109.963 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.2 m -70.31 132.13 45.21 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.617 0.644 . . . . 74.24 111.05 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -80.49 -60.94 2.13 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.237 1.015 . . . . 73.33 109.416 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.08 170.17 21.82 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.19 -0.914 . . . . 75.23 111.22 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -141.99 112.42 7.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.196 -1.366 . . . . 63.23 107.368 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 70.7 m -111.93 104.4 12.68 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.469 0.708 . . . . 71.42 111.016 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.436 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.7 tt0 -113.4 115.74 28.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.406 1.082 . . . . 72.34 109.636 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.04 115.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.952 0.901 . . . . 75.23 109.399 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.2 mt-30 -84.86 85.62 7.45 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.966 -0.753 . . . . 73.35 108.966 169.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.39 96.2 4.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.515 0.726 . . . . 72.33 109.814 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.66 147.45 22.09 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 111.852 -0.499 . . . . 52.01 111.852 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -143.19 143.16 12.1 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.661 -0.975 . . . . 73.2 110.661 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -109.24 127.65 65.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.044 -1.095 . . . . 74.32 108.044 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.579 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.8 m-85 -128.72 120.17 25.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.14 -1.059 . . . . 74.25 108.14 -171.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -88.88 110.19 20.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.493 -0.929 . . . . 73.0 108.493 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.567 HD11 HD13 ' A' ' 89' ' ' ILE . 2.5 pp -124.76 162.47 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.089 1.356 . . . . 74.52 109.915 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.78 135.89 1.91 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.326 0.65 . . . . 70.52 109.659 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.97 8.77 27.28 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.218 -0.768 . . . . 65.12 114.076 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.567 HD13 HD11 ' A' ' 86' ' ' ILE . 2.2 pp -120.91 154.09 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 117.931 0.865 . . . . 75.33 112.044 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.57 170.96 18.87 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.094 -0.957 . . . . 65.21 108.62 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.31 -119.02 9.29 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 115.962 1.145 . . . . 72.1 115.962 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -76.19 -20.29 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.424 0.689 . . . . 74.31 111.818 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.99 -50.35 23.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.098 0.559 . . . . 72.51 110.253 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -64.26 -35.69 81.67 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.504 0.502 . . . . 74.14 109.83 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.37 91.02 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.648 0.779 . . . . 71.53 111.004 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -70.75 -28.93 65.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.3 -0.864 . . . . 73.3 110.75 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 32.6 t -73.43 -37.17 65.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.2 0.524 . . . . 74.14 110.292 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.2 mt -78.59 -36.01 44.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.13 0.972 . . . . 74.43 112.016 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.82 3.96 34.14 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.637 -0.535 . . . . 62.34 114.294 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -148.14 -63.88 0.25 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.623 0.711 . . . . 73.52 112.818 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 57.4 t80 -62.84 -61.28 2.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.435 1.094 . . . . 74.42 112.831 -169.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -70.78 -34.89 3.94 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.495 0.924 . . . . 71.31 113.495 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -46.12 -48.37 13.05 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.701 2.267 . . . . 75.34 113.881 162.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.65 -27.89 68.71 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.312 1.045 . . . . 74.13 111.013 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 13' ' ' ILE . 43.5 mm -70.07 -47.69 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.591 0.756 . . . . 73.11 110.593 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.439 HD22 ' HA3' ' A' ' 82' ' ' GLY . 89.4 mt -73.61 -31.25 63.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.335 -0.848 . . . . 73.52 112.177 -171.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.487 ' HZ ' HD11 ' A' ' 128' ' ' LEU . 45.2 t80 -59.13 -44.18 98.22 Favored Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 113.866 1.062 . . . . 72.32 113.866 -170.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.81 -38.64 94.2 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.567 2.178 . . . . 74.21 114.359 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -71.41 -40.13 70.68 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.27 0.628 . . . . 74.45 111.64 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.23 -42.15 93.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.938 0.495 . . . . 75.22 109.951 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -53.39 -55.02 28.41 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 124.583 1.177 . . . . 73.52 110.41 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.55 -41.26 93.22 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.151 0.907 . . . . 75.54 110.662 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' ' 18' ' ' THR . 47.5 t -58.5 -36.29 73.55 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.104 0.478 . . . . 75.31 111.302 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 118' ' ' VAL . 24.2 mt -72.23 -51.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.963 0.905 . . . . 74.42 109.982 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.7 m -53.81 -40.69 66.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.765 1.226 . . . . 74.12 111.346 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -62.29 -48.96 77.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.318 -1.31 . . . . 63.32 109.514 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.0 mtm -64.05 -40.66 96.79 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.563 0.745 . . . . 75.55 111.24 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.2 t -58.33 -48.63 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.058 0.943 . . . . 74.11 110.364 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.4 t -71.45 -28.99 64.34 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.331 -0.85 . . . . 73.32 111.253 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -71.11 -29.1 64.84 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.502 0.721 . . . . 75.12 110.195 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.58 2.79 66.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.65 0.594 . . . . 71.2 112.936 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.2 m 65.86 24.17 11.3 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.211 1.404 . . . . 73.5 110.521 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -94.45 140.54 22.75 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.538 -1.282 . . . . 75.03 107.538 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -44.5 134.46 9.55 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.079 2.519 . . . . 63.24 113.898 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -46.5 130.79 11.14 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.411 1.084 . . . . 74.3 112.864 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.588 HD21 HG12 ' A' ' 64' ' ' VAL . 23.1 tp -108.11 100.99 10.26 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.541 1.137 . . . . 73.4 109.48 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -101.94 103.2 13.83 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.926 -1.139 . . . . 64.21 107.926 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.487 HD11 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -68.18 124.55 23.75 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 108.635 -0.876 . . . . 75.43 108.635 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.09 130.7 89.26 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.384 0.674 . . . . 74.03 111.854 -173.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 3.1 Cg_exo -76.56 146.17 27.01 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.988 2.459 . . . . 71.34 112.351 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.5 t -130.56 131.4 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.833 0.853 . . . . 74.03 109.408 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.09 96.03 2.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.977 -0.749 . . . . 73.11 108.977 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -72.47 -26.55 61.86 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.76 -0.654 . . . . 72.35 111.451 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.409 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-20 . . . . . 0 N--CA 1.476 0.838 0 C-N-CA 123.106 0.562 . . . . 73.33 110.225 176.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 C--O 1.237 0.401 0 N-CA-C 107.416 -1.327 . . . . 74.42 107.416 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -134.98 113.25 11.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.703 -0.481 . . . . 74.12 109.703 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.26 139.31 33.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.891 . . . . 72.44 108.678 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.46 134.94 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 109.026 -0.731 . . . . 75.5 109.026 177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -93.24 -52.64 4.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.255 -0.646 . . . . 74.42 109.255 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -155.65 132.78 10.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.955 -0.566 . . . . 75.14 109.86 -172.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.31 136.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.349 -1.723 . . . . 74.41 106.349 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.418 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.6 p90 -166.99 148.55 5.95 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.907 0.384 . . . . 73.01 110.961 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.8 m -77.28 129.21 35.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.964 -0.754 . . . . 71.14 108.964 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.7 mtpt -98.87 -31.13 12.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.641 0.776 . . . . 70.25 110.865 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -154.43 145.73 22.95 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.392 0.433 . . . . 75.43 111.662 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.718 HD12 ' SG ' ' B' ' 113' ' ' CYS . 39.1 mm -137.18 148.18 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.199 1.399 . . . . 75.11 109.03 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.5 m -146.97 140.41 25.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.746 -1.116 . . . . 75.44 109.445 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.6 t80 -147.5 110.34 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 105.825 -1.917 . . . . 73.12 105.825 162.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.26 111.88 15.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.103 -1.073 . . . . 72.53 108.103 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.524 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -116.47 87.03 19.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 108.543 -0.91 . . . . 71.2 108.543 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.16 -25.17 19.34 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.443 2.095 . . . . 71.22 111.475 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -103.34 7.8 38.2 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.483 1.113 . . . . 74.23 110.457 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -40.86 -54.48 5.33 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 115.907 1.817 . . . . 74.13 115.907 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.3 Cg_exo -72.75 -50.25 0.22 Allowed 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.54 2.16 . . . . 72.3 111.955 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.3 m80 -85.37 5.51 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.724 -1.126 . . . . 75.51 112.133 -173.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.76 -16.72 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.197 0.599 . . . . 74.25 111.904 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -51.34 -32.72 26.53 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.787 0.835 . . . . 72.44 112.206 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.553 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.3 pt20 -73.21 -48.93 30.92 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.269 -0.423 . . . . 75.31 110.858 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.553 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 83.7 mttt -110.82 62.41 0.61 Allowed 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.937 0.875 . . . . 72.42 109.513 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -117.11 118.69 33.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.032 -1.84 . . . . 64.41 106.032 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 169.01 -168.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.64 1.976 . . . . 73.53 106.217 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.58 109.8 1.62 Allowed Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 122.977 0.511 . . . . 73.41 112.193 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.476 ' HG2' HG12 ' B' ' 40' ' ' VAL . 91.6 Cg_endo -94.69 162.79 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.99 2.46 . . . . 75.12 112.099 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -80.52 103.53 10.44 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.293 -1.373 . . . . 71.42 107.293 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.476 HG12 ' HG2' ' B' ' 38' ' ' PRO . 5.4 m -99.3 143.2 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.149 -0.932 . . . . 74.14 109.576 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.99 132.67 32.61 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.609 -0.886 . . . . 64.24 108.609 -171.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 mt -99.92 123.9 44.66 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.899 -0.778 . . . . 73.45 108.899 173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.512 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.4 t70 -126.12 111.73 14.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.902 -0.777 . . . . 73.54 108.902 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 9.9 mp -100.33 131.65 46.14 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.69 -0.687 . . . . 75.21 109.302 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.6 t70 -120.7 125.97 49.01 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.464 -1.31 . . . . 71.13 107.464 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -109.2 103.69 12.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.305 -0.861 . . . . 72.53 109.506 -168.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 130.84 44.13 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.747 0.819 . . . . 65.42 109.159 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 74.9 p -142.45 162.8 34.54 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.962 0.505 . . . . 74.51 110.389 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 p -152.87 137.46 16.86 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.916 0.886 . . . . 74.03 109.346 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.95 122.99 28.48 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.013 0.525 . . . . 71.13 109.764 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.09 -43.2 16.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.058 0.543 . . . . 72.35 110.459 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -169.03 2.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.373 0.669 . . . . 73.41 111.082 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.89 112.32 2.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.488 1.115 . . . . 72.45 110.681 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.06 1.64 2.43 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.278 1.431 . . . . 71.51 112.805 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.1 t -105.26 110.89 32.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.563 -0.903 . . . . 64.43 108.563 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -115.16 160.23 19.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.779 0.832 . . . . 74.13 108.993 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -132.75 106.25 7.64 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.782 -1.562 . . . . 63.51 106.782 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -105.51 122.6 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.372 1.069 . . . . 74.4 109.817 -171.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.69 128.78 62.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.125 0.97 . . . . 73.44 108.846 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -118.7 111.77 18.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.464 -1.31 . . . . 71.1 107.464 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 38.6 ttm180 -87.16 132.51 33.84 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.669 0.788 . . . . 71.22 109.587 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.4 107.16 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.768 -1.197 . . . . 71.31 107.768 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 38.8 m -97.19 137.94 35.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.642 -0.873 . . . . 71.52 108.642 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.522 HG22 HG21 ' B' ' 114' ' ' ILE . 61.2 t -121.86 97.35 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -90.27 137.8 32.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.579 -0.737 . . . . 64.22 109.155 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.411 ' HB1' HG13 ' B' ' 40' ' ' VAL . . . -143.26 145.94 33.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.362 0.665 . . . . 71.25 109.753 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -159.31 135.97 9.32 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.816 0.698 . . . . 60.3 110.51 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.429 HD13 ' HB1' ' B' ' 73' ' ' ALA . 5.5 mp -113.45 137.96 50.78 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.558 -0.905 . . . . 75.33 108.558 168.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.1 -127.74 13.21 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.919 -0.473 . . . . 61.53 111.919 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -109.87 6.01 22.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.264 1.025 . . . . 75.53 110.412 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.01 167.12 12.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.559 0.743 . . . . 73.0 111.088 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.2 m -68.91 155.14 40.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.185 0.994 . . . . 75.24 110.542 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' B' ' 68' ' ' LEU . . . -109.88 -60.54 1.77 Allowed 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 73.42 108.581 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -164.27 156.17 16.41 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.767 -1.106 . . . . 74.54 108.336 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 mt -132.24 108.96 9.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.383 -1.339 . . . . 74.14 107.383 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.75 157.04 26.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.197 -1.038 . . . . 74.55 108.197 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.4 tt0 -164.9 142.49 6.23 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.153 0.581 . . . . 74.25 109.856 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.9 t -132.57 144.51 36.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 170.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -123.83 90.83 3.34 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.914 -1.143 . . . . 74.54 107.914 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -84.74 102.02 12.68 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 74.32 108.905 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.39 167.83 34.4 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.368 -0.833 . . . . 71.12 111.608 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.26 126.37 1.43 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.558 -0.353 . . . . 72.22 112.415 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.418 HG13 ' HE1' ' B' ' 17' ' ' TYR . 53.4 mt -85.37 128.09 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.56 -0.904 . . . . 75.25 108.56 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -135.8 135.11 39.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.626 1.171 . . . . 74.1 109.233 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.2 m -91.32 99.96 12.84 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.663 0.785 . . . . 74.13 108.99 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 pt -121.8 138.69 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.582 0.753 . . . . 74.32 110.439 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.28 169.36 24.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.374 1.07 . . . . 71.31 109.89 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.84 -47.63 3.74 Favored Glycine 0 N--CA 1.478 1.45 0 C-N-CA 123.356 0.503 . . . . 51.12 112.668 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 16.9 pt -64.15 148.37 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.285 1.034 . . . . 74.43 111.73 173.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.566 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 42.6 tt0 -157.73 144.44 17.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.143 0.977 . . . . 72.11 109.909 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.51 -108.88 1.85 Allowed Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.381 -0.677 . . . . 72.5 113.602 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 36.5 m -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.386 0.675 . . . . 74.33 110.948 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.566 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.8 mt-30 -62.97 -45.22 93.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.598 0.759 . . . . 73.2 109.513 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ttt -73.71 -38.77 64.72 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.037 -0.983 . . . . 74.45 110.511 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.58 69.61 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.346 0.658 . . . . 70.3 111.161 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -79.2 -35.8 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.03 0.932 . . . . 63.51 110.124 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.15 -68.4 0.38 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.356 -0.384 . . . . 73.42 110.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.8 -8.27 56.45 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.462 0.541 . . . . 75.44 112.462 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.99 -9.19 46.12 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 114.303 0.481 . . . . 50.43 114.303 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.17 -54.72 0.4 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.49 0.645 . . . . 73.44 110.962 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -68.0 -55.75 11.48 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.879 0.872 . . . . 72.43 111.506 -172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.59 -44.06 79.82 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.374 1.069 . . . . 65.1 112.286 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -48.75 -53.52 6.79 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.837 2.358 . . . . 72.31 112.601 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.14 -18.89 50.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.966 0.728 . . . . 64.35 112.966 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.403 ' HA ' HH21 ' D' ' 111' ' ' ARG . 71.7 mt -77.26 -57.09 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.189 0.596 . . . . 72.33 110.623 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.33 -4.83 59.29 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.093 0.557 . . . . 74.41 112.234 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.53 -46.74 47.61 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.48 1.112 . . . . 74.41 112.454 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.3 -34.78 94.77 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 121.875 1.717 . . . . 72.14 112.978 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.474 ' HE2' HG22 ' D' ' 115' ' ' THR . 57.2 m-85 -65.25 -52.57 53.63 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.122 0.969 . . . . 75.32 110.752 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.422 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.09 -43.19 91.83 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.501 0.72 . . . . 72.35 110.341 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -56.23 -56.33 22.27 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.926 1.291 . . . . 72.32 111.259 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -38.88 92.49 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.611 0.569 . . . . 74.33 109.602 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.718 ' SG ' HD12 ' B' ' 21' ' ' ILE . 6.5 t -64.97 -38.94 92.62 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 123.522 0.514 . . . . 74.0 111.719 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.522 HG21 HG22 ' B' ' 64' ' ' VAL . 57.6 mt -65.35 -52.66 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.242 0.617 . . . . 74.44 109.542 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.483 HG21 ' NE2' ' C' ' 125' ' ' GLN . 23.3 m -61.45 -29.02 69.69 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 115.089 -0.959 . . . . 72.11 111.475 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.9 t -63.14 -49.48 74.2 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.72 0.808 . . . . 65.21 109.326 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -69.96 -34.41 73.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.733 0.813 . . . . 74.44 111.16 -175.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.561 HG22 HD13 ' B' ' 126' ' ' LEU . 80.6 t -64.52 -39.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.669 0.788 . . . . 74.31 110.239 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 16.4 t -71.29 -31.28 67.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.222 0.609 . . . . 73.44 110.83 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.8 mtt-85 -67.87 -22.89 65.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.244 0.618 . . . . 74.31 110.279 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.71 17.98 56.48 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.504 0.502 . . . . 53.24 113.221 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.591 HG21 ' HB3' ' A' ' 17' ' ' TYR . 75.0 p 62.96 14.87 7.88 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.559 1.944 . . . . 73.15 113.7 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -92.47 148.7 36.88 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 122.921 0.488 . . . . 72.05 109.887 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' C' ' 125' ' ' GLN . 96.6 Cg_endo -74.21 -159.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.062 2.508 . . . . 72.02 113.059 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.602 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.4 122.74 17.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.368 -0.833 . . . . 73.04 113.153 -167.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.561 HD13 HG22 ' B' ' 118' ' ' VAL . 9.4 tt -109.89 127.42 54.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 106.018 -1.845 . . . . 74.4 106.018 166.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 106.67 9.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.313 -0.625 . . . . 72.53 109.313 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.65 107.88 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.005 -1.109 . . . . 75.3 108.005 169.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.39 135.07 88.76 Favored Pre-proline 0 CA--C 1.548 0.896 0 O-C-N 124.075 0.859 . . . . 73.31 110.256 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.28 109.25 0.39 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.278 2.652 . . . . 70.44 112.206 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.17 113.41 26.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.511 -0.922 . . . . 72.42 108.511 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.15 76.93 6.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.695 -0.854 . . . . 75.54 108.695 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 124.215 1.006 . . . . 72.42 111.017 -179.806 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.47 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 51.4 ttp . . . . . 0 CA--C 1.55 0.945 0 N-CA-C 112.773 0.657 . . . . 75.1 112.773 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -91.38 92.87 8.77 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.076 -1.453 . . . . 75.23 107.076 166.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.456 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 72.6 t80 -108.57 154.35 22.08 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.884 -1.053 . . . . 72.35 109.67 -175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -163.54 139.59 6.75 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.308 1.043 . . . . 74.41 109.017 173.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pp -80.89 141.32 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.447 0.699 . . . . 74.34 109.369 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -109.83 -51.25 2.89 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.777 0.431 . . . . 74.43 110.009 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -172.43 123.82 0.47 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.471 0.482 . . . . 74.32 109.846 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -109.01 136.02 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.012 -1.107 . . . . 71.34 108.012 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.506 ' HE1' HG12 ' C' ' 83' ' ' ILE . 19.5 p90 -168.68 162.92 11.99 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.861 0.839 . . . . 72.43 112.432 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.6 p -86.38 103.75 15.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.375 -1.284 . . . . 73.12 108.662 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -67.8 -35.21 78.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.64 0.733 . . . . 74.41 109.981 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.9 t70 -148.21 139.48 23.43 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.473 -1.24 . . . . 70.4 109.095 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.439 HG21 ' HE2' ' C' ' 117' ' ' MET . 59.2 mt -133.55 141.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.077 -1.453 . . . . 63.42 107.077 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -152.87 146.34 24.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.411 -0.588 . . . . 72.13 109.411 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.95 113.63 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.131 -1.433 . . . . 72.33 107.131 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.48 111.26 20.49 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.297 -1.001 . . . . 74.12 108.297 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.75 80.21 55.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.356 1.063 . . . . 74.11 108.262 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.39 -16.78 24.44 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.172 1.915 . . . . 75.44 109.898 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.96 11.86 25.91 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.231 1.412 . . . . 62.44 110.041 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.55 97.72 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.028 1.122 . . . . 75.43 114.028 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.28 -36.15 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 121.404 1.402 . . . . 62.51 113.032 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -67.67 -25.68 65.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.884 1.274 . . . . 72.03 112.869 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.428 HG11 ' HE1' ' C' ' 123' ' ' PHE . 14.4 p -62.31 -27.13 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.455 1.102 . . . . 73.14 111.853 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . 0.506 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 30.0 t80 -65.9 -26.76 67.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.588 -0.733 . . . . 72.43 111.96 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -99.0 6.12 46.84 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.455 0.539 . . . . 75.22 112.455 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.529 ' HB3' ' HZ1' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -99.7 173.11 6.86 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.467 0.576 . . . . 75.23 110.054 175.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.26 123.38 25.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.455 -0.943 . . . . 74.05 108.455 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.506 ' HZ2' ' HA ' ' C' ' 32' ' ' PHE . 59.4 m95 -85.37 69.76 10.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.186 0.595 . . . . 72.35 110.683 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -163.17 60.1 0.91 Allowed Pre-proline 0 CA--C 1.56 1.344 0 CA-C-N 115.087 -0.96 . . . . 75.35 109.003 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.12 158.98 37.62 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.034 2.489 . . . . 72.22 111.61 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.43 88.84 6.58 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 106.664 -1.606 . . . . 75.55 106.664 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.93 102.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 113.61 -1.632 . . . . 74.33 109.749 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.1 110.82 22.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.553 -1.203 . . . . 74.22 108.537 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.15 130.57 34.58 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.366 -1.346 . . . . 64.13 107.366 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.9 t70 -119.36 103.81 9.81 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.882 1.273 . . . . 65.44 107.78 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 23.5 tp -100.16 112.53 24.84 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.348 -0.982 . . . . 74.03 108.348 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -114.67 139.62 49.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.763 1.225 . . . . 54.34 108.921 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -114.53 145.62 41.71 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.436 0.694 . . . . 71.55 110.361 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 150.5 29.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.607 0.763 . . . . 73.21 109.739 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.8 m -155.78 155.24 32.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.249 0.62 . . . . 74.01 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.3 p -148.85 140.42 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.53 0.732 . . . . 74.12 109.918 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.47 115.41 22.06 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.211 -1.033 . . . . 72.25 108.211 170.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.489 HD13 HD13 ' C' ' 83' ' ' ILE . 74.6 mt -88.88 -39.01 14.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.516 0.726 . . . . 74.55 110.343 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.08 -168.79 2.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.017 -0.992 . . . . 70.44 110.348 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.98 100.55 0.16 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.356 1.063 . . . . 54.34 110.654 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 66.94 10.69 7.85 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.497 1.519 . . . . 75.42 113.234 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -94.27 114.13 30.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.866 -1.161 . . . . 63.52 107.866 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -123.23 124.23 42.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.108 0.963 . . . . 74.11 109.057 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.67 120.52 26.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.326 -0.852 . . . . 75.43 109.34 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -97.65 114.12 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.135 -1.061 . . . . 72.24 108.135 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.6 134.55 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.28 -1.007 . . . . 73.33 108.28 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -128.9 102.81 6.7 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.905 -1.146 . . . . 74.43 107.905 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.515 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 23.8 ttt180 -82.69 108.21 15.89 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.525 -0.761 . . . . 74.24 109.279 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.4 t -100.08 121.77 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 107.477 -1.305 . . . . 74.25 107.477 172.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.4 m -127.31 117.47 22.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.648 -0.871 . . . . 74.41 108.648 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.1 110.28 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.699 -0.852 . . . . 74.43 108.699 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.4 m -99.83 144.04 29.35 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.666 -0.865 . . . . 73.2 108.666 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' C' ' 73' ' ' ALA . . . -130.56 130.46 44.11 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.752 -1.203 . . . . 71.44 107.752 172.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.1 m -147.88 130.44 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.03 0.443 . . . . 74.23 110.965 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.07 58.1 4.86 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.016 1.326 . . . . 74.14 107.476 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.23 -118.0 5.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 114.732 -1.122 . . . . 61.34 110.567 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.06 -28.67 18.87 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.449 0.7 . . . . 54.4 109.308 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.68 102.63 0.76 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.939 0.896 . . . . 65.51 109.666 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -72.92 144.43 47.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.239 0.616 . . . . 74.22 111.021 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' C' ' 66' ' ' ALA . . . -97.65 -56.27 2.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.507 1.123 . . . . 63.22 109.455 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -158.03 172.01 19.21 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.99 -0.55 . . . . 74.54 110.923 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.404 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -136.37 146.16 46.2 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 106.9 -1.518 . . . . 74.51 106.9 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.404 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.76 113.58 4.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.13 0.572 . . . . 74.41 109.789 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -117.34 117.51 29.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.653 0.781 . . . . 74.24 110.04 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -121.84 122.24 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.504 -0.554 . . . . 71.4 109.504 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.8 mt-30 -99.04 91.34 4.97 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.043 -1.095 . . . . 73.44 108.043 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -83.14 104.86 13.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.235 -0.893 . . . . 63.33 110.062 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 146.6 18.3 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.108 -0.497 . . . . 74.14 112.015 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.05 116.85 1.11 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.07 -1.212 . . . . 43.32 110.07 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' D' ' 29' ' ' PRO . 15.5 mm -81.46 122.33 36.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.449 -0.945 . . . . 74.44 108.449 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -138.51 148.68 44.57 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.35 -0.981 . . . . 71.43 108.35 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.1 p -110.17 119.02 37.93 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.458 -0.941 . . . . 52.04 108.458 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.88 120.68 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.267 -1.012 . . . . 73.1 108.267 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.47 165.02 30.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.132 0.973 . . . . 73.1 109.565 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.08 -46.68 1.14 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.965 -0.561 . . . . 63.43 112.242 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' C' ' 9' ' ' MET . 0.2 OUTLIER -121.81 171.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.24 0.616 . . . . 75.51 111.253 -177.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.74 -173.03 4.11 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.019 -0.991 . . . . 74.45 109.425 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.78 -139.72 39.3 Favored Glycine 0 C--N 1.344 1.011 0 O-C-N 123.529 0.518 . . . . 65.42 114.159 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -70.56 -21.72 62.66 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.117 0.967 . . . . 75.12 112.038 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -71.48 -38.01 71.25 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.537 0.735 . . . . 75.53 110.388 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 9.8 tmm? -71.99 -41.08 68.05 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.018 -0.734 . . . . 70.25 109.018 174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.65 69.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.569 0.747 . . . . 63.51 111.262 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -70.64 -34.18 71.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.504 0.722 . . . . 74.21 110.491 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.47 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 40.6 t -68.21 -64.66 0.82 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.444 0.465 . . . . 71.24 110.398 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -12.69 54.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.047 -0.408 . . . . 75.43 112.093 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 -7.84 46.32 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 114.706 0.642 . . . . 73.5 114.706 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.33 -55.93 0.48 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.395 0.598 . . . . 75.22 110.847 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.436 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 81.0 t80 -69.12 -56.54 7.36 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.907 0.883 . . . . 71.15 111.822 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.76 -44.97 74.99 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.59 1.156 . . . . 72.42 112.951 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.94 -34.37 81.48 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 121.758 1.639 . . . . 75.21 111.995 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -28.5 67.28 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.317 0.647 . . . . 64.15 111.695 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 33.3 mm -66.24 -53.52 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.978 -0.378 . . . . 74.11 109.978 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -87.21 -8.35 56.95 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.412 0.523 . . . . 75.41 112.412 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.13 -50.09 89.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 124.21 1.004 . . . . 75.2 113.416 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.87 -25.74 74.47 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 121.489 1.459 . . . . 75.51 113.121 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -69.51 -46.07 67.4 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.285 0.634 . . . . 73.34 110.232 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.4 89.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.603 0.761 . . . . 73.4 110.396 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.518 ' HG3' HD21 ' C' ' 128' ' ' LEU . 39.5 ttt180 -58.38 -55.68 31.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 113.945 -1.48 . . . . 75.22 111.157 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.452 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -67.81 -27.46 66.75 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.979 0.512 . . . . 54.13 110.328 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' C' ' 21' ' ' ILE . 32.0 t -71.5 -36.57 71.15 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.744 0.418 . . . . 72.03 111.407 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.5 mt -72.67 -48.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.454 0.701 . . . . 75.25 110.025 174.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 49.1 m -60.92 -33.71 73.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.09 0.956 . . . . 74.53 111.36 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.5 t -62.2 -47.73 83.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.791 -0.64 . . . . 73.24 109.444 173.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.57 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.28 -37.5 87.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.709 1.203 . . . . 62.11 112.226 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.33 -42.21 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.181 0.592 . . . . 74.1 109.407 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.3 t -69.05 -28.99 67.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.641 0.777 . . . . 74.25 111.711 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.6 mtt-85 -76.03 -28.8 57.84 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.694 0.797 . . . . 75.41 110.468 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.52 4.63 81.18 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.525 0.516 . . . . 74.31 112.433 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.546 HG21 ' HB3' ' D' ' 17' ' ' TYR . 20.8 p 62.38 33.04 16.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.044 1.738 . . . . 73.44 111.961 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG11 ' C' ' 31' ' ' VAL . 24.8 m-85 -102.17 154.05 37.64 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 115.004 -0.998 . . . . 64.35 110.608 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -53.7 132.18 47.88 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.263 2.642 . . . . 73.32 112.949 177.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.483 ' NE2' HG21 ' B' ' 115' ' ' THR . 14.6 mm-40 -59.63 142.74 52.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.026 0.829 . . . . 73.24 112.461 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -126.82 126.32 43.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.744 0.818 . . . . 74.44 108.863 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.43 127.28 48.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.206 1.003 . . . . 61.35 109.128 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.518 HD21 ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -80.48 141.36 35.28 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.697 0.623 . . . . 74.12 110.159 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.34 158.96 57.15 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 124.856 1.262 . . . . 73.34 111.183 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.34 107.45 2.46 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.102 2.535 . . . . 75.04 111.532 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.9 t -98.44 107.48 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.54 -0.911 . . . . 72.43 108.54 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -113.73 99.24 7.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.588 1.155 . . . . 75.02 108.83 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.51 -42.99 99.88 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.794 0.838 . . . . 74.25 111.337 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.478 0.927 0 CA-C-N 114.865 -1.061 . . . . 74.14 111.714 -179.273 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m . . . . . 0 C--O 1.239 0.505 0 N-CA-C 108.898 -0.779 . . . . 75.42 108.898 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -163.03 104.48 1.01 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.387 -1.338 . . . . 71.41 107.387 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -127.48 140.95 51.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.394 -0.965 . . . . 71.43 108.394 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.25 133.21 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.147 -1.057 . . . . 75.22 108.147 171.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 68.6 mt-30 -89.21 -39.6 13.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.345 0.403 . . . . 74.53 110.384 173.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 176.07 150.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.336 1.054 . . . . 72.45 110.6 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.26 134.45 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.546 ' HB3' HG21 ' C' ' 122' ' ' THR . 25.0 p90 -147.73 162.53 39.0 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.267 1.027 . . . . 73.2 110.347 -176.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -95.44 119.68 34.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.764 -1.107 . . . . 71.42 109.52 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -90.56 -27.44 19.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.781 0.432 . . . . 72.31 110.585 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -154.76 140.27 17.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.087 -0.961 . . . . 74.11 108.696 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.57 HG21 ' HE1' ' C' ' 117' ' ' MET . 71.9 mt -137.95 143.05 34.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.081 -1.081 . . . . 74.31 108.081 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -148.07 123.36 10.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.142 0.977 . . . . 73.53 109.293 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.438 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -131.3 120.72 23.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.103 -1.814 . . . . 72.2 106.103 170.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.9 mt-10 -123.06 144.55 49.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.67 -0.492 . . . . 70.14 109.67 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.62 76.54 47.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 106.27 -1.752 . . . . 74.25 106.27 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.63 -25.26 24.78 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.695 2.263 . . . . 74.15 112.541 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -112.73 25.77 11.14 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.157 0.983 . . . . 75.2 109.169 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.489 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -49.02 -62.18 2.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 114.453 1.279 . . . . 72.44 114.453 -166.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.542 ' HB3' HD11 ' C' ' 83' ' ' ILE . 37.7 Cg_endo -83.14 -8.91 10.74 Favored 'Trans proline' 0 C--N 1.373 1.841 0 CA-C-N 122.358 1.878 . . . . 73.45 113.245 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -78.73 -36.78 42.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.67 1.188 . . . . 73.42 109.67 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' D' ' 73' ' ' ALA . 6.0 p -80.31 -21.66 11.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 CA-C-N 116.057 -0.52 . . . . 74.02 109.729 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -66.07 -6.51 13.27 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.427 0.899 . . . . 73.11 113.427 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -78.49 -36.22 45.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 74.33 109.541 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -131.38 61.36 1.64 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.122 0.969 . . . . 75.34 110.438 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -108.44 82.77 1.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.376 -0.828 . . . . 75.43 110.065 -172.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.601 ' H ' HD22 ' D' ' 68' ' ' LEU . 8.2 m95 -124.14 -159.71 0.88 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.987 -1.116 . . . . 73.53 107.987 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 45.8 tt0 -59.91 109.62 2.13 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.512 0.725 . . . . 74.25 111.763 -171.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 3.4 Cg_endo -84.76 150.87 11.33 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.093 2.528 . . . . 73.32 113.522 -175.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -73.73 120.46 19.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.093 -0.958 . . . . 75.02 109.253 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.36 129.05 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 124.104 0.962 . . . . 72.45 110.896 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -130.62 117.75 19.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.238 1.015 . . . . 73.12 110.113 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.692 HD11 HD13 ' D' ' 128' ' ' LEU . 8.8 tt -98.15 137.97 36.12 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.103 -0.703 . . . . 73.13 109.103 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.663 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.0 m-20 -127.68 147.34 50.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.189 0.996 . . . . 75.21 108.845 172.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.83 150.76 39.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.346 0.659 . . . . 75.41 109.614 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 14.5 t70 -149.56 125.25 10.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.487 1.115 . . . . 74.52 108.108 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -104.21 144.27 31.82 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.431 0.692 . . . . 75.2 110.638 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.35 156.94 31.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.936 0.894 . . . . 70.45 109.332 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -168.61 154.31 6.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.328 0.651 . . . . 72.13 110.292 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -155.63 136.24 13.37 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.635 0.774 . . . . 63.41 109.357 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -74.32 122.94 23.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.529 -0.545 . . . . 71.3 109.529 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.2 mt -90.58 -37.94 13.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.033 0.533 . . . . 75.35 110.58 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.17 -176.35 5.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.381 0.673 . . . . 70.44 111.023 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.11 119.21 7.4 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.932 -1.031 . . . . 50.43 110.365 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.87 19.18 10.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.343 1.057 . . . . 75.32 112.058 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.17 126.62 75.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.086 0.954 . . . . 72.45 109.076 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -132.85 129.93 39.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.008 -1.108 . . . . 73.51 108.008 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.1 tt0 -91.12 119.42 31.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.567 -0.901 . . . . 61.52 108.567 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.96 129.35 52.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.935 -1.135 . . . . 75.32 107.935 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.4 t -116.84 128.34 74.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.157 -1.053 . . . . 74.14 108.157 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -126.54 105.91 9.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.307 -1.368 . . . . 72.34 107.307 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.4 ttm180 -84.17 123.25 29.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.573 -0.74 . . . . 74.53 109.4 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -112.07 137.12 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.45 -0.944 . . . . 75.12 108.45 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.9 m -126.55 138.89 53.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.373 0.669 . . . . 72.01 109.515 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.557 HG12 ' HG ' ' D' ' 126' ' ' LEU . 75.5 t -127.72 108.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.244 1.018 . . . . 62.31 109.445 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.5 m -99.92 124.53 45.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.709 0.804 . . . . 74.32 109.013 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 126.69 54.45 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.485 0.714 . . . . 70.4 110.127 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 33.9 p -140.79 121.11 13.95 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 109.313 -0.625 . . . . 55.22 109.313 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.601 HD22 ' H ' ' D' ' 36' ' ' TRP . 1.0 OUTLIER -98.95 135.25 40.63 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.706 0.803 . . . . 72.41 110.104 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.35 -111.44 4.16 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.43 -0.668 . . . . 71.13 111.43 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.14 18.26 9.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.336 1.054 . . . . 75.01 109.961 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -124.15 143.75 50.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.839 1.256 . . . . 72.13 109.973 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -76.89 121.98 24.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.951 0.5 . . . . 63.35 110.979 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.596 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -77.39 -65.49 0.95 Allowed 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.395 0.678 . . . . 74.53 109.608 175.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.53 164.25 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.391 -1.277 . . . . 70.04 110.549 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 67.2 mt -126.47 142.54 51.5 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.245 -1.391 . . . . 73.02 107.245 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.556 ' SG ' HG22 ' D' ' 114' ' ' ILE . 42.2 t -147.87 139.06 23.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.33 -0.618 . . . . 71.53 109.33 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -157.74 139.86 14.31 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.896 0.878 . . . . 70.23 109.22 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.47 118.89 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.742 0.817 . . . . 75.54 109.334 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.97 82.74 6.12 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.174 -1.047 . . . . 70.51 108.174 173.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.46 102.48 12.11 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.463 -0.79 . . . . 74.52 109.9 -171.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 170.26 29.94 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 116.324 -0.398 . . . . 64.01 112.385 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.56 137.68 4.47 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.534 -0.627 . . . . 71.13 111.534 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.443 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.6 mt -90.28 135.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 109.175 -0.676 . . . . 74.02 109.175 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.01 126.08 29.47 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.443 0.697 . . . . 74.23 109.875 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -78.88 94.98 5.29 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.633 0.773 . . . . 63.42 109.092 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.557 HG23 HD12 ' D' ' 89' ' ' ILE . 21.8 mt -113.13 131.76 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.625 0.77 . . . . 75.22 110.142 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.45 169.25 23.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.075 0.95 . . . . 72.13 110.35 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.42 21.39 79.45 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.078 -0.51 . . . . 73.23 113.617 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.557 HD12 HG23 ' D' ' 86' ' ' ILE . 1.5 pp -135.46 160.55 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.565 1.146 . . . . 75.42 109.604 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -168.4 166.53 12.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.522 0.729 . . . . 74.13 110.515 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.69 -135.47 47.04 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.998 0.811 . . . . 54.13 114.149 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -77.0 -22.86 52.48 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.842 0.857 . . . . 74.44 111.066 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -62.31 -46.12 90.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.784 0.834 . . . . 72.45 110.444 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.3 ptm -77.75 -24.09 49.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.657 -0.701 . . . . 75.1 110.905 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -32.97 74.75 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.812 0.445 . . . . 74.0 111.148 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -77.59 -39.04 46.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.182 0.593 . . . . 73.22 111.276 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -63.66 -44.18 94.56 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.25 0.548 . . . . 71.53 110.963 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.04 -41.38 17.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.473 1.109 . . . . 72.23 111.11 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.62 -10.39 73.28 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 114.702 0.641 . . . . 74.12 114.702 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.29 -61.42 0.87 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.234 0.517 . . . . 75.12 111.232 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -65.25 -44.14 89.1 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.698 0.629 . . . . 73.3 112.698 -173.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 79.8 m -64.38 -44.68 76.45 Favored Pre-proline 0 CA--C 1.567 1.608 0 CA-C-O 118.824 -0.608 . . . . 70.34 112.498 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -48.19 -42.26 33.4 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.51 2.14 . . . . 75.35 114.093 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -64.75 -20.51 66.39 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.758 0.651 . . . . 73.45 112.758 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.3 mm -82.21 -46.8 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.398 0.618 . . . . 74.4 110.382 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -79.72 -28.85 40.53 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.169 -0.923 . . . . 74.55 111.826 -171.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -62.55 -42.56 80.13 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 124.205 1.002 . . . . 74.24 113.474 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -52.64 -39.98 74.47 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.48 2.12 . . . . 74.33 114.352 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -77.69 -32.69 53.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.522 0.729 . . . . 73.52 111.6 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.96 81.87 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.072 -0.714 . . . . 72.34 109.072 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.568 ' HA ' HD23 ' D' ' 128' ' ' LEU . 24.9 ttp180 -54.01 -55.37 27.89 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.899 1.374 . . . . 72.32 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -66.27 -39.71 89.63 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.142 0.901 . . . . 75.23 111.149 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' D' ' 21' ' ' ILE . 41.8 t -60.9 -44.1 97.61 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.31 0.381 . . . . 74.05 110.429 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.556 HG22 ' SG ' ' D' ' 76' ' ' CYS . 93.5 mt -59.03 -54.98 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.176 0.99 . . . . 72.04 110.238 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.562 HG23 ' HB2' ' D' ' 125' ' ' GLN . 71.7 m -52.08 -48.3 64.76 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 125.078 1.351 . . . . 74.31 111.595 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.2 t -67.81 -41.56 82.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.626 -1.17 . . . . 72.03 110.797 -175.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.481 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 70.9 mtm -65.61 -36.68 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.709 0.404 . . . . 75.21 111.663 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.444 HG22 ' O ' ' D' ' 114' ' ' ILE . 86.1 t -64.63 -44.74 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.605 -0.725 . . . . 64.42 109.969 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 119' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' D' ' 125' ' ' GLN . 88.1 p -69.62 -31.48 69.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.849 0.459 . . . . 71.2 111.614 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.6 mtt-85 -69.79 -30.52 68.08 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.8 0.84 . . . . 75.25 110.488 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.01 11.55 59.97 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.375 -0.829 . . . . 42.41 112.281 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.3 p 60.67 14.57 5.1 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 127.092 2.157 . . . . 70.31 113.782 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -91.41 160.69 36.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.493 1.117 . . . . 72.14 108.495 173.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.54 115.66 4.41 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.429 2.086 . . . . 74.32 110.805 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.562 ' HB2' HG23 ' D' ' 115' ' ' THR . 12.6 pt20 -51.21 139.17 19.13 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.425 1.078 . . . . 74.33 112.407 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.557 ' HG ' HG12 ' D' ' 64' ' ' VAL . 0.7 OUTLIER -107.15 110.48 22.57 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.469 -0.567 . . . . 55.51 109.469 -165.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -98.59 102.57 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.468 0.707 . . . . 73.53 109.362 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.692 HD13 HD11 ' D' ' 42' ' ' LEU . 3.2 mm? -70.11 115.7 9.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.252 1.021 . . . . 74.13 109.912 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.1 137.55 95.81 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-O 119.581 -0.247 . . . . 54.52 110.376 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.23 133.06 23.84 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.131 1.888 . . . . 73.14 110.995 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -108.06 136.38 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.291 -1.003 . . . . 75.22 108.291 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -78.36 86.78 4.41 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.366 -0.605 . . . . 72.43 109.366 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 N--CA 1.476 0.848 0 CA-C-N 115.447 -0.797 . . . . 75.41 110.713 178.295 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.5 m . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 109.854 -0.424 . . . . 75.13 109.854 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 18.7 t80 -133.05 124.79 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 75.32 108.887 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -146.56 110.02 4.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.96 -0.756 . . . . 75.43 108.96 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.662 HG12 ' HD2' ' A' ' 84' ' ' PHE . 37.6 mt -69.65 128.69 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.639 -0.874 . . . . 71.14 108.639 173.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.599 ' HA ' HE21 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -97.73 -36.98 10.06 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 122.936 0.494 . . . . 74.23 110.461 177.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.8 ttt85 -166.86 142.99 4.46 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.885 -0.413 . . . . 75.33 109.885 -174.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.69 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.549 0.74 . . . . 74.23 109.027 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.491 ' HE1' HG13 ' A' ' 83' ' ' ILE . 21.2 p90 -169.02 149.8 4.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.919 0.888 . . . . 63.24 110.299 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -79.33 119.81 22.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.899 -1.046 . . . . 74.52 108.83 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.2 mtpt -88.22 -17.93 29.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.847 0.356 . . . . 74.41 110.284 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.1 t70 -156.53 141.76 17.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.305 1.042 . . . . 72.45 109.141 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 64.4 mt -138.14 144.91 29.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 107.238 -1.393 . . . . 61.52 107.238 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.605 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 28.3 t -150.8 130.51 13.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.852 0.861 . . . . 74.34 108.935 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.534 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -132.64 136.44 46.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.406 -1.701 . . . . 75.1 106.406 167.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -133.91 140.13 46.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.414 -0.587 . . . . 75.11 109.414 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 69.23 10.92 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 106.065 -1.828 . . . . 74.25 106.065 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.46 -19.41 21.93 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.324 2.016 . . . . 73.24 112.453 -171.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -110.52 20.53 17.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.867 0.867 . . . . 64.11 109.798 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.74 -61.28 3.13 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.05 -0.976 . . . . 71.11 113.38 -167.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.4 -20.66 49.52 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.404 2.069 . . . . 74.22 113.912 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -83.85 -53.19 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.104 0.954 . . . . 73.34 109.906 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -77.43 -12.74 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-N 114.61 -1.177 . . . . 71.2 111.8 -162.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -74.18 -18.03 60.82 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.641 0.776 . . . . 64.43 112.606 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.07 -8.92 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.787 0.662 . . . . 75.43 112.787 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -79.9 168.95 18.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.957 0.503 . . . . 75.32 112.296 -174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.93 138.62 58.48 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.67 1.188 . . . . 73.34 111.153 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -86.84 80.43 8.49 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.483 0.659 . . . . 73.34 110.146 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -137.31 77.53 41.26 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 114.938 -1.028 . . . . 71.22 109.006 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -81.4 138.82 11.18 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.38 2.054 . . . . 64.1 111.762 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.56 84.32 3.39 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 106.006 -1.85 . . . . 65.54 106.006 164.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 65' ' ' THR . 12.0 p -81.91 123.39 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.748 -1.114 . . . . 73.44 109.153 -175.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.542 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 18.0 pttp -123.6 127.62 48.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 75.52 110.591 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tt -98.55 109.49 22.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.629 -1.619 . . . . 70.33 106.629 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.654 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -106.34 147.89 28.69 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.792 0.837 . . . . 75.15 108.815 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -126.19 125.57 42.66 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.74 0.816 . . . . 74.11 109.342 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.5 t70 -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.093 0.957 . . . . 75.53 108.455 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -108.17 129.46 55.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.879 0.872 . . . . 73.11 111.597 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.16 130.72 17.83 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.705 0.802 . . . . 71.34 109.987 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -125.05 151.58 45.43 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.896 -0.779 . . . . 73.12 108.896 172.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 t -158.33 133.66 8.71 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.486 0.714 . . . . 72.24 109.857 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -78.32 125.53 29.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.227 0.611 . . . . 75.34 110.018 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.12 -34.28 13.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.453 0.701 . . . . 75.53 110.64 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -178.58 6.05 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.057 0.943 . . . . 72.24 109.707 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -69.26 125.34 26.39 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.902 -0.407 . . . . 75.22 109.902 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 68.58 -8.22 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.968 1.707 . . . . 64.44 112.805 -171.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -101.33 109.52 25.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.997 -0.742 . . . . 71.3 108.997 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.532 ' HB2' HD11 ' A' ' 86' ' ' ILE . 93.2 m-85 -123.64 127.19 47.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.965 0.906 . . . . 74.14 108.607 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.31 132.04 37.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.681 -1.145 . . . . 73.4 108.992 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.58 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 58.9 t -116.86 121.43 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.694 -1.224 . . . . 73.45 107.694 169.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.41 129.76 49.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.839 0.855 . . . . 73.21 108.711 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -120.57 100.5 7.17 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.547 -1.649 . . . . 74.55 106.547 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 6.6 ttm180 -87.35 131.22 34.34 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.843 -0.799 . . . . 74.41 108.843 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 114' ' ' ILE . 47.9 t -117.84 130.61 72.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.328 -0.989 . . . . 72.43 108.328 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 69.2 m -113.72 140.97 47.82 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.635 0.584 . . . . 65.32 109.693 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.517 HG23 HD21 ' A' ' 126' ' ' LEU . 92.7 t -130.43 113.29 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.961 0.904 . . . . 72.44 108.747 174.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.5 m -112.73 131.49 55.65 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.114 -0.698 . . . . 72.41 109.114 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.27 105.74 8.75 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.316 -0.994 . . . . 72.44 108.316 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 51.6 m -110.58 122.92 48.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.29 0.495 . . . . 70.1 110.816 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.631 HD12 ' HB1' ' A' ' 73' ' ' ALA . 10.4 mp -89.57 86.96 6.87 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.111 0.964 . . . . 74.11 109.012 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.1 -84.41 1.43 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.757 -1.111 . . . . 61.43 110.5 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -25.37 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.627 0.771 . . . . 64.34 110.446 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -98.4 129.87 45.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.312 1.045 . . . . 71.31 110.225 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.6 m -79.85 135.49 36.47 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.196 0.522 . . . . 73.53 112.19 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.631 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -77.64 -63.81 1.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.2 1.4 . . . . 72.34 109.766 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -147.09 159.75 43.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.104 -0.953 . . . . 75.12 111.645 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.65 117.26 11.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.399 -1.273 . . . . 75.31 108.335 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 63' ' ' THR . 83.9 m -110.61 136.72 49.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.392 0.677 . . . . 60.14 110.709 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 43.2 mp0 -135.9 131.27 35.02 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.618 -1.253 . . . . 71.21 107.618 169.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 72.5 t -138.27 115.2 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.6 -0.889 . . . . 73.3 108.6 174.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 42.3 mt-30 -90.23 86.98 6.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 172.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.71 93.11 4.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.727 -1.124 . . . . 73.3 108.62 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.01 148.24 22.3 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.264 -0.88 . . . . 71.24 111.082 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.74 123.27 2.01 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 111.349 -0.7 . . . . 74.21 111.349 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.491 HG13 ' HE1' ' A' ' 17' ' ' TYR . 56.3 mt -80.97 123.67 37.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.896 -1.149 . . . . 72.15 107.896 170.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.662 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.3 m-85 -133.83 162.9 30.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.263 -1.014 . . . . 63.23 108.263 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 t -118.43 102.47 8.95 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.489 -0.93 . . . . 74.55 108.489 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 56' ' ' TYR . 3.3 mp -112.82 137.13 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.568 0.747 . . . . 74.42 109.032 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.8 174.87 13.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.981 0.912 . . . . 61.2 109.876 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.21 16.14 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.742 0.657 . . . . 61.22 114.742 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 94' ' ' MET . 11.2 pt -121.29 157.07 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.918 0.887 . . . . 74.24 110.776 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 2.8 tt0 -140.31 174.63 10.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.96 0.904 . . . . 73.43 109.32 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.482 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 41.91 -116.11 0.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.927 1.131 . . . . 72.34 115.927 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.6 p -73.05 -28.58 62.4 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.7 1.2 . . . . 72.34 111.978 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.08 -46.74 87.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.383 0.673 . . . . 74.34 109.206 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.437 ' HA ' HD12 ' A' ' 89' ' ' ILE . 1.4 ppp? -83.59 -21.7 32.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.49 -0.777 . . . . 61.04 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -27.42 66.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.156 0.583 . . . . 70.02 110.692 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -64.52 -35.14 80.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.773 0.829 . . . . 75.24 110.597 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 45.1 t -72.33 -41.11 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.878 -0.601 . . . . 61.14 110.91 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.57 -51.1 21.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.3 0.24 . . . . 73.4 111.605 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.9 3.79 77.83 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 114.871 0.708 . . . . 54.45 114.871 -165.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.706 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -149.64 -58.26 0.2 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.013 0.907 . . . . 75.22 113.271 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 64.3 t80 -70.55 -59.21 2.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.692 -1.14 . . . . 72.51 112.086 -167.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.02 -32.48 2.91 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.546 0.943 . . . . 63.21 113.546 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.16 -45.58 25.25 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.732 2.288 . . . . 75.52 113.011 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.18 -27.76 69.29 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.747 0.819 . . . . 74.25 111.439 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.74 -47.59 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.634 0.774 . . . . 74.32 110.257 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.54 -29.68 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.623 0.769 . . . . 74.55 112.798 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -65.15 -38.65 29.79 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 113.599 0.962 . . . . 75.13 113.599 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.81 -40.68 79.34 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 122.14 1.893 . . . . 71.32 113.608 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.502 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.6 m-85 -73.44 -40.56 64.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 75.2 111.636 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.87 84.0 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.814 0.446 . . . . 64.0 109.939 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -49.61 -53.75 22.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.096 1.498 . . . . 70.54 110.522 175.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.6 -41.11 93.16 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.178 0.924 . . . . 70.5 111.658 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.8 -31.59 72.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.034 0.533 . . . . 55.33 111.249 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.7 mt -71.84 -51.78 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.555 0.742 . . . . 75.32 109.206 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.0 m -53.57 -40.04 65.27 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.705 1.202 . . . . 75.02 111.609 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -59.72 -55.2 37.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.719 -1.128 . . . . 42.33 110.386 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.534 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.4 mtm -60.75 -43.33 98.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.24 111.515 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 114' ' ' ILE . 78.5 t -57.38 -46.38 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.411 1.084 . . . . 50.21 110.691 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -70.67 -29.25 65.53 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.15 -0.932 . . . . 74.0 111.369 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.55 -30.74 66.22 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.788 0.835 . . . . 73.53 110.653 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.08 6.25 76.21 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.774 -0.459 . . . . 74.21 112.992 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.642 ' HB ' HH21 ' B' ' 15' ' ' ARG . 1.6 m 67.9 18.71 9.58 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.258 1.423 . . . . 75.32 111.681 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.92 151.57 64.2 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 109.284 -0.635 . . . . 72.44 109.284 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -58.97 146.01 95.43 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.795 2.33 . . . . 72.43 111.53 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.412 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.23 129.58 38.86 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.747 0.654 . . . . 75.25 111.393 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 64' ' ' VAL . 48.0 tp -112.3 96.14 5.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.765 -1.107 . . . . 75.31 110.004 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.57 105.46 15.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.562 -1.273 . . . . 75.42 107.562 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 143.53 57.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.871 0.468 . . . . 74.13 110.045 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.17 130.51 94.24 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 122.95 0.5 . . . . 74.11 111.141 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.419 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 56.2 Cg_endo -72.37 104.9 1.77 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.241 1.961 . . . . 65.04 111.246 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.7 t -101.02 122.78 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.27 -1.011 . . . . 73.3 108.27 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -68.29 86.62 0.28 Allowed 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.65 -0.87 . . . . 75.21 108.65 170.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.467 -1.242 . . . . 75.43 109.922 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.706 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 5.2 t70 . . . . . 0 C--O 1.217 -0.652 0 CA-C-N 114.239 -1.346 . . . . 62.13 111.498 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.9 m . . . . . 0 C--O 1.24 0.561 0 N-CA-C 109.85 -0.426 . . . . 71.21 109.85 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.472 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 74.4 t80 -110.45 117.38 33.42 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.072 -1.084 . . . . 71.02 108.072 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -126.31 106.28 9.4 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.705 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -79.77 118.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 106.887 -1.523 . . . . 74.45 106.887 167.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -87.07 -53.61 4.77 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.472 -0.331 . . . . 75.41 110.188 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.642 HH21 ' HB ' ' A' ' 122' ' ' THR . 52.6 ttt180 -156.35 139.93 15.94 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.093 -0.336 . . . . 73.33 110.093 -172.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.705 HG13 HD11 ' B' ' 13' ' ' ILE . 92.5 mt -116.8 140.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 106.722 -1.584 . . . . 75.33 106.722 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -168.51 159.64 10.41 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 123.569 0.543 . . . . 72.32 110.552 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -85.93 120.26 27.13 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.403 -0.591 . . . . 74.05 109.403 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -87.81 -30.63 20.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.089 0.556 . . . . 73.41 110.689 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -158.86 146.81 17.96 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.715 0.293 . . . . 54.13 111.552 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.705 HD12 ' SG ' ' B' ' 113' ' ' CYS . 42.0 mm -132.46 141.61 44.76 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 125.281 1.432 . . . . 72.13 108.911 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.538 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.2 t -139.44 130.84 26.93 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.921 1.288 . . . . 75.54 107.655 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.459 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -148.13 125.17 11.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.462 -1.311 . . . . 74.41 107.462 168.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 45.9 mt-10 -122.92 144.99 48.86 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.623 -0.881 . . . . 72.13 108.623 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -142.22 74.88 20.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.6 -1.259 . . . . 75.31 107.6 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.31 -38.28 6.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.663 2.242 . . . . 72.34 112.566 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.456 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 71.9 m-20 -105.41 10.96 33.18 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.28 0.632 . . . . 74.22 111.01 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -44.59 -50.71 23.12 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 115.016 1.487 . . . . 71.45 115.016 -171.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.72 -30.35 17.94 Favored 'Trans proline' 0 C--N 1.383 2.384 0 CA-C-N 121.141 1.443 . . . . 73.33 112.829 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.422 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.0 m80 -97.61 -2.36 41.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.873 0.869 . . . . 71.44 112.956 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.53 -12.73 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.928 0.491 . . . . 74.11 110.492 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -61.36 -29.52 69.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.289 1.036 . . . . 72.35 111.735 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 pt20 -62.06 -31.98 72.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.193 0.597 . . . . 72.41 110.58 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.595 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 35.3 mmtp -97.05 64.98 2.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.311 -0.996 . . . . 74.42 108.311 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.91 99.72 11.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.802 -0.635 . . . . 75.13 110.324 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 163.89 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 126.953 2.101 . . . . 73.43 110.231 160.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -59.35 125.11 78.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.112 0.965 . . . . 64.1 112.589 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 87.9 Cg_endo -84.98 150.61 10.97 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.115 2.544 . . . . 74.32 112.56 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.44 106.45 3.94 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.015 -1.106 . . . . 74.25 108.015 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' B' ' 65' ' ' THR . 91.9 t -93.13 128.69 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.62 0.768 . . . . 75.53 110.862 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.583 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.8 tttp -109.98 124.39 51.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.165 0.986 . . . . 74.32 109.478 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.21 152.51 22.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.43 0.692 . . . . 71.32 109.94 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.09 111.7 1.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.715 0.635 . . . . 71.45 109.525 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.42 ' HG ' HG21 ' B' ' 62' ' ' VAL . 10.1 mp -99.1 139.21 35.09 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.949 -1.13 . . . . 74.45 107.949 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.8 t70 -121.75 126.24 48.42 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.89 0.876 . . . . 75.3 108.841 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -106.96 103.93 13.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.17 0.988 . . . . 74.22 108.418 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 140.73 50.28 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.482 -0.781 . . . . 73.23 109.014 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 p -144.52 163.88 32.55 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.619 0.368 . . . . 72.45 111.28 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -153.06 140.38 19.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.04 0.936 . . . . 72.02 109.536 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -80.03 133.6 36.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.574 0.35 . . . . 75.53 110.527 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.49 HD12 HG22 ' B' ' 83' ' ' ILE . 74.2 mt -94.84 -44.31 7.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.325 0.65 . . . . 73.15 110.592 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.62 -167.55 1.59 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.656 0.782 . . . . 74.05 110.965 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -63.9 106.08 0.96 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.884 -1.053 . . . . 72.0 110.784 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' B' ' 85' ' ' SER . 33.8 m-20 73.18 -1.72 2.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.303 1.841 . . . . 75.14 112.057 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.93 124.13 58.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.524 0 C-N-CA 124.182 0.993 . . . . 74.53 108.782 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -134.39 -178.62 5.13 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.512 0.725 . . . . 70.31 109.235 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.441 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.0 tm-20 -138.17 116.64 12.03 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.805 -1.554 . . . . 75.15 106.805 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.83 127.17 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.835 0.854 . . . . 73.53 110.309 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.48 112.89 37.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.297 1.039 . . . . 74.33 108.829 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.4 97.81 8.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.367 -1.346 . . . . 75.32 107.367 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 27.8 ttm180 -84.81 133.31 34.34 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.873 -0.788 . . . . 75.3 108.873 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.42 HG21 ' HG ' ' B' ' 44' ' ' LEU . 57.6 t -117.77 109.23 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.577 -1.268 . . . . 52.12 107.577 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -96.23 136.64 36.43 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.627 -0.879 . . . . 75.24 108.627 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -133.03 132.27 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.417 1.087 . . . . 72.34 108.455 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 59.7 m -123.19 144.08 49.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.686 -1.227 . . . . 72.52 107.686 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.04 135.14 39.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.953 -1.499 . . . . 70.11 106.953 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 14.8 p -145.77 139.03 26.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 122.982 0.513 . . . . 73.11 110.683 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.595 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 23.7 mt -129.46 104.67 7.61 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.853 1.261 . . . . 73.35 109.694 -171.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -135.92 19.79 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.542 -0.588 . . . . 74.11 111.953 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.7 11.08 18.56 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.546 0.673 . . . . 75.24 111.532 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.456 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.4 pt-20 -130.13 167.59 18.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.341 0.657 . . . . 72.23 110.936 -175.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -79.56 145.87 32.91 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.495 -0.775 . . . . 75.53 109.807 174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.46 -67.11 0.88 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.947 0.499 . . . . 54.0 109.668 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -160.63 152.08 19.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.975 -1.011 . . . . 73.51 108.792 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 65.9 mt -128.07 137.1 52.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.56 1.144 . . . . 65.42 108.309 -174.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -146.49 147.03 30.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.522 -0.548 . . . . 74.24 109.522 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.538 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.3 tt0 -160.88 138.61 9.42 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' B' ' 110' ' ' ALA . 74.5 t -130.15 146.26 34.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.677 -1.231 . . . . 62.12 107.677 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.9 91.79 3.59 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.777 -1.194 . . . . 72.41 107.777 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.8 tp-100 -88.04 100.07 12.65 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.343 -0.984 . . . . 71.25 108.343 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.34 162.11 30.52 Favored Glycine 0 C--O 1.241 0.574 0 N-CA-C 111.047 -0.821 . . . . 64.23 111.047 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.64 126.8 1.6 Allowed Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.938 -0.865 . . . . 34.05 110.938 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.49 HG22 HD12 ' B' ' 51' ' ' LEU . 59.0 mt -84.39 129.62 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.467 -0.938 . . . . 74.31 108.467 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -131.81 148.75 52.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.38 -0.6 . . . . 75.14 109.38 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 22.6 m -131.23 106.64 8.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.43 1.092 . . . . 73.22 109.161 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.69 145.02 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 122.946 0.498 . . . . 74.14 110.634 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.13 161.73 39.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.865 0.866 . . . . 65.2 109.986 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.47 -41.2 2.51 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.895 -0.593 . . . . 74.34 111.775 -178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.599 HD13 ' HA ' ' B' ' 94' ' ' MET . 11.0 pt -71.66 143.38 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.727 0.811 . . . . 74.4 110.574 173.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.18 145.0 24.36 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.857 -0.794 . . . . 74.45 108.857 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.73 -109.4 2.83 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.831 0.707 . . . . 74.41 113.68 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.09 -53.44 45.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.233 1.013 . . . . 73.33 111.487 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -66.55 -34.3 77.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.248 -1.342 . . . . 74.13 110.417 -172.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.599 ' HA ' HD13 ' B' ' 89' ' ' ILE . 52.2 ttp -65.86 -50.94 62.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.679 1.192 . . . . 75.3 110.606 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.9 77.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.14 0.976 . . . . 72.22 111.919 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -78.2 -36.02 47.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.215 0.606 . . . . 74.45 111.227 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -65.11 -52.18 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.07 0.548 . . . . 70.11 111.673 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.1 pp -86.75 -31.95 20.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.591 -0.277 . . . . 75.44 111.532 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.08 73.4 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.09 0.396 . . . . 54.32 114.09 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.75 -51.6 2.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.808 0.443 . . . . 74.15 111.801 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.486 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 49.7 t80 -75.54 -40.75 56.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.806 0.442 . . . . 71.33 111.99 -170.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.4 m -66.49 -43.89 53.88 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 113.466 0.913 . . . . 73.43 113.466 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.86 -37.09 97.61 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.359 2.039 . . . . 74.23 113.218 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.23 -19.7 66.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.497 0.719 . . . . 55.41 112.491 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 86.3 mt -81.68 -48.31 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.344 0.658 . . . . 72.24 110.75 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.24 -25.82 58.4 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.915 -0.584 . . . . 72.33 111.591 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -57.68 -52.54 73.61 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.066 1.136 . . . . 74.24 114.066 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.71 -41.42 61.96 Favored 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.439 2.093 . . . . 72.42 113.731 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.432 ' HE2' HG23 ' D' ' 115' ' ' THR . 91.7 m-85 -65.15 -48.13 74.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.8 0.84 . . . . 75.45 111.396 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.449 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.73 -38.54 82.0 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.486 -0.779 . . . . 62.52 110.988 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 ttp-105 -65.71 -49.73 67.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.047 -1.433 . . . . 74.04 111.386 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -35.37 79.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.995 0.518 . . . . 75.04 110.232 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.705 ' SG ' HD12 ' B' ' 21' ' ' ILE . 7.6 t -67.21 -32.0 72.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.623 0.369 . . . . 71.23 111.405 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.63 -45.63 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.499 0.72 . . . . 74.43 109.651 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.686 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.8 m -60.51 -25.01 65.77 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.382 1.073 . . . . 74.22 111.521 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -75.24 -51.4 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.652 0.781 . . . . 72.45 110.136 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.31 -34.99 73.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.914 0.486 . . . . 72.03 111.933 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.55 -39.47 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.463 0.705 . . . . 74.24 110.039 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.3 t -72.92 -27.51 61.91 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.702 0.801 . . . . 62.5 111.605 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.4 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.4 mtt-85 -73.34 -33.34 65.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.413 0.685 . . . . 71.13 110.086 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.34 1.75 69.49 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 123.855 0.722 . . . . 52.42 112.305 168.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.417 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.7 p 63.33 38.61 10.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.85 2.06 . . . . 72.22 112.606 172.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.11 156.76 40.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.484 1.114 . . . . 64.32 109.869 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -66.58 143.42 68.53 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.428 2.085 . . . . 72.41 111.54 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.686 ' HB2' HG23 ' B' ' 115' ' ' THR . 16.7 pt20 -65.14 161.65 18.64 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.28 1.432 . . . . 74.51 114.566 -167.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 26.5 tp -135.29 104.38 5.86 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.345 -1.298 . . . . 74.01 109.876 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.5 HD22 ' NE2' ' B' ' 125' ' ' GLN . 6.1 m-80 -92.2 107.43 19.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 106.48 -1.674 . . . . 74.01 106.48 167.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.1 tp -62.88 134.98 57.05 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.302 0.376 . . . . 70.1 110.153 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.25 156.46 50.42 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.775 1.23 . . . . 74.51 111.867 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.9 108.43 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.754 2.302 . . . . 72.01 111.992 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.14 108.57 18.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.775 -1.565 . . . . 73.42 106.775 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -90.23 88.99 7.45 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.854 -0.795 . . . . 75.03 108.854 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 . . . . . 0 N--CA 1.477 0.918 0 CA-C-N 115.199 -0.909 . . . . 74.54 110.466 178.431 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.705 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.3 tmm? . . . . . 0 CA--C 1.55 0.978 0 CA-C-O 121.325 0.584 . . . . 75.34 112.222 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 31.1 m -100.14 92.07 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.816 0.846 . . . . 73.32 109.36 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.705 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 49.0 t80 -92.01 145.78 24.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.799 -0.815 . . . . 74.21 108.799 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.01 132.2 4.8 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.844 -0.798 . . . . 72.12 108.844 167.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -70.88 134.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 109.17 -0.678 . . . . 73.14 109.17 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -103.19 -45.13 5.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.488 -0.56 . . . . 73.25 109.488 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 ttt85 -169.09 147.0 3.75 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.999 -0.546 . . . . 74.43 109.73 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -130.02 136.22 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.328 -1.36 . . . . 75.31 107.328 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.565 ' HB3' HG21 ' D' ' 122' ' ' THR . 19.2 p90 -171.22 154.1 3.88 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.418 0.627 . . . . 74.2 111.258 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -77.95 109.26 11.84 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.237 -1.023 . . . . 72.34 108.237 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -70.28 -45.55 66.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.74 0.781 . . . . 75.25 108.945 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.9 t70 -138.09 141.53 40.24 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.362 -1.29 . . . . 74.32 109.318 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.9 mt -136.16 142.71 37.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.718 1.607 . . . . 74.52 106.686 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -155.92 150.91 26.4 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.298 0.57 . . . . 62.13 110.987 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -152.45 121.61 6.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.595 -1.184 . . . . 75.52 107.842 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 72.41 109.157 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.1 86.18 20.83 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.453 -0.943 . . . . 51.13 108.453 174.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.27 -39.08 10.72 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.386 2.057 . . . . 75.44 111.316 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -99.26 33.77 2.34 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.188 0.995 . . . . 75.31 110.035 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.42 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -59.78 -51.9 77.63 Favored Pre-proline 0 CA--C 1.569 1.689 0 C-N-CA 124.615 1.166 . . . . 73.24 114.128 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 4.4 Cg_exo -74.85 -26.95 10.74 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.718 1.612 . . . . 74.41 111.37 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -66.03 -18.34 65.28 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.138 1.375 . . . . 73.35 112.166 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -54.71 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 N-CA-C 113.324 0.861 . . . . 63.11 113.324 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -68.25 -26.4 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.974 0.416 . . . . 74.21 111.886 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.44 30.95 6.67 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.508 1.123 . . . . 72.11 109.683 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.698 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -95.32 137.07 34.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.175 0.99 . . . . 73.0 108.7 171.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.73 130.37 42.14 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.576 -0.898 . . . . 73.23 108.576 170.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -83.79 66.59 9.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.109 0.564 . . . . 74.54 111.238 -170.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -165.7 78.34 1.22 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.543 0.737 . . . . 70.03 109.824 172.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.437 ' HB2' HG22 ' C' ' 40' ' ' VAL . 12.3 Cg_exo -73.29 163.4 38.0 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.716 2.277 . . . . 74.2 112.941 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -86.85 76.61 9.41 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 107.269 -1.382 . . . . 74.51 107.269 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.437 HG22 ' HB2' ' C' ' 38' ' ' PRO . 64.1 t -73.7 97.96 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.234 -1.348 . . . . 71.34 108.468 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -133.22 128.21 35.42 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.105 0.962 . . . . 73.24 108.757 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.565 ' HG ' HD21 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -89.41 161.86 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.701 0.626 . . . . 75.53 109.999 175.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.5 t70 -139.12 141.58 38.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.307 1.043 . . . . 72.04 108.703 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -112.36 113.02 25.01 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.241 0.616 . . . . 75.02 109.455 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.467 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.4 t70 -114.89 142.01 47.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.484 -0.932 . . . . 73.22 108.484 172.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.4 p -128.39 136.94 51.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.915 0.486 . . . . 75.53 110.335 -172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 167.29 24.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 74.12 109.347 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -159.18 164.37 35.19 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.341 0.656 . . . . 75.22 111.365 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 92.3 p -145.91 155.23 42.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.008 0.923 . . . . 75.53 109.791 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -101.72 114.76 29.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.892 -0.781 . . . . 75.31 108.892 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' C' ' 57' ' ' GLU . 39.5 mt -94.06 -32.52 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.635 0.774 . . . . 74.11 110.456 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.92 -170.2 1.3 Allowed 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.001 0.92 . . . . 73.2 110.219 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.7 111.92 2.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.791 0.836 . . . . 74.51 109.417 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.3 -5.56 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.37 1.468 . . . . 73.54 112.88 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.19 94.87 5.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 106.935 -1.505 . . . . 75.33 106.935 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -114.0 124.36 51.94 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.72 -1.127 . . . . 74.33 108.442 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.561 ' HB2' HD12 ' C' ' 51' ' ' LEU . 36.2 tt0 -82.62 125.15 30.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.871 -0.788 . . . . 72.22 108.871 176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.99 118.52 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 73.51 108.669 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 72.5 t -102.9 127.76 56.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 107.696 -1.224 . . . . 74.41 107.696 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -129.44 94.5 3.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.993 -1.484 . . . . 73.41 106.993 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.9 ttm180 -82.67 121.69 27.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.717 -0.674 . . . . 73.1 109.211 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' C' ' 114' ' ' ILE . 18.3 t -115.72 117.63 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.735 -1.209 . . . . 71.21 107.735 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 41.1 m -110.35 137.76 47.63 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.259 -1.015 . . . . 74.24 108.259 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.474 HG23 HG21 ' C' ' 114' ' ' ILE . 97.8 t -120.64 109.93 26.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.332 -0.988 . . . . 71.41 108.332 170.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -99.55 140.64 33.43 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.863 -0.792 . . . . 73.23 108.863 171.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.64 97.28 3.23 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -141.64 146.25 35.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.169 0.588 . . . . 74.14 109.765 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.47 36.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.664 1.186 . . . . 73.35 108.819 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.48 -111.75 3.25 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.059 -1.216 . . . . 60.24 110.059 -168.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.77 -19.6 23.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.773 0.829 . . . . 71.14 110.415 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -78.0 84.43 4.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.298 1.039 . . . . 71.23 109.712 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -73.09 126.97 31.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.853 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -74.48 -52.14 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.748 0.819 . . . . 72.1 109.039 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -170.56 175.68 4.6 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.128 -1.396 . . . . 73.12 109.237 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.433 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.991 -1.485 . . . . 75.24 106.991 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.433 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.2 t -148.47 150.01 32.69 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.814 -0.81 . . . . 72.33 108.814 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -158.28 133.53 8.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.953 0.501 . . . . 71.34 109.829 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.07 115.45 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.939 0.896 . . . . 65.3 109.044 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.4 mt-30 -90.39 90.49 8.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.426 -0.953 . . . . 65.33 108.426 173.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.12 116.61 20.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.541 -1.209 . . . . 71.03 110.364 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 149.56 18.48 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 112.065 -0.414 . . . . 63.34 112.065 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.22 117.64 0.94 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.53 -1.028 . . . . 75.43 110.53 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' D' ' 29' ' ' PRO . 15.7 mm -80.89 114.66 22.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.963 -1.125 . . . . 73.3 107.963 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.66 147.54 49.92 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.87 0.468 . . . . 72.14 109.935 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.9 m -106.99 113.37 26.81 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.24 106.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 107.969 -1.123 . . . . 74.42 107.969 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.572 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -123.35 170.27 10.49 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.977 0.911 . . . . 74.13 110.659 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.12 -60.16 1.97 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.103 -0.499 . . . . 74.24 113.031 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' C' ' 94' ' ' MET . 1.3 pp -99.39 171.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.158 0.583 . . . . 74.31 111.966 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.93 -177.52 5.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.403 1.081 . . . . 73.24 109.026 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.46 -130.11 49.43 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 123.758 0.694 . . . . 74.42 114.747 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -70.13 -25.99 63.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.215 1.006 . . . . 74.23 111.543 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.48 -31.36 57.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.325 0.65 . . . . 73.31 110.251 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.555 ' HA ' HD12 ' C' ' 89' ' ' ILE . 0.7 OUTLIER -74.06 -42.29 60.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.326 -0.62 . . . . 65.14 109.326 172.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.94 67.9 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.181 0.926 . . . . 62.02 112.057 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -69.88 -51.12 35.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.661 0.384 . . . . 75.52 110.412 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.28 -32.43 68.67 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.266 0.626 . . . . 63.23 111.438 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.13 -53.83 10.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.087 0.955 . . . . 65.4 109.36 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 -29.0 64.48 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.506 -1.225 . . . . 41.14 114.118 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.615 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -114.0 -45.65 3.06 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.461 0.63 . . . . 73.03 111.569 -168.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 22.0 t80 -76.36 -43.55 40.38 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 111.567 0.21 . . . . 74.11 111.567 -174.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -66.23 -45.69 61.13 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-O 118.446 -0.788 . . . . 75.05 112.913 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.38 -35.11 99.06 Favored 'Trans proline' 0 C--N 1.401 3.292 0 C-N-CA 122.316 2.011 . . . . 74.25 113.417 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.86 -36.17 76.32 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.005 0.922 . . . . 72.4 110.725 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -74.76 -46.22 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.506 0.722 . . . . 74.5 111.091 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -78.7 -20.26 50.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.733 0.642 . . . . 73.52 112.733 -170.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.408 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.8 t80 -58.26 -52.68 72.82 Favored Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 124.5 1.12 . . . . 74.2 113.242 -175.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 33.0 Cg_exo -61.32 -37.09 75.47 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.976 1.784 . . . . 74.43 112.964 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.58 -39.55 80.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.578 0.751 . . . . 73.44 111.682 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.78 81.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.306 -0.406 . . . . 70.02 110.347 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -58.09 -63.26 1.32 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 75.2 111.469 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -30.99 72.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.334 0.397 . . . . 52.14 110.524 -173.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.435 ' O ' ' SD ' ' C' ' 117' ' ' MET . 34.3 t -66.52 -41.26 89.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.334 0.654 . . . . 74.41 111.362 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.474 HG21 HG23 ' C' ' 64' ' ' VAL . 67.1 mt -65.49 -48.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.231 0.613 . . . . 72.44 110.041 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.2 m -60.77 -29.36 69.36 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.87 -1.059 . . . . 72.02 110.848 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.81 -47.05 67.06 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.143 0.977 . . . . 74.01 110.356 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.613 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.59 -45.19 89.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.327 0.651 . . . . 75.31 111.905 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.51 -39.05 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.493 0.717 . . . . 73.01 110.534 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.509 ' HB3' HE21 ' C' ' 125' ' ' GLN . 80.6 p -74.01 -29.24 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.749 -0.66 . . . . 74.14 112.144 -176.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.438 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 74.1 mtt-85 -75.44 -31.37 60.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.941 0.897 . . . . 72.12 110.75 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.09 -2.47 62.26 Favored Glycine 0 C--N 1.356 1.656 0 O-C-N 123.485 0.491 . . . . 65.32 112.427 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.504 HG21 ' HB3' ' D' ' 17' ' ' TYR . 27.9 p 63.74 27.93 14.78 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 126.692 1.997 . . . . 74.2 111.674 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -99.22 142.86 25.36 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 114.506 -1.225 . . . . 75.23 108.915 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.66 124.13 13.76 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.248 2.632 . . . . 64.43 112.768 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.509 HE21 ' HB3' ' C' ' 119' ' ' SER . 97.7 mt-30 -59.84 154.6 18.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.27 1.211 . . . . 63.11 114.27 -172.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp -127.89 119.98 26.75 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.531 -1.213 . . . . 74.11 108.635 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -98.97 130.12 45.31 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.111 -1.07 . . . . 72.13 108.111 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.565 HD21 ' HG ' ' C' ' 42' ' ' LEU . 0.2 OUTLIER -74.85 128.21 35.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 109.446 -0.576 . . . . 72.53 109.446 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.56 137.52 95.22 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.869 0.868 . . . . 73.34 110.708 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.502 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 10.0 Cg_endo -51.64 103.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.38 2.72 . . . . 75.44 111.757 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.24 110.34 24.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.118 -1.067 . . . . 74.13 108.118 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -77.6 83.73 3.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.912 -1.04 . . . . 64.23 111.18 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.9 -43.55 71.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.303 -1.317 . . . . 74.24 107.803 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.615 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.4 p-10 . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 113.12 -1.855 . . . . 74.41 112.118 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.239 0.546 0 N-CA-C 108.888 -0.782 . . . . 74.31 108.888 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -164.57 91.7 0.59 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.144 -1.428 . . . . 74.14 107.144 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -119.73 115.39 23.8 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.869 -0.789 . . . . 74.44 108.869 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.493 HD11 HG21 ' D' ' 105' ' ' ILE . 13.5 mt -74.94 122.95 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.473 -0.936 . . . . 74.15 108.473 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -88.51 -49.02 7.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.935 0.334 . . . . 74.11 110.559 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -156.43 147.33 21.98 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.629 0.772 . . . . 74.33 109.837 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.428 HD12 HG22 ' D' ' 13' ' ' ILE . 2.9 mp -117.81 122.82 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 105.582 -2.007 . . . . 75.33 105.582 161.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG21 ' C' ' 122' ' ' THR . 32.8 p90 -152.23 162.08 41.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.926 0.869 . . . . 74.5 110.361 -171.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -90.02 114.64 26.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.184 -1.371 . . . . 64.21 109.424 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -82.69 -23.8 33.96 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.793 -0.64 . . . . 74.32 109.406 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.705 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -152.29 142.17 22.06 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.794 1.238 . . . . 65.11 109.11 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.613 HG23 ' HE1' ' C' ' 117' ' ' MET . 50.4 mt -138.69 142.13 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.187 1.395 . . . . 73.14 107.398 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.74 103.8 1.92 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.225 0.61 . . . . 73.53 110.476 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.573 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -109.68 120.37 42.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.114 -1.439 . . . . 75.04 107.114 166.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -124.72 120.02 30.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.457 0.703 . . . . 75.32 109.454 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 82.39 5.06 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 108.0 -1.111 . . . . 64.42 108.0 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -28.31 11.88 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.536 2.157 . . . . 71.21 112.77 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.533 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 43.1 m-20 -116.52 40.85 2.8 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.21 1.004 . . . . 74.44 108.91 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.457 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -59.76 -68.99 0.6 Allowed Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 117.628 -1.177 . . . . 73.55 113.791 -170.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.554 ' HB3' HD11 ' C' ' 83' ' ' ILE . 98.3 Cg_endo -74.26 -14.32 23.05 Favored 'Trans proline' 0 C--N 1.39 2.761 0 CA-C-N 123.144 2.159 . . . . 74.35 112.022 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -68.6 -43.48 76.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.004 1.322 . . . . 75.21 110.313 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.457 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.6 p -72.73 -33.08 43.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-O 119.136 -0.459 . . . . 71.11 110.245 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -61.83 -4.52 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.4 0.889 . . . . 71.31 113.4 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -84.28 -38.63 20.21 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.636 0.774 . . . . 73.44 110.578 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -128.58 61.0 1.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.374 1.07 . . . . 74.42 109.287 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' D' ' 31' ' ' VAL . 32.0 t0 -113.62 93.74 4.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.482 0.658 . . . . 64.23 110.858 -171.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.46 ' H ' HD11 ' D' ' 68' ' ' LEU . 40.3 m95 -126.09 -158.04 0.83 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 106.636 -1.616 . . . . 74.11 106.636 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.05 112.95 5.23 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-N 119.34 0.973 . . . . 74.4 110.934 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.25 135.14 20.18 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.715 1.61 . . . . 71.25 111.338 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -64.98 113.31 3.78 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 107.089 -1.448 . . . . 62.13 107.089 165.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -104.9 142.64 17.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.691 0.796 . . . . 73.43 110.42 -173.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.51 127.52 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.059 1.343 . . . . 72.43 108.006 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.43 111.87 23.95 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.721 -1.585 . . . . 74.04 106.721 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.781 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.3 m-20 -106.4 128.18 53.84 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.163 -1.051 . . . . 64.45 108.163 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.19 140.25 48.09 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.282 -0.636 . . . . 74.13 109.282 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.7 t70 -140.98 130.76 24.27 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.093 -1.077 . . . . 70.14 108.093 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -104.63 143.7 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.623 0.769 . . . . 65.52 110.808 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.713 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.77 151.87 30.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.632 0.773 . . . . 63.21 109.808 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.7 p -157.08 157.72 35.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.976 0.51 . . . . 75.34 109.745 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.2 p -153.06 154.29 34.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.665 0.786 . . . . 72.23 109.336 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -97.1 121.12 38.63 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.078 -1.453 . . . . 74.53 107.078 164.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.403 HD13 HG22 ' D' ' 83' ' ' ILE . 82.0 mt -91.0 -30.05 17.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.77 0.428 . . . . 74.32 110.383 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.73 -173.99 1.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.59 0.756 . . . . 73.44 111.008 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.0 123.93 20.75 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.929 -1.032 . . . . 72.32 108.995 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 66.86 10.89 7.95 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.575 1.15 . . . . 73.21 112.09 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.9 t -123.5 123.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.151 -0.685 . . . . 72.12 109.151 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.68 149.61 51.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.801 0.84 . . . . 74.44 109.077 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -119.49 133.56 55.63 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.788 0.835 . . . . 75.34 109.733 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.49 112.63 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.689 -1.226 . . . . 73.21 107.689 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.713 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.0 t -101.76 127.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.774 -1.195 . . . . 75.33 107.774 172.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 59.3 tp -124.15 111.63 16.13 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.85 -0.796 . . . . 74.54 108.85 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.698 ' HB2' ' HG2' ' D' ' 79' ' ' GLN . 16.3 ttp180 -84.74 108.25 17.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.054 -0.976 . . . . 75.32 109.481 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.42 129.44 48.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.704 -1.221 . . . . 73.3 107.704 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.781 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.1 m -126.76 136.85 52.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.565 -0.902 . . . . 74.33 108.565 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.462 HG22 HD12 ' D' ' 114' ' ' ILE . 84.6 t -121.17 109.8 26.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.926 0.891 . . . . 61.52 108.706 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -93.03 118.99 31.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.161 -1.051 . . . . 72.13 108.161 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.29 129.49 56.64 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.658 -0.497 . . . . 75.45 109.658 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 68.1 m -134.75 128.12 32.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.842 0.857 . . . . 61.15 109.677 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.46 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.3 OUTLIER -92.04 92.38 8.25 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.019 0.528 . . . . 72.41 109.925 177.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.27 -125.48 10.74 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.332 -0.849 . . . . 73.14 111.351 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.05 9.08 18.24 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.578 0.751 . . . . 74.15 111.334 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -115.82 155.18 28.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.931 0.892 . . . . 75.31 109.918 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 72' ' ' THR . . . . . 0.533 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 94.1 m -82.32 136.21 35.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.556 -0.535 . . . . 74.4 109.556 168.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.59 -68.07 0.78 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -155.43 167.65 29.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.401 -1.272 . . . . 64.22 109.974 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.0 mt -133.05 142.99 49.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.946 1.299 . . . . 75.45 107.65 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 49.0 t -145.66 136.24 24.23 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.37 -0.604 . . . . 75.3 109.37 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.18 134.9 11.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.147 0.579 . . . . 74.23 110.514 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.69 122.99 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.658 0.783 . . . . 75.23 109.759 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.705 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.1 mt-30 -89.04 89.45 7.98 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.763 -0.829 . . . . 72.24 108.763 168.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.62 96.63 8.16 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.965 -1.016 . . . . 75.01 109.158 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.65 142.46 17.15 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.358 -0.697 . . . . 55.24 111.358 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.33 128.65 4.59 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.342 -1.103 . . . . 72.02 110.342 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.403 HG22 HD13 ' D' ' 51' ' ' LEU . 60.8 mt -90.73 128.23 42.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.846 -0.798 . . . . 74.34 108.846 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.96 124.82 26.98 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.304 0.642 . . . . 73.12 109.606 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -77.4 93.94 4.16 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.855 -0.794 . . . . 73.34 108.855 171.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.496 HG22 ' HE2' ' D' ' 94' ' ' MET . 49.2 mt -109.11 125.94 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.555 0.742 . . . . 75.15 110.359 -173.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.88 158.1 34.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.049 0.939 . . . . 72.42 109.924 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.97 -20.64 41.38 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-O 119.911 -0.383 . . . . 74.04 113.684 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.08 142.24 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.561 -0.903 . . . . 52.41 108.561 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -136.69 156.59 48.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.285 0.634 . . . . 74.23 111.883 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.61 -125.75 35.98 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 124.58 1.175 . . . . 75.33 115.055 166.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.33 -32.61 73.68 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.392 1.077 . . . . 71.52 112.127 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.68 -28.57 40.72 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.032 0.533 . . . . 75.22 110.499 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.496 ' HE2' HG22 ' D' ' 86' ' ' ILE . 0.1 OUTLIER -77.55 -33.28 54.18 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.069 -0.715 . . . . 74.2 109.069 173.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.94 -30.91 71.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.828 0.851 . . . . 72.3 110.695 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' D' ' 100' ' ' ALA . 10.5 t60 -66.09 -52.24 50.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 75.32 109.093 169.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.09 -35.27 78.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.849 0.46 . . . . 74.32 112.003 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.04 -40.33 16.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.046 0.938 . . . . 74.34 110.223 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.13 11.72 58.69 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.165 -0.47 . . . . 64.24 113.9 -173.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.493 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -144.44 -57.6 0.36 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.463 0.632 . . . . 74.42 112.073 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -73.66 -61.01 1.99 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.62 0.368 . . . . 75.15 111.287 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -56.04 -44.08 99.53 Favored Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 124.404 1.082 . . . . 70.22 113.758 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.3 -40.47 68.08 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 122.338 2.025 . . . . 74.35 112.691 173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -68.4 -26.57 65.61 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.576 0.75 . . . . 71.33 111.494 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.493 HG21 HD11 ' D' ' 13' ' ' ILE . 47.5 mm -69.52 -50.87 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.948 0.499 . . . . 72.3 110.624 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.73 -12.89 52.84 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.759 -0.655 . . . . 73.13 112.243 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -62.24 -43.79 86.63 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.174 0.99 . . . . 75.34 113.635 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.67 -33.19 68.43 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.197 1.932 . . . . 70.42 113.912 172.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -79.14 -35.58 41.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.432 0.693 . . . . 74.51 110.708 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.97 82.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.439 0.696 . . . . 74.21 110.448 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.682 HH12 ' HB3' ' D' ' 130' ' ' PRO . 31.6 ttp180 -56.27 -50.37 71.56 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.322 -1.308 . . . . 74.32 110.627 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.17 -32.33 73.97 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.119 0.968 . . . . 74.21 111.501 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.438 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -70.35 -44.98 67.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.962 0.505 . . . . 71.23 111.021 176.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.503 HG22 ' SG ' ' D' ' 76' ' ' CYS . 61.8 mt -56.9 -54.79 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.408 1.083 . . . . 75.45 110.826 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.432 HG23 ' HE2' ' B' ' 109' ' ' TYR . 33.0 m -53.77 -45.72 70.75 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.083 1.353 . . . . 75.34 111.677 -173.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.5 t -63.52 -43.39 97.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.429 -1.259 . . . . 64.13 110.842 -176.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.578 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.2 mtm -68.93 -36.04 77.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.879 0.472 . . . . 74.02 111.817 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.418 HG21 ' O ' ' D' ' 114' ' ' ILE . 91.7 t -61.21 -45.14 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.76 -0.654 . . . . 74.21 109.897 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -71.25 -28.2 64.0 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.116 0.566 . . . . 75.13 111.498 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.0 mtt-85 -72.42 -28.69 63.12 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.709 0.804 . . . . 75.34 111.208 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.7 11.45 59.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.678 -0.512 . . . . 74.31 112.916 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.565 HG21 ' HB3' ' C' ' 17' ' ' TYR . 32.6 p 65.44 17.74 11.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 126.689 1.996 . . . . 75.12 113.215 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -93.52 159.39 35.1 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.197 0.999 . . . . 74.53 108.524 173.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.86 127.6 16.42 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.648 2.232 . . . . 75.43 111.342 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -53.38 120.81 6.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 123.761 0.663 . . . . 72.22 110.483 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.422 HD12 HG12 ' D' ' 64' ' ' VAL . 5.1 tt -104.04 102.52 12.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.427 -1.323 . . . . 70.51 107.427 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -94.84 85.09 4.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.195 -1.039 . . . . 72.24 108.195 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.525 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 33.0 tp -61.25 123.19 17.02 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.377 -1.738 . . . . 72.12 111.347 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.85 133.13 89.46 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 123.919 0.888 . . . . 64.13 111.645 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.682 ' HB3' HH12 ' D' ' 111' ' ' ARG . 90.3 Cg_endo -82.86 134.23 7.14 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.292 1.995 . . . . 74.25 112.478 -169.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.04 110.06 30.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.466 -0.939 . . . . 74.41 108.466 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -89.6 93.49 9.5 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.113 -0.699 . . . . 74.32 109.113 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 76.4 m-85 . . . . . 0 N--CA 1.472 0.642 0 CA-C-N 115.242 -0.89 . . . . 72.44 110.479 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 78.8 m . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.762 -0.459 . . . . 74.41 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.61 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.9 t80 -138.35 133.27 32.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.617 0.767 . . . . 74.23 109.954 170.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -160.58 116.32 2.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.813 0.845 . . . . 74.34 109.975 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.57 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.0 mt -76.17 125.68 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.536 -0.542 . . . . 70.51 109.536 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -97.3 -33.69 11.35 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.078 0.551 . . . . 75.25 111.13 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -172.24 128.41 0.57 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 110.079 -0.341 . . . . 74.33 110.079 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -121.79 126.9 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 123.664 0.785 . . . . 74.34 109.852 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -164.19 153.71 14.06 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.311 0.645 . . . . 75.31 111.202 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.55 111.02 12.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.966 -1.015 . . . . 72.24 109.533 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -76.43 -28.38 56.59 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.189 -0.459 . . . . 75.42 110.912 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -151.99 142.38 22.52 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.006 -0.997 . . . . 74.3 109.528 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.449 HG22 ' SD ' ' A' ' 117' ' ' MET . 75.8 mt -135.24 141.47 42.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 125.276 1.43 . . . . 75.34 107.293 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.78 130.4 14.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.966 -0.753 . . . . 72.44 108.966 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -133.5 120.48 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.482 -1.673 . . . . 73.32 106.482 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.1 114.29 20.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.773 0.429 . . . . 75.11 110.592 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 70.3 81.6 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 107.09 -1.448 . . . . 62.53 107.09 165.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.37 -3.56 13.48 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.246 1.964 . . . . 72.05 111.573 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -119.86 17.06 12.65 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.417 1.087 . . . . 70.11 109.317 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.98 -58.84 4.24 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.801 -1.095 . . . . 71.33 113.818 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.31 -25.71 71.6 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.376 2.051 . . . . 74.2 112.432 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.94 -48.1 17.08 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.5 -0.773 . . . . 72.1 109.914 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 34' ' ' LYS . 6.2 p -77.29 -10.57 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.731 -0.668 . . . . 75.35 112.151 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.62 -18.23 61.61 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.159 0.583 . . . . 74.44 112.392 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.27 -8.54 21.17 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.339 0.866 . . . . 74.44 113.339 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 71' ' ' GLU . 8.7 mmpt? -55.11 164.07 0.95 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.13 1.159 . . . . 73.31 114.13 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.4 133.69 54.44 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.699 -1.137 . . . . 75.45 109.498 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -77.57 73.99 4.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.631 0.772 . . . . 74.53 111.791 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.66 79.05 24.9 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.299 1.039 . . . . 73.42 108.993 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 114.89 4.16 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.042 1.828 . . . . 72.4 111.867 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.22 83.96 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.333 -1.729 . . . . 75.1 106.333 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.8 t -98.08 102.69 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 113.983 -1.462 . . . . 75.3 108.441 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.12 144.19 32.26 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.85 0.86 . . . . 74.41 110.41 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tt -97.51 111.65 23.83 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.167 -1.42 . . . . 71.13 107.167 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.645 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.2 m-20 -102.9 112.49 25.33 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.86 -1.163 . . . . 71.44 107.86 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tt -110.05 129.09 55.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.588 0.355 . . . . 75.25 110.339 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -139.51 145.35 38.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.659 1.183 . . . . 72.24 108.583 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -136.64 153.22 50.98 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.265 0.626 . . . . 72.02 110.828 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.432 ' HB1' ' HB ' ' A' ' 59' ' ' VAL . . . -141.84 153.26 44.36 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.512 1.125 . . . . 71.51 110.423 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 p -119.47 172.46 7.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.709 0.804 . . . . 70.0 109.231 168.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.4 t -160.86 144.78 13.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.862 0.865 . . . . 74.33 109.467 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -114.82 109.79 18.71 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 74.4 109.292 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.1 mt -82.4 -40.32 21.45 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.529 0.732 . . . . 74.13 109.722 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.01 -178.12 7.13 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.682 1.193 . . . . 65.02 109.073 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 121.55 17.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.267 -0.642 . . . . 75.03 109.267 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.02 -8.5 1.12 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.904 1.682 . . . . 73.21 112.879 -171.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.05 103.42 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.135 -1.061 . . . . 73.2 108.135 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.08 163.56 18.17 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.232 -0.894 . . . . 72.31 108.615 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 29.2 tt0 -133.7 145.11 49.59 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.527 1.131 . . . . 72.43 108.737 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.83 133.86 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.876 -1.157 . . . . 64.22 107.876 168.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.461 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.5 t -111.39 139.04 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.585 1.154 . . . . 75.1 108.437 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.04 106.11 10.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.896 -1.15 . . . . 75.14 107.896 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -84.41 102.35 12.7 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.827 -0.805 . . . . 73.34 108.827 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' A' ' 114' ' ' ILE . 24.1 t -95.34 115.91 35.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.05 -1.092 . . . . 75.44 108.05 172.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 48.5 m -117.92 138.55 52.07 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.48 -0.933 . . . . 72.11 108.48 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.537 HG12 HD21 ' A' ' 126' ' ' LEU . 99.1 t -129.94 117.83 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 124.6 1.16 . . . . 64.2 108.209 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 20.8 m -101.88 136.61 41.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.332 -0.988 . . . . 71.5 108.332 171.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.34 125.34 21.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.741 -1.207 . . . . 54.12 107.741 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.0 m -146.02 127.76 15.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.582 0.551 . . . . 60.33 110.464 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.87 86.23 6.58 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.01 -1.108 . . . . 74.14 108.01 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.46 -123.22 6.05 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.569 -1.196 . . . . 74.34 110.613 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -88.1 -28.01 21.56 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.285 0.634 . . . . 64.35 111.094 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 34' ' ' LYS . 27.6 tt0 -90.03 126.14 35.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.977 0.511 . . . . 73.35 110.475 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 m -72.65 129.29 37.92 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.97 0.908 . . . . 75.05 111.744 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.5 -65.5 0.75 Allowed 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.162 0.913 . . . . 74.0 108.762 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.425 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 50.3 p90 -155.92 144.42 20.16 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.785 -0.643 . . . . 74.31 110.748 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -121.13 110.15 15.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.154 -1.054 . . . . 64.51 108.154 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.425 ' SG ' ' HD2' ' A' ' 74' ' ' PHE . 84.0 m -111.15 114.84 28.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.182 0.993 . . . . 74.41 110.892 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.5 124.98 39.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.5 -0.926 . . . . 72.12 108.5 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.3 t -132.81 108.52 13.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.844 -1.169 . . . . 74.43 107.844 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.2 mt-30 -85.28 80.19 9.26 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.299 -1.371 . . . . 63.11 107.299 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -76.46 96.54 4.09 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.176 -1.375 . . . . 72.02 108.651 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -94.1 166.18 27.05 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.955 -0.566 . . . . 65.5 112.124 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.21 128.41 1.73 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.933 -0.867 . . . . 63.44 110.933 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.7 mt -80.57 120.28 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.635 -0.876 . . . . 64.51 108.635 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.61 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.8 m-85 -125.7 117.3 23.18 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.739 -1.208 . . . . 75.41 107.739 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -79.67 86.77 5.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.92 -0.77 . . . . 71.21 108.92 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 pt -113.49 143.93 22.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.833 0.853 . . . . 73.31 110.496 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.09 161.37 12.53 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.706 -1.134 . . . . 72.33 109.806 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 2.75 58.81 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.59 -0.732 . . . . 64.51 114.15 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.56 137.35 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.192 0.597 . . . . 74.44 110.441 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -142.72 -177.59 5.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.724 1.21 . . . . 64.22 109.653 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.89 -125.15 29.93 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.459 0.475 . . . . 71.31 112.537 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.5 t -82.56 -19.42 38.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.053 0.541 . . . . 74.31 111.012 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -71.34 -39.2 71.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.063 0.545 . . . . 75.12 110.992 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 95' ' ' ALA . 3.8 ppp? -70.95 -32.09 68.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.055 0.222 . . . . 75.34 110.478 175.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' N ' ' SD ' ' A' ' 94' ' ' MET . . . -75.97 -23.91 55.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.314 0.646 . . . . 65.32 111.215 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -83.98 -32.52 24.94 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.335 0.654 . . . . 74.22 109.56 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.1 t -67.35 -43.56 81.18 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.182 0.593 . . . . 74.12 110.3 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.8 mt -88.42 -31.44 18.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.289 -0.869 . . . . 75.54 111.84 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.09 3.77 58.55 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-O 119.62 -0.545 . . . . 65.14 114.241 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 134' ' ' ASP . . . -149.25 -65.58 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.504 0.652 . . . . 70.4 111.699 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.408 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 74.3 t80 -64.36 -68.95 0.31 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.11 0.964 . . . . 73.23 112.974 -168.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.6 m -66.34 -33.52 6.81 Favored Pre-proline 0 CA--C 1.571 1.754 0 N-CA-C 114.26 1.207 . . . . 74.02 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 56.2 Cg_endo -69.49 -22.41 33.38 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 121.813 1.675 . . . . 73.41 113.083 169.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -72.13 -19.48 61.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.229 0.468 . . . . 70.2 110.804 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.639 -0.875 . . . . 64.21 108.639 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -78.66 -29.78 45.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.249 1.02 . . . . 74.44 112.547 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -60.39 -45.12 97.44 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.064 1.135 . . . . 74.32 114.064 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.28 -31.71 34.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.894 1.73 . . . . 72.34 113.204 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -72.0 -37.67 69.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.912 0.485 . . . . 64.14 110.907 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.56 79.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.228 0.611 . . . . 61.32 109.628 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.487 ' NH1' HD13 ' C' ' 105' ' ' ILE . 34.8 ttm180 -52.23 -51.39 58.58 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 124.803 1.314 . . . . 75.41 110.382 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.77 -45.36 86.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.036 0.934 . . . . 74.03 111.537 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.58 -41.89 82.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.816 0.698 . . . . 64.11 110.451 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 ' HB ' ' A' ' 62' ' ' VAL . 85.1 mt -69.11 -45.7 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.177 -0.919 . . . . 74.44 110.072 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.5 m -54.95 -40.73 70.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.438 0.695 . . . . 72.01 110.802 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 t -68.87 -53.46 21.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.923 -1.035 . . . . 71.14 110.306 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.449 ' SD ' HG22 ' A' ' 21' ' ' ILE . 13.7 mtp -51.94 -47.09 64.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.282 1.033 . . . . 75.21 111.734 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.84 -45.68 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.544 -1.207 . . . . 73.4 110.813 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -66.72 -28.6 68.56 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.275 0.63 . . . . 73.33 111.396 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.53 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.0 mtt-85 -72.07 -31.16 65.84 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.433 0.693 . . . . 75.12 110.296 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.81 1.79 82.35 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.205 -0.452 . . . . 62.32 113.133 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.1 m 64.99 24.84 12.66 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 125.361 1.464 . . . . 73.31 110.711 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -93.42 160.13 33.73 Favored Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 114.559 -1.2 . . . . 74.24 110.263 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.54 137.52 57.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 124.398 3.399 . . . . 75.01 115.38 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -50.34 122.98 7.69 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.651 0.594 . . . . 74.23 110.549 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.537 HD21 HG12 ' A' ' 64' ' ' VAL . 21.4 tp -118.99 105.27 11.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.491 -1.232 . . . . 74.44 109.63 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -135.7 107.99 7.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.44 -1.254 . . . . 70.35 107.877 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.9 146.76 54.49 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.761 0.824 . . . . 73.42 111.893 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.25 148.18 96.09 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.734 0.813 . . . . 73.22 111.175 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.76 105.28 0.19 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.775 2.317 . . . . 72.43 112.834 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.35 116.91 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.998 -0.742 . . . . 71.03 108.998 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -93.14 77.97 4.58 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.369 1.068 . . . . 74.01 108.422 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -55.79 -34.89 65.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.7 1.2 . . . . 73.21 112.725 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 6.0 p-10 . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 123.849 0.86 . . . . 54.3 112.097 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' B' ' 87' ' ' ALA . 61.2 m . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 108.175 -1.046 . . . . 61.44 108.175 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.72 124.24 11.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.388 0.675 . . . . 74.44 109.274 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.5 132.94 21.98 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.885 0.474 . . . . 63.13 110.102 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.628 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -77.39 120.73 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.186 -0.915 . . . . 74.42 108.83 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -86.24 -50.26 7.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.329 -0.396 . . . . 74.42 111.055 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.52 140.02 5.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.467 0.307 . . . . 73.23 110.424 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.628 HG13 HD11 ' B' ' 13' ' ' ILE . 90.6 mt -115.53 139.48 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.107 0.963 . . . . 74.02 108.879 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -164.89 164.76 20.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.731 0.777 . . . . 74.12 112.219 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.3 m -93.74 124.69 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.99 -1.004 . . . . 70.51 108.474 171.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -88.9 -33.49 17.29 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.124 0.57 . . . . 72.21 110.677 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -155.31 142.29 19.14 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.164 0.431 . . . . 74.2 112.164 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.788 HD12 ' SG ' ' B' ' 113' ' ' CYS . 47.5 mm -133.13 142.16 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.492 1.117 . . . . 72.52 109.301 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 58.6 m -143.13 131.67 22.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.597 -1.183 . . . . 73.01 108.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -144.12 107.6 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.808 -1.552 . . . . 72.0 106.808 167.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -119.23 115.46 24.25 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.844 -0.799 . . . . 75.14 108.844 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.17 88.28 3.72 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.583 1.153 . . . . 75.31 109.185 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.45 -44.1 1.77 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.722 2.281 . . . . 75.22 112.681 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 77.1 m-20 -102.61 23.0 12.64 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.964 0.906 . . . . 71.32 109.705 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.5 -46.67 59.49 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 115.774 1.768 . . . . 74.21 115.774 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.79 -29.65 6.83 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.286 1.99 . . . . 73.34 112.325 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -94.36 1.0 55.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.39 1.076 . . . . 71.34 111.557 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 4.5 p -83.57 -17.19 10.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 C-N-CA 123.38 0.672 . . . . 74.44 110.419 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.59 -28.66 63.82 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 118.481 0.582 . . . . 73.51 112.093 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -73.65 -45.77 50.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.446 0.698 . . . . 72.31 111.07 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.514 ' HB3' HD13 ' B' ' 68' ' ' LEU . 10.9 mmmm -107.37 62.62 0.62 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.288 1.035 . . . . 72.54 108.97 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' B' ' 31' ' ' VAL . 6.9 t70 -119.07 80.73 1.59 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.691 -0.855 . . . . 72.13 108.691 -171.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -152.64 -177.27 6.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.087 0.955 . . . . 74.0 109.511 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -59.53 109.19 1.75 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.509 0.724 . . . . 72.35 110.835 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -86.34 173.87 6.35 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.587 2.191 . . . . 72.31 112.902 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.28 103.77 4.09 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.385 -1.339 . . . . 74.34 107.385 164.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.41 151.9 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.699 -1.137 . . . . 73.03 110.492 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 55.5 mtpt -138.11 138.81 39.07 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.116 0.966 . . . . 72.41 109.393 175.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.76 126.25 45.79 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.992 -1.855 . . . . 73.42 105.992 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.419 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.1 t70 -124.7 139.95 53.39 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.423 -0.955 . . . . 72.51 108.423 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -125.55 141.19 52.17 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.021 -0.733 . . . . 75.33 109.021 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.2 t70 -130.45 137.36 49.77 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.139 0.976 . . . . 64.23 108.575 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -108.69 103.11 12.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.841 0.857 . . . . 71.24 110.393 -172.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 141.07 50.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.218 1.007 . . . . 70.21 109.416 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 p -145.58 168.45 20.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.166 0.586 . . . . 61.21 110.903 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.72 138.64 18.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.11 0.564 . . . . 72.12 110.482 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -82.45 101.27 10.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.079 -0.711 . . . . 72.5 109.079 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.495 HD12 HG22 ' B' ' 83' ' ' ILE . 63.0 mt -74.54 -35.99 63.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.305 0.642 . . . . 75.02 109.996 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.23 -174.2 3.43 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.295 -1.32 . . . . 75.43 109.232 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.61 128.06 35.27 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.133 -0.94 . . . . 75.35 109.821 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 67.62 -5.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.437 1.495 . . . . 74.22 112.955 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.91 115.14 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.808 . . . . 74.34 109.146 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.91 143.38 50.77 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.369 0.668 . . . . 73.31 110.416 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -99.8 116.16 31.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.144 -1.058 . . . . 73.33 108.144 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -91.42 118.02 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.038 0.935 . . . . 72.45 109.001 172.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -114.42 112.64 40.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.053 0.941 . . . . 71.02 108.561 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.93 108.68 20.31 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.872 -1.158 . . . . 74.34 107.872 176.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.618 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 18.9 ttm-85 -85.58 112.41 20.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.78 -0.822 . . . . 75.24 108.78 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.35 103.02 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.872 -1.159 . . . . 75.25 107.872 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.0 m -100.96 130.95 47.04 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.055 -0.72 . . . . 72.43 109.055 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.424 HG12 HD23 ' B' ' 126' ' ' LEU . 68.9 t -117.53 115.86 49.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 85.8 m -92.57 141.67 28.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.147 0.979 . . . . 73.52 108.612 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.77 121.5 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.723 -0.843 . . . . 72.4 108.723 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 40.4 p -147.2 127.8 14.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.637 0.775 . . . . 43.44 109.456 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.678 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.3 OUTLIER -118.31 134.6 54.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.446 0.698 . . . . 74.23 109.305 -176.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.78 -118.28 6.43 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.206 -0.758 . . . . 74.14 111.206 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.17 11.35 12.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.874 0.87 . . . . 72.12 110.315 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.431 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 3.7 pm0 -127.67 158.96 36.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.677 0.791 . . . . 74.12 110.682 -176.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -78.81 135.99 37.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.942 -0.572 . . . . 74.21 110.328 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.678 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -83.72 -64.75 1.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.901 0.858 . . . . 75.43 108.993 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.83 152.95 16.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.563 -1.653 . . . . 71.31 108.094 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -123.74 137.02 54.77 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.324 -0.991 . . . . 70.41 108.324 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.0 t -134.18 148.18 50.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.809 -0.812 . . . . 65.52 108.809 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.7 tt0 -156.16 138.8 15.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.925 -0.768 . . . . 61.41 108.925 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -132.14 145.27 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.403 1.081 . . . . 74.5 108.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -118.82 97.1 5.54 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.285 -1.376 . . . . 74.2 107.285 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -87.74 100.11 12.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.043 -1.095 . . . . 74.02 108.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.37 157.65 25.92 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.392 -1.083 . . . . 72.34 110.392 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.93 125.65 1.37 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.177 -0.769 . . . . 72.14 111.177 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.495 HG22 HD12 ' B' ' 51' ' ' LEU . 44.0 mt -84.7 130.91 35.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.825 -0.805 . . . . 74.41 108.825 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.72 165.63 22.48 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.109 0.963 . . . . 73.2 108.633 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.35 120.91 26.39 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.921 -0.77 . . . . 73.13 108.921 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 36.7 pt -119.13 145.81 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.584 1.153 . . . . 72.21 110.742 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' B' ' 10' ' ' THR . . . -156.21 157.67 36.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.608 1.163 . . . . 73.25 108.682 172.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -42.39 2.57 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 116.856 -0.156 . . . . 71.31 112.889 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 35.5 pt -79.31 149.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.086 0.555 . . . . 75.31 110.655 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -170.64 160.08 6.97 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 73.51 109.376 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.77 -119.42 12.22 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.398 0.436 . . . . 73.21 112.452 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.0 m -73.69 -28.55 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.929 0.892 . . . . 75.04 111.292 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.97 -24.39 62.4 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 75.15 112.317 -167.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.5 ptp -67.25 -32.02 72.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.938 -0.574 . . . . 73.31 110.592 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -22.14 66.6 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.603 0.761 . . . . 73.54 112.027 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -83.83 -45.9 12.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.934 0.494 . . . . 74.12 109.907 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -74.95 -67.8 0.61 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.181 -0.463 . . . . 74.33 111.457 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.611 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.0 pp -80.73 -20.75 42.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 119.488 -0.291 . . . . 73.3 111.683 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.9 -32.57 26.29 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 113.887 0.315 . . . . 64.11 113.887 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.18 -59.23 2.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 71.51 110.899 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -67.17 -45.62 76.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.462 0.705 . . . . 74.44 112.779 -169.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 60.4 m -65.99 -45.07 63.28 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.606 -0.712 . . . . 63.42 112.761 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -34.48 98.29 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 122.303 2.002 . . . . 71.22 112.901 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -66.61 -27.63 67.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.117 0.567 . . . . 75.31 111.905 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.93 -45.41 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.221 0.608 . . . . 71.21 110.049 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.13 -17.42 49.94 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.478 -0.783 . . . . 74.14 111.692 -174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -61.17 -47.22 95.3 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.602 1.161 . . . . 72.33 113.944 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.41 -35.44 83.23 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.027 1.818 . . . . 72.33 112.978 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -68.9 -44.67 72.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.356 0.662 . . . . 74.41 110.618 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.36 0.664 . . . . 71.55 110.475 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.548 HH12 HD13 ' D' ' 16' ' ' ILE . 33.6 mtp180 -54.87 -60.46 3.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.191 0.996 . . . . 75.05 111.262 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.57 -31.71 70.83 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.244 0.965 . . . . 72.24 110.519 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.788 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.9 t -73.76 -37.74 64.94 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.967 -0.56 . . . . 44.24 111.344 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.09 -45.63 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 123.134 0.574 . . . . 74.33 109.836 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.491 HG22 ' OG ' ' C' ' 119' ' ' SER . 10.2 m -62.13 -39.67 93.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 73.51 111.385 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -61.68 -42.35 98.8 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.787 0.835 . . . . 71.22 110.516 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 10.0 mmt -72.48 -31.58 65.51 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.726 0.41 . . . . 73.43 111.186 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.615 HG22 HD21 ' B' ' 126' ' ' LEU . 92.8 t -65.83 -41.23 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.803 0.841 . . . . 75.44 110.221 172.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 53.0 m -64.31 -36.85 85.46 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.18 0.992 . . . . 75.53 111.05 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 84.0 mtt-85 -71.05 -27.58 63.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.815 -0.629 . . . . 73.5 110.714 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.04 14.51 61.86 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.513 -0.604 . . . . 74.32 113.082 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 55.05 45.69 25.73 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.397 1.479 . . . . 74.4 113.12 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -119.87 149.25 48.28 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.657 0.783 . . . . 74.43 110.253 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.59 -165.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.352 3.368 . . . . 74.13 114.945 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.7 tp60 -60.13 128.51 37.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.564 1.146 . . . . 72.34 113.587 -168.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.615 HD21 HG22 ' B' ' 118' ' ' VAL . 12.3 tp -136.05 108.86 7.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 71.22 108.59 165.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -128.46 135.75 49.89 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.382 -0.969 . . . . 74.4 108.382 167.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.25 139.27 34.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.924 -0.769 . . . . 75.32 108.924 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.94 148.18 98.43 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.698 0.799 . . . . 71.12 111.504 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.36 92.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.159 2.573 . . . . 72.13 111.504 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.86 108.34 19.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.804 -0.813 . . . . 73.44 108.804 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -83.16 109.18 16.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.34 -1.356 . . . . 71.22 107.34 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 122.53 0.332 . . . . 75.12 111.145 -178.533 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 56.9 ttp . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.165 0.507 . . . . 75.14 112.364 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.6 m -98.54 101.85 13.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.181 -1.044 . . . . 61.52 108.181 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -120.14 134.97 55.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.354 0.662 . . . . 74.32 110.03 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -154.92 144.48 21.38 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.998 0.919 . . . . 75.34 108.769 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -88.84 112.55 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 N-CA-C 109.641 -0.503 . . . . 75.03 109.641 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.35 -50.53 10.71 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.078 -0.389 . . . . 75.1 111.02 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -166.91 125.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.335 -0.617 . . . . 64.14 109.335 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.19 141.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 107.865 -1.161 . . . . 74.21 107.865 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.446 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.2 p90 -173.23 159.88 3.92 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.644 0.735 . . . . 73.45 112.187 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.2 114.63 22.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.747 -0.834 . . . . 73.33 108.747 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -80.7 -33.87 35.04 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.128 0.49 . . . . 73.14 110.112 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 33.5 t70 -147.33 139.51 24.47 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.429 -0.805 . . . . 72.54 109.395 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 73.8 mt -140.04 139.69 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.632 -1.247 . . . . 73.32 107.632 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 61.8 m -148.46 146.76 28.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.197 0.599 . . . . 74.32 110.54 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -145.08 107.62 4.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.472 -1.677 . . . . 71.5 106.472 165.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -118.82 109.63 16.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.165 -0.68 . . . . 75.44 109.165 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.28 80.7 12.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.137 -1.06 . . . . 74.54 108.137 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.98 -18.57 35.89 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.073 2.515 . . . . 75.12 112.041 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.94 32.69 5.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.052 0.941 . . . . 74.03 110.041 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.488 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -51.64 -51.31 71.09 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 113.813 1.042 . . . . 73.4 113.813 -175.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 11.5 Cg_exo -72.89 -30.76 10.86 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.175 1.916 . . . . 74.43 113.786 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -70.3 -40.1 74.45 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.14 0.576 . . . . 74.43 111.719 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 7.3 p -78.68 -20.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.665 0.786 . . . . 75.0 110.72 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -62.26 -20.79 64.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.948 1.299 . . . . 75.21 111.451 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -122.5 23.58 9.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 72.5 111.415 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 2.1 tppp? -98.0 146.79 25.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.2 0.6 . . . . 74.23 109.772 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.71 122.71 17.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.928 0.891 . . . . 74.3 110.276 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -72.07 90.32 1.18 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.842 0.857 . . . . 71.52 111.571 -166.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -127.67 64.11 62.57 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 124.078 0.951 . . . . 74.34 108.924 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.95 109.21 1.01 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.469 2.779 . . . . 73.43 113.302 -165.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -84.55 106.37 16.08 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.504 -0.925 . . . . 72.35 108.504 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -84.38 139.72 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.892 -1.049 . . . . 75.34 109.369 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.45 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 23.6 mtpp -131.87 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 72.31 109.038 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -91.72 120.31 32.35 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.255 -1.387 . . . . 74.12 107.255 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.725 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 2.1 m-20 -119.94 104.3 10.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.254 1.022 . . . . 64.43 108.421 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 110.97 23.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.506 -1.294 . . . . 73.41 107.506 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.7 t70 -116.35 149.25 39.63 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.36 1.464 . . . . 71.44 108.53 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.8 p -120.5 143.13 48.71 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.086 0.554 . . . . 73.45 109.756 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.22 145.92 33.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.178 0.991 . . . . 70.23 108.654 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -160.6 146.85 15.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.963 0.347 . . . . 73.23 111.213 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -154.35 144.01 21.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.836 0.854 . . . . 71.44 109.752 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.73 122.99 27.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.845 0.458 . . . . 73.13 109.813 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.676 HD12 ' HB2' ' C' ' 57' ' ' GLU . 40.3 mt -95.85 -36.4 11.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.485 0.714 . . . . 72.5 110.661 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.22 -177.51 6.64 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.172 -0.922 . . . . 62.05 109.976 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -65.22 116.65 6.79 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.013 -0.994 . . . . 75.52 109.592 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' C' ' 87' ' ' ALA . 23.6 m-20 67.05 12.12 8.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.953 1.301 . . . . 73.15 112.048 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.05 107.38 21.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.244 1.018 . . . . 74.52 109.096 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.63 ' HB2' HD11 ' C' ' 86' ' ' ILE . 89.7 m-85 -116.74 134.45 54.79 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.23 1.012 . . . . 74.24 108.62 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.676 ' HB2' HD12 ' C' ' 51' ' ' LEU . 41.7 tt0 -83.58 119.58 24.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.752 -0.658 . . . . 72.54 109.294 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.55 118.97 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.792 -1.188 . . . . 71.25 107.792 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.82 133.76 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.564 0.746 . . . . 74.43 109.168 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.558 HD21 HD12 ' C' ' 106' ' ' LEU . 4.1 mm? -118.96 106.38 12.4 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.324 1.05 . . . . 75.24 108.699 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.6 ttm-85 -81.07 106.51 13.13 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.855 -1.165 . . . . 73.13 107.855 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.72 119.51 50.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.766 -1.198 . . . . 72.54 107.766 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.725 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 55.9 m -116.39 141.08 48.63 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.951 -1.129 . . . . 65.11 107.951 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.521 HG21 HG23 ' C' ' 114' ' ' ILE . 88.1 t -135.34 128.0 47.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 71.34 107.671 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.0 m -122.57 125.84 46.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.705 -0.85 . . . . 72.11 108.705 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.49 123.64 48.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.535 -1.283 . . . . 63.23 107.535 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.8 m -143.44 123.9 13.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.877 0.471 . . . . 63.03 110.746 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.08 57.65 3.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.649 1.18 . . . . 75.35 109.798 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.45 -111.53 4.05 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 110.558 -1.017 . . . . 75.34 110.558 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -89.53 -28.09 19.85 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.732 0.813 . . . . 72.21 109.429 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.91 117.65 7.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.043 -0.98 . . . . 74.21 110.175 173.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 87.8 m -87.6 125.64 34.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.706 -0.849 . . . . 75.31 108.706 167.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.07 -63.02 1.36 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.572 -1.195 . . . . 71.54 109.806 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.34 177.11 11.83 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 114.85 -1.068 . . . . 71.2 111.217 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.98 147.51 48.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.83 -1.915 . . . . 73.53 105.83 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.3 t -150.48 113.08 4.71 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.148 -1.056 . . . . 71.34 108.148 176.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.4 126.78 31.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.207 -0.664 . . . . 72.33 109.207 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -130.21 113.74 26.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.917 0.887 . . . . 74.21 108.842 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.621 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -89.83 90.52 8.23 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.849 -1.167 . . . . 64.35 107.849 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -81.25 104.04 11.44 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.473 -1.239 . . . . 71.33 109.46 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.85 150.73 19.73 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 112.08 -0.408 . . . . 71.14 112.08 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.34 125.0 1.98 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.226 -1.15 . . . . 53.43 110.226 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' D' ' 29' ' ' PRO . 9.8 mm -81.93 126.52 39.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.759 -1.2 . . . . 71.23 107.759 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -136.51 154.72 50.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.419 0.688 . . . . 75.41 109.144 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.2 m -96.45 116.12 28.55 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.459 -0.941 . . . . 74.43 108.459 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.638 HG21 ' HE3' ' C' ' 94' ' ' MET . 3.8 mp -116.73 118.16 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.503 -0.925 . . . . 75.51 108.503 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' C' ' 54' ' ' ASP . . . -153.21 170.51 20.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.134 0.974 . . . . 74.34 110.054 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.4 -59.39 0.4 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.54 -0.3 . . . . 74.21 113.434 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.23 -179.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.383 0.673 . . . . 73.21 112.176 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.93 -173.31 4.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 72.53 109.822 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.21 -140.76 38.13 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.533 0.521 . . . . 71.32 113.305 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -75.2 -17.64 60.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.856 0.863 . . . . 71.24 112.182 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -73.47 -36.58 65.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.025 0.53 . . . . 70.21 110.595 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.694 ' HE1' HD21 ' C' ' 98' ' ' LEU . 1.2 tmt? -72.15 -41.63 66.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.373 -0.603 . . . . 74.22 109.373 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.89 66.07 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.854 -1.066 . . . . 74.42 111.568 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.484 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 39.9 t-80 -66.84 -41.66 87.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 74.32 111.254 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -77.74 -57.43 3.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.856 -0.424 . . . . 75.01 109.856 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.694 HD21 ' HE1' ' C' ' 94' ' ' MET . 61.2 tp -62.44 -39.65 94.03 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.366 1.066 . . . . 62.24 112.542 -173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.81 11.21 57.6 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.543 -0.587 . . . . 72.44 114.155 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -144.63 -63.41 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.59 0.695 . . . . 75.41 111.51 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -69.34 -55.12 11.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.723 0.409 . . . . 74.4 111.887 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.9 m -55.88 -44.77 99.84 Favored Pre-proline 0 CA--C 1.573 1.85 0 C-N-CA 123.581 0.752 . . . . 71.53 112.567 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -51.18 -43.46 48.5 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.062 2.508 . . . . 75.31 114.344 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.404 HD21 ' N ' ' C' ' 104' ' ' ASN . 0.9 OUTLIER -74.24 -20.19 60.25 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.463 0.705 . . . . 75.53 111.715 -174.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.487 HD13 ' NH1' ' A' ' 111' ' ' ARG . 32.3 mm -76.88 -44.86 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.984 0.514 . . . . 73.42 110.061 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.558 HD12 HD21 ' C' ' 60' ' ' LEU . 73.1 mt -81.61 -18.72 43.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.044 -0.526 . . . . 74.03 112.004 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -57.11 -54.25 56.63 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 117.72 -1.133 . . . . 75.43 113.08 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.79 -27.45 84.84 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.026 1.818 . . . . 71.4 113.221 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -71.08 -45.98 62.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.208 0.603 . . . . 73.21 110.79 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.59 84.65 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.795 -0.638 . . . . 73.24 110.315 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.708 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 33.6 ttt180 -60.13 -47.88 84.07 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.489 1.516 . . . . 75.22 111.47 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -38.71 86.15 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.907 0.755 . . . . 75.51 109.765 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.2 m -58.5 -46.67 86.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.38 0.672 . . . . 71.24 112.357 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.526 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 86.9 mt -66.16 -48.43 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 122.916 0.486 . . . . 71.5 110.762 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.6 m -65.81 -32.71 74.39 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.088 0.555 . . . . 70.41 111.272 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -69.41 -37.99 77.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.325 0.65 . . . . 74.53 109.98 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.509 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -70.9 -35.97 72.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.661 0.784 . . . . 74.11 111.514 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.8 t -63.76 -37.31 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.543 -0.54 . . . . 70.33 109.543 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.491 ' OG ' HG22 ' B' ' 115' ' ' THR . 42.1 t -67.77 -35.34 78.52 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.85 0.86 . . . . 70.14 112.194 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.68 -32.46 65.81 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.2 0.6 . . . . 74.33 110.022 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.2 1.6 86.66 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.465 0.478 . . . . 72.4 112.612 171.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p 62.42 19.59 11.25 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.836 2.054 . . . . 70.45 113.17 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.64 150.04 45.31 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.09 0.956 . . . . 74.31 109.43 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.444 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 35.7 Cg_endo -62.54 113.25 1.87 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.722 2.281 . . . . 74.14 111.442 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -55.47 141.79 35.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.254 -1.339 . . . . 73.21 113.168 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.36 121.24 36.23 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.822 -1.548 . . . . 75.3 106.822 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.86 126.55 41.19 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.941 0.896 . . . . 72.42 108.653 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.708 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -63.92 145.02 56.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.218 0.607 . . . . 75.41 110.403 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.49 164.33 45.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.095 0.958 . . . . 53.12 111.232 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -66.52 117.26 4.59 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.064 1.842 . . . . 73.21 111.729 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.36 109.34 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.944 0.878 . . . . 73.44 108.964 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -107.9 94.4 5.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.044 -0.98 . . . . 75.14 109.708 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -75.9 -40.59 54.1 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.139 -0.689 . . . . 74.45 109.139 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 N--CA 1.47 0.548 0 C-N-CA 123.824 0.85 . . . . 74.13 110.91 -176.132 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 73.13 107.989 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -154.66 98.36 2.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.01 -1.107 . . . . 65.33 108.01 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -131.26 125.9 34.04 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.604 -1.258 . . . . 72.42 107.604 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mt -69.59 124.42 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.504 -0.924 . . . . 73.41 108.504 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.484 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 19.7 mm-40 -74.31 -48.98 24.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.707 -0.479 . . . . 74.43 109.707 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -161.85 156.63 22.86 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.824 1.25 . . . . 75.02 109.845 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.548 HD13 HH12 ' B' ' 111' ' ' ARG . 0.2 OUTLIER -126.87 125.41 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 105.631 -1.988 . . . . 75.12 105.631 165.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 32.4 p90 -155.36 153.74 30.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.889 0.852 . . . . 74.05 110.707 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.77 110.75 12.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.172 -1.376 . . . . 70.11 108.438 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.471 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.7 mtpt -77.57 -36.54 51.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.061 -0.718 . . . . 74.31 109.061 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.5 t70 -140.49 137.86 34.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.537 -1.21 . . . . 74.15 109.324 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.509 HG23 ' HE1' ' C' ' 117' ' ' MET . 90.2 mt -132.81 142.95 41.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.821 1.249 . . . . 73.22 107.963 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -147.16 136.54 22.68 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.569 1.148 . . . . 74.31 108.653 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -143.36 123.58 13.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.592 -1.633 . . . . 75.52 106.592 167.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.3 mt-10 -127.37 127.03 43.54 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.397 0.679 . . . . 73.15 109.269 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.72 84.18 8.04 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.549 -1.649 . . . . 72.1 106.549 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.46 -30.22 12.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.823 2.349 . . . . 71.23 112.633 -167.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -115.26 36.36 3.95 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.266 1.026 . . . . 54.11 108.89 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.446 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -48.48 -61.54 3.1 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 115.076 1.51 . . . . 70.34 115.076 -165.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.578 ' HB3' HD11 ' C' ' 83' ' ' ILE . 33.0 Cg_endo -85.65 -4.03 9.13 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 122.671 1.99 . . . . 75.11 113.075 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -80.92 -42.0 22.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 74.0 109.414 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.738 HG23 ' HA ' ' D' ' 73' ' ' ALA . 14.0 p -76.27 -34.02 24.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.248 -0.887 . . . . 73.33 110.295 -173.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -57.23 -16.78 9.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.12 0.968 . . . . 72.43 113.403 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.59 -37.21 60.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.887 0.475 . . . . 75.33 110.535 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -130.85 57.93 1.72 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.461 0.304 . . . . 73.52 110.899 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -100.7 94.96 6.35 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.354 -0.841 . . . . 55.23 109.556 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.413 ' H ' HD23 ' D' ' 68' ' ' LEU . 16.4 m95 -124.08 -164.85 1.28 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.576 -1.638 . . . . 75.24 106.576 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 0.0 OUTLIER -51.41 106.65 0.68 Allowed Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 119.167 0.894 . . . . 74.34 112.172 -176.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 4.7 Cg_exo -78.35 144.82 20.77 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.589 2.193 . . . . 73.41 111.291 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -79.09 112.89 16.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.276 -1.379 . . . . 61.55 107.276 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.9 142.58 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.496 0.718 . . . . 75.23 110.099 -168.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -118.89 147.46 43.96 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.534 1.134 . . . . 74.53 109.421 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.433 HD22 HD22 ' D' ' 128' ' ' LEU . 95.1 mt -106.83 118.38 36.54 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.04 -1.096 . . . . 73.0 108.04 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.3 t70 -106.46 129.93 54.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.908 -1.145 . . . . 75.33 107.908 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.82 156.52 18.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.698 0.799 . . . . 75.32 111.106 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.3 t70 -168.16 129.29 1.37 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.274 -0.876 . . . . 70.01 109.265 172.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -106.09 148.49 27.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.647 0.779 . . . . 74.43 110.072 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.85 155.53 40.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.93 0.892 . . . . 64.13 108.789 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.0 p -163.17 153.91 16.53 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.275 0.63 . . . . 73.33 110.441 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.3 p -163.7 143.52 8.36 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.539 0.736 . . . . 73.11 110.079 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -78.4 122.59 25.99 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.463 -0.569 . . . . 71.22 109.463 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -93.05 -39.43 11.09 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.454 -0.573 . . . . 73.21 109.454 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.5 -176.67 5.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 75.04 110.49 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.34 119.85 13.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.201 -0.909 . . . . 62.12 109.594 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 64.03 7.02 3.12 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.811 1.245 . . . . 72.44 112.686 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 56.1 t -114.89 108.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.365 -0.976 . . . . 74.42 108.365 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -128.39 129.71 46.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.649 -1.16 . . . . 62.23 108.776 -169.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -96.69 129.26 44.13 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.267 1.027 . . . . 71.14 109.919 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.4 t -110.9 116.98 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.81 -1.182 . . . . 74.23 107.81 170.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.4 t -99.66 131.88 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.521 -0.918 . . . . 73.33 108.521 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.85 108.92 12.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.064 -1.087 . . . . 75.43 108.064 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.4 ttm180 -85.54 113.08 21.51 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.481 0.713 . . . . 73.22 109.796 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.49 103.43 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.26 -1.015 . . . . 74.42 108.26 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.4 m -102.37 138.87 38.73 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.097 -0.705 . . . . 72.23 109.097 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.63 122.61 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.203 1.001 . . . . 75.33 109.91 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 39.8 m -120.49 100.37 7.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.987 0.915 . . . . 52.11 109.59 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 133.7 42.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.333 0.653 . . . . 74.42 109.879 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 20.7 m -148.03 126.7 12.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.064 0.946 . . . . 75.52 109.636 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.475 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.0 pp -126.53 140.26 52.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.267 0.627 . . . . 74.5 111.404 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 -111.84 3.72 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.196 -1.161 . . . . 55.23 110.196 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 4.47 9.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 74.01 110.797 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.99 173.7 7.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.981 0.512 . . . . 75.41 110.542 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -82.09 139.15 34.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 63.35 109.638 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.738 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -84.7 -67.36 0.8 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.567 -0.901 . . . . 31.24 108.567 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -155.2 164.89 38.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.443 -1.253 . . . . 72.12 110.061 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 94.6 mt -134.38 151.68 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.229 1.412 . . . . 75.4 108.529 -176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.571 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.6 t -158.22 148.11 19.92 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.229 0.612 . . . . 71.11 110.097 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.59 126.05 6.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.476 0.71 . . . . 74.54 109.593 171.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.23 114.79 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.899 0.48 . . . . 74.2 109.772 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.8 mt-30 -90.56 88.78 7.27 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.949 -0.76 . . . . 74.5 108.949 173.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.34 96.39 6.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.657 -1.156 . . . . 73.14 109.328 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.01 141.64 17.81 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.046 -0.822 . . . . 74.52 111.046 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.427 ' HA3' HD23 ' D' ' 106' ' ' LEU . . . -136.41 128.59 4.56 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 110.537 -1.025 . . . . 62.01 110.537 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 29.5 mt -93.39 127.04 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.987 -1.116 . . . . 71.11 107.987 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -128.78 126.66 40.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.658 0.783 . . . . 72.41 110.18 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -82.99 93.4 7.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.602 -0.888 . . . . 64.23 108.602 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.9 mt -108.45 109.73 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.772 -0.825 . . . . 74.15 108.772 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.48 167.15 21.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.16 0.984 . . . . 64.3 110.428 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.94 0.78 57.32 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.787 0.675 . . . . 64.41 114.787 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.466 HG21 HE21 ' D' ' 93' ' ' GLN . 29.0 pt -137.92 162.21 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.513 1.125 . . . . 74.44 109.73 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.29 3.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.326 1.051 . . . . 73.34 109.501 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.41 -122.79 29.31 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 115.514 0.966 . . . . 75.32 115.514 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -60.31 -54.13 49.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.911 1.284 . . . . 74.2 112.137 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.466 HE21 HG21 ' D' ' 89' ' ' ILE . 29.3 tt0 -70.94 -39.72 72.45 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.383 0.427 . . . . 74.2 111.752 -172.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -42.89 59.23 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.908 0.483 . . . . 74.43 111.269 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.92 83.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.94 0.496 . . . . 73.23 110.817 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -74.7 -27.18 60.28 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.681 -0.69 . . . . 75.34 110.771 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.51 -50.76 64.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.036 0.534 . . . . 71.01 110.381 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.66 -17.51 53.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.404 0.282 . . . . 74.54 111.391 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.36 -5.7 84.81 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.327 0.392 . . . . 74.33 114.069 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.12 -59.03 0.31 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.908 0.354 . . . . 73.43 111.534 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -74.38 -53.71 9.07 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.413 0.685 . . . . 75.04 112.118 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.45 -43.27 88.55 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.053 1.131 . . . . 74.33 114.053 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.79 -29.15 50.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.823 1.682 . . . . 71.12 111.874 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.9 -22.32 59.74 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.191 0.996 . . . . 73.12 110.664 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.1 mm -76.95 -45.01 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.387 0.675 . . . . 74.03 109.95 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.427 HD23 ' HA3' ' D' ' 82' ' ' GLY . 95.7 mt -72.47 -30.98 65.04 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.576 -0.738 . . . . 74.01 111.807 -174.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.78 -41.96 60.14 Favored Pre-proline 0 CA--C 1.568 1.662 0 N-CA-C 114.405 1.261 . . . . 64.24 114.405 -169.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.48 -39.56 74.02 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.381 2.054 . . . . 65.12 113.578 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -75.72 -35.5 60.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.612 0.765 . . . . 74.3 110.913 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.8 79.01 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.234 0.614 . . . . 72.53 110.279 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -59.6 -46.17 89.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.626 1.17 . . . . 73.12 110.78 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.73 -44.78 96.24 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.141 0.901 . . . . 74.32 111.014 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.82 -45.14 93.3 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.864 0.728 . . . . 74.3 110.691 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.571 HG12 ' SG ' ' D' ' 76' ' ' CYS . 57.6 mt -59.53 -54.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.017 0.927 . . . . 75.22 110.686 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -47.62 66.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.481 1.112 . . . . 62.42 111.302 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.5 t -65.06 -42.8 93.87 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.425 -1.261 . . . . 72.4 110.809 -173.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.416 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -70.68 -37.34 73.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.777 0.431 . . . . 73.52 111.812 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.403 HG22 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -65.15 -41.51 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.684 -0.689 . . . . 75.35 109.774 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -72.21 -29.04 63.58 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 122.985 0.514 . . . . 62.12 111.241 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' D' ' 116' ' ' SER . 63.5 mtt-85 -70.82 -29.07 65.13 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.397 0.679 . . . . 74.52 110.418 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 10.1 60.11 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.954 -0.566 . . . . 42.03 112.576 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.9 p 59.87 23.43 12.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.853 2.061 . . . . 74.13 112.985 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.551 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 51.5 m-85 -88.84 174.61 4.83 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 125.193 1.397 . . . . 70.32 108.831 170.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 33.9 Cg_endo -59.21 167.36 6.04 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.913 2.408 . . . . 75.31 113.929 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.478 ' NE2' HD22 ' D' ' 127' ' ' ASN . 3.5 pt20 -73.82 131.28 41.37 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.937 -1.135 . . . . 74.45 107.937 164.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.46 93.59 4.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.706 -1.22 . . . . 74.42 107.706 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.478 HD22 ' NE2' ' D' ' 125' ' ' GLN . 50.3 m-20 -98.23 99.01 10.2 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.539 -1.282 . . . . 74.41 107.539 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.433 HD22 HD22 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -71.08 136.03 48.04 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.768 -0.651 . . . . 73.24 109.664 -176.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.81 137.31 87.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.417 1.087 . . . . 73.42 111.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.449 ' HD3' HG23 ' B' ' 13' ' ' ILE . 16.9 Cg_exo -68.91 106.26 1.48 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.935 2.423 . . . . 71.41 111.921 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.81 109.16 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.554 0.741 . . . . 74.54 109.152 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -85.73 106.88 17.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.338 0.655 . . . . 73.21 109.795 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 124.148 0.979 . . . . 72.31 111.429 -179.718 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.241 0.633 0 N-CA-C 108.391 -0.966 . . . . 55.45 108.391 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.505 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -134.25 134.87 42.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.168 -0.678 . . . . 73.4 109.168 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -152.39 117.71 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.89 -1.152 . . . . 75.45 107.89 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -75.07 126.78 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.123 -0.695 . . . . 73.54 109.123 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -92.04 -37.93 12.52 Favored 'General case' 0 C--O 1.243 0.758 0 O-C-N 123.829 0.705 . . . . 74.14 110.793 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -176.92 127.92 0.17 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.78 0.675 . . . . 72.4 111.629 -173.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.52 136.62 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.328 -0.99 . . . . 70.12 108.328 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -170.02 156.45 6.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 73.42 111.226 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -82.27 113.55 20.16 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.801 -0.814 . . . . 71.53 108.801 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -75.04 -31.23 61.26 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.66 -0.496 . . . . 74.52 109.66 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -150.88 141.13 22.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.008 -0.996 . . . . 73.02 109.889 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -134.67 143.86 36.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 125.503 1.521 . . . . 65.21 107.167 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 35.9 t -153.02 132.83 13.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.841 0.856 . . . . 64.13 108.738 174.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.545 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 82.4 t80 -139.87 119.21 12.91 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.78 -1.563 . . . . 73.24 106.78 174.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.19 131.09 54.85 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.147 0.579 . . . . 72.33 109.869 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.62 77.67 63.8 Favored Pre-proline 0 C--O 1.243 0.761 0 N-CA-C 106.709 -1.589 . . . . 72.05 106.709 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.75 -39.89 24.46 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.519 2.146 . . . . 74.13 111.764 -173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.13 25.38 5.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.353 -0.84 . . . . 70.43 110.154 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -57.09 9.22 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 117.565 -1.207 . . . . 65.11 113.458 -169.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.0 -21.78 68.33 Favored 'Trans proline' 0 C--N 1.398 3.135 0 CA-C-N 122.132 1.797 . . . . 72.3 112.804 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -85.07 -40.31 16.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.15 0.98 . . . . 74.4 110.643 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.9 p -76.92 -20.35 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.545 -0.752 . . . . 74.5 112.079 -159.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.002 0.521 . . . . 74.1 112.231 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -103.9 -11.13 17.67 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.43 0.692 . . . . 73.55 112.755 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HE3' ' HG2' ' A' ' 71' ' ' GLU . 20.9 mmtt -65.4 171.1 4.18 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.136 0.974 . . . . 74.32 113.598 -170.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.12 122.05 5.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.181 1.393 . . . . 71.44 111.948 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -86.95 63.26 7.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.085 0.554 . . . . 75.42 110.241 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -147.38 82.31 8.27 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 123.871 0.868 . . . . 74.55 109.082 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -84.47 165.52 12.39 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.98 2.454 . . . . 75.52 112.772 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.36 106.05 8.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.288 -1.375 . . . . 74.14 107.288 161.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 p -79.0 91.54 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 123.066 1.412 . . . . 74.35 108.467 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.61 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 40.6 tttm -83.7 118.15 23.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 113.924 -1.489 . . . . 73.51 109.89 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -97.22 111.35 23.63 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.388 -1.338 . . . . 70.42 107.388 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.639 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 19.6 m-20 -108.4 108.35 19.27 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.38 118.09 34.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.487 -1.301 . . . . 75.23 107.487 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.64 153.99 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.984 0.914 . . . . 64.43 109.074 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -135.16 156.61 48.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.07 0.948 . . . . 71.2 110.415 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -163.97 142.5 7.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 71.42 109.493 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.4 p -128.81 158.46 38.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.611 . . . . 60.43 109.532 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -154.85 136.77 14.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.933 0.893 . . . . 72.54 108.599 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -103.72 103.39 13.28 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.515 -0.92 . . . . 74.34 108.515 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.49 -31.21 37.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.339 0.655 . . . . 74.24 110.807 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -162.83 176.77 9.9 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.618 1.167 . . . . 72.12 109.243 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.69 135.91 54.75 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.091 -0.707 . . . . 74.43 109.091 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t70 69.36 -7.79 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.929 1.291 . . . . 72.22 111.975 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 90.9 t -119.88 98.24 6.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.667 0.787 . . . . 74.2 109.046 -172.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -120.57 125.28 47.4 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.734 -1.121 . . . . 74.23 108.386 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.78 131.48 39.1 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.921 0.888 . . . . 75.2 110.126 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.4 t -108.58 126.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.584 -1.265 . . . . 72.25 107.584 168.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 57.3 t -109.39 133.72 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.612 -0.884 . . . . 75.13 108.612 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -125.41 106.09 9.56 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.171 -1.418 . . . . 72.43 107.171 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.562 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 31.6 ttp180 -92.28 109.31 20.68 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 122.911 0.485 . . . . 73.04 109.745 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.69 126.84 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 106.934 -1.506 . . . . 73.22 106.934 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 98.0 m -123.82 123.26 40.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.498 -0.927 . . . . 54.53 108.498 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.558 HG12 HD21 ' A' ' 126' ' ' LEU . 69.8 t -116.51 108.25 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.184 0.994 . . . . 74.42 109.19 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 9.8 m -105.05 146.37 29.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.153 -0.684 . . . . 54.31 109.153 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 121.81 20.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.985 -1.117 . . . . 74.2 107.985 169.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.2 m -124.59 127.38 47.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.259 0.552 . . . . 73.32 110.86 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.67 85.26 7.05 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 126.134 1.773 . . . . 74.15 110.259 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.95 -80.88 1.55 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.897 -0.881 . . . . 73.22 110.897 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -130.75 -25.94 2.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.78 0.832 . . . . 74.1 110.83 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.477 ' HG2' ' HE3' ' A' ' 34' ' ' LYS . 7.8 tp10 -82.96 134.91 35.04 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.648 0.779 . . . . 75.51 110.795 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 90.8 m -79.54 139.29 37.59 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 118.738 0.699 . . . . 74.12 111.893 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.702 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -81.79 -68.49 0.69 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.169 0.988 . . . . 71.51 110.512 170.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -152.82 167.28 29.58 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.492 -0.777 . . . . 72.25 111.126 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 tp -141.39 142.95 33.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.639 1.175 . . . . 74.3 108.65 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.507 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.2 m -142.37 104.53 4.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.633 0.373 . . . . 71.5 111.154 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 7.0 mp0 -103.5 132.86 49.39 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.259 -0.645 . . . . 71.31 109.259 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -140.4 110.38 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.16 -0.681 . . . . 71.51 109.16 173.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.562 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.7 mt-30 -85.27 85.39 7.46 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.139 -1.06 . . . . 75.53 108.139 171.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -77.23 97.03 4.69 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.102 -0.954 . . . . 74.34 108.887 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.71 146.16 20.52 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.434 -0.803 . . . . 75.21 111.5 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -148.39 120.82 1.25 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 110.397 -1.081 . . . . 73.44 110.397 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.0 mt -83.03 122.94 38.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.646 -0.872 . . . . 73.55 108.646 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.505 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 49.9 m-85 -126.37 120.49 29.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.133 -0.692 . . . . 73.31 109.133 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.7 t -81.67 104.48 12.1 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.001 -1.111 . . . . 72.32 108.001 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 pt -137.9 149.41 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 73.3 110.598 -171.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -173.75 177.99 2.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.988 1.315 . . . . 65.31 109.512 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.18 10.27 71.75 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.553 0.533 . . . . 74.2 114.061 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.19 138.08 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.89 0.876 . . . . 74.13 109.749 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -130.39 170.15 14.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.234 0.614 . . . . 73.31 110.841 -173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.42 -117.04 2.2 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.176 0.923 . . . . 75.33 115.22 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -64.25 -26.9 68.71 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.133 0.973 . . . . 74.54 112.261 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.06 -44.01 55.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.607 0.763 . . . . 71.44 110.828 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -71.17 -34.16 70.69 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.706 -0.479 . . . . 64.43 109.706 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.28 86.12 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.418 -0.81 . . . . 73.43 110.174 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -67.85 -29.6 68.77 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.154 -0.93 . . . . 75.21 110.444 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 29.6 t -66.79 -38.56 86.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.859 0.464 . . . . 74.33 110.957 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.6 mt -81.71 -43.57 18.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.493 0.317 . . . . 72.45 110.804 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.96 -20.69 77.5 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.709 0.644 . . . . 72.24 114.709 -171.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.58 -63.39 0.45 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.407 0.604 . . . . 61.21 112.56 -168.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 53.8 t80 -56.71 -64.45 0.87 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.529 1.532 . . . . 73.23 113.024 -167.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.417 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 90.9 m -77.42 -35.57 1.34 Allowed Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 114.426 1.269 . . . . 62.54 114.426 -173.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 55.6 Cg_endo -67.81 -20.08 46.22 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.022 1.815 . . . . 74.02 112.999 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -74.66 -18.09 60.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.217 0.607 . . . . 73.33 110.091 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.7 mm -74.85 -39.28 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.74 0.816 . . . . 72.35 109.281 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 82' ' ' GLY . 87.1 mt -75.29 -37.87 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.294 1.038 . . . . 75.32 112.495 -173.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.421 ' HZ ' ' HG ' ' A' ' 128' ' ' LEU . 52.4 t80 -57.26 -43.13 99.01 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.04 1.126 . . . . 74.53 114.04 -169.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.99 -39.06 86.59 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.188 1.925 . . . . 72.35 113.726 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -76.77 -38.63 53.73 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.41 0.684 . . . . 74.11 111.904 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.67 94.9 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.847 -0.427 . . . . 74.51 109.847 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.406 ' NH2' ' HB3' ' A' ' 130' ' ' PRO . 33.8 ttm180 -57.71 -49.93 74.89 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.618 1.199 . . . . 75.54 110.278 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.74 -44.43 96.24 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.577 1.173 . . . . 75.01 110.905 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.45 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.6 t -56.72 -48.54 77.52 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.099 0.874 . . . . 74.43 110.23 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.2 mt -64.69 -42.26 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.263 0.977 . . . . 75.11 110.814 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.427 HG23 ' HE2' ' C' ' 109' ' ' TYR . 95.9 m -54.63 -48.04 72.75 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.562 0.745 . . . . 63.42 110.422 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.1 t -63.8 -46.05 86.9 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.306 -1.316 . . . . 74.35 109.838 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.545 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 20.1 mtp -57.64 -46.44 84.17 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.118 0.967 . . . . 72.32 112.115 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.5 HG22 HD22 ' A' ' 126' ' ' LEU . 89.0 t -63.27 -45.02 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.232 1.013 . . . . 75.25 110.283 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.2 t -66.19 -30.43 70.89 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.813 -1.085 . . . . 74.42 110.788 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.13 -28.6 60.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.702 0.801 . . . . 75.11 110.435 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 10.27 52.64 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 116.146 -0.479 . . . . 43.32 113.345 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.3 m 71.33 13.34 6.63 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.428 1.491 . . . . 71.11 112.122 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -96.16 145.8 30.19 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.732 -1.21 . . . . 73.14 107.732 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.05 157.59 28.83 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.722 2.281 . . . . 75.52 112.213 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.412 ' OE1' ' HB ' ' C' ' 16' ' ' ILE . 2.4 tt0 -50.71 125.39 13.09 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 124.195 0.934 . . . . 63.22 111.28 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.558 HD21 HG12 ' A' ' 64' ' ' VAL . 17.9 tp -109.2 119.48 39.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.146 -0.934 . . . . 72.54 109.222 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -134.85 94.94 3.24 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.394 1.078 . . . . 70.04 108.18 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . 0.421 ' HG ' ' HZ ' ' A' ' 107' ' ' PHE . 18.8 tp -62.12 131.78 50.64 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.027 -0.988 . . . . 74.42 109.723 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.91 129.27 47.57 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.266 1.027 . . . . 73.41 111.641 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.679 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 37.9 Cg_endo -67.16 104.19 0.84 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.397 2.064 . . . . 72.32 111.034 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.71 117.6 43.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.026 -1.102 . . . . 73.54 108.026 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 33.5 t30 -63.48 99.65 0.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.409 1.068 . . . . 70.23 109.475 178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -67.1 -24.21 65.91 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.176 -0.466 . . . . 73.03 111.247 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.896 0.878 . . . . 74.43 110.654 173.662 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.693 HG21 HE22 ' B' ' 12' ' ' GLN . 41.4 m . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 108.923 -0.769 . . . . 74.44 108.923 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.96 138.61 51.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.525 0.73 . . . . 64.45 109.734 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.693 HE22 HG21 ' B' ' 10' ' ' THR . 0.0 OUTLIER -152.53 135.47 15.56 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.346 0.658 . . . . 71.13 110.116 168.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.46 118.38 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.331 1.053 . . . . 72.23 108.549 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -82.5 -39.12 22.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.659 0.384 . . . . 73.41 111.655 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.524 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 28.4 ttm180 -166.28 145.86 5.99 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.51 0.724 . . . . 75.24 110.258 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.456 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 86.6 mt -119.54 145.88 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.44 -1.689 . . . . 74.52 106.44 166.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.524 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 35.1 p90 -170.03 163.85 9.37 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.935 0.874 . . . . 75.32 111.977 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 71.5 m -92.01 122.79 34.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.612 -1.176 . . . . 75.4 109.072 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -89.12 -37.93 14.7 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.87 0.868 . . . . 74.21 110.043 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -155.82 143.77 19.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.102 -0.499 . . . . 73.44 110.766 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.4 mm -134.76 139.18 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.914 1.286 . . . . 74.15 108.201 176.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -140.72 132.08 26.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.018 -1.105 . . . . 75.34 108.018 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.443 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -147.03 114.81 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.608 -1.256 . . . . 75.22 107.608 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.58 130.72 56.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.851 0.86 . . . . 74.41 108.989 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.8 83.43 65.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 106.847 -1.538 . . . . 71.15 106.847 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -68.7 -32.81 22.92 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.923 2.415 . . . . 73.12 111.971 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -106.6 25.8 10.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.88 1.272 . . . . 72.34 110.206 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.68 -50.01 44.36 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 115.558 1.688 . . . . 73.22 115.558 -168.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.8 -33.98 4.45 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.232 1.476 . . . . 74.41 112.505 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.404 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.1 m80 -82.99 -22.51 33.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.645 0.778 . . . . 72.45 112.283 -169.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.401 HG11 ' HZ ' ' B' ' 123' ' ' PHE . 4.6 p -67.93 -4.38 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 124.391 1.076 . . . . 70.52 111.963 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -56.49 -27.49 57.27 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.758 0.823 . . . . 75.34 110.931 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -76.86 -34.99 57.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.65 0.38 . . . . 74.04 110.737 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 98.9 mttt -109.99 77.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.565 0.746 . . . . 72.31 112.313 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.12 82.76 1.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.628 -1.249 . . . . 71.15 107.628 163.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -148.62 160.15 43.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.156 -1.424 . . . . 75.42 107.156 -171.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.418 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 23.9 pt20 -53.6 102.22 0.3 Allowed Pre-proline 0 CA--C 1.564 1.494 0 O-C-N 124.376 1.047 . . . . 73.41 111.7 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 6.1 Cg_endo -85.93 170.21 8.67 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.807 2.338 . . . . 73.43 112.305 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -80.9 100.65 8.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 106.344 -1.724 . . . . 74.22 106.344 165.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -114.74 142.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.923 0.889 . . . . 74.43 108.72 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.603 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 27.9 ttpt -136.72 136.63 39.17 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.496 0.718 . . . . 73.33 109.377 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.573 HD12 HD11 ' B' ' 128' ' ' LEU . 4.6 tt -85.6 127.46 34.47 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 106.28 -1.748 . . . . 75.32 106.28 165.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.603 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 12.6 t70 -122.27 110.61 15.9 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.358 -1.349 . . . . 74.3 107.358 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 3.5 pp -100.22 137.45 38.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.438 0.695 . . . . 75.23 109.292 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 32.9 t70 -124.23 135.85 53.72 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.972 -0.751 . . . . 65.12 108.972 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.04 110.15 21.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.899 0.879 . . . . 72.12 110.402 -171.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.97 140.26 52.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.514 0.726 . . . . 63.53 109.213 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 75.6 m -144.07 165.2 28.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.777 0.831 . . . . 74.31 110.199 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.4 p -152.0 162.23 41.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.398 1.079 . . . . 73.1 109.033 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -106.78 112.88 26.06 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.346 -0.613 . . . . 74.32 109.346 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.461 HD12 HG23 ' B' ' 83' ' ' ILE . 89.9 mt -80.99 -40.71 23.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.827 0.451 . . . . 71.31 110.327 176.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.95 -172.91 4.11 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.27 0.628 . . . . 72.25 110.575 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.06 116.03 4.98 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.442 -1.254 . . . . 75.42 109.774 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 71.33 -3.41 2.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.775 1.63 . . . . 65.1 112.636 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.52 113.38 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.96 -0.755 . . . . 73.33 108.96 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.77 137.8 53.73 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.177 -0.919 . . . . 74.43 109.428 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -100.57 98.16 8.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.976 -1.49 . . . . 72.23 106.976 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.11 128.61 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.734 1.214 . . . . 70.44 109.644 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 36.3 t -119.21 143.06 31.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.757 1.223 . . . . 75.52 108.957 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -136.7 111.75 8.97 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.727 -1.212 . . . . 73.21 107.727 171.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -86.12 122.67 30.46 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.155 -0.683 . . . . 75.21 109.155 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.81 103.23 15.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.92 -1.141 . . . . 74.54 107.92 173.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.7 m -103.79 129.89 51.26 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.42 -0.585 . . . . 64.45 109.42 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.423 HG23 HD12 ' B' ' 114' ' ' ILE . 61.3 t -115.0 100.99 11.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 109.248 -0.649 . . . . 74.45 109.248 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.3 m -97.8 138.06 35.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.068 -0.969 . . . . 71.32 109.146 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.77 149.76 34.97 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.881 0.472 . . . . 63.31 110.347 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -149.18 141.92 24.57 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.541 -0.754 . . . . 71.04 110.544 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.0 mt -125.55 110.4 13.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.685 1.194 . . . . 71.21 108.663 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.23 -123.39 6.3 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.627 -0.715 . . . . 75.45 111.489 -174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -108.42 2.44 22.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.116 0.967 . . . . 73.43 109.983 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.23 -179.44 3.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.748 0.819 . . . . 74.02 110.344 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -77.09 155.21 32.59 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.744 1.218 . . . . 75.2 110.703 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.08 -50.3 3.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.611 -0.885 . . . . 74.32 108.611 167.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -166.83 152.79 8.17 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.822 -1.081 . . . . 72.31 108.812 167.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -123.54 124.45 42.86 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.165 -1.05 . . . . 72.13 108.165 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.2 t -142.08 157.14 45.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.219 0.608 . . . . 74.35 109.536 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.5 tt0 -164.42 141.56 6.53 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.851 0.86 . . . . 74.44 109.121 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -134.22 143.81 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.677 -1.231 . . . . 70.23 107.677 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.5 96.53 5.24 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.952 -1.129 . . . . 75.41 107.952 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.415 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.5 tp-100 -91.34 101.59 14.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.367 -0.975 . . . . 71.01 108.367 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.38 167.55 32.77 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.143 -0.935 . . . . 71.14 110.881 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.16 127.56 1.65 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.562 -0.615 . . . . 74.22 111.562 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.461 HG23 HD12 ' B' ' 51' ' ' LEU . 46.8 mt -85.61 124.5 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 75.02 108.062 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.67 159.14 38.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.069 0.948 . . . . 72.43 108.699 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 17.1 m -132.14 120.38 22.2 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.379 -0.971 . . . . 70.31 108.379 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 pt -133.75 138.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.47 1.108 . . . . 72.11 109.367 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.4 155.65 39.06 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.649 0.78 . . . . 71.53 110.158 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.32 -71.17 0.2 Allowed Glycine 0 C--N 1.341 0.822 0 O-C-N 123.703 0.627 . . . . 63.14 112.469 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 32.6 pt -81.95 159.49 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 122.98 0.512 . . . . 74.01 110.942 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -153.56 156.93 38.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.666 -0.697 . . . . 72.31 110.16 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.47 -114.76 6.49 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.329 0.49 . . . . 73.23 113.539 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -67.14 -39.0 86.48 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.981 0.912 . . . . 63.12 111.536 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.87 -50.71 65.53 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.023 -0.989 . . . . 73.23 110.311 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -24.92 58.54 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.545 -0.752 . . . . 74.44 111.638 -175.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.7 -31.36 68.17 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.729 0.812 . . . . 71.13 111.792 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -69.75 -46.47 65.79 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.941 -0.572 . . . . 72.32 110.689 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -73.38 -32.52 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.327 0.651 . . . . 74.04 112.465 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -96.6 -39.23 9.62 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.858 0.863 . . . . 73.21 109.447 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.31 -25.57 43.18 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 114.693 0.637 . . . . 63.53 114.693 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -49.45 2.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.888 0.475 . . . . 55.31 111.334 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -79.21 -42.43 26.04 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.536 0.569 . . . . 74.15 112.536 -169.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.17 -45.46 79.17 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 118.416 -0.802 . . . . 73.52 112.016 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 47.2 Cg_exo -60.89 -31.44 91.58 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 122.427 2.084 . . . . 73.31 113.148 171.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.51 -34.87 77.75 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.707 0.803 . . . . 73.44 110.94 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.74 -44.47 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.431 0.692 . . . . 75.23 110.628 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.96 -24.99 59.71 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 123.607 0.567 . . . . 73.45 111.846 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -56.86 -52.68 72.01 Favored Pre-proline 0 CA--C 1.557 1.233 0 CA-C-O 117.029 -1.463 . . . . 74.05 113.494 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.92 -34.61 67.24 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.582 2.188 . . . . 74.12 113.976 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.502 ' HE2' HG22 ' D' ' 115' ' ' THR . 80.0 m-85 -72.76 -48.81 35.22 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.44 0.696 . . . . 74.52 110.218 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.16 80.99 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.749 -0.66 . . . . 74.21 110.439 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -63.38 -52.49 61.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.831 1.652 . . . . 73.43 110.987 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -38.44 89.89 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.973 0.796 . . . . 74.13 109.286 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.2 t -65.46 -37.63 87.43 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.042 0.537 . . . . 62.33 111.186 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.423 HD12 HG23 ' B' ' 64' ' ' VAL . 76.3 mt -64.08 -49.12 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.387 0.675 . . . . 75.42 109.587 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -61.44 -30.16 70.41 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.634 0.773 . . . . 73.14 111.231 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -69.47 -44.43 71.2 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.528 0.731 . . . . 63.12 109.146 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -68.1 -29.34 68.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.942 0.497 . . . . 75.1 111.124 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.471 HG22 HD21 ' B' ' 126' ' ' LEU . 78.7 t -69.34 -41.18 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.096 0.959 . . . . 75.25 110.015 173.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -67.66 -28.35 67.63 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.994 0.918 . . . . 70.21 111.724 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 73.5 mtt-85 -79.41 -35.72 40.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.52 0.728 . . . . 73.23 110.044 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.35 3.75 71.2 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.022 -0.536 . . . . 55.14 112.72 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 45.7 p 59.67 56.11 3.73 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.953 1.701 . . . . 74.3 112.744 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.401 ' HZ ' HG11 ' B' ' 31' ' ' VAL . 44.1 m-85 -119.49 157.9 50.48 Favored Pre-proline 0 N--CA 1.48 1.053 0 C-N-CA 124.192 0.997 . . . . 73.4 109.835 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.28 -173.83 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.78 2.32 . . . . 71.22 113.884 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.442 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -59.37 116.59 4.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.645 1.178 . . . . 74.23 112.41 -172.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.471 HD21 HG22 ' B' ' 118' ' ' VAL . 43.8 tp -123.06 93.7 4.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.473 0.709 . . . . 74.22 109.811 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -92.09 126.87 37.34 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.1 -1.074 . . . . 74.41 108.1 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.573 HD11 HD12 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -73.28 129.35 37.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.133 -1.062 . . . . 72.04 108.133 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.53 129.66 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.353 0.661 . . . . 73.13 111.073 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.568 ' HG3' HD12 ' D' ' 16' ' ' ILE . 68.0 Cg_endo -68.38 130.95 22.12 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.544 2.163 . . . . 74.41 112.115 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.71 114.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.532 0.733 . . . . 73.04 109.435 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -85.22 98.11 10.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.731 0.812 . . . . 74.33 110.811 178.79 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.606 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.1 tmm? . . . . . 0 CA--C 1.556 1.175 0 CA-C-O 121.48 0.657 . . . . 73.01 112.701 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -91.28 98.65 11.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.584 0.754 . . . . 75.02 109.926 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.606 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 50.0 t80 -97.13 142.14 29.41 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.322 0.649 . . . . 74.13 109.474 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -156.81 144.55 19.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.267 0.627 . . . . 73.32 109.327 166.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.91 137.57 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.298 -1.001 . . . . 73.12 108.298 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -95.89 -50.15 5.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.488 -0.56 . . . . 73.52 109.488 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -164.23 124.25 2.05 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.889 -0.596 . . . . 75.22 110.72 -169.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . 0.412 ' HB ' ' OE1' ' A' ' 125' ' ' GLN . 64.9 mt -109.7 130.72 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.532 -1.285 . . . . 73.44 107.532 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.473 ' HB3' HG21 ' D' ' 122' ' ' THR . 20.8 p90 -163.05 149.58 12.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.776 0.798 . . . . 75.21 111.947 -172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -77.93 103.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.933 -1.136 . . . . 71.21 107.933 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -70.87 -28.81 64.84 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.818 -0.438 . . . . 72.53 109.818 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.0 t70 -148.91 143.14 26.03 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.216 -0.902 . . . . 71.41 109.853 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -138.05 145.17 29.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.631 1.572 . . . . 74.35 106.76 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -158.4 152.19 23.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.279 0.562 . . . . 72.11 110.133 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -148.14 133.29 18.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.254 -1.388 . . . . 64.22 107.254 173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 49.0 mt-10 -125.14 132.84 53.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.853 -0.795 . . . . 74.42 108.853 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.39 77.67 5.94 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.085 0.954 . . . . 74.12 108.806 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 -22.12 17.92 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.096 1.864 . . . . 72.52 111.319 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -99.91 28.58 4.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.51 1.124 . . . . 74.3 110.816 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.68 97.12 Favored Pre-proline 0 CA--C 1.569 1.673 0 C-N-CA 123.951 0.9 . . . . 71.33 112.925 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.97 -25.83 8.5 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 121.433 1.422 . . . . 75.4 112.048 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -69.41 -21.37 63.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.077 1.351 . . . . 73.04 112.063 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 p -51.4 -29.98 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 113.018 0.748 . . . . 73.12 113.018 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -70.94 -34.53 71.56 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.339 0.656 . . . . 73.35 111.842 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -93.62 6.05 49.57 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.448 0.699 . . . . 74.04 111.015 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 2.9 ttmp? -90.95 147.76 22.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.277 0.631 . . . . 75.13 111.486 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.77 135.76 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.795 1.638 . . . . 75.51 110.148 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -81.79 79.38 8.36 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 122.122 -0.362 . . . . 74.55 110.182 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.407 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 4.7 tp-100 -153.0 55.66 1.48 Allowed Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.693 0.397 . . . . 75.23 111.216 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' C' ' 37' ' ' GLN . 17.3 Cg_endo -90.47 144.23 3.85 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.06 1.84 . . . . 73.32 112.226 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -86.3 83.73 7.63 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.227 -1.397 . . . . 74.01 107.227 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 p -76.97 99.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.882 -1.053 . . . . 72.35 108.693 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.551 ' HZ2' ' HB3' ' C' ' 41' ' ' LYS . 6.4 ttpm? -125.21 140.65 52.67 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.66 -1.154 . . . . 74.2 108.652 -175.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.58 HD12 HD11 ' C' ' 128' ' ' LEU . 2.6 pt? -87.75 163.47 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.252 0.549 . . . . 74.43 110.089 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.1 t70 -148.18 145.41 28.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.36 1.064 . . . . 72.44 108.145 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 41.1 tp -130.78 135.51 47.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.734 -0.469 . . . . 72.43 109.734 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.672 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 3.9 m-20 -118.61 142.29 47.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.918 0.887 . . . . 73.41 108.82 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.8 p -114.26 113.98 25.34 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.132 0.973 . . . . 73.44 109.561 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.89 141.97 38.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.556 0.742 . . . . 65.55 110.171 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -145.78 154.29 41.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.251 0.621 . . . . 70.03 110.547 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.9 p -144.61 131.51 20.29 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.936 0.894 . . . . 64.02 108.644 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -79.21 116.67 19.62 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.268 -0.641 . . . . 73.12 109.268 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' C' ' 57' ' ' GLU . 32.1 mt -93.3 -32.24 14.39 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.387 -0.824 . . . . 72.23 109.684 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.77 -177.03 5.28 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.153 -0.93 . . . . 71.51 110.387 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.98 128.05 34.5 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.638 -1.164 . . . . 70.03 108.97 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.48 -7.1 0.73 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.201 1.4 . . . . 73.31 113.183 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.94 112.93 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.607 0.763 . . . . 75.25 109.462 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -129.28 133.87 47.68 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.84 -1.073 . . . . 75.24 108.382 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.575 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.3 tt0 -83.31 115.67 22.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.919 -0.771 . . . . 72.05 108.919 173.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.52 118.11 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.017 -1.105 . . . . 75.44 108.017 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.73 127.75 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 122.867 0.467 . . . . 72.34 110.062 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.527 HD21 HD11 ' C' ' 106' ' ' LEU . 3.6 mm? -120.94 112.62 18.99 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.138 -1.06 . . . . 73.12 108.138 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 35.4 ttm180 -82.06 110.82 17.64 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.701 -0.851 . . . . 73.51 108.701 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.7 t -99.94 112.27 31.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.048 -1.093 . . . . 65.43 108.048 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.2 m -114.67 142.13 46.89 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.791 -1.095 . . . . 62.12 108.114 -175.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -136.02 108.34 7.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.817 -1.179 . . . . 64.04 107.817 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.0 m -108.68 142.31 39.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.287 -0.634 . . . . 73.52 109.287 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.81 113.12 11.92 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.705 -1.22 . . . . 65.4 107.705 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.7 m -142.46 150.7 40.9 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.236 0.541 . . . . 63.34 111.076 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.21 19.04 15.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.615 1.566 . . . . 74.15 109.849 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.48 -108.73 1.3 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 110.416 -1.074 . . . . 63.12 110.416 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -89.9 -33.09 16.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.282 -1.007 . . . . 74.52 108.282 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.85 102.83 0.38 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.975 1.31 . . . . 64.32 109.953 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -88.59 129.67 35.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.923 0.329 . . . . 65.13 110.255 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.598 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -73.54 -59.79 2.55 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 173.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -173.09 174.55 3.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.211 0.945 . . . . 75.12 110.534 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -134.96 145.27 47.99 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.047 -1.464 . . . . 74.32 107.047 172.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.3 t -151.71 121.45 7.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.884 -1.154 . . . . 75.32 107.884 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.41 130.3 18.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.902 0.382 . . . . 65.32 110.141 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.31 115.43 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.925 1.29 . . . . 71.04 108.716 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.0 mt-30 -89.09 88.78 7.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.849 -1.167 . . . . 72.55 107.849 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.49 112.35 17.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.623 -1.171 . . . . 71.45 109.664 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.39 148.32 18.31 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 111.269 -0.733 . . . . 73.13 111.269 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.417 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -144.3 130.97 4.17 Favored Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 111.398 -0.681 . . . . 74.24 111.398 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' D' ' 29' ' ' PRO . 13.7 mm -84.52 120.87 35.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.439 -0.949 . . . . 73.51 108.439 174.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -130.98 139.88 50.07 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.402 0.681 . . . . 74.14 109.474 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 m -110.49 109.03 19.23 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.765 -0.828 . . . . 72.1 108.765 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.477 ' HB ' ' HE2' ' C' ' 94' ' ' MET . 3.9 mp -115.33 122.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.141 -1.059 . . . . 75.22 108.141 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.78 170.32 12.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.188 0.995 . . . . 75.24 110.187 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.81 -60.61 0.33 Allowed Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.968 -0.56 . . . . 64.11 112.803 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.71 -176.65 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 117.084 0.442 . . . . 72.12 111.446 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.93 -171.98 3.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.144 0.977 . . . . 70.32 109.472 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.36 -148.94 41.44 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 116.157 -0.474 . . . . 71.55 113.8 173.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.5 p -63.32 -26.98 69.02 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.382 1.073 . . . . 41.11 112.052 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -64.71 -54.29 33.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.352 1.061 . . . . 74.42 110.655 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.477 ' HE2' ' HB ' ' C' ' 86' ' ' ILE . 1.2 tmt? -70.0 -38.14 75.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.283 -0.872 . . . . 73.32 109.974 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.47 -22.74 65.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 73.51 112.071 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -71.79 -41.59 68.13 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.778 -0.453 . . . . 75.43 109.778 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.65 -31.5 69.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.137 0.494 . . . . 71.44 110.657 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.54 -48.73 12.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.427 1.091 . . . . 75.55 109.901 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.15 9.53 67.64 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.355 -0.839 . . . . 72.32 114.283 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.13 -51.72 0.24 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.442 0.621 . . . . 74.23 111.607 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.679 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 46.8 t80 -74.77 -41.98 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.534 0.333 . . . . 75.15 111.412 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.444 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 68.8 m -66.93 -45.14 53.57 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 118.373 -0.823 . . . . 64.15 111.726 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.424 ' HG3' HD23 ' C' ' 60' ' ' LEU . 92.7 Cg_exo -50.2 -38.93 52.11 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.933 2.422 . . . . 75.53 114.017 168.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -61.74 -34.41 75.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.294 0.638 . . . . 74.1 111.992 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.34 -42.77 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.927 -0.397 . . . . 73.51 109.927 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.527 HD11 HD21 ' C' ' 60' ' ' LEU . 85.5 mt -76.03 -26.9 57.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.69 -0.686 . . . . 75.34 112.015 -174.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.83 -52.75 69.77 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 117.703 -1.141 . . . . 74.34 113.493 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.61 -32.66 93.63 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.177 1.918 . . . . 73.02 113.327 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.427 ' HE2' HG23 ' A' ' 115' ' ' THR . 67.9 m-85 -70.88 -44.44 66.32 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 70.35 110.819 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.3 -45.6 93.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.811 -0.631 . . . . 62.22 109.691 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.6 ttt-85 -56.28 -47.21 79.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.055 1.342 . . . . 72.2 111.652 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.9 -36.51 78.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.668 0.605 . . . . 75.0 109.732 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.7 t -68.2 -35.13 77.51 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.391 0.676 . . . . 73.23 111.103 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.15 -47.91 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.673 0.789 . . . . 74.1 109.974 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -64.4 -31.42 72.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.468 0.707 . . . . 74.12 110.825 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -66.38 -47.72 72.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.413 -0.812 . . . . 73.54 109.462 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.538 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.3 -36.61 84.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.45 0.7 . . . . 74.55 112.428 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.44 -37.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.21 0.604 . . . . 61.33 109.786 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.2 t -68.53 -35.1 76.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.437 0.695 . . . . 75.33 111.584 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 76.3 mtt-85 -70.67 -35.58 72.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.731 0.812 . . . . 74.11 110.428 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.27 4.61 80.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.893 -0.594 . . . . 73.41 113.046 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.2 p 60.96 35.19 19.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.768 1.627 . . . . 73.04 112.372 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -105.01 150.75 39.1 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.557 1.143 . . . . 61.33 110.05 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 76.5 Cg_exo -53.92 110.31 0.49 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.397 2.731 . . . . 53.23 113.001 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -60.34 144.46 50.63 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.507 1.13 . . . . 74.13 111.224 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.99 124.14 11.47 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.72 -1.585 . . . . 74.14 106.72 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -90.76 130.41 36.74 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.892 -0.781 . . . . 71.2 108.892 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.58 HD11 HD12 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -64.62 131.74 47.82 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.427 -0.953 . . . . 74.5 108.427 177.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.06 140.19 90.74 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.971 0.909 . . . . 71.04 111.334 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 103.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.18 2.587 . . . . 75.15 112.708 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.28 108.33 21.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 N-CA-C 108.319 -0.993 . . . . 73.51 108.319 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -96.49 92.2 6.16 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.319 -0.855 . . . . 74.55 109.156 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -61.51 -39.19 90.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.218 -0.901 . . . . 73.23 110.475 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 124.173 0.989 . . . . 75.42 112.031 -177.736 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 108.801 -0.814 . . . . 74.54 108.801 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' D' ' 85' ' ' SER . 23.4 t80 -160.23 110.73 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.592 -2.003 . . . . 73.34 105.592 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -130.98 114.79 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.921 -0.77 . . . . 74.52 108.921 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.77 123.18 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.854 0.359 . . . . 74.41 110.141 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.08 -40.4 12.3 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.346 -0.843 . . . . 73.44 109.712 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.49 ' HB3' ' HD1' ' D' ' 17' ' ' TYR . 22.1 mmt-85 -156.87 150.52 24.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.408 0.683 . . . . 74.34 112.016 -170.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.568 HD12 ' HG3' ' B' ' 130' ' ' PRO . 0.3 OUTLIER -138.85 118.0 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 105.072 -2.196 . . . . 74.14 105.072 165.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.49 ' HD1' ' HB3' ' D' ' 15' ' ' ARG . 28.2 p90 -150.39 157.91 43.57 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.866 0.841 . . . . 74.33 111.657 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -93.71 113.65 25.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.033 -0.985 . . . . 65.24 108.76 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -81.4 -35.65 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.171 0.51 . . . . 75.41 109.629 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -144.67 141.75 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.064 -0.971 . . . . 74.43 108.444 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.538 HG23 ' HE1' ' C' ' 117' ' ' MET . 95.7 mt -137.09 143.9 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.698 1.199 . . . . 75.45 107.845 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 99.1 p -147.76 141.9 26.08 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.702 0.801 . . . . 72.04 108.993 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.542 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.2 t80 -146.48 113.81 6.28 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 105.944 -1.872 . . . . 75.54 105.944 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -126.87 109.45 11.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 73.24 110.106 -173.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.97 91.18 3.45 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 107.412 -1.329 . . . . 72.11 107.412 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.02 -43.16 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.262 1.975 . . . . 74.0 112.416 -173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -97.75 37.63 1.37 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.916 -1.142 . . . . 64.32 107.916 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -51.32 -64.6 1.3 Allowed Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.786 -1.102 . . . . 74.33 113.858 -161.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' C' ' 83' ' ' ILE . 81.7 Cg_endo -78.21 -14.55 14.87 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 122.195 1.82 . . . . 64.03 113.002 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -67.25 -41.47 85.55 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.54 1.136 . . . . 72.53 109.395 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.41 -41.42 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 123.962 0.789 . . . . 74.51 110.126 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -69.61 -18.6 63.62 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.377 0.88 . . . . 71.11 113.377 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.99 -2.98 58.58 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.623 0.769 . . . . 72.2 111.999 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -124.78 116.04 21.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.096 1.358 . . . . 73.32 108.571 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -89.34 97.42 11.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.877 0.871 . . . . 63.51 112.812 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.54 ' CH2' HD11 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -167.85 -179.39 4.2 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 124.165 0.986 . . . . 73.21 112.97 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -93.22 145.48 30.11 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.484 1.114 . . . . 73.34 112.755 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.532 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 76.9 Cg_endo -79.74 135.57 11.54 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.418 2.078 . . . . 73.11 112.765 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.73 111.61 7.15 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.504 -1.295 . . . . 73.13 107.504 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.78 144.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.157 0.583 . . . . 74.21 110.774 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 85.0 tttt -124.69 127.6 47.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.288 1.035 . . . . 74.02 109.109 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.15 120.76 39.12 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.002 -1.481 . . . . 75.54 107.002 173.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.49 143.04 50.91 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.527 -0.916 . . . . 72.52 108.527 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.19 148.76 50.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.097 0.475 . . . . 74.52 110.64 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.4 t70 -139.5 150.03 44.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.185 -1.042 . . . . 72.42 108.185 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 24.2 p -116.75 143.65 45.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.746 0.818 . . . . 72.52 109.785 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.88 155.88 32.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.511 1.124 . . . . 73.11 108.246 174.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 27.1 p -169.26 163.96 10.87 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.844 0.457 . . . . 74.13 110.733 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -159.57 132.71 6.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.668 0.787 . . . . 72.15 110.009 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -77.43 117.47 18.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.769 -0.826 . . . . 75.51 108.769 170.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' D' ' 57' ' ' GLU . 70.6 mt -90.29 -32.59 16.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.858 0.463 . . . . 74.34 110.508 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.92 -171.17 1.12 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.645 0.778 . . . . 71.03 110.632 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.93 114.79 4.78 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.779 -1.101 . . . . 70.25 109.391 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 68.3 2.18 3.18 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.147 1.379 . . . . 75.35 113.012 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.67 120.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.409 -0.96 . . . . 74.43 108.409 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -136.51 131.2 33.6 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.558 0.536 . . . . 74.23 109.884 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.539 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.7 tt0 -87.43 126.59 34.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.298 -1.001 . . . . 62.2 108.298 169.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.89 112.77 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.715 -1.217 . . . . 74.24 107.715 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.514 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.7 t -102.65 130.74 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.233 0.613 . . . . 73.41 109.618 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.01 109.03 13.02 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.143 -1.428 . . . . 75.32 107.143 171.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.0 ttm-85 -84.34 106.66 16.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.446 -0.797 . . . . 75.51 109.16 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.32 129.74 45.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.568 -0.901 . . . . 75.52 108.568 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 31.3 m -125.87 135.67 52.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.573 0.749 . . . . 74.32 109.544 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 91.2 t -124.81 111.99 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.041 0.936 . . . . 74.5 109.382 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 58.7 m -105.39 119.67 39.66 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.245 -0.65 . . . . 73.12 109.245 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.03 133.24 56.21 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.275 0.63 . . . . 73.45 110.635 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -141.93 125.18 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.143 0.977 . . . . 72.13 109.649 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.635 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -126.7 138.99 53.48 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.283 1.033 . . . . 63.52 110.841 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.85 -111.91 3.51 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.8 -0.52 . . . . 54.1 111.8 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.15 4.05 17.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.202 1.001 . . . . 75.33 110.023 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.17 168.58 21.3 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.212 0.529 . . . . 73.14 112.358 -157.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -84.56 126.58 33.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.143 -0.935 . . . . 74.32 110.428 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.635 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -71.78 -69.45 0.39 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.97 0.908 . . . . 64.45 109.706 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -158.67 147.5 18.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.543 -1.662 . . . . 63.1 109.953 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.92 152.93 20.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.194 -1.41 . . . . 75.2 107.194 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.5 t -154.27 135.78 14.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.955 -0.757 . . . . 70.11 108.955 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -153.54 134.44 13.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.522 -0.547 . . . . 70.21 109.522 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.5 t -136.52 116.79 17.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.745 -0.835 . . . . 63.32 108.745 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.81 86.54 7.17 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.843 -1.169 . . . . 70.33 107.843 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.54 92.89 5.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.951 -1.022 . . . . 64.44 109.254 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.67 148.27 19.43 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.104 -0.798 . . . . 64.01 111.104 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.63 131.53 3.69 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 110.961 -0.856 . . . . 73.14 110.961 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -89.18 122.47 40.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.446 -0.946 . . . . 74.23 108.446 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.3 138.78 52.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.37 1.068 . . . . 74.25 108.996 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 19.4 m -90.69 97.34 11.13 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.207 -1.034 . . . . 75.31 108.207 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.98 123.03 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.547 -0.538 . . . . 74.32 109.547 -171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.23 170.95 20.09 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.56 1.144 . . . . 61.53 109.442 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.1 -18.48 51.23 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 116.301 -0.409 . . . . 74.41 113.222 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.35 159.05 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.439 1.095 . . . . 74.44 109.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 158.98 40.83 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.142 0.577 . . . . 75.41 110.795 -174.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.57 -97.48 0.01 OUTLIER Glycine 0 C--N 1.351 1.377 0 O-C-N 125.165 1.54 . . . . 75.3 115.793 161.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.3 p -58.89 -54.53 46.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.957 1.303 . . . . 74.13 112.597 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -82.12 -27.02 33.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.22 -0.445 . . . . 71.03 110.698 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 27.8 ttt -67.46 -35.05 78.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.831 -0.433 . . . . 74.43 109.831 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -53.87 51.98 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 123.615 0.766 . . . . 63.11 110.61 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -57.24 -45.27 84.07 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.229 0.956 . . . . 75.31 110.824 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.39 -33.13 75.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.446 0.699 . . . . 62.5 111.706 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.453 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.2 tp -75.41 -32.4 60.72 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 72.42 110.994 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.85 13.59 34.77 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.21 -0.45 . . . . 72.25 113.658 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -129.7 -61.2 1.01 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.172 0.486 . . . . 74.4 110.345 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -75.33 -46.51 32.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.4 0.68 . . . . 75.41 111.095 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 60.5 m -62.47 -48.94 85.67 Favored Pre-proline 0 CA--C 1.569 1.687 0 CA-C-O 118.306 -0.854 . . . . 54.54 112.114 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.63 -16.19 33.87 Favored 'Trans proline' 0 C--N 1.402 3.376 0 C-N-CA 122.1 1.867 . . . . 73.13 112.735 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.16 -24.48 62.26 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.833 0.453 . . . . 75.54 110.259 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.38 -39.29 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.281 0.632 . . . . 75.24 109.853 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 -37.0 64.22 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.765 0.826 . . . . 71.24 112.201 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.14 -40.9 57.49 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-O 117.787 -1.102 . . . . 75.32 113.515 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -53.93 -39.73 83.58 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.377 2.051 . . . . 71.22 113.816 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -80.26 -32.81 38.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.369 0.667 . . . . 74.33 111.368 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.69 81.3 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.168 -0.679 . . . . 62.21 109.168 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -53.53 -53.55 49.94 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.906 1.282 . . . . 74.15 110.771 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.65 -40.76 92.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.504 1.128 . . . . 74.13 110.698 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.62 -44.11 96.7 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.576 0.548 . . . . 75.24 110.757 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.59 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.1 mt -63.22 -53.19 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 72.31 109.884 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.502 HG22 ' HE2' ' B' ' 109' ' ' TYR . 95.9 m -52.8 -45.07 67.05 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.085 1.354 . . . . 75.51 111.923 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.39 -44.94 77.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.944 -1.025 . . . . 71.42 110.151 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 77.7 mtm -62.55 -37.79 87.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.857 0.463 . . . . 73.15 112.0 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.458 HG22 ' O ' ' D' ' 114' ' ' ILE . 85.7 t -61.59 -44.63 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 124.093 0.871 . . . . 73.53 110.014 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.57 -27.33 61.26 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.878 0.471 . . . . 64.32 111.718 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -72.39 -31.64 65.72 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.347 0.659 . . . . 75.42 110.076 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.25 10.81 62.48 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.445 -0.798 . . . . 61.22 112.368 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.473 HG21 ' HB3' ' C' ' 17' ' ' TYR . 67.6 p 65.75 15.04 9.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.964 2.105 . . . . 74.43 113.961 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.74 156.97 55.51 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 107.437 -1.319 . . . . 74.22 107.437 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.02 146.09 36.52 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.682 2.255 . . . . 73.44 111.588 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' D' ' 115' ' ' THR . 20.2 pt20 -51.3 127.71 20.34 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 124.275 0.985 . . . . 72.51 112.134 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -107.49 100.77 10.16 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.483 -0.932 . . . . 74.34 108.483 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 3.1 m-20 -98.89 107.1 19.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.298 1.039 . . . . 73.33 110.18 -166.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.501 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.7 mm? -72.22 116.01 12.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.069 0.948 . . . . 75.51 109.908 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.57 154.42 94.53 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.534 0.334 . . . . 75.21 111.494 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.78 123.87 14.5 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.499 2.133 . . . . 64.14 111.951 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 63.4 t -108.41 125.49 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.905 0.882 . . . . 64.4 108.773 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -72.17 93.88 1.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.171 0.588 . . . . 64.23 109.632 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.464 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 70.7 m-85 . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 115.583 -0.735 . . . . 74.2 111.352 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 109.602 -0.518 . . . . 73.13 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.602 ' HA ' HG23 ' A' ' 86' ' ' ILE . 54.1 t80 -136.2 132.16 35.53 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.495 -1.668 . . . . 74.54 106.495 164.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -150.82 120.3 6.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.855 -0.424 . . . . 75.1 109.855 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -77.81 128.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.929 -1.137 . . . . 71.24 107.929 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -101.78 -39.9 7.2 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.605 -0.517 . . . . 62.41 109.605 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -174.68 127.62 0.31 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.672 0.389 . . . . 73.53 109.961 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -112.48 145.94 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.02 -0.733 . . . . 72.42 109.02 175.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -165.39 174.64 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.716 0.807 . . . . 75.13 111.195 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -99.68 122.56 42.88 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.212 -0.662 . . . . 72.35 109.212 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.94 -24.6 23.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.738 0.415 . . . . 72.25 110.042 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.28 137.36 17.32 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.175 -0.921 . . . . 63.32 109.416 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -133.77 132.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.319 -1.363 . . . . 63.31 107.319 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -139.57 124.89 19.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 72.12 108.641 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -135.23 128.49 32.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.397 -1.705 . . . . 75.01 106.397 170.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -137.32 121.7 18.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.995 0.518 . . . . 74.35 109.666 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.11 77.57 67.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.599 -1.63 . . . . 71.21 106.599 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.77 -46.06 9.64 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.578 2.186 . . . . 73.51 111.36 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.22 23.37 3.88 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.653 -1.158 . . . . 74.41 109.704 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -45.03 -55.64 10.7 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.111 -0.947 . . . . 75.22 112.916 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.18 -26.89 83.07 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.378 2.052 . . . . 71.03 113.305 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.97 -26.7 20.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.988 0.915 . . . . 72.42 110.763 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -82.52 -17.69 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 122.744 0.417 . . . . 72.31 111.281 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -79.81 -12.46 59.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.271 0.628 . . . . 73.45 111.78 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -101.94 -9.14 20.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.174 0.99 . . . . 74.3 110.933 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -71.94 158.62 35.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.3 0.64 . . . . 75.11 111.663 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.59 138.16 58.42 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.048 -0.978 . . . . 73.25 110.19 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -94.01 63.23 3.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.623 0.725 . . . . 73.01 111.645 -165.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.45 83.77 16.9 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.123 0.969 . . . . 74.35 109.188 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.92 167.04 8.36 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.643 2.229 . . . . 75.15 111.648 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.14 99.62 7.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.316 -1.364 . . . . 74.42 107.316 167.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 65' ' ' THR . 59.7 t -85.08 129.87 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.04 -0.726 . . . . 64.45 109.04 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -125.09 120.15 30.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.528 1.131 . . . . 72.51 109.296 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tt -96.71 109.07 21.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.281 -1.748 . . . . 75.23 106.281 170.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -127.1 128.2 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.906 -1.146 . . . . 73.34 107.906 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.73 162.13 14.74 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.269 0.556 . . . . 73.32 110.853 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 10.1 t70 -131.05 134.51 46.71 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.015 1.326 . . . . 64.23 108.081 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -115.76 125.08 52.3 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.018 0.927 . . . . 74.45 110.695 -171.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.38 124.06 11.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.23 0.612 . . . . 72.51 111.586 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.5 p -90.91 155.68 18.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.296 0.638 . . . . 74.21 109.568 168.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 40.8 t -150.58 150.56 31.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.223 1.009 . . . . 70.3 109.027 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -115.24 138.84 50.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.194 0.598 . . . . 64.22 110.228 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 83' ' ' ILE . 65.1 mt -110.04 -34.63 6.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.824 0.85 . . . . 75.53 109.856 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -166.75 -176.01 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 71.04 109.986 -176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.39 122.07 21.48 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.955 -0.758 . . . . 75.32 108.955 173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 72.75 -7.02 1.52 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.36 1.464 . . . . 75.31 112.468 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 57.5 t -114.86 111.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 107.506 -1.294 . . . . 74.4 107.506 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -128.68 170.96 12.65 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 123.65 0.78 . . . . 75.53 108.997 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 37.8 tt0 -130.59 147.25 52.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.978 0.911 . . . . 74.12 109.076 176.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.98 122.33 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.923 -1.14 . . . . 71.11 107.923 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.448 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.2 t -105.35 129.68 57.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 109.239 -0.652 . . . . 75.43 109.239 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -118.61 100.41 7.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 106.482 -1.673 . . . . 72.43 106.482 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttp180 -84.96 109.0 17.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.764 -0.653 . . . . 72.33 109.276 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.429 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.4 t -92.81 132.59 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 107.966 -1.124 . . . . 73.34 107.966 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -120.27 138.39 53.7 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.485 -0.561 . . . . 71.32 109.485 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.56 108.98 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 124.874 1.27 . . . . 74.14 107.573 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 m -105.02 134.72 47.65 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 109.461 -0.57 . . . . 73.44 109.461 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.77 111.63 15.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.232 -1.396 . . . . 71.53 107.232 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.2 t -138.15 134.99 35.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.004 0.522 . . . . 71.13 110.464 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.42 52.06 2.01 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.078 1.351 . . . . 64.32 109.608 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.83 -90.69 1.46 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.61 -0.596 . . . . 60.25 111.61 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.62 -27.59 17.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.996 0.518 . . . . 73.04 112.381 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.31 125.13 53.54 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.662 -0.496 . . . . 70.05 109.662 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.5 m -81.26 135.3 35.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.571 0.748 . . . . 73.31 111.237 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.598 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -73.87 -65.08 0.88 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.466 0.706 . . . . 73.05 110.217 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -160.53 163.47 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.988 -1.006 . . . . 75.4 111.366 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.93 124.89 30.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.862 1.265 . . . . 65.01 108.371 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 118' ' ' VAL . 54.7 m -123.88 105.61 9.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.115 0.966 . . . . 75.24 109.067 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.7 122.16 28.38 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.348 0.659 . . . . 61.32 109.718 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 113' ' ' CYS . 46.7 t -130.47 112.75 23.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.915 0.886 . . . . 74.12 109.458 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 44.4 mt-30 -84.87 89.16 7.49 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.466 0.706 . . . . 74.21 109.506 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.23 7.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.136 -0.938 . . . . 74.01 109.023 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -101.1 145.25 16.91 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.426 -0.67 . . . . 64.53 111.426 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.98 137.27 6.58 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 111.639 -0.585 . . . . 71.21 111.639 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 51' ' ' LEU . 42.6 mt -77.9 126.15 38.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.843 -0.799 . . . . 60.4 108.843 175.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -129.52 118.98 22.93 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.621 -0.881 . . . . 73.33 108.621 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -86.25 99.11 11.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.778 -0.823 . . . . 71.5 108.778 172.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.602 HG23 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.88 157.32 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.313 0.645 . . . . 73.25 110.512 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.88 161.6 15.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.941 -1.027 . . . . 65.14 110.476 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.3 8.04 83.09 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.287 0.367 . . . . 73.33 113.797 170.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 pt -111.45 143.69 20.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 123.956 0.902 . . . . 73.53 108.901 -176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.7 tt0 -159.13 174.92 14.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.834 0.454 . . . . 74.41 109.879 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.493 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 58.87 -127.91 46.41 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 123.904 0.764 . . . . 72.23 114.274 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -82.66 -15.19 52.98 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.296 0.638 . . . . 73.14 111.527 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.53 -40.31 61.81 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.353 0.661 . . . . 74.14 110.097 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.8 ptm -71.01 -29.5 65.47 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.272 -0.422 . . . . 72.41 110.065 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.14 -28.85 63.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.561 0.745 . . . . 64.41 111.131 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -81.6 -31.49 32.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.419 0.687 . . . . 73.01 110.494 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.12 -57.57 5.23 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.965 0.506 . . . . 74.33 109.925 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.8 -51.83 44.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.284 -0.871 . . . . 73.41 111.001 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.57 -6.09 88.16 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 115.147 0.819 . . . . 73.54 115.147 -167.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.39 -54.14 0.19 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.254 0.835 . . . . 74.33 113.254 -170.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -69.39 -46.91 65.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.611 0.365 . . . . 73.03 111.575 -171.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.9 m -67.98 -43.56 37.02 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.003 0.921 . . . . 71.01 112.609 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.69 -43.26 40.72 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 123.096 2.531 . . . . 73.11 113.148 168.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -63.25 -37.14 86.07 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.089 0.868 . . . . 70.34 110.837 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.0 -45.53 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.326 0.65 . . . . 74.43 111.015 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.33 -24.49 34.55 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.566 -0.743 . . . . 74.14 112.292 -170.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -61.29 -42.49 85.64 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 113.824 1.046 . . . . 72.14 113.824 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 76.6 Cg_exo -55.04 -41.8 75.26 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.47 2.114 . . . . 74.31 114.399 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.148 0.579 . . . . 62.31 111.62 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.87 97.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.032 0.533 . . . . 74.11 110.657 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.533 ' NH1' HD13 ' C' ' 105' ' ' ILE . 31.1 ttm105 -50.69 -57.67 7.73 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.776 1.298 . . . . 74.32 110.825 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.88 -40.76 95.62 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.991 0.807 . . . . 74.1 110.802 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.566 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.2 t -60.76 -33.21 72.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.659 0.599 . . . . 73.43 111.786 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.549 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 96.1 mt -74.01 -55.74 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.623 0.769 . . . . 71.2 109.843 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -51.41 -44.3 62.2 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.246 1.418 . . . . 65.54 112.64 -173.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 34.3 t -65.3 -42.75 92.77 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.93 -1.032 . . . . 74.14 110.106 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.549 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 51.4 mtm -64.63 -40.39 95.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.84 0.456 . . . . 72.21 111.05 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.1 t -57.27 -48.29 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.576 0.75 . . . . 65.5 109.945 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -71.16 -31.89 68.24 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.737 -0.665 . . . . 75.41 111.765 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 116' ' ' SER . 73.1 mtt-85 -67.58 -28.74 68.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.85 0.86 . . . . 72.1 110.885 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.87 23.85 8.61 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 119.627 -0.54 . . . . 74.24 113.972 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.4 p 50.13 26.08 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.809 1.644 . . . . 74.23 113.625 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.36 149.17 36.26 Favored Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 108.83 -0.804 . . . . 64.14 108.83 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.02 139.3 84.76 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.818 2.346 . . . . 72.21 111.488 174.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG21 ' A' ' 115' ' ' THR . 32.1 tt0 -54.71 132.6 46.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.13 0.894 . . . . 70.42 111.092 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.1 tp -111.92 118.3 35.11 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.85 -0.796 . . . . 72.5 108.85 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.471 ' HB2' HD12 ' C' ' 13' ' ' ILE . 89.9 m-20 -110.0 110.36 21.25 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.995 -1.113 . . . . 75.02 107.995 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.15 117.33 14.76 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.932 -1.136 . . . . 74.01 107.932 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.12 140.27 90.93 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 118.406 0.548 . . . . 75.0 110.996 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.696 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 1.7 Cg_endo -74.03 109.84 2.96 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.027 1.818 . . . . 72.53 110.645 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.36 123.74 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.501 -0.925 . . . . 73.45 108.501 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -73.75 99.73 3.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.807 0.843 . . . . 73.54 109.929 -173.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -72.15 -46.31 56.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.475 0.71 . . . . 75.5 111.85 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 4.9 p-10 . . . . . 0 N--CA 1.479 1.007 0 O-C-N 123.425 0.453 . . . . 73.32 111.441 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.241 0.638 0 N-CA-C 108.012 -1.107 . . . . 75.35 108.012 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -151.68 128.6 11.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.936 0.494 . . . . 73.23 110.104 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -159.67 144.27 15.09 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.678 0.791 . . . . 75.43 108.942 161.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.548 HG23 ' HE2' ' B' ' 84' ' ' PHE . 2.7 pp -59.13 138.4 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.498 -0.774 . . . . 73.24 109.957 168.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.436 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.7 mm100 -100.47 -45.98 5.38 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.575 -0.898 . . . . 75.34 108.575 172.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -164.84 129.93 2.64 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.99 -1.004 . . . . 75.14 108.882 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -115.03 135.98 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 106.667 -1.605 . . . . 74.32 106.667 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -166.5 158.44 13.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.482 0.658 . . . . 75.33 111.331 -173.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 78.2 m -85.46 119.71 26.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.162 -0.926 . . . . 75.02 108.962 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 44.3 mtpt -88.32 -34.68 17.57 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.273 0.629 . . . . 73.14 110.177 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.2 t70 -153.79 147.16 24.87 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.568 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.62 HD13 ' SG ' ' B' ' 113' ' ' CYS . 41.0 mm -139.76 142.94 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.86 1.664 . . . . 74.34 107.573 177.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -148.43 138.17 22.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.665 -0.865 . . . . 74.51 108.665 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -151.18 123.3 8.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.239 -1.393 . . . . 75.44 107.239 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -120.89 149.52 42.49 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.081 0.552 . . . . 75.31 109.542 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.557 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -143.72 80.26 12.92 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.11 -1.07 . . . . 71.21 108.11 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.41 -17.66 39.03 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.057 2.505 . . . . 73.01 111.872 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -122.87 27.84 7.53 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.501 1.121 . . . . 72.22 109.439 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -47.05 -50.05 47.87 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 124.275 1.03 . . . . 75.32 112.836 172.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 1.0 OUTLIER -85.21 -35.29 0.16 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.504 2.136 . . . . 62.34 112.709 178.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.1 m80 -90.84 2.35 56.2 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 75.31 112.908 -170.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.83 -28.59 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 125.075 1.35 . . . . 71.0 111.898 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -66.62 -13.82 61.62 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.753 1.221 . . . . 73.42 112.381 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.595 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 10.3 pt20 -73.34 -32.45 64.56 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.427 0.632 . . . . 74.3 110.253 174.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.595 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 29.3 mmtp -107.03 81.81 1.6 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.04 1.336 . . . . 51.25 108.922 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.39 77.17 8.29 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.547 -0.751 . . . . 73.44 111.644 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.535 ' HE3' ' HA ' ' B' ' 36' ' ' TRP 0.258 0.0 OUTLIER 160.56 -171.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 127.084 2.153 . . . . 71.33 111.141 156.19 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -59.02 132.2 87.11 Favored Pre-proline 0 C--N 1.361 1.068 0 C-N-CA 124.755 1.222 . . . . 74.21 113.278 -168.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.42 171.77 15.48 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.418 2.746 . . . . 74.23 112.784 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -69.39 109.41 4.17 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 108.596 -0.89 . . . . 72.43 108.596 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 m -95.16 135.0 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.407 -0.815 . . . . 72.52 109.931 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -141.65 124.28 15.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.329 1.052 . . . . 73.55 108.294 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.638 HD23 HD21 ' B' ' 128' ' ' LEU . 64.7 tp -97.41 145.49 26.12 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.454 -0.573 . . . . 74.33 109.454 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -146.66 154.25 41.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.999 -1.112 . . . . 71.01 107.999 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -138.38 141.97 39.63 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.484 -0.932 . . . . 75.33 108.484 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.676 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 15.1 t70 -124.34 144.02 50.25 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.966 0.906 . . . . 61.31 108.699 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.3 p -112.23 112.08 23.43 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.423 -0.808 . . . . 74.3 110.225 -170.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.96 125.36 31.4 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.314 -0.995 . . . . 71.35 108.314 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.6 p -142.82 168.17 20.34 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.36 0.664 . . . . 64.32 109.621 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 57.8 p -150.99 141.06 22.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.129 0.572 . . . . 74.33 109.909 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -82.02 109.74 16.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.826 -0.805 . . . . 71.43 108.826 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.528 HD12 HG22 ' B' ' 83' ' ' ILE . 55.1 mt -75.83 -41.03 53.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.445 . . . . 75.54 110.245 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.75 -171.77 3.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.184 0.994 . . . . 72.25 110.062 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.88 111.37 1.44 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 115.555 -0.748 . . . . 74.34 110.446 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 65.55 12.53 8.27 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.637 1.175 . . . . 75.54 112.516 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.06 115.14 47.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.094 -1.076 . . . . 72.42 108.094 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -124.14 138.49 54.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.225 -0.657 . . . . 72.44 109.225 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.434 ' HB2' HD13 ' B' ' 51' ' ' LEU . 7.8 tm-20 -107.08 106.92 17.66 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.278 -1.379 . . . . 73.32 107.278 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.1 t -96.4 121.57 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.088 1.355 . . . . 74.34 110.04 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 30.0 t -105.39 120.19 55.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.437 0.695 . . . . 54.11 109.149 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 103' ' ' PRO . 50.2 tp -95.16 99.16 11.18 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 73.3 108.605 172.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.676 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 65.2 ttt180 -88.48 107.94 19.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.813 -0.81 . . . . 71.53 108.813 177.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.415 HG13 HD12 ' B' ' 42' ' ' LEU . 77.2 t -104.9 102.87 14.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.177 0.991 . . . . 65.53 108.934 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -100.93 128.47 46.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.376 0.67 . . . . 72.43 109.836 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.43 135.29 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.333 1.053 . . . . 72.44 108.932 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.9 m -124.83 143.59 50.74 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.528 0.731 . . . . 64.5 109.571 174.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.74 130.25 24.0 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.915 -1.142 . . . . 64.22 107.915 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.4 m -135.14 126.53 28.47 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 120.81 0.338 . . . . 74.4 111.586 -176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' B' ' 34' ' ' LYS . 56.9 mt -93.9 109.75 21.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.409 1.084 . . . . 73.24 108.467 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.9 -111.17 3.86 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.051 -0.82 . . . . 73.23 111.051 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -121.97 18.42 10.91 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.657 0.742 . . . . 73.22 110.214 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -122.2 142.79 50.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.529 -0.732 . . . . 75.21 109.132 178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.7 m -66.78 118.45 10.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.909 0.484 . . . . 75.4 110.983 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.48 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -68.03 -55.46 12.51 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.973 -0.751 . . . . 71.4 108.973 177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -164.4 164.98 21.96 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.203 -1.362 . . . . 75.24 109.214 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.76 151.91 42.75 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.439 1.096 . . . . 74.04 108.514 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.4 t -155.52 115.66 3.75 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.221 -0.659 . . . . 74.43 109.221 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -123.62 127.04 47.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.143 -1.058 . . . . 74.15 108.143 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.491 HG12 HD11 ' B' ' 21' ' ' ILE . 57.3 t -122.55 148.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.875 -0.787 . . . . 74.05 108.875 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.5 mt-30 -123.4 99.46 6.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.218 -1.031 . . . . 64.24 108.218 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -93.71 100.45 12.67 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.35 -0.981 . . . . 74.35 108.35 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.94 162.0 29.7 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 123.677 0.61 . . . . 45.15 111.912 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.89 127.13 1.64 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.226 -0.75 . . . . 71.53 111.226 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.528 HG22 HD12 ' B' ' 51' ' ' LEU . 33.9 mt -83.98 133.81 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.057 -1.09 . . . . 74.24 108.057 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.548 ' HE2' HG23 ' B' ' 13' ' ' ILE . 49.2 m-85 -135.42 138.61 43.41 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.454 0.702 . . . . 75.13 109.45 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -91.86 103.74 16.25 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.791 -0.818 . . . . 74.33 108.791 169.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.423 ' HB ' HD11 ' B' ' 89' ' ' ILE . 26.1 pt -120.21 122.04 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.879 0.872 . . . . 72.2 110.007 -176.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.87 21.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.839 0.855 . . . . 61.54 109.876 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.36 -45.32 3.48 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.525 0.516 . . . . 74.13 113.108 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' B' ' 86' ' ' ILE . 20.9 pt -64.03 158.88 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.655 1.182 . . . . 73.4 112.439 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -170.21 166.57 8.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.581 1.152 . . . . 74.3 109.8 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -119.1 16.6 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.297 -0.411 . . . . 71.35 113.881 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -80.27 -18.87 48.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 74.33 111.345 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.89 -44.35 97.24 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 73.42 110.954 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -73.24 -32.7 64.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.661 0.384 . . . . 71.14 110.612 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.57 -33.7 76.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.721 0.808 . . . . 63.52 111.406 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -85.24 -26.64 26.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.667 0.787 . . . . 74.0 110.488 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.97 -67.18 0.53 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.562 0.345 . . . . 75.15 110.569 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.442 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -95.14 -6.48 41.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.517 0.562 . . . . 74.53 112.517 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.8 2.38 45.19 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.216 0.322 . . . . 71.5 113.036 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.76 -58.36 0.32 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.094 0.558 . . . . 63.43 111.037 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.41 -46.8 46.57 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.198 0.599 . . . . 73.2 111.963 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 68.8 m -66.04 -42.46 51.67 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.546 0.738 . . . . 74.31 111.781 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.406 ' HA ' HD23 ' B' ' 60' ' ' LEU . 89.9 Cg_exo -50.87 -43.72 45.46 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.628 2.218 . . . . 74.11 112.893 166.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.87 -25.04 67.0 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.183 0.593 . . . . 71.44 112.523 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mt -76.8 -50.55 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.407 0.683 . . . . 71.03 110.346 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.36 -15.95 57.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.562 0.745 . . . . 70.43 111.521 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.458 ' HE1' HD13 ' B' ' 128' ' ' LEU . 37.8 t80 -62.5 -53.33 58.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.609 -1.186 . . . . 75.3 112.799 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 71.4 Cg_exo -54.26 -37.76 88.31 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.187 1.925 . . . . 75.15 113.59 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.511 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 80.0 m-85 -68.33 -51.38 45.22 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.737 0.815 . . . . 72.02 110.947 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.72 81.23 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.959 0.904 . . . . 64.03 111.33 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -64.95 -52.71 54.82 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.457 1.503 . . . . 73.21 110.296 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -34.84 78.4 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.903 0.752 . . . . 73.34 109.776 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.62 ' SG ' HD13 ' B' ' 21' ' ' ILE . 1.8 t -68.66 -43.29 76.53 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.904 0.482 . . . . 75.15 111.363 -177.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.85 -43.78 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 123.445 0.698 . . . . 75.14 110.338 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.717 HG23 ' HB2' ' B' ' 125' ' ' GLN . 44.5 m -64.02 -27.7 69.29 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.203 -0.908 . . . . 74.35 111.052 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.8 t -73.59 -45.01 55.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.458 0.703 . . . . 74.14 110.122 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -72.5 -37.78 68.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.991 0.517 . . . . 72.33 112.025 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.59 -31.07 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.002 0.43 . . . . 73.43 110.46 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.45 ' OG ' HG21 ' C' ' 115' ' ' THR . 21.5 t -70.98 -30.54 66.84 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.925 0.89 . . . . 72.04 111.611 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.566 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.7 mtt-85 -74.03 -31.16 62.78 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.213 -0.903 . . . . 75.11 109.683 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.4 0.7 68.09 Favored Glycine 0 C--N 1.362 2.027 0 O-C-N 123.911 0.757 . . . . 53.34 112.203 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.543 HG21 HH22 ' C' ' 111' ' ' ARG . 29.3 p 65.5 23.62 11.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.93 2.092 . . . . 75.44 113.244 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.59 150.85 39.53 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 122.893 0.477 . . . . 74.55 110.079 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -42.0 137.76 3.07 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.381 3.387 . . . . 73.01 113.226 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.717 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.0 pt20 -66.57 157.33 32.6 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.267 1.21 . . . . 75.51 114.267 -174.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.77 95.86 5.82 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.521 -1.659 . . . . 75.31 106.521 165.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -88.33 92.6 9.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.923 -1.51 . . . . 72.41 106.923 173.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.638 HD21 HD23 ' B' ' 42' ' ' LEU . 1.2 tt -63.44 133.91 54.76 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.785 -1.098 . . . . 72.42 110.892 -165.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.99 146.6 95.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.155 0.982 . . . . 74.44 111.051 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.77 116.16 3.11 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.682 2.254 . . . . 72.24 111.516 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.76 118.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.226 -0.657 . . . . 73.03 109.226 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -96.74 103.67 15.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.578 0.751 . . . . 71.5 109.823 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 123.625 0.77 . . . . 73.11 110.707 177.057 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.533 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 57.9 ttp . . . . . 0 CA--C 1.555 1.136 0 CA-C-O 121.926 0.87 . . . . 73.44 112.704 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 67.6 m -119.11 97.17 5.55 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.894 -1.521 . . . . 70.23 106.894 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.92 121.68 45.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.338 0.655 . . . . 74.4 109.633 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -137.84 145.13 41.87 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.363 0.665 . . . . 71.5 109.748 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 127' ' ' ASN . 2.6 pp -82.42 142.68 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.615 -0.883 . . . . 73.41 108.615 171.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -110.09 -50.19 3.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.855 -0.424 . . . . 75.14 109.855 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -169.71 130.95 1.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.245 0.341 . . . . 75.21 110.464 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.61 140.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.826 1.25 . . . . 73.2 107.92 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.419 ' HE1' HG12 ' C' ' 83' ' ' ILE . 12.8 p90 -171.89 154.5 3.56 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.018 0.826 . . . . 74.42 112.212 -175.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -80.44 106.44 12.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.661 -1.154 . . . . 71.42 107.974 170.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -68.73 -48.16 64.51 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.872 0.844 . . . . 72.42 109.205 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.8 t70 -134.65 141.81 46.68 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.237 -1.347 . . . . 74.02 109.244 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.3 mt -135.63 145.33 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.353 1.461 . . . . 75.24 107.219 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -155.59 152.01 28.24 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.212 0.529 . . . . 74.13 110.355 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.3 t80 -147.94 119.11 7.74 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.298 -1.371 . . . . 72.04 107.298 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 41.4 mt-10 -118.7 118.23 31.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.163 0.585 . . . . 72.43 109.628 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.54 86.0 35.71 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.627 0.771 . . . . 72.02 109.313 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -71.25 -28.71 18.17 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.954 2.436 . . . . 65.24 111.781 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.594 ' HB3' ' HZ1' ' C' ' 34' ' ' LYS . 2.0 m-20 -96.99 19.81 12.2 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.397 1.079 . . . . 64.42 110.465 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.0 99.34 Favored Pre-proline 0 CA--C 1.567 1.596 0 C-N-CA 124.812 1.245 . . . . 74.03 113.953 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.94 -31.06 6.62 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.775 1.65 . . . . 65.52 111.875 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -66.68 -21.84 66.09 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.896 1.278 . . . . 75.24 112.744 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.53 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 8.3 p -50.92 -33.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 113.856 1.058 . . . . 73.32 113.856 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -58.35 -30.8 67.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.569 0.748 . . . . 71.42 112.624 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.25 28.06 9.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.232 1.013 . . . . 73.33 110.593 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.631 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 14.1 ttmm -104.15 147.27 27.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.242 0.617 . . . . 70.52 109.739 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.25 130.74 42.83 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.347 0.659 . . . . 74.11 109.836 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -84.7 62.81 7.59 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 123.731 0.644 . . . . 75.13 111.246 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -156.28 77.66 4.33 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.361 1.065 . . . . 74.24 108.348 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.467 ' HB2' ' HB1' ' C' ' 66' ' ' ALA . 72.5 Cg_endo -88.45 140.2 4.4 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 122.454 2.103 . . . . 73.41 111.608 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.03 115.52 24.47 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.249 -1.019 . . . . 73.32 108.249 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.85 106.22 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.86 -0.793 . . . . 74.52 108.86 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -92.11 108.31 19.84 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.18 122.85 32.21 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.281 -1.377 . . . . 75.41 107.281 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.777 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.0 m-20 -119.88 118.27 30.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.769 0.827 . . . . 74.34 109.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.45 126.34 53.39 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.908 -0.775 . . . . 75.52 108.908 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 19.8 t70 -128.53 135.68 49.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.719 1.208 . . . . 75.03 108.107 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.0 p -113.73 126.58 55.39 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.946 0.498 . . . . 65.32 110.358 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.508 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -126.58 145.66 50.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.951 0.9 . . . . 74.15 110.081 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.4 p -144.04 148.68 35.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.256 0.622 . . . . 74.0 109.458 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -145.38 140.28 27.56 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.564 -0.902 . . . . 72.35 108.564 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -94.29 115.82 28.12 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.044 -1.095 . . . . 73.21 108.044 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.513 HD13 HD13 ' C' ' 83' ' ' ILE . 35.1 mt -87.92 -40.83 13.62 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.745 0.818 . . . . 71.43 109.618 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.81 -175.77 5.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.085 1.354 . . . . 63.14 108.371 175.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -62.45 122.94 16.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.389 0.431 . . . . 62.3 109.943 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 68.93 -7.09 0.8 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.67 1.588 . . . . 74.42 113.604 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.22 107.05 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.837 -1.171 . . . . 74.42 107.837 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.421 ' HB2' HD12 ' C' ' 86' ' ' ILE . 72.9 m-85 -118.18 122.87 44.12 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.927 -1.138 . . . . 74.11 107.927 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.22 120.77 26.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.158 0.983 . . . . 75.5 109.141 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.2 t -97.05 116.07 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 72.21 108.375 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 59.6 t -117.82 134.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.643 0.777 . . . . 72.34 109.132 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.91 111.02 19.06 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.2 ttm180 -79.96 105.83 11.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.041 -1.466 . . . . 75.43 107.041 167.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.25 114.07 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.09 -1.078 . . . . 75.13 108.09 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.777 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 64.2 m -114.71 137.73 51.57 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.715 0.806 . . . . 72.43 108.882 -174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.604 HG23 HG21 ' C' ' 114' ' ' ILE . 61.0 t -128.23 112.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.667 -1.234 . . . . 62.25 107.667 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -106.24 139.89 40.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.613 -0.884 . . . . 72.45 108.613 169.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' C' ' 38' ' ' PRO . . . -121.34 112.89 19.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.881 -1.526 . . . . 74.32 106.881 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.0 m -148.12 137.44 22.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.116 0.566 . . . . 72.05 110.354 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.5 58.79 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.391 1.076 . . . . 75.4 109.347 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 -117.78 5.3 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.808 -1.087 . . . . 73.2 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.53 -30.25 18.36 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.925 -0.769 . . . . 75.51 108.925 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -63.61 100.05 0.25 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 124.236 0.96 . . . . 63.24 109.476 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -85.56 134.96 34.0 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.053 0.541 . . . . 73.41 109.856 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.631 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -80.83 -61.05 2.08 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.995 0.918 . . . . 61.21 109.173 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -167.59 178.0 5.6 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.952 0.782 . . . . 74.31 110.934 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -138.49 144.85 40.2 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.548 -1.279 . . . . 75.01 107.548 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.0 t -148.98 142.92 25.78 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.792 -1.188 . . . . 74.2 107.792 174.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.64 134.54 11.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.896 0.316 . . . . 61.14 110.722 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -138.48 116.08 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.458 1.103 . . . . 54.01 110.027 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.496 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 2.2 mp0 -89.99 88.4 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.179 0.992 . . . . 72.24 108.426 174.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.39 103.41 9.29 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.061 -0.972 . . . . 70.25 110.081 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.54 153.11 20.86 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.784 -0.644 . . . . 63.21 111.763 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.08 117.37 0.82 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 110.225 -1.15 . . . . 74.44 110.225 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.513 HD13 HD13 ' C' ' 51' ' ' LEU . 12.9 mm -81.2 122.31 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.11 -0.7 . . . . 74.22 109.11 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.412 ' HB2' HD11 ' C' ' 86' ' ' ILE . 60.3 m-85 -132.07 152.82 50.98 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.534 -0.914 . . . . 71.41 108.534 176.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -110.27 113.15 25.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.542 -0.91 . . . . 74.12 108.542 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' C' ' 56' ' ' TYR . 2.9 mp -115.75 103.15 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.204 -1.406 . . . . 70.22 107.204 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.52 169.83 10.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.339 0.656 . . . . 72.45 110.903 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.06 -50.69 2.8 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.913 -0.585 . . . . 74.02 112.484 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 170.32 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.002 0.521 . . . . 72.25 111.769 -171.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.22 -173.99 4.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.767 0.827 . . . . 73.25 109.823 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -138.63 39.12 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.738 -0.479 . . . . 63.54 113.627 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 92' ' ' THR . . . . . 0.473 ' HA ' ' HB1' ' C' ' 95' ' ' ALA . 35.7 p -68.54 -22.3 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.915 0.886 . . . . 74.11 111.818 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.41 -50.07 61.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 74.42 110.041 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -66.83 -38.21 85.98 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.871 -0.604 . . . . 71.31 109.985 172.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' C' ' 92' ' ' THR . . . -60.88 -27.69 68.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.874 0.87 . . . . 62.44 112.331 -175.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -74.91 -47.88 27.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.007 -0.368 . . . . 71.5 110.007 172.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.533 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 18.7 t -70.73 -22.3 62.45 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 111.984 0.364 . . . . 72.34 111.984 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.24 -43.48 5.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.084 0.954 . . . . 75.01 109.521 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.66 -5.36 64.85 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.56 -0.746 . . . . 75.5 114.139 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -133.87 -54.7 0.87 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.192 0.496 . . . . 54.31 111.361 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.696 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 33.4 t80 -67.13 -55.92 12.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.156 0.983 . . . . 71.35 112.079 -172.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.83 -45.49 87.59 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 113.044 0.757 . . . . 72.31 113.044 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -56.61 -39.89 88.24 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.715 2.277 . . . . 70.11 113.72 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.69 -28.7 69.26 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.937 0.895 . . . . 64.34 110.982 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.533 HD13 ' NH1' ' A' ' 111' ' ' ARG . 24.0 mm -72.79 -44.87 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.449 0.7 . . . . 73.21 110.592 173.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.08 -15.01 54.96 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.635 -0.711 . . . . 72.25 112.134 -173.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.472 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 78.1 t80 -57.11 -50.57 87.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 124.837 1.255 . . . . 71.52 113.139 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 34.4 Cg_exo -62.85 -32.79 77.2 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 122.129 1.886 . . . . 73.13 113.428 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.34 -44.88 86.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.688 0.795 . . . . 73.44 111.626 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.64 95.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.001 -0.545 . . . . 73.43 110.117 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.543 HH22 HG21 ' B' ' 122' ' ' THR . 48.2 ttt180 -56.44 -55.1 37.91 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.224 0.952 . . . . 75.45 111.255 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.41 -30.7 71.54 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.294 0.638 . . . . 71.4 110.69 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.74 -39.82 63.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.812 0.445 . . . . 74.4 111.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.604 HG21 HG23 ' C' ' 64' ' ' VAL . 66.5 mt -62.62 -47.0 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.958 0.903 . . . . 70.04 109.87 172.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 115' ' ' THR . . . . . 0.45 HG21 ' OG ' ' B' ' 119' ' ' SER . 86.8 m -67.62 -29.33 68.63 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 114.088 -1.414 . . . . 74.44 110.846 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -68.33 -46.26 70.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.384 0.674 . . . . 73.21 109.592 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.602 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.46 -42.71 95.79 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.302 1.041 . . . . 73.21 113.248 -176.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 22.8 m -66.65 -32.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.576 0.227 . . . . 73.43 110.438 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.53 -34.42 77.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.111 0.964 . . . . 74.11 111.473 174.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.4 mtt-85 -72.77 -33.25 66.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.743 0.817 . . . . 73.45 110.498 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.26 64.46 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 123.661 0.601 . . . . 45.13 112.465 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.412 ' OG1' ' HD3' ' D' ' 15' ' ' ARG . 69.3 p 58.04 31.36 20.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.152 1.781 . . . . 62.52 112.943 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.42 148.41 36.27 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.539 1.135 . . . . 72.3 108.771 174.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.46 138.58 47.5 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.416 2.744 . . . . 75.34 112.821 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.418 ' HB3' HG22 ' C' ' 115' ' ' THR . 95.9 mt-30 -63.36 149.3 46.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 113.865 1.061 . . . . 75.33 113.865 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.7 98.24 6.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 106.863 -1.532 . . . . 75.04 106.863 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -92.38 130.44 38.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.313 0.645 . . . . 72.25 109.603 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.05 136.64 37.23 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.594 0.758 . . . . 65.15 110.495 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.02 157.8 73.24 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.263 1.025 . . . . 70.23 109.963 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.76 98.9 0.31 Allowed 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 122.358 2.038 . . . . 71.25 113.075 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.57 109.28 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.482 -1.303 . . . . 74.43 107.482 170.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -110.45 101.35 10.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.221 -1.029 . . . . 71.1 108.221 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 64.0 m-85 -69.72 -30.09 67.63 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.454 -0.794 . . . . 72.41 110.923 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 123.671 0.788 . . . . 74.41 110.7 177.763 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 C--O 1.242 0.686 0 N-CA-C 108.436 -0.95 . . . . 73.01 108.436 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -149.76 94.95 2.25 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.947 -1.131 . . . . 75.52 107.947 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -117.94 125.87 51.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.314 0.645 . . . . 65.22 109.421 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.37 124.89 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.713 -0.847 . . . . 74.54 108.713 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -87.42 -34.96 18.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.287 -0.634 . . . . 50.41 109.287 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.412 ' HD3' ' OG1' ' C' ' 122' ' ' THR . 17.7 ttm180 -175.64 144.37 0.65 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.102 -0.953 . . . . 75.31 109.357 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.11 130.13 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 106.455 -1.683 . . . . 74.14 106.455 171.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 27.5 p90 -164.52 173.42 12.07 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.834 0.826 . . . . 72.15 111.249 -165.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.26 121.62 41.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.694 -1.139 . . . . 70.3 108.896 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.2 mtpt -85.46 -39.86 17.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.3 0.571 . . . . 75.33 109.732 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 19.9 t70 -149.78 126.76 11.19 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 114.67 -1.15 . . . . 70.04 108.984 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.602 HG21 ' HE1' ' C' ' 117' ' ' MET . 70.0 mt -118.87 147.1 22.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.429 -0.952 . . . . 71.01 108.429 175.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -143.77 136.01 26.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.21 1.004 . . . . 72.41 109.097 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.504 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.3 t80 -140.28 117.63 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.126 -1.805 . . . . 74.54 106.126 168.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -123.71 122.35 37.87 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.269 0.628 . . . . 74.44 109.811 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.38 81.26 3.9 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 107.181 -1.415 . . . . 75.34 107.181 168.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.2 -33.47 18.64 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.734 2.289 . . . . 71.24 112.116 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -111.66 29.76 7.57 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 108.768 -0.827 . . . . 65.2 108.768 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.423 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -46.39 -61.52 2.57 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 114.989 1.477 . . . . 71.24 114.989 -166.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.491 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.1 Cg_endo -81.81 -13.03 10.73 Favored 'Trans proline' 0 C--N 1.378 2.089 0 CA-C-N 121.54 1.586 . . . . 74.51 113.329 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -69.35 -41.38 76.68 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.859 0.864 . . . . 75.23 109.249 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' D' ' 35' ' ' ASP . 36.1 t -70.8 -35.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 CA-C-N 114.909 -1.041 . . . . 75.45 109.98 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -64.36 -6.79 7.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.969 1.1 . . . . 73.1 113.969 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -84.62 -35.46 22.67 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.027 0.531 . . . . 74.12 109.915 170.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -128.7 60.09 1.53 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.114 0.966 . . . . 72.33 110.352 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . 0.495 ' HB2' HG11 ' D' ' 31' ' ' VAL . 5.7 t0 -110.08 94.56 5.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.737 . . . . 75.41 109.463 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.525 ' H ' HD23 ' D' ' 68' ' ' LEU . 10.8 m95 -124.4 -159.5 0.88 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.927 -1.508 . . . . 73.25 106.927 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -63.35 112.32 6.79 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 118.374 0.534 . . . . 73.32 111.558 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.54 151.78 13.36 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.111 2.541 . . . . 71.32 112.313 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.89 113.68 20.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.996 -0.742 . . . . 73.43 108.996 166.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -99.28 106.37 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.074 0.95 . . . . 72.55 109.602 -176.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.0 mmtt -88.31 128.76 35.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.349 1.06 . . . . 75.5 108.952 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.05 113.05 24.8 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.532 -0.544 . . . . 75.51 109.532 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -122.94 115.75 22.45 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.892 -0.781 . . . . 63.24 108.892 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.96 145.75 31.88 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.28 0.632 . . . . 72.31 109.973 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -137.15 131.31 32.39 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.364 1.066 . . . . 73.31 108.511 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 56.6 p -105.71 144.67 32.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.469 0.708 . . . . 73.14 110.195 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.22 155.03 35.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.498 0.719 . . . . 52.53 109.885 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -164.07 153.27 13.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.781 0.832 . . . . 54.21 109.883 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.9 p -160.47 151.77 19.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 70.32 110.101 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -81.8 118.57 22.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.078 0.551 . . . . 71.03 109.688 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.518 HD13 HG22 ' D' ' 83' ' ' ILE . 77.3 mt -92.34 -31.3 15.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.339 0.656 . . . . 74.35 110.488 177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.02 -179.34 7.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.277 0.631 . . . . 73.2 110.707 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.58 116.92 5.57 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.702 -1.135 . . . . 74.51 110.117 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.58 ' HB3' ' HB1' ' D' ' 87' ' ' ALA . 11.7 m-20 60.47 24.66 14.27 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.258 0.974 . . . . 73.12 111.539 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.48 116.54 44.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.053 -1.092 . . . . 75.45 108.053 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.533 ' HB2' HD13 ' D' ' 86' ' ' ILE . 96.8 m-85 -129.82 129.03 43.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.335 1.054 . . . . 74.51 108.738 -174.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -90.32 139.1 30.99 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.989 0.915 . . . . 73.12 109.744 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.45 117.28 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 107.354 -1.35 . . . . 74.43 107.354 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.7 t -100.18 128.82 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.279 -1.008 . . . . 74.43 108.279 172.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 107.23 12.55 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.769 -1.197 . . . . 74.42 107.769 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.572 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 16.1 ttm-85 -87.17 105.71 17.38 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.218 -0.901 . . . . 75.21 109.566 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.22 120.47 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.685 -0.857 . . . . 73.44 108.685 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.3 m -125.84 135.85 52.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.705 0.802 . . . . 75.21 109.137 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.494 HG12 HD11 ' D' ' 126' ' ' LEU . 44.0 t -129.95 117.95 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.436 1.094 . . . . 65.13 109.68 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 57.0 m -105.57 100.6 10.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.135 0.974 . . . . 62.33 110.093 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.71 125.15 40.97 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.234 -0.291 . . . . 51.44 110.773 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.5 m -138.94 123.32 18.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.841 0.856 . . . . 61.11 109.611 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.6 OUTLIER -103.07 128.09 50.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.354 0.662 . . . . 71.31 109.852 177.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.24 -111.73 3.95 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.95 -0.86 . . . . 72.2 110.95 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.81 5.68 11.49 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.56 0.744 . . . . 73.44 110.877 175.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.04 140.28 50.3 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.1 0.56 . . . . 75.4 110.449 -172.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.8 m -71.98 117.38 13.52 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.607 0.763 . . . . 75.51 111.115 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.594 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -68.45 -65.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.279 0.987 . . . . 70.44 109.914 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -154.51 156.64 37.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.408 -1.269 . . . . 75.52 110.406 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.84 145.93 47.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.747 1.219 . . . . 72.15 107.714 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' D' ' 114' ' ' ILE . 49.6 t -150.75 142.11 23.35 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.622 -0.51 . . . . 64.02 109.622 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.04 138.31 14.75 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.988 -0.745 . . . . 74.4 108.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.64 115.57 8.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.331 -0.989 . . . . 74.2 108.331 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.572 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 66.4 mt-30 -88.97 84.49 6.62 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.099 -1.074 . . . . 70.43 108.099 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.52 93.45 5.43 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.208 -0.906 . . . . 70.51 109.031 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.69 142.29 16.55 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.802 -0.919 . . . . 65.13 110.802 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.423 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.99 128.59 3.48 Favored Glycine 0 CA--C 1.499 -0.919 0 N-CA-C 110.327 -1.109 . . . . 72.13 110.327 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.518 HG22 HD13 ' D' ' 51' ' ' LEU . 39.7 mt -90.93 132.3 35.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.701 0.801 . . . . 74.24 109.061 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -134.01 133.43 41.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.88 0.472 . . . . 75.32 110.157 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -79.11 98.88 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.486 0.714 . . . . 64.34 109.27 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' D' ' 56' ' ' TYR . 48.2 mt -109.08 106.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.907 0.883 . . . . 74.3 109.506 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' D' ' 54' ' ' ASP . . . -144.07 148.54 35.31 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.048 0.939 . . . . 72.43 110.092 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.48 -20.82 44.28 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.842 -0.421 . . . . 54.32 113.438 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.488 ' HB ' ' HG3' ' D' ' 94' ' ' MET . 0.4 OUTLIER -106.39 139.76 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.675 -1.231 . . . . 71.23 107.675 179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.77 157.85 41.72 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.15 0.58 . . . . 74.45 111.425 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -134.96 51.81 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.597 1.186 . . . . 70.14 115.782 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -63.82 -29.17 70.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.235 1.014 . . . . 74.25 111.841 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -40.5 77.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.624 0.77 . . . . 64.41 109.216 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.488 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 9.9 ttp -75.92 -41.99 50.21 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.813 -0.631 . . . . 73.44 110.773 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.21 69.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.884 0.874 . . . . 73.41 111.2 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -66.23 -46.63 76.52 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.143 -0.48 . . . . 71.44 109.996 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.62 -36.61 78.88 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.017 0.527 . . . . 72.51 111.276 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.573 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.1 tt -77.45 -30.75 53.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.394 0.678 . . . . 70.35 110.02 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.06 -16.44 55.96 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.127 -0.488 . . . . 72.12 113.663 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.09 -64.32 1.32 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.398 0.599 . . . . 75.11 111.289 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -66.03 -47.27 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.151 0.58 . . . . 64.25 111.414 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 58.0 m -61.43 -48.47 90.72 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.348 -0.834 . . . . 70.23 112.731 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.2 Cg_exo -54.9 -39.41 90.45 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.76 2.306 . . . . 73.44 113.91 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -72.47 -14.04 61.58 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.298 0.639 . . . . 62.34 112.541 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -81.09 -40.95 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 121.597 0.713 . . . . 73.53 109.864 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.423 HD22 ' HA3' ' D' ' 82' ' ' GLY . 71.9 mt -78.46 -31.75 48.08 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.909 -1.041 . . . . 75.43 111.802 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -63.72 -42.1 69.39 Favored Pre-proline 0 CA--C 1.56 1.361 0 N-CA-C 114.146 1.165 . . . . 75.33 114.146 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.45 -43.67 55.57 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.152 1.901 . . . . 70.12 113.132 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -74.98 -31.71 61.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.662 0.785 . . . . 74.13 111.891 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.62 -54.53 34.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.068 0.547 . . . . 60.22 109.797 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -56.73 -46.57 81.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 114.091 -1.413 . . . . 72.4 110.899 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.63 -44.49 90.36 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.104 0.878 . . . . 74.12 111.214 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.5 t -58.61 -41.36 85.69 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.533 0.52 . . . . 74.05 110.947 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.568 HG21 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -62.32 -53.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.939 0.896 . . . . 73.23 110.369 174.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -53.84 -42.95 69.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.725 1.21 . . . . 71.02 111.426 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -66.97 -44.65 79.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.754 -1.112 . . . . 65.22 110.654 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.507 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.1 mtm -66.32 -33.76 76.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.863 0.465 . . . . 73.35 111.656 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.3 t -67.78 -43.3 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.545 -0.752 . . . . 73.31 109.919 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.35 -28.9 64.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.751 0.42 . . . . 73.44 111.699 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -75.04 -32.06 61.46 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.924 0.89 . . . . 75.22 110.085 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.14 5.66 75.48 Favored Glycine 0 C--N 1.356 1.676 0 CA-C-N 115.586 -0.734 . . . . 62.43 111.853 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 65.54 14.15 9.31 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.488 2.315 . . . . 73.32 114.257 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -84.89 158.28 59.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.207 1.003 . . . . 75.21 108.867 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.11 136.74 49.26 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.871 2.381 . . . . 74.04 112.175 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -47.19 129.92 12.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.488 1.115 . . . . 74.24 112.135 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.494 HD11 HG12 ' D' ' 64' ' ' VAL . 5.1 tt -107.22 93.93 4.82 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.234 -1.024 . . . . 61.42 108.234 -170.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -105.09 100.47 10.07 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.9 -1.148 . . . . 73.22 107.9 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.427 HD12 ' H ' ' D' ' 129' ' ' ALA . 20.5 tp -75.86 141.46 42.4 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.004 0.522 . . . . 73.13 110.814 177.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.427 ' H ' HD12 ' D' ' 128' ' ' LEU . . . -56.24 132.84 75.5 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.447 1.099 . . . . 73.24 111.326 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.0 116.65 4.8 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.448 2.099 . . . . 75.32 110.363 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.48 138.44 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.477 0.711 . . . . 63.34 109.577 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -79.97 103.55 9.94 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.602 0.761 . . . . 73.23 110.02 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.478 0.972 0 C-N-CA 123.33 0.652 . . . . 74.23 111.406 177.693 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.9 m . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.104 -0.702 . . . . 74.11 109.104 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.4 t80 -137.2 122.84 19.79 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.623 -1.251 . . . . 72.42 107.623 166.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -146.74 129.61 16.27 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.161 -0.681 . . . . 64.43 109.161 173.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.635 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.7 mt -86.24 119.85 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 109.437 -0.579 . . . . 71.11 109.437 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.5 -40.38 13.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.062 0.945 . . . . 74.51 109.281 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -166.42 141.7 4.51 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.533 -166.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER -131.87 126.31 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.032 -1.47 . . . . 73.41 107.032 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 24.6 p90 -161.08 152.55 19.16 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.512 0.672 . . . . 73.52 111.491 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -76.57 107.87 9.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.614 -1.176 . . . . 74.51 108.161 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.5 mtpt -67.26 -33.15 74.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.198 0.523 . . . . 75.13 109.603 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.4 t70 -153.12 144.16 22.99 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.193 -1.367 . . . . 74.22 109.682 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -133.06 143.64 38.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.941 1.296 . . . . 65.21 107.863 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 44.0 t -147.21 126.89 13.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.855 0.862 . . . . 54.13 109.171 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 87.2 t80 -127.93 126.68 41.95 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.892 -1.892 . . . . 75.25 105.892 168.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -133.95 116.6 15.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.016 -0.735 . . . . 71.42 109.016 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.417 ' HB3' ' HB1' ' A' ' 28' ' ' ALA . . . -127.55 74.45 77.96 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.573 -1.269 . . . . 75.24 107.573 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.13 -43.63 2.25 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.553 2.169 . . . . 74.21 111.127 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -89.4 12.15 17.14 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 118.057 -0.973 . . . . 75.23 111.414 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 25' ' ' ALA . . . -44.76 -56.26 9.0 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.136 -0.935 . . . . 62.05 112.372 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.75 -22.97 64.15 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.579 2.186 . . . . 74.21 113.888 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 -31.58 12.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.746 0.818 . . . . 75.14 110.503 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.58 -17.02 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 120.895 0.379 . . . . 72.22 110.165 -170.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . 0.436 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 21.9 m-85 -73.86 -30.4 62.63 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.61 0.764 . . . . 74.25 111.807 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -85.37 -12.86 51.15 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.485 0.314 . . . . 74.54 111.364 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 31.4 mmtp -79.16 152.24 30.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.311 0.644 . . . . 73.13 110.872 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.05 140.18 58.81 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.22 0.95 . . . . 71.42 109.623 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.436 ' HH2' ' HA ' ' A' ' 32' ' ' PHE . 32.2 m95 -74.28 83.47 1.89 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.689 0.796 . . . . 73.21 110.912 -173.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -134.56 71.23 71.45 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.575 1.15 . . . . 73.52 109.609 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.32 127.76 5.3 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.009 1.806 . . . . 75.43 112.174 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.9 88.82 5.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 106.423 -1.695 . . . . 64.12 106.423 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -82.22 114.72 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.761 -1.109 . . . . 74.34 111.11 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 88.3 mttt -80.18 152.86 28.95 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.454 1.102 . . . . 74.12 110.84 167.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.1 tt -122.72 109.61 14.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.539 -2.022 . . . . 74.42 105.539 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.665 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -117.77 107.73 14.51 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.793 -0.817 . . . . 74.02 108.793 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -99.06 150.45 21.99 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.321 -0.622 . . . . 74.01 109.321 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 30.1 t70 -145.5 136.6 24.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.678 0.791 . . . . 63.3 109.39 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -121.76 126.76 49.61 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.684 0.794 . . . . 75.33 110.942 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.3 113.56 4.57 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.366 0.667 . . . . 70.13 110.193 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.9 p -98.77 162.3 13.18 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.683 -0.488 . . . . 71.24 109.683 173.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 41.2 t -152.94 158.07 41.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.321 1.048 . . . . 71.4 109.196 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -114.07 126.3 54.96 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.944 -1.132 . . . . 72.34 107.944 166.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -93.5 -41.53 9.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.011 0.525 . . . . 75.53 110.25 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.25 178.75 9.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.866 0.866 . . . . 74.42 109.702 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.85 123.13 18.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.991 -0.744 . . . . 73.14 108.991 171.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 73.02 -7.23 1.53 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.796 1.638 . . . . 64.3 112.237 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.7 111.45 35.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.286 -1.005 . . . . 64.24 108.286 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -123.38 161.06 25.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.274 -0.639 . . . . 65.43 109.274 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 41.3 tt0 -131.56 138.99 49.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.859 -1.064 . . . . 74.54 108.784 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.46 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.9 t -126.22 117.02 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.849 -1.538 . . . . 75.51 106.849 169.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.416 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 t -101.23 130.45 50.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.986 -0.746 . . . . 72.43 108.986 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 106' ' ' LEU . 3.8 mm? -117.57 109.78 17.12 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.212 -1.032 . . . . 75.12 108.212 170.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.629 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 13.2 ttp180 -85.57 112.64 21.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.108 -0.701 . . . . 74.31 109.108 172.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.0 t -94.2 128.62 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 107.359 -1.348 . . . . 74.44 107.359 170.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 47.3 m -127.05 126.5 43.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.213 -1.032 . . . . 74.3 108.213 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.559 HG12 HD21 ' A' ' 126' ' ' LEU . 44.9 t -118.75 109.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.46 -0.941 . . . . 74.31 108.46 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.3 m -103.71 133.28 48.98 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.292 -0.632 . . . . 74.03 109.292 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.37 31.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.439 -1.319 . . . . 72.22 107.439 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 55.6 m -135.93 127.91 29.56 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.819 0.447 . . . . 71.23 110.479 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -88.83 72.28 8.56 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.917 -1.142 . . . . 74.3 107.917 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.24 -84.46 0.83 Allowed Glycine 0 C--N 1.35 1.333 0 CA-C-N 114.934 -1.03 . . . . 71.41 110.713 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -110.88 -29.22 8.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 74.01 109.86 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.538 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 3.3 tp10 -82.89 91.48 7.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.721 0.809 . . . . 74.14 110.322 -173.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 86.5 m -64.71 130.89 45.26 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.284 0.564 . . . . 75.21 111.495 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.53 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -78.29 -63.36 1.42 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.91 -1.041 . . . . 74.34 110.011 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -162.04 170.94 18.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.467 -1.242 . . . . 73.32 110.97 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.4 tp -142.62 113.77 7.69 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.551 -1.204 . . . . 74.22 108.284 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.4 m -113.42 100.87 8.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.387 0.675 . . . . 71.34 110.77 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 31.4 tt0 -119.16 118.65 31.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.285 1.034 . . . . 71.04 109.617 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.12 112.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.236 1.015 . . . . 72.23 109.224 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 49.7 mt-30 -84.24 84.47 7.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.686 -0.857 . . . . 73.34 108.686 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.85 97.89 7.59 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.775 -1.102 . . . . 71.21 108.592 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.22 146.64 18.34 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.723 -0.671 . . . . 71.14 111.524 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.23 137.87 9.11 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 110.716 -0.954 . . . . 74.33 110.716 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -93.02 123.72 45.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.806 -0.813 . . . . 70.14 108.806 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.635 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.8 m-85 -132.56 118.64 19.48 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.71 -1.219 . . . . 74.3 107.71 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.3 p -81.68 98.52 8.43 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.327 -0.62 . . . . 75.12 109.327 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 10' ' ' THR . 2.8 pp -113.24 160.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.417 0.687 . . . . 74.15 111.258 -175.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.37 174.58 2.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.001 1.32 . . . . 71.2 109.495 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.08 -6.48 49.36 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 115.514 0.966 . . . . 75.11 115.514 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -126.18 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.216 -1.031 . . . . 65.23 108.216 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -133.16 173.74 11.12 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.692 0.797 . . . . 75.34 109.461 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.34 -139.45 47.4 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.702 0.626 . . . . 73.41 113.737 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -72.9 -18.63 61.39 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.595 0.758 . . . . 72.21 111.208 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.47 -36.63 76.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.599 0.76 . . . . 64.52 110.323 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.78 -42.19 41.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.943 0.497 . . . . 74.24 109.777 173.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -16.88 64.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.431 -0.804 . . . . 75.12 112.682 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 52.9 t-80 -68.9 -28.72 66.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.953 0.501 . . . . 73.5 110.15 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.2 t -78.01 -39.2 42.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.064 0.546 . . . . 75.35 110.008 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.66 -51.77 56.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.354 0.662 . . . . 74.31 112.081 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.56 4.91 47.46 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.424 -0.807 . . . . 74.31 114.33 -164.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 96' ' ' HIS . . . -144.91 -63.8 0.35 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 117.281 0.541 . . . . 75.01 112.388 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.494 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 82.0 t80 -71.05 -57.1 4.86 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.901 0.704 . . . . 75.35 112.901 -169.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 88.5 m -67.4 -32.28 4.4 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 118.189 -0.91 . . . . 73.11 112.882 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.28 -50.12 12.79 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.413 2.075 . . . . 62.51 112.876 159.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -61.35 -25.01 66.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.656 0.782 . . . . 73.02 111.957 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -76.68 -48.92 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 75.44 110.111 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 60' ' ' LEU . 95.8 mt -81.18 -23.01 38.48 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.446 0.698 . . . . 73.43 112.214 -170.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.34 -42.57 59.47 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.216 1.006 . . . . 75.44 112.957 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 -32.11 85.47 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.83 1.687 . . . . 63.11 113.077 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -74.22 -39.65 62.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.209 0.603 . . . . 74.41 111.618 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.47 78.32 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.419 -0.586 . . . . 72.13 109.419 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -54.37 -46.27 72.98 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.777 1.298 . . . . 74.24 110.728 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.54 -48.47 77.36 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.295 0.997 . . . . 72.43 110.552 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.54 -45.25 85.29 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.772 0.67 . . . . 62.23 110.697 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.411 ' O ' HG21 ' A' ' 118' ' ' VAL . 91.8 mt -60.29 -52.58 59.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 114.855 -1.066 . . . . 74.43 110.05 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.538 HG21 ' HG3' ' A' ' 125' ' ' GLN . 78.4 m -53.19 -46.22 68.91 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.919 0.888 . . . . 74.21 111.515 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -64.88 -47.51 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.179 -0.919 . . . . 71.45 110.034 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 13.4 mtp -54.58 -43.7 72.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.09 0.956 . . . . 72.1 111.449 175.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 114' ' ' ILE . 67.5 t -65.9 -47.16 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.862 1.265 . . . . 75.54 111.312 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.5 p -66.69 -32.66 74.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.095 0.558 . . . . 75.44 111.264 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.17 -33.08 74.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.753 0.821 . . . . 74.04 110.49 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.58 20.43 18.61 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.08 -0.845 . . . . 72.31 114.28 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 48.39 47.35 20.04 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.366 1.466 . . . . 73.3 112.352 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -117.05 149.84 44.95 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 107.777 -1.194 . . . . 72.25 107.777 169.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.48 153.68 77.1 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.189 1.926 . . . . 72.41 110.392 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.538 ' HG3' HG21 ' A' ' 115' ' ' THR . 31.8 tt0 -51.1 126.9 17.68 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.332 1.02 . . . . 75.14 111.995 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.559 HD21 HG12 ' A' ' 64' ' ' VAL . 33.3 tp -110.19 94.66 5.13 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.205 -0.907 . . . . 75.42 109.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -111.91 104.32 12.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.405 -1.27 . . . . 72.5 107.968 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.74 128.04 34.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.943 -1.132 . . . . 72.2 107.943 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.26 144.13 8.7 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 124.208 1.003 . . . . 63.32 111.709 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.411 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 40.9 Cg_exo -58.52 110.0 0.59 Allowed 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.644 2.229 . . . . 73.51 112.064 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 t -101.07 112.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.737 -0.838 . . . . 73.32 108.737 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.98 85.21 5.61 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.662 0.785 . . . . 64.52 109.537 174.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -59.48 -32.86 70.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.666 0.787 . . . . 73.3 111.366 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 124.125 0.97 . . . . 72.22 111.184 177.634 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.516 HG21 HE22 ' B' ' 12' ' ' GLN . 82.2 m . . . . . 0 C--O 1.238 0.451 0 N-CA-C 107.858 -1.164 . . . . 73.01 107.858 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -132.94 136.74 46.29 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.558 -0.534 . . . . 65.24 109.558 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.516 HE22 HG21 ' B' ' 10' ' ' THR . 0.2 OUTLIER -152.05 139.52 19.57 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.281 1.032 . . . . 74.55 108.954 171.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -83.42 144.55 9.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.738 -0.838 . . . . 74.1 108.738 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -103.63 -43.35 5.39 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.17 0.588 . . . . 64.42 110.194 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -166.99 134.88 2.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.866 -0.606 . . . . 71.22 109.673 -171.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.5 mt -118.52 133.78 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 106.831 -1.544 . . . . 73.24 106.831 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -164.64 147.13 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.65 0.593 . . . . 73.53 112.098 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.8 m -73.25 124.47 25.72 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.343 -0.844 . . . . 73.44 108.879 170.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -97.95 -32.93 11.41 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.923 0.489 . . . . 73.42 110.89 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -152.81 140.99 20.44 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.338 -0.392 . . . . 73.42 110.361 -171.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.425 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.3 mm -132.88 137.33 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.212 1.005 . . . . 74.43 109.292 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.4 m -133.69 112.04 11.08 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.986 1.315 . . . . 74.42 108.444 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -130.5 110.02 11.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.053 -1.462 . . . . 73.24 107.053 167.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.66 111.9 18.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.431 -0.952 . . . . 74.2 108.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.92 85.56 14.96 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.296 -1.002 . . . . 63.01 108.296 172.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.91 -22.9 35.45 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.515 2.144 . . . . 73.24 111.388 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.83 13.84 25.99 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.653 1.181 . . . . 73.23 110.656 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' A' ' 17' ' ' TYR . . . -45.21 -51.62 24.16 Favored Pre-proline 0 CA--C 1.57 1.732 0 N-CA-C 114.3 1.222 . . . . 73.22 114.3 -175.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.5 -46.37 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 CA-C-N 121.511 1.575 . . . . 74.43 112.965 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -77.66 3.34 14.15 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.814 1.042 . . . . 70.4 113.814 -171.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.546 HG23 HD11 ' B' ' 68' ' ' LEU . 14.7 p -73.62 -30.64 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 109.63 -0.507 . . . . 63.32 109.63 171.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.54 -31.27 61.99 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 125.145 1.378 . . . . 75.3 112.993 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.409 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.5 pt20 -63.76 -50.37 69.32 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.367 0.417 . . . . 73.5 110.886 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.49 ' HZ3' ' HG2' ' B' ' 71' ' ' GLU . 54.1 pttt -116.48 60.31 0.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.943 0.897 . . . . 75.45 110.501 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -101.27 119.74 39.21 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.762 -0.586 . . . . 74.12 109.648 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.35 -167.93 0.14 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.071 1.482 . . . . 75.42 108.984 163.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.91 105.45 0.49 Allowed Pre-proline 0 CA--C 1.566 1.581 0 C-N-CA 124.421 1.089 . . . . 65.22 112.783 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.02 169.66 2.89 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.526 2.818 . . . . 75.13 113.066 -173.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.86 107.84 5.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 61.31 108.652 172.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' B' ' 65' ' ' THR . 16.2 m -105.71 141.01 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.678 -0.692 . . . . 75.11 110.77 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -126.79 121.96 33.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.984 0.914 . . . . 73.04 109.06 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 tp -98.44 124.59 43.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.683 0.793 . . . . 73.15 108.984 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.752 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.7 m-20 -125.47 118.73 26.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.982 0.913 . . . . 72.2 108.626 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.2 126.44 46.48 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.405 -1.331 . . . . 75.55 107.405 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.83 139.4 46.23 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 74.45 109.216 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -117.74 113.74 22.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.279 0.632 . . . . 74.12 110.787 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.61 147.78 42.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.39 1.076 . . . . 61.32 108.23 172.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.5 p -145.95 174.33 11.36 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 118.064 0.393 . . . . 60.34 111.546 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.9 p -153.32 145.11 23.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.385 1.074 . . . . 72.43 109.248 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -97.28 104.2 16.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.502 -0.555 . . . . 71.14 109.502 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.64 -42.49 51.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.16 0.584 . . . . 74.1 110.943 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.12 -179.95 7.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.111 0.965 . . . . 72.51 109.306 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.23 123.41 21.59 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.514 -0.766 . . . . 61.44 109.31 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 74.33 -3.1 2.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.82 1.648 . . . . 70.35 112.838 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -106.34 114.1 44.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.498 -0.927 . . . . 75.05 108.498 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -116.29 139.87 49.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.793 -0.818 . . . . 63.13 108.793 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -111.87 99.92 8.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.418 -1.327 . . . . 72.11 107.418 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.41 127.87 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.908 0.883 . . . . 61.35 110.277 -174.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.548 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.6 t -111.97 112.37 40.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 124.912 1.285 . . . . 75.42 108.738 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 106.0 18.17 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.667 -0.864 . . . . 63.33 108.667 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -86.03 123.85 31.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.576 -0.738 . . . . 73.35 109.535 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.44 105.76 19.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.709 -1.219 . . . . 64.43 107.709 168.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 32.4 m -94.42 137.49 33.49 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.659 -0.867 . . . . 74.23 108.659 176.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.94 130.14 61.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.429 -1.323 . . . . 71.14 107.429 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 97.1 m -120.04 144.93 47.29 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.528 -0.915 . . . . 75.1 108.528 173.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.61 134.11 40.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.806 -1.183 . . . . 62.3 107.806 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 61.2 p -147.36 133.91 19.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.297 0.639 . . . . 74.45 109.976 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -125.48 138.27 53.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.564 0.746 . . . . 74.23 110.016 177.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -127.69 9.03 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.213 -0.903 . . . . 75.35 111.444 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.98 11.35 29.89 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.129 0.972 . . . . 74.35 111.932 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.49 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 17.0 pt-20 -154.88 -179.49 8.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.585 0.354 . . . . 75.24 110.986 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -64.18 154.39 34.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 75.45 112.424 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.581 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -103.91 -60.35 1.59 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.774 -1.195 . . . . 73.01 107.774 166.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -166.34 164.39 17.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.346 -1.297 . . . . 72.55 109.161 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 29.4 mt -123.65 135.84 54.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.129 -1.434 . . . . 74.1 107.129 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 48.7 t -144.96 131.58 19.91 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.083 -0.71 . . . . 53.2 109.083 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.645 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.7 tt0 -156.22 143.65 19.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.615 -0.883 . . . . 71.34 108.615 -170.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.69 146.9 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.555 -0.905 . . . . 64.12 108.555 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -121.58 95.61 4.74 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.628 -1.249 . . . . 73.13 107.628 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.3 tp-100 -89.0 101.05 13.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.642 -0.873 . . . . 73.22 108.642 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.45 168.74 36.81 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.749 0.656 . . . . 64.45 111.874 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.54 127.74 1.48 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.574 -0.611 . . . . 71.14 111.574 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -84.46 128.86 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.053 -1.091 . . . . 73.22 108.053 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.64 163.51 29.59 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.835 1.254 . . . . 74.24 108.853 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -131.87 113.11 13.07 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.66 -0.867 . . . . 73.32 108.66 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.39 129.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.7 -0.852 . . . . 74.12 108.7 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.28 170.1 18.01 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.582 1.153 . . . . 71.53 108.857 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -70.8 3.02 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.803 -0.519 . . . . 54.04 111.803 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -87.55 152.22 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.166 0.586 . . . . 75.22 110.553 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 14.4 pt-20 -158.69 175.86 13.1 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.696 0.623 . . . . 74.02 111.822 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.69 -130.09 28.04 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.006 -0.997 . . . . 74.44 113.857 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.7 m -65.52 -32.9 74.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.158 0.983 . . . . 75.11 110.833 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -75.41 -31.09 60.29 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.922 -1.035 . . . . 75.12 109.933 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.491 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 26.3 ttt -70.13 -32.4 70.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.908 -0.405 . . . . 74.11 109.908 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.33 -25.42 61.93 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.059 0.543 . . . . 71.22 112.133 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 55.5 t-80 -79.56 -26.49 41.35 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.481 0.713 . . . . 75.12 111.157 173.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -79.15 -65.66 0.97 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.755 0.422 . . . . 65.35 110.407 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.7 pp -63.53 -21.4 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.622 0.769 . . . . 74.42 112.776 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . 0.467 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -107.06 3.62 35.53 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 114.431 0.532 . . . . 61.14 114.431 -172.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -151.32 -51.92 0.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.903 0.352 . . . . 73.2 111.725 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.549 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 29.5 t80 -68.65 -48.49 63.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.763 0.825 . . . . 74.3 110.646 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.447 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 56.1 m -68.89 -46.51 31.94 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.186 0.594 . . . . 65.14 111.466 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -55.38 -35.16 91.18 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 122.686 2.257 . . . . 72.25 114.003 168.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.64 -35.32 74.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.357 0.663 . . . . 73.31 110.881 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.6 -51.13 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.303 -0.862 . . . . 74.33 110.146 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.31 -23.94 54.33 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.564 0.746 . . . . 73.1 112.667 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.93 -50.71 79.84 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 117.567 -1.206 . . . . 65.33 113.125 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.77 -40.5 74.21 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.643 2.229 . . . . 71.51 113.911 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.5 m-85 -69.86 -45.58 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.411 0.684 . . . . 75.44 110.591 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.48 86.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.547 0.739 . . . . 72.02 110.859 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.642 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 32.1 ttt180 -63.28 -54.63 34.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.758 1.623 . . . . 73.54 110.994 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -36.98 81.66 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.226 0.954 . . . . 73.32 109.663 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -69.0 -38.95 79.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.756 -0.656 . . . . 72.42 111.951 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.27 -51.94 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.129 0.572 . . . . 74.4 109.463 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.612 HG23 ' HB2' ' B' ' 125' ' ' GLN . 29.6 m -61.37 -28.25 69.1 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.323 -0.853 . . . . 74.11 111.498 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.4 t -69.47 -43.29 73.52 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.514 0.726 . . . . 75.4 110.22 176.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -73.27 -30.68 63.6 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.582 0.353 . . . . 74.24 111.129 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.77 -39.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 73.14 109.704 172.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.4 t -62.99 -35.72 81.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.374 1.07 . . . . 73.5 111.294 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.426 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 82.3 mtt-85 -75.99 -31.04 58.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.831 0.852 . . . . 74.11 110.716 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -0.77 86.58 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 123.572 0.545 . . . . 54.53 112.469 171.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 17' ' ' TYR . 48.9 p 62.57 32.68 16.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.512 1.925 . . . . 71.4 112.512 173.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' B' ' 31' ' ' VAL . 40.6 m-85 -101.71 151.94 38.0 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 115.095 -0.957 . . . . 74.31 110.479 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.55 119.0 5.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.67 2.247 . . . . 75.22 110.635 172.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.612 ' HB2' HG23 ' B' ' 115' ' ' THR . 19.9 pt20 -60.42 152.26 26.0 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.231 1.012 . . . . 74.24 113.175 -168.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 pp -112.26 120.81 43.01 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.544 -1.28 . . . . 73.12 107.544 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -93.33 104.37 16.53 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.469 -0.938 . . . . 72.44 108.469 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.642 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -58.25 118.41 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.67 -0.863 . . . . 74.12 108.67 175.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.03 144.89 59.95 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 109.837 -0.431 . . . . 74.31 109.837 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -64.12 110.36 1.33 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.954 2.436 . . . . 65.44 112.381 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.68 112.79 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.421 -1.326 . . . . 71.31 107.421 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.22 75.45 4.75 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.191 -1.04 . . . . 73.02 108.191 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 125.058 1.343 . . . . 74.54 111.581 -172.619 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.54 0.686 . . . . 75.13 112.129 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.3 m -125.68 107.91 11.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.883 -0.784 . . . . 71.13 108.883 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.411 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 61.1 t80 -123.18 133.84 54.21 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.079 0.952 . . . . 74.14 108.432 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.18 144.49 21.08 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.42 0.688 . . . . 73.31 110.036 166.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.526 HG23 ' HE2' ' C' ' 84' ' ' PHE . 2.9 pp -65.23 141.35 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.073 -0.967 . . . . 73.53 109.313 171.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.548 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.3 mm-40 -112.07 -50.62 2.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.681 -0.489 . . . . 73.43 109.681 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -168.24 123.7 0.99 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.175 -0.676 . . . . 71.41 109.175 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.28 145.61 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.262 -1.385 . . . . 75.45 107.262 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' D' ' 28' ' ' ALA . 35.0 p90 -176.88 168.49 2.49 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.842 0.83 . . . . 75.02 111.242 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -90.12 113.41 25.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.532 -1.213 . . . . 71.32 108.725 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.66 -38.61 89.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.354 0.662 . . . . 75.43 109.793 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.57 144.48 26.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.812 -1.086 . . . . 71.44 109.257 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.1 mt -134.83 137.89 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.006 -1.479 . . . . 72.33 107.006 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -149.5 150.73 32.77 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.31 0.644 . . . . 75.03 109.495 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -154.23 135.31 13.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.74 -1.207 . . . . 74.21 107.74 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.7 mt-10 -131.43 117.74 19.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.044 -0.724 . . . . 75.21 109.044 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.8 72.46 55.53 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.352 -0.981 . . . . 73.1 108.352 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.06 -15.68 25.83 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.576 2.184 . . . . 72.04 111.912 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . 0.447 ' O ' HG23 ' C' ' 31' ' ' VAL . 2.0 m-20 -105.18 18.4 22.39 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.356 1.062 . . . . 65.14 110.093 178.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.24 -48.82 54.67 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 114.356 1.243 . . . . 74.54 114.356 -171.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.43 ' HB3' HD12 ' D' ' 51' ' ' LEU . 13.5 Cg_exo -68.59 -38.35 11.05 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 121.818 1.679 . . . . 64.53 111.815 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -67.66 -22.68 65.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.406 1.482 . . . . 74.31 112.381 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.447 HG23 ' O ' ' C' ' 27' ' ' ASN . 78.2 t -65.91 -37.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.813 0.445 . . . . 72.13 111.952 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -69.65 -28.67 66.08 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 111.976 0.361 . . . . 72.2 111.976 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -87.8 12.92 11.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.208 0.603 . . . . 74.32 111.656 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.49 ' HD2' HD21 ' C' ' 68' ' ' LEU . 5.4 ttpm? -112.93 148.98 33.86 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.822 0.849 . . . . 73.13 110.915 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.97 130.24 39.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.147 0.979 . . . . 72.13 109.88 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -85.44 80.85 8.96 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.104 0.962 . . . . 75.12 111.721 -165.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . 0.48 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 1.0 OUTLIER -152.94 44.74 0.26 Allowed Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 114.0 1.111 . . . . 74.31 114.0 173.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.64 ' HA ' ' HB3' ' C' ' 68' ' ' LEU . 22.7 Cg_exo -67.0 149.0 82.75 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 122.253 1.968 . . . . 73.02 111.1 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.48 118.73 25.19 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 170.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.683 HG21 HD11 ' C' ' 126' ' ' LEU . 14.2 p -82.1 142.89 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.992 -1.004 . . . . 75.3 109.537 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -131.8 124.46 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.933 0.893 . . . . 64.52 108.934 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -88.77 129.98 35.45 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 105.764 -1.939 . . . . 75.52 105.764 164.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.01 108.43 10.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.933 -1.136 . . . . 72.24 107.933 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 43.5 tp -96.6 151.96 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.124 0.57 . . . . 71.2 110.265 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.9 t0 -131.15 154.44 48.35 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.908 0.883 . . . . 73.51 108.642 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.5 p -119.64 111.77 18.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.813 0.845 . . . . 70.24 109.586 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.81 146.5 43.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.966 0.906 . . . . 72.22 109.436 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -161.76 152.94 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.055 0.542 . . . . 75.22 110.505 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -149.52 146.03 27.17 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.196 0.598 . . . . 73.15 110.394 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -86.26 124.73 32.97 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.443 -0.576 . . . . 74.01 109.443 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.489 HD13 HD13 ' C' ' 83' ' ' ILE . 70.2 mt -96.53 -44.89 6.96 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.731 0.813 . . . . 74.44 109.78 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.38 -177.19 5.71 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.115 -0.948 . . . . 75.21 109.644 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.83 115.82 3.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.301 0.64 . . . . 64.14 109.886 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 64.48 0.96 1.19 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.205 1.402 . . . . 63.45 113.206 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 94.5 t -94.17 111.09 24.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.885 -1.154 . . . . 74.21 107.885 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -126.86 125.72 42.1 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.182 0.993 . . . . 71.43 109.112 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -84.65 122.62 29.33 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.318 -0.855 . . . . 74.04 109.193 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.13 124.59 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.993 -1.114 . . . . 63.13 107.993 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.64 131.16 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.963 0.905 . . . . 74.54 109.236 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.12 105.74 12.14 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.693 -1.225 . . . . 74.0 107.693 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.8 tmm_? -82.64 108.28 15.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.433 -1.321 . . . . 74.43 107.433 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.4 t -100.23 136.54 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.247 -1.02 . . . . 74.1 108.247 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 59.9 m -134.85 121.32 20.46 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.168 -0.679 . . . . 45.22 109.168 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -103.75 109.27 26.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.951 . . . . 72.42 108.434 174.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.431 HG21 HD23 ' C' ' 75' ' ' LEU . 6.2 m -99.28 150.21 22.34 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.2 -0.909 . . . . 74.33 109.792 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.97 110.09 8.32 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.419 0.688 . . . . 73.14 109.17 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.0 m -148.0 138.64 23.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.924 0.49 . . . . 61.45 110.32 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.64 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.7 OUTLIER -112.41 56.11 0.67 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.405 1.082 . . . . 74.12 108.764 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.44 -116.56 4.4 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.27 -1.332 . . . . 54.22 110.519 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -88.79 -29.03 20.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.195 0.598 . . . . 75.23 110.146 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -79.18 106.14 11.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.999 0.919 . . . . 75.52 110.056 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -78.74 126.01 30.14 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.715 -0.675 . . . . 72.22 109.778 171.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.32 -56.55 4.92 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.666 -1.152 . . . . 73.34 109.437 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -167.75 178.71 5.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.645 0.778 . . . . 74.3 110.691 173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -138.38 143.76 39.95 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.613 1.165 . . . . 75.41 107.956 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 50.2 t -140.2 137.51 34.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.612 -1.255 . . . . 74.02 107.612 173.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -152.88 134.55 14.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.667 0.387 . . . . 75.34 110.601 -173.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.05 120.76 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.684 1.194 . . . . 72.44 108.735 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 72.4 mt-30 -88.42 100.18 12.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.455 -1.313 . . . . 72.42 107.455 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -87.95 112.23 22.33 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.674 -0.491 . . . . 74.02 109.674 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.08 154.11 17.7 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.851 -0.5 . . . . 73.42 111.851 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.424 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -154.11 123.97 1.48 Allowed Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 110.69 -0.964 . . . . 61.34 110.69 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.4 mm -81.38 129.51 37.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 108.452 -0.944 . . . . 74.23 108.452 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.526 ' HE2' HG23 ' C' ' 13' ' ' ILE . 50.4 m-85 -138.02 151.73 48.17 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.399 -0.593 . . . . 74.03 109.399 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.9 p -110.36 117.08 32.66 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.364 -0.976 . . . . 74.24 108.364 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.99 116.71 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.157 0.983 . . . . 72.34 109.597 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.4 163.52 34.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.35 0.66 . . . . 73.34 111.439 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.77 -29.58 7.8 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.401 -0.818 . . . . 72.31 113.977 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.14 157.11 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.166 0.987 . . . . 71.24 111.013 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -149.91 159.67 44.19 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.134 0.974 . . . . 73.25 109.582 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.34 -144.58 17.98 Favored Glycine 0 C--N 1.348 1.246 0 C-N-CA 123.279 0.466 . . . . 71.05 112.458 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -64.5 -21.29 66.63 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.708 0.803 . . . . 71.52 111.677 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -65.8 -52.24 52.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.915 1.286 . . . . 71.2 109.747 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.463 ' HE3' HD12 ' C' ' 98' ' ' LEU . 3.5 ppp? -77.76 -21.6 51.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.612 -0.722 . . . . 71.43 110.515 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.67 70.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.87 0.868 . . . . 73.03 111.82 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -69.85 -34.28 73.4 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.058 170.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -69.59 -43.05 73.58 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.695 0.398 . . . . 72.52 110.73 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.463 HD12 ' HE3' ' C' ' 94' ' ' MET . 0.8 OUTLIER -79.79 -55.09 5.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.969 0.907 . . . . 74.24 110.06 -174.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.03 11.46 69.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.519 -0.764 . . . . 75.42 114.639 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -148.23 -52.02 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.457 0.628 . . . . 74.23 111.84 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -76.27 -41.95 47.18 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.541 0.736 . . . . 74.53 111.203 -173.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 86.6 m -67.36 -47.71 48.01 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 118.517 -0.754 . . . . 73.41 111.478 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.68 -35.8 79.3 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.756 2.304 . . . . 62.45 113.715 169.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.28 -40.23 81.37 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.672 0.789 . . . . 71.21 110.912 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.59 -46.25 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.632 0.773 . . . . 72.23 110.901 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.424 HD22 ' HA3' ' C' ' 82' ' ' GLY . 92.8 mt -82.46 -23.33 34.81 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.163 0.801 . . . . 62.43 113.163 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -57.06 -49.39 94.22 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.162 0.985 . . . . 73.35 112.842 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.21 -33.72 97.83 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.504 2.136 . . . . 72.43 113.982 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.424 ' HE2' HG23 ' A' ' 115' ' ' THR . 95.9 m-85 -70.66 -48.39 55.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.387 0.675 . . . . 64.14 111.285 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.13 89.95 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.472 0.482 . . . . 75.11 109.86 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.497 ' HA ' HD21 ' C' ' 128' ' ' LEU . 31.1 ttt-85 -52.64 -55.98 18.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.251 1.421 . . . . 72.22 111.78 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.11 -32.79 72.45 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.476 0.485 . . . . 71.21 110.546 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -69.39 -33.51 73.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.996 0.518 . . . . 74.14 111.257 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' C' ' 62' ' ' VAL . 90.1 mt -69.22 -52.29 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.73 0.812 . . . . 75.22 109.283 172.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.1 m -59.11 -33.79 71.25 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.272 1.029 . . . . 74.12 111.478 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.7 t -64.14 -48.72 74.95 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.614 0.766 . . . . 71.2 109.41 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.649 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.0 -38.24 90.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.392 1.077 . . . . 64.21 112.404 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.59 -42.37 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 O-C-N 123.559 0.537 . . . . 74.5 109.715 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -66.79 -32.99 74.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.034 0.934 . . . . 74.14 111.68 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.6 mtt-85 -72.12 -31.68 66.25 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.781 0.832 . . . . 73.41 110.76 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.03 8.48 70.12 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 119.521 -0.599 . . . . 71.23 112.715 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p 62.02 34.05 16.84 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.772 1.629 . . . . 65.2 112.408 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . 0.425 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 29.1 m-85 -104.84 163.05 17.98 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 124.803 1.241 . . . . 74.54 109.486 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 63.1 Cg_endo -68.51 162.57 40.24 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.015 2.477 . . . . 71.14 113.502 -173.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' B' ' 125' ' ' GLN . 64.9 mm-40 -60.85 128.05 34.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.116 -0.947 . . . . 75.21 112.721 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.683 HD11 HG21 ' C' ' 40' ' ' VAL . 6.3 tt -140.65 89.28 2.26 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.731 -1.211 . . . . 74.3 107.731 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -97.47 131.31 44.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.706 0.802 . . . . 74.25 109.128 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' C' ' 111' ' ' ARG . 3.5 mm? -70.88 135.59 48.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.743 0.817 . . . . 73.14 111.123 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.97 160.29 52.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 124.925 1.29 . . . . 73.32 112.156 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.88 102.57 0.77 Allowed 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 123.304 2.669 . . . . 73.53 112.343 -175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -99.4 110.24 26.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.303 -0.999 . . . . 74.24 108.303 171.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -81.39 88.34 6.12 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.422 0.689 . . . . 75.55 110.613 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -65.26 -34.86 79.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.007 -0.997 . . . . 65.44 109.344 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.554 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.7 p-10 . . . . . 0 CA--C 1.545 0.78 0 CA-C-N 114.417 -1.265 . . . . 75.01 111.701 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.586 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 96.0 m . . . . . 0 C--O 1.235 0.328 0 N-CA-C 107.612 -1.255 . . . . 72.51 107.612 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -152.37 91.35 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.646 -1.242 . . . . 71.31 107.646 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 77.0 mt-30 -114.44 115.77 27.8 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.48 -0.933 . . . . 74.3 108.48 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -72.69 115.86 13.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.298 -1.001 . . . . 74.1 108.298 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -83.14 -50.06 8.85 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.062 -0.347 . . . . 71.14 110.062 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -172.83 151.28 2.22 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.792 0.33 . . . . 74.55 111.879 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.406 HD13 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -128.85 126.89 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.896 -1.52 . . . . 73.44 106.896 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -144.6 150.28 37.17 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.246 1.019 . . . . 73.24 109.645 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.5 p -83.97 109.03 17.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.839 -1.073 . . . . 74.22 108.909 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' D' ' 57' ' ' GLU . 37.3 mtpt -76.28 -23.52 54.41 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.727 -0.67 . . . . 73.51 110.48 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -163.33 140.18 7.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.968 -1.014 . . . . 70.31 108.823 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.649 HG21 ' HE1' ' C' ' 117' ' ' MET . 85.2 mt -135.11 148.02 29.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 108.127 -1.064 . . . . 73.14 108.127 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -147.47 143.22 27.72 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.893 0.877 . . . . 44.35 109.769 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.8 t80 -153.56 126.77 8.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.969 -1.863 . . . . 71.24 105.969 169.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.65 153.66 45.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.651 . . . . 75.02 109.361 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.545 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -145.95 77.02 12.33 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.506 -0.924 . . . . 74.43 108.506 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.28 -31.18 23.19 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.922 2.415 . . . . 73.11 113.322 -172.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -116.06 36.32 4.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.473 0.709 . . . . 71.04 109.621 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -49.84 -64.12 1.4 Allowed Pre-proline 0 CA--C 1.568 1.646 0 N-CA-C 113.418 0.896 . . . . 72.21 113.418 -172.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.504 ' HB3' HD11 ' C' ' 83' ' ' ILE . 55.1 Cg_endo -78.39 -9.96 16.17 Favored 'Trans proline' 0 C--N 1.385 2.48 0 CA-C-N 121.73 1.654 . . . . 75.53 112.618 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -82.9 -38.69 22.54 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.896 1.679 . . . . 73.35 109.615 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.496 HG21 ' CZ2' ' D' ' 36' ' ' TRP . 2.0 p -85.56 -19.61 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.791 0.836 . . . . 74.51 110.886 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -68.85 -10.57 57.64 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.5 0.72 . . . . 64.42 112.33 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -83.62 3.07 34.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.065 0.946 . . . . 73.01 111.505 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -126.23 112.7 16.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.012 0.925 . . . . 72.21 109.347 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -90.51 97.6 11.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.666 0.786 . . . . 71.45 111.72 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.496 ' CZ2' HG21 ' D' ' 31' ' ' VAL . 0.0 OUTLIER -150.62 -173.93 4.61 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.805 0.842 . . . . 75.42 112.222 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.1 115.93 65.68 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-N 114.974 -1.012 . . . . 71.01 110.1 165.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.587 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.0 Cg_exo -63.3 131.04 30.56 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.164 2.576 . . . . 73.34 111.746 163.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.6 112.28 20.29 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.163 -1.791 . . . . 72.25 106.163 163.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' D' ' 66' ' ' ALA . 26.8 m -98.29 112.29 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.635 -1.246 . . . . 63.41 107.635 177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -84.2 124.33 31.07 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.45 -0.945 . . . . 74.11 108.45 -172.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.1 mt -97.21 112.77 24.42 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.284 -1.326 . . . . 74.51 109.145 -170.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 31.2 t70 -114.0 130.69 56.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.257 -1.016 . . . . 74.42 108.257 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.62 136.5 47.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.706 -0.85 . . . . 74.05 108.706 177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -132.64 127.94 35.98 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.865 -1.161 . . . . 73.52 107.865 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.2 p -105.54 151.96 23.66 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.249 0.62 . . . . 74.04 110.302 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.03 160.53 43.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.29 -0.868 . . . . 75.45 109.331 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 66.1 p -155.33 156.79 36.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.649 0.78 . . . . 75.34 109.535 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.6 m -150.63 146.85 26.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.419 -1.326 . . . . 74.41 107.419 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.34 116.56 32.61 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.207 -1.405 . . . . 74.4 107.207 162.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.43 HD12 ' HB3' ' C' ' 29' ' ' PRO . 40.9 mt -92.23 -29.55 16.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.801 0.441 . . . . 72.23 110.263 -176.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.46 -178.73 7.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.647 0.779 . . . . 71.21 110.083 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.76 123.67 20.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.174 -0.921 . . . . 73.42 109.645 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 64.25 9.71 5.02 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.586 1.154 . . . . 61.23 112.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 96.7 t -118.63 117.29 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.305 -0.628 . . . . 72.42 109.305 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -128.36 128.33 44.34 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.118 0.967 . . . . 70.43 108.685 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.416 ' CD ' ' HZ2' ' D' ' 19' ' ' LYS . 29.0 tt0 -89.81 132.13 35.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.886 0.874 . . . . 74.33 108.795 170.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -117.03 122.26 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.047 -1.464 . . . . 65.11 107.047 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.9 t -112.86 129.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.317 -0.624 . . . . 74.55 109.317 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.485 HD23 HD12 ' D' ' 106' ' ' LEU . 3.8 mm? -116.76 107.52 14.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 75.32 108.994 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -88.29 112.35 22.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.489 -0.778 . . . . 74.43 109.071 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -99.88 120.65 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.038 -1.097 . . . . 75.13 108.038 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 33.6 m -115.4 140.01 49.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.792 0.837 . . . . 74.44 109.595 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.605 HG13 ' HB ' ' D' ' 40' ' ' VAL . 88.1 t -137.15 127.81 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.754 1.222 . . . . 74.21 108.764 -172.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.3 m -133.91 103.8 5.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.178 0.591 . . . . 73.51 109.648 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.774 ' HB3' HG12 ' D' ' 40' ' ' VAL . . . -102.06 130.42 48.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.577 0.751 . . . . 75.23 109.976 177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 16.2 p -154.43 124.37 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.996 -0.742 . . . . 70.22 108.996 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.587 HD11 ' HA ' ' D' ' 38' ' ' PRO . 3.0 mm? -114.85 134.07 55.44 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.971 0.508 . . . . 75.11 110.083 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.5 -110.24 3.06 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.902 0.751 . . . . 73.13 112.037 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.4 7.68 10.15 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.231 1.012 . . . . 70.14 110.85 -175.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -137.55 154.87 49.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 122.874 0.47 . . . . 74.25 110.697 -173.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.9 m -83.26 124.94 31.07 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.744 -0.662 . . . . 64.33 110.309 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -71.03 -65.73 0.7 Allowed 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.897 0.748 . . . . 64.1 109.555 176.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.34 158.49 37.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.962 -1.017 . . . . 72.14 110.765 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -120.69 151.94 38.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.502 -1.295 . . . . 72.14 107.502 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' D' ' 114' ' ' ILE . 33.7 t -159.52 136.12 9.21 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.978 -0.379 . . . . 72.34 109.978 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.66 139.86 15.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.746 0.418 . . . . 73.44 110.046 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.8 120.45 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.177 0.591 . . . . 74.33 110.087 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -89.03 88.27 7.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.658 -0.868 . . . . 72.41 108.658 168.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -84.36 92.21 7.97 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.019 -0.991 . . . . 64.51 108.738 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 143.93 18.97 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.946 -0.861 . . . . 62.22 110.946 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.86 129.59 3.23 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 110.808 -0.917 . . . . 54.34 110.808 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.7 mt -89.56 134.1 29.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 123.22 0.608 . . . . 72.44 109.505 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -132.0 129.59 40.31 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.177 0.991 . . . . 74.22 109.291 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 50.0 m -75.77 94.35 3.28 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.896 -0.779 . . . . 70.51 108.896 166.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 19.5 mt -107.05 123.32 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 107.824 -1.176 . . . . 74.31 107.824 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.586 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -148.22 161.98 40.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.759 0.824 . . . . 71.33 110.297 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.02 19.68 75.66 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.761 0.663 . . . . 43.21 113.875 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.526 HD11 ' HG3' ' D' ' 93' ' ' GLN . 16.2 tt -135.45 149.91 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.817 -0.808 . . . . 74.51 108.817 -169.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.03 156.96 44.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.068 0.547 . . . . 72.22 111.689 -170.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 33.87 -96.17 0.01 OUTLIER Glycine 0 C--N 1.357 1.73 0 N-CA-C 117.094 1.598 . . . . 61.52 117.094 153.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 44.0 p -64.89 -50.63 65.77 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.98 0.912 . . . . 74.3 112.529 -173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.526 ' HG3' HD11 ' D' ' 89' ' ' ILE . 52.9 tp60 -79.78 -28.91 40.29 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 111.803 0.298 . . . . 73.5 111.803 -172.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.486 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -70.65 -34.02 71.59 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.746 -0.465 . . . . 74.31 109.746 176.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . 0.405 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -59.92 -35.99 76.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.634 0.774 . . . . 61.32 110.727 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.14 -36.57 72.13 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.873 -1.058 . . . . 75.02 110.712 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -73.02 -52.22 15.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.006 0.522 . . . . 74.23 112.366 -173.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.0 pp -94.84 -20.47 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.04 0.536 . . . . 74.42 111.912 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.45 -6.84 60.91 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.72 -0.489 . . . . 62.33 113.721 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.85 -58.66 0.47 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.161 0.48 . . . . 73.13 111.402 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.5 -45.47 68.84 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.221 0.608 . . . . 75.15 112.547 -171.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -43.06 57.26 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 123.56 0.744 . . . . 64.33 111.426 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.88 -43.47 35.1 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.831 2.354 . . . . 75.21 113.906 163.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.28 -21.19 65.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.402 0.681 . . . . 70.34 112.285 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.78 -42.2 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.948 0.499 . . . . 72.22 110.532 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.485 HD12 HD23 ' D' ' 60' ' ' LEU . 74.3 mt -91.13 -20.92 21.49 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.888 0.699 . . . . 70.05 112.888 -170.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -65.85 -41.67 48.12 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.152 -0.927 . . . . 65.11 112.715 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.19 -40.35 69.41 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.383 2.055 . . . . 73.33 113.399 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -73.97 -36.39 64.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.748 0.819 . . . . 74.42 111.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.95 -45.09 83.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.003 0.521 . . . . 74.21 110.219 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -60.75 -46.05 91.94 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.575 -1.193 . . . . 73.41 110.46 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.92 -47.23 87.37 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.238 0.961 . . . . 74.14 110.779 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.99 -41.06 86.69 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.682 0.614 . . . . 70.35 110.945 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.626 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.8 mt -66.3 -47.95 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.496 0.718 . . . . 73.32 110.243 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.472 HG22 ' HB3' ' D' ' 125' ' ' GLN . 99.4 m -53.17 -46.82 69.08 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.489 1.116 . . . . 74.35 111.229 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.5 t -66.84 -41.7 86.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.071 -0.968 . . . . 71.4 110.731 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.578 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 77.2 mtm -67.8 -45.26 75.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.86 0.464 . . . . 74.33 112.185 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 -32.03 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.313 -0.858 . . . . 70.55 110.082 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.9 p -72.22 -33.67 67.76 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.917 0.487 . . . . 64.33 110.819 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtt-85 -68.26 -26.68 65.79 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.744 0.817 . . . . 72.22 110.917 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.0 10.46 65.63 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.615 0.572 . . . . 63.41 112.889 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 58.1 p 57.57 19.85 5.71 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 126.524 1.929 . . . . 75.2 113.248 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.576 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 63.7 m-85 -91.4 178.06 1.95 Allowed Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.487 1.515 . . . . 73.44 107.688 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 83.1 Cg_endo -74.82 160.79 40.22 Favored 'Trans proline' 0 C--N 1.39 2.75 0 CA-C-N 121.843 1.694 . . . . 75.33 112.434 -174.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.472 ' HB3' HG22 ' D' ' 115' ' ' THR . 15.9 mt-30 -66.34 128.12 34.91 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.287 -1.005 . . . . 74.21 108.287 166.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.99 91.55 4.17 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.433 -1.321 . . . . 75.33 107.433 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -103.88 93.31 4.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.089 -1.414 . . . . 71.2 108.323 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.87 127.89 34.22 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.196 -0.668 . . . . 73.31 109.196 174.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -56.24 134.32 75.42 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 124.269 0.981 . . . . 73.13 110.554 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.549 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 5.8 Cg_exo -73.63 96.67 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.702 2.268 . . . . 61.55 109.876 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.69 110.06 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.712 -1.218 . . . . 64.31 107.712 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -68.99 114.76 7.58 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.048 -0.978 . . . . 43.03 109.94 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.01 111.356 -178.453 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 110.163 -0.31 . . . . 74.51 110.163 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.712 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 7.1 t80 -120.09 134.71 55.18 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.457 1.103 . . . . 72.45 108.488 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -155.28 117.17 4.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.978 -0.749 . . . . 64.35 108.978 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.662 HG22 ' HG2' ' C' ' 130' ' ' PRO . 24.4 mt -76.8 124.17 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.892 -0.41 . . . . 74.35 109.892 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.68 -43.65 18.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.775 0.83 . . . . 74.11 110.858 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -173.4 131.57 0.46 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.248 -0.278 . . . . 72.31 110.248 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -116.75 138.31 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.716 0.806 . . . . 74.4 108.867 174.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 34.8 p90 -171.19 166.48 7.21 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.775 0.798 . . . . 73.33 111.082 -172.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -95.51 119.43 34.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.947 -1.024 . . . . 75.32 108.895 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 38.6 mtpt -82.71 -28.38 30.56 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.642 0.377 . . . . 75.21 110.125 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.21 145.95 21.05 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.062 -0.972 . . . . 52.54 109.631 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.65 134.84 54.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.981 1.312 . . . . 75.12 107.652 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -136.18 123.84 22.38 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.49 -1.3 . . . . 71.01 107.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 84.5 t80 -136.85 126.5 25.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.896 -1.52 . . . . 75.11 106.896 173.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.4 139.12 43.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.824 -0.435 . . . . 74.24 109.824 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.22 70.59 9.98 Favored Pre-proline 0 C--O 1.245 0.833 0 N-CA-C 107.777 -1.194 . . . . 63.24 107.777 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.59 -21.98 38.79 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.226 1.95 . . . . 73.04 111.744 -173.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 16.5 m-20 -118.33 23.42 11.57 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.825 0.85 . . . . 74.11 109.77 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.22 -54.56 24.21 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-O 118.318 -0.849 . . . . 64.42 113.222 -175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HG2' ' HD2' ' A' ' 30' ' ' HIS . 17.9 Cg_endo -59.28 -34.25 97.98 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.536 2.157 . . . . 55.21 112.716 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.41 ' HD2' ' HG2' ' A' ' 29' ' ' PRO . 15.7 m-70 -70.8 -42.02 70.84 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.456 -0.793 . . . . 73.33 110.148 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.78 -28.56 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.364 -0.835 . . . . 72.32 111.596 -170.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -60.85 -33.31 72.86 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.472 0.483 . . . . 72.44 112.019 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -88.83 -15.89 33.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.596 0.358 . . . . 74.32 111.541 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -68.01 163.89 21.25 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.328 0.585 . . . . 75.34 111.408 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.96 149.01 50.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.085 -0.961 . . . . 75.42 109.973 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -83.36 63.76 7.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.319 0.648 . . . . 75.04 109.955 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -148.05 70.19 11.0 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.597 0.759 . . . . 75.0 109.986 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -92.35 166.92 2.91 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.269 1.979 . . . . 72.15 111.585 163.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.5 104.4 16.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.336 -1.357 . . . . 73.1 107.336 167.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 65' ' ' THR . 85.1 t -85.06 95.36 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.937 -0.764 . . . . 74.23 108.937 175.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -87.8 115.24 25.12 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.897 -0.779 . . . . 73.23 108.897 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mp -103.09 120.72 41.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.417 -0.586 . . . . 75.14 109.417 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 1.0 OUTLIER -103.01 136.5 42.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.376 1.071 . . . . 73.12 108.583 179.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.0 tp -114.56 118.83 34.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.108 -1.071 . . . . 72.23 108.108 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 29.5 t70 -128.73 147.5 50.77 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.979 0.912 . . . . 71.13 108.969 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -149.15 136.92 20.45 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.242 -1.021 . . . . 72.32 108.242 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.25 134.5 38.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 71.44 109.01 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -129.26 151.44 49.91 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.616 0.644 . . . . 75.21 110.874 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -164.92 133.02 3.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.765 0.826 . . . . 73.14 109.767 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -79.01 119.49 22.23 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.692 0.397 . . . . 72.52 110.933 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 HD12 HG22 ' A' ' 83' ' ' ILE . 79.6 mt -84.07 -43.12 15.4 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.725 0.81 . . . . 62.15 111.281 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.9 -179.76 7.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.609 0.764 . . . . 65.42 110.012 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.24 116.73 5.25 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.252 -0.647 . . . . 73.31 109.252 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 68.25 19.36 9.07 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.564 1.145 . . . . 74.31 111.991 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.51 120.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.152 0.981 . . . . 72.5 108.758 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.517 ' HE2' HD12 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -128.46 171.13 12.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.328 -0.619 . . . . 74.23 109.328 169.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -127.89 133.28 49.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.37 1.068 . . . . 75.05 108.253 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.4 121.4 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.031 -1.099 . . . . 73.35 108.031 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 56.2 t -97.85 136.85 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.503 1.121 . . . . 72.44 108.86 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.496 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -116.03 99.71 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.327 -1.36 . . . . 74.42 107.327 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.3 ttp180 -89.05 101.83 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.106 -0.701 . . . . 73.23 109.106 174.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.2 t -93.6 127.76 45.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.8 -1.556 . . . . 74.52 106.8 170.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 77' ' ' GLU . 11.1 m -117.46 130.84 56.71 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.147 -0.686 . . . . 71.55 109.147 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.8 t -120.37 107.28 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.745 -1.206 . . . . 74.02 107.745 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.7 m -111.68 134.45 53.24 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.846 -0.798 . . . . 71.21 108.846 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -124.88 126.64 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.663 -1.236 . . . . 64.22 107.663 173.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -141.32 128.49 20.91 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.313 -0.625 . . . . 75.44 109.313 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD11 HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -102.05 86.03 2.79 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.804 -1.184 . . . . 73.21 107.804 173.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -126.12 7.49 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.92 -1.036 . . . . 72.24 110.825 -171.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.36 -26.51 22.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.274 0.63 . . . . 71.31 110.452 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 29.9 tt0 -77.78 120.16 22.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.584 0.353 . . . . 61.33 110.303 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -79.66 130.5 35.42 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.47 0.708 . . . . 72.14 110.163 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -73.96 -62.14 1.6 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.609 0.764 . . . . 63.21 110.485 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.0 p90 -160.25 171.03 19.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.127 -0.942 . . . . 74.44 111.332 178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -138.14 131.88 31.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.995 -1.457 . . . . 73.13 107.443 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.8 m -135.51 97.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.748 0.819 . . . . 75.32 109.196 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' A' ' 63' ' ' THR . 42.0 tt0 -123.26 116.34 23.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.264 -1.014 . . . . 73.51 108.264 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.21 121.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.195 -0.669 . . . . 70.41 109.195 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 84.41 6.13 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.512 -0.922 . . . . 73.02 108.512 173.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.01 94.24 5.25 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.051 -0.977 . . . . 75.2 109.207 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.62 142.37 20.16 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.465 -0.654 . . . . 73.44 111.465 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.03 120.82 1.52 Allowed Glycine 0 CA--C 1.502 -0.736 0 N-CA-C 109.929 -1.269 . . . . 74.32 109.929 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 51' ' ' LEU . 41.8 mt -83.14 125.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.671 -0.863 . . . . 73.4 108.671 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.712 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.8 m-85 -124.63 127.39 47.26 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 109.297 -0.631 . . . . 63.53 109.297 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.9 t -83.82 119.1 24.43 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.394 0.678 . . . . 73.3 109.344 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.517 HD12 ' HE2' ' A' ' 56' ' ' TYR . 12.9 tt -103.4 146.59 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.194 0.997 . . . . 75.4 109.486 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 157.47 18.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.414 0.686 . . . . 74.12 109.892 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.29 -33.25 3.2 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.846 0.716 . . . . 61.45 114.413 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.78 164.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 117.571 0.685 . . . . 75.31 112.469 -172.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.48 -179.97 6.34 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.015 0.926 . . . . 72.25 109.545 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.47 22.36 Favored Glycine 0 N--CA 1.478 1.476 0 C-N-CA 123.116 0.389 . . . . 72.43 113.829 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -66.94 -28.24 68.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.947 1.299 . . . . 73.21 111.659 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -64.11 -51.31 64.58 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.35 -0.841 . . . . 71.13 110.322 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -73.93 -28.28 61.44 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.222 -0.899 . . . . 74.53 110.666 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.78 92.37 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.282 0.563 . . . . 73.32 111.0 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -69.57 -36.49 76.32 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.154 -0.93 . . . . 73.35 110.036 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 23.7 t -73.68 -27.17 61.09 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.88 0.472 . . . . 74.12 111.276 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.06 -42.19 14.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.989 0.916 . . . . 74.32 110.988 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.09 4.78 52.49 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.59 0.556 . . . . 61.03 114.132 -168.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.802 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.51 -60.13 0.24 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 117.627 0.714 . . . . 63.22 112.493 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.6 t80 -68.2 -62.12 1.54 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.154 0.981 . . . . 63.23 112.125 -170.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 97.8 m -69.06 -32.85 3.61 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 114.315 1.228 . . . . 73.34 114.315 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.92 -42.74 20.22 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.985 2.456 . . . . 74.53 113.713 164.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.44 -26.19 64.48 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.762 0.825 . . . . 72.04 111.485 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -72.39 -45.34 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.599 0.76 . . . . 74.53 109.743 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 60' ' ' LEU . 48.9 mt -70.85 -35.68 72.53 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.409 -1.269 . . . . 71.11 112.394 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -59.75 -43.05 94.34 Favored Pre-proline 0 CA--C 1.572 1.791 0 C-N-CA 124.701 1.2 . . . . 74.01 114.227 -167.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -59.41 -37.34 90.51 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.27 1.98 . . . . 73.44 113.487 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.47 -35.92 68.34 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.294 0.638 . . . . 75.43 111.863 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.97 94.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 60.43 109.515 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -63.05 -35.83 81.54 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 124.287 0.992 . . . . 74.52 110.309 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 22.2 tt0 -56.64 -56.37 22.21 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.624 0.77 . . . . 75.15 110.91 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -63.35 -45.02 93.12 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 114.397 -1.274 . . . . 73.24 110.766 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 62' ' ' VAL . 66.2 mt -62.93 -59.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 123.987 0.804 . . . . 72.14 110.775 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.4 m -56.77 -32.8 65.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.181 0.593 . . . . 73.25 111.966 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.0 t -68.52 -46.45 69.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.86 -0.609 . . . . 74.41 110.529 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.454 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mtp -58.37 -42.87 87.95 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 75.33 111.049 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.532 HG21 ' SG ' ' A' ' 76' ' ' CYS . 94.3 t -62.3 -44.64 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.419 1.087 . . . . 74.21 110.225 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -73.56 -29.96 62.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.355 -0.384 . . . . 74.03 111.3 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -68.3 -37.12 80.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.418 0.687 . . . . 74.13 109.815 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.97 -3.42 89.39 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.811 -0.631 . . . . 72.21 113.033 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.711 HG23 HE21 ' D' ' 125' ' ' GLN . 24.3 p 54.56 48.8 19.62 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.167 1.787 . . . . 75.05 111.572 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . 0.414 ' HB2' HG13 ' A' ' 118' ' ' VAL . 74.5 m-85 -104.56 154.41 38.47 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 113.807 -1.542 . . . . 75.44 108.43 169.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -59.75 131.32 39.28 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.335 2.023 . . . . 75.14 110.615 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -47.84 133.69 13.91 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.472 1.108 . . . . 75.11 111.785 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.437 HD23 HG12 ' A' ' 64' ' ' VAL . 31.8 tp -107.17 110.31 22.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.296 -0.631 . . . . 71.51 109.296 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.67 84.02 1.95 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.851 -1.537 . . . . 71.42 106.851 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.5 tp -71.7 128.81 36.99 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.092 -0.958 . . . . 74.12 109.623 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -52.97 131.57 49.43 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 124.689 1.243 . . . . 74.12 111.517 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.649 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 3.4 Cg_endo -77.47 116.25 4.06 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.265 1.977 . . . . 65.53 109.866 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.41 123.96 53.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.643 -0.873 . . . . 63.21 108.643 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -76.79 86.83 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.211 -1.033 . . . . 71.03 108.211 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.994 . . . . 73.34 110.662 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.802 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 t70 . . . . . 0 C--N 1.348 0.542 0 CA-C-N 114.984 -1.007 . . . . 74.42 110.426 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 90.7 m . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.11 -0.33 . . . . 73.13 110.11 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.54 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 47.9 t80 -151.06 113.76 4.69 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.905 -0.776 . . . . 74.23 108.905 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -142.11 137.63 31.09 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.37 0.668 . . . . 72.3 109.935 170.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.466 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -82.3 128.0 39.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.825 -0.805 . . . . 74.24 108.825 174.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -98.39 -43.62 6.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.015 -0.539 . . . . 74.53 110.075 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -164.33 130.93 3.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.517 -0.31 . . . . 72.43 110.574 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -115.86 127.9 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.545 1.138 . . . . 72.32 108.902 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -162.49 147.59 12.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.982 0.42 . . . . 73.31 111.869 -171.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.6 m -73.95 123.42 24.25 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.984 0.913 . . . . 70.34 109.367 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -98.96 -27.56 13.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.098 0.559 . . . . 73.31 111.506 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.2 t70 -156.67 144.53 19.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.316 0.246 . . . . 73.41 110.641 -170.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 36.2 mm -144.66 141.43 23.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.326 1.451 . . . . 72.14 108.251 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -145.61 109.36 4.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 124.103 0.877 . . . . 74.45 108.699 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.0 117.48 29.34 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 107.186 -1.413 . . . . 75.24 107.186 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 39.3 mt-10 -119.95 133.01 55.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.372 0.669 . . . . 70.11 109.404 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.41 83.33 66.46 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.664 -1.236 . . . . 70.21 107.664 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . 0.408 ' HG2' HD21 ' B' ' 27' ' ' ASN . 44.9 Cg_endo -66.23 -29.53 46.88 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.902 2.402 . . . . 71.14 112.167 -174.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.408 HD21 ' HG2' ' B' ' 26' ' ' PRO . 27.6 m-80 -108.43 21.06 17.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 74.53 110.877 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.447 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.44 -57.67 6.21 Favored Pre-proline 0 CA--C 1.582 2.193 0 N-CA-C 114.743 1.386 . . . . 74.35 114.743 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 71.0 Cg_endo -80.24 -26.92 3.89 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 122.302 2.001 . . . . 64.34 113.11 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 2.3 m-70 -93.99 1.13 56.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.545 0.738 . . . . 72.11 112.344 -171.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.67 -28.1 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.036 0.534 . . . . 73.54 111.686 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -53.69 -26.02 20.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.589 1.156 . . . . 72.02 113.365 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 25.0 pt20 -66.6 -52.45 45.19 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.338 0.255 . . . . 72.35 110.781 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -118.13 68.15 0.77 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 123.552 0.741 . . . . 64.31 110.167 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.429 ' O ' ' HE3' ' B' ' 36' ' ' TRP . 11.0 t70 -98.53 118.16 34.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 106.932 -1.507 . . . . 75.22 106.932 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.429 ' HE3' ' O ' ' B' ' 35' ' ' ASP . 2.2 t-105 -176.1 175.29 1.93 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.832 -1.173 . . . . 72.2 107.832 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.55 112.07 3.81 Favored Pre-proline 0 CA--C 1.56 1.359 0 O-C-N 123.582 0.552 . . . . 73.53 110.996 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.77 164.84 15.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.62 2.213 . . . . 72.32 112.388 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.09 101.94 4.07 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.185 -1.042 . . . . 71.34 108.185 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.09 146.43 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.407 -0.815 . . . . 72.44 108.931 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.57 133.07 32.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.121 0.969 . . . . 74.04 109.307 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.487 HD23 HD12 ' B' ' 128' ' ' LEU . 4.6 mp -90.97 150.1 21.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.346 -0.843 . . . . 75.23 108.953 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.3 t70 -158.99 154.58 26.04 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.419 -0.956 . . . . 74.03 108.419 172.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.2 154.55 48.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.002 0.521 . . . . 74.24 110.582 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.5 t70 -140.02 124.62 18.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.419 -1.326 . . . . 53.12 107.419 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -110.21 104.76 13.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.023 0.929 . . . . 74.41 109.741 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.24 155.39 45.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.97 0.908 . . . . 54.23 109.984 -175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.6 m -144.11 172.64 12.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.296 0.639 . . . . 71.43 110.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.0 p -151.76 134.88 15.85 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.11 0.964 . . . . 63.31 108.647 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -84.47 114.68 22.1 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.86 -0.422 . . . . 74.33 109.86 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.489 HD12 HG22 ' B' ' 83' ' ' ILE . 69.4 mt -80.49 -45.72 17.05 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.447 -0.575 . . . . 72.43 109.447 173.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.48 -173.43 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.666 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.14 119.43 18.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.872 . . . . 75.05 109.968 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 71.45 -6.4 1.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 125.965 1.706 . . . . 75.12 112.668 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -104.99 104.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 108.08 -1.082 . . . . 73.32 108.08 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.82 137.96 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -101.16 101.51 12.25 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.017 -1.475 . . . . 71.44 107.017 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.33 123.18 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.074 0.949 . . . . 75.12 109.879 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.0 t -102.95 144.4 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.085 0.954 . . . . 74.2 109.417 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' B' ' 103' ' ' PRO . 61.0 tp -129.77 115.02 16.68 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.555 -0.905 . . . . 72.53 108.555 170.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 37.3 ttm180 -92.85 125.86 37.65 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.373 -0.603 . . . . 73.45 109.373 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 92.9 t -111.25 104.55 17.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.305 -1.369 . . . . 65.51 107.305 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 36.4 m -97.0 136.96 36.82 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.481 -0.781 . . . . 73.12 109.437 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.11 129.32 67.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.947 -1.024 . . . . 73.54 108.476 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.5 m -124.82 137.87 54.29 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.406 0.682 . . . . 71.14 109.408 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.51 143.4 35.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.034 0.534 . . . . 73.14 109.63 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -158.09 140.37 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.698 0.624 . . . . 71.32 111.362 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 73' ' ' ALA . 5.2 mp -103.24 118.92 37.87 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.45 -0.944 . . . . 71.42 108.45 167.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.63 -141.77 39.18 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.587 0.554 . . . . 75.31 112.882 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 9.43 12.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.327 1.051 . . . . 74.02 111.875 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -127.41 143.35 51.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.545 0.738 . . . . 73.31 110.147 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -70.78 140.47 51.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.574 0.75 . . . . 74.14 110.855 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB3' HD11 ' B' ' 68' ' ' LEU . . . -90.99 -62.58 1.42 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.97 0.908 . . . . 61.54 108.744 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -156.29 167.02 31.73 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.572 -1.195 . . . . 73.33 109.144 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.3 mt -137.08 131.03 32.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.802 -1.555 . . . . 71.44 106.802 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 37.7 t -141.33 132.7 26.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.759 -0.83 . . . . 65.01 108.759 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -154.19 135.37 13.99 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.009 -0.737 . . . . 72.2 109.009 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t -133.33 146.44 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.637 0.775 . . . . 75.32 109.019 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.574 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -119.48 95.93 4.99 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.405 -1.331 . . . . 71.41 107.405 168.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -85.19 104.57 15.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.69 -0.855 . . . . 75.11 108.69 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.68 159.85 29.66 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 123.927 0.767 . . . . 75.41 111.186 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.29 126.34 1.57 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.922 -0.871 . . . . 64.31 110.922 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.489 HG22 HD12 ' B' ' 51' ' ' LEU . 54.2 mt -84.26 119.11 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.12 -1.067 . . . . 75.22 108.12 175.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.11 134.26 54.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.752 0.821 . . . . 74.42 108.892 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -92.36 97.17 10.7 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.4 -0.963 . . . . 74.21 108.4 168.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.16 139.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.194 -0.912 . . . . 75.31 110.421 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.1 160.92 39.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.014 0.926 . . . . 71.23 109.555 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.95 -31.9 4.2 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.398 0.436 . . . . 72.12 114.072 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.63 136.5 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.296 0.638 . . . . 74.51 111.048 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.91 151.62 16.45 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.717 0.807 . . . . 75.12 109.695 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.54 -110.37 3.32 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 123.614 0.626 . . . . 44.43 113.189 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -74.59 -42.9 57.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.826 0.822 . . . . 72.22 110.088 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -67.64 -32.6 73.42 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.977 -1.465 . . . . 74.24 111.206 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.3 ptm -68.47 -37.37 80.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.957 -0.565 . . . . 74.23 110.748 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.88 -26.73 64.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.522 0.729 . . . . 63.42 110.721 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -89.39 -19.3 25.37 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.354 0.662 . . . . 54.45 110.839 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.5 t -86.69 -70.17 0.63 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.497 0.319 . . . . 72.2 111.436 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.524 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.2 pp -80.43 -24.83 39.32 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.431 0.292 . . . . 72.41 111.478 -175.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.29 1.82 56.18 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-O 119.66 -0.522 . . . . 75.3 114.153 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.03 -53.08 0.38 Allowed 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.548 0.674 . . . . 64.04 111.827 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -75.34 -45.17 41.11 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.086 0.554 . . . . 74.25 112.075 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.54 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 56.0 m -65.97 -43.71 58.7 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.161 0.584 . . . . 72.35 111.82 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.546 ' HA ' HD23 ' B' ' 60' ' ' LEU . 65.2 Cg_exo -48.42 -42.97 33.89 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.868 2.378 . . . . 75.54 114.295 167.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -61.31 -30.24 70.37 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.552 0.741 . . . . 75.24 112.64 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.89 -43.79 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.152 0.581 . . . . 72.52 110.635 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.42 -20.5 47.4 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.062 -0.517 . . . . 74.33 111.571 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -61.15 -49.35 88.81 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.892 -1.052 . . . . 75.12 113.275 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.9 -46.38 30.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.938 2.426 . . . . 63.54 113.841 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -67.16 -44.88 78.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 74.52 111.32 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.58 96.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.284 0.634 . . . . 74.41 110.979 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.444 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 8.7 ttp-105 -71.75 -44.86 63.36 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.086 -0.961 . . . . 74.23 110.743 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.97 -34.04 77.47 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.872 0.732 . . . . 74.42 110.166 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.491 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.5 t -68.79 -36.5 78.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 122.877 0.471 . . . . 74.35 110.86 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.521 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 62.0 mt -62.84 -48.92 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.255 0.622 . . . . 74.41 109.773 172.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -62.03 -32.17 72.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.678 0.791 . . . . 74.13 111.527 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 30.9 t -65.78 -46.55 78.31 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.633 -0.712 . . . . 52.32 110.238 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -72.94 -38.1 66.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.802 0.441 . . . . 75.51 111.329 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.45 -38.49 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.396 0.678 . . . . 62.35 110.339 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -68.05 -34.58 76.72 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.892 -1.049 . . . . 72.35 111.19 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -71.27 -26.79 63.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.914 0.486 . . . . 73.12 110.458 176.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.92 1.39 63.17 Favored Glycine 0 C--N 1.358 1.796 0 O-C-N 123.446 0.467 . . . . 63.14 112.59 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 17' ' ' TYR . 41.5 p 62.73 49.54 3.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.915 2.086 . . . . 74.12 112.22 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -119.98 154.46 55.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.393 -1.276 . . . . 75.25 109.924 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.37 -169.96 0.12 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.581 2.854 . . . . 74.33 114.143 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 15.4 tp60 -57.34 124.26 18.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.448 1.099 . . . . 72.22 112.771 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -141.49 83.35 1.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.864 -0.791 . . . . 73.45 108.864 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -104.5 131.42 51.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.385 -1.339 . . . . 72.14 107.385 165.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.487 HD12 HD23 ' B' ' 42' ' ' LEU . 33.1 tp -70.74 149.74 46.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.091 0.557 . . . . 64.03 110.253 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.2 149.4 87.05 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.894 0.878 . . . . 64.33 111.898 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -63.45 93.51 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.925 2.417 . . . . 72.42 111.825 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 t -92.0 110.07 22.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.301 -1.0 . . . . 71.34 108.301 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -92.75 88.25 6.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.026 -1.101 . . . . 74.43 108.026 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 N--CA 1.479 0.993 0 CA-C-N 115.037 -0.983 . . . . 73.14 110.298 -177.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.424 ' HA ' HG13 ' C' ' 89' ' ' ILE . 56.3 ttp . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.333 0.587 . . . . 72.21 112.45 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.693 HG21 HE22 ' C' ' 12' ' ' GLN . 7.0 m -97.22 105.57 17.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.172 -1.047 . . . . 65.45 108.172 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.596 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.4 t80 -124.27 119.38 29.15 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.529 -0.545 . . . . 71.34 109.529 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.693 HE22 HG21 ' C' ' 10' ' ' THR . 1.6 mp0 -136.92 142.26 42.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.486 -0.931 . . . . 71.25 108.486 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.14 97.29 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -74.19 -28.25 61.19 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 122.423 0.289 . . . . 71.54 110.649 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' C' ' 15' ' ' ARG . 10.0 ttt180 -172.55 152.76 2.68 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 123.727 0.642 . . . . 73.43 110.94 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 89.3 mt -133.6 137.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.269 -1.382 . . . . 73.21 107.269 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.419 ' CE2' ' HD2' ' C' ' 19' ' ' LYS . 18.6 p90 -175.52 166.24 3.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.88 0.472 . . . . 75.31 110.052 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -89.26 120.24 30.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.267 -0.642 . . . . 75.23 109.267 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 13.6 mmmm -66.49 -44.55 82.31 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.614 -0.884 . . . . 71.24 108.614 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.2 t70 -139.79 145.71 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.112 -0.949 . . . . 73.33 110.598 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.9 mt -135.53 142.83 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 125.587 1.555 . . . . 71.02 107.038 170.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -156.84 151.34 25.48 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.129 0.49 . . . . 72.42 110.702 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -149.36 112.14 4.81 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 106.895 -1.52 . . . . 73.53 106.895 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -116.24 125.71 52.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.286 0.634 . . . . 74.43 109.855 -176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.64 82.08 18.82 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.086 -1.079 . . . . 62.53 108.086 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.86 -28.16 75.46 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.522 2.148 . . . . 72.55 111.646 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.86 31.87 2.53 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.519 1.128 . . . . 60.54 110.47 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.41 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -58.13 -54.04 59.77 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.441 1.275 . . . . 63.44 114.441 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 58.8 Cg_endo -79.83 -25.99 4.86 Favored 'Trans proline' 0 C--N 1.385 2.464 0 CA-C-N 122.072 1.776 . . . . 63.15 112.654 172.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.06 -23.32 67.39 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.044 1.338 . . . . 65.52 111.997 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -18.75 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.88 1.272 . . . . 74.2 112.022 -174.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.04 -38.55 75.88 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.676 0.39 . . . . 74.32 111.461 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.99 34.42 1.1 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.424 0.69 . . . . 75.42 110.912 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.517 ' HZ1' ' HB2' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -98.0 150.9 20.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.181 0.992 . . . . 75.55 111.012 -175.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.81 138.95 58.25 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.952 1.301 . . . . 73.32 111.533 172.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -85.24 67.21 10.08 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.864 0.866 . . . . 72.11 110.784 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -162.94 71.0 2.01 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.118 0.567 . . . . 71.04 110.81 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -87.05 115.9 1.2 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.315 2.677 . . . . 71.15 112.015 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.87 112.77 22.08 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.352 -0.981 . . . . 74.13 108.352 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.89 104.51 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.726 -0.67 . . . . 73.34 109.355 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.412 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 58.7 tttm -95.03 103.25 15.09 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.616 -0.883 . . . . 74.1 108.616 173.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.78 138.05 31.87 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.153 -1.054 . . . . 72.41 108.153 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.4 t70 -128.89 141.55 51.24 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.42 1.088 . . . . 75.02 109.042 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 61.7 tp -134.29 132.01 39.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.111 -0.7 . . . . 72.05 109.111 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.772 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 17.1 t70 -123.27 141.76 51.65 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.106 0.963 . . . . 75.31 109.133 174.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -114.51 111.08 20.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.993 -0.743 . . . . 74.15 108.993 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -117.03 164.29 14.94 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.341 1.056 . . . . 72.42 110.09 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -146.83 155.49 42.38 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.391 0.676 . . . . 71.14 109.884 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.51 126.84 14.89 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 72.23 108.598 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -82.72 117.76 22.87 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.447 -0.946 . . . . 74.44 108.447 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.517 HD13 HD13 ' C' ' 83' ' ' ILE . 83.1 mt -90.89 -42.51 10.56 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.621 -0.718 . . . . 74.53 109.463 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.45 -177.85 6.84 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.802 -1.09 . . . . 71.41 109.728 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.4 126.62 30.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.991 -1.004 . . . . 75.43 109.182 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.7 10.51 7.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.622 1.169 . . . . 74.12 111.732 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -126.22 112.96 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.918 0.887 . . . . 72.11 109.206 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -131.14 125.54 33.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.889 0.876 . . . . 73.3 109.11 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -83.61 124.48 30.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.279 1.031 . . . . 75.12 109.66 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.49 130.09 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.572 -1.27 . . . . 64.31 107.572 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 86.0 t -123.44 139.91 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.505 0.722 . . . . 71.11 109.978 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' C' ' 103' ' ' PRO . 69.5 mt -128.76 118.72 23.27 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 124.283 1.033 . . . . 61.02 109.315 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.772 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 45.0 mtt180 -82.96 108.55 16.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.689 -0.856 . . . . 75.44 108.689 166.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -103.92 116.38 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.456 -1.313 . . . . 75.55 107.456 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 20.2 m -130.12 118.24 21.18 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.056 0.542 . . . . 70.04 109.594 -170.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.584 HG23 HG21 ' C' ' 114' ' ' ILE . 67.0 t -104.0 118.18 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 73.13 108.586 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 22.4 m -110.77 141.45 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.463 -0.94 . . . . 72.34 108.463 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.76 106.61 9.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.963 -1.865 . . . . 73.35 105.963 170.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.5 m -138.91 152.28 47.63 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.338 0.59 . . . . 74.44 109.71 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.452 HD11 ' HD2' ' C' ' 34' ' ' LYS . 4.3 mp -116.32 31.48 6.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.462 -1.244 . . . . 73.51 108.635 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.54 -117.63 4.02 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 109.802 -1.319 . . . . 75.13 109.802 -170.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -88.85 -30.61 18.8 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.433 -0.58 . . . . 63.24 109.433 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.68 95.12 1.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.223 1.009 . . . . 74.32 109.227 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 64.3 m -87.49 139.65 30.33 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.219 0.608 . . . . 74.24 110.737 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.6 -65.02 1.01 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.098 -0.955 . . . . 74.52 109.395 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -157.91 176.19 12.87 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.167 0.587 . . . . 75.13 110.784 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.447 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -140.79 147.47 39.12 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.671 1.188 . . . . 72.34 108.162 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.447 ' N ' HD13 ' C' ' 75' ' ' LEU . 51.0 t -151.08 129.36 11.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.129 0.971 . . . . 60.52 108.596 175.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -136.86 134.58 37.06 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.976 0.51 . . . . 74.1 110.025 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' C' ' 110' ' ' ALA . 36.5 t -131.39 115.6 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 52.34 109.021 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 27.2 mt-30 -89.48 96.39 10.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.018 . . . . 63.15 108.25 169.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.598 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.7 tp-100 -80.07 125.45 29.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.273 0.629 . . . . 71.33 109.86 176.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.23 154.19 16.81 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.831 -0.507 . . . . 72.12 111.831 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.471 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.25 120.24 1.05 Allowed Glycine 0 CA--C 1.504 -0.65 0 N-CA-C 111.865 -0.494 . . . . 72.12 111.865 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.517 HD13 HD13 ' C' ' 51' ' ' LEU . 9.0 mm -87.92 122.6 39.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 64.04 108.371 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -133.75 127.33 32.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.933 -0.766 . . . . 74.31 108.933 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -87.91 104.28 16.47 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.659 -0.867 . . . . 73.23 108.659 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' C' ' 10' ' ' THR . 21.9 pt -115.54 134.36 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.352 1.061 . . . . 73.55 110.234 -173.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.34 172.2 14.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 74.12 111.272 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.68 -49.15 2.3 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.648 -0.705 . . . . 72.21 113.054 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.8 pp -119.94 172.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.567 0.747 . . . . 73.12 110.828 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.81 -172.91 4.27 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.776 -0.647 . . . . 72.32 110.186 -171.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.85 -129.01 44.47 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.736 0.647 . . . . 71.12 113.835 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -69.75 -28.03 65.44 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.319 1.048 . . . . 75.45 111.916 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.8 -47.83 83.37 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.745 0.818 . . . . 73.22 109.838 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 36.6 ttp -83.38 -29.18 28.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.449 -0.796 . . . . 72.35 110.829 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.33 -30.86 71.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.981 0.513 . . . . 74.24 111.368 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -68.77 -34.53 75.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.285 0.634 . . . . 75.05 110.434 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -70.3 -61.86 1.61 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.761 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.546 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.9 OUTLIER -77.83 -13.5 59.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.819 0.674 . . . . 54.5 112.819 -176.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -7.35 49.9 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 119.757 -0.468 . . . . 62.01 113.875 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.56 -58.28 0.63 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.311 0.555 . . . . 73.33 110.951 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.649 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 39.4 t80 -70.99 -45.04 64.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.271 1.028 . . . . 74.34 112.089 -169.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.596 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 33.4 m -70.45 -44.13 17.79 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.549 0.739 . . . . 73.21 111.739 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.579 ' HA ' HD13 ' C' ' 60' ' ' LEU . 86.9 Cg_exo -50.5 -41.57 51.94 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.459 2.106 . . . . 75.53 113.91 168.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -62.41 -26.81 68.68 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.64 0.776 . . . . 72.23 112.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -80.95 -45.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.139 0.576 . . . . 75.22 110.86 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.471 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.3 mt -78.12 -33.13 50.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.735 -0.666 . . . . 75.11 112.124 -171.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.509 ' HE1' HD23 ' C' ' 128' ' ' LEU . 25.0 t80 -51.36 -52.03 63.3 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.692 -1.147 . . . . 73.44 113.708 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 93.6 Cg_exo -48.89 -36.49 34.2 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.938 2.425 . . . . 73.42 114.685 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -72.9 -43.9 61.9 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.88 -0.6 . . . . 73.11 111.622 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -64.87 -39.4 93.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.744 0.418 . . . . 61.32 110.645 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -55.8 -57.06 13.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.481 1.513 . . . . 74.12 111.275 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -68.09 -31.73 71.56 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.514 0.725 . . . . 74.41 110.913 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' C' ' 21' ' ' ILE . 14.0 t -67.91 -37.93 82.32 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.255 0.622 . . . . 60.55 111.199 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.584 HG21 HG23 ' C' ' 64' ' ' VAL . 70.1 mt -64.78 -49.29 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.497 -0.774 . . . . 72.15 109.729 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -60.16 -34.45 73.59 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 123.882 0.739 . . . . 75.1 111.534 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -67.78 -38.84 83.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.256 -0.884 . . . . 75.22 110.083 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.688 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -69.43 -37.87 77.61 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.101 0.96 . . . . 73.22 112.273 178.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.06 -34.16 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.14 0.576 . . . . 73.23 109.498 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.454 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 39.5 t -65.19 -38.81 91.66 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-N 115.381 -0.827 . . . . 71.14 111.727 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.422 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.5 mtt-85 -72.21 -23.81 61.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.19 -0.914 . . . . 74.15 111.18 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.43 6.42 83.29 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 119.865 -0.408 . . . . 54.14 113.146 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.409 HG22 ' HB3' ' D' ' 17' ' ' TYR . 38.0 p 60.75 35.64 19.56 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.014 1.726 . . . . 75.31 112.18 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -115.06 148.12 39.88 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.534 0.734 . . . . 75.34 110.89 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -45.89 109.03 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.295 3.33 . . . . 73.3 112.822 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.06 131.55 51.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.304 -1.316 . . . . 73.51 111.967 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.3 tp -108.58 102.16 11.25 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.401 0.68 . . . . 74.42 109.443 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -90.97 111.89 23.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.952 -1.129 . . . . 71.52 107.952 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.548 HD12 ' H ' ' C' ' 129' ' ' ALA . 16.9 tp -73.43 149.05 42.69 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.113 0.782 . . . . 72.33 113.113 -164.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . 0.548 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -65.9 157.92 77.85 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.611 1.565 . . . . 74.31 112.784 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.662 ' HG2' HG22 ' A' ' 13' ' ' ILE . 8.2 Cg_exo -73.73 129.49 13.6 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.059 2.506 . . . . 74.41 112.56 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.53 107.66 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.751 -1.574 . . . . 73.43 106.751 168.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -102.78 103.64 13.87 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.234 -1.025 . . . . 73.33 108.234 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -62.25 -35.83 80.15 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.781 -0.645 . . . . 63.22 110.523 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 N--CA 1.476 0.832 0 C-N-CA 123.578 0.751 . . . . 74.23 112.092 176.371 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 57.5 m . . . . . 0 C--O 1.24 0.555 0 N-CA-C 108.031 -1.1 . . . . 72.43 108.031 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -157.59 93.32 1.28 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.728 -1.212 . . . . 75.53 107.728 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -117.56 115.88 26.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.87 -0.789 . . . . 74.42 108.87 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 22.0 mt -68.41 127.67 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.135 -1.061 . . . . 70.41 108.135 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.95 -42.47 14.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.65 -0.87 . . . . 72.11 108.65 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 178.92 150.6 0.28 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.312 1.045 . . . . 74.35 109.759 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.433 HD12 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -116.1 144.07 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.466 -1.309 . . . . 63.54 107.466 169.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 13.6 p90 -165.53 150.46 8.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.669 0.747 . . . . 74.33 111.108 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -78.02 109.76 12.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.623 -1.171 . . . . 75.11 109.228 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.549 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 46.6 mtpt -75.83 -32.86 59.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.819 -0.628 . . . . 74.24 109.435 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.4 t70 -149.23 137.42 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.697 -1.138 . . . . 64.43 109.452 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.688 HG21 ' HE1' ' C' ' 117' ' ' MET . 81.0 mt -135.73 146.82 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.321 1.048 . . . . 71.41 108.674 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 m -147.66 138.3 23.25 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.161 0.984 . . . . 73.45 110.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.6 t80 -142.62 111.67 6.48 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 105.516 -2.031 . . . . 75.42 105.516 166.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.1 mt-10 -123.08 110.89 15.89 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.897 -0.779 . . . . 74.13 108.897 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.609 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -113.64 83.25 6.99 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.477 0.711 . . . . 75.33 109.336 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.27 -36.9 6.45 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.505 2.137 . . . . 71.24 111.807 -175.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 30.8 m-20 -112.41 22.77 14.32 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.041 0.936 . . . . 75.52 109.891 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -49.82 -60.48 4.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 114.394 1.257 . . . . 62.35 114.394 -168.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HE3' ' C' ' 19' ' ' LYS . 82.7 Cg_endo -75.12 -8.76 20.21 Favored 'Trans proline' 0 C--N 1.387 2.585 0 CA-C-N 121.751 1.661 . . . . 73.15 112.845 -175.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.3 t-160 -83.5 -37.17 23.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.43 1.492 . . . . 64.31 109.427 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' D' ' 73' ' ' ALA . 96.3 t -72.42 -32.49 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.777 . . . . 73.35 110.357 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -69.07 -3.1 11.87 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.528 0.936 . . . . 73.51 113.528 -176.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.94 -9.92 58.34 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.57 0.748 . . . . 72.23 111.306 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -110.4 114.29 27.61 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.672 1.189 . . . . 75.13 109.677 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.11 93.9 5.96 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.826 0.85 . . . . 75.14 112.106 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.449 ' CH2' ' HB3' ' D' ' 68' ' ' LEU . 0.0 OUTLIER -168.78 -164.48 0.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.684 0.794 . . . . 75.41 111.262 -177.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -89.12 122.08 69.05 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 124.193 0.997 . . . . 74.4 111.544 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.753 ' HB3' HD12 ' D' ' 68' ' ' LEU . 74.2 Cg_exo -56.43 134.52 64.79 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.51 2.807 . . . . 73.51 114.531 165.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.11 114.0 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.553 -1.647 . . . . 75.13 106.553 166.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.18 138.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.554 0.742 . . . . 72.1 109.852 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -130.92 153.18 49.43 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.424 1.09 . . . . 73.44 111.134 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.6 120.0 37.18 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.847 -1.168 . . . . 62.3 107.847 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.544 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -105.66 145.38 31.13 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.105 -1.072 . . . . 74.12 108.105 171.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.68 147.34 44.79 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.489 0.661 . . . . 63.51 111.93 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.67 146.85 27.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.328 1.451 . . . . 62.41 107.705 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -123.62 155.76 37.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.411 0.684 . . . . 73.22 110.757 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.613 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -159.25 158.37 32.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.506 0.722 . . . . 74.24 110.312 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 60.7 p -160.25 153.22 21.52 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.395 0.678 . . . . 74.11 109.434 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 26.7 p -157.56 123.31 4.66 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.521 0.728 . . . . 71.21 109.582 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -70.36 120.46 16.05 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.434 -0.58 . . . . 72.12 109.434 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -89.88 -38.35 13.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 71.33 110.138 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.0 -175.95 5.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 75.12 110.262 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -67.19 128.26 35.71 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.671 -0.695 . . . . 71.32 109.291 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 45.5 m-20 63.13 13.99 7.3 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.349 1.06 . . . . 75.22 112.135 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.28 119.9 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.238 1.015 . . . . 71.44 108.483 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -132.86 128.61 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.185 -1.043 . . . . 63.31 108.185 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -94.71 130.97 41.01 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.367 -0.605 . . . . 71.3 109.367 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 59.6 t -106.87 119.08 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.839 -1.171 . . . . 73.44 107.839 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.9 t -106.28 129.42 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.85 -0.796 . . . . 75.44 108.85 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.29 113.1 20.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.115 -1.069 . . . . 72.12 108.115 176.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -86.87 98.26 11.11 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.884 -0.784 . . . . 71.33 108.884 172.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -91.48 127.32 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.008 -1.108 . . . . 74.55 108.008 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 16.9 m -126.62 148.33 49.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.988 -0.745 . . . . 54.02 108.988 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.1 t -136.42 109.49 8.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 125.317 1.447 . . . . 72.43 108.192 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 122.27 44.78 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.994 0.518 . . . . 74.44 109.633 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.63 135.14 49.57 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.78 -0.822 . . . . 72.2 108.78 172.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -135.39 116.22 14.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.031 -1.47 . . . . 62.54 107.031 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.753 HD12 ' HB3' ' D' ' 38' ' ' PRO . 9.9 mp -122.42 115.45 22.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.555 -0.748 . . . . 72.02 110.662 -167.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.79 -111.32 3.27 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.799 -0.92 . . . . 71.24 110.799 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.59 6.61 8.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.067 0.947 . . . . 73.52 109.172 174.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.5 174.92 7.48 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.846 0.858 . . . . 72.21 110.035 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -84.18 135.29 34.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.249 0.619 . . . . 73.21 110.793 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.531 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -81.19 -73.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.725 . . . . 74.33 109.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -153.6 155.55 36.31 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.272 -1.331 . . . . 74.44 109.947 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.2 mt -123.08 110.93 15.94 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 107.928 -1.138 . . . . 74.42 107.928 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.4 t -115.78 133.74 55.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.966 -0.753 . . . . 64.24 108.966 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -153.86 132.87 12.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.637 0.375 . . . . 72.12 110.252 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.58 115.69 15.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.901 0.881 . . . . 74.13 109.327 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -88.7 86.82 7.06 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.723 -0.843 . . . . 75.03 108.723 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.21 95.13 6.19 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.704 -1.135 . . . . 73.53 109.468 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.549 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -91.96 143.35 16.5 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.208 -0.757 . . . . 61.43 111.208 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.57 130.03 3.92 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 110.274 -1.13 . . . . 74.34 110.274 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -89.8 127.1 42.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.816 . . . . 75.11 108.795 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.4 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 36.6 m-85 -130.21 125.41 34.85 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.602 -0.518 . . . . 75.51 109.602 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.3 m -79.33 95.24 5.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.471 0.709 . . . . 73.12 109.304 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 mt -108.4 123.32 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.721 0.808 . . . . 61.53 109.625 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.47 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -152.64 169.84 21.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.278 1.031 . . . . 73.24 109.711 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.63 2.01 73.79 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.9 0.72 . . . . 62.24 114.9 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 pt -135.93 148.5 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.005 0.922 . . . . 74.21 109.517 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.86 159.71 41.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.566 0.746 . . . . 63.23 110.813 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.82 -115.53 7.38 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 124.279 0.987 . . . . 70.33 115.372 167.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.4 m -68.68 -33.04 73.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.063 0.945 . . . . 64.44 111.891 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.08 -44.74 62.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.762 0.425 . . . . 72.35 111.025 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.82 67.68 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.979 -0.378 . . . . 72.32 109.979 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.19 82.35 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.547 0.739 . . . . 54.21 110.649 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -63.61 -42.27 98.24 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.849 0.46 . . . . 73.44 110.034 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.4 -47.77 80.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.848 0.459 . . . . 74.41 110.955 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -34.36 46.92 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.452 0.701 . . . . 63.14 110.576 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.82 -15.57 72.57 Favored Glycine 0 N--CA 1.466 0.677 0 CA-C-N 116.271 -0.422 . . . . 61.1 113.47 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.17 -63.89 0.83 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.618 0.599 . . . . 73.22 112.618 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -72.46 -48.02 44.21 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 112.634 0.605 . . . . 75.2 112.634 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.35 -46.23 90.13 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.556 0.742 . . . . 73.12 112.855 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.16 -31.19 54.7 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.043 1.828 . . . . 74.32 112.182 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -72.09 -17.99 61.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.703 0.801 . . . . 73.31 111.024 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.0 mm -80.2 -43.81 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.478 0.711 . . . . 74.23 110.051 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.81 -32.62 57.75 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.545 0.738 . . . . 71.11 112.571 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.06 -44.79 95.47 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 124.154 0.981 . . . . 74.34 113.095 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.85 -37.24 98.6 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.536 2.157 . . . . 75.43 114.075 172.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -79.91 -25.96 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.087 0.555 . . . . 73.44 111.838 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.22 -50.07 62.14 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.105 -0.702 . . . . 61.31 109.105 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.5 -35.59 76.29 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.564 1.165 . . . . 73.24 111.301 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . 0.422 ' HG2' HH12 ' C' ' 120' ' ' ARG . 26.8 tt0 -56.35 -52.13 65.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.151 0.98 . . . . 71.03 110.865 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.915 -1.039 . . . . 73.3 111.132 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.427 HG12 ' SG ' ' D' ' 76' ' ' CYS . 87.7 mt -58.74 -63.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.185 0.994 . . . . 71.34 110.508 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 34.9 m -52.03 -38.17 56.0 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.467 1.107 . . . . 75.21 112.206 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 25.9 t -66.41 -45.21 80.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.52 0.728 . . . . 73.34 111.04 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.416 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.9 mtm -67.95 -36.71 80.57 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.886 0.475 . . . . 73.12 111.554 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.407 HG22 ' O ' ' D' ' 114' ' ' ILE . 97.9 t -64.4 -40.27 88.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 115.306 -0.861 . . . . 71.42 110.224 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -31.33 65.99 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.601 0.36 . . . . 73.35 111.202 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 93.8 mtt-85 -73.16 -23.52 60.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.286 0.634 . . . . 74.32 110.994 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.31 12.41 69.01 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.743 0.652 . . . . 60.51 112.861 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 54.3 p 59.78 22.21 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.277 1.831 . . . . 71.11 113.619 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.23 161.64 30.45 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.423 1.089 . . . . 71.31 109.387 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -74.9 144.34 30.5 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.256 1.971 . . . . 64.12 111.172 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.711 HE21 HG23 ' A' ' 122' ' ' THR . 5.0 pt20 -44.84 121.78 2.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.666 1.186 . . . . 73.34 111.934 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.78 95.42 5.72 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.616 -1.253 . . . . 74.15 107.616 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -103.77 109.26 20.91 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.303 -0.862 . . . . 72.3 109.134 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.83 118.97 11.77 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.614 -0.721 . . . . 72.55 109.057 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.2 138.66 97.49 Favored Pre-proline 0 CA--C 1.55 0.953 0 O-C-N 123.963 0.789 . . . . 73.13 111.15 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.45 132.12 10.97 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.429 2.086 . . . . 73.54 112.882 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.71 121.96 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.366 -0.976 . . . . 73.41 108.366 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -77.27 97.54 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.084 -0.71 . . . . 70.32 109.084 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 CA--C 1.542 0.659 0 CA-C-N 115.48 -0.782 . . . . 65.21 111.156 -179.404 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 109.665 -0.495 . . . . 63.31 109.665 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.7 t80 -135.89 122.33 20.67 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.908 -1.145 . . . . 73.55 107.908 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -144.78 102.71 3.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.099 -0.334 . . . . 72.52 110.099 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.797 HG22 ' HG2' ' C' ' 130' ' ' PRO . 58.2 mt -71.93 128.34 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.101 -0.703 . . . . 71.34 109.101 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -103.68 -37.55 7.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.917 0.487 . . . . 71.44 110.011 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -165.53 138.73 4.42 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 110.209 -0.293 . . . . 74.22 110.209 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.406 HD11 ' HD3' ' C' ' 130' ' ' PRO . 0.2 OUTLIER -128.4 134.01 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.57 -0.9 . . . . 74.21 108.57 172.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -165.07 147.02 7.87 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 65.43 110.961 -172.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.44 110.48 11.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.79 -0.819 . . . . 75.3 108.79 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -76.05 -22.52 55.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.025 -0.534 . . . . 74.43 110.511 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.87 142.16 17.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.797 -1.092 . . . . 71.43 109.441 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.7 140.2 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 106.732 -1.581 . . . . 73.03 106.732 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 31.1 t -150.85 141.75 22.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.8 -0.815 . . . . 74.14 108.8 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.519 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 86.8 t80 -151.78 110.78 3.87 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 105.955 -1.869 . . . . 64.42 105.955 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -122.35 118.15 27.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.356 -0.609 . . . . 74.23 109.356 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.89 83.73 1.11 Allowed Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 107.802 -1.185 . . . . 73.01 107.802 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.88 -42.64 36.19 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.859 2.372 . . . . 71.4 112.929 -166.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -109.64 29.89 7.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 118.415 -0.803 . . . . 73.02 109.815 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.89 -57.06 5.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 117.583 -1.199 . . . . 73.02 113.669 -173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -64.42 -29.33 62.52 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.618 1.614 . . . . 74.43 112.348 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -79.8 -35.75 38.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.853 -1.067 . . . . 72.22 110.883 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.1 p -80.88 -13.49 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 115.749 -0.66 . . . . 73.05 111.879 -168.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -76.57 -11.72 59.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.174 0.59 . . . . 72.34 110.781 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -91.25 -12.5 35.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.495 1.118 . . . . 75.5 110.913 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 27.9 mmmt -81.62 166.2 20.4 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.671 0.788 . . . . 75.23 112.103 -173.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.14 139.18 39.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.254 -1.339 . . . . 75.3 108.576 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -81.31 69.35 7.92 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.579 0.704 . . . . 74.43 111.16 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -134.35 71.48 72.01 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.871 0.868 . . . . 71.33 108.93 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 67' ' ' SER . 92.4 Cg_endo -81.91 143.18 12.92 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.28 1.987 . . . . 74.3 111.704 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -104.65 102.37 11.97 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.79 -1.189 . . . . 65.35 107.79 164.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 65' ' ' THR . 42.4 t -74.43 94.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 60.1 tttm -80.85 113.84 19.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.129 0.972 . . . . 75.53 109.519 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.13 125.67 44.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.121 -1.066 . . . . 73.41 108.121 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.619 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -120.01 129.65 54.36 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.334 -0.987 . . . . 75.11 108.334 176.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.43 117.56 34.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.15 -0.685 . . . . 73.12 109.15 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.079 -1.082 . . . . 75.45 108.079 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -152.14 163.46 39.32 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 122.834 0.454 . . . . 75.05 111.15 -174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -160.91 153.23 20.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.099 0.96 . . . . 74.12 109.974 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -131.23 151.45 51.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.814 -0.81 . . . . 73.32 108.814 167.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -158.21 145.5 18.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.859 0.464 . . . . 73.24 110.675 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -88.19 113.62 23.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.504 0.722 . . . . 72.44 109.585 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.46 -35.81 24.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.836 0.455 . . . . 74.12 110.269 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.74 -174.61 4.7 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.364 1.066 . . . . 73.15 109.839 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.64 130.09 40.31 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.225 -0.658 . . . . 74.42 109.225 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 69.37 -9.89 0.6 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.819 1.648 . . . . 63.02 112.813 -170.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.57 109.41 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.649 0.78 . . . . 74.22 109.188 -170.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -126.81 157.2 39.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.039 -1.097 . . . . 73.34 108.039 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -132.51 146.08 51.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.027 0.931 . . . . 74.43 109.355 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.92 132.87 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.853 -1.166 . . . . 64.13 107.853 167.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.22 133.63 58.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.774 -0.824 . . . . 72.54 108.774 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 103' ' ' PRO . 75.5 mt -116.69 100.55 7.89 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.969 -1.122 . . . . 73.5 107.969 173.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -85.32 102.31 13.28 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.647 -0.871 . . . . 74.02 108.647 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.9 t -92.13 119.78 40.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.133 -1.062 . . . . 73.11 108.133 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -103.7 135.08 45.93 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.391 0.615 . . . . 74.02 110.207 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.567 HG12 HD23 ' A' ' 126' ' ' LEU . 72.9 t -131.12 114.17 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.589 -1.187 . . . . 74.13 108.738 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 1.1 m -115.35 138.72 50.68 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 108.627 -0.879 . . . . 71.2 108.627 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.27 129.08 42.82 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.105 -0.702 . . . . 73.54 109.105 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 64.1 m -134.18 124.34 25.86 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.589 -0.523 . . . . 72.32 109.589 173.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HB1' ' A' ' 73' ' ' ALA . 9.5 mp -88.4 85.14 6.82 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.398 -0.964 . . . . 75.22 108.398 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 -82.59 1.64 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.011 -0.995 . . . . 70.14 110.711 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -27.15 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.122 0.969 . . . . 75.22 111.612 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.32 127.18 45.3 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.086 0.555 . . . . 72.14 110.239 -172.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 65.8 m -74.05 138.36 43.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.471 0.709 . . . . 72.13 111.909 -175.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -87.3 -64.06 1.21 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.63 1.172 . . . . 72.22 110.56 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -153.76 172.56 17.12 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.264 -0.88 . . . . 71.34 111.781 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.0 tp -141.53 137.95 32.38 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.813 -1.539 . . . . 61.54 107.799 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.9 m -121.86 139.62 53.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.702 0.801 . . . . 52.15 109.864 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 22.3 mp0 -137.25 122.78 19.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.614 1.166 . . . . 71.34 108.068 169.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.95 108.03 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 108.184 -1.043 . . . . 72.41 108.184 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.01 81.76 8.37 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 124.296 0.998 . . . . 74.11 108.314 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.06 93.84 3.36 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.93 153.58 27.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.407 -0.815 . . . . 65.44 111.376 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -155.29 122.17 1.19 Allowed Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.083 -0.807 . . . . 43.43 111.083 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mt -82.78 116.3 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.397 0.679 . . . . 63.42 109.431 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.595 ' HD2' HG12 ' A' ' 13' ' ' ILE . 31.6 m-85 -120.63 118.7 30.81 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 74.13 108.267 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 t -91.33 99.71 12.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.583 -0.895 . . . . 64.2 108.583 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.454 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -121.14 152.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.255 0.622 . . . . 71.14 111.191 -173.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 162.89 33.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.117 0.967 . . . . 72.14 109.843 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.61 -14.38 47.25 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.793 -0.448 . . . . 72.25 114.013 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.466 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.76 136.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.618 0.709 . . . . 74.12 109.676 177.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -145.56 175.28 10.46 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.99 1.316 . . . . 72.14 108.467 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.52 -121.45 26.63 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 123.439 0.462 . . . . 60.25 113.798 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -73.07 -25.7 61.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.285 0.634 . . . . 73.32 111.416 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -67.67 -47.11 70.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.446 0.698 . . . . 74.34 110.057 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.475 ' HE2' HD13 ' A' ' 98' ' ' LEU . 21.7 ttt -81.93 -19.47 40.68 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.571 -0.741 . . . . 75.45 110.518 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.22 73.67 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.599 0.36 . . . . 62.12 110.395 171.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -79.46 -37.56 36.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.357 0.663 . . . . 74.13 110.503 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.6 t -63.91 -44.76 92.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.228 0.611 . . . . 62.15 110.752 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.475 HD13 ' HE2' ' A' ' 94' ' ' MET . 15.9 mt -92.39 -9.42 41.77 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.53 0.332 . . . . 74.03 111.049 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.65 -29.04 17.27 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.28 0.472 . . . . 64.42 114.28 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.42 -46.14 0.14 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.485 0.55 . . . . 75.2 112.485 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.0 t80 -60.88 -65.63 0.66 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.053 0.941 . . . . 75.13 112.699 -171.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.4 m -70.75 -34.04 3.42 Favored Pre-proline 0 CA--C 1.565 1.52 0 C-N-CA 123.72 0.808 . . . . 74.3 112.647 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 60' ' ' LEU . 98.0 Cg_exo -49.5 -39.85 45.31 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.263 1.975 . . . . 73.03 113.874 162.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.28 -12.79 61.64 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.364 0.665 . . . . 70.32 111.802 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -78.11 -48.38 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.285 -0.635 . . . . 75.41 109.285 171.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.518 HD23 ' HA3' ' A' ' 82' ' ' GLY . 95.0 mt -82.31 -28.43 31.69 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.917 0.887 . . . . 72.42 113.103 -170.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.23 -41.5 69.35 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.169 -0.92 . . . . 75.12 113.425 -172.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.33 -36.51 87.18 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.93 1.753 . . . . 74.15 113.138 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -69.89 -42.38 73.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.062 0.545 . . . . 75.0 111.452 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.0 94.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.176 0.591 . . . . 73.43 109.846 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -54.02 -51.86 62.64 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.676 1.235 . . . . 75.14 110.425 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.12 -47.04 86.36 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.395 1.06 . . . . 72.54 110.979 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.402 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 36.4 t -57.61 -43.56 84.8 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.082 0.864 . . . . 72.43 110.763 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 62' ' ' VAL . 81.2 mt -65.81 -51.19 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 124.074 0.859 . . . . 75.21 110.303 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -53.96 -41.88 68.31 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.094 0.871 . . . . 73.51 111.096 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.9 t -68.93 -45.82 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.63 -1.168 . . . . 71.13 110.471 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.519 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 17.2 mtp -56.76 -41.86 78.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.648 0.779 . . . . 54.32 111.428 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.1 -45.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.655 1.182 . . . . 64.21 110.544 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.4 p -73.52 -26.72 61.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.331 -0.395 . . . . 74.02 111.181 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.7 mtt-85 -73.81 -33.12 64.05 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.668 0.787 . . . . 70.52 109.399 172.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' B' ' 18' ' ' THR . . . -74.95 -1.38 62.57 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 115.437 -0.801 . . . . 73.41 112.686 170.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.34 31.98 17.14 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.744 2.018 . . . . 74.32 112.433 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -94.01 154.91 40.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.758 -1.201 . . . . 75.51 107.758 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -51.78 142.19 42.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.776 2.318 . . . . 72.12 112.161 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.24 127.26 28.5 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.878 0.736 . . . . 73.12 111.516 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.567 HD23 HG12 ' A' ' 64' ' ' VAL . 32.9 tp -111.05 95.18 5.38 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.608 -1.178 . . . . 73.21 109.294 -176.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -103.04 107.53 18.37 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.843 -1.169 . . . . 73.33 107.843 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.2 tp -72.39 134.15 45.28 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.381 -0.6 . . . . 73.3 109.381 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.63 141.24 97.9 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.578 0.751 . . . . 73.32 111.861 -176.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.625 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 21.0 Cg_endo -87.21 110.91 0.81 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.562 2.174 . . . . 73.33 111.838 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.7 125.05 54.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.422 -0.955 . . . . 72.13 108.422 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.73 79.93 7.28 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -61.85 -34.21 75.57 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.6 -0.727 . . . . 73.23 110.041 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--N 1.351 0.655 0 CA-C-N 114.549 -1.205 . . . . 75.24 111.094 179.614 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.69 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 19.9 m . . . . . 0 C--O 1.24 0.554 0 N-CA-C 107.948 -1.13 . . . . 71.43 107.948 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -146.67 113.71 6.17 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.175 -0.676 . . . . 73.44 109.175 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.66 140.12 27.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.885 -0.783 . . . . 74.33 108.885 165.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' D' ' 127' ' ' ASN . 0.0 OUTLIER -90.66 126.81 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.275 -0.875 . . . . 71.11 108.816 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.69 -52.6 5.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.52 0.676 . . . . 73.35 109.988 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -151.07 132.9 15.02 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.944 -0.472 . . . . 74.22 110.878 -169.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.636 HG13 HD13 ' B' ' 13' ' ' ILE . 96.5 mt -114.36 140.73 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.214 -1.773 . . . . 71.4 106.214 166.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.423 ' HE1' HG13 ' B' ' 83' ' ' ILE . 34.9 p90 -164.09 150.73 11.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.416 0.627 . . . . 75.12 111.333 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.414 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 96.3 m -74.18 126.83 31.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.589 -1.187 . . . . 71.32 108.246 167.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -91.91 -48.04 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.769 -1.197 . . . . 73.32 107.769 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 21.5 m-20 -138.88 143.0 38.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 115.091 -0.959 . . . . 75.22 110.471 -165.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.543 HD13 ' SG ' ' B' ' 113' ' ' CYS . 43.5 mm -136.23 144.44 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.939 1.296 . . . . 75.0 109.164 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.522 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 60.3 m -142.83 135.29 27.62 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.201 1.4 . . . . 73.53 108.166 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.36 107.95 3.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.364 -1.717 . . . . 74.44 106.364 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.73 124.02 47.45 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.993 -0.743 . . . . 75.12 108.993 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.02 82.11 61.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 106.917 -1.512 . . . . 63.44 106.917 173.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.33 -22.11 34.5 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.317 2.678 . . . . 75.22 112.164 -172.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -122.64 29.77 6.75 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.751 1.22 . . . . 61.55 109.392 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.3 -45.42 42.8 Favored Pre-proline 0 CA--C 1.576 1.944 0 N-CA-C 115.819 1.785 . . . . 72.42 115.819 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 59.8 Cg_endo -75.51 -30.12 6.79 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.543 1.496 . . . . 53.2 113.137 172.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.408 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 71.0 m80 -90.92 -15.2 30.22 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.322 0.86 . . . . 72.32 113.322 -170.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -19.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.927 0.891 . . . . 70.24 111.819 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.26 -19.11 64.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.977 1.311 . . . . 73.35 112.295 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 23.8 pt20 -64.36 -36.92 85.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.811 0.444 . . . . 64.52 110.442 175.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.459 ' HB2' HD13 ' B' ' 68' ' ' LEU . 90.5 mttt -106.34 65.48 0.68 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.671 -0.863 . . . . 73.14 108.671 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.28 100.43 5.1 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.322 -0.399 . . . . 73.32 110.045 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.405 ' HE3' ' HA ' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 163.41 -177.36 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 127.643 2.377 . . . . 75.32 109.731 156.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.15 121.15 28.91 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.984 1.314 . . . . 72.13 114.175 -170.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.06 174.55 10.0 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.413 2.075 . . . . 75.34 110.816 163.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.57 103.23 6.45 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.481 -1.303 . . . . 73.53 107.481 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.72 141.13 14.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.864 -0.791 . . . . 74.43 108.864 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -132.65 130.85 40.7 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.355 -0.609 . . . . 72.12 109.355 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -86.22 140.6 29.99 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.02 -1.104 . . . . 75.42 108.02 165.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.38 151.52 46.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.671 -1.233 . . . . 65.02 107.671 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.84 134.1 40.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.147 0.431 . . . . 75.44 110.171 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.452 ' HB2' ' HD2' ' B' ' 61' ' ' ARG . 7.8 m-20 -123.4 138.2 54.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.973 0.909 . . . . 71.02 109.06 173.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.2 p -109.62 146.75 34.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.207 0.603 . . . . 63.42 110.315 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.76 143.51 15.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.958 0.903 . . . . 70.35 108.933 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.2 p -141.75 160.93 39.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.895 0.316 . . . . 65.54 110.626 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.19 141.83 21.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.53 0.732 . . . . 71.24 110.446 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.44 121.83 30.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.438 0.695 . . . . 73.11 109.927 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 mt -94.17 -40.12 10.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 70.41 110.435 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' B' ' 55' ' ' VAL . . . -162.69 -168.33 1.78 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.728 -1.124 . . . . 72.42 109.716 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.66 112.77 14.82 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.164 -0.925 . . . . 72.31 109.387 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 65.26 3.95 2.45 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.184 1.394 . . . . 73.43 112.745 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' B' ' 52' ' ' ALA . 92.8 t -104.73 113.64 42.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.902 -1.148 . . . . 73.14 107.902 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.14 169.81 13.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.441 -0.8 . . . . 75.22 109.101 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -138.5 107.77 6.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.783 -0.821 . . . . 73.04 108.783 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.09 127.75 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.343 1.457 . . . . 65.2 109.577 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.69 132.29 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.888 0.875 . . . . 75.21 109.631 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' B' ' 103' ' ' PRO . 50.0 tp -124.5 118.3 26.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.942 -0.762 . . . . 75.54 108.942 171.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.452 ' HD2' ' HB2' ' B' ' 45' ' ' ASP . 28.9 ttm180 -84.17 133.22 34.61 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.127 -1.064 . . . . 74.11 108.127 169.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.97 116.58 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.193 -1.04 . . . . 74.53 108.193 169.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -104.98 146.43 29.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.808 1.243 . . . . 74.31 109.017 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.75 97.8 3.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 107.907 -1.146 . . . . 74.23 107.907 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.0 m -93.89 135.32 35.34 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.21 -0.663 . . . . 71.22 109.21 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.1 136.64 25.29 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.751 0.821 . . . . 63.41 108.887 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -147.66 130.3 15.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.154 0.582 . . . . 71.34 111.067 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' B' ' 34' ' ' LYS . 57.8 mt -98.99 104.85 16.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.374 1.069 . . . . 75.33 109.651 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.44 -110.23 3.2 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.908 -0.587 . . . . 71.32 111.643 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.94 4.71 14.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.73 0.812 . . . . 72.12 111.121 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.17 176.17 5.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.462 -0.569 . . . . 72.41 109.462 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 7.4 m -75.72 157.25 33.82 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.702 0.801 . . . . 71.14 110.34 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.449 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -110.18 -61.73 1.62 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.034 -0.728 . . . . 65.14 109.034 166.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -166.04 141.09 4.67 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.738 -1.119 . . . . 74.43 108.644 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.26 132.55 54.87 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.381 -0.97 . . . . 74.21 108.381 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.4 t -140.74 153.59 45.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.591 -0.892 . . . . 51.33 108.591 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.3 tt0 -166.18 141.59 4.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.134 -0.691 . . . . 75.54 109.134 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -129.45 146.29 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.257 -1.016 . . . . 75.4 108.257 173.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 49.2 mt-30 -122.54 96.93 5.23 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.96 -1.126 . . . . 72.03 107.96 171.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -92.85 106.85 18.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.877 -1.056 . . . . 72.14 108.811 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.34 171.58 35.34 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.632 -0.587 . . . . 73.02 111.632 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.83 126.99 1.54 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 112.056 -0.418 . . . . 70.02 112.056 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.423 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.8 mt -84.68 116.69 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.877 0.871 . . . . 73.42 109.038 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -124.0 146.83 48.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.467 1.107 . . . . 75.5 108.609 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 61.3 m -106.86 104.61 14.34 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.153 -0.684 . . . . 54.32 109.153 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -114.03 134.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.828 0.851 . . . . 73.32 109.693 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.69 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.5 167.9 29.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.522 1.129 . . . . 73.14 109.317 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.66 -50.21 4.32 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.323 0.389 . . . . 65.54 112.9 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -62.68 146.39 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.403 0.681 . . . . 72.12 111.504 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.3 178.46 6.21 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.731 0.813 . . . . 72.32 110.627 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -122.05 27.41 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 123.845 0.715 . . . . 63.05 113.536 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.7 m -78.3 -37.38 44.94 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.023 0.929 . . . . 74.42 110.569 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -76.03 -26.97 57.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.561 -0.745 . . . . 65.32 111.987 -166.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -66.11 -30.85 71.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.479 0.181 . . . . 74.55 110.693 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.52 75.72 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.868 0.73 . . . . 72.53 110.515 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -76.01 -32.4 59.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.451 0.3 . . . . 74.0 110.896 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.47 -55.65 9.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.946 0.498 . . . . 75.4 110.629 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.75 -38.43 38.77 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.806 0.842 . . . . 73.2 110.0 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.68 -1.62 85.24 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.084 0.794 . . . . 55.25 115.084 -171.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.02 -56.88 0.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.909 0.855 . . . . 73.32 111.524 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.87 -46.03 47.27 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.451 0.537 . . . . 74.21 112.451 -170.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -62.04 -46.34 91.68 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.503 -0.761 . . . . 50.11 112.988 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.464 ' HB2' HD22 ' B' ' 60' ' ' LEU . 59.4 Cg_endo -68.9 -22.2 36.54 Favored 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 121.889 1.726 . . . . 74.23 112.849 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -71.76 -30.49 65.63 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.407 0.683 . . . . 75.32 111.13 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.52 -48.16 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 75.25 110.986 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.63 -10.78 57.03 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.866 -0.606 . . . . 72.22 111.941 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -56.5 -47.6 98.64 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-O 117.895 -1.05 . . . . 73.54 113.656 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.03 -31.3 53.03 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.531 2.154 . . . . 70.14 114.323 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -74.06 -43.64 57.08 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.12 0.568 . . . . 65.44 110.515 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.92 91.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.105 0.562 . . . . 74.42 110.4 174.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . 0.697 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 52.7 ttt-85 -51.35 -53.72 33.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.081 1.752 . . . . 74.43 112.215 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -70.59 -34.01 71.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.308 0.643 . . . . 75.31 110.703 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' B' ' 21' ' ' ILE . 7.6 t -71.13 -30.41 66.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.04 0.536 . . . . 62.45 111.446 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.28 -52.18 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 109.525 -0.546 . . . . 75.0 109.525 173.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -60.06 -34.08 72.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.926 0.89 . . . . 75.24 111.854 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -57.98 -49.8 75.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.549 0.74 . . . . 75.32 110.493 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.0 mmt -72.22 -34.32 68.25 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.665 0.786 . . . . 74.24 111.563 -173.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.88 -37.19 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.776 0.83 . . . . 74.21 110.798 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 119' ' ' SER . . . . . 0.436 ' HB2' ' OE1' ' C' ' 125' ' ' GLN . 3.6 t -74.18 -30.85 62.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.628 0.771 . . . . 63.4 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' B' ' 116' ' ' SER . 87.6 mtt-85 -67.02 -30.09 70.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.326 0.65 . . . . 74.22 110.295 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.41 12.99 59.32 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-O 119.468 -0.629 . . . . 70.31 113.554 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 60.3 p 58.23 27.08 14.65 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.843 1.657 . . . . 75.25 113.364 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -91.8 165.26 21.0 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.07 0.948 . . . . 72.55 110.736 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.55 177.48 0.44 Allowed 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.436 2.757 . . . . 70.15 115.696 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.749 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 67.3 tp60 -64.44 143.57 57.81 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.565 -1.198 . . . . 75.52 111.806 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 30.7 tp -134.77 93.02 2.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.998 -0.742 . . . . 74.41 108.998 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -92.86 98.89 11.67 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.46 -0.941 . . . . 74.22 108.46 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.697 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 42.8 tp -71.93 131.17 42.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.216 0.606 . . . . 73.35 109.764 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.25 151.5 56.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.835 0.854 . . . . 54.43 112.199 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -54.93 124.58 16.64 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.505 2.803 . . . . 75.12 113.297 171.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.61 112.64 40.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.633 -1.247 . . . . 75.13 107.633 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -79.94 83.44 5.85 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.657 -0.868 . . . . 71.45 108.657 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 N--CA 1.48 1.065 0 C-N-CA 123.979 0.911 . . . . 72.32 111.125 -177.87 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.403 ' HA ' HG13 ' C' ' 89' ' ' ILE . 56.8 ttp . . . . . 0 CA--C 1.551 1.015 0 CA-C-O 121.235 0.541 . . . . 73.33 111.508 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.44 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 28.6 m -87.6 97.65 10.98 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.253 -1.017 . . . . 73.44 108.253 172.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -124.51 140.58 52.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.623 -0.717 . . . . 72.24 109.971 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' C' ' 85' ' ' SER . 0.1 OUTLIER -161.05 140.63 10.61 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 125.174 1.39 . . . . 75.34 107.491 172.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.59 130.25 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.249 -0.649 . . . . 71.31 109.249 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -95.24 -46.52 6.72 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.314 -0.624 . . . . 71.45 109.314 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -169.78 151.47 4.23 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.666 0.604 . . . . 71.23 110.741 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.74 133.91 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.949 1.3 . . . . 74.11 107.546 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.401 ' HB3' HG21 ' D' ' 122' ' ' THR . 20.0 p90 -171.0 157.05 5.1 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.433 0.635 . . . . 75.02 111.693 -172.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.0 p -85.8 108.37 18.07 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.469 -0.787 . . . . 65.51 109.433 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.413 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 13.0 mtmt -76.58 -35.95 57.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.441 0.639 . . . . 74.13 109.709 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.9 t70 -142.14 122.63 14.1 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.777 -1.102 . . . . 72.52 109.048 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -116.57 140.91 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.775 -1.565 . . . . 72.44 106.775 166.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -150.9 146.26 26.18 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.224 0.535 . . . . 72.21 110.203 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -152.43 109.8 3.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.491 -1.299 . . . . 74.43 107.491 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.7 116.27 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 75.12 108.551 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.01 89.78 10.16 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 106.914 -1.513 . . . . 73.24 106.914 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -49.99 0.92 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.595 2.196 . . . . 73.23 111.605 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.96 22.7 3.07 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 118.619 -0.705 . . . . 75.11 110.339 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -38.94 -53.3 3.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 115.524 1.676 . . . . 74.1 115.524 -171.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 2.7 Cg_exo -75.49 -39.41 1.06 Allowed 'Trans proline' 0 C--N 1.393 2.91 0 CA-C-N 121.472 1.561 . . . . 72.02 112.23 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -70.08 -26.23 63.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.643 1.177 . . . . 74.51 112.884 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -80.72 -22.71 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.754 0.422 . . . . 74.14 110.82 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . 0.489 ' HA ' ' CH2' ' C' ' 36' ' ' TRP . 19.0 m-30 -62.87 -32.87 74.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.759 0.424 . . . . 71.41 111.38 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -86.24 6.28 30.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.052 0.541 . . . . 73.3 111.415 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.451 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -100.4 144.08 29.82 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.39 0.676 . . . . 74.14 110.505 -179.041 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.62 122.59 15.08 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.921 0.888 . . . . 62.41 110.011 171.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . 0.489 ' CH2' ' HA ' ' C' ' 32' ' ' PHE . 47.9 m95 -67.96 96.32 0.59 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.947 0.899 . . . . 71.23 112.147 -172.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -145.69 73.43 13.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.996 -0.547 . . . . 75.12 109.811 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -83.24 133.7 6.54 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.986 2.457 . . . . 72.54 112.41 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.7 91.66 8.36 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.253 -1.388 . . . . 73.44 107.253 167.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' C' ' 65' ' ' THR . 58.3 t -76.3 111.84 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.331 -0.849 . . . . 74.55 109.303 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.561 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 59.2 mttm -99.98 117.54 34.48 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.562 -0.903 . . . . 75.24 108.562 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.497 HD13 HD11 ' C' ' 128' ' ' LEU . 3.7 tt -86.6 122.34 30.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.333 -1.358 . . . . 73.43 107.333 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.47 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 18.9 m-20 -127.02 132.28 50.78 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.524 1.13 . . . . 71.21 109.13 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -128.45 124.47 36.28 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.943 0.897 . . . . 73.05 109.37 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 16.6 t70 -116.31 150.86 36.97 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.647 1.179 . . . . 70.43 108.902 172.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 41.7 p -130.78 118.38 20.74 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.834 0.854 . . . . 64.3 109.649 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -125.69 149.1 48.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.834 0.854 . . . . 72.34 110.206 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -154.38 153.46 31.64 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.237 0.615 . . . . 63.25 110.802 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 71.6 p -157.37 152.31 25.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.252 0.621 . . . . 62.03 110.573 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -89.36 119.53 29.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.647 0.779 . . . . 71.0 109.265 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' C' ' 57' ' ' GLU . 40.1 mt -95.87 -31.61 13.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.114 0.566 . . . . 73.25 110.342 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.49 -172.87 3.32 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.083 0.953 . . . . 71.34 109.687 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -77.23 119.33 20.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.594 0.757 . . . . 63.23 109.265 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 69.89 -3.17 1.79 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.714 1.605 . . . . 73.13 112.556 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 81.5 t -104.34 115.2 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.631 0.772 . . . . 75.03 109.536 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.8 125.53 33.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.805 0.842 . . . . 71.33 108.878 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.641 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.2 tt0 -81.77 123.84 29.12 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.392 -0.596 . . . . 75.33 109.392 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -102.65 115.74 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.881 -1.155 . . . . 62.13 107.881 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 61.2 t -104.8 132.19 52.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.845 -0.798 . . . . 74.54 108.845 172.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.7 102.34 10.16 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.936 -1.505 . . . . 74.14 106.936 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.469 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 30.0 ttm180 -83.34 125.7 31.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.788 -0.819 . . . . 74.42 108.788 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.4 t -115.52 131.41 67.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.442 -1.318 . . . . 74.12 107.442 172.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 24.1 m -127.85 125.45 39.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.292 -1.003 . . . . 75.42 108.292 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.579 HG23 HG21 ' C' ' 114' ' ' ILE . 50.3 t -120.37 115.1 46.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.026 -0.731 . . . . 74.25 109.026 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.1 m -99.29 148.39 24.2 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 109.425 -0.583 . . . . 72.24 109.425 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.09 106.81 4.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.071 -1.085 . . . . 72.24 108.071 171.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.8 m -135.9 127.49 28.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.081 -0.34 . . . . 74.51 110.081 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.428 ' N ' HD13 ' C' ' 68' ' ' LEU . 4.2 mp -86.78 56.43 4.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.365 1.466 . . . . 74.32 108.238 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.34 -108.19 3.45 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 109.728 -1.349 . . . . 74.41 109.728 -173.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -25.61 17.37 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.193 0.997 . . . . 71.43 109.318 168.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.451 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 18.6 tp10 -68.03 83.85 0.22 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.416 1.486 . . . . 73.41 110.884 -176.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.1 m -73.55 120.35 19.03 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 121.083 0.468 . . . . 73.01 111.136 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.79 -55.72 7.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.536 -1.211 . . . . 74.2 108.847 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -167.16 169.36 12.75 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.789 -1.096 . . . . 73.41 111.477 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.85 138.51 49.88 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 105.232 -2.136 . . . . 75.31 105.232 165.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.6 t -139.88 111.99 7.58 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.888 -0.782 . . . . 70.22 108.888 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.45 128.12 52.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.019 0.527 . . . . 72.03 109.907 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.84 114.5 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.836 0.854 . . . . 74.22 108.75 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.622 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -88.73 91.05 8.66 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.911 -1.144 . . . . 74.11 107.911 170.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -78.95 97.72 6.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.806 -1.088 . . . . 75.14 109.146 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -84.49 151.47 26.73 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.731 -0.668 . . . . 71.1 111.832 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -152.81 120.89 1.1 Allowed Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.823 -0.911 . . . . 63.32 110.823 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' D' ' 29' ' ' PRO . 17.7 mm -81.72 128.56 38.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.616 -0.883 . . . . 74.31 108.616 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -137.62 151.62 48.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.38 -0.97 . . . . 73.44 108.38 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.531 ' HB2' ' NE2' ' C' ' 12' ' ' GLN . 34.9 m -111.31 121.49 45.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.824 -0.806 . . . . 63.3 108.824 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.547 HG23 ' HG2' ' C' ' 94' ' ' MET . 3.9 mp -113.5 120.88 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.224 -1.399 . . . . 72.5 107.224 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -149.21 171.07 17.07 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.707 0.803 . . . . 63.01 110.326 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.51 -57.4 3.07 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.807 -0.633 . . . . 72.13 112.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' C' ' 9' ' ' MET . 2.6 pp -113.94 179.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.054 0.941 . . . . 71.3 111.013 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.44 -169.42 3.22 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.825 0.85 . . . . 75.24 109.706 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.73 -135.17 20.09 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.964 -0.353 . . . . 72.13 113.539 171.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -66.83 -28.6 68.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.767 0.827 . . . . 71.12 111.489 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -64.49 -43.13 95.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.202 0.601 . . . . 75.34 110.44 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.547 ' HG2' HG23 ' C' ' 86' ' ' ILE . 0.3 OUTLIER -72.73 -43.8 62.48 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.961 -0.563 . . . . 75.32 110.317 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.03 -30.94 71.97 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.433 0.693 . . . . 74.41 111.671 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -71.5 -41.81 68.81 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.657 0.783 . . . . 75.12 110.275 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.84 -40.63 91.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.83 0.452 . . . . 62.24 111.024 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.5 tp -73.67 -37.66 65.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.302 1.041 . . . . 70.05 110.875 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 -3.85 56.91 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 115.117 0.807 . . . . 71.22 115.117 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.3 -54.36 0.63 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.903 0.851 . . . . 61.11 112.052 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.625 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 15.7 t80 -71.84 -49.21 40.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.635 0.374 . . . . 74.42 111.978 -171.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.1 m -68.8 -44.06 29.81 Favored Pre-proline 0 CA--C 1.569 1.674 0 CA-C-O 118.726 -0.654 . . . . 74.14 112.041 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -56.85 -37.65 97.65 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 122.703 2.269 . . . . 74.44 113.865 170.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -56.84 -38.69 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.892 0.877 . . . . 74.44 110.927 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -73.16 -47.16 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.177 -0.919 . . . . 74.44 111.2 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' C' ' 82' ' ' GLY . 98.0 mt -79.11 -24.33 43.47 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.923 0.712 . . . . 74.21 112.923 -170.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.68 -53.13 66.03 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.244 1.018 . . . . 74.12 113.568 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.7 -31.15 49.83 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.788 1.659 . . . . 62.34 112.809 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -68.5 -38.52 81.04 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.241 0.616 . . . . 64.34 111.317 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.77 91.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.231 -0.441 . . . . 73.11 110.154 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -53.34 -59.89 3.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.084 0.954 . . . . 75.22 111.906 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . 0.435 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -65.27 -31.33 72.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 73.13 110.837 -172.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.498 ' SG ' HG12 ' C' ' 21' ' ' ILE . 47.5 t -69.09 -36.83 78.02 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.1 0.56 . . . . 71.32 111.457 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.579 HG21 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -70.7 -50.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.638 0.775 . . . . 74.2 110.174 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.1 m -64.4 -29.14 70.21 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.574 0.749 . . . . 74.14 111.052 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 24.1 t -63.53 -49.94 71.53 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.596 0.758 . . . . 73.41 109.316 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.568 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.39 -40.34 82.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.569 1.148 . . . . 73.21 112.315 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.697 0.799 . . . . 74.43 109.852 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.445 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 41.4 t -65.92 -31.75 72.85 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.992 0.917 . . . . 62.3 112.188 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -73.98 -37.43 64.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.599 0.76 . . . . 74.45 110.817 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.18 6.08 64.77 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.469 0.481 . . . . 74.11 112.591 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.2 p 63.98 20.11 12.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.865 2.066 . . . . 73.23 113.145 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -84.82 141.2 38.01 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.292 1.037 . . . . 62.11 108.987 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.749 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 84.3 Cg_exo -53.07 140.16 60.56 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.811 3.008 . . . . 70.41 116.854 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 9.1 mm-40 -56.45 117.06 3.47 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.601 1.56 . . . . 73.23 113.175 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 66.6 tp -119.57 125.41 48.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.996 0.918 . . . . 74.52 108.91 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -121.55 132.58 54.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 71.35 109.388 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.497 HD11 HD13 ' C' ' 42' ' ' LEU . 0.1 OUTLIER -71.5 138.43 48.93 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.581 0.753 . . . . 74.11 109.808 179.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.54 161.02 79.41 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.25 1.02 . . . . 72.34 110.833 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.797 ' HG2' HG22 ' A' ' 13' ' ' ILE . 35.0 Cg_exo -59.58 108.64 0.48 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.275 1.983 . . . . 73.04 112.563 177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.48 108.52 21.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.526 -1.287 . . . . 74.12 107.526 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -91.34 99.37 12.35 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.004 -1.11 . . . . 74.3 108.004 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -64.36 -38.54 91.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.546 -0.752 . . . . 75.24 110.393 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 70.35 112.0 176.904 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 21.4 m . . . . . 0 C--O 1.238 0.473 0 N-CA-C 109.192 -0.67 . . . . 72.22 109.192 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.75 94.38 0.95 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.447 -1.316 . . . . 72.43 107.447 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.56 123.24 37.26 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.854 -0.795 . . . . 64.53 108.854 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.534 HD12 HG21 ' D' ' 105' ' ' ILE . 5.8 mt -82.16 119.32 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.206 -0.665 . . . . 62.54 109.206 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -86.3 -34.21 20.4 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.374 -0.376 . . . . 75.32 111.104 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -179.74 133.61 0.11 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.672 0.607 . . . . 74.14 110.094 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.463 ' N ' HD13 ' D' ' 16' ' ' ILE . 2.2 mp -114.21 119.39 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.205 -1.776 . . . . 75.04 106.205 174.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -144.3 153.45 42.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 122.073 0.939 . . . . 74.22 110.16 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -85.27 113.69 21.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.235 -1.348 . . . . 71.35 108.766 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.415 ' HZ2' ' CD ' ' D' ' 57' ' ' GLU . 37.9 mtpt -78.79 -30.95 45.82 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.156 0.503 . . . . 75.23 109.769 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.0 142.3 24.21 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.482 -1.236 . . . . 54.53 109.89 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.568 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.3 mt -137.73 138.31 44.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.072 1.349 . . . . 74.01 107.96 173.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -139.4 136.82 35.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.301 1.04 . . . . 73.54 108.297 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -140.67 117.83 11.27 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.38 -1.711 . . . . 75.23 106.38 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.7 mt-10 -122.36 139.42 53.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.485 0.714 . . . . 74.32 109.158 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.29 79.91 72.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 106.906 -1.516 . . . . 73.21 106.906 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.25 -38.87 8.28 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.947 2.431 . . . . 65.55 113.036 -169.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -110.67 35.09 3.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.336 -0.987 . . . . 70.12 108.336 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.419 ' HB3' ' HD3' ' D' ' 29' ' ' PRO . . . -49.71 -66.53 0.6 Allowed Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 113.845 1.054 . . . . 74.11 113.845 -166.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.51 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.0 Cg_endo -74.69 -16.47 21.02 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 121.852 1.697 . . . . 74.12 112.653 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.46 -42.3 87.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.925 1.29 . . . . 64.44 110.26 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.06 -41.48 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.492 0.717 . . . . 73.21 110.594 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -67.25 -15.38 63.66 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 124.02 0.825 . . . . 72.5 112.571 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -86.09 -7.57 58.51 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.506 1.122 . . . . 75.13 112.703 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -127.31 114.62 17.82 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.678 1.191 . . . . 75.03 108.605 -172.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -98.42 95.26 7.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.428 1.013 . . . . 73.23 112.68 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.424 ' CH2' HD11 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -157.65 -179.54 8.26 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.859 0.864 . . . . 75.14 112.935 178.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -91.51 141.98 26.44 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 124.693 1.197 . . . . 73.32 112.185 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 67.0 Cg_endo -91.74 124.5 0.8 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.578 2.852 . . . . 75.43 113.389 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.61 113.08 11.46 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.316 -0.994 . . . . 73.53 108.316 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -101.06 125.17 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.517 0.727 . . . . 74.44 110.498 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -109.56 144.33 38.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.1 0.96 . . . . 72.41 108.851 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tt -119.59 124.45 46.38 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.49 -0.93 . . . . 73.32 108.49 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.662 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -108.82 133.43 52.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.516 1.126 . . . . 75.03 108.805 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.62 130.95 55.59 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.973 -0.751 . . . . 74.41 108.973 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.69 146.44 43.78 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.815 0.846 . . . . 75.1 108.943 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -125.45 147.3 49.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.364 0.665 . . . . 70.22 110.651 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -150.42 164.02 36.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.745 1.218 . . . . 63.24 108.872 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -175.6 154.33 1.59 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.745 0.818 . . . . 63.23 110.708 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -165.76 138.79 4.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.368 0.667 . . . . 73.0 110.462 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.95 123.82 24.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.896 0.479 . . . . 74.13 109.926 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.32 -41.61 10.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.158 0.583 . . . . 64.35 110.593 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.22 -174.92 5.05 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.276 0.63 . . . . 73.53 110.541 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.59 111.4 3.6 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.209 -0.905 . . . . 71.45 109.87 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 67.37 21.61 9.7 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.415 1.086 . . . . 63.23 110.956 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -126.52 117.51 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.398 1.079 . . . . 74.22 108.614 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.549 ' HB2' HD12 ' D' ' 86' ' ' ILE . 54.1 m-85 -131.0 137.25 49.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.206 1.002 . . . . 74.02 108.503 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -92.24 136.24 33.35 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.832 0.853 . . . . 71.24 109.362 173.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -118.65 118.66 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.373 -1.343 . . . . 75.45 107.373 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 40.1 t -103.13 130.81 52.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.613 -0.884 . . . . 72.21 108.613 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -124.15 108.28 12.14 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.846 -1.168 . . . . 71.44 107.846 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.9 ttm180 -86.26 117.88 25.35 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.977 -0.556 . . . . 73.54 109.79 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.1 t -104.62 121.55 56.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.887 -1.153 . . . . 75.02 107.887 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -120.32 139.44 52.75 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.566 -0.531 . . . . 72.15 109.566 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 83.8 t -128.33 102.26 8.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 74.43 108.451 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.4 p -98.49 93.71 6.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.231 -1.026 . . . . 74.51 108.231 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.57 142.07 32.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.513 -1.221 . . . . 75.4 109.684 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 52.1 p -155.52 130.43 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 122.931 0.492 . . . . 62.3 110.717 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' D' ' 73' ' ' ALA . 0.2 OUTLIER -121.79 137.83 54.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.655 1.182 . . . . 71.43 109.461 177.214 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -113.43 4.0 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.392 0.433 . . . . 73.44 112.855 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.84 3.84 10.55 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.606 0.763 . . . . 74.45 110.288 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -130.69 173.5 10.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.144 0.578 . . . . 75.22 111.917 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 68.6 m -74.31 139.42 44.18 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.069 -0.969 . . . . 74.04 109.958 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.499 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . . . -81.85 -70.66 0.53 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.802 -0.814 . . . . 54.12 108.802 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.54 139.78 18.48 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.155 -0.93 . . . . 72.23 109.552 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 96.3 mt -105.82 109.0 20.81 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.065 -1.087 . . . . 74.32 108.065 174.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' D' ' 114' ' ' ILE . 48.9 t -125.36 114.4 18.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.311 -0.626 . . . . 65.22 109.311 -174.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.17 122.24 17.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.14 -0.689 . . . . 74.53 109.14 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.86 117.61 48.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.836 0.854 . . . . 73.44 109.215 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.29 86.72 6.9 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.239 -1.023 . . . . 72.11 108.239 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.97 94.88 6.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.667 -1.151 . . . . 73.11 109.32 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.77 146.43 19.93 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.431 -0.668 . . . . 65.32 111.431 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD23 ' D' ' 106' ' ' LEU . . . -145.47 131.82 4.36 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.912 -0.875 . . . . 60.22 110.912 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.478 HG22 HD13 ' D' ' 51' ' ' LEU . 42.5 mt -90.24 131.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.897 -0.779 . . . . 70.51 108.897 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -132.51 139.93 48.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.24 0.616 . . . . 75.14 110.162 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -80.14 102.1 9.19 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 107.912 -1.144 . . . . 71.05 107.912 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' D' ' 56' ' ' TYR . 58.2 mt -106.6 110.31 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.378 -0.601 . . . . 75.24 109.378 -175.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -152.73 165.1 36.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.285 1.034 . . . . 72.13 110.18 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.33 44.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.733 0.653 . . . . 74.4 114.733 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.469 HD12 HG22 ' D' ' 86' ' ' ILE . 28.8 pt -124.94 147.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.907 1.283 . . . . 62.44 108.503 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.37 177.55 11.32 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 74.22 110.95 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.95 -137.44 46.12 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 123.596 0.56 . . . . 63.42 113.782 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -80.21 -15.77 56.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.515 0.726 . . . . 72.22 111.655 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.85 -51.13 66.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.303 0.641 . . . . 72.44 109.802 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -73.32 -28.79 62.27 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.612 -0.722 . . . . 72.4 110.303 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.66 72.53 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.831 0.453 . . . . 74.34 111.017 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -72.97 -40.68 65.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.807 0.843 . . . . 73.22 110.552 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -65.63 -44.66 85.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.267 0.627 . . . . 61.53 110.606 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.473 HD22 HD11 ' D' ' 86' ' ' ILE . 3.8 mm? -77.73 -20.18 53.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.078 0.951 . . . . 75.34 111.403 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 13.93 57.74 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.73 -0.483 . . . . 65.13 113.456 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.59 -64.04 0.09 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.031 0.416 . . . . 63.11 111.978 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -72.53 -48.96 36.12 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.418 0.687 . . . . 72.23 112.654 -167.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 59.9 m -63.58 -45.57 83.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.578 0.751 . . . . 71.3 112.506 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 43.7 Cg_exo -61.88 -30.97 84.74 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.261 1.974 . . . . 73.54 113.439 171.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -66.54 -28.24 68.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.768 0.827 . . . . 75.23 110.755 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.534 HG21 HD12 ' D' ' 13' ' ' ILE . 40.9 mm -67.82 -46.4 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.222 0.609 . . . . 75.23 110.478 174.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.426 HD23 ' HA3' ' D' ' 82' ' ' GLY . 64.9 mt -76.99 -23.37 52.27 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.231 -0.895 . . . . 74.03 111.734 -170.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -66.08 -44.22 59.42 Favored Pre-proline 0 CA--C 1.569 1.7 0 N-CA-C 113.572 0.953 . . . . 74.42 113.572 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.85 -32.46 95.37 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.42 2.08 . . . . 72.03 113.725 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.09 -31.68 50.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.206 0.602 . . . . 74.25 111.232 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.64 -51.6 58.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.333 -0.618 . . . . 71.54 109.333 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.15 -49.42 69.29 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.752 1.282 . . . . 75.22 111.069 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.53 -45.86 91.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.196 0.935 . . . . 75.32 110.783 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.1 -45.13 87.75 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.801 0.688 . . . . 73.3 110.997 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.595 HG21 ' SG ' ' D' ' 76' ' ' CYS . 73.5 mt -64.57 -53.41 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.021 0.928 . . . . 75.31 110.786 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -53.91 -42.97 69.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.347 1.059 . . . . 72.31 111.564 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.8 t -67.77 -32.07 72.4 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.275 -0.875 . . . . 65.54 111.666 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.548 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.0 mtm -80.04 -36.05 36.28 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.668 0.387 . . . . 65.32 111.999 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' D' ' 114' ' ' ILE . 47.4 t -67.14 -34.99 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 122.979 0.511 . . . . 71.24 110.025 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -69.42 -33.89 73.66 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.363 0.665 . . . . 72.14 111.27 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.8 mtt-85 -68.96 -34.14 74.86 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.282 0.633 . . . . 75.22 110.994 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.01 8.76 65.48 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.209 -0.45 . . . . 75.25 113.196 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.401 HG21 ' HB3' ' C' ' 17' ' ' TYR . 30.4 p 61.93 20.86 11.86 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.616 1.966 . . . . 75.11 113.567 175.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.429 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 47.9 m-85 -87.83 167.16 21.17 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.653 1.181 . . . . 73.32 107.862 165.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.429 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 72.9 Cg_endo -67.82 -166.5 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.614 2.209 . . . . 70.15 113.875 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -75.24 156.6 35.57 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.679 -0.691 . . . . 70.21 110.851 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.6 tp -127.61 95.23 4.18 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.456 -1.313 . . . . 72.43 107.456 164.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.642 ' HB3' HD12 ' B' ' 13' ' ' ILE . 78.6 m-20 -99.2 89.55 4.27 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.187 -1.042 . . . . 74.23 108.187 -175.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 123.06 17.32 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.172 -0.922 . . . . 73.5 110.687 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.67 124.04 86.31 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.641 0.776 . . . . 71.22 110.405 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.31 127.36 11.84 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.284 1.99 . . . . 62.31 111.692 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.49 133.85 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.801 0.84 . . . . 72.12 109.165 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -76.64 85.18 3.3 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.966 -0.753 . . . . 70.04 108.966 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 N--CA 1.474 0.738 0 CA-C-N 115.744 -0.662 . . . . 74.32 110.791 178.296 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.55 ' HB ' ' HB1' ' A' ' 87' ' ' ALA . 96.8 m . . . . . 0 C--O 1.24 0.596 0 N-CA-C 108.483 -0.932 . . . . 71.23 108.483 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.665 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.1 t80 -139.63 135.56 33.43 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.717 0.636 . . . . 74.22 110.511 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -154.44 126.16 7.58 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.528 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.9 mt -81.32 113.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.604 -0.887 . . . . 74.2 108.604 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.416 ' HB3' HG21 ' A' ' 83' ' ' ILE . 41.5 tp60 -79.13 -31.05 43.98 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.16 0.913 . . . . 75.5 109.771 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -173.25 143.64 1.12 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.361 0.664 . . . . 72.23 110.293 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.63 140.2 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.788 0.835 . . . . 74.3 109.161 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.567 ' HB3' HG23 ' B' ' 122' ' ' THR . 23.7 p90 -173.63 175.68 2.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.955 0.902 . . . . 75.31 110.495 -169.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.1 p -100.15 119.54 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.725 0.81 . . . . 60.23 109.009 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -84.48 -32.75 23.82 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.5 0.32 . . . . 72.14 110.405 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -148.93 139.44 22.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.695 -0.684 . . . . 73.41 109.641 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 89.2 mt -138.42 139.5 41.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.398 -1.704 . . . . 72.14 106.398 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 t -154.85 110.21 3.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.711 0.632 . . . . 71.44 109.636 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.551 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 74.1 t80 -110.54 113.65 26.45 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.268 -1.382 . . . . 73.32 107.268 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.44 118.27 31.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.21 0.604 . . . . 74.14 109.748 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.61 78.77 0.93 Allowed Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 107.271 -1.381 . . . . 74.45 107.271 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 -39.03 34.24 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.814 2.343 . . . . 70.11 112.464 -166.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 7.2 m-20 -106.85 48.32 0.84 Allowed 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.998 -1.482 . . . . 74.54 106.998 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -54.39 -62.13 4.47 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.503 -1.237 . . . . 62.33 111.499 -176.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 16.7 Cg_exo -64.59 -21.95 65.2 Favored 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 121.578 1.599 . . . . 73.32 113.23 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 1.9 t60 -81.44 -55.78 4.47 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.489 0.715 . . . . 73.42 110.118 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 73' ' ' ALA . 5.0 p -67.99 -18.22 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.85 0.86 . . . . 74.13 111.626 -165.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -62.87 -27.03 69.07 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.281 1.032 . . . . 74.23 112.718 176.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -96.83 -12.93 22.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.085 0.402 . . . . 74.55 112.085 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.4 tmtp? -74.59 141.62 44.72 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.213 0.605 . . . . 75.13 109.838 -173.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.505 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 25.1 t70 -51.03 128.16 20.79 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.408 1.483 . . . . 60.3 112.348 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -78.11 90.4 4.24 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.019 0.825 . . . . 74.22 111.262 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -139.94 78.22 25.04 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 114.651 -1.159 . . . . 74.21 108.446 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.52 121.36 3.36 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.828 2.352 . . . . 63.35 112.662 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -96.39 95.39 8.02 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.006 -1.479 . . . . 74.42 107.006 171.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 65' ' ' THR . 20.0 t -84.27 97.94 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.318 -0.855 . . . . 74.42 110.075 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 55.8 tttm -82.53 125.83 31.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.626 0.77 . . . . 73.34 110.418 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -111.43 115.59 29.51 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.596 -0.89 . . . . 72.25 108.596 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.694 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -106.75 129.67 54.59 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 74.4 109.165 173.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -113.96 116.31 29.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.967 -0.753 . . . . 75.21 108.967 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -132.99 153.93 51.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.81 0.844 . . . . 75.44 109.292 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -151.43 163.47 38.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.322 0.649 . . . . 74.11 110.883 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -164.26 154.42 14.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.154 0.982 . . . . 71.21 109.838 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.5 p -131.16 159.85 36.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.97 0.35 . . . . 73.53 111.21 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -150.53 128.51 11.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.736 0.815 . . . . 72.44 109.46 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.54 110.74 12.58 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.05 -0.722 . . . . 72.23 109.05 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 83' ' ' ILE . 74.1 mt -94.54 -38.67 10.78 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.78 -0.646 . . . . 74.14 109.571 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -151.62 -179.51 7.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.733 0.813 . . . . 55.32 110.042 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -73.3 126.52 30.31 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.846 -0.798 . . . . 54.33 108.846 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 68.78 1.78 3.22 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.318 1.447 . . . . 61.2 112.258 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.533 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 94.5 t -115.68 107.33 22.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.883 -0.784 . . . . 72.14 108.883 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.629 ' HB2' HD11 ' A' ' 86' ' ' ILE . 76.0 m-85 -126.85 126.87 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.184 -1.414 . . . . 74.53 107.184 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -84.47 133.1 34.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.191 -1.04 . . . . 75.34 108.191 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -113.06 127.06 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.343 -1.354 . . . . 73.43 107.343 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.2 t -100.65 138.02 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 172.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.63 109.35 12.0 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -95.31 124.02 39.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 74.2 110.326 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.74 132.14 57.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.409 -1.33 . . . . 74.24 107.409 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.9 m -120.29 121.46 38.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.037 -0.727 . . . . 72.41 109.037 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 114' ' ' ILE . 50.1 t -114.72 106.65 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.532 1.133 . . . . 75.42 108.679 -174.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 11.6 m -105.94 145.52 31.2 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 108.04 -1.096 . . . . 65.12 108.04 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.87 103.88 7.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.252 -1.388 . . . . 74.2 107.252 168.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 36.0 m -108.09 124.16 49.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.98 0.419 . . . . 71.0 109.992 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 ' HB1' ' A' ' 73' ' ' ALA . 5.8 mp -100.52 80.54 2.23 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.658 -1.608 . . . . 74.43 106.658 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -117.81 5.46 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.212 -1.155 . . . . 73.4 110.212 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.09 -26.31 22.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.397 0.679 . . . . 73.33 109.972 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.1 100.35 11.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.24 0.616 . . . . 72.24 111.061 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.3 m -72.53 133.85 44.96 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 120.923 0.392 . . . . 75.25 110.298 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.462 ' HA ' HG13 ' A' ' 31' ' ' VAL . . . -77.5 -63.48 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.645 1.178 . . . . 73.02 110.183 177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -149.2 162.96 38.97 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.591 -1.186 . . . . 71.5 110.689 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 14.0 tp -141.29 140.6 33.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.613 -1.625 . . . . 71.32 106.613 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.477 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 16.3 m -145.51 99.08 3.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.186 -0.672 . . . . 72.11 109.186 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.01 116.68 29.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.661 -0.866 . . . . 74.41 108.661 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.49 110.39 20.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.715 0.806 . . . . 71.34 109.392 -174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -84.85 89.21 7.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.302 -0.999 . . . . 73.13 108.302 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -76.71 97.21 4.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.118 -0.697 . . . . 75.52 109.118 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.3 143.25 16.81 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.552 -0.619 . . . . 73.21 111.552 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.47 122.91 2.15 Favored Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.44 -1.064 . . . . 73.21 110.44 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.436 HG22 HD12 ' A' ' 51' ' ' LEU . 43.5 mt -80.12 116.33 24.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.656 -1.238 . . . . 73.05 107.656 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.665 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -122.38 158.57 29.36 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.281 0.632 . . . . 73.15 109.416 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 42.8 m -104.57 98.76 8.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.226 -1.028 . . . . 65.24 108.226 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 56' ' ' TYR . 3.9 mp -97.46 124.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.739 -1.208 . . . . 72.42 107.739 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' A' ' 10' ' ' THR . . . -162.04 151.93 16.55 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.772 0.67 . . . . 43.13 110.714 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.55 -33.24 6.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.334 -0.848 . . . . 64.14 113.081 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -116.67 147.5 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.339 0.656 . . . . 54.43 111.467 -168.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.52 173.88 10.85 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.226 -0.897 . . . . 45.51 110.708 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -114.46 5.79 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.639 1.212 . . . . 71.45 115.011 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -65.42 -42.54 92.38 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.019 0.928 . . . . 61.0 111.551 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -70.39 -36.91 74.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.226 0.611 . . . . 73.12 111.042 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -65.19 -44.03 89.7 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.368 0.667 . . . . 74.43 109.799 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.83 88.74 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.044 0.938 . . . . 74.3 111.243 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -74.07 -31.09 62.7 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 65.14 110.79 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.76 -44.36 70.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.336 0.589 . . . . 74.51 110.055 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.34 -44.28 37.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.876 -1.056 . . . . 72.12 111.403 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.36 62.42 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.434 0.933 . . . . 72.12 115.434 -167.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -149.63 -61.23 0.21 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.708 0.754 . . . . 75.41 112.055 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.1 t80 -61.75 -59.33 5.32 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 74.21 112.625 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.41 -36.5 4.75 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 118.557 -0.735 . . . . 74.41 112.951 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.48 -40.96 45.1 Favored 'Trans proline' 0 C--N 1.387 2.59 0 C-N-CA 123.089 2.526 . . . . 75.34 114.287 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -60.04 -35.33 74.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.942 0.897 . . . . 74.44 111.108 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mm -68.15 -42.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.638 0.775 . . . . 75.42 110.145 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.61 -33.09 60.51 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.582 -1.19 . . . . 72.12 112.547 -172.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.65 -43.76 96.14 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.032 1.123 . . . . 72.43 114.032 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.06 -38.23 96.34 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.483 2.122 . . . . 72.1 113.73 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 50.3 m-85 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.494 0.718 . . . . 75.32 111.845 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.52 87.28 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.728 0.411 . . . . 75.03 110.16 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.421 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.2 ttm180 -54.07 -52.43 60.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.637 1.175 . . . . 73.13 110.477 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -62.98 -46.13 89.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.809 0.844 . . . . 71.34 111.141 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 40.5 t -55.16 -47.12 75.59 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.855 0.722 . . . . 63.14 110.469 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -60.69 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.918 -1.037 . . . . 63.32 110.371 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.574 HG21 ' HG3' ' A' ' 125' ' ' GLN . 99.3 m -52.41 -46.66 66.41 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 124.248 1.019 . . . . 71.54 112.18 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.04 -44.04 85.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.061 -0.972 . . . . 74.41 109.848 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 mtp -58.87 -42.08 88.61 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.785 0.834 . . . . 75.02 111.206 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.4 t -59.96 -49.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.788 0.835 . . . . 75.33 110.307 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.0 p -69.25 -28.97 66.79 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.866 0.467 . . . . 64.12 112.135 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -66.49 -28.34 68.49 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.813 0.845 . . . . 74.12 111.235 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.04 11.85 61.56 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.478 -0.623 . . . . 62.04 114.053 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.422 ' HB ' HH21 ' B' ' 15' ' ' ARG . 3.8 m 65.62 16.11 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.0 1.32 . . . . 74.42 111.192 -175.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -88.21 141.23 30.81 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.736 -0.838 . . . . 74.44 108.736 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 144.4 84.71 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.14 2.56 . . . . 73.11 112.71 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.574 ' HG3' HG21 ' A' ' 115' ' ' THR . 33.8 tt0 -53.71 138.85 34.21 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.352 1.033 . . . . 65.43 111.958 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.46 114.92 18.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.632 -0.713 . . . . 74.4 109.398 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -112.0 118.89 36.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.462 -1.31 . . . . 74.3 107.462 172.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.36 122.64 20.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.274 -0.639 . . . . 65.54 109.274 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.18 134.91 94.75 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 123.399 0.437 . . . . 72.41 110.913 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.0 106.62 0.8 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.783 2.322 . . . . 64.24 111.975 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.15 117.77 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.716 -1.216 . . . . 73.34 107.716 175.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -80.98 73.22 8.03 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.668 0.747 . . . . 72.22 110.628 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -67.2 -33.75 76.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.78 -1.1 . . . . 74.52 108.997 169.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.67 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 4.4 p-10 . . . . . 0 C--O 1.24 0.577 0 CA-C-N 114.328 -1.306 . . . . 75.53 111.654 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 99.6 m . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 107.185 -1.413 . . . . 74.31 107.185 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -121.69 143.46 49.33 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.298 -0.63 . . . . 74.15 109.298 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.15 132.18 9.88 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.6 -0.889 . . . . 73.33 108.6 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.464 HG23 ' HE2' ' B' ' 84' ' ' PHE . 1.8 pp -76.4 104.33 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 122.112 0.958 . . . . 73.41 108.842 173.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . 0.416 ' HG3' ' OG ' ' B' ' 85' ' ' SER . 1.4 tm0? -76.71 -36.37 57.24 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.963 -0.754 . . . . 61.01 108.963 -170.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.422 HH21 ' HB ' ' A' ' 122' ' ' THR . 21.8 ttt180 -168.06 140.08 2.97 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 124.036 0.835 . . . . 75.11 109.199 173.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.0 mt -124.82 134.38 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.597 -1.26 . . . . 73.32 107.597 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.412 ' HE2' ' HB1' ' A' ' 28' ' ' ALA . 30.9 p90 -166.27 157.39 13.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.576 0.547 . . . . 74.21 111.813 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -83.0 127.9 33.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.407 -0.815 . . . . 71.55 109.039 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 25.4 mtpp -93.51 -41.05 9.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.549 -0.75 . . . . 75.33 110.095 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.5 t70 -152.4 145.63 24.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.827 -0.624 . . . . 74.34 111.4 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.794 HD12 ' SG ' ' B' ' 113' ' ' CYS . 46.8 mm -140.02 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 C-N-CA 125.291 1.437 . . . . 73.23 108.411 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -146.22 134.9 22.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.454 1.101 . . . . 74.45 108.325 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.443 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -148.2 120.14 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.061 -1.459 . . . . 75.44 107.061 170.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -119.08 142.91 47.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.153 -1.055 . . . . 72.34 108.153 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -139.25 77.59 29.82 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.635 -1.246 . . . . 74.11 107.635 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.62 -40.4 10.22 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.902 2.401 . . . . 74.43 112.509 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -109.03 21.06 17.69 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.255 -0.884 . . . . 74.11 110.072 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.401 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -45.44 -48.88 35.24 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 115.524 1.676 . . . . 72.01 115.524 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.93 -38.44 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.539 2.16 . . . . 74.1 112.256 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 37.8 m80 -90.09 -4.98 57.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.147 0.795 . . . . 65.31 113.147 -171.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.439 HG22 HD12 ' B' ' 68' ' ' LEU . 7.6 p -69.99 -18.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.115 0.566 . . . . 75.32 111.082 -175.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -66.47 -14.95 62.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.645 0.778 . . . . 73.34 111.865 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.516 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -69.15 -37.3 78.18 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.602 -0.518 . . . . 75.41 109.602 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.516 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.6 mttt -110.75 62.46 0.61 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.615 -0.883 . . . . 72.43 108.615 172.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -88.17 98.44 11.56 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.03 -0.419 . . . . 73.24 110.662 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 172.36 -174.96 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.244 1.417 . . . . 72.33 111.429 163.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -49.03 110.1 1.41 Allowed Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.464 1.506 . . . . 65.35 113.494 -169.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.51 165.84 16.0 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.688 2.259 . . . . 71.54 110.836 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.86 104.46 4.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.205 -1.406 . . . . 75.22 107.205 169.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.65 143.53 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.164 -1.05 . . . . 71.05 108.164 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -138.96 116.75 11.5 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.231 0.612 . . . . 73.31 109.909 -170.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -86.78 125.72 34.13 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 74.44 108.55 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.473 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -133.83 107.41 7.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.814 -1.18 . . . . 65.01 107.814 177.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.39 127.37 53.52 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.72 -0.844 . . . . 63.21 108.72 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.1 t70 -123.14 136.91 54.98 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.801 -1.185 . . . . 73.11 107.801 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -109.19 115.05 29.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.325 0.65 . . . . 75.2 110.998 -168.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.522 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -119.63 144.57 47.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.909 0.884 . . . . 73.22 109.161 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.8 p -145.14 163.21 35.04 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.375 0.67 . . . . 75.51 109.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -151.26 167.28 28.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.525 0.73 . . . . 74.53 109.804 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -113.42 112.61 23.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.885 -0.783 . . . . 73.12 108.885 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.49 -40.21 23.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.894 0.477 . . . . 75.42 110.035 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.78 -173.32 4.32 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.28 -0.873 . . . . 74.32 110.706 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.2 106.62 0.45 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.645 -1.162 . . . . 75.35 109.73 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 73.49 5.22 4.94 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.197 1.399 . . . . 71.12 112.209 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.81 113.07 39.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 107.958 -1.127 . . . . 73.45 107.958 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -122.5 140.76 52.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.22 0.608 . . . . 71.15 110.119 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.605 ' HG2' HG12 ' B' ' 83' ' ' ILE . 3.9 tm-20 -108.15 98.31 7.88 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.58 -1.267 . . . . 74.12 107.58 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -93.96 119.87 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.703 1.201 . . . . 62.41 110.236 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.522 ' HB ' ' HB1' ' B' ' 47' ' ' ALA . 21.8 t -107.13 139.21 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.204 1.002 . . . . 72.25 109.981 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.749 HD11 ' HA ' ' B' ' 103' ' ' PRO . 84.9 mt -121.56 112.85 18.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.373 0.669 . . . . 74.24 109.376 174.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.2 ttm-85 -86.89 107.6 18.41 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.185 -1.043 . . . . 74.21 108.185 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.83 101.88 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.075 -1.454 . . . . 74.25 107.075 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 32.3 m -97.31 139.12 33.74 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.931 -1.486 . . . . 73.43 108.443 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.61 114.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.203 -1.036 . . . . 71.23 108.203 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -101.38 140.58 35.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.371 -0.974 . . . . 73.45 108.371 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.95 126.38 23.34 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.314 -0.995 . . . . 72.14 108.314 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.4 p -146.27 140.03 26.2 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.357 0.663 . . . . 74.21 110.514 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.621 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -133.36 140.87 47.63 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.992 0.917 . . . . 74.4 109.655 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.84 -111.75 3.66 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.434 -0.803 . . . . 53.33 111.429 -172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -121.6 2.5 10.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 74.1 109.885 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -135.63 171.95 13.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.949 0.5 . . . . 72.53 110.877 -169.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -75.03 140.37 43.5 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.493 -0.776 . . . . 75.02 111.352 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.621 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -86.04 -62.2 1.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.247 -1.02 . . . . 71.51 108.247 172.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -163.07 167.08 22.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.475 -1.693 . . . . 74.34 107.917 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.63 143.31 49.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 75.3 108.013 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.7 t -143.33 144.34 32.05 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.372 -0.973 . . . . 72.15 108.372 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -160.12 139.01 10.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.97 -0.752 . . . . 64.31 108.97 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.534 HG11 ' HA ' ' B' ' 110' ' ' ALA . 69.7 t -135.43 145.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.547 -1.279 . . . . 74.25 107.547 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.0 mt-30 -124.88 92.78 3.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.939 -1.134 . . . . 64.02 107.939 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -89.38 104.42 16.97 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.956 -1.02 . . . . 61.54 108.848 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.535 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.21 156.65 25.3 Favored Glycine 0 C--O 1.244 0.767 0 N-CA-C 111.131 -0.788 . . . . 74.14 111.131 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.18 1.33 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.072 -0.811 . . . . 73.11 111.072 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.605 HG12 ' HG2' ' B' ' 57' ' ' GLU . 26.0 mt -85.99 134.55 27.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 108.076 -1.083 . . . . 72.35 108.076 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . 0.464 ' HE2' HG23 ' B' ' 13' ' ' ILE . 65.4 m-85 -133.64 135.08 43.94 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 74.31 108.343 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' B' ' 14' ' ' GLN . 65.5 m -107.61 91.85 3.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 172.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.527 ' HB ' HD13 ' B' ' 89' ' ' ILE . 35.2 pt -98.11 138.21 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.386 -0.825 . . . . 65.33 110.974 -169.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.598 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -145.01 167.77 21.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.28 1.032 . . . . 75.21 109.945 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.79 -63.72 4.42 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.696 -0.684 . . . . 75.42 112.006 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.527 HD13 ' HB ' ' B' ' 86' ' ' ILE . 2.3 pp -61.35 138.1 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.618 0.767 . . . . 73.13 112.123 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 35.7 tt0 -161.12 149.66 16.08 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.477 -0.783 . . . . 73.41 109.197 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.08 -124.9 14.69 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.68 0.613 . . . . 43.12 112.793 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.0 m -67.19 -33.37 75.25 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.402 0.681 . . . . 65.03 110.964 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.88 -33.24 71.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.763 -0.653 . . . . 71.21 110.468 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 1.2 tmt? -65.57 -45.57 82.8 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.024 0.53 . . . . 75.24 110.138 173.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.14 -31.87 70.5 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.812 0.845 . . . . 71.04 112.09 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -77.71 -43.92 29.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.168 0.587 . . . . 74.55 111.2 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.46 -47.26 56.82 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.37 0.605 . . . . 70.43 111.909 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.572 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.1 tm? -89.38 -37.61 14.73 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.112 0.965 . . . . 73.43 110.202 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.28 -26.32 57.68 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.34 0.4 . . . . 64.25 114.015 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.91 -48.99 2.23 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.985 0.514 . . . . 75.2 112.203 -173.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.507 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 67.2 t80 -77.84 -45.71 23.57 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.51 0.559 . . . . 73.51 112.51 -172.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 78.5 m -59.48 -42.55 92.82 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 112.981 0.734 . . . . 62.04 112.981 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.749 ' HA ' HD11 ' B' ' 60' ' ' LEU . 83.6 Cg_exo -52.08 -39.61 70.0 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.529 2.153 . . . . 73.41 114.818 168.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.54 -24.05 65.5 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.114 0.566 . . . . 72.41 112.062 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.472 HG22 ' NH2' ' D' ' 111' ' ' ARG . 92.8 mt -73.15 -47.39 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.778 0.831 . . . . 72.01 111.348 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.425 ' HB2' HD13 ' B' ' 60' ' ' LEU . 75.1 mt -79.72 -18.79 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.871 -0.604 . . . . 74.23 110.987 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.76 -50.55 86.42 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-O 117.699 -1.143 . . . . 73.53 113.733 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.1 -35.86 97.18 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.552 2.168 . . . . 71.2 113.959 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -69.44 -46.73 66.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.481 0.712 . . . . 73.53 110.575 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.534 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.3 -41.28 88.63 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.398 -0.819 . . . . 75.33 110.616 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -63.14 -50.43 70.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.557 1.543 . . . . 74.32 111.268 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.85 -37.99 89.47 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.95 0.781 . . . . 74.52 109.998 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.794 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.7 t -68.62 -39.21 80.91 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.508 0.505 . . . . 64.4 111.169 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.2 -49.69 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.062 0.545 . . . . 73.05 110.014 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -56.53 -39.37 73.25 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.301 -0.863 . . . . 74.32 111.168 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -68.05 -46.53 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.123 -0.944 . . . . 72.23 110.394 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -66.74 -39.48 87.95 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.006 0.523 . . . . 73.21 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.28 -39.47 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.867 0.467 . . . . 75.13 110.251 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -68.5 -28.57 67.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.071 0.948 . . . . 64.22 111.761 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.0 mtt-85 -73.58 -35.79 65.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.744 0.818 . . . . 73.14 110.101 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 3.4 55.0 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 123.757 0.661 . . . . 73.44 112.673 170.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 17' ' ' TYR . 49.1 p 58.81 28.87 18.01 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.516 1.926 . . . . 73.52 112.304 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -98.77 153.03 38.07 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 114.849 -1.069 . . . . 75.45 109.645 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.2 102.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.13 2.553 . . . . 74.23 111.523 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -62.38 155.41 25.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.604 -1.18 . . . . 75.35 111.527 -171.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.6 tp -109.29 100.82 9.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.459 -0.791 . . . . 73.22 109.612 -168.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -89.37 92.85 9.31 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 106.44 -1.689 . . . . 73.14 106.44 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.25 150.1 46.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.959 -1.473 . . . . 75.1 111.19 -168.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.26 74.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 122.97 0.508 . . . . 71.1 110.779 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.08 111.8 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.942 2.428 . . . . 75.11 112.233 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.64 113.85 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.479 -0.934 . . . . 72.13 108.479 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.38 80.11 7.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.279 0.632 . . . . 74.11 109.375 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 N--CA 1.486 1.372 0 C-N-CA 123.653 0.781 . . . . 74.31 111.303 -179.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.509 ' HB2' HG23 ' C' ' 89' ' ' ILE . 46.9 ttp . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 121.435 0.636 . . . . 74.03 111.088 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.2 m -85.77 88.38 7.54 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.975 -1.12 . . . . 72.42 107.975 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.459 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 52.1 t80 -96.62 122.31 39.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.784 -0.821 . . . . 73.41 108.784 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -138.57 139.11 38.51 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.465 0.706 . . . . 73.35 110.472 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.58 96.79 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.764 -0.828 . . . . 73.41 108.764 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.5 mm100 -75.98 -43.47 44.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.69 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -169.84 122.99 0.73 Allowed 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.894 0.746 . . . . 73.43 109.892 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.84 133.54 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.347 -0.983 . . . . 74.34 108.347 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.412 ' HB2' ' HA2' ' D' ' 121' ' ' GLY . 28.0 p90 -169.67 158.72 7.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.697 0.761 . . . . 72.31 112.267 -173.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -81.56 110.37 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.518 -1.219 . . . . 74.53 108.864 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -79.47 -23.92 42.71 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 122.277 -0.264 . . . . 74.5 110.605 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -150.06 142.08 23.94 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.954 0.783 . . . . 74.34 109.467 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -137.26 144.26 32.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 106.916 -1.513 . . . . 74.21 106.916 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 22' ' ' SER . . . . . 0.54 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 40.3 t -151.82 147.71 26.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.482 0.713 . . . . 73.21 110.125 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -154.87 119.93 4.93 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.342 -1.355 . . . . 74.5 107.342 168.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.48 130.14 54.16 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.489 0.716 . . . . 75.54 109.236 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.31 77.36 76.3 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.652 -1.24 . . . . 73.53 107.652 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -68.02 -27.72 35.91 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.037 2.491 . . . . 75.2 112.051 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -109.91 41.96 1.61 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.496 1.118 . . . . 72.05 109.457 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.64 -54.94 49.83 Favored Pre-proline 0 CA--C 1.571 1.753 0 N-CA-C 114.47 1.285 . . . . 63.1 114.47 -175.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 12.5 Cg_exo -72.66 -28.42 14.11 Favored 'Trans proline' 0 C--N 1.386 2.533 0 CA-C-N 121.891 1.711 . . . . 73.41 111.775 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -68.7 -22.08 64.38 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.04 1.336 . . . . 74.0 111.953 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -72.2 -18.84 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.539 0.736 . . . . 74.32 111.497 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -68.79 -23.48 64.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.623 0.369 . . . . 75.14 111.201 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -109.52 24.04 13.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.51 0.724 . . . . 74.24 110.722 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.667 ' HD2' HD23 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -81.08 148.05 29.83 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.35 0.66 . . . . 75.14 110.046 -176.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . 0.469 ' HB3' HD12 ' C' ' 68' ' ' LEU . 12.7 t70 -69.37 125.01 25.37 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.315 -0.994 . . . . 75.04 108.315 169.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -86.76 63.12 7.79 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.882 0.738 . . . . 74.24 110.372 -168.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -164.95 77.4 1.39 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.227 1.011 . . . . 62.23 108.403 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.97 156.11 26.62 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.77 2.313 . . . . 73.12 111.371 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.37 86.85 7.35 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.132 -1.433 . . . . 73.51 107.132 170.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -69.42 112.43 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.427 -1.26 . . . . 63.12 109.835 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -134.29 127.12 31.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.749 0.82 . . . . 74.31 109.852 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . 0.402 HD21 ' N ' ' C' ' 43' ' ' ASP . 6.1 tt -86.41 139.14 31.21 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 107.648 -1.241 . . . . 75.23 107.648 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.4 t70 -119.61 107.5 13.33 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.577 -1.268 . . . . 61.15 107.577 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.17 116.16 28.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.268 1.027 . . . . 74.42 109.059 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.9 t70 -115.08 143.94 44.41 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.606 -0.887 . . . . 71.44 108.606 172.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -131.19 134.96 47.0 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.614 0.766 . . . . 72.12 109.789 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.435 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -148.21 157.34 43.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.138 0.575 . . . . 64.12 110.628 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -161.28 145.75 13.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.87 0.868 . . . . 72.33 110.413 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -156.06 140.85 17.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 75.43 109.898 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -72.55 127.87 33.87 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' C' ' 57' ' ' GLU . 34.9 mt -96.06 -39.67 9.62 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 73.43 109.581 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.32 176.59 12.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.919 -1.491 . . . . 54.34 108.964 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -68.31 121.98 17.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.673 -0.694 . . . . 71.11 109.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 76.51 -8.37 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 126.401 1.881 . . . . 72.34 112.632 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.81 96.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 73.51 108.879 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.8 161.97 13.72 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.493 0.717 . . . . 74.34 109.378 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.73 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.0 tt0 -124.73 133.61 53.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.14 0.576 . . . . 73.52 109.768 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.422 HG21 HD13 ' C' ' 98' ' ' LEU . 77.2 t -110.69 129.22 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.402 -1.333 . . . . 70.34 107.402 169.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 96.7 t -114.18 136.76 49.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.257 -1.016 . . . . 74.53 108.257 173.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.13 101.76 5.95 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.324 -1.361 . . . . 74.25 107.324 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 8.1 ttm180 -87.29 135.13 33.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.262 0.625 . . . . 74.3 109.687 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.533 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.5 t -125.81 121.89 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.137 -1.431 . . . . 73.31 107.137 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 30.7 m -124.7 119.56 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.423 -0.584 . . . . 74.21 109.423 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.544 HG23 HG21 ' C' ' 114' ' ' ILE . 59.1 t -100.35 116.43 43.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.635 -0.876 . . . . 74.33 108.635 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.5 m -106.21 137.71 43.68 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.688 0.618 . . . . 74.02 109.511 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.64 94.49 3.2 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.516 -1.291 . . . . 74.24 107.516 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -143.57 139.15 29.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.392 -0.966 . . . . 64.24 108.392 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.667 HD23 ' HD2' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 23.65 8.74 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.506 0.722 . . . . 74.02 110.329 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.94 -120.57 1.4 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.827 -1.309 . . . . 72.44 109.827 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.79 -28.47 21.66 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.56 -0.904 . . . . 75.31 108.56 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.0 99.2 0.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.466 1.106 . . . . 64.54 109.608 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.1 m -87.75 130.24 34.9 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.058 0.543 . . . . 75.44 110.644 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.66 5.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.495 -0.775 . . . . 72.24 109.256 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -167.21 169.75 12.33 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.827 0.851 . . . . 74.41 110.768 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -142.87 144.67 32.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.939 -1.134 . . . . 75.45 107.939 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 53.6 t -146.68 146.28 30.3 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.353 -0.98 . . . . 61.44 108.353 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 38.4 tt0 -153.76 137.49 16.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.25 0.62 . . . . 75.01 110.218 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' C' ' 110' ' ' ALA . 54.4 t -141.9 115.02 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.305 1.042 . . . . 74.33 108.615 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 73.2 mt-30 -95.03 97.69 10.14 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.889 -0.782 . . . . 64.34 108.889 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -87.1 102.32 14.32 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 73.2 110.009 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.16 151.82 21.8 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.918 -0.473 . . . . 73.43 111.918 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.548 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -148.97 128.59 2.82 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.645 -0.582 . . . . 61.45 111.645 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' D' ' 29' ' ' PRO . 8.3 mm -90.14 130.38 39.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 108.491 -0.929 . . . . 73.33 108.491 178.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.98 119.91 17.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.316 -0.624 . . . . 74.03 109.316 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.0 p -85.93 99.9 11.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.212 -1.033 . . . . 54.33 108.212 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.63 124.7 68.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.472 0.709 . . . . 75.1 109.645 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 169.06 25.23 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.029 -0.987 . . . . 72.22 110.228 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.69 -28.58 11.9 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.033 -0.985 . . . . 63.02 111.045 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.547 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.2 OUTLIER -119.14 167.51 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.943 0.897 . . . . 74.43 110.903 -173.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -160.1 -171.76 3.34 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.799 -1.092 . . . . 75.55 108.954 173.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.52 -124.44 33.43 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.824 0.703 . . . . 74.1 114.109 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.6 t -63.62 -32.19 73.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.103 0.961 . . . . 75.01 112.789 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -68.28 -57.52 5.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.249 0.62 . . . . 73.24 111.218 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.547 ' HB3' HG12 ' C' ' 89' ' ' ILE . 3.3 ppp? -73.92 -21.19 60.14 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.698 -0.683 . . . . 71.55 110.739 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.4 96.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.946 0.498 . . . . 73.45 110.414 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.29 -39.18 75.22 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.007 -0.542 . . . . 74.25 110.844 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 94.2 m -67.49 -52.98 32.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.028 -0.533 . . . . 74.32 110.232 175.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.422 HD13 HG21 ' C' ' 58' ' ' VAL . 52.2 tp -60.38 -53.98 51.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.072 0.949 . . . . 70.43 111.546 -168.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.53 11.29 59.64 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.433 -0.648 . . . . 75.44 114.687 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.23 -63.79 0.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.837 0.818 . . . . 74.31 112.477 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 38.5 t80 -72.76 -53.25 12.12 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.823 0.449 . . . . 70.31 111.919 -168.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.459 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 44.1 m -59.11 -47.39 98.58 Favored Pre-proline 0 CA--C 1.569 1.675 0 C-N-CA 123.969 0.908 . . . . 73.33 112.352 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 86.5 Cg_exo -54.55 -37.28 90.4 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.96 2.44 . . . . 73.2 113.711 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -66.58 -38.49 87.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.886 0.741 . . . . 75.25 110.286 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.421 HD13 ' NH1' ' A' ' 111' ' ' ARG . 41.1 mm -61.53 -44.6 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.05 0.54 . . . . 74.13 110.324 175.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.548 HD23 ' HA3' ' C' ' 82' ' ' GLY . 97.0 mt -75.31 -30.85 60.46 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.291 -0.868 . . . . 74.23 112.302 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . 0.402 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 61.5 t80 -53.94 -49.77 87.73 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.298 1.221 . . . . 73.43 114.298 -171.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.09 -31.85 94.12 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.299 1.999 . . . . 72.35 113.841 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . 0.419 ' HE2' HG23 ' A' ' 115' ' ' THR . 68.5 m-85 -71.98 -43.15 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.238 0.615 . . . . 73.45 110.64 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -65.3 -38.33 89.89 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 116.038 -0.528 . . . . 72.54 110.484 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 39.2 ttt-85 -56.66 -53.48 57.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.556 1.542 . . . . 73.0 111.797 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.35 -32.91 74.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.825 0.45 . . . . 74.25 110.307 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.13 -32.38 71.72 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.065 0.546 . . . . 73.14 111.269 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.544 HG21 HG23 ' C' ' 64' ' ' VAL . 59.3 mt -70.29 -56.06 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.408 0.683 . . . . 73.52 109.739 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -63.33 -27.14 69.12 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.563 0.745 . . . . 72.3 111.276 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.5 t -66.36 -48.83 68.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.422 0.689 . . . . 50.35 109.544 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.88 -32.79 74.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.482 0.713 . . . . 74.12 112.16 178.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.65 -46.97 95.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.473 0.709 . . . . 75.41 109.549 174.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 58.9 p -73.73 -23.78 59.81 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.275 0.63 . . . . 72.14 112.185 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 116' ' ' SER . 82.3 mtt-85 -72.76 -37.8 67.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.575 0.75 . . . . 75.42 110.192 176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.16 1.86 73.26 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.524 0.515 . . . . 62.3 112.43 169.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 62.42 36.97 13.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.93 2.092 . . . . 70.34 112.665 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -94.94 154.15 39.77 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.781 -1.1 . . . . 73.42 109.44 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 -177.78 1.49 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.032 2.488 . . . . 74.25 113.591 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.71 133.9 56.33 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.133 1.16 . . . . 74.21 114.133 -169.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.3 tt -138.7 85.31 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.079 -1.822 . . . . 73.13 106.079 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.7 129.88 44.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.787 0.835 . . . . 75.21 109.493 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.517 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.6 mm? -80.47 143.89 33.0 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.642 0.589 . . . . 73.54 110.472 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.72 150.23 50.24 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.951 0.9 . . . . 72.22 111.376 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.416 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 88.2 Cg_endo -81.06 130.08 7.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.174 2.583 . . . . 73.31 112.297 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 9.4 t -135.08 112.97 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 109.067 -0.716 . . . . 74.32 109.067 173.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.34 90.75 5.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.438 0.695 . . . . 73.11 110.128 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.63 -39.07 77.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.778 0.799 . . . . 73.53 109.705 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 N--CA 1.473 0.7 0 CA-C-N 113.984 -1.462 . . . . 75.23 112.193 -176.717 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.24 0.559 0 N-CA-C 108.897 -0.779 . . . . 71.22 108.897 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -171.87 104.46 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.164 -1.791 . . . . 73.45 106.164 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -156.07 138.39 14.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.826 0.851 . . . . 74.42 108.844 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 HD11 ' D' ' 16' ' ' ILE . 10.1 mt -76.4 137.28 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.536 0.522 . . . . 75.02 110.368 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -99.93 -40.56 7.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.64 0.776 . . . . 74.31 110.257 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -167.15 125.9 1.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.474 -0.33 . . . . 73.43 111.207 -170.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.475 HD11 HG21 ' D' ' 13' ' ' ILE . 1.3 mp -103.91 132.56 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.13 -1.433 . . . . 74.04 107.13 165.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.566 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 26.0 p90 -166.09 154.95 11.27 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.954 0.784 . . . . 74.53 110.475 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -80.22 121.31 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.218 -0.901 . . . . 70.32 109.05 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 42.4 mtpt -87.28 -30.51 20.84 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.767 -0.457 . . . . 72.13 109.767 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.17 135.33 17.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.891 -1.049 . . . . 62.45 109.018 -177.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.551 HG23 ' HE1' ' C' ' 117' ' ' MET . 48.7 mt -134.84 144.26 35.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 107.991 -1.114 . . . . 74.43 107.991 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -151.82 137.78 18.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.359 0.664 . . . . 73.41 110.313 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 55.2 t80 -143.88 115.66 8.24 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 106.767 -1.568 . . . . 71.12 106.767 171.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.56 126.19 48.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.13 0.572 . . . . 75.42 109.601 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.56 80.35 22.8 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.578 -1.267 . . . . 64.23 107.578 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.24 -31.91 17.54 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.017 2.478 . . . . 74.44 112.672 -170.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -114.95 36.49 3.84 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.45 -0.944 . . . . 75.4 108.45 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.442 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -56.38 -62.48 4.8 Favored Pre-proline 0 CA--C 1.559 1.321 0 N-CA-C 113.919 1.081 . . . . 74.44 113.919 -167.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.557 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -78.07 -2.21 12.33 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 122.796 2.034 . . . . 65.5 113.318 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -84.35 -42.17 16.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.758 1.223 . . . . 74.53 109.75 174.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' D' ' 73' ' ' ALA . 11.0 p -76.6 -27.26 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.102 0.561 . . . . 75.12 111.049 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -68.2 -7.95 34.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.247 0.832 . . . . 72.21 113.247 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -82.72 -18.79 39.57 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.799 0.84 . . . . 74.31 111.19 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.99 99.46 8.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.101 0.96 . . . . 75.51 110.954 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -75.52 94.63 3.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.861 0.865 . . . . 74.43 111.743 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.449 ' CE3' HD23 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -155.84 175.02 14.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.71 0.804 . . . . 75.13 111.961 174.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -94.92 109.56 44.81 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 124.299 1.04 . . . . 71.51 110.942 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -65.3 146.13 85.26 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.231 2.62 . . . . 71.12 111.85 -177.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.27 156.17 38.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.903 -0.777 . . . . 72.34 108.903 164.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.487 HG21 HG13 ' D' ' 64' ' ' VAL . 1.3 p -136.3 118.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.775 -1.194 . . . . 75.34 107.775 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -106.1 125.69 51.3 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.104 0.962 . . . . 73.41 108.514 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.5 tt -95.89 126.54 41.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.277 -1.008 . . . . 75.2 108.277 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.9 t70 -114.95 125.87 54.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.879 -1.156 . . . . 64.45 107.879 169.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.06 130.85 46.26 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.1 -0.704 . . . . 73.42 109.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -134.01 143.29 48.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.723 -0.843 . . . . 73.21 108.723 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -121.47 147.74 45.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.139 0.976 . . . . 71.13 110.019 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.48 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.07 142.74 18.71 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.785 0.834 . . . . 63.44 109.261 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -160.64 153.4 21.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.889 0.476 . . . . 75.32 109.98 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -164.08 147.17 9.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.33 0.652 . . . . 74.22 109.948 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.8 122.13 25.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.162 -0.681 . . . . 72.55 109.162 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' C' ' 29' ' ' PRO . 71.6 mt -89.95 -34.61 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.549 0.74 . . . . 75.12 110.524 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 -177.8 6.43 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.349 -0.841 . . . . 72.44 109.667 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.43 116.25 5.92 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.75 -0.659 . . . . 72.32 110.495 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 62.4 24.59 14.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.435 1.094 . . . . 71.25 111.899 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.08 116.82 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.396 -0.964 . . . . 75.45 108.396 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.466 ' HB2' HD13 ' D' ' 86' ' ' ILE . 82.3 m-85 -131.91 129.05 39.8 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.745 1.218 . . . . 71.43 108.036 -173.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -102.52 139.7 37.77 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.599 0.76 . . . . 73.02 109.803 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.484 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 96.6 t -118.72 122.82 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.617 -1.253 . . . . 75.42 107.617 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 39.1 t -108.55 131.99 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.329 -0.989 . . . . 74.51 108.329 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tt -116.43 116.96 28.64 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.373 -1.343 . . . . 73.32 107.373 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -97.63 108.69 21.47 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.116 -0.698 . . . . 74.52 109.116 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.92 129.09 43.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 107.645 -1.243 . . . . 72.13 107.645 166.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.0 m -120.41 134.06 55.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.243 0.544 . . . . 73.21 109.701 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 78.5 t -125.62 106.81 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.128 1.371 . . . . 73.12 108.199 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -113.21 106.75 15.01 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.465 -0.568 . . . . 75.51 109.465 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.87 123.93 48.75 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.209 0.604 . . . . 74.45 109.679 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.7 m -147.31 121.54 9.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.304 -0.998 . . . . 72.34 108.304 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.449 HD23 ' CE3' ' D' ' 36' ' ' TRP . 17.3 tp -137.55 136.85 38.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.808 0.443 . . . . 74.14 110.013 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . 0.431 ' H ' HD13 ' D' ' 68' ' ' LEU . . . 91.75 -136.11 13.11 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.336 -1.106 . . . . 74.54 110.336 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 16.4 23.65 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.316 0.558 . . . . 73.31 110.881 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -136.21 164.66 27.55 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.071 0.548 . . . . 65.51 111.562 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -79.85 129.74 34.73 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.874 -1.057 . . . . 64.44 109.764 170.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -77.91 -66.15 0.88 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.178 -0.675 . . . . 74.44 109.178 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.35 165.88 32.36 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.061 -0.972 . . . . 75.33 111.191 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -129.07 146.54 51.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.888 1.275 . . . . 74.12 108.481 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.608 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 5.4 m -148.66 138.23 21.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.015 0.926 . . . . 70.35 109.661 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.57 122.31 5.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.332 -0.988 . . . . 74.34 108.332 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . 0.505 HG23 HG21 ' D' ' 21' ' ' ILE . 91.6 t -130.54 118.49 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.448 -0.575 . . . . 71.41 109.448 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 76.6 mt-30 -90.02 90.81 8.3 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.132 -0.94 . . . . 74.42 108.651 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.28 103.66 10.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.427 -0.806 . . . . 75.12 109.401 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 143.37 16.51 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.519 -0.633 . . . . 71.43 111.519 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.43 128.47 4.16 Favored Glycine 0 CA--C 1.506 -0.515 0 N-CA-C 109.942 -1.263 . . . . 73.03 109.942 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.27 131.68 36.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.12 -1.067 . . . . 74.43 108.12 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.484 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 18.7 m-85 -130.65 139.72 50.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.428 -0.582 . . . . 73.43 109.428 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.7 m -82.65 100.9 10.47 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 108.084 -1.08 . . . . 72.44 108.084 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' D' ' 56' ' ' TYR . 36.3 mt -117.28 138.65 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.294 0.638 . . . . 74.34 110.218 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 167.52 15.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.804 0.841 . . . . 65.54 110.456 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.8 -19.78 10.95 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 114.914 0.726 . . . . 53.41 114.914 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 pt -121.67 138.31 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.969 -1.122 . . . . 74.34 107.969 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -141.87 167.67 21.57 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.681 0.792 . . . . 64.35 110.809 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.87 -135.19 40.76 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.849 0.718 . . . . 44.32 113.054 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -66.08 -29.86 70.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.265 0.626 . . . . 64.04 111.324 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.48 HE21 ' HA ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -63.77 -40.96 97.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.371 0.669 . . . . 74.32 110.728 -178.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -81.34 -34.6 31.69 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.301 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.21 -23.92 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.64 0.776 . . . . 75.21 112.545 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . 0.53 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.6 t-80 -69.91 -38.55 76.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.695 0.398 . . . . 73.02 110.506 171.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.18 -33.67 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 110.338 -0.245 . . . . 64.02 110.338 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.52 -54.16 11.47 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.475 1.11 . . . . 74.42 109.877 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.92 14.31 64.86 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.562 -0.745 . . . . 61.43 114.405 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -145.23 -56.42 0.32 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 117.405 0.603 . . . . 70.41 112.333 -175.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -75.63 -51.6 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.532 0.567 . . . . 74.13 112.532 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.9 m -59.14 -48.61 96.11 Favored Pre-proline 0 CA--C 1.568 1.653 0 C-N-CA 124.206 1.002 . . . . 72.44 112.93 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.81 -30.79 78.09 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 122.265 1.976 . . . . 74.23 112.852 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.94 -32.2 73.45 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.298 0.639 . . . . 74.44 111.126 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -74.21 -42.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.584 0.754 . . . . 73.4 110.678 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.16 -30.25 49.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.325 -0.852 . . . . 73.31 111.997 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.51 -44.4 97.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.187 1.18 . . . . 75.52 114.187 -170.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.42 -41.59 51.22 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.452 2.101 . . . . 63.12 114.159 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -75.92 -38.62 57.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.811 . . . . 75.3 111.756 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.67 99.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.476 0.71 . . . . 74.42 110.753 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.535 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.7 ttp180 -62.56 -49.91 73.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.542 -1.208 . . . . 72.22 110.59 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -58.4 -48.47 80.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.379 1.072 . . . . 71.35 111.531 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.69 -40.12 75.03 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.811 0.694 . . . . 73.35 111.224 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.491 ' HA ' ' HE3' ' D' ' 117' ' ' MET . 93.7 mt -65.98 -50.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.132 -0.94 . . . . 74.43 110.582 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.6 m -53.9 -38.88 65.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.507 1.123 . . . . 75.51 111.759 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -70.54 -50.24 39.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.54 110.316 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.491 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 75.1 mtm -56.62 -43.16 79.95 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.453 0.701 . . . . 73.33 111.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.528 HG13 HD22 ' D' ' 126' ' ' LEU . 82.3 t -63.73 -42.28 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 114.441 -1.254 . . . . 72.15 110.814 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 59.6 p -68.8 -30.79 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 120.817 0.341 . . . . 75.13 110.965 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -69.63 -29.45 66.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.072 0.949 . . . . 73.44 110.525 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.45 11.42 69.97 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-N 115.579 -0.737 . . . . 71.12 112.905 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p 61.31 16.04 7.02 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 126.771 2.028 . . . . 73.05 113.721 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -90.41 164.66 26.21 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.237 1.015 . . . . 75.23 108.359 170.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -86.65 150.77 8.77 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.655 2.237 . . . . 74.42 112.466 -172.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.17 133.21 28.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.949 0.9 . . . . 72.5 112.749 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.528 HD22 HG13 ' D' ' 118' ' ' VAL . 3.8 mm? -105.82 95.0 5.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.533 -0.914 . . . . 75.13 108.533 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -98.87 98.79 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.435 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.9 mm? -76.08 135.15 39.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.3 -0.864 . . . . 74.34 109.625 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.88 128.69 92.74 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-O 119.56 -0.257 . . . . 75.32 110.989 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.535 ' HB3' HH12 ' D' ' 111' ' ' ARG . 65.6 Cg_endo -74.65 117.48 4.96 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.508 2.139 . . . . 74.22 111.299 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.76 110.3 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.534 -0.913 . . . . 73.21 108.534 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -78.4 98.8 6.13 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.859 -0.793 . . . . 74.13 108.859 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . 0.503 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 62.8 m-85 . . . . . 0 N--CA 1.473 0.678 0 CA-C-N 115.102 -0.953 . . . . 74.04 111.267 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 110.181 -0.303 . . . . 75.35 110.181 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.485 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 28.1 t80 -138.83 127.59 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 171.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -159.17 110.91 2.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.466 0.479 . . . . 74.44 110.143 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.679 HG12 ' HD2' ' A' ' 84' ' ' PHE . 56.6 mt -69.5 116.02 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.057 0.543 . . . . 75.24 110.329 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -81.43 -36.04 29.91 Favored 'General case' 0 C--O 1.248 0.996 0 O-C-N 124.159 0.912 . . . . 72.22 110.007 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -176.28 123.01 0.17 Allowed 'General case' 0 C--N 1.363 1.195 0 O-C-N 123.557 0.536 . . . . 72.5 111.025 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.06 142.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 123.614 0.766 . . . . 75.44 109.024 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -168.44 155.83 7.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.674 0.75 . . . . 75.12 111.71 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -86.6 114.99 23.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.953 -1.021 . . . . 52.31 109.193 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 39.2 mtpt -79.3 -22.07 45.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.147 -0.479 . . . . 74.25 111.009 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -159.84 144.27 14.82 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.88 0.872 . . . . 62.11 109.357 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 84.3 mt -141.93 143.88 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.361 1.464 . . . . 75.22 107.806 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -145.73 128.29 16.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.525 0.73 . . . . 74.13 109.537 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 89.7 t80 -126.12 117.25 22.76 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 106.082 -1.821 . . . . 72.43 106.082 162.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 47.1 mt-10 -118.99 140.56 49.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.965 -0.754 . . . . 73.51 108.965 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.53 72.96 69.16 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 105.804 -1.925 . . . . 74.2 105.804 168.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.58 -20.27 41.24 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.798 2.332 . . . . 73.2 112.042 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.408 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 37.9 m-20 -119.42 23.43 11.24 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.242 1.017 . . . . 64.3 109.434 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -47.95 -57.45 10.2 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.625 -1.179 . . . . 54.22 113.485 -170.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 14.1 Cg_exo -65.9 -19.4 58.42 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 121.873 1.715 . . . . 74.11 112.572 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.61 -44.62 14.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.803 0.841 . . . . 64.41 109.889 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -78.99 -19.6 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.824 -1.08 . . . . 75.44 111.943 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.61 -6.25 42.88 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.497 0.719 . . . . 74.44 111.301 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -102.2 -12.55 17.94 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.661 1.185 . . . . 74.15 111.978 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -71.42 168.66 17.0 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.719 0.808 . . . . 75.24 113.016 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.463 ' O ' HD22 ' A' ' 68' ' ' LEU . 23.3 m-20 -69.97 135.19 49.14 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.182 -0.917 . . . . 74.33 109.368 169.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -82.77 67.18 8.73 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.491 1.116 . . . . 73.33 110.617 -169.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -141.75 71.0 25.01 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.137 0.975 . . . . 72.15 109.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -91.26 129.47 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.61 2.873 . . . . 75.4 112.217 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -96.63 110.5 22.91 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.034 -1.098 . . . . 75.15 108.034 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 t -79.22 136.64 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.672 0.789 . . . . 64.5 109.108 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -117.04 118.58 32.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.486 1.114 . . . . 75.01 108.136 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -102.37 107.72 18.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.109 -1.071 . . . . 61.33 108.109 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.699 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 14.8 m-20 -108.01 151.16 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.935 0.894 . . . . 73.54 108.982 172.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -139.0 134.58 33.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.202 1.001 . . . . 72.23 108.42 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 35.0 t70 -135.96 137.27 41.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.076 0.951 . . . . 73.14 109.354 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 p -124.86 134.9 52.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.339 1.056 . . . . 71.11 110.157 -172.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.95 143.09 25.0 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 61.24 109.77 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -132.18 161.1 34.2 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.28 0.632 . . . . 74.54 109.338 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -163.49 127.8 2.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.499 0.72 . . . . 74.15 109.74 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -74.23 114.06 12.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.845 -0.798 . . . . 65.0 108.845 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 57' ' ' GLU . 39.9 mt -79.42 -43.96 22.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.146 0.578 . . . . 75.52 109.629 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.64 -172.69 2.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.939 -1.028 . . . . 75.52 109.815 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.34 120.99 14.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.371 0.668 . . . . 64.35 109.387 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.37 16.55 9.6 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.668 1.187 . . . . 73.23 112.528 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 51' ' ' LEU . 28.7 t -127.48 106.32 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.301 -1.0 . . . . 74.25 108.301 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -133.78 127.9 33.68 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.089 0.956 . . . . 74.12 108.479 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.619 ' HB2' HD13 ' A' ' 51' ' ' LEU . 33.7 tt0 -104.65 134.41 47.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.36 0.664 . . . . 70.32 109.762 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.608 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 97.2 t -122.82 123.79 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.967 -1.123 . . . . 71.43 107.967 169.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.536 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -99.68 135.48 34.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.357 1.063 . . . . 73.13 109.374 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.14 99.52 6.4 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.158 -1.423 . . . . 73.14 107.158 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.7 ttp180 -87.46 113.29 23.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.045 0.538 . . . . 73.31 109.806 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' A' ' 114' ' ' ILE . 13.6 t -93.76 143.33 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.498 -1.297 . . . . 74.11 107.498 171.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.5 m -131.56 133.86 45.47 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.42 -0.585 . . . . 62.53 109.42 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.8 t -131.19 111.02 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.1 1.36 . . . . 72.24 108.709 -173.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 m -120.69 121.64 38.71 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.326 0.512 . . . . 74.41 110.212 173.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.33 22.53 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.339 -1.356 . . . . 72.0 107.339 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 66.2 m -118.25 126.56 52.42 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.306 0.503 . . . . 73.42 110.485 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.463 HD22 ' O ' ' A' ' 35' ' ' ASP . 5.3 mp -90.22 85.72 6.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.879 -1.156 . . . . 74.42 107.879 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.15 -85.11 1.53 Allowed Glycine 0 C--N 1.343 0.94 0 CA-C-N 114.434 -1.257 . . . . 53.12 110.643 -173.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.13 -28.74 3.11 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.482 0.713 . . . . 65.01 110.872 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 30.4 tt0 -95.73 125.65 40.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.835 0.35 . . . . 75.11 110.307 -174.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 29.5 m -77.77 142.23 38.78 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.783 1.233 . . . . 73.13 112.805 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -80.04 -65.98 0.94 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.522 1.129 . . . . 74.22 109.199 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 50.6 p90 -146.1 148.94 33.15 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.513 -1.221 . . . . 75.54 111.865 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -109.29 143.08 39.25 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.22 -1.355 . . . . 72.04 107.904 167.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.596 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.3 m -143.06 109.7 5.45 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.6 119.54 17.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.755 -0.461 . . . . 70.45 109.755 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.09 114.37 32.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.382 1.073 . . . . 75.22 109.404 -171.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.86 84.22 7.65 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.38 -0.97 . . . . 74.3 108.38 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.57 91.7 5.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.811 -0.811 . . . . 63.24 108.811 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.09 167.27 37.69 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.39 -0.823 . . . . 52.43 111.715 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 124.95 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.186 -0.366 . . . . 75.34 112.186 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -81.98 115.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.964 -0.754 . . . . 63.32 108.964 171.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.679 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.7 m-85 -116.98 120.08 37.31 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.17 1.388 . . . . 75.55 107.81 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 t -75.57 94.17 3.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.797 -0.816 . . . . 71.41 108.797 171.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.657 HD11 HD21 ' A' ' 98' ' ' LEU . 50.8 pt -112.72 155.57 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.165 0.586 . . . . 74.13 110.708 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.76 167.69 11.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.456 -1.247 . . . . 71.45 109.111 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -11.65 57.6 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 114.511 0.564 . . . . 71.24 114.511 173.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.47 144.21 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.755 0.822 . . . . 61.22 110.3 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -162.06 173.31 14.55 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.785 -1.561 . . . . 65.31 106.785 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.25 -129.82 48.11 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 117.888 0.313 . . . . 61.04 113.543 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.3 p -75.09 -20.98 59.23 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.805 0.842 . . . . 74.43 111.826 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -69.82 -44.59 69.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.135 0.574 . . . . 74.35 109.619 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.4 ttm -68.95 -34.27 75.08 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.01 -0.541 . . . . 72.24 110.066 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.98 -28.34 68.94 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.188 0.595 . . . . 73.3 111.777 177.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 52.8 t-80 -88.47 -31.13 18.92 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.297 0.639 . . . . 71.43 111.065 171.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.11 -64.69 0.84 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.582 0.353 . . . . 72.33 111.149 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.657 HD21 HD11 ' A' ' 86' ' ' ILE . 47.2 mt -90.09 -12.74 37.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.168 0.433 . . . . 72.52 112.168 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.78 -2.45 55.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.768 -0.462 . . . . 71.42 113.347 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -149.19 -53.17 0.17 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.365 0.582 . . . . 73.33 112.186 -174.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -77.3 -56.94 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 64.34 112.085 -168.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 80.5 m -74.97 -34.48 1.72 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.563 0.949 . . . . 73.32 113.563 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.6 Cg_endo -67.06 -23.01 46.8 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 121.958 1.772 . . . . 74.4 112.936 168.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -70.19 -33.76 72.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.3 0.64 . . . . 62.31 109.487 174.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 13' ' ' ILE . 45.3 mm -63.04 -42.17 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.799 0.84 . . . . 74.21 110.14 173.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.66 -32.62 69.97 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.982 -1.008 . . . . 72.52 111.981 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.27 -39.99 55.75 Favored Pre-proline 0 CA--C 1.575 1.927 0 N-CA-C 114.597 1.332 . . . . 74.41 114.597 -169.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.05 -41.75 73.69 Favored 'Trans proline' 0 C--N 1.392 2.835 0 C-N-CA 122.592 2.195 . . . . 73.55 113.489 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -71.97 -37.3 69.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.985 0.514 . . . . 64.25 111.376 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.46 88.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.785 0.434 . . . . 74.24 109.86 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.427 ' NH1' HD13 ' C' ' 105' ' ' ILE . 38.7 ttm180 -54.97 -53.38 56.44 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 124.726 1.266 . . . . 75.23 110.126 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.52 -42.75 95.59 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.044 0.84 . . . . 73.41 111.231 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.515 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.4 t -60.64 -34.52 74.39 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.504 0.722 . . . . 74.3 111.257 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.5 mt -73.44 -55.51 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.593 0.757 . . . . 72.23 109.867 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.491 HG23 ' HG3' ' A' ' 125' ' ' GLN . 90.0 m -53.08 -40.33 63.98 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 125.199 1.4 . . . . 61.23 111.952 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -61.49 -50.78 71.33 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 61.52 110.303 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -61.17 -44.22 97.65 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.461 0.704 . . . . 71.44 111.527 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.4 t -55.83 -46.81 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 O-C-N 124.25 0.969 . . . . 63.02 110.299 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.6 t -69.87 -29.58 66.83 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.199 -0.91 . . . . 74.43 111.504 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -70.95 -27.67 63.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.363 0.665 . . . . 73.41 111.259 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.78 11.77 58.71 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.93 -0.372 . . . . 62.44 113.339 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.488 ' HB ' HH21 ' B' ' 15' ' ' ARG . 2.4 m 61.03 25.62 15.63 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 125.141 1.376 . . . . 73.23 111.022 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -94.01 146.23 31.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.825 -0.806 . . . . 74.24 108.825 171.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.73 149.55 90.55 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.66 2.24 . . . . 74.03 112.088 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.491 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.6 tt0 -58.37 133.16 55.49 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.295 0.997 . . . . 61.42 112.003 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.01 103.73 9.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.256 1.022 . . . . 75.24 108.783 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -105.97 110.89 23.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.127 -1.064 . . . . 75.35 108.127 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.55 135.5 54.27 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 123.404 0.44 . . . . 73.03 110.402 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.418 ' HA ' HD12 ' C' ' 13' ' ' ILE . . . -69.38 155.93 92.59 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.39 0.676 . . . . 72.24 110.312 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.24 125.33 14.94 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.524 2.149 . . . . 75.24 112.181 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -99.8 113.1 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.717 -1.586 . . . . 70.04 106.717 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -72.79 81.33 1.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 74.11 110.488 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.09 -44.26 97.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.449 0.7 . . . . 63.32 110.951 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 11.2 p-10 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 114.286 -1.325 . . . . 75.21 111.707 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 109.381 -0.6 . . . . 70.52 109.381 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.482 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 31.9 t80 -139.58 131.33 27.46 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.224 -0.658 . . . . 73.45 109.224 176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' B' ' 85' ' ' SER . 3.9 pp0? -152.29 140.9 20.81 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.055 0.542 . . . . 75.12 109.54 168.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.562 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -69.28 113.8 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.247 -0.888 . . . . 72.12 109.344 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -88.24 -35.31 17.38 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.008 -0.738 . . . . 65.35 109.008 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.488 HH21 ' HB ' ' A' ' 122' ' ' THR . 24.3 ttt180 -168.47 142.0 3.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.999 0.92 . . . . 73.13 109.726 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.11 137.66 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.007 -1.479 . . . . 72.04 107.007 172.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -166.28 159.24 14.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.687 0.756 . . . . 75.24 110.96 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.9 m -84.63 119.42 25.21 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.283 -1.006 . . . . 75.51 108.283 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -87.03 -34.44 19.2 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.289 0.635 . . . . 75.51 111.142 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -158.84 146.26 17.64 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.322 -0.399 . . . . 73.52 110.746 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.406 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.7 mm -142.49 138.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 125.965 1.706 . . . . 73.22 107.619 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -140.1 118.9 12.44 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.522 -1.288 . . . . 73.22 107.522 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.5 t80 -131.59 136.42 47.77 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.08 -1.081 . . . . 73.33 108.08 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.76 145.28 38.05 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.131 0.972 . . . . 72.31 108.696 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.34 72.3 10.93 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 105.9 -1.889 . . . . 74.34 105.9 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.55 -14.71 30.65 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.79 2.327 . . . . 73.23 112.177 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -127.04 28.53 5.76 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.032 0.933 . . . . 60.14 109.502 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.69 -59.35 5.25 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.477 1.111 . . . . 71.1 113.305 -173.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.29 -18.97 34.16 Favored 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 121.926 1.751 . . . . 70.03 113.029 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -94.73 -21.81 18.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.439 0.696 . . . . 74.1 112.382 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -81.94 -28.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 110.051 -0.351 . . . . 73.22 110.051 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -62.47 -27.03 68.85 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.278 1.031 . . . . 74.12 113.216 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -72.77 -16.18 61.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.235 0.614 . . . . 75.1 112.204 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -107.55 113.34 26.59 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.149 0.98 . . . . 74.2 109.227 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -110.38 104.57 13.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 118.707 0.685 . . . . 70.01 112.605 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.46 ' HE3' ' N ' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 179.21 -177.38 0.3 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.384 1.474 . . . . 74.22 110.898 176.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.54 133.73 70.45 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.293 1.037 . . . . 74.41 111.956 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.583 ' HB3' HD21 ' B' ' 68' ' ' LEU . 93.1 Cg_endo -93.43 170.6 2.08 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.329 2.686 . . . . 74.02 114.564 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -80.98 101.69 9.67 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.879 -1.526 . . . . 64.43 106.879 164.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' B' ' 65' ' ' THR . 10.9 t -99.7 134.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.343 -0.984 . . . . 74.21 108.343 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.431 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.3 tttp -125.35 117.17 23.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.251 0.62 . . . . 74.42 110.195 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.88 136.57 33.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.968 -1.123 . . . . 71.53 107.968 169.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.572 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 15.4 t70 -145.93 154.72 42.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.19 0.596 . . . . 61.33 109.584 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.5 tp -135.42 128.32 31.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.228 1.011 . . . . 74.43 109.71 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.6 t70 -124.01 130.99 53.49 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.232 -1.025 . . . . 64.31 108.232 170.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -118.31 104.54 10.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.36 0.664 . . . . 74.43 109.947 -176.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.27 118.77 33.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.575 -0.898 . . . . 73.2 108.575 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 41.1 p -129.31 160.58 32.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.22 0.608 . . . . 63.44 110.53 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.1 p -165.69 138.37 4.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.972 0.909 . . . . 62.34 110.016 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 50.3 tt0 -81.16 115.46 20.59 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.477 0.711 . . . . 74.43 109.405 175.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.421 HD12 HG22 ' B' ' 83' ' ' ILE . 32.7 mt -75.5 -43.38 49.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.67 0.788 . . . . 73.55 110.538 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.65 -171.21 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.84 0.856 . . . . 73.12 110.481 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.62 116.49 4.05 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.36 0.664 . . . . 74.11 110.243 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 67.12 -3.36 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.568 1.547 . . . . 73.54 113.383 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -102.92 110.56 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.822 -1.177 . . . . 74.44 107.822 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 45.6 m-85 -111.68 172.04 7.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.379 -0.828 . . . . 74.0 108.996 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -142.43 129.0 20.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.485 -0.931 . . . . 61.43 108.485 172.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -112.51 119.0 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.504 -1.295 . . . . 75.44 107.504 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -103.09 111.91 34.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 108.965 -0.754 . . . . 75.11 108.965 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.49 101.47 13.67 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.993 -1.003 . . . . 74.42 108.772 -176.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.7 ttm-85 -94.93 121.0 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.366 -0.605 . . . . 63.44 109.366 174.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . 0.438 HG11 HD22 ' B' ' 128' ' ' LEU . 41.3 t -115.75 125.48 72.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.222 -1.029 . . . . 72.41 108.222 172.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.6 m -111.96 140.34 46.71 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.616 0.722 . . . . 72.33 110.129 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.515 HG22 HG21 ' B' ' 114' ' ' ILE . 54.5 t -124.72 130.81 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 113.818 -1.537 . . . . 61.1 108.161 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.1 m -122.23 143.61 49.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.127 0.571 . . . . 72.25 109.466 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.05 125.77 13.42 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.524 -1.287 . . . . 70.55 107.524 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 55.8 p -140.82 140.08 34.61 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.303 0.641 . . . . 72.44 109.566 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.583 HD21 ' HB3' ' B' ' 38' ' ' PRO . 3.2 mm? -124.68 123.0 39.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.59 1.156 . . . . 65.05 109.974 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.89 -113.03 4.75 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.595 0.56 . . . . 63.35 112.057 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -113.02 4.16 16.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.856 0.863 . . . . 73.54 110.326 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.6 146.51 48.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.063 0.545 . . . . 75.53 110.282 -169.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -83.03 124.89 30.85 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.469 0.308 . . . . 74.43 110.341 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.576 ' HB1' HD22 ' B' ' 68' ' ' LEU . . . -71.45 -63.98 1.01 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.257 0.973 . . . . 73.13 109.262 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -157.03 149.44 23.17 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 121.657 0.741 . . . . 73.05 112.511 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 83.6 mt -113.89 118.96 35.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.946 -1.501 . . . . 74.52 106.946 166.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 34.5 t -125.42 124.8 42.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.797 -0.816 . . . . 71.33 108.797 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -148.55 130.81 15.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.5 -0.926 . . . . 65.21 108.5 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -124.45 146.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 123.953 0.901 . . . . 74.24 109.512 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -121.66 96.49 5.09 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.193 -1.04 . . . . 63.25 108.193 170.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.509 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -90.99 99.33 12.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.292 -1.003 . . . . 74.13 108.292 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.13 142.66 16.07 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 110.788 -0.925 . . . . 61.44 110.788 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.27 124.93 3.35 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.43 -1.068 . . . . 64.33 110.43 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.421 HG22 HD12 ' B' ' 51' ' ' LEU . 56.7 mt -85.69 127.7 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.305 -1.369 . . . . 74.42 107.305 172.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.73 133.66 43.77 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.402 -0.962 . . . . 75.32 108.402 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.585 ' HB2' ' NE2' ' B' ' 12' ' ' GLN . 48.4 m -94.04 103.58 15.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.628 -1.249 . . . . 71.42 107.628 171.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.86 146.16 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.405 1.082 . . . . 73.52 110.265 -171.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.05 172.22 16.08 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.798 1.239 . . . . 70.03 109.198 172.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.0 -30.39 6.7 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.173 0.416 . . . . 71.51 114.003 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.36 162.79 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.343 0.657 . . . . 72.12 112.135 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -172.09 145.38 1.79 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.925 1.29 . . . . 73.42 109.04 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -111.3 3.3 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 114.74 0.656 . . . . 75.25 114.74 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -65.49 -44.02 88.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.833 0.853 . . . . 75.02 110.122 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -69.07 -29.77 67.95 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.693 -1.594 . . . . 75.31 110.545 -171.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.469 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 19.9 ptm -81.84 -34.09 30.35 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 116.496 -0.32 . . . . 74.45 111.016 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -34.75 74.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.515 0.726 . . . . 72.33 111.912 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -77.83 -34.02 52.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.238 0.615 . . . . 74.13 111.05 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.92 -65.84 0.63 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.698 0.399 . . . . 71.35 111.013 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.554 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.4 pp -70.95 -24.1 62.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.735 0.414 . . . . 75.42 111.961 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . 0.433 ' N ' HD13 ' B' ' 98' ' ' LEU . . . -84.4 -32.89 21.34 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.661 0.601 . . . . 54.14 113.729 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.7 -50.35 1.49 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.007 0.523 . . . . 70.43 111.564 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . 0.415 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 70.3 t80 -71.22 -40.8 70.9 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.361 0.664 . . . . 74.43 111.945 -172.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 55.6 m -72.21 -46.99 10.93 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.803 -0.618 . . . . 74.12 111.121 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.1 Cg_exo -57.62 -33.24 96.32 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.462 2.108 . . . . 65.21 113.708 168.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.78 -37.57 68.75 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.886 0.874 . . . . 54.41 110.919 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.19 -48.87 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.865 -1.062 . . . . 72.22 111.159 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.439 ' HB2' HD11 ' B' ' 60' ' ' LEU . 62.3 mt -77.72 -19.33 55.42 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.538 0.735 . . . . 74.33 112.405 -170.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.26 -45.56 85.12 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 114.164 1.172 . . . . 74.32 114.164 -170.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -57.02 -38.94 94.75 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 122.511 2.141 . . . . 74.1 113.351 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.1 m-85 -69.14 -40.11 78.45 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.153 -0.93 . . . . 73.51 109.858 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.99 93.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.523 0.729 . . . . 73.24 110.308 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -54.86 -57.59 11.0 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.623 1.169 . . . . 71.42 111.373 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.43 80.53 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.989 0.805 . . . . 74.2 110.244 -175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.1 t -72.37 -32.58 66.56 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.868 0.467 . . . . 64.13 111.643 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.515 HG21 HG22 ' B' ' 64' ' ' VAL . 50.9 mt -65.3 -51.81 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.357 -0.979 . . . . 73.32 108.357 171.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 115' ' ' THR . . . . . 0.428 HG22 ' OG ' ' C' ' 119' ' ' SER . 24.8 m -61.28 -30.17 70.31 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.667 -1.152 . . . . 74.52 111.698 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.2 t -64.86 -46.7 80.74 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.789 0.836 . . . . 74.21 109.443 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.511 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 13.3 mmt -72.54 -30.54 64.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.217 0.607 . . . . 74.53 110.944 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.497 HG22 HD23 ' B' ' 126' ' ' LEU . 83.3 t -64.46 -41.16 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.911 0.884 . . . . 75.02 110.311 172.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -65.65 -35.11 79.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.058 0.943 . . . . 72.03 111.452 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.4 mtt-85 -73.03 -37.21 66.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.614 -0.721 . . . . 75.35 110.317 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.39 1.94 74.14 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.737 0.648 . . . . 71.31 112.59 173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p 63.93 18.32 11.11 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.581 1.952 . . . . 73.42 113.544 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.57 152.79 81.08 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.47 0.708 . . . . 73.5 109.433 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.54 -178.81 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 123.106 2.538 . . . . 73.43 114.236 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.558 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 26.5 tp60 -65.37 113.48 4.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.753 -0.658 . . . . 63.12 112.445 -170.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.497 HD23 HG22 ' B' ' 118' ' ' VAL . 55.9 tp -114.35 93.78 4.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.05 -0.977 . . . . 73.42 108.855 171.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.08 128.5 36.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.591 -1.262 . . . . 74.41 107.591 166.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.438 HD22 HG11 ' B' ' 62' ' ' VAL . 30.2 tp -75.77 145.6 40.64 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.377 0.671 . . . . 73.31 110.51 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 127.49 85.02 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.817 0.847 . . . . 72.51 111.316 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.47 122.84 10.62 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.891 2.394 . . . . 74.2 111.594 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.91 116.85 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.409 0.684 . . . . 73.02 109.978 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -86.23 86.47 7.35 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.546 -0.909 . . . . 73.52 108.546 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.474 0.736 0 CA-C-N 115.742 -0.663 . . . . 73.24 109.668 178.567 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.485 ' HE2' HG12 ' C' ' 89' ' ' ILE . 73.5 mtp . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 112.365 0.506 . . . . 72.22 112.365 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -86.26 99.5 11.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.677 -0.86 . . . . 72.23 108.677 169.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -124.33 126.76 46.55 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.789 -1.189 . . . . 71.03 107.789 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -151.85 144.09 23.99 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.918 0.487 . . . . 73.02 110.257 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . 0.448 HG13 ' HE2' ' C' ' 84' ' ' PHE . 3.1 mp -82.63 115.73 25.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.219 -1.03 . . . . 75.53 108.219 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -80.93 -44.08 18.79 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.951 -0.388 . . . . 74.25 109.951 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -169.11 141.78 2.67 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.304 0.378 . . . . 75.11 110.098 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -125.45 135.52 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.053 -1.091 . . . . 73.41 108.053 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.526 ' HH ' HD11 ' C' ' 83' ' ' ILE . 32.6 p90 -173.77 155.9 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.914 0.387 . . . . 72.11 111.129 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -77.36 115.59 17.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.392 -0.822 . . . . 74.33 109.871 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -65.1 -41.02 95.34 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.995 -0.743 . . . . 74.22 108.995 171.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -149.34 150.11 31.96 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.316 -1.311 . . . . 74.14 110.353 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -142.14 145.28 24.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.501 1.92 . . . . 65.34 106.507 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -161.87 150.87 15.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.822 0.449 . . . . 72.33 110.053 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.86 106.67 2.68 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.436 -1.32 . . . . 71.23 107.436 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.39 120.22 36.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.747 0.819 . . . . 70.33 109.41 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.95 83.34 61.42 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.343 1.057 . . . . 70.31 108.496 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.92 -39.21 34.01 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.628 2.219 . . . . 73.13 112.081 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -97.13 20.9 10.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.957 0.903 . . . . 71.32 110.952 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.15 76.08 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.419 1.266 . . . . 70.25 114.419 -171.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.75 -26.35 8.32 Favored 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 121.235 1.477 . . . . 74.41 112.655 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.66 -30.37 65.65 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.336 1.054 . . . . 72.22 112.511 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' C' ' 73' ' ' ALA . 99.4 t -80.02 -20.17 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.32 0.648 . . . . 64.21 110.639 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -60.47 -28.97 68.75 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.072 0.549 . . . . 74.24 111.348 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.42 26.26 6.82 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.558 0.743 . . . . 75.21 110.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.25 152.36 37.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.605 0.762 . . . . 74.23 111.084 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.62 130.71 43.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.816 0.847 . . . . 71.5 110.449 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -76.34 98.14 4.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.838 0.855 . . . . 74.03 110.889 -172.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -156.59 75.82 4.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.397 -0.964 . . . . 74.41 108.397 173.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -86.63 130.09 3.17 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.391 2.06 . . . . 75.53 112.126 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.53 80.25 9.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.582 -1.636 . . . . 74.42 106.582 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.459 HG12 HD21 ' C' ' 126' ' ' LEU . 90.2 t -74.45 118.26 19.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.226 -1.352 . . . . 75.45 108.617 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -128.71 141.34 51.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.276 -1.379 . . . . 74.32 107.276 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.16 166.39 14.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.554 -0.906 . . . . 74.3 108.554 167.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.1 t70 -140.0 127.91 22.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.611 -1.255 . . . . 54.44 107.611 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 tp -104.85 140.62 37.86 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.691 0.796 . . . . 64.33 109.991 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 29.3 t70 -144.84 149.93 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.17 0.988 . . . . 73.4 108.676 172.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 66.3 p -126.77 141.09 51.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 75.34 109.928 -172.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -150.25 139.98 21.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.055 0.542 . . . . 71.22 110.104 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p -148.01 156.07 42.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.533 0.733 . . . . 71.42 109.529 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -152.68 165.55 34.93 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.282 0.633 . . . . 74.01 109.937 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -105.16 118.08 35.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.824 -0.806 . . . . 63.41 108.824 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.52 HD13 HD13 ' C' ' 83' ' ' ILE . 76.4 mt -89.04 -35.61 16.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.181 0.592 . . . . 73.2 110.366 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -171.3 2.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.036 0.934 . . . . 75.14 110.219 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.43 116.41 8.96 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.278 -0.874 . . . . 75.22 109.423 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 69.57 -0.46 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.371 1.468 . . . . 75.43 112.601 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.32 112.29 38.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 108.146 -1.057 . . . . 74.21 108.146 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.402 ' HB2' HD12 ' C' ' 86' ' ' ILE . 94.0 m-85 -129.56 144.13 51.13 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.889 0.876 . . . . 73.41 108.856 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -99.73 136.42 39.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.529 1.132 . . . . 74.52 110.021 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . 0.449 HG21 HD21 ' C' ' 98' ' ' LEU . 40.8 t -114.95 120.04 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.816 -1.179 . . . . 74.42 107.816 173.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 88.7 t -118.59 129.92 74.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.764 -0.828 . . . . 71.02 108.764 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 2.6 tm? -125.01 107.0 10.38 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.948 -1.501 . . . . 73.43 106.948 176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 25.5 ttm180 -84.06 127.02 33.62 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.906 -0.588 . . . . 71.3 109.774 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.15 121.28 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.52 -1.218 . . . . 73.2 107.881 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 68.5 m -120.59 142.54 49.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.566 -0.902 . . . . 72.15 108.566 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.484 HG23 HG21 ' C' ' 114' ' ' ILE . 72.8 t -122.39 115.31 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.889 0.876 . . . . 74.31 109.421 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 28.2 m -99.31 135.79 40.21 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.879 -0.786 . . . . 65.2 108.879 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.29 107.29 7.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.082 -1.451 . . . . 74.43 107.082 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 67' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.3 m -143.44 128.36 18.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.286 0.634 . . . . 73.3 109.468 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' C' ' 73' ' ' ALA . 5.3 mp -85.8 56.71 4.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.469 1.507 . . . . 74.42 109.313 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.0 -82.33 0.44 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 109.893 -1.283 . . . . 71.54 109.893 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.12 -30.6 4.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.604 1.161 . . . . 73.22 109.104 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.19 91.79 0.08 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.191 1.397 . . . . 75.11 110.796 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 72' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 38.6 m -71.98 121.36 19.0 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.749 0.309 . . . . 74.43 111.389 -173.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -68.72 -62.67 1.29 Allowed 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.722 1.263 . . . . 61.23 109.646 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -163.48 175.66 10.52 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.442 -1.254 . . . . 75.22 109.794 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.41 145.71 37.4 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.251 -1.759 . . . . 73.3 106.251 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.0 t -144.92 149.61 35.56 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.325 -0.991 . . . . 70.44 108.325 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.88 121.03 3.93 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.61 -0.515 . . . . 62.42 109.61 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -119.64 114.41 44.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.869 -0.789 . . . . 73.42 108.869 170.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.1 96.79 10.84 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.628 -1.249 . . . . 74.51 107.628 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . 0.531 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.1 tp-100 -82.75 129.22 34.94 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.941 0.496 . . . . 53.44 109.678 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.16 154.84 16.72 Favored Glycine 0 N--CA 1.461 0.328 0 O-C-N 123.51 0.506 . . . . 61.43 112.051 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.436 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.47 122.25 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.147 -0.781 . . . . 73.43 111.147 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.526 HD11 ' HH ' ' C' ' 17' ' ' TYR . 12.0 mm -89.25 127.08 42.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.468 -0.938 . . . . 74.34 108.468 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . 0.448 ' HE2' HG13 ' C' ' 13' ' ' ILE . 83.8 m-85 -136.59 131.68 34.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 74.34 109.871 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -81.05 104.09 11.31 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.405 -0.961 . . . . 71.44 108.405 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.552 HD11 ' SD ' ' C' ' 94' ' ' MET . 10.5 pt -119.45 120.55 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.705 0.802 . . . . 75.43 109.867 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.35 168.05 25.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.715 0.806 . . . . 75.53 110.72 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.28 -61.17 3.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.048 -0.978 . . . . 71.55 111.411 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.485 HG12 ' HE2' ' C' ' 9' ' ' MET . 2.3 pp -81.17 142.52 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.789 0.328 . . . . 74.44 110.331 172.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 12.2 pt-20 -147.91 179.03 8.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.797 0.839 . . . . 63.23 109.397 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -122.43 29.81 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 123.687 0.617 . . . . 71.03 113.652 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -78.79 -22.99 45.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.93 0.892 . . . . 73.31 111.595 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -72.86 -31.7 64.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.882 0.473 . . . . 74.41 109.913 173.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.552 ' SD ' HD11 ' C' ' 86' ' ' ILE . 51.6 tpp -66.66 -40.52 88.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.659 -0.7 . . . . 72.42 110.114 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.11 70.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.934 0.894 . . . . 73.34 112.767 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 43.7 t-80 -69.27 -39.06 78.61 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.737 0.415 . . . . 65.43 111.426 177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -76.16 -41.47 49.71 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.168 0.509 . . . . 73.3 110.732 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.449 HD21 HG21 ' C' ' 58' ' ' VAL . 3.4 tm? -82.62 -53.38 5.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.995 1.318 . . . . 73.14 110.75 -168.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.7 -0.19 69.58 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.708 -0.678 . . . . 72.32 114.176 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.557 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -128.97 -66.81 0.81 Allowed 'General case' 0 C--N 1.35 0.598 0 CA-C-N 117.211 0.506 . . . . 74.04 111.503 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.15 -49.01 63.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.678 0.622 . . . . 73.4 112.678 -169.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.12 -42.67 77.87 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 118.237 -0.887 . . . . 74.12 112.477 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . 0.401 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 89.0 Cg_exo -49.57 -41.36 44.99 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.129 2.553 . . . . 63.34 113.691 166.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 89.0 m-20 -67.62 -31.22 71.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.766 0.827 . . . . 75.41 111.467 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.427 HD13 ' NH1' ' A' ' 111' ' ' ARG . 39.6 mm -70.39 -44.23 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.16 0.584 . . . . 75.14 109.735 175.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.436 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.4 mt -79.24 -21.56 46.01 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.452 -0.794 . . . . 74.13 111.773 -173.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.42 -54.88 46.1 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.788 1.235 . . . . 74.44 113.199 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.67 -30.26 78.46 Favored 'Trans proline' 0 C--N 1.392 2.867 0 C-N-CA 122.024 1.816 . . . . 74.12 112.662 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.26 -48.75 64.23 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.574 0.75 . . . . 73.33 110.809 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.75 -37.22 86.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.426 0.69 . . . . 75.44 110.802 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -42.01 72.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.534 1.134 . . . . 74.22 110.568 -174.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.66 -36.45 73.36 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.616 0.766 . . . . 54.12 109.581 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.8 t -67.04 -35.18 79.3 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.69 0.796 . . . . 74.3 111.256 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.484 HG21 HG23 ' C' ' 64' ' ' VAL . 51.7 mt -68.61 -49.0 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.135 0.574 . . . . 74.41 110.083 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 30.4 m -61.01 -33.25 72.96 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.55 0.74 . . . . 74.41 111.249 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -61.26 -51.81 67.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.917 0.887 . . . . 71.53 109.359 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.558 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.68 -42.02 78.33 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.716 1.207 . . . . 71.01 112.622 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' C' ' 126' ' ' LEU . 61.2 t -65.62 -41.7 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.156 0.582 . . . . 73.32 110.595 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.428 ' OG ' HG22 ' B' ' 115' ' ' THR . 32.1 t -68.16 -33.79 75.11 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.623 0.769 . . . . 73.24 111.218 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -64.92 -38.68 91.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.417 0.687 . . . . 74.43 110.282 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 7.86 55.58 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 123.8 0.688 . . . . 72.2 113.059 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 41.2 p 60.6 34.15 20.25 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.016 1.726 . . . . 74.2 112.195 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -108.41 152.82 42.2 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.808 1.243 . . . . 73.45 109.094 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.558 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 34.0 Cg_exo -60.99 158.82 32.23 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.684 2.923 . . . . 75.23 114.776 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -51.9 111.0 0.53 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.916 1.286 . . . . 63.22 112.477 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . 0.459 HD21 HG12 ' C' ' 40' ' ' VAL . 2.8 tm? -112.2 99.16 7.82 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.594 -1.261 . . . . 74.5 107.594 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.51 127.61 49.76 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.168 0.987 . . . . 71.41 108.709 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.403 HD21 ' N ' ' C' ' 129' ' ' ALA . 2.2 tt -71.74 143.03 49.75 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.763 0.825 . . . . 74.54 109.677 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . 0.403 ' N ' HD21 ' C' ' 128' ' ' LEU . . . -72.2 146.9 90.16 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.278 1.031 . . . . 72.13 111.855 -177.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.0 124.61 16.35 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.24 2.627 . . . . 70.21 112.045 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 p -133.64 126.86 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.631 0.773 . . . . 75.22 109.746 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.98 90.83 7.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.452 0.701 . . . . 70.43 110.535 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -65.42 -30.41 71.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.536 -0.542 . . . . 72.04 109.536 169.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.557 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.9 t70 . . . . . 0 C--N 1.351 0.668 0 CA-C-N 114.755 -1.111 . . . . 71.52 111.28 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 23.5 m . . . . . 0 C--O 1.24 0.559 0 N-CA-C 110.17 -0.307 . . . . 74.42 110.17 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' D' ' 85' ' ' SER . 30.1 t80 -158.57 114.02 2.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.213 1.005 . . . . 72.13 108.474 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -135.07 131.14 36.62 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.905 -0.776 . . . . 73.53 108.905 175.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.48 132.95 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.652 . . . . 74.41 109.238 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.411 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 40.9 mt-30 -95.48 -35.04 11.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 122.562 0.345 . . . . 73.54 110.446 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 178.79 160.92 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.187 0.995 . . . . 75.11 110.766 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.24 118.61 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.542 -1.651 . . . . 74.34 106.542 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.428 ' HE1' HG13 ' D' ' 83' ' ' ILE . 9.9 p90 -140.7 141.88 34.91 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.298 0.639 . . . . 55.3 110.503 -173.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 41.1 p -76.85 119.68 20.94 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.658 -0.497 . . . . 72.33 109.658 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -93.84 -21.82 19.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.094 0.558 . . . . 74.02 109.928 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.4 t70 -153.91 137.06 15.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.378 1.071 . . . . 73.34 109.343 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.574 HD11 ' SG ' ' D' ' 113' ' ' CYS . 30.1 mt -139.36 146.76 25.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 124.857 1.263 . . . . 74.54 107.682 174.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -154.13 137.9 16.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.328 0.651 . . . . 74.12 109.849 168.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.479 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 78.9 t80 -133.93 121.49 21.75 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 105.798 -1.927 . . . . 71.52 105.798 165.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -122.4 131.24 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.188 -0.671 . . . . 73.05 109.188 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.8 83.52 9.32 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 106.34 -1.726 . . . . 72.53 106.34 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.5 -37.54 69.93 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.732 2.288 . . . . 74.15 112.614 -167.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 25.48 10.35 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.893 0.877 . . . . 74.21 109.247 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.468 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.42 -68.58 0.05 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 N-CA-C 117.413 2.375 . . . . 73.42 117.413 -167.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.74 -24.84 15.26 Favored 'Trans proline' 0 C--N 1.395 2.979 0 CA-C-N 122.777 2.028 . . . . 54.52 112.976 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . 0.433 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 16.9 t-160 -66.25 -35.11 79.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.894 1.277 . . . . 73.13 109.725 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.443 HG13 ' HA ' ' D' ' 73' ' ' ALA . 94.1 t -70.98 -39.9 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.707 -0.679 . . . . 73.24 111.604 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -65.71 -15.0 62.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.706 1.002 . . . . 64.35 113.706 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.73 -33.08 74.84 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.131 0.572 . . . . 74.41 110.581 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.44 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 44.9 mtpt -87.42 111.18 20.87 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.933 0.893 . . . . 74.34 108.594 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -99.7 99.32 10.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.256 1.023 . . . . 75.32 111.374 -173.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.503 ' CD2' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -156.7 -176.65 6.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.758 1.021 . . . . 74.35 113.758 -170.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -97.43 102.94 14.07 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 124.761 1.224 . . . . 75.31 112.975 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.587 ' HA ' HD11 ' D' ' 68' ' ' LEU . 75.2 Cg_exo -53.2 131.84 45.06 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 124.059 3.173 . . . . 74.23 115.32 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -98.15 115.44 28.29 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.048 -1.433 . . . . 62.54 107.177 170.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' D' ' 66' ' ' ALA . 31.9 m -98.64 143.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.605 0.762 . . . . 73.41 110.073 -176.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 83.1 tttt -107.22 130.54 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.168 0.987 . . . . 73.54 109.243 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -96.61 128.77 43.87 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.316 -1.364 . . . . 75.21 107.316 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.4 t70 -132.59 126.6 33.15 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.571 -1.27 . . . . 72.24 107.571 172.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.36 139.91 41.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.558 0.743 . . . . 64.03 110.764 -172.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.4 t70 -138.88 139.63 38.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.588 0.755 . . . . 74.22 109.003 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 46.6 p -108.11 144.07 35.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.691 0.796 . . . . 74.13 110.76 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.8 161.99 41.85 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.688 0.795 . . . . 72.22 109.653 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -170.9 156.41 4.97 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.113 0.965 . . . . 72.21 109.499 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 64.7 p -149.53 120.35 7.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.532 0.733 . . . . 75.21 109.154 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -69.99 118.35 12.72 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.389 -0.597 . . . . 75.23 109.389 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.551 HD11 HG22 ' D' ' 83' ' ' ILE . 46.5 mt -90.31 -30.02 17.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.941 -0.572 . . . . 75.31 110.211 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.13 -179.89 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.6 -0.727 . . . . 72.31 110.601 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.35 130.44 40.74 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.926 -1.033 . . . . 75.44 108.538 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 69.21 2.24 3.57 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.395 1.478 . . . . 74.03 112.23 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.26 117.65 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.284 -0.636 . . . . 74.22 109.284 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.66 ' HB2' HD13 ' D' ' 86' ' ' ILE . 97.6 m-85 -128.37 130.13 47.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.036 -1.098 . . . . 75.14 108.036 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -90.91 135.85 33.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.68 -1.6 . . . . 74.24 106.68 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.95 131.67 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.042 0.937 . . . . 75.44 108.637 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 17.5 t -115.16 135.85 53.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.068 -0.716 . . . . 71.41 109.068 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.21 114.84 20.16 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.873 -1.158 . . . . 73.22 107.873 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.8 ttm180 -96.57 114.9 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.136 0.574 . . . . 73.31 110.01 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.49 122.26 55.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.638 -0.875 . . . . 74.02 108.638 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.8 m -115.32 128.65 56.24 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.276 0.631 . . . . 73.53 109.434 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.4 t -115.8 117.64 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.069 1.348 . . . . 75.12 109.342 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.5 m -119.03 95.21 4.72 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.741 -0.837 . . . . 74.4 108.741 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' D' ' 40' ' ' VAL . . . -98.05 135.0 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.998 -0.741 . . . . 75.45 108.998 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 39.9 p -163.82 135.73 4.88 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.869 0.731 . . . . 71.22 109.704 -173.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.587 HD11 ' HA ' ' D' ' 38' ' ' PRO . 4.7 mp -134.74 136.44 42.65 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.54 0.736 . . . . 72.03 110.701 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.66 -111.6 3.35 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.238 -0.745 . . . . 62.11 111.238 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.55 11.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.231 1.012 . . . . 75.5 109.588 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -139.82 144.11 37.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.04 0.536 . . . . 71.24 111.409 -163.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.1 m -67.53 140.54 57.0 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 124.298 1.039 . . . . 72.53 110.633 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.443 ' HA ' HG13 ' D' ' 31' ' ' VAL . . . -84.96 -69.48 0.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.748 -0.834 . . . . 72.35 108.748 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -154.91 148.45 25.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.623 -1.171 . . . . 73.51 109.074 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.2 mt -108.24 152.94 23.92 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.853 1.261 . . . . 74.35 108.979 172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.582 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.3 t -158.87 144.02 16.14 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.659 0.784 . . . . 75.15 109.002 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.857 -0.794 . . . . 64.4 108.857 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.94 119.71 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.819 0.448 . . . . 74.3 110.054 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.706 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 16.0 mt-30 -89.5 91.79 8.85 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 109.02 -0.733 . . . . 75.21 109.02 166.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -81.1 101.64 9.74 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.889 -1.051 . . . . 73.1 108.391 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 171.39 44.16 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 111.442 -0.663 . . . . 73.35 111.442 175.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.56 131.59 1.96 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.433 -0.667 . . . . 71.11 111.433 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.551 HG22 HD11 ' D' ' 51' ' ' LEU . 32.7 mt -89.43 134.19 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 109.151 -0.685 . . . . 74.41 109.151 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.475 ' HB2' HD12 ' D' ' 86' ' ' ILE . 32.8 m-85 -133.63 162.29 32.33 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.3 0.64 . . . . 74.32 109.687 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 36.2 m -109.61 103.23 12.06 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.409 -0.96 . . . . 64.22 108.409 171.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.1 mp -107.15 117.57 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.999 0.92 . . . . 72.51 108.837 -176.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -149.8 164.55 35.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.738 0.815 . . . . 72.25 110.336 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.51 -0.98 59.11 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 116.103 1.201 . . . . 64.21 116.103 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.67 133.47 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.58 0.752 . . . . 73.11 109.737 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -133.61 154.23 51.05 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.866 0.866 . . . . 74.41 110.299 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.02 -110.59 2.75 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.23 0.956 . . . . 73.25 114.489 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 m -65.82 -41.04 92.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.359 1.064 . . . . 72.32 112.298 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -72.78 -36.73 67.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.781 0.432 . . . . 74.22 111.106 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -79.92 -23.93 41.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.531 0.205 . . . . 74.42 110.602 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -32.38 68.78 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.79 -0.448 . . . . 63.33 109.79 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -74.04 -45.45 49.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.546 0.738 . . . . 74.32 110.6 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -66.58 -51.6 54.67 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 122.743 0.417 . . . . 64.02 110.285 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.45 HD13 ' SG ' ' D' ' 102' ' ' CYS . 3.8 mm? -78.98 -19.11 52.44 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.959 0.503 . . . . 72.55 110.87 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.11 -1.98 64.59 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-O 119.775 -0.459 . . . . 74.22 114.154 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 -61.31 0.23 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.345 0.573 . . . . 73.51 111.135 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.41 -50.59 51.76 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.195 0.998 . . . . 74.24 113.278 -166.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' D' ' 98' ' ' LEU . 22.1 m -68.1 -45.78 40.69 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.797 0.839 . . . . 63.11 112.202 -175.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.02 -24.28 45.51 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 121.54 1.494 . . . . 74.01 112.847 172.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -66.36 -32.62 74.12 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.457 0.703 . . . . 64.3 110.285 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.16 -46.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 64.01 110.193 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -75.9 -32.72 59.78 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.271 -0.877 . . . . 72.54 111.987 -172.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.608 ' HZ ' HD11 ' D' ' 128' ' ' LEU . 75.7 t80 -59.76 -46.01 98.43 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.81 1.411 . . . . 65.31 114.81 -167.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.18 -33.11 91.15 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 121.919 1.746 . . . . 72.41 112.618 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -75.67 -34.91 60.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.645 0.778 . . . . 73.12 110.993 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.9 84.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.479 0.711 . . . . 61.51 110.06 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -60.66 -46.64 89.57 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.585 -1.189 . . . . 74.53 110.956 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.67 -38.33 83.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 64.3 111.117 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' D' ' 21' ' ' ILE . 46.7 t -60.49 -41.86 95.14 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.715 0.635 . . . . 62.4 110.14 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.582 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.5 mt -63.05 -56.19 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.21 0.944 . . . . 75.02 110.061 173.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.9 m -51.76 -45.13 63.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.971 1.308 . . . . 74.33 112.003 -172.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -66.4 -43.14 86.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.832 -1.076 . . . . 72.4 110.724 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 62.7 mtm -66.12 -34.61 78.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.945 0.498 . . . . 74.22 111.812 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.415 HG21 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -66.11 -42.75 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.155 -0.93 . . . . 73.11 109.913 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.9 p -72.49 -30.76 64.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.834 0.454 . . . . 75.52 111.392 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -69.83 -30.89 68.51 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.345 0.658 . . . . 63.54 110.167 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.06 11.16 65.79 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.492 -0.777 . . . . 64.14 112.613 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p 59.27 13.98 3.38 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.865 2.066 . . . . 72.22 114.424 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -82.15 162.67 56.06 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 107.417 -1.327 . . . . 72.31 107.417 164.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.34 152.74 15.91 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.017 1.811 . . . . 75.35 112.444 -171.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -54.02 120.46 6.43 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.372 0.669 . . . . 62.11 110.906 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 48.7 tp -104.58 108.59 20.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.281 -1.007 . . . . 75.04 108.281 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.435 ' HB3' HG13 ' B' ' 13' ' ' ILE . 57.9 m-20 -100.28 93.09 5.5 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.463 -0.94 . . . . 74.41 108.463 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.608 HD11 ' HZ ' ' D' ' 107' ' ' PHE . 0.3 OUTLIER -61.61 137.48 58.25 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.079 1.352 . . . . 75.23 109.785 -178.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.28 129.3 83.23 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 123.902 0.881 . . . . 71.4 112.295 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.422 ' HD3' HD13 ' B' ' 13' ' ' ILE . 59.3 Cg_endo -76.13 117.63 4.72 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.717 1.612 . . . . 74.04 109.841 168.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 95.4 t -106.1 110.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.679 -0.86 . . . . 74.5 108.679 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 99.43 1.55 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.336 -0.847 . . . . 74.14 109.665 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 CA--C 1.538 0.514 0 CA-C-N 115.484 -0.78 . . . . 73.42 111.249 179.16 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.4 m . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 109.458 -0.571 . . . . 71.33 109.458 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.503 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 29.1 t80 -140.16 129.4 23.8 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.214 -1.032 . . . . 74.41 108.214 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -148.77 109.44 4.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.706 0.289 . . . . 75.54 110.744 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.644 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.2 mt -73.0 111.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.237 -0.653 . . . . 74.41 109.237 172.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -91.7 -27.46 18.07 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.82 0.7 . . . . 74.32 110.209 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -164.27 144.29 7.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 121.382 -0.127 . . . . 75.34 110.924 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.51 118.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.074 1.349 . . . . 72.22 108.72 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.492 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.8 p90 -166.63 176.66 7.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.864 0.84 . . . . 75.52 111.821 -163.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -103.55 112.36 25.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.712 -1.131 . . . . 71.32 108.582 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -76.83 -19.63 57.3 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 110.103 -0.332 . . . . 73.45 110.103 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.14 144.88 17.68 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.716 0.806 . . . . 65.45 109.646 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.402 HG22 ' SD ' ' A' ' 117' ' ' MET . 66.1 mt -135.22 145.47 31.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 124.993 1.317 . . . . 75.21 107.742 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.57 ' HG ' ' HB3' ' A' ' 77' ' ' GLU . 81.9 p -147.9 138.95 23.37 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.039 -0.726 . . . . 53.34 109.039 166.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 93.6 t80 -136.06 111.17 8.94 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.831 -1.914 . . . . 75.21 105.831 170.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.25 107.24 13.17 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.292 -0.633 . . . . 75.42 109.292 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -117.29 78.41 10.55 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 107.477 -1.305 . . . . 71.52 107.477 171.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.47 -34.74 5.48 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.155 1.903 . . . . 74.2 111.737 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -89.41 10.67 21.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.69 -0.686 . . . . 71.23 110.879 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HB2' ' HE2' ' B' ' 17' ' ' TYR . . . -47.98 -57.59 9.9 Favored Pre-proline 0 CA--C 1.566 1.573 0 CA-C-O 117.455 -1.259 . . . . 73.32 113.426 -166.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -47.8 -41.88 31.24 Favored 'Trans proline' 0 C--N 1.403 3.411 0 C-N-CA 123.381 2.721 . . . . 71.21 113.885 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -100.95 -14.04 18.05 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.145 0.794 . . . . 74.22 113.145 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.6 -18.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.29 0.495 . . . . 73.52 110.582 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.25 -5.37 41.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.767 0.827 . . . . 72.44 111.689 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -99.95 -18.79 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.203 1.001 . . . . 72.15 111.18 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -67.57 150.19 49.13 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 75.21 111.912 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.39 134.83 55.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.581 0.753 . . . . 75.31 110.139 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -78.82 75.91 5.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.273 0.629 . . . . 75.01 112.101 -169.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -132.91 74.86 73.44 Favored Pre-proline 0 N--CA 1.48 1.033 0 N-CA-C 108.324 -0.991 . . . . 72.12 108.324 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.75 128.09 2.8 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.102 2.535 . . . . 74.43 112.113 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.72 98.47 11.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.312 -2.107 . . . . 72.1 105.312 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.8 t -91.78 102.04 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.312 -1.313 . . . . 75.52 108.997 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -78.91 148.08 32.84 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.572 0.749 . . . . 75.32 111.048 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.51 111.53 18.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.617 -1.253 . . . . 75.44 107.617 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.766 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -107.3 144.06 34.67 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.277 -1.008 . . . . 73.11 108.277 170.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.68 129.45 24.65 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.903 0.481 . . . . 75.31 109.918 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.1 m-20 -127.22 127.4 44.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.194 0.998 . . . . 74.45 109.317 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.9 p -118.17 122.83 44.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.56 1.144 . . . . 75.4 109.522 -175.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.97 147.28 31.52 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.082 0.553 . . . . 51.11 110.938 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 p -119.42 167.12 12.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.76 0.824 . . . . 74.35 110.014 170.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -156.07 153.16 28.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.617 1.167 . . . . 73.4 108.355 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -113.44 127.04 55.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.488 0.315 . . . . 64.03 110.349 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 57' ' ' GLU . 41.6 mt -93.65 -44.33 8.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.604 0.762 . . . . 75.2 110.495 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.413 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -150.1 -179.01 6.82 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.482 -1.235 . . . . 75.44 108.914 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.39 118.87 8.68 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 109.483 -0.562 . . . . 71.42 109.483 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 71.96 -4.61 1.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.707 1.603 . . . . 72.03 113.312 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.413 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 42.1 t -104.86 118.62 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.915 -0.772 . . . . 73.51 108.915 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -122.3 160.43 25.34 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.488 0.715 . . . . 73.14 110.676 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.505 ' HB2' HD13 ' A' ' 51' ' ' LEU . 8.1 tm-20 -132.71 136.87 46.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.318 -1.364 . . . . 73.51 107.318 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.42 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 86.3 t -126.49 125.88 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.449 -0.945 . . . . 73.3 108.449 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.4 t -101.71 136.94 31.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.159 0.584 . . . . 72.12 110.025 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -122.3 97.68 5.58 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.67 -1.604 . . . . 72.25 106.67 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.639 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 47.2 ttp180 -86.53 109.81 19.36 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 109.319 -0.622 . . . . 74.54 109.319 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.8 139.49 18.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.295 -1.372 . . . . 62.5 107.295 169.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 40.3 m -132.27 136.03 46.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.611 -0.885 . . . . 72.52 108.611 173.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 126' ' ' LEU . 92.5 t -134.85 109.07 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.464 1.106 . . . . 74.12 108.421 -173.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.3 m -106.05 137.22 44.35 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 108.684 -0.858 . . . . 75.55 108.684 174.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.39 123.57 38.24 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.021 -0.733 . . . . 75.53 109.021 176.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 63.8 m -132.14 125.45 31.29 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.768 0.427 . . . . 72.13 110.143 175.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -89.39 84.41 6.44 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.239 -1.393 . . . . 75.01 107.239 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.98 -98.86 1.23 Allowed Glycine 0 C--N 1.344 1.011 0 CA-C-N 114.245 -1.343 . . . . 35.22 110.93 -170.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -104.88 -25.87 12.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.299 1.04 . . . . 64.51 110.253 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.88 106.13 17.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 75.14 110.277 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.77 130.31 42.46 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.506 0.669 . . . . 70.31 111.248 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -80.53 -60.76 2.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.898 -1.046 . . . . 73.13 109.724 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -155.82 162.98 40.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.956 -1.02 . . . . 72.4 111.478 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -135.9 111.32 9.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.55 1.14 . . . . 74.03 108.465 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.43 124.05 48.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.25 1.02 . . . . 64.11 109.865 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.57 ' HB3' ' HG ' ' A' ' 22' ' ' SER . 35.0 tt0 -135.54 119.01 16.87 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.211 -0.663 . . . . 71.35 109.211 176.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.96 110.36 21.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.912 0.885 . . . . 71.52 109.132 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -83.91 82.8 8.18 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.396 -1.335 . . . . 75.51 107.396 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 7.8 tp-100 -76.91 94.51 3.94 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.624 -0.88 . . . . 62.34 108.624 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.15 149.79 19.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.3 -0.864 . . . . 73.01 111.754 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 134.76 5.12 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.802 -0.519 . . . . 63.22 111.802 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . 0.477 HD11 ' HA ' ' B' ' 29' ' ' PRO . 63.8 mt -81.72 123.86 38.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.941 -0.763 . . . . 73.23 108.941 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.644 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.3 m-85 -132.78 117.14 17.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.792 -1.188 . . . . 75.52 107.792 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 t -77.93 93.84 4.48 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.565 -0.902 . . . . 74.14 108.565 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.5 mt -104.34 131.61 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.862 -0.792 . . . . 75.11 108.862 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -153.34 162.65 41.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.721 0.808 . . . . 63.25 110.133 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.2 -28.92 8.12 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.938 -0.573 . . . . 73.12 114.521 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.79 140.9 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.448 0.699 . . . . 75.23 111.636 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.19 176.03 10.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.15 0.98 . . . . 63.24 108.6 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.59 -135.82 23.93 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.561 -0.577 . . . . 72.5 112.055 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.1 p -71.85 -14.99 62.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 72.21 111.729 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -74.25 -57.43 3.95 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.173 0.989 . . . . 75.52 110.253 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.7 ttt -80.27 -15.32 57.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.821 -0.172 . . . . 71.52 110.648 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.66 94.4 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.884 0.373 . . . . 71.15 110.108 166.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.7 t-80 -77.3 -19.54 56.29 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.878 -0.601 . . . . 74.31 110.988 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.6 -61.05 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.813 -0.554 . . . . 74.14 110.278 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.46 -45.5 72.29 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.873 0.869 . . . . 70.4 111.702 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.69 6.38 79.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.116 -0.825 . . . . 74.55 114.559 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -149.37 -61.71 0.22 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.117 0.958 . . . . 62.13 112.714 -175.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 87.5 t80 -78.32 -55.46 5.22 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.036 1.124 . . . . 71.54 114.036 -164.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.5 m -70.21 -33.06 3.1 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 114.048 1.129 . . . . 74.32 114.048 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.4 Cg_endo -63.8 -16.8 56.91 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.039 1.826 . . . . 71.24 113.149 167.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -71.98 -14.95 62.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.59 . . . . 53.21 110.825 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.615 HD13 HD22 ' C' ' 132' ' ' ASN . 36.0 mm -84.11 -41.8 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.848 0.832 . . . . 72.33 109.855 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 76.0 mt -76.35 -44.38 36.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.251 -1.341 . . . . 74.01 111.598 -171.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -59.82 -41.35 85.13 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 113.706 1.002 . . . . 74.03 113.706 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.96 -44.73 33.01 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.12 1.88 . . . . 72.44 113.375 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.604 ' CE1' ' HA ' ' C' ' 108' ' ' PRO . 26.7 m-85 -73.7 -24.06 59.88 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.989 0.516 . . . . 72.45 111.997 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -51.69 23.28 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.832 -0.803 . . . . 61.32 108.832 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -50.91 -46.78 60.8 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.944 1.402 . . . . 73.01 110.488 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -65.36 -42.02 93.22 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 124.765 1.291 . . . . 74.04 111.073 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.5 t -62.26 -45.43 93.35 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.739 0.649 . . . . 73.15 110.188 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.56 -43.0 98.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 O-C-N 124.267 0.98 . . . . 74.55 110.105 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.5 m -57.14 -44.06 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.824 0.85 . . . . 65.25 110.552 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 14.6 t -67.77 -47.7 68.47 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.071 -0.968 . . . . 73.2 110.589 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.402 ' SD ' HG22 ' A' ' 21' ' ' ILE . 12.7 mtp -57.11 -48.58 78.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 71.44 111.502 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.81 -43.44 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.069 1.348 . . . . 71.03 110.859 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -67.51 -33.61 75.43 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.795 0.838 . . . . 75.32 111.59 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 116' ' ' SER . 37.0 mtt180 -72.13 -29.63 64.25 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.428 0.691 . . . . 74.33 110.659 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.87 14.25 38.6 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.498 -0.612 . . . . 75.5 113.555 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 57.51 22.48 8.13 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.105 1.762 . . . . 73.13 113.329 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.22 156.51 48.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 73.43 108.759 171.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.71 151.98 81.52 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.813 2.342 . . . . 71.45 111.755 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.9 tt0 -53.99 127.74 27.64 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.976 0.797 . . . . 72.15 111.569 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.669 HD21 HG12 ' A' ' 64' ' ' VAL . 16.5 tp -110.71 101.15 9.81 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.21 -0.904 . . . . 73.43 109.825 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -107.48 100.07 9.53 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.377 -1.342 . . . . 74.5 107.377 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.77 121.38 14.43 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.492 -0.558 . . . . 75.45 109.492 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.63 129.82 27.0 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.119 0.968 . . . . 65.24 112.219 -170.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -84.1 115.86 2.05 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.678 2.252 . . . . 72.23 113.07 -175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.65 141.43 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.573 -0.899 . . . . 73.14 108.573 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.34 72.43 4.86 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.37 -0.974 . . . . 71.55 108.37 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.46 -35.74 75.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.818 1.247 . . . . 75.21 110.586 -172.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.649 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 6.0 p-10 . . . . . 0 CA--C 1.546 0.824 0 CA-C-N 114.655 -1.157 . . . . 72.43 111.511 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.241 0.639 0 N-CA-C 107.377 -1.342 . . . . 65.44 107.377 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.86 156.69 44.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.807 0.813 . . . . 74.02 110.957 161.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.1 pm0 -126.43 132.67 51.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 113.644 -1.616 . . . . 65.33 107.722 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 35.5 pt -76.89 108.68 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.497 -0.774 . . . . 72.13 109.136 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -74.93 -46.68 34.04 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.611 -0.515 . . . . 73.31 109.611 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -162.04 135.62 6.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 110.28 -0.267 . . . . 73.2 110.28 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.9 mt -116.74 131.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 106.147 -1.797 . . . . 73.35 106.147 170.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.475 ' HE2' ' HB2' ' A' ' 28' ' ' ALA . 11.3 p90 -164.01 141.58 7.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.644 0.378 . . . . 72.11 110.975 -171.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 45.2 m -72.34 116.89 13.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.726 -0.842 . . . . 74.13 108.726 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -84.99 -40.28 17.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.944 -0.571 . . . . 72.52 110.458 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 11.6 t70 -145.62 144.2 30.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.108 -0.496 . . . . 63.21 111.081 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.522 HD12 ' SG ' ' B' ' 113' ' ' CYS . 32.2 mm -137.15 145.85 29.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.277 1.431 . . . . 65.52 108.487 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 26.7 t -146.25 138.86 25.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.284 -1.326 . . . . 62.2 107.434 176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -155.92 143.12 19.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.024 -1.102 . . . . 73.53 108.024 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.3 mt-10 -143.6 155.59 44.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.733 1.213 . . . . 74.3 108.716 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.27 86.09 4.85 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 107.878 -1.156 . . . . 72.02 107.878 172.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.5 -43.22 4.31 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.779 2.319 . . . . 71.13 113.006 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 38.0 m-80 -105.0 29.02 6.66 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.018 0.527 . . . . 75.4 109.893 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.55 -54.06 25.42 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.866 1.266 . . . . 75.04 113.233 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.477 ' HA ' HD11 ' A' ' 83' ' ' ILE . 2.5 Cg_endo -80.35 -20.44 8.36 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 121.527 1.485 . . . . 61.31 112.77 -176.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.531 ' HB3' ' NE2' ' B' ' 33' ' ' GLN . 51.5 m-70 -97.41 2.66 50.68 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.405 1.082 . . . . 71.33 112.686 -175.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.25 -15.12 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.62 0.768 . . . . 75.2 112.08 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -84.94 -27.11 26.78 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.606 0.762 . . . . 75.33 112.836 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' B' ' 30' ' ' HIS . 23.0 pt20 -75.69 -29.43 59.01 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.591 0.356 . . . . 74.15 111.626 -172.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.426 ' HB2' ' CZ2' ' B' ' 36' ' ' TRP . 38.1 mtpt -108.85 117.44 34.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.726 1.21 . . . . 62.44 108.707 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -89.71 117.41 28.55 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.458 0.572 . . . . 75.23 110.857 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.452 ' CZ2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -171.39 162.5 6.72 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 123.982 0.913 . . . . 71.53 112.916 -178.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -93.24 132.72 29.89 Favored Pre-proline 0 N--CA 1.485 1.322 0 C-N-CA 124.328 1.051 . . . . 73.22 109.997 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.44 147.39 36.48 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.25 1.966 . . . . 73.34 112.83 171.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.23 109.65 16.7 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.845 -1.169 . . . . 62.4 107.845 163.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.24 123.21 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.731 -0.668 . . . . 72.24 109.422 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.3 142.24 35.41 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.776 0.83 . . . . 73.02 109.555 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.571 HD13 HD21 ' B' ' 128' ' ' LEU . 3.7 tt -106.52 134.98 48.83 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.962 -1.496 . . . . 70.52 106.962 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.734 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 4.7 m-20 -128.42 114.55 16.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.215 -1.032 . . . . 75.35 108.215 -177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.17 127.2 46.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.239 -1.393 . . . . 73.53 107.239 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -137.66 147.12 44.62 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.453 0.701 . . . . 73.23 109.199 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.1 p -121.82 128.85 52.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.412 0.685 . . . . 74.31 110.217 -173.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -131.57 137.3 48.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.044 -1.095 . . . . 73.43 108.044 174.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.7 p -144.6 163.17 34.72 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.132 0.491 . . . . 73.0 110.559 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.88 173.09 15.79 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.065 -0.97 . . . . 75.53 108.845 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -120.51 125.14 47.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.801 0.44 . . . . 73.51 110.25 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . 0.453 HD12 HG22 ' B' ' 83' ' ' ILE . 65.1 mt -87.45 -46.56 9.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.397 0.679 . . . . 75.04 109.459 176.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.25 -174.33 4.93 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.209 -0.905 . . . . 54.24 111.059 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.79 120.72 13.01 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.5 -0.773 . . . . 72.22 110.197 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 70.02 -5.48 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.522 1.529 . . . . 75.21 112.542 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -102.43 111.62 32.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.728 -0.842 . . . . 73.31 108.728 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -119.79 139.93 51.56 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.597 -0.729 . . . . 73.32 109.861 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . 0.566 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.9 tm-20 -104.05 97.13 7.15 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.694 -1.595 . . . . 71.33 106.694 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -92.62 118.72 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.864 0.866 . . . . 74.02 109.533 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.61 119.23 51.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 123.632 0.773 . . . . 64.31 110.033 176.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.23 109.14 20.97 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.096 -1.076 . . . . 73.22 108.096 172.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.7 122.95 33.91 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.351 -0.611 . . . . 74.42 109.351 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.43 124.99 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 107.985 -1.117 . . . . 74.54 107.985 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 12.4 m -119.7 138.53 53.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.579 0.752 . . . . 73.11 109.227 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.567 HG23 HD12 ' B' ' 114' ' ' ILE . 51.6 t -122.0 128.78 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 123.932 0.893 . . . . 71.55 109.164 175.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -118.84 144.28 46.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.576 -0.898 . . . . 75.02 108.576 171.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.81 133.79 30.86 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.66 -0.867 . . . . 71.23 108.66 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.4 p -149.88 140.11 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.883 0.473 . . . . 74.15 110.321 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.546 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -137.41 144.3 42.33 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.597 1.159 . . . . 71.33 109.228 -171.154 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.86 -108.06 1.95 Allowed Glycine 0 C--N 1.347 1.143 0 O-C-N 123.341 0.401 . . . . 74.14 113.81 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -116.05 1.17 13.2 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.226 1.01 . . . . 74.34 110.11 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.434 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 0.9 OUTLIER -139.88 177.98 7.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.002 0.742 . . . . 73.22 113.002 -169.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 140.34 29.68 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.419 1.088 . . . . 65.23 109.808 171.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.546 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -80.44 -67.58 0.76 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.106 0.962 . . . . 73.0 109.477 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -159.3 157.79 31.19 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.146 -1.388 . . . . 73.22 109.472 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.98 150.51 47.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.608 1.163 . . . . 75.54 108.22 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.5 t -157.96 152.02 24.24 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.44 -0.578 . . . . 74.21 109.44 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -164.85 131.51 2.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.147 -0.686 . . . . 63.41 109.147 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -124.23 146.39 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.771 -0.826 . . . . 72.34 108.771 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -125.09 98.26 5.59 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.939 . . . . 75.32 108.463 171.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -86.52 102.08 13.78 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.445 -0.798 . . . . 72.32 109.186 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.62 148.66 20.61 Favored Glycine 0 C--O 1.24 0.516 0 N-CA-C 111.189 -0.765 . . . . 64.14 111.189 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.38 125.46 1.82 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.889 -0.885 . . . . 73.55 110.889 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.566 HG12 ' HG2' ' B' ' 57' ' ' GLU . 38.0 mt -88.94 117.22 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.113 -0.699 . . . . 75.32 109.113 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -122.27 131.37 53.88 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.195 -1.409 . . . . 75.14 107.195 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.7 m -97.62 88.87 4.47 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.216 -1.031 . . . . 75.33 108.216 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' B' ' 89' ' ' ILE . 4.4 pt -95.67 121.98 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.24 -1.346 . . . . 75.42 110.028 -169.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.46 159.68 40.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.924 0.889 . . . . 55.21 109.89 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.19 -56.55 3.6 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.989 -0.55 . . . . 64.34 111.957 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.426 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.3 pp -58.5 153.04 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.152 0.981 . . . . 75.25 113.308 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -169.28 146.5 3.54 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.842 -1.072 . . . . 75.35 108.43 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -130.45 13.13 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 120.028 -0.318 . . . . 62.12 113.465 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -65.8 -33.22 75.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.479 1.111 . . . . 60.21 110.883 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.83 -40.54 97.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.202 -0.908 . . . . 74.3 110.561 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 23.0 ttt -76.93 -31.73 56.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.808 -0.633 . . . . 70.11 110.438 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.05 -21.3 66.37 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.877 -0.602 . . . . 71.22 111.517 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -84.71 -37.0 21.47 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.22 0.608 . . . . 73.1 110.552 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.47 -67.2 0.45 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.482 0.313 . . . . 74.03 111.38 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -12.79 42.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.383 0.512 . . . . 72.51 112.383 -176.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.03 -4.97 53.9 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-O 119.715 -0.492 . . . . 74.14 113.82 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.43 -58.41 0.49 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.185 0.493 . . . . 74.42 111.753 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -75.28 -44.61 44.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.2 0.6 . . . . 72.1 111.922 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.9 m -67.21 -44.68 49.23 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 118.572 -0.728 . . . . 73.31 111.721 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -57.16 -36.27 99.1 Favored 'Trans proline' 0 C--N 1.397 3.088 0 C-N-CA 122.435 2.09 . . . . 75.0 113.143 168.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -61.87 -35.91 79.72 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.389 0.676 . . . . 74.45 110.429 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -48.02 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.328 0.651 . . . . 74.13 110.752 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.5 mt -74.26 -21.12 59.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.188 0.595 . . . . 65.02 112.24 -173.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.561 ' HZ ' HD23 ' B' ' 128' ' ' LEU . 50.0 t80 -60.64 -52.32 73.48 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-O 117.143 -1.408 . . . . 65.22 113.578 -171.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.88 -35.58 80.34 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.204 1.936 . . . . 71.52 113.267 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -68.81 -49.87 54.9 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.683 0.793 . . . . 74.42 110.548 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.54 92.0 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.574 0.749 . . . . 50.41 111.087 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -57.23 -62.09 2.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.236 1.814 . . . . 73.34 111.7 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . 0.454 ' HG2' ' NH2' ' C' ' 120' ' ' ARG . 13.7 tp10 -70.34 -23.89 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.498 0.719 . . . . 72.41 110.709 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.522 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.1 t -69.97 -35.84 74.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.683 -0.199 . . . . 75.43 110.632 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.567 HD12 HG23 ' B' ' 64' ' ' VAL . 61.7 mt -63.82 -54.86 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.048 -0.723 . . . . 72.44 109.048 171.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.6 m -56.62 -34.69 67.5 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.382 1.073 . . . . 74.52 112.072 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -66.64 -45.01 80.41 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.644 -0.707 . . . . 71.04 110.43 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 13.7 mmt -71.2 -33.93 70.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.498 0.499 . . . . 74.45 111.165 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.61 -44.0 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.833 0.853 . . . . 64.51 109.746 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -72.0 -25.48 61.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.35 -0.841 . . . . 65.34 111.399 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -72.94 -27.51 61.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.877 0.471 . . . . 74.33 109.883 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.71 38.6 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.837 0.711 . . . . 54.02 112.756 169.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.9 p 54.86 46.6 24.13 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 125.888 1.675 . . . . 74.53 112.253 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -108.8 158.5 33.95 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.523 1.129 . . . . 74.5 109.099 174.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.93 -163.21 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.073 2.515 . . . . 75.12 113.696 -174.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.564 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 21.6 tp60 -64.08 130.38 43.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.724 0.81 . . . . 75.3 112.098 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 29.9 tp -130.5 85.09 2.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.141 0.576 . . . . 74.52 109.615 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -91.01 115.55 28.1 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.623 -0.88 . . . . 74.34 108.623 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.571 HD21 HD13 ' B' ' 42' ' ' LEU . 1.6 tt -77.12 140.22 40.18 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.841 -1.17 . . . . 71.44 107.841 173.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.77 148.31 79.13 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.143 0.577 . . . . 71.45 111.057 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.87 109.67 0.48 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.576 2.184 . . . . 71.31 112.354 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.84 110.37 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.747 -0.834 . . . . 72.44 108.747 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -90.31 85.44 6.21 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.724 -0.843 . . . . 64.13 108.724 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 123.921 0.889 . . . . 74.44 111.525 179.243 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.52 0.676 . . . . 72.21 112.379 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -122.45 97.12 5.32 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.492 -1.299 . . . . 61.3 107.492 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -105.59 129.3 53.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.446 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . 0.6 ' HG2' ' HB2' ' C' ' 85' ' ' SER . 0.7 OUTLIER -137.71 108.87 6.8 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.401 0.681 . . . . 73.1 109.254 173.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.7 120.07 13.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.222 -0.899 . . . . 63.32 108.626 171.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -86.15 -49.91 7.39 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.685 -0.689 . . . . 70.22 109.9 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -171.69 129.41 0.66 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.174 -0.467 . . . . 72.34 109.893 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.21 143.88 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.197 -1.409 . . . . 72.33 107.197 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.555 ' HB3' HG21 ' D' ' 122' ' ' THR . 15.7 p90 -175.73 151.4 1.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.315 0.579 . . . . 71.55 110.444 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -76.6 107.12 8.67 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.622 -0.881 . . . . 73.24 108.622 171.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -70.48 -29.73 66.35 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.008 -0.738 . . . . 73.42 109.008 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.753 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -145.84 140.51 27.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.26 -0.882 . . . . 63.34 110.687 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.504 HG12 ' SG ' ' C' ' 113' ' ' CYS . 93.4 mt -134.66 144.98 33.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.275 -1.75 . . . . 73.34 106.275 170.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.0 t -159.68 151.77 20.71 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.484 0.659 . . . . 62.13 110.674 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 80.7 t80 -149.36 109.7 4.18 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.335 -1.357 . . . . 75.14 107.335 171.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.3 119.17 35.41 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.98 -0.748 . . . . 72.15 108.98 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.07 79.62 12.98 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.626 -0.879 . . . . 73.14 108.626 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.17 -12.53 25.62 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.815 2.343 . . . . 72.11 111.409 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -103.97 13.25 33.05 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.453 1.101 . . . . 75.11 109.357 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.02 96.0 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.613 1.338 . . . . 75.43 114.613 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.24 -39.72 22.09 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.624 1.549 . . . . 62.43 112.181 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -68.76 -41.59 78.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.977 -1.011 . . . . 72.45 112.359 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . 0.454 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 13.5 p -70.94 -25.83 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.065 0.394 . . . . 72.2 112.065 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -69.63 -12.16 61.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.668 0.787 . . . . 75.11 112.173 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -128.47 22.84 5.95 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.584 0.753 . . . . 72.03 110.635 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.56 ' HE3' HD22 ' C' ' 68' ' ' LEU . 31.9 ttpt -109.1 168.1 9.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.934 0.894 . . . . 75.35 110.626 -174.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.67 125.23 19.03 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.942 1.297 . . . . 73.23 112.243 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -85.53 68.21 10.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.955 0.902 . . . . 72.34 111.39 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -149.3 71.65 10.02 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 109.379 -0.6 . . . . 75.24 109.379 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.03 143.19 4.0 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.673 2.249 . . . . 74.12 112.023 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -88.06 91.6 8.83 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.61 -1.256 . . . . 75.53 107.61 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.41 129.02 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.662 -0.866 . . . . 74.22 108.662 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.77 118.24 22.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.394 0.678 . . . . 71.1 109.222 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -87.17 119.76 27.74 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.423 -1.325 . . . . 73.51 107.423 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.73 114.35 19.81 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.959 -0.756 . . . . 74.42 108.959 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.83 150.11 24.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.38 0.672 . . . . 73.32 109.284 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.717 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 6.5 t70 -148.02 150.93 34.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.345 1.058 . . . . 74.42 109.158 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -119.34 131.12 55.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.886 0.874 . . . . 73.04 110.272 -174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -134.57 145.77 49.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 74.3 109.509 174.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -151.89 146.05 25.36 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.734 . . . . 74.14 110.262 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.8 p -148.09 137.09 21.96 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.556 0.742 . . . . 75.43 109.93 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -83.58 116.62 22.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.096 -0.705 . . . . 70.32 109.096 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' C' ' 57' ' ' GLU . 43.7 mt -93.91 -34.02 13.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.453 0.701 . . . . 74.4 109.933 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.71 -173.99 4.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.896 . . . . 73.54 110.101 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.95 116.39 5.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.32 -0.854 . . . . 75.15 110.188 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 70.28 -5.85 1.26 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.559 1.543 . . . . 72.41 113.129 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -94.76 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.724 -0.843 . . . . 75.33 108.724 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -124.62 126.18 45.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.518 1.127 . . . . 75.53 108.748 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.63 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.1 tt0 -82.21 116.17 21.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.051 -0.977 . . . . 75.42 108.783 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -97.23 122.82 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.597 -1.26 . . . . 72.41 107.597 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 92.5 t -115.85 132.81 64.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.536 -0.912 . . . . 73.45 108.536 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.94 102.59 9.49 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.343 -1.354 . . . . 75.52 107.343 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.717 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.2 tmt_? -82.59 110.03 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.226 1.01 . . . . 74.13 108.481 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.5 t -102.57 136.88 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.92 -1.141 . . . . 72.41 107.92 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -140.03 116.54 10.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.217 -0.66 . . . . 72.12 109.217 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 78.4 t -102.35 109.09 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.793 -1.094 . . . . 71.22 108.1 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.0 m -98.67 150.68 21.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.623 -1.171 . . . . 71.34 109.301 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.94 111.24 7.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 74.24 107.141 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -144.39 127.08 16.16 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.621 -0.511 . . . . 43.3 109.621 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.573 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -90.29 60.5 4.76 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.283 1.039 . . . . 71.22 108.798 176.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 -122.7 6.41 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 114.063 -1.426 . . . . 64.14 110.517 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.86 -23.93 19.5 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.449 -0.945 . . . . 73.12 108.449 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.11 115.89 5.94 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.424 1.09 . . . . 72.21 109.722 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -85.73 140.19 30.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.427 . . . . 63.34 111.085 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.37 -61.54 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.962 0.905 . . . . 72.43 109.058 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -164.47 176.42 9.03 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.454 0.702 . . . . 72.23 110.653 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -141.57 143.9 33.96 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.934 -1.135 . . . . 70.42 107.934 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG21 ' C' ' 114' ' ' ILE . 42.7 t -147.17 129.83 16.02 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.558 0.743 . . . . 65.04 109.113 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -132.15 139.6 48.47 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.344 0.658 . . . . 71.13 110.407 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' C' ' 110' ' ' ALA . 25.5 t -136.97 114.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.526 1.13 . . . . 72.33 108.365 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.753 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -92.31 93.62 8.73 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 75.43 108.849 171.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.04 105.39 11.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.407 -0.815 . . . . 75.53 110.073 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.06 155.0 27.06 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.917 -0.583 . . . . 73.24 112.08 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . 0.461 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -156.57 116.22 0.71 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.703 -0.959 . . . . 73.22 110.703 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' D' ' 29' ' ' PRO . 15.3 mm -81.41 122.73 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.192 -1.04 . . . . 75.4 108.192 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -132.68 142.07 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.912 -0.773 . . . . 74.41 108.912 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 85' ' ' SER . . . . . 0.6 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 38.3 m -109.8 121.47 45.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.633 -1.247 . . . . 74.11 107.633 169.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.514 ' HB ' HD13 ' C' ' 89' ' ' ILE . 1.9 pp -121.49 141.41 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.873 0.869 . . . . 75.44 110.852 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.76 164.22 36.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.003 0.921 . . . . 74.1 109.645 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.64 -19.11 34.56 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 114.092 0.397 . . . . 71.51 114.092 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.514 HD13 ' HB ' ' C' ' 86' ' ' ILE . 0.8 OUTLIER -101.91 141.88 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.76 1.224 . . . . 74.24 110.581 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -156.15 148.24 23.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.591 0.757 . . . . 74.02 110.068 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.18 -146.06 35.69 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.27 -0.423 . . . . 73.32 112.874 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -67.83 -21.54 65.2 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.481 0.712 . . . . 72.45 111.357 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.6 -36.74 84.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.588 0.755 . . . . 71.35 110.926 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.502 ' HG3' HD11 ' C' ' 89' ' ' ILE . 28.1 ttt -70.42 -29.92 66.65 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 116.288 -0.415 . . . . 74.3 110.883 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.82 69.02 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.313 0.645 . . . . 54.44 111.679 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 50.1 t-80 -74.14 -26.93 60.61 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.154 0.582 . . . . 72.52 110.816 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -81.18 -60.68 2.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.511 0.324 . . . . 74.11 110.712 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.452 HD22 ' HG2' ' C' ' 94' ' ' MET . 4.6 pp -73.23 -36.96 66.52 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.257 0.623 . . . . 75.03 111.695 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . 0.43 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -90.95 -14.65 57.54 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 114.3 0.48 . . . . 75.41 114.3 -170.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -127.09 -58.16 1.29 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.725 0.41 . . . . 70.12 111.579 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.8 -45.24 75.36 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.602 0.361 . . . . 73.14 111.935 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -63.94 -45.52 80.65 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.641 -0.695 . . . . 73.34 112.124 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.63 -39.73 81.97 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.559 2.173 . . . . 72.43 113.87 165.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.9 -18.75 65.55 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.826 0.451 . . . . 73.55 112.202 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mm -86.66 -45.94 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.254 0.622 . . . . 75.25 110.537 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.461 HD23 ' HA3' ' C' ' 82' ' ' GLY . 88.7 mt -79.85 -43.53 22.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.936 0.717 . . . . 60.31 112.936 -168.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.4 -42.08 89.87 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.239 1.016 . . . . 73.13 113.041 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . 0.604 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 69.9 Cg_exo -44.36 -46.97 11.34 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.628 2.219 . . . . 54.23 115.091 169.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -69.64 -42.21 74.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.155 0.582 . . . . 72.31 111.252 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . 0.407 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -66.82 -29.8 69.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.705 -0.679 . . . . 75.44 111.354 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.61 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 34.7 ttp180 -56.08 -58.27 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 123.93 0.769 . . . . 74.51 111.179 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -73.5 -32.69 64.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.258 0.623 . . . . 75.2 110.338 -176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . 0.504 ' SG ' HG12 ' C' ' 21' ' ' ILE . 36.2 t -62.54 -34.68 77.42 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.396 0.678 . . . . 74.04 111.865 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.504 HG21 ' SG ' ' C' ' 76' ' ' CYS . 96.7 mt -71.36 -47.16 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.608 0.763 . . . . 75.02 110.206 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -64.7 -28.32 69.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.327 0.651 . . . . 63.52 111.852 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -68.28 -39.97 81.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.581 0.753 . . . . 72.13 110.011 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.725 ' HE2' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.06 -41.11 95.41 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.729 0.811 . . . . 74.0 111.105 175.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.24 -34.14 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.831 0.852 . . . . 72.32 110.246 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 119' ' ' SER . . . . . 0.453 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 42.0 t -65.59 -43.04 90.91 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.57 -0.741 . . . . 62.11 110.98 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.454 ' NH2' ' HG2' ' B' ' 112' ' ' GLU . 91.3 mtt-85 -72.28 -21.28 61.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.22 -0.9 . . . . 74.02 111.439 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.65 -1.04 87.7 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.79 -0.45 . . . . 65.2 113.365 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.422 HG22 ' HB3' ' D' ' 17' ' ' TYR . 30.2 p 59.66 43.09 16.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.507 1.523 . . . . 64.23 111.489 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -119.69 141.11 30.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.733 0.813 . . . . 72.43 110.033 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . 0.564 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 13.1 Cg_endo -53.09 107.16 0.18 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.729 2.953 . . . . 71.21 112.898 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -55.74 143.21 31.63 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.058 1.343 . . . . 74.23 113.52 -170.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tt -134.61 114.65 12.99 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.787 -1.19 . . . . 75.14 107.787 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -92.12 126.24 37.13 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.395 -0.965 . . . . 75.52 108.395 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.61 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.0 mm? -66.67 148.33 52.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.667 0.787 . . . . 73.42 111.447 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.92 153.4 60.33 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 123.356 0.663 . . . . 74.42 110.86 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -76.9 125.53 8.12 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.301 2.668 . . . . 75.24 112.295 -172.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.37 110.6 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.13 0.572 . . . . 75.02 109.493 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . 0.615 HD22 HD13 ' A' ' 105' ' ' ILE . 3.4 m-20 -91.3 93.89 9.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 75.55 109.451 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -76.57 -33.11 58.5 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.36 0.6 . . . . 75.31 109.592 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 N--CA 1.471 0.619 0 CA-C-N 114.885 -1.052 . . . . 54.22 111.503 -178.424 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' D' D ' 10' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 57.5 m . . . . . 0 C--O 1.237 0.427 0 N-CA-C 109.45 -0.574 . . . . 75.32 109.45 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -157.47 105.77 2.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.492 -1.299 . . . . 74.42 107.492 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -125.26 119.19 27.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 74.12 109.257 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mt -73.4 114.93 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 107.837 -1.171 . . . . 71.02 107.837 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.91 -45.54 16.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.27 -0.641 . . . . 74.05 109.27 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -174.04 159.73 3.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.025 0.93 . . . . 73.42 109.897 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.428 HD12 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -130.03 143.2 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.375 1.07 . . . . 70.24 108.128 174.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HB3' HG22 ' C' ' 122' ' ' THR . 31.0 p90 -170.26 172.27 6.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.933 0.873 . . . . 75.3 110.988 -169.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -98.74 115.77 29.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.507 -1.224 . . . . 73.0 109.56 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -87.69 -23.42 24.19 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.356 -0.609 . . . . 74.54 109.356 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.1 t70 -151.23 134.56 16.11 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.553 -1.203 . . . . 63.11 109.338 175.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.725 HD12 ' HE2' ' C' ' 117' ' ' MET . 72.0 mt -129.45 138.39 54.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.562 -1.273 . . . . 75.24 107.562 171.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -143.08 128.47 18.91 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.107 -1.071 . . . . 74.02 108.107 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.501 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 56.6 t80 -138.0 113.63 9.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.653 -1.98 . . . . 72.3 105.653 167.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.36 138.54 54.21 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.373 -0.603 . . . . 74.31 109.373 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' D' ' 28' ' ' ALA . . . -143.53 77.06 15.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.436 -1.32 . . . . 55.14 107.436 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.46 -45.44 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.664 2.243 . . . . 63.32 111.901 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -93.48 30.09 1.82 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.442 1.097 . . . . 73.0 108.78 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' D' ' 25' ' ' ALA . . . -59.47 -57.45 26.81 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 124.112 0.965 . . . . 65.51 112.702 -172.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.501 ' HB3' HD11 ' C' ' 83' ' ' ILE . 52.3 Cg_endo -76.88 -12.19 17.97 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.468 1.56 . . . . 71.52 112.163 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -78.19 -41.65 33.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.02 1.328 . . . . 75.43 109.982 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -79.32 -32.48 14.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-O 118.812 -0.613 . . . . 73.03 110.097 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -50.95 -28.67 10.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.094 0.872 . . . . 73.44 113.197 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.43 -38.01 89.48 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.442 0.697 . . . . 73.12 111.141 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -132.5 64.07 1.61 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.639 0.776 . . . . 73.33 110.202 168.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -112.16 95.98 5.77 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.795 0.807 . . . . 74.22 110.152 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -123.01 -157.45 0.75 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.044 1.738 . . . . 71.42 106.804 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 15.9 pm0 -50.87 106.28 0.63 Allowed Pre-proline 0 CA--C 1.567 1.618 0 C-N-CA 123.386 0.674 . . . . 75.42 111.915 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 4.7 Cg_exo -78.06 147.32 23.66 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.737 2.291 . . . . 72.23 112.295 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.4 110.98 5.63 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 107.243 -1.392 . . . . 74.53 107.243 168.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.74 114.81 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.539 -0.755 . . . . 64.12 110.18 -169.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 86.5 tttt -94.56 138.49 32.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.109 0.964 . . . . 72.22 109.767 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . 0.437 HD13 HD23 ' D' ' 128' ' ' LEU . 6.2 tt -98.8 131.91 44.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.331 -1.359 . . . . 74.14 107.331 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -132.33 147.14 52.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.865 -0.791 . . . . 75.04 108.865 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.16 139.39 49.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.251 0.62 . . . . 75.25 110.394 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 12.1 t70 -137.43 135.27 36.74 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.109 -1.071 . . . . 75.51 108.109 170.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -113.42 144.4 42.87 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 73.1 109.584 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.16 155.1 39.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.355 0.662 . . . . 63.32 110.197 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 73.6 p -164.72 153.14 12.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.191 0.596 . . . . 74.25 110.649 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -154.31 137.06 15.26 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.356 0.663 . . . . 70.43 109.449 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.19 116.99 15.48 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.912 -0.773 . . . . 72.0 108.912 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.474 HD13 HG22 ' D' ' 83' ' ' ILE . 37.3 mt -91.89 -32.12 15.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.674 0.39 . . . . 65.4 110.358 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.83 -175.25 5.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.785 -0.643 . . . . 75.21 111.361 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.67 118.08 7.16 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.598 -1.183 . . . . 74.21 109.749 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 13.0 m-20 65.09 11.05 6.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.508 1.123 . . . . 74.5 112.314 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.83 120.21 64.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 123.779 0.831 . . . . 75.21 109.239 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.604 ' HB2' HD12 ' D' ' 86' ' ' ILE . 73.8 m-85 -129.67 128.88 43.48 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.502 -1.295 . . . . 72.4 107.502 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -92.27 128.37 38.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.116 -0.698 . . . . 75.34 109.116 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.92 118.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.849 -1.167 . . . . 73.42 107.849 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 49.0 t -99.97 133.41 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.365 -0.976 . . . . 73.12 108.365 172.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.29 109.74 13.17 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.384 -0.969 . . . . 73.22 108.384 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -88.53 112.65 23.26 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.475 0.71 . . . . 74.41 110.051 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.7 t -101.27 126.31 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 74.5 108.564 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.0 m -129.42 134.3 47.77 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.97 0.508 . . . . 73.44 110.2 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.576 HG12 HD12 ' D' ' 126' ' ' LEU . 47.6 t -130.72 113.44 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.425 1.09 . . . . 72.02 108.892 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 21.4 m -103.87 101.12 10.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.465 0.706 . . . . 71.32 109.415 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.47 124.79 43.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.827 -0.435 . . . . 72.21 109.827 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.7 m -139.2 124.61 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.694 0.798 . . . . 73.05 108.894 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.6 103.36 15.96 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.771 -1.196 . . . . 75.44 107.771 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.19 -115.94 4.61 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.885 0.741 . . . . 75.24 112.465 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.47 5.0 51.75 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.741 0.816 . . . . 64.11 110.742 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . 0.432 ' HB3' ' HZ3' ' D' ' 34' ' ' LYS . 6.4 tp10 -135.86 145.83 46.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.763 0.825 . . . . 64.43 110.473 -165.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -73.08 130.57 40.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.298 0.639 . . . . 62.43 111.334 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.36 -61.38 1.78 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.991 . . . . 63.01 108.679 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . 0.558 ' HE2' HD11 ' D' ' 126' ' ' LEU . 42.9 p90 -159.05 151.69 21.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.175 -1.375 . . . . 63.32 110.311 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 84.1 mt -113.65 151.49 31.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.489 1.116 . . . . 75.44 109.127 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG21 ' D' ' 114' ' ' ILE . 34.7 t -154.64 134.68 13.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.722 -0.473 . . . . 65.44 109.722 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.485 0.714 . . . . 73.31 109.832 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.44 121.09 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.61 0.764 . . . . 65.21 109.473 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.5 mt-30 -89.87 89.84 7.92 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.722 -0.844 . . . . 75.1 108.722 171.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.22 93.39 5.86 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.821 -1.081 . . . . 75.54 109.107 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.6 140.38 17.25 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.36 -0.696 . . . . 70.12 111.36 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.19 128.09 3.58 Favored Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 110.189 -1.164 . . . . 61.41 110.189 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.474 HG22 HD13 ' D' ' 51' ' ' LEU . 53.2 mt -90.85 129.23 41.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.834 -0.802 . . . . 71.12 108.834 -177.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' D' ' 86' ' ' ILE . 22.1 m-85 -132.48 158.26 42.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.353 0.408 . . . . 72.33 110.368 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 25.4 m -107.14 102.29 11.63 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.504 -0.924 . . . . 75.32 108.504 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.604 HD12 ' HB2' ' D' ' 56' ' ' TYR . 4.0 mp -107.51 113.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.818 -1.179 . . . . 74.0 107.818 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' D' ' 54' ' ' ASP . . . -142.57 124.79 15.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.177 0.591 . . . . 72.11 110.492 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.19 5.65 57.09 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.421 -0.655 . . . . 52.13 114.577 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.96 126.39 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.69 -0.856 . . . . 74.41 108.69 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 -177.83 4.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.776 0.83 . . . . 74.12 110.56 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.59 -141.06 39.83 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.501 -0.772 . . . . 75.1 113.799 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.2 p -84.31 -13.5 52.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.635 0.774 . . . . 75.14 111.656 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.89 0.476 . . . . 74.33 110.403 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.465 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -69.95 -31.84 69.79 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 110.421 -0.214 . . . . 74.24 110.421 175.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.62 68.6 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.866 0.729 . . . . 75.02 111.218 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -72.62 -35.67 67.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.224 0.61 . . . . 75.04 110.204 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.25 -51.45 52.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.859 0.464 . . . . 74.22 110.908 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' D' ' 94' ' ' MET . 2.9 pp -75.84 -19.74 58.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.755 0.422 . . . . 70.34 112.065 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -7.79 60.32 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.73 -0.483 . . . . 71.21 113.364 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.56 -62.6 0.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.342 0.571 . . . . 62.12 111.952 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -68.13 -52.33 36.02 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.424 0.527 . . . . 75.22 112.424 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 60.7 m -61.55 -43.81 89.9 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 123.673 0.789 . . . . 63.34 111.944 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.13 -46.52 32.08 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.13 1.887 . . . . 71.03 112.898 165.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -66.9 -15.79 63.89 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.442 0.697 . . . . 72.2 112.584 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -80.11 -49.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.464 -0.569 . . . . 72.42 109.464 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.41 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.3 mt -79.22 -28.91 42.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.73 0.812 . . . . 74.32 112.247 -169.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.93 -40.43 16.39 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.035 -0.983 . . . . 73.53 113.07 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -50.91 -43.52 46.83 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.282 1.988 . . . . 75.45 113.229 169.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -74.84 -37.08 62.35 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.477 0.711 . . . . 70.31 111.6 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.3 67.59 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.084 0.553 . . . . 74.22 110.281 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -43.6 79.72 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.905 1.378 . . . . 75.41 111.13 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -73.2 -36.48 66.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.779 0.832 . . . . 75.51 111.236 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -62.92 -44.92 94.77 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.893 0.477 . . . . 45.02 110.163 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.532 HG21 ' SG ' ' D' ' 76' ' ' CYS . 73.0 mt -61.83 -50.3 80.74 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.225 1.01 . . . . 71.52 110.213 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.58 HG23 ' HB3' ' D' ' 125' ' ' GLN . 30.4 m -50.84 -46.9 60.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.494 1.117 . . . . 73.33 111.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.8 t -73.53 -22.63 60.05 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.065 0.946 . . . . 64.42 112.635 -172.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.45 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.8 mtm -87.31 -43.46 12.14 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.062 0.458 . . . . 64.42 111.243 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.5 -34.45 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 114.691 -1.14 . . . . 72.02 110.382 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -66.55 -36.81 83.59 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.387 0.675 . . . . 74.23 111.405 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.5 mtt-85 -69.65 -26.74 64.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.143 0.577 . . . . 73.15 111.164 177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 11.04 60.71 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-O 119.689 -0.506 . . . . 74.43 113.316 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 122' ' ' THR . . . . . 0.555 HG21 ' HB3' ' C' ' 17' ' ' TYR . 25.6 p 65.42 16.36 10.48 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.581 1.952 . . . . 72.11 112.921 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -96.31 165.66 15.79 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.707 1.203 . . . . 72.44 108.406 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.64 150.58 24.59 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.258 1.972 . . . . 74.1 112.628 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . 0.58 ' HB3' HG23 ' D' ' 115' ' ' THR . 21.4 mt-30 -57.54 135.25 56.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.144 0.578 . . . . 74.55 111.092 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.576 HD12 HG12 ' D' ' 64' ' ' VAL . 88.4 mt -106.33 93.32 4.54 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.367 -0.605 . . . . 74.24 109.367 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -100.43 100.36 11.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.474 -0.936 . . . . 74.15 108.474 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.437 HD23 HD13 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.39 132.79 48.36 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.961 0.904 . . . . 73.25 109.136 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.21 146.95 87.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.815 0.846 . . . . 72.41 111.615 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.05 111.54 2.02 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 121.939 1.759 . . . . 71.15 111.393 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -106.65 124.99 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.375 -0.972 . . . . 75.31 108.375 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.02 92.41 5.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.242 0.617 . . . . 73.41 110.036 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.476 0.873 0 C-N-CA 124.023 0.929 . . . . 74.22 111.202 178.066 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.2 m . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 109.088 -0.708 . . . . 74.4 109.088 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.474 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 20.4 t80 -136.76 120.83 17.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.824 -1.176 . . . . 74.4 107.824 171.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 45.9 tp60 -142.83 108.25 5.04 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.087 -0.708 . . . . 73.1 109.087 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.51 HG12 ' HD2' ' A' ' 84' ' ' PHE . 20.0 mt -71.03 125.2 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.2 -0.455 . . . . 71.31 109.91 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -101.23 -31.89 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.975 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -179.27 132.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 119.369 -0.348 . . . . 72.35 110.996 -167.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.402 HD11 ' HG3' ' C' ' 130' ' ' PRO . 3.6 mp -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 107.417 -1.327 . . . . 75.41 107.417 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 23.5 p90 -164.06 167.53 20.22 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 122.218 1.009 . . . . 64.1 111.299 -174.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.5 109.09 21.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.038 -1.437 . . . . 65.22 108.674 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.9 mtpt -78.26 -29.97 48.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.105 0.479 . . . . 64.31 109.791 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.33 141.4 27.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.902 -1.045 . . . . 75.35 109.616 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 61.8 mt -137.54 136.68 46.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.077 -1.823 . . . . 75.2 106.077 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -148.08 125.59 11.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.66 -0.867 . . . . 75.02 108.66 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.0 t80 -127.18 140.15 52.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.18 -1.415 . . . . 73.25 107.18 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -134.74 151.58 51.09 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.752 -0.832 . . . . 65.11 108.752 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . 0.506 ' HB3' ' HB1' ' A' ' 28' ' ' ALA . . . -147.24 73.96 11.87 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 105.682 -1.97 . . . . 73.31 105.682 167.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.66 -43.02 10.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.893 2.396 . . . . 75.32 113.197 -165.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.34 30.19 5.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.971 -0.751 . . . . 71.52 108.971 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB1' ' HB3' ' A' ' 25' ' ' ALA . . . -46.38 -57.92 7.62 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.595 -1.193 . . . . 75.14 113.052 -174.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.74 -20.31 27.8 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.979 2.453 . . . . 75.12 113.722 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -98.96 -38.14 9.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.018 0.927 . . . . 75.25 110.798 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.85 -15.4 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.074 0.549 . . . . 72.45 111.444 -164.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.73 -30.95 71.97 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.081 0.553 . . . . 74.05 111.193 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -90.93 -7.12 52.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 112.363 0.505 . . . . 73.05 112.363 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HZ1' ' HB2' ' A' ' 71' ' ' GLU . 19.9 mmtp -64.01 173.05 2.02 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.016 1.117 . . . . 73.04 114.016 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.45 159.12 30.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.928 1.291 . . . . 74.31 111.691 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -94.14 64.46 3.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.063 0.459 . . . . 74.32 110.166 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -142.81 82.84 11.95 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.918 0.887 . . . . 72.4 109.241 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.57 138.44 13.64 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 121.735 1.623 . . . . 72.21 110.891 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -92.57 82.58 4.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.978 -1.86 . . . . 71.25 105.978 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 65' ' ' THR . 10.2 m -82.53 114.65 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.993 -1.458 . . . . 73.44 109.382 -176.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -121.48 143.95 48.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.753 0.821 . . . . 74.21 109.96 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -112.97 118.91 36.15 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.865 0.866 . . . . 75.14 109.786 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -107.41 143.13 36.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.594 -1.261 . . . . 64.25 107.594 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.59 129.24 32.61 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.728 -0.842 . . . . 73.4 108.728 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.3 m-20 -117.74 120.81 39.09 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.738 -1.208 . . . . 74.52 107.738 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -107.29 121.81 45.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 75.33 108.627 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.0 140.33 28.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.991 0.517 . . . . 74.3 110.377 -173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 p -130.35 158.79 38.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.415 0.686 . . . . 75.44 110.616 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 154.98 39.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.336 1.054 . . . . 73.14 109.534 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -103.76 105.61 15.87 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.693 -0.855 . . . . 75.41 108.693 172.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.0 mt -79.22 -38.2 36.29 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.221 0.609 . . . . 74.23 110.55 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.62 -178.19 6.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.333 1.053 . . . . 63.23 109.246 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.47 123.15 18.89 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 71.18 -9.81 0.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.019 1.728 . . . . 75.53 112.771 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.67 110.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 N-CA-C 108.385 -0.969 . . . . 71.24 108.385 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -125.3 164.13 21.02 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.703 0.801 . . . . 74.54 109.536 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -131.69 142.73 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.693 0.797 . . . . 65.15 109.449 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.36 132.52 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.601 -1.259 . . . . 75.5 107.601 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.2 t -125.08 131.36 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 123.625 0.77 . . . . 74.4 108.934 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.432 HD21 HD11 ' A' ' 106' ' ' LEU . 3.9 mm? -117.99 106.0 12.47 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.106 -1.072 . . . . 73.12 108.106 177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 23.9 ttp180 -83.82 102.63 12.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.151 -1.055 . . . . 74.2 108.151 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.31 119.75 39.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.995 -1.483 . . . . 70.41 106.995 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 44.0 m -118.97 122.64 42.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.344 -0.613 . . . . 74.11 109.344 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.612 HG12 HD21 ' A' ' 126' ' ' LEU . 28.9 t -118.52 108.99 25.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.652 -0.87 . . . . 62.53 108.652 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.0 m -107.63 137.4 45.73 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.537 -0.542 . . . . 73.43 109.537 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.95 105.25 8.78 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.362 -0.977 . . . . 63.41 108.362 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -114.2 127.56 55.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.996 0.519 . . . . 72.31 110.796 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.12 85.19 2.09 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.91 -1.145 . . . . 71.23 107.91 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -111.29 3.23 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.562 -1.015 . . . . 75.22 110.562 -171.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -100.8 -8.49 22.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.058 0.543 . . . . 74.44 110.512 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HB2' ' HZ1' ' A' ' 34' ' ' LYS . 10.9 mp0 -102.26 97.71 7.95 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.753 0.821 . . . . 64.24 110.383 -171.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -66.86 124.29 22.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 122.911 0.484 . . . . 73.42 110.823 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.57 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -67.64 -57.3 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.203 1.001 . . . . 64.34 109.974 175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -157.48 158.85 36.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.528 -1.215 . . . . 62.44 112.204 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.6 tp -126.89 135.17 50.57 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.95 1.3 . . . . 71.23 108.035 171.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 m -130.64 97.75 4.45 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.404 -0.591 . . . . 71.33 109.404 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -116.9 116.28 27.12 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.021 0.929 . . . . 74.43 109.392 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -133.94 110.94 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.784 0.834 . . . . 70.42 109.215 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -84.93 89.31 7.55 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.684 -0.858 . . . . 74.45 108.684 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.86 96.69 7.09 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.506 -0.77 . . . . 70.32 109.048 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.99 151.52 22.21 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.48 -0.782 . . . . 72.45 111.92 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.553 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -153.19 124.55 1.61 Allowed Glycine 0 CA--C 1.509 -0.309 0 N-CA-C 111.302 -0.719 . . . . 44.45 111.302 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -85.14 124.59 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.208 0.603 . . . . 74.24 109.763 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.51 ' HD2' HG12 ' A' ' 13' ' ' ILE . 37.9 m-85 -132.94 119.87 20.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.764 -1.198 . . . . 63.21 107.764 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 25.8 t -82.19 98.61 8.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 109.493 -0.558 . . . . 65.52 109.493 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 98' ' ' LEU . 45.3 pt -103.49 147.46 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.999 0.919 . . . . 74.35 110.411 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -169.68 161.08 9.19 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.228 0.611 . . . . 63.4 111.863 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.31 -33.96 3.54 Favored Glycine 0 C--N 1.356 1.655 0 CA-C-N 115.605 -0.725 . . . . 75.24 113.964 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -117.04 135.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.877 0.871 . . . . 75.23 109.432 -176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -139.56 175.86 9.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.376 0.67 . . . . 75.12 110.326 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -115.32 7.85 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.77 0.669 . . . . 65.3 112.831 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.1 t -74.58 -30.46 61.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.54 0.736 . . . . 74.33 111.567 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -67.32 -37.5 83.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.536 -0.757 . . . . 74.13 109.562 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.44 ' HG2' ' HG ' ' A' ' 98' ' ' LEU . 3.4 ttp -82.3 -24.45 34.65 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.311 -0.859 . . . . 74.45 110.833 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.48 -34.74 78.6 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.086 0.402 . . . . 75.44 112.086 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 134' ' ' ASP . 58.6 t-80 -77.28 -30.77 54.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.559 -0.292 . . . . 74.45 110.34 174.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.39 -65.05 0.76 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.582 0.353 . . . . 74.42 110.951 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 86' ' ' ILE . 14.7 mt -75.66 -23.81 56.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.742 0.417 . . . . 70.4 111.739 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.94 -5.97 59.44 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.313 -0.715 . . . . 65.33 114.751 -172.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.41 -57.78 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.992 0.896 . . . . 72.13 112.319 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.474 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 89.8 t80 -68.4 -54.89 14.15 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.245 0.618 . . . . 73.42 112.066 -171.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.0 m -71.01 -33.16 2.71 Favored Pre-proline 0 CA--C 1.569 1.674 0 C-N-CA 123.673 0.789 . . . . 72.12 112.876 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.96 -41.96 60.87 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.493 2.128 . . . . 72.12 113.154 160.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -70.87 -14.03 62.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.384 0.674 . . . . 64.11 111.766 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -78.86 -41.39 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.98 -0.748 . . . . 75.32 108.98 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.553 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.9 mt -84.33 -30.21 25.69 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.059 0.944 . . . . 74.24 113.189 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -64.94 -38.63 30.97 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.037 -0.983 . . . . 75.43 113.537 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.54 -38.45 93.8 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.923 1.749 . . . . 74.24 113.25 171.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -73.84 -37.45 64.81 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.985 0.514 . . . . 75.45 111.141 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -44.6 91.55 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.777 -0.453 . . . . 73.34 109.777 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -52.51 -53.58 44.09 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.777 1.298 . . . . 74.11 110.72 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -68.19 -38.92 82.52 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.242 0.964 . . . . 73.4 111.374 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.5 t -61.79 -32.25 72.53 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.978 0.511 . . . . 74.1 110.648 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 84.9 mt -74.34 -52.94 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.287 -0.869 . . . . 74.43 110.323 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.7 m -55.28 -41.56 72.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.223 1.009 . . . . 72.22 111.297 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -64.96 -44.86 88.0 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.72 -1.127 . . . . 72.34 110.776 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.4 mtm -64.52 -38.59 91.56 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.689 0.395 . . . . 75.15 111.492 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 126' ' ' LEU . 93.2 t -64.36 -42.01 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.664 0.785 . . . . 74.52 110.704 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.3 p -72.4 -30.73 64.92 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.09 -0.505 . . . . 73.35 110.907 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -68.3 -25.32 65.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.594 0.758 . . . . 70.33 110.882 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 7.51 65.36 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-O 120.004 -0.331 . . . . 75.52 113.595 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 m 61.86 35.49 16.45 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.255 1.422 . . . . 73.01 110.945 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -107.31 160.89 24.87 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.064 0.946 . . . . 65.2 109.723 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.25 146.22 61.91 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.242 1.961 . . . . 73.13 111.522 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.11 148.19 48.63 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.775 0.322 . . . . 74.32 110.3 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.612 HD21 HG12 ' A' ' 64' ' ' VAL . 48.7 tp -113.72 113.48 25.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.004 0.522 . . . . 70.42 110.127 -177.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -114.17 114.19 25.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.653 -1.24 . . . . 71.23 107.653 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.4 135.14 42.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.92 0.391 . . . . 72.31 110.152 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -71.87 132.23 85.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.935 -0.575 . . . . 73.32 110.368 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.46 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 0.9 OUTLIER -77.54 116.95 4.17 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.505 2.136 . . . . 74.02 111.515 -177.012 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.76 135.36 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.189 0.596 . . . . 74.51 109.953 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -76.78 69.94 3.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.334 1.054 . . . . 74.54 110.605 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -56.08 -38.74 71.09 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.247 1.019 . . . . 75.1 111.749 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.483 ' HB2' ' HE2' ' A' ' 96' ' ' HIS . 9.9 p-10 . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 114.487 -1.233 . . . . 73.03 111.917 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.613 ' HB ' ' HB1' ' B' ' 87' ' ' ALA . 87.9 m . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 108.536 -0.913 . . . . 73.22 108.536 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . 0.407 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 49.4 t80 -135.32 132.8 38.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.828 0.851 . . . . 74.35 109.492 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.409 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 9.3 pt20 -156.41 140.17 16.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.942 0.897 . . . . 71.44 109.022 173.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.71 135.42 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.834 -1.173 . . . . 75.11 107.834 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -93.19 -53.84 3.95 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.858 -0.423 . . . . 75.2 109.858 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -155.49 131.52 10.06 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.914 -0.402 . . . . 73.12 109.914 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.451 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 83.7 mt -114.97 136.96 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.287 -1.746 . . . . 75.3 106.287 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -165.45 140.44 4.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.881 0.472 . . . . 75.51 111.142 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.0 m -73.47 117.85 15.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.873 0.869 . . . . 64.15 109.24 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -94.59 -22.41 18.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.471 0.708 . . . . 72.13 111.58 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.1 t70 -163.1 142.48 8.69 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.337 0.398 . . . . 65.05 110.473 -172.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.482 HD12 ' SG ' ' B' ' 113' ' ' CYS . 33.1 mm -137.27 141.59 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.975 1.31 . . . . 74.21 108.467 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.5 t -142.8 124.09 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.785 -1.191 . . . . 74.13 107.785 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.527 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -146.56 115.73 7.0 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 107.274 -1.38 . . . . 72.52 107.274 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -119.91 158.81 25.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.448 0.699 . . . . 75.54 109.513 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.99 78.19 8.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.664 -1.235 . . . . 74.45 107.664 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.88 -22.65 42.19 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.936 2.424 . . . . 71.14 112.675 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -122.97 24.55 8.92 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.959 . . . . 74.44 109.663 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.42 -50.16 59.26 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.744 1.387 . . . . 71.3 114.744 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -28.7 2.77 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 121.849 1.7 . . . . 71.44 112.789 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.449 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 51.5 m80 -96.18 4.67 52.27 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.354 1.061 . . . . 74.35 112.09 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.31 -26.25 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.632 0.773 . . . . 75.42 110.788 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . 0.551 ' HA ' ' HB2' ' B' ' 35' ' ' ASP . 30.2 t80 -69.0 -16.09 63.64 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.104 0.779 . . . . 74.35 113.104 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.2 pt20 -73.16 -47.08 46.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.065 0.393 . . . . 75.53 110.73 176.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.512 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 45.4 pttt -112.62 66.79 0.65 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.548 -1.279 . . . . 75.21 107.548 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.551 ' HB2' ' HA ' ' B' ' 32' ' ' PHE . 39.1 t70 -96.86 108.47 21.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.275 -0.875 . . . . 73.51 111.563 -164.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.465 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.8 OUTLIER 177.74 -170.86 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.597 1.186 . . . . 73.03 109.437 163.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.89 116.77 7.59 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.096 0.958 . . . . 73.3 111.995 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.65 156.73 18.68 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.651 2.234 . . . . 75.01 111.464 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.03 102.19 0.47 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.123 -1.066 . . . . 73.13 108.123 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.4 151.16 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.066 -0.97 . . . . 72.21 109.632 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -139.12 137.42 36.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.34 0.656 . . . . 74.2 109.621 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . 0.499 HD12 HD13 ' B' ' 128' ' ' LEU . 2.4 tt -93.18 126.11 38.12 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.148 -1.427 . . . . 72.42 107.148 167.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.4 t0 -131.34 145.21 51.75 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 106.547 -1.649 . . . . 73.42 106.547 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.62 133.27 28.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.667 -0.864 . . . . 73.54 108.667 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.7 t70 -124.3 134.38 53.22 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.694 1.198 . . . . 75.11 108.701 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -107.9 108.25 19.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.455 0.702 . . . . 64.43 109.759 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.91 119.3 32.22 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.538 -0.912 . . . . 72.21 108.538 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.2 p -139.15 166.08 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.141 0.577 . . . . 73.13 110.688 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.2 p -151.16 165.99 32.22 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.136 0.974 . . . . 73.11 109.146 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -115.07 107.74 15.74 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.454 -0.943 . . . . 73.42 108.454 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.11 -42.52 84.39 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.585 0.754 . . . . 75.11 110.892 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.77 -170.98 3.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.667 0.787 . . . . 63.13 110.363 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.41 114.39 5.4 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.226 -0.897 . . . . 75.21 109.517 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 73.22 -6.69 1.67 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 126.332 1.853 . . . . 70.41 113.202 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.74 120.59 52.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 109.151 -0.685 . . . . 73.31 109.151 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -114.11 173.11 6.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.605 -0.725 . . . . 73.21 110.945 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -142.17 95.19 2.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 105.541 -2.022 . . . . 74.52 105.541 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.35 122.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.03 0.932 . . . . 72.35 109.09 -175.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -111.7 143.47 21.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.57 0.748 . . . . 75.31 109.454 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' B' ' 103' ' ' PRO . 93.6 mt -120.1 112.43 19.11 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.753 -0.462 . . . . 74.45 109.753 174.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.7 ttm-85 -86.6 107.24 18.07 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.155 -1.054 . . . . 73.43 108.155 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 105.54 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.27 -1.382 . . . . 75.01 107.27 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 28.6 m -96.48 137.79 35.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.447 -0.797 . . . . 74.43 108.994 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -134.62 101.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.887 -1.153 . . . . 73.32 107.887 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.5 m -98.08 141.58 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 72.1 109.516 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.73 148.44 52.58 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.02 -0.733 . . . . 75.31 109.02 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -157.39 128.61 6.76 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.368 0.417 . . . . 73.21 111.238 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.597 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -127.84 143.19 51.12 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.552 0.741 . . . . 70.23 109.917 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.25 -112.24 3.51 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.929 -0.869 . . . . 70.4 110.929 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -123.86 6.1 8.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.966 0.906 . . . . 73.34 109.922 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . 0.512 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 8.8 pt-20 -149.28 -178.98 6.71 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.625 0.37 . . . . 74.41 111.209 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -64.6 147.69 52.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.685 1.194 . . . . 73.23 111.674 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.597 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -96.34 -63.49 1.14 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.111 -1.07 . . . . 75.43 108.111 171.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -152.78 163.66 39.28 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.622 -1.626 . . . . 75.14 108.041 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -125.84 144.69 50.55 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.736 1.215 . . . . 75.4 108.543 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' B' ' 114' ' ' ILE . 33.8 t -147.44 144.08 28.37 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.53 -0.915 . . . . 61.31 108.53 173.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.1 tt0 -164.95 138.98 4.95 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.171 -0.677 . . . . 74.51 109.171 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -132.07 148.07 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.675 0.79 . . . . 74.04 109.257 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 41.5 mt-30 -122.6 103.17 8.51 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.407 -0.96 . . . . 74.14 108.407 168.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.05 105.29 17.3 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.14 -1.059 . . . . 72.42 108.14 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 155.0 24.18 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.205 -0.758 . . . . 61.55 111.205 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 125.29 1.72 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.566 -0.614 . . . . 65.13 111.566 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.28 126.36 40.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.055 -1.091 . . . . 73.42 108.055 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.74 162.57 28.12 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 74.53 108.988 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.409 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 48.7 m -132.5 113.26 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.083 -0.71 . . . . 74.35 109.083 168.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 32.9 pt -119.17 137.85 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.919 0.888 . . . . 70.13 110.084 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.613 ' HB1' ' HB ' ' B' ' 10' ' ' THR . . . -155.23 164.0 39.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 72.34 109.743 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.63 -47.46 3.6 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.242 -0.435 . . . . 73.31 112.493 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' B' ' 94' ' ' MET . 19.9 pt -64.04 148.89 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.523 1.129 . . . . 75.52 113.211 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -157.36 162.7 39.07 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.306 1.042 . . . . 72.44 109.704 172.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.57 -115.07 6.61 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.398 0.436 . . . . 54.24 113.614 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.9 m -77.77 -28.88 50.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.413 0.685 . . . . 55.5 110.79 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -58.56 -42.15 87.26 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.053 0.541 . . . . 73.32 110.588 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.562 ' HA ' HD12 ' B' ' 89' ' ' ILE . 23.9 ttt -71.87 -41.54 67.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 74.43 110.767 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.55 82.54 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.783 0.677 . . . . 74.23 111.29 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -79.54 -20.15 47.82 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.963 -1.017 . . . . 75.22 110.916 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -83.29 -67.05 0.82 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.293 0.237 . . . . 63.45 111.009 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.455 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.5 pp -83.92 -15.0 49.58 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.64 0.608 . . . . 75.12 112.64 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.64 -27.75 11.15 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.986 -0.341 . . . . 55.14 112.929 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.93 -60.24 1.91 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.252 0.621 . . . . 71.43 111.391 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.87 -46.0 66.46 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.195 0.598 . . . . 73.11 112.133 -170.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 62.6 m -68.38 -40.86 21.72 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.851 -0.595 . . . . 74.55 112.299 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.617 ' HA ' HD13 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -52.91 -39.9 77.16 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 122.273 1.982 . . . . 72.31 113.961 165.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -16.43 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 111.715 0.265 . . . . 63.54 111.715 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.67 -55.76 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.368 0.667 . . . . 71.42 110.526 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . 0.403 ' HB2' HD12 ' B' ' 60' ' ' LEU . 91.0 mt -76.83 -25.32 53.09 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.265 0.626 . . . . 73.55 112.681 -169.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.7 -48.98 88.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 CA-C-O 117.72 -1.134 . . . . 70.41 113.628 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.92 -38.47 86.18 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.052 1.835 . . . . 75.41 113.374 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.434 ' HE2' HG21 ' D' ' 115' ' ' THR . 29.3 m-85 -65.3 -45.33 84.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.596 0.759 . . . . 74.02 110.296 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.19 79.82 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.791 -0.641 . . . . 74.1 111.044 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ttt-85 -61.2 -56.23 23.1 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.331 1.052 . . . . 75.4 111.106 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -36.86 85.03 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.517 0.511 . . . . 63.45 110.087 -176.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.517 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.0 t -69.44 -26.9 64.83 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 123.684 0.615 . . . . 74.42 111.503 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.502 HG21 ' SG ' ' B' ' 76' ' ' CYS . 81.7 mt -74.56 -52.35 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 122.889 0.475 . . . . 73.33 109.846 170.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 28.9 m -60.26 -27.74 67.49 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.053 0.941 . . . . 71.44 111.665 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.16 -48.73 64.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.632 0.773 . . . . 71.23 109.769 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.517 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -71.72 -32.2 67.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.921 0.488 . . . . 75.12 111.484 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.33 -38.94 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.228 0.611 . . . . 73.31 110.139 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.5 t -65.66 -38.99 90.87 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 71.33 111.166 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.439 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -67.66 -33.76 75.59 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.608 0.763 . . . . 74.13 110.356 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.82 11.66 61.59 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.875 -0.602 . . . . 73.13 112.963 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.2 p 56.97 29.69 16.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.735 1.614 . . . . 54.11 113.847 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -109.72 145.47 32.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.106 0.962 . . . . 74.35 109.045 172.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 61.6 Cg_exo -57.21 140.34 92.56 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.838 2.358 . . . . 72.43 113.843 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . 0.475 ' NE2' HD22 ' B' ' 127' ' ' ASN . 20.3 pt20 -65.43 160.01 22.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 113.476 -1.693 . . . . 74.35 112.695 -174.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.4 116.38 15.11 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.574 -1.269 . . . . 65.1 107.574 168.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . 0.475 HD22 ' NE2' ' B' ' 125' ' ' GLN . 54.8 m-80 -89.97 104.08 16.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 106.924 -1.51 . . . . 71.04 106.924 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . 0.499 HD13 HD12 ' B' ' 42' ' ' LEU . 16.0 tp -66.46 134.85 53.3 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.846 -0.616 . . . . 75.11 110.874 -172.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.14 137.97 94.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.228 1.011 . . . . 73.51 111.745 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.46 111.72 0.5 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.143 2.562 . . . . 72.34 112.013 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.15 108.13 18.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.14 -1.059 . . . . 65.55 108.14 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.47 77.24 2.6 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.436 -0.95 . . . . 75.15 108.436 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 t80 . . . . . 0 CA--C 1.55 0.951 0 CA-C-N 114.862 -1.063 . . . . 75.1 109.917 178.352 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.468 ' HE2' ' HB2' ' C' ' 11' ' ' PHE . 23.7 ttt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.34 0.59 . . . . 70.15 111.651 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 10' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 91.0 m -98.58 96.36 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.836 -0.801 . . . . 63.31 108.836 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.478 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 57.1 t80 -99.38 128.38 45.49 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.652 -0.87 . . . . 74.35 108.652 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -152.79 136.74 16.31 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.262 -0.644 . . . . 74.24 109.262 175.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 66.7 mt -90.07 104.39 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.069 0.947 . . . . 74.14 109.745 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -73.56 -50.51 20.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.309 -0.256 . . . . 71.33 110.309 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -169.48 123.83 0.8 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.734 -0.469 . . . . 74.33 109.734 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -107.98 137.3 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.388 -0.967 . . . . 74.32 108.388 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.422 ' HH ' HD11 ' C' ' 83' ' ' ILE . 33.6 p90 -168.56 159.54 10.24 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.815 0.817 . . . . 73.25 111.09 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -77.5 114.32 16.21 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.138 -1.392 . . . . 72.33 108.763 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . 0.476 ' HZ3' ' HB2' ' D' ' 28' ' ' ALA . 19.0 mmmt -68.89 -41.59 78.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.864 0.84 . . . . 73.11 109.469 173.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -145.23 140.85 28.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.033 -1.439 . . . . 75.53 109.058 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 65.6 mt -134.63 141.51 43.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.333 -1.358 . . . . 75.11 107.333 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -161.74 150.7 15.79 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.397 0.618 . . . . 72.41 111.276 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 88.4 t80 -141.86 131.0 23.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.584 -1.265 . . . . 75.02 107.584 173.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.2 mt-10 -123.73 123.73 41.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.351 0.66 . . . . 73.31 109.266 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.8 83.21 62.19 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 107.432 -1.321 . . . . 73.1 107.432 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.28 -35.45 62.69 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.708 2.272 . . . . 75.12 111.875 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -110.66 33.39 4.57 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.811 -1.086 . . . . 75.02 109.223 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.417 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -47.23 -50.19 48.8 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 114.299 1.222 . . . . 73.13 114.299 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 15.2 Cg_exo -66.47 -39.51 16.48 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 121.788 1.659 . . . . 75.33 112.971 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -67.2 -57.58 6.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.313 1.045 . . . . 73.41 112.333 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.91 -24.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 125.176 1.39 . . . . 73.12 112.877 -177.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -51.95 -35.11 44.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.113 0.565 . . . . 75.31 112.05 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.48 45.9 0.95 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.666 0.787 . . . . 70.25 110.749 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.583 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 1.6 tppp? -124.53 151.86 44.16 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.011 0.924 . . . . 75.41 110.82 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.37 131.84 33.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.384 1.074 . . . . 72.34 112.636 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -86.39 69.31 10.41 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.082 0.953 . . . . 75.14 111.253 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -158.13 77.87 3.44 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.313 0.645 . . . . 71.32 109.679 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.51 ' HA ' ' HB3' ' C' ' 68' ' ' LEU . 95.7 Cg_endo -90.83 154.13 4.06 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.814 2.342 . . . . 74.52 113.122 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.05 95.2 9.86 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.455 -1.313 . . . . 73.45 107.455 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.4 114.3 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.938 -1.028 . . . . 73.21 109.461 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 89.6 mttt -102.24 146.51 27.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.757 0.823 . . . . 72.34 109.752 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.34 123.42 39.36 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 106.836 -1.542 . . . . 72.34 106.836 171.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.53 104.19 7.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.832 -1.173 . . . . 74.25 107.832 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.42 154.5 17.17 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.036 0.534 . . . . 75.52 110.224 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 10.6 t70 -146.79 151.91 37.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.774 0.83 . . . . 75.25 109.036 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -121.52 122.01 38.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.296 0.638 . . . . 73.05 110.093 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.76 138.7 48.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.503 -0.925 . . . . 75.3 108.503 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 48' ' ' SER . . . . . 0.558 ' HB3' ' HE1' ' C' ' 56' ' ' TYR . 71.2 m -155.06 151.54 28.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.038 0.535 . . . . 74.22 110.692 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -152.91 138.07 17.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.077 0.551 . . . . 72.34 110.498 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.53 122.92 27.07 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.671 -0.492 . . . . 75.2 109.671 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.452 HD13 HD13 ' C' ' 83' ' ' ILE . 41.1 mt -95.44 -43.32 8.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.767 0.827 . . . . 75.14 111.103 -172.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -158.83 -168.1 2.3 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.676 0.79 . . . . 75.45 110.066 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.91 103.63 0.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.093 -0.958 . . . . 74.22 110.066 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 72.77 -6.35 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 126.126 1.77 . . . . 64.31 113.024 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 60.2 t -91.85 107.49 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.792 -1.188 . . . . 73.54 107.792 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . 0.558 ' HE1' ' HB3' ' C' ' 48' ' ' SER . 2.1 t80 -128.59 141.0 51.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.11 -1.07 . . . . 74.3 108.11 -173.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -98.05 129.33 44.9 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.348 0.659 . . . . 70.14 110.829 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -110.35 114.69 47.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.08 -1.081 . . . . 74.44 108.08 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.21 135.84 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.831 -0.803 . . . . 55.43 108.831 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.16 109.38 12.81 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.945 -1.502 . . . . 75.04 106.945 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.2 ttm-85 -80.55 125.0 29.44 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.102 -0.703 . . . . 75.45 109.102 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' C' ' 114' ' ' ILE . 43.9 t -116.11 105.75 19.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.468 -1.308 . . . . 75.55 107.468 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.8 m -108.57 119.17 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.741 -0.837 . . . . 62.2 108.741 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.52 130.44 74.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.742 -0.836 . . . . 61.55 108.742 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 65' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 9.7 m -121.22 152.11 39.21 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.245 1.018 . . . . 72.22 109.309 -171.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.67 112.83 10.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.476 -1.305 . . . . 73.31 107.476 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -145.02 135.06 23.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.329 -0.619 . . . . 74.25 109.329 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.5 OUTLIER -120.23 57.01 0.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 122.216 1.008 . . . . 73.44 110.49 -173.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.29 -119.94 4.47 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.692 -1.594 . . . . 73.45 110.285 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.92 -30.59 18.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.855 -0.794 . . . . 73.31 108.855 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.583 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 11.7 tp10 -72.72 109.72 6.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.743 -1.117 . . . . 64.04 109.984 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -83.41 122.76 28.93 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.975 -0.75 . . . . 65.54 108.975 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.64 -54.77 8.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.407 1.067 . . . . 75.25 109.264 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -165.82 171.65 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.476 -0.784 . . . . 71.42 111.45 171.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -137.86 145.97 42.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.185 1.394 . . . . 74.53 107.242 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG21 ' C' ' 114' ' ' ILE . 42.0 t -152.85 121.39 6.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.044 0.537 . . . . 73.22 109.671 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.45 127.98 47.35 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.963 0.505 . . . . 73.3 110.285 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.91 124.46 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.895 -0.78 . . . . 74.2 108.895 169.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.543 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 23.3 mt-30 -96.62 105.52 17.63 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.988 -1.116 . . . . 71.33 107.988 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -92.24 112.05 23.84 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.724 0.41 . . . . 72.31 110.656 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 155.5 23.75 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.93 -0.577 . . . . 73.42 111.92 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.95 116.62 0.74 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.825 -1.31 . . . . 54.2 109.825 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' D' ' 29' ' ' PRO . 19.4 mm -81.71 119.51 31.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.322 -0.992 . . . . 74.2 108.322 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -126.93 119.18 26.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.661 -1.237 . . . . 74.24 107.661 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -84.65 98.61 10.29 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.505 -1.294 . . . . 74.14 107.505 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' C' ' 10' ' ' THR . 0.2 OUTLIER -121.34 142.29 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.169 0.509 . . . . 74.43 111.242 -175.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.58 168.38 27.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.547 1.139 . . . . 62.1 109.416 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.77 -45.67 2.71 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.939 -0.464 . . . . 63.11 111.939 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' C' ' 93' ' ' GLN . 1.6 pp -80.93 145.66 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.482 0.713 . . . . 75.21 111.021 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -162.04 148.32 13.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.791 0.837 . . . . 74.23 109.081 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 -117.22 10.79 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.603 0.564 . . . . 73.34 113.328 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 56.6 p -65.12 -35.66 81.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.875 . . . . 74.3 111.532 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . 0.579 ' HB3' HG22 ' C' ' 89' ' ' ILE . 26.4 mt-30 -67.64 -43.3 80.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.92 -0.582 . . . . 72.22 110.623 178.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.491 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.5 ttt -75.78 -23.51 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.32 110.801 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.49 96.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.038 0.535 . . . . 74.53 110.674 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.25 -34.19 74.41 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.433 -0.803 . . . . 75.1 110.745 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -65.74 -61.26 2.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.797 -0.638 . . . . 75.53 111.317 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -87.08 -12.97 45.62 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.502 0.556 . . . . 75.43 112.502 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.15 8.02 60.62 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-O 119.584 -0.564 . . . . 60.32 113.36 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -154.79 -59.95 0.11 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.93 0.492 . . . . 72.52 111.273 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.46 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 43.2 t80 -74.53 -49.59 21.4 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.556 0.742 . . . . 75.13 112.094 -168.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . 0.478 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -69.86 -44.52 22.68 Favored Pre-proline 0 CA--C 1.561 1.401 0 CA-C-O 118.156 -0.926 . . . . 73.11 113.223 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.59 -38.42 62.26 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 121.722 1.615 . . . . 74.34 111.259 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -62.95 -22.74 67.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.591 0.756 . . . . 75.04 112.392 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -73.32 -54.46 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 110.224 -0.287 . . . . 74.34 110.224 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 pp -87.16 -8.51 56.86 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.955 -0.566 . . . . 75.5 112.517 -170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -58.44 -50.67 86.77 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.421 1.088 . . . . 71.14 113.303 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.51 -29.94 89.67 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 121.654 1.57 . . . . 63.15 113.189 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.68 -45.78 67.55 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.223 0.609 . . . . 74.32 110.462 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.63 91.95 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.547 0.739 . . . . 73.13 110.631 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . 0.52 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 36.1 ttt180 -61.78 -53.74 51.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.431 -1.713 . . . . 75.32 111.927 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.322 0.649 . . . . 73.22 110.315 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -67.91 -31.35 71.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.2 0.6 . . . . 73.43 111.449 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.444 HG21 ' SG ' ' C' ' 76' ' ' CYS . 83.2 mt -75.4 -49.97 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.617 0.767 . . . . 72.45 110.526 174.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -62.2 -29.37 70.33 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.515 0.726 . . . . 74.33 111.457 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -67.26 -49.69 63.41 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.56 -0.745 . . . . 74.14 109.622 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.726 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.04 -36.59 75.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.055 0.942 . . . . 63.43 112.615 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.88 -41.74 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.588 0.755 . . . . 75.01 110.346 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.1 p -74.91 -27.01 60.05 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.031 -0.532 . . . . 72.31 111.349 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -70.3 -39.44 74.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.835 0.854 . . . . 75.41 110.742 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' D' ' 18' ' ' THR . . . -83.89 10.06 61.23 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.045 -0.525 . . . . 61.43 113.461 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p 55.12 62.28 2.57 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 125.482 1.513 . . . . 73.35 111.718 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -126.59 154.39 75.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.867 1.267 . . . . 74.35 109.139 170.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.32 167.8 13.99 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.276 2.651 . . . . 72.01 113.759 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . 0.513 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 17.3 mm-40 -56.26 123.64 15.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.571 1.148 . . . . 74.14 113.912 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.97 84.18 1.91 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.117 -1.438 . . . . 74.13 107.117 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . 0.402 ' OD1' ' HB3' ' C' ' 125' ' ' GLN . 13.7 m120 -91.77 102.11 14.71 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.248 -1.019 . . . . 73.15 108.248 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . 0.52 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 14.8 tp -68.08 137.15 54.76 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 64.53 110.382 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . 0.436 ' H ' HD11 ' C' ' 128' ' ' LEU . . . -81.08 152.19 70.99 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.035 0.934 . . . . 64.03 111.146 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.402 ' HG3' HD11 ' A' ' 16' ' ' ILE . 41.3 Cg_exo -50.11 142.19 28.43 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.16 2.573 . . . . 74.21 113.111 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.11 110.29 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.779 -0.823 . . . . 72.14 108.779 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -97.98 85.65 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.389 0.676 . . . . 74.01 109.922 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.411 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 91.0 m-85 -69.59 -46.65 65.84 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.264 -0.426 . . . . 75.23 110.866 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.411 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 29.8 t70 . . . . . 0 N--CA 1.475 0.804 0 CA-C-N 115.72 -0.673 . . . . 73.13 110.801 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.242 0.707 0 N-CA-C 108.924 -0.769 . . . . 73.53 108.924 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -157.15 100.66 1.87 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.945 -1.131 . . . . 73.54 107.945 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.3 143.53 51.03 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.842 0.857 . . . . 73.53 109.221 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 47.7 mt -96.11 136.22 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.016 0.526 . . . . 63.41 109.754 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . 0.427 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.6 mt-30 -89.13 -42.1 11.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.978 -0.379 . . . . 63.52 109.978 172.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -176.03 153.64 1.34 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 65.31 110.919 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.842 -1.54 . . . . 75.51 106.842 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -149.43 170.81 17.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.173 0.987 . . . . 64.43 111.613 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 18' ' ' THR . . . . . 0.432 ' H ' ' HA2' ' C' ' 121' ' ' GLY . 68.4 p -105.09 117.65 34.54 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.312 -1.313 . . . . 71.11 109.726 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -85.6 -29.29 24.21 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.889 -0.596 . . . . 75.44 109.458 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 24.5 t70 -151.03 139.1 20.08 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.338 -1.301 . . . . 72.55 108.924 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.726 HG21 ' HE1' ' C' ' 117' ' ' MET . 92.1 mt -132.49 146.84 32.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.729 -1.211 . . . . 74.44 107.729 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.8 t -148.75 140.0 23.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.65 0.78 . . . . 75.44 109.715 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -149.35 117.67 6.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.372 -2.084 . . . . 74.23 105.372 167.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -121.88 135.64 54.9 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.966 -0.753 . . . . 70.22 108.966 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.04 83.45 55.66 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.371 -1.344 . . . . 73.31 107.371 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.38 -29.82 10.84 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.89 2.393 . . . . 74.15 113.558 -169.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -114.71 33.22 5.49 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.03 -0.73 . . . . 72.22 109.03 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HZ3' ' C' ' 19' ' ' LYS . . . -43.15 -62.33 1.39 Allowed Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.433 1.642 . . . . 73.13 115.433 -163.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.477 ' HB3' HD11 ' C' ' 83' ' ' ILE . 42.9 Cg_endo -83.21 -15.61 7.69 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 121.794 1.676 . . . . 61.15 112.888 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -68.18 -34.29 76.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.815 1.246 . . . . 75.03 109.079 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.569 HG13 ' HH2' ' D' ' 36' ' ' TRP . 55.8 t -68.44 -38.97 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.81 0.844 . . . . 73.14 110.398 175.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -74.04 4.69 5.12 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.831 0.678 . . . . 74.15 112.831 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -87.04 -17.75 32.21 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.058 0.543 . . . . 73.03 111.181 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.621 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 29.5 mtpt -126.34 107.3 10.18 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.336 1.054 . . . . 73.54 110.656 -167.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.47 97.6 9.56 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 118.905 0.775 . . . . 65.33 111.295 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.621 ' HE1' ' HE2' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -136.4 176.67 8.48 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 73.44 110.4 175.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.43 111.82 39.63 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.046 0.938 . . . . 75.15 110.336 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.566 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.1 Cg_exo -64.35 140.07 68.47 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.049 2.499 . . . . 74.43 113.871 173.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . 0.438 ' H ' HD11 ' D' ' 68' ' ' LEU . 14.4 pt-20 -82.77 130.15 35.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.042 -1.095 . . . . 75.1 108.042 162.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.446 HG13 HG13 ' D' ' 64' ' ' VAL . 77.2 t -105.57 104.74 17.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 107.694 -1.224 . . . . 74.11 107.694 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.16 127.86 36.75 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.17 -0.307 . . . . 75.44 110.17 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -95.89 124.43 39.9 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.621 -1.251 . . . . 75.44 107.621 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -137.59 138.26 39.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.36 -0.978 . . . . 74.12 108.36 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.88 147.36 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.417 0.627 . . . . 75.2 110.945 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -133.07 137.52 46.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.823 -1.177 . . . . 73.33 107.823 170.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.1 p -105.16 144.16 32.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 64.23 110.205 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.33 145.08 23.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.462 0.705 . . . . 71.43 109.32 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -151.22 157.46 42.65 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.873 0.469 . . . . 74.24 109.973 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 6.4 m -147.82 149.62 32.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.98 -1.118 . . . . 72.44 107.98 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -101.1 118.03 36.18 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.56 -1.274 . . . . 73.4 107.56 161.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 mt -89.68 -34.02 16.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.805 -0.442 . . . . 74.03 109.805 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.68 -177.8 6.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.599 -0.728 . . . . 73.15 110.679 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.34 130.94 45.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.252 -0.885 . . . . 74.54 109.126 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 66.33 5.64 3.82 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.63 1.172 . . . . 72.52 112.4 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.86 123.32 71.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 C-N-CA 123.381 0.672 . . . . 63.44 109.937 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -128.11 127.34 42.86 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.316 -0.994 . . . . 74.42 108.316 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -88.15 143.0 27.31 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.776 0.831 . . . . 64.43 109.114 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 48.6 t -125.32 123.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.268 -1.012 . . . . 74.41 108.268 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 43.4 t -109.83 131.33 61.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.167 -1.049 . . . . 61.21 108.167 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -126.38 117.66 23.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.588 -0.893 . . . . 75.31 108.588 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.1 ttm-85 -95.64 106.93 19.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.78 0.832 . . . . 74.41 109.938 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -94.46 112.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.778 -0.823 . . . . 73.31 108.778 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -112.15 128.59 56.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.485 0.66 . . . . 70.44 109.868 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . 0.446 HG13 HG13 ' D' ' 40' ' ' VAL . 42.2 t -124.8 107.42 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.458 1.503 . . . . 72.14 108.649 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.9 m -106.02 117.46 34.09 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.904 0.881 . . . . 74.44 110.375 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.48 126.55 53.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.307 -0.627 . . . . 72.23 109.307 172.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.2 m -153.76 122.83 6.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.304 0.641 . . . . 74.34 109.344 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' D' ' 38' ' ' PRO . 2.5 mm? -130.49 135.46 47.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.795 0.838 . . . . 74.21 109.448 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 -116.39 4.93 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.972 -0.851 . . . . 73.23 110.972 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.03 8.3 8.64 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.998 -0.742 . . . . 65.13 108.998 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.46 155.87 33.98 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.651 0.78 . . . . 74.15 110.793 -173.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -82.64 129.14 34.9 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 72.23 110.529 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -69.33 -68.61 0.39 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.093 -1.077 . . . . 73.53 108.093 173.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.88 152.61 28.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.388 -0.824 . . . . 74.33 109.596 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 77.1 mt -110.64 150.27 29.23 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.426 1.09 . . . . 71.34 108.243 167.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.553 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 38.1 t -150.9 136.23 17.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.432 -0.951 . . . . 75.13 108.432 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -155.53 129.56 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.644 0.378 . . . . 75.02 110.313 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -134.43 120.1 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.049 0.539 . . . . 74.54 110.07 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 7.1 mt-30 -87.7 91.25 8.68 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.607 -0.886 . . . . 73.32 108.607 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.72 95.54 6.65 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.383 -0.969 . . . . 74.15 108.383 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 144.18 16.95 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.83 -0.623 . . . . 61.14 111.562 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.39 136.22 6.61 Favored Glycine 0 CA--C 1.507 -0.43 0 N-CA-C 110.515 -1.034 . . . . 50.12 110.515 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.8 mt -88.42 126.54 41.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.6 -0.889 . . . . 65.01 108.6 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . 0.404 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 52.6 m-85 -123.92 148.65 46.69 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.565 -0.532 . . . . 72.55 109.565 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 27.0 m -103.57 94.22 5.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.671 -1.233 . . . . 74.23 107.671 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.8 mt -110.17 116.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.999 0.919 . . . . 74.33 108.72 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.45 153.5 15.47 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.145 0.578 . . . . 75.11 110.33 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.05 59.97 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.127 -0.488 . . . . 71.45 112.738 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.65 129.1 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.736 -0.839 . . . . 74.35 108.736 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -134.5 168.07 19.62 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.883 0.873 . . . . 73.14 110.362 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.42 -135.61 23.95 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.855 -0.611 . . . . 70.24 114.177 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -70.61 -34.63 72.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.166 0.987 . . . . 64.31 112.056 -173.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.98 -38.76 83.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.971 0.508 . . . . 72.13 110.726 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -44.11 76.66 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.5 -0.555 . . . . 73.0 109.5 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.54 71.66 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.204 0.94 . . . . 71.33 111.508 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -72.01 -45.0 62.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.572 0.749 . . . . 64.45 110.646 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.44 -37.9 88.27 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.807 0.443 . . . . 63.11 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 41.3 tp -79.32 -37.77 36.81 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.262 1.025 . . . . 74.21 111.301 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -7.79 76.09 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.657 -0.524 . . . . 74.24 113.769 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 -54.98 0.73 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.763 0.782 . . . . 73.31 112.211 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -72.37 -49.02 37.16 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.064 0.393 . . . . 75.22 111.573 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.0 m -60.78 -48.47 92.89 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.252 -0.88 . . . . 75.34 112.531 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.24 -27.75 48.22 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 121.636 1.557 . . . . 74.31 112.604 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -71.99 -24.09 61.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.066 0.546 . . . . 75.52 111.099 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -80.64 -41.68 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.607 0.763 . . . . 71.01 110.455 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.77 -30.57 62.84 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.202 0.601 . . . . 73.42 111.547 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -63.87 -42.36 70.09 Favored Pre-proline 0 CA--C 1.564 1.508 0 N-CA-C 114.187 1.18 . . . . 75.31 114.187 -170.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.57 -45.09 32.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.413 2.076 . . . . 75.42 113.821 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -79.63 -30.98 41.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.357 0.663 . . . . 74.13 111.798 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.91 74.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.912 0.485 . . . . 73.42 109.863 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.85 -51.27 70.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.293 -1.321 . . . . 70.33 110.352 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.54 -42.17 91.72 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.218 0.949 . . . . 73.45 111.385 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -44.56 94.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.754 0.659 . . . . 65.21 110.793 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.487 HG22 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -62.46 -52.38 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.073 0.949 . . . . 75.24 110.697 175.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.434 HG21 ' HE2' ' B' ' 109' ' ' TYR . 32.0 m -56.36 -41.25 75.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.824 1.249 . . . . 65.13 111.135 -171.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -67.93 -43.58 78.84 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.549 -1.205 . . . . 74.12 110.507 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.553 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.9 mtm -66.64 -31.55 72.31 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.371 0.508 . . . . 62.5 112.371 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.46 HG21 ' O ' ' D' ' 114' ' ' ILE . 94.5 t -68.34 -44.83 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.27 0.628 . . . . 73.53 109.712 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.0 p -70.37 -28.96 65.52 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.994 0.518 . . . . 74.02 111.45 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -73.38 -31.71 64.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.337 0.655 . . . . 74.52 110.186 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 3.0 86.12 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.959 -0.564 . . . . 73.44 112.851 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 69.3 p 63.29 14.43 7.81 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.794 2.038 . . . . 73.34 113.672 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.443 ' HE1' HG12 ' D' ' 31' ' ' VAL . 87.8 m-85 -80.29 158.83 71.34 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 165.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -70.88 134.29 25.32 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 121.61 1.54 . . . . 73.32 110.878 -168.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -48.72 116.94 1.81 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.333 1.021 . . . . 73.51 110.349 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -105.5 104.79 14.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.039 -0.726 . . . . 64.43 109.039 -164.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . 0.451 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 78.6 m-20 -99.0 94.24 6.44 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.513 -1.221 . . . . 74.23 107.998 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 127.48 32.43 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.121 0.969 . . . . 72.04 109.368 -175.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.88 128.63 87.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.58 0.752 . . . . 72.42 111.235 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . 0.407 ' HG2' ' HE2' ' B' ' 11' ' ' PHE . 1.2 Cg_endo -79.73 122.61 5.0 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.852 2.368 . . . . 73.03 111.391 -177.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.36 115.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.273 0.629 . . . . 74.53 109.448 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -76.55 105.28 7.52 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.143 -0.688 . . . . 65.44 109.143 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 123.798 0.839 . . . . 73.31 110.571 -177.202 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 C--O 1.24 0.562 0 N-CA-C 108.382 -0.97 . . . . 71.34 108.382 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.484 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 47.5 t80 -137.08 129.07 29.27 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.818 -1.178 . . . . 74.15 107.818 172.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -153.02 119.29 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.074 -0.713 . . . . 73.52 109.074 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.603 HG21 ' HG2' ' C' ' 130' ' ' PRO . 52.8 mt -65.69 133.24 31.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 114.922 -1.036 . . . . 73.44 110.026 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -115.66 -22.32 9.24 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.568 0.747 . . . . 74.23 112.447 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -176.12 122.81 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.192 0.451 . . . . 74.31 111.628 -175.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.43 HD11 ' HG2' ' C' ' 130' ' ' PRO . 1.4 mp -110.11 127.45 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.209 -1.034 . . . . 72.51 108.209 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -158.44 150.69 21.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.014 0.926 . . . . 74.21 110.284 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' SG ' ' A' ' 113' ' ' CYS . 82.2 p -76.81 119.02 20.01 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.834 -0.802 . . . . 73.55 108.834 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -81.68 -42.36 20.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 71.44 109.568 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.703 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 15.3 m-20 -136.26 137.31 40.64 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.724 -1.125 . . . . 73.41 109.053 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.3 mt -133.74 142.53 41.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.458 -1.312 . . . . 75.45 107.458 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -150.49 133.93 16.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.849 -0.797 . . . . 70.51 108.849 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.53 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.9 t80 -136.22 132.65 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.564 -1.643 . . . . 65.05 106.564 172.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.42 138.09 42.91 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.622 -0.881 . . . . 74.23 108.622 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.82 79.83 63.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.356 -1.72 . . . . 75.51 106.356 171.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.68 -40.81 76.69 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.297 2.664 . . . . 71.21 113.049 -164.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.37 38.5 3.97 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.748 -0.834 . . . . 74.02 108.748 -177.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -46.06 -57.63 7.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 117.935 -1.031 . . . . 61.21 113.262 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 22.5 Cg_exo -62.79 -20.25 70.67 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 122.073 1.849 . . . . 73.5 113.383 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -94.24 -31.87 13.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.178 0.991 . . . . 74.55 111.049 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.1 p -78.33 -19.45 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.716 0.807 . . . . 62.35 111.025 -169.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -73.78 -7.52 52.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.744 0.818 . . . . 73.44 111.397 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -98.33 -19.8 17.56 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 72.51 111.003 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -82.03 166.61 19.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.659 0.783 . . . . 72.44 111.546 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.94 149.18 49.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.996 0.918 . . . . 70.52 110.02 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -86.77 62.35 7.35 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.266 0.555 . . . . 75.44 111.948 -168.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -134.34 66.71 71.4 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.007 0.523 . . . . 75.02 111.298 173.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.18 126.65 2.81 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.008 1.805 . . . . 61.22 110.615 167.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -95.54 105.31 17.27 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.459 -0.941 . . . . 72.23 108.459 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 64' ' ' VAL . 2.1 p -75.52 129.64 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.278 -1.328 . . . . 74.44 110.218 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -99.92 141.17 33.09 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 74.21 110.089 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.65 118.67 37.26 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.954 -1.128 . . . . 64.5 107.954 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.54 145.05 33.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.012 0.525 . . . . 64.13 110.068 170.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.87 141.49 51.27 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.355 -0.979 . . . . 74.45 108.355 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.624 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.9 t70 -119.37 138.0 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.583 -1.266 . . . . 73.12 107.583 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -106.66 138.21 43.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.374 0.669 . . . . 75.41 110.629 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.16 110.45 0.91 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.17 0.588 . . . . 60.14 110.492 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -112.76 159.76 18.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.019 -0.734 . . . . 73.33 109.019 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -154.14 150.42 28.12 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.536 0.734 . . . . 62.21 109.716 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.46 143.45 30.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.403 -0.962 . . . . 73.11 108.403 171.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 57' ' ' GLU . 28.6 mt -115.94 -43.88 2.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.396 0.679 . . . . 75.33 109.719 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.86 -167.94 2.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.108 -0.951 . . . . 74.31 110.073 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.76 106.41 0.8 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.553 0.741 . . . . 73.51 110.132 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.441 ' HB3' ' HB1' ' A' ' 87' ' ' ALA . 23.9 m-20 67.34 13.87 9.5 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.727 1.211 . . . . 73.45 113.095 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.25 117.14 45.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.379 -0.971 . . . . 74.23 108.379 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 64.0 m-85 -125.06 123.39 39.68 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.512 -0.921 . . . . 73.34 108.512 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' HB2' HD11 ' A' ' 51' ' ' LEU . 27.4 tt0 -88.88 143.11 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.094 -0.957 . . . . 75.2 108.761 173.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.7 t -119.08 136.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.815 -1.18 . . . . 72.21 107.815 172.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.8 t -127.13 132.38 69.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.065 0.946 . . . . 74.4 108.762 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 106' ' ' LEU . 4.5 mm? -119.67 110.09 16.42 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.336 1.055 . . . . 73.25 108.344 175.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.73 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 26.3 ttp180 -83.81 99.55 10.37 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.012 -0.736 . . . . 75.51 109.012 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 117.35 34.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.313 -1.365 . . . . 74.25 107.313 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 m -116.03 122.24 44.6 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.911 0.862 . . . . 74.45 109.544 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 49.1 t -112.98 120.93 64.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.492 -1.685 . . . . 72.24 108.181 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -121.45 125.95 48.12 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.934 -0.765 . . . . 73.43 108.934 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.94 121.63 38.44 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.97 -1.122 . . . . 75.03 107.97 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -136.93 132.86 35.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.095 0.558 . . . . 70.15 110.344 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.409 HD22 HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -97.24 85.18 3.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.003 0.921 . . . . 72.43 109.166 174.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -90.98 1.54 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-N 114.45 -1.25 . . . . 74.55 110.889 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -122.36 -30.2 4.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.637 0.775 . . . . 75.3 110.423 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.01 131.35 35.78 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.333 -0.617 . . . . 75.13 109.333 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 m -87.01 136.23 32.99 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.232 0.539 . . . . 73.13 111.156 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.61 -65.22 0.93 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.893 -1.049 . . . . 72.42 109.323 172.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.69 159.28 44.62 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.511 -1.222 . . . . 74.21 111.319 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.9 tp -132.14 115.4 15.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.173 1.389 . . . . 74.23 107.964 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.609 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 67.7 m -105.76 138.28 42.21 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.26 -1.015 . . . . 73.12 108.26 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -146.81 115.39 6.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.28 -1.007 . . . . 65.24 108.28 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.39 110.14 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.448 0.699 . . . . 74.2 109.501 -175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.73 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 39.5 mt-30 -84.64 83.19 8.1 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.894 -1.15 . . . . 65.21 107.894 169.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.41 ' NE2' HG22 ' A' ' 18' ' ' THR . 8.2 tp-100 -76.22 102.22 5.73 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.443 -1.253 . . . . 63.5 107.884 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 156.31 24.77 Favored Glycine 0 C--O 1.243 0.685 0 CA-C-N 115.939 -0.573 . . . . 71.04 111.882 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.3 120.61 1.09 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.503 -1.039 . . . . 71.32 110.503 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.75 125.99 39.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 N-CA-C 108.267 -1.012 . . . . 75.4 108.267 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.535 ' CD2' HG12 ' A' ' 13' ' ' ILE . 4.7 m-85 -135.65 144.75 46.22 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.642 -1.244 . . . . 74.13 107.642 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -84.47 93.53 8.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.907 -1.145 . . . . 63.23 107.907 169.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 55.3 mt -100.08 117.92 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 108.56 -0.904 . . . . 73.32 108.56 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 54' ' ' ASP . . . -151.03 158.33 43.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.679 0.791 . . . . 73.41 110.38 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.75 10.13 86.11 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.339 0.399 . . . . 71.33 113.788 171.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 pp -113.26 163.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.967 1.307 . . . . 74.45 110.299 -173.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.56 170.64 6.75 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.296 -1.001 . . . . 73.52 108.296 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.05 -126.53 26.88 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 124.07 0.843 . . . . 74.4 114.947 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -72.97 -22.47 60.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.086 0.955 . . . . 75.14 111.639 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.6 -43.96 65.31 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.926 0.491 . . . . 75.11 110.3 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.4 ttt -71.42 -38.52 71.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.759 -0.655 . . . . 64.14 109.358 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.93 72.93 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.49 -0.777 . . . . 65.35 111.233 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -78.98 -27.03 43.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.861 0.464 . . . . 74.0 110.695 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.1 t -73.95 -66.03 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.161 0.184 . . . . 75.51 110.519 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.65 -17.26 36.58 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.445 0.535 . . . . 73.32 112.445 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.85 1.33 44.97 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.43 -0.65 . . . . 73.45 114.265 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.96 -56.8 0.2 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.885 0.842 . . . . 74.2 113.25 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.484 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.6 t80 -76.04 -59.05 2.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.477 0.711 . . . . 75.13 111.221 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.82 -31.99 4.57 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.913 0.885 . . . . 64.53 113.105 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.54 -49.06 14.01 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.647 2.231 . . . . 74.13 113.192 160.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -68.67 -26.53 65.36 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.574 0.75 . . . . 74.23 110.437 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 13' ' ' ILE . 35.9 mm -69.62 -42.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.194 0.597 . . . . 73.25 110.196 172.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.533 HD11 HD23 ' A' ' 60' ' ' LEU . 96.7 mt -80.75 -17.42 51.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.733 0.813 . . . . 75.41 111.568 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.85 -45.8 65.17 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 118.075 -0.964 . . . . 72.44 113.277 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.25 -30.91 64.21 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.986 1.791 . . . . 70.41 112.616 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -78.89 -36.46 42.07 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.423 0.689 . . . . 73.1 111.356 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.53 74.67 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.853 -0.795 . . . . 72.22 108.853 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -51.25 -50.31 59.46 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 125.098 1.499 . . . . 74.02 110.757 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -72.81 -37.63 67.44 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.197 0.936 . . . . 72.3 111.106 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . 0.479 ' SG ' HG23 ' A' ' 18' ' ' THR . 41.8 t -62.9 -35.89 81.52 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.08 0.467 . . . . 71.55 110.651 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.13 -52.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.333 -0.849 . . . . 71.33 109.527 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' HG3' ' A' ' 125' ' ' GLN . 92.6 m -52.25 -44.8 65.08 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.775 1.23 . . . . 71.0 111.422 -174.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -66.42 -45.8 78.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.412 -1.267 . . . . 74.2 110.546 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.3 mtm -61.91 -41.16 97.59 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.789 0.436 . . . . 72.53 111.147 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.5 -49.46 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.227 1.011 . . . . 73.4 110.334 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -69.14 -27.45 65.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.847 0.459 . . . . 75.23 111.383 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.1 mtt-85 -73.61 -20.75 60.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.717 0.807 . . . . 74.44 110.837 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.95 10.83 64.18 Favored Glycine 0 C--N 1.354 1.568 0 CA-C-O 119.676 -0.513 . . . . 73.45 113.539 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m 56.94 32.74 22.08 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.171 1.389 . . . . 73.11 110.646 -173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -99.09 153.85 37.59 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-N 114.897 -1.047 . . . . 75.13 109.097 173.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.47 144.97 95.54 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.365 2.043 . . . . 72.31 110.944 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.448 ' HG3' HG21 ' A' ' 115' ' ' THR . 35.1 tt0 -55.05 130.13 40.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.864 0.728 . . . . 75.14 111.298 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.4 tp -111.51 102.71 11.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.03 0.932 . . . . 71.34 109.516 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.36 102.63 14.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.753 -1.203 . . . . 70.22 107.753 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.65 116.97 6.17 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 107.765 -1.198 . . . . 63.14 107.765 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.61 135.92 94.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.428 0.691 . . . . 70.2 112.241 -172.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.24 137.81 49.01 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.763 2.308 . . . . 64.41 112.983 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.94 134.7 65.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.033 0.933 . . . . 74.54 109.258 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -84.01 77.61 9.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.201 1.0 . . . . 71.3 110.908 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -66.59 -40.79 89.06 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.45 0.643 . . . . 73.41 109.932 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 11.3 p-10 . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 125.036 1.334 . . . . 71.54 111.69 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 107.394 -1.336 . . . . 74.41 107.394 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -140.62 135.72 32.01 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.314 0.646 . . . . 74.24 109.314 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -152.99 140.59 19.86 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.146 0.903 . . . . 72.24 109.708 167.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 pp -80.51 140.21 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.333 -1.358 . . . . 75.24 107.333 169.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -98.02 -44.32 6.7 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.071 -0.714 . . . . 72.55 109.071 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -164.41 138.67 5.42 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.331 -0.85 . . . . 74.45 109.28 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.77 137.22 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 106.344 -1.724 . . . . 75.12 106.344 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -166.08 161.64 17.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.414 0.626 . . . . 74.44 111.88 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.9 m -90.24 117.66 29.16 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.017 -0.992 . . . . 71.31 108.818 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -87.67 -27.91 22.15 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.453 -0.794 . . . . 75.23 111.056 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -159.81 143.69 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.411 0.444 . . . . 73.32 111.928 -174.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . 0.8 HD12 ' SG ' ' B' ' 113' ' ' CYS . 44.9 mm -134.63 143.46 37.68 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 125.286 1.435 . . . . 74.13 109.055 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -144.37 130.53 19.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.757 -1.201 . . . . 53.43 107.757 173.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -145.59 114.45 6.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.352 -1.351 . . . . 71.03 107.352 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.1 mt-10 -118.78 137.51 53.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.131 0.572 . . . . 72.41 109.673 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . 0.491 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -129.34 78.69 75.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.814 -1.18 . . . . 74.45 107.814 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.4 -18.24 38.78 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.471 2.781 . . . . 65.44 113.448 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -126.81 12.88 7.36 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.315 1.446 . . . . 71.0 110.739 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . 0.491 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -44.71 -57.18 7.19 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 115.817 1.784 . . . . 75.44 115.817 -165.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.01 -26.8 50.63 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.528 2.152 . . . . 74.45 112.336 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.9 m80 -91.46 -43.79 9.5 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.129 -0.941 . . . . 71.32 111.465 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.7 -26.37 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.244 0.618 . . . . 73.03 112.389 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -58.8 -24.01 61.23 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.026 0.93 . . . . 75.23 113.029 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 24.2 pt20 -76.47 -6.52 52.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.224 0.61 . . . . 71.2 112.424 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -103.93 109.49 21.26 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.162 -0.681 . . . . 74.44 109.162 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -95.46 96.93 9.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.266 0.469 . . . . 74.55 112.266 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.18 177.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.18 1.392 . . . . 74.23 110.511 162.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -78.7 138.03 58.36 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.121 0.968 . . . . 75.14 112.082 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HA ' ' HB3' ' B' ' 68' ' ' LEU . 78.2 Cg_endo -84.41 158.3 12.72 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.796 2.33 . . . . 73.01 112.881 167.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.49 128.2 35.23 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.813 -1.18 . . . . 74.22 107.813 162.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.9 t -108.48 131.72 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.302 0.641 . . . . 74.25 109.891 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.74 135.6 46.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.603 1.161 . . . . 74.23 109.194 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -109.16 125.62 52.38 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.222 1.009 . . . . 72.54 108.331 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -141.01 118.55 11.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.217 0.607 . . . . 61.12 109.368 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 pp -99.75 165.31 11.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.789 -0.449 . . . . 63.42 109.789 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -146.82 136.52 23.1 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.805 1.242 . . . . 71.13 108.095 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -120.93 105.54 10.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.609 0.764 . . . . 65.21 111.189 -167.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.19 155.27 31.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.861 0.864 . . . . 72.21 109.984 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.2 p -146.85 169.04 19.95 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.272 1.029 . . . . 73.24 109.885 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -153.46 137.63 16.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.308 0.643 . . . . 63.01 109.523 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -83.54 111.69 19.31 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.716 -0.476 . . . . 71.45 109.716 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.24 -45.78 13.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.689 0.618 . . . . 74.23 110.257 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 -168.01 2.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.218 -0.901 . . . . 60.32 110.701 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.01 108.32 3.03 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.997 -1.001 . . . . 72.43 109.883 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.8 11.11 7.37 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.945 1.298 . . . . 72.14 112.641 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.42 113.63 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.646 -0.872 . . . . 74.5 108.646 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.92 139.87 53.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.438 0.695 . . . . 74.02 109.522 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -101.78 106.39 17.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.528 -1.286 . . . . 74.43 107.528 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.19 123.6 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.256 1.022 . . . . 73.42 110.213 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -103.39 113.47 40.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.003 0.921 . . . . 75.01 109.496 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.61 100.02 10.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.614 -1.254 . . . . 75.52 107.614 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.7 ttm180 -85.3 128.18 34.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.116 -0.698 . . . . 71.43 109.116 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.26 106.13 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.1 -1.074 . . . . 73.42 108.1 172.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -98.55 126.72 44.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.522 0.729 . . . . 75.52 109.375 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . 0.628 HG22 HG21 ' B' ' 114' ' ' ILE . 93.7 t -118.33 116.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.889 -1.05 . . . . 75.43 108.575 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.7 m -116.32 140.48 49.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.653 -0.869 . . . . 75.23 108.653 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.92 142.73 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.81 -1.181 . . . . 75.05 107.81 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 38.9 p -150.31 141.96 23.59 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.074 0.55 . . . . 74.15 110.64 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.517 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -138.1 136.53 36.84 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.223 1.009 . . . . 71.22 110.534 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.4 -124.1 26.68 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.766 -0.652 . . . . 63.25 112.455 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -96.98 2.91 52.11 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.328 1.051 . . . . 74.33 111.066 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.65 -179.87 7.45 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.469 0.544 . . . . 71.12 112.469 -167.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -73.29 154.67 40.06 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.518 1.127 . . . . 53.2 111.235 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.517 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -97.77 -57.8 2.15 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.052 -1.092 . . . . 52.21 108.052 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -160.28 161.41 33.36 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.492 -1.231 . . . . 73.13 109.674 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 50.7 mt -116.95 131.34 56.98 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.273 -1.38 . . . . 75.34 107.273 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.09 150.46 39.54 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.09 -0.707 . . . . 75.35 109.09 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 45.0 tt0 -164.55 133.71 3.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.66 0.784 . . . . 75.33 108.975 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.3 t -130.61 145.7 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.276 1.03 . . . . 71.34 108.289 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -121.87 95.68 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.668 -1.234 . . . . 74.23 107.668 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.6 tp-100 -90.4 99.69 12.67 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.28 -1.007 . . . . 74.25 108.28 177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 165.49 32.14 Favored Glycine 0 C--O 1.242 0.631 0 N-CA-C 111.165 -0.774 . . . . 72.42 111.165 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.51 127.18 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.025 -0.83 . . . . 42.41 111.025 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.58 129.09 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.961 -1.125 . . . . 63.41 107.961 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -133.02 134.79 44.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.074 0.95 . . . . 75.03 109.084 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.8 m -99.36 105.15 17.09 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 64.14 107.75 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.476 HD12 HD13 ' B' ' 89' ' ' ILE . 29.9 pt -119.75 142.88 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.631 0.772 . . . . 74.03 110.065 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.58 161.12 41.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.757 0.823 . . . . 64.45 109.984 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.49 -54.43 3.83 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 123.647 0.592 . . . . 74.11 112.13 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.476 HD13 HD12 ' B' ' 86' ' ' ILE . 28.6 pt -54.44 145.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.531 1.132 . . . . 71.5 112.026 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -165.99 152.5 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.553 0.533 . . . . 73.31 110.485 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.95 -128.29 34.19 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.869 0.73 . . . . 44.35 114.058 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.6 m -69.25 -29.94 67.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.726 0.811 . . . . 74.32 110.77 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.65 -26.81 58.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.919 0.888 . . . . 74.11 110.392 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 35.3 ttm -62.71 -32.96 74.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.826 0.85 . . . . 71.54 110.422 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.77 -29.01 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.96 0.904 . . . . 72.15 112.608 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 51.4 t-80 -69.07 -26.55 65.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.522 0.329 . . . . 74.34 110.773 175.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -80.94 -63.17 1.46 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.179 -0.304 . . . . 72.02 110.179 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.473 HD11 ' N ' ' B' ' 99' ' ' GLY . 3.5 pp -67.12 -31.66 72.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.656 0.613 . . . . 74.3 112.656 -172.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . 0.473 ' N ' HD11 ' B' ' 98' ' ' LEU . . . -108.32 3.08 32.94 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 119.718 -0.49 . . . . 61.42 114.284 -171.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -144.16 -57.64 0.38 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.377 0.588 . . . . 63.53 111.7 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.38 -53.75 11.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.312 0.645 . . . . 73.43 111.459 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 68.0 m -64.28 -45.05 78.27 Favored Pre-proline 0 CA--C 1.565 1.522 0 C-N-CA 123.956 0.903 . . . . 64.33 111.601 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.7 Cg_exo -55.6 -39.96 88.09 Favored 'Trans proline' 0 C--N 1.402 3.348 0 C-N-CA 122.649 2.233 . . . . 74.21 113.236 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -58.4 -29.17 65.86 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 123.579 0.752 . . . . 61.44 111.29 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . 0.405 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 73.1 mt -80.54 -53.42 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.786 0.834 . . . . 74.4 110.886 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.48 -24.54 56.95 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.367 0.667 . . . . 73.41 112.545 -170.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -63.53 -48.15 81.71 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.913 -1.041 . . . . 65.13 112.893 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 84.7 Cg_exo -51.9 -43.09 54.3 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.455 2.103 . . . . 71.05 113.966 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.7 m-85 -67.1 -47.43 71.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.348 0.659 . . . . 75.25 110.888 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . 0.53 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.09 -48.27 80.67 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.813 0.696 . . . . 72.32 110.127 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -51.85 -52.27 50.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.806 1.642 . . . . 73.44 111.628 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.39 -35.0 78.43 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 123.657 0.598 . . . . 63.03 109.727 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.8 ' SG ' HD12 ' B' ' 21' ' ' ILE . 1.8 t -68.08 -31.0 70.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 122.93 0.492 . . . . 72.33 111.527 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . 0.628 HG21 HG22 ' B' ' 64' ' ' VAL . 53.7 mt -70.14 -55.25 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.562 -0.903 . . . . 74.32 108.562 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -54.93 -33.91 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.88 1.363 . . . . 65.21 111.628 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -63.35 -51.56 65.4 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.398 -0.819 . . . . 71.33 109.552 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.76 -34.17 69.26 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.786 0.679 . . . . 75.2 111.318 -174.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . 0.434 HG22 HD21 ' B' ' 126' ' ' LEU . 85.0 t -62.64 -44.73 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.879 0.872 . . . . 74.11 110.011 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.8 t -68.6 -35.28 77.13 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.179 -0.919 . . . . 71.21 110.634 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.59 -29.42 69.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.026 0.53 . . . . 65.24 110.326 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.7 18.28 35.38 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.967 0.792 . . . . 74.12 112.629 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 35.5 p 54.51 44.98 27.94 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.876 1.67 . . . . 65.23 112.881 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -112.78 147.32 36.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.403 0.681 . . . . 73.12 109.709 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.01 -165.63 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.41 2.74 . . . . 64.45 113.954 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.27 129.56 41.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.967 1.099 . . . . 71.22 113.967 -163.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . 0.434 HD21 HG22 ' B' ' 118' ' ' VAL . 27.5 tp -136.3 118.35 15.37 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.609 1.163 . . . . 74.51 108.951 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -134.5 134.48 41.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.157 -1.053 . . . . 74.54 108.157 166.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.58 148.17 24.98 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.928 0.394 . . . . 74.34 111.342 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.07 147.94 55.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.204 1.002 . . . . 54.21 112.352 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' D' ' 16' ' ' ILE . 85.0 Cg_endo -75.82 79.78 2.77 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.53 2.82 . . . . 75.13 111.306 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 58.4 t -88.99 111.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.781 -1.192 . . . . 74.54 107.781 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -71.54 94.52 1.31 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 124.162 0.914 . . . . 75.05 109.341 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 . . . . . 0 N--CA 1.483 1.179 0 C-N-CA 124.091 0.956 . . . . 74.03 111.391 -177.596 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.491 ' HE2' HG21 ' C' ' 89' ' ' ILE . 41.0 ttm . . . . . 0 CA--C 1.549 0.92 0 CA-C-O 121.384 0.611 . . . . 72.55 111.703 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.2 m -89.82 79.57 6.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.486 -0.931 . . . . 73.34 108.486 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -90.78 120.88 32.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -146.14 125.7 13.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.292 0.637 . . . . 74.22 109.594 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.29 138.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.433 -0.803 . . . . 72.3 110.395 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.86 -51.65 3.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.02 -0.363 . . . . 73.54 110.02 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -172.22 129.81 0.59 Allowed 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.276 0.36 . . . . 74.52 110.466 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.347 -0.982 . . . . 73.43 108.347 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG12 ' C' ' 83' ' ' ILE . 39.9 p90 -173.32 172.5 3.76 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.428 0.632 . . . . 74.34 111.417 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -92.16 114.95 27.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.647 -0.706 . . . . 73.33 110.103 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -64.48 -38.41 90.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.033 -0.728 . . . . 74.51 109.033 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.7 t70 -153.73 148.14 26.04 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.571 -1.195 . . . . 74.23 110.043 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -136.15 143.26 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 105.606 -1.998 . . . . 73.25 105.606 171.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -156.18 150.1 25.16 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.391 0.615 . . . . 63.31 109.868 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -152.59 118.19 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.481 -1.303 . . . . 71.45 107.481 173.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -115.44 139.43 50.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.655 -1.239 . . . . 75.42 107.655 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 84.25 53.48 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.66 -1.237 . . . . 75.1 107.66 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.32 -45.09 28.77 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.101 2.534 . . . . 74.35 112.226 -176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.27 50.73 0.79 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.591 -0.892 . . . . 72.21 108.591 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.531 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -55.73 -48.15 97.17 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 115.518 -0.764 . . . . 73.23 112.832 -175.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 1.9 Cg_endo -85.91 -33.7 0.2 Allowed 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.929 1.752 . . . . 74.02 112.836 169.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . 0.402 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 55.8 t60 -70.23 -33.52 71.75 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.657 0.984 . . . . 72.05 113.657 -167.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -79.44 -14.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 122.815 0.446 . . . . 75.02 111.224 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -71.31 -14.91 62.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.624 0.77 . . . . 74.04 111.601 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.1 pt20 -105.14 12.51 31.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.525 0.73 . . . . 63.13 110.824 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.471 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.1 mptm? -97.45 176.71 5.77 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.021 0.915 . . . . 73.55 112.994 -170.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -87.91 128.5 35.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.384 -1.735 . . . . 72.03 108.938 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.648 0.592 . . . . 73.44 111.206 -168.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -148.24 58.89 4.06 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.247 0.619 . . . . 53.42 110.319 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.37 123.31 10.1 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.767 2.311 . . . . 64.54 112.387 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.98 77.57 8.42 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.551 -1.648 . . . . 64.43 106.551 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -73.83 97.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.838 -1.074 . . . . 72.41 108.4 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -93.49 122.08 35.55 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.95 -1.023 . . . . 74.31 109.01 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.31 121.51 28.98 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.308 -1.368 . . . . 74.43 107.308 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.0 t70 -121.85 135.43 54.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.691 -1.225 . . . . 74.03 107.691 176.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tt -137.21 120.12 16.43 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.335 -0.987 . . . . 71.23 108.335 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 5.6 t70 -113.46 148.11 36.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.056 0.942 . . . . 75.14 108.71 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 62.0 p -117.19 118.85 33.46 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.212 -0.904 . . . . 75.45 109.753 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' C' ' 59' ' ' VAL . . . -124.37 146.6 48.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.0 0.92 . . . . 70.14 109.5 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.6 p -151.48 157.4 42.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.687 0.395 . . . . 75.21 110.584 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 49' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 20.0 m -143.81 147.53 34.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.133 0.973 . . . . 71.14 108.635 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -101.93 115.76 31.23 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.953 -1.129 . . . . 74.34 107.953 168.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.648 HD12 ' HB2' ' C' ' 57' ' ' GLU . 28.5 mt -98.18 -27.6 14.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.324 0.65 . . . . 75.04 110.034 -175.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.72 -171.38 1.83 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.242 1.017 . . . . 70.32 110.334 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.51 124.76 25.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.254 -0.884 . . . . 74.52 109.237 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 69.85 -8.88 0.75 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.878 1.671 . . . . 74.41 112.728 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.91 112.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.407 -0.59 . . . . 64.31 109.407 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -127.54 126.08 41.52 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.476 1.11 . . . . 63.44 108.685 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.648 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.4 tt0 -82.52 118.53 23.33 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.809 0.843 . . . . 75.33 108.745 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.15 114.75 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.952 -1.129 . . . . 60.22 107.952 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' C' ' 47' ' ' ALA . 43.6 t -110.64 131.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.071 -0.714 . . . . 73.34 109.071 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 36.2 tp -111.97 103.14 11.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.971 -1.122 . . . . 74.02 107.971 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 55.1 ttm-85 -81.32 115.36 20.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.883 -1.154 . . . . 71.41 107.883 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . 0.467 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -116.73 108.74 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.905 -1.146 . . . . 75.43 107.905 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.1 m -116.02 124.37 50.29 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.834 0.854 . . . . 71.12 108.755 -174.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 56.2 t -117.8 113.71 43.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.846 -0.798 . . . . 73.31 108.846 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -100.88 146.84 26.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.595 -0.73 . . . . 72.13 109.343 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.66 13.06 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.132 -0.692 . . . . 74.24 109.132 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -131.63 126.28 34.32 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.841 -0.799 . . . . 73.52 108.841 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' C' ' 73' ' ' ALA . 9.2 mp -84.56 57.32 4.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.894 0.878 . . . . 72.43 109.399 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.1 -114.03 4.2 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.072 -1.211 . . . . 73.52 110.072 -174.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -90.8 -22.83 20.83 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.87 0.868 . . . . 62.54 110.322 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . 0.471 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.3 tp10 -87.87 117.83 26.98 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.433 0.693 . . . . 70.12 110.844 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -76.23 128.05 34.13 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.006 0.431 . . . . 73.33 110.647 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . 0.504 ' HB3' HD13 ' C' ' 68' ' ' LEU . . . -77.32 -60.45 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.792 -1.094 . . . . 72.1 109.422 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.11 176.47 12.21 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.88 -1.055 . . . . 72.32 110.58 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -140.98 120.86 13.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 106.357 -1.72 . . . . 73.52 106.357 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -117.01 119.89 36.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.439 -0.949 . . . . 72.02 108.439 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.69 141.71 51.53 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.72 -0.844 . . . . 70.31 108.72 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -147.41 115.14 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.444 1.098 . . . . 73.41 108.823 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.1 mt-30 -89.41 97.84 11.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.988 -1.115 . . . . 71.15 107.988 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -88.97 100.86 13.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.719 -0.673 . . . . 72.14 109.328 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.21 147.24 18.5 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.146 -0.479 . . . . 71.1 112.366 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.38 125.57 2.37 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 111.008 -0.837 . . . . 75.21 111.008 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' D' ' 29' ' ' PRO . 13.4 mm -81.76 122.66 37.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.765 -0.828 . . . . 74.43 108.765 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.54 138.17 45.93 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.3 p -109.34 106.17 15.86 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.933 -0.765 . . . . 71.21 108.933 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.46 142.24 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.856 0.863 . . . . 72.45 110.709 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.8 163.18 35.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.942 0.897 . . . . 72.35 110.406 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.82 -21.13 34.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.833 -0.621 . . . . 64.51 113.406 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . 0.491 HG21 ' HE2' ' C' ' 9' ' ' MET . 36.4 pt -114.18 148.16 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.063 0.945 . . . . 71.41 109.914 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -160.22 148.19 16.61 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.494 0.497 . . . . 74.44 110.099 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.51 -112.66 4.49 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 124.293 0.996 . . . . 72.22 113.543 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -64.69 -37.22 86.85 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.062 0.945 . . . . 72.44 111.775 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.88 -46.73 77.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.135 0.574 . . . . 73.3 110.937 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 94' ' ' MET . . . . . 0.431 ' HE3' HD22 ' C' ' 98' ' ' LEU . 3.1 ppp? -74.53 -20.97 59.76 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.509 -0.769 . . . . 72.44 110.146 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.66 72.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.408 0.683 . . . . 72.43 111.074 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -68.18 -46.86 69.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.247 -0.433 . . . . 74.32 110.596 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.98 -56.56 9.62 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.141 -0.481 . . . . 64.02 110.376 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . 0.431 HD22 ' HE3' ' C' ' 94' ' ' MET . 54.7 tp -64.02 -40.43 96.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.449 1.1 . . . . 65.23 111.894 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.93 70.42 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.481 -0.622 . . . . 70.04 114.415 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -149.87 -59.76 0.2 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.808 0.804 . . . . 73.12 111.988 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -75.0 -50.93 14.91 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.244 -0.435 . . . . 74.42 112.008 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.66 -45.76 97.09 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.577 0.751 . . . . 63.45 112.95 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.65 -24.72 41.11 Favored 'Trans proline' 0 C--N 1.393 2.875 0 C-N-CA 121.983 1.788 . . . . 74.32 112.882 174.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.47 -40.49 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.257 0.623 . . . . 73.31 109.392 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.08 -46.76 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.634 -0.712 . . . . 74.34 110.195 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.07 -20.84 44.23 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.27 -0.877 . . . . 70.41 112.226 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.9 -54.74 48.78 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.109 -0.948 . . . . 73.55 113.538 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.49 -31.52 71.53 Favored 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.994 1.796 . . . . 63.22 112.972 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -66.1 -45.38 81.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.524 0.73 . . . . 72.35 110.756 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.13 -37.78 86.54 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.852 -0.613 . . . . 74.04 110.439 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -60.56 -54.11 49.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.298 1.439 . . . . 74.12 111.425 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -35.39 80.28 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.608 0.568 . . . . 74.12 110.172 -177.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.09 -38.87 86.46 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.079 0.552 . . . . 74.14 111.822 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.467 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -67.76 -50.94 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.436 0.694 . . . . 74.21 110.169 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.4 m -63.14 -28.79 70.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.368 0.667 . . . . 73.45 111.311 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.6 t -67.58 -47.85 68.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.18 -0.674 . . . . 62.23 109.18 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.541 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.45 -37.67 86.82 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.961 0.904 . . . . 75.41 112.325 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.52 -40.58 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.049 0.539 . . . . 74.3 109.918 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.33 -33.96 76.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.651 0.78 . . . . 75.24 111.229 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 71.4 mtt-85 -70.48 -27.11 63.96 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.9 0.88 . . . . 75.24 110.901 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.24 15.01 62.13 Favored Glycine 0 C--N 1.352 1.45 0 O-C-N 123.63 0.581 . . . . 54.41 112.817 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.527 HG22 ' HB3' ' D' ' 17' ' ' TYR . 49.6 p 55.0 26.39 7.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.901 1.681 . . . . 71.44 112.638 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -103.46 141.86 23.38 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 124.425 1.09 . . . . 73.01 108.887 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -40.6 111.77 0.16 Allowed 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 124.148 3.232 . . . . 75.15 113.893 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -57.23 123.67 16.13 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.148 0.905 . . . . 75.32 111.268 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -112.36 110.75 21.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.128 -1.064 . . . . 73.54 108.128 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -94.97 117.38 30.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.635 -0.876 . . . . 71.33 108.635 175.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.55 142.25 53.66 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.516 0.51 . . . . 75.33 110.268 175.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.2 160.84 81.73 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 115.099 -0.955 . . . . 63.32 111.065 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.603 ' HG2' HG21 ' A' ' 13' ' ' ILE . 26.0 Cg_exo -59.76 100.73 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.65 2.233 . . . . 72.33 112.455 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.2 t -98.85 107.12 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.399 -0.963 . . . . 74.01 108.399 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -114.34 106.25 14.09 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.232 1.013 . . . . 74.33 108.559 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . 0.566 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 51.1 m-85 -63.91 -30.64 71.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.731 0.812 . . . . 72.43 111.429 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.482 1.126 0 C-N-CA 123.849 0.86 . . . . 74.1 110.515 173.844 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.5 m . . . . . 0 C--O 1.236 0.365 0 N-CA-C 107.735 -1.209 . . . . 74.34 107.735 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -156.8 92.93 1.32 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.05 -1.463 . . . . 72.33 107.05 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -122.02 156.44 33.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.674 0.79 . . . . 63.52 109.363 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.418 HD11 HG21 ' D' ' 105' ' ' ILE . 11.3 mt -102.0 122.48 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.983 -0.747 . . . . 63.14 108.983 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.25 -49.57 10.6 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.433 -0.58 . . . . 74.11 109.433 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . 0.47 ' HE ' HD13 ' D' ' 83' ' ' ILE . 19.4 ptt180 -173.65 152.67 2.11 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 112.171 0.434 . . . . 72.5 112.171 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.449 ' CD1' ' HG3' ' B' ' 130' ' ' PRO . 4.0 mp -114.36 139.35 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.621 -1.622 . . . . 73.23 106.621 167.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.531 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 41.2 p90 -162.56 157.67 22.43 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.833 0.853 . . . . 72.5 109.691 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -81.42 113.55 19.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.459 -1.246 . . . . 72.45 109.175 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 33.9 mtpt -83.33 -33.2 25.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.098 0.475 . . . . 74.41 109.812 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.6 t70 -144.93 135.54 24.45 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.537 -1.21 . . . . 71.34 109.038 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.541 HD12 ' HG3' ' C' ' 117' ' ' MET . 53.4 mt -133.43 140.89 45.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.351 -1.351 . . . . 64.05 107.351 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -154.44 102.32 2.41 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.675 0.79 . . . . 75.31 109.466 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.529 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.0 t80 -108.39 115.49 30.2 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 105.783 -1.932 . . . . 75.14 105.783 167.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -121.01 131.78 54.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.149 -0.686 . . . . 74.23 109.149 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.45 78.26 45.77 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.284 -1.376 . . . . 75.13 107.284 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.9 -35.15 36.49 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.675 2.25 . . . . 71.33 111.522 -172.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -109.91 22.29 15.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.775 0.83 . . . . 72.01 109.99 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.409 ' HB3' ' HD3' ' D' ' 29' ' ' PRO . . . -35.43 -64.82 0.31 Allowed Pre-proline 0 CA--C 1.571 1.773 0 N-CA-C 116.13 1.9 . . . . 74.13 116.13 -171.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.578 ' HB3' HD11 ' C' ' 83' ' ' ILE . 40.0 Cg_endo -81.03 -14.5 10.91 Favored 'Trans proline' 0 C--N 1.39 2.744 0 CA-C-N 122.023 1.758 . . . . 74.41 113.339 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -71.35 -37.43 71.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.901 1.28 . . . . 71.44 109.06 172.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.62 HG11 HD11 ' D' ' 68' ' ' LEU . 76.1 t -74.12 -30.98 28.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 115.131 -0.94 . . . . 74.32 109.95 175.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -70.84 6.76 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.644 0.979 . . . . 74.44 113.644 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -84.48 -37.84 20.84 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.367 -0.605 . . . . 75.24 109.367 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . 0.425 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 30.4 pttt -132.45 95.87 3.72 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 124.23 1.012 . . . . 74.12 112.319 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -108.72 92.74 4.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 72.42 109.522 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . 0.425 ' HZ3' ' HA ' ' D' ' 34' ' ' LYS . 12.3 m-90 -125.86 -179.99 4.93 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.364 -1.347 . . . . 75.13 107.364 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.05 104.65 0.44 Allowed Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.476 0.71 . . . . 75.0 112.055 -163.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.69 109.72 2.91 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.958 2.438 . . . . 70.41 109.464 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.62 113.9 4.04 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.589 -0.893 . . . . 74.54 108.589 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . 0.424 HG11 HD12 ' D' ' 126' ' ' LEU . 1.2 m -104.78 114.2 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 114.436 -1.256 . . . . 52.04 110.64 -166.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 81.1 tttt -87.54 128.65 35.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.198 1.399 . . . . 73.51 108.945 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -101.77 114.17 27.99 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.382 0.673 . . . . 75.55 109.828 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.641 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -106.84 109.43 21.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.256 -1.387 . . . . 75.2 107.256 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.5 130.88 44.54 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.245 -1.02 . . . . 74.44 108.245 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -133.49 130.39 38.48 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.149 -1.056 . . . . 72.23 108.149 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -103.88 142.4 34.47 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.6 0.76 . . . . 73.4 109.781 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -155.24 150.65 27.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.549 0.74 . . . . 71.22 109.251 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.5 p -164.63 153.32 12.72 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.393 0.677 . . . . 64.3 109.332 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -158.65 142.55 15.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.063 0.545 . . . . 72.32 110.054 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -73.05 128.47 35.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.356 0.662 . . . . 75.41 109.393 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -100.88 -26.32 13.79 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.884 0.474 . . . . 75.11 110.552 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.52 -179.09 4.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.753 0.821 . . . . 61.21 110.82 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.04 119.82 12.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.852 -1.067 . . . . 62.51 108.858 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 40.5 m-20 66.39 16.79 10.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.044 1.338 . . . . 75.03 111.891 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.81 114.81 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.934 0.894 . . . . 72.23 108.969 175.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . 0.428 ' HB2' HD12 ' D' ' 86' ' ' ILE . 90.4 m-85 -132.81 129.45 38.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.352 1.061 . . . . 73.22 108.489 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -100.27 139.73 35.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.384 1.074 . . . . 73.23 109.789 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.58 118.8 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 73.45 108.305 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.5 t -104.99 131.4 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.442 -0.947 . . . . 73.52 108.442 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.93 109.76 12.84 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.991 -1.115 . . . . 72.23 107.991 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.2 ttm-85 -87.05 109.36 19.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.537 0.735 . . . . 74.12 109.838 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.56 104.25 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.591 -1.263 . . . . 72.21 107.591 166.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.641 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.8 m -100.0 136.51 39.8 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.433 -0.58 . . . . 74.22 109.433 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.06 110.12 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.46 1.104 . . . . 72.25 108.255 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 65' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 39.6 m -102.97 103.08 13.17 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.597 0.759 . . . . 74.5 109.244 175.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.59 135.99 36.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 29.5 p -148.36 124.28 10.64 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.641 0.588 . . . . 63.33 110.433 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.641 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.5 OUTLIER -113.04 126.7 55.78 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.422 -0.955 . . . . 65.43 108.422 172.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -134.03 28.11 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.474 -0.65 . . . . 65.32 111.474 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.26 4.2 54.38 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.979 0.512 . . . . 73.33 110.874 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -119.07 144.18 46.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 75.41 111.337 -168.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.8 m -74.72 120.1 19.81 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 123.469 0.708 . . . . 75.13 109.895 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.641 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -67.94 -61.53 1.82 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.252 0.97 . . . . 72.42 110.191 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.37 168.56 26.24 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.247 -1.342 . . . . 75.2 110.454 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.7 mt -127.45 139.57 52.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.65 -1.611 . . . . 72.31 106.65 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.628 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 36.2 t -153.38 110.21 3.42 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.415 -0.587 . . . . 70.32 109.415 -175.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -136.45 132.18 35.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.45 1.1 . . . . 75.21 108.998 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.39 121.79 20.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.117 0.567 . . . . 73.21 109.614 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.52 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -88.74 88.83 7.74 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.321 -0.992 . . . . 70.54 108.321 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -81.11 96.63 7.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.565 -1.198 . . . . 72.34 108.958 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.09 144.24 17.01 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.579 -0.608 . . . . 64.45 111.579 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.74 130.0 4.03 Favored Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 110.834 -0.906 . . . . 74.33 110.834 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . 0.47 HD13 ' HE ' ' D' ' 15' ' ' ARG . 48.0 mt -89.82 127.04 42.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.527 -0.916 . . . . 73.41 108.527 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -129.12 133.51 47.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.724 0.809 . . . . 75.41 109.759 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.1 m -80.92 94.98 6.61 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 108.901 -0.777 . . . . 75.33 108.901 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' D' ' 56' ' ' TYR . 40.1 mt -111.34 123.63 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.444 0.698 . . . . 71.32 110.202 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -149.67 165.01 33.63 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.767 0.827 . . . . 72.51 110.671 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.71 -19.44 24.73 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.411 0.925 . . . . 72.21 115.411 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 19.7 pt -129.2 134.73 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 117.835 0.817 . . . . 74.22 111.879 -170.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.33 -171.26 3.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.617 0.767 . . . . 63.04 110.061 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 -140.41 34.5 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.622 0.576 . . . . 73.12 112.18 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -78.19 -20.87 51.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.381 0.672 . . . . 70.31 111.57 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -60.44 -52.96 63.01 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.759 0.823 . . . . 75.21 110.17 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.27 -41.56 69.87 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 114.86 -1.063 . . . . 72.3 109.923 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.38 -26.92 68.68 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.476 0.71 . . . . 75.11 112.36 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.88 -42.04 25.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.347 0.659 . . . . 73.44 109.694 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.39 -31.03 71.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.068 0.547 . . . . 75.34 110.836 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -46.59 18.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 72.33 108.611 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.14 -20.05 79.41 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.97 -1.013 . . . . 75.2 114.377 -173.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.98 -61.71 1.22 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 117.17 0.485 . . . . 72.55 111.805 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -67.11 -40.89 86.95 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 112.677 0.621 . . . . 75.44 112.677 -170.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.5 m -63.76 -47.48 81.52 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-O 118.72 -0.657 . . . . 65.33 111.742 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.3 -40.2 35.43 Favored 'Trans proline' 0 C--N 1.4 3.269 0 C-N-CA 123.045 2.497 . . . . 74.21 114.196 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -59.78 -27.0 66.17 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 112.764 0.653 . . . . 64.11 112.764 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.418 HG21 HD11 ' D' ' 13' ' ' ILE . 41.6 mm -82.42 -44.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-O 121.157 0.503 . . . . 65.22 110.572 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.1 mt -76.29 -32.2 58.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.97 -1.014 . . . . 75.53 111.722 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . 0.41 ' HZ ' ' HG ' ' D' ' 128' ' ' LEU . 62.8 t80 -63.48 -42.86 76.36 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.566 1.146 . . . . 75.44 113.872 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.08 -42.65 45.37 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 122.386 2.058 . . . . 64.34 113.19 171.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -81.26 -27.67 35.07 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.58 0.752 . . . . 75.21 111.858 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.61 -53.54 49.97 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.317 -0.623 . . . . 73.04 109.317 173.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 39.1 ttp180 -58.74 -42.08 87.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.837 -1.529 . . . . 74.31 110.99 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.74 -49.92 74.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.771 0.828 . . . . 72.24 110.708 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' D' ' 21' ' ' ILE . 46.6 t -60.19 -44.2 95.28 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.843 0.714 . . . . 54.33 111.176 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.548 HG22 ' SG ' ' D' ' 76' ' ' CYS . 49.8 mt -58.57 -55.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 74.43 111.07 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 115' ' ' THR . . . . . 0.46 HG22 ' HE2' ' B' ' 109' ' ' TYR . 63.2 m -53.24 -47.46 69.01 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.239 1.016 . . . . 72.43 111.758 -174.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 46.7 t -62.14 -37.8 86.54 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.655 -1.157 . . . . 64.23 111.204 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.628 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.6 mtm -75.17 -32.14 61.19 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.871 0.469 . . . . 74.22 111.998 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.497 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -68.07 -36.93 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 116.066 -0.515 . . . . 70.45 109.733 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.2 p -72.54 -28.44 62.84 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.874 0.47 . . . . 72.3 111.085 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.4 mtt-85 -73.06 -27.23 61.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.673 0.789 . . . . 72.34 110.635 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.95 8.42 76.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.015 -0.538 . . . . 74.43 112.395 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p 66.54 13.67 9.39 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.084 2.154 . . . . 54.43 114.02 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . 0.481 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 76.5 m-85 -90.99 169.19 12.12 Favored Pre-proline 0 CA--C 1.568 1.647 0 C-N-CA 124.536 1.135 . . . . 70.02 107.964 169.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 93.0 Cg_endo -74.47 166.94 28.29 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.532 2.155 . . . . 75.23 112.92 -172.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -60.9 121.69 13.02 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.114 -0.494 . . . . 70.45 109.757 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . 0.424 HD12 HG11 ' D' ' 40' ' ' VAL . 7.5 tt -104.24 93.53 4.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.16 -1.422 . . . . 74.11 107.16 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -103.25 89.82 3.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.011 -1.45 . . . . 74.01 108.596 -171.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.41 ' HG ' ' HZ ' ' D' ' 107' ' ' PHE . 23.1 tp -71.96 122.78 21.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.854 -0.612 . . . . 73.21 110.514 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.91 140.31 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.492 1.117 . . . . 74.44 112.223 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.67 114.42 3.67 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.661 2.241 . . . . 73.35 110.371 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.56 143.56 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.555 0.742 . . . . 62.31 109.682 -172.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -69.67 101.72 1.72 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.189 0.996 . . . . 73.34 110.302 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 N--CA 1.476 0.852 0 C-N-CA 123.262 0.625 . . . . 73.22 111.175 179.006 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 108.7 -0.852 . . . . 75.05 108.7 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.621 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.8 t80 -126.34 123.47 38.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.079 0.952 . . . . 71.23 108.646 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -143.3 103.5 4.13 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.423 0.452 . . . . 73.12 109.878 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.627 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.4 mt -64.9 121.57 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.041 -0.725 . . . . 74.43 109.041 174.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -87.61 -41.39 13.46 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.677 0.611 . . . . 75.43 109.656 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.471 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 59.0 ttt180 -168.28 144.01 3.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.996 -0.281 . . . . 74.42 111.428 -162.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.67 137.29 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.09 -1.078 . . . . 75.42 108.09 172.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.471 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 21.4 p90 -160.96 165.97 29.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.453 0.701 . . . . 75.4 110.996 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -100.24 117.57 34.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.651 -0.87 . . . . 43.53 108.651 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -77.83 -26.69 49.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.382 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.35 142.39 16.93 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 123.912 0.757 . . . . 70.31 109.223 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 95.9 mt -134.75 142.38 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 106.612 -1.625 . . . . 74.23 106.612 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -155.14 114.0 3.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.413 0.446 . . . . 72.3 110.045 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -109.08 117.89 35.36 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 106.766 -1.568 . . . . 73.53 106.766 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.81 137.1 52.44 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.273 -0.64 . . . . 65.03 109.273 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.45 72.2 12.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.818 -1.549 . . . . 75.24 106.818 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.16 -30.98 37.27 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.772 2.315 . . . . 64.24 111.577 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.04 28.31 8.62 Favored 'General case' 0 C--O 1.213 -0.842 0 C-N-CA 124.207 1.003 . . . . 73.51 108.381 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -50.29 -53.5 43.9 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.272 -0.871 . . . . 64.12 112.486 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 16.0 Cg_exo -66.63 -17.53 52.86 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 121.882 1.721 . . . . 74.42 112.696 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -95.9 -29.16 14.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 74.23 111.285 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -82.94 -25.39 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.791 0.436 . . . . 74.12 111.652 -172.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -72.49 -9.6 58.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.516 0.726 . . . . 73.21 112.277 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -102.71 -10.78 18.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.651 0.78 . . . . 64.51 111.472 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -77.73 165.44 24.2 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.152 0.581 . . . . 62.42 111.965 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.74 145.15 55.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.376 1.07 . . . . 72.52 110.922 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -81.13 90.3 6.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.516 0.726 . . . . 75.35 110.183 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tp60 -141.8 50.04 1.62 Allowed Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 114.729 -1.123 . . . . 71.11 109.261 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' N ' ' A' ' 37' ' ' GLN . 6.9 Cg_exo -74.99 96.43 1.02 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 122.539 2.159 . . . . 73.21 111.624 -172.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.14 98.0 10.67 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.279 -1.008 . . . . 71.25 108.279 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 65' ' ' THR . 2.6 p -93.33 104.94 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 114.055 -1.429 . . . . 72.53 110.616 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -83.17 137.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.007 1.323 . . . . 74.24 110.15 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 tt -105.72 127.56 53.15 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.122 -1.066 . . . . 75.13 108.122 174.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.732 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.8 m-20 -120.34 144.21 47.98 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.095 -1.076 . . . . 73.34 108.095 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.541 HD13 HD11 ' A' ' 60' ' ' LEU . 27.1 tp -139.31 124.61 19.1 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.73 -0.47 . . . . 74.44 109.73 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.3 m-20 -119.3 127.09 52.88 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.763 0.825 . . . . 74.12 109.042 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -106.33 121.42 44.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.053 0.941 . . . . 71.21 109.485 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.88 147.08 38.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.975 0.91 . . . . 72.31 109.544 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -133.08 168.57 18.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.693 0.797 . . . . 70.2 110.271 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -161.71 154.44 20.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.385 1.074 . . . . 74.42 109.506 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -111.25 121.87 46.38 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.152 -1.055 . . . . 54.21 108.152 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 57' ' ' GLU . 26.9 mt -97.43 -33.88 11.23 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.338 0.655 . . . . 74.22 110.599 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.14 -173.13 3.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.266 0.626 . . . . 72.23 110.729 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.04 112.35 3.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.229 1.012 . . . . 70.34 110.093 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' SER . 62.0 m-20 70.45 1.69 3.74 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.579 1.552 . . . . 75.53 113.323 -175.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -100.86 115.82 43.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.508 0.723 . . . . 64.32 109.382 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -131.64 124.76 30.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.4 tt0 -95.59 116.54 28.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.261 1.025 . . . . 73.41 109.408 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.1 124.11 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.418 -1.327 . . . . 75.34 107.418 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 t -112.7 129.84 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.595 0.758 . . . . 71.45 109.195 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.541 HD11 HD13 ' A' ' 44' ' ' LEU . 3.9 mm? -120.86 104.27 9.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.708 1.203 . . . . 73.22 108.443 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 30.4 ttp180 -84.49 104.55 14.59 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.743 -0.836 . . . . 74.2 108.743 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.9 120.48 43.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.393 -1.336 . . . . 74.0 107.393 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.732 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 36.9 m -122.07 130.6 53.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.225 -0.657 . . . . 71.52 109.225 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -123.47 116.46 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 124.932 1.293 . . . . 73.54 108.777 -174.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.9 m -118.61 130.15 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.249 0.477 . . . . 74.02 110.12 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.36 130.28 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.556 -0.905 . . . . 71.44 108.556 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.9 m -127.35 126.82 43.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.125 0.57 . . . . 74.4 109.704 176.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.664 HD13 ' HB1' ' A' ' 73' ' ' ALA . 11.0 mp -88.65 85.89 6.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.97 -1.122 . . . . 74.21 107.97 174.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.94 -88.29 1.17 Allowed Glycine 0 C--N 1.346 1.091 0 CA-C-N 114.924 -1.034 . . . . 52.41 111.488 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.21 -27.78 7.16 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.472 0.709 . . . . 73.13 111.357 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -102.75 132.93 48.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.188 0.595 . . . . 72.14 110.629 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 47.2 m -69.03 130.61 43.24 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.077 0.951 . . . . 74.32 111.315 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.664 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -74.63 -61.51 1.85 Allowed 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.998 0.919 . . . . 74.51 109.504 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -152.9 163.26 40.12 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.564 -1.198 . . . . 73.25 111.38 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 tp -130.67 137.5 49.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.149 -1.387 . . . . 75.11 107.274 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.2 m -137.03 98.99 3.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.557 0.743 . . . . 75.43 109.306 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -119.13 117.83 29.75 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.23 -1.026 . . . . 73.12 108.23 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.54 109.22 15.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.985 0.914 . . . . 72.41 109.148 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -84.59 81.24 8.94 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.593 -1.262 . . . . 75.13 107.593 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.63 93.56 3.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.718 -0.845 . . . . 74.43 108.718 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.16 147.26 21.56 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.073 -0.811 . . . . 71.45 111.073 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.618 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.68 122.97 1.41 Allowed Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 111.783 -0.527 . . . . 60.34 111.783 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.79 125.62 39.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.233 -0.654 . . . . 71.43 109.233 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.627 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.0 m-85 -132.17 148.76 52.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.767 -1.197 . . . . 74.41 107.767 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 41.9 t -102.51 110.84 22.9 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.425 -0.954 . . . . 71.33 108.425 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.545 HG21 ' HG2' ' A' ' 94' ' ' MET . 4.2 mp -112.95 125.27 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.97 44.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.559 0.744 . . . . 60.53 109.644 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.26 -32.55 7.34 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 123.72 0.637 . . . . 73.41 113.667 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.444 ' H ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.82 147.75 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.435 0.694 . . . . 73.25 110.287 -175.135 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -138.82 -179.08 5.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.706 0.802 . . . . 74.34 109.38 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.61 -132.88 32.35 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 119.623 -0.543 . . . . 62.24 112.897 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 18.6 p -74.96 -17.54 60.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.64 0.776 . . . . 71.41 111.977 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -72.01 -42.67 66.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.999 0.52 . . . . 73.14 109.668 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' MET . . . . . 0.545 ' HG2' HG21 ' A' ' 86' ' ' ILE . 1.1 tmt? -81.7 -24.84 35.94 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.637 0.775 . . . . 74.53 110.043 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.488 ' HB2' ' HA ' ' A' ' 92' ' ' THR . . . -68.65 -37.18 79.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.368 0.667 . . . . 64.23 110.135 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.71 -34.47 77.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.357 0.663 . . . . 74.13 110.11 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.5 t -67.89 -42.42 81.24 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.016 -0.538 . . . . 64.24 110.999 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.0 mt -86.15 -29.19 23.46 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.912 0.708 . . . . 72.41 112.912 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.78 3.89 34.2 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.597 0.599 . . . . 54.02 114.597 -170.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -51.22 0.16 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.42 0.61 . . . . 74.23 111.745 -174.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -79.46 -66.84 0.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.445 1.098 . . . . 74.2 112.23 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' CYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 67.2 m -70.72 -32.17 2.42 Favored Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 114.78 1.4 . . . . 72.21 114.78 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 36.3 Cg_endo -63.99 -20.66 68.13 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 122.055 1.77 . . . . 72.51 112.775 171.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -76.14 -17.75 59.43 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.227 0.611 . . . . 74.04 109.981 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 13' ' ' ILE . 42.2 mm -75.41 -39.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.961 -0.755 . . . . 72.52 108.961 170.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.618 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.5 mt -78.47 -33.02 48.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.953 0.901 . . . . 74.32 112.959 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -62.16 -43.75 86.88 Favored Pre-proline 0 CA--C 1.572 1.789 0 N-CA-C 113.758 1.022 . . . . 75.24 113.758 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.53 -28.08 22.01 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.113 1.875 . . . . 75.02 113.157 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -76.02 -34.56 59.68 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.084 0.553 . . . . 75.51 111.156 175.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.27 78.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.111 -0.699 . . . . 53.13 109.111 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.426 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.7 ttm180 -55.18 -49.86 70.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.594 1.184 . . . . 75.1 109.845 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.266 0.979 . . . . 73.45 110.738 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 28.3 t -59.51 -44.25 93.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.386 0.674 . . . . 74.23 110.558 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.41 -54.13 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.818 0.847 . . . . 65.44 109.965 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.416 HG23 ' HG3' ' A' ' 125' ' ' GLN . 58.2 m -55.22 -39.77 70.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.126 0.97 . . . . 75.15 111.212 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -64.22 -51.35 64.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.824 -1.08 . . . . 63.31 109.793 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.478 ' SD ' HG22 ' A' ' 21' ' ' ILE . 16.0 mtp -56.83 -44.49 82.12 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.376 1.07 . . . . 73.1 111.646 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.5 -45.82 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.324 1.05 . . . . 74.24 110.436 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.4 t -68.77 -31.68 70.88 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.402 -0.817 . . . . 72.44 110.881 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -70.63 -31.98 69.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.807 0.843 . . . . 74.51 110.11 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.68 2.68 78.11 Favored Glycine 0 C--N 1.355 1.629 0 O-C-N 123.858 0.724 . . . . 60.33 113.181 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m 65.69 32.86 8.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.824 1.25 . . . . 73.54 111.159 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -101.09 140.63 21.45 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 106.723 -1.584 . . . . 72.33 106.723 168.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -56.94 149.79 59.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.562 2.174 . . . . 53.21 111.672 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.416 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.5 tt0 -51.53 136.47 26.18 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.349 1.03 . . . . 74.34 113.202 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.552 HD21 HG12 ' A' ' 64' ' ' VAL . 10.3 tp -125.69 120.65 31.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.306 -1.315 . . . . 75.01 108.064 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.01 120.18 32.58 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.44 -0.948 . . . . 71.23 108.44 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.06 118.32 15.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.935 -0.765 . . . . 74.31 108.935 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.66 139.67 59.76 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 124.209 1.004 . . . . 75.42 111.98 -174.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . 0.438 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 4.6 Cg_exo -72.25 110.17 2.89 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.835 1.69 . . . . 74.31 110.208 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.84 123.75 52.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -65.54 97.3 0.3 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.409 1.084 . . . . 64.2 110.835 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.2 -50.27 6.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.256 0.623 . . . . 74.31 109.556 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 11.0 p-10 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 124.704 1.201 . . . . 74.53 111.312 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' THR . . . . . 0.659 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 39.2 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.694 -0.484 . . . . 73.45 109.694 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -134.7 139.89 45.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.724 -1.213 . . . . 74.45 107.724 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' GLN . . . . . 0.437 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 2.7 pp0? -163.39 139.61 6.93 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.057 -0.72 . . . . 72.31 109.057 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ILE . . . . . 0.607 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -91.79 134.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.378 -0.971 . . . . 65.21 108.378 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -97.97 -52.67 3.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.164 0.586 . . . . 73.22 110.566 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -151.3 134.52 16.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.609 -0.269 . . . . 75.13 110.45 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' ILE . . . . . 0.607 HG13 HD11 ' B' ' 13' ' ' ILE . 98.5 mt -114.4 136.12 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.072 -1.455 . . . . 73.43 107.072 167.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' TYR . . . . . 0.451 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.2 p90 -166.21 144.98 5.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.943 0.497 . . . . 75.3 110.882 -172.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.5 m -76.67 120.52 21.97 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.484 -0.78 . . . . 72.33 109.295 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 44.5 mtpt -92.1 -30.82 15.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.451 0.7 . . . . 74.11 111.34 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.6 142.18 17.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.59 0.233 . . . . 75.02 110.636 -173.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mm -141.1 139.35 33.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.633 1.573 . . . . 74.52 108.02 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -143.0 130.61 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.486 -1.302 . . . . 71.24 107.486 172.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 79.2 t80 -137.45 119.23 15.13 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.708 -1.589 . . . . 75.33 106.708 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -117.38 122.49 43.98 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.402 -0.962 . . . . 75.14 108.402 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.49 79.84 21.74 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 107.302 -1.369 . . . . 73.14 107.302 165.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.26 -18.25 34.76 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.207 1.938 . . . . 62.15 110.419 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -111.59 15.67 21.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.984 1.314 . . . . 73.31 110.821 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.1 -54.5 7.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 N-CA-C 114.396 1.258 . . . . 75.32 114.396 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' PRO . . . . . 0.543 ' HG2' ' HD1' ' B' ' 30' ' ' HIS . 95.0 Cg_endo -78.76 -31.75 2.32 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 121.765 1.643 . . . . 74.32 113.274 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' HIS . . . . . 0.543 ' HD1' ' HG2' ' B' ' 29' ' ' PRO . 77.0 m80 -92.35 4.11 54.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.096 0.959 . . . . 74.13 113.303 -169.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 7.7 p -79.06 -6.96 10.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 C-N-CA 123.516 0.726 . . . . 72.44 110.061 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.14 -33.04 74.57 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.797 0.439 . . . . 71.43 111.141 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -76.03 -41.85 49.66 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.358 0.663 . . . . 72.22 109.931 175.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' LYS . . . . . 0.616 ' HB3' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -108.42 64.34 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.584 1.154 . . . . 75.32 109.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 31' ' ' VAL . 13.6 t70 -118.82 118.55 31.88 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.565 -0.531 . . . . 73.34 109.565 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -179.81 179.43 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.029 1.732 . . . . 73.34 107.883 155.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -47.35 106.43 0.59 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.011 0.925 . . . . 74.2 110.92 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.23 169.1 7.42 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.723 2.282 . . . . 73.5 110.667 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.26 100.69 3.19 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 106.907 -1.516 . . . . 73.21 106.907 170.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.25 126.66 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.68 -1.145 . . . . 72.23 109.401 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -128.05 135.09 49.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.738 0.815 . . . . 74.31 109.477 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.41 151.79 19.6 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.337 -0.986 . . . . 73.2 108.337 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -148.2 109.9 4.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.419 -1.326 . . . . 75.01 107.419 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mp -103.72 129.63 51.11 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.136 0.574 . . . . 75.21 109.478 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ASP . . . . . 0.522 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.2 t70 -122.62 149.92 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.335 1.054 . . . . 74.21 110.192 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -118.07 128.57 54.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.631 -1.168 . . . . 74.22 109.438 -170.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.13 126.74 15.14 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.038 0.535 . . . . 72.04 110.175 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 56.5 p -136.49 160.78 37.75 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.348 . . . . 72.43 110.795 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -157.64 137.66 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.723 -0.671 . . . . 63.54 110.045 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.93 114.69 20.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.197 0.599 . . . . 75.12 110.263 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 23.5 mt -88.41 -34.55 17.5 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.603 0.761 . . . . 75.1 110.461 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.83 -167.93 1.5 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.654 0.782 . . . . 73.4 110.573 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.86 106.24 0.98 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.576 -1.193 . . . . 65.24 110.166 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.29 9.16 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.954 1.301 . . . . 72.3 113.044 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -103.89 108.46 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.262 -1.014 . . . . 71.32 108.262 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.14 140.13 51.55 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.168 0.987 . . . . 74.53 109.239 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -103.6 99.96 9.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.234 -1.024 . . . . 74.23 108.234 -174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 77.0 t -88.68 125.93 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.354 1.462 . . . . 74.03 109.925 -175.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.3 t -118.7 131.26 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.874 0.869 . . . . 74.14 109.543 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.33 108.12 18.09 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.762 -1.199 . . . . 74.14 107.762 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.5 ttm180 -88.21 113.79 24.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.622 -0.881 . . . . 72.43 108.622 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.7 104.17 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.891 -1.151 . . . . 72.43 107.891 169.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -98.7 132.99 43.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.589 -0.522 . . . . 74.31 109.589 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -122.09 120.22 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.347 1.059 . . . . 72.43 108.933 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -115.11 143.03 45.84 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.354 0.661 . . . . 70.42 109.305 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.3 136.58 38.14 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.75 -0.833 . . . . 74.34 108.75 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 52.1 p -147.1 139.01 24.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.879 0.472 . . . . 75.41 110.672 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -136.45 139.67 42.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.905 1.282 . . . . 73.51 108.615 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.09 -115.95 6.84 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.016 -0.834 . . . . 72.44 111.016 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -122.94 3.01 9.41 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.061 0.944 . . . . 72.13 108.853 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.1 168.96 9.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.338 0.59 . . . . 74.32 111.342 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 14.8 m -71.04 143.77 50.61 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.651 -1.158 . . . . 74.14 111.028 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 73' ' ' ALA . . . . . 0.592 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -95.32 -60.02 1.76 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.27 -1.011 . . . . 64.05 108.27 169.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -164.68 155.52 14.76 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.339 -1.3 . . . . 74.14 108.401 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 62.9 mt -128.23 136.52 51.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.663 -1.236 . . . . 74.35 107.663 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -148.69 152.71 37.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.235 0.614 . . . . 75.13 109.357 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -160.39 129.19 4.84 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.952 -1.129 . . . . 72.13 107.952 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -124.04 142.37 41.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.676 -0.861 . . . . 73.43 108.676 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -125.32 93.23 3.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.138 -1.06 . . . . 73.24 108.138 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 80' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -83.52 102.8 12.37 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.23 -1.026 . . . . 70.34 108.23 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.29 166.85 35.25 Favored Glycine 0 C--O 1.244 0.724 0 N-CA-C 111.02 -0.832 . . . . 70.54 111.02 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.33 126.91 1.57 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.15 -0.78 . . . . 71.23 111.15 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.451 HG13 ' HE1' ' B' ' 17' ' ' TYR . 69.1 mt -83.68 118.51 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.67 -1.233 . . . . 64.35 107.67 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -124.34 166.84 15.23 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.358 1.063 . . . . 72.42 108.68 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 85' ' ' SER . . . . . 0.437 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 40.9 m -130.53 112.69 13.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.466 -0.939 . . . . 64.14 108.466 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 86' ' ' ILE . . . . . 0.631 ' HB ' HD13 ' B' ' 89' ' ' ILE . 2.6 pp -117.36 133.77 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.985 0.914 . . . . 75.14 109.743 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 87' ' ' ALA . . . . . 0.659 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -155.37 158.35 38.54 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.107 0.963 . . . . 61.41 109.399 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.71 3.11 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.302 -0.408 . . . . 73.44 112.526 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 89' ' ' ILE . . . . . 0.631 HD13 ' HB ' ' B' ' 86' ' ' ILE . 20.5 pt -68.5 150.12 10.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 123.041 0.536 . . . . 64.43 110.297 169.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 90' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 39.8 tt0 -164.31 146.32 8.74 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.537 -0.756 . . . . 63.1 109.818 -174.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.76 -103.75 1.5 Allowed Glycine 0 C--N 1.349 1.298 0 O-C-N 123.332 0.395 . . . . 45.21 113.109 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.4 m -88.3 -29.28 20.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.486 0.714 . . . . 72.45 110.947 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 93' ' ' GLN . . . . . 0.437 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 47.9 mt-30 -58.66 -45.21 89.85 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.787 0.835 . . . . 74.4 110.986 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 94' ' ' MET . . . . . 0.605 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.8 ptt? -65.1 -39.56 93.33 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.214 -0.903 . . . . 72.31 110.864 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.33 82.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.738 0.815 . . . . 75.33 110.884 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -76.57 -33.56 58.48 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.591 0.757 . . . . 64.43 110.837 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -62.46 -63.11 1.33 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.89 0.476 . . . . 75.02 110.531 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' B' ' 102' ' ' CYS . 0.3 OUTLIER -81.86 -3.43 54.08 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.102 0.408 . . . . 71.25 112.102 177.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.21 -1.78 56.9 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 119.648 -0.529 . . . . 73.35 113.49 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.26 0.18 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.477 0.639 . . . . 64.13 111.585 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -72.02 -55.54 7.22 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.377 0.671 . . . . 72.43 111.547 -170.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' B' ' 98' ' ' LEU . 58.9 m -65.43 -37.65 21.09 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 123.875 0.87 . . . . 74.44 112.583 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -49.6 -48.79 17.72 Favored 'Trans proline' 0 C--N 1.397 3.117 0 C-N-CA 122.885 2.39 . . . . 74.02 113.052 164.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -64.89 -15.89 62.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 112.52 0.563 . . . . 74.24 112.52 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -80.02 -49.86 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.92 0.488 . . . . 73.2 110.264 171.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.15 -19.52 39.8 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.396 0.678 . . . . 63.51 112.784 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 84.3 t80 -66.49 -45.53 58.34 Favored Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.54 1.136 . . . . 72.33 113.423 -172.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.6 Cg_endo -57.58 -35.7 98.77 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 122.105 1.87 . . . . 75.14 113.256 176.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' TYR . . . . . 0.402 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.9 m-85 -68.05 -45.13 74.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.292 0.637 . . . . 73.05 110.418 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.57 84.47 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.925 -0.58 . . . . 71.43 110.813 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -59.84 -57.55 12.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.482 1.113 . . . . 72.12 110.254 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -31.69 71.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.697 0.799 . . . . 62.31 110.831 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 113' ' ' CYS . . . . . 0.461 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.2 t -72.04 -43.56 64.77 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.931 0.492 . . . . 75.1 111.269 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.99 -44.74 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.347 0.659 . . . . 74.14 109.671 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -61.56 -30.83 70.91 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.995 -1.002 . . . . 75.52 111.344 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -73.58 -52.95 11.7 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.317 0.647 . . . . 73.32 110.07 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 117' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 36.4 mmt -59.31 -46.94 87.22 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.903 0.881 . . . . 75.34 111.641 -173.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.65 -34.9 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 74.21 110.879 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t -67.99 -30.76 70.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.357 -0.383 . . . . 74.32 110.74 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -68.76 -18.93 64.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.435 0.694 . . . . 74.42 110.823 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.1 15.71 42.42 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-O 119.533 -0.593 . . . . 74.41 112.488 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 17' ' ' TYR . 57.6 p 62.14 28.8 17.32 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.856 2.063 . . . . 70.25 112.809 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -97.16 150.93 37.36 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.817 0.447 . . . . 73.53 110.938 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.86 -165.06 0.11 Allowed 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 123.751 2.967 . . . . 72.1 113.579 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -63.78 115.79 5.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.753 -0.658 . . . . 75.41 112.565 -170.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -119.43 100.92 7.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.899 -1.148 . . . . 74.53 107.899 168.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.49 135.19 54.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 73.31 109.766 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.09 139.26 33.32 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 124.255 0.972 . . . . 72.24 110.39 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.37 147.26 52.68 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.101 0.961 . . . . 73.22 110.35 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.13 109.37 1.31 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.939 2.426 . . . . 74.4 111.489 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.24 131.5 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.896 0.879 . . . . 72.04 109.897 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -82.12 90.3 6.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.33 0.586 . . . . 71.42 109.771 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.48 1.073 0 CA-C-N 114.993 -1.003 . . . . 75.23 111.363 177.106 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' C' C ' 9' ' ' MET . . . . . 0.561 ' HE3' ' SG ' ' C' ' 97' ' ' CYS . 48.6 ttp . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 113.039 0.755 . . . . 75.43 113.039 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 3.8 m -84.77 85.12 7.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.333 -1.358 . . . . 71.3 107.333 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 11' ' ' PHE . . . . . 0.435 ' HB2' ' HE1' ' C' ' 9' ' ' MET . 59.4 t80 -93.77 120.17 33.69 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.635 -0.712 . . . . 72.23 109.875 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -138.79 142.64 38.75 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.464 0.706 . . . . 74.05 110.144 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -77.96 137.79 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.945 0.778 . . . . 71.34 109.279 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 14' ' ' GLN . . . . . 0.407 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.3 mm100 -101.78 -51.17 3.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.802 -0.444 . . . . 64.32 109.802 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -167.86 124.77 1.12 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.092 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.73 147.14 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -175.15 160.77 2.76 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.142 0.496 . . . . 73.23 110.807 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.8 p -78.87 115.03 18.3 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.005 -0.998 . . . . 75.14 108.534 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -66.6 -43.68 84.17 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.904 0.859 . . . . 71.14 109.415 172.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.1 t70 -150.52 145.94 26.28 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.959 -1.473 . . . . 75.42 109.211 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.2 mt -140.25 141.27 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.6 -1.629 . . . . 65.4 106.6 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.3 t -153.16 150.62 29.24 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.111 0.481 . . . . 75.22 110.116 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -151.14 115.42 5.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.579 -1.267 . . . . 72.13 107.579 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -116.22 116.1 27.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.966 -1.124 . . . . 75.53 107.966 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.19 85.53 5.5 Favored Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.285 -1.376 . . . . 73.01 107.285 170.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.31 -26.11 30.0 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.635 2.223 . . . . 65.24 112.025 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.31 36.83 4.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 124.142 0.977 . . . . 74.52 109.081 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 28' ' ' ALA . . . . . 0.452 ' HB2' ' CE2' ' D' ' 17' ' ' TYR . . . -45.31 -52.77 20.25 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 124.613 1.165 . . . . 73.53 114.012 -177.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.22 -32.81 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 121.563 1.509 . . . . 74.3 113.345 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -70.06 -27.1 64.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.887 0.875 . . . . 74.32 113.071 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.22 -15.15 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.542 0.737 . . . . 73.34 110.271 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.06 -34.9 79.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.102 0.561 . . . . 74.55 111.3 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -89.75 7.49 36.62 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.964 0.906 . . . . 74.12 111.889 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 34' ' ' LYS . . . . . 0.455 ' HD2' HD12 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -98.73 147.25 25.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 75.35 111.202 -171.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.74 131.09 44.9 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.414 1.085 . . . . 60.12 109.832 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -80.06 71.33 6.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.737 0.815 . . . . 75.24 110.786 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -143.98 72.53 16.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 108.179 -1.045 . . . . 71.4 108.179 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 38' ' ' PRO . . . . . 0.624 ' HG2' HG13 ' C' ' 40' ' ' VAL . 69.4 Cg_endo -90.97 155.84 3.94 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.795 2.33 . . . . 75.22 111.18 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -87.1 81.39 8.05 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 106.893 -1.521 . . . . 71.32 106.893 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 40' ' ' VAL . . . . . 0.624 HG13 ' HG2' ' C' ' 38' ' ' PRO . 12.6 m -68.35 123.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 CA-C-N 114.517 -1.219 . . . . 75.11 109.383 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 41' ' ' LYS . . . . . 0.623 ' HB3' ' HZ3' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -136.86 126.73 25.74 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.528 -0.916 . . . . 74.21 108.528 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.56 138.41 31.73 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.121 0.968 . . . . 74.33 108.637 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 43' ' ' ASP . . . . . 0.801 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.2 m-20 -119.01 119.1 33.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.114 0.965 . . . . 73.44 109.177 -175.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.02 125.54 52.6 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.125 -1.065 . . . . 70.52 108.125 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 45' ' ' ASP . . . . . 0.627 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 7.3 t70 -137.12 142.67 42.29 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.698 0.799 . . . . 75.14 109.583 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -115.4 116.73 28.74 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.962 0.905 . . . . 75.51 110.836 -171.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.03 153.01 47.25 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.371 1.068 . . . . 73.34 110.072 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.3 p -166.13 159.05 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.985 0.514 . . . . 74.0 111.732 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -149.88 153.88 37.43 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.556 0.742 . . . . 74.52 111.08 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.2 122.75 33.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 108.991 -0.744 . . . . 73.1 108.991 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 51' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -96.58 -44.17 7.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.717 0.807 . . . . 75.22 110.205 -176.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 52' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -157.94 -165.31 1.71 Allowed 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.139 -0.937 . . . . 75.33 109.952 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -70.4 102.78 2.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.725 0.81 . . . . 74.03 109.601 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 71.62 -3.24 2.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.726 1.61 . . . . 64.43 113.444 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 55' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 95.5 t -92.09 113.48 27.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.242 -1.392 . . . . 74.52 107.242 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.34 149.17 49.36 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.074 0.95 . . . . 72.44 108.945 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 57' ' ' GLU . . . . . 0.585 ' HB2' HD13 ' C' ' 51' ' ' LEU . 45.9 tt0 -104.41 136.23 44.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.112 -0.699 . . . . 71.43 109.112 172.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.43 120.84 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.442 -1.688 . . . . 73.52 106.442 171.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.53 135.56 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.078 0.951 . . . . 73.55 109.048 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 60' ' ' LEU . . . . . 0.425 HD21 HD12 ' C' ' 106' ' ' LEU . 3.8 mm? -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.698 0.799 . . . . 73.45 109.072 172.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 61' ' ' ARG . . . . . 0.627 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 17.2 ttm-85 -81.84 106.15 13.53 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.443 -0.947 . . . . 74.15 108.443 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.85 120.4 59.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.92 -1.141 . . . . 62.43 107.92 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 63' ' ' THR . . . . . 0.801 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 48.0 m -133.26 145.77 50.8 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.242 1.017 . . . . 74.2 108.405 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 64' ' ' VAL . . . . . 0.429 HG22 HD12 ' C' ' 114' ' ' ILE . 98.9 t -127.08 121.23 57.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.9 -0.778 . . . . 72.33 108.9 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -104.58 142.5 34.54 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.007 0.817 . . . . 74.43 109.514 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 100.42 4.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.137 -1.06 . . . . 71.41 108.137 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -139.23 126.59 21.51 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.888 -0.412 . . . . 71.24 109.888 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 68' ' ' LEU . . . . . 0.455 HD12 ' HD2' ' C' ' 34' ' ' LYS . 0.3 OUTLIER -100.82 60.04 0.95 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 122.172 0.987 . . . . 74.24 109.416 176.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -122.05 7.18 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 113.979 -1.464 . . . . 73.31 110.4 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -89.65 -16.96 29.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.498 0.719 . . . . 65.15 109.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -75.92 92.49 3.12 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.249 1.019 . . . . 73.11 109.091 170.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 84.9 m -83.35 121.7 27.49 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 109.036 -0.727 . . . . 73.31 109.036 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.7 -51.48 10.51 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.45 -1.25 . . . . 71.53 109.478 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -161.08 175.64 12.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.663 0.745 . . . . 62.33 110.976 168.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -145.12 144.36 30.87 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.403 -1.702 . . . . 72.13 106.403 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.3 t -146.21 112.03 5.64 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.158 -0.682 . . . . 75.05 109.158 175.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -118.38 117.39 28.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.06 0.544 . . . . 72.2 110.459 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.44 122.01 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.129 0.572 . . . . 73.25 109.554 172.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -99.68 105.04 16.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.956 -1.127 . . . . 75.23 107.956 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.2 112.96 25.05 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.516 0.727 . . . . 72.34 110.234 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.58 161.57 25.06 Favored Glycine 0 C--N 1.337 0.627 0 O-C-N 123.473 0.483 . . . . 73.34 112.782 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.81 120.58 0.98 Allowed Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.253 -0.739 . . . . 73.45 111.253 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 83' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 12.6 mm -84.31 122.76 38.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.207 -1.034 . . . . 73.4 108.207 176.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -133.49 130.59 38.75 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 73.55 109.062 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -85.96 106.58 17.24 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.892 -0.781 . . . . 73.1 108.892 171.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 86' ' ' ILE . . . . . 0.417 HG21 ' SD ' ' C' ' 9' ' ' MET . 66.7 mt -116.32 107.93 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.954 0.902 . . . . 75.43 108.987 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.15 138.32 20.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.786 0.835 . . . . 73.31 109.458 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.33 -47.74 1.0 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.641 0.588 . . . . 75.1 112.366 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.89 172.68 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.147 0.579 . . . . 64.53 111.526 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.28 151.31 17.26 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.594 0.758 . . . . 75.42 110.585 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.11 -112.62 4.47 Favored Glycine 0 C--N 1.356 1.669 0 O-C-N 123.731 0.644 . . . . 64.52 114.191 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.3 p -64.3 -35.03 79.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.982 0.913 . . . . 71.24 111.842 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -77.86 -35.69 50.69 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.914 -0.585 . . . . 74.0 111.41 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -70.66 -23.66 62.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 110.333 -0.247 . . . . 72.41 110.333 175.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.75 92.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.762 0.425 . . . . 73.21 110.878 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 96' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 57.3 t-80 -73.7 -32.45 63.93 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 116.203 -0.453 . . . . 65.31 111.305 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 97' ' ' CYS . . . . . 0.561 ' SG ' ' HE3' ' C' ' 9' ' ' MET . 52.4 t -81.81 -62.55 1.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.157 0.503 . . . . 72.11 110.628 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.42 -43.83 96.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.484 1.113 . . . . 72.41 111.817 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.57 5.27 82.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.295 -0.725 . . . . 72.12 114.876 -172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 100' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -149.39 -56.35 0.19 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.306 1.053 . . . . 73.42 112.908 -173.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 101' ' ' TYR . . . . . 0.438 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 89.3 t80 -71.13 -49.43 44.14 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.349 1.06 . . . . 75.44 111.543 -173.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.53 -44.42 65.83 Favored Pre-proline 0 CA--C 1.571 1.788 0 C-N-CA 124.144 0.977 . . . . 65.23 112.249 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.06 -40.64 67.73 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.948 2.432 . . . . 70.4 114.196 169.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -64.14 -31.64 72.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.787 0.679 . . . . 63.22 110.825 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 105' ' ' ILE . . . . . 0.426 HG23 ' NH1' ' A' ' 111' ' ' ARG . 39.9 mm -68.2 -41.55 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.82 0.448 . . . . 75.53 110.856 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 106' ' ' LEU . . . . . 0.425 HD12 HD21 ' C' ' 60' ' ' LEU . 86.4 mt -88.88 -22.22 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.701 0.8 . . . . 54.41 113.014 -172.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -56.36 -48.54 96.79 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 113.947 1.092 . . . . 74.54 113.947 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.8 -33.27 76.6 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 121.912 1.741 . . . . 71.13 113.64 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -48.04 69.4 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.432 0.693 . . . . 73.34 110.359 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.36 81.25 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.948 -1.023 . . . . 71.05 110.597 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.48 -52.47 64.6 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.938 -1.483 . . . . 75.45 112.003 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -33.27 73.91 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.607 0.363 . . . . 74.42 110.568 -173.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.46 -29.44 66.0 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 122.999 0.519 . . . . 75.43 110.839 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 114' ' ' ILE . . . . . 0.429 HD12 HG22 ' C' ' 64' ' ' VAL . 73.3 mt -72.04 -44.16 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.599 0.76 . . . . 74.24 109.768 170.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -64.34 -30.13 71.18 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.47 0.708 . . . . 72.21 111.174 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.9 t -71.76 -49.57 37.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.824 0.85 . . . . 74.1 109.002 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.0 -39.88 94.12 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.097 0.959 . . . . 74.05 113.041 -175.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.7 -34.78 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 109.944 -0.391 . . . . 74.53 109.944 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -72.71 -32.07 65.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.559 0.744 . . . . 62.02 111.587 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -68.16 -26.76 65.92 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.21 0.604 . . . . 75.42 110.42 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 11.52 68.35 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 119.246 -0.752 . . . . 74.03 113.271 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 122' ' ' THR . . . . . 0.523 HG22 ' HB3' ' D' ' 17' ' ' TYR . 52.7 p 58.76 26.86 15.21 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.91 1.684 . . . . 71.51 112.82 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -102.05 151.64 38.07 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.706 0.802 . . . . 75.31 109.922 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -59.87 121.55 10.01 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.016 2.477 . . . . 71.53 113.108 -171.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -60.33 146.37 44.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.111 0.882 . . . . 73.43 112.496 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -141.66 127.58 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 108.316 -0.994 . . . . 65.4 108.316 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.13 114.88 25.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.587 -1.264 . . . . 70.24 107.587 172.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 29.9 tp -64.86 129.01 38.14 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.86 0.725 . . . . 74.04 110.532 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.2 151.09 97.46 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.98 1.312 . . . . 74.11 112.039 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 130' ' ' PRO . . . . . 0.442 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.1 Cg_exo -64.02 109.88 1.21 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.979 2.453 . . . . 74.44 112.28 -177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.16 108.67 21.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.619 -1.252 . . . . 72.51 107.619 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -82.23 101.39 10.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.557 -0.747 . . . . 75.23 110.239 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -80.02 -38.46 31.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.332 -0.988 . . . . 73.42 108.332 168.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' C' C ' 134' ' ' ASP . . . . . 0.547 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.1 p-10 . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 126.118 1.767 . . . . 65.12 112.856 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.245 0.863 0 CA-C-O 121.301 0.572 . . . . 72.1 109.611 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -143.87 112.11 6.34 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.233 -1.025 . . . . 61.32 108.233 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 12' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 71.3 mt-30 -131.59 154.54 48.76 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.467 -0.938 . . . . 75.32 108.467 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 13' ' ' ILE . . . . . 0.407 HD11 HG21 ' D' ' 105' ' ' ILE . 35.6 mt -104.02 132.94 49.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.913 -1.143 . . . . 74.45 107.913 168.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.36 -48.14 8.23 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.627 -0.509 . . . . 75.03 109.627 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -155.64 148.29 24.08 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.32 0.648 . . . . 75.31 109.873 -176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 16' ' ' ILE . . . . . 0.414 ' H ' HD12 ' D' ' 16' ' ' ILE . 0.2 OUTLIER -124.05 111.21 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.345 -1.354 . . . . 71.21 107.345 168.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 17' ' ' TYR . . . . . 0.523 ' HB3' HG22 ' C' ' 122' ' ' THR . 31.8 p90 -140.56 170.2 16.23 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.82 0.819 . . . . 73.51 111.764 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.4 p -101.2 121.31 41.61 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.556 -1.202 . . . . 65.03 108.883 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -88.23 -30.62 19.56 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.984 0.513 . . . . 73.43 110.346 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 20' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.6 t70 -152.86 127.02 9.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.142 -0.935 . . . . 73.22 108.573 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE1' ' C' ' 117' ' ' MET . 82.7 mt -123.93 144.07 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.335 -1.357 . . . . 72.03 107.335 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -152.49 110.67 3.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 124.188 0.93 . . . . 71.32 109.494 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 75.1 t80 -108.39 128.75 55.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.109 -1.812 . . . . 73.12 106.109 162.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -123.86 151.01 43.91 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.851 -0.796 . . . . 75.03 108.851 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 25' ' ' ALA . . . . . 0.506 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -132.82 76.59 70.55 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 106.616 -1.624 . . . . 74.21 106.616 170.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.5 -45.23 31.47 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.561 2.841 . . . . 73.14 113.113 -166.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 27' ' ' ASN . . . . . 0.455 ' HB2' HG22 ' D' ' 31' ' ' VAL . 20.3 m-80 -114.59 25.99 10.57 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.232 -0.895 . . . . 74.12 110.101 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 28' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -39.01 -60.02 1.27 Allowed Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 115.798 1.777 . . . . 72.24 115.798 -163.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 29' ' ' PRO . . . . . 0.446 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 31.3 Cg_endo -81.94 -14.47 9.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 CA-C-N 122.282 1.851 . . . . 74.44 113.542 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.02 -38.77 69.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.36 1.064 . . . . 74.33 109.301 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 31' ' ' VAL . . . . . 0.591 HG11 HD11 ' D' ' 68' ' ' LEU . 52.8 t -63.35 -39.04 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.914 0.886 . . . . 62.24 109.991 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 32' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.9 m-30 -60.12 -9.22 2.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.378 1.251 . . . . 74.05 114.378 -173.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -77.77 -37.67 48.44 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.974 0.51 . . . . 75.34 111.108 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -132.8 62.83 1.65 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.847 0.859 . . . . 75.3 109.979 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 42.5 t0 -107.79 83.28 1.77 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.847 0.832 . . . . 65.31 110.706 -169.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -126.5 -178.53 4.39 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.713 -1.131 . . . . 71.44 108.062 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pm0 -48.56 100.59 0.24 Allowed Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 123.571 0.749 . . . . 74.13 112.728 -162.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 38' ' ' PRO . . . . . 0.449 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 59.9 Cg_endo -71.62 149.09 54.65 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.601 2.201 . . . . 64.21 111.107 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.63 111.45 4.79 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.873 -1.158 . . . . 73.42 107.873 173.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -103.54 106.27 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.919 0.888 . . . . 74.22 109.164 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -100.95 129.98 46.88 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.069 0.948 . . . . 74.42 109.952 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 tp -97.09 119.53 35.76 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.05 -0.722 . . . . 75.41 109.05 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 43' ' ' ASP . . . . . 0.626 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.2 m-20 -120.32 130.82 54.61 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.782 0.833 . . . . 75.0 109.15 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.02 137.42 47.81 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.831 0.853 . . . . 75.32 109.155 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 45' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 6.3 t70 -135.83 132.27 36.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 44.4 p -104.94 143.61 32.93 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.717 0.807 . . . . 71.25 109.773 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 47' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.18 155.47 36.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.892 0.877 . . . . 71.03 110.025 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 28.6 p -158.99 162.8 36.82 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.219 0.533 . . . . 65.0 111.228 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -150.01 150.02 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.649 -1.16 . . . . 74.4 109.462 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -100.71 122.52 43.49 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.335 -1.358 . . . . 74.42 107.335 159.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 51' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' D' ' 57' ' ' GLU . 23.0 mt -96.3 -26.36 15.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.453 0.701 . . . . 74.2 109.38 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.33 173.46 5.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.758 1.223 . . . . 75.0 109.532 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.93 131.47 46.33 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.623 -0.88 . . . . 73.44 108.623 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 70.15 -2.05 2.23 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.112 1.365 . . . . 61.11 113.086 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.65 116.34 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.35 0.66 . . . . 72.04 109.29 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.01 162.13 31.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.979 -0.749 . . . . 72.51 108.979 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 57' ' ' GLU . . . . . 0.485 ' HB2' HD12 ' D' ' 51' ' ' LEU . 28.4 tt0 -130.42 118.31 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.084 0.954 . . . . 74.51 108.604 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 77.3 t -100.48 113.31 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.387 -1.338 . . . . 75.24 107.387 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 59' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.9 t -107.01 127.72 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.997 -1.112 . . . . 75.55 107.997 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 60' ' ' LEU . . . . . 0.46 ' HB3' HD22 ' D' ' 106' ' ' LEU . 0.9 OUTLIER -128.94 112.65 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.762 -1.199 . . . . 75.42 107.762 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 61' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.3 ttm180 -85.18 118.4 24.71 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.733 0.813 . . . . 75.44 109.459 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.59 122.0 62.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.943 -1.132 . . . . 74.1 107.943 170.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 63' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.4 m -119.36 137.27 53.83 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.561 0.745 . . . . 73.53 109.92 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 71.5 t -128.24 103.73 10.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 C-N-CA 125.146 1.378 . . . . 70.53 107.729 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.2 m -101.91 105.24 16.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.515 0.726 . . . . 70.34 109.454 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 66' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -99.28 128.5 45.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.276 0.63 . . . . 74.05 110.633 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -144.81 126.06 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.174 0.589 . . . . 65.41 110.443 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 68' ' ' LEU . . . . . 0.591 HD11 HG11 ' D' ' 31' ' ' VAL . 3.4 pp -124.96 139.81 53.49 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.723 0.809 . . . . 75.44 111.187 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.57 -111.47 3.34 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 110.479 -1.049 . . . . 33.14 110.479 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 3.35 8.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 75.02 110.446 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.78 167.76 14.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.109 0.564 . . . . 75.23 110.082 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.0 m -84.65 126.47 33.39 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.492 -0.777 . . . . 75.42 110.593 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 73' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -69.7 -64.95 0.78 Allowed 'General case' 0 C--O 1.242 0.668 0 O-C-N 124.259 0.974 . . . . 64.51 109.299 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.1 162.2 39.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.559 -1.201 . . . . 74.31 110.432 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -124.12 141.42 52.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.898 1.279 . . . . 72.03 108.012 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 76' ' ' CYS . . . . . 0.592 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 21.8 t -152.27 109.5 3.55 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.652 -0.499 . . . . 73.23 109.652 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.41 130.65 25.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.404 1.082 . . . . 74.53 108.848 -171.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.68 116.36 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.428 0.691 . . . . 73.53 109.788 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 79' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -88.04 83.93 6.99 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.851 -1.166 . . . . 74.55 107.851 166.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 80' ' ' GLN . . . . . 0.449 ' HB3' HD23 ' D' ' 106' ' ' LEU . 4.4 tp-100 -79.84 114.82 19.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.44 -1.318 . . . . 75.54 107.44 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.16 142.03 16.11 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.194 -0.762 . . . . 73.43 111.194 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.9 5.92 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.058 -0.817 . . . . 73.34 111.058 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.31 126.06 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.062 -1.088 . . . . 72.32 108.062 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -123.65 127.96 48.97 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.593 1.157 . . . . 75.11 109.229 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 85' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 43.8 m -78.63 101.16 7.32 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.301 -1.0 . . . . 73.15 108.301 169.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 86' ' ' ILE . . . . . 0.429 HG21 HD11 ' D' ' 89' ' ' ILE . 61.4 mt -108.59 128.99 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.914 0.886 . . . . 71.4 109.725 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.24 159.15 25.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.973 0.909 . . . . 72.22 110.328 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.79 14.96 78.79 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 115.011 0.765 . . . . 72.14 115.011 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 89' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' D' ' 94' ' ' MET . 18.3 pt -136.67 134.93 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.355 -0.979 . . . . 75.23 108.355 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.98 157.66 45.93 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.949 -0.47 . . . . 73.51 111.202 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -118.51 14.5 Favored Glycine 0 C--N 1.355 1.605 0 O-C-N 124.658 1.224 . . . . 74.43 113.565 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 17.4 m -69.6 -31.36 69.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.738 0.815 . . . . 75.23 111.985 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -72.99 -42.33 63.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.828 0.451 . . . . 73.02 110.871 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 94' ' ' MET . . . . . 0.437 ' HA ' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -72.04 -34.37 68.73 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.234 -0.284 . . . . 70.21 110.234 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.84 92.54 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.782 0.833 . . . . 71.21 110.893 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -67.7 -36.42 80.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 72.53 110.953 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.8 -51.41 34.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.582 0.353 . . . . 73.12 110.85 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.19 -20.48 44.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.649 0.379 . . . . 71.04 111.652 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.39 -2.98 55.59 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.608 -0.551 . . . . 63.21 114.007 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.82 -64.48 0.41 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.69 0.745 . . . . 65.41 111.251 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -64.23 -56.11 16.92 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.812 0.671 . . . . 74.32 112.812 -170.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.3 m -60.2 -45.41 97.76 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.31 1.044 . . . . 74.51 112.417 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.76 -40.2 80.91 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 122.65 2.234 . . . . 74.02 113.254 168.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.33 -22.81 57.35 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.465 0.706 . . . . 71.45 112.406 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 13' ' ' ILE . 29.0 mm -71.74 -42.77 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 122.302 1.048 . . . . 74.35 109.166 169.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 106' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' D' ' 60' ' ' LEU . 8.6 tt -76.55 -27.82 56.06 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 113.562 -1.653 . . . . 74.23 111.171 -173.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.91 -40.83 72.52 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 125.254 1.422 . . . . 74.1 113.905 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.38 -34.42 88.87 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.477 2.118 . . . . 62.2 114.272 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -79.55 -30.9 41.88 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.185 0.594 . . . . 73.02 111.055 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.35 79.14 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.363 -0.606 . . . . 75.12 109.363 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 111' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 25.2 ttp180 -54.52 -55.41 29.42 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.098 -1.41 . . . . 73.34 111.158 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -60.16 -43.93 95.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.027 0.829 . . . . 71.04 111.177 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -63.26 -45.44 91.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.804 0.442 . . . . 74.21 111.318 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 114' ' ' ILE . . . . . 0.579 HG22 ' SG ' ' D' ' 76' ' ' CYS . 69.2 mt -58.06 -59.39 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.877 0.871 . . . . 73.5 110.555 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 94.9 m -51.64 -43.57 62.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.569 1.548 . . . . 71.01 112.426 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.2 t -68.9 -39.33 79.79 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.204 -0.907 . . . . 74.33 110.741 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 117' ' ' MET . . . . . 0.592 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 70.8 mtm -71.33 -32.33 68.44 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.0 0.52 . . . . 70.22 111.721 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 118' ' ' VAL . . . . . 0.401 HG21 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -63.65 -44.98 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 O-C-N 123.683 0.614 . . . . 74.2 109.432 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -73.02 -27.84 62.0 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.171 0.588 . . . . 74.31 111.808 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -73.4 -31.4 63.85 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.6 0.76 . . . . 74.21 110.499 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.94 5.44 75.85 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.599 0.562 . . . . 72.15 111.933 171.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p 61.5 14.67 6.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.128 2.171 . . . . 75.21 113.333 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -80.01 158.81 72.04 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.483 1.113 . . . . 72.43 108.585 169.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -67.42 124.5 12.13 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.746 2.297 . . . . 75.2 111.419 -168.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -53.3 116.8 2.61 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.298 0.999 . . . . 72.32 110.282 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -109.13 131.45 55.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.831 -1.174 . . . . 74.11 107.831 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -107.34 98.2 7.86 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.37 -0.974 . . . . 71.12 108.37 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 128' ' ' LEU . . . . . 0.403 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 65.3 tp -56.73 115.7 2.71 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.874 1.27 . . . . 73.14 111.053 -176.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.13 95.85 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.933 0.893 . . . . 74.52 110.895 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.26 139.05 25.87 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.104 1.869 . . . . 74.41 111.719 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.48 111.27 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.727 -0.842 . . . . 74.31 108.727 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.41 81.39 4.76 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.402 -0.962 . . . . 72.33 108.402 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 31.2 t80 . . . . . 0 C--O 1.241 0.63 0 CA-C-N 114.862 -1.063 . . . . 75.41 111.44 -173.022 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.774 -0.454 . . . . 74.32 109.774 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 t -162.73 50.05 0.17 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.965 -0.754 . . . . 74.42 108.965 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.88 -38.87 76.53 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.084 0.954 . . . . 71.34 111.23 -173.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 55.5 63.07 2.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.546 1.138 . . . . 71.23 110.481 165.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -80.13 80.23 6.58 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.545 0.688 . . . . 73.24 109.894 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -97.53 162.04 13.49 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.842 -1.072 . . . . 74.31 108.282 173.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 p -72.93 8.31 1.61 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.976 0.91 . . . . 74.45 112.277 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.69 -175.21 0.37 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.14 0.976 . . . . 73.11 110.29 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.9 mtm 72.95 145.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.531 1.132 . . . . 75.44 111.56 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.3 m -142.47 142.33 32.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.675 0.79 . . . . 74.14 109.098 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.531 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -138.47 132.28 31.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.199 1.0 . . . . 75.25 109.76 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -153.56 109.11 3.23 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.153 0.581 . . . . 71.41 109.764 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.584 HG12 ' HD2' ' A' ' 84' ' ' PHE . 45.5 mt -75.06 122.92 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.294 -0.632 . . . . 73.13 109.294 177.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -93.57 -35.34 12.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.598 0.561 . . . . 72.42 110.677 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -169.23 140.29 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.658 -0.246 . . . . 75.23 110.356 -170.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.577 HD13 ' HG3' ' C' ' 130' ' ' PRO . 0.2 OUTLIER -125.95 141.54 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.175 -1.046 . . . . 75.22 108.175 173.389 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.6 p90 -174.16 155.7 2.49 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.926 0.49 . . . . 73.13 111.365 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -78.36 121.29 24.29 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.808 -0.633 . . . . 72.51 109.569 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.412 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.5 mtpt -87.02 -25.2 24.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.625 0.37 . . . . 75.44 110.187 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.2 t70 -151.27 139.31 20.07 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.462 -0.79 . . . . 75.21 109.623 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.425 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.3 mt -131.38 139.47 50.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 106.77 -1.567 . . . . 75.41 106.77 176.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -147.59 127.4 13.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.235 -1.024 . . . . 74.31 108.235 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.2 t80 -135.63 113.12 10.73 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.227 -1.397 . . . . 74.03 107.227 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.82 130.03 55.55 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.797 -0.816 . . . . 72.25 108.797 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -121.1 78.52 33.38 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.222 -1.399 . . . . 62.23 107.222 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.05 -46.77 23.56 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 123.641 2.894 . . . . 71.34 113.272 -164.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.16 41.68 3.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.759 -0.83 . . . . 74.03 108.759 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -45.65 -53.5 19.41 Favored Pre-proline 0 CA--C 1.561 1.379 0 O-C-N 124.199 0.937 . . . . 74.12 112.322 175.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -63.96 -23.84 67.71 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 121.951 1.767 . . . . 72.41 113.173 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -95.35 -21.95 18.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.728 0.811 . . . . 65.41 111.342 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.593 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.2 t -80.79 -32.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.002 0.921 . . . . 72.22 112.424 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.08 -1.47 20.27 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.453 0.701 . . . . 74.51 112.863 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -105.71 -11.3 16.35 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.003 0.921 . . . . 64.24 112.236 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.17 170.96 15.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.567 0.951 . . . . 73.44 113.567 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -61.01 134.36 57.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.766 1.226 . . . . 75.54 110.013 174.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -85.44 62.29 7.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 73.34 111.604 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -146.59 76.73 11.73 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.153 0.981 . . . . 73.15 109.906 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.512 ' HD2' ' HB1' ' E' ' 295' ' ' ALA . 59.4 Cg_endo -75.88 149.14 32.85 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.525 2.15 . . . . 73.03 112.428 163.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.49 102.12 13.81 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.707 -1.219 . . . . 75.42 107.707 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 t -84.92 95.44 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.746 -0.464 . . . . 72.41 109.746 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -85.32 119.74 26.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.087 -0.961 . . . . 74.01 109.605 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.504 HD22 ' HB2' ' E' ' 290' ' ' TRP . 2.1 pt? -97.58 146.18 25.54 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.382 0.61 . . . . 74.43 109.423 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.674 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.9 m-20 -136.84 146.8 46.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.41 1.084 . . . . 75.31 108.531 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 tt -141.32 125.34 17.22 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.715 -1.217 . . . . 71.32 107.715 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.627 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.9 m-20 -116.32 131.95 56.8 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.102 -1.073 . . . . 71.42 108.102 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -106.06 125.02 50.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.812 -1.085 . . . . 72.53 109.085 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.05 126.05 9.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.257 0.623 . . . . 74.34 109.352 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 p -110.57 162.67 14.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.638 0.775 . . . . 74.1 109.21 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.445 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 44.4 t -148.44 153.61 38.75 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.502 0.721 . . . . 71.35 109.665 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.538 ' HB2' ' HE3' ' E' ' 275' ' ' LYS . 45.4 tt0 -104.96 116.44 31.96 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.151 -1.055 . . . . 75.31 108.151 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.5 mt -96.36 -35.78 11.09 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.07 0.462 . . . . 73.14 109.96 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.87 -179.03 7.47 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.164 -0.925 . . . . 73.0 109.653 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.29 121.94 16.37 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.585 -0.895 . . . . 71.42 108.585 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 67.3 8.22 6.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.57 1.148 . . . . 74.22 112.515 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -113.51 106.2 20.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 107.929 -1.137 . . . . 74.04 107.929 174.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.98 125.27 50.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.772 -1.104 . . . . 71.12 108.593 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 34.9 tt0 -91.98 148.95 21.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.346 -0.843 . . . . 62.32 109.315 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.585 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 41.2 t -127.13 130.11 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.58 -1.267 . . . . 74.13 107.58 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.55 131.1 72.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.432 -0.951 . . . . 75.1 108.432 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 103' ' ' PRO . 2.7 mm? -119.52 114.9 22.97 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.842 -1.17 . . . . 74.44 107.842 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.627 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 21.5 ttp180 -85.18 100.35 11.69 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' A' ' 114' ' ' ILE . 10.1 t -93.99 110.1 23.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.522 -1.288 . . . . 71.11 107.522 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -109.12 126.91 53.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.962 -0.755 . . . . 72.54 108.962 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.6 t -116.03 124.17 72.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 106.906 -1.516 . . . . 70.24 106.906 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 2.6 m -127.16 129.65 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.351 -0.611 . . . . 73.11 109.351 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.65 124.16 37.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.814 -0.81 . . . . 74.25 108.814 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.9 m -134.03 127.42 32.23 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.298 0.639 . . . . 73.13 109.938 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.412 HD12 HG22 ' A' ' 31' ' ' VAL . 5.2 mp -87.4 80.66 8.08 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.559 -1.275 . . . . 72.04 107.559 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.44 -83.49 1.32 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.232 -1.349 . . . . 64.22 111.286 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.34 -21.73 10.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 72.43 111.586 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.73 119.32 38.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.53 0.332 . . . . 75.13 111.207 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 25.0 m -70.47 133.24 46.64 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.75 0.648 . . . . 73.22 112.75 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.593 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -81.12 -63.62 1.36 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.885 1.274 . . . . 74.54 109.99 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -153.35 168.82 24.78 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 114.694 -1.139 . . . . 75.44 110.931 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -143.89 107.29 4.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.599 -1.637 . . . . 64.21 107.352 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.456 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.9 m -105.8 97.91 7.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.102 0.561 . . . . 73.55 110.525 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.99 115.48 29.0 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.859 0.863 . . . . 73.41 108.796 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.83 109.89 17.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.656 0.783 . . . . 72.11 109.317 -173.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.0 mt-30 -85.38 86.44 7.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.753 -0.832 . . . . 74.31 108.753 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.49 104.6 9.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.806 -1.088 . . . . 72.44 108.876 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.73 160.11 28.6 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.797 -0.638 . . . . 62.22 112.106 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.02 123.33 1.23 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.115 -0.794 . . . . 45.43 111.115 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.364 0.666 . . . . 75.23 109.463 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.585 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 33.7 m-85 -134.44 118.89 17.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.445 -0.946 . . . . 72.41 108.445 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -83.48 100.69 10.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.77 -0.826 . . . . 72.41 108.77 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.39 140.53 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.328 0.651 . . . . 72.14 110.697 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.16 165.87 30.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.461 1.104 . . . . 63.22 109.534 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.89 86.61 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.086 0.395 . . . . 64.44 114.086 176.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.498 ' H ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -110.1 134.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.236 0.615 . . . . 73.21 109.522 -172.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -146.56 171.68 14.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.581 1.152 . . . . 74.34 108.6 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.44 -129.02 24.53 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 115.404 0.922 . . . . 61.43 115.404 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.538 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 8.9 t -76.44 -15.18 59.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.454 0.702 . . . . 72.24 111.922 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -67.64 -45.21 76.02 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.618 -0.512 . . . . 71.43 109.618 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -27.96 49.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.683 0.393 . . . . 63.3 110.625 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.538 ' HB2' ' HA ' ' A' ' 92' ' ' THR . . . -68.65 -32.01 71.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.293 0.637 . . . . 63.22 111.718 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -87.31 -33.91 19.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.206 0.603 . . . . 74.33 110.209 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -61.65 -45.91 92.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.95 0.5 . . . . 71.4 110.355 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.02 -30.21 18.9 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.487 -0.779 . . . . 71.24 111.176 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.65 -3.27 81.0 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 114.846 0.698 . . . . 71.13 114.846 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.96 -60.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.937 0.868 . . . . 71.34 112.208 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 71.0 t80 -68.89 -70.68 0.26 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 113.101 0.778 . . . . 74.13 113.101 -168.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.454 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 79.3 m -63.71 -33.11 9.17 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.889 1.44 . . . . 64.33 114.889 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.528 ' HA ' HD22 ' A' ' 60' ' ' LEU . 30.0 Cg_endo -62.64 -33.46 77.39 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 121.768 1.645 . . . . 75.41 112.98 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -74.54 -15.92 60.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.185 0.594 . . . . 73.43 111.097 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.72 -40.97 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.46 0.648 . . . . 54.43 109.527 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.97 -17.89 27.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.15 -0.932 . . . . 73.5 112.346 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.32 -45.37 99.09 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.243 -0.884 . . . . 73.22 113.156 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.99 -31.25 76.94 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.202 1.934 . . . . 73.42 113.509 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -76.64 -36.48 57.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.365 0.666 . . . . 72.53 111.911 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.77 77.91 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 109.133 -0.692 . . . . 75.42 109.133 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -52.62 -52.01 57.43 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.742 1.276 . . . . 74.32 109.932 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.81 -48.68 78.05 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.394 1.059 . . . . 75.15 110.601 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.429 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.2 t -57.59 -43.22 84.46 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.77 0.669 . . . . 70.43 111.252 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 118' ' ' VAL . 76.9 mt -62.78 -56.9 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.164 -0.925 . . . . 74.5 109.785 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 89.7 m -50.55 -43.72 56.29 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.595 1.184 . . . . 74.1 111.667 -175.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -62.72 -48.4 79.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.539 -1.209 . . . . 75.34 109.945 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.457 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 36.6 mtm -64.4 -40.41 95.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.163 0.585 . . . . 73.33 111.296 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.5 t -56.46 -48.18 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 123.906 0.754 . . . . 72.14 109.807 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.3 t -73.38 -26.87 61.18 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 114.955 -1.02 . . . . 73.42 111.438 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -73.06 -27.93 62.02 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.619 0.768 . . . . 73.12 110.59 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.86 3.6 74.62 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.779 0.674 . . . . 62.25 112.896 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.3 m 62.1 44.16 8.18 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.077 1.351 . . . . 70.11 110.272 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -116.97 145.42 35.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.201 -1.363 . . . . 75.02 108.068 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.54 131.82 0.39 Allowed 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 124.196 3.264 . . . . 71.43 114.263 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.95 133.6 56.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.033 0.833 . . . . 71.13 110.969 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.501 HD12 ' HH2' ' E' ' 290' ' ' TRP . 50.9 tp -110.06 110.67 21.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.254 -0.647 . . . . 75.33 109.254 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -99.57 108.69 21.16 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.284 -1.376 . . . . 75.54 107.284 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.31 117.43 7.85 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.647 -0.871 . . . . 72.53 108.647 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.95 98.14 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.314 0.646 . . . . 71.35 111.08 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.426 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 76.4 Cg_exo -54.78 109.42 0.4 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.119 2.546 . . . . 73.2 113.484 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.413 HG11 HG13 ' E' ' 288' ' ' VAL . 57.4 t -101.95 112.8 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.035 -1.469 . . . . 75.12 107.035 168.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.441 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 43.3 t30 -81.39 95.03 6.91 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.768 -0.827 . . . . 72.33 108.768 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -57.8 -32.48 67.6 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.735 -1.121 . . . . 72.23 111.45 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.69 -52.6 64.76 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.309 1.005 . . . . 71.23 110.741 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.441 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . . . -62.1 -54.64 38.42 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.118 0.886 . . . . 74.42 111.339 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.56 -32.65 72.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.645 0.378 . . . . 75.35 111.357 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -71.32 -36.44 71.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.277 0.631 . . . . 73.32 109.828 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -38.56 90.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.389 0.676 . . . . 72.11 110.887 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.82 -30.41 61.36 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.105 0.562 . . . . 72.22 110.43 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -85.27 -52.48 5.87 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.03 -0.987 . . . . 75.12 110.923 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.53 -51.02 47.61 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.521 0.934 . . . . 74.22 113.521 -162.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -151.81 -4.16 0.27 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.095 0.405 . . . . 73.1 112.095 -169.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 69.63 123.3 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.556 1.143 . . . . 73.43 111.357 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -137.98 104.75 5.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.173 0.589 . . . . 73.14 110.452 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.611 ' HB1' ' HB2' ' C' ' 5' ' ' ASN . . . -177.35 144.89 0.42 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.908 1.283 . . . . 75.12 109.416 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.6 131.75 2.69 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 119.785 -0.453 . . . . 71.53 112.808 170.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -147.34 146.28 29.62 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.201 1.0 . . . . 54.03 110.497 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -95.25 57.38 1.72 Allowed Glycine 0 C--N 1.352 1.464 0 O-C-N 123.534 0.521 . . . . 62.44 112.939 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 42.9 p -95.53 109.54 21.75 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.305 0.642 . . . . 65.54 109.891 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.91 -49.52 0.09 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.768 0.285 . . . . 71.55 111.768 -174.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.74 145.15 31.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.904 0.881 . . . . 73.12 110.905 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -128.18 155.88 43.79 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.324 1.049 . . . . 74.44 108.93 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.85 105.36 0.45 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.56 0.744 . . . . 71.44 109.505 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.02 154.88 21.02 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.837 0.855 . . . . 74.02 109.753 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 123.678 0.791 . . . . 72.05 108.955 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.472 -0.566 . . . . 75.4 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m 62.65 43.61 7.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.247 1.019 . . . . 75.21 111.37 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -62.79 95.21 0.07 Allowed 'General case' 0 C--N 1.357 0.894 0 N-CA-C 109.612 -0.514 . . . . 71.14 109.612 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -71.59 91.29 1.07 Allowed 'General case' 0 C--N 1.348 0.534 0 CA-C-N 115.267 -0.879 . . . . 73.01 109.666 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -83.55 152.89 24.65 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.897 -1.047 . . . . 73.34 109.588 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -63.57 -37.15 86.23 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.438 0.695 . . . . 74.14 110.165 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 16.3 m -93.34 102.47 14.73 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.033 -0.985 . . . . 74.51 108.868 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.46 100.33 2.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.262 -1.384 . . . . 73.54 107.262 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.5 ptm 51.77 169.7 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.984 2.114 . . . . 71.0 114.378 -173.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 61.8 m -154.5 140.31 18.13 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.047 -1.464 . . . . 74.14 107.047 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.502 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 77.2 t80 -140.88 132.34 26.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.01 -0.737 . . . . 73.03 109.01 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.435 HE21 ' HB2' ' B' ' 85' ' ' SER . 8.6 tt0 -144.07 131.61 21.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.306 -0.998 . . . . 74.44 108.306 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' D' ' 129' ' ' ALA . 13.3 tt -82.02 126.73 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.044 -0.724 . . . . 74.3 109.044 174.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.12 -42.44 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.25 0.62 . . . . 71.2 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -165.01 151.02 10.0 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.466 0.174 . . . . 75.31 110.764 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.71 135.16 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.244 -1.762 . . . . 63.35 106.244 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.441 ' HE1' HG13 ' B' ' 83' ' ' ILE . 7.3 p90 -168.24 146.29 4.29 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.166 0.586 . . . . 75.23 109.962 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.5 m -76.97 122.55 25.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.511 -0.768 . . . . 73.23 108.982 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -98.08 -27.22 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 74.03 111.379 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.7 t70 -158.35 139.69 13.39 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.527 0.517 . . . . 72.41 111.261 -172.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.558 HD13 ' SG ' ' B' ' 113' ' ' CYS . 48.2 mm -140.88 141.86 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.423 1.489 . . . . 74.04 108.001 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -145.78 131.58 19.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.211 -1.403 . . . . 64.41 107.211 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.425 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.5 t80 -145.76 110.28 5.06 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.73 -1.211 . . . . 75.14 107.73 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.42 134.3 54.99 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.803 -0.814 . . . . 74.33 108.803 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.6 81.22 60.5 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 106.419 -1.696 . . . . 62.23 106.419 171.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.69 -32.62 37.5 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.371 2.714 . . . . 74.15 112.469 -171.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.45 31.56 6.66 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.605 1.162 . . . . 72.21 109.855 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.07 -48.4 14.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 115.818 1.784 . . . . 73.44 115.818 -176.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.74 -25.02 4.6 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 121.843 1.696 . . . . 74.33 112.789 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.422 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 72.0 m80 -94.74 -16.19 23.25 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.024 0.75 . . . . 72.11 113.024 -171.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.643 HG23 ' HA ' ' B' ' 73' ' ' ALA . 12.0 p -64.23 -12.75 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.803 0.841 . . . . 75.15 111.96 175.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -56.37 -25.74 50.55 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.013 0.925 . . . . 73.15 112.637 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 24.8 pt20 -71.44 -29.13 64.52 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 73.44 111.108 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.652 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 32.2 mmtp -107.52 80.3 1.39 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.342 1.057 . . . . 74.33 108.691 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.71 109.19 18.54 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.408 -0.815 . . . . 62.44 110.283 -174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.43 ' O ' HD22 ' B' ' 68' ' ' LEU . 0.0 OUTLIER 161.69 -158.91 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.965 2.506 . . . . 74.33 109.262 157.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 15.0 mp0 -49.44 106.99 0.69 Allowed Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 124.679 1.192 . . . . 72.42 111.621 -177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.22 153.07 14.12 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.479 2.119 . . . . 73.23 110.944 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -71.1 102.33 2.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.269 -1.011 . . . . 74.1 108.269 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -88.9 140.61 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.481 -0.933 . . . . 74.43 108.481 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -134.56 125.61 27.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.35 1.06 . . . . 75.31 109.211 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.2 148.0 23.52 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.131 0.972 . . . . 75.04 109.17 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -158.69 112.5 2.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.903 -0.777 . . . . 72.34 108.903 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.18 134.04 43.68 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.127 -0.694 . . . . 75.15 109.127 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.06 142.06 51.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.13 0.972 . . . . 55.31 108.882 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -109.19 117.5 34.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.538 0.735 . . . . 72.41 110.427 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.474 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -124.68 140.25 53.1 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.248 1.019 . . . . 75.21 109.036 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.5 p -145.12 162.89 35.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.848 0.459 . . . . 72.04 111.102 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -158.89 145.81 17.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.301 1.04 . . . . 64.54 109.238 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -96.49 112.05 23.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.527 -0.916 . . . . 74.14 108.527 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.24 -45.12 50.02 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.424 0.69 . . . . 75.43 110.681 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.4 -174.1 4.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.669 -1.151 . . . . 72.32 109.584 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.59 116.92 11.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.353 -0.84 . . . . 73.43 109.065 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 70.6 -2.29 2.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.541 1.536 . . . . 71.14 112.978 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.9 t -104.52 113.52 41.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -117.63 169.16 9.78 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.745 . . . . 73.23 109.31 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.409 ' HG2' HG12 ' B' ' 83' ' ' ILE . 4.7 tm-20 -142.47 105.92 4.64 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.721 -1.214 . . . . 74.43 107.721 -174.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.08 121.15 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.515 1.126 . . . . 54.0 109.434 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.476 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.3 t -106.02 121.74 58.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 124.24 1.016 . . . . 72.31 108.694 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.419 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 2.2 tm? -108.51 114.36 28.13 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.795 -1.187 . . . . 73.41 107.795 175.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -93.38 129.92 39.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.306 -0.861 . . . . 74.43 109.442 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.21 104.27 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.707 -1.22 . . . . 73.42 107.707 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -98.99 131.09 45.3 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.578 -0.527 . . . . 74.03 109.578 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 91.4 t -122.53 122.12 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.41 1.084 . . . . 73.24 108.922 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -115.05 143.71 44.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.625 -0.88 . . . . 72.14 108.625 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.81 142.87 38.7 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.766 -0.827 . . . . 71.31 108.766 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.5 p -161.37 148.02 14.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.826 0.704 . . . . 62.42 111.041 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.652 ' HB2' ' HB3' ' B' ' 34' ' ' LYS . 2.7 mp -123.73 130.78 53.16 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.636 -0.875 . . . . 74.43 108.636 173.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.17 -119.02 7.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.723 -0.951 . . . . 71.01 110.723 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.41 4.93 14.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.046 0.538 . . . . 75.22 110.967 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.23 161.95 18.65 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.572 0.349 . . . . 74.13 110.259 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.8 m -78.53 152.35 32.01 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.112 0.965 . . . . 73.35 111.538 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.643 ' HA ' HG23 ' B' ' 31' ' ' VAL . . . -97.49 -62.21 1.28 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.859 -1.164 . . . . 65.42 107.859 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.97 153.29 22.15 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.439 -1.255 . . . . 73.44 109.657 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.1 mt -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.608 -1.256 . . . . 71.5 107.608 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.45 152.2 33.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.993 0.517 . . . . 70.13 109.811 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -163.39 132.14 3.89 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.384 -0.969 . . . . 73.5 108.384 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.411 HG21 HD12 ' B' ' 21' ' ' ILE . 88.5 t -124.94 146.63 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.558 -0.904 . . . . 74.13 108.558 175.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.527 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.9 mt-30 -124.08 95.39 4.54 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.545 -1.28 . . . . 75.32 107.545 170.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -86.61 102.57 14.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.827 -1.175 . . . . 75.53 107.827 176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.57 159.48 29.5 Favored Glycine 0 C--O 1.242 0.64 0 N-CA-C 110.958 -0.857 . . . . 50.41 110.958 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 125.69 1.55 Allowed Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.025 -0.83 . . . . 73.3 111.025 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.441 HG13 ' HE1' ' B' ' 17' ' ' TYR . 52.3 mt -85.71 131.36 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.89 -1.152 . . . . 74.22 107.89 175.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -139.05 132.84 30.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.43 -0.952 . . . . 74.54 108.43 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.435 ' HB2' HE21 ' B' ' 12' ' ' GLN . 66.1 m -89.8 101.91 14.61 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.422 HG21 ' HA ' ' B' ' 11' ' ' PHE . 15.1 pt -125.69 138.45 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.014 0.926 . . . . 72.21 109.605 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.65 166.54 33.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.566 1.146 . . . . 74.43 108.941 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 -28.16 2.64 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-N 117.569 0.168 . . . . 62.1 113.438 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.596 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 40.6 pt -54.35 135.31 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.322 1.449 . . . . 74.22 111.249 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -151.7 140.65 21.07 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.94 -0.573 . . . . 75.2 110.41 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.96 -110.78 2.11 Favored Glycine 0 C--N 1.355 1.611 0 O-C-N 124.738 1.274 . . . . 71.44 113.402 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' THR . . . . . 0.461 HG22 HD12 ' B' ' 141' ' ' LEU . 63.4 m -66.48 -42.93 86.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.113 0.965 . . . . 63.41 111.196 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -68.88 -31.93 71.22 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.62 0.768 . . . . 71.4 111.137 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.596 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 24.6 ttt -67.28 -57.32 6.89 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 123.512 0.507 . . . . 73.2 110.026 173.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.402 ' HB2' ' HB3' ' H' ' 280' ' ' LEU . . . -57.96 -36.58 72.77 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.438 1.086 . . . . 74.52 111.95 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.85 -31.73 59.46 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.421 0.688 . . . . 65.45 111.188 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.97 -67.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.654 0.264 . . . . 63.53 110.593 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.471 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -83.62 -13.14 54.98 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.831 0.678 . . . . 74.44 112.831 -174.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.16 0.09 41.04 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.178 0.431 . . . . 74.51 114.178 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.587 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -144.24 -54.04 0.34 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 117.244 0.522 . . . . 74.02 110.954 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -71.33 -52.43 18.79 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.688 0.795 . . . . 75.43 111.181 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.502 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 33.4 m -67.03 -45.93 52.89 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 123.872 0.869 . . . . 71.52 112.538 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 84.9 Cg_exo -55.45 -38.25 94.13 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.544 2.163 . . . . 62.21 113.649 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -69.67 -22.41 63.44 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.874 0.734 . . . . 74.41 111.276 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.14 -46.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.172 0.589 . . . . 73.5 109.864 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.83 -26.64 60.7 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.484 -0.78 . . . . 73.54 111.586 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.4 -50.32 88.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.223 1.194 . . . . 73.34 114.223 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.43 -38.48 74.14 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.6 2.2 . . . . 75.53 114.138 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' D' ' 115' ' ' THR . 52.5 m-85 -70.79 -45.08 65.32 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.812 0.845 . . . . 73.04 110.562 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.38 85.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.39 -0.823 . . . . 71.53 110.901 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -63.62 -51.42 65.29 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.269 1.428 . . . . 73.04 110.207 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -68.24 -29.82 68.72 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.75 0.656 . . . . 72.14 110.301 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.558 ' SG ' HD13 ' B' ' 21' ' ' ILE . 3.2 t -67.82 -42.12 82.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.533 0.333 . . . . 74.14 110.427 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 76.5 mt -62.21 -48.18 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.42 0.688 . . . . 65.01 109.623 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 89.3 m -56.67 -34.71 67.64 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.369 1.068 . . . . 65.43 111.599 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.9 t -69.42 -48.19 61.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.289 0.636 . . . . 73.23 110.066 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.496 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -70.47 -33.51 71.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.031 0.532 . . . . 74.4 111.545 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.46 -39.06 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.446 0.698 . . . . 74.22 109.855 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.483 ' OG ' HG21 ' C' ' 115' ' ' THR . 11.9 t -69.93 -27.2 64.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.456 -0.793 . . . . 73.11 111.824 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.5 mtt-85 -76.61 -32.1 57.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.304 0.642 . . . . 72.54 109.84 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.73 0.2 82.71 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.547 0.529 . . . . 73.0 112.259 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 61.4 p 61.38 33.88 18.58 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.675 1.99 . . . . 63.24 112.518 171.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -94.68 155.85 38.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.237 -0.892 . . . . 74.21 109.801 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -55.62 167.02 2.31 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.54 2.827 . . . . 72.12 114.422 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.434 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 5.7 tp60 -59.56 134.03 56.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.835 -1.075 . . . . 74.21 113.413 -172.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.77 96.13 4.9 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.42 -1.263 . . . . 65.23 107.867 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.408 HD21 ' HG3' ' B' ' 125' ' ' GLN . 4.0 p30 -108.28 112.79 25.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.574 -0.899 . . . . 75.03 108.574 172.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.414 HD13 ' H ' ' B' ' 129' ' ' ALA . 20.5 tp -75.18 139.76 42.87 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.001 -0.545 . . . . 74.21 109.828 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.414 ' H ' HD13 ' B' ' 128' ' ' LEU . . . -63.05 148.05 93.33 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.48 1.112 . . . . 71.12 111.619 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.494 ' HG3' HD11 ' D' ' 16' ' ' ILE . 5.5 Cg_exo -71.09 110.41 2.81 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.24 1.96 . . . . 75.13 110.21 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.4 t -99.39 121.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.55 -1.278 . . . . 63.11 107.55 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -74.21 88.69 1.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.357 -0.979 . . . . 72.03 108.357 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -62.38 -32.36 73.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.479 0.712 . . . . 72.51 111.137 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.587 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 24.7 t70 -60.0 -59.05 6.05 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.522 1.129 . . . . 73.33 111.142 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.72 77.11 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.691 0.796 . . . . 54.54 111.203 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 55.1 tp -59.28 -39.36 82.67 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.948 0.899 . . . . 73.45 110.791 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -77.71 -30.23 51.7 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.686 -0.688 . . . . 73.34 110.838 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.2 mtt -62.94 -35.86 81.53 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.819 -0.437 . . . . 74.02 109.819 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.58 -31.94 62.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.158 0.983 . . . . 74.11 110.456 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -62.06 -36.39 81.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.802 0.841 . . . . 73.24 110.146 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.461 HD12 HG22 ' B' ' 92' ' ' THR . 58.1 mt -99.77 22.09 11.53 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.216 1.007 . . . . 75.51 110.914 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 67.84 -79.14 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.859 1.263 . . . . 73.03 109.554 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -153.13 150.41 29.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.646 1.179 . . . . 73.32 109.0 170.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.61 178.99 8.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.529 0.731 . . . . 70.22 110.76 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.11 139.22 30.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.809 0.843 . . . . 63.33 111.342 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.38 43.63 1.0 Allowed Glycine 0 N--CA 1.47 0.924 0 N-CA-C 110.8 -0.92 . . . . 62.42 110.8 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -151.35 137.6 18.43 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.21 1.004 . . . . 74.23 108.447 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.56 169.05 38.45 Favored Glycine 0 C--N 1.347 1.162 0 O-C-N 123.645 0.591 . . . . 71.33 112.522 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 35.2 m -93.75 134.54 35.97 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.653 0.781 . . . . 74.12 109.374 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.36 142.83 48.76 Favored 'General case' 0 C--O 1.24 0.604 0 O-C-N 123.845 0.716 . . . . 74.11 110.944 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -144.37 94.97 2.64 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.836 -1.172 . . . . 64.32 107.836 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -142.41 127.94 19.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.612 0.765 . . . . 60.23 110.715 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.35 154.51 14.5 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.386 -1.339 . . . . 75.25 107.386 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -52.68 124.78 14.69 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.9 0.88 . . . . 73.34 110.955 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.878 0 C-N-CA 123.899 0.88 . . . . 73.35 108.707 177.827 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.427 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.341 -0.615 . . . . 75.21 109.341 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 17.4 t -176.5 88.92 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.626 1.17 . . . . 73.05 108.58 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.96 128.14 3.66 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.522 0.729 . . . . 61.41 109.899 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -87.19 99.89 12.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.061 0.545 . . . . 73.11 110.688 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.611 ' HB2' ' HB1' ' A' ' 145' ' ' ALA . 65.7 t30 -87.18 127.93 35.14 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.674 -0.862 . . . . 74.1 108.674 173.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -154.98 118.78 4.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.513 -0.551 . . . . 74.53 109.513 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 75.3 m 66.25 80.91 0.21 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 122.267 1.032 . . . . 72.4 109.338 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.47 ' HG3' HD22 ' C' ' 5' ' ' ASN . 0.2 OUTLIER -139.36 24.2 2.5 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.786 -1.097 . . . . 71.21 110.145 -168.997 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.419 ' SD ' ' HB2' ' C' ' 97' ' ' CYS . 54.3 ttp 65.83 114.54 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.947 1.299 . . . . 73.3 111.081 -166.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -109.0 99.69 8.98 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.593 -1.262 . . . . 74.32 107.593 173.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -105.76 130.27 53.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.027 -0.988 . . . . 74.3 109.533 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -151.14 139.17 20.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.902 0.881 . . . . 75.4 109.575 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.412 ' O ' HG13 ' G' ' 306' ' ' VAL . 2.8 pp -86.94 142.5 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.661 0.784 . . . . 74.15 110.004 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 75.9 mt-30 -101.56 -49.89 3.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.596 0.358 . . . . 71.31 110.584 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.493 HH12 HD13 ' G' ' 301' ' ' ILE . 57.3 ttt180 -167.79 127.04 1.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.466 0.306 . . . . 74.43 110.824 -173.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -107.89 143.63 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.108 -1.071 . . . . 75.43 108.108 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -172.03 164.07 6.14 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.535 0.683 . . . . 72.41 111.139 -177.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.4 p -85.33 109.69 18.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.382 -0.969 . . . . 75.22 108.382 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -33.12 74.9 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.177 0.513 . . . . 75.23 109.875 173.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.565 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -155.41 150.29 26.54 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.577 -1.192 . . . . 72.3 109.572 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 60.2 mt -138.63 149.09 23.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.506 -1.665 . . . . 71.13 106.506 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 21.2 t -160.67 152.08 19.33 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.332 0.587 . . . . 65.22 110.789 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -147.02 141.86 26.85 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.691 -1.226 . . . . 73.54 107.691 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.589 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 50.2 mt-10 -132.92 150.89 52.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.707 0.803 . . . . 75.42 109.189 170.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.73 80.7 7.38 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 106.957 -1.497 . . . . 72.32 106.957 170.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.07 -35.04 20.99 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.488 2.125 . . . . 75.44 111.741 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.39 32.03 3.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.266 1.027 . . . . 74.01 109.489 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.43 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -59.67 -51.2 82.68 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 114.512 1.301 . . . . 72.31 114.512 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 15.4 Cg_exo -71.46 -35.55 7.99 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 121.627 1.617 . . . . 71.33 111.073 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -62.68 -23.41 67.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.131 1.772 . . . . 75.24 112.85 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.437 HG22 ' HD2' ' C' ' 34' ' ' LYS . 4.0 p -61.28 -20.33 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.03 0.752 . . . . 72.31 113.03 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.52 -40.3 96.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.436 0.695 . . . . 75.44 110.826 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -97.48 23.19 7.92 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.864 0.866 . . . . 74.41 110.461 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.661 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 4.2 ttmp? -109.06 150.28 28.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.071 . . . . 75.45 109.913 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.75 125.96 30.07 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.889 -0.782 . . . . 70.3 108.889 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -84.74 75.59 10.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.331 0.586 . . . . 74.51 109.958 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -162.8 80.05 1.73 Allowed Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 107.895 -1.15 . . . . 73.01 107.895 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -87.65 154.2 7.57 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.901 2.4 . . . . 65.23 112.477 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.87 89.31 7.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 106.3 -1.741 . . . . 64.33 106.3 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.97 120.67 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.999 -1.001 . . . . 75.03 109.062 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -109.98 130.8 55.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.77 1.228 . . . . 71.43 109.592 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.487 HD23 HD23 ' C' ' 128' ' ' LEU . 16.9 mt -87.32 122.89 31.68 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.025 -0.731 . . . . 74.24 109.025 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.39 103.19 8.57 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.467 1.107 . . . . 73.23 108.167 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -111.71 146.51 37.4 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.483 0.713 . . . . 64.23 109.518 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 21.4 t70 -138.8 135.32 34.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.283 -1.377 . . . . 71.23 107.283 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 22.0 p -127.13 126.94 43.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.456 0.302 . . . . 72.41 111.05 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.47 164.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.915 0.886 . . . . 71.42 110.058 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -144.46 148.36 34.48 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.984 0.914 . . . . 75.02 108.974 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 16.0 p -147.64 129.02 14.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.12 0.568 . . . . 74.01 109.964 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -75.4 125.38 28.87 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 109.295 -0.632 . . . . 72.13 109.295 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.406 HD13 HD13 ' C' ' 83' ' ' ILE . 73.5 mt -99.65 -31.4 11.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.696 0.798 . . . . 74.42 110.547 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 -177.79 6.22 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.269 1.028 . . . . 73.53 109.644 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.84 121.85 13.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.603 -0.726 . . . . 64.33 109.506 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 69.0 -3.0 1.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.85 1.26 . . . . 54.33 112.791 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -100.38 112.66 33.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.844 -0.799 . . . . 63.43 108.844 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -126.89 124.47 39.64 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.201 -1.037 . . . . 74.44 108.201 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.63 119.48 23.87 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.969 -1.014 . . . . 75.13 108.434 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.8 t -96.16 124.55 48.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.119 -1.067 . . . . 73.45 108.119 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.35 129.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.057 -1.09 . . . . 75.3 108.057 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -122.68 95.67 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.931 -1.137 . . . . 75.45 107.931 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.514 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.7 tmt_? -86.05 114.12 22.67 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.822 -1.177 . . . . 74.42 107.822 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.493 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.9 t -113.28 132.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.107 -1.071 . . . . 72.51 108.107 175.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -128.81 124.2 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.493 -0.928 . . . . 74.42 108.493 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.625 HG23 HG21 ' C' ' 114' ' ' ILE . 39.0 t -106.55 110.48 31.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.928 -1.138 . . . . 62.33 107.928 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 8.0 m -106.71 127.03 53.04 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.113 -0.699 . . . . 71.52 109.113 175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.9 20.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.065 -1.087 . . . . 71.21 108.065 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.7 m -148.15 126.7 12.44 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.966 0.506 . . . . 74.42 109.782 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.425 HD21 ' H ' ' C' ' 68' ' ' LEU . 0.2 OUTLIER -87.44 58.6 5.05 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.727 0.811 . . . . 74.01 109.473 177.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 -119.18 5.86 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.877 -1.289 . . . . 64.43 109.877 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.71 -24.02 21.67 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.616 0.766 . . . . 74.55 109.512 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.606 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 14.7 tp10 -68.2 96.1 0.62 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.192 0.997 . . . . 71.24 110.553 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.2 m -83.12 126.52 32.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.738 0.78 . . . . 74.24 111.259 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.661 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -82.78 -53.67 5.71 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.174 1.39 . . . . 61.52 110.19 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.88 170.46 16.75 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.022 0.826 . . . . 74.21 110.379 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.589 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.8 tm? -136.99 137.9 39.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 106.507 -1.664 . . . . 74.33 106.507 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.441 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -146.8 143.04 28.34 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.284 -1.006 . . . . 74.05 108.284 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -155.32 135.53 13.09 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.061 0.544 . . . . 72.05 109.887 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -138.3 135.23 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.235 1.014 . . . . 74.14 108.355 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.565 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -105.92 89.15 2.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.944 -1.132 . . . . 75.12 107.944 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -81.21 107.73 14.25 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.045 -0.979 . . . . 74.24 109.749 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.62 145.67 16.23 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.98 -0.448 . . . . 74.31 111.98 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.5 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.05 127.71 3.34 Favored Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 110.416 -1.074 . . . . 61.32 110.416 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.429 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 10.2 mm -81.28 114.64 22.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.842 -1.17 . . . . 75.53 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -121.55 137.11 54.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.037 -0.727 . . . . 74.3 109.037 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 m -109.96 105.59 14.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.425 -0.954 . . . . 74.24 108.425 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.617 ' HB ' ' HE2' ' C' ' 94' ' ' MET . 2.2 mp -114.7 111.88 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.648 -1.612 . . . . 73.53 106.648 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.64 157.94 31.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.994 0.518 . . . . 74.35 111.726 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.07 -60.51 0.97 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.016 -0.993 . . . . 71.42 112.384 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.68 178.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.833 0.453 . . . . 72.33 111.726 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' F' ' 277' ' ' LEU . 9.9 pt-20 -154.32 -171.07 3.74 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.631 -0.713 . . . . 72.43 110.419 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.45 -128.8 44.34 Favored Glycine 0 C--N 1.355 1.634 0 O-C-N 123.856 0.723 . . . . 61.13 114.166 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -68.18 -31.92 71.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.065 0.946 . . . . 71.42 111.743 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.88 -46.32 82.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.658 0.783 . . . . 74.14 110.117 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.725 ' HG2' HD23 ' C' ' 98' ' ' LEU . 27.9 ttt -78.32 -25.69 46.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.342 -0.845 . . . . 74.14 110.987 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -32.73 74.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.999 0.52 . . . . 72.14 111.003 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.453 ' HD2' ' HB3' ' C' ' 137' ' ' PHE . 38.9 t-80 -65.49 -36.75 84.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.644 -0.707 . . . . 71.45 111.073 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.419 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 53.9 t -76.17 -61.35 1.97 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.627 0.371 . . . . 64.52 111.143 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.725 HD23 ' HG2' ' C' ' 94' ' ' MET . 3.4 pp -70.71 -34.04 71.51 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.186 0.594 . . . . 74.24 110.989 -175.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.65 -2.47 75.84 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.65 0.62 . . . . 71.53 114.65 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.448 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -137.24 -57.86 0.7 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.349 0.575 . . . . 74.44 111.193 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 68.0 t80 -72.59 -48.95 35.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 122.897 0.479 . . . . 74.13 111.586 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.593 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 81.2 m -58.21 -45.03 99.76 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.383 0.883 . . . . 72.44 113.383 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' C' ' 98' ' ' LEU . 50.3 Cg_exo -56.92 -36.5 99.1 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 122.548 2.165 . . . . 75.3 113.209 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.417 HD22 ' HD2' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -68.7 -22.53 64.35 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.714 0.805 . . . . 73.21 111.734 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.3 mm -83.33 -36.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.803 0.441 . . . . 73.23 110.052 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.5 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.4 mt -82.34 -24.89 34.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.75 0.82 . . . . 74.44 112.131 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.77 -48.84 96.08 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 113.571 0.952 . . . . 72.41 113.571 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.96 -40.03 75.26 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.066 1.844 . . . . 74.21 113.184 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -70.51 -42.91 70.69 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.405 -0.816 . . . . 74.44 111.519 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.88 -46.47 87.75 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.357 0.663 . . . . 73.41 109.215 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -55.93 -51.64 66.92 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.483 1.513 . . . . 75.25 111.827 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.68 -33.2 70.65 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.503 0.321 . . . . 75.43 110.163 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.2 t -70.59 -31.02 67.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.637 0.375 . . . . 64.21 111.013 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.625 HG21 HG23 ' C' ' 64' ' ' VAL . 77.1 mt -72.05 -51.17 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.676 0.79 . . . . 74.54 109.76 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.483 HG21 ' OG ' ' B' ' 119' ' ' SER . 88.4 m -59.23 -41.27 88.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.626 0.77 . . . . 75.42 111.071 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.439 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 26.2 t -60.3 -44.38 95.45 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.064 0.853 . . . . 61.35 109.653 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.576 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.92 -39.95 91.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.312 0.645 . . . . 74.4 111.824 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.403 HG21 ' O ' ' C' ' 114' ' ' ILE . 72.6 t -62.16 -40.66 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.022 0.529 . . . . 64.22 110.116 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.411 ' HB2' ' NE2' ' B' ' 125' ' ' GLN . 84.1 p -76.17 -26.41 56.21 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.568 -0.742 . . . . 71.45 111.742 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.439 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.9 mtt-85 -71.52 -34.58 70.21 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.758 0.823 . . . . 75.24 110.168 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.62 6.06 59.25 Favored Glycine 0 C--N 1.355 1.593 0 O-C-N 123.576 0.548 . . . . 73.52 112.384 170.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p 61.67 19.49 10.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.168 2.187 . . . . 75.2 113.314 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.406 ' HE1' HG13 ' C' ' 31' ' ' VAL . 52.2 m-85 -85.88 156.27 58.18 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.136 0.974 . . . . 73.32 109.688 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.464 ' HG3' ' HB2' ' F' ' 300' ' ' ASN . 68.3 Cg_exo -51.68 120.58 7.24 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.033 2.489 . . . . 72.54 111.958 173.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.434 ' HG3' ' HB2' ' B' ' 125' ' ' GLN . 96.2 mt-30 -57.08 143.99 36.31 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.309 1.006 . . . . 73.11 112.477 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.717 HD21 ' HH2' ' F' ' 290' ' ' TRP . 5.9 tt -119.28 109.18 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.178 -1.045 . . . . 75.0 108.178 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.95 119.0 31.29 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.43 -0.952 . . . . 73.41 108.43 170.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.487 HD23 HD23 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -73.13 136.75 44.87 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.083 -0.71 . . . . 75.41 109.083 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.9 151.75 94.56 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.288 1.035 . . . . 74.42 111.574 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.577 ' HG3' HD13 ' A' ' 16' ' ' ILE . 15.0 Cg_exo -66.39 98.54 0.4 Allowed 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.486 2.124 . . . . 62.32 111.325 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.92 108.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.908 -1.145 . . . . 74.31 107.908 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -95.04 99.05 11.12 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.762 -0.829 . . . . 74.2 108.762 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.417 ' HD2' HD22 ' C' ' 104' ' ' ASN . 78.1 m-85 -68.71 -37.0 79.16 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 72.45 109.949 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.448 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 31.3 t70 -63.9 -27.99 69.53 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.474 1.11 . . . . 75.44 112.265 -175.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.46 91.16 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.789 0.836 . . . . 74.02 111.552 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.98 -46.38 87.95 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.176 0.59 . . . . 75.35 110.534 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.453 ' HB3' ' HD2' ' C' ' 96' ' ' HIS . 55.0 m-85 -64.79 -31.58 72.88 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.321 -0.854 . . . . 74.42 111.146 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 48.1 ttm -66.97 -38.48 86.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.93 0.892 . . . . 53.3 110.822 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -68.57 -38.98 81.15 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 116.154 -0.476 . . . . 72.21 110.962 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -71.01 -88.27 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 O-C-N 123.568 0.542 . . . . 73.13 110.826 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 15.1 tp -177.63 176.2 1.28 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.971 0.908 . . . . 74.23 108.691 -171.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 75.04 8.76 4.04 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.396 1.478 . . . . 71.12 111.277 179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.77 -15.85 61.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.465 1.106 . . . . 61.33 111.211 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -65.27 115.63 5.78 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.499 1.12 . . . . 73.15 111.199 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.9 -178.22 6.24 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.892 0.877 . . . . 73.05 110.202 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.69 109.46 0.61 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 108.437 -1.865 . . . . 72.24 108.437 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.86 148.74 50.75 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.639 0.775 . . . . 70.54 112.295 -165.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.63 -114.38 0.42 Allowed Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.157 -0.929 . . . . 70.0 111.508 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 50.4 p -140.14 131.17 26.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.905 0.882 . . . . 71.32 111.278 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.52 166.98 12.56 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.239 0.616 . . . . 73.32 110.324 172.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -106.83 -70.85 0.77 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.005 0.522 . . . . 71.24 111.544 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 m170 61.54 72.63 0.5 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 124.157 0.911 . . . . 74.52 110.363 -166.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -143.75 10.31 1.59 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.186 -0.915 . . . . 73.33 109.248 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -133.05 102.28 5.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.849 0.859 . . . . 74.21 108.803 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.358 0 C-N-CA 124.107 0.963 . . . . 74.11 111.636 -173.652 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 108.805 -0.813 . . . . 71.22 108.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' SER . . . . . 0.473 ' H ' ' HA ' ' D' ' 150' ' ' GLU . 20.2 m -145.34 161.82 38.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.154 0.582 . . . . 72.3 111.001 -174.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.84 121.31 3.6 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.059 0.944 . . . . 74.33 109.805 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -128.13 105.08 8.13 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.907 0.883 . . . . 65.55 110.025 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -156.17 162.74 40.17 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 107.987 -1.116 . . . . 73.03 107.987 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -146.46 109.46 4.65 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.694 0.398 . . . . 72.13 110.186 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.712 ' HB ' ' HA2' ' D' ' 88' ' ' GLY . 32.1 m -80.88 166.91 20.47 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 108.352 -0.981 . . . . 52.41 108.352 169.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.09 94.12 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.338 0.655 . . . . 71.3 111.209 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.427 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 7.6 ttp -35.34 128.55 0.56 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.232 1.413 . . . . 72.42 113.416 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 30.1 m -139.72 140.31 36.76 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.094 -1.076 . . . . 70.44 108.094 171.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' D' ' 85' ' ' SER . 51.0 t80 -161.63 99.39 1.14 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.39 -0.967 . . . . 73.22 108.39 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -136.42 131.26 33.88 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.544 -0.91 . . . . 63.45 108.544 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 22.8 mt -82.34 122.12 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.206 -0.665 . . . . 63.33 109.206 178.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.63 -31.78 19.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.819 0.448 . . . . 73.43 110.826 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -167.3 144.66 4.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 110.48 -0.193 . . . . 75.13 110.48 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.494 HD11 ' HG3' ' B' ' 130' ' ' PRO . 0.1 OUTLIER -133.56 133.15 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 106.357 -1.72 . . . . 74.52 106.357 173.038 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.431 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 21.6 p90 -168.31 166.79 12.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.793 0.806 . . . . 75.32 111.12 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -93.09 121.63 34.63 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.371 -1.286 . . . . 74.13 108.769 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -88.77 -31.26 18.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.884 0.474 . . . . 75.23 110.069 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.01 139.44 18.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.946 -1.024 . . . . 51.12 109.012 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.576 HG21 ' HE1' ' C' ' 117' ' ' MET . 63.2 mt -139.59 151.3 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.771 -1.196 . . . . 72.11 107.771 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -158.68 121.67 3.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.663 0.785 . . . . 74.12 110.264 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.521 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.9 t80 -113.65 121.22 43.5 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 106.657 -1.609 . . . . 72.22 106.657 165.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.485 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.4 mt-10 -121.88 117.63 26.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.708 -0.478 . . . . 72.53 109.708 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.68 87.66 2.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.806 -1.183 . . . . 74.43 107.806 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.13 -36.77 5.35 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.739 2.293 . . . . 72.21 112.727 -170.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -113.0 40.1 2.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.27 1.028 . . . . 64.25 108.623 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -51.98 -65.09 1.1 Allowed Pre-proline 0 CA--C 1.563 1.468 0 CA-C-O 117.916 -1.04 . . . . 63.1 113.799 -166.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.92 -9.81 11.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 122.6 1.964 . . . . 73.4 112.91 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -74.07 -42.44 60.18 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.688 1.195 . . . . 75.35 110.377 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.28 -33.69 14.29 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 115.951 -0.568 . . . . 75.42 109.909 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -56.16 -22.55 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 74.04 113.699 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -70.6 -36.16 73.37 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.015 0.526 . . . . 72.11 110.436 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 63.32 1.63 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.778 0.831 . . . . 72.21 111.381 171.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.489 ' HB3' HD11 ' G' ' 301' ' ' ILE . 9.6 t70 -107.47 97.93 7.61 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.529 0.732 . . . . 74.5 109.714 -175.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.448 ' O ' HD22 ' D' ' 68' ' ' LEU . 13.2 m95 -121.87 -155.12 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.037 -1.097 . . . . 74.14 108.037 -169.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.542 HE21 ' HA ' ' G' ' 295' ' ' ALA . 63.1 tt0 -54.45 109.04 1.32 Allowed Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.082 0.771 . . . . 72.11 113.082 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.702 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 9.8 Cg_exo -72.03 139.45 32.87 Favored 'Trans proline' 0 C--N 1.386 2.525 0 C-N-CA 123.102 2.535 . . . . 72.31 112.968 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.0 116.48 29.0 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.561 -1.274 . . . . 74.04 107.561 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.32 149.85 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.923 0.889 . . . . 74.45 112.21 -170.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -127.83 139.35 52.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.72 1.608 . . . . 73.44 108.473 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.513 HD13 HG11 ' G' ' 288' ' ' VAL . 1.2 tt -120.84 114.7 21.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.944 -0.762 . . . . 70.31 108.944 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -109.08 141.98 40.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.209 1.004 . . . . 74.34 108.501 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.538 HD23 ' SD ' ' G' ' 286' ' ' MET . 4.9 mp -122.04 145.03 48.54 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.335 -0.617 . . . . 73.52 109.335 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.04 159.55 44.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.177 0.991 . . . . 73.04 108.47 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -136.6 168.78 18.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.13 0.572 . . . . 74.1 110.501 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.489 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.32 154.31 36.48 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.603 1.161 . . . . 72.34 108.347 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.482 ' HB2' ' HG ' ' G' ' 278' ' ' LEU . 58.6 p -149.44 150.67 32.75 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.31 0.244 . . . . 74.32 111.117 -174.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -174.18 127.73 0.36 Allowed 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.34 1.056 . . . . 73.13 108.93 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.89 127.31 32.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.898 -0.779 . . . . 74.34 108.898 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.484 HD11 ' HB2' ' D' ' 57' ' ' GLU . 57.6 mt -92.55 -36.01 13.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.886 0.474 . . . . 74.33 111.147 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.61 -171.1 1.99 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.433 0.693 . . . . 65.42 111.115 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -58.13 114.31 2.32 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.869 -1.06 . . . . 65.44 110.785 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 62.29 13.01 5.61 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.591 1.156 . . . . 74.33 112.501 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 80.6 t -115.52 118.48 58.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.512 -0.921 . . . . 71.31 108.512 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.609 ' HB3' HD22 ' G' ' 278' ' ' LEU . 96.1 m-85 -131.25 132.54 44.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.657 1.183 . . . . 74.52 108.144 -174.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.484 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.5 tt0 -99.77 126.0 45.77 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.375 0.422 . . . . 72.34 110.596 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -107.36 117.75 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 107.248 -1.389 . . . . 73.5 107.248 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.545 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.0 t -100.27 132.25 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.649 -1.241 . . . . 72.3 107.649 172.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -124.26 110.81 15.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.555 -0.906 . . . . 73.45 108.555 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.07 118.4 29.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.272 1.029 . . . . 74.12 109.694 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 65.3 t -102.42 130.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.867 -1.161 . . . . 72.31 107.867 166.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.3 m -121.4 131.2 54.04 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.449 0.642 . . . . 74.35 109.887 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.403 HG22 HG22 ' D' ' 114' ' ' ILE . 88.5 t -122.42 105.89 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.473 1.509 . . . . 65.0 108.938 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -107.45 108.84 20.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.847 0.859 . . . . 73.22 109.258 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.59 137.0 37.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.451 -0.574 . . . . 74.14 109.451 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -139.21 123.08 17.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.309 -0.996 . . . . 61.02 108.309 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.702 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.4 pp -129.1 137.55 51.3 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.711 -0.478 . . . . 74.03 109.711 174.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.38 -113.09 3.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.683 -0.689 . . . . 73.34 112.119 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -116.37 3.14 13.29 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.723 0.809 . . . . 72.23 111.21 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.78 176.05 13.12 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.071 0.462 . . . . 74.51 111.497 -168.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 78.1 m -66.78 138.13 57.13 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.918 -1.037 . . . . 74.22 111.015 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.4 -65.79 0.97 Allowed 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.06 -1.089 . . . . 65.25 108.06 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -156.52 164.72 37.89 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.787 -1.551 . . . . 74.24 109.231 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.6 mt -126.26 144.31 50.84 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.665 1.186 . . . . 71.22 107.842 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.408 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 0.7 OUTLIER -145.7 139.24 26.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.204 1.002 . . . . 72.1 108.348 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -157.79 130.1 7.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.52 -0.548 . . . . 74.12 109.52 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 55.3 t -137.6 119.52 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.4 0.68 . . . . 74.35 109.682 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -89.29 91.24 8.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.539 0.735 . . . . 64.11 109.083 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.59 94.66 6.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.259 0.624 . . . . 72.01 109.491 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.7 141.73 18.11 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.524 -0.63 . . . . 64.14 111.524 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.432 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.23 129.83 5.05 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 110.953 -0.859 . . . . 63.43 110.953 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.416 HG23 HD13 ' D' ' 51' ' ' LEU . 45.8 mt -89.41 119.42 36.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.793 -1.188 . . . . 65.34 107.793 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -121.47 147.52 45.66 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.04 0.936 . . . . 73.11 109.199 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 19.5 m -99.57 93.3 5.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.173 -1.418 . . . . 74.2 107.173 172.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.425 HG22 ' HE1' ' D' ' 94' ' ' MET . 71.9 mt -106.78 118.35 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.107 -0.701 . . . . 64.01 109.107 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -151.94 160.74 43.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.114 0.966 . . . . 73.22 109.447 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.712 ' HA2' ' HB ' ' D' ' 7' ' ' THR . . . 81.44 -23.16 4.91 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 115.696 1.038 . . . . 53.14 115.696 170.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.419 HG13 ' HG2' ' D' ' 94' ' ' MET . 26.2 pt -96.11 135.7 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.597 -0.89 . . . . 75.05 108.597 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.05 172.93 15.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.518 -0.765 . . . . 74.43 110.153 -169.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.464 ' H ' ' HG3' ' G' ' 276' ' ' PRO . . . 62.69 -137.28 44.39 Favored Glycine 0 C--N 1.35 1.309 0 O-C-N 123.492 0.495 . . . . 73.23 112.595 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -77.58 -20.41 54.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.861 0.864 . . . . 75.42 111.511 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -62.38 -47.38 84.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.77 0.828 . . . . 74.2 110.318 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.55 ' HG3' HD22 ' G' ' 277' ' ' LEU . 0.0 OUTLIER -64.69 -46.96 80.15 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.246 -0.888 . . . . 74.33 109.681 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.17 67.41 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.341 1.026 . . . . 71.3 112.182 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -67.25 -50.55 60.11 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.247 -0.888 . . . . 65.43 111.159 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.84 -35.54 78.55 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.058 0.543 . . . . 75.14 111.462 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.529 HD11 ' SD ' ' D' ' 94' ' ' MET . 4.1 tt -70.27 -45.64 65.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.94 1.296 . . . . 63.21 109.226 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.74 -22.39 72.31 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 75.15 113.831 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.33 -66.82 1.04 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.405 0.52 . . . . 74.34 112.405 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -72.92 -48.19 39.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.551 0.741 . . . . 74.51 112.51 -166.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -60.1 -48.71 93.77 Favored Pre-proline 0 CA--C 1.571 1.781 0 C-N-CA 123.89 0.876 . . . . 71.21 112.784 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.64 -21.72 18.86 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.964 1.776 . . . . 73.31 112.906 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.09 -31.58 72.15 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.226 0.61 . . . . 64.5 110.577 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.8 mm -68.0 -42.82 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.674 0.79 . . . . 74.01 110.332 175.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.432 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.1 mt -73.73 -29.9 62.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.235 -0.893 . . . . 75.42 111.716 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -59.98 -44.11 96.0 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.338 1.236 . . . . 74.33 114.338 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.48 -41.09 80.15 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.445 2.097 . . . . 74.11 114.03 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -74.29 -37.36 63.7 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.258 0.623 . . . . 74.11 111.371 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . 0.406 ' O ' HG13 ' D' ' 114' ' ' ILE . . . -63.71 -47.45 81.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.086 0.554 . . . . 73.32 109.975 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -53.9 -53.51 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.772 1.295 . . . . 63.32 110.562 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.56 -46.98 85.74 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 124.523 1.139 . . . . 74.53 110.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.3 t -59.44 -32.88 70.62 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.579 0.549 . . . . 75.45 111.708 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.541 ' HA ' ' HE3' ' D' ' 117' ' ' MET . 73.3 mt -73.24 -49.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.157 0.583 . . . . 74.43 109.916 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' B' ' 109' ' ' TYR . 21.8 m -55.07 -40.99 70.95 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.719 1.208 . . . . 72.13 111.577 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -71.65 -37.51 70.81 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.335 -0.848 . . . . 72.11 110.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.541 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 71.3 mtm -63.37 -45.34 91.56 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 122.742 0.417 . . . . 75.03 111.287 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.428 HG22 ' O ' ' D' ' 114' ' ' ILE . 57.6 t -63.05 -41.87 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.142 -0.936 . . . . 71.24 110.451 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.2 p -68.16 -31.86 71.72 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.207 0.603 . . . . 71.15 111.754 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -71.93 -30.1 64.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.74 0.816 . . . . 72.42 110.931 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.62 8.63 64.7 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.965 -0.561 . . . . 71.11 112.569 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.6 p 60.73 24.97 14.8 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.018 2.127 . . . . 72.4 113.036 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.23 161.17 27.02 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.836 1.255 . . . . 74.12 109.499 172.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 120.04 7.16 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.475 2.117 . . . . 73.44 111.102 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.87 139.68 50.66 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.689 0.618 . . . . 74.5 110.093 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tt -109.19 117.75 34.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.401 -0.592 . . . . 75.21 109.401 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -99.98 95.39 6.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.969 -1.014 . . . . 72.54 108.362 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.12 121.19 12.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.433 0.693 . . . . 74.02 110.08 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.4 ' HA ' HG22 ' B' ' 13' ' ' ILE . . . -66.95 140.7 96.25 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.38 0.672 . . . . 63.55 110.577 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -75.0 108.65 2.77 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.549 2.166 . . . . 74.41 110.777 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.94 138.88 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.443 0.697 . . . . 75.13 109.199 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -74.17 112.37 10.26 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 123.97 0.794 . . . . 74.25 110.428 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -74.83 -32.2 61.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.56 0.744 . . . . 72.53 110.988 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -49.77 -55.02 15.63 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.17 0.988 . . . . 73.55 111.445 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.41 -41.59 85.29 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.215 1.006 . . . . 64.03 112.63 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 73.5 mt -63.14 -40.15 96.74 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.18 -0.918 . . . . 74.0 111.055 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -78.76 -26.46 44.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.353 1.061 . . . . 75.23 112.991 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.401 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 21.1 mmt -46.74 -47.47 20.66 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.202 0.601 . . . . 73.45 110.99 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.98 -48.96 78.02 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.947 -1.024 . . . . 73.44 110.953 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.69 -35.98 75.57 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.114 0.966 . . . . 74.1 112.028 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.6 -28.67 62.92 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.873 0.869 . . . . 73.02 110.939 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' D' ' 138' ' ' MET . 66.0 mt-30 -87.04 3.7 44.98 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.125 0.97 . . . . 73.31 111.059 174.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -130.84 51.1 2.16 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.244 1.018 . . . . 74.4 110.276 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -144.45 155.0 43.53 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.193 0.597 . . . . 73.31 109.786 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.31 89.81 1.07 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.548 -0.908 . . . . 74.22 108.548 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.7 65.24 0.02 OUTLIER Glycine 0 C--N 1.343 0.972 0 N-CA-C 110.44 -1.064 . . . . 72.15 110.44 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -81.57 169.67 16.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.821 0.848 . . . . 75.24 110.041 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.47 -24.73 73.81 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.784 0.677 . . . . 41.44 114.517 -172.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.3 t -161.5 177.74 9.77 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 123.374 0.67 . . . . 75.34 110.068 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . 0.473 ' HA ' ' H ' ' D' ' 2' ' ' SER . 34.3 tt0 -132.76 104.71 6.75 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.822 -0.807 . . . . 63.1 108.822 170.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -151.35 93.24 1.87 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.128 -1.064 . . . . 71.22 108.128 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -67.2 93.76 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.763 -1.108 . . . . 74.45 110.66 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -94.43 152.73 18.38 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.617 -0.883 . . . . 73.53 108.617 165.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -159.88 161.61 34.43 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.319 0.648 . . . . 72.45 109.705 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 123.45 0.7 . . . . 54.42 110.374 177.931 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.213 -0.292 . . . . 62.15 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -154.26 126.51 7.89 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.887 -0.783 . . . . 62.43 108.887 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.26 97.42 8.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.586 0.754 . . . . 72.35 109.436 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -78.56 104.9 9.47 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . 0.538 ' HE3' ' HB2' ' A' ' 50' ' ' GLN . 21.6 pttm -82.27 118.76 73.09 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.173 0.589 . . . . 73.52 110.37 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.39 -1.8 11.51 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.822 2.348 . . . . 74.35 113.559 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 78.9 mt -78.72 -35.78 44.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.655 0.782 . . . . 75.51 111.776 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.81 104.27 15.5 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.334 -1.358 . . . . 74.14 107.334 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -154.39 31.26 0.7 Allowed Glycine 0 C--N 1.343 0.955 0 O-C-N 123.631 0.582 . . . . 65.33 112.15 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.415 HD22 ' HA ' ' A' ' 95' ' ' ALA . 4.5 tt -164.46 167.02 20.0 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 107.998 -1.112 . . . . 74.34 107.998 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 72.6 t80 73.94 30.15 1.33 Allowed 'General case' 0 CA--C 1.561 1.388 0 CA-C-O 122.862 1.315 . . . . 73.42 110.3 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -109.18 13.05 24.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.69 -1.141 . . . . 74.03 109.063 166.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -148.93 147.22 28.38 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.657 1.183 . . . . 65.14 109.398 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.71 100.03 0.35 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.558 -0.617 . . . . 61.04 111.558 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . 0.423 ' HB2' ' SD ' ' E' ' 286' ' ' MET . 18.8 m120 -57.99 -51.08 71.12 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.157 0.983 . . . . 71.44 112.276 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 286' ' ' MET . . . . . 0.423 ' SD ' ' HB2' ' E' ' 285' ' ' ASN . 0.0 OUTLIER -145.28 146.09 29.03 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.595 0.758 . . . . 73.3 110.202 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.46 128.35 20.06 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.998 2.466 . . . . 74.52 112.258 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . 0.413 HG13 HG11 ' A' ' 131' ' ' VAL . 99.8 t -95.73 122.63 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.556 -0.905 . . . . 70.01 108.556 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -78.12 149.62 33.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.891 -0.781 . . . . 75.02 108.891 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . 0.504 ' HB2' HD22 ' A' ' 42' ' ' LEU . 5.0 t-105 -91.62 124.95 36.16 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.639 -0.504 . . . . 74.42 109.639 174.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.5 15.78 28.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.108 0.963 . . . . 73.45 110.846 -171.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -128.07 64.98 0.58 Allowed Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.404 -0.664 . . . . 65.43 112.475 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.52 177.29 9.01 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.385 2.057 . . . . 63.12 111.653 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt 67.77 12.77 9.0 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.308 1.043 . . . . 72.33 111.388 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . 0.512 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . 68.52 153.97 0.1 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.342 1.457 . . . . 71.4 113.192 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 6.0 t -85.09 70.35 10.89 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 122.426 1.108 . . . . 65.35 110.421 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -151.94 -67.98 0.17 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.673 -1.148 . . . . 75.24 109.309 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 64.9 14.29 9.15 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.888 1.275 . . . . 73.45 110.826 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 159.51 -166.24 34.75 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 116.243 -0.435 . . . . 50.02 112.496 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -79.52 175.98 10.11 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.056 0.942 . . . . 75.05 110.103 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 20.7 pt -136.52 -153.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.59 0.756 . . . . 73.53 110.11 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.54 -172.78 0.08 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.161 0.984 . . . . 70.13 111.369 162.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -146.8 164.45 23.68 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 122.689 0.396 . . . . 63.12 110.872 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.49 55.13 4.1 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.835 2.357 . . . . 73.21 112.532 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -167.07 115.84 0.84 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.975 1.31 . . . . 73.42 108.152 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 95.3 t -73.89 -79.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.786 0.434 . . . . 72.42 110.338 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 307' ' ' THR . . . . . 0.407 HG21 ' HB1' ' G' ' 295' ' ' ALA . 20.2 p -141.15 -84.63 0.2 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.835 0.454 . . . . 73.14 110.703 -173.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . 0.526 ' SG ' ' HD2' ' E' ' 310' ' ' PRO . 48.9 t -178.73 -176.96 0.49 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.442 1.097 . . . . 74.11 109.226 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 309' ' ' THR . . . . . 0.447 ' HA ' HD21 ' G' ' 291' ' ' LEU . 4.4 p -135.34 -45.52 0.02 OUTLIER Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.952 -1.023 . . . . 75.54 112.581 170.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . 0.526 ' HD2' ' SG ' ' E' ' 308' ' ' CYS . 51.3 Cg_exo . . . . . 0 C--N 1.398 3.157 0 C-N-CA 122.382 2.054 . . . . 75.15 112.5 168.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.939 -0.393 . . . . 54.23 109.939 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -150.96 -77.97 0.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.821 -0.807 . . . . 74.5 108.821 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -146.13 -79.27 0.17 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.598 0.759 . . . . 74.42 109.87 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -109.51 125.08 52.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.704 0.802 . . . . 74.21 110.582 -170.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -113.93 96.66 42.32 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 108.172 -1.048 . . . . 74.24 108.172 172.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.05 146.46 97.68 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.899 2.4 . . . . 62.43 112.694 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.494 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 96.0 mt 61.22 27.97 17.63 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.982 1.313 . . . . 71.01 112.594 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . 0.595 HD12 HD21 ' C' ' 98' ' ' LEU . 8.9 tp -167.12 178.32 5.74 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.772 0.829 . . . . 72.31 109.027 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 155.61 37.1 0.02 OUTLIER Glycine 0 C--N 1.353 1.497 0 CA-C-O 119.793 -0.449 . . . . 63.14 113.677 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . 0.612 HD13 ' H ' ' F' ' 281' ' ' PHE . 0.2 OUTLIER -168.5 168.46 11.06 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.607 -1.257 . . . . 75.32 107.607 178.171 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . 0.612 ' H ' HD13 ' F' ' 280' ' ' LEU . 22.2 m-30 80.64 -62.16 0.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 126.265 1.826 . . . . 74.34 110.906 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.43 38.69 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.949 0.9 . . . . 73.31 111.59 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -68.77 -35.25 76.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.754 0.822 . . . . 63.12 110.803 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 165.13 4.68 0.04 OUTLIER Glycine 0 C--N 1.355 1.588 0 CA-C-O 118.729 -1.039 . . . . 74.3 114.444 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 67.8 117.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.969 1.308 . . . . 75.13 110.752 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 28.4 ttt -69.84 115.46 33.73 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 122.932 0.493 . . . . 65.45 110.506 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.45 142.71 26.84 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.467 2.112 . . . . 74.23 112.412 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.16 130.83 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.447 0.699 . . . . 73.01 109.145 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -105.83 145.97 30.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.923 0.889 . . . . 72.13 109.146 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . 0.717 ' HH2' HD21 ' C' ' 126' ' ' LEU . 47.8 m95 -76.84 162.11 27.9 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.842 0.83 . . . . 72.23 112.309 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 4.8 mp -93.25 -45.73 7.71 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 113.946 -1.479 . . . . 71.32 108.074 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.74 122.51 0.66 Allowed Glycine 0 CA--C 1.532 1.15 0 CA-C-N 114.996 -1.002 . . . . 74.3 111.387 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.26 -2.93 13.2 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.09 2.527 . . . . 74.55 112.798 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -61.67 -33.2 73.57 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.653 1.181 . . . . 73.34 112.029 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.51 -16.98 63.55 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.14 0.976 . . . . 65.45 112.552 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 27.1 m -125.22 151.92 45.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.675 0.79 . . . . 71.02 110.376 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.427 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 6.4 t80 70.31 51.87 0.37 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.387 1.075 . . . . 74.5 111.375 165.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -92.75 5.64 50.41 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.758 0.79 . . . . 75.1 109.876 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 115.68 139.65 6.8 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.676 -0.693 . . . . 61.11 111.987 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . 0.464 ' HB2' ' HG3' ' C' ' 124' ' ' PRO . 15.6 t-20 -132.01 -22.01 2.35 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.027 -0.731 . . . . 73.33 109.027 168.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.504 HG23 ' HB1' ' F' ' 305' ' ' ALA . 2.6 mp -115.88 78.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.931 0 C-N-CA 124.147 0.979 . . . . 71.41 109.645 -175.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -97.21 164.88 12.3 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.136 -1.061 . . . . 64.44 108.136 166.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 65.62 -164.8 0.01 OUTLIER Pre-proline 0 CA--C 1.576 1.968 0 CA-C-O 118.395 -0.812 . . . . 75.22 109.566 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -72.41 20.13 0.31 Allowed 'Trans proline' 0 C--N 1.389 2.705 0 CA-C-N 122.506 1.931 . . . . 73.54 113.977 165.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . 0.504 ' HB1' HG23 ' F' ' 301' ' ' ILE . . . 67.36 -75.75 0.06 Allowed 'General case' 0 C--N 1.366 1.296 0 C-N-CA 125.658 1.583 . . . . 72.13 111.574 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 57.1 t -110.18 113.12 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.752 -1.944 . . . . 74.24 105.752 171.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 18.8 m -83.91 -24.35 30.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.801 0.44 . . . . 73.54 111.145 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 67.8 m -144.47 139.67 28.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.846 0.459 . . . . 74.22 111.075 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 309' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 130' ' ' PRO . 38.1 m -124.52 113.03 27.5 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.788 0.835 . . . . 72.54 109.984 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 C--N 1.379 2.184 0 C-N-CA 123.49 2.793 . . . . 73.14 111.501 175.404 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.484 -0.562 . . . . 52.12 109.484 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -163.12 109.8 1.18 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 107.458 -1.312 . . . . 72.55 107.458 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -142.43 166.16 25.42 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.349 -0.982 . . . . 74.3 108.349 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . 0.451 ' HA ' HD12 ' G' ' 277' ' ' LEU . 15.8 mt-30 69.5 38.73 1.71 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.4 1.08 . . . . 75.4 110.598 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . 0.503 ' HB2' ' HD3' ' G' ' 276' ' ' PRO . 18.9 mtmt -69.66 -52.43 14.05 Favored Pre-proline 0 CA--C 1.566 1.573 0 CA-C-N 115.137 -0.938 . . . . 72.41 111.442 -173.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . 0.503 ' HD3' ' HB2' ' G' ' 275' ' ' LYS . 43.1 Cg_endo -90.37 -5.13 4.83 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 121.69 1.593 . . . . 75.13 112.572 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.55 HD22 ' HG3' ' D' ' 94' ' ' MET . 94.3 mt -74.96 93.66 2.72 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 123.007 0.523 . . . . 72.44 109.884 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . 0.609 HD22 ' HB3' ' D' ' 56' ' ' TYR . 22.6 tp 74.34 80.57 0.12 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 113.879 -1.509 . . . . 73.4 111.71 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . 0.444 ' H ' HD12 ' D' ' 98' ' ' LEU . . . 165.46 53.28 0.02 OUTLIER Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.591 -0.731 . . . . 72.15 112.09 174.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . 0.454 ' HB2' HD13 ' D' ' 98' ' ' LEU . 2.9 tm? -92.78 -68.11 0.82 Allowed 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 109.609 -0.515 . . . . 65.34 109.609 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -110.07 142.99 40.75 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.922 0.489 . . . . 72.43 109.708 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -148.44 -31.68 0.26 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.707 0.803 . . . . 74.5 110.92 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -59.8 -49.61 77.04 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.413 1.085 . . . . 70.31 111.742 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.05 -166.17 29.65 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.849 -0.614 . . . . 63.33 113.166 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 19.6 m120 52.43 85.67 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.315 1.446 . . . . 74.25 111.743 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 286' ' ' MET . . . . . 0.538 ' SD ' HD23 ' D' ' 44' ' ' LEU . 64.0 mtt -76.07 161.19 76.32 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-N 115.398 -0.819 . . . . 74.41 109.528 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.48 38.04 0.54 Allowed 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.941 2.427 . . . . 73.41 113.764 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . 0.513 HG11 HD13 ' D' ' 42' ' ' LEU . 48.1 t -80.51 94.69 2.28 Favored 'Isoleucine or valine' 0 C--N 1.353 0.743 0 N-CA-C 108.568 -0.901 . . . . 75.1 108.568 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -92.21 27.03 2.32 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.32 1.048 . . . . 74.31 109.327 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 66.6 m95 63.6 172.39 0.17 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.93 1.292 . . . . 74.01 112.891 -171.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.447 HD21 ' HA ' ' E' ' 309' ' ' THR . 3.5 mp -104.99 -15.02 15.23 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.026 -1.443 . . . . 74.04 108.638 173.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -161.87 94.67 0.13 Allowed Glycine 0 C--N 1.349 1.279 0 N-CA-C 109.2 -1.56 . . . . 75.33 109.2 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.06 -23.21 59.59 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.523 2.815 . . . . 72.33 114.629 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -144.44 88.5 1.94 Allowed 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.16 -0.682 . . . . 75.22 109.16 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . 0.542 ' HA ' HE21 ' D' ' 37' ' ' GLN . . . -169.03 99.51 0.37 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.083 -0.962 . . . . 74.22 109.138 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 296' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' D' ' 38' ' ' PRO . 5.6 m -146.48 -62.31 0.3 Allowed 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.015 0.526 . . . . 75.22 110.34 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.436 ' O ' ' HA ' ' D' ' 37' ' ' GLN . 0.0 OUTLIER -157.97 163.88 37.37 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 123.107 0.563 . . . . 75.42 110.906 -177.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -161.36 134.46 6.33 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.637 -0.875 . . . . 63.24 108.637 170.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -161.49 -146.01 4.5 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-O 119.848 -0.418 . . . . 74.4 113.007 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -147.73 97.86 2.88 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.335 0.654 . . . . 74.15 109.369 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.493 HD13 HH12 ' C' ' 15' ' ' ARG . 80.6 mt -72.16 125.48 30.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.104 -0.953 . . . . 74.34 111.432 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -171.36 149.33 2.72 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 124.509 1.131 . . . . 73.13 108.619 163.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . 0.51 ' HD3' ' HB ' ' G' ' 306' ' ' VAL . 1.0 OUTLIER -60.61 141.97 91.75 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 123.894 0.878 . . . . 75.02 110.467 174.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.83 81.32 1.37 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.584 2.189 . . . . 72.35 112.545 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . 70.53 -68.07 0.22 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.954 1.701 . . . . 71.43 111.795 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.51 ' HB ' ' HD3' ' G' ' 303' ' ' LYS . 33.4 t 35.9 70.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 126.405 1.882 . . . . 74.34 112.698 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 40.9 p -90.63 -60.07 2.01 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.306 -0.861 . . . . 75.31 109.91 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 83.8 m -149.36 148.64 29.74 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.701 0.8 . . . . 72.44 110.139 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 309' ' ' THR . . . . . 0.499 ' N ' ' HD2' ' G' ' 310' ' ' PRO . 15.8 p -78.54 -32.82 0.86 Allowed Pre-proline 0 CA--C 1.572 1.824 0 CA-C-O 117.627 -1.178 . . . . 65.21 114.001 175.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' G' ' 309' ' ' THR . 11.2 Cg_endo . . . . . 0 C--N 1.408 3.705 0 C-N-CA 122.492 2.128 . . . . 64.11 112.976 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 109.841 -0.429 . . . . 74.42 109.841 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -72.33 -9.7 58.84 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.571 0.748 . . . . 74.34 111.27 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -63.36 93.84 0.07 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.276 1.03 . . . . 73.41 110.024 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -114.5 162.21 17.0 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.365 1.066 . . . . 74.53 109.463 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -147.33 103.19 3.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 122.905 0.482 . . . . 74.14 110.362 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.44 133.62 24.72 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 121.869 1.713 . . . . 74.41 109.993 165.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 9.7 tt -60.33 -36.53 78.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.071 0.548 . . . . 73.11 109.845 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.51 90.68 1.01 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.196 -0.668 . . . . 72.4 109.196 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -116.52 -64.46 0.35 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 110.446 -1.061 . . . . 62.25 110.446 173.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . 0.402 ' HB3' ' HB2' ' B' ' 95' ' ' ALA . 4.4 mm? -71.21 74.06 0.68 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.527 1.131 . . . . 74.33 111.625 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -176.49 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 123.619 0.768 . . . . 72.34 110.939 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -85.69 80.64 8.92 Favored 'General case' 0 C--N 1.357 0.917 0 CA-C-O 121.438 0.637 . . . . 72.13 109.903 -170.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -126.1 -36.26 2.36 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.691 -1.14 . . . . 71.14 108.951 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.85 148.95 19.76 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.032 -0.986 . . . . 62.45 111.053 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -73.12 165.63 24.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.274 0.63 . . . . 74.11 111.072 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 52.2 ttp -126.01 89.95 51.28 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.307 0.643 . . . . 73.04 109.554 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.65 111.96 2.93 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.8 2.334 . . . . 64.41 110.919 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 87.6 t -74.03 127.2 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.003 0.521 . . . . 74.3 109.658 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -64.91 112.64 3.38 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 108.761 -0.829 . . . . 75.34 108.761 173.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -61.05 124.05 19.39 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 124.118 0.886 . . . . 74.04 111.16 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.32 139.74 45.89 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.166 0.987 . . . . 70.5 108.598 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 178.83 85.31 0.06 OUTLIER Glycine 0 C--N 1.336 0.556 0 N-CA-C 110.333 -1.107 . . . . 34.4 110.333 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.36 -33.57 94.22 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.143 2.562 . . . . 74.53 113.167 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -81.06 -20.11 42.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.036 0.534 . . . . 74.22 111.308 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 65.24 -176.85 0.18 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.729 1.212 . . . . 75.51 112.678 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 43.9 m -94.05 -63.22 1.22 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.923 0.889 . . . . 61.22 110.262 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.68 148.14 28.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.076 -0.965 . . . . 74.42 109.531 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -136.96 -72.01 0.44 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.006 -0.739 . . . . 75.23 109.006 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.93 62.31 0.14 Allowed Glycine 0 C--N 1.352 1.454 0 C-N-CA 121.24 -0.505 . . . . 70.05 113.416 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -136.83 109.69 7.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.624 1.169 . . . . 74.11 108.334 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . 0.516 HG12 ' H ' ' H' ' 302' ' ' ASP . 10.7 tt -163.05 179.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 O-C-N 123.405 0.44 . . . . 73.02 110.653 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . 0.516 ' H ' HG12 ' H' ' 301' ' ' ILE . 5.4 m-20 -55.68 106.85 0.28 Allowed 'General case' 0 C--N 1.363 1.185 0 C-N-CA 124.943 1.297 . . . . 74.34 110.48 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.608 ' HB3' ' HD3' ' H' ' 304' ' ' PRO . 37.6 ttpt -162.17 -54.57 0.01 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.219 -1.03 . . . . 75.42 108.219 171.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . 0.608 ' HD3' ' HB3' ' H' ' 303' ' ' LYS . 10.4 Cg_endo -95.95 47.7 0.16 Allowed 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 122.689 2.259 . . . . 73.22 109.973 163.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.14 -171.34 1.68 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.364 1.065 . . . . 75.43 111.874 -174.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 19.5 t -79.97 76.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-O 122.144 0.973 . . . . 73.2 109.848 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 31.4 m -121.42 -38.22 2.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.133 0.973 . . . . 74.34 108.604 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 85.7 m -85.7 77.17 9.85 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.56 -0.746 . . . . 71.22 110.82 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 16.5 p -135.47 78.01 51.77 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.229 1.011 . . . . 74.04 108.554 172.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 C--N 1.377 2.073 0 C-N-CA 122.964 2.443 . . . . 71.33 111.636 178.758 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.652 -0.499 . . . . 71.31 109.652 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.5 t -160.07 -64.88 0.07 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.386 0.674 . . . . 74.33 109.548 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.29 -58.5 0.64 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.229 1.012 . . . . 71.43 110.079 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.08 -15.15 59.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.47 0.708 . . . . 74.52 112.807 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.8 t30 73.76 138.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.542 1.537 . . . . 73.41 111.451 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -105.33 -7.23 18.99 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.642 0.777 . . . . 64.12 111.961 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -92.78 25.45 3.13 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.899 0.48 . . . . 75.25 111.028 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.413 ' O ' ' HA3' ' A' ' 88' ' ' GLY . 40.7 tt0 -124.72 122.51 37.68 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.625 0.77 . . . . 72.41 109.633 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.513 ' HG3' HG22 ' A' ' 89' ' ' ILE . 1.9 mpp? -75.6 146.88 40.02 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.675 0.79 . . . . 71.42 110.0 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m -142.73 135.77 28.27 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.415 0.686 . . . . 72.24 109.932 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.448 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 21.7 t80 -137.08 131.69 33.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.784 0.834 . . . . 71.12 109.442 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -154.96 108.09 2.81 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.688 0.618 . . . . 72.44 109.904 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.683 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.4 mt -70.84 119.56 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 110.015 -0.365 . . . . 74.14 110.015 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.646 ' HA ' ' HA ' ' H' ' 307' ' ' THR . 1.5 tm0? -82.68 -33.01 27.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.646 0.778 . . . . 73.13 110.674 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -173.37 136.77 0.62 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.011 0.524 . . . . 75.43 110.182 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.5 pp -122.59 139.39 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.058 -0.719 . . . . 74.32 109.058 170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' HB3' HG23 ' B' ' 122' ' ' THR . 12.4 p90 -173.91 172.28 3.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.422 0.63 . . . . 73.42 111.189 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -94.93 123.45 38.41 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.386 -0.825 . . . . 61.53 108.849 171.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.8 mtpt -83.24 -34.89 25.74 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 110.003 -0.369 . . . . 74.12 110.003 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -152.99 140.66 19.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.524 -0.762 . . . . 72.32 109.127 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.5 mt -129.96 143.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.268 1.027 . . . . 64.15 108.5 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.64 122.53 10.65 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.313 0.383 . . . . 75.33 110.41 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.471 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 91.6 t80 -123.58 140.72 52.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 107.721 -1.214 . . . . 72.34 107.721 166.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.36 133.93 31.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.828 0.451 . . . . 75.41 110.438 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.563 ' HB1' ' HB3' ' A' ' 28' ' ' ALA . . . -150.34 72.61 9.19 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.606 1.562 . . . . 75.24 107.414 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.42 -42.57 3.63 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.791 2.327 . . . . 73.31 111.465 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.94 27.7 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.631 -1.168 . . . . 70.22 110.803 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.563 ' HB3' ' HB1' ' A' ' 25' ' ' ALA . . . -49.24 -53.2 41.76 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 118.216 -0.897 . . . . 74.33 112.211 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.93 -30.41 83.61 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.945 1.763 . . . . 74.01 113.036 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -74.42 -50.03 20.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.58 0.705 . . . . 71.53 110.139 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.4 p -70.42 -22.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 114.49 -1.232 . . . . 73.21 112.168 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -64.74 -27.94 69.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.105 0.409 . . . . 71.41 112.105 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -100.94 -10.81 20.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.653 0.612 . . . . 74.42 112.653 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.639 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmtp -72.0 172.67 9.61 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.744 0.646 . . . . 74.54 112.744 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -50.79 117.56 2.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.599 1.16 . . . . 74.02 110.997 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -69.61 65.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.063 1.745 . . . . 75.11 110.691 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -148.63 68.96 10.13 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.603 1.161 . . . . 71.45 109.491 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HG2' ' HB ' ' E' ' 296' ' ' THR . 56.6 Cg_endo -85.94 120.3 1.95 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.791 2.327 . . . . 73.03 112.706 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.93 105.16 17.19 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.651 -1.24 . . . . 74.41 107.651 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.1 p -85.09 124.98 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.487 -0.779 . . . . 72.01 109.932 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.409 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 67.0 tttm -102.82 117.77 35.35 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.552 1.141 . . . . 73.24 108.737 -178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.437 ' HB2' ' NE1' ' E' ' 290' ' ' TRP . 1.1 tt -96.82 129.02 44.32 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.045 -1.094 . . . . 74.42 108.045 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.735 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.0 m-20 -134.51 140.01 45.87 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.669 0.788 . . . . 74.42 109.951 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.48 119.06 31.89 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.219 -1.03 . . . . 74.14 108.219 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 32.3 t70 -121.42 141.56 50.87 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.18 -1.415 . . . . 73.1 107.18 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -149.07 159.18 44.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.881 0.309 . . . . 74.0 111.518 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.44 116.12 1.08 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.697 0.623 . . . . 72.34 110.917 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.2 p -89.91 153.45 20.61 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.809 -0.811 . . . . 75.51 108.809 168.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -159.02 159.65 35.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.327 -0.99 . . . . 64.34 108.327 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.29 129.78 56.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.432 -0.581 . . . . 74.02 109.432 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.754 HD12 ' HB2' ' A' ' 57' ' ' GLU . 77.4 mt -99.1 -39.43 8.5 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.947 0.899 . . . . 65.43 110.965 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.7 178.43 8.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.627 0.771 . . . . 72.24 109.556 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -62.07 117.64 6.26 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.952 -0.758 . . . . 70.42 108.952 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 71.51 0.72 3.58 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.275 1.43 . . . . 64.34 112.835 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -108.51 119.02 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.567 -0.901 . . . . 74.44 108.567 178.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -130.14 141.1 50.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.952 0.501 . . . . 75.52 110.108 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.754 ' HB2' HD12 ' A' ' 51' ' ' LEU . 39.9 tt0 -104.03 142.49 34.36 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.419 0.688 . . . . 74.23 109.899 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.83 128.28 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.423 -0.954 . . . . 72.13 108.423 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.88 131.13 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.137 -0.69 . . . . 75.42 109.137 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.51 HD23 HD11 ' A' ' 106' ' ' LEU . 4.1 mm? -110.94 100.8 9.44 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.767 -1.197 . . . . 74.41 107.767 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.449 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 37.6 ttp85 -84.01 100.52 11.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.423 -0.954 . . . . 71.43 108.423 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.505 ' HB ' HD11 ' A' ' 114' ' ' ILE . 35.7 t -95.08 121.62 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.414 -0.958 . . . . 73.31 108.414 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.735 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.4 m -108.52 131.38 54.89 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.66 -0.496 . . . . 73.23 109.66 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG22 HG21 ' A' ' 114' ' ' ILE . 67.0 t -128.86 109.27 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.824 1.249 . . . . 74.55 107.805 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.8 m -108.1 151.49 25.81 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.062 -1.088 . . . . 74.41 108.062 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.28 128.14 23.49 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.149 -1.056 . . . . 71.13 108.149 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.505 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.7 m -137.54 127.61 25.94 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.202 0.456 . . . . 72.12 111.594 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.75 80.45 6.55 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.837 1.255 . . . . 74.4 108.354 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.53 -84.04 0.88 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.22 -1.152 . . . . 63.45 110.22 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.95 -12.94 5.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.132 0.973 . . . . 72.41 111.387 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.639 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.5 tp10 -90.17 99.77 12.73 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.634 . . . . 72.34 110.553 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 87.4 m -67.58 129.58 40.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.206 0.526 . . . . 64.51 111.985 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -76.12 -64.07 1.18 Allowed 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.394 0.678 . . . . 62.53 110.077 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.11 158.92 41.16 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.179 -0.919 . . . . 72.42 111.854 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.29 107.54 9.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.622 -1.172 . . . . 73.44 107.882 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.471 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -108.98 110.53 21.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.327 1.051 . . . . 74.41 109.191 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -130.29 117.37 19.71 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 63.5 108.603 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.423 HG11 ' SG ' ' A' ' 113' ' ' CYS . 66.1 t -123.63 120.55 60.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.745 0.818 . . . . 75.24 110.241 -173.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -90.68 82.49 5.76 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 124.217 1.007 . . . . 73.42 108.358 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.36 100.32 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.909 -1.041 . . . . 75.21 109.571 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.96 145.32 17.54 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.796 -0.521 . . . . 74.11 111.796 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.02 120.31 1.88 Allowed Glycine 0 CA--C 1.504 -0.624 0 N-CA-C 110.388 -1.085 . . . . 64.3 110.388 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.551 HG22 HD11 ' A' ' 51' ' ' LEU . 55.7 mt -87.45 127.72 40.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.555 -0.905 . . . . 74.35 108.555 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.683 ' HD2' HG12 ' A' ' 13' ' ' ILE . 1.4 m-85 -133.54 162.78 30.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 74.13 108.959 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.4 t -119.73 113.47 20.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 63.22 108.494 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.469 HD11 ' SG ' ' A' ' 97' ' ' CYS . 11.5 tt -126.71 148.71 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 122.964 0.506 . . . . 75.11 110.529 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 165.83 22.93 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.02 0.928 . . . . 75.44 109.308 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 8' ' ' GLU . . . 88.49 11.78 65.84 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.883 -0.954 . . . . 71.31 114.693 171.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.513 HG22 ' HG3' ' A' ' 9' ' ' MET . 1.6 pp -141.61 161.77 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.92 0.86 . . . . 75.41 112.24 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.8 tt0 -160.59 -175.59 5.08 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 124.951 1.3 . . . . 74.41 107.689 167.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.54 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.43 -140.04 31.5 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 118.04 0.382 . . . . 75.13 113.348 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -72.6 -29.94 63.93 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.386 0.674 . . . . 75.33 111.116 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -61.64 -45.69 92.97 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.604 0.762 . . . . 73.31 111.027 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.502 ' SD ' HD21 ' A' ' 98' ' ' LEU . 9.0 tmm? -66.64 -51.22 58.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.452 -0.795 . . . . 71.2 110.116 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.413 ' HB3' HD21 ' E' ' 280' ' ' LEU . . . -60.7 -22.74 64.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.021 0.928 . . . . 72.33 112.528 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -77.23 -32.16 55.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.548 0.739 . . . . 72.42 110.846 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.469 ' SG ' HD11 ' A' ' 86' ' ' ILE . 49.4 t -69.65 -64.52 0.86 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.375 0.27 . . . . 74.03 110.886 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.502 HD21 ' SD ' ' A' ' 94' ' ' MET . 1.2 pt? -67.97 -27.14 66.34 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 119.09 -0.481 . . . . 72.22 110.671 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -8.99 71.02 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 114.913 0.725 . . . . 73.33 114.913 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.399 1.099 . . . . 75.32 111.821 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.448 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.0 t80 -63.33 -62.51 1.64 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.202 1.001 . . . . 75.12 112.442 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.9 m -65.53 -33.29 7.32 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 114.114 1.153 . . . . 73.21 114.114 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.17 -50.79 12.42 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.451 2.1 . . . . 75.32 112.405 161.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -64.92 -22.63 67.03 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.606 0.762 . . . . 64.21 112.069 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.16 -50.34 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.385 -0.598 . . . . 72.2 109.385 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.51 HD11 HD23 ' A' ' 60' ' ' LEU . 77.7 mt -82.87 -19.54 37.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.736 -0.666 . . . . 63.34 112.749 -171.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -62.3 -42.97 83.79 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.09 0.956 . . . . 72.13 112.785 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -37.73 91.75 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.106 1.871 . . . . 73.12 113.713 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -71.21 -39.72 71.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.218 0.607 . . . . 73.53 111.487 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.402 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -65.76 -47.83 73.91 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.459 -0.571 . . . . 72.14 109.459 175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.42 ' NH1' HD13 ' C' ' 105' ' ' ILE . 37.4 ttm105 -51.61 -48.56 63.21 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.728 1.267 . . . . 71.31 110.891 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.95 -48.91 72.37 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.609 0.764 . . . . 72.03 110.906 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.423 ' SG ' HG11 ' A' ' 78' ' ' VAL . 48.8 t -62.16 -30.06 70.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.953 0.501 . . . . 74.22 111.958 -176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.4 mt -72.17 -59.16 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.375 -0.602 . . . . 72.33 109.375 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.7 m -51.48 -40.32 59.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.882 1.273 . . . . 74.04 112.676 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -66.4 -41.83 88.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.473 -0.785 . . . . 75.33 110.368 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.436 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 30.5 mtm -69.21 -35.62 76.4 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.468 0.307 . . . . 73.44 110.832 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.7 t -59.67 -44.27 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 O-C-N 123.848 0.717 . . . . 73.33 109.948 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -75.29 -32.25 60.94 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 116.059 -0.519 . . . . 72.52 111.411 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -68.84 -31.75 70.95 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.434 0.694 . . . . 72.13 110.528 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.3 7.15 68.91 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.531 0.519 . . . . 74.25 112.613 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 p 56.17 49.71 14.91 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 126.493 1.917 . . . . 74.35 112.483 175.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.42 161.61 23.89 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 113.028 -1.896 . . . . 73.34 108.329 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.836 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 33.5 Cg_endo -59.98 162.11 17.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.157 2.571 . . . . 74.0 111.982 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.55 137.7 46.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.535 0.684 . . . . 72.31 110.71 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.699 -1.137 . . . . 73.02 108.611 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -135.12 127.14 29.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.763 -0.828 . . . . 73.0 108.763 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.44 125.77 27.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.229 -0.656 . . . . 74.1 109.229 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.538 ' HB1' HD12 ' E' ' 291' ' ' LEU . . . -71.78 150.51 93.14 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 122.844 0.458 . . . . 72.14 111.382 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.488 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.2 Cg_exo -60.29 105.12 0.27 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.764 2.309 . . . . 74.41 111.931 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.36 116.16 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.132 -1.432 . . . . 70.21 107.132 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -77.86 83.05 4.21 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.691 0.62 . . . . 55.31 109.506 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -62.55 -33.39 74.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.088 -0.96 . . . . 73.55 110.555 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -56.74 -49.2 75.95 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.405 1.066 . . . . 74.3 110.41 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.73 80.32 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.151 0.907 . . . . 73.21 111.99 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.64 -46.03 70.4 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.324 0.65 . . . . 74.45 110.259 -176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -82.82 -35.61 26.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.553 0.741 . . . . 75.35 111.108 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.2 tpt -73.22 -32.09 64.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.202 0.601 . . . . 75.22 112.321 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.8 m-20 -64.4 -31.27 72.42 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.801 0.84 . . . . 73.13 111.238 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -82.48 -32.57 28.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.059 -0.973 . . . . 75.22 110.375 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 tp -67.05 -49.33 65.52 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.294 0.638 . . . . 74.35 110.765 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -169.74 -4.24 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 115.435 -0.802 . . . . 71.35 111.69 -174.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.741 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 29.1 tt0 69.33 147.93 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.523 1.529 . . . . 74.23 111.997 -169.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -72.24 133.45 45.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.049 0.54 . . . . 72.12 110.748 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.79 124.34 52.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.516 0.727 . . . . 72.42 109.354 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.51 66.12 0.41 Allowed Glycine 0 C--N 1.345 1.04 0 N-CA-C 111.672 -0.571 . . . . 74.0 111.672 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.82 145.72 28.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.473 0.709 . . . . 72.23 110.226 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.34 71.79 0.01 OUTLIER Glycine 0 C--N 1.346 1.136 0 N-CA-C 110.33 -1.108 . . . . 55.31 110.33 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.1 p -94.53 126.8 40.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.085 0.954 . . . . 72.03 111.749 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.678 ' H ' ' HG2' ' C' ' 90' ' ' GLU . 44.0 mt-10 -133.16 179.64 6.06 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.707 1.603 . . . . 73.04 107.597 170.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.92 133.27 50.91 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.72 -1.215 . . . . 65.31 107.72 172.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.483 ' HA ' ' O ' ' F' ' 275' ' ' LYS . 31.8 p-80 -121.4 145.82 47.52 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.678 0.275 . . . . 63.14 111.695 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.493 ' HB3' ' HG3' ' F' ' 274' ' ' GLN . 8.5 pt20 -91.11 -178.4 5.16 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.526 0.73 . . . . 74.21 110.953 172.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.12 160.16 23.2 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.914 -1.039 . . . . 75.31 110.305 170.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.229 -0.891 . . . . 73.24 109.77 -178.117 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.041 0.448 . . . . 75.14 109.805 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -166.57 132.68 2.37 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.948 -1.13 . . . . 65.43 107.948 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -79.11 75.23 5.64 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 122.37 1.081 . . . . 74.51 110.094 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -82.04 89.12 6.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.698 -1.137 . . . . 72.54 109.042 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -102.47 150.04 23.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.478 0.711 . . . . 72.51 109.657 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -140.0 105.16 5.02 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.654 -0.869 . . . . 75.0 108.654 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p -114.15 169.37 9.07 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 124.814 1.246 . . . . 64.21 109.706 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -69.77 -20.56 63.48 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.764 0.826 . . . . 70.33 111.089 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.579 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.1 ptm 58.45 174.65 0.06 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.14 2.176 . . . . 74.15 113.905 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.429 ' HB ' ' HB1' ' B' ' 87' ' ' ALA . 52.1 m -149.88 121.9 8.25 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.187 0.995 . . . . 54.23 108.348 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.466 ' HB2' ' HE3' ' B' ' 9' ' ' MET . 78.7 t80 -137.91 128.9 27.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.514 0.725 . . . . 74.52 109.824 -177.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 3.1 pm0 -147.25 129.35 15.52 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.657 0.783 . . . . 75.31 109.568 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.32 143.19 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.01 108.987 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -105.48 -50.78 3.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.505 0.322 . . . . 63.45 110.136 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -159.39 135.6 8.96 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.802 -167.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.14 129.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 75.01 109.162 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.428 ' HE1' HG13 ' B' ' 83' ' ' ILE . 17.5 p90 -157.81 151.26 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.525 0.679 . . . . 74.43 111.366 -173.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.6 m -76.26 122.13 23.94 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.672 -1.149 . . . . 73.23 109.099 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.93 -17.64 19.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.961 0.504 . . . . 70.32 112.082 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -167.97 139.16 2.85 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.104 0.252 . . . . 73.02 111.031 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.566 HD13 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -134.35 141.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.713 1.205 . . . . 71.31 109.414 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.6 t -139.15 137.14 35.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.779 1.232 . . . . 74.51 107.811 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.465 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -143.76 119.61 10.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.904 -1.517 . . . . 73.43 106.904 169.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 31.6 mt-10 -120.61 117.87 28.68 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.537 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -121.92 83.45 43.7 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.012 -0.736 . . . . 65.04 109.012 170.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.11 -24.77 32.27 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.879 2.386 . . . . 75.34 111.215 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -114.91 24.5 11.69 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.502 1.121 . . . . 75.05 109.785 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -44.08 -55.48 9.38 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.014 1.325 . . . . 74.02 114.047 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -77.61 -33.74 2.22 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.235 1.957 . . . . 75.41 111.89 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.517 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 70.5 m80 -96.0 4.3 52.76 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 124.245 1.018 . . . . 73.04 112.83 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.14 -25.78 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.886 0.875 . . . . 71.15 111.889 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -66.29 -26.5 67.35 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.594 1.158 . . . . 72.44 112.281 -174.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 24.4 pt20 -67.83 -33.58 75.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 110.047 -0.353 . . . . 74.52 110.047 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.529 ' HB2' HD12 ' B' ' 68' ' ' LEU . 80.1 mttt -108.27 65.48 0.63 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.584 -0.895 . . . . 73.3 108.584 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.39 108.32 14.9 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.698 -0.482 . . . . 65.41 109.698 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.432 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 161.5 -171.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.842 2.457 . . . . 75.41 109.605 157.133 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -58.56 128.36 83.16 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 122.635 0.374 . . . . 74.33 111.758 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -88.19 161.55 7.08 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.069 2.513 . . . . 75.23 112.099 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -75.49 107.53 7.68 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.92 -0.77 . . . . 72.04 108.92 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 142.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.198 -0.91 . . . . 64.11 110.693 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.407 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.7 tttm -139.39 144.1 38.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 75.12 109.528 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 84.7 mt -105.24 156.09 18.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.215 0.606 . . . . 71.4 110.702 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.463 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.8 t70 -152.04 109.97 3.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.967 -1.015 . . . . 64.24 108.409 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.36 128.89 55.46 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.607 -0.886 . . . . 75.32 108.607 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -131.45 145.19 51.67 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.78 0.832 . . . . 74.44 109.331 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 75.3 p -116.0 119.45 35.93 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.308 0.643 . . . . 72.12 110.308 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.93 139.79 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.765 -0.828 . . . . 53.33 108.765 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 p -143.32 162.85 34.61 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 111.763 0.283 . . . . 73.14 111.763 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 63.7 p -165.55 153.6 11.15 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.018 0.824 . . . . 72.43 110.024 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.0 126.51 31.48 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.098 -0.704 . . . . 74.41 109.098 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.564 HD13 ' HB2' ' B' ' 57' ' ' GLU . 34.5 mt -93.66 -49.37 5.9 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.37 0.668 . . . . 74.14 109.495 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.57 -166.21 2.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.536 -0.756 . . . . 71.14 110.845 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.84 108.95 1.11 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.669 1.188 . . . . 73.0 111.062 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 66.35 6.75 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.273 1.429 . . . . 54.2 112.107 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.98 115.05 46.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.752 -0.832 . . . . 75.41 108.752 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.83 144.82 50.09 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.563 -0.903 . . . . 73.51 108.563 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.564 ' HB2' HD13 ' B' ' 51' ' ' LEU . 38.4 tt0 -99.53 127.61 45.61 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.489 0.715 . . . . 71.51 109.539 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.0 116.95 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.408 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 48.4 t -103.64 128.82 56.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 107.379 -1.341 . . . . 75.44 107.379 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.01 100.15 7.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.063 -1.458 . . . . 75.14 107.063 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -85.7 108.28 17.96 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.0 -1.0 . . . . 71.0 109.159 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 102.88 14.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.567 -1.272 . . . . 75.21 107.567 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.1 m -101.68 130.35 48.03 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.341 -0.845 . . . . 75.24 108.757 177.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 71.7 t -118.14 133.47 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 124.166 0.986 . . . . 70.45 108.594 178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.407 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.5 m -118.88 144.45 46.39 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.927 0.891 . . . . 74.11 109.037 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.96 21.27 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.606 -1.257 . . . . 71.34 107.606 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.0 p -139.89 128.43 22.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.949 0.5 . . . . 70.45 111.825 -174.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' B' ' 34' ' ' LYS . 28.6 mt -95.48 100.96 12.64 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.563 1.145 . . . . 73.13 109.017 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.77 -125.44 10.02 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 112.007 -0.437 . . . . 74.13 112.007 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -99.06 18.69 16.74 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.763 0.825 . . . . 74.22 110.283 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.41 ' HB3' ' HZ3' ' B' ' 34' ' ' LYS . 10.8 tp10 -126.45 147.23 49.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.94 0.896 . . . . 71.01 109.888 -177.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.9 m -70.12 133.13 46.83 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.568 0.747 . . . . 75.43 110.717 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.473 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -86.66 -62.19 1.56 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.054 -0.721 . . . . 75.01 109.054 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -162.95 154.93 18.16 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.45 -1.25 . . . . 72.42 108.737 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.542 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 87.6 mt -130.92 144.91 51.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 70.01 108.386 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.1 t -147.55 152.56 38.19 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.746 -0.835 . . . . 73.24 108.746 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.4 tt0 -159.53 132.16 6.71 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.606 -0.887 . . . . 73.51 108.606 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.403 HG21 HD12 ' B' ' 21' ' ' ILE . 75.5 t -128.59 144.41 38.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.427 -0.953 . . . . 75.05 108.427 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.64 91.87 3.59 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.938 -1.134 . . . . 73.22 107.938 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.95 101.85 12.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.738 -0.838 . . . . 74.41 108.738 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.77 142.83 16.8 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 111.124 -0.79 . . . . 74.15 111.124 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 126.31 3.21 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.741 -0.944 . . . . 71.14 110.741 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.428 HG13 ' HE1' ' B' ' 17' ' ' TYR . 65.2 mt -84.25 123.2 38.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 108.431 -0.951 . . . . 73.4 108.431 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.75 134.74 45.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.321 1.048 . . . . 72.33 108.309 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 16.4 m -103.85 99.81 9.59 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.564 -1.273 . . . . 53.55 107.564 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.52 ' HB ' HD12 ' B' ' 89' ' ' ILE . 34.2 pt -107.03 139.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.368 0.667 . . . . 71.22 110.521 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.429 ' HB1' ' HB ' ' B' ' 10' ' ' THR . . . -156.52 161.49 40.0 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.11 0.964 . . . . 72.34 109.55 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.579 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.78 -59.17 4.94 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.259 -0.428 . . . . 74.42 113.298 176.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.52 HD12 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.19 125.87 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.355 0.598 . . . . 73.24 110.691 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.73 167.86 29.19 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.672 -0.695 . . . . 73.42 110.877 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -118.04 12.97 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.18 -0.918 . . . . 73.23 113.191 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.2 m -71.72 -35.01 70.06 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.343 0.657 . . . . 72.13 110.945 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -66.58 -36.89 83.73 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.184 -0.916 . . . . 72.2 111.093 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.544 ' HE2' ' HA ' ' H' ' 277' ' ' LEU . 16.9 ptp -60.28 -43.32 96.32 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 123.576 0.547 . . . . 71.34 110.008 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.4 69.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.492 0.717 . . . . 74.1 111.383 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -75.4 -40.66 57.57 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.888 0.475 . . . . 74.4 110.65 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -68.32 -67.48 0.46 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.011 0.524 . . . . 61.42 110.945 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' B' ' 94' ' ' MET . 4.0 pp -75.81 -12.62 60.21 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.917 0.487 . . . . 74.53 112.185 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -23.01 24.93 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.945 -0.364 . . . . 74.22 113.986 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.69 -58.7 1.16 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.2 0.5 . . . . 75.23 110.717 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.14 -50.78 72.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.489 1.115 . . . . 72.31 112.181 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.4 m -69.03 -47.27 30.12 Favored Pre-proline 0 CA--C 1.569 1.691 0 C-N-CA 123.481 0.712 . . . . 61.44 112.048 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.8 Cg_exo -53.71 -35.23 77.49 Favored 'Trans proline' 0 C--N 1.397 3.121 0 C-N-CA 122.721 2.28 . . . . 73.34 114.098 170.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . 0.542 HD22 ' HD1' ' B' ' 133' ' ' PHE . 0.9 OUTLIER -67.68 -24.57 65.43 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.399 0.68 . . . . 74.55 111.856 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.41 -45.24 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.997 0.519 . . . . 63.43 110.213 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.08 -21.92 49.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.732 -0.667 . . . . 72.53 112.066 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.451 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 75.5 t80 -56.67 -51.74 78.97 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 117.997 -1.001 . . . . 73.5 113.098 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.451 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.8 Cg_exo -58.25 -38.92 88.86 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.437 2.091 . . . . 74.51 113.584 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -67.5 -41.73 83.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.411 0.684 . . . . 74.4 111.191 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.24 88.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.018 0.527 . . . . 73.13 110.573 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.415 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.5 ttt180 -59.56 -60.27 4.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.69 1.596 . . . . 74.51 111.062 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.77 -31.12 70.49 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.38 1.072 . . . . 74.24 111.135 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.566 ' SG ' HD13 ' B' ' 21' ' ' ILE . 4.7 t -70.96 -36.65 72.66 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 122.483 -0.136 . . . . 60.11 111.022 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.3 mt -68.18 -45.92 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.167 0.587 . . . . 73.25 109.448 173.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.3 m -56.92 -38.68 73.21 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.749 -1.114 . . . . 75.22 111.164 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.9 t -63.97 -47.79 79.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.582 0.753 . . . . 71.41 110.667 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.454 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.1 mmt -72.14 -34.73 68.75 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.972 0.509 . . . . 74.02 111.573 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.7 t -67.64 -38.46 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.186 0.594 . . . . 72.11 110.15 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -67.97 -30.92 70.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.913 0.885 . . . . 72.42 111.013 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -72.62 -34.18 67.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.624 0.77 . . . . 75.51 110.504 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.32 3.39 53.54 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.626 0.579 . . . . 74.05 112.3 170.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.44 HG23 ' HB3' ' A' ' 17' ' ' TYR . 49.8 p 58.21 54.56 5.7 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.445 1.898 . . . . 73.21 111.357 175.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -119.44 154.1 54.08 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.139 -1.391 . . . . 54.53 110.265 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -60.22 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.319 2.679 . . . . 75.33 114.776 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.591 ' H ' HD22 ' F' ' 300' ' ' ASN . 15.6 tp60 -64.98 129.89 41.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.167 -0.924 . . . . 63.1 112.814 -159.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.9 84.78 2.24 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.439 -1.689 . . . . 74.35 106.439 170.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -115.73 127.55 55.21 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.352 -0.981 . . . . 70.15 108.352 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.415 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 4.3 mm? -72.07 147.86 46.35 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.871 0.732 . . . . 75.41 110.311 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.408 ' HB2' HD23 ' H' ' 291' ' ' LEU . . . -79.67 150.79 73.42 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 115.464 -0.789 . . . . 71.22 109.205 175.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.03 102.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.63 2.22 . . . . 64.23 110.938 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.23 110.23 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 109.284 -0.635 . . . . 74.34 109.284 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.456 ' ND2' ' HB3' ' B' ' 135' ' ' ALA . 44.6 t30 -85.75 88.32 7.53 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 73.34 108.8 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.542 ' HD1' HD22 ' B' ' 104' ' ' ASN . 98.7 m-85 -62.84 -26.03 68.56 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.438 -0.801 . . . . 73.22 111.378 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.28 -38.88 88.37 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.303 1.002 . . . . 74.1 110.641 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.456 ' HB3' ' ND2' ' B' ' 132' ' ' ASN . . . -58.92 -47.37 85.26 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.996 0.518 . . . . 75.32 110.689 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.87 -41.69 99.48 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.368 -0.833 . . . . 73.32 110.084 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -71.56 -28.39 63.81 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.922 -1.036 . . . . 72.11 111.296 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 19.2 mmt -69.22 -38.68 78.66 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.425 0.69 . . . . 73.42 110.012 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -79.49 -25.38 41.83 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.276 0.63 . . . . 62.02 111.111 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -63.62 -48.27 77.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.261 0.625 . . . . 74.04 111.144 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 pp -119.8 31.5 6.51 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.582 -0.735 . . . . 75.12 110.93 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.34 100.0 0.16 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.815 0.846 . . . . 74.02 110.777 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -155.14 109.94 2.99 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.336 -0.987 . . . . 65.53 108.336 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -104.86 147.18 28.02 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.684 -0.858 . . . . 74.43 108.684 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -134.95 137.63 43.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.68 0.792 . . . . 72.32 109.634 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.39 152.52 24.64 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.681 -0.568 . . . . 64.05 111.681 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -148.95 146.3 27.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.982 0.913 . . . . 75.23 109.239 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.37 86.53 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.27 -1.132 . . . . 71.53 110.27 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -135.78 140.32 44.19 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.488 0.715 . . . . 61.34 109.074 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -158.6 156.04 29.35 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.528 0.731 . . . . 64.31 110.495 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -166.04 135.41 3.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.285 1.034 . . . . 75.14 108.787 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -156.34 83.4 0.98 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.675 -0.861 . . . . 74.02 108.675 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -125.97 107.42 10.43 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 124.047 0.939 . . . . 74.1 108.899 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -138.04 110.27 7.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.898 0.879 . . . . 75.22 109.311 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.411 0.685 . . . . 63.21 109.986 -179.683 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.551 ' HE2' ' HG3' ' E' ' 287' ' ' PRO . 26.0 ttt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.3 p -96.2 13.66 26.67 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.63 0.772 . . . . 73.42 112.016 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 65.9 109.12 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.818 1.247 . . . . 75.13 111.466 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -74.74 79.1 2.06 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-O 122.108 0.956 . . . . 75.41 110.575 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.72 93.83 0.27 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.089 -0.96 . . . . 74.34 109.279 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -141.84 118.46 11.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.696 -0.684 . . . . 60.21 109.616 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -148.13 5.11 0.74 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.007 0.923 . . . . 73.25 109.079 166.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -68.93 126.61 30.33 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.217 1.007 . . . . 73.43 108.368 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.56 ' HB2' HG22 ' C' ' 89' ' ' ILE . 50.2 ttp 66.23 119.2 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.801 1.313 . . . . 74.21 111.878 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -86.02 78.01 9.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.286 -1.005 . . . . 72.34 108.286 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 35.0 t80 -112.42 133.96 54.22 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.035 -0.984 . . . . 73.25 109.096 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -154.76 142.15 19.61 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.201 0.6 . . . . 65.04 109.646 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -77.21 97.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.317 -0.856 . . . . 73.34 109.308 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.449 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.7 mm-40 -75.06 -42.11 57.66 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.603 -0.517 . . . . 75.03 109.603 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.491 ' NH2' ' HB3' ' G' ' 302' ' ' ASP . 49.7 ttt180 -174.25 147.42 1.2 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.274 0.984 . . . . 73.43 109.561 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.1 mt -129.1 142.03 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 107.62 -1.252 . . . . 74.32 107.62 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -172.64 158.29 4.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.468 0.651 . . . . 74.4 111.418 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 66.7 p -83.22 106.35 14.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.804 -1.089 . . . . 70.21 108.387 173.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -65.93 -47.47 74.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.554 0.692 . . . . 75.34 109.268 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -135.51 140.42 44.76 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.611 -1.177 . . . . 74.13 109.204 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.44 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 69.9 mt -134.22 138.32 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.325 -1.361 . . . . 73.34 107.325 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -154.79 150.53 27.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.964 0.411 . . . . 72.03 110.034 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.14 108.59 3.62 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.912 -1.144 . . . . 73.3 107.912 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.77 108.82 16.83 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.148 0.579 . . . . 73.24 109.546 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.14 85.45 18.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.398 -0.964 . . . . 70.32 108.398 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -36.22 31.69 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.009 2.473 . . . . 73.13 112.368 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -107.6 34.29 3.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.516 0.726 . . . . 73.22 109.413 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.48 -50.76 63.72 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.223 1.194 . . . . 72.41 114.223 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.97 -32.96 8.2 Favored 'Trans proline' 0 C--N 1.388 2.625 0 CA-C-N 121.036 1.406 . . . . 74.33 112.78 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.18 -37.13 75.08 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.836 0.854 . . . . 75.24 112.642 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.36 -21.09 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.165 0.586 . . . . 75.3 110.608 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.457 ' HE2' ' HB ' ' F' ' 301' ' ' ILE . 2.3 t80 -75.47 -2.26 27.96 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.268 0.627 . . . . 74.11 111.095 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -124.12 26.28 7.54 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.417 1.087 . . . . 74.25 109.837 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.633 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -111.98 147.44 35.93 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.248 1.019 . . . . 75.55 109.947 -178.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.44 131.13 49.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 73.42 111.114 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.429 ' HB3' ' HD2' ' F' ' 297' ' ' TYR . 20.4 m95 -71.61 93.57 1.24 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.148 0.979 . . . . 73.41 112.011 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -154.91 74.49 5.64 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.738 0.815 . . . . 70.34 108.991 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.765 ' HD2' ' HG2' ' F' ' 294' ' ' LYS . 55.7 Cg_endo -84.44 127.95 3.97 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.563 2.175 . . . . 74.21 112.357 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.56 97.22 10.4 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 106.502 -1.666 . . . . 74.13 106.502 166.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.96 117.05 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.57 -1.196 . . . . 73.3 109.8 -169.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -97.36 109.0 21.85 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.053 -1.091 . . . . 72.54 108.053 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tt -86.81 123.8 32.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.264 -1.754 . . . . 75.52 106.264 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.581 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.9 t70 -120.02 147.91 44.21 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.642 0.777 . . . . 75.21 109.462 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -134.54 131.85 38.44 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.396 1.078 . . . . 72.15 108.129 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.3 t70 -133.52 135.26 44.3 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.511 -0.551 . . . . 75.52 109.511 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -113.41 111.2 21.56 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.754 0.822 . . . . 72.21 109.559 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.79 157.62 35.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.204 1.002 . . . . 74.52 109.851 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 67.5 p -155.15 167.25 30.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.817 0.447 . . . . 75.15 110.95 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -164.86 127.34 2.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.661 0.785 . . . . 73.15 109.839 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.31 135.96 33.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.264 0.483 . . . . 75.42 109.784 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.539 HD13 HD13 ' C' ' 83' ' ' ILE . 41.2 mt -106.11 -47.01 3.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.03 0.932 . . . . 74.45 109.993 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.7 -178.01 5.45 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.138 0.975 . . . . 70.31 108.973 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.64 110.91 1.24 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.6 0.76 . . . . 71.31 111.019 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' C' ' 87' ' ' ALA . 19.1 m-20 62.85 30.75 16.6 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.493 1.117 . . . . 73.42 111.768 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -118.98 111.59 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.619 -1.252 . . . . 75.42 107.619 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -123.51 125.85 45.65 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.772 0.829 . . . . 52.24 109.81 -177.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.78 120.3 24.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 74.43 108.917 168.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -96.78 117.33 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.585 -1.265 . . . . 75.25 107.585 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.08 131.61 52.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.006 -1.109 . . . . 71.22 108.006 173.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.62 105.85 9.0 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.191 -1.04 . . . . 75.21 108.191 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.733 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 59.3 mtt180 -83.3 134.61 34.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.646 -0.502 . . . . 71.52 109.646 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.611 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.0 123.77 69.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.798 -1.556 . . . . 73.04 106.798 162.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.581 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.8 m -121.17 112.33 18.53 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.446 0.641 . . . . 72.54 109.321 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.591 HG23 HG21 ' C' ' 114' ' ' ILE . 51.5 t -101.13 117.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 73.13 108.586 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.426 HG21 HD21 ' C' ' 75' ' ' LEU . 4.4 m -115.13 141.89 47.4 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.667 -0.864 . . . . 71.54 108.667 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.07 123.0 22.54 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.941 -1.133 . . . . 73.23 107.941 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 127.07 16.97 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 122.852 0.461 . . . . 73.13 110.548 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.514 ' H ' HD12 ' C' ' 68' ' ' LEU . 1.5 mp -90.63 49.25 1.64 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.045 1.338 . . . . 54.44 109.121 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.01 -106.58 2.81 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.212 -0.903 . . . . 73.05 110.901 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -90.35 -30.88 17.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.962 0.905 . . . . 70.03 110.162 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -66.32 115.47 6.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.308 1.043 . . . . 74.43 109.891 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.2 m -89.82 125.6 35.38 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.714 0.688 . . . . 75.53 109.653 168.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.482 ' HB3' HD13 ' C' ' 68' ' ' LEU . . . -72.23 -64.02 1.03 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.79 -1.095 . . . . 65.1 109.502 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.59 170.16 23.02 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.564 -1.198 . . . . 73.32 110.814 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.426 HD21 HG21 ' C' ' 65' ' ' THR . 3.0 tm? -133.69 146.61 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.562 -2.014 . . . . 72.24 105.562 172.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.414 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -151.47 145.26 25.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.394 -0.965 . . . . 63.3 108.394 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . 0.447 ' HB2' HG22 ' C' ' 63' ' ' THR . 34.3 tt0 -157.56 136.37 11.5 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.294 -0.632 . . . . 73.42 109.294 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.58 123.7 49.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.114 -0.948 . . . . 74.32 108.927 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.678 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 29.1 mt-30 -92.33 87.56 6.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.656 -1.239 . . . . 75.41 107.656 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -79.08 96.88 5.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.317 -0.624 . . . . 73.12 109.317 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.07 149.05 24.88 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 115.26 -0.882 . . . . 50.33 111.577 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.92 117.23 0.81 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 110.825 -0.91 . . . . 73.13 110.825 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.546 HD11 ' HB3' ' D' ' 29' ' ' PRO . 14.5 mm -80.98 121.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.398 -0.964 . . . . 75.33 108.398 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.97 126.73 29.16 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.596 -0.89 . . . . 73.1 108.596 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -69.61 119.26 13.58 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.344 -0.984 . . . . 73.14 108.344 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.6 HG21 HD13 ' C' ' 89' ' ' ILE . 59.1 mt -116.3 100.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.066 -0.716 . . . . 73.23 109.066 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' C' ' 54' ' ' ASP . . . -148.71 164.47 34.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.648 1.179 . . . . 73.31 109.031 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.34 32.5 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 123.13 0.269 . . . . 70.55 112.988 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.6 HD13 HG21 ' C' ' 86' ' ' ILE . 11.9 pt -114.45 156.18 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.598 1.159 . . . . 73.25 110.37 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.678 ' HG2' ' H ' ' A' ' 150' ' ' GLU . 9.1 tp10 -164.96 156.21 14.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.945 -1.025 . . . . 71.21 109.264 -176.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.449 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 63.08 -110.37 3.32 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.423 0.452 . . . . 73.45 114.006 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -83.1 -27.19 30.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.664 0.386 . . . . 74.03 111.797 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -42.07 75.25 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.46 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.2 ptt? -63.57 -35.78 81.62 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.67 -0.696 . . . . 73.33 110.004 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.64 93.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.708 0.803 . . . . 60.11 112.024 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.494 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 47.7 t-80 -78.76 -20.92 48.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.304 -0.407 . . . . 73.41 111.265 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.5 t -82.56 -63.25 1.41 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.154 -0.342 . . . . 64.55 111.27 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.575 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 4.6 pp -77.51 -32.16 53.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.847 0.459 . . . . 70.52 111.387 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.34 8.77 64.7 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.727 -0.485 . . . . 73.44 113.702 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.494 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -148.64 -56.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.246 0.523 . . . . 75.3 111.838 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -74.49 -40.27 61.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.193 0.442 . . . . 75.43 112.193 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 85.4 m -64.84 -47.24 75.14 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.723 -0.656 . . . . 63.31 111.176 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 55.3 Cg_exo -57.34 -37.24 98.21 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.123 1.882 . . . . 72.24 113.023 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.09 -37.97 81.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.787 0.835 . . . . 74.33 111.348 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.42 HD13 ' NH1' ' A' ' 111' ' ' ARG . 35.2 mm -73.23 -46.78 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.242 0.617 . . . . 75.31 110.92 178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.92 -20.56 49.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.552 -0.749 . . . . 73.34 112.298 -172.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -58.56 -51.86 78.77 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.747 -1.121 . . . . 72.45 113.192 -175.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -56.71 -38.57 95.37 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.036 1.824 . . . . 74.21 113.518 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -69.16 -42.64 75.63 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.322 0.649 . . . . 75.52 111.517 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.72 99.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.255 0.622 . . . . 74.33 109.637 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.447 ' NH2' ' HB3' ' C' ' 127' ' ' ASN . 41.1 ttt180 -58.43 -53.88 53.34 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.924 1.69 . . . . 75.24 111.469 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.57 -34.77 78.64 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.579 0.549 . . . . 73.21 110.321 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 6.4 t -68.56 -32.91 73.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.034 0.534 . . . . 70.33 111.128 -179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.611 HD11 ' HB ' ' C' ' 62' ' ' VAL . 78.6 mt -71.52 -53.64 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.777 -0.647 . . . . 74.32 109.869 174.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.2 m -63.05 -28.87 70.38 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.258 0.623 . . . . 72.12 111.693 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.5 t -64.42 -51.51 62.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.498 0.719 . . . . 72.02 109.424 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.647 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.21 -38.9 81.05 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.325 1.05 . . . . 74.24 112.213 178.33 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 86.9 t -60.7 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.561 0.744 . . . . 73.1 109.749 176.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 41.1 t -67.08 -35.36 79.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.671 0.789 . . . . 73.31 112.083 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 116' ' ' SER . 82.0 mtt-85 -69.3 -31.84 70.6 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.432 0.693 . . . . 75.34 110.551 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.61 12.18 70.08 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.559 0.537 . . . . 71.41 113.073 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.479 HG21 ' HB3' ' D' ' 17' ' ' TYR . 6.9 p 64.84 20.88 12.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.652 1.981 . . . . 74.31 113.423 173.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -89.1 151.1 46.38 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.267 -0.642 . . . . 75.53 109.267 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.673 ' HG2' ' HB3' ' F' ' 297' ' ' TYR . 31.9 Cg_exo -61.78 144.28 96.87 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.205 2.603 . . . . 75.42 113.282 -176.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.457 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -51.08 111.07 0.5 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 71.51 111.415 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.11 85.71 2.16 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.332 -0.988 . . . . 74.14 108.332 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.447 ' HB3' ' NH2' ' C' ' 111' ' ' ARG . 17.5 m120 -91.6 109.32 20.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.47 -1.241 . . . . 73.45 108.427 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.65 135.08 57.29 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.263 0.977 . . . . 74.13 111.929 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.24 157.85 88.93 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.281 1.032 . . . . 65.12 110.345 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.54 105.49 0.76 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.389 2.059 . . . . 74.45 112.171 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.435 HG23 HD13 ' F' ' 291' ' ' LEU . 46.4 t -99.59 107.85 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.488 -1.301 . . . . 74.31 107.488 171.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -105.72 93.91 4.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.432 -0.803 . . . . 73.21 110.004 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -63.7 -41.84 98.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.117 -0.697 . . . . 73.22 109.117 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.416 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.9 p-10 -53.32 -46.96 69.64 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.959 1.304 . . . . 74.44 111.822 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.43 -38.28 74.53 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 123.9 0.88 . . . . 65.44 111.416 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.6 mp -64.1 -37.04 86.02 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.454 0.702 . . . . 75.02 111.946 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.69 -42.81 73.59 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 122.86 0.464 . . . . 75.42 111.087 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 75.3 mtm -72.05 -28.59 63.45 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.272 0.629 . . . . 74.55 111.129 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -60.46 -37.02 79.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.966 1.306 . . . . 74.52 110.717 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -59.73 -82.87 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 O-C-N 124.019 0.825 . . . . 74.31 109.883 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.498 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 17.5 tp 65.85 -176.35 0.18 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.159 0.984 . . . . 73.43 110.565 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . 0.498 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 63.2 tt0 -150.78 -43.79 0.12 Allowed 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.844 -0.535 . . . . 73.32 109.995 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -131.02 155.42 46.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.13 0.572 . . . . 74.42 109.69 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -86.36 170.78 11.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.883 0.473 . . . . 64.45 111.048 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.15 166.16 13.11 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.749 -0.66 . . . . 75.11 110.877 174.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.92 -166.0 35.74 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.724 -0.671 . . . . 75.34 111.907 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -164.19 135.86 4.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.872 0.869 . . . . 60.12 108.905 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.55 156.61 28.34 Favored Glycine 0 C--N 1.345 1.06 0 C-N-CA 121.669 -0.3 . . . . 74.54 113.215 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 28.7 m -104.47 93.0 4.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.883 0.873 . . . . 74.23 108.865 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -82.98 101.27 10.97 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.122 -0.49 . . . . 74.42 110.72 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -81.32 122.34 27.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.819 0.848 . . . . 73.43 110.111 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -114.08 86.28 2.39 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.937 -1.134 . . . . 75.01 107.937 173.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -81.94 127.31 32.91 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.067 -0.97 . . . . 72.41 109.418 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.56 155.57 39.0 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.261 0.624 . . . . 75.25 111.162 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.973 0 CA-C-N 115.363 -0.835 . . . . 73.24 110.469 -176.253 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 111.583 0.216 . . . . 70.52 111.583 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -153.73 59.91 0.74 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.04 0.936 . . . . 71.44 109.401 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.72 81.39 7.78 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.229 -0.896 . . . . 72.34 109.286 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.13 110.92 13.52 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.541 -0.754 . . . . 74.33 109.522 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -141.46 90.08 2.27 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.658 -0.868 . . . . 73.22 108.658 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -135.78 16.33 3.33 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.518 0.727 . . . . 73.52 110.568 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -155.66 162.55 40.57 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.332 0.653 . . . . 64.15 110.324 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 66.46 -178.31 0.2 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.254 1.422 . . . . 75.02 111.814 -173.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.602 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 2.1 ptm -32.93 140.43 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.819 1.248 . . . . 75.51 113.88 170.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 95.1 m -112.6 119.89 39.69 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.185 0.594 . . . . 75.0 110.381 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.8 t80 -138.98 122.56 17.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.053 -1.462 . . . . 72.05 107.053 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.5 130.52 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.446 -0.576 . . . . 64.22 109.446 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.88 125.79 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.67 -1.233 . . . . 74.43 107.67 168.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -99.06 -43.6 6.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.766 0.426 . . . . 71.4 110.259 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.629 HH11 HG12 ' F' ' 306' ' ' VAL . 7.8 tpt180 -179.69 141.0 0.15 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.827 0.851 . . . . 72.35 110.627 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.95 141.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.15 -1.055 . . . . 74.01 108.15 171.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.479 ' HB3' HG21 ' C' ' 122' ' ' THR . 27.1 p90 -156.55 173.39 16.99 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.847 0.832 . . . . 74.31 111.2 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -104.81 119.62 39.45 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.437 -1.256 . . . . 74.01 109.111 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.428 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -90.52 -26.87 19.54 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.279 -0.419 . . . . 72.33 110.42 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -159.71 110.72 1.97 Allowed 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.792 0.682 . . . . 72.24 109.278 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.647 HG21 ' HE1' ' C' ' 117' ' ' MET . 69.0 mt -111.27 149.44 14.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.708 -0.849 . . . . 74.04 108.708 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -148.82 142.29 25.3 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.955 0.902 . . . . 74.42 109.82 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.44 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.0 t80 -152.55 120.08 6.01 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 106.406 -1.702 . . . . 52.35 106.406 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.32 120.28 26.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.499 0.72 . . . . 73.02 109.269 -178.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.97 85.01 4.75 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.01 -1.107 . . . . 74.13 108.01 171.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.29 -28.68 8.49 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.114 2.543 . . . . 75.53 113.502 -167.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.402 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 14.5 m-80 -115.05 28.61 8.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.206 -0.664 . . . . 74.34 109.206 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.85 -66.1 0.47 Allowed Pre-proline 0 CA--C 1.566 1.569 0 N-CA-C 114.992 1.478 . . . . 73.13 114.992 -165.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.546 ' HB3' HD11 ' C' ' 83' ' ' ILE . 78.7 Cg_endo -77.22 -15.22 16.22 Favored 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.566 1.952 . . . . 75.42 113.199 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.432 ' HA ' HE21 ' D' ' 33' ' ' GLN . 19.5 t-160 -70.23 -38.87 75.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 74.12 109.609 174.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.61 -39.82 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.266 1.026 . . . . 75.22 110.66 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -75.85 -3.77 37.01 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.754 -1.112 . . . . 73.12 113.764 -168.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . 0.432 HE21 ' HA ' ' D' ' 30' ' ' HIS . 43.4 mt-30 -85.33 -6.88 59.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.774 0.83 . . . . 75.42 111.305 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -121.92 115.21 22.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.386 1.474 . . . . 73.23 108.093 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.58 ' HA ' ' HB ' ' G' ' 301' ' ' ILE . 3.8 p-10 -92.83 93.94 8.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.556 0.743 . . . . 71.14 112.381 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -165.22 -179.19 5.47 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.951 0.9 . . . . 73.31 111.848 177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.86 140.58 26.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.603 0.761 . . . . 74.42 111.935 -176.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.68 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 58.6 Cg_endo -75.03 156.13 42.83 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.019 2.479 . . . . 73.33 114.152 168.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -89.17 140.68 29.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.354 -1.294 . . . . 73.22 108.058 164.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.624 HG23 ' HE1' ' G' ' 290' ' ' TRP . 4.6 m -119.78 119.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.337 0.655 . . . . 74.43 110.778 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.43 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 61.7 tttt -98.74 137.15 37.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.93 0.892 . . . . 71.0 109.339 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.61 123.51 44.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.589 0.756 . . . . 64.22 109.789 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.618 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.2 m-20 -118.84 127.49 53.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.15 0.98 . . . . 75.04 108.541 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' G' ' 286' ' ' MET . 3.8 mp -109.06 138.17 45.83 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.251 -0.648 . . . . 73.33 109.251 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.1 t70 -150.49 152.94 34.98 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.536 0.735 . . . . 73.23 109.082 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 20.6 p -140.94 160.88 39.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.008 0.923 . . . . 74.45 110.393 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.95 167.82 29.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.006 0.922 . . . . 73.33 109.593 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 42.2 p -159.07 153.01 23.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.176 0.59 . . . . 75.14 109.799 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 92.6 p -151.9 149.08 28.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.281 -0.637 . . . . 74.42 109.281 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -89.01 118.35 28.68 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.35 -0.611 . . . . 70.51 109.35 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.583 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.6 mt -92.02 -36.7 13.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.021 0.529 . . . . 74.32 110.152 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.506 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.33 -179.75 8.22 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.294 -0.867 . . . . 71.43 109.955 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.41 125.85 28.83 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.987 -0.746 . . . . 63.54 108.987 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 65.82 14.84 9.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.374 1.07 . . . . 74.34 111.773 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 41.9 t -129.57 124.74 60.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 124.125 0.97 . . . . 75.31 109.145 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.61 ' HB2' HD13 ' D' ' 86' ' ' ILE . 62.7 m-85 -136.1 141.18 44.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.342 0.591 . . . . 73.55 109.805 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.583 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.6 tt0 -91.83 132.66 36.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.471 -1.24 . . . . 74.32 109.792 173.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.57 125.85 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 107.541 -1.281 . . . . 72.33 107.541 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 34.1 t -110.15 129.58 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.039 -0.726 . . . . 74.41 109.039 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.489 HD21 HD11 ' D' ' 106' ' ' LEU . 1.8 mm? -118.65 106.21 12.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.529 0.731 . . . . 73.51 109.599 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.514 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.7 ttm180 -88.39 102.03 14.47 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.622 -0.717 . . . . 74.42 109.443 177.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -91.74 121.18 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.786 -1.19 . . . . 74.23 107.786 170.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.618 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.4 m -127.0 146.07 50.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.602 0.761 . . . . 61.4 109.298 -175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.481 HG12 HD22 ' D' ' 126' ' ' LEU . 54.0 t -139.5 111.74 5.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.997 1.319 . . . . 65.02 109.038 -172.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.43 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.2 m -96.75 95.63 8.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.768 -0.827 . . . . 60.2 108.768 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.82 44.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.35 -0.611 . . . . 73.4 109.35 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.49 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.0 m -142.33 141.1 32.32 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.361 0.665 . . . . 74.15 110.778 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.68 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 0.3 OUTLIER -132.17 135.64 46.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.912 1.285 . . . . 64.05 110.17 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 -114.51 5.57 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.902 -0.879 . . . . 74.15 110.902 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.61 4.69 12.36 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.039 0.535 . . . . 73.52 110.418 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -127.36 161.84 27.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.074 0.55 . . . . 73.02 110.946 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -80.75 131.55 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.964 0.505 . . . . 73.35 111.469 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.49 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -72.68 -71.62 0.28 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.754 1.222 . . . . 74.14 108.379 173.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -153.93 140.32 18.68 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.746 -0.661 . . . . 73.25 111.033 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.37 110.2 22.17 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.272 -1.381 . . . . 65.25 107.272 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.583 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 48.2 t -119.0 132.89 56.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.478 -0.564 . . . . 74.51 109.478 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -152.08 132.13 13.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.14 0.576 . . . . 61.23 110.249 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.71 117.35 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.356 0.663 . . . . 73.1 109.669 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -87.28 87.33 7.4 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.852 -1.166 . . . . 73.51 107.852 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.33 91.17 5.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.289 -0.869 . . . . 71.42 108.796 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.94 143.61 17.61 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.071 -0.811 . . . . 53.14 111.071 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.92 132.13 5.08 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 111.209 -0.756 . . . . 72.12 111.209 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.509 HG22 HD13 ' D' ' 51' ' ' LEU . 49.1 mt -88.19 124.37 41.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 108.407 -0.96 . . . . 73.23 108.407 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -129.48 160.77 32.13 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.26 0.552 . . . . 74.1 110.112 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 35.5 m -104.9 117.19 33.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.992 -1.114 . . . . 74.51 107.992 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.61 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.4 mp -118.15 108.76 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.197 -0.668 . . . . 75.35 109.197 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.32 160.82 41.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.037 0.935 . . . . 74.01 110.014 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 79.01 -4.13 62.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.728 -0.669 . . . . 73.41 113.904 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.439 HD12 HG21 ' D' ' 86' ' ' ILE . 15.0 pt -126.65 142.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.123 0.969 . . . . 73.14 109.696 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.8 167.21 22.68 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.43 0.692 . . . . 74.34 110.114 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.17 -122.7 27.1 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 124.605 1.191 . . . . 72.05 114.606 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 m -66.27 -44.38 83.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.162 0.985 . . . . 72.44 112.128 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.69 -38.33 88.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.027 0.531 . . . . 70.43 110.873 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.67 -0.695 . . . . 72.44 110.199 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -28.7 67.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.748 0.819 . . . . 71.32 111.767 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -78.69 -30.64 46.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.745 . . . . 74.12 110.513 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -76.61 -50.86 12.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.295 0.569 . . . . 72.23 110.071 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.591 HD11 HG12 ' D' ' 86' ' ' ILE . 6.3 tt -81.96 -23.28 36.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.654 -0.703 . . . . 65.24 111.124 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.18 57.09 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.447 -0.641 . . . . 61.1 114.145 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.414 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -141.01 -53.96 0.48 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.868 0.834 . . . . 73.55 111.782 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -73.89 -54.32 8.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 72.51 110.978 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 61.2 m -59.25 -44.95 99.14 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 113.895 1.072 . . . . 74.22 113.895 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.72 -35.49 94.51 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 121.915 1.743 . . . . 71.12 112.794 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -80.78 -7.57 59.43 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.518 0.727 . . . . 70.23 111.415 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.71 -37.38 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.491 0.662 . . . . 74.44 109.747 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.489 HD11 HD21 ' D' ' 60' ' ' LEU . 50.9 mt -81.79 -32.02 31.55 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.129 -0.941 . . . . 74.25 111.409 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.54 -44.21 98.84 Favored Pre-proline 0 CA--C 1.572 1.805 0 N-CA-C 114.195 1.183 . . . . 63.41 114.195 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.56 -39.99 78.09 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.317 2.011 . . . . 72.11 113.421 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -74.9 -33.61 62.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.295 0.638 . . . . 72.44 110.97 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.35 88.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.217 0.607 . . . . 72.35 109.994 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.485 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.4 ttp180 -59.42 -52.19 66.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 114.412 -1.267 . . . . 73.33 110.754 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.72 -45.34 94.39 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.176 0.923 . . . . 74.23 110.925 -175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.3 -41.47 84.51 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.761 0.663 . . . . 75.43 110.953 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.568 HG22 ' SG ' ' D' ' 76' ' ' CYS . 47.6 mt -63.29 -55.66 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.612 -0.722 . . . . 74.52 110.39 174.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -53.49 -39.68 64.76 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.337 1.055 . . . . 64.43 111.47 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 20.6 t -65.95 -45.91 80.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.987 -1.006 . . . . 74.22 110.501 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.583 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.9 mtm -67.39 -35.89 80.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.967 0.507 . . . . 74.11 111.776 -178.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.444 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.7 t -64.04 -43.59 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 123.838 0.711 . . . . 75.14 109.399 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.0 p -71.62 -29.32 64.53 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.007 0.523 . . . . 73.51 111.87 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' D' ' 116' ' ' SER . 86.3 mtt-85 -72.86 -34.28 66.64 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.574 0.75 . . . . 74.21 110.473 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 9.01 63.96 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.759 0.662 . . . . 74.44 112.202 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.4 p 62.14 18.7 10.29 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.935 2.094 . . . . 64.35 113.544 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -83.34 165.46 40.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 107.557 -1.275 . . . . 75.05 107.557 162.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -84.05 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.284 1.989 . . . . 74.15 113.549 -165.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -74.44 120.57 20.18 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 122.442 0.297 . . . . 74.1 110.891 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.481 HD22 HG12 ' D' ' 64' ' ' VAL . 63.1 tp -116.51 95.0 4.85 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 72.15 108.184 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.27 104.26 13.61 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.508 -0.923 . . . . 71.23 108.508 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.485 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.5 mm? -62.99 113.87 3.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.607 0.763 . . . . 75.12 109.372 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.16 137.12 97.02 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 122.946 0.499 . . . . 74.32 110.477 -176.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -65.3 131.63 28.92 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.939 2.426 . . . . 72.45 112.273 -173.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.593 HG22 HD22 ' G' ' 291' ' ' LEU . 65.1 t -109.28 130.92 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.23 0.612 . . . . 73.34 109.788 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -86.6 85.51 7.3 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.428 -0.953 . . . . 71.54 108.428 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -63.46 -22.49 66.92 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.377 -0.829 . . . . 72.43 111.185 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.414 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 6.5 t70 -59.88 -53.85 53.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.924 1.29 . . . . 73.14 111.566 -176.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.421 ' HA ' ' CE ' ' D' ' 138' ' ' MET . . . -64.32 -43.25 95.27 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.344 -0.844 . . . . 71.44 111.468 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 65.4 mt -62.53 -37.88 87.79 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 124.208 0.942 . . . . 71.45 111.261 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -67.55 -47.26 70.38 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.44 -0.8 . . . . 73.52 110.517 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.467 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 71.4 mtm -62.89 -41.99 99.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.121 0.568 . . . . 72.23 110.894 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.7 -27.32 66.33 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.769 0.828 . . . . 74.42 112.425 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -65.37 -48.98 71.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.91 0.484 . . . . 74.53 110.561 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.03 -27.05 68.85 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.667 0.787 . . . . 75.01 111.352 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' D' ' 138' ' ' MET . 19.6 mt-30 -74.72 1.98 11.08 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.979 0.912 . . . . 75.11 112.795 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.92 44.44 1.47 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.141 0.496 . . . . 75.21 111.433 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.75 167.64 18.73 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.894 0.877 . . . . 74.23 109.92 173.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.47 25.28 9.22 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.741 0.816 . . . . 75.03 112.139 -171.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.9 -69.49 3.36 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.211 -0.449 . . . . 63.22 112.543 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.59 122.96 21.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.166 0.986 . . . . 72.51 110.581 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.22 -145.03 4.9 Favored Glycine 0 C--N 1.346 1.087 0 C-N-CA 121.169 -0.539 . . . . 73.32 113.281 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 44.8 m -63.98 106.33 1.02 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.406 0.683 . . . . 75.3 110.48 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . 0.526 ' HB2' HE21 ' G' ' 274' ' ' GLN . 17.0 pt-20 -147.28 137.91 23.49 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.434 -0.803 . . . . 73.33 109.139 -176.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -86.58 141.1 29.26 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.339 -0.846 . . . . 74.32 110.576 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -70.45 108.35 4.24 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.594 -0.891 . . . . 61.52 108.594 173.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . 0.453 ' HG3' ' HA2' ' G' ' 279' ' ' GLY . 0.1 OUTLIER -84.9 116.36 23.29 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.244 -1.391 . . . . 71.44 107.244 176.621 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.1 87.72 3.0 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.944 0.778 . . . . 70.44 110.075 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 N-CA-C 107.621 -1.252 . . . . 63.5 107.621 178.054 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.934 0.397 . . . . 62.04 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -70.7 91.03 0.79 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.904 0.859 . . . . 54.51 110.278 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.08 -138.01 0.27 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.37 1.068 . . . . 73.44 109.522 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -74.73 81.16 2.06 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.028 0.918 . . . . 75.51 110.239 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -82.69 147.87 56.53 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 113.905 -1.498 . . . . 74.11 108.515 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -40.94 98.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 123.148 2.566 . . . . 74.34 112.91 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.56 -48.49 7.54 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 113.59 -1.641 . . . . 70.24 109.964 -168.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 89.1 mt -72.36 126.35 29.6 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.78 0.832 . . . . 72.23 111.802 -171.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -160.47 143.47 9.04 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 118.82 -0.989 . . . . 64.43 110.861 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.413 HD21 ' HB3' ' A' ' 95' ' ' ALA . 59.0 tp 66.1 107.84 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.754 1.221 . . . . 75.32 110.844 -175.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -171.7 -57.87 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 CA-C-O 121.154 0.502 . . . . 75.53 111.802 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -82.9 27.4 0.54 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.254 1.022 . . . . 63.23 112.092 -173.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -99.83 142.1 31.76 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.142 0.977 . . . . 73.24 108.994 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.55 70.86 1.9 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 111.286 -0.726 . . . . 74.41 111.286 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -102.79 -22.46 13.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.896 1.278 . . . . 75.33 109.375 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 286' ' ' MET . . . . . 0.568 ' HB3' HG22 ' E' ' 288' ' ' VAL . 64.9 mtt -100.54 114.59 65.78 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.235 1.014 . . . . 74.32 110.351 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . 0.551 ' HG3' ' HE2' ' C' ' 1' ' ' MET . 26.0 Cg_endo -92.63 38.5 0.24 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.458 2.772 . . . . 72.02 112.249 173.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . 0.568 HG22 ' HB3' ' E' ' 286' ' ' MET . 66.4 t -66.05 128.72 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.799 0.839 . . . . 61.23 111.353 -171.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -149.92 -166.1 2.45 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 124.525 1.13 . . . . 74.43 108.555 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . 0.437 ' NE1' ' HB2' ' A' ' 42' ' ' LEU . 98.6 m95 -77.32 118.39 19.76 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.339 -0.615 . . . . 74.43 109.339 172.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.59 ' H ' HD13 ' E' ' 291' ' ' LEU . 0.0 OUTLIER -82.86 -11.43 58.23 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.446 1.098 . . . . 72.42 110.602 178.899 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . 0.456 ' HA2' ' SG ' ' G' ' 308' ' ' CYS . . . -126.99 177.48 17.33 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 115.328 -0.851 . . . . 73.34 112.472 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.15 147.22 66.28 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.202 2.601 . . . . 63.42 112.67 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.94 82.96 6.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.524 0.73 . . . . 74.24 109.434 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' G' ' 305' ' ' ALA . . . -71.33 -77.83 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.265 -0.643 . . . . 64.33 109.265 175.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 296' ' ' THR . . . . . 0.578 ' HB ' ' HG2' ' A' ' 38' ' ' PRO . 1.9 m 58.59 12.1 2.0 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 125.005 1.322 . . . . 74.52 112.7 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.836 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 0.6 OUTLIER -151.31 -171.67 4.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.761 1.624 . . . . 73.03 108.664 176.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 54.9 m80 74.85 28.95 1.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.383 1.473 . . . . 74.02 111.433 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -148.76 11.5 1.1 Allowed Glycine 0 C--N 1.357 1.727 0 N-CA-C 115.956 1.143 . . . . 71.4 115.956 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -169.58 -165.4 0.5 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.263 -1.014 . . . . 74.31 108.263 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 68.3 mt 66.94 96.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.291 1.436 . . . . 71.05 109.269 -176.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.52 -68.67 0.79 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.322 -0.853 . . . . 55.32 111.279 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' E' ' 304' ' ' PRO . 65.6 tttp -175.34 127.78 0.39 Allowed Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.395 0.678 . . . . 74.44 109.54 -174.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' E' ' 303' ' ' LYS . 2.9 Cg_endo -83.35 50.06 3.16 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.481 2.787 . . . . 65.43 111.944 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -171.03 127.52 0.71 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.001 0.92 . . . . 73.1 109.305 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 83.0 t -127.62 142.37 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.611 0.764 . . . . 75.33 109.232 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 307' ' ' THR . . . . . 0.478 ' HB ' ' HD2' ' G' ' 293' ' ' PRO . 18.9 m -70.4 128.38 35.97 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.35 0.66 . . . . 74.42 110.024 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 29.7 p -76.43 172.47 12.88 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.324 0.65 . . . . 72.22 111.162 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 34.3 p -65.27 113.3 10.84 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.489 0.716 . . . . 62.24 110.16 173.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 C--N 1.381 2.286 0 C-N-CA 123.322 2.682 . . . . 71.14 111.434 177.892 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 110.161 -0.311 . . . . 64.43 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -153.22 170.18 21.2 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.201 1.0 . . . . 74.24 108.472 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -73.24 79.94 1.31 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.669 0.747 . . . . 64.33 109.532 175.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . 0.493 ' HG3' ' HB3' ' A' ' 153' ' ' GLN . 6.5 tp-100 -133.17 -11.58 2.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.673 1.189 . . . . 75.44 108.821 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 152' ' ' HIS . 25.5 tptp 68.22 99.81 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 124.257 1.023 . . . . 75.31 111.507 166.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.91 156.89 8.67 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.319 2.012 . . . . 74.44 111.287 167.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.6 -40.2 95.09 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.419 0.628 . . . . 75.34 110.16 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . 0.402 HD11 ' CD2' ' F' ' 281' ' ' PHE . 3.0 mm? -98.34 66.04 1.72 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.372 0.669 . . . . 71.43 109.267 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -99.29 -60.41 0.86 Allowed Glycine 0 C--N 1.356 1.649 0 CA-C-N 115.695 -0.684 . . . . 52.32 112.029 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -68.04 -19.14 64.87 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.6 0.76 . . . . 64.13 111.217 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . 0.402 ' CD2' HD11 ' F' ' 278' ' ' LEU . 24.2 t80 -74.73 -11.22 60.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.538 1.135 . . . . 74.3 111.668 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.36 68.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.51 0.724 . . . . 61.21 110.554 172.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -137.7 96.33 3.22 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.9 0.88 . . . . 74.21 109.473 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -94.61 61.68 1.71 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.017 -0.833 . . . . 70.43 111.017 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -72.4 87.36 1.16 Allowed 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.079 0.552 . . . . 73.32 109.852 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 51.4 tpp -97.04 123.69 52.36 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 107.427 -1.323 . . . . 71.43 107.427 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.88 74.86 2.26 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.61 2.207 . . . . 74.45 112.286 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 45.3 t -80.84 96.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 108.138 -1.06 . . . . 73.22 108.138 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -95.52 34.07 1.52 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.165 0.986 . . . . 74.51 110.543 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . 0.472 ' HE3' ' H ' ' F' ' 291' ' ' LEU . 7.0 m95 61.37 162.99 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.529 1.531 . . . . 74.13 113.05 -173.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.472 ' H ' ' HE3' ' F' ' 290' ' ' TRP . 51.7 mt -118.47 -21.54 7.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 113.807 -1.542 . . . . 73.31 109.282 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -149.16 96.62 0.17 Allowed Glycine 0 C--N 1.358 1.766 0 C-N-CA 124.252 0.93 . . . . 51.42 111.163 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.66 -65.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 123.066 2.511 . . . . 75.32 114.114 -170.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . 0.765 ' HG2' ' HD2' ' C' ' 38' ' ' PRO . 0.0 OUTLIER -96.99 14.83 24.18 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.692 0.758 . . . . 75.22 110.081 -174.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.04 -14.96 63.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.863 0.865 . . . . 75.11 112.625 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 32.5 m -59.73 -55.78 30.05 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.458 0.703 . . . . 74.13 110.854 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.673 ' HB3' ' HG2' ' C' ' 124' ' ' PRO . 16.4 p90 -146.82 106.31 3.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.476 0.655 . . . . 75.3 111.448 169.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 62.1 t60 -80.92 -41.14 23.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.673 -1.148 . . . . 72.42 108.808 167.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 165.25 50.94 0.02 OUTLIER Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.548 -0.751 . . . . 75.21 112.506 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . 0.591 HD22 ' H ' ' B' ' 125' ' ' GLN . 61.0 t30 -84.26 -51.71 6.8 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.323 0.583 . . . . 74.15 110.064 176.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.457 ' HB ' ' HE2' ' C' ' 32' ' ' PHE . 47.6 pt -87.14 37.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 115.18 -0.918 . . . . 62.42 109.982 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.33 -25.79 68.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.067 1.347 . . . . 74.12 111.649 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -99.86 129.38 28.71 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.58 0.752 . . . . 74.2 109.569 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -84.4 23.25 0.85 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.669 2.913 . . . . 72.34 113.957 -172.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -158.5 141.38 14.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.676 0.79 . . . . 74.24 109.346 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . 0.629 HG12 HH11 ' D' ' 15' ' ' ARG . 17.4 m -88.81 -51.57 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 123.107 0.255 . . . . 74.01 110.338 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 307' ' ' THR . . . . . 0.606 HG23 ' HB3' ' H' ' 291' ' ' LEU . 64.1 m -161.65 125.81 3.32 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.676 -1.231 . . . . 74.33 107.676 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 60.7 m -85.31 82.8 8.19 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.863 -0.791 . . . . 74.12 108.863 172.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' F' F ' 309' ' ' THR . . . . . 0.424 ' HA ' ' HD3' ' F' ' 310' ' ' PRO . 8.0 t -115.36 134.52 22.58 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 123.104 0.562 . . . . 72.13 110.753 -174.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' F' ' 309' ' ' THR . 6.9 Cg_endo . . . . . 0 C--N 1.375 1.974 0 C-N-CA 122.861 2.374 . . . . 75.53 111.124 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.992 -0.373 . . . . 75.51 109.992 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -99.81 159.71 14.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.546 0.738 . . . . 73.53 109.931 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -114.09 26.85 9.96 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.143 0.973 . . . . 74.22 109.57 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . 0.526 HE21 ' HB2' ' D' ' 150' ' ' GLU . 62.6 mt-30 -89.6 -163.94 1.08 Allowed 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.152 -0.931 . . . . 74.44 109.933 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -63.06 134.45 95.81 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 118.518 -0.753 . . . . 74.43 109.047 171.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -49.81 -43.24 41.55 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.946 2.431 . . . . 74.22 113.033 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.418 HD23 HG22 ' D' ' 86' ' ' ILE . 3.2 tm? -106.88 111.63 24.22 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.127 -1.064 . . . . 72.04 108.127 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 70.06 166.8 0.29 Allowed 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.593 1.183 . . . . 72.33 112.992 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . 0.453 ' HA2' ' HG3' ' D' ' 153' ' ' GLN . . . 158.29 -73.11 0.23 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 114.791 -1.095 . . . . 61.52 111.235 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.22 137.43 33.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.069 0.548 . . . . 74.54 111.073 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 22.1 t80 176.88 174.78 0.39 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.641 1.577 . . . . 75.33 108.459 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . 77.27 89.18 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.598 1.559 . . . . 53.14 111.845 171.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -150.87 145.03 25.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.99 1.316 . . . . 72.15 108.606 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -120.96 0.76 11.84 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.842 -0.421 . . . . 75.1 113.074 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -94.88 58.79 2.28 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.377 0.589 . . . . 54.14 109.865 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 286' ' ' MET . . . . . 0.519 ' HB2' HD22 ' D' ' 44' ' ' LEU . 94.8 mmm -102.64 98.71 11.57 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 109.064 -0.717 . . . . 74.52 109.064 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.3 97.6 1.14 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.841 2.361 . . . . 73.23 111.087 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 10.4 p -99.79 5.14 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 C-N-CA 123.585 0.754 . . . . 72.35 110.187 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? 71.54 4.32 5.0 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.911 1.284 . . . . 75.14 111.352 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.624 ' HE1' HG23 ' D' ' 40' ' ' VAL . 0.1 OUTLIER 62.15 27.4 16.49 Favored 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 124.595 1.158 . . . . 75.25 110.349 -173.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.593 HD22 HG22 ' D' ' 131' ' ' VAL . 4.8 mp 53.54 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.727 1.611 . . . . 64.43 112.889 173.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -163.52 139.89 6.15 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.509 -1.036 . . . . 63.01 110.509 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' E' ' 307' ' ' THR . 72.9 Cg_endo -76.68 117.54 4.56 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.693 2.262 . . . . 72.22 112.707 -173.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -76.64 140.86 41.12 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.417 -0.957 . . . . 74.15 108.417 165.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -68.49 139.02 55.66 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 123.519 0.512 . . . . 63.21 109.75 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 8.3 p -98.79 -65.35 0.97 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.598 0.759 . . . . 71.43 109.819 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -118.72 140.91 49.18 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.353 -0.61 . . . . 74.32 109.353 172.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.74 -42.71 63.78 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.046 0.538 . . . . 73.21 109.941 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 175.53 54.47 0.06 OUTLIER Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.134 -0.786 . . . . 75.04 111.134 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . 0.528 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 9.8 p30 -157.19 -174.21 4.8 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.323 0.649 . . . . 65.53 109.837 -176.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.58 ' HB ' ' HA ' ' D' ' 35' ' ' ASP . 10.2 tp -155.44 9.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.749 0.42 . . . . 74.41 111.051 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . 0.491 ' HB3' ' NH2' ' C' ' 15' ' ' ARG . 31.0 t70 70.16 98.88 0.06 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.556 1.543 . . . . 73.15 110.765 -167.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -134.29 85.72 37.86 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 107.58 -1.267 . . . . 74.25 107.58 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.91 120.37 7.6 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.238 1.959 . . . . 74.31 110.092 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . 0.403 ' HB2' ' HB2' ' E' ' 295' ' ' ALA . . . -66.59 83.76 0.1 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.315 0.646 . . . . 75.14 110.534 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 61.5 t -116.5 89.98 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 106.187 -1.783 . . . . 73.2 106.187 174.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 25.9 p -117.76 12.0 13.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.935 0.894 . . . . 75.23 111.143 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . 0.456 ' SG ' ' HA2' ' E' ' 292' ' ' GLY . 21.2 p -166.69 126.49 1.54 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.609 0.764 . . . . 72.42 110.287 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 39.0 m -142.99 69.55 18.45 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.455 1.102 . . . . 74.22 108.218 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.381 2.285 0 C-N-CA 123.365 2.71 . . . . 72.44 110.905 -179.378 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.512 0.196 . . . . 71.23 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -122.24 119.26 30.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.638 0.775 . . . . 63.24 108.989 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.68 178.58 6.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.731 0.812 . . . . 75.14 109.645 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . 0.415 ' NE2' ' HB3' ' B' ' 87' ' ' ALA . 79.2 mt-30 -58.21 -49.23 77.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.94 0.496 . . . . 71.31 110.377 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -168.83 163.39 7.88 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 125.406 1.482 . . . . 75.24 109.053 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.96 -31.34 56.26 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.603 2.202 . . . . 75.23 112.793 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.544 ' HA ' ' HE2' ' B' ' 94' ' ' MET . 9.2 mp 62.24 -165.56 0.23 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.299 1.04 . . . . 73.0 111.27 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 8.0 mp 68.99 -159.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.983 0.913 . . . . 74.35 111.36 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 117.6 -45.72 1.24 Allowed Glycine 0 C--N 1.352 1.426 0 N-CA-C 112.087 -0.405 . . . . 74.24 112.087 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.3 -23.89 64.79 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.335 0.654 . . . . 74.05 110.507 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -72.95 173.53 9.12 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.585 -0.734 . . . . 75.32 111.424 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . 59.0 28.18 17.35 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 124.039 0.837 . . . . 75.4 109.874 -170.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -165.34 -89.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.154 -1.385 . . . . 64.24 107.602 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 56.37 30.38 58.34 Favored Glycine 0 C--N 1.353 1.474 0 C-N-CA 123.05 0.357 . . . . 74.42 112.783 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -77.71 80.37 4.17 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.811 0.844 . . . . 71.24 109.949 -174.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 286' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' H' ' 287' ' ' PRO . 73.8 mtm -115.66 132.22 23.26 Favored Pre-proline 0 C--O 1.238 0.493 0 N-CA-C 107.268 -1.382 . . . . 70.42 107.268 171.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' H' ' 286' ' ' MET . 12.8 Cg_exo -67.98 90.15 0.37 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.438 2.092 . . . . 75.54 111.667 -175.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 82.0 t -75.35 -55.11 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.29 -1.004 . . . . 72.33 108.29 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 59.58 -82.67 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 O-C-N 124.796 1.31 . . . . 73.14 110.066 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -172.02 157.13 4.27 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 126.364 1.866 . . . . 75.12 106.31 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.606 ' HB3' HG23 ' F' ' 307' ' ' THR . 6.8 mp -92.42 41.4 1.07 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.384 -0.969 . . . . 74.44 108.384 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 102.55 143.43 13.23 Favored Glycine 0 C--N 1.358 1.759 0 CA-C-N 114.656 -1.156 . . . . 64.53 111.426 -170.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.08 116.98 4.03 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.981 2.454 . . . . 72.15 111.227 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -92.64 146.37 23.71 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 110.088 -0.338 . . . . 75.32 110.088 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.26 67.06 9.65 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.488 0.715 . . . . 71.54 110.181 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 89.8 m -71.21 145.69 49.51 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.236 1.015 . . . . 74.53 109.093 174.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 43.1 t80 74.37 -64.34 0.39 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.713 1.205 . . . . 74.41 108.91 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 62.55 -82.4 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.461 1.504 . . . . 73.34 111.747 167.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 164.76 69.62 0.02 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.36 -1.096 . . . . 71.52 110.36 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . 0.573 ' HB2' ' HB2' ' F' ' 300' ' ' ASN . 7.0 t30 -113.16 0.61 14.98 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.201 0.6 . . . . 74.1 110.496 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 48.6 mt -68.23 85.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.77 0 N-CA-C 107.412 -1.329 . . . . 74.54 107.412 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.94 -64.31 0.95 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.899 0.88 . . . . 71.22 111.042 -170.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -139.67 158.73 67.5 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.781 0.832 . . . . 73.45 109.392 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.48 73.08 0.2 Allowed 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.131 2.554 . . . . 72.34 111.461 169.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -88.07 -57.9 2.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.785 -1.098 . . . . 62.35 112.367 -166.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 5.2 p -65.39 -34.81 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.203 -0.908 . . . . 70.53 111.484 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 307' ' ' THR . . . . . 0.646 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 12.0 t -69.99 -21.64 63.2 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.319 0.647 . . . . 73.51 111.999 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . 0.529 ' SG ' HG22 ' H' ' 307' ' ' THR . 57.4 m -131.84 76.9 1.73 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.335 0.654 . . . . 71.33 109.323 -177.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 23.3 p -69.91 110.13 6.03 Favored Pre-proline 0 CA--C 1.558 1.284 0 O-C-N 123.464 0.477 . . . . 72.11 109.746 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo . . . . . 0 C--N 1.379 2.18 0 C-N-CA 123.044 2.496 . . . . 73.2 111.628 -177.535 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.396 -0.594 . . . . 75.32 109.396 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 t -72.31 95.58 1.74 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.515 0.726 . . . . 64.01 109.179 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.65 140.96 48.7 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.97 0.908 . . . . 73.2 110.226 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.47 174.36 7.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.483 0.713 . . . . 73.24 110.663 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -165.86 139.36 4.34 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.292 1.037 . . . . 75.44 109.14 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -166.45 150.9 7.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.417 0.687 . . . . 74.12 109.542 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p -66.86 92.83 0.24 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.651 0.78 . . . . 64.01 111.299 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.78 5.47 15.78 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.769 1.228 . . . . 72.31 111.544 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.8 mtt -61.75 133.4 55.49 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.822 0.849 . . . . 63.32 110.629 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -153.37 137.06 16.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.958 0.903 . . . . 71.42 109.442 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 27.2 t80 -137.81 126.13 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.214 1.005 . . . . 71.24 108.712 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -151.06 128.51 11.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.307 0.643 . . . . 72.03 109.502 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.482 ' CD1' HG21 ' A' ' 105' ' ' ILE . 56.4 mt -85.12 129.03 38.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 120.921 0.391 . . . . 73.15 109.955 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -88.6 -42.71 11.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.108 -0.951 . . . . 74.41 110.255 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.422 ' HB3' HD13 ' A' ' 83' ' ' ILE . 60.1 ttt180 -169.83 140.75 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.314 -0.403 . . . . 74.2 110.714 -170.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.81 137.95 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.221 -1.029 . . . . 74.34 108.221 172.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.526 ' HB3' HG23 ' B' ' 122' ' ' THR . 7.2 p90 -168.23 143.58 3.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.388 0.675 . . . . 73.44 110.463 -171.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -76.59 111.01 11.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.735 -0.839 . . . . 75.32 108.735 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.429 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 40.4 mtpt -77.27 -25.28 51.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.969 0.508 . . . . 74.03 110.565 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.24 146.71 24.94 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.941 -1.027 . . . . 72.42 109.895 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.401 HD12 ' HB3' ' B' ' 117' ' ' MET . 47.4 mt -140.24 145.2 26.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 125.06 1.344 . . . . 62.34 107.498 177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.495 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 36.5 t -154.7 138.39 16.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.634 0.774 . . . . 72.13 109.103 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -143.58 131.63 21.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.565 -1.643 . . . . 75.42 106.565 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -134.51 128.81 34.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.006 -0.739 . . . . 74.14 109.006 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 78.65 72.94 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 107.33 -1.359 . . . . 73.44 107.33 171.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.73 -26.07 19.75 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.68 2.253 . . . . 70.24 112.055 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -109.39 24.22 13.38 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.773 0.829 . . . . 62.35 109.019 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.21 -61.17 2.48 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 117.879 -1.057 . . . . 70.22 112.595 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.7 Cg_exo -63.21 -24.3 72.5 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 122.28 1.987 . . . . 73.15 113.008 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -77.95 -47.37 18.75 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.673 0.789 . . . . 73.24 110.442 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.594 HG22 ' HA ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -73.9 -20.02 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 CA-C-N 115.16 -0.927 . . . . 75.12 110.949 -163.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.9 -19.22 62.62 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.354 1.062 . . . . 75.41 112.765 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -102.53 -10.28 19.47 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.696 0.398 . . . . 71.13 111.979 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.429 ' HZ2' ' HG2' ' A' ' 71' ' ' GLU . 36.6 mtpt -82.12 167.63 18.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.875 0.47 . . . . 74.44 112.248 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -61.53 141.33 57.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.457 1.103 . . . . 71.34 111.933 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.467 ' HB3' ' HB3' ' E' ' 297' ' ' TYR . 48.4 m95 -91.87 64.08 4.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.07 0.548 . . . . 74.12 110.68 -172.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -127.07 73.68 76.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.393 0.677 . . . . 75.54 110.054 175.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -89.72 118.44 0.78 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.619 2.213 . . . . 74.45 112.187 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.73 101.1 12.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.901 -1.518 . . . . 74.54 106.901 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.3 t -76.46 114.89 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.355 -0.839 . . . . 72.21 110.133 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.35 134.41 35.57 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.355 0.662 . . . . 74.21 109.565 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.2 mt -103.28 108.61 19.9 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.527 -0.916 . . . . 74.34 108.527 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.488 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -104.26 113.9 27.77 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.004 0.922 . . . . 71.32 108.735 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.48 135.87 39.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.312 0.645 . . . . 73.2 109.586 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.57 134.44 30.56 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.397 -0.964 . . . . 75.03 108.397 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.477 HG23 HD23 ' A' ' 60' ' ' LEU . 11.5 m -148.63 140.57 23.84 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.64 0.376 . . . . 74.32 110.092 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.06 135.07 13.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.369 0.668 . . . . 74.31 110.644 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.484 ' HG ' HD13 ' E' ' 278' ' ' LEU . 45.7 p -96.45 164.09 12.77 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.859 0.864 . . . . 64.42 111.013 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -162.09 119.99 2.2 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.45 1.1 . . . . 73.32 108.752 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.39 118.69 18.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.958 -0.386 . . . . 74.33 109.958 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -89.25 -33.1 17.1 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.487 0.715 . . . . 75.13 111.137 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.53 -174.07 4.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.414 0.686 . . . . 72.35 110.765 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.24 116.66 5.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.425 0.69 . . . . 72.12 110.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 66.16 -0.14 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.403 1.481 . . . . 72.12 113.091 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.91 106.57 19.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.334 -0.987 . . . . 74.35 108.334 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -119.57 124.04 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.801 -1.185 . . . . 74.2 107.801 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -88.77 136.16 33.15 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.563 1.145 . . . . 71.42 108.532 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.478 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 99.0 t -122.76 125.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.644 -1.243 . . . . 74.02 107.644 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.517 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.6 t -104.97 128.02 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.023 0.529 . . . . 74.12 109.875 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.707 HD22 HD11 ' A' ' 106' ' ' LEU . 3.9 mm? -106.28 98.17 7.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 73.42 108.906 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 17.2 ttp180 -87.18 100.88 12.99 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.651 -0.87 . . . . 73.14 108.651 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.554 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.5 t -93.64 122.66 45.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.999 -1.482 . . . . 72.33 106.999 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.488 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.3 m -116.35 121.38 41.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.531 0.681 . . . . 74.45 109.281 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.649 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 t -111.18 109.84 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.95 1.3 . . . . 74.23 108.672 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.7 m -103.56 140.07 38.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 108.31 -0.996 . . . . 73.2 108.31 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.16 121.22 37.33 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.182 -0.673 . . . . 71.2 109.182 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -122.73 124.82 44.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.245 0.545 . . . . 60.51 110.768 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 5.1 mp -88.81 77.08 7.87 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.351 1.46 . . . . 71.43 107.578 173.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.01 -86.78 0.88 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.865 -1.061 . . . . 74.11 111.15 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -113.9 -27.89 7.58 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.882 0.873 . . . . 55.55 110.65 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.429 ' HG2' ' HZ2' ' A' ' 34' ' ' LYS . 8.0 tp10 -86.07 133.71 33.87 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.351 0.66 . . . . 75.32 111.042 -172.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.4 m -78.26 147.24 34.43 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.127 0.421 . . . . 74.32 110.526 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.594 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -96.8 -63.25 1.15 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.971 0.908 . . . . 71.44 108.964 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -151.6 163.86 38.15 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.154 -1.384 . . . . 74.4 110.548 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.7 tp -132.89 121.26 22.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.498 1.119 . . . . 74.13 108.461 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.649 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.2 m -105.79 141.03 37.92 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.603 1.161 . . . . 55.21 108.719 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.4 tt0 -146.66 115.35 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.091 -1.077 . . . . 74.33 108.091 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 113' ' ' CYS . 46.4 t -131.32 109.96 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.102 -0.703 . . . . 75.31 109.102 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.453 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 64.5 mt-30 -87.7 81.79 7.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.3 -0.864 . . . . 74.13 109.086 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -75.87 93.11 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.108 -0.951 . . . . 74.14 108.633 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.517 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.55 145.4 21.92 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.317 -0.713 . . . . 70.15 111.317 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.07 142.82 12.15 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.539 -1.024 . . . . 64.15 110.539 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.422 HD13 ' HB3' ' A' ' 15' ' ' ARG . 54.8 mt -106.9 126.41 62.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.578 -0.897 . . . . 74.43 108.578 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.478 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 14.5 m-85 -131.45 117.43 18.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.393 0.677 . . . . 73.33 109.199 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 t -78.55 90.63 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.889 0.876 . . . . 52.23 108.661 168.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 48.5 pt -106.44 143.94 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.654 0.782 . . . . 70.01 110.286 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.22 154.88 28.0 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.809 0.844 . . . . 62.31 109.544 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.66 5.37 88.27 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 115.155 0.822 . . . . 74.24 115.155 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.494 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.6 134.51 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.392 -0.966 . . . . 74.35 108.392 174.079 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -142.47 171.93 13.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.227 1.011 . . . . 70.23 108.946 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.06 -120.18 14.27 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.459 0.543 . . . . 61.3 114.459 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -80.21 -24.17 40.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.01 0.924 . . . . 74.31 111.593 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -36.91 75.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.348 0.659 . . . . 74.24 109.949 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.56 ' SD ' HD23 ' E' ' 277' ' ' LEU . 52.1 ttp -65.98 -43.06 88.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.915 0.886 . . . . 74.53 110.193 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.93 82.39 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.347 -0.842 . . . . 73.15 111.426 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.731 0.813 . . . . 72.41 110.763 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.46 -49.56 68.67 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.01 0.524 . . . . 55.43 110.836 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 mt -85.03 -32.2 23.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.037 -0.529 . . . . 74.22 111.512 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.58 -1.88 63.69 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 114.823 0.689 . . . . 74.25 114.823 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.75 -54.65 0.19 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.998 0.899 . . . . 62.52 112.445 -176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -71.31 -64.4 0.92 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.318 1.047 . . . . 72.04 112.629 -167.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.462 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.9 m -70.37 -34.25 3.84 Favored Pre-proline 0 CA--C 1.574 1.87 0 N-CA-C 113.933 1.086 . . . . 65.33 113.933 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.592 ' HB3' HD21 ' A' ' 60' ' ' LEU . 26.2 Cg_endo -64.03 -31.53 65.8 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.249 1.966 . . . . 71.32 113.319 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -62.05 -34.93 77.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.246 0.618 . . . . 73.3 109.666 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.482 HG21 ' CD1' ' A' ' 13' ' ' ILE . 45.6 mm -60.03 -47.3 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.855 0.862 . . . . 73.44 110.603 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.707 HD11 HD22 ' A' ' 60' ' ' LEU . 98.4 mt -76.27 -25.62 55.1 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.454 -0.793 . . . . 71.13 112.091 -171.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.16 -44.58 98.74 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.003 1.112 . . . . 62.33 114.003 -170.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.92 -33.98 95.48 Favored 'Trans proline' 0 C--N 1.392 2.818 0 C-N-CA 122.117 1.878 . . . . 64.54 113.7 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.16 -35.27 56.12 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 75.51 110.98 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.27 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.504 -0.554 . . . . 73.03 109.504 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.475 ' NH1' HG21 ' C' ' 105' ' ' ILE . 38.1 ttm180 -54.28 -53.91 47.35 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 124.663 1.227 . . . . 74.54 110.116 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.48 -43.4 98.92 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.542 1.151 . . . . 75.42 110.98 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.503 ' HB3' HG12 ' A' ' 78' ' ' VAL . 48.0 t -60.15 -40.51 90.11 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.581 0.551 . . . . 61.33 111.002 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.576 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 94.7 mt -65.49 -54.76 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.901 0.751 . . . . 75.32 109.669 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 93.5 m -53.17 -39.06 63.31 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.936 1.397 . . . . 74.31 111.343 -175.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.8 t -65.94 -47.63 74.05 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.546 -1.206 . . . . 64.42 109.257 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.576 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 44.4 mtm -61.85 -42.94 99.65 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.194 0.598 . . . . 73.31 111.066 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.9 t -56.21 -50.48 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 124.388 1.055 . . . . 75.04 109.957 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -72.0 -32.29 67.06 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.222 -0.899 . . . . 74.25 111.588 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 61.6 mtt-85 -72.16 -27.43 62.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.5 0.72 . . . . 75.03 110.036 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.67 12.36 56.67 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.749 -0.659 . . . . 73.52 113.182 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.5 p 57.99 17.77 4.63 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.808 2.043 . . . . 62.22 113.393 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.28 145.75 49.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.245 -1.391 . . . . 73.43 107.245 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 141.74 80.89 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.494 2.129 . . . . 74.45 111.149 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -48.03 123.16 5.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.619 1.199 . . . . 72.32 111.336 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.47 118.94 38.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.256 0.622 . . . . 73.41 109.387 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -115.48 114.85 25.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.153 -0.684 . . . . 71.31 109.153 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.63 122.09 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.644 0.778 . . . . 74.05 109.939 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.554 ' HB3' HD12 ' E' ' 291' ' ' LEU . . . -64.12 132.28 95.25 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 109.276 -0.639 . . . . 64.13 109.276 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.642 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 4.3 Cg_endo -76.72 113.49 3.66 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.119 1.879 . . . . 74.33 110.569 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -98.99 123.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.713 -1.217 . . . . 62.43 107.713 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -76.72 89.98 3.41 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.425 -0.954 . . . . 75.31 108.425 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -62.66 -31.91 72.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.881 0.873 . . . . 73.21 110.902 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -59.93 -48.93 79.69 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.672 0.789 . . . . 64.03 110.566 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.72 89.45 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.23 0.956 . . . . 73.54 111.027 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.66 -50.94 69.2 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.038 0.836 . . . . 74.44 110.145 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -64.95 -38.86 92.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.44 0.696 . . . . 74.31 110.466 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.597 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 12.5 tpt -66.68 -44.79 80.83 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 115.413 -0.812 . . . . 75.41 110.146 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.52 -36.89 64.72 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.464 0.706 . . . . 75.25 112.006 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -70.31 -40.62 74.09 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.094 0.558 . . . . 75.54 110.555 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.457 HD22 ' SD ' ' A' ' 138' ' ' MET . 35.2 tp -65.97 -16.57 64.0 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.88 1.272 . . . . 73.3 112.289 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.682 ' HB2' ' HA ' ' C' ' 2' ' ' SER . 11.2 pt20 -144.74 29.36 1.24 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.925 0.89 . . . . 71.52 110.293 -173.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -59.74 98.18 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.564 1.146 . . . . 65.03 113.775 -171.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 174.1 158.04 0.15 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.775 1.63 . . . . 74.15 109.055 164.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.47 102.98 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.333 1.021 . . . . 74.0 110.929 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' C' ' 3' ' ' GLU . . . -86.89 133.62 11.93 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.617 -0.72 . . . . 44.32 112.209 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.68 122.88 12.95 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.196 -1.039 . . . . 74.54 108.196 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.74 126.19 1.02 Allowed Glycine 0 C--N 1.343 0.958 0 O-C-N 123.556 0.535 . . . . 63.54 111.834 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.2 t -145.91 120.55 9.81 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.503 0.721 . . . . 71.44 109.604 173.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -91.29 84.85 5.68 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.877 -0.786 . . . . 70.24 108.877 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -99.49 107.56 19.79 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.274 -0.876 . . . . 72.32 108.769 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.416 ' HD1' ' HB2' ' A' ' 154' ' ' ASP . 58.3 t-80 -125.22 109.22 12.58 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.924 0.889 . . . . 75.22 108.947 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.76 87.02 2.21 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.655 -0.868 . . . . 74.41 108.655 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.416 ' HB2' ' HD1' ' A' ' 152' ' ' HIS . 17.2 t70 -85.59 118.43 25.1 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.972 -0.751 . . . . 63.42 108.972 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 N-CA-C 109.141 -0.688 . . . . 73.14 109.141 -177.058 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.363 -0.606 . . . . 73.2 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 39.9 m -66.77 98.71 0.55 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.757 -0.831 . . . . 73.22 108.757 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' B' ' 151' ' ' GLU . 23.7 tt0 -124.77 127.58 47.43 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.724 -0.671 . . . . 73.13 111.981 -169.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -159.18 161.8 36.24 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.195 1.398 . . . . 74.22 108.821 176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -144.97 136.08 24.91 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.033 0.533 . . . . 75.31 109.972 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.433 ' ND2' ' HB3' ' B' ' 147' ' ' GLU . 6.5 t30 -164.9 106.25 0.82 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.173 0.989 . . . . 74.12 109.216 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.589 HG23 ' HB2' ' E' ' 310' ' ' PRO . 41.1 p -118.26 100.77 7.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.395 0.678 . . . . 72.44 109.601 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -80.86 163.3 23.5 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.126 -0.488 . . . . 74.25 110.626 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.56 ' HB3' HG23 ' B' ' 89' ' ' ILE . 24.2 ptm 49.43 -174.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.261 1.824 . . . . 74.45 113.874 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.8 m -135.95 123.47 22.16 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.295 -1.002 . . . . 74.1 108.295 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.424 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 56.6 t80 -127.68 112.61 15.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.736 -1.209 . . . . 74.33 107.736 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.525 ' HG2' HG22 ' E' ' 309' ' ' THR . 0.0 OUTLIER -131.83 135.29 46.61 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.008 -1.108 . . . . 75.15 108.008 -178.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.421 HD13 ' O ' ' B' ' 13' ' ' ILE . 2.4 pp -94.99 130.52 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.397 0.679 . . . . 74.31 110.277 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -99.12 -50.83 4.02 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.807 -0.558 . . . . 63.34 110.06 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.464 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 41.8 ttt180 -162.59 134.23 5.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.998 -0.546 . . . . 74.3 110.452 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -113.91 142.55 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.71 -1.589 . . . . 72.13 106.71 172.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -168.9 149.35 4.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.615 0.643 . . . . 73.04 112.733 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 37.9 m -79.71 120.1 23.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.345 -0.843 . . . . 72.53 109.529 172.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.558 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 9.3 mtpt -89.14 -28.88 19.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.4 0.68 . . . . 74.45 110.835 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.7 136.92 14.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.846 -0.616 . . . . 72.24 110.406 -169.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.696 HD11 ' SG ' ' B' ' 113' ' ' CYS . 31.2 mm -124.99 148.88 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.398 1.079 . . . . 75.25 108.155 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.479 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.7 t -154.15 141.37 19.51 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.789 -0.641 . . . . 71.51 109.576 170.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -152.71 109.0 3.39 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.26 -1.385 . . . . 72.12 107.26 171.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -118.08 111.53 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.456 -1.313 . . . . 74.53 107.456 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.79 88.23 6.42 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 108.313 -0.995 . . . . 54.42 108.313 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.74 -24.33 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.095 2.53 . . . . 61.34 111.938 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -121.6 24.14 9.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.936 0.895 . . . . 73.25 110.391 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.468 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -41.69 -54.41 6.74 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 124.788 1.235 . . . . 74.31 114.16 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.9 Cg_endo -66.17 -32.93 41.74 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.317 2.011 . . . . 74.3 113.157 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -94.42 -15.5 24.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.877 0.695 . . . . 75.22 112.877 -169.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.64 -23.25 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.743 1.217 . . . . 71.42 113.682 -169.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -66.57 -21.72 66.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.122 0.969 . . . . 73.23 112.149 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.403 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.6 pt20 -61.98 -29.06 70.0 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.879 0.472 . . . . 63.23 110.619 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.403 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 32.8 mmtp -105.1 67.65 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.536 -1.283 . . . . 74.04 107.536 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.02 79.5 6.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.546 0.738 . . . . 73.0 111.93 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 164.79 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.899 2.079 . . . . 71.33 110.647 160.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.2 126.25 67.2 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.553 1.141 . . . . 72.21 112.335 -170.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.71 176.15 9.33 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.752 2.301 . . . . 75.31 111.597 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.04 104.22 7.4 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.11 -1.441 . . . . 74.24 107.11 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.46 154.91 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.503 0.721 . . . . 70.02 109.197 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -147.18 138.7 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.813 0.845 . . . . 75.35 109.801 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.643 HD22 HD12 ' B' ' 128' ' ' LEU . 5.5 mp -85.4 141.11 30.21 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.052 -1.092 . . . . 75.14 108.052 165.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.8 t70 -141.18 109.99 6.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.35 -1.352 . . . . 72.13 107.35 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.33 131.6 48.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.846 0.458 . . . . 75.33 109.886 -173.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.3 135.41 54.73 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.968 1.307 . . . . 72.54 107.895 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -109.97 145.87 36.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.385 0.674 . . . . 73.1 110.195 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.4 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -154.83 148.3 25.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 71.14 109.282 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.2 m -144.69 167.89 21.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.365 0.666 . . . . 73.55 110.784 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -157.63 154.17 27.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.161 0.985 . . . . 74.53 109.599 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -102.85 130.5 49.89 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.974 -0.75 . . . . 74.43 108.974 171.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 67.2 mt -97.74 -38.05 9.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.194 0.597 . . . . 71.4 110.459 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.7 -171.95 2.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.437 0.695 . . . . 73.52 110.808 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.7 114.48 4.47 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.631 -1.168 . . . . 71.42 110.123 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 72.08 -3.81 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.691 1.597 . . . . 73.22 112.589 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.08 110.74 31.22 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 N-CA-C 107.859 -1.163 . . . . 75.41 107.859 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -122.11 173.24 7.69 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.038 -0.727 . . . . 74.25 109.038 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -142.87 109.98 5.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.022 -1.103 . . . . 71.43 108.022 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -101.65 134.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.331 1.052 . . . . 73.45 109.965 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' B' ' 47' ' ' ALA . 22.9 t -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.532 1.133 . . . . 74.32 109.059 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.44 112.32 17.39 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.931 -0.766 . . . . 74.15 108.931 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.756 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 28.0 ttm180 -89.92 124.93 35.14 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.607 0.763 . . . . 72.53 109.62 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -111.61 126.56 69.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.76 -1.2 . . . . 73.44 107.76 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.4 m -121.11 122.1 39.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.775 0.798 . . . . 70.25 109.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.636 HG13 HD23 ' B' ' 126' ' ' LEU . 87.8 t -102.05 95.99 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.29 1.436 . . . . 63.3 108.331 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 24.7 m -85.48 137.06 33.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.749 -0.834 . . . . 75.53 108.749 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.99 127.3 13.04 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.652 -0.499 . . . . 73.0 109.652 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 64.3 p -145.89 144.72 30.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.203 0.601 . . . . 63.24 110.809 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.583 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -133.54 102.31 5.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 72.32 109.406 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.73 -132.97 11.43 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.949 -0.569 . . . . 53.23 112.594 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.81 8.77 24.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.172 0.589 . . . . 63.14 110.744 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.19 154.68 49.13 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.522 0.729 . . . . 74.52 110.675 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' THR . . . . . 0.4 HG21 ' HG ' ' B' ' 75' ' ' LEU . 66.4 m -83.79 138.67 33.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.301 0.64 . . . . 62.23 110.273 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.583 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -76.61 -60.24 2.43 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.894 0.878 . . . . 70.0 108.974 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -165.69 153.01 10.36 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 113.656 -1.611 . . . . 73.03 109.054 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.4 ' HG ' HG21 ' B' ' 72' ' ' THR . 94.8 mt -124.1 112.78 17.52 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.562 -1.273 . . . . 75.21 107.562 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.425 ' SG ' HG22 ' B' ' 114' ' ' ILE . 35.8 t -115.98 143.43 45.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.776 -1.194 . . . . 72.32 107.776 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.4 tt0 -157.26 124.2 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 -173.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.481 HG12 HD12 ' B' ' 21' ' ' ILE . 95.4 t -129.78 142.02 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.215 0.606 . . . . 74.44 109.574 177.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.756 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 42.1 mt-30 -108.1 114.58 28.58 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.739 -1.208 . . . . 74.43 107.739 166.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' B' ' 106' ' ' LEU . 8.4 tp-100 -103.11 110.86 22.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.297 -1.001 . . . . 70.14 108.297 172.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.558 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.96 166.9 19.32 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.682 0.613 . . . . 65.22 111.719 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.84 127.56 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.446 -0.661 . . . . 72.24 111.446 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.17 125.05 40.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.605 0.762 . . . . 71.1 109.066 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.69 132.56 42.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.227 1.011 . . . . 74.33 108.959 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 49.6 m -96.59 97.98 9.83 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.732 0.813 . . . . 62.31 108.908 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.416 HG22 ' SG ' ' B' ' 97' ' ' CYS . 30.1 pt -116.06 132.9 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.398 0.679 . . . . 65.35 110.09 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.24 172.86 16.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.004 0.922 . . . . 63.35 110.605 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -62.46 1.04 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.045 -0.525 . . . . 54.02 112.346 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.56 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.2 OUTLIER -90.48 170.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.915 0.886 . . . . 74.34 111.126 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.58 171.91 16.36 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.19 0.596 . . . . 72.54 111.089 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.28 42.91 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.121 -0.945 . . . . 74.1 113.286 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -70.73 -28.06 64.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.139 0.976 . . . . 75.5 111.689 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.82 -37.93 89.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.221 0.608 . . . . 75.44 109.822 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.462 ' HG2' HD22 ' B' ' 98' ' ' LEU . 22.9 ttt -80.32 -33.99 37.09 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 73.43 110.133 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -28.07 69.51 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.922 0.889 . . . . 62.53 111.814 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -62.0 -43.31 99.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.602 0.761 . . . . 72.51 110.247 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.416 ' SG ' HG22 ' B' ' 86' ' ' ILE . 53.4 t -70.72 -64.04 0.98 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.577 -0.738 . . . . 72.03 110.81 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.462 HD22 ' HG2' ' B' ' 94' ' ' MET . 4.5 pp -71.04 -30.84 67.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.569 0.747 . . . . 72.43 112.496 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -33.67 11.13 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.575 0.547 . . . . 74.41 113.264 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.88 -67.17 1.02 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.887 0.475 . . . . 63.14 111.33 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -60.18 -46.76 88.61 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.586 0.754 . . . . 73.23 112.898 -172.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.476 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.7 m -63.86 -51.41 64.63 Favored Pre-proline 0 CA--C 1.569 1.678 0 C-N-CA 123.932 0.893 . . . . 75.15 112.292 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.3 Cg_exo -58.94 -30.12 92.33 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.659 2.239 . . . . 75.24 113.733 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -27.98 62.78 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.301 0.64 . . . . 71.1 111.437 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.48 -40.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.543 0.737 . . . . 73.13 109.902 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' B' ' 80' ' ' GLN . 86.4 mt -75.39 -29.34 59.81 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.943 -1.026 . . . . 73.22 111.709 -173.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -55.52 -47.55 98.39 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-O 117.66 -1.162 . . . . 73.43 113.782 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.58 -43.36 33.74 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.131 2.554 . . . . 74.44 114.622 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.426 ' HE2' HG21 ' D' ' 115' ' ' THR . 81.4 m-85 -70.6 -42.58 70.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.382 0.673 . . . . 72.2 110.325 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.54 -32.17 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.702 -0.681 . . . . 72.41 110.888 176.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.76 -58.09 10.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.292 1.037 . . . . 73.25 110.482 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.533 0.52 . . . . 75.21 109.878 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.696 ' SG ' HD11 ' B' ' 21' ' ' ILE . 0.0 OUTLIER -67.4 -40.13 85.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.232 0.613 . . . . 74.52 110.776 177.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.587 HG21 HG22 ' B' ' 64' ' ' VAL . 78.5 mt -67.37 -54.3 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 75.24 109.868 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -60.15 -33.0 71.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.222 1.009 . . . . 71.13 111.55 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -60.69 -49.79 76.11 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.47 0.708 . . . . 64.12 110.124 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.479 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.7 mmt -71.26 -34.89 71.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.57 0.748 . . . . 75.25 111.584 -172.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.502 HG22 HD21 ' B' ' 126' ' ' LEU . 97.0 t -66.33 -40.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 75.33 110.153 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.6 t -68.67 -28.13 66.6 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.288 -0.869 . . . . 74.31 111.024 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.48 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 88.9 mtt-85 -72.64 -25.11 61.17 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.187 0.595 . . . . 74.43 110.753 176.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.23 13.8 43.2 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 123.346 0.404 . . . . 74.11 112.557 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.526 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.6 p 61.45 31.48 19.05 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 126.903 2.081 . . . . 74.22 112.227 176.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -95.79 148.36 34.44 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 115.575 -0.739 . . . . 75.23 110.175 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.42 ' HG3' ' HA ' ' H' ' 297' ' ' TYR . 36.4 Cg_endo -63.76 -171.23 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.597 2.865 . . . . 73.33 114.252 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 17.7 tp60 -59.13 113.44 2.12 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.385 -1.279 . . . . 72.23 112.011 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.636 HD23 HG13 ' B' ' 64' ' ' VAL . 66.5 tp -111.09 100.58 9.23 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.614 -0.884 . . . . 63.2 108.614 171.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.21 123.26 41.82 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.95 0.9 . . . . 75.22 109.875 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.643 HD12 HD22 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -87.28 144.33 26.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.789 0.836 . . . . 73.43 109.011 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.4 ' N ' HD13 ' B' ' 128' ' ' LEU . . . -64.61 143.36 98.63 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.34 1.056 . . . . 72.1 111.568 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.05 90.53 1.08 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.797 2.331 . . . . 75.33 111.311 178.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.501 HG11 HG12 ' H' ' 288' ' ' VAL . 37.7 t -91.33 111.33 23.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.983 -0.747 . . . . 64.44 108.983 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -93.01 91.97 7.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.568 -0.901 . . . . 73.12 108.568 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -63.65 -29.51 70.74 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.764 0.826 . . . . 74.13 111.319 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -67.0 -36.83 83.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.76 0.824 . . . . 72.24 110.994 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.58 81.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.905 0.882 . . . . 75.55 111.256 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.47 -25.76 54.67 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.022 -0.535 . . . . 72.43 110.585 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -74.97 -17.45 60.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.944 0.498 . . . . 65.35 111.356 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.0 mtm -58.18 -29.51 65.68 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.959 0.504 . . . . 74.11 111.171 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -78.26 -6.56 55.34 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.27 1.028 . . . . 74.5 112.155 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -88.93 -31.59 18.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.656 -0.498 . . . . 73.34 109.656 166.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 68.4 mt -88.73 6.2 39.76 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.662 0.785 . . . . 72.53 111.968 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -65.27 103.49 0.8 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.214 1.006 . . . . 74.3 111.23 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . 0.607 ' HA ' HE21 ' B' ' 143' ' ' GLN . 0.0 OUTLIER -142.07 -96.66 0.13 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.067 -1.457 . . . . 74.14 107.067 169.565 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -157.51 157.27 33.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.058 1.743 . . . . 75.12 106.726 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.39 177.49 10.93 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.822 0.449 . . . . 64.53 110.377 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -175.29 55.49 0.12 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 112.192 -0.363 . . . . 73.41 112.192 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . 0.433 ' HB3' ' ND2' ' B' ' 6' ' ' ASN . 39.1 mt-10 -78.71 145.91 34.25 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 122.612 0.365 . . . . 75.21 110.435 176.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.83 134.38 34.92 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 124.166 0.916 . . . . 75.04 112.432 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 36.7 m -76.55 155.04 33.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.683 0.793 . . . . 72.32 109.85 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . 0.634 ' H ' HD12 ' D' ' 136' ' ' LEU . 23.5 mm-40 -82.2 43.0 0.77 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.75 0.82 . . . . 63.42 111.535 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.6 pt-20 -90.06 83.33 6.07 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 108.185 -1.043 . . . . 73.14 108.185 170.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -154.4 139.98 17.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.342 0.657 . . . . 65.42 109.32 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? -67.11 134.93 52.78 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.018 -1.104 . . . . 71.35 108.018 172.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . 0.424 ' O ' ' HD2' ' G' ' 289' ' ' ARG . 38.6 t70 -153.44 119.17 5.31 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.807 -1.182 . . . . 73.43 107.807 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 107.946 -1.131 . . . . 75.55 107.946 177.568 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.401 -0.222 . . . . 72.3 110.401 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.682 ' HA ' ' HB2' ' A' ' 142' ' ' GLN . 55.9 p -164.83 157.01 15.93 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.647 0.779 . . . . 75.51 111.357 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . 0.559 ' HA ' ' HA3' ' A' ' 146' ' ' GLY . 28.9 tt0 -168.95 149.82 4.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.98 0.912 . . . . 73.31 109.628 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -167.12 104.79 0.55 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.13 -0.692 . . . . 72.33 109.13 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -83.92 132.83 34.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.81 -0.811 . . . . 71.11 108.81 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -67.62 -60.88 2.19 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.46 0.704 . . . . 62.4 111.746 -173.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.9 p -153.67 97.91 2.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.742 1.217 . . . . 75.03 108.247 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -128.24 144.19 51.1 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.901 0.881 . . . . 73.0 109.792 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.3 ttm 64.5 114.49 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.336 1.455 . . . . 72.43 112.492 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 63.6 m -103.76 92.8 4.58 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.826 -1.175 . . . . 75.54 107.826 166.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.481 ' CE1' ' SG ' ' C' ' 102' ' ' CYS . 87.8 t80 -112.43 132.66 54.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.248 -1.019 . . . . 74.21 108.248 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.527 ' HG2' ' HA ' ' G' ' 307' ' ' THR . 50.1 tp60 -147.35 144.59 28.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.034 0.445 . . . . 75.02 111.209 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.432 HG23 ' HE2' ' C' ' 84' ' ' PHE . 2.3 pp -93.7 139.76 17.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.09 -0.959 . . . . 74.25 108.451 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -110.55 -51.09 2.9 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.863 -0.421 . . . . 72.41 109.863 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -166.79 128.86 1.75 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.777 -0.647 . . . . 72.12 110.312 -170.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.55 143.05 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 106.838 -1.541 . . . . 75.54 106.838 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.422 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.2 p90 -174.34 158.67 2.95 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.575 0.625 . . . . 74.44 111.291 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -81.29 119.26 23.43 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.09 -0.708 . . . . 74.23 109.09 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.52 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 11.7 mmmm -73.39 -42.0 62.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 169.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 32.3 t70 -143.95 142.33 30.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.777 -1.101 . . . . 61.44 110.526 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -139.74 143.65 30.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.521 1.528 . . . . 75.4 107.2 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 30.8 t -158.76 151.38 21.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.275 0.559 . . . . 73.44 110.283 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -150.41 125.66 10.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.767 -1.198 . . . . 74.42 107.767 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.406 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 45.0 mt-10 -118.26 140.53 49.67 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.291 0.636 . . . . 60.31 110.215 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.59 77.65 22.61 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.787 -1.56 . . . . 75.33 106.787 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.94 -32.78 65.3 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.064 2.51 . . . . 74.45 112.467 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.692 ' HB2' ' HB3' ' C' ' 30' ' ' HIS . 9.2 p30 -112.22 45.49 1.27 Allowed 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.815 0.846 . . . . 74.54 109.677 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.516 ' HB2' ' HE3' ' D' ' 19' ' ' LYS . . . -53.31 -41.34 85.94 Favored Pre-proline 0 CA--C 1.577 1.995 0 N-CA-C 114.697 1.369 . . . . 65.34 114.697 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.7 -37.9 1.1 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 121.744 1.63 . . . . 70.32 112.97 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.692 ' HB3' ' HB2' ' C' ' 27' ' ' ASN . 75.5 t60 -69.19 -21.9 63.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.317 1.047 . . . . 74.14 112.338 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.69 -13.84 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.667 0.787 . . . . 74.43 112.566 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.55 -15.45 60.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.563 -0.71 . . . . 71.15 112.301 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -109.1 21.67 16.88 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.578 0.751 . . . . 71.33 110.355 172.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.603 ' HB2' ' HZ2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -82.69 136.96 34.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.223 1.009 . . . . 75.15 109.028 175.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.17 123.56 19.41 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.058 -0.719 . . . . 71.11 109.058 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.487 ' HZ2' ' HB3' ' F' ' 302' ' ' ASP . 22.7 m95 -85.16 58.94 5.32 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.55 0.34 . . . . 73.51 111.04 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -156.51 53.91 0.81 Allowed Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 124.367 1.067 . . . . 71.13 109.448 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.08 153.3 36.68 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.927 1.751 . . . . 71.11 112.208 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -84.29 115.59 22.56 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.362 -1.347 . . . . 75.53 107.362 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.24 133.82 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.505 -0.554 . . . . 74.52 109.505 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -123.57 112.13 17.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.205 1.002 . . . . 74.01 108.416 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.406 HD23 HD22 ' C' ' 128' ' ' LEU . 8.4 mp -86.06 133.93 33.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.241 -1.392 . . . . 75.44 107.241 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.45 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.5 t70 -117.36 103.11 9.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.176 -1.416 . . . . 62.1 107.176 172.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.34 112.63 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.876 -1.528 . . . . 73.52 106.876 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.3 t70 -127.8 135.1 49.63 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.157 -0.683 . . . . 73.34 109.157 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -114.94 123.62 49.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.84 0.856 . . . . 74.42 109.952 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.11 34.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.32 0.648 . . . . 73.52 110.168 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.9 p -163.38 152.4 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.185 0.594 . . . . 53.11 110.438 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.2 p -151.25 159.35 44.41 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.81 0.844 . . . . 74.52 109.406 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -75.21 120.61 20.94 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.612 -0.722 . . . . 74.44 110.479 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.404 HD13 ' HB2' ' C' ' 57' ' ' GLU . 83.3 mt -84.95 -46.32 11.36 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.87 -0.789 . . . . 64.21 108.87 169.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.33 178.27 9.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.532 -1.213 . . . . 73.24 108.88 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -66.05 122.37 17.26 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.34 -0.391 . . . . 73.3 110.052 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 74.55 -5.6 2.08 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.813 1.645 . . . . 73.23 112.599 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.536 HG21 ' HG ' ' C' ' 85' ' ' SER . 92.0 t -104.9 116.62 49.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 124.035 0.934 . . . . 75.22 109.475 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 135.58 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.411 -0.959 . . . . 73.22 108.411 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.436 ' CD ' ' HZ1' ' C' ' 19' ' ' LYS . 43.2 tt0 -87.52 120.24 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.799 -0.815 . . . . 61.14 108.799 173.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.31 111.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.399 -0.963 . . . . 74.4 108.399 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.8 t -106.57 127.26 62.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.838 -1.171 . . . . 75.41 107.838 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -130.4 105.48 7.9 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.758 -1.201 . . . . 72.23 107.758 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 24.0 ttm180 -82.65 125.12 30.84 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.855 -0.611 . . . . 71.45 109.614 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -116.71 106.97 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.791 -1.559 . . . . 73.21 106.791 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.45 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.4 m -116.29 114.05 23.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.521 0.677 . . . . 74.41 109.618 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.93 111.36 35.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 114.619 -1.173 . . . . 73.51 108.486 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 13.8 m -111.33 125.86 54.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.471 0.708 . . . . 72.44 110.238 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.86 116.83 31.92 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.338 -1.356 . . . . 73.53 107.338 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.5 m -148.39 152.65 37.36 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.827 0.451 . . . . 70.2 110.78 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.476 HD21 ' HD2' ' C' ' 34' ' ' LYS . 4.1 mm? -95.37 26.98 3.53 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.63 1.172 . . . . 74.43 110.203 172.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.85 -104.95 0.95 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.36 -25.47 21.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.359 0.664 . . . . 72.51 110.261 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.54 113.62 21.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.056 0.942 . . . . 71.04 109.679 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.3 m -88.88 129.65 35.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.944 0.497 . . . . 74.31 111.525 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 -57.83 4.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.961 . . . . 74.31 109.728 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.73 155.04 29.21 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.503 -0.771 . . . . 72.02 109.941 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.423 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -117.02 145.28 43.78 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.367 -1.345 . . . . 73.43 107.367 171.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.423 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.9 t -150.07 131.86 15.05 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 173.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -139.79 132.88 29.6 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.526 0.73 . . . . 75.3 110.24 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.62 138.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.867 0.867 . . . . 73.4 109.07 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.456 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -113.21 96.65 6.03 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.983 -1.488 . . . . 74.34 106.983 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.45 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.7 tp-100 -83.52 107.36 15.94 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.044 -0.526 . . . . 71.0 109.631 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 145.94 18.27 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.788 -0.642 . . . . 71.13 111.68 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.76 117.44 0.91 Allowed Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.518 -1.033 . . . . 74.22 110.518 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . . . . . . . . . 15.9 mm -81.56 119.73 31.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.627 -0.879 . . . . 74.33 108.627 177.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.432 ' HE2' HG23 ' C' ' 13' ' ' ILE . 97.3 m-85 -132.52 145.29 51.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.837 0.855 . . . . 63.34 109.552 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.536 ' HG ' HG21 ' C' ' 55' ' ' VAL . 65.9 m -110.69 112.43 24.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.781 0.833 . . . . 53.54 109.287 173.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.511 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.5 mp -116.11 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.895 -1.15 . . . . 72.12 107.895 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.41 162.75 34.95 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.357 1.063 . . . . 73.51 109.843 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.08 -58.51 4.25 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.944 -0.571 . . . . 65.04 112.258 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.51 168.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.622 0.769 . . . . 64.32 111.536 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.28 -177.22 5.88 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.867 1.267 . . . . 64.42 109.012 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.79 -124.45 36.16 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.772 0.67 . . . . 73.33 113.683 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 49.0 p -70.22 -36.57 74.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.491 1.116 . . . . 75.43 111.953 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -66.16 -36.23 82.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.097 0.559 . . . . 73.53 110.858 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.552 ' HE1' ' HB3' ' F' ' 277' ' ' LEU . 0.1 OUTLIER -83.14 -33.83 26.18 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.426 0.69 . . . . 75.43 109.971 178.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.569 ' HB2' ' HB2' ' F' ' 280' ' ' LEU . . . -60.41 -44.46 95.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.075 0.95 . . . . 74.43 111.263 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -76.8 -26.44 54.42 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.642 -0.708 . . . . 71.22 111.079 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.411 ' O ' ' HB3' ' C' ' 101' ' ' TYR . 47.2 t -73.86 -61.84 1.7 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.739 0.416 . . . . 73.54 110.491 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.667 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 8.4 tt -79.89 -25.5 40.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.404 0.282 . . . . 74.2 110.791 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.539 ' HA3' HD21 ' F' ' 280' ' ' LEU . . . -86.75 -7.16 78.86 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 115.083 0.793 . . . . 51.32 115.083 -174.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -55.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.491 0.646 . . . . 75.12 111.369 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.642 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 82.8 t80 -65.89 -39.11 90.35 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.998 0.919 . . . . 75.01 111.734 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.667 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 38.3 m -76.37 -47.19 3.39 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.474 -0.774 . . . . 64.34 112.288 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.7 Cg_exo -53.14 -40.36 77.27 Favored 'Trans proline' 0 C--N 1.399 3.206 0 C-N-CA 122.761 2.307 . . . . 75.13 112.891 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.27 -29.34 67.5 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.692 0.797 . . . . 71.23 112.52 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.475 HG21 ' NH1' ' A' ' 111' ' ' ARG . 29.4 mm -75.6 -43.66 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.096 0.558 . . . . 75.25 110.943 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 pp -93.29 -11.07 33.35 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 112.738 0.644 . . . . 74.31 112.738 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -57.44 -49.47 93.66 Favored Pre-proline 0 N--CA 1.491 1.604 0 CA-C-O 117.968 -1.015 . . . . 75.41 112.776 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.99 -31.29 89.5 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 121.94 1.76 . . . . 72.33 112.755 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -68.37 -48.5 64.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.951 0.9 . . . . 74.11 111.147 178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.45 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -58.72 -41.22 85.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 63.31 110.539 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -69.57 -47.73 62.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.954 -1.476 . . . . 74.33 111.252 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.06 -31.92 72.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.161 0.584 . . . . 74.14 109.95 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.417 ' O ' ' SD ' ' C' ' 117' ' ' MET . 43.0 t -63.99 -40.96 97.54 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.551 0.532 . . . . 73.34 110.589 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 86.6 mt -68.02 -41.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.329 0.651 . . . . 75.44 110.823 175.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.473 HG22 ' HB3' ' C' ' 125' ' ' GLN . 30.8 m -62.98 -30.16 71.37 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.432 0.693 . . . . 62.55 110.684 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -74.16 -46.23 43.59 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.922 0.889 . . . . 73.1 109.973 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.608 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.69 -42.71 84.21 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.923 0.889 . . . . 74.15 111.642 177.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 97.9 t -70.91 -33.99 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.86 0.864 . . . . 74.35 110.185 177.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.487 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 38.5 t -65.59 -33.02 74.94 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.389 0.676 . . . . 72.01 111.464 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.535 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 73.4 mtt-85 -81.66 -31.89 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.07 0.948 . . . . 74.53 110.618 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 -1.56 86.45 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.791 -0.641 . . . . 73.2 112.29 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 49.6 p 61.88 31.72 18.16 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 126.075 1.75 . . . . 64.55 112.262 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.0 150.06 37.88 Favored Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 114.495 -1.23 . . . . 71.34 109.385 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.533 ' HG2' ' HA ' ' F' ' 297' ' ' TYR . 23.9 Cg_exo -40.3 109.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 124.365 3.377 . . . . 71.35 113.908 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.473 ' HB3' HG22 ' C' ' 115' ' ' THR . 50.6 mt-30 -60.54 142.54 55.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.755 1.222 . . . . 73.45 111.99 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp -121.2 106.5 11.57 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.306 0.642 . . . . 74.23 109.553 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.34 108.44 20.48 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.458 -1.312 . . . . 71.22 107.458 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.406 HD22 HD23 ' C' ' 42' ' ' LEU . 85.2 mt -63.24 144.69 56.71 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.687 0.795 . . . . 75.35 111.868 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.418 ' HB2' HD21 ' F' ' 291' ' ' LEU . . . -67.54 159.57 77.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.838 1.255 . . . . 74.31 111.475 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -63.8 104.22 0.45 Allowed 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.528 2.152 . . . . 74.23 111.76 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.97 109.35 23.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.445 -0.946 . . . . 72.15 108.445 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -104.04 88.62 3.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.818 -1.083 . . . . 75.21 109.576 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.62 -37.98 83.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.099 -0.955 . . . . 72.53 108.763 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -67.05 -50.33 62.24 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.895 -1.048 . . . . 65.25 111.83 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.437 ' HA ' ' HB2' ' C' ' 138' ' ' MET . . . -66.0 -33.56 76.09 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.113 0.965 . . . . 72.32 112.172 -169.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 94.1 mt -52.27 -47.66 65.7 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.436 1.085 . . . . 75.24 110.8 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -76.3 -38.7 55.71 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.477 -0.783 . . . . 73.24 111.14 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.437 ' HB2' ' HA ' ' C' ' 135' ' ' ALA . 88.1 mtp -56.11 -26.66 50.78 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.332 1.053 . . . . 73.51 113.434 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -47.31 -30.88 3.43 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.246 1.019 . . . . 73.41 113.288 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -152.72 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 123.714 0.806 . . . . 75.24 111.8 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 42.4 tp 74.1 119.8 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.801 1.241 . . . . 74.01 111.845 167.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -107.19 125.15 50.74 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.653 0.781 . . . . 73.24 108.925 176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.8 127.41 31.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.06 -0.719 . . . . 75.04 109.06 172.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -88.36 -169.99 2.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.562 0.745 . . . . 75.2 111.24 -173.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.86 166.85 10.1 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.968 0.907 . . . . 71.04 109.985 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.35 142.19 8.86 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.431 -0.349 . . . . 62.13 112.75 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -176.35 105.94 0.07 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.487 1.115 . . . . 74.34 108.432 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.45 82.75 0.11 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.95 -0.46 . . . . 70.1 111.95 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p -135.68 96.82 3.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.824 0.85 . . . . 74.53 110.731 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -122.29 111.47 16.95 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.784 -1.191 . . . . 75.35 107.784 167.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -151.47 132.47 14.28 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.234 0.614 . . . . 72.03 109.595 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -154.98 85.69 1.1 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.701 0.8 . . . . 70.04 109.474 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -101.39 88.52 3.48 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.79 -0.819 . . . . 73.43 108.79 170.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -121.38 103.66 9.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.48 0.712 . . . . 72.31 109.391 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.796 0.838 . . . . 73.3 109.113 -177.267 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.406 -0.59 . . . . 74.52 109.406 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 31.3 m 58.69 56.03 4.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.663 0.785 . . . . 63.22 110.486 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -75.12 169.85 17.2 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.123 -0.944 . . . . 74.34 111.861 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -99.96 105.36 17.04 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.718 0.807 . . . . 75.51 110.509 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -173.34 115.07 0.25 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.073 0.949 . . . . 73.14 109.236 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -103.41 87.16 2.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.034 0.534 . . . . 74.25 110.022 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m -67.12 153.04 44.64 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.131 0.573 . . . . 61.23 110.829 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.46 161.24 17.57 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.243 0.617 . . . . 74.52 109.946 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -28.47 122.17 0.12 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 125.922 1.689 . . . . 75.43 114.685 -166.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m -146.49 143.76 29.18 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.141 0.976 . . . . 74.31 108.83 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -174.07 97.1 0.1 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.848 -1.538 . . . . 74.44 106.848 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -133.13 119.81 20.43 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.198 -0.91 . . . . 74.04 108.658 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mt -70.55 107.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 114.711 -1.132 . . . . 74.35 109.482 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.87 -37.64 62.12 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.203 -0.295 . . . . 75.22 110.203 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -170.5 143.89 2.33 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.963 0.79 . . . . 73.54 109.95 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.498 HD11 ' H ' ' D' ' 16' ' ' ILE . 0.1 OUTLIER -120.29 108.36 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.468 1.107 . . . . 72.4 108.205 175.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -138.25 158.69 43.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.447 1.118 . . . . 71.1 111.195 -170.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -92.56 110.31 21.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.768 -1.56 . . . . 74.51 108.873 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.516 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 41.3 mtpt -74.05 -31.69 62.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.149 0.5 . . . . 73.14 110.124 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -150.61 141.66 23.03 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.781 -1.1 . . . . 74.33 109.367 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.608 HG23 ' HE1' ' C' ' 117' ' ' MET . 28.8 mt -136.55 141.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.825 1.25 . . . . 74.41 107.802 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.2 t -146.55 137.5 24.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.988 0.915 . . . . 72.12 109.656 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -149.32 121.06 8.09 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 106.127 -1.805 . . . . 64.43 106.127 167.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -131.1 124.78 31.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.48 82.45 68.23 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.106 -1.072 . . . . 73.13 108.106 178.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.58 -34.34 5.76 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.866 2.377 . . . . 73.55 112.327 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.496 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 64.7 m-20 -106.98 23.55 14.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.403 1.081 . . . . 75.14 109.573 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.52 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -45.57 -59.77 4.14 Favored Pre-proline 0 CA--C 1.571 1.751 0 C-N-CA 125.194 1.398 . . . . 73.43 114.492 -168.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.19 -16.73 15.45 Favored 'Trans proline' 0 C--N 1.392 2.86 0 CA-C-N 121.886 1.709 . . . . 74.34 113.133 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -68.52 -43.55 76.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.082 0.953 . . . . 75.23 109.972 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.642 HG23 ' HA ' ' D' ' 73' ' ' ALA . 99.0 t -65.62 -34.82 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.857 0.863 . . . . 73.22 110.533 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.28 -7.98 46.67 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.871 1.063 . . . . 70.31 113.871 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -84.81 -29.33 25.46 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.102 0.561 . . . . 73.54 111.274 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -109.9 114.26 27.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.76 1.224 . . . . 75.34 108.7 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.42 ' HB2' ' HA ' ' G' ' 300' ' ' ASN . 7.2 p-10 -91.11 95.09 9.9 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.312 0.577 . . . . 73.41 112.081 -177.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.86 171.29 15.43 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.639 0.776 . . . . 74.24 112.333 175.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' G' ' 297' ' ' TYR . 21.8 mp0 -84.22 134.34 43.46 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.094 1.358 . . . . 64.43 111.388 -169.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.576 ' HD3' ' HB2' ' G' ' 297' ' ' TYR . 16.6 Cg_exo -68.23 117.55 5.02 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 73.44 114.301 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.91 114.37 10.98 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.19 -1.411 . . . . 72.24 107.19 163.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.85 123.24 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.65 0.738 . . . . 74.23 110.216 -170.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 51.7 tttp -93.44 125.59 38.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.841 1.256 . . . . 73.42 109.132 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.451 ' HB2' ' NE1' ' G' ' 290' ' ' TRP . 4.8 tt -97.66 114.62 26.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.662 -1.607 . . . . 75.13 106.662 173.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.406 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 15.8 t70 -127.89 129.85 47.55 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.665 -0.865 . . . . 73.22 108.665 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 64.0 tp -122.71 135.61 54.63 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.558 0.743 . . . . 72.04 110.118 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.483 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -134.51 148.88 50.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.682 1.193 . . . . 75.54 108.165 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -124.08 149.07 46.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.295 0.638 . . . . 55.44 110.674 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.39 152.09 35.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.971 0.908 . . . . 74.12 109.266 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.698 ' HB2' HD22 ' G' ' 278' ' ' LEU . 16.6 p -174.8 154.17 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.319 0.648 . . . . 73.22 111.373 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 55.2 p -171.46 158.57 5.26 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.369 1.068 . . . . 63.44 109.81 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -87.5 125.61 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.397 -0.594 . . . . 71.33 109.397 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' D' ' 57' ' ' GLU . 50.4 mt -91.36 -42.23 10.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.363 0.665 . . . . 74.41 110.456 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.15 -172.36 4.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.431 -0.804 . . . . 64.11 110.31 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.73 118.2 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.022 -0.99 . . . . 72.11 109.895 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 66.65 0.81 1.96 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.772 1.629 . . . . 75.21 112.661 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -108.49 124.82 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.048 0.539 . . . . 75.21 109.988 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -127.15 159.88 32.93 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.317 1.047 . . . . 75.24 109.403 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.575 ' HB2' HD12 ' D' ' 51' ' ' LEU . 39.6 tt0 -118.27 137.29 53.15 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.889 0.876 . . . . 72.43 108.715 174.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.473 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 69.3 t -121.11 121.43 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.509 -1.293 . . . . 74.42 107.509 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 31.2 t -117.89 129.77 73.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.965 -0.754 . . . . 74.1 108.965 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.33 110.93 20.11 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.636 -0.875 . . . . 73.05 108.636 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 13.7 ttm180 -84.16 99.71 10.69 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.717 -0.846 . . . . 74.24 108.717 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.27 122.38 45.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.116 -0.947 . . . . 75.44 108.487 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.406 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.1 m -129.28 130.29 46.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.367 -0.833 . . . . 75.14 109.908 -171.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 82.2 t -124.01 126.43 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.665 1.586 . . . . 74.13 108.146 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.613 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 89.2 m -126.42 110.63 13.54 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.76 -0.459 . . . . 74.31 109.76 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.84 124.19 49.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.068 0.547 . . . . 71.3 109.948 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' D' ' 72' ' ' THR . 58.8 m -135.91 119.61 17.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.571 -1.27 . . . . 61.54 107.571 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' D' ' 73' ' ' ALA . 6.8 mp -123.35 133.78 54.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.838 0.855 . . . . 74.21 109.734 -170.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.6 -116.87 5.9 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -112.26 3.76 17.32 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.201 0.6 . . . . 73.34 110.52 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.496 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 9.7 pm0 -127.54 164.57 21.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.681 0.792 . . . . 71.13 110.814 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 72' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' D' ' 67' ' ' SER . 53.4 m -86.46 129.98 34.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.147 0.579 . . . . 73.31 110.278 169.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.642 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -72.39 -68.61 0.46 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.325 0.65 . . . . 73.24 109.47 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.8 152.03 31.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.906 -1.043 . . . . 72.1 111.947 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -119.63 116.64 26.43 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.572 1.549 . . . . 75.31 107.574 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.588 ' SG ' HG21 ' D' ' 114' ' ' ILE . 17.1 t -127.83 134.94 49.45 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.784 -0.451 . . . . 72.21 109.784 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.7 133.71 13.22 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.189 0.596 . . . . 75.4 109.941 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.63 119.78 22.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.656 0.782 . . . . 74.05 109.324 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.497 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 64.6 mt-30 -90.53 88.52 7.18 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 174.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -79.33 97.95 6.51 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.451 -0.795 . . . . 75.13 109.118 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 143.88 16.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.183 -0.767 . . . . 75.11 111.183 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.79 130.96 3.8 Favored Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.224 -1.15 . . . . 70.31 110.224 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.429 HG22 HD11 ' D' ' 51' ' ' LEU . 46.3 mt -90.02 131.82 36.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.94 -0.763 . . . . 74.41 108.94 179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.473 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 30.0 m-85 -134.02 125.31 27.85 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.889 -0.782 . . . . 74.41 108.889 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -76.14 103.42 6.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.878 -1.156 . . . . 72.55 107.878 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.522 HG22 HD12 ' D' ' 89' ' ' ILE . 75.0 mt -107.8 132.18 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.358 1.063 . . . . 72.25 109.475 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.66 164.86 19.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.431 0.692 . . . . 62.45 110.948 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.81 47.75 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 115.262 0.865 . . . . 73.14 115.262 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.522 HD12 HG22 ' D' ' 86' ' ' ILE . 15.9 pt -123.97 128.43 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.628 1.171 . . . . 73.42 108.036 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -137.29 159.7 41.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.115 0.566 . . . . 73.1 111.352 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -123.42 31.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 115.46 -0.791 . . . . 73.05 113.201 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -69.19 -25.74 64.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 74.21 111.685 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -72.9 -39.74 66.1 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.385 0.674 . . . . 75.2 110.133 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -31.83 56.18 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.528 -0.545 . . . . 73.43 109.528 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.44 90.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.901 0.88 . . . . 74.32 111.89 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -61.53 -48.13 82.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.582 -0.736 . . . . 74.02 110.34 172.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.17 -29.36 62.79 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.927 -0.579 . . . . 74.15 112.128 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 29.7 tp -95.52 -51.21 4.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.217 1.007 . . . . 71.34 110.834 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.77 5.18 66.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.702 -0.681 . . . . 44.53 114.057 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.491 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -136.86 -55.96 0.73 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.064 0.432 . . . . 74.22 110.696 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -75.61 -41.24 54.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.809 0.67 . . . . 73.3 112.809 -173.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.24 -46.98 90.85 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.834 -0.603 . . . . 74.22 111.026 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.63 -40.0 87.85 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 122.299 1.999 . . . . 72.44 113.061 165.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -60.98 -28.08 68.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.406 0.682 . . . . 74.11 111.4 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -79.42 -50.54 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.842 0.857 . . . . 74.25 110.921 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.11 -28.63 32.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.057 0.762 . . . . 72.34 113.057 -167.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -65.83 -42.57 54.48 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.21 1.004 . . . . 71.11 112.873 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.19 -37.41 94.26 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 121.922 1.748 . . . . 75.44 113.087 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -77.2 -31.04 55.03 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 71.43 111.887 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.55 -51.91 63.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.299 0.64 . . . . 71.44 109.67 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.501 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.3 ttp180 -55.83 -54.32 45.96 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.074 -1.421 . . . . 74.53 110.396 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.8 -39.22 84.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 75.31 111.58 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.535 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -62.21 -47.54 83.99 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.029 0.532 . . . . 64.22 111.02 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.588 HG21 ' SG ' ' D' ' 76' ' ' CYS . 85.5 mt -60.11 -51.73 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.099 0.96 . . . . 73.24 110.225 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.426 HG21 ' HE2' ' B' ' 109' ' ' TYR . 87.0 m -54.71 -43.66 72.78 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.881 1.672 . . . . 73.31 112.452 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.1 t -66.65 -38.49 86.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.486 0.714 . . . . 71.54 110.718 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.582 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.1 mtm -72.1 -29.78 64.44 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.771 0.428 . . . . 74.25 111.842 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.441 HG21 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -64.49 -44.32 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.376 0.67 . . . . 73.12 109.73 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.1 p -72.27 -29.95 64.37 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.07 0.548 . . . . 74.32 111.417 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -69.69 -32.39 70.96 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.583 0.753 . . . . 73.12 110.574 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.76 81.44 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 115.908 -0.587 . . . . 73.34 112.818 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 60.09 21.38 10.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 126.819 2.048 . . . . 65.42 113.311 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -86.74 163.06 42.73 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.957 1.303 . . . . 75.11 109.627 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.71 133.69 20.73 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.114 1.876 . . . . 75.04 110.68 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.8 135.51 56.82 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.752 0.658 . . . . 75.41 111.455 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.65 107.75 18.86 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.134 -1.432 . . . . 73.44 107.134 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.464 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 75.8 m-20 -97.81 93.27 6.27 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.069 -1.456 . . . . 74.23 107.069 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -74.18 120.08 19.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.24 -0.891 . . . . 73.34 109.507 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.65 123.22 78.45 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.618 0.767 . . . . 73.53 111.781 -173.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.501 ' HB3' HH12 ' D' ' 111' ' ' ARG . 18.7 Cg_endo -86.86 115.31 1.21 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.082 2.521 . . . . 75.22 111.58 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.8 110.13 30.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.668 -1.234 . . . . 74.11 107.668 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.453 ' ND2' ' HB1' ' D' ' 135' ' ' ALA . 57.5 t30 -79.03 87.99 4.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.021 0.528 . . . . 74.33 110.208 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -72.39 -19.13 61.66 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.658 -0.701 . . . . 73.3 111.06 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.491 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 20.7 t70 -61.75 -35.55 78.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.629 0.772 . . . . 64.2 111.28 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.453 ' HB1' ' ND2' ' D' ' 132' ' ' ASN . . . -59.35 -37.25 77.39 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 124.338 1.024 . . . . 72.31 113.023 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.634 HD12 ' H ' ' B' ' 150' ' ' GLU . 24.5 mt -59.66 -47.71 84.54 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.93 0.892 . . . . 74.23 111.173 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -77.45 -31.03 53.61 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.018 -0.992 . . . . 74.32 110.897 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 33.4 ttm -59.76 -39.41 84.74 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.423 1.489 . . . . 72.44 110.606 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -58.54 -21.84 53.78 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.682 1.239 . . . . 73.12 112.827 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -84.63 -35.95 22.33 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.647 0.779 . . . . 72.52 110.932 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.66 -30.25 46.14 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.014 0.376 . . . . 63.01 112.014 -176.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -88.96 44.5 1.22 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.967 0.507 . . . . 73.24 111.484 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -120.44 46.03 2.08 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.764 0.826 . . . . 54.11 109.829 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -162.31 -81.84 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.412 0.285 . . . . 75.44 111.115 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.97 162.29 31.84 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.503 0.721 . . . . 63.41 111.835 -169.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.25 138.19 3.04 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.796 -0.522 . . . . 70.31 111.796 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -113.63 137.59 51.38 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.694 0.747 . . . . 74.31 110.215 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.82 160.77 11.1 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.554 -0.618 . . . . 63.32 111.554 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 76.4 m -143.88 -90.25 0.12 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.447 0.699 . . . . 74.42 109.252 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . 0.45 ' HA ' ' HE3' ' H' ' 286' ' ' MET . 0.3 OUTLIER -165.51 152.19 10.07 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.655 -1.239 . . . . 71.14 107.655 -178.336 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -98.08 118.88 35.68 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.587 -0.894 . . . . 75.1 108.587 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -79.55 82.59 5.65 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.807 -1.183 . . . . 72.34 107.807 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . 0.533 ' HA ' HE21 ' D' ' 153' ' ' GLN . 0.0 OUTLIER -66.06 90.85 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.515 -1.22 . . . . 74.24 110.619 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -142.96 115.3 8.47 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.411 -1.268 . . . . 73.0 108.583 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 C-N-CA 123.771 0.828 . . . . 72.13 109.792 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 110.377 -0.231 . . . . 71.42 110.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.52 130.83 35.38 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.941 -0.763 . . . . 71.45 108.941 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -96.04 166.75 11.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.33 0.652 . . . . 75.23 110.561 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -167.11 164.23 15.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.04 0.936 . . . . 74.4 110.048 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.15 102.32 1.56 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.25 0.62 . . . . 73.35 110.067 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -71.91 125.71 11.24 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.672 2.248 . . . . 75.01 112.861 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . 0.56 HD23 ' SD ' ' A' ' 94' ' ' MET . 0.6 OUTLIER -96.79 31.37 2.36 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.553 -0.906 . . . . 72.34 108.553 170.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . 0.484 HD13 ' HG ' ' A' ' 48' ' ' SER . 15.5 tp -164.38 37.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.208 1.003 . . . . 75.51 108.386 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -66.85 -26.93 73.15 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 114.726 -1.125 . . . . 55.45 114.571 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.86 142.72 27.95 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 122.749 0.419 . . . . 75.12 111.002 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -176.92 -21.72 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 O-C-N 124.61 1.194 . . . . 74.32 110.424 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.04 -7.0 31.59 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.657 0.783 . . . . 74.23 112.735 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.82 89.79 0.58 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.992 0.917 . . . . 61.22 110.488 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -99.42 -131.04 7.17 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.335 -0.706 . . . . 74.14 111.335 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.28 74.69 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.711 1.204 . . . . 74.44 111.751 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 65.4 mtt -118.43 142.74 31.91 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 123.739 0.816 . . . . 75.41 109.344 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.78 33.94 0.54 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.218 2.612 . . . . 64.31 113.444 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.61 88.0 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 108.71 -0.848 . . . . 72.32 108.71 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -128.34 44.35 2.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.42 1.088 . . . . 74.23 108.88 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 96.9 m95 73.83 158.36 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.794 1.637 . . . . 75.25 112.979 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.554 HD12 ' HB3' ' A' ' 129' ' ' ALA . 3.9 mp -109.42 66.13 0.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.119 -1.4 . . . . 75.03 108.777 -171.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 106.47 -152.3 16.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.224 -0.898 . . . . 71.02 112.626 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.09 120.79 6.19 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.25 2.633 . . . . 64.55 112.748 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . 0.484 ' HD3' ' H ' ' E' ' 294' ' ' LYS . 0.0 OUTLIER -114.64 88.21 2.81 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.784 0.802 . . . . 74.44 110.24 -178.49 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.96 83.69 4.78 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.486 -0.931 . . . . 74.21 108.486 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 47.2 m -59.54 -58.09 10.11 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 115.277 -0.874 . . . . 74.43 108.879 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.467 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 21.5 m-30 -67.75 89.95 0.27 Allowed 'General case' 0 C--N 1.35 0.624 0 N-CA-C 108.464 -0.939 . . . . 75.12 108.464 168.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -78.67 -2.5 39.47 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.243 -1.344 . . . . 70.05 112.712 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 172.03 -168.66 41.76 Favored Glycine 0 C--O 1.247 0.922 0 N-CA-C 110.748 -0.941 . . . . 44.35 110.748 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -70.94 108.38 4.51 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.077 0.551 . . . . 74.42 109.876 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . 0.444 HG21 HH22 ' B' ' 15' ' ' ARG . 13.8 mt -75.78 -64.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.71 -1.218 . . . . 72.42 107.71 171.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 32.3 t70 58.26 -80.38 0.02 OUTLIER 'General case' 0 C--N 1.359 0.979 0 C-N-CA 125.67 1.588 . . . . 52.23 111.304 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 17.1 pttp 169.0 156.94 0.17 Allowed Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 126.966 2.106 . . . . 74.03 107.841 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.0 120.83 9.02 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.1 1.867 . . . . 71.32 110.928 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' G' ' 295' ' ' ALA . . . -70.41 86.54 0.61 Allowed 'General case' 0 C--N 1.352 0.699 0 CA-C-O 121.786 0.803 . . . . 70.42 110.236 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . 0.708 ' HA ' ' HD2' ' G' ' 293' ' ' PRO . 6.6 m -131.51 135.38 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.712 1.605 . . . . 71.21 106.804 170.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 15.4 t -163.22 20.85 0.08 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.753 0.311 . . . . 73.4 111.062 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.52 128.38 33.23 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 122.111 -0.368 . . . . 64.22 110.434 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' E' E ' 309' ' ' THR . . . . . 0.55 HG23 HD21 ' G' ' 291' ' ' LEU . 23.1 p -130.49 158.46 74.47 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.698 1.199 . . . . 71.35 109.304 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . 0.589 ' HB2' HG23 ' B' ' 7' ' ' THR . 19.2 Cg_endo . . . . . 0 C--N 1.377 2.039 0 C-N-CA 122.595 2.197 . . . . 74.21 111.412 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 109.533 -0.543 . . . . 71.11 109.533 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -98.24 119.41 36.86 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.654 0.781 . . . . 75.55 109.169 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -82.0 77.27 8.84 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.354 0.662 . . . . 75.01 111.177 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -71.68 -33.28 68.69 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.73 0.812 . . . . 74.14 109.982 167.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -64.1 129.16 93.82 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.09 -0.959 . . . . 72.21 109.245 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.27 107.31 0.47 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.978 1.786 . . . . 72.31 109.998 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.552 ' HB3' ' HE1' ' C' ' 94' ' ' MET . 17.0 tp -69.72 2.59 3.15 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 125.06 1.344 . . . . 74.23 112.809 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . 0.516 HD22 HD21 ' C' ' 98' ' ' LEU . 19.6 mt -71.3 161.79 30.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.979 1.312 . . . . 75.24 111.602 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -154.87 25.33 0.63 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.8 -0.636 . . . . 73.1 112.023 173.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . 0.569 ' HB2' ' HB2' ' C' ' 95' ' ' ALA . 8.7 tt -165.6 -62.61 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.339 0.656 . . . . 74.14 109.282 -173.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . 0.455 ' HB2' ' HA2' ' C' ' 99' ' ' GLY . 38.6 t80 -65.05 133.76 52.35 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.185 -0.916 . . . . 62.35 110.132 -173.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 71.95 147.2 0.08 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.894 1.371 . . . . 61.22 111.288 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 68.45 -72.3 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.002 1.321 . . . . 65.42 111.218 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -86.01 60.08 4.65 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 112.182 -0.367 . . . . 73.24 112.182 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -82.52 144.08 30.65 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.028 0.531 . . . . 75.41 110.395 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 63.9 ttp -102.38 103.6 32.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 108.253 -1.018 . . . . 74.54 108.253 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.11 108.58 2.5 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.479 2.12 . . . . 71.5 111.981 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 58.9 t -74.33 90.38 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 108.818 -0.808 . . . . 72.45 108.818 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 36.8 ttp-105 -84.14 80.19 9.27 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.719 -1.128 . . . . 75.33 108.541 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 13.2 m95 65.96 168.07 0.21 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 114.098 -1.41 . . . . 74.3 113.821 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.418 HD21 ' HB2' ' C' ' 129' ' ' ALA . 4.8 mp -119.85 -33.09 4.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.229 -1.35 . . . . 65.32 109.905 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -159.21 -100.94 0.17 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-O 118.961 -0.911 . . . . 63.22 112.198 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.75 154.25 63.92 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.019 2.479 . . . . 65.02 112.24 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.5 14.92 4.08 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.519 0.727 . . . . 74.54 112.454 -176.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -102.19 155.53 18.15 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.963 0.505 . . . . 75.22 110.923 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 72.7 m -134.96 163.69 29.28 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.69 1.196 . . . . 75.54 108.168 173.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.533 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 48.9 m-85 69.36 -89.08 0.03 OUTLIER 'General case' 0 C--N 1.353 0.72 0 C-N-CA 125.219 1.408 . . . . 74.52 109.532 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 51.77 32.96 10.3 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.81 1.244 . . . . 72.04 111.248 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -164.58 144.25 9.22 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 114.826 -1.079 . . . . 71.53 111.424 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -73.72 77.82 1.55 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.237 1.015 . . . . 71.15 110.739 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 32.0 pt -78.44 -13.16 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 116.304 -0.407 . . . . 74.42 110.813 177.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . 0.487 ' HB3' ' HZ2' ' C' ' 36' ' ' TRP . 3.9 p30 -57.24 -26.58 60.97 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.308 1.043 . . . . 72.43 112.288 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -66.75 115.03 20.61 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 123.958 0.786 . . . . 74.44 109.821 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.5 97.34 1.14 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.201 1.934 . . . . 71.32 111.889 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -87.28 17.64 4.25 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.814 0.846 . . . . 64.52 111.031 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 93.1 t -102.22 -68.34 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.596 1.158 . . . . 70.4 109.031 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 77.5 p 43.59 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.795 1.638 . . . . 74.03 113.184 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 18.0 p -161.75 168.71 22.75 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.703 -1.221 . . . . 73.33 107.703 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 9.6 m -128.43 68.54 77.66 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-N 117.934 0.334 . . . . 74.44 110.598 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--N 1.389 2.672 0 C-N-CA 123.954 3.103 . . . . 73.44 111.631 175.371 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.681 -0.488 . . . . 55.54 109.681 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -64.5 91.67 0.08 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.88 0.472 . . . . 74.15 110.061 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -82.09 94.63 7.25 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.09 -1.078 . . . . 71.44 108.09 170.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -162.64 170.72 18.03 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-N 114.24 -1.345 . . . . 74.22 108.514 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 12.8 mptt 68.91 145.57 0.11 Allowed Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 124.69 1.196 . . . . 73.11 110.644 -173.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.87 177.0 1.53 Allowed 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.036 1.824 . . . . 75.22 111.659 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 36.9 mt -85.01 38.0 0.69 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.565 0.698 . . . . 62.01 110.447 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . 0.698 HD22 ' HB2' ' D' ' 48' ' ' SER . 0.4 OUTLIER -156.35 136.82 13.11 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.231 -1.396 . . . . 74.33 107.231 -175.726 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 165.22 -49.38 0.28 Allowed Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.88 -0.2 . . . . 71.43 113.269 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.37 77.58 3.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.519 0.728 . . . . 73.25 111.645 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -143.38 2.52 1.27 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.859 1.264 . . . . 75.5 110.379 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -102.8 153.78 19.84 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.536 0.734 . . . . 52.34 110.396 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -71.0 95.76 1.22 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.349 0.66 . . . . 73.11 109.854 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.57 -75.1 0.37 Allowed Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.825 -0.51 . . . . 74.33 111.825 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -157.52 23.31 0.29 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 107.945 -1.131 . . . . 71.41 107.945 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 72.9 mmm -90.02 117.33 67.99 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.337 1.055 . . . . 75.14 110.262 -170.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -93.02 154.72 2.66 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.888 2.392 . . . . 75.24 112.426 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.93 -61.82 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 107.855 -1.165 . . . . 75.33 107.855 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' B' ' 154' ' ' ASP . 71.2 mtp180 60.5 -86.54 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 125.454 1.502 . . . . 71.45 110.725 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.578 ' HE3' ' H ' ' G' ' 291' ' ' LEU . 0.8 OUTLIER -179.68 159.57 0.88 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.397 1.479 . . . . 74.11 108.905 -176.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.578 ' H ' ' HE3' ' G' ' 290' ' ' TRP . 4.7 mp -125.21 143.67 50.83 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.226 1.01 . . . . 73.31 108.929 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 82.9 167.65 41.47 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 116.304 -0.407 . . . . 61.44 113.582 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . 0.708 ' HD2' ' HA ' ' E' ' 306' ' ' VAL . 61.2 Cg_endo -69.9 -20.26 34.39 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.877 2.385 . . . . 75.14 112.57 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . 0.453 ' HD3' ' CG ' ' G' ' 290' ' ' TRP . 7.1 mtmp? 68.39 89.85 0.1 Allowed 'General case' 0 C--N 1.362 1.109 0 C-N-CA 125.097 1.359 . . . . 71.11 111.333 174.102 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . 0.774 ' HB2' ' HB2' ' E' ' 305' ' ' ALA . . . -141.13 78.42 1.64 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.998 -1.112 . . . . 71.31 107.998 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m -62.26 -37.73 86.56 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.729 -1.123 . . . . 71.32 111.497 -171.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.576 ' HB2' ' HD3' ' D' ' 38' ' ' PRO . 0.1 OUTLIER -91.11 115.32 27.93 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.607 -1.257 . . . . 73.11 107.607 171.513 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -97.08 10.58 38.93 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.582 0.23 . . . . 74.33 110.632 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -167.51 -155.84 9.52 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.587 -0.279 . . . . 61.44 113.627 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . 0.42 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 23.8 t-20 -68.58 151.1 47.21 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.061 0.945 . . . . 73.43 111.242 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . . . . . . . . . 16.9 tt -98.08 -38.06 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.47 0.708 . . . . 72.15 112.315 -173.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.68 157.09 32.05 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.33 0.652 . . . . 71.32 110.02 -173.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -113.21 102.79 55.26 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.536 0.734 . . . . 75.41 109.882 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.59 80.02 0.86 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.841 2.36 . . . . 74.14 111.114 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -83.71 177.38 8.39 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.183 -0.917 . . . . 63.01 110.406 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.43 HG21 ' NE2' ' C' ' 12' ' ' GLN . 9.3 m -59.18 149.98 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.276 0.631 . . . . 73.44 110.943 174.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 307' ' ' THR . . . . . 0.527 ' HA ' ' HG2' ' C' ' 12' ' ' GLN . 11.5 t -151.09 18.69 0.77 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.75 0.42 . . . . 74.43 111.358 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 31.4 m -126.28 80.3 1.91 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.744 0.418 . . . . 72.34 110.915 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -51.03 0.31 Allowed Pre-proline 0 CA--C 1.567 1.618 0 CA-C-O 118.258 -0.877 . . . . 75.53 111.892 172.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.396 3.068 0 C-N-CA 122.454 2.103 . . . . 71.5 111.705 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.874 0.368 . . . . 65.11 110.419 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -121.16 109.43 14.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.04 -1.096 . . . . 75.13 108.04 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -173.16 124.14 0.41 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.724 0.81 . . . . 74.15 109.08 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -147.57 131.19 16.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.312 0.645 . . . . 74.03 109.534 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.23 133.54 21.98 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 123.765 0.826 . . . . 73.01 109.711 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.95 155.14 15.05 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.752 2.301 . . . . 75.44 111.377 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.89 -10.36 59.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.415 0.686 . . . . 73.13 112.239 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . 0.432 HD22 HD23 ' B' ' 98' ' ' LEU . 71.9 mt -58.86 -45.02 91.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.469 0.708 . . . . 74.14 111.226 -177.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 75.89 -76.39 1.4 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.253 -0.885 . . . . 61.22 112.088 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 3.3 pp -153.46 157.55 40.04 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.464 1.106 . . . . 75.15 109.311 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -100.77 91.94 4.85 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.938 -0.764 . . . . 74.35 108.938 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . 48.35 69.23 0.57 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.858 1.263 . . . . 64.34 112.591 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -94.16 143.17 26.61 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.317 -0.401 . . . . 75.33 111.124 -173.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 138.17 -164.69 25.56 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.607 -0.724 . . . . 52.41 112.379 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -133.54 139.54 46.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.187 0.995 . . . . 74.41 109.407 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 286' ' ' MET . . . . . 0.45 ' HE3' ' HA ' ' D' ' 150' ' ' GLU . 54.8 ttp -165.31 102.43 0.77 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.049 0.939 . . . . 75.32 108.738 178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.57 98.03 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.346 2.698 . . . . 72.21 113.48 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . 0.501 HG12 HG11 ' B' ' 131' ' ' VAL . 56.1 t -126.69 95.61 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.643 1.177 . . . . 72.15 108.566 176.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -125.49 -156.46 0.73 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.176 0.99 . . . . 74.54 108.596 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -64.89 122.05 16.07 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-N 118.098 0.408 . . . . 74.33 110.993 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -25.64 63.44 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.107 0.88 . . . . 74.52 111.16 168.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -178.62 96.64 0.1 Allowed Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.018 -0.833 . . . . 73.53 111.018 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.31 34.72 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.696 2.931 . . . . 70.2 112.972 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.15 3.71 41.37 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.163 0.985 . . . . 73.34 110.53 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.21 159.28 28.63 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.668 0.787 . . . . 74.12 110.494 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 9.0 m 72.4 155.32 0.15 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.657 1.183 . . . . 71.24 111.507 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.42 ' HA ' ' HG3' ' B' ' 124' ' ' PRO . 15.3 m-85 67.99 7.76 6.03 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.161 1.384 . . . . 64.25 112.081 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -95.84 76.29 3.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.997 -1.112 . . . . 70.43 107.997 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 119.7 170.55 14.49 Favored Glycine 0 C--O 1.247 0.923 0 CA-C-N 114.215 -1.357 . . . . 74.23 111.085 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 23.3 m120 65.77 -176.93 0.18 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.688 1.195 . . . . 75.43 111.027 -173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 25.8 pt 46.94 25.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 126.038 1.735 . . . . 74.31 112.923 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -67.21 -37.86 84.33 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 124.697 1.199 . . . . 72.32 110.717 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.431 ' HA ' ' HE3' ' H' ' 303' ' ' LYS . 0.1 OUTLIER -136.08 92.26 16.32 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.01 -0.995 . . . . 74.44 108.997 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.85 157.13 55.72 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.525 2.15 . . . . 75.43 110.826 169.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 70.69 122.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.768 1.227 . . . . 72.14 111.172 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 52.6 t -61.66 -41.38 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.36 0.664 . . . . 72.43 110.163 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 5.7 m 54.89 80.39 0.13 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.318 1.447 . . . . 72.34 111.917 173.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 57.7 m 69.51 139.44 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.166 1.386 . . . . 73.4 112.34 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 24.6 p -112.99 94.55 30.36 Favored Pre-proline 0 N--CA 1.476 0.837 0 N-CA-C 108.619 -0.882 . . . . 72.14 108.619 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--N 1.379 2.171 0 C-N-CA 123.095 2.53 . . . . 75.05 112.144 -178.564 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.755 ' HA ' ' HA ' ' C' ' 149' ' ' THR . 61.9 mtt . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 109.614 -0.513 . . . . 75.11 109.614 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.6 m 66.9 37.54 3.96 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.199 1.0 . . . . 62.53 113.569 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -87.71 173.83 8.77 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.933 -0.766 . . . . 74.53 108.933 166.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.55 91.86 7.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 106.62 -1.622 . . . . 63.04 106.62 167.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -109.54 117.27 33.52 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.359 0.664 . . . . 75.24 109.884 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -143.98 121.52 11.76 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.208 -1.034 . . . . 74.52 108.208 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.511 ' HA ' ' HA ' ' C' ' 144' ' ' GLN . 31.5 p -116.93 162.04 18.39 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.62 0.768 . . . . 64.04 110.922 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -65.22 125.45 25.07 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.96 0.904 . . . . 72.52 110.05 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 82.1 mtp -116.09 161.63 18.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.524 0.73 . . . . 72.44 109.622 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.557 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.3 m -141.23 126.69 18.79 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.731 -1.211 . . . . 75.04 107.731 172.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.733 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.4 t80 -135.63 132.82 37.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.725 0.41 . . . . 74.24 110.028 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.451 ' NE2' ' HA ' ' H' ' 307' ' ' THR . 53.6 tp60 -152.9 114.31 4.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.824 . . . . 73.52 108.794 172.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.634 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -83.13 119.79 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.797 -0.446 . . . . 74.32 109.797 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -87.19 -31.05 20.55 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.463 0.705 . . . . 74.0 109.651 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -163.43 142.17 8.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.757 -0.201 . . . . 74.2 110.999 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.94 140.27 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 124.553 1.141 . . . . 75.41 108.166 170.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.514 ' HB3' HG23 ' B' ' 122' ' ' THR . 40.3 p90 -172.76 167.95 5.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.662 0.744 . . . . 72.14 111.023 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -95.88 119.04 33.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.961 -1.018 . . . . 75.45 108.729 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.522 ' HE3' ' HB2' ' B' ' 28' ' ' ALA . 29.7 mtpt -81.87 -23.46 36.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.111 0.481 . . . . 74.0 110.464 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.2 t70 -154.58 144.15 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.97 -1.014 . . . . 72.45 110.026 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.7 mt -137.26 144.36 32.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.887 1.675 . . . . 74.21 106.987 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -153.71 125.99 7.99 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.258 0.551 . . . . 63.11 110.033 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 90.1 t80 -124.1 120.85 33.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.939 -1.874 . . . . 74.2 105.939 168.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.422 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 35.4 mt-10 -126.95 108.41 10.94 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.715 0.689 . . . . 74.41 110.702 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.18 79.02 2.64 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 106.424 -1.695 . . . . 73.24 106.424 168.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.4 -46.12 3.1 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.388 2.058 . . . . 72.13 111.192 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.8 m-20 -100.81 28.38 5.24 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.914 -1.039 . . . . 75.2 108.874 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.437 ' O ' HG11 ' A' ' 31' ' ' VAL . . . -41.47 -56.77 4.28 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.038 -0.982 . . . . 72.15 113.093 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.517 ' HG2' ' HD2' ' A' ' 30' ' ' HIS . 36.3 Cg_endo -63.19 -30.32 74.49 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 121.794 1.663 . . . . 73.54 112.878 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.517 ' HD2' ' HG2' ' A' ' 29' ' ' PRO . 9.3 m-70 -79.53 -30.2 41.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.748 0.819 . . . . 74.11 111.279 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -82.25 -18.39 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.55 0.34 . . . . 74.2 110.939 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -75.96 -31.07 58.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.203 0.601 . . . . 73.11 110.498 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -82.19 -18.96 40.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.768 0.427 . . . . 75.2 110.595 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -68.82 142.09 54.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.873 0.469 . . . . 71.41 110.166 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.47 139.46 58.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.156 0.582 . . . . 65.42 109.847 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.418 ' CZ2' ' HA ' ' E' ' 300' ' ' ASN . 8.1 m95 -66.66 90.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.078 0.861 . . . . 71.41 109.889 -171.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -133.81 63.11 61.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.365 1.066 . . . . 74.51 108.389 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.446 ' HG3' ' HB3' ' E' ' 297' ' ' TYR . 91.4 Cg_endo -81.47 133.29 8.35 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.212 1.941 . . . . 64.32 112.063 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.47 91.96 6.05 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.523 -1.288 . . . . 75.12 107.523 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.426 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.5 t -78.38 107.56 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -94.27 156.78 16.36 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.317 1.047 . . . . 73.22 109.69 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.431 HD11 HD13 ' A' ' 128' ' ' LEU . 3.5 tt -137.82 109.01 6.81 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.363 -0.977 . . . . 75.13 108.363 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.559 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.4 m-20 -125.46 141.88 51.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.178 0.991 . . . . 73.22 109.252 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.24 126.67 37.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 63.52 109.245 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -118.82 129.08 55.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.675 1.19 . . . . 75.05 108.622 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.8 p -110.38 144.9 38.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.859 0.864 . . . . 75.21 110.339 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.22 131.78 12.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.166 0.586 . . . . 74.15 110.55 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -133.81 151.92 51.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.235 0.614 . . . . 70.41 109.994 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.3 t -154.71 162.19 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.652 0.781 . . . . 72.11 109.672 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -109.22 113.17 25.78 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.762 0.825 . . . . 72.01 108.784 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.5 mt -82.79 -33.63 27.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.259 0.624 . . . . 75.21 110.301 178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.404 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -170.91 -174.42 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.337 1.055 . . . . 73.04 109.989 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.98 123.2 19.18 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.084 0.554 . . . . 65.45 109.738 173.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 67.52 -4.43 0.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.455 1.502 . . . . 74.22 112.943 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 59.3 t -112.1 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.241 -1.022 . . . . 74.03 108.241 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.82 167.14 16.2 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.103 0.961 . . . . 64.2 108.611 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -129.58 138.8 51.49 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.427 0.691 . . . . 74.51 109.326 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -126.66 129.07 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.415 -1.328 . . . . 73.34 107.415 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.65 131.6 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.118 0.967 . . . . 75.32 109.068 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.6 103.45 9.71 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.987 -1.116 . . . . 75.13 107.987 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.636 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 9.8 ttp180 -84.74 110.51 18.84 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.453 -0.573 . . . . 72.51 109.453 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.442 ' HB ' HD11 ' A' ' 114' ' ' ILE . 12.4 t -92.92 128.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.394 -1.336 . . . . 73.23 107.394 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 16.8 m -123.9 126.83 47.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.471 -0.566 . . . . 62.15 109.471 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.487 HG12 HD21 ' A' ' 126' ' ' LEU . 47.2 t -125.0 131.72 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.767 1.227 . . . . 74.34 107.823 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.426 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.6 m -116.38 151.64 35.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.702 -0.851 . . . . 75.43 108.702 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.54 115.69 11.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.926 -1.509 . . . . 71.42 106.926 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.8 t -130.02 128.21 41.52 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.99 0.424 . . . . 75.2 110.228 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.482 HD12 ' HB1' ' A' ' 73' ' ' ALA . 8.2 mp -90.3 85.74 6.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.687 1.195 . . . . 74.34 107.984 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.43 -98.28 2.08 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 114.822 -1.081 . . . . 72.52 110.534 -172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.68 -5.03 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.4 0.68 . . . . 74.41 110.01 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -85.83 100.8 12.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.005 -1.109 . . . . 75.21 108.005 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.49 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 59.8 m -71.21 129.66 39.46 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.269 0.556 . . . . 72.23 111.671 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -77.24 -59.74 2.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.06 -1.427 . . . . 74.22 109.897 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.562 ' HE2' HD23 ' A' ' 126' ' ' LEU . 43.1 p90 -159.57 136.9 9.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.322 -0.854 . . . . 72.4 111.4 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 tp -112.54 107.85 16.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.054 1.342 . . . . 74.52 107.495 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.534 ' HB3' HG23 ' A' ' 114' ' ' ILE . 72.6 m -107.93 106.05 16.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.809 0.844 . . . . 74.0 111.156 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.43 ' HB2' HG23 ' A' ' 63' ' ' THR . 40.8 tt0 -127.64 125.04 39.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.928 1.291 . . . . 75.11 109.186 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.43 115.32 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.872 0.869 . . . . 75.2 109.752 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.636 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 73.4 mt-30 -83.36 89.33 7.01 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.378 -0.971 . . . . 63.52 108.378 168.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -83.12 106.4 14.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.444 -0.947 . . . . 75.11 108.444 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.2 -177.38 19.13 Favored Glycine 0 N--CA 1.465 0.614 0 O-C-N 123.528 0.518 . . . . 53.44 112.422 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.3 155.71 15.65 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 112.443 -0.263 . . . . 73.25 112.443 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -90.34 115.84 30.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.873 -0.788 . . . . 75.42 108.873 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.733 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -121.1 119.67 33.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.946 0.899 . . . . 75.42 109.564 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 t -83.33 97.94 9.19 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.685 -0.858 . . . . 64.45 108.685 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 89' ' ' ILE . 25.6 pt -112.53 142.9 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.603 0.761 . . . . 71.05 110.386 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.557 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -154.81 164.33 38.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.098 0.959 . . . . 55.44 110.184 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.36 -5.89 83.33 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.86 -0.609 . . . . 71.22 113.925 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.431 HD12 ' HG3' ' A' ' 94' ' ' MET . 18.8 pt -114.57 144.79 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.008 0.923 . . . . 75.13 111.118 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -163.18 172.18 15.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.754 0.822 . . . . 72.33 108.783 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.47 -124.6 11.9 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.692 0.637 . . . . 75.11 114.692 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -74.8 -23.62 58.52 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.867 0.867 . . . . 72.45 111.399 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -68.04 -36.98 80.81 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 73.32 109.411 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.431 ' HG3' HD12 ' A' ' 89' ' ' ILE . 24.8 ttt -81.55 -24.68 36.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.715 -0.675 . . . . 72.53 110.822 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.05 85.48 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.852 0.461 . . . . 72.32 111.115 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -68.25 -37.17 80.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.404 -0.816 . . . . 70.41 110.781 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.473 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.3 t -73.82 -42.33 61.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 74.14 111.647 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.38 -47.3 20.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.365 0.666 . . . . 71.42 110.264 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.4 -2.69 88.99 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 115.077 0.791 . . . . 70.04 115.077 -170.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.11 -56.75 0.23 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 117.91 0.855 . . . . 74.3 112.279 -175.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.473 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.8 t80 -64.78 -47.76 76.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.731 1.213 . . . . 72.14 113.065 -168.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.32 -35.5 1.17 Allowed Pre-proline 0 CA--C 1.57 1.727 0 CA-C-O 118.851 -0.595 . . . . 62.43 112.502 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.85 -39.68 48.64 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.77 2.314 . . . . 60.41 113.295 161.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -61.1 -25.93 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.42 0.688 . . . . 71.1 111.419 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.1 mm -78.95 -55.42 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.695 0.798 . . . . 73.34 110.227 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.95 -24.46 33.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.75 1.018 . . . . 72.45 113.75 -165.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -64.13 -41.57 62.49 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.382 -0.818 . . . . 74.32 112.68 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.34 -43.17 61.15 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 122.095 1.863 . . . . 74.35 113.225 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -67.95 -38.62 83.03 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.441 0.696 . . . . 74.33 112.092 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 -45.96 76.3 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.684 -0.487 . . . . 64.22 109.684 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -53.71 -46.49 70.79 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.576 1.173 . . . . 75.34 110.755 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.23 -49.37 72.2 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.43 1.081 . . . . 73.42 111.148 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.7 t -58.22 -41.47 84.13 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.834 0.709 . . . . 70.25 110.735 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.534 HG23 ' HB3' ' A' ' 76' ' ' CYS . 78.7 mt -64.94 -48.49 83.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 O-C-N 124.097 0.873 . . . . 74.41 109.958 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.623 HG21 ' HG3' ' A' ' 125' ' ' GLN . 91.0 m -51.76 -49.98 61.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.133 0.973 . . . . 74.43 111.768 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -64.02 -42.94 96.94 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.088 0.867 . . . . 64.32 110.409 -175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.43 ' SD ' HG22 ' A' ' 21' ' ' ILE . 5.7 mtp -56.38 -46.76 79.95 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.835 0.854 . . . . 72.02 111.442 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.454 HG22 ' SG ' ' A' ' 76' ' ' CYS . 77.5 t -65.69 -44.2 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.195 0.998 . . . . 74.23 111.68 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.7 p -67.66 -31.35 71.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.981 0.513 . . . . 72.21 111.346 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.413 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 88.3 mtt-85 -68.02 -29.6 68.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.602 0.761 . . . . 74.15 110.858 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.47 3.04 80.2 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.177 -0.465 . . . . 63.53 113.547 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.8 m 63.74 35.75 11.09 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.808 1.243 . . . . 75.34 110.045 -178.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.421 ' HD1' ' HE1' ' E' ' 297' ' ' TYR . 93.6 m-85 -105.58 151.66 39.86 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 114.547 -1.206 . . . . 72.12 108.386 170.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.05 147.87 91.38 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.431 2.087 . . . . 70.35 111.94 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.623 ' HG3' HG21 ' A' ' 115' ' ' THR . 24.2 tt0 -52.9 128.67 27.83 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.772 0.829 . . . . 63.35 112.472 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.562 HD23 ' HE2' ' A' ' 74' ' ' PHE . 38.4 tp -108.48 118.44 36.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.256 0.623 . . . . 74.54 109.419 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -140.05 109.05 6.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.162 0.985 . . . . 72.21 108.939 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.431 HD13 HD11 ' A' ' 42' ' ' LEU . 17.9 tp -67.48 135.74 53.54 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.198 0.599 . . . . 63.42 110.544 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.408 ' H ' HD12 ' A' ' 128' ' ' LEU . . . -53.52 133.29 54.2 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.647 1.179 . . . . 64.14 112.293 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.407 ' HD3' HD13 ' C' ' 13' ' ' ILE . 6.0 Cg_exo -78.3 92.88 1.11 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.039 2.493 . . . . 75.01 110.864 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 66.9 t -100.54 126.85 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.222 -1.029 . . . . 75.2 108.222 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.448 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 40.9 t-20 -73.28 98.69 2.72 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.357 0.663 . . . . 71.4 110.143 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.08 -27.15 62.48 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.928 0.891 . . . . 75.31 110.756 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.448 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 7.1 t70 -63.55 -42.04 98.39 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.904 0.881 . . . . 74.31 110.587 175.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.31 -35.11 69.43 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.01 0.819 . . . . 71.04 111.639 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.05 -51.46 66.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.114 0.565 . . . . 73.0 109.521 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -66.98 -29.2 68.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.751 0.82 . . . . 73.12 112.472 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 82.0 mmm -78.87 -39.22 35.81 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 119.606 -0.235 . . . . 75.45 110.737 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 95.0 m-20 -60.17 -42.63 95.37 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.066 0.546 . . . . 74.42 109.834 174.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -56.71 -41.64 77.79 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.717 1.207 . . . . 73.44 111.449 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.58 -54.22 15.1 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.128 0.268 . . . . 72.44 111.62 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.87 28.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.202 1.001 . . . . 72.2 108.863 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.705 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.9 OUTLIER 63.02 -91.35 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.011 -1.107 . . . . 73.41 108.011 -172.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -156.49 133.44 10.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.255 1.422 . . . . 72.41 107.613 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.46 148.93 38.66 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.455 -0.572 . . . . 72.31 109.455 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.57 65.41 3.14 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 123.3 0.375 . . . . 72.4 113.119 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -97.36 124.4 41.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.067 0.947 . . . . 74.41 108.58 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -124.39 75.53 0.39 Allowed Glycine 0 C--N 1.342 0.866 0 N-CA-C 111.212 -0.755 . . . . 72.11 111.212 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.0 p -87.81 124.1 33.28 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.896 0.478 . . . . 75.41 110.801 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -132.39 152.46 51.45 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.394 1.077 . . . . 75.25 109.313 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -149.41 173.22 13.78 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.736 0.814 . . . . 72.34 110.265 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -146.39 125.78 13.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.16 0.984 . . . . 64.42 109.161 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -68.02 109.22 3.38 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.309 0.576 . . . . 72.54 110.061 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.36 -22.0 61.22 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.628 0.771 . . . . 65.31 110.574 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.471 1.109 . . . . 74.34 108.668 176.419 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttm . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.953 -0.388 . . . . 61.24 109.953 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -120.34 109.66 15.62 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.67 -0.863 . . . . 73.44 108.67 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.52 -37.74 80.27 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.697 0.799 . . . . 73.22 110.19 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.474 HE22 ' HA3' ' B' ' 91' ' ' GLY . 48.7 tt0 -75.79 102.87 5.63 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.456 -0.793 . . . . 65.2 108.984 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -127.22 153.97 45.43 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.279 1.032 . . . . 74.41 110.047 -170.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.444 HD22 ' HG2' ' B' ' 93' ' ' GLN . 4.9 m-80 -100.24 -179.18 4.05 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.55 -0.907 . . . . 75.23 108.55 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 48.1 m -138.93 -85.8 0.25 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.906 -0.496 . . . . 64.1 110.772 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -102.38 -37.8 7.88 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.154 0.582 . . . . 75.22 110.591 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.734 ' HE3' ' HB2' ' B' ' 11' ' ' PHE . 27.8 ttt 65.68 168.4 0.2 Allowed 'General case' 0 CA--C 1.563 1.449 0 O-C-N 124.845 1.341 . . . . 62.14 111.18 -171.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 94.0 m -150.6 101.62 2.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.334 -1.358 . . . . 73.51 107.334 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.734 ' HB2' ' HE3' ' B' ' 9' ' ' MET . 22.3 t80 -116.59 114.71 24.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.0 -1.111 . . . . 72.52 108.0 170.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.41 ' HB3' ' HB ' ' E' ' 309' ' ' THR . 8.6 pt20 -134.75 141.0 46.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.235 0.614 . . . . 74.23 110.344 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -86.2 102.18 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.884 -1.053 . . . . 74.2 110.656 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -77.38 -32.02 54.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 122.019 -0.425 . . . . 74.51 110.055 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 37.6 ttt180 -173.75 134.13 0.47 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.19 -0.67 . . . . 73.44 109.19 174.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.7 mt -113.8 134.62 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 106.915 -1.513 . . . . 74.44 106.915 171.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -166.17 151.24 8.29 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.679 0.752 . . . . 73.52 112.163 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.7 m -77.45 122.12 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.905 -1.043 . . . . 63.31 109.027 170.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -89.71 -39.33 13.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.141 0.576 . . . . 72.42 111.105 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.3 t70 -150.09 136.04 18.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.57 -0.286 . . . . 74.21 110.632 -169.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.504 HG22 ' HE1' ' B' ' 117' ' ' MET . 47.9 mm -128.59 139.13 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.477 1.111 . . . . 75.1 108.687 173.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -141.56 121.55 13.68 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.719 -1.215 . . . . 61.45 107.719 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.503 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.2 t80 -136.19 137.33 40.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.664 -0.865 . . . . 75.14 108.664 172.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.4 mt-10 -136.42 153.35 51.1 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.862 1.265 . . . . 74.03 108.833 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 82.49 7.15 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.833 -1.543 . . . . 74.55 106.833 172.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.62 -46.44 7.01 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.882 2.388 . . . . 73.1 111.712 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.526 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 53.8 m-20 -96.89 28.21 3.61 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.928 0.891 . . . . 75.23 109.641 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.522 ' HB2' ' HE3' ' A' ' 19' ' ' LYS . . . -46.86 -51.71 37.26 Favored Pre-proline 0 CA--C 1.568 1.655 0 N-CA-C 114.22 1.193 . . . . 64.24 114.22 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -79.56 -24.21 6.49 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.715 1.61 . . . . 73.44 112.538 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.4 m80 -97.09 2.18 50.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.225 1.01 . . . . 74.5 112.81 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.475 HG22 HD11 ' B' ' 68' ' ' LEU . 11.1 p -71.51 -19.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.053 0.941 . . . . 75.21 111.334 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -67.08 -23.12 65.82 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.516 1.127 . . . . 75.33 111.938 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.596 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 28.4 pt20 -69.91 -34.04 72.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.373 0.669 . . . . 71.13 110.44 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.601 ' HB2' HD12 ' B' ' 68' ' ' LEU . 31.9 mmtp -107.67 63.71 0.62 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.329 -0.989 . . . . 73.11 108.329 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.05 105.21 14.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.147 -0.686 . . . . 74.13 109.147 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 162.65 -165.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 127.39 2.276 . . . . 74.24 109.216 159.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -61.08 127.35 87.74 Favored Pre-proline 0 C--N 1.363 1.159 0 O-C-N 123.248 0.342 . . . . 75.1 111.18 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.11 160.86 15.55 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.542 2.161 . . . . 73.03 112.112 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.19 106.25 3.23 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.999 -1.112 . . . . 71.25 107.999 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.95 158.33 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.346 0.659 . . . . 75.54 111.705 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.0 tttm -143.64 108.84 5.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.377 1.071 . . . . 72.05 109.058 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 tt -86.59 135.47 33.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 106.772 -1.566 . . . . 73.3 106.772 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.592 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 16.9 t70 -144.51 147.45 33.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.944 -0.761 . . . . 74.23 108.944 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.4 140.01 53.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.294 -0.632 . . . . 74.04 109.294 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 8.7 t70 -123.49 140.95 52.48 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.403 1.081 . . . . 73.22 108.615 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.0 p -108.81 115.53 30.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.281 -0.872 . . . . 74.45 109.977 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -136.22 133.68 37.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.743 0.817 . . . . 72.3 108.892 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.5 p -144.7 167.68 21.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.326 0.65 . . . . 73.42 110.032 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -150.56 137.38 19.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.19 0.596 . . . . 75.11 110.089 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -90.81 94.73 9.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.455 0.702 . . . . 61.14 109.401 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 38.5 mt -69.87 -39.41 76.35 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.38 0.609 . . . . 71.05 110.102 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.44 -179.59 8.32 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.648 -1.16 . . . . 75.51 109.413 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -67.08 120.43 13.67 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.357 -0.609 . . . . 75.25 109.357 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 73.9 -4.79 2.18 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.375 1.47 . . . . 75.21 112.394 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.9 t -104.51 111.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 N-CA-C 108.05 -1.093 . . . . 74.1 108.05 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -126.51 137.6 53.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.602 . . . . 75.33 109.706 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -101.64 102.01 12.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.738 -1.579 . . . . 75.21 106.738 173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.7 t -95.54 121.92 46.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.67 1.188 . . . . 74.33 110.219 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.467 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.1 t -104.95 120.79 56.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 124.731 1.213 . . . . 64.45 109.633 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.651 HD23 ' HA ' ' B' ' 103' ' ' PRO . 61.7 tp -104.39 104.66 14.57 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.811 -0.811 . . . . 73.32 108.811 172.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 38.5 ttm180 -88.67 114.09 24.92 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.356 -0.609 . . . . 73.22 109.356 173.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.4 t -106.43 112.03 37.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.084 -1.08 . . . . 73.45 108.084 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.9 m -98.2 138.36 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.992 0.917 . . . . 64.34 110.038 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.621 HG22 HG21 ' B' ' 114' ' ' ILE . 55.5 t -127.34 124.3 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.822 1.249 . . . . 72.15 108.355 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 85.0 m -119.18 145.61 45.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.008 -1.108 . . . . 74.33 108.008 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.1 131.72 17.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.673 -0.862 . . . . 73.54 108.673 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.6 p -152.98 126.91 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.088 0.555 . . . . 74.2 110.433 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.619 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 0.1 OUTLIER -104.65 123.75 48.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.816 0.847 . . . . 75.0 109.188 -176.095 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -111.49 3.26 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.14 -1.184 . . . . 73.03 110.14 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.46 6.25 6.93 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 72.25 109.798 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.526 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 10.8 pt-20 -113.52 143.4 44.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.531 . . . . 74.43 109.745 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 54.4 m -70.0 133.71 47.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.104 0.562 . . . . 72.31 111.932 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.619 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -88.55 -59.46 2.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.303 1.041 . . . . 72.12 109.426 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.02 150.4 9.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.896 -1.502 . . . . 75.21 109.242 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.32 123.66 39.89 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 124.819 1.248 . . . . 75.32 107.695 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.7 t -129.85 149.91 51.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.257 -0.645 . . . . 73.42 109.257 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -162.78 132.53 4.39 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.026 -0.731 . . . . 65.01 109.026 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.416 HG21 HD12 ' B' ' 21' ' ' ILE . 85.3 t -126.83 145.62 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.612 0.765 . . . . 72.53 109.505 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -118.01 103.24 9.71 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.288 -1.375 . . . . 72.51 107.288 167.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 5.8 tp-100 -93.21 99.48 12.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.378 -1.341 . . . . 63.14 107.378 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.467 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 171.62 38.79 Favored Glycine 0 C--O 1.248 1.024 0 N-CA-C 110.724 -0.95 . . . . 75.43 110.724 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.18 126.66 1.16 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.915 -0.659 . . . . 52.41 112.022 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 28.4 mt -84.73 129.0 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.042 -1.096 . . . . 74.34 108.042 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -133.74 150.59 51.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.602 1.161 . . . . 74.01 108.222 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -114.46 114.8 26.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.074 -1.084 . . . . 74.33 108.074 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.448 ' HA ' ' O ' ' B' ' 10' ' ' THR . 46.3 pt -121.02 130.69 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.348 0.659 . . . . 75.03 110.712 -174.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.66 171.11 19.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.311 1.045 . . . . 71.25 109.79 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.7 -47.08 3.79 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.091 0.377 . . . . 64.52 112.391 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.42 ' HA ' ' OD1' ' B' ' 6' ' ' ASN . 1.8 pp -70.18 152.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.691 0.797 . . . . 73.33 111.154 169.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -150.41 143.28 24.71 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 111.726 0.269 . . . . 73.22 111.726 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.474 ' HA3' HE22 ' B' ' 4' ' ' GLN . . . 58.55 -111.1 2.95 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.99 0.805 . . . . 63.02 113.934 173.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' THR . . . . . 0.596 HG23 HD22 ' B' ' 141' ' ' LEU . 2.8 m -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.97 0.908 . . . . 73.15 110.144 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.444 ' HG2' HD22 ' B' ' 6' ' ' ASN . 25.3 mp0 -76.02 -25.82 56.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.049 0.939 . . . . 75.05 110.327 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.407 ' SD ' ' HG ' ' H' ' 277' ' ' LEU . 43.7 ttp -73.32 -34.8 65.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.913 0.885 . . . . 73.44 110.307 170.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.38 68.75 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.604 -0.726 . . . . 72.22 110.814 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 57.1 t-80 -73.56 -24.12 60.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.419 0.687 . . . . 74.43 111.198 173.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -73.59 -63.54 1.18 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.672 0.389 . . . . 71.05 111.024 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.717 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -87.02 -19.23 28.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.577 0.584 . . . . 75.52 112.577 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.71 2.8 52.81 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.83 -0.428 . . . . 63.11 113.972 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.463 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -146.39 -46.8 0.19 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.034 0.417 . . . . 74.13 111.43 -177.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -83.23 -38.39 22.31 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 111.577 0.214 . . . . 73.43 111.577 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.717 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.7 m -62.1 -46.54 91.43 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.47 -0.776 . . . . 74.33 111.077 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.651 ' HA ' HD23 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -49.26 -42.2 40.7 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 122.547 2.165 . . . . 62.22 113.878 166.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -58.01 -36.86 73.29 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.547 0.739 . . . . 72.42 111.68 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.401 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 47.3 mt -80.49 -48.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.591 0.756 . . . . 73.35 111.484 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.38 -21.13 53.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.258 0.623 . . . . 75.53 112.167 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.5 -47.73 67.77 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 117.665 -1.159 . . . . 73.32 113.064 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 97.2 Cg_exo -49.98 -45.89 30.57 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.741 2.294 . . . . 74.34 113.917 172.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.482 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.8 m-85 -65.61 -43.45 89.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.3 0.64 . . . . 71.25 110.893 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.417 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -66.4 -34.41 77.9 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 115.877 -0.602 . . . . 75.33 110.623 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -59.42 -57.27 13.72 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.152 0.981 . . . . 73.43 110.466 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.18 -33.05 74.64 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.807 0.692 . . . . 71.01 110.307 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.6 t -74.03 -36.44 64.43 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.193 -0.458 . . . . 74.42 111.427 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.621 HG21 HG22 ' B' ' 64' ' ' VAL . 81.6 mt -67.83 -51.77 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 74.54 109.05 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.643 HG23 ' HB2' ' B' ' 125' ' ' GLN . 66.6 m -62.19 -28.33 69.59 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 114.359 -1.292 . . . . 64.23 111.194 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -65.3 -46.34 80.77 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.344 0.658 . . . . 71.1 109.7 174.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.79 -33.02 68.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.999 0.52 . . . . 73.21 111.249 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.41 -41.61 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.407 0.683 . . . . 73.44 109.909 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.1 t -68.68 -31.07 69.92 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.321 -0.854 . . . . 71.42 111.515 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -74.53 -32.27 62.41 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.319 0.648 . . . . 75.41 110.227 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.73 -3.32 83.49 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.443 0.464 . . . . 72.24 112.432 170.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 17' ' ' TYR . 43.2 p 59.45 51.17 6.8 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 126.424 1.89 . . . . 75.45 111.819 175.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.85 145.76 40.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.013 -1.449 . . . . 75.05 109.01 170.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.16 130.05 27.11 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.31 2.673 . . . . 73.25 112.432 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.643 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.7 pt20 -65.43 156.94 30.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.849 -1.069 . . . . 72.13 113.148 -171.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.46 114.05 25.29 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.503 -1.295 . . . . 75.13 107.503 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -91.47 108.65 20.04 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.959 -1.126 . . . . 53.54 107.959 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.87 150.2 45.4 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.821 0.849 . . . . 71.04 112.326 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.22 138.46 71.96 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.849 -1.069 . . . . 65.3 109.789 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.601 ' HG3' HD13 ' D' ' 16' ' ' ILE . 60.5 Cg_endo -71.48 97.22 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.499 2.133 . . . . 75.53 110.811 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.73 109.34 20.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.261 -1.014 . . . . 73.34 108.261 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.434 ' HB3' ' HB3' ' B' ' 135' ' ' ALA . 9.5 m120 -76.29 87.34 3.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.705 0.802 . . . . 75.34 109.871 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -64.51 -37.77 88.69 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.467 -0.568 . . . . 61.33 109.467 171.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.463 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 5.7 p-10 -57.43 -61.49 2.45 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.501 1.12 . . . . 73.23 111.411 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' B' ' 132' ' ' ASN . . . -66.51 -34.87 78.89 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.666 0.786 . . . . 75.44 111.83 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.55 -49.55 70.8 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.676 0.791 . . . . 72.44 110.953 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -73.72 -15.24 61.22 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.373 -0.831 . . . . 74.02 111.348 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 88.5 mtp -62.25 -35.98 80.61 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.983 0.513 . . . . 75.52 110.851 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -75.02 -20.72 59.49 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.371 0.668 . . . . 74.32 111.275 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -68.63 -42.56 77.9 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.766 0.826 . . . . 75.21 110.626 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.596 HD22 HG23 ' B' ' 92' ' ' THR . 1.4 pp -118.89 36.71 4.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.741 1.216 . . . . 74.35 110.147 -174.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -58.46 99.72 0.05 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.748 0.819 . . . . 75.43 111.541 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.82 116.87 29.26 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.268 1.027 . . . . 74.44 109.321 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -74.22 120.35 19.67 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.912 0.885 . . . . 74.21 109.962 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.29 176.42 5.38 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.777 0.831 . . . . 74.54 110.548 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.32 134.83 13.18 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.981 -0.554 . . . . 62.45 112.149 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -82.03 -61.09 2.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.551 0.74 . . . . 71.22 110.117 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.84 -155.29 26.39 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.583 -0.735 . . . . 72.04 111.336 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 t -135.27 147.75 49.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.353 0.661 . . . . 70.32 109.688 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.7 142.26 51.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.953 0.901 . . . . 72.22 109.772 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -104.21 97.96 7.84 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.907 0.883 . . . . 75.15 109.72 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -100.18 101.8 12.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.999 -0.741 . . . . 74.44 108.999 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -66.67 99.91 0.64 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.088 0.955 . . . . 60.44 110.68 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.77 139.44 58.33 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.259 1.023 . . . . 73.53 111.861 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.879 0 C-N-CA 123.875 0.87 . . . . 74.1 109.184 179.394 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.948 -0.39 . . . . 72.03 109.948 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -109.02 71.72 0.78 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.165 0.586 . . . . 64.4 109.952 -175.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -83.07 126.43 32.56 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.447 -0.797 . . . . 71.12 109.606 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -58.3 -45.43 88.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.94 0.896 . . . . 73.54 110.301 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -153.96 155.24 35.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.52 -1.218 . . . . 64.2 109.22 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -161.27 132.11 5.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.733 -0.84 . . . . 75.45 108.733 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.9 p -108.88 115.54 30.27 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.372 -0.973 . . . . 63.51 108.372 171.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -75.78 -21.16 57.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.388 0.675 . . . . 71.31 110.978 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.505 ' HG3' HD13 ' C' ' 89' ' ' ILE . 26.9 ttt 64.48 113.99 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.104 1.361 . . . . 70.4 111.512 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.1 m -92.35 88.74 6.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.573 0.749 . . . . 71.41 109.116 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -119.61 126.55 51.45 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.711 -0.848 . . . . 63.21 108.711 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -150.75 131.04 13.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.872 0.869 . . . . 72.4 108.995 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.407 HD13 ' HD3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -78.52 132.02 33.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.768 -0.827 . . . . 75.22 108.768 174.267 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.448 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 85.6 mm-40 -93.57 -46.04 7.47 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.077 0.551 . . . . 74.25 109.553 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -176.31 126.0 0.19 Allowed 'General case' 0 C--N 1.356 0.891 0 O-C-N 124.168 0.917 . . . . 75.23 110.192 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.01 142.99 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.636 -1.246 . . . . 75.2 107.636 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.419 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -176.79 156.01 1.34 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.617 0.644 . . . . 74.54 111.806 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -75.94 121.79 23.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.786 0.834 . . . . 74.32 109.061 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' D' ' 28' ' ' ALA . 12.6 mmmm -76.15 -47.99 22.23 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.305 1.05 . . . . 73.32 108.875 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -140.59 146.0 37.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 113.772 -1.558 . . . . 62.1 109.198 -173.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.7 mt -140.91 144.84 26.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.096 1.358 . . . . 72.12 107.482 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -156.22 151.14 26.2 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.573 0.702 . . . . 73.44 110.433 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -148.89 127.58 12.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.531 -1.285 . . . . 75.42 107.531 171.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.504 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.1 mt-10 -120.84 133.89 55.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.789 0.835 . . . . 75.43 109.411 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.53 79.36 24.76 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.335 -0.987 . . . . 74.23 108.335 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.87 -25.13 12.45 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.679 2.253 . . . . 73.22 112.112 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.445 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 96.9 m-20 -106.87 34.96 3.18 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.444 1.098 . . . . 73.02 109.504 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.559 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -60.38 -55.6 43.58 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.388 -0.815 . . . . 73.32 112.997 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 26.0 Cg_exo -65.53 -30.09 52.3 Favored 'Trans proline' 0 C--N 1.394 2.932 0 CA-C-N 121.421 1.543 . . . . 72.45 112.204 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.445 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.1 t60 -62.76 -23.51 67.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.784 1.234 . . . . 75.34 112.001 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.435 ' O ' ' HB3' ' C' ' 34' ' ' LYS . 8.8 p -52.67 -25.34 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 N-CA-C 112.828 0.677 . . . . 75.33 112.828 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -79.7 -24.56 41.62 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.583 -0.698 . . . . 74.2 112.305 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -102.24 17.63 22.92 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.274 0.559 . . . . 74.12 110.503 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.705 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.07 138.26 33.15 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.085 0.954 . . . . 74.32 110.333 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -77.04 129.17 35.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 72.51 108.927 170.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' F' ' 300' ' ' ASN . 29.7 m95 -80.2 77.55 6.92 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.334 0.588 . . . . 75.14 110.667 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.437 ' O ' ' HB3' ' C' ' 68' ' ' LEU . 36.6 tt0 -160.45 63.64 1.98 Allowed Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 115.048 -0.978 . . . . 73.04 109.293 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.72 126.67 6.01 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.216 1.944 . . . . 74.34 111.416 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -85.88 99.11 11.17 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.609 -1.626 . . . . 75.22 106.609 169.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.435 HG12 HD13 ' C' ' 126' ' ' LEU . 43.2 t -73.19 122.93 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.794 -1.094 . . . . 71.1 109.038 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -124.62 112.34 16.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.345 1.058 . . . . 72.34 109.254 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 145.66 26.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.839 0.856 . . . . 73.03 109.156 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.454 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.5 t70 -132.95 143.63 49.59 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.909 -1.145 . . . . 73.44 107.909 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -135.08 115.01 12.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.247 -0.649 . . . . 74.41 109.247 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.0 t70 -111.44 143.39 42.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.104 -1.072 . . . . 73.1 108.104 175.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -115.05 117.39 30.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.728 0.811 . . . . 75.55 110.224 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.603 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -112.74 141.98 45.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 72.4 108.824 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -151.32 158.1 43.36 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.134 0.574 . . . . 73.32 110.518 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -167.62 131.88 1.81 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.858 0.863 . . . . 72.21 109.434 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.63 117.91 24.81 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.82 -0.807 . . . . 73.44 108.82 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.409 HD13 HD13 ' C' ' 83' ' ' ILE . 56.6 mt -86.33 -38.97 16.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.022 0.929 . . . . 74.04 111.354 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -171.19 3.08 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.669 -0.696 . . . . 73.53 110.572 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -57.5 110.39 0.86 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.983 -1.008 . . . . 75.31 110.104 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 70.26 -2.19 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.927 1.291 . . . . 63.11 112.781 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.42 HG23 ' HG ' ' C' ' 85' ' ' SER . 91.1 t -94.28 103.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 71.34 108.859 -179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -115.48 126.15 53.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.084 0.954 . . . . 60.51 109.534 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -84.43 119.26 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.44 -0.578 . . . . 73.41 109.44 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -98.23 128.43 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.495 1.118 . . . . 74.35 108.244 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 70.2 t -131.7 137.38 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.441 0.696 . . . . 72.21 109.413 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.502 HD11 ' HA ' ' C' ' 103' ' ' PRO . 92.9 mt -125.51 112.42 16.2 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.741 0.816 . . . . 75.13 109.917 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 27.4 ttm180 -82.61 105.79 13.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.024 -0.732 . . . . 75.33 109.024 168.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.62 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.3 t -101.19 125.36 55.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.968 -1.123 . . . . 71.53 107.968 171.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.454 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 15.5 m -124.41 113.29 17.97 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.795 -0.817 . . . . 73.11 108.795 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.629 HG23 HG21 ' C' ' 114' ' ' ILE . 60.2 t -102.19 114.22 40.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.681 0.792 . . . . 73.03 109.065 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -102.41 150.71 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.535 -0.913 . . . . 72.14 108.535 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.5 106.09 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.48 -1.674 . . . . 73.31 106.48 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -148.39 146.22 28.38 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.913 0.485 . . . . 62.45 110.544 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.705 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.3 OUTLIER -110.78 55.79 0.64 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.095 0.958 . . . . 72.52 108.544 174.04 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.95 -113.72 4.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.48 -1.237 . . . . 72.24 111.131 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.36 -17.78 29.83 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.457 0.703 . . . . 74.13 110.301 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -88.96 99.35 12.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.072 0.949 . . . . 74.54 109.529 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -85.57 132.78 34.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.94 0.496 . . . . 73.1 111.096 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -77.47 -64.25 1.19 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.146 0.979 . . . . 63.41 109.591 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -163.58 175.67 10.43 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.416 -0.811 . . . . 73.43 110.324 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.504 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -139.27 144.21 38.29 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 107.901 -1.148 . . . . 74.51 107.901 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.405 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.5 t -143.87 149.13 36.46 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.27 -1.011 . . . . 70.33 108.27 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.25 136.46 11.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.922 0.489 . . . . 75.02 110.056 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -138.08 134.79 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.237 1.015 . . . . 75.02 108.456 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.43 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 63.3 mt-30 -110.57 91.22 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.951 -1.129 . . . . 72.15 107.951 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.05 117.43 20.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.626 -0.715 . . . . 73.21 110.55 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.37 162.52 20.75 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 123.517 0.51 . . . . 63.14 112.556 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.5 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -166.94 118.19 0.78 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.306 -0.718 . . . . 62.44 111.306 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.448 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 13.6 mm -83.21 122.73 37.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.764 -0.828 . . . . 75.41 108.764 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -132.78 132.25 42.03 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.65 0.78 . . . . 74.52 109.417 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.42 ' HG ' HG23 ' C' ' 55' ' ' VAL . 47.8 m -94.18 114.36 26.46 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.594 -0.891 . . . . 72.04 108.594 169.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 50.8 mt -115.08 119.26 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.554 1.142 . . . . 75.11 107.994 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.55 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.246 1.019 . . . . 75.45 109.923 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.78 -34.3 4.59 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.271 -0.422 . . . . 70.25 112.772 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.505 HD13 ' HG3' ' C' ' 9' ' ' MET . 0.2 OUTLIER -121.9 165.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 75.44 110.176 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -156.46 -179.9 8.61 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.41 0.684 . . . . 61.03 110.42 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' C' ' 94' ' ' MET . . . 68.81 -130.35 25.16 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.384 -0.371 . . . . 73.01 113.052 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -78.95 -20.72 48.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.254 0.622 . . . . 72.43 111.272 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.21 -44.52 95.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.392 0.677 . . . . 75.15 110.184 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.57 ' HG2' HD23 ' F' ' 277' ' ' LEU . 0.0 OUTLIER -76.58 -26.32 54.93 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 116.029 -0.532 . . . . 70.43 110.785 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.66 -32.13 70.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.892 0.477 . . . . 75.41 111.087 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.412 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 60.1 t-80 -73.73 -24.3 59.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.288 0.635 . . . . 54.45 110.73 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -81.67 -58.57 2.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.205 0.602 . . . . 64.21 110.324 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.33 -48.37 42.52 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.19 1.396 . . . . 72.23 110.826 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.83 11.46 72.05 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.547 -0.585 . . . . 64.31 114.111 -171.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -148.61 -59.3 0.23 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.554 0.677 . . . . 71.04 112.217 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -74.85 -38.88 61.86 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.981 0.512 . . . . 75.33 112.243 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.9 -45.46 74.41 Favored Pre-proline 0 CA--C 1.557 1.249 0 CA-C-O 118.833 -0.603 . . . . 63.24 111.277 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.502 ' HA ' HD11 ' C' ' 60' ' ' LEU . 69.9 Cg_exo -48.8 -42.8 36.45 Favored 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.647 2.232 . . . . 73.2 114.457 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -60.7 -40.21 91.39 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.784 0.833 . . . . 74.44 110.798 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.11 -48.21 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.919 0.488 . . . . 75.02 110.72 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.5 HD22 ' HA3' ' C' ' 82' ' ' GLY . 80.3 mt -80.11 -19.57 47.05 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.76 -0.655 . . . . 74.2 112.53 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -58.64 -48.42 96.92 Favored Pre-proline 0 CA--C 1.566 1.593 0 CA-C-O 118.061 -0.971 . . . . 74.43 113.29 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.94 -36.64 96.52 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.358 2.039 . . . . 73.45 113.463 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -66.69 -45.18 79.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.425 0.69 . . . . 75.42 111.146 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.77 88.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.282 0.633 . . . . 74.12 109.64 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -53.7 -49.23 68.49 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.639 1.576 . . . . 73.45 112.091 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.94 -39.01 72.88 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.81 0.694 . . . . 74.21 110.163 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.49 -33.6 74.44 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.994 0.517 . . . . 73.0 111.274 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.629 HG21 HG23 ' C' ' 64' ' ' VAL . 81.3 mt -66.27 -52.29 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.597 0.759 . . . . 75.21 109.53 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 29.1 m -65.28 -29.08 69.82 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.049 -0.978 . . . . 74.52 110.75 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -66.84 -43.75 82.85 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.694 0.798 . . . . 51.21 109.925 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.51 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.44 -37.64 85.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.524 0.73 . . . . 74.03 111.646 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.03 -37.78 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.253 0.621 . . . . 71.21 109.811 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.0 t -66.24 -35.9 81.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.229 1.012 . . . . 74.12 111.829 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.4 mtt-85 -74.35 -35.76 63.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.614 0.766 . . . . 74.44 110.332 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.17 1.14 76.85 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.622 0.576 . . . . 74.32 112.592 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.3 p 61.36 24.05 14.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.035 1.734 . . . . 72.34 112.656 172.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -90.42 155.24 46.46 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.127 0.971 . . . . 73.03 110.03 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.08 122.43 11.8 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.058 2.505 . . . . 71.52 112.38 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.13 153.59 25.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.311 1.045 . . . . 72.33 112.881 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.49 HD23 ' HD2' ' F' ' 294' ' ' LYS . 5.1 tt -141.52 114.01 8.27 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 106.68 -1.6 . . . . 75.12 106.68 171.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -90.9 131.73 36.35 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.799 0.84 . . . . 72.44 109.749 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.43 141.69 56.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.444 0.698 . . . . 70.24 110.964 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.516 ' HB2' HD11 ' F' ' 291' ' ' LEU . . . -83.76 148.89 55.65 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.025 0.93 . . . . 75.22 110.907 -176.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.432 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.9 Cg_exo -64.52 94.69 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.144 2.563 . . . . 72.41 112.465 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.38 106.71 19.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.938 -1.134 . . . . 71.23 107.938 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.89 102.42 11.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.609 -1.256 . . . . 63.35 107.609 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -63.06 -42.3 99.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.454 0.645 . . . . 74.01 109.308 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.67 -49.01 76.83 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.195 1.398 . . . . 73.2 112.382 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.26 -23.15 60.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.328 0.651 . . . . 72.54 111.133 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tt -69.61 -40.02 76.89 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.552 0.741 . . . . 74.31 109.374 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -64.27 -34.78 78.91 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.928 0.491 . . . . 73.33 110.973 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 91.0 mtp -77.51 -30.82 53.13 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.686 0.795 . . . . 71.42 111.204 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.69 -36.17 82.85 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.811 1.244 . . . . 74.41 111.555 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -42.36 -84.72 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 125.304 1.442 . . . . 71.23 112.956 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 5.1 tt -81.94 115.24 21.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.161 -0.681 . . . . 74.42 109.161 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -147.28 90.76 1.91 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.594 1.158 . . . . 62.51 109.016 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -73.03 160.63 31.77 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.04 0.536 . . . . 71.44 109.588 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.511 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -115.15 93.28 4.23 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.859 -0.793 . . . . 74.22 108.859 178.09 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -174.9 104.63 0.09 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.821 1.249 . . . . 65.24 109.218 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.96 161.3 11.0 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.562 -0.29 . . . . 54.01 112.44 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.4 -52.37 2.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.167 0.987 . . . . 74.1 109.186 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.36 175.55 14.38 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.27 -0.877 . . . . 73.04 111.824 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.755 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 95.2 m -68.96 -51.83 35.45 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.095 -0.705 . . . . 72.54 109.095 169.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 58.7 103.0 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.113 1.365 . . . . 73.04 112.519 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.49 140.49 4.98 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.223 -1.399 . . . . 75.43 107.223 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -63.31 128.69 36.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.921 0.488 . . . . 64.22 110.526 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -79.81 97.67 6.74 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.983 0.897 . . . . 72.24 109.752 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.07 31.72 4.4 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.293 1.037 . . . . 61.55 109.557 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 C-N-CA 123.671 0.788 . . . . 72.14 110.14 179.89 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.734 0.302 . . . . 75.33 110.761 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 82.1 p -162.1 171.17 17.91 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.055 0.942 . . . . 71.32 109.665 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.04 64.69 4.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.58 0.705 . . . . 75.2 109.528 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.14 97.95 11.49 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.49 -1.3 . . . . 74.34 107.49 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -141.31 94.44 2.7 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.473 -0.936 . . . . 74.22 108.473 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -148.92 -174.69 4.7 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.174 0.99 . . . . 72.34 108.367 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -51.43 100.82 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 121.766 0.793 . . . . 75.21 111.136 170.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -83.08 -174.76 5.48 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.04 -0.982 . . . . 74.52 111.422 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 1.4 ptm -30.13 145.32 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.422 1.489 . . . . 72.02 113.407 165.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.5 m -105.09 143.88 32.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 64.55 110.299 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -159.88 90.62 0.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.629 -1.619 . . . . 73.22 106.629 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.85 114.97 28.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.066 -1.087 . . . . 74.5 108.066 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.5 ' O ' ' HB ' ' F' ' 306' ' ' VAL . 14.5 mt -77.13 104.5 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 108.203 -1.036 . . . . 72.21 108.203 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.96 -45.48 60.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.769 -0.456 . . . . 75.43 109.769 -170.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' D' ' 15' ' ' ARG . 3.4 mmp_? -157.66 147.75 20.54 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.374 1.07 . . . . 73.41 110.138 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.601 HD13 ' HG3' ' B' ' 130' ' ' PRO . 2.7 mp -120.04 113.38 40.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 106.496 -1.668 . . . . 75.15 106.496 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.53 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 42.0 p90 -145.93 150.73 36.62 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.759 0.79 . . . . 71.14 111.282 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -81.38 115.28 20.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.897 -1.047 . . . . 75.24 109.549 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.53 -33.14 28.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.424 0.631 . . . . 74.22 109.885 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -144.26 137.2 27.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.483 -1.235 . . . . 51.24 109.524 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.51 HG23 ' HE1' ' C' ' 117' ' ' MET . 93.3 mt -132.05 140.52 47.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.68 1.192 . . . . 73.23 107.885 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 38.6 t -142.34 133.74 26.44 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.562 1.145 . . . . 73.32 108.053 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.578 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -147.91 124.7 11.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.754 -1.573 . . . . 73.21 106.754 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -129.19 137.09 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.488 1.115 . . . . 74.01 108.898 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.11 85.36 59.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.703 -1.591 . . . . 53.22 106.703 172.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.39 -61.59 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.901 2.401 . . . . 74.02 112.547 -172.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.76 41.83 1.09 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.0 -1.111 . . . . 72.32 108.0 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.503 ' HB2' ' HE3' ' C' ' 19' ' ' LYS . . . -49.07 -59.72 5.93 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 114.389 1.255 . . . . 53.4 114.389 -167.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.414 ' HB3' HD11 ' C' ' 83' ' ' ILE . 86.5 Cg_endo -78.54 -12.86 15.13 Favored 'Trans proline' 0 C--N 1.385 2.462 0 CA-C-N 121.727 1.652 . . . . 61.43 112.772 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.2 -41.4 57.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.122 1.369 . . . . 74.21 109.597 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.06 -40.69 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.746 -1.116 . . . . 64.44 110.471 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.593 ' HA ' HG23 ' G' ' 301' ' ' ILE . 20.9 m-85 -67.68 -18.37 64.91 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.146 -0.933 . . . . 71.22 113.064 -174.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -78.79 -14.65 59.15 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.386 0.674 . . . . 71.35 112.222 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -109.04 114.51 28.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.06 0.944 . . . . 72.44 108.593 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -88.14 96.17 10.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.627 0.603 . . . . 64.4 112.627 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.451 ' CZ3' HD21 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -169.42 -174.26 1.89 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.097 0.777 . . . . 73.04 113.097 171.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -92.1 126.5 52.9 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 125.05 1.34 . . . . 75.4 111.509 -173.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.564 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 56.0 Cg_endo -75.31 150.59 37.09 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.928 2.419 . . . . 74.2 113.783 172.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -83.21 135.59 34.72 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.504 1.122 . . . . 74.22 108.392 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 67.8 t -118.82 138.82 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.381 0.672 . . . . 74.42 109.262 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.474 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 47.9 tttm -125.81 121.26 32.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.186 0.994 . . . . 73.43 108.653 -172.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.499 HD13 HD13 ' D' ' 128' ' ' LEU . 0.4 OUTLIER -97.62 112.68 24.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.586 0.754 . . . . 74.12 109.062 -172.524 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.586 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.9 m-20 -111.75 127.8 55.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.277 1.031 . . . . 74.23 108.848 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.17 140.02 49.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.376 0.67 . . . . 75.32 109.431 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.6 t70 -142.0 136.47 30.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.107 0.963 . . . . 74.31 108.723 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -105.47 143.9 32.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.461 0.704 . . . . 72.31 110.193 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.69 159.02 44.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.694 0.798 . . . . 74.41 109.772 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.2 p -168.27 166.68 12.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.119 0.568 . . . . 73.32 111.166 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -158.84 145.56 17.17 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.368 1.067 . . . . 62.35 109.107 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.0 117.71 25.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.942 -0.762 . . . . 71.23 108.942 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.491 HD13 HG22 ' D' ' 83' ' ' ILE . 31.5 mt -92.85 -24.78 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.598 0.359 . . . . 55.34 110.281 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.87 -178.84 3.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.125 0.97 . . . . 74.35 110.608 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.56 118.92 9.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.914 -1.039 . . . . 75.11 108.937 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 70.07 5.17 5.16 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.696 1.198 . . . . 73.31 112.088 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.26 114.91 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.767 -0.827 . . . . 74.14 108.767 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.59 129.8 39.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.356 1.062 . . . . 70.12 108.883 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.458 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.4 tt0 -88.42 124.79 34.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.428 -0.953 . . . . 74.03 108.428 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.488 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 47.4 t -108.77 122.99 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.039 -1.467 . . . . 75.23 107.039 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 23.3 t -106.28 128.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.724 -0.843 . . . . 73.32 108.724 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.634 HD23 HD13 ' D' ' 106' ' ' LEU . 4.1 mm? -112.06 114.21 26.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.677 -0.49 . . . . 74.3 109.677 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -86.93 106.08 17.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.633 -0.712 . . . . 75.12 109.152 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.95 127.73 48.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.895 -1.15 . . . . 70.51 107.895 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 39.6 m -125.66 130.13 50.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.382 -0.826 . . . . 72.31 108.793 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -120.42 121.27 65.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.785 1.234 . . . . 75.35 108.474 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 87.6 m -120.63 100.43 7.12 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.054 0.942 . . . . 74.34 109.099 -170.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.15 137.47 37.63 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.187 -0.46 . . . . 65.22 110.098 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 53.4 p -150.47 140.12 21.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.603 0.761 . . . . 71.14 109.598 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.681 ' HG ' ' HB1' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -136.22 136.4 39.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.501 1.12 . . . . 75.12 110.135 -174.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.67 3.78 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.337 -0.705 . . . . 73.54 111.337 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.52 4.2 8.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.703 0.801 . . . . 74.12 110.346 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.63 166.85 13.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.15 0.58 . . . . 73.03 110.821 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 87.1 m -80.97 139.14 35.99 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.821 -0.627 . . . . 71.11 110.483 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.681 ' HB1' ' HG ' ' D' ' 68' ' ' LEU . . . -80.56 -72.02 0.43 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.027 -1.101 . . . . 75.44 108.027 172.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.45 146.46 25.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.17 -0.923 . . . . 63.21 108.928 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -110.34 130.06 55.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.57 -1.271 . . . . 74.11 107.57 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.542 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.4 t -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 72.31 108.871 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 41.9 tt0 -154.59 121.8 5.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.085 0.554 . . . . 63.33 110.065 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -130.21 118.11 42.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.068 -0.715 . . . . 75.14 109.068 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -87.8 86.78 7.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.612 -1.255 . . . . 74.01 107.612 169.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.98 97.38 6.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.184 -1.371 . . . . 71.22 108.565 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.52 144.0 18.82 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.453 -0.659 . . . . 72.23 111.453 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.28 4.58 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 109.826 -1.31 . . . . 71.44 109.826 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.491 HG22 HD13 ' D' ' 51' ' ' LEU . 63.7 mt -88.75 130.23 38.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.173 . . . . 63.3 107.834 176.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.488 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 42.3 m-85 -129.0 136.16 49.94 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.483 0.49 . . . . 73.41 109.98 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.9 m -86.52 93.32 9.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.924 -1.139 . . . . 74.02 107.924 167.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.46 HG23 ' HE1' ' D' ' 94' ' ' MET . 14.9 mt -106.58 114.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 109.437 -0.579 . . . . 75.01 109.437 -172.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.4 163.0 35.06 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.915 0.886 . . . . 64.21 109.679 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -6.3 83.76 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.508 -0.607 . . . . 64.03 114.568 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 pt -129.11 147.97 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.639 0.719 . . . . 73.51 111.716 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 173.57 13.18 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.823 1.249 . . . . 74.3 109.426 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.24 -127.28 43.08 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 115.258 0.863 . . . . 74.42 115.258 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 90.1 m -66.23 -38.46 87.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.68 1.192 . . . . 75.2 111.642 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -69.2 -36.77 77.63 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.881 0.873 . . . . 75.13 110.75 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.676 ' SD ' HD21 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -72.12 -42.52 65.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.508 -0.553 . . . . 75.34 109.508 176.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.82 88.46 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.588 0.755 . . . . 70.52 110.805 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -64.91 -36.55 84.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.158 -0.928 . . . . 74.05 110.669 178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -68.03 -50.53 54.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.513 0.325 . . . . 74.44 111.236 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.676 HD21 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -71.18 -30.3 66.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.9 0.48 . . . . 74.31 111.305 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.24 7.5 56.66 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.61 -0.55 . . . . 75.0 114.06 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.05 -57.82 0.24 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.465 0.633 . . . . 73.41 111.762 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -70.62 -52.94 18.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.211 0.604 . . . . 75.21 111.238 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.423 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 34.0 m -60.58 -45.7 97.2 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.873 0.869 . . . . 74.24 112.127 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.447 ' HA ' ' HG ' ' D' ' 60' ' ' LEU . 75.0 Cg_exo -53.93 -45.59 39.9 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.747 2.298 . . . . 75.33 113.156 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.03 -26.31 68.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.559 0.743 . . . . 71.12 111.725 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.0 mm -73.51 -49.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.373 0.669 . . . . 64.35 110.962 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.634 HD13 HD23 ' D' ' 60' ' ' LEU . 83.2 mt -87.13 -13.95 42.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.13 0.572 . . . . 73.41 112.46 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -67.51 -45.69 47.29 Favored Pre-proline 0 CA--C 1.559 1.326 0 CA-C-O 118.188 -0.91 . . . . 73.2 112.328 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.79 -33.43 96.87 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.21 1.94 . . . . 72.35 113.408 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -78.96 -34.96 43.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.533 0.733 . . . . 73.33 112.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.56 -50.05 68.81 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.933 -0.766 . . . . 74.12 108.933 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -54.18 -48.01 71.4 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.991 1.432 . . . . 74.15 110.574 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.34 -50.1 74.29 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.169 0.918 . . . . 74.13 110.911 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.422 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.6 t -55.32 -43.29 74.76 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.973 0.795 . . . . 73.51 110.913 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.542 HG12 ' SG ' ' D' ' 76' ' ' CYS . 86.1 mt -65.8 -51.91 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 124.355 1.034 . . . . 75.13 110.624 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.402 HG22 ' HB2' ' D' ' 125' ' ' GLN . 68.9 m -51.03 -44.45 61.04 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.986 1.315 . . . . 72.54 111.658 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -69.41 -45.61 68.8 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.849 -1.069 . . . . 72.44 110.812 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.425 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 77.1 mtm -62.98 -36.96 85.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.741 0.416 . . . . 74.44 111.981 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.433 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.2 t -66.79 -44.33 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.097 -0.956 . . . . 71.54 109.998 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -69.73 -27.31 64.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.817 0.447 . . . . 73.15 111.414 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -73.21 -29.72 63.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 74.32 110.205 175.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.89 11.48 66.69 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.69 -0.686 . . . . 62.12 112.438 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.9 p 57.87 14.11 2.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.725 2.01 . . . . 74.23 113.518 -177.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.02 162.91 55.55 Favored Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.482 1.113 . . . . 74.3 108.342 169.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.565 ' HG2' HG21 ' G' ' 296' ' ' THR . 90.1 Cg_endo -75.32 127.02 10.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.212 1.941 . . . . 74.43 111.41 -174.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.402 ' HB2' HG22 ' D' ' 115' ' ' THR . 0.0 OUTLIER -54.12 142.8 24.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.319 0.648 . . . . 75.11 111.291 -176.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.89 103.79 13.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.021 -0.733 . . . . 73.33 109.021 -161.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -97.05 91.92 5.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.98 -1.118 . . . . 74.41 107.98 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.499 HD13 HD13 ' D' ' 42' ' ' LEU . 0.1 OUTLIER -73.82 126.81 31.23 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.453 -0.943 . . . . 74.14 108.453 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.17 141.52 95.95 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.6 0.76 . . . . 65.33 111.374 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.31 122.8 11.65 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.408 2.072 . . . . 74.31 111.261 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.17 117.9 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.217 -1.031 . . . . 74.24 108.217 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -72.09 84.29 1.0 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.448 0.699 . . . . 72.5 109.686 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -62.6 -29.76 70.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.654 0.782 . . . . 74.52 110.903 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.44 -59.62 5.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.841 0.857 . . . . 73.34 111.233 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.427 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -60.99 -37.91 84.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.559 0.744 . . . . 73.43 111.969 -175.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.97 -41.76 74.06 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.342 -0.844 . . . . 65.22 111.75 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.404 ' O ' ' HB3' ' D' ' 140' ' ' TYR . 64.6 t80 -75.04 -40.58 60.32 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.884 0.474 . . . . 74.31 111.199 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.427 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 51.1 mtm -63.08 -38.97 93.3 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.832 0.453 . . . . 73.55 110.395 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 18.8 t-20 -69.58 -27.63 65.28 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.618 -0.719 . . . . 74.35 110.745 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . 0.404 ' HB3' ' O ' ' D' ' 137' ' ' PHE . 45.1 t80 -60.26 -33.71 72.7 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.438 0.695 . . . . 72.4 111.708 176.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mp -62.32 -34.66 77.06 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.294 0.638 . . . . 73.42 111.754 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -91.96 21.85 4.68 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.707 0.403 . . . . 75.11 112.07 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 89.0 mt-30 -120.39 88.5 2.95 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.48 0.712 . . . . 73.0 109.524 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -172.3 66.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.945 0.898 . . . . 75.4 109.149 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.76 -40.16 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.768 -0.651 . . . . 72.54 111.347 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.59 -79.66 0.55 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 112.213 -0.355 . . . . 60.11 112.213 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.3 -177.43 6.44 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.849 0.86 . . . . 72.15 110.558 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.44 137.23 3.43 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 111.62 -0.592 . . . . 72.42 111.62 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.9 t -131.86 142.1 49.59 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.737 0.78 . . . . 63.43 111.307 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -129.18 74.61 1.59 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.861 1.265 . . . . 71.34 107.714 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -87.14 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.092 -0.958 . . . . 74.45 110.848 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 m170 65.08 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.708 1.203 . . . . 71.02 112.899 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -121.26 159.6 25.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.035 0.934 . . . . 73.43 110.669 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -74.07 137.51 43.39 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.663 -0.699 . . . . 64.13 110.124 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 108.81 -0.811 . . . . 73.21 108.81 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.348 -0.241 . . . . 74.22 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -94.35 103.62 15.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.714 -0.846 . . . . 73.13 108.714 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -75.58 162.81 27.96 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.115 0.484 . . . . 64.52 110.107 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -95.98 14.01 25.07 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.939 0.896 . . . . 74.44 111.079 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 57.22 80.91 0.27 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.385 1.474 . . . . 75.51 112.502 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.8 27.54 0.57 Allowed 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.082 2.522 . . . . 73.51 111.896 169.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.59 76.13 6.22 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.394 -0.965 . . . . 72.34 108.394 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 176.2 143.54 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.137 -1.431 . . . . 72.22 107.137 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . 177.31 -120.01 0.71 Allowed Glycine 0 C--N 1.343 0.949 0 C-N-CA 121.546 -0.359 . . . . 61.52 112.947 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.575 ' H ' HD23 ' E' ' 280' ' ' LEU . 1.5 pt? -64.87 86.26 0.05 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.667 1.187 . . . . 74.32 111.981 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 67.5 t80 179.03 -26.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.094 1.358 . . . . 73.21 109.608 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -71.74 -1.48 14.1 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 121.486 0.66 . . . . 74.11 110.711 168.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -137.56 -168.66 2.36 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.536 1.934 . . . . 73.12 108.069 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 85.84 72.77 1.29 Allowed Glycine 0 C--N 1.343 0.946 0 CA-C-O 120.964 0.202 . . . . 74.33 113.053 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.82 99.76 1.43 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.811 0.845 . . . . 71.44 109.419 173.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 85.6 mtp -70.41 117.1 51.73 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.485 0.714 . . . . 74.45 110.305 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.83 90.58 0.94 Allowed 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.985 2.457 . . . . 73.01 110.815 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.4 107.07 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.947 -1.131 . . . . 71.34 107.947 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.01 160.46 14.3 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.015 0.926 . . . . 75.3 110.631 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 93.8 m95 -72.46 144.37 48.11 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.691 -0.686 . . . . 74.54 109.621 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -109.14 -11.22 14.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.7 1.2 . . . . 73.33 110.672 -177.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -149.47 72.34 0.3 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.277 -0.729 . . . . 74.44 111.277 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.62 175.48 11.04 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.291 2.661 . . . . 74.33 112.848 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? 77.8 -29.45 0.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.424 1.489 . . . . 75.34 111.191 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -66.2 170.86 5.27 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.91 0.884 . . . . 72.23 111.599 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 5.1 m 70.75 21.35 5.26 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.208 1.003 . . . . 74.34 110.751 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.476 ' HE2' HD23 ' A' ' 68' ' ' LEU . 11.0 t80 -168.69 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.125 0.488 . . . . 72.3 110.959 -175.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -92.36 -2.57 56.28 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.87 0.468 . . . . 72.52 110.796 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.14 130.51 9.87 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.817 -0.435 . . . . 72.43 112.743 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . 0.418 ' HA ' ' CZ2' ' A' ' 36' ' ' TRP . 4.4 m-20 -72.78 85.14 1.22 Allowed 'General case' 0 C--N 1.355 0.83 0 C-N-CA 123.062 0.545 . . . . 75.14 110.225 174.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 14.0 pt -78.56 79.48 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 122.291 1.043 . . . . 65.42 109.041 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . 0.425 ' HB3' ' CE1' ' G' ' 298' ' ' HIS . 12.6 t70 -118.73 -155.65 0.61 Allowed 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 114.211 -1.359 . . . . 61.24 108.635 -169.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . 0.483 ' HE3' ' N ' ' E' ' 303' ' ' LYS . 0.6 OUTLIER -73.11 142.4 82.39 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.332 0.653 . . . . 63.14 110.459 -178.473 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -84.89 -165.21 0.28 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.292 2.662 . . . . 70.22 111.685 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -89.9 25.81 1.99 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.606 0.763 . . . . 73.53 112.309 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 21.8 m -69.68 147.11 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.13 0.572 . . . . 61.14 109.694 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 5.0 t -154.58 -48.71 0.09 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.667 0.387 . . . . 63.5 110.974 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 79.2 m -155.09 119.26 4.66 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.879 0.872 . . . . 75.41 108.989 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' E' E ' 309' ' ' THR . . . . . 0.41 ' HB ' ' HB3' ' B' ' 12' ' ' GLN . 29.6 m -145.03 116.07 5.15 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 108.377 -0.971 . . . . 64.35 108.377 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 C--N 1.38 2.2 0 C-N-CA 123.307 2.671 . . . . 74.51 112.367 179.876 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 108.578 -0.897 . . . . 75.41 108.578 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -137.38 -66.68 0.5 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.783 0.833 . . . . 74.44 109.644 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 53.01 -107.95 0.38 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.994 0.918 . . . . 71.4 109.522 -166.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -171.27 110.08 0.31 Allowed 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.557 -1.275 . . . . 71.23 107.557 168.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -139.83 115.74 8.08 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 107.763 -1.199 . . . . 74.23 107.763 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.83 94.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.756 2.304 . . . . 71.13 111.833 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.57 HD23 ' HG2' ' C' ' 94' ' ' MET . 51.4 mt -78.41 75.75 4.92 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.933 0.873 . . . . 75.31 108.756 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.66 89.93 1.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 106.467 -1.679 . . . . 75.13 106.467 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -128.14 -59.79 0.12 Allowed Glycine 0 N--CA 1.471 0.998 0 N-CA-C 111.152 -0.779 . . . . 65.2 111.152 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.4 116.32 31.72 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.473 -1.306 . . . . 73.25 107.473 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -164.46 -54.57 0.03 OUTLIER 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.669 0.606 . . . . 74.3 110.495 178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.75 -74.01 0.06 Allowed 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.486 1.117 . . . . 73.1 111.999 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -171.39 170.42 5.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.343 0.657 . . . . 74.13 110.714 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 176.13 -63.25 0.1 OUTLIER Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.603 -1.399 . . . . 71.4 109.603 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -175.25 108.19 0.1 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.514 1.126 . . . . 74.23 108.882 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 14.9 tpt -148.24 113.74 3.85 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.141 0.577 . . . . 71.43 109.468 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.83 83.76 2.04 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.812 2.342 . . . . 63.45 112.78 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 66.4 t -141.14 99.72 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.605 -0.887 . . . . 71.21 108.605 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -117.75 -71.08 0.75 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.006 -1.109 . . . . 73.42 108.006 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 27.6 m95 -147.3 130.0 16.04 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.691 0.796 . . . . 65.03 110.305 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.516 HD11 ' HB2' ' C' ' 129' ' ' ALA . 4.7 mp -79.75 79.91 6.2 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.314 1.009 . . . . 74.14 108.857 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.09 132.66 4.98 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.116 -0.824 . . . . 62.32 111.562 -172.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.16 122.9 11.28 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.581 2.187 . . . . 73.42 111.201 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . 0.49 ' HD2' HD23 ' C' ' 126' ' ' LEU . 0.1 OUTLIER -141.16 161.9 36.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.553 0.741 . . . . 74.33 110.957 -174.227 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -132.03 144.9 51.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.097 -0.956 . . . . 74.53 109.724 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 35.4 p -70.73 -52.84 18.23 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.534 0.521 . . . . 64.54 110.002 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -73.42 89.86 1.66 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.024 -0.732 . . . . 75.21 109.024 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -83.55 66.08 8.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.287 1.035 . . . . 74.55 109.103 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 101.09 -162.35 18.25 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.61 -0.723 . . . . 72.33 112.413 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . 0.436 ' HA ' ' CD1' ' C' ' 36' ' ' TRP . 2.2 m-20 -80.07 98.35 7.22 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.652 0.781 . . . . 75.14 110.135 -176.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 12.4 pt -81.68 -5.55 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 112.634 0.605 . . . . 64.21 112.634 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -40.96 115.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.097 1.759 . . . . 74.33 113.855 -165.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -158.09 116.14 1.82 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.629 0.771 . . . . 75.4 109.913 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.91 -12.44 17.87 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.591 2.194 . . . . 74.11 110.673 161.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 65.52 -87.8 0.03 OUTLIER 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.691 1.597 . . . . 62.25 112.279 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . 0.5 ' HB ' ' O ' ' D' ' 13' ' ' ILE . 16.4 t -96.49 60.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 123.064 1.412 . . . . 71.11 109.645 -172.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 12.7 t -117.29 -10.82 10.7 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 113.384 -1.735 . . . . 75.22 108.446 165.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 25.4 t -135.57 87.4 2.32 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.984 1.313 . . . . 74.53 107.627 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' F' F ' 309' ' ' THR . . . . . 0.435 ' HB ' ' HD3' ' F' ' 310' ' ' PRO . 97.5 m -155.64 -52.63 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.655 1.182 . . . . 74.01 110.24 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' F' ' 309' ' ' THR . 6.4 Cg_exo . . . . . 0 C--N 1.403 3.4 0 C-N-CA 122.116 1.877 . . . . 71.42 111.535 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.903 -0.406 . . . . 43.42 109.903 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -74.38 83.57 1.94 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.585 0.754 . . . . 72.43 110.084 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -108.54 76.87 1.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.672 -1.232 . . . . 62.32 107.672 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -105.1 23.63 13.31 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.944 -1.025 . . . . 74.24 110.457 -172.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -60.83 126.69 86.06 Favored Pre-proline 0 N--CA 1.482 1.139 0 N-CA-C 108.058 -1.09 . . . . 74.24 108.058 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.06 -49.6 14.91 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.782 2.322 . . . . 71.24 111.967 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.408 HD23 ' N ' ' G' ' 278' ' ' LEU . 8.2 tt -178.05 153.83 0.83 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.044 -1.465 . . . . 72.23 107.044 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . 0.532 HD23 HD22 ' D' ' 98' ' ' LEU . 0.2 OUTLIER 74.85 125.12 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.758 1.223 . . . . 75.12 109.812 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.88 -99.44 0.21 Allowed Glycine 0 C--N 1.346 1.108 0 N-CA-C 111.435 -0.666 . . . . 75.24 111.435 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.84 96.6 1.68 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.845 -1.169 . . . . 74.25 107.845 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -137.53 90.84 2.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.512 0.672 . . . . 74.01 109.292 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -161.12 -172.13 3.32 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 114.305 -1.316 . . . . 70.22 108.615 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.71 94.58 1.38 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.497 0.665 . . . . 72.42 109.342 173.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -74.05 -110.35 0.08 OUTLIER Glycine 0 C--N 1.352 1.469 0 CA-C-N 115.515 -0.766 . . . . 71.21 111.412 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -93.88 98.28 10.95 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.936 -1.135 . . . . 72.13 107.936 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 18.8 mmt -114.86 86.84 13.86 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.754 0.822 . . . . 74.31 109.264 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -91.46 27.99 0.4 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.046 2.497 . . . . 64.41 111.335 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 29.2 t -76.65 82.54 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.886 -0.783 . . . . 63.34 108.886 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -98.51 19.2 14.96 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.961 -1.018 . . . . 73.04 110.761 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 43.6 m95 70.64 153.89 0.12 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.266 1.426 . . . . 73.41 112.446 -170.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.2 9.36 21.81 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.574 -1.193 . . . . 73.21 110.013 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 120.95 88.37 1.01 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 111.374 -0.69 . . . . 74.44 111.374 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -98.91 11.87 0.72 Allowed 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.627 2.885 . . . . 73.22 113.531 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -89.52 49.16 1.7 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.982 0.513 . . . . 74.41 112.154 -174.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -168.62 35.69 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.284 1.034 . . . . 71.01 109.179 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 296' ' ' THR . . . . . 0.565 HG21 ' HG2' ' D' ' 124' ' ' PRO . 11.5 m -61.85 -56.6 17.66 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.379 -0.828 . . . . 74.31 110.846 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.79 -46.2 15.76 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.332 -0.618 . . . . 74.15 109.332 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . 0.425 ' CE1' ' HB3' ' E' ' 302' ' ' ASP . 62.6 t-80 68.43 -75.99 0.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.278 1.431 . . . . 75.44 111.331 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.58 70.31 3.09 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.248 -0.433 . . . . 71.22 113.693 -174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.21 -162.28 0.25 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.796 0.838 . . . . 75.12 111.878 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.593 HG23 ' HA ' ' D' ' 32' ' ' PHE . 11.2 mt -128.42 92.19 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.423 -1.325 . . . . 71.14 107.423 165.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -87.94 153.69 21.1 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.99 -0.55 . . . . 74.15 110.611 -177.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -136.06 150.46 71.32 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.82 1.248 . . . . 75.25 109.088 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.28 -60.68 0.25 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.136 1.891 . . . . 74.24 111.441 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . 51.85 85.65 0.04 OUTLIER 'General case' 0 C--N 1.364 1.23 0 C-N-CA 124.704 1.202 . . . . 73.0 112.299 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.68 62.12 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 122.447 1.118 . . . . 75.25 110.339 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 11.0 m -89.93 58.92 4.37 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.304 1.049 . . . . 71.55 109.799 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 34.3 m -129.55 -10.08 4.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.767 -1.106 . . . . 65.54 110.743 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 70.0 p -67.36 165.4 29.16 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.826 0.85 . . . . 75.43 110.193 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo . . . . . 0 C--N 1.39 2.717 0 C-N-CA 123.641 2.894 . . . . 64.34 114.217 178.21 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.393 -0.225 . . . . 72.34 110.393 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -85.81 132.99 34.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.357 0.663 . . . . 75.21 109.955 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -89.11 -32.57 17.45 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.976 0.91 . . . . 73.43 110.452 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.26 86.36 1.44 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.749 0.82 . . . . 62.41 110.665 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -138.97 168.0 17.18 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 124.252 1.021 . . . . 75.32 109.97 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.13 173.41 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.596 2.197 . . . . 65.23 113.232 168.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.407 ' HG ' ' SD ' ' B' ' 94' ' ' MET . 19.7 tp -84.08 41.7 0.83 Allowed 'General case' 0 CA--C 1.566 1.59 0 CA-C-O 122.019 0.914 . . . . 73.15 111.086 -177.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.1 -60.79 1.82 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.53 -1.285 . . . . 73.31 107.53 168.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 82.98 -55.54 5.04 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 115.304 -0.862 . . . . 71.43 112.827 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . 0.588 ' HG ' ' H ' ' H' ' 281' ' ' PHE . 15.6 tp -128.61 -167.37 1.76 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.257 1.023 . . . . 74.24 108.658 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . 0.588 ' H ' ' HG ' ' H' ' 280' ' ' LEU . 23.8 t80 81.63 0.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.407 1.483 . . . . 73.33 111.952 170.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -100.25 86.25 3.17 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.032 -1.47 . . . . 73.44 107.032 168.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 21.6 t70 74.21 134.76 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.011 1.325 . . . . 73.54 110.664 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -168.83 144.35 8.69 Favored Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.677 -0.569 . . . . 71.42 111.677 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -122.83 127.71 49.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.276 0.63 . . . . 75.3 110.435 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -135.22 152.49 76.97 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.634 1.174 . . . . 74.23 108.252 173.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.79 70.48 2.12 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.847 2.365 . . . . 73.31 112.064 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 15.3 t -130.5 24.77 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 124.025 0.93 . . . . 74.0 109.014 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -55.99 -60.14 3.9 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.809 -0.811 . . . . 72.43 108.809 169.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -166.26 -179.9 5.31 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.508 1.523 . . . . 73.34 108.637 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 -169.01 1.63 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.365 1.066 . . . . 74.11 108.835 172.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.62 114.54 5.31 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 118.553 -1.137 . . . . 61.21 111.206 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.99 117.54 5.21 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.756 2.304 . . . . 74.32 113.535 -169.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -90.26 139.2 30.88 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.877 -1.157 . . . . 71.43 107.877 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -56.26 109.86 0.67 Allowed 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.088 0.867 . . . . 65.1 110.801 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 94.0 m -78.01 -51.38 10.44 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.908 0.883 . . . . 73.44 111.506 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -67.38 -75.98 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.481 -0.781 . . . . 72.41 111.614 -165.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 70.57 -56.23 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.868 1.267 . . . . 64.24 111.451 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 154.55 171.39 21.35 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 112.262 -0.335 . . . . 73.11 112.262 171.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -171.14 -46.47 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 106.378 -1.712 . . . . 74.03 106.378 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 29.5 pt -61.62 150.65 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 113.449 -1.705 . . . . 71.12 110.124 165.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -165.09 171.87 13.31 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.191 -0.67 . . . . 61.52 109.191 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.409 ' HB2' ' HD3' ' H' ' 304' ' ' PRO . 52.2 mtpt -76.18 -54.66 1.95 Allowed Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 118.672 -0.68 . . . . 72.2 111.548 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . 0.409 ' HD3' ' HB2' ' H' ' 303' ' ' LYS . 42.0 Cg_endo -84.12 44.06 1.48 Allowed 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.14 1.893 . . . . 71.41 111.747 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.75 -71.82 0.08 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.236 1.014 . . . . 75.23 111.619 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 15.6 m -144.4 123.96 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.197 0.599 . . . . 74.43 110.202 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 307' ' ' THR . . . . . 0.451 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 2.0 p -151.52 117.38 5.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.907 1.283 . . . . 54.44 108.908 172.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 57.9 m 62.43 173.31 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.612 1.165 . . . . 75.32 112.389 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 64.5 p -113.56 94.06 30.55 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.062 0.545 . . . . 74.33 109.982 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 C--N 1.377 2.045 0 C-N-CA 122.671 2.247 . . . . 62.02 109.897 167.133 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.954 0.407 . . . . 74.02 110.017 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.6 m -91.26 -69.19 0.75 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.652 0.781 . . . . 73.15 109.51 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 58.39 26.14 13.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.34 1.056 . . . . 71.43 112.93 174.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -86.42 165.32 16.42 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.235 0.614 . . . . 70.32 109.56 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -170.62 133.43 1.0 Allowed 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.989 0.916 . . . . 75.33 108.884 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 9' ' ' MET . 44.3 t-20 -87.81 108.83 19.34 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.939 -1.134 . . . . 74.42 107.939 176.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 p -66.21 -28.18 68.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.361 0.664 . . . . 71.23 111.743 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.28 -17.55 51.83 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.565 0.746 . . . . 52.42 111.622 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.449 ' HG3' HD13 ' A' ' 89' ' ' ILE . 57.3 ttp -60.8 134.23 56.88 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.304 0.573 . . . . 75.54 110.3 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m -143.04 117.48 9.68 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 114.611 -1.177 . . . . 74.23 108.384 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.721 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.2 t80 -123.83 117.69 25.44 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.527 -0.916 . . . . 73.01 108.527 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -141.62 112.67 7.37 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.832 -0.803 . . . . 74.5 108.832 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.624 HG12 ' HD2' ' A' ' 84' ' ' PHE . 66.5 mt -69.91 130.64 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 122.844 0.458 . . . . 73.35 109.986 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' H' ' 305' ' ' ALA . 63.9 tt0 -96.47 -38.29 10.08 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.954 -0.546 . . . . 74.5 110.567 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -173.01 123.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.196 0.907 . . . . 74.25 112.686 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.83 133.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.582 -0.896 . . . . 73.23 108.582 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' HB3' HG23 ' B' ' 122' ' ' THR . 16.6 p90 -167.88 158.5 10.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.243 1.017 . . . . 73.1 110.653 -172.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -91.73 115.24 27.89 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.347 -0.842 . . . . 72.05 109.425 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -85.56 -18.87 32.12 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.381 -0.372 . . . . 75.25 110.405 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.447 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.5 t70 -155.9 140.84 17.25 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.906 0.882 . . . . 75.14 109.735 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -140.73 135.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.447 1.499 . . . . 72.22 107.301 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 39.6 t -141.45 125.77 17.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.423 -0.955 . . . . 61.44 108.423 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -136.42 110.13 8.08 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.639 -1.245 . . . . 75.21 107.639 171.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.13 120.14 35.35 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.813 0.445 . . . . 61.22 109.945 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.78 80.79 14.45 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 107.633 -1.247 . . . . 54.23 107.633 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.75 -24.74 29.36 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.825 2.35 . . . . 73.53 113.061 -170.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.02 12.98 28.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.395 0.678 . . . . 54.23 111.269 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.08 4.24 Favored Pre-proline 0 CA--C 1.565 1.53 0 N-CA-C 114.964 1.468 . . . . 72.42 114.964 -165.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.509 ' HB3' HD23 ' B' ' 51' ' ' LEU . 26.1 Cg_exo -56.74 -46.51 29.1 Favored 'Trans proline' 0 C--N 1.396 3.037 0 CA-C-N 122.107 1.788 . . . . 64.11 113.045 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -98.7 -6.99 28.54 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.94 0.896 . . . . 72.11 112.911 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.525 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.5 p -79.88 -20.18 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.615 -0.678 . . . . 52.41 111.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -86.52 -3.86 59.08 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.446 0.698 . . . . 74.14 112.016 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -100.64 -7.73 23.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.653 0.781 . . . . 74.41 111.0 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -70.29 163.92 25.52 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.738 0.815 . . . . 72.21 112.469 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.39 144.22 51.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.216 1.006 . . . . 64.24 110.049 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -87.24 73.98 9.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.703 0.764 . . . . 74.23 111.404 -169.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -143.41 84.1 10.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 114.614 -1.175 . . . . 74.4 108.066 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.26 136.28 11.29 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.335 2.023 . . . . 61.35 112.131 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -95.13 93.88 7.6 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.765 -1.569 . . . . 62.22 106.765 170.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' THR . 34.0 t -92.46 96.51 6.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.983 -1.008 . . . . 64.52 111.061 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.9 tttm -80.47 111.53 16.97 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.1 -0.955 . . . . 73.52 108.938 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 tt -98.74 121.9 41.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.343 -0.984 . . . . 74.42 108.343 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.548 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 24.0 m-20 -116.72 150.32 38.4 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.356 1.062 . . . . 61.54 108.849 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -130.52 133.47 46.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.946 -0.761 . . . . 71.43 108.946 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -132.97 144.14 49.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.076 0.95 . . . . 73.51 108.769 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.49 ' HB ' ' CZ ' ' E' ' 281' ' ' PHE . 41.6 p -136.36 136.38 39.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.778 0.831 . . . . 63.32 109.466 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.6 111.03 5.59 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.977 0.511 . . . . 71.24 110.079 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -92.05 152.07 20.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.501 -0.555 . . . . 74.1 109.501 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -151.96 154.98 37.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.435 -1.32 . . . . 73.41 107.435 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -117.46 130.97 56.8 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.962 -0.755 . . . . 73.33 108.962 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -93.45 -40.48 10.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.513 0.725 . . . . 73.45 110.539 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.26 -177.23 6.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.904 0.882 . . . . 71.4 110.077 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.25 123.61 20.41 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.386 -0.598 . . . . 73.42 109.386 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 69.0 -8.1 0.71 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.809 1.643 . . . . 73.11 112.963 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.36 109.77 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.032 -0.729 . . . . 73.32 109.032 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.73 153.53 32.22 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.947 0.899 . . . . 72.13 108.67 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -129.73 118.95 22.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.337 1.055 . . . . 73.54 108.852 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.77 118.92 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.205 -1.035 . . . . 71.45 108.205 174.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.474 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 95.3 t -98.28 128.22 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 108.848 -0.797 . . . . 73.42 108.848 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.24 97.92 6.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.401 -1.703 . . . . 73.44 106.401 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.425 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 16.8 ttp180 -88.41 109.13 19.76 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.375 -0.602 . . . . 73.55 109.375 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 11.1 t -93.87 130.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.266 -1.383 . . . . 73.51 107.266 171.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -120.87 128.57 52.94 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.73 -0.841 . . . . 75.44 108.73 176.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.643 HG12 HD23 ' A' ' 126' ' ' LEU . 52.9 t -130.73 107.72 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.349 0.66 . . . . 75.3 109.874 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 13.5 m -102.81 141.23 35.97 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.465 -0.939 . . . . 71.41 108.465 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.53 46.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.004 -1.109 . . . . 74.33 108.004 173.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -142.76 127.46 18.1 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.858 0.463 . . . . 74.2 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' A' ' 73' ' ' ALA . 9.2 mp -95.17 84.93 4.17 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.471 -1.307 . . . . 73.43 107.471 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -127.13 8.29 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.268 -1.333 . . . . 54.34 111.281 -171.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.28 -25.09 22.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 75.24 110.028 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.21 117.53 20.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.277 1.031 . . . . 73.53 110.296 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -66.79 128.4 36.16 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.122 0.889 . . . . 74.43 110.749 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.633 ' HB3' HD13 ' A' ' 68' ' ' LEU . . . -70.89 -62.91 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.393 -0.966 . . . . 74.32 108.393 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.22 166.07 33.29 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.713 -1.13 . . . . 73.03 110.183 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -132.41 135.8 46.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.163 -1.421 . . . . 71.12 107.163 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.1 m -134.96 101.05 4.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.562 0.745 . . . . 73.12 109.829 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 34.7 tt0 -125.81 116.01 20.91 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.207 -0.664 . . . . 73.4 109.207 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -128.88 111.63 23.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.088 0.955 . . . . 71.13 108.94 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.447 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.6 mt-30 -84.39 84.28 7.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.316 -0.994 . . . . 73.24 108.316 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.78 93.33 3.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.784 -1.098 . . . . 71.4 108.391 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.474 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.49 145.29 21.06 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.379 -0.828 . . . . 74.13 111.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.5 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -146.74 121.46 1.43 Allowed Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 111.188 -0.765 . . . . 63.41 111.188 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.415 HG21 ' HB3' ' A' ' 14' ' ' GLN . 40.2 mt -82.09 116.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.624 -0.88 . . . . 72.33 108.624 175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.721 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.3 m-85 -121.83 121.55 37.44 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.335 1.054 . . . . 65.44 108.32 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -79.72 99.84 7.62 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.603 -0.888 . . . . 73.34 108.603 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.94 121.04 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.061 0.944 . . . . 73.42 109.375 -174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.27 161.53 42.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.387 0.675 . . . . 61.45 110.063 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.418 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 94.33 -29.81 8.47 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.69 0.636 . . . . 64.44 114.69 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.497 ' H ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.67 170.19 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.423 0.689 . . . . 71.14 109.976 178.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -152.74 172.29 16.92 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 123.553 0.533 . . . . 74.43 110.225 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.41 -116.31 3.49 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.422 1.487 . . . . 62.32 115.544 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 t -57.07 -31.74 65.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.31 1.444 . . . . 72.44 112.445 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -75.42 -39.15 59.28 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.482 0.713 . . . . 73.21 110.437 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mtp -77.4 -21.18 53.54 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.266 0.354 . . . . 75.53 110.617 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.476 ' HB1' HD12 ' E' ' 280' ' ' LEU . . . -72.28 -33.45 67.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.124 0.57 . . . . 73.22 109.708 172.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 44.1 t-80 -76.16 -35.15 59.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.199 -0.91 . . . . 65.33 110.204 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -70.25 -47.52 60.95 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 122.234 -0.291 . . . . 74.53 110.226 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.16 -40.48 62.54 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.878 -0.601 . . . . 75.44 110.942 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.69 4.25 59.49 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.239 -0.756 . . . . 51.11 114.781 -168.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -146.41 -68.51 0.27 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.178 0.989 . . . . 61.4 112.434 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.477 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 92.1 t80 -68.84 -51.37 41.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.87 0.868 . . . . 75.12 113.065 -167.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.8 m -73.57 -31.74 1.44 Allowed Pre-proline 0 CA--C 1.563 1.48 0 CA-C-O 118.402 -0.808 . . . . 74.42 113.081 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.4 -42.64 34.24 Favored 'Trans proline' 0 C--N 1.395 3.01 0 C-N-CA 122.594 2.196 . . . . 72.11 112.799 159.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.553 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 91.9 m-20 -64.63 -19.51 65.74 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.646 0.778 . . . . 71.23 112.093 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.404 HD13 ' ND2' ' C' ' 132' ' ' ASN . 39.1 mm -81.6 -46.43 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.307 -0.627 . . . . 74.55 109.307 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.5 HD22 ' HA3' ' A' ' 82' ' ' GLY . 94.3 mt -78.67 -30.56 46.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.049 0.94 . . . . 71.41 113.073 -171.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -69.78 -38.36 9.47 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.005 -0.997 . . . . 72.11 112.6 -169.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -41.93 71.07 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 122.277 1.984 . . . . 64.32 113.543 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -76.53 -32.37 58.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.146 0.578 . . . . 72.52 111.848 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.23 68.44 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.296 -0.631 . . . . 75.12 109.296 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -54.86 -47.19 74.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.651 1.18 . . . . 74.14 110.623 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.38 -47.14 74.33 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.161 0.913 . . . . 73.11 110.809 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -57.6 -43.79 84.95 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.382 0.673 . . . . 75.41 110.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.461 HG23 ' HB3' ' A' ' 76' ' ' CYS . 87.0 mt -64.69 -46.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 O-C-N 124.255 0.972 . . . . 74.32 110.142 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.511 HG21 ' HG3' ' A' ' 125' ' ' GLN . 95.7 m -52.89 -45.75 67.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.651 0.78 . . . . 72.42 111.28 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -69.37 -44.92 70.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.887 -1.051 . . . . 75.42 110.511 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -55.86 -44.59 78.19 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.654 0.781 . . . . 74.24 111.362 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 123' ' ' PHE . 41.0 t -61.9 -48.25 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.971 1.308 . . . . 74.21 110.59 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 77.9 p -68.02 -32.26 72.52 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.001 0.52 . . . . 75.5 111.628 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.29 -33.82 75.04 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.688 0.795 . . . . 74.04 110.366 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 9.53 66.54 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.462 -0.79 . . . . 64.13 113.308 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.797 HG23 ' HD2' ' B' ' 15' ' ' ARG . 17.9 m 73.2 9.13 5.28 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.388 1.075 . . . . 64.25 112.782 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.436 ' HB2' HG13 ' A' ' 118' ' ' VAL . 96.1 m-85 -85.47 138.5 36.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 107.762 -1.199 . . . . 74.32 107.762 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.419 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 24.5 Cg_endo -62.24 160.2 31.87 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.702 2.268 . . . . 75.51 112.622 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.511 ' HG3' HG21 ' A' ' 115' ' ' THR . 31.1 tt0 -45.44 121.95 3.27 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 124.795 1.31 . . . . 71.43 112.507 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.643 HD23 HG12 ' A' ' 64' ' ' VAL . 48.8 tp -108.4 115.49 30.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.885 -1.052 . . . . 75.13 108.374 174.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -129.28 124.15 33.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.641 -1.163 . . . . 62.21 107.977 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.77 138.86 46.72 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.318 -0.623 . . . . 75.35 109.318 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.712 ' HB3' HD12 ' E' ' 291' ' ' LEU . . . -63.22 145.61 96.76 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 122.774 0.429 . . . . 64.11 110.359 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.601 ' HD3' HG21 ' C' ' 13' ' ' ILE . 23.8 Cg_exo -64.6 104.74 0.56 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.967 2.445 . . . . 75.14 112.455 -173.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.612 HG21 HD22 ' E' ' 291' ' ' LEU . 14.5 t -100.12 112.46 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.881 -1.155 . . . . 72.31 107.881 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -85.82 86.23 7.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.207 -1.405 . . . . 75.15 107.207 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -60.71 -29.18 69.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.523 -0.762 . . . . 74.1 110.659 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.553 ' HB2' ' ND2' ' A' ' 104' ' ' ASN . 6.8 t70 -65.54 -50.73 64.13 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 123.762 0.825 . . . . 74.22 109.377 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.54 -38.73 88.5 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 124.773 1.295 . . . . 74.44 111.252 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -58.73 -47.41 84.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.734 0.814 . . . . 75.41 111.022 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -79.22 -24.21 43.26 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.133 0.573 . . . . 72.44 110.593 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.464 ' SD ' HD21 ' A' ' 141' ' ' LEU . 51.9 tpp -68.82 -30.72 69.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.494 0.718 . . . . 74.01 110.354 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 64.4 m-80 -69.63 -25.52 63.97 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.169 -0.469 . . . . 64.12 111.665 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -80.8 -36.84 31.19 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.993 0.517 . . . . 74.51 109.98 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.464 HD21 ' SD ' ' A' ' 138' ' ' MET . 29.8 tp -67.36 -48.36 67.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.254 1.022 . . . . 72.22 111.884 -174.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.29 11.82 0.11 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.085 0.554 . . . . 74.13 112.387 -172.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.636 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 20.6 tt0 64.84 -110.24 0.22 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.604 1.162 . . . . 75.42 110.081 -171.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.447 ' HA ' HE21 ' A' ' 144' ' ' GLN . 0.0 OUTLIER -176.78 125.43 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.678 0.672 . . . . 71.43 109.79 -177.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.53 86.17 5.96 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.123 0.569 . . . . 71.13 109.914 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.62 138.78 16.65 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.76 -0.655 . . . . 74.31 112.626 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -162.42 144.22 10.68 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.195 0.598 . . . . 74.41 110.004 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.93 171.74 44.66 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.712 -0.676 . . . . 60.31 111.948 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 t -158.88 -175.16 5.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.4 0.68 . . . . 71.42 109.937 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.43 176.54 8.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.134 0.974 . . . . 74.43 109.503 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -151.68 125.01 8.8 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.854 -0.425 . . . . 63.5 109.854 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -89.07 157.01 18.48 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.95 0.5 . . . . 74.44 111.076 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -139.33 140.24 37.48 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.94 0.896 . . . . 74.44 109.119 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -123.42 174.98 7.01 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.442 0.697 . . . . 74.23 110.24 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.845 0.858 . . . . 61.2 109.41 179.249 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 109.576 -0.527 . . . . 75.12 109.576 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.1 m -131.98 7.17 4.33 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.166 0.987 . . . . 75.25 110.224 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 56.19 22.9 6.5 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.954 1.301 . . . . 70.51 112.061 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 -141.03 127.71 20.23 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.223 1.409 . . . . 74.42 107.489 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' D' ' 148' ' ' GLY . 27.7 m120 -99.47 114.37 27.29 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.166 0.432 . . . . 70.13 112.166 -168.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -166.02 -72.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 44.31 109.885 171.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m 70.08 122.42 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.55 1.54 . . . . 74.55 112.29 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -124.7 -55.85 1.6 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.515 1.126 . . . . 73.32 109.274 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 13.8 ptm 52.52 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.084 2.553 . . . . 74.32 113.522 -164.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.435 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 25.3 m -159.02 123.82 4.11 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 106.935 -1.505 . . . . 74.04 106.935 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -139.74 130.69 26.22 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.25 -0.648 . . . . 75.12 109.25 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.517 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 2.6 pm0 -148.47 129.82 14.73 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.573 -0.528 . . . . 75.32 109.573 172.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.17 144.33 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 115.565 -0.743 . . . . 71.32 109.16 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -108.49 -47.49 3.49 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.456 -0.572 . . . . 74.43 109.456 169.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.797 ' HD2' HG23 ' A' ' 122' ' ' THR . 34.8 ttp180 -165.79 152.95 10.14 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.784 -0.644 . . . . 74.52 110.98 -170.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -131.73 139.25 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 107.343 -1.355 . . . . 64.41 107.343 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.585 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.6 p90 -161.46 168.69 23.27 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.785 0.803 . . . . 73.02 112.256 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.2 m -93.25 121.21 34.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.473 -1.239 . . . . 73.5 108.763 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.591 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 24.6 mtpp -87.66 -30.46 20.39 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.428 0.691 . . . . 75.25 110.614 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.86 145.6 18.58 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -174.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.739 HD12 ' SG ' ' B' ' 113' ' ' CYS . 28.3 mm -138.81 141.94 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.031 1.732 . . . . 71.25 109.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -150.45 117.4 5.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.181 -1.044 . . . . 71.31 108.181 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -131.81 116.18 16.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.259 -1.385 . . . . 74.11 107.259 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 157.56 27.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.405 0.682 . . . . 74.1 109.694 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.88 79.2 8.62 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.333 -1.358 . . . . 75.45 107.333 175.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.58 -9.81 20.09 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.006 2.471 . . . . 74.2 112.602 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.402 ' OD1' ' HB ' ' B' ' 72' ' ' THR . 3.0 m120 -116.63 11.25 14.64 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.214 1.006 . . . . 74.4 109.043 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.66 -54.51 26.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.779 1.232 . . . . 64.21 114.216 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.71 -23.27 14.63 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 121.696 1.597 . . . . 73.21 112.436 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.469 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 3.4 m-70 -90.33 -0.36 57.6 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.833 0.853 . . . . 63.14 112.044 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.95 -28.39 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.66 0.784 . . . . 72.31 111.857 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.0 -23.15 64.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.083 0.953 . . . . 75.42 112.146 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.574 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -70.0 -40.01 75.53 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.746 -0.465 . . . . 71.33 109.746 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.574 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 78.5 mttt -109.73 64.52 0.61 Allowed 'General case' 0 C--N 1.359 1.02 0 N-CA-C 108.434 -0.95 . . . . 73.24 108.434 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 9.4 p-10 -78.61 94.06 4.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.921 -0.581 . . . . 64.32 110.388 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.406 ' HB2' ' O ' ' B' ' 35' ' ' ASP . 0.4 OUTLIER 173.93 -173.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.945 1.298 . . . . 75.13 111.024 159.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -55.08 117.99 16.22 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.037 1.335 . . . . 55.04 112.503 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.49 169.31 22.12 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.742 2.295 . . . . 74.31 111.166 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.55 102.01 3.73 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 106.882 -1.525 . . . . 74.53 106.882 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.597 HG23 ' HB2' ' H' ' 295' ' ' ALA . 13.7 m -89.95 140.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.807 -1.088 . . . . 74.12 108.976 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -119.1 130.57 55.66 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.239 -0.652 . . . . 75.43 109.239 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.615 HD22 HD13 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -86.04 136.91 33.05 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.032 -1.47 . . . . 74.03 107.032 168.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 18.4 t0 -142.88 128.36 19.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.77 -1.196 . . . . 75.43 107.77 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' H' ' 285' ' ' ASN . 1.4 mp -131.38 126.49 35.34 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.093 -1.077 . . . . 73.21 108.093 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.3 t70 -123.3 142.61 50.76 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.49 1.116 . . . . 75.3 108.371 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.402 HG23 ' HE1' ' H' ' 286' ' ' MET . 61.2 p -117.39 119.26 34.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.088 0.555 . . . . 72.53 110.411 -172.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.32 135.29 33.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.9 0.88 . . . . 64.34 108.912 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -134.62 169.91 16.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.318 0.647 . . . . 74.04 110.054 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -151.97 163.86 38.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.561 0.744 . . . . 70.33 110.232 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -108.58 120.08 41.39 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.812 -0.811 . . . . 75.45 108.812 170.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.57 HD13 ' HB2' ' B' ' 57' ' ' GLU . 17.6 mt -92.06 -46.03 8.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.847 0.859 . . . . 74.32 109.336 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.93 -178.86 6.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.3 -1.318 . . . . 74.52 108.803 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.52 122.39 18.94 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.956 -1.02 . . . . 73.22 108.825 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 71.59 -4.3 1.92 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.644 1.577 . . . . 73.11 112.699 -173.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.6 t -106.16 107.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.925 -0.769 . . . . 75.03 108.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.414 ' CE2' ' HB2' ' H' ' 278' ' ' LEU . 92.5 m-85 -120.43 140.71 50.97 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.182 0.993 . . . . 75.12 109.586 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.57 ' HB2' HD13 ' B' ' 51' ' ' LEU . 40.2 tt0 -102.72 138.48 39.57 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.916 0.886 . . . . 55.11 109.369 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -115.08 122.94 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.309 1.044 . . . . 75.01 108.301 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.94 116.21 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.539 0.736 . . . . 73.13 109.479 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.59 108.44 19.96 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.907 -0.775 . . . . 74.23 108.907 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.526 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 55.0 ttt180 -86.89 106.19 17.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.828 0.851 . . . . 72.14 108.834 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.02 115.72 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.948 -0.76 . . . . 64.11 108.948 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 16.8 m -116.12 136.12 53.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.211 1.004 . . . . 73.1 109.302 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.427 HG23 HD12 ' B' ' 114' ' ' ILE . 54.1 t -120.0 125.03 73.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.811 1.245 . . . . 75.41 109.086 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -124.89 125.9 44.68 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.689 -0.486 . . . . 74.52 109.689 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.88 146.48 48.39 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.309 1.044 . . . . 74.43 109.335 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.2 p -149.16 128.93 13.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.443 0.535 . . . . 72.02 112.443 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' B' ' 34' ' ' LYS . 82.7 mt -97.32 108.4 21.12 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.396 1.079 . . . . 74.12 109.299 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.57 -124.2 7.96 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.002 -0.545 . . . . 73.0 111.784 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.9 1.96 46.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.378 0.671 . . . . 60.24 110.857 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -127.71 177.18 6.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.942 -0.474 . . . . 74.03 110.651 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' THR . . . . . 0.402 ' HB ' ' OD1' ' B' ' 27' ' ' ASN . 11.9 m -68.49 157.46 35.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.534 1.133 . . . . 74.12 110.709 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.59 -58.68 2.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.018 -0.734 . . . . 75.1 109.018 168.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -162.73 158.45 22.98 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.237 -1.347 . . . . 63.21 108.266 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -124.08 138.71 54.4 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.724 1.209 . . . . 74.31 108.589 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -146.88 149.47 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.274 -0.639 . . . . 72.04 109.274 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -165.34 133.76 3.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.535 0.734 . . . . 73.21 109.036 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' B' ' 110' ' ' ALA . 96.6 t -127.02 145.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.526 1.13 . . . . 73.33 108.704 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.526 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.1 mt-30 -126.03 96.89 4.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.258 -1.015 . . . . 71.33 108.258 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -94.42 107.17 19.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.634 -0.712 . . . . 75.42 109.127 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.591 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -109.35 141.59 16.06 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.237 -0.745 . . . . 55.43 111.237 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.71 132.4 5.89 Favored Glycine 0 CA--C 1.503 -0.682 0 N-CA-C 110.35 -1.1 . . . . 73.45 110.35 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.439 HG23 HD12 ' B' ' 51' ' ' LEU . 80.5 mt -85.73 125.95 40.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 123.509 0.724 . . . . 75.44 109.164 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -133.06 160.93 35.75 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.421 1.088 . . . . 74.34 108.629 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.517 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 50.9 m -129.41 112.96 14.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.29 -1.004 . . . . 74.24 108.29 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.662 ' HB ' HD13 ' B' ' 89' ' ' ILE . 40.1 pt -119.31 144.45 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.228 1.011 . . . . 74.04 110.314 -173.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.435 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.57 156.65 33.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 73.33 109.092 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.72 -61.11 3.5 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.304 0.377 . . . . 73.2 112.542 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.662 HD13 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 133.59 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.524 0.73 . . . . 74.21 111.676 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -152.02 147.51 26.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.073 0.549 . . . . 74.14 110.433 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.42 -104.41 0.98 Allowed Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.468 -0.787 . . . . 53.35 112.506 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -78.58 -35.04 46.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 75.43 110.465 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -64.99 -41.71 95.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.329 0.652 . . . . 72.44 110.021 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 58.4 ttp -70.13 -37.43 75.3 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.813 -0.631 . . . . 73.4 110.66 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.19 75.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.066 0.547 . . . . 73.3 111.258 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.82 -41.8 59.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.504 0.722 . . . . 73.41 110.628 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.83 -65.53 0.73 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.85 -0.614 . . . . 63.04 110.235 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -34.42 78.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.277 1.031 . . . . 71.35 111.305 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.79 54.73 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.568 -0.573 . . . . 53.51 114.509 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.41 -57.84 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 117.824 0.812 . . . . 74.44 112.012 -173.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -61.88 -56.83 15.26 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.991 0.916 . . . . 72.51 112.036 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.499 ' HA ' HD13 ' B' ' 105' ' ' ILE . 61.9 m -62.39 -43.24 84.28 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 124.124 0.969 . . . . 72.53 112.808 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.38 -46.38 33.88 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.536 2.157 . . . . 74.43 112.757 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -20.44 63.58 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 123.719 0.808 . . . . 74.43 112.743 -177.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.499 HD13 ' HA ' ' B' ' 102' ' ' CYS . 73.3 mt -71.58 -52.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.022 0.529 . . . . 74.41 110.311 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 pp -91.41 -6.18 53.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.554 -0.748 . . . . 74.45 112.166 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.22 -44.36 88.46 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.58 1.152 . . . . 75.35 112.684 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -53.21 -34.82 71.11 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.674 2.25 . . . . 74.44 113.802 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -73.46 -42.57 61.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.16 0.584 . . . . 74.15 110.515 -178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.464 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -60.97 -42.31 98.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.132 0.573 . . . . 52.41 110.558 174.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 47.8 ttt-85 -57.27 -57.66 11.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.903 1.281 . . . . 73.13 111.089 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.03 -28.07 68.59 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.225 1.01 . . . . 75.45 110.876 -172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.739 ' SG ' HD12 ' B' ' 21' ' ' ILE . 8.1 t -74.0 -41.51 61.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.623 0.369 . . . . 73.41 110.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.562 HG22 HD21 ' B' ' 126' ' ' LEU . 63.1 mt -62.09 -41.68 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.375 -0.602 . . . . 74.35 109.375 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.569 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.5 m -62.28 -35.99 80.7 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.714 1.206 . . . . 64.52 111.449 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -70.01 -52.77 21.42 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.12 0.568 . . . . 73.21 109.875 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -65.43 -36.97 85.53 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.713 0.633 . . . . 74.14 112.028 -170.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 10.7 p -69.63 -34.12 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 122.481 0.312 . . . . 73.51 110.651 179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -77.05 -21.73 54.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.341 0.656 . . . . 70.23 111.066 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -73.54 -34.65 65.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.13 0.572 . . . . 75.23 109.822 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.71 5.65 45.14 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.706 0.629 . . . . 62.24 112.549 169.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 17' ' ' TYR . 49.4 p 59.43 46.83 11.87 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.614 1.965 . . . . 73.54 111.679 176.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -119.48 157.05 52.64 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 113.898 -1.501 . . . . 75.01 109.781 174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.437 ' HG3' ' O ' ' H' ' 300' ' ' ASN . 50.3 Cg_exo -55.57 143.89 76.73 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.902 2.401 . . . . 74.24 112.178 173.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.569 ' HB2' HG23 ' B' ' 115' ' ' THR . 3.4 pt20 -63.44 156.68 25.39 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.064 0.852 . . . . 71.35 111.993 -174.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.562 HD21 HG22 ' B' ' 114' ' ' ILE . 9.7 tt -125.23 105.01 8.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.353 -1.351 . . . . 75.32 107.353 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -91.44 115.72 28.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.997 -0.742 . . . . 70.44 108.997 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.615 HD13 HD22 ' B' ' 42' ' ' LEU . 1.1 mm? -67.16 107.56 2.37 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.197 -1.038 . . . . 74.24 108.197 166.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 158.05 54.68 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.127 0.971 . . . . 74.33 111.154 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -61.43 85.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 122.261 1.974 . . . . 74.12 112.153 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.07 110.79 22.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.269 -0.641 . . . . 75.45 109.269 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' B' ' 135' ' ' ALA . 22.8 t30 -82.3 104.22 12.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.256 -1.016 . . . . 73.15 108.256 173.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . 0.447 ' HE1' HD23 ' B' ' 44' ' ' LEU . 87.1 m-85 -58.94 -37.05 75.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.429 0.692 . . . . 74.41 111.306 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.74 -27.98 69.27 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.758 0.823 . . . . 73.22 111.68 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.497 ' HB3' ' ND2' ' B' ' 132' ' ' ASN . . . -64.74 -35.65 81.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.689 0.396 . . . . 71.42 110.902 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.9 mp -67.69 -45.49 75.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.302 0.641 . . . . 74.23 109.743 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -65.67 -35.63 81.34 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.018 -0.537 . . . . 74.3 111.391 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -70.8 -40.51 72.48 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.314 0.645 . . . . 75.01 110.39 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -75.48 -8.09 55.81 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.399 0.279 . . . . 74.4 111.6 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -79.05 -49.95 11.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.748 0.419 . . . . 75.24 110.946 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.8 -4.64 16.74 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.362 0.505 . . . . 75.34 112.362 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -136.82 139.56 41.83 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.327 0.584 . . . . 62.44 110.316 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.22 -178.26 6.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.279 1.032 . . . . 75.42 110.71 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -65.18 132.47 49.19 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.898 -0.592 . . . . 75.41 109.544 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.82 126.97 13.78 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.832 -0.803 . . . . 71.21 108.832 174.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.598 ' HA3' ' HG2' ' D' ' 8' ' ' GLU . . . -88.24 54.75 4.24 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.584 0.553 . . . . 73.01 112.539 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.36 170.94 9.02 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.922 0.889 . . . . 72.34 110.603 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.02 172.04 39.61 Favored Glycine 0 C--O 1.24 0.511 0 N-CA-C 110.912 -0.875 . . . . 72.13 110.912 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.2 m -142.55 142.77 32.25 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.201 -0.666 . . . . 61.44 109.201 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.15 107.63 19.72 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.861 0.864 . . . . 72.01 109.438 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.11 110.31 16.5 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.016 0.526 . . . . 73.11 110.116 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -85.42 141.69 29.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.196 -0.911 . . . . 65.21 109.983 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -149.43 131.71 15.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.988 0.915 . . . . 74.14 109.397 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -115.64 93.4 4.25 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.217 -1.031 . . . . 75.42 108.217 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.116 0 C-N-CA 124.113 0.965 . . . . 72.0 110.547 -176.552 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.689 -0.486 . . . . 75.45 109.689 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.6 p -170.04 177.24 4.36 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.702 0.801 . . . . 73.42 110.707 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.36 -176.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.656 1.182 . . . . 75.34 112.196 177.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -136.95 136.24 38.41 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.858 -0.423 . . . . 74.41 109.858 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -83.18 110.29 17.92 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.238 1.015 . . . . 73.4 110.33 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.429 ' OD1' ' HG2' ' C' ' 8' ' ' GLU . 23.2 t-20 -66.59 135.83 54.72 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.46 0.704 . . . . 73.51 109.457 170.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -118.55 78.0 1.22 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.567 0.747 . . . . 75.1 110.781 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.429 ' HG2' ' OD1' ' C' ' 6' ' ' ASN . 62.1 mm-40 -71.78 144.09 49.31 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.702 -0.681 . . . . 73.41 109.853 168.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.62 ' HA ' HD12 ' C' ' 89' ' ' ILE . 58.0 ttp 65.47 115.76 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.912 1.285 . . . . 74.03 113.133 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.6 m -93.77 80.52 4.21 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.588 -0.893 . . . . 72.2 108.588 173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -104.45 126.91 51.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.597 -0.729 . . . . 70.12 109.669 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.662 ' HG2' ' HB3' ' C' ' 85' ' ' SER . 1.6 pm0 -143.23 132.85 23.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.855 0.862 . . . . 72.33 109.808 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.601 HG21 ' HD3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -79.56 130.28 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.516 0.726 . . . . 72.31 109.213 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.444 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.6 mm100 -92.58 -54.2 3.88 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.398 -0.364 . . . . 72.52 110.104 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -169.02 126.84 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.825 0.45 . . . . 72.15 109.961 -173.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.556 HG13 HD12 ' C' ' 13' ' ' ILE . 80.0 mt -106.13 145.0 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.428 -1.323 . . . . 74.2 107.428 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 36.8 p90 -174.38 143.74 0.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.045 -0.724 . . . . 75.53 109.045 -177.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -69.84 111.35 5.52 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.644 -0.873 . . . . 65.51 108.644 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -65.36 -42.18 93.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.594 0.711 . . . . 73.41 109.506 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.61 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -149.06 141.87 24.63 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.433 -1.258 . . . . 73.24 108.951 -176.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.1 mt -130.46 143.43 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.092 -1.447 . . . . 73.22 107.092 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -152.87 151.29 30.22 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.41 0.624 . . . . 72.24 110.897 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 73.1 t80 -152.41 121.19 6.51 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 107.101 -1.444 . . . . 73.45 107.101 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.498 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.3 mt-10 -122.85 112.08 17.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.23 80.96 67.18 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.032 -1.099 . . . . 64.12 108.032 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.2 -36.65 16.08 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.169 1.912 . . . . 75.44 111.135 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.45 ' O ' HG21 ' C' ' 31' ' ' VAL . 1.7 m-20 -85.07 14.25 5.24 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.465 1.106 . . . . 73.34 111.174 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.3 -56.99 4.88 Favored Pre-proline 0 N--CA 1.497 1.88 0 C-N-CA 125.773 1.629 . . . . 75.23 114.599 -171.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.4 -29.43 13.74 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.754 1.636 . . . . 74.11 111.997 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -69.76 -24.92 63.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.211 1.004 . . . . 74.53 112.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.565 HG11 ' HH ' ' F' ' 297' ' ' TYR . 58.4 t -64.4 -26.87 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.246 0.218 . . . . 75.03 111.226 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.02 0.0 12.61 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.875 0.695 . . . . 75.34 112.875 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -127.97 9.17 6.28 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.393 0.677 . . . . 73.04 110.959 170.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.684 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 3.4 ttmp? -87.9 151.92 22.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.335 1.054 . . . . 74.2 111.229 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.36 125.82 26.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.805 1.242 . . . . 73.15 109.617 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -82.78 70.84 9.85 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.277 0.631 . . . . 74.31 110.181 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -163.08 71.38 1.97 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.154 0.581 . . . . 73.23 109.924 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.04 154.14 8.37 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.86 2.374 . . . . 72.24 110.629 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.14 88.08 7.61 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.522 -1.288 . . . . 73.43 107.522 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.502 HG23 ' NE1' ' F' ' 290' ' ' TRP . 3.5 m -59.04 137.34 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 114.4 -1.273 . . . . 73.43 109.948 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 8.8 tmtt? -135.99 115.77 13.04 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.026 0.531 . . . . 70.43 109.771 -166.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.58 130.37 34.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.024 0.929 . . . . 75.21 108.591 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.442 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.2 t70 -142.78 106.34 4.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.827 0.451 . . . . 62.4 109.933 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.42 123.02 49.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.463 0.705 . . . . 74.31 110.315 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.663 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 2.5 m-20 -111.71 154.29 25.2 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.426 -0.953 . . . . 75.1 108.426 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -113.35 111.69 22.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.672 0.789 . . . . 74.13 109.379 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.21 136.49 53.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.159 0.984 . . . . 74.15 108.914 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.5 p -134.85 156.68 48.48 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.999 0.52 . . . . 73.33 110.283 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.28 126.82 15.08 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.257 1.023 . . . . 63.43 108.376 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -88.25 117.25 27.02 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.105 -1.072 . . . . 73.0 108.105 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.52 HD13 HD13 ' C' ' 83' ' ' ILE . 58.3 mt -87.71 -40.47 14.09 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.502 -0.772 . . . . 72.24 109.521 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.75 -173.01 3.07 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.718 -1.128 . . . . 73.54 110.101 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.56 120.56 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.719 -1.128 . . . . 61.23 109.049 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 69.64 1.13 3.25 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.978 1.311 . . . . 74.4 112.831 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -112.01 95.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 107.757 -1.201 . . . . 72.34 107.757 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -119.64 125.59 49.1 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.759 0.824 . . . . 74.4 109.615 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.2 119.43 24.54 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.022 -0.99 . . . . 62.45 109.531 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.11 123.02 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.854 -1.165 . . . . 74.31 107.854 172.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.84 132.76 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.875 0.87 . . . . 73.54 108.699 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.78 112.23 23.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.38 -0.97 . . . . 73.24 108.38 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.663 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 1.6 tmm_? -82.53 104.18 12.61 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.847 -1.538 . . . . 72.44 106.847 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.22 133.22 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.264 -1.013 . . . . 62.44 108.264 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 94.3 m -128.77 133.88 48.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.159 -1.052 . . . . 72.11 108.159 175.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 39.1 t -121.43 112.2 34.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.751 -0.833 . . . . 71.53 108.751 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.484 HG21 HD23 ' C' ' 75' ' ' LEU . 2.2 m -99.74 148.72 24.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.704 -0.85 . . . . 75.14 108.704 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.96 108.43 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.342 -1.355 . . . . 75.3 107.342 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.0 m -146.67 139.85 25.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.06 -0.718 . . . . 73.33 109.06 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.92 45.99 0.94 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.131 0.972 . . . . 73.43 109.228 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.88 -116.61 4.05 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 114.795 -1.093 . . . . 74.41 111.043 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 -19.85 26.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.318 0.647 . . . . 73.31 110.024 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.684 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 12.4 tp10 -81.31 99.84 8.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.178 0.991 . . . . 73.44 109.252 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -87.96 131.25 34.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.984 0.421 . . . . 75.1 110.602 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.672 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -79.0 -64.0 1.29 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.616 1.166 . . . . 71.5 110.385 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -163.34 176.57 9.74 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.586 0.708 . . . . 71.23 110.149 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.498 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.9 tm? -141.56 139.13 33.1 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.603 -1.628 . . . . 74.34 106.603 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.585 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 50.0 t -143.87 116.25 8.54 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.029 -0.73 . . . . 73.25 109.029 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -124.77 131.96 53.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.515 0.726 . . . . 72.21 109.414 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -132.99 115.73 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.233 1.013 . . . . 75.31 109.386 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.649 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 40.4 mt-30 -89.45 91.25 8.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.319 1.048 . . . . 71.32 108.209 172.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -88.79 119.04 28.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.321 -0.854 . . . . 75.2 110.122 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.39 159.3 15.04 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 123.588 0.555 . . . . 64.2 112.26 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.04 119.13 0.88 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.567 -1.013 . . . . 74.12 110.567 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.52 HD13 HD13 ' C' ' 51' ' ' LEU . 18.2 mm -79.78 122.08 34.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.607 -1.257 . . . . 75.11 107.607 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.72 124.79 36.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.548 0.739 . . . . 73.25 109.233 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.662 ' HB3' ' HG2' ' C' ' 12' ' ' GLN . 10.5 t -87.46 109.84 19.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.091 -1.077 . . . . 60.24 108.091 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.407 HD12 ' SD ' ' C' ' 94' ' ' MET . 22.6 pt -115.32 123.24 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.801 1.24 . . . . 73.44 109.205 -175.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.75 170.42 19.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.816 0.446 . . . . 72.34 111.726 -171.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.34 -48.34 1.92 Allowed Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.372 -0.831 . . . . 33.12 113.149 170.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.62 HD12 ' HA ' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.74 176.32 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.401 0.681 . . . . 62.54 110.929 -174.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.48 -171.23 3.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.028 0.931 . . . . 72.32 109.196 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.592 ' HA2' ' HB2' ' F' ' 275' ' ' LYS . . . 69.08 -147.98 47.02 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.527 0.517 . . . . 73.3 113.193 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 73.7 p -67.9 -18.69 64.86 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.007 0.923 . . . . 73.35 111.733 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.558 ' HG3' ' HB3' ' F' ' 272' ' ' ASN . 17.6 mt-30 -66.25 -43.95 85.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.684 0.794 . . . . 75.1 110.278 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.407 ' SD ' HD12 ' C' ' 86' ' ' ILE . 3.5 tmm? -81.32 -44.56 17.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.518 -0.765 . . . . 73.51 109.189 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' F' ' 280' ' ' LEU . . . -61.8 -25.67 67.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.237 1.015 . . . . 64.04 112.117 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 28.0 t-80 -58.56 -47.16 85.17 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.701 0.8 . . . . 71.14 110.334 171.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.86 -55.07 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.352 -0.386 . . . . 73.21 111.292 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tt -62.09 -35.83 79.87 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.014 0.525 . . . . 74.34 111.462 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.0 -4.86 62.91 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.045 -0.864 . . . . 73.21 114.437 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.35 -53.07 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 118.558 1.179 . . . . 74.52 112.681 -176.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.76 -48.18 60.26 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.973 0.509 . . . . 74.35 112.121 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.28 -43.76 94.29 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.449 0.7 . . . . 75.22 111.988 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.94 -47.37 21.69 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.78 2.32 . . . . 65.43 113.909 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -62.37 -29.12 70.25 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.392 0.677 . . . . 64.35 112.178 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -75.1 -50.84 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.926 0.491 . . . . 72.03 110.252 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.14 -18.41 53.23 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.909 -0.587 . . . . 73.44 112.225 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.52 -54.6 53.27 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.677 -1.154 . . . . 71.31 112.702 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.79 -32.2 92.63 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.939 1.759 . . . . 75.1 112.843 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -66.45 -47.32 73.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.541 0.737 . . . . 73.3 110.962 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.91 84.62 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.122 0.569 . . . . 72.15 110.524 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.583 ' HG3' HD22 ' C' ' 128' ' ' LEU . 56.2 ttt180 -61.1 -49.17 78.4 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.907 1.283 . . . . 75.13 110.943 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.34 -29.99 69.69 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.619 0.574 . . . . 73.14 110.082 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.493 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.0 t -73.91 -36.56 64.73 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.182 0.593 . . . . 74.22 111.42 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.585 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 91.7 mt -68.63 -47.85 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.486 0.714 . . . . 75.22 109.754 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 98.7 m -60.45 -35.78 76.67 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.077 1.351 . . . . 71.34 111.306 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -41.68 80.67 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.51 0.724 . . . . 74.45 109.844 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.59 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.37 -35.09 78.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.334 0.654 . . . . 75.44 111.796 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.445 HG22 ' O ' ' C' ' 114' ' ' ILE . 96.7 t -62.56 -44.11 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.407 0.683 . . . . 73.31 109.896 173.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.7 p -75.03 -25.78 58.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.549 -0.75 . . . . 75.14 112.223 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.513 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.2 mtt-85 -74.58 -40.17 61.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.69 0.796 . . . . 74.43 110.391 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 3.1 66.13 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.736 0.647 . . . . 72.03 112.56 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.424 HG22 ' O ' ' D' ' 16' ' ' ILE . 43.0 p 61.31 24.32 14.44 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.154 1.781 . . . . 72.31 112.533 170.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -83.88 154.65 64.6 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.739 -1.119 . . . . 74.12 110.118 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.751 ' HD3' HD11 ' F' ' 301' ' ' ILE . 92.9 Cg_exo -47.71 137.16 21.27 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.483 2.789 . . . . 75.12 113.154 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' B' ' 125' ' ' GLN . 23.7 mm-40 -60.95 147.26 43.91 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.205 1.187 . . . . 63.21 114.205 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 68.3 tp -125.14 96.1 4.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.483 -1.235 . . . . 75.35 108.693 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.8 105.1 16.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.489 -0.93 . . . . 74.42 108.489 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.583 HD22 ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -71.15 151.26 44.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.699 0.8 . . . . 74.42 111.935 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.09 155.61 72.35 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 115.151 -0.931 . . . . 74.21 109.946 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.611 ' HG2' HG21 ' A' ' 13' ' ' ILE . 34.4 Cg_exo -60.54 102.63 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.375 2.05 . . . . 65.33 111.95 171.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.18 106.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 106.7 -1.592 . . . . 74.42 106.7 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.404 ' ND2' HD13 ' A' ' 105' ' ' ILE . 78.7 m-20 -113.03 91.63 3.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.109 -0.951 . . . . 74.51 109.767 -169.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.52 ' HD1' ' SD ' ' F' ' 286' ' ' MET . 89.9 m-85 -64.35 -43.91 93.1 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 74.11 110.878 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.75 -38.77 70.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.245 -0.889 . . . . 74.24 111.419 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.59 -28.84 68.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.413 -0.812 . . . . 70.51 111.63 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 61.9 tp -54.45 -45.57 73.11 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.693 0.797 . . . . 73.54 110.668 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -64.58 -43.07 95.03 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.772 -0.649 . . . . 74.13 111.008 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 59.5 mtt -60.35 -42.96 96.81 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.076 0.95 . . . . 75.24 112.714 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -60.31 -36.56 78.18 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.601 0.76 . . . . 72.04 112.57 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -61.85 -83.35 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.188 0.995 . . . . 73.23 112.238 -171.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.87 105.58 5.2 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.28 0.632 . . . . 63.12 110.878 -173.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.39 130.4 36.48 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.552 -1.277 . . . . 73.25 107.552 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -78.71 -73.63 0.32 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.153 0.581 . . . . 73.53 110.09 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -172.76 -179.7 2.17 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.861 0.865 . . . . 75.24 110.059 -173.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.53 140.73 42.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.136 0.974 . . . . 71.31 108.774 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.97 -134.86 5.38 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.121 -0.792 . . . . 75.23 111.121 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -111.46 175.47 5.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.294 0.638 . . . . 75.33 110.569 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.13 -154.43 11.6 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.012 -0.995 . . . . 71.1 110.964 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.2 m 51.51 53.8 12.16 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.795 1.238 . . . . 74.14 111.943 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -123.36 94.13 4.16 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 108.674 -0.862 . . . . 75.14 108.674 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.57 106.93 15.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.994 -1.003 . . . . 74.13 110.358 -177.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -109.57 136.67 48.57 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.72 -0.844 . . . . 75.11 108.72 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -145.92 137.77 25.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.686 0.794 . . . . 73.52 109.507 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -153.68 155.98 37.01 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.133 0.973 . . . . 65.35 109.308 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 N-CA-C 108.985 -0.746 . . . . 72.53 108.985 -178.101 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.918 -0.401 . . . . 70.52 109.918 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.4 t -132.13 81.66 1.98 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.448 -1.316 . . . . 72.22 107.448 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -79.02 -52.98 7.49 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.153 -0.93 . . . . 73.1 111.689 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 69.05 -66.84 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.416 1.486 . . . . 74.51 110.813 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.76 39.25 8.63 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.113 1.365 . . . . 64.12 110.843 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -119.76 -64.64 1.24 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.078 0.951 . . . . 53.32 108.908 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -153.2 83.22 1.2 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.121 0.968 . . . . 71.35 109.547 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.598 ' HG2' ' HA3' ' B' ' 146' ' ' GLY . 4.6 mp0 -90.2 -165.32 1.32 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.365 0.666 . . . . 70.13 109.796 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.1 ttp -33.28 125.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.249 1.02 . . . . 74.12 111.961 167.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.8 m -129.96 137.53 50.38 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.11 -0.7 . . . . 72.42 109.11 175.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' D' ' 85' ' ' SER . 29.1 t80 -157.79 98.62 1.65 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.057 -1.46 . . . . 74.24 107.057 179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -130.18 128.1 41.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.652 -1.24 . . . . 74.43 107.652 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.401 ' O ' ' HB ' ' F' ' 306' ' ' VAL . 17.5 mt -70.87 136.28 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 123.685 0.616 . . . . 72.12 110.329 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.626 ' HA ' ' HB3' ' F' ' 304' ' ' PRO . 73.7 mt-30 -94.71 -47.54 6.45 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.682 -0.69 . . . . 74.44 110.29 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.04 145.88 22.48 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.3 0.64 . . . . 71.32 110.558 -166.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.424 ' O ' HG22 ' C' ' 122' ' ' THR . 1.1 mp -133.23 137.02 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 105.033 -2.21 . . . . 75.24 105.033 169.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -169.22 153.3 5.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.634 0.73 . . . . 74.41 110.691 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -84.4 118.43 24.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.688 -0.856 . . . . 74.2 108.688 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 39.4 mtpt -80.2 -37.61 32.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 74.21 110.228 176.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.402 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 22.3 t70 -151.1 140.87 21.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.914 -1.039 . . . . 72.43 109.129 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.59 HG23 ' HE1' ' C' ' 117' ' ' MET . 67.1 mt -135.98 145.65 30.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 124.252 1.021 . . . . 73.44 108.25 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 22' ' ' SER . . . . . 0.458 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 45.2 t -147.88 133.52 18.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 62.11 108.244 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.4 t80 -144.68 117.58 8.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.849 -1.908 . . . . 71.11 105.849 170.218 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.14 129.0 51.93 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.294 -0.632 . . . . 71.31 109.294 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.21 79.67 27.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.205 -1.035 . . . . 73.04 108.205 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.86 -28.28 20.15 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.66 2.24 . . . . 72.25 112.743 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -113.71 40.69 2.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.501 -0.925 . . . . 74.12 108.501 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.433 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -58.97 -65.08 2.22 Favored Pre-proline 0 CA--C 1.568 1.666 0 N-CA-C 114.139 1.163 . . . . 72.43 114.139 -167.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.498 ' HB3' HD11 ' C' ' 83' ' ' ILE . 61.6 Cg_endo -81.82 -11.0 11.53 Favored 'Trans proline' 0 C--N 1.393 2.901 0 CA-C-N 122.624 1.973 . . . . 74.34 112.067 177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -71.4 -42.9 67.78 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.931 1.292 . . . . 75.14 110.107 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.23 -35.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 N-CA-C 109.504 -0.554 . . . . 74.51 109.504 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -58.05 -12.13 3.12 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.395 1.078 . . . . 74.11 113.55 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.64 -36.55 51.42 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.181 0.593 . . . . 75.45 110.685 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 60.97 1.67 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.861 0.464 . . . . 75.21 111.399 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -98.6 101.23 12.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.675 . . . . 73.11 111.044 -169.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -122.59 -158.98 0.81 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.195 0.998 . . . . 75.13 108.671 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -58.24 106.52 0.71 Allowed Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.539 0.736 . . . . 74.3 110.589 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.35 122.21 5.06 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.819 2.346 . . . . 71.52 110.515 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.96 111.28 6.22 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.902 -1.148 . . . . 72.41 107.902 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.581 HG21 ' HE1' ' G' ' 290' ' ' TRP . 29.3 m -100.9 144.86 12.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.318 0.647 . . . . 73.31 110.081 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -120.05 129.22 54.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 74.35 108.468 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.01 112.11 24.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.506 -0.553 . . . . 75.23 109.506 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.753 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 12.9 m-20 -108.07 132.05 53.96 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.994 0.918 . . . . 75.21 109.912 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . 0.525 HD12 HG12 ' G' ' 288' ' ' VAL . 5.0 mp -110.8 131.41 55.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.262 0.625 . . . . 73.12 109.434 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.529 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.8 t70 -133.55 131.46 39.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.487 -1.301 . . . . 52.41 107.487 172.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -105.52 141.81 36.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.98 0.512 . . . . 74.41 109.883 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.64 164.04 37.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.787 0.835 . . . . 70.32 109.071 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.543 ' HB2' HD11 ' G' ' 278' ' ' LEU . 51.1 p -174.92 161.04 2.94 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.376 0.67 . . . . 74.32 110.896 -178.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 86.6 p -152.17 145.71 24.91 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.76 0.824 . . . . 73.43 109.474 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -81.92 130.93 35.22 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.284 -0.636 . . . . 73.51 109.284 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.464 HD11 ' HB2' ' D' ' 57' ' ' GLU . 54.6 mt -104.38 -34.93 8.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.134 0.573 . . . . 75.4 109.511 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . 0.449 ' HB2' ' HB ' ' D' ' 55' ' ' VAL . . . -162.51 -174.88 4.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.159 0.584 . . . . 71.24 111.082 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.34 116.14 7.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.535 -1.211 . . . . 71.42 109.189 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 68.05 7.25 5.7 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.465 1.106 . . . . 64.14 112.126 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' D' ' 52' ' ' ALA . 88.1 t -113.51 119.06 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.322 1.049 . . . . 71.33 108.533 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.515 ' HH ' ' HB2' ' G' ' 277' ' ' LEU . 92.9 m-85 -139.49 134.2 31.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.705 0.402 . . . . 75.12 110.055 -175.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.464 ' HB2' HD11 ' D' ' 51' ' ' LEU . 11.0 tt0 -88.22 114.5 24.9 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.857 -1.164 . . . . 73.43 107.857 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.09 120.11 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.617 -1.253 . . . . 75.55 107.617 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.411 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.9 t -105.61 131.93 53.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.668 0.787 . . . . 73.31 109.064 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.24 108.15 13.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.497 -1.297 . . . . 75.0 107.497 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.529 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.3 ttm-85 -84.11 106.24 15.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.991 -0.744 . . . . 74.22 108.991 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.26 130.49 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.267 -1.012 . . . . 73.22 108.267 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.753 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 54.2 m -124.73 147.47 48.62 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.429 0.691 . . . . 75.15 109.15 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -135.95 115.74 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.666 1.186 . . . . 74.24 109.07 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.5 m -106.29 103.63 13.15 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 74.11 109.446 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.18 125.06 41.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.456 0.302 . . . . 70.21 110.386 -178.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 52.2 p -125.55 125.47 43.27 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.001 0.92 . . . . 73.11 109.359 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.497 ' HB2' ' HB2' ' D' ' 73' ' ' ALA . 3.2 tm? -104.47 114.05 28.02 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.455 -0.943 . . . . 75.13 108.455 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -111.22 3.84 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.621 0.575 . . . . 34.52 111.998 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 8.38 19.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.12 0.968 . . . . 74.42 110.97 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 175.26 9.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.492 0.717 . . . . 73.34 110.119 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -80.28 137.06 36.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.495 0.718 . . . . 74.42 111.07 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.497 ' HB2' ' HB2' ' D' ' 68' ' ' LEU . . . -84.89 -63.97 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.718 -0.845 . . . . 71.51 108.718 170.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.46 168.67 24.75 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.423 -1.262 . . . . 73.21 109.994 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 97.7 mt -132.7 151.62 51.93 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.89 -1.152 . . . . 74.24 107.89 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.598 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -154.9 141.29 18.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.155 0.582 . . . . 74.34 109.939 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.458 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 33.3 tt0 -158.14 134.68 9.59 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 71.13 109.995 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.94 126.23 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.746 0.818 . . . . 74.42 109.302 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -97.22 87.22 4.12 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.678 -1.23 . . . . 72.01 107.678 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.89 98.76 8.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.847 -0.615 . . . . 70.12 109.562 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.49 144.36 17.13 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.596 -0.729 . . . . 60.42 111.698 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.49 131.05 3.74 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.314 -0.715 . . . . 73.05 111.314 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -90.33 126.98 43.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.376 -0.972 . . . . 70.12 108.376 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -126.96 144.39 51.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.01 0.924 . . . . 64.2 110.075 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 4.4 m -96.81 94.51 7.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.51 -0.922 . . . . 74.25 108.51 174.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.49 HG23 ' HE3' ' D' ' 94' ' ' MET . 15.1 mt -108.78 101.06 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.361 -0.607 . . . . 74.5 109.361 -175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.42 1.088 . . . . 61.34 109.838 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.81 -11.33 59.97 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 114.343 0.497 . . . . 64.14 114.343 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.21 154.46 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.021 0.928 . . . . 74.31 110.781 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 -174.52 4.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.283 1.033 . . . . 75.33 110.043 172.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.54 -140.51 39.01 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 114.282 0.473 . . . . 71.0 114.282 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.9 p -70.84 -32.6 69.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.315 1.046 . . . . 75.12 112.037 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.19 -43.45 78.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.715 0.806 . . . . 72.34 110.649 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.49 ' HE3' HG23 ' D' ' 86' ' ' ILE . 1.3 tmt? -74.06 -32.81 63.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.811 -0.631 . . . . 72.33 110.506 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.431 ' HB1' ' HB2' ' G' ' 280' ' ' LEU . . . -60.38 -43.37 96.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.943 0.497 . . . . 65.31 110.461 174.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.09 -36.05 76.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.715 0.806 . . . . 74.4 110.884 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.54 -50.43 67.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.864 0.465 . . . . 75.43 111.498 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.488 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 2.9 pp -75.63 -23.35 56.35 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 111.974 0.361 . . . . 74.45 111.974 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . 0.444 ' HA3' HD22 ' G' ' 280' ' ' LEU . . . -99.33 -0.98 56.84 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.53 -0.595 . . . . 72.4 114.361 -172.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.6 -60.69 0.51 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.241 0.52 . . . . 53.2 111.068 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -68.18 -45.71 72.71 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.577 0.751 . . . . 73.45 111.51 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.488 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 63.5 m -65.66 -45.76 67.06 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-O 118.695 -0.669 . . . . 74.32 112.018 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -54.25 -34.93 81.62 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.665 2.243 . . . . 70.32 113.908 168.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -66.85 -26.43 66.9 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.85 0.46 . . . . 75.3 111.775 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 32.6 mm -75.71 -47.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.165 0.586 . . . . 74.55 109.775 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.02 -32.23 59.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.154 -0.93 . . . . 70.34 112.609 -169.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -62.71 -44.57 86.75 Favored Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 118.177 -0.916 . . . . 65.22 113.042 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.98 -39.02 80.48 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.552 2.168 . . . . 63.33 113.996 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -79.87 -28.31 39.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.156 0.582 . . . . 75.53 111.906 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.21 66.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.798 -0.815 . . . . 65.43 108.798 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -60.84 -35.08 75.63 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.003 1.321 . . . . 73.14 111.396 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.513 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.0 tt0 -56.05 -53.54 55.74 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.021 0.928 . . . . 75.23 110.424 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.8 t -67.25 -42.3 84.14 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.806 -1.088 . . . . 71.42 111.306 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.598 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.7 mt -58.57 -60.05 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.822 0.849 . . . . 54.1 110.486 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.431 HG23 ' HB3' ' D' ' 125' ' ' GLN . 97.6 m -52.51 -43.56 65.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.512 1.125 . . . . 72.31 112.1 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.9 t -68.15 -36.96 80.49 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.501 -0.772 . . . . 73.02 111.014 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.517 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 77.7 mtm -67.87 -37.77 82.22 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.662 0.385 . . . . 55.34 111.315 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.9 t -65.41 -41.6 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.324 -0.853 . . . . 73.33 110.337 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 78.3 p -72.28 -30.47 64.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.162 0.585 . . . . 73.14 111.388 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.51 -29.95 65.38 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.927 0.491 . . . . 74.33 110.56 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 6.67 73.66 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.591 0.557 . . . . 75.15 112.456 174.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 60.5 25.45 15.08 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 126.591 1.956 . . . . 74.33 113.342 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.18 159.68 31.57 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.575 1.15 . . . . 72.24 108.441 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.434 ' HD3' ' CZ ' ' G' ' 297' ' ' TYR . 61.5 Cg_endo -69.76 135.01 29.36 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.473 2.116 . . . . 73.3 111.021 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.431 ' HB3' HG23 ' D' ' 115' ' ' THR . 26.7 mt-30 -49.19 120.03 3.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.381 1.051 . . . . 74.15 110.842 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.02 94.05 5.03 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.501 -0.925 . . . . 75.35 108.501 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -100.65 104.23 15.54 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.207 -1.361 . . . . 73.32 107.946 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.37 143.76 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.863 -0.608 . . . . 73.31 111.459 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.554 ' HB1' HG23 ' E' ' 306' ' ' VAL . . . -63.46 133.3 95.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 114.968 -1.014 . . . . 63.45 110.757 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -80.39 124.61 5.37 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.643 2.229 . . . . 73.02 111.119 -176.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.516 HG23 HD21 ' G' ' 291' ' ' LEU . 60.3 t -107.72 109.36 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.628 -0.879 . . . . 72.44 108.628 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -72.63 96.37 1.98 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.043 -1.095 . . . . 73.44 108.043 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -62.19 -31.1 71.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.302 0.641 . . . . 72.34 112.023 -174.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -54.84 -37.3 66.01 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.844 0.857 . . . . 75.53 111.346 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.36 97.39 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.536 0.735 . . . . 74.22 110.707 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.03 -42.28 94.47 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.919 0.762 . . . . 75.02 110.631 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -64.83 -41.86 95.41 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.812 -0.631 . . . . 71.35 111.211 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.5 mtm -72.83 -30.42 64.02 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.994 0.518 . . . . 70.43 111.52 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.465 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 79.6 m-20 -60.19 -37.72 81.08 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.542 0.737 . . . . 72.02 110.426 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -56.86 -31.7 65.08 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.121 0.969 . . . . 75.11 111.055 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.9 -48.84 8.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.015 0.526 . . . . 74.3 111.583 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.465 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 13.8 pt20 -89.02 33.33 0.79 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.293 0.849 . . . . 75.11 113.293 -164.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -116.62 48.63 1.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.733 -1.21 . . . . 73.14 107.733 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -143.52 -55.11 0.38 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.208 -1.815 . . . . 65.05 107.188 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.45 111.43 10.72 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.678 -0.86 . . . . 72.32 108.678 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.14 120.47 5.62 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.817 0.698 . . . . 61.34 111.789 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.67 110.43 11.37 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.911 -1.144 . . . . 72.22 107.911 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' B' ' 5' ' ' ASN . . . -158.83 143.58 9.42 Favored Glycine 0 C--N 1.34 0.75 0 N-CA-C 110.781 -0.928 . . . . 53.04 110.781 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 72.1 p -86.2 -13.17 47.71 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 117.585 0.693 . . . . 72.24 112.04 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -78.92 151.83 31.48 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.184 0.994 . . . . 72.11 109.44 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.01 -164.51 1.15 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.074 0.949 . . . . 75.03 113.15 -168.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . 0.605 ' HE1' ' HB2' ' D' ' 155' ' ' ALA . 52.9 t-80 -126.75 147.45 49.98 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 124.58 1.152 . . . . 75.41 109.033 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -73.65 -179.47 3.6 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.684 0.794 . . . . 75.33 111.911 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.25 93.69 1.12 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.834 0.454 . . . . 75.33 110.768 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . 0.605 ' HB2' ' HE1' ' D' ' 152' ' ' HIS . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 124.568 1.147 . . . . 74.2 108.106 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 109.074 -0.713 . . . . 74.32 109.074 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . 0.414 ' HA ' HE22 ' E' ' 274' ' ' GLN . 88.2 m-20 -117.03 75.88 1.0 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.508 0.723 . . . . 71.5 110.46 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -120.11 22.09 11.55 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.126 -0.943 . . . . 74.54 109.301 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . 0.414 HE22 ' HA ' ' E' ' 272' ' ' ASN . 1.6 mp0 -74.26 118.18 16.92 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 124.198 0.999 . . . . 74.4 109.759 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -107.65 98.38 24.17 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.139 0.976 . . . . 73.31 108.381 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.7 88.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.906 2.404 . . . . 74.1 112.368 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 41.4 tp -73.45 -24.28 60.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.706 -1.134 . . . . 71.12 109.75 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 pp -76.56 169.43 18.28 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.093 -0.958 . . . . 73.32 110.896 172.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -158.63 -68.29 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.294 -0.722 . . . . 62.33 111.294 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.476 HD12 ' HB1' ' A' ' 95' ' ' ALA . 3.2 tm? -74.12 123.21 24.0 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.802 0.441 . . . . 73.34 110.535 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . 0.49 ' CZ ' ' HB ' ' A' ' 46' ' ' THR . 1.6 t80 -167.9 13.91 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.601 1.188 . . . . 72.24 109.406 170.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -79.44 -16.44 56.13 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.704 0.801 . . . . 72.41 112.037 -173.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.25 -72.89 0.14 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.608 -0.886 . . . . 72.53 108.608 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 67.16 -80.59 0.14 Allowed Glycine 0 C--N 1.352 1.435 0 O-C-N 123.882 0.739 . . . . 72.05 114.789 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -78.22 105.79 9.69 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.878 0.871 . . . . 73.33 109.762 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -78.53 143.85 64.43 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.767 -0.827 . . . . 65.21 108.767 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.55 40.92 1.04 Allowed 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.493 2.796 . . . . 72.04 113.278 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 98.4 t -71.25 -52.87 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.896 0.879 . . . . 61.41 110.3 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 62.16 -77.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.153 1.381 . . . . 71.51 109.984 -170.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -134.18 144.55 48.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.571 0.748 . . . . 74.51 109.754 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.712 HD12 ' HB3' ' A' ' 129' ' ' ALA . 5.2 mp -83.24 -46.01 13.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.996 0.918 . . . . 71.11 109.879 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -157.14 144.8 11.06 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.041 -0.866 . . . . 75.51 111.152 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.62 133.29 29.36 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.74 2.293 . . . . 73.04 111.198 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . 0.541 ' HB3' ' HA ' ' G' ' 306' ' ' VAL . 0.0 OUTLIER -155.91 15.68 0.35 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.86 0.864 . . . . 73.0 111.359 -176.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 66.3 157.05 0.11 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.173 1.389 . . . . 73.21 112.483 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 296' ' ' THR . . . . . 0.408 ' HG1' HG22 ' A' ' 40' ' ' VAL . 27.9 m -99.62 -43.87 6.34 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.525 -0.917 . . . . 71.05 108.525 171.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.419 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 51.0 m-85 -78.79 110.59 14.09 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.965 -1.016 . . . . 74.43 110.58 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -116.65 8.14 13.74 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.638 1.175 . . . . 72.35 111.393 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . 0.467 ' HA3' ' HB ' ' G' ' 301' ' ' ILE . . . 108.86 101.01 2.67 Favored Glycine 0 C--N 1.361 1.944 0 N-CA-C 115.05 0.78 . . . . 74.24 115.05 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -162.05 -110.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.191 -1.411 . . . . 75.31 107.191 168.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 48.1 mm 68.02 -14.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.883 0 C-N-CA 125.956 1.702 . . . . 74.1 114.713 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 48.93 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.563 1.545 . . . . 64.43 112.389 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -71.77 129.65 88.03 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 119.123 -0.465 . . . . 74.41 109.958 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -41.68 110.89 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 123.911 3.074 . . . . 42.42 113.991 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -109.9 -176.53 3.03 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.27 1.028 . . . . 70.22 109.616 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . 0.554 HG23 ' HB1' ' D' ' 129' ' ' ALA . 59.2 t 68.69 126.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 124.672 1.189 . . . . 74.31 111.844 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 307' ' ' THR . . . . . 0.496 ' H ' ' HA3' ' G' ' 292' ' ' GLY . 62.3 m -74.58 -66.71 0.71 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.21 -0.663 . . . . 72.54 109.21 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 91.0 m -159.35 160.47 35.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.603 0.761 . . . . 73.34 110.941 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 7.0 m -128.33 84.21 63.87 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 107.647 -1.242 . . . . 63.0 107.647 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 C--N 1.377 2.048 0 C-N-CA 123.289 2.659 . . . . 75.31 111.035 174.369 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.01 -0.367 . . . . 63.52 110.01 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . 0.558 ' HB3' ' HG3' ' C' ' 93' ' ' GLN . 85.1 m-20 74.25 -67.47 0.26 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.169 1.788 . . . . 74.12 112.914 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -73.09 -158.35 0.05 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.556 1.142 . . . . 73.04 112.289 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 76.06 11.26 3.01 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.255 1.422 . . . . 71.42 109.89 -172.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . 0.592 ' HB2' ' HA2' ' C' ' 91' ' ' GLY . 97.1 mttt -132.29 134.22 24.7 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 124.502 1.121 . . . . 74.14 108.564 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.73 160.64 14.22 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.745 2.297 . . . . 72.02 112.446 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.39 -60.1 4.15 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.61 0.764 . . . . 72.22 110.817 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.49 93.2 0.34 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.039 0.535 . . . . 72.01 110.088 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -166.02 158.11 30.87 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.751 -0.94 . . . . 64.14 110.751 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' C' ' 95' ' ' ALA . 5.2 tt 60.85 75.99 0.39 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.366 1.066 . . . . 73.21 108.795 -176.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -170.96 45.11 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.773 0.797 . . . . 74.32 109.621 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -151.95 97.2 2.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.689 0.796 . . . . 73.44 109.485 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 57.49 77.31 0.28 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.757 1.223 . . . . 74.01 111.511 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -148.59 30.95 1.26 Allowed Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.297 -0.865 . . . . 71.43 112.207 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -74.22 137.63 43.17 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.921 -0.77 . . . . 73.13 108.921 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 286' ' ' MET . . . . . 0.52 ' SD ' ' HD1' ' C' ' 133' ' ' PHE . 1.0 OUTLIER -64.43 158.27 67.26 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.365 1.066 . . . . 63.43 109.953 178.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.21 77.88 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.641 2.227 . . . . 61.54 112.517 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 64.0 t -104.17 84.87 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.522 1.129 . . . . 75.11 108.775 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -82.83 -76.34 0.28 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 106.198 -1.778 . . . . 75.15 106.198 168.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . 0.502 ' NE1' HG23 ' C' ' 40' ' ' VAL . 54.2 m95 -152.66 -177.62 6.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.346 1.058 . . . . 74.03 109.872 170.054 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.84 86.34 2.17 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.709 -1.589 . . . . 75.1 106.709 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 108.21 136.49 7.9 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 114.922 -1.035 . . . . 73.53 110.601 -167.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.38 122.27 11.25 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 123.158 2.572 . . . . 74.34 112.563 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . 0.513 ' HB2' ' HZ2' ' F' ' 294' ' ' LYS . 7.9 mtmp? 68.38 176.01 0.27 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.338 1.455 . . . . 74.21 112.656 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -169.69 135.66 1.52 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 113.823 -1.535 . . . . 63.22 107.378 170.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 296' ' ' THR . . . . . 0.604 HG23 ' HD1' ' F' ' 297' ' ' TYR . 56.0 m 73.01 159.91 0.23 Allowed 'General case' 0 CA--C 1.568 1.648 0 O-C-N 123.73 0.644 . . . . 74.1 112.696 169.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.604 ' HD1' HG23 ' F' ' 296' ' ' THR . 5.1 m-85 65.83 78.16 0.28 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.936 1.294 . . . . 75.3 112.072 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -153.36 157.44 40.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.086 0.955 . . . . 74.42 109.043 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' H' ' 299' ' ' GLY . . . 86.43 -131.75 10.72 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.906 -0.588 . . . . 54.23 112.16 -174.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.57 129.81 11.24 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.135 0.574 . . . . 73.13 110.121 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.751 HD11 ' HD3' ' C' ' 124' ' ' PRO . 38.7 pt -117.45 14.99 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 124.284 1.033 . . . . 74.2 110.347 173.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -93.9 -174.24 3.37 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.488 1.115 . . . . 71.5 109.455 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? 74.23 108.24 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.412 1.485 . . . . 72.24 111.833 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . 0.626 ' HB3' ' HA ' ' D' ' 14' ' ' GLN . 35.5 Cg_exo -60.5 104.73 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.02 2.48 . . . . 74.34 111.739 173.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -92.84 -5.71 50.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.898 0.479 . . . . 74.44 111.141 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . 0.455 ' HA ' HD22 ' H' ' 291' ' ' LEU . 19.3 t -76.93 -13.34 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 123.715 0.806 . . . . 74.24 111.017 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 8.3 t -70.23 78.12 0.53 Allowed 'General case' 0 CA--C 1.563 1.475 0 CA-C-O 122.08 0.943 . . . . 73.4 111.11 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 52.3 t -172.44 -36.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.427 1.091 . . . . 54.3 109.509 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 3.3 t -104.65 106.32 54.14 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.027 0.931 . . . . 73.51 109.933 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 CA--C 1.565 2.067 0 C-N-CA 122.698 2.265 . . . . 71.2 110.846 169.682 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.451 -0.203 . . . . 51.05 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -159.34 -30.15 0.07 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.236 0.615 . . . . 74.32 111.265 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -62.95 -33.01 74.46 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.74 0.816 . . . . 74.45 111.744 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -69.8 155.63 40.25 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.498 -0.556 . . . . 74.5 109.498 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . 0.554 ' H ' ' HD3' ' G' ' 275' ' ' LYS . 0.0 OUTLIER -104.21 141.19 22.01 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 122.888 0.475 . . . . 74.22 110.017 -178.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.55 142.55 71.83 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.786 2.324 . . . . 75.34 111.609 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.515 ' HB2' ' HH ' ' D' ' 56' ' ' TYR . 69.7 mt 67.62 22.05 9.21 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.884 1.274 . . . . 63.54 112.227 176.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' D' ' 48' ' ' SER . 14.6 tp -159.45 98.25 1.39 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.896 -0.779 . . . . 73.53 108.896 174.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -174.42 -140.29 3.23 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.799 -0.637 . . . . 63.14 112.232 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . 0.444 HD22 ' HA3' ' D' ' 99' ' ' GLY . 43.4 tp 67.59 -58.55 0.43 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 126.879 2.071 . . . . 75.43 112.61 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -44.19 -58.53 2.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.731 1.213 . . . . 70.0 111.379 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . 57.04 -86.95 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.621 1.169 . . . . 74.53 111.022 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -96.3 -40.1 9.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.51 0.724 . . . . 75.25 109.387 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.36 173.63 34.94 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.461 -0.791 . . . . 73.42 111.674 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -93.5 -179.88 5.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.33 0.652 . . . . 74.21 110.248 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.98 125.76 89.81 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-N 115.801 -0.636 . . . . 74.43 110.628 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.66 133.71 43.73 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.633 2.222 . . . . 73.12 111.525 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . 0.525 HG12 HD12 ' D' ' 44' ' ' LEU . 11.6 p -64.9 -27.98 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.355 0.662 . . . . 74.11 111.396 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 66.37 -83.69 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.898 1.279 . . . . 73.02 109.196 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.581 ' HE1' HG21 ' D' ' 40' ' ' VAL . 0.1 OUTLIER -176.31 176.96 1.58 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.456 1.502 . . . . 73.31 107.869 173.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.574 ' H ' ' HE3' ' G' ' 290' ' ' TRP . 3.7 mp -126.02 6.69 7.25 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.042 0.937 . . . . 74.52 110.683 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . 0.496 ' HA3' ' H ' ' E' ' 307' ' ' THR . . . 153.64 -152.88 24.44 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-O 119.234 -0.759 . . . . 74.25 112.649 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.97 151.77 69.51 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.699 2.933 . . . . 72.2 113.392 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -105.57 12.83 30.8 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.735 1.214 . . . . 75.31 110.023 178.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.96 84.78 0.51 Allowed 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.077 0.951 . . . . 74.3 110.518 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m -91.94 -32.25 15.33 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.191 -0.913 . . . . 73.32 110.226 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.434 ' CZ ' ' HD3' ' D' ' 124' ' ' PRO . 1.5 m-85 -78.06 141.0 39.13 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.769 -0.456 . . . . 74.15 109.769 169.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -98.46 7.46 46.14 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.469 0.708 . . . . 74.31 110.035 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 85.72 -156.13 29.89 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.051 -1.22 . . . . 74.03 110.051 -163.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 52.46 64.23 1.93 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.647 1.179 . . . . 62.1 111.252 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.467 ' HB ' ' HA3' ' E' ' 299' ' ' GLY . 0.0 OUTLIER -155.6 132.53 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 113.858 -1.519 . . . . 65.54 108.299 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -164.36 -174.57 3.55 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 108.537 -0.912 . . . . 73.23 108.537 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -67.35 122.58 83.65 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.107 -1.072 . . . . 74.12 108.107 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -62.22 104.23 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.394 2.062 . . . . 73.35 110.469 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -77.03 79.74 3.56 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.823 0.849 . . . . 72.32 110.477 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.541 ' HA ' ' HB3' ' E' ' 294' ' ' LYS . 5.3 t -74.56 107.28 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.503 -0.925 . . . . 74.43 108.503 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 25.8 m -61.67 -67.98 0.36 Allowed 'General case' 0 CA--C 1.545 0.783 0 O-C-N 124.061 0.851 . . . . 73.41 110.65 -174.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 84.7 m -160.57 134.79 7.23 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.669 0.788 . . . . 75.53 109.683 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' G' G ' 309' ' ' THR . . . . . 0.485 ' HB ' ' HD3' ' G' ' 310' ' ' PRO . 94.1 m -71.89 -50.59 9.45 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 118.732 -0.651 . . . . 74.32 109.896 166.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . 0.485 ' HD3' ' HB ' ' G' ' 309' ' ' THR . 3.7 Cg_endo . . . . . 0 C--N 1.406 3.569 0 C-N-CA 122.738 2.292 . . . . 75.33 111.679 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 110.513 -0.18 . . . . 71.11 110.513 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -85.22 85.56 7.45 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.266 -1.013 . . . . 74.42 108.266 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -126.83 120.3 28.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.888 0.875 . . . . 74.01 109.564 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.89 23.35 0.84 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.933 0.893 . . . . 74.43 111.568 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -134.34 82.77 45.89 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.595 1.158 . . . . 72.21 109.14 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -99.79 -166.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 123.625 2.883 . . . . 64.32 112.261 173.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 90.4 mt -103.48 43.06 1.11 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.024 0.93 . . . . 73.42 109.369 171.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . 0.414 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 17.9 tp -149.55 153.25 36.86 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.204 -0.907 . . . . 74.22 109.375 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 146.01 164.66 11.0 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-O 119.405 -0.664 . . . . 54.22 111.536 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 61.4 tp 77.52 -51.28 0.53 Allowed 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.709 1.604 . . . . 75.1 112.353 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -85.8 47.93 1.52 Allowed 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.104 1.362 . . . . 75.3 110.392 -173.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -121.92 -6.11 9.03 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.053 0.941 . . . . 64.2 110.599 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -147.65 -77.42 0.17 Allowed 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.432 -0.951 . . . . 74.13 108.432 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 56.78 -89.29 0.01 OUTLIER Glycine 0 C--N 1.357 1.742 0 O-C-N 123.971 0.794 . . . . 75.12 113.646 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' B' ' 44' ' ' LEU . 3.5 t-20 59.64 87.66 0.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.576 1.551 . . . . 73.42 111.541 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 286' ' ' MET . . . . . 0.409 ' HB3' HG23 ' H' ' 288' ' ' VAL . 1.2 mpt? -68.37 119.36 67.54 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 115.445 -0.798 . . . . 75.31 109.959 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.21 37.91 0.71 Allowed 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.927 3.084 . . . . 71.31 112.709 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . 0.409 HG23 ' HB3' ' H' ' 286' ' ' MET . 53.2 t -68.12 115.6 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.519 0.727 . . . . 73.54 109.177 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -65.03 -68.61 0.35 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.701 -0.851 . . . . 73.14 108.701 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -175.11 169.58 3.29 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.921 1.688 . . . . 75.44 109.588 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' F' ' 306' ' ' VAL . 5.9 mp -100.84 78.07 1.92 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.98 -1.489 . . . . 70.41 106.98 167.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 74.72 172.0 28.37 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 114.64 -1.163 . . . . 71.44 112.96 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.32 32.35 0.52 Allowed 'Trans proline' 0 CA--C 1.557 1.631 0 C-N-CA 122.951 2.434 . . . . 75.31 112.151 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -93.72 31.39 1.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.454 1.101 . . . . 75.12 110.533 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . 0.597 ' HB2' HG23 ' B' ' 40' ' ' VAL . . . -92.47 -80.64 0.36 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.069 0.548 . . . . 74.5 110.159 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 296' ' ' THR . . . . . 0.405 ' OG1' HD12 ' B' ' 126' ' ' LEU . 21.2 m -104.99 149.14 26.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.634 0.774 . . . . 73.32 110.551 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.539 ' HE1' HD13 ' H' ' 301' ' ' ILE . 74.1 m-85 57.66 83.82 0.11 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.797 1.239 . . . . 74.12 111.69 -176.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -88.1 26.41 1.39 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.414 -0.812 . . . . 64.25 109.925 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . 0.431 ' HA3' ' HA3' ' F' ' 299' ' ' GLY . . . 87.85 -26.3 7.67 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 120.174 -0.237 . . . . 63.04 112.97 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' B' ' 124' ' ' PRO . 8.6 t30 -67.72 93.49 0.39 Allowed 'General case' 0 C--N 1.352 0.713 0 C-N-CA 123.693 0.797 . . . . 64.2 110.898 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . 0.539 HD13 ' HE1' ' H' ' 297' ' ' TYR . 13.2 tt -138.97 12.59 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 107.458 -1.312 . . . . 75.21 107.458 169.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.44 83.37 1.97 Allowed 'General case' 0 C--N 1.362 1.124 0 CA-C-N 114.828 -1.078 . . . . 73.51 110.463 -169.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.488 ' HA ' ' HE2' ' H' ' 303' ' ' LYS . 0.7 OUTLIER 169.68 93.38 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.117 2.167 . . . . 73.23 105.284 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.74 77.4 1.07 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.611 2.207 . . . . 74.21 111.58 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 14' ' ' GLN . . . 60.04 -151.56 0.41 Allowed 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.346 1.058 . . . . 74.34 110.482 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.81 -24.76 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.161 0.584 . . . . 74.1 110.171 168.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 49.1 m 65.98 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.967 1.307 . . . . 75.32 110.274 -172.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 42.7 t -165.35 137.29 4.16 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.214 -1.032 . . . . 72.34 108.214 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 6.7 m -102.5 104.98 41.39 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 108.723 -0.843 . . . . 74.42 108.723 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 C--N 1.381 2.259 0 C-N-CA 122.899 2.399 . . . . 72.31 112.367 -177.047 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.613 -0.514 . . . . 72.23 109.613 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m 68.65 148.47 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.788 1.635 . . . . 63.12 113.562 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -101.51 108.33 19.88 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.131 0.972 . . . . 74.45 109.773 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -141.29 55.75 1.54 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.195 0.998 . . . . 74.01 110.325 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.494 ' HB3' ' NE2' ' A' ' 93' ' ' GLN . 12.9 m120 -117.24 33.02 5.83 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.951 -1.022 . . . . 64.13 109.373 172.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -78.15 79.91 4.58 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.289 -1.004 . . . . 75.32 108.289 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -99.98 154.95 17.97 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.688 0.795 . . . . 71.42 110.34 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -33.29 73.04 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.822 0.701 . . . . 64.2 110.699 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.434 ' SD ' ' HB3' ' A' ' 147' ' ' GLU . 46.9 mtt 63.53 172.3 0.16 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.779 1.632 . . . . 72.23 112.593 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 m -140.99 134.52 29.99 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.702 -0.851 . . . . 75.35 108.702 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.576 ' HB3' HG21 ' A' ' 149' ' ' THR . 3.1 t80 -137.7 134.42 35.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 73.51 110.139 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -154.54 136.0 14.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.101 -1.409 . . . . 74.3 107.396 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.559 HD12 HD22 ' C' ' 132' ' ' ASN . 32.0 mt -92.44 130.84 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.322 -0.622 . . . . 75.4 109.322 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.454 ' O ' ' HA ' ' H' ' 307' ' ' THR . 24.6 tt0 -98.1 -41.33 7.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.779 -0.629 . . . . 71.31 110.537 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.545 ' HA ' HG12 ' H' ' 306' ' ' VAL . 18.2 ttt180 -177.89 123.5 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 112.926 0.713 . . . . 64.32 112.926 -170.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.596 HD11 ' HG3' ' C' ' 130' ' ' PRO . 4.0 mp -104.61 134.74 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.836 -1.172 . . . . 71.45 107.836 168.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.502 ' HB3' HG23 ' B' ' 122' ' ' THR . 22.9 p90 -166.16 152.42 9.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.484 1.113 . . . . 71.31 109.416 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -75.51 118.28 18.2 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.871 -0.788 . . . . 74.01 108.871 172.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -80.56 -24.33 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.65 -0.5 . . . . 72.43 109.65 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -158.91 143.3 15.62 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.1 -0.954 . . . . 75.21 109.8 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 86.0 mt -132.33 146.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.914 1.286 . . . . 71.51 107.972 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.89 135.13 15.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.491 0.717 . . . . 73.21 109.516 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.9 t80 -138.06 131.21 30.26 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.686 -1.598 . . . . 74.21 106.686 171.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -133.6 114.21 13.28 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.276 0.63 . . . . 64.24 109.556 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.39 83.03 1.37 Allowed Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.496 -1.668 . . . . 70.22 106.496 162.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.58 -31.94 16.04 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 122.605 2.203 . . . . 73.44 112.155 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -113.88 22.9 13.52 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.278 1.031 . . . . 75.0 109.053 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.54 -63.11 1.11 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-O 117.997 -1.002 . . . . 74.13 113.384 -168.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.51 -17.42 59.92 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.024 1.816 . . . . 73.43 113.354 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -85.9 -52.4 5.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.929 0.871 . . . . 72.23 109.995 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.627 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -70.52 -21.7 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.034 -1.439 . . . . 71.01 111.941 -160.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -64.42 -30.1 71.15 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.534 0.734 . . . . 74.44 112.22 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.83 -11.58 20.64 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.217 0.607 . . . . 75.34 112.423 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -78.64 171.74 14.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.01 0.524 . . . . 71.44 111.086 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.37 118.22 6.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.052 0.941 . . . . 75.44 110.741 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.456 ' CE2' HD13 ' E' ' 301' ' ' ILE . 20.9 m0 -79.84 82.37 5.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.573 0.702 . . . . 74.2 110.097 -177.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -126.12 70.28 68.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.419 1.087 . . . . 74.03 108.948 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.697 ' HG3' ' HB3' ' E' ' 297' ' ' TYR . 94.8 Cg_endo -78.74 127.67 8.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.609 2.206 . . . . 74.31 112.045 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -97.97 93.95 6.6 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.854 -1.536 . . . . 64.25 106.854 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.5 m -76.73 106.11 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.617 -1.174 . . . . 75.02 110.578 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.524 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 16.7 mtpp -81.73 134.96 35.5 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.959 -1.019 . . . . 74.43 110.402 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tt -110.74 106.45 15.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 106.154 -1.795 . . . . 75.13 106.154 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.683 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.3 m-20 -114.16 142.33 46.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.228 -1.397 . . . . 64.42 107.228 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.729 ' HB3' ' HA ' ' E' ' 287' ' ' PRO . 5.7 tt -141.46 128.64 20.93 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.948 -1.13 . . . . 74.12 107.948 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.523 ' HA ' HD22 ' E' ' 285' ' ' ASN . 13.1 t70 -117.15 134.28 54.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.581 1.153 . . . . 74.44 108.678 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.403 ' HB ' ' CD1' ' E' ' 281' ' ' PHE . 50.4 p -110.57 123.1 49.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.906 -1.043 . . . . 74.41 110.589 -167.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.93 131.69 37.55 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.683 0.793 . . . . 71.23 110.477 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.55 152.56 51.92 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.035 0.445 . . . . 64.22 110.325 171.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 163.64 39.01 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.952 1.301 . . . . 71.1 108.233 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.503 HE22 ' HB3' ' C' ' 152' ' ' HIS . 48.7 tt0 -112.54 146.56 38.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.206 0.602 . . . . 73.0 109.515 174.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.474 HD12 HG22 ' A' ' 83' ' ' ILE . 57.8 mt -117.62 -43.75 2.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.878 0.871 . . . . 71.34 110.361 178.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.58 -168.52 3.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.204 0.601 . . . . 73.32 110.819 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.493 ' HA ' ' HG2' ' C' ' 150' ' ' GLU . 4.6 m-20 -64.43 112.33 3.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.781 0.832 . . . . 71.55 110.346 178.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.4 0.39 2.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.516 1.527 . . . . 63.23 112.364 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.509 HG21 ' HG ' ' A' ' 85' ' ' SER . 97.2 t -96.81 107.09 19.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.475 -1.306 . . . . 75.12 107.475 -174.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.471 -0.937 . . . . 74.34 108.471 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -92.07 112.83 24.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.938 0.895 . . . . 74.25 109.396 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.14 111.32 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.619 -1.252 . . . . 71.13 107.619 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.414 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 32.1 t -106.7 129.54 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.621 0.768 . . . . 74.04 110.001 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.708 HD11 HD22 ' A' ' 44' ' ' LEU . 4.2 mm? -117.89 110.04 17.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.643 -0.873 . . . . 71.13 108.643 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.526 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 11.0 ttp180 -84.82 107.44 16.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.58 -0.896 . . . . 74.24 108.58 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 16.4 t -92.45 125.34 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 107.807 -1.183 . . . . 75.32 107.807 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.683 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.9 m -118.79 136.89 53.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.019 -0.734 . . . . 64.22 109.019 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.542 HG12 HD23 ' A' ' 126' ' ' LEU . 45.4 t -136.78 115.88 15.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 124.44 1.096 . . . . 75.31 108.068 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 7.1 m -105.25 148.02 27.43 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.912 -0.773 . . . . 74.42 108.912 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.23 106.65 7.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.086 -1.45 . . . . 73.21 107.086 168.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.583 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 17.9 t -116.8 126.97 53.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.682 -0.488 . . . . 73.22 109.682 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.514 HD22 HG22 ' A' ' 31' ' ' VAL . 7.7 mp -87.56 82.49 7.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 74.01 107.914 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.28 -84.72 0.83 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 114.976 -1.011 . . . . 70.22 111.881 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -111.92 -27.88 8.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.294 1.037 . . . . 71.13 111.686 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.7 125.15 54.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.564 0.346 . . . . 73.44 111.005 -169.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 63.7 m -73.7 129.3 37.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.573 0.749 . . . . 74.45 112.441 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.627 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -69.75 -65.64 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.868 -1.06 . . . . 73.01 109.911 169.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.13 167.77 27.46 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.289 -0.869 . . . . 74.22 111.607 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 tp -141.36 116.09 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.354 1.461 . . . . 71.31 107.728 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.6 m -105.66 131.79 52.6 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.332 0.653 . . . . 64.2 109.559 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 32.6 tt0 -146.59 115.38 6.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.58 -0.526 . . . . 74.32 109.58 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.74 114.27 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.97 0.908 . . . . 74.43 109.231 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.526 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 48.5 mt-30 -83.88 84.39 7.59 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.265 -1.013 . . . . 75.43 108.265 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.86 98.26 6.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.322 -0.992 . . . . 74.24 108.322 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.414 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.89 145.88 21.04 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.202 -0.759 . . . . 72.03 111.202 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.675 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -150.14 121.79 1.31 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 111.047 -0.821 . . . . 64.54 111.047 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.474 HG22 HD12 ' A' ' 51' ' ' LEU . 34.6 mt -87.78 123.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 123.87 0.868 . . . . 54.44 108.736 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.528 ' HD2' HG12 ' A' ' 13' ' ' ILE . 46.9 m-85 -131.71 120.26 22.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.509 ' HG ' HG21 ' A' ' 55' ' ' VAL . 25.2 m -77.78 90.91 4.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.551 0.74 . . . . 73.31 109.333 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.496 HG22 ' SG ' ' A' ' 97' ' ' CYS . 1.6 pp -118.69 133.26 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.806 0.842 . . . . 75.12 110.509 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.4 177.15 11.48 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.695 0.798 . . . . 75.0 111.125 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.52 86.68 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.758 0.662 . . . . 74.4 112.298 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.76 136.12 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.497 1.119 . . . . 75.13 109.936 -171.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -131.41 172.07 12.62 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.136 0.974 . . . . 74.51 108.863 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.42 4.59 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 115.001 0.761 . . . . 65.4 115.001 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.425 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.2 -18.74 58.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.953 0.901 . . . . 70.23 112.041 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.494 ' NE2' ' HB3' ' A' ' 5' ' ' ASN . 98.4 mt-30 -67.87 -48.88 64.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.176 0.591 . . . . 74.35 110.236 175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.719 ' SD ' ' HB3' ' E' ' 277' ' ' LEU . 50.2 ttm -80.63 -18.56 47.77 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.592 -0.276 . . . . 72.52 110.454 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.436 ' HA ' HD22 ' E' ' 280' ' ' LEU . . . -66.38 -33.87 76.69 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.037 0.446 . . . . 73.12 110.428 169.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -68.66 -41.74 78.92 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.874 -0.603 . . . . 75.14 110.26 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG22 ' A' ' 86' ' ' ILE . 47.3 t -64.26 -54.21 36.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.984 0.514 . . . . 72.41 111.959 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 mt -76.26 -35.94 58.69 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.409 0.443 . . . . 71.11 111.719 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.09 4.59 38.58 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 114.858 0.703 . . . . 70.4 114.858 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -146.6 -52.23 0.23 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.85 0.825 . . . . 72.33 112.436 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.581 ' HA ' ' HB3' ' A' ' 134' ' ' ASP . 66.4 t80 -79.81 -68.92 0.62 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.52 0.728 . . . . 74.1 111.939 -168.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.486 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.3 m -68.86 -32.36 3.45 Favored Pre-proline 0 CA--C 1.572 1.826 0 N-CA-C 114.844 1.424 . . . . 74.35 114.844 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 28.8 Cg_endo -61.45 -21.87 73.03 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 122.556 2.17 . . . . 72.13 113.458 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -68.12 -26.12 65.64 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.203 0.601 . . . . 75.23 110.034 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -71.2 -36.01 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.477 0.711 . . . . 74.53 109.858 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.675 HD23 ' HA3' ' A' ' 82' ' ' GLY . 97.0 mt -83.48 -30.68 26.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.936 0.894 . . . . 73.54 112.883 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -62.9 -39.79 56.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 113.818 1.044 . . . . 65.22 113.818 -170.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.01 -37.67 51.58 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.387 2.058 . . . . 71.04 113.281 172.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -71.76 -38.62 70.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.14 0.576 . . . . 73.35 111.625 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -45.18 83.42 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.572 -0.529 . . . . 74.33 109.572 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.436 HH22 ' HB3' ' A' ' 130' ' ' PRO . 40.1 ttm180 -53.75 -50.45 65.97 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 124.646 1.216 . . . . 73.54 110.905 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.65 -41.6 75.36 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.204 0.94 . . . . 75.24 111.303 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 44.0 t -56.17 -42.21 76.69 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.576 0.547 . . . . 74.23 110.169 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.417 ' O ' HG21 ' A' ' 118' ' ' VAL . 92.8 mt -66.13 -50.33 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.593 -1.185 . . . . 75.13 110.296 175.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 63.0 m -52.8 -41.93 64.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.301 1.041 . . . . 64.53 111.375 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -69.17 -51.22 40.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.647 -1.161 . . . . 75.24 110.616 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.1 mtp -51.05 -42.91 60.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.026 0.931 . . . . 74.14 111.725 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -64.82 -50.96 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-N 114.376 -1.284 . . . . 74.11 110.718 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 93.2 p -70.38 -22.71 62.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.029 0.532 . . . . 60.31 111.947 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.603 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -75.19 -31.19 60.88 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.796 0.838 . . . . 74.33 110.048 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 -3.26 86.13 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 116.124 -0.489 . . . . 74.34 112.604 171.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.553 ' HB ' HH21 ' B' ' 15' ' ' ARG . 23.3 m 60.05 43.73 14.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.318 1.532 . . . . 73.12 110.133 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.519 ' HA ' HG22 ' E' ' 301' ' ' ILE . 69.1 m-85 -99.53 163.9 17.65 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 113.029 -1.896 . . . . 74.44 108.888 169.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.485 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 17.4 Cg_exo -68.12 136.46 37.76 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.766 2.311 . . . . 75.44 111.795 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.0 tt0 -48.31 124.37 7.82 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.584 1.177 . . . . 72.44 111.521 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.542 HD23 HG12 ' A' ' 64' ' ' VAL . 12.4 tp -108.13 100.54 9.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.695 0.798 . . . . 73.43 110.484 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.84 97.75 7.22 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.891 -1.152 . . . . 73.14 107.891 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.67 120.89 18.92 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.239 -0.437 . . . . 75.13 110.314 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 133.04 88.87 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.118 0.967 . . . . 72.34 111.934 -173.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.436 ' HB3' HH22 ' A' ' 111' ' ' ARG . 18.0 Cg_endo -87.22 166.49 8.08 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.646 2.231 . . . . 74.43 113.351 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.58 142.51 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 106.779 -1.563 . . . . 72.54 106.779 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.45 75.46 6.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.907 -1.146 . . . . 72.54 107.907 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.5 -43.73 89.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.475 1.11 . . . . 75.1 111.843 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.581 ' HB3' ' HA ' ' A' ' 101' ' ' TYR . 5.3 p-10 -61.12 -45.26 95.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.994 0.917 . . . . 74.42 111.806 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.75 87.86 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.76 0.662 . . . . 70.11 110.982 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.3 tp -68.45 -39.41 81.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.823 0.702 . . . . 72.11 111.124 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -70.35 -36.9 74.48 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.44 -0.578 . . . . 75.31 109.44 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.587 ' HE1' ' HA ' ' A' ' 138' ' ' MET . 11.0 mmt -64.46 -56.92 11.02 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 123.408 0.443 . . . . 75.3 110.59 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -62.75 -27.72 69.48 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.017 0.527 . . . . 75.14 111.835 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -73.33 -42.24 62.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.694 0.798 . . . . 62.44 111.156 173.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.8 tp -69.19 -56.71 6.8 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-O 119.211 -0.423 . . . . 75.43 111.144 -174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -168.42 -12.92 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.348 1.459 . . . . 72.4 111.154 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.408 ' HB3' ' O ' ' C' ' 2' ' ' SER . 0.1 OUTLIER 69.44 72.42 0.25 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.588 1.555 . . . . 74.44 108.867 -177.029 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -157.79 116.01 3.11 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.58 0.752 . . . . 73.01 109.899 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.24 156.47 48.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.289 1.036 . . . . 62.13 109.73 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.46 40.39 0.02 OUTLIER Glycine 0 N--CA 1.47 0.914 0 N-CA-C 111.818 -0.513 . . . . 71.33 111.818 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.434 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 1.7 pm0 -68.96 125.68 27.42 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.849 0.86 . . . . 72.23 111.167 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.66 140.91 27.75 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.75 -0.659 . . . . 71.44 112.363 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.576 HG21 ' HB3' ' A' ' 11' ' ' PHE . 25.5 p -113.84 125.71 54.37 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.857 0.863 . . . . 74.13 110.285 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.74 138.18 10.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.6 0.76 . . . . 71.24 109.666 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.01 156.1 23.59 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.428 0.691 . . . . 74.21 112.81 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -173.49 140.94 0.84 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.073 1.349 . . . . 73.14 107.747 164.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.536 HE22 ' HB1' ' A' ' 155' ' ' ALA . 11.2 tm0? -140.29 107.8 5.58 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.897 -1.149 . . . . 75.31 107.897 -178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -105.61 -35.56 7.38 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.777 0.831 . . . . 75.12 111.182 -176.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.536 ' HB1' HE22 ' A' ' 153' ' ' GLN . . . . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 124.806 1.243 . . . . 74.02 112.229 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 110.497 -0.186 . . . . 74.3 110.497 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 43.5 p -72.77 101.41 3.1 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 123.928 0.767 . . . . 74.54 109.308 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.59 154.86 19.99 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.734 -0.839 . . . . 71.43 108.734 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -60.71 100.64 0.11 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.805 0.842 . . . . 74.42 110.419 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 59.4 t30 55.54 98.75 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.326 1.45 . . . . 73.35 111.818 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -58.73 -61.4 2.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.645 0.778 . . . . 74.32 111.196 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m 51.36 45.3 28.16 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.369 1.08 . . . . 72.43 110.154 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.65 174.38 9.84 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.616 -1.175 . . . . 71.23 110.331 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.419 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 9.5 ptt? 54.49 -166.62 0.09 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 126.079 1.751 . . . . 71.31 112.966 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 63.1 m -148.7 125.65 11.29 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.765 -1.198 . . . . 72.13 107.765 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.574 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 19.4 t80 -141.86 118.59 11.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.556 0.742 . . . . 72.02 109.312 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.513 ' HB3' ' HB ' ' E' ' 309' ' ' THR . 7.3 pt20 -154.88 130.38 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.743 0.817 . . . . 75.22 109.155 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -81.31 132.53 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.142 0.577 . . . . 72.4 109.825 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -89.24 -48.54 7.31 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.884 -0.413 . . . . 74.24 109.884 168.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.553 HH21 ' HB ' ' A' ' 122' ' ' THR . 58.9 ttt180 -162.95 154.85 18.07 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 111.395 0.146 . . . . 74.22 111.395 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 87.3 mt -137.39 111.37 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.403 1.081 . . . . 75.22 108.083 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.416 ' HE1' HG13 ' B' ' 83' ' ' ILE . 24.9 p90 -137.2 147.92 46.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.853 0.461 . . . . 75.44 110.379 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -75.3 119.05 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.742 -0.663 . . . . 74.13 109.744 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -89.92 -23.15 21.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.68 0.792 . . . . 75.14 111.121 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.37 141.64 4.54 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.217 0.323 . . . . 74.35 111.789 -173.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.805 HD12 ' SG ' ' B' ' 113' ' ' CYS . 45.5 mm -133.12 146.41 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.195 1.398 . . . . 74.54 109.084 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.605 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.0 t -149.08 151.94 35.32 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.881 0.872 . . . . 74.42 109.009 172.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.402 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -156.01 122.7 5.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.2 mt-10 -125.12 113.05 17.2 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.031 -0.729 . . . . 71.13 109.031 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.494 ' HB1' ' CB ' ' B' ' 28' ' ' ALA . . . -114.42 84.03 9.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.874 -1.158 . . . . 74.24 107.874 170.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.7 -22.96 17.31 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.661 2.241 . . . . 73.45 111.638 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -113.37 15.31 19.22 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.538 1.135 . . . . 73.1 110.576 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.494 ' CB ' ' HB1' ' B' ' 25' ' ' ALA . . . -48.68 -58.1 9.29 Favored Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 125.335 1.454 . . . . 62.52 114.607 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.475 ' HG2' ' HD1' ' B' ' 30' ' ' HIS . 33.7 Cg_endo -67.76 -25.63 39.52 Favored 'Trans proline' 0 C--N 1.398 3.154 0 C-N-CA 121.903 1.735 . . . . 70.34 112.712 -176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.487 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 75.2 m80 -97.99 1.21 47.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.485 0.714 . . . . 73.3 112.876 -174.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.91 -22.66 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.227 0.611 . . . . 73.35 112.521 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -64.95 -30.77 71.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.941 0.897 . . . . 75.01 112.175 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.7 pt20 -65.49 -36.08 82.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 110.101 -0.333 . . . . 71.34 110.101 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.639 ' HB2' HD13 ' B' ' 68' ' ' LEU . 83.3 mttt -108.89 65.63 0.62 Allowed 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.616 0.722 . . . . 74.25 109.169 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -75.28 108.29 7.95 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.116 -0.947 . . . . 64.12 109.643 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 162.13 -171.69 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 127.61 2.364 . . . . 74.13 108.985 159.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.523 ' HB3' ' H ' ' H' ' 297' ' ' TYR . 1.8 pt20 -72.3 128.8 88.38 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 122.963 0.164 . . . . 72.42 110.838 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.52 -176.22 3.0 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.673 2.249 . . . . 75.43 111.05 168.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -76.04 106.78 7.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.796 -1.187 . . . . 72.0 107.796 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.13 136.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.079 -1.082 . . . . 74.35 108.079 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -150.98 142.41 23.43 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.279 0.631 . . . . 72.33 109.653 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -85.97 159.72 19.55 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.976 0.893 . . . . 74.42 110.505 171.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 33.7 t70 -140.09 110.46 6.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.448 -2.056 . . . . 64.42 105.448 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.87 134.63 47.66 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.885 -0.783 . . . . 73.44 108.885 -167.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.619 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.8 t70 -131.36 139.97 49.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.844 -0.799 . . . . 73.52 108.844 172.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -109.71 124.94 52.09 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.124 0.969 . . . . 73.35 109.605 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.61 43.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.699 0.8 . . . . 75.31 108.893 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -143.19 161.33 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.674 0.389 . . . . 73.14 110.198 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 84.9 p -153.06 150.76 29.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.786 0.834 . . . . 64.22 109.514 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.99 114.91 29.26 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.862 -0.792 . . . . 75.03 108.862 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.402 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 77.5 mt -77.75 -42.83 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.807 0.443 . . . . 74.12 110.343 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.11 -171.07 2.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.63 -0.714 . . . . 64.53 111.118 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.33 118.53 9.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.438 -1.256 . . . . 72.42 110.091 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.75 -3.94 1.3 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.296 1.438 . . . . 75.41 112.488 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.96 107.11 21.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.462 -0.94 . . . . 74.03 108.462 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.636 ' HH ' ' HB3' ' H' ' 277' ' ' LEU . 72.1 m-85 -120.22 156.63 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.401 -0.818 . . . . 72.41 109.136 -179.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.402 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 7.4 tm-20 -133.12 97.26 3.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.214 -1.402 . . . . 75.1 107.214 -167.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.4 128.83 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.341 1.056 . . . . 74.14 109.238 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.33 143.65 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.917 0.887 . . . . 75.22 109.401 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.44 HD13 ' HB3' ' B' ' 103' ' ' PRO . 58.6 mt -129.32 122.8 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.419 0.687 . . . . 74.12 109.406 170.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.619 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.8 ttm180 -92.19 108.57 20.04 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.469 -0.937 . . . . 71.31 108.469 172.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.12 103.14 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.197 -1.408 . . . . 75.12 107.197 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 10.8 m -104.53 124.43 49.28 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.228 -0.656 . . . . 74.25 109.228 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.596 HG22 HG21 ' B' ' 114' ' ' ILE . 90.8 t -103.09 104.72 17.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.626 0.77 . . . . 65.11 109.124 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.4 m -94.96 136.89 34.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.341 -0.845 . . . . 73.2 109.415 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.62 136.05 24.1 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.586 -0.894 . . . . 73.53 108.586 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.9 p -142.05 130.59 22.58 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.531 0.519 . . . . 55.04 111.532 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.639 HD13 ' HB2' ' B' ' 34' ' ' LYS . 46.5 mt -92.29 99.34 12.13 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -109.82 2.96 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.473 -0.785 . . . . 75.23 111.742 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.8 4.3 18.3 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.453 1.101 . . . . 75.22 111.564 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.66 170.88 9.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.609 0.764 . . . . 74.24 109.726 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -76.49 152.53 36.07 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.876 0.47 . . . . 73.33 110.903 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.529 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -104.98 -63.28 1.24 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.271 -1.011 . . . . 62.25 108.271 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.94 156.67 22.69 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.13 -1.396 . . . . 74.54 108.253 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 80.0 mt -132.77 148.82 52.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.532 1.133 . . . . 74.34 108.3 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.92 159.63 44.02 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.333 -0.988 . . . . 64.33 108.333 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.605 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.4 tt0 -163.34 137.78 6.14 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.671 0.388 . . . . 75.23 110.004 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' B' ' 110' ' ' ALA . 78.5 t -135.97 144.63 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.154 0.981 . . . . 64.45 109.202 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -122.56 105.43 10.11 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.5 -1.296 . . . . 73.03 107.5 169.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.508 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -99.59 108.75 21.23 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 149.94 20.55 Favored Glycine 0 C--O 1.242 0.605 0 N-CA-C 110.914 -0.874 . . . . 61.14 110.914 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.44 123.66 2.03 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.015 -0.834 . . . . 74.12 111.015 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.416 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.3 mt -88.11 126.78 41.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.691 -0.855 . . . . 64.5 108.691 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -135.36 134.38 39.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.483 1.113 . . . . 75.21 108.819 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.451 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 32.7 m -93.92 96.65 9.85 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.75 -0.833 . . . . 72.13 108.75 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -110.7 135.4 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.018 0.927 . . . . 70.02 110.668 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.442 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -152.16 164.47 37.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 74.51 109.296 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.67 -39.02 2.8 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 123.003 0.335 . . . . 70.42 113.776 175.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.587 HG13 HD13 ' H' ' 277' ' ' LEU . 28.9 pt -60.85 145.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.326 1.05 . . . . 75.14 111.587 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -166.28 163.1 17.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.663 0.785 . . . . 75.22 109.891 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.8 -123.19 32.65 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.87 0.732 . . . . 73.33 113.391 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -67.98 -36.21 79.66 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.407 1.083 . . . . 64.53 110.936 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.64 -29.97 67.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.794 -1.094 . . . . 74.31 110.674 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.4 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 0.6 OUTLIER -67.98 -49.66 60.33 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.358 -0.837 . . . . 75.43 109.632 175.165 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.3 73.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.123 0.969 . . . . 72.43 111.85 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -69.7 -34.22 73.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.89 0.876 . . . . 70.15 110.709 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -70.35 -66.88 0.54 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.043 -0.526 . . . . 73.41 111.112 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.564 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.0 OUTLIER -87.9 -14.47 39.27 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.339 0.496 . . . . 73.21 112.339 -169.151 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.23 -4.22 53.66 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.896 -0.391 . . . . 63.01 113.379 -177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.82 -58.79 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 117.149 0.475 . . . . 63.34 111.66 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -73.41 -44.93 57.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 73.04 111.999 -172.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.574 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 35.2 m -68.01 -43.8 37.46 Favored Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 118.752 -0.642 . . . . 73.53 111.64 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.44 ' HB3' HD13 ' B' ' 60' ' ' LEU . 29.1 Cg_exo -44.94 -53.03 5.61 Favored 'Trans proline' 0 C--N 1.4 3.241 0 C-N-CA 123.038 2.492 . . . . 63.51 113.354 167.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -56.62 -23.65 42.52 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.219 1.008 . . . . 73.03 113.467 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 74.7 mt -78.81 -52.57 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.06 0.544 . . . . 72.44 110.929 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -87.38 -7.99 57.1 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -65.28 -45.02 70.61 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.669 1.188 . . . . 71.32 113.186 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.87 -37.66 66.79 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.627 2.218 . . . . 73.45 113.531 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.508 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 44.0 m-85 -68.96 -39.84 79.25 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.243 -0.89 . . . . 74.43 110.393 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -66.37 -45.49 79.93 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.669 0.388 . . . . 72.5 110.669 176.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -54.66 -56.13 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.329 1.452 . . . . 74.32 111.699 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.856 0.863 . . . . 75.14 110.791 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.805 ' SG ' HD12 ' B' ' 21' ' ' ILE . 6.0 t -66.86 -31.75 72.56 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.0 -0.545 . . . . 74.13 111.385 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.596 HG21 HG22 ' B' ' 64' ' ' VAL . 70.8 mt -67.53 -50.31 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.561 0.744 . . . . 73.04 110.314 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.5 m -61.84 -27.68 68.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 123.945 0.778 . . . . 73.35 111.245 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.429 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.14 -50.31 68.71 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.746 0.818 . . . . 64.34 110.295 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -72.49 -34.36 67.61 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.188 0.595 . . . . 73.43 111.653 -171.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.73 -38.55 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.469 0.708 . . . . 75.3 110.029 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t -72.94 -26.19 61.3 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.064 -0.971 . . . . 65.23 111.344 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.429 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.4 mtt-85 -73.81 -25.07 59.92 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.143 0.577 . . . . 75.34 110.5 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.24 14.71 32.33 Favored Glycine 0 C--N 1.357 1.697 0 O-C-N 123.541 0.525 . . . . 74.4 112.342 168.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.502 HG23 ' HB3' ' A' ' 17' ' ' TYR . 51.7 p 56.43 47.67 18.41 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.756 2.022 . . . . 63.24 112.612 175.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.08 151.96 46.17 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.205 -1.361 . . . . 74.12 109.658 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.26 -160.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.957 2.438 . . . . 74.12 113.33 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.621 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.43 125.69 25.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.347 1.059 . . . . 71.4 113.115 -170.548 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 59.5 tp -136.93 95.38 3.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.438 -0.949 . . . . 74.22 108.438 171.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -103.74 135.97 44.3 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.032 0.933 . . . . 73.41 110.547 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.3 tp -83.35 137.33 34.0 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.681 0.792 . . . . 73.31 109.709 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.458 ' HB2' HD13 ' H' ' 291' ' ' LEU . . . -70.51 152.82 95.34 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.278 1.031 . . . . 73.53 112.054 -173.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.4 111.28 1.42 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.492 2.795 . . . . 71.45 112.863 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.505 HG21 HD12 ' H' ' 291' ' ' LEU . 35.4 t -106.6 110.28 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 61.41 109.341 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.432 ' ND2' ' HB1' ' B' ' 135' ' ' ALA . 52.8 t30 -97.25 100.25 11.71 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.355 -0.98 . . . . 74.03 108.355 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -68.4 -31.31 70.57 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.464 0.706 . . . . 73.14 110.701 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.23 -33.91 75.48 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.528 -0.76 . . . . 75.33 111.475 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.432 ' HB1' ' ND2' ' B' ' 132' ' ' ASN . . . -55.94 -55.6 30.78 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.919 0.762 . . . . 63.55 111.353 -175.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.63 -38.99 84.68 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.996 0.518 . . . . 72.45 110.598 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.58 -36.34 83.47 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.803 0.841 . . . . 75.23 111.088 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 95.1 mmm -85.31 -36.32 20.9 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.211 0.604 . . . . 75.42 110.868 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -73.23 -13.18 61.1 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 117.672 0.215 . . . . 64.23 111.394 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -62.18 -48.66 79.05 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 123.774 0.671 . . . . 73.15 110.607 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 pp -115.71 -4.5 12.17 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.845 0.858 . . . . 74.22 112.336 -168.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -147.26 95.6 2.58 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.671 0.788 . . . . 75.44 109.023 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -86.39 -8.36 57.72 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.987 -1.006 . . . . 75.14 111.624 -176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -70.14 -30.05 67.13 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.02 0.928 . . . . 72.34 111.687 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.31 87.98 2.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.369 0.668 . . . . 75.22 110.038 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.76 -160.36 30.25 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.833 -0.621 . . . . 61.24 111.872 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -142.44 160.93 39.31 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.798 0.839 . . . . 73.14 110.016 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.48 61.34 4.21 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.122 -0.945 . . . . 74.42 111.113 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 58.6 p -67.21 143.79 56.34 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 123.355 0.662 . . . . 74.23 111.265 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 69.63 138.05 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.736 1.614 . . . . 63.1 111.371 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -60.36 110.17 1.18 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 107.774 -1.195 . . . . 64.42 107.774 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -60.91 108.14 0.82 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.09 0.869 . . . . 65.04 110.593 -170.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -68.72 95.75 0.69 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.258 0.974 . . . . 72.11 110.393 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -102.74 -26.09 13.29 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.017 -0.992 . . . . 74.3 110.004 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 C-N-CA 125.49 1.516 . . . . 73.14 112.109 170.407 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.153 -0.684 . . . . 73.45 109.153 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' C' C ' 2' ' ' SER . . . . . 0.408 ' O ' ' HB3' ' A' ' 143' ' ' GLN . 49.6 m -144.18 131.53 20.85 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.25 0.62 . . . . 73.33 109.563 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.2 122.12 33.18 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.471 0.709 . . . . 74.12 109.118 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -152.15 133.59 14.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.867 0.867 . . . . 63.25 110.325 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -125.29 81.37 1.96 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.475 -1.305 . . . . 62.34 107.475 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.53 -61.19 1.75 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.397 -0.819 . . . . 71.54 108.844 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -104.09 127.56 51.68 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.053 0.941 . . . . 64.24 110.03 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' C' ' 9' ' ' MET . 4.4 pt-20 -97.15 -51.13 4.32 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.5 0.32 . . . . 72.24 110.279 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.493 ' HA ' HG13 ' C' ' 89' ' ' ILE . 59.6 ttp 63.38 128.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.601 1.56 . . . . 73.54 113.573 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 26.6 m -120.5 94.19 4.29 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.689 -1.226 . . . . 74.34 107.689 167.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -97.13 157.25 16.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.133 -0.939 . . . . 74.41 108.902 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.523 ' HB2' HG21 ' G' ' 306' ' ' VAL . 10.9 pt20 -170.92 129.28 0.77 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.533 0.733 . . . . 75.52 110.155 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.576 ' H ' HD12 ' C' ' 13' ' ' ILE . 0.2 OUTLIER -90.88 107.88 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.7 0.8 . . . . 73.42 109.594 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.422 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 79.7 mm-40 -76.52 -52.83 9.02 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.079 -0.388 . . . . 63.54 110.609 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.482 HH12 HD12 ' G' ' 301' ' ' ILE . 63.3 ttt180 -166.21 128.58 1.92 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.987 -0.375 . . . . 72.4 109.987 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -108.07 146.36 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.849 -1.167 . . . . 74.34 107.849 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.416 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -176.93 163.39 2.2 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.565 0.698 . . . . 75.4 110.912 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -85.08 117.44 24.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.108 -0.951 . . . . 75.24 108.892 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -68.82 -42.93 76.57 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.844 0.831 . . . . 72.13 108.772 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.27 141.18 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.092 -1.413 . . . . 74.12 109.155 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.9 mt -129.21 140.7 48.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.769 -1.567 . . . . 75.13 106.769 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -157.61 145.84 19.1 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.259 0.552 . . . . 72.22 110.611 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -146.45 105.65 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.236 -1.764 . . . . 74.41 106.236 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -114.73 110.19 19.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.069 -1.086 . . . . 74.21 108.069 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.55 80.06 61.38 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.342 1.057 . . . . 74.33 108.827 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.92 -4.18 13.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.491 2.127 . . . . 74.32 111.731 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -117.7 18.65 14.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.1 . . . . 72.25 109.617 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -58.07 -52.3 75.5 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 114.177 1.177 . . . . 75.13 114.177 -170.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.498 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 73.8 Cg_endo -75.92 -31.61 4.97 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.47 1.561 . . . . 71.44 112.009 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.61 -23.69 62.6 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.968 1.307 . . . . 64.34 112.734 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.549 HG21 ' HA2' ' F' ' 299' ' ' GLY . 9.5 p -79.51 -16.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.837 -0.54 . . . . 70.42 111.576 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -67.39 -8.37 32.37 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.054 0.542 . . . . 64.33 112.251 176.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -116.09 25.18 10.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.784 0.834 . . . . 73.32 111.105 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.519 ' HG2' HD13 ' C' ' 68' ' ' LEU . 3.9 tppt? -91.83 172.69 8.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.002 0.521 . . . . 74.13 111.252 -173.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.64 130.31 35.32 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.729 -0.841 . . . . 72.14 108.729 168.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -70.18 85.15 0.55 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.642 1.177 . . . . 74.3 110.334 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -157.44 66.37 3.7 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.91 0.884 . . . . 63.4 108.967 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.34 109.16 2.84 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.667 2.244 . . . . 74.01 112.33 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -85.86 88.76 7.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.753 -1.573 . . . . 74.51 106.753 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.81 134.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.842 -1.072 . . . . 75.41 109.269 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.617 ' HE3' ' HB2' ' C' ' 43' ' ' ASP . 29.2 ttpt -114.97 129.18 56.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.141 -1.059 . . . . 75.35 108.141 169.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.442 HD22 HD13 ' C' ' 128' ' ' LEU . 49.4 tp -88.03 141.49 28.53 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.463 -1.31 . . . . 64.13 107.463 166.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.617 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 20.8 t70 -140.54 109.7 6.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.008 0.523 . . . . 64.23 109.692 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -105.64 145.73 30.63 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.245 -0.65 . . . . 71.14 109.245 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -143.29 149.76 38.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.519 1.127 . . . . 73.23 108.993 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.468 ' OG1' ' HA ' ' F' ' 282' ' ' ALA . 34.1 p -115.23 140.78 48.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.895 0.878 . . . . 72.11 110.257 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -143.11 151.31 40.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 73.24 109.527 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 24.3 m -141.29 155.96 45.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.937 0.495 . . . . 73.14 111.289 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -149.08 126.6 11.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.332 -0.988 . . . . 61.51 108.332 168.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -81.63 117.48 22.03 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 107.828 -1.175 . . . . 70.21 107.828 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.608 HD12 ' HB2' ' C' ' 57' ' ' GLU . 37.9 mt -97.07 -25.76 15.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.892 0.477 . . . . 75.44 110.549 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.44 -179.72 6.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.773 0.829 . . . . 74.03 110.119 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -62.67 122.35 15.64 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.937 -0.764 . . . . 75.51 108.937 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.8 21.19 12.64 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 124.447 1.092 . . . . 75.05 111.44 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.69 117.34 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 124.01 0.924 . . . . 71.21 108.63 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.66 130.42 43.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.931 0.892 . . . . 75.04 110.19 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.608 ' HB2' HD12 ' C' ' 51' ' ' LEU . 34.8 tt0 -82.02 109.28 16.2 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.527 -1.286 . . . . 72.42 107.527 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -96.39 114.12 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.031 -1.47 . . . . 71.13 107.031 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 48.9 t -111.88 131.28 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.455 0.702 . . . . 72.34 109.321 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.545 HD23 HD11 ' C' ' 106' ' ' LEU . 3.6 mm? -117.22 111.31 19.26 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.334 1.054 . . . . 75.2 108.312 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.4 ttm180 -81.99 114.76 20.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.912 -0.773 . . . . 74.12 108.912 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' C' ' 114' ' ' ILE . 33.9 t -105.28 117.03 50.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.854 -1.165 . . . . 74.1 107.854 173.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.0 m -123.74 139.83 53.59 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.417 1.087 . . . . 54.43 108.075 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.7 113.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.136 0.974 . . . . 75.22 108.971 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 45.8 m -98.24 137.09 37.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.278 -0.874 . . . . 74.54 108.658 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.29 112.9 10.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.878 -1.527 . . . . 72.51 106.878 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 48.7 m -145.35 127.6 15.77 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.052 -0.721 . . . . 71.21 109.052 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.519 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.8 mp -90.47 48.78 1.59 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.301 0.572 . . . . 64.2 110.543 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 -117.82 3.21 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.179 -1.168 . . . . 74.12 110.179 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.72 -33.19 16.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.134 0.974 . . . . 63.22 109.267 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.71 121.3 25.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.592 1.157 . . . . 73.3 110.851 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 91.7 m -78.77 137.84 37.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.081 0.952 . . . . 62.42 111.584 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.63 -66.11 0.74 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.106 0.963 . . . . 74.43 109.241 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -159.32 175.87 12.84 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.702 0.763 . . . . 72.4 110.858 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.4 143.36 51.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.982 -1.488 . . . . 73.25 106.982 171.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.44 140.21 41.13 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.659 -1.237 . . . . 74.3 107.659 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -151.46 119.74 6.36 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.373 0.533 . . . . 62.15 110.875 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -117.24 114.14 44.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.512 -0.922 . . . . 74.54 108.512 170.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.498 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 25.9 mt-30 -90.25 97.53 11.24 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.615 -1.254 . . . . 74.35 107.615 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -87.14 119.67 27.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.754 0.822 . . . . 65.34 109.806 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.23 148.95 18.28 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 123.188 0.305 . . . . 72.53 112.593 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.7 2.82 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 110.902 -0.879 . . . . 71.41 110.902 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.502 HD13 HD12 ' C' ' 51' ' ' LEU . 16.2 mm -81.26 119.85 31.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -129.41 142.89 50.69 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.418 -0.956 . . . . 72.03 108.418 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -105.98 123.31 47.78 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.124 -1.065 . . . . 74.3 108.124 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.538 HG23 ' HE3' ' C' ' 94' ' ' MET . 71.9 mt -112.87 100.66 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.914 0.886 . . . . 74.22 108.757 -173.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 169.34 14.22 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.871 1.269 . . . . 75.23 108.818 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.18 -40.94 3.03 Favored Glycine 0 N--CA 1.466 0.7 0 CA-C-N 116.567 -0.288 . . . . 71.02 112.966 174.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.493 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.9 pp -124.86 165.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.041 0.937 . . . . 63.43 110.489 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' C' ' 91' ' ' GLY . 28.4 tt0 -152.97 166.0 33.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.417 0.687 . . . . 74.12 109.985 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' C' ' 90' ' ' GLU . . . 70.59 -118.44 7.74 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.565 -0.289 . . . . 75.2 113.71 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -77.96 -24.48 48.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.503 0.721 . . . . 55.21 111.194 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -41.01 69.23 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.567 -0.531 . . . . 73.41 109.567 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.538 ' HE3' HG23 ' C' ' 86' ' ' ILE . 20.0 ptm -76.98 -28.34 55.08 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.12 -0.491 . . . . 73.31 110.755 176.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' F' ' 280' ' ' LEU . . . -66.46 -29.2 69.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.149 0.58 . . . . 75.13 110.836 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -70.92 -36.07 72.51 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.656 0.782 . . . . 74.35 110.496 171.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -67.8 -62.13 1.56 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 63.12 110.568 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.57 -12.42 60.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.628 0.603 . . . . 75.11 112.628 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.48 -4.41 57.22 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.58 -0.567 . . . . 72.33 113.917 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.49 -50.87 0.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.761 0.781 . . . . 71.14 111.726 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -75.98 -54.2 7.23 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.293 0.637 . . . . 74.11 111.677 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.61 -42.32 71.78 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 123.766 0.827 . . . . 75.33 113.167 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.59 -30.84 79.66 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 122.209 1.94 . . . . 72.44 112.68 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.14 -33.77 73.97 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.232 0.613 . . . . 75.03 110.743 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -65.87 -50.49 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.055 0.542 . . . . 74.04 110.091 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.545 HD11 HD23 ' C' ' 60' ' ' LEU . 82.3 mt -79.52 -15.55 57.54 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.831 -0.622 . . . . 74.13 112.409 -172.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.437 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 87.8 t80 -56.41 -55.6 40.69 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.284 1.034 . . . . 72.5 113.131 -175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 21.0 Cg_exo -66.24 -29.87 46.43 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.914 1.743 . . . . 74.23 112.828 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.409 ' HE2' HG22 ' A' ' 115' ' ' THR . 86.1 m-85 -65.64 -45.78 81.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.364 0.666 . . . . 73.33 110.881 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.63 91.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.437 0.695 . . . . 75.23 110.651 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -60.92 -57.1 14.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.749 1.22 . . . . 75.24 111.484 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -33.38 75.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.415 0.447 . . . . 75.33 110.008 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.491 ' SG ' HG12 ' C' ' 21' ' ' ILE . 26.1 t -61.2 -43.87 98.19 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.978 0.511 . . . . 71.54 110.565 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.426 ' CD1' HG13 ' C' ' 62' ' ' VAL . 66.4 mt -65.15 -43.98 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.177 0.591 . . . . 72.24 110.542 173.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -63.19 -33.15 74.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.441 0.697 . . . . 71.41 111.471 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.406 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 42.2 p -76.78 -41.61 43.95 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.84 -0.8 . . . . 73.12 108.84 178.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.598 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -54.95 -46.4 75.0 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.89 0.876 . . . . 70.03 112.111 178.043 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.81 -26.89 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.736 0.414 . . . . 72.12 111.126 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -70.88 -29.89 66.11 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.537 0.735 . . . . 72.55 111.416 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 50.6 mtt-85 -78.68 -33.17 47.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.744 0.818 . . . . 75.04 109.39 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.69 1.53 61.82 Favored Glycine 0 C--N 1.361 1.937 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.881 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 61.74 25.2 15.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.381 1.873 . . . . 60.21 113.069 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -103.4 156.44 35.46 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.35 1.06 . . . . 72.24 110.421 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -40.66 118.9 0.67 Allowed 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 124.238 3.292 . . . . 73.43 113.779 175.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.16 139.55 57.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.54 -0.754 . . . . 72.31 111.743 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.18 105.7 15.86 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.029 -1.1 . . . . 75.44 108.029 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.18 112.66 22.98 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.211 -1.403 . . . . 72.44 107.211 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.442 HD13 HD22 ' C' ' 42' ' ' LEU . 20.4 tp -84.6 141.86 30.37 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 123.597 0.561 . . . . 75.21 110.039 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.35 145.29 63.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.686 -0.688 . . . . 71.24 112.095 -170.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.596 ' HG3' HD11 ' A' ' 16' ' ' ILE . 5.3 Cg_endo -46.8 102.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.977 3.118 . . . . 73.2 112.762 169.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -96.25 106.71 18.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.042 -1.466 . . . . 65.51 107.042 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.559 HD22 HD12 ' A' ' 13' ' ' ILE . 77.6 m-20 -98.77 85.68 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.541 -1.281 . . . . 72.01 107.541 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -51.22 -38.3 51.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.342 1.057 . . . . 71.34 111.9 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.48 -38.47 62.9 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.211 1.004 . . . . 71.55 111.811 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.93 -28.86 67.03 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.935 0.494 . . . . 63.13 111.078 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 mp -56.13 -41.02 74.68 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.821 0.701 . . . . 72.13 110.888 171.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -66.48 -29.92 70.14 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.088 0.555 . . . . 75.22 111.883 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 65.1 mtt -74.07 -31.59 62.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.186 0.594 . . . . 72.32 110.843 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . 0.482 HD22 ' HB2' ' H' ' 310' ' ' PRO . 83.7 m-20 -69.64 -38.09 77.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.529 0.732 . . . . 72.24 109.897 174.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -66.56 -82.52 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.57 0.748 . . . . 74.3 110.068 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 41.7 tp -115.17 93.06 4.14 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.001 0.52 . . . . 73.32 110.586 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.17 -98.97 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.421 -1.326 . . . . 75.3 107.421 168.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -156.62 112.82 3.01 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.656 1.182 . . . . 73.43 108.411 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -90.83 93.93 9.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.652 -1.24 . . . . 74.35 107.652 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.74 141.62 15.81 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.623 0.769 . . . . 53.41 110.352 -170.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -174.76 144.94 7.68 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.806 -0.634 . . . . 61.31 112.088 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -167.4 148.76 5.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.713 0.405 . . . . 55.22 110.735 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.17 -89.7 0.08 OUTLIER Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.773 -0.931 . . . . 73.55 110.773 174.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.466 ' HA ' ' HB3' ' A' ' 53' ' ' ASP . 33.6 p 61.6 128.43 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.079 2.152 . . . . 73.45 111.71 -175.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 16.0 pt-20 -135.85 -175.06 3.84 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.524 0.73 . . . . 74.44 110.787 -171.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.26 111.54 10.32 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.027 -1.842 . . . . 73.31 106.027 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.503 ' HB3' HE22 ' A' ' 50' ' ' GLN . 33.9 t-80 -167.89 112.4 0.66 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.431 -0.952 . . . . 75.04 108.431 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -83.26 120.9 26.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.409 0.684 . . . . 73.44 109.927 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -119.19 147.08 44.62 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.176 0.59 . . . . 74.31 111.078 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.306 0 C-N-CA 123.992 0.917 . . . . 74.55 110.66 -178.886 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.844 -0.428 . . . . 72.33 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -84.14 76.07 10.12 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.261 0.625 . . . . 70.13 109.836 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -86.0 93.68 9.03 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.775 -0.648 . . . . 64.42 110.188 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -76.46 176.58 8.12 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.614 -0.721 . . . . 72.54 110.588 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -156.04 -60.8 0.1 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.301 0.64 . . . . 74.34 109.454 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -143.31 124.46 14.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.808 0.843 . . . . 71.1 109.196 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -123.21 -12.72 7.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.597 0.759 . . . . 73.14 110.274 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.29 -0.48 56.7 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.156 0.982 . . . . 75.01 111.013 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 8.1 ttp -30.88 127.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.457 1.503 . . . . 73.35 113.583 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.549 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 25.7 m -118.83 139.34 51.77 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.437 0.695 . . . . 70.41 109.726 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -157.68 116.4 3.19 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.537 -1.283 . . . . 71.34 107.537 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.59 140.52 44.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.876 -1.157 . . . . 60.22 107.876 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.494 HD12 HG21 ' D' ' 105' ' ' ILE . 8.7 mt -97.46 124.77 50.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.017 -0.735 . . . . 73.54 109.017 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.82 -37.54 12.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.485 0.714 . . . . 64.24 110.344 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -161.12 148.34 15.17 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 75.54 110.675 -173.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.46 HD12 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -135.34 114.66 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.302 -2.11 . . . . 75.32 105.302 166.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -151.72 151.53 31.55 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.576 0.703 . . . . 72.21 111.081 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -77.32 109.89 11.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.761 -1.108 . . . . 72.53 109.134 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.498 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 34.9 mtpt -79.28 -33.16 43.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.46 . . . . 75.45 110.041 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -141.33 142.2 33.82 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.371 -0.974 . . . . 72.42 108.371 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.598 HG23 ' HE1' ' C' ' 117' ' ' MET . 98.0 mt -133.06 140.91 46.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.574 -1.639 . . . . 75.31 106.574 173.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -146.7 136.47 23.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.605 0.762 . . . . 51.43 109.116 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 57.2 t80 -148.72 123.68 10.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.764 -1.939 . . . . 73.22 105.764 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.12 142.12 51.69 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.431 0.692 . . . . 75.21 109.298 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.66 80.36 66.55 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.913 -1.143 . . . . 64.45 107.913 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.79 -29.97 27.96 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.733 2.289 . . . . 74.01 111.784 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -114.47 40.74 2.47 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.959 1.304 . . . . 73.53 108.775 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.475 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -55.11 -66.41 1.0 Allowed Pre-proline 0 CA--C 1.563 1.453 0 N-CA-C 114.315 1.228 . . . . 74.44 114.315 -166.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' D' ' 28' ' ' ALA . 24.9 Cg_endo -86.21 -3.92 8.66 Favored 'Trans proline' 0 C--N 1.387 2.578 0 CA-C-N 123.074 2.134 . . . . 74.44 112.123 176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.25 -39.86 68.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.933 1.293 . . . . 74.33 109.901 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.29 -28.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.337 -0.392 . . . . 75.25 110.1 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.98 -2.33 3.89 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.235 1.198 . . . . 64.04 114.235 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -76.83 -38.18 54.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.145 0.578 . . . . 64.12 109.672 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.478 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -136.3 96.69 3.42 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.373 0.669 . . . . 74.42 112.303 173.011 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -107.13 98.03 7.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 164.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.543 ' H ' HD12 ' D' ' 68' ' ' LEU . 5.6 m-90 -122.31 -162.85 1.03 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.231 -1.766 . . . . 71.15 106.231 169.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.574 ' HB3' ' HB1' ' G' ' 295' ' ' ALA . 26.6 mt-30 -52.52 104.23 0.42 Allowed Pre-proline 0 N--CA 1.486 1.367 0 CA-C-N 118.66 0.664 . . . . 75.02 112.521 -168.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -75.7 105.07 2.01 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.662 2.241 . . . . 53.51 109.892 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -61.23 111.0 1.56 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.701 -1.222 . . . . 74.44 107.701 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.533 HG11 HD13 ' D' ' 126' ' ' LEU . 2.2 m -104.61 149.42 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.797 -1.092 . . . . 74.22 110.876 -165.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.574 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.7 mmtt -109.17 133.05 53.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.069 0.947 . . . . 75.24 108.511 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -96.9 111.97 23.93 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.568 -1.271 . . . . 75.21 107.568 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.621 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -124.29 141.47 52.04 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.873 0.869 . . . . 72.22 108.79 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.74 167.14 22.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.22 0.533 . . . . 73.25 110.762 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.508 ' HB3' ' HD2' ' D' ' 61' ' ' ARG . 4.3 t70 -156.31 145.83 20.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.825 -1.176 . . . . 73.43 107.825 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.5 p -106.59 141.79 37.3 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.019 -0.734 . . . . 70.5 109.019 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.402 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -153.5 159.39 42.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.528 -0.915 . . . . 72.42 108.528 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 20.4 p -170.89 162.08 7.3 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.576 0.35 . . . . 63.43 110.931 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -152.0 152.24 32.2 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.212 0.605 . . . . 63.24 110.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -90.75 117.56 29.48 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.604 -0.887 . . . . 74.04 108.604 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.6 mt -93.21 -27.98 16.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.393 0.677 . . . . 72.41 109.434 176.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.94 177.11 6.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.319 1.048 . . . . 74.12 110.218 176.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.28 127.06 31.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.998 -1.112 . . . . 72.04 107.998 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 70.85 5.92 5.64 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.445 1.098 . . . . 74.42 111.856 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.3 t -125.51 115.22 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.252 1.021 . . . . 75.35 108.277 173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -135.92 130.84 34.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.12 0.568 . . . . 72.23 109.553 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' D' ' 51' ' ' LEU . 25.9 tt0 -90.26 136.12 33.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 73.0 109.881 178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.12 114.55 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.654 1.182 . . . . 74.12 108.26 175.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -101.85 108.89 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.553 0.741 . . . . 75.0 109.339 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.86 111.25 23.57 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.25 -1.019 . . . . 74.02 108.25 175.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.508 ' HD2' ' HB3' ' D' ' 45' ' ' ASP . 14.7 ttm180 -83.91 114.34 21.6 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.324 0.65 . . . . 72.41 109.489 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.4 123.69 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.202 -1.036 . . . . 75.21 108.202 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -129.65 135.32 48.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.324 0.65 . . . . 74.02 109.817 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.9 109.27 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.974 0.91 . . . . 74.55 109.574 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 31.3 m -102.46 102.37 12.66 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.08 -0.711 . . . . 73.3 109.08 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.77 129.35 43.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 110.059 -0.348 . . . . 73.53 110.059 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -124.27 124.11 41.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 64.14 109.152 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.543 HD12 ' H ' ' D' ' 36' ' ' TRP . 0.1 OUTLIER -90.9 96.57 10.7 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.512 -1.292 . . . . 75.33 107.512 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.14 -112.99 4.68 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.477 0.485 . . . . 74.33 112.548 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.95 6.43 48.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.306 1.042 . . . . 72.22 111.908 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -146.75 157.2 43.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.667 0.787 . . . . 73.23 109.336 -171.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -66.66 132.47 48.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.973 0.909 . . . . 70.02 111.909 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.08 -64.51 1.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.925 -0.769 . . . . 74.34 108.925 169.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.58 159.26 38.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.432 -1.258 . . . . 74.11 110.004 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.79 146.59 34.75 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 73.12 108.6 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.8 t -152.29 140.84 20.75 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.999 0.52 . . . . 72.32 110.171 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . 0.443 ' HG3' ' HG1' ' D' ' 63' ' ' THR . 33.5 tt0 -157.95 145.79 18.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.712 0.805 . . . . 74.03 109.872 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.8 116.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.322 1.049 . . . . 73.25 109.018 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.75 90.58 8.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.847 -0.797 . . . . 75.13 108.847 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -82.4 98.23 8.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.353 -0.84 . . . . 73.13 109.819 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.63 144.68 17.52 Favored Glycine 0 C--N 1.342 0.917 0 N-CA-C 111.602 -0.599 . . . . 53.51 111.602 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.31 130.92 4.15 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 111.142 -0.783 . . . . 71.31 111.142 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.7 123.23 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.525 -0.917 . . . . 72.22 108.525 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.68 126.66 37.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.814 0.846 . . . . 74.31 110.024 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.3 m -76.26 98.01 4.34 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.82 -0.807 . . . . 74.25 108.82 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 63.6 mt -107.81 109.94 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.376 -0.972 . . . . 74.53 108.376 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.549 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -151.16 168.33 25.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.108 0.963 . . . . 74.02 110.133 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.52 -20.2 19.63 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.04 -0.527 . . . . 44.01 114.008 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 pt -124.22 162.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.938 0.895 . . . . 73.41 111.178 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 173.67 13.83 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.368 -0.833 . . . . 70.01 111.054 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.83 -118.62 12.39 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 124.156 0.91 . . . . 70.32 114.042 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.7 m -74.54 -31.05 61.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 74.25 111.684 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.52 -43.76 89.06 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.994 0.518 . . . . 75.51 110.987 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' G' ' 276' ' ' PRO . 0.0 OUTLIER -75.55 -34.91 60.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.012 -0.54 . . . . 64.43 110.363 177.263 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.36 -29.35 68.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.136 0.574 . . . . 74.11 111.504 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -71.49 -49.74 38.3 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.614 0.766 . . . . 70.43 109.492 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.73 -39.06 93.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.753 -0.658 . . . . 71.1 111.155 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.441 HD21 HD13 ' G' ' 278' ' ' LEU . 58.5 tp -78.78 -37.08 41.87 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.499 1.12 . . . . 75.32 111.013 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.33 -23.28 24.79 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.089 -0.505 . . . . 55.0 113.901 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.86 -58.43 2.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.395 0.598 . . . . 71.34 111.635 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.63 -46.29 47.69 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.251 0.463 . . . . 71.31 112.251 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 76.1 m -64.91 -47.27 74.65 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.297 -0.858 . . . . 61.22 112.279 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.2 -34.27 97.49 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.444 2.096 . . . . 74.03 112.998 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.2 -30.11 69.96 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.093 0.957 . . . . 71.54 111.24 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.494 HG21 HD12 ' D' ' 13' ' ' ILE . 49.2 mm -72.41 -43.58 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.267 0.627 . . . . 73.31 110.266 175.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.93 -34.57 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.301 -0.863 . . . . 74.41 112.214 -170.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.71 -42.6 92.24 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 114.372 1.249 . . . . 74.22 114.372 -168.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.65 -42.84 54.44 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.464 2.109 . . . . 74.4 113.858 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -76.5 -27.99 56.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.458 0.703 . . . . 75.33 111.493 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.01 -54.29 36.58 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.983 0.42 . . . . 70.02 109.955 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -62.51 -34.22 76.44 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.622 -1.172 . . . . 75.13 111.285 -178.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.64 -52.87 58.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.357 1.063 . . . . 53.41 110.84 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.416 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 50.9 t -65.44 -43.68 89.7 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 114.841 -1.072 . . . . 73.42 111.377 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.3 mt -60.58 -56.7 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.752 0.821 . . . . 74.3 110.86 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 97.7 m -51.83 -42.71 62.75 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.32 1.048 . . . . 71.44 111.825 -179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.6 t -71.05 -28.4 64.35 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.399 -0.819 . . . . 75.23 111.645 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.459 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 77.0 mtm -77.99 -36.65 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.832 0.453 . . . . 75.3 111.391 177.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.481 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.7 t -64.5 -36.6 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.614 0.766 . . . . 75.51 110.752 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.542 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 84.9 p -69.71 -31.07 68.88 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.437 0.695 . . . . 65.52 111.322 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' D' ' 116' ' ' SER . 68.8 mtt-85 -74.79 -26.06 59.48 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.559 0.743 . . . . 74.25 110.821 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.32 10.07 62.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.572 0.545 . . . . 72.21 112.538 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p 63.7 23.14 13.39 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.386 1.874 . . . . 74.53 113.287 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.44 163.83 18.94 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.487 1.115 . . . . 71.42 109.438 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.64 155.48 44.68 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.221 1.947 . . . . 75.21 110.555 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.423 ' HG3' ' HG3' ' E' ' 304' ' ' PRO . 16.7 pt20 -55.57 147.27 18.36 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.513 0.725 . . . . 72.13 111.694 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.533 HD13 HG11 ' D' ' 40' ' ' VAL . 3.0 tt -126.39 106.19 9.32 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.059 -0.719 . . . . 74.35 109.059 -175.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -112.52 110.38 20.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.233 1.013 . . . . 70.43 110.577 -172.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.76 125.39 28.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.639 0.776 . . . . 73.53 108.993 171.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 145.54 99.01 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 122.395 0.278 . . . . 73.33 110.719 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.75 134.41 25.83 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.317 2.011 . . . . 73.5 111.378 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.41 HG21 HD22 ' G' ' 291' ' ' LEU . 41.5 t -108.89 120.23 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.152 -0.684 . . . . 52.54 109.152 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -86.41 82.42 7.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.395 0.678 . . . . 73.44 109.656 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -62.38 -28.57 69.86 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.174 0.99 . . . . 73.12 111.14 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -49.32 77.73 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 125.068 1.347 . . . . 73.25 110.439 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.83 94.44 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.944 0.898 . . . . 64.45 111.783 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.63 -34.42 77.84 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.197 -0.91 . . . . 75.41 111.683 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -80.3 -44.24 19.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.31 0.644 . . . . 72.53 110.738 -178.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.7 ptp -64.38 -26.38 68.44 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.876 0.47 . . . . 71.55 111.736 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -54.66 -49.35 70.81 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.432 1.093 . . . . 73.31 111.199 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -59.06 -36.42 75.02 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.937 0.895 . . . . 74.24 111.77 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.58 -31.73 62.16 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.435 0.694 . . . . 74.42 112.254 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -90.76 12.53 18.9 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.16 0.43 . . . . 74.12 112.16 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -116.68 75.52 0.97 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.641 0.734 . . . . 73.52 109.153 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.06 -25.36 0.08 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.523 -1.217 . . . . 75.03 110.652 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.24 132.48 23.22 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.671 -1.233 . . . . 60.22 107.671 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.22 73.49 2.47 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 123.734 0.646 . . . . 72.22 112.454 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -79.41 118.67 21.51 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.263 0.625 . . . . 74.11 109.347 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.05 57.51 0.12 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 123.489 0.493 . . . . 63.55 112.963 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 82.0 m -64.54 89.93 0.07 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.803 0.841 . . . . 73.34 110.038 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -179.17 166.23 1.52 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.365 1.466 . . . . 65.11 109.655 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -152.99 -59.24 0.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.103 0.961 . . . . 74.13 108.421 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 84.5 t60 42.5 75.38 0.09 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.83 1.652 . . . . 72.05 112.115 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -65.32 108.3 1.89 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.936 -0.575 . . . . 72.42 109.857 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -156.33 28.71 0.34 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.751 -0.658 . . . . 74.42 109.352 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 C-N-CA 124.033 0.933 . . . . 62.34 111.165 -174.68 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.873 -0.417 . . . . 73.54 109.873 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -169.12 154.09 5.83 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.216 1.006 . . . . 73.2 109.724 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -168.35 -85.22 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.811 0.845 . . . . 64.24 108.833 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -144.54 102.05 3.76 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.109 -1.071 . . . . 74.15 108.109 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -78.45 150.0 76.03 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.144 0.578 . . . . 75.24 111.11 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.84 132.08 36.04 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 123.953 3.102 . . . . 64.54 113.608 -173.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . 0.719 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 40.5 mt -73.73 -60.82 2.07 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.817 -1.083 . . . . 71.03 110.095 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.33 51.03 1.42 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.004 0.921 . . . . 72.15 109.568 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -102.8 16.81 54.16 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.099 -0.5 . . . . 73.12 112.643 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.436 HD22 ' HA ' ' A' ' 95' ' ' ALA . 64.3 tp -92.66 -65.37 1.01 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.122 0.569 . . . . 64.15 111.43 -173.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . 0.403 ' CD1' ' HB ' ' A' ' 46' ' ' THR . 21.7 m-30 -67.48 -36.48 81.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.639 0.776 . . . . 75.45 110.805 -176.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.05 -29.01 70.0 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.6 -1.182 . . . . 73.24 111.225 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.34 -54.87 4.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.859 0.864 . . . . 64.02 110.767 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -141.59 120.82 1.73 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.598 -0.728 . . . . 72.32 112.128 -171.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . 0.523 HD22 ' HA ' ' A' ' 45' ' ' ASP . 26.1 t-20 -80.07 120.77 24.67 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.423 1.089 . . . . 72.0 108.894 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 28.3 ttt -112.45 104.58 56.03 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.116 0.567 . . . . 72.21 111.118 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . 0.729 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 65.7 Cg_endo -85.04 176.04 6.21 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.724 2.283 . . . . 74.41 112.532 168.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.19 151.34 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.097 0.959 . . . . 74.04 109.105 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -103.57 156.24 17.93 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.568 0.747 . . . . 73.34 109.438 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -63.51 143.26 57.97 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.258 0.623 . . . . 72.25 110.844 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 6.9 mp -89.15 81.61 6.73 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.47 0.708 . . . . 75.3 109.992 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.25 -113.28 5.05 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-O 118.619 -1.101 . . . . 71.11 113.691 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.39 107.59 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.1 2.533 . . . . 73.33 111.688 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -115.37 19.68 15.34 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.667 1.187 . . . . 73.13 110.753 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.09 72.85 5.65 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.94 0.876 . . . . 52.23 110.337 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 296' ' ' THR . . . . . 0.411 HG21 HD11 ' A' ' 126' ' ' LEU . 43.9 m -86.8 -34.31 19.59 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.469 -1.241 . . . . 73.42 110.622 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.697 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 45.7 t80 -85.13 91.08 8.03 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.231 -0.895 . . . . 72.01 110.382 -172.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -93.72 -166.63 1.54 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.421 1.088 . . . . 75.5 109.977 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.25 67.72 0.22 Allowed Glycine 0 C--N 1.344 1.008 0 C-N-CA 122.796 0.236 . . . . 72.43 113.682 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -107.09 7.54 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.035 -0.728 . . . . 73.41 109.035 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 123' ' ' PHE . 25.2 pt -81.69 48.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.217 1.407 . . . . 72.45 110.397 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -108.24 -179.69 3.96 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.434 -0.803 . . . . 72.34 109.988 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -100.61 136.28 19.94 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-N 114.92 -1.037 . . . . 74.33 108.782 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . 0.423 ' HG3' ' HG3' ' D' ' 125' ' ' GLN . 74.1 Cg_exo -49.22 -41.41 41.97 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.476 2.117 . . . . 72.41 110.91 160.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . 0.544 ' HB3' ' HG2' ' G' ' 294' ' ' LYS . . . 50.14 47.73 23.12 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 125.468 1.73 . . . . 73.3 110.956 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 p -68.56 81.35 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-O 123.233 1.492 . . . . 73.43 108.566 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 11.6 t -101.4 175.4 5.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 112.908 -1.951 . . . . 72.13 109.205 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 53.9 m 63.46 20.84 12.47 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.079 0.952 . . . . 74.34 111.703 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' E' E ' 309' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' B' ' 12' ' ' GLN . 36.7 m -70.54 142.54 89.1 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.249 1.019 . . . . 65.44 108.548 171.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo . . . . . 0 C--N 1.379 2.159 0 C-N-CA 122.819 2.346 . . . . 73.43 112.315 172.063 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 110.198 -0.297 . . . . 74.33 110.198 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.8 -176.29 4.0 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.709 0.804 . . . . 73.53 109.398 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -84.93 -171.3 3.56 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.17 0.588 . . . . 70.25 109.651 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.76 99.07 0.08 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.832 0.853 . . . . 72.51 108.859 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -45.55 -40.54 14.1 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 115.073 1.509 . . . . 74.21 115.073 -168.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.43 61.23 6.7 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 121.364 1.376 . . . . 71.14 111.873 163.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.509 ' HB3' ' SD ' ' C' ' 94' ' ' MET . 5.5 mp -61.5 101.86 0.21 Allowed 'General case' 0 C--N 1.363 1.195 0 C-N-CA 122.916 0.486 . . . . 74.11 110.16 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 15.6 tp -168.66 168.17 10.93 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.226 0.61 . . . . 73.23 109.785 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -171.15 -126.84 0.9 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 111.358 -0.697 . . . . 75.11 111.358 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . 0.401 ' HB3' ' HB1' ' C' ' 95' ' ' ALA . 8.0 tt -63.97 108.5 1.52 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.276 1.03 . . . . 73.32 109.562 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -162.5 -69.72 0.05 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.256 0.622 . . . . 75.41 110.787 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . 0.468 ' HA ' ' OG1' ' C' ' 46' ' ' THR . . . -68.24 -46.55 70.18 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.358 0.663 . . . . 64.24 111.314 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -86.57 -0.0 55.27 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.507 -0.77 . . . . 71.0 110.712 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -91.15 15.65 60.56 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 115.908 -0.587 . . . . 73.4 113.508 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -71.43 95.3 1.34 Allowed 'General case' 0 C--N 1.351 0.64 0 N-CA-C 108.333 -0.988 . . . . 74.23 108.333 174.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 69.7 mtm -67.24 133.11 93.35 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.25 -0.886 . . . . 74.12 109.617 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.74 84.29 0.23 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.74 2.294 . . . . 75.42 112.233 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 84.6 t -90.28 -51.84 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 114.72 -1.127 . . . . 63.02 108.251 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 67.24 -75.27 0.06 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.322 1.449 . . . . 64.22 109.992 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -137.89 124.25 20.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.321 -0.992 . . . . 74.33 108.321 169.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.595 ' H ' HD12 ' F' ' 291' ' ' LEU . 0.0 OUTLIER -74.93 -14.97 60.7 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.252 0.621 . . . . 74.25 110.563 174.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -173.77 97.81 0.12 Allowed Glycine 0 C--N 1.35 1.323 0 CA-C-O 118.884 -0.953 . . . . 73.41 111.035 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.47 -174.7 1.1 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.807 2.338 . . . . 65.05 111.439 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 62.0 29.47 17.72 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.113 0.958 . . . . 75.43 109.944 -176.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . 0.705 ' HA ' ' HB3' ' H' ' 303' ' ' LYS . . . -117.77 117.98 30.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.209 1.004 . . . . 75.12 110.877 -172.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 41.4 m 63.58 98.88 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.14 1.376 . . . . 73.34 111.867 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -77.16 156.43 31.59 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.637 0.375 . . . . 74.54 110.37 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -149.67 102.27 3.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.824 1.25 . . . . 74.25 108.49 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . 0.549 ' HA2' HG21 ' C' ' 31' ' ' VAL . . . -167.14 -139.28 2.63 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.8 -0.444 . . . . 75.55 112.341 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -71.44 141.22 50.27 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.114 -0.699 . . . . 71.54 109.114 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 30.5 mm -116.33 147.75 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.772 0.429 . . . . 74.44 110.117 -170.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.88 91.35 0.09 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.687 -0.486 . . . . 74.41 109.687 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 42.4 tptt 49.45 82.77 0.23 Allowed Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 126.229 1.812 . . . . 73.33 112.54 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.23 9.03 3.54 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.833 2.355 . . . . 71.33 114.425 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -83.23 145.43 29.14 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.069 0.548 . . . . 64.21 110.927 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.68 151.49 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.016 -0.735 . . . . 74.01 109.016 172.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 5.0 m -80.59 62.6 4.73 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.756 0.822 . . . . 74.43 110.807 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 82.9 m 51.75 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.813 1.645 . . . . 72.54 113.518 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 20.5 p -73.21 146.63 87.13 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 119.036 -0.507 . . . . 73.13 110.664 173.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 C--N 1.38 2.189 0 C-N-CA 122.957 2.438 . . . . 74.34 111.904 -179.537 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.674 0.273 . . . . 71.43 110.661 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -145.39 174.54 11.04 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.841 -0.8 . . . . 74.12 108.841 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 73.61 128.64 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.165 1.386 . . . . 65.44 110.717 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.89 139.92 58.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.027 0.931 . . . . 73.51 111.882 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -95.34 101.28 7.25 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 107.549 -1.278 . . . . 71.1 107.549 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' D' ' 94' ' ' MET . 71.3 Cg_exo -53.12 -44.48 48.52 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.475 2.783 . . . . 72.42 113.135 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.58 144.52 51.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.954 0.902 . . . . 75.12 108.888 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . 0.441 HD13 HD21 ' D' ' 98' ' ' LEU . 3.8 mm? 64.78 41.81 4.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.064 0.946 . . . . 75.53 111.354 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -102.56 -1.37 50.0 Favored Glycine 0 N--CA 1.472 1.087 0 CA-C-N 115.427 -0.806 . . . . 72.23 113.398 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 4.6 tt -163.96 114.81 1.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.088 -1.078 . . . . 74.31 108.088 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -163.82 -70.8 0.04 OUTLIER 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.565 0.746 . . . . 74.11 110.77 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.54 68.78 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.408 0.683 . . . . 74.14 111.692 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -78.28 -4.96 50.5 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.393 1.077 . . . . 74.32 111.669 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.78 80.73 0.33 Allowed Glycine 0 C--N 1.352 1.448 0 O-C-N 123.886 0.741 . . . . 75.31 112.371 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -76.69 91.07 3.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.414 1.085 . . . . 72.01 110.144 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 88.9 mtp -118.56 90.57 39.75 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 107.568 -1.271 . . . . 75.22 107.568 170.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.92 101.98 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.137 2.558 . . . . 74.42 112.742 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 51.8 t -84.69 108.64 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.565 0.746 . . . . 72.23 109.401 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -69.22 159.14 33.58 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.637 0.775 . . . . 74.21 110.783 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 103.76 6.25 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 107.139 -1.43 . . . . 70.32 107.139 171.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.459 HD21 HG23 ' E' ' 309' ' ' THR . 0.3 OUTLIER -82.49 25.11 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.273 1.029 . . . . 75.42 112.246 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -150.84 91.98 0.14 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 110.627 -0.989 . . . . 63.35 110.627 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.03 -15.36 29.18 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.166 2.577 . . . . 75.13 112.407 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . 0.544 ' HG2' ' HB3' ' E' ' 305' ' ' ALA . 17.4 tppt? -78.81 123.94 27.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.395 0.678 . . . . 75.45 109.665 174.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' D' ' 37' ' ' GLN . . . -89.65 131.49 35.61 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.263 -1.014 . . . . 73.24 108.263 172.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 5.5 t -62.7 96.08 0.08 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.81 0.844 . . . . 74.33 113.232 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.481 ' HB2' ' HA ' ' D' ' 37' ' ' GLN . 0.2 OUTLIER 179.12 163.17 0.83 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.775 1.63 . . . . 71.11 108.21 171.058 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -159.29 -37.52 0.06 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.303 1.041 . . . . 74.11 109.381 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -88.74 -125.14 2.43 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.815 -0.63 . . . . 52.3 112.271 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -168.23 151.82 5.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.351 0.66 . . . . 75.42 111.489 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.482 HD12 HH12 ' C' ' 15' ' ' ARG . 2.8 pp -125.64 146.47 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.95 -1.13 . . . . 75.4 107.95 158.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -132.53 169.48 16.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.522 -0.918 . . . . 75.25 108.522 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -55.42 110.66 2.38 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.716 1.206 . . . . 62.42 110.859 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.61 144.6 22.52 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.134 1.89 . . . . 75.44 110.625 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -138.27 86.16 2.14 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.853 0.461 . . . . 64.33 109.888 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.523 HG21 ' HB2' ' C' ' 12' ' ' GLN . 26.6 m -91.69 153.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.118 -1.067 . . . . 74.4 108.118 169.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 30.1 m -149.05 149.42 31.08 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.947 0.499 . . . . 75.13 109.814 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 53.8 t 67.13 87.17 0.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.995 1.318 . . . . 70.2 112.16 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 96.8 m -122.86 103.87 36.59 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 108.126 -1.064 . . . . 61.04 108.126 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 C--N 1.378 2.084 0 C-N-CA 123.573 2.849 . . . . 74.25 111.796 176.351 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.544 -0.169 . . . . 73.23 110.544 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -157.23 -81.9 0.06 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.604 0.762 . . . . 72.13 109.189 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 63.69 127.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.043 1.337 . . . . 73.42 111.908 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.29 136.48 47.93 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.649 0.379 . . . . 72.21 110.735 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . 0.562 ' HB2' ' HZ1' ' H' ' 275' ' ' LYS . 4.8 ttmp? -107.51 102.37 44.1 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.519 0.727 . . . . 75.31 109.204 177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.82 -65.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.575 2.183 . . . . 74.42 110.467 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.636 ' HB3' ' HH ' ' B' ' 56' ' ' TYR . 35.6 tp -160.82 46.45 0.21 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.849 -1.537 . . . . 64.22 106.849 172.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 26.3 tp -167.51 136.11 2.56 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.253 -1.34 . . . . 73.02 108.399 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 173.1 -43.69 0.16 Allowed Glycine 0 C--N 1.345 1.071 0 O-C-N 123.178 0.299 . . . . 72.52 112.794 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 97.4 mt -96.04 109.45 21.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.417 0.687 . . . . 75.32 110.068 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -163.12 -66.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.151 0.581 . . . . 75.45 109.973 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -84.43 12.76 6.3 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.248 1.019 . . . . 75.22 112.261 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.31 -46.56 10.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.079 0.952 . . . . 74.23 110.26 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -85.6 74.05 2.49 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.927 -0.579 . . . . 72.54 111.756 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -78.61 78.74 5.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.321 0.648 . . . . 70.23 109.593 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 72.8 mtm -77.31 119.82 79.02 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.738 -1.208 . . . . 62.25 107.738 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.99 81.8 0.48 Allowed 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.763 2.309 . . . . 73.11 112.002 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.52 81.62 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 108.497 -0.927 . . . . 73.11 108.497 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -78.92 -67.82 0.71 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.747 -1.115 . . . . 74.22 109.272 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -159.85 155.46 25.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.626 1.17 . . . . 74.41 110.16 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.505 HD12 HG21 ' B' ' 131' ' ' VAL . 4.9 mp -97.33 76.61 2.6 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.095 -0.957 . . . . 73.22 108.546 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 82.4 177.35 51.85 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.106 -0.952 . . . . 73.25 113.798 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.45 126.41 20.66 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.844 3.03 . . . . 60.23 111.405 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . 0.567 ' HZ3' ' HB2' ' H' ' 294' ' ' LYS . 0.1 OUTLIER -132.0 114.3 14.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.67 0.271 . . . . 71.52 110.821 -172.439 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . 0.528 ' HB1' ' HB2' ' H' ' 298' ' ' HIS . . . -77.25 102.49 6.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.758 0.823 . . . . 72.12 110.276 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 11.3 m -64.45 -49.55 70.99 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.818 0.818 . . . . 64.03 109.977 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.523 ' H ' ' HB3' ' B' ' 37' ' ' GLN . 28.0 m-85 -128.32 -20.31 3.72 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.191 -1.368 . . . . 73.54 110.1 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . 0.528 ' HB2' ' HB1' ' H' ' 295' ' ' ALA . 55.3 t-80 60.29 -83.21 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.921 1.288 . . . . 73.01 110.074 -171.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -174.88 28.65 0.08 OUTLIER Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.642 -1.383 . . . . 65.45 109.642 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -132.01 53.76 1.98 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.284 1.034 . . . . 74.33 109.804 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 21.5 pt -78.1 69.38 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 107.022 -1.473 . . . . 74.15 107.022 163.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -46.32 -56.08 6.34 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 113.544 -1.662 . . . . 74.23 112.195 -163.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.705 ' HB3' ' HA ' ' F' ' 295' ' ' ALA . 39.6 ttmt -175.23 111.65 0.27 Allowed Pre-proline 0 C--O 1.243 0.721 0 O-C-N 124.825 1.328 . . . . 75.33 108.035 166.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.99 94.8 0.41 Allowed 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.07 1.847 . . . . 74.33 108.809 165.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' F' ' 295' ' ' ALA . . . -65.56 84.78 0.07 Allowed 'General case' 0 C--N 1.35 0.599 0 O-C-N 123.831 0.707 . . . . 73.43 109.91 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . 0.545 HG12 ' HA ' ' A' ' 15' ' ' ARG . 70.7 t -154.85 -34.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.276 2.23 . . . . 74.32 106.468 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 307' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 37.7 p -59.58 110.91 1.23 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.318 -1.31 . . . . 63.3 112.36 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 85.9 m 69.43 95.04 0.07 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.485 1.514 . . . . 73.13 112.105 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 36.4 p -132.19 135.48 26.52 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.43 1.092 . . . . 72.53 109.684 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . 0.482 ' HB2' HD22 ' C' ' 139' ' ' ASN . 60.6 Cg_endo . . . . . 0 CA--C 1.568 2.188 0 C-N-CA 123.073 2.515 . . . . 62.41 111.756 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.142 0.02 . . . . 74.2 110.98 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -82.8 102.3 11.5 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.316 0.646 . . . . 73.32 110.618 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -138.31 30.98 2.39 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.385 1.074 . . . . 63.41 109.648 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -79.12 106.9 11.49 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.904 0.482 . . . . 74.21 110.082 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -76.25 165.11 25.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.16 0.984 . . . . 74.22 109.223 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.2 t30 67.49 42.11 2.22 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.573 1.178 . . . . 72.5 108.799 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 t -74.47 92.85 2.39 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.547 -1.206 . . . . 65.33 109.261 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' C' ' 144' ' ' GLN . 39.6 tt0 -62.17 -57.79 10.2 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.041 -0.981 . . . . 72.1 112.123 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.582 ' H ' ' HA3' ' A' ' 88' ' ' GLY . 44.7 ttp 63.08 133.69 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 113.646 -1.615 . . . . 72.02 111.815 -170.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m -151.59 143.08 23.53 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.675 -1.231 . . . . 72.5 107.675 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.558 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.7 t80 -137.59 124.6 21.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.982 0.513 . . . . 73.02 109.984 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -153.38 112.02 3.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.731 -0.84 . . . . 73.13 108.731 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.579 HG12 ' HD2' ' A' ' 84' ' ' PHE . 67.8 mt -73.96 130.31 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.986 0.514 . . . . 75.03 110.418 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -91.55 -32.13 15.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.478 1.111 . . . . 72.33 111.068 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -164.69 140.71 5.86 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.752 0.421 . . . . 74.23 110.764 -172.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.78 123.73 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.935 -1.506 . . . . 74.32 106.935 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.591 ' HB3' HG21 ' B' ' 122' ' ' THR . 3.2 p90 -163.52 149.22 11.38 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.534 0.683 . . . . 74.55 112.703 -173.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.474 HG22 ' SG ' ' A' ' 113' ' ' CYS . 76.7 p -77.61 112.68 14.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.116 -0.947 . . . . 53.44 109.075 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -77.94 -25.97 48.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.362 -0.381 . . . . 73.45 110.522 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.663 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.4 t70 -152.42 144.12 23.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.245 0.966 . . . . 75.24 110.301 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -138.08 141.85 37.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 125.635 1.574 . . . . 73.25 107.055 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.32 119.01 4.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.594 0.559 . . . . 74.42 109.807 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 81.2 t80 -111.31 127.18 55.56 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 106.381 -1.711 . . . . 73.35 106.381 167.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.61 108.9 9.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.533 -0.544 . . . . 73.33 109.533 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.92 82.99 1.97 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.841 -1.17 . . . . 71.14 107.841 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.77 -35.84 26.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.006 2.471 . . . . 74.41 112.347 -169.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -116.4 33.8 5.36 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.142 -0.935 . . . . 60.25 108.867 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.66 -61.04 3.95 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.279 -0.867 . . . . 74.42 113.021 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 -0.2 8.18 Favored 'Trans proline' 0 C--N 1.386 2.522 0 CA-C-N 121.765 1.666 . . . . 72.43 113.812 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -99.59 -42.61 6.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.139 0.976 . . . . 75.32 110.916 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.519 HG22 ' HA ' ' A' ' 73' ' ' ALA . 9.4 p -77.1 -21.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.309 -0.859 . . . . 72.1 111.876 -163.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -76.8 0.57 20.17 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.126 0.57 . . . . 74.2 111.259 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -100.95 -22.57 14.75 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.631 1.173 . . . . 74.2 111.513 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.69 172.73 13.3 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.971 0.908 . . . . 75.22 113.24 -168.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 136.9 51.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.11 0.964 . . . . 71.14 111.249 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.404 ' HB3' ' O ' ' E' ' 298' ' ' HIS . 19.2 m95 -82.17 75.71 9.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.718 0.807 . . . . 75.52 110.478 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.96 69.37 9.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.961 -1.018 . . . . 75.1 110.043 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HG3' ' HB3' ' E' ' 297' ' ' TYR . 60.0 Cg_endo -73.06 118.12 5.41 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.029 1.819 . . . . 65.54 111.107 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.72 118.66 31.7 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.601 -1.629 . . . . 74.51 106.601 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.643 ' HB ' ' HE1' ' E' ' 290' ' ' TRP . 43.9 t -104.9 116.45 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 122.855 0.462 . . . . 75.32 110.115 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.423 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 27.8 ttpp -100.19 123.52 44.52 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.217 1.007 . . . . 74.53 109.694 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.463 1.105 . . . . 75.3 108.204 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.708 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -111.65 115.39 29.04 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.466 -0.939 . . . . 71.5 108.466 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 tt -97.9 117.95 33.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.176 -1.416 . . . . 71.13 107.176 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.63 136.24 28.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.624 0.77 . . . . 75.1 109.197 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 m -149.3 150.91 33.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.793 0.437 . . . . 74.33 110.5 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.57 154.7 41.82 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.92 0.888 . . . . 60.35 110.142 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.8 p -120.48 161.59 21.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.848 0.459 . . . . 64.34 110.702 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -156.58 119.17 4.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 63.12 108.249 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -80.95 104.79 11.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.672 -0.862 . . . . 72.21 108.672 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.729 HD12 ' HB2' ' A' ' 57' ' ' GLU . 60.1 mt -79.33 -41.95 26.79 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.682 0.793 . . . . 73.25 111.127 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.455 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -147.17 -172.65 4.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.777 0.831 . . . . 74.32 109.978 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.519 ' HB2' ' HA ' ' C' ' 150' ' ' GLU . 7.8 p-10 -73.62 125.06 27.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.021 -0.733 . . . . 64.41 109.021 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 66.56 5.56 3.91 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.731 1.212 . . . . 61.23 113.15 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 84.2 t -121.94 120.59 61.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.678 0.791 . . . . 74.22 108.904 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.454 ' CE2' HG12 ' A' ' 86' ' ' ILE . 2.0 p90 -133.91 171.04 14.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.499 0.666 . . . . 72.41 110.061 172.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.729 ' HB2' HD12 ' A' ' 51' ' ' LEU . 34.4 tt0 -121.44 140.42 52.17 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.821 -1.536 . . . . 73.43 108.653 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -123.26 126.7 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 107.154 -1.424 . . . . 74.12 107.154 165.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.9 t -106.65 115.45 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.24 -0.652 . . . . 74.35 109.24 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 100.48 12.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.457 -1.312 . . . . 64.23 107.457 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.49 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 12.4 ttp180 -85.82 106.38 17.01 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.878 -0.786 . . . . 72.42 108.878 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.61 131.46 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.142 -1.429 . . . . 72.14 107.142 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.708 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.5 m -127.81 125.58 40.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.575 -0.898 . . . . 72.14 108.575 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG12 HD21 ' A' ' 126' ' ' LEU . 44.7 t -119.35 115.22 47.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.055 -0.975 . . . . 74.32 108.81 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.8 m -102.14 146.21 28.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.64 -0.874 . . . . 75.11 108.64 172.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.08 132.08 26.15 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.868 -1.16 . . . . 74.45 107.868 172.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 m -142.78 128.01 18.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.52 0.513 . . . . 72.33 110.619 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.422 HD11 ' HB2' ' A' ' 73' ' ' ALA . 10.3 mp -87.05 84.29 7.33 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.561 -1.274 . . . . 73.01 107.561 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.6 -116.4 4.88 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 114.708 -1.133 . . . . 64.24 111.757 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.26 -16.05 34.21 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.053 0.941 . . . . 72.43 110.823 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -95.27 116.29 28.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.279 1.032 . . . . 73.41 109.963 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.2 m -70.31 132.13 45.21 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.617 0.644 . . . . 74.24 111.05 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -80.49 -60.94 2.13 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.237 1.015 . . . . 73.33 109.416 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.08 170.17 21.82 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.19 -0.914 . . . . 75.23 111.22 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -141.99 112.42 7.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.196 -1.366 . . . . 63.23 107.368 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 70.7 m -111.93 104.4 12.68 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.469 0.708 . . . . 71.42 111.016 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.436 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.7 tt0 -113.4 115.74 28.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.406 1.082 . . . . 72.34 109.636 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.04 115.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.952 0.901 . . . . 75.23 109.399 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.2 mt-30 -84.86 85.62 7.45 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.966 -0.753 . . . . 73.35 108.966 169.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.39 96.2 4.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.515 0.726 . . . . 72.33 109.814 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.66 147.45 22.09 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 111.852 -0.499 . . . . 52.01 111.852 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.439 ' HA3' HD22 ' A' ' 106' ' ' LEU . . . -143.19 143.16 12.1 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.661 -0.975 . . . . 73.2 110.661 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -109.24 127.65 65.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.044 -1.095 . . . . 74.32 108.044 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.579 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.8 m-85 -128.72 120.17 25.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.14 -1.059 . . . . 74.25 108.14 -171.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -88.88 110.19 20.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.493 -0.929 . . . . 73.0 108.493 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.567 HD11 HD13 ' A' ' 89' ' ' ILE . 2.5 pp -124.76 162.47 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.089 1.356 . . . . 74.52 109.915 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.78 135.89 1.91 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.326 0.65 . . . . 70.52 109.659 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.582 ' HA3' ' H ' ' A' ' 9' ' ' MET . . . 108.97 8.77 27.28 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.218 -0.768 . . . . 65.12 114.076 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.567 HD13 HD11 ' A' ' 86' ' ' ILE . 2.2 pp -120.91 154.09 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 117.931 0.865 . . . . 75.33 112.044 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.57 170.96 18.87 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.094 -0.957 . . . . 65.21 108.62 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.31 -119.02 9.29 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 115.962 1.145 . . . . 72.1 115.962 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -76.19 -20.29 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.424 0.689 . . . . 74.31 111.818 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.99 -50.35 23.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.098 0.559 . . . . 72.51 110.253 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -64.26 -35.69 81.67 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.504 0.502 . . . . 74.14 109.83 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.37 91.02 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.648 0.779 . . . . 71.53 111.004 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.5 t-80 -70.75 -28.93 65.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.3 -0.864 . . . . 73.3 110.75 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 32.6 t -73.43 -37.17 65.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.2 0.524 . . . . 74.14 110.292 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.53 HD11 HD23 ' E' ' 278' ' ' LEU . 82.2 mt -78.59 -36.01 44.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.13 0.972 . . . . 74.43 112.016 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.82 3.96 34.14 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.637 -0.535 . . . . 62.34 114.294 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.409 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -148.14 -63.88 0.25 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.623 0.711 . . . . 73.52 112.818 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 57.4 t80 -62.84 -61.28 2.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.435 1.094 . . . . 74.42 112.831 -169.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -70.78 -34.89 3.94 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.495 0.924 . . . . 71.31 113.495 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -46.12 -48.37 13.05 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.701 2.267 . . . . 75.34 113.881 162.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.65 -27.89 68.71 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.312 1.045 . . . . 74.13 111.013 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 13' ' ' ILE . 43.5 mm -70.07 -47.69 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.591 0.756 . . . . 73.11 110.593 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.439 HD22 ' HA3' ' A' ' 82' ' ' GLY . 89.4 mt -73.61 -31.25 63.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.335 -0.848 . . . . 73.52 112.177 -171.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.487 ' HZ ' HD11 ' A' ' 128' ' ' LEU . 45.2 t80 -59.13 -44.18 98.22 Favored Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 113.866 1.062 . . . . 72.32 113.866 -170.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.81 -38.64 94.2 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.567 2.178 . . . . 74.21 114.359 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -71.41 -40.13 70.68 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.27 0.628 . . . . 74.45 111.64 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.23 -42.15 93.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.938 0.495 . . . . 75.22 109.951 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -53.39 -55.02 28.41 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 124.583 1.177 . . . . 73.52 110.41 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.55 -41.26 93.22 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.151 0.907 . . . . 75.54 110.662 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.474 ' SG ' HG22 ' A' ' 18' ' ' THR . 47.5 t -58.5 -36.29 73.55 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.104 0.478 . . . . 75.31 111.302 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 118' ' ' VAL . 24.2 mt -72.23 -51.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.963 0.905 . . . . 74.42 109.982 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 97.7 m -53.81 -40.69 66.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.765 1.226 . . . . 74.12 111.346 -173.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -62.29 -48.96 77.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.318 -1.31 . . . . 63.32 109.514 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.491 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.0 mtm -64.05 -40.66 96.79 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.563 0.745 . . . . 75.55 111.24 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.2 t -58.33 -48.63 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.058 0.943 . . . . 74.11 110.364 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.4 t -71.45 -28.99 64.34 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.331 -0.85 . . . . 73.32 111.253 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -71.11 -29.1 64.84 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.502 0.721 . . . . 75.12 110.195 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.58 2.79 66.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.65 0.594 . . . . 71.2 112.936 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.2 m 65.86 24.17 11.3 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.211 1.404 . . . . 73.5 110.521 177.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -94.45 140.54 22.75 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.538 -1.282 . . . . 75.03 107.538 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.411 ' HG2' ' CD1' ' E' ' 297' ' ' TYR . 64.2 Cg_exo -44.5 134.46 9.55 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.079 2.519 . . . . 63.24 113.898 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.489 ' HB3' ' HZ2' ' G' ' 303' ' ' LYS . 28.6 tt0 -46.5 130.79 11.14 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.411 1.084 . . . . 74.3 112.864 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.588 HD21 HG12 ' A' ' 64' ' ' VAL . 23.1 tp -108.11 100.99 10.26 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.541 1.137 . . . . 73.4 109.48 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -101.94 103.2 13.83 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.926 -1.139 . . . . 64.21 107.926 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.487 HD11 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -68.18 124.55 23.75 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 108.635 -0.876 . . . . 75.43 108.635 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.502 ' HB2' HD13 ' E' ' 291' ' ' LEU . . . -60.09 130.7 89.26 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.384 0.674 . . . . 74.03 111.854 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' G' ' 309' ' ' THR . 3.1 Cg_exo -76.56 146.17 27.01 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.988 2.459 . . . . 71.34 112.351 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.5 t -130.56 131.4 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.833 0.853 . . . . 74.03 109.408 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.09 96.03 2.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.977 -0.749 . . . . 73.11 108.977 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -72.47 -26.55 61.86 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.76 -0.654 . . . . 72.35 111.451 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.409 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 7.1 m-20 -62.0 -35.37 78.32 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.106 0.562 . . . . 73.33 110.225 176.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.5 -55.88 7.89 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.22 -0.9 . . . . 74.42 110.61 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 mt -65.3 -28.14 69.11 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.115 0.783 . . . . 74.54 113.115 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.05 -45.87 91.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.395 0.678 . . . . 74.41 109.567 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.555 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 10.6 mmt -69.71 -36.33 75.82 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.473 -0.785 . . . . 73.12 110.87 178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -68.94 -26.94 65.32 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.237 -0.892 . . . . 71.21 111.838 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -95.3 -44.1 7.74 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.535 0.334 . . . . 73.44 111.233 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 68.0 tp -60.46 -45.2 94.56 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.532 0.733 . . . . 73.03 112.149 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -147.55 5.52 0.81 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.902 0.481 . . . . 73.33 111.986 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 63.56 22.16 13.05 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.583 1.153 . . . . 72.03 112.642 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -161.81 159.01 26.47 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.89 0.876 . . . . 72.55 109.132 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.25 -179.88 7.52 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.775 0.43 . . . . 74.31 110.625 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.59 -144.29 4.22 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 119.312 -0.715 . . . . 73.45 111.907 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 63.79 92.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.745 1.218 . . . . 64.21 110.815 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.83 128.47 1.43 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.7 -0.56 . . . . 74.42 111.7 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.8 p -119.19 123.76 45.12 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.754 0.822 . . . . 72.53 109.982 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.13 91.24 8.37 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.505 0.722 . . . . 73.35 110.286 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -86.33 141.24 29.36 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.553 -0.536 . . . . 72.54 109.553 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -118.01 118.82 32.98 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.483 0.713 . . . . 75.15 109.651 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -83.79 110.44 18.34 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.398 0.679 . . . . 75.12 109.734 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -105.77 159.11 16.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.155 0.982 . . . . 71.32 110.327 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.816 0.847 . . . . 73.31 109.218 -177.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.026 -0.361 . . . . 73.23 110.026 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.443 ' O ' ' HA3' ' B' ' 91' ' ' GLY . 61.7 m -127.41 -83.17 0.61 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.868 0.467 . . . . 74.52 110.1 175.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 59.65 175.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.72 0.808 . . . . 63.41 112.427 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -162.26 142.34 9.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.018 0.527 . . . . 61.44 110.528 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -169.73 93.4 0.25 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.291 -1.374 . . . . 72.3 107.291 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -56.57 112.44 1.28 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.834 0.854 . . . . 73.55 111.064 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.548 HG22 ' H ' ' B' ' 9' ' ' MET . 32.0 m -137.55 148.82 46.24 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.477 -0.935 . . . . 61.5 108.477 177.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.54 -12.29 56.97 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.231 1.012 . . . . 73.35 112.293 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.548 ' H ' HG22 ' B' ' 7' ' ' THR . 19.6 ptm 55.91 -173.75 0.06 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.766 2.026 . . . . 72.11 113.245 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.6 m -138.77 118.74 13.33 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.416 -1.327 . . . . 74.42 107.416 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.479 ' HB2' ' HE1' ' B' ' 9' ' ' MET . 42.5 t80 -134.98 113.25 11.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.703 -0.481 . . . . 74.12 109.703 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.26 139.31 33.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.891 . . . . 72.44 108.678 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -87.46 134.94 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 109.026 -0.731 . . . . 75.5 109.026 177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -93.24 -52.64 4.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.255 -0.646 . . . . 74.42 109.255 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 31.0 ttt180 -155.65 132.78 10.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.955 -0.566 . . . . 75.14 109.86 -172.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.31 136.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.349 -1.723 . . . . 74.41 106.349 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.418 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.6 p90 -166.99 148.55 5.95 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.907 0.384 . . . . 73.01 110.961 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 94.8 m -77.28 129.21 35.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.964 -0.754 . . . . 71.14 108.964 171.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.407 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.7 mtpt -98.87 -31.13 12.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.641 0.776 . . . . 70.25 110.865 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -154.43 145.73 22.95 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.392 0.433 . . . . 75.43 111.662 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.718 HD12 ' SG ' ' B' ' 113' ' ' CYS . 39.1 mm -137.18 148.18 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.199 1.399 . . . . 75.11 109.03 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.411 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.5 m -146.97 140.41 25.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.746 -1.116 . . . . 75.44 109.445 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.439 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.6 t80 -147.5 110.34 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 105.825 -1.917 . . . . 73.12 105.825 162.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.26 111.88 15.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.103 -1.073 . . . . 72.53 108.103 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.524 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -116.47 87.03 19.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 108.543 -0.91 . . . . 71.2 108.543 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.16 -25.17 19.34 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.443 2.095 . . . . 71.22 111.475 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -103.34 7.8 38.2 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.483 1.113 . . . . 74.23 110.457 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.524 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -40.86 -54.48 5.33 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 115.907 1.817 . . . . 74.13 115.907 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.3 Cg_exo -72.75 -50.25 0.22 Allowed 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.54 2.16 . . . . 72.3 111.955 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.534 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.3 m80 -85.37 5.51 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.724 -1.126 . . . . 75.51 112.133 -173.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.76 -16.72 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.197 0.599 . . . . 74.25 111.904 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -51.34 -32.72 26.53 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.787 0.835 . . . . 72.44 112.206 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.553 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.3 pt20 -73.21 -48.93 30.92 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.269 -0.423 . . . . 75.31 110.858 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.553 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 83.7 mttt -110.82 62.41 0.61 Allowed 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.937 0.875 . . . . 72.42 109.513 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -117.11 118.69 33.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.032 -1.84 . . . . 64.41 106.032 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 169.01 -168.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.64 1.976 . . . . 73.53 106.217 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.58 109.8 1.62 Allowed Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 122.977 0.511 . . . . 73.41 112.193 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.476 ' HG2' HG12 ' B' ' 40' ' ' VAL . 91.6 Cg_endo -94.69 162.79 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.99 2.46 . . . . 75.12 112.099 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -80.52 103.53 10.44 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.293 -1.373 . . . . 71.42 107.293 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.476 HG12 ' HG2' ' B' ' 38' ' ' PRO . 5.4 m -99.3 143.2 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.149 -0.932 . . . . 74.14 109.576 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.99 132.67 32.61 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.609 -0.886 . . . . 64.24 108.609 -171.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.435 ' HB2' ' HB ' ' H' ' 288' ' ' VAL . 51.4 mt -99.92 123.9 44.66 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.899 -0.778 . . . . 73.45 108.899 173.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.512 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.4 t70 -126.12 111.73 14.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.902 -0.777 . . . . 73.54 108.902 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 9.9 mp -100.33 131.65 46.14 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.69 -0.687 . . . . 75.21 109.302 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.412 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.6 t70 -120.7 125.97 49.01 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.464 -1.31 . . . . 71.13 107.464 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -109.2 103.69 12.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.305 -0.861 . . . . 72.53 109.506 -168.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 130.84 44.13 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.747 0.819 . . . . 65.42 109.159 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 74.9 p -142.45 162.8 34.54 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.962 0.505 . . . . 74.51 110.389 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 p -152.87 137.46 16.86 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.916 0.886 . . . . 74.03 109.346 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.95 122.99 28.48 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.013 0.525 . . . . 71.13 109.764 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.09 -43.2 16.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.058 0.543 . . . . 72.35 110.459 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -169.03 2.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.373 0.669 . . . . 73.41 111.082 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.89 112.32 2.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.488 1.115 . . . . 72.45 110.681 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.06 1.64 2.43 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.278 1.431 . . . . 71.51 112.805 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.1 t -105.26 110.89 32.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.563 -0.903 . . . . 64.43 108.563 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -115.16 160.23 19.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.779 0.832 . . . . 74.13 108.993 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -132.75 106.25 7.64 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.782 -1.562 . . . . 63.51 106.782 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -105.51 122.6 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.372 1.069 . . . . 74.4 109.817 -171.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.69 128.78 62.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.125 0.97 . . . . 73.44 108.846 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -118.7 111.77 18.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.464 -1.31 . . . . 71.1 107.464 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.443 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 38.6 ttm180 -87.16 132.51 33.84 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.669 0.788 . . . . 71.22 109.587 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.4 107.16 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.768 -1.197 . . . . 71.31 107.768 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.512 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 38.8 m -97.19 137.94 35.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.642 -0.873 . . . . 71.52 108.642 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.522 HG22 HG21 ' B' ' 114' ' ' ILE . 61.2 t -121.86 97.35 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -90.27 137.8 32.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.579 -0.737 . . . . 64.22 109.155 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.411 ' HB1' HG13 ' B' ' 40' ' ' VAL . . . -143.26 145.94 33.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.362 0.665 . . . . 71.25 109.753 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -159.31 135.97 9.32 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.816 0.698 . . . . 60.3 110.51 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.429 HD13 ' HB1' ' B' ' 73' ' ' ALA . 5.5 mp -113.45 137.96 50.78 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.558 -0.905 . . . . 75.33 108.558 168.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.1 -127.74 13.21 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.919 -0.473 . . . . 61.53 111.919 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -109.87 6.01 22.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.264 1.025 . . . . 75.53 110.412 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.01 167.12 12.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.559 0.743 . . . . 73.0 111.088 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.2 m -68.91 155.14 40.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.185 0.994 . . . . 75.24 110.542 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.429 ' HB1' HD13 ' B' ' 68' ' ' LEU . . . -109.88 -60.54 1.77 Allowed 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 73.42 108.581 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -164.27 156.17 16.41 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.767 -1.106 . . . . 74.54 108.336 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 mt -132.24 108.96 9.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.383 -1.339 . . . . 74.14 107.383 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.75 157.04 26.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.197 -1.038 . . . . 74.55 108.197 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.411 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.4 tt0 -164.9 142.49 6.23 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.153 0.581 . . . . 74.25 109.856 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.9 t -132.57 144.51 36.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.79 -1.189 . . . . 75.24 107.79 170.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -123.83 90.83 3.34 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.914 -1.143 . . . . 74.54 107.914 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -84.74 102.02 12.68 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 74.32 108.905 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.39 167.83 34.4 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.368 -0.833 . . . . 71.12 111.608 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.26 126.37 1.43 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.558 -0.353 . . . . 72.22 112.415 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.418 HG13 ' HE1' ' B' ' 17' ' ' TYR . 53.4 mt -85.37 128.09 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.56 -0.904 . . . . 75.25 108.56 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -135.8 135.11 39.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.626 1.171 . . . . 74.1 109.233 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.2 m -91.32 99.96 12.84 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.663 0.785 . . . . 74.13 108.99 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 29.5 pt -121.8 138.69 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.582 0.753 . . . . 74.32 110.439 -176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.28 169.36 24.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.374 1.07 . . . . 71.31 109.89 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.84 -47.63 3.74 Favored Glycine 0 N--CA 1.478 1.45 0 C-N-CA 123.356 0.503 . . . . 51.12 112.668 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.418 ' O ' HD12 ' H' ' 277' ' ' LEU . 16.9 pt -64.15 148.37 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.285 1.034 . . . . 74.43 111.73 173.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.566 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 42.6 tt0 -157.73 144.44 17.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.143 0.977 . . . . 72.11 109.909 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' B' ' 2' ' ' SER . . . 59.51 -108.88 1.85 Allowed Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.381 -0.677 . . . . 72.5 113.602 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 36.5 m -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.386 0.675 . . . . 74.33 110.948 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.566 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.8 mt-30 -62.97 -45.22 93.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.598 0.759 . . . . 73.2 109.513 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.593 ' SD ' ' HG ' ' H' ' 277' ' ' LEU . 25.9 ttt -73.71 -38.77 64.72 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.037 -0.983 . . . . 74.45 110.511 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.58 69.61 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.346 0.658 . . . . 70.3 111.161 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -79.2 -35.8 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.03 0.932 . . . . 63.51 110.124 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.15 -68.4 0.38 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.356 -0.384 . . . . 73.42 110.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' H' ' 280' ' ' LEU . 1.6 pp -75.8 -8.27 56.45 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.462 0.541 . . . . 75.44 112.462 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.99 -9.19 46.12 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 114.303 0.481 . . . . 50.43 114.303 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.17 -54.72 0.4 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.49 0.645 . . . . 73.44 110.962 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -68.0 -55.75 11.48 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.879 0.872 . . . . 72.43 111.506 -172.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.59 -44.06 79.82 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.374 1.069 . . . . 65.1 112.286 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -48.75 -53.52 6.79 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.837 2.358 . . . . 72.31 112.601 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.14 -18.89 50.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.966 0.728 . . . . 64.35 112.966 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.403 ' HA ' HH21 ' D' ' 111' ' ' ARG . 71.7 mt -77.26 -57.09 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.189 0.596 . . . . 72.33 110.623 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.33 -4.83 59.29 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.093 0.557 . . . . 74.41 112.234 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.53 -46.74 47.61 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.48 1.112 . . . . 74.41 112.454 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.3 -34.78 94.77 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 121.875 1.717 . . . . 72.14 112.978 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.474 ' HE2' HG22 ' D' ' 115' ' ' THR . 57.2 m-85 -65.25 -52.57 53.63 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.122 0.969 . . . . 75.32 110.752 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.422 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.09 -43.19 91.83 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.501 0.72 . . . . 72.35 110.341 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -56.23 -56.33 22.27 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.926 1.291 . . . . 72.32 111.259 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -38.88 92.49 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.611 0.569 . . . . 74.33 109.602 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.718 ' SG ' HD12 ' B' ' 21' ' ' ILE . 6.5 t -64.97 -38.94 92.62 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 123.522 0.514 . . . . 74.0 111.719 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.522 HG21 HG22 ' B' ' 64' ' ' VAL . 57.6 mt -65.35 -52.66 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.242 0.617 . . . . 74.44 109.542 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.483 HG21 ' NE2' ' C' ' 125' ' ' GLN . 23.3 m -61.45 -29.02 69.69 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 115.089 -0.959 . . . . 72.11 111.475 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.9 t -63.14 -49.48 74.2 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.72 0.808 . . . . 65.21 109.326 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -69.96 -34.41 73.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.733 0.813 . . . . 74.44 111.16 -175.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.561 HG22 HD13 ' B' ' 126' ' ' LEU . 80.6 t -64.52 -39.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.669 0.788 . . . . 74.31 110.239 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 16.4 t -71.29 -31.28 67.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.222 0.609 . . . . 73.44 110.83 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.8 mtt-85 -67.87 -22.89 65.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.244 0.618 . . . . 74.31 110.279 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.71 17.98 56.48 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.504 0.502 . . . . 53.24 113.221 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.591 HG21 ' HB3' ' A' ' 17' ' ' TYR . 75.0 p 62.96 14.87 7.88 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.559 1.944 . . . . 73.15 113.7 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -92.47 148.7 36.88 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 122.921 0.488 . . . . 72.05 109.887 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' C' ' 125' ' ' GLN . 96.6 Cg_endo -74.21 -159.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.062 2.508 . . . . 72.02 113.059 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.602 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.4 122.74 17.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.368 -0.833 . . . . 73.04 113.153 -167.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.561 HD13 HG22 ' B' ' 118' ' ' VAL . 9.4 tt -109.89 127.42 54.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 106.018 -1.845 . . . . 74.4 106.018 166.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 106.67 9.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.313 -0.625 . . . . 72.53 109.313 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.65 107.88 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.005 -1.109 . . . . 75.3 108.005 169.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.39 135.07 88.76 Favored Pre-proline 0 CA--C 1.548 0.896 0 O-C-N 124.075 0.859 . . . . 73.31 110.256 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.28 109.25 0.39 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.278 2.652 . . . . 70.44 112.206 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.17 113.41 26.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.511 -0.922 . . . . 72.42 108.511 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.15 76.93 6.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.695 -0.854 . . . . 75.54 108.695 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -54.47 -36.27 63.95 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.215 1.006 . . . . 72.42 111.017 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.67 -52.0 66.11 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.152 -1.386 . . . . 64.32 111.127 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.16 83.24 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.659 0.784 . . . . 72.32 111.762 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.48 -31.84 73.22 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.52 0.728 . . . . 74.13 111.098 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.37 -26.49 22.16 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.299 0.64 . . . . 72.32 109.989 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 39.5 ttm -70.29 -37.05 74.72 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.98 0.912 . . . . 74.43 111.295 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -74.08 -26.15 60.22 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.079 0.551 . . . . 62.12 110.781 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -68.13 -32.89 73.49 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.106 0.479 . . . . 74.4 110.377 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.2 mt -103.82 14.59 30.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.227 1.011 . . . . 64.24 111.649 -174.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -76.6 147.66 37.48 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.12 0.568 . . . . 75.34 111.615 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -91.51 176.64 6.48 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.241 1.017 . . . . 71.43 110.815 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -74.47 -74.6 0.19 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.028 0.531 . . . . 75.24 110.527 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.47 -174.1 1.84 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.274 0.63 . . . . 63.43 111.383 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.15 -168.71 16.72 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 110.826 -0.91 . . . . 74.52 110.826 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -160.38 142.55 12.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.992 0.517 . . . . 70.35 110.752 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.77 131.95 10.75 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.529 -0.628 . . . . 61.12 111.529 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 17.7 p -97.93 143.03 28.94 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.275 0.63 . . . . 72.13 110.466 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -146.62 98.22 3.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.744 -0.836 . . . . 65.11 108.744 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.67 149.92 27.08 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.372 1.069 . . . . 75.45 110.864 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -126.58 159.11 34.46 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.028 0.931 . . . . 75.34 110.013 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -147.35 98.29 2.98 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.56 1.144 . . . . 72.23 108.617 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.9 147.36 25.81 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.77 -0.456 . . . . 70.31 109.77 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.593 -0.718 . . . . 74.53 110.463 -179.722 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 120.656 0.265 . . . . 74.31 111.394 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -148.68 18.56 1.02 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.674 0.79 . . . . 70.21 110.612 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.96 128.24 48.46 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.222 0.609 . . . . 74.21 110.803 -168.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -126.03 138.78 53.75 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.433 -1.321 . . . . 74.03 107.433 168.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -68.15 109.45 3.55 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.014 -0.736 . . . . 74.22 109.014 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -66.04 127.06 30.6 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 109.429 -0.582 . . . . 75.42 109.429 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -87.61 35.94 0.74 Allowed 'General case' 0 CA--C 1.556 1.189 0 CA-C-O 121.999 0.905 . . . . 72.3 110.031 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -143.44 118.03 9.78 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.073 0.949 . . . . 74.53 108.595 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.47 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 51.4 ttp 63.58 112.02 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.984 1.714 . . . . 75.1 112.773 175.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -91.38 92.87 8.77 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.076 -1.453 . . . . 75.23 107.076 166.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.456 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 72.6 t80 -108.57 154.35 22.08 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.884 -1.053 . . . . 72.35 109.67 -175.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -163.54 139.59 6.75 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.308 1.043 . . . . 74.41 109.017 173.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pp -80.89 141.32 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.447 0.699 . . . . 74.34 109.369 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -109.83 -51.25 2.89 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.777 0.431 . . . . 74.43 110.009 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.526 HH12 HD11 ' G' ' 301' ' ' ILE . 72.0 ttt180 -172.43 123.82 0.47 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.471 0.482 . . . . 74.32 109.846 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -109.01 136.02 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.012 -1.107 . . . . 71.34 108.012 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.506 ' HE1' HG12 ' C' ' 83' ' ' ILE . 19.5 p90 -168.68 162.92 11.99 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.861 0.839 . . . . 72.43 112.432 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.6 p -86.38 103.75 15.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.375 -1.284 . . . . 73.12 108.662 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -67.8 -35.21 78.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.64 0.733 . . . . 74.41 109.981 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.713 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.9 t70 -148.21 139.48 23.43 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.473 -1.24 . . . . 70.4 109.095 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.439 HG21 ' HE2' ' C' ' 117' ' ' MET . 59.2 mt -133.55 141.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.077 -1.453 . . . . 63.42 107.077 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -152.87 146.34 24.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.411 -0.588 . . . . 72.13 109.411 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.95 113.63 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.131 -1.433 . . . . 72.33 107.131 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.48 111.26 20.49 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.297 -1.001 . . . . 74.12 108.297 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.75 80.21 55.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.356 1.063 . . . . 74.11 108.262 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.39 -16.78 24.44 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.172 1.915 . . . . 75.44 109.898 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.96 11.86 25.91 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.231 1.412 . . . . 62.44 110.041 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.55 97.72 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.028 1.122 . . . . 75.43 114.028 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.28 -36.15 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 121.404 1.402 . . . . 62.51 113.032 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -67.67 -25.68 65.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.884 1.274 . . . . 72.03 112.869 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.428 HG11 ' HE1' ' C' ' 123' ' ' PHE . 14.4 p -62.31 -27.13 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.455 1.102 . . . . 73.14 111.853 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.506 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 30.0 t80 -65.9 -26.76 67.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.588 -0.733 . . . . 72.43 111.96 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -99.0 6.12 46.84 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.455 0.539 . . . . 75.22 112.455 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.529 ' HB3' ' HZ1' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -99.7 173.11 6.86 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.467 0.576 . . . . 75.23 110.054 175.543 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.26 123.38 25.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.455 -0.943 . . . . 74.05 108.455 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.506 ' HZ2' ' HA ' ' C' ' 32' ' ' PHE . 59.4 m95 -85.37 69.76 10.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.186 0.595 . . . . 72.35 110.683 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -163.17 60.1 0.91 Allowed Pre-proline 0 CA--C 1.56 1.344 0 CA-C-N 115.087 -0.96 . . . . 75.35 109.003 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.12 158.98 37.62 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.034 2.489 . . . . 72.22 111.61 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.43 88.84 6.58 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 106.664 -1.606 . . . . 75.55 106.664 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.93 102.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 113.61 -1.632 . . . . 74.33 109.749 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.1 110.82 22.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.553 -1.203 . . . . 74.22 108.537 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.15 130.57 34.58 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.366 -1.346 . . . . 64.13 107.366 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.9 t70 -119.36 103.81 9.81 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.882 1.273 . . . . 65.44 107.78 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 23.5 tp -100.16 112.53 24.84 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.348 -0.982 . . . . 74.03 108.348 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.43 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -114.67 139.62 49.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.763 1.225 . . . . 54.34 108.921 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -114.53 145.62 41.71 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.436 0.694 . . . . 71.55 110.361 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 150.5 29.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.607 0.763 . . . . 73.21 109.739 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.8 m -155.78 155.24 32.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.249 0.62 . . . . 74.01 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.3 p -148.85 140.42 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.53 0.732 . . . . 74.12 109.918 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.47 115.41 22.06 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.211 -1.033 . . . . 72.25 108.211 170.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.489 HD13 HD13 ' C' ' 83' ' ' ILE . 74.6 mt -88.88 -39.01 14.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.516 0.726 . . . . 74.55 110.343 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.08 -168.79 2.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.017 -0.992 . . . . 70.44 110.348 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.98 100.55 0.16 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.356 1.063 . . . . 54.34 110.654 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 66.94 10.69 7.85 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.497 1.519 . . . . 75.42 113.234 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -94.27 114.13 30.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.866 -1.161 . . . . 63.52 107.866 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -123.23 124.23 42.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.108 0.963 . . . . 74.11 109.057 -177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -83.67 120.52 26.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.326 -0.852 . . . . 75.43 109.34 174.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -97.65 114.12 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.135 -1.061 . . . . 72.24 108.135 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.6 134.55 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.28 -1.007 . . . . 73.33 108.28 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -128.9 102.81 6.7 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.905 -1.146 . . . . 74.43 107.905 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.515 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 23.8 ttt180 -82.69 108.21 15.89 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.525 -0.761 . . . . 74.24 109.279 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.4 t -100.08 121.77 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 107.477 -1.305 . . . . 74.25 107.477 172.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.4 m -127.31 117.47 22.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.648 -0.871 . . . . 74.41 108.648 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.1 110.28 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.699 -0.852 . . . . 74.43 108.699 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.4 m -99.83 144.04 29.35 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.666 -0.865 . . . . 73.2 108.666 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' C' ' 73' ' ' ALA . . . -130.56 130.46 44.11 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.752 -1.203 . . . . 71.44 107.752 172.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.1 m -147.88 130.44 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.03 0.443 . . . . 74.23 110.965 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.07 58.1 4.86 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.016 1.326 . . . . 74.14 107.476 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.23 -118.0 5.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 114.732 -1.122 . . . . 61.34 110.567 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.06 -28.67 18.87 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.449 0.7 . . . . 54.4 109.308 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.68 102.63 0.76 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.939 0.896 . . . . 65.51 109.666 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -72.92 144.43 47.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.239 0.616 . . . . 74.22 111.021 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' C' ' 66' ' ' ALA . . . -97.65 -56.27 2.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.507 1.123 . . . . 63.22 109.455 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -158.03 172.01 19.21 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.99 -0.55 . . . . 74.54 110.923 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.404 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -136.37 146.16 46.2 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 106.9 -1.518 . . . . 74.51 106.9 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.404 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.76 113.58 4.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.13 0.572 . . . . 74.41 109.789 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -117.34 117.51 29.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.653 0.781 . . . . 74.24 110.04 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -121.84 122.24 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.504 -0.554 . . . . 71.4 109.504 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.713 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.8 mt-30 -99.04 91.34 4.97 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.043 -1.095 . . . . 73.44 108.043 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -83.14 104.86 13.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.235 -0.893 . . . . 63.33 110.062 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 146.6 18.3 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.108 -0.497 . . . . 74.14 112.015 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.05 116.85 1.11 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.07 -1.212 . . . . 43.32 110.07 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.542 HD11 ' HB3' ' D' ' 29' ' ' PRO . 15.5 mm -81.46 122.33 36.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.449 -0.945 . . . . 74.44 108.449 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -138.51 148.68 44.57 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.35 -0.981 . . . . 71.43 108.35 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.1 p -110.17 119.02 37.93 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.458 -0.941 . . . . 52.04 108.458 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.88 120.68 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.267 -1.012 . . . . 73.1 108.267 -175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.47 165.02 30.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.132 0.973 . . . . 73.1 109.565 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.08 -46.68 1.14 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.965 -0.561 . . . . 63.43 112.242 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.416 HD12 ' HA ' ' C' ' 9' ' ' MET . 0.2 OUTLIER -121.81 171.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.24 0.616 . . . . 75.51 111.253 -177.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.74 -173.03 4.11 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.019 -0.991 . . . . 74.45 109.425 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.78 -139.72 39.3 Favored Glycine 0 C--N 1.344 1.011 0 O-C-N 123.529 0.518 . . . . 65.42 114.159 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -70.56 -21.72 62.66 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.117 0.967 . . . . 75.12 112.038 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -71.48 -38.01 71.25 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.537 0.735 . . . . 75.53 110.388 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.47 ' HE3' ' O ' ' F' ' 277' ' ' LEU . 9.8 tmm? -71.99 -41.08 68.05 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.018 -0.734 . . . . 70.25 109.018 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.65 69.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.569 0.747 . . . . 63.51 111.262 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -70.64 -34.18 71.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.504 0.722 . . . . 74.21 110.491 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.47 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 40.6 t -68.21 -64.66 0.82 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.444 0.465 . . . . 71.24 110.398 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.04 -12.69 54.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.047 -0.408 . . . . 75.43 112.093 -172.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 -7.84 46.32 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 114.706 0.642 . . . . 73.5 114.706 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.33 -55.93 0.48 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.395 0.598 . . . . 75.22 110.847 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.436 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 81.0 t80 -69.12 -56.54 7.36 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.907 0.883 . . . . 71.15 111.822 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.76 -44.97 74.99 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.59 1.156 . . . . 72.42 112.951 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.94 -34.37 81.48 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 121.758 1.639 . . . . 75.21 111.995 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -28.5 67.28 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.317 0.647 . . . . 64.15 111.695 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 33.3 mm -66.24 -53.52 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.978 -0.378 . . . . 74.11 109.978 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -87.21 -8.35 56.95 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.412 0.523 . . . . 75.41 112.412 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.13 -50.09 89.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 124.21 1.004 . . . . 75.2 113.416 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.87 -25.74 74.47 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 121.489 1.459 . . . . 75.51 113.121 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -69.51 -46.07 67.4 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.285 0.634 . . . . 73.34 110.232 175.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.4 89.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.603 0.761 . . . . 73.4 110.396 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.518 ' HG3' HD21 ' C' ' 128' ' ' LEU . 39.5 ttt180 -58.38 -55.68 31.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 113.945 -1.48 . . . . 75.22 111.157 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.452 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -67.81 -27.46 66.75 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.979 0.512 . . . . 54.13 110.328 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' C' ' 21' ' ' ILE . 32.0 t -71.5 -36.57 71.15 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.744 0.418 . . . . 72.03 111.407 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.51 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.5 mt -72.67 -48.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.454 0.701 . . . . 75.25 110.025 174.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 49.1 m -60.92 -33.71 73.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.09 0.956 . . . . 74.53 111.36 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 33.5 t -62.2 -47.73 83.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.791 -0.64 . . . . 73.24 109.444 173.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.57 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.28 -37.5 87.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.709 1.203 . . . . 62.11 112.226 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.33 -42.21 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.181 0.592 . . . . 74.1 109.407 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.3 t -69.05 -28.99 67.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.641 0.777 . . . . 74.25 111.711 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' C' ' 116' ' ' SER . 76.6 mtt-85 -76.03 -28.8 57.84 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.694 0.797 . . . . 75.41 110.468 178.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.52 4.63 81.18 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.525 0.516 . . . . 74.31 112.433 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.546 HG21 ' HB3' ' D' ' 17' ' ' TYR . 20.8 p 62.38 33.04 16.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.044 1.738 . . . . 73.44 111.961 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.428 ' HE1' HG11 ' C' ' 31' ' ' VAL . 24.8 m-85 -102.17 154.05 37.64 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 115.004 -0.998 . . . . 64.35 110.608 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.508 ' HD3' HD13 ' F' ' 301' ' ' ILE . 75.4 Cg_exo -53.7 132.18 47.88 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.263 2.642 . . . . 73.32 112.949 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.483 ' NE2' HG21 ' B' ' 115' ' ' THR . 14.6 mm-40 -59.63 142.74 52.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.026 0.829 . . . . 73.24 112.461 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.585 HD11 ' HH2' ' F' ' 290' ' ' TRP . 3.0 tm? -126.82 126.32 43.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.744 0.818 . . . . 74.44 108.863 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.43 127.28 48.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.206 1.003 . . . . 61.35 109.128 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.518 HD21 ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -80.48 141.36 35.28 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.697 0.623 . . . . 74.12 110.159 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.575 ' HB3' HD11 ' F' ' 291' ' ' LEU . . . -85.34 158.96 57.15 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 124.856 1.262 . . . . 73.34 111.183 -177.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.34 107.45 2.46 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.102 2.535 . . . . 75.04 111.532 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.472 HG22 HD13 ' F' ' 291' ' ' LEU . 44.9 t -98.44 107.48 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.54 -0.911 . . . . 72.43 108.54 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -113.73 99.24 7.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.588 1.155 . . . . 75.02 108.83 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.51 -42.99 99.88 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.794 0.838 . . . . 74.25 111.337 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -66.85 -37.69 84.94 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.865 -1.061 . . . . 74.14 111.714 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.35 -33.83 75.48 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.831 0.707 . . . . 72.21 111.246 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.0 -36.14 82.57 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.294 0.638 . . . . 75.2 110.99 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -71.5 -33.39 69.21 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.269 0.627 . . . . 75.24 110.989 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.424 ' HE1' ' HA ' ' C' ' 138' ' ' MET . 29.9 mmt -72.42 -34.54 67.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.342 0.657 . . . . 74.21 110.98 177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -72.27 -35.68 68.82 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.199 0.999 . . . . 65.24 110.432 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -54.13 -80.74 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.316 1.047 . . . . 70.55 111.037 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 34.3 tp -73.28 85.15 1.42 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.3 0.571 . . . . 72.11 110.866 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -142.65 168.36 19.91 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.786 1.234 . . . . 72.33 108.869 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.32 87.84 1.06 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 105.964 -1.865 . . . . 75.51 105.964 172.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 8' ' ' GLU . 85.4 mm-40 -145.66 156.87 43.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.788 0.835 . . . . 65.31 111.338 -173.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.46 65.64 0.33 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.894 0.878 . . . . 64.43 109.615 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -89.55 -146.63 14.56 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.548 -0.751 . . . . 73.21 112.892 -176.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.91 145.33 44.17 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.152 0.501 . . . . 73.53 111.839 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.91 131.36 10.34 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.668 -1.151 . . . . 62.22 110.372 167.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 58.3 m -101.56 138.28 38.77 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.02 0.928 . . . . 74.23 111.178 -171.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.519 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 12.2 pt-20 -70.83 140.81 51.27 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.368 -0.604 . . . . 72.41 109.368 172.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.466 ' HG3' ' HB3' ' E' ' 277' ' ' LEU . 3.1 mm-40 -161.9 161.62 28.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.342 -0.39 . . . . 73.23 111.224 -173.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -176.54 141.75 0.41 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.984 1.314 . . . . 74.21 109.213 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -156.8 117.64 3.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.431 -1.322 . . . . 75.52 107.431 174.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.77 152.7 45.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.548 0.739 . . . . 63.44 111.75 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.553 -0.737 . . . . 73.31 109.344 -179.155 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.456 -0.572 . . . . 74.03 109.456 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 42.3 t -156.36 143.14 18.69 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.196 0.998 . . . . 74.12 108.784 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -71.14 -64.43 0.91 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.302 -0.999 . . . . 73.33 108.302 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -176.82 -68.47 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.662 -1.607 . . . . 73.25 106.662 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -165.71 143.86 5.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.295 1.038 . . . . 64.33 109.092 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -168.43 154.44 6.99 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.616 1.167 . . . . 74.45 108.494 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 37.5 p -69.65 83.41 0.44 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.893 0.877 . . . . 73.12 110.919 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.91 131.47 35.81 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.331 -1.359 . . . . 74.25 107.331 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.9 ttp 16.37 119.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 127.448 2.299 . . . . 73.44 115.718 -169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m -129.27 143.37 50.83 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.898 -0.779 . . . . 75.42 108.898 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -163.03 104.48 1.01 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.387 -1.338 . . . . 71.41 107.387 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -127.48 140.95 51.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.394 -0.965 . . . . 71.43 108.394 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.25 133.21 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.147 -1.057 . . . . 75.22 108.147 171.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.404 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 68.6 mt-30 -89.21 -39.6 13.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.345 0.403 . . . . 74.53 110.384 173.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 176.07 150.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.336 1.054 . . . . 72.45 110.6 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.26 134.45 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.546 ' HB3' HG21 ' C' ' 122' ' ' THR . 25.0 p90 -147.73 162.53 39.0 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.267 1.027 . . . . 73.2 110.347 -176.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 75.6 p -95.44 119.68 34.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.764 -1.107 . . . . 71.42 109.52 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -90.56 -27.44 19.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.781 0.432 . . . . 72.31 110.585 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -154.76 140.27 17.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.087 -0.961 . . . . 74.11 108.696 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.57 HG21 ' HE1' ' C' ' 117' ' ' MET . 71.9 mt -137.95 143.05 34.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.081 -1.081 . . . . 74.31 108.081 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -148.07 123.36 10.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.142 0.977 . . . . 73.53 109.293 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.438 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -131.3 120.72 23.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.103 -1.814 . . . . 72.2 106.103 170.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.436 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.9 mt-10 -123.06 144.55 49.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.67 -0.492 . . . . 70.14 109.67 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.62 76.54 47.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 106.27 -1.752 . . . . 74.25 106.27 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.63 -25.26 24.78 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.695 2.263 . . . . 74.15 112.541 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -112.73 25.77 11.14 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.157 0.983 . . . . 75.2 109.169 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.489 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -49.02 -62.18 2.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 114.453 1.279 . . . . 72.44 114.453 -166.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.542 ' HB3' HD11 ' C' ' 83' ' ' ILE . 37.7 Cg_endo -83.14 -8.91 10.74 Favored 'Trans proline' 0 C--N 1.373 1.841 0 CA-C-N 122.358 1.878 . . . . 73.45 113.245 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -78.73 -36.78 42.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.67 1.188 . . . . 73.42 109.67 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' D' ' 73' ' ' ALA . 6.0 p -80.31 -21.66 11.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 CA-C-N 116.057 -0.52 . . . . 74.02 109.729 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -66.07 -6.51 13.27 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.427 0.899 . . . . 73.11 113.427 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -78.49 -36.22 45.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 74.33 109.541 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -131.38 61.36 1.64 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.122 0.969 . . . . 75.34 110.438 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.645 ' HB3' HD13 ' G' ' 301' ' ' ILE . 20.6 t0 -108.44 82.77 1.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.376 -0.828 . . . . 75.43 110.065 -172.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.601 ' H ' HD22 ' D' ' 68' ' ' LEU . 8.2 m95 -124.14 -159.71 0.88 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.987 -1.116 . . . . 73.53 107.987 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.43 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 45.8 tt0 -59.91 109.62 2.13 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.512 0.725 . . . . 74.25 111.763 -171.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' G' ' 297' ' ' TYR . 3.4 Cg_endo -84.76 150.87 11.33 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.093 2.528 . . . . 73.32 113.522 -175.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -73.73 120.46 19.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.093 -0.958 . . . . 75.02 109.253 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.646 HG21 ' HE1' ' G' ' 290' ' ' TRP . 16.4 m -99.36 129.05 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 124.104 0.962 . . . . 72.45 110.896 -172.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -130.62 117.75 19.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.238 1.015 . . . . 73.12 110.113 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.692 HD11 HD13 ' D' ' 128' ' ' LEU . 8.8 tt -98.15 137.97 36.12 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.103 -0.703 . . . . 73.13 109.103 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.663 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.0 m-20 -127.68 147.34 50.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.189 0.996 . . . . 75.21 108.845 172.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.83 150.76 39.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.346 0.659 . . . . 75.41 109.614 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 14.5 t70 -149.56 125.25 10.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.487 1.115 . . . . 74.52 108.108 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -104.21 144.27 31.82 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.431 0.692 . . . . 75.2 110.638 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.35 156.94 31.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.936 0.894 . . . . 70.45 109.332 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -168.61 154.31 6.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.328 0.651 . . . . 72.13 110.292 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -155.63 136.24 13.37 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.635 0.774 . . . . 63.41 109.357 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -74.32 122.94 23.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.529 -0.545 . . . . 71.3 109.529 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.452 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.2 mt -90.58 -37.94 13.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.033 0.533 . . . . 75.35 110.58 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.17 -176.35 5.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.381 0.673 . . . . 70.44 111.023 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.11 119.21 7.4 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.932 -1.031 . . . . 50.43 110.365 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.87 19.18 10.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.343 1.057 . . . . 75.32 112.058 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.17 126.62 75.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.086 0.954 . . . . 72.45 109.076 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -132.85 129.93 39.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.008 -1.108 . . . . 73.51 108.008 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.1 tt0 -91.12 119.42 31.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.567 -0.901 . . . . 61.52 108.567 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.96 129.35 52.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.935 -1.135 . . . . 75.32 107.935 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.46 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.4 t -116.84 128.34 74.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.157 -1.053 . . . . 74.14 108.157 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -126.54 105.91 9.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.307 -1.368 . . . . 72.34 107.307 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.4 ttm180 -84.17 123.25 29.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.573 -0.74 . . . . 74.53 109.4 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -112.07 137.12 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.45 -0.944 . . . . 75.12 108.45 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.663 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.9 m -126.55 138.89 53.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.373 0.669 . . . . 72.01 109.515 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.557 HG12 ' HG ' ' D' ' 126' ' ' LEU . 75.5 t -127.72 108.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.244 1.018 . . . . 62.31 109.445 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.5 m -99.92 124.53 45.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.709 0.804 . . . . 74.32 109.013 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 126.69 54.45 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.485 0.714 . . . . 70.4 110.127 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 33.9 p -140.79 121.11 13.95 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 109.313 -0.625 . . . . 55.22 109.313 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.601 HD22 ' H ' ' D' ' 36' ' ' TRP . 1.0 OUTLIER -98.95 135.25 40.63 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.706 0.803 . . . . 72.41 110.104 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.35 -111.44 4.16 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.43 -0.668 . . . . 71.13 111.43 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.14 18.26 9.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.336 1.054 . . . . 75.01 109.961 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -124.15 143.75 50.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.839 1.256 . . . . 72.13 109.973 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -76.89 121.98 24.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.951 0.5 . . . . 63.35 110.979 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.596 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -77.39 -65.49 0.95 Allowed 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.395 0.678 . . . . 74.53 109.608 175.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.53 164.25 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.391 -1.277 . . . . 70.04 110.549 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.436 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 67.2 mt -126.47 142.54 51.5 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.245 -1.391 . . . . 73.02 107.245 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.556 ' SG ' HG22 ' D' ' 114' ' ' ILE . 42.2 t -147.87 139.06 23.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.33 -0.618 . . . . 71.53 109.33 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -157.74 139.86 14.31 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.896 0.878 . . . . 70.23 109.22 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.47 118.89 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.742 0.817 . . . . 75.54 109.334 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.97 82.74 6.12 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.174 -1.047 . . . . 70.51 108.174 173.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.46 102.48 12.11 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.463 -0.79 . . . . 74.52 109.9 -171.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 170.26 29.94 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 116.324 -0.398 . . . . 64.01 112.385 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.56 137.68 4.47 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.534 -0.627 . . . . 71.13 111.534 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.443 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.6 mt -90.28 135.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 109.175 -0.676 . . . . 74.02 109.175 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.01 126.08 29.47 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.443 0.697 . . . . 74.23 109.875 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -78.88 94.98 5.29 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.633 0.773 . . . . 63.42 109.092 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.557 HG23 HD12 ' D' ' 89' ' ' ILE . 21.8 mt -113.13 131.76 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.625 0.77 . . . . 75.22 110.142 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.45 169.25 23.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.075 0.95 . . . . 72.13 110.35 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.42 21.39 79.45 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.078 -0.51 . . . . 73.23 113.617 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.557 HD12 HG23 ' D' ' 86' ' ' ILE . 1.5 pp -135.46 160.55 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.565 1.146 . . . . 75.42 109.604 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -168.4 166.53 12.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.522 0.729 . . . . 74.13 110.515 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.69 -135.47 47.04 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.998 0.811 . . . . 54.13 114.149 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -77.0 -22.86 52.48 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.842 0.857 . . . . 74.44 111.066 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -62.31 -46.12 90.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.784 0.834 . . . . 72.45 110.444 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.3 ptm -77.75 -24.09 49.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.657 -0.701 . . . . 75.1 110.905 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -32.97 74.75 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.812 0.445 . . . . 74.0 111.148 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -77.59 -39.04 46.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.182 0.593 . . . . 73.22 111.276 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -63.66 -44.18 94.56 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.25 0.548 . . . . 71.53 110.963 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.579 ' HB3' ' HE2' ' G' ' 281' ' ' PHE . 4.6 mm? -84.04 -41.38 17.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.473 1.109 . . . . 72.23 111.11 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.62 -10.39 73.28 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 114.702 0.641 . . . . 74.12 114.702 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.29 -61.42 0.87 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.234 0.517 . . . . 75.12 111.232 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -65.25 -44.14 89.1 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.698 0.629 . . . . 73.3 112.698 -173.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 79.8 m -64.38 -44.68 76.45 Favored Pre-proline 0 CA--C 1.567 1.608 0 CA-C-O 118.824 -0.608 . . . . 70.34 112.498 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -48.19 -42.26 33.4 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.51 2.14 . . . . 75.35 114.093 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -64.75 -20.51 66.39 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.758 0.651 . . . . 73.45 112.758 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.3 mm -82.21 -46.8 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.398 0.618 . . . . 74.4 110.382 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -79.72 -28.85 40.53 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.169 -0.923 . . . . 74.55 111.826 -171.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -62.55 -42.56 80.13 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 124.205 1.002 . . . . 74.24 113.474 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -52.64 -39.98 74.47 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.48 2.12 . . . . 74.33 114.352 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -77.69 -32.69 53.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.522 0.729 . . . . 73.52 111.6 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.96 81.87 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.072 -0.714 . . . . 72.34 109.072 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.568 ' HA ' HD23 ' D' ' 128' ' ' LEU . 24.9 ttp180 -54.01 -55.37 27.89 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.899 1.374 . . . . 72.32 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -66.27 -39.71 89.63 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.142 0.901 . . . . 75.23 111.149 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.42 ' SG ' HD11 ' D' ' 21' ' ' ILE . 41.8 t -60.9 -44.1 97.61 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.31 0.381 . . . . 74.05 110.429 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.556 HG22 ' SG ' ' D' ' 76' ' ' CYS . 93.5 mt -59.03 -54.98 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.176 0.99 . . . . 72.04 110.238 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.562 HG23 ' HB2' ' D' ' 125' ' ' GLN . 71.7 m -52.08 -48.3 64.76 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 125.078 1.351 . . . . 74.31 111.595 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 33.2 t -67.81 -41.56 82.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.626 -1.17 . . . . 72.03 110.797 -175.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.481 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 70.9 mtm -65.61 -36.68 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.709 0.404 . . . . 75.21 111.663 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.444 HG22 ' O ' ' D' ' 114' ' ' ILE . 86.1 t -64.63 -44.74 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.605 -0.725 . . . . 64.42 109.969 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 119' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' D' ' 125' ' ' GLN . 88.1 p -69.62 -31.48 69.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.849 0.459 . . . . 71.2 111.614 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' D' ' 116' ' ' SER . 92.6 mtt-85 -69.79 -30.52 68.08 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.8 0.84 . . . . 75.25 110.488 175.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.01 11.55 59.97 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.375 -0.829 . . . . 42.41 112.281 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.3 p 60.67 14.57 5.1 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 127.092 2.157 . . . . 70.31 113.782 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -91.41 160.69 36.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.493 1.117 . . . . 72.14 108.495 173.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.54 115.66 4.41 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.429 2.086 . . . . 74.32 110.805 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.562 ' HB2' HG23 ' D' ' 115' ' ' THR . 12.6 pt20 -51.21 139.17 19.13 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.425 1.078 . . . . 74.33 112.407 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.557 ' HG ' HG12 ' D' ' 64' ' ' VAL . 0.7 OUTLIER -107.15 110.48 22.57 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.469 -0.567 . . . . 55.51 109.469 -165.701 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -98.59 102.57 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.468 0.707 . . . . 73.53 109.362 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.692 HD13 HD11 ' D' ' 42' ' ' LEU . 3.2 mm? -70.11 115.7 9.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.252 1.021 . . . . 74.13 109.912 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.67 ' HB3' HD12 ' G' ' 291' ' ' LEU . . . -66.1 137.55 95.81 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-O 119.581 -0.247 . . . . 54.52 110.376 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.23 133.06 23.84 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.131 1.888 . . . . 73.14 110.995 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -108.06 136.38 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.291 -1.003 . . . . 75.22 108.291 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -78.36 86.78 4.41 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.366 -0.605 . . . . 72.43 109.366 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -64.76 -31.63 72.95 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.447 -0.797 . . . . 75.41 110.713 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' D' ' 138' ' ' MET . 6.1 m-20 -63.52 -58.43 7.03 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.221 1.008 . . . . 73.51 111.245 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.9 91.17 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.503 0.721 . . . . 75.01 112.339 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.48 -37.56 87.75 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.076 -0.966 . . . . 75.01 110.965 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -77.39 -30.76 53.81 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.642 -0.708 . . . . 72.13 111.512 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.47 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 57.4 mtt -59.81 -28.38 67.41 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.572 0.749 . . . . 65.45 111.603 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.408 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 18.3 m120 -60.14 -35.86 76.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.186 0.595 . . . . 74.45 111.359 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -64.93 -41.76 95.26 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.928 0.891 . . . . 75.0 110.863 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.74 -35.16 77.28 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.035 0.534 . . . . 75.35 110.579 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -80.42 9.2 6.2 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.968 0.907 . . . . 71.04 111.63 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 69.8 mt-30 -121.99 46.98 1.98 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.739 1.216 . . . . 64.33 108.541 176.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -161.97 111.29 1.51 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.588 -0.733 . . . . 74.13 109.593 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.48 146.98 31.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.029 0.532 . . . . 61.44 110.384 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.66 54.31 4.79 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.326 0.391 . . . . 72.51 112.631 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -105.24 27.71 7.99 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.218 1.007 . . . . 75.35 109.196 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.37 64.96 3.92 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.713 -0.676 . . . . 54.04 112.526 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 35.3 p -76.14 85.54 2.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.074 0.95 . . . . 71.41 108.613 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.0 85.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.613 1.565 . . . . 72.11 113.253 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -83.85 87.83 7.1 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.087 -1.449 . . . . 71.32 107.087 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -140.48 150.19 43.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.774 0.83 . . . . 73.01 109.849 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -67.05 149.64 50.31 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 124.035 0.834 . . . . 74.23 110.718 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.05 141.17 58.25 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.787 0.679 . . . . 70.32 110.787 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 N-CA-C 107.929 -1.138 . . . . 72.15 107.929 -178.94 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.66 0.267 . . . . 75.14 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -62.7 138.24 58.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.327 0.651 . . . . 75.02 109.396 172.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -71.05 -37.96 72.52 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.416 -0.587 . . . . 75.22 109.416 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 58.35 76.17 0.35 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.896 1.278 . . . . 72.23 109.103 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 9.4 ptmm? -115.62 137.61 23.3 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 114.371 -1.286 . . . . 74.33 109.538 -171.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.21 9.11 4.24 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.431 2.754 . . . . 74.3 114.307 -172.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . 0.466 ' HB3' ' HG3' ' C' ' 151' ' ' GLU . 3.8 tt -166.36 144.58 5.48 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 106.545 -1.65 . . . . 74.33 106.545 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . 0.53 HD23 HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER 66.82 42.89 2.45 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.463 1.105 . . . . 73.13 109.939 176.088 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -71.63 -25.05 75.94 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 115.615 -0.72 . . . . 53.25 113.754 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 3.6 pp -149.74 -174.45 4.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.997 0.919 . . . . 64.54 110.016 -177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . 0.428 ' CD2' ' HB3' ' A' ' 98' ' ' LEU . 76.8 t80 -140.39 123.61 16.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.83 0.852 . . . . 75.01 109.642 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 61.96 -172.7 0.15 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.415 1.086 . . . . 73.22 112.614 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -106.63 -33.85 7.51 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.741 0.817 . . . . 73.21 110.533 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -175.68 -157.48 17.05 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 111.681 -0.568 . . . . 73.13 111.681 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -116.54 148.09 41.18 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.584 0.754 . . . . 63.4 109.965 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -119.68 92.23 46.0 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.704 0.802 . . . . 73.04 109.944 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.5 107.4 0.7 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.69 2.26 . . . . 74.44 110.791 166.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.69 134.66 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.41 1.084 . . . . 65.4 109.135 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -83.31 -63.94 1.26 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.273 0.629 . . . . 75.12 109.579 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . 0.643 ' HE1' ' HB ' ' A' ' 40' ' ' VAL . 28.4 m95 -153.7 -173.17 4.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.268 1.027 . . . . 75.15 110.508 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 129' ' ' ALA . 5.1 mp -106.34 31.4 5.19 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.94 1.296 . . . . 74.25 109.023 177.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 132.45 162.82 10.45 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.074 -0.811 . . . . 70.03 111.074 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.22 90.34 0.46 Allowed 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.837 2.358 . . . . 75.0 111.275 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' G' ' 304' ' ' PRO . 5.1 ptmm? -146.24 128.2 15.48 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.99 -0.55 . . . . 74.41 110.871 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -86.65 -166.38 1.54 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.52 0.728 . . . . 61.2 109.542 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 25.2 m -120.05 -14.02 8.92 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 121.327 0.584 . . . . 51.31 110.147 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.603 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 51.2 t80 -147.82 154.35 40.35 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.898 0.879 . . . . 72.45 110.091 -172.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' A' ' 36' ' ' TRP . 9.1 t60 -162.06 -76.04 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 106.434 -1.691 . . . . 74.14 106.434 167.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.55 120.49 6.55 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 119.212 -0.771 . . . . 61.03 111.364 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . 0.496 ' HB3' ' HE1' ' E' ' 297' ' ' TYR . 10.8 t-20 173.72 -174.4 0.06 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.736 1.614 . . . . 74.53 107.507 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 72.6 mt 73.41 100.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.03 1.332 . . . . 75.34 110.067 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -74.49 156.17 37.2 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.153 -0.684 . . . . 72.13 109.153 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -88.02 105.26 8.64 Favored Pre-proline 0 C--O 1.242 0.71 0 C-N-CA 123.964 0.905 . . . . 71.54 109.569 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.65 91.04 0.89 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.291 1.994 . . . . 74.34 111.229 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -82.09 -56.62 3.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.539 -0.912 . . . . 70.44 108.539 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 10.9 t 48.26 64.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 125.359 1.463 . . . . 72.21 110.51 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 33.4 p -105.93 116.99 32.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.229 -0.896 . . . . 73.25 109.67 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 48.4 t 65.17 102.36 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.261 1.424 . . . . 73.03 112.062 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 97.7 m -68.66 -46.59 34.66 Favored Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.132 0.973 . . . . 73.31 112.297 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 C--N 1.394 2.959 0 C-N-CA 122.069 1.846 . . . . 72.14 112.558 178.813 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.774 -0.454 . . . . 63.03 109.774 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -164.18 35.24 0.08 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.782 -1.192 . . . . 74.3 107.782 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.77 114.03 19.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.726 -1.125 . . . . 74.03 110.038 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -165.22 144.88 6.8 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.985 0.914 . . . . 63.12 109.312 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.56 157.88 34.01 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.098 0.959 . . . . 75.01 109.33 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -63.29 -155.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.29 2.66 . . . . 72.03 113.176 172.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.47 ' O ' ' HE3' ' C' ' 94' ' ' MET . 66.3 tp -58.3 -40.13 81.2 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.741 -0.466 . . . . 64.54 109.741 172.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 45.1 tp -71.03 138.83 50.17 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.167 -0.924 . . . . 73.11 110.655 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -156.69 -86.92 0.06 OUTLIER Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.494 -0.642 . . . . 65.42 111.494 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 tt -83.57 121.92 27.88 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.737 -0.838 . . . . 73.22 108.737 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -92.41 -86.62 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.294 -1.373 . . . . 74.14 107.294 172.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -160.02 -166.75 1.78 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.727 0.811 . . . . 64.51 109.378 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 26.0 t70 71.23 174.74 0.3 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.528 1.131 . . . . 71.54 110.891 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 106.78 -74.21 0.22 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.668 -0.973 . . . . 74.21 110.668 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -73.29 -24.71 60.45 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.999 0.519 . . . . 72.15 109.879 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -119.23 95.81 49.56 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.995 0.918 . . . . 71.41 110.391 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . 0.402 ' HG2' HH21 ' F' ' 289' ' ' ARG . 60.4 Cg_endo -76.39 89.66 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.148 1.899 . . . . 74.3 109.628 166.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.82 91.39 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.645 -0.707 . . . . 74.21 110.396 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . 0.402 HH21 ' HG2' ' F' ' 287' ' ' PRO . 0.1 OUTLIER -92.35 -41.54 10.3 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.153 -0.93 . . . . 74.25 109.493 179.513 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . 0.585 ' HH2' HD11 ' C' ' 126' ' ' LEU . 13.6 m95 179.68 175.6 0.74 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.85 2.06 . . . . 73.55 109.081 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' C' ' 129' ' ' ALA . 5.2 mp -118.93 -1.46 10.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.752 0.821 . . . . 74.41 110.722 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -148.6 -175.38 21.1 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.335 -0.703 . . . . 34.41 112.608 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.81 -68.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.901 2.401 . . . . 62.23 112.496 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -175.83 153.5 1.39 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.125 0.97 . . . . 75.11 109.237 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -150.95 -36.5 0.14 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.014 0.526 . . . . 63.2 111.773 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 4.3 m -62.93 136.17 57.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.46 0.704 . . . . 64.21 111.435 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.408 ' CE2' ' HB1' ' C' ' 73' ' ' ALA . 5.1 m-30 74.55 -19.56 0.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.098 1.359 . . . . 63.04 113.633 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -65.87 96.92 0.32 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.419 0.687 . . . . 74.54 109.232 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 161.05 -20.27 0.21 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-N 114.423 -1.262 . . . . 63.3 111.026 -170.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . 0.444 ' HA ' ' HB2' ' C' ' 36' ' ' TRP . 26.5 t-20 81.22 -43.14 0.18 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.441 1.497 . . . . 74.0 113.388 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.508 HD13 ' HD3' ' C' ' 124' ' ' PRO . 53.7 mt 66.27 108.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 124.524 1.13 . . . . 75.11 109.344 -168.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.22 -73.8 0.08 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.619 0.768 . . . . 74.12 110.609 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . 0.505 ' HA ' ' HZ ' ' C' ' 32' ' ' PHE . 98.2 mttt -147.86 161.01 36.54 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 124.287 1.035 . . . . 74.24 109.611 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.64 102.02 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.478 2.119 . . . . 62.24 110.28 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . 0.423 ' HB3' ' HA3' ' H' ' 292' ' ' GLY . . . -56.59 -31.56 64.36 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.89 1.276 . . . . 44.35 112.85 -173.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 t -70.7 101.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.892 -0.781 . . . . 74.44 108.892 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 15.1 t -160.97 -2.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.587 0.755 . . . . 73.04 110.338 173.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 60.8 m -97.19 24.3 6.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.471 0.708 . . . . 72.41 110.769 179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' F' F ' 309' ' ' THR . . . . . 0.405 HG22 HD12 ' H' ' 291' ' ' LEU . 3.4 t -154.12 79.17 5.15 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.574 0.749 . . . . 73.53 110.072 -176.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo . . . . . 0 C--N 1.374 1.894 0 C-N-CA 122.544 2.163 . . . . 65.11 111.276 172.178 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.379 0.609 . . . . 55.32 111.054 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -125.34 83.56 2.18 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.164 1.386 . . . . 65.34 107.575 172.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -71.85 90.73 1.13 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.291 -0.868 . . . . 72.15 111.013 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -156.26 95.62 1.61 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.361 1.064 . . . . 74.24 109.373 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -118.37 97.82 50.97 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.17 0.588 . . . . 64.32 109.446 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.15 90.93 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.618 2.212 . . . . 65.13 110.095 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.52 144.65 49.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.33 0.652 . . . . 75.14 110.161 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 34.4 tp 69.82 71.46 0.23 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.526 1.13 . . . . 62.22 109.988 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -100.72 41.75 2.08 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 114.848 -1.069 . . . . 75.33 111.822 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -153.76 -176.78 5.99 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.943 0.897 . . . . 71.02 109.917 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . 0.579 ' HE2' ' HB3' ' D' ' 98' ' ' LEU . 72.6 m-85 71.69 82.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.033 1.333 . . . . 74.42 110.33 -171.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -166.69 -35.65 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.765 1.226 . . . . 75.13 108.689 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.33 131.83 34.84 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.365 1.066 . . . . 71.22 108.763 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -127.89 61.27 0.65 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.725 0.641 . . . . 75.23 112.422 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -73.82 81.19 1.61 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.407 0.622 . . . . 74.55 110.053 171.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 49.7 tpp -103.99 120.02 52.49 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.242 1.017 . . . . 73.55 108.364 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -70.38 80.79 1.03 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.907 2.405 . . . . 75.22 111.831 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . 0.585 HG11 HD22 ' D' ' 42' ' ' LEU . 67.0 t -85.45 96.59 5.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.562 -1.273 . . . . 72.43 107.562 174.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -69.4 -31.85 70.48 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.01 -0.995 . . . . 75.13 110.716 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.646 ' HE1' HG21 ' D' ' 40' ' ' VAL . 57.9 t-105 69.09 161.25 0.2 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.903 1.281 . . . . 74.24 112.083 175.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.67 HD12 ' HB3' ' D' ' 129' ' ' ALA . 5.7 mp -74.91 112.56 11.27 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.336 -0.847 . . . . 74.45 109.712 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.53 -57.87 15.91 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 123.813 0.695 . . . . 72.34 111.724 165.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.68 123.79 12.97 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.462 2.108 . . . . 63.34 112.984 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -99.87 142.27 31.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.192 0.997 . . . . 74.54 109.938 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -144.7 88.88 1.94 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.031 -0.729 . . . . 74.33 109.031 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 4.4 p -150.2 -88.13 0.07 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.653 0.781 . . . . 72.31 110.796 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.46 ' HB2' ' HD3' ' D' ' 38' ' ' PRO . 0.1 OUTLIER -102.3 179.8 4.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.995 0.918 . . . . 75.24 109.166 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -166.14 -38.77 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.168 -0.679 . . . . 72.15 109.168 171.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 176.02 163.41 28.61 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.881 -0.6 . . . . 42.42 113.195 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 62.35 109.61 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.385 1.474 . . . . 72.15 112.524 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.645 HD13 ' HB3' ' D' ' 35' ' ' ASP . 10.5 pt -122.46 11.43 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.303 1.041 . . . . 75.02 109.797 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.95 136.59 34.08 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.068 -0.969 . . . . 74.34 111.171 -163.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . 0.489 ' HZ2' ' HB3' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -104.47 131.1 22.19 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.86 -1.163 . . . . 75.44 107.86 173.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . 0.404 ' HB2' ' HB2' ' E' ' 294' ' ' LYS . 85.3 Cg_exo -49.67 128.93 22.39 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.1 2.534 . . . . 74.03 113.127 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -69.91 148.3 49.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.691 0.796 . . . . 65.12 111.898 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 15.4 t -87.54 146.95 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.391 -0.966 . . . . 72.1 108.391 175.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 73.9 p -68.08 -65.95 0.63 Allowed 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.03 0.532 . . . . 72.41 109.75 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 66.9 m -154.67 109.76 3.08 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.326 -1.361 . . . . 71.13 107.326 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' G' G ' 309' ' ' THR . . . . . 0.453 HG22 ' HD2' ' A' ' 130' ' ' PRO . 67.7 p -74.69 120.63 82.46 Favored Pre-proline 0 C--N 1.351 0.662 0 N-CA-C 108.154 -1.054 . . . . 75.21 108.154 171.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo . . . . . 0 C--N 1.374 1.88 0 C-N-CA 122.129 1.886 . . . . 73.21 110.613 174.06 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.214 -0.291 . . . . 63.22 110.214 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.4 -72.72 0.11 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.384 1.474 . . . . 71.23 111.958 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.1 104.99 0.63 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.391 0.676 . . . . 73.11 110.603 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -100.37 -44.45 5.91 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.586 0.754 . . . . 74.24 109.999 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -151.5 135.73 9.81 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.617 1.167 . . . . 71.02 108.889 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.98 -172.41 0.6 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.744 2.296 . . . . 73.51 111.773 169.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.593 ' HG ' ' SD ' ' B' ' 94' ' ' MET . 23.3 tp -58.55 -42.61 88.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.394 0.678 . . . . 75.44 110.204 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 38.5 tp -69.93 89.99 0.61 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.367 -1.288 . . . . 74.22 110.094 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -94.94 -24.53 17.03 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.011 -0.995 . . . . 64.54 113.213 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . 0.438 ' HB3' HD13 ' B' ' 98' ' ' LEU . 13.4 tp -117.86 170.21 8.99 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.173 0.589 . . . . 75.12 109.43 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 67.42 45.03 1.66 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.526 1.13 . . . . 74.32 111.875 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -114.48 -2.34 13.22 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.791 -1.095 . . . . 73.51 111.189 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -153.78 -93.94 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.773 0.429 . . . . 74.12 111.035 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 142.87 99.95 0.34 Allowed Glycine 0 C--N 1.356 1.669 0 CA-C-N 118.21 0.459 . . . . 65.33 112.348 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -118.68 67.25 0.77 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.049 0.94 . . . . 72.53 109.548 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 48.1 ttm -163.34 84.3 1.39 Allowed Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 116.401 -0.363 . . . . 73.13 110.973 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.4 89.31 1.27 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.331 2.687 . . . . 73.31 109.516 166.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' B' ' 42' ' ' LEU . 60.0 t -69.76 112.72 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.554 0.742 . . . . 72.21 111.261 -172.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -78.64 138.81 38.5 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 107.059 -1.46 . . . . 74.25 107.059 164.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -57.37 151.75 15.63 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.697 0.76 . . . . 74.32 112.726 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.405 HD12 HG22 ' F' ' 309' ' ' THR . 21.8 mt -90.57 7.57 38.46 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.401 -1.272 . . . . 75.25 110.299 176.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . 0.423 ' HA3' ' HB3' ' F' ' 305' ' ' ALA . . . 148.67 84.15 0.05 OUTLIER Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.831 -1.308 . . . . 63.22 109.831 -176.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.3 -51.41 2.69 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.557 2.171 . . . . 72.43 113.075 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' H' ' 294' ' ' LYS . 8.3 mmpt? 55.02 31.08 15.38 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.682 1.193 . . . . 73.2 113.448 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 65.55 101.39 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.395 1.078 . . . . 74.03 112.183 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 80.5 m -63.56 -27.77 69.48 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.619 -0.718 . . . . 74.52 111.171 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 3.9 m-30 -86.25 176.45 7.93 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.229 1.011 . . . . 74.42 111.947 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -68.28 117.89 10.67 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 114.861 -1.063 . . . . 72.23 110.113 -172.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -66.24 -23.63 71.66 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.854 0.721 . . . . 63.12 112.033 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -143.7 129.15 19.02 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.439 1.096 . . . . 73.54 110.33 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 98.8 mt -121.62 125.36 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.623 -1.251 . . . . 70.23 107.623 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -132.48 -73.26 0.51 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.846 -0.798 . . . . 74.52 108.846 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -138.59 151.2 68.44 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 123.87 0.868 . . . . 73.34 109.739 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.06 166.38 23.2 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.64 2.226 . . . . 74.11 112.624 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.03 8.47 8.45 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.462 0.705 . . . . 74.21 111.482 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.51 136.95 32.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 C-N-CA 124.38 1.072 . . . . 75.32 109.482 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 9.9 t -168.7 -34.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.132 0.973 . . . . 74.12 110.69 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 64.4 m -144.11 110.74 5.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.933 0.893 . . . . 74.24 108.992 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' H' H ' 309' ' ' THR . . . . . 0.535 HG21 HD22 ' F' ' 291' ' ' LEU . 32.1 p -64.45 142.8 98.46 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 123.024 0.529 . . . . 75.43 110.323 175.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . 0.477 ' HD3' ' HG ' ' F' ' 291' ' ' LEU . 55.0 Cg_endo . . . . . 0 C--N 1.379 2.154 0 C-N-CA 123.104 2.536 . . . . 74.32 112.43 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.732 -0.47 . . . . 73.42 109.732 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.4 p -78.48 82.68 4.73 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.791 0.805 . . . . 74.03 109.64 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -125.95 -53.36 1.53 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.376 1.071 . . . . 74.5 108.826 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -88.91 126.52 35.42 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.179 -1.045 . . . . 74.25 108.179 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -70.12 111.14 5.55 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.474 -0.936 . . . . 72.42 108.474 175.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.425 ' HB3' HG21 ' A' ' 89' ' ' ILE . 11.5 m120 -84.22 58.38 4.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.467 0.707 . . . . 63.22 111.214 -172.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 m 62.03 -74.89 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.533 1.533 . . . . 75.31 110.6 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -151.98 -53.58 0.12 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.172 1.389 . . . . 74.52 107.645 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 71.39 137.03 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.902 1.681 . . . . 74.31 111.163 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.5 m -142.41 138.32 31.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.571 0.748 . . . . 75.13 109.854 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.434 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 18.7 t80 -133.05 124.79 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 75.32 108.887 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -146.56 110.02 4.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.96 -0.756 . . . . 75.43 108.96 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.662 HG12 ' HD2' ' A' ' 84' ' ' PHE . 37.6 mt -69.65 128.69 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.639 -0.874 . . . . 71.14 108.639 173.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.599 HE21 ' HA ' ' A' ' 14' ' ' GLN . 0.0 OUTLIER -97.73 -36.98 10.06 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 122.936 0.494 . . . . 74.23 110.461 177.344 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.542 HH11 ' HB1' ' H' ' 305' ' ' ALA . 40.8 ttt85 -166.86 142.99 4.46 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.885 -0.413 . . . . 75.33 109.885 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.69 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.549 0.74 . . . . 74.23 109.027 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.491 ' HE1' HG13 ' A' ' 83' ' ' ILE . 21.2 p90 -169.02 149.8 4.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.919 0.888 . . . . 63.24 110.299 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -79.33 119.81 22.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.899 -1.046 . . . . 74.52 108.83 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.2 mtpt -88.22 -17.93 29.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.847 0.356 . . . . 74.41 110.284 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.563 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.1 t70 -156.53 141.76 17.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.305 1.042 . . . . 72.45 109.141 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 64.4 mt -138.14 144.91 29.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 107.238 -1.393 . . . . 61.52 107.238 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.605 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 28.3 t -150.8 130.51 13.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.852 0.861 . . . . 74.34 108.935 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.534 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -132.64 136.44 46.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.406 -1.701 . . . . 75.1 106.406 167.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -133.91 140.13 46.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.414 -0.587 . . . . 75.11 109.414 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 69.23 10.92 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 106.065 -1.828 . . . . 74.25 106.065 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.46 -19.41 21.93 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.324 2.016 . . . . 73.24 112.453 -171.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -110.52 20.53 17.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.867 0.867 . . . . 64.11 109.798 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.74 -61.28 3.13 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.05 -0.976 . . . . 71.11 113.38 -167.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.4 -20.66 49.52 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.404 2.069 . . . . 74.22 113.912 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -83.85 -53.19 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.104 0.954 . . . . 73.34 109.906 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.546 HG12 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -77.43 -12.74 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-N 114.61 -1.177 . . . . 71.2 111.8 -162.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -74.18 -18.03 60.82 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.641 0.776 . . . . 64.43 112.606 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.07 -8.92 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.787 0.662 . . . . 75.43 112.787 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -79.9 168.95 18.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.957 0.503 . . . . 75.32 112.296 -174.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.93 138.62 58.48 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.67 1.188 . . . . 73.34 111.153 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -86.84 80.43 8.49 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.483 0.659 . . . . 73.34 110.146 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -137.31 77.53 41.26 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 114.938 -1.028 . . . . 71.22 109.006 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -81.4 138.82 11.18 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.38 2.054 . . . . 64.1 111.762 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.56 84.32 3.39 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 106.006 -1.85 . . . . 65.54 106.006 164.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 65' ' ' THR . 12.0 p -81.91 123.39 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.748 -1.114 . . . . 73.44 109.153 -175.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.542 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 18.0 pttp -123.6 127.62 48.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 75.52 110.591 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tt -98.55 109.49 22.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.629 -1.619 . . . . 70.33 106.629 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.654 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -106.34 147.89 28.69 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.792 0.837 . . . . 75.15 108.815 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -126.19 125.57 42.66 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.74 0.816 . . . . 74.11 109.342 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.5 t70 -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.093 0.957 . . . . 75.53 108.455 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -108.17 129.46 55.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.879 0.872 . . . . 73.11 111.597 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.16 130.72 17.83 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.705 0.802 . . . . 71.34 109.987 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -125.05 151.58 45.43 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.896 -0.779 . . . . 73.12 108.896 172.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 t -158.33 133.66 8.71 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.486 0.714 . . . . 72.24 109.857 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -78.32 125.53 29.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.227 0.611 . . . . 75.34 110.018 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.12 -34.28 13.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.453 0.701 . . . . 75.53 110.64 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -178.58 6.05 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.057 0.943 . . . . 72.24 109.707 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -69.26 125.34 26.39 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.902 -0.407 . . . . 75.22 109.902 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 68.58 -8.22 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.968 1.707 . . . . 64.44 112.805 -171.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -101.33 109.52 25.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.997 -0.742 . . . . 71.3 108.997 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.532 ' HB2' HD11 ' A' ' 86' ' ' ILE . 93.2 m-85 -123.64 127.19 47.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.965 0.906 . . . . 74.14 108.607 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.31 132.04 37.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.681 -1.145 . . . . 73.4 108.992 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.58 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 58.9 t -116.86 121.43 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.694 -1.224 . . . . 73.45 107.694 169.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.41 129.76 49.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.839 0.855 . . . . 73.21 108.711 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -120.57 100.5 7.17 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.547 -1.649 . . . . 74.55 106.547 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.576 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 6.6 ttm180 -87.35 131.22 34.34 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.843 -0.799 . . . . 74.41 108.843 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 114' ' ' ILE . 47.9 t -117.84 130.61 72.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.328 -0.989 . . . . 72.43 108.328 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.654 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 69.2 m -113.72 140.97 47.82 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.635 0.584 . . . . 65.32 109.693 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.517 HG23 HD21 ' A' ' 126' ' ' LEU . 92.7 t -130.43 113.29 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.961 0.904 . . . . 72.44 108.747 174.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.5 m -112.73 131.49 55.65 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.114 -0.698 . . . . 72.41 109.114 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.27 105.74 8.75 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.316 -0.994 . . . . 72.44 108.316 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.571 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 51.6 m -110.58 122.92 48.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.29 0.495 . . . . 70.1 110.816 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.631 HD12 ' HB1' ' A' ' 73' ' ' ALA . 10.4 mp -89.57 86.96 6.87 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.111 0.964 . . . . 74.11 109.012 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.1 -84.41 1.43 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.757 -1.111 . . . . 61.43 110.5 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -25.37 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.627 0.771 . . . . 64.34 110.446 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -98.4 129.87 45.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.312 1.045 . . . . 71.31 110.225 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.6 m -79.85 135.49 36.47 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.196 0.522 . . . . 73.53 112.19 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.631 ' HB1' HD12 ' A' ' 68' ' ' LEU . . . -77.64 -63.81 1.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.2 1.4 . . . . 72.34 109.766 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -147.09 159.75 43.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.104 -0.953 . . . . 75.12 111.645 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.65 117.26 11.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.399 -1.273 . . . . 75.31 108.335 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 63' ' ' THR . 83.9 m -110.61 136.72 49.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.392 0.677 . . . . 60.14 110.709 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.605 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 43.2 mp0 -135.9 131.27 35.02 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.618 -1.253 . . . . 71.21 107.618 169.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 61' ' ' ARG . 72.5 t -138.27 115.2 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.6 -0.889 . . . . 73.3 108.6 174.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.563 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 42.3 mt-30 -90.23 86.98 6.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 172.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.71 93.11 4.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.727 -1.124 . . . . 73.3 108.62 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.01 148.24 22.3 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.264 -0.88 . . . . 71.24 111.082 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.74 123.27 2.01 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 111.349 -0.7 . . . . 74.21 111.349 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.491 HG13 ' HE1' ' A' ' 17' ' ' TYR . 56.3 mt -80.97 123.67 37.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.896 -1.149 . . . . 72.15 107.896 170.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.662 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.3 m-85 -133.83 162.9 30.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.263 -1.014 . . . . 63.23 108.263 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 t -118.43 102.47 8.95 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.489 -0.93 . . . . 74.55 108.489 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.532 HD11 ' HB2' ' A' ' 56' ' ' TYR . 3.3 mp -112.82 137.13 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.568 0.747 . . . . 74.42 109.032 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.8 174.87 13.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.981 0.912 . . . . 61.2 109.876 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.21 16.14 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.742 0.657 . . . . 61.22 114.742 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 94' ' ' MET . 11.2 pt -121.29 157.07 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.918 0.887 . . . . 74.24 110.776 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.482 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 2.8 tt0 -140.31 174.63 10.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.96 0.904 . . . . 73.43 109.32 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.482 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 41.91 -116.11 0.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.927 1.131 . . . . 72.34 115.927 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.6 p -73.05 -28.58 62.4 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.7 1.2 . . . . 72.34 111.978 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.08 -46.74 87.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.383 0.673 . . . . 74.34 109.206 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.772 ' HE3' ' HB3' ' E' ' 277' ' ' LEU . 1.4 ppp? -83.59 -21.7 32.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.49 -0.777 . . . . 61.04 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -27.42 66.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.156 0.583 . . . . 70.02 110.692 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -64.52 -35.14 80.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.773 0.829 . . . . 75.24 110.597 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 45.1 t -72.33 -41.11 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.878 -0.601 . . . . 61.14 110.91 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.57 -51.1 21.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.3 0.24 . . . . 73.4 111.605 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.9 3.79 77.83 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 114.871 0.708 . . . . 54.45 114.871 -165.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.706 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -149.64 -58.26 0.2 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.013 0.907 . . . . 75.22 113.271 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 64.3 t80 -70.55 -59.21 2.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.692 -1.14 . . . . 72.51 112.086 -167.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.02 -32.48 2.91 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.546 0.943 . . . . 63.21 113.546 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.16 -45.58 25.25 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.732 2.288 . . . . 75.52 113.011 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.18 -27.76 69.29 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.747 0.819 . . . . 74.25 111.439 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.9 mm -74.74 -47.59 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.634 0.774 . . . . 74.32 110.257 175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.54 -29.68 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.623 0.769 . . . . 74.55 112.798 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -65.15 -38.65 29.79 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 113.599 0.962 . . . . 75.13 113.599 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.81 -40.68 79.34 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 122.14 1.893 . . . . 71.32 113.608 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.502 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 96.6 m-85 -73.44 -40.56 64.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 75.2 111.636 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.87 84.0 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.814 0.446 . . . . 64.0 109.939 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -49.61 -53.75 22.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.096 1.498 . . . . 70.54 110.522 175.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.6 -41.11 93.16 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.178 0.924 . . . . 70.5 111.658 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.8 -31.59 72.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.034 0.533 . . . . 55.33 111.249 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.439 ' O ' HG23 ' A' ' 118' ' ' VAL . 89.7 mt -71.84 -51.78 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.555 0.742 . . . . 75.32 109.206 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.0 m -53.57 -40.04 65.27 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.705 1.202 . . . . 75.02 111.609 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -59.72 -55.2 37.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.719 -1.128 . . . . 42.33 110.386 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.534 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.4 mtm -60.75 -43.33 98.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.24 111.515 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 114' ' ' ILE . 78.5 t -57.38 -46.38 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.411 1.084 . . . . 50.21 110.691 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -70.67 -29.25 65.53 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.15 -0.932 . . . . 74.0 111.369 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.407 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.55 -30.74 66.22 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.788 0.835 . . . . 73.53 110.653 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.08 6.25 76.21 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.774 -0.459 . . . . 74.21 112.992 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.642 ' HB ' HH21 ' B' ' 15' ' ' ARG . 1.6 m 67.9 18.71 9.58 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.258 1.423 . . . . 75.32 111.681 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.92 151.57 64.2 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 109.284 -0.635 . . . . 72.44 109.284 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -58.97 146.01 95.43 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.795 2.33 . . . . 72.43 111.53 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.412 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.23 129.58 38.86 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.747 0.654 . . . . 75.25 111.393 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.517 HD21 HG23 ' A' ' 64' ' ' VAL . 48.0 tp -112.3 96.14 5.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.765 -1.107 . . . . 75.31 110.004 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.57 105.46 15.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.562 -1.273 . . . . 75.42 107.562 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 143.53 57.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.871 0.468 . . . . 74.13 110.045 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' E' ' 291' ' ' LEU . . . -63.17 130.51 94.24 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 122.95 0.5 . . . . 74.11 111.141 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.419 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 56.2 Cg_endo -72.37 104.9 1.77 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.241 1.961 . . . . 65.04 111.246 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.408 HG21 HD23 ' E' ' 291' ' ' LEU . 32.7 t -101.02 122.78 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.27 -1.011 . . . . 73.3 108.27 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.451 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 51.3 t30 -68.29 86.62 0.28 Allowed 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.65 -0.87 . . . . 75.21 108.65 170.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.467 -1.242 . . . . 75.43 109.922 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.706 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 5.2 t70 -66.27 -36.31 82.64 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 114.239 -1.346 . . . . 62.13 111.498 -174.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.451 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . . . -66.91 -53.4 32.4 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 120.568 0.223 . . . . 75.52 110.606 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.443 HD23 ' HG1' ' C' ' 149' ' ' THR . 64.4 mt -65.64 -28.07 68.84 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.894 0.478 . . . . 71.04 112.277 -173.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -81.98 -50.44 9.13 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.929 -0.578 . . . . 71.25 110.167 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.63 ' HE1' HD21 ' A' ' 141' ' ' LEU . 0.0 OUTLIER -72.03 -39.98 68.74 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.481 0.712 . . . . 74.41 110.979 -169.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 87.1 m-20 -53.94 -41.06 67.34 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.226 0.611 . . . . 72.32 110.675 174.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -78.28 -31.94 49.23 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.901 -0.59 . . . . 74.41 111.459 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.63 HD21 ' HE1' ' A' ' 138' ' ' MET . 20.7 tp -67.54 -51.18 53.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.322 0.649 . . . . 75.33 111.465 -175.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -166.59 18.21 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.517 0.727 . . . . 75.1 110.015 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 64.0 tt0 67.49 135.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.101 1.361 . . . . 75.03 111.052 -171.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -83.36 43.28 0.87 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.948 0.88 . . . . 71.42 110.311 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.49 104.62 9.21 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.196 0.998 . . . . 74.14 109.694 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -145.19 121.97 1.63 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.648 -0.706 . . . . 73.41 111.517 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -161.19 103.29 1.27 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.713 0.805 . . . . 72.4 108.925 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.15 77.23 0.23 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.33 -0.708 . . . . 71.11 111.33 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.6 p -73.16 86.09 1.38 Allowed 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 121.613 0.72 . . . . 74.21 109.421 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -85.15 141.48 30.16 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.433 1.093 . . . . 75.3 111.615 -170.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.01 151.08 20.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.545 0.738 . . . . 73.31 109.724 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -145.69 89.37 1.9 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.232 1.013 . . . . 74.4 110.003 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -162.66 102.41 1.04 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 107.208 -1.404 . . . . 71.4 107.208 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -86.23 -45.43 11.31 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.571 0.748 . . . . 60.44 111.937 -171.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.798 0 C-N-CA 123.593 0.757 . . . . 75.14 109.097 -172.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 110.362 -0.236 . . . . 74.11 110.362 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 61.3 p -163.82 57.15 0.17 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.909 1.284 . . . . 72.32 108.458 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -105.9 171.82 7.13 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.763 -1.108 . . . . 73.33 111.374 -167.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 70.36 107.77 0.06 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.273 1.429 . . . . 74.43 111.965 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -65.21 133.09 50.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.435 0.694 . . . . 74.32 110.376 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -139.92 145.11 37.55 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.166 0.986 . . . . 73.41 108.762 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 56.3 m 74.42 129.62 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.197 1.399 . . . . 73.43 112.011 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -83.54 -157.59 0.25 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.122 0.969 . . . . 75.42 109.565 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.499 ' HE2' ' SG ' ' B' ' 97' ' ' CYS . 17.1 ptm 59.46 -177.8 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 126.137 1.775 . . . . 75.53 113.368 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.9 m -148.09 113.31 5.55 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.28 0.632 . . . . 71.21 109.85 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.472 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 74.4 t80 -110.45 117.38 33.42 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.072 -1.084 . . . . 71.02 108.072 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -126.31 106.28 9.4 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.705 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -79.77 118.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 106.887 -1.523 . . . . 74.45 106.887 167.053 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -87.07 -53.61 4.77 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.472 -0.331 . . . . 75.41 110.188 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.642 HH21 ' HB ' ' A' ' 122' ' ' THR . 52.6 ttt180 -156.35 139.93 15.94 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.093 -0.336 . . . . 73.33 110.093 -172.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.705 HG13 HD11 ' B' ' 13' ' ' ILE . 92.5 mt -116.8 140.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 106.722 -1.584 . . . . 75.33 106.722 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -168.51 159.64 10.41 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 123.569 0.543 . . . . 72.32 110.552 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -85.93 120.26 27.13 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.403 -0.591 . . . . 74.05 109.403 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -87.81 -30.63 20.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.089 0.556 . . . . 73.41 110.689 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -158.86 146.81 17.96 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.715 0.293 . . . . 54.13 111.552 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.705 HD12 ' SG ' ' B' ' 113' ' ' CYS . 42.0 mm -132.46 141.61 44.76 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 125.281 1.432 . . . . 72.13 108.911 175.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.538 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.2 t -139.44 130.84 26.93 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.921 1.288 . . . . 75.54 107.655 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.459 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -148.13 125.17 11.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.462 -1.311 . . . . 74.41 107.462 168.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.429 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 45.9 mt-10 -122.92 144.99 48.86 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.623 -0.881 . . . . 72.13 108.623 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' B' ' 28' ' ' ALA . . . -142.22 74.88 20.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.6 -1.259 . . . . 75.31 107.6 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.31 -38.28 6.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.663 2.242 . . . . 72.34 112.566 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.456 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 71.9 m-20 -105.41 10.96 33.18 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.28 0.632 . . . . 74.22 111.01 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.585 ' HB3' ' HB3' ' B' ' 25' ' ' ALA . . . -44.59 -50.71 23.12 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 115.016 1.487 . . . . 71.45 115.016 -171.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.72 -30.35 17.94 Favored 'Trans proline' 0 C--N 1.383 2.384 0 CA-C-N 121.141 1.443 . . . . 73.33 112.829 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.422 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.0 m80 -97.61 -2.36 41.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.873 0.869 . . . . 71.44 112.956 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.53 -12.73 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.928 0.491 . . . . 74.11 110.492 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . 0.588 ' HZ ' ' HG2' ' H' ' 303' ' ' LYS . 71.8 t80 -61.36 -29.52 69.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.289 1.036 . . . . 72.35 111.735 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 pt20 -62.06 -31.98 72.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.193 0.597 . . . . 72.41 110.58 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.595 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 35.3 mmtp -97.05 64.98 2.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.311 -0.996 . . . . 74.42 108.311 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.91 99.72 11.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.802 -0.635 . . . . 75.13 110.324 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.516 ' HZ3' HG23 ' H' ' 301' ' ' ILE . 0.0 OUTLIER 163.89 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 126.953 2.101 . . . . 73.43 110.231 160.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.498 ' HA ' ' HB2' ' H' ' 297' ' ' TYR . 26.6 pt20 -59.35 125.11 78.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.112 0.965 . . . . 64.1 112.589 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.422 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 87.9 Cg_endo -84.98 150.61 10.97 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.115 2.544 . . . . 74.32 112.56 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.44 106.45 3.94 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.015 -1.106 . . . . 74.25 108.015 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' B' ' 65' ' ' THR . 91.9 t -93.13 128.69 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.62 0.768 . . . . 75.53 110.862 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.583 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.8 tttp -109.98 124.39 51.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.165 0.986 . . . . 74.32 109.478 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.21 152.51 22.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.43 0.692 . . . . 71.32 109.94 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.09 111.7 1.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.715 0.635 . . . . 71.45 109.525 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.42 ' HG ' HG21 ' B' ' 62' ' ' VAL . 10.1 mp -99.1 139.21 35.09 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.949 -1.13 . . . . 74.45 107.949 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.8 t70 -121.75 126.24 48.42 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.89 0.876 . . . . 75.3 108.841 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -106.96 103.93 13.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.17 0.988 . . . . 74.22 108.418 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 140.73 50.28 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.482 -0.781 . . . . 73.23 109.014 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 p -144.52 163.88 32.55 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.619 0.368 . . . . 72.45 111.28 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -153.06 140.38 19.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.04 0.936 . . . . 72.02 109.536 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -80.03 133.6 36.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.574 0.35 . . . . 75.53 110.527 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.49 HD12 HG22 ' B' ' 83' ' ' ILE . 74.2 mt -94.84 -44.31 7.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.325 0.65 . . . . 73.15 110.592 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.62 -167.55 1.59 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.656 0.782 . . . . 74.05 110.965 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -63.9 106.08 0.96 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.884 -1.053 . . . . 72.0 110.784 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' B' ' 85' ' ' SER . 33.8 m-20 73.18 -1.72 2.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.303 1.841 . . . . 75.14 112.057 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.93 124.13 58.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.524 0 C-N-CA 124.182 0.993 . . . . 74.53 108.782 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -134.39 -178.62 5.13 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.512 0.725 . . . . 70.31 109.235 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.441 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.0 tm-20 -138.17 116.64 12.03 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.805 -1.554 . . . . 75.15 106.805 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.83 127.17 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.835 0.854 . . . . 73.53 110.309 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.6 t -102.48 112.89 37.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.297 1.039 . . . . 74.33 108.829 174.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.4 97.81 8.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.367 -1.346 . . . . 75.32 107.367 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.6 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 27.8 ttm180 -84.81 133.31 34.34 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.873 -0.788 . . . . 75.3 108.873 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.42 HG21 ' HG ' ' B' ' 44' ' ' LEU . 57.6 t -117.77 109.23 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.577 -1.268 . . . . 52.12 107.577 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -96.23 136.64 36.43 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.627 -0.879 . . . . 75.24 108.627 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -133.03 132.27 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.417 1.087 . . . . 72.34 108.455 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 59.7 m -123.19 144.08 49.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.686 -1.227 . . . . 72.52 107.686 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.04 135.14 39.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.953 -1.499 . . . . 70.11 106.953 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 14.8 p -145.77 139.03 26.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 122.982 0.513 . . . . 73.11 110.683 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.595 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 23.7 mt -129.46 104.67 7.61 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.853 1.261 . . . . 73.35 109.694 -171.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -135.92 19.79 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.542 -0.588 . . . . 74.11 111.953 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.7 11.08 18.56 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.546 0.673 . . . . 75.24 111.532 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.456 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.4 pt-20 -130.13 167.59 18.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.341 0.657 . . . . 72.23 110.936 -175.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -79.56 145.87 32.91 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.495 -0.775 . . . . 75.53 109.807 174.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.46 -67.11 0.88 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.947 0.499 . . . . 54.0 109.668 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -160.63 152.08 19.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.975 -1.011 . . . . 73.51 108.792 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.429 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 65.9 mt -128.07 137.1 52.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.56 1.144 . . . . 65.42 108.309 -174.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -146.49 147.03 30.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.522 -0.548 . . . . 74.24 109.522 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.538 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.3 tt0 -160.88 138.61 9.42 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.449 HG11 ' HA ' ' B' ' 110' ' ' ALA . 74.5 t -130.15 146.26 34.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.677 -1.231 . . . . 62.12 107.677 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.9 91.79 3.59 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.777 -1.194 . . . . 72.41 107.777 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.426 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.8 tp-100 -88.04 100.07 12.65 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.343 -0.984 . . . . 71.25 108.343 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.34 162.11 30.52 Favored Glycine 0 C--O 1.241 0.574 0 N-CA-C 111.047 -0.821 . . . . 64.23 111.047 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.64 126.8 1.6 Allowed Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.938 -0.865 . . . . 34.05 110.938 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.49 HG22 HD12 ' B' ' 51' ' ' LEU . 59.0 mt -84.39 129.62 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.467 -0.938 . . . . 74.31 108.467 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -131.81 148.75 52.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.38 -0.6 . . . . 75.14 109.38 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 22.6 m -131.23 106.64 8.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.43 1.092 . . . . 73.22 109.161 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.69 145.02 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 122.946 0.498 . . . . 74.14 110.634 -178.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.13 161.73 39.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.865 0.866 . . . . 65.2 109.986 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.47 -41.2 2.51 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.895 -0.593 . . . . 74.34 111.775 -178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.599 HD13 ' HA ' ' B' ' 94' ' ' MET . 11.0 pt -71.66 143.38 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.727 0.811 . . . . 74.4 110.574 173.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.18 145.0 24.36 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.857 -0.794 . . . . 74.45 108.857 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.73 -109.4 2.83 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.831 0.707 . . . . 74.41 113.68 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.09 -53.44 45.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.233 1.013 . . . . 73.33 111.487 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -66.55 -34.3 77.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.248 -1.342 . . . . 74.13 110.417 -172.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.599 ' HA ' HD13 ' B' ' 89' ' ' ILE . 52.2 ttp -65.86 -50.94 62.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.679 1.192 . . . . 75.3 110.606 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.9 77.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.14 0.976 . . . . 72.22 111.919 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -78.2 -36.02 47.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.215 0.606 . . . . 74.45 111.227 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.499 ' SG ' ' HE2' ' B' ' 9' ' ' MET . 52.2 t -65.11 -52.18 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.07 0.548 . . . . 70.11 111.673 -175.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.1 pp -86.75 -31.95 20.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.591 -0.277 . . . . 75.44 111.532 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.08 73.4 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.09 0.396 . . . . 54.32 114.09 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.75 -51.6 2.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.808 0.443 . . . . 74.15 111.801 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.486 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 49.7 t80 -75.54 -40.75 56.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.806 0.442 . . . . 71.33 111.99 -170.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.4 m -66.49 -43.89 53.88 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 113.466 0.913 . . . . 73.43 113.466 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.86 -37.09 97.61 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.359 2.039 . . . . 74.23 113.218 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.23 -19.7 66.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.497 0.719 . . . . 55.41 112.491 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 86.3 mt -81.68 -48.31 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.344 0.658 . . . . 72.24 110.75 177.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.24 -25.82 58.4 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.915 -0.584 . . . . 72.33 111.591 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -57.68 -52.54 73.61 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.066 1.136 . . . . 74.24 114.066 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.71 -41.42 61.96 Favored 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.439 2.093 . . . . 72.42 113.731 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.432 ' HE2' HG23 ' D' ' 115' ' ' THR . 91.7 m-85 -65.15 -48.13 74.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.8 0.84 . . . . 75.45 111.396 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.449 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.73 -38.54 82.0 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.486 -0.779 . . . . 62.52 110.988 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 ttp-105 -65.71 -49.73 67.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.047 -1.433 . . . . 74.04 111.386 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -35.37 79.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.995 0.518 . . . . 75.04 110.232 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.705 ' SG ' HD12 ' B' ' 21' ' ' ILE . 7.6 t -67.21 -32.0 72.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.623 0.369 . . . . 71.23 111.405 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.63 -45.63 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.499 0.72 . . . . 74.43 109.651 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.686 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.8 m -60.51 -25.01 65.77 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.382 1.073 . . . . 74.22 111.521 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -75.24 -51.4 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.652 0.781 . . . . 72.45 110.136 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.481 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.31 -34.99 73.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.914 0.486 . . . . 72.03 111.933 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.55 -39.47 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.463 0.705 . . . . 74.24 110.039 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.3 t -72.92 -27.51 61.91 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.702 0.801 . . . . 62.5 111.605 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.4 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.4 mtt-85 -73.34 -33.34 65.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.413 0.685 . . . . 71.13 110.086 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.34 1.75 69.49 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 123.855 0.722 . . . . 52.42 112.305 168.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.417 HG23 ' HB3' ' A' ' 17' ' ' TYR . 30.7 p 63.33 38.61 10.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.85 2.06 . . . . 72.22 112.606 172.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.11 156.76 40.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.484 1.114 . . . . 64.32 109.869 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.527 ' HG3' ' HB2' ' H' ' 300' ' ' ASN . 11.8 Cg_exo -66.58 143.42 68.53 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.428 2.085 . . . . 72.41 111.54 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.686 ' HB2' HG23 ' B' ' 115' ' ' THR . 16.7 pt20 -65.14 161.65 18.64 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.28 1.432 . . . . 74.51 114.566 -167.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.628 HD13 ' HH2' ' H' ' 290' ' ' TRP . 26.5 tp -135.29 104.38 5.86 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.345 -1.298 . . . . 74.01 109.876 168.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.5 HD22 ' NE2' ' B' ' 125' ' ' GLN . 6.1 m-80 -92.2 107.43 19.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 106.48 -1.674 . . . . 74.01 106.48 167.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.1 tp -62.88 134.98 57.05 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.302 0.376 . . . . 70.1 110.153 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.473 ' HB1' ' HA2' ' H' ' 292' ' ' GLY . . . -61.25 156.46 50.42 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.775 1.23 . . . . 74.51 111.867 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.9 108.43 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.754 2.302 . . . . 72.01 111.992 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.445 HG22 HD13 ' H' ' 291' ' ' LEU . 38.2 t -88.14 108.57 18.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.775 -1.565 . . . . 73.42 106.775 176.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' B' ' 135' ' ' ALA . 64.9 t30 -90.23 88.99 7.45 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.854 -0.795 . . . . 75.03 108.854 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -63.33 -28.62 70.13 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.199 -0.909 . . . . 74.54 110.466 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.419 ' HB3' ' OD1' ' B' ' 132' ' ' ASN . 7.6 t70 -51.5 -51.07 58.23 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.49 1.116 . . . . 74.4 111.398 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.507 ' HB3' ' ND2' ' B' ' 132' ' ' ASN . . . -65.44 -32.43 74.05 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 123.877 0.736 . . . . 74.55 112.221 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.74 -45.61 93.18 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.873 0.869 . . . . 75.54 110.686 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 71.4 m-85 -78.53 -34.91 46.87 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.8 -0.636 . . . . 75.24 110.853 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -36.96 85.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.657 0.783 . . . . 74.02 110.528 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -77.53 -7.66 56.62 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.368 -0.833 . . . . 72.44 111.35 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -89.0 -29.23 19.65 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 109.356 -0.609 . . . . 74.04 109.356 168.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 62.9 mt -86.81 26.3 1.15 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.983 0.913 . . . . 74.01 111.792 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -71.21 95.67 1.3 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.373 -0.602 . . . . 71.34 109.373 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.23 162.82 26.29 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.669 0.787 . . . . 70.52 111.68 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -87.56 173.29 9.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.171 0.988 . . . . 74.31 111.433 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.28 134.84 20.93 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.919 0.888 . . . . 72.52 109.339 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.58 148.8 18.68 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 111.759 -0.537 . . . . 64.24 111.759 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -165.75 112.42 0.91 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.534 0.734 . . . . 74.22 110.116 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -94.81 -149.18 25.3 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.159 -0.377 . . . . 71.44 112.159 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 88.3 m -146.95 126.47 13.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.288 0.635 . . . . 72.53 110.478 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.59 103.77 5.85 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.743 -0.836 . . . . 74.14 108.743 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -80.38 166.16 21.55 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.79 0.805 . . . . 74.21 112.741 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -118.81 106.99 13.08 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 113.854 -1.521 . . . . 74.43 109.39 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -87.56 89.28 7.93 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.2 0.524 . . . . 74.34 110.056 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.8 155.59 20.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.167 0.987 . . . . 72.13 110.581 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 123.721 0.808 . . . . 75.41 109.721 -177.146 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.789 -0.449 . . . . 72.32 109.789 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.7 m -154.36 169.09 24.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.872 0.869 . . . . 75.23 110.26 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -138.9 88.49 2.29 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.332 -1.358 . . . . 74.24 107.332 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.19 142.3 45.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.547 0.739 . . . . 74.24 109.592 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -60.63 -41.41 94.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.189 0.596 . . . . 73.33 111.669 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -70.41 128.19 35.34 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.22 0.325 . . . . 63.41 110.216 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 35.4 p -132.36 94.8 3.51 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.485 1.114 . . . . 73.0 108.581 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.57 139.84 45.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.97 0.908 . . . . 72.04 110.365 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.705 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.3 tmm? 65.7 115.23 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.391 1.476 . . . . 75.34 112.222 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.572 ' HB ' ' HB2' ' C' ' 87' ' ' ALA . 31.1 m -100.14 92.07 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.816 0.846 . . . . 73.32 109.36 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.705 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 49.0 t80 -92.01 145.78 24.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.799 -0.815 . . . . 74.21 108.799 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.01 132.2 4.8 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.844 -0.798 . . . . 72.12 108.844 167.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -70.88 134.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 109.17 -0.678 . . . . 73.14 109.17 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -103.19 -45.13 5.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.488 -0.56 . . . . 73.25 109.488 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.518 HH12 HG21 ' G' ' 301' ' ' ILE . 29.8 ttt85 -169.09 147.0 3.75 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.999 -0.546 . . . . 74.43 109.73 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -130.02 136.22 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.328 -1.36 . . . . 75.31 107.328 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.565 ' HB3' HG21 ' D' ' 122' ' ' THR . 19.2 p90 -171.22 154.1 3.88 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.418 0.627 . . . . 74.2 111.258 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -77.95 109.26 11.84 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.237 -1.023 . . . . 72.34 108.237 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -70.28 -45.55 66.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.74 0.781 . . . . 75.25 108.945 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.606 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.9 t70 -138.09 141.53 40.24 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.362 -1.29 . . . . 74.32 109.318 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.573 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.9 mt -136.16 142.71 37.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.718 1.607 . . . . 74.52 106.686 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -155.92 150.91 26.4 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.298 0.57 . . . . 62.13 110.987 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.485 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -152.45 121.61 6.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.595 -1.184 . . . . 75.52 107.842 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 72.41 109.157 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.1 86.18 20.83 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.453 -0.943 . . . . 51.13 108.453 174.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.27 -39.08 10.72 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.386 2.057 . . . . 75.44 111.316 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -99.26 33.77 2.34 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.188 0.995 . . . . 75.31 110.035 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.42 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -59.78 -51.9 77.63 Favored Pre-proline 0 CA--C 1.569 1.689 0 C-N-CA 124.615 1.166 . . . . 73.24 114.128 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 4.4 Cg_exo -74.85 -26.95 10.74 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.718 1.612 . . . . 74.41 111.37 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -66.03 -18.34 65.28 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.138 1.375 . . . . 73.35 112.166 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -54.71 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 N-CA-C 113.324 0.861 . . . . 63.11 113.324 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -68.25 -26.4 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.974 0.416 . . . . 74.21 111.886 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.44 30.95 6.67 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.508 1.123 . . . . 72.11 109.683 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.698 ' HZ2' ' HB2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -95.32 137.07 34.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.175 0.99 . . . . 73.0 108.7 171.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.73 130.37 42.14 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.576 -0.898 . . . . 73.23 108.576 170.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -83.79 66.59 9.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.109 0.564 . . . . 74.54 111.238 -170.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -165.7 78.34 1.22 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.543 0.737 . . . . 70.03 109.824 172.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.44 ' HD2' ' HB1' ' F' ' 295' ' ' ALA . 12.3 Cg_exo -73.29 163.4 38.0 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.716 2.277 . . . . 74.2 112.941 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -86.85 76.61 9.41 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 107.269 -1.382 . . . . 74.51 107.269 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.629 HG21 ' H ' ' F' ' 296' ' ' THR . 64.1 t -73.7 97.96 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.234 -1.348 . . . . 71.34 108.468 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' F' ' 290' ' ' TRP . 98.8 mttt -133.22 128.21 35.42 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.105 0.962 . . . . 73.24 108.757 -175.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.565 ' HG ' HD21 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -89.41 161.86 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.701 0.626 . . . . 75.53 109.999 175.494 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.5 t70 -139.12 141.58 38.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.307 1.043 . . . . 72.04 108.703 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -112.36 113.02 25.01 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.241 0.616 . . . . 75.02 109.455 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.575 ' HA ' HD21 ' F' ' 285' ' ' ASN . 20.4 t70 -114.89 142.01 47.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.484 -0.932 . . . . 73.22 108.484 172.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.4 p -128.39 136.94 51.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.915 0.486 . . . . 75.53 110.335 -172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 167.29 24.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 74.12 109.347 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -159.18 164.37 35.19 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.341 0.656 . . . . 75.22 111.365 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 92.3 p -145.91 155.23 42.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.008 0.923 . . . . 75.53 109.791 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -101.72 114.76 29.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.892 -0.781 . . . . 75.31 108.892 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.561 HD12 ' HB2' ' C' ' 57' ' ' GLU . 39.5 mt -94.06 -32.52 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.635 0.774 . . . . 74.11 110.456 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.92 -170.2 1.3 Allowed 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.001 0.92 . . . . 73.2 110.219 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.7 111.92 2.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.791 0.836 . . . . 74.51 109.417 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.3 -5.56 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.37 1.468 . . . . 73.54 112.88 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.19 94.87 5.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 106.935 -1.505 . . . . 75.33 106.935 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -114.0 124.36 51.94 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.72 -1.127 . . . . 74.33 108.442 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.561 ' HB2' HD12 ' C' ' 51' ' ' LEU . 36.2 tt0 -82.62 125.15 30.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.871 -0.788 . . . . 72.22 108.871 176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.99 118.52 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 73.51 108.669 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 72.5 t -102.9 127.76 56.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 107.696 -1.224 . . . . 74.41 107.696 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -129.44 94.5 3.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.993 -1.484 . . . . 73.41 106.993 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.467 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.9 ttm180 -82.67 121.69 27.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.717 -0.674 . . . . 73.1 109.211 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.473 ' HB ' HD11 ' C' ' 114' ' ' ILE . 18.3 t -115.72 117.63 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.735 -1.209 . . . . 71.21 107.735 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 41.1 m -110.35 137.76 47.63 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.259 -1.015 . . . . 74.24 108.259 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.474 HG23 HG21 ' C' ' 114' ' ' ILE . 97.8 t -120.64 109.93 26.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.332 -0.988 . . . . 71.41 108.332 170.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -99.55 140.64 33.43 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.863 -0.792 . . . . 73.23 108.863 171.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.64 97.28 3.23 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -141.64 146.25 35.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.169 0.588 . . . . 74.14 109.765 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.47 36.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.664 1.186 . . . . 73.35 108.819 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.48 -111.75 3.25 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.059 -1.216 . . . . 60.24 110.059 -168.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.77 -19.6 23.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.773 0.829 . . . . 71.14 110.415 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -78.0 84.43 4.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.298 1.039 . . . . 71.23 109.712 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -73.09 126.97 31.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.159 -0.473 . . . . 72.41 110.853 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.632 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -74.48 -52.14 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.748 0.819 . . . . 72.1 109.039 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.401 ' HZ ' HG22 ' F' ' 296' ' ' THR . 55.8 p90 -170.56 175.68 4.6 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.128 -1.396 . . . . 73.12 109.237 173.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.433 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.991 -1.485 . . . . 75.24 106.991 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.433 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.2 t -148.47 150.01 32.69 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.814 -0.81 . . . . 72.33 108.814 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -158.28 133.53 8.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.953 0.501 . . . . 71.34 109.829 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.07 115.45 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.939 0.896 . . . . 65.3 109.044 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.606 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.4 mt-30 -90.39 90.49 8.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.426 -0.953 . . . . 65.33 108.426 173.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.12 116.61 20.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.541 -1.209 . . . . 71.03 110.364 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 149.56 18.48 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 112.065 -0.414 . . . . 63.34 112.065 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.475 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.22 117.64 0.94 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.53 -1.028 . . . . 75.43 110.53 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.554 HD11 ' HB3' ' D' ' 29' ' ' PRO . 15.7 mm -80.89 114.66 22.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.963 -1.125 . . . . 73.3 107.963 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.66 147.54 49.92 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.87 0.468 . . . . 72.14 109.935 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.9 m -106.99 113.37 26.81 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.24 106.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 107.969 -1.123 . . . . 74.42 107.969 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.572 ' HB2' ' HB ' ' C' ' 10' ' ' THR . . . -123.35 170.27 10.49 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.977 0.911 . . . . 74.13 110.659 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.12 -60.16 1.97 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.103 -0.499 . . . . 74.24 113.031 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' C' ' 94' ' ' MET . 1.3 pp -99.39 171.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.158 0.583 . . . . 74.31 111.966 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.93 -177.52 5.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.403 1.081 . . . . 73.24 109.026 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.46 -130.11 49.43 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 123.758 0.694 . . . . 74.42 114.747 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -70.13 -25.99 63.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.215 1.006 . . . . 74.23 111.543 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.418 ' HG2' ' NE2' ' C' ' 143' ' ' GLN . 23.7 mt-30 -76.48 -31.36 57.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.325 0.65 . . . . 73.31 110.251 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.555 ' HA ' HD12 ' C' ' 89' ' ' ILE . 0.7 OUTLIER -74.06 -42.29 60.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.326 -0.62 . . . . 65.14 109.326 172.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.483 ' HB1' HD11 ' F' ' 280' ' ' LEU . . . -64.04 -24.94 67.9 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.181 0.926 . . . . 62.02 112.057 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -69.88 -51.12 35.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.661 0.384 . . . . 75.52 110.412 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.28 -32.43 68.67 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.266 0.626 . . . . 63.23 111.438 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.13 -53.83 10.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.087 0.955 . . . . 65.4 109.36 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 -29.0 64.48 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.506 -1.225 . . . . 41.14 114.118 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.615 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -114.0 -45.65 3.06 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.461 0.63 . . . . 73.03 111.569 -168.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.419 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 22.0 t80 -76.36 -43.55 40.38 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 111.567 0.21 . . . . 74.11 111.567 -174.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -66.23 -45.69 61.13 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-O 118.446 -0.788 . . . . 75.05 112.913 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.38 -35.11 99.06 Favored 'Trans proline' 0 C--N 1.401 3.292 0 C-N-CA 122.316 2.011 . . . . 74.25 113.417 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.86 -36.17 76.32 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.005 0.922 . . . . 72.4 110.725 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -74.76 -46.22 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.506 0.722 . . . . 74.5 111.091 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.475 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -78.7 -20.26 50.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.733 0.642 . . . . 73.52 112.733 -170.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.408 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.8 t80 -58.26 -52.68 72.82 Favored Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 124.5 1.12 . . . . 74.2 113.242 -175.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 33.0 Cg_exo -61.32 -37.09 75.47 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.976 1.784 . . . . 74.43 112.964 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.58 -39.55 80.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.578 0.751 . . . . 73.44 111.682 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.78 81.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.306 -0.406 . . . . 70.02 110.347 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -58.09 -63.26 1.32 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 75.2 111.469 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -30.99 72.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.334 0.397 . . . . 52.14 110.524 -173.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.435 ' O ' ' SD ' ' C' ' 117' ' ' MET . 34.3 t -66.52 -41.26 89.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.334 0.654 . . . . 74.41 111.362 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.474 HG21 HG23 ' C' ' 64' ' ' VAL . 67.1 mt -65.49 -48.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.231 0.613 . . . . 72.44 110.041 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.2 m -60.77 -29.36 69.36 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.87 -1.059 . . . . 72.02 110.848 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.81 -47.05 67.06 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.143 0.977 . . . . 74.01 110.356 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.613 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.59 -45.19 89.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.327 0.651 . . . . 75.31 111.905 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.51 -39.05 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.493 0.717 . . . . 73.01 110.534 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.509 ' HB3' HE21 ' C' ' 125' ' ' GLN . 80.6 p -74.01 -29.24 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.749 -0.66 . . . . 74.14 112.144 -176.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.438 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 74.1 mtt-85 -75.44 -31.37 60.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.941 0.897 . . . . 72.12 110.75 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.09 -2.47 62.26 Favored Glycine 0 C--N 1.356 1.656 0 O-C-N 123.485 0.491 . . . . 65.32 112.427 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.504 HG21 ' HB3' ' D' ' 17' ' ' TYR . 27.9 p 63.74 27.93 14.78 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 126.692 1.997 . . . . 74.2 111.674 176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -99.22 142.86 25.36 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 114.506 -1.225 . . . . 75.23 108.915 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.66 124.13 13.76 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.248 2.632 . . . . 64.43 112.768 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.509 HE21 ' HB3' ' C' ' 119' ' ' SER . 97.7 mt-30 -59.84 154.6 18.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.27 1.211 . . . . 63.11 114.27 -172.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp -127.89 119.98 26.75 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.531 -1.213 . . . . 74.11 108.635 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -98.97 130.12 45.31 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.111 -1.07 . . . . 72.13 108.111 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.565 HD21 ' HG ' ' C' ' 42' ' ' LEU . 0.2 OUTLIER -74.85 128.21 35.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 109.446 -0.576 . . . . 72.53 109.446 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.512 ' HB2' HG21 ' H' ' 306' ' ' VAL . . . -66.56 137.52 95.22 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.869 0.868 . . . . 73.34 110.708 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.502 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 10.0 Cg_endo -51.64 103.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.38 2.72 . . . . 75.44 111.757 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.24 110.34 24.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.118 -1.067 . . . . 74.13 108.118 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.433 ' HB3' ' HB1' ' C' ' 135' ' ' ALA . 11.2 m120 -77.6 83.73 3.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.912 -1.04 . . . . 64.23 111.18 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.49 ' CZ ' ' HG3' ' F' ' 286' ' ' MET . 0.3 OUTLIER -69.9 -43.55 71.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.303 -1.317 . . . . 74.24 107.803 171.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.615 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.4 p-10 -54.39 -50.33 67.82 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.12 -1.855 . . . . 74.41 112.118 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' C' ' 132' ' ' ASN . . . -67.63 -35.26 78.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.384 0.673 . . . . 74.52 112.002 -171.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 tp -55.36 -43.93 75.52 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 124.112 0.883 . . . . 74.44 110.395 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -80.65 -18.6 47.56 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.098 -0.956 . . . . 72.3 112.329 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 67.1 mtt -75.24 -50.34 16.44 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.751 0.42 . . . . 73.52 110.692 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -70.76 -36.89 73.32 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.344 0.402 . . . . 73.02 111.048 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -66.44 -84.36 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.632 0.773 . . . . 72.32 111.019 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.21 96.17 6.46 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.573 -0.899 . . . . 74.43 108.573 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -76.62 122.62 24.9 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.873 0.869 . . . . 72.13 110.079 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.418 ' NE2' ' HG2' ' C' ' 93' ' ' GLN . 96.9 mt-30 -126.13 174.55 8.41 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.371 1.069 . . . . 75.21 109.615 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -69.19 122.17 18.27 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.543 -0.91 . . . . 74.0 108.543 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.37 90.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.136 0.974 . . . . 73.04 112.725 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.03 117.84 2.19 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 120.293 -0.171 . . . . 71.53 112.9 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -114.22 153.52 29.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.166 0.986 . . . . 74.21 109.17 173.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.54 37.37 0.03 OUTLIER Glycine 0 C--N 1.344 0.989 0 CA-C-O 120.109 -0.273 . . . . 65.42 112.621 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.443 ' HG1' HD23 ' A' ' 136' ' ' LEU . 89.0 m -75.32 95.79 3.26 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 121.507 0.67 . . . . 64.45 109.89 177.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.37 148.55 51.84 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.422 1.089 . . . . 64.35 109.971 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -149.74 112.53 4.8 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.389 0.676 . . . . 71.24 109.576 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -132.77 118.84 19.54 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.523 -1.288 . . . . 74.33 107.523 168.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -120.45 130.17 54.2 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.138 -1.06 . . . . 74.52 108.138 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -117.08 112.38 20.82 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.454 -0.943 . . . . 63.42 108.454 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 N-CA-C 108.306 -0.998 . . . . 65.1 108.306 174.04 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.024 -0.362 . . . . 72.22 110.024 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 57.6 m -86.09 54.0 2.99 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.572 0.749 . . . . 73.14 110.916 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -138.11 176.96 8.25 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.242 1.017 . . . . 74.35 108.419 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -160.74 142.38 12.22 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.652 -1.24 . . . . 73.45 107.652 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -132.96 168.69 18.0 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.868 0.467 . . . . 74.51 111.476 -172.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -168.53 142.64 3.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.484 1.114 . . . . 75.04 108.607 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -86.04 -59.56 2.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.327 0.651 . . . . 64.35 110.018 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.78 -31.63 1.03 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.833 0.853 . . . . 74.21 109.9 172.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 7.9 ttp -33.87 134.29 0.17 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.126 1.37 . . . . 74.1 112.342 167.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.3 m -139.39 137.95 36.13 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.888 -0.782 . . . . 74.31 108.888 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -164.57 91.7 0.59 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.144 -1.428 . . . . 74.14 107.144 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -119.73 115.39 23.8 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.869 -0.789 . . . . 74.44 108.869 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.493 HD11 HG21 ' D' ' 105' ' ' ILE . 13.5 mt -74.94 122.95 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.473 -0.936 . . . . 74.15 108.473 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.448 ' HA ' HG12 ' F' ' 306' ' ' VAL . 74.8 mt-30 -88.51 -49.02 7.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.935 0.334 . . . . 74.11 110.559 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -156.43 147.33 21.98 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.629 0.772 . . . . 74.33 109.837 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.428 HD12 HG22 ' D' ' 13' ' ' ILE . 2.9 mp -117.81 122.82 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 105.582 -2.007 . . . . 75.33 105.582 161.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG21 ' C' ' 122' ' ' THR . 32.8 p90 -152.23 162.08 41.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.926 0.869 . . . . 74.5 110.361 -171.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -90.02 114.64 26.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.184 -1.371 . . . . 64.21 109.424 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -82.69 -23.8 33.96 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.793 -0.64 . . . . 74.32 109.406 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.705 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -152.29 142.17 22.06 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.794 1.238 . . . . 65.11 109.11 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.613 HG23 ' HE1' ' C' ' 117' ' ' MET . 50.4 mt -138.69 142.13 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.187 1.395 . . . . 73.14 107.398 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.74 103.8 1.92 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.225 0.61 . . . . 73.53 110.476 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.573 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -109.68 120.37 42.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.114 -1.439 . . . . 75.04 107.114 166.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -124.72 120.02 30.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.457 0.703 . . . . 75.32 109.454 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 82.39 5.06 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 108.0 -1.111 . . . . 64.42 108.0 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -28.31 11.88 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.536 2.157 . . . . 71.21 112.77 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.533 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 43.1 m-20 -116.52 40.85 2.8 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.21 1.004 . . . . 74.44 108.91 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.457 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -59.76 -68.99 0.6 Allowed Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 117.628 -1.177 . . . . 73.55 113.791 -170.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.554 ' HB3' HD11 ' C' ' 83' ' ' ILE . 98.3 Cg_endo -74.26 -14.32 23.05 Favored 'Trans proline' 0 C--N 1.39 2.761 0 CA-C-N 123.144 2.159 . . . . 74.35 112.022 -179.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -68.6 -43.48 76.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.004 1.322 . . . . 75.21 110.313 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.457 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.6 p -72.73 -33.08 43.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-O 119.136 -0.459 . . . . 71.11 110.245 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -61.83 -4.52 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.4 0.889 . . . . 71.31 113.4 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -84.28 -38.63 20.21 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.636 0.774 . . . . 73.44 110.578 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -128.58 61.0 1.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.374 1.07 . . . . 74.42 109.287 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.445 ' HB2' ' O ' ' D' ' 31' ' ' VAL . 32.0 t0 -113.62 93.74 4.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.482 0.658 . . . . 64.23 110.858 -171.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.46 ' H ' HD11 ' D' ' 68' ' ' LEU . 40.3 m95 -126.09 -158.04 0.83 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 106.636 -1.616 . . . . 74.11 106.636 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.58 ' HA ' ' HB2' ' G' ' 297' ' ' TYR . 0.0 OUTLIER -57.05 112.95 5.23 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-N 119.34 0.973 . . . . 74.4 110.934 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' G' ' 296' ' ' THR . 54.2 Cg_endo -74.25 135.14 20.18 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.715 1.61 . . . . 71.25 111.338 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -64.98 113.31 3.78 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 107.089 -1.448 . . . . 62.13 107.089 165.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -104.9 142.64 17.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.691 0.796 . . . . 73.43 110.42 -173.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.51 127.52 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.059 1.343 . . . . 72.43 108.006 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.43 111.87 23.95 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.721 -1.585 . . . . 74.04 106.721 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.781 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.3 m-20 -106.4 128.18 53.84 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.163 -1.051 . . . . 64.45 108.163 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.19 140.25 48.09 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.282 -0.636 . . . . 74.13 109.282 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.7 t70 -140.98 130.76 24.27 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.093 -1.077 . . . . 70.14 108.093 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -104.63 143.7 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.623 0.769 . . . . 65.52 110.808 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.713 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.77 151.87 30.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.632 0.773 . . . . 63.21 109.808 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.7 p -157.08 157.72 35.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.976 0.51 . . . . 75.34 109.745 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.2 p -153.06 154.29 34.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.665 0.786 . . . . 72.23 109.336 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -97.1 121.12 38.63 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.078 -1.453 . . . . 74.53 107.078 164.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.403 HD13 HG22 ' D' ' 83' ' ' ILE . 82.0 mt -91.0 -30.05 17.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.77 0.428 . . . . 74.32 110.383 -178.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.73 -173.99 1.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.59 0.756 . . . . 73.44 111.008 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.0 123.93 20.75 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.929 -1.032 . . . . 72.32 108.995 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 66.86 10.89 7.95 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.575 1.15 . . . . 73.21 112.09 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.9 t -123.5 123.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.151 -0.685 . . . . 72.12 109.151 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.68 149.61 51.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.801 0.84 . . . . 74.44 109.077 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -119.49 133.56 55.63 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.788 0.835 . . . . 75.34 109.733 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.49 112.63 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.689 -1.226 . . . . 73.21 107.689 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.713 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.0 t -101.76 127.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.774 -1.195 . . . . 75.33 107.774 172.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 59.3 tp -124.15 111.63 16.13 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.85 -0.796 . . . . 74.54 108.85 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.698 ' HB2' ' HG2' ' D' ' 79' ' ' GLN . 16.3 ttp180 -84.74 108.25 17.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.054 -0.976 . . . . 75.32 109.481 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.42 129.44 48.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.704 -1.221 . . . . 73.3 107.704 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.781 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.1 m -126.76 136.85 52.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.565 -0.902 . . . . 74.33 108.565 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.462 HG22 HD12 ' D' ' 114' ' ' ILE . 84.6 t -121.17 109.8 26.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.926 0.891 . . . . 61.52 108.706 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -93.03 118.99 31.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.161 -1.051 . . . . 72.13 108.161 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.29 129.49 56.64 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.658 -0.497 . . . . 75.45 109.658 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 68.1 m -134.75 128.12 32.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.842 0.857 . . . . 61.15 109.677 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.46 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.3 OUTLIER -92.04 92.38 8.25 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.019 0.528 . . . . 72.41 109.925 177.368 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.27 -125.48 10.74 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.332 -0.849 . . . . 73.14 111.351 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.05 9.08 18.24 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.578 0.751 . . . . 74.15 111.334 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -115.82 155.18 28.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.931 0.892 . . . . 75.31 109.918 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 72' ' ' THR . . . . . 0.533 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 94.1 m -82.32 136.21 35.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.556 -0.535 . . . . 74.4 109.556 168.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.59 -68.07 0.78 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -155.43 167.65 29.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.401 -1.272 . . . . 64.22 109.974 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.0 mt -133.05 142.99 49.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.946 1.299 . . . . 75.45 107.65 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 49.0 t -145.66 136.24 24.23 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.37 -0.604 . . . . 75.3 109.37 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.18 134.9 11.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.147 0.579 . . . . 74.23 110.514 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.69 122.99 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.658 0.783 . . . . 75.23 109.759 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.705 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.1 mt-30 -89.04 89.45 7.98 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.763 -0.829 . . . . 72.24 108.763 168.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.62 96.63 8.16 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.965 -1.016 . . . . 75.01 109.158 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.65 142.46 17.15 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.358 -0.697 . . . . 55.24 111.358 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.33 128.65 4.59 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.342 -1.103 . . . . 72.02 110.342 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.403 HG22 HD13 ' D' ' 51' ' ' LEU . 60.8 mt -90.73 128.23 42.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.846 -0.798 . . . . 74.34 108.846 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.96 124.82 26.98 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.304 0.642 . . . . 73.12 109.606 178.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -77.4 93.94 4.16 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.855 -0.794 . . . . 73.34 108.855 171.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.496 HG22 ' HE2' ' D' ' 94' ' ' MET . 49.2 mt -109.11 125.94 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.555 0.742 . . . . 75.15 110.359 -173.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.88 158.1 34.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.049 0.939 . . . . 72.42 109.924 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.97 -20.64 41.38 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-O 119.911 -0.383 . . . . 74.04 113.684 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.08 142.24 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.561 -0.903 . . . . 52.41 108.561 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -136.69 156.59 48.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.285 0.634 . . . . 74.23 111.883 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.61 -125.75 35.98 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 124.58 1.175 . . . . 75.33 115.055 166.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.33 -32.61 73.68 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.392 1.077 . . . . 71.52 112.127 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.68 -28.57 40.72 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.032 0.533 . . . . 75.22 110.499 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.607 ' HG3' ' HB3' ' G' ' 277' ' ' LEU . 0.1 OUTLIER -77.55 -33.28 54.18 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.069 -0.715 . . . . 74.2 109.069 173.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.552 ' HB1' ' HB3' ' G' ' 280' ' ' LEU . . . -65.94 -30.91 71.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.828 0.851 . . . . 72.3 110.695 173.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.411 ' O ' ' HB2' ' D' ' 100' ' ' ALA . 10.5 t60 -66.09 -52.24 50.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 75.32 109.093 169.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.09 -35.27 78.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.849 0.46 . . . . 74.32 112.003 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.463 HD13 ' HB2' ' G' ' 281' ' ' PHE . 1.1 tm? -85.04 -40.33 16.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.046 0.938 . . . . 74.34 110.223 -173.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.13 11.72 58.69 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.165 -0.47 . . . . 64.24 113.9 -173.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.493 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -144.44 -57.6 0.36 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.463 0.632 . . . . 74.42 112.073 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -73.66 -61.01 1.99 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.62 0.368 . . . . 75.15 111.287 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -56.04 -44.08 99.53 Favored Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 124.404 1.082 . . . . 70.22 113.758 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.3 -40.47 68.08 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 122.338 2.025 . . . . 74.35 112.691 173.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -68.4 -26.57 65.61 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.576 0.75 . . . . 71.33 111.494 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.493 HG21 HD11 ' D' ' 13' ' ' ILE . 47.5 mm -69.52 -50.87 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.948 0.499 . . . . 72.3 110.624 177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.73 -12.89 52.84 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.759 -0.655 . . . . 73.13 112.243 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -62.24 -43.79 86.63 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.174 0.99 . . . . 75.34 113.635 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.67 -33.19 68.43 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.197 1.932 . . . . 70.42 113.912 172.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -79.14 -35.58 41.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.432 0.693 . . . . 74.51 110.708 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.97 82.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.439 0.696 . . . . 74.21 110.448 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.682 HH12 ' HB3' ' D' ' 130' ' ' PRO . 31.6 ttp180 -56.27 -50.37 71.56 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.322 -1.308 . . . . 74.32 110.627 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.17 -32.33 73.97 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.119 0.968 . . . . 74.21 111.501 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.438 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -70.35 -44.98 67.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.962 0.505 . . . . 71.23 111.021 176.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.503 HG22 ' SG ' ' D' ' 76' ' ' CYS . 61.8 mt -56.9 -54.79 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.408 1.083 . . . . 75.45 110.826 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.432 HG23 ' HE2' ' B' ' 109' ' ' TYR . 33.0 m -53.77 -45.72 70.75 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.083 1.353 . . . . 75.34 111.677 -173.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.5 t -63.52 -43.39 97.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.429 -1.259 . . . . 64.13 110.842 -176.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.578 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 74.2 mtm -68.93 -36.04 77.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.879 0.472 . . . . 74.02 111.817 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.418 HG21 ' O ' ' D' ' 114' ' ' ILE . 91.7 t -61.21 -45.14 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.76 -0.654 . . . . 74.21 109.897 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -71.25 -28.2 64.0 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.116 0.566 . . . . 75.13 111.498 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.0 mtt-85 -72.42 -28.69 63.12 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.709 0.804 . . . . 75.34 111.208 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.7 11.45 59.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.678 -0.512 . . . . 74.31 112.916 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.565 HG21 ' HB3' ' C' ' 17' ' ' TYR . 32.6 p 65.44 17.74 11.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 126.689 1.996 . . . . 75.12 113.215 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -93.52 159.39 35.1 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.197 0.999 . . . . 74.53 108.524 173.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.866 ' HG3' ' HA ' ' G' ' 297' ' ' TYR . 71.8 Cg_endo -67.86 127.6 16.42 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.648 2.232 . . . . 75.43 111.342 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -53.38 120.81 6.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 123.761 0.663 . . . . 72.22 110.483 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.422 HD12 HG12 ' D' ' 64' ' ' VAL . 5.1 tt -104.04 102.52 12.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.427 -1.323 . . . . 70.51 107.427 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -94.84 85.09 4.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.195 -1.039 . . . . 72.24 108.195 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.525 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 33.0 tp -61.25 123.19 17.02 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.377 -1.738 . . . . 72.12 111.347 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.85 133.13 89.46 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 123.919 0.888 . . . . 64.13 111.645 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.682 ' HB3' HH12 ' D' ' 111' ' ' ARG . 90.3 Cg_endo -82.86 134.23 7.14 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.292 1.995 . . . . 74.25 112.478 -169.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.417 HG22 HD11 ' G' ' 291' ' ' LEU . 44.3 t -108.04 110.06 30.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.466 -0.939 . . . . 74.41 108.466 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.428 ' ND2' ' HB1' ' D' ' 135' ' ' ALA . 50.8 t30 -89.6 93.49 9.5 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.113 -0.699 . . . . 74.32 109.113 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.493 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 76.4 m-85 -65.86 -30.5 71.12 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.242 -0.89 . . . . 72.44 110.479 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.423 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.4 t70 -58.6 -42.22 87.62 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.103 0.961 . . . . 71.01 110.284 -178.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.428 ' HB1' ' ND2' ' D' ' 132' ' ' ASN . . . -60.55 -46.57 89.71 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.717 -1.128 . . . . 75.41 111.25 175.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 72.7 mt -56.62 -47.59 79.33 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.819 0.699 . . . . 75.33 111.593 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -69.29 -39.58 78.24 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 122.904 0.482 . . . . 71.24 112.085 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 18.5 ptp -73.74 -29.74 62.41 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 117.839 0.29 . . . . 75.02 111.283 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -75.33 -9.59 58.69 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.083 0.953 . . . . 70.31 111.781 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -65.07 -38.78 91.91 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 109.474 -0.565 . . . . 70.02 109.474 164.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 mp -83.39 -55.64 4.2 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.934 0.894 . . . . 73.41 112.297 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -91.93 35.98 0.97 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.266 1.21 . . . . 74.13 114.266 -162.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -117.64 75.49 0.99 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.0 0.905 . . . . 74.42 109.345 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -160.46 19.34 0.14 Allowed 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 113.921 -1.49 . . . . 73.23 109.263 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.3 108.29 7.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.775 0.83 . . . . 63.34 110.43 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.0 106.77 1.48 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 109.932 -1.267 . . . . 72.53 109.932 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -118.87 -84.08 0.65 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 117.201 0.501 . . . . 74.13 111.773 -170.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.71 89.28 0.57 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.346 -0.388 . . . . 73.14 112.841 -166.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.9 t -155.8 93.77 1.49 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.867 0.841 . . . . 71.14 110.017 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.45 -31.27 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.299 -0.864 . . . . 65.1 111.065 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -97.84 48.52 1.01 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.386 0.612 . . . . 72.25 109.933 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -73.42 100.52 3.24 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.196 -0.911 . . . . 61.22 108.733 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -59.3 136.87 58.1 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.043 0.937 . . . . 73.02 110.759 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.48 -43.26 99.25 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.961 0.788 . . . . 71.21 109.998 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-N 114.602 -1.181 . . . . 74.53 107.909 176.312 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.947 -0.39 . . . . 73.4 109.947 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 49.5 t30 65.48 -76.05 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.417 1.487 . . . . 64.4 111.507 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 60.76 75.43 0.41 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 124.945 1.298 . . . . 74.13 110.845 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -103.2 128.44 50.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.827 -1.175 . . . . 73.41 107.827 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -80.03 167.09 36.12 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.787 0.835 . . . . 73.11 109.949 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.57 143.83 97.86 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 121.776 1.651 . . . . 71.43 109.885 164.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . 0.772 ' HB3' ' HE3' ' A' ' 94' ' ' MET . 7.9 mp -71.51 -177.44 1.84 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.778 0.431 . . . . 75.11 110.681 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 40.1 mt 75.88 -172.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.675 1.59 . . . . 73.53 110.022 -174.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . 125.65 -49.67 0.9 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.558 -0.617 . . . . 64.33 111.558 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.442 ' H ' HD21 ' E' ' 280' ' ' LEU . 2.2 pt? -121.08 125.14 46.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.584 0.753 . . . . 75.13 109.369 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -172.7 48.33 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.48 1.112 . . . . 73.4 108.531 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -132.77 172.19 12.89 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.015 -0.993 . . . . 73.44 110.325 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 28.1 t70 67.27 131.1 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.47 1.508 . . . . 74.54 111.25 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -59.73 107.16 1.17 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.358 -0.697 . . . . 70.34 111.358 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . 0.447 ' HB2' ' SD ' ' E' ' 286' ' ' MET . 14.3 m120 -62.81 -35.54 80.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.046 0.938 . . . . 74.32 111.306 -176.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 286' ' ' MET . . . . . 0.447 ' SD ' ' HB2' ' E' ' 285' ' ' ASN . 0.0 OUTLIER -143.73 134.89 12.55 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.457 1.103 . . . . 75.51 108.861 174.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.53 92.95 0.67 Allowed 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.474 2.116 . . . . 73.3 110.394 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.17 -55.81 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.113 -0.949 . . . . 72.32 110.614 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 56.92 -83.68 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.915 1.286 . . . . 74.31 110.292 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -168.83 155.28 6.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.333 1.853 . . . . 74.43 107.846 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' A' ' 129' ' ' ALA . 5.5 mp -106.22 119.9 40.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.794 0.438 . . . . 73.14 110.007 -175.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.48 162.45 33.19 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.517 -0.765 . . . . 64.34 111.475 -169.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.29 83.91 1.2 Allowed 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 122.355 2.037 . . . . 65.41 111.153 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt 62.09 107.59 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.31 1.444 . . . . 74.23 110.448 -174.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -100.29 -1.01 37.37 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.179 0.807 . . . . 73.05 113.179 -173.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 40.8 m -147.46 142.79 27.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.643 0.377 . . . . 72.44 110.887 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 1.1 t80 71.29 95.38 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.022 1.329 . . . . 74.52 110.296 168.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -131.7 -43.09 1.01 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.103 0.561 . . . . 75.33 111.236 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -154.65 62.53 0.36 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 110.631 -0.988 . . . . 71.22 110.631 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . 0.407 HD22 ' HB2' ' G' ' 302' ' ' ASP . 17.1 m120 -125.68 166.03 17.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.548 0.739 . . . . 74.14 111.085 -170.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 68.4 mt 70.97 138.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 125.638 1.575 . . . . 75.31 111.301 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' G' ' 298' ' ' HIS . 38.6 t70 -153.2 169.55 22.73 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 122.748 0.419 . . . . 71.42 110.094 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . 0.48 ' H ' ' HD2' ' E' ' 303' ' ' LYS . 10.3 mptt -60.08 141.14 90.45 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 125.361 1.464 . . . . 74.42 110.665 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -67.48 -51.59 0.7 Allowed 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.347 2.032 . . . . 73.14 112.611 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . 46.84 67.95 0.7 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.123 1.369 . . . . 64.01 112.057 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.3 28.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 122.778 1.275 . . . . 73.55 108.484 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 31.3 p -73.66 87.01 1.66 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.541 -1.209 . . . . 74.13 109.293 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 26.7 p -157.72 -22.1 0.09 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.145 -0.934 . . . . 65.25 110.79 -171.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' E' E ' 309' ' ' THR . . . . . 0.531 HG22 HD12 ' G' ' 291' ' ' LEU . 17.0 p -66.8 151.31 96.92 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.034 1.334 . . . . 73.05 111.797 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo . . . . . 0 C--N 1.378 2.122 0 C-N-CA 123.507 2.805 . . . . 74.43 112.874 176.129 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.035 -0.358 . . . . 71.02 110.035 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -66.52 132.5 48.37 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.738 0.815 . . . . 71.22 110.946 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -108.3 157.66 18.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.868 0.867 . . . . 71.4 109.385 173.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -119.42 -55.57 2.12 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.469 0.707 . . . . 63.42 110.635 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -159.35 87.05 2.13 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.496 0.718 . . . . 75.31 109.432 -170.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -89.28 141.67 4.17 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.469 2.113 . . . . 74.12 112.324 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.507 ' HB3' ' HG3' ' C' ' 94' ' ' MET . 6.2 mp -70.19 -24.42 63.12 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.66 0.784 . . . . 74.13 109.097 170.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.37 123.07 17.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.346 1.458 . . . . 75.31 110.813 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -177.89 90.74 0.08 OUTLIER Glycine 0 C--N 1.351 1.411 0 O-C-N 123.35 0.406 . . . . 63.31 113.169 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . 0.483 HD11 ' HB1' ' C' ' 95' ' ' ALA . 6.8 tt -171.49 -58.31 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.395 -0.965 . . . . 62.11 108.395 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -71.35 86.36 0.82 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.294 -0.867 . . . . 73.44 111.729 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -169.34 -61.22 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.493 -1.299 . . . . 75.54 107.493 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.76 -34.66 11.83 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.051 -0.977 . . . . 54.42 110.262 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.05 71.0 2.97 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.641 0.588 . . . . 55.35 112.945 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . 0.575 HD21 ' HA ' ' C' ' 45' ' ' ASP . 10.8 m120 -68.64 -41.85 78.82 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.447 1.099 . . . . 74.42 111.489 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 286' ' ' MET . . . . . 0.49 ' HG3' ' CZ ' ' C' ' 133' ' ' PHE . 20.3 mmt 60.39 89.23 0.11 Allowed Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.705 1.202 . . . . 73.31 109.124 -167.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.02 84.31 0.25 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.966 2.444 . . . . 75.32 112.516 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.05 120.88 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.878 -1.156 . . . . 71.22 107.878 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -123.56 175.94 6.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.109 0.964 . . . . 75.23 108.739 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . 0.501 ' HB2' ' HA ' ' C' ' 41' ' ' LYS . 2.0 t-105 -55.84 130.64 44.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.128 0.971 . . . . 75.1 111.556 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.07 -0.28 27.42 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.424 0.898 . . . . 74.35 113.424 -165.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 169.01 -134.61 3.27 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.395 -0.67 . . . . 51.12 112.446 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -87.64 -161.9 0.13 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.443 2.762 . . . . 74.31 112.406 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 11.3 mptt 76.2 164.37 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.035 1.334 . . . . 63.33 112.419 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . 0.44 ' HB1' ' HD2' ' C' ' 38' ' ' PRO . . . -158.42 173.1 17.16 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.997 -1.001 . . . . 72.31 110.132 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 296' ' ' THR . . . . . 0.629 ' H ' HG21 ' C' ' 40' ' ' VAL . 40.5 p -66.04 -52.99 44.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.753 0.821 . . . . 72.11 110.748 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -77.01 82.62 3.53 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.905 -1.146 . . . . 62.55 107.905 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -75.07 -46.14 36.74 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.184 0.594 . . . . 73.23 110.831 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 178.63 -52.64 0.09 OUTLIER Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.969 -0.559 . . . . 71.3 112.572 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -81.61 82.14 7.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.482 0.658 . . . . 72.22 111.13 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 6.1 tt -167.52 118.22 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.493 1.517 . . . . 73.1 107.042 169.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -134.57 -79.13 0.45 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.418 0.687 . . . . 71.13 109.441 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -116.98 152.67 48.99 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.994 0.918 . . . . 65.4 109.528 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.5 109.27 2.81 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.171 1.914 . . . . 61.42 111.853 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' H' ' 293' ' ' PRO . . . -75.33 93.52 2.9 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.177 -1.046 . . . . 73.55 108.177 169.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . 0.448 HG12 ' HA ' ' D' ' 14' ' ' GLN . 3.4 p -134.52 -29.15 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.436 1.094 . . . . 64.35 109.567 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 40.1 p -88.9 28.02 1.24 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.36 1.064 . . . . 73.24 111.336 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.28 13.48 13.33 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.099 0.96 . . . . 55.55 110.401 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 16.7 p -64.49 147.62 97.26 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 125.108 1.363 . . . . 73.15 112.56 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.39 2.747 0 C-N-CA 124.547 3.498 . . . . 74.12 114.409 -178.851 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.544 -0.169 . . . . 70.44 110.544 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -85.76 120.86 27.65 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.223 -0.658 . . . . 74.32 109.223 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -158.81 90.94 1.02 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.546 0.738 . . . . 75.51 109.963 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -85.26 64.06 8.45 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.388 0.613 . . . . 74.42 110.122 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -91.14 146.4 33.49 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.542 0.737 . . . . 74.21 110.01 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.66 87.99 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.764 2.31 . . . . 72.43 110.067 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.607 ' HB3' ' HG3' ' D' ' 94' ' ' MET . 71.6 mt -59.93 -48.17 82.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.486 0.714 . . . . 74.23 111.164 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.59 173.47 9.53 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.586 -0.734 . . . . 73.53 110.917 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 171.39 -57.13 0.18 Allowed Glycine 0 C--N 1.344 1.007 0 N-CA-C 110.845 -0.902 . . . . 74.31 110.845 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . 0.552 ' HB3' ' HB1' ' D' ' 95' ' ' ALA . 7.2 tt -76.38 113.05 13.53 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.672 -0.862 . . . . 72.25 108.672 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . 0.463 ' HB2' HD13 ' D' ' 98' ' ' LEU . 39.2 t80 -170.92 -60.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.319 1.048 . . . . 75.35 108.328 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -97.66 25.55 5.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.888 -1.051 . . . . 50.0 109.306 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -123.29 138.23 54.67 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.997 0.919 . . . . 75.34 109.417 -171.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 73.87 -110.87 3.24 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.269 -0.732 . . . . 75.45 111.269 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -165.69 134.55 3.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.996 0.918 . . . . 74.0 109.739 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 96.5 mmm -123.51 80.64 54.14 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 124.463 1.105 . . . . 73.13 108.461 173.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -88.27 125.78 1.88 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.022 2.481 . . . . 73.15 113.627 -173.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.82 -26.43 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.111 0.964 . . . . 70.41 109.959 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 60.17 -88.8 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.461 1.504 . . . . 75.23 109.986 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.6 124.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 105.456 -2.053 . . . . 72.4 105.456 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.531 HD12 HG22 ' E' ' 309' ' ' THR . 89.7 mt -66.59 -50.37 63.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.564 0.346 . . . . 74.33 110.61 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -156.58 99.28 0.18 Allowed Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.369 -0.684 . . . . 72.52 112.208 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -83.94 -177.73 3.21 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.75 2.3 . . . . 74.45 111.367 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 69.04 168.34 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.842 1.257 . . . . 65.22 112.242 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . 58.88 9.65 1.27 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.375 1.47 . . . . 73.31 112.715 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 296' ' ' THR . . . . . 0.44 ' HB ' ' HD2' ' D' ' 38' ' ' PRO . 26.5 m -62.57 -24.52 67.59 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.383 1.073 . . . . 74.04 113.327 -163.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.866 ' HA ' ' HG3' ' D' ' 124' ' ' PRO . 2.5 t80 -74.6 -75.53 0.16 Allowed 'General case' 0 C--N 1.359 0.993 0 CA-C-N 117.921 0.328 . . . . 75.23 110.789 -175.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . 0.564 ' HB3' ' HB3' ' E' ' 302' ' ' ASP . 78.7 m-70 73.46 -53.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.794 1.238 . . . . 71.21 113.089 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -64.63 -33.68 87.89 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 116.006 1.162 . . . . 75.04 116.006 -168.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . 0.404 ' H ' ' HD1' ' G' ' 297' ' ' TYR . 49.6 t30 66.32 149.07 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.823 1.249 . . . . 73.42 112.769 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.518 HG21 HH12 ' C' ' 15' ' ' ARG . 2.8 mp -77.12 125.39 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.919 0.887 . . . . 74.21 109.37 177.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . 0.407 ' HB2' HD22 ' E' ' 300' ' ' ASN . 12.2 t70 -96.98 145.5 25.87 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.275 -0.639 . . . . 74.24 109.275 170.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . 0.415 ' HD2' ' N ' ' G' ' 303' ' ' LYS . 0.1 OUTLIER -103.44 122.16 45.98 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.837 0.855 . . . . 73.3 108.871 -175.413 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.64 113.58 3.22 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.641 2.227 . . . . 64.31 111.26 176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.82 22.72 0.73 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.778 0.831 . . . . 74.11 111.695 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.07 84.66 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 124.728 1.211 . . . . 73.23 110.987 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 28.8 m -82.72 100.42 10.24 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.369 -0.832 . . . . 75.4 110.253 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 59.6 m 63.67 87.73 0.11 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.871 1.268 . . . . 70.32 111.698 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 8.4 t -134.21 101.21 12.47 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 123.629 0.772 . . . . 73.04 109.51 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo . . . . . 0 C--N 1.383 2.367 0 C-N-CA 123.481 2.787 . . . . 71.2 112.69 -175.764 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.893 -0.41 . . . . 73.44 109.893 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -168.88 126.84 1.02 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.838 0.855 . . . . 71.53 109.896 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -84.08 171.89 12.48 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.852 0.861 . . . . 74.44 109.594 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -78.29 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.092 0.557 . . . . 70.33 109.953 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 47.8 tttt 178.03 149.28 0.38 Allowed Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.163 0.985 . . . . 75.15 108.633 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.48 170.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.853 3.035 . . . . 62.32 115.245 170.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 8.4 tt -57.68 -53.09 62.08 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.787 1.235 . . . . 75.24 109.621 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 22.6 tp -89.51 52.1 2.26 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.405 -0.961 . . . . 74.42 108.405 176.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -83.49 56.02 5.04 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.182 -0.917 . . . . 71.34 111.784 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 34.0 tp 165.55 161.97 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.867 2.067 . . . . 75.44 105.915 -169.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 1.6 t80 79.95 -49.83 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.692 1.197 . . . . 71.21 111.76 168.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.24 67.85 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.202 -0.666 . . . . 74.21 109.202 159.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -135.99 120.44 18.1 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 107.696 -1.224 . . . . 63.22 107.696 167.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 169.97 78.44 0.04 OUTLIER Glycine 0 C--O 1.243 0.677 0 O-C-N 121.873 -0.517 . . . . 72.1 111.847 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.22 130.1 42.07 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.881 0.872 . . . . 74.54 110.09 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 14.9 ptp -139.38 125.38 12.16 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.441 0.696 . . . . 75.03 110.423 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.08 123.54 5.7 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.636 2.224 . . . . 62.44 111.524 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.62 -53.51 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.928 -0.578 . . . . 74.43 109.619 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 69.48 153.96 0.11 Allowed 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.689 1.243 . . . . 73.33 110.265 -172.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . 0.628 ' HH2' HD13 ' B' ' 126' ' ' LEU . 0.0 OUTLIER -74.97 76.17 2.19 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.252 -1.018 . . . . 75.14 108.252 177.623 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.445 HD13 HG22 ' B' ' 131' ' ' VAL . 2.3 pp -91.73 -11.06 37.85 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.289 -0.869 . . . . 71.05 112.47 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . 0.473 ' HA2' ' HB1' ' B' ' 129' ' ' ALA . . . -97.51 -166.29 32.24 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 123.525 0.516 . . . . 73.04 114.295 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . 0.54 ' HA ' ' HB2' ' F' ' 305' ' ' ALA . 46.1 Cg_endo -68.12 100.84 0.66 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.03 2.487 . . . . 75.33 111.872 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -77.54 57.68 1.62 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.352 1.061 . . . . 73.35 110.015 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -160.04 35.55 0.18 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.878 1.271 . . . . 73.42 108.766 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 296' ' ' THR . . . . . 0.513 HG23 ' HB2' ' B' ' 126' ' ' LEU . 36.8 m -45.87 -50.77 14.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.67 1.588 . . . . 73.23 111.786 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.58 ' HE1' ' HB ' ' H' ' 301' ' ' ILE . 0.3 OUTLIER -81.06 91.53 6.11 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.032 -0.985 . . . . 74.24 108.597 177.118 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -79.62 14.72 1.55 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.047 0.939 . . . . 71.44 112.327 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 93.82 -4.83 72.45 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.625 -0.542 . . . . 71.23 113.088 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . 0.527 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 1.8 m-20 -73.99 92.46 2.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.443 0.64 . . . . 73.15 109.291 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . 0.58 ' HB ' ' HE1' ' H' ' 297' ' ' TYR . 13.1 tt -149.58 132.46 6.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.492 1.117 . . . . 74.23 108.593 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . 0.52 ' HB2' HH12 ' A' ' 15' ' ' ARG . 3.0 m-20 -119.81 129.3 54.38 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.104 -0.702 . . . . 73.01 109.104 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.588 ' HG2' ' HZ ' ' B' ' 32' ' ' PHE . 40.1 mtmt -78.68 -51.39 1.44 Allowed Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 123.208 0.603 . . . . 74.33 110.712 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . 0.46 ' HD3' ' HB2' ' H' ' 303' ' ' LYS . 33.3 Cg_endo -93.4 -21.08 0.38 Allowed 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 121.916 1.744 . . . . 62.22 113.181 170.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . 0.542 ' HB1' HH11 ' A' ' 15' ' ' ARG . . . 52.49 -80.36 0.01 OUTLIER 'General case' 0 C--N 1.363 1.155 0 C-N-CA 125.608 1.563 . . . . 73.15 111.771 -166.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . 0.512 HG21 ' HB2' ' C' ' 129' ' ' ALA . 18.6 t -88.16 98.27 7.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.177 -1.046 . . . . 74.32 108.177 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 68.8 m -55.56 -58.61 7.07 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.164 0.985 . . . . 74.41 110.586 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 30.6 t -172.24 165.92 5.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.474 1.11 . . . . 74.54 109.277 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 68.7 p -126.99 152.95 76.35 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 124.002 0.921 . . . . 74.24 109.871 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo . . . . . 0 C--N 1.379 2.141 0 C-N-CA 122.762 2.308 . . . . 74.3 111.85 173.102 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 109.174 -0.676 . . . . 74.21 109.174 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m -116.8 9.48 13.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.852 0.861 . . . . 64.21 113.01 -170.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -55.29 8.28 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 119.296 -0.383 . . . . 73.33 110.802 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 59.35 116.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.148 1.379 . . . . 73.43 112.987 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -109.67 -62.81 1.44 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.176 0.59 . . . . 72.34 109.751 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -173.03 155.64 3.08 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.857 0.863 . . . . 64.31 109.319 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -138.63 159.99 40.71 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.301 0.64 . . . . 72.42 109.642 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.02 -39.05 90.96 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.138 0.975 . . . . 73.11 111.076 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.1 mtm 71.18 144.73 0.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.619 1.568 . . . . 74.31 111.639 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 78.8 m -140.95 135.4 31.18 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.823 0.849 . . . . 74.41 109.762 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.61 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.9 t80 -138.35 133.27 32.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.617 0.767 . . . . 74.23 109.954 170.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -160.58 116.32 2.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.813 0.845 . . . . 74.34 109.975 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.57 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.0 mt -76.17 125.68 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.536 -0.542 . . . . 70.51 109.536 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -97.3 -33.69 11.35 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.078 0.551 . . . . 75.25 111.13 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -172.24 128.41 0.57 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 110.079 -0.341 . . . . 74.33 110.079 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -121.79 126.9 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 123.664 0.785 . . . . 74.34 109.852 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -164.19 153.71 14.06 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.311 0.645 . . . . 75.31 111.202 -169.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.55 111.02 12.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.966 -1.015 . . . . 72.24 109.533 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.1 mtpt -76.43 -28.38 56.59 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.189 -0.459 . . . . 75.42 110.912 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -151.99 142.38 22.52 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.006 -0.997 . . . . 74.3 109.528 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.449 HG22 ' SD ' ' A' ' 117' ' ' MET . 75.8 mt -135.24 141.47 42.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 125.276 1.43 . . . . 75.34 107.293 174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.78 130.4 14.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.966 -0.753 . . . . 72.44 108.966 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -133.5 120.48 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.482 -1.673 . . . . 73.32 106.482 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.1 114.29 20.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.773 0.429 . . . . 75.11 110.592 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 70.3 81.6 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 107.09 -1.448 . . . . 62.53 107.09 165.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.37 -3.56 13.48 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.246 1.964 . . . . 72.05 111.573 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -119.86 17.06 12.65 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.417 1.087 . . . . 70.11 109.317 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.98 -58.84 4.24 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.801 -1.095 . . . . 71.33 113.818 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.31 -25.71 71.6 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.376 2.051 . . . . 74.2 112.432 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.94 -48.1 17.08 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.5 -0.773 . . . . 72.1 109.914 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG21 ' HG3' ' A' ' 34' ' ' LYS . 6.2 p -77.29 -10.57 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.731 -0.668 . . . . 75.35 112.151 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.448 ' HA ' HD11 ' E' ' 301' ' ' ILE . 22.5 m-85 -72.62 -18.23 61.61 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.159 0.583 . . . . 74.44 112.392 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.27 -8.54 21.17 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.339 0.866 . . . . 74.44 113.339 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 71' ' ' GLU . 8.7 mmpt? -55.11 164.07 0.95 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.13 1.159 . . . . 73.31 114.13 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.4 133.69 54.44 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.699 -1.137 . . . . 75.45 109.498 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -77.57 73.99 4.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.631 0.772 . . . . 74.53 111.791 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.66 79.05 24.9 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.299 1.039 . . . . 73.42 108.993 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 114.89 4.16 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.042 1.828 . . . . 72.4 111.867 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.22 83.96 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.333 -1.729 . . . . 75.1 106.333 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.8 t -98.08 102.69 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 113.983 -1.462 . . . . 75.3 108.441 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.12 144.19 32.26 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.85 0.86 . . . . 74.41 110.41 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tt -97.51 111.65 23.83 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.167 -1.42 . . . . 71.13 107.167 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.645 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.2 m-20 -102.9 112.49 25.33 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.86 -1.163 . . . . 71.44 107.86 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tt -110.05 129.09 55.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.588 0.355 . . . . 75.25 110.339 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -139.51 145.35 38.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.659 1.183 . . . . 72.24 108.583 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.425 ' HB ' ' CZ ' ' E' ' 281' ' ' PHE . 19.1 p -136.64 153.22 50.98 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.265 0.626 . . . . 72.02 110.828 -178.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.462 ' HA ' ' HB1' ' E' ' 282' ' ' ALA . . . -141.84 153.26 44.36 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.512 1.125 . . . . 71.51 110.423 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 p -119.47 172.46 7.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.709 0.804 . . . . 70.0 109.231 168.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.4 t -160.86 144.78 13.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.862 0.865 . . . . 74.33 109.467 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -114.82 109.79 18.71 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 74.4 109.292 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.1 mt -82.4 -40.32 21.45 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.529 0.732 . . . . 74.13 109.722 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.01 -178.12 7.13 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.682 1.193 . . . . 65.02 109.073 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 121.55 17.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.267 -0.642 . . . . 75.03 109.267 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.02 -8.5 1.12 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.904 1.682 . . . . 73.21 112.879 -171.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.05 103.42 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.135 -1.061 . . . . 73.2 108.135 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.08 163.56 18.17 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.232 -0.894 . . . . 72.31 108.615 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 29.2 tt0 -133.7 145.11 49.59 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.527 1.131 . . . . 72.43 108.737 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.83 133.86 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.876 -1.157 . . . . 64.22 107.876 168.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.461 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.5 t -111.39 139.04 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.585 1.154 . . . . 75.1 108.437 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.04 106.11 10.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.896 -1.15 . . . . 75.14 107.896 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -84.41 102.35 12.7 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.827 -0.805 . . . . 73.34 108.827 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.416 ' HB ' HD11 ' A' ' 114' ' ' ILE . 24.1 t -95.34 115.91 35.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.05 -1.092 . . . . 75.44 108.05 172.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.645 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 48.5 m -117.92 138.55 52.07 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.48 -0.933 . . . . 72.11 108.48 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.537 HG12 HD21 ' A' ' 126' ' ' LEU . 99.1 t -129.94 117.83 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 124.6 1.16 . . . . 64.2 108.209 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.446 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 20.8 m -101.88 136.61 41.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.332 -0.988 . . . . 71.5 108.332 171.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.34 125.34 21.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.741 -1.207 . . . . 54.12 107.741 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.0 m -146.02 127.76 15.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.582 0.551 . . . . 60.33 110.464 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.87 86.23 6.58 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.01 -1.108 . . . . 74.14 108.01 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.46 -123.22 6.05 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.569 -1.196 . . . . 74.34 110.613 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -88.1 -28.01 21.56 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.285 0.634 . . . . 64.35 111.094 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.451 ' HB3' ' HD2' ' A' ' 34' ' ' LYS . 27.6 tt0 -90.03 126.14 35.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.977 0.511 . . . . 73.35 110.475 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 m -72.65 129.29 37.92 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.97 0.908 . . . . 75.05 111.744 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.5 -65.5 0.75 Allowed 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.162 0.913 . . . . 74.0 108.762 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.425 ' HD2' ' SG ' ' A' ' 76' ' ' CYS . 50.3 p90 -155.92 144.42 20.16 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.785 -0.643 . . . . 74.31 110.748 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -121.13 110.15 15.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.154 -1.054 . . . . 64.51 108.154 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.425 ' SG ' ' HD2' ' A' ' 74' ' ' PHE . 84.0 m -111.15 114.84 28.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.182 0.993 . . . . 74.41 110.892 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.5 124.98 39.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.5 -0.926 . . . . 72.12 108.5 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.3 t -132.81 108.52 13.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.844 -1.169 . . . . 74.43 107.844 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.2 mt-30 -85.28 80.19 9.26 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.299 -1.371 . . . . 63.11 107.299 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -76.46 96.54 4.09 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.176 -1.375 . . . . 72.02 108.651 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -94.1 166.18 27.05 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.955 -0.566 . . . . 65.5 112.124 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.21 128.41 1.73 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.933 -0.867 . . . . 63.44 110.933 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.7 mt -80.57 120.28 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.635 -0.876 . . . . 64.51 108.635 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.61 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.8 m-85 -125.7 117.3 23.18 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.739 -1.208 . . . . 75.41 107.739 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -79.67 86.77 5.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.92 -0.77 . . . . 71.21 108.92 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 pt -113.49 143.93 22.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.833 0.853 . . . . 73.31 110.496 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.09 161.37 12.53 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.706 -1.134 . . . . 72.33 109.806 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 2.75 58.81 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.59 -0.732 . . . . 64.51 114.15 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.56 137.35 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.192 0.597 . . . . 74.44 110.441 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -142.72 -177.59 5.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.724 1.21 . . . . 64.22 109.653 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.89 -125.15 29.93 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.459 0.475 . . . . 71.31 112.537 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.5 t -82.56 -19.42 38.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.053 0.541 . . . . 74.31 111.012 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -71.34 -39.2 71.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.063 0.545 . . . . 75.12 110.992 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 95' ' ' ALA . 3.8 ppp? -70.95 -32.09 68.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.055 0.222 . . . . 75.34 110.478 175.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.478 ' HB1' HD11 ' E' ' 280' ' ' LEU . . . -75.97 -23.91 55.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.314 0.646 . . . . 65.32 111.215 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -83.98 -32.52 24.94 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.335 0.654 . . . . 74.22 109.56 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.1 t -67.35 -43.56 81.18 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.182 0.593 . . . . 74.12 110.3 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.8 mt -88.42 -31.44 18.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.289 -0.869 . . . . 75.54 111.84 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.09 3.77 58.55 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-O 119.62 -0.545 . . . . 65.14 114.241 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.439 ' HB2' ' HB3' ' A' ' 134' ' ' ASP . . . -149.25 -65.58 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.504 0.652 . . . . 70.4 111.699 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.408 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 74.3 t80 -64.36 -68.95 0.31 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.11 0.964 . . . . 73.23 112.974 -168.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.6 m -66.34 -33.52 6.81 Favored Pre-proline 0 CA--C 1.571 1.754 0 N-CA-C 114.26 1.207 . . . . 74.02 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 56.2 Cg_endo -69.49 -22.41 33.38 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 121.813 1.675 . . . . 73.41 113.083 169.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -72.13 -19.48 61.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.229 0.468 . . . . 70.2 110.804 173.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.639 -0.875 . . . . 64.21 108.639 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -78.66 -29.78 45.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.249 1.02 . . . . 74.44 112.547 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -60.39 -45.12 97.44 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.064 1.135 . . . . 74.32 114.064 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.28 -31.71 34.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.894 1.73 . . . . 72.34 113.204 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -72.0 -37.67 69.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.912 0.485 . . . . 64.14 110.907 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.56 79.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.228 0.611 . . . . 61.32 109.628 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.487 ' NH1' HD13 ' C' ' 105' ' ' ILE . 34.8 ttm180 -52.23 -51.39 58.58 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 124.803 1.314 . . . . 75.41 110.382 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.77 -45.36 86.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.036 0.934 . . . . 74.03 111.537 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.58 -41.89 82.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.816 0.698 . . . . 64.11 110.451 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.416 HD11 ' HB ' ' A' ' 62' ' ' VAL . 85.1 mt -69.11 -45.7 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.177 -0.919 . . . . 74.44 110.072 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.5 m -54.95 -40.73 70.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.438 0.695 . . . . 72.01 110.802 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 t -68.87 -53.46 21.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.923 -1.035 . . . . 71.14 110.306 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.449 ' SD ' HG22 ' A' ' 21' ' ' ILE . 13.7 mtp -51.94 -47.09 64.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.282 1.033 . . . . 75.21 111.734 178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.84 -45.68 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.544 -1.207 . . . . 73.4 110.813 -178.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -66.72 -28.6 68.56 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.275 0.63 . . . . 73.33 111.396 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.53 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.0 mtt-85 -72.07 -31.16 65.84 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.433 0.693 . . . . 75.12 110.296 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.81 1.79 82.35 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.205 -0.452 . . . . 62.32 113.133 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.1 m 64.99 24.84 12.66 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 125.361 1.464 . . . . 73.31 110.711 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -93.42 160.13 33.73 Favored Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 114.559 -1.2 . . . . 74.24 110.263 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.717 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 12.1 Cg_endo -52.54 137.52 57.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 124.398 3.399 . . . . 75.01 115.38 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -50.34 122.98 7.69 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.651 0.594 . . . . 74.23 110.549 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.537 HD21 HG12 ' A' ' 64' ' ' VAL . 21.4 tp -118.99 105.27 11.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.491 -1.232 . . . . 74.44 109.63 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -135.7 107.99 7.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.44 -1.254 . . . . 70.35 107.877 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.9 146.76 54.49 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.761 0.824 . . . . 73.42 111.893 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.25 148.18 96.09 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.734 0.813 . . . . 73.22 111.175 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.76 105.28 0.19 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.775 2.317 . . . . 72.43 112.834 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.35 116.91 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.998 -0.742 . . . . 71.03 108.998 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 3.5 t30 -93.14 77.97 4.58 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.369 1.068 . . . . 74.01 108.422 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -55.79 -34.89 65.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.7 1.2 . . . . 73.21 112.725 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 6.0 p-10 -66.62 -32.51 73.88 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.849 0.86 . . . . 54.3 112.097 -176.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.435 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . . . -64.75 -52.63 55.98 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.576 0.35 . . . . 64.14 110.314 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 tt -57.3 -42.03 80.99 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.97 0.794 . . . . 74.54 110.002 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -62.04 -42.62 99.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.759 0.823 . . . . 75.34 111.491 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.476 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 22.4 mmt -68.81 -44.38 73.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.597 0.359 . . . . 75.45 110.344 179.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -64.54 -34.41 78.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.841 0.856 . . . . 75.01 111.105 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -74.0 -39.44 63.64 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.165 -0.925 . . . . 71.53 110.546 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.81 -55.72 26.96 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.522 0.514 . . . . 75.21 110.725 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . 0.48 ' HB3' ' HG2' ' A' ' 144' ' ' GLN . 11.6 mm-40 -166.47 -17.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.859 0.864 . . . . 70.33 111.258 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 55.23 26.29 8.3 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.048 1.339 . . . . 64.21 111.605 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.48 ' HG2' ' HB3' ' A' ' 142' ' ' GLN . 9.2 pt20 -134.96 170.11 16.38 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.046 0.539 . . . . 74.11 111.047 -175.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.92 135.9 8.63 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.397 1.079 . . . . 62.12 109.139 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.31 163.15 29.46 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 123.388 0.43 . . . . 71.32 112.164 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.99 149.68 44.76 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.981 0.512 . . . . 75.05 109.877 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.32 69.77 0.05 OUTLIER Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.291 -0.724 . . . . 72.4 111.291 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -162.94 159.1 23.21 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.178 0.591 . . . . 73.21 110.659 -176.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.48 134.39 4.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.641 1.176 . . . . 70.31 108.855 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -95.01 88.47 5.26 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.338 -1.356 . . . . 71.41 107.338 168.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -133.46 145.23 50.03 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.643 1.177 . . . . 75.12 108.113 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -76.24 74.39 3.05 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.438 0.637 . . . . 73.12 110.307 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -93.91 79.58 4.15 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.159 -1.052 . . . . 51.04 108.159 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 118.535 -0.745 . . . . 74.33 109.185 -179.394 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.03 -0.73 . . . . 73.43 109.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.6 m -145.77 125.41 13.32 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.847 -0.797 . . . . 73.41 108.847 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.67 83.82 1.59 Allowed 'General case' 0 C--N 1.346 0.454 0 N-CA-C 108.532 -0.914 . . . . 75.33 108.532 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.89 70.33 9.87 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.696 -0.853 . . . . 71.32 108.696 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -148.41 125.97 11.72 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.804 -1.089 . . . . 73.52 108.167 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . 0.645 ' HB2' HE22 ' B' ' 93' ' ' GLN . 3.2 p-10 -89.91 12.07 18.5 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.608 1.163 . . . . 74.55 112.448 -170.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -117.58 -60.07 1.86 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.222 0.609 . . . . 70.33 110.969 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -71.68 -41.87 68.16 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.311 0.645 . . . . 72.01 111.547 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.493 ' HE1' ' HB2' ' B' ' 11' ' ' PHE . 22.6 ptm 47.28 -163.04 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 125.692 1.597 . . . . 74.31 112.765 -173.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' B' ' 87' ' ' ALA . 61.2 m -143.14 122.68 13.21 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.175 -1.046 . . . . 61.44 108.175 174.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.493 ' HB2' ' HE1' ' B' ' 9' ' ' MET . 63.3 t80 -146.72 124.24 11.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.388 0.675 . . . . 74.44 109.274 -175.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.5 132.94 21.98 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.885 0.474 . . . . 63.13 110.102 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.628 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -77.39 120.73 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.186 -0.915 . . . . 74.42 108.83 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -86.24 -50.26 7.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.329 -0.396 . . . . 74.42 111.055 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.52 140.02 5.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.467 0.307 . . . . 73.23 110.424 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.628 HG13 HD11 ' B' ' 13' ' ' ILE . 90.6 mt -115.53 139.48 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.107 0.963 . . . . 74.02 108.879 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -164.89 164.76 20.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.731 0.777 . . . . 74.12 112.219 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.3 m -93.74 124.69 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.99 -1.004 . . . . 70.51 108.474 171.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -88.9 -33.49 17.29 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.124 0.57 . . . . 72.21 110.677 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -155.31 142.29 19.14 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.164 0.431 . . . . 74.2 112.164 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.788 HD12 ' SG ' ' B' ' 113' ' ' CYS . 47.5 mm -133.13 142.16 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.492 1.117 . . . . 72.52 109.301 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 58.6 m -143.13 131.67 22.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.597 -1.183 . . . . 73.01 108.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -144.12 107.6 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.808 -1.552 . . . . 72.0 106.808 167.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -119.23 115.46 24.25 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.844 -0.799 . . . . 75.14 108.844 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -107.17 88.28 3.72 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.583 1.153 . . . . 75.31 109.185 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.45 -44.1 1.77 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.722 2.281 . . . . 75.22 112.681 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.431 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 77.1 m-20 -102.61 23.0 12.64 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.964 0.906 . . . . 71.32 109.705 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.5 -46.67 59.49 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 115.774 1.768 . . . . 74.21 115.774 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -75.79 -29.65 6.83 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.286 1.99 . . . . 73.34 112.325 174.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -94.36 1.0 55.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.39 1.076 . . . . 71.34 111.557 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.402 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 4.5 p -83.57 -17.19 10.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 C-N-CA 123.38 0.672 . . . . 74.44 110.419 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.59 -28.66 63.82 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 118.481 0.582 . . . . 73.51 112.093 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -73.65 -45.77 50.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.446 0.698 . . . . 72.31 111.07 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.514 ' HB3' HD13 ' B' ' 68' ' ' LEU . 10.9 mmmm -107.37 62.62 0.62 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.288 1.035 . . . . 72.54 108.97 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' B' ' 31' ' ' VAL . 6.9 t70 -119.07 80.73 1.59 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.691 -0.855 . . . . 72.13 108.691 -171.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -152.64 -177.27 6.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.087 0.955 . . . . 74.0 109.511 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -59.53 109.19 1.75 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.509 0.724 . . . . 72.35 110.835 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -86.34 173.87 6.35 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.587 2.191 . . . . 72.31 112.902 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.28 103.77 4.09 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.385 -1.339 . . . . 74.34 107.385 164.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.474 HG11 ' HG1' ' H' ' 296' ' ' THR . 44.4 t -101.41 151.9 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.699 -1.137 . . . . 73.03 110.492 -173.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.421 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 55.5 mtpt -138.11 138.81 39.07 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.116 0.966 . . . . 72.41 109.393 175.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.76 126.25 45.79 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.992 -1.855 . . . . 73.42 105.992 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.419 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.1 t70 -124.7 139.95 53.39 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.423 -0.955 . . . . 72.51 108.423 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -125.55 141.19 52.17 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.021 -0.733 . . . . 75.33 109.021 175.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.618 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.2 t70 -130.45 137.36 49.77 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.139 0.976 . . . . 64.23 108.575 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -108.69 103.11 12.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.841 0.857 . . . . 71.24 110.393 -172.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 141.07 50.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.218 1.007 . . . . 70.21 109.416 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 p -145.58 168.45 20.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.166 0.586 . . . . 61.21 110.903 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.72 138.64 18.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.11 0.564 . . . . 72.12 110.482 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -82.45 101.27 10.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.079 -0.711 . . . . 72.5 109.079 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.495 HD12 HG22 ' B' ' 83' ' ' ILE . 63.0 mt -74.54 -35.99 63.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.305 0.642 . . . . 75.02 109.996 178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.23 -174.2 3.43 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.295 -1.32 . . . . 75.43 109.232 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.61 128.06 35.27 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.133 -0.94 . . . . 75.35 109.821 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 67.62 -5.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.437 1.495 . . . . 74.22 112.955 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.91 115.14 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.808 . . . . 74.34 109.146 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.91 143.38 50.77 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.369 0.668 . . . . 73.31 110.416 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -99.8 116.16 31.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.144 -1.058 . . . . 73.33 108.144 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -91.42 118.02 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.038 0.935 . . . . 72.45 109.001 172.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -114.42 112.64 40.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.053 0.941 . . . . 71.02 108.561 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.93 108.68 20.31 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.872 -1.158 . . . . 74.34 107.872 176.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.618 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 18.9 ttm-85 -85.58 112.41 20.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.78 -0.822 . . . . 75.24 108.78 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.35 103.02 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.872 -1.159 . . . . 75.25 107.872 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.0 m -100.96 130.95 47.04 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.055 -0.72 . . . . 72.43 109.055 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.424 HG12 HD23 ' B' ' 126' ' ' LEU . 68.9 t -117.53 115.86 49.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.421 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 85.8 m -92.57 141.67 28.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.147 0.979 . . . . 73.52 108.612 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.77 121.5 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.723 -0.843 . . . . 72.4 108.723 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 40.4 p -147.2 127.8 14.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.637 0.775 . . . . 43.44 109.456 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.678 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.3 OUTLIER -118.31 134.6 54.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.446 0.698 . . . . 74.23 109.305 -176.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.78 -118.28 6.43 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.206 -0.758 . . . . 74.14 111.206 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.17 11.35 12.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.874 0.87 . . . . 72.12 110.315 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.431 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 3.7 pm0 -127.67 158.96 36.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.677 0.791 . . . . 74.12 110.682 -176.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -78.81 135.99 37.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.942 -0.572 . . . . 74.21 110.328 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.678 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -83.72 -64.75 1.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.901 0.858 . . . . 75.43 108.993 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.83 152.95 16.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.563 -1.653 . . . . 71.31 108.094 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -123.74 137.02 54.77 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.324 -0.991 . . . . 70.41 108.324 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.0 t -134.18 148.18 50.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.809 -0.812 . . . . 65.52 108.809 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.413 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.7 tt0 -156.16 138.8 15.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.925 -0.768 . . . . 61.41 108.925 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -132.14 145.27 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.403 1.081 . . . . 74.5 108.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -118.82 97.1 5.54 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.285 -1.376 . . . . 74.2 107.285 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -87.74 100.11 12.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.043 -1.095 . . . . 74.02 108.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.37 157.65 25.92 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.392 -1.083 . . . . 72.34 110.392 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.93 125.65 1.37 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.177 -0.769 . . . . 72.14 111.177 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.495 HG22 HD12 ' B' ' 51' ' ' LEU . 44.0 mt -84.7 130.91 35.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.825 -0.805 . . . . 74.41 108.825 177.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.72 165.63 22.48 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.109 0.963 . . . . 73.2 108.633 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.35 120.91 26.39 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.921 -0.77 . . . . 73.13 108.921 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 36.7 pt -119.13 145.81 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.584 1.153 . . . . 72.21 110.742 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' B' ' 10' ' ' THR . . . -156.21 157.67 36.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.608 1.163 . . . . 73.25 108.682 172.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -42.39 2.57 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 116.856 -0.156 . . . . 71.31 112.889 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 35.5 pt -79.31 149.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.086 0.555 . . . . 75.31 110.655 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -170.64 160.08 6.97 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 73.51 109.376 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.77 -119.42 12.22 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.398 0.436 . . . . 73.21 112.452 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.0 m -73.69 -28.55 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.929 0.892 . . . . 75.04 111.292 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.645 HE22 ' HB2' ' B' ' 6' ' ' ASN . 18.2 tt0 -70.97 -24.39 62.4 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 75.15 112.317 -167.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.5 ptp -67.25 -32.02 72.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.938 -0.574 . . . . 73.31 110.592 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.598 ' HA ' HD23 ' H' ' 280' ' ' LEU . . . -62.97 -22.14 66.6 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.603 0.761 . . . . 73.54 112.027 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -83.83 -45.9 12.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.934 0.494 . . . . 74.12 109.907 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -74.95 -67.8 0.61 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.181 -0.463 . . . . 74.33 111.457 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.611 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.0 pp -80.73 -20.75 42.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 119.488 -0.291 . . . . 73.3 111.683 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.9 -32.57 26.29 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 113.887 0.315 . . . . 64.11 113.887 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.18 -59.23 2.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 71.51 110.899 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -67.17 -45.62 76.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.462 0.705 . . . . 74.44 112.779 -169.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 60.4 m -65.99 -45.07 63.28 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.606 -0.712 . . . . 63.42 112.761 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -34.48 98.29 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 122.303 2.002 . . . . 71.22 112.901 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -66.61 -27.63 67.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.117 0.567 . . . . 75.31 111.905 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.93 -45.41 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.221 0.608 . . . . 71.21 110.049 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.13 -17.42 49.94 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.478 -0.783 . . . . 74.14 111.692 -174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -61.17 -47.22 95.3 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.602 1.161 . . . . 72.33 113.944 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.41 -35.44 83.23 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.027 1.818 . . . . 72.33 112.978 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -68.9 -44.67 72.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.356 0.662 . . . . 74.41 110.618 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.36 0.664 . . . . 71.55 110.475 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.548 HH12 HD13 ' D' ' 16' ' ' ILE . 33.6 mtp180 -54.87 -60.46 3.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.191 0.996 . . . . 75.05 111.262 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.57 -31.71 70.83 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.244 0.965 . . . . 72.24 110.519 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.788 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.9 t -73.76 -37.74 64.94 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.967 -0.56 . . . . 44.24 111.344 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 69.0 mt -67.09 -45.63 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 123.134 0.574 . . . . 74.33 109.836 174.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.491 HG22 ' OG ' ' C' ' 119' ' ' SER . 10.2 m -62.13 -39.67 93.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 73.51 111.385 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -61.68 -42.35 98.8 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.787 0.835 . . . . 71.22 110.516 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 10.0 mmt -72.48 -31.58 65.51 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.726 0.41 . . . . 73.43 111.186 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.615 HG22 HD21 ' B' ' 126' ' ' LEU . 92.8 t -65.83 -41.23 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.803 0.841 . . . . 75.44 110.221 172.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 53.0 m -64.31 -36.85 85.46 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.18 0.992 . . . . 75.53 111.05 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 84.0 mtt-85 -71.05 -27.58 63.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.815 -0.629 . . . . 73.5 110.714 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.04 14.51 61.86 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.513 -0.604 . . . . 74.32 113.082 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 55.05 45.69 25.73 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.397 1.479 . . . . 74.4 113.12 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -119.87 149.25 48.28 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.657 0.783 . . . . 74.43 110.253 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.59 -165.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.352 3.368 . . . . 74.13 114.945 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.444 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.7 tp60 -60.13 128.51 37.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.564 1.146 . . . . 72.34 113.587 -168.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.615 HD21 HG22 ' B' ' 118' ' ' VAL . 12.3 tp -136.05 108.86 7.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 71.22 108.59 165.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -128.46 135.75 49.89 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.382 -0.969 . . . . 74.4 108.382 167.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.25 139.27 34.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.924 -0.769 . . . . 75.32 108.924 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.448 ' HB2' HG12 ' F' ' 306' ' ' VAL . . . -67.94 148.18 98.43 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.698 0.799 . . . . 71.12 111.504 -175.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.36 92.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.159 2.573 . . . . 72.13 111.504 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.86 108.34 19.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.804 -0.813 . . . . 73.44 108.804 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -83.16 109.18 16.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.34 -1.356 . . . . 71.22 107.34 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -63.89 -31.51 72.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.53 0.332 . . . . 75.12 111.145 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.41 -34.38 75.27 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.729 0.643 . . . . 75.5 111.385 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.48 85.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.029 0.531 . . . . 65.41 109.926 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.57 -34.42 75.57 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.513 0.725 . . . . 73.02 111.233 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -64.86 -53.17 50.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.903 0.481 . . . . 72.13 110.445 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.449 ' O ' ' HG2' ' B' ' 142' ' ' GLN . 70.5 mtm -68.39 -40.28 81.43 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.368 0.507 . . . . 75.41 112.368 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -76.15 -12.11 60.05 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 122.768 0.427 . . . . 74.13 111.289 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -87.46 -43.77 11.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.136 -0.691 . . . . 75.33 109.136 171.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.11 -5.76 58.91 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.623 -0.717 . . . . 73.14 112.615 -172.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 138' ' ' MET . 8.7 pt20 -163.13 152.31 14.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.399 0.68 . . . . 73.05 110.07 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -98.93 5.82 47.07 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.748 0.819 . . . . 71.33 111.021 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -81.87 85.21 6.7 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.22 0.608 . . . . 73.34 109.506 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.8 -46.19 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.066 1.346 . . . . 74.01 108.792 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.64 85.89 0.71 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 109.834 -1.306 . . . . 75.52 109.834 -171.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.93 119.21 5.07 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.445 0.698 . . . . 73.01 110.305 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.58 29.0 3.35 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.242 -0.436 . . . . 73.3 113.855 -171.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' THR . . . . . 0.408 ' HA ' ' SG ' ' F' ' 308' ' ' CYS . 42.6 p -79.12 82.92 5.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.083 0.953 . . . . 74.12 110.887 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -92.82 93.88 8.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.375 -0.829 . . . . 73.23 108.919 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.81 176.67 10.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.988 0.915 . . . . 75.34 110.774 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -164.85 67.09 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.679 -1.6 . . . . 73.35 106.679 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -63.45 96.47 0.11 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.975 -1.011 . . . . 73.21 111.494 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -88.54 149.28 23.69 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.681 0.792 . . . . 71.33 110.534 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 C-N-CA 124.143 0.977 . . . . 70.24 108.699 -178.113 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.701 -0.481 . . . . 74.21 109.701 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 24.1 p -120.48 86.67 2.61 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.837 -0.801 . . . . 74.05 108.837 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.46 73.27 8.51 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.933 -1.03 . . . . 73.34 109.072 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -109.91 46.65 1.0 Allowed 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.741 -1.118 . . . . 72.32 108.694 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.09 133.39 50.64 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.413 -0.812 . . . . 73.02 110.618 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -117.31 142.17 47.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.376 1.07 . . . . 73.11 108.366 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.0 m -139.72 45.87 1.9 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.898 0.856 . . . . 61.22 109.422 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.66 153.31 38.98 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.604 -0.726 . . . . 63.31 109.825 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.415 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 56.9 ttp 65.44 115.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.163 1.385 . . . . 75.14 112.364 -174.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.6 m -98.54 101.85 13.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.181 -1.044 . . . . 61.52 108.181 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -120.14 134.97 55.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.354 0.662 . . . . 74.32 110.03 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -154.92 144.48 21.38 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.998 0.919 . . . . 75.34 108.769 174.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -88.84 112.55 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 N-CA-C 109.641 -0.503 . . . . 75.03 109.641 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.35 -50.53 10.71 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.078 -0.389 . . . . 75.1 111.02 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -166.91 125.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.335 -0.617 . . . . 64.14 109.335 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.19 141.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 107.865 -1.161 . . . . 74.21 107.865 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.446 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.2 p90 -173.23 159.88 3.92 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.644 0.735 . . . . 73.45 112.187 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.2 114.63 22.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.747 -0.834 . . . . 73.33 108.747 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -80.7 -33.87 35.04 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.128 0.49 . . . . 73.14 110.112 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.621 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 33.5 t70 -147.33 139.51 24.47 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.429 -0.805 . . . . 72.54 109.395 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . . . . . . . . . 73.8 mt -140.04 139.69 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.632 -1.247 . . . . 73.32 107.632 178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 61.8 m -148.46 146.76 28.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.197 0.599 . . . . 74.32 110.54 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -145.08 107.62 4.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.472 -1.677 . . . . 71.5 106.472 165.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -118.82 109.63 16.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.165 -0.68 . . . . 75.44 109.165 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.28 80.7 12.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.137 -1.06 . . . . 74.54 108.137 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.98 -18.57 35.89 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.073 2.515 . . . . 75.12 112.041 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.94 32.69 5.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.052 0.941 . . . . 74.03 110.041 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.488 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -51.64 -51.31 71.09 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 113.813 1.042 . . . . 73.4 113.813 -175.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 11.5 Cg_exo -72.89 -30.76 10.86 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.175 1.916 . . . . 74.43 113.786 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -70.3 -40.1 74.45 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.14 0.576 . . . . 74.43 111.719 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 7.3 p -78.68 -20.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.665 0.786 . . . . 75.0 110.72 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -62.26 -20.79 64.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.948 1.299 . . . . 75.21 111.451 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -122.5 23.58 9.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 72.5 111.415 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.421 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 2.1 tppp? -98.0 146.79 25.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.2 0.6 . . . . 74.23 109.772 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.71 122.71 17.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.928 0.891 . . . . 74.3 110.276 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -72.07 90.32 1.18 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.842 0.857 . . . . 71.52 111.571 -166.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -127.67 64.11 62.57 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 124.078 0.951 . . . . 74.34 108.924 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.95 109.21 1.01 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.469 2.779 . . . . 73.43 113.302 -165.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -84.55 106.37 16.08 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.504 -0.925 . . . . 72.35 108.504 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -84.38 139.72 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.892 -1.049 . . . . 75.34 109.369 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.45 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 23.6 mtpp -131.87 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 72.31 109.038 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -91.72 120.31 32.35 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.255 -1.387 . . . . 74.12 107.255 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.725 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 2.1 m-20 -119.94 104.3 10.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.254 1.022 . . . . 64.43 108.421 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 110.97 23.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.506 -1.294 . . . . 73.41 107.506 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.425 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.7 t70 -116.35 149.25 39.63 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.36 1.464 . . . . 71.44 108.53 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.8 p -120.5 143.13 48.71 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.086 0.554 . . . . 73.45 109.756 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.22 145.92 33.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.178 0.991 . . . . 70.23 108.654 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -160.6 146.85 15.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.963 0.347 . . . . 73.23 111.213 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -154.35 144.01 21.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.836 0.854 . . . . 71.44 109.752 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.73 122.99 27.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.845 0.458 . . . . 73.13 109.813 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.676 HD12 ' HB2' ' C' ' 57' ' ' GLU . 40.3 mt -95.85 -36.4 11.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.485 0.714 . . . . 72.5 110.661 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.22 -177.51 6.64 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.172 -0.922 . . . . 62.05 109.976 -176.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -65.22 116.65 6.79 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.013 -0.994 . . . . 75.52 109.592 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . 0.474 ' HB3' ' HB3' ' C' ' 87' ' ' ALA . 23.6 m-20 67.05 12.12 8.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.953 1.301 . . . . 73.15 112.048 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 69.2 t -119.05 107.38 21.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.244 1.018 . . . . 74.52 109.096 179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.63 ' HB2' HD11 ' C' ' 86' ' ' ILE . 89.7 m-85 -116.74 134.45 54.79 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.23 1.012 . . . . 74.24 108.62 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.676 ' HB2' HD12 ' C' ' 51' ' ' LEU . 41.7 tt0 -83.58 119.58 24.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.752 -0.658 . . . . 72.54 109.294 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.55 118.97 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.792 -1.188 . . . . 71.25 107.792 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.82 133.76 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.564 0.746 . . . . 74.43 109.168 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.558 HD21 HD12 ' C' ' 106' ' ' LEU . 4.1 mm? -118.96 106.38 12.4 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.324 1.05 . . . . 75.24 108.699 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.425 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.6 ttm-85 -81.07 106.51 13.13 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.855 -1.165 . . . . 73.13 107.855 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.72 119.51 50.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.766 -1.198 . . . . 72.54 107.766 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.725 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 55.9 m -116.39 141.08 48.63 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.951 -1.129 . . . . 65.11 107.951 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.521 HG21 HG23 ' C' ' 114' ' ' ILE . 88.1 t -135.34 128.0 47.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 71.34 107.671 173.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.45 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.0 m -122.57 125.84 46.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.705 -0.85 . . . . 72.11 108.705 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.49 123.64 48.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.535 -1.283 . . . . 63.23 107.535 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.8 m -143.44 123.9 13.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.877 0.471 . . . . 63.03 110.746 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.08 57.65 3.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.649 1.18 . . . . 75.35 109.798 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.45 -111.53 4.05 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 110.558 -1.017 . . . . 75.34 110.558 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -89.53 -28.09 19.85 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.732 0.813 . . . . 72.21 109.429 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.91 117.65 7.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.043 -0.98 . . . . 74.21 110.175 173.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 87.8 m -87.6 125.64 34.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.706 -0.849 . . . . 75.31 108.706 167.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.619 ' HB1' ' HH ' ' F' ' 297' ' ' TYR . . . -75.07 -63.02 1.36 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.572 -1.195 . . . . 71.54 109.806 177.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.34 177.11 11.83 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 114.85 -1.068 . . . . 71.2 111.217 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -135.98 147.51 48.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.83 -1.915 . . . . 73.53 105.83 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.526 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.3 t -150.48 113.08 4.71 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.148 -1.056 . . . . 71.34 108.148 176.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.4 126.78 31.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.207 -0.664 . . . . 72.33 109.207 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 80.2 t -130.21 113.74 26.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.917 0.887 . . . . 74.21 108.842 -179.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.621 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -89.83 90.52 8.23 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.849 -1.167 . . . . 64.35 107.849 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -81.25 104.04 11.44 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.473 -1.239 . . . . 71.33 109.46 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.85 150.73 19.73 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 112.08 -0.408 . . . . 71.14 112.08 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.34 125.0 1.98 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.226 -1.15 . . . . 53.43 110.226 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' D' ' 29' ' ' PRO . 9.8 mm -81.93 126.52 39.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.759 -1.2 . . . . 71.23 107.759 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -136.51 154.72 50.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.419 0.688 . . . . 75.41 109.144 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 31.2 m -96.45 116.12 28.55 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.459 -0.941 . . . . 74.43 108.459 169.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.638 HG21 ' HE3' ' C' ' 94' ' ' MET . 3.8 mp -116.73 118.16 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.503 -0.925 . . . . 75.51 108.503 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.474 ' HB3' ' HB3' ' C' ' 54' ' ' ASP . . . -153.21 170.51 20.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.134 0.974 . . . . 74.34 110.054 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.4 -59.39 0.4 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.54 -0.3 . . . . 74.21 113.434 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.23 -179.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.383 0.673 . . . . 73.21 112.176 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.93 -173.31 4.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 72.53 109.822 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.21 -140.76 38.13 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.533 0.521 . . . . 71.32 113.305 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -75.2 -17.64 60.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.856 0.863 . . . . 71.24 112.182 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -73.47 -36.58 65.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.025 0.53 . . . . 70.21 110.595 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.694 ' HE1' HD21 ' C' ' 98' ' ' LEU . 1.2 tmt? -72.15 -41.63 66.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.373 -0.603 . . . . 74.22 109.373 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.89 66.07 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.854 -1.066 . . . . 74.42 111.568 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.497 ' HD2' ' HB3' ' C' ' 137' ' ' PHE . 39.9 t-80 -66.84 -41.66 87.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 74.32 111.254 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -77.74 -57.43 3.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.856 -0.424 . . . . 75.01 109.856 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.694 HD21 ' HE1' ' C' ' 94' ' ' MET . 61.2 tp -62.44 -39.65 94.03 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.366 1.066 . . . . 62.24 112.542 -173.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.81 11.21 57.6 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.543 -0.587 . . . . 72.44 114.155 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -144.63 -63.41 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.59 0.695 . . . . 75.41 111.51 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -69.34 -55.12 11.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.723 0.409 . . . . 74.4 111.887 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.9 m -55.88 -44.77 99.84 Favored Pre-proline 0 CA--C 1.573 1.85 0 C-N-CA 123.581 0.752 . . . . 71.53 112.567 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -51.18 -43.46 48.5 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.062 2.508 . . . . 75.31 114.344 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.404 HD21 ' N ' ' C' ' 104' ' ' ASN . 0.9 OUTLIER -74.24 -20.19 60.25 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.463 0.705 . . . . 75.53 111.715 -174.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.487 HD13 ' NH1' ' A' ' 111' ' ' ARG . 32.3 mm -76.88 -44.86 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.984 0.514 . . . . 73.42 110.061 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.558 HD12 HD21 ' C' ' 60' ' ' LEU . 73.1 mt -81.61 -18.72 43.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.044 -0.526 . . . . 74.03 112.004 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -57.11 -54.25 56.63 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 117.72 -1.133 . . . . 75.43 113.08 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.79 -27.45 84.84 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.026 1.818 . . . . 71.4 113.221 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -71.08 -45.98 62.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.208 0.603 . . . . 73.21 110.79 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.59 84.65 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.795 -0.638 . . . . 73.24 110.315 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.708 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 33.6 ttt180 -60.13 -47.88 84.07 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.489 1.516 . . . . 75.22 111.47 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -38.71 86.15 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.907 0.755 . . . . 75.51 109.765 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.2 m -58.5 -46.67 86.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.38 0.672 . . . . 71.24 112.357 175.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.526 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 86.9 mt -66.16 -48.43 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 122.916 0.486 . . . . 71.5 110.762 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.6 m -65.81 -32.71 74.39 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.088 0.555 . . . . 70.41 111.272 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -69.41 -37.99 77.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.325 0.65 . . . . 74.53 109.98 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.509 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -70.9 -35.97 72.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.661 0.784 . . . . 74.11 111.514 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.8 t -63.76 -37.31 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.543 -0.54 . . . . 70.33 109.543 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.491 ' OG ' HG22 ' B' ' 115' ' ' THR . 42.1 t -67.77 -35.34 78.52 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.85 0.86 . . . . 70.14 112.194 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.68 -32.46 65.81 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.2 0.6 . . . . 74.33 110.022 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.2 1.6 86.66 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.465 0.478 . . . . 72.4 112.612 171.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p 62.42 19.59 11.25 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.836 2.054 . . . . 70.45 113.17 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.64 150.04 45.31 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.09 0.956 . . . . 74.31 109.43 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.498 ' HD3' HG22 ' F' ' 301' ' ' ILE . 35.7 Cg_endo -62.54 113.25 1.87 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.722 2.281 . . . . 74.14 111.442 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -55.47 141.79 35.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.254 -1.339 . . . . 73.21 113.168 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.36 121.24 36.23 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.822 -1.548 . . . . 75.3 106.822 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.86 126.55 41.19 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.941 0.896 . . . . 72.42 108.653 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.708 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -63.92 145.02 56.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.218 0.607 . . . . 75.41 110.403 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.485 ' HB2' ' HE2' ' F' ' 294' ' ' LYS . . . -83.49 164.33 45.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.095 0.958 . . . . 53.12 111.232 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -66.52 117.26 4.59 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.064 1.842 . . . . 73.21 111.729 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.36 109.34 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.944 0.878 . . . . 73.44 108.964 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.405 ' O ' ' HG ' ' C' ' 136' ' ' LEU . 9.1 m120 -107.9 94.4 5.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.044 -0.98 . . . . 75.14 109.708 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -75.9 -40.59 54.1 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.139 -0.689 . . . . 74.45 109.139 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' C' ' 138' ' ' MET . 11.3 p-10 -60.64 -41.54 95.13 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.824 0.85 . . . . 74.13 110.91 -176.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.82 -24.97 61.8 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.039 0.935 . . . . 71.44 111.691 -176.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 98.8 mt -74.43 -40.13 62.15 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.187 0.595 . . . . 75.04 109.801 172.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . 0.497 ' HB3' ' HD2' ' C' ' 96' ' ' HIS . 52.7 m-85 -80.74 -11.45 59.61 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.912 0.885 . . . . 72.52 112.736 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 66.3 mtt -62.11 -32.92 73.54 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.092 0.557 . . . . 74.34 110.704 170.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -64.16 -33.73 76.46 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.295 1.038 . . . . 74.04 111.342 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -58.75 -83.74 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.048 0.939 . . . . 74.13 111.519 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.48 125.54 15.37 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.35 -0.982 . . . . 73.44 108.35 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -124.5 121.59 35.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.056 0.943 . . . . 74.34 109.177 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -97.58 169.53 9.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.65 0.78 . . . . 74.12 110.202 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -87.65 89.72 8.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.684 -0.858 . . . . 75.31 108.684 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.21 146.52 54.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.98 0.912 . . . . 75.04 112.454 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.54 132.44 11.08 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.682 -0.69 . . . . 71.31 111.63 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -147.48 142.52 27.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.445 0.698 . . . . 73.11 109.85 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.25 -169.59 35.14 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.178 -0.769 . . . . 72.01 111.178 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 51.8 m -147.99 81.0 1.49 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.328 -0.619 . . . . 73.24 109.328 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.426 ' HB3' ' HB2' ' G' ' 310' ' ' PRO . 3.0 tm-20 -74.48 102.76 4.58 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.289 -1.374 . . . . 71.0 107.289 170.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -68.62 108.94 3.54 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.119 -0.697 . . . . 75.21 109.119 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -125.12 137.71 54.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.043 0.937 . . . . 74.42 109.957 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -142.69 133.18 25.01 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.351 1.06 . . . . 74.55 109.099 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -137.41 131.31 31.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.968 -1.123 . . . . 75.51 107.968 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.817 0 N-CA-C 108.862 -0.792 . . . . 74.14 108.862 -177.132 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.148 -0.686 . . . . 64.4 109.148 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 62.2 m -154.3 96.78 1.96 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.793 -1.188 . . . . 72.32 107.793 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.7 151.17 40.78 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.482 0.713 . . . . 64.35 110.149 -172.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -129.2 102.5 6.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.632 0.773 . . . . 73.2 109.909 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . 0.425 ' ND2' HG23 ' D' ' 89' ' ' ILE . 4.5 p-10 -92.53 139.12 30.9 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.896 0.878 . . . . 64.33 110.852 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -150.18 112.38 4.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.785 0.834 . . . . 64.14 109.257 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -179.62 -40.31 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.966 1.307 . . . . 72.11 109.51 171.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -98.83 -29.23 13.09 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.239 1.016 . . . . 74.54 110.095 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.416 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.4 ptm -34.21 142.53 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.284 1.587 . . . . 74.14 115.284 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m -143.89 142.93 31.05 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 73.13 107.989 169.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -154.66 98.36 2.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.01 -1.107 . . . . 65.33 108.01 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -131.26 125.9 34.04 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.604 -1.258 . . . . 72.42 107.604 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mt -69.59 124.42 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.504 -0.924 . . . . 73.41 108.504 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.484 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 19.7 mm-40 -74.31 -48.98 24.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.707 -0.479 . . . . 74.43 109.707 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -161.85 156.63 22.86 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.824 1.25 . . . . 75.02 109.845 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.548 HD13 HH12 ' B' ' 111' ' ' ARG . 0.2 OUTLIER -126.87 125.41 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 105.631 -1.988 . . . . 75.12 105.631 165.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.471 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 32.4 p90 -155.36 153.74 30.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.889 0.852 . . . . 74.05 110.707 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.77 110.75 12.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.172 -1.376 . . . . 70.11 108.438 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.471 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.7 mtpt -77.57 -36.54 51.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.061 -0.718 . . . . 74.31 109.061 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.633 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.5 t70 -140.49 137.86 34.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.537 -1.21 . . . . 74.15 109.324 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.509 HG23 ' HE1' ' C' ' 117' ' ' MET . 90.2 mt -132.81 142.95 41.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.821 1.249 . . . . 73.22 107.963 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -147.16 136.54 22.68 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.569 1.148 . . . . 74.31 108.653 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -143.36 123.58 13.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.592 -1.633 . . . . 75.52 106.592 167.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.557 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.3 mt-10 -127.37 127.03 43.54 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.397 0.679 . . . . 73.15 109.269 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.72 84.18 8.04 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.549 -1.649 . . . . 72.1 106.549 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.46 -30.22 12.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.823 2.349 . . . . 71.23 112.633 -167.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -115.26 36.36 3.95 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.266 1.026 . . . . 54.11 108.89 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.446 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -48.48 -61.54 3.1 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 115.076 1.51 . . . . 70.34 115.076 -165.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.578 ' HB3' HD11 ' C' ' 83' ' ' ILE . 33.0 Cg_endo -85.65 -4.03 9.13 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 122.671 1.99 . . . . 75.11 113.075 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -80.92 -42.0 22.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 74.0 109.414 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.738 HG23 ' HA ' ' D' ' 73' ' ' ALA . 14.0 p -76.27 -34.02 24.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.248 -0.887 . . . . 73.33 110.295 -173.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -57.23 -16.78 9.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.12 0.968 . . . . 72.43 113.403 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.59 -37.21 60.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.887 0.475 . . . . 75.33 110.535 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -130.85 57.93 1.72 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.461 0.304 . . . . 73.52 110.899 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.406 ' HB3' ' CD1' ' G' ' 301' ' ' ILE . 12.0 t70 -100.7 94.96 6.35 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.354 -0.841 . . . . 55.23 109.556 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.413 ' H ' HD23 ' D' ' 68' ' ' LEU . 16.4 m95 -124.08 -164.85 1.28 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.576 -1.638 . . . . 75.24 106.576 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.475 ' HA ' ' HB3' ' G' ' 297' ' ' TYR . 0.0 OUTLIER -51.41 106.65 0.68 Allowed Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 119.167 0.894 . . . . 74.34 112.172 -176.413 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.475 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 4.7 Cg_exo -78.35 144.82 20.77 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.589 2.193 . . . . 73.41 111.291 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -79.09 112.89 16.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.276 -1.379 . . . . 61.55 107.276 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.9 142.58 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.496 0.718 . . . . 75.23 110.099 -168.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -118.89 147.46 43.96 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.534 1.134 . . . . 74.53 109.421 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.433 HD22 HD22 ' D' ' 128' ' ' LEU . 95.1 mt -106.83 118.38 36.54 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.04 -1.096 . . . . 73.0 108.04 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.3 t70 -106.46 129.93 54.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.908 -1.145 . . . . 75.33 107.908 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.82 156.52 18.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.698 0.799 . . . . 75.32 111.106 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.531 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.3 t70 -168.16 129.29 1.37 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.274 -0.876 . . . . 70.01 109.265 172.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -106.09 148.49 27.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.647 0.779 . . . . 74.43 110.072 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.602 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.85 155.53 40.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.93 0.892 . . . . 64.13 108.789 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.0 p -163.17 153.91 16.53 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.275 0.63 . . . . 73.33 110.441 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.3 p -163.7 143.52 8.36 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.539 0.736 . . . . 73.11 110.079 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -78.4 122.59 25.99 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.463 -0.569 . . . . 71.22 109.463 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -93.05 -39.43 11.09 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.454 -0.573 . . . . 73.21 109.454 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.5 -176.67 5.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 75.04 110.49 179.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.34 119.85 13.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.201 -0.909 . . . . 62.12 109.594 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 64.03 7.02 3.12 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.811 1.245 . . . . 72.44 112.686 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 56.1 t -114.89 108.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.365 -0.976 . . . . 74.42 108.365 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -128.39 129.71 46.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.649 -1.16 . . . . 62.23 108.776 -169.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -96.69 129.26 44.13 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.267 1.027 . . . . 71.14 109.919 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.4 t -110.9 116.98 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.81 -1.182 . . . . 74.23 107.81 170.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.4 t -99.66 131.88 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.521 -0.918 . . . . 73.33 108.521 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.85 108.92 12.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.064 -1.087 . . . . 75.43 108.064 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.531 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.4 ttm180 -85.54 113.08 21.51 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.481 0.713 . . . . 73.22 109.796 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.49 103.43 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.26 -1.015 . . . . 74.42 108.26 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.591 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.4 m -102.37 138.87 38.73 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.097 -0.705 . . . . 72.23 109.097 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.63 122.61 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.203 1.001 . . . . 75.33 109.91 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 39.8 m -120.49 100.37 7.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.987 0.915 . . . . 52.11 109.59 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 133.7 42.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.333 0.653 . . . . 74.42 109.879 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 20.7 m -148.03 126.7 12.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.064 0.946 . . . . 75.52 109.636 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.475 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.0 pp -126.53 140.26 52.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.267 0.627 . . . . 74.5 111.404 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 -111.84 3.72 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.196 -1.161 . . . . 55.23 110.196 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 4.47 9.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 74.01 110.797 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.99 173.7 7.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.981 0.512 . . . . 75.41 110.542 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -82.09 139.15 34.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 63.35 109.638 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.738 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -84.7 -67.36 0.8 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.567 -0.901 . . . . 31.24 108.567 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -155.2 164.89 38.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.443 -1.253 . . . . 72.12 110.061 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.557 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 94.6 mt -134.38 151.68 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.229 1.412 . . . . 75.4 108.529 -176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.571 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.6 t -158.22 148.11 19.92 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.229 0.612 . . . . 71.11 110.097 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.59 126.05 6.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.476 0.71 . . . . 74.54 109.593 171.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.23 114.79 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.899 0.48 . . . . 74.2 109.772 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.633 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.8 mt-30 -90.56 88.78 7.27 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.949 -0.76 . . . . 74.5 108.949 173.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.34 96.39 6.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.657 -1.156 . . . . 73.14 109.328 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.538 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.01 141.64 17.81 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.046 -0.822 . . . . 74.52 111.046 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.427 ' HA3' HD23 ' D' ' 106' ' ' LEU . . . -136.41 128.59 4.56 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 110.537 -1.025 . . . . 62.01 110.537 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.484 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 29.5 mt -93.39 127.04 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.987 -1.116 . . . . 71.11 107.987 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -128.78 126.66 40.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.658 0.783 . . . . 72.41 110.18 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -82.99 93.4 7.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.602 -0.888 . . . . 64.23 108.602 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.9 mt -108.45 109.73 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.772 -0.825 . . . . 74.15 108.772 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.48 167.15 21.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.16 0.984 . . . . 64.3 110.428 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.94 0.78 57.32 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.787 0.675 . . . . 64.41 114.787 170.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.466 HG21 HE21 ' D' ' 93' ' ' GLN . 29.0 pt -137.92 162.21 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.513 1.125 . . . . 74.44 109.73 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.29 3.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.326 1.051 . . . . 73.34 109.501 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.41 -122.79 29.31 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 115.514 0.966 . . . . 75.32 115.514 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -60.31 -54.13 49.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.911 1.284 . . . . 74.2 112.137 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.466 HE21 HG21 ' D' ' 89' ' ' ILE . 29.3 tt0 -70.94 -39.72 72.45 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.383 0.427 . . . . 74.2 111.752 -172.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -42.89 59.23 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.908 0.483 . . . . 74.43 111.269 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.92 83.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.94 0.496 . . . . 73.23 110.817 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -74.7 -27.18 60.28 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.681 -0.69 . . . . 75.34 110.771 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.51 -50.76 64.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.036 0.534 . . . . 71.01 110.381 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.587 HD22 ' HA ' ' G' ' 278' ' ' LEU . 4.3 pp -79.66 -17.51 53.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.404 0.282 . . . . 74.54 111.391 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.36 -5.7 84.81 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.327 0.392 . . . . 74.33 114.069 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.12 -59.03 0.31 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.908 0.354 . . . . 73.43 111.534 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -74.38 -53.71 9.07 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.413 0.685 . . . . 75.04 112.118 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.45 -43.27 88.55 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.053 1.131 . . . . 74.33 114.053 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.79 -29.15 50.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.823 1.682 . . . . 71.12 111.874 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.9 -22.32 59.74 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.191 0.996 . . . . 73.12 110.664 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.1 mm -76.95 -45.01 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.387 0.675 . . . . 74.03 109.95 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.427 HD23 ' HA3' ' D' ' 82' ' ' GLY . 95.7 mt -72.47 -30.98 65.04 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.576 -0.738 . . . . 74.01 111.807 -174.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.78 -41.96 60.14 Favored Pre-proline 0 CA--C 1.568 1.662 0 N-CA-C 114.405 1.261 . . . . 64.24 114.405 -169.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.48 -39.56 74.02 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.381 2.054 . . . . 65.12 113.578 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -75.72 -35.5 60.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.612 0.765 . . . . 74.3 110.913 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.8 79.01 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.234 0.614 . . . . 72.53 110.279 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -59.6 -46.17 89.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.626 1.17 . . . . 73.12 110.78 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.73 -44.78 96.24 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.141 0.901 . . . . 74.32 111.014 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.82 -45.14 93.3 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.864 0.728 . . . . 74.3 110.691 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.571 HG12 ' SG ' ' D' ' 76' ' ' CYS . 57.6 mt -59.53 -54.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.017 0.927 . . . . 75.22 110.686 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -47.62 66.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.481 1.112 . . . . 62.42 111.302 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.4 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.5 t -65.06 -42.8 93.87 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.425 -1.261 . . . . 72.4 110.809 -173.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.416 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -70.68 -37.34 73.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.777 0.431 . . . . 73.52 111.812 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.403 HG22 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -65.15 -41.51 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.684 -0.689 . . . . 75.35 109.774 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -72.21 -29.04 63.58 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 122.985 0.514 . . . . 62.12 111.241 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' D' ' 116' ' ' SER . 63.5 mtt-85 -70.82 -29.07 65.13 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.397 0.679 . . . . 74.52 110.418 174.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 10.1 60.11 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.954 -0.566 . . . . 42.03 112.576 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.9 p 59.87 23.43 12.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.853 2.061 . . . . 74.13 112.985 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.551 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 51.5 m-85 -88.84 174.61 4.83 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 125.193 1.397 . . . . 70.32 108.831 170.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.551 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 33.9 Cg_endo -59.21 167.36 6.04 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.913 2.408 . . . . 75.31 113.929 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.478 ' NE2' HD22 ' D' ' 127' ' ' ASN . 3.5 pt20 -73.82 131.28 41.37 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.937 -1.135 . . . . 74.45 107.937 164.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.46 93.59 4.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.706 -1.22 . . . . 74.42 107.706 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.478 HD22 ' NE2' ' D' ' 125' ' ' GLN . 50.3 m-20 -98.23 99.01 10.2 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.539 -1.282 . . . . 74.41 107.539 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.433 HD22 HD22 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -71.08 136.03 48.04 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.768 -0.651 . . . . 73.24 109.664 -176.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.81 137.31 87.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.417 1.087 . . . . 73.42 111.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.449 ' HD3' HG23 ' B' ' 13' ' ' ILE . 16.9 Cg_exo -68.91 106.26 1.48 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.935 2.423 . . . . 71.41 111.921 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.81 109.16 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.554 0.741 . . . . 74.54 109.152 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -85.73 106.88 17.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.338 0.655 . . . . 73.21 109.795 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -64.42 -31.84 73.22 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.148 0.979 . . . . 72.31 111.429 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -62.72 -46.78 86.52 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.106 -0.952 . . . . 74.21 110.772 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.5 92.95 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.288 0.993 . . . . 72.44 111.815 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.16 -48.58 67.58 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.423 0.689 . . . . 73.43 111.513 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -71.86 -32.12 67.17 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.097 0.559 . . . . 74.45 111.059 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.46 ' HE1' ' HB2' ' D' ' 138' ' ' MET . 43.7 ttm -58.68 -37.57 76.34 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.558 1.143 . . . . 63.05 111.379 -178.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.21 -35.46 78.95 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.022 -0.99 . . . . 75.42 111.695 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -57.84 -43.74 86.03 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.351 0.661 . . . . 74.24 110.921 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.538 ' HA ' HE21 ' D' ' 144' ' ' GLN . 8.2 mp -67.14 -43.15 83.08 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.771 -0.65 . . . . 71.21 111.336 -177.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.409 ' OE1' ' HG3' ' D' ' 143' ' ' GLN . 0.0 OUTLIER -90.34 4.24 51.37 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.92 0.711 . . . . 71.12 112.92 -174.454 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.409 ' HG3' ' OE1' ' D' ' 142' ' ' GLN . 75.6 mt-30 -119.62 46.95 1.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.345 0.593 . . . . 73.34 109.889 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . 0.538 HE21 ' HA ' ' D' ' 141' ' ' LEU . 28.2 pt20 -159.05 19.76 0.19 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.527 -0.761 . . . . 64.32 110.919 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.62 6.72 8.21 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.503 0.721 . . . . 73.02 111.224 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.78 -84.24 0.47 Allowed Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.02 -0.832 . . . . 75.01 111.02 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -130.17 -59.0 1.06 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.017 -1.105 . . . . 72.11 108.017 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.27 -77.06 1.58 Allowed Glycine 0 C--N 1.346 1.111 0 CA-C-N 114.83 -1.077 . . . . 72.21 111.696 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.7 t -151.29 157.88 43.12 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.977 0.911 . . . . 73.53 109.293 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -175.96 5.0 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.495 0.718 . . . . 73.31 109.974 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -131.63 -64.4 0.79 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.223 0.609 . . . . 73.11 109.389 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -84.33 84.75 7.52 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.737 -0.838 . . . . 73.11 108.737 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.35 108.83 1.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.468 0.707 . . . . 72.35 111.688 -170.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -160.74 86.08 0.71 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.482 -0.932 . . . . 75.34 108.482 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 123.879 0.872 . . . . 73.41 109.188 178.715 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 119.267 -0.397 . . . . 72.44 110.186 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 66.1 t30 79.86 -12.21 1.08 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.683 1.593 . . . . 72.12 111.818 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 67.18 -73.11 0.08 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 126.168 1.787 . . . . 74.41 111.878 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -60.95 -74.58 0.08 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.664 1.186 . . . . 73.22 111.459 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -125.08 88.9 53.49 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 122.809 0.443 . . . . 72.24 110.504 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.14 -32.11 7.13 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.408 2.739 . . . . 75.3 114.406 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.13 -30.4 70.39 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.702 0.401 . . . . 72.25 110.427 -173.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.31 55.88 0.84 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.078 0.551 . . . . 72.34 110.182 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -75.86 -38.21 36.82 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.97 -0.559 . . . . 74.41 112.226 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.478 HD11 ' HB1' ' A' ' 95' ' ' ALA . 1.0 OUTLIER -133.17 -168.62 2.12 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.016 0.926 . . . . 73.12 109.634 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . 0.425 ' CZ ' ' HB ' ' A' ' 46' ' ' THR . 85.3 t80 73.41 132.95 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.839 1.656 . . . . 74.4 110.096 -171.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . 0.462 ' HB1' ' HA ' ' A' ' 47' ' ' ALA . . . 72.87 5.38 5.19 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.215 1.406 . . . . 64.45 111.457 -169.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.1 -9.11 49.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.612 0.765 . . . . 73.5 110.611 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -157.97 -58.61 0.01 OUTLIER Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.963 -0.455 . . . . 65.54 111.963 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 70.08 172.58 0.31 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.474 1.51 . . . . 75.31 111.904 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 286' ' ' MET . . . . . 0.406 ' HA ' ' HD3' ' E' ' 287' ' ' PRO . 0.0 OUTLIER -131.45 122.84 19.13 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.399 0.679 . . . . 75.54 110.171 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' E' ' 286' ' ' MET . 2.0 Cg_endo -82.15 115.32 2.62 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.702 2.268 . . . . 74.55 111.169 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 84.1 t -86.09 125.36 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.569 -0.9 . . . . 71.55 108.569 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -89.23 172.74 8.84 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.554 0.741 . . . . 65.53 109.747 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -72.27 150.01 43.99 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.314 0.578 . . . . 74.04 111.556 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.23 11.12 17.33 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.603 -1.181 . . . . 74.13 110.932 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -159.49 -176.74 31.89 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.978 -0.556 . . . . 65.15 112.42 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -87.89 -155.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.893 3.062 . . . . 74.31 113.842 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -56.75 87.31 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.565 1.146 . . . . 73.13 110.597 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -142.15 -168.64 2.76 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.472 -0.786 . . . . 74.31 109.815 -172.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 46.6 m 79.22 -28.47 0.15 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.93 1.692 . . . . 75.33 112.114 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.717 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 21.7 t80 -77.0 86.3 3.52 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.784 0.834 . . . . 70.41 111.691 -170.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . 0.704 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 1.2 p-80 -145.76 54.69 1.17 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 125.067 1.347 . . . . 73.53 111.279 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.06 166.5 19.04 Favored Glycine 0 N--CA 1.482 1.708 0 CA-C-O 119.062 -0.854 . . . . 55.24 112.016 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . 0.527 ' HA ' ' ND2' ' G' ' 300' ' ' ASN . 9.4 t30 -64.42 96.48 0.16 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.97 0.508 . . . . 74.12 110.224 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . 0.448 HD11 ' HA ' ' A' ' 32' ' ' PHE . 15.4 tt -133.54 4.76 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.859 0.864 . . . . 70.33 110.446 -172.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -52.79 -63.99 0.96 Allowed 'General case' 0 C--N 1.363 1.163 0 C-N-CA 124.5 1.12 . . . . 74.43 111.495 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 53.73 70.02 1.95 Allowed Pre-proline 0 CA--C 1.558 1.286 0 O-C-N 124.785 1.303 . . . . 74.41 110.432 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.35 -63.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.265 1.977 . . . . 73.11 112.468 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -171.82 124.56 0.55 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.923 0.889 . . . . 72.14 109.352 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 86.4 t -100.46 122.13 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.822 -0.807 . . . . 74.42 108.822 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 27.0 m -77.02 132.53 39.0 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.171 0.588 . . . . 74.22 110.34 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 53.9 m -66.76 159.63 27.54 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.054 0.941 . . . . 63.35 111.133 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 6.1 p -68.67 -40.77 19.24 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-O 117.887 -1.054 . . . . 73.33 113.364 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.399 3.234 0 CA-C-N 121.733 1.655 . . . . 73.45 111.573 170.05 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.219 -0.289 . . . . 72.43 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -80.68 142.82 33.54 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.789 0.836 . . . . 73.54 111.859 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -113.85 -50.81 2.82 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.904 0.882 . . . . 72.31 109.504 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -155.91 129.14 8.16 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.66 0.784 . . . . 74.35 109.65 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.78 -50.3 71.81 Favored Pre-proline 0 N--CA 1.49 1.542 0 CA-C-O 118.422 -0.799 . . . . 73.35 112.927 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.63 -174.0 0.97 Allowed 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 121.623 1.549 . . . . 72.31 112.423 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.659 ' HB3' ' HE2' ' C' ' 94' ' ' MET . 7.1 mp -64.27 168.63 5.37 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.435 -0.802 . . . . 74.35 110.304 175.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 5.4 mp 79.15 95.18 0.06 Allowed 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 125.211 1.404 . . . . 74.55 109.874 -170.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -139.54 43.78 1.13 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.058 -0.519 . . . . 74.33 113.104 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 10.5 tt -178.98 -53.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.938 -1.134 . . . . 72.42 107.938 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -80.9 172.0 14.29 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.133 -1.394 . . . . 73.11 110.549 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 72.04 20.55 4.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.001 1.32 . . . . 73.04 109.664 -171.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -140.82 134.49 30.23 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.973 1.709 . . . . 62.42 108.001 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -80.07 64.63 3.91 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 112.007 -0.437 . . . . 60.41 112.007 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -67.91 -49.89 59.28 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.709 0.804 . . . . 73.31 110.724 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 65.6 mtt -103.36 106.32 51.0 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.884 0.874 . . . . 73.31 109.284 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.97 -38.16 23.71 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.32 2.68 . . . . 74.51 112.817 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 17.6 t 56.42 55.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.986 1.314 . . . . 72.4 110.548 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -79.62 71.01 6.21 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.511 -0.768 . . . . 71.13 110.724 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 98.6 m95 61.17 91.85 0.06 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.962 1.705 . . . . 75.24 114.144 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 91.66 0.17 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.75 -1.114 . . . . 75.44 108.808 163.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.89 108.68 0.98 Allowed Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.493 -1.17 . . . . 71.12 110.517 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.16 113.51 1.56 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.528 2.819 . . . . 71.11 112.539 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . 0.485 ' HE2' ' HB2' ' C' ' 129' ' ' ALA . 60.7 mttp -126.87 86.31 2.49 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.849 0.859 . . . . 74.43 109.165 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -77.32 142.32 39.46 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.303 -0.862 . . . . 62.43 111.778 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 296' ' ' THR . . . . . 0.49 HG22 ' H ' ' F' ' 297' ' ' TYR . 4.6 m -80.17 178.45 8.25 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 108.132 -1.062 . . . . 75.04 108.132 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.619 ' HH ' ' HB1' ' C' ' 73' ' ' ALA . 94.1 m-85 64.4 19.67 11.88 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.882 0.873 . . . . 71.41 112.596 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -68.15 116.64 8.99 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 108.439 -0.948 . . . . 72.44 108.439 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 90.0 123.89 2.59 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.629 -0.989 . . . . 44.24 110.629 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -60.78 116.53 4.49 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.195 0.998 . . . . 75.31 110.734 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.498 HG22 ' HD3' ' C' ' 124' ' ' PRO . 2.7 pp -114.92 14.83 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.49 0.716 . . . . 75.22 111.796 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -55.36 -27.84 49.94 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.318 1.047 . . . . 73.02 111.306 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . 0.453 ' HD2' ' N ' ' F' ' 303' ' ' LYS . 0.3 OUTLIER -78.28 123.11 85.92 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 114.779 -1.101 . . . . 71.32 108.762 175.033 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.59 -31.29 48.86 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 124.081 3.188 . . . . 71.4 114.072 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 76.21 -47.13 0.55 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.579 1.552 . . . . 63.41 112.017 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . 0.448 HG12 ' HB2' ' B' ' 129' ' ' ALA . 57.5 t -71.85 101.83 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.058 -0.719 . . . . 74.11 109.058 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 15.0 t -162.17 -175.59 4.67 Favored 'General case' 0 C--O 1.247 0.933 0 C-N-CA 125.164 1.386 . . . . 74.23 107.399 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . 0.408 ' SG ' ' HA ' ' B' ' 149' ' ' THR . 52.0 t 64.69 30.45 12.51 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.768 0.794 . . . . 52.1 110.455 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 40.4 p -88.48 119.96 70.25 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.028 0.931 . . . . 71.13 109.773 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 C--N 1.38 2.186 0 C-N-CA 122.764 2.31 . . . . 74.1 111.311 174.542 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 110.308 -0.256 . . . . 73.4 110.308 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -79.33 86.38 5.07 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.342 -0.614 . . . . 73.22 109.342 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -121.48 154.46 36.58 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.22 0.608 . . . . 75.34 109.781 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -123.7 149.53 45.4 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.218 1.007 . . . . 65.23 109.209 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 57.9 mttp 55.27 65.54 4.64 Favored Pre-proline 0 CA--C 1.562 1.429 0 C-N-CA 124.486 1.114 . . . . 72.25 110.306 -171.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.12 80.08 2.97 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.51 2.14 . . . . 70.44 110.706 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 50.7 mt 66.29 170.57 0.23 Allowed 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.838 1.255 . . . . 75.41 111.241 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . 0.587 ' HA ' HD22 ' D' ' 98' ' ' LEU . 3.8 mm? 67.06 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.246 1.418 . . . . 62.32 112.3 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 67.84 -97.46 0.42 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 111.903 -0.479 . . . . 75.43 111.903 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . 0.488 HD12 ' H ' ' G' ' 283' ' ' ASP . 2.8 pp -165.18 168.88 16.69 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.272 1.029 . . . . 73.5 110.204 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -76.76 -70.32 0.46 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.392 0.433 . . . . 72.54 110.023 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -158.26 43.5 0.29 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.32 -0.622 . . . . 63.42 109.32 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . 0.488 ' H ' HD12 ' G' ' 280' ' ' LEU . 6.3 m-20 58.25 78.06 0.26 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.728 1.211 . . . . 64.14 110.126 -176.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.64 -159.77 25.05 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.428 -0.806 . . . . 72.22 111.549 -170.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -95.82 145.53 25.27 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.663 0.785 . . . . 73.24 110.111 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 54.7 tpp -65.82 128.16 93.62 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.671 0.789 . . . . 73.03 110.05 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -65.97 86.47 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.43 2.086 . . . . 71.34 112.018 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 89.7 t -79.23 114.22 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.596 0.758 . . . . 74.13 109.409 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -121.07 147.51 45.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.902 0.881 . . . . 73.33 109.697 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.426 ' NE1' ' HG ' ' D' ' 42' ' ' LEU . 15.5 m95 -70.84 115.1 9.59 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.046 0.539 . . . . 72.12 110.407 173.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.79 -48.92 77.04 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.404 0.682 . . . . 73.41 109.248 173.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -127.5 99.78 0.53 Allowed Glycine 0 C--N 1.345 1.047 0 CA-C-O 118.763 -1.02 . . . . 62.25 110.672 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.94 -11.88 23.38 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.545 2.83 . . . . 63.24 114.085 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -138.78 25.78 2.54 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.043 0.937 . . . . 74.24 110.571 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -73.32 -1.61 18.7 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.67 0.788 . . . . 75.04 112.554 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 77.4 m -124.02 130.93 53.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.12 1.368 . . . . 73.24 109.462 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.475 ' HB3' ' HA ' ' D' ' 37' ' ' GLN . 0.6 OUTLIER 75.43 160.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.035 1.334 . . . . 73.54 112.165 172.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.38 -42.61 0.12 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.247 1.419 . . . . 71.52 107.776 170.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 152.58 112.23 0.5 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.555 -0.618 . . . . 45.21 111.555 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . 0.527 ' ND2' ' HA ' ' E' ' 300' ' ' ASN . 38.2 m-80 -115.67 -2.71 12.4 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 117.166 0.483 . . . . 73.03 111.187 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.406 ' CD1' ' HB3' ' D' ' 35' ' ' ASP . 63.0 mt -72.86 89.16 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-O 121.976 0.893 . . . . 74.04 109.498 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -161.36 175.52 12.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.941 1.696 . . . . 70.23 106.852 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 67.14 127.04 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.895 0 C-N-CA 124.144 0.978 . . . . 74.52 111.913 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -61.52 156.37 47.4 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.702 2.268 . . . . 75.21 112.687 175.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -154.04 125.32 7.42 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.955 -0.757 . . . . 74.03 108.955 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 99.9 t 67.17 136.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.887 1.275 . . . . 72.12 111.885 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 38.8 m -140.58 143.87 35.53 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.453 -0.943 . . . . 72.52 108.453 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 11.3 p -58.55 140.27 54.47 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.811 0.844 . . . . 73.14 110.575 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 24.8 p -55.2 103.69 0.38 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.929 1.291 . . . . 72.4 112.192 -172.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' C' ' 150' ' ' GLU . 60.1 Cg_endo . . . . . 0 C--N 1.38 2.207 0 C-N-CA 123.204 2.603 . . . . 73.43 111.551 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.588 -0.523 . . . . 74.33 109.588 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 14.4 m120 60.31 36.49 20.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.397 1.079 . . . . 70.41 112.021 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -61.83 -24.25 66.76 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.216 0.607 . . . . 74.32 111.314 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -92.54 134.22 35.19 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 107.494 -1.298 . . . . 75.34 107.494 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -109.19 93.16 12.49 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.953 -0.758 . . . . 71.53 108.953 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -85.03 112.78 1.47 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.543 2.162 . . . . 75.23 111.401 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.17 -44.52 92.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.326 0.65 . . . . 74.34 110.23 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' H' ' 281' ' ' PHE . 1.9 tm? -58.48 118.07 5.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.156 0.982 . . . . 73.33 111.257 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -144.74 50.66 0.64 Allowed Glycine 0 C--N 1.345 1.06 0 O-C-N 123.842 0.714 . . . . 74.44 111.694 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . 0.598 HD23 ' HA ' ' B' ' 95' ' ' ALA . 47.8 tp -146.11 -59.64 0.31 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.828 0.451 . . . . 73.31 110.85 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . 0.561 ' HB2' HD11 ' H' ' 278' ' ' LEU . 38.4 m-85 -61.89 103.42 0.35 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.064 0.546 . . . . 75.45 110.926 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.81 -73.29 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.836 0.854 . . . . 61.42 108.714 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -133.89 -34.05 1.02 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.034 0.934 . . . . 70.34 110.297 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.63 93.24 0.37 Allowed Glycine 0 C--N 1.348 1.245 0 O-C-N 123.568 0.543 . . . . 74.04 112.739 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -124.27 154.18 40.61 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.83 0.852 . . . . 65.15 109.043 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -72.54 121.11 84.02 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.213 0.605 . . . . 75.1 109.502 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.45 99.87 0.45 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.28 1.987 . . . . 70.44 111.267 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.02 -33.23 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.335 1.054 . . . . 75.12 111.043 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 76.93 -20.03 0.4 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 125.086 1.354 . . . . 75.1 112.535 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 66.98 124.31 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.187 1.395 . . . . 74.01 109.845 -167.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.56 155.24 30.09 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.239 1.016 . . . . 71.21 112.105 -168.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -52.84 -59.59 9.1 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 124.653 1.221 . . . . 51.13 113.881 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.97 127.28 10.58 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.565 2.177 . . . . 73.51 111.474 170.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -94.12 112.66 24.5 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.612 -0.884 . . . . 75.02 108.612 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.14 -9.89 59.38 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.708 0.803 . . . . 71.44 112.169 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 296' ' ' THR . . . . . 0.474 ' HG1' HG11 ' B' ' 40' ' ' VAL . 4.7 m -70.92 130.24 41.12 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.396 1.078 . . . . 73.22 111.556 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 1.7 t80 59.62 98.94 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.398 1.479 . . . . 74.51 111.305 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -131.52 131.63 43.56 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.449 0.7 . . . . 73.21 109.384 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 109.39 170.41 20.49 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.476 -1.05 . . . . 65.4 110.476 -167.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -132.75 161.96 32.69 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.983 0.913 . . . . 75.11 108.981 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 67.9 mt -63.58 -58.91 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.628 -0.878 . . . . 74.34 108.628 172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 37.3 t70 61.94 -76.93 0.03 OUTLIER 'General case' 0 C--N 1.356 0.89 0 C-N-CA 126.005 1.722 . . . . 62.43 112.021 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -106.06 119.79 51.04 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.895 0.878 . . . . 72.2 109.202 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.33 85.97 0.16 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.73 2.287 . . . . 75.13 111.021 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.41 -9.96 59.04 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.962 0.905 . . . . 75.3 112.574 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.72 78.82 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 108.505 -0.924 . . . . 74.12 108.505 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 21.5 p -110.31 -178.14 3.43 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 114.289 -1.323 . . . . 74.13 109.957 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 74.6 m -58.43 120.17 8.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.182 0.593 . . . . 74.22 109.979 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 41.2 p -55.54 113.79 6.2 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.771 1.229 . . . . 74.44 111.429 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--N 1.38 2.233 0 C-N-CA 122.88 2.386 . . . . 71.05 112.509 -175.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.111 -0.7 . . . . 74.12 109.111 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 m -64.9 119.58 10.96 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.069 0.948 . . . . 74.4 111.118 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -87.9 0.08 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 106.908 -1.516 . . . . 71.53 106.908 170.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 61.04 11.67 3.53 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 114.758 1.392 . . . . 63.34 114.758 167.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -74.81 -28.68 60.81 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.873 0.469 . . . . 72.43 110.693 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.522 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 87.2 m-20 59.75 47.92 9.82 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.085 0.866 . . . . 73.44 111.608 172.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 p -78.13 -67.26 0.75 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.714 0.805 . . . . 75.33 111.798 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -90.67 3.18 54.91 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.339 0.656 . . . . 72.25 112.187 -171.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.522 ' SD ' ' HB3' ' A' ' 6' ' ' ASN . 17.7 ptm -58.28 133.78 55.98 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-O 121.526 0.679 . . . . 74.42 111.883 -172.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.9 m -151.06 140.17 21.15 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.7 -1.136 . . . . 55.45 108.391 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.505 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -134.25 134.87 42.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.168 -0.678 . . . . 73.4 109.168 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -152.39 117.71 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.89 -1.152 . . . . 75.45 107.89 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 51.5 mt -75.07 126.78 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.123 -0.695 . . . . 73.54 109.123 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -92.04 -37.93 12.52 Favored 'General case' 0 C--O 1.243 0.758 0 O-C-N 123.829 0.705 . . . . 74.14 110.793 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -176.92 127.92 0.17 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.78 0.675 . . . . 72.4 111.629 -173.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.52 136.62 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.328 -0.99 . . . . 70.12 108.328 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -170.02 156.45 6.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 73.42 111.226 -176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -82.27 113.55 20.16 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.801 -0.814 . . . . 71.53 108.801 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -75.04 -31.23 61.26 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.66 -0.496 . . . . 74.52 109.66 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -150.88 141.13 22.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.008 -0.996 . . . . 73.02 109.889 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -134.67 143.86 36.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 125.503 1.521 . . . . 65.21 107.167 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 35.9 t -153.02 132.83 13.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.841 0.856 . . . . 64.13 108.738 174.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.545 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 82.4 t80 -139.87 119.21 12.91 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.78 -1.563 . . . . 73.24 106.78 174.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.19 131.09 54.85 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.147 0.579 . . . . 72.33 109.869 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.62 77.67 63.8 Favored Pre-proline 0 C--O 1.243 0.761 0 N-CA-C 106.709 -1.589 . . . . 72.05 106.709 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.75 -39.89 24.46 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.519 2.146 . . . . 74.13 111.764 -173.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.13 25.38 5.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.353 -0.84 . . . . 70.43 110.154 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -57.09 9.22 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 117.565 -1.207 . . . . 65.11 113.458 -169.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.0 -21.78 68.33 Favored 'Trans proline' 0 C--N 1.398 3.135 0 CA-C-N 122.132 1.797 . . . . 72.3 112.804 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -85.07 -40.31 16.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.15 0.98 . . . . 74.4 110.643 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.702 HG22 ' HA ' ' A' ' 73' ' ' ALA . 5.9 p -76.92 -20.35 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.545 -0.752 . . . . 74.5 112.079 -159.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.5 ' HA ' HD13 ' E' ' 301' ' ' ILE . 38.5 m-85 -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.002 0.521 . . . . 74.1 112.231 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -103.9 -11.13 17.67 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.43 0.692 . . . . 73.55 112.755 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HE3' ' HG2' ' A' ' 71' ' ' GLU . 20.9 mmtt -65.4 171.1 4.18 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.136 0.974 . . . . 74.32 113.598 -170.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.12 122.05 5.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.181 1.393 . . . . 71.44 111.948 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -86.95 63.26 7.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.085 0.554 . . . . 75.42 110.241 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -147.38 82.31 8.27 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 123.871 0.868 . . . . 74.55 109.082 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' E' ' 294' ' ' LYS . 5.2 Cg_endo -84.47 165.52 12.39 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.98 2.454 . . . . 75.52 112.772 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.36 106.05 8.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.288 -1.375 . . . . 74.14 107.288 161.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 p -79.0 91.54 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 123.066 1.412 . . . . 74.35 108.467 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.61 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 40.6 tttm -83.7 118.15 23.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 113.924 -1.489 . . . . 73.51 109.89 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -97.22 111.35 23.63 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.388 -1.338 . . . . 70.42 107.388 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.639 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 19.6 m-20 -108.4 108.35 19.27 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.38 118.09 34.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.487 -1.301 . . . . 75.23 107.487 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.64 153.99 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.984 0.914 . . . . 64.43 109.074 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -135.16 156.61 48.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.07 0.948 . . . . 71.2 110.415 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.513 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -163.97 142.5 7.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 71.42 109.493 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.524 ' HB2' HD13 ' E' ' 278' ' ' LEU . 37.4 p -128.81 158.46 38.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.611 . . . . 60.43 109.532 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -154.85 136.77 14.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.933 0.893 . . . . 72.54 108.599 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -103.72 103.39 13.28 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.515 -0.92 . . . . 74.34 108.515 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.49 -31.21 37.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.339 0.655 . . . . 74.24 110.807 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -162.83 176.77 9.9 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.618 1.167 . . . . 72.12 109.243 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.69 135.91 54.75 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.091 -0.707 . . . . 74.43 109.091 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t70 69.36 -7.79 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.929 1.291 . . . . 72.22 111.975 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.446 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 90.9 t -119.88 98.24 6.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.667 0.787 . . . . 74.2 109.046 -172.516 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -120.57 125.28 47.4 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.734 -1.121 . . . . 74.23 108.386 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.78 131.48 39.1 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.921 0.888 . . . . 75.2 110.126 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.4 t -108.58 126.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.584 -1.265 . . . . 72.25 107.584 168.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.513 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 57.3 t -109.39 133.72 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.612 -0.884 . . . . 75.13 108.612 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -125.41 106.09 9.56 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.171 -1.418 . . . . 72.43 107.171 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.562 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 31.6 ttp180 -92.28 109.31 20.68 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 122.911 0.485 . . . . 73.04 109.745 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.69 126.84 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 106.934 -1.506 . . . . 73.22 106.934 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.639 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 98.0 m -123.82 123.26 40.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.498 -0.927 . . . . 54.53 108.498 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.558 HG12 HD21 ' A' ' 126' ' ' LEU . 69.8 t -116.51 108.25 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.184 0.994 . . . . 74.42 109.19 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.61 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 9.8 m -105.05 146.37 29.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.153 -0.684 . . . . 54.31 109.153 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 121.81 20.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.985 -1.117 . . . . 74.2 107.985 169.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.2 m -124.59 127.38 47.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.259 0.552 . . . . 73.32 110.86 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.67 85.26 7.05 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 126.134 1.773 . . . . 74.15 110.259 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.95 -80.88 1.55 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.897 -0.881 . . . . 73.22 110.897 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -130.75 -25.94 2.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.78 0.832 . . . . 74.1 110.83 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.477 ' HG2' ' HE3' ' A' ' 34' ' ' LYS . 7.8 tp10 -82.96 134.91 35.04 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.648 0.779 . . . . 75.51 110.795 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 90.8 m -79.54 139.29 37.59 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 118.738 0.699 . . . . 74.12 111.893 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.702 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -81.79 -68.49 0.69 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.169 0.988 . . . . 71.51 110.512 170.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -152.82 167.28 29.58 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.492 -0.777 . . . . 72.25 111.126 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 tp -141.39 142.95 33.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.639 1.175 . . . . 74.3 108.65 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.507 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.2 m -142.37 104.53 4.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.633 0.373 . . . . 71.5 111.154 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 7.0 mp0 -103.5 132.86 49.39 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.259 -0.645 . . . . 71.31 109.259 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -140.4 110.38 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.16 -0.681 . . . . 71.51 109.16 173.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.562 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.7 mt-30 -85.27 85.39 7.46 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.139 -1.06 . . . . 75.53 108.139 171.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -77.23 97.03 4.69 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.102 -0.954 . . . . 74.34 108.887 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.71 146.16 20.52 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.434 -0.803 . . . . 75.21 111.5 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.592 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -148.39 120.82 1.25 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 110.397 -1.081 . . . . 73.44 110.397 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.0 mt -83.03 122.94 38.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.646 -0.872 . . . . 73.55 108.646 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.505 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 49.9 m-85 -126.37 120.49 29.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.133 -0.692 . . . . 73.31 109.133 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.7 t -81.67 104.48 12.1 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.001 -1.111 . . . . 72.32 108.001 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 pt -137.9 149.41 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 73.3 110.598 -171.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -173.75 177.99 2.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.988 1.315 . . . . 65.31 109.512 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.18 10.27 71.75 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.553 0.533 . . . . 74.2 114.061 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.19 138.08 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.89 0.876 . . . . 74.13 109.749 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -130.39 170.15 14.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.234 0.614 . . . . 73.31 110.841 -173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.42 -117.04 2.2 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.176 0.923 . . . . 75.33 115.22 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -64.25 -26.9 68.71 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.133 0.973 . . . . 74.54 112.261 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.06 -44.01 55.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.607 0.763 . . . . 71.44 110.828 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -71.17 -34.16 70.69 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.706 -0.479 . . . . 64.43 109.706 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.401 ' HB3' HD21 ' E' ' 280' ' ' LEU . . . -67.28 -40.28 86.12 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.418 -0.81 . . . . 73.43 110.174 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -67.85 -29.6 68.77 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.154 -0.93 . . . . 75.21 110.444 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.537 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 29.6 t -66.79 -38.56 86.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.859 0.464 . . . . 74.33 110.957 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.66 HD21 HD22 ' E' ' 278' ' ' LEU . 74.6 mt -81.71 -43.57 18.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.493 0.317 . . . . 72.45 110.804 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.96 -20.69 77.5 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.709 0.644 . . . . 72.24 114.709 -171.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.58 -63.39 0.45 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.407 0.604 . . . . 61.21 112.56 -168.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.537 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 53.8 t80 -56.71 -64.45 0.87 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.529 1.532 . . . . 73.23 113.024 -167.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.417 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 90.9 m -77.42 -35.57 1.34 Allowed Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 114.426 1.269 . . . . 62.54 114.426 -173.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 55.6 Cg_endo -67.81 -20.08 46.22 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.022 1.815 . . . . 74.02 112.999 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.3 t30 -74.66 -18.09 60.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.217 0.607 . . . . 73.33 110.091 177.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.7 mm -74.85 -39.28 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.74 0.816 . . . . 72.35 109.281 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.592 HD23 ' HA3' ' A' ' 82' ' ' GLY . 87.1 mt -75.29 -37.87 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.294 1.038 . . . . 75.32 112.495 -173.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.421 ' HZ ' ' HG ' ' A' ' 128' ' ' LEU . 52.4 t80 -57.26 -43.13 99.01 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.04 1.126 . . . . 74.53 114.04 -169.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.99 -39.06 86.59 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.188 1.925 . . . . 72.35 113.726 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -76.77 -38.63 53.73 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.41 0.684 . . . . 74.11 111.904 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.67 94.9 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.847 -0.427 . . . . 74.51 109.847 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.406 ' NH2' ' HB3' ' A' ' 130' ' ' PRO . 33.8 ttm180 -57.71 -49.93 74.89 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.618 1.199 . . . . 75.54 110.278 177.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.74 -44.43 96.24 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.577 1.173 . . . . 75.01 110.905 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.45 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.6 t -56.72 -48.54 77.52 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.099 0.874 . . . . 74.43 110.23 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.2 mt -64.69 -42.26 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.263 0.977 . . . . 75.11 110.814 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.427 HG23 ' HE2' ' C' ' 109' ' ' TYR . 95.9 m -54.63 -48.04 72.75 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.562 0.745 . . . . 63.42 110.422 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.1 t -63.8 -46.05 86.9 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.306 -1.316 . . . . 74.35 109.838 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.545 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 20.1 mtp -57.64 -46.44 84.17 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.118 0.967 . . . . 72.32 112.115 178.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.5 HG22 HD22 ' A' ' 126' ' ' LEU . 89.0 t -63.27 -45.02 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.232 1.013 . . . . 75.25 110.283 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.2 t -66.19 -30.43 70.89 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.813 -1.085 . . . . 74.42 110.788 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.13 -28.6 60.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.702 0.801 . . . . 75.11 110.435 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 10.27 52.64 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 116.146 -0.479 . . . . 43.32 113.345 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.3 m 71.33 13.34 6.63 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.428 1.491 . . . . 71.11 112.122 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -96.16 145.8 30.19 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.732 -1.21 . . . . 73.14 107.732 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.43 ' HB2' ' HD2' ' G' ' 303' ' ' LYS . 36.7 Cg_endo -59.05 157.59 28.83 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.722 2.281 . . . . 75.52 112.213 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.412 ' OE1' ' HB ' ' C' ' 16' ' ' ILE . 2.4 tt0 -50.71 125.39 13.09 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 124.195 0.934 . . . . 63.22 111.28 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.558 HD21 HG12 ' A' ' 64' ' ' VAL . 17.9 tp -109.2 119.48 39.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.146 -0.934 . . . . 72.54 109.222 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -134.85 94.94 3.24 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.394 1.078 . . . . 70.04 108.18 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.421 ' HG ' ' HZ ' ' A' ' 107' ' ' PHE . 18.8 tp -62.12 131.78 50.64 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.027 -0.988 . . . . 74.42 109.723 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.91 129.27 47.57 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.266 1.027 . . . . 73.41 111.641 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.679 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 37.9 Cg_endo -67.16 104.19 0.84 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.397 2.064 . . . . 72.32 111.034 175.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.555 HG22 HG13 ' E' ' 288' ' ' VAL . 85.3 t -98.71 117.6 43.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.026 -1.102 . . . . 73.54 108.026 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' ND2' ' HB3' ' A' ' 135' ' ' ALA . 33.5 t30 -63.48 99.65 0.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.409 1.068 . . . . 70.23 109.475 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -67.1 -24.21 65.91 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.176 -0.466 . . . . 73.03 111.247 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -56.09 -47.79 77.35 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.896 0.878 . . . . 74.43 110.654 173.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.564 ' HB1' HG21 ' C' ' 7' ' ' THR . . . -57.82 -37.66 74.2 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.503 1.127 . . . . 72.22 112.679 -172.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.46 -37.9 85.3 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 120.925 0.393 . . . . 74.15 111.324 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -86.22 -29.9 22.8 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.548 0.739 . . . . 71.52 111.425 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 59.6 tpp -74.01 -39.89 63.31 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.826 0.851 . . . . 75.14 111.231 -171.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -56.13 -39.95 73.03 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.98 0.8 . . . . 72.15 110.458 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -76.27 -38.92 55.53 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.295 -0.866 . . . . 74.54 111.004 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.68 -50.95 69.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.87 0.468 . . . . 75.34 111.427 -170.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -178.31 12.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.237 0.961 . . . . 65.04 112.085 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 65.74 144.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.967 1.307 . . . . 75.35 112.562 -173.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.04 143.66 32.32 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.73 0.812 . . . . 72.33 112.059 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -168.86 177.88 4.82 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 125.34 1.456 . . . . 53.23 108.647 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.53 174.92 21.31 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 116.125 -0.489 . . . . 62.53 112.421 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -137.76 -173.44 3.5 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.13 0.972 . . . . 75.15 109.03 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.46 67.58 0.55 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.654 -0.978 . . . . 54.0 110.654 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.3 t -76.31 151.58 36.68 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.052 0.541 . . . . 75.52 110.17 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -70.75 125.42 26.78 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.279 0.632 . . . . 72.11 110.456 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -81.83 68.05 8.05 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.18 0.99 . . . . 73.32 110.859 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -132.23 106.17 7.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.608 0.763 . . . . 75.5 109.56 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -158.88 52.14 0.4 Allowed 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.901 -1.148 . . . . 74.53 107.901 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -160.45 133.64 6.69 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.48 -0.782 . . . . 72.14 110.878 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.988 0 C-N-CA 123.488 0.715 . . . . 74.23 109.095 170.721 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.9 ttp . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.643 -0.502 . . . . 75.31 109.643 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -150.28 123.99 9.18 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.935 0.894 . . . . 55.4 109.593 -174.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -95.0 -60.26 1.72 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.198 0.599 . . . . 73.1 109.977 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -74.68 81.14 2.04 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.613 0.765 . . . . 72.32 109.778 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -155.15 144.02 20.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.042 0.937 . . . . 73.42 108.903 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -78.63 76.4 5.13 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.417 0.687 . . . . 54.33 110.122 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -106.8 -34.04 7.38 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.183 0.993 . . . . 64.4 110.832 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.3 -25.73 61.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.316 0.647 . . . . 71.02 110.615 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.604 ' HB3' HG21 ' B' ' 89' ' ' ILE . 0.9 OUTLIER 56.25 -165.85 0.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 126.005 1.722 . . . . 74.3 113.106 177.275 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.693 HG21 HE22 ' B' ' 12' ' ' GLN . 41.4 m -149.28 120.83 7.98 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.111 0.964 . . . . 74.44 108.923 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.96 138.61 51.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.525 0.73 . . . . 64.45 109.734 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.693 HE22 HG21 ' B' ' 10' ' ' THR . 0.0 OUTLIER -152.53 135.47 15.56 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.346 0.658 . . . . 71.13 110.116 168.223 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.46 118.38 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.331 1.053 . . . . 72.23 108.549 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.589 ' HB3' ' HB3' ' E' ' 304' ' ' PRO . 76.4 mm-40 -82.5 -39.12 22.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.659 0.384 . . . . 73.41 111.655 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.524 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 28.4 ttm180 -166.28 145.86 5.99 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.51 0.724 . . . . 75.24 110.258 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.456 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 86.6 mt -119.54 145.88 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.44 -1.689 . . . . 74.52 106.44 166.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.524 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 35.1 p90 -170.03 163.85 9.37 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.935 0.874 . . . . 75.32 111.977 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 71.5 m -92.01 122.79 34.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.612 -1.176 . . . . 75.4 109.072 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -89.12 -37.93 14.7 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.87 0.868 . . . . 74.21 110.043 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -155.82 143.77 19.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.102 -0.499 . . . . 73.44 110.766 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.4 mm -134.76 139.18 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.914 1.286 . . . . 74.15 108.201 176.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.554 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -140.72 132.08 26.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.018 -1.105 . . . . 75.34 108.018 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.443 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -147.03 114.81 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.608 -1.256 . . . . 75.22 107.608 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.58 130.72 56.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.851 0.86 . . . . 74.41 108.989 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.8 83.43 65.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 106.847 -1.538 . . . . 71.15 106.847 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -68.7 -32.81 22.92 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.923 2.415 . . . . 73.12 111.971 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -106.6 25.8 10.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.88 1.272 . . . . 72.34 110.206 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.68 -50.01 44.36 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 115.558 1.688 . . . . 73.22 115.558 -168.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.8 -33.98 4.45 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.232 1.476 . . . . 74.41 112.505 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.404 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.1 m80 -82.99 -22.51 33.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.645 0.778 . . . . 72.45 112.283 -169.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.401 HG11 ' HZ ' ' B' ' 123' ' ' PHE . 4.6 p -67.93 -4.38 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 124.391 1.076 . . . . 70.52 111.963 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -56.49 -27.49 57.27 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.758 0.823 . . . . 75.34 110.931 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.565 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -76.86 -34.99 57.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.65 0.38 . . . . 74.04 110.737 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 98.9 mttt -109.99 77.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.565 0.746 . . . . 72.31 112.313 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.12 82.76 1.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.628 -1.249 . . . . 71.15 107.628 163.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -148.62 160.15 43.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.156 -1.424 . . . . 75.42 107.156 -171.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.418 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 23.9 pt20 -53.6 102.22 0.3 Allowed Pre-proline 0 CA--C 1.564 1.494 0 O-C-N 124.376 1.047 . . . . 73.41 111.7 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.52 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 6.1 Cg_endo -85.93 170.21 8.67 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.807 2.338 . . . . 73.43 112.305 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -80.9 100.65 8.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 106.344 -1.724 . . . . 74.22 106.344 165.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -114.74 142.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.923 0.889 . . . . 74.43 108.72 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.603 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 27.9 ttpt -136.72 136.63 39.17 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.496 0.718 . . . . 73.33 109.377 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.573 HD12 HD11 ' B' ' 128' ' ' LEU . 4.6 tt -85.6 127.46 34.47 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 106.28 -1.748 . . . . 75.32 106.28 165.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.603 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 12.6 t70 -122.27 110.61 15.9 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.358 -1.349 . . . . 74.3 107.358 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.427 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 3.5 pp -100.22 137.45 38.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.438 0.695 . . . . 75.23 109.292 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 32.9 t70 -124.23 135.85 53.72 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.972 -0.751 . . . . 65.12 108.972 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.04 110.15 21.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.899 0.879 . . . . 72.12 110.402 -171.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.97 140.26 52.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.514 0.726 . . . . 63.53 109.213 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 75.6 m -144.07 165.2 28.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.777 0.831 . . . . 74.31 110.199 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.4 p -152.0 162.23 41.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.398 1.079 . . . . 73.1 109.033 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -106.78 112.88 26.06 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.346 -0.613 . . . . 74.32 109.346 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.461 HD12 HG23 ' B' ' 83' ' ' ILE . 89.9 mt -80.99 -40.71 23.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.827 0.451 . . . . 71.31 110.327 176.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.95 -172.91 4.11 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.27 0.628 . . . . 72.25 110.575 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.06 116.03 4.98 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.442 -1.254 . . . . 75.42 109.774 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 71.33 -3.41 2.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.775 1.63 . . . . 65.1 112.636 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.52 113.38 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.96 -0.755 . . . . 73.33 108.96 -175.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.77 137.8 53.73 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.177 -0.919 . . . . 74.43 109.428 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -100.57 98.16 8.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.976 -1.49 . . . . 72.23 106.976 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.11 128.61 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.734 1.214 . . . . 70.44 109.644 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 36.3 t -119.21 143.06 31.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.757 1.223 . . . . 75.52 108.957 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.43 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -136.7 111.75 8.97 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.727 -1.212 . . . . 73.21 107.727 171.243 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.558 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -86.12 122.67 30.46 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.155 -0.683 . . . . 75.21 109.155 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.81 103.23 15.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.92 -1.141 . . . . 74.54 107.92 173.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.7 m -103.79 129.89 51.26 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.42 -0.585 . . . . 64.45 109.42 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.423 HG23 HD12 ' B' ' 114' ' ' ILE . 61.3 t -115.0 100.99 11.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 109.248 -0.649 . . . . 74.45 109.248 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.3 m -97.8 138.06 35.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.068 -0.969 . . . . 71.32 109.146 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.77 149.76 34.97 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.881 0.472 . . . . 63.31 110.347 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -149.18 141.92 24.57 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.541 -0.754 . . . . 71.04 110.544 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.0 mt -125.55 110.4 13.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.685 1.194 . . . . 71.21 108.663 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.23 -123.39 6.3 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.627 -0.715 . . . . 75.45 111.489 -174.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -108.42 2.44 22.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.116 0.967 . . . . 73.43 109.983 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.23 -179.44 3.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.748 0.819 . . . . 74.02 110.344 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -77.09 155.21 32.59 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.744 1.218 . . . . 75.2 110.703 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.08 -50.3 3.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.611 -0.885 . . . . 74.32 108.611 167.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -166.83 152.79 8.17 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.822 -1.081 . . . . 72.31 108.812 167.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -123.54 124.45 42.86 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.165 -1.05 . . . . 72.13 108.165 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.2 t -142.08 157.14 45.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.219 0.608 . . . . 74.35 109.536 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.554 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.5 tt0 -164.42 141.56 6.53 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.851 0.86 . . . . 74.44 109.121 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -134.22 143.81 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.677 -1.231 . . . . 70.23 107.677 170.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.5 96.53 5.24 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.952 -1.129 . . . . 75.41 107.952 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.415 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.5 tp-100 -91.34 101.59 14.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.367 -0.975 . . . . 71.01 108.367 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.38 167.55 32.77 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.143 -0.935 . . . . 71.14 110.881 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.16 127.56 1.65 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.562 -0.615 . . . . 74.22 111.562 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.461 HG23 HD12 ' B' ' 51' ' ' LEU . 46.8 mt -85.61 124.5 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 75.02 108.062 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.67 159.14 38.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.069 0.948 . . . . 72.43 108.699 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 17.1 m -132.14 120.38 22.2 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.379 -0.971 . . . . 70.31 108.379 172.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 pt -133.75 138.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.47 1.108 . . . . 72.11 109.367 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -151.4 155.65 39.06 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.649 0.78 . . . . 71.53 110.158 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.32 -71.17 0.2 Allowed Glycine 0 C--N 1.341 0.822 0 O-C-N 123.703 0.627 . . . . 63.14 112.469 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.604 HG21 ' HB3' ' B' ' 9' ' ' MET . 32.6 pt -81.95 159.49 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 122.98 0.512 . . . . 74.01 110.942 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -153.56 156.93 38.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.666 -0.697 . . . . 72.31 110.16 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.47 -114.76 6.49 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.329 0.49 . . . . 73.23 113.539 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -67.14 -39.0 86.48 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.981 0.912 . . . . 63.12 111.536 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.87 -50.71 65.53 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.023 -0.989 . . . . 73.23 110.311 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.428 ' HG3' HD22 ' H' ' 277' ' ' LEU . 0.0 OUTLIER -74.96 -24.92 58.54 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.545 -0.752 . . . . 74.44 111.638 -175.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.401 ' HB3' HD21 ' H' ' 280' ' ' LEU . . . -58.7 -31.36 68.17 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.729 0.812 . . . . 71.13 111.792 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.405 ' HE2' ' HB3' ' B' ' 134' ' ' ASP . 41.3 t-80 -69.75 -46.47 65.79 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.941 -0.572 . . . . 72.32 110.689 173.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.483 ' SG ' ' HE1' ' B' ' 9' ' ' MET . 54.1 t -73.38 -32.52 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.327 0.651 . . . . 74.04 112.465 -174.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -96.6 -39.23 9.62 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.858 0.863 . . . . 73.21 109.447 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.31 -25.57 43.18 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 114.693 0.637 . . . . 63.53 114.693 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -49.45 2.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.888 0.475 . . . . 55.31 111.334 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -79.21 -42.43 26.04 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.536 0.569 . . . . 74.15 112.536 -169.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.17 -45.46 79.17 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 118.416 -0.802 . . . . 73.52 112.016 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 47.2 Cg_exo -60.89 -31.44 91.58 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 122.427 2.084 . . . . 73.31 113.148 171.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.51 -34.87 77.75 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.707 0.803 . . . . 73.44 110.94 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.74 -44.47 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.431 0.692 . . . . 75.23 110.628 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.96 -24.99 59.71 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 123.607 0.567 . . . . 73.45 111.846 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -56.86 -52.68 72.01 Favored Pre-proline 0 CA--C 1.557 1.233 0 CA-C-O 117.029 -1.463 . . . . 74.05 113.494 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.92 -34.61 67.24 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.582 2.188 . . . . 74.12 113.976 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.502 ' HE2' HG22 ' D' ' 115' ' ' THR . 80.0 m-85 -72.76 -48.81 35.22 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.44 0.696 . . . . 74.52 110.218 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.16 80.99 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.749 -0.66 . . . . 74.21 110.439 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -63.38 -52.49 61.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.831 1.652 . . . . 73.43 110.987 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -38.44 89.89 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.973 0.796 . . . . 74.13 109.286 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.503 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.2 t -65.46 -37.63 87.43 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.042 0.537 . . . . 62.33 111.186 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.423 HD12 HG23 ' B' ' 64' ' ' VAL . 76.3 mt -64.08 -49.12 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.387 0.675 . . . . 75.42 109.587 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -61.44 -30.16 70.41 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.634 0.773 . . . . 73.14 111.231 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -69.47 -44.43 71.2 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.528 0.731 . . . . 63.12 109.146 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.503 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -68.1 -29.34 68.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.942 0.497 . . . . 75.1 111.124 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.471 HG22 HD21 ' B' ' 126' ' ' LEU . 78.7 t -69.34 -41.18 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.096 0.959 . . . . 75.25 110.015 173.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -67.66 -28.35 67.63 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.994 0.918 . . . . 70.21 111.724 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.45 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 73.5 mtt-85 -79.41 -35.72 40.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.52 0.728 . . . . 73.23 110.044 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.35 3.75 71.2 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.022 -0.536 . . . . 55.14 112.72 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 45.7 p 59.67 56.11 3.73 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.953 1.701 . . . . 74.3 112.744 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.401 ' HZ ' HG11 ' B' ' 31' ' ' VAL . 44.1 m-85 -119.49 157.9 50.48 Favored Pre-proline 0 N--CA 1.48 1.053 0 C-N-CA 124.192 0.997 . . . . 73.4 109.835 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.28 -173.83 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.78 2.32 . . . . 71.22 113.884 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.442 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -59.37 116.59 4.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.645 1.178 . . . . 74.23 112.41 -172.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.471 HD21 HG22 ' B' ' 118' ' ' VAL . 43.8 tp -123.06 93.7 4.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.473 0.709 . . . . 74.22 109.811 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -92.09 126.87 37.34 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.1 -1.074 . . . . 74.41 108.1 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.573 HD11 HD12 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -73.28 129.35 37.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.133 -1.062 . . . . 72.04 108.133 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.53 129.66 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.353 0.661 . . . . 73.13 111.073 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.568 ' HG3' HD12 ' D' ' 16' ' ' ILE . 68.0 Cg_endo -68.38 130.95 22.12 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.544 2.163 . . . . 74.41 112.115 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.454 HG21 HD13 ' H' ' 291' ' ' LEU . 21.8 t -115.71 114.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.532 0.733 . . . . 73.04 109.435 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -85.22 98.11 10.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -74.52 -34.14 62.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.731 0.812 . . . . 74.33 110.811 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.405 ' HB3' ' HE2' ' B' ' 96' ' ' HIS . 4.3 m-20 -59.42 -51.63 69.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.857 1.263 . . . . 74.5 111.194 -174.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -43.76 98.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.454 1.102 . . . . 75.53 111.466 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.11 -43.66 97.83 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.033 0.933 . . . . 75.53 110.238 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -69.41 -24.82 63.89 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.964 0.906 . . . . 73.41 111.803 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.477 ' HA ' ' HE1' ' B' ' 138' ' ' MET . 31.3 mmt -67.67 -31.99 72.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.846 0.458 . . . . 75.03 111.668 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -74.76 -29.02 61.0 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.097 0.559 . . . . 71.13 110.199 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.89 -28.58 69.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.491 0.716 . . . . 74.14 111.07 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.95 16.52 23.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.477 0.711 . . . . 73.04 111.727 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -73.1 111.73 8.49 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.9 0.48 . . . . 72.01 111.533 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -169.12 138.07 2.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.45 1.1 . . . . 64.53 108.799 171.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -108.31 -55.68 2.35 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.238 0.615 . . . . 74.34 110.405 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.55 -175.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.704 1.202 . . . . 65.51 112.819 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.08 92.59 0.2 Allowed Glycine 0 C--N 1.353 1.488 0 N-CA-C 112.109 -0.397 . . . . 74.52 112.109 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.78 161.32 39.77 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.693 0.797 . . . . 75.03 110.928 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.23 107.55 3.2 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.359 -0.837 . . . . 43.42 112.234 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 3.6 p -133.84 102.47 5.46 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.193 0.997 . . . . 75.13 109.406 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -80.77 88.68 5.79 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.69 -0.856 . . . . 75.11 108.69 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.0 -17.7 59.58 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.242 -0.89 . . . . 75.44 111.1 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -64.18 131.21 46.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.924 0.89 . . . . 75.4 110.608 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -156.4 116.3 3.58 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.279 -1.008 . . . . 74.45 108.279 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -154.29 163.59 39.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.483 0.713 . . . . 75.21 109.838 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.886 0 N-CA-C 108.44 -0.948 . . . . 75.32 108.44 178.368 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.583 -0.525 . . . . 73.43 109.583 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 34.6 p -80.2 94.49 6.06 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.122 -0.696 . . . . 72.43 109.122 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.55 116.1 6.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.121 -0.945 . . . . 72.21 110.426 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -65.3 152.36 43.96 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.478 0.711 . . . . 71.14 111.185 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -120.42 163.21 18.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.449 0.7 . . . . 72.31 109.906 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . 0.533 HD21 ' HG2' ' G' ' 310' ' ' PRO . 9.2 m120 -112.52 97.54 6.67 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.138 -1.06 . . . . 71.31 108.138 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 7' ' ' THR . . . . . 0.564 HG21 ' HB1' ' A' ' 135' ' ' ALA . 80.6 p -76.59 -66.09 0.85 Allowed 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.721 -0.672 . . . . 64.42 109.268 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 177.74 143.11 0.1 Allowed 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.017 1.727 . . . . 75.01 107.72 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.606 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.1 tmm? 64.71 115.48 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.587 1.155 . . . . 73.01 112.701 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -91.28 98.65 11.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.584 0.754 . . . . 75.02 109.926 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.606 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 50.0 t80 -97.13 142.14 29.41 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.322 0.649 . . . . 74.13 109.474 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -156.81 144.55 19.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.267 0.627 . . . . 73.32 109.327 166.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.91 137.57 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.298 -1.001 . . . . 73.12 108.298 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -95.89 -50.15 5.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.488 -0.56 . . . . 73.52 109.488 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -164.23 124.25 2.05 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.889 -0.596 . . . . 75.22 110.72 -169.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . 0.412 ' HB ' ' OE1' ' A' ' 125' ' ' GLN . 64.9 mt -109.7 130.72 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.532 -1.285 . . . . 73.44 107.532 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.473 ' HB3' HG21 ' D' ' 122' ' ' THR . 20.8 p90 -163.05 149.58 12.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.776 0.798 . . . . 75.21 111.947 -172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -77.93 103.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.933 -1.136 . . . . 71.21 107.933 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -70.87 -28.81 64.84 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.818 -0.438 . . . . 72.53 109.818 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.0 t70 -148.91 143.14 26.03 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.216 -0.902 . . . . 71.41 109.853 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.542 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -138.05 145.17 29.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.631 1.572 . . . . 74.35 106.76 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -158.4 152.19 23.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.279 0.562 . . . . 72.11 110.133 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -148.14 133.29 18.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.254 -1.388 . . . . 64.22 107.254 173.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 49.0 mt-10 -125.14 132.84 53.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.853 -0.795 . . . . 74.42 108.853 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.39 77.67 5.94 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.085 0.954 . . . . 74.12 108.806 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 -22.12 17.92 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.096 1.864 . . . . 72.52 111.319 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -99.91 28.58 4.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.51 1.124 . . . . 74.3 110.816 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.68 97.12 Favored Pre-proline 0 CA--C 1.569 1.673 0 C-N-CA 123.951 0.9 . . . . 71.33 112.925 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.97 -25.83 8.5 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 121.433 1.422 . . . . 75.4 112.048 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -69.41 -21.37 63.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.077 1.351 . . . . 73.04 112.063 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 p -51.4 -29.98 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 113.018 0.748 . . . . 73.12 113.018 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -70.94 -34.53 71.56 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.339 0.656 . . . . 73.35 111.842 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -93.62 6.05 49.57 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.448 0.699 . . . . 74.04 111.015 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.598 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 2.9 ttmp? -90.95 147.76 22.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.277 0.631 . . . . 75.13 111.486 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.77 135.76 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.795 1.638 . . . . 75.51 110.148 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -81.79 79.38 8.36 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 122.122 -0.362 . . . . 74.55 110.182 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.407 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 4.7 tp-100 -153.0 55.66 1.48 Allowed Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.693 0.397 . . . . 75.23 111.216 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' C' ' 37' ' ' GLN . 17.3 Cg_endo -90.47 144.23 3.85 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.06 1.84 . . . . 73.32 112.226 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -86.3 83.73 7.63 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.227 -1.397 . . . . 74.01 107.227 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.406 HG12 ' HG1' ' F' ' 296' ' ' THR . 2.9 p -76.97 99.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.882 -1.053 . . . . 72.35 108.693 174.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.551 ' HZ2' ' HB3' ' C' ' 41' ' ' LYS . 6.4 ttpm? -125.21 140.65 52.67 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.66 -1.154 . . . . 74.2 108.652 -175.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.58 HD12 HD11 ' C' ' 128' ' ' LEU . 2.6 pt? -87.75 163.47 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.252 0.549 . . . . 74.43 110.089 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.545 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.1 t70 -148.18 145.41 28.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.36 1.064 . . . . 72.44 108.145 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 41.1 tp -130.78 135.51 47.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.734 -0.469 . . . . 72.43 109.734 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.672 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 3.9 m-20 -118.61 142.29 47.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.918 0.887 . . . . 73.41 108.82 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.8 p -114.26 113.98 25.34 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.132 0.973 . . . . 73.44 109.561 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.89 141.97 38.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.556 0.742 . . . . 65.55 110.171 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -145.78 154.29 41.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.251 0.621 . . . . 70.03 110.547 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.9 p -144.61 131.51 20.29 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.936 0.894 . . . . 64.02 108.644 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . 0.446 ' HB3' ' HA ' ' F' ' 271' ' ' ALA . 59.5 tt0 -79.21 116.67 19.62 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.268 -0.641 . . . . 73.12 109.268 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.575 HD12 ' HB2' ' C' ' 57' ' ' GLU . 32.1 mt -93.3 -32.24 14.39 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.387 -0.824 . . . . 72.23 109.684 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.77 -177.03 5.28 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.153 -0.93 . . . . 71.51 110.387 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.98 128.05 34.5 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.638 -1.164 . . . . 70.03 108.97 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.48 -7.1 0.73 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.201 1.4 . . . . 73.31 113.183 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.94 112.93 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.607 0.763 . . . . 75.25 109.462 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -129.28 133.87 47.68 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.84 -1.073 . . . . 75.24 108.382 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.575 ' HB2' HD12 ' C' ' 51' ' ' LEU . 37.3 tt0 -83.31 115.67 22.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.919 -0.771 . . . . 72.05 108.919 173.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.52 118.11 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.017 -1.105 . . . . 75.44 108.017 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.73 127.75 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 122.867 0.467 . . . . 72.34 110.062 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.527 HD21 HD11 ' C' ' 106' ' ' LEU . 3.6 mm? -120.94 112.62 18.99 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.138 -1.06 . . . . 73.12 108.138 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.672 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 35.4 ttm180 -82.06 110.82 17.64 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.701 -0.851 . . . . 73.51 108.701 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.7 t -99.94 112.27 31.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.048 -1.093 . . . . 65.43 108.048 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.545 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.2 m -114.67 142.13 46.89 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.791 -1.095 . . . . 62.12 108.114 -175.034 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 87.4 t -136.02 108.34 7.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.817 -1.179 . . . . 64.04 107.817 178.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.0 m -108.68 142.31 39.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.287 -0.634 . . . . 73.52 109.287 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.81 113.12 11.92 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.705 -1.22 . . . . 65.4 107.705 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.7 m -142.46 150.7 40.9 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.236 0.541 . . . . 63.34 111.076 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.21 19.04 15.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.615 1.566 . . . . 74.15 109.849 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.48 -108.73 1.3 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 110.416 -1.074 . . . . 63.12 110.416 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -89.9 -33.09 16.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.282 -1.007 . . . . 74.52 108.282 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.85 102.83 0.38 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.975 1.31 . . . . 64.32 109.953 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -88.59 129.67 35.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.923 0.329 . . . . 65.13 110.255 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.598 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -73.54 -59.79 2.55 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 173.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -173.09 174.55 3.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.211 0.945 . . . . 75.12 110.534 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.537 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -134.96 145.27 47.99 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.047 -1.464 . . . . 74.32 107.047 172.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.3 t -151.71 121.45 7.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.884 -1.154 . . . . 75.32 107.884 177.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.41 130.3 18.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.902 0.382 . . . . 65.32 110.141 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.31 115.43 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.925 1.29 . . . . 71.04 108.716 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.0 mt-30 -89.09 88.78 7.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.849 -1.167 . . . . 72.55 107.849 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.49 112.35 17.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.623 -1.171 . . . . 71.45 109.664 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.39 148.32 18.31 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 111.269 -0.733 . . . . 73.13 111.269 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.417 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -144.3 130.97 4.17 Favored Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 111.398 -0.681 . . . . 74.24 111.398 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.576 HD11 ' HB3' ' D' ' 29' ' ' PRO . 13.7 mm -84.52 120.87 35.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.439 -0.949 . . . . 73.51 108.439 174.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -130.98 139.88 50.07 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.402 0.681 . . . . 74.14 109.474 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 m -110.49 109.03 19.23 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.765 -0.828 . . . . 72.1 108.765 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.477 ' HB ' ' HE2' ' C' ' 94' ' ' MET . 3.9 mp -115.33 122.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.141 -1.059 . . . . 75.22 108.141 178.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.78 170.32 12.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.188 0.995 . . . . 75.24 110.187 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.81 -60.61 0.33 Allowed Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.968 -0.56 . . . . 64.11 112.803 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -122.71 -176.65 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 117.084 0.442 . . . . 72.12 111.446 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.93 -171.98 3.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.144 0.977 . . . . 70.32 109.472 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.36 -148.94 41.44 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 116.157 -0.474 . . . . 71.55 113.8 173.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.5 p -63.32 -26.98 69.02 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.382 1.073 . . . . 41.11 112.052 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -64.71 -54.29 33.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.352 1.061 . . . . 74.42 110.655 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.477 ' HE2' ' HB ' ' C' ' 86' ' ' ILE . 1.2 tmt? -70.0 -38.14 75.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.283 -0.872 . . . . 73.32 109.974 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.502 ' HB2' ' HB3' ' F' ' 280' ' ' LEU . . . -67.47 -22.74 65.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 73.51 112.071 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -71.79 -41.59 68.13 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.778 -0.453 . . . . 75.43 109.778 171.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.65 -31.5 69.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.137 0.494 . . . . 71.44 110.657 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.539 ' HG ' ' HG ' ' F' ' 278' ' ' LEU . 1.3 tm? -80.54 -48.73 12.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.427 1.091 . . . . 75.55 109.901 -176.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.15 9.53 67.64 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.355 -0.839 . . . . 72.32 114.283 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.13 -51.72 0.24 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.442 0.621 . . . . 74.23 111.607 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.679 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 46.8 t80 -74.77 -41.98 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.534 0.333 . . . . 75.15 111.412 -176.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.444 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 68.8 m -66.93 -45.14 53.57 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 118.373 -0.823 . . . . 64.15 111.726 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.424 ' HG3' HD23 ' C' ' 60' ' ' LEU . 92.7 Cg_exo -50.2 -38.93 52.11 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.933 2.422 . . . . 75.53 114.017 168.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -61.74 -34.41 75.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.294 0.638 . . . . 74.1 111.992 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.34 -42.77 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.927 -0.397 . . . . 73.51 109.927 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.527 HD11 HD21 ' C' ' 60' ' ' LEU . 85.5 mt -76.03 -26.9 57.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.69 -0.686 . . . . 75.34 112.015 -174.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.83 -52.75 69.77 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 117.703 -1.141 . . . . 74.34 113.493 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.61 -32.66 93.63 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.177 1.918 . . . . 73.02 113.327 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.427 ' HE2' HG23 ' A' ' 115' ' ' THR . 67.9 m-85 -70.88 -44.44 66.32 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 70.35 110.819 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.3 -45.6 93.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.811 -0.631 . . . . 62.22 109.691 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.6 ttt-85 -56.28 -47.21 79.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.055 1.342 . . . . 72.2 111.652 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.9 -36.51 78.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.668 0.605 . . . . 75.0 109.732 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.7 t -68.2 -35.13 77.51 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.391 0.676 . . . . 73.23 111.103 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 60.6 mt -72.15 -47.91 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.673 0.789 . . . . 74.1 109.974 177.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -64.4 -31.42 72.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.468 0.707 . . . . 74.12 110.825 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -66.38 -47.72 72.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.413 -0.812 . . . . 73.54 109.462 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.538 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.3 -36.61 84.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.45 0.7 . . . . 74.55 112.428 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -64.44 -37.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.21 0.604 . . . . 61.33 109.786 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.2 t -68.53 -35.1 76.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.437 0.695 . . . . 75.33 111.584 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 76.3 mtt-85 -70.67 -35.58 72.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.731 0.812 . . . . 74.11 110.428 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.27 4.61 80.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.893 -0.594 . . . . 73.41 113.046 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.2 p 60.96 35.19 19.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.768 1.627 . . . . 73.04 112.372 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -105.01 150.75 39.1 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.557 1.143 . . . . 61.33 110.05 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.558 ' HG2' ' HA ' ' F' ' 297' ' ' TYR . 76.5 Cg_exo -53.92 110.31 0.49 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.397 2.731 . . . . 53.23 113.001 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -60.34 144.46 50.63 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.507 1.13 . . . . 74.13 111.224 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.99 124.14 11.47 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.72 -1.585 . . . . 74.14 106.72 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -90.76 130.41 36.74 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.892 -0.781 . . . . 71.2 108.892 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.58 HD11 HD12 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -64.62 131.74 47.82 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.427 -0.953 . . . . 74.5 108.427 177.714 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.5 ' HB1' HG12 ' H' ' 306' ' ' VAL . . . -60.06 140.19 90.74 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.971 0.909 . . . . 71.04 111.334 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 103.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.18 2.587 . . . . 75.15 112.708 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.28 108.33 21.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 N-CA-C 108.319 -0.993 . . . . 73.51 108.319 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -96.49 92.2 6.16 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.319 -0.855 . . . . 74.55 109.156 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -61.51 -39.19 90.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.218 -0.901 . . . . 73.23 110.475 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -69.32 -38.85 78.41 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.173 0.989 . . . . 75.42 112.031 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -77.66 -26.22 50.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.126 -0.943 . . . . 75.42 111.768 -173.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.42 HD11 ' HG3' ' F' ' 286' ' ' MET . 76.2 mt -59.75 -36.96 77.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 123.854 0.721 . . . . 74.22 111.837 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -62.39 -44.12 97.21 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.033 0.533 . . . . 71.13 111.333 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 59.4 mtt -73.61 -29.38 62.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.892 0.877 . . . . 74.4 111.032 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -68.28 -40.62 81.78 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.022 1.329 . . . . 73.34 111.111 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -70.67 -88.23 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.345 -0.613 . . . . 74.32 109.345 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.17 120.27 41.88 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 109.111 -0.7 . . . . 72.22 109.111 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -82.65 172.58 12.78 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.441 0.696 . . . . 74.5 110.832 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.2 pm0 -135.41 151.43 50.44 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.432 0.693 . . . . 75.22 110.441 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -83.79 157.08 22.21 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.481 -0.782 . . . . 63.03 110.187 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.47 166.01 13.64 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.859 0.863 . . . . 74.2 109.597 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.32 -179.44 23.32 Favored Glycine 0 N--CA 1.472 1.064 0 CA-C-O 120.151 -0.249 . . . . 64.23 113.048 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 66.99 155.09 0.1 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.263 1.425 . . . . 72.43 111.567 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.15 151.88 23.2 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 112.083 -0.407 . . . . 73.14 112.083 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -156.76 154.62 30.26 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.804 0.842 . . . . 73.43 109.334 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.65 98.26 1.92 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.309 0.643 . . . . 73.43 110.276 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.37 130.15 18.13 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.586 -1.264 . . . . 74.11 107.586 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -160.65 66.81 0.32 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.929 -1.137 . . . . 74.22 107.929 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -64.44 95.25 0.13 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.581 -0.736 . . . . 73.45 110.145 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.44 98.08 11.18 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 109.022 -0.732 . . . . 73.52 109.022 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 N-CA-C 108.17 -1.048 . . . . 52.4 108.17 178.874 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' D' ' 138' ' ' MET . 53.4 ttp . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.097 -0.705 . . . . 72.25 109.097 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 69.33 -167.04 0.18 Allowed 'General case' 0 C--O 1.253 1.279 0 C-N-CA 124.891 1.276 . . . . 72.42 110.253 -172.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . 0.455 ' HB3' HE22 ' D' ' 93' ' ' GLN . 44.9 mm-40 64.48 -153.92 0.3 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.824 0.85 . . . . 72.24 110.79 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 76.29 0.6 3.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.096 1.358 . . . . 71.01 110.843 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -82.13 134.63 35.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.953 0.901 . . . . 75.13 109.321 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.49 95.24 6.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.434 0.694 . . . . 75.34 110.637 -174.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 90.6 m -74.07 72.89 1.69 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.532 0.733 . . . . 73.32 109.562 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 56.31 12.89 1.1 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.662 1.185 . . . . 63.54 112.362 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ttp -33.93 126.24 0.43 Allowed 'General case' 0 C--N 1.365 1.242 0 C-N-CA 126.115 1.766 . . . . 75.12 112.968 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.7 m -106.35 136.85 45.37 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.801 -0.814 . . . . 74.54 108.801 173.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' D' ' 85' ' ' SER . 23.4 t80 -160.23 110.73 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.592 -2.003 . . . . 73.34 105.592 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -130.98 114.79 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.921 -0.77 . . . . 74.52 108.921 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.77 123.18 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.854 0.359 . . . . 74.41 110.141 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.08 -40.4 12.3 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.346 -0.843 . . . . 73.44 109.712 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.49 ' HB3' ' HD1' ' D' ' 17' ' ' TYR . 22.1 mmt-85 -156.87 150.52 24.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.408 0.683 . . . . 74.34 112.016 -170.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.568 HD12 ' HG3' ' B' ' 130' ' ' PRO . 0.3 OUTLIER -138.85 118.0 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 105.072 -2.196 . . . . 74.14 105.072 165.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.49 ' HD1' ' HB3' ' D' ' 15' ' ' ARG . 28.2 p90 -150.39 157.91 43.57 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.866 0.841 . . . . 74.33 111.657 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -93.71 113.65 25.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.033 -0.985 . . . . 65.24 108.76 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt -81.4 -35.65 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.171 0.51 . . . . 75.41 109.629 178.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -144.67 141.75 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.064 -0.971 . . . . 74.43 108.444 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.538 HG23 ' HE1' ' C' ' 117' ' ' MET . 95.7 mt -137.09 143.9 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.698 1.199 . . . . 75.45 107.845 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 99.1 p -147.76 141.9 26.08 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.702 0.801 . . . . 72.04 108.993 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.542 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.2 t80 -146.48 113.81 6.28 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 105.944 -1.872 . . . . 75.54 105.944 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -126.87 109.45 11.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 73.24 110.106 -173.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.97 91.18 3.45 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 107.412 -1.329 . . . . 72.11 107.412 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.02 -43.16 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.262 1.975 . . . . 74.0 112.416 -173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -97.75 37.63 1.37 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.916 -1.142 . . . . 64.32 107.916 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.408 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -51.32 -64.6 1.3 Allowed Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.786 -1.102 . . . . 74.33 113.858 -161.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.576 ' HB3' HD11 ' C' ' 83' ' ' ILE . 81.7 Cg_endo -78.21 -14.55 14.87 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 122.195 1.82 . . . . 64.03 113.002 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -67.25 -41.47 85.55 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.54 1.136 . . . . 72.53 109.395 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.41 -41.42 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 123.962 0.789 . . . . 74.51 110.126 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -69.61 -18.6 63.62 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.377 0.88 . . . . 71.11 113.377 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.99 -2.98 58.58 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.623 0.769 . . . . 72.2 111.999 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -124.78 116.04 21.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.096 1.358 . . . . 73.32 108.571 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -89.34 97.42 11.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.877 0.871 . . . . 63.51 112.812 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.54 ' CH2' HD11 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -167.85 -179.39 4.2 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 124.165 0.986 . . . . 73.21 112.97 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' G' ' 295' ' ' ALA . 11.6 pt20 -93.22 145.48 30.11 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.484 1.114 . . . . 73.34 112.755 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.532 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 76.9 Cg_endo -79.74 135.57 11.54 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.418 2.078 . . . . 73.11 112.765 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.73 111.61 7.15 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.504 -1.295 . . . . 73.13 107.504 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.78 144.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.157 0.583 . . . . 74.21 110.774 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 85.0 tttt -124.69 127.6 47.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.288 1.035 . . . . 74.02 109.109 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.15 120.76 39.12 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.002 -1.481 . . . . 75.54 107.002 173.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.49 143.04 50.91 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.527 -0.916 . . . . 72.52 108.527 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.19 148.76 50.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.097 0.475 . . . . 74.52 110.64 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.518 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.4 t70 -139.5 150.03 44.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.185 -1.042 . . . . 72.42 108.185 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 24.2 p -116.75 143.65 45.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.746 0.818 . . . . 72.52 109.785 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.88 155.88 32.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.511 1.124 . . . . 73.11 108.246 174.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 27.1 p -169.26 163.96 10.87 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.844 0.457 . . . . 74.13 110.733 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -159.57 132.71 6.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.668 0.787 . . . . 72.15 110.009 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -77.43 117.47 18.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.769 -0.826 . . . . 75.51 108.769 170.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' D' ' 57' ' ' GLU . 70.6 mt -90.29 -32.59 16.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.858 0.463 . . . . 74.34 110.508 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.92 -171.17 1.12 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.645 0.778 . . . . 71.03 110.632 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.93 114.79 4.78 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.779 -1.101 . . . . 70.25 109.391 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 68.3 2.18 3.18 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.147 1.379 . . . . 75.35 113.012 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.67 120.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.409 -0.96 . . . . 74.43 108.409 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -136.51 131.2 33.6 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.558 0.536 . . . . 74.23 109.884 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.539 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.7 tt0 -87.43 126.59 34.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.298 -1.001 . . . . 62.2 108.298 169.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.89 112.77 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.715 -1.217 . . . . 74.24 107.715 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.514 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.7 t -102.65 130.74 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.233 0.613 . . . . 73.41 109.618 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.01 109.03 13.02 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.143 -1.428 . . . . 75.32 107.143 171.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.518 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.0 ttm-85 -84.34 106.66 16.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.446 -0.797 . . . . 75.51 109.16 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.32 129.74 45.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.568 -0.901 . . . . 75.52 108.568 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 31.3 m -125.87 135.67 52.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.573 0.749 . . . . 74.32 109.544 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' D' ' 41' ' ' LYS . 91.2 t -124.81 111.99 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.041 0.936 . . . . 74.5 109.382 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 58.7 m -105.39 119.67 39.66 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.245 -0.65 . . . . 73.12 109.245 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.532 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.03 133.24 56.21 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.275 0.63 . . . . 73.45 110.635 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -141.93 125.18 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.143 0.977 . . . . 72.13 109.649 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.635 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -126.7 138.99 53.48 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.283 1.033 . . . . 63.52 110.841 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.85 -111.91 3.51 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.8 -0.52 . . . . 54.1 111.8 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.15 4.05 17.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.202 1.001 . . . . 75.33 110.023 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.17 168.58 21.3 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.212 0.529 . . . . 73.14 112.358 -157.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -84.56 126.58 33.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.143 -0.935 . . . . 74.32 110.428 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.635 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -71.78 -69.45 0.39 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.97 0.908 . . . . 64.45 109.706 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -158.67 147.5 18.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.543 -1.662 . . . . 63.1 109.953 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.92 152.93 20.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.194 -1.41 . . . . 75.2 107.194 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.5 t -154.27 135.78 14.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.955 -0.757 . . . . 70.11 108.955 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -153.54 134.44 13.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.522 -0.547 . . . . 70.21 109.522 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.5 t -136.52 116.79 17.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.745 -0.835 . . . . 63.32 108.745 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.81 86.54 7.17 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.843 -1.169 . . . . 70.33 107.843 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.54 92.89 5.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.951 -1.022 . . . . 64.44 109.254 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.67 148.27 19.43 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.104 -0.798 . . . . 64.01 111.104 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.63 131.53 3.69 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 110.961 -0.856 . . . . 73.14 110.961 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 68.2 mt -89.18 122.47 40.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.446 -0.946 . . . . 74.23 108.446 178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.3 138.78 52.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.37 1.068 . . . . 74.25 108.996 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 19.4 m -90.69 97.34 11.13 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.207 -1.034 . . . . 75.31 108.207 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.98 123.03 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.547 -0.538 . . . . 74.32 109.547 -171.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.23 170.95 20.09 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.56 1.144 . . . . 61.53 109.442 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.1 -18.48 51.23 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 116.301 -0.409 . . . . 74.41 113.222 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.35 159.05 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.439 1.095 . . . . 74.44 109.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 158.98 40.83 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.142 0.577 . . . . 75.41 110.795 -174.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.57 -97.48 0.01 OUTLIER Glycine 0 C--N 1.351 1.377 0 O-C-N 125.165 1.54 . . . . 75.3 115.793 161.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.3 p -58.89 -54.53 46.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.957 1.303 . . . . 74.13 112.597 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.455 HE22 ' HB3' ' D' ' 3' ' ' GLU . 6.8 tp-100 -82.12 -27.02 33.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.22 -0.445 . . . . 71.03 110.698 -173.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.523 ' SD ' ' HB3' ' G' ' 277' ' ' LEU . 27.8 ttt -67.46 -35.05 78.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.831 -0.433 . . . . 74.43 109.831 173.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -53.87 51.98 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 123.615 0.766 . . . . 63.11 110.61 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -57.24 -45.27 84.07 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.229 0.956 . . . . 75.31 110.824 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.39 -33.13 75.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.446 0.699 . . . . 62.5 111.706 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.453 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.2 tp -75.41 -32.4 60.72 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 72.42 110.994 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.85 13.59 34.77 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.21 -0.45 . . . . 72.25 113.658 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.464 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -129.7 -61.2 1.01 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.172 0.486 . . . . 74.4 110.345 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -75.33 -46.51 32.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.4 0.68 . . . . 75.41 111.095 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 60.5 m -62.47 -48.94 85.67 Favored Pre-proline 0 CA--C 1.569 1.687 0 CA-C-O 118.306 -0.854 . . . . 54.54 112.114 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.63 -16.19 33.87 Favored 'Trans proline' 0 C--N 1.402 3.376 0 C-N-CA 122.1 1.867 . . . . 73.13 112.735 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.16 -24.48 62.26 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.833 0.453 . . . . 75.54 110.259 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.38 -39.29 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.281 0.632 . . . . 75.24 109.853 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 -37.0 64.22 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.765 0.826 . . . . 71.24 112.201 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.14 -40.9 57.49 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-O 117.787 -1.102 . . . . 75.32 113.515 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -53.93 -39.73 83.58 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.377 2.051 . . . . 71.22 113.816 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -80.26 -32.81 38.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.369 0.667 . . . . 74.33 111.368 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.69 81.3 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.168 -0.679 . . . . 62.21 109.168 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.501 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -53.53 -53.55 49.94 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.906 1.282 . . . . 74.15 110.771 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.65 -40.76 92.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.504 1.128 . . . . 74.13 110.698 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.62 -44.11 96.7 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.576 0.548 . . . . 75.24 110.757 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.59 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.1 mt -63.22 -53.19 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 72.31 109.884 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.502 HG22 ' HE2' ' B' ' 109' ' ' TYR . 95.9 m -52.8 -45.07 67.05 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.085 1.354 . . . . 75.51 111.923 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.39 -44.94 77.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.944 -1.025 . . . . 71.42 110.151 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 77.7 mtm -62.55 -37.79 87.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.857 0.463 . . . . 73.15 112.0 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.458 HG22 ' O ' ' D' ' 114' ' ' ILE . 85.7 t -61.59 -44.63 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 124.093 0.871 . . . . 73.53 110.014 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.57 -27.33 61.26 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.878 0.471 . . . . 64.32 111.718 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -72.39 -31.64 65.72 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.347 0.659 . . . . 75.42 110.076 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.25 10.81 62.48 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.445 -0.798 . . . . 61.22 112.368 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.473 HG21 ' HB3' ' C' ' 17' ' ' TYR . 67.6 p 65.75 15.04 9.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.964 2.105 . . . . 74.43 113.961 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.74 156.97 55.51 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 107.437 -1.319 . . . . 74.22 107.437 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.68 ' HG2' HG21 ' G' ' 296' ' ' THR . 71.7 Cg_endo -74.02 146.09 36.52 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.682 2.255 . . . . 73.44 111.588 -177.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.432 ' HB2' HG23 ' D' ' 115' ' ' THR . 20.2 pt20 -51.3 127.71 20.34 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 124.275 0.985 . . . . 72.51 112.134 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -107.49 100.77 10.16 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.483 -0.932 . . . . 74.34 108.483 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.456 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 3.1 m-20 -98.89 107.1 19.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.298 1.039 . . . . 73.33 110.18 -166.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.501 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.7 mm? -72.22 116.01 12.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.069 0.948 . . . . 75.51 109.908 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.484 ' HB3' HD11 ' G' ' 291' ' ' LEU . . . -68.57 154.42 94.53 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.534 0.334 . . . . 75.21 111.494 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.78 123.87 14.5 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.499 2.133 . . . . 64.14 111.951 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 63.4 t -108.41 125.49 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.905 0.882 . . . . 64.4 108.773 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -72.17 93.88 1.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.171 0.588 . . . . 64.23 109.632 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.464 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 70.7 m-85 -72.82 -21.89 60.89 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.583 -0.735 . . . . 74.2 111.352 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' D' ' 138' ' ' MET . 12.7 m-20 -56.19 -57.25 12.98 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.585 0.754 . . . . 72.51 111.38 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.54 95.25 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.078 0.861 . . . . 70.14 112.493 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 85.6 mt -71.37 -48.82 47.68 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.498 -0.774 . . . . 64.32 111.25 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -72.28 -26.92 62.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 74.24 111.089 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.475 ' SD ' ' N ' ' D' ' 1' ' ' MET . 33.7 ttm -55.06 -35.76 64.87 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.035 0.934 . . . . 71.32 111.157 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -79.53 -13.1 59.78 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.093 0.957 . . . . 75.05 112.071 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -79.03 -37.08 39.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.703 0.801 . . . . 74.35 110.201 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.66 -34.78 79.1 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.474 0.71 . . . . 75.55 112.217 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -78.2 0.89 23.33 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.053 0.541 . . . . 71.54 112.072 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -135.05 82.05 1.93 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.641 0.776 . . . . 73.44 109.348 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.96 125.29 1.94 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.524 -0.917 . . . . 75.12 108.524 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.97 136.18 36.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.333 0.653 . . . . 63.23 109.835 176.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.38 59.15 5.0 Favored Glycine 0 C--N 1.344 0.997 0 C-N-CA 122.723 0.201 . . . . 71.55 112.683 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.93 112.63 24.48 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.331 -0.989 . . . . 63.43 108.331 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.91 68.03 0.33 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 111.532 -0.627 . . . . 61.53 111.532 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -117.06 157.6 25.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.984 0.914 . . . . 74.31 109.706 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -132.88 133.51 43.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.768 0.827 . . . . 72.41 109.808 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -115.87 135.23 54.19 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.651 0.78 . . . . 74.11 110.96 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -136.94 135.01 37.36 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.557 1.143 . . . . 74.31 107.946 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -130.23 112.65 13.55 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.009 -0.737 . . . . 74.33 109.009 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -67.61 146.37 53.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.652 0.781 . . . . 72.23 110.581 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 124.067 0.947 . . . . 75.25 108.76 179.677 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 110.018 -0.364 . . . . 74.24 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -76.07 87.26 2.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.336 0.655 . . . . 73.52 109.313 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -82.98 178.53 8.11 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.204 -0.907 . . . . 71.0 109.399 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -77.06 82.74 3.57 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.079 -0.712 . . . . 74.51 109.079 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -150.7 139.55 13.09 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.384 0.674 . . . . 73.23 111.066 -172.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.19 106.3 1.35 Allowed 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.009 1.806 . . . . 72.12 110.573 163.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 10.2 tt -66.67 -24.6 66.3 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.381 0.672 . . . . 73.54 110.182 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . 0.66 HD22 HD21 ' A' ' 98' ' ' LEU . 25.0 mt -84.16 144.62 28.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.08 0.952 . . . . 75.2 110.548 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . 175.65 40.24 0.05 OUTLIER Glycine 0 C--N 1.35 1.312 0 N-CA-C 114.109 0.404 . . . . 42.24 114.109 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.401 HD21 ' HB3' ' A' ' 95' ' ' ALA . 62.5 tp -159.5 107.4 1.76 Allowed 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 117.323 0.562 . . . . 62.14 109.876 172.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -173.75 176.35 2.71 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.558 1.543 . . . . 75.02 110.159 168.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.38 -70.82 0.12 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.625 1.57 . . . . 74.02 111.534 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.54 108.67 2.94 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.648 0.779 . . . . 74.4 109.623 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 168.65 102.55 0.16 Allowed Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.554 0.534 . . . . 74.03 112.496 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -71.14 92.16 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 107.792 -1.188 . . . . 74.34 107.792 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 286' ' ' MET . . . . . 0.519 ' HG3' HG21 ' E' ' 288' ' ' VAL . 14.1 tpt -82.23 116.55 64.23 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.829 0.852 . . . . 75.22 110.841 -169.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -77.07 85.85 1.71 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.133 2.555 . . . . 74.12 111.762 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . 0.555 HG13 HG22 ' A' ' 131' ' ' VAL . 88.7 t -125.52 -83.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 115.603 -0.726 . . . . 64.41 109.053 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 54.89 -165.24 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.176 0.991 . . . . 72.23 111.455 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -101.46 121.29 41.67 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.678 -0.639 . . . . 75.24 110.077 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.42 52.8 2.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.482 1.113 . . . . 74.11 109.704 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 171.22 -148.65 11.34 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.7 -1.055 . . . . 53.22 111.309 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -81.41 -172.59 1.53 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.915 2.41 . . . . 74.53 112.62 177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 38' ' ' PRO . 11.7 mptt -78.16 -52.69 8.32 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.434 -0.803 . . . . 63.31 108.868 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 69.73 -73.33 0.09 Allowed 'General case' 0 CA--C 1.553 1.078 0 O-C-N 125.033 1.458 . . . . 75.11 113.343 168.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 43.7 m -56.69 99.8 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.251 1.421 . . . . 73.12 113.103 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 51.7 t80 179.83 -60.7 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.069 1.348 . . . . 74.12 108.923 170.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -78.3 135.14 37.46 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.615 0.572 . . . . 74.25 110.106 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.63 -92.84 0.11 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.22 -0.752 . . . . 62.24 111.22 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -93.36 16.88 12.3 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 65.33 110.793 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . 0.5 HD13 ' HA ' ' A' ' 32' ' ' PHE . 5.6 tt -104.76 142.8 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.714 1.205 . . . . 71.31 110.864 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -174.0 171.61 3.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 63.04 108.682 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -77.05 157.07 81.8 Favored Pre-proline 0 CA--C 1.568 1.664 0 C-N-CA 123.558 0.743 . . . . 75.13 109.546 167.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . 0.589 ' HB3' ' HB3' ' B' ' 14' ' ' GLN . 87.1 Cg_exo -47.63 136.97 20.99 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 123.507 2.804 . . . . 73.23 114.313 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -147.0 22.17 1.23 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.109 0.564 . . . . 71.34 111.841 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 97.9 t -82.25 114.63 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 120.934 0.397 . . . . 73.42 110.413 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 14.7 m -65.51 -9.0 22.34 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 125.572 1.549 . . . . 74.34 114.332 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . 0.431 ' SG ' ' NE2' ' B' ' 12' ' ' GLN . 36.3 t 78.14 147.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.107 1.363 . . . . 70.13 112.152 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 40.7 m -65.17 116.14 27.66 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.751 0.821 . . . . 73.25 109.826 176.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo . . . . . 0 C--N 1.374 1.883 0 C-N-CA 122.925 2.417 . . . . 72.41 111.051 -177.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . 0.446 ' HA ' ' HB3' ' C' ' 50' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 110.204 -0.295 . . . . 64.32 110.204 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -78.81 80.94 5.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.376 0.67 . . . . 72.33 109.361 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 64.08 176.51 0.18 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.797 1.239 . . . . 71.5 111.508 -172.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 62.59 104.51 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.525 1.13 . . . . 75.03 111.487 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . 0.572 ' HD2' HD22 ' F' ' 278' ' ' LEU . 46.0 mtmt -105.57 92.69 6.22 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.715 0.806 . . . . 75.14 109.248 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.88 -36.34 97.1 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.53 2.82 . . . . 74.2 114.021 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 8.0 mp -83.86 -33.05 24.92 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.904 0.482 . . . . 75.42 111.491 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . 0.572 HD22 ' HD2' ' F' ' 275' ' ' LYS . 8.0 mp -89.34 106.24 18.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.543 0.737 . . . . 75.13 110.656 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . 0.411 ' H ' ' HB1' ' C' ' 95' ' ' ALA . . . -97.39 -6.31 57.61 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.938 -0.574 . . . . 74.43 112.153 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . 0.502 ' HB3' ' HB2' ' C' ' 95' ' ' ALA . 9.1 tt -158.23 110.05 2.26 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.754 0.821 . . . . 74.21 109.578 -172.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -175.94 54.8 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.877 1.271 . . . . 75.32 109.172 162.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -167.13 99.71 0.53 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.899 -1.046 . . . . 71.01 108.346 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.95 17.65 10.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.659 1.184 . . . . 75.25 111.866 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -95.99 104.64 3.13 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.558 -0.579 . . . . 31.44 112.39 -172.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 16.2 m120 69.46 176.62 0.27 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.895 1.278 . . . . 74.25 113.089 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 286' ' ' MET . . . . . 0.42 ' HG3' HD11 ' C' ' 136' ' ' LEU . 4.9 mpp? 52.73 78.54 0.39 Allowed Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.112 1.365 . . . . 72.44 112.186 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -78.52 64.33 8.56 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.766 2.31 . . . . 62.32 110.653 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 63.6 t -71.85 113.67 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 114.973 -1.012 . . . . 73.41 110.674 -173.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -119.93 160.07 23.44 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.247 -1.02 . . . . 75.3 108.247 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -60.68 137.3 58.2 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.093 0.557 . . . . 73.41 111.875 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.487 ' H ' HD12 ' F' ' 291' ' ' LEU . 0.0 OUTLIER -100.1 155.4 17.75 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.686 1.194 . . . . 70.32 110.634 -174.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . 0.405 ' N ' HG23 ' H' ' 307' ' ' THR . . . 76.7 -167.62 54.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.203 -0.776 . . . . 52.12 112.573 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.26 -72.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.213 1.942 . . . . 74.2 110.796 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -155.36 -56.2 0.09 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.607 1.163 . . . . 75.34 109.035 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . 63.04 -165.15 0.24 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.972 0.909 . . . . 71.33 109.73 -169.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 296' ' ' THR . . . . . 0.406 ' HG1' HG12 ' C' ' 40' ' ' VAL . 11.1 m 64.92 150.56 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.416 1.086 . . . . 74.14 111.486 -176.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.558 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 3.4 m-30 65.7 14.16 9.37 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.906 0.883 . . . . 74.13 112.698 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . 0.457 ' HE1' ' HA ' ' H' ' 302' ' ' ASP . 32.2 p80 -95.33 119.01 33.1 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.989 -1.115 . . . . 75.42 107.989 170.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 138.33 163.89 9.75 Favored Glycine 0 N--CA 1.469 0.878 0 N-CA-C 112.086 -0.405 . . . . 52.14 112.086 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.73 88.75 7.74 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.292 0.637 . . . . 74.43 109.89 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.44 18.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.301 1.041 . . . . 74.51 111.279 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -81.31 -72.41 0.43 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 109.145 -0.687 . . . . 71.35 109.145 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 178.38 91.95 0.15 Allowed Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 123.924 0.89 . . . . 75.52 109.653 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.54 -56.63 0.4 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.939 1.759 . . . . 61.31 110.833 169.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -174.61 128.35 0.33 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.851 1.261 . . . . 71.41 108.354 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 7.7 p -169.74 -39.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.349 1.06 . . . . 62.23 110.383 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 23.7 m -75.53 80.64 2.55 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.443 1.097 . . . . 75.1 110.437 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 48.9 m -146.71 3.44 0.85 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.513 -1.221 . . . . 74.33 110.421 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 9.3 t -140.65 149.12 55.8 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 123.671 0.788 . . . . 73.41 110.468 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 C--N 1.372 1.77 0 C-N-CA 122.329 2.019 . . . . 74.34 113.329 167.961 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.492 -0.559 . . . . 65.45 109.492 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -73.3 85.9 1.45 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.989 -0.745 . . . . 72.52 108.989 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -56.68 120.05 7.16 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.26 1.024 . . . . 73.51 110.598 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -77.22 135.0 38.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.109 0.564 . . . . 72.41 110.873 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.77 118.08 7.22 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.381 0.672 . . . . 74.3 110.21 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -89.77 101.93 0.33 Allowed 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.721 2.281 . . . . 75.11 111.162 170.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.523 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 5.7 mp -82.0 -17.43 46.89 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 120.827 0.346 . . . . 75.34 110.338 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.82 114.79 28.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.117 0.967 . . . . 75.11 108.864 -176.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . 0.403 ' H ' HD23 ' G' ' 280' ' ' LEU . . . 164.27 78.91 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.852 -0.899 . . . . 73.51 110.852 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . 0.403 HD23 ' H ' ' G' ' 279' ' ' GLY . 1.1 pt? -154.62 -38.79 0.09 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.77 0.828 . . . . 75.33 111.304 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -61.97 101.24 0.2 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.332 0.653 . . . . 75.03 110.982 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -90.06 -151.36 0.23 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.354 1.062 . . . . 64.11 108.421 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -75.45 75.44 2.52 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.722 -0.844 . . . . 74.44 108.722 166.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -86.52 58.85 4.66 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.31 -0.859 . . . . 52.3 113.021 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -78.47 97.04 5.56 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.985 -1.117 . . . . 73.21 107.985 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 71.5 mtm -78.18 140.79 61.65 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.815 -0.612 . . . . 62.43 109.396 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.86 83.86 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.919 2.413 . . . . 73.35 111.964 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 81.7 t -101.38 119.13 49.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.95 0.9 . . . . 72.3 108.632 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -104.59 153.53 21.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.173 0.989 . . . . 74.51 109.503 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.413 ' CH2' HD13 ' D' ' 128' ' ' LEU . 53.1 m95 -65.65 169.26 6.48 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.211 1.005 . . . . 74.32 111.89 171.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.484 HD11 ' HB3' ' D' ' 129' ' ' ALA . 5.5 mp -76.21 -41.55 49.01 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 113.706 -1.588 . . . . 70.22 110.333 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -171.97 173.52 45.14 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.701 -0.681 . . . . 72.01 113.621 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.62 -25.75 10.61 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 123.772 2.981 . . . . 75.14 113.332 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -69.04 92.52 0.53 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.919 0.487 . . . . 75.03 109.836 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . 0.488 ' HB2' ' HB2' ' D' ' 37' ' ' GLN . . . -75.52 173.67 10.68 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.322 -0.854 . . . . 73.53 111.295 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 296' ' ' THR . . . . . 0.68 HG21 ' HG2' ' D' ' 124' ' ' PRO . 4.4 t -72.16 -14.38 61.8 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 115.083 -0.962 . . . . 61.34 113.071 -173.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.512 ' HA ' ' HG3' ' D' ' 124' ' ' PRO . 0.1 OUTLIER -84.08 76.85 10.03 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 118.612 0.642 . . . . 74.43 110.793 -177.608 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -121.45 143.46 49.23 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.161 0.985 . . . . 75.25 108.447 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.73 -77.78 0.35 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.376 -1.089 . . . . 53.41 110.376 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.78 160.89 3.01 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.447 1.499 . . . . 74.31 108.114 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . . . . . . . . . 6.0 tt -80.97 -25.87 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.387 -0.821 . . . . 74.02 111.873 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -155.95 -161.33 1.13 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.604 -0.517 . . . . 64.15 109.604 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' G' ' 303' ' ' LYS . 0.9 OUTLIER -124.1 163.96 32.56 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.627 1.171 . . . . 71.23 108.448 175.203 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -63.51 132.42 35.57 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.38 2.053 . . . . 73.44 112.093 172.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.66 161.56 30.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.358 0.663 . . . . 71.01 111.034 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 34.6 m -75.23 166.49 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.099 0.56 . . . . 75.34 111.079 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 65.9 p -77.19 -66.87 0.77 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.739 -0.664 . . . . 75.04 110.728 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 84.0 m -157.28 146.45 20.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.637 0.775 . . . . 72.31 110.212 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 40.5 m -140.93 82.24 15.38 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 108.777 -0.823 . . . . 75.44 108.777 171.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . 0.533 ' HG2' HD21 ' C' ' 6' ' ' ASN . 21.9 Cg_endo . . . . . 0 C--N 1.38 2.193 0 C-N-CA 123.605 2.87 . . . . 72.35 111.417 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.059 -0.348 . . . . 63.21 110.059 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -164.82 -38.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.53 1.132 . . . . 73.42 109.226 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -142.18 47.76 1.6 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.905 1.282 . . . . 75.31 109.406 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -84.01 18.78 1.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.608 1.163 . . . . 72.3 110.812 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -93.37 109.62 41.48 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.222 1.409 . . . . 74.43 108.615 -173.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.2 173.07 9.15 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.079 1.853 . . . . 72.5 111.323 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.428 HD22 ' HG3' ' B' ' 94' ' ' MET . 9.7 tt -68.48 -37.82 80.47 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.278 -1.008 . . . . 71.01 108.278 170.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 61.0 tp -79.17 73.9 5.75 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.189 0.996 . . . . 70.41 110.038 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -74.55 -33.3 56.31 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.266 -0.424 . . . . 75.25 112.256 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . 0.401 HD22 ' HE1' ' B' ' 94' ' ' MET . 2.2 pt? -154.55 175.11 14.04 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.2 1.4 . . . . 72.12 108.455 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -98.18 -88.51 0.31 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.219 -1.4 . . . . 75.2 107.219 170.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -114.13 -47.26 2.95 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.343 -0.984 . . . . 71.3 108.343 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 17.0 t70 65.15 -161.99 0.27 Allowed 'General case' 0 CA--C 1.567 1.626 0 O-C-N 124.6 1.188 . . . . 74.22 110.636 171.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 74.69 -109.43 2.78 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 110.231 -1.148 . . . . 71.13 110.231 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -173.15 133.98 0.53 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.119 0.968 . . . . 70.34 108.705 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 286' ' ' MET . . . . . 0.517 ' HB3' HG22 ' H' ' 288' ' ' VAL . 63.1 mtt -126.69 95.22 38.24 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.869 0.867 . . . . 74.2 109.703 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -82.01 53.36 4.54 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.116 2.544 . . . . 65.51 111.577 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . 0.517 HG22 ' HB3' ' H' ' 286' ' ' MET . 87.3 t -71.13 130.39 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.777 0.831 . . . . 74.11 110.638 -174.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -122.83 -88.07 0.62 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.002 -1.11 . . . . 73.35 108.002 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -151.79 162.06 41.65 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.051 0.94 . . . . 75.11 110.328 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.454 HD13 HG21 ' B' ' 131' ' ' VAL . 5.6 mp -90.98 -10.75 41.19 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.541 -1.209 . . . . 72.32 110.023 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 176.46 82.05 0.06 OUTLIER Glycine 0 C--N 1.351 1.401 0 N-CA-C 111.474 -0.65 . . . . 50.0 111.474 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.87 80.08 2.93 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.048 2.498 . . . . 74.14 111.371 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -154.24 -29.94 0.12 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.655 -0.702 . . . . 74.34 110.996 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.76 88.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.696 0.798 . . . . 55.25 111.38 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 9.3 m -62.23 114.99 3.77 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.928 0.891 . . . . 71.33 110.012 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 69.28 -69.63 0.16 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.15 1.38 . . . . 74.31 111.439 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 31.1 t60 79.73 -60.25 0.33 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.46 1.904 . . . . 71.42 110.611 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 161.54 46.72 0.02 OUTLIER Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.27 -0.739 . . . . 63.5 113.496 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -160.78 117.47 2.33 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.053 0.926 . . . . 74.42 111.199 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 26.1 mm -64.63 147.76 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.369 0 C-N-CA 124.283 1.033 . . . . 75.52 110.448 177.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . 0.457 ' HA ' ' HE1' ' F' ' 298' ' ' HIS . 14.4 p-10 -58.27 -53.21 60.91 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.115 0.966 . . . . 75.53 110.862 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.484 ' HB3' ' HZ3' ' H' ' 303' ' ' LYS . 9.7 mtpm? -153.64 139.23 12.0 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.839 1.656 . . . . 74.54 106.904 177.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.08 -25.02 80.57 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.327 2.018 . . . . 75.31 112.433 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -163.67 177.45 8.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.568 1.147 . . . . 71.5 109.144 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . 0.5 HG12 ' HB1' ' C' ' 129' ' ' ALA . 3.6 t -62.99 -31.15 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 122.995 0.518 . . . . 72.3 110.803 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 307' ' ' THR . . . . . 0.405 HG23 ' N ' ' F' ' 292' ' ' GLY . 24.2 m 84.76 141.65 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.326 1.85 . . . . 75.1 110.76 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 15.3 p -66.59 131.31 45.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.886 0.874 . . . . 63.33 111.382 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 35.8 p -120.28 88.7 42.32 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.461 1.104 . . . . 71.24 109.151 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 C--N 1.378 2.084 0 C-N-CA 123.23 2.62 . . . . 64.31 112.018 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.1 mmm . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.252 -0.647 . . . . 74.31 109.252 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 m -76.06 86.27 2.95 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.536 0.734 . . . . 71.24 110.865 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -155.64 -71.34 0.12 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.961 -0.755 . . . . 74.31 108.961 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.647 ' HG2' HE22 ' E' ' 273' ' ' GLN . 82.8 mm-40 -86.67 62.28 7.31 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.723 0.773 . . . . 63.41 109.431 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -85.03 -18.46 34.32 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.017 -0.992 . . . . 75.3 111.05 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -70.73 123.84 22.87 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.555 -0.535 . . . . 74.21 109.555 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 m -87.8 -3.53 58.94 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.258 1.023 . . . . 64.1 111.368 -171.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -99.1 141.31 32.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.009 0.524 . . . . 72.23 111.188 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.2 mtm -88.07 159.66 18.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.002 0.921 . . . . 63.41 110.278 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -147.18 135.94 22.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.921 0.888 . . . . 73.13 109.602 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.602 ' HA ' HG23 ' A' ' 86' ' ' ILE . 54.1 t80 -136.2 132.16 35.53 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.495 -1.668 . . . . 74.54 106.495 164.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -150.82 120.3 6.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.855 -0.424 . . . . 75.1 109.855 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -77.81 128.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.929 -1.137 . . . . 71.24 107.929 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -101.78 -39.9 7.2 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.605 -0.517 . . . . 62.41 109.605 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -174.68 127.62 0.31 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.672 0.389 . . . . 73.53 109.961 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.437 ' H ' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -112.48 145.94 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.02 -0.733 . . . . 72.42 109.02 175.74 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -165.39 174.64 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.716 0.807 . . . . 75.13 111.195 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -99.68 122.56 42.88 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.212 -0.662 . . . . 72.35 109.212 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.94 -24.6 23.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.738 0.415 . . . . 72.25 110.042 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.28 137.36 17.32 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.175 -0.921 . . . . 63.32 109.416 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -133.77 132.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.319 -1.363 . . . . 63.31 107.319 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -139.57 124.89 19.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 72.12 108.641 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.52 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -135.23 128.49 32.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.397 -1.705 . . . . 75.01 106.397 170.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -137.32 121.7 18.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.995 0.518 . . . . 74.35 109.666 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.11 77.57 67.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.599 -1.63 . . . . 71.21 106.599 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.77 -46.06 9.64 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.578 2.186 . . . . 73.51 111.36 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.22 23.37 3.88 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.653 -1.158 . . . . 74.41 109.704 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.508 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -45.03 -55.64 10.7 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.111 -0.947 . . . . 75.22 112.916 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -61.18 -26.89 83.07 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.378 2.052 . . . . 71.03 113.305 178.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.97 -26.7 20.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.988 0.915 . . . . 72.42 110.763 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -82.52 -17.69 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 122.744 0.417 . . . . 72.31 111.281 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -79.81 -12.46 59.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.271 0.628 . . . . 73.45 111.78 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -101.94 -9.14 20.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.174 0.99 . . . . 74.3 110.933 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -71.94 158.62 35.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.3 0.64 . . . . 75.11 111.663 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.59 138.16 58.42 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.048 -0.978 . . . . 73.25 110.19 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -94.01 63.23 3.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.623 0.725 . . . . 73.01 111.645 -165.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.45 83.77 16.9 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.123 0.969 . . . . 74.35 109.188 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.92 167.04 8.36 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.643 2.229 . . . . 75.15 111.648 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.14 99.62 7.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.316 -1.364 . . . . 74.42 107.316 167.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 65' ' ' THR . 59.7 t -85.08 129.87 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.04 -0.726 . . . . 64.45 109.04 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -125.09 120.15 30.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.528 1.131 . . . . 72.51 109.296 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tt -96.71 109.07 21.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.281 -1.748 . . . . 75.23 106.281 170.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -127.1 128.2 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.906 -1.146 . . . . 73.34 107.906 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.73 162.13 14.74 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.269 0.556 . . . . 73.32 110.853 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 10.1 t70 -131.05 134.51 46.71 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.015 1.326 . . . . 64.23 108.081 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.479 ' HB ' ' CE1' ' E' ' 281' ' ' PHE . 26.8 p -115.76 125.08 52.3 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.018 0.927 . . . . 74.45 110.695 -171.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.38 124.06 11.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.23 0.612 . . . . 72.51 111.586 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.519 ' HB2' HD11 ' E' ' 278' ' ' LEU . 6.5 p -90.91 155.68 18.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.296 0.638 . . . . 74.21 109.568 168.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.406 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 40.8 t -150.58 150.56 31.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.223 1.009 . . . . 70.3 109.027 -174.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -115.24 138.84 50.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.194 0.598 . . . . 64.22 110.228 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.418 HD12 HG22 ' A' ' 83' ' ' ILE . 65.1 mt -110.04 -34.63 6.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.824 0.85 . . . . 75.53 109.856 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.514 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -166.75 -176.01 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 71.04 109.986 -176.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.39 122.07 21.48 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.955 -0.758 . . . . 75.32 108.955 173.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 72.75 -7.02 1.52 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.36 1.464 . . . . 75.31 112.468 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.514 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 57.5 t -114.86 111.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 107.506 -1.294 . . . . 74.4 107.506 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -128.68 170.96 12.65 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 123.65 0.78 . . . . 75.53 108.997 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.406 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 37.8 tt0 -130.59 147.25 52.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.978 0.911 . . . . 74.12 109.076 176.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.412 HG11 ' HE2' ' E' ' 281' ' ' PHE . 96.4 t -125.98 122.33 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.923 -1.14 . . . . 71.11 107.923 171.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.448 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.2 t -105.35 129.68 57.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 109.239 -0.652 . . . . 75.43 109.239 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -118.61 100.41 7.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 106.482 -1.673 . . . . 72.43 106.482 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.567 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttp180 -84.96 109.0 17.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.764 -0.653 . . . . 72.33 109.276 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.429 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.4 t -92.81 132.59 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 107.966 -1.124 . . . . 73.34 107.966 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -120.27 138.39 53.7 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.485 -0.561 . . . . 71.32 109.485 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.56 108.98 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 124.874 1.27 . . . . 74.14 107.573 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 m -105.02 134.72 47.65 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 109.461 -0.57 . . . . 73.44 109.461 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.77 111.63 15.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.232 -1.396 . . . . 71.53 107.232 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.2 t -138.15 134.99 35.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.004 0.522 . . . . 71.13 110.464 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.42 52.06 2.01 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.078 1.351 . . . . 64.32 109.608 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.83 -90.69 1.46 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.61 -0.596 . . . . 60.25 111.61 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.62 -27.59 17.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.996 0.518 . . . . 73.04 112.381 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.31 125.13 53.54 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.662 -0.496 . . . . 70.05 109.662 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 43.5 m -81.26 135.3 35.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.571 0.748 . . . . 73.31 111.237 -177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.598 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -73.87 -65.08 0.88 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.466 0.706 . . . . 73.05 110.217 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -160.53 163.47 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.988 -1.006 . . . . 75.4 111.366 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.93 124.89 30.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.862 1.265 . . . . 65.01 108.371 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.409 ' SG ' HG21 ' A' ' 118' ' ' VAL . 54.7 m -123.88 105.61 9.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.115 0.966 . . . . 75.24 109.067 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.7 122.16 28.38 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.348 0.659 . . . . 61.32 109.718 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.406 HG12 ' HB3' ' A' ' 113' ' ' CYS . 46.7 t -130.47 112.75 23.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.915 0.886 . . . . 74.12 109.458 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.544 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 44.4 mt-30 -84.87 89.16 7.49 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.466 0.706 . . . . 74.21 109.506 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.23 7.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.136 -0.938 . . . . 74.01 109.023 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.448 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -101.1 145.25 16.91 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.426 -0.67 . . . . 64.53 111.426 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.98 137.27 6.58 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 111.639 -0.585 . . . . 71.21 111.639 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 51' ' ' LEU . 42.6 mt -77.9 126.15 38.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.843 -0.799 . . . . 60.4 108.843 175.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -129.52 118.98 22.93 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.621 -0.881 . . . . 73.33 108.621 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -86.25 99.11 11.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.778 -0.823 . . . . 71.5 108.778 172.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.602 HG23 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.88 157.32 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.313 0.645 . . . . 73.25 110.512 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.455 ' HA ' HD23 ' E' ' 277' ' ' LEU . . . -166.88 161.6 15.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.941 -1.027 . . . . 65.14 110.476 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.3 8.04 83.09 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.287 0.367 . . . . 73.33 113.797 170.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 pt -111.45 143.69 20.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 123.956 0.902 . . . . 73.53 108.901 -176.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.493 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.7 tt0 -159.13 174.92 14.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.834 0.454 . . . . 74.41 109.879 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.493 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 58.87 -127.91 46.41 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 123.904 0.764 . . . . 72.23 114.274 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -82.66 -15.19 52.98 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.296 0.638 . . . . 73.14 111.527 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.53 -40.31 61.81 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.353 0.661 . . . . 74.14 110.097 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.8 ptm -71.01 -29.5 65.47 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.272 -0.422 . . . . 72.41 110.065 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.14 -28.85 63.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.561 0.745 . . . . 64.41 111.131 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -81.6 -31.49 32.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.419 0.687 . . . . 73.01 110.494 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.12 -57.57 5.23 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.965 0.506 . . . . 74.33 109.925 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.8 -51.83 44.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.284 -0.871 . . . . 73.41 111.001 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.57 -6.09 88.16 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 115.147 0.819 . . . . 73.54 115.147 -167.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.39 -54.14 0.19 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.254 0.835 . . . . 74.33 113.254 -170.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -69.39 -46.91 65.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.611 0.365 . . . . 73.03 111.575 -171.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.9 m -67.98 -43.56 37.02 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.003 0.921 . . . . 71.01 112.609 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.69 -43.26 40.72 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 123.096 2.531 . . . . 73.11 113.148 168.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -63.25 -37.14 86.07 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.089 0.868 . . . . 70.34 110.837 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.0 -45.53 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.326 0.65 . . . . 74.43 111.015 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.33 -24.49 34.55 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.566 -0.743 . . . . 74.14 112.292 -170.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -61.29 -42.49 85.64 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 113.824 1.046 . . . . 72.14 113.824 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.453 ' HA ' ' NH1' ' A' ' 111' ' ' ARG . 76.6 Cg_exo -55.04 -41.8 75.26 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.47 2.114 . . . . 74.31 114.399 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.148 0.579 . . . . 62.31 111.62 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.87 97.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.032 0.533 . . . . 74.11 110.657 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.533 ' NH1' HD13 ' C' ' 105' ' ' ILE . 31.1 ttm105 -50.69 -57.67 7.73 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.776 1.298 . . . . 74.32 110.825 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.88 -40.76 95.62 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.991 0.807 . . . . 74.1 110.802 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.566 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.2 t -60.76 -33.21 72.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.659 0.599 . . . . 73.43 111.786 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.549 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 96.1 mt -74.01 -55.74 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.623 0.769 . . . . 71.2 109.843 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.433 HG21 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -51.41 -44.3 62.2 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.246 1.418 . . . . 65.54 112.64 -173.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 34.3 t -65.3 -42.75 92.77 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.93 -1.032 . . . . 74.14 110.106 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.549 ' HE1' ' HA ' ' A' ' 114' ' ' ILE . 51.4 mtm -64.63 -40.39 95.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.84 0.456 . . . . 72.21 111.05 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.1 t -57.27 -48.29 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.576 0.75 . . . . 65.5 109.945 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -71.16 -31.89 68.24 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.737 -0.665 . . . . 75.41 111.765 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.433 ' HG3' ' O ' ' A' ' 116' ' ' SER . 73.1 mtt-85 -67.58 -28.74 68.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.85 0.86 . . . . 72.1 110.885 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.87 23.85 8.61 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 119.627 -0.54 . . . . 74.24 113.972 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 75.4 p 50.13 26.08 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.809 1.644 . . . . 74.23 113.625 -173.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.36 149.17 36.26 Favored Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 108.83 -0.804 . . . . 64.14 108.83 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.534 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 50.3 Cg_exo -56.02 139.3 84.76 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.818 2.346 . . . . 72.21 111.488 174.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.433 ' HG3' HG21 ' A' ' 115' ' ' THR . 32.1 tt0 -54.71 132.6 46.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.13 0.894 . . . . 70.42 111.092 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.1 tp -111.92 118.3 35.11 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.85 -0.796 . . . . 72.5 108.85 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.471 ' HB2' HD12 ' C' ' 13' ' ' ILE . 89.9 m-20 -110.0 110.36 21.25 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.995 -1.113 . . . . 75.02 107.995 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -73.15 117.33 14.76 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.932 -1.136 . . . . 74.01 107.932 177.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.12 140.27 90.93 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 118.406 0.548 . . . . 75.0 110.996 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.696 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 1.7 Cg_endo -74.03 109.84 2.96 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.027 1.818 . . . . 72.53 110.645 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.36 123.74 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.501 -0.925 . . . . 73.45 108.501 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -73.75 99.73 3.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.807 0.843 . . . . 73.54 109.929 -173.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -72.15 -46.31 56.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.475 0.71 . . . . 75.5 111.85 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.572 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 4.9 p-10 -63.25 -41.63 99.09 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.425 0.453 . . . . 73.32 111.441 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.33 -51.98 60.73 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.449 0.468 . . . . 64.51 109.991 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.37 -42.62 67.04 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.988 1.43 . . . . 74.33 110.969 -173.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -61.28 -44.87 96.51 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.22 0.95 . . . . 73.34 110.198 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 84.1 mmm -71.38 -42.71 68.06 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.058 0.543 . . . . 71.51 112.22 -173.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 7.8 p30 -71.05 -26.43 63.08 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.69 0.223 . . . . 60.42 111.096 178.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -76.36 -35.25 58.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.986 0.514 . . . . 72.52 110.423 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.8 tp -68.73 -51.76 37.97 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 74.33 112.059 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -169.78 19.33 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.716 -0.674 . . . . 74.21 110.615 -168.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.588 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 62.0 mm-40 64.98 -80.24 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.414 1.086 . . . . 63.31 110.828 -174.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -88.72 131.72 34.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.491 1.116 . . . . 73.53 111.08 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.42 165.03 20.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.021 0.928 . . . . 73.41 111.463 174.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.66 170.46 48.23 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.169 -0.469 . . . . 74.44 113.805 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.46 130.45 56.32 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.211 1.005 . . . . 65.3 110.445 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.9 69.73 2.83 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 111.493 -0.643 . . . . 73.42 111.493 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.6 p -89.31 129.9 35.78 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.706 0.802 . . . . 73.34 111.865 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -89.77 145.65 25.03 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 107.909 -1.145 . . . . 65.1 107.909 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -136.22 -12.98 1.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.745 0.418 . . . . 73.03 111.67 -169.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -86.24 109.48 18.96 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.785 -0.572 . . . . 65.14 111.818 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.09 118.53 21.89 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.379 1.072 . . . . 74.33 108.682 171.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.07 -49.14 76.76 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.957 0.903 . . . . 75.04 111.693 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 N-CA-C 108.782 -0.821 . . . . 73.31 108.782 177.385 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.736 -0.468 . . . . 62.23 109.736 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -141.32 97.78 3.23 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.889 0.875 . . . . 73.53 109.898 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -107.72 159.87 16.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.741 0.816 . . . . 73.31 109.76 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -142.01 171.41 14.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.748 1.219 . . . . 74.54 109.501 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -68.94 157.99 35.55 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.232 0.613 . . . . 74.51 110.772 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -67.96 145.07 54.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.478 0.711 . . . . 70.43 112.123 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.411 HG22 ' HB2' ' E' ' 310' ' ' PRO . 14.9 t -133.62 -160.09 1.02 Allowed 'General case' 0 C--O 1.246 0.904 0 C-N-CA 124.528 1.131 . . . . 74.4 108.504 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -55.6 115.65 2.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.07 0.548 . . . . 72.14 110.298 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.545 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 15.2 ptm 58.46 177.79 0.07 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.472 1.909 . . . . 75.13 114.267 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m -152.48 130.32 11.69 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.797 1.239 . . . . 75.35 108.012 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -151.68 128.6 11.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.936 0.494 . . . . 73.23 110.104 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -159.67 144.27 15.09 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.678 0.791 . . . . 75.43 108.942 161.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.548 HG23 ' HE2' ' B' ' 84' ' ' PHE . 2.7 pp -59.13 138.4 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.498 -0.774 . . . . 73.24 109.957 168.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.436 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.7 mm100 -100.47 -45.98 5.38 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.575 -0.898 . . . . 75.34 108.575 172.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -164.84 129.93 2.64 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.99 -1.004 . . . . 75.14 108.882 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -115.03 135.98 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 106.667 -1.605 . . . . 74.32 106.667 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 26.5 p90 -166.5 158.44 13.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.482 0.658 . . . . 75.33 111.331 -173.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 78.2 m -85.46 119.71 26.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.162 -0.926 . . . . 75.02 108.962 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 44.3 mtpt -88.32 -34.68 17.57 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.273 0.629 . . . . 73.14 110.177 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.582 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.2 t70 -153.79 147.16 24.87 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.568 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.62 HD13 ' SG ' ' B' ' 113' ' ' CYS . 41.0 mm -139.76 142.94 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.86 1.664 . . . . 74.34 107.573 177.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -148.43 138.17 22.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.665 -0.865 . . . . 74.51 108.665 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.435 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -151.18 123.3 8.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.239 -1.393 . . . . 75.44 107.239 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -120.89 149.52 42.49 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.081 0.552 . . . . 75.31 109.542 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.557 ' HB2' ' HB1' ' B' ' 28' ' ' ALA . . . -143.72 80.26 12.92 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.11 -1.07 . . . . 71.21 108.11 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.41 -17.66 39.03 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.057 2.505 . . . . 73.01 111.872 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -122.87 27.84 7.53 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.501 1.121 . . . . 72.22 109.439 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.557 ' HB1' ' HB2' ' B' ' 25' ' ' ALA . . . -47.05 -50.05 47.87 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 124.275 1.03 . . . . 75.32 112.836 172.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 1.0 OUTLIER -85.21 -35.29 0.16 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.504 2.136 . . . . 62.34 112.709 178.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.407 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.1 m80 -90.84 2.35 56.2 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 75.31 112.908 -170.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.83 -28.59 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 125.075 1.35 . . . . 71.0 111.898 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -66.62 -13.82 61.62 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.753 1.221 . . . . 73.42 112.381 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.595 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 10.3 pt20 -73.34 -32.45 64.56 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.427 0.632 . . . . 74.3 110.253 174.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.595 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 29.3 mmtp -107.03 81.81 1.6 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.04 1.336 . . . . 51.25 108.922 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.39 77.17 8.29 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.547 -0.751 . . . . 73.44 111.644 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.535 ' HE3' ' HA ' ' B' ' 36' ' ' TRP 0.258 0.0 OUTLIER 160.56 -171.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 127.084 2.153 . . . . 71.33 111.141 156.19 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.599 ' HA ' ' HB3' ' H' ' 297' ' ' TYR . 12.4 pt20 -59.02 132.2 87.11 Favored Pre-proline 0 C--N 1.361 1.068 0 C-N-CA 124.755 1.222 . . . . 74.21 113.278 -168.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.42 171.77 15.48 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.418 2.746 . . . . 74.23 112.784 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -69.39 109.41 4.17 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 108.596 -0.89 . . . . 72.43 108.596 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.573 HG23 ' HA ' ' H' ' 295' ' ' ALA . 9.3 m -95.16 135.0 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.407 -0.815 . . . . 72.52 109.931 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -141.65 124.28 15.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.329 1.052 . . . . 73.55 108.294 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.638 HD23 HD21 ' B' ' 128' ' ' LEU . 64.7 tp -97.41 145.49 26.12 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.454 -0.573 . . . . 74.33 109.454 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -146.66 154.25 41.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.999 -1.112 . . . . 71.01 107.999 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -138.38 141.97 39.63 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.484 -0.932 . . . . 75.33 108.484 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.676 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 15.1 t70 -124.34 144.02 50.25 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.966 0.906 . . . . 61.31 108.699 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.3 p -112.23 112.08 23.43 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.423 -0.808 . . . . 74.3 110.225 -170.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.96 125.36 31.4 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.314 -0.995 . . . . 71.35 108.314 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.6 p -142.82 168.17 20.34 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.36 0.664 . . . . 64.32 109.621 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 57.8 p -150.99 141.06 22.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.129 0.572 . . . . 74.33 109.909 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -82.02 109.74 16.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.826 -0.805 . . . . 71.43 108.826 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.528 HD12 HG22 ' B' ' 83' ' ' ILE . 55.1 mt -75.83 -41.03 53.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.445 . . . . 75.54 110.245 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.75 -171.77 3.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.184 0.994 . . . . 72.25 110.062 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.88 111.37 1.44 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 115.555 -0.748 . . . . 74.34 110.446 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 65.55 12.53 8.27 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.637 1.175 . . . . 75.54 112.516 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.06 115.14 47.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.094 -1.076 . . . . 72.42 108.094 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -124.14 138.49 54.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.225 -0.657 . . . . 72.44 109.225 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.434 ' HB2' HD13 ' B' ' 51' ' ' LEU . 7.8 tm-20 -107.08 106.92 17.66 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.278 -1.379 . . . . 73.32 107.278 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.1 t -96.4 121.57 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.088 1.355 . . . . 74.34 110.04 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.485 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 30.0 t -105.39 120.19 55.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.437 0.695 . . . . 54.11 109.149 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' B' ' 103' ' ' PRO . 50.2 tp -95.16 99.16 11.18 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 73.3 108.605 172.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.676 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 65.2 ttt180 -88.48 107.94 19.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.813 -0.81 . . . . 71.53 108.813 177.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.415 HG13 HD12 ' B' ' 42' ' ' LEU . 77.2 t -104.9 102.87 14.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.177 0.991 . . . . 65.53 108.934 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -100.93 128.47 46.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.376 0.67 . . . . 72.43 109.836 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.43 135.29 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.333 1.053 . . . . 72.44 108.932 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.9 m -124.83 143.59 50.74 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.528 0.731 . . . . 64.5 109.571 174.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.74 130.25 24.0 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.915 -1.142 . . . . 64.22 107.915 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 8.4 m -135.14 126.53 28.47 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 120.81 0.338 . . . . 74.4 111.586 -176.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.533 HD11 ' HB2' ' B' ' 34' ' ' LYS . 56.9 mt -93.9 109.75 21.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.409 1.084 . . . . 73.24 108.467 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.9 -111.17 3.86 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.051 -0.82 . . . . 73.23 111.051 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -121.97 18.42 10.91 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.657 0.742 . . . . 73.22 110.214 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -122.2 142.79 50.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.529 -0.732 . . . . 75.21 109.132 178.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.7 m -66.78 118.45 10.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.909 0.484 . . . . 75.4 110.983 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.48 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -68.03 -55.46 12.51 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.973 -0.751 . . . . 71.4 108.973 177.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . 0.415 ' CZ ' HG21 ' H' ' 296' ' ' THR . 50.4 p90 -164.4 164.98 21.96 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.203 -1.362 . . . . 75.24 109.214 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.76 151.91 42.75 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.439 1.096 . . . . 74.04 108.514 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.4 t -155.52 115.66 3.75 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.221 -0.659 . . . . 74.43 109.221 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -123.62 127.04 47.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.143 -1.058 . . . . 74.15 108.143 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.491 HG12 HD11 ' B' ' 21' ' ' ILE . 57.3 t -122.55 148.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.875 -0.787 . . . . 74.05 108.875 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.582 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.5 mt-30 -123.4 99.46 6.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.218 -1.031 . . . . 64.24 108.218 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.511 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -93.71 100.45 12.67 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.35 -0.981 . . . . 74.35 108.35 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.485 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.94 162.0 29.7 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 123.677 0.61 . . . . 45.15 111.912 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.89 127.13 1.64 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.226 -0.75 . . . . 71.53 111.226 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.528 HG22 HD12 ' B' ' 51' ' ' LEU . 33.9 mt -83.98 133.81 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.057 -1.09 . . . . 74.24 108.057 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.548 ' HE2' HG23 ' B' ' 13' ' ' ILE . 49.2 m-85 -135.42 138.61 43.41 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.454 0.702 . . . . 75.13 109.45 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -91.86 103.74 16.25 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.791 -0.818 . . . . 74.33 108.791 169.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.423 ' HB ' HD11 ' B' ' 89' ' ' ILE . 26.1 pt -120.21 122.04 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.879 0.872 . . . . 72.2 110.007 -176.024 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.87 21.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.839 0.855 . . . . 61.54 109.876 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.36 -45.32 3.48 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.525 0.516 . . . . 74.13 113.108 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.452 HG13 HD12 ' H' ' 277' ' ' LEU . 20.9 pt -64.03 158.88 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.655 1.182 . . . . 73.4 112.439 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -170.21 166.57 8.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.581 1.152 . . . . 74.3 109.8 176.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -119.1 16.6 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.297 -0.411 . . . . 71.35 113.881 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -80.27 -18.87 48.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 74.33 111.345 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -60.89 -44.35 97.24 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 73.42 110.954 177.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.4 ' HE1' ' O ' ' H' ' 277' ' ' LEU . 3.3 ppp? -73.24 -32.7 64.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.661 0.384 . . . . 71.14 110.612 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.57 -33.7 76.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.721 0.808 . . . . 63.52 111.406 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -85.24 -26.64 26.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.667 0.787 . . . . 74.0 110.488 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.97 -67.18 0.53 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.562 0.345 . . . . 75.15 110.569 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.442 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -95.14 -6.48 41.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.517 0.562 . . . . 74.53 112.517 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.8 2.38 45.19 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.216 0.322 . . . . 71.5 113.036 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.76 -58.36 0.32 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.094 0.558 . . . . 63.43 111.037 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.41 -46.8 46.57 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.198 0.599 . . . . 73.2 111.963 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 68.8 m -66.04 -42.46 51.67 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.546 0.738 . . . . 74.31 111.781 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.406 ' HA ' HD23 ' B' ' 60' ' ' LEU . 89.9 Cg_exo -50.87 -43.72 45.46 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.628 2.218 . . . . 74.11 112.893 166.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.87 -25.04 67.0 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.183 0.593 . . . . 71.44 112.523 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mt -76.8 -50.55 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.407 0.683 . . . . 71.03 110.346 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.36 -15.95 57.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.562 0.745 . . . . 70.43 111.521 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.458 ' HE1' HD13 ' B' ' 128' ' ' LEU . 37.8 t80 -62.5 -53.33 58.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.609 -1.186 . . . . 75.3 112.799 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 71.4 Cg_exo -54.26 -37.76 88.31 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.187 1.925 . . . . 75.15 113.59 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.511 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 80.0 m-85 -68.33 -51.38 45.22 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.737 0.815 . . . . 72.02 110.947 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.72 81.23 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.959 0.904 . . . . 64.03 111.33 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -64.95 -52.71 54.82 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.457 1.503 . . . . 73.21 110.296 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -34.84 78.4 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.903 0.752 . . . . 73.34 109.776 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.62 ' SG ' HD13 ' B' ' 21' ' ' ILE . 1.8 t -68.66 -43.29 76.53 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.904 0.482 . . . . 75.15 111.363 -177.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.85 -43.78 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 123.445 0.698 . . . . 75.14 110.338 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.717 HG23 ' HB2' ' B' ' 125' ' ' GLN . 44.5 m -64.02 -27.7 69.29 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.203 -0.908 . . . . 74.35 111.052 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.8 t -73.59 -45.01 55.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.458 0.703 . . . . 74.14 110.122 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.516 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -72.5 -37.78 68.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.991 0.517 . . . . 72.33 112.025 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.59 -31.07 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.002 0.43 . . . . 73.43 110.46 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.45 ' OG ' HG21 ' C' ' 115' ' ' THR . 21.5 t -70.98 -30.54 66.84 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.925 0.89 . . . . 72.04 111.611 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.566 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.7 mtt-85 -74.03 -31.16 62.78 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.213 -0.903 . . . . 75.11 109.683 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.4 0.7 68.09 Favored Glycine 0 C--N 1.362 2.027 0 O-C-N 123.911 0.757 . . . . 53.34 112.203 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.543 HG21 HH22 ' C' ' 111' ' ' ARG . 29.3 p 65.5 23.62 11.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.93 2.092 . . . . 75.44 113.244 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.59 150.85 39.53 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 122.893 0.477 . . . . 74.55 110.079 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.505 ' O ' HG23 ' H' ' 296' ' ' THR . 91.9 Cg_exo -42.0 137.76 3.07 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.381 3.387 . . . . 73.01 113.226 173.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.717 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.0 pt20 -66.57 157.33 32.6 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.267 1.21 . . . . 75.51 114.267 -174.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.458 ' HB2' HG22 ' H' ' 296' ' ' THR . 2.1 tt -110.77 95.86 5.82 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.521 -1.659 . . . . 75.31 106.521 165.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -88.33 92.6 9.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.923 -1.51 . . . . 72.41 106.923 173.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.638 HD21 HD23 ' B' ' 42' ' ' LEU . 1.2 tt -63.44 133.91 54.76 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.785 -1.098 . . . . 72.42 110.892 -165.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' H' ' 291' ' ' LEU . . . -62.99 146.6 95.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.155 0.982 . . . . 74.44 111.051 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.77 116.16 3.11 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.682 2.254 . . . . 72.24 111.516 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.48 HG22 HD22 ' H' ' 291' ' ' LEU . 12.7 t -90.76 118.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.226 -0.657 . . . . 73.03 109.226 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' B' ' 135' ' ' ALA . 59.7 t30 -96.74 103.67 15.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.578 0.751 . . . . 71.5 109.823 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -87.08 -23.31 24.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.625 0.77 . . . . 73.11 110.707 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -60.25 -34.86 74.29 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.509 -0.768 . . . . 74.31 110.685 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.534 ' HB3' ' ND2' ' B' ' 132' ' ' ASN . . . -51.52 -40.19 59.13 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.087 0.955 . . . . 75.32 113.193 -176.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 57.0 tp -72.08 -52.26 17.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.74 0.416 . . . . 73.13 110.835 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -69.37 -29.52 67.32 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.274 0.63 . . . . 73.4 112.682 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.7 -41.52 65.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.521 0.728 . . . . 63.54 109.438 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -78.73 -25.08 44.54 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.231 -1.35 . . . . 72.2 110.112 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -65.52 -38.38 89.52 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.215 -0.902 . . . . 75.22 110.358 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.1 mt -91.01 3.09 55.64 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.301 -0.863 . . . . 63.35 111.51 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -81.02 98.05 7.78 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-O 121.304 0.573 . . . . 75.35 109.986 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -139.46 -31.56 0.68 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.505 1.122 . . . . 75.35 110.137 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -92.23 163.53 13.88 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.687 0.795 . . . . 75.0 110.456 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.1 111.14 8.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.621 0.768 . . . . 72.42 110.361 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -175.49 39.83 0.11 Allowed Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.347 -0.701 . . . . 73.42 111.347 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.54 -153.6 0.53 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.242 1.017 . . . . 74.45 109.358 -174.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.96 55.1 1.66 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 110.289 -1.124 . . . . 54.24 110.289 -173.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -152.19 166.65 31.05 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 124.364 1.066 . . . . 73.33 109.727 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -68.93 115.87 8.74 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.71 0.804 . . . . 73.11 109.597 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -75.75 73.44 2.7 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.294 -1.002 . . . . 74.31 108.294 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -69.25 129.42 39.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.862 -1.063 . . . . 71.41 111.051 -171.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' F' ' 310' ' ' PRO . 11.6 pt20 -173.93 166.82 4.35 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.233 1.413 . . . . 74.21 109.646 175.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.49 76.09 0.81 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.977 -0.749 . . . . 70.45 108.977 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.836 -1.074 . . . . 74.51 109.024 177.107 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.193 -0.669 . . . . 73.3 109.193 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.5 t 63.0 81.44 0.2 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.95 1.3 . . . . 65.42 110.945 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.72 16.98 5.06 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.212 1.005 . . . . 71.44 112.439 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 66.32 125.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.33 1.452 . . . . 74.44 112.082 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -155.68 142.29 18.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.273 0.629 . . . . 74.42 110.218 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -151.21 172.74 15.35 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.24 1.016 . . . . 71.05 108.637 173.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 87.0 m -129.29 -71.81 0.61 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.295 -1.002 . . . . 74.14 108.295 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.18 64.89 1.61 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.745 1.218 . . . . 72.34 109.904 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.533 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 57.9 ttp 65.89 144.43 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.001 1.32 . . . . 73.44 112.704 -170.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 67.6 m -119.11 97.17 5.55 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.894 -1.521 . . . . 70.23 106.894 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.92 121.68 45.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.338 0.655 . . . . 74.4 109.633 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -137.84 145.13 41.87 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.363 0.665 . . . . 71.5 109.748 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.471 HD12 ' HB2' ' A' ' 127' ' ' ASN . 2.6 pp -82.42 142.68 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.615 -0.883 . . . . 73.41 108.615 171.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -110.09 -50.19 3.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.855 -0.424 . . . . 75.14 109.855 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.684 HH12 HD11 ' G' ' 301' ' ' ILE . 62.7 ttt180 -169.71 130.95 1.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.245 0.341 . . . . 75.21 110.464 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 65.6 mt -109.61 140.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.826 1.25 . . . . 73.2 107.92 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.419 ' HE1' HG12 ' C' ' 83' ' ' ILE . 12.8 p90 -171.89 154.5 3.56 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.018 0.826 . . . . 74.42 112.212 -175.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -80.44 106.44 12.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.661 -1.154 . . . . 71.42 107.974 170.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -68.73 -48.16 64.51 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.872 0.844 . . . . 72.42 109.205 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.8 t70 -134.65 141.81 46.68 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.237 -1.347 . . . . 74.02 109.244 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.3 mt -135.63 145.33 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.353 1.461 . . . . 75.24 107.219 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -155.59 152.01 28.24 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.212 0.529 . . . . 74.13 110.355 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.3 t80 -147.94 119.11 7.74 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.298 -1.371 . . . . 72.04 107.298 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.515 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 41.4 mt-10 -118.7 118.23 31.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.163 0.585 . . . . 72.43 109.628 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.54 86.0 35.71 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.627 0.771 . . . . 72.02 109.313 175.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -71.25 -28.71 18.17 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.954 2.436 . . . . 65.24 111.781 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.594 ' HB3' ' HZ1' ' C' ' 34' ' ' LYS . 2.0 m-20 -96.99 19.81 12.2 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.397 1.079 . . . . 64.42 110.465 -179.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.0 99.34 Favored Pre-proline 0 CA--C 1.567 1.596 0 C-N-CA 124.812 1.245 . . . . 74.03 113.953 -177.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.94 -31.06 6.62 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.775 1.65 . . . . 65.52 111.875 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -66.68 -21.84 66.09 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.896 1.278 . . . . 75.24 112.744 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.53 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 8.3 p -50.92 -33.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 113.856 1.058 . . . . 73.32 113.856 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -58.35 -30.8 67.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.569 0.748 . . . . 71.42 112.624 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.25 28.06 9.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.232 1.013 . . . . 73.33 110.593 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.631 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 14.1 ttmm -104.15 147.27 27.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.242 0.617 . . . . 70.52 109.739 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.25 130.74 42.83 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.347 0.659 . . . . 74.11 109.836 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -84.7 62.81 7.59 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 123.731 0.644 . . . . 75.13 111.246 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -156.28 77.66 4.33 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.361 1.065 . . . . 74.24 108.348 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.467 ' HB2' ' HB1' ' C' ' 66' ' ' ALA . 72.5 Cg_endo -88.45 140.2 4.4 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 122.454 2.103 . . . . 73.41 111.608 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.03 115.52 24.47 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.249 -1.019 . . . . 73.32 108.249 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.85 106.22 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.86 -0.793 . . . . 74.52 108.86 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -92.11 108.31 19.84 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.18 122.85 32.21 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.281 -1.377 . . . . 75.41 107.281 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.777 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.0 m-20 -119.88 118.27 30.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.769 0.827 . . . . 74.34 109.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.45 126.34 53.39 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.908 -0.775 . . . . 75.52 108.908 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.592 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 19.8 t70 -128.53 135.68 49.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.719 1.208 . . . . 75.03 108.107 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.0 p -113.73 126.58 55.39 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.946 0.498 . . . . 65.32 110.358 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.508 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -126.58 145.66 50.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.951 0.9 . . . . 74.15 110.081 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.4 p -144.04 148.68 35.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.256 0.622 . . . . 74.0 109.458 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -145.38 140.28 27.56 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.564 -0.902 . . . . 72.35 108.564 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -94.29 115.82 28.12 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.044 -1.095 . . . . 73.21 108.044 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.513 HD13 HD13 ' C' ' 83' ' ' ILE . 35.1 mt -87.92 -40.83 13.62 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.745 0.818 . . . . 71.43 109.618 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.81 -175.77 5.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.085 1.354 . . . . 63.14 108.371 175.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -62.45 122.94 16.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.389 0.431 . . . . 62.3 109.943 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 68.93 -7.09 0.8 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.67 1.588 . . . . 74.42 113.604 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.22 107.05 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.837 -1.171 . . . . 74.42 107.837 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.421 ' HB2' HD12 ' C' ' 86' ' ' ILE . 72.9 m-85 -118.18 122.87 44.12 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.927 -1.138 . . . . 74.11 107.927 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.22 120.77 26.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.158 0.983 . . . . 75.5 109.141 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.2 t -97.05 116.07 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 72.21 108.375 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.508 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 59.6 t -117.82 134.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.643 0.777 . . . . 72.34 109.132 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.91 111.02 19.06 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.592 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.2 ttm180 -79.96 105.83 11.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.041 -1.466 . . . . 75.43 107.041 167.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.25 114.07 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.09 -1.078 . . . . 75.13 108.09 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.777 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 64.2 m -114.71 137.73 51.57 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.715 0.806 . . . . 72.43 108.882 -174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.604 HG23 HG21 ' C' ' 114' ' ' ILE . 61.0 t -128.23 112.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.667 -1.234 . . . . 62.25 107.667 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -106.24 139.89 40.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.613 -0.884 . . . . 72.45 108.613 169.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . 0.467 ' HB1' ' HB2' ' C' ' 38' ' ' PRO . . . -121.34 112.89 19.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.881 -1.526 . . . . 74.32 106.881 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.0 m -148.12 137.44 22.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.116 0.566 . . . . 72.05 110.354 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.5 58.79 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.391 1.076 . . . . 75.4 109.347 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 -117.78 5.3 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.808 -1.087 . . . . 73.2 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.53 -30.25 18.36 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.925 -0.769 . . . . 75.51 108.925 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -63.61 100.05 0.25 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 124.236 0.96 . . . . 63.24 109.476 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -85.56 134.96 34.0 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.053 0.541 . . . . 73.41 109.856 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.631 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -80.83 -61.05 2.08 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.995 0.918 . . . . 61.21 109.173 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -167.59 178.0 5.6 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.952 0.782 . . . . 74.31 110.934 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.515 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -138.49 144.85 40.2 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.548 -1.279 . . . . 75.01 107.548 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.0 t -148.98 142.92 25.78 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.792 -1.188 . . . . 74.2 107.792 174.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.64 134.54 11.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.896 0.316 . . . . 61.14 110.722 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -138.48 116.08 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.458 1.103 . . . . 54.01 110.027 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.496 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 2.2 mp0 -89.99 88.4 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.179 0.992 . . . . 72.24 108.426 174.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.39 103.41 9.29 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.061 -0.972 . . . . 70.25 110.081 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.54 153.11 20.86 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.784 -0.644 . . . . 63.21 111.763 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.08 117.37 0.82 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 110.225 -1.15 . . . . 74.44 110.225 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.513 HD13 HD13 ' C' ' 51' ' ' LEU . 12.9 mm -81.2 122.31 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.11 -0.7 . . . . 74.22 109.11 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.412 ' HB2' HD11 ' C' ' 86' ' ' ILE . 60.3 m-85 -132.07 152.82 50.98 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.534 -0.914 . . . . 71.41 108.534 176.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -110.27 113.15 25.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.542 -0.91 . . . . 74.12 108.542 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' C' ' 56' ' ' TYR . 2.9 mp -115.75 103.15 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.204 -1.406 . . . . 70.22 107.204 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.52 169.83 10.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.339 0.656 . . . . 72.45 110.903 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.06 -50.69 2.8 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.913 -0.585 . . . . 74.02 112.484 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 170.32 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.002 0.521 . . . . 72.25 111.769 -171.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.22 -173.99 4.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.767 0.827 . . . . 73.25 109.823 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -138.63 39.12 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.738 -0.479 . . . . 63.54 113.627 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 92' ' ' THR . . . . . 0.473 ' HA ' ' HB1' ' C' ' 95' ' ' ALA . 35.7 p -68.54 -22.3 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.915 0.886 . . . . 74.11 111.818 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.41 -50.07 61.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 74.42 110.041 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -66.83 -38.21 85.98 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.871 -0.604 . . . . 71.31 109.985 172.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.473 ' HB1' ' HA ' ' C' ' 92' ' ' THR . . . -60.88 -27.69 68.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.874 0.87 . . . . 62.44 112.331 -175.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -74.91 -47.88 27.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.007 -0.368 . . . . 71.5 110.007 172.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.533 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 18.7 t -70.73 -22.3 62.45 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 111.984 0.364 . . . . 72.34 111.984 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.24 -43.48 5.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.084 0.954 . . . . 75.01 109.521 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.66 -5.36 64.85 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.56 -0.746 . . . . 75.5 114.139 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.433 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -133.87 -54.7 0.87 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.192 0.496 . . . . 54.31 111.361 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.696 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 33.4 t80 -67.13 -55.92 12.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.156 0.983 . . . . 71.35 112.079 -172.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.83 -45.49 87.59 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 113.044 0.757 . . . . 72.31 113.044 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -56.61 -39.89 88.24 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.715 2.277 . . . . 70.11 113.72 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.69 -28.7 69.26 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.937 0.895 . . . . 64.34 110.982 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.533 HD13 ' NH1' ' A' ' 111' ' ' ARG . 24.0 mm -72.79 -44.87 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.449 0.7 . . . . 73.21 110.592 173.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.08 -15.01 54.96 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.635 -0.711 . . . . 72.25 112.134 -173.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.472 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 78.1 t80 -57.11 -50.57 87.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 124.837 1.255 . . . . 71.52 113.139 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.472 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 34.4 Cg_exo -62.85 -32.79 77.2 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 122.129 1.886 . . . . 73.13 113.428 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.34 -44.88 86.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.688 0.795 . . . . 73.44 111.626 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.64 95.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.001 -0.545 . . . . 73.43 110.117 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.543 HH22 HG21 ' B' ' 122' ' ' THR . 48.2 ttt180 -56.44 -55.1 37.91 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.224 0.952 . . . . 75.45 111.255 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.41 -30.7 71.54 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.294 0.638 . . . . 71.4 110.69 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.74 -39.82 63.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.812 0.445 . . . . 74.4 111.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.604 HG21 HG23 ' C' ' 64' ' ' VAL . 66.5 mt -62.62 -47.0 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.958 0.903 . . . . 70.04 109.87 172.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 115' ' ' THR . . . . . 0.45 HG21 ' OG ' ' B' ' 119' ' ' SER . 86.8 m -67.62 -29.33 68.63 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 114.088 -1.414 . . . . 74.44 110.846 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -68.33 -46.26 70.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.384 0.674 . . . . 73.21 109.592 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.602 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.46 -42.71 95.79 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.302 1.041 . . . . 73.21 113.248 -176.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 22.8 m -66.65 -32.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.576 0.227 . . . . 73.43 110.438 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.53 -34.42 77.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.111 0.964 . . . . 74.11 111.473 174.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.449 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.4 mtt-85 -72.77 -33.25 66.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.743 0.817 . . . . 73.45 110.498 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.26 64.46 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 123.661 0.601 . . . . 45.13 112.465 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.412 ' OG1' ' HD3' ' D' ' 15' ' ' ARG . 69.3 p 58.04 31.36 20.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.152 1.781 . . . . 62.52 112.943 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.42 148.41 36.27 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.539 1.135 . . . . 72.3 108.771 174.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.408 ' HG2' ' HA ' ' F' ' 297' ' ' TYR . 77.6 Cg_exo -51.46 138.58 47.5 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.416 2.744 . . . . 75.34 112.821 176.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.418 ' HB3' HG22 ' C' ' 115' ' ' THR . 95.9 mt-30 -63.36 149.3 46.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 113.865 1.061 . . . . 75.33 113.865 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.7 98.24 6.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 106.863 -1.532 . . . . 75.04 106.863 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -92.38 130.44 38.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.313 0.645 . . . . 72.25 109.603 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.05 136.64 37.23 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.594 0.758 . . . . 65.15 110.495 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.536 ' HB2' HD13 ' F' ' 291' ' ' LEU . . . -80.02 157.8 73.24 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.263 1.025 . . . . 70.23 109.963 177.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.76 98.9 0.31 Allowed 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 122.358 2.038 . . . . 71.25 113.075 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.57 109.28 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.482 -1.303 . . . . 74.43 107.482 170.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -110.45 101.35 10.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.221 -1.029 . . . . 71.1 108.221 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.433 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 64.0 m-85 -69.72 -30.09 67.63 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.454 -0.794 . . . . 72.41 110.923 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.39 -52.0 67.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.671 0.788 . . . . 74.41 110.7 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.19 72.83 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.007 1.323 . . . . 73.03 111.734 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 tt -51.65 -57.84 8.05 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.53 1.144 . . . . 74.51 110.275 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.37 -18.34 49.26 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.076 0.55 . . . . 74.33 111.77 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 27.8 ttt -75.79 -26.59 57.46 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.587 1.155 . . . . 63.11 111.024 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -51.47 -45.87 62.91 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.446 0.698 . . . . 64.4 110.688 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -71.15 -87.08 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 108.868 -0.79 . . . . 73.15 108.868 169.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 56.1 tp 53.22 120.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.838 1.655 . . . . 73.42 113.85 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -140.45 11.79 2.33 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.354 0.597 . . . . 74.4 110.062 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.18 -79.72 0.32 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.921 -1.14 . . . . 73.31 107.921 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 49.86 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.118 1.367 . . . . 72.14 112.791 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.95 -54.73 2.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.839 -0.8 . . . . 60.03 108.839 173.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.08 71.71 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.1 -0.955 . . . . 73.33 113.593 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.24 -165.69 1.28 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.954 0.902 . . . . 73.43 108.939 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.41 98.38 0.19 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.738 -0.945 . . . . 64.33 110.738 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 98.3 m -139.97 137.35 34.65 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.427 0.691 . . . . 61.15 109.789 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.12 139.71 26.17 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.664 -1.236 . . . . 74.34 107.664 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.4 ' HG2' ' HB2' ' C' ' 153' ' ' GLN . 40.9 tt0 -95.81 110.45 22.61 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.522 -0.918 . . . . 75.44 108.522 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -87.72 73.69 9.28 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.765 0.793 . . . . 74.44 109.009 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.4 ' HB2' ' HG2' ' C' ' 151' ' ' GLU . 17.6 tm0? -113.16 100.93 8.96 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.623 -1.251 . . . . 74.11 107.623 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -135.08 177.77 7.55 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.061 0.945 . . . . 74.33 109.727 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 C-N-CA 123.71 0.804 . . . . 60.11 109.226 -179.565 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 108.776 -0.824 . . . . 74.43 108.776 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -88.27 -65.65 1.0 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.136 -0.69 . . . . 65.15 109.136 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -175.94 99.02 0.07 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.437 1.095 . . . . 74.42 109.39 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . 0.446 HE22 ' HB2' ' D' ' 8' ' ' GLU . 24.8 tp60 -78.38 89.59 4.39 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -91.22 -64.41 1.13 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.259 1.024 . . . . 72.2 110.685 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -134.26 -156.61 0.75 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.648 0.779 . . . . 72.33 110.431 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 38.0 p -55.03 102.2 0.06 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.948 0.899 . . . . 65.51 111.35 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.446 ' HB2' HE22 ' D' ' 4' ' ' GLN . 50.6 mt-10 -132.98 -140.97 0.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.077 1.351 . . . . 63.41 108.419 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.431 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.2 tmt? -29.69 129.7 0.09 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.828 1.651 . . . . 72.23 114.518 173.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m -148.44 139.58 23.23 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.384 1.474 . . . . 73.01 108.436 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -149.76 94.95 2.25 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.947 -1.131 . . . . 75.52 107.947 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -117.94 125.87 51.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.314 0.645 . . . . 65.22 109.421 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.37 124.89 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.713 -0.847 . . . . 74.54 108.713 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' F' ' 305' ' ' ALA . 56.2 mt-30 -87.42 -34.96 18.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.287 -0.634 . . . . 50.41 109.287 175.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.756 HH22 HD13 ' F' ' 301' ' ' ILE . 17.7 ttm180 -175.64 144.37 0.65 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.102 -0.953 . . . . 75.31 109.357 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -131.11 130.13 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 106.455 -1.683 . . . . 74.14 106.455 171.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 27.5 p90 -164.52 173.42 12.07 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.834 0.826 . . . . 72.15 111.249 -165.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.26 121.62 41.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.694 -1.139 . . . . 70.3 108.896 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.2 mtpt -85.46 -39.86 17.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.3 0.571 . . . . 75.33 109.732 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.407 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 19.9 t70 -149.78 126.76 11.19 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 114.67 -1.15 . . . . 70.04 108.984 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.602 HG21 ' HE1' ' C' ' 117' ' ' MET . 70.0 mt -118.87 147.1 22.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.429 -0.952 . . . . 71.01 108.429 175.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -143.77 136.01 26.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.21 1.004 . . . . 72.41 109.097 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.504 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.3 t80 -140.28 117.63 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.126 -1.805 . . . . 74.54 106.126 168.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -123.71 122.35 37.87 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.269 0.628 . . . . 74.44 109.811 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.38 81.26 3.9 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 107.181 -1.415 . . . . 75.34 107.181 168.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.2 -33.47 18.64 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.734 2.289 . . . . 71.24 112.116 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -111.66 29.76 7.57 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 108.768 -0.827 . . . . 65.2 108.768 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.423 ' HB2' ' HD3' ' D' ' 29' ' ' PRO . . . -46.39 -61.52 2.57 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 114.989 1.477 . . . . 71.24 114.989 -166.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.491 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.1 Cg_endo -81.81 -13.03 10.73 Favored 'Trans proline' 0 C--N 1.378 2.089 0 CA-C-N 121.54 1.586 . . . . 74.51 113.329 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -69.35 -41.38 76.68 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.859 0.864 . . . . 75.23 109.249 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' D' ' 35' ' ' ASP . 36.1 t -70.8 -35.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 CA-C-N 114.909 -1.041 . . . . 75.45 109.98 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.401 ' O ' HD12 ' G' ' 301' ' ' ILE . 22.2 m-30 -64.36 -6.79 7.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.969 1.1 . . . . 73.1 113.969 -177.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -84.62 -35.46 22.67 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.027 0.531 . . . . 74.12 109.915 170.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -128.7 60.09 1.53 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.114 0.966 . . . . 72.33 110.352 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.538 ' HB3' HD13 ' G' ' 301' ' ' ILE . 5.7 t0 -110.08 94.56 5.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.737 . . . . 75.41 109.463 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.525 ' H ' HD23 ' D' ' 68' ' ' LEU . 10.8 m95 -124.4 -159.5 0.88 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.927 -1.508 . . . . 73.25 106.927 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.402 ' HA ' ' HB3' ' G' ' 297' ' ' TYR . 9.1 tt0 -63.35 112.32 6.79 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 118.374 0.534 . . . . 73.32 111.558 -177.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.54 151.78 13.36 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.111 2.541 . . . . 71.32 112.313 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.89 113.68 20.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.996 -0.742 . . . . 73.43 108.996 166.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.524 HG21 ' NE1' ' G' ' 290' ' ' TRP . 3.6 m -99.28 106.37 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.074 0.95 . . . . 72.55 109.602 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.0 mmtt -88.31 128.76 35.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.349 1.06 . . . . 75.5 108.952 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.05 113.05 24.8 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.532 -0.544 . . . . 75.51 109.532 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -122.94 115.75 22.45 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.892 -0.781 . . . . 63.24 108.892 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.96 145.75 31.88 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.28 0.632 . . . . 72.31 109.973 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -137.15 131.31 32.39 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.364 1.066 . . . . 73.31 108.511 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 56.6 p -105.71 144.67 32.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.469 0.708 . . . . 73.14 110.195 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.22 155.03 35.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.498 0.719 . . . . 52.53 109.885 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -164.07 153.27 13.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.781 0.832 . . . . 54.21 109.883 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.9 p -160.47 151.77 19.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 70.32 110.101 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -81.8 118.57 22.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.078 0.551 . . . . 71.03 109.688 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.518 HD13 HG22 ' D' ' 83' ' ' ILE . 77.3 mt -92.34 -31.3 15.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.339 0.656 . . . . 74.35 110.488 177.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.02 -179.34 7.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.277 0.631 . . . . 73.2 110.707 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.58 116.92 5.57 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.702 -1.135 . . . . 74.51 110.117 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.58 ' HB3' ' HB1' ' D' ' 87' ' ' ALA . 11.7 m-20 60.47 24.66 14.27 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.258 0.974 . . . . 73.12 111.539 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.48 116.54 44.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.053 -1.092 . . . . 75.45 108.053 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.641 ' HH ' HD12 ' G' ' 277' ' ' LEU . 96.8 m-85 -129.82 129.03 43.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.335 1.054 . . . . 74.51 108.738 -174.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -90.32 139.1 30.99 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.989 0.915 . . . . 73.12 109.744 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.45 117.28 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 107.354 -1.35 . . . . 74.43 107.354 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.7 t -100.18 128.82 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.279 -1.008 . . . . 74.43 108.279 172.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 107.23 12.55 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.769 -1.197 . . . . 74.42 107.769 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.572 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 16.1 ttm-85 -87.17 105.71 17.38 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.218 -0.901 . . . . 75.21 109.566 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.22 120.47 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.685 -0.857 . . . . 73.44 108.685 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.3 m -125.84 135.85 52.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.705 0.802 . . . . 75.21 109.137 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.494 HG12 HD11 ' D' ' 126' ' ' LEU . 44.0 t -129.95 117.95 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.436 1.094 . . . . 65.13 109.68 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 57.0 m -105.57 100.6 10.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.135 0.974 . . . . 62.33 110.093 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.71 125.15 40.97 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.234 -0.291 . . . . 51.44 110.773 -178.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.5 m -138.94 123.32 18.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.841 0.856 . . . . 61.11 109.611 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.6 OUTLIER -103.07 128.09 50.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.354 0.662 . . . . 71.31 109.852 177.054 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.24 -111.73 3.95 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.95 -0.86 . . . . 72.2 110.95 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.81 5.68 11.49 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.56 0.744 . . . . 73.44 110.877 175.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.04 140.28 50.3 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.1 0.56 . . . . 75.4 110.449 -172.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.8 m -71.98 117.38 13.52 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.607 0.763 . . . . 75.51 111.115 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.594 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -68.45 -65.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.279 0.987 . . . . 70.44 109.914 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -154.51 156.64 37.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.408 -1.269 . . . . 75.52 110.406 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.84 145.93 47.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.747 1.219 . . . . 72.15 107.714 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.568 ' SG ' HG21 ' D' ' 114' ' ' ILE . 49.6 t -150.75 142.11 23.35 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.622 -0.51 . . . . 64.02 109.622 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.04 138.31 14.75 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.988 -0.745 . . . . 74.4 108.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.64 115.57 8.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.331 -0.989 . . . . 74.2 108.331 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.572 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 66.4 mt-30 -88.97 84.49 6.62 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.099 -1.074 . . . . 70.43 108.099 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.52 93.45 5.43 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.208 -0.906 . . . . 70.51 109.031 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.69 142.29 16.55 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.802 -0.919 . . . . 65.13 110.802 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.423 ' HA3' HD22 ' D' ' 106' ' ' LEU . . . -142.99 128.59 3.48 Favored Glycine 0 CA--C 1.499 -0.919 0 N-CA-C 110.327 -1.109 . . . . 72.13 110.327 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.518 HG22 HD13 ' D' ' 51' ' ' LEU . 39.7 mt -90.93 132.3 35.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.701 0.801 . . . . 74.24 109.061 -179.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -134.01 133.43 41.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.88 0.472 . . . . 75.32 110.157 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -79.11 98.88 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.486 0.714 . . . . 64.34 109.27 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.533 HD13 ' HB2' ' D' ' 56' ' ' TYR . 48.2 mt -109.08 106.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.907 0.883 . . . . 74.3 109.506 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.58 ' HB1' ' HB3' ' D' ' 54' ' ' ASP . . . -144.07 148.54 35.31 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.048 0.939 . . . . 72.43 110.092 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 93.48 -20.82 44.28 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.842 -0.421 . . . . 54.32 113.438 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.488 ' HB ' ' HG3' ' D' ' 94' ' ' MET . 0.4 OUTLIER -106.39 139.76 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.675 -1.231 . . . . 71.23 107.675 179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.77 157.85 41.72 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.15 0.58 . . . . 74.45 111.425 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -134.96 51.81 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.597 1.186 . . . . 70.14 115.782 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -63.82 -29.17 70.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.235 1.014 . . . . 74.25 111.841 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -40.5 77.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.624 0.77 . . . . 64.41 109.216 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.488 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 9.9 ttp -75.92 -41.99 50.21 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.813 -0.631 . . . . 73.44 110.773 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.21 69.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.884 0.874 . . . . 73.41 111.2 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -66.23 -46.63 76.52 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.143 -0.48 . . . . 71.44 109.996 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.62 -36.61 78.88 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.017 0.527 . . . . 72.51 111.276 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.573 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.1 tt -77.45 -30.75 53.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.394 0.678 . . . . 70.35 110.02 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.06 -16.44 55.96 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.127 -0.488 . . . . 72.12 113.663 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.09 -64.32 1.32 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.398 0.599 . . . . 75.11 111.289 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -66.03 -47.27 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.151 0.58 . . . . 64.25 111.414 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 58.0 m -61.43 -48.47 90.72 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.348 -0.834 . . . . 70.23 112.731 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.2 Cg_exo -54.9 -39.41 90.45 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.76 2.306 . . . . 73.44 113.91 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -72.47 -14.04 61.58 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.298 0.639 . . . . 62.34 112.541 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -81.09 -40.95 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 121.597 0.713 . . . . 73.53 109.864 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.423 HD22 ' HA3' ' D' ' 82' ' ' GLY . 71.9 mt -78.46 -31.75 48.08 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.909 -1.041 . . . . 75.43 111.802 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -63.72 -42.1 69.39 Favored Pre-proline 0 CA--C 1.56 1.361 0 N-CA-C 114.146 1.165 . . . . 75.33 114.146 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.45 -43.67 55.57 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.152 1.901 . . . . 70.12 113.132 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -74.98 -31.71 61.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.662 0.785 . . . . 74.13 111.891 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.62 -54.53 34.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.068 0.547 . . . . 60.22 109.797 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -56.73 -46.57 81.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 114.091 -1.413 . . . . 72.4 110.899 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.63 -44.49 90.36 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.104 0.878 . . . . 74.12 111.214 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.428 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.5 t -58.61 -41.36 85.69 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.533 0.52 . . . . 74.05 110.947 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.568 HG21 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -62.32 -53.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.939 0.896 . . . . 73.23 110.369 174.071 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -53.84 -42.95 69.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.725 1.21 . . . . 71.02 111.426 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -66.97 -44.65 79.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.754 -1.112 . . . . 65.22 110.654 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.507 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.1 mtm -66.32 -33.76 76.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.863 0.465 . . . . 73.35 111.656 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.412 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.3 t -67.78 -43.3 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.545 -0.752 . . . . 73.31 109.919 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.35 -28.9 64.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.751 0.42 . . . . 73.44 111.699 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -75.04 -32.06 61.46 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.924 0.89 . . . . 75.22 110.085 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.14 5.66 75.48 Favored Glycine 0 C--N 1.356 1.676 0 CA-C-N 115.586 -0.734 . . . . 62.43 111.853 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 65.54 14.15 9.31 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.488 2.315 . . . . 73.32 114.257 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -84.89 158.28 59.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.207 1.003 . . . . 75.21 108.867 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' G' ' 297' ' ' TYR . 55.4 Cg_endo -65.11 136.74 49.26 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.871 2.381 . . . . 74.04 112.175 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -47.19 129.92 12.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.488 1.115 . . . . 74.24 112.135 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.494 HD11 HG12 ' D' ' 64' ' ' VAL . 5.1 tt -107.22 93.93 4.82 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.234 -1.024 . . . . 61.42 108.234 -170.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -105.09 100.47 10.07 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.9 -1.148 . . . . 73.22 107.9 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.427 HD12 ' H ' ' D' ' 129' ' ' ALA . 20.5 tp -75.86 141.46 42.4 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.004 0.522 . . . . 73.13 110.814 177.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.427 ' H ' HD12 ' D' ' 128' ' ' LEU . . . -56.24 132.84 75.5 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.447 1.099 . . . . 73.24 111.326 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.0 116.65 4.8 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.448 2.099 . . . . 75.32 110.363 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.48 138.44 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.477 0.711 . . . . 63.34 109.577 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -79.97 103.55 9.94 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.602 0.761 . . . . 73.23 110.02 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -77.25 -20.99 54.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.33 0.652 . . . . 74.23 111.406 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -59.46 -46.38 88.95 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.611 0.764 . . . . 62.35 110.577 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.646 ' HA ' ' HE3' ' D' ' 138' ' ' MET . . . -62.78 -42.28 99.63 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.269 0.981 . . . . 74.43 111.804 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 69.7 mt -61.12 -39.96 91.98 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 124.375 1.047 . . . . 74.23 111.121 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.41 ' O ' HD12 ' D' ' 141' ' ' LEU . 27.9 m-85 -78.71 -34.75 45.79 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.592 0.757 . . . . 63.33 111.543 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.646 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 67.3 mtm -63.21 -30.0 71.23 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.984 0.514 . . . . 72.1 111.273 178.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -57.43 -43.31 83.74 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.771 0.828 . . . . 73.41 110.616 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -69.65 -33.74 73.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.834 0.854 . . . . 74.32 111.447 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.41 HD12 ' O ' ' D' ' 137' ' ' PHE . 7.6 mp -62.98 -29.16 70.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.751 0.82 . . . . 74.11 111.135 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.6 10.28 18.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.965 0.906 . . . . 74.45 111.813 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.69 52.06 1.2 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.919 0.888 . . . . 72.43 110.433 -173.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -151.53 141.01 21.59 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.253 -0.885 . . . . 74.44 109.651 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.13 162.55 18.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.984 0.913 . . . . 70.33 110.058 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -171.56 178.58 43.8 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.192 -0.458 . . . . 43.02 112.314 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -117.48 168.84 10.02 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.15 0.98 . . . . 71.42 110.503 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.74 75.18 0.25 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.492 -0.643 . . . . 72.42 111.492 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -78.06 128.1 33.32 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.212 0.605 . . . . 73.55 109.672 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.54 87.33 5.13 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 106.888 -1.523 . . . . 73.3 106.888 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -76.18 114.15 14.51 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.831 -0.622 . . . . 70.14 110.092 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -122.4 80.82 1.77 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.582 -0.896 . . . . 75.3 108.582 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -127.33 133.16 50.12 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.151 0.98 . . . . 73.33 108.883 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.7 167.4 12.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.148 0.579 . . . . 73.35 110.948 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 N-CA-C 109.192 -0.67 . . . . 71.14 109.192 177.687 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.525 -0.176 . . . . 64.13 110.525 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -76.39 142.3 41.18 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.533 -0.543 . . . . 75.1 109.533 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . 0.647 HE22 ' HG2' ' A' ' 4' ' ' GLN . 25.1 tt0 -83.24 107.35 15.72 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.656 -0.868 . . . . 75.23 108.656 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -67.01 -24.65 66.04 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.086 0.954 . . . . 73.31 111.728 -170.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -107.65 91.45 7.32 Favored Pre-proline 0 N--CA 1.475 0.794 0 N-CA-C 107.221 -1.4 . . . . 74.15 107.221 166.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.96 -57.37 1.17 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.671 2.247 . . . . 74.44 110.463 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 87' ' ' ALA . 5.5 tt -179.45 -46.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 105.054 -2.202 . . . . 75.24 105.054 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . 0.519 HD11 ' HB2' ' A' ' 48' ' ' SER . 20.1 tp -86.57 147.22 26.03 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 114.559 -1.201 . . . . 71.12 108.593 170.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -178.46 160.32 26.22 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.612 -0.995 . . . . 70.22 110.612 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 45.59 -167.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.87 1.668 . . . . 74.12 112.432 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . 0.485 ' HD2' ' HB3' ' A' ' 48' ' ' SER . 56.4 t80 68.37 19.69 8.84 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 123.997 0.919 . . . . 65.24 111.867 171.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -72.8 -33.53 66.31 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.437 -0.949 . . . . 75.11 108.437 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -122.68 -170.75 2.15 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 114.66 -1.155 . . . . 73.41 108.93 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 154.89 -80.25 0.18 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.663 -0.575 . . . . 63.41 111.663 175.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 59.95 85.48 0.11 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 124.26 1.024 . . . . 75.02 109.488 -173.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 96.2 mmm -57.42 130.93 81.31 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.556 0.743 . . . . 75.25 110.408 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.19 78.17 0.83 Allowed 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.199 2.599 . . . . 74.3 111.847 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 92.2 t -98.75 101.93 12.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 108.137 -1.06 . . . . 74.03 108.137 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -70.82 125.79 27.8 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.282 -0.872 . . . . 75.51 109.242 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -64.56 131.53 47.31 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.024 0.916 . . . . 75.33 110.733 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.665 ' HB3' ' HB ' ' G' ' 309' ' ' THR . 0.0 OUTLIER -100.82 4.7 43.07 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.972 -1.467 . . . . 64.44 112.005 -169.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.91 127.24 43.8 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-O 118.203 -1.332 . . . . 75.44 111.924 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.94 -70.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.934 2.423 . . . . 72.25 113.144 -171.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -147.0 -46.97 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.349 1.06 . . . . 73.55 108.905 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -144.22 166.95 23.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.249 -0.887 . . . . 62.4 110.143 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 47.7 m -114.35 -30.8 6.47 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.061 0.945 . . . . 65.43 110.423 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.534 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 22.8 m-85 -72.18 125.98 28.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.123 -0.49 . . . . 73.33 109.89 174.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . 0.419 ' HA ' ' HB2' ' G' ' 302' ' ' ASP . 32.9 p80 -82.11 57.25 3.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.549 0.69 . . . . 75.11 109.773 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 62.2 -136.01 45.59 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.208 -1.157 . . . . 71.32 110.208 -168.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . 0.407 ' HB2' ' ND1' ' G' ' 298' ' ' HIS . 0.8 OUTLIER -68.82 125.49 26.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.489 0.645 . . . . 61.2 109.552 175.273 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.61 -57.95 9.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.113 -1.069 . . . . 64.15 108.113 170.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -146.79 167.73 23.15 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.677 -1.601 . . . . 75.42 108.469 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . 0.541 ' H ' ' HD2' ' E' ' 304' ' ' PRO . 13.3 tmtt? -154.26 -52.69 0.02 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 CA-C-O 117.901 -1.047 . . . . 73.34 110.061 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . 0.541 ' HD2' ' H ' ' E' ' 303' ' ' LYS . 55.5 Cg_endo -65.62 89.43 0.22 Allowed 'Trans proline' 0 C--N 1.4 3.272 0 C-N-CA 121.642 1.562 . . . . 74.01 112.385 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -75.9 154.45 36.0 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.89 -1.05 . . . . 71.23 110.557 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.35 163.51 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.936 -0.574 . . . . 74.1 111.466 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 34.6 p -92.99 -164.54 1.19 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.045 0.938 . . . . 75.03 111.057 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 10.9 p -59.23 -55.18 38.2 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 124.492 1.117 . . . . 75.22 112.075 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 95.8 m 56.14 80.55 0.29 Allowed Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 124.477 1.111 . . . . 74.54 110.965 -174.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . 0.411 ' HB2' HG22 ' B' ' 7' ' ' THR . 29.5 Cg_endo . . . . . 0 CA--C 1.555 1.566 0 C-N-CA 123.505 2.803 . . . . 74.11 111.717 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 119.569 -0.253 . . . . 72.23 111.403 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 69.07 -74.16 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.785 1.234 . . . . 73.4 111.315 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -79.59 -178.2 6.22 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.336 0.655 . . . . 75.23 110.37 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -64.54 170.27 4.14 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.473 0.654 . . . . 70.2 111.222 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . 0.761 ' HB2' ' HB3' ' F' ' 278' ' ' LEU . 17.7 mmtp -90.54 131.56 37.75 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 107.302 -1.37 . . . . 74.3 107.302 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -36.66 -64.68 0.17 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 124.783 3.655 . . . . 73.44 115.988 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.17 -3.59 44.15 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.865 0.466 . . . . 63.42 111.795 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . 0.761 ' HB3' ' HB2' ' F' ' 275' ' ' LYS . 6.9 tt -118.78 102.66 8.99 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.98 0.912 . . . . 75.44 108.802 -169.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -112.94 16.75 22.93 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 116.084 -0.507 . . . . 62.34 112.795 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 10.3 tt -154.25 146.16 23.51 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.109 -1.071 . . . . 71.32 108.109 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 67.9 t80 88.94 -22.44 0.12 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.982 2.113 . . . . 65.01 111.05 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.2 -25.55 68.12 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.115 0.566 . . . . 73.12 111.18 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -111.31 148.51 32.78 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.55 1.14 . . . . 51.13 109.358 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.21 73.26 1.1 Allowed Glycine 0 C--N 1.355 1.639 0 O-C-N 123.764 0.665 . . . . 75.33 112.457 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -99.24 3.73 46.38 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.358 1.063 . . . . 73.4 110.515 -174.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 97.7 mmm -120.85 83.9 37.39 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.578 0.751 . . . . 70.25 109.799 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -97.26 92.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.326 2.684 . . . . 74.13 112.92 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 96.0 t -81.83 96.43 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-O 121.243 0.544 . . . . 72.53 109.819 178.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -89.43 60.76 5.34 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.349 0.66 . . . . 73.24 109.684 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 44.0 m95 63.12 -172.9 0.16 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.65 -1.159 . . . . 73.44 112.544 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.536 HD13 ' HB2' ' C' ' 129' ' ' ALA . 0.0 OUTLIER -130.15 16.77 5.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.409 -1.269 . . . . 71.41 109.842 178.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 147.64 -147.15 17.62 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-O 118.989 -0.895 . . . . 63.13 110.927 -176.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.23 174.26 13.06 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.982 2.455 . . . . 73.4 111.277 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -159.22 -63.58 0.08 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.279 -0.638 . . . . 73.44 109.279 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . 65.11 -178.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.781 1.233 . . . . 74.32 111.407 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 96.0 m -142.94 -67.38 0.37 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.956 0.502 . . . . 74.33 109.747 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.408 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 22.8 m-30 -66.09 109.29 2.53 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 122.769 0.428 . . . . 74.24 110.295 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -143.31 148.82 36.91 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.868 -1.16 . . . . 73.05 107.868 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.28 -144.86 22.77 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.631 0.582 . . . . 71.13 112.116 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -137.71 128.91 27.67 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.787 0.435 . . . . 73.03 110.899 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.756 HD13 HH22 ' D' ' 15' ' ' ARG . 41.0 pt -129.19 15.33 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.385 1.074 . . . . 71.14 108.935 167.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.07 90.13 4.22 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.664 1.186 . . . . 71.53 109.167 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -150.97 130.04 6.37 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.374 -0.973 . . . . 74.22 108.374 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.42 -32.18 71.65 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.148 2.566 . . . . 74.44 113.672 -173.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' D' ' 14' ' ' GLN . . . -162.01 167.65 24.09 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.358 0.663 . . . . 74.03 110.183 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 36.4 t -79.17 71.09 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 108.3 -1.0 . . . . 73.25 108.3 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 5.7 m -93.71 73.02 4.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.462 -1.31 . . . . 74.22 107.462 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . 0.594 ' SG ' ' HD2' ' H' ' 293' ' ' PRO . 85.5 m -149.56 -55.08 0.17 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.667 -1.152 . . . . 75.11 108.608 -173.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 309' ' ' THR . . . . . 0.407 ' OG1' HD23 ' H' ' 291' ' ' LEU . 7.8 m -67.47 137.58 93.54 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 114.779 -1.1 . . . . 64.34 110.805 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . 0.428 ' HA ' ' HA ' ' B' ' 153' ' ' GLN . 7.2 Cg_exo . . . . . 0 CA--C 1.556 1.608 0 C-N-CA 122.741 2.294 . . . . 63.33 111.038 164.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 110.039 -0.356 . . . . 71.05 110.039 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -86.84 138.81 31.26 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.594 0.757 . . . . 75.33 109.326 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -124.81 82.02 2.01 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.298 0.639 . . . . 73.54 109.862 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.07 109.93 6.97 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.67 -0.863 . . . . 63.35 108.67 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -136.56 154.82 77.01 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 109.947 -0.39 . . . . 75.32 109.947 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -65.54 159.34 48.45 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.003 2.469 . . . . 64.42 112.759 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.641 HD12 ' HH ' ' D' ' 56' ' ' TYR . 68.9 mt -91.9 -77.56 0.43 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.286 -0.635 . . . . 73.32 109.286 177.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 45.9 tp -78.66 119.51 22.01 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.68 0.792 . . . . 75.31 109.939 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -169.11 61.68 0.19 Allowed Glycine 0 C--N 1.348 1.23 0 O-C-N 123.359 0.412 . . . . 72.31 112.352 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . 0.438 HD23 HD21 ' D' ' 98' ' ' LEU . 2.2 pt? -156.28 -172.06 3.95 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.605 0.762 . . . . 71.32 110.017 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 66.09 81.93 0.19 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.633 1.173 . . . . 71.15 111.279 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -154.6 -52.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.398 -0.964 . . . . 73.44 108.398 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -146.7 173.47 12.33 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.695 -1.139 . . . . 74.44 109.334 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 157.23 143.78 3.75 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.59 -1.004 . . . . 62.01 110.59 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -71.59 91.21 1.06 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.157 0.583 . . . . 74.13 109.662 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 26.5 mmt -100.5 99.16 9.25 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.378 1.071 . . . . 74.04 109.762 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . 0.419 ' HA ' ' NH1' ' G' ' 289' ' ' ARG . 43.5 Cg_endo -94.1 35.05 0.19 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.469 2.779 . . . . 72.11 111.772 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.17 79.64 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.759 0.79 . . . . 72.13 110.371 -172.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . 0.419 ' NH1' ' HA ' ' G' ' 287' ' ' PRO . 1.4 mpt_? -121.12 178.27 4.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 107.507 -1.294 . . . . 75.34 107.507 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.524 ' NE1' HG21 ' D' ' 40' ' ' VAL . 85.9 m95 -70.71 123.48 22.01 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 110.177 -0.305 . . . . 73.42 110.177 176.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.35 -60.86 1.86 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.688 0.795 . . . . 71.23 108.95 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -86.84 -178.03 49.17 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.289 -0.869 . . . . 34.45 112.447 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.68 175.35 1.25 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.575 2.85 . . . . 72.41 113.712 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -107.49 103.55 12.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.321 0.648 . . . . 73.13 110.235 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -87.08 98.31 11.21 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.957 -0.757 . . . . 55.32 108.957 173.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 1.3 p -150.26 -70.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.277 1.031 . . . . 75.2 110.085 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.518 ' HB2' ' HG3' ' D' ' 124' ' ' PRO . 0.3 OUTLIER -130.82 123.49 29.21 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.349 -0.982 . . . . 74.03 108.349 -169.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . 0.407 ' ND1' ' HB2' ' E' ' 300' ' ' ASN . 50.5 t-80 -83.16 -50.68 8.21 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.849 -0.426 . . . . 73.41 109.849 174.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 153.66 -177.95 30.89 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 115.475 -0.784 . . . . 75.1 112.148 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 64.35 148.7 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.572 1.549 . . . . 74.51 111.596 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.684 HD11 HH12 ' C' ' 15' ' ' ARG . 15.2 tt -141.24 29.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 122.13 0.967 . . . . 75.45 110.116 -171.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' E' ' 298' ' ' HIS . 7.8 m-20 -61.88 104.73 0.48 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.589 -1.187 . . . . 63.32 110.371 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -98.44 163.7 18.59 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.28 1.432 . . . . 71.24 109.895 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.84 81.09 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.473 2.115 . . . . 75.32 111.729 171.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -78.09 97.33 5.39 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.766 -0.827 . . . . 72.05 108.766 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.551 HG23 HD21 ' E' ' 291' ' ' LEU . 98.9 t -69.33 82.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.991 0.916 . . . . 64.45 110.319 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 43.5 p -106.91 -26.27 11.29 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.893 -1.049 . . . . 74.4 110.125 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 58.9 m -68.24 -38.02 81.4 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.76 0.824 . . . . 75.14 111.48 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' G' G ' 309' ' ' THR . . . . . 0.665 ' HB ' ' HB3' ' E' ' 291' ' ' LEU . 96.8 m -147.05 78.58 10.37 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.473 0.709 . . . . 71.43 109.737 177.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 CA--C 1.564 2.011 0 C-N-CA 123.362 2.708 . . . . 72.44 112.293 174.618 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 110.256 -0.276 . . . . 64.14 110.256 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -75.43 85.32 2.55 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.592 0.757 . . . . 71.1 109.296 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -165.52 175.57 8.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.308 1.043 . . . . 64.12 110.238 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -120.45 29.28 7.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.18 0.992 . . . . 75.03 110.044 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 73.46 166.94 0.12 Allowed Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 124.347 1.059 . . . . 75.23 111.369 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.28 -152.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 122.202 1.935 . . . . 74.35 111.543 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.452 HD12 HG13 ' B' ' 89' ' ' ILE . 45.1 tp -59.94 -37.25 78.97 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 110.316 -0.253 . . . . 73.41 110.316 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 31.3 tp -80.2 81.9 6.36 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.074 0.55 . . . . 74.51 110.078 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -93.37 -40.79 4.69 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.149 -0.932 . . . . 32.45 111.56 174.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.81 -175.31 3.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.75 0.82 . . . . 74.42 109.178 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 12.4 t80 70.27 63.99 0.22 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.111 0.964 . . . . 74.23 110.894 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -149.49 115.78 5.78 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.61 -1.177 . . . . 71.12 108.78 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 67.84 8.65 6.58 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.736 1.214 . . . . 70.31 113.444 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 167.45 155.33 9.13 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 112.116 -0.394 . . . . 72.2 112.116 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.48 -57.82 2.1 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.199 1.0 . . . . 74.32 108.361 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 22.6 ptp -171.77 145.02 1.61 Allowed Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 124.07 0.948 . . . . 75.13 110.061 -176.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.81 105.61 0.67 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.149 2.566 . . . . 71.2 111.625 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.44 -43.71 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.238 0.615 . . . . 74.41 109.916 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 66.16 -74.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.552 1.541 . . . . 74.3 110.558 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . 0.509 ' NE1' HG21 ' B' ' 40' ' ' VAL . 1.5 t-105 -170.13 139.64 1.83 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.983 1.313 . . . . 75.02 107.523 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.48 HD22 HG22 ' B' ' 131' ' ' VAL . 6.5 mp -69.17 -41.94 76.56 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.679 0.792 . . . . 75.43 110.725 -173.192 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 150.38 -149.67 21.58 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-O 119.049 -0.861 . . . . 61.14 112.926 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . 0.594 ' HD2' ' SG ' ' F' ' 308' ' ' CYS . 75.2 Cg_exo -51.56 95.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.246 3.297 . . . . 72.33 113.761 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . 0.484 ' HA ' ' HE3' ' H' ' 294' ' ' LYS . 0.5 OUTLIER -167.1 33.68 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.549 0.74 . . . . 75.31 109.851 -175.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . 0.573 ' HA ' HG23 ' B' ' 40' ' ' VAL . . . -60.23 142.29 54.75 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.894 0.378 . . . . 73.15 111.869 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 296' ' ' THR . . . . . 0.505 HG23 ' O ' ' B' ' 124' ' ' PRO . 5.2 m -58.06 -49.81 75.61 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.333 -1.303 . . . . 64.11 111.672 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.599 ' HB3' ' HA ' ' B' ' 37' ' ' GLN . 10.8 t80 -90.37 41.98 1.08 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.407 -1.269 . . . . 73.53 111.546 -165.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 11.8 m80 -87.63 -37.14 17.04 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.254 0.622 . . . . 74.24 110.178 172.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.59 -165.74 3.8 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.644 0.59 . . . . 65.35 113.9 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -73.17 120.39 18.72 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.664 -0.315 . . . . 75.44 110.658 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 9.1 tt -61.28 -31.03 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.391 0.676 . . . . 75.13 109.903 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 28.0 t70 73.28 115.01 0.06 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.986 1.714 . . . . 72.24 111.232 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -138.97 80.67 23.56 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 106.661 -1.607 . . . . 74.11 106.661 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -90.06 -7.14 4.54 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.174 2.583 . . . . 74.53 112.05 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 49.35 77.73 0.1 Allowed 'General case' 0 C--N 1.368 1.401 0 C-N-CA 125.557 1.543 . . . . 72.33 110.572 -172.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.42 105.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 123.9 0.75 . . . . 74.1 109.997 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 11.3 t -110.54 176.24 5.12 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.168 0.987 . . . . 72.23 108.816 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 49.0 t -68.32 83.95 0.25 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.002 0.921 . . . . 74.23 110.61 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 4.7 t -94.32 120.91 64.71 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.996 0.919 . . . . 73.21 110.664 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo . . . . . 0 C--N 1.378 2.097 0 C-N-CA 122.932 2.421 . . . . 75.41 110.494 171.933 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 109.679 -0.489 . . . . 73.33 109.679 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 p -95.28 3.8 54.15 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.25 0.62 . . . . 73.21 111.592 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -65.23 124.91 23.42 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.6 0.76 . . . . 73.42 110.215 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -166.3 170.94 12.63 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.59 0.756 . . . . 74.41 109.565 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -117.84 106.84 13.42 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.125 -1.435 . . . . 73.42 107.125 170.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -172.65 169.78 4.93 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 124.3 1.0 . . . . 72.02 108.771 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 m 82.95 -63.27 0.12 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.723 1.609 . . . . 75.33 112.291 167.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.78 79.16 1.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.451 0.7 . . . . 73.42 110.049 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.451 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 23.9 ptm -87.98 153.14 21.53 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.49 -0.777 . . . . 71.13 111.252 -173.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.438 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.9 m -142.95 139.01 30.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.745 -1.116 . . . . 74.11 109.104 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.4 t80 -137.2 122.84 19.79 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.623 -1.251 . . . . 72.42 107.623 166.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -146.74 129.61 16.27 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.161 -0.681 . . . . 64.43 109.161 173.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.635 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.7 mt -86.24 119.85 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 109.437 -0.579 . . . . 71.11 109.437 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.5 -40.38 13.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.062 0.945 . . . . 74.51 109.281 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -166.42 141.7 4.51 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.203 -0.453 . . . . 74.22 110.533 -166.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.502 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER -131.87 126.31 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.032 -1.47 . . . . 73.41 107.032 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 24.6 p90 -161.08 152.55 19.16 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.512 0.672 . . . . 73.52 111.491 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -76.57 107.87 9.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.614 -1.176 . . . . 74.51 108.161 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.427 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.5 mtpt -67.26 -33.15 74.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.198 0.523 . . . . 75.13 109.603 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.4 t70 -153.12 144.16 22.99 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.193 -1.367 . . . . 74.22 109.682 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -133.06 143.64 38.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.941 1.296 . . . . 65.21 107.863 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.421 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 44.0 t -147.21 126.89 13.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.855 0.862 . . . . 54.13 109.171 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 87.2 t80 -127.93 126.68 41.95 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.892 -1.892 . . . . 75.25 105.892 168.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -133.95 116.6 15.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.016 -0.735 . . . . 71.42 109.016 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.417 ' HB3' ' HB1' ' A' ' 28' ' ' ALA . . . -127.55 74.45 77.96 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.573 -1.269 . . . . 75.24 107.573 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.13 -43.63 2.25 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.553 2.169 . . . . 74.21 111.127 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -89.4 12.15 17.14 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 118.057 -0.973 . . . . 75.23 111.414 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 25' ' ' ALA . . . -44.76 -56.26 9.0 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.136 -0.935 . . . . 62.05 112.372 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -58.75 -22.97 64.15 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.579 2.186 . . . . 74.21 113.888 -179.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 -31.58 12.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.746 0.818 . . . . 75.14 110.503 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.58 -17.02 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 120.895 0.379 . . . . 72.22 110.165 -170.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.436 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 21.9 m-85 -73.86 -30.4 62.63 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.61 0.764 . . . . 74.25 111.807 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -85.37 -12.86 51.15 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.485 0.314 . . . . 74.54 111.364 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.538 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 31.4 mmtp -79.16 152.24 30.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.311 0.644 . . . . 73.13 110.872 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.05 140.18 58.81 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.22 0.95 . . . . 71.42 109.623 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.759 ' HB3' ' HB3' ' E' ' 297' ' ' TYR . 32.2 m95 -74.28 83.47 1.89 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.689 0.796 . . . . 73.21 110.912 -173.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -134.56 71.23 71.45 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.575 1.15 . . . . 73.52 109.609 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.32 127.76 5.3 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.009 1.806 . . . . 75.43 112.174 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.9 88.82 5.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 106.423 -1.695 . . . . 64.12 106.423 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -82.22 114.72 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.761 -1.109 . . . . 74.34 111.11 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.447 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 88.3 mttt -80.18 152.86 28.95 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.454 1.102 . . . . 74.12 110.84 167.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.1 tt -122.72 109.61 14.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.539 -2.022 . . . . 74.42 105.539 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.665 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -117.77 107.73 14.51 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.793 -0.817 . . . . 74.02 108.793 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -99.06 150.45 21.99 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.321 -0.622 . . . . 74.01 109.321 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.574 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 30.1 t70 -145.5 136.6 24.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.678 0.791 . . . . 63.3 109.39 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -121.76 126.76 49.61 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.684 0.794 . . . . 75.33 110.942 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.3 113.56 4.57 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.366 0.667 . . . . 70.13 110.193 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.9 p -98.77 162.3 13.18 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.683 -0.488 . . . . 71.24 109.683 173.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.4 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 41.2 t -152.94 158.07 41.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.321 1.048 . . . . 71.4 109.196 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -114.07 126.3 54.96 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.944 -1.132 . . . . 72.34 107.944 166.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -93.5 -41.53 9.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.011 0.525 . . . . 75.53 110.25 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.25 178.75 9.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.866 0.866 . . . . 74.42 109.702 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.85 123.13 18.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.991 -0.744 . . . . 73.14 108.991 171.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 73.02 -7.23 1.53 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.796 1.638 . . . . 64.3 112.237 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.9 t -106.7 111.45 35.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.286 -1.005 . . . . 64.24 108.286 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -123.38 161.06 25.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.274 -0.639 . . . . 65.43 109.274 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.4 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 41.3 tt0 -131.56 138.99 49.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.859 -1.064 . . . . 74.54 108.784 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.46 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.9 t -126.22 117.02 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.849 -1.538 . . . . 75.51 106.849 169.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.416 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 t -101.23 130.45 50.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.986 -0.746 . . . . 72.43 108.986 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.614 HD21 HD13 ' A' ' 106' ' ' LEU . 3.8 mm? -117.57 109.78 17.12 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.212 -1.032 . . . . 75.12 108.212 170.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.629 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 13.2 ttp180 -85.57 112.64 21.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.108 -0.701 . . . . 74.31 109.108 172.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.0 t -94.2 128.62 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 107.359 -1.348 . . . . 74.44 107.359 170.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.665 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 47.3 m -127.05 126.5 43.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.213 -1.032 . . . . 74.3 108.213 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.559 HG12 HD21 ' A' ' 126' ' ' LEU . 44.9 t -118.75 109.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.46 -0.941 . . . . 74.31 108.46 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.447 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.3 m -103.71 133.28 48.98 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.292 -0.632 . . . . 74.03 109.292 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.37 31.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.439 -1.319 . . . . 72.22 107.439 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.576 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 55.6 m -135.93 127.91 29.56 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.819 0.447 . . . . 71.23 110.479 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -88.83 72.28 8.56 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.917 -1.142 . . . . 74.3 107.917 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.24 -84.46 0.83 Allowed Glycine 0 C--N 1.35 1.333 0 CA-C-N 114.934 -1.03 . . . . 71.41 110.713 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -110.88 -29.22 8.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 74.01 109.86 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.538 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 3.3 tp10 -82.89 91.48 7.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.721 0.809 . . . . 74.14 110.322 -173.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 86.5 m -64.71 130.89 45.26 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.284 0.564 . . . . 75.21 111.495 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.53 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -78.29 -63.36 1.42 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.91 -1.041 . . . . 74.34 110.011 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -162.04 170.94 18.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.467 -1.242 . . . . 73.32 110.97 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.4 tp -142.62 113.77 7.69 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.551 -1.204 . . . . 74.22 108.284 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 76.4 m -113.42 100.87 8.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.387 0.675 . . . . 71.34 110.77 -177.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 31.4 tt0 -119.16 118.65 31.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.285 1.034 . . . . 71.04 109.617 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.12 112.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.236 1.015 . . . . 72.23 109.224 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.629 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 49.7 mt-30 -84.24 84.47 7.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.686 -0.857 . . . . 73.34 108.686 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.85 97.89 7.59 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.775 -1.102 . . . . 71.21 108.592 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.416 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.22 146.64 18.34 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.723 -0.671 . . . . 71.14 111.524 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.23 137.87 9.11 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 110.716 -0.954 . . . . 74.33 110.716 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -93.02 123.72 45.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.806 -0.813 . . . . 70.14 108.806 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.635 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.8 m-85 -132.56 118.64 19.48 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.71 -1.219 . . . . 74.3 107.71 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.3 p -81.68 98.52 8.43 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.327 -0.62 . . . . 75.12 109.327 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.438 ' HA ' ' O ' ' A' ' 10' ' ' THR . 2.8 pp -113.24 160.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.417 0.687 . . . . 74.15 111.258 -175.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.37 174.58 2.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.001 1.32 . . . . 71.2 109.495 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 78.08 -6.48 49.36 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 115.514 0.966 . . . . 75.11 115.514 169.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -126.18 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.216 -1.031 . . . . 65.23 108.216 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.572 ' HB3' ' HG2' ' E' ' 276' ' ' PRO . 19.2 mp0 -133.16 173.74 11.12 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.692 0.797 . . . . 75.34 109.461 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.34 -139.45 47.4 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.702 0.626 . . . . 73.41 113.737 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.1 t -72.9 -18.63 61.39 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.595 0.758 . . . . 72.21 111.208 177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.47 -36.63 76.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.599 0.76 . . . . 64.52 110.323 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.492 ' HE1' ' HB3' ' E' ' 277' ' ' LEU . 0.5 OUTLIER -76.78 -42.19 41.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.943 0.497 . . . . 74.24 109.777 173.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -16.88 64.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.431 -0.804 . . . . 75.12 112.682 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 100' ' ' ALA . 52.9 t-80 -68.9 -28.72 66.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.953 0.501 . . . . 73.5 110.15 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.494 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.2 t -78.01 -39.2 42.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.064 0.546 . . . . 75.35 110.008 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.66 -51.77 56.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.354 0.662 . . . . 74.31 112.081 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.56 4.91 47.46 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.424 -0.807 . . . . 74.31 114.33 -164.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 96' ' ' HIS . . . -144.91 -63.8 0.35 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 117.281 0.541 . . . . 75.01 112.388 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.494 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 82.0 t80 -71.05 -57.1 4.86 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.901 0.704 . . . . 75.35 112.901 -169.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 88.5 m -67.4 -32.28 4.4 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 118.189 -0.91 . . . . 73.11 112.882 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.28 -50.12 12.79 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.413 2.075 . . . . 62.51 112.876 159.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -61.35 -25.01 66.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.656 0.782 . . . . 73.02 111.957 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -76.68 -48.92 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 75.44 110.111 174.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.614 HD13 HD21 ' A' ' 60' ' ' LEU . 95.8 mt -81.18 -23.01 38.48 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.446 0.698 . . . . 73.43 112.214 -170.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -65.34 -42.57 59.47 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.216 1.006 . . . . 75.44 112.957 -171.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 -32.11 85.47 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.83 1.687 . . . . 63.11 113.077 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -74.22 -39.65 62.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.209 0.603 . . . . 74.41 111.618 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.47 78.32 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.419 -0.586 . . . . 72.13 109.419 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -54.37 -46.27 72.98 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.777 1.298 . . . . 74.24 110.728 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.54 -48.47 77.36 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.295 0.997 . . . . 72.43 110.552 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.54 -45.25 85.29 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.772 0.67 . . . . 62.23 110.697 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.411 ' O ' HG21 ' A' ' 118' ' ' VAL . 91.8 mt -60.29 -52.58 59.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 114.855 -1.066 . . . . 74.43 110.05 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.538 HG21 ' HG3' ' A' ' 125' ' ' GLN . 78.4 m -53.19 -46.22 68.91 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.919 0.888 . . . . 74.21 111.515 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -64.88 -47.51 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.179 -0.919 . . . . 71.45 110.034 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 13.4 mtp -54.58 -43.7 72.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.09 0.956 . . . . 72.1 111.449 175.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.411 HG21 ' O ' ' A' ' 114' ' ' ILE . 67.5 t -65.9 -47.16 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.862 1.265 . . . . 75.54 111.312 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.5 p -66.69 -32.66 74.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.095 0.558 . . . . 75.44 111.264 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.17 -33.08 74.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.753 0.821 . . . . 74.04 110.49 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.58 20.43 18.61 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.08 -0.845 . . . . 72.31 114.28 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 48.39 47.35 20.04 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.366 1.466 . . . . 73.3 112.352 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.487 ' HA ' HD12 ' E' ' 301' ' ' ILE . 61.8 m-85 -117.05 149.84 44.95 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 107.777 -1.194 . . . . 72.25 107.777 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.558 ' HB3' ' HB2' ' E' ' 300' ' ' ASN . 44.8 Cg_endo -65.48 153.68 77.1 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.189 1.926 . . . . 72.41 110.392 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.538 ' HG3' HG21 ' A' ' 115' ' ' THR . 31.8 tt0 -51.1 126.9 17.68 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.332 1.02 . . . . 75.14 111.995 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.559 HD21 HG12 ' A' ' 64' ' ' VAL . 33.3 tp -110.19 94.66 5.13 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.205 -0.907 . . . . 75.42 109.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -111.91 104.32 12.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.405 -1.27 . . . . 72.5 107.968 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.74 128.04 34.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.943 -1.132 . . . . 72.2 107.943 179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.26 144.13 8.7 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 124.208 1.003 . . . . 63.32 111.709 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.411 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 40.9 Cg_exo -58.52 110.0 0.59 Allowed 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.644 2.229 . . . . 73.51 112.064 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 t -101.07 112.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.737 -0.838 . . . . 73.32 108.737 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.98 85.21 5.61 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.662 0.785 . . . . 64.52 109.537 174.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -59.48 -32.86 70.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.666 0.787 . . . . 73.3 111.366 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -67.03 -40.72 87.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.125 0.97 . . . . 72.22 111.184 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.73 -37.44 67.75 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.758 0.661 . . . . 74.0 111.173 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.51 -42.99 81.94 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.061 0.545 . . . . 72.34 110.906 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -62.02 -38.18 87.69 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.27 -0.877 . . . . 73.4 109.97 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.519 ' SD ' ' HG2' ' A' ' 144' ' ' GLN . 36.7 tpp -68.5 -38.64 81.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.886 0.874 . . . . 72.11 111.073 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -58.84 -35.25 72.61 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.161 0.585 . . . . 73.12 110.756 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -81.08 -36.14 30.82 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.271 0.628 . . . . 71.11 110.952 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.91 -51.62 68.52 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.006 0.923 . . . . 75.15 110.827 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 178.7 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.883 1.273 . . . . 61.32 109.471 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.464 ' HA ' ' HG3' ' A' ' 138' ' ' MET . 0.0 OUTLIER 69.9 118.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.042 1.737 . . . . 74.32 110.668 178.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.519 ' HG2' ' SD ' ' A' ' 138' ' ' MET . 2.4 pt20 -133.0 107.51 8.31 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.278 1.031 . . . . 63.43 109.162 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.23 172.24 18.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.743 0.817 . . . . 74.44 110.568 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.81 169.25 13.21 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.648 -0.705 . . . . 70.33 112.045 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -140.08 142.53 36.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.083 0.553 . . . . 74.51 110.69 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.81 41.75 62.48 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.945 -0.571 . . . . 73.24 111.744 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.1 p -62.42 -56.32 19.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.713 0.805 . . . . 71.22 109.772 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -172.46 129.45 0.55 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.557 -1.646 . . . . 74.45 106.557 165.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -77.89 -67.03 0.77 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.222 1.009 . . . . 71.04 110.072 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -178.26 111.01 0.06 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.642 0.777 . . . . 72.15 110.862 -172.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -143.51 92.57 2.38 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.991 0.9 . . . . 71.52 109.8 167.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -79.2 78.4 5.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.787 0.804 . . . . 75.34 109.992 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.318 0 CA-C-N 115.219 -0.901 . . . . 62.04 110.558 -176.353 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.237 -0.653 . . . . 64.51 109.237 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.2 m -101.27 -176.02 3.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.159 0.984 . . . . 75.44 110.732 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.43 4.02 33.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.106 0.962 . . . . 73.45 112.314 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 63.52 -78.42 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.559 1.143 . . . . 73.41 110.896 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 51.0 t30 64.25 106.68 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.418 1.487 . . . . 70.12 111.292 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -127.11 79.66 1.9 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.964 -0.754 . . . . 73.04 108.964 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 39.6 p -134.56 135.82 42.56 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.412 0.685 . . . . 73.05 110.498 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.05 -63.4 1.39 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.441 -0.948 . . . . 72.45 108.441 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ptm 49.36 171.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 127.144 2.178 . . . . 74.44 115.08 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.516 HG21 HE22 ' B' ' 12' ' ' GLN . 82.2 m -155.3 111.15 3.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.858 -1.164 . . . . 73.01 107.858 173.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -132.94 136.74 46.29 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.558 -0.534 . . . . 65.24 109.558 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.61 ' HB3' HG21 ' E' ' 309' ' ' THR . 0.2 OUTLIER -152.05 139.52 19.57 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.281 1.032 . . . . 74.55 108.954 171.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -83.42 144.55 9.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.738 -0.838 . . . . 74.1 108.738 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' E' ' 306' ' ' VAL . 69.3 mt-30 -103.63 -43.35 5.39 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.17 0.588 . . . . 64.42 110.194 173.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -166.99 134.88 2.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.866 -0.606 . . . . 71.22 109.673 -171.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.5 mt -118.52 133.78 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 106.831 -1.544 . . . . 73.24 106.831 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -164.64 147.13 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.65 0.593 . . . . 73.53 112.098 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.8 m -73.25 124.47 25.72 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.343 -0.844 . . . . 73.44 108.879 170.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -97.95 -32.93 11.41 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.923 0.489 . . . . 73.42 110.89 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.465 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -152.81 140.99 20.44 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.338 -0.392 . . . . 73.42 110.361 -171.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.425 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.3 mm -132.88 137.33 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.212 1.005 . . . . 74.43 109.292 176.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.645 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.4 m -133.69 112.04 11.08 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.986 1.315 . . . . 74.42 108.444 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -130.5 110.02 11.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.053 -1.462 . . . . 73.24 107.053 167.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.66 111.9 18.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.431 -0.952 . . . . 74.2 108.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -115.92 85.56 14.96 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.296 -1.002 . . . . 63.01 108.296 172.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.91 -22.9 35.45 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.515 2.144 . . . . 73.24 111.388 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.83 13.84 25.99 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.653 1.181 . . . . 73.23 110.656 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.516 ' HB1' ' CE2' ' A' ' 17' ' ' TYR . . . -45.21 -51.62 24.16 Favored Pre-proline 0 CA--C 1.57 1.732 0 N-CA-C 114.3 1.222 . . . . 73.22 114.3 -175.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.5 -46.37 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 CA-C-N 121.511 1.575 . . . . 74.43 112.965 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -77.66 3.34 14.15 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.814 1.042 . . . . 70.4 113.814 -171.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.546 HG23 HD11 ' B' ' 68' ' ' LEU . 14.7 p -73.62 -30.64 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 109.63 -0.507 . . . . 63.32 109.63 171.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.54 -31.27 61.99 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 125.145 1.378 . . . . 75.3 112.993 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.409 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.5 pt20 -63.76 -50.37 69.32 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.367 0.417 . . . . 73.5 110.886 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.49 ' HZ3' ' HG2' ' B' ' 71' ' ' GLU . 54.1 pttt -116.48 60.31 0.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.943 0.897 . . . . 75.45 110.501 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -101.27 119.74 39.21 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.762 -0.586 . . . . 74.12 109.648 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.35 -167.93 0.14 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.071 1.482 . . . . 75.42 108.984 163.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.91 105.45 0.49 Allowed Pre-proline 0 CA--C 1.566 1.581 0 C-N-CA 124.421 1.089 . . . . 65.22 112.783 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.02 169.66 2.89 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.526 2.818 . . . . 75.13 113.066 -173.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.86 107.84 5.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 61.31 108.652 172.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' B' ' 65' ' ' THR . 16.2 m -105.71 141.01 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.678 -0.692 . . . . 75.11 110.77 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -126.79 121.96 33.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.984 0.914 . . . . 73.04 109.06 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 tp -98.44 124.59 43.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.683 0.793 . . . . 73.15 108.984 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.752 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.7 m-20 -125.47 118.73 26.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.982 0.913 . . . . 72.2 108.626 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.2 126.44 46.48 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.405 -1.331 . . . . 75.55 107.405 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.83 139.4 46.23 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 74.45 109.216 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -117.74 113.74 22.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.279 0.632 . . . . 74.12 110.787 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.61 147.78 42.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.39 1.076 . . . . 61.32 108.23 172.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.5 p -145.95 174.33 11.36 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 118.064 0.393 . . . . 60.34 111.546 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.9 p -153.32 145.11 23.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.385 1.074 . . . . 72.43 109.248 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -97.28 104.2 16.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.502 -0.555 . . . . 71.14 109.502 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.64 -42.49 51.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.16 0.584 . . . . 74.1 110.943 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.12 -179.95 7.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.111 0.965 . . . . 72.51 109.306 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.23 123.41 21.59 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.514 -0.766 . . . . 61.44 109.31 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 74.33 -3.1 2.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.82 1.648 . . . . 70.35 112.838 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -106.34 114.1 44.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.498 -0.927 . . . . 75.05 108.498 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.645 ' HH ' HD21 ' H' ' 277' ' ' LEU . 23.8 m-85 -116.29 139.87 49.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.793 -0.818 . . . . 63.13 108.793 -178.224 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -111.87 99.92 8.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.418 -1.327 . . . . 72.11 107.418 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.41 127.87 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.908 0.883 . . . . 61.35 110.277 -174.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.548 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.6 t -111.97 112.37 40.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 124.912 1.285 . . . . 75.42 108.738 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 106.0 18.17 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.667 -0.864 . . . . 63.33 108.667 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -86.03 123.85 31.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.576 -0.738 . . . . 73.35 109.535 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.44 105.76 19.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.709 -1.219 . . . . 64.43 107.709 168.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.752 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 32.4 m -94.42 137.49 33.49 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.659 -0.867 . . . . 74.23 108.659 176.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.94 130.14 61.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.429 -1.323 . . . . 71.14 107.429 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 97.1 m -120.04 144.93 47.29 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.528 -0.915 . . . . 75.1 108.528 173.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.61 134.11 40.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.806 -1.183 . . . . 62.3 107.806 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 61.2 p -147.36 133.91 19.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.297 0.639 . . . . 74.45 109.976 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -125.48 138.27 53.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.564 0.746 . . . . 74.23 110.016 177.848 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -127.69 9.03 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.213 -0.903 . . . . 75.35 111.444 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.98 11.35 29.89 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.129 0.972 . . . . 74.35 111.932 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.49 ' HG2' ' HZ3' ' B' ' 34' ' ' LYS . 17.0 pt-20 -154.88 -179.49 8.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.585 0.354 . . . . 75.24 110.986 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -64.18 154.39 34.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 75.45 112.424 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.581 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . . . -103.91 -60.35 1.59 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.774 -1.195 . . . . 73.01 107.774 166.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -166.34 164.39 17.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.346 -1.297 . . . . 72.55 109.161 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 29.4 mt -123.65 135.84 54.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.129 -1.434 . . . . 74.1 107.129 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 48.7 t -144.96 131.58 19.91 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.083 -0.71 . . . . 53.2 109.083 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.645 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.7 tt0 -156.22 143.65 19.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.615 -0.883 . . . . 71.34 108.615 -170.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 93.3 t -135.69 146.9 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.555 -0.905 . . . . 64.12 108.555 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -121.58 95.61 4.74 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.628 -1.249 . . . . 73.13 107.628 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.456 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.3 tp-100 -89.0 101.05 13.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.642 -0.873 . . . . 73.22 108.642 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.45 168.74 36.81 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.749 0.656 . . . . 64.45 111.874 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.54 127.74 1.48 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.574 -0.611 . . . . 71.14 111.574 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -84.46 128.86 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.053 -1.091 . . . . 73.22 108.053 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.64 163.51 29.59 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.835 1.254 . . . . 74.24 108.853 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -131.87 113.11 13.07 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.66 -0.867 . . . . 73.32 108.66 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.39 129.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.7 -0.852 . . . . 74.12 108.7 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.28 170.1 18.01 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.582 1.153 . . . . 71.53 108.857 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -70.8 3.02 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.803 -0.519 . . . . 54.04 111.803 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -87.55 152.22 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.166 0.586 . . . . 75.22 110.553 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.472 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 14.4 pt-20 -158.69 175.86 13.1 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.696 0.623 . . . . 74.02 111.822 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.69 -130.09 28.04 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.006 -0.997 . . . . 74.44 113.857 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 92' ' ' THR . . . . . 0.429 ' HA ' HD23 ' H' ' 280' ' ' LEU . 17.7 m -65.52 -32.9 74.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.158 0.983 . . . . 75.11 110.833 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -75.41 -31.09 60.29 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.922 -1.035 . . . . 75.12 109.933 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.499 ' SD ' ' HA ' ' H' ' 278' ' ' LEU . 26.3 ttt -70.13 -32.4 70.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.908 -0.405 . . . . 74.11 109.908 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.33 -25.42 61.93 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.059 0.543 . . . . 71.22 112.133 175.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' B' ' 100' ' ' ALA . 55.5 t-80 -79.56 -26.49 41.35 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.481 0.713 . . . . 75.12 111.157 173.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -79.15 -65.66 0.97 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.755 0.422 . . . . 65.35 110.407 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.7 pp -63.53 -21.4 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.622 0.769 . . . . 74.42 112.776 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.467 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -107.06 3.62 35.53 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 114.431 0.532 . . . . 61.14 114.431 -172.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.464 ' HB2' ' O ' ' B' ' 96' ' ' HIS . . . -151.32 -51.92 0.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.903 0.352 . . . . 73.2 111.725 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.549 ' HH ' ' HB2' ' D' ' 130' ' ' PRO . 29.5 t80 -68.65 -48.49 63.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.763 0.825 . . . . 74.3 110.646 -177.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.447 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 56.1 m -68.89 -46.51 31.94 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.186 0.594 . . . . 65.14 111.466 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -55.38 -35.16 91.18 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 122.686 2.257 . . . . 72.25 114.003 168.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.64 -35.32 74.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.357 0.663 . . . . 73.31 110.881 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.6 -51.13 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.303 -0.862 . . . . 74.33 110.146 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.31 -23.94 54.33 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.564 0.746 . . . . 73.1 112.667 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.93 -50.71 79.84 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 117.567 -1.206 . . . . 65.33 113.125 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.77 -40.5 74.21 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.643 2.229 . . . . 71.51 113.911 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.456 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.5 m-85 -69.86 -45.58 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.411 0.684 . . . . 75.44 110.591 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.48 86.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.547 0.739 . . . . 72.02 110.859 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.642 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 32.1 ttt180 -63.28 -54.63 34.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.758 1.623 . . . . 73.54 110.994 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -36.98 81.66 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.226 0.954 . . . . 73.32 109.663 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.498 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -69.0 -38.95 79.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.756 -0.656 . . . . 72.42 111.951 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 58.3 mt -63.27 -51.94 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.129 0.572 . . . . 74.4 109.463 174.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.612 HG23 ' HB2' ' B' ' 125' ' ' GLN . 29.6 m -61.37 -28.25 69.1 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.323 -0.853 . . . . 74.11 111.498 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.4 t -69.47 -43.29 73.52 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.514 0.726 . . . . 75.4 110.22 176.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -73.27 -30.68 63.6 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.582 0.353 . . . . 74.24 111.129 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.77 -39.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 73.14 109.704 172.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.4 t -62.99 -35.72 81.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.374 1.07 . . . . 73.5 111.294 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.426 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 82.3 mtt-85 -75.99 -31.04 58.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.831 0.852 . . . . 74.11 110.716 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -0.77 86.58 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 123.572 0.545 . . . . 54.53 112.469 171.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.459 HG23 ' HB3' ' A' ' 17' ' ' TYR . 48.9 p 62.57 32.68 16.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.512 1.925 . . . . 71.4 112.512 173.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . 0.423 ' CE1' HG13 ' B' ' 31' ' ' VAL . 40.6 m-85 -101.71 151.94 38.0 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 115.095 -0.957 . . . . 74.31 110.479 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.638 ' HB2' ' HA ' ' H' ' 297' ' ' TYR . 36.3 Cg_exo -57.55 119.0 5.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.67 2.247 . . . . 75.22 110.635 172.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.612 ' HB2' HG23 ' B' ' 115' ' ' THR . 19.9 pt20 -60.42 152.26 26.0 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.231 1.012 . . . . 74.24 113.175 -168.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.489 ' HB3' HG23 ' H' ' 296' ' ' THR . 3.4 pp -112.26 120.81 43.01 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.544 -1.28 . . . . 73.12 107.544 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -93.33 104.37 16.53 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.469 -0.938 . . . . 72.44 108.469 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.642 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -58.25 118.41 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.67 -0.863 . . . . 74.12 108.67 175.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' H' ' 291' ' ' LEU . . . -80.03 144.89 59.95 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 109.837 -0.431 . . . . 74.31 109.837 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.456 ' HD2' HG22 ' F' ' 309' ' ' THR . 14.4 Cg_exo -64.12 110.36 1.33 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.954 2.436 . . . . 65.44 112.381 -173.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.68 112.79 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.421 -1.326 . . . . 71.31 107.421 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.22 75.45 4.75 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.191 -1.04 . . . . 73.02 108.191 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -54.9 -47.21 74.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.058 1.343 . . . . 74.54 111.581 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.31 -49.86 73.94 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 113.944 -1.48 . . . . 74.41 112.395 -174.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.86 96.26 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.871 0.732 . . . . 71.54 110.959 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.504 HD11 ' SD ' ' H' ' 286' ' ' MET . 2.1 tm? -65.08 -43.86 90.8 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.927 0.891 . . . . 74.4 110.034 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -67.04 -27.52 67.46 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.416 0.686 . . . . 73.44 111.536 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 94.2 mtp -66.94 -29.92 69.92 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.857 0.463 . . . . 73.32 111.204 176.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -77.63 -20.24 54.17 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.392 0.677 . . . . 72.24 111.177 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.78 -34.94 79.04 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.936 -0.394 . . . . 75.11 109.936 173.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.77 33.91 0.92 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.059 0.944 . . . . 74.43 109.973 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? 63.24 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.159 1.383 . . . . 61.42 108.792 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -169.15 141.47 2.59 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.189 0.995 . . . . 73.21 109.842 164.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -177.85 145.14 0.38 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.884 1.274 . . . . 74.33 108.643 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.94 109.84 3.88 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.777 0.831 . . . . 74.32 108.941 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.34 150.93 5.95 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 111.754 -0.538 . . . . 75.51 111.754 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -92.27 -3.46 55.43 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.109 0.564 . . . . 64.03 112.226 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.53 44.98 61.65 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.643 0.589 . . . . 75.24 112.574 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.3 m -140.82 85.03 1.97 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.454 0.701 . . . . 73.24 109.327 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -174.17 117.18 0.22 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.473 1.109 . . . . 74.5 109.297 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.16 118.97 11.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.777 0.831 . . . . 65.13 110.436 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -137.01 164.87 27.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.988 1.315 . . . . 73.21 107.635 163.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -68.66 112.51 5.46 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.667 0.746 . . . . 75.13 110.679 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -64.54 118.11 8.34 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.149 -0.932 . . . . 63.41 109.603 174.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.096 0.559 . . . . 75.03 110.316 -173.369 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.487 -0.56 . . . . 75.31 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.1 t -150.27 -52.62 0.14 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.565 -0.902 . . . . 65.33 108.565 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.35 92.79 1.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 106.417 -1.698 . . . . 65.54 106.417 170.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -165.77 122.77 1.42 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.488 0.315 . . . . 75.05 110.878 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -86.68 -68.06 0.77 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.199 -1.408 . . . . 75.43 107.199 167.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -149.79 160.35 43.62 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.659 1.184 . . . . 74.2 109.083 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 86.4 m -152.03 95.81 2.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.502 0.321 . . . . 74.53 111.309 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 67.93 155.42 0.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.804 1.241 . . . . 63.43 113.43 165.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ttt 65.09 121.72 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.132 1.373 . . . . 75.13 112.129 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.3 m -125.68 107.91 11.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.883 -0.784 . . . . 71.13 108.883 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.411 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 61.1 t80 -123.18 133.84 54.21 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.079 0.952 . . . . 74.14 108.432 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.18 144.49 21.08 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.42 0.688 . . . . 73.31 110.036 166.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.526 HG23 ' HE2' ' C' ' 84' ' ' PHE . 2.9 pp -65.23 141.35 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.073 -0.967 . . . . 73.53 109.313 171.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.548 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.3 mm-40 -112.07 -50.62 2.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.681 -0.489 . . . . 73.43 109.681 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -168.24 123.7 0.99 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.175 -0.676 . . . . 71.41 109.175 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.28 145.61 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.262 -1.385 . . . . 75.45 107.262 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' D' ' 28' ' ' ALA . 35.0 p90 -176.88 168.49 2.49 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.842 0.83 . . . . 75.02 111.242 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -90.12 113.41 25.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.532 -1.213 . . . . 71.32 108.725 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.66 -38.61 89.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.354 0.662 . . . . 75.43 109.793 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.57 144.48 26.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.812 -1.086 . . . . 71.44 109.257 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.1 mt -134.83 137.89 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.006 -1.479 . . . . 72.33 107.006 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -149.5 150.73 32.77 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.31 0.644 . . . . 75.03 109.495 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -154.23 135.31 13.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.74 -1.207 . . . . 74.21 107.74 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.546 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.7 mt-10 -131.43 117.74 19.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.044 -0.724 . . . . 75.21 109.044 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.8 72.46 55.53 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.352 -0.981 . . . . 73.1 108.352 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.06 -15.68 25.83 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.576 2.184 . . . . 72.04 111.912 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . 0.447 ' O ' HG23 ' C' ' 31' ' ' VAL . 2.0 m-20 -105.18 18.4 22.39 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.356 1.062 . . . . 65.14 110.093 178.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.24 -48.82 54.67 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 114.356 1.243 . . . . 74.54 114.356 -171.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.43 ' HB3' HD12 ' D' ' 51' ' ' LEU . 13.5 Cg_exo -68.59 -38.35 11.05 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 121.818 1.679 . . . . 64.53 111.815 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -67.66 -22.68 65.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.406 1.482 . . . . 74.31 112.381 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.447 HG23 ' O ' ' C' ' 27' ' ' ASN . 78.2 t -65.91 -37.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.813 0.445 . . . . 72.13 111.952 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -69.65 -28.67 66.08 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 111.976 0.361 . . . . 72.2 111.976 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -87.8 12.92 11.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.208 0.603 . . . . 74.32 111.656 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.49 ' HD2' HD21 ' C' ' 68' ' ' LEU . 5.4 ttpm? -112.93 148.98 33.86 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.822 0.849 . . . . 73.13 110.915 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.97 130.24 39.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.147 0.979 . . . . 72.13 109.88 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -85.44 80.85 8.96 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.104 0.962 . . . . 75.12 111.721 -165.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . 0.48 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 1.0 OUTLIER -152.94 44.74 0.26 Allowed Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 114.0 1.111 . . . . 74.31 114.0 173.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.64 ' HA ' ' HB3' ' C' ' 68' ' ' LEU . 22.7 Cg_exo -67.0 149.0 82.75 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 122.253 1.968 . . . . 73.02 111.1 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.48 118.73 25.19 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 170.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.683 HG21 HD11 ' C' ' 126' ' ' LEU . 14.2 p -82.1 142.89 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.992 -1.004 . . . . 75.3 109.537 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -131.8 124.46 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.933 0.893 . . . . 64.52 108.934 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -88.77 129.98 35.45 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 105.764 -1.939 . . . . 75.52 105.764 164.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -130.01 108.43 10.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.933 -1.136 . . . . 72.24 107.933 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 43.5 tp -96.6 151.96 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.124 0.57 . . . . 71.2 110.265 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.9 t0 -131.15 154.44 48.35 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.908 0.883 . . . . 73.51 108.642 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.5 p -119.64 111.77 18.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.813 0.845 . . . . 70.24 109.586 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.81 146.5 43.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.966 0.906 . . . . 72.22 109.436 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -161.76 152.94 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.055 0.542 . . . . 75.22 110.505 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -149.52 146.03 27.17 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.196 0.598 . . . . 73.15 110.394 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -86.26 124.73 32.97 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.443 -0.576 . . . . 74.01 109.443 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.489 HD13 HD13 ' C' ' 83' ' ' ILE . 70.2 mt -96.53 -44.89 6.96 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.731 0.813 . . . . 74.44 109.78 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.38 -177.19 5.71 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.115 -0.948 . . . . 75.21 109.644 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.83 115.82 3.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.301 0.64 . . . . 64.14 109.886 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 64.48 0.96 1.19 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.205 1.402 . . . . 63.45 113.206 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 94.5 t -94.17 111.09 24.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.885 -1.154 . . . . 74.21 107.885 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -126.86 125.72 42.1 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.182 0.993 . . . . 71.43 109.112 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -84.65 122.62 29.33 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.318 -0.855 . . . . 74.04 109.193 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.13 124.59 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.993 -1.114 . . . . 63.13 107.993 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.64 131.16 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.963 0.905 . . . . 74.54 109.236 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.12 105.74 12.14 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.693 -1.225 . . . . 74.0 107.693 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.8 tmm_? -82.64 108.28 15.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.433 -1.321 . . . . 74.43 107.433 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.423 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.4 t -100.23 136.54 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.247 -1.02 . . . . 74.1 108.247 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 59.9 m -134.85 121.32 20.46 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.168 -0.679 . . . . 45.22 109.168 178.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 76.7 t -103.75 109.27 26.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.951 . . . . 72.42 108.434 174.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.431 HG21 HD23 ' C' ' 75' ' ' LEU . 6.2 m -99.28 150.21 22.34 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.2 -0.909 . . . . 74.33 109.792 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.97 110.09 8.32 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.419 0.688 . . . . 73.14 109.17 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.0 m -148.0 138.64 23.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.924 0.49 . . . . 61.45 110.32 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.64 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.7 OUTLIER -112.41 56.11 0.67 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.405 1.082 . . . . 74.12 108.764 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.44 -116.56 4.4 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.27 -1.332 . . . . 54.22 110.519 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -88.79 -29.03 20.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.195 0.598 . . . . 75.23 110.146 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -79.18 106.14 11.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.999 0.919 . . . . 75.52 110.056 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -78.74 126.01 30.14 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.715 -0.675 . . . . 72.22 109.778 171.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.32 -56.55 4.92 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.666 -1.152 . . . . 73.34 109.437 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -167.75 178.71 5.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.645 0.778 . . . . 74.3 110.691 173.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.546 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -138.38 143.76 39.95 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.613 1.165 . . . . 75.41 107.956 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 50.2 t -140.2 137.51 34.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.612 -1.255 . . . . 74.02 107.612 173.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -152.88 134.55 14.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.667 0.387 . . . . 75.34 110.601 -173.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.05 120.76 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.684 1.194 . . . . 72.44 108.735 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 72.4 mt-30 -88.42 100.18 12.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.455 -1.313 . . . . 72.42 107.455 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -87.95 112.23 22.33 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.674 -0.491 . . . . 74.02 109.674 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.08 154.11 17.7 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.851 -0.5 . . . . 73.42 111.851 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.424 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -154.11 123.97 1.48 Allowed Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 110.69 -0.964 . . . . 61.34 110.69 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.548 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 9.4 mm -81.38 129.51 37.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 108.452 -0.944 . . . . 74.23 108.452 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.526 ' HE2' HG23 ' C' ' 13' ' ' ILE . 50.4 m-85 -138.02 151.73 48.17 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.399 -0.593 . . . . 74.03 109.399 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.9 p -110.36 117.08 32.66 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.364 -0.976 . . . . 74.24 108.364 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.99 116.71 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.157 0.983 . . . . 72.34 109.597 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.4 163.52 34.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.35 0.66 . . . . 73.34 111.439 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.77 -29.58 7.8 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.401 -0.818 . . . . 72.31 113.977 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.14 157.11 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.166 0.987 . . . . 71.24 111.013 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -149.91 159.67 44.19 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.134 0.974 . . . . 73.25 109.582 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.34 -144.58 17.98 Favored Glycine 0 C--N 1.348 1.246 0 C-N-CA 123.279 0.466 . . . . 71.05 112.458 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -64.5 -21.29 66.63 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.708 0.803 . . . . 71.52 111.677 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -65.8 -52.24 52.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.915 1.286 . . . . 71.2 109.747 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.463 ' HE3' HD12 ' C' ' 98' ' ' LEU . 3.5 ppp? -77.76 -21.6 51.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.612 -0.722 . . . . 71.43 110.515 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.67 70.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.87 0.868 . . . . 73.03 111.82 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 40.3 t-80 -69.85 -34.28 73.4 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.058 170.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -69.59 -43.05 73.58 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.695 0.398 . . . . 72.52 110.73 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.503 HD13 HD23 ' F' ' 278' ' ' LEU . 0.8 OUTLIER -79.79 -55.09 5.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.969 0.907 . . . . 74.24 110.06 -174.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.03 11.46 69.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.519 -0.764 . . . . 75.42 114.639 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.554 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -148.23 -52.02 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.457 0.628 . . . . 74.23 111.84 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -76.27 -41.95 47.18 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.541 0.736 . . . . 74.53 111.203 -173.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 86.6 m -67.36 -47.71 48.01 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 118.517 -0.754 . . . . 73.41 111.478 177.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -53.68 -35.8 79.3 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.756 2.304 . . . . 62.45 113.715 169.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.28 -40.23 81.37 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.672 0.789 . . . . 71.21 110.912 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.59 -46.25 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.632 0.773 . . . . 72.23 110.901 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.424 HD22 ' HA3' ' C' ' 82' ' ' GLY . 92.8 mt -82.46 -23.33 34.81 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.163 0.801 . . . . 62.43 113.163 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -57.06 -49.39 94.22 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.162 0.985 . . . . 73.35 112.842 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.21 -33.72 97.83 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.504 2.136 . . . . 72.43 113.982 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.424 ' HE2' HG23 ' A' ' 115' ' ' THR . 95.9 m-85 -70.66 -48.39 55.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.387 0.675 . . . . 64.14 111.285 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.13 89.95 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.472 0.482 . . . . 75.11 109.86 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.497 ' HA ' HD21 ' C' ' 128' ' ' LEU . 31.1 ttt-85 -52.64 -55.98 18.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.251 1.421 . . . . 72.22 111.78 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.11 -32.79 72.45 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.476 0.485 . . . . 71.21 110.546 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -69.39 -33.51 73.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.996 0.518 . . . . 74.14 111.257 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.423 HD11 ' HB ' ' C' ' 62' ' ' VAL . 90.1 mt -69.22 -52.29 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.73 0.812 . . . . 75.22 109.283 172.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.1 m -59.11 -33.79 71.25 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.272 1.029 . . . . 74.12 111.478 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.407 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.7 t -64.14 -48.72 74.95 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.614 0.766 . . . . 71.2 109.41 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.649 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.0 -38.24 90.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.392 1.077 . . . . 64.21 112.404 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.59 -42.37 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 O-C-N 123.559 0.537 . . . . 74.5 109.715 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -66.79 -32.99 74.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.034 0.934 . . . . 74.14 111.68 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.6 mtt-85 -72.12 -31.68 66.25 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.781 0.832 . . . . 73.41 110.76 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.03 8.48 70.12 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 119.521 -0.599 . . . . 71.23 112.715 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p 62.02 34.05 16.84 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.772 1.629 . . . . 65.2 112.408 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.425 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 29.1 m-85 -104.84 163.05 17.98 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 124.803 1.241 . . . . 74.54 109.486 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 63.1 Cg_endo -68.51 162.57 40.24 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.015 2.477 . . . . 71.14 113.502 -173.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.467 HE21 ' HB3' ' B' ' 125' ' ' GLN . 64.9 mm-40 -60.85 128.05 34.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.116 -0.947 . . . . 75.21 112.721 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.683 HD11 HG21 ' C' ' 40' ' ' VAL . 6.3 tt -140.65 89.28 2.26 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.731 -1.211 . . . . 74.3 107.731 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -97.47 131.31 44.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.706 0.802 . . . . 74.25 109.128 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.497 HD21 ' HA ' ' C' ' 111' ' ' ARG . 3.5 mm? -70.88 135.59 48.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.743 0.817 . . . . 73.14 111.123 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.429 ' HB3' HD11 ' F' ' 291' ' ' LEU . . . -85.97 160.29 52.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 124.925 1.29 . . . . 73.32 112.156 -173.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.88 102.57 0.77 Allowed 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 123.304 2.669 . . . . 73.53 112.343 -175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -99.4 110.24 26.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.303 -0.999 . . . . 74.24 108.303 171.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -81.39 88.34 6.12 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.422 0.689 . . . . 75.55 110.613 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -65.26 -34.86 79.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.007 -0.997 . . . . 65.44 109.344 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.554 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.7 p-10 -65.38 -46.78 78.77 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.417 -1.265 . . . . 75.01 111.701 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.82 -31.21 71.68 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.567 0.747 . . . . 73.21 111.623 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -54.34 -52.02 62.89 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.322 1.014 . . . . 72.32 109.288 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -73.07 -16.44 61.48 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.795 0.838 . . . . 74.23 112.365 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 32.2 mmt -75.48 -27.37 58.8 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.987 0.515 . . . . 73.42 111.704 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -54.15 -34.16 59.7 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.525 0.73 . . . . 75.24 111.71 172.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -57.84 -85.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.309 1.044 . . . . 75.34 111.323 171.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.492 HD11 HE22 ' C' ' 143' ' ' GLN . 1.3 pp -76.28 159.3 30.72 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.684 0.624 . . . . 74.51 112.684 -168.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -148.37 108.21 4.02 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.287 1.035 . . . . 63.42 109.188 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.492 HE22 HD11 ' C' ' 141' ' ' LEU . 1.7 mp0 -94.62 83.47 4.1 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.686 -0.487 . . . . 74.32 109.686 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -85.84 86.09 7.37 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.14 -0.689 . . . . 74.24 109.14 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.46 -174.77 3.29 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.006 0.922 . . . . 75.14 109.731 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.03 -126.19 22.99 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-O 118.952 -0.915 . . . . 73.5 112.45 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 62.84 102.38 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.972 1.309 . . . . 75.55 111.726 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.97 120.91 0.6 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.816 -0.435 . . . . 71.24 112.698 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 15.7 p -137.46 164.46 28.62 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.056 0.942 . . . . 70.12 110.444 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 69.72 117.14 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.544 1.538 . . . . 74.43 110.681 170.447 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -98.62 9.31 43.55 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.155 0.982 . . . . 72.33 111.65 -170.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 59.47 67.2 0.92 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.969 1.308 . . . . 74.43 109.155 -168.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -72.08 108.72 5.43 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.311 -0.859 . . . . 64.13 110.653 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -159.93 150.01 18.47 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.727 0.811 . . . . 75.34 109.453 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.132 0 N-CA-C 108.549 -0.908 . . . . 73.13 108.549 176.056 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.226 -0.657 . . . . 74.25 109.226 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -134.59 -165.01 1.59 Allowed 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.568 -0.901 . . . . 54.53 108.568 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.43 159.81 44.21 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.897 0.879 . . . . 74.35 109.027 169.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -170.73 129.44 0.8 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.276 -0.638 . . . . 74.33 109.276 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -127.5 78.63 1.83 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 108.984 -0.747 . . . . 62.32 108.984 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -93.5 134.01 36.21 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.788 -0.449 . . . . 73.13 109.788 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 27.0 m -63.18 -35.5 80.5 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.025 -0.731 . . . . 72.34 109.025 164.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.07 175.5 2.05 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.896 -1.047 . . . . 71.04 111.133 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.0 ttp -33.3 124.6 0.4 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.902 1.281 . . . . 72.42 113.403 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.586 ' HB ' ' HB1' ' D' ' 87' ' ' ALA . 96.0 m -132.18 141.91 49.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.612 -1.255 . . . . 72.51 107.612 175.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -152.37 91.35 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.646 -1.242 . . . . 71.31 107.646 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 77.0 mt-30 -114.44 115.77 27.8 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.48 -0.933 . . . . 74.3 108.48 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -72.69 115.86 13.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.298 -1.001 . . . . 74.1 108.298 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -83.14 -50.06 8.85 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.062 -0.347 . . . . 71.14 110.062 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -172.83 151.28 2.22 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.792 0.33 . . . . 74.55 111.879 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.406 HD13 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -128.85 126.89 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.896 -1.52 . . . . 73.44 106.896 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -144.6 150.28 37.17 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.246 1.019 . . . . 73.24 109.645 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.5 p -83.97 109.03 17.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.839 -1.073 . . . . 74.22 108.909 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.416 ' HZ2' ' CD ' ' D' ' 57' ' ' GLU . 37.3 mtpt -76.28 -23.52 54.41 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.727 -0.67 . . . . 73.51 110.48 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -163.33 140.18 7.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.968 -1.014 . . . . 70.31 108.823 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.649 HG21 ' HE1' ' C' ' 117' ' ' MET . 85.2 mt -135.11 148.02 29.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 108.127 -1.064 . . . . 73.14 108.127 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -147.47 143.22 27.72 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.893 0.877 . . . . 44.35 109.769 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.8 t80 -153.56 126.77 8.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.969 -1.863 . . . . 71.24 105.969 169.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.65 153.66 45.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.651 . . . . 75.02 109.361 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.545 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -145.95 77.02 12.33 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.506 -0.924 . . . . 74.43 108.506 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.28 -31.18 23.19 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.922 2.415 . . . . 73.11 113.322 -172.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -116.06 36.32 4.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.473 0.709 . . . . 71.04 109.621 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.545 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -49.84 -64.12 1.4 Allowed Pre-proline 0 CA--C 1.568 1.646 0 N-CA-C 113.418 0.896 . . . . 72.21 113.418 -172.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.504 ' HB3' HD11 ' C' ' 83' ' ' ILE . 55.1 Cg_endo -78.39 -9.96 16.17 Favored 'Trans proline' 0 C--N 1.385 2.48 0 CA-C-N 121.73 1.654 . . . . 75.53 112.618 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -82.9 -38.69 22.54 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.896 1.679 . . . . 73.35 109.615 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.496 HG21 ' CZ2' ' D' ' 36' ' ' TRP . 2.0 p -85.56 -19.61 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.791 0.836 . . . . 74.51 110.886 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.405 ' HA ' HD12 ' G' ' 301' ' ' ILE . 20.1 m-85 -68.85 -10.57 57.64 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.5 0.72 . . . . 64.42 112.33 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -83.62 3.07 34.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.065 0.946 . . . . 73.01 111.505 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -126.23 112.7 16.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.012 0.925 . . . . 72.21 109.347 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -90.51 97.6 11.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.666 0.786 . . . . 71.45 111.72 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.496 ' CZ2' HG21 ' D' ' 31' ' ' VAL . 0.0 OUTLIER -150.62 -173.93 4.61 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.805 0.842 . . . . 75.42 112.222 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.1 115.93 65.68 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-N 114.974 -1.012 . . . . 71.01 110.1 165.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.587 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.0 Cg_exo -63.3 131.04 30.56 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.164 2.576 . . . . 73.34 111.746 163.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.6 112.28 20.29 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.163 -1.791 . . . . 72.25 106.163 163.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.774 HG12 ' HB3' ' D' ' 66' ' ' ALA . 26.8 m -98.29 112.29 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.635 -1.246 . . . . 63.41 107.635 177.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -84.2 124.33 31.07 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.45 -0.945 . . . . 74.11 108.45 -172.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.1 mt -97.21 112.77 24.42 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.284 -1.326 . . . . 74.51 109.145 -170.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.467 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 31.2 t70 -114.0 130.69 56.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.257 -1.016 . . . . 74.42 108.257 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.62 136.5 47.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.706 -0.85 . . . . 74.05 108.706 177.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -132.64 127.94 35.98 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.865 -1.161 . . . . 73.52 107.865 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.2 p -105.54 151.96 23.66 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.249 0.62 . . . . 74.04 110.302 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.654 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.03 160.53 43.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.29 -0.868 . . . . 75.45 109.331 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 66.1 p -155.33 156.79 36.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.649 0.78 . . . . 75.34 109.535 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.6 m -150.63 146.85 26.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.419 -1.326 . . . . 74.41 107.419 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.34 116.56 32.61 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.207 -1.405 . . . . 74.4 107.207 162.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.43 HD12 ' HB3' ' C' ' 29' ' ' PRO . 40.9 mt -92.23 -29.55 16.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.801 0.441 . . . . 72.23 110.263 -176.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.46 -178.73 7.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.647 0.779 . . . . 71.21 110.083 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.76 123.67 20.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.174 -0.921 . . . . 73.42 109.645 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 64.25 9.71 5.02 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.586 1.154 . . . . 61.23 112.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 96.7 t -118.63 117.29 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.305 -0.628 . . . . 72.42 109.305 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -128.36 128.33 44.34 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.118 0.967 . . . . 70.43 108.685 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.416 ' CD ' ' HZ2' ' D' ' 19' ' ' LYS . 29.0 tt0 -89.81 132.13 35.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.886 0.874 . . . . 74.33 108.795 170.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.571 HG11 ' HZ ' ' G' ' 281' ' ' PHE . 97.9 t -117.03 122.26 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.047 -1.464 . . . . 65.11 107.047 176.001 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.654 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.9 t -112.86 129.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.317 -0.624 . . . . 74.55 109.317 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.485 HD23 HD12 ' D' ' 106' ' ' LEU . 3.8 mm? -116.76 107.52 14.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 75.32 108.994 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -88.29 112.35 22.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.489 -0.778 . . . . 74.43 109.071 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -99.88 120.65 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.038 -1.097 . . . . 75.13 108.038 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.467 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 33.6 m -115.4 140.01 49.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.792 0.837 . . . . 74.44 109.595 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.605 HG13 ' HB ' ' D' ' 40' ' ' VAL . 88.1 t -137.15 127.81 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.754 1.222 . . . . 74.21 108.764 -172.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.3 m -133.91 103.8 5.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.178 0.591 . . . . 73.51 109.648 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.774 ' HB3' HG12 ' D' ' 40' ' ' VAL . . . -102.06 130.42 48.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.577 0.751 . . . . 75.23 109.976 177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 16.2 p -154.43 124.37 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.996 -0.742 . . . . 70.22 108.996 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.587 HD11 ' HA ' ' D' ' 38' ' ' PRO . 3.0 mm? -114.85 134.07 55.44 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.971 0.508 . . . . 75.11 110.083 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.5 -110.24 3.06 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.902 0.751 . . . . 73.13 112.037 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.4 7.68 10.15 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.231 1.012 . . . . 70.14 110.85 -175.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -137.55 154.87 49.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 122.874 0.47 . . . . 74.25 110.697 -173.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.9 m -83.26 124.94 31.07 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.744 -0.662 . . . . 64.33 110.309 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.447 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -71.03 -65.73 0.7 Allowed 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.897 0.748 . . . . 64.1 109.555 176.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.34 158.49 37.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.962 -1.017 . . . . 72.14 110.765 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -120.69 151.94 38.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.502 -1.295 . . . . 72.14 107.502 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.626 ' SG ' HG23 ' D' ' 114' ' ' ILE . 33.7 t -159.52 136.12 9.21 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.978 -0.379 . . . . 72.34 109.978 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.66 139.86 15.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.746 0.418 . . . . 73.44 110.046 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.8 120.45 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.177 0.591 . . . . 74.33 110.087 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -89.03 88.27 7.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.658 -0.868 . . . . 72.41 108.658 168.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -84.36 92.21 7.97 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.019 -0.991 . . . . 64.51 108.738 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 143.93 18.97 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.946 -0.861 . . . . 62.22 110.946 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.86 129.59 3.23 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 110.808 -0.917 . . . . 54.34 110.808 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.7 mt -89.56 134.1 29.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 123.22 0.608 . . . . 72.44 109.505 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -132.0 129.59 40.31 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.177 0.991 . . . . 74.22 109.291 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 50.0 m -75.77 94.35 3.28 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.896 -0.779 . . . . 70.51 108.896 166.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 19.5 mt -107.05 123.32 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 107.824 -1.176 . . . . 74.31 107.824 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.586 ' HB1' ' HB ' ' D' ' 10' ' ' THR . . . -148.22 161.98 40.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.759 0.824 . . . . 71.33 110.297 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.02 19.68 75.66 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.761 0.663 . . . . 43.21 113.875 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.526 HD11 ' HG3' ' D' ' 93' ' ' GLN . 16.2 tt -135.45 149.91 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.817 -0.808 . . . . 74.51 108.817 -169.489 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.03 156.96 44.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.068 0.547 . . . . 72.22 111.689 -170.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 33.87 -96.17 0.01 OUTLIER Glycine 0 C--N 1.357 1.73 0 N-CA-C 117.094 1.598 . . . . 61.52 117.094 153.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 44.0 p -64.89 -50.63 65.77 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.98 0.912 . . . . 74.3 112.529 -173.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.526 ' HG3' HD11 ' D' ' 89' ' ' ILE . 52.9 tp60 -79.78 -28.91 40.29 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 111.803 0.298 . . . . 73.5 111.803 -172.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.486 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -70.65 -34.02 71.59 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.746 -0.465 . . . . 74.31 109.746 176.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.452 ' HB1' HD21 ' G' ' 280' ' ' LEU . . . -59.92 -35.99 76.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.634 0.774 . . . . 61.32 110.727 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.14 -36.57 72.13 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.873 -1.058 . . . . 75.02 110.712 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -73.02 -52.22 15.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.006 0.522 . . . . 74.23 112.366 -173.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.0 pp -94.84 -20.47 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.04 0.536 . . . . 74.42 111.912 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.45 -6.84 60.91 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.72 -0.489 . . . . 62.33 113.721 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.85 -58.66 0.47 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.161 0.48 . . . . 73.13 111.402 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.5 -45.47 68.84 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.221 0.608 . . . . 75.15 112.547 -171.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -43.06 57.26 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 123.56 0.744 . . . . 64.33 111.426 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.88 -43.47 35.1 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.831 2.354 . . . . 75.21 113.906 163.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.28 -21.19 65.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.402 0.681 . . . . 70.34 112.285 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.78 -42.2 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.948 0.499 . . . . 72.22 110.532 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.485 HD12 HD23 ' D' ' 60' ' ' LEU . 74.3 mt -91.13 -20.92 21.49 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.888 0.699 . . . . 70.05 112.888 -170.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -65.85 -41.67 48.12 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.152 -0.927 . . . . 65.11 112.715 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.19 -40.35 69.41 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.383 2.055 . . . . 73.33 113.399 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -73.97 -36.39 64.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.748 0.819 . . . . 74.42 111.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.95 -45.09 83.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.003 0.521 . . . . 74.21 110.219 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -60.75 -46.05 91.94 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.575 -1.193 . . . . 73.41 110.46 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.92 -47.23 87.37 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.238 0.961 . . . . 74.14 110.779 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.99 -41.06 86.69 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.682 0.614 . . . . 70.35 110.945 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.626 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.8 mt -66.3 -47.95 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.496 0.718 . . . . 73.32 110.243 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.472 HG22 ' HB3' ' D' ' 125' ' ' GLN . 99.4 m -53.17 -46.82 69.08 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.489 1.116 . . . . 74.35 111.229 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.5 t -66.84 -41.7 86.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.071 -0.968 . . . . 71.4 110.731 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.578 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 77.2 mtm -67.8 -45.26 75.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.86 0.464 . . . . 74.33 112.185 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 -32.03 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.313 -0.858 . . . . 70.55 110.082 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.9 p -72.22 -33.67 67.76 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.917 0.487 . . . . 64.33 110.819 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtt-85 -68.26 -26.68 65.79 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.744 0.817 . . . . 72.22 110.917 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.0 10.46 65.63 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.615 0.572 . . . . 63.41 112.889 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 58.1 p 57.57 19.85 5.71 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 126.524 1.929 . . . . 75.2 113.248 -177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.576 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 63.7 m-85 -91.4 178.06 1.95 Allowed Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.487 1.515 . . . . 73.44 107.688 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.576 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 83.1 Cg_endo -74.82 160.79 40.22 Favored 'Trans proline' 0 C--N 1.39 2.75 0 CA-C-N 121.843 1.694 . . . . 75.33 112.434 -174.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.472 ' HB3' HG22 ' D' ' 115' ' ' THR . 15.9 mt-30 -66.34 128.12 34.91 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.287 -1.005 . . . . 74.21 108.287 166.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.99 91.55 4.17 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.433 -1.321 . . . . 75.33 107.433 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -103.88 93.31 4.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.089 -1.414 . . . . 71.2 108.323 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.87 127.89 34.22 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.196 -0.668 . . . . 73.31 109.196 174.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -56.24 134.32 75.42 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 124.269 0.981 . . . . 73.13 110.554 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.549 ' HB2' ' HH ' ' B' ' 101' ' ' TYR . 5.8 Cg_exo -73.63 96.67 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.702 2.268 . . . . 61.55 109.876 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.69 110.06 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.712 -1.218 . . . . 64.31 107.712 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -68.99 114.76 7.58 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.048 -0.978 . . . . 43.03 109.94 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -63.2 -36.63 84.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.01 111.356 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.14 -44.02 92.04 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.121 0.968 . . . . 73.13 110.217 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.88 67.36 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 114.961 -1.018 . . . . 74.45 110.313 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 79.8 mt -57.66 -40.23 78.85 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.758 0.423 . . . . 74.11 111.929 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -63.29 -52.6 61.32 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.895 -1.048 . . . . 71.13 110.728 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.6 ptp -73.64 -32.85 64.24 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.022 0.529 . . . . 74.4 111.007 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.665 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 4.7 m-80 -66.44 -32.5 73.91 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.776 0.83 . . . . 75.34 111.043 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -61.07 -39.24 89.13 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.452 0.47 . . . . 63.41 110.964 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.45 -37.64 31.56 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.173 0.589 . . . . 75.41 111.104 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.665 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 12.0 pt20 -89.6 0.58 56.83 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.758 0.651 . . . . 71.44 112.758 -171.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -119.29 87.56 2.76 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.426 -0.953 . . . . 73.02 108.426 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -145.48 103.27 3.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.439 -1.255 . . . . 72.31 107.99 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.37 141.68 19.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.012 0.925 . . . . 74.14 110.252 -174.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.61 -157.7 33.85 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.376 0.423 . . . . 61.13 112.31 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -163.24 122.78 2.15 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.954 -1.128 . . . . 70.42 107.954 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.69 82.0 1.12 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.691 -0.564 . . . . 54.03 111.691 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 49.4 m -58.75 129.38 41.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.623 0.769 . . . . 74.31 110.573 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -127.5 147.15 50.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.962 0.905 . . . . 74.43 108.568 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.67 -172.4 3.23 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.057 0.943 . . . . 75.31 110.255 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -134.76 105.28 6.37 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.735 -0.839 . . . . 74.54 108.735 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -62.51 111.65 2.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.302 0.641 . . . . 74.3 110.125 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -97.19 123.35 40.94 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.42 -0.956 . . . . 74.11 108.42 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.946 0 CA-C-O 118.484 -0.769 . . . . 71.33 109.632 -178.757 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.888 -0.412 . . . . 64.25 109.888 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -68.76 137.27 53.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.58 0.752 . . . . 74.23 109.758 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -77.59 74.63 4.15 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.632 0.73 . . . . 74.14 110.073 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -151.32 -0.38 0.36 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.778 -1.101 . . . . 61.13 109.472 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 56.6 84.03 0.21 Allowed Pre-proline 0 C--N 1.361 1.069 0 C-N-CA 124.7 1.2 . . . . 75.53 109.744 -170.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . 0.572 ' HG2' ' HB3' ' A' ' 90' ' ' GLU . 38.9 Cg_endo -66.6 77.91 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.003 2.469 . . . . 63.12 112.334 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . 0.492 ' HB3' ' HE1' ' A' ' 94' ' ' MET . 62.2 mt -103.16 -63.46 1.17 Allowed 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 108.022 -1.103 . . . . 73.02 108.022 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . 0.418 HD23 ' HB2' ' E' ' 277' ' ' LEU . 0.8 OUTLIER -96.5 87.2 4.34 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.316 -0.994 . . . . 63.3 108.316 176.482 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.98 -60.5 0.02 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.309 -0.717 . . . . 72.32 111.309 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 56.0 tp -88.29 61.66 6.31 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.838 0.855 . . . . 75.5 109.901 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -176.58 91.5 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.241 -0.89 . . . . 71.24 109.89 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -160.55 -55.64 0.05 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.261 -1.014 . . . . 64.12 108.261 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.4 125.45 49.12 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.26 -0.882 . . . . 75.23 109.511 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -120.1 81.81 0.34 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.413 -1.075 . . . . 54.01 110.413 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -77.87 71.55 4.35 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.592 0.711 . . . . 71.11 109.227 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 90.6 mtp -131.14 84.57 56.97 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.56 1.144 . . . . 74.45 108.757 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.36 90.83 0.99 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.801 2.334 . . . . 75.31 111.003 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.4 -46.82 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.69 0.796 . . . . 74.44 110.175 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 61.07 31.75 19.78 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.1 0.96 . . . . 75.3 111.075 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 69.4 m95 67.02 170.87 0.25 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.371 1.081 . . . . 75.31 112.618 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 3.1 mp -117.35 1.58 12.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.061 -1.427 . . . . 74.44 109.959 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -147.47 167.6 28.57 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 118.972 -0.904 . . . . 73.04 112.06 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.58 -75.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.371 2.714 . . . . 64.1 113.237 -175.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -123.77 -63.2 1.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.883 -0.784 . . . . 75.44 108.883 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 73.73 -55.5 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.373 1.469 . . . . 70.32 111.108 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 23.7 m -65.12 143.09 58.11 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.758 0.823 . . . . 63.55 110.18 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.759 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 16.7 m-30 68.97 26.4 5.72 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.097 1.359 . . . . 74.55 111.964 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -91.07 63.12 5.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.277 -1.008 . . . . 64.23 108.277 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 86.4 -151.59 24.56 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.454 -1.248 . . . . 72.33 113.372 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 124' ' ' PRO . 3.3 m-20 73.14 -63.52 0.43 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.213 1.805 . . . . 74.23 111.742 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 123' ' ' PHE . 20.0 pt -105.42 154.49 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.375 0.607 . . . . 71.33 111.608 -177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . 0.541 ' HA ' ' HZ2' ' A' ' 36' ' ' TRP . 21.7 t70 -157.54 -176.87 6.19 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.527 -1.215 . . . . 74.21 107.867 167.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -48.52 150.49 2.38 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 125.228 1.411 . . . . 72.45 113.023 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -53.18 124.08 14.76 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.403 2.735 . . . . 65.25 113.423 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . 0.582 ' HB1' ' HB1' ' G' ' 295' ' ' ALA . . . -80.28 -64.53 1.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.034 0.934 . . . . 74.42 110.97 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 16.7 m -66.86 133.58 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.709 -0.678 . . . . 75.11 109.735 174.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 13.6 t -166.03 7.0 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.219 0.607 . . . . 72.51 110.95 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . 0.453 ' HB2' ' HG3' ' G' ' 293' ' ' PRO . 66.7 m -144.41 152.42 40.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.989 0.515 . . . . 73.1 111.074 -173.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 309' ' ' THR . . . . . 0.61 HG21 ' HB3' ' B' ' 12' ' ' GLN . 16.2 p -126.69 130.59 23.81 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.407 1.083 . . . . 74.23 109.614 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.376 1.983 0 C-N-CA 122.784 2.323 . . . . 73.54 111.451 177.031 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.924 0.392 . . . . 75.52 110.219 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -86.06 149.82 24.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.344 0.658 . . . . 74.13 109.289 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -88.8 -29.91 19.38 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.682 0.793 . . . . 74.53 111.887 -171.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.55 -74.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.432 1.493 . . . . 71.03 111.044 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 63.32 73.76 0.48 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.191 1.396 . . . . 72.15 110.267 -170.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -66.72 -38.47 17.98 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.819 2.346 . . . . 73.03 112.111 175.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 2.5 tt -149.36 69.43 1.05 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.468 -1.308 . . . . 74.44 107.468 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . 0.503 HD23 HD13 ' C' ' 98' ' ' LEU . 96.4 mt -140.54 122.95 16.0 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.22 1.008 . . . . 74.34 109.249 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . 0.45 ' N ' ' SD ' ' C' ' 94' ' ' MET . . . -112.0 132.89 11.08 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-O 119.148 -0.807 . . . . 61.34 111.219 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . 0.28 2.3 pp 40.07 -127.32 0.4 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.229 1.812 . . . . 73.42 113.388 -175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 34.0 t80 72.41 31.81 1.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.917 1.287 . . . . 75.51 109.84 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -139.68 -86.22 0.22 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.799 -1.091 . . . . 73.12 108.237 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 54.91 26.88 8.35 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.524 1.129 . . . . 72.42 111.591 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 85.21 -73.27 2.64 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 109.824 -1.31 . . . . 62.51 109.824 -167.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -176.29 147.91 0.73 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.863 1.265 . . . . 73.52 108.512 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 53.7 ttm -93.91 100.91 5.29 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 108.65 -0.87 . . . . 72.51 108.65 171.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.66 91.15 1.21 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.525 2.15 . . . . 72.51 111.995 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 68.5 t -97.95 104.05 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.491 -0.929 . . . . 73.43 108.491 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -92.15 -90.44 0.17 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.984 -0.747 . . . . 74.13 108.984 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -140.18 155.91 46.74 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.401 0.62 . . . . 74.4 111.799 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.429 HD11 ' HB3' ' C' ' 129' ' ' ALA . 3.9 mp -92.81 -43.84 8.81 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.193 -1.367 . . . . 65.32 110.346 -173.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -151.31 -96.17 0.14 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 118.871 -0.96 . . . . 70.51 111.747 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.37 129.22 22.11 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.705 2.27 . . . . 73.21 112.46 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . 0.528 ' HZ3' ' HB2' ' F' ' 294' ' ' LYS . 10.1 mtmp? -115.34 -150.63 0.47 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.423 1.089 . . . . 75.44 109.12 178.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . 71.08 128.28 0.03 OUTLIER 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.053 1.341 . . . . 72.01 110.766 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 9.3 m -71.43 -53.32 14.41 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.332 0.587 . . . . 73.11 111.09 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.63 52.41 2.04 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.943 0.878 . . . . 75.51 108.657 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -65.65 -32.27 73.74 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 113.295 -1.775 . . . . 73.1 109.37 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.24 115.32 4.88 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 114.624 -1.171 . . . . 62.52 110.386 165.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -71.35 94.31 1.21 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.306 0.642 . . . . 73.51 110.354 -175.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 46.7 pt -81.14 15.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.15 0.58 . . . . 72.02 111.545 176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -69.77 76.78 0.45 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.546 1.138 . . . . 74.34 110.902 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -153.41 139.84 12.58 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 126.065 1.746 . . . . 71.1 106.63 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -48.39 -42.58 34.24 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.914 2.409 . . . . 74.25 112.181 169.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 54.92 -91.83 0.03 OUTLIER 'General case' 0 C--N 1.361 1.099 0 C-N-CA 125.514 1.526 . . . . 64.35 112.383 171.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.37 110.35 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 108.49 -0.93 . . . . 75.14 108.49 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 9.6 t -179.62 -35.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.154 1.382 . . . . 72.22 108.443 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.51 42.07 1.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.332 1.053 . . . . 71.24 109.575 171.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' F' F ' 309' ' ' THR . . . . . 0.456 HG22 ' HD2' ' B' ' 130' ' ' PRO . 92.5 m -69.48 -51.74 16.05 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 114.21 -1.359 . . . . 75.43 112.182 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . 0.412 ' HD3' ' HB ' ' F' ' 309' ' ' THR . 13.2 Cg_exo . . . . . 0 C--N 1.394 2.96 0 C-N-CA 121.866 1.711 . . . . 72.31 111.284 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.244 -0.65 . . . . 75.51 109.244 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -68.71 94.29 0.58 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.667 -0.864 . . . . 75.1 108.667 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.51 43.26 1.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.451 1.119 . . . . 75.45 109.152 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -71.18 -33.69 70.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.503 -1.226 . . . . 74.14 110.514 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -88.15 127.48 57.17 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 109.08 -0.711 . . . . 73.44 109.08 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.22 -176.44 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.335 2.69 . . . . 74.44 113.508 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.42 HD21 ' O ' ' G' ' 277' ' ' LEU . 6.1 tt -74.47 -32.21 62.5 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.606 -0.724 . . . . 74.23 110.372 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 27.4 tp -112.01 111.02 21.64 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.693 -0.63 . . . . 73.44 109.381 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -150.9 -96.33 0.14 Allowed Glycine 0 C--N 1.351 1.384 0 N-CA-C 111.467 -0.653 . . . . 72.23 111.467 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . 0.452 HD21 ' HB1' ' D' ' 95' ' ' ALA . 7.5 tt -65.38 115.87 6.1 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.589 -0.893 . . . . 73.23 108.589 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . 0.571 ' HZ ' HG11 ' D' ' 58' ' ' VAL . 2.9 t80 -125.53 102.44 7.38 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.327 -0.99 . . . . 70.41 108.327 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . 66.04 103.43 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.61 1.164 . . . . 73.31 111.528 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -132.2 161.35 33.61 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.384 0.673 . . . . 71.3 109.729 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 108.23 -23.14 25.73 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-O 119.38 -0.678 . . . . 73.23 112.18 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 50.37 80.61 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.92 1.288 . . . . 75.31 111.723 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 38.0 mtm -89.46 126.33 58.65 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.431 0.693 . . . . 75.34 109.527 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.04 -29.85 48.13 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.109 2.54 . . . . 75.43 113.004 -175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 86.6 t 70.76 -66.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.646 1.578 . . . . 75.31 110.963 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 65.92 -93.59 0.03 OUTLIER 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.02 1.328 . . . . 74.01 109.15 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.448 ' HE1' HG23 ' D' ' 40' ' ' VAL . 0.0 OUTLIER 178.4 28.65 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.629 1.171 . . . . 75.12 108.86 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 6.3 mp 63.03 -83.75 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.375 1.07 . . . . 71.5 109.706 -171.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -170.75 -77.37 0.04 OUTLIER Glycine 0 C--N 1.348 1.243 0 N-CA-C 111.342 -0.703 . . . . 65.22 111.342 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . 0.453 ' HG3' ' HB2' ' E' ' 308' ' ' CYS . 91.0 Cg_endo -78.43 71.19 6.92 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.267 2.644 . . . . 74.42 111.791 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . 0.497 ' HG3' ' H ' ' G' ' 295' ' ' ALA . 35.0 pttt -67.52 -82.07 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.239 1.016 . . . . 74.45 110.998 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . 0.582 ' HB1' ' HB1' ' E' ' 305' ' ' ALA . . . 52.58 39.63 28.48 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 124.474 1.11 . . . . 75.03 112.887 173.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 18.4 m -47.37 -42.9 22.69 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.429 1.492 . . . . 75.5 114.012 -167.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.585 ' HB2' ' HD2' ' D' ' 38' ' ' PRO . 0.3 OUTLIER -87.29 -69.29 0.69 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.069 -0.715 . . . . 74.41 109.069 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . 0.493 ' HD2' ' HB3' ' E' ' 302' ' ' ASP . 76.8 t60 55.48 24.11 6.49 Favored 'General case' 0 CA--C 1.569 1.674 0 O-C-N 124.74 1.275 . . . . 73.02 110.143 -168.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -81.57 119.07 4.76 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 114.917 -1.038 . . . . 74.52 111.836 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -81.15 52.44 1.8 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.092 0.957 . . . . 74.13 110.454 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' D' ' 32' ' ' PHE . 22.2 pt -72.45 152.42 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.194 0.998 . . . . 74.32 111.478 -174.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -154.28 169.09 24.48 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.689 0.795 . . . . 74.11 109.042 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -57.86 144.36 74.68 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 123.437 0.695 . . . . 74.24 110.444 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . 0.468 ' HG2' ' HB3' ' C' ' 14' ' ' GLN . 24.1 Cg_exo -65.41 122.46 10.16 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.427 2.084 . . . . 73.12 111.311 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -87.29 9.31 20.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.604 0.761 . . . . 71.25 111.438 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 20.1 t -77.19 95.02 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 108.073 -1.084 . . . . 73.21 108.073 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 10.4 t -124.64 0.43 8.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.471 0.708 . . . . 74.13 110.5 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 19.2 p -124.95 99.65 6.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.557 0.743 . . . . 71.12 110.388 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' G' G ' 309' ' ' THR . . . . . 0.441 ' N ' ' HD3' ' G' ' 310' ' ' PRO . 21.7 m -150.59 62.97 5.66 Favored Pre-proline 0 CA--C 1.564 1.51 0 N-CA-C 108.7 -0.852 . . . . 62.13 108.7 165.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' G' ' 309' ' ' THR . 58.9 Cg_endo . . . . . 0 C--N 1.385 2.473 0 C-N-CA 123.472 2.781 . . . . 72.34 111.981 172.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.796 -0.446 . . . . 64.2 109.796 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -75.28 144.56 42.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.591 0.756 . . . . 73.53 109.919 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -81.57 146.8 29.95 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.595 0.758 . . . . 63.22 110.805 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -74.44 133.98 42.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.558 0.743 . . . . 74.34 110.055 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -151.1 110.88 3.06 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 123.482 0.489 . . . . 74.54 109.97 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.72 -164.79 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.555 2.17 . . . . 63.32 110.168 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.645 HD21 ' HH ' ' B' ' 56' ' ' TYR . 6.5 tt 78.34 -47.97 0.45 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 124.409 1.084 . . . . 73.2 110.067 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . 0.499 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 1.6 tm? -50.04 -59.39 3.94 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.156 1.382 . . . . 71.34 109.748 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 75.43 -79.1 1.09 Allowed Glycine 0 C--N 1.352 1.417 0 CA-C-N 115.267 -0.879 . . . . 75.52 112.27 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' B' ' 92' ' ' THR . 2.3 pt? -143.83 146.55 33.15 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.291 1.036 . . . . 73.01 109.193 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -96.58 -178.11 4.15 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.478 -0.783 . . . . 73.22 109.229 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.9 81.99 0.2 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.881 0.872 . . . . 75.33 110.906 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -123.33 154.21 39.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.021 0.928 . . . . 71.54 108.59 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 133.61 -22.92 3.84 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 111.299 -0.72 . . . . 43.51 111.299 -173.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 60.57 88.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.749 1.22 . . . . 62.34 111.012 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 286' ' ' MET . . . . . 0.504 ' SD ' HD11 ' B' ' 136' ' ' LEU . 62.6 mtm -81.1 109.76 15.08 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 109.284 -0.635 . . . . 73.32 109.284 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.41 87.57 1.07 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.905 2.404 . . . . 74.43 111.241 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.21 -38.44 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.716 -0.674 . . . . 72.25 109.641 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 59.08 33.14 22.74 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.172 1.389 . . . . 75.34 111.207 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 43.0 m95 65.53 162.45 0.14 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.075 1.35 . . . . 75.14 112.163 -170.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.655 ' HB2' ' HB1' ' B' ' 129' ' ' ALA . 0.5 OUTLIER -117.88 11.81 13.61 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.969 -1.014 . . . . 74.22 109.091 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 169.75 70.65 0.04 OUTLIER Glycine 0 C--N 1.342 0.893 0 N-CA-C 109.74 -1.344 . . . . 74.55 109.74 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.58 -21.77 59.14 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.185 2.59 . . . . 73.11 113.092 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -95.23 0.8 54.31 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.89 1.276 . . . . 73.45 112.299 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.48 12.51 18.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.72 0.808 . . . . 74.41 111.567 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 296' ' ' THR . . . . . 0.489 HG23 ' HB3' ' B' ' 126' ' ' LEU . 20.6 m -78.1 -82.44 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.557 0.743 . . . . 64.41 110.65 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.638 ' HA ' ' HB2' ' B' ' 124' ' ' PRO . 3.3 m-30 -84.09 102.0 12.21 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 121.758 -0.589 . . . . 75.31 109.547 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -77.88 -11.31 59.88 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.527 -1.215 . . . . 72.23 109.904 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 91.94 169.77 41.26 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.673 -0.694 . . . . 53.24 111.559 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 66.0 t30 173.81 -27.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.275 1.43 . . . . 75.53 108.844 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.9 104.99 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.113 0.965 . . . . 73.21 110.444 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -168.39 98.21 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.102 -1.814 . . . . 75.32 106.102 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt 61.52 74.17 0.52 Allowed Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 107.677 -1.231 . . . . 72.13 107.677 -162.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.78 4.46 6.69 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.634 2.89 . . . . 72.05 113.624 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -127.09 138.39 53.19 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.797 0.839 . . . . 74.44 109.234 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 15.5 m -71.27 119.92 18.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.811 -0.811 . . . . 73.44 108.811 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 40.5 p -74.23 89.84 2.05 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.342 -0.845 . . . . 74.4 109.839 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 63.4 m 71.35 108.32 0.06 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.378 1.471 . . . . 73.41 112.153 175.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 4.7 p -79.92 157.79 73.49 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.593 1.157 . . . . 72.04 110.073 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.387 2.595 0 C-N-CA 123.667 2.912 . . . . 71.41 114.111 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.402 -0.592 . . . . 75.12 109.402 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m -81.9 145.97 30.06 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.999 0.92 . . . . 73.51 110.302 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 76.97 -4.02 2.42 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.441 1.496 . . . . 74.41 112.647 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -86.8 68.59 10.16 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.944 0.498 . . . . 75.24 110.841 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -103.93 177.32 4.88 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.9 0.88 . . . . 74.4 110.441 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.8 t30 62.27 14.86 7.1 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.608 1.163 . . . . 74.34 111.558 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -100.89 23.67 10.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.605 1.162 . . . . 72.55 109.038 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.76 -160.4 0.84 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.078 1.351 . . . . 64.31 109.637 -167.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.553 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 4.5 ppp? -71.43 158.5 36.19 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.011 0.524 . . . . 74.24 111.017 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m -142.03 135.78 29.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.089 0.556 . . . . 74.51 110.163 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.712 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 7.1 t80 -120.09 134.71 55.18 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.457 1.103 . . . . 72.45 108.488 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -155.28 117.17 4.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.978 -0.749 . . . . 64.35 108.978 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.662 HG22 ' HG2' ' C' ' 130' ' ' PRO . 24.4 mt -76.8 124.17 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.892 -0.41 . . . . 74.35 109.892 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.68 -43.65 18.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.775 0.83 . . . . 74.11 110.858 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -173.4 131.57 0.46 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.248 -0.278 . . . . 72.31 110.248 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -116.75 138.31 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.716 0.806 . . . . 74.4 108.867 174.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 34.8 p90 -171.19 166.48 7.21 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.775 0.798 . . . . 73.33 111.082 -172.071 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -95.51 119.43 34.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.947 -1.024 . . . . 75.32 108.895 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.506 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 38.6 mtpt -82.71 -28.38 30.56 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.642 0.377 . . . . 75.21 110.125 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.21 145.95 21.05 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.062 -0.972 . . . . 52.54 109.631 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 69.9 mt -134.65 134.84 54.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.981 1.312 . . . . 75.12 107.652 176.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -136.18 123.84 22.38 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.49 -1.3 . . . . 71.01 107.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.528 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 84.5 t80 -136.85 126.5 25.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.896 -1.52 . . . . 75.11 106.896 173.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.4 139.12 43.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.824 -0.435 . . . . 74.24 109.824 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.22 70.59 9.98 Favored Pre-proline 0 C--O 1.245 0.833 0 N-CA-C 107.777 -1.194 . . . . 63.24 107.777 175.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.59 -21.98 38.79 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.226 1.95 . . . . 73.04 111.744 -173.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.465 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 16.5 m-20 -118.33 23.42 11.57 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.825 0.85 . . . . 74.11 109.77 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.22 -54.56 24.21 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-O 118.318 -0.849 . . . . 64.42 113.222 -175.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HG2' ' HD2' ' A' ' 30' ' ' HIS . 17.9 Cg_endo -59.28 -34.25 97.98 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.536 2.157 . . . . 55.21 112.716 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.41 ' HD2' ' HG2' ' A' ' 29' ' ' PRO . 15.7 m-70 -70.8 -42.02 70.84 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.456 -0.793 . . . . 73.33 110.148 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.578 HG22 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.78 -28.56 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.364 -0.835 . . . . 72.32 111.596 -170.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -60.85 -33.31 72.86 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.472 0.483 . . . . 72.44 112.019 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -88.83 -15.89 33.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.596 0.358 . . . . 74.32 111.541 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -68.01 163.89 21.25 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.328 0.585 . . . . 75.34 111.408 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.96 149.01 50.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.085 -0.961 . . . . 75.42 109.973 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -83.36 63.76 7.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.319 0.648 . . . . 75.04 109.955 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -148.05 70.19 11.0 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.597 0.759 . . . . 75.0 109.986 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -92.35 166.92 2.91 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.269 1.979 . . . . 72.15 111.585 163.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.5 104.4 16.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.336 -1.357 . . . . 73.1 107.336 167.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 65' ' ' THR . 85.1 t -85.06 95.36 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.937 -0.764 . . . . 74.23 108.937 175.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -87.8 115.24 25.12 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.897 -0.779 . . . . 73.23 108.897 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mp -103.09 120.72 41.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.417 -0.586 . . . . 75.14 109.417 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.4 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 1.0 OUTLIER -103.01 136.5 42.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.376 1.071 . . . . 73.12 108.583 179.028 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.442 ' HB3' ' O ' ' E' ' 286' ' ' MET . 34.0 tp -114.56 118.83 34.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.108 -1.071 . . . . 72.23 108.108 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 29.5 t70 -128.73 147.5 50.77 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.979 0.912 . . . . 71.13 108.969 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -149.15 136.92 20.45 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.242 -1.021 . . . . 72.32 108.242 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.25 134.5 38.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 71.44 109.01 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -129.26 151.44 49.91 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.616 0.644 . . . . 75.21 110.874 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -164.92 133.02 3.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.765 0.826 . . . . 73.14 109.767 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -79.01 119.49 22.23 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.692 0.397 . . . . 72.52 110.933 -179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 HD12 HG22 ' A' ' 83' ' ' ILE . 79.6 mt -84.07 -43.12 15.4 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.725 0.81 . . . . 62.15 111.281 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.9 -179.76 7.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.609 0.764 . . . . 65.42 110.012 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.24 116.73 5.25 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.252 -0.647 . . . . 73.31 109.252 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 68.25 19.36 9.07 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.564 1.145 . . . . 74.31 111.991 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.51 120.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.152 0.981 . . . . 72.5 108.758 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.517 ' HE2' HD12 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -128.46 171.13 12.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.328 -0.619 . . . . 74.23 109.328 169.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -127.89 133.28 49.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.37 1.068 . . . . 75.05 108.253 176.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.4 121.4 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.031 -1.099 . . . . 73.35 108.031 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.518 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 56.2 t -97.85 136.85 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.503 1.121 . . . . 72.44 108.86 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.496 ' HB2' HD11 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -116.03 99.71 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.327 -1.36 . . . . 74.42 107.327 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.3 ttp180 -89.05 101.83 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.106 -0.701 . . . . 73.23 109.106 174.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.528 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.2 t -93.6 127.76 45.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.8 -1.556 . . . . 74.52 106.8 170.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.457 HG23 ' HB2' ' A' ' 77' ' ' GLU . 11.1 m -117.46 130.84 56.71 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.147 -0.686 . . . . 71.55 109.147 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.553 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.8 t -120.37 107.28 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.745 -1.206 . . . . 74.02 107.745 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.432 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.7 m -111.68 134.45 53.24 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.846 -0.798 . . . . 71.21 108.846 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 73' ' ' ALA . . . -124.88 126.64 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.663 -1.236 . . . . 64.22 107.663 173.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -141.32 128.49 20.91 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.313 -0.625 . . . . 75.44 109.313 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD11 HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -102.05 86.03 2.79 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.804 -1.184 . . . . 73.21 107.804 173.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -126.12 7.49 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.92 -1.036 . . . . 72.24 110.825 -171.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.36 -26.51 22.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.274 0.63 . . . . 71.31 110.452 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 29.9 tt0 -77.78 120.16 22.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.584 0.353 . . . . 61.33 110.303 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -79.66 130.5 35.42 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.47 0.708 . . . . 72.14 110.163 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -73.96 -62.14 1.6 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.609 0.764 . . . . 63.21 110.485 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.428 ' HE1' ' HE1' ' E' ' 297' ' ' TYR . 39.0 p90 -160.25 171.03 19.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.127 -0.942 . . . . 74.44 111.332 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -138.14 131.88 31.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.995 -1.457 . . . . 73.13 107.443 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.8 m -135.51 97.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.748 0.819 . . . . 75.32 109.196 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' A' ' 63' ' ' THR . 42.0 tt0 -123.26 116.34 23.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.264 -1.014 . . . . 73.51 108.264 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.21 121.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.195 -0.669 . . . . 70.41 109.195 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 84.41 6.13 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.512 -0.922 . . . . 73.02 108.512 173.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.01 94.24 5.25 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.051 -0.977 . . . . 75.2 109.207 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.518 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.62 142.37 20.16 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.465 -0.654 . . . . 73.44 111.465 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.03 120.82 1.52 Allowed Glycine 0 CA--C 1.502 -0.736 0 N-CA-C 109.929 -1.269 . . . . 74.32 109.929 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.503 HG22 HD12 ' A' ' 51' ' ' LEU . 41.8 mt -83.14 125.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.671 -0.863 . . . . 73.4 108.671 178.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.712 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.8 m-85 -124.63 127.39 47.26 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 109.297 -0.631 . . . . 63.53 109.297 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.9 t -83.82 119.1 24.43 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.394 0.678 . . . . 73.3 109.344 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.517 HD12 ' HE2' ' A' ' 56' ' ' TYR . 12.9 tt -103.4 146.59 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.194 0.997 . . . . 75.4 109.486 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 157.47 18.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.414 0.686 . . . . 74.12 109.892 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.553 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 84.29 -33.25 3.2 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.846 0.716 . . . . 61.45 114.413 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.466 HG22 ' HB3' ' A' ' 9' ' ' MET . 2.8 pp -128.78 164.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 117.571 0.685 . . . . 75.31 112.469 -172.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.48 -179.97 6.34 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.015 0.926 . . . . 72.25 109.545 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.47 22.36 Favored Glycine 0 N--CA 1.478 1.476 0 C-N-CA 123.116 0.389 . . . . 72.43 113.829 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -66.94 -28.24 68.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.947 1.299 . . . . 73.21 111.659 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -64.11 -51.31 64.58 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.35 -0.841 . . . . 71.13 110.322 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -73.93 -28.28 61.44 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.222 -0.899 . . . . 74.53 110.666 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.78 92.37 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.282 0.563 . . . . 73.32 111.0 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 39.2 t-80 -69.57 -36.49 76.32 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.154 -0.93 . . . . 73.35 110.036 173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.558 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 23.7 t -73.68 -27.17 61.09 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.88 0.472 . . . . 74.12 111.276 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.06 -42.19 14.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.989 0.916 . . . . 74.32 110.988 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.09 4.78 52.49 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.59 0.556 . . . . 61.03 114.132 -168.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.802 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.51 -60.13 0.24 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 117.627 0.714 . . . . 63.22 112.493 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.558 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.6 t80 -68.2 -62.12 1.54 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.154 0.981 . . . . 63.23 112.125 -170.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 97.8 m -69.06 -32.85 3.61 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 114.315 1.228 . . . . 73.34 114.315 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.92 -42.74 20.22 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.985 2.456 . . . . 74.53 113.713 164.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.44 -26.19 64.48 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.762 0.825 . . . . 72.04 111.485 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -72.39 -45.34 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.599 0.76 . . . . 74.53 109.743 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 60' ' ' LEU . 48.9 mt -70.85 -35.68 72.53 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.409 -1.269 . . . . 71.11 112.394 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -59.75 -43.05 94.34 Favored Pre-proline 0 CA--C 1.572 1.791 0 C-N-CA 124.701 1.2 . . . . 74.01 114.227 -167.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -59.41 -37.34 90.51 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.27 1.98 . . . . 73.44 113.487 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.47 -35.92 68.34 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.294 0.638 . . . . 75.43 111.863 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.97 94.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 60.43 109.515 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -63.05 -35.83 81.54 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 124.287 0.992 . . . . 74.52 110.309 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.421 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 22.2 tt0 -56.64 -56.37 22.21 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.624 0.77 . . . . 75.15 110.91 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -63.35 -45.02 93.12 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 114.397 -1.274 . . . . 73.24 110.766 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.528 HD11 ' HB ' ' A' ' 62' ' ' VAL . 66.2 mt -62.93 -59.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 123.987 0.804 . . . . 72.14 110.775 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.4 m -56.77 -32.8 65.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.181 0.593 . . . . 73.25 111.966 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.0 t -68.52 -46.45 69.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.86 -0.609 . . . . 74.41 110.529 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.454 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mtp -58.37 -42.87 87.95 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 75.33 111.049 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.532 HG21 ' SG ' ' A' ' 76' ' ' CYS . 94.3 t -62.3 -44.64 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.419 1.087 . . . . 74.21 110.225 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -73.56 -29.96 62.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.355 -0.384 . . . . 74.03 111.3 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -68.3 -37.12 80.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.418 0.687 . . . . 74.13 109.815 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.97 -3.42 89.39 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.811 -0.631 . . . . 72.21 113.033 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.711 HG23 HE21 ' D' ' 125' ' ' GLN . 24.3 p 54.56 48.8 19.62 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.167 1.787 . . . . 75.05 111.572 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.597 ' HA ' HD12 ' E' ' 301' ' ' ILE . 74.5 m-85 -104.56 154.41 38.47 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 113.807 -1.542 . . . . 75.44 108.43 169.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.506 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 26.4 Cg_exo -59.75 131.32 39.28 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.335 2.023 . . . . 75.14 110.615 -172.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -47.84 133.69 13.91 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.472 1.108 . . . . 75.11 111.785 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.437 HD23 HG12 ' A' ' 64' ' ' VAL . 31.8 tp -107.17 110.31 22.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.296 -0.631 . . . . 71.51 109.296 -177.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.67 84.02 1.95 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.851 -1.537 . . . . 71.42 106.851 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.5 tp -71.7 128.81 36.99 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.092 -0.958 . . . . 74.12 109.623 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -52.97 131.57 49.43 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 124.689 1.243 . . . . 74.12 111.517 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.649 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 3.4 Cg_endo -77.47 116.25 4.06 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.265 1.977 . . . . 65.53 109.866 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.41 123.96 53.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.643 -0.873 . . . . 63.21 108.643 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -76.79 86.83 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.211 -1.033 . . . . 71.03 108.211 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.994 . . . . 73.34 110.662 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.802 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 t70 -65.42 -44.21 88.13 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.984 -1.007 . . . . 74.42 110.426 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.79 94.64 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.357 -0.838 . . . . 65.22 111.182 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.28 -48.3 80.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.236 0.614 . . . . 54.15 111.223 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -67.37 -31.18 71.24 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.161 -0.927 . . . . 74.14 110.427 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.4 tpp -69.45 -41.95 75.58 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.055 0.542 . . . . 65.44 110.506 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.57 -26.5 68.62 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.724 0.809 . . . . 74.11 110.933 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -90.87 -31.83 16.28 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.776 0.83 . . . . 64.52 111.457 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.18 -45.58 92.77 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.112 0.965 . . . . 75.44 110.528 -172.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 173.57 -13.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 125.942 1.697 . . . . 74.12 110.122 167.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 63.05 31.18 16.1 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 124.269 1.027 . . . . 74.41 110.387 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -149.97 144.83 26.1 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.921 -0.581 . . . . 73.13 109.724 -170.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.93 143.65 31.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.511 0.724 . . . . 74.12 110.461 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.34 118.69 5.85 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.147 -0.781 . . . . 71.32 111.147 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -80.51 134.58 35.97 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 117.17 0.485 . . . . 70.11 110.726 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.8 121.46 7.12 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.662 -0.575 . . . . 75.42 111.662 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.0 m -82.8 135.44 34.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.63 0.772 . . . . 75.2 110.459 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.06 178.59 5.55 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.634 0.773 . . . . 72.3 110.932 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -153.59 110.18 3.37 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.054 -0.721 . . . . 64.51 109.054 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -112.63 131.19 55.75 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.16 -0.682 . . . . 74.04 109.16 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -106.39 120.51 42.08 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.988 -1.116 . . . . 52.42 107.988 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.49 134.88 37.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.934 0.494 . . . . 72.25 109.754 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 C-N-CA 123.137 0.575 . . . . 74.25 110.401 -177.251 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tmm? . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.472 -0.566 . . . . 72.23 109.472 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.0 t -153.83 130.58 10.82 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.34 0.656 . . . . 73.02 109.735 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -95.29 100.72 12.46 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.602 -0.888 . . . . 75.13 108.602 173.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -84.41 171.58 12.48 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.714 -0.476 . . . . 72.24 109.714 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -64.63 131.12 46.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.951 0.501 . . . . 75.25 110.613 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -65.14 156.74 30.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.406 0.682 . . . . 72.45 111.027 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 61.4 m -72.28 151.14 43.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.61 0.764 . . . . 72.13 110.023 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.432 ' O ' ' HG3' ' B' ' 9' ' ' MET . 35.1 mt-10 -64.64 -175.06 0.16 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.083 0.953 . . . . 75.32 111.655 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.0 OUTLIER 51.38 -150.98 0.26 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.145 1.378 . . . . 63.23 110.146 -171.05 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.591 ' N ' ' SD ' ' B' ' 9' ' ' MET . 90.7 m -152.78 128.6 10.22 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.922 1.237 . . . . 73.13 110.11 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.54 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 47.9 t80 -151.06 113.76 4.69 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.905 -0.776 . . . . 74.23 108.905 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -142.11 137.63 31.09 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.37 0.668 . . . . 72.3 109.935 170.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.466 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -82.3 128.0 39.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.825 -0.805 . . . . 74.24 108.825 174.182 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.429 ' HA ' ' HA ' ' E' ' 305' ' ' ALA . 11.9 mm-40 -98.39 -43.62 6.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.015 -0.539 . . . . 74.53 110.075 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.518 HH22 ' HB ' ' E' ' 301' ' ' ILE . 23.2 ttt180 -164.33 130.93 3.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.517 -0.31 . . . . 72.43 110.574 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -115.86 127.9 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.545 1.138 . . . . 72.32 108.902 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -162.49 147.59 12.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.982 0.42 . . . . 73.31 111.869 -171.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.6 m -73.95 123.42 24.25 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.984 0.913 . . . . 70.34 109.367 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -98.96 -27.56 13.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.098 0.559 . . . . 73.31 111.506 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.2 t70 -156.67 144.53 19.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.316 0.246 . . . . 73.41 110.641 -170.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.528 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 36.2 mm -144.66 141.43 23.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.326 1.451 . . . . 72.14 108.251 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -145.61 109.36 4.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 124.103 0.877 . . . . 74.45 108.699 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -118.0 117.48 29.34 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 107.186 -1.413 . . . . 75.24 107.186 170.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 39.3 mt-10 -119.95 133.01 55.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.372 0.669 . . . . 70.11 109.404 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.41 83.33 66.46 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.664 -1.236 . . . . 70.21 107.664 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . 0.408 ' HG2' HD21 ' B' ' 27' ' ' ASN . 44.9 Cg_endo -66.23 -29.53 46.88 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.902 2.402 . . . . 71.14 112.167 -174.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.408 HD21 ' HG2' ' B' ' 26' ' ' PRO . 27.6 m-80 -108.43 21.06 17.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 74.53 110.877 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.447 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.44 -57.67 6.21 Favored Pre-proline 0 CA--C 1.582 2.193 0 N-CA-C 114.743 1.386 . . . . 74.35 114.743 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.506 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 71.0 Cg_endo -80.24 -26.92 3.89 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 122.302 2.001 . . . . 64.34 113.11 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 2.3 m-70 -93.99 1.13 56.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.545 0.738 . . . . 72.11 112.344 -171.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.67 -28.1 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.036 0.534 . . . . 73.54 111.686 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -53.69 -26.02 20.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.589 1.156 . . . . 72.02 113.365 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.432 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 25.0 pt20 -66.6 -52.45 45.19 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.338 0.255 . . . . 72.35 110.781 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -118.13 68.15 0.77 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 123.552 0.741 . . . . 64.31 110.167 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.429 ' O ' ' HE3' ' B' ' 36' ' ' TRP . 11.0 t70 -98.53 118.16 34.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 106.932 -1.507 . . . . 75.22 106.932 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.429 ' HE3' ' O ' ' B' ' 35' ' ' ASP . 2.2 t-105 -176.1 175.29 1.93 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.832 -1.173 . . . . 72.2 107.832 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.55 112.07 3.81 Favored Pre-proline 0 CA--C 1.56 1.359 0 O-C-N 123.582 0.552 . . . . 73.53 110.996 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.77 164.84 15.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.62 2.213 . . . . 72.32 112.388 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.09 101.94 4.07 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.185 -1.042 . . . . 71.34 108.185 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.09 146.43 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.407 -0.815 . . . . 72.44 108.931 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.57 133.07 32.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.121 0.969 . . . . 74.04 109.307 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.487 HD23 HD12 ' B' ' 128' ' ' LEU . 4.6 mp -90.97 150.1 21.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.346 -0.843 . . . . 75.23 108.953 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.565 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.3 t70 -158.99 154.58 26.04 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.419 -0.956 . . . . 74.03 108.419 172.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.2 154.55 48.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.002 0.521 . . . . 74.24 110.582 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.5 t70 -140.02 124.62 18.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.419 -1.326 . . . . 53.12 107.419 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -110.21 104.76 13.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.023 0.929 . . . . 74.41 109.741 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.24 155.39 45.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.97 0.908 . . . . 54.23 109.984 -175.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.6 m -144.11 172.64 12.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.296 0.639 . . . . 71.43 110.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.0 p -151.76 134.88 15.85 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.11 0.964 . . . . 63.31 108.647 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -84.47 114.68 22.1 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.86 -0.422 . . . . 74.33 109.86 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.489 HD12 HG22 ' B' ' 83' ' ' ILE . 69.4 mt -80.49 -45.72 17.05 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.447 -0.575 . . . . 72.43 109.447 173.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.48 -173.43 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.666 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.14 119.43 18.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.872 . . . . 75.05 109.968 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 71.45 -6.4 1.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 125.965 1.706 . . . . 75.12 112.668 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -104.99 104.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 108.08 -1.082 . . . . 73.32 108.08 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.82 137.96 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -101.16 101.51 12.25 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.017 -1.475 . . . . 71.44 107.017 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.33 123.18 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.074 0.949 . . . . 75.12 109.879 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.433 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.0 t -102.95 144.4 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.085 0.954 . . . . 74.2 109.417 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' B' ' 103' ' ' PRO . 61.0 tp -129.77 115.02 16.68 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.555 -0.905 . . . . 72.53 108.555 170.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.562 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 37.3 ttm180 -92.85 125.86 37.65 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.373 -0.603 . . . . 73.45 109.373 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 92.9 t -111.25 104.55 17.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.305 -1.369 . . . . 65.51 107.305 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 36.4 m -97.0 136.96 36.82 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.481 -0.781 . . . . 73.12 109.437 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.11 129.32 67.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.947 -1.024 . . . . 73.54 108.476 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.5 m -124.82 137.87 54.29 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.406 0.682 . . . . 71.14 109.408 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.51 143.4 35.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.034 0.534 . . . . 73.14 109.63 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -158.09 140.37 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.698 0.624 . . . . 71.32 111.362 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.563 HD11 ' HB3' ' B' ' 73' ' ' ALA . 5.2 mp -103.24 118.92 37.87 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.45 -0.944 . . . . 71.42 108.45 167.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.63 -141.77 39.18 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.587 0.554 . . . . 75.31 112.882 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 9.43 12.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.327 1.051 . . . . 74.02 111.875 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -127.41 143.35 51.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.545 0.738 . . . . 73.31 110.147 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -70.78 140.47 51.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.574 0.75 . . . . 74.14 110.855 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB3' HD11 ' B' ' 68' ' ' LEU . . . -90.99 -62.58 1.42 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.97 0.908 . . . . 61.54 108.744 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -156.29 167.02 31.73 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.572 -1.195 . . . . 73.33 109.144 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.3 mt -137.08 131.03 32.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.802 -1.555 . . . . 71.44 106.802 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.521 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 37.7 t -141.33 132.7 26.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.759 -0.83 . . . . 65.01 108.759 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -154.19 135.37 13.99 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.009 -0.737 . . . . 72.2 109.009 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 61.9 t -133.33 146.44 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.637 0.775 . . . . 75.32 109.019 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.574 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -119.48 95.93 4.99 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.405 -1.331 . . . . 71.41 107.405 168.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -85.19 104.57 15.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.69 -0.855 . . . . 75.11 108.69 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.68 159.85 29.66 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 123.927 0.767 . . . . 75.41 111.186 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.29 126.34 1.57 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.922 -0.871 . . . . 64.31 110.922 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.489 HG22 HD12 ' B' ' 51' ' ' LEU . 54.2 mt -84.26 119.11 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.12 -1.067 . . . . 75.22 108.12 175.089 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.11 134.26 54.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.752 0.821 . . . . 74.42 108.892 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -92.36 97.17 10.7 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.4 -0.963 . . . . 74.21 108.4 168.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.16 139.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.194 -0.912 . . . . 75.31 110.421 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.475 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.1 160.92 39.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.014 0.926 . . . . 71.23 109.555 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.95 -31.9 4.2 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.398 0.436 . . . . 72.12 114.072 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.63 136.5 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.296 0.638 . . . . 74.51 111.048 -178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.91 151.62 16.45 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.717 0.807 . . . . 75.12 109.695 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.54 -110.37 3.32 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 123.614 0.626 . . . . 44.43 113.189 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -74.59 -42.9 57.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.826 0.822 . . . . 72.22 110.088 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -67.64 -32.6 73.42 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.977 -1.465 . . . . 74.24 111.206 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.402 ' HE2' ' H ' ' H' ' 279' ' ' GLY . 8.3 ptm -68.47 -37.37 80.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.957 -0.565 . . . . 74.23 110.748 178.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.88 -26.73 64.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.522 0.729 . . . . 63.42 110.721 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.404 ' HD2' ' HB2' ' B' ' 137' ' ' PHE . 41.9 t-80 -89.39 -19.3 25.37 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.354 0.662 . . . . 54.45 110.839 175.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.5 t -86.69 -70.17 0.63 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.497 0.319 . . . . 72.2 111.436 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.524 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.2 pp -80.43 -24.83 39.32 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.431 0.292 . . . . 72.41 111.478 -175.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.29 1.82 56.18 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-O 119.66 -0.522 . . . . 75.3 114.153 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.552 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -143.03 -53.08 0.38 Allowed 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.548 0.674 . . . . 64.04 111.827 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -75.34 -45.17 41.11 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.086 0.554 . . . . 74.25 112.075 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.54 ' SG ' ' HE1' ' B' ' 11' ' ' PHE . 56.0 m -65.97 -43.71 58.7 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.161 0.584 . . . . 72.35 111.82 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.546 ' HA ' HD23 ' B' ' 60' ' ' LEU . 65.2 Cg_exo -48.42 -42.97 33.89 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.868 2.378 . . . . 75.54 114.295 167.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -61.31 -30.24 70.37 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.552 0.741 . . . . 75.24 112.64 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.89 -43.79 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.152 0.581 . . . . 72.52 110.635 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.42 -20.5 47.4 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.062 -0.517 . . . . 74.33 111.571 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -61.15 -49.35 88.81 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.892 -1.052 . . . . 75.12 113.275 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.9 -46.38 30.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.938 2.426 . . . . 63.54 113.841 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -67.16 -44.88 78.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 74.52 111.32 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.58 96.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.284 0.634 . . . . 74.41 110.979 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.444 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 8.7 ttp-105 -71.75 -44.86 63.36 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.086 -0.961 . . . . 74.23 110.743 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.97 -34.04 77.47 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.872 0.732 . . . . 74.42 110.166 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.491 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.5 t -68.79 -36.5 78.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 122.877 0.471 . . . . 74.35 110.86 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.521 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 62.0 mt -62.84 -48.92 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.255 0.622 . . . . 74.41 109.773 172.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -62.03 -32.17 72.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.678 0.791 . . . . 74.13 111.527 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 30.9 t -65.78 -46.55 78.31 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.633 -0.712 . . . . 52.32 110.238 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.491 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -72.94 -38.1 66.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.802 0.441 . . . . 75.51 111.329 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.45 -38.49 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.396 0.678 . . . . 62.35 110.339 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -68.05 -34.58 76.72 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.892 -1.049 . . . . 72.35 111.19 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -71.27 -26.79 63.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.914 0.486 . . . . 73.12 110.458 176.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.92 1.39 63.17 Favored Glycine 0 C--N 1.358 1.796 0 O-C-N 123.446 0.467 . . . . 63.14 112.59 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.425 HG23 ' HB3' ' A' ' 17' ' ' TYR . 41.5 p 62.73 49.54 3.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.915 2.086 . . . . 74.12 112.22 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -119.98 154.46 55.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.393 -1.276 . . . . 75.25 109.924 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.37 -169.96 0.12 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.581 2.854 . . . . 74.33 114.143 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 15.4 tp60 -57.34 124.26 18.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.448 1.099 . . . . 72.22 112.771 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -141.49 83.35 1.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.864 -0.791 . . . . 73.45 108.864 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -104.5 131.42 51.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.385 -1.339 . . . . 72.14 107.385 165.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.487 HD12 HD23 ' B' ' 42' ' ' LEU . 33.1 tp -70.74 149.74 46.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.091 0.557 . . . . 64.03 110.253 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.2 149.4 87.05 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.894 0.878 . . . . 64.33 111.898 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.406 ' HD2' HG11 ' F' ' 306' ' ' VAL . 20.4 Cg_exo -63.45 93.51 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.925 2.417 . . . . 72.42 111.825 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 t -92.0 110.07 22.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.301 -1.0 . . . . 71.34 108.301 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -92.75 88.25 6.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.026 -1.101 . . . . 74.43 108.026 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -61.36 -37.32 82.95 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.037 -0.983 . . . . 73.14 110.298 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.552 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 15.5 t70 -59.67 -44.75 93.46 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.794 -1.093 . . . . 60.23 111.768 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.27 -33.0 72.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.173 0.589 . . . . 60.21 111.446 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.23 -55.03 39.97 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.327 0.651 . . . . 72.13 109.806 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . 0.404 ' HB2' ' HD2' ' B' ' 96' ' ' HIS . 89.1 m-85 -68.31 -31.76 71.42 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.732 -0.667 . . . . 73.3 111.343 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 55.2 ttm -64.78 -37.76 88.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.493 0.317 . . . . 74.33 111.184 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -75.22 -28.16 59.82 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.812 0.445 . . . . 75.12 110.779 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -69.11 -36.3 77.37 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.037 0.446 . . . . 70.14 110.196 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.6 mt -93.86 -5.35 48.24 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.555 0.742 . . . . 73.52 111.304 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -77.0 93.1 3.77 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.098 0.559 . . . . 74.15 109.797 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -138.74 -28.87 0.8 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.108 0.963 . . . . 75.4 109.059 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -83.35 126.46 32.74 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.775 -0.648 . . . . 73.4 110.431 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.78 3.55 54.88 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.255 1.022 . . . . 65.32 111.324 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 100.92 153.87 26.61 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 111.819 -0.512 . . . . 72.45 111.819 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.85 139.59 50.9 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.762 0.425 . . . . 71.23 110.153 175.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.72 147.6 18.73 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 123.807 0.692 . . . . 74.43 112.282 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 72.8 p -93.71 -159.97 0.73 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.216 1.006 . . . . 74.24 109.227 172.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.29 177.58 5.33 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.496 -0.927 . . . . 73.22 108.496 163.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -165.24 157.28 15.25 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.308 0.575 . . . . 74.23 111.691 172.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -147.91 92.99 2.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.203 -1.406 . . . . 70.01 107.203 165.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -78.36 110.3 13.27 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.132 0.573 . . . . 75.3 109.704 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -102.68 169.65 8.5 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.884 0.874 . . . . 62.53 110.539 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.907 1.283 . . . . 73.44 111.131 174.581 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.738 -0.468 . . . . 74.21 109.738 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 60.2 m -156.29 169.47 24.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.202 1.001 . . . . 60.43 109.748 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.32 73.39 8.36 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 122.12 0.962 . . . . 72.43 109.119 170.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -77.22 126.7 31.36 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.228 -0.896 . . . . 74.41 109.042 -177.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -71.78 96.63 1.66 Allowed 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.767 -0.827 . . . . 74.21 108.767 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -66.83 160.19 26.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.354 0.662 . . . . 73.31 110.049 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 66.3 p -58.15 126.48 27.68 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.383 0.673 . . . . 64.42 110.388 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.76 -76.11 0.09 Allowed 'General case' 0 CA--C 1.549 0.904 0 O-C-N 123.84 0.713 . . . . 73.3 109.45 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.424 ' HA ' HG13 ' C' ' 89' ' ' ILE . 56.3 ttp 57.95 111.22 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.326 1.45 . . . . 72.21 112.45 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.693 HG21 HE22 ' C' ' 12' ' ' GLN . 7.0 m -97.22 105.57 17.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.172 -1.047 . . . . 65.45 108.172 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.596 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.4 t80 -124.27 119.38 29.15 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.529 -0.545 . . . . 71.34 109.529 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.693 HE22 HG21 ' C' ' 10' ' ' THR . 1.6 mp0 -136.92 142.26 42.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.486 -0.931 . . . . 71.25 108.486 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.14 97.29 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -74.19 -28.25 61.19 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 122.423 0.289 . . . . 71.54 110.649 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' C' ' 15' ' ' ARG . 10.0 ttt180 -172.55 152.76 2.68 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 123.727 0.642 . . . . 73.43 110.94 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 89.3 mt -133.6 137.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.269 -1.382 . . . . 73.21 107.269 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.419 ' CE2' ' HD2' ' C' ' 19' ' ' LYS . 18.6 p90 -175.52 166.24 3.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.88 0.472 . . . . 75.31 110.052 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -89.26 120.24 30.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.267 -0.642 . . . . 75.23 109.267 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 13.6 mmmm -66.49 -44.55 82.31 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.614 -0.884 . . . . 71.24 108.614 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.2 t70 -139.79 145.71 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.112 -0.949 . . . . 73.33 110.598 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.483 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.9 mt -135.53 142.83 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 125.587 1.555 . . . . 71.02 107.038 170.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -156.84 151.34 25.48 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.129 0.49 . . . . 72.42 110.702 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -149.36 112.14 4.81 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 106.895 -1.52 . . . . 73.53 106.895 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -116.24 125.71 52.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.286 0.634 . . . . 74.43 109.855 -176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.64 82.08 18.82 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.086 -1.079 . . . . 62.53 108.086 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.86 -28.16 75.46 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.522 2.148 . . . . 72.55 111.646 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.86 31.87 2.53 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.519 1.128 . . . . 60.54 110.47 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.41 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -58.13 -54.04 59.77 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.441 1.275 . . . . 63.44 114.441 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.476 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 58.8 Cg_endo -79.83 -25.99 4.86 Favored 'Trans proline' 0 C--N 1.385 2.464 0 CA-C-N 122.072 1.776 . . . . 63.15 112.654 172.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.06 -23.32 67.39 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.044 1.338 . . . . 65.52 111.997 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.615 HG21 ' HH ' ' F' ' 297' ' ' TYR . 0.4 OUTLIER -62.12 -18.75 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.88 1.272 . . . . 74.2 112.022 -174.336 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.04 -38.55 75.88 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.676 0.39 . . . . 74.32 111.461 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.99 34.42 1.1 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.424 0.69 . . . . 75.42 110.912 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.517 ' HZ1' ' HB2' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -98.0 150.9 20.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.181 0.992 . . . . 75.55 111.012 -175.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.81 138.95 58.25 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.952 1.301 . . . . 73.32 111.533 172.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.525 ' HA ' ' HD1' ' F' ' 298' ' ' HIS . 18.0 m95 -85.24 67.21 10.08 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.864 0.866 . . . . 72.11 110.784 -175.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -162.94 71.0 2.01 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.118 0.567 . . . . 71.04 110.81 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -87.05 115.9 1.2 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.315 2.677 . . . . 71.15 112.015 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.87 112.77 22.08 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.352 -0.981 . . . . 74.13 108.352 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.89 104.51 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.726 -0.67 . . . . 73.34 109.355 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.412 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 58.7 tttm -95.03 103.25 15.09 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.616 -0.883 . . . . 74.1 108.616 173.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.78 138.05 31.87 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.153 -1.054 . . . . 72.41 108.153 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.4 t70 -128.89 141.55 51.24 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.42 1.088 . . . . 75.02 109.042 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 61.7 tp -134.29 132.01 39.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.111 -0.7 . . . . 72.05 109.111 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.772 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 17.1 t70 -123.27 141.76 51.65 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.106 0.963 . . . . 75.31 109.133 174.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -114.51 111.08 20.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.993 -0.743 . . . . 74.15 108.993 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.431 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -117.03 164.29 14.94 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.341 1.056 . . . . 72.42 110.09 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -146.83 155.49 42.38 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.391 0.676 . . . . 71.14 109.884 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.51 126.84 14.89 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 72.23 108.598 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -82.72 117.76 22.87 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.447 -0.946 . . . . 74.44 108.447 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.517 HD13 HD13 ' C' ' 83' ' ' ILE . 83.1 mt -90.89 -42.51 10.56 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.621 -0.718 . . . . 74.53 109.463 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.45 -177.85 6.84 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.802 -1.09 . . . . 71.41 109.728 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.4 126.62 30.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.991 -1.004 . . . . 75.43 109.182 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.7 10.51 7.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.622 1.169 . . . . 74.12 111.732 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -126.22 112.96 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.918 0.887 . . . . 72.11 109.206 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -131.14 125.54 33.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.889 0.876 . . . . 73.3 109.11 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -83.61 124.48 30.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.279 1.031 . . . . 75.12 109.66 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.49 130.09 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.572 -1.27 . . . . 64.31 107.572 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 86.0 t -123.44 139.91 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.505 0.722 . . . . 71.11 109.978 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.579 HD13 ' HA ' ' C' ' 103' ' ' PRO . 69.5 mt -128.76 118.72 23.27 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 124.283 1.033 . . . . 61.02 109.315 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.772 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 45.0 mtt180 -82.96 108.55 16.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.689 -0.856 . . . . 75.44 108.689 166.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -103.92 116.38 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.456 -1.313 . . . . 75.55 107.456 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 20.2 m -130.12 118.24 21.18 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.056 0.542 . . . . 70.04 109.594 -170.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.584 HG23 HG21 ' C' ' 114' ' ' ILE . 67.0 t -104.0 118.18 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 73.13 108.586 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.412 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 22.4 m -110.77 141.45 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.463 -0.94 . . . . 72.34 108.463 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.76 106.61 9.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.963 -1.865 . . . . 73.35 105.963 170.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.5 m -138.91 152.28 47.63 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.338 0.59 . . . . 74.44 109.71 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.452 HD11 ' HD2' ' C' ' 34' ' ' LYS . 4.3 mp -116.32 31.48 6.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.462 -1.244 . . . . 73.51 108.635 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.54 -117.63 4.02 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 109.802 -1.319 . . . . 75.13 109.802 -170.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -88.85 -30.61 18.8 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.433 -0.58 . . . . 63.24 109.433 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.68 95.12 1.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.223 1.009 . . . . 74.32 109.227 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 64.3 m -87.49 139.65 30.33 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.219 0.608 . . . . 74.24 110.737 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.6 -65.02 1.01 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.098 -0.955 . . . . 74.52 109.395 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . 0.591 ' HE1' ' HB2' ' F' ' 297' ' ' TYR . 40.7 p90 -157.91 176.19 12.87 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.167 0.587 . . . . 75.13 110.784 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.447 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -140.79 147.47 39.12 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.671 1.188 . . . . 72.34 108.162 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.447 ' N ' HD13 ' C' ' 75' ' ' LEU . 51.0 t -151.08 129.36 11.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.129 0.971 . . . . 60.52 108.596 175.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -136.86 134.58 37.06 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.976 0.51 . . . . 74.1 110.025 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.489 HG12 ' HA ' ' C' ' 110' ' ' ALA . 36.5 t -131.39 115.6 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 52.34 109.021 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.569 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 27.2 mt-30 -89.48 96.39 10.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.018 . . . . 63.15 108.25 169.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.598 ' HB2' ' HB1' ' C' ' 110' ' ' ALA . 8.7 tp-100 -80.07 125.45 29.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.273 0.629 . . . . 71.33 109.86 176.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.23 154.19 16.81 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.831 -0.507 . . . . 72.12 111.831 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.471 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.25 120.24 1.05 Allowed Glycine 0 CA--C 1.504 -0.65 0 N-CA-C 111.865 -0.494 . . . . 72.12 111.865 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.517 HD13 HD13 ' C' ' 51' ' ' LEU . 9.0 mm -87.92 122.6 39.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 64.04 108.371 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -133.75 127.33 32.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.933 -0.766 . . . . 74.31 108.933 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -87.91 104.28 16.47 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.659 -0.867 . . . . 73.23 108.659 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' C' ' 10' ' ' THR . 21.9 pt -115.54 134.36 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.352 1.061 . . . . 73.55 110.234 -173.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.34 172.2 14.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 74.12 111.272 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.68 -49.15 2.3 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.648 -0.705 . . . . 72.21 113.054 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.424 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.8 pp -119.94 172.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.567 0.747 . . . . 73.12 110.828 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.81 -172.91 4.27 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.776 -0.647 . . . . 72.32 110.186 -171.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.85 -129.01 44.47 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.736 0.647 . . . . 71.12 113.835 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -69.75 -28.03 65.44 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.319 1.048 . . . . 75.45 111.916 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.8 -47.83 83.37 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.745 0.818 . . . . 73.22 109.838 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 36.6 ttp -83.38 -29.18 28.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.449 -0.796 . . . . 72.35 110.829 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' F' ' 280' ' ' LEU . . . -65.33 -30.86 71.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.981 0.513 . . . . 74.24 111.368 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -68.77 -34.53 75.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.285 0.634 . . . . 75.05 110.434 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -70.3 -61.86 1.61 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.159 -0.473 . . . . 74.45 110.761 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.546 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.9 OUTLIER -77.83 -13.5 59.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.819 0.674 . . . . 54.5 112.819 -176.009 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -7.35 49.9 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 119.757 -0.468 . . . . 62.01 113.875 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.56 -58.28 0.63 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.311 0.555 . . . . 73.33 110.951 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.649 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 39.4 t80 -70.99 -45.04 64.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.271 1.028 . . . . 74.34 112.089 -169.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.596 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 33.4 m -70.45 -44.13 17.79 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.549 0.739 . . . . 73.21 111.739 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.579 ' HA ' HD13 ' C' ' 60' ' ' LEU . 86.9 Cg_exo -50.5 -41.57 51.94 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.459 2.106 . . . . 75.53 113.91 168.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -62.41 -26.81 68.68 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.64 0.776 . . . . 72.23 112.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -80.95 -45.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.139 0.576 . . . . 75.22 110.86 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.471 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.3 mt -78.12 -33.13 50.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.735 -0.666 . . . . 75.11 112.124 -171.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.509 ' HE1' HD23 ' C' ' 128' ' ' LEU . 25.0 t80 -51.36 -52.03 63.3 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.692 -1.147 . . . . 73.44 113.708 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 93.6 Cg_exo -48.89 -36.49 34.2 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.938 2.425 . . . . 73.42 114.685 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -72.9 -43.9 61.9 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.88 -0.6 . . . . 73.11 111.622 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.598 ' HB1' ' HB2' ' C' ' 80' ' ' GLN . . . -64.87 -39.4 93.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.744 0.418 . . . . 61.32 110.645 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -55.8 -57.06 13.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.481 1.513 . . . . 74.12 111.275 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -68.09 -31.73 71.56 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.514 0.725 . . . . 74.41 110.913 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' C' ' 21' ' ' ILE . 14.0 t -67.91 -37.93 82.32 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.255 0.622 . . . . 60.55 111.199 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.584 HG21 HG23 ' C' ' 64' ' ' VAL . 70.1 mt -64.78 -49.29 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.497 -0.774 . . . . 72.15 109.729 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -60.16 -34.45 73.59 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 123.882 0.739 . . . . 75.1 111.534 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.41 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -67.78 -38.84 83.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.256 -0.884 . . . . 75.22 110.083 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.688 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -69.43 -37.87 77.61 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.101 0.96 . . . . 73.22 112.273 178.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.06 -34.16 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.14 0.576 . . . . 73.23 109.498 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.454 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 39.5 t -65.19 -38.81 91.66 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-N 115.381 -0.827 . . . . 71.14 111.727 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.422 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.5 mtt-85 -72.21 -23.81 61.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.19 -0.914 . . . . 74.15 111.18 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.43 6.42 83.29 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 119.865 -0.408 . . . . 54.14 113.146 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.409 HG22 ' HB3' ' D' ' 17' ' ' TYR . 38.0 p 60.75 35.64 19.56 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.014 1.726 . . . . 75.31 112.18 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -115.06 148.12 39.88 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.534 0.734 . . . . 75.34 110.89 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -45.89 109.03 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.295 3.33 . . . . 73.3 112.822 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.06 131.55 51.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.304 -1.316 . . . . 73.51 111.967 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.3 tp -108.58 102.16 11.25 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.401 0.68 . . . . 74.42 109.443 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -90.97 111.89 23.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.952 -1.129 . . . . 71.52 107.952 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.548 HD12 ' H ' ' C' ' 129' ' ' ALA . 16.9 tp -73.43 149.05 42.69 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.113 0.782 . . . . 72.33 113.113 -164.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.548 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -65.9 157.92 77.85 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.611 1.565 . . . . 74.31 112.784 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.662 ' HG2' HG22 ' A' ' 13' ' ' ILE . 8.2 Cg_exo -73.73 129.49 13.6 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.059 2.506 . . . . 74.41 112.56 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.53 107.66 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.751 -1.574 . . . . 73.43 106.751 168.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -102.78 103.64 13.87 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.234 -1.025 . . . . 73.33 108.234 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.471 ' HD1' ' SD ' ' F' ' 286' ' ' MET . 65.8 m-85 -62.25 -35.83 80.15 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.781 -0.645 . . . . 63.22 110.523 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.441 ' O ' ' HG3' ' C' ' 138' ' ' MET . 14.0 m-20 -66.17 -35.28 80.04 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.578 0.751 . . . . 74.23 112.092 176.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.06 -30.46 71.01 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.925 0.49 . . . . 64.41 111.405 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.92 -42.79 97.29 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.194 -0.912 . . . . 74.13 110.868 171.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -73.65 -23.68 59.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.538 0.735 . . . . 74.02 112.064 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 138' ' ' MET . . . . . 0.441 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 64.5 mtt -69.01 -29.42 67.6 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.584 0.754 . . . . 72.02 110.605 177.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -60.18 -36.32 77.34 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.417 1.087 . . . . 74.12 111.219 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -57.48 -83.15 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.346 1.058 . . . . 74.32 110.959 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.411 HD11 ' O ' ' C' ' 141' ' ' LEU . 1.8 pp -132.47 122.8 25.47 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.075 0.398 . . . . 62.32 110.678 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -179.2 89.28 0.02 OUTLIER 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.041 1.337 . . . . 70.24 107.654 173.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -93.78 142.48 27.31 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.863 -0.608 . . . . 73.02 110.534 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.83 104.37 16.04 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.176 -1.046 . . . . 64.54 108.176 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.63 112.25 5.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.187 0.595 . . . . 74.42 109.535 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 148.4 -172.76 28.57 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.308 0.38 . . . . 70.1 113.971 176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -137.91 168.34 19.9 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.934 1.293 . . . . 72.14 109.43 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.05 146.65 8.52 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 120.139 -0.256 . . . . 72.33 112.694 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 12.8 t -159.43 129.7 5.71 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.688 0.795 . . . . 74.43 109.89 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -121.47 178.23 4.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.054 0.542 . . . . 74.34 111.06 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -155.68 81.12 1.02 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.429 0.691 . . . . 74.12 109.314 174.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -154.06 121.48 5.8 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.169 -1.049 . . . . 65.51 108.169 172.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -111.93 91.56 3.7 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.71 -0.848 . . . . 73.34 108.71 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -161.26 159.73 29.01 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.753 0.821 . . . . 73.51 110.195 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 C-N-CA 124.687 1.195 . . . . 73.02 108.585 179.706 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.58 -0.526 . . . . 74.31 109.58 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -114.59 100.26 8.14 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.519 0.728 . . . . 73.53 109.682 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.89 97.97 8.3 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.383 0.611 . . . . 72.2 109.42 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -80.68 136.29 36.17 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 108.603 -0.888 . . . . 72.21 108.603 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -125.71 145.39 50.2 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.908 0.883 . . . . 65.33 109.479 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -83.8 6.89 19.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.145 0.578 . . . . 73.32 111.133 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -65.69 86.5 0.08 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.559 0.744 . . . . 70.53 109.947 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.46 178.63 7.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.71 0.804 . . . . 64.54 110.171 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.6 ttp -32.75 124.61 0.35 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.763 1.225 . . . . 72.34 113.61 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 57.5 m -108.69 140.81 41.56 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.031 -1.1 . . . . 72.43 108.031 165.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -157.59 93.32 1.28 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.728 -1.212 . . . . 75.53 107.728 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -117.56 115.88 26.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.87 -0.789 . . . . 74.42 108.87 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 22.0 mt -68.41 127.67 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.135 -1.061 . . . . 70.41 108.135 172.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.95 -42.47 14.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.65 -0.87 . . . . 72.11 108.65 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 178.92 150.6 0.28 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.312 1.045 . . . . 74.35 109.759 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.433 HD12 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -116.1 144.07 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.466 -1.309 . . . . 63.54 107.466 169.245 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.41 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 13.6 p90 -165.53 150.46 8.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.669 0.747 . . . . 74.33 111.108 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -78.02 109.76 12.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.623 -1.171 . . . . 75.11 109.228 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.549 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 46.6 mtpt -75.83 -32.86 59.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.819 -0.628 . . . . 74.24 109.435 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.431 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.4 t70 -149.23 137.42 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.697 -1.138 . . . . 64.43 109.452 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.688 HG21 ' HE1' ' C' ' 117' ' ' MET . 81.0 mt -135.73 146.82 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.321 1.048 . . . . 71.41 108.674 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 m -147.66 138.3 23.25 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.161 0.984 . . . . 73.45 110.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.483 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.6 t80 -142.62 111.67 6.48 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 105.516 -2.031 . . . . 75.42 105.516 166.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.1 mt-10 -123.08 110.89 15.89 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.897 -0.779 . . . . 74.13 108.897 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.609 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -113.64 83.25 6.99 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.477 0.711 . . . . 75.33 109.336 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.27 -36.9 6.45 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.505 2.137 . . . . 71.24 111.807 -175.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.415 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 30.8 m-20 -112.41 22.77 14.32 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.041 0.936 . . . . 75.52 109.891 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.609 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -49.82 -60.48 4.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 114.394 1.257 . . . . 62.35 114.394 -168.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.454 ' HD3' ' HE3' ' C' ' 19' ' ' LYS . 82.7 Cg_endo -75.12 -8.76 20.21 Favored 'Trans proline' 0 C--N 1.387 2.585 0 CA-C-N 121.751 1.661 . . . . 73.15 112.845 -175.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.415 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.3 t-160 -83.5 -37.17 23.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.43 1.492 . . . . 64.31 109.427 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.531 HG23 ' HA ' ' D' ' 73' ' ' ALA . 96.3 t -72.42 -32.49 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.777 . . . . 73.35 110.357 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.451 ' HA ' HG12 ' G' ' 301' ' ' ILE . 21.9 m-85 -69.07 -3.1 11.87 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.528 0.936 . . . . 73.51 113.528 -176.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.94 -9.92 58.34 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.57 0.748 . . . . 72.23 111.306 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -110.4 114.29 27.61 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.672 1.189 . . . . 75.13 109.677 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.449 ' HB2' ' HA ' ' G' ' 300' ' ' ASN . 12.1 p-10 -100.11 93.9 5.96 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.826 0.85 . . . . 75.14 112.106 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.449 ' CH2' ' HB3' ' D' ' 68' ' ' LEU . 0.0 OUTLIER -168.78 -164.48 0.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.684 0.794 . . . . 75.41 111.262 -177.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -89.12 122.08 69.05 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 124.193 0.997 . . . . 74.4 111.544 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.753 ' HB3' HD12 ' D' ' 68' ' ' LEU . 74.2 Cg_exo -56.43 134.52 64.79 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.51 2.807 . . . . 73.51 114.531 165.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.11 114.0 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.553 -1.647 . . . . 75.13 106.553 166.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.18 138.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.554 0.742 . . . . 72.1 109.852 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -130.92 153.18 49.43 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.424 1.09 . . . . 73.44 111.134 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.6 120.0 37.18 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.847 -1.168 . . . . 62.3 107.847 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.544 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -105.66 145.38 31.13 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.105 -1.072 . . . . 74.12 108.105 171.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.68 147.34 44.79 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.489 0.661 . . . . 63.51 111.93 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.67 146.85 27.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.328 1.451 . . . . 62.41 107.705 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.467 ' HG1' ' HA ' ' G' ' 282' ' ' ALA . 47.6 p -123.62 155.76 37.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.411 0.684 . . . . 73.22 110.757 -174.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.613 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -159.25 158.37 32.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.506 0.722 . . . . 74.24 110.312 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 60.7 p -160.25 153.22 21.52 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.395 0.678 . . . . 74.11 109.434 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 26.7 p -157.56 123.31 4.66 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.521 0.728 . . . . 71.21 109.582 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -70.36 120.46 16.05 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.434 -0.58 . . . . 72.12 109.434 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -89.88 -38.35 13.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 71.33 110.138 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.0 -175.95 5.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 75.12 110.262 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -67.19 128.26 35.71 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.671 -0.695 . . . . 71.32 109.291 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 45.5 m-20 63.13 13.99 7.3 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.349 1.06 . . . . 75.22 112.135 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.28 119.9 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.238 1.015 . . . . 71.44 108.483 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -132.86 128.61 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.185 -1.043 . . . . 63.31 108.185 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -94.71 130.97 41.01 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.367 -0.605 . . . . 71.3 109.367 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.4 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 59.6 t -106.87 119.08 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.839 -1.171 . . . . 73.44 107.839 174.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.9 t -106.28 129.42 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.85 -0.796 . . . . 75.44 108.85 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.29 113.1 20.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.115 -1.069 . . . . 72.12 108.115 176.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -86.87 98.26 11.11 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.884 -0.784 . . . . 71.33 108.884 172.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -91.48 127.32 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.008 -1.108 . . . . 74.55 108.008 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.544 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 16.9 m -126.62 148.33 49.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.988 -0.745 . . . . 54.02 108.988 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.1 t -136.42 109.49 8.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 125.317 1.447 . . . . 72.43 108.192 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 122.27 44.78 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.994 0.518 . . . . 74.44 109.633 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.63 135.14 49.57 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.78 -0.822 . . . . 72.2 108.78 172.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -135.39 116.22 14.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.031 -1.47 . . . . 62.54 107.031 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.753 HD12 ' HB3' ' D' ' 38' ' ' PRO . 9.9 mp -122.42 115.45 22.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.555 -0.748 . . . . 72.02 110.662 -167.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.79 -111.32 3.27 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.799 -0.92 . . . . 71.24 110.799 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.59 6.61 8.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.067 0.947 . . . . 73.52 109.172 174.337 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.5 174.92 7.48 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.846 0.858 . . . . 72.21 110.035 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -84.18 135.29 34.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.249 0.619 . . . . 73.21 110.793 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.531 ' HA ' HG23 ' D' ' 31' ' ' VAL . . . -81.19 -73.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.725 . . . . 74.33 109.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -153.6 155.55 36.31 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.272 -1.331 . . . . 74.44 109.947 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.2 mt -123.08 110.93 15.94 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 107.928 -1.138 . . . . 74.42 107.928 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.427 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.4 t -115.78 133.74 55.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.966 -0.753 . . . . 64.24 108.966 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -153.86 132.87 12.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.637 0.375 . . . . 72.12 110.252 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.58 115.69 15.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.901 0.881 . . . . 74.13 109.327 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.431 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -88.7 86.82 7.06 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.723 -0.843 . . . . 75.03 108.723 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.21 95.13 6.19 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.704 -1.135 . . . . 73.53 109.468 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.549 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -91.96 143.35 16.5 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.208 -0.757 . . . . 61.43 111.208 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.57 130.03 3.92 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 110.274 -1.13 . . . . 74.34 110.274 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -89.8 127.1 42.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.816 . . . . 75.11 108.795 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.4 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 36.6 m-85 -130.21 125.41 34.85 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.602 -0.518 . . . . 75.51 109.602 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.3 m -79.33 95.24 5.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.471 0.709 . . . . 73.12 109.304 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 mt -108.4 123.32 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.721 0.808 . . . . 61.53 109.625 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.47 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -152.64 169.84 21.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.278 1.031 . . . . 73.24 109.711 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.63 2.01 73.79 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.9 0.72 . . . . 62.24 114.9 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 pt -135.93 148.5 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.005 0.922 . . . . 74.21 109.517 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.86 159.71 41.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.566 0.746 . . . . 63.23 110.813 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.82 -115.53 7.38 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 124.279 0.987 . . . . 70.33 115.372 167.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.4 m -68.68 -33.04 73.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.063 0.945 . . . . 64.44 111.891 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.08 -44.74 62.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.762 0.425 . . . . 72.35 111.025 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.82 67.68 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.979 -0.378 . . . . 72.32 109.979 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.404 ' HB2' HD22 ' G' ' 280' ' ' LEU . . . -68.24 -39.19 82.35 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.547 0.739 . . . . 54.21 110.649 176.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -63.61 -42.27 98.24 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.849 0.46 . . . . 73.44 110.034 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.4 -47.77 80.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.848 0.459 . . . . 74.41 110.955 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -34.36 46.92 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.452 0.701 . . . . 63.14 110.576 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.82 -15.57 72.57 Favored Glycine 0 N--CA 1.466 0.677 0 CA-C-N 116.271 -0.422 . . . . 61.1 113.47 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.17 -63.89 0.83 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.618 0.599 . . . . 73.22 112.618 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -72.46 -48.02 44.21 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 112.634 0.605 . . . . 75.2 112.634 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.35 -46.23 90.13 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.556 0.742 . . . . 73.12 112.855 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.16 -31.19 54.7 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.043 1.828 . . . . 74.32 112.182 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -72.09 -17.99 61.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.703 0.801 . . . . 73.31 111.024 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.0 mm -80.2 -43.81 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.478 0.711 . . . . 74.23 110.051 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.81 -32.62 57.75 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.545 0.738 . . . . 71.11 112.571 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.06 -44.79 95.47 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 124.154 0.981 . . . . 74.34 113.095 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.85 -37.24 98.6 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.536 2.157 . . . . 75.43 114.075 172.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -79.91 -25.96 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.087 0.555 . . . . 73.44 111.838 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.22 -50.07 62.14 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.105 -0.702 . . . . 61.31 109.105 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.5 -35.59 76.29 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.564 1.165 . . . . 73.24 111.301 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . 0.422 ' HG2' HH12 ' C' ' 120' ' ' ARG . 26.8 tt0 -56.35 -52.13 65.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.151 0.98 . . . . 71.03 110.865 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.915 -1.039 . . . . 73.3 111.132 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.427 HG12 ' SG ' ' D' ' 76' ' ' CYS . 87.7 mt -58.74 -63.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.185 0.994 . . . . 71.34 110.508 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 34.9 m -52.03 -38.17 56.0 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.467 1.107 . . . . 75.21 112.206 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 25.9 t -66.41 -45.21 80.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.52 0.728 . . . . 73.34 111.04 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.416 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.9 mtm -67.95 -36.71 80.57 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.886 0.475 . . . . 73.12 111.554 179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.407 HG22 ' O ' ' D' ' 114' ' ' ILE . 97.9 t -64.4 -40.27 88.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 115.306 -0.861 . . . . 71.42 110.224 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -31.33 65.99 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.601 0.36 . . . . 73.35 111.202 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.416 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 93.8 mtt-85 -73.16 -23.52 60.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.286 0.634 . . . . 74.32 110.994 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.31 12.41 69.01 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.743 0.652 . . . . 60.51 112.861 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 54.3 p 59.78 22.21 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.277 1.831 . . . . 71.11 113.619 176.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.23 161.64 30.45 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.423 1.089 . . . . 71.31 109.387 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -74.9 144.34 30.5 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.256 1.971 . . . . 64.12 111.172 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.711 HE21 HG23 ' A' ' 122' ' ' THR . 5.0 pt20 -44.84 121.78 2.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.666 1.186 . . . . 73.34 111.934 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.78 95.42 5.72 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.616 -1.253 . . . . 74.15 107.616 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -103.77 109.26 20.91 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.303 -0.862 . . . . 72.3 109.134 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.83 118.97 11.77 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.614 -0.721 . . . . 72.55 109.057 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.403 ' HB2' HG11 ' E' ' 306' ' ' VAL . . . -64.2 138.66 97.49 Favored Pre-proline 0 CA--C 1.55 0.953 0 O-C-N 123.963 0.789 . . . . 73.13 111.15 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.45 132.12 10.97 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.429 2.086 . . . . 73.54 112.882 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.71 121.96 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.366 -0.976 . . . . 73.41 108.366 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.644 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 53.9 t30 -77.27 97.54 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.084 -0.71 . . . . 70.32 109.084 175.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -71.1 -32.9 69.62 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.48 -0.782 . . . . 65.21 111.156 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -56.21 -38.8 71.5 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.101 0.96 . . . . 71.52 112.135 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.644 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -73.38 -27.89 61.72 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.825 0.703 . . . . 75.0 112.086 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.462 HD13 ' HD2' ' G' ' 287' ' ' PRO . 74.7 mt -67.29 -43.9 80.61 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.62 0.768 . . . . 75.52 110.244 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -75.58 -32.05 60.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.634 0.774 . . . . 75.12 111.191 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.51 ' HE3' ' HA ' ' D' ' 135' ' ' ALA . 34.8 ttm -59.02 -32.35 69.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.415 1.086 . . . . 64.13 111.819 -178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -58.59 -39.0 79.17 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.291 -0.868 . . . . 71.43 111.18 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -65.79 -39.51 91.02 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.138 0.575 . . . . 75.31 111.411 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.98 -34.53 78.65 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.896 0.878 . . . . 74.44 112.376 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.07 25.29 2.19 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.146 0.579 . . . . 74.15 112.223 -177.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -116.79 48.13 1.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 122.271 1.034 . . . . 73.23 108.215 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -151.52 151.04 31.07 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.049 -1.432 . . . . 64.34 107.796 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.71 146.77 54.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.842 0.457 . . . . 73.43 111.433 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.42 70.98 0.3 Allowed Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.578 -1.009 . . . . 71.22 110.578 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.73 109.79 0.88 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.515 1.126 . . . . 74.32 110.684 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.65 68.64 0.23 Allowed Glycine 0 C--N 1.342 0.884 0 N-CA-C 110.815 -0.914 . . . . 63.13 110.815 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 26.9 m -60.56 112.96 2.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.521 0.728 . . . . 61.24 111.066 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.96 155.41 40.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.22 1.008 . . . . 63.43 110.89 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.77 141.19 21.55 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.454 0.702 . . . . 74.45 110.061 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -149.81 166.13 30.42 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.091 1.356 . . . . 73.11 108.8 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -152.53 149.53 28.61 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.894 0.877 . . . . 60.11 109.611 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -105.59 117.99 35.44 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.133 -1.062 . . . . 75.2 108.133 172.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 N-CA-C 109.094 -0.706 . . . . 62.32 109.094 179.13 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.525 -0.546 . . . . 74.34 109.525 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -70.27 103.15 2.29 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.966 -0.753 . . . . 75.3 108.966 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.62 -9.24 58.84 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.512 0.725 . . . . 72.41 112.207 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . 0.629 ' HG3' ' HA3' ' E' ' 279' ' ' GLY . 34.3 tt0 -85.52 53.88 2.92 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 121.924 0.869 . . . . 74.34 109.745 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -89.0 -46.16 0.43 Allowed Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.703 0.801 . . . . 74.42 110.445 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.15 176.92 9.43 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.53 1.487 . . . . 74.41 111.79 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.05 66.08 9.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.736 0.814 . . . . 75.42 109.844 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -169.81 97.27 0.3 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 105.961 -1.866 . . . . 51.33 105.961 175.318 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . 0.629 ' HA3' ' HG3' ' E' ' 274' ' ' GLN . . . -153.49 17.41 0.67 Allowed Glycine 0 C--N 1.348 1.232 0 N-CA-C 114.302 0.481 . . . . 72.31 114.302 -174.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 5.0 tt -163.59 100.49 0.91 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.893 -1.521 . . . . 75.14 106.893 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -166.98 131.31 1.97 Allowed 'General case' 0 CA--C 1.542 0.672 0 O-C-N 123.797 0.686 . . . . 72.31 110.263 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -98.76 151.42 20.8 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.624 0.769 . . . . 74.23 109.461 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.79 91.53 3.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.416 0.687 . . . . 73.31 110.067 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 74.24 -81.49 0.81 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.833 -0.621 . . . . 72.24 111.743 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 74.8 -62.33 0.46 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.946 1.698 . . . . 65.32 113.109 171.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 286' ' ' MET . . . . . 0.442 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 43.2 ttm -67.63 113.29 13.48 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.831 0.852 . . . . 74.1 110.617 -177.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -91.52 108.72 0.29 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.501 2.134 . . . . 72.2 110.269 171.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.51 -27.06 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.276 0.23 . . . . 71.01 110.794 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 61.95 -88.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.023 1.329 . . . . 75.43 111.77 172.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . 0.496 ' HE3' ' H ' ' E' ' 291' ' ' LEU . 0.0 OUTLIER -167.24 146.94 5.28 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.515 1.126 . . . . 74.44 109.468 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.496 ' H ' ' HE3' ' E' ' 290' ' ' TRP . 3.1 mp -126.76 82.68 2.1 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.516 -0.92 . . . . 74.31 108.516 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 114.14 -94.86 0.71 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.974 -0.903 . . . . 62.14 112.758 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -70.0 175.05 8.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.03 2.486 . . . . 74.45 113.012 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -106.18 -16.63 14.54 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.225 1.01 . . . . 71.44 110.483 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -156.23 163.75 39.19 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.242 0.544 . . . . 71.13 111.527 -172.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 12.1 t -90.64 -19.56 23.51 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.098 -0.956 . . . . 73.15 109.967 171.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 6.2 m-85 -72.54 139.51 47.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.488 0.715 . . . . 73.41 111.92 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . 0.772 ' HB3' ' HB3' ' G' ' 303' ' ' LYS . 80.6 t60 -175.7 -41.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 O-C-N 125.058 1.473 . . . . 74.23 107.16 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.44 -140.86 3.24 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.354 -0.839 . . . . 75.35 112.075 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . 0.495 ' HB2' ' HA ' ' G' ' 302' ' ' ASP . 3.3 t-20 82.59 -16.08 0.62 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.938 1.695 . . . . 74.12 113.576 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . 0.597 HD12 ' HA ' ' A' ' 123' ' ' PHE . 9.3 pt -137.03 48.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 113.309 0.855 . . . . 73.51 113.309 -170.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . 0.765 ' HB2' ' HA ' ' G' ' 297' ' ' TYR . 76.6 m-20 -68.93 144.97 54.03 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 121.557 -0.714 . . . . 72.52 109.876 170.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . 0.492 ' H ' ' HD3' ' E' ' 303' ' ' LYS . 0.0 OUTLIER -70.44 137.04 86.17 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 123.329 0.651 . . . . 75.12 111.142 -178.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.15 -57.88 0.45 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.127 2.551 . . . . 70.1 112.806 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . 0.429 ' HA ' ' HA ' ' B' ' 14' ' ' GLN . . . 55.29 85.04 0.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.821 1.248 . . . . 71.24 111.658 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . 0.403 HG11 ' HB2' ' D' ' 129' ' ' ALA . 57.6 t -73.18 122.45 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.965 0.506 . . . . 75.34 110.2 -176.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 15.2 t -70.27 154.67 41.64 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.784 0.833 . . . . 74.12 111.2 -174.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 28.1 p -66.42 138.36 57.5 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.313 0.645 . . . . 60.54 111.11 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 17.7 p -65.55 152.46 92.46 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.841 1.256 . . . . 62.14 112.022 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.387 2.59 0 C-N-CA 123.768 2.979 . . . . 71.44 113.48 -175.021 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.864 -0.421 . . . . 71.24 109.864 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -77.36 -13.27 59.96 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.359 0.664 . . . . 71.54 111.306 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . 0.609 ' HG2' ' HG3' ' F' ' 274' ' ' GLN . 53.7 tt0 -67.26 130.34 42.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.04 0.936 . . . . 73.1 111.999 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . 0.609 ' HG3' ' HG2' ' F' ' 273' ' ' GLN . 92.5 mt-30 65.59 111.99 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.498 1.519 . . . . 75.34 111.94 175.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -104.86 98.92 16.55 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 108.19 -1.041 . . . . 75.04 108.19 170.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.16 -67.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.852 2.368 . . . . 75.24 112.995 -171.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 62.2 mt -102.05 123.31 45.72 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.828 -0.434 . . . . 72.41 109.828 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 70.65 81.52 0.16 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.519 1.528 . . . . 75.02 109.511 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -114.17 -84.99 1.31 Allowed Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.008 -0.997 . . . . 54.41 110.648 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . 0.499 ' HB3' ' HB2' ' C' ' 95' ' ' ALA . 2.4 tt -78.92 78.33 5.37 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.444 -0.947 . . . . 72.43 108.444 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -179.89 84.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.093 0.957 . . . . 74.04 109.771 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -167.62 106.2 0.54 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.183 -1.043 . . . . 74.45 108.183 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 37.3 t70 63.77 23.59 13.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.097 0.873 . . . . 74.3 110.481 -177.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.9 89.34 0.39 Allowed Glycine 0 C--N 1.354 1.571 0 CA-C-N 115.37 -0.832 . . . . 73.25 113.159 -171.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -98.78 106.22 18.46 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.739 0.816 . . . . 65.34 109.135 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 286' ' ' MET . . . . . 0.471 ' SD ' ' HD1' ' C' ' 133' ' ' PHE . 58.9 mtt -73.7 157.12 87.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-O 118.907 -0.568 . . . . 74.13 109.476 171.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.48 79.77 0.24 Allowed 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.592 2.194 . . . . 74.31 112.609 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.16 84.54 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.853 -1.165 . . . . 73.31 107.853 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.13 130.46 40.94 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.787 -1.19 . . . . 73.1 107.787 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 15.1 t-105 -62.73 129.12 39.1 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 123.639 0.587 . . . . 63.12 110.542 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.86 -175.06 3.07 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.012 1.325 . . . . 74.1 111.268 -167.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 73.25 173.96 26.81 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 114.995 -1.002 . . . . 51.23 113.672 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.81 133.5 15.48 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 122.682 2.255 . . . . 75.5 110.964 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.97 30.85 0.9 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.102 0.961 . . . . 72.33 110.93 -177.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -76.22 78.5 3.01 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.994 0.902 . . . . 73.44 108.9 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 31.5 m -136.78 149.43 47.78 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.404 1.481 . . . . 64.23 107.14 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.615 ' HH ' HG21 ' C' ' 31' ' ' VAL . 18.9 t80 68.33 -73.61 0.08 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.298 1.039 . . . . 73.35 111.303 -177.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . 0.525 ' HD1' ' HA ' ' C' ' 36' ' ' TRP . 13.1 m170 -103.41 26.95 7.78 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.09 0.556 . . . . 65.12 110.147 174.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -78.95 70.82 2.69 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.046 -0.822 . . . . 41.21 111.046 167.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . 0.608 ' HB2' ' HA2' ' H' ' 299' ' ' GLY . 40.6 m-80 61.97 82.16 0.18 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.605 1.562 . . . . 71.53 112.282 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 36.5 pt -102.73 170.65 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.67 0.748 . . . . 74.13 110.257 170.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -151.44 -179.81 7.7 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 107.255 -1.387 . . . . 64.04 107.255 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -64.84 133.35 95.72 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 108.428 -0.953 . . . . 73.42 108.428 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.33 11.58 0.45 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.49 2.793 . . . . 73.44 115.226 -168.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.03 27.13 8.83 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.57 1.148 . . . . 74.11 111.539 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . 0.406 HG11 ' HD2' ' B' ' 130' ' ' PRO . 55.8 t -102.53 122.38 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.569 0.748 . . . . 73.14 109.189 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 62.4 m -142.02 155.09 45.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.004 0.921 . . . . 54.11 108.557 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 53.2 t -63.05 126.58 27.82 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.817 0.447 . . . . 74.24 110.461 175.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 3.6 t -134.05 103.44 11.79 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.937 0.895 . . . . 72.15 108.678 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 CA--C 1.564 1.981 0 C-N-CA 122.419 2.079 . . . . 73.23 112.375 174.028 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 110.599 -0.149 . . . . 72.25 110.599 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 65.44 30.01 11.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.832 1.253 . . . . 74.03 111.697 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -78.95 102.15 8.13 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.776 0.831 . . . . 60.34 109.343 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -115.22 -54.45 2.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.194 0.998 . . . . 74.24 112.061 -168.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -69.92 154.17 94.88 Favored Pre-proline 0 N--CA 1.485 1.287 0 CA-C-O 119.092 -0.48 . . . . 72.12 111.202 -168.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -37.38 116.65 0.19 Allowed 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 124.473 3.449 . . . . 70.34 115.666 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.07 -11.09 48.16 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 114.584 -1.189 . . . . 74.31 108.59 169.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 34.2 tp -135.7 118.75 16.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.4 1.08 . . . . 74.23 108.194 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 167.27 65.66 0.03 OUTLIER Glycine 0 C--N 1.35 1.315 0 O-C-N 123.074 0.234 . . . . 74.12 113.554 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . 0.615 ' HG ' ' H ' ' G' ' 281' ' ' PHE . 13.4 tp -166.74 -162.84 0.52 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.864 -1.162 . . . . 75.24 107.864 170.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . 0.615 ' H ' ' HG ' ' G' ' 280' ' ' LEU . 9.4 t80 87.77 -48.84 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.969 1.708 . . . . 75.42 111.925 163.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . 0.467 ' HA ' ' HG1' ' D' ' 46' ' ' THR . . . -75.28 77.33 2.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.075 0.55 . . . . 74.4 109.905 173.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.87 -52.67 0.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.658 0.783 . . . . 75.13 110.833 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 67.25 40.43 92.22 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 111.629 -0.588 . . . . 71.21 111.629 -172.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -71.06 -32.94 69.75 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.267 1.027 . . . . 75.02 110.939 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.73 125.99 84.18 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 115.533 -0.758 . . . . 75.43 109.73 171.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . 0.462 ' HD2' HD13 ' D' ' 136' ' ' LEU . 14.8 Cg_endo -54.44 -63.69 0.2 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.185 2.59 . . . . 72.54 112.859 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 60.0 t 60.84 -75.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 124.638 1.175 . . . . 63.1 110.958 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 74.23 -12.07 0.93 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.433 1.493 . . . . 75.41 112.553 172.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' G' ' 293' ' ' PRO . 9.8 t-105 73.91 123.8 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.72 1.608 . . . . 72.42 109.705 -164.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 3.3 mp -88.68 19.21 4.1 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.491 1.116 . . . . 73.32 112.288 -161.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 141.51 101.65 0.44 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.123 -0.821 . . . . 62.34 112.09 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . 0.409 ' HA ' ' HE1' ' G' ' 290' ' ' TRP . 73.4 Cg_endo -72.95 168.6 24.26 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.595 2.197 . . . . 74.1 111.835 172.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . 0.486 ' HB2' ' HZ2' ' G' ' 294' ' ' LYS . 6.9 mtmp? 67.71 11.63 8.47 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.322 1.049 . . . . 74.44 112.532 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.35 60.46 6.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.75 0.82 . . . . 74.0 109.96 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.63 132.4 6.74 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.502 1.521 . . . . 73.11 107.992 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.765 ' HA ' ' HB2' ' E' ' 302' ' ' ASP . 5.2 m-85 57.11 -175.37 0.07 Allowed 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.352 1.061 . . . . 72.32 113.374 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -143.89 -56.5 0.38 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.08 -0.963 . . . . 71.24 109.087 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -164.91 30.44 0.23 Allowed Glycine 0 C--N 1.35 1.327 0 N-CA-C 114.48 0.552 . . . . 73.23 114.48 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . 0.449 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 12.1 p30 -148.67 155.78 41.5 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.266 0.533 . . . . 75.23 109.837 168.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.451 HG12 ' HA ' ' D' ' 32' ' ' PHE . 6.9 tp -113.27 -39.91 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.847 0.859 . . . . 72.23 110.886 -175.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' E' ' 300' ' ' ASN . 3.5 p30 -166.77 -165.19 0.71 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.965 0.888 . . . . 75.13 113.115 -175.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . 0.772 ' HB3' ' HB3' ' E' ' 298' ' ' HIS . 0.0 OUTLIER -136.62 125.15 15.12 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 126.025 1.73 . . . . 74.52 108.375 172.239 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.9 -42.11 12.28 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.3 2.0 . . . . 71.42 111.171 168.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . 60.37 -84.84 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.425 1.49 . . . . 44.42 112.089 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 20.2 m -90.17 113.41 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.371 0.605 . . . . 74.35 109.646 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 33.0 m -142.18 -32.4 0.51 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.19 0.996 . . . . 70.51 108.801 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 73.8 m -116.1 76.38 1.01 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.92 0.888 . . . . 73.42 108.739 168.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 90.6 m -65.07 -53.58 40.27 Favored Pre-proline 0 CA--C 1.563 1.461 0 CA-C-N 115.487 -0.779 . . . . 65.2 112.098 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo . . . . . 0 C--N 1.396 3.032 0 C-N-CA 122.356 2.038 . . . . 75.03 111.407 -178.19 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.5 0.19 . . . . 74.45 110.575 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -81.37 -14.51 57.12 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.244 0.618 . . . . 72.04 111.408 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.69 158.01 34.24 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.721 0.808 . . . . 74.31 109.634 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -123.97 144.55 49.74 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.69 0.796 . . . . 72.11 109.249 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -51.43 51.57 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 123.7 0.8 . . . . 63.14 111.07 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -83.68 172.97 9.76 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 121.519 1.479 . . . . 74.43 112.238 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 85.8 mt 64.99 175.13 0.2 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.739 1.216 . . . . 65.43 112.343 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 62.51 18.87 10.79 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.257 1.023 . . . . 74.43 112.535 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . 0.402 ' H ' ' HE2' ' B' ' 94' ' ' MET . . . -79.39 129.49 9.2 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-O 119.477 -0.624 . . . . 70.22 112.651 -175.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 2.2 tt 56.46 75.94 0.32 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.166 1.386 . . . . 75.23 109.645 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -167.18 -43.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.775 -0.648 . . . . 71.35 110.482 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.66 -27.37 68.63 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.156 0.582 . . . . 71.21 111.272 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -78.64 -82.72 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.844 0.857 . . . . 55.11 110.249 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 73.79 108.81 0.07 OUTLIER Glycine 0 CA--C 1.54 1.639 0 CA-C-N 118.304 0.502 . . . . 72.42 113.999 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -136.22 -101.05 0.21 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 108.193 -1.04 . . . . 73.23 108.193 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 44.8 ttp 46.62 84.8 0.19 Allowed Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 124.93 1.292 . . . . 73.24 112.797 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.57 111.86 2.46 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.858 2.372 . . . . 64.31 111.466 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.71 -33.98 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.662 0.785 . . . . 70.52 110.633 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 65.59 -170.01 0.2 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.792 1.237 . . . . 74.34 110.876 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -102.69 138.97 38.88 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.237 0.541 . . . . 72.12 110.49 171.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.43 -14.54 30.39 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.584 -1.189 . . . . 62.34 109.887 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.23 177.57 41.83 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 116.007 -0.542 . . . . 74.45 112.656 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.94 145.59 25.21 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 123.278 2.652 . . . . 73.22 112.578 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -104.82 130.01 53.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.229 0.611 . . . . 73.54 111.5 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.64 101.19 13.73 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 108.423 -0.955 . . . . 74.13 108.423 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 3.0 m -132.52 160.8 35.48 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.946 -1.131 . . . . 72.23 107.946 179.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 70.84 -67.26 0.26 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.614 1.166 . . . . 73.22 111.007 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -63.26 94.09 0.07 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.438 0.695 . . . . 74.11 110.517 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' F' ' 300' ' ' ASN . . . -154.45 -64.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.909 -1.276 . . . . 51.03 109.909 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -125.62 79.95 1.86 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.493 -1.299 . . . . 73.43 107.493 172.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 10.1 tt -139.84 108.41 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 115.271 -0.877 . . . . 75.41 110.156 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -169.53 -67.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.465 -1.309 . . . . 70.54 107.465 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -123.56 87.72 52.07 Favored Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 108.027 -1.101 . . . . 74.04 108.027 170.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.46 3.03 7.15 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.581 2.187 . . . . 75.22 112.511 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -70.61 121.26 17.56 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.425 1.09 . . . . 73.45 111.001 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 13' ' ' ILE . 58.1 t -77.4 86.83 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.923 -1.14 . . . . 74.14 107.923 168.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 32.4 p -86.9 135.8 33.18 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.294 -0.866 . . . . 72.21 109.327 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 63.7 m 71.42 142.62 0.06 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.555 1.542 . . . . 64.3 111.059 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 94.0 m 67.99 109.53 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.883 1.273 . . . . 72.5 111.303 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.377 2.066 0 C-N-CA 122.311 2.007 . . . . 74.32 111.494 173.326 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtm . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 108.791 -0.818 . . . . 75.3 108.791 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.4 t -121.36 153.72 37.4 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.268 -0.641 . . . . 73.14 109.268 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.52 102.56 3.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.139 -0.689 . . . . 73.04 109.139 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -73.76 85.5 1.67 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.577 0.703 . . . . 74.23 111.977 -171.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -78.68 128.59 33.66 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.912 -1.04 . . . . 72.41 109.661 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.89 -27.17 60.92 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.534 0.734 . . . . 73.24 110.864 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.5 p 54.18 -170.64 0.05 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.491 1.516 . . . . 70.33 112.802 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -100.21 168.81 9.56 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.213 0.605 . . . . 74.31 109.721 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -59.63 133.52 56.17 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.611 0.764 . . . . 75.4 110.733 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.9 m -144.52 142.35 30.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.62 0.768 . . . . 63.31 109.665 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.568 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.7 t80 -135.89 122.33 20.67 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.908 -1.145 . . . . 73.55 107.908 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.599 HE22 HG12 ' H' ' 306' ' ' VAL . 61.2 tp60 -144.78 102.71 3.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.099 -0.334 . . . . 72.52 110.099 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.797 HG22 ' HG2' ' C' ' 130' ' ' PRO . 58.2 mt -71.93 128.34 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.101 -0.703 . . . . 71.34 109.101 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -103.68 -37.55 7.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.917 0.487 . . . . 71.44 110.011 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -165.53 138.73 4.42 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 110.209 -0.293 . . . . 74.22 110.209 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.406 HD11 ' HD3' ' C' ' 130' ' ' PRO . 0.2 OUTLIER -128.4 134.01 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.57 -0.9 . . . . 74.21 108.57 172.851 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -165.07 147.02 7.87 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 65.43 110.961 -172.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.44 110.48 11.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.79 -0.819 . . . . 75.3 108.79 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -76.05 -22.52 55.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.025 -0.534 . . . . 74.43 110.511 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.87 142.16 17.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.797 -1.092 . . . . 71.43 109.441 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.7 140.2 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 106.732 -1.581 . . . . 73.03 106.732 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 31.1 t -150.85 141.75 22.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.8 -0.815 . . . . 74.14 108.8 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.519 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 86.8 t80 -151.78 110.78 3.87 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 105.955 -1.869 . . . . 64.42 105.955 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -122.35 118.15 27.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.356 -0.609 . . . . 74.23 109.356 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.89 83.73 1.11 Allowed Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 107.802 -1.185 . . . . 73.01 107.802 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.88 -42.64 36.19 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.859 2.372 . . . . 71.4 112.929 -166.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.3 m-20 -109.64 29.89 7.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 118.415 -0.803 . . . . 73.02 109.815 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.89 -57.06 5.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 117.583 -1.199 . . . . 73.02 113.669 -173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -64.42 -29.33 62.52 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.618 1.614 . . . . 74.43 112.348 -178.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -79.8 -35.75 38.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.853 -1.067 . . . . 72.22 110.883 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.545 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.1 p -80.88 -13.49 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 115.749 -0.66 . . . . 73.05 111.879 -168.205 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -76.57 -11.72 59.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.174 0.59 . . . . 72.34 110.781 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -91.25 -12.5 35.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.495 1.118 . . . . 75.5 110.913 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.541 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 27.9 mmmt -81.62 166.2 20.4 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.671 0.788 . . . . 75.23 112.103 -173.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.14 139.18 39.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.254 -1.339 . . . . 75.3 108.576 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -81.31 69.35 7.92 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.579 0.704 . . . . 74.43 111.16 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -134.35 71.48 72.01 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.871 0.868 . . . . 71.33 108.93 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HG2' ' HA ' ' E' ' 295' ' ' ALA . 92.4 Cg_endo -81.91 143.18 12.92 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.28 1.987 . . . . 74.3 111.704 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -104.65 102.37 11.97 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.79 -1.189 . . . . 65.35 107.79 164.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 65' ' ' THR . 42.4 t -74.43 94.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.515 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 60.1 tttm -80.85 113.84 19.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.129 0.972 . . . . 75.53 109.519 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.13 125.67 44.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.121 -1.066 . . . . 73.41 108.121 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.619 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -120.01 129.65 54.36 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.334 -0.987 . . . . 75.11 108.334 176.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.43 117.56 34.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.15 -0.685 . . . . 73.12 109.15 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.079 -1.082 . . . . 75.45 108.079 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -152.14 163.46 39.32 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 122.834 0.454 . . . . 75.05 111.15 -174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -160.91 153.23 20.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.099 0.96 . . . . 74.12 109.974 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -131.23 151.45 51.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.814 -0.81 . . . . 73.32 108.814 167.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -158.21 145.5 18.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.859 0.464 . . . . 73.24 110.675 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -88.19 113.62 23.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.504 0.722 . . . . 72.44 109.585 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.46 -35.81 24.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.836 0.455 . . . . 74.12 110.269 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.74 -174.61 4.7 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.364 1.066 . . . . 73.15 109.839 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.64 130.09 40.31 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.225 -0.658 . . . . 74.42 109.225 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 69.37 -9.89 0.6 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.819 1.648 . . . . 63.02 112.813 -170.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.57 109.41 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.649 0.78 . . . . 74.22 109.188 -170.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -126.81 157.2 39.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.039 -1.097 . . . . 73.34 108.039 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -132.51 146.08 51.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.027 0.931 . . . . 74.43 109.355 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.92 132.87 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.853 -1.166 . . . . 64.13 107.853 167.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.22 133.63 58.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.774 -0.824 . . . . 72.54 108.774 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.512 HD12 ' HA ' ' A' ' 103' ' ' PRO . 75.5 mt -116.69 100.55 7.89 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.969 -1.122 . . . . 73.5 107.969 173.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -85.32 102.31 13.28 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.647 -0.871 . . . . 74.02 108.647 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.548 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.9 t -92.13 119.78 40.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.133 -1.062 . . . . 73.11 108.133 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.619 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -103.7 135.08 45.93 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.391 0.615 . . . . 74.02 110.207 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.567 HG12 HD23 ' A' ' 126' ' ' LEU . 72.9 t -131.12 114.17 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.589 -1.187 . . . . 74.13 108.738 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.515 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 1.1 m -115.35 138.72 50.68 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 108.627 -0.879 . . . . 71.2 108.627 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.27 129.08 42.82 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.105 -0.702 . . . . 73.54 109.105 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 64.1 m -134.18 124.34 25.86 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.589 -0.523 . . . . 72.32 109.589 173.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.491 HD13 ' HB1' ' A' ' 73' ' ' ALA . 9.5 mp -88.4 85.14 6.82 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.398 -0.964 . . . . 75.22 108.398 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 -82.59 1.64 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.011 -0.995 . . . . 70.14 110.711 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -27.15 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.122 0.969 . . . . 75.22 111.612 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.32 127.18 45.3 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.086 0.555 . . . . 72.14 110.239 -172.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 65.8 m -74.05 138.36 43.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.471 0.709 . . . . 72.13 111.909 -175.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -87.3 -64.06 1.21 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.63 1.172 . . . . 72.22 110.56 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -153.76 172.56 17.12 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.264 -0.88 . . . . 71.34 111.781 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.0 tp -141.53 137.95 32.38 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.813 -1.539 . . . . 61.54 107.799 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.9 m -121.86 139.62 53.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.702 0.801 . . . . 52.15 109.864 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.405 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 22.3 mp0 -137.25 122.78 19.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.614 1.166 . . . . 71.34 108.068 169.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.95 108.03 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 108.184 -1.043 . . . . 72.41 108.184 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.01 81.76 8.37 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 124.296 0.998 . . . . 74.11 108.314 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.06 93.84 3.36 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.309 -0.997 . . . . 74.41 108.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.93 153.58 27.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.407 -0.815 . . . . 65.44 111.376 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.518 ' HA3' HD23 ' A' ' 106' ' ' LEU . . . -155.29 122.17 1.19 Allowed Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.083 -0.807 . . . . 43.43 111.083 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mt -82.78 116.3 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.397 0.679 . . . . 63.42 109.431 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.595 ' HD2' HG12 ' A' ' 13' ' ' ILE . 31.6 m-85 -120.63 118.7 30.81 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 74.13 108.267 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 t -91.33 99.71 12.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.583 -0.895 . . . . 64.2 108.583 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.454 HD12 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -121.14 152.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.255 0.622 . . . . 71.14 111.191 -173.788 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 162.89 33.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.117 0.967 . . . . 72.14 109.843 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.61 -14.38 47.25 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.793 -0.448 . . . . 72.25 114.013 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.466 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.76 136.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.618 0.709 . . . . 74.12 109.676 177.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -145.56 175.28 10.46 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.99 1.316 . . . . 72.14 108.467 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.52 -121.45 26.63 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 123.439 0.462 . . . . 60.25 113.798 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -73.07 -25.7 61.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.285 0.634 . . . . 73.32 111.416 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -67.67 -47.11 70.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.446 0.698 . . . . 74.34 110.057 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.475 ' HE2' HD13 ' A' ' 98' ' ' LEU . 21.7 ttt -81.93 -19.47 40.68 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.571 -0.741 . . . . 75.45 110.518 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.22 73.67 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.599 0.36 . . . . 62.12 110.395 171.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -79.46 -37.56 36.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.357 0.663 . . . . 74.13 110.503 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.469 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.6 t -63.91 -44.76 92.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.228 0.611 . . . . 62.15 110.752 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.572 HD12 ' H ' ' E' ' 279' ' ' GLY . 15.9 mt -92.39 -9.42 41.77 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.53 0.332 . . . . 74.03 111.049 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.537 ' HA2' HD11 ' E' ' 280' ' ' LEU . . . -89.65 -29.04 17.27 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.28 0.472 . . . . 64.42 114.28 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.42 -46.14 0.14 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.485 0.55 . . . . 75.2 112.485 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.469 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.0 t80 -60.88 -65.63 0.66 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.053 0.941 . . . . 75.13 112.699 -171.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.4 m -70.75 -34.04 3.42 Favored Pre-proline 0 CA--C 1.565 1.52 0 C-N-CA 123.72 0.808 . . . . 74.3 112.647 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.512 ' HA ' HD12 ' A' ' 60' ' ' LEU . 98.0 Cg_exo -49.5 -39.85 45.31 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.263 1.975 . . . . 73.03 113.874 162.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.28 -12.79 61.64 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.364 0.665 . . . . 70.32 111.802 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -78.11 -48.38 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.285 -0.635 . . . . 75.41 109.285 171.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.518 HD23 ' HA3' ' A' ' 82' ' ' GLY . 95.0 mt -82.31 -28.43 31.69 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.917 0.887 . . . . 72.42 113.103 -170.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.23 -41.5 69.35 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.169 -0.92 . . . . 75.12 113.425 -172.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.33 -36.51 87.18 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.93 1.753 . . . . 74.15 113.138 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -69.89 -42.38 73.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.062 0.545 . . . . 75.0 111.452 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.0 94.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.176 0.591 . . . . 73.43 109.846 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -54.02 -51.86 62.64 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.676 1.235 . . . . 75.14 110.425 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.12 -47.04 86.36 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.395 1.06 . . . . 72.54 110.979 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.402 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 36.4 t -57.61 -43.56 84.8 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.082 0.864 . . . . 72.43 110.763 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.548 HD11 ' HB ' ' A' ' 62' ' ' VAL . 81.2 mt -65.81 -51.19 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 124.074 0.859 . . . . 75.21 110.303 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 87.4 m -53.96 -41.88 68.31 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.094 0.871 . . . . 73.51 111.096 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.9 t -68.93 -45.82 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.63 -1.168 . . . . 71.13 110.471 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.519 ' HE2' ' HB2' ' A' ' 23' ' ' PHE . 17.2 mtp -56.76 -41.86 78.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.648 0.779 . . . . 54.32 111.428 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 73.5 t -66.1 -45.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.655 1.182 . . . . 64.21 110.544 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.4 p -73.52 -26.72 61.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.331 -0.395 . . . . 74.02 111.181 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.458 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.7 mtt-85 -73.81 -33.12 64.05 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.668 0.787 . . . . 70.52 109.399 172.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' B' ' 18' ' ' THR . . . -74.95 -1.38 62.57 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 115.437 -0.801 . . . . 73.41 112.686 170.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.34 31.98 17.14 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.744 2.018 . . . . 74.32 112.433 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -94.01 154.91 40.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.758 -1.201 . . . . 75.51 107.758 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.589 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 70.5 Cg_exo -51.78 142.19 42.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.776 2.318 . . . . 72.12 112.161 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.24 127.26 28.5 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.878 0.736 . . . . 73.12 111.516 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.567 HD23 HG12 ' A' ' 64' ' ' VAL . 32.9 tp -111.05 95.18 5.38 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.608 -1.178 . . . . 73.21 109.294 -176.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -103.04 107.53 18.37 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.843 -1.169 . . . . 73.33 107.843 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.2 tp -72.39 134.15 45.28 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.381 -0.6 . . . . 73.3 109.381 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.446 ' HB1' HG22 ' G' ' 306' ' ' VAL . . . -63.63 141.24 97.9 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.578 0.751 . . . . 73.32 111.861 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.625 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 21.0 Cg_endo -87.21 110.91 0.81 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.562 2.174 . . . . 73.33 111.838 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.7 125.05 54.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.422 -0.955 . . . . 72.13 108.422 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.73 79.93 7.28 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -61.85 -34.21 75.57 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.6 -0.727 . . . . 73.23 110.041 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.08 -34.66 72.24 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.549 -1.205 . . . . 75.24 111.094 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -57.45 11.82 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 123.894 0.746 . . . . 75.44 111.245 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.99 -41.64 97.44 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.315 0.646 . . . . 74.13 110.281 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.3 -43.12 92.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.272 1.029 . . . . 74.14 110.31 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.444 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 4.5 mmt -68.68 -48.69 63.28 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 115.058 -0.974 . . . . 72.13 111.015 177.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -57.97 -44.5 87.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 123.921 0.763 . . . . 70.42 111.573 -174.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -65.8 -37.06 85.26 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.14 0.9 . . . . 72.21 110.87 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.31 -45.84 75.33 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.466 0.479 . . . . 73.11 111.472 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 179.53 -13.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.919 0.711 . . . . 73.33 112.919 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -76.02 146.56 39.39 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.196 0.443 . . . . 74.33 112.196 -168.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -168.53 -179.83 4.04 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.724 1.21 . . . . 73.22 109.476 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.13 97.06 0.08 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.196 0.598 . . . . 74.44 110.459 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.6 64.94 0.18 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.345 -1.102 . . . . 65.12 110.345 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.579 ' HG2' ' H ' ' C' ' 144' ' ' GLN . 36.6 mt-10 -60.34 125.41 23.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.113 0.965 . . . . 75.3 110.856 -176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.33 60.38 4.56 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.765 -0.534 . . . . 72.33 111.765 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.2 p -75.68 98.48 4.08 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.642 0.777 . . . . 72.13 110.656 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -147.96 136.86 21.95 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.872 0.869 . . . . 73.33 108.717 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . 0.433 ' HG2' ' H ' ' A' ' 153' ' ' GLN . 30.3 tt0 -84.21 -67.16 0.82 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.726 0.81 . . . . 71.22 109.278 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.6 t60 57.0 16.85 3.04 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.483 1.113 . . . . 73.42 112.097 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . 0.433 ' H ' ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -96.43 82.74 3.42 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.499 -1.297 . . . . 73.13 107.499 -176.209 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.73 141.68 32.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.699 -1.137 . . . . 64.33 109.393 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 C-N-CA 123.632 0.773 . . . . 75.23 110.024 -174.306 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.462 ' HB3' ' SD ' ' B' ' 138' ' ' MET . 25.1 mmt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.48 -0.563 . . . . 74.32 109.48 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 40.2 m -74.15 102.83 4.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.225 -0.898 . . . . 72.32 110.855 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -112.17 148.78 33.3 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.613 -0.514 . . . . 75.34 109.613 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -148.82 124.85 10.69 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.31 1.044 . . . . 73.0 108.69 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -105.27 70.71 0.9 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.782 0.801 . . . . 72.34 109.068 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -73.51 77.9 1.44 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.427 -1.26 . . . . 74.11 109.771 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' THR . . . . . 0.419 HG21 ' HB3' ' B' ' 9' ' ' MET . 36.3 m -154.55 124.22 6.59 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.177 0.991 . . . . 74.25 108.332 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.76 -48.76 80.33 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.987 0.915 . . . . 75.11 109.771 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.542 ' HE1' ' HB2' ' B' ' 11' ' ' PHE . 21.5 ptm 47.87 -169.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 126.57 1.948 . . . . 73.33 114.529 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.69 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 19.9 m -140.22 123.25 16.65 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.948 -1.13 . . . . 71.43 107.948 173.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.542 ' HB2' ' HE1' ' B' ' 9' ' ' MET . 23.4 t80 -146.67 113.71 6.17 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.175 -0.676 . . . . 73.44 109.175 -179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.66 140.12 27.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.885 -0.783 . . . . 74.33 108.885 165.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.642 HD12 ' HB3' ' D' ' 127' ' ' ASN . 0.0 OUTLIER -90.66 126.81 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.275 -0.875 . . . . 71.11 108.816 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.69 -52.6 5.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.52 0.676 . . . . 73.35 109.988 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -151.07 132.9 15.02 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.944 -0.472 . . . . 74.22 110.878 -169.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.636 HG13 HD13 ' B' ' 13' ' ' ILE . 96.5 mt -114.36 140.73 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.214 -1.773 . . . . 71.4 106.214 166.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.423 ' HE1' HG13 ' B' ' 83' ' ' ILE . 34.9 p90 -164.09 150.73 11.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.416 0.627 . . . . 75.12 111.333 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.414 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 96.3 m -74.18 126.83 31.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.589 -1.187 . . . . 71.32 108.246 167.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -91.91 -48.04 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.769 -1.197 . . . . 73.32 107.769 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.577 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 21.5 m-20 -138.88 143.0 38.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 115.091 -0.959 . . . . 75.22 110.471 -165.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.543 HD13 ' SG ' ' B' ' 113' ' ' CYS . 43.5 mm -136.23 144.44 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.939 1.296 . . . . 75.0 109.164 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.522 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 60.3 m -142.83 135.29 27.62 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.201 1.4 . . . . 73.53 108.166 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.36 107.95 3.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.364 -1.717 . . . . 74.44 106.364 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.73 124.02 47.45 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.993 -0.743 . . . . 75.12 108.993 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.02 82.11 61.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 106.917 -1.512 . . . . 63.44 106.917 173.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.33 -22.11 34.5 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.317 2.678 . . . . 75.22 112.164 -172.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -122.64 29.77 6.75 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.751 1.22 . . . . 61.55 109.392 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.3 -45.42 42.8 Favored Pre-proline 0 CA--C 1.576 1.944 0 N-CA-C 115.819 1.785 . . . . 72.42 115.819 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.418 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 59.8 Cg_endo -75.51 -30.12 6.79 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.543 1.496 . . . . 53.2 113.137 172.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.408 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 71.0 m80 -90.92 -15.2 30.22 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.322 0.86 . . . . 72.32 113.322 -170.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -19.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.927 0.891 . . . . 70.24 111.819 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.26 -19.11 64.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.977 1.311 . . . . 73.35 112.295 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.408 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 23.8 pt20 -64.36 -36.92 85.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.811 0.444 . . . . 64.52 110.442 175.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.459 ' HB2' HD13 ' B' ' 68' ' ' LEU . 90.5 mttt -106.34 65.48 0.68 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.671 -0.863 . . . . 73.14 108.671 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.477 ' HA ' ' HH ' ' H' ' 297' ' ' TYR . 9.3 p-10 -76.28 100.43 5.1 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.322 -0.399 . . . . 73.32 110.045 -178.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.412 ' HZ3' HG23 ' H' ' 301' ' ' ILE . 0.0 OUTLIER 163.41 -177.36 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 127.643 2.377 . . . . 75.32 109.731 156.5 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.553 ' HA ' ' HB3' ' H' ' 297' ' ' TYR . 0.0 OUTLIER -54.15 121.15 28.91 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.984 1.314 . . . . 72.13 114.175 -170.811 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.06 174.55 10.0 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.413 2.075 . . . . 75.34 110.816 163.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.57 103.23 6.45 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.481 -1.303 . . . . 73.53 107.481 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.72 141.13 14.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.864 -0.791 . . . . 74.43 108.864 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -132.65 130.85 40.7 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.355 -0.609 . . . . 72.12 109.355 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 pp -86.22 140.6 29.99 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.02 -1.104 . . . . 75.42 108.02 165.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.38 151.52 46.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.671 -1.233 . . . . 65.02 107.671 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.84 134.1 40.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.147 0.431 . . . . 75.44 110.171 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.452 ' HB2' ' HD2' ' B' ' 61' ' ' ARG . 7.8 m-20 -123.4 138.2 54.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.973 0.909 . . . . 71.02 109.06 173.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.2 p -109.62 146.75 34.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.207 0.603 . . . . 63.42 110.315 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.76 143.51 15.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.958 0.903 . . . . 70.35 108.933 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.2 p -141.75 160.93 39.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.895 0.316 . . . . 65.54 110.626 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.19 141.83 21.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.53 0.732 . . . . 71.24 110.446 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.44 121.83 30.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.438 0.695 . . . . 73.11 109.927 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 mt -94.17 -40.12 10.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 70.41 110.435 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . 0.533 ' HB2' ' HB ' ' B' ' 55' ' ' VAL . . . -162.69 -168.33 1.78 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.728 -1.124 . . . . 72.42 109.716 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.66 112.77 14.82 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.164 -0.925 . . . . 72.31 109.387 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 65.26 3.95 2.45 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.184 1.394 . . . . 73.43 112.745 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . 0.533 ' HB ' ' HB2' ' B' ' 52' ' ' ALA . 92.8 t -104.73 113.64 42.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.902 -1.148 . . . . 73.14 107.902 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.14 169.81 13.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.441 -0.8 . . . . 75.22 109.101 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -138.5 107.77 6.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.783 -0.821 . . . . 73.04 108.783 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.09 127.75 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.343 1.457 . . . . 65.2 109.577 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.69 132.29 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.888 0.875 . . . . 75.21 109.631 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' B' ' 103' ' ' PRO . 50.0 tp -124.5 118.3 26.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.942 -0.762 . . . . 75.54 108.942 171.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.452 ' HD2' ' HB2' ' B' ' 45' ' ' ASP . 28.9 ttm180 -84.17 133.22 34.61 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.127 -1.064 . . . . 74.11 108.127 169.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.97 116.58 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.193 -1.04 . . . . 74.53 108.193 169.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -104.98 146.43 29.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.808 1.243 . . . . 74.31 109.017 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.75 97.8 3.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 107.907 -1.146 . . . . 74.23 107.907 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.0 m -93.89 135.32 35.34 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.21 -0.663 . . . . 71.22 109.21 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.1 136.64 25.29 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.751 0.821 . . . . 63.41 108.887 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -147.66 130.3 15.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.154 0.582 . . . . 71.34 111.067 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.459 HD13 ' HB2' ' B' ' 34' ' ' LYS . 57.8 mt -98.99 104.85 16.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.374 1.069 . . . . 75.33 109.651 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.44 -110.23 3.2 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.908 -0.587 . . . . 71.32 111.643 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.94 4.71 14.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.73 0.812 . . . . 72.12 111.121 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.17 176.17 5.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.462 -0.569 . . . . 72.41 109.462 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 7.4 m -75.72 157.25 33.82 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.702 0.801 . . . . 71.14 110.34 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.449 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -110.18 -61.73 1.62 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.034 -0.728 . . . . 65.14 109.034 166.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -166.04 141.09 4.67 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.738 -1.119 . . . . 74.43 108.644 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.26 132.55 54.87 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.381 -0.97 . . . . 74.21 108.381 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.4 t -140.74 153.59 45.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.591 -0.892 . . . . 51.33 108.591 175.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.522 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.3 tt0 -166.18 141.59 4.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.134 -0.691 . . . . 75.54 109.134 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 86.2 t -129.45 146.29 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.257 -1.016 . . . . 75.4 108.257 173.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.577 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 49.2 mt-30 -122.54 96.93 5.23 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.96 -1.126 . . . . 72.03 107.96 171.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -92.85 106.85 18.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.877 -1.056 . . . . 72.14 108.811 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.34 171.58 35.34 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.632 -0.587 . . . . 73.02 111.632 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.83 126.99 1.54 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 112.056 -0.418 . . . . 70.02 112.056 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.423 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.8 mt -84.68 116.69 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.877 0.871 . . . . 73.42 109.038 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -124.0 146.83 48.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.467 1.107 . . . . 75.5 108.609 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 61.3 m -106.86 104.61 14.34 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.153 -0.684 . . . . 54.32 109.153 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -114.03 134.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.828 0.851 . . . . 73.32 109.693 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.69 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.5 167.9 29.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.522 1.129 . . . . 73.14 109.317 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.66 -50.21 4.32 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.323 0.389 . . . . 65.54 112.9 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -62.68 146.39 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.403 0.681 . . . . 72.12 111.504 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.3 178.46 6.21 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.731 0.813 . . . . 72.32 110.627 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -122.05 27.41 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 123.845 0.715 . . . . 63.05 113.536 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 92' ' ' THR . . . . . 0.469 HG23 HD12 ' B' ' 141' ' ' LEU . 4.7 m -78.3 -37.38 44.94 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.023 0.929 . . . . 74.42 110.569 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -76.03 -26.97 57.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.561 -0.745 . . . . 65.32 111.987 -166.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -66.11 -30.85 71.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.479 0.181 . . . . 74.55 110.693 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.52 75.72 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.868 0.73 . . . . 72.53 110.515 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -76.01 -32.4 59.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.451 0.3 . . . . 74.0 110.896 177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.47 -55.65 9.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.946 0.498 . . . . 75.4 110.629 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.75 -38.43 38.77 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.806 0.842 . . . . 73.2 110.0 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.47 ' HA2' ' CD1' ' H' ' 281' ' ' PHE . . . -86.68 -1.62 85.24 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.084 0.794 . . . . 55.25 115.084 -171.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.02 -56.88 0.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.909 0.855 . . . . 73.32 111.524 -177.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.87 -46.03 47.27 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.451 0.537 . . . . 74.21 112.451 -170.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -62.04 -46.34 91.68 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.503 -0.761 . . . . 50.11 112.988 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.464 ' HB2' HD22 ' B' ' 60' ' ' LEU . 59.4 Cg_endo -68.9 -22.2 36.54 Favored 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 121.889 1.726 . . . . 74.23 112.849 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -71.76 -30.49 65.63 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.407 0.683 . . . . 75.32 111.13 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.52 -48.16 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 75.25 110.986 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.63 -10.78 57.03 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.866 -0.606 . . . . 72.22 111.941 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -56.5 -47.6 98.64 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-O 117.895 -1.05 . . . . 73.54 113.656 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.03 -31.3 53.03 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.531 2.154 . . . . 70.14 114.323 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -74.06 -43.64 57.08 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.12 0.568 . . . . 65.44 110.515 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.92 91.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.105 0.562 . . . . 74.42 110.4 174.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.697 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 52.7 ttt-85 -51.35 -53.72 33.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.081 1.752 . . . . 74.43 112.215 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -70.59 -34.01 71.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.308 0.643 . . . . 75.31 110.703 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.543 ' SG ' HD13 ' B' ' 21' ' ' ILE . 7.6 t -71.13 -30.41 66.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.04 0.536 . . . . 62.45 111.446 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 63.7 mt -65.28 -52.18 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 109.525 -0.546 . . . . 75.0 109.525 173.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -60.06 -34.08 72.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.926 0.89 . . . . 75.24 111.854 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -57.98 -49.8 75.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.549 0.74 . . . . 75.32 110.493 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.431 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.0 mmt -72.22 -34.32 68.25 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.665 0.786 . . . . 74.24 111.563 -173.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.88 -37.19 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.776 0.83 . . . . 74.21 110.798 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 119' ' ' SER . . . . . 0.436 ' HB2' ' OE1' ' C' ' 125' ' ' GLN . 3.6 t -74.18 -30.85 62.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.628 0.771 . . . . 63.4 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' B' ' 116' ' ' SER . 87.6 mtt-85 -67.02 -30.09 70.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.326 0.65 . . . . 74.22 110.295 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.41 12.99 59.32 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-O 119.468 -0.629 . . . . 70.31 113.554 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 60.3 p 58.23 27.08 14.65 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.843 1.657 . . . . 75.25 113.364 177.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -91.8 165.26 21.0 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.07 0.948 . . . . 72.55 110.736 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.653 ' HG2' ' HA ' ' H' ' 297' ' ' TYR . 51.2 Cg_exo -59.55 177.48 0.44 Allowed 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.436 2.757 . . . . 70.15 115.696 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.749 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 67.3 tp60 -64.44 143.57 57.81 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.565 -1.198 . . . . 75.52 111.806 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 30.7 tp -134.77 93.02 2.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.998 -0.742 . . . . 74.41 108.998 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -92.86 98.89 11.67 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.46 -0.941 . . . . 74.22 108.46 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.697 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 42.8 tp -71.93 131.17 42.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.216 0.606 . . . . 73.35 109.764 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.25 151.5 56.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.835 0.854 . . . . 54.43 112.199 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -54.93 124.58 16.64 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.505 2.803 . . . . 75.12 113.297 171.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.61 112.64 40.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.633 -1.247 . . . . 75.13 107.633 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -79.94 83.44 5.85 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.657 -0.868 . . . . 71.45 108.657 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -62.05 -37.52 85.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.979 0.911 . . . . 72.32 111.125 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.42 -40.65 95.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.278 1.031 . . . . 72.11 111.649 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.37 -50.88 63.87 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.009 0.524 . . . . 71.11 111.223 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.32 -45.0 81.78 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.96 0.904 . . . . 72.41 110.934 -173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -71.14 -27.31 63.47 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.3 0.64 . . . . 71.31 111.226 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.462 ' SD ' ' HB3' ' B' ' 1' ' ' MET . 1.2 tmt? -62.89 -35.8 81.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.106 0.562 . . . . 72.41 110.518 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.43 HD22 ' HG3' ' B' ' 1' ' ' MET . 0.9 OUTLIER -75.78 -20.02 58.55 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.207 0.603 . . . . 75.04 111.023 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -75.22 -30.16 60.5 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.787 -0.449 . . . . 75.3 109.787 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . 0.469 HD12 HG23 ' B' ' 92' ' ' THR . 61.7 mt -99.92 31.41 3.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.704 0.802 . . . . 73.45 110.311 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -61.54 120.76 11.18 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.364 0.602 . . . . 74.11 111.515 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -161.85 171.83 17.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.115 1.366 . . . . 73.12 108.836 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -124.06 136.88 54.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.732 0.413 . . . . 73.44 110.262 -176.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.82 157.31 25.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.761 0.825 . . . . 75.4 111.458 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.72 -147.96 7.8 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.243 -0.743 . . . . 74.43 111.243 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.22 165.26 31.82 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.481 0.641 . . . . 73.33 111.109 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.4 43.31 1.33 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.915 -0.874 . . . . 72.44 110.915 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -76.63 158.57 30.98 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.445 0.698 . . . . 72.3 110.807 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.59 148.74 26.98 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.459 0.704 . . . . 74.4 110.379 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' B' ' 152' ' ' HIS . 23.6 tt0 -164.19 176.32 9.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.582 -0.896 . . . . 75.24 108.582 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . 0.507 ' H ' ' HG2' ' B' ' 151' ' ' GLU . 55.4 p-80 -62.88 106.62 0.84 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.446 0.698 . . . . 72.55 111.075 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -80.35 74.98 7.18 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.25 -1.018 . . . . 75.43 108.25 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -66.14 130.17 42.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.917 -1.038 . . . . 72.4 110.601 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 C-N-CA 123.956 0.902 . . . . 73.11 109.06 -175.819 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.519 -0.548 . . . . 72.1 109.519 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m 59.78 -170.44 0.14 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.281 1.032 . . . . 61.23 112.565 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.8 149.74 30.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.889 0.876 . . . . 74.23 109.078 176.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . 0.411 ' NE2' ' HG2' ' C' ' 8' ' ' GLU . 8.4 tt0 -84.76 110.97 19.19 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.475 0.31 . . . . 74.31 110.181 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -62.01 -46.98 86.84 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.384 -0.826 . . . . 75.41 109.578 164.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.7 p30 179.19 -17.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.599 1.159 . . . . 71.12 110.153 -178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 23.7 p -90.19 123.45 34.02 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.846 1.258 . . . . 75.15 111.76 -171.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . 0.485 ' HB2' ' HA ' ' C' ' 149' ' ' THR . 7.0 pt-20 -161.39 -45.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.962 0.505 . . . . 75.54 111.859 175.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' C' ' 8' ' ' GLU . 56.8 ttp 63.81 112.63 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.565 1.546 . . . . 73.33 111.508 -164.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.44 ' HB ' ' HB1' ' C' ' 87' ' ' ALA . 28.6 m -87.6 97.65 10.98 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.253 -1.017 . . . . 73.44 108.253 172.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -124.51 140.58 52.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.623 -0.717 . . . . 72.24 109.971 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.531 ' NE2' ' HB2' ' C' ' 85' ' ' SER . 0.1 OUTLIER -161.05 140.63 10.61 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 125.174 1.39 . . . . 75.34 107.491 172.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.59 130.25 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.249 -0.649 . . . . 71.31 109.249 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -95.24 -46.52 6.72 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.314 -0.624 . . . . 71.45 109.314 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' G' ' 302' ' ' ASP . 28.4 ttt85 -169.78 151.47 4.23 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.666 0.604 . . . . 71.23 110.741 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.74 133.91 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.949 1.3 . . . . 74.11 107.546 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.401 ' HB3' HG21 ' D' ' 122' ' ' THR . 20.0 p90 -171.0 157.05 5.1 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.433 0.635 . . . . 75.02 111.693 -172.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.0 p -85.8 108.37 18.07 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.469 -0.787 . . . . 65.51 109.433 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.413 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 13.0 mtmt -76.58 -35.95 57.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.441 0.639 . . . . 74.13 109.709 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.622 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.9 t70 -142.14 122.63 14.1 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.777 -1.102 . . . . 72.52 109.048 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.533 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -116.57 140.91 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.775 -1.565 . . . . 72.44 106.775 166.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -150.9 146.26 26.18 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.224 0.535 . . . . 72.21 110.203 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -152.43 109.8 3.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.491 -1.299 . . . . 74.43 107.491 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.7 116.27 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 75.12 108.551 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.01 89.78 10.16 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 106.914 -1.513 . . . . 73.24 106.914 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -49.99 0.92 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.595 2.196 . . . . 73.23 111.605 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.96 22.7 3.07 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 118.619 -0.705 . . . . 75.11 110.339 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.446 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -38.94 -53.3 3.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 115.524 1.676 . . . . 74.1 115.524 -171.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 2.7 Cg_exo -75.49 -39.41 1.06 Allowed 'Trans proline' 0 C--N 1.393 2.91 0 CA-C-N 121.472 1.561 . . . . 72.02 112.23 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -70.08 -26.23 63.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.643 1.177 . . . . 74.51 112.884 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -80.72 -22.71 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.754 0.422 . . . . 74.14 110.82 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.489 ' HA ' ' CH2' ' C' ' 36' ' ' TRP . 19.0 m-30 -62.87 -32.87 74.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.759 0.424 . . . . 71.41 111.38 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -86.24 6.28 30.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.052 0.541 . . . . 73.3 111.415 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.451 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 0.0 OUTLIER -100.4 144.08 29.82 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.39 0.676 . . . . 74.14 110.505 -179.041 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.62 122.59 15.08 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.921 0.888 . . . . 62.41 110.011 171.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.489 ' CH2' ' HA ' ' C' ' 32' ' ' PHE . 47.9 m95 -67.96 96.32 0.59 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.947 0.899 . . . . 71.23 112.147 -172.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -145.69 73.43 13.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.996 -0.547 . . . . 75.12 109.811 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -83.24 133.7 6.54 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.986 2.457 . . . . 72.54 112.41 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.7 91.66 8.36 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.253 -1.388 . . . . 73.44 107.253 167.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' C' ' 65' ' ' THR . 58.3 t -76.3 111.84 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.331 -0.849 . . . . 74.55 109.303 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.561 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 59.2 mttm -99.98 117.54 34.48 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.562 -0.903 . . . . 75.24 108.562 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.497 HD13 HD11 ' C' ' 128' ' ' LEU . 3.7 tt -86.6 122.34 30.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.333 -1.358 . . . . 73.43 107.333 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.47 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 18.9 m-20 -127.02 132.28 50.78 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.524 1.13 . . . . 71.21 109.13 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -128.45 124.47 36.28 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.943 0.897 . . . . 73.05 109.37 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.469 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 16.6 t70 -116.31 150.86 36.97 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.647 1.179 . . . . 70.43 108.902 172.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 41.7 p -130.78 118.38 20.74 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.834 0.854 . . . . 64.3 109.649 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.466 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -125.69 149.1 48.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.834 0.854 . . . . 72.34 110.206 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -154.38 153.46 31.64 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.237 0.615 . . . . 63.25 110.802 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 71.6 p -157.37 152.31 25.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.252 0.621 . . . . 62.03 110.573 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -89.36 119.53 29.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.647 0.779 . . . . 71.0 109.265 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.641 HD12 ' HB2' ' C' ' 57' ' ' GLU . 40.1 mt -95.87 -31.61 13.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.114 0.566 . . . . 73.25 110.342 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.514 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.49 -172.87 3.32 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.083 0.953 . . . . 71.34 109.687 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -77.23 119.33 20.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.594 0.757 . . . . 63.23 109.265 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 69.89 -3.17 1.79 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.714 1.605 . . . . 73.13 112.556 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.514 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 81.5 t -104.34 115.2 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.631 0.772 . . . . 75.03 109.536 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.8 125.53 33.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.805 0.842 . . . . 71.33 108.878 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.641 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.2 tt0 -81.77 123.84 29.12 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.392 -0.596 . . . . 75.33 109.392 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -102.65 115.74 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.881 -1.155 . . . . 62.13 107.881 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 61.2 t -104.8 132.19 52.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.845 -0.798 . . . . 74.54 108.845 172.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.7 102.34 10.16 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.936 -1.505 . . . . 74.14 106.936 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.469 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 30.0 ttm180 -83.34 125.7 31.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.788 -0.819 . . . . 74.42 108.788 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.4 t -115.52 131.41 67.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.442 -1.318 . . . . 74.12 107.442 172.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 24.1 m -127.85 125.45 39.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.292 -1.003 . . . . 75.42 108.292 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.579 HG23 HG21 ' C' ' 114' ' ' ILE . 50.3 t -120.37 115.1 46.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.026 -0.731 . . . . 74.25 109.026 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.561 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.1 m -99.29 148.39 24.2 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 109.425 -0.583 . . . . 72.24 109.425 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.09 106.81 4.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.071 -1.085 . . . . 72.24 108.071 171.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.8 m -135.9 127.49 28.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.081 -0.34 . . . . 74.51 110.081 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.428 ' N ' HD13 ' C' ' 68' ' ' LEU . 4.2 mp -86.78 56.43 4.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.365 1.466 . . . . 74.32 108.238 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.34 -108.19 3.45 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 109.728 -1.349 . . . . 74.41 109.728 -173.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -25.61 17.37 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.193 0.997 . . . . 71.43 109.318 168.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.451 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 18.6 tp10 -68.03 83.85 0.22 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.416 1.486 . . . . 73.41 110.884 -176.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.1 m -73.55 120.35 19.03 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 121.083 0.468 . . . . 73.01 111.136 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.429 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.79 -55.72 7.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.536 -1.211 . . . . 74.2 108.847 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -167.16 169.36 12.75 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.789 -1.096 . . . . 73.41 111.477 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.85 138.51 49.88 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 105.232 -2.136 . . . . 75.31 105.232 165.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.6 t -139.88 111.99 7.58 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.888 -0.782 . . . . 70.22 108.888 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.45 128.12 52.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.019 0.527 . . . . 72.03 109.907 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.84 114.5 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.836 0.854 . . . . 74.22 108.75 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.622 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -88.73 91.05 8.66 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.911 -1.144 . . . . 74.11 107.911 170.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -78.95 97.72 6.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.806 -1.088 . . . . 75.14 109.146 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.413 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -84.49 151.47 26.73 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.731 -0.668 . . . . 71.1 111.832 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD22 ' C' ' 106' ' ' LEU . . . -152.81 120.89 1.1 Allowed Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.823 -0.911 . . . . 63.32 110.823 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.51 HD11 ' HB3' ' D' ' 29' ' ' PRO . 17.7 mm -81.72 128.56 38.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.616 -0.883 . . . . 74.31 108.616 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -137.62 151.62 48.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.38 -0.97 . . . . 73.44 108.38 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.531 ' HB2' ' NE2' ' C' ' 12' ' ' GLN . 34.9 m -111.31 121.49 45.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.824 -0.806 . . . . 63.3 108.824 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.547 HG23 ' HG2' ' C' ' 94' ' ' MET . 3.9 mp -113.5 120.88 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.224 -1.399 . . . . 72.5 107.224 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . 0.44 ' HB1' ' HB ' ' C' ' 10' ' ' THR . . . -149.21 171.07 17.07 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.707 0.803 . . . . 63.01 110.326 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.51 -57.4 3.07 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.807 -0.633 . . . . 72.13 112.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.403 HG13 ' HA ' ' C' ' 9' ' ' MET . 2.6 pp -113.94 179.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.054 0.941 . . . . 71.3 111.013 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.44 -169.42 3.22 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.825 0.85 . . . . 75.24 109.706 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.73 -135.17 20.09 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.964 -0.353 . . . . 72.13 113.539 171.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -66.83 -28.6 68.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.767 0.827 . . . . 71.12 111.489 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -64.49 -43.13 95.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.202 0.601 . . . . 75.34 110.44 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.547 ' HG2' HG23 ' C' ' 86' ' ' ILE . 0.3 OUTLIER -72.73 -43.8 62.48 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.961 -0.563 . . . . 75.32 110.317 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.03 -30.94 71.97 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.433 0.693 . . . . 74.41 111.671 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -71.5 -41.81 68.81 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.657 0.783 . . . . 75.12 110.275 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.84 -40.63 91.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.83 0.452 . . . . 62.24 111.024 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.5 tp -73.67 -37.66 65.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.302 1.041 . . . . 70.05 110.875 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 -3.85 56.91 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 115.117 0.807 . . . . 71.22 115.117 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.3 -54.36 0.63 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.903 0.851 . . . . 61.11 112.052 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.625 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 15.7 t80 -71.84 -49.21 40.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.635 0.374 . . . . 74.42 111.978 -171.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.1 m -68.8 -44.06 29.81 Favored Pre-proline 0 CA--C 1.569 1.674 0 CA-C-O 118.726 -0.654 . . . . 74.14 112.041 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.459 ' HG3' ' HZ ' ' F' ' 281' ' ' PHE . 61.3 Cg_exo -56.85 -37.65 97.65 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 122.703 2.269 . . . . 74.44 113.865 170.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -56.84 -38.69 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.892 0.877 . . . . 74.44 110.927 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -73.16 -47.16 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.177 -0.919 . . . . 74.44 111.2 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.426 HD22 ' HA3' ' C' ' 82' ' ' GLY . 98.0 mt -79.11 -24.33 43.47 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.923 0.712 . . . . 74.21 112.923 -170.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.68 -53.13 66.03 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.244 1.018 . . . . 74.12 113.568 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.7 -31.15 49.83 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.788 1.659 . . . . 62.34 112.809 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -68.5 -38.52 81.04 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.241 0.616 . . . . 64.34 111.317 179.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.77 91.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.231 -0.441 . . . . 73.11 110.154 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -53.34 -59.89 3.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.084 0.954 . . . . 75.22 111.906 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . 0.435 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -65.27 -31.33 72.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 73.13 110.837 -172.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.498 ' SG ' HG12 ' C' ' 21' ' ' ILE . 47.5 t -69.09 -36.83 78.02 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.1 0.56 . . . . 71.32 111.457 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.579 HG21 HG23 ' C' ' 64' ' ' VAL . 96.7 mt -70.7 -50.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.638 0.775 . . . . 74.2 110.174 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.1 m -64.4 -29.14 70.21 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.574 0.749 . . . . 74.14 111.052 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 24.1 t -63.53 -49.94 71.53 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.596 0.758 . . . . 73.41 109.316 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.568 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.39 -40.34 82.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.569 1.148 . . . . 73.21 112.315 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 94.1 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.697 0.799 . . . . 74.43 109.852 176.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.445 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 41.4 t -65.92 -31.75 72.85 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.992 0.917 . . . . 62.3 112.188 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -73.98 -37.43 64.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.599 0.76 . . . . 74.45 110.817 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.18 6.08 64.77 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.469 0.481 . . . . 74.11 112.591 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.2 p 63.98 20.11 12.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.865 2.066 . . . . 73.23 113.145 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' F' ' 301' ' ' ILE . 71.1 m-85 -84.82 141.2 38.01 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.292 1.037 . . . . 62.11 108.987 173.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.749 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 84.3 Cg_exo -53.07 140.16 60.56 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.811 3.008 . . . . 70.41 116.854 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.445 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 9.1 mm-40 -56.45 117.06 3.47 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.601 1.56 . . . . 73.23 113.175 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 66.6 tp -119.57 125.41 48.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.996 0.918 . . . . 74.52 108.91 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -121.55 132.58 54.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 71.35 109.388 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.497 HD11 HD13 ' C' ' 42' ' ' LEU . 0.1 OUTLIER -71.5 138.43 48.93 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.581 0.753 . . . . 74.11 109.808 179.019 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.54 161.02 79.41 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.25 1.02 . . . . 72.34 110.833 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.797 ' HG2' HG22 ' A' ' 13' ' ' ILE . 35.0 Cg_exo -59.58 108.64 0.48 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.275 1.983 . . . . 73.04 112.563 177.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.48 108.52 21.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.526 -1.287 . . . . 74.12 107.526 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -91.34 99.37 12.35 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.004 -1.11 . . . . 74.3 108.004 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -64.36 -38.54 91.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.546 -0.752 . . . . 75.24 110.393 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.8 -40.75 80.66 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 70.35 112.0 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.45 -42.28 95.8 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.886 0.741 . . . . 63.55 111.562 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.03 -46.01 92.47 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.154 0.982 . . . . 74.13 110.226 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -75.79 -22.58 56.24 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.393 0.677 . . . . 74.34 111.888 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 27.0 ttt -76.36 -32.79 58.82 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.832 0.853 . . . . 72.52 110.254 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -56.87 -38.52 72.85 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.602 0.761 . . . . 64.24 110.281 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -70.04 -87.2 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.093 0.957 . . . . 75.33 110.798 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.18 141.44 51.74 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.097 0.959 . . . . 74.24 108.985 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -107.98 110.17 21.82 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.845 0.858 . . . . 73.25 110.219 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.1 137.87 32.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.408 -0.814 . . . . 64.12 109.914 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.579 ' H ' ' HG2' ' A' ' 147' ' ' GLU . 43.3 mt-30 -125.17 100.27 6.47 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.037 0.935 . . . . 74.42 108.598 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -173.92 158.42 3.18 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.944 1.298 . . . . 74.51 109.359 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.96 53.99 0.05 OUTLIER Glycine 0 N--CA 1.47 0.918 0 N-CA-C 111.242 -0.743 . . . . 65.55 111.242 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.11 -38.26 85.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.665 1.186 . . . . 72.42 111.551 -171.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.66 159.79 10.02 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.294 -0.867 . . . . 75.44 111.389 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.485 ' HA ' ' HB2' ' C' ' 8' ' ' GLU . 9.3 t -78.08 133.62 37.87 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.047 0.539 . . . . 73.44 109.71 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -175.79 104.49 0.08 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.768 -1.197 . . . . 73.23 107.768 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.13 96.19 0.8 Allowed 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 108.477 -0.934 . . . . 74.41 108.477 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -146.02 -69.39 0.27 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.481 0.712 . . . . 74.3 109.561 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 58.46 89.58 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.219 1.407 . . . . 72.1 112.002 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -86.15 -49.41 7.78 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.043 -0.526 . . . . 74.53 110.458 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 C-N-CA 123.52 0.728 . . . . 74.23 109.704 -175.66 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.906 -0.405 . . . . 72.01 109.906 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 16.2 p -167.78 144.78 4.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.088 0.955 . . . . 63.42 109.135 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -81.76 72.28 8.8 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.647 0.737 . . . . 74.3 111.775 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -71.04 91.92 0.92 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.494 0.664 . . . . 70.04 109.944 173.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -67.99 86.3 0.24 Allowed 'General case' 0 C--N 1.355 0.838 0 N-CA-C 108.53 -0.915 . . . . 73.3 108.53 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -158.55 171.41 20.18 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 125.267 1.427 . . . . 61.53 107.443 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.9 p -79.53 68.44 5.57 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.55 0.69 . . . . 71.21 110.023 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -69.44 -54.51 13.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.285 1.034 . . . . 70.01 108.802 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 7.6 ttp 18.65 121.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 128.187 2.595 . . . . 72.51 116.14 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 21.4 m -118.44 139.32 51.6 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.192 -0.67 . . . . 72.22 109.192 169.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.75 94.38 0.95 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.447 -1.316 . . . . 72.43 107.447 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.56 123.24 37.26 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.854 -0.795 . . . . 64.53 108.854 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.534 HD12 HG21 ' D' ' 105' ' ' ILE . 5.8 mt -82.16 119.32 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.206 -0.665 . . . . 62.54 109.206 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' F' ' 304' ' ' PRO . 74.8 mt-30 -86.3 -34.21 20.4 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.374 -0.376 . . . . 75.32 111.104 -173.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -179.74 133.61 0.11 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.672 0.607 . . . . 74.14 110.094 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.463 ' N ' HD13 ' D' ' 16' ' ' ILE . 2.2 mp -114.21 119.39 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.205 -1.776 . . . . 75.04 106.205 174.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -144.3 153.45 42.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 122.073 0.939 . . . . 74.22 110.16 -173.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -85.27 113.69 21.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.235 -1.348 . . . . 71.35 108.766 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.415 ' HZ2' ' CD ' ' D' ' 57' ' ' GLU . 37.9 mtpt -78.79 -30.95 45.82 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.156 0.503 . . . . 75.23 109.769 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.0 142.3 24.21 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.482 -1.236 . . . . 54.53 109.89 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.568 HG23 ' HE1' ' C' ' 117' ' ' MET . 69.3 mt -137.73 138.31 44.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.072 1.349 . . . . 74.01 107.96 173.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -139.4 136.82 35.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.301 1.04 . . . . 73.54 108.297 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.533 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -140.67 117.83 11.27 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.38 -1.711 . . . . 75.23 106.38 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.7 mt-10 -122.36 139.42 53.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.485 0.714 . . . . 74.32 109.158 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.29 79.91 72.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 106.906 -1.516 . . . . 73.21 106.906 173.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.25 -38.87 8.28 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.947 2.431 . . . . 65.55 113.036 -169.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -110.67 35.09 3.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.336 -0.987 . . . . 70.12 108.336 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.419 ' HB3' ' HD3' ' D' ' 29' ' ' PRO . . . -49.71 -66.53 0.6 Allowed Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 113.845 1.054 . . . . 74.11 113.845 -166.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.51 ' HB3' HD11 ' C' ' 83' ' ' ILE . 84.0 Cg_endo -74.69 -16.47 21.02 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 121.852 1.697 . . . . 74.12 112.653 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.46 -42.3 87.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.925 1.29 . . . . 64.44 110.26 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.06 -41.48 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.492 0.717 . . . . 73.21 110.594 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -67.25 -15.38 63.66 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 124.02 0.825 . . . . 72.5 112.571 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -86.09 -7.57 58.51 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.506 1.122 . . . . 75.13 112.703 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -127.31 114.62 17.82 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.678 1.191 . . . . 75.03 108.605 -172.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -98.42 95.26 7.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.428 1.013 . . . . 73.23 112.68 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.424 ' CH2' HD11 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -157.65 -179.54 8.26 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.859 0.864 . . . . 75.14 112.935 178.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -91.51 141.98 26.44 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 124.693 1.197 . . . . 73.32 112.185 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 67.0 Cg_endo -91.74 124.5 0.8 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.578 2.852 . . . . 75.43 113.389 -178.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.61 113.08 11.46 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.316 -0.994 . . . . 73.53 108.316 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -101.06 125.17 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.517 0.727 . . . . 74.44 110.498 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -109.56 144.33 38.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.1 0.96 . . . . 72.41 108.851 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tt -119.59 124.45 46.38 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.49 -0.93 . . . . 73.32 108.49 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.662 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -108.82 133.43 52.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.516 1.126 . . . . 75.03 108.805 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.62 130.95 55.59 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.973 -0.751 . . . . 74.41 108.973 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.69 146.44 43.78 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.815 0.846 . . . . 75.1 108.943 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -125.45 147.3 49.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.364 0.665 . . . . 70.22 110.651 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.42 ' HB1' ' HB ' ' D' ' 59' ' ' VAL . . . -150.42 164.02 36.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.745 1.218 . . . . 63.24 108.872 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -175.6 154.33 1.59 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.745 0.818 . . . . 63.23 110.708 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -165.76 138.79 4.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.368 0.667 . . . . 73.0 110.462 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.95 123.82 24.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.896 0.479 . . . . 74.13 109.926 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.32 -41.61 10.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.158 0.583 . . . . 64.35 110.593 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.22 -174.92 5.05 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.276 0.63 . . . . 73.53 110.541 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.59 111.4 3.6 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.209 -0.905 . . . . 71.45 109.87 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 67.37 21.61 9.7 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.415 1.086 . . . . 63.23 110.956 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 81.8 t -126.52 117.51 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.398 1.079 . . . . 74.22 108.614 176.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.549 ' HB2' HD12 ' D' ' 86' ' ' ILE . 54.1 m-85 -131.0 137.25 49.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.206 1.002 . . . . 74.02 108.503 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -92.24 136.24 33.35 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.832 0.853 . . . . 71.24 109.362 173.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -118.65 118.66 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.373 -1.343 . . . . 75.45 107.373 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.459 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 40.1 t -103.13 130.81 52.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.613 -0.884 . . . . 72.21 108.613 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -124.15 108.28 12.14 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.846 -1.168 . . . . 71.44 107.846 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.9 ttm180 -86.26 117.88 25.35 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.977 -0.556 . . . . 73.54 109.79 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.1 t -104.62 121.55 56.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.887 -1.153 . . . . 75.02 107.887 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.662 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -120.32 139.44 52.75 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.566 -0.531 . . . . 72.15 109.566 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 83.8 t -128.33 102.26 8.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 74.43 108.451 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.4 p -98.49 93.71 6.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.231 -1.026 . . . . 74.51 108.231 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.57 142.07 32.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.513 -1.221 . . . . 75.4 109.684 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 52.1 p -155.52 130.43 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 122.931 0.492 . . . . 62.3 110.717 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' D' ' 73' ' ' ALA . 0.2 OUTLIER -121.79 137.83 54.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.655 1.182 . . . . 71.43 109.461 177.214 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -113.43 4.0 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.392 0.433 . . . . 73.44 112.855 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.84 3.84 10.55 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.606 0.763 . . . . 74.45 110.288 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -130.69 173.5 10.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.144 0.578 . . . . 75.22 111.917 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 68.6 m -74.31 139.42 44.18 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.069 -0.969 . . . . 74.04 109.958 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.499 ' HB3' ' HG ' ' D' ' 68' ' ' LEU . . . -81.85 -70.66 0.53 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.802 -0.814 . . . . 54.12 108.802 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.54 139.78 18.48 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.155 -0.93 . . . . 72.23 109.552 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . 0.422 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 96.3 mt -105.82 109.0 20.81 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.065 -1.087 . . . . 74.32 108.065 174.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.595 ' SG ' HG21 ' D' ' 114' ' ' ILE . 48.9 t -125.36 114.4 18.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.311 -0.626 . . . . 65.22 109.311 -174.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.17 122.24 17.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.14 -0.689 . . . . 74.53 109.14 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.86 117.61 48.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.836 0.854 . . . . 73.44 109.215 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.29 86.72 6.9 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.239 -1.023 . . . . 72.11 108.239 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.97 94.88 6.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.667 -1.151 . . . . 73.11 109.32 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.77 146.43 19.93 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.431 -0.668 . . . . 65.32 111.431 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.426 ' HA3' HD23 ' D' ' 106' ' ' LEU . . . -145.47 131.82 4.36 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.912 -0.875 . . . . 60.22 110.912 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.478 HG22 HD13 ' D' ' 51' ' ' LEU . 42.5 mt -90.24 131.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.897 -0.779 . . . . 70.51 108.897 179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -132.51 139.93 48.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.24 0.616 . . . . 75.14 110.162 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -80.14 102.1 9.19 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 107.912 -1.144 . . . . 71.05 107.912 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.549 HD12 ' HB2' ' D' ' 56' ' ' TYR . 58.2 mt -106.6 110.31 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.378 -0.601 . . . . 75.24 109.378 -175.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.562 ' HB2' ' HB ' ' D' ' 10' ' ' THR . . . -152.73 165.1 36.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.285 1.034 . . . . 72.13 110.18 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.33 44.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.733 0.653 . . . . 74.4 114.733 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.469 HD12 HG22 ' D' ' 86' ' ' ILE . 28.8 pt -124.94 147.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.907 1.283 . . . . 62.44 108.503 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.37 177.55 11.32 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 74.22 110.95 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.95 -137.44 46.12 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 123.596 0.56 . . . . 63.42 113.782 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -80.21 -15.77 56.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.515 0.726 . . . . 72.22 111.655 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.85 -51.13 66.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.303 0.641 . . . . 72.44 109.802 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -73.32 -28.79 62.27 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.612 -0.722 . . . . 72.4 110.303 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.481 ' HA ' ' HA2' ' G' ' 279' ' ' GLY . . . -68.81 -32.66 72.53 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.831 0.453 . . . . 74.34 111.017 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -72.97 -40.68 65.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.807 0.843 . . . . 73.22 110.552 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -65.63 -44.66 85.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.267 0.627 . . . . 61.53 110.606 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.483 ' HB3' ' HE1' ' G' ' 281' ' ' PHE . 3.8 mm? -77.73 -20.18 53.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.078 0.951 . . . . 75.34 111.403 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 13.93 57.74 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.73 -0.483 . . . . 65.13 113.456 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.59 -64.04 0.09 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.031 0.416 . . . . 63.11 111.978 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -72.53 -48.96 36.12 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.418 0.687 . . . . 72.23 112.654 -167.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.41 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 59.9 m -63.58 -45.57 83.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.578 0.751 . . . . 71.3 112.506 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . 0.41 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 43.7 Cg_exo -61.88 -30.97 84.74 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.261 1.974 . . . . 73.54 113.439 171.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -66.54 -28.24 68.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.768 0.827 . . . . 75.23 110.755 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.534 HG21 HD12 ' D' ' 13' ' ' ILE . 40.9 mm -67.82 -46.4 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.222 0.609 . . . . 75.23 110.478 174.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.426 HD23 ' HA3' ' D' ' 82' ' ' GLY . 64.9 mt -76.99 -23.37 52.27 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.231 -0.895 . . . . 74.03 111.734 -170.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -66.08 -44.22 59.42 Favored Pre-proline 0 CA--C 1.569 1.7 0 N-CA-C 113.572 0.953 . . . . 74.42 113.572 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.85 -32.46 95.37 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.42 2.08 . . . . 72.03 113.725 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.09 -31.68 50.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.206 0.602 . . . . 74.25 111.232 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.64 -51.6 58.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.333 -0.618 . . . . 71.54 109.333 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.15 -49.42 69.29 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.752 1.282 . . . . 75.22 111.069 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.53 -45.86 91.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.196 0.935 . . . . 75.32 110.783 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.1 -45.13 87.75 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.801 0.688 . . . . 73.3 110.997 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.595 HG21 ' SG ' ' D' ' 76' ' ' CYS . 73.5 mt -64.57 -53.41 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.021 0.928 . . . . 75.31 110.786 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -53.91 -42.97 69.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.347 1.059 . . . . 72.31 111.564 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.8 t -67.77 -32.07 72.4 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.275 -0.875 . . . . 65.54 111.666 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.548 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 75.0 mtm -80.04 -36.05 36.28 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.668 0.387 . . . . 65.32 111.999 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.477 HG23 ' O ' ' D' ' 114' ' ' ILE . 47.4 t -67.14 -34.99 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 122.979 0.511 . . . . 71.24 110.025 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -69.42 -33.89 73.66 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.363 0.665 . . . . 72.14 111.27 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.8 mtt-85 -68.96 -34.14 74.86 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.282 0.633 . . . . 75.22 110.994 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.01 8.76 65.48 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.209 -0.45 . . . . 75.25 113.196 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.401 HG21 ' HB3' ' C' ' 17' ' ' TYR . 30.4 p 61.93 20.86 11.86 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.616 1.966 . . . . 75.11 113.567 175.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.429 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 47.9 m-85 -87.83 167.16 21.17 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.653 1.181 . . . . 73.32 107.862 165.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' G' ' 297' ' ' TYR . 72.9 Cg_endo -67.82 -166.5 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.614 2.209 . . . . 70.15 113.875 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -75.24 156.6 35.57 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.679 -0.691 . . . . 70.21 110.851 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.6 tp -127.61 95.23 4.18 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.456 -1.313 . . . . 72.43 107.456 164.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.642 ' HB3' HD12 ' B' ' 13' ' ' ILE . 78.6 m-20 -99.2 89.55 4.27 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.187 -1.042 . . . . 74.23 108.187 -175.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 123.06 17.32 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.172 -0.922 . . . . 73.5 110.687 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.67 124.04 86.31 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.641 0.776 . . . . 71.22 110.405 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.31 127.36 11.84 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.284 1.99 . . . . 62.31 111.692 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.49 133.85 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.801 0.84 . . . . 72.12 109.165 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -76.64 85.18 3.3 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.966 -0.753 . . . . 70.04 108.966 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -65.09 -33.45 76.06 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.744 -0.662 . . . . 74.32 110.791 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' D' ' 138' ' ' MET . 3.7 t70 -60.21 -57.63 11.98 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.604 1.161 . . . . 64.25 110.856 -173.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.33 96.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.292 1.037 . . . . 71.14 112.657 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 91.9 mt -70.17 -34.09 72.56 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.361 0.664 . . . . 75.21 111.704 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -65.77 -32.27 73.71 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.089 0.956 . . . . 71.55 111.027 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 48.3 mtt -61.27 -42.63 98.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.037 0.935 . . . . 71.35 111.032 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.58 -31.28 71.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.889 0.876 . . . . 71.1 111.759 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -69.71 -36.22 75.74 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.54 -0.755 . . . . 74.34 111.053 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.7 mp -68.86 -24.51 64.35 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.197 0.999 . . . . 71.43 112.205 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -71.29 2.56 4.59 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.984 0.914 . . . . 74.33 112.337 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -116.7 92.49 3.88 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.874 -1.158 . . . . 74.35 107.874 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -143.54 165.87 26.38 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.555 0.742 . . . . 74.11 110.203 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.14 145.4 29.55 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.089 0.555 . . . . 74.22 109.524 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.93 64.33 3.92 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.544 0.528 . . . . 62.01 111.923 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.1 130.73 43.06 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.17 -1.419 . . . . 72.31 107.17 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.72 58.58 0.43 Allowed Glycine 0 C--N 1.344 1.004 0 O-C-N 123.081 0.238 . . . . 70.23 112.802 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.0 p -66.63 96.85 0.41 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.909 0.385 . . . . 74.34 110.368 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.51 -39.96 9.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.76 0.824 . . . . 75.05 109.862 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 64.62 131.8 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.898 1.679 . . . . 73.55 113.867 170.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -117.38 147.12 42.94 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.484 1.113 . . . . 71.22 109.801 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.77 159.58 38.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.522 0.729 . . . . 71.01 110.618 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -116.21 164.68 14.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.049 0.94 . . . . 54.25 111.57 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 124.57 1.148 . . . . 72.32 108.572 173.849 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.965 -0.383 . . . . 74.24 109.965 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -84.4 132.46 34.58 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.24 0.616 . . . . 73.11 109.808 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -79.75 -58.44 3.18 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.078 -0.712 . . . . 74.31 109.078 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 58.38 -171.81 0.1 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.75 1.22 . . . . 72.4 111.757 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt 52.89 84.23 0.21 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.751 1.22 . . . . 75.33 111.401 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.63 103.05 0.37 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 121.755 1.637 . . . . 75.53 109.761 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tt -75.9 73.05 2.81 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.578 -1.267 . . . . 73.14 107.578 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 90.4 mt -142.64 -170.03 3.12 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 125.689 1.596 . . . . 72.45 108.17 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . 0.572 ' H ' HD12 ' A' ' 98' ' ' LEU . . . -106.35 -120.68 4.68 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 111.596 -0.602 . . . . 75.13 111.596 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.537 HD11 ' HA2' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -95.53 -117.59 0.11 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 118.414 -0.803 . . . . 71.42 110.77 177.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 76.93 -43.65 0.45 Allowed 'General case' 0 C--N 1.37 1.484 0 C-N-CA 125.946 1.699 . . . . 71.13 111.13 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.26 86.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.509 0.723 . . . . 74.34 110.686 168.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -125.72 173.22 9.18 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.007 0.923 . . . . 74.01 110.434 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 72.79 83.17 0.28 Allowed Glycine 0 C--N 1.349 1.257 0 O-C-N 123.919 0.762 . . . . 74.42 112.247 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -39.77 87.45 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.157 0.983 . . . . 64.2 110.862 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 5.8 tpt 64.68 93.73 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.642 1.177 . . . . 75.42 110.577 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.34 101.13 0.29 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.726 2.284 . . . . 74.41 111.806 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 90.7 t -82.73 -63.49 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.889 0.875 . . . . 74.11 110.32 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 66.05 145.88 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.224 1.41 . . . . 75.41 111.616 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.6 135.31 37.22 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.413 -0.588 . . . . 73.5 109.413 173.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.5 109.45 19.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.483 0.713 . . . . 74.4 109.716 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.35 -167.99 54.33 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 115.569 -0.742 . . . . 64.54 112.619 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.05 120.41 7.39 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.326 2.018 . . . . 75.42 111.471 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . 0.532 ' HD3' ' H ' ' E' ' 294' ' ' LYS . 0.0 OUTLIER -84.44 68.68 10.36 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.551 0.741 . . . . 71.03 110.783 -177.515 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . 0.554 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . . . -134.57 86.71 2.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.195 0.598 . . . . 74.43 110.946 -174.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 296' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 124' ' ' PRO . 25.7 m -66.35 -42.15 88.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.993 0.917 . . . . 74.33 112.447 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.589 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -75.66 140.16 42.38 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.617 0.767 . . . . 75.33 110.051 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -163.42 23.73 0.08 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.707 0.803 . . . . 75.24 110.143 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 110.23 -136.29 13.48 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.039 -0.867 . . . . 62.22 111.353 -170.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 8.3 t30 68.65 -67.79 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.685 1.594 . . . . 75.32 110.613 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 40.8 pt -78.87 23.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.913 0.885 . . . . 72.41 112.658 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.42 -65.85 0.59 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.682 1.593 . . . . 43.33 112.109 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -110.41 101.71 49.28 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.169 0.588 . . . . 75.42 110.372 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -91.9 5.92 3.55 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.1 2.533 . . . . 74.05 113.593 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.6 76.36 1.5 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.871 0.469 . . . . 73.31 110.419 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.42 -36.17 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.913 0.885 . . . . 75.14 111.826 -171.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 41.0 m -145.33 135.73 24.13 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.067 0.547 . . . . 75.3 110.536 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 77.2 m -104.04 85.47 2.4 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.906 0.882 . . . . 73.42 109.833 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 68.5 p -78.19 169.55 20.35 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 123.638 0.775 . . . . 71.15 110.206 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo . . . . . 0 C--N 1.381 2.286 0 C-N-CA 122.171 1.914 . . . . 74.43 112.468 167.659 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 110.466 -0.198 . . . . 71.21 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -101.52 -173.87 2.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.83 0.852 . . . . 63.51 110.133 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . 0.457 ' HG2' HE21 ' F' ' 274' ' ' GLN . 51.5 tt0 -159.86 -57.93 0.06 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.724 0.81 . . . . 73.44 109.039 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . 0.457 HE21 ' HG2' ' F' ' 273' ' ' GLN . 30.3 mm-40 -111.14 152.36 27.09 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.931 0.893 . . . . 61.12 110.263 -177.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . 0.561 ' HZ1' ' HB3' ' F' ' 275' ' ' LYS . 5.8 ttpm? -151.12 79.52 6.84 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.465 -0.939 . . . . 64.42 108.465 175.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.12 -16.46 17.79 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.137 2.558 . . . . 61.34 112.92 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.513 ' HA ' ' HG3' ' C' ' 94' ' ' MET . 49.8 mt -96.96 42.77 1.08 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.526 0.731 . . . . 74.44 110.707 -175.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . 0.532 ' HB3' ' HE2' ' F' ' 275' ' ' LYS . 0.3 OUTLIER -172.29 92.44 0.12 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 106.791 -1.559 . . . . 53.24 106.791 175.337 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -133.15 25.77 3.63 Favored Glycine 0 N--CA 1.478 1.444 0 CA-C-N 116.392 -0.367 . . . . 70.53 112.367 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 22.0 tp -163.82 167.5 20.74 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.051 -1.092 . . . . 71.1 108.051 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . 0.459 ' HZ ' ' HG3' ' C' ' 103' ' ' PRO . 2.6 m-85 67.74 -168.65 0.19 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.925 0.89 . . . . 73.13 111.004 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 64.91 97.78 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.705 1.202 . . . . 64.31 111.448 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 28.2 t70 63.61 42.01 6.76 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.665 1.186 . . . . 75.24 110.755 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -138.45 156.22 23.95 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 114.863 -1.062 . . . . 73.12 111.383 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -122.36 171.49 9.02 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.917 0.887 . . . . 74.55 110.061 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 286' ' ' MET . . . . . 0.415 ' HA ' ' HD3' ' F' ' 287' ' ' PRO . 90.7 mtp -125.6 136.9 28.96 Favored Pre-proline 0 N--CA 1.474 0.773 0 N-CA-C 108.57 -0.9 . . . . 70.24 108.57 172.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' F' ' 286' ' ' MET . 2.5 Cg_endo -82.62 44.93 1.79 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.397 2.731 . . . . 75.41 112.582 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 97.5 t -77.48 103.18 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.479 -0.934 . . . . 74.01 108.479 174.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 65.1 mtt-85 -98.0 -179.45 4.41 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.95 0.9 . . . . 72.23 109.463 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -69.22 155.44 40.39 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.343 0.592 . . . . 72.21 110.699 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.87 -7.32 57.36 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.882 -1.054 . . . . 71.54 110.305 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -140.28 -174.42 13.86 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.681 -0.968 . . . . 70.53 110.681 173.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.6 -61.62 0.12 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.828 2.352 . . . . 74.42 112.026 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -173.84 150.77 1.7 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.167 0.987 . . . . 74.11 109.543 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -173.78 87.86 0.06 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.768 0.827 . . . . 71.21 109.405 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 296' ' ' THR . . . . . 0.521 HG21 ' HD2' ' F' ' 297' ' ' TYR . 3.5 m -149.6 162.26 40.55 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.113 -0.699 . . . . 71.32 109.113 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.521 ' HD2' HG21 ' F' ' 296' ' ' THR . 2.2 m-85 71.02 -159.92 0.13 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.782 1.233 . . . . 73.02 110.786 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 71.15 17.03 6.17 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.192 0.997 . . . . 74.11 110.778 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.1 -127.81 5.7 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.966 -0.561 . . . . 75.32 112.577 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -106.34 110.49 22.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.783 0.833 . . . . 72.42 109.598 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' C' ' 123' ' ' PHE . 16.7 tt -162.71 152.45 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 124.244 1.018 . . . . 74.04 108.969 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 36.5 t70 70.31 -174.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.266 1.026 . . . . 72.45 110.283 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 80.15 137.2 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 126.098 1.759 . . . . 73.21 111.159 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . 0.5 ' HA ' ' HA ' ' D' ' 14' ' ' GLN . 55.3 Cg_endo -71.03 101.03 1.03 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.97 2.447 . . . . 75.15 111.578 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.4 -53.44 8.15 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.596 0.758 . . . . 63.44 111.603 -176.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . 0.64 HG12 HG23 ' F' ' 309' ' ' THR . 91.5 t -72.84 96.46 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.695 0.798 . . . . 70.12 109.762 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 40.2 p -129.67 -36.36 1.63 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.859 1.264 . . . . 71.44 110.252 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 43.6 t -88.54 -2.78 58.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.056 0.943 . . . . 73.5 112.059 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' F' F ' 309' ' ' THR . . . . . 0.64 HG23 HG12 ' F' ' 306' ' ' VAL . 6.2 t -141.14 149.92 57.05 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.989 0.916 . . . . 73.14 108.835 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 C--N 1.379 2.14 0 C-N-CA 122.182 1.921 . . . . 75.44 111.542 171.137 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.975 -0.38 . . . . 75.42 109.975 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -85.62 -57.37 3.08 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.615 0.766 . . . . 74.31 109.408 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -167.53 108.14 0.59 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.458 1.103 . . . . 72.43 108.972 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -169.74 150.29 3.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.528 0.731 . . . . 73.23 109.46 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . 0.449 ' HD2' ' N ' ' G' ' 275' ' ' LYS . 0.1 OUTLIER -76.45 107.92 5.45 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.322 -0.992 . . . . 74.54 108.322 176.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.77 -39.77 24.79 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.14 2.56 . . . . 63.53 112.727 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 97.2 mt -128.78 84.71 2.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.467 0.707 . . . . 74.42 110.704 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.34 17.45 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.939 0.896 . . . . 74.21 109.476 168.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' D' ' 95' ' ' ALA . . . 62.86 -106.92 1.43 Allowed Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.182 -0.463 . . . . 72.22 113.366 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.31 17.74 0.34 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.74 0.816 . . . . 74.11 110.684 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . 0.483 ' HE1' ' HB3' ' D' ' 98' ' ' LEU . 77.6 m-85 -64.45 -18.2 64.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.571 0.748 . . . . 75.21 112.274 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.95 79.0 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.899 0.88 . . . . 54.33 111.479 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -157.24 99.53 1.79 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.44 0.696 . . . . 63.12 109.296 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.19 111.41 0.24 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.39 -0.368 . . . . 64.54 112.816 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -139.28 162.8 34.11 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.219 1.408 . . . . 71.15 108.715 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 18.1 ptm -143.2 103.5 5.13 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 122.928 0.491 . . . . 75.05 109.948 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.55 108.48 1.85 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.651 2.234 . . . . 73.01 110.458 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 13.9 p -62.55 -31.16 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.318 0.647 . . . . 74.01 111.218 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 67.24 3.08 3.07 Favored 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 124.414 1.086 . . . . 75.43 112.196 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 87.6 m95 70.45 153.81 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.29 1.436 . . . . 71.1 111.459 -163.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.414 HD11 ' N ' ' G' ' 291' ' ' LEU . 3.0 mp -97.44 28.9 3.48 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.546 0.738 . . . . 75.51 109.795 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 89.34 83.53 1.31 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.311 -0.716 . . . . 70.05 112.423 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.14 153.34 46.29 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.626 2.217 . . . . 73.34 112.661 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -130.92 84.76 2.21 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.402 0.681 . . . . 75.14 109.217 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . 62.02 -172.32 0.15 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.916 0.887 . . . . 70.22 110.825 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 2.0 m -146.94 -32.18 0.31 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.284 -1.006 . . . . 71.03 108.284 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.554 ' HE1' HG12 ' G' ' 301' ' ' ILE . 3.5 p90 -153.61 169.38 23.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.671 0.789 . . . . 74.43 110.228 169.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -154.63 138.46 16.23 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.827 0.851 . . . . 75.24 108.823 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 121.83 -172.38 15.46 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 110.46 -1.056 . . . . 71.21 110.46 -174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.02 138.0 40.61 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.926 -0.398 . . . . 71.52 109.926 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.554 HG12 ' HE1' ' G' ' 297' ' ' TYR . 7.5 mt -78.55 -47.4 23.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.697 -0.853 . . . . 73.01 108.697 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . 0.492 ' HA ' ' NH1' ' C' ' 15' ' ' ARG . 7.0 p-10 -72.82 172.58 10.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.024 -1.443 . . . . 71.1 110.744 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -147.68 103.17 3.68 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.143 -0.688 . . . . 74.25 109.143 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.99 139.58 8.52 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.868 2.379 . . . . 75.25 112.171 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -170.12 -60.16 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.778 0.831 . . . . 71.34 110.154 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.446 HG22 ' HB1' ' A' ' 129' ' ' ALA . 42.1 t -95.92 108.58 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.406 0.682 . . . . 73.24 110.19 -174.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 6.2 p -111.96 121.06 43.98 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.362 -0.977 . . . . 65.23 108.362 171.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 22.8 t 59.63 -164.73 0.21 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.977 1.311 . . . . 54.02 110.42 -172.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 51.4 m -132.35 72.82 78.03 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 108.148 -1.056 . . . . 63.21 108.148 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . 0.403 ' HA ' HG21 ' C' ' 149' ' ' THR . 41.9 Cg_endo . . . . . 0 C--N 1.384 2.434 0 C-N-CA 123.321 2.681 . . . . 73.42 111.74 177.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.451 -0.574 . . . . 65.03 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 66.8 156.21 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.105 1.362 . . . . 72.15 113.445 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.72 124.04 48.14 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.724 -1.126 . . . . 74.13 109.098 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -114.89 129.73 56.76 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.764 -0.828 . . . . 74.2 108.764 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -124.49 86.04 55.56 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.87 0.868 . . . . 64.03 109.905 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . 0.407 ' HG2' ' O ' ' H' ' 278' ' ' LEU . 92.0 Cg_endo -88.67 -174.76 1.1 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.269 1.979 . . . . 73.33 111.129 165.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.77 32.63 1.59 Allowed 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.456 0.646 . . . . 73.41 109.822 175.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . 0.552 HD12 ' H ' ' H' ' 279' ' ' GLY . 0.4 OUTLIER -153.9 156.36 37.4 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 106.971 -1.492 . . . . 74.41 106.971 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . 0.552 ' H ' HD12 ' H' ' 278' ' ' LEU . . . 122.9 6.55 7.69 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.535 -0.626 . . . . 74.24 111.535 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 6.8 tt -138.86 161.88 36.18 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 107.332 -1.358 . . . . 73.21 107.332 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . 0.47 ' CD1' ' HA2' ' B' ' 99' ' ' GLY . 57.1 t80 74.24 75.6 0.12 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.072 0.949 . . . . 72.54 109.245 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -152.97 3.39 0.32 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.889 -1.05 . . . . 71.5 111.256 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -127.37 123.6 36.63 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.812 -0.81 . . . . 75.51 108.812 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.42 -84.49 0.11 Allowed Glycine 0 C--N 1.347 1.147 0 O-C-N 123.598 0.561 . . . . 73.15 112.045 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 71.69 -15.65 0.43 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.613 1.165 . . . . 75.35 113.452 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 63.9 mtt -61.72 107.41 1.12 Allowed Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.007 0.923 . . . . 71.44 111.366 -167.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.23 61.44 2.37 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.174 2.583 . . . . 73.01 110.962 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.22 117.71 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.735 -0.839 . . . . 72.2 108.735 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -87.36 43.65 1.12 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.923 0.889 . . . . 73.41 109.757 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 4.2 m95 64.36 175.16 0.19 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.702 1.201 . . . . 61.21 112.546 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 78.3 mt -130.53 43.43 3.11 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.732 -1.577 . . . . 74.4 107.546 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -170.11 -172.25 36.39 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 115.242 -0.89 . . . . 72.23 113.501 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.34 -10.79 27.35 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.666 2.911 . . . . 54.04 114.853 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . 0.452 ' HZ3' ' HB2' ' H' ' 294' ' ' LYS . 10.3 mtmp? 59.32 22.84 11.23 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.583 1.153 . . . . 74.33 111.477 -175.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -131.36 65.43 1.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.627 1.171 . . . . 63.23 108.831 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 84.2 m -63.53 -45.57 89.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.19 0.996 . . . . 74.53 111.862 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.653 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 0.8 OUTLIER -84.49 69.3 10.54 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.78 1.232 . . . . 71.43 109.796 -175.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -72.4 -82.2 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.908 -0.587 . . . . 75.41 109.89 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -158.58 19.5 0.31 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-O 119.536 -0.591 . . . . 64.23 113.791 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -87.59 63.61 7.67 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.291 1.043 . . . . 71.12 108.52 170.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . 0.412 HG23 ' HZ3' ' B' ' 36' ' ' TRP . 14.4 tt -116.16 -24.32 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.924 1.29 . . . . 74.41 107.66 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.55 91.93 1.87 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.463 -1.244 . . . . 73.44 108.925 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -97.21 144.21 27.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.317 -1.364 . . . . 74.3 107.317 165.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.1 79.13 2.09 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.177 1.918 . . . . 63.43 110.356 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -71.83 172.76 9.27 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 114.555 -1.202 . . . . 73.43 110.365 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . 0.599 HG12 HE22 ' A' ' 12' ' ' GLN . 48.7 t -64.96 97.76 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 109.32 -0.622 . . . . 71.04 109.32 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 25.0 m -72.85 -49.18 31.7 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.31 -0.996 . . . . 73.31 108.31 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 42.2 t -172.61 119.69 0.38 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.215 -1.357 . . . . 71.54 108.472 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' H' H ' 309' ' ' THR . . . . . 0.571 HG21 HG11 ' H' ' 306' ' ' VAL . 11.7 p -78.99 149.62 73.78 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.19 0.596 . . . . 73.12 110.019 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 C--N 1.378 2.101 0 C-N-CA 123.037 2.492 . . . . 70.51 111.455 173.763 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 108.608 -0.886 . . . . 74.43 108.608 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 m 61.0 78.68 0.28 Allowed 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.257 0.973 . . . . 75.04 111.395 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.31 67.42 8.32 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.259 0.624 . . . . 74.13 110.082 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -156.7 113.3 3.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.752 -1.203 . . . . 73.41 107.752 171.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.452 ' HB2' ' HG2' ' A' ' 93' ' ' GLN . 29.9 p30 -166.43 -12.14 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.472 -0.786 . . . . 75.44 111.416 -169.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -101.28 97.59 8.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.962 0.905 . . . . 74.33 110.759 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -120.2 -71.26 0.74 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.79 0.836 . . . . 72.43 108.957 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -164.18 175.06 10.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.567 1.147 . . . . 72.42 108.987 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 90.6 mtp -136.33 150.44 48.86 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.891 0.477 . . . . 74.14 110.643 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.55 ' HB ' ' HB1' ' A' ' 87' ' ' ALA . 96.8 m -142.25 126.32 17.37 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.291 1.036 . . . . 71.23 108.483 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.665 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.1 t80 -139.63 135.56 33.43 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.717 0.636 . . . . 74.22 110.511 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -154.44 126.16 7.58 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.528 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.9 mt -81.32 113.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.604 -0.887 . . . . 74.2 108.604 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.416 ' HB3' HG21 ' A' ' 83' ' ' ILE . 41.5 tp60 -79.13 -31.05 43.98 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.16 0.913 . . . . 75.5 109.771 -178.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -173.25 143.64 1.12 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.361 0.664 . . . . 72.23 110.293 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.63 140.2 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.788 0.835 . . . . 74.3 109.161 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.567 ' HB3' HG23 ' B' ' 122' ' ' THR . 23.7 p90 -173.63 175.68 2.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.955 0.902 . . . . 75.31 110.495 -169.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.1 p -100.15 119.54 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.725 0.81 . . . . 60.23 109.009 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -84.48 -32.75 23.82 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.5 0.32 . . . . 72.14 110.405 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -148.93 139.44 22.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.695 -0.684 . . . . 73.41 109.641 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.443 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 89.2 mt -138.42 139.5 41.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.398 -1.704 . . . . 72.14 106.398 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 t -154.85 110.21 3.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.711 0.632 . . . . 71.44 109.636 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.551 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 74.1 t80 -110.54 113.65 26.45 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.268 -1.382 . . . . 73.32 107.268 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.44 118.27 31.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.21 0.604 . . . . 74.14 109.748 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.61 78.77 0.93 Allowed Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 107.271 -1.381 . . . . 74.45 107.271 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 -39.03 34.24 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.814 2.343 . . . . 70.11 112.464 -166.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.401 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 7.2 m-20 -106.85 48.32 0.84 Allowed 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.998 -1.482 . . . . 74.54 106.998 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.491 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -54.39 -62.13 4.47 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.503 -1.237 . . . . 62.33 111.499 -176.059 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.491 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 16.7 Cg_exo -64.59 -21.95 65.2 Favored 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 121.578 1.599 . . . . 73.32 113.23 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 1.9 t60 -81.44 -55.78 4.47 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.489 0.715 . . . . 73.42 110.118 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 73' ' ' ALA . 5.0 p -67.99 -18.22 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.85 0.86 . . . . 74.13 111.626 -165.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 -62.87 -27.03 69.07 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.281 1.032 . . . . 74.23 112.718 176.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -96.83 -12.93 22.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.085 0.402 . . . . 74.55 112.085 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.505 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.4 tmtp? -74.59 141.62 44.72 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.213 0.605 . . . . 75.13 109.838 -173.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.505 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 25.1 t70 -51.03 128.16 20.79 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.408 1.483 . . . . 60.3 112.348 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 51.8 m95 -78.11 90.4 4.24 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.019 0.825 . . . . 74.22 111.262 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -139.94 78.22 25.04 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 114.651 -1.159 . . . . 74.21 108.446 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.52 121.36 3.36 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.828 2.352 . . . . 63.35 112.662 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -96.39 95.39 8.02 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.006 -1.479 . . . . 74.42 107.006 171.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 65' ' ' THR . 20.0 t -84.27 97.94 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.318 -0.855 . . . . 74.42 110.075 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.486 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 55.8 tttm -82.53 125.83 31.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.626 0.77 . . . . 73.34 110.418 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -111.43 115.59 29.51 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.596 -0.89 . . . . 72.25 108.596 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.694 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -106.75 129.67 54.59 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 74.4 109.165 173.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -113.96 116.31 29.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.967 -0.753 . . . . 75.21 108.967 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -132.99 153.93 51.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.81 0.844 . . . . 75.44 109.292 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -151.43 163.47 38.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.322 0.649 . . . . 74.11 110.883 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -164.26 154.42 14.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.154 0.982 . . . . 71.21 109.838 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.5 p -131.16 159.85 36.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.97 0.35 . . . . 73.53 111.21 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -150.53 128.51 11.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.736 0.815 . . . . 72.44 109.46 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.54 110.74 12.58 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.05 -0.722 . . . . 72.23 109.05 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.436 HD12 HG22 ' A' ' 83' ' ' ILE . 74.1 mt -94.54 -38.67 10.78 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.78 -0.646 . . . . 74.14 109.571 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB1' ' HB ' ' A' ' 55' ' ' VAL . . . -151.62 -179.51 7.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.733 0.813 . . . . 55.32 110.042 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -73.3 126.52 30.31 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.846 -0.798 . . . . 54.33 108.846 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 68.78 1.78 3.22 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.318 1.447 . . . . 61.2 112.258 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.533 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 94.5 t -115.68 107.33 22.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.883 -0.784 . . . . 72.14 108.883 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.629 ' HB2' HD11 ' A' ' 86' ' ' ILE . 76.0 m-85 -126.85 126.87 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.184 -1.414 . . . . 74.53 107.184 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -84.47 133.1 34.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.191 -1.04 . . . . 75.34 108.191 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -113.06 127.06 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.343 -1.354 . . . . 73.43 107.343 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.493 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.2 t -100.65 138.02 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 172.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.63 109.35 12.0 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -95.31 124.02 39.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 74.2 110.326 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.74 132.14 57.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.409 -1.33 . . . . 74.24 107.409 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.9 m -120.29 121.46 38.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.037 -0.727 . . . . 72.41 109.037 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.438 HG22 HG21 ' A' ' 114' ' ' ILE . 50.1 t -114.72 106.65 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.532 1.133 . . . . 75.42 108.679 -174.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 11.6 m -105.94 145.52 31.2 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 108.04 -1.096 . . . . 65.12 108.04 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.87 103.88 7.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.252 -1.388 . . . . 74.2 107.252 168.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 36.0 m -108.09 124.16 49.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.98 0.419 . . . . 71.0 109.992 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD12 ' HB1' ' A' ' 73' ' ' ALA . 5.8 mp -100.52 80.54 2.23 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.658 -1.608 . . . . 74.43 106.658 175.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -117.81 5.46 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.212 -1.155 . . . . 73.4 110.212 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.09 -26.31 22.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.397 0.679 . . . . 73.33 109.972 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.1 100.35 11.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.24 0.616 . . . . 72.24 111.061 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.3 m -72.53 133.85 44.96 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 120.923 0.392 . . . . 75.25 110.298 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.462 ' HA ' HG13 ' A' ' 31' ' ' VAL . . . -77.5 -63.48 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.645 1.178 . . . . 73.02 110.183 177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -149.2 162.96 38.97 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.591 -1.186 . . . . 71.5 110.689 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 14.0 tp -141.29 140.6 33.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.613 -1.625 . . . . 71.32 106.613 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.477 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 16.3 m -145.51 99.08 3.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.186 -0.672 . . . . 72.11 109.186 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.01 116.68 29.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.661 -0.866 . . . . 74.41 108.661 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.49 110.39 20.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.715 0.806 . . . . 71.34 109.392 -174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -84.85 89.21 7.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.302 -0.999 . . . . 73.13 108.302 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -76.71 97.21 4.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.118 -0.697 . . . . 75.52 109.118 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.3 143.25 16.81 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.552 -0.619 . . . . 73.21 111.552 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.47 122.91 2.15 Favored Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.44 -1.064 . . . . 73.21 110.44 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.436 HG22 HD12 ' A' ' 51' ' ' LEU . 43.5 mt -80.12 116.33 24.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.656 -1.238 . . . . 73.05 107.656 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.665 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -122.38 158.57 29.36 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.281 0.632 . . . . 73.15 109.416 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 42.8 m -104.57 98.76 8.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.226 -1.028 . . . . 65.24 108.226 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 56' ' ' TYR . 3.9 mp -97.46 124.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.739 -1.208 . . . . 72.42 107.739 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.55 ' HB1' ' HB ' ' A' ' 10' ' ' THR . . . -162.04 151.93 16.55 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.772 0.67 . . . . 43.13 110.714 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.55 -33.24 6.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.334 -0.848 . . . . 64.14 113.081 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.482 HD11 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -116.67 147.5 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.339 0.656 . . . . 54.43 111.467 -168.486 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.52 173.88 10.85 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.226 -0.897 . . . . 45.51 110.708 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -114.46 5.79 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.639 1.212 . . . . 71.45 115.011 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -65.42 -42.54 92.38 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.019 0.928 . . . . 61.0 111.551 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.452 ' HG2' ' HB2' ' A' ' 5' ' ' ASN . 82.9 mm-40 -70.39 -36.91 74.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.226 0.611 . . . . 73.12 111.042 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -65.19 -44.03 89.7 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.368 0.667 . . . . 74.43 109.799 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.83 88.74 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.044 0.938 . . . . 74.3 111.243 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -74.07 -31.09 62.7 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 65.14 110.79 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.76 -44.36 70.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.336 0.589 . . . . 74.51 110.055 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.34 -44.28 37.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.876 -1.056 . . . . 72.12 111.403 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.36 62.42 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.434 0.933 . . . . 72.12 115.434 -167.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.67 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -149.63 -61.23 0.21 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.708 0.754 . . . . 75.41 112.055 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.448 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.1 t80 -61.75 -59.33 5.32 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 74.21 112.625 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.41 -36.5 4.75 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 118.557 -0.735 . . . . 74.41 112.951 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.48 -40.96 45.1 Favored 'Trans proline' 0 C--N 1.387 2.59 0 C-N-CA 123.089 2.526 . . . . 75.34 114.287 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -60.04 -35.33 74.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.942 0.897 . . . . 74.44 111.108 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.8 mm -68.15 -42.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.638 0.775 . . . . 75.42 110.145 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.61 -33.09 60.51 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.582 -1.19 . . . . 72.12 112.547 -172.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.65 -43.76 96.14 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.032 1.123 . . . . 72.43 114.032 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.06 -38.23 96.34 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.483 2.122 . . . . 72.1 113.73 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HH ' ' HB3' ' C' ' 130' ' ' PRO . 50.3 m-85 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.494 0.718 . . . . 75.32 111.845 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.52 87.28 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.728 0.411 . . . . 75.03 110.16 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.421 ' NH1' HD13 ' C' ' 105' ' ' ILE . 33.2 ttm180 -54.07 -52.43 60.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.637 1.175 . . . . 73.13 110.477 176.269 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -62.98 -46.13 89.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.809 0.844 . . . . 71.34 111.141 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 40.5 t -55.16 -47.12 75.59 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.855 0.722 . . . . 63.14 110.469 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -60.69 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.918 -1.037 . . . . 63.32 110.371 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.574 HG21 ' HG3' ' A' ' 125' ' ' GLN . 99.3 m -52.41 -46.66 66.41 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 124.248 1.019 . . . . 71.54 112.18 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.04 -44.04 85.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.061 -0.972 . . . . 74.41 109.848 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 mtp -58.87 -42.08 88.61 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.785 0.834 . . . . 75.02 111.206 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.4 t -59.96 -49.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.788 0.835 . . . . 75.33 110.307 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.0 p -69.25 -28.97 66.79 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.866 0.467 . . . . 64.12 112.135 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -66.49 -28.34 68.49 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.813 0.845 . . . . 74.12 111.235 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.04 11.85 61.56 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.478 -0.623 . . . . 62.04 114.053 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.422 ' HB ' HH21 ' B' ' 15' ' ' ARG . 3.8 m 65.62 16.11 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.0 1.32 . . . . 74.42 111.192 -175.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -88.21 141.23 30.81 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.736 -0.838 . . . . 74.44 108.736 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 144.4 84.71 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.14 2.56 . . . . 73.11 112.71 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.574 ' HG3' HG21 ' A' ' 115' ' ' THR . 33.8 tt0 -53.71 138.85 34.21 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.352 1.033 . . . . 65.43 111.958 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.46 114.92 18.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.632 -0.713 . . . . 74.4 109.398 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -112.0 118.89 36.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.462 -1.31 . . . . 74.3 107.462 172.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.36 122.64 20.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.274 -0.639 . . . . 65.54 109.274 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.18 134.91 94.75 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 123.399 0.437 . . . . 72.41 110.913 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.0 106.62 0.8 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.783 2.322 . . . . 64.24 111.975 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.15 117.77 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.716 -1.216 . . . . 73.34 107.716 175.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -80.98 73.22 8.03 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.668 0.747 . . . . 72.22 110.628 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -67.2 -33.75 76.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.78 -1.1 . . . . 74.52 108.997 169.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.67 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 4.4 p-10 -60.19 -43.16 96.11 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.328 -1.306 . . . . 75.53 111.654 176.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.75 -38.73 67.27 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.474 0.71 . . . . 72.4 110.594 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.475 HD22 ' HG2' ' E' ' 286' ' ' MET . 8.9 tt -55.25 -52.86 62.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.398 1.061 . . . . 74.43 109.988 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . 0.462 ' HB2' ' SD ' ' E' ' 286' ' ' MET . 10.9 t80 -69.04 -23.45 64.06 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.607 -1.178 . . . . 73.35 110.883 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -46.4 19.37 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.681 0.792 . . . . 75.35 111.291 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -71.06 -19.77 62.45 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 120.879 0.371 . . . . 63.11 111.206 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -82.98 -30.59 28.09 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.531 0.732 . . . . 72.23 110.345 170.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 26.5 tp -63.48 -51.27 66.32 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.318 1.047 . . . . 73.22 112.848 -173.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -158.29 22.06 0.24 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.385 0.674 . . . . 74.33 109.563 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.46 ' HG3' ' HG3' ' C' ' 144' ' ' GLN . 18.6 tp60 68.69 -70.52 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.875 1.27 . . . . 73.54 110.354 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.418 ' HB2' ' HG2' ' C' ' 144' ' ' GLN . 1.1 mm-40 -171.79 168.34 6.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.982 1.713 . . . . 72.11 108.547 170.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.16 -59.79 0.31 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.381 -0.97 . . . . 74.24 108.381 176.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.42 -146.3 50.22 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 114.954 -1.021 . . . . 73.21 112.866 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 63.61 109.06 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.451 1.501 . . . . 73.52 110.412 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.11 60.53 0.54 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.869 -0.892 . . . . 61.15 110.869 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.6 m -77.71 -59.17 2.89 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.6 0.76 . . . . 74.41 110.546 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 57.49 87.61 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.509 1.123 . . . . 75.25 111.598 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.62 120.98 3.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.695 -0.854 . . . . 74.11 108.695 176.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -166.21 28.7 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.72 0.808 . . . . 71.22 110.14 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.78 107.76 2.71 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.297 0.57 . . . . 74.21 110.521 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -110.28 141.98 42.52 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.41 1.084 . . . . 73.04 109.773 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.5 0 O-C-N 124.068 0.855 . . . . 71.14 110.541 178.33 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.637 ' HG2' ' HA ' ' D' ' 141' ' ' LEU . 66.0 mtm . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.501 -0.926 . . . . 74.33 108.501 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.56 ' HB3' ' HG2' ' B' ' 4' ' ' GLN . 23.1 t -165.18 175.76 9.03 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.977 -0.749 . . . . 71.31 108.977 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -16.03 61.5 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.859 0.464 . . . . 73.21 111.21 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.56 ' HG2' ' HB3' ' B' ' 2' ' ' SER . 20.9 pt20 -74.35 164.45 26.58 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.489 1.115 . . . . 72.23 111.993 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -137.42 178.96 6.7 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.364 -0.835 . . . . 74.52 108.913 169.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.95 177.88 8.98 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.224 0.61 . . . . 74.41 109.698 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 53.6 p -63.45 118.81 8.64 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.416 -0.587 . . . . 64.55 109.416 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -86.69 34.25 0.65 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.574 1.15 . . . . 63.35 110.256 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.555 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 10.1 ptt? 51.48 -170.05 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 126.811 2.044 . . . . 75.41 113.347 -172.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.598 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 99.6 m -155.39 108.64 2.78 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.185 -1.413 . . . . 74.31 107.185 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -121.69 143.46 49.33 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.298 -0.63 . . . . 74.15 109.298 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.596 ' NE2' ' HB ' ' E' ' 306' ' ' VAL . 0.0 OUTLIER -156.15 132.18 9.88 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.6 -0.889 . . . . 73.33 108.6 175.577 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.464 HG23 ' HE2' ' B' ' 84' ' ' PHE . 1.8 pp -76.4 104.33 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 122.112 0.958 . . . . 73.41 108.842 173.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . 0.416 ' HG3' ' OG ' ' B' ' 85' ' ' SER . 1.4 tm0? -76.71 -36.37 57.24 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.963 -0.754 . . . . 61.01 108.963 -170.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.422 HH21 ' HB ' ' A' ' 122' ' ' THR . 21.8 ttt180 -168.06 140.08 2.97 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 124.036 0.835 . . . . 75.11 109.199 173.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.0 mt -124.82 134.38 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.597 -1.26 . . . . 73.32 107.597 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.412 ' HE2' ' HB1' ' A' ' 28' ' ' ALA . 30.9 p90 -166.27 157.39 13.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.576 0.547 . . . . 74.21 111.813 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -83.0 127.9 33.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.407 -0.815 . . . . 71.55 109.039 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.535 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 25.4 mtpp -93.51 -41.05 9.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.549 -0.75 . . . . 75.33 110.095 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 14.5 t70 -152.4 145.63 24.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.827 -0.624 . . . . 74.34 111.4 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.794 HD12 ' SG ' ' B' ' 113' ' ' CYS . 46.8 mm -140.02 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 C-N-CA 125.291 1.437 . . . . 73.23 108.411 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.48 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -146.22 134.9 22.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.454 1.101 . . . . 74.45 108.325 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.443 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -148.2 120.14 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.061 -1.459 . . . . 75.44 107.061 170.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -119.08 142.91 47.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.153 -1.055 . . . . 72.34 108.153 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.401 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -139.25 77.59 29.82 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.635 -1.246 . . . . 74.11 107.635 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.62 -40.4 10.22 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.902 2.401 . . . . 74.43 112.509 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -109.03 21.06 17.69 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.255 -0.884 . . . . 74.11 110.072 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.401 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -45.44 -48.88 35.24 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 115.524 1.676 . . . . 72.01 115.524 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -74.93 -38.44 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.539 2.16 . . . . 74.1 112.256 176.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 37.8 m80 -90.09 -4.98 57.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.147 0.795 . . . . 65.31 113.147 -171.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.439 HG22 HD12 ' B' ' 68' ' ' LEU . 7.6 p -69.99 -18.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.115 0.566 . . . . 75.32 111.082 -175.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -66.47 -14.95 62.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.645 0.778 . . . . 73.34 111.865 -178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.516 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -69.15 -37.3 78.18 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.602 -0.518 . . . . 75.41 109.602 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.516 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.6 mttt -110.75 62.46 0.61 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.615 -0.883 . . . . 72.43 108.615 172.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -88.17 98.44 11.56 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.03 -0.419 . . . . 73.24 110.662 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 172.36 -174.96 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.244 1.417 . . . . 72.33 111.429 163.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.537 ' HA ' ' HB2' ' H' ' 297' ' ' TYR . 29.4 pt20 -49.03 110.1 1.41 Allowed Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.464 1.506 . . . . 65.35 113.494 -169.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.51 165.84 16.0 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.688 2.259 . . . . 71.54 110.836 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.86 104.46 4.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.205 -1.406 . . . . 75.22 107.205 169.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.65 143.53 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.164 -1.05 . . . . 71.05 108.164 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -138.96 116.75 11.5 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.231 0.612 . . . . 73.31 109.909 -170.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -86.78 125.72 34.13 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 74.44 108.55 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.473 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -133.83 107.41 7.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.814 -1.18 . . . . 65.01 107.814 177.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.39 127.37 53.52 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.72 -0.844 . . . . 63.21 108.72 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.49 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.1 t70 -123.14 136.91 54.98 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.801 -1.185 . . . . 73.11 107.801 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -109.19 115.05 29.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.325 0.65 . . . . 75.2 110.998 -168.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.522 ' HB1' ' HB ' ' B' ' 59' ' ' VAL . . . -119.63 144.57 47.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.909 0.884 . . . . 73.22 109.161 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.8 p -145.14 163.21 35.04 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.375 0.67 . . . . 75.51 109.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -151.26 167.28 28.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.525 0.73 . . . . 74.53 109.804 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -113.42 112.61 23.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.885 -0.783 . . . . 73.12 108.885 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.49 -40.21 23.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.894 0.477 . . . . 75.42 110.035 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.78 -173.32 4.32 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.28 -0.873 . . . . 74.32 110.706 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.2 106.62 0.45 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.645 -1.162 . . . . 75.35 109.73 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 73.49 5.22 4.94 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.197 1.399 . . . . 71.12 112.209 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.81 113.07 39.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 107.958 -1.127 . . . . 73.45 107.958 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -122.5 140.76 52.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.22 0.608 . . . . 71.15 110.119 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.605 ' HG2' HG12 ' B' ' 83' ' ' ILE . 3.9 tm-20 -108.15 98.31 7.88 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.58 -1.267 . . . . 74.12 107.58 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -93.96 119.87 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.703 1.201 . . . . 62.41 110.236 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.522 ' HB ' ' HB1' ' B' ' 47' ' ' ALA . 21.8 t -107.13 139.21 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.204 1.002 . . . . 72.25 109.981 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.749 HD11 ' HA ' ' B' ' 103' ' ' PRO . 84.9 mt -121.56 112.85 18.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.373 0.669 . . . . 74.24 109.376 174.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.2 ttm-85 -86.89 107.6 18.41 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.185 -1.043 . . . . 74.21 108.185 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.83 101.88 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.075 -1.454 . . . . 74.25 107.075 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 32.3 m -97.31 139.12 33.74 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.931 -1.486 . . . . 73.43 108.443 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.61 114.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.203 -1.036 . . . . 71.23 108.203 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -101.38 140.58 35.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.371 -0.974 . . . . 73.45 108.371 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.95 126.38 23.34 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.314 -0.995 . . . . 72.14 108.314 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.4 p -146.27 140.03 26.2 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.357 0.663 . . . . 74.21 110.514 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.621 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -133.36 140.87 47.63 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.992 0.917 . . . . 74.4 109.655 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.84 -111.75 3.66 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.434 -0.803 . . . . 53.33 111.429 -172.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -121.6 2.5 10.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 74.1 109.885 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -135.63 171.95 13.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.949 0.5 . . . . 72.53 110.877 -169.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -75.03 140.37 43.5 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.493 -0.776 . . . . 75.02 111.352 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.621 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -86.04 -62.2 1.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.247 -1.02 . . . . 71.51 108.247 172.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -163.07 167.08 22.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.475 -1.693 . . . . 74.34 107.917 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.63 143.31 49.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 75.3 108.013 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.7 t -143.33 144.34 32.05 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.372 -0.973 . . . . 72.15 108.372 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.48 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -160.12 139.01 10.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.97 -0.752 . . . . 64.31 108.97 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.534 HG11 ' HA ' ' B' ' 110' ' ' ALA . 69.7 t -135.43 145.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.547 -1.279 . . . . 74.25 107.547 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.0 mt-30 -124.88 92.78 3.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.939 -1.134 . . . . 64.02 107.939 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -89.38 104.42 16.97 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.956 -1.02 . . . . 61.54 108.848 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.535 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.21 156.65 25.3 Favored Glycine 0 C--O 1.244 0.767 0 N-CA-C 111.131 -0.788 . . . . 74.14 111.131 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.18 1.33 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.072 -0.811 . . . . 73.11 111.072 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.605 HG12 ' HG2' ' B' ' 57' ' ' GLU . 26.0 mt -85.99 134.55 27.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 108.076 -1.083 . . . . 72.35 108.076 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . 0.464 ' HE2' HG23 ' B' ' 13' ' ' ILE . 65.4 m-85 -133.64 135.08 43.94 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 74.31 108.343 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.416 ' OG ' ' HG3' ' B' ' 14' ' ' GLN . 65.5 m -107.61 91.85 3.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 172.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.527 ' HB ' HD13 ' B' ' 89' ' ' ILE . 35.2 pt -98.11 138.21 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.386 -0.825 . . . . 65.33 110.974 -169.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.598 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -145.01 167.77 21.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.28 1.032 . . . . 75.21 109.945 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.79 -63.72 4.42 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.696 -0.684 . . . . 75.42 112.006 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.527 HD13 ' HB ' ' B' ' 86' ' ' ILE . 2.3 pp -61.35 138.1 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.618 0.767 . . . . 73.13 112.123 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.401 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 35.7 tt0 -161.12 149.66 16.08 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.477 -0.783 . . . . 73.41 109.197 177.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.08 -124.9 14.69 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.68 0.613 . . . . 43.12 112.793 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.0 m -67.19 -33.37 75.25 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.402 0.681 . . . . 65.03 110.964 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.88 -33.24 71.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.763 -0.653 . . . . 71.21 110.468 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.401 ' HB2' ' HA ' ' B' ' 90' ' ' GLU . 1.2 tmt? -65.57 -45.57 82.8 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.024 0.53 . . . . 75.24 110.138 173.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.14 -31.87 70.5 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.812 0.845 . . . . 71.04 112.09 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -77.71 -43.92 29.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.168 0.587 . . . . 74.55 111.2 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.46 -47.26 56.82 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.37 0.605 . . . . 70.43 111.909 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.572 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.1 tm? -89.38 -37.61 14.73 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.112 0.965 . . . . 73.43 110.202 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.28 -26.32 57.68 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.34 0.4 . . . . 64.25 114.015 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.57 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -120.91 -48.99 2.23 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.985 0.514 . . . . 75.2 112.203 -173.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.507 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 67.2 t80 -77.84 -45.71 23.57 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.51 0.559 . . . . 73.51 112.51 -172.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.572 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 78.5 m -59.48 -42.55 92.82 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 112.981 0.734 . . . . 62.04 112.981 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.749 ' HA ' HD11 ' B' ' 60' ' ' LEU . 83.6 Cg_exo -52.08 -39.61 70.0 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.529 2.153 . . . . 73.41 114.818 168.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.54 -24.05 65.5 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.114 0.566 . . . . 72.41 112.062 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.472 HG22 ' NH2' ' D' ' 111' ' ' ARG . 92.8 mt -73.15 -47.39 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.778 0.831 . . . . 72.01 111.348 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.425 ' HB2' HD13 ' B' ' 60' ' ' LEU . 75.1 mt -79.72 -18.79 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.871 -0.604 . . . . 74.23 110.987 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.76 -50.55 86.42 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-O 117.699 -1.143 . . . . 73.53 113.733 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.1 -35.86 97.18 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.552 2.168 . . . . 71.2 113.959 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -69.44 -46.73 66.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.481 0.712 . . . . 73.53 110.575 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.534 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.3 -41.28 88.63 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.398 -0.819 . . . . 75.33 110.616 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -63.14 -50.43 70.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.557 1.543 . . . . 74.32 111.268 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.85 -37.99 89.47 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.95 0.781 . . . . 74.52 109.998 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.794 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.7 t -68.62 -39.21 80.91 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.508 0.505 . . . . 64.4 111.169 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.2 -49.69 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.062 0.545 . . . . 73.05 110.014 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -56.53 -39.37 73.25 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.301 -0.863 . . . . 74.32 111.168 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -68.05 -46.53 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.123 -0.944 . . . . 72.23 110.394 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.534 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -66.74 -39.48 87.95 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.006 0.523 . . . . 73.21 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.28 -39.47 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.867 0.467 . . . . 75.13 110.251 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -68.5 -28.57 67.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.071 0.948 . . . . 64.22 111.761 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.438 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.0 mtt-85 -73.58 -35.79 65.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.744 0.818 . . . . 73.14 110.101 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 3.4 55.0 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 123.757 0.661 . . . . 73.44 112.673 170.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.567 HG23 ' HB3' ' A' ' 17' ' ' TYR . 49.1 p 58.81 28.87 18.01 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.516 1.926 . . . . 73.52 112.304 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -98.77 153.03 38.07 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 114.849 -1.069 . . . . 75.45 109.645 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.602 ' HG2' ' HA ' ' H' ' 297' ' ' TYR . 54.0 Cg_exo -51.2 102.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.13 2.553 . . . . 74.23 111.523 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -62.38 155.41 25.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.604 -1.18 . . . . 75.35 111.527 -171.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.6 tp -109.29 100.82 9.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.459 -0.791 . . . . 73.22 109.612 -168.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -89.37 92.85 9.31 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 106.44 -1.689 . . . . 73.14 106.44 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.25 150.1 46.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.959 -1.473 . . . . 75.1 111.19 -168.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.26 74.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 122.97 0.508 . . . . 71.1 110.779 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.08 111.8 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.942 2.428 . . . . 75.11 112.233 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.64 113.85 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.479 -0.934 . . . . 72.13 108.479 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.38 80.11 7.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.279 0.632 . . . . 74.11 109.375 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -59.64 -34.68 73.11 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.653 0.781 . . . . 74.31 111.303 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.57 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 12.3 t70 -63.0 -44.72 95.23 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.781 -1.099 . . . . 74.11 111.671 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.92 -36.73 75.59 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.295 0.638 . . . . 74.05 111.276 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.82 -30.87 71.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.007 0.523 . . . . 71.41 110.737 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -76.76 -32.09 57.51 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.397 0.679 . . . . 72.33 110.077 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 63.2 mtt -67.49 -25.43 65.86 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.336 0.654 . . . . 72.35 110.951 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.76 -29.86 61.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.381 0.672 . . . . 53.55 110.532 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -72.7 -36.43 67.85 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.244 0.617 . . . . 73.33 109.71 174.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 53.7 mt -100.08 22.16 11.74 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.705 0.802 . . . . 75.22 110.868 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -70.74 100.14 1.83 Allowed 'General case' 0 C--N 1.351 0.64 0 CA-C-O 121.2 0.524 . . . . 72.02 110.675 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -151.23 96.44 2.3 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 106.568 -1.642 . . . . 74.33 106.568 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -138.97 151.37 46.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.681 0.793 . . . . 62.12 110.059 -173.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.39 -44.98 49.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.878 0.871 . . . . 71.41 111.372 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.13 88.16 0.9 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.892 -0.595 . . . . 51.04 112.517 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -139.32 138.73 36.94 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.831 0.852 . . . . 74.23 109.346 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.23 101.51 0.15 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.761 -1.336 . . . . 75.52 109.761 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 72.6 p -64.57 169.54 4.79 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.37 0.668 . . . . 65.45 111.443 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.64 44.23 2.44 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.6 0.76 . . . . 63.53 109.423 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.91 102.91 0.18 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.966 0.888 . . . . 74.25 109.862 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -128.62 58.56 1.56 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.869 -1.06 . . . . 73.44 109.661 -172.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -72.78 -46.74 51.69 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.338 -1.356 . . . . 74.51 107.338 158.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 68.5 -68.24 0.18 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.552 1.541 . . . . 73.24 111.971 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.364 0 C-N-CA 124.175 0.99 . . . . 72.33 108.576 174.782 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.415 ' SD ' ' N ' ' C' ' 1' ' ' MET . 3.0 mpp? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.568 -0.53 . . . . 71.03 109.568 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -151.83 101.84 2.79 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.664 -0.495 . . . . 63.54 109.664 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -160.5 104.64 1.42 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.296 -1.001 . . . . 75.05 108.296 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.42 109.43 4.47 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.625 0.77 . . . . 64.05 109.82 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -155.73 69.51 0.68 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.611 -1.255 . . . . 74.51 107.611 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -154.03 147.92 25.5 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.013 -0.994 . . . . 72.22 110.493 -170.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.9 p -80.89 120.54 24.85 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.769 -0.826 . . . . 74.54 108.769 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -58.44 -25.57 62.35 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.13 0.972 . . . . 74.42 112.412 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.509 ' HB2' HG23 ' C' ' 89' ' ' ILE . 46.9 ttp 67.29 115.93 0.03 OUTLIER 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.385 1.474 . . . . 74.03 111.088 -172.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.2 m -85.77 88.38 7.54 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.975 -1.12 . . . . 72.42 107.975 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.459 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 52.1 t80 -96.62 122.31 39.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.784 -0.821 . . . . 73.41 108.784 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -138.57 139.11 38.51 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.465 0.706 . . . . 73.35 110.472 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.58 96.79 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.764 -0.828 . . . . 73.41 108.764 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.456 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.5 mm100 -75.98 -43.47 44.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.69 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -169.84 122.99 0.73 Allowed 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.894 0.746 . . . . 73.43 109.892 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.84 133.54 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.347 -0.983 . . . . 74.34 108.347 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.412 ' HB2' ' HA2' ' D' ' 121' ' ' GLY . 28.0 p90 -169.67 158.72 7.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.697 0.761 . . . . 72.31 112.267 -173.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -81.56 110.37 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.518 -1.219 . . . . 74.53 108.864 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -79.47 -23.92 42.71 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 122.277 -0.264 . . . . 74.5 110.605 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -150.06 142.08 23.94 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.954 0.783 . . . . 74.34 109.467 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.588 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -137.26 144.26 32.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 106.916 -1.513 . . . . 74.21 106.916 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 22' ' ' SER . . . . . 0.54 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 40.3 t -151.82 147.71 26.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.482 0.713 . . . . 73.21 110.125 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -154.87 119.93 4.93 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.342 -1.355 . . . . 74.5 107.342 168.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.48 130.14 54.16 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.489 0.716 . . . . 75.54 109.236 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.31 77.36 76.3 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.652 -1.24 . . . . 73.53 107.652 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -68.02 -27.72 35.91 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.037 2.491 . . . . 75.2 112.051 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -109.91 41.96 1.61 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.496 1.118 . . . . 72.05 109.457 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.566 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.64 -54.94 49.83 Favored Pre-proline 0 CA--C 1.571 1.753 0 N-CA-C 114.47 1.285 . . . . 63.1 114.47 -175.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.52 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 12.5 Cg_exo -72.66 -28.42 14.11 Favored 'Trans proline' 0 C--N 1.386 2.533 0 CA-C-N 121.891 1.711 . . . . 73.41 111.775 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -68.7 -22.08 64.38 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.04 1.336 . . . . 74.0 111.953 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.462 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -72.2 -18.84 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.539 0.736 . . . . 74.32 111.497 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -68.79 -23.48 64.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.623 0.369 . . . . 75.14 111.201 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -109.52 24.04 13.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.51 0.724 . . . . 74.24 110.722 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.667 ' HD2' HD23 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -81.08 148.05 29.83 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.35 0.66 . . . . 75.14 110.046 -176.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . 0.469 ' HB3' HD12 ' C' ' 68' ' ' LEU . 12.7 t70 -69.37 125.01 25.37 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.315 -0.994 . . . . 75.04 108.315 169.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -86.76 63.12 7.79 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.882 0.738 . . . . 74.24 110.372 -168.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -164.95 77.4 1.39 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.227 1.011 . . . . 62.23 108.403 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.97 156.11 26.62 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.77 2.313 . . . . 73.12 111.371 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.37 86.85 7.35 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.132 -1.433 . . . . 73.51 107.132 170.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -69.42 112.43 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.427 -1.26 . . . . 63.12 109.835 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -134.29 127.12 31.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.749 0.82 . . . . 74.31 109.852 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . 0.402 HD21 ' N ' ' C' ' 43' ' ' ASP . 6.1 tt -86.41 139.14 31.21 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 107.648 -1.241 . . . . 75.23 107.648 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.577 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.4 t70 -119.61 107.5 13.33 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.577 -1.268 . . . . 61.15 107.577 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.17 116.16 28.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.268 1.027 . . . . 74.42 109.059 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.588 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.9 t70 -115.08 143.94 44.41 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.606 -0.887 . . . . 71.44 108.606 172.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -131.19 134.96 47.0 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.614 0.766 . . . . 72.12 109.789 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.435 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -148.21 157.34 43.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.138 0.575 . . . . 64.12 110.628 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.425 ' HB3' ' HE2' ' F' ' 281' ' ' PHE . 57.6 p -161.28 145.75 13.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.87 0.868 . . . . 72.33 110.413 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -156.06 140.85 17.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 75.43 109.898 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -72.55 127.87 33.87 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.73 HD12 ' HB2' ' C' ' 57' ' ' GLU . 34.9 mt -96.06 -39.67 9.62 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 73.43 109.581 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.32 176.59 12.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.919 -1.491 . . . . 54.34 108.964 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -68.31 121.98 17.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.673 -0.694 . . . . 71.11 109.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 76.51 -8.37 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 126.401 1.881 . . . . 72.34 112.632 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.81 96.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 73.51 108.879 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.8 161.97 13.72 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.493 0.717 . . . . 74.34 109.378 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.73 ' HB2' HD12 ' C' ' 51' ' ' LEU . 42.0 tt0 -124.73 133.61 53.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.14 0.576 . . . . 73.52 109.768 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.422 HG21 HD13 ' C' ' 98' ' ' LEU . 77.2 t -110.69 129.22 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.402 -1.333 . . . . 70.34 107.402 169.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 96.7 t -114.18 136.76 49.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.257 -1.016 . . . . 74.53 108.257 173.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.13 101.76 5.95 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.324 -1.361 . . . . 74.25 107.324 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.588 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 8.1 ttm180 -87.29 135.13 33.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.262 0.625 . . . . 74.3 109.687 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.533 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.5 t -125.81 121.89 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.137 -1.431 . . . . 73.31 107.137 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 30.7 m -124.7 119.56 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.423 -0.584 . . . . 74.21 109.423 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.544 HG23 HG21 ' C' ' 114' ' ' ILE . 59.1 t -100.35 116.43 43.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.635 -0.876 . . . . 74.33 108.635 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.5 m -106.21 137.71 43.68 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.688 0.618 . . . . 74.02 109.511 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.64 94.49 3.2 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.516 -1.291 . . . . 74.24 107.516 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -143.57 139.15 29.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.392 -0.966 . . . . 64.24 108.392 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.667 HD23 ' HD2' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 23.65 8.74 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.506 0.722 . . . . 74.02 110.329 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.94 -120.57 1.4 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.827 -1.309 . . . . 72.44 109.827 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.79 -28.47 21.66 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.56 -0.904 . . . . 75.31 108.56 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.0 99.2 0.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.466 1.106 . . . . 64.54 109.608 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.1 m -87.75 130.24 34.9 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.058 0.543 . . . . 75.44 110.644 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.66 5.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.495 -0.775 . . . . 72.24 109.256 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -167.21 169.75 12.33 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.827 0.851 . . . . 74.41 110.768 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -142.87 144.67 32.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.939 -1.134 . . . . 75.45 107.939 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 53.6 t -146.68 146.28 30.3 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.353 -0.98 . . . . 61.44 108.353 176.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . 0.54 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 38.4 tt0 -153.76 137.49 16.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.25 0.62 . . . . 75.01 110.218 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.574 HG12 ' HA ' ' C' ' 110' ' ' ALA . 54.4 t -141.9 115.02 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.305 1.042 . . . . 74.33 108.615 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 73.2 mt-30 -95.03 97.69 10.14 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.889 -0.782 . . . . 64.34 108.889 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -87.1 102.32 14.32 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 73.2 110.009 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.16 151.82 21.8 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.918 -0.473 . . . . 73.43 111.918 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.548 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -148.97 128.59 2.82 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.645 -0.582 . . . . 61.45 111.645 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' D' ' 29' ' ' PRO . 8.3 mm -90.14 130.38 39.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 108.491 -0.929 . . . . 73.33 108.491 178.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.98 119.91 17.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.316 -0.624 . . . . 74.03 109.316 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.0 p -85.93 99.9 11.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.212 -1.033 . . . . 54.33 108.212 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.63 124.7 68.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.472 0.709 . . . . 75.1 109.645 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 169.06 25.23 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.029 -0.987 . . . . 72.22 110.228 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.69 -28.58 11.9 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.033 -0.985 . . . . 63.02 111.045 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.547 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.2 OUTLIER -119.14 167.51 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.943 0.897 . . . . 74.43 110.903 -173.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -160.1 -171.76 3.34 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.799 -1.092 . . . . 75.55 108.954 173.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.52 -124.44 33.43 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.824 0.703 . . . . 74.1 114.109 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.6 t -63.62 -32.19 73.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.103 0.961 . . . . 75.01 112.789 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -68.28 -57.52 5.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.249 0.62 . . . . 73.24 111.218 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.547 ' HB3' HG12 ' C' ' 89' ' ' ILE . 3.3 ppp? -73.92 -21.19 60.14 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.698 -0.683 . . . . 71.55 110.739 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.4 96.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.946 0.498 . . . . 73.45 110.414 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.29 -39.18 75.22 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.007 -0.542 . . . . 74.25 110.844 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.497 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 94.2 m -67.49 -52.98 32.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.028 -0.533 . . . . 74.32 110.232 175.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.422 HD13 HG21 ' C' ' 58' ' ' VAL . 52.2 tp -60.38 -53.98 51.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.072 0.949 . . . . 70.43 111.546 -168.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.438 ' HA3' HD21 ' F' ' 280' ' ' LEU . . . -100.53 11.29 59.64 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.433 -0.648 . . . . 75.44 114.687 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.23 -63.79 0.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.837 0.818 . . . . 74.31 112.477 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 38.5 t80 -72.76 -53.25 12.12 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.823 0.449 . . . . 70.31 111.919 -168.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.459 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 44.1 m -59.11 -47.39 98.58 Favored Pre-proline 0 CA--C 1.569 1.675 0 C-N-CA 123.969 0.908 . . . . 73.33 112.352 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.444 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 86.5 Cg_exo -54.55 -37.28 90.4 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.96 2.44 . . . . 73.2 113.711 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -66.58 -38.49 87.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.886 0.741 . . . . 75.25 110.286 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.421 HD13 ' NH1' ' A' ' 111' ' ' ARG . 41.1 mm -61.53 -44.6 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.05 0.54 . . . . 74.13 110.324 175.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.548 HD23 ' HA3' ' C' ' 82' ' ' GLY . 97.0 mt -75.31 -30.85 60.46 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.291 -0.868 . . . . 74.23 112.302 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . 0.402 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 61.5 t80 -53.94 -49.77 87.73 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.298 1.221 . . . . 73.43 114.298 -171.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.09 -31.85 94.12 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.299 1.999 . . . . 72.35 113.841 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . 0.419 ' HE2' HG23 ' A' ' 115' ' ' THR . 68.5 m-85 -71.98 -43.15 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.238 0.615 . . . . 73.45 110.64 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.574 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -65.3 -38.33 89.89 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 116.038 -0.528 . . . . 72.54 110.484 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.517 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 39.2 ttt-85 -56.66 -53.48 57.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.556 1.542 . . . . 73.0 111.797 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.35 -32.91 74.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.825 0.45 . . . . 74.25 110.307 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.13 -32.38 71.72 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.065 0.546 . . . . 73.14 111.269 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.544 HG21 HG23 ' C' ' 64' ' ' VAL . 59.3 mt -70.29 -56.06 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.408 0.683 . . . . 73.52 109.739 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -63.33 -27.14 69.12 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.563 0.745 . . . . 72.3 111.276 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.5 t -66.36 -48.83 68.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.422 0.689 . . . . 50.35 109.544 171.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.551 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.88 -32.79 74.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.482 0.713 . . . . 74.12 112.16 178.45 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.65 -46.97 95.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.473 0.709 . . . . 75.41 109.549 174.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 58.9 p -73.73 -23.78 59.81 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.275 0.63 . . . . 72.14 112.185 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 116' ' ' SER . 82.3 mtt-85 -72.76 -37.8 67.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.575 0.75 . . . . 75.42 110.192 176.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.16 1.86 73.26 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.524 0.515 . . . . 62.3 112.43 169.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 62.42 36.97 13.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.93 2.092 . . . . 70.34 112.665 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -94.94 154.15 39.77 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.781 -1.1 . . . . 73.42 109.44 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 -177.78 1.49 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.032 2.488 . . . . 74.25 113.591 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.71 133.9 56.33 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.133 1.16 . . . . 74.21 114.133 -169.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.3 tt -138.7 85.31 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.079 -1.822 . . . . 73.13 106.079 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.7 129.88 44.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.787 0.835 . . . . 75.21 109.493 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.517 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.6 mm? -80.47 143.89 33.0 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.642 0.589 . . . . 73.54 110.472 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.564 ' HB1' HD13 ' F' ' 291' ' ' LEU . . . -86.72 150.23 50.24 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.951 0.9 . . . . 72.22 111.376 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.416 ' HB3' ' HH ' ' A' ' 109' ' ' TYR . 88.2 Cg_endo -81.06 130.08 7.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.174 2.583 . . . . 73.31 112.297 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.525 HG22 HD22 ' F' ' 291' ' ' LEU . 9.4 t -135.08 112.97 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 109.067 -0.716 . . . . 74.32 109.067 173.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.34 90.75 5.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.438 0.695 . . . . 73.11 110.128 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.63 -39.07 77.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.778 0.799 . . . . 73.53 109.705 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -65.21 -42.46 93.49 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.984 -1.462 . . . . 75.23 112.193 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.54 92.48 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.685 0.794 . . . . 71.31 110.551 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.4 tt -64.66 -38.27 90.42 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.297 0.998 . . . . 71.51 110.817 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -70.93 -30.06 66.28 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.532 0.733 . . . . 74.12 110.734 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 72.5 mtm -81.44 -30.05 33.61 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.099 0.56 . . . . 74.24 111.274 170.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -64.77 -39.62 93.92 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.223 1.009 . . . . 74.02 111.817 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -68.16 -85.93 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 117.696 -1.145 . . . . 73.44 108.083 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . 0.619 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 15.6 tp 48.41 -179.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.281 1.432 . . . . 65.33 114.073 173.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -164.49 15.77 0.05 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.654 0.782 . . . . 72.12 110.114 163.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.619 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 78.3 mt-30 -111.32 178.43 4.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.406 1.082 . . . . 75.21 110.997 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.46 ' HG3' ' HG3' ' A' ' 143' ' ' GLN . 7.3 tm0? -135.42 143.68 46.08 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.068 -1.086 . . . . 73.11 108.068 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.91 138.11 35.36 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.946 0.899 . . . . 73.43 109.899 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.24 173.49 25.29 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.654 0.596 . . . . 74.42 113.069 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -84.9 145.85 27.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.738 0.815 . . . . 73.32 109.643 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -120.3 -167.23 13.4 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 112.012 -0.435 . . . . 75.55 112.012 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 37.8 m -152.06 142.58 22.66 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.492 0.717 . . . . 73.22 110.067 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . 0.494 ' H ' ' HG2' ' G' ' 310' ' ' PRO . 2.3 mm-40 -130.4 84.17 2.18 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.026 1.33 . . . . 73.43 107.591 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -121.75 103.55 8.95 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.677 -0.692 . . . . 74.33 109.685 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -167.44 138.26 2.99 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.928 0.891 . . . . 73.14 109.318 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -153.06 108.53 3.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.973 0.909 . . . . 62.5 108.814 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -154.0 105.81 2.77 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.1 -1.074 . . . . 63.44 108.1 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 108.813 -0.81 . . . . 74.34 108.813 176.441 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 110.111 -0.329 . . . . 75.24 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 24.3 t -141.32 21.61 2.22 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.69 0.796 . . . . 63.15 108.945 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.65 105.95 5.19 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 115.772 -0.649 . . . . 70.34 109.658 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -71.18 86.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.195 -1.039 . . . . 74.03 108.195 168.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.31 176.23 2.9 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.696 -1.138 . . . . 74.43 109.787 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -48.77 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.73 0.812 . . . . 74.31 110.549 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.9 m -84.71 69.66 10.7 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-O 122.439 1.114 . . . . 74.21 108.487 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -83.27 -10.89 58.27 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 113.995 -1.457 . . . . 74.32 109.917 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.497 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 5.4 ttp -29.86 126.0 0.14 Allowed 'General case' 0 C--N 1.375 1.695 0 C-N-CA 126.039 1.736 . . . . 62.23 113.117 172.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m -114.09 146.36 40.35 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.897 -0.779 . . . . 71.22 108.897 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -171.87 104.46 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.164 -1.791 . . . . 73.45 106.164 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -156.07 138.39 14.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.826 0.851 . . . . 74.42 108.844 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.475 HG21 HD11 ' D' ' 16' ' ' ILE . 10.1 mt -76.4 137.28 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.536 0.522 . . . . 75.02 110.368 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -99.93 -40.56 7.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.64 0.776 . . . . 74.31 110.257 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -167.15 125.9 1.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.474 -0.33 . . . . 73.43 111.207 -170.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.475 HD11 HG21 ' D' ' 13' ' ' ILE . 1.3 mp -103.91 132.56 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.13 -1.433 . . . . 74.04 107.13 165.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.566 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 26.0 p90 -166.09 154.95 11.27 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.954 0.784 . . . . 74.53 110.475 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -80.22 121.31 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.218 -0.901 . . . . 70.32 109.05 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.514 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 42.4 mtpt -87.28 -30.51 20.84 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.767 -0.457 . . . . 72.13 109.767 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.17 135.33 17.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.891 -1.049 . . . . 62.45 109.018 -177.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.551 HG23 ' HE1' ' C' ' 117' ' ' MET . 48.7 mt -134.84 144.26 35.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 107.991 -1.114 . . . . 74.43 107.991 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -151.82 137.78 18.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.359 0.664 . . . . 73.41 110.313 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.588 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 55.2 t80 -143.88 115.66 8.24 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 106.767 -1.568 . . . . 71.12 106.767 171.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.56 126.19 48.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.13 0.572 . . . . 75.42 109.601 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.56 80.35 22.8 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.578 -1.267 . . . . 64.23 107.578 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.24 -31.91 17.54 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.017 2.478 . . . . 74.44 112.672 -170.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -114.95 36.49 3.84 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.45 -0.944 . . . . 75.4 108.45 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.442 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -56.38 -62.48 4.8 Favored Pre-proline 0 CA--C 1.559 1.321 0 N-CA-C 113.919 1.081 . . . . 74.44 113.919 -167.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.557 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -78.07 -2.21 12.33 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 122.796 2.034 . . . . 65.5 113.318 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -84.35 -42.17 16.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.758 1.223 . . . . 74.53 109.75 174.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 ' HA ' ' D' ' 73' ' ' ALA . 11.0 p -76.6 -27.26 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.102 0.561 . . . . 75.12 111.049 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.537 ' HA ' HG13 ' G' ' 301' ' ' ILE . 21.5 m-85 -68.2 -7.95 34.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.247 0.832 . . . . 72.21 113.247 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -82.72 -18.79 39.57 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.799 0.84 . . . . 74.31 111.19 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.99 99.46 8.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.101 0.96 . . . . 75.51 110.954 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -75.52 94.63 3.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.861 0.865 . . . . 74.43 111.743 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.449 ' CE3' HD23 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -155.84 175.02 14.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.71 0.804 . . . . 75.13 111.961 174.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.597 ' HA ' ' HB2' ' G' ' 297' ' ' TYR . 1.9 mp0 -94.92 109.56 44.81 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 124.299 1.04 . . . . 71.51 110.942 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.548 ' HD3' ' HD2' ' G' ' 297' ' ' TYR . 19.0 Cg_exo -65.3 146.13 85.26 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.231 2.62 . . . . 71.12 111.85 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.27 156.17 38.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.903 -0.777 . . . . 72.34 108.903 164.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.487 HG21 HG13 ' D' ' 64' ' ' VAL . 1.3 p -136.3 118.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.775 -1.194 . . . . 75.34 107.775 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -106.1 125.69 51.3 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.104 0.962 . . . . 73.41 108.514 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.5 tt -95.89 126.54 41.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.277 -1.008 . . . . 75.2 108.277 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.439 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.9 t70 -114.95 125.87 54.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.879 -1.156 . . . . 64.45 107.879 169.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.06 130.85 46.26 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.1 -0.704 . . . . 73.42 109.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -134.01 143.29 48.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.723 -0.843 . . . . 73.21 108.723 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -121.47 147.74 45.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.139 0.976 . . . . 71.13 110.019 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.48 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.07 142.74 18.71 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.785 0.834 . . . . 63.44 109.261 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -160.64 153.4 21.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.889 0.476 . . . . 75.32 109.98 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -164.08 147.17 9.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.33 0.652 . . . . 74.22 109.948 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.8 122.13 25.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.162 -0.681 . . . . 72.55 109.162 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' C' ' 29' ' ' PRO . 71.6 mt -89.95 -34.61 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.549 0.74 . . . . 75.12 110.524 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 -177.8 6.43 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.349 -0.841 . . . . 72.44 109.667 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.43 116.25 5.92 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.75 -0.659 . . . . 72.32 110.495 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 62.4 24.59 14.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.435 1.094 . . . . 71.25 111.899 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.08 116.82 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.396 -0.964 . . . . 75.45 108.396 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.466 ' HB2' HD13 ' D' ' 86' ' ' ILE . 82.3 m-85 -131.91 129.05 39.8 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.745 1.218 . . . . 71.43 108.036 -173.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -102.52 139.7 37.77 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.599 0.76 . . . . 73.02 109.803 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.484 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 96.6 t -118.72 122.82 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.617 -1.253 . . . . 75.42 107.617 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 39.1 t -108.55 131.99 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.329 -0.989 . . . . 74.51 108.329 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tt -116.43 116.96 28.64 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.373 -1.343 . . . . 73.32 107.373 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -97.63 108.69 21.47 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.116 -0.698 . . . . 74.52 109.116 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.92 129.09 43.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 107.645 -1.243 . . . . 72.13 107.645 166.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.439 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.0 m -120.41 134.06 55.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.243 0.544 . . . . 73.21 109.701 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 78.5 t -125.62 106.81 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.128 1.371 . . . . 73.12 108.199 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -113.21 106.75 15.01 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.465 -0.568 . . . . 75.51 109.465 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.87 123.93 48.75 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.209 0.604 . . . . 74.45 109.679 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.7 m -147.31 121.54 9.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.304 -0.998 . . . . 72.34 108.304 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.449 HD23 ' CE3' ' D' ' 36' ' ' TRP . 17.3 tp -137.55 136.85 38.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.808 0.443 . . . . 74.14 110.013 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . 0.431 ' H ' HD13 ' D' ' 68' ' ' LEU . . . 91.75 -136.11 13.11 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.336 -1.106 . . . . 74.54 110.336 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 16.4 23.65 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.316 0.558 . . . . 73.31 110.881 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -136.21 164.66 27.55 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.071 0.548 . . . . 65.51 111.562 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -79.85 129.74 34.73 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.874 -1.057 . . . . 64.44 109.764 170.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.515 ' HA ' HG22 ' D' ' 31' ' ' VAL . . . -77.91 -66.15 0.88 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.178 -0.675 . . . . 74.44 109.178 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.35 165.88 32.36 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.061 -0.972 . . . . 75.33 111.191 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -129.07 146.54 51.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.888 1.275 . . . . 74.12 108.481 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.608 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 5.4 m -148.66 138.23 21.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.015 0.926 . . . . 70.35 109.661 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.57 122.31 5.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.332 -0.988 . . . . 74.34 108.332 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . 0.505 HG23 HG21 ' D' ' 21' ' ' ILE . 91.6 t -130.54 118.49 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.448 -0.575 . . . . 71.41 109.448 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 76.6 mt-30 -90.02 90.81 8.3 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.132 -0.94 . . . . 74.42 108.651 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.28 103.66 10.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.427 -0.806 . . . . 75.12 109.401 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 143.37 16.51 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.519 -0.633 . . . . 71.43 111.519 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.43 128.47 4.16 Favored Glycine 0 CA--C 1.506 -0.515 0 N-CA-C 109.942 -1.263 . . . . 73.03 109.942 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.27 131.68 36.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.12 -1.067 . . . . 74.43 108.12 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.484 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 18.7 m-85 -130.65 139.72 50.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.428 -0.582 . . . . 73.43 109.428 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.7 m -82.65 100.9 10.47 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 108.084 -1.08 . . . . 72.44 108.084 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.466 HD13 ' HB2' ' D' ' 56' ' ' TYR . 36.3 mt -117.28 138.65 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.294 0.638 . . . . 74.34 110.218 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 167.52 15.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.804 0.841 . . . . 65.54 110.456 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.8 -19.78 10.95 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 114.914 0.726 . . . . 53.41 114.914 169.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.445 HG21 ' HG3' ' D' ' 9' ' ' MET . 13.1 pt -121.67 138.31 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.969 -1.122 . . . . 74.34 107.969 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . 0.59 ' HB2' ' HA ' ' G' ' 272' ' ' ASN . 40.9 mt-10 -141.87 167.67 21.57 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.681 0.792 . . . . 64.35 110.809 -176.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.87 -135.19 40.76 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.849 0.718 . . . . 44.32 113.054 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -66.08 -29.86 70.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.265 0.626 . . . . 64.04 111.324 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.48 HE21 ' HA ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -63.77 -40.96 97.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.371 0.669 . . . . 74.32 110.728 -178.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -81.34 -34.6 31.69 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.301 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' G' ' 280' ' ' LEU . . . -63.21 -23.92 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.64 0.776 . . . . 75.21 112.545 -177.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . 0.53 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.6 t-80 -69.91 -38.55 76.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.695 0.398 . . . . 73.02 110.506 171.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.18 -33.67 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 110.338 -0.245 . . . . 64.02 110.338 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.52 -54.16 11.47 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.475 1.11 . . . . 74.42 109.877 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.92 14.31 64.86 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.562 -0.745 . . . . 61.43 114.405 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -145.23 -56.42 0.32 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 117.405 0.603 . . . . 70.41 112.333 -175.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -75.63 -51.6 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.532 0.567 . . . . 74.13 112.532 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.9 m -59.14 -48.61 96.11 Favored Pre-proline 0 CA--C 1.568 1.653 0 C-N-CA 124.206 1.002 . . . . 72.44 112.93 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.81 -30.79 78.09 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 122.265 1.976 . . . . 74.23 112.852 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.94 -32.2 73.45 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.298 0.639 . . . . 74.44 111.126 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.5 mm -74.21 -42.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.584 0.754 . . . . 73.4 110.678 178.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.16 -30.25 49.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.325 -0.852 . . . . 73.31 111.997 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.51 -44.4 97.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.187 1.18 . . . . 75.52 114.187 -170.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.42 -41.59 51.22 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.452 2.101 . . . . 63.12 114.159 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -75.92 -38.62 57.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.811 . . . . 75.3 111.756 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.67 99.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.476 0.71 . . . . 74.42 110.753 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.535 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.7 ttp180 -62.56 -49.91 73.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.542 -1.208 . . . . 72.22 110.59 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -58.4 -48.47 80.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.379 1.072 . . . . 71.35 111.531 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.69 -40.12 75.03 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.811 0.694 . . . . 73.35 111.224 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.491 ' HA ' ' HE3' ' D' ' 117' ' ' MET . 93.7 mt -65.98 -50.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.132 -0.94 . . . . 74.43 110.582 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.6 m -53.9 -38.88 65.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.507 1.123 . . . . 75.51 111.759 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -70.54 -50.24 39.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.54 110.316 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.491 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 75.1 mtm -56.62 -43.16 79.95 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.453 0.701 . . . . 73.33 111.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.528 HG13 HD22 ' D' ' 126' ' ' LEU . 82.3 t -63.73 -42.28 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 114.441 -1.254 . . . . 72.15 110.814 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 59.6 p -68.8 -30.79 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 120.817 0.341 . . . . 75.13 110.965 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -69.63 -29.45 66.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.072 0.949 . . . . 73.44 110.525 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . 0.412 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.45 11.42 69.97 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-N 115.579 -0.737 . . . . 71.12 112.905 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 81.7 p 61.31 16.04 7.02 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 126.771 2.028 . . . . 73.05 113.721 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -90.41 164.66 26.21 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.237 1.015 . . . . 75.23 108.359 170.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.629 ' HG3' ' HA ' ' G' ' 297' ' ' TYR . 37.8 Cg_endo -86.65 150.77 8.77 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.655 2.237 . . . . 74.42 112.466 -172.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.17 133.21 28.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.949 0.9 . . . . 72.5 112.749 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.528 HD22 HG13 ' D' ' 118' ' ' VAL . 3.8 mm? -105.82 95.0 5.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.533 -0.914 . . . . 75.13 108.533 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -98.87 98.79 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.435 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.9 mm? -76.08 135.15 39.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.3 -0.864 . . . . 74.34 109.625 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . 0.424 ' HB1' HD13 ' G' ' 291' ' ' LEU . . . -68.88 128.69 92.74 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-O 119.56 -0.257 . . . . 75.32 110.989 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.535 ' HB3' HH12 ' D' ' 111' ' ' ARG . 65.6 Cg_endo -74.65 117.48 4.96 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.508 2.139 . . . . 74.22 111.299 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.76 110.3 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.534 -0.913 . . . . 73.21 108.534 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.517 ' ND2' ' HB1' ' D' ' 135' ' ' ALA . 32.9 t30 -78.4 98.8 6.13 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.859 -0.793 . . . . 74.13 108.859 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . 0.503 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 62.8 m-85 -70.09 -28.54 65.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.102 -0.953 . . . . 74.04 111.267 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . 0.407 ' HA ' ' HB2' ' D' ' 100' ' ' ALA . 1.9 t70 -63.95 -38.12 89.9 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.272 0.629 . . . . 71.04 110.52 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.517 ' HB1' ' ND2' ' D' ' 132' ' ' ASN . . . -61.76 -40.94 96.92 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.544 1.152 . . . . 71.35 112.181 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 82.3 mt -55.31 -48.38 74.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.01 0.924 . . . . 63.51 112.312 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.441 ' HB2' ' HE2' ' D' ' 96' ' ' HIS . 86.9 m-85 -75.72 -36.4 59.98 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.353 0.661 . . . . 75.02 110.631 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.42 ' O ' ' HG2' ' D' ' 142' ' ' GLN . 32.2 ttm -58.96 -33.16 70.32 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.717 1.207 . . . . 74.32 111.417 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.443 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 85.2 m-20 -57.51 -35.2 69.95 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.424 1.09 . . . . 72.11 111.669 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -64.55 -40.67 96.0 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.375 0.67 . . . . 75.02 110.695 175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . 0.637 ' HA ' ' HG2' ' B' ' 1' ' ' MET . 8.6 mp -70.73 -42.81 70.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.624 0.77 . . . . 75.53 111.674 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.42 ' HG2' ' O ' ' D' ' 138' ' ' MET . 13.6 pt20 -89.91 43.95 1.18 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.917 0.887 . . . . 74.31 111.684 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 19.6 mm-40 -125.76 93.76 3.93 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.595 0.758 . . . . 74.34 111.496 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -162.22 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.037 1.335 . . . . 73.02 108.181 172.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.62 103.31 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.403 1.081 . . . . 71.51 108.516 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.9 82.27 0.29 Allowed Glycine 0 C--N 1.342 0.874 0 O-C-N 123.295 0.372 . . . . 75.03 112.404 -174.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -164.38 123.26 1.86 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.789 0.836 . . . . 62.52 109.34 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.1 151.58 19.44 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 110.904 -0.878 . . . . 73.24 110.904 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 31.8 p -78.61 97.74 5.91 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.027 0.531 . . . . 73.24 110.856 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -86.81 116.56 24.98 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.98 0.512 . . . . 72.33 109.941 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -122.34 140.9 52.13 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.667 -1.234 . . . . 70.3 107.667 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -71.31 144.44 49.95 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.743 0.417 . . . . 74.33 110.492 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -74.47 132.65 42.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.551 0.741 . . . . 73.44 109.32 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -49.89 121.98 6.01 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.979 1.312 . . . . 74.32 111.645 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 123.733 0.813 . . . . 72.22 110.247 -176.143 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.226 -0.657 . . . . 71.11 109.226 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -71.93 -64.09 1.0 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.002 0.814 . . . . 71.02 109.042 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -168.71 172.9 7.6 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.762 0.825 . . . . 71.12 110.728 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -174.22 118.37 0.24 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.382 1.073 . . . . 74.44 108.223 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.57 104.79 50.01 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.598 0.759 . . . . 74.32 109.97 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.75 89.35 1.34 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.241 1.961 . . . . 71.31 110.934 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.52 -45.33 76.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 108.151 -1.055 . . . . 71.23 108.151 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.46 91.57 7.4 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.23 -1.35 . . . . 72.43 107.666 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -131.12 -78.96 0.18 Allowed Glycine 0 C--N 1.35 1.34 0 N-CA-C 112.652 -0.179 . . . . 53.41 112.652 -172.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.57 100.93 2.88 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.88 -0.785 . . . . 74.4 108.88 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -170.47 120.9 0.6 Allowed 'General case' 0 C--N 1.35 0.616 0 O-C-N 124.122 0.889 . . . . 73.2 110.481 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -151.4 -65.88 0.18 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 124.201 0.938 . . . . 60.04 108.897 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -157.97 -163.02 1.24 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.926 0.89 . . . . 63.11 109.085 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -151.85 176.67 30.1 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 111.728 -0.549 . . . . 74.51 111.728 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . 0.432 ' N ' HD21 ' E' ' 285' ' ' ASN . 0.8 OUTLIER -87.13 25.91 1.27 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.712 0.805 . . . . 71.03 110.817 176.474 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 286' ' ' MET . . . . . 0.475 ' HG2' HD22 ' A' ' 136' ' ' LEU . 32.9 mtm -99.03 106.44 38.08 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.307 -1.368 . . . . 74.31 107.307 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.76 -58.82 0.35 Allowed 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.992 2.461 . . . . 74.34 112.825 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 12.5 t 54.34 37.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 123.616 1.674 . . . . 71.45 109.512 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -96.03 50.04 1.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 113.834 -1.53 . . . . 74.25 108.372 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 53.6 m95 69.25 174.47 0.29 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.132 1.373 . . . . 74.43 113.08 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.423 HD11 ' N ' ' E' ' 291' ' ' LEU . 2.2 mp -112.7 -52.8 2.76 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 113.28 -1.782 . . . . 72.14 106.376 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -154.31 114.01 0.6 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-N 114.316 -1.311 . . . . 74.42 110.257 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.11 177.17 5.38 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.771 2.314 . . . . 74.05 112.443 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? 64.23 103.18 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.42 1.088 . . . . 74.45 110.36 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -160.26 -34.29 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.606 1.162 . . . . 74.24 108.226 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 11.6 m -66.87 145.34 55.57 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 114.581 -1.19 . . . . 71.45 109.909 171.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 74.38 175.12 0.26 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.749 1.619 . . . . 74.32 110.772 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -163.4 -50.68 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.64 0.376 . . . . 72.41 109.998 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -125.49 -81.57 0.44 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.494 -0.642 . . . . 74.33 111.494 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -152.87 132.35 12.96 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.156 0.582 . . . . 72.13 110.498 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . 0.671 ' HA ' ' HB3' ' G' ' 298' ' ' HIS . 24.4 pt -96.73 10.02 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.419 0.288 . . . . 72.54 111.103 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.65 165.35 35.7 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.03 0.932 . . . . 73.22 110.633 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . 0.545 ' HB3' ' HD3' ' E' ' 304' ' ' PRO 0.268 57.2 tttm 104.3 -68.49 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.654 0 C-N-CA 128.385 2.674 . . . . 73.33 111.761 174.701 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' E' ' 303' ' ' LYS . 13.7 Cg_exo -72.57 97.6 0.89 Allowed 'Trans proline' 0 C--N 1.391 2.779 0 CA-C-N 122.381 1.886 . . . . 75.3 111.85 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -92.04 -170.45 2.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.813 0.845 . . . . 71.3 111.474 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . 0.596 ' HB ' ' NE2' ' B' ' 12' ' ' GLN . 21.5 t -86.36 144.94 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.867 0.867 . . . . 74.41 110.393 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 40.2 p -72.28 149.58 44.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.378 0.671 . . . . 63.22 110.857 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 35.6 m -107.7 163.11 13.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.69 0.796 . . . . 75.43 110.642 -175.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 12.1 t -147.62 147.54 27.96 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.194 0.597 . . . . 73.11 109.818 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 C--N 1.372 1.788 0 C-N-CA 122.539 2.159 . . . . 73.33 112.855 167.442 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 111.578 0.214 . . . . 75.31 111.578 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -89.1 146.87 24.54 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.267 0.627 . . . . 75.3 110.151 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 57.97 85.39 0.09 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 124.824 1.328 . . . . 74.54 110.52 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.74 177.75 10.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.281 0.632 . . . . 75.45 111.167 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -141.14 164.45 35.57 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.322 1.449 . . . . 75.43 108.351 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.57 -7.87 6.27 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.301 2.667 . . . . 72.21 114.271 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.85 -56.3 24.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.149 0.58 . . . . 64.33 109.487 169.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.66 122.09 17.8 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.111 -0.95 . . . . 75.15 110.387 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 159.07 94.15 0.1 OUTLIER Glycine 0 C--N 1.348 1.201 0 O-C-N 123.43 0.457 . . . . 62.54 111.999 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . 0.438 HD21 ' HA3' ' C' ' 99' ' ' GLY . 27.9 tp -163.97 -22.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.192 0.597 . . . . 74.32 110.658 176.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . 0.425 ' HE2' ' HB3' ' C' ' 48' ' ' SER . 12.1 m-85 -70.23 -49.29 51.61 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.288 0.635 . . . . 73.41 112.37 -177.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 64.33 -156.85 0.31 Allowed 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.314 1.009 . . . . 73.23 109.58 -167.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.7 -19.7 63.56 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.683 0.393 . . . . 64.04 110.266 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 164.41 151.96 6.77 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 110.352 -1.099 . . . . 74.1 110.352 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -148.39 146.88 28.67 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.833 -0.803 . . . . 72.03 108.833 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 61.8 mtt 59.15 69.43 1.35 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.593 1.157 . . . . 70.35 110.91 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.89 94.81 0.55 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.457 2.105 . . . . 64.23 110.859 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.52 107.57 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.183 -0.917 . . . . 74.21 109.826 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.51 37.6 0.83 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.391 1.077 . . . . 72.43 110.677 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 94.6 m95 68.32 164.91 0.24 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.221 1.408 . . . . 75.22 112.1 -169.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.564 HD13 ' HB1' ' C' ' 129' ' ' ALA . 4.5 mp -107.33 64.86 0.64 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.168 -1.419 . . . . 70.22 107.168 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.58 88.65 0.77 Allowed Glycine 0 C--N 1.347 1.18 0 CA-C-N 114.716 -1.129 . . . . 53.22 110.623 -167.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.38 115.54 1.62 Allowed 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 123.914 3.076 . . . . 71.33 113.226 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -82.32 142.35 32.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.695 -0.684 . . . . 73.35 110.548 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.8 72.55 7.78 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.338 -0.616 . . . . 71.2 109.338 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 86.7 m -60.67 -53.87 52.17 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.999 -1.0 . . . . 74.11 110.352 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -82.3 74.88 9.25 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.916 0.865 . . . . 75.45 109.364 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -78.28 -37.31 45.26 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.891 -1.504 . . . . 71.13 111.131 -172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 120.09 -141.77 15.59 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.019 -0.832 . . . . 74.33 111.019 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 14.2 m120 71.7 -2.55 2.44 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.286 1.434 . . . . 75.3 112.666 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 35.9 pt -102.7 22.85 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.584 1.153 . . . . 74.55 109.232 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.73 2.51 11.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.705 1.202 . . . . 64.41 112.394 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.49 148.51 67.78 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.052 0.941 . . . . 71.25 110.021 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.24 147.58 29.62 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.878 2.385 . . . . 65.12 111.32 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -124.44 -167.21 1.62 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.618 0.767 . . . . 63.2 108.988 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 4.3 t 67.58 3.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 124.738 1.215 . . . . 75.04 111.953 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 37.1 p -77.52 11.98 1.8 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.24 1.016 . . . . 62.15 112.836 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . 0.452 ' HB2' ' HG ' ' H' ' 291' ' ' LEU . 60.9 m -97.66 1.53 48.77 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.105 0.962 . . . . 71.5 111.129 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 14.5 t -139.29 134.52 16.62 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 122.675 0.39 . . . . 74.4 110.455 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 CA--C 1.564 2.017 0 C-N-CA 123.417 2.745 . . . . 73.33 111.707 170.644 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 110.481 -0.192 . . . . 61.44 110.481 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . 0.59 ' HA ' ' HB2' ' D' ' 90' ' ' GLU . 26.1 t-20 -86.67 146.84 26.14 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.833 0.453 . . . . 74.04 110.655 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -153.02 78.26 1.17 Allowed 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.463 -0.94 . . . . 73.53 108.463 172.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 65.92 126.17 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.936 1.294 . . . . 73.32 112.162 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . 0.493 ' HZ1' ' HB2' ' G' ' 275' ' ' LYS . 0.1 OUTLIER 68.83 168.58 0.12 Allowed Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 124.048 0.939 . . . . 70.0 112.068 177.282 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' G' ' 275' ' ' LYS . 46.0 Cg_endo -65.57 -164.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.278 1.986 . . . . 72.25 113.643 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 6.1 mp -67.27 -37.17 83.02 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.893 0.877 . . . . 75.12 112.057 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.17 107.4 11.9 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.147 -0.686 . . . . 75.0 109.147 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -137.59 -101.57 0.57 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.534 0.521 . . . . 73.25 112.137 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . 0.533 ' HB3' ' HB2' ' D' ' 95' ' ' ALA . 6.7 tt -72.09 122.25 20.63 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.937 0.895 . . . . 61.52 109.079 178.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -163.26 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.502 1.126 . . . . 74.04 109.349 170.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -79.66 -18.69 50.86 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.104 -0.498 . . . . 74.44 110.763 175.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . 0.521 ' HB3' ' HG ' ' G' ' 280' ' ' LEU . 25.5 t70 -66.94 99.96 0.69 Allowed 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.528 0.731 . . . . 64.34 109.487 174.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.36 73.92 2.3 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.562 -0.745 . . . . 63.11 111.504 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -57.0 -36.75 70.77 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.85 0.86 . . . . 64.02 110.697 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 286' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' G' ' 286' ' ' MET . 0.0 OUTLIER -122.9 101.58 38.98 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.192 0.997 . . . . 71.22 109.698 177.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.48 85.68 1.25 Allowed 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.303 2.002 . . . . 62.4 110.418 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.44 -52.38 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.153 -0.93 . . . . 74.31 110.283 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 63.7 -77.39 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.8 1.24 . . . . 73.15 111.226 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.479 ' HE3' ' H ' ' G' ' 291' ' ' LEU . 3.6 m95 -150.98 175.79 11.74 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.726 1.21 . . . . 70.51 109.681 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.479 ' H ' ' HE3' ' G' ' 290' ' ' TRP . 5.1 mp -93.71 -32.93 13.83 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.313 1.045 . . . . 73.25 108.894 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 155.36 -161.25 30.38 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 114.842 -1.072 . . . . 55.43 111.496 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.0 167.03 25.83 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.629 2.219 . . . . 72.5 112.147 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . 0.468 ' HE3' HG13 ' D' ' 40' ' ' VAL . 22.1 pttp -160.24 149.7 17.66 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 122.911 0.485 . . . . 75.2 109.919 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -74.53 96.32 2.92 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.295 -1.002 . . . . 74.44 108.295 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 296' ' ' THR . . . . . 0.473 HG22 ' HG2' ' D' ' 124' ' ' PRO . 78.7 m -73.3 -58.95 2.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.801 -0.636 . . . . 75.35 110.967 -173.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.629 ' HA ' ' HG3' ' D' ' 124' ' ' PRO . 0.2 OUTLIER -71.09 135.51 47.75 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.004 0.431 . . . . 74.53 111.22 -178.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . 0.671 ' HB3' ' HA ' ' E' ' 301' ' ' ILE . 42.1 m-70 -151.36 -41.62 0.12 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.728 -1.124 . . . . 72.44 110.295 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.02 -89.43 0.02 OUTLIER Glycine 0 CA--C 1.533 1.206 0 O-C-N 123.792 0.682 . . . . 74.4 113.144 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -160.57 143.8 13.39 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.79 -0.818 . . . . 72.52 108.79 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.537 HG13 ' HA ' ' D' ' 32' ' ' PHE . 9.9 tt -148.23 102.55 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.726 0 C-N-CA 124.928 1.291 . . . . 74.1 108.059 174.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -159.92 159.19 32.05 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.378 -0.971 . . . . 64.34 108.378 -175.016 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 5.8 tmtp? -95.89 -54.11 0.22 Allowed Pre-proline 0 CA--C 1.57 1.732 0 CA-C-O 118.821 -0.609 . . . . 71.33 110.761 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -90.22 159.56 4.69 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.077 1.851 . . . . 75.21 112.88 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -100.18 -70.39 0.74 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.37 0.668 . . . . 64.45 109.993 177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.02 176.98 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.734 0.813 . . . . 74.25 110.345 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 27.0 m -87.09 -60.04 2.09 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.497 0.719 . . . . 75.04 111.18 -176.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 60.1 m -127.28 158.08 38.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.195 0.998 . . . . 72.32 110.047 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' G' G ' 309' ' ' THR . . . . . 0.451 ' HB ' ' HD3' ' G' ' 310' ' ' PRO . 28.1 m -73.4 -52.04 5.35 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-O 118.877 -0.583 . . . . 75.14 109.604 167.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . 0.494 ' HG2' ' H ' ' C' ' 150' ' ' GLU . 98.3 Cg_endo . . . . . 0 C--N 1.394 2.962 0 C-N-CA 122.221 1.947 . . . . 61.21 111.504 172.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.062 -0.347 . . . . 74.31 110.062 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -132.47 145.41 51.16 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.938 -0.764 . . . . 71.44 108.938 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -104.38 32.19 4.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.48 0.712 . . . . 72.13 109.978 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -60.84 -36.09 78.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.932 0.893 . . . . 75.42 110.815 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . 0.431 ' HD2' ' N ' ' H' ' 275' ' ' LYS . 0.0 OUTLIER -98.98 130.95 26.36 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 107.521 -1.289 . . . . 72.1 107.521 171.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.26 -58.41 1.65 Allowed 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.945 3.096 . . . . 74.01 114.556 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.97 -46.41 9.88 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.283 -0.636 . . . . 74.33 109.283 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' H' ' 275' ' ' LYS . 39.0 tp -76.99 74.67 3.57 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-O 122.098 0.951 . . . . 72.21 111.05 -176.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -111.98 -4.77 25.79 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 114.767 -1.106 . . . . 70.02 111.669 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.65 129.76 12.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.017 0.927 . . . . 74.52 108.944 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -158.94 22.19 0.21 Allowed 'General case' 0 CA--C 1.559 1.311 0 O-C-N 124.245 0.966 . . . . 74.31 109.179 171.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -148.54 131.56 16.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.305 0.642 . . . . 74.41 110.213 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.11 -74.65 0.39 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.283 0.633 . . . . 75.24 110.331 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 159.48 -54.27 0.36 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.577 -0.609 . . . . 73.11 111.577 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -148.62 109.01 4.14 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.018 0.527 . . . . 72.11 109.841 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 55.6 ttp -169.69 89.17 0.56 Allowed Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 108.165 -1.05 . . . . 73.42 108.165 172.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -73.62 148.64 42.37 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.746 2.298 . . . . 64.41 111.96 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 61.9 t -77.1 89.98 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.652 -0.87 . . . . 75.2 108.652 175.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -75.23 148.49 39.44 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.769 -1.105 . . . . 72.15 109.78 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -66.13 131.54 46.41 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.259 0.552 . . . . 73.1 111.947 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' F' ' 308' ' ' CYS . 4.5 mp -88.65 1.24 55.4 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.513 -1.221 . . . . 75.21 109.917 171.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -178.27 95.47 0.1 OUTLIER Glycine 0 C--N 1.345 1.056 0 N-CA-C 109.255 -1.538 . . . . 63.02 109.255 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -58.59 -28.89 87.44 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.11 2.54 . . . . 74.41 112.945 -173.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -93.05 116.02 28.65 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.669 -0.863 . . . . 74.34 108.669 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -148.74 -59.94 0.23 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.911 0.485 . . . . 74.32 110.616 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 296' ' ' THR . . . . . 0.537 HG21 ' HD2' ' H' ' 297' ' ' TYR . 7.8 m -84.09 145.04 28.66 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.196 0.598 . . . . 71.53 110.534 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.602 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 27.2 m-85 59.99 103.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.081 1.352 . . . . 74.55 112.161 -174.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -148.4 -50.82 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.427 -0.806 . . . . 72.42 110.252 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -165.94 123.85 1.19 Allowed Glycine 0 C--N 1.347 1.144 0 C-N-CA 120.732 -0.747 . . . . 72.21 113.965 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' B' ' 124' ' ' PRO . 28.7 p-10 171.44 -40.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.807 1.643 . . . . 74.0 108.861 174.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 33.3 pt -94.35 18.32 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.093 0.957 . . . . 61.03 111.568 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.47 -43.31 77.25 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.951 0.9 . . . . 73.02 108.983 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -126.14 85.01 60.47 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.88 -1.156 . . . . 75.23 107.88 165.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -87.65 -161.77 0.13 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.266 2.644 . . . . 74.43 111.434 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 70.46 157.33 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.655 1.182 . . . . 72.53 113.188 171.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.35 120.5 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.361 -1.348 . . . . 72.5 107.361 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 13.4 t -160.28 168.66 24.84 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.256 0.622 . . . . 74.22 110.067 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 43.9 t 61.55 34.17 18.01 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.455 1.102 . . . . 72.51 110.335 -176.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' H' H ' 309' ' ' THR . . . . . 0.483 ' HG1' HD23 ' F' ' 291' ' ' LEU . 47.6 m -64.69 111.95 6.85 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 114.986 -1.007 . . . . 61.24 109.989 178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.375 1.922 0 C-N-CA 122.465 2.11 . . . . 64.44 111.325 178.564 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.062 -0.718 . . . . 73.32 109.062 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.3 m -147.74 39.67 0.96 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.446 1.098 . . . . 74.12 109.102 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.32 95.86 7.13 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.912 0.485 . . . . 72.03 110.839 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.661 HE21 ' HB3' ' A' ' 90' ' ' GLU . 2.0 mp0 -80.99 124.24 28.99 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.78 -0.822 . . . . 73.1 108.78 168.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -89.68 157.57 17.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.51 0.724 . . . . 75.54 109.876 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -69.4 90.34 0.52 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.864 0.866 . . . . 63.34 109.765 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.3 p -141.89 164.47 30.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.672 1.189 . . . . 73.12 110.411 -171.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.63 122.63 32.27 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.478 0.711 . . . . 63.21 109.316 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.4 mpt? -67.76 134.01 50.26 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.982 -0.747 . . . . 73.53 108.982 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m -140.69 137.4 33.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.294 0.638 . . . . 75.35 110.181 -173.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.485 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 28.1 t80 -138.83 127.59 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.005 -0.739 . . . . 73.22 109.005 171.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -159.17 110.91 2.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.466 0.479 . . . . 74.44 110.143 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.679 HG12 ' HD2' ' A' ' 84' ' ' PHE . 56.6 mt -69.5 116.02 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.057 0.543 . . . . 75.24 110.329 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.476 ' HA ' ' HA ' ' H' ' 307' ' ' THR . 22.7 tm0? -81.43 -36.04 29.91 Favored 'General case' 0 C--O 1.248 0.996 0 O-C-N 124.159 0.912 . . . . 72.22 110.007 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.407 ' HA ' HG23 ' H' ' 306' ' ' VAL . 67.7 ttt180 -176.28 123.01 0.17 Allowed 'General case' 0 C--N 1.363 1.195 0 O-C-N 123.557 0.536 . . . . 72.5 111.025 -173.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.06 142.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 123.614 0.766 . . . . 75.44 109.024 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -168.44 155.83 7.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.674 0.75 . . . . 75.12 111.71 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -86.6 114.99 23.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.953 -1.021 . . . . 52.31 109.193 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 39.2 mtpt -79.3 -22.07 45.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.147 -0.479 . . . . 74.25 111.009 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -159.84 144.27 14.82 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.88 0.872 . . . . 62.11 109.357 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.539 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 84.3 mt -141.93 143.88 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.361 1.464 . . . . 75.22 107.806 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -145.73 128.29 16.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.525 0.73 . . . . 74.13 109.537 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 89.7 t80 -126.12 117.25 22.76 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 106.082 -1.821 . . . . 72.43 106.082 162.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 47.1 mt-10 -118.99 140.56 49.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.965 -0.754 . . . . 73.51 108.965 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.53 72.96 69.16 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 105.804 -1.925 . . . . 74.2 105.804 168.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.58 -20.27 41.24 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.798 2.332 . . . . 73.2 112.042 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.408 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 37.9 m-20 -119.42 23.43 11.24 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.242 1.017 . . . . 64.3 109.434 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -47.95 -57.45 10.2 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.625 -1.179 . . . . 54.22 113.485 -170.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 14.1 Cg_exo -65.9 -19.4 58.42 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 121.873 1.715 . . . . 74.11 112.572 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.61 -44.62 14.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.803 0.841 . . . . 64.41 109.889 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -78.99 -19.6 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.824 -1.08 . . . . 75.44 111.943 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.61 -6.25 42.88 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.497 0.719 . . . . 74.44 111.301 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -102.2 -12.55 17.94 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.661 1.185 . . . . 74.15 111.978 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -71.42 168.66 17.0 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.719 0.808 . . . . 75.24 113.016 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.463 ' O ' HD22 ' A' ' 68' ' ' LEU . 23.3 m-20 -69.97 135.19 49.14 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.182 -0.917 . . . . 74.33 109.368 169.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -82.77 67.18 8.73 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.491 1.116 . . . . 73.33 110.617 -169.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -141.75 71.0 25.01 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.137 0.975 . . . . 72.15 109.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.617 ' HG2' ' HB3' ' E' ' 297' ' ' TYR . 2.0 Cg_endo -91.26 129.47 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.61 2.873 . . . . 75.4 112.217 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -96.63 110.5 22.91 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.034 -1.098 . . . . 75.15 108.034 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 t -79.22 136.64 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.672 0.789 . . . . 64.5 109.108 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -117.04 118.58 32.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.486 1.114 . . . . 75.01 108.136 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.681 HD12 HG11 ' E' ' 288' ' ' VAL . 4.0 tt -102.37 107.72 18.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.109 -1.071 . . . . 61.33 108.109 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.699 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 14.8 m-20 -108.01 151.16 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.935 0.894 . . . . 73.54 108.982 172.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -139.0 134.58 33.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.202 1.001 . . . . 72.23 108.42 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 35.0 t70 -135.96 137.27 41.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.076 0.951 . . . . 73.14 109.354 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 p -124.86 134.9 52.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.339 1.056 . . . . 71.11 110.157 -172.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.95 143.09 25.0 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 61.24 109.77 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -132.18 161.1 34.2 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.28 0.632 . . . . 74.54 109.338 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -163.49 127.8 2.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.499 0.72 . . . . 74.15 109.74 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -74.23 114.06 12.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.845 -0.798 . . . . 65.0 108.845 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.619 HD13 ' HB2' ' A' ' 57' ' ' GLU . 39.9 mt -79.42 -43.96 22.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.146 0.578 . . . . 75.52 109.629 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.64 -172.69 2.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.939 -1.028 . . . . 75.52 109.815 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.34 120.99 14.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.371 0.668 . . . . 64.35 109.387 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.37 16.55 9.6 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.668 1.187 . . . . 73.23 112.528 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.455 HG13 HD12 ' A' ' 51' ' ' LEU . 28.7 t -127.48 106.32 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.301 -1.0 . . . . 74.25 108.301 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -133.78 127.9 33.68 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.089 0.956 . . . . 74.12 108.479 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.619 ' HB2' HD13 ' A' ' 51' ' ' LEU . 33.7 tt0 -104.65 134.41 47.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.36 0.664 . . . . 70.32 109.762 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.608 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 97.2 t -122.82 123.79 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.967 -1.123 . . . . 71.43 107.967 169.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.536 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -99.68 135.48 34.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.357 1.063 . . . . 73.13 109.374 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.14 99.52 6.4 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.158 -1.423 . . . . 73.14 107.158 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.538 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.7 ttp180 -87.46 113.29 23.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.045 0.538 . . . . 73.31 109.806 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.406 ' HB ' HD11 ' A' ' 114' ' ' ILE . 13.6 t -93.76 143.33 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.498 -1.297 . . . . 74.11 107.498 171.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.699 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.5 m -131.56 133.86 45.47 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.42 -0.585 . . . . 62.53 109.42 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.596 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.8 t -131.19 111.02 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.1 1.36 . . . . 72.24 108.709 -173.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 m -120.69 121.64 38.71 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.326 0.512 . . . . 74.41 110.212 173.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.33 22.53 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.339 -1.356 . . . . 72.0 107.339 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 66.2 m -118.25 126.56 52.42 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.306 0.503 . . . . 73.42 110.485 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.463 HD22 ' O ' ' A' ' 35' ' ' ASP . 5.3 mp -90.22 85.72 6.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.879 -1.156 . . . . 74.42 107.879 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.15 -85.11 1.53 Allowed Glycine 0 C--N 1.343 0.94 0 CA-C-N 114.434 -1.257 . . . . 53.12 110.643 -173.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.13 -28.74 3.11 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.482 0.713 . . . . 65.01 110.872 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.408 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 30.4 tt0 -95.73 125.65 40.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.835 0.35 . . . . 75.11 110.307 -174.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 29.5 m -77.77 142.23 38.78 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.783 1.233 . . . . 73.13 112.805 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -80.04 -65.98 0.94 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.522 1.129 . . . . 74.22 109.199 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.407 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 50.6 p90 -146.1 148.94 33.15 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.513 -1.221 . . . . 75.54 111.865 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -109.29 143.08 39.25 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.22 -1.355 . . . . 72.04 107.904 167.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.596 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.3 m -143.06 109.7 5.45 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.6 119.54 17.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.755 -0.461 . . . . 70.45 109.755 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.09 114.37 32.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.382 1.073 . . . . 75.22 109.404 -171.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.86 84.22 7.65 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.38 -0.97 . . . . 74.3 108.38 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.57 91.7 5.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.811 -0.811 . . . . 63.24 108.811 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.09 167.27 37.69 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.39 -0.823 . . . . 52.43 111.715 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 124.95 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.186 -0.366 . . . . 75.34 112.186 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -81.98 115.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.964 -0.754 . . . . 63.32 108.964 171.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.679 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.7 m-85 -116.98 120.08 37.31 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.17 1.388 . . . . 75.55 107.81 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 t -75.57 94.17 3.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.797 -0.816 . . . . 71.41 108.797 171.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.657 HD11 HD21 ' A' ' 98' ' ' LEU . 50.8 pt -112.72 155.57 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.165 0.586 . . . . 74.13 110.708 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.76 167.69 11.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.456 -1.247 . . . . 71.45 109.111 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -11.65 57.6 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 114.511 0.564 . . . . 71.24 114.511 173.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.47 144.21 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.755 0.822 . . . . 61.22 110.3 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.661 ' HB3' HE21 ' A' ' 4' ' ' GLN . 1.3 tm-20 -162.06 173.31 14.55 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.785 -1.561 . . . . 65.31 106.785 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.25 -129.82 48.11 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 117.888 0.313 . . . . 61.04 113.543 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 71.3 p -75.09 -20.98 59.23 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.805 0.842 . . . . 74.43 111.826 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -69.82 -44.59 69.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.135 0.574 . . . . 74.35 109.619 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.718 ' SD ' ' HA ' ' E' ' 278' ' ' LEU . 50.4 ttm -68.95 -34.27 75.08 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.01 -0.541 . . . . 72.24 110.066 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.488 ' HA ' HD23 ' E' ' 280' ' ' LEU . . . -60.98 -28.34 68.94 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.188 0.595 . . . . 73.3 111.777 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.426 ' O ' ' HB1' ' A' ' 100' ' ' ALA . 52.8 t-80 -88.47 -31.13 18.92 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.297 0.639 . . . . 71.43 111.065 171.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.11 -64.69 0.84 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.582 0.353 . . . . 72.33 111.149 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.657 HD21 HD11 ' A' ' 86' ' ' ILE . 47.2 mt -90.09 -12.74 37.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.168 0.433 . . . . 72.52 112.168 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.78 -2.45 55.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.768 -0.462 . . . . 71.42 113.347 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -149.19 -53.17 0.17 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.365 0.582 . . . . 73.33 112.186 -174.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -77.3 -56.94 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 64.34 112.085 -168.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.422 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 80.5 m -74.97 -34.48 1.72 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.563 0.949 . . . . 73.32 113.563 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.6 Cg_endo -67.06 -23.01 46.8 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 121.958 1.772 . . . . 74.4 112.936 168.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -70.19 -33.76 72.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.3 0.64 . . . . 62.31 109.487 174.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.401 HG21 HD13 ' A' ' 13' ' ' ILE . 45.3 mm -63.04 -42.17 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.799 0.84 . . . . 74.21 110.14 173.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.66 -32.62 69.97 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.982 -1.008 . . . . 72.52 111.981 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.27 -39.99 55.75 Favored Pre-proline 0 CA--C 1.575 1.927 0 N-CA-C 114.597 1.332 . . . . 74.41 114.597 -169.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.05 -41.75 73.69 Favored 'Trans proline' 0 C--N 1.392 2.835 0 C-N-CA 122.592 2.195 . . . . 73.55 113.489 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -71.97 -37.3 69.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.985 0.514 . . . . 64.25 111.376 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.46 88.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.785 0.434 . . . . 74.24 109.86 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.427 ' NH1' HD13 ' C' ' 105' ' ' ILE . 38.7 ttm180 -54.97 -53.38 56.44 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 124.726 1.266 . . . . 75.23 110.126 179.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.52 -42.75 95.59 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.044 0.84 . . . . 73.41 111.231 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.515 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.4 t -60.64 -34.52 74.39 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.504 0.722 . . . . 74.3 111.257 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.5 mt -73.44 -55.51 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.593 0.757 . . . . 72.23 109.867 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.491 HG23 ' HG3' ' A' ' 125' ' ' GLN . 90.0 m -53.08 -40.33 63.98 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 125.199 1.4 . . . . 61.23 111.952 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -61.49 -50.78 71.33 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 61.52 110.303 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.482 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -61.17 -44.22 97.65 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.461 0.704 . . . . 71.44 111.527 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.4 t -55.83 -46.81 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 O-C-N 124.25 0.969 . . . . 63.02 110.299 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.6 t -69.87 -29.58 66.83 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.199 -0.91 . . . . 74.43 111.504 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -70.95 -27.67 63.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.363 0.665 . . . . 73.41 111.259 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.78 11.77 58.71 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.93 -0.372 . . . . 62.44 113.339 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.488 ' HB ' HH21 ' B' ' 15' ' ' ARG . 2.4 m 61.03 25.62 15.63 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 125.141 1.376 . . . . 73.23 111.022 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -94.01 146.23 31.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.825 -0.806 . . . . 74.24 108.825 171.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.73 149.55 90.55 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.66 2.24 . . . . 74.03 112.088 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.491 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.6 tt0 -58.37 133.16 55.49 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.295 0.997 . . . . 61.42 112.003 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.01 103.73 9.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.256 1.022 . . . . 75.24 108.783 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -105.97 110.89 23.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.127 -1.064 . . . . 75.35 108.127 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.55 135.5 54.27 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 123.404 0.44 . . . . 73.03 110.402 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.458 ' HB3' HD11 ' E' ' 291' ' ' LEU . . . -69.38 155.93 92.59 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.39 0.676 . . . . 72.24 110.312 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.24 125.33 14.94 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.524 2.149 . . . . 75.24 112.181 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -99.8 113.1 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.717 -1.586 . . . . 70.04 106.717 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.443 ' HB2' ' HB1' ' A' ' 135' ' ' ALA . 2.3 p-10 -72.79 81.33 1.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 74.11 110.488 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.09 -44.26 97.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.449 0.7 . . . . 63.32 110.951 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.546 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 11.2 p-10 -71.92 -40.33 68.86 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.286 -1.325 . . . . 75.21 111.707 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.443 ' HB1' ' HB2' ' A' ' 132' ' ' ASN . . . -72.44 -41.58 65.97 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.61 0.569 . . . . 65.02 111.16 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.13 -51.09 65.59 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.441 0.696 . . . . 74.02 109.794 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.98 -36.09 82.83 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.699 0.624 . . . . 72.31 110.979 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.471 ' HE1' ' HA ' ' A' ' 138' ' ' MET . 4.5 tpt -63.26 -43.95 96.51 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.573 0.545 . . . . 74.31 110.104 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.682 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 43.5 m-80 -62.89 -38.79 92.31 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.786 0.679 . . . . 72.23 111.368 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -69.12 -39.33 79.0 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.944 -0.571 . . . . 71.12 110.852 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.0 tp -69.15 -50.87 43.83 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.117 0.567 . . . . 74.32 111.72 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -178.43 21.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.016 0.526 . . . . 75.15 111.416 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.682 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 40.3 mt-30 58.47 -75.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.384 1.874 . . . . 65.42 114.66 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -135.2 34.07 3.07 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.803 0.811 . . . . 74.1 109.093 -174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.97 -169.15 3.25 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.051 -0.977 . . . . 71.0 110.195 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.85 137.38 8.82 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.854 -0.898 . . . . 70.1 110.854 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -72.74 129.26 37.8 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.083 0.553 . . . . 75.31 110.908 -174.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.98 124.63 6.72 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.981 -0.554 . . . . 64.24 112.354 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.5 p -81.75 138.7 35.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.885 0.874 . . . . 74.25 111.195 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -107.45 118.0 35.58 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.733 0.813 . . . . 72.21 109.912 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.9 128.32 34.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.316 0.646 . . . . 73.02 110.293 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -176.53 123.5 0.16 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.658 1.183 . . . . 72.24 108.013 168.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.39 66.88 8.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.855 0.862 . . . . 53.34 110.288 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.1 86.9 7.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.424 -0.954 . . . . 54.01 108.424 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 N-CA-C 108.401 -0.963 . . . . 74.25 108.401 174.998 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.756 -0.461 . . . . 72.24 109.756 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' D' ' 137' ' ' PHE . 47.3 m -74.61 85.43 2.09 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.246 0.618 . . . . 62.03 110.181 175.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -75.51 168.39 20.1 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.292 -0.867 . . . . 75.23 112.15 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 63.03 -161.9 0.29 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 124.546 1.139 . . . . 62.45 110.555 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -157.14 145.06 19.16 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.713 -1.217 . . . . 75.15 107.713 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.47 137.35 42.51 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.818 -0.808 . . . . 72.43 108.818 171.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.8 m -72.0 78.35 0.92 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.528 -0.916 . . . . 65.32 108.528 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -108.64 103.25 12.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.256 -1.387 . . . . 73.31 107.256 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.464 ' HE3' ' HB2' ' B' ' 11' ' ' PHE . 21.2 ptm 48.84 -171.77 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.729 1.612 . . . . 75.55 113.76 -175.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 52.6 m -137.35 116.69 12.71 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.537 0.735 . . . . 70.52 109.381 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.482 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 31.9 t80 -139.58 131.33 27.46 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.224 -0.658 . . . . 73.45 109.224 176.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' B' ' 85' ' ' SER . 3.9 pp0? -152.29 140.9 20.81 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.055 0.542 . . . . 75.12 109.54 168.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.562 ' H ' HD12 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -69.28 113.8 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.247 -0.888 . . . . 72.12 109.344 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -88.24 -35.31 17.38 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.008 -0.738 . . . . 65.35 109.008 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.488 HH21 ' HB ' ' A' ' 122' ' ' THR . 24.3 ttt180 -168.47 142.0 3.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.999 0.92 . . . . 73.13 109.726 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.11 137.66 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.007 -1.479 . . . . 72.04 107.007 172.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -166.28 159.24 14.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.687 0.756 . . . . 75.24 110.96 -178.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.9 m -84.63 119.42 25.21 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.283 -1.006 . . . . 75.51 108.283 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -87.03 -34.44 19.2 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.289 0.635 . . . . 75.51 111.142 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -158.84 146.26 17.64 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.322 -0.399 . . . . 73.52 110.746 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.406 HD13 ' SG ' ' B' ' 113' ' ' CYS . 46.7 mm -142.49 138.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 125.965 1.706 . . . . 73.22 107.619 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -140.1 118.9 12.44 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.522 -1.288 . . . . 73.22 107.522 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.539 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.5 t80 -131.59 136.42 47.77 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.08 -1.081 . . . . 73.33 108.08 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.76 145.28 38.05 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.131 0.972 . . . . 72.31 108.696 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.34 72.3 10.93 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 105.9 -1.889 . . . . 74.34 105.9 171.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.55 -14.71 30.65 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.79 2.327 . . . . 73.23 112.177 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -127.04 28.53 5.76 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.032 0.933 . . . . 60.14 109.502 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.69 -59.35 5.25 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.477 1.111 . . . . 71.1 113.305 -173.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.29 -18.97 34.16 Favored 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 121.926 1.751 . . . . 70.03 113.029 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -94.73 -21.81 18.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.439 0.696 . . . . 74.1 112.382 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -81.94 -28.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 110.051 -0.351 . . . . 73.22 110.051 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -62.47 -27.03 68.85 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.278 1.031 . . . . 74.12 113.216 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -72.77 -16.18 61.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.235 0.614 . . . . 75.1 112.204 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -107.55 113.34 26.59 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.149 0.98 . . . . 74.2 109.227 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -110.38 104.57 13.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 118.707 0.685 . . . . 70.01 112.605 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.46 ' HE3' ' N ' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 179.21 -177.38 0.3 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.384 1.474 . . . . 74.22 110.898 176.563 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.54 133.73 70.45 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.293 1.037 . . . . 74.41 111.956 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.583 ' HB3' HD21 ' B' ' 68' ' ' LEU . 93.1 Cg_endo -93.43 170.6 2.08 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.329 2.686 . . . . 74.02 114.564 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -80.98 101.69 9.67 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.879 -1.526 . . . . 64.43 106.879 164.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.476 ' H ' ' HE3' ' H' ' 294' ' ' LYS . 10.9 t -99.7 134.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.343 -0.984 . . . . 74.21 108.343 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.431 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.3 tttp -125.35 117.17 23.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.251 0.62 . . . . 74.42 110.195 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.88 136.57 33.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.968 -1.123 . . . . 71.53 107.968 169.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.572 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 15.4 t70 -145.93 154.72 42.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.19 0.596 . . . . 61.33 109.584 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.5 tp -135.42 128.32 31.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.228 1.011 . . . . 74.43 109.71 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.6 t70 -124.01 130.99 53.49 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.232 -1.025 . . . . 64.31 108.232 170.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -118.31 104.54 10.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.36 0.664 . . . . 74.43 109.947 -176.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.27 118.77 33.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.575 -0.898 . . . . 73.2 108.575 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 41.1 p -129.31 160.58 32.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.22 0.608 . . . . 63.44 110.53 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.1 p -165.69 138.37 4.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.972 0.909 . . . . 62.34 110.016 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . 0.45 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 50.3 tt0 -81.16 115.46 20.59 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.477 0.711 . . . . 74.43 109.405 175.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.421 HD12 HG22 ' B' ' 83' ' ' ILE . 32.7 mt -75.5 -43.38 49.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.67 0.788 . . . . 73.55 110.538 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.65 -171.21 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.84 0.856 . . . . 73.12 110.481 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.62 116.49 4.05 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.36 0.664 . . . . 74.11 110.243 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 67.12 -3.36 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.568 1.547 . . . . 73.54 113.383 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -102.92 110.56 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.822 -1.177 . . . . 74.44 107.822 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 45.6 m-85 -111.68 172.04 7.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.379 -0.828 . . . . 74.0 108.996 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 20.3 tt0 -142.43 129.0 20.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.485 -0.931 . . . . 61.43 108.485 172.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -112.51 119.0 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.504 -1.295 . . . . 75.44 107.504 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -103.09 111.91 34.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 108.965 -0.754 . . . . 75.11 108.965 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.49 101.47 13.67 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.993 -1.003 . . . . 74.42 108.772 -176.883 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.7 ttm-85 -94.93 121.0 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.366 -0.605 . . . . 63.44 109.366 174.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . 0.438 HG11 HD22 ' B' ' 128' ' ' LEU . 41.3 t -115.75 125.48 72.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.222 -1.029 . . . . 72.41 108.222 172.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.572 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.6 m -111.96 140.34 46.71 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.616 0.722 . . . . 72.33 110.129 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.515 HG22 HG21 ' B' ' 114' ' ' ILE . 54.5 t -124.72 130.81 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 113.818 -1.537 . . . . 61.1 108.161 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' THR . . . . . 0.431 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.1 m -122.23 143.61 49.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.127 0.571 . . . . 72.25 109.466 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.05 125.77 13.42 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.524 -1.287 . . . . 70.55 107.524 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 55.8 p -140.82 140.08 34.61 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.303 0.641 . . . . 72.44 109.566 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.583 HD21 ' HB3' ' B' ' 38' ' ' PRO . 3.2 mm? -124.68 123.0 39.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.59 1.156 . . . . 65.05 109.974 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.89 -113.03 4.75 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.595 0.56 . . . . 63.35 112.057 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -113.02 4.16 16.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.856 0.863 . . . . 73.54 110.326 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -123.6 146.51 48.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.063 0.545 . . . . 75.53 110.282 -169.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -83.03 124.89 30.85 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.469 0.308 . . . . 74.43 110.341 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.576 ' HB1' HD22 ' B' ' 68' ' ' LEU . . . -71.45 -63.98 1.01 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.257 0.973 . . . . 73.13 109.262 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -157.03 149.44 23.17 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 121.657 0.741 . . . . 73.05 112.511 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' B' ' 23' ' ' PHE . 83.6 mt -113.89 118.96 35.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.946 -1.501 . . . . 74.52 106.946 166.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 34.5 t -125.42 124.8 42.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.797 -0.816 . . . . 71.33 108.797 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -148.55 130.81 15.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.5 -0.926 . . . . 65.21 108.5 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -124.45 146.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 123.953 0.901 . . . . 74.24 109.512 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -121.66 96.49 5.09 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.193 -1.04 . . . . 63.25 108.193 170.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.509 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -90.99 99.33 12.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.292 -1.003 . . . . 74.13 108.292 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.13 142.66 16.07 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 110.788 -0.925 . . . . 61.44 110.788 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.27 124.93 3.35 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.43 -1.068 . . . . 64.33 110.43 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.421 HG22 HD12 ' B' ' 51' ' ' LEU . 56.7 mt -85.69 127.7 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.305 -1.369 . . . . 74.42 107.305 172.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.73 133.66 43.77 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.402 -0.962 . . . . 75.32 108.402 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.585 ' HB2' ' NE2' ' B' ' 12' ' ' GLN . 48.4 m -94.04 103.58 15.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.628 -1.249 . . . . 71.42 107.628 171.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.86 146.16 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.405 1.082 . . . . 73.52 110.265 -171.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.05 172.22 16.08 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.798 1.239 . . . . 70.03 109.198 172.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.0 -30.39 6.7 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.173 0.416 . . . . 71.51 114.003 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.36 162.79 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.343 0.657 . . . . 72.12 112.135 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -172.09 145.38 1.79 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.925 1.29 . . . . 73.42 109.04 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -111.3 3.3 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 114.74 0.656 . . . . 75.25 114.74 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -65.49 -44.02 88.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.833 0.853 . . . . 75.02 110.122 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -69.07 -29.77 67.95 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.693 -1.594 . . . . 75.31 110.545 -171.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.469 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 19.9 ptm -81.84 -34.09 30.35 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 116.496 -0.32 . . . . 74.45 111.016 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -34.75 74.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.515 0.726 . . . . 72.33 111.912 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -77.83 -34.02 52.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.238 0.615 . . . . 74.13 111.05 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.92 -65.84 0.63 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.698 0.399 . . . . 71.35 111.013 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.554 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.4 pp -70.95 -24.1 62.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.735 0.414 . . . . 75.42 111.961 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.433 ' N ' HD13 ' B' ' 98' ' ' LEU . . . -84.4 -32.89 21.34 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.661 0.601 . . . . 54.14 113.729 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.7 -50.35 1.49 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.007 0.523 . . . . 70.43 111.564 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . 0.415 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 70.3 t80 -71.22 -40.8 70.9 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.361 0.664 . . . . 74.43 111.945 -172.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.554 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 55.6 m -72.21 -46.99 10.93 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.803 -0.618 . . . . 74.12 111.121 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.1 Cg_exo -57.62 -33.24 96.32 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.462 2.108 . . . . 65.21 113.708 168.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.78 -37.57 68.75 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.886 0.874 . . . . 54.41 110.919 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.19 -48.87 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.865 -1.062 . . . . 72.22 111.159 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.439 ' HB2' HD11 ' B' ' 60' ' ' LEU . 62.3 mt -77.72 -19.33 55.42 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.538 0.735 . . . . 74.33 112.405 -170.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.26 -45.56 85.12 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 114.164 1.172 . . . . 74.32 114.164 -170.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -57.02 -38.94 94.75 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 122.511 2.141 . . . . 74.1 113.351 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.509 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.1 m-85 -69.14 -40.11 78.45 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.153 -0.93 . . . . 73.51 109.858 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.99 93.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.523 0.729 . . . . 73.24 110.308 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -54.86 -57.59 11.0 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.623 1.169 . . . . 71.42 111.373 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.43 80.53 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.989 0.805 . . . . 74.2 110.244 -175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.1 t -72.37 -32.58 66.56 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.868 0.467 . . . . 64.13 111.643 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.515 HG21 HG22 ' B' ' 64' ' ' VAL . 50.9 mt -65.3 -51.81 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.357 -0.979 . . . . 73.32 108.357 171.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' THR . . . . . 0.428 HG22 ' OG ' ' C' ' 119' ' ' SER . 24.8 m -61.28 -30.17 70.31 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.667 -1.152 . . . . 74.52 111.698 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.47 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.2 t -64.86 -46.7 80.74 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.789 0.836 . . . . 74.21 109.443 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.511 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 13.3 mmt -72.54 -30.54 64.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.217 0.607 . . . . 74.53 110.944 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.497 HG22 HD23 ' B' ' 126' ' ' LEU . 83.3 t -64.46 -41.16 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.911 0.884 . . . . 75.02 110.311 172.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -65.65 -35.11 79.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.058 0.943 . . . . 72.03 111.452 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.515 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.4 mtt-85 -73.03 -37.21 66.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.614 -0.721 . . . . 75.35 110.317 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.39 1.94 74.14 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.737 0.648 . . . . 71.31 112.59 173.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p 63.93 18.32 11.11 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.581 1.952 . . . . 73.42 113.544 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.57 152.79 81.08 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.47 0.708 . . . . 73.5 109.433 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.437 ' HG2' ' HA ' ' H' ' 297' ' ' TYR . 32.1 Cg_exo -60.54 -178.81 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 123.106 2.538 . . . . 73.43 114.236 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.558 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 26.5 tp60 -65.37 113.48 4.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.753 -0.658 . . . . 63.12 112.445 -170.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.497 HD23 HG22 ' B' ' 118' ' ' VAL . 55.9 tp -114.35 93.78 4.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.05 -0.977 . . . . 73.42 108.855 171.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.08 128.5 36.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.591 -1.262 . . . . 74.41 107.591 166.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.438 HD22 HG11 ' B' ' 62' ' ' VAL . 30.2 tp -75.77 145.6 40.64 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.377 0.671 . . . . 73.31 110.51 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 127.49 85.02 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.817 0.847 . . . . 72.51 111.316 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.47 122.84 10.62 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.891 2.394 . . . . 74.2 111.594 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.91 116.85 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.409 0.684 . . . . 73.02 109.978 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -86.23 86.47 7.35 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.546 -0.909 . . . . 73.52 108.546 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -73.31 -32.17 64.45 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.742 -0.663 . . . . 73.24 109.668 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -58.63 -51.01 71.73 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.55 1.14 . . . . 74.2 111.502 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.74 -39.98 73.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.623 0.769 . . . . 70.14 111.364 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.34 -47.7 84.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.424 0.69 . . . . 75.41 109.514 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -73.79 -24.77 59.87 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.132 -0.94 . . . . 73.4 111.086 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.4 ttt -67.67 -37.98 83.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.357 0.663 . . . . 75.0 110.485 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -79.49 -26.12 41.69 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 115.906 -0.588 . . . . 75.13 110.739 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -63.88 -39.1 93.4 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.918 0.887 . . . . 73.11 110.108 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.11 -6.4 55.46 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.479 -0.782 . . . . 73.43 112.124 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 68.0 135.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.802 1.241 . . . . 65.3 111.629 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -76.6 85.56 3.27 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.184 0.516 . . . . 50.41 111.166 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -167.36 115.05 0.78 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.269 1.028 . . . . 75.33 108.265 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.41 97.55 1.35 Allowed 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.185 -0.672 . . . . 64.41 109.185 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.56 66.03 4.0 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.717 -0.553 . . . . 72.04 111.717 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.25 139.0 49.88 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.215 1.006 . . . . 75.54 110.757 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.85 86.27 0.08 OUTLIER Glycine 0 C--N 1.342 0.882 0 N-CA-C 110.325 -1.11 . . . . 73.15 110.325 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 24.0 p -74.51 84.15 2.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.659 0.784 . . . . 75.23 111.347 -176.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.26 147.3 32.6 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.551 -0.749 . . . . 73.22 109.265 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -156.45 132.38 9.72 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.914 0.388 . . . . 73.35 111.522 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -128.9 105.61 8.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.498 1.119 . . . . 75.14 108.795 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.31 91.28 2.17 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.088 -0.708 . . . . 72.24 109.088 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.54 139.92 35.53 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.373 1.069 . . . . 73.42 110.318 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.916 0 C-N-CA 123.64 0.776 . . . . 74.24 109.234 177.582 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.404 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.3 mpt? . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.373 -0.603 . . . . 75.02 109.373 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 17.6 m -76.24 76.41 3.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.395 0.678 . . . . 63.11 109.618 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.25 -44.88 82.44 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.395 0.617 . . . . 72.02 110.499 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -153.19 130.5 11.28 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.854 -1.066 . . . . 63.41 109.469 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.487 ' HA ' ' OG1' ' C' ' 149' ' ' THR . 19.2 m120 -132.31 127.5 35.71 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.66 -1.237 . . . . 61.12 107.66 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -153.55 118.71 5.12 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.132 -0.692 . . . . 73.53 109.132 -168.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 51.1 m -103.24 101.47 11.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.291 1.036 . . . . 72.34 110.337 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.05 117.88 30.93 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.154 -1.054 . . . . 65.13 108.154 167.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.485 ' HE2' HG12 ' C' ' 89' ' ' ILE . 73.5 mtp 64.71 117.33 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.364 1.466 . . . . 72.22 112.365 -176.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.502 ' HA ' ' SG ' ' G' ' 308' ' ' CYS . 89.3 m -86.26 99.5 11.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.677 -0.86 . . . . 72.23 108.677 169.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -124.33 126.76 46.55 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.789 -1.189 . . . . 71.03 107.789 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.416 ' HB2' ' O ' ' G' ' 306' ' ' VAL . 13.0 pt20 -151.85 144.09 23.99 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.918 0.487 . . . . 73.02 110.257 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.448 HG13 ' HE2' ' C' ' 84' ' ' PHE . 3.1 mp -82.63 115.73 25.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.219 -1.03 . . . . 75.53 108.219 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -80.93 -44.08 18.79 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.951 -0.388 . . . . 74.25 109.951 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -169.11 141.78 2.67 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.304 0.378 . . . . 75.11 110.098 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -125.45 135.52 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.053 -1.091 . . . . 73.41 108.053 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.526 ' HH ' HD11 ' C' ' 83' ' ' ILE . 32.6 p90 -173.77 155.9 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.914 0.387 . . . . 72.11 111.129 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -77.36 115.59 17.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.392 -0.822 . . . . 74.33 109.871 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -65.1 -41.02 95.34 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.995 -0.743 . . . . 74.22 108.995 171.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.573 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -149.34 150.11 31.96 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.316 -1.311 . . . . 74.14 110.353 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -142.14 145.28 24.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.501 1.92 . . . . 65.34 106.507 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -161.87 150.87 15.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.822 0.449 . . . . 72.33 110.053 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.86 106.67 2.68 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.436 -1.32 . . . . 71.23 107.436 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.39 120.22 36.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.747 0.819 . . . . 70.33 109.41 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.95 83.34 61.42 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.343 1.057 . . . . 70.31 108.496 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.92 -39.21 34.01 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.628 2.219 . . . . 73.13 112.081 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -97.13 20.9 10.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.957 0.903 . . . . 71.32 110.952 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.15 76.08 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.419 1.266 . . . . 70.25 114.419 -171.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.75 -26.35 8.32 Favored 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 121.235 1.477 . . . . 74.41 112.655 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.66 -30.37 65.65 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.336 1.054 . . . . 72.22 112.511 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.603 HG21 ' HA ' ' C' ' 73' ' ' ALA . 99.4 t -80.02 -20.17 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.32 0.648 . . . . 64.21 110.639 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -60.47 -28.97 68.75 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.072 0.549 . . . . 74.24 111.348 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.42 26.26 6.82 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.558 0.743 . . . . 75.21 110.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.25 152.36 37.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.605 0.762 . . . . 74.23 111.084 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.62 130.71 43.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.816 0.847 . . . . 71.5 110.449 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.465 ' HE1' ' ND2' ' F' ' 300' ' ' ASN . 18.0 m95 -76.34 98.14 4.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.838 0.855 . . . . 74.03 110.889 -172.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -156.59 75.82 4.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.397 -0.964 . . . . 74.41 108.397 173.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -86.63 130.09 3.17 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.391 2.06 . . . . 75.53 112.126 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.53 80.25 9.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.582 -1.636 . . . . 74.42 106.582 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.459 HG12 HD21 ' C' ' 126' ' ' LEU . 90.2 t -74.45 118.26 19.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.226 -1.352 . . . . 75.45 108.617 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -128.71 141.34 51.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.276 -1.379 . . . . 74.32 107.276 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.16 166.39 14.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.554 -0.906 . . . . 74.3 108.554 167.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.534 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.1 t70 -140.0 127.91 22.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.611 -1.255 . . . . 54.44 107.611 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 tp -104.85 140.62 37.86 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.691 0.796 . . . . 64.33 109.991 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.501 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 29.3 t70 -144.84 149.93 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.17 0.988 . . . . 73.4 108.676 172.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 66.3 p -126.77 141.09 51.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 75.34 109.928 -172.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.473 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -150.25 139.98 21.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.055 0.542 . . . . 71.22 110.104 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p -148.01 156.07 42.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.533 0.733 . . . . 71.42 109.529 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -152.68 165.55 34.93 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.282 0.633 . . . . 74.01 109.937 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -105.16 118.08 35.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.824 -0.806 . . . . 63.41 108.824 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.52 HD13 HD13 ' C' ' 83' ' ' ILE . 76.4 mt -89.04 -35.61 16.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.181 0.592 . . . . 73.2 110.366 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -171.3 2.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.036 0.934 . . . . 75.14 110.219 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.43 116.41 8.96 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.278 -0.874 . . . . 75.22 109.423 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 69.57 -0.46 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.371 1.468 . . . . 75.43 112.601 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.32 112.29 38.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 108.146 -1.057 . . . . 74.21 108.146 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.402 ' HB2' HD12 ' C' ' 86' ' ' ILE . 94.0 m-85 -129.56 144.13 51.13 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.889 0.876 . . . . 73.41 108.856 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -99.73 136.42 39.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.529 1.132 . . . . 74.52 110.021 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . 0.449 HG21 HD21 ' C' ' 98' ' ' LEU . 40.8 t -114.95 120.04 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.816 -1.179 . . . . 74.42 107.816 173.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.473 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 88.7 t -118.59 129.92 74.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.764 -0.828 . . . . 71.02 108.764 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.401 ' HG ' ' HB3' ' C' ' 103' ' ' PRO . 2.6 tm? -125.01 107.0 10.38 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.948 -1.501 . . . . 73.43 106.948 176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.501 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 25.5 ttm180 -84.06 127.02 33.62 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.906 -0.588 . . . . 71.3 109.774 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.15 121.28 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.52 -1.218 . . . . 73.2 107.881 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 68.5 m -120.59 142.54 49.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.566 -0.902 . . . . 72.15 108.566 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.484 HG23 HG21 ' C' ' 114' ' ' ILE . 72.8 t -122.39 115.31 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.889 0.876 . . . . 74.31 109.421 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 28.2 m -99.31 135.79 40.21 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.879 -0.786 . . . . 65.2 108.879 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.29 107.29 7.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.082 -1.451 . . . . 74.43 107.082 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 67' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.3 m -143.44 128.36 18.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.286 0.634 . . . . 73.3 109.468 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' C' ' 73' ' ' ALA . 5.3 mp -85.8 56.71 4.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.469 1.507 . . . . 74.42 109.313 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.0 -82.33 0.44 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 109.893 -1.283 . . . . 71.54 109.893 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.12 -30.6 4.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.604 1.161 . . . . 73.22 109.104 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.19 91.79 0.08 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.191 1.397 . . . . 75.11 110.796 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 72' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 38.6 m -71.98 121.36 19.0 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.749 0.309 . . . . 74.43 111.389 -173.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.603 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -68.72 -62.67 1.29 Allowed 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.722 1.263 . . . . 61.23 109.646 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -163.48 175.66 10.52 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.442 -1.254 . . . . 75.22 109.794 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -140.41 145.71 37.4 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.251 -1.759 . . . . 73.3 106.251 175.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 45.0 t -144.92 149.61 35.56 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.325 -0.991 . . . . 70.44 108.325 178.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.88 121.03 3.93 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.61 -0.515 . . . . 62.42 109.61 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -119.64 114.41 44.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.869 -0.789 . . . . 73.42 108.869 170.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.573 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.1 96.79 10.84 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.628 -1.249 . . . . 74.51 107.628 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . 0.531 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.1 tp-100 -82.75 129.22 34.94 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.941 0.496 . . . . 53.44 109.678 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.16 154.84 16.72 Favored Glycine 0 N--CA 1.461 0.328 0 O-C-N 123.51 0.506 . . . . 61.43 112.051 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.436 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.47 122.25 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.147 -0.781 . . . . 73.43 111.147 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.526 HD11 ' HH ' ' C' ' 17' ' ' TYR . 12.0 mm -89.25 127.08 42.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.468 -0.938 . . . . 74.34 108.468 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . 0.448 ' HE2' HG13 ' C' ' 13' ' ' ILE . 83.8 m-85 -136.59 131.68 34.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 74.34 109.871 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -81.05 104.09 11.31 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.405 -0.961 . . . . 71.44 108.405 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.552 HD11 ' SD ' ' C' ' 94' ' ' MET . 10.5 pt -119.45 120.55 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.705 0.802 . . . . 75.43 109.867 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.35 168.05 25.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.715 0.806 . . . . 75.53 110.72 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.28 -61.17 3.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.048 -0.978 . . . . 71.55 111.411 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.485 HG12 ' HE2' ' C' ' 9' ' ' MET . 2.3 pp -81.17 142.52 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.789 0.328 . . . . 74.44 110.331 172.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.464 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 12.2 pt-20 -147.91 179.03 8.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.797 0.839 . . . . 63.23 109.397 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -122.43 29.81 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 123.687 0.617 . . . . 71.03 113.652 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -78.79 -22.99 45.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.93 0.892 . . . . 73.31 111.595 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -72.86 -31.7 64.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.882 0.473 . . . . 74.41 109.913 173.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.552 ' SD ' HD11 ' C' ' 86' ' ' ILE . 51.6 tpp -66.66 -40.52 88.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.659 -0.7 . . . . 72.42 110.114 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.11 70.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.934 0.894 . . . . 73.34 112.767 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.454 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 43.7 t-80 -69.27 -39.06 78.61 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.737 0.415 . . . . 65.43 111.426 177.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -76.16 -41.47 49.71 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.168 0.509 . . . . 73.3 110.732 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.449 HD21 HG21 ' C' ' 58' ' ' VAL . 3.4 tm? -82.62 -53.38 5.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.995 1.318 . . . . 73.14 110.75 -168.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.7 -0.19 69.58 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.708 -0.678 . . . . 72.32 114.176 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.557 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -128.97 -66.81 0.81 Allowed 'General case' 0 C--N 1.35 0.598 0 CA-C-N 117.211 0.506 . . . . 74.04 111.503 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.15 -49.01 63.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.678 0.622 . . . . 73.4 112.678 -169.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.12 -42.67 77.87 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 118.237 -0.887 . . . . 74.12 112.477 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . 0.401 ' HB3' ' HG ' ' C' ' 60' ' ' LEU . 89.0 Cg_exo -49.57 -41.36 44.99 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.129 2.553 . . . . 63.34 113.691 166.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 89.0 m-20 -67.62 -31.22 71.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.766 0.827 . . . . 75.41 111.467 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.427 HD13 ' NH1' ' A' ' 111' ' ' ARG . 39.6 mm -70.39 -44.23 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.16 0.584 . . . . 75.14 109.735 175.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.436 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.4 mt -79.24 -21.56 46.01 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.452 -0.794 . . . . 74.13 111.773 -173.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.42 -54.88 46.1 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.788 1.235 . . . . 74.44 113.199 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.67 -30.26 78.46 Favored 'Trans proline' 0 C--N 1.392 2.867 0 C-N-CA 122.024 1.816 . . . . 74.12 112.662 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.26 -48.75 64.23 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.574 0.75 . . . . 73.33 110.809 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.531 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.75 -37.22 86.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.426 0.69 . . . . 75.44 110.802 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -42.01 72.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.534 1.134 . . . . 74.22 110.568 -174.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.66 -36.45 73.36 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.616 0.766 . . . . 54.12 109.581 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.8 t -67.04 -35.18 79.3 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.69 0.796 . . . . 74.3 111.256 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.484 HG21 HG23 ' C' ' 64' ' ' VAL . 51.7 mt -68.61 -49.0 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.135 0.574 . . . . 74.41 110.083 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 30.4 m -61.01 -33.25 72.96 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.55 0.74 . . . . 74.41 111.249 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -61.26 -51.81 67.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.917 0.887 . . . . 71.53 109.359 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.558 ' HE1' HG23 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.68 -42.02 78.33 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.716 1.207 . . . . 71.01 112.622 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . 0.424 HG23 ' HB3' ' C' ' 126' ' ' LEU . 61.2 t -65.62 -41.7 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.156 0.582 . . . . 73.32 110.595 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.428 ' OG ' HG22 ' B' ' 115' ' ' THR . 32.1 t -68.16 -33.79 75.11 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.623 0.769 . . . . 73.24 111.218 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -64.92 -38.68 91.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.417 0.687 . . . . 74.43 110.282 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 7.86 55.58 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 123.8 0.688 . . . . 72.2 113.059 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 41.2 p 60.6 34.15 20.25 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.016 1.726 . . . . 74.2 112.195 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -108.41 152.82 42.2 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.808 1.243 . . . . 73.45 109.094 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.577 ' HD3' HG21 ' F' ' 301' ' ' ILE . 34.0 Cg_exo -60.99 158.82 32.23 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.684 2.923 . . . . 75.23 114.776 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -51.9 111.0 0.53 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.916 1.286 . . . . 63.22 112.477 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.491 HD22 HG21 ' F' ' 296' ' ' THR . 2.8 tm? -112.2 99.16 7.82 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.594 -1.261 . . . . 74.5 107.594 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.51 127.61 49.76 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.168 0.987 . . . . 71.41 108.709 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.403 HD21 ' N ' ' C' ' 129' ' ' ALA . 2.2 tt -71.74 143.03 49.75 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.763 0.825 . . . . 74.54 109.677 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.504 ' HB2' HD21 ' F' ' 291' ' ' LEU . . . -72.2 146.9 90.16 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.278 1.031 . . . . 72.13 111.855 -177.345 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.0 124.61 16.35 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.24 2.627 . . . . 70.21 112.045 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.67 ' HB ' HD22 ' F' ' 291' ' ' LEU . 5.8 p -133.64 126.86 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.631 0.773 . . . . 75.22 109.746 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.98 90.83 7.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.452 0.701 . . . . 70.43 110.535 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -65.42 -30.41 71.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.536 -0.542 . . . . 72.04 109.536 169.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.557 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.9 t70 -66.28 -47.11 74.74 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.755 -1.111 . . . . 71.52 111.28 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.21 79.91 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.099 0.875 . . . . 70.31 111.428 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.62 -51.54 69.46 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.029 0.932 . . . . 72.31 109.621 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -73.45 -15.1 61.35 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.723 0.809 . . . . 75.55 112.336 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 90.3 mmm -81.86 -29.42 32.49 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 123.475 0.71 . . . . 74.22 112.552 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -53.22 -35.63 60.14 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.211 1.004 . . . . 73.14 113.351 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.62 -88.7 0.0 OUTLIER 'General case' 0 CA--C 1.587 2.392 0 C-N-CA 125.2 1.4 . . . . 70.13 113.507 -170.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -134.95 88.79 2.46 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.792 1.637 . . . . 72.42 106.648 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -81.38 89.04 6.08 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.544 0.688 . . . . 72.53 109.379 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -130.03 22.88 5.3 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.251 1.02 . . . . 72.1 111.256 -173.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -132.26 115.4 15.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.915 0.486 . . . . 64.21 110.435 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.48 102.54 6.2 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.429 1.091 . . . . 74.23 108.272 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.4 -173.44 25.03 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-O 121.457 0.476 . . . . 54.21 114.287 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -107.66 133.25 52.35 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.273 1.029 . . . . 75.22 109.509 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.34 99.55 0.21 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 109.998 -1.241 . . . . 74.32 109.998 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.487 ' OG1' ' HA ' ' C' ' 5' ' ' ASN . 39.1 p -104.77 -173.51 2.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.593 0.757 . . . . 64.02 110.975 -175.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -159.12 168.52 26.4 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.511 0.724 . . . . 73.33 110.823 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -167.8 -76.45 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 O-C-N 123.912 0.758 . . . . 73.34 109.631 170.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -174.0 32.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.415 0.686 . . . . 72.11 110.478 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -73.43 125.67 28.42 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.074 -0.391 . . . . 73.14 110.338 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . 0.623 ' HA ' ' HD3' ' E' ' 293' ' ' PRO . 6.6 m-20 -83.68 95.23 8.32 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.099 -0.955 . . . . 75.25 110.0 -175.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . 0.452 ' HB3' HG22 ' G' ' 307' ' ' THR . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.527 -0.749 . . . . 52.02 109.903 174.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.513 -0.551 . . . . 74.22 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 33.9 m -80.57 75.78 7.44 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.669 0.788 . . . . 73.45 109.435 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.49 115.4 18.18 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.643 -1.162 . . . . 74.13 108.296 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 tm0? -126.46 99.3 5.77 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.951 -1.129 . . . . 73.32 107.951 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -85.18 -21.14 29.29 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.012 0.525 . . . . 75.4 111.23 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -79.62 77.56 6.22 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 121.747 0.784 . . . . 74.33 110.413 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 22.4 m -138.82 113.99 9.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.787 -1.19 . . . . 71.13 107.787 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.36 116.56 4.74 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.977 0.911 . . . . 71.55 111.165 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -32.76 127.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.694 1.197 . . . . 75.15 113.093 168.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 23.5 m -144.48 140.59 29.01 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.054 0.541 . . . . 74.42 110.17 173.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' D' ' 85' ' ' SER . 30.1 t80 -158.57 114.02 2.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.213 1.005 . . . . 72.13 108.474 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -135.07 131.14 36.62 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.905 -0.776 . . . . 73.53 108.905 175.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.48 132.95 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.652 . . . . 74.41 109.238 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.411 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 40.9 mt-30 -95.48 -35.04 11.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 122.562 0.345 . . . . 73.54 110.446 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 178.79 160.92 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.187 0.995 . . . . 75.11 110.766 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.24 118.61 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.542 -1.651 . . . . 74.34 106.542 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.428 ' HE1' HG13 ' D' ' 83' ' ' ILE . 9.9 p90 -140.7 141.88 34.91 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.298 0.639 . . . . 55.3 110.503 -173.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 41.1 p -76.85 119.68 20.94 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.658 -0.497 . . . . 72.33 109.658 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -93.84 -21.82 19.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.094 0.558 . . . . 74.02 109.928 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.706 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.4 t70 -153.91 137.06 15.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.378 1.071 . . . . 73.34 109.343 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.574 HD11 ' SG ' ' D' ' 113' ' ' CYS . 30.1 mt -139.36 146.76 25.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 124.857 1.263 . . . . 74.54 107.682 174.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -154.13 137.9 16.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.328 0.651 . . . . 74.12 109.849 168.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.479 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 78.9 t80 -133.93 121.49 21.75 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 105.798 -1.927 . . . . 71.52 105.798 165.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -122.4 131.24 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.188 -0.671 . . . . 73.05 109.188 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.8 83.52 9.32 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 106.34 -1.726 . . . . 72.53 106.34 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.5 -37.54 69.93 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.732 2.288 . . . . 74.15 112.614 -167.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 25.48 10.35 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.893 0.877 . . . . 74.21 109.247 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.468 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.42 -68.58 0.05 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 N-CA-C 117.413 2.375 . . . . 73.42 117.413 -167.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.74 -24.84 15.26 Favored 'Trans proline' 0 C--N 1.395 2.979 0 CA-C-N 122.777 2.028 . . . . 54.52 112.976 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . 0.433 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 16.9 t-160 -66.25 -35.11 79.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.894 1.277 . . . . 73.13 109.725 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.443 HG13 ' HA ' ' D' ' 73' ' ' ALA . 94.1 t -70.98 -39.9 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.707 -0.679 . . . . 73.24 111.604 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -65.71 -15.0 62.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.706 1.002 . . . . 64.35 113.706 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.73 -33.08 74.84 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.131 0.572 . . . . 74.41 110.581 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.44 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 44.9 mtpt -87.42 111.18 20.87 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.933 0.893 . . . . 74.34 108.594 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.555 ' HB2' ' H ' ' G' ' 301' ' ' ILE . 11.9 p-10 -99.7 99.32 10.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.256 1.023 . . . . 75.32 111.374 -173.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.503 ' CD2' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -156.7 -176.65 6.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.758 1.021 . . . . 74.35 113.758 -170.004 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.432 ' HA ' ' HB2' ' G' ' 297' ' ' TYR . 51.5 tt0 -97.43 102.94 14.07 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 124.761 1.224 . . . . 75.31 112.975 175.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.587 ' HA ' HD11 ' D' ' 68' ' ' LEU . 75.2 Cg_exo -53.2 131.84 45.06 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 124.059 3.173 . . . . 74.23 115.32 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.686 ' HG2' ' HG2' ' G' ' 294' ' ' LYS . 36.7 mt-10 -98.15 115.44 28.29 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.048 -1.433 . . . . 62.54 107.177 170.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.535 HG12 ' HB3' ' D' ' 66' ' ' ALA . 31.9 m -98.64 143.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.605 0.762 . . . . 73.41 110.073 -176.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.473 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 83.1 tttt -107.22 130.54 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.168 0.987 . . . . 73.54 109.243 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -96.61 128.77 43.87 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.316 -1.364 . . . . 75.21 107.316 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.462 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.4 t70 -132.59 126.6 33.15 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.571 -1.27 . . . . 72.24 107.571 172.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.36 139.91 41.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.558 0.743 . . . . 64.03 110.764 -172.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.4 t70 -138.88 139.63 38.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.588 0.755 . . . . 74.22 109.003 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 46' ' ' THR . . . . . 0.475 ' HB ' ' HD1' ' G' ' 281' ' ' PHE . 46.6 p -108.11 144.07 35.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.691 0.796 . . . . 74.13 110.76 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.671 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.8 161.99 41.85 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.688 0.795 . . . . 72.22 109.653 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -170.9 156.41 4.97 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.113 0.965 . . . . 72.21 109.499 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 64.7 p -149.53 120.35 7.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.532 0.733 . . . . 75.21 109.154 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -69.99 118.35 12.72 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.389 -0.597 . . . . 75.23 109.389 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.551 HD11 HG22 ' D' ' 83' ' ' ILE . 46.5 mt -90.31 -30.02 17.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.941 -0.572 . . . . 75.31 110.211 179.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.13 -179.89 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.6 -0.727 . . . . 72.31 110.601 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.35 130.44 40.74 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.926 -1.033 . . . . 75.44 108.538 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 69.21 2.24 3.57 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.395 1.478 . . . . 74.03 112.23 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.26 117.65 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.284 -0.636 . . . . 74.22 109.284 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.66 ' HB2' HD13 ' D' ' 86' ' ' ILE . 97.6 m-85 -128.37 130.13 47.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.036 -1.098 . . . . 75.14 108.036 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -90.91 135.85 33.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.68 -1.6 . . . . 74.24 106.68 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.95 131.67 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.042 0.937 . . . . 75.44 108.637 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.671 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 17.5 t -115.16 135.85 53.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.068 -0.716 . . . . 71.41 109.068 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.21 114.84 20.16 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.873 -1.158 . . . . 73.22 107.873 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.8 ttm180 -96.57 114.9 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.136 0.574 . . . . 73.31 110.01 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.49 122.26 55.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.638 -0.875 . . . . 74.02 108.638 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.8 m -115.32 128.65 56.24 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.276 0.631 . . . . 73.53 109.434 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.4 t -115.8 117.64 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.069 1.348 . . . . 75.12 109.342 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.473 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.5 m -119.03 95.21 4.72 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.741 -0.837 . . . . 74.4 108.741 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.535 ' HB3' HG12 ' D' ' 40' ' ' VAL . . . -98.05 135.0 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.998 -0.741 . . . . 75.45 108.998 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 39.9 p -163.82 135.73 4.88 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.869 0.731 . . . . 71.22 109.704 -173.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.587 HD11 ' HA ' ' D' ' 38' ' ' PRO . 4.7 mp -134.74 136.44 42.65 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.54 0.736 . . . . 72.03 110.701 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.66 -111.6 3.35 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.238 -0.745 . . . . 62.11 111.238 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.55 11.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.231 1.012 . . . . 75.5 109.588 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -139.82 144.11 37.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.04 0.536 . . . . 71.24 111.409 -163.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.1 m -67.53 140.54 57.0 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 124.298 1.039 . . . . 72.53 110.633 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.443 ' HA ' HG13 ' D' ' 31' ' ' VAL . . . -84.96 -69.48 0.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.748 -0.834 . . . . 72.35 108.748 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -154.91 148.45 25.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.623 -1.171 . . . . 73.51 109.074 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.2 mt -108.24 152.94 23.92 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.853 1.261 . . . . 74.35 108.979 172.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.582 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.3 t -158.87 144.02 16.14 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.659 0.784 . . . . 75.15 109.002 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.857 -0.794 . . . . 64.4 108.857 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 51.1 t -125.94 119.71 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.819 0.448 . . . . 74.3 110.054 178.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.706 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 16.0 mt-30 -89.5 91.79 8.85 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 109.02 -0.733 . . . . 75.21 109.02 166.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -81.1 101.64 9.74 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.889 -1.051 . . . . 73.1 108.391 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.458 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 171.39 44.16 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 111.442 -0.663 . . . . 73.35 111.442 175.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.56 131.59 1.96 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.433 -0.667 . . . . 71.11 111.433 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.551 HG22 HD11 ' D' ' 51' ' ' LEU . 32.7 mt -89.43 134.19 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 109.151 -0.685 . . . . 74.41 109.151 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.475 ' HB2' HD12 ' D' ' 86' ' ' ILE . 32.8 m-85 -133.63 162.29 32.33 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.3 0.64 . . . . 74.32 109.687 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 36.2 m -109.61 103.23 12.06 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.409 -0.96 . . . . 64.22 108.409 171.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.66 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.1 mp -107.15 117.57 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.999 0.92 . . . . 72.51 108.837 -176.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.458 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -149.8 164.55 35.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.738 0.815 . . . . 72.25 110.336 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.51 -0.98 59.11 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 116.103 1.201 . . . . 64.21 116.103 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.67 133.47 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.58 0.752 . . . . 73.11 109.737 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -133.61 154.23 51.05 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.866 0.866 . . . . 74.41 110.299 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.02 -110.59 2.75 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.23 0.956 . . . . 73.25 114.489 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 m -65.82 -41.04 92.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.359 1.064 . . . . 72.32 112.298 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -72.78 -36.73 67.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.781 0.432 . . . . 74.22 111.106 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.797 ' SD ' ' HB2' ' G' ' 277' ' ' LEU . 20.4 ptt? -79.92 -23.93 41.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.531 0.205 . . . . 74.42 110.602 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -32.38 68.78 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.79 -0.448 . . . . 63.33 109.79 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -74.04 -45.45 49.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.546 0.738 . . . . 74.32 110.6 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -66.58 -51.6 54.67 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 122.743 0.417 . . . . 64.02 110.285 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.652 ' HG ' HD11 ' G' ' 278' ' ' LEU . 3.8 mm? -78.98 -19.11 52.44 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.959 0.503 . . . . 72.55 110.87 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.11 -1.98 64.59 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-O 119.775 -0.459 . . . . 74.22 114.154 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 -61.31 0.23 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.345 0.573 . . . . 73.51 111.135 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.41 -50.59 51.76 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.195 0.998 . . . . 74.24 113.278 -166.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . 0.45 ' SG ' HD13 ' D' ' 98' ' ' LEU . 22.1 m -68.1 -45.78 40.69 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.797 0.839 . . . . 63.11 112.202 -175.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.02 -24.28 45.51 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 121.54 1.494 . . . . 74.01 112.847 172.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -66.36 -32.62 74.12 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.457 0.703 . . . . 64.3 110.285 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.16 -46.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 64.01 110.193 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -75.9 -32.72 59.78 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.271 -0.877 . . . . 72.54 111.987 -172.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.608 ' HZ ' HD11 ' D' ' 128' ' ' LEU . 75.7 t80 -59.76 -46.01 98.43 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.81 1.411 . . . . 65.31 114.81 -167.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.18 -33.11 91.15 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 121.919 1.746 . . . . 72.41 112.618 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -75.67 -34.91 60.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.645 0.778 . . . . 73.12 110.993 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.9 84.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.479 0.711 . . . . 61.51 110.06 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -60.66 -46.64 89.57 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.585 -1.189 . . . . 74.53 110.956 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.67 -38.33 83.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 64.3 111.117 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' D' ' 21' ' ' ILE . 46.7 t -60.49 -41.86 95.14 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.715 0.635 . . . . 62.4 110.14 178.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.582 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.5 mt -63.05 -56.19 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.21 0.944 . . . . 75.02 110.061 173.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 88.9 m -51.76 -45.13 63.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.971 1.308 . . . . 74.33 112.003 -172.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -66.4 -43.14 86.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.832 -1.076 . . . . 72.4 110.724 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 62.7 mtm -66.12 -34.61 78.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.945 0.498 . . . . 74.22 111.812 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.415 HG21 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -66.11 -42.75 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.155 -0.93 . . . . 73.11 109.913 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.9 p -72.49 -30.76 64.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.834 0.454 . . . . 75.52 111.392 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -69.83 -30.89 68.51 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.345 0.658 . . . . 63.54 110.167 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.06 11.16 65.79 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.492 -0.777 . . . . 64.14 112.613 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 75.7 p 59.27 13.98 3.38 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.865 2.066 . . . . 72.22 114.424 178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -82.15 162.67 56.06 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 107.417 -1.327 . . . . 72.31 107.417 164.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.478 ' HG2' ' HB ' ' G' ' 296' ' ' THR . 62.1 Cg_endo -82.34 152.74 15.91 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.017 1.811 . . . . 75.35 112.444 -171.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -54.02 120.46 6.43 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.372 0.669 . . . . 62.11 110.906 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 48.7 tp -104.58 108.59 20.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.281 -1.007 . . . . 75.04 108.281 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.435 ' HB3' HG13 ' B' ' 13' ' ' ILE . 57.9 m-20 -100.28 93.09 5.5 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.463 -0.94 . . . . 74.41 108.463 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.608 HD11 ' HZ ' ' D' ' 107' ' ' PHE . 0.3 OUTLIER -61.61 137.48 58.25 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.079 1.352 . . . . 75.23 109.785 -178.545 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.28 129.3 83.23 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 123.902 0.881 . . . . 71.4 112.295 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.422 ' HD3' HD13 ' B' ' 13' ' ' ILE . 59.3 Cg_endo -76.13 117.63 4.72 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.717 1.612 . . . . 74.04 109.841 168.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 95.4 t -106.1 110.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.679 -0.86 . . . . 74.5 108.679 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 99.43 1.55 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.336 -0.847 . . . . 74.14 109.665 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -71.36 -21.85 61.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.484 -0.78 . . . . 73.42 111.249 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.68 -51.27 70.08 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 123.083 0.553 . . . . 73.01 111.042 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.75 -53.76 43.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.831 0.852 . . . . 73.21 112.002 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.7 pp -75.45 -25.74 57.7 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.964 -0.562 . . . . 74.13 112.335 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . 0.437 ' HA ' ' HB3' ' B' ' 2' ' ' SER . 44.0 t80 -74.83 -53.93 8.22 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.772 -0.455 . . . . 75.23 109.772 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 69.6 mtm -58.5 -25.95 62.92 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 124.144 0.978 . . . . 74.21 111.115 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.46 -36.24 71.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.639 0.776 . . . . 74.33 111.25 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -73.35 -38.12 65.85 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.711 0.804 . . . . 75.3 110.528 174.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp -76.23 -30.13 57.82 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.023 0.929 . . . . 73.14 112.985 -174.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -83.91 25.68 0.79 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.066 0.546 . . . . 75.45 112.155 -170.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -113.96 46.64 1.29 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.384 1.088 . . . . 75.12 108.772 -170.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -147.12 146.2 29.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.64 -1.618 . . . . 74.41 107.277 168.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.83 102.72 1.29 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.471 -0.566 . . . . 72.54 109.471 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.89 57.08 5.07 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.151 0.405 . . . . 63.34 112.112 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.81 102.99 1.66 Allowed 'General case' 0 C--N 1.351 0.659 0 C-N-CA 123.928 0.891 . . . . 73.44 109.651 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -164.64 41.32 0.3 Allowed Glycine 0 C--O 1.238 0.399 0 N-CA-C 109.963 -1.255 . . . . 53.43 109.963 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 48.3 p -64.73 97.62 0.23 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.825 0.85 . . . . 73.31 110.154 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -86.79 148.88 25.21 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.514 0.726 . . . . 73.34 109.811 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -146.52 124.58 12.1 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.702 -0.851 . . . . 73.45 108.702 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -157.65 80.52 0.88 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 122.24 1.019 . . . . 73.25 109.298 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -119.77 121.02 38.22 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.86 -1.163 . . . . 74.03 107.86 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.7 166.72 28.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.096 0.958 . . . . 74.44 109.009 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 C-N-CA 123.484 0.714 . . . . 74.3 109.636 176.256 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.804 -0.443 . . . . 62.25 109.804 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -67.81 139.82 56.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.938 0.895 . . . . 73.23 110.063 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -74.68 143.45 44.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.318 0.647 . . . . 73.55 110.461 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -122.45 77.21 1.39 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.584 0.753 . . . . 74.41 109.524 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -145.15 113.49 4.85 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.052 -0.976 . . . . 73.41 108.628 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.14 174.45 10.02 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.154 1.903 . . . . 60.2 111.941 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 4.9 tt -155.01 -58.29 0.1 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.689 -1.597 . . . . 74.32 106.689 174.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . 0.718 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 5.6 mp -81.15 78.3 7.96 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.882 -0.784 . . . . 64.34 108.882 175.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -84.95 61.48 4.67 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.598 -0.728 . . . . 54.22 112.177 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.488 HD23 ' HA ' ' A' ' 95' ' ' ALA . 42.7 tp -168.79 170.45 9.25 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.101 0.961 . . . . 73.43 109.035 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 70.76 -177.35 0.21 Allowed 'General case' 0 C--N 1.367 1.334 0 C-N-CA 125.205 1.402 . . . . 75.31 110.158 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.27 -69.78 0.14 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.496 1.118 . . . . 73.14 109.554 -171.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.04 94.68 5.99 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.385 -0.969 . . . . 73.01 108.385 166.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 171.02 125.66 0.83 Allowed Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.731 -0.668 . . . . 71.3 111.689 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -111.07 -52.74 2.77 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.539 0.736 . . . . 74.44 111.358 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 20.7 mmt 60.12 77.94 0.35 Allowed Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 124.058 0.943 . . . . 73.31 110.489 -166.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.49 129.12 9.97 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.221 2.614 . . . . 74.43 112.199 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . 0.681 HG11 HD12 ' A' ' 42' ' ' LEU . 50.3 t -116.45 124.86 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.696 -0.853 . . . . 75.14 108.696 173.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 19.5 mmt85 -103.82 -3.27 25.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.434 1.094 . . . . 73.52 111.429 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 64.7 m95 78.04 149.6 0.1 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.67 1.588 . . . . 75.34 111.414 -167.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.458 HD11 ' HB3' ' A' ' 129' ' ' ALA . 29.9 mt -90.69 -7.49 52.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 113.518 -1.674 . . . . 74.41 111.151 -172.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 169.87 -150.93 15.73 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-O 119.221 -0.766 . . . . 73.44 112.737 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . 0.623 ' HD3' ' HA ' ' C' ' 154' ' ' ASP . 88.5 Cg_endo -77.17 173.06 14.98 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 123.399 2.733 . . . . 74.35 113.561 -177.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -83.2 176.95 8.78 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.412 1.085 . . . . 75.34 110.621 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -175.92 -25.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.636 1.174 . . . . 75.12 110.007 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 19.8 m -60.8 124.89 21.78 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.641 1.177 . . . . 50.53 111.157 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.617 ' HB3' ' HG2' ' A' ' 38' ' ' PRO . 22.8 t80 71.31 10.54 6.68 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.292 1.437 . . . . 75.55 112.7 173.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -80.35 101.08 8.75 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.04 -1.467 . . . . 75.2 107.04 166.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -169.36 -141.92 3.38 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-O 119.872 -0.404 . . . . 74.32 112.268 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -143.64 125.45 15.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.359 0.664 . . . . 74.04 110.015 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 74.1 mt -122.79 100.85 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 108.2 -1.037 . . . . 75.44 108.2 169.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -133.59 -179.77 5.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.557 1.143 . . . . 74.42 108.53 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 65.03 134.31 0.04 OUTLIER Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 125.283 1.433 . . . . 74.4 113.556 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.71 -177.67 3.55 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.966 1.777 . . . . 74.35 111.395 170.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -131.38 144.52 51.28 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.108 0.563 . . . . 74.43 110.185 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 17.9 t 60.76 29.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 124.458 1.103 . . . . 75.24 111.528 173.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 3.0 m -87.71 37.76 0.81 Allowed 'General case' 0 CA--C 1.567 1.605 0 O-C-N 120.995 -1.066 . . . . 74.44 110.842 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 70.7 m -112.23 -0.81 15.38 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.577 1.151 . . . . 72.03 110.468 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 24.2 m -75.1 133.64 75.18 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.574 0.749 . . . . 73.41 110.512 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo . . . . . 0 C--N 1.394 2.97 0 C-N-CA 124.383 3.389 . . . . 74.13 114.776 177.301 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.533 0.206 . . . . 74.41 110.496 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.9 -47.48 58.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.95 0.9 . . . . 60.42 109.953 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -115.97 171.21 7.93 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.24 1.016 . . . . 73.43 109.734 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.94 -64.5 1.17 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.038 -1.097 . . . . 74.53 108.038 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -143.08 140.39 17.85 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.708 -1.219 . . . . 75.01 107.708 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.46 131.12 40.81 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.72 2.28 . . . . 72.51 112.804 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 10.5 tt -58.54 -36.54 74.02 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.979 0.912 . . . . 74.22 109.955 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 6.3 tt -122.73 117.68 26.29 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.919 -1.511 . . . . 75.41 106.919 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -146.22 33.46 1.47 Allowed Glycine 0 C--N 1.343 0.926 0 O-C-N 123.355 0.41 . . . . 44.12 112.897 -174.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 4.1 pp -161.23 -172.73 3.53 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.011 0.924 . . . . 71.24 109.878 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -145.43 -90.06 0.1 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.101 -1.074 . . . . 71.13 108.101 169.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -94.32 176.82 6.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.498 0.719 . . . . 74.51 110.074 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.56 -35.47 80.58 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.72 0.808 . . . . 73.24 110.968 175.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.98 -43.12 2.59 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.928 -0.578 . . . . 73.34 112.243 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -93.46 47.39 1.24 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.947 0.899 . . . . 74.44 110.001 -175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 90.6 mtp -125.89 87.68 55.56 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.116 0.966 . . . . 64.5 109.238 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.8 100.73 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.84 2.36 . . . . 73.44 111.101 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.04 -42.01 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.089 0.556 . . . . 74.24 110.074 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 62.94 -81.43 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.515 1.526 . . . . 73.04 111.657 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -173.57 125.7 0.39 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.35 -1.352 . . . . 73.33 107.35 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.67 HD22 ' HB ' ' C' ' 131' ' ' VAL . 7.4 mp -65.96 -23.71 66.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.961 0.905 . . . . 73.41 113.145 -166.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -162.99 -175.95 34.55 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-O 119.291 -0.727 . . . . 72.12 111.835 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -83.38 46.68 2.16 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.309 2.673 . . . . 73.43 111.613 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -91.31 83.77 5.53 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.452 0.701 . . . . 74.11 109.574 -173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -100.06 154.23 18.58 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.581 -0.736 . . . . 71.31 110.365 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 296' ' ' THR . . . . . 0.491 HG21 HD22 ' C' ' 126' ' ' LEU . 14.2 p -88.59 -165.72 1.41 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.872 0.869 . . . . 74.11 110.512 174.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.474 ' OH ' ' HB1' ' C' ' 73' ' ' ALA . 50.0 m-85 62.76 14.31 7.18 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.802 1.241 . . . . 71.32 112.567 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -72.64 130.13 39.86 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.664 0.786 . . . . 72.31 109.822 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' H' ' 298' ' ' HIS . . . 85.54 -83.34 1.63 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.347 -1.101 . . . . 73.32 110.347 -169.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . 0.465 ' ND2' ' HE1' ' C' ' 36' ' ' TRP . 3.9 t-20 -177.38 163.39 2.0 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.12 0.968 . . . . 64.22 108.867 177.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.577 HG21 ' HD3' ' C' ' 124' ' ' PRO . 30.4 pt -104.29 24.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 123.428 0.691 . . . . 64.31 109.965 171.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -48.51 -43.99 35.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.598 1.959 . . . . 74.53 114.713 -168.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.33 76.87 0.5 Allowed Pre-proline 0 CA--C 1.561 1.368 0 O-C-N 124.348 1.03 . . . . 63.2 109.53 -174.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . 0.528 ' HB2' ' HD2' ' H' ' 293' ' ' PRO . 75.0 Cg_endo -86.38 -31.13 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.668 2.245 . . . . 74.45 114.149 -173.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -77.66 86.71 3.95 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.196 0.598 . . . . 74.31 109.548 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 7.6 p 168.1 -24.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 125.785 1.634 . . . . 75.42 109.076 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 75.5 p -75.12 12.69 0.84 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.55 0.945 . . . . 53.53 113.55 -170.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 36.9 t -144.7 37.14 1.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.568 0.747 . . . . 73.12 110.199 176.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 17.4 p -69.74 128.88 91.69 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.12 0.568 . . . . 72.41 110.642 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--N 1.382 2.295 0 C-N-CA 122.801 2.334 . . . . 74.23 111.844 176.613 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.835 -0.432 . . . . 61.44 109.835 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.17 -58.81 3.07 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.341 -0.614 . . . . 70.15 109.341 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -122.23 -70.7 0.76 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.428 -0.952 . . . . 61.33 108.428 169.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . 0.428 ' HG2' ' N ' ' G' ' 275' ' ' LYS . 62.1 tt0 64.79 179.09 0.18 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.899 1.28 . . . . 73.14 111.032 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . 0.428 ' N ' ' HG2' ' G' ' 274' ' ' GLN . 32.1 mtmt 71.72 83.08 0.15 Allowed Pre-proline 0 C--N 1.362 1.126 0 C-N-CA 125.11 1.364 . . . . 72.23 109.251 170.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.74 89.88 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.421 2.081 . . . . 73.42 111.063 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.797 ' HB2' ' SD ' ' D' ' 94' ' ' MET . 2.7 pt? -79.6 -174.86 4.5 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.357 -0.838 . . . . 75.13 110.005 176.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . 0.652 HD11 ' HG ' ' D' ' 98' ' ' LEU . 40.1 tp 66.4 94.45 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.368 1.067 . . . . 74.12 110.426 -171.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -102.66 4.64 50.48 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.588 -0.733 . . . . 73.23 112.389 173.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 78.0 mt -101.83 175.88 5.4 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.943 0.897 . . . . 75.42 111.257 -175.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . 0.475 ' HD1' ' HB ' ' D' ' 46' ' ' THR . 90.3 m-85 65.16 6.19 3.41 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.292 1.437 . . . . 73.44 112.208 -175.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -105.96 86.9 2.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.232 1.013 . . . . 74.33 108.781 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 62.55 19.33 11.17 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.458 1.103 . . . . 72.2 112.573 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -89.94 91.25 1.68 Allowed Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.314 -0.403 . . . . 64.23 112.25 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -70.45 109.16 4.63 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.517 0.727 . . . . 75.54 110.031 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 286' ' ' MET . . . . . 0.425 ' SD ' ' HD2' ' G' ' 287' ' ' PRO . 16.0 tpt -91.34 123.88 62.82 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 108.575 -0.898 . . . . 74.11 108.575 172.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . 0.425 ' HD2' ' SD ' ' G' ' 286' ' ' MET . 72.7 Cg_endo -74.25 72.09 4.24 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.5 2.133 . . . . 75.42 112.442 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 57.0 t -82.44 95.34 3.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.94 -0.763 . . . . 74.5 108.94 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -71.46 135.55 47.23 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.306 -0.861 . . . . 75.42 110.374 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.507 ' NE1' ' HA ' ' G' ' 293' ' ' PRO . 1.3 t-105 -82.07 120.03 24.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.625 0.77 . . . . 75.22 110.486 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.422 ' H ' HD12 ' G' ' 291' ' ' LEU . 1.8 mp -88.01 91.08 8.63 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.456 1.102 . . . . 64.13 109.903 -173.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 81.03 86.91 0.64 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.269 -0.74 . . . . 75.53 112.838 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . 0.507 ' HA ' ' NE1' ' G' ' 290' ' ' TRP . 34.8 Cg_endo -63.21 -27.62 72.62 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.034 2.489 . . . . 74.43 113.148 176.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . 0.686 ' HG2' ' HG2' ' D' ' 39' ' ' GLU . 42.8 mtmt -88.66 92.51 9.23 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.291 0.636 . . . . 74.34 109.621 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -162.05 65.94 0.24 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.291 0.567 . . . . 73.14 110.822 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 296' ' ' THR . . . . . 0.478 ' HB ' ' HG2' ' D' ' 124' ' ' PRO . 7.9 p -142.04 -97.79 0.13 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.962 0.905 . . . . 75.11 109.973 -177.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.432 ' HB2' ' HA ' ' D' ' 37' ' ' GLN . 31.6 m-85 -73.42 166.37 23.33 Favored 'General case' 0 C--N 1.371 1.542 0 N-CA-C 108.767 -0.827 . . . . 73.24 108.767 170.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -143.97 14.66 1.7 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.428 -0.953 . . . . 75.53 108.428 165.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -155.24 -172.38 22.83 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.321 -0.854 . . . . 64.1 111.745 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -82.31 154.06 25.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.703 0.801 . . . . 73.34 112.233 -174.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.555 ' H ' ' HB2' ' D' ' 35' ' ' ASP . 41.3 mt -90.74 -5.73 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 125.1 1.36 . . . . 75.21 110.452 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -57.37 97.42 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.83 1.252 . . . . 70.21 112.658 -170.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -143.5 96.62 5.68 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 106.671 -1.603 . . . . 72.23 106.671 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -59.94 -63.04 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.562 2.175 . . . . 74.11 113.092 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -175.06 164.76 3.38 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.086 0.955 . . . . 55.13 109.779 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.416 ' O ' ' HB2' ' C' ' 12' ' ' GLN . 10.4 p -80.24 143.48 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 107.357 -1.349 . . . . 74.24 107.357 162.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 307' ' ' THR . . . . . 0.452 HG22 ' HB3' ' C' ' 155' ' ' ALA . 14.0 m -74.43 138.36 43.25 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.841 0.456 . . . . 75.33 111.259 -173.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . 0.502 ' SG ' ' HA ' ' C' ' 10' ' ' THR . 41.5 t -68.48 162.05 26.43 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.819 0.848 . . . . 71.32 111.094 174.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 36.0 p -65.42 113.57 12.1 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.149 0.98 . . . . 73.21 111.061 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 C--N 1.377 2.034 0 C-N-CA 123.212 2.608 . . . . 72.51 112.066 175.77 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.697 -0.483 . . . . 71.34 109.697 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . 0.423 ' ND2' HE22 ' H' ' 274' ' ' GLN . 28.4 p-10 -168.19 154.54 7.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.581 0.753 . . . . 73.41 110.404 -177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -140.75 -35.64 0.48 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.524 0.73 . . . . 63.12 111.112 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . 0.423 HE22 ' ND2' ' H' ' 272' ' ' ASN . 1.8 mp0 55.28 88.37 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.633 1.173 . . . . 73.52 110.65 -175.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -66.93 135.55 94.17 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.591 -0.731 . . . . 74.14 109.994 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.51 158.31 41.87 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.104 2.536 . . . . 74.24 112.46 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.436 ' HB3' ' HH ' ' B' ' 56' ' ' TYR . 6.6 tt -67.44 -32.95 74.17 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.116 -0.698 . . . . 74.03 109.116 176.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . 0.423 ' HA ' ' HE2' ' B' ' 94' ' ' MET . 39.3 tp -58.99 127.04 30.21 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 123.8 0.687 . . . . 73.3 111.432 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -170.89 148.96 11.77 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.13 -0.788 . . . . 71.45 111.13 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 46.6 mt 67.08 161.91 0.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.191 1.396 . . . . 75.33 112.298 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -165.67 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.436 -0.95 . . . . 74.41 108.436 172.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -173.92 127.36 0.38 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.362 1.065 . . . . 72.34 109.962 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -98.95 163.82 12.44 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.595 -0.891 . . . . 75.41 108.595 173.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.22 26.12 1.25 Allowed Glycine 0 CA--C 1.54 1.651 0 N-CA-C 115.996 1.159 . . . . 74.53 115.996 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -68.39 -20.18 64.67 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 117.727 0.764 . . . . 64.52 111.212 173.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -128.47 90.84 45.49 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.43 1.092 . . . . 73.01 109.29 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.3 121.55 7.28 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.87 2.38 . . . . 62.41 112.994 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 85.3 t -86.33 91.96 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 121.812 0.815 . . . . 74.41 109.635 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -117.22 -173.91 2.5 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.156 1.382 . . . . 74.24 108.312 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -59.83 134.78 57.36 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.519 0.6 . . . . 74.24 112.167 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 5.1 mp -93.88 41.45 1.09 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.256 1.023 . . . . 71.35 110.091 -175.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 158.93 -173.56 35.84 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 114.293 -1.321 . . . . 44.52 110.612 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' F' ' 304' ' ' PRO . 80.3 Cg_endo -81.64 68.87 7.92 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.672 2.248 . . . . 73.31 112.584 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . 0.476 ' HE3' ' H ' ' B' ' 40' ' ' VAL . 50.2 mttp 60.6 -158.43 0.33 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.087 0.955 . . . . 73.31 112.297 173.332 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -158.54 -173.71 4.42 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 125.199 1.4 . . . . 74.5 107.975 168.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 1.4 m 72.06 164.64 0.28 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.308 1.043 . . . . 73.42 112.346 168.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.437 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 5.9 m-85 60.51 29.75 19.25 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.146 1.378 . . . . 74.23 113.126 176.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . 0.577 ' HB3' ' HA3' ' F' ' 299' ' ' GLY . 2.2 m80 -73.46 88.6 1.62 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.074 0.55 . . . . 74.25 110.856 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 70.3 23.87 77.07 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-N 115.359 -0.837 . . . . 64.41 113.583 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -166.4 136.75 3.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.908 0.385 . . . . 65.1 111.36 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 15.3 tt -134.45 -33.03 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.86 1.264 . . . . 74.0 108.27 165.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.37 -170.78 3.35 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.939 1.696 . . . . 74.41 107.48 -177.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.407 ' HB2' ' HD3' ' H' ' 304' ' ' PRO 0.266 42.9 mtmt 108.61 -57.26 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.204 0 C-N-CA 127.706 2.403 . . . . 71.02 112.392 171.083 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . 0.407 ' HD3' ' HB2' ' H' ' 303' ' ' LYS . 8.2 Cg_exo -74.88 -53.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.395 2.987 0 CA-C-N 122.034 1.762 . . . . 74.13 110.656 166.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 41.51 -106.53 0.07 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 125.377 1.471 . . . . 75.54 111.82 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 15' ' ' ARG . 34.6 m -144.6 29.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.559 1.144 . . . . 75.4 108.428 168.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 307' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 29.4 p -39.25 -66.56 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.577 1.951 . . . . 74.34 114.922 -162.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 27.2 p -154.2 151.4 29.15 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.921 0.391 . . . . 71.24 111.61 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 3.8 t -144.07 110.35 5.1 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.286 1.034 . . . . 75.32 108.473 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo . . . . . 0 C--N 1.379 2.154 0 C-N-CA 122.453 2.102 . . . . 65.15 111.21 175.42 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 110.331 -0.248 . . . . 75.15 110.331 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.3 t 68.42 173.94 0.28 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.001 1.32 . . . . 74.44 111.972 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.84 124.29 24.51 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.414 0.685 . . . . 72.52 110.651 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -79.15 120.13 23.23 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.26 0.624 . . . . 73.44 110.759 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.574 ' H ' ' HB1' ' C' ' 145' ' ' ALA . 21.8 m120 -93.53 163.86 13.4 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.103 0.961 . . . . 63.13 110.819 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -136.59 -71.41 0.45 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.431 0.692 . . . . 73.32 110.987 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 m -79.24 -12.82 59.96 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.646 0.778 . . . . 74.22 111.687 -171.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -85.05 69.2 10.77 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.425 0.69 . . . . 75.0 109.789 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.7 mtm -149.58 133.56 17.08 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.063 -1.088 . . . . 75.41 108.063 170.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.4 m -149.05 130.26 14.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.345 0.658 . . . . 71.33 109.458 172.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.503 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 29.1 t80 -140.16 129.4 23.8 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.214 -1.032 . . . . 74.41 108.214 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -148.77 109.44 4.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.706 0.289 . . . . 75.54 110.744 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.644 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.2 mt -73.0 111.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.237 -0.653 . . . . 74.41 109.237 172.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -91.7 -27.46 18.07 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.82 0.7 . . . . 74.32 110.209 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -164.27 144.29 7.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 121.382 -0.127 . . . . 75.34 110.924 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -143.51 118.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.074 1.349 . . . . 72.22 108.72 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.492 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.8 p90 -166.63 176.66 7.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.864 0.84 . . . . 75.52 111.821 -163.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -103.55 112.36 25.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.712 -1.131 . . . . 71.32 108.582 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.492 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -76.83 -19.63 57.3 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 110.103 -0.332 . . . . 73.45 110.103 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.14 144.88 17.68 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.716 0.806 . . . . 65.45 109.646 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.402 HG22 ' SD ' ' A' ' 117' ' ' MET . 66.1 mt -135.22 145.47 31.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 124.993 1.317 . . . . 75.21 107.742 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.57 ' HG ' ' HB3' ' A' ' 77' ' ' GLU . 81.9 p -147.9 138.95 23.37 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.039 -0.726 . . . . 53.34 109.039 166.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 93.6 t80 -136.06 111.17 8.94 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.831 -1.914 . . . . 75.21 105.831 170.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.25 107.24 13.17 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.292 -0.633 . . . . 75.42 109.292 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.411 ' O ' ' HB3' ' A' ' 28' ' ' ALA . . . -117.29 78.41 10.55 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 107.477 -1.305 . . . . 71.52 107.477 171.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.47 -34.74 5.48 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.155 1.903 . . . . 74.2 111.737 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -89.41 10.67 21.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.69 -0.686 . . . . 71.23 110.879 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.475 ' HB2' ' HE2' ' B' ' 17' ' ' TYR . . . -47.98 -57.59 9.9 Favored Pre-proline 0 CA--C 1.566 1.573 0 CA-C-O 117.455 -1.259 . . . . 73.32 113.426 -166.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -47.8 -41.88 31.24 Favored 'Trans proline' 0 C--N 1.403 3.411 0 C-N-CA 123.381 2.721 . . . . 71.21 113.885 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -100.95 -14.04 18.05 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.145 0.794 . . . . 74.22 113.145 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.458 HG23 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.6 -18.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.29 0.495 . . . . 73.52 110.582 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.25 -5.37 41.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.767 0.827 . . . . 72.44 111.689 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -99.95 -18.79 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.203 1.001 . . . . 72.15 111.18 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -67.57 150.19 49.13 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 75.21 111.912 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.39 134.83 55.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.581 0.753 . . . . 75.31 110.139 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -78.82 75.91 5.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.273 0.629 . . . . 75.01 112.101 -169.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -132.91 74.86 73.44 Favored Pre-proline 0 N--CA 1.48 1.033 0 N-CA-C 108.324 -0.991 . . . . 72.12 108.324 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.75 128.09 2.8 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.102 2.535 . . . . 74.43 112.113 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.72 98.47 11.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.312 -2.107 . . . . 72.1 105.312 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' H ' ' HD3' ' E' ' 294' ' ' LYS . 39.8 t -91.78 102.04 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.312 -1.313 . . . . 75.52 108.997 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -78.91 148.08 32.84 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.572 0.749 . . . . 75.32 111.048 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.51 111.53 18.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.617 -1.253 . . . . 75.44 107.617 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.766 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -107.3 144.06 34.67 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.277 -1.008 . . . . 73.11 108.277 170.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.68 129.45 24.65 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.903 0.481 . . . . 75.31 109.918 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.1 m-20 -127.22 127.4 44.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.194 0.998 . . . . 74.45 109.317 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.42 ' HB ' ' CE1' ' E' ' 281' ' ' PHE . 44.9 p -118.17 122.83 44.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.56 1.144 . . . . 75.4 109.522 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.97 147.28 31.52 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.082 0.553 . . . . 51.11 110.938 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 p -119.42 167.12 12.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.76 0.824 . . . . 74.35 110.014 170.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -156.07 153.16 28.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.617 1.167 . . . . 73.4 108.355 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -113.44 127.04 55.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.488 0.315 . . . . 64.03 110.349 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 57' ' ' GLU . 41.6 mt -93.65 -44.33 8.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.604 0.762 . . . . 75.2 110.495 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.67 ' HB3' ' HA ' ' C' ' 155' ' ' ALA . . . -150.1 -179.01 6.82 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.482 -1.235 . . . . 75.44 108.914 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.39 118.87 8.68 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 109.483 -0.562 . . . . 71.42 109.483 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 71.96 -4.61 1.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.707 1.603 . . . . 72.03 113.312 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.413 ' HB ' ' HB1' ' A' ' 52' ' ' ALA . 42.1 t -104.86 118.62 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.915 -0.772 . . . . 73.51 108.915 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -122.3 160.43 25.34 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.488 0.715 . . . . 73.14 110.676 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.505 ' HB2' HD13 ' A' ' 51' ' ' LEU . 8.1 tm-20 -132.71 136.87 46.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.318 -1.364 . . . . 73.51 107.318 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.42 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 86.3 t -126.49 125.88 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.449 -0.945 . . . . 73.3 108.449 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.4 t -101.71 136.94 31.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.159 0.584 . . . . 72.12 110.025 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -122.3 97.68 5.58 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.67 -1.604 . . . . 72.25 106.67 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.639 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 47.2 ttp180 -86.53 109.81 19.36 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 109.319 -0.622 . . . . 74.54 109.319 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.8 139.49 18.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.295 -1.372 . . . . 62.5 107.295 169.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.766 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 40.3 m -132.27 136.03 46.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.611 -0.885 . . . . 72.52 108.611 173.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 126' ' ' LEU . 92.5 t -134.85 109.07 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.464 1.106 . . . . 74.12 108.421 -173.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.3 m -106.05 137.22 44.35 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 108.684 -0.858 . . . . 75.55 108.684 174.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.39 123.57 38.24 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.021 -0.733 . . . . 75.53 109.021 176.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 63.8 m -132.14 125.45 31.29 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.768 0.427 . . . . 72.13 110.143 175.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -89.39 84.41 6.44 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.239 -1.393 . . . . 75.01 107.239 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.98 -98.86 1.23 Allowed Glycine 0 C--N 1.344 1.011 0 CA-C-N 114.245 -1.343 . . . . 35.22 110.93 -170.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -104.88 -25.87 12.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.299 1.04 . . . . 64.51 110.253 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.88 106.13 17.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 75.14 110.277 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.77 130.31 42.46 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.506 0.669 . . . . 70.31 111.248 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.458 ' HA ' HG23 ' A' ' 31' ' ' VAL . . . -80.53 -60.76 2.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.898 -1.046 . . . . 73.13 109.724 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -155.82 162.98 40.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.956 -1.02 . . . . 72.4 111.478 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -135.9 111.32 9.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.55 1.14 . . . . 74.03 108.465 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.43 124.05 48.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.25 1.02 . . . . 64.11 109.865 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.57 ' HB3' ' HG ' ' A' ' 22' ' ' SER . 35.0 tt0 -135.54 119.01 16.87 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.211 -0.663 . . . . 71.35 109.211 176.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.96 110.36 21.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.912 0.885 . . . . 71.52 109.132 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -83.91 82.8 8.18 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.396 -1.335 . . . . 75.51 107.396 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 7.8 tp-100 -76.91 94.51 3.94 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.624 -0.88 . . . . 62.34 108.624 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.15 149.79 19.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.3 -0.864 . . . . 73.01 111.754 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 134.76 5.12 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.802 -0.519 . . . . 63.22 111.802 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . 0.477 HD11 ' HA ' ' B' ' 29' ' ' PRO . 63.8 mt -81.72 123.86 38.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.941 -0.763 . . . . 73.23 108.941 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.644 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.3 m-85 -132.78 117.14 17.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.792 -1.188 . . . . 75.52 107.792 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 t -77.93 93.84 4.48 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.565 -0.902 . . . . 74.14 108.565 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.5 mt -104.34 131.61 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.862 -0.792 . . . . 75.11 108.862 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -153.34 162.65 41.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.721 0.808 . . . . 63.25 110.133 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' C' ' 147' ' ' GLU . . . 92.2 -28.92 8.12 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.938 -0.573 . . . . 73.12 114.521 168.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.79 140.9 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.448 0.699 . . . . 75.23 111.636 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.673 ' HB2' ' HA3' ' C' ' 148' ' ' GLY . 0.4 OUTLIER -147.19 176.03 10.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.15 0.98 . . . . 63.24 108.6 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.59 -135.82 23.93 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.561 -0.577 . . . . 72.5 112.055 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.1 p -71.85 -14.99 62.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 72.21 111.729 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.684 ' HG3' ' HB3' ' C' ' 144' ' ' GLN . 23.2 mp0 -74.25 -57.43 3.95 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.173 0.989 . . . . 75.52 110.253 -176.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.562 ' SD ' ' HB3' ' E' ' 277' ' ' LEU . 25.7 ttt -80.27 -15.32 57.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.821 -0.172 . . . . 71.52 110.648 175.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.57 -39.66 94.4 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.884 0.373 . . . . 71.15 110.108 166.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.7 t-80 -77.3 -19.54 56.29 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.878 -0.601 . . . . 74.31 110.988 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.6 -61.05 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.813 -0.554 . . . . 74.14 110.278 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.46 -45.5 72.29 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.873 0.869 . . . . 70.4 111.702 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.69 6.38 79.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.116 -0.825 . . . . 74.55 114.559 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.649 ' HB2' ' HA ' ' A' ' 134' ' ' ASP . . . -149.37 -61.71 0.22 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.117 0.958 . . . . 62.13 112.714 -175.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 87.5 t80 -78.32 -55.46 5.22 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.036 1.124 . . . . 71.54 114.036 -164.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.5 m -70.21 -33.06 3.1 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 114.048 1.129 . . . . 74.32 114.048 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.4 Cg_endo -63.8 -16.8 56.91 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.039 1.826 . . . . 71.24 113.149 167.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.462 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -71.98 -14.95 62.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.59 . . . . 53.21 110.825 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.615 HD13 HD22 ' C' ' 132' ' ' ASN . 36.0 mm -84.11 -41.8 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.848 0.832 . . . . 72.33 109.855 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.422 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 76.0 mt -76.35 -44.38 36.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.251 -1.341 . . . . 74.01 111.598 -171.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -59.82 -41.35 85.13 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 113.706 1.002 . . . . 74.03 113.706 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.96 -44.73 33.01 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.12 1.88 . . . . 72.44 113.375 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.604 ' CE1' ' HA ' ' C' ' 108' ' ' PRO . 26.7 m-85 -73.7 -24.06 59.88 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.989 0.516 . . . . 72.45 111.997 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -51.69 23.28 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.832 -0.803 . . . . 61.32 108.832 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -50.91 -46.78 60.8 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.944 1.402 . . . . 73.01 110.488 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -65.36 -42.02 93.22 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 124.765 1.291 . . . . 74.04 111.073 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.5 t -62.26 -45.43 93.35 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.739 0.649 . . . . 73.15 110.188 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.56 -43.0 98.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 O-C-N 124.267 0.98 . . . . 74.55 110.105 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.559 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.5 m -57.14 -44.06 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.824 0.85 . . . . 65.25 110.552 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 14.6 t -67.77 -47.7 68.47 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.071 -0.968 . . . . 73.2 110.589 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.402 ' SD ' HG22 ' A' ' 21' ' ' ILE . 12.7 mtp -57.11 -48.58 78.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 71.44 111.502 178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.81 -43.44 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.069 1.348 . . . . 71.03 110.859 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -67.51 -33.61 75.43 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.795 0.838 . . . . 75.32 111.59 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 116' ' ' SER . 37.0 mtt180 -72.13 -29.63 64.25 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.428 0.691 . . . . 74.33 110.659 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.87 14.25 38.6 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.498 -0.612 . . . . 75.5 113.555 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 57.51 22.48 8.13 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.105 1.762 . . . . 73.13 113.329 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . 0.451 ' HA ' HD12 ' E' ' 301' ' ' ILE . 91.4 m-85 -89.22 156.51 48.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 73.43 108.759 171.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.631 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 60.1 Cg_endo -66.71 151.98 81.52 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.813 2.342 . . . . 71.45 111.755 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.559 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.9 tt0 -53.99 127.74 27.64 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.976 0.797 . . . . 72.15 111.569 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.669 HD21 HG12 ' A' ' 64' ' ' VAL . 16.5 tp -110.71 101.15 9.81 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.21 -0.904 . . . . 73.43 109.825 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -107.48 100.07 9.53 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.377 -1.342 . . . . 74.5 107.377 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.77 121.38 14.43 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.492 -0.558 . . . . 75.45 109.492 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -50.63 129.82 27.0 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.119 0.968 . . . . 65.24 112.219 -170.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -84.1 115.86 2.05 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.678 2.252 . . . . 72.23 113.07 -175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.65 141.43 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.573 -0.899 . . . . 73.14 108.573 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.34 72.43 4.86 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.37 -0.974 . . . . 71.55 108.37 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.46 -35.74 75.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.818 1.247 . . . . 75.21 110.586 -172.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.649 ' HA ' ' HB2' ' A' ' 100' ' ' ALA . 6.0 p-10 -62.03 -38.87 90.31 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.655 -1.157 . . . . 72.43 111.511 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.75 -27.55 36.75 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.442 0.697 . . . . 74.35 111.336 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.01 -38.35 90.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.965 0.906 . . . . 75.25 109.946 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.82 -31.55 72.57 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.214 -0.448 . . . . 65.41 111.051 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 93.5 mmm -74.66 -31.21 61.86 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.719 0.408 . . . . 74.43 111.201 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.637 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 50.0 m-80 -65.48 -38.94 91.25 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 116.351 -0.386 . . . . 62.21 110.118 172.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.15 -36.91 72.23 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.396 0.679 . . . . 71.33 110.783 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.45 -49.1 75.02 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.633 0.773 . . . . 75.14 110.911 -172.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -169.36 18.07 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.497 0.498 . . . . 73.13 110.758 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.637 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 34.3 tt0 59.86 34.82 21.82 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.325 1.05 . . . . 73.33 111.11 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -98.12 116.45 30.37 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.435 -0.802 . . . . 73.34 109.69 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.78 -49.3 6.34 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.123 0.569 . . . . 63.02 109.601 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.82 -163.94 49.75 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.246 -0.888 . . . . 63.52 113.571 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.453 ' HB3' ' ND2' ' C' ' 5' ' ' ASN . 8.2 pt-20 -161.45 165.84 28.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.128 0.971 . . . . 73.43 110.012 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 163.63 97.02 0.11 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 112.301 -0.32 . . . . 72.02 112.301 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.0 p -126.75 150.25 49.19 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.912 0.885 . . . . 71.41 110.576 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.85 108.56 19.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.746 0.818 . . . . 73.22 110.336 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -98.24 78.16 2.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.266 -1.013 . . . . 73.54 108.266 169.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -83.34 -17.16 43.39 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 116.384 -0.371 . . . . 74.13 111.12 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 61.59 78.57 0.28 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.807 1.243 . . . . 74.22 112.193 175.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -173.03 -73.15 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.778 0.831 . . . . 64.05 108.981 170.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 C-N-CA 123.787 0.835 . . . . 71.34 109.171 177.704 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.258 -0.275 . . . . 71.41 110.258 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t -159.58 113.67 2.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.354 0.662 . . . . 75.45 109.331 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -102.42 107.19 18.09 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.343 0.592 . . . . 72.42 109.822 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -82.86 82.6 8.09 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.463 0.705 . . . . 74.02 110.098 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -164.67 -172.46 2.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.389 -0.967 . . . . 64.35 108.389 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -49.3 111.8 0.54 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.812 0.845 . . . . 75.32 112.748 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 89.8 m -67.15 -50.61 60.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.196 0.998 . . . . 75.21 110.341 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 73.57 -56.99 0.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.698 1.599 . . . . 75.04 112.795 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.558 ' HE1' ' SG ' ' B' ' 97' ' ' CYS . 12.1 ptm 56.83 166.17 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.072 2.549 . . . . 73.21 113.564 -168.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -163.87 139.59 6.38 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.377 -1.342 . . . . 65.44 107.377 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.86 156.69 44.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.807 0.813 . . . . 74.02 110.957 161.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.584 ' HB2' HG13 ' E' ' 306' ' ' VAL . 17.1 pm0 -126.43 132.67 51.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 113.644 -1.616 . . . . 65.33 107.722 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 35.5 pt -76.89 108.68 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.497 -0.774 . . . . 72.13 109.136 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -74.93 -46.68 34.04 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.611 -0.515 . . . . 73.31 109.611 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.737 HH22 HG21 ' E' ' 301' ' ' ILE . 18.2 ttt85 -162.04 135.62 6.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 110.28 -0.267 . . . . 73.2 110.28 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.9 mt -116.74 131.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 106.147 -1.797 . . . . 73.35 106.147 170.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.475 ' HE2' ' HB2' ' A' ' 28' ' ' ALA . 11.3 p90 -164.01 141.58 7.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.644 0.378 . . . . 72.11 110.975 -171.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 45.2 m -72.34 116.89 13.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.726 -0.842 . . . . 74.13 108.726 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -84.99 -40.28 17.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.944 -0.571 . . . . 72.52 110.458 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 11.6 t70 -145.62 144.2 30.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.108 -0.496 . . . . 63.21 111.081 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.522 HD12 ' SG ' ' B' ' 113' ' ' CYS . 32.2 mm -137.15 145.85 29.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.277 1.431 . . . . 65.52 108.487 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.536 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 26.7 t -146.25 138.86 25.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.284 -1.326 . . . . 62.2 107.434 176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -155.92 143.12 19.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.024 -1.102 . . . . 73.53 108.024 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.3 mt-10 -143.6 155.59 44.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.733 1.213 . . . . 74.3 108.716 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -151.27 86.09 4.85 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 107.878 -1.156 . . . . 72.02 107.878 172.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.5 -43.22 4.31 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.779 2.319 . . . . 71.13 113.006 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.434 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 38.0 m-80 -105.0 29.02 6.66 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.018 0.527 . . . . 75.4 109.893 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.55 -54.06 25.42 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.866 1.266 . . . . 75.04 113.233 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.477 ' HA ' HD11 ' A' ' 83' ' ' ILE . 2.5 Cg_endo -80.35 -20.44 8.36 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 121.527 1.485 . . . . 61.31 112.77 -176.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.531 ' HB3' ' NE2' ' B' ' 33' ' ' GLN . 51.5 m-70 -97.41 2.66 50.68 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.405 1.082 . . . . 71.33 112.686 -175.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.25 -15.12 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.62 0.768 . . . . 75.2 112.08 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -84.94 -27.11 26.78 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.606 0.762 . . . . 75.33 112.836 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.531 ' NE2' ' HB3' ' B' ' 30' ' ' HIS . 23.0 pt20 -75.69 -29.43 59.01 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.591 0.356 . . . . 74.15 111.626 -172.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.426 ' HB2' ' CZ2' ' B' ' 36' ' ' TRP . 38.1 mtpt -108.85 117.44 34.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.726 1.21 . . . . 62.44 108.707 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -89.71 117.41 28.55 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.458 0.572 . . . . 75.23 110.857 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.452 ' CZ2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -171.39 162.5 6.72 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 123.982 0.913 . . . . 71.53 112.916 -178.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -93.24 132.72 29.89 Favored Pre-proline 0 N--CA 1.485 1.322 0 C-N-CA 124.328 1.051 . . . . 73.22 109.997 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.44 147.39 36.48 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.25 1.966 . . . . 73.34 112.83 171.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.23 109.65 16.7 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.845 -1.169 . . . . 62.4 107.845 163.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.24 123.21 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.731 -0.668 . . . . 72.24 109.422 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.3 142.24 35.41 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.776 0.83 . . . . 73.02 109.555 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.571 HD13 HD21 ' B' ' 128' ' ' LEU . 3.7 tt -106.52 134.98 48.83 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.962 -1.496 . . . . 70.52 106.962 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.734 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 4.7 m-20 -128.42 114.55 16.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.215 -1.032 . . . . 75.35 108.215 -177.043 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.17 127.2 46.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.239 -1.393 . . . . 73.53 107.239 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -137.66 147.12 44.62 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.453 0.701 . . . . 73.23 109.199 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.1 p -121.82 128.85 52.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.412 0.685 . . . . 74.31 110.217 -173.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . 0.408 ' HB2' ' HB ' ' B' ' 59' ' ' VAL . . . -131.57 137.3 48.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.044 -1.095 . . . . 73.43 108.044 174.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.7 p -144.6 163.17 34.72 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.132 0.491 . . . . 73.0 110.559 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.88 173.09 15.79 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.065 -0.97 . . . . 75.53 108.845 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -120.51 125.14 47.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.801 0.44 . . . . 73.51 110.25 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . 0.453 HD12 HG22 ' B' ' 83' ' ' ILE . 65.1 mt -87.45 -46.56 9.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.397 0.679 . . . . 75.04 109.459 176.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.25 -174.33 4.93 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.209 -0.905 . . . . 54.24 111.059 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.79 120.72 13.01 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.5 -0.773 . . . . 72.22 110.197 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 70.02 -5.48 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.522 1.529 . . . . 75.21 112.542 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -102.43 111.62 32.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.728 -0.842 . . . . 73.31 108.728 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.403 ' HE1' HD23 ' H' ' 277' ' ' LEU . 78.3 m-85 -119.79 139.93 51.56 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.597 -0.729 . . . . 73.32 109.861 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . 0.566 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.9 tm-20 -104.05 97.13 7.15 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.694 -1.595 . . . . 71.33 106.694 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -92.62 118.72 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.864 0.866 . . . . 74.02 109.533 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.421 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.61 119.23 51.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 123.632 0.773 . . . . 64.31 110.033 176.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.23 109.14 20.97 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.096 -1.076 . . . . 73.22 108.096 172.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.7 122.95 33.91 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.351 -0.611 . . . . 74.42 109.351 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.43 124.99 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 107.985 -1.117 . . . . 74.54 107.985 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 12.4 m -119.7 138.53 53.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.579 0.752 . . . . 73.11 109.227 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.567 HG23 HD12 ' B' ' 114' ' ' ILE . 51.6 t -122.0 128.78 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 123.932 0.893 . . . . 71.55 109.164 175.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -118.84 144.28 46.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.576 -0.898 . . . . 75.02 108.576 171.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.81 133.79 30.86 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.66 -0.867 . . . . 71.23 108.66 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.4 p -149.88 140.11 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.883 0.473 . . . . 74.15 110.321 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.546 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -137.41 144.3 42.33 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.597 1.159 . . . . 71.33 109.228 -171.154 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.86 -108.06 1.95 Allowed Glycine 0 C--N 1.347 1.143 0 O-C-N 123.341 0.401 . . . . 74.14 113.81 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -116.05 1.17 13.2 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.226 1.01 . . . . 74.34 110.11 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.434 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 0.9 OUTLIER -139.88 177.98 7.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.002 0.742 . . . . 73.22 113.002 -169.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 140.34 29.68 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.419 1.088 . . . . 65.23 109.808 171.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.546 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -80.44 -67.58 0.76 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.106 0.962 . . . . 73.0 109.477 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -159.3 157.79 31.19 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.146 -1.388 . . . . 73.22 109.472 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.511 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.98 150.51 47.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.608 1.163 . . . . 75.54 108.22 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.5 t -157.96 152.02 24.24 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.44 -0.578 . . . . 74.21 109.44 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.536 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -164.85 131.51 2.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.147 -0.686 . . . . 63.41 109.147 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -124.23 146.39 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.771 -0.826 . . . . 72.34 108.771 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -125.09 98.26 5.59 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.939 . . . . 75.32 108.463 171.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.413 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -86.52 102.08 13.78 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.445 -0.798 . . . . 72.32 109.186 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.62 148.66 20.61 Favored Glycine 0 C--O 1.24 0.516 0 N-CA-C 111.189 -0.765 . . . . 64.14 111.189 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.38 125.46 1.82 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.889 -0.885 . . . . 73.55 110.889 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.566 HG12 ' HG2' ' B' ' 57' ' ' GLU . 38.0 mt -88.94 117.22 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.113 -0.699 . . . . 75.32 109.113 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -122.27 131.37 53.88 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.195 -1.409 . . . . 75.14 107.195 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.7 m -97.62 88.87 4.47 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.216 -1.031 . . . . 75.33 108.216 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' B' ' 89' ' ' ILE . 4.4 pt -95.67 121.98 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.24 -1.346 . . . . 75.42 110.028 -169.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.46 159.68 40.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.924 0.889 . . . . 55.21 109.89 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.19 -56.55 3.6 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.989 -0.55 . . . . 64.34 111.957 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.426 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.3 pp -58.5 153.04 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.152 0.981 . . . . 75.25 113.308 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -169.28 146.5 3.54 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.842 -1.072 . . . . 75.35 108.43 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -130.45 13.13 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 120.028 -0.318 . . . . 62.12 113.465 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -65.8 -33.22 75.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.479 1.111 . . . . 60.21 110.883 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.83 -40.54 97.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.202 -0.908 . . . . 74.3 110.561 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.425 ' SD ' ' O ' ' H' ' 277' ' ' LEU . 23.0 ttt -76.93 -31.73 56.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.808 -0.633 . . . . 70.11 110.438 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.05 -21.3 66.37 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.877 -0.602 . . . . 71.22 111.517 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -84.71 -37.0 21.47 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.22 0.608 . . . . 73.1 110.552 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . 0.558 ' SG ' ' HE1' ' B' ' 9' ' ' MET . 43.2 t -63.47 -67.2 0.45 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.482 0.313 . . . . 74.03 111.38 -177.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -12.79 42.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.383 0.512 . . . . 72.51 112.383 -176.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.03 -4.97 53.9 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-O 119.715 -0.492 . . . . 74.14 113.82 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.43 -58.41 0.49 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.185 0.493 . . . . 74.42 111.753 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -75.28 -44.61 44.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.2 0.6 . . . . 72.1 111.922 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.9 m -67.21 -44.68 49.23 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 118.572 -0.728 . . . . 73.31 111.721 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -57.16 -36.27 99.1 Favored 'Trans proline' 0 C--N 1.397 3.088 0 C-N-CA 122.435 2.09 . . . . 75.0 113.143 168.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -61.87 -35.91 79.72 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.389 0.676 . . . . 74.45 110.429 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -48.02 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.328 0.651 . . . . 74.13 110.752 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.5 mt -74.26 -21.12 59.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.188 0.595 . . . . 65.02 112.24 -173.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.561 ' HZ ' HD23 ' B' ' 128' ' ' LEU . 50.0 t80 -60.64 -52.32 73.48 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-O 117.143 -1.408 . . . . 65.22 113.578 -171.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.88 -35.58 80.34 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.204 1.936 . . . . 71.52 113.267 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -68.81 -49.87 54.9 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.683 0.793 . . . . 74.42 110.548 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.54 92.0 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.574 0.749 . . . . 50.41 111.087 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -57.23 -62.09 2.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.236 1.814 . . . . 73.34 111.7 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . 0.454 ' HG2' ' NH2' ' C' ' 120' ' ' ARG . 13.7 tp10 -70.34 -23.89 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.498 0.719 . . . . 72.41 110.709 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.522 ' SG ' HD12 ' B' ' 21' ' ' ILE . 4.1 t -69.97 -35.84 74.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.683 -0.199 . . . . 75.43 110.632 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.567 HD12 HG23 ' B' ' 64' ' ' VAL . 61.7 mt -63.82 -54.86 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.048 -0.723 . . . . 72.44 109.048 171.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.6 m -56.62 -34.69 67.5 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.382 1.073 . . . . 74.52 112.072 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -66.64 -45.01 80.41 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.644 -0.707 . . . . 71.04 110.43 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.521 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 13.7 mmt -71.2 -33.93 70.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.498 0.499 . . . . 74.45 111.165 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.61 -44.0 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.833 0.853 . . . . 64.51 109.746 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -72.0 -25.48 61.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.35 -0.841 . . . . 65.34 111.399 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.521 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -72.94 -27.51 61.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.877 0.471 . . . . 74.33 109.883 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.71 38.6 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.837 0.711 . . . . 54.02 112.756 169.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.9 p 54.86 46.6 24.13 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 125.888 1.675 . . . . 74.53 112.253 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -108.8 158.5 33.95 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.523 1.129 . . . . 74.5 109.099 174.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.408 ' HG2' HG21 ' H' ' 296' ' ' THR . 89.8 Cg_endo -72.93 -163.21 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.073 2.515 . . . . 75.12 113.696 -174.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.564 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 21.6 tp60 -64.08 130.38 43.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.724 0.81 . . . . 75.3 112.098 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.423 ' HB2' HG23 ' H' ' 296' ' ' THR . 29.9 tp -130.5 85.09 2.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.141 0.576 . . . . 74.52 109.615 171.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -91.01 115.55 28.1 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.623 -0.88 . . . . 74.34 108.623 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.571 HD21 HD13 ' B' ' 42' ' ' LEU . 1.6 tt -77.12 140.22 40.18 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.841 -1.17 . . . . 71.44 107.841 173.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' H' ' 291' ' ' LEU . . . -76.77 148.31 79.13 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.143 0.577 . . . . 71.45 111.057 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.87 109.67 0.48 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.576 2.184 . . . . 71.31 112.354 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.84 110.37 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.747 -0.834 . . . . 72.44 108.747 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -90.31 85.44 6.21 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.724 -0.843 . . . . 64.13 108.724 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -59.05 -36.37 74.91 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.921 0.889 . . . . 74.44 111.525 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' B' ' 138' ' ' MET . 4.2 m-20 -61.05 -47.81 84.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.874 -1.057 . . . . 73.33 110.391 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.62 -37.01 83.96 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.679 0.612 . . . . 64.54 111.466 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.76 -41.98 98.4 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 123.659 0.6 . . . . 74.0 110.888 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -74.27 -31.7 62.64 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.704 -0.68 . . . . 72.33 110.486 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 138' ' ' MET . . . . . 0.447 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 24.2 mmt -67.48 -38.84 84.99 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.763 -0.458 . . . . 75.35 109.763 173.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 142' ' ' GLN . 0.9 OUTLIER -75.04 -8.05 55.42 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.387 0.675 . . . . 64.43 111.567 -175.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -69.3 -38.79 78.46 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 110.101 -0.333 . . . . 74.44 110.101 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.17 4.57 10.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.209 0.818 . . . . 74.22 113.209 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' B' ' 139' ' ' ASN . 58.1 tt0 -143.38 141.38 30.88 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.028 0.531 . . . . 73.4 110.443 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -124.0 171.01 10.07 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.193 0.597 . . . . 75.35 110.078 173.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -115.42 172.65 6.96 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.931 0.892 . . . . 74.14 109.254 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.46 74.33 0.46 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.325 0.65 . . . . 65.23 109.275 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . 0.533 ' HA2' HG22 ' D' ' 7' ' ' THR . . . -95.26 120.11 6.39 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.731 -0.548 . . . . 73.41 111.731 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -166.4 98.11 0.59 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.081 0.552 . . . . 75.04 110.181 -173.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.39 -120.22 1.62 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.059 -0.817 . . . . 75.5 111.059 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 10.2 t -173.65 129.59 0.42 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.931 0.892 . . . . 72.54 109.076 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.17 127.93 1.86 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.425 -0.583 . . . . 72.34 109.425 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -133.04 105.83 7.29 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.099 -1.445 . . . . 73.3 107.099 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -114.55 109.34 18.11 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.616 0.367 . . . . 72.42 110.92 -168.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -111.62 100.17 8.76 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.869 -1.16 . . . . 72.31 107.869 170.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.95 158.13 29.45 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.945 0.498 . . . . 75.03 110.802 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 C-N-CA 124.073 0.949 . . . . 73.43 108.618 179.926 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.446 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 108.654 -0.869 . . . . 73.25 108.654 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 54.3 m -151.81 112.19 4.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.855 0.862 . . . . 73.5 108.985 171.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.49 151.04 25.63 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.292 0.637 . . . . 74.51 110.499 177.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -148.83 140.04 23.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.192 0.597 . . . . 73.43 109.922 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 147' ' ' GLU . 5.2 p30 -112.08 141.72 45.41 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.459 1.103 . . . . 73.55 109.408 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.51 73.34 10.12 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.639 0.733 . . . . 65.32 109.508 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.1 m -120.82 95.2 4.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.057 0.943 . . . . 72.45 108.616 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -80.45 -40.97 25.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.874 -0.603 . . . . 72.33 110.737 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 89.3 mtp 59.69 115.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.065 1.346 . . . . 72.21 112.379 -173.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -122.45 97.12 5.32 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.492 -1.299 . . . . 61.3 107.492 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -105.59 129.3 53.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.446 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.617 ' HB3' ' H ' ' G' ' 308' ' ' CYS . 0.7 OUTLIER -137.71 108.87 6.8 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.401 0.681 . . . . 73.1 109.254 173.521 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.7 120.07 13.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.222 -0.899 . . . . 63.32 108.626 171.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -86.15 -49.91 7.39 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.685 -0.689 . . . . 70.22 109.9 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . 0.672 HH12 HD12 ' G' ' 301' ' ' ILE . 58.7 ttt180 -171.69 129.41 0.66 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.174 -0.467 . . . . 72.34 109.893 -176.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.21 143.88 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.197 -1.409 . . . . 72.33 107.197 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.555 ' HB3' HG21 ' D' ' 122' ' ' THR . 15.7 p90 -175.73 151.4 1.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.315 0.579 . . . . 71.55 110.444 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -76.6 107.12 8.67 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.622 -0.881 . . . . 73.24 108.622 171.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -70.48 -29.73 66.35 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.008 -0.738 . . . . 73.42 109.008 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.753 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -145.84 140.51 27.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.26 -0.882 . . . . 63.34 110.687 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.504 HG12 ' SG ' ' C' ' 113' ' ' CYS . 93.4 mt -134.66 144.98 33.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.275 -1.75 . . . . 73.34 106.275 170.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.0 t -159.68 151.77 20.71 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.484 0.659 . . . . 62.13 110.674 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.446 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 80.7 t80 -149.36 109.7 4.18 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.335 -1.357 . . . . 75.14 107.335 171.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.3 119.17 35.41 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.98 -0.748 . . . . 72.15 108.98 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.07 79.62 12.98 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.626 -0.879 . . . . 73.14 108.626 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.17 -12.53 25.62 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.815 2.343 . . . . 72.11 111.409 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -103.97 13.25 33.05 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.453 1.101 . . . . 75.11 109.357 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.02 96.0 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.613 1.338 . . . . 75.43 114.613 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.24 -39.72 22.09 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.624 1.549 . . . . 62.43 112.181 178.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -68.76 -41.59 78.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.977 -1.011 . . . . 72.45 112.359 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . 0.454 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 13.5 p -70.94 -25.83 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.065 0.394 . . . . 72.2 112.065 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . 0.427 ' HE2' ' HD3' ' F' ' 304' ' ' PRO . 67.9 t80 -69.63 -12.16 61.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.668 0.787 . . . . 75.11 112.173 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -128.47 22.84 5.95 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.584 0.753 . . . . 72.03 110.635 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.56 ' HE3' HD22 ' C' ' 68' ' ' LEU . 31.9 ttpt -109.1 168.1 9.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.934 0.894 . . . . 75.35 110.626 -174.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.67 125.23 19.03 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.942 1.297 . . . . 73.23 112.243 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -85.53 68.21 10.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.955 0.902 . . . . 72.34 111.39 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -149.3 71.65 10.02 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 109.379 -0.6 . . . . 75.24 109.379 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.03 143.19 4.0 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.673 2.249 . . . . 74.12 112.023 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -88.06 91.6 8.83 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.61 -1.256 . . . . 75.53 107.61 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.41 129.02 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.662 -0.866 . . . . 74.22 108.662 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.77 118.24 22.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.394 0.678 . . . . 71.1 109.222 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -87.17 119.76 27.74 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.423 -1.325 . . . . 73.51 107.423 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.73 114.35 19.81 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.959 -0.756 . . . . 74.42 108.959 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.83 150.11 24.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.38 0.672 . . . . 73.32 109.284 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.717 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 6.5 t70 -148.02 150.93 34.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.345 1.058 . . . . 74.42 109.158 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -119.34 131.12 55.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.886 0.874 . . . . 73.04 110.272 -174.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.523 ' HB2' ' HB ' ' C' ' 59' ' ' VAL . . . -134.57 145.77 49.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 74.3 109.509 174.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -151.89 146.05 25.36 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.734 . . . . 74.14 110.262 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.8 p -148.09 137.09 21.96 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.556 0.742 . . . . 75.43 109.93 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -83.58 116.62 22.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.096 -0.705 . . . . 70.32 109.096 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.63 HD12 ' HB2' ' C' ' 57' ' ' GLU . 43.7 mt -93.91 -34.02 13.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.453 0.701 . . . . 74.4 109.933 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.71 -173.99 4.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.896 . . . . 73.54 110.101 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.95 116.39 5.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.32 -0.854 . . . . 75.15 110.188 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 70.28 -5.85 1.26 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.559 1.543 . . . . 72.41 113.129 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -94.76 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.724 -0.843 . . . . 75.33 108.724 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -124.62 126.18 45.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.518 1.127 . . . . 75.53 108.748 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.63 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.1 tt0 -82.21 116.17 21.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.051 -0.977 . . . . 75.42 108.783 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -97.23 122.82 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.597 -1.26 . . . . 72.41 107.597 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.523 ' HB ' ' HB2' ' C' ' 47' ' ' ALA . 92.5 t -115.85 132.81 64.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.536 -0.912 . . . . 73.45 108.536 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.94 102.59 9.49 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.343 -1.354 . . . . 75.52 107.343 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.717 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.2 tmt_? -82.59 110.03 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.226 1.01 . . . . 74.13 108.481 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.461 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.5 t -102.57 136.88 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.92 -1.141 . . . . 72.41 107.92 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -140.03 116.54 10.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.217 -0.66 . . . . 72.12 109.217 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 78.4 t -102.35 109.09 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.793 -1.094 . . . . 71.22 108.1 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.0 m -98.67 150.68 21.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.623 -1.171 . . . . 71.34 109.301 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.94 111.24 7.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 74.24 107.141 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -144.39 127.08 16.16 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.621 -0.511 . . . . 43.3 109.621 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.573 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -90.29 60.5 4.76 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.283 1.039 . . . . 71.22 108.798 176.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 -122.7 6.41 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 114.063 -1.426 . . . . 64.14 110.517 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.86 -23.93 19.5 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.449 -0.945 . . . . 73.12 108.449 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.11 115.89 5.94 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.424 1.09 . . . . 72.21 109.722 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -85.73 140.19 30.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.427 . . . . 63.34 111.085 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.37 -61.54 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.962 0.905 . . . . 72.43 109.058 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -164.47 176.42 9.03 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.454 0.702 . . . . 72.23 110.653 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -141.57 143.9 33.96 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.934 -1.135 . . . . 70.42 107.934 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.504 ' SG ' HG21 ' C' ' 114' ' ' ILE . 42.7 t -147.17 129.83 16.02 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.558 0.743 . . . . 65.04 109.113 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -132.15 139.6 48.47 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.344 0.658 . . . . 71.13 110.407 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . 0.407 HG12 ' HA ' ' C' ' 110' ' ' ALA . 25.5 t -136.97 114.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.526 1.13 . . . . 72.33 108.365 172.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.753 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -92.31 93.62 8.73 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 75.43 108.849 171.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.04 105.39 11.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.407 -0.815 . . . . 75.53 110.073 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.06 155.0 27.06 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.917 -0.583 . . . . 73.24 112.08 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . 0.461 ' HA3' HD23 ' C' ' 106' ' ' LEU . . . -156.57 116.22 0.71 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.703 -0.959 . . . . 73.22 110.703 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.501 HD11 ' HB3' ' D' ' 29' ' ' PRO . 15.3 mm -81.41 122.73 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.192 -1.04 . . . . 75.4 108.192 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -132.68 142.07 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.912 -0.773 . . . . 74.41 108.912 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 85' ' ' SER . . . . . 0.6 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 38.3 m -109.8 121.47 45.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.633 -1.247 . . . . 74.11 107.633 169.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.514 ' HB ' HD13 ' C' ' 89' ' ' ILE . 1.9 pp -121.49 141.41 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.873 0.869 . . . . 75.44 110.852 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.76 164.22 36.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.003 0.921 . . . . 74.1 109.645 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.64 -19.11 34.56 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 114.092 0.397 . . . . 71.51 114.092 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.514 HD13 ' HB ' ' C' ' 86' ' ' ILE . 0.8 OUTLIER -101.91 141.88 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.76 1.224 . . . . 74.24 110.581 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -156.15 148.24 23.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.591 0.757 . . . . 74.02 110.068 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.18 -146.06 35.69 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.27 -0.423 . . . . 73.32 112.874 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -67.83 -21.54 65.2 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.481 0.712 . . . . 72.45 111.357 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.6 -36.74 84.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.588 0.755 . . . . 71.35 110.926 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.708 ' HE3' ' HG ' ' F' ' 277' ' ' LEU . 28.1 ttt -70.42 -29.92 66.65 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 116.288 -0.415 . . . . 74.3 110.883 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.82 69.02 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.313 0.645 . . . . 54.44 111.679 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.427 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 50.1 t-80 -74.14 -26.93 60.61 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.154 0.582 . . . . 72.52 110.816 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -81.18 -60.68 2.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.511 0.324 . . . . 74.11 110.712 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.621 HD23 HD22 ' F' ' 278' ' ' LEU . 4.6 pp -73.23 -36.96 66.52 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.257 0.623 . . . . 75.03 111.695 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . 0.43 ' N ' HD11 ' C' ' 98' ' ' LEU . . . -90.95 -14.65 57.54 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 114.3 0.48 . . . . 75.41 114.3 -170.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' C' ' 96' ' ' HIS . . . -127.09 -58.16 1.29 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.725 0.41 . . . . 70.12 111.579 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.8 -45.24 75.36 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.602 0.361 . . . . 73.14 111.935 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -63.94 -45.52 80.65 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.641 -0.695 . . . . 73.34 112.124 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.63 -39.73 81.97 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.559 2.173 . . . . 72.43 113.87 165.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.9 -18.75 65.55 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.826 0.451 . . . . 73.55 112.202 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mm -86.66 -45.94 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.254 0.622 . . . . 75.25 110.537 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.461 HD23 ' HA3' ' C' ' 82' ' ' GLY . 88.7 mt -79.85 -43.53 22.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.936 0.717 . . . . 60.31 112.936 -168.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.4 -42.08 89.87 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.239 1.016 . . . . 73.13 113.041 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . 0.604 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 69.9 Cg_exo -44.36 -46.97 11.34 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.628 2.219 . . . . 54.23 115.091 169.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -69.64 -42.21 74.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.155 0.582 . . . . 72.31 111.252 -177.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . 0.407 ' HA ' HG12 ' C' ' 78' ' ' VAL . . . -66.82 -29.8 69.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.705 -0.679 . . . . 75.44 111.354 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.61 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 34.7 ttp180 -56.08 -58.27 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 123.93 0.769 . . . . 74.51 111.179 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -73.5 -32.69 64.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.258 0.623 . . . . 75.2 110.338 -176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . 0.504 ' SG ' HG12 ' C' ' 21' ' ' ILE . 36.2 t -62.54 -34.68 77.42 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.396 0.678 . . . . 74.04 111.865 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.504 HG21 ' SG ' ' C' ' 76' ' ' CYS . 96.7 mt -71.36 -47.16 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.608 0.763 . . . . 75.02 110.206 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -64.7 -28.32 69.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.327 0.651 . . . . 63.52 111.852 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -68.28 -39.97 81.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.581 0.753 . . . . 72.13 110.011 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.725 ' HE2' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.06 -41.11 95.41 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.729 0.811 . . . . 74.0 111.105 175.877 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.24 -34.14 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.831 0.852 . . . . 72.32 110.246 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 119' ' ' SER . . . . . 0.453 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 42.0 t -65.59 -43.04 90.91 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.57 -0.741 . . . . 62.11 110.98 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.454 ' NH2' ' HG2' ' B' ' 112' ' ' GLU . 91.3 mtt-85 -72.28 -21.28 61.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.22 -0.9 . . . . 74.02 111.439 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.65 -1.04 87.7 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.79 -0.45 . . . . 65.2 113.365 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.422 HG22 ' HB3' ' D' ' 17' ' ' TYR . 30.2 p 59.66 43.09 16.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.507 1.523 . . . . 64.23 111.489 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -119.69 141.11 30.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.733 0.813 . . . . 72.43 110.033 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.564 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 13.1 Cg_endo -53.09 107.16 0.18 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.729 2.953 . . . . 71.21 112.898 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -55.74 143.21 31.63 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.058 1.343 . . . . 74.23 113.52 -170.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tt -134.61 114.65 12.99 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.787 -1.19 . . . . 75.14 107.787 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -92.12 126.24 37.13 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.395 -0.965 . . . . 75.52 108.395 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.61 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.0 mm? -66.67 148.33 52.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.667 0.787 . . . . 73.42 111.447 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.92 153.4 60.33 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 123.356 0.663 . . . . 74.42 110.86 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -76.9 125.53 8.12 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.301 2.668 . . . . 75.24 112.295 -172.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.37 110.6 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.13 0.572 . . . . 75.02 109.493 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.615 HD22 HD13 ' A' ' 105' ' ' ILE . 3.4 m-20 -91.3 93.89 9.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 75.55 109.451 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -76.57 -33.11 58.5 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.36 0.6 . . . . 75.31 109.592 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -70.69 -40.78 72.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.885 -1.052 . . . . 54.22 111.503 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.26 83.35 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.107 0.879 . . . . 63.24 111.842 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.32 -23.22 57.27 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 123.937 0.773 . . . . 75.13 111.372 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -80.63 -33.61 35.62 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.176 0.59 . . . . 75.4 111.097 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 95.0 mmm -74.05 -30.91 62.64 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.698 -0.482 . . . . 75.22 109.698 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -53.73 -37.07 62.96 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.411 1.484 . . . . 72.24 111.076 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -52.96 -83.75 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.502 1.521 . . . . 74.21 112.342 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 95.0 mt -95.34 10.63 35.54 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.448 0.907 . . . . 63.43 113.448 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -122.94 150.0 43.52 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.165 0.439 . . . . 61.51 110.418 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -160.46 163.08 33.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.049 0.94 . . . . 74.51 110.634 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . 0.684 ' HB3' ' HG3' ' A' ' 93' ' ' GLN . 51.3 mt-30 -130.62 147.07 52.26 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.13 0.972 . . . . 73.43 108.711 170.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.574 ' HB1' ' H ' ' A' ' 5' ' ' ASN . . . -132.71 119.71 20.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.257 0.623 . . . . 62.44 110.696 -173.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.5 98.82 0.13 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.36 -1.096 . . . . 74.4 110.36 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 88' ' ' GLY . 15.1 pt-20 -72.96 164.89 26.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.446 0.641 . . . . 73.42 112.468 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . 0.673 ' HA3' ' HB2' ' A' ' 90' ' ' GLU . . . -177.27 141.21 5.21 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 114.653 -1.158 . . . . 43.44 110.817 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.7 t -171.33 163.3 6.97 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.21 0.604 . . . . 65.32 110.592 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -170.13 119.8 0.61 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.7 -1.592 . . . . 75.35 106.7 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.63 89.06 0.24 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.321 0.649 . . . . 63.33 109.436 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -77.36 153.19 33.99 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.731 0.812 . . . . 73.13 112.362 -168.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -61.06 130.79 48.15 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.165 . . . . 75.24 111.105 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.6 t70 72.04 132.7 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.571 1.549 . . . . 75.34 111.576 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . 0.67 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.508 0.723 . . . . 74.31 109.749 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.454 ' SD ' ' N ' ' D' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.123 -0.695 . . . . 74.02 109.123 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.9 t -78.98 105.93 10.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.289 0.635 . . . . 72.4 110.691 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -112.38 107.87 16.84 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.993 -1.114 . . . . 75.3 107.993 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -102.92 173.85 6.13 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.93 0.892 . . . . 74.54 109.046 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -161.18 93.69 0.97 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.576 0.703 . . . . 64.34 110.645 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . 0.44 ' HB3' ' HG2' ' D' ' 8' ' ' GLU . 61.3 t30 -163.03 175.02 11.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.427 0.691 . . . . 74.21 109.327 177.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 7' ' ' THR . . . . . 0.533 HG22 ' HA2' ' B' ' 146' ' ' GLY . 8.1 t -82.78 59.16 4.64 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 122.411 1.1 . . . . 71.33 110.76 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . 0.44 ' HG2' ' HB3' ' D' ' 6' ' ' ASN . 11.1 mm-40 -85.75 -2.01 57.78 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.901 -1.045 . . . . 75.23 110.927 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.5 ttp -30.65 127.96 0.14 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.332 1.853 . . . . 73.42 113.698 170.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 10' ' ' THR . . . . . 0.46 ' HB ' ' HB2' ' D' ' 87' ' ' ALA . 57.5 m -135.65 138.26 42.67 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.608 0.763 . . . . 75.32 109.45 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -157.47 105.77 2.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.492 -1.299 . . . . 74.42 107.492 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -125.26 119.19 27.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 74.12 109.257 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mt -73.4 114.93 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 107.837 -1.171 . . . . 71.02 107.837 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.91 -45.54 16.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.27 -0.641 . . . . 74.05 109.27 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -174.04 159.73 3.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.025 0.93 . . . . 73.42 109.897 172.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.428 HD12 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -130.03 143.2 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.375 1.07 . . . . 70.24 108.128 174.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.422 ' HB3' HG22 ' C' ' 122' ' ' THR . 31.0 p90 -170.26 172.27 6.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.933 0.873 . . . . 75.3 110.988 -169.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -98.74 115.77 29.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.507 -1.224 . . . . 73.0 109.56 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -87.69 -23.42 24.19 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.356 -0.609 . . . . 74.54 109.356 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.1 t70 -151.23 134.56 16.11 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.553 -1.203 . . . . 63.11 109.338 175.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.725 HD12 ' HE2' ' C' ' 117' ' ' MET . 72.0 mt -129.45 138.39 54.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.562 -1.273 . . . . 75.24 107.562 171.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -143.08 128.47 18.91 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.107 -1.071 . . . . 74.02 108.107 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.501 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 56.6 t80 -138.0 113.63 9.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.653 -1.98 . . . . 72.3 105.653 167.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.36 138.54 54.21 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.373 -0.603 . . . . 74.31 109.373 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' D' ' 28' ' ' ALA . . . -143.53 77.06 15.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.436 -1.32 . . . . 55.14 107.436 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.46 -45.44 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.664 2.243 . . . . 63.32 111.901 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -93.48 30.09 1.82 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.442 1.097 . . . . 73.0 108.78 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' D' ' 25' ' ' ALA . . . -59.47 -57.45 26.81 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 124.112 0.965 . . . . 65.51 112.702 -172.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.501 ' HB3' HD11 ' C' ' 83' ' ' ILE . 52.3 Cg_endo -76.88 -12.19 17.97 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.468 1.56 . . . . 71.52 112.163 -179.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -78.19 -41.65 33.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.02 1.328 . . . . 75.43 109.982 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.47 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -79.32 -32.48 14.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-O 118.812 -0.613 . . . . 73.03 110.097 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -50.95 -28.67 10.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.094 0.872 . . . . 73.44 113.197 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.43 -38.01 89.48 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.442 0.697 . . . . 73.12 111.141 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -132.5 64.07 1.61 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.639 0.776 . . . . 73.33 110.202 168.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.547 ' HB3' HD11 ' G' ' 301' ' ' ILE . 17.5 t70 -112.16 95.98 5.77 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.795 0.807 . . . . 74.22 110.152 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -123.01 -157.45 0.75 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.044 1.738 . . . . 71.42 106.804 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . 0.408 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 15.9 pm0 -50.87 106.28 0.63 Allowed Pre-proline 0 CA--C 1.567 1.618 0 C-N-CA 123.386 0.674 . . . . 75.42 111.915 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 4.7 Cg_exo -78.06 147.32 23.66 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.737 2.291 . . . . 72.23 112.295 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.4 110.98 5.63 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 107.243 -1.392 . . . . 74.53 107.243 168.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.74 114.81 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.539 -0.755 . . . . 64.12 110.18 -169.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.401 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 86.5 tttt -94.56 138.49 32.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.109 0.964 . . . . 72.22 109.767 173.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . 0.437 HD13 HD23 ' D' ' 128' ' ' LEU . 6.2 tt -98.8 131.91 44.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.331 -1.359 . . . . 74.14 107.331 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -132.33 147.14 52.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.865 -0.791 . . . . 75.04 108.865 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.16 139.39 49.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.251 0.62 . . . . 75.25 110.394 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 12.1 t70 -137.43 135.27 36.74 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.109 -1.071 . . . . 75.51 108.109 170.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -113.42 144.4 42.87 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 73.1 109.584 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.57 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.16 155.1 39.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.355 0.662 . . . . 63.32 110.197 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 73.6 p -164.72 153.14 12.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.191 0.596 . . . . 74.25 110.649 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -154.31 137.06 15.26 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.356 0.663 . . . . 70.43 109.449 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.19 116.99 15.48 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.912 -0.773 . . . . 72.0 108.912 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.474 HD13 HG22 ' D' ' 83' ' ' ILE . 37.3 mt -91.89 -32.12 15.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.674 0.39 . . . . 65.4 110.358 -178.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.83 -175.25 5.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.785 -0.643 . . . . 75.21 111.361 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.67 118.08 7.16 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.598 -1.183 . . . . 74.21 109.749 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.496 ' HB3' ' HB3' ' D' ' 87' ' ' ALA . 13.0 m-20 65.09 11.05 6.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.508 1.123 . . . . 74.5 112.314 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.83 120.21 64.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 123.779 0.831 . . . . 75.21 109.239 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.604 ' HB2' HD12 ' D' ' 86' ' ' ILE . 73.8 m-85 -129.67 128.88 43.48 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.502 -1.295 . . . . 72.4 107.502 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -92.27 128.37 38.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.116 -0.698 . . . . 75.34 109.116 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.92 118.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.849 -1.167 . . . . 73.42 107.849 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.57 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 49.0 t -99.97 133.41 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.365 -0.976 . . . . 73.12 108.365 172.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.29 109.74 13.17 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.384 -0.969 . . . . 73.22 108.384 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -88.53 112.65 23.26 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.475 0.71 . . . . 74.41 110.051 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.7 t -101.27 126.31 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 74.5 108.564 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.0 m -129.42 134.3 47.77 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.97 0.508 . . . . 73.44 110.2 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.576 HG12 HD12 ' D' ' 126' ' ' LEU . 47.6 t -130.72 113.44 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.425 1.09 . . . . 72.02 108.892 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.401 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 21.4 m -103.87 101.12 10.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.465 0.706 . . . . 71.32 109.415 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.47 124.79 43.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.827 -0.435 . . . . 72.21 109.827 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.442 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.7 m -139.2 124.61 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.694 0.798 . . . . 73.05 108.894 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.6 103.36 15.96 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.771 -1.196 . . . . 75.44 107.771 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.19 -115.94 4.61 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.885 0.741 . . . . 75.24 112.465 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.47 5.0 51.75 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.741 0.816 . . . . 64.11 110.742 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . 0.432 ' HB3' ' HZ3' ' D' ' 34' ' ' LYS . 6.4 tp10 -135.86 145.83 46.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.763 0.825 . . . . 64.43 110.473 -165.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -73.08 130.57 40.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.298 0.639 . . . . 62.43 111.334 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.47 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.36 -61.38 1.78 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.991 . . . . 63.01 108.679 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . 0.558 ' HE2' HD11 ' D' ' 126' ' ' LEU . 42.9 p90 -159.05 151.69 21.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.175 -1.375 . . . . 63.32 110.311 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 84.1 mt -113.65 151.49 31.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.489 1.116 . . . . 75.44 109.127 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.532 ' SG ' HG21 ' D' ' 114' ' ' ILE . 34.7 t -154.64 134.68 13.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.722 -0.473 . . . . 65.44 109.722 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.485 0.714 . . . . 73.31 109.832 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.44 121.09 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.61 0.764 . . . . 65.21 109.473 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.422 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.5 mt-30 -89.87 89.84 7.92 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.722 -0.844 . . . . 75.1 108.722 171.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.22 93.39 5.86 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.821 -1.081 . . . . 75.54 109.107 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.6 140.38 17.25 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.36 -0.696 . . . . 70.12 111.36 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . 0.41 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.19 128.09 3.58 Favored Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 110.189 -1.164 . . . . 61.41 110.189 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.474 HG22 HD13 ' D' ' 51' ' ' LEU . 53.2 mt -90.85 129.23 41.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.834 -0.802 . . . . 71.12 108.834 -177.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' D' ' 86' ' ' ILE . 22.1 m-85 -132.48 158.26 42.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.353 0.408 . . . . 72.33 110.368 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 25.4 m -107.14 102.29 11.63 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.504 -0.924 . . . . 75.32 108.504 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.604 HD12 ' HB2' ' D' ' 56' ' ' TYR . 4.0 mp -107.51 113.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.818 -1.179 . . . . 74.0 107.818 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.599 ' HA ' HD11 ' G' ' 277' ' ' LEU . . . -142.57 124.79 15.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.177 0.591 . . . . 72.11 110.492 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.19 5.65 57.09 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.421 -0.655 . . . . 52.13 114.577 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 mp -114.96 126.39 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.69 -0.856 . . . . 74.41 108.69 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 -177.83 4.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.776 0.83 . . . . 74.12 110.56 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.59 -141.06 39.83 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.501 -0.772 . . . . 75.1 113.799 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.2 p -84.31 -13.5 52.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.635 0.774 . . . . 75.14 111.656 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.89 0.476 . . . . 74.33 110.403 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.465 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -69.95 -31.84 69.79 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 110.421 -0.214 . . . . 74.24 110.421 175.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.62 68.6 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.866 0.729 . . . . 75.02 111.218 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -72.62 -35.67 67.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.224 0.61 . . . . 75.04 110.204 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.25 -51.45 52.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.859 0.464 . . . . 74.22 110.908 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.525 HD13 ' CD1' ' G' ' 281' ' ' PHE . 2.9 pp -75.84 -19.74 58.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.755 0.422 . . . . 70.34 112.065 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -7.79 60.32 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.73 -0.483 . . . . 71.21 113.364 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.56 -62.6 0.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.342 0.571 . . . . 62.12 111.952 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -68.13 -52.33 36.02 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.424 0.527 . . . . 75.22 112.424 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 60.7 m -61.55 -43.81 89.9 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 123.673 0.789 . . . . 63.34 111.944 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.13 -46.52 32.08 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.13 1.887 . . . . 71.03 112.898 165.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -66.9 -15.79 63.89 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.442 0.697 . . . . 72.2 112.584 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -80.11 -49.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.464 -0.569 . . . . 72.42 109.464 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.41 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.3 mt -79.22 -28.91 42.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.73 0.812 . . . . 74.32 112.247 -169.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.93 -40.43 16.39 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.035 -0.983 . . . . 73.53 113.07 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -50.91 -43.52 46.83 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.282 1.988 . . . . 75.45 113.229 169.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -74.84 -37.08 62.35 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.477 0.711 . . . . 70.31 111.6 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.3 67.59 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.084 0.553 . . . . 74.22 110.281 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -43.6 79.72 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.905 1.378 . . . . 75.41 111.13 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -73.2 -36.48 66.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.779 0.832 . . . . 75.51 111.236 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -62.92 -44.92 94.77 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.893 0.477 . . . . 45.02 110.163 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.532 HG21 ' SG ' ' D' ' 76' ' ' CYS . 73.0 mt -61.83 -50.3 80.74 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.225 1.01 . . . . 71.52 110.213 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.58 HG23 ' HB3' ' D' ' 125' ' ' GLN . 30.4 m -50.84 -46.9 60.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.494 1.117 . . . . 73.33 111.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.8 t -73.53 -22.63 60.05 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.065 0.946 . . . . 64.42 112.635 -172.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.45 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.8 mtm -87.31 -43.46 12.14 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.062 0.458 . . . . 64.42 111.243 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.5 -34.45 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 114.691 -1.14 . . . . 72.02 110.382 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -66.55 -36.81 83.59 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.387 0.675 . . . . 74.23 111.405 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.5 mtt-85 -69.65 -26.74 64.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.143 0.577 . . . . 73.15 111.164 177.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 11.04 60.71 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-O 119.689 -0.506 . . . . 74.43 113.316 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 122' ' ' THR . . . . . 0.555 HG21 ' HB3' ' C' ' 17' ' ' TYR . 25.6 p 65.42 16.36 10.48 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.581 1.952 . . . . 72.11 112.921 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -96.31 165.66 15.79 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.707 1.203 . . . . 72.44 108.406 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.406 ' HG3' ' HB2' ' G' ' 297' ' ' TYR . 64.8 Cg_endo -78.64 150.58 24.59 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.258 1.972 . . . . 74.1 112.628 -174.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . 0.58 ' HB3' HG23 ' D' ' 115' ' ' THR . 21.4 mt-30 -57.54 135.25 56.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.144 0.578 . . . . 74.55 111.092 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.576 HD12 HG12 ' D' ' 64' ' ' VAL . 88.4 mt -106.33 93.32 4.54 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.367 -0.605 . . . . 74.24 109.367 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -100.43 100.36 11.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.474 -0.936 . . . . 74.15 108.474 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.437 HD23 HD13 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.39 132.79 48.36 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.961 0.904 . . . . 73.25 109.136 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.21 146.95 87.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.815 0.846 . . . . 72.41 111.615 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.05 111.54 2.02 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 121.939 1.759 . . . . 71.15 111.393 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . 0.483 HG22 HD23 ' G' ' 291' ' ' LEU . 77.1 t -106.65 124.99 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.375 -0.972 . . . . 75.31 108.375 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.02 92.41 5.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.242 0.617 . . . . 73.41 110.036 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -64.01 -33.11 74.99 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.023 0.929 . . . . 74.22 111.202 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -59.68 -54.04 50.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.862 0.865 . . . . 73.44 111.071 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.3 88.57 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.133 0.896 . . . . 71.42 111.592 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.92 -42.38 99.78 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.174 0.921 . . . . 73.42 111.536 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -69.74 -52.31 26.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.093 0.557 . . . . 75.33 110.272 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.0 mtm -66.2 -19.86 65.96 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.873 0.869 . . . . 74.45 111.825 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -66.27 -42.28 88.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.706 0.802 . . . . 52.51 109.877 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -63.97 -34.94 79.11 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.329 1.051 . . . . 75.25 111.322 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp -62.57 -28.55 69.95 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.821 0.848 . . . . 74.52 111.082 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -90.27 9.11 29.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.946 0.899 . . . . 62.31 111.63 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -126.71 45.83 2.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.499 0.72 . . . . 74.33 109.682 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -154.49 145.81 22.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.241 0.616 . . . . 72.35 110.138 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.31 19.66 2.76 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.19 0.596 . . . . 64.22 110.657 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.82 69.9 2.62 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.023 -0.831 . . . . 73.42 111.023 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.9 -48.71 80.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.014 0.925 . . . . 75.24 111.087 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 79.78 -49.73 3.73 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.015 -0.538 . . . . 75.01 114.281 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 79.0 p 55.52 89.2 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.565 1.546 . . . . 75.21 111.976 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -143.68 152.61 41.54 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.92 0.888 . . . . 74.45 109.28 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -73.19 164.27 26.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.414 0.686 . . . . 64.41 111.248 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -166.82 155.07 9.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.378 1.071 . . . . 73.31 108.415 -175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.62 146.34 53.95 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.766 -0.457 . . . . 74.53 109.766 171.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -116.84 154.49 30.66 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.496 0.718 . . . . 72.11 109.882 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.158 0 C-N-CA 124.531 1.132 . . . . 72.41 108.422 177.435 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.327 0.584 . . . . 73.54 110.143 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -86.83 123.2 31.71 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.315 -0.857 . . . . 71.33 108.997 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -78.18 81.1 4.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.031 0.92 . . . . 64.04 109.259 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -106.26 -161.89 0.82 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.35 -1.295 . . . . 74.04 108.186 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -65.6 124.62 87.82 Favored Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 108.983 -0.747 . . . . 72.25 108.983 170.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.49 -49.73 6.89 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.74 2.294 . . . . 75.44 112.141 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . 0.562 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 52.2 mt -154.64 -43.71 0.09 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.067 1.747 . . . . 75.43 107.531 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 77.2 mt -66.26 88.54 0.12 Allowed 'General case' 0 C--N 1.358 0.953 0 C-N-CA 123.525 0.73 . . . . 74.55 110.76 174.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -96.0 -67.58 0.98 Allowed Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.757 -0.656 . . . . 73.5 111.922 177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 40.0 tp -91.38 122.08 33.66 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.728 0.411 . . . . 75.23 111.865 -175.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . 0.42 ' CE1' ' HB ' ' A' ' 46' ' ' THR . 0.8 OUTLIER -177.74 138.5 0.21 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.363 1.865 . . . . 73.55 107.906 158.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -152.85 -161.67 1.34 Allowed 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.199 1.0 . . . . 74.54 108.795 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.19 78.49 0.7 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.875 -0.787 . . . . 62.14 108.875 173.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 57.63 -136.85 50.32 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 115.867 -0.606 . . . . 73.45 112.103 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -176.37 -61.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 107.036 -1.468 . . . . 72.55 107.036 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -83.86 124.22 75.06 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.933 -1.136 . . . . 64.3 107.933 170.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -26.52 62.32 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.55 2.167 . . . . 73.14 112.938 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 58.7 t 64.19 -76.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 125.154 1.382 . . . . 73.43 110.144 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 62.02 33.16 17.4 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.17 0.988 . . . . 75.31 110.363 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 72.0 m95 69.18 152.79 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.419 1.487 . . . . 72.34 111.402 -165.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.403 ' HB3' ' OG1' ' G' ' 309' ' ' THR . 9.8 mp -69.78 -40.31 76.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.313 -0.858 . . . . 75.23 110.826 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.58 -70.38 0.11 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.657 -0.977 . . . . 71.44 110.657 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . 0.428 ' HB2' HG13 ' G' ' 306' ' ' VAL . 6.6 Cg_exo -75.02 167.79 26.26 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.658 2.239 . . . . 73.21 111.362 172.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . 0.531 ' HD3' ' H ' ' A' ' 40' ' ' VAL . 22.1 ttmm -138.18 -62.18 0.59 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.774 0.83 . . . . 75.35 108.879 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 57.61 -87.16 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.077 1.351 . . . . 74.0 112.487 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 11.9 m 68.51 -65.17 0.28 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.552 1.541 . . . . 65.52 112.561 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.631 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 3.1 m-85 -85.7 -84.83 0.16 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.326 0.861 . . . . 72.11 113.326 -174.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 33.8 m170 70.65 -55.77 0.62 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.381 1.472 . . . . 73.52 111.22 -164.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . 0.551 ' HA3' ' HB2' ' G' ' 300' ' ' ASN . . . -160.26 -113.24 0.32 Allowed Glycine 0 C--N 1.345 1.067 0 CA-C-O 119.497 -0.613 . . . . 73.4 112.003 173.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 26.8 t30 69.04 -66.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.632 1.573 . . . . 74.13 111.522 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . 0.737 HG21 HH22 ' B' ' 15' ' ' ARG . 27.4 mt -74.36 144.91 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.622 0.769 . . . . 71.44 111.451 -172.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' G' ' 298' ' ' HIS . 44.0 t0 -156.93 169.93 23.67 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.924 1.29 . . . . 64.34 107.73 169.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -72.23 117.35 57.72 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 108.787 -0.82 . . . . 74.02 108.787 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -81.95 91.27 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.225 1.95 . . . . 73.31 109.99 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.62 76.51 3.3 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.41 -0.814 . . . . 72.24 110.79 -176.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . 0.584 HG13 ' HB2' ' B' ' 12' ' ' GLN . 47.6 t -89.73 121.0 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.495 -0.928 . . . . 74.22 108.495 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 72.0 p -103.96 168.16 9.3 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.4 0.68 . . . . 75.32 111.325 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 78.8 m -58.65 99.99 0.06 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 124.17 0.988 . . . . 73.42 110.909 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' E' E ' 309' ' ' THR . . . . . 0.414 HG23 ' HB3' ' G' ' 291' ' ' LEU . 91.0 m -68.42 122.29 83.88 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.403 -1.271 . . . . 72.33 112.069 -171.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo . . . . . 0 C--N 1.38 2.189 0 C-N-CA 122.548 2.165 . . . . 75.44 111.021 166.824 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.491 -0.559 . . . . 74.41 109.491 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -68.85 -67.56 0.46 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.329 0.652 . . . . 72.24 109.843 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 67.11 -71.71 0.1 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.924 1.29 . . . . 75.2 112.011 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -131.79 161.9 31.8 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.072 0.949 . . . . 74.45 111.422 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -128.31 169.35 12.92 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.331 1.452 . . . . 74.15 108.808 171.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.68 -156.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.124 1.883 . . . . 72.04 111.966 169.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.708 ' HG ' ' HE3' ' C' ' 94' ' ' MET . 35.9 tp -77.63 66.23 3.29 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-O 122.347 1.07 . . . . 74.12 108.487 173.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . 0.621 HD22 HD23 ' C' ' 98' ' ' LEU . 1.6 tm? -175.35 97.24 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 105.891 -1.892 . . . . 74.42 105.891 -171.212 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -138.19 154.71 23.01 Favored Glycine 0 N--CA 1.47 0.962 0 CA-C-O 119.414 -0.659 . . . . 72.22 111.551 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 4.8 tt 57.53 77.27 0.28 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.108 0.963 . . . . 73.02 108.926 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -154.37 43.37 0.52 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.626 -0.716 . . . . 75.03 109.763 -176.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -129.94 125.32 35.19 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.554 0.742 . . . . 72.45 109.659 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -75.2 157.24 34.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.219 0.608 . . . . 75.13 109.994 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 147.71 -1.36 0.7 Allowed Glycine 0 N--CA 1.469 0.898 0 CA-C-N 116.003 -0.544 . . . . 72.44 112.102 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -124.17 137.43 54.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.204 1.002 . . . . 75.54 108.306 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 51.6 ttp 64.24 94.14 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.317 0 O-C-N 124.299 1.0 . . . . 72.43 110.091 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.26 94.32 0.2 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.621 2.214 . . . . 75.1 113.465 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 44.5 t -81.99 78.09 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.246 -1.02 . . . . 70.53 108.246 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -79.55 -64.58 1.15 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.688 -1.142 . . . . 75.4 110.187 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . 0.404 ' HE3' ' H ' ' F' ' 291' ' ' LEU . 0.8 OUTLIER -155.8 155.99 33.97 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.424 -0.807 . . . . 74.11 110.297 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.404 ' H ' ' HE3' ' F' ' 290' ' ' TRP . 2.4 mp -118.41 26.72 9.4 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.449 -1.25 . . . . 64.23 108.567 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -173.47 105.18 0.21 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 110.653 -0.979 . . . . 75.03 110.653 -173.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -85.23 98.62 0.66 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.863 2.375 . . . . 63.13 112.779 -168.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' F' ' 294' ' ' LYS . 35.0 mtmt 63.98 42.92 5.51 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.353 1.061 . . . . 74.41 111.388 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.59 41.03 0.61 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.905 0.482 . . . . 70.12 111.733 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 37.2 m -134.1 138.8 45.51 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.522 1.129 . . . . 71.12 109.418 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 63.26 -97.16 0.06 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.256 1.422 . . . . 72.42 112.282 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 19.2 m170 56.42 -85.65 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.503 1.121 . . . . 74.32 113.156 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -91.39 38.33 3.23 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.477 -0.624 . . . . 75.5 114.086 -171.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 67.74 143.05 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.754 1.221 . . . . 73.05 112.166 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 46.7 mt -71.91 -68.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.258 0.551 . . . . 75.24 109.787 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 11.9 t70 176.64 175.11 0.36 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.929 1.692 . . . . 73.14 107.388 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -135.21 148.79 67.92 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.48 0.712 . . . . 72.32 109.244 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . 0.427 ' HD3' ' HE2' ' C' ' 32' ' ' PHE . 30.1 Cg_endo -61.14 85.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 123.212 2.608 . . . . 71.23 113.448 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -103.11 3.97 36.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.148 0.979 . . . . 65.32 110.03 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 23.9 m -78.13 12.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.567 1.147 . . . . 74.52 112.688 -174.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 7.6 t -84.07 29.45 0.56 Allowed 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 125.162 1.385 . . . . 65.1 111.783 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 49.0 t -142.35 94.99 2.72 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.58 -0.7 . . . . 74.05 109.95 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 17.7 p -91.37 -47.48 0.35 Allowed Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 118.169 -0.919 . . . . 75.45 112.627 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 C--N 1.397 3.13 0 C-N-CA 122.77 2.313 . . . . 63.22 112.152 -177.135 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.709 0.29 . . . . 70.14 110.933 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -86.62 -4.92 59.24 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.565 0.746 . . . . 73.34 111.617 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -123.59 83.16 2.1 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.513 0.725 . . . . 74.34 109.295 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -86.29 140.68 29.87 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.895 -1.15 . . . . 62.55 107.895 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -120.06 152.97 55.05 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.22 -1.03 . . . . 72.2 108.22 177.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.71 82.32 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.405 2.07 . . . . 74.53 110.649 175.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.599 HD11 ' HA ' ' D' ' 87' ' ' ALA . 5.4 tt 66.26 -84.82 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.161 1.384 . . . . 75.41 110.121 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.9 112.39 25.0 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.861 -1.162 . . . . 73.53 107.861 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -164.1 26.93 0.21 Allowed Glycine 0 C--N 1.345 1.067 0 C-N-CA 121.589 -0.338 . . . . 64.02 113.76 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.49 80.29 1.66 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.77 -1.196 . . . . 70.52 107.77 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . 0.525 ' CD1' HD13 ' D' ' 98' ' ' LEU . 2.3 t80 -147.49 43.22 1.1 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.847 -1.168 . . . . 72.01 107.847 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -82.36 -166.78 1.36 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.934 -1.485 . . . . 71.2 110.88 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.86 149.05 9.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.766 0.826 . . . . 74.32 112.409 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 142.34 -54.14 0.61 Allowed Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.809 -0.632 . . . . 74.13 111.678 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 15.6 m120 61.79 -169.23 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.278 1.031 . . . . 71.1 111.395 -175.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 95.9 mmm -111.85 133.11 21.67 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.791 -0.818 . . . . 74.44 108.791 173.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.81 79.41 2.86 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.29 1.993 . . . . 73.22 111.012 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.74 -30.84 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.405 0.682 . . . . 75.54 110.602 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 64.74 -81.81 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.955 1.302 . . . . 72.44 111.196 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.91 -60.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.482 -0.933 . . . . 74.02 108.482 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . 0.483 HD23 HG22 ' D' ' 131' ' ' VAL . 10.2 mp 65.44 22.91 11.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.082 1.353 . . . . 74.24 113.17 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -132.34 140.62 11.97 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.011 -0.883 . . . . 74.43 112.197 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . 0.476 ' HG3' ' HA ' ' E' ' 306' ' ' VAL . 57.0 Cg_endo -71.77 119.97 6.57 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.68 2.253 . . . . 74.34 111.087 175.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -78.05 73.67 4.61 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.656 1.217 . . . . 75.44 110.904 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -142.24 33.44 1.51 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.733 -1.576 . . . . 73.03 107.786 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 8.3 m -63.66 -30.19 71.33 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.096 -1.411 . . . . 74.23 112.465 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.406 ' HB2' ' HG3' ' D' ' 124' ' ' PRO . 0.7 OUTLIER -120.58 142.15 49.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 120.705 0.288 . . . . 74.35 111.087 -174.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . 0.405 ' HB2' ' HB2' ' E' ' 302' ' ' ASP . 70.9 t60 -95.04 -15.39 23.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.549 0.739 . . . . 65.1 110.347 175.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 71.36 -132.47 20.83 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 119.334 -0.703 . . . . 74.43 112.627 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . 0.551 ' HB2' ' HA3' ' E' ' 299' ' ' GLY . 30.6 m-80 61.45 34.02 18.33 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.309 1.044 . . . . 75.41 111.322 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.672 HD12 HH12 ' C' ' 15' ' ' ARG . 1.9 pp -120.73 10.21 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 114.684 -1.144 . . . . 74.11 111.015 -176.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.57 -16.25 64.02 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.127 1.371 . . . . 75.54 112.341 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . 0.493 ' HD2' ' H ' ' G' ' 303' ' ' LYS . 0.0 OUTLIER -103.46 151.92 38.72 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.472 1.109 . . . . 73.42 109.695 178.304 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.25 179.78 6.19 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 123.035 2.49 . . . . 70.31 113.854 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -75.44 -56.13 5.01 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.812 0.845 . . . . 64.33 110.199 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.428 HG13 ' HB2' ' E' ' 293' ' ' PRO . 26.9 m -134.91 160.69 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.692 0.797 . . . . 72.31 110.157 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 4.5 t -145.31 95.3 2.65 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.663 0.785 . . . . 73.11 109.066 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . 0.617 ' H ' ' HB3' ' C' ' 12' ' ' GLN . 52.9 t 66.05 160.46 0.13 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.566 1.546 . . . . 72.4 112.346 -175.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 309' ' ' THR . . . . . 0.403 ' OG1' ' HB3' ' E' ' 291' ' ' LEU . 6.0 t -159.7 97.66 1.55 Allowed Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.283 0.633 . . . . 64.53 110.556 175.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 CA--C 1.562 1.895 0 C-N-CA 122.829 2.353 . . . . 73.35 111.665 168.187 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.67 0.271 . . . . 61.31 110.936 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -72.96 163.73 27.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.994 0.918 . . . . 74.05 110.365 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 75.36 -33.48 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.722 1.609 . . . . 71.51 111.818 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -64.77 156.26 31.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.852 0.861 . . . . 75.15 110.062 166.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -65.43 144.14 98.89 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 109.787 -0.449 . . . . 73.41 109.787 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.92 172.69 9.32 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.025 1.817 . . . . 74.53 110.917 167.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.425 ' O ' ' SD ' ' B' ' 94' ' ' MET . 36.7 tp -58.19 -49.33 77.42 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.552 -0.536 . . . . 72.5 109.552 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.71 94.99 5.18 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.154 -1.054 . . . . 72.3 108.154 168.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -72.87 -49.51 17.02 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.958 -0.857 . . . . 64.12 110.958 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 3.8 pp -147.78 163.75 35.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.48 1.112 . . . . 64.51 109.234 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -82.16 -64.73 1.12 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.303 -0.628 . . . . 75.43 109.303 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -165.7 138.64 4.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.048 0.939 . . . . 73.23 108.775 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.63 125.11 39.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.369 -0.604 . . . . 75.23 109.369 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 155.84 -115.69 0.68 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.087 -1.205 . . . . 71.23 110.087 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -174.59 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.994 0.917 . . . . 71.51 108.622 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 61.96 76.92 0.37 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.445 1.098 . . . . 74.32 109.869 -168.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.77 65.93 8.69 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.914 2.409 . . . . 64.01 110.806 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.24 89.0 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.041 -0.981 . . . . 75.4 109.415 -175.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -94.89 173.71 7.45 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.148 -1.387 . . . . 75.42 107.669 170.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . 0.522 ' HZ3' ' HA ' ' B' ' 128' ' ' LEU . 94.9 m95 -58.02 113.73 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.421 0.629 . . . . 75.4 111.932 176.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.468 HD12 ' HB1' ' B' ' 129' ' ' ALA . 3.0 mp -77.34 -13.01 60.02 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.321 -1.308 . . . . 73.45 110.884 -173.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -156.13 -82.0 0.04 OUTLIER Glycine 0 C--N 1.353 1.506 0 CA-C-O 118.921 -0.933 . . . . 73.14 112.888 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -58.51 129.58 33.22 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.629 2.886 . . . . 73.04 113.366 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.1 99.91 12.83 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.72 -0.845 . . . . 73.34 108.72 176.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 72.07 172.57 0.31 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.3 1.44 . . . . 72.34 113.232 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 296' ' ' THR . . . . . 0.423 HG23 ' HB2' ' B' ' 126' ' ' LEU . 8.8 m -71.85 -39.97 69.36 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.971 -1.013 . . . . 70.2 110.382 177.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -87.21 91.71 8.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.006 -0.997 . . . . 74.12 110.523 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -82.53 -54.86 4.84 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.677 -0.692 . . . . 71.11 109.59 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.29 49.97 1.48 Allowed Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.235 -0.439 . . . . 63.52 112.761 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 64.27 178.11 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.928 1.291 . . . . 70.33 112.881 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 20.2 tt -82.06 -12.9 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 115.57 -0.741 . . . . 73.1 110.632 171.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.66 93.76 0.39 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.765 0.826 . . . . 73.3 112.213 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -115.7 148.75 41.81 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.231 -1.396 . . . . 74.21 107.231 158.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.82 -1.52 5.18 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.752 2.301 . . . . 64.11 114.686 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 68.26 -172.58 0.19 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.961 1.304 . . . . 55.22 111.337 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 20.4 m -84.55 133.8 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.224 0.535 . . . . 75.13 110.034 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 54.4 m -82.34 143.66 31.1 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.864 0.866 . . . . 73.1 110.865 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 26.5 p -66.01 111.89 3.57 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 108.392 -0.966 . . . . 70.52 108.392 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 33.1 p -62.41 117.34 29.74 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.221 0.608 . . . . 74.5 110.456 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.381 2.259 0 C-N-CA 122.683 2.256 . . . . 71.33 112.394 -177.216 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.062 -0.018 . . . . 74.32 110.999 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.45 ' HA ' HE21 ' E' ' 274' ' ' GLN . 21.8 p -62.39 115.16 3.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.342 0.657 . . . . 74.4 110.389 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.514 ' HG3' ' H ' ' A' ' 5' ' ' ASN . 10.5 tp10 -80.72 143.27 33.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.685 0.794 . . . . 75.52 112.983 -166.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.41 1.37 25.64 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.681 1.192 . . . . 70.22 111.553 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . 0.514 ' H ' ' HG3' ' A' ' 3' ' ' GLU . 45.7 t-20 -67.76 112.81 5.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.266 0.626 . . . . 70.5 110.115 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -91.79 132.95 36.05 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.533 -0.758 . . . . 64.15 109.092 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 m -76.33 82.28 3.08 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.473 0.654 . . . . 71.03 110.804 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -124.04 101.02 7.01 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.358 -1.349 . . . . 73.22 107.358 173.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 9' ' ' MET . 2.0 mpp? -64.47 133.89 53.38 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.45 0.468 . . . . 75.04 110.592 -171.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.56 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.2 m -140.22 124.02 17.34 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.088 -0.708 . . . . 74.4 109.088 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.474 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 20.4 t80 -136.76 120.83 17.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.824 -1.176 . . . . 74.4 107.824 171.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.424 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 45.9 tp60 -142.83 108.25 5.04 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.087 -0.708 . . . . 73.1 109.087 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.51 HG12 ' HD2' ' A' ' 84' ' ' PHE . 20.0 mt -71.03 125.2 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.2 -0.455 . . . . 71.31 109.91 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -101.23 -31.89 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.975 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -179.27 132.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 119.369 -0.348 . . . . 72.35 110.996 -167.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.402 HD11 ' HG3' ' C' ' 130' ' ' PRO . 3.6 mp -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 107.417 -1.327 . . . . 75.41 107.417 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 23.5 p90 -164.06 167.53 20.22 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 122.218 1.009 . . . . 64.1 111.299 -174.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.5 109.09 21.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.038 -1.437 . . . . 65.22 108.674 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.439 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.9 mtpt -78.26 -29.97 48.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.105 0.479 . . . . 64.31 109.791 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.33 141.4 27.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.902 -1.045 . . . . 75.35 109.616 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.527 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 61.8 mt -137.54 136.68 46.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.077 -1.823 . . . . 75.2 106.077 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -148.08 125.59 11.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.66 -0.867 . . . . 75.02 108.66 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.542 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.0 t80 -127.18 140.15 52.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.18 -1.415 . . . . 73.25 107.18 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -134.74 151.58 51.09 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.752 -0.832 . . . . 65.11 108.752 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.506 ' HB3' ' HB1' ' A' ' 28' ' ' ALA . . . -147.24 73.96 11.87 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 105.682 -1.97 . . . . 73.31 105.682 167.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.66 -43.02 10.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.893 2.396 . . . . 75.32 113.197 -165.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.34 30.19 5.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.971 -0.751 . . . . 71.52 108.971 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.506 ' HB1' ' HB3' ' A' ' 25' ' ' ALA . . . -46.38 -57.92 7.62 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.595 -1.193 . . . . 75.14 113.052 -174.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -55.74 -20.31 27.8 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.979 2.453 . . . . 75.12 113.722 179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -98.96 -38.14 9.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.018 0.927 . . . . 75.25 110.798 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.85 -15.4 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.074 0.549 . . . . 72.45 111.444 -164.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.73 -30.95 71.97 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.081 0.553 . . . . 74.05 111.193 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -90.93 -7.12 52.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 112.363 0.505 . . . . 73.05 112.363 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.422 ' HZ1' ' HB2' ' A' ' 71' ' ' GLU . 19.9 mmtp -64.01 173.05 2.02 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.016 1.117 . . . . 73.04 114.016 -179.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.45 159.12 30.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.928 1.291 . . . . 74.31 111.691 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -94.14 64.46 3.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.063 0.459 . . . . 74.32 110.166 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -142.81 82.84 11.95 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.918 0.887 . . . . 72.4 109.241 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.57 138.44 13.64 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 121.735 1.623 . . . . 72.21 110.891 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -92.57 82.58 4.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.978 -1.86 . . . . 71.25 105.978 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 65' ' ' THR . 10.2 m -82.53 114.65 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.993 -1.458 . . . . 73.44 109.382 -176.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -121.48 143.95 48.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.753 0.821 . . . . 74.21 109.96 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -112.97 118.91 36.15 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.865 0.866 . . . . 75.14 109.786 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.498 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -107.41 143.13 36.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.594 -1.261 . . . . 64.25 107.594 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.59 129.24 32.61 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.728 -0.842 . . . . 73.4 108.728 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.3 m-20 -117.74 120.81 39.09 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.738 -1.208 . . . . 74.52 107.738 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -107.29 121.81 45.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 75.33 108.627 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.0 140.33 28.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.991 0.517 . . . . 74.3 110.377 -173.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 p -130.35 158.79 38.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.415 0.686 . . . . 75.44 110.616 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 154.98 39.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.336 1.054 . . . . 73.14 109.534 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -103.76 105.61 15.87 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.693 -0.855 . . . . 75.41 108.693 172.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 52.0 mt -79.22 -38.2 36.29 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.221 0.609 . . . . 74.23 110.55 -179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.62 -178.19 6.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.333 1.053 . . . . 63.23 109.246 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.47 123.15 18.89 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 71.18 -9.81 0.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.019 1.728 . . . . 75.53 112.771 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.67 110.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 N-CA-C 108.385 -0.969 . . . . 71.24 108.385 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -125.3 164.13 21.02 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.703 0.801 . . . . 74.54 109.536 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -131.69 142.73 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.693 0.797 . . . . 65.15 109.449 -178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.36 132.52 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.601 -1.259 . . . . 75.5 107.601 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.2 t -125.08 131.36 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 123.625 0.77 . . . . 74.4 108.934 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.432 HD21 HD11 ' A' ' 106' ' ' LEU . 3.9 mm? -117.99 106.0 12.47 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.106 -1.072 . . . . 73.12 108.106 177.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 23.9 ttp180 -83.82 102.63 12.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.151 -1.055 . . . . 74.2 108.151 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.31 119.75 39.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.995 -1.483 . . . . 70.41 106.995 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.498 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 44.0 m -118.97 122.64 42.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.344 -0.613 . . . . 74.11 109.344 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.612 HG12 HD21 ' A' ' 126' ' ' LEU . 28.9 t -118.52 108.99 25.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.652 -0.87 . . . . 62.53 108.652 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.0 m -107.63 137.4 45.73 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.537 -0.542 . . . . 73.43 109.537 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.95 105.25 8.78 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.362 -0.977 . . . . 63.41 108.362 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -114.2 127.56 55.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.996 0.519 . . . . 72.31 110.796 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.12 85.19 2.09 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.91 -1.145 . . . . 71.23 107.91 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -111.29 3.23 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.562 -1.015 . . . . 75.22 110.562 -171.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -100.8 -8.49 22.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.058 0.543 . . . . 74.44 110.512 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.422 ' HB2' ' HZ1' ' A' ' 34' ' ' LYS . 10.9 mp0 -102.26 97.71 7.95 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.753 0.821 . . . . 64.24 110.383 -171.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -66.86 124.29 22.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 122.911 0.484 . . . . 73.42 110.823 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.57 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -67.64 -57.3 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.203 1.001 . . . . 64.34 109.974 175.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -157.48 158.85 36.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.528 -1.215 . . . . 62.44 112.204 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.6 tp -126.89 135.17 50.57 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.95 1.3 . . . . 71.23 108.035 171.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 51.2 m -130.64 97.75 4.45 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.404 -0.591 . . . . 71.33 109.404 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -116.9 116.28 27.12 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.021 0.929 . . . . 74.43 109.392 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -133.94 110.94 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.784 0.834 . . . . 70.42 109.215 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -84.93 89.31 7.55 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.684 -0.858 . . . . 74.45 108.684 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.86 96.69 7.09 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.506 -0.77 . . . . 70.32 109.048 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.99 151.52 22.21 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.48 -0.782 . . . . 72.45 111.92 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.553 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -153.19 124.55 1.61 Allowed Glycine 0 CA--C 1.509 -0.309 0 N-CA-C 111.302 -0.719 . . . . 44.45 111.302 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -85.14 124.59 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.208 0.603 . . . . 74.24 109.763 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.51 ' HD2' HG12 ' A' ' 13' ' ' ILE . 37.9 m-85 -132.94 119.87 20.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.764 -1.198 . . . . 63.21 107.764 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.424 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 25.8 t -82.19 98.61 8.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 109.493 -0.558 . . . . 65.52 109.493 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.524 HD13 HD21 ' A' ' 98' ' ' LEU . 45.3 pt -103.49 147.46 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.999 0.919 . . . . 74.35 110.411 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.56 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -169.68 161.08 9.19 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.228 0.611 . . . . 63.4 111.863 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.31 -33.96 3.54 Favored Glycine 0 C--N 1.356 1.655 0 CA-C-N 115.605 -0.725 . . . . 75.24 113.964 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.1 pp -117.04 135.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.877 0.871 . . . . 75.23 109.432 -176.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -139.56 175.86 9.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.376 0.67 . . . . 75.12 110.326 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -115.32 7.85 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.77 0.669 . . . . 65.3 112.831 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.1 t -74.58 -30.46 61.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.54 0.736 . . . . 74.33 111.567 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -67.32 -37.5 83.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.536 -0.757 . . . . 74.13 109.562 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.44 ' HG2' ' HG ' ' A' ' 98' ' ' LEU . 3.4 ttp -82.3 -24.45 34.65 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.311 -0.859 . . . . 74.45 110.833 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.671 ' HA ' HD22 ' E' ' 280' ' ' LEU . . . -66.48 -34.74 78.6 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.086 0.402 . . . . 75.44 112.086 -177.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.483 ' HE2' ' HB2' ' A' ' 134' ' ' ASP . 58.6 t-80 -77.28 -30.77 54.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.559 -0.292 . . . . 74.45 110.34 174.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.39 -65.05 0.76 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.582 0.353 . . . . 74.42 110.951 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.524 HD21 HD13 ' A' ' 86' ' ' ILE . 14.7 mt -75.66 -23.81 56.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.742 0.417 . . . . 70.4 111.739 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.94 -5.97 59.44 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.313 -0.715 . . . . 65.33 114.751 -172.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.41 -57.78 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.992 0.896 . . . . 72.13 112.319 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.474 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 89.8 t80 -68.4 -54.89 14.15 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.245 0.618 . . . . 73.42 112.066 -171.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.0 m -71.01 -33.16 2.71 Favored Pre-proline 0 CA--C 1.569 1.674 0 C-N-CA 123.673 0.789 . . . . 72.12 112.876 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.96 -41.96 60.87 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.493 2.128 . . . . 72.12 113.154 160.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -70.87 -14.03 62.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.384 0.674 . . . . 64.11 111.766 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -78.86 -41.39 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.98 -0.748 . . . . 75.32 108.98 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.553 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.9 mt -84.33 -30.21 25.69 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.059 0.944 . . . . 74.24 113.189 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -64.94 -38.63 30.97 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.037 -0.983 . . . . 75.43 113.537 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.54 -38.45 93.8 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.923 1.749 . . . . 74.24 113.25 171.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -73.84 -37.45 64.81 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.985 0.514 . . . . 75.45 111.141 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -44.6 91.55 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.777 -0.453 . . . . 73.34 109.777 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -52.51 -53.58 44.09 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.777 1.298 . . . . 74.11 110.72 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -68.19 -38.92 82.52 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.242 0.964 . . . . 73.4 111.374 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.5 t -61.79 -32.25 72.53 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.978 0.511 . . . . 74.1 110.648 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 84.9 mt -74.34 -52.94 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.287 -0.869 . . . . 74.43 110.323 174.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.7 m -55.28 -41.56 72.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.223 1.009 . . . . 72.22 111.297 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -64.96 -44.86 88.0 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.72 -1.127 . . . . 72.34 110.776 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.542 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.4 mtm -64.52 -38.59 91.56 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.689 0.395 . . . . 75.15 111.492 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.404 HG23 ' HB3' ' A' ' 126' ' ' LEU . 93.2 t -64.36 -42.01 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.664 0.785 . . . . 74.52 110.704 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.3 p -72.4 -30.73 64.92 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.09 -0.505 . . . . 73.35 110.907 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -68.3 -25.32 65.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.594 0.758 . . . . 70.33 110.882 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 7.51 65.36 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-O 120.004 -0.331 . . . . 75.52 113.595 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 m 61.86 35.49 16.45 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.255 1.422 . . . . 73.01 110.945 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -107.31 160.89 24.87 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.064 0.946 . . . . 65.2 109.723 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.25 146.22 61.91 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.242 1.961 . . . . 73.13 111.522 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.11 148.19 48.63 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.775 0.322 . . . . 74.32 110.3 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.612 HD21 HG12 ' A' ' 64' ' ' VAL . 48.7 tp -113.72 113.48 25.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.004 0.522 . . . . 70.42 110.127 -177.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -114.17 114.19 25.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.653 -1.24 . . . . 71.23 107.653 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.4 135.14 42.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.92 0.391 . . . . 72.31 110.152 174.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . 0.585 ' HB1' HD12 ' E' ' 291' ' ' LEU . . . -71.87 132.23 85.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.935 -0.575 . . . . 73.32 110.368 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.46 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 0.9 OUTLIER -77.54 116.95 4.17 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.505 2.136 . . . . 74.02 111.515 -177.012 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.492 HG21 HD21 ' E' ' 291' ' ' LEU . 48.3 t -101.76 135.36 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.189 0.596 . . . . 74.51 109.953 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.455 HD21 ' HB1' ' A' ' 135' ' ' ALA . 1.2 p-10 -76.78 69.94 3.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.334 1.054 . . . . 74.54 110.605 172.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.509 ' HB3' ' HE2' ' E' ' 286' ' ' MET . 76.7 m-85 -56.08 -38.74 71.09 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.247 1.019 . . . . 75.1 111.749 -179.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.483 ' HB2' ' HE2' ' A' ' 96' ' ' HIS . 9.9 p-10 -65.51 -35.36 80.66 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.487 -1.233 . . . . 73.03 111.917 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.455 ' HB1' HD21 ' A' ' 132' ' ' ASN . . . -71.19 -34.17 70.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.049 0.54 . . . . 51.02 111.307 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.3 mp -61.72 -42.89 99.55 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.81 0.444 . . . . 75.43 110.204 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -63.04 -31.55 72.72 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.038 0.935 . . . . 73.23 110.345 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.3 mmt -75.93 -35.25 59.8 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 116.009 -0.541 . . . . 72.54 111.398 175.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 30.2 m-80 -61.31 -39.68 91.37 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.506 0.322 . . . . 73.33 110.933 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . 0.423 ' CE2' ' HB ' ' C' ' 149' ' ' THR . 83.9 t80 -67.3 -43.98 80.34 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.377 0.423 . . . . 73.53 110.406 171.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.4 tp -57.67 -51.57 69.0 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.106 0.879 . . . . 73.52 111.569 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 175.31 30.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 125.259 1.423 . . . . 72.31 109.843 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.5 OUTLIER 65.41 -83.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.713 1.205 . . . . 75.51 108.238 -169.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -158.83 164.45 35.74 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.948 1.299 . . . . 74.41 109.155 173.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.5 114.97 17.43 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.956 0.903 . . . . 74.43 108.785 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.5 156.08 38.5 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.766 -0.533 . . . . 61.24 111.766 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -74.92 0.08 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 122.973 0.509 . . . . 74.12 110.258 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 56.46 29.39 57.17 Favored Glycine 0 C--N 1.361 1.962 0 N-CA-C 113.972 0.349 . . . . 73.35 113.972 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -119.25 102.6 8.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.497 1.119 . . . . 53.42 110.111 -171.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -95.36 132.33 40.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.309 0.644 . . . . 75.21 109.422 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.97 150.22 43.27 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.761 0.824 . . . . 63.14 109.534 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -85.09 125.2 32.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.824 0.45 . . . . 65.31 109.865 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -66.03 -61.29 2.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.99 0.916 . . . . 72.41 112.394 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -157.52 141.91 16.33 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.97 0.508 . . . . 73.43 109.885 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 C-N-CA 123.454 0.702 . . . . 73.15 109.652 179.66 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.424 ' HE3' ' H ' ' G' ' 286' ' ' MET . 49.9 ttm . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.765 -0.457 . . . . 74.24 109.765 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.3 p -167.19 142.86 4.16 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.39 1.076 . . . . 74.12 109.178 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -167.39 153.68 7.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.97 0.908 . . . . 73.45 109.786 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -79.31 77.12 5.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.998 -1.112 . . . . 72.22 107.998 169.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.52 115.13 8.41 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.014 -0.993 . . . . 72.43 111.202 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -163.21 142.54 8.59 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.383 1.073 . . . . 71.13 108.306 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -110.06 143.25 40.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.1 0.56 . . . . 71.33 109.61 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.3 176.87 7.73 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.862 0.865 . . . . 71.22 110.446 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 21.9 ptm 43.86 -153.04 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 125.575 1.55 . . . . 73.04 111.969 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.613 ' HB ' ' HB1' ' B' ' 87' ' ' ALA . 87.9 m -143.52 114.94 8.02 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.536 -0.913 . . . . 73.22 108.536 167.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . 0.407 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 49.4 t80 -135.32 132.8 38.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.828 0.851 . . . . 74.35 109.492 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.562 ' HB3' ' HB ' ' E' ' 309' ' ' THR . 9.3 pt20 -156.41 140.17 16.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.942 0.897 . . . . 71.44 109.022 173.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.71 135.42 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.834 -1.173 . . . . 75.11 107.834 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -93.19 -53.84 3.95 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.858 -0.423 . . . . 75.2 109.858 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.518 ' HB2' ' HB3' ' E' ' 304' ' ' PRO . 20.9 ttt180 -155.49 131.52 10.06 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.914 -0.402 . . . . 73.12 109.914 -172.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.451 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 83.7 mt -114.97 136.96 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.287 -1.746 . . . . 75.3 106.287 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -165.45 140.44 4.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.881 0.472 . . . . 75.51 111.142 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.0 m -73.47 117.85 15.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.873 0.869 . . . . 64.15 109.24 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -94.59 -22.41 18.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.471 0.708 . . . . 72.13 111.58 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.1 t70 -163.1 142.48 8.69 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.337 0.398 . . . . 65.05 110.473 -172.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.482 HD12 ' SG ' ' B' ' 113' ' ' CYS . 33.1 mm -137.27 141.59 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.975 1.31 . . . . 74.21 108.467 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.504 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.5 t -142.8 124.09 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.785 -1.191 . . . . 74.13 107.785 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.527 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -146.56 115.73 7.0 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 107.274 -1.38 . . . . 72.52 107.274 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -119.91 158.81 25.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.448 0.699 . . . . 75.54 109.513 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.99 78.19 8.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.664 -1.235 . . . . 74.45 107.664 175.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.88 -22.65 42.19 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.936 2.424 . . . . 71.14 112.675 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -122.97 24.55 8.92 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.959 . . . . 74.44 109.663 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -48.42 -50.16 59.26 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.744 1.387 . . . . 71.3 114.744 -178.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -28.7 2.77 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 121.849 1.7 . . . . 71.44 112.789 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.449 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 51.5 m80 -96.18 4.67 52.27 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.354 1.061 . . . . 74.35 112.09 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.31 -26.25 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.632 0.773 . . . . 75.42 110.788 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . 0.551 ' HA ' ' HB2' ' B' ' 35' ' ' ASP . 30.2 t80 -69.0 -16.09 63.64 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.104 0.779 . . . . 74.35 113.104 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.2 pt20 -73.16 -47.08 46.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.065 0.393 . . . . 75.53 110.73 176.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.512 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 45.4 pttt -112.62 66.79 0.65 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.548 -1.279 . . . . 75.21 107.548 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.551 ' HB2' ' HA ' ' B' ' 32' ' ' PHE . 39.1 t70 -96.86 108.47 21.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.275 -0.875 . . . . 73.51 111.563 -164.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.465 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.8 OUTLIER 177.74 -170.86 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.597 1.186 . . . . 73.03 109.437 163.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.89 116.77 7.59 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.096 0.958 . . . . 73.3 111.995 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.65 156.73 18.68 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.651 2.234 . . . . 75.01 111.464 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.03 102.19 0.47 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.123 -1.066 . . . . 73.13 108.123 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.4 151.16 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.066 -0.97 . . . . 72.21 109.632 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -139.12 137.42 36.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.34 0.656 . . . . 74.2 109.621 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.499 HD12 HD13 ' B' ' 128' ' ' LEU . 2.4 tt -93.18 126.11 38.12 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.148 -1.427 . . . . 72.42 107.148 167.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . 0.57 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.4 t0 -131.34 145.21 51.75 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 106.547 -1.649 . . . . 73.42 106.547 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.62 133.27 28.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.667 -0.864 . . . . 73.54 108.667 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.7 t70 -124.3 134.38 53.22 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.694 1.198 . . . . 75.11 108.701 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -107.9 108.25 19.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.455 0.702 . . . . 64.43 109.759 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.91 119.3 32.22 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.538 -0.912 . . . . 72.21 108.538 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.2 p -139.15 166.08 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.141 0.577 . . . . 73.13 110.688 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.2 p -151.16 165.99 32.22 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.136 0.974 . . . . 73.11 109.146 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -115.07 107.74 15.74 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.454 -0.943 . . . . 73.42 108.454 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.11 -42.52 84.39 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.585 0.754 . . . . 75.11 110.892 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.77 -170.98 3.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.667 0.787 . . . . 63.13 110.363 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.41 114.39 5.4 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.226 -0.897 . . . . 75.21 109.517 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 73.22 -6.69 1.67 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 126.332 1.853 . . . . 70.41 113.202 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.74 120.59 52.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 109.151 -0.685 . . . . 73.31 109.151 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . 0.528 ' HE2' ' HB2' ' H' ' 278' ' ' LEU . 36.9 m-85 -114.11 173.11 6.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.605 -0.725 . . . . 73.21 110.945 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -142.17 95.19 2.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 105.541 -2.022 . . . . 74.52 105.541 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.35 122.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.03 0.932 . . . . 72.35 109.09 -175.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -111.7 143.47 21.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.57 0.748 . . . . 75.31 109.454 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . 0.617 HD13 ' HA ' ' B' ' 103' ' ' PRO . 93.6 mt -120.1 112.43 19.11 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.753 -0.462 . . . . 74.45 109.753 174.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.572 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.7 ttm-85 -86.6 107.24 18.07 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.155 -1.054 . . . . 73.43 108.155 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 105.54 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.27 -1.382 . . . . 75.01 107.27 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' THR . . . . . 0.57 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 28.6 m -96.48 137.79 35.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.447 -0.797 . . . . 74.43 108.994 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -134.62 101.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.887 -1.153 . . . . 73.32 107.887 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.5 m -98.08 141.58 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 72.1 109.516 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.73 148.44 52.58 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.02 -0.733 . . . . 75.31 109.02 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -157.39 128.61 6.76 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.368 0.417 . . . . 73.21 111.238 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.597 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -127.84 143.19 51.12 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.552 0.741 . . . . 70.23 109.917 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.25 -112.24 3.51 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.929 -0.869 . . . . 70.4 110.929 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -123.86 6.1 8.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.966 0.906 . . . . 73.34 109.922 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . 0.512 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 8.8 pt-20 -149.28 -178.98 6.71 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.625 0.37 . . . . 74.41 111.209 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -64.6 147.69 52.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.685 1.194 . . . . 73.23 111.674 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.597 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -96.34 -63.49 1.14 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.111 -1.07 . . . . 75.43 108.111 171.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -152.78 163.66 39.28 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.622 -1.626 . . . . 75.14 108.041 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -125.84 144.69 50.55 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.736 1.215 . . . . 75.4 108.543 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . 0.502 ' SG ' HG21 ' B' ' 114' ' ' ILE . 33.8 t -147.44 144.08 28.37 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.53 -0.915 . . . . 61.31 108.53 173.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.1 tt0 -164.95 138.98 4.95 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.171 -0.677 . . . . 74.51 109.171 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 97.4 t -132.07 148.07 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.675 0.79 . . . . 74.04 109.257 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 41.5 mt-30 -122.6 103.17 8.51 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.407 -0.96 . . . . 74.14 108.407 168.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.05 105.29 17.3 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.14 -1.059 . . . . 72.42 108.14 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 155.0 24.18 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.205 -0.758 . . . . 61.55 111.205 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 125.29 1.72 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.566 -0.614 . . . . 65.13 111.566 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.28 126.36 40.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.055 -1.091 . . . . 73.42 108.055 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.74 162.57 28.12 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 74.53 108.988 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.409 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 48.7 m -132.5 113.26 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.083 -0.71 . . . . 74.35 109.083 168.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 32.9 pt -119.17 137.85 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.919 0.888 . . . . 70.13 110.084 -177.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.613 ' HB1' ' HB ' ' B' ' 10' ' ' THR . . . -155.23 164.0 39.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 72.34 109.743 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.63 -47.46 3.6 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.242 -0.435 . . . . 73.31 112.493 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' B' ' 94' ' ' MET . 19.9 pt -64.04 148.89 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.523 1.129 . . . . 75.52 113.211 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -157.36 162.7 39.07 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.306 1.042 . . . . 72.44 109.704 172.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.57 -115.07 6.61 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.398 0.436 . . . . 54.24 113.614 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.9 m -77.77 -28.88 50.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.413 0.685 . . . . 55.5 110.79 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -58.56 -42.15 87.26 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.053 0.541 . . . . 73.32 110.588 177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.562 ' HA ' HD12 ' B' ' 89' ' ' ILE . 23.9 ttt -71.87 -41.54 67.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 74.43 110.767 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.55 82.54 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.783 0.677 . . . . 74.23 111.29 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -79.54 -20.15 47.82 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.963 -1.017 . . . . 75.22 110.916 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -83.29 -67.05 0.82 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.293 0.237 . . . . 63.45 111.009 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.455 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.5 pp -83.92 -15.0 49.58 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.64 0.608 . . . . 75.12 112.64 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.64 -27.75 11.15 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.986 -0.341 . . . . 55.14 112.929 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -114.93 -60.24 1.91 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.252 0.621 . . . . 71.43 111.391 -177.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.87 -46.0 66.46 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.195 0.598 . . . . 73.11 112.133 -170.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.455 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 62.6 m -68.38 -40.86 21.72 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.851 -0.595 . . . . 74.55 112.299 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.617 ' HA ' HD13 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -52.91 -39.9 77.16 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 122.273 1.982 . . . . 72.31 113.961 165.744 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -16.43 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 111.715 0.265 . . . . 63.54 111.715 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.67 -55.76 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.368 0.667 . . . . 71.42 110.526 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . 0.403 ' HB2' HD12 ' B' ' 60' ' ' LEU . 91.0 mt -76.83 -25.32 53.09 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.265 0.626 . . . . 73.55 112.681 -169.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.7 -48.98 88.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 CA-C-O 117.72 -1.134 . . . . 70.41 113.628 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.92 -38.47 86.18 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.052 1.835 . . . . 75.41 113.374 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.434 ' HE2' HG21 ' D' ' 115' ' ' THR . 29.3 m-85 -65.3 -45.33 84.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.596 0.759 . . . . 74.02 110.296 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.19 79.82 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.791 -0.641 . . . . 74.1 111.044 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ttt-85 -61.2 -56.23 23.1 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.331 1.052 . . . . 75.4 111.106 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -36.86 85.03 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.517 0.511 . . . . 63.45 110.087 -176.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.517 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.0 t -69.44 -26.9 64.83 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 123.684 0.615 . . . . 74.42 111.503 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.502 HG21 ' SG ' ' B' ' 76' ' ' CYS . 81.7 mt -74.56 -52.35 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 122.889 0.475 . . . . 73.33 109.846 170.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 28.9 m -60.26 -27.74 67.49 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.053 0.941 . . . . 71.44 111.665 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.16 -48.73 64.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.632 0.773 . . . . 71.23 109.769 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.517 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -71.72 -32.2 67.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.921 0.488 . . . . 75.12 111.484 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.33 -38.94 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.228 0.611 . . . . 73.31 110.139 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.5 t -65.66 -38.99 90.87 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 71.33 111.166 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.439 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -67.66 -33.76 75.59 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.608 0.763 . . . . 74.13 110.356 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.82 11.66 61.59 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.875 -0.602 . . . . 73.13 112.963 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.2 p 56.97 29.69 16.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.735 1.614 . . . . 54.11 113.847 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -109.72 145.47 32.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.106 0.962 . . . . 74.35 109.045 172.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . 0.513 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 61.6 Cg_exo -57.21 140.34 92.56 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.838 2.358 . . . . 72.43 113.843 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . 0.475 ' NE2' HD22 ' B' ' 127' ' ' ASN . 20.3 pt20 -65.43 160.01 22.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 113.476 -1.693 . . . . 74.35 112.695 -174.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.4 116.38 15.11 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.574 -1.269 . . . . 65.1 107.574 168.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . 0.475 HD22 ' NE2' ' B' ' 125' ' ' GLN . 54.8 m-80 -89.97 104.08 16.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 106.924 -1.51 . . . . 71.04 106.924 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . 0.499 HD13 HD12 ' B' ' 42' ' ' LEU . 16.0 tp -66.46 134.85 53.3 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.846 -0.616 . . . . 75.11 110.874 -172.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.14 137.97 94.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.228 1.011 . . . . 73.51 111.745 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.46 111.72 0.5 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.143 2.562 . . . . 72.34 112.013 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.15 108.13 18.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.14 -1.059 . . . . 65.55 108.14 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.47 77.24 2.6 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.436 -0.95 . . . . 75.15 108.436 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -70.74 -21.41 62.53 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.862 -1.063 . . . . 75.1 109.917 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.79 -46.07 86.87 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.815 0.846 . . . . 73.44 109.087 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.84 -32.59 70.81 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 114.838 -1.074 . . . . 74.23 112.011 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . 0.479 HD22 ' SD ' ' H' ' 286' ' ' MET . 7.3 tt -57.07 -50.43 72.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.544 0.737 . . . . 73.1 110.31 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -67.4 -33.56 75.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.278 0.631 . . . . 75.32 111.758 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.2 mmt -69.51 -33.77 73.31 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.139 0.576 . . . . 75.52 111.44 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -82.85 -14.81 53.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.453 0.701 . . . . 74.01 110.896 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -72.95 -29.71 63.3 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.247 -0.649 . . . . 74.51 109.247 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 58.2 mt -104.86 33.69 3.5 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.186 0.994 . . . . 74.21 109.957 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.72 93.71 1.68 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.077 0.951 . . . . 74.14 111.85 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -166.47 109.88 0.75 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.59 0.756 . . . . 65.24 109.35 171.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -156.66 130.67 8.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.361 0.665 . . . . 72.33 109.658 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . 0.587 ' HA ' ' HE2' ' D' ' 1' ' ' MET . . . -80.07 145.36 32.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.08 0.552 . . . . 75.55 110.76 173.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.41 139.71 14.58 Favored Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.487 -0.645 . . . . 73.13 111.487 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -97.8 130.84 44.71 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.465 0.706 . . . . 73.34 110.242 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.8 160.35 41.02 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.515 0.509 . . . . 72.21 112.189 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 50.2 m -103.04 108.8 20.11 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.477 -0.934 . . . . 74.45 108.477 172.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.6 104.83 2.92 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.822 -0.807 . . . . 72.52 108.822 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.33 90.16 0.1 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.821 -0.807 . . . . 65.33 108.821 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -68.24 102.45 1.37 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.52 -0.764 . . . . 72.11 109.933 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.99 115.92 8.85 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.635 -1.617 . . . . 75.21 106.635 168.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.76 137.42 54.01 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.514 0.509 . . . . 74.01 110.522 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 123.429 0.692 . . . . 72.21 110.548 -178.023 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.479 ' N ' ' SD ' ' C' ' 1' ' ' MET . 2.7 mpp? . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 109.023 -0.732 . . . . 74.25 109.023 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -67.63 126.28 28.86 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 122.991 0.516 . . . . 74.11 110.244 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.38 79.42 1.38 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.731 0.812 . . . . 71.0 110.079 175.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.18 89.59 5.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.828 -0.804 . . . . 73.22 108.828 -178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . 0.419 ' N ' HD21 ' C' ' 5' ' ' ASN . 0.0 OUTLIER -168.03 126.32 1.19 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.556 1.142 . . . . 75.42 108.726 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -161.81 125.68 3.22 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.982 0.913 . . . . 74.11 109.178 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 16.9 p -142.46 179.29 7.04 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.237 1.015 . . . . 72.11 110.101 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.47 159.37 34.61 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.13 0.572 . . . . 73.4 109.527 167.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.468 ' HE2' ' HB2' ' C' ' 11' ' ' PHE . 23.7 ttt 64.25 114.84 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.319 1.047 . . . . 70.15 111.651 -174.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 10' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 91.0 m -98.58 96.36 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.836 -0.801 . . . . 63.31 108.836 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.478 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 57.1 t80 -99.38 128.38 45.49 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.652 -0.87 . . . . 74.35 108.652 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -152.79 136.74 16.31 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.262 -0.644 . . . . 74.24 109.262 175.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . 0.412 ' HB ' HG22 ' G' ' 306' ' ' VAL . 66.7 mt -90.07 104.39 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.069 0.947 . . . . 74.14 109.745 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -73.56 -50.51 20.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.309 -0.256 . . . . 71.33 110.309 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -169.48 123.83 0.8 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.734 -0.469 . . . . 74.33 109.734 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -107.98 137.3 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.388 -0.967 . . . . 74.32 108.388 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.422 ' HH ' HD11 ' C' ' 83' ' ' ILE . 33.6 p90 -168.56 159.54 10.24 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.815 0.817 . . . . 73.25 111.09 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -77.5 114.32 16.21 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.138 -1.392 . . . . 72.33 108.763 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . 0.476 ' HZ3' ' HB2' ' D' ' 28' ' ' ALA . 19.0 mmmt -68.89 -41.59 78.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.864 0.84 . . . . 73.11 109.469 173.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -145.23 140.85 28.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.033 -1.439 . . . . 75.53 109.058 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.468 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 65.6 mt -134.63 141.51 43.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.333 -1.358 . . . . 75.11 107.333 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -161.74 150.7 15.79 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.397 0.618 . . . . 72.41 111.276 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . 0.429 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 88.4 t80 -141.86 131.0 23.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.584 -1.265 . . . . 75.02 107.584 173.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.2 mt-10 -123.73 123.73 41.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.351 0.66 . . . . 73.31 109.266 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.8 83.21 62.19 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 107.432 -1.321 . . . . 73.1 107.432 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.28 -35.45 62.69 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.708 2.272 . . . . 75.12 111.875 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -110.66 33.39 4.57 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.811 -1.086 . . . . 75.02 109.223 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.417 ' HB2' ' HD3' ' C' ' 29' ' ' PRO . . . -47.23 -50.19 48.8 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 114.299 1.222 . . . . 73.13 114.299 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.417 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 15.2 Cg_exo -66.47 -39.51 16.48 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 121.788 1.659 . . . . 75.33 112.971 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -67.2 -57.58 6.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.313 1.045 . . . . 73.41 112.333 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 46.0 t -54.91 -24.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 125.176 1.39 . . . . 73.12 112.877 -177.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -51.95 -35.11 44.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.113 0.565 . . . . 75.31 112.05 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.48 45.9 0.95 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.666 0.787 . . . . 70.25 110.749 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.583 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 1.6 tppp? -124.53 151.86 44.16 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.011 0.924 . . . . 75.41 110.82 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.37 131.84 33.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.384 1.074 . . . . 72.34 112.636 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -86.39 69.31 10.41 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.082 0.953 . . . . 75.14 111.253 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -158.13 77.87 3.44 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.313 0.645 . . . . 71.32 109.679 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.737 ' HG3' ' HB3' ' F' ' 297' ' ' TYR . 95.7 Cg_endo -90.83 154.13 4.06 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.814 2.342 . . . . 74.52 113.122 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.05 95.2 9.86 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.455 -1.313 . . . . 73.45 107.455 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.4 114.3 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.938 -1.028 . . . . 73.21 109.461 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 89.6 mttt -102.24 146.51 27.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.757 0.823 . . . . 72.34 109.752 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.34 123.42 39.36 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 106.836 -1.542 . . . . 72.34 106.836 171.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.53 104.19 7.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.832 -1.173 . . . . 74.25 107.832 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.42 154.5 17.17 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.036 0.534 . . . . 75.52 110.224 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.569 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 10.6 t70 -146.79 151.91 37.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.774 0.83 . . . . 75.25 109.036 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -121.52 122.01 38.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.296 0.638 . . . . 73.05 110.093 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.76 138.7 48.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.503 -0.925 . . . . 75.3 108.503 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 48' ' ' SER . . . . . 0.558 ' HB3' ' HE1' ' C' ' 56' ' ' TYR . 71.2 m -155.06 151.54 28.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.038 0.535 . . . . 74.22 110.692 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -152.91 138.07 17.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.077 0.551 . . . . 72.34 110.498 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.53 122.92 27.07 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.671 -0.492 . . . . 75.2 109.671 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.452 HD13 HD13 ' C' ' 83' ' ' ILE . 41.1 mt -95.44 -43.32 8.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.767 0.827 . . . . 75.14 111.103 -172.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.42 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -158.83 -168.1 2.3 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.676 0.79 . . . . 75.45 110.066 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.91 103.63 0.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.093 -0.958 . . . . 74.22 110.066 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 72.77 -6.35 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 126.126 1.77 . . . . 64.31 113.024 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 60.2 t -91.85 107.49 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.792 -1.188 . . . . 73.54 107.792 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . 0.558 ' HE1' ' HB3' ' C' ' 48' ' ' SER . 2.1 t80 -128.59 141.0 51.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.11 -1.07 . . . . 74.3 108.11 -173.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -98.05 129.33 44.9 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.348 0.659 . . . . 70.14 110.829 -178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -110.35 114.69 47.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.08 -1.081 . . . . 74.44 108.08 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.21 135.84 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.831 -0.803 . . . . 55.43 108.831 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.16 109.38 12.81 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.945 -1.502 . . . . 75.04 106.945 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.569 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.2 ttm-85 -80.55 125.0 29.44 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.102 -0.703 . . . . 75.45 109.102 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' C' ' 114' ' ' ILE . 43.9 t -116.11 105.75 19.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.468 -1.308 . . . . 75.55 107.468 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.8 m -108.57 119.17 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.741 -0.837 . . . . 62.2 108.741 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.52 130.44 74.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.742 -0.836 . . . . 61.55 108.742 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 65' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 9.7 m -121.22 152.11 39.21 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.245 1.018 . . . . 72.22 109.309 -171.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.67 112.83 10.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.476 -1.305 . . . . 73.31 107.476 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -145.02 135.06 23.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.329 -0.619 . . . . 74.25 109.329 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.51 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.5 OUTLIER -120.23 57.01 0.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 122.216 1.008 . . . . 73.44 110.49 -173.76 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.29 -119.94 4.47 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.692 -1.594 . . . . 73.45 110.285 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.92 -30.59 18.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.855 -0.794 . . . . 73.31 108.855 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.583 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 11.7 tp10 -72.72 109.72 6.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.743 -1.117 . . . . 64.04 109.984 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -83.41 122.76 28.93 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.975 -0.75 . . . . 65.54 108.975 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.64 -54.77 8.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.407 1.067 . . . . 75.25 109.264 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -165.82 171.65 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.476 -0.784 . . . . 71.42 111.45 171.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -137.86 145.97 42.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.185 1.394 . . . . 74.53 107.242 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG21 ' C' ' 114' ' ' ILE . 42.0 t -152.85 121.39 6.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.044 0.537 . . . . 73.22 109.671 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.45 127.98 47.35 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.963 0.505 . . . . 73.3 110.285 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.91 124.46 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.895 -0.78 . . . . 74.2 108.895 169.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.543 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 23.3 mt-30 -96.62 105.52 17.63 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.988 -1.116 . . . . 71.33 107.988 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -92.24 112.05 23.84 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.724 0.41 . . . . 72.31 110.656 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 155.5 23.75 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.93 -0.577 . . . . 73.42 111.92 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.95 116.62 0.74 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.825 -1.31 . . . . 54.2 109.825 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' D' ' 29' ' ' PRO . 19.4 mm -81.71 119.51 31.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.322 -0.992 . . . . 74.2 108.322 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -126.93 119.18 26.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.661 -1.237 . . . . 74.24 107.661 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -84.65 98.61 10.29 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.505 -1.294 . . . . 74.14 107.505 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.428 ' HA ' ' O ' ' C' ' 10' ' ' THR . 0.2 OUTLIER -121.34 142.29 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.169 0.509 . . . . 74.43 111.242 -175.439 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.58 168.38 27.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.547 1.139 . . . . 62.1 109.416 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.77 -45.67 2.71 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.939 -0.464 . . . . 63.11 111.939 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.579 HG22 ' HB3' ' C' ' 93' ' ' GLN . 1.6 pp -80.93 145.66 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.482 0.713 . . . . 75.21 111.021 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -162.04 148.32 13.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.791 0.837 . . . . 74.23 109.081 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 -117.22 10.79 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.603 0.564 . . . . 73.34 113.328 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 56.6 p -65.12 -35.66 81.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.875 . . . . 74.3 111.532 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . 0.579 ' HB3' HG22 ' C' ' 89' ' ' ILE . 26.4 mt-30 -67.64 -43.3 80.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.92 -0.582 . . . . 72.22 110.623 178.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.491 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.5 ttt -75.78 -23.51 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.32 110.801 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.49 96.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.038 0.535 . . . . 74.53 110.674 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.25 -34.19 74.41 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.433 -0.803 . . . . 75.1 110.745 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -65.74 -61.26 2.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.797 -0.638 . . . . 75.53 111.317 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.496 HD11 ' HB3' ' F' ' 280' ' ' LEU . 4.2 pp -87.08 -12.97 45.62 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.502 0.556 . . . . 75.43 112.502 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.15 8.02 60.62 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-O 119.584 -0.564 . . . . 60.32 113.36 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.411 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -154.79 -59.95 0.11 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.93 0.492 . . . . 72.52 111.273 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.46 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 43.2 t80 -74.53 -49.59 21.4 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.556 0.742 . . . . 75.13 112.094 -168.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . 0.478 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -69.86 -44.52 22.68 Favored Pre-proline 0 CA--C 1.561 1.401 0 CA-C-O 118.156 -0.926 . . . . 73.11 113.223 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -61.59 -38.42 62.26 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 121.722 1.615 . . . . 74.34 111.259 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -62.95 -22.74 67.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.591 0.756 . . . . 75.04 112.392 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -73.32 -54.46 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 110.224 -0.287 . . . . 74.34 110.224 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 pp -87.16 -8.51 56.86 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.955 -0.566 . . . . 75.5 112.517 -170.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -58.44 -50.67 86.77 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.421 1.088 . . . . 71.14 113.303 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.51 -29.94 89.67 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 121.654 1.57 . . . . 63.15 113.189 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.68 -45.78 67.55 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.223 0.609 . . . . 74.32 110.462 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.63 91.95 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.547 0.739 . . . . 73.13 110.631 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . 0.52 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 36.1 ttt180 -61.78 -53.74 51.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.431 -1.713 . . . . 75.32 111.927 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.322 0.649 . . . . 73.22 110.315 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -67.91 -31.35 71.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.2 0.6 . . . . 73.43 111.449 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.444 HG21 ' SG ' ' C' ' 76' ' ' CYS . 83.2 mt -75.4 -49.97 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.617 0.767 . . . . 72.45 110.526 174.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -62.2 -29.37 70.33 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.515 0.726 . . . . 74.33 111.457 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -67.26 -49.69 63.41 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.56 -0.745 . . . . 74.14 109.622 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.726 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.04 -36.59 75.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.055 0.942 . . . . 63.43 112.615 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 93.4 t -64.88 -41.74 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.588 0.755 . . . . 75.01 110.346 177.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.1 p -74.91 -27.01 60.05 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.031 -0.532 . . . . 72.31 111.349 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -70.3 -39.44 74.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.835 0.854 . . . . 75.41 110.742 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . 0.432 ' HA2' ' H ' ' D' ' 18' ' ' THR . . . -83.89 10.06 61.23 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.045 -0.525 . . . . 61.43 113.461 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p 55.12 62.28 2.57 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 125.482 1.513 . . . . 73.35 111.718 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' F' ' 301' ' ' ILE . 69.8 m-85 -126.59 154.39 75.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.867 1.267 . . . . 74.35 109.139 170.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.32 167.8 13.99 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.276 2.651 . . . . 72.01 113.759 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . 0.513 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 17.3 mm-40 -56.26 123.64 15.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.571 1.148 . . . . 74.14 113.912 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.97 84.18 1.91 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.117 -1.438 . . . . 74.13 107.117 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . 0.47 ' HB2' ' HD3' ' F' ' 294' ' ' LYS . 13.7 m120 -91.77 102.11 14.71 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.248 -1.019 . . . . 73.15 108.248 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . 0.52 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 14.8 tp -68.08 137.15 54.76 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 64.53 110.382 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . 0.436 ' H ' HD11 ' C' ' 128' ' ' LEU . . . -81.08 152.19 70.99 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.035 0.934 . . . . 64.03 111.146 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.451 ' O ' HG12 ' H' ' 306' ' ' VAL . 41.3 Cg_exo -50.11 142.19 28.43 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.16 2.573 . . . . 74.21 113.111 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.529 ' HA ' HG23 ' H' ' 309' ' ' THR . 22.0 t -123.11 110.29 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.779 -0.823 . . . . 72.14 108.779 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.549 ' HB3' ' HB1' ' C' ' 135' ' ' ALA . 3.5 m-20 -97.98 85.65 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.389 0.676 . . . . 74.01 109.922 -176.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.411 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 91.0 m-85 -69.59 -46.65 65.84 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.264 -0.426 . . . . 75.23 110.866 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.411 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 29.8 t70 -65.98 -48.35 71.53 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.72 -0.673 . . . . 73.13 110.801 -176.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . 0.549 ' HB1' ' HB3' ' C' ' 132' ' ' ASN . . . -58.39 -21.02 48.87 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.147 0.904 . . . . 73.14 112.958 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.11 -56.66 4.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.913 0.885 . . . . 74.43 109.638 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -72.53 -47.31 49.37 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.041 0.756 . . . . 73.44 113.041 -171.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -25.75 60.6 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.911 0.885 . . . . 75.23 113.224 -170.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -50.79 -37.52 42.9 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.488 1.115 . . . . 74.22 113.767 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -34.09 -80.5 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 126.262 1.825 . . . . 75.3 114.365 -168.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.25 117.36 7.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 106.816 -1.55 . . . . 73.13 106.816 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 177.98 10.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.286 1.034 . . . . 63.13 109.617 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -152.65 150.66 29.72 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.171 0.588 . . . . 73.15 109.821 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -155.04 136.55 14.22 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.032 -0.729 . . . . 75.54 109.032 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.69 -167.94 1.96 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.342 0.657 . . . . 72.44 110.929 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.43 121.32 1.57 Allowed Glycine 0 C--N 1.35 1.324 0 C-N-CA 121.457 -0.402 . . . . 75.03 113.928 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -173.61 104.54 0.12 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.256 1.422 . . . . 75.31 107.965 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.46 75.42 2.14 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.968 -0.56 . . . . 70.54 113.706 -168.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 149' ' ' THR . . . . . 0.423 ' HB ' ' CE2' ' A' ' 140' ' ' TYR . 47.2 m -147.0 153.91 40.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.95 0.9 . . . . 73.4 108.572 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.48 179.2 9.35 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.851 0.86 . . . . 73.12 108.831 173.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -109.99 133.4 53.23 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.909 0.385 . . . . 64.31 110.456 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -89.92 134.59 34.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.6 0.76 . . . . 75.21 109.697 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.596 ' HB3' ' HB3' ' E' ' 287' ' ' PRO . 59.5 tt0 -123.66 93.41 3.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.477 -0.934 . . . . 55.34 108.477 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -75.67 96.27 3.56 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.951 -1.022 . . . . 72.31 109.741 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.03 0 CA-C-N 115.649 -0.705 . . . . 74.05 109.68 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' D' D ' 1' ' ' MET . . . . . 0.587 ' HE2' ' HA ' ' B' ' 145' ' ' ALA . 26.0 ptp . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.92 -0.4 . . . . 62.45 109.92 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 46.7 m -64.08 92.25 0.08 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.567 0.747 . . . . 75.13 111.304 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.57 74.22 8.58 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.682 -1.229 . . . . 72.43 107.682 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -176.76 150.59 0.83 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.987 -1.46 . . . . 73.53 108.772 -172.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -71.08 84.58 0.72 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.381 0.61 . . . . 73.12 110.223 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -146.61 -165.48 2.24 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.554 1.142 . . . . 70.44 109.616 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -78.17 70.62 4.56 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 121.88 0.848 . . . . 75.24 111.724 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -169.63 -166.31 0.58 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.965 1.706 . . . . 73.54 108.414 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -32.43 123.58 0.33 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.674 1.19 . . . . 71.43 113.383 168.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -149.39 141.53 23.98 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.841 0.857 . . . . 73.53 108.924 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -157.15 100.66 1.87 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.945 -1.131 . . . . 73.54 107.945 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.3 143.53 51.03 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.842 0.857 . . . . 73.53 109.221 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 47.7 mt -96.11 136.22 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.016 0.526 . . . . 63.41 109.754 175.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . 0.427 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.6 mt-30 -89.13 -42.1 11.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.978 -0.379 . . . . 63.52 109.978 172.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -176.03 153.64 1.34 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 65.31 110.919 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.842 -1.54 . . . . 75.51 106.842 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -149.43 170.81 17.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.173 0.987 . . . . 64.43 111.613 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 18' ' ' THR . . . . . 0.432 ' H ' ' HA2' ' C' ' 121' ' ' GLY . 68.4 p -105.09 117.65 34.54 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.312 -1.313 . . . . 71.11 109.726 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -85.6 -29.29 24.21 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.889 -0.596 . . . . 75.44 109.458 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.414 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 24.5 t70 -151.03 139.1 20.08 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.338 -1.301 . . . . 72.55 108.924 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.726 HG21 ' HE1' ' C' ' 117' ' ' MET . 92.1 mt -132.49 146.84 32.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.729 -1.211 . . . . 74.44 107.729 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.8 t -148.75 140.0 23.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.65 0.78 . . . . 75.44 109.715 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.468 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -149.35 117.67 6.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.372 -2.084 . . . . 74.23 105.372 167.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -121.88 135.64 54.9 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.966 -0.753 . . . . 70.22 108.966 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.04 83.45 55.66 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.371 -1.344 . . . . 73.31 107.371 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.38 -29.82 10.84 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.89 2.393 . . . . 74.15 113.558 -169.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -114.71 33.22 5.49 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.03 -0.73 . . . . 72.22 109.03 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.476 ' HB2' ' HZ3' ' C' ' 19' ' ' LYS . . . -43.15 -62.33 1.39 Allowed Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.433 1.642 . . . . 73.13 115.433 -163.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.477 ' HB3' HD11 ' C' ' 83' ' ' ILE . 42.9 Cg_endo -83.21 -15.61 7.69 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 121.794 1.676 . . . . 61.15 112.888 -178.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -68.18 -34.29 76.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.815 1.246 . . . . 75.03 109.079 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.569 HG13 ' HH2' ' D' ' 36' ' ' TRP . 55.8 t -68.44 -38.97 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.81 0.844 . . . . 73.14 110.398 175.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.429 ' HD1' HG12 ' G' ' 301' ' ' ILE . 24.5 m-85 -74.04 4.69 5.12 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.831 0.678 . . . . 74.15 112.831 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -87.04 -17.75 32.21 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.058 0.543 . . . . 73.03 111.181 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.621 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 29.5 mtpt -126.34 107.3 10.18 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.336 1.054 . . . . 73.54 110.656 -167.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.47 97.6 9.56 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 118.905 0.775 . . . . 65.33 111.295 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.621 ' HE1' ' HE2' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -136.4 176.67 8.48 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 73.44 110.4 175.397 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.43 111.82 39.63 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.046 0.938 . . . . 75.15 110.336 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.566 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.1 Cg_exo -64.35 140.07 68.47 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.049 2.499 . . . . 74.43 113.871 173.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . 0.438 ' H ' HD11 ' D' ' 68' ' ' LEU . 14.4 pt-20 -82.77 130.15 35.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.042 -1.095 . . . . 75.1 108.042 162.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.446 HG13 HG13 ' D' ' 64' ' ' VAL . 77.2 t -105.57 104.74 17.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 107.694 -1.224 . . . . 74.11 107.694 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.16 127.86 36.75 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.17 -0.307 . . . . 75.44 110.17 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -95.89 124.43 39.9 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.621 -1.251 . . . . 75.44 107.621 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -137.59 138.26 39.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.36 -0.978 . . . . 74.12 108.36 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.88 147.36 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.417 0.627 . . . . 75.2 110.945 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -133.07 137.52 46.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.823 -1.177 . . . . 73.33 107.823 170.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.1 p -105.16 144.16 32.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 64.23 110.205 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.33 145.08 23.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.462 0.705 . . . . 71.43 109.32 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -151.22 157.46 42.65 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.873 0.469 . . . . 74.24 109.973 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 6.4 m -147.82 149.62 32.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.98 -1.118 . . . . 72.44 107.98 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -101.1 118.03 36.18 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.56 -1.274 . . . . 73.4 107.56 161.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 mt -89.68 -34.02 16.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.805 -0.442 . . . . 74.03 109.805 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.68 -177.8 6.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.599 -0.728 . . . . 73.15 110.679 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.34 130.94 45.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.252 -0.885 . . . . 74.54 109.126 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 66.33 5.64 3.82 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.63 1.172 . . . . 72.52 112.4 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.86 123.32 71.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 C-N-CA 123.381 0.672 . . . . 63.44 109.937 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -128.11 127.34 42.86 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.316 -0.994 . . . . 74.42 108.316 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -88.15 143.0 27.31 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.776 0.831 . . . . 64.43 109.114 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 48.6 t -125.32 123.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.268 -1.012 . . . . 74.41 108.268 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.638 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 43.4 t -109.83 131.33 61.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.167 -1.049 . . . . 61.21 108.167 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -126.38 117.66 23.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.588 -0.893 . . . . 75.31 108.588 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.1 ttm-85 -95.64 106.93 19.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.78 0.832 . . . . 74.41 109.938 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -94.46 112.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.778 -0.823 . . . . 73.31 108.778 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -112.15 128.59 56.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.485 0.66 . . . . 70.44 109.868 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . 0.446 HG13 HG13 ' D' ' 40' ' ' VAL . 42.2 t -124.8 107.42 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.458 1.503 . . . . 72.14 108.649 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.9 m -106.02 117.46 34.09 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.904 0.881 . . . . 74.44 110.375 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.48 126.55 53.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.307 -0.627 . . . . 72.23 109.307 172.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 67' ' ' SER . . . . . 0.46 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.2 m -153.76 122.83 6.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.304 0.641 . . . . 74.34 109.344 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.566 HD11 ' HA ' ' D' ' 38' ' ' PRO . 2.5 mm? -130.49 135.46 47.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.795 0.838 . . . . 74.21 109.448 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 -116.39 4.93 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.972 -0.851 . . . . 73.23 110.972 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.03 8.3 8.64 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.998 -0.742 . . . . 65.13 108.998 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.46 155.87 33.98 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.651 0.78 . . . . 74.15 110.793 -173.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -82.64 129.14 34.9 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 72.23 110.529 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.46 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -69.33 -68.61 0.39 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.093 -1.077 . . . . 73.53 108.093 173.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.88 152.61 28.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.388 -0.824 . . . . 74.33 109.596 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 77.1 mt -110.64 150.27 29.23 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.426 1.09 . . . . 71.34 108.243 167.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.553 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 38.1 t -150.9 136.23 17.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.432 -0.951 . . . . 75.13 108.432 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -155.53 129.56 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.644 0.378 . . . . 75.02 110.313 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -134.43 120.1 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.049 0.539 . . . . 74.54 110.07 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.414 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 7.1 mt-30 -87.7 91.25 8.68 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.607 -0.886 . . . . 73.32 108.607 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.72 95.54 6.65 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.383 -0.969 . . . . 74.15 108.383 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 144.18 16.95 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.83 -0.623 . . . . 61.14 111.562 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.39 136.22 6.61 Favored Glycine 0 CA--C 1.507 -0.43 0 N-CA-C 110.515 -1.034 . . . . 50.12 110.515 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.427 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.8 mt -88.42 126.54 41.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.6 -0.889 . . . . 65.01 108.6 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . 0.404 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 52.6 m-85 -123.92 148.65 46.69 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.565 -0.532 . . . . 72.55 109.565 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 27.0 m -103.57 94.22 5.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.671 -1.233 . . . . 74.23 107.671 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.8 mt -110.17 116.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.999 0.919 . . . . 74.33 108.72 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.45 153.5 15.47 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.145 0.578 . . . . 75.11 110.33 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.05 59.97 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.127 -0.488 . . . . 71.45 112.738 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.65 129.1 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.736 -0.839 . . . . 74.35 108.736 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -134.5 168.07 19.62 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.883 0.873 . . . . 73.14 110.362 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . 0.416 ' HA2' ' HD2' ' G' ' 276' ' ' PRO . . . 71.42 -135.61 23.95 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.855 -0.611 . . . . 70.24 114.177 174.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -70.61 -34.63 72.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.166 0.987 . . . . 64.31 112.056 -173.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.98 -38.76 83.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.971 0.508 . . . . 72.13 110.726 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -44.11 76.66 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.5 -0.555 . . . . 73.0 109.5 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.54 71.66 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.204 0.94 . . . . 71.33 111.508 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -72.01 -45.0 62.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.572 0.749 . . . . 64.45 110.646 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.44 -37.9 88.27 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.807 0.443 . . . . 63.11 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . 0.545 ' HG ' ' HB2' ' G' ' 281' ' ' PHE . 41.3 tp -79.32 -37.77 36.81 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.262 1.025 . . . . 74.21 111.301 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -7.79 76.09 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.657 -0.524 . . . . 74.24 113.769 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 -54.98 0.73 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.763 0.782 . . . . 73.31 112.211 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -72.37 -49.02 37.16 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.064 0.393 . . . . 75.22 111.573 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.0 m -60.78 -48.47 92.89 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.252 -0.88 . . . . 75.34 112.531 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.24 -27.75 48.22 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 121.636 1.557 . . . . 74.31 112.604 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -71.99 -24.09 61.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.066 0.546 . . . . 75.52 111.099 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -80.64 -41.68 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.607 0.763 . . . . 71.01 110.455 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.77 -30.57 62.84 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.202 0.601 . . . . 73.42 111.547 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -63.87 -42.36 70.09 Favored Pre-proline 0 CA--C 1.564 1.508 0 N-CA-C 114.187 1.18 . . . . 75.31 114.187 -170.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.57 -45.09 32.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.413 2.076 . . . . 75.42 113.821 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -79.63 -30.98 41.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.357 0.663 . . . . 74.13 111.798 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.91 74.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.912 0.485 . . . . 73.42 109.863 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.85 -51.27 70.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.293 -1.321 . . . . 70.33 110.352 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.54 -42.17 91.72 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.218 0.949 . . . . 73.45 111.385 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -44.56 94.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.754 0.659 . . . . 65.21 110.793 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.487 HG22 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -62.46 -52.38 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.073 0.949 . . . . 75.24 110.697 175.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.434 HG21 ' HE2' ' B' ' 109' ' ' TYR . 32.0 m -56.36 -41.25 75.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.824 1.249 . . . . 65.13 111.135 -171.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -67.93 -43.58 78.84 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.549 -1.205 . . . . 74.12 110.507 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.553 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 76.9 mtm -66.64 -31.55 72.31 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.371 0.508 . . . . 62.5 112.371 -179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.46 HG21 ' O ' ' D' ' 114' ' ' ILE . 94.5 t -68.34 -44.83 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.27 0.628 . . . . 73.53 109.712 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.0 p -70.37 -28.96 65.52 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.994 0.518 . . . . 74.02 111.45 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -73.38 -31.71 64.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.337 0.655 . . . . 74.52 110.186 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 3.0 86.12 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.959 -0.564 . . . . 73.44 112.851 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 69.3 p 63.29 14.43 7.81 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.794 2.038 . . . . 73.34 113.672 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.46 ' HA ' ' HH ' ' G' ' 297' ' ' TYR . 87.8 m-85 -80.29 158.83 71.34 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 165.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -70.88 134.29 25.32 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 121.61 1.54 . . . . 73.32 110.878 -168.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -48.72 116.94 1.81 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.333 1.021 . . . . 73.51 110.349 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -105.5 104.79 14.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.039 -0.726 . . . . 64.43 109.039 -164.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . 0.451 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 78.6 m-20 -99.0 94.24 6.44 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.513 -1.221 . . . . 74.23 107.998 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 127.48 32.43 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.121 0.969 . . . . 72.04 109.368 -175.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.88 128.63 87.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.58 0.752 . . . . 72.42 111.235 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . 0.407 ' HG2' ' HE2' ' B' ' 11' ' ' PHE . 1.2 Cg_endo -79.73 122.61 5.0 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.852 2.368 . . . . 73.03 111.391 -177.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.36 115.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.273 0.629 . . . . 74.53 109.448 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . 0.415 ' ND2' ' HB1' ' D' ' 135' ' ' ALA . 28.1 t30 -76.55 105.28 7.52 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.143 -0.688 . . . . 65.44 109.143 174.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -68.21 -37.75 81.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.798 0.839 . . . . 73.31 110.571 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.73 -46.52 77.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.998 0.919 . . . . 72.23 111.282 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . 0.415 ' HB1' ' ND2' ' D' ' 132' ' ' ASN . . . -53.45 -48.21 69.02 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.985 1.428 . . . . 75.32 111.006 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 66.0 mt -55.99 -49.37 73.79 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 124.719 1.262 . . . . 74.23 112.206 -176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -72.43 -42.24 65.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.267 -0.879 . . . . 75.11 112.127 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 24.4 ptp -73.13 -25.85 60.99 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 120.619 0.247 . . . . 75.22 110.813 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' D' ' 143' ' ' GLN . 0.4 OUTLIER -68.9 -35.72 77.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.258 1.023 . . . . 73.33 111.398 178.787 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 75.3 t80 -48.68 -36.87 17.03 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.613 0.765 . . . . 73.55 111.27 177.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.24 -57.88 3.66 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.318 -0.856 . . . . 72.13 110.39 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 30.1 pt20 -88.38 38.86 0.88 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.185 0.994 . . . . 63.04 112.409 -169.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' D' ' 139' ' ' ASN . 22.7 tt0 -116.18 91.52 3.62 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.927 -0.768 . . . . 63.54 108.927 -174.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -155.73 26.2 0.39 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.893 -1.049 . . . . 74.11 109.828 -178.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.8 169.04 16.79 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.709 0.804 . . . . 71.13 110.695 -174.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.62 118.91 1.26 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.422 -1.071 . . . . 62.23 110.422 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.46 148.86 24.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.316 0.646 . . . . 71.31 111.045 -176.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.16 81.12 0.26 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 124.345 1.028 . . . . 73.43 113.6 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 44.3 m -84.05 98.71 10.01 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.793 0.837 . . . . 61.54 109.947 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -100.25 139.62 35.66 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.065 0.546 . . . . 75.14 109.595 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.28 134.73 29.79 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.124 -1.065 . . . . 75.41 108.124 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -99.73 103.51 15.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.816 0.446 . . . . 74.14 111.076 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.35 139.23 37.17 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.304 -0.999 . . . . 75.34 108.304 171.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -107.71 108.75 20.12 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.131 -0.692 . . . . 74.44 109.131 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 C-N-CA 123.893 0.877 . . . . 65.31 108.782 172.77 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.341 -0.614 . . . . 74.23 109.341 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -170.66 46.53 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.76 1.224 . . . . 70.23 107.767 -174.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -68.75 96.23 0.72 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.575 -0.739 . . . . 74.14 109.783 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 2' ' ' SER . 93.3 mt-30 -102.76 37.4 1.94 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.277 1.031 . . . . 75.45 111.466 -173.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . 0.453 ' HE3' ' HA3' ' E' ' 279' ' ' GLY . 61.4 tttp -144.73 86.17 8.05 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.604 -0.888 . . . . 74.34 108.604 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.34 79.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 124.684 3.59 . . . . 74.11 115.489 -165.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 61.4 mt 50.21 -82.38 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.405 1.882 . . . . 75.35 113.181 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.44 90.73 0.25 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.451 0.7 . . . . 72.31 111.894 -172.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . 0.453 ' HA3' ' HE3' ' E' ' 275' ' ' LYS . . . -135.05 34.36 2.33 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 109.859 -1.297 . . . . 71.22 109.859 169.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.671 HD22 ' HA ' ' A' ' 95' ' ' ALA . 39.5 tp -134.69 167.97 19.87 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.85 1.26 . . . . 73.2 108.91 -173.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . 0.417 ' N ' ' HG ' ' E' ' 280' ' ' LEU . 21.8 m-30 79.11 -26.71 0.17 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.534 1.534 . . . . 75.41 111.87 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -47.24 -43.84 22.22 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.188 0.995 . . . . 72.22 110.763 168.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -130.92 102.68 6.16 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.716 -1.216 . . . . 75.54 107.716 164.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -163.59 38.06 0.32 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.667 -0.697 . . . . 74.14 112.663 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.9 102.55 5.59 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.726 -0.842 . . . . 75.11 108.726 170.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 286' ' ' MET . . . . . 0.509 ' HE2' ' HB3' ' A' ' 133' ' ' PHE . 13.0 mmt -65.14 143.73 98.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 116.119 -0.491 . . . . 73.53 111.461 177.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . 0.596 ' HB3' ' HB3' ' C' ' 153' ' ' GLN . 22.3 Cg_exo -66.98 77.82 0.4 Allowed 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.571 2.181 . . . . 74.14 111.347 168.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 11.2 t -89.83 65.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 122.665 1.221 . . . . 74.54 108.689 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -88.2 128.96 35.46 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 113.706 -1.588 . . . . 74.44 107.135 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -53.2 124.53 14.76 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.449 0.7 . . . . 72.53 111.785 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.585 HD12 ' HB1' ' A' ' 129' ' ' ALA . 3.2 mp -83.82 76.51 10.01 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.134 -1.432 . . . . 74.25 107.134 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . 0.521 ' HA3' ' HB ' ' G' ' 307' ' ' THR . . . 80.44 90.29 0.51 Allowed Glycine 0 C--N 1.347 1.151 0 CA-C-N 114.459 -1.246 . . . . 64.32 111.552 -165.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.9 27.67 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.57 2.847 . . . . 75.42 114.162 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . 0.504 ' HZ3' ' HB2' ' E' ' 294' ' ' LYS . 4.9 ttmp? -133.92 91.9 2.89 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.647 -0.872 . . . . 72.12 108.647 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' G' ' 305' ' ' ALA . . . -164.92 174.1 10.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.214 1.006 . . . . 64.34 109.112 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 83.9 m 64.98 -86.62 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.774 0.671 . . . . 71.13 110.615 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -97.83 92.55 5.89 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.227 -0.657 . . . . 75.12 109.227 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -157.58 10.69 0.19 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.589 -0.522 . . . . 73.0 109.589 170.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.68 174.81 24.96 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.762 -0.654 . . . . 62.02 112.137 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -70.42 117.54 12.09 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.827 -0.805 . . . . 75.11 108.827 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 10.4 tp -52.63 134.12 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.139 0.976 . . . . 72.4 111.583 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -65.16 126.41 28.01 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.992 -0.373 . . . . 73.23 109.992 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -78.95 139.65 57.47 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 114.787 -1.097 . . . . 72.42 110.054 -174.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . 0.518 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 4.8 Cg_endo -46.5 -25.56 3.5 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 124.042 3.162 . . . . 71.13 114.692 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . 74.3 -66.0 0.32 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.332 1.453 . . . . 52.04 112.314 172.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . 0.537 ' HA ' ' HD2' ' G' ' 293' ' ' PRO . 20.9 m -79.22 40.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 124.491 1.116 . . . . 72.42 111.915 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 2.5 m -79.59 1.23 26.82 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.382 1.073 . . . . 73.31 111.178 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 80.0 m -144.57 118.78 9.51 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.189 0.996 . . . . 73.22 109.396 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' E' E ' 309' ' ' THR . . . . . 0.562 ' HB ' ' HB3' ' B' ' 12' ' ' GLN . 94.7 m -141.08 94.72 7.74 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 107.503 -1.295 . . . . 74.43 107.503 170.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 C--N 1.379 2.158 0 C-N-CA 123.335 2.69 . . . . 73.44 113.461 -172.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.549 -0.537 . . . . 74.03 109.549 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -79.17 80.75 5.5 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.551 0.691 . . . . 74.51 111.42 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -79.2 70.06 5.51 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.06 -0.719 . . . . 75.33 109.06 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -82.77 147.16 28.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.4 -0.818 . . . . 74.43 110.122 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.92 77.09 30.24 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 108.571 -0.9 . . . . 74.14 108.571 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.27 178.23 7.83 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.455 2.103 . . . . 75.22 111.401 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.61 109.63 3.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.238 -0.653 . . . . 73.15 109.238 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . 0.408 HD12 HD21 ' C' ' 98' ' ' LEU . 13.7 tp -161.36 -81.9 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.842 -0.429 . . . . 73.44 109.842 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 87.16 -82.3 1.62 Allowed Glycine 0 C--N 1.352 1.435 0 N-CA-C 114.995 0.758 . . . . 52.43 114.995 171.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . 0.496 ' HB3' HD11 ' C' ' 98' ' ' LEU . 9.8 tt -62.1 -28.52 69.68 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.482 0.713 . . . . 70.01 112.405 -169.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -73.53 79.51 1.45 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.676 0.751 . . . . 75.25 109.891 173.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -170.12 35.36 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.355 1.462 . . . . 75.31 108.478 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 27.4 t70 77.18 131.78 0.05 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.752 1.621 . . . . 71.41 111.727 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -128.75 157.27 21.43 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 123.161 0.41 . . . . 73.3 112.307 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -85.62 77.4 9.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.283 0.633 . . . . 70.13 110.259 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 17.2 ptp -156.49 89.26 2.72 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.232 -0.894 . . . . 75.12 109.588 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.72 -60.07 1.0 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.3 2.666 . . . . 72.45 113.621 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 46.4 t 50.55 -83.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 124.852 1.261 . . . . 73.31 112.176 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 57.75 -88.15 0.02 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.429 1.492 . . . . 74.54 111.282 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -137.07 157.29 47.03 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.461 0.648 . . . . 64.31 111.523 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.468 HD22 HG11 ' H' ' 306' ' ' VAL . 5.3 mp -118.93 -4.44 10.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.685 -1.143 . . . . 73.14 110.173 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -170.37 154.62 23.47 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.45 -0.639 . . . . 71.24 112.341 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.88 -39.95 47.81 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.61 2.873 . . . . 75.43 114.163 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . 0.47 ' HD3' ' HB2' ' C' ' 127' ' ' ASN . 0.1 OUTLIER 70.28 173.19 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.914 1.286 . . . . 75.41 111.271 178.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . 0.418 ' H ' ' HG3' ' F' ' 294' ' ' LYS . . . -78.29 6.69 7.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.169 0.988 . . . . 75.03 112.761 177.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 34.0 m -60.67 105.23 0.42 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.685 1.194 . . . . 62.34 111.483 -176.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.737 ' HB3' ' HG3' ' C' ' 38' ' ' PRO . 68.7 t80 55.73 38.91 30.69 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.75 1.22 . . . . 72.13 111.215 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -118.79 143.59 46.83 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.696 -0.628 . . . . 75.42 109.564 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.02 -81.37 1.74 Allowed Glycine 0 C--N 1.35 1.313 0 N-CA-C 111.69 -0.564 . . . . 70.1 111.69 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -170.01 164.53 9.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.445 1.098 . . . . 64.11 109.629 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' C' ' 123' ' ' PHE . 40.4 mm -62.18 -70.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.634 0.774 . . . . 72.14 109.92 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 174.79 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.826 1.651 . . . . 74.13 107.803 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 140.69 29.45 Favored Pre-proline 0 N--CA 1.48 1.064 0 N-CA-C 109.497 -0.557 . . . . 71.32 109.497 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.4 -32.58 3.79 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.724 2.283 . . . . 71.53 111.509 166.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -164.29 169.56 17.35 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.505 1.122 . . . . 62.23 109.36 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.47 129.41 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.444 -0.947 . . . . 72.34 108.444 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 307' ' ' THR . . . . . 0.534 HG23 ' HA3' ' H' ' 292' ' ' GLY . 18.5 m -82.27 100.13 9.73 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.458 0.703 . . . . 74.23 111.516 -168.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 75.3 m 75.46 -63.71 0.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.702 1.601 . . . . 70.25 113.107 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' F' F ' 309' ' ' THR . . . . . 0.699 HG23 HD23 ' H' ' 291' ' ' LEU . 10.1 t -61.91 145.51 92.54 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 123.427 0.691 . . . . 75.21 110.732 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo . . . . . 0 CA--C 1.561 1.863 0 C-N-CA 121.613 1.542 . . . . 62.14 110.301 168.391 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.795 0.331 . . . . 71.52 110.59 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -146.07 156.92 43.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.905 0.882 . . . . 72.34 109.891 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -29.86 70.38 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.121 -0.945 . . . . 73.01 111.51 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -75.99 -60.84 2.15 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.327 0.651 . . . . 75.15 111.866 -174.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 56.35 84.99 0.2 Allowed Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 123.984 0.914 . . . . 75.14 111.276 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . 0.416 ' HD2' ' HA2' ' D' ' 91' ' ' GLY . 91.8 Cg_endo -80.77 150.29 18.56 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.54 2.16 . . . . 74.31 113.582 -173.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.24 21.45 6.94 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.021 0.928 . . . . 64.31 108.993 173.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 43.4 tp -168.85 118.07 0.7 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.189 1.396 . . . . 74.24 107.396 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 178.06 169.63 39.2 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 114.199 0.44 . . . . 55.33 114.199 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 67.7 tp 78.07 -48.11 0.47 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 126.378 1.871 . . . . 73.53 112.18 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . 0.545 ' HB2' ' HG ' ' D' ' 98' ' ' LEU . 16.3 t80 -59.58 -30.31 68.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.446 1.098 . . . . 74.1 112.344 -172.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.32 88.36 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.319 0.647 . . . . 75.12 111.078 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -77.98 -40.38 39.41 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.739 0.816 . . . . 74.23 109.847 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 87.59 -60.66 4.23 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.592 -0.731 . . . . 70.34 112.511 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 5.4 t30 53.14 68.07 0.9 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.744 1.218 . . . . 75.43 110.154 -170.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 286' ' ' MET . . . . . 0.424 ' H ' ' HE3' ' B' ' 1' ' ' MET . 21.9 mmt -133.24 89.85 31.84 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.79 0.836 . . . . 74.1 110.143 -176.216 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -93.06 50.38 0.4 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.629 2.886 . . . . 72.21 111.1 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.16 -39.61 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.855 1.262 . . . . 73.42 112.762 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 61.68 -155.9 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.304 1.042 . . . . 75.22 110.61 -174.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -128.21 132.08 48.82 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.417 -0.957 . . . . 72.53 108.417 165.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.96 3.11 11.54 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.705 0.802 . . . . 74.11 111.79 -175.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -87.62 124.64 7.19 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 119.045 -0.864 . . . . 53.53 112.181 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . 0.537 ' HD2' ' HA ' ' E' ' 306' ' ' VAL . 52.4 Cg_exo -57.22 127.82 27.2 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.672 2.248 . . . . 71.24 112.388 174.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.72 84.49 1.63 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.258 1.023 . . . . 75.31 109.91 -175.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -147.03 34.74 0.9 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.953 0.901 . . . . 75.55 110.187 -174.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 296' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' D' ' 38' ' ' PRO . 2.4 m -66.28 -63.7 1.02 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.921 0.888 . . . . 74.24 111.588 -169.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.516 ' H ' ' HD2' ' D' ' 38' ' ' PRO . 16.7 m-85 -73.28 162.87 28.87 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.943 -0.762 . . . . 73.45 108.943 165.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -153.84 -20.28 0.14 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.084 -0.507 . . . . 72.4 109.976 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 166.44 65.1 0.03 OUTLIER Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.999 -0.44 . . . . 74.12 111.999 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -118.01 -40.74 2.95 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.728 0.811 . . . . 74.53 110.158 -175.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.429 HG12 ' HD1' ' D' ' 32' ' ' PHE . 18.2 mt -65.22 -36.9 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.211 1.004 . . . . 73.34 110.963 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -80.46 15.55 1.61 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.873 0.694 . . . . 73.24 112.873 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . 0.688 ' HA ' ' HE3' ' G' ' 303' ' ' LYS . 0.6 OUTLIER -143.11 103.05 5.17 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 110.003 -0.369 . . . . 75.14 110.003 165.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.79 -174.28 2.09 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.942 2.428 . . . . 63.12 112.388 170.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . 0.588 ' HA ' ' HB2' ' E' ' 295' ' ' ALA . . . -113.39 167.82 10.26 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.778 0.831 . . . . 74.33 109.773 174.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.412 HG22 ' HB ' ' C' ' 13' ' ' ILE . 58.6 t 53.31 98.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 124.725 1.21 . . . . 72.02 112.371 -177.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 307' ' ' THR . . . . . 0.521 ' HB ' ' HA3' ' E' ' 292' ' ' GLY . 18.2 m -68.39 156.73 37.23 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 115.546 -0.752 . . . . 73.21 109.924 177.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 28.5 p -51.4 114.31 1.2 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.573 1.149 . . . . 64.14 112.933 -174.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 60.3 m -118.07 96.17 49.28 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.087 0.955 . . . . 73.54 109.871 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.378 2.114 0 C-N-CA 123.448 2.765 . . . . 75.24 112.259 171.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.799 -0.445 . . . . 61.41 109.799 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -163.21 147.79 11.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.827 0.851 . . . . 71.54 109.5 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -73.29 86.29 1.45 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.113 -1.069 . . . . 74.34 108.113 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -85.69 32.99 0.57 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.686 1.194 . . . . 74.41 113.497 -162.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -159.8 102.76 1.45 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.316 0.646 . . . . 64.14 109.405 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.99 128.61 9.26 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.755 2.303 . . . . 71.54 110.067 168.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 54.6 tp -66.09 -28.65 68.98 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.916 -0.402 . . . . 75.03 109.916 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . 0.528 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 32.9 tp -65.48 96.38 0.25 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.588 0.755 . . . . 74.33 110.014 175.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -92.38 -17.06 47.56 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.733 -0.667 . . . . 72.25 113.494 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 92.7 mt -131.2 -169.73 2.23 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.273 1.029 . . . . 73.42 109.93 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 28.2 t80 80.5 -29.4 0.13 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 125.091 1.357 . . . . 74.44 113.599 167.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.98 -26.5 65.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.305 0.642 . . . . 51.42 112.534 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.4 -24.74 34.24 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.516 0.726 . . . . 74.31 110.46 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 73.53 -92.51 0.69 Allowed Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.435 -0.666 . . . . 74.12 111.435 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 69.09 163.05 0.23 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.278 1.431 . . . . 71.43 112.236 175.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 286' ' ' MET . . . . . 0.479 ' SD ' HD22 ' B' ' 136' ' ' LEU . 66.6 mtm 64.23 77.95 0.29 Allowed Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.072 1.349 . . . . 71.21 110.358 -177.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.2 131.77 46.76 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.385 2.723 . . . . 70.42 113.293 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.08 -45.99 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 O-C-N 123.848 0.718 . . . . 71.22 110.2 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 65.94 -78.42 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.956 1.302 . . . . 73.21 111.267 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -171.26 142.47 1.74 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.366 1.066 . . . . 72.24 108.559 175.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.699 HD23 HG23 ' F' ' 309' ' ' THR . 5.6 mp -93.85 56.48 2.31 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.983 -1.117 . . . . 65.14 107.983 172.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . 0.534 ' HA3' HG23 ' F' ' 307' ' ' THR . . . 74.0 165.37 11.67 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 115.351 -0.84 . . . . 71.15 113.318 -174.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.24 151.54 30.04 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.525 2.15 . . . . 61.12 112.215 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -124.42 158.72 32.09 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 108.898 -0.779 . . . . 71.22 108.898 169.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.63 72.25 7.55 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.515 1.126 . . . . 70.14 111.282 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 17.0 m -85.17 148.21 26.22 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.28 1.032 . . . . 74.31 109.311 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 64.14 30.55 13.72 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.979 0.912 . . . . 75.12 111.666 -173.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -100.83 162.88 12.6 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 120.726 0.298 . . . . 74.03 110.265 173.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 90.15 -160.74 28.56 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.693 -0.685 . . . . 73.25 111.694 -171.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -89.57 88.93 7.61 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.022 -0.733 . . . . 74.42 109.022 176.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . 0.457 HG21 ' HG2' ' B' ' 124' ' ' PRO . 8.8 pt -71.1 -18.22 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.298 0.57 . . . . 71.45 111.091 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -86.17 -159.85 0.5 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.558 1.143 . . . . 72.54 110.334 174.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.494 ' N ' ' HD3' ' H' ' 304' ' ' PRO . 39.8 mttp 63.12 50.79 1.32 Allowed Pre-proline 0 CA--C 1.577 1.997 0 C-N-CA 124.639 1.175 . . . . 74.43 111.84 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . 0.494 ' HD3' ' N ' ' H' ' 303' ' ' LYS . 64.8 Cg_endo -101.95 6.22 0.51 Allowed 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 123.167 2.578 . . . . 75.43 112.813 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -98.78 157.16 16.47 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.246 1.018 . . . . 72.3 111.772 -170.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . 0.468 HG11 HD22 ' F' ' 291' ' ' LEU . 13.9 m -124.98 110.33 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.593 -0.731 . . . . 74.44 109.557 173.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 14.8 p -66.09 -53.53 37.03 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.012 -0.994 . . . . 74.34 110.092 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . 0.422 ' O ' ' HD3' ' H' ' 310' ' ' PRO . 47.5 t -172.05 150.28 2.49 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.531 1.133 . . . . 75.03 108.656 172.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 309' ' ' THR . . . . . 0.529 HG23 ' HA ' ' C' ' 131' ' ' VAL . 29.5 p -109.58 85.0 3.46 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.636 0.774 . . . . 63.02 109.961 175.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' H' ' 308' ' ' CYS . 37.8 Cg_endo . . . . . 0 C--N 1.38 2.219 0 C-N-CA 123.697 2.932 . . . . 61.3 111.359 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.924 -0.398 . . . . 63.35 109.924 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 p -164.83 97.14 0.74 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.496 1.118 . . . . 73.03 108.179 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.1 158.23 23.52 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.069 0.947 . . . . 75.51 111.402 -172.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 64.11 32.86 12.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.317 1.047 . . . . 72.12 112.703 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -151.45 91.15 1.64 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.945 0.498 . . . . 74.04 110.129 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -167.92 33.5 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 123.596 0.758 . . . . 75.42 110.027 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.563 ' HA ' ' HG2' ' C' ' 143' ' ' GLN . 73.3 m -142.86 -57.34 0.43 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.139 -0.689 . . . . 51.12 109.139 174.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -172.86 4.38 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.992 -1.004 . . . . 74.25 109.891 173.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.491 ' HG3' HG22 ' A' ' 89' ' ' ILE . 54.8 ttm 68.86 133.31 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.319 1.447 . . . . 74.4 111.511 -176.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.8 m -148.85 131.22 15.64 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.164 0.986 . . . . 71.34 108.382 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.484 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 47.5 t80 -137.08 129.07 29.27 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.818 -1.178 . . . . 74.15 107.818 172.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -153.02 119.29 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.074 -0.713 . . . . 73.52 109.074 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.603 HG21 ' HG2' ' C' ' 130' ' ' PRO . 52.8 mt -65.69 133.24 31.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 114.922 -1.036 . . . . 73.44 110.026 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -115.66 -22.32 9.24 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.568 0.747 . . . . 74.23 112.447 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.568 ' HD2' ' HG3' ' H' ' 304' ' ' PRO . 24.6 ttt85 -176.12 122.81 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.192 0.451 . . . . 74.31 111.628 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.43 HD11 ' HG2' ' C' ' 130' ' ' PRO . 1.4 mp -110.11 127.45 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.209 -1.034 . . . . 72.51 108.209 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -158.44 150.69 21.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.014 0.926 . . . . 74.21 110.284 -178.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.479 HG23 ' SG ' ' A' ' 113' ' ' CYS . 82.2 p -76.81 119.02 20.01 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.834 -0.802 . . . . 73.55 108.834 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -81.68 -42.36 20.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 71.44 109.568 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.703 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 15.3 m-20 -136.26 137.31 40.64 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.724 -1.125 . . . . 73.41 109.053 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.3 mt -133.74 142.53 41.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.458 -1.312 . . . . 75.45 107.458 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -150.49 133.93 16.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.849 -0.797 . . . . 70.51 108.849 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.53 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.9 t80 -136.22 132.65 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.564 -1.643 . . . . 65.05 106.564 172.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.42 138.09 42.91 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.622 -0.881 . . . . 74.23 108.622 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.82 79.83 63.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.356 -1.72 . . . . 75.51 106.356 171.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.68 -40.81 76.69 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.297 2.664 . . . . 71.21 113.049 -164.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.37 38.5 3.97 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.748 -0.834 . . . . 74.02 108.748 -177.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.492 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -46.06 -57.63 7.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 117.935 -1.031 . . . . 61.21 113.262 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 28' ' ' ALA . 22.5 Cg_exo -62.79 -20.25 70.67 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 122.073 1.849 . . . . 73.5 113.383 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -94.24 -31.87 13.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.178 0.991 . . . . 74.55 111.049 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.621 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.1 p -78.33 -19.45 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.716 0.807 . . . . 62.35 111.025 -169.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -73.78 -7.52 52.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.744 0.818 . . . . 73.44 111.397 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -98.33 -19.8 17.56 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 72.51 111.003 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -82.03 166.61 19.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.659 0.783 . . . . 72.44 111.546 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.94 149.18 49.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.996 0.918 . . . . 70.52 110.02 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -86.77 62.35 7.35 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.266 0.555 . . . . 75.44 111.948 -168.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -134.34 66.71 71.4 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.007 0.523 . . . . 75.02 111.298 173.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.18 126.65 2.81 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.008 1.805 . . . . 61.22 110.615 167.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -95.54 105.31 17.27 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.459 -0.941 . . . . 72.23 108.459 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.601 HG21 HG13 ' A' ' 64' ' ' VAL . 2.1 p -75.52 129.64 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.278 -1.328 . . . . 74.44 110.218 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -99.92 141.17 33.09 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 74.21 110.089 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -100.65 118.67 37.26 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.954 -1.128 . . . . 64.5 107.954 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.54 145.05 33.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.012 0.525 . . . . 64.13 110.068 170.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.87 141.49 51.27 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.355 -0.979 . . . . 74.45 108.355 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.624 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.9 t70 -119.37 138.0 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.583 -1.266 . . . . 73.12 107.583 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -106.66 138.21 43.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.374 0.669 . . . . 75.41 110.629 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.16 110.45 0.91 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.17 0.588 . . . . 60.14 110.492 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -112.76 159.76 18.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.019 -0.734 . . . . 73.33 109.019 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -154.14 150.42 28.12 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.536 0.734 . . . . 62.21 109.716 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.46 143.45 30.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.403 -0.962 . . . . 73.11 108.403 171.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.591 HD11 ' HB2' ' A' ' 57' ' ' GLU . 28.6 mt -115.94 -43.88 2.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.396 0.679 . . . . 75.33 109.719 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.86 -167.94 2.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.108 -0.951 . . . . 74.31 110.073 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.76 106.41 0.8 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.553 0.741 . . . . 73.51 110.132 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.441 ' HB3' ' HB1' ' A' ' 87' ' ' ALA . 23.9 m-20 67.34 13.87 9.5 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.727 1.211 . . . . 73.45 113.095 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.25 117.14 45.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.379 -0.971 . . . . 74.23 108.379 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 64.0 m-85 -125.06 123.39 39.68 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.512 -0.921 . . . . 73.34 108.512 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' HB2' HD11 ' A' ' 51' ' ' LEU . 27.4 tt0 -88.88 143.11 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.094 -0.957 . . . . 75.2 108.761 173.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.447 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.7 t -119.08 136.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.815 -1.18 . . . . 72.21 107.815 172.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.8 t -127.13 132.38 69.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.065 0.946 . . . . 74.4 108.762 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.533 HD23 HD11 ' A' ' 106' ' ' LEU . 4.5 mm? -119.67 110.09 16.42 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.336 1.055 . . . . 73.25 108.344 175.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.73 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 26.3 ttp180 -83.81 99.55 10.37 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.012 -0.736 . . . . 75.51 109.012 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 117.35 34.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.313 -1.365 . . . . 74.25 107.313 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 m -116.03 122.24 44.6 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.911 0.862 . . . . 74.45 109.544 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.609 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 49.1 t -112.98 120.93 64.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.492 -1.685 . . . . 72.24 108.181 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -121.45 125.95 48.12 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.934 -0.765 . . . . 73.43 108.934 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.94 121.63 38.44 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.97 -1.122 . . . . 75.03 107.97 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -136.93 132.86 35.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.095 0.558 . . . . 70.15 110.344 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.409 HD22 HG21 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -97.24 85.18 3.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.003 0.921 . . . . 72.43 109.166 174.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -90.98 1.54 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-N 114.45 -1.25 . . . . 74.55 110.889 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -122.36 -30.2 4.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.637 0.775 . . . . 75.3 110.423 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.01 131.35 35.78 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.333 -0.617 . . . . 75.13 109.333 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 m -87.01 136.23 32.99 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.232 0.539 . . . . 73.13 111.156 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.621 ' HA ' HG22 ' A' ' 31' ' ' VAL . . . -75.61 -65.22 0.93 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.893 -1.049 . . . . 72.42 109.323 172.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.69 159.28 44.62 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.511 -1.222 . . . . 74.21 111.319 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.9 tp -132.14 115.4 15.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.173 1.389 . . . . 74.23 107.964 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.609 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 67.7 m -105.76 138.28 42.21 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.26 -1.015 . . . . 73.12 108.26 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -146.81 115.39 6.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.28 -1.007 . . . . 65.24 108.28 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.39 110.14 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.448 0.699 . . . . 74.2 109.501 -175.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.73 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 39.5 mt-30 -84.64 83.19 8.1 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.894 -1.15 . . . . 65.21 107.894 169.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.41 ' NE2' HG22 ' A' ' 18' ' ' THR . 8.2 tp-100 -76.22 102.22 5.73 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.443 -1.253 . . . . 63.5 107.884 178.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 156.31 24.77 Favored Glycine 0 C--O 1.243 0.685 0 CA-C-N 115.939 -0.573 . . . . 71.04 111.882 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.3 120.61 1.09 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.503 -1.039 . . . . 71.32 110.503 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.75 125.99 39.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 N-CA-C 108.267 -1.012 . . . . 75.4 108.267 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' CD2' HG12 ' A' ' 13' ' ' ILE . 4.7 m-85 -135.65 144.75 46.22 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.642 -1.244 . . . . 74.13 107.642 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -84.47 93.53 8.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.907 -1.145 . . . . 63.23 107.907 169.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 55.3 mt -100.08 117.92 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 108.56 -0.904 . . . . 73.32 108.56 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 54' ' ' ASP . . . -151.03 158.33 43.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.679 0.791 . . . . 73.41 110.38 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.75 10.13 86.11 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.339 0.399 . . . . 71.33 113.788 171.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.491 HG22 ' HG3' ' A' ' 9' ' ' MET . 1.2 pp -113.26 163.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.967 1.307 . . . . 74.45 110.299 -173.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.56 170.64 6.75 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.296 -1.001 . . . . 73.52 108.296 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.05 -126.53 26.88 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 124.07 0.843 . . . . 74.4 114.947 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -72.97 -22.47 60.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.086 0.955 . . . . 75.14 111.639 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.6 -43.96 65.31 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.926 0.491 . . . . 75.11 110.3 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.4 ttt -71.42 -38.52 71.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.759 -0.655 . . . . 64.14 109.358 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.93 72.93 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.49 -0.777 . . . . 65.35 111.233 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -78.98 -27.03 43.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.861 0.464 . . . . 74.0 110.695 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.1 t -73.95 -66.03 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.161 0.184 . . . . 75.51 110.519 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.65 -17.26 36.58 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.445 0.535 . . . . 73.32 112.445 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.85 1.33 44.97 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.43 -0.65 . . . . 73.45 114.265 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.96 -56.8 0.2 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.885 0.842 . . . . 74.2 113.25 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.484 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.6 t80 -76.04 -59.05 2.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.477 0.711 . . . . 75.13 111.221 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.82 -31.99 4.57 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.913 0.885 . . . . 64.53 113.105 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.54 -49.06 14.01 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.647 2.231 . . . . 74.13 113.192 160.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -68.67 -26.53 65.36 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.574 0.75 . . . . 74.23 110.437 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.405 HG23 HD13 ' A' ' 13' ' ' ILE . 35.9 mm -69.62 -42.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.194 0.597 . . . . 73.25 110.196 172.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.533 HD11 HD23 ' A' ' 60' ' ' LEU . 96.7 mt -80.75 -17.42 51.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.733 0.813 . . . . 75.41 111.568 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.85 -45.8 65.17 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 118.075 -0.964 . . . . 72.44 113.277 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.25 -30.91 64.21 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.986 1.791 . . . . 70.41 112.616 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -78.89 -36.46 42.07 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.423 0.689 . . . . 73.1 111.356 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.53 74.67 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.853 -0.795 . . . . 72.22 108.853 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -51.25 -50.31 59.46 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 125.098 1.499 . . . . 74.02 110.757 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -72.81 -37.63 67.44 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.197 0.936 . . . . 72.3 111.106 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.479 ' SG ' HG23 ' A' ' 18' ' ' THR . 41.8 t -62.9 -35.89 81.52 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.08 0.467 . . . . 71.55 110.651 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 97.0 mt -68.13 -52.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.333 -0.849 . . . . 71.33 109.527 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.448 HG21 ' HG3' ' A' ' 125' ' ' GLN . 92.6 m -52.25 -44.8 65.08 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.775 1.23 . . . . 71.0 111.422 -174.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -66.42 -45.8 78.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.412 -1.267 . . . . 74.2 110.546 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.53 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.3 mtm -61.91 -41.16 97.59 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.789 0.436 . . . . 72.53 111.147 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.4 t -58.5 -49.46 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.227 1.011 . . . . 73.4 110.334 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -69.14 -27.45 65.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.847 0.459 . . . . 75.23 111.383 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.1 mtt-85 -73.61 -20.75 60.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.717 0.807 . . . . 74.44 110.837 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.95 10.83 64.18 Favored Glycine 0 C--N 1.354 1.568 0 CA-C-O 119.676 -0.513 . . . . 73.45 113.539 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m 56.94 32.74 22.08 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.171 1.389 . . . . 73.11 110.646 -173.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -99.09 153.85 37.59 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-N 114.897 -1.047 . . . . 75.13 109.097 173.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.456 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 36.4 Cg_endo -62.47 144.97 95.54 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.365 2.043 . . . . 72.31 110.944 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.448 ' HG3' HG21 ' A' ' 115' ' ' THR . 35.1 tt0 -55.05 130.13 40.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.864 0.728 . . . . 75.14 111.298 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.4 tp -111.51 102.71 11.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.03 0.932 . . . . 71.34 109.516 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.36 102.63 14.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.753 -1.203 . . . . 70.22 107.753 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.65 116.97 6.17 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 107.765 -1.198 . . . . 63.14 107.765 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.61 135.92 94.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.428 0.691 . . . . 70.2 112.241 -172.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.24 137.81 49.01 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.763 2.308 . . . . 64.41 112.983 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.94 134.7 65.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.033 0.933 . . . . 74.54 109.258 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.625 ' HB2' ' HB2' ' A' ' 135' ' ' ALA . 15.9 p-10 -84.01 77.61 9.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.201 1.0 . . . . 71.3 110.908 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -66.59 -40.79 89.06 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.45 0.643 . . . . 73.41 109.932 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.548 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 11.3 p-10 -61.28 -40.75 95.26 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.036 1.334 . . . . 71.54 111.69 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.625 ' HB2' ' HB2' ' A' ' 132' ' ' ASN . . . -79.11 -34.64 43.25 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.844 0.858 . . . . 74.1 110.582 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.3 tt -53.12 -48.47 67.84 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.962 0.905 . . . . 75.31 110.285 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -60.36 -42.76 96.42 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.095 -0.957 . . . . 75.23 111.734 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 mmt -73.07 -33.76 65.84 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 112.691 0.626 . . . . 72.34 112.691 -175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -61.82 -31.41 71.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.462 0.705 . . . . 74.1 110.247 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -88.43 -37.44 15.85 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.029 -0.987 . . . . 74.31 110.814 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.6 tp -68.84 -49.68 56.35 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.277 0.631 . . . . 72.2 111.927 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -157.52 14.39 0.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.902 -0.59 . . . . 70.13 111.55 -172.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 68.75 -72.75 0.1 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.866 1.266 . . . . 72.14 110.211 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 71.99 127.0 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.835 1.254 . . . . 74.1 110.298 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.9 143.5 14.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.158 0.583 . . . . 74.51 109.804 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.34 153.99 15.43 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.942 -0.463 . . . . 71.21 111.942 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -123.42 -172.44 2.51 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.217 1.007 . . . . 61.11 110.629 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.66 93.09 0.19 Allowed Glycine 0 C--N 1.348 1.213 0 N-CA-C 110.332 -1.107 . . . . 64.3 110.332 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.3 p -139.07 107.41 5.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.175 0.99 . . . . 73.23 110.502 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.02 -36.21 64.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.684 0.794 . . . . 74.53 109.981 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 75.67 15.18 2.67 Favored 'General case' 0 C--N 1.367 1.369 0 O-C-N 125.35 1.656 . . . . 72.22 110.338 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -87.7 85.66 7.09 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.058 0.943 . . . . 64.25 110.42 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -174.96 99.37 0.08 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.582 1.153 . . . . 72.33 108.956 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.63 132.01 35.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.17 0.988 . . . . 61.44 110.161 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.458 ' HA ' HD21 ' F' ' 285' ' ' ASN . . . . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.461 0.704 . . . . 75.43 110.363 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.795 -0.446 . . . . 75.14 109.795 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 33.2 t -166.18 94.5 0.55 Allowed 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.114 -1.069 . . . . 63.3 108.114 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -77.65 78.82 4.16 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.746 0.784 . . . . 73.23 109.237 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -135.09 28.74 3.44 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.88 -1.055 . . . . 75.13 110.109 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -77.1 83.23 3.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.985 -0.746 . . . . 74.21 108.985 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -175.51 98.66 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.093 -1.077 . . . . 74.25 108.093 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -146.15 94.38 2.46 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.869 0.842 . . . . 72.25 110.683 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -167.69 -59.35 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.845 -1.168 . . . . 72.15 107.845 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.45 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 5.0 ptt? 53.62 -171.67 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.239 1.816 . . . . 74.3 113.352 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m -154.97 132.15 11.0 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.394 -1.336 . . . . 74.41 107.394 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -140.62 135.72 32.01 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.314 0.646 . . . . 74.24 109.314 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' E' ' 308' ' ' CYS . 3.1 mm-40 -152.99 140.59 19.86 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.146 0.903 . . . . 72.24 109.708 167.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.451 ' O ' ' HB ' ' E' ' 306' ' ' VAL . 2.4 pp -80.51 140.21 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.333 -1.358 . . . . 75.24 107.333 169.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -98.02 -44.32 6.7 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.071 -0.714 . . . . 72.55 109.071 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -164.41 138.67 5.42 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.331 -0.85 . . . . 74.45 109.28 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.77 137.22 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 106.344 -1.724 . . . . 75.12 106.344 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -166.08 161.64 17.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.414 0.626 . . . . 74.44 111.88 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.9 m -90.24 117.66 29.16 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.017 -0.992 . . . . 71.31 108.818 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -87.67 -27.91 22.15 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.453 -0.794 . . . . 75.23 111.056 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -159.81 143.69 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.411 0.444 . . . . 73.32 111.928 -174.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . 0.8 HD12 ' SG ' ' B' ' 113' ' ' CYS . 44.9 mm -134.63 143.46 37.68 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 125.286 1.435 . . . . 74.13 109.055 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' SER . . . . . 0.512 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -144.37 130.53 19.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.757 -1.201 . . . . 53.43 107.757 173.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -145.59 114.45 6.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.352 -1.351 . . . . 71.03 107.352 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.1 mt-10 -118.78 137.51 53.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.131 0.572 . . . . 72.41 109.673 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . 0.491 ' CB ' ' HB1' ' B' ' 28' ' ' ALA . . . -129.34 78.69 75.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.814 -1.18 . . . . 74.45 107.814 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.4 -18.24 38.78 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.471 2.781 . . . . 65.44 113.448 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -126.81 12.88 7.36 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.315 1.446 . . . . 71.0 110.739 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . 0.491 ' HB1' ' CB ' ' B' ' 25' ' ' ALA . . . -44.71 -57.18 7.19 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 115.817 1.784 . . . . 75.44 115.817 -165.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -66.01 -26.8 50.63 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.528 2.152 . . . . 74.45 112.336 -173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.457 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.9 m80 -91.46 -43.79 9.5 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.129 -0.941 . . . . 71.32 111.465 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.7 -26.37 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.244 0.618 . . . . 73.03 112.389 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . 0.533 ' HA ' HG23 ' H' ' 301' ' ' ILE . 21.9 m-30 -58.8 -24.01 61.23 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.026 0.93 . . . . 75.23 113.029 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.635 ' HA ' ' HE2' ' H' ' 303' ' ' LYS . 24.2 pt20 -76.47 -6.52 52.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.224 0.61 . . . . 71.2 112.424 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.677 ' HG2' ' HB2' ' C' ' 153' ' ' GLN . 31.0 mtpt -103.93 109.49 21.26 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.162 -0.681 . . . . 74.44 109.162 -177.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -95.46 96.93 9.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.266 0.469 . . . . 74.55 112.266 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.18 177.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.18 1.392 . . . . 74.23 110.511 162.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -78.7 138.03 58.36 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.121 0.968 . . . . 75.14 112.082 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . 0.403 ' HA ' ' HB3' ' B' ' 68' ' ' LEU . 78.2 Cg_endo -84.41 158.3 12.72 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.796 2.33 . . . . 73.01 112.881 167.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.49 128.2 35.23 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.813 -1.18 . . . . 74.22 107.813 162.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.9 t -108.48 131.72 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.302 0.641 . . . . 74.25 109.891 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.74 135.6 46.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.603 1.161 . . . . 74.23 109.194 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -109.16 125.62 52.38 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.222 1.009 . . . . 72.54 108.331 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -141.01 118.55 11.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.217 0.607 . . . . 61.12 109.368 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 pp -99.75 165.31 11.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.789 -0.449 . . . . 63.42 109.789 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.555 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -146.82 136.52 23.1 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.805 1.242 . . . . 71.13 108.095 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -120.93 105.54 10.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.609 0.764 . . . . 65.21 111.189 -167.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.19 155.27 31.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.861 0.864 . . . . 72.21 109.984 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.2 p -146.85 169.04 19.95 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.272 1.029 . . . . 73.24 109.885 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -153.46 137.63 16.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.308 0.643 . . . . 63.01 109.523 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -83.54 111.69 19.31 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.716 -0.476 . . . . 71.45 109.716 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.24 -45.78 13.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.689 0.618 . . . . 74.23 110.257 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 -168.01 2.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.218 -0.901 . . . . 60.32 110.701 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.01 108.32 3.03 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.997 -1.001 . . . . 72.43 109.883 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.8 11.11 7.37 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.945 1.298 . . . . 72.14 112.641 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.42 113.63 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.646 -0.872 . . . . 74.5 108.646 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.92 139.87 53.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.438 0.695 . . . . 74.02 109.522 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -101.78 106.39 17.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.528 -1.286 . . . . 74.43 107.528 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.19 123.6 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.256 1.022 . . . . 73.42 110.213 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -103.39 113.47 40.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.003 0.921 . . . . 75.01 109.496 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.61 100.02 10.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.614 -1.254 . . . . 75.52 107.614 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.555 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.7 ttm180 -85.3 128.18 34.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.116 -0.698 . . . . 71.43 109.116 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.26 106.13 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.1 -1.074 . . . . 73.42 108.1 172.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -98.55 126.72 44.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.522 0.729 . . . . 75.52 109.375 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . 0.628 HG22 HG21 ' B' ' 114' ' ' ILE . 93.7 t -118.33 116.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.889 -1.05 . . . . 75.43 108.575 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.7 m -116.32 140.48 49.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.653 -0.869 . . . . 75.23 108.653 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.92 142.73 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.81 -1.181 . . . . 75.05 107.81 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 38.9 p -150.31 141.96 23.59 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.074 0.55 . . . . 74.15 110.64 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.517 ' HG ' ' HB1' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -138.1 136.53 36.84 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.223 1.009 . . . . 71.22 110.534 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.4 -124.1 26.68 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.766 -0.652 . . . . 63.25 112.455 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -96.98 2.91 52.11 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.328 1.051 . . . . 74.33 111.066 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.65 -179.87 7.45 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.469 0.544 . . . . 71.12 112.469 -167.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -73.29 154.67 40.06 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.518 1.127 . . . . 53.2 111.235 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.517 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -97.77 -57.8 2.15 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.052 -1.092 . . . . 52.21 108.052 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -160.28 161.41 33.36 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.492 -1.231 . . . . 73.13 109.674 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.46 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 50.7 mt -116.95 131.34 56.98 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.273 -1.38 . . . . 75.34 107.273 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.09 150.46 39.54 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.09 -0.707 . . . . 75.35 109.09 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 45.0 tt0 -164.55 133.71 3.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.66 0.784 . . . . 75.33 108.975 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.3 t -130.61 145.7 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.276 1.03 . . . . 71.34 108.289 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -121.87 95.68 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.668 -1.234 . . . . 74.23 107.668 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.6 tp-100 -90.4 99.69 12.67 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.28 -1.007 . . . . 74.25 108.28 177.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 165.49 32.14 Favored Glycine 0 C--O 1.242 0.631 0 N-CA-C 111.165 -0.774 . . . . 72.42 111.165 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.51 127.18 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.025 -0.83 . . . . 42.41 111.025 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.58 129.09 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.961 -1.125 . . . . 63.41 107.961 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -133.02 134.79 44.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.074 0.95 . . . . 75.03 109.084 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.8 m -99.36 105.15 17.09 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 64.14 107.75 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.476 HD12 HD13 ' B' ' 89' ' ' ILE . 29.9 pt -119.75 142.88 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.631 0.772 . . . . 74.03 110.065 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.58 161.12 41.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.757 0.823 . . . . 64.45 109.984 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . 0.45 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 89.49 -54.43 3.83 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 123.647 0.592 . . . . 74.11 112.13 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.476 HD13 HD12 ' B' ' 86' ' ' ILE . 28.6 pt -54.44 145.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.531 1.132 . . . . 71.5 112.026 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -165.99 152.5 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.553 0.533 . . . . 73.31 110.485 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.95 -128.29 34.19 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.869 0.73 . . . . 44.35 114.058 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.6 m -69.25 -29.94 67.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.726 0.811 . . . . 74.32 110.77 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.65 -26.81 58.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.919 0.888 . . . . 74.11 110.392 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 35.3 ttm -62.71 -32.96 74.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.826 0.85 . . . . 71.54 110.422 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . 0.448 ' HB3' HD22 ' H' ' 280' ' ' LEU . . . -64.77 -29.01 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.96 0.904 . . . . 72.15 112.608 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . 0.458 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 51.4 t-80 -69.07 -26.55 65.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.522 0.329 . . . . 74.34 110.773 175.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -80.94 -63.17 1.46 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.179 -0.304 . . . . 72.02 110.179 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.493 HD21 ' HB2' ' H' ' 281' ' ' PHE . 3.5 pp -67.12 -31.66 72.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.656 0.613 . . . . 74.3 112.656 -172.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . 0.473 ' N ' HD11 ' B' ' 98' ' ' LEU . . . -108.32 3.08 32.94 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 119.718 -0.49 . . . . 61.42 114.284 -171.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . 0.458 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -144.16 -57.64 0.38 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.377 0.588 . . . . 63.53 111.7 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.38 -53.75 11.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.312 0.645 . . . . 73.43 111.459 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 68.0 m -64.28 -45.05 78.27 Favored Pre-proline 0 CA--C 1.565 1.522 0 C-N-CA 123.956 0.903 . . . . 64.33 111.601 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.7 Cg_exo -55.6 -39.96 88.09 Favored 'Trans proline' 0 C--N 1.402 3.348 0 C-N-CA 122.649 2.233 . . . . 74.21 113.236 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -58.4 -29.17 65.86 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 123.579 0.752 . . . . 61.44 111.29 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . 0.405 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 73.1 mt -80.54 -53.42 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.786 0.834 . . . . 74.4 110.886 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.48 -24.54 56.95 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.367 0.667 . . . . 73.41 112.545 -170.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -63.53 -48.15 81.71 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.913 -1.041 . . . . 65.13 112.893 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.405 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 84.7 Cg_exo -51.9 -43.09 54.3 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.455 2.103 . . . . 71.05 113.966 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.464 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 86.7 m-85 -67.1 -47.43 71.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.348 0.659 . . . . 75.25 110.888 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . 0.53 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.09 -48.27 80.67 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.813 0.696 . . . . 72.32 110.127 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -51.85 -52.27 50.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.806 1.642 . . . . 73.44 111.628 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.39 -35.0 78.43 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 123.657 0.598 . . . . 63.03 109.727 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.8 ' SG ' HD12 ' B' ' 21' ' ' ILE . 1.8 t -68.08 -31.0 70.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 122.93 0.492 . . . . 72.33 111.527 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . 0.628 HG21 HG22 ' B' ' 64' ' ' VAL . 53.7 mt -70.14 -55.25 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.562 -0.903 . . . . 74.32 108.562 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -54.93 -33.91 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.88 1.363 . . . . 65.21 111.628 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' SER . . . . . 0.422 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -63.35 -51.56 65.4 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.398 -0.819 . . . . 71.33 109.552 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.76 -34.17 69.26 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.786 0.679 . . . . 75.2 111.318 -174.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . 0.434 HG22 HD21 ' B' ' 126' ' ' LEU . 85.0 t -62.64 -44.73 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.879 0.872 . . . . 74.11 110.011 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.8 t -68.6 -35.28 77.13 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.179 -0.919 . . . . 71.21 110.634 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.59 -29.42 69.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.026 0.53 . . . . 65.24 110.326 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.7 18.28 35.38 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.967 0.792 . . . . 74.12 112.629 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 35.5 p 54.51 44.98 27.94 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.876 1.67 . . . . 65.23 112.881 176.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -112.78 147.32 36.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.403 0.681 . . . . 73.12 109.709 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -70.01 -165.63 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.41 2.74 . . . . 64.45 113.954 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -61.27 129.56 41.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.967 1.099 . . . . 71.22 113.967 -163.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . 0.564 ' HB2' HG21 ' H' ' 296' ' ' THR . 27.5 tp -136.3 118.35 15.37 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.609 1.163 . . . . 74.51 108.951 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -134.5 134.48 41.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.157 -1.053 . . . . 74.54 108.157 166.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.58 148.17 24.98 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.928 0.394 . . . . 74.34 111.342 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.07 147.94 55.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.204 1.002 . . . . 54.21 112.352 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . 0.449 ' HG3' ' CD1' ' D' ' 16' ' ' ILE . 85.0 Cg_endo -75.82 79.78 2.77 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.53 2.82 . . . . 75.13 111.306 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 58.4 t -88.99 111.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.781 -1.192 . . . . 74.54 107.781 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' B' ' 134' ' ' ASP . 5.8 t30 -71.54 94.52 1.31 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 124.162 0.914 . . . . 75.05 109.341 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -62.65 -27.46 69.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.091 0.956 . . . . 74.03 111.391 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . 0.449 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . 2.6 m-20 -58.45 -44.26 89.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.624 1.169 . . . . 53.31 109.683 175.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.92 76.72 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.737 -1.119 . . . . 75.23 110.658 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 82.9 mt -60.81 -36.92 80.29 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.535 0.734 . . . . 75.43 111.772 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -85.32 -46.82 10.62 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.221 -0.445 . . . . 71.1 111.04 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.92 -33.24 75.37 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.711 0.404 . . . . 73.31 111.971 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -75.81 -22.31 56.48 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.359 0.663 . . . . 72.1 111.779 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -65.63 -37.46 86.63 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.785 0.802 . . . . 70.33 109.535 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.11 6.48 48.43 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.345 -1.298 . . . . 74.34 110.414 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 69.58 112.34 0.05 OUTLIER 'General case' 0 C--N 1.363 1.163 0 C-N-CA 125.107 1.363 . . . . 73.11 109.569 -168.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -67.49 124.94 24.6 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.143 0.577 . . . . 72.33 110.936 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -104.46 130.02 52.4 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.195 -1.039 . . . . 73.24 108.195 167.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.52 -73.92 0.56 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.983 0.513 . . . . 75.51 109.752 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.91 61.64 3.94 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.477 -0.649 . . . . 75.21 111.477 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.84 117.85 13.94 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.525 0.73 . . . . 73.33 109.74 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.75 121.96 3.41 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.904 -0.479 . . . . 75.24 111.904 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 31.6 p -107.05 95.87 6.03 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.579 0.752 . . . . 74.44 109.708 177.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -83.39 146.56 28.39 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.806 -0.633 . . . . 71.04 110.179 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . 0.734 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 47.2 mt-10 -140.77 95.94 2.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.109 0.964 . . . . 63.31 108.897 174.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -104.69 130.93 52.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.065 0.546 . . . . 73.31 109.675 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.91 84.04 2.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.453 0.701 . . . . 72.45 109.825 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -163.78 -170.23 2.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.707 0.803 . . . . 74.11 109.717 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.595 0.758 . . . . 72.44 109.187 -178.486 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 111.744 0.275 . . . . 75.45 111.744 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -63.98 111.02 2.32 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.126 0.571 . . . . 54.43 109.635 177.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -130.63 151.16 51.39 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.586 0.754 . . . . 65.33 109.673 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -60.12 135.86 57.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.616 0.766 . . . . 73.45 110.659 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -148.34 -66.45 0.24 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.207 0.603 . . . . 73.45 109.65 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -87.48 67.45 9.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.826 0.822 . . . . 74.43 110.219 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -156.1 81.82 1.0 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.332 -1.359 . . . . 72.04 107.332 175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.72 150.31 27.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.253 -0.885 . . . . 74.33 109.235 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.491 ' HE2' HG21 ' C' ' 89' ' ' ILE . 41.0 ttm 65.24 113.52 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.977 1.311 . . . . 72.55 111.703 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.2 m -89.82 79.57 6.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.486 -0.931 . . . . 73.34 108.486 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -90.78 120.88 32.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . 0.632 ' HB2' ' HB ' ' G' ' 306' ' ' VAL . 12.5 pt20 -146.14 125.7 13.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.292 0.637 . . . . 74.22 109.594 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.29 138.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.433 -0.803 . . . . 72.3 110.395 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.86 -51.65 3.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.02 -0.363 . . . . 73.54 110.02 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -172.22 129.81 0.59 Allowed 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.276 0.36 . . . . 74.52 110.466 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.347 -0.982 . . . . 73.43 108.347 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . 0.421 ' HE1' HG12 ' C' ' 83' ' ' ILE . 39.9 p90 -173.32 172.5 3.76 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.428 0.632 . . . . 74.34 111.417 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -92.16 114.95 27.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.647 -0.706 . . . . 73.33 110.103 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -64.48 -38.41 90.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.033 -0.728 . . . . 74.51 109.033 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.7 t70 -153.73 148.14 26.04 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.571 -1.195 . . . . 74.23 110.043 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.529 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -136.15 143.26 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 105.606 -1.998 . . . . 73.25 105.606 171.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -156.18 150.1 25.16 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.391 0.615 . . . . 63.31 109.868 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -152.59 118.19 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.481 -1.303 . . . . 71.45 107.481 173.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -115.44 139.43 50.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.655 -1.239 . . . . 75.42 107.655 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 84.25 53.48 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.66 -1.237 . . . . 75.1 107.66 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.32 -45.09 28.77 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.101 2.534 . . . . 74.35 112.226 -176.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.27 50.73 0.79 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.591 -0.892 . . . . 72.21 108.591 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.531 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -55.73 -48.15 97.17 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 115.518 -0.764 . . . . 73.23 112.832 -175.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' C' ' 28' ' ' ALA . 1.9 Cg_endo -85.91 -33.7 0.2 Allowed 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.929 1.752 . . . . 74.02 112.836 169.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . 0.402 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 55.8 t60 -70.23 -33.52 71.75 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.657 0.984 . . . . 72.05 113.657 -167.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -79.44 -14.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 122.815 0.446 . . . . 75.02 111.224 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -71.31 -14.91 62.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.624 0.77 . . . . 74.04 111.601 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.1 pt20 -105.14 12.51 31.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.525 0.73 . . . . 63.13 110.824 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.471 ' HZ1' ' HG2' ' C' ' 71' ' ' GLU . 1.1 mptm? -97.45 176.71 5.77 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.021 0.915 . . . . 73.55 112.994 -170.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -87.91 128.5 35.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.384 -1.735 . . . . 72.03 108.938 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.648 0.592 . . . . 73.44 111.206 -168.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -148.24 58.89 4.06 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.247 0.619 . . . . 53.42 110.319 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.37 123.31 10.1 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.767 2.311 . . . . 64.54 112.387 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.98 77.57 8.42 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.551 -1.648 . . . . 64.43 106.551 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -73.83 97.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.838 -1.074 . . . . 72.41 108.4 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -93.49 122.08 35.55 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.95 -1.023 . . . . 74.31 109.01 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.31 121.51 28.98 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.308 -1.368 . . . . 74.43 107.308 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.527 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.0 t70 -121.85 135.43 54.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.691 -1.225 . . . . 74.03 107.691 176.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tt -137.21 120.12 16.43 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.335 -0.987 . . . . 71.23 108.335 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.554 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 5.6 t70 -113.46 148.11 36.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.056 0.942 . . . . 75.14 108.71 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 46' ' ' THR . . . . . 0.471 ' HB ' ' CG ' ' F' ' 281' ' ' PHE . 62.0 p -117.19 118.85 33.46 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.212 -0.904 . . . . 75.45 109.753 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . 0.535 ' HB1' ' HB ' ' C' ' 59' ' ' VAL . . . -124.37 146.6 48.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.0 0.92 . . . . 70.14 109.5 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.6 p -151.48 157.4 42.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.687 0.395 . . . . 75.21 110.584 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 49' ' ' SER . . . . . 0.483 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 20.0 m -143.81 147.53 34.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.133 0.973 . . . . 71.14 108.635 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -101.93 115.76 31.23 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.953 -1.129 . . . . 74.34 107.953 168.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.648 HD12 ' HB2' ' C' ' 57' ' ' GLU . 28.5 mt -98.18 -27.6 14.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.324 0.65 . . . . 75.04 110.034 -175.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.72 -171.38 1.83 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.242 1.017 . . . . 70.32 110.334 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.51 124.76 25.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.254 -0.884 . . . . 74.52 109.237 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 69.85 -8.88 0.75 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.878 1.671 . . . . 74.41 112.728 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.91 112.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.407 -0.59 . . . . 64.31 109.407 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -127.54 126.08 41.52 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.476 1.11 . . . . 63.44 108.685 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.648 ' HB2' HD12 ' C' ' 51' ' ' LEU . 38.4 tt0 -82.52 118.53 23.33 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.809 0.843 . . . . 75.33 108.745 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.15 114.75 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.952 -1.129 . . . . 60.22 107.952 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' C' ' 47' ' ' ALA . 43.6 t -110.64 131.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.071 -0.714 . . . . 73.34 109.071 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 36.2 tp -111.97 103.14 11.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.971 -1.122 . . . . 74.02 107.971 178.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.554 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 55.1 ttm-85 -81.32 115.36 20.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.883 -1.154 . . . . 71.41 107.883 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . 0.467 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -116.73 108.74 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.905 -1.146 . . . . 75.43 107.905 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.527 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.1 m -116.02 124.37 50.29 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.834 0.854 . . . . 71.12 108.755 -174.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 56.2 t -117.8 113.71 43.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.846 -0.798 . . . . 73.31 108.846 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -100.88 146.84 26.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.595 -0.73 . . . . 72.13 109.343 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.66 13.06 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.132 -0.692 . . . . 74.24 109.132 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -131.63 126.28 34.32 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.841 -0.799 . . . . 73.52 108.841 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.504 HD13 ' HB3' ' C' ' 73' ' ' ALA . 9.2 mp -84.56 57.32 4.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.894 0.878 . . . . 72.43 109.399 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.1 -114.03 4.2 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.072 -1.211 . . . . 73.52 110.072 -174.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -90.8 -22.83 20.83 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.87 0.868 . . . . 62.54 110.322 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . 0.471 ' HG2' ' HZ1' ' C' ' 34' ' ' LYS . 7.3 tp10 -87.87 117.83 26.98 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.433 0.693 . . . . 70.12 110.844 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -76.23 128.05 34.13 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.006 0.431 . . . . 73.33 110.647 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . 0.504 ' HB3' HD13 ' C' ' 68' ' ' LEU . . . -77.32 -60.45 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.792 -1.094 . . . . 72.1 109.422 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.11 176.47 12.21 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.88 -1.055 . . . . 72.32 110.58 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -140.98 120.86 13.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 106.357 -1.72 . . . . 73.52 106.357 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 48.9 t -117.01 119.89 36.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.439 -0.949 . . . . 72.02 108.439 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.69 141.71 51.53 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.72 -0.844 . . . . 70.31 108.72 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -147.41 115.14 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.444 1.098 . . . . 73.41 108.823 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.1 mt-30 -89.41 97.84 11.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.988 -1.115 . . . . 71.15 107.988 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -88.97 100.86 13.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.719 -0.673 . . . . 72.14 109.328 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.21 147.24 18.5 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.146 -0.479 . . . . 71.1 112.366 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.38 125.57 2.37 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 111.008 -0.837 . . . . 75.21 111.008 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.578 HD11 ' HB3' ' D' ' 29' ' ' PRO . 13.4 mm -81.76 122.66 37.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.765 -0.828 . . . . 74.43 108.765 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.54 138.17 45.93 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.3 p -109.34 106.17 15.86 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.933 -0.765 . . . . 71.21 108.933 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.46 142.24 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.856 0.863 . . . . 72.45 110.709 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.8 163.18 35.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.942 0.897 . . . . 72.35 110.406 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.82 -21.13 34.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.833 -0.621 . . . . 64.51 113.406 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . 0.491 HG21 ' HE2' ' C' ' 9' ' ' MET . 36.4 pt -114.18 148.16 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.063 0.945 . . . . 71.41 109.914 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . 0.512 ' HG3' ' HA ' ' F' ' 277' ' ' LEU . 35.6 tt0 -160.22 148.19 16.61 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.494 0.497 . . . . 74.44 110.099 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.51 -112.66 4.49 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 124.293 0.996 . . . . 72.22 113.543 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -64.69 -37.22 86.85 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.062 0.945 . . . . 72.44 111.775 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.88 -46.73 77.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.135 0.574 . . . . 73.3 110.937 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.431 ' HE3' HD22 ' C' ' 98' ' ' LEU . 3.1 ppp? -74.53 -20.97 59.76 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.509 -0.769 . . . . 72.44 110.146 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.66 72.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.408 0.683 . . . . 72.43 111.074 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -68.18 -46.86 69.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.247 -0.433 . . . . 74.32 110.596 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.98 -56.56 9.62 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.141 -0.481 . . . . 64.02 110.376 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . 0.431 HD22 ' HE3' ' C' ' 94' ' ' MET . 54.7 tp -64.02 -40.43 96.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.449 1.1 . . . . 65.23 111.894 -174.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.93 70.42 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.481 -0.622 . . . . 70.04 114.415 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -149.87 -59.76 0.2 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.808 0.804 . . . . 73.12 111.988 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -75.0 -50.93 14.91 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.244 -0.435 . . . . 74.42 112.008 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.66 -45.76 97.09 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.577 0.751 . . . . 63.45 112.95 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -67.65 -24.72 41.11 Favored 'Trans proline' 0 C--N 1.393 2.875 0 C-N-CA 121.983 1.788 . . . . 74.32 112.882 174.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.47 -40.49 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.257 0.623 . . . . 73.31 109.392 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.08 -46.76 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.634 -0.712 . . . . 74.34 110.195 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.07 -20.84 44.23 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.27 -0.877 . . . . 70.41 112.226 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.9 -54.74 48.78 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.109 -0.948 . . . . 73.55 113.538 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.49 -31.52 71.53 Favored 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.994 1.796 . . . . 63.22 112.972 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -66.1 -45.38 81.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.524 0.73 . . . . 72.35 110.756 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.13 -37.78 86.54 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.852 -0.613 . . . . 74.04 110.439 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -60.56 -54.11 49.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.298 1.439 . . . . 74.12 111.425 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -35.39 80.28 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.608 0.568 . . . . 74.12 110.172 -177.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.09 -38.87 86.46 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.079 0.552 . . . . 74.14 111.822 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.467 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -67.76 -50.94 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.436 0.694 . . . . 74.21 110.169 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.4 m -63.14 -28.79 70.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.368 0.667 . . . . 73.45 111.311 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.6 t -67.58 -47.85 68.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.18 -0.674 . . . . 62.23 109.18 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.541 ' HG3' HD12 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.45 -37.67 86.82 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.961 0.904 . . . . 75.41 112.325 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.52 -40.58 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.049 0.539 . . . . 74.3 109.918 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.33 -33.96 76.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.651 0.78 . . . . 75.24 111.229 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.493 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 71.4 mtt-85 -70.48 -27.11 63.96 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.9 0.88 . . . . 75.24 110.901 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.24 15.01 62.13 Favored Glycine 0 C--N 1.352 1.45 0 O-C-N 123.63 0.581 . . . . 54.41 112.817 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.527 HG22 ' HB3' ' D' ' 17' ' ' TYR . 49.6 p 55.0 26.39 7.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.901 1.681 . . . . 71.44 112.638 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -103.46 141.86 23.38 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 124.425 1.09 . . . . 73.01 108.887 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -40.6 111.77 0.16 Allowed 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 124.148 3.232 . . . . 75.15 113.893 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -57.23 123.67 16.13 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.148 0.905 . . . . 75.32 111.268 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . 0.469 HD12 ' HH2' ' F' ' 290' ' ' TRP . 3.1 tm? -112.36 110.75 21.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.128 -1.064 . . . . 73.54 108.128 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -94.97 117.38 30.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.635 -0.876 . . . . 71.33 108.635 175.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.55 142.25 53.66 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.516 0.51 . . . . 75.33 110.268 175.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.2 160.84 81.73 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 115.099 -0.955 . . . . 63.32 111.065 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.603 ' HG2' HG21 ' A' ' 13' ' ' ILE . 26.0 Cg_exo -59.76 100.73 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.65 2.233 . . . . 72.33 112.455 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . 0.42 HG13 HG23 ' F' ' 288' ' ' VAL . 61.2 t -98.85 107.12 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.399 -0.963 . . . . 74.01 108.399 175.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -114.34 106.25 14.09 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.232 1.013 . . . . 74.33 108.559 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . 0.566 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 51.1 m-85 -63.91 -30.64 71.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.731 0.812 . . . . 72.43 111.429 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.43 -50.57 73.42 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.849 0.86 . . . . 74.1 110.515 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.46 87.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.213 -0.903 . . . . 72.43 110.693 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.12 -41.37 96.58 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.199 1.0 . . . . 74.3 110.401 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -64.05 -33.4 75.67 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.352 0.661 . . . . 74.53 111.333 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 62.3 mtt -77.71 -45.37 24.97 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.228 0.611 . . . . 74.15 111.046 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -59.69 -33.74 71.97 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.198 0.999 . . . . 74.54 111.766 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -29.54 -82.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.112 1.765 . . . . 65.12 112.548 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 50.1 tp -107.21 87.47 2.51 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.417 -0.586 . . . . 75.13 109.417 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -145.73 -168.85 3.09 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.7 1.2 . . . . 71.51 109.261 172.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . 0.563 ' HG2' ' HA ' ' A' ' 7' ' ' THR . 30.1 tp60 -117.34 131.29 56.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.062 0.945 . . . . 74.43 109.66 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -118.97 127.34 53.38 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.953 0.901 . . . . 75.52 109.577 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.85 -70.82 0.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.184 0.593 . . . . 70.52 109.797 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.15 176.94 40.65 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 116.153 -0.476 . . . . 64.13 112.117 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.96 -65.67 1.12 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.529 0.732 . . . . 75.33 111.386 -172.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 142.62 -145.97 16.47 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.335 -0.848 . . . . 64.51 111.327 -173.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 99.8 m -148.96 150.13 32.35 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.398 1.079 . . . . 73.4 108.464 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -172.86 0.99 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 122.98 0.512 . . . . 70.54 110.723 174.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . 0.451 ' HG2' ' H ' ' C' ' 152' ' ' HIS . 23.0 tt0 -133.44 -174.96 3.65 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.887 -0.783 . . . . 72.23 108.887 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . 0.451 ' H ' ' HG2' ' C' ' 151' ' ' GLU . 8.2 p80 -152.04 138.41 18.5 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.12 0.418 . . . . 55.23 111.642 -177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . 0.677 ' HB2' ' HG2' ' B' ' 34' ' ' LYS . 90.2 mt-30 -114.76 118.54 33.88 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.021 -1.103 . . . . 75.21 108.021 169.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -97.84 120.67 38.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.627 0.771 . . . . 74.23 109.646 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 C-N-CA 123.505 0.722 . . . . 74.53 109.227 176.124 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.951 -0.389 . . . . 55.3 109.951 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -163.86 86.76 0.5 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.273 -1.01 . . . . 75.22 108.273 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.98 63.21 6.95 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.171 0.986 . . . . 74.04 111.192 -175.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -138.71 118.04 12.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.335 1.054 . . . . 75.31 109.044 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -149.68 84.02 1.41 Allowed 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.337 -1.357 . . . . 75.14 107.337 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -84.29 161.03 20.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.075 -0.966 . . . . 72.34 111.31 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -155.4 151.8 28.28 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.104 0.962 . . . . 74.21 109.77 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -139.7 71.5 1.38 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.635 -1.246 . . . . 74.32 107.635 164.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.8 ttp -34.58 126.34 0.5 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.67 -1.15 . . . . 75.13 111.713 166.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.5 m -136.79 139.87 42.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.735 -1.209 . . . . 74.34 107.735 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -156.8 92.93 1.32 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.05 -1.463 . . . . 72.33 107.05 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -122.02 156.44 33.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.674 0.79 . . . . 63.52 109.363 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.418 HD11 HG21 ' D' ' 105' ' ' ILE . 11.3 mt -102.0 122.48 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.983 -0.747 . . . . 63.14 108.983 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.25 -49.57 10.6 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.433 -0.58 . . . . 74.11 109.433 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . 0.47 ' HE ' HD13 ' D' ' 83' ' ' ILE . 19.4 ptt180 -173.65 152.67 2.11 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 112.171 0.434 . . . . 72.5 112.171 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.449 ' CD1' ' HG3' ' B' ' 130' ' ' PRO . 4.0 mp -114.36 139.35 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.621 -1.622 . . . . 73.23 106.621 167.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.531 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 41.2 p90 -162.56 157.67 22.43 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.833 0.853 . . . . 72.5 109.691 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -81.42 113.55 19.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.459 -1.246 . . . . 72.45 109.175 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' C' ' 28' ' ' ALA . 33.9 mtpt -83.33 -33.2 25.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.098 0.475 . . . . 74.41 109.812 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.6 t70 -144.93 135.54 24.45 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.537 -1.21 . . . . 71.34 109.038 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.541 HD12 ' HG3' ' C' ' 117' ' ' MET . 53.4 mt -133.43 140.89 45.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.351 -1.351 . . . . 64.05 107.351 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -154.44 102.32 2.41 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.675 0.79 . . . . 75.31 109.466 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.529 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.0 t80 -108.39 115.49 30.2 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 105.783 -1.932 . . . . 75.14 105.783 167.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -121.01 131.78 54.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.149 -0.686 . . . . 74.23 109.149 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.45 78.26 45.77 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.284 -1.376 . . . . 75.13 107.284 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.9 -35.15 36.49 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.675 2.25 . . . . 71.33 111.522 -172.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 -109.91 22.29 15.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.775 0.83 . . . . 72.01 109.99 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.409 ' HB3' ' HD3' ' D' ' 29' ' ' PRO . . . -35.43 -64.82 0.31 Allowed Pre-proline 0 CA--C 1.571 1.773 0 N-CA-C 116.13 1.9 . . . . 74.13 116.13 -171.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.578 ' HB3' HD11 ' C' ' 83' ' ' ILE . 40.0 Cg_endo -81.03 -14.5 10.91 Favored 'Trans proline' 0 C--N 1.39 2.744 0 CA-C-N 122.023 1.758 . . . . 74.41 113.339 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -71.35 -37.43 71.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.901 1.28 . . . . 71.44 109.06 172.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.62 HG11 HD11 ' D' ' 68' ' ' LEU . 76.1 t -74.12 -30.98 28.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 115.131 -0.94 . . . . 74.32 109.95 175.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -70.84 6.76 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.644 0.979 . . . . 74.44 113.644 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -84.48 -37.84 20.84 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.367 -0.605 . . . . 75.24 109.367 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . 0.425 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 30.4 pttt -132.45 95.87 3.72 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 124.23 1.012 . . . . 74.12 112.319 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.419 ' CG ' HD13 ' G' ' 301' ' ' ILE . 92.2 m-20 -108.72 92.74 4.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 72.42 109.522 170.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . 0.425 ' HZ3' ' HA ' ' D' ' 34' ' ' LYS . 12.3 m-90 -125.86 -179.99 4.93 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.364 -1.347 . . . . 75.13 107.364 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.05 104.65 0.44 Allowed Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.476 0.71 . . . . 75.0 112.055 -163.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.69 109.72 2.91 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.958 2.438 . . . . 70.41 109.464 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.62 113.9 4.04 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.589 -0.893 . . . . 74.54 108.589 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.424 HG11 HD12 ' D' ' 126' ' ' LEU . 1.2 m -104.78 114.2 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 114.436 -1.256 . . . . 52.04 110.64 -166.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . 0.408 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 81.1 tttt -87.54 128.65 35.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.198 1.399 . . . . 73.51 108.945 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -101.77 114.17 27.99 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.382 0.673 . . . . 75.55 109.828 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.641 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -106.84 109.43 21.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.256 -1.387 . . . . 75.2 107.256 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.5 130.88 44.54 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.245 -1.02 . . . . 74.44 108.245 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -133.49 130.39 38.48 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.149 -1.056 . . . . 72.23 108.149 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -103.88 142.4 34.47 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.6 0.76 . . . . 73.4 109.781 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.473 ' HB2' ' HB ' ' D' ' 59' ' ' VAL . . . -155.24 150.65 27.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.549 0.74 . . . . 71.22 109.251 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.5 p -164.63 153.32 12.72 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.393 0.677 . . . . 64.3 109.332 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -158.65 142.55 15.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.063 0.545 . . . . 72.32 110.054 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -73.05 128.47 35.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.356 0.662 . . . . 75.41 109.393 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -100.88 -26.32 13.79 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.884 0.474 . . . . 75.11 110.552 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.52 -179.09 4.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.753 0.821 . . . . 61.21 110.82 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.04 119.82 12.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.852 -1.067 . . . . 62.51 108.858 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . 0.444 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 40.5 m-20 66.39 16.79 10.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.044 1.338 . . . . 75.03 111.891 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.81 114.81 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.934 0.894 . . . . 72.23 108.969 175.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . 0.428 ' HB2' HD12 ' D' ' 86' ' ' ILE . 90.4 m-85 -132.81 129.45 38.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.352 1.061 . . . . 73.22 108.489 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -100.27 139.73 35.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.384 1.074 . . . . 73.23 109.789 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.58 118.8 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 73.45 108.305 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.539 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.5 t -104.99 131.4 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.442 -0.947 . . . . 73.52 108.442 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.93 109.76 12.84 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.991 -1.115 . . . . 72.23 107.991 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.595 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.2 ttm-85 -87.05 109.36 19.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.537 0.735 . . . . 74.12 109.838 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.56 104.25 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.591 -1.263 . . . . 72.21 107.591 166.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.641 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.8 m -100.0 136.51 39.8 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.433 -0.58 . . . . 74.22 109.433 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.06 110.12 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.46 1.104 . . . . 72.25 108.255 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 65' ' ' THR . . . . . 0.408 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 39.6 m -102.97 103.08 13.17 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.597 0.759 . . . . 74.5 109.244 175.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.59 135.99 36.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 29.5 p -148.36 124.28 10.64 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.641 0.588 . . . . 63.33 110.433 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.641 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.5 OUTLIER -113.04 126.7 55.78 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.422 -0.955 . . . . 65.43 108.422 172.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -134.03 28.11 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.474 -0.65 . . . . 65.32 111.474 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.26 4.2 54.38 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.979 0.512 . . . . 73.33 110.874 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -119.07 144.18 46.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 75.41 111.337 -168.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.8 m -74.72 120.1 19.81 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 123.469 0.708 . . . . 75.13 109.895 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.641 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -67.94 -61.53 1.82 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.252 0.97 . . . . 72.42 110.191 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.37 168.56 26.24 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.247 -1.342 . . . . 75.2 110.454 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.7 mt -127.45 139.57 52.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.65 -1.611 . . . . 72.31 106.65 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.628 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 36.2 t -153.38 110.21 3.42 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.415 -0.587 . . . . 70.32 109.415 -175.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -136.45 132.18 35.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.45 1.1 . . . . 75.21 108.998 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.39 121.79 20.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.117 0.567 . . . . 73.21 109.614 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.52 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -88.74 88.83 7.74 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.321 -0.992 . . . . 70.54 108.321 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -81.11 96.63 7.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.565 -1.198 . . . . 72.34 108.958 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.09 144.24 17.01 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.579 -0.608 . . . . 64.45 111.579 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.74 130.0 4.03 Favored Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 110.834 -0.906 . . . . 74.33 110.834 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . 0.47 HD13 ' HE ' ' D' ' 15' ' ' ARG . 48.0 mt -89.82 127.04 42.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.527 -0.916 . . . . 73.41 108.527 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -129.12 133.51 47.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.724 0.809 . . . . 75.41 109.759 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.1 m -80.92 94.98 6.61 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 108.901 -0.777 . . . . 75.33 108.901 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.428 HD12 ' HB2' ' D' ' 56' ' ' TYR . 40.1 mt -111.34 123.63 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.444 0.698 . . . . 71.32 110.202 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -149.67 165.01 33.63 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.767 0.827 . . . . 72.51 110.671 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.71 -19.44 24.73 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.411 0.925 . . . . 72.21 115.411 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.534 ' O ' HD22 ' G' ' 277' ' ' LEU . 19.7 pt -129.2 134.73 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 117.835 0.817 . . . . 74.22 111.879 -170.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.33 -171.26 3.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.617 0.767 . . . . 63.04 110.061 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 -140.41 34.5 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.622 0.576 . . . . 73.12 112.18 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -78.19 -20.87 51.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.381 0.672 . . . . 70.31 111.57 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . 0.408 HE21 ' HA ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -60.44 -52.96 63.01 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.759 0.823 . . . . 75.21 110.17 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.27 -41.56 69.87 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 114.86 -1.063 . . . . 72.3 109.923 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.38 -26.92 68.68 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.476 0.71 . . . . 75.11 112.36 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.88 -42.04 25.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.347 0.659 . . . . 73.44 109.694 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.39 -31.03 71.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.068 0.547 . . . . 75.34 110.836 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -46.59 18.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 72.33 108.611 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.14 -20.05 79.41 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.97 -1.013 . . . . 75.2 114.377 -173.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.98 -61.71 1.22 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 117.17 0.485 . . . . 72.55 111.805 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -67.11 -40.89 86.95 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 112.677 0.621 . . . . 75.44 112.677 -170.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.5 m -63.76 -47.48 81.52 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-O 118.72 -0.657 . . . . 65.33 111.742 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.3 -40.2 35.43 Favored 'Trans proline' 0 C--N 1.4 3.269 0 C-N-CA 123.045 2.497 . . . . 74.21 114.196 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -59.78 -27.0 66.17 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 112.764 0.653 . . . . 64.11 112.764 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.418 HG21 HD11 ' D' ' 13' ' ' ILE . 41.6 mm -82.42 -44.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-O 121.157 0.503 . . . . 65.22 110.572 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.1 mt -76.29 -32.2 58.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.97 -1.014 . . . . 75.53 111.722 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . 0.41 ' HZ ' ' HG ' ' D' ' 128' ' ' LEU . 62.8 t80 -63.48 -42.86 76.36 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.566 1.146 . . . . 75.44 113.872 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.08 -42.65 45.37 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 122.386 2.058 . . . . 64.34 113.19 171.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -81.26 -27.67 35.07 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.58 0.752 . . . . 75.21 111.858 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.61 -53.54 49.97 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.317 -0.623 . . . . 73.04 109.317 173.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 39.1 ttp180 -58.74 -42.08 87.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.837 -1.529 . . . . 74.31 110.99 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.74 -49.92 74.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.771 0.828 . . . . 72.24 110.708 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' D' ' 21' ' ' ILE . 46.6 t -60.19 -44.2 95.28 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.843 0.714 . . . . 54.33 111.176 -178.601 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.548 HG22 ' SG ' ' D' ' 76' ' ' CYS . 49.8 mt -58.57 -55.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 74.43 111.07 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 115' ' ' THR . . . . . 0.46 HG22 ' HE2' ' B' ' 109' ' ' TYR . 63.2 m -53.24 -47.46 69.01 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.239 1.016 . . . . 72.43 111.758 -174.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 116' ' ' SER . . . . . 0.443 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 46.7 t -62.14 -37.8 86.54 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.655 -1.157 . . . . 64.23 111.204 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.628 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 72.6 mtm -75.17 -32.14 61.19 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.871 0.469 . . . . 74.22 111.998 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.497 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -68.07 -36.93 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 116.066 -0.515 . . . . 70.45 109.733 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.2 p -72.54 -28.44 62.84 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.874 0.47 . . . . 72.3 111.085 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.4 mtt-85 -73.06 -27.23 61.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.673 0.789 . . . . 72.34 110.635 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.95 8.42 76.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.015 -0.538 . . . . 74.43 112.395 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p 66.54 13.67 9.39 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.084 2.154 . . . . 54.43 114.02 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . 0.481 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 76.5 m-85 -90.99 169.19 12.12 Favored Pre-proline 0 CA--C 1.568 1.647 0 C-N-CA 124.536 1.135 . . . . 70.02 107.964 169.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 93.0 Cg_endo -74.47 166.94 28.29 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.532 2.155 . . . . 75.23 112.92 -172.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -60.9 121.69 13.02 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.114 -0.494 . . . . 70.45 109.757 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . 0.424 HD12 HG11 ' D' ' 40' ' ' VAL . 7.5 tt -104.24 93.53 4.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.16 -1.422 . . . . 74.11 107.16 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -103.25 89.82 3.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.011 -1.45 . . . . 74.01 108.596 -171.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.41 ' HG ' ' HZ ' ' D' ' 107' ' ' PHE . 23.1 tp -71.96 122.78 21.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.854 -0.612 . . . . 73.21 110.514 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.91 140.31 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.492 1.117 . . . . 74.44 112.223 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.67 114.42 3.67 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.661 2.241 . . . . 73.35 110.371 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.56 143.56 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.555 0.742 . . . . 62.31 109.682 -172.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -69.67 101.72 1.72 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.189 0.996 . . . . 73.34 110.302 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -71.24 -33.31 69.73 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.262 0.625 . . . . 73.22 111.175 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.07 -57.57 12.01 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.467 0.707 . . . . 74.24 111.799 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.91 89.86 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.911 0.757 . . . . 75.4 111.674 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.496 HD13 ' HD2' ' G' ' 287' ' ' PRO . 87.5 mt -64.78 -36.47 84.42 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.57 -0.741 . . . . 73.52 111.246 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -71.63 -41.43 68.87 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.701 -0.681 . . . . 72.52 110.579 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 138' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 78.3 mtm -69.51 -31.68 70.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.015 0.526 . . . . 75.44 110.852 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . 0.475 ' HA ' HE21 ' D' ' 142' ' ' GLN . 32.0 m-80 -75.68 -25.4 56.72 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 119.083 -0.484 . . . . 73.13 111.82 174.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -59.9 -43.37 94.87 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 120.896 0.379 . . . . 71.23 110.735 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.57 -31.06 71.81 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.891 0.876 . . . . 75.33 111.32 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . 0.734 ' HG2' ' HA ' ' B' ' 151' ' ' GLU . 42.0 mt-30 -83.08 3.26 31.24 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.688 0.795 . . . . 74.4 112.311 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -117.27 53.48 0.92 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.917 0.865 . . . . 74.34 108.779 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -159.54 151.41 20.51 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 113.859 -1.519 . . . . 65.41 109.073 173.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.31 150.64 36.89 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.492 -0.558 . . . . 71.41 109.492 173.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.88 56.55 4.94 Favored Glycine 0 C--N 1.345 1.064 0 O-C-N 123.35 0.406 . . . . 64.13 112.113 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.21 112.97 9.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.542 0.737 . . . . 74.53 109.051 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.94 127.49 27.83 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.795 0.684 . . . . 74.13 112.903 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 149' ' ' THR . . . . . 0.423 HG22 ' HG3' ' D' ' 151' ' ' GLU . 38.8 m -106.82 111.89 24.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.253 1.021 . . . . 74.43 108.559 175.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -98.82 94.33 6.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.325 -0.62 . . . . 74.04 109.325 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . 0.423 ' HG3' HG22 ' D' ' 149' ' ' THR . 46.1 mt-10 -112.1 154.75 24.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.929 0.892 . . . . 74.21 109.673 172.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -158.55 126.01 5.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.236 1.014 . . . . 75.32 109.083 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -65.29 -53.26 46.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.962 0.905 . . . . 73.34 111.304 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 73.42 177.07 0.25 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.229 1.412 . . . . 74.43 111.482 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.327 0 C-N-CA 123.843 0.857 . . . . 70.45 109.036 176.962 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.768 0.318 . . . . 74.53 110.898 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -104.16 126.14 51.04 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.684 -0.858 . . . . 74.42 108.684 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -70.13 98.31 1.31 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.128 0.571 . . . . 74.24 109.963 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -163.55 166.02 22.95 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.643 1.177 . . . . 73.04 108.164 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.77 68.88 0.94 Allowed Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 124.474 1.11 . . . . 74.15 109.765 -172.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.19 110.58 2.29 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.662 2.241 . . . . 74.23 110.902 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 60.0 tp -54.47 -39.79 67.81 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.962 0.905 . . . . 73.34 110.374 175.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.89 107.23 17.61 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.839 -1.073 . . . . 72.45 109.721 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.92 26.37 1.29 Allowed Glycine 0 C--N 1.347 1.155 0 O-C-N 123.701 0.625 . . . . 74.13 112.356 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -153.14 76.17 1.1 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.532 -0.914 . . . . 74.32 108.532 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 5.0 t80 176.42 -176.26 0.12 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.042 1.337 . . . . 73.45 108.107 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 72.29 105.97 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.665 1.186 . . . . 72.12 110.741 171.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 16.8 t70 72.92 136.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.043 1.337 . . . . 74.15 110.451 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 110.48 80.63 1.15 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.149 -0.78 . . . . 71.31 111.149 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -75.97 153.44 36.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.337 0.655 . . . . 71.22 110.875 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 62.5 mtt -88.85 141.27 29.67 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.777 -0.647 . . . . 73.44 109.429 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.7 70.7 5.69 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.85 2.367 . . . . 70.11 110.925 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 62.3 t -76.54 134.31 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 114.787 -1.097 . . . . 73.35 109.859 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -62.49 142.61 57.84 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.835 0.709 . . . . 73.23 109.907 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . 0.424 ' HE1' HG12 ' A' ' 40' ' ' VAL . 1.7 t-105 -92.27 109.08 20.45 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.831 -1.174 . . . . 73.52 107.831 170.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.507 ' HB3' HG11 ' G' ' 306' ' ' VAL . 4.9 mp -74.12 -16.33 61.01 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.818 -1.083 . . . . 73.45 111.769 -172.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -118.75 82.12 0.33 Allowed Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.183 -0.787 . . . . 63.21 111.925 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.57 46.44 2.26 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.316 2.677 . . . . 71.42 111.14 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -111.71 132.99 54.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.258 1.423 . . . . 75.54 108.0 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -64.14 123.29 18.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.026 -0.731 . . . . 65.32 109.026 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 20.9 m -55.29 -49.37 72.3 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 124.179 0.924 . . . . 75.43 111.611 -172.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.456 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 21.6 m-85 -68.19 87.31 0.28 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.437 0.636 . . . . 73.21 110.719 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -136.86 -42.61 0.59 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.642 1.177 . . . . 75.02 108.327 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -72.69 -132.37 0.16 Allowed Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.549 -0.75 . . . . 55.33 113.15 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . 0.426 ' HB2' ' HB3' ' D' ' 124' ' ' PRO . 9.9 p30 -72.21 120.89 18.46 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 117.136 0.468 . . . . 73.44 110.472 -174.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 9.4 tp -153.69 -45.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 122.604 0.362 . . . . 75.44 110.453 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . 0.404 ' HA ' ' HB3' ' G' ' 298' ' ' HIS . 9.0 t70 63.6 -178.83 0.15 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 124.727 1.211 . . . . 62.15 112.07 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . 0.547 ' H ' ' HD2' ' E' ' 304' ' ' PRO . 39.8 ttmt -162.72 -48.66 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.417 0 C-N-CA 124.57 1.148 . . . . 73.34 111.241 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . 0.547 ' HD2' ' H ' ' E' ' 303' ' ' LYS . 4.6 Cg_endo -45.52 -39.3 17.13 Favored 'Trans proline' 0 C--N 1.406 3.563 0 C-N-CA 123.51 2.806 . . . . 72.42 115.064 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.32 162.7 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.719 1.208 . . . . 73.22 111.855 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' B' ' 13' ' ' ILE . 58.5 t -74.34 127.75 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 122.879 0.472 . . . . 70.13 110.114 -174.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 24.4 m -74.7 141.35 44.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.761 0.824 . . . . 71.43 111.11 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . 0.548 ' HA ' ' HG3' ' B' ' 12' ' ' GLN . 67.3 m -64.48 152.29 42.08 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.311 1.044 . . . . 70.43 111.731 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 309' ' ' THR . . . . . 0.406 ' HA ' ' HD3' ' E' ' 310' ' ' PRO . 9.0 t -144.62 140.01 16.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.145 0.578 . . . . 74.44 110.454 -178.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' E' ' 309' ' ' THR . 7.9 Cg_exo . . . . . 0 C--N 1.373 1.834 0 C-N-CA 122.978 2.452 . . . . 65.3 111.155 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 110.882 -0.044 . . . . 74.33 110.882 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 65.97 -169.44 0.2 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.678 1.191 . . . . 72.02 110.268 -171.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 61.71 35.05 17.12 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.091 0.956 . . . . 75.33 110.435 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -87.56 59.88 5.7 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.997 0.904 . . . . 74.42 109.733 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -121.25 79.56 35.66 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 124.306 1.042 . . . . 73.33 108.682 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -92.38 -84.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.021 2.48 . . . . 73.01 110.894 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.512 ' HA ' ' HG3' ' C' ' 90' ' ' GLU . 7.9 tt -88.56 -41.11 12.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.616 -1.253 . . . . 74.22 107.616 168.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 45.8 tp -67.01 112.02 4.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.66 1.184 . . . . 75.11 110.248 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -97.49 -80.72 1.55 Allowed Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.237 -0.438 . . . . 73.31 113.216 -175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.12 -172.41 1.08 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.581 0.752 . . . . 74.03 111.755 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . 0.471 ' CG ' ' HB ' ' C' ' 46' ' ' THR . 4.1 m-85 67.85 93.13 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.477 1.111 . . . . 74.1 111.22 177.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -161.4 -34.29 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.452 0.701 . . . . 72.14 111.432 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -132.71 -171.84 2.76 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.787 0.835 . . . . 74.33 109.957 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . 0.547 ' HA2' ' HA ' ' C' ' 45' ' ' ASP . . . -95.24 124.15 7.88 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-O 119.897 -0.39 . . . . 73.42 112.316 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . 0.458 HD21 ' HA ' ' A' ' 155' ' ' ALA . 10.5 t-20 -163.5 177.85 8.51 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.243 1.017 . . . . 63.33 108.263 174.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 286' ' ' MET . . . . . 0.454 ' N ' ' HD3' ' F' ' 287' ' ' PRO . 17.8 mmt 62.74 47.29 0.9 Allowed Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 124.455 1.102 . . . . 75.15 111.094 -170.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . 0.454 ' HD3' ' N ' ' F' ' 286' ' ' MET . 20.3 Cg_exo -65.29 -34.95 42.86 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 122.083 1.855 . . . . 72.32 112.244 -174.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . 0.42 HG23 HG13 ' C' ' 131' ' ' VAL . 60.6 t 70.53 124.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.131 1.373 . . . . 74.43 110.371 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -72.34 -81.44 0.05 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.736 0.414 . . . . 73.42 110.62 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . 0.469 ' HH2' HD12 ' C' ' 126' ' ' LEU . 0.5 OUTLIER -175.62 148.81 0.93 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.987 1.315 . . . . 73.42 108.157 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.521 ' HB2' ' HA ' ' H' ' 306' ' ' VAL . 0.0 OUTLIER -103.44 -3.82 24.9 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.13 0.972 . . . . 72.2 110.725 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -163.92 168.32 38.38 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.439 -0.8 . . . . 72.43 111.303 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.05 42.8 1.38 Allowed 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.855 3.037 . . . . 75.3 112.791 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 69.86 115.28 0.04 OUTLIER 'General case' 0 C--N 1.364 1.235 0 C-N-CA 125.385 1.474 . . . . 74.24 112.187 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.84 -10.48 57.11 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.554 0.741 . . . . 45.0 111.133 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 3.7 m -68.68 121.41 16.4 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.809 0.844 . . . . 72.04 109.654 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.568 ' HH ' HD11 ' F' ' 301' ' ' ILE . 95.2 m-85 64.28 48.31 2.89 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.539 1.136 . . . . 71.25 111.687 -173.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -67.85 -27.43 66.68 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 107.912 -1.144 . . . . 71.32 107.912 165.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -129.06 149.54 18.55 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 110.316 -1.114 . . . . 75.44 110.316 166.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -75.48 151.03 38.08 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.551 0.74 . . . . 74.3 110.236 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.568 HD11 ' HH ' ' F' ' 297' ' ' TYR . 36.1 pt -90.57 43.23 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.547 0.689 . . . . 64.51 111.883 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.91 86.86 2.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.468 -0.938 . . . . 72.42 108.468 169.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . 0.563 ' HE2' ' SG ' ' F' ' 308' ' ' CYS . 0.1 OUTLIER 64.88 70.39 0.61 Allowed Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 125.598 1.559 . . . . 73.51 111.05 -178.526 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . 0.476 ' HG3' ' HB ' ' F' ' 301' ' ' ILE . 24.0 Cg_exo -60.36 -40.39 58.72 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.256 2.637 . . . . 75.05 112.36 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -169.07 -76.6 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.647 1.217 . . . . 73.34 109.372 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 5.6 t -93.44 97.2 6.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.098 -1.075 . . . . 73.31 108.098 179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 307' ' ' THR . . . . . 0.444 ' OG1' ' HD2' ' F' ' 304' ' ' PRO . 82.0 m -149.82 -46.74 0.13 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.729 0.411 . . . . 74.3 111.517 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . 0.563 ' SG ' ' HE2' ' F' ' 303' ' ' LYS . 85.2 m -136.11 104.08 5.55 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.787 0.327 . . . . 75.4 111.443 -172.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 48.7 p -88.37 117.95 68.94 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 107.346 -1.353 . . . . 74.03 107.346 162.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--N 1.377 2.03 0 C-N-CA 123.389 2.726 . . . . 70.42 113.189 -176.535 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 121.018 0.437 . . . . 63.22 110.286 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -88.59 109.64 20.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.131 -0.692 . . . . 74.45 109.131 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -111.5 70.49 0.71 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.719 -0.845 . . . . 74.01 108.719 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -116.16 178.12 4.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.695 -1.139 . . . . 73.4 110.203 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . 0.481 ' H ' ' HD3' ' G' ' 275' ' ' LYS . 0.3 OUTLIER -121.38 149.04 51.31 Favored Pre-proline 0 C--O 1.247 0.935 0 CA-C-N 115.241 -0.89 . . . . 72.41 109.539 -174.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.37 -178.85 3.18 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.635 2.223 . . . . 74.23 111.945 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.534 HD22 ' O ' ' D' ' 89' ' ' ILE . 56.5 mt 62.62 22.49 13.35 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.792 0.837 . . . . 74.4 111.304 -176.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 29.2 tp -161.33 -66.04 0.06 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.014 -1.106 . . . . 73.14 108.014 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 72.34 -83.47 0.54 Allowed Glycine 0 C--N 1.348 1.198 0 CA-C-N 115.606 -0.724 . . . . 75.24 112.781 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 pp -158.17 157.1 32.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.723 0.809 . . . . 73.15 110.977 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -159.81 86.82 0.79 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.509 -1.293 . . . . 74.11 107.509 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -148.67 -160.44 1.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.957 -1.02 . . . . 73.35 109.406 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 22.6 t70 76.75 148.2 0.1 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.455 1.502 . . . . 74.01 111.455 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -114.98 12.98 19.89 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.935 -0.925 . . . . 72.14 114.615 -170.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -79.21 92.64 5.11 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.26 1.03 . . . . 75.01 109.303 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -134.98 94.33 16.36 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.102 -1.074 . . . . 73.53 108.102 176.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . 0.496 ' HD2' HD13 ' D' ' 136' ' ' LEU . 32.1 Cg_exo -63.79 15.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 124.113 3.209 . . . . 72.25 116.227 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.09 86.56 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.874 -0.787 . . . . 74.45 108.874 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -121.07 29.24 7.44 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.191 0.996 . . . . 75.13 108.631 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 94.7 m95 67.97 113.11 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.087 1.355 . . . . 75.41 110.961 -168.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.41 7.06 37.82 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 114.858 -1.065 . . . . 71.42 110.661 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -179.26 68.45 0.07 OUTLIER Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.387 -0.685 . . . . 63.12 111.387 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . 0.413 ' HB2' ' H ' ' G' ' 294' ' ' LYS . 57.5 Cg_endo -80.65 -142.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.327 2.684 . . . . 71.13 111.719 -178.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . 0.413 ' H ' ' HB2' ' G' ' 293' ' ' PRO . 52.2 mtpt 65.22 28.3 12.08 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.211 1.005 . . . . 75.42 111.61 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -160.33 112.37 1.98 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.927 -1.033 . . . . 74.55 109.948 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -68.0 0.06 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.003 1.321 . . . . 73.15 107.667 173.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . 0.447 ' CD2' ' HD3' ' D' ' 124' ' ' PRO . 0.3 OUTLIER -122.35 71.69 1.02 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.856 -0.424 . . . . 73.33 109.856 -173.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . 0.404 ' HB3' ' HA ' ' E' ' 302' ' ' ASP . 71.6 t60 -88.35 74.26 8.68 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.492 -1.299 . . . . 73.4 107.492 164.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -115.39 -140.26 7.05 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 114.997 -1.001 . . . . 72.41 111.145 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . 0.426 ' ND2' ' HB2' ' G' ' 302' ' ' ASP . 56.7 t30 -156.26 -37.71 0.08 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.663 0.385 . . . . 71.14 111.046 -176.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.419 HD13 ' CG ' ' D' ' 35' ' ' ASP . 97.0 mt 73.37 -71.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 125.148 1.379 . . . . 72.14 110.188 -166.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . 0.426 ' HB2' ' ND2' ' G' ' 300' ' ' ASN . 35.7 t70 62.99 118.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.949 1.3 . . . . 72.3 110.363 -174.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -49.98 122.25 14.02 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.517 0.727 . . . . 73.13 112.477 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.61 170.34 14.44 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.02 2.48 . . . . 64.13 110.892 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -163.48 -37.68 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.014 0.525 . . . . 64.15 111.287 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' C' ' 12' ' ' GLN . 62.2 t 68.46 147.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 124.092 0.957 . . . . 73.42 110.517 -172.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 44.8 p -64.1 -70.99 0.19 Allowed 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 109.569 -0.53 . . . . 70.42 109.569 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 49.3 t 169.33 158.29 0.05 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.352 1.461 . . . . 72.22 109.199 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 21.8 p -77.92 141.87 64.1 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.417 0.687 . . . . 63.54 109.869 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.38 2.206 0 C-N-CA 123.651 2.901 . . . . 73.12 113.434 -179.121 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 110.39 -0.226 . . . . 65.25 110.39 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -71.41 -57.45 4.43 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.967 0.507 . . . . 61.32 109.901 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 60.34 90.76 0.06 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.216 1.007 . . . . 73.34 111.099 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -73.27 82.76 1.37 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.978 0.894 . . . . 73.21 111.736 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -91.79 134.49 28.95 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-N 115.224 -0.898 . . . . 75.53 109.171 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.79 -42.66 24.09 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.185 2.59 . . . . 73.34 113.229 -175.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 58.3 mt -118.52 167.14 11.89 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.121 0.569 . . . . 75.44 110.54 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.12 19.58 9.18 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.416 1.486 . . . . 75.21 112.458 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -87.49 39.14 3.11 Favored Glycine 0 C--N 1.353 1.472 0 C-N-CA 122.676 0.179 . . . . 63.44 112.789 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . 0.448 HD22 ' HB3' ' B' ' 95' ' ' ALA . 18.1 tp -165.17 33.67 0.06 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.852 1.261 . . . . 72.43 107.833 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . 0.493 ' HB2' HD21 ' B' ' 98' ' ' LEU . 6.6 t80 -147.23 113.99 6.07 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.045 -0.979 . . . . 73.34 109.574 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -166.53 -54.4 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.724 0.64 . . . . 65.32 110.541 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -148.77 147.53 28.91 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.077 0.951 . . . . 63.41 109.304 -174.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 153.06 61.06 0.01 OUTLIER Glycine 0 C--N 1.346 1.133 0 O-C-N 123.077 0.236 . . . . 61.22 112.628 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -73.06 128.9 36.8 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.584 -0.524 . . . . 75.32 109.584 172.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 286' ' ' MET . . . . . 0.402 ' N ' ' SD ' ' H' ' 286' ' ' MET . 1.5 mpt? -71.47 135.88 83.89 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.211 -1.033 . . . . 73.12 108.211 172.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.45 80.25 1.09 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.415 2.077 . . . . 74.41 110.857 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.4 102.91 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.448 -0.796 . . . . 74.43 109.427 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -95.27 24.31 5.12 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.414 1.086 . . . . 75.22 109.505 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 97.4 m95 69.95 -175.41 0.19 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.492 1.517 . . . . 74.54 111.758 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 5.5 mp -71.13 -18.79 62.5 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.016 0.926 . . . . 74.42 111.563 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 152.69 -66.87 0.33 Allowed Glycine 0 C--N 1.34 0.755 0 N-CA-C 109.555 -1.418 . . . . 64.32 109.555 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.16 144.88 23.92 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.456 2.104 . . . . 75.43 110.909 167.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 132.73 49.86 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.603 -0.726 . . . . 74.01 110.384 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -107.36 -176.7 3.14 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.595 0.758 . . . . 71.32 111.365 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 296' ' ' THR . . . . . 0.564 HG21 ' HB2' ' B' ' 126' ' ' LEU . 3.8 m 74.71 146.26 0.09 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.415 1.486 . . . . 73.05 111.135 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . 0.557 ' HD1' HG22 ' H' ' 296' ' ' THR . 2.7 m-85 64.16 -82.73 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.612 1.165 . . . . 72.32 110.617 -173.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 61.18 99.98 0.03 OUTLIER 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.913 1.285 . . . . 73.13 110.353 -168.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 125.77 -96.76 0.5 Allowed Glycine 0 C--N 1.339 0.701 0 CA-C-N 114.521 -1.218 . . . . 62.31 110.081 -173.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -171.31 -175.44 1.66 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.235 1.014 . . . . 74.3 109.239 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . 0.533 HG23 ' HA ' ' B' ' 32' ' ' PHE . 37.7 mt -78.87 108.34 12.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 N-CA-C 108.197 -1.038 . . . . 72.3 108.197 170.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.39 128.77 37.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.016 -0.735 . . . . 73.3 109.016 176.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . 0.635 ' HE2' ' HA ' ' B' ' 33' ' ' GLN . 98.5 mttt -88.01 157.56 51.15 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.92 0.888 . . . . 71.11 112.23 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . 0.568 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 52.1 Cg_exo -54.98 123.23 13.28 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 123.46 2.773 . . . . 74.23 113.009 176.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.41 79.91 0.96 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.519 0.728 . . . . 72.42 110.325 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . 0.521 ' HA ' ' HB2' ' F' ' 291' ' ' LEU . 81.6 t -114.35 98.35 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 108.336 -0.987 . . . . 71.04 108.336 173.185 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 8.7 m -93.12 158.51 15.73 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.484 0.713 . . . . 62.23 110.036 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 56.0 m -55.27 104.3 0.12 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.384 1.074 . . . . 75.21 110.694 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 4.3 t -118.23 103.45 49.52 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.504 0.722 . . . . 64.25 111.038 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 CA--C 1.559 1.765 0 C-N-CA 122.861 2.374 . . . . 65.32 109.594 162.931 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 108.955 -0.757 . . . . 63.03 108.955 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.4 p -152.89 121.28 6.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.566 0.746 . . . . 73.22 109.252 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -86.72 83.68 7.53 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.273 -0.64 . . . . 71.44 109.273 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -75.37 83.66 2.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.603 0.761 . . . . 74.1 109.012 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -100.55 91.34 4.62 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.977 -1.011 . . . . 74.2 110.328 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -130.12 64.18 1.53 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 106.853 -1.536 . . . . 74.23 106.853 168.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -83.55 105.43 14.47 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.02 -1.446 . . . . 74.43 110.191 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -69.81 85.5 0.49 Allowed 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.992 -0.744 . . . . 72.12 108.992 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.598 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 25.5 ptp -90.82 153.28 20.35 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.679 -0.691 . . . . 72.32 110.774 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m -144.29 131.46 20.64 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.045 0.938 . . . . 75.05 108.7 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.621 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.8 t80 -126.34 123.47 38.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.079 0.952 . . . . 71.23 108.646 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -143.3 103.5 4.13 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.423 0.452 . . . . 73.12 109.878 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.627 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.4 mt -64.9 121.57 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.041 -0.725 . . . . 74.43 109.041 174.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -87.61 -41.39 13.46 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.677 0.611 . . . . 75.43 109.656 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.471 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 59.0 ttt180 -168.28 144.01 3.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.996 -0.281 . . . . 74.42 111.428 -162.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.67 137.29 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.09 -1.078 . . . . 75.42 108.09 172.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.471 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 21.4 p90 -160.96 165.97 29.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.453 0.701 . . . . 75.4 110.996 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -100.24 117.57 34.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.651 -0.87 . . . . 43.53 108.651 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -77.83 -26.69 49.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.382 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.35 142.39 16.93 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 123.912 0.757 . . . . 70.31 109.223 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.513 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 95.9 mt -134.75 142.38 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 106.612 -1.625 . . . . 74.23 106.612 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -155.14 114.0 3.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.413 0.446 . . . . 72.3 110.045 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -109.08 117.89 35.36 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 106.766 -1.568 . . . . 73.53 106.766 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.81 137.1 52.44 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.273 -0.64 . . . . 65.03 109.273 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.45 72.2 12.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.818 -1.549 . . . . 75.24 106.818 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.16 -30.98 37.27 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.772 2.315 . . . . 64.24 111.577 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.04 28.31 8.62 Favored 'General case' 0 C--O 1.213 -0.842 0 C-N-CA 124.207 1.003 . . . . 73.51 108.381 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.419 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . . . -50.29 -53.5 43.9 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.272 -0.871 . . . . 64.12 112.486 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.435 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 16.0 Cg_exo -66.63 -17.53 52.86 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 121.882 1.721 . . . . 74.42 112.696 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -95.9 -29.16 14.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 74.23 111.285 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.531 HG22 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -82.94 -25.39 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.791 0.436 . . . . 74.12 111.652 -172.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . 0.415 ' O ' HG12 ' E' ' 301' ' ' ILE . 23.5 m-85 -72.49 -9.6 58.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.516 0.726 . . . . 73.21 112.277 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -102.71 -10.78 18.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.651 0.78 . . . . 64.51 111.472 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -77.73 165.44 24.2 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.152 0.581 . . . . 62.42 111.965 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.74 145.15 55.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.376 1.07 . . . . 72.52 110.922 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -81.13 90.3 6.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.516 0.726 . . . . 75.35 110.183 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.419 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tp60 -141.8 50.04 1.62 Allowed Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 114.729 -1.123 . . . . 71.11 109.261 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.6 ' HG2' ' HB2' ' E' ' 297' ' ' TYR . 6.9 Cg_exo -74.99 96.43 1.02 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 122.539 2.159 . . . . 73.21 111.624 -172.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.14 98.0 10.67 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.279 -1.008 . . . . 71.25 108.279 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 65' ' ' THR . 2.6 p -93.33 104.94 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 114.055 -1.429 . . . . 72.53 110.616 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -83.17 137.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.007 1.323 . . . . 74.24 110.15 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.559 HD22 ' HB ' ' E' ' 288' ' ' VAL . 4.6 tt -105.72 127.56 53.15 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.122 -1.066 . . . . 75.13 108.122 174.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.732 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.8 m-20 -120.34 144.21 47.98 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.095 -1.076 . . . . 73.34 108.095 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.541 HD13 HD11 ' A' ' 60' ' ' LEU . 27.1 tp -139.31 124.61 19.1 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.73 -0.47 . . . . 74.44 109.73 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.596 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.3 m-20 -119.3 127.09 52.88 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.763 0.825 . . . . 74.12 109.042 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -106.33 121.42 44.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.053 0.941 . . . . 71.21 109.485 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.88 147.08 38.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.975 0.91 . . . . 72.31 109.544 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -133.08 168.57 18.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.693 0.797 . . . . 70.2 110.271 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -161.71 154.44 20.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.385 1.074 . . . . 74.42 109.506 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -111.25 121.87 46.38 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.152 -1.055 . . . . 54.21 108.152 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.596 HD11 ' HB2' ' A' ' 57' ' ' GLU . 26.9 mt -97.43 -33.88 11.23 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.338 0.655 . . . . 74.22 110.599 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.14 -173.13 3.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.266 0.626 . . . . 72.23 110.729 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.04 112.35 3.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.229 1.012 . . . . 70.34 110.093 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 85' ' ' SER . 62.0 m-20 70.45 1.69 3.74 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.579 1.552 . . . . 75.53 113.323 -175.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -100.86 115.82 43.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.508 0.723 . . . . 64.32 109.382 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -131.64 124.76 30.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.596 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.4 tt0 -95.59 116.54 28.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.261 1.025 . . . . 73.41 109.408 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.1 124.11 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.418 -1.327 . . . . 75.34 107.418 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 t -112.7 129.84 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.595 0.758 . . . . 71.45 109.195 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.541 HD11 HD13 ' A' ' 44' ' ' LEU . 3.9 mm? -120.86 104.27 9.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.708 1.203 . . . . 73.22 108.443 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . 0.596 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 30.4 ttp180 -84.49 104.55 14.59 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.743 -0.836 . . . . 74.2 108.743 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.9 120.48 43.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.393 -1.336 . . . . 74.0 107.393 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.732 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 36.9 m -122.07 130.6 53.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.225 -0.657 . . . . 71.52 109.225 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.68 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -123.47 116.46 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 124.932 1.293 . . . . 73.54 108.777 -174.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.9 m -118.61 130.15 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.249 0.477 . . . . 74.02 110.12 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.36 130.28 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.556 -0.905 . . . . 71.44 108.556 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.407 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.9 m -127.35 126.82 43.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.125 0.57 . . . . 74.4 109.704 176.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.664 HD13 ' HB1' ' A' ' 73' ' ' ALA . 11.0 mp -88.65 85.89 6.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.97 -1.122 . . . . 74.21 107.97 174.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.94 -88.29 1.17 Allowed Glycine 0 C--N 1.346 1.091 0 CA-C-N 114.924 -1.034 . . . . 52.41 111.488 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.21 -27.78 7.16 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.472 0.709 . . . . 73.13 111.357 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -102.75 132.93 48.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.188 0.595 . . . . 72.14 110.629 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 47.2 m -69.03 130.61 43.24 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.077 0.951 . . . . 74.32 111.315 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.664 ' HB1' HD13 ' A' ' 68' ' ' LEU . . . -74.63 -61.51 1.85 Allowed 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.998 0.919 . . . . 74.51 109.504 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -152.9 163.26 40.12 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.564 -1.198 . . . . 73.25 111.38 -178.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 tp -130.67 137.5 49.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.149 -1.387 . . . . 75.11 107.274 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . 0.68 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.2 m -137.03 98.99 3.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.557 0.743 . . . . 75.43 109.306 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -119.13 117.83 29.75 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.23 -1.026 . . . . 73.12 108.23 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.54 109.22 15.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.985 0.914 . . . . 72.41 109.148 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -84.59 81.24 8.94 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.593 -1.262 . . . . 75.13 107.593 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.63 93.56 3.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.718 -0.845 . . . . 74.43 108.718 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.16 147.26 21.56 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.073 -0.811 . . . . 71.45 111.073 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.618 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.68 122.97 1.41 Allowed Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 111.783 -0.527 . . . . 60.34 111.783 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.79 125.62 39.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.233 -0.654 . . . . 71.43 109.233 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.627 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.0 m-85 -132.17 148.76 52.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.767 -1.197 . . . . 74.41 107.767 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 41.9 t -102.51 110.84 22.9 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.425 -0.954 . . . . 71.33 108.425 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.545 HG21 ' HG2' ' A' ' 94' ' ' MET . 4.2 mp -112.95 125.27 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.97 44.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.559 0.744 . . . . 60.53 109.644 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 101.26 -32.55 7.34 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 123.72 0.637 . . . . 73.41 113.667 175.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.444 ' H ' HD12 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.82 147.75 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.435 0.694 . . . . 73.25 110.287 -175.135 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' E' ' 275' ' ' LYS . 32.4 mt-10 -138.82 -179.08 5.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.706 0.802 . . . . 74.34 109.38 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.61 -132.88 32.35 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 119.623 -0.543 . . . . 62.24 112.897 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 95' ' ' ALA . 18.6 p -74.96 -17.54 60.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.64 0.776 . . . . 71.41 111.977 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -72.01 -42.67 66.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.999 0.52 . . . . 73.14 109.668 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' MET . . . . . 0.545 ' HG2' HG21 ' A' ' 86' ' ' ILE . 1.1 tmt? -81.7 -24.84 35.94 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.637 0.775 . . . . 74.53 110.043 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.509 ' HB1' HD13 ' E' ' 280' ' ' LEU . . . -68.65 -37.18 79.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.368 0.667 . . . . 64.23 110.135 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.71 -34.47 77.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.357 0.663 . . . . 74.13 110.11 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 48.5 t -67.89 -42.42 81.24 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.016 -0.538 . . . . 64.24 110.999 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.0 mt -86.15 -29.19 23.46 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.912 0.708 . . . . 72.41 112.912 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.78 3.89 34.2 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.597 0.599 . . . . 54.02 114.597 -170.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -51.22 0.16 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.42 0.61 . . . . 74.23 111.745 -174.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -79.46 -66.84 0.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.445 1.098 . . . . 74.2 112.23 -169.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' CYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 67.2 m -70.72 -32.17 2.42 Favored Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 114.78 1.4 . . . . 72.21 114.78 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 36.3 Cg_endo -63.99 -20.66 68.13 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 122.055 1.77 . . . . 72.51 112.775 171.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -76.14 -17.75 59.43 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.227 0.611 . . . . 74.04 109.981 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 13' ' ' ILE . 42.2 mm -75.41 -39.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.961 -0.755 . . . . 72.52 108.961 170.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.618 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.5 mt -78.47 -33.02 48.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.953 0.901 . . . . 74.32 112.959 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -62.16 -43.75 86.88 Favored Pre-proline 0 CA--C 1.572 1.789 0 N-CA-C 113.758 1.022 . . . . 75.24 113.758 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.53 -28.08 22.01 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.113 1.875 . . . . 75.02 113.157 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -76.02 -34.56 59.68 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.084 0.553 . . . . 75.51 111.156 175.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.27 78.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.111 -0.699 . . . . 53.13 109.111 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.426 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.7 ttm180 -55.18 -49.86 70.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.594 1.184 . . . . 75.1 109.845 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.266 0.979 . . . . 73.45 110.738 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 28.3 t -59.51 -44.25 93.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.386 0.674 . . . . 74.23 110.558 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 96.4 mt -64.41 -54.13 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.818 0.847 . . . . 65.44 109.965 177.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.416 HG23 ' HG3' ' A' ' 125' ' ' GLN . 58.2 m -55.22 -39.77 70.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.126 0.97 . . . . 75.15 111.212 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -64.22 -51.35 64.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.824 -1.08 . . . . 63.31 109.793 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.478 ' SD ' HG22 ' A' ' 21' ' ' ILE . 16.0 mtp -56.83 -44.49 82.12 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.376 1.07 . . . . 73.1 111.646 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 75.9 t -62.5 -45.82 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.324 1.05 . . . . 74.24 110.436 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.4 t -68.77 -31.68 70.88 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.402 -0.817 . . . . 72.44 110.881 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -70.63 -31.98 69.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.807 0.843 . . . . 74.51 110.11 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.68 2.68 78.11 Favored Glycine 0 C--N 1.355 1.629 0 O-C-N 123.858 0.724 . . . . 60.33 113.181 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m 65.69 32.86 8.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.824 1.25 . . . . 73.54 111.159 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -101.09 140.63 21.45 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 106.723 -1.584 . . . . 72.33 106.723 168.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.542 ' HB2' ' HD1' ' E' ' 298' ' ' HIS . 25.0 Cg_endo -56.94 149.79 59.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.562 2.174 . . . . 53.21 111.672 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.416 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.5 tt0 -51.53 136.47 26.18 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.349 1.03 . . . . 74.34 113.202 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.552 HD21 HG12 ' A' ' 64' ' ' VAL . 10.3 tp -125.69 120.65 31.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.306 -1.315 . . . . 75.01 108.064 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.01 120.18 32.58 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.44 -0.948 . . . . 71.23 108.44 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.06 118.32 15.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.935 -0.765 . . . . 74.31 108.935 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.66 139.67 59.76 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 124.209 1.004 . . . . 75.42 111.98 -174.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . 0.438 ' HB2' ' HH ' ' C' ' 101' ' ' TYR . 4.6 Cg_exo -72.25 110.17 2.89 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.835 1.69 . . . . 74.31 110.208 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.84 123.75 52.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.65 ' HB3' ' HB2' ' A' ' 135' ' ' ALA . 7.1 m-20 -65.54 97.3 0.3 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.409 1.084 . . . . 64.2 110.835 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.2 -50.27 6.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.256 0.623 . . . . 74.31 109.556 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.578 ' HA ' ' HB3' ' A' ' 100' ' ' ALA . 11.0 p-10 -61.59 -45.22 95.03 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.704 1.201 . . . . 74.53 111.312 -177.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.65 ' HB2' ' HB3' ' A' ' 132' ' ' ASN . . . -66.07 -52.73 46.15 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.07 0.856 . . . . 62.51 110.545 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.71 -50.61 65.53 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.687 1.242 . . . . 63.42 110.449 -174.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -58.14 -37.16 74.09 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.073 0.858 . . . . 72.42 110.848 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . 0.575 ' HE2' ' HA ' ' A' ' 138' ' ' MET . 17.2 mmt -73.86 -50.58 19.64 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.108 0.563 . . . . 72.02 111.909 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 12.1 p30 -69.94 -24.19 63.31 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 111.54 0.2 . . . . 65.11 111.54 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -79.61 -44.33 21.21 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.559 0.744 . . . . 65.41 110.913 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.13 -49.74 66.42 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.523 0.515 . . . . 74.13 111.259 -172.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -162.69 27.14 0.1 Allowed 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.384 0.428 . . . . 65.12 111.156 -174.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.508 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 41.1 mt-30 56.95 34.58 25.12 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.595 0.758 . . . . 64.03 110.862 176.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 6.0 tp-100 -60.87 116.15 4.24 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.006 0.922 . . . . 74.5 111.664 -172.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.36 137.76 24.58 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.407 1.083 . . . . 75.5 109.243 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.42 -97.32 1.06 Allowed Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.522 -0.631 . . . . 62.32 111.522 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 66.21 137.16 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.291 1.436 . . . . 64.11 111.964 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 136.27 -170.64 23.19 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 116.394 -0.366 . . . . 73.34 112.203 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.3 t -164.64 162.59 21.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.036 0.934 . . . . 70.13 109.703 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.26 153.83 47.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 74.1 109.967 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -178.06 97.85 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.44 1.096 . . . . 73.11 108.518 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -147.33 103.53 3.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.883 0.473 . . . . 74.12 110.17 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -93.75 150.33 20.49 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.155 0.982 . . . . 74.41 109.428 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.97 -63.31 1.29 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.692 0.797 . . . . 64.53 109.72 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.213 0 C-N-CA 124.272 1.029 . . . . 73.23 108.477 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.534 0.207 . . . . 75.13 111.521 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 40.8 m -74.25 77.31 1.82 Allowed 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.595 0.712 . . . . 75.4 109.822 174.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' GLU . . . . . 0.49 ' HG3' ' HG2' ' B' ' 4' ' ' GLN . 8.5 pt-20 -158.14 -28.69 0.08 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.98 0.912 . . . . 72.04 110.544 -172.88 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLN . . . . . 0.49 ' HG2' ' HG3' ' B' ' 3' ' ' GLU . 9.2 pt20 -134.19 88.92 2.5 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.513 0.725 . . . . 71.24 110.32 -177.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -168.81 175.26 6.06 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.197 0.999 . . . . 74.25 108.627 175.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -66.26 95.52 0.3 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.845 0.858 . . . . 72.31 109.748 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -66.89 141.42 57.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.796 0.839 . . . . 62.11 111.269 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 76.23 -44.57 0.49 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.173 1.789 . . . . 73.32 113.512 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' MET . . . . . 0.676 ' SD ' HG22 ' B' ' 89' ' ' ILE . 1.9 ptt? 51.68 -159.12 0.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.613 1.565 . . . . 70.14 112.341 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' THR . . . . . 0.659 ' HB ' ' HB2' ' B' ' 87' ' ' ALA . 39.2 m -146.04 124.71 12.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.303 0.641 . . . . 73.45 109.694 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -134.7 139.89 45.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.724 -1.213 . . . . 74.45 107.724 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' GLN . . . . . 0.437 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 2.7 pp0? -163.39 139.61 6.93 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.057 -0.72 . . . . 72.31 109.057 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ILE . . . . . 0.607 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -91.79 134.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.378 -0.971 . . . . 65.21 108.378 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -97.97 -52.67 3.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.164 0.586 . . . . 73.22 110.566 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -151.3 134.52 16.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.609 -0.269 . . . . 75.13 110.45 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' ILE . . . . . 0.607 HG13 HD11 ' B' ' 13' ' ' ILE . 98.5 mt -114.4 136.12 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.072 -1.455 . . . . 73.43 107.072 167.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' TYR . . . . . 0.451 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.2 p90 -166.21 144.98 5.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.943 0.497 . . . . 75.3 110.882 -172.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.5 m -76.67 120.52 21.97 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.484 -0.78 . . . . 72.33 109.295 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 44.5 mtpt -92.1 -30.82 15.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.451 0.7 . . . . 74.11 111.34 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.6 142.18 17.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.59 0.233 . . . . 75.02 110.636 -173.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mm -141.1 139.35 33.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.633 1.573 . . . . 74.52 108.02 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -143.0 130.61 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.486 -1.302 . . . . 71.24 107.486 172.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' PHE . . . . . 0.513 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 79.2 t80 -137.45 119.23 15.13 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.708 -1.589 . . . . 75.33 106.708 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -117.38 122.49 43.98 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.402 -0.962 . . . . 75.14 108.402 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.49 79.84 21.74 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 107.302 -1.369 . . . . 73.14 107.302 165.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.26 -18.25 34.76 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.207 1.938 . . . . 62.15 110.419 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -111.59 15.67 21.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.984 1.314 . . . . 73.31 110.821 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.1 -54.5 7.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 N-CA-C 114.396 1.258 . . . . 75.32 114.396 -174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PRO . . . . . 0.543 ' HG2' ' HD1' ' B' ' 30' ' ' HIS . 95.0 Cg_endo -78.76 -31.75 2.32 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 121.765 1.643 . . . . 74.32 113.274 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' HIS . . . . . 0.543 ' HD1' ' HG2' ' B' ' 29' ' ' PRO . 77.0 m80 -92.35 4.11 54.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.096 0.959 . . . . 74.13 113.303 -169.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' VAL . . . . . 0.403 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 7.7 p -79.06 -6.96 10.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 C-N-CA 123.516 0.726 . . . . 72.44 110.061 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.14 -33.04 74.57 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.797 0.439 . . . . 71.43 111.141 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -76.03 -41.85 49.66 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.358 0.663 . . . . 72.22 109.931 175.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' LYS . . . . . 0.616 ' HB3' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -108.42 64.34 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.584 1.154 . . . . 75.32 109.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 31' ' ' VAL . 13.6 t70 -118.82 118.55 31.88 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.565 -0.531 . . . . 73.34 109.565 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -179.81 179.43 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.029 1.732 . . . . 73.34 107.883 155.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -47.35 106.43 0.59 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.011 0.925 . . . . 74.2 110.92 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.23 169.1 7.42 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.723 2.282 . . . . 73.5 110.667 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.26 100.69 3.19 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 106.907 -1.516 . . . . 73.21 106.907 170.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.25 126.66 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.68 -1.145 . . . . 72.23 109.401 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -128.05 135.09 49.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.738 0.815 . . . . 74.31 109.477 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' LEU . . . . . 0.537 ' HB2' ' O ' ' H' ' 288' ' ' VAL . 22.5 mt -97.41 151.79 19.6 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.337 -0.986 . . . . 73.2 108.337 172.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -148.2 109.9 4.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.419 -1.326 . . . . 75.01 107.419 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.42 HD21 HG22 ' H' ' 288' ' ' VAL . 11.0 mp -103.72 129.63 51.11 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.136 0.574 . . . . 75.21 109.478 -174.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ASP . . . . . 0.709 ' HA ' ' HA3' ' H' ' 284' ' ' GLY . 9.2 t70 -122.62 149.92 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.335 1.054 . . . . 74.21 110.192 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -118.07 128.57 54.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.631 -1.168 . . . . 74.22 109.438 -170.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.13 126.74 15.14 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.038 0.535 . . . . 72.04 110.175 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 56.5 p -136.49 160.78 37.75 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.348 . . . . 72.43 110.795 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -157.64 137.66 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.723 -0.671 . . . . 63.54 110.045 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.93 114.69 20.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.197 0.599 . . . . 75.12 110.263 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 23.5 mt -88.41 -34.55 17.5 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.603 0.761 . . . . 75.1 110.461 178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.83 -167.93 1.5 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.654 0.782 . . . . 73.4 110.573 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.86 106.24 0.98 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.576 -1.193 . . . . 65.24 110.166 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.29 9.16 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.954 1.301 . . . . 72.3 113.044 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -103.89 108.46 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.262 -1.014 . . . . 71.32 108.262 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.14 140.13 51.55 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.168 0.987 . . . . 74.53 109.239 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -103.6 99.96 9.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.234 -1.024 . . . . 74.23 108.234 -174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' VAL . . . . . 0.4 HG12 ' CZ ' ' H' ' 281' ' ' PHE . 77.0 t -88.68 125.93 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.354 1.462 . . . . 74.03 109.925 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.3 t -118.7 131.26 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.874 0.869 . . . . 74.14 109.543 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.33 108.12 18.09 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.762 -1.199 . . . . 74.14 107.762 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' ARG . . . . . 0.522 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.5 ttm180 -88.21 113.79 24.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.622 -0.881 . . . . 72.43 108.622 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.7 104.17 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.891 -1.151 . . . . 72.43 107.891 169.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -98.7 132.99 43.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.589 -0.522 . . . . 74.31 109.589 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 95.8 t -122.09 120.22 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.347 1.059 . . . . 72.43 108.933 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -115.11 143.03 45.84 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.354 0.661 . . . . 70.42 109.305 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.3 136.58 38.14 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.75 -0.833 . . . . 74.34 108.75 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 52.1 p -147.1 139.01 24.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.879 0.472 . . . . 75.41 110.672 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' LEU . . . . . 0.616 HD13 ' HB3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -136.45 139.67 42.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.905 1.282 . . . . 73.51 108.615 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.09 -115.95 6.84 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.016 -0.834 . . . . 72.44 111.016 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -122.94 3.01 9.41 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.061 0.944 . . . . 72.13 108.853 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.1 168.96 9.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.338 0.59 . . . . 74.32 111.342 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 14.8 m -71.04 143.77 50.61 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.651 -1.158 . . . . 74.14 111.028 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ALA . . . . . 0.592 ' HB1' ' HG ' ' B' ' 68' ' ' LEU . . . -95.32 -60.02 1.76 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.27 -1.011 . . . . 64.05 108.27 169.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -164.68 155.52 14.76 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.339 -1.3 . . . . 74.14 108.401 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 62.9 mt -128.23 136.52 51.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.663 -1.236 . . . . 74.35 107.663 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -148.69 152.71 37.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.235 0.614 . . . . 75.13 109.357 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -160.39 129.19 4.84 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.952 -1.129 . . . . 72.13 107.952 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -124.04 142.37 41.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.676 -0.861 . . . . 73.43 108.676 176.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -125.32 93.23 3.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.138 -1.06 . . . . 73.24 108.138 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 80' ' ' GLN . . . . . 0.402 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -83.52 102.8 12.37 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.23 -1.026 . . . . 70.34 108.23 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.29 166.85 35.25 Favored Glycine 0 C--O 1.244 0.724 0 N-CA-C 111.02 -0.832 . . . . 70.54 111.02 176.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.33 126.91 1.57 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.15 -0.78 . . . . 71.23 111.15 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.451 HG13 ' HE1' ' B' ' 17' ' ' TYR . 69.1 mt -83.68 118.51 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.67 -1.233 . . . . 64.35 107.67 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -124.34 166.84 15.23 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.358 1.063 . . . . 72.42 108.68 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 85' ' ' SER . . . . . 0.437 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 40.9 m -130.53 112.69 13.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.466 -0.939 . . . . 64.14 108.466 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 86' ' ' ILE . . . . . 0.631 ' HB ' HD13 ' B' ' 89' ' ' ILE . 2.6 pp -117.36 133.77 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.985 0.914 . . . . 75.14 109.743 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 87' ' ' ALA . . . . . 0.659 ' HB2' ' HB ' ' B' ' 10' ' ' THR . . . -155.37 158.35 38.54 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.107 0.963 . . . . 61.41 109.399 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.71 3.11 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.302 -0.408 . . . . 73.44 112.526 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 89' ' ' ILE . . . . . 0.676 HG22 ' SD ' ' B' ' 9' ' ' MET . 20.5 pt -68.5 150.12 10.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 123.041 0.536 . . . . 64.43 110.297 169.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 90' ' ' GLU . . . . . 0.437 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 39.8 tt0 -164.31 146.32 8.74 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.537 -0.756 . . . . 63.1 109.818 -174.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.76 -103.75 1.5 Allowed Glycine 0 C--N 1.349 1.298 0 O-C-N 123.332 0.395 . . . . 45.21 113.109 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.4 m -88.3 -29.28 20.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.486 0.714 . . . . 72.45 110.947 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 93' ' ' GLN . . . . . 0.437 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 47.9 mt-30 -58.66 -45.21 89.85 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.787 0.835 . . . . 74.4 110.986 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 94' ' ' MET . . . . . 0.605 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.8 ptt? -65.1 -39.56 93.33 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.214 -0.903 . . . . 72.31 110.864 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.33 82.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.738 0.815 . . . . 75.33 110.884 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -76.57 -33.56 58.48 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.591 0.757 . . . . 64.43 110.837 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -62.46 -63.11 1.33 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.89 0.476 . . . . 75.02 110.531 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.403 ' HA ' ' HB2' ' B' ' 102' ' ' CYS . 0.3 OUTLIER -81.86 -3.43 54.08 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.102 0.408 . . . . 71.25 112.102 177.119 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.21 -1.78 56.9 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 119.648 -0.529 . . . . 73.35 113.49 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.26 0.18 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.477 0.639 . . . . 64.13 111.585 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -72.02 -55.54 7.22 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.377 0.671 . . . . 72.43 111.547 -170.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' B' ' 98' ' ' LEU . 58.9 m -65.43 -37.65 21.09 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 123.875 0.87 . . . . 74.44 112.583 -178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -49.6 -48.79 17.72 Favored 'Trans proline' 0 C--N 1.397 3.117 0 C-N-CA 122.885 2.39 . . . . 74.02 113.052 164.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -64.89 -15.89 62.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 112.52 0.563 . . . . 74.24 112.52 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -80.02 -49.86 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.92 0.488 . . . . 73.2 110.264 171.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.15 -19.52 39.8 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.396 0.678 . . . . 63.51 112.784 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' PHE . . . . . 0.412 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 84.3 t80 -66.49 -45.53 58.34 Favored Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.54 1.136 . . . . 72.33 113.423 -172.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.6 Cg_endo -57.58 -35.7 98.77 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 122.105 1.87 . . . . 75.14 113.256 176.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' TYR . . . . . 0.402 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.9 m-85 -68.05 -45.13 74.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.292 0.637 . . . . 73.05 110.418 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.57 84.47 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.925 -0.58 . . . . 71.43 110.813 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -59.84 -57.55 12.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.482 1.113 . . . . 72.12 110.254 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -31.69 71.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.697 0.799 . . . . 62.31 110.831 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.461 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.2 t -72.04 -43.56 64.77 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.931 0.492 . . . . 75.1 111.269 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 87.4 mt -62.99 -44.74 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.347 0.659 . . . . 74.14 109.671 174.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -61.56 -30.83 70.91 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.995 -1.002 . . . . 75.52 111.344 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -73.58 -52.95 11.7 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.317 0.647 . . . . 73.32 110.07 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 117' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 36.4 mmt -59.31 -46.94 87.22 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.903 0.881 . . . . 75.34 111.641 -173.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.65 -34.9 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 74.21 110.879 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t -67.99 -30.76 70.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.357 -0.383 . . . . 74.32 110.74 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -68.76 -18.93 64.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.435 0.694 . . . . 74.42 110.823 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.1 15.71 42.42 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-O 119.533 -0.593 . . . . 74.41 112.488 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' THR . . . . . 0.43 HG21 ' HB3' ' A' ' 17' ' ' TYR . 57.6 p 62.14 28.8 17.32 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.856 2.063 . . . . 70.25 112.809 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -97.16 150.93 37.36 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.817 0.447 . . . . 73.53 110.938 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.86 -165.06 0.11 Allowed 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 123.751 2.967 . . . . 72.1 113.579 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 18.3 tp60 -63.78 115.79 5.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.753 -0.658 . . . . 75.41 112.565 -170.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -119.43 100.92 7.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.899 -1.148 . . . . 74.53 107.899 168.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.49 135.19 54.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 73.31 109.766 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.09 139.26 33.32 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 124.255 0.972 . . . . 72.24 110.39 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 129' ' ' ALA . . . . . 0.523 ' HB2' HD11 ' H' ' 291' ' ' LEU . . . -83.37 147.26 52.68 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.101 0.961 . . . . 73.22 110.35 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.13 109.37 1.31 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.939 2.426 . . . . 74.4 111.489 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 131' ' ' VAL . . . . . 0.485 HG21 HD13 ' H' ' 291' ' ' LEU . 56.0 t -95.24 131.5 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.896 0.879 . . . . 72.04 109.897 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 132' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' B' ' 135' ' ' ALA . 57.1 t30 -82.12 90.3 6.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.33 0.586 . . . . 71.42 109.771 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -69.83 -25.01 63.55 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.993 -1.003 . . . . 75.23 111.363 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -59.95 -38.62 82.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.852 0.861 . . . . 71.14 110.727 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 135' ' ' ALA . . . . . 0.49 ' HB3' ' ND2' ' B' ' 132' ' ' ASN . . . -63.55 -38.49 91.32 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.725 0.81 . . . . 65.35 112.289 -178.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.2 -42.64 81.66 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 123.955 0.784 . . . . 70.53 110.596 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -77.34 -42.23 37.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.584 -1.189 . . . . 70.3 111.462 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -58.97 -35.71 73.64 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.423 1.089 . . . . 72.1 112.292 -170.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -73.29 -38.75 65.76 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.338 -0.392 . . . . 74.43 110.284 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -70.4 -30.68 67.63 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.07 0.462 . . . . 73.52 111.17 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 42.2 mt -99.58 9.3 43.43 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.125 0.97 . . . . 74.33 111.261 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -68.29 114.92 7.17 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.491 0.717 . . . . 75.11 110.734 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -122.71 131.98 54.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.676 0.79 . . . . 75.14 110.592 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -99.93 140.76 33.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.777 0.831 . . . . 74.11 110.02 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.84 152.29 38.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.439 1.096 . . . . 71.54 109.458 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.89 -159.38 9.58 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.472 -0.331 . . . . 72.3 112.995 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.93 -173.63 2.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.797 0.839 . . . . 74.33 109.891 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.96 135.88 13.28 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.475 -0.625 . . . . 62.13 111.573 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 38.7 p -65.32 106.88 1.46 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.558 0.743 . . . . 73.43 110.542 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -88.84 121.74 31.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.983 0.513 . . . . 70.43 110.52 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -81.73 174.93 10.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.24 0.616 . . . . 73.44 110.583 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -131.22 147.91 52.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.226 0.61 . . . . 72.03 110.104 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -80.6 121.48 25.88 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.245 -0.65 . . . . 75.43 109.245 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -129.35 119.67 24.28 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.572 -1.27 . . . . 71.13 107.572 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.004 0.922 . . . . 74.44 110.001 -172.062 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' C' C ' 1' ' ' MET . . . . . 0.435 ' N ' ' SD ' ' C' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.484 1.225 0 CA-C-O 120.788 0.328 . . . . 71.04 110.127 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -162.38 151.99 15.98 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.55 0.74 . . . . 73.14 109.374 -173.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.75 114.45 28.67 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.097 -0.705 . . . . 73.05 109.097 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.25 172.2 13.64 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.407 0.623 . . . . 73.43 111.497 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -144.73 151.23 38.57 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.824 1.25 . . . . 72.53 108.817 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -167.85 158.13 10.54 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.334 0.654 . . . . 73.55 109.438 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 73.4 p -117.76 72.9 0.86 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.235 0.614 . . . . 71.51 111.871 -170.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -138.59 89.68 2.39 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.736 0.814 . . . . 73.41 109.667 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 9' ' ' MET . . . . . 0.561 ' HE3' ' SG ' ' C' ' 97' ' ' CYS . 48.6 ttp 65.28 119.35 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.91 1.284 . . . . 75.43 113.039 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 3.8 m -84.77 85.12 7.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.333 -1.358 . . . . 71.3 107.333 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 11' ' ' PHE . . . . . 0.435 ' HB2' ' HE1' ' C' ' 9' ' ' MET . 59.4 t80 -93.77 120.17 33.69 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.635 -0.712 . . . . 72.23 109.875 -175.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -138.79 142.64 38.75 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.464 0.706 . . . . 74.05 110.144 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -77.96 137.79 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.945 0.778 . . . . 71.34 109.279 174.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 14' ' ' GLN . . . . . 0.41 ' HA ' ' HB3' ' G' ' 304' ' ' PRO . 15.3 mm100 -101.78 -51.17 3.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.802 -0.444 . . . . 64.32 109.802 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -167.86 124.77 1.12 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.092 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.73 147.14 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -175.15 160.77 2.76 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.142 0.496 . . . . 73.23 110.807 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.8 p -78.87 115.03 18.3 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.005 -0.998 . . . . 75.14 108.534 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -66.6 -43.68 84.17 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.904 0.859 . . . . 71.14 109.415 172.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.1 t70 -150.52 145.94 26.28 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.959 -1.473 . . . . 75.42 109.211 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 21' ' ' ILE . . . . . 0.417 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.2 mt -140.25 141.27 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.6 -1.629 . . . . 65.4 106.6 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.3 t -153.16 150.62 29.24 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.111 0.481 . . . . 75.22 110.116 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -151.14 115.42 5.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.579 -1.267 . . . . 72.13 107.579 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -116.22 116.1 27.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.966 -1.124 . . . . 75.53 107.966 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.19 85.53 5.5 Favored Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.285 -1.376 . . . . 73.01 107.285 170.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.31 -26.11 30.0 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.635 2.223 . . . . 65.24 112.025 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.31 36.83 4.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 124.142 0.977 . . . . 74.52 109.081 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 28' ' ' ALA . . . . . 0.452 ' HB2' ' CE2' ' D' ' 17' ' ' TYR . . . -45.31 -52.77 20.25 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 124.613 1.165 . . . . 73.53 114.012 -177.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.22 -32.81 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 121.563 1.509 . . . . 74.3 113.345 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -70.06 -27.1 64.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.887 0.875 . . . . 74.32 113.071 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.22 -15.15 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.542 0.737 . . . . 73.34 110.271 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.06 -34.9 79.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.102 0.561 . . . . 74.55 111.3 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -89.75 7.49 36.62 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.964 0.906 . . . . 74.12 111.889 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 34' ' ' LYS . . . . . 0.455 ' HD2' HD12 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -98.73 147.25 25.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 75.35 111.202 -171.142 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.74 131.09 44.9 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.414 1.085 . . . . 60.12 109.832 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 36' ' ' TRP . . . . . 0.592 ' HB3' ' HB3' ' F' ' 297' ' ' TYR . 26.7 m95 -80.06 71.33 6.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.737 0.815 . . . . 75.24 110.786 -174.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -143.98 72.53 16.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 108.179 -1.045 . . . . 71.4 108.179 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 38' ' ' PRO . . . . . 0.71 ' HG3' ' HD2' ' F' ' 297' ' ' TYR . 69.4 Cg_endo -90.97 155.84 3.94 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.795 2.33 . . . . 75.22 111.18 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -87.1 81.39 8.05 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 106.893 -1.521 . . . . 71.32 106.893 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 40' ' ' VAL . . . . . 0.624 HG13 ' HG2' ' C' ' 38' ' ' PRO . 12.6 m -68.35 123.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 CA-C-N 114.517 -1.219 . . . . 75.11 109.383 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 41' ' ' LYS . . . . . 0.623 ' HB3' ' HZ3' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -136.86 126.73 25.74 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.528 -0.916 . . . . 74.21 108.528 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.56 138.41 31.73 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.121 0.968 . . . . 74.33 108.637 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 43' ' ' ASP . . . . . 0.801 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.2 m-20 -119.01 119.1 33.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.114 0.965 . . . . 73.44 109.177 -175.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.02 125.54 52.6 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.125 -1.065 . . . . 70.52 108.125 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 45' ' ' ASP . . . . . 0.627 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 7.3 t70 -137.12 142.67 42.29 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.698 0.799 . . . . 75.14 109.583 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -115.4 116.73 28.74 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.962 0.905 . . . . 75.51 110.836 -171.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.03 153.01 47.25 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.371 1.068 . . . . 73.34 110.072 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.3 p -166.13 159.05 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.985 0.514 . . . . 74.0 111.732 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -149.88 153.88 37.43 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.556 0.742 . . . . 74.52 111.08 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.2 122.75 33.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 108.991 -0.744 . . . . 73.1 108.991 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 51' ' ' LEU . . . . . 0.585 HD13 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -96.58 -44.17 7.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.717 0.807 . . . . 75.22 110.205 -176.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 52' ' ' ALA . . . . . 0.472 ' HB2' ' HB ' ' C' ' 55' ' ' VAL . . . -157.94 -165.31 1.71 Allowed 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.139 -0.937 . . . . 75.33 109.952 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -70.4 102.78 2.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.725 0.81 . . . . 74.03 109.601 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 71.62 -3.24 2.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.726 1.61 . . . . 64.43 113.444 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 55' ' ' VAL . . . . . 0.472 ' HB ' ' HB2' ' C' ' 52' ' ' ALA . 95.5 t -92.09 113.48 27.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.242 -1.392 . . . . 74.52 107.242 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.34 149.17 49.36 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.074 0.95 . . . . 72.44 108.945 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 57' ' ' GLU . . . . . 0.585 ' HB2' HD13 ' C' ' 51' ' ' LEU . 45.9 tt0 -104.41 136.23 44.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.112 -0.699 . . . . 71.43 109.112 172.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.43 120.84 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.442 -1.688 . . . . 73.52 106.442 171.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.53 135.56 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.078 0.951 . . . . 73.55 109.048 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 60' ' ' LEU . . . . . 0.425 HD21 HD12 ' C' ' 106' ' ' LEU . 3.8 mm? -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.698 0.799 . . . . 73.45 109.072 172.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 61' ' ' ARG . . . . . 0.627 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 17.2 ttm-85 -81.84 106.15 13.53 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.443 -0.947 . . . . 74.15 108.443 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.85 120.4 59.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.92 -1.141 . . . . 62.43 107.92 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 63' ' ' THR . . . . . 0.801 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 48.0 m -133.26 145.77 50.8 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.242 1.017 . . . . 74.2 108.405 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 64' ' ' VAL . . . . . 0.429 HG22 HD12 ' C' ' 114' ' ' ILE . 98.9 t -127.08 121.23 57.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.9 -0.778 . . . . 72.33 108.9 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -104.58 142.5 34.54 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.007 0.817 . . . . 74.43 109.514 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 100.42 4.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.137 -1.06 . . . . 71.41 108.137 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -139.23 126.59 21.51 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.888 -0.412 . . . . 71.24 109.888 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 68' ' ' LEU . . . . . 0.455 HD12 ' HD2' ' C' ' 34' ' ' LYS . 0.3 OUTLIER -100.82 60.04 0.95 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 122.172 0.987 . . . . 74.24 109.416 176.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -122.05 7.18 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 113.979 -1.464 . . . . 73.31 110.4 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -89.65 -16.96 29.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.498 0.719 . . . . 65.15 109.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -75.92 92.49 3.12 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.249 1.019 . . . . 73.11 109.091 170.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 84.9 m -83.35 121.7 27.49 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 109.036 -0.727 . . . . 73.31 109.036 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.7 -51.48 10.51 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.45 -1.25 . . . . 71.53 109.478 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -161.08 175.64 12.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.663 0.745 . . . . 62.33 110.976 168.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -145.12 144.36 30.87 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.403 -1.702 . . . . 72.13 106.403 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.3 t -146.21 112.03 5.64 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.158 -0.682 . . . . 75.05 109.158 175.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -118.38 117.39 28.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.06 0.544 . . . . 72.2 110.459 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.44 122.01 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.129 0.572 . . . . 73.25 109.554 172.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -99.68 105.04 16.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.956 -1.127 . . . . 75.23 107.956 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -93.2 112.96 25.05 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.516 0.727 . . . . 72.34 110.234 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.58 161.57 25.06 Favored Glycine 0 C--N 1.337 0.627 0 O-C-N 123.473 0.483 . . . . 73.34 112.782 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.81 120.58 0.98 Allowed Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.253 -0.739 . . . . 73.45 111.253 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 83' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 12.6 mm -84.31 122.76 38.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.207 -1.034 . . . . 73.4 108.207 176.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -133.49 130.59 38.75 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 73.55 109.062 -176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -85.96 106.58 17.24 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.892 -0.781 . . . . 73.1 108.892 171.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 86' ' ' ILE . . . . . 0.417 HG21 ' SD ' ' C' ' 9' ' ' MET . 66.7 mt -116.32 107.93 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.954 0.902 . . . . 75.43 108.987 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.15 138.32 20.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.786 0.835 . . . . 73.31 109.458 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.33 -47.74 1.0 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.641 0.588 . . . . 75.1 112.366 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.89 172.68 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.147 0.579 . . . . 64.53 111.526 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.28 151.31 17.26 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.594 0.758 . . . . 75.42 110.585 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.11 -112.62 4.47 Favored Glycine 0 C--N 1.356 1.669 0 O-C-N 123.731 0.644 . . . . 64.52 114.191 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.3 p -64.3 -35.03 79.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.982 0.913 . . . . 71.24 111.842 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -77.86 -35.69 50.69 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.914 -0.585 . . . . 74.0 111.41 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 94' ' ' MET . . . . . 0.64 ' SD ' ' HA ' ' F' ' 277' ' ' LEU . 12.6 ptt? -70.66 -23.66 62.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 110.333 -0.247 . . . . 72.41 110.333 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.75 92.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.762 0.425 . . . . 73.21 110.878 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 96' ' ' HIS . . . . . 0.429 ' O ' ' HB2' ' C' ' 100' ' ' ALA . 57.3 t-80 -73.7 -32.45 63.93 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 116.203 -0.453 . . . . 65.31 111.305 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 97' ' ' CYS . . . . . 0.561 ' SG ' ' HE3' ' C' ' 9' ' ' MET . 52.4 t -81.81 -62.55 1.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.157 0.503 . . . . 72.11 110.628 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.42 -43.83 96.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.484 1.113 . . . . 72.41 111.817 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.57 5.27 82.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.295 -0.725 . . . . 72.12 114.876 -172.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . 0.547 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -149.39 -56.35 0.19 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.306 1.053 . . . . 73.42 112.908 -173.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 101' ' ' TYR . . . . . 0.438 ' HH ' ' HB2' ' A' ' 130' ' ' PRO . 89.3 t80 -71.13 -49.43 44.14 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.349 1.06 . . . . 75.44 111.543 -173.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.53 -44.42 65.83 Favored Pre-proline 0 CA--C 1.571 1.788 0 C-N-CA 124.144 0.977 . . . . 65.23 112.249 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.06 -40.64 67.73 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.948 2.432 . . . . 70.4 114.196 169.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -64.14 -31.64 72.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.787 0.679 . . . . 63.22 110.825 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 105' ' ' ILE . . . . . 0.426 HG23 ' NH1' ' A' ' 111' ' ' ARG . 39.9 mm -68.2 -41.55 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.82 0.448 . . . . 75.53 110.856 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 106' ' ' LEU . . . . . 0.425 HD12 HD21 ' C' ' 60' ' ' LEU . 86.4 mt -88.88 -22.22 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.701 0.8 . . . . 54.41 113.014 -172.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -56.36 -48.54 96.79 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 113.947 1.092 . . . . 74.54 113.947 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.8 -33.27 76.6 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 121.912 1.741 . . . . 71.13 113.64 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -48.04 69.4 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.432 0.693 . . . . 73.34 110.359 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.36 81.25 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.948 -1.023 . . . . 71.05 110.597 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.48 -52.47 64.6 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.938 -1.483 . . . . 75.45 112.003 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -33.27 73.91 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.607 0.363 . . . . 74.42 110.568 -173.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.46 -29.44 66.0 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 122.999 0.519 . . . . 75.43 110.839 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 114' ' ' ILE . . . . . 0.429 HD12 HG22 ' C' ' 64' ' ' VAL . 73.3 mt -72.04 -44.16 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.599 0.76 . . . . 74.24 109.768 170.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -64.34 -30.13 71.18 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.47 0.708 . . . . 72.21 111.174 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 116' ' ' SER . . . . . 0.404 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.9 t -71.76 -49.57 37.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.824 0.85 . . . . 74.1 109.002 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 117' ' ' MET . . . . . 0.549 ' HE1' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.0 -39.88 94.12 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.097 0.959 . . . . 74.05 113.041 -175.24 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.7 -34.78 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 109.944 -0.391 . . . . 74.53 109.944 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -72.71 -32.07 65.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.559 0.744 . . . . 62.02 111.587 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 120' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -68.16 -26.76 65.92 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.21 0.604 . . . . 75.42 110.42 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 11.52 68.35 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 119.246 -0.752 . . . . 74.03 113.271 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 122' ' ' THR . . . . . 0.523 HG22 ' HB3' ' D' ' 17' ' ' TYR . 52.7 p 58.76 26.86 15.21 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.91 1.684 . . . . 71.51 112.82 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -102.05 151.64 38.07 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.706 0.802 . . . . 75.31 109.922 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 124' ' ' PRO . . . . . 0.549 ' HD3' HD13 ' F' ' 301' ' ' ILE . 35.3 Cg_exo -59.87 121.55 10.01 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.016 2.477 . . . . 71.53 113.108 -171.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -60.33 146.37 44.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.111 0.882 . . . . 73.43 112.496 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -141.66 127.58 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 108.316 -0.994 . . . . 65.4 108.316 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.13 114.88 25.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.587 -1.264 . . . . 70.24 107.587 172.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 29.9 tp -64.86 129.01 38.14 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.86 0.725 . . . . 74.04 110.532 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.2 151.09 97.46 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.98 1.312 . . . . 74.11 112.039 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 130' ' ' PRO . . . . . 0.442 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.1 Cg_exo -64.02 109.88 1.21 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.979 2.453 . . . . 74.44 112.28 -177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.16 108.67 21.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.619 -1.252 . . . . 72.51 107.619 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 132' ' ' ASN . . . . . 0.435 ' O ' HD22 ' C' ' 136' ' ' LEU . 14.7 m120 -82.23 101.39 10.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.557 -0.747 . . . . 75.23 110.239 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -80.02 -38.46 31.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.332 -0.988 . . . . 73.42 108.332 168.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 134' ' ' ASP . . . . . 0.547 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.1 p-10 -55.71 -44.74 77.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.118 1.767 . . . . 65.12 112.856 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.04 -37.85 75.69 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.013 0.925 . . . . 73.05 111.798 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 136' ' ' LEU . . . . . 0.435 HD22 ' O ' ' C' ' 132' ' ' ASN . 4.5 mm? -66.51 -46.38 76.4 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.548 -0.751 . . . . 74.42 110.953 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -74.4 -18.65 60.63 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.414 0.686 . . . . 73.51 112.433 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 55.6 ttp -66.75 -38.41 86.55 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.478 0.711 . . . . 73.33 109.926 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.75 -37.33 86.95 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.025 -0.989 . . . . 72.03 110.594 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -69.78 -84.94 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.079 0.952 . . . . 75.44 110.218 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.5 90.64 3.47 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.736 0.814 . . . . 71.43 109.966 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.36 97.23 6.25 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.73 -1.211 . . . . 74.24 107.73 169.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -161.29 132.51 5.41 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 108.454 -0.943 . . . . 75.43 108.454 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.65 150.92 45.51 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 123.619 0.574 . . . . 71.31 111.365 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . 0.435 ' HB1' ' HE2' ' C' ' 9' ' ' MET . . . -167.46 130.63 1.71 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.668 1.187 . . . . 64.32 108.717 176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.31 -39.47 0.55 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 111.082 -0.807 . . . . 72.44 111.082 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.82 134.95 36.36 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.016 -1.105 . . . . 72.31 108.016 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.21 66.36 0.39 Allowed Glycine 0 N--CA 1.476 1.343 0 CA-C-N 118.686 0.675 . . . . 75.43 112.516 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.0 m -83.41 73.34 10.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.611 0.764 . . . . 75.12 111.445 -174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -136.83 140.07 42.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.611 0.764 . . . . 71.45 110.137 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -135.9 179.26 6.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.187 1.395 . . . . 73.43 109.46 -177.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 63.7 112.24 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.907 1.283 . . . . 72.44 111.642 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -97.92 173.82 6.88 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 116.099 -0.5 . . . . 73.23 110.158 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -136.15 125.71 25.26 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.133 0.973 . . . . 74.33 109.116 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 123.523 0.729 . . . . 72.43 109.152 178.199 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 110.441 -0.207 . . . . 75.3 110.441 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -63.82 138.09 58.33 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.651 0.78 . . . . 73.3 111.056 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.57 -72.82 0.26 Allowed 'General case' 0 CA--C 1.551 1.006 0 O-C-N 123.869 0.731 . . . . 74.44 110.768 -174.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 73.08 -36.26 0.35 Allowed 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 125.413 1.485 . . . . 71.12 111.966 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 73.58 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.329 1.852 . . . . 73.14 110.132 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 178.5 15.22 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.859 1.264 . . . . 71.25 109.844 -172.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 55.8 p -73.27 -16.52 61.39 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.447 0.699 . . . . 73.33 111.926 -170.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -99.25 -66.19 0.92 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.356 -0.979 . . . . 74.34 108.356 166.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 9' ' ' MET . . . . . 0.601 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER 23.11 170.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 129.178 2.991 . . . . 74.43 118.858 -170.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.7 m -141.92 136.64 30.63 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.631 -1.168 . . . . 72.1 109.611 172.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -143.87 112.11 6.34 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.233 -1.025 . . . . 61.32 108.233 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 12' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 71.3 mt-30 -131.59 154.54 48.76 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.467 -0.938 . . . . 75.32 108.467 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 13' ' ' ILE . . . . . 0.407 HD11 HG21 ' D' ' 105' ' ' ILE . 35.6 mt -104.02 132.94 49.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.913 -1.143 . . . . 74.45 107.913 168.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.36 -48.14 8.23 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.627 -0.509 . . . . 75.03 109.627 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -155.64 148.29 24.08 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.32 0.648 . . . . 75.31 109.873 -176.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 16' ' ' ILE . . . . . 0.414 ' H ' HD12 ' D' ' 16' ' ' ILE . 0.2 OUTLIER -124.05 111.21 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.345 -1.354 . . . . 71.21 107.345 168.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 17' ' ' TYR . . . . . 0.523 ' HB3' HG22 ' C' ' 122' ' ' THR . 31.8 p90 -140.56 170.2 16.23 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.82 0.819 . . . . 73.51 111.764 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.4 p -101.2 121.31 41.61 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.556 -1.202 . . . . 65.03 108.883 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 40.0 mtpt -88.23 -30.62 19.56 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.984 0.513 . . . . 73.43 110.346 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 20' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.6 t70 -152.86 127.02 9.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.142 -0.935 . . . . 73.22 108.573 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 21' ' ' ILE . . . . . 0.549 HG21 ' HE1' ' C' ' 117' ' ' MET . 82.7 mt -123.93 144.07 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.335 -1.357 . . . . 72.03 107.335 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -152.49 110.67 3.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 124.188 0.93 . . . . 71.32 109.494 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 23' ' ' PHE . . . . . 0.417 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 75.1 t80 -108.39 128.75 55.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.109 -1.812 . . . . 73.12 106.109 162.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -123.86 151.01 43.91 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.851 -0.796 . . . . 75.03 108.851 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 25' ' ' ALA . . . . . 0.506 ' HB2' ' HB1' ' D' ' 28' ' ' ALA . . . -132.82 76.59 70.55 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 106.616 -1.624 . . . . 74.21 106.616 170.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.5 -45.23 31.47 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.561 2.841 . . . . 73.14 113.113 -166.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 27' ' ' ASN . . . . . 0.455 ' HB2' HG22 ' D' ' 31' ' ' VAL . 20.3 m-80 -114.59 25.99 10.57 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.232 -0.895 . . . . 74.12 110.101 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 28' ' ' ALA . . . . . 0.506 ' HB1' ' HB2' ' D' ' 25' ' ' ALA . . . -39.01 -60.02 1.27 Allowed Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 115.798 1.777 . . . . 72.24 115.798 -163.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 29' ' ' PRO . . . . . 0.446 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 31.3 Cg_endo -81.94 -14.47 9.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 CA-C-N 122.282 1.851 . . . . 74.44 113.542 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.02 -38.77 69.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.36 1.064 . . . . 74.33 109.301 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 31' ' ' VAL . . . . . 0.591 HG11 HD11 ' D' ' 68' ' ' LEU . 52.8 t -63.35 -39.04 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.914 0.886 . . . . 62.24 109.991 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 32' ' ' PHE . . . . . 0.446 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.9 m-30 -60.12 -9.22 2.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.378 1.251 . . . . 74.05 114.378 -173.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -77.77 -37.67 48.44 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.974 0.51 . . . . 75.34 111.108 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -132.8 62.83 1.65 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.847 0.859 . . . . 75.3 109.979 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 35' ' ' ASP . . . . . 0.537 ' HB3' HD13 ' G' ' 301' ' ' ILE . 42.5 t0 -107.79 83.28 1.77 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.847 0.832 . . . . 65.31 110.706 -169.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -126.5 -178.53 4.39 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.713 -1.131 . . . . 71.44 108.062 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pm0 -48.56 100.59 0.24 Allowed Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 123.571 0.749 . . . . 74.13 112.728 -162.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 38' ' ' PRO . . . . . 0.449 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 59.9 Cg_endo -71.62 149.09 54.65 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.601 2.201 . . . . 64.21 111.107 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.63 111.45 4.79 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.873 -1.158 . . . . 73.42 107.873 173.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 40' ' ' VAL . . . . . 0.436 HG23 ' NE1' ' G' ' 290' ' ' TRP . 2.8 m -103.54 106.27 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.919 0.888 . . . . 74.22 109.164 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -100.95 129.98 46.88 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.069 0.948 . . . . 74.42 109.952 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 tp -97.09 119.53 35.76 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.05 -0.722 . . . . 75.41 109.05 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 43' ' ' ASP . . . . . 0.626 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.2 m-20 -120.32 130.82 54.61 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.782 0.833 . . . . 75.0 109.15 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.02 137.42 47.81 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.831 0.853 . . . . 75.32 109.155 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 45' ' ' ASP . . . . . 0.596 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 6.3 t70 -135.83 132.27 36.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 44.4 p -104.94 143.61 32.93 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.717 0.807 . . . . 71.25 109.773 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 47' ' ' ALA . . . . . 0.585 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.18 155.47 36.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.892 0.877 . . . . 71.03 110.025 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 48' ' ' SER . . . . . 0.432 ' HB2' HD23 ' G' ' 278' ' ' LEU . 28.6 p -158.99 162.8 36.82 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.219 0.533 . . . . 65.0 111.228 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -150.01 150.02 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.649 -1.16 . . . . 74.4 109.462 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -100.71 122.52 43.49 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.335 -1.358 . . . . 74.42 107.335 159.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 51' ' ' LEU . . . . . 0.485 HD12 ' HB2' ' D' ' 57' ' ' GLU . 23.0 mt -96.3 -26.36 15.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.453 0.701 . . . . 74.2 109.38 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.33 173.46 5.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.758 1.223 . . . . 75.0 109.532 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.93 131.47 46.33 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.623 -0.88 . . . . 73.44 108.623 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 70.15 -2.05 2.23 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.112 1.365 . . . . 61.11 113.086 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.65 116.34 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.35 0.66 . . . . 72.04 109.29 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.01 162.13 31.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.979 -0.749 . . . . 72.51 108.979 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 57' ' ' GLU . . . . . 0.485 ' HB2' HD12 ' D' ' 51' ' ' LEU . 28.4 tt0 -130.42 118.31 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.084 0.954 . . . . 74.51 108.604 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 58' ' ' VAL . . . . . 0.518 HG11 ' HZ ' ' G' ' 281' ' ' PHE . 77.3 t -100.48 113.31 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.387 -1.338 . . . . 75.24 107.387 175.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 59' ' ' VAL . . . . . 0.585 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.9 t -107.01 127.72 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.997 -1.112 . . . . 75.55 107.997 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 60' ' ' LEU . . . . . 0.46 ' HB3' HD22 ' D' ' 106' ' ' LEU . 0.9 OUTLIER -128.94 112.65 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.762 -1.199 . . . . 75.42 107.762 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 61' ' ' ARG . . . . . 0.596 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.3 ttm180 -85.18 118.4 24.71 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.733 0.813 . . . . 75.44 109.459 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.59 122.0 62.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.943 -1.132 . . . . 74.1 107.943 170.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 63' ' ' THR . . . . . 0.626 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.4 m -119.36 137.27 53.83 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.561 0.745 . . . . 73.53 109.92 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 71.5 t -128.24 103.73 10.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 C-N-CA 125.146 1.378 . . . . 70.53 107.729 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.2 m -101.91 105.24 16.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.515 0.726 . . . . 70.34 109.454 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . 0.449 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -99.28 128.5 45.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.276 0.63 . . . . 74.05 110.633 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -144.81 126.06 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.174 0.589 . . . . 65.41 110.443 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 68' ' ' LEU . . . . . 0.591 HD11 HG11 ' D' ' 31' ' ' VAL . 3.4 pp -124.96 139.81 53.49 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.723 0.809 . . . . 75.44 111.187 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.57 -111.47 3.34 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 110.479 -1.049 . . . . 33.14 110.479 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 3.35 8.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 75.02 110.446 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.78 167.76 14.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.109 0.564 . . . . 75.23 110.082 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.0 m -84.65 126.47 33.39 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.492 -0.777 . . . . 75.42 110.593 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 73' ' ' ALA . . . . . 0.407 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -69.7 -64.95 0.78 Allowed 'General case' 0 C--O 1.242 0.668 0 O-C-N 124.259 0.974 . . . . 64.51 109.299 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.1 162.2 39.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.559 -1.201 . . . . 74.31 110.432 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -124.12 141.42 52.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.898 1.279 . . . . 72.03 108.012 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 76' ' ' CYS . . . . . 0.592 ' SG ' ' HE2' ' D' ' 117' ' ' MET . 21.8 t -152.27 109.5 3.55 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.652 -0.499 . . . . 73.23 109.652 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -140.41 130.65 25.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.404 1.082 . . . . 74.53 108.848 -171.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.68 116.36 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.428 0.691 . . . . 73.53 109.788 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 79' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -88.04 83.93 6.99 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.851 -1.166 . . . . 74.55 107.851 166.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 80' ' ' GLN . . . . . 0.449 ' HB3' HD23 ' D' ' 106' ' ' LEU . 4.4 tp-100 -79.84 114.82 19.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.44 -1.318 . . . . 75.54 107.44 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -109.16 142.03 16.11 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.194 -0.762 . . . . 73.43 111.194 178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.9 5.92 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.058 -0.817 . . . . 73.34 111.058 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.31 126.06 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.062 -1.088 . . . . 72.32 108.062 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -123.65 127.96 48.97 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.593 1.157 . . . . 75.11 109.229 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 85' ' ' SER . . . . . 0.549 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 43.8 m -78.63 101.16 7.32 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.301 -1.0 . . . . 73.15 108.301 169.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 86' ' ' ILE . . . . . 0.484 HG22 HD21 ' G' ' 277' ' ' LEU . 61.4 mt -108.59 128.99 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.914 0.886 . . . . 71.4 109.725 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.24 159.15 25.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.973 0.909 . . . . 72.22 110.328 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 88' ' ' GLY . . . . . 0.601 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.79 14.96 78.79 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 115.011 0.765 . . . . 72.14 115.011 169.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 89' ' ' ILE . . . . . 0.437 HD13 ' HA ' ' D' ' 94' ' ' MET . 18.3 pt -136.67 134.93 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.355 -0.979 . . . . 75.23 108.355 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.98 157.66 45.93 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.949 -0.47 . . . . 73.51 111.202 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -118.51 14.5 Favored Glycine 0 C--N 1.355 1.605 0 O-C-N 124.658 1.224 . . . . 74.43 113.565 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 17.4 m -69.6 -31.36 69.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.738 0.815 . . . . 75.23 111.985 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -72.99 -42.33 63.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.828 0.451 . . . . 73.02 110.871 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 94' ' ' MET . . . . . 0.437 ' HA ' HD13 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -72.04 -34.37 68.73 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.234 -0.284 . . . . 70.21 110.234 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.84 92.54 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.782 0.833 . . . . 71.21 110.893 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -67.7 -36.42 80.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 72.53 110.953 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.8 -51.41 34.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.582 0.353 . . . . 73.12 110.85 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.19 -20.48 44.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.649 0.379 . . . . 71.04 111.652 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.39 -2.98 55.59 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.608 -0.551 . . . . 63.21 114.007 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.82 -64.48 0.41 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.69 0.745 . . . . 65.41 111.251 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -64.23 -56.11 16.92 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.812 0.671 . . . . 74.32 112.812 -170.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.3 m -60.2 -45.41 97.76 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.31 1.044 . . . . 74.51 112.417 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.76 -40.2 80.91 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 122.65 2.234 . . . . 74.02 113.254 168.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.33 -22.81 57.35 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.465 0.706 . . . . 71.45 112.406 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 13' ' ' ILE . 29.0 mm -71.74 -42.77 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 122.302 1.048 . . . . 74.35 109.166 169.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 106' ' ' LEU . . . . . 0.46 HD22 ' HB3' ' D' ' 60' ' ' LEU . 8.6 tt -76.55 -27.82 56.06 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 113.562 -1.653 . . . . 74.23 111.171 -173.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.91 -40.83 72.52 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 125.254 1.422 . . . . 74.1 113.905 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.38 -34.42 88.87 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.477 2.118 . . . . 62.2 114.272 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -79.55 -30.9 41.88 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.185 0.594 . . . . 73.02 111.055 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.35 79.14 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.363 -0.606 . . . . 75.12 109.363 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 111' ' ' ARG . . . . . 0.403 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 25.2 ttp180 -54.52 -55.41 29.42 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.098 -1.41 . . . . 73.34 111.158 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -60.16 -43.93 95.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.027 0.829 . . . . 71.04 111.177 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -63.26 -45.44 91.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.804 0.442 . . . . 74.21 111.318 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 114' ' ' ILE . . . . . 0.579 HG22 ' SG ' ' D' ' 76' ' ' CYS . 69.2 mt -58.06 -59.39 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.877 0.871 . . . . 73.5 110.555 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 94.9 m -51.64 -43.57 62.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.569 1.548 . . . . 71.01 112.426 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.2 t -68.9 -39.33 79.79 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.204 -0.907 . . . . 74.33 110.741 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 117' ' ' MET . . . . . 0.592 ' HE2' ' SG ' ' D' ' 76' ' ' CYS . 70.8 mtm -71.33 -32.33 68.44 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.0 0.52 . . . . 70.22 111.721 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 118' ' ' VAL . . . . . 0.401 HG21 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -63.65 -44.98 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 O-C-N 123.683 0.614 . . . . 74.2 109.432 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -73.02 -27.84 62.0 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.171 0.588 . . . . 74.31 111.808 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -73.4 -31.4 63.85 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.6 0.76 . . . . 74.21 110.499 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.94 5.44 75.85 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.599 0.562 . . . . 72.15 111.933 171.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p 61.5 14.67 6.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.128 2.171 . . . . 75.21 113.333 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -80.01 158.81 72.04 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.483 1.113 . . . . 72.43 108.585 169.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -67.42 124.5 12.13 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.746 2.297 . . . . 75.2 111.419 -168.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -53.3 116.8 2.61 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.298 0.999 . . . . 72.32 110.282 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -109.13 131.45 55.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.831 -1.174 . . . . 74.11 107.831 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -107.34 98.2 7.86 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.37 -0.974 . . . . 71.12 108.37 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 128' ' ' LEU . . . . . 0.403 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 65.3 tp -56.73 115.7 2.71 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.874 1.27 . . . . 73.14 111.053 -176.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.13 95.85 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.933 0.893 . . . . 74.52 110.895 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.26 139.05 25.87 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.104 1.869 . . . . 74.41 111.719 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.48 111.27 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.727 -0.842 . . . . 74.31 108.727 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.41 81.39 4.76 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.402 -0.962 . . . . 72.33 108.402 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -77.04 -29.28 55.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.862 -1.063 . . . . 75.41 111.44 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.84 -46.45 74.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.813 0.445 . . . . 75.43 111.497 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.98 -60.77 2.9 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.014 0.926 . . . . 63.13 112.367 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 136' ' ' LEU . . . . . 0.52 HD12 ' HB3' ' G' ' 285' ' ' ASN . 3.3 pp -64.97 -27.04 68.56 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.404 -0.816 . . . . 73.44 112.197 -175.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.67 -40.6 33.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.402 0.681 . . . . 63.22 110.565 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.0 mtm -72.7 -26.85 61.75 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.486 0.714 . . . . 73.54 111.297 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -56.15 -40.02 73.2 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.679 0.612 . . . . 74.32 110.666 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.46 -43.72 96.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.312 1.045 . . . . 75.44 111.179 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.94 -29.29 70.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.264 1.026 . . . . 73.53 111.561 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -83.06 4.54 25.79 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.757 0.823 . . . . 74.13 112.419 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -118.63 88.55 2.95 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.173 -0.677 . . . . 75.42 109.173 -174.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.58 112.95 1.73 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.685 -1.143 . . . . 75.23 107.997 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.48 101.5 6.21 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.43 0.692 . . . . 63.22 109.312 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -127.28 76.43 0.4 Allowed Glycine 0 C--N 1.343 0.921 0 N-CA-C 110.492 -1.043 . . . . 63.35 110.492 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.68 142.9 50.62 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.493 0.717 . . . . 74.22 110.628 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.92 152.49 11.29 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.573 -0.74 . . . . 65.24 111.85 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.0 t -146.61 174.86 11.05 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.227 0.611 . . . . 55.5 110.14 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.99 -77.89 0.12 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.219 -2.141 . . . . 65.44 105.219 169.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -174.26 94.87 0.09 Allowed 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.957 -1.127 . . . . 72.13 107.957 173.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -159.35 66.76 0.4 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.413 -0.958 . . . . 73.34 108.413 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -18.83 57.87 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.866 -1.061 . . . . 74.51 111.303 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -76.16 167.22 22.25 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.037 0.935 . . . . 74.24 110.097 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 123.731 0.812 . . . . 74.21 109.01 176.373 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.66 -0.496 . . . . 53.53 109.66 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -81.0 156.01 26.11 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.286 -0.635 . . . . 64.24 109.286 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -60.03 113.05 2.12 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.03 0.932 . . . . 74.12 108.746 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -69.45 -66.86 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.882 0.739 . . . . 73.21 110.069 -168.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 275' ' ' LYS . . . . . 0.436 ' O ' ' HB3' ' A' ' 90' ' ' GLU . 26.9 mtmt -161.1 148.52 12.16 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 124.408 1.083 . . . . 72.12 108.936 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -43.21 129.7 6.13 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 124.421 3.414 . . . . 74.4 114.763 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 67.0 mt -54.43 140.53 33.72 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.858 1.263 . . . . 75.01 110.666 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 7.3 mp 76.61 2.18 3.38 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.04 1.336 . . . . 74.01 112.003 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -76.72 89.86 0.95 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.872 -0.491 . . . . 71.24 111.872 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . 0.509 HD13 ' HB1' ' A' ' 95' ' ' ALA . 47.9 tp -159.98 -67.34 0.07 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.494 0.718 . . . . 71.35 110.174 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -53.78 -70.17 0.1 Allowed 'General case' 0 C--N 1.359 0.994 0 O-C-N 124.376 1.047 . . . . 72.32 112.641 -163.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 57.77 -82.83 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.158 0.983 . . . . 70.05 110.52 -171.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -113.91 148.01 37.51 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.391 1.076 . . . . 72.1 109.141 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.59 68.48 3.18 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 111.461 -0.656 . . . . 74.42 111.461 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -80.56 -8.34 59.56 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.848 0.859 . . . . 74.02 112.029 -169.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 52.3 mtm -118.73 87.96 33.87 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.129 0.572 . . . . 74.32 109.674 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -86.27 135.62 4.56 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.787 2.325 . . . . 73.23 110.058 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 288' ' ' VAL . . . . . 0.559 ' HB ' HD22 ' A' ' 42' ' ' LEU . 80.4 t -69.25 103.63 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 109.597 -0.52 . . . . 74.35 109.597 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -58.07 137.4 56.93 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.26 -1.015 . . . . 71.4 108.26 170.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -74.28 74.93 1.84 Allowed 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.708 0.63 . . . . 74.02 111.536 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 291' ' ' LEU . . . . . 0.454 HD11 ' HB ' ' G' ' 306' ' ' VAL . 24.0 mt 51.7 25.69 3.01 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.732 1.613 . . . . 74.21 113.824 163.082 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.06 -137.23 20.27 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-O 119.173 -0.793 . . . . 71.2 112.428 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.45 87.76 1.43 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.69 2.26 . . . . 75.31 112.45 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -143.17 167.21 22.65 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.778 0.831 . . . . 73.21 110.997 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -149.16 175.89 10.97 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.296 1.038 . . . . 74.51 110.653 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 99.0 m -133.69 113.08 11.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.475 0.71 . . . . 65.24 110.22 176.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 297' ' ' TYR . . . . . 0.6 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . 58.3 t80 -167.34 146.56 5.09 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.438 -1.319 . . . . 75.24 107.438 171.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 298' ' ' HIS . . . . . 0.542 ' HD1' ' HB2' ' A' ' 124' ' ' PRO . 70.9 m80 -134.68 -49.26 0.76 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.145 -1.057 . . . . 74.42 108.145 176.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 299' ' ' GLY . . . . . 0.506 ' H ' ' HG3' ' A' ' 124' ' ' PRO . . . 148.44 129.86 1.88 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.669 -0.696 . . . . 63.51 111.603 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -152.55 7.74 0.44 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.326 1.05 . . . . 71.35 110.221 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 301' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 32' ' ' PHE . 4.1 mp -117.31 137.68 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.522 0.729 . . . . 72.13 109.652 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -169.42 -89.79 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.646 -1.242 . . . . 73.42 107.646 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -175.15 75.29 0.3 Allowed Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 105.993 -1.855 . . . . 71.2 105.993 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.35 121.05 6.55 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 121.596 1.53 . . . . 73.25 109.285 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -160.1 137.9 9.86 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.914 0.486 . . . . 63.24 109.98 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.59 1.07 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 124.146 0.978 . . . . 75.01 110.001 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 71.6 p 67.05 -69.85 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.715 2.006 . . . . 62.24 111.459 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 74.3 m -154.6 136.07 14.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.419 1.087 . . . . 74.45 109.051 171.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 63.3 m -74.26 -41.03 4.84 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 124.528 1.131 . . . . 74.35 110.992 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 C--N 1.402 3.366 0 C-N-CA 122.057 1.838 . . . . 71.5 111.167 166.842 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.022 0.439 . . . . 55.2 110.154 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' F' F ' 272' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' F' ' 274' ' ' GLN . 52.2 t30 -96.85 120.78 37.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.2 -1.037 . . . . 71.21 108.2 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -71.62 -14.74 62.15 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.72 0.638 . . . . 71.31 111.935 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 274' ' ' GLN . . . . . 0.445 ' HB3' ' ND2' ' F' ' 272' ' ' ASN . 1.1 tm0? -57.55 -32.58 67.25 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.184 0.594 . . . . 73.25 110.65 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -73.47 113.47 22.74 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 109.051 -0.722 . . . . 71.15 109.051 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.44 -151.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 123.238 2.625 . . . . 72.43 110.706 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . 0.64 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 59.1 mt -50.14 137.67 17.34 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 123.586 0.754 . . . . 63.22 111.987 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 77.65 -173.02 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 O-C-N 125.05 1.469 . . . . 74.23 110.816 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 87.69 -57.59 4.4 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.473 -0.651 . . . . 73.41 111.473 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -75.71 77.01 2.68 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 108.193 -1.04 . . . . 74.43 108.193 175.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -165.82 33.66 0.05 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.698 1.199 . . . . 73.24 108.332 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -141.42 89.97 2.26 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.988 -0.745 . . . . 64.03 108.988 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -168.56 151.17 5.2 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.297 -1.001 . . . . 74.21 108.297 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -84.93 57.84 4.99 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.588 0.555 . . . . 65.11 112.744 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.34 127.09 31.82 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.986 0.915 . . . . 74.04 109.929 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 4.4 mpp? 55.27 88.66 0.12 Allowed Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.75 1.22 . . . . 71.43 111.11 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.62 -42.71 18.77 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.92 3.08 . . . . 75.24 114.493 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 48.7 t 46.31 84.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.957 1.303 . . . . 71.52 111.772 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -59.27 2.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.956 -1.498 . . . . 73.33 106.956 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -152.21 178.15 9.79 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.953 1.301 . . . . 73.44 109.234 165.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 291' ' ' LEU . . . . . 0.594 ' HG ' HG21 ' H' ' 309' ' ' THR . 4.7 mp -114.64 16.07 17.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.745 0.818 . . . . 74.4 110.973 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -166.32 162.09 35.72 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 119.275 -0.736 . . . . 73.25 111.898 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.82 1.4 8.15 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.347 2.698 . . . . 71.3 113.244 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -87.66 -178.86 6.19 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.933 1.293 . . . . 72.55 112.524 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 295' ' ' ALA . . . . . 0.502 ' HA ' HG22 ' C' ' 40' ' ' VAL . . . -143.65 155.95 44.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.171 0.988 . . . . 61.33 110.313 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 296' ' ' THR . . . . . 0.518 ' H ' HG12 ' C' ' 40' ' ' VAL . 7.5 m -63.31 -33.6 75.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.512 0.725 . . . . 74.53 111.064 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 297' ' ' TYR . . . . . 0.71 ' HD2' ' HG3' ' C' ' 38' ' ' PRO . 42.3 m-85 -87.39 60.79 6.26 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.65 0.738 . . . . 72.23 110.455 169.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.43 109.92 3.39 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.776 -1.564 . . . . 63.31 106.776 158.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -61.73 79.78 0.02 OUTLIER Glycine 0 C--N 1.353 1.485 0 O-C-N 124.788 1.305 . . . . 75.13 115.348 -165.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -100.0 -21.73 15.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.216 1.006 . . . . 64.31 109.493 173.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 301' ' ' ILE . . . . . 0.549 HD13 ' HD3' ' C' ' 124' ' ' PRO . 46.9 mt -69.35 96.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.119 0 N-CA-C 109.035 -0.728 . . . . 75.11 109.035 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -155.92 -42.35 0.08 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.955 -1.021 . . . . 74.33 108.669 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -96.92 127.33 39.4 Favored Pre-proline 0 N--CA 1.476 0.838 0 N-CA-C 108.783 -0.821 . . . . 73.0 108.783 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.27 163.08 39.75 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.914 2.41 . . . . 73.21 112.317 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -95.61 -32.63 12.71 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.371 0.668 . . . . 72.43 110.893 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.98 116.53 52.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 C-N-CA 123.956 0.902 . . . . 72.2 108.989 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 91.5 m -133.66 93.82 3.19 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 107.676 -1.231 . . . . 64.34 107.676 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 56.0 m 65.63 175.02 0.22 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.985 1.314 . . . . 63.53 111.783 -173.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 16.3 p -132.69 156.97 79.49 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.832 1.253 . . . . 65.32 109.029 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' F' F ' 310' ' ' PRO . . . . . 0.412 ' HG2' ' HB3' ' B' ' 132' ' ' ASN . 9.5 Cg_endo . . . . . 0 C--N 1.387 2.587 0 C-N-CA 123.014 2.476 . . . . 75.11 112.331 174.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.743 -0.466 . . . . 74.12 109.743 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -158.38 177.12 11.6 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.152 0.581 . . . . 74.53 109.961 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -67.5 106.14 2.05 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.469 0.652 . . . . 74.34 109.736 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -160.71 -175.29 4.88 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.666 0.786 . . . . 75.0 109.36 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 275' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' G' ' 278' ' ' LEU . 2.4 mppt? -110.65 89.47 9.13 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.898 -1.149 . . . . 75.1 107.898 174.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 276' ' ' PRO . . . . . 0.4 ' O ' ' HG2' ' D' ' 94' ' ' MET . 88.8 Cg_endo -78.41 -2.66 12.7 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.579 2.186 . . . . 73.42 112.119 -177.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . 0.484 HD21 HG22 ' D' ' 86' ' ' ILE . 96.1 mt -131.16 17.85 4.99 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.858 1.263 . . . . 75.11 110.832 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 278' ' ' LEU . . . . . 0.432 HD23 ' HB2' ' D' ' 48' ' ' SER . 0.4 OUTLIER -153.69 101.38 2.46 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.803 -0.443 . . . . 75.3 109.803 -179.241 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -173.58 143.93 7.41 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.008 -0.885 . . . . 73.44 111.4 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 65.5 tp 62.29 106.95 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.038 1.335 . . . . 74.24 111.77 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 281' ' ' PHE . . . . . 0.518 ' HZ ' HG11 ' D' ' 58' ' ' VAL . 0.1 OUTLIER -134.31 -45.42 0.77 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.664 0.385 . . . . 75.33 110.209 -174.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' G' G ' 282' ' ' ALA . . . . . 0.65 ' HA ' ' HG2' ' G' ' 286' ' ' MET . . . -123.87 72.32 1.15 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.255 0.622 . . . . 73.44 111.499 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -171.12 116.48 0.44 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.167 0.987 . . . . 70.13 109.343 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 151.02 -75.86 0.24 Allowed Glycine 0 C--N 1.346 1.089 0 N-CA-C 110.721 -0.951 . . . . 74.41 110.721 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 285' ' ' ASN . . . . . 0.52 ' HB3' HD12 ' D' ' 136' ' ' LEU . 17.0 t-20 -159.93 31.68 0.18 Allowed 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 122.37 1.081 . . . . 72.31 109.192 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 286' ' ' MET . . . . . 0.65 ' HG2' ' HA ' ' G' ' 282' ' ' ALA . 1.5 mpt? -69.18 -31.77 2.92 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 115.478 1.658 . . . . 75.54 115.478 -172.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.23 77.2 0.33 Allowed 'Trans proline' 0 C--N 1.4 3.251 0 CA-C-N 122.424 1.901 . . . . 74.53 112.541 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.19 121.14 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.457 0.703 . . . . 70.02 109.42 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -69.36 165.48 20.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.322 1.049 . . . . 74.51 110.753 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 290' ' ' TRP . . . . . 0.436 ' NE1' HG23 ' D' ' 40' ' ' VAL . 20.2 t-105 -73.82 123.99 25.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.844 0.458 . . . . 71.41 110.161 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.74 129.19 35.6 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.585 0.754 . . . . 74.03 109.935 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 86.12 166.02 41.62 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.62 0.575 . . . . 61.14 114.028 175.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.57 162.59 19.21 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.239 2.626 . . . . 74.32 112.513 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -80.39 74.79 7.24 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.472 1.13 . . . . 72.14 109.364 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.71 24.77 3.4 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.726 -1.124 . . . . 73.25 110.636 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 16.0 p -68.27 -76.8 0.08 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.444 1.098 . . . . 74.24 112.186 -173.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.52 111.35 21.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.509 0.324 . . . . 65.22 111.218 -167.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -145.68 107.14 4.22 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.857 0.863 . . . . 72.23 109.155 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 177.12 -141.15 5.23 Favored Glycine 0 C--N 1.337 0.607 0 O-C-N 123.835 0.71 . . . . 74.23 111.693 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -150.5 109.21 3.84 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.193 0.997 . . . . 74.25 109.047 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 301' ' ' ILE . . . . . 0.537 HD13 ' HB3' ' D' ' 35' ' ' ASP . 50.3 mt -93.12 61.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-O 122.52 1.152 . . . . 72.43 109.446 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -165.47 72.48 0.18 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.731 -1.581 . . . . 62.14 106.731 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -168.11 74.95 0.89 Allowed Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.557 -0.747 . . . . 74.21 110.36 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 304' ' ' PRO . . . . . 0.46 ' HG2' ' HA ' ' G' ' 307' ' ' THR . 37.3 Cg_endo -70.29 133.74 25.28 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.835 1.69 . . . . 70.11 110.972 171.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.72 -33.65 68.65 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.833 0.853 . . . . 70.13 110.801 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 306' ' ' VAL . . . . . 0.454 ' HB ' HD11 ' E' ' 291' ' ' LEU . 5.1 p -114.04 100.56 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.43 -0.952 . . . . 73.02 108.43 164.397 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 307' ' ' THR . . . . . 0.46 ' HA ' ' HG2' ' G' ' 304' ' ' PRO . 9.4 m -73.18 -32.21 64.69 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.531 -0.759 . . . . 73.24 110.538 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 19.3 p -162.17 125.5 3.03 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 124.539 1.136 . . . . 75.1 108.735 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 61.7 m -76.46 130.18 77.74 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-O 118.101 -0.952 . . . . 75.21 109.222 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo . . . . . 0 C--N 1.398 3.134 1 C-N-CA 125.406 4.07 . . . . 64.41 115.892 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.432 -0.21 . . . . 50.02 110.432 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -115.4 -48.95 2.77 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.483 1.113 . . . . 75.02 108.524 174.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.94 78.38 8.28 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.205 -0.907 . . . . 73.01 109.149 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -68.58 -33.8 74.69 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.774 -0.648 . . . . 60.11 110.747 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -114.14 87.34 13.0 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 109.165 -0.68 . . . . 75.21 109.165 172.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -88.2 128.33 2.23 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.545 2.163 . . . . 72.02 111.328 172.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . 0.503 HD22 ' SD ' ' B' ' 94' ' ' MET . 1.2 tt -81.31 65.97 6.66 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.755 -1.202 . . . . 72.33 107.755 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 47.8 tp -175.59 136.6 0.34 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.131 1.372 . . . . 74.3 107.98 -174.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.55 -69.11 0.03 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.517 -1.033 . . . . 61.33 110.517 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.74 -176.92 6.52 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.476 0.711 . . . . 74.13 109.633 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 281' ' ' PHE . . . . . 0.4 ' CZ ' HG12 ' B' ' 58' ' ' VAL . 38.4 t80 69.39 85.09 0.14 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.26 1.024 . . . . 71.31 110.203 176.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -174.09 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.585 1.154 . . . . 63.41 108.97 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -112.71 100.17 8.49 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.237 -1.023 . . . . 75.23 108.237 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 284' ' ' GLY . . . . . 0.709 ' HA3' ' HA ' ' B' ' 45' ' ' ASP . . . -81.84 91.36 1.49 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.812 -0.515 . . . . 74.42 111.812 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -117.61 28.24 8.57 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.068 0.947 . . . . 73.25 110.552 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -105.54 96.74 12.59 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 109.312 -0.625 . . . . 75.23 109.312 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.62 94.26 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.674 2.25 . . . . 73.34 110.208 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 288' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' B' ' 42' ' ' LEU . 57.3 t -61.03 111.4 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.728 -0.669 . . . . 75.1 110.32 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -82.28 150.15 27.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.796 -0.816 . . . . 75.1 108.796 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -61.03 142.98 56.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.165 0.586 . . . . 74.53 111.225 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 291' ' ' LEU . . . . . 0.523 HD11 ' HB2' ' B' ' 129' ' ' ALA . 5.6 mp -82.23 81.26 8.19 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.206 1.002 . . . . 73.24 108.949 -174.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 80.19 -130.53 9.85 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.834 -0.981 . . . . 72.4 111.19 -172.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.82 179.24 4.39 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.812 2.341 . . . . 75.24 113.013 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -155.48 -65.16 0.12 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.064 -0.971 . . . . 74.43 109.46 172.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 63.91 109.93 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.07 1.348 . . . . 74.53 111.794 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 25.9 m -77.68 -59.76 2.65 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.879 0.472 . . . . 72.24 109.861 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -109.05 111.05 22.49 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 108.27 -1.011 . . . . 74.34 108.27 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -154.92 150.02 26.96 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.784 0.433 . . . . 65.22 110.166 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 69.35 -95.97 0.46 Allowed Glycine 0 C--N 1.35 1.343 0 O-C-N 124.068 0.855 . . . . 62.3 111.912 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -120.53 111.02 17.17 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.1 -1.074 . . . . 73.41 108.1 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 301' ' ' ILE . . . . . 0.473 HG21 ' O ' ' H' ' 302' ' ' ASP . 1.2 tt -68.36 -24.35 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.357 1.063 . . . . 75.22 111.612 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 302' ' ' ASP . . . . . 0.473 ' O ' HG21 ' H' ' 301' ' ' ILE . 2.5 t70 85.82 -161.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 126.573 1.949 . . . . 71.23 107.162 -163.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -158.12 101.39 1.75 Allowed Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 108.301 -1.0 . . . . 73.24 108.301 165.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.96 77.92 0.77 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.556 2.17 . . . . 73.55 110.628 172.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -144.28 81.05 1.66 Allowed 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.441 -1.254 . . . . 75.45 108.976 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 306' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 13' ' ' ILE . 45.3 t -65.29 114.1 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 115.42 -0.809 . . . . 74.43 109.023 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 5.0 m -123.62 6.16 8.87 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.57 0.748 . . . . 75.3 109.815 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 24.6 p -168.04 164.71 13.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.246 1.019 . . . . 63.22 109.727 -174.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' H' H ' 309' ' ' THR . . . . . 0.594 HG21 ' HG ' ' F' ' 291' ' ' LEU . 17.5 m -145.64 61.79 7.93 Favored Pre-proline 0 CA--C 1.565 1.542 0 C-N-CA 123.507 0.723 . . . . 73.22 109.302 170.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 C--N 1.38 2.192 0 C-N-CA 122.3 2.0 . . . . 71.11 111.102 178.753 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.3 m . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.098 -0.704 . . . . 73.32 109.098 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.523 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -138.47 132.28 31.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.199 1.0 . . . . 72.51 109.76 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -153.56 109.11 3.23 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.153 0.581 . . . . 71.41 109.764 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 84' ' ' PHE . 45.5 mt -75.06 122.92 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.294 -0.632 . . . . 73.13 109.294 177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -93.57 -35.34 12.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.598 0.561 . . . . 70.4 110.677 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -169.23 140.29 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.658 -0.246 . . . . 63.25 110.356 -170.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.63 HD12 ' HG3' ' C' ' 130' ' ' PRO . 0.2 OUTLIER -125.95 141.54 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.175 -1.046 . . . . 75.22 108.175 173.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.6 p90 -174.16 155.7 2.49 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.926 0.49 . . . . 73.13 111.365 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -78.36 121.29 24.29 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.808 -0.633 . . . . 72.51 109.569 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.5 mtpt -87.02 -25.2 24.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.625 0.37 . . . . 73.23 110.187 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.2 t70 -151.27 139.31 20.07 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.462 -0.79 . . . . 75.21 109.623 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.3 mt -131.38 139.47 50.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 106.77 -1.567 . . . . 75.41 106.77 176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -147.59 127.4 13.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.235 -1.024 . . . . 65.5 108.235 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.2 t80 -135.63 113.12 10.73 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.227 -1.397 . . . . 64.0 107.227 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.82 130.03 55.55 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.797 -0.816 . . . . 63.03 108.797 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -121.1 78.52 33.38 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.222 -1.399 . . . . 62.23 107.222 174.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.05 -46.77 23.56 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 123.641 2.894 . . . . 62.31 113.272 -164.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.16 41.68 3.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.759 -0.83 . . . . 74.03 108.759 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -45.65 -53.5 19.41 Favored Pre-proline 0 CA--C 1.561 1.379 0 O-C-N 124.199 0.937 . . . . 61.44 112.322 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -63.96 -23.84 67.71 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 121.951 1.767 . . . . 72.41 113.173 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -95.35 -21.95 18.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.728 0.811 . . . . 65.41 111.342 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.2 t -80.79 -32.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.002 0.921 . . . . 63.54 112.424 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.08 -1.47 20.27 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.453 0.701 . . . . 74.51 112.863 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -105.71 -11.3 16.35 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.003 0.921 . . . . 64.12 112.236 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.17 170.96 15.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.567 0.951 . . . . 73.44 113.567 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.427 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.9 m-20 -61.01 134.36 57.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.766 1.226 . . . . 65.23 110.013 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -85.44 62.29 7.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 73.34 111.604 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -146.59 76.73 11.73 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.153 0.981 . . . . 73.11 109.906 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.88 149.14 32.85 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.525 2.15 . . . . 73.03 112.428 163.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.49 102.12 13.81 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.707 -1.219 . . . . 75.42 107.707 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 t -84.92 95.44 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.746 -0.464 . . . . 72.41 109.746 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -85.32 119.74 26.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.087 -0.961 . . . . 70.41 109.605 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -97.58 146.18 25.54 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.382 0.61 . . . . 72.41 109.423 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.676 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.9 m-20 -136.84 146.8 46.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.41 1.084 . . . . 73.51 108.531 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 tt -141.32 125.34 17.22 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.715 -1.217 . . . . 70.21 107.715 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.9 m-20 -116.32 131.95 56.8 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.102 -1.073 . . . . 71.42 108.102 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -106.06 125.02 50.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.812 -1.085 . . . . 61.13 109.085 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.05 126.05 9.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.257 0.623 . . . . 74.34 109.352 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 p -110.57 162.67 14.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.638 0.775 . . . . 73.34 109.21 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 44.4 t -148.44 153.61 38.75 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.502 0.721 . . . . 44.02 109.665 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -104.96 116.44 31.96 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.151 -1.055 . . . . 72.14 108.151 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.5 mt -96.36 -35.78 11.09 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.07 0.462 . . . . 65.34 109.96 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -153.87 -179.03 7.47 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.164 -0.925 . . . . 73.0 109.653 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.29 121.94 16.37 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.585 -0.895 . . . . 71.42 108.585 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 67.3 8.22 6.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.57 1.148 . . . . 53.1 112.515 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 67.8 t -113.51 106.2 20.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 107.929 -1.137 . . . . 72.05 107.929 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.98 125.27 50.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.772 -1.104 . . . . 71.12 108.593 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 34.9 tt0 -91.98 148.95 21.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.346 -0.843 . . . . 52.22 109.315 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.587 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 41.2 t -127.13 130.11 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.58 -1.267 . . . . 74.13 107.58 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.55 131.1 72.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.432 -0.951 . . . . 75.1 108.432 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 103' ' ' PRO . 2.7 mm? -119.52 114.9 22.97 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.842 -1.17 . . . . 73.4 107.842 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 21.5 ttp180 -85.18 100.35 11.69 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -93.99 110.1 23.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.522 -1.288 . . . . 44.41 107.522 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.676 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -109.12 126.91 53.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.962 -0.755 . . . . 72.54 108.962 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.6 t -116.03 124.17 72.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 106.906 -1.516 . . . . 63.01 106.906 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 2.6 m -127.16 129.65 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.351 -0.611 . . . . 42.44 109.351 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.65 124.16 37.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.814 -0.81 . . . . 72.22 108.814 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.9 m -134.03 127.42 32.23 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.298 0.639 . . . . 54.22 109.938 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 35' ' ' ASP . 5.2 mp -87.4 80.66 8.08 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.559 -1.275 . . . . 70.04 107.559 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.44 -83.49 1.32 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.232 -1.349 . . . . 35.22 111.286 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.34 -21.73 10.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 72.43 111.586 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.73 119.32 38.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.53 0.332 . . . . 73.23 111.207 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 25.0 m -70.47 133.24 46.64 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.75 0.648 . . . . 63.43 112.75 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.12 -63.62 1.36 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.885 1.274 . . . . 54.31 109.99 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -153.35 168.82 24.78 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 114.694 -1.139 . . . . 73.31 110.931 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -143.89 107.29 4.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.599 -1.637 . . . . 62.42 107.352 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.9 m -105.8 97.91 7.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.102 0.561 . . . . 64.03 110.525 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.99 115.48 29.0 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.859 0.863 . . . . 73.41 108.796 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.83 109.89 17.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.656 0.783 . . . . 71.12 109.317 -173.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.0 mt-30 -85.38 86.44 7.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.753 -0.832 . . . . 74.02 108.753 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -78.49 104.6 9.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.806 -1.088 . . . . 72.44 108.876 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.73 160.11 28.6 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.797 -0.638 . . . . 62.22 112.106 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.02 123.33 1.23 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.115 -0.794 . . . . 45.43 111.115 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.364 0.666 . . . . 70.23 109.463 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.598 ' HD2' HG12 ' A' ' 13' ' ' ILE . 33.7 m-85 -134.44 118.89 17.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.445 -0.946 . . . . 61.22 108.445 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -83.48 100.69 10.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.77 -0.826 . . . . 72.41 108.77 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.39 140.53 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.328 0.651 . . . . 51.01 110.697 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.16 165.87 30.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.461 1.104 . . . . 63.22 109.534 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.89 86.61 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.086 0.395 . . . . 64.44 114.086 176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -110.1 134.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.236 0.615 . . . . 51.42 109.522 -172.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -146.56 171.68 14.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.581 1.152 . . . . 74.34 108.6 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.44 -129.02 24.53 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 115.404 0.922 . . . . 43.34 115.404 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.585 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.44 -15.18 59.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.454 0.702 . . . . 72.24 111.922 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -67.64 -45.21 76.02 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.618 -0.512 . . . . 71.43 109.618 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -27.96 49.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.683 0.393 . . . . 45.11 110.625 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.65 -32.01 71.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.293 0.637 . . . . 63.22 111.718 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -87.31 -33.91 19.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.206 0.603 . . . . 61.43 110.209 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -61.65 -45.91 92.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.95 0.5 . . . . 70.44 110.355 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.02 -30.21 18.9 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.487 -0.779 . . . . 53.42 111.176 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.65 -3.27 81.0 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 114.846 0.698 . . . . 64.02 114.846 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.96 -60.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.937 0.868 . . . . 71.34 112.208 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.484 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 71.0 t80 -68.89 -70.68 0.26 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 113.101 0.778 . . . . 74.13 113.101 -168.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 79.3 m -63.71 -33.11 9.17 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.889 1.44 . . . . 64.33 114.889 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HA ' HD21 ' A' ' 60' ' ' LEU . 30.0 Cg_endo -62.64 -33.46 77.39 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 121.768 1.645 . . . . 50.25 112.98 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -74.54 -15.92 60.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.185 0.594 . . . . 73.43 111.097 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.72 -40.97 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.46 0.648 . . . . 54.14 109.527 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.97 -17.89 27.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.15 -0.932 . . . . 73.5 112.346 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.32 -45.37 99.09 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.243 -0.884 . . . . 72.43 113.156 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.99 -31.25 76.94 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.202 1.934 . . . . 73.32 113.509 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -76.64 -36.48 57.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.365 0.666 . . . . 72.23 111.911 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.77 77.91 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 109.133 -0.692 . . . . 63.15 109.133 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.548 HH12 HD12 ' C' ' 105' ' ' ILE . 31.6 ttm180 -52.62 -52.01 57.43 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.742 1.276 . . . . 72.15 109.932 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.81 -48.68 78.05 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.394 1.059 . . . . 75.15 110.601 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.436 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.2 t -57.59 -43.22 84.46 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.77 0.669 . . . . 70.43 111.252 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 76.9 mt -62.78 -56.9 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.164 -0.925 . . . . 74.5 109.785 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.427 HG21 ' HE2' ' C' ' 109' ' ' TYR . 89.7 m -50.55 -43.72 56.29 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.595 1.184 . . . . 64.11 111.667 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -62.72 -48.4 79.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.539 -1.209 . . . . 65.03 109.945 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.433 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 36.6 mtm -64.4 -40.41 95.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.163 0.585 . . . . 62.11 111.296 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.5 t -56.46 -48.18 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 123.906 0.754 . . . . 64.2 109.807 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.3 t -73.38 -26.87 61.18 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 114.955 -1.02 . . . . 73.13 111.438 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -73.06 -27.93 62.02 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.619 0.768 . . . . 73.12 110.59 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.86 3.6 74.62 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.779 0.674 . . . . 44.44 112.896 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.3 m 62.1 44.16 8.18 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.077 1.351 . . . . 70.11 110.272 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -116.97 145.42 35.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.201 -1.363 . . . . 75.02 108.068 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.54 131.82 0.39 Allowed 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 124.196 3.264 . . . . 61.21 114.263 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.95 133.6 56.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.033 0.833 . . . . 71.13 110.969 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.06 110.67 21.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.254 -0.647 . . . . 74.35 109.254 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -99.57 108.69 21.16 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.284 -1.376 . . . . 75.54 107.284 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.31 117.43 7.85 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.647 -0.871 . . . . 72.53 108.647 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.95 98.14 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.314 0.646 . . . . 71.35 111.08 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 76.4 Cg_exo -54.78 109.42 0.4 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.119 2.546 . . . . 63.23 113.484 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.95 112.8 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.035 -1.469 . . . . 74.12 107.035 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -81.39 95.03 6.91 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.768 -0.827 . . . . 72.33 108.768 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -57.8 -32.48 67.6 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.735 -1.121 . . . . 62.31 111.45 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.473 0.702 0 O-C-N 124.309 1.005 . . . . 65.25 110.741 177.225 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.243 0.719 0 N-CA-C 107.047 -1.464 . . . . 74.14 107.047 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.568 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 77.2 t80 -140.88 132.34 26.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.01 -0.737 . . . . 71.22 109.01 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -144.07 131.61 21.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.306 -0.998 . . . . 72.13 108.306 171.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -82.02 126.73 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.044 -0.724 . . . . 74.3 109.044 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.12 -42.44 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.25 0.62 . . . . 71.2 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -165.01 151.02 10.0 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.466 0.174 . . . . 75.31 110.764 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.71 135.16 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.244 -1.762 . . . . 63.35 106.244 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HE1' HG13 ' B' ' 83' ' ' ILE . 7.3 p90 -168.24 146.29 4.29 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.166 0.586 . . . . 75.23 109.962 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.5 m -76.97 122.55 25.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.511 -0.768 . . . . 53.24 108.982 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -98.08 -27.22 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 72.23 111.379 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.7 t70 -158.35 139.69 13.39 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.527 0.517 . . . . 72.41 111.261 -172.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.2 mm -140.88 141.86 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.423 1.489 . . . . 74.04 108.001 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -145.78 131.58 19.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.211 -1.403 . . . . 54.42 107.211 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.5 t80 -145.76 110.28 5.06 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.73 -1.211 . . . . 63.23 107.73 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.42 134.3 54.99 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.803 -0.814 . . . . 74.33 108.803 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.6 81.22 60.5 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 106.419 -1.696 . . . . 62.23 106.419 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.69 -32.62 37.5 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.371 2.714 . . . . 74.15 112.469 -171.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.45 31.56 6.66 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.605 1.162 . . . . 72.21 109.855 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -43.07 -48.4 14.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 115.818 1.784 . . . . 71.54 115.818 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.74 -25.02 4.6 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 121.843 1.696 . . . . 35.4 112.789 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.42 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 72.0 m80 -94.74 -16.19 23.25 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.024 0.75 . . . . 72.11 113.024 -171.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' B' ' 73' ' ' ALA . 12.0 p -64.23 -12.75 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.803 0.841 . . . . 75.15 111.96 175.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -56.37 -25.74 50.55 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.013 0.925 . . . . 73.15 112.637 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.423 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 24.8 pt20 -71.44 -29.13 64.52 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.42 111.108 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 32.2 mmtp -107.52 80.3 1.39 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.342 1.057 . . . . 74.33 108.691 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.71 109.19 18.54 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.408 -0.815 . . . . 62.42 110.283 -174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.436 ' O ' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER 161.69 -158.91 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.965 2.506 . . . . 74.33 109.262 157.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 15.0 mp0 -49.44 106.99 0.69 Allowed Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 124.679 1.192 . . . . 72.42 111.621 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.22 153.07 14.12 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.479 2.119 . . . . 62.42 110.944 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -71.1 102.33 2.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.269 -1.011 . . . . 62.45 108.269 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -88.9 140.61 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.481 -0.933 . . . . 74.43 108.481 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -134.56 125.61 27.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.35 1.06 . . . . 75.31 109.211 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.2 148.0 23.52 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.131 0.972 . . . . 64.34 109.17 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -158.69 112.5 2.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.903 -0.777 . . . . 72.34 108.903 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.18 134.04 43.68 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.127 -0.694 . . . . 70.14 109.127 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.06 142.06 51.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.13 0.972 . . . . 52.13 108.882 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -109.19 117.5 34.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.538 0.735 . . . . 61.11 110.427 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -124.68 140.25 53.1 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.248 1.019 . . . . 75.21 109.036 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.5 p -145.12 162.89 35.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.848 0.459 . . . . 53.33 111.102 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -158.89 145.81 17.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.301 1.04 . . . . 64.54 109.238 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -96.49 112.05 23.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.527 -0.916 . . . . 74.14 108.527 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.24 -45.12 50.02 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.424 0.69 . . . . 74.2 110.681 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.4 -174.1 4.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.669 -1.151 . . . . 40.13 109.584 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.59 116.92 11.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.353 -0.84 . . . . 73.43 109.065 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 70.6 -2.29 2.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.541 1.536 . . . . 71.14 112.978 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.9 t -104.52 113.52 41.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -117.63 169.16 9.78 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.745 . . . . 73.23 109.31 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.427 ' HG2' HG12 ' B' ' 83' ' ' ILE . 4.7 tm-20 -142.47 105.92 4.64 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.721 -1.214 . . . . 74.43 107.721 -174.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.08 121.15 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.515 1.126 . . . . 54.0 109.434 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.3 t -106.02 121.74 58.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 124.24 1.016 . . . . 64.25 108.694 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.51 114.36 28.13 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.795 -1.187 . . . . 73.41 107.795 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -93.38 129.92 39.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.306 -0.861 . . . . 74.43 109.442 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.21 104.27 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.707 -1.22 . . . . 73.42 107.707 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -98.99 131.09 45.3 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.578 -0.527 . . . . 74.03 109.578 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.411 HG23 HD13 ' B' ' 114' ' ' ILE . 91.4 t -122.53 122.12 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.41 1.084 . . . . 73.24 108.922 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -115.05 143.71 44.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.625 -0.88 . . . . 72.14 108.625 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.81 142.87 38.7 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.766 -0.827 . . . . 63.14 108.766 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.5 p -161.37 148.02 14.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.826 0.704 . . . . 62.42 111.041 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' B' ' 34' ' ' LYS . 2.7 mp -123.73 130.78 53.16 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.636 -0.875 . . . . 74.43 108.636 173.243 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.17 -119.02 7.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.723 -0.951 . . . . 71.01 110.723 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.41 4.93 14.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.046 0.538 . . . . 64.51 110.967 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.23 161.95 18.65 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.572 0.349 . . . . 71.34 110.259 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.8 m -78.53 152.35 32.01 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.112 0.965 . . . . 71.2 111.538 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -97.49 -62.21 1.28 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.859 -1.164 . . . . 65.42 107.859 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.97 153.29 22.15 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.439 -1.255 . . . . 61.43 109.657 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.1 mt -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.608 -1.256 . . . . 55.34 107.608 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.45 152.2 33.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.993 0.517 . . . . 70.13 109.811 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -163.39 132.14 3.89 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.384 -0.969 . . . . 44.01 108.384 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.94 146.63 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.558 -0.904 . . . . 73.33 108.558 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.9 mt-30 -124.08 95.39 4.54 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.545 -1.28 . . . . 74.43 107.545 170.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -86.61 102.57 14.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.827 -1.175 . . . . 74.4 107.827 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.57 159.48 29.5 Favored Glycine 0 C--O 1.242 0.64 0 N-CA-C 110.958 -0.857 . . . . 50.41 110.958 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 125.69 1.55 Allowed Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.025 -0.83 . . . . 73.3 111.025 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.446 HG13 ' HE1' ' B' ' 17' ' ' TYR . 52.3 mt -85.71 131.36 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.89 -1.152 . . . . 74.22 107.89 175.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -139.05 132.84 30.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.43 -0.952 . . . . 74.54 108.43 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.1 m -89.8 101.91 14.61 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' B' ' 11' ' ' PHE . 15.1 pt -125.69 138.45 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.014 0.926 . . . . 72.21 109.605 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.65 166.54 33.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.566 1.146 . . . . 44.2 108.941 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 -28.16 2.64 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-N 117.569 0.168 . . . . 62.1 113.438 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 40.6 pt -54.35 135.31 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.322 1.449 . . . . 61.13 111.249 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -151.7 140.65 21.07 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.94 -0.573 . . . . 75.2 110.41 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.96 -110.78 2.11 Favored Glycine 0 C--N 1.355 1.611 0 O-C-N 124.738 1.274 . . . . 71.44 113.402 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 63.4 m -66.48 -42.93 86.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.113 0.965 . . . . 62.14 111.196 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -68.88 -31.93 71.22 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.62 0.768 . . . . 71.14 111.137 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.609 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 24.6 ttt -67.28 -57.32 6.89 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 123.512 0.507 . . . . 73.2 110.026 173.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.58 72.77 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.438 1.086 . . . . 74.52 111.95 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.85 -31.73 59.46 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.421 0.688 . . . . 65.45 111.188 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.97 -67.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.654 0.264 . . . . 42.25 110.593 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.468 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -83.62 -13.14 54.98 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.831 0.678 . . . . 74.44 112.831 -174.01 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.16 0.09 41.04 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.178 0.431 . . . . 74.51 114.178 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.24 -54.04 0.34 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 117.244 0.522 . . . . 74.02 110.954 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -71.33 -52.43 18.79 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.688 0.795 . . . . 75.43 111.181 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.568 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 33.4 m -67.03 -45.93 52.89 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 123.872 0.869 . . . . 55.41 112.538 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.9 Cg_exo -55.45 -38.25 94.13 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.544 2.163 . . . . 62.21 113.649 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -69.67 -22.41 63.44 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.874 0.734 . . . . 51.13 111.276 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.14 -46.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.172 0.589 . . . . 64.54 109.864 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.83 -26.64 60.7 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.484 -0.78 . . . . 73.54 111.586 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.4 -50.32 88.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.223 1.194 . . . . 71.02 114.223 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.43 -38.48 74.14 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.6 2.2 . . . . 75.53 114.138 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.486 ' HE2' HG21 ' D' ' 115' ' ' THR . 52.5 m-85 -70.79 -45.08 65.32 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.812 0.845 . . . . 73.04 110.562 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.38 85.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.39 -0.823 . . . . 64.55 110.901 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -63.62 -51.42 65.29 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.269 1.428 . . . . 71.3 110.207 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -68.24 -29.82 68.72 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.75 0.656 . . . . 72.14 110.301 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -67.82 -42.12 82.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.533 0.333 . . . . 60.43 110.427 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.411 HD13 HG23 ' B' ' 64' ' ' VAL . 76.5 mt -62.21 -48.18 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.42 0.688 . . . . 65.01 109.623 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.416 HG23 ' OE1' ' B' ' 125' ' ' GLN . 89.3 m -56.67 -34.71 67.64 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.369 1.068 . . . . 62.42 111.599 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.9 t -69.42 -48.19 61.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.289 0.636 . . . . 70.2 110.066 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -70.47 -33.51 71.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.031 0.532 . . . . 54.21 111.545 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.46 -39.06 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.446 0.698 . . . . 74.22 109.855 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.485 ' OG ' HG21 ' C' ' 115' ' ' THR . 11.9 t -69.93 -27.2 64.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.456 -0.793 . . . . 63.34 111.824 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.5 mtt-85 -76.61 -32.1 57.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.304 0.642 . . . . 72.54 109.84 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.73 0.2 82.71 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.547 0.529 . . . . 73.0 112.259 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.456 HG22 ' OD1' ' C' ' 127' ' ' ASN . 61.4 p 61.38 33.88 18.58 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.675 1.99 . . . . 52.35 112.518 171.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -94.68 155.85 38.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.237 -0.892 . . . . 71.23 109.801 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -55.62 167.02 2.31 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.54 2.827 . . . . 72.12 114.422 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.433 ' HB2' ' HG3' ' C' ' 125' ' ' GLN . 5.7 tp60 -59.56 134.03 56.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.835 -1.075 . . . . 74.21 113.413 -172.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.77 96.13 4.9 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.42 -1.263 . . . . 65.23 107.867 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -108.28 112.79 25.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.574 -0.899 . . . . 75.03 108.574 172.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.406 HD12 ' H ' ' B' ' 129' ' ' ALA . 20.5 tp -75.18 139.76 42.87 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.001 -0.545 . . . . 74.21 109.828 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.406 ' H ' HD12 ' B' ' 128' ' ' LEU . . . -63.05 148.05 93.33 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.48 1.112 . . . . 71.12 111.619 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' D' ' 16' ' ' ILE . 5.5 Cg_exo -71.09 110.41 2.81 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.24 1.96 . . . . 74.32 110.21 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.4 t -99.39 121.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.55 -1.278 . . . . 63.11 107.55 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -74.21 88.69 1.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.357 -0.979 . . . . 72.03 108.357 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 123.479 0.712 . . . . 72.51 111.137 -177.459 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' C' ' 97' ' ' CYS . 54.3 ttp . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 121.259 0.552 . . . . 73.3 111.081 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -109.0 99.69 8.98 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.593 -1.262 . . . . 74.32 107.593 173.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -105.76 130.27 53.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.027 -0.988 . . . . 72.31 109.533 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -151.14 139.17 20.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.902 0.881 . . . . 75.4 109.575 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -86.94 142.5 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.661 0.784 . . . . 55.31 110.004 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 75.9 mt-30 -101.56 -49.89 3.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.596 0.358 . . . . 62.01 110.584 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -167.79 127.04 1.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.466 0.306 . . . . 65.34 110.824 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -107.89 143.63 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.108 -1.071 . . . . 72.13 108.108 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -172.03 164.07 6.14 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.535 0.683 . . . . 72.41 111.139 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.4 p -85.33 109.69 18.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.382 -0.969 . . . . 55.13 108.382 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -33.12 74.9 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.177 0.513 . . . . 75.23 109.875 173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -155.41 150.29 26.54 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.577 -1.192 . . . . 72.3 109.572 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 60.2 mt -138.63 149.09 23.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.506 -1.665 . . . . 63.42 106.506 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 21.2 t -160.67 152.08 19.33 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.332 0.587 . . . . 65.22 110.789 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -147.02 141.86 26.85 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.691 -1.226 . . . . 73.54 107.691 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 50.2 mt-10 -132.92 150.89 52.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.707 0.803 . . . . 75.42 109.189 170.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.73 80.7 7.38 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 106.957 -1.497 . . . . 72.32 106.957 170.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.07 -35.04 20.99 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.488 2.125 . . . . 75.44 111.741 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.39 32.03 3.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.266 1.027 . . . . 74.01 109.489 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' D' ' 17' ' ' TYR . . . -59.67 -51.2 82.68 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 114.512 1.301 . . . . 21.55 114.512 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 15.4 Cg_exo -71.46 -35.55 7.99 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 121.627 1.617 . . . . 71.33 111.073 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -62.68 -23.41 67.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.131 1.772 . . . . 73.21 112.85 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 4.0 p -61.28 -20.33 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.03 0.752 . . . . 72.31 113.03 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.52 -40.3 96.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.436 0.695 . . . . 74.11 110.826 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -97.48 23.19 7.92 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.864 0.866 . . . . 74.41 110.461 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 4.2 ttmp? -109.06 150.28 28.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.071 . . . . 73.03 109.913 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.75 125.96 30.07 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.889 -0.782 . . . . 51.51 108.889 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -84.74 75.59 10.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.331 0.586 . . . . 74.51 109.958 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -162.8 80.05 1.73 Allowed Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 107.895 -1.15 . . . . 73.01 107.895 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -87.65 154.2 7.57 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.901 2.4 . . . . 63.45 112.477 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.87 89.31 7.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 106.3 -1.741 . . . . 62.33 106.3 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.97 120.67 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.999 -1.001 . . . . 75.03 109.062 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -109.98 130.8 55.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.77 1.228 . . . . 53.32 109.592 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.472 HD21 HD21 ' C' ' 128' ' ' LEU . 16.9 mt -87.32 122.89 31.68 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.025 -0.731 . . . . 55.45 109.025 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.39 103.19 8.57 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.467 1.107 . . . . 64.42 108.167 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -111.71 146.51 37.4 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.483 0.713 . . . . 51.01 109.518 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 21.4 t70 -138.8 135.32 34.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.283 -1.377 . . . . 50.52 107.283 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 22.0 p -127.13 126.94 43.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.456 0.302 . . . . 43.32 111.05 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.47 164.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.915 0.886 . . . . 50.14 110.058 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -144.46 148.36 34.48 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.984 0.914 . . . . 51.12 108.974 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 16.0 p -147.64 129.02 14.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.12 0.568 . . . . 60.04 109.964 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -75.4 125.38 28.87 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 109.295 -0.632 . . . . 72.13 109.295 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.459 HD11 HD12 ' C' ' 83' ' ' ILE . 73.5 mt -99.65 -31.4 11.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.696 0.798 . . . . 71.41 110.547 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 -177.79 6.22 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.269 1.028 . . . . 73.32 109.644 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.84 121.85 13.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.603 -0.726 . . . . 64.33 109.506 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 69.0 -3.0 1.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.85 1.26 . . . . 54.33 112.791 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -100.38 112.66 33.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.844 -0.799 . . . . 63.43 108.844 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -126.89 124.47 39.64 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.201 -1.037 . . . . 72.23 108.201 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.63 119.48 23.87 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.969 -1.014 . . . . 75.13 108.434 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.8 t -96.16 124.55 48.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.119 -1.067 . . . . 41.24 108.119 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.35 129.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.057 -1.09 . . . . 75.3 108.057 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -122.68 95.67 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.931 -1.137 . . . . 75.45 107.931 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.524 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.7 tmt_? -86.05 114.12 22.67 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.822 -1.177 . . . . 72.1 107.822 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.9 t -113.28 132.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.107 -1.071 . . . . 63.35 108.107 175.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -128.81 124.2 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.493 -0.928 . . . . 53.23 108.493 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.5 HG11 HD13 ' C' ' 126' ' ' LEU . 39.0 t -106.55 110.48 31.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.928 -1.138 . . . . 55.31 107.928 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.452 HG23 HD23 ' C' ' 75' ' ' LEU . 8.0 m -106.71 127.03 53.04 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.113 -0.699 . . . . 71.02 109.113 175.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.9 20.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.065 -1.087 . . . . 63.33 108.065 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.7 m -148.15 126.7 12.44 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.966 0.506 . . . . 74.42 109.782 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.503 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.2 OUTLIER -87.44 58.6 5.05 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.727 0.811 . . . . 73.32 109.473 177.013 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 -119.18 5.86 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.877 -1.289 . . . . 64.43 109.877 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.71 -24.02 21.67 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.616 0.766 . . . . 74.33 109.512 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.624 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 14.7 tp10 -68.2 96.1 0.62 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.192 0.997 . . . . 71.24 110.553 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.2 m -83.12 126.52 32.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.738 0.78 . . . . 61.41 111.259 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -82.78 -53.67 5.71 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.174 1.39 . . . . 51.0 110.19 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.88 170.46 16.75 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.022 0.826 . . . . 74.0 110.379 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.8 tm? -136.99 137.9 39.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 106.507 -1.664 . . . . 71.32 106.507 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -146.8 143.04 28.34 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.284 -1.006 . . . . 74.05 108.284 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -155.32 135.53 13.09 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.061 0.544 . . . . 72.0 109.887 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -138.3 135.23 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.235 1.014 . . . . 63.33 108.355 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -105.92 89.15 2.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.944 -1.132 . . . . 75.12 107.944 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -81.21 107.73 14.25 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.045 -0.979 . . . . 74.24 109.749 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.62 145.67 16.23 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.98 -0.448 . . . . 74.31 111.98 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.05 127.71 3.34 Favored Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 110.416 -1.074 . . . . 61.32 110.416 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.459 HD12 HD11 ' C' ' 51' ' ' LEU . 10.2 mm -81.28 114.64 22.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.842 -1.17 . . . . 72.34 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -121.55 137.11 54.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.037 -0.727 . . . . 74.3 109.037 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 m -109.96 105.59 14.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.425 -0.954 . . . . 71.13 108.425 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.422 HG21 ' HG3' ' C' ' 94' ' ' MET . 2.2 mp -114.7 111.88 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.648 -1.612 . . . . 73.53 106.648 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.64 157.94 31.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.994 0.518 . . . . 62.23 111.726 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.07 -60.51 0.97 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.016 -0.993 . . . . 53.32 112.384 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.68 178.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.833 0.453 . . . . 72.33 111.726 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.32 -171.07 3.74 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.631 -0.713 . . . . 72.43 110.419 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.45 -128.8 44.34 Favored Glycine 0 C--N 1.355 1.634 0 O-C-N 123.856 0.723 . . . . 60.01 114.166 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -68.18 -31.92 71.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.065 0.946 . . . . 63.14 111.743 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.88 -46.32 82.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.658 0.783 . . . . 74.14 110.117 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.736 ' HG2' HD23 ' C' ' 98' ' ' LEU . 27.9 ttt -78.32 -25.69 46.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.342 -0.845 . . . . 74.14 110.987 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -32.73 74.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.999 0.52 . . . . 72.14 111.003 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.503 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 38.9 t-80 -65.49 -36.75 84.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.644 -0.707 . . . . 65.33 111.073 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.404 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 53.9 t -76.17 -61.35 1.97 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.627 0.371 . . . . 64.52 111.143 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.736 HD23 ' HG2' ' C' ' 94' ' ' MET . 3.4 pp -70.71 -34.04 71.51 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.186 0.594 . . . . 74.24 110.989 -175.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.65 -2.47 75.84 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.65 0.62 . . . . 71.25 114.65 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -137.24 -57.86 0.7 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.349 0.575 . . . . 74.42 111.193 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.425 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 68.0 t80 -72.59 -48.95 35.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 122.897 0.479 . . . . 74.13 111.586 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.589 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 81.2 m -58.21 -45.03 99.76 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.383 0.883 . . . . 72.44 113.383 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 98' ' ' LEU . 50.3 Cg_exo -56.92 -36.5 99.1 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 122.548 2.165 . . . . 75.3 113.209 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.7 -22.53 64.35 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.714 0.805 . . . . 55.14 111.734 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.548 HD12 HH12 ' A' ' 111' ' ' ARG . 35.3 mm -83.33 -36.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.803 0.441 . . . . 50.41 110.052 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.52 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.4 mt -82.34 -24.89 34.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.75 0.82 . . . . 71.25 112.131 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.77 -48.84 96.08 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 113.571 0.952 . . . . 53.51 113.571 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.96 -40.03 75.26 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.066 1.844 . . . . 74.21 113.184 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.427 ' HE2' HG21 ' A' ' 115' ' ' THR . 97.0 m-85 -70.51 -42.91 70.69 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.405 -0.816 . . . . 74.44 111.519 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.88 -46.47 87.75 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.357 0.663 . . . . 73.41 109.215 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -55.93 -51.64 66.92 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.483 1.513 . . . . 64.5 111.827 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.68 -33.2 70.65 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.503 0.321 . . . . 75.43 110.163 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.2 t -70.59 -31.02 67.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.637 0.375 . . . . 64.04 111.013 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -72.05 -51.17 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.676 0.79 . . . . 74.54 109.76 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.485 HG21 ' OG ' ' B' ' 119' ' ' SER . 88.4 m -59.23 -41.27 88.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.626 0.77 . . . . 75.42 111.071 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 26.2 t -60.3 -44.38 95.45 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.064 0.853 . . . . 61.35 109.653 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.537 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.92 -39.95 91.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.312 0.645 . . . . 74.4 111.824 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 72.6 t -62.16 -40.66 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.022 0.529 . . . . 63.55 110.116 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.427 ' HB2' ' NE2' ' B' ' 125' ' ' GLN . 84.1 p -76.17 -26.41 56.21 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.568 -0.742 . . . . 71.45 111.742 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.9 mtt-85 -71.52 -34.58 70.21 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.758 0.823 . . . . 75.24 110.168 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.62 6.06 59.25 Favored Glycine 0 C--N 1.355 1.593 0 O-C-N 123.576 0.548 . . . . 50.15 112.384 170.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p 61.67 19.49 10.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.168 2.187 . . . . 75.2 113.314 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HE1' HG11 ' C' ' 31' ' ' VAL . 52.2 m-85 -85.88 156.27 58.18 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.136 0.974 . . . . 73.32 109.688 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.68 120.58 7.24 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.033 2.489 . . . . 72.54 111.958 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' B' ' 125' ' ' GLN . 96.2 mt-30 -57.08 143.99 36.31 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.309 1.006 . . . . 73.11 112.477 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.5 HD13 HG11 ' C' ' 64' ' ' VAL . 5.9 tt -119.28 109.18 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.178 -1.045 . . . . 75.0 108.178 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.456 ' OD1' HG22 ' B' ' 122' ' ' THR . 1.0 OUTLIER -91.95 119.0 31.29 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.43 -0.952 . . . . 71.43 108.43 170.206 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.472 HD21 HD21 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -73.13 136.75 44.87 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.083 -0.71 . . . . 75.41 109.083 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.9 151.75 94.56 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.288 1.035 . . . . 62.13 111.574 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.63 ' HG3' HD12 ' A' ' 16' ' ' ILE . 15.0 Cg_exo -66.39 98.54 0.4 Allowed 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.486 2.124 . . . . 35.51 111.325 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.92 108.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.908 -1.145 . . . . 54.31 107.908 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -95.04 99.05 11.12 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.762 -0.829 . . . . 73.41 108.762 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -68.71 -37.0 79.16 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 71.12 109.949 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 N--CA 1.477 0.907 0 C-N-CA 124.474 1.11 . . . . 75.44 112.265 -175.513 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.1 m . . . . . 0 C--O 1.243 0.759 0 N-CA-C 108.094 -1.076 . . . . 62.53 108.094 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -161.63 99.39 1.14 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.39 -0.967 . . . . 73.22 108.39 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -136.42 131.26 33.88 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.544 -0.91 . . . . 53.14 108.544 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.444 HD11 HG21 ' D' ' 105' ' ' ILE . 22.8 mt -82.34 122.12 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.206 -0.665 . . . . 63.33 109.206 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.63 -31.78 19.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.819 0.448 . . . . 73.43 110.826 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -167.3 144.66 4.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 110.48 -0.193 . . . . 75.13 110.48 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.602 HD12 ' HG3' ' B' ' 130' ' ' PRO . 0.1 OUTLIER -133.56 133.15 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 106.357 -1.72 . . . . 74.52 106.357 173.038 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.472 ' CE2' ' HB1' ' C' ' 28' ' ' ALA . 21.6 p90 -168.31 166.79 12.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.793 0.806 . . . . 71.4 111.12 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -93.09 121.63 34.63 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.371 -1.286 . . . . 74.13 108.769 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -88.77 -31.26 18.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.884 0.474 . . . . 75.23 110.069 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.01 139.44 18.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.946 -1.024 . . . . 51.12 109.012 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.2 mt -139.59 151.3 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.771 -1.196 . . . . 63.3 107.771 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -158.68 121.67 3.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.663 0.785 . . . . 74.12 110.264 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.9 t80 -113.65 121.22 43.5 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 106.657 -1.609 . . . . 72.22 106.657 165.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.4 mt-10 -121.88 117.63 26.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.708 -0.478 . . . . 72.53 109.708 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.68 87.66 2.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.806 -1.183 . . . . 42.25 107.806 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.13 -36.77 5.35 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.739 2.293 . . . . 70.32 112.727 -170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -113.0 40.1 2.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.27 1.028 . . . . 64.25 108.623 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -51.98 -65.09 1.1 Allowed Pre-proline 0 CA--C 1.563 1.468 0 CA-C-O 117.916 -1.04 . . . . 61.44 113.799 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.92 -9.81 11.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 122.6 1.964 . . . . 72.51 112.91 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -74.07 -42.44 60.18 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.688 1.195 . . . . 75.35 110.377 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.28 -33.69 14.29 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 115.951 -0.568 . . . . 61.15 109.909 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -56.16 -22.55 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 74.04 113.699 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -70.6 -36.16 73.37 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.015 0.526 . . . . 51.03 110.436 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 63.32 1.63 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.778 0.831 . . . . 64.41 111.381 171.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 35' ' ' ASP . . . . . 0.431 ' OD2' HD21 ' D' ' 68' ' ' LEU . 9.6 t70 -107.47 97.93 7.61 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.529 0.732 . . . . 50.2 109.714 -175.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.453 ' O ' HD22 ' D' ' 68' ' ' LEU . 13.2 m95 -121.87 -155.12 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.037 -1.097 . . . . 62.32 108.037 -169.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -54.45 109.04 1.32 Allowed Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.082 0.771 . . . . 72.11 113.082 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.709 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 9.8 Cg_exo -72.03 139.45 32.87 Favored 'Trans proline' 0 C--N 1.386 2.525 0 C-N-CA 123.102 2.535 . . . . 64.25 112.968 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.0 116.48 29.0 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.561 -1.274 . . . . 74.04 107.561 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.32 149.85 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.923 0.889 . . . . 74.45 112.21 -170.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -127.83 139.35 52.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.72 1.608 . . . . 73.14 108.473 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.455 HD21 HG13 ' D' ' 62' ' ' VAL . 1.2 tt -120.84 114.7 21.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.944 -0.762 . . . . 62.34 108.944 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -109.08 141.98 40.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.209 1.004 . . . . 74.34 108.501 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.04 145.03 48.54 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.335 -0.617 . . . . 61.21 109.335 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.04 159.55 44.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.177 0.991 . . . . 70.34 108.47 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -136.6 168.78 18.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.13 0.572 . . . . 74.1 110.501 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.32 154.31 36.48 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.603 1.161 . . . . 72.34 108.347 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 58.6 p -149.44 150.67 32.75 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.31 0.244 . . . . 73.42 111.117 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -174.18 127.73 0.36 Allowed 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.34 1.056 . . . . 73.13 108.93 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.89 127.31 32.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.898 -0.779 . . . . 74.34 108.898 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' D' ' 57' ' ' GLU . 57.6 mt -92.55 -36.01 13.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.886 0.474 . . . . 65.5 111.147 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.61 -171.1 1.99 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.433 0.693 . . . . 65.04 111.115 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -58.13 114.31 2.32 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.869 -1.06 . . . . 65.44 110.785 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 62.29 13.01 5.61 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.591 1.156 . . . . 62.15 112.501 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 80.6 t -115.52 118.48 58.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.512 -0.921 . . . . 70.44 108.512 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -131.25 132.54 44.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.657 1.183 . . . . 74.35 108.144 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.5 tt0 -99.77 126.0 45.77 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.375 0.422 . . . . 72.12 110.596 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -107.36 117.75 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 107.248 -1.389 . . . . 73.5 107.248 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.0 t -100.27 132.25 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.649 -1.241 . . . . 72.3 107.649 172.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -124.26 110.81 15.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.555 -0.906 . . . . 73.45 108.555 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.07 118.4 29.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.272 1.029 . . . . 74.11 109.694 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 62' ' ' VAL . . . . . 0.455 HG13 HD21 ' D' ' 42' ' ' LEU . 65.3 t -102.42 130.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.867 -1.161 . . . . 72.23 107.867 166.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.3 m -121.4 131.2 54.04 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.449 0.642 . . . . 74.35 109.887 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.437 HG21 HG21 ' D' ' 114' ' ' ILE . 88.5 t -122.42 105.89 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.473 1.509 . . . . 63.21 108.938 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -107.45 108.84 20.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.847 0.859 . . . . 73.22 109.258 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.59 137.0 37.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.451 -0.574 . . . . 74.14 109.451 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -139.21 123.08 17.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.309 -0.996 . . . . 53.43 108.309 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.709 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.4 pp -129.1 137.55 51.3 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.711 -0.478 . . . . 74.03 109.711 174.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.38 -113.09 3.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.683 -0.689 . . . . 71.04 112.119 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -116.37 3.14 13.29 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.723 0.809 . . . . 72.23 111.21 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.78 176.05 13.12 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.071 0.462 . . . . 74.51 111.497 -168.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 78.1 m -66.78 138.13 57.13 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.918 -1.037 . . . . 55.21 111.015 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.4 -65.79 0.97 Allowed 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.06 -1.089 . . . . 65.25 108.06 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -156.52 164.72 37.89 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.787 -1.551 . . . . 74.24 109.231 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.6 mt -126.26 144.31 50.84 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.665 1.186 . . . . 71.22 107.842 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.406 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 0.7 OUTLIER -145.7 139.24 26.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.204 1.002 . . . . 54.12 108.348 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -157.79 130.1 7.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.52 -0.548 . . . . 74.12 109.52 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 55.3 t -137.6 119.52 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.4 0.68 . . . . 74.35 109.682 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -89.29 91.24 8.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.539 0.735 . . . . 62.44 109.083 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -80.59 94.66 6.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.259 0.624 . . . . 72.01 109.491 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.7 141.73 18.11 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.524 -0.63 . . . . 52.23 111.524 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.447 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.23 129.83 5.05 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 110.953 -0.859 . . . . 63.43 110.953 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.417 HG23 HD12 ' D' ' 51' ' ' LEU . 45.8 mt -89.41 119.42 36.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.793 -1.188 . . . . 65.34 107.793 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -121.47 147.52 45.66 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.04 0.936 . . . . 73.11 109.199 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -99.57 93.3 5.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.173 -1.418 . . . . 74.2 107.173 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 71.9 mt -106.78 118.35 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.107 -0.701 . . . . 64.01 109.107 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -151.94 160.74 43.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.114 0.966 . . . . 71.35 109.447 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.44 -23.16 4.91 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 115.696 1.038 . . . . 53.14 115.696 170.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.419 HG13 ' HG2' ' D' ' 94' ' ' MET . 26.2 pt -96.11 135.7 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.597 -0.89 . . . . 73.23 108.597 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.05 172.93 15.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.518 -0.765 . . . . 74.43 110.153 -169.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.69 -137.28 44.39 Favored Glycine 0 C--N 1.35 1.309 0 O-C-N 123.492 0.495 . . . . 70.05 112.595 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -77.58 -20.41 54.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.861 0.864 . . . . 75.42 111.511 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -62.38 -47.38 84.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.77 0.828 . . . . 71.34 110.318 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.539 ' SD ' HD12 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -64.69 -46.96 80.15 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.246 -0.888 . . . . 74.33 109.681 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.17 67.41 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.341 1.026 . . . . 71.3 112.182 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -67.25 -50.55 60.11 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.247 -0.888 . . . . 65.43 111.159 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.84 -35.54 78.55 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.058 0.543 . . . . 75.14 111.462 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.539 HD12 ' SD ' ' D' ' 94' ' ' MET . 4.1 tt -70.27 -45.64 65.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.94 1.296 . . . . 63.21 109.226 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.74 -22.39 72.31 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 72.55 113.831 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.33 -66.82 1.04 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.405 0.52 . . . . 74.34 112.405 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -72.92 -48.19 39.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.551 0.741 . . . . 74.51 112.51 -166.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -60.1 -48.71 93.77 Favored Pre-proline 0 CA--C 1.571 1.781 0 C-N-CA 123.89 0.876 . . . . 71.21 112.784 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.64 -21.72 18.86 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.964 1.776 . . . . 53.15 112.906 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.09 -31.58 72.15 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.226 0.61 . . . . 64.5 110.577 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.444 HG21 HD11 ' D' ' 13' ' ' ILE . 47.8 mm -68.0 -42.82 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.674 0.79 . . . . 74.01 110.332 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.447 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.1 mt -73.73 -29.9 62.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.235 -0.893 . . . . 74.0 111.716 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -59.98 -44.11 96.0 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.338 1.236 . . . . 74.33 114.338 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.48 -41.09 80.15 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.445 2.097 . . . . 74.11 114.03 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -74.29 -37.36 63.7 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.258 0.623 . . . . 74.11 111.371 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 110' ' ' ALA . . . . . 0.4 ' O ' HG13 ' D' ' 114' ' ' ILE . . . -63.71 -47.45 81.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.086 0.554 . . . . 71.54 109.975 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -53.9 -53.51 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.772 1.295 . . . . 60.41 110.562 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.56 -46.98 85.74 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 124.523 1.139 . . . . 74.44 110.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.3 t -59.44 -32.88 70.62 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.579 0.549 . . . . 75.45 111.708 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' D' ' 118' ' ' VAL . 73.3 mt -73.24 -49.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.157 0.583 . . . . 71.44 109.916 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.486 HG21 ' HE2' ' B' ' 109' ' ' TYR . 21.8 m -55.07 -40.99 70.95 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.719 1.208 . . . . 72.13 111.577 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -71.65 -37.51 70.81 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.335 -0.848 . . . . 72.11 110.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.3 mtm -63.37 -45.34 91.56 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 122.742 0.417 . . . . 75.03 111.287 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.6 t -63.05 -41.87 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.142 -0.936 . . . . 65.21 110.451 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.2 p -68.16 -31.86 71.72 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.207 0.603 . . . . 63.33 111.754 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -71.93 -30.1 64.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.74 0.816 . . . . 63.13 110.931 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.62 8.63 64.7 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.965 -0.561 . . . . 71.11 112.569 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.6 p 60.73 24.97 14.8 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.018 2.127 . . . . 72.4 113.036 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.23 161.17 27.02 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.836 1.255 . . . . 72.43 109.499 172.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 120.04 7.16 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.475 2.117 . . . . 73.44 111.102 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.87 139.68 50.66 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.689 0.618 . . . . 74.5 110.093 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tt -109.19 117.75 34.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.401 -0.592 . . . . 74.32 109.401 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -99.98 95.39 6.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.969 -1.014 . . . . 72.54 108.362 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.12 121.19 12.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.433 0.693 . . . . 74.02 110.08 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -66.95 140.7 96.25 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.38 0.672 . . . . 51.21 110.577 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -75.0 108.65 2.77 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.549 2.166 . . . . 73.34 110.777 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.94 138.88 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.443 0.697 . . . . 74.31 109.199 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -74.17 112.37 10.26 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 123.97 0.794 . . . . 74.25 110.428 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 123.56 0.744 . . . . 72.53 110.988 177.794 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.932 -0.395 . . . . 63.13 109.932 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.451 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 21.7 t80 -137.08 131.69 33.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.784 0.834 . . . . 71.12 109.442 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -154.96 108.09 2.81 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.688 0.618 . . . . 64.51 109.904 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.684 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.4 mt -70.84 119.56 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 110.015 -0.365 . . . . 74.14 110.015 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.68 -33.01 27.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.646 0.778 . . . . 73.13 110.674 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -173.37 136.77 0.62 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.011 0.524 . . . . 64.25 110.182 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 16' ' ' ILE . 2.5 pp -122.59 139.39 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.058 -0.719 . . . . 74.32 109.058 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 12.4 p90 -173.91 172.28 3.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.422 0.63 . . . . 73.41 111.189 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -94.93 123.45 38.41 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.386 -0.825 . . . . 61.53 108.849 171.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.8 mtpt -83.24 -34.89 25.74 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 110.003 -0.369 . . . . 74.12 110.003 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 10.2 t70 -152.99 140.66 19.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.524 -0.762 . . . . 72.32 109.127 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.5 mt -129.96 143.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.268 1.027 . . . . 62.32 108.5 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.64 122.53 10.65 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.313 0.383 . . . . 74.22 110.41 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 91.6 t80 -123.58 140.72 52.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 107.721 -1.214 . . . . 72.34 107.721 166.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.36 133.93 31.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.828 0.451 . . . . 75.41 110.438 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -150.34 72.61 9.19 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.606 1.562 . . . . 75.24 107.414 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.42 -42.57 3.63 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.791 2.327 . . . . 73.31 111.465 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.94 27.7 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.631 -1.168 . . . . 63.45 110.803 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -49.24 -53.2 41.76 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 118.216 -0.897 . . . . 74.33 112.211 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.93 -30.41 83.61 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.945 1.763 . . . . 74.01 113.036 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -74.42 -50.03 20.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.58 0.705 . . . . 61.33 110.139 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.4 p -70.42 -22.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 114.49 -1.232 . . . . 73.21 112.168 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -64.74 -27.94 69.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.105 0.409 . . . . 63.41 112.105 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -100.94 -10.81 20.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.653 0.612 . . . . 74.12 112.653 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.641 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmtp -72.0 172.67 9.61 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.744 0.646 . . . . 73.23 112.744 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -50.79 117.56 2.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.599 1.16 . . . . 73.32 110.997 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -69.61 65.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.063 1.745 . . . . 73.21 110.691 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -148.63 68.96 10.13 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.603 1.161 . . . . 71.45 109.491 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -85.94 120.3 1.95 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.791 2.327 . . . . 72.2 112.706 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.93 105.16 17.19 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.651 -1.24 . . . . 53.53 107.651 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.1 p -85.09 124.98 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.487 -0.779 . . . . 72.01 109.932 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -102.82 117.77 35.35 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.552 1.141 . . . . 61.15 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tt -96.82 129.02 44.32 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.045 -1.094 . . . . 61.44 108.045 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.734 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.0 m-20 -134.51 140.01 45.87 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.669 0.788 . . . . 74.42 109.951 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.48 119.06 31.89 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.219 -1.03 . . . . 74.14 108.219 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 32.3 t70 -121.42 141.56 50.87 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.18 -1.415 . . . . 73.1 107.18 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -149.07 159.18 44.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.881 0.309 . . . . 74.0 111.518 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.44 116.12 1.08 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.697 0.623 . . . . 72.34 110.917 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.2 p -89.91 153.45 20.61 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.809 -0.811 . . . . 64.52 108.809 168.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -159.02 159.65 35.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.327 -0.99 . . . . 64.34 108.327 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.29 129.78 56.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.432 -0.581 . . . . 74.02 109.432 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 57' ' ' GLU . 77.4 mt -99.1 -39.43 8.5 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.947 0.899 . . . . 62.34 110.965 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -148.7 178.43 8.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.627 0.771 . . . . 72.24 109.556 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -62.07 117.64 6.26 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.952 -0.758 . . . . 70.42 108.952 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 71.51 0.72 3.58 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.275 1.43 . . . . 64.34 112.835 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 61.7 t -108.51 119.02 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.567 -0.901 . . . . 74.44 108.567 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -130.14 141.1 50.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.952 0.501 . . . . 75.52 110.108 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.649 ' HB2' HD11 ' A' ' 51' ' ' LEU . 39.9 tt0 -104.03 142.49 34.36 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.419 0.688 . . . . 72.32 109.899 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.83 128.28 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.423 -0.954 . . . . 64.04 108.423 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.88 131.13 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.137 -0.69 . . . . 70.44 109.137 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.523 HD23 HD12 ' A' ' 106' ' ' LEU . 4.1 mm? -110.94 100.8 9.44 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.767 -1.197 . . . . 62.3 107.767 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 37.6 ttp85 -84.01 100.52 11.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.423 -0.954 . . . . 71.43 108.423 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' A' ' 114' ' ' ILE . 35.7 t -95.08 121.62 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.414 -0.958 . . . . 71.34 108.414 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.4 m -108.52 131.38 54.89 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.66 -0.496 . . . . 72.11 109.66 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.41 HG21 HG21 ' A' ' 114' ' ' ILE . 67.0 t -128.86 109.27 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.824 1.249 . . . . 64.34 107.805 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.8 m -108.1 151.49 25.81 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.062 -1.088 . . . . 73.41 108.062 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.28 128.14 23.49 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.149 -1.056 . . . . 64.13 108.149 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.7 m -137.54 127.61 25.94 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.202 0.456 . . . . 51.54 111.594 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.75 80.45 6.55 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.837 1.255 . . . . 43.12 108.354 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.53 -84.04 0.88 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.22 -1.152 . . . . 63.45 110.22 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.95 -12.94 5.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.132 0.973 . . . . 65.21 111.387 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.641 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.5 tp10 -90.17 99.77 12.73 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.634 . . . . 72.34 110.553 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 87.4 m -67.58 129.58 40.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.206 0.526 . . . . 64.51 111.985 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.12 -64.07 1.18 Allowed 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.394 0.678 . . . . 54.03 110.077 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.11 158.92 41.16 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.179 -0.919 . . . . 72.33 111.854 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.29 107.54 9.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.622 -1.172 . . . . 54.25 107.882 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.47 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -108.98 110.53 21.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.327 1.051 . . . . 72.14 109.191 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -130.29 117.37 19.71 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 62.32 108.603 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.63 120.55 60.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.745 0.818 . . . . 72.33 110.241 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -90.68 82.49 5.76 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 124.217 1.007 . . . . 73.42 108.358 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -80.36 100.32 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.909 -1.041 . . . . 73.15 109.571 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.96 145.32 17.54 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.796 -0.521 . . . . 74.11 111.796 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.02 120.31 1.88 Allowed Glycine 0 CA--C 1.504 -0.624 0 N-CA-C 110.388 -1.085 . . . . 64.3 110.388 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 51' ' ' LEU . 55.7 mt -87.45 127.72 40.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.555 -0.905 . . . . 74.31 108.555 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.684 ' HD2' HG12 ' A' ' 13' ' ' ILE . 1.4 m-85 -133.54 162.78 30.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 74.13 108.959 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.4 t -119.73 113.47 20.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 63.22 108.494 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.473 HD12 ' SG ' ' A' ' 97' ' ' CYS . 11.5 tt -126.71 148.71 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 122.964 0.506 . . . . 74.43 110.529 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 165.83 22.93 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.02 0.928 . . . . 74.11 109.308 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.49 11.78 65.84 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.883 -0.954 . . . . 71.31 114.693 171.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.61 161.77 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.92 0.86 . . . . 63.53 112.24 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.8 tt0 -160.59 -175.59 5.08 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 124.951 1.3 . . . . 74.41 107.689 167.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.52 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.43 -140.04 31.5 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 118.04 0.382 . . . . 72.02 113.348 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -72.6 -29.94 63.93 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.386 0.674 . . . . 74.31 111.116 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -61.64 -45.69 92.97 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.604 0.762 . . . . 50.54 111.027 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.516 ' SD ' HD21 ' A' ' 98' ' ' LEU . 9.0 tmm? -66.64 -51.22 58.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.452 -0.795 . . . . 64.04 110.116 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.7 -22.74 64.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.021 0.928 . . . . 71.04 112.528 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -77.23 -32.16 55.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.548 0.739 . . . . 72.11 110.846 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 86' ' ' ILE . 49.4 t -69.65 -64.52 0.86 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.375 0.27 . . . . 72.34 110.886 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -67.97 -27.14 66.34 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 119.09 -0.481 . . . . 72.22 110.671 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -8.99 71.02 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 114.913 0.725 . . . . 60.22 114.913 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.399 1.099 . . . . 74.02 111.821 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.451 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.0 t80 -63.33 -62.51 1.64 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.202 1.001 . . . . 75.12 112.442 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.9 m -65.53 -33.29 7.32 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 114.114 1.153 . . . . 55.02 114.114 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.17 -50.79 12.42 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.451 2.1 . . . . 73.11 112.405 161.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -64.92 -22.63 67.03 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.606 0.762 . . . . 64.21 112.069 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 13' ' ' ILE . 49.7 mm -71.16 -50.34 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.385 -0.598 . . . . 54.3 109.385 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.523 HD12 HD23 ' A' ' 60' ' ' LEU . 77.7 mt -82.87 -19.54 37.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.736 -0.666 . . . . 60.15 112.749 -171.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -62.3 -42.97 83.79 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.09 0.956 . . . . 72.13 112.785 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -37.73 91.75 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.106 1.871 . . . . 73.12 113.713 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -71.21 -39.72 71.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.218 0.607 . . . . 72.32 111.487 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.83 73.91 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.459 -0.571 . . . . 72.14 109.459 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 -51.61 -48.56 63.21 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.728 1.267 . . . . 71.31 110.891 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.95 -48.91 72.37 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.609 0.764 . . . . 64.41 110.906 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.16 -30.06 70.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.953 0.501 . . . . 64.31 111.958 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.4 mt -72.17 -59.16 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.375 -0.602 . . . . 72.33 109.375 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.7 m -51.48 -40.32 59.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.882 1.273 . . . . 72.1 112.676 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -66.4 -41.83 88.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.473 -0.785 . . . . 75.33 110.368 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 30.5 mtm -69.21 -35.62 76.4 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.468 0.307 . . . . 65.53 110.832 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.7 t -59.67 -44.27 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 O-C-N 123.848 0.717 . . . . 72.34 109.948 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -75.29 -32.25 60.94 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 116.059 -0.519 . . . . 72.11 111.411 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -68.84 -31.75 70.95 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.434 0.694 . . . . 72.13 110.528 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.3 7.15 68.91 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.531 0.519 . . . . 74.25 112.613 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 p 56.17 49.71 14.91 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 126.493 1.917 . . . . 64.42 112.483 175.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.42 161.61 23.89 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 113.028 -1.896 . . . . 73.34 108.329 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -59.98 162.11 17.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.157 2.571 . . . . 73.01 111.982 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.55 137.7 46.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.535 0.684 . . . . 72.31 110.71 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.699 -1.137 . . . . 73.02 108.611 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -135.12 127.14 29.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.763 -0.828 . . . . 73.0 108.763 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.44 125.77 27.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.229 -0.656 . . . . 74.1 109.229 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.78 150.51 93.14 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 122.844 0.458 . . . . 72.14 111.382 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.2 Cg_exo -60.29 105.12 0.27 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.764 2.309 . . . . 60.52 111.931 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.36 116.16 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.132 -1.432 . . . . 70.21 107.132 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -77.86 83.05 4.21 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.691 0.62 . . . . 52.03 109.506 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -62.55 -33.39 74.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.088 -0.96 . . . . 70.32 110.555 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.474 0.762 0 O-C-N 124.405 1.066 . . . . 73.13 110.41 177.003 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 52.1 m . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 108.348 -0.982 . . . . 54.23 108.348 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -137.91 128.9 27.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.514 0.725 . . . . 74.52 109.824 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 3.1 pm0 -147.25 129.35 15.52 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.657 0.783 . . . . 63.31 109.568 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.32 143.19 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.01 108.987 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -105.48 -50.78 3.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.505 0.322 . . . . 63.23 110.136 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -159.39 135.6 8.96 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.802 -167.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.14 129.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 75.01 109.162 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.43 ' HE1' HG13 ' B' ' 83' ' ' ILE . 17.5 p90 -157.81 151.26 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.525 0.679 . . . . 73.44 111.366 -173.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.6 m -76.26 122.13 23.94 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.672 -1.149 . . . . 65.1 109.099 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.93 -17.64 19.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.961 0.504 . . . . 70.32 112.082 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -167.97 139.16 2.85 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.104 0.252 . . . . 73.02 111.031 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.467 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -134.35 141.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.713 1.205 . . . . 65.43 109.414 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.6 t -139.15 137.14 35.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.779 1.232 . . . . 74.51 107.811 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.466 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -143.76 119.61 10.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.904 -1.517 . . . . 73.43 106.904 169.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 31.6 mt-10 -120.61 117.87 28.68 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -121.92 83.45 43.7 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.012 -0.736 . . . . 44.44 109.012 170.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.11 -24.77 32.27 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.879 2.386 . . . . 75.34 111.215 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -114.91 24.5 11.69 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.502 1.121 . . . . 74.32 109.785 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.612 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.08 -55.48 9.38 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.014 1.325 . . . . 74.02 114.047 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -77.61 -33.74 2.22 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.235 1.957 . . . . 62.2 111.89 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.515 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 70.5 m80 -96.0 4.3 52.76 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 124.245 1.018 . . . . 73.04 112.83 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.14 -25.78 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.886 0.875 . . . . 71.15 111.889 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -66.29 -26.5 67.35 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.594 1.158 . . . . 65.24 112.281 -174.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 5.5 pt20 -67.83 -33.58 75.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 110.047 -0.353 . . . . 55.35 110.047 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.548 ' HB2' HD13 ' B' ' 68' ' ' LEU . 80.1 mttt -108.27 65.48 0.63 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.584 -0.895 . . . . 72.22 108.584 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.39 108.32 14.9 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.698 -0.482 . . . . 64.43 109.698 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.505 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 161.5 -171.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.842 2.457 . . . . 71.34 109.605 157.133 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -58.56 128.36 83.16 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 122.635 0.374 . . . . 61.52 111.758 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -88.19 161.55 7.08 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.069 2.513 . . . . 75.23 112.099 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -75.49 107.53 7.68 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.92 -0.77 . . . . 72.04 108.92 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 142.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.198 -0.91 . . . . 62.04 110.693 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.419 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.7 tttm -139.39 144.1 38.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 74.01 109.528 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 84.7 mt -105.24 156.09 18.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.215 0.606 . . . . 71.4 110.702 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.8 t70 -152.04 109.97 3.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.967 -1.015 . . . . 64.24 108.409 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.36 128.89 55.46 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.607 -0.886 . . . . 74.02 108.607 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -131.45 145.19 51.67 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.78 0.832 . . . . 74.44 109.331 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 75.3 p -116.0 119.45 35.93 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.308 0.643 . . . . 70.21 110.308 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.93 139.79 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.765 -0.828 . . . . 51.13 108.765 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 p -143.32 162.85 34.61 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 111.763 0.283 . . . . 71.14 111.763 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 63.7 p -165.55 153.6 11.15 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.018 0.824 . . . . 72.43 110.024 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.0 126.51 31.48 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.098 -0.704 . . . . 74.41 109.098 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' B' ' 57' ' ' GLU . 34.5 mt -93.66 -49.37 5.9 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.37 0.668 . . . . 73.44 109.495 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.57 -166.21 2.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.536 -0.756 . . . . 62.33 110.845 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.84 108.95 1.11 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.669 1.188 . . . . 73.0 111.062 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 66.35 6.75 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.273 1.429 . . . . 54.2 112.107 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.98 115.05 46.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.752 -0.832 . . . . 72.3 108.752 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.83 144.82 50.09 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.563 -0.903 . . . . 64.02 108.563 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.573 ' HB2' HD11 ' B' ' 51' ' ' LEU . 38.4 tt0 -99.53 127.61 45.61 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.489 0.715 . . . . 63.42 109.539 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.0 116.95 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 48.4 t -103.64 128.82 56.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 107.379 -1.341 . . . . 75.44 107.379 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.01 100.15 7.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.063 -1.458 . . . . 73.41 107.063 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -85.7 108.28 17.96 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.0 -1.0 . . . . 70.54 109.159 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 102.88 14.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.567 -1.272 . . . . 73.23 107.567 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.1 m -101.68 130.35 48.03 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.341 -0.845 . . . . 61.23 108.757 177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.451 HG23 HD13 ' B' ' 114' ' ' ILE . 71.7 t -118.14 133.47 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 124.166 0.986 . . . . 70.45 108.594 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.5 m -118.88 144.45 46.39 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.927 0.891 . . . . 74.11 109.037 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.96 21.27 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.606 -1.257 . . . . 71.34 107.606 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.0 p -139.89 128.43 22.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.949 0.5 . . . . 70.45 111.825 -174.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' B' ' 34' ' ' LYS . 28.6 mt -95.48 100.96 12.64 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.563 1.145 . . . . 64.25 109.017 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.77 -125.44 10.02 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 112.007 -0.437 . . . . 65.33 112.007 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -99.06 18.69 16.74 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.763 0.825 . . . . 73.21 110.283 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -126.45 147.23 49.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.94 0.896 . . . . 71.01 109.888 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.9 m -70.12 133.13 46.83 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.568 0.747 . . . . 75.43 110.717 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.524 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.66 -62.19 1.56 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.054 -0.721 . . . . 72.31 109.054 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -162.95 154.93 18.16 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.45 -1.25 . . . . 72.42 108.737 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 87.6 mt -130.92 144.91 51.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 63.54 108.386 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.1 t -147.55 152.56 38.19 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.746 -0.835 . . . . 73.24 108.746 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.4 tt0 -159.53 132.16 6.71 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.606 -0.887 . . . . 64.12 108.606 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' B' ' 113' ' ' CYS . 75.5 t -128.59 144.41 38.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.427 -0.953 . . . . 75.05 108.427 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.64 91.87 3.59 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.938 -1.134 . . . . 72.23 107.938 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.95 101.85 12.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.738 -0.838 . . . . 74.41 108.738 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.77 142.83 16.8 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 111.124 -0.79 . . . . 64.31 111.124 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 126.31 3.21 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.741 -0.944 . . . . 41.23 110.741 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.432 HG23 HD12 ' B' ' 51' ' ' LEU . 65.2 mt -84.25 123.2 38.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 108.431 -0.951 . . . . 65.04 108.431 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.75 134.74 45.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.321 1.048 . . . . 71.31 108.309 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 16.4 m -103.85 99.81 9.59 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.564 -1.273 . . . . 53.55 107.564 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.537 ' HB ' HD11 ' B' ' 89' ' ' ILE . 34.2 pt -107.03 139.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.368 0.667 . . . . 45.44 110.521 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.52 161.49 40.0 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.11 0.964 . . . . 72.34 109.55 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.78 -59.17 4.94 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.259 -0.428 . . . . 74.42 113.298 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.19 125.87 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.355 0.598 . . . . 71.33 110.691 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.73 167.86 29.19 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.672 -0.695 . . . . 73.42 110.877 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -118.04 12.97 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.18 -0.918 . . . . 73.23 113.191 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.2 m -71.72 -35.01 70.06 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.343 0.657 . . . . 64.13 110.945 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -66.58 -36.89 83.73 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.184 -0.916 . . . . 72.2 111.093 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.544 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 16.9 ptp -60.28 -43.32 96.32 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 123.576 0.547 . . . . 64.33 110.008 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.4 69.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.492 0.717 . . . . 71.44 111.383 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -75.4 -40.66 57.57 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.888 0.475 . . . . 74.4 110.65 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -68.32 -67.48 0.46 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.011 0.524 . . . . 61.41 110.945 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 94' ' ' MET . 4.0 pp -75.81 -12.62 60.21 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.917 0.487 . . . . 73.33 112.185 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -23.01 24.93 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.945 -0.364 . . . . 35.44 113.986 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.69 -58.7 1.16 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.2 0.5 . . . . 72.0 110.717 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.14 -50.78 72.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.489 1.115 . . . . 72.31 112.181 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.4 m -69.03 -47.27 30.12 Favored Pre-proline 0 CA--C 1.569 1.691 0 C-N-CA 123.481 0.712 . . . . 41.25 112.048 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.8 Cg_exo -53.71 -35.23 77.49 Favored 'Trans proline' 0 C--N 1.397 3.121 0 C-N-CA 122.721 2.28 . . . . 73.34 114.098 170.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -67.68 -24.57 65.43 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.399 0.68 . . . . 72.11 111.856 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.41 -45.24 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.997 0.519 . . . . 52.43 110.213 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.08 -21.92 49.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.732 -0.667 . . . . 71.35 112.066 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.457 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 75.5 t80 -56.67 -51.74 78.97 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 117.997 -1.001 . . . . 73.5 113.098 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.8 Cg_exo -58.25 -38.92 88.86 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.437 2.091 . . . . 74.51 113.584 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -67.5 -41.73 83.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.411 0.684 . . . . 74.4 111.191 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.24 88.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.018 0.527 . . . . 73.13 110.573 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.5 ttt180 -59.56 -60.27 4.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.69 1.596 . . . . 74.1 111.062 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.77 -31.12 70.49 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.38 1.072 . . . . 74.22 111.135 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.7 t -70.96 -36.65 72.66 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 122.483 -0.136 . . . . 60.11 111.022 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.451 HD13 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -68.18 -45.92 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.167 0.587 . . . . 73.2 109.448 173.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.3 m -56.92 -38.68 73.21 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.749 -1.114 . . . . 72.23 111.164 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.9 t -63.97 -47.79 79.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.582 0.753 . . . . 71.41 110.667 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.1 mmt -72.14 -34.73 68.75 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.972 0.509 . . . . 74.02 111.573 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.7 t -67.64 -38.46 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.186 0.594 . . . . 72.11 110.15 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -67.97 -30.92 70.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.913 0.885 . . . . 72.42 111.013 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -72.62 -34.18 67.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.624 0.77 . . . . 75.51 110.504 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.32 3.39 53.54 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.626 0.579 . . . . 74.05 112.3 170.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.8 p 58.21 54.56 5.7 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.445 1.898 . . . . 73.21 111.357 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -119.44 154.1 54.08 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.139 -1.391 . . . . 53.52 110.265 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -60.22 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.319 2.679 . . . . 63.21 114.776 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -64.98 129.89 41.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.167 -0.924 . . . . 62.34 112.814 -159.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.9 84.78 2.24 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.439 -1.689 . . . . 74.25 106.439 170.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -115.73 127.55 55.21 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.352 -0.981 . . . . 64.1 108.352 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.416 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 4.3 mm? -72.07 147.86 46.35 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.871 0.732 . . . . 71.1 110.311 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.67 150.79 73.42 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 115.464 -0.789 . . . . 63.04 109.205 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.03 102.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.63 2.22 . . . . 64.23 110.938 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.23 110.23 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 109.284 -0.635 . . . . 71.13 109.284 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -85.75 88.32 7.53 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 71.34 108.8 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 N--CA 1.481 1.093 0 CA-C-N 115.438 -0.801 . . . . 64.43 111.378 179.171 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.563 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 50.2 ttp . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.304 0.573 . . . . 74.21 111.878 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -86.02 78.01 9.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.286 -1.005 . . . . 61.13 108.286 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.563 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 35.0 t80 -112.42 133.96 54.22 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.035 -0.984 . . . . 73.25 109.096 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -154.76 142.15 19.61 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.201 0.6 . . . . 65.04 109.646 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -77.21 97.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.317 -0.856 . . . . 53.05 109.308 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.7 mm-40 -75.06 -42.11 57.66 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.603 -0.517 . . . . 74.44 109.603 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -174.25 147.42 1.2 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.274 0.984 . . . . 73.24 109.561 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.1 mt -129.1 142.03 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 107.62 -1.252 . . . . 72.35 107.62 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -172.64 158.29 4.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.468 0.651 . . . . 74.4 111.418 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 18' ' ' THR . . . . . 0.407 HG21 ' SG ' ' C' ' 113' ' ' CYS . 66.7 p -83.22 106.35 14.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.804 -1.089 . . . . 64.41 108.387 173.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -65.93 -47.47 74.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.554 0.692 . . . . 62.42 109.268 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -135.51 140.42 44.76 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.611 -1.177 . . . . 50.5 109.204 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 69.9 mt -134.22 138.32 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.325 -1.361 . . . . 64.14 107.325 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -154.79 150.53 27.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.964 0.411 . . . . 72.03 110.034 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.14 108.59 3.62 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.912 -1.144 . . . . 63.4 107.912 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.77 108.82 16.83 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.148 0.579 . . . . 73.24 109.546 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.14 85.45 18.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.398 -0.964 . . . . 53.11 108.398 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -36.22 31.69 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.009 2.473 . . . . 71.41 112.368 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -107.6 34.29 3.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.516 0.726 . . . . 73.22 109.413 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.48 -50.76 63.72 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.223 1.194 . . . . 65.32 114.223 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.97 -32.96 8.2 Favored 'Trans proline' 0 C--N 1.388 2.625 0 CA-C-N 121.036 1.406 . . . . 71.43 112.78 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.18 -37.13 75.08 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.836 0.854 . . . . 73.32 112.642 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.36 -21.09 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.165 0.586 . . . . 75.3 110.608 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.47 -2.26 27.96 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.268 0.627 . . . . 74.11 111.095 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -124.12 26.28 7.54 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.417 1.087 . . . . 73.42 109.837 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 147.44 35.93 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.248 1.019 . . . . 70.44 109.947 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.44 131.13 49.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 73.42 111.114 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -71.61 93.57 1.24 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.148 0.979 . . . . 73.41 112.011 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -154.91 74.49 5.64 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.738 0.815 . . . . 70.34 108.991 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -84.44 127.95 3.97 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.563 2.175 . . . . 74.21 112.357 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.56 97.22 10.4 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 106.502 -1.666 . . . . 74.13 106.502 166.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.96 117.05 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.57 -1.196 . . . . 73.01 109.8 -169.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -97.36 109.0 21.85 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.053 -1.091 . . . . 64.44 108.053 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tt -86.81 123.8 32.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.264 -1.754 . . . . 75.52 106.264 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.9 t70 -120.02 147.91 44.21 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.642 0.777 . . . . 75.21 109.462 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -134.54 131.85 38.44 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.396 1.078 . . . . 64.31 108.129 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.742 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.3 t70 -133.52 135.26 44.3 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.511 -0.551 . . . . 75.52 109.511 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -113.41 111.2 21.56 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.754 0.822 . . . . 64.33 109.559 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.79 157.62 35.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.204 1.002 . . . . 52.2 109.851 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 67.5 p -155.15 167.25 30.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.817 0.447 . . . . 63.52 110.95 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -164.86 127.34 2.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.661 0.785 . . . . 73.15 109.839 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.31 135.96 33.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.264 0.483 . . . . 75.42 109.784 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.653 HD11 HD12 ' C' ' 83' ' ' ILE . 41.2 mt -106.11 -47.01 3.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.03 0.932 . . . . 74.45 109.993 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.7 -178.01 5.45 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.138 0.975 . . . . 70.31 108.973 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.64 110.91 1.24 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.6 0.76 . . . . 71.31 111.019 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 19.1 m-20 62.85 30.75 16.6 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.493 1.117 . . . . 71.43 111.768 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -118.98 111.59 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.619 -1.252 . . . . 75.42 107.619 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.421 ' HB2' HD12 ' C' ' 86' ' ' ILE . 95.4 m-85 -123.51 125.85 45.65 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.772 0.829 . . . . 52.24 109.81 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.78 120.3 24.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 65.21 108.917 168.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -96.78 117.33 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.585 -1.265 . . . . 75.25 107.585 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.08 131.61 52.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.006 -1.109 . . . . 71.22 108.006 173.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.62 105.85 9.0 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.191 -1.04 . . . . 75.21 108.191 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.742 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 59.3 mtt180 -83.3 134.61 34.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.646 -0.502 . . . . 63.24 109.646 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.0 123.77 69.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.798 -1.556 . . . . 73.04 106.798 162.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.8 m -121.17 112.33 18.53 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.446 0.641 . . . . 72.54 109.321 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.455 HG21 HG21 ' C' ' 114' ' ' ILE . 51.5 t -101.13 117.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 54.23 108.586 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -115.13 141.89 47.4 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.667 -0.864 . . . . 65.01 108.667 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.07 123.0 22.54 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.941 -1.133 . . . . 70.52 107.941 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 127.07 16.97 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 122.852 0.461 . . . . 73.13 110.548 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.51 ' H ' HD12 ' C' ' 68' ' ' LEU . 1.5 mp -90.63 49.25 1.64 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.045 1.338 . . . . 53.54 109.121 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.01 -106.58 2.81 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.212 -0.903 . . . . 73.05 110.901 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -90.35 -30.88 17.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.962 0.905 . . . . 70.03 110.162 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -66.32 115.47 6.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.308 1.043 . . . . 65.42 109.891 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.2 m -89.82 125.6 35.38 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.714 0.688 . . . . 64.22 109.653 168.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' C' ' 68' ' ' LEU . . . -72.23 -64.02 1.03 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.79 -1.095 . . . . 65.1 109.502 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.59 170.16 23.02 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.564 -1.198 . . . . 73.32 110.814 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.426 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -133.69 146.61 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.562 -2.014 . . . . 72.24 105.562 172.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.426 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -151.47 145.26 25.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.394 -0.965 . . . . 54.23 108.394 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 77' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' C' ' 63' ' ' THR . 34.3 tt0 -157.56 136.37 11.5 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.294 -0.632 . . . . 73.42 109.294 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.58 123.7 49.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.114 -0.948 . . . . 74.32 108.927 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.732 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 29.1 mt-30 -92.33 87.56 6.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.656 -1.239 . . . . 75.41 107.656 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -79.08 96.88 5.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.317 -0.624 . . . . 73.12 109.317 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.07 149.05 24.88 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 115.26 -0.882 . . . . 42.33 111.577 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.92 117.23 0.81 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 110.825 -0.91 . . . . 73.13 110.825 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.653 HD12 HD11 ' C' ' 51' ' ' LEU . 14.5 mm -80.98 121.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.398 -0.964 . . . . 75.33 108.398 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.97 126.73 29.16 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.596 -0.89 . . . . 53.15 108.596 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -69.61 119.26 13.58 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.344 -0.984 . . . . 44.33 108.344 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.611 HG23 HD11 ' C' ' 89' ' ' ILE . 59.1 mt -116.3 100.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.066 -0.716 . . . . 71.01 109.066 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -148.71 164.47 34.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.648 1.179 . . . . 73.31 109.031 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.34 32.5 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 123.13 0.269 . . . . 70.55 112.988 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.611 HD11 HG23 ' C' ' 86' ' ' ILE . 11.9 pt -114.45 156.18 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.598 1.159 . . . . 73.25 110.37 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -164.96 156.21 14.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.945 -1.025 . . . . 71.21 109.264 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 63.08 -110.37 3.32 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.423 0.452 . . . . 73.45 114.006 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -83.1 -27.19 30.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.664 0.386 . . . . 72.13 111.797 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -42.07 75.25 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.476 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.2 ptt? -63.57 -35.78 81.62 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.67 -0.696 . . . . 73.33 110.004 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.64 93.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.708 0.803 . . . . 45.11 112.024 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 47.7 t-80 -78.76 -20.92 48.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.304 -0.407 . . . . 73.41 111.265 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.5 t -82.56 -63.25 1.41 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.154 -0.342 . . . . 64.55 111.27 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.566 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 4.6 pp -77.51 -32.16 53.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.847 0.459 . . . . 45.32 111.387 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.34 8.77 64.7 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.727 -0.485 . . . . 73.44 113.702 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -148.64 -56.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.246 0.523 . . . . 63.34 111.838 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -74.49 -40.27 61.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.193 0.442 . . . . 72.2 112.193 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 85.4 m -64.84 -47.24 75.14 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.723 -0.656 . . . . 63.31 111.176 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 55.3 Cg_exo -57.34 -37.24 98.21 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.123 1.882 . . . . 72.24 113.023 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.09 -37.97 81.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.787 0.835 . . . . 74.33 111.348 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -73.23 -46.78 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.242 0.617 . . . . 63.02 110.92 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.92 -20.56 49.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.552 -0.749 . . . . 73.34 112.298 -172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 61.4 t80 -58.56 -51.86 78.77 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.747 -1.121 . . . . 72.45 113.192 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.3 Cg_exo -56.71 -38.57 95.37 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.036 1.824 . . . . 74.21 113.518 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -69.16 -42.64 75.63 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.322 0.649 . . . . 73.22 111.517 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.72 99.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.255 0.622 . . . . 74.33 109.637 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' C' ' 127' ' ' ASN . 41.1 ttt180 -58.43 -53.88 53.34 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.924 1.69 . . . . 75.24 111.469 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.57 -34.77 78.64 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.579 0.549 . . . . 70.33 110.321 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' C' ' 18' ' ' THR . 6.4 t -68.56 -32.91 73.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.034 0.534 . . . . 70.33 111.128 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' C' ' 62' ' ' VAL . 78.6 mt -71.52 -53.64 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.777 -0.647 . . . . 71.32 109.869 174.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.2 m -63.05 -28.87 70.38 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.258 0.623 . . . . 64.32 111.693 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -64.42 -51.51 62.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.498 0.719 . . . . 55.21 109.424 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.605 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.21 -38.9 81.05 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.325 1.05 . . . . 65.32 112.213 178.33 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.9 t -60.7 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.561 0.744 . . . . 71.33 109.749 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 41.1 t -67.08 -35.36 79.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.671 0.789 . . . . 73.31 112.083 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -69.3 -31.84 70.6 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.432 0.693 . . . . 75.34 110.551 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.61 12.18 70.08 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.559 0.537 . . . . 71.41 113.073 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.422 HG22 ' NH2' ' D' ' 15' ' ' ARG . 6.9 p 64.84 20.88 12.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.652 1.981 . . . . 74.31 113.423 173.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -89.1 151.1 46.38 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.267 -0.642 . . . . 62.53 109.267 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.78 144.28 96.87 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.205 2.603 . . . . 75.42 113.282 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.473 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -51.08 111.07 0.5 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 71.51 111.415 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.11 85.71 2.16 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.332 -0.988 . . . . 74.14 108.332 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.461 ' HB3' ' NH2' ' C' ' 111' ' ' ARG . 17.5 m120 -91.6 109.32 20.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.47 -1.241 . . . . 73.45 108.427 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.65 135.08 57.29 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.263 0.977 . . . . 52.43 111.929 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.24 157.85 88.93 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.281 1.032 . . . . 42.41 110.345 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.54 105.49 0.76 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.389 2.059 . . . . 72.25 112.171 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.59 107.85 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.488 -1.301 . . . . 74.31 107.488 171.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -105.72 93.91 4.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.432 -0.803 . . . . 73.21 110.004 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -63.7 -41.84 98.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.117 -0.697 . . . . 73.22 109.117 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.449 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.9 p-10 . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 124.959 1.304 . . . . 63.23 111.822 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 95.1 m . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.113 0.483 . . . . 75.0 110.381 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.8 t80 -138.98 122.56 17.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.053 -1.462 . . . . 72.05 107.053 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.5 130.52 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.446 -0.576 . . . . 64.22 109.446 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.88 125.79 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.67 -1.233 . . . . 74.43 107.67 168.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -99.06 -43.6 6.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.766 0.426 . . . . 71.2 110.259 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.422 ' NH2' HG22 ' C' ' 122' ' ' THR . 7.8 tpt180 -179.69 141.0 0.15 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.827 0.851 . . . . 72.35 110.627 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.95 141.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.15 -1.055 . . . . 70.51 108.15 171.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.1 p90 -156.55 173.39 16.99 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.847 0.832 . . . . 74.31 111.2 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -104.81 119.62 39.45 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.437 -1.256 . . . . 74.01 109.111 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -90.52 -26.87 19.54 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.279 -0.419 . . . . 62.42 110.42 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -159.71 110.72 1.97 Allowed 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.792 0.682 . . . . 72.24 109.278 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.605 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.0 mt -111.27 149.44 14.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.708 -0.849 . . . . 65.11 108.708 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -148.82 142.29 25.3 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.955 0.902 . . . . 51.54 109.82 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.441 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.0 t80 -152.55 120.08 6.01 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 106.406 -1.702 . . . . 44.15 106.406 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' D' ' 74' ' ' PHE . 45.0 mt-10 -128.32 120.28 26.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.499 0.72 . . . . 71.14 109.269 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.97 85.01 4.75 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.01 -1.107 . . . . 74.13 108.01 171.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.29 -28.68 8.49 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.114 2.543 . . . . 75.53 113.502 -167.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 14.5 m-80 -115.05 28.61 8.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.206 -0.664 . . . . 64.45 109.206 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.85 -66.1 0.47 Allowed Pre-proline 0 CA--C 1.566 1.569 0 N-CA-C 114.992 1.478 . . . . 44.42 114.992 -165.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.456 ' HB3' HD11 ' C' ' 83' ' ' ILE . 78.7 Cg_endo -77.22 -15.22 16.22 Favored 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.566 1.952 . . . . 75.42 113.199 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.5 t-160 -70.23 -38.87 75.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 74.12 109.609 174.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.61 -39.82 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.266 1.026 . . . . 64.44 110.66 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -75.85 -3.77 37.01 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.754 -1.112 . . . . 73.12 113.764 -168.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -85.33 -6.88 59.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.774 0.83 . . . . 75.42 111.305 172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -121.92 115.21 22.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.386 1.474 . . . . 73.23 108.093 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.83 93.94 8.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.556 0.743 . . . . 71.14 112.381 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.415 ' HE3' ' H ' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -165.22 -179.19 5.47 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.951 0.9 . . . . 73.31 111.848 177.765 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.86 140.58 26.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.603 0.761 . . . . 73.31 111.935 -176.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 58.6 Cg_endo -75.03 156.13 42.83 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.019 2.479 . . . . 73.33 114.152 168.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -89.17 140.68 29.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.354 -1.294 . . . . 61.21 108.058 164.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -119.78 119.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.337 0.655 . . . . 63.43 110.778 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 61.7 tttt -98.74 137.15 37.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.93 0.892 . . . . 71.0 109.339 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.61 123.51 44.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.589 0.756 . . . . 60.03 109.789 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.2 m-20 -118.84 127.49 53.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.15 0.98 . . . . 75.04 108.541 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mp -109.06 138.17 45.83 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.251 -0.648 . . . . 65.12 109.251 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.1 t70 -150.49 152.94 34.98 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.536 0.735 . . . . 60.32 109.082 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 20.6 p -140.94 160.88 39.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.008 0.923 . . . . 73.14 110.393 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.95 167.82 29.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.006 0.922 . . . . 73.33 109.593 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 42.2 p -159.07 153.01 23.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.176 0.59 . . . . 75.14 109.799 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 92.6 p -151.9 149.08 28.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.281 -0.637 . . . . 74.42 109.281 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -89.01 118.35 28.68 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.35 -0.611 . . . . 64.1 109.35 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.6 mt -92.02 -36.7 13.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.021 0.529 . . . . 73.32 110.152 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.33 -179.75 8.22 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.294 -0.867 . . . . 55.34 109.955 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.41 125.85 28.83 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.987 -0.746 . . . . 63.54 108.987 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 65.82 14.84 9.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.374 1.07 . . . . 74.34 111.773 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 41.9 t -129.57 124.74 60.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 124.125 0.97 . . . . 63.12 109.145 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.621 ' HB2' HD13 ' D' ' 86' ' ' ILE . 62.7 m-85 -136.1 141.18 44.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.342 0.591 . . . . 73.55 109.805 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.6 tt0 -91.83 132.66 36.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.471 -1.24 . . . . 74.32 109.792 173.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.57 125.85 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 107.541 -1.281 . . . . 63.44 107.541 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 34.1 t -110.15 129.58 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.039 -0.726 . . . . 72.2 109.039 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.504 HD23 HD12 ' D' ' 106' ' ' LEU . 1.8 mm? -118.65 106.21 12.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.529 0.731 . . . . 70.44 109.599 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.7 ttm180 -88.39 102.03 14.47 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.622 -0.717 . . . . 61.43 109.443 177.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -91.74 121.18 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.786 -1.19 . . . . 74.23 107.786 170.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.4 m -127.0 146.07 50.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.602 0.761 . . . . 52.4 109.298 -175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.505 HG11 HD21 ' D' ' 126' ' ' LEU . 54.0 t -139.5 111.74 5.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.997 1.319 . . . . 65.02 109.038 -172.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.2 m -96.75 95.63 8.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.768 -0.827 . . . . 51.11 108.768 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.82 44.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.35 -0.611 . . . . 73.4 109.35 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.503 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.0 m -142.33 141.1 32.32 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.361 0.665 . . . . 74.15 110.778 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -132.17 135.64 46.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.912 1.285 . . . . 63.32 110.17 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 -114.51 5.57 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.902 -0.879 . . . . 53.42 110.902 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.61 4.69 12.36 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.039 0.535 . . . . 65.54 110.418 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -127.36 161.84 27.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.074 0.55 . . . . 73.02 110.946 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -80.75 131.55 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.964 0.505 . . . . 65.01 111.469 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.718 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -72.68 -71.62 0.28 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.754 1.222 . . . . 74.14 108.379 173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' D' ' 24' ' ' GLU . 51.4 p90 -153.93 140.32 18.68 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.746 -0.661 . . . . 73.04 111.033 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.37 110.2 22.17 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.272 -1.381 . . . . 44.5 107.272 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.584 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.2 t -119.0 132.89 56.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.478 -0.564 . . . . 74.51 109.478 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.412 ' HB2' HG23 ' D' ' 63' ' ' THR . 32.3 tt0 -152.08 132.13 13.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.14 0.576 . . . . 60.42 110.249 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.71 117.35 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.356 0.663 . . . . 61.43 109.669 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -87.28 87.33 7.4 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.852 -1.166 . . . . 73.51 107.852 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.33 91.17 5.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.289 -0.869 . . . . 63.35 108.796 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.94 143.61 17.61 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.071 -0.811 . . . . 53.14 111.071 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.92 132.13 5.08 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 111.209 -0.756 . . . . 62.45 111.209 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.495 HG13 ' HE1' ' D' ' 17' ' ' TYR . 49.1 mt -88.19 124.37 41.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 108.407 -0.96 . . . . 65.11 108.407 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -129.48 160.77 32.13 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.26 0.552 . . . . 74.1 110.112 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 35.5 m -104.9 117.19 33.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.992 -1.114 . . . . 74.51 107.992 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.4 mp -118.15 108.76 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.197 -0.668 . . . . 72.12 109.197 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.32 160.82 41.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.037 0.935 . . . . 74.01 110.014 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.01 -4.13 62.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.728 -0.669 . . . . 72.53 113.904 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.447 HD11 HG23 ' D' ' 86' ' ' ILE . 15.0 pt -126.65 142.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.123 0.969 . . . . 73.14 109.696 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.8 167.21 22.68 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.43 0.692 . . . . 74.34 110.114 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.17 -122.7 27.1 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 124.605 1.191 . . . . 72.05 114.606 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 m -66.27 -44.38 83.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.162 0.985 . . . . 61.0 112.128 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.69 -38.33 88.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.027 0.531 . . . . 70.43 110.873 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.67 -0.695 . . . . 72.44 110.199 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -28.7 67.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.748 0.819 . . . . 71.32 111.767 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 53.0 t-80 -78.69 -30.64 46.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.745 . . . . 74.12 110.513 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -76.61 -50.86 12.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.295 0.569 . . . . 54.12 110.071 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.601 HD12 HG12 ' D' ' 86' ' ' ILE . 6.3 tt -81.96 -23.28 36.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.654 -0.703 . . . . 62.43 111.124 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.18 57.09 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.447 -0.641 . . . . 44.5 114.145 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -141.01 -53.96 0.48 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.868 0.834 . . . . 73.55 111.782 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -73.89 -54.32 8.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 71.12 110.978 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 61.2 m -59.25 -44.95 99.14 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 113.895 1.072 . . . . 74.22 113.895 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.72 -35.49 94.51 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 121.915 1.743 . . . . 71.12 112.794 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -80.78 -7.57 59.43 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.518 0.727 . . . . 70.23 111.415 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.71 -37.38 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.491 0.662 . . . . 74.1 109.747 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.504 HD12 HD23 ' D' ' 60' ' ' LEU . 50.9 mt -81.79 -32.02 31.55 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.129 -0.941 . . . . 53.11 111.409 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.54 -44.21 98.84 Favored Pre-proline 0 CA--C 1.572 1.805 0 N-CA-C 114.195 1.183 . . . . 63.41 114.195 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.56 -39.99 78.09 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.317 2.011 . . . . 72.11 113.421 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -74.9 -33.61 62.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.295 0.638 . . . . 65.13 110.97 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.35 88.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.217 0.607 . . . . 72.35 109.994 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.4 ttp180 -59.42 -52.19 66.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 114.412 -1.267 . . . . 73.33 110.754 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.72 -45.34 94.39 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.176 0.923 . . . . 74.23 110.925 -175.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.3 -41.47 84.51 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.761 0.663 . . . . 75.43 110.953 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.584 HG23 ' SG ' ' D' ' 76' ' ' CYS . 47.6 mt -63.29 -55.66 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.612 -0.722 . . . . 74.52 110.39 174.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -53.49 -39.68 64.76 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.337 1.055 . . . . 64.43 111.47 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 20.6 t -65.95 -45.91 80.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.987 -1.006 . . . . 74.22 110.501 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.9 mtm -67.39 -35.89 80.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.967 0.507 . . . . 73.02 111.776 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.7 t -64.04 -43.59 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 123.838 0.711 . . . . 71.33 109.399 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.0 p -71.62 -29.32 64.53 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.007 0.523 . . . . 73.51 111.87 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' D' ' 116' ' ' SER . 86.3 mtt-85 -72.86 -34.28 66.64 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.574 0.75 . . . . 74.21 110.473 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 9.01 63.96 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.759 0.662 . . . . 24.04 112.202 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.4 p 62.14 18.7 10.29 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.935 2.094 . . . . 64.35 113.544 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -83.34 165.46 40.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 107.557 -1.275 . . . . 75.05 107.557 162.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -84.05 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.284 1.989 . . . . 63.45 113.549 -165.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -74.44 120.57 20.18 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 122.442 0.297 . . . . 74.1 110.891 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.505 HD21 HG11 ' D' ' 64' ' ' VAL . 63.1 tp -116.51 95.0 4.85 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 42.24 108.184 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.27 104.26 13.61 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.508 -0.923 . . . . 62.21 108.508 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.495 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.5 mm? -62.99 113.87 3.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.607 0.763 . . . . 75.12 109.372 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -64.16 137.12 97.02 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 122.946 0.499 . . . . 64.13 110.477 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 15.8 Cg_exo -65.3 131.63 28.92 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.939 2.426 . . . . 72.45 112.273 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 65.1 t -109.28 130.92 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.23 0.612 . . . . 73.34 109.788 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -86.6 85.51 7.3 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.428 -0.953 . . . . 43.14 108.428 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 . . . . . 0 N--CA 1.484 1.272 0 CA-C-N 115.377 -0.829 . . . . 72.43 111.185 177.27 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.442 -0.577 . . . . 60.44 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 27.2 t80 -137.81 126.13 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.214 1.005 . . . . 71.15 108.712 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -151.06 128.51 11.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.307 0.643 . . . . 72.03 109.502 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CD1' HG21 ' A' ' 105' ' ' ILE . 56.4 mt -85.12 129.03 38.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 120.921 0.391 . . . . 73.15 109.955 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -88.6 -42.71 11.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.108 -0.951 . . . . 73.43 110.255 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' HB3' HD12 ' A' ' 83' ' ' ILE . 60.1 ttt180 -169.83 140.75 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.314 -0.403 . . . . 74.2 110.714 -170.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -122.81 137.95 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.221 -1.029 . . . . 74.34 108.221 172.014 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -168.23 143.58 3.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.388 0.675 . . . . 73.44 110.463 -171.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -76.59 111.01 11.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.735 -0.839 . . . . 70.43 108.735 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 40.4 mtpt -77.27 -25.28 51.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.969 0.508 . . . . 74.03 110.565 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.24 146.71 24.94 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.941 -1.027 . . . . 72.25 109.895 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.4 mt -140.24 145.2 26.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 125.06 1.344 . . . . 54.42 107.498 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 36.5 t -154.7 138.39 16.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.634 0.774 . . . . 61.2 109.103 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -143.58 131.63 21.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.565 -1.643 . . . . 74.52 106.565 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -134.51 128.81 34.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.006 -0.739 . . . . 74.14 109.006 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 78.65 72.94 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 107.33 -1.359 . . . . 73.44 107.33 171.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.73 -26.07 19.75 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.68 2.253 . . . . 70.24 112.055 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -109.39 24.22 13.38 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.773 0.829 . . . . 62.35 109.019 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.21 -61.17 2.48 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 117.879 -1.057 . . . . 70.22 112.595 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.7 Cg_exo -63.21 -24.3 72.5 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 122.28 1.987 . . . . 73.15 113.008 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.407 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 16.2 m-70 -77.95 -47.37 18.75 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.673 0.789 . . . . 45.34 110.442 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -73.9 -20.02 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 CA-C-N 115.16 -0.927 . . . . 75.12 110.949 -163.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.9 -19.22 62.62 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.354 1.062 . . . . 75.41 112.765 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -102.53 -10.28 19.47 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.696 0.398 . . . . 55.32 111.979 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 30' ' ' HIS . 36.6 mtpt -82.12 167.63 18.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.875 0.47 . . . . 74.44 112.248 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -61.53 141.33 57.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.457 1.103 . . . . 71.34 111.933 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -91.87 64.08 4.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.07 0.548 . . . . 74.12 110.68 -172.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -127.07 73.68 76.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.393 0.677 . . . . 75.54 110.054 175.384 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -89.72 118.44 0.78 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.619 2.213 . . . . 74.45 112.187 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.73 101.1 12.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.901 -1.518 . . . . 72.14 106.901 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.3 t -76.46 114.89 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.355 -0.839 . . . . 54.04 110.133 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.35 134.41 35.57 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.355 0.662 . . . . 53.53 109.565 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.2 mt -103.28 108.61 19.9 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.527 -0.916 . . . . 71.01 108.527 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -104.26 113.9 27.77 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.004 0.922 . . . . 64.35 108.735 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.48 135.87 39.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.312 0.645 . . . . 64.42 109.586 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.57 134.44 30.56 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.397 -0.964 . . . . 75.03 108.397 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.454 HG23 HD22 ' A' ' 60' ' ' LEU . 11.5 m -148.63 140.57 23.84 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.64 0.376 . . . . 63.12 110.092 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.06 135.07 13.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.369 0.668 . . . . 74.31 110.644 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -96.45 164.09 12.77 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.859 0.864 . . . . 63.33 111.013 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -162.09 119.99 2.2 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.45 1.1 . . . . 73.32 108.752 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.39 118.69 18.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.958 -0.386 . . . . 74.33 109.958 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -89.25 -33.1 17.1 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.487 0.715 . . . . 75.13 111.137 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.53 -174.07 4.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.414 0.686 . . . . 72.35 110.765 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.24 116.66 5.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.425 0.69 . . . . 72.12 110.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 66.16 -0.14 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.403 1.481 . . . . 70.05 113.091 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.91 106.57 19.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.334 -0.987 . . . . 74.35 108.334 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -119.57 124.04 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.801 -1.185 . . . . 74.2 107.801 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -88.77 136.16 33.15 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.563 1.145 . . . . 71.42 108.532 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 99.0 t -122.76 125.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.644 -1.243 . . . . 74.02 107.644 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.516 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.6 t -104.97 128.02 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.023 0.529 . . . . 62.34 109.875 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.75 HD23 HD12 ' A' ' 106' ' ' LEU . 3.9 mm? -106.28 98.17 7.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 73.42 108.906 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 17.2 ttp180 -87.18 100.88 12.99 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.651 -0.87 . . . . 73.14 108.651 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.5 t -93.64 122.66 45.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.999 -1.482 . . . . 65.32 106.999 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.3 m -116.35 121.38 41.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.531 0.681 . . . . 71.44 109.281 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 t -111.18 109.84 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.95 1.3 . . . . 72.32 108.672 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.7 m -103.56 140.07 38.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 108.31 -0.996 . . . . 73.11 108.31 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.16 121.22 37.33 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.182 -0.673 . . . . 71.14 109.182 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -122.73 124.82 44.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.245 0.545 . . . . 60.51 110.768 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 5.1 mp -88.81 77.08 7.87 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.351 1.46 . . . . 71.43 107.578 173.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.01 -86.78 0.88 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.865 -1.061 . . . . 62.44 111.15 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -113.9 -27.89 7.58 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.882 0.873 . . . . 52.52 110.65 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -86.07 133.71 33.87 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.351 0.66 . . . . 71.13 111.042 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.4 m -78.26 147.24 34.43 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.127 0.421 . . . . 74.32 110.526 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.734 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -96.8 -63.25 1.15 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.971 0.908 . . . . 71.44 108.964 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -151.6 163.86 38.15 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.154 -1.384 . . . . 74.4 110.548 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.7 tp -132.89 121.26 22.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.498 1.119 . . . . 72.22 108.461 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.657 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.2 m -105.79 141.03 37.92 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.603 1.161 . . . . 43.51 108.719 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.4 tt0 -146.66 115.35 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.091 -1.077 . . . . 54.31 108.091 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 113' ' ' CYS . 46.4 t -131.32 109.96 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.102 -0.703 . . . . 75.31 109.102 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 64.5 mt-30 -87.7 81.79 7.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.3 -0.864 . . . . 55.24 109.086 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -75.87 93.11 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.108 -0.951 . . . . 74.13 108.633 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.55 145.4 21.92 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.317 -0.713 . . . . 65.31 111.317 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.07 142.82 12.15 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.539 -1.024 . . . . 64.15 110.539 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 15' ' ' ARG . 54.8 mt -106.9 126.41 62.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.578 -0.897 . . . . 73.25 108.578 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.48 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 14.5 m-85 -131.45 117.43 18.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.393 0.677 . . . . 71.43 109.199 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 t -78.55 90.63 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.889 0.876 . . . . 51.35 108.661 168.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 89' ' ' ILE . 48.5 pt -106.44 143.94 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.654 0.782 . . . . 61.02 110.286 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.22 154.88 28.0 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.809 0.844 . . . . 61.31 109.544 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.66 5.37 88.27 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 115.155 0.822 . . . . 61.21 115.155 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.6 134.51 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.392 -0.966 . . . . 74.35 108.392 174.079 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -142.47 171.93 13.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.227 1.011 . . . . 70.23 108.946 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.06 -120.18 14.27 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.459 0.543 . . . . 61.3 114.459 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -80.21 -24.17 40.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.01 0.924 . . . . 72.22 111.593 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -36.91 75.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.348 0.659 . . . . 64.43 109.949 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 52.1 ttp -65.98 -43.06 88.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.915 0.886 . . . . 51.44 110.193 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.93 82.39 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.347 -0.842 . . . . 73.15 111.426 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.731 0.813 . . . . 72.33 110.763 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.46 -49.56 68.67 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.01 0.524 . . . . 53.24 110.836 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 mt -85.03 -32.2 23.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.037 -0.529 . . . . 64.02 111.512 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.58 -1.88 63.69 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 114.823 0.689 . . . . 74.25 114.823 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.75 -54.65 0.19 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.998 0.899 . . . . 62.25 112.445 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -71.31 -64.4 0.92 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.318 1.047 . . . . 71.31 112.629 -167.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.9 m -70.37 -34.25 3.84 Favored Pre-proline 0 CA--C 1.574 1.87 0 N-CA-C 113.933 1.086 . . . . 55.43 113.933 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.61 ' HB3' HD21 ' A' ' 60' ' ' LEU . 26.2 Cg_endo -64.03 -31.53 65.8 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.249 1.966 . . . . 55.35 113.319 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -62.05 -34.93 77.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.246 0.618 . . . . 72.23 109.666 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.532 HG21 ' CD1' ' A' ' 13' ' ' ILE . 45.6 mm -60.03 -47.3 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.855 0.862 . . . . 73.44 110.603 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.75 HD12 HD23 ' A' ' 60' ' ' LEU . 98.4 mt -76.27 -25.62 55.1 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.454 -0.793 . . . . 60.25 112.091 -171.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.16 -44.58 98.74 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.003 1.112 . . . . 62.33 114.003 -170.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.92 -33.98 95.48 Favored 'Trans proline' 0 C--N 1.392 2.818 0 C-N-CA 122.117 1.878 . . . . 53.21 113.7 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.16 -35.27 56.12 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 75.23 110.98 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.27 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.504 -0.554 . . . . 30.02 109.504 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HG23 ' C' ' 105' ' ' ILE . 38.1 ttm180 -54.28 -53.91 47.35 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 124.663 1.227 . . . . 74.54 110.116 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.48 -43.4 98.92 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.542 1.151 . . . . 75.42 110.98 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.488 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 48.0 t -60.15 -40.51 90.11 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.581 0.551 . . . . 44.13 111.002 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 94.7 mt -65.49 -54.76 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.901 0.751 . . . . 72.23 109.669 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.584 HG21 ' HE2' ' C' ' 109' ' ' TYR . 93.5 m -53.17 -39.06 63.31 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.936 1.397 . . . . 71.12 111.343 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.8 t -65.94 -47.63 74.05 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.546 -1.206 . . . . 64.42 109.257 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.554 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 44.4 mtm -61.85 -42.94 99.65 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.194 0.598 . . . . 73.31 111.066 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.9 t -56.21 -50.48 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 124.388 1.055 . . . . 55.2 109.957 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -72.0 -32.29 67.06 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.222 -0.899 . . . . 61.21 111.588 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.511 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 61.6 mtt-85 -72.16 -27.43 62.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.5 0.72 . . . . 75.03 110.036 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.67 12.36 56.67 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.749 -0.659 . . . . 73.52 113.182 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.5 p 57.99 17.77 4.63 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.808 2.043 . . . . 53.52 113.393 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.28 145.75 49.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.245 -1.391 . . . . 73.43 107.245 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 141.74 80.89 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.494 2.129 . . . . 74.45 111.149 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -48.03 123.16 5.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.619 1.199 . . . . 72.32 111.336 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.47 118.94 38.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.256 0.622 . . . . 54.25 109.387 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -115.48 114.85 25.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.153 -0.684 . . . . 71.31 109.153 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.63 122.09 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.644 0.778 . . . . 70.22 109.939 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.12 132.28 95.25 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 109.276 -0.639 . . . . 63.0 109.276 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.432 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 4.3 Cg_endo -76.72 113.49 3.66 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.119 1.879 . . . . 74.33 110.569 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -98.99 123.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.713 -1.217 . . . . 51.33 107.713 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -76.72 89.98 3.41 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.425 -0.954 . . . . 75.31 108.425 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -62.66 -31.91 72.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.881 0.873 . . . . 73.21 110.902 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.406 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.6 m-20 . . . . . 0 N--CA 1.472 0.656 0 C-N-CA 123.672 0.789 . . . . 64.03 110.566 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.8 m . . . . . 0 C--O 1.233 0.212 0 N-CA-C 108.295 -1.002 . . . . 70.54 108.295 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.463 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 56.6 t80 -127.68 112.61 15.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.736 -1.209 . . . . 74.33 107.736 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.423 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -131.83 135.29 46.61 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.008 -1.108 . . . . 73.03 108.008 -178.328 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.476 ' O ' HD12 ' B' ' 13' ' ' ILE . 2.4 pp -94.99 130.52 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.397 0.679 . . . . 71.02 110.277 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -99.12 -50.83 4.02 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.807 -0.558 . . . . 63.34 110.06 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.459 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 41.8 ttt180 -162.59 134.23 5.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.998 -0.546 . . . . 74.3 110.452 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -113.91 142.55 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.71 -1.589 . . . . 53.31 106.71 172.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -168.9 149.35 4.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.615 0.643 . . . . 73.04 112.733 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.661 HG21 HD11 ' B' ' 21' ' ' ILE . 37.9 m -79.71 120.1 23.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.345 -0.843 . . . . 72.53 109.529 172.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.579 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 9.3 mtpt -89.14 -28.88 19.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.4 0.68 . . . . 74.45 110.835 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.7 136.92 14.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.846 -0.616 . . . . 72.24 110.406 -169.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.661 HD11 HG21 ' B' ' 18' ' ' THR . 31.2 mm -124.99 148.88 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.398 1.079 . . . . 75.25 108.155 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.7 t -154.15 141.37 19.51 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.789 -0.641 . . . . 71.51 109.576 170.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -152.71 109.0 3.39 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.26 -1.385 . . . . 65.35 107.26 171.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -118.08 111.53 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.456 -1.313 . . . . 74.53 107.456 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.79 88.23 6.42 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 108.313 -0.995 . . . . 43.12 108.313 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.74 -24.33 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.095 2.53 . . . . 61.34 111.938 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -121.6 24.14 9.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.936 0.895 . . . . 73.25 110.391 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -41.69 -54.41 6.74 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 124.788 1.235 . . . . 72.31 114.16 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.9 Cg_endo -66.17 -32.93 41.74 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.317 2.011 . . . . 74.3 113.157 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -94.42 -15.5 24.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.877 0.695 . . . . 65.22 112.877 -169.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.64 -23.25 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.743 1.217 . . . . 71.42 113.682 -169.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -66.57 -21.72 66.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.122 0.969 . . . . 54.21 112.149 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.421 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.6 pt20 -61.98 -29.06 70.0 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.879 0.472 . . . . 51.03 110.619 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 32.8 mmtp -105.1 67.65 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.536 -1.283 . . . . 74.04 107.536 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.02 79.5 6.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.546 0.738 . . . . 73.0 111.93 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 164.79 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.899 2.079 . . . . 71.33 110.647 160.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.2 126.25 67.2 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.553 1.141 . . . . 72.21 112.335 -170.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.71 176.15 9.33 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.752 2.301 . . . . 62.23 111.597 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.04 104.22 7.4 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.11 -1.441 . . . . 74.24 107.11 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.46 154.91 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.503 0.721 . . . . 70.02 109.197 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -147.18 138.7 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.813 0.845 . . . . 71.13 109.801 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.658 HD21 HD11 ' B' ' 128' ' ' LEU . 5.5 mp -85.4 141.11 30.21 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.052 -1.092 . . . . 75.14 108.052 165.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.8 t70 -141.18 109.99 6.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.35 -1.352 . . . . 72.13 107.35 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.33 131.6 48.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.846 0.458 . . . . 75.33 109.886 -173.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.3 135.41 54.73 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.968 1.307 . . . . 72.54 107.895 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -109.97 145.87 36.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.385 0.674 . . . . 72.53 110.195 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.83 148.3 25.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 54.32 109.282 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.2 m -144.69 167.89 21.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.365 0.666 . . . . 73.55 110.784 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -157.63 154.17 27.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.161 0.985 . . . . 71.05 109.599 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -102.85 130.5 49.89 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.974 -0.75 . . . . 74.43 108.974 171.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 67.2 mt -97.74 -38.05 9.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.194 0.597 . . . . 64.42 110.459 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.7 -171.95 2.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.437 0.695 . . . . 73.52 110.808 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.7 114.48 4.47 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.631 -1.168 . . . . 71.42 110.123 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 72.08 -3.81 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.691 1.597 . . . . 60.21 112.589 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.08 110.74 31.22 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 N-CA-C 107.859 -1.163 . . . . 71.12 107.859 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -122.11 173.24 7.69 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.038 -0.727 . . . . 74.25 109.038 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -142.87 109.98 5.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.022 -1.103 . . . . 71.43 108.022 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -101.65 134.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.331 1.052 . . . . 70.31 109.965 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.532 1.133 . . . . 73.31 109.059 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.44 112.32 17.39 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.931 -0.766 . . . . 53.33 108.931 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.76 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 28.0 ttm180 -89.92 124.93 35.14 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.607 0.763 . . . . 72.53 109.62 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -111.61 126.56 69.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.76 -1.2 . . . . 44.13 107.76 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.4 m -121.11 122.1 39.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.775 0.798 . . . . 62.13 109.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.662 HG11 HD21 ' B' ' 126' ' ' LEU . 87.8 t -102.05 95.99 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.29 1.436 . . . . 63.3 108.331 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 24.7 m -85.48 137.06 33.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.749 -0.834 . . . . 75.53 108.749 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.99 127.3 13.04 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.652 -0.499 . . . . 55.41 109.652 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 64.3 p -145.89 144.72 30.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.203 0.601 . . . . 63.24 110.809 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -133.54 102.31 5.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 50.11 109.406 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.73 -132.97 11.43 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.949 -0.569 . . . . 20.12 112.594 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.81 8.77 24.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.172 0.589 . . . . 63.14 110.744 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.19 154.68 49.13 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.522 0.729 . . . . 71.35 110.675 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 72' ' ' THR . . . . . 0.434 HG21 ' HG ' ' B' ' 75' ' ' LEU . 66.4 m -83.79 138.67 33.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.301 0.64 . . . . 62.23 110.273 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -76.61 -60.24 2.43 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.894 0.878 . . . . 64.32 108.974 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -165.69 153.01 10.36 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 113.656 -1.611 . . . . 71.03 109.054 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.434 ' HG ' HG21 ' B' ' 72' ' ' THR . 94.8 mt -124.1 112.78 17.52 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.562 -1.273 . . . . 70.21 107.562 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.8 t -115.98 143.43 45.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.776 -1.194 . . . . 61.21 107.776 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.4 tt0 -157.26 124.2 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 -173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.78 142.02 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.215 0.606 . . . . 74.44 109.574 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 42.1 mt-30 -108.1 114.58 28.58 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.739 -1.208 . . . . 74.43 107.739 166.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.4 tp-100 -103.11 110.86 22.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.297 -1.001 . . . . 70.14 108.297 172.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.96 166.9 19.32 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.682 0.613 . . . . 65.22 111.719 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.84 127.56 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.446 -0.661 . . . . 63.31 111.446 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.17 125.05 40.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.605 0.762 . . . . 71.1 109.066 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.69 132.56 42.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.227 1.011 . . . . 74.33 108.959 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 49.6 m -96.59 97.98 9.83 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.732 0.813 . . . . 62.31 108.908 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.06 132.9 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.398 0.679 . . . . 52.34 110.09 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.24 172.86 16.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.004 0.922 . . . . 63.12 110.605 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -62.46 1.04 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.045 -0.525 . . . . 52.23 112.346 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.439 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -90.48 170.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.915 0.886 . . . . 74.34 111.126 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.58 171.91 16.36 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.19 0.596 . . . . 72.54 111.089 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.28 42.91 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.121 -0.945 . . . . 43.42 113.286 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -70.73 -28.06 64.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.139 0.976 . . . . 71.42 111.689 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.82 -37.93 89.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.221 0.608 . . . . 54.33 109.822 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.504 ' HG2' HD23 ' B' ' 98' ' ' LEU . 22.9 ttt -80.32 -33.99 37.09 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 73.43 110.133 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -28.07 69.51 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.922 0.889 . . . . 62.53 111.814 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -62.0 -43.31 99.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.602 0.761 . . . . 65.22 110.247 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -70.72 -64.04 0.98 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.577 -0.738 . . . . 72.03 110.81 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.504 HD23 ' HG2' ' B' ' 94' ' ' MET . 4.5 pp -71.04 -30.84 67.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.569 0.747 . . . . 72.43 112.496 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -33.67 11.13 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.575 0.547 . . . . 74.41 113.264 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.88 -67.17 1.02 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.887 0.475 . . . . 61.43 111.33 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -60.18 -46.76 88.61 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.586 0.754 . . . . 71.42 112.898 -172.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.504 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.7 m -63.86 -51.41 64.63 Favored Pre-proline 0 CA--C 1.569 1.678 0 C-N-CA 123.932 0.893 . . . . 75.15 112.292 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.3 Cg_exo -58.94 -30.12 92.33 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.659 2.239 . . . . 53.12 113.733 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -27.98 62.78 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.301 0.64 . . . . 62.03 111.437 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.48 -40.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.543 0.737 . . . . 73.1 109.902 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' B' ' 80' ' ' GLN . 86.4 mt -75.39 -29.34 59.81 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.943 -1.026 . . . . 73.22 111.709 -173.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -55.52 -47.55 98.39 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-O 117.66 -1.162 . . . . 71.23 113.782 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.58 -43.36 33.74 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.131 2.554 . . . . 74.44 114.622 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE2' HG21 ' D' ' 115' ' ' THR . 81.4 m-85 -70.6 -42.58 70.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.382 0.673 . . . . 72.2 110.325 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -65.54 -32.17 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.702 -0.681 . . . . 53.01 110.888 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.76 -58.09 10.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.292 1.037 . . . . 71.12 110.482 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.533 0.52 . . . . 75.21 109.878 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' B' ' 21' ' ' ILE . 0.0 OUTLIER -67.4 -40.13 85.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.232 0.613 . . . . 74.52 110.776 177.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.457 HG21 HG21 ' B' ' 64' ' ' VAL . 78.5 mt -67.37 -54.3 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 75.24 109.868 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -60.15 -33.0 71.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.222 1.009 . . . . 62.32 111.55 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -60.69 -49.79 76.11 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.47 0.708 . . . . 64.12 110.124 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.7 mmt -71.26 -34.89 71.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.57 0.748 . . . . 75.25 111.584 -172.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.503 HG21 HD23 ' B' ' 126' ' ' LEU . 97.0 t -66.33 -40.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 75.33 110.153 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.6 t -68.67 -28.13 66.6 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.288 -0.869 . . . . 74.31 111.024 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.488 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 88.9 mtt-85 -72.64 -25.11 61.17 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.187 0.595 . . . . 65.33 110.753 176.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.23 13.8 43.2 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 123.346 0.404 . . . . 50.34 112.557 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 61.45 31.48 19.05 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 126.903 2.081 . . . . 74.22 112.227 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -95.79 148.36 34.44 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 115.575 -0.739 . . . . 75.23 110.175 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.76 -171.23 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.597 2.865 . . . . 64.33 114.252 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.501 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 17.7 tp60 -59.13 113.44 2.12 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.385 -1.279 . . . . 72.23 112.011 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.662 HD21 HG11 ' B' ' 64' ' ' VAL . 66.5 tp -111.09 100.58 9.23 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.614 -0.884 . . . . 63.2 108.614 171.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.21 123.26 41.82 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.95 0.9 . . . . 62.34 109.875 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.658 HD11 HD21 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -87.28 144.33 26.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.789 0.836 . . . . 73.43 109.011 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 129' ' ' ALA . . . . . 0.428 ' N ' HD13 ' B' ' 128' ' ' LEU . . . -64.61 143.36 98.63 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.34 1.056 . . . . 43.04 111.568 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 5.8 Cg_exo -75.05 90.53 1.08 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.797 2.331 . . . . 70.11 111.311 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.7 t -91.33 111.33 23.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.983 -0.747 . . . . 42.11 108.983 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -93.01 91.97 7.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.568 -0.901 . . . . 73.12 108.568 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 123.764 0.826 . . . . 74.13 111.319 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 121.461 0.648 . . . . 72.43 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 63.6 m -103.76 92.8 4.58 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.826 -1.175 . . . . 74.21 107.826 166.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.478 ' CE1' ' SG ' ' C' ' 102' ' ' CYS . 87.8 t80 -112.43 132.66 54.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.248 -1.019 . . . . 74.21 108.248 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -147.35 144.59 28.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.034 0.445 . . . . 75.02 111.209 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.472 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.3 pp -93.7 139.76 17.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.09 -0.959 . . . . 70.15 108.451 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -110.55 -51.09 2.9 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.863 -0.421 . . . . 63.03 109.863 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -166.79 128.86 1.75 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.777 -0.647 . . . . 71.12 110.312 -170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.55 143.05 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 106.838 -1.541 . . . . 73.25 106.838 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.493 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.2 p90 -174.34 158.67 2.95 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.575 0.625 . . . . 72.44 111.291 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -81.29 119.26 23.43 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.09 -0.708 . . . . 71.32 109.09 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.7 mmmm -73.39 -42.0 62.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 169.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 32.3 t70 -143.95 142.33 30.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.777 -1.101 . . . . 61.13 110.526 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -139.74 143.65 30.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.521 1.528 . . . . 74.02 107.2 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 30.8 t -158.76 151.38 21.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.275 0.559 . . . . 72.11 110.283 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -150.41 125.66 10.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.767 -1.198 . . . . 72.43 107.767 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.26 140.53 49.67 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.291 0.636 . . . . 52.01 110.215 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.59 77.65 22.61 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.787 -1.56 . . . . 75.33 106.787 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.94 -32.78 65.3 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.064 2.51 . . . . 65.44 112.467 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' C' ' 30' ' ' HIS . 9.2 p30 -112.22 45.49 1.27 Allowed 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.815 0.846 . . . . 44.44 109.677 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.574 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -53.31 -41.34 85.94 Favored Pre-proline 0 CA--C 1.577 1.995 0 N-CA-C 114.697 1.369 . . . . 65.34 114.697 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.7 -37.9 1.1 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 121.744 1.63 . . . . 64.24 112.97 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.714 ' HB3' ' HB2' ' C' ' 27' ' ' ASN . 75.5 t60 -69.19 -21.9 63.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.317 1.047 . . . . 65.12 112.338 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.69 -13.84 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.667 0.787 . . . . 74.43 112.566 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.55 -15.45 60.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.563 -0.71 . . . . 71.15 112.301 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -109.1 21.67 16.88 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.578 0.751 . . . . 71.33 110.355 172.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.548 ' HZ3' ' HB2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -82.69 136.96 34.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.223 1.009 . . . . 71.32 109.028 175.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.17 123.56 19.41 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.058 -0.719 . . . . 60.21 109.058 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -85.16 58.94 5.32 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.55 0.34 . . . . 71.23 111.04 -173.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -156.51 53.91 0.81 Allowed Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 124.367 1.067 . . . . 71.13 109.448 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.08 153.3 36.68 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.927 1.751 . . . . 70.24 112.208 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -84.29 115.59 22.56 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.362 -1.347 . . . . 75.53 107.362 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.24 133.82 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.505 -0.554 . . . . 64.01 109.505 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -123.57 112.13 17.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.205 1.002 . . . . 74.01 108.416 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.432 HD21 HD22 ' C' ' 128' ' ' LEU . 8.4 mp -86.06 133.93 33.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.241 -1.392 . . . . 75.44 107.241 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.447 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.5 t70 -117.36 103.11 9.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.176 -1.416 . . . . 62.1 107.176 172.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.34 112.63 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.876 -1.528 . . . . 73.13 106.876 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.3 t70 -127.8 135.1 49.63 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.157 -0.683 . . . . 51.44 109.157 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -114.94 123.62 49.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.84 0.856 . . . . 74.42 109.952 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.11 34.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.32 0.648 . . . . 71.25 110.168 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.9 p -163.38 152.4 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.185 0.594 . . . . 53.11 110.438 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.2 p -151.25 159.35 44.41 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.81 0.844 . . . . 74.52 109.406 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -75.21 120.61 20.94 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.612 -0.722 . . . . 74.31 110.479 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' C' ' 57' ' ' GLU . 83.3 mt -84.95 -46.32 11.36 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.87 -0.789 . . . . 62.22 108.87 169.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.33 178.27 9.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.532 -1.213 . . . . 72.33 108.88 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -66.05 122.37 17.26 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.34 -0.391 . . . . 73.3 110.052 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 74.55 -5.6 2.08 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.813 1.645 . . . . 64.34 112.599 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -104.9 116.62 49.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 124.035 0.934 . . . . 64.41 109.475 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 135.58 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.411 -0.959 . . . . 73.22 108.411 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.2 tt0 -87.52 120.24 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.799 -0.815 . . . . 53.41 108.799 173.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.31 111.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.399 -0.963 . . . . 74.11 108.399 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.8 t -106.57 127.26 62.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.838 -1.171 . . . . 70.14 107.838 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -130.4 105.48 7.9 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.758 -1.201 . . . . 72.23 107.758 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 24.0 ttm180 -82.65 125.12 30.84 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.855 -0.611 . . . . 71.45 109.614 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -116.71 106.97 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.791 -1.559 . . . . 71.11 106.791 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.4 m -116.29 114.05 23.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.521 0.677 . . . . 64.23 109.618 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.93 111.36 35.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 114.619 -1.173 . . . . 65.12 108.486 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 13.8 m -111.33 125.86 54.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.471 0.708 . . . . 71.02 110.238 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.86 116.83 31.92 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.338 -1.356 . . . . 60.43 107.338 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.5 m -148.39 152.65 37.36 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.827 0.451 . . . . 64.41 110.78 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.497 HD23 ' HD2' ' C' ' 34' ' ' LYS . 4.1 mm? -95.37 26.98 3.53 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.63 1.172 . . . . 73.02 110.203 172.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.85 -104.95 0.95 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.36 -25.47 21.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.359 0.664 . . . . 72.51 110.261 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.54 113.62 21.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.056 0.942 . . . . 65.13 109.679 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.3 m -88.88 129.65 35.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.944 0.497 . . . . 51.24 111.525 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 -57.83 4.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.961 . . . . 44.14 109.728 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.73 155.04 29.21 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.503 -0.771 . . . . 72.02 109.941 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.455 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -117.02 145.28 43.78 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.367 -1.345 . . . . 73.43 107.367 171.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.455 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.9 t -150.07 131.86 15.05 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 173.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -139.79 132.88 29.6 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.526 0.73 . . . . 74.12 110.24 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.62 138.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.867 0.867 . . . . 71.42 109.07 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -113.21 96.65 6.03 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.983 -1.488 . . . . 72.14 106.983 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.7 tp-100 -83.52 107.36 15.94 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.044 -0.526 . . . . 71.0 109.631 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 145.94 18.27 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.788 -0.642 . . . . 71.13 111.68 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.76 117.44 0.91 Allowed Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.518 -1.033 . . . . 23.2 110.518 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.403 HD12 HD11 ' C' ' 51' ' ' LEU . 15.9 mm -81.56 119.73 31.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.627 -0.879 . . . . 71.11 108.627 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.472 ' HE2' HG22 ' C' ' 13' ' ' ILE . 97.3 m-85 -132.52 145.29 51.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.837 0.855 . . . . 63.11 109.552 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 65.9 m -110.69 112.43 24.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.781 0.833 . . . . 41.15 109.287 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.513 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.5 mp -116.11 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.895 -1.15 . . . . 72.12 107.895 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.41 162.75 34.95 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.357 1.063 . . . . 65.51 109.843 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.08 -58.51 4.25 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.944 -0.571 . . . . 53.43 112.258 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.51 168.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.622 0.769 . . . . 54.41 111.536 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.28 -177.22 5.88 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.867 1.267 . . . . 64.42 109.012 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.79 -124.45 36.16 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.772 0.67 . . . . 73.33 113.683 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 49.0 p -70.22 -36.57 74.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.491 1.116 . . . . 73.41 111.953 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -66.16 -36.23 82.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.097 0.559 . . . . 72.13 110.858 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.513 ' HG2' HG21 ' C' ' 86' ' ' ILE . 0.1 OUTLIER -83.14 -33.83 26.18 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.426 0.69 . . . . 75.43 109.971 178.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.41 -44.46 95.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.075 0.95 . . . . 72.1 111.263 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -76.8 -26.44 54.42 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.642 -0.708 . . . . 71.22 111.079 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' C' ' 101' ' ' TYR . 47.2 t -73.86 -61.84 1.7 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.739 0.416 . . . . 71.1 110.491 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.66 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 8.4 tt -79.89 -25.5 40.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.404 0.282 . . . . 55.22 110.791 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.75 -7.16 78.86 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 115.083 0.793 . . . . 51.32 115.083 -174.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -55.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.491 0.646 . . . . 75.12 111.369 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.468 ' O ' HG12 ' C' ' 105' ' ' ILE . 82.8 t80 -65.89 -39.11 90.35 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.998 0.919 . . . . 72.32 111.734 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.66 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 38.3 m -76.37 -47.19 3.39 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.474 -0.774 . . . . 61.44 112.288 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.7 Cg_exo -53.14 -40.36 77.27 Favored 'Trans proline' 0 C--N 1.399 3.206 0 C-N-CA 122.761 2.307 . . . . 54.21 112.891 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.27 -29.34 67.5 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.692 0.797 . . . . 71.23 112.52 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.484 HG23 ' NH1' ' A' ' 111' ' ' ARG . 29.4 mm -75.6 -43.66 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.096 0.558 . . . . 75.25 110.943 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 pp -93.29 -11.07 33.35 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 112.738 0.644 . . . . 73.42 112.738 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -57.44 -49.47 93.66 Favored Pre-proline 0 N--CA 1.491 1.604 0 CA-C-O 117.968 -1.015 . . . . 75.41 112.776 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.99 -31.29 89.5 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 121.94 1.76 . . . . 71.11 112.755 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.584 ' HE2' HG21 ' A' ' 115' ' ' THR . 92.8 m-85 -68.37 -48.5 64.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.951 0.9 . . . . 64.34 111.147 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -58.72 -41.22 85.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 61.41 110.539 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -69.57 -47.73 62.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.954 -1.476 . . . . 74.33 111.252 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.06 -31.92 72.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.161 0.584 . . . . 64.43 109.95 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.417 ' O ' ' SD ' ' C' ' 117' ' ' MET . 43.0 t -63.99 -40.96 97.54 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.551 0.532 . . . . 73.34 110.589 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.419 ' O ' HG23 ' C' ' 118' ' ' VAL . 86.6 mt -68.02 -41.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.329 0.651 . . . . 75.44 110.823 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.469 HG23 ' HB3' ' C' ' 125' ' ' GLN . 30.8 m -62.98 -30.16 71.37 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.432 0.693 . . . . 54.33 110.684 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -74.16 -46.23 43.59 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.922 0.889 . . . . 73.1 109.973 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.469 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.69 -42.71 84.21 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.923 0.889 . . . . 60.33 111.642 177.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.9 t -70.91 -33.99 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.86 0.864 . . . . 74.35 110.185 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.501 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 38.5 t -65.59 -33.02 74.94 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.389 0.676 . . . . 53.21 111.464 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.539 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 73.4 mtt-85 -81.66 -31.89 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.07 0.948 . . . . 73.55 110.618 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 -1.56 86.45 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.791 -0.641 . . . . 73.2 112.29 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 49.6 p 61.88 31.72 18.16 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 126.075 1.75 . . . . 64.55 112.262 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.0 150.06 37.88 Favored Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 114.495 -1.23 . . . . 71.14 109.385 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -40.3 109.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 124.365 3.377 . . . . 71.35 113.908 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.469 ' HB3' HG23 ' C' ' 115' ' ' THR . 50.6 mt-30 -60.54 142.54 55.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.755 1.222 . . . . 63.43 111.99 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp -121.2 106.5 11.57 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.306 0.642 . . . . 60.14 109.553 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.34 108.44 20.48 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.458 -1.312 . . . . 71.22 107.458 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.432 HD22 HD21 ' C' ' 42' ' ' LEU . 85.2 mt -63.24 144.69 56.71 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.687 0.795 . . . . 73.25 111.868 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.54 159.57 77.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.838 1.255 . . . . 74.31 111.475 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.418 ' HG2' HG21 ' A' ' 13' ' ' ILE . 22.4 Cg_exo -63.8 104.22 0.45 Allowed 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.528 2.152 . . . . 74.23 111.76 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.97 109.35 23.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.445 -0.946 . . . . 72.15 108.445 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -104.04 88.62 3.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.818 -1.083 . . . . 75.21 109.576 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.62 -37.98 83.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.099 -0.955 . . . . 72.53 108.763 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 . . . . . 0 CA--C 1.541 0.623 0 CA-C-N 114.895 -1.048 . . . . 65.25 111.83 -178.471 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.243 0.736 0 N-CA-C 108.83 -0.804 . . . . 50.22 108.83 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -174.07 97.1 0.1 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.848 -1.538 . . . . 73.44 106.848 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -133.13 119.81 20.43 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.198 -0.91 . . . . 64.25 108.658 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mt -70.55 107.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 114.711 -1.132 . . . . 71.0 109.482 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.87 -37.64 62.12 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.203 -0.295 . . . . 75.22 110.203 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -170.5 143.89 2.33 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.963 0.79 . . . . 73.54 109.95 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.622 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.1 OUTLIER -120.29 108.36 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.468 1.107 . . . . 72.4 108.205 175.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -138.25 158.69 43.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.447 1.118 . . . . 63.14 111.195 -170.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -92.56 110.31 21.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.768 -1.56 . . . . 74.51 108.873 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.574 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 41.3 mtpt -74.05 -31.69 62.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.149 0.5 . . . . 73.14 110.124 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -150.61 141.66 23.03 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.781 -1.1 . . . . 63.53 109.367 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.469 HD13 ' HE3' ' C' ' 117' ' ' MET . 28.8 mt -136.55 141.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.825 1.25 . . . . 74.32 107.802 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.2 t -146.55 137.5 24.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.988 0.915 . . . . 72.12 109.656 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -149.32 121.06 8.09 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 106.127 -1.805 . . . . 64.43 106.127 167.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -131.1 124.78 31.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -127.48 82.45 68.23 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.106 -1.072 . . . . 73.13 108.106 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.58 -34.34 5.76 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.866 2.377 . . . . 73.55 112.327 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.47 ' O ' HG23 ' D' ' 31' ' ' VAL . 14.7 m120 -106.98 23.55 14.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.403 1.081 . . . . 75.14 109.573 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.589 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -45.57 -59.77 4.14 Favored Pre-proline 0 CA--C 1.571 1.751 0 C-N-CA 125.194 1.398 . . . . 73.43 114.492 -168.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.19 -16.73 15.45 Favored 'Trans proline' 0 C--N 1.392 2.86 0 CA-C-N 121.886 1.709 . . . . 63.44 113.133 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -68.52 -43.55 76.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.082 0.953 . . . . 73.11 109.972 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' D' ' 73' ' ' ALA . 99.0 t -65.62 -34.82 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.857 0.863 . . . . 73.22 110.533 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.28 -7.98 46.67 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.871 1.063 . . . . 70.31 113.871 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -84.81 -29.33 25.46 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.102 0.561 . . . . 73.14 111.274 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -109.9 114.26 27.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.76 1.224 . . . . 62.24 108.7 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -91.11 95.09 9.9 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.312 0.577 . . . . 73.41 112.081 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.406 ' HE3' ' H ' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -146.86 171.29 15.43 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.639 0.776 . . . . 72.52 112.333 175.07 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -84.22 134.34 43.46 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.094 1.358 . . . . 64.43 111.388 -169.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' D' ' 68' ' ' LEU . 16.6 Cg_exo -68.23 117.55 5.02 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.13 114.301 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.91 114.37 10.98 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.19 -1.411 . . . . 52.44 107.19 163.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.85 123.24 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.65 0.738 . . . . 50.5 110.216 -170.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.625 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 51.7 tttp -93.44 125.59 38.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.841 1.256 . . . . 70.12 109.132 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -97.66 114.62 26.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.662 -1.607 . . . . 72.45 106.662 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 15.8 t70 -127.89 129.85 47.55 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.665 -0.865 . . . . 65.31 108.665 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 64.0 tp -122.71 135.61 54.63 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.558 0.743 . . . . 72.04 110.118 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -134.51 148.88 50.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.682 1.193 . . . . 75.54 108.165 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -124.08 149.07 46.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.295 0.638 . . . . 55.44 110.674 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.651 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.39 152.09 35.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.971 0.908 . . . . 64.24 109.266 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.6 p -174.8 154.17 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.319 0.648 . . . . 72.14 111.373 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 55.2 p -171.46 158.57 5.26 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.369 1.068 . . . . 41.32 109.81 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -87.5 125.61 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.397 -0.594 . . . . 64.3 109.397 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.4 mt -91.36 -42.23 10.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.363 0.665 . . . . 44.23 110.456 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.15 -172.36 4.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.431 -0.804 . . . . 64.11 110.31 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.73 118.2 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.022 -0.99 . . . . 72.11 109.895 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 66.65 0.81 1.96 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.772 1.629 . . . . 73.23 112.661 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -108.49 124.82 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.048 0.539 . . . . 75.21 109.988 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -127.15 159.88 32.93 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.317 1.047 . . . . 75.24 109.403 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' D' ' 51' ' ' LEU . 39.6 tt0 -118.27 137.29 53.15 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.889 0.876 . . . . 72.43 108.715 174.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.471 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 69.3 t -121.11 121.43 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.509 -1.293 . . . . 71.24 107.509 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.651 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 31.2 t -117.89 129.77 73.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.965 -0.754 . . . . 74.1 108.965 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.33 110.93 20.11 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.636 -0.875 . . . . 72.24 108.636 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 13.7 ttm180 -84.16 99.71 10.69 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.717 -0.846 . . . . 74.24 108.717 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.27 122.38 45.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.116 -0.947 . . . . 73.31 108.487 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.1 m -129.28 130.29 46.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.367 -0.833 . . . . 75.14 109.908 -171.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 82.2 t -124.01 126.43 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.665 1.586 . . . . 72.42 108.146 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 89.2 m -126.42 110.63 13.54 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.76 -0.459 . . . . 61.31 109.76 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.84 124.19 49.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.068 0.547 . . . . 64.35 109.948 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' D' ' 72' ' ' THR . 58.8 m -135.91 119.61 17.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.571 -1.27 . . . . 53.52 107.571 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' D' ' 73' ' ' ALA . 6.8 mp -123.35 133.78 54.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.838 0.855 . . . . 74.21 109.734 -170.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.6 -116.87 5.9 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -112.26 3.76 17.32 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.201 0.6 . . . . 64.3 110.52 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -127.54 164.57 21.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.681 0.792 . . . . 62.53 110.814 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 72' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' D' ' 67' ' ' SER . 53.4 m -86.46 129.98 34.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.147 0.579 . . . . 73.31 110.278 169.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.737 ' HB2' HD13 ' D' ' 68' ' ' LEU . . . -72.39 -68.61 0.46 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.325 0.65 . . . . 64.54 109.47 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.8 152.03 31.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.906 -1.043 . . . . 72.1 111.947 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -119.63 116.64 26.43 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.572 1.549 . . . . 71.54 107.574 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.601 ' SG ' HG23 ' D' ' 114' ' ' ILE . 17.1 t -127.83 134.94 49.45 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.784 -0.451 . . . . 72.21 109.784 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.7 133.71 13.22 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.189 0.596 . . . . 75.4 109.941 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.63 119.78 22.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.656 0.782 . . . . 74.05 109.324 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.506 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 64.6 mt-30 -90.53 88.52 7.18 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 174.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -79.33 97.95 6.51 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.451 -0.795 . . . . 75.13 109.118 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 143.88 16.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.183 -0.767 . . . . 53.45 111.183 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.79 130.96 3.8 Favored Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.224 -1.15 . . . . 70.31 110.224 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.3 mt -90.02 131.82 36.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.94 -0.763 . . . . 74.05 108.94 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.471 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 30.0 m-85 -134.02 125.31 27.85 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.889 -0.782 . . . . 74.41 108.889 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -76.14 103.42 6.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.878 -1.156 . . . . 62.54 107.878 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.533 HG23 HD11 ' D' ' 89' ' ' ILE . 75.0 mt -107.8 132.18 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.358 1.063 . . . . 64.44 109.475 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.66 164.86 19.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.431 0.692 . . . . 62.45 110.948 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.81 47.75 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 115.262 0.865 . . . . 73.14 115.262 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.533 HD11 HG23 ' D' ' 86' ' ' ILE . 15.9 pt -123.97 128.43 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.628 1.171 . . . . 73.42 108.036 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -137.29 159.7 41.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.115 0.566 . . . . 73.1 111.352 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -123.42 31.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 115.46 -0.791 . . . . 73.05 113.201 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -69.19 -25.74 64.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 74.21 111.685 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -72.9 -39.74 66.1 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.385 0.674 . . . . 75.2 110.133 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -31.83 56.18 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.528 -0.545 . . . . 73.43 109.528 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.44 90.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.901 0.88 . . . . 71.5 111.89 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.47 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 17.6 t-80 -61.53 -48.13 82.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.582 -0.736 . . . . 74.02 110.34 172.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.17 -29.36 62.79 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.927 -0.579 . . . . 72.31 112.128 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 29.7 tp -95.52 -51.21 4.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.217 1.007 . . . . 71.34 110.834 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.77 5.18 66.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.702 -0.681 . . . . 44.53 114.057 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -136.86 -55.96 0.73 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.064 0.432 . . . . 74.22 110.696 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -75.61 -41.24 54.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.809 0.67 . . . . 73.3 112.809 -173.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.24 -46.98 90.85 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.834 -0.603 . . . . 51.14 111.026 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.63 -40.0 87.85 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 122.299 1.999 . . . . 72.44 113.061 165.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -60.98 -28.08 68.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.406 0.682 . . . . 74.11 111.4 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -79.42 -50.54 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.842 0.857 . . . . 74.25 110.921 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.11 -28.63 32.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.057 0.762 . . . . 71.33 113.057 -167.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -65.83 -42.57 54.48 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.21 1.004 . . . . 61.32 112.873 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.19 -37.41 94.26 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 121.922 1.748 . . . . 73.12 113.087 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -77.2 -31.04 55.03 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 64.34 111.887 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.55 -51.91 63.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.299 0.64 . . . . 71.44 109.67 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.502 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.3 ttp180 -55.83 -54.32 45.96 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.074 -1.421 . . . . 74.25 110.396 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.8 -39.22 84.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 75.31 111.58 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -62.21 -47.54 83.99 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.029 0.532 . . . . 64.22 111.02 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.601 HG23 ' SG ' ' D' ' 76' ' ' CYS . 85.5 mt -60.11 -51.73 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.099 0.96 . . . . 73.24 110.225 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.505 HG21 ' HE2' ' B' ' 109' ' ' TYR . 87.0 m -54.71 -43.66 72.78 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.881 1.672 . . . . 64.42 112.452 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.1 t -66.65 -38.49 86.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.486 0.714 . . . . 71.54 110.718 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.1 mtm -72.1 -29.78 64.44 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.771 0.428 . . . . 64.02 111.842 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -64.49 -44.32 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.376 0.67 . . . . 71.33 109.73 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.1 p -72.27 -29.95 64.37 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.07 0.548 . . . . 74.32 111.417 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -69.69 -32.39 70.96 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.583 0.753 . . . . 64.24 110.574 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.76 81.44 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 115.908 -0.587 . . . . 43.43 112.818 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 60.09 21.38 10.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 126.819 2.048 . . . . 65.42 113.311 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -86.74 163.06 42.73 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.957 1.303 . . . . 75.11 109.627 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.71 133.69 20.73 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.114 1.876 . . . . 75.04 110.68 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.8 135.51 56.82 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.752 0.658 . . . . 72.11 111.455 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.65 107.75 18.86 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.134 -1.432 . . . . 55.23 107.134 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 75.8 m-20 -97.81 93.27 6.27 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.069 -1.456 . . . . 74.23 107.069 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -74.18 120.08 19.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.24 -0.891 . . . . 62.4 109.507 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.65 123.22 78.45 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.618 0.767 . . . . 73.53 111.781 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.502 ' HB3' HH12 ' D' ' 111' ' ' ARG . 18.7 Cg_endo -86.86 115.31 1.21 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.082 2.521 . . . . 64.25 111.58 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.8 110.13 30.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.668 -1.234 . . . . 73.52 107.668 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -79.03 87.99 4.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.021 0.528 . . . . 74.05 110.208 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 . . . . . 0 N--CA 1.476 0.827 0 CA-C-N 115.658 -0.701 . . . . 73.22 111.06 174.063 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.3 m . . . . . 0 C--O 1.237 0.402 0 N-CA-C 107.731 -1.211 . . . . 75.04 107.731 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.738 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.4 t80 -135.63 132.82 37.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.725 0.41 . . . . 73.33 110.028 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -152.9 114.31 4.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.824 . . . . 73.52 108.794 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.639 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -83.13 119.79 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.797 -0.446 . . . . 74.32 109.797 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -87.19 -31.05 20.55 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.463 0.705 . . . . 74.0 109.651 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -163.43 142.17 8.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.757 -0.201 . . . . 53.33 110.999 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -130.94 140.27 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 124.553 1.141 . . . . 53.21 108.166 170.083 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 40.3 p90 -172.76 167.95 5.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.662 0.744 . . . . 72.14 111.023 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -95.88 119.04 33.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.961 -1.018 . . . . 75.45 108.729 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 29.7 mtpt -81.87 -23.46 36.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.111 0.481 . . . . 63.12 110.464 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.2 t70 -154.58 144.15 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.97 -1.014 . . . . 72.45 110.026 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.7 mt -137.26 144.36 32.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.887 1.675 . . . . 72.25 106.987 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -153.71 125.99 7.99 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.258 0.551 . . . . 63.11 110.033 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 90.1 t80 -124.1 120.85 33.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.939 -1.874 . . . . 74.2 105.939 168.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 35.4 mt-10 -126.95 108.41 10.94 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.715 0.689 . . . . 74.41 110.702 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -112.18 79.02 2.64 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 106.424 -1.695 . . . . 55.03 106.424 168.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.4 -46.12 3.1 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.388 2.058 . . . . 72.13 111.192 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.8 m-20 -100.81 28.38 5.24 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.914 -1.039 . . . . 74.02 108.874 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -41.47 -56.77 4.28 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.038 -0.982 . . . . 63.42 113.093 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.19 -30.32 74.49 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 121.794 1.663 . . . . 62.21 112.878 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.5 m80 -79.53 -30.2 41.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.748 0.819 . . . . 74.11 111.279 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -82.25 -18.39 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.55 0.34 . . . . 54.2 110.939 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -75.96 -31.07 58.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.203 0.601 . . . . 73.11 110.498 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -82.19 -18.96 40.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.768 0.427 . . . . 75.2 110.595 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -68.82 142.09 54.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.873 0.469 . . . . 71.41 110.166 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.47 139.46 58.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.156 0.582 . . . . 64.33 109.847 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -66.66 90.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.078 0.861 . . . . 71.41 109.889 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 94.1 mt-30 -133.81 63.11 61.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.365 1.066 . . . . 74.51 108.389 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.47 133.29 8.35 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.212 1.941 . . . . 43.31 112.063 -172.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.47 91.96 6.05 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.523 -1.288 . . . . 75.12 107.523 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.5 t -78.38 107.56 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -94.27 156.78 16.36 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.317 1.047 . . . . 72.33 109.69 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 128' ' ' LEU . 3.5 tt -137.82 109.01 6.81 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.363 -0.977 . . . . 74.54 108.363 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.4 m-20 -125.46 141.88 51.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.178 0.991 . . . . 73.22 109.252 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.24 126.67 37.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 63.34 109.245 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -118.82 129.08 55.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.675 1.19 . . . . 75.05 108.622 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.8 p -110.38 144.9 38.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.859 0.864 . . . . 70.35 110.339 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.22 131.78 12.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.166 0.586 . . . . 74.12 110.55 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -133.81 151.92 51.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.235 0.614 . . . . 70.41 109.994 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.3 t -154.71 162.19 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.652 0.781 . . . . 72.11 109.672 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -109.22 113.17 25.78 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.762 0.825 . . . . 72.01 108.784 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB2' HG12 ' A' ' 55' ' ' VAL . 65.5 mt -82.79 -33.63 27.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.259 0.624 . . . . 64.24 110.301 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -170.91 -174.42 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.337 1.055 . . . . 73.04 109.989 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.98 123.2 19.18 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.084 0.554 . . . . 65.45 109.738 173.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 67.52 -4.43 0.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.455 1.502 . . . . 74.22 112.943 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.3 t -112.1 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.241 -1.022 . . . . 63.53 108.241 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.82 167.14 16.2 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.103 0.961 . . . . 64.2 108.611 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -129.58 138.8 51.49 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.427 0.691 . . . . 74.51 109.326 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -126.66 129.07 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.415 -1.328 . . . . 73.34 107.415 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.65 131.6 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.118 0.967 . . . . 75.31 109.068 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.6 103.45 9.71 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.987 -1.116 . . . . 70.34 107.987 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.645 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 9.8 ttp180 -84.74 110.51 18.84 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.453 -0.573 . . . . 72.51 109.453 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 114' ' ' ILE . 12.4 t -92.92 128.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.394 -1.336 . . . . 72.23 107.394 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 16.8 m -123.9 126.83 47.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.471 -0.566 . . . . 61.35 109.471 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.762 HG11 HD21 ' A' ' 126' ' ' LEU . 47.2 t -125.0 131.72 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.767 1.227 . . . . 73.22 107.823 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.6 m -116.38 151.64 35.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.702 -0.851 . . . . 63.34 108.702 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.54 115.69 11.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.926 -1.509 . . . . 64.14 106.926 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.8 t -130.02 128.21 41.52 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.99 0.424 . . . . 55.2 110.228 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 73' ' ' ALA . 8.2 mp -90.3 85.74 6.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.687 1.195 . . . . 64.43 107.984 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.43 -98.28 2.08 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 114.822 -1.081 . . . . 65.45 110.534 -172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.68 -5.03 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.4 0.68 . . . . 74.41 110.01 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -85.83 100.8 12.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.005 -1.109 . . . . 73.31 108.005 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 59.8 m -71.21 129.66 39.46 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.269 0.556 . . . . 72.23 111.671 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.24 -59.74 2.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.06 -1.427 . . . . 74.22 109.897 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.594 ' HE2' HD22 ' A' ' 126' ' ' LEU . 43.1 p90 -159.57 136.9 9.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.322 -0.854 . . . . 72.11 111.4 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 tp -112.54 107.85 16.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.054 1.342 . . . . 74.52 107.495 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.614 ' HB3' HG23 ' A' ' 114' ' ' ILE . 72.6 m -107.93 106.05 16.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.809 0.844 . . . . 61.45 111.156 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 63' ' ' THR . 40.8 tt0 -127.64 125.04 39.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.928 1.291 . . . . 71.31 109.186 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.43 115.32 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.872 0.869 . . . . 52.12 109.752 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.645 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 73.4 mt-30 -83.36 89.33 7.01 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.378 -0.971 . . . . 63.52 108.378 168.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -83.12 106.4 14.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.444 -0.947 . . . . 73.4 108.444 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.2 -177.38 19.13 Favored Glycine 0 N--CA 1.465 0.614 0 O-C-N 123.528 0.518 . . . . 41.35 112.422 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.3 155.71 15.65 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 112.443 -0.263 . . . . 51.23 112.443 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -90.34 115.84 30.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.873 -0.788 . . . . 65.02 108.873 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.738 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -121.1 119.67 33.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.946 0.899 . . . . 75.42 109.564 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 t -83.33 97.94 9.19 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.685 -0.858 . . . . 64.45 108.685 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.6 pt -112.53 142.9 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.603 0.761 . . . . 71.05 110.386 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -154.81 164.33 38.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.098 0.959 . . . . 55.44 110.184 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.36 -5.89 83.33 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.86 -0.609 . . . . 71.22 113.925 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 94' ' ' MET . 18.8 pt -114.57 144.79 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.008 0.923 . . . . 75.13 111.118 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -163.18 172.18 15.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.754 0.822 . . . . 72.33 108.783 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.47 -124.6 11.9 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.692 0.637 . . . . 73.22 114.692 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -74.8 -23.62 58.52 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.867 0.867 . . . . 72.45 111.399 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -68.04 -36.98 80.81 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 63.15 109.411 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG3' HD12 ' A' ' 89' ' ' ILE . 24.8 ttt -81.55 -24.68 36.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.715 -0.675 . . . . 72.53 110.822 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.05 85.48 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.852 0.461 . . . . 72.32 111.115 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -68.25 -37.17 80.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.404 -0.816 . . . . 65.22 110.781 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.3 t -73.82 -42.33 61.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 53.4 111.647 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.38 -47.3 20.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.365 0.666 . . . . 62.14 110.264 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.4 -2.69 88.99 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 115.077 0.791 . . . . 55.04 115.077 -170.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.11 -56.75 0.23 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 117.91 0.855 . . . . 74.3 112.279 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.8 t80 -64.78 -47.76 76.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.731 1.213 . . . . 72.14 113.065 -168.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.32 -35.5 1.17 Allowed Pre-proline 0 CA--C 1.57 1.727 0 CA-C-O 118.851 -0.595 . . . . 62.43 112.502 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.85 -39.68 48.64 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.77 2.314 . . . . 60.41 113.295 161.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -61.1 -25.93 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.42 0.688 . . . . 64.14 111.419 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.451 HG21 ' CD1' ' A' ' 13' ' ' ILE . 36.1 mm -78.95 -55.42 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.695 0.798 . . . . 72.05 110.227 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.95 -24.46 33.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.75 1.018 . . . . 72.45 113.75 -165.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -64.13 -41.57 62.49 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.382 -0.818 . . . . 71.31 112.68 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.34 -43.17 61.15 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 122.095 1.863 . . . . 73.52 113.225 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -67.95 -38.62 83.03 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.441 0.696 . . . . 74.0 112.092 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 -45.96 76.3 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.684 -0.487 . . . . 61.1 109.684 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -53.71 -46.49 70.79 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.576 1.173 . . . . 75.34 110.755 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.23 -49.37 72.2 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.43 1.081 . . . . 73.42 111.148 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.7 t -58.22 -41.47 84.13 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.834 0.709 . . . . 70.25 110.735 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 76' ' ' CYS . 78.7 mt -64.94 -48.49 83.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 O-C-N 124.097 0.873 . . . . 52.51 109.958 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.648 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.0 m -51.76 -49.98 61.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.133 0.973 . . . . 74.21 111.768 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -64.02 -42.94 96.94 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.088 0.867 . . . . 64.32 110.409 -175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.432 ' SD ' HG23 ' A' ' 21' ' ' ILE . 5.7 mtp -56.38 -46.76 79.95 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.835 0.854 . . . . 72.02 111.442 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 126' ' ' LEU . 77.5 t -65.69 -44.2 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.195 0.998 . . . . 71.24 111.68 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.7 p -67.66 -31.35 71.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.981 0.513 . . . . 72.21 111.346 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 88.3 mtt-85 -68.02 -29.6 68.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.602 0.761 . . . . 54.21 110.858 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.47 3.04 80.2 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.177 -0.465 . . . . 54.2 113.547 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.423 ' HB ' HH21 ' B' ' 15' ' ' ARG . 6.8 m 63.74 35.75 11.09 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.808 1.243 . . . . 75.34 110.045 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -105.58 151.66 39.86 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 114.547 -1.206 . . . . 72.12 108.386 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.05 147.87 91.38 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.431 2.087 . . . . 70.35 111.94 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.648 ' HG3' HG23 ' A' ' 115' ' ' THR . 24.2 tt0 -52.9 128.67 27.83 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.772 0.829 . . . . 63.35 112.472 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.762 HD21 HG11 ' A' ' 64' ' ' VAL . 38.4 tp -108.48 118.44 36.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.256 0.623 . . . . 74.54 109.419 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.05 109.05 6.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.162 0.985 . . . . 62.35 108.939 -179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 42' ' ' LEU . 17.9 tp -67.48 135.74 53.54 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.198 0.599 . . . . 63.42 110.544 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -53.52 133.29 54.2 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.647 1.179 . . . . 63.41 112.293 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD3' HD12 ' C' ' 13' ' ' ILE . 6.0 Cg_exo -78.3 92.88 1.11 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.039 2.493 . . . . 75.01 110.864 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 66.9 t -100.54 126.85 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.222 -1.029 . . . . 65.33 108.222 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 40.9 t-20 -73.28 98.69 2.72 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.357 0.663 . . . . 71.4 110.143 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.08 -27.15 62.48 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.928 0.891 . . . . 75.31 110.756 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 7.1 t70 . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 123.904 0.881 . . . . 74.31 110.587 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 94.0 m . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 107.334 -1.358 . . . . 73.51 107.334 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -116.59 114.71 24.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.0 -1.111 . . . . 72.52 108.0 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -134.75 141.0 46.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.235 0.614 . . . . 74.23 110.344 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -86.2 102.18 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.884 -1.053 . . . . 74.2 110.656 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -77.38 -32.02 54.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 122.019 -0.425 . . . . 62.14 110.055 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.423 HH21 ' HB ' ' A' ' 122' ' ' THR . 37.6 ttt180 -173.75 134.13 0.47 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.19 -0.67 . . . . 63.45 109.19 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.7 mt -113.8 134.62 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 106.915 -1.513 . . . . 74.14 106.915 171.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -166.17 151.24 8.29 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.679 0.752 . . . . 73.52 112.163 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.7 m -77.45 122.12 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.905 -1.043 . . . . 63.31 109.027 170.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.511 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 43.7 mtpt -89.71 -39.33 13.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.141 0.576 . . . . 60.41 111.105 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.3 t70 -150.09 136.04 18.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.57 -0.286 . . . . 74.21 110.632 -169.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.471 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.9 mm -128.59 139.13 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.477 1.111 . . . . 43.24 108.687 173.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -141.56 121.55 13.68 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.719 -1.215 . . . . 50.21 107.719 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.2 t80 -136.19 137.33 40.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.664 -0.865 . . . . 75.14 108.664 172.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.4 mt-10 -136.42 153.35 51.1 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.862 1.265 . . . . 74.03 108.833 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 82.49 7.15 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.833 -1.543 . . . . 74.55 106.833 172.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.62 -46.44 7.01 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.882 2.388 . . . . 73.1 111.712 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -96.89 28.21 3.61 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.928 0.891 . . . . 75.23 109.641 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.582 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -46.86 -51.71 37.26 Favored Pre-proline 0 CA--C 1.568 1.655 0 N-CA-C 114.22 1.193 . . . . 53.21 114.22 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 9.3 Cg_endo -79.56 -24.21 6.49 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.715 1.61 . . . . 73.31 112.538 176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.463 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.4 m80 -97.09 2.18 50.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.225 1.01 . . . . 74.5 112.81 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.539 HG23 HD11 ' B' ' 68' ' ' LEU . 11.1 p -71.51 -19.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.053 0.941 . . . . 75.21 111.334 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -67.08 -23.12 65.82 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.516 1.127 . . . . 73.03 111.938 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.614 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 28.4 pt20 -69.91 -34.04 72.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.373 0.669 . . . . 71.13 110.44 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.635 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.9 mmtp -107.67 63.71 0.62 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.329 -0.989 . . . . 63.51 108.329 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.05 105.21 14.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.147 -0.686 . . . . 74.13 109.147 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.445 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 162.65 -165.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 127.39 2.276 . . . . 74.24 109.216 159.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.414 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 28.7 pt20 -61.08 127.35 87.74 Favored Pre-proline 0 C--N 1.363 1.159 0 O-C-N 123.248 0.342 . . . . 75.1 111.18 -171.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.11 160.86 15.55 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.542 2.161 . . . . 71.1 112.112 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.19 106.25 3.23 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.999 -1.112 . . . . 71.25 107.999 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.95 158.33 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.346 0.659 . . . . 73.23 111.705 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.0 tttm -143.64 108.84 5.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.377 1.071 . . . . 72.05 109.058 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 tt -86.59 135.47 33.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 106.772 -1.566 . . . . 73.3 106.772 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 16.9 t70 -144.51 147.45 33.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.944 -0.761 . . . . 74.23 108.944 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.4 140.01 53.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.294 -0.632 . . . . 51.23 109.294 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 8.7 t70 -123.49 140.95 52.48 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.403 1.081 . . . . 73.22 108.615 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.0 p -108.81 115.53 30.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.281 -0.872 . . . . 61.33 109.977 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -136.22 133.68 37.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.743 0.817 . . . . 72.3 108.892 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.5 p -144.7 167.68 21.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.326 0.65 . . . . 53.22 110.032 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -150.56 137.38 19.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.19 0.596 . . . . 75.11 110.089 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -90.81 94.73 9.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.455 0.702 . . . . 61.14 109.401 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' B' ' 57' ' ' GLU . 38.5 mt -69.87 -39.41 76.35 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.38 0.609 . . . . 71.05 110.102 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -157.44 -179.59 8.32 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.648 -1.16 . . . . 71.41 109.413 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -67.08 120.43 13.67 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.357 -0.609 . . . . 60.22 109.357 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 73.9 -4.79 2.18 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.375 1.47 . . . . 64.22 112.394 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 87.9 t -104.51 111.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 N-CA-C 108.05 -1.093 . . . . 72.03 108.05 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -126.51 137.6 53.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.602 . . . . 75.33 109.706 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' B' ' 51' ' ' LEU . 6.1 tm-20 -101.64 102.01 12.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.738 -1.579 . . . . 75.21 106.738 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.7 t -95.54 121.92 46.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.67 1.188 . . . . 74.11 110.219 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.1 t -104.95 120.79 56.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 124.731 1.213 . . . . 23.01 109.633 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' B' ' 103' ' ' PRO . 61.7 tp -104.39 104.66 14.57 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.811 -0.811 . . . . 70.24 108.811 172.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 38.5 ttm180 -88.67 114.09 24.92 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.356 -0.609 . . . . 73.22 109.356 173.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.4 t -106.43 112.03 37.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.084 -1.08 . . . . 62.43 108.084 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.9 m -98.2 138.36 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.992 0.917 . . . . 62.42 110.038 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.679 HG21 HG21 ' B' ' 114' ' ' ILE . 55.5 t -127.34 124.3 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.822 1.249 . . . . 55.44 108.355 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 85.0 m -119.18 145.61 45.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.008 -1.108 . . . . 74.33 108.008 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.1 131.72 17.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.673 -0.862 . . . . 73.54 108.673 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.6 p -152.98 126.91 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.088 0.555 . . . . 64.03 110.433 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.1 OUTLIER -104.65 123.75 48.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.816 0.847 . . . . 73.25 109.188 -176.095 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -111.49 3.26 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.14 -1.184 . . . . 60.05 110.14 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.46 6.25 6.93 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 72.25 109.798 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -113.52 143.4 44.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.531 . . . . 72.31 109.745 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 54.4 m -70.0 133.71 47.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.104 0.562 . . . . 71.21 111.932 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -88.55 -59.46 2.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.303 1.041 . . . . 72.12 109.426 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.02 150.4 9.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.896 -1.502 . . . . 75.21 109.242 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.32 123.66 39.89 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 124.819 1.248 . . . . 70.42 107.695 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.7 t -129.85 149.91 51.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.257 -0.645 . . . . 73.42 109.257 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -162.78 132.53 4.39 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.026 -0.731 . . . . 60.12 109.026 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' B' ' 113' ' ' CYS . 85.3 t -126.83 145.62 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.612 0.765 . . . . 35.32 109.505 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -118.01 103.24 9.71 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.288 -1.375 . . . . 72.51 107.288 167.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 32.3 tp60 -93.21 99.48 12.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.378 -1.341 . . . . 61.43 107.378 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 171.62 38.79 Favored Glycine 0 C--O 1.248 1.024 0 N-CA-C 110.724 -0.95 . . . . 72.33 110.724 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.18 126.66 1.16 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.915 -0.659 . . . . 52.41 112.022 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 28.4 mt -84.73 129.0 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.042 -1.096 . . . . 70.43 108.042 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -133.74 150.59 51.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.602 1.161 . . . . 74.01 108.222 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -114.46 114.8 26.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.074 -1.084 . . . . 74.33 108.074 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' B' ' 10' ' ' THR . 46.3 pt -121.02 130.69 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.348 0.659 . . . . 75.03 110.712 -174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.66 171.11 19.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.311 1.045 . . . . 71.25 109.79 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.7 -47.08 3.79 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.091 0.377 . . . . 64.52 112.391 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.403 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -70.18 152.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.691 0.797 . . . . 73.33 111.154 169.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -150.41 143.28 24.71 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 111.726 0.269 . . . . 63.4 111.726 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.55 -111.1 2.95 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.99 0.805 . . . . 63.02 113.934 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.97 0.908 . . . . 71.25 110.144 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -76.02 -25.82 56.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.049 0.939 . . . . 73.12 110.327 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 43.7 ttp -73.32 -34.8 65.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.913 0.885 . . . . 73.44 110.307 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.38 68.75 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.604 -0.726 . . . . 71.32 110.814 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 57.1 t-80 -73.56 -24.12 60.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.419 0.687 . . . . 74.43 111.198 173.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -73.59 -63.54 1.18 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.672 0.389 . . . . 64.01 111.024 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.716 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -87.02 -19.23 28.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.577 0.584 . . . . 73.12 112.577 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.71 2.8 52.81 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.83 -0.428 . . . . 63.11 113.972 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -146.39 -46.8 0.19 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.034 0.417 . . . . 64.32 111.43 -177.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -83.23 -38.39 22.31 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 111.577 0.214 . . . . 72.24 111.577 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.716 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.7 m -62.1 -46.54 91.43 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.47 -0.776 . . . . 74.33 111.077 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.652 ' HA ' HD22 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -49.26 -42.2 40.7 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 122.547 2.165 . . . . 62.22 113.878 166.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -58.01 -36.86 73.29 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.547 0.739 . . . . 72.14 111.68 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.402 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 47.3 mt -80.49 -48.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.591 0.756 . . . . 73.35 111.484 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.38 -21.13 53.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.258 0.623 . . . . 74.22 112.167 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.5 -47.73 67.77 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 117.665 -1.159 . . . . 71.3 113.064 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 97.2 Cg_exo -49.98 -45.89 30.57 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.741 2.294 . . . . 73.01 113.917 172.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.8 m-85 -65.61 -43.45 89.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.3 0.64 . . . . 71.25 110.893 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.413 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -66.4 -34.41 77.9 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 115.877 -0.602 . . . . 55.52 110.623 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -59.42 -57.27 13.72 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.152 0.981 . . . . 73.43 110.466 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.18 -33.05 74.64 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.807 0.692 . . . . 71.01 110.307 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.6 t -74.03 -36.44 64.43 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.193 -0.458 . . . . 74.42 111.427 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.679 HG21 HG21 ' B' ' 64' ' ' VAL . 81.6 mt -67.83 -51.77 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 74.01 109.05 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.674 HG23 ' HB2' ' B' ' 125' ' ' GLN . 66.6 m -62.19 -28.33 69.59 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 114.359 -1.292 . . . . 64.23 111.194 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -65.3 -46.34 80.77 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.344 0.658 . . . . 63.52 109.7 174.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.79 -33.02 68.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.999 0.52 . . . . 55.12 111.249 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.41 -41.61 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.407 0.683 . . . . 73.44 109.909 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.1 t -68.68 -31.07 69.92 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.321 -0.854 . . . . 61.12 111.515 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -74.53 -32.27 62.41 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.319 0.648 . . . . 43.2 110.227 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.73 -3.32 83.49 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.443 0.464 . . . . 72.24 112.432 170.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 59.45 51.17 6.8 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 126.424 1.89 . . . . 75.45 111.819 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.85 145.76 40.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.013 -1.449 . . . . 75.05 109.01 170.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.16 130.05 27.11 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.31 2.673 . . . . 72.42 112.432 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.674 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.7 pt20 -65.43 156.94 30.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.849 -1.069 . . . . 72.13 113.148 -171.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.46 114.05 25.29 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.503 -1.295 . . . . 41.35 107.503 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -91.47 108.65 20.04 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.959 -1.126 . . . . 45.43 107.959 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.87 150.2 45.4 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.821 0.849 . . . . 70.31 112.326 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.22 138.46 71.96 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.849 -1.069 . . . . 65.3 109.789 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.599 ' HG3' HD11 ' D' ' 16' ' ' ILE . 60.5 Cg_endo -71.48 97.22 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.499 2.133 . . . . 73.44 110.811 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.73 109.34 20.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.261 -1.014 . . . . 65.3 108.261 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -76.29 87.34 3.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.705 0.802 . . . . 75.34 109.871 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.467 -0.568 . . . . 54.43 109.467 171.174 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.514 ' HG3' HD12 ' C' ' 89' ' ' ILE . 26.9 ttt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.188 0.518 . . . . 70.4 111.512 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.1 m -92.35 88.74 6.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.573 0.749 . . . . 63.15 109.116 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -119.61 126.55 51.45 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.711 -0.848 . . . . 53.53 108.711 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -150.75 131.04 13.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.872 0.869 . . . . 72.4 108.995 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.418 HD12 ' HD3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -78.52 132.02 33.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.768 -0.827 . . . . 74.34 108.768 174.267 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.0 mm100 -93.57 -46.04 7.47 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.077 0.551 . . . . 63.33 109.553 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -176.31 126.0 0.19 Allowed 'General case' 0 C--N 1.356 0.891 0 O-C-N 124.168 0.917 . . . . 75.23 110.192 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.01 142.99 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.636 -1.246 . . . . 75.2 107.636 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.443 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -176.79 156.01 1.34 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.617 0.644 . . . . 74.54 111.806 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -75.94 121.79 23.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.786 0.834 . . . . 74.32 109.061 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 12.6 mmmm -76.15 -47.99 22.23 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.305 1.05 . . . . 73.32 108.875 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -140.59 146.0 37.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 113.772 -1.558 . . . . 62.1 109.198 -173.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.7 mt -140.91 144.84 26.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.096 1.358 . . . . 63.44 107.482 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -156.22 151.14 26.2 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.573 0.702 . . . . 73.44 110.433 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -148.89 127.58 12.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.531 -1.285 . . . . 75.42 107.531 171.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.1 mt-10 -120.84 133.89 55.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.789 0.835 . . . . 75.43 109.411 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.53 79.36 24.76 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.335 -0.987 . . . . 74.23 108.335 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.87 -25.13 12.45 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.679 2.253 . . . . 71.14 112.112 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.441 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 96.9 m-20 -106.87 34.96 3.18 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.444 1.098 . . . . 73.02 109.504 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.38 -55.6 43.58 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.388 -0.815 . . . . 51.54 112.997 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 26.0 Cg_exo -65.53 -30.09 52.3 Favored 'Trans proline' 0 C--N 1.394 2.932 0 CA-C-N 121.421 1.543 . . . . 72.45 112.204 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.441 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.1 t60 -62.76 -23.51 67.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.784 1.234 . . . . 71.45 112.001 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' C' ' 34' ' ' LYS . 8.8 p -52.67 -25.34 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 N-CA-C 112.828 0.677 . . . . 75.33 112.828 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -79.7 -24.56 41.62 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.583 -0.698 . . . . 74.2 112.305 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -102.24 17.63 22.92 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.274 0.559 . . . . 53.31 110.503 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.73 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.07 138.26 33.15 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.085 0.954 . . . . 62.25 110.333 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -77.04 129.17 35.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 72.51 108.927 170.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -80.2 77.55 6.92 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.334 0.588 . . . . 75.14 110.667 -174.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' C' ' 68' ' ' LEU . 36.6 tt0 -160.45 63.64 1.98 Allowed Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 115.048 -0.978 . . . . 64.54 109.293 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.72 126.67 6.01 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.216 1.944 . . . . 74.34 111.416 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -85.88 99.11 11.17 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.609 -1.626 . . . . 75.22 106.609 169.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.437 HG11 HD13 ' C' ' 126' ' ' LEU . 43.2 t -73.19 122.93 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.794 -1.094 . . . . 70.12 109.038 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -124.62 112.34 16.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.345 1.058 . . . . 63.2 109.254 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 145.66 26.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.839 0.856 . . . . 62.45 109.156 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.5 t70 -132.95 143.63 49.59 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.909 -1.145 . . . . 63.33 107.909 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -135.08 115.01 12.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.247 -0.649 . . . . 72.4 109.247 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.0 t70 -111.44 143.39 42.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.104 -1.072 . . . . 73.1 108.104 175.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -115.05 117.39 30.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.728 0.811 . . . . 75.55 110.224 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -112.74 141.98 45.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 71.21 108.824 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -151.32 158.1 43.36 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.134 0.574 . . . . 73.32 110.518 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -167.62 131.88 1.81 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.858 0.863 . . . . 52.45 109.434 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.63 117.91 24.81 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.82 -0.807 . . . . 73.44 108.82 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.515 HD11 HD12 ' C' ' 83' ' ' ILE . 56.6 mt -86.33 -38.97 16.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.022 0.929 . . . . 74.04 111.354 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -171.19 3.08 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.669 -0.696 . . . . 73.53 110.572 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -57.5 110.39 0.86 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.983 -1.008 . . . . 75.31 110.104 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 70.26 -2.19 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.927 1.291 . . . . 63.11 112.781 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -94.28 103.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 71.34 108.859 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -115.48 126.15 53.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.084 0.954 . . . . 60.51 109.534 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -84.43 119.26 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.44 -0.578 . . . . 63.15 109.44 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -98.23 128.43 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.495 1.118 . . . . 74.35 108.244 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 70.2 t -131.7 137.38 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.441 0.696 . . . . 65.24 109.413 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' C' ' 103' ' ' PRO . 92.9 mt -125.51 112.42 16.2 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.741 0.816 . . . . 75.13 109.917 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 27.4 ttm180 -82.61 105.79 13.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.024 -0.732 . . . . 75.12 109.024 168.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.658 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.3 t -101.19 125.36 55.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.968 -1.123 . . . . 62.12 107.968 171.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 15.5 m -124.41 113.29 17.97 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.795 -0.817 . . . . 73.02 108.795 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.502 HG21 HG21 ' C' ' 114' ' ' ILE . 60.2 t -102.19 114.22 40.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.681 0.792 . . . . 73.03 109.065 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -102.41 150.71 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.535 -0.913 . . . . 71.23 108.535 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.5 106.09 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.48 -1.674 . . . . 73.31 106.48 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -148.39 146.22 28.38 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.913 0.485 . . . . 62.45 110.544 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.73 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.3 OUTLIER -110.78 55.79 0.64 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.095 0.958 . . . . 71.53 108.544 174.04 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.95 -113.72 4.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.48 -1.237 . . . . 40.32 111.131 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.36 -17.78 29.83 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.457 0.703 . . . . 74.13 110.301 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -88.96 99.35 12.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.072 0.949 . . . . 74.54 109.529 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -85.57 132.78 34.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.94 0.496 . . . . 60.45 111.096 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -77.47 -64.25 1.19 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.146 0.979 . . . . 63.41 109.591 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -163.58 175.67 10.43 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.416 -0.811 . . . . 73.43 110.324 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -139.27 144.21 38.29 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 107.901 -1.148 . . . . 74.51 107.901 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.435 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.5 t -143.87 149.13 36.46 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.27 -1.011 . . . . 70.11 108.27 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.25 136.46 11.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.922 0.489 . . . . 53.12 110.056 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -138.08 134.79 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.237 1.015 . . . . 71.4 108.456 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 63.3 mt-30 -110.57 91.22 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.951 -1.129 . . . . 64.14 107.951 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -80.05 117.43 20.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.626 -0.715 . . . . 71.53 110.55 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.37 162.52 20.75 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 123.517 0.51 . . . . 61.24 112.556 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.524 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -166.94 118.19 0.78 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.306 -0.718 . . . . 62.44 111.306 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.515 HD12 HD11 ' C' ' 51' ' ' LEU . 13.6 mm -83.21 122.73 37.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.764 -0.828 . . . . 71.22 108.764 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -132.78 132.25 42.03 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.65 0.78 . . . . 73.21 109.417 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 47.8 m -94.18 114.36 26.46 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.594 -0.891 . . . . 72.04 108.594 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 50.8 mt -115.08 119.26 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.554 1.142 . . . . 74.52 107.994 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.55 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.246 1.019 . . . . 63.55 109.923 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.78 -34.3 4.59 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.271 -0.422 . . . . 52.05 112.772 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.525 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -121.9 165.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 71.32 110.176 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -156.46 -179.9 8.61 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.41 0.684 . . . . 61.03 110.42 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' C' ' 94' ' ' MET . . . 68.81 -130.35 25.16 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.384 -0.371 . . . . 73.01 113.052 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -78.95 -20.72 48.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.254 0.622 . . . . 72.43 111.272 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.21 -44.52 95.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.392 0.677 . . . . 75.15 110.184 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' C' ' 91' ' ' GLY . 0.0 OUTLIER -76.58 -26.32 54.93 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 116.029 -0.532 . . . . 70.43 110.785 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.66 -32.13 70.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.892 0.477 . . . . 75.41 111.087 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 60.1 t-80 -73.73 -24.3 59.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.288 0.635 . . . . 54.45 110.73 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -81.67 -58.57 2.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.205 0.602 . . . . 54.35 110.324 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.33 -48.37 42.52 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.19 1.396 . . . . 72.23 110.826 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.83 11.46 72.05 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.547 -0.585 . . . . 61.42 114.111 -171.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -148.61 -59.3 0.23 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.554 0.677 . . . . 71.04 112.217 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -74.85 -38.88 61.86 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.981 0.512 . . . . 75.33 112.243 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.9 -45.46 74.41 Favored Pre-proline 0 CA--C 1.557 1.249 0 CA-C-O 118.833 -0.603 . . . . 55.21 111.277 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HA ' HD11 ' C' ' 60' ' ' LEU . 69.9 Cg_exo -48.8 -42.8 36.45 Favored 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.647 2.232 . . . . 73.2 114.457 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -60.7 -40.21 91.39 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.784 0.833 . . . . 74.44 110.798 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.11 -48.21 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.919 0.488 . . . . 75.02 110.72 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.524 HD21 ' HA3' ' C' ' 82' ' ' GLY . 80.3 mt -80.11 -19.57 47.05 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.76 -0.655 . . . . 74.14 112.53 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -58.64 -48.42 96.92 Favored Pre-proline 0 CA--C 1.566 1.593 0 CA-C-O 118.061 -0.971 . . . . 71.04 113.29 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.94 -36.64 96.52 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.358 2.039 . . . . 73.45 113.463 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -66.69 -45.18 79.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.425 0.69 . . . . 75.42 111.146 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.77 88.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.282 0.633 . . . . 74.12 109.64 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -53.7 -49.23 68.49 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.639 1.576 . . . . 72.02 112.091 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.94 -39.01 72.88 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.81 0.694 . . . . 65.53 110.163 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.49 -33.6 74.44 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.994 0.517 . . . . 65.45 111.274 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.658 HD11 ' HB ' ' C' ' 62' ' ' VAL . 81.3 mt -66.27 -52.29 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.597 0.759 . . . . 72.13 109.53 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 29.1 m -65.28 -29.08 69.82 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.049 -0.978 . . . . 61.44 110.75 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -66.84 -43.75 82.85 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.694 0.798 . . . . 50.34 109.925 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.562 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.44 -37.64 85.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.524 0.73 . . . . 74.03 111.646 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.03 -37.78 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.253 0.621 . . . . 63.13 109.811 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.0 t -66.24 -35.9 81.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.229 1.012 . . . . 74.12 111.829 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.4 mtt-85 -74.35 -35.76 63.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.614 0.766 . . . . 74.22 110.332 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.17 1.14 76.85 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.622 0.576 . . . . 74.13 112.592 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.3 p 61.36 24.05 14.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.035 1.734 . . . . 61.01 112.656 172.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -90.42 155.24 46.46 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.127 0.971 . . . . 73.03 110.03 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.08 122.43 11.8 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.058 2.505 . . . . 71.52 112.38 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -61.13 153.59 25.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.311 1.045 . . . . 62.45 112.881 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.437 HD13 HG11 ' C' ' 40' ' ' VAL . 5.1 tt -141.52 114.01 8.27 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 106.68 -1.6 . . . . 75.11 106.68 171.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -90.9 131.73 36.35 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.799 0.84 . . . . 65.43 109.749 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.43 141.69 56.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.444 0.698 . . . . 70.24 110.964 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.76 148.89 55.65 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.025 0.93 . . . . 72.1 110.907 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.542 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.9 Cg_exo -64.52 94.69 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.144 2.563 . . . . 71.23 112.465 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.38 106.71 19.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.938 -1.134 . . . . 71.23 107.938 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.89 102.42 11.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.609 -1.256 . . . . 63.35 107.609 173.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -63.06 -42.3 99.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.454 0.645 . . . . 61.24 109.308 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 N--CA 1.474 0.725 0 C-N-CA 125.195 1.398 . . . . 73.2 112.382 179.117 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 121.14 0.495 . . . . 64.4 110.299 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -159.88 90.62 0.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.629 -1.619 . . . . 62.31 106.629 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.85 114.97 28.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.066 -1.087 . . . . 70.24 108.066 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mt -77.13 104.5 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 108.203 -1.036 . . . . 72.21 108.203 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.96 -45.48 60.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.769 -0.456 . . . . 75.43 109.769 -170.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' D' ' 15' ' ' ARG . 3.4 mmp_? -157.66 147.75 20.54 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.374 1.07 . . . . 73.21 110.138 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.599 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.7 mp -120.04 113.38 40.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 106.496 -1.668 . . . . 74.54 106.496 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.577 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 42.0 p90 -145.93 150.73 36.62 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.759 0.79 . . . . 63.34 111.282 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -81.38 115.28 20.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.897 -1.047 . . . . 43.45 109.549 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.53 -33.14 28.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.424 0.631 . . . . 74.22 109.885 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -144.26 137.2 27.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.483 -1.235 . . . . 51.24 109.524 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.562 HD13 ' HE3' ' C' ' 117' ' ' MET . 93.3 mt -132.05 140.52 47.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.68 1.192 . . . . 73.21 107.885 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 38.6 t -142.34 133.74 26.44 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.562 1.145 . . . . 73.32 108.053 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -147.91 124.7 11.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.754 -1.573 . . . . 73.21 106.754 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -129.19 137.09 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.488 1.115 . . . . 74.01 108.898 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.11 85.36 59.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.703 -1.591 . . . . 53.22 106.703 172.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.39 -61.59 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.901 2.401 . . . . 74.02 112.547 -172.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.76 41.83 1.09 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.0 -1.111 . . . . 72.32 108.0 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -49.07 -59.72 5.93 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 114.389 1.255 . . . . 53.4 114.389 -167.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.54 -12.86 15.13 Favored 'Trans proline' 0 C--N 1.385 2.462 0 CA-C-N 121.727 1.652 . . . . 54.01 112.772 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.2 -41.4 57.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.122 1.369 . . . . 62.32 109.597 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.06 -40.69 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.746 -1.116 . . . . 64.44 110.471 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.68 -18.37 64.91 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.146 -0.933 . . . . 71.22 113.064 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -78.79 -14.65 59.15 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.386 0.674 . . . . 71.35 112.222 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -109.04 114.51 28.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.06 0.944 . . . . 61.11 108.593 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -88.14 96.17 10.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.627 0.603 . . . . 64.4 112.627 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.475 ' CZ3' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -169.42 -174.26 1.89 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.097 0.777 . . . . 73.04 113.097 171.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -92.1 126.5 52.9 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 125.05 1.34 . . . . 72.03 111.509 -173.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.588 ' HB3' HD23 ' D' ' 68' ' ' LEU . 56.0 Cg_endo -75.31 150.59 37.09 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.928 2.419 . . . . 74.2 113.783 172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -83.21 135.59 34.72 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.504 1.122 . . . . 65.22 108.392 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 67.8 t -118.82 138.82 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.381 0.672 . . . . 54.33 109.262 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 47.9 tttm -125.81 121.26 32.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.186 0.994 . . . . 73.43 108.653 -172.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.47 HD11 HD11 ' D' ' 128' ' ' LEU . 0.4 OUTLIER -97.62 112.68 24.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.586 0.754 . . . . 41.45 109.062 -172.524 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.609 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.9 m-20 -111.75 127.8 55.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.277 1.031 . . . . 74.23 108.848 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.17 140.02 49.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.376 0.67 . . . . 75.32 109.431 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.6 t70 -142.0 136.47 30.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.107 0.963 . . . . 74.31 108.723 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -105.47 143.9 32.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.461 0.704 . . . . 70.42 110.193 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.69 159.02 44.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.694 0.798 . . . . 23.23 109.772 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.2 p -168.27 166.68 12.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.119 0.568 . . . . 64.04 111.166 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -158.84 145.56 17.17 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.368 1.067 . . . . 62.35 109.107 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.0 117.71 25.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.942 -0.762 . . . . 71.23 108.942 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' D' ' 57' ' ' GLU . 31.5 mt -92.85 -24.78 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.598 0.359 . . . . 53.34 110.281 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.87 -178.84 3.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.125 0.97 . . . . 74.35 110.608 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.56 118.92 9.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.914 -1.039 . . . . 74.24 108.937 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 70.07 5.17 5.16 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.696 1.198 . . . . 64.45 112.088 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.26 114.91 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.767 -0.827 . . . . 70.41 108.767 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.59 129.8 39.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.356 1.062 . . . . 63.11 108.883 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.457 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.4 tt0 -88.42 124.79 34.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.428 -0.953 . . . . 74.03 108.428 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.495 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 47.4 t -108.77 122.99 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.039 -1.467 . . . . 62.13 107.039 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 23.3 t -106.28 128.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.724 -0.843 . . . . 65.42 108.724 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.64 HD23 HD12 ' D' ' 106' ' ' LEU . 4.1 mm? -112.06 114.21 26.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.677 -0.49 . . . . 74.3 109.677 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -86.93 106.08 17.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.633 -0.712 . . . . 73.11 109.152 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.95 127.73 48.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.895 -1.15 . . . . 70.51 107.895 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 39.6 m -125.66 130.13 50.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.382 -0.826 . . . . 61.51 108.793 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -120.42 121.27 65.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.785 1.234 . . . . 61.35 108.474 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 87.6 m -120.63 100.43 7.12 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.054 0.942 . . . . 74.34 109.099 -170.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.15 137.47 37.63 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.187 -0.46 . . . . 65.22 110.098 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 53.4 p -150.47 140.12 21.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.603 0.761 . . . . 71.14 109.598 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.652 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -136.22 136.4 39.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.501 1.12 . . . . 75.12 110.135 -174.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.67 3.78 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.337 -0.705 . . . . 73.54 111.337 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.52 4.2 8.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.703 0.801 . . . . 74.12 110.346 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.63 166.85 13.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.15 0.58 . . . . 72.13 110.821 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 87.1 m -80.97 139.14 35.99 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.821 -0.627 . . . . 63.33 110.483 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.652 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -80.56 -72.02 0.43 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.027 -1.101 . . . . 75.44 108.027 172.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.45 146.46 25.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.17 -0.923 . . . . 63.21 108.928 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -110.34 130.06 55.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.57 -1.271 . . . . 74.11 107.57 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.554 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.4 t -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 72.31 108.871 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 41.9 tt0 -154.59 121.8 5.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.085 0.554 . . . . 63.33 110.065 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -130.21 118.11 42.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.068 -0.715 . . . . 75.14 109.068 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -87.8 86.78 7.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.612 -1.255 . . . . 63.44 107.612 169.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.98 97.38 6.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.184 -1.371 . . . . 64.32 108.565 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.52 144.0 18.82 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.453 -0.659 . . . . 53.14 111.453 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.28 4.58 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 109.826 -1.31 . . . . 71.44 109.826 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.75 130.23 38.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.173 . . . . 63.3 107.834 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.495 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 42.3 m-85 -129.0 136.16 49.94 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.483 0.49 . . . . 64.02 109.98 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.9 m -86.52 93.32 9.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.924 -1.139 . . . . 74.02 107.924 167.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 14.9 mt -106.58 114.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 109.437 -0.579 . . . . 73.43 109.437 -172.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.4 163.0 35.06 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.915 0.886 . . . . 63.32 109.679 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -6.3 83.76 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.508 -0.607 . . . . 51.2 114.568 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 pt -129.11 147.97 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.639 0.719 . . . . 73.42 111.716 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 173.57 13.18 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.823 1.249 . . . . 53.12 109.426 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.24 -127.28 43.08 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 115.258 0.863 . . . . 74.42 115.258 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 90.1 m -66.23 -38.46 87.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.68 1.192 . . . . 74.14 111.642 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -69.2 -36.77 77.63 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.881 0.873 . . . . 75.13 110.75 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.683 ' SD ' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -72.12 -42.52 65.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.508 -0.553 . . . . 72.11 109.508 176.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.82 88.46 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.588 0.755 . . . . 64.22 110.805 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 15.0 t-80 -64.91 -36.55 84.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.158 -0.928 . . . . 71.42 110.669 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -68.03 -50.53 54.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.513 0.325 . . . . 74.44 111.236 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.683 HD23 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -71.18 -30.3 66.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.9 0.48 . . . . 74.31 111.305 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.24 7.5 56.66 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.61 -0.55 . . . . 75.0 114.06 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.05 -57.82 0.24 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.465 0.633 . . . . 54.25 111.762 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -70.62 -52.94 18.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.211 0.604 . . . . 75.21 111.238 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.436 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 34.0 m -60.58 -45.7 97.2 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.873 0.869 . . . . 34.45 112.127 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 75.0 Cg_exo -53.93 -45.59 39.9 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.747 2.298 . . . . 72.2 113.156 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.03 -26.31 68.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.559 0.743 . . . . 71.12 111.725 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.0 mm -73.51 -49.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.373 0.669 . . . . 61.24 110.962 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.64 HD12 HD23 ' D' ' 60' ' ' LEU . 83.2 mt -87.13 -13.95 42.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.13 0.572 . . . . 73.41 112.46 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -67.51 -45.69 47.29 Favored Pre-proline 0 CA--C 1.559 1.326 0 CA-C-O 118.188 -0.91 . . . . 72.31 112.328 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.79 -33.43 96.87 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.21 1.94 . . . . 72.35 113.408 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -78.96 -34.96 43.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.533 0.733 . . . . 73.33 112.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.56 -50.05 68.81 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.933 -0.766 . . . . 74.12 108.933 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -54.18 -48.01 71.4 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.991 1.432 . . . . 71.43 110.574 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.34 -50.1 74.29 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.169 0.918 . . . . 74.13 110.911 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.422 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.6 t -55.32 -43.29 74.76 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.973 0.795 . . . . 73.51 110.913 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.554 HG12 ' SG ' ' D' ' 76' ' ' CYS . 86.1 mt -65.8 -51.91 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 124.355 1.034 . . . . 50.0 110.624 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.458 HG23 ' HB2' ' D' ' 125' ' ' GLN . 68.9 m -51.03 -44.45 61.04 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.986 1.315 . . . . 72.54 111.658 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -69.41 -45.61 68.8 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.849 -1.069 . . . . 72.44 110.812 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.98 -36.96 85.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.741 0.416 . . . . 65.03 111.981 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.2 t -66.79 -44.33 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.097 -0.956 . . . . 70.31 109.998 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -69.73 -27.31 64.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.817 0.447 . . . . 73.15 111.414 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -73.21 -29.72 63.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 73.42 110.205 175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.89 11.48 66.69 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.69 -0.686 . . . . 43.11 112.438 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.428 HG23 ' HB3' ' C' ' 17' ' ' TYR . 59.9 p 57.87 14.11 2.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.725 2.01 . . . . 74.23 113.518 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.02 162.91 55.55 Favored Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.482 1.113 . . . . 43.35 108.342 169.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.32 127.02 10.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.212 1.941 . . . . 74.43 111.41 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.458 ' HB2' HG23 ' D' ' 115' ' ' THR . 1.6 pp0? -54.12 142.8 24.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.319 0.648 . . . . 64.11 111.291 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.89 103.79 13.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.021 -0.733 . . . . 55.13 109.021 -161.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -97.05 91.92 5.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.98 -1.118 . . . . 74.41 107.98 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.47 HD11 HD11 ' D' ' 42' ' ' LEU . 0.1 OUTLIER -73.82 126.81 31.23 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.453 -0.943 . . . . 64.13 108.453 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.17 141.52 95.95 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.6 0.76 . . . . 64.45 111.374 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.31 122.8 11.65 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.408 2.072 . . . . 60.22 111.261 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.17 117.9 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.217 -1.031 . . . . 71.42 108.217 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -72.09 84.29 1.0 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.448 0.699 . . . . 72.5 109.686 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 N--CA 1.478 0.968 0 C-N-CA 123.654 0.782 . . . . 74.52 110.903 179.52 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 C--O 1.238 0.476 0 N-CA-C 108.384 -0.969 . . . . 72.43 108.384 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.72 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.2 t80 -123.83 117.69 25.44 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.527 -0.916 . . . . 73.01 108.527 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -141.62 112.67 7.37 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.832 -0.803 . . . . 74.5 108.832 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.662 HG21 ' HG2' ' C' ' 130' ' ' PRO . 66.5 mt -69.91 130.64 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 122.844 0.458 . . . . 73.05 109.986 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -96.47 -38.29 10.08 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.954 -0.546 . . . . 74.5 110.567 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -173.01 123.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.196 0.907 . . . . 73.34 112.686 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.83 133.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.582 -0.896 . . . . 70.55 108.582 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -167.88 158.5 10.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.243 1.017 . . . . 62.34 110.653 -172.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -91.73 115.24 27.89 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.347 -0.842 . . . . 72.05 109.425 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -85.56 -18.87 32.12 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.381 -0.372 . . . . 75.25 110.405 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.5 t70 -155.9 140.84 17.25 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.906 0.882 . . . . 75.14 109.735 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -140.73 135.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.447 1.499 . . . . 64.14 107.301 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 39.6 t -141.45 125.77 17.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.423 -0.955 . . . . 45.3 108.423 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -136.42 110.13 8.08 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.639 -1.245 . . . . 74.42 107.639 171.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.13 120.14 35.35 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.813 0.445 . . . . 55.02 109.945 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.78 80.79 14.45 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 107.633 -1.247 . . . . 34.34 107.633 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.75 -24.74 29.36 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.825 2.35 . . . . 73.53 113.061 -170.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -107.02 12.98 28.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.395 0.678 . . . . 54.23 111.269 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.08 4.24 Favored Pre-proline 0 CA--C 1.565 1.53 0 N-CA-C 114.964 1.468 . . . . 72.42 114.964 -165.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HB3' HD22 ' B' ' 51' ' ' LEU . 26.1 Cg_exo -56.74 -46.51 29.1 Favored 'Trans proline' 0 C--N 1.396 3.037 0 CA-C-N 122.107 1.788 . . . . 64.11 113.045 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -98.7 -6.99 28.54 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.94 0.896 . . . . 72.11 112.911 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.5 p -79.88 -20.18 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.615 -0.678 . . . . 52.22 111.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -86.52 -3.86 59.08 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.446 0.698 . . . . 74.14 112.016 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -100.64 -7.73 23.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.653 0.781 . . . . 73.33 111.0 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -70.29 163.92 25.52 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.738 0.815 . . . . 71.32 112.469 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.39 144.22 51.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.216 1.006 . . . . 64.24 110.049 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -87.24 73.98 9.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.703 0.764 . . . . 74.23 111.404 -169.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -143.41 84.1 10.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 114.614 -1.175 . . . . 74.4 108.066 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.26 136.28 11.29 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.335 2.023 . . . . 43.42 112.131 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -95.13 93.88 7.6 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.765 -1.569 . . . . 62.22 106.765 170.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 34.0 t -92.46 96.51 6.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.983 -1.008 . . . . 52.52 111.061 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.9 tttm -80.47 111.53 16.97 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.1 -0.955 . . . . 73.52 108.938 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 tt -98.74 121.9 41.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.343 -0.984 . . . . 64.22 108.343 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.55 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 24.0 m-20 -116.72 150.32 38.4 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.356 1.062 . . . . 61.43 108.849 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -130.52 133.47 46.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.946 -0.761 . . . . 64.24 108.946 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -132.97 144.14 49.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.076 0.95 . . . . 73.51 108.769 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 p -136.36 136.38 39.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.778 0.831 . . . . 63.11 109.466 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.6 111.03 5.59 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.977 0.511 . . . . 43.41 110.079 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -92.05 152.07 20.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.501 -0.555 . . . . 74.1 109.501 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -151.96 154.98 37.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.435 -1.32 . . . . 73.41 107.435 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -117.46 130.97 56.8 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.962 -0.755 . . . . 73.33 108.962 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -93.45 -40.48 10.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.513 0.725 . . . . 73.45 110.539 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.26 -177.23 6.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.904 0.882 . . . . 54.22 110.077 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.25 123.61 20.41 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.386 -0.598 . . . . 63.52 109.386 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 69.0 -8.1 0.71 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.809 1.643 . . . . 73.11 112.963 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.36 109.77 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.032 -0.729 . . . . 73.32 109.032 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.73 153.53 32.22 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.947 0.899 . . . . 64.53 108.67 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -129.73 118.95 22.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.337 1.055 . . . . 73.54 108.852 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.77 118.92 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.205 -1.035 . . . . 70.01 108.205 174.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 95.3 t -98.28 128.22 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 108.848 -0.797 . . . . 61.44 108.848 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.24 97.92 6.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.401 -1.703 . . . . 73.44 106.401 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 16.8 ttp180 -88.41 109.13 19.76 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.375 -0.602 . . . . 73.55 109.375 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 11.1 t -93.87 130.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.266 -1.383 . . . . 71.12 107.266 171.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -120.87 128.57 52.94 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.73 -0.841 . . . . 75.44 108.73 176.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.831 HG11 HD21 ' A' ' 126' ' ' LEU . 52.9 t -130.73 107.72 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.349 0.66 . . . . 75.3 109.874 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 13.5 m -102.81 141.23 35.97 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.465 -0.939 . . . . 61.44 108.465 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.53 46.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.004 -1.109 . . . . 73.3 108.004 173.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -142.76 127.46 18.1 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.858 0.463 . . . . 74.2 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 73' ' ' ALA . 9.2 mp -95.17 84.93 4.17 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.471 -1.307 . . . . 64.31 107.471 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -127.13 8.29 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.268 -1.333 . . . . 54.34 111.281 -171.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.28 -25.09 22.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 75.24 110.028 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.21 117.53 20.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.277 1.031 . . . . 72.41 110.296 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -66.79 128.4 36.16 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.122 0.889 . . . . 74.43 110.749 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -70.89 -62.91 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.393 -0.966 . . . . 72.13 108.393 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.22 166.07 33.29 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.713 -1.13 . . . . 73.03 110.183 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -132.41 135.8 46.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.163 -1.421 . . . . 71.12 107.163 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.1 m -134.96 101.05 4.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.562 0.745 . . . . 73.12 109.829 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 34.7 tt0 -125.81 116.01 20.91 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.207 -0.664 . . . . 62.0 109.207 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -128.88 111.63 23.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.088 0.955 . . . . 52.51 108.94 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.6 mt-30 -84.39 84.28 7.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.316 -0.994 . . . . 71.13 108.316 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.78 93.33 3.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.784 -1.098 . . . . 71.4 108.391 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.49 145.29 21.06 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.379 -0.828 . . . . 74.13 111.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -146.74 121.46 1.43 Allowed Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 111.188 -0.765 . . . . 63.41 111.188 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.2 mt -82.09 116.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.624 -0.88 . . . . 61.32 108.624 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.72 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.3 m-85 -121.83 121.55 37.44 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.335 1.054 . . . . 63.0 108.32 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -79.72 99.84 7.62 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.603 -0.888 . . . . 72.13 108.603 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.94 121.04 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.061 0.944 . . . . 65.45 109.375 -174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.27 161.53 42.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.387 0.675 . . . . 55.12 110.063 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.33 -29.81 8.47 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.69 0.636 . . . . 53.12 114.69 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.67 170.19 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.423 0.689 . . . . 71.14 109.976 178.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -152.74 172.29 16.92 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 123.553 0.533 . . . . 73.1 110.225 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.41 -116.31 3.49 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.422 1.487 . . . . 55.55 115.544 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 t -57.07 -31.74 65.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.31 1.444 . . . . 51.2 112.445 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -75.42 -39.15 59.28 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.482 0.713 . . . . 70.01 110.437 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mtp -77.4 -21.18 53.54 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.266 0.354 . . . . 75.53 110.617 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.28 -33.45 67.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.124 0.57 . . . . 73.22 109.708 172.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 44.1 t-80 -76.16 -35.15 59.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.199 -0.91 . . . . 65.33 110.204 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -70.25 -47.52 60.95 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 122.234 -0.291 . . . . 74.53 110.226 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.16 -40.48 62.54 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.878 -0.601 . . . . 75.44 110.942 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.69 4.25 59.49 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.239 -0.756 . . . . 43.31 114.781 -168.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.41 -68.51 0.27 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.178 0.989 . . . . 61.04 112.434 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 92.1 t80 -68.84 -51.37 41.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.87 0.868 . . . . 75.12 113.065 -167.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.8 m -73.57 -31.74 1.44 Allowed Pre-proline 0 CA--C 1.563 1.48 0 CA-C-O 118.402 -0.808 . . . . 63.23 113.081 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.4 -42.64 34.24 Favored 'Trans proline' 0 C--N 1.395 3.01 0 C-N-CA 122.594 2.196 . . . . 72.11 112.799 159.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.559 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 91.9 m-20 -64.63 -19.51 65.74 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.646 0.778 . . . . 71.23 112.093 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.1 mm -81.6 -46.43 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.307 -0.627 . . . . 63.11 109.307 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.509 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.3 mt -78.67 -30.56 46.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.049 0.94 . . . . 61.11 113.073 -171.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -69.78 -38.36 9.47 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.005 -0.997 . . . . 72.11 112.6 -169.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -41.93 71.07 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 122.277 1.984 . . . . 64.32 113.543 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -76.53 -32.37 58.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.146 0.578 . . . . 72.52 111.848 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.23 68.44 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.296 -0.631 . . . . 71.1 109.296 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -54.86 -47.19 74.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.651 1.18 . . . . 74.14 110.623 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.38 -47.14 74.33 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.161 0.913 . . . . 63.52 110.809 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -57.6 -43.79 84.95 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.382 0.673 . . . . 75.41 110.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.431 HG23 ' HB3' ' A' ' 76' ' ' CYS . 87.0 mt -64.69 -46.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 O-C-N 124.255 0.972 . . . . 74.32 110.142 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.7 m -52.89 -45.75 67.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.651 0.78 . . . . 61.4 111.28 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -69.37 -44.92 70.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.887 -1.051 . . . . 75.42 110.511 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -55.86 -44.59 78.19 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.654 0.781 . . . . 73.0 111.362 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 123' ' ' PHE . 41.0 t -61.9 -48.25 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.971 1.308 . . . . 74.21 110.59 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 77.9 p -68.02 -32.26 72.52 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.001 0.52 . . . . 63.45 111.628 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.29 -33.82 75.04 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.688 0.795 . . . . 74.04 110.366 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 9.53 66.54 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.462 -0.79 . . . . 61.32 113.308 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.825 HG21 ' HD2' ' B' ' 15' ' ' ARG . 17.9 m 73.2 9.13 5.28 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.388 1.075 . . . . 64.25 112.782 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PHE . . . . . 0.427 ' HB2' HG13 ' A' ' 118' ' ' VAL . 96.1 m-85 -85.47 138.5 36.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 107.762 -1.199 . . . . 74.32 107.762 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.24 160.2 31.87 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.702 2.268 . . . . 75.51 112.622 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.1 tt0 -45.44 121.95 3.27 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 124.795 1.31 . . . . 71.43 112.507 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.831 HD21 HG11 ' A' ' 64' ' ' VAL . 48.8 tp -108.4 115.49 30.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.885 -1.052 . . . . 75.13 108.374 174.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.28 124.15 33.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.641 -1.163 . . . . 62.21 107.977 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.77 138.86 46.72 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.318 -0.623 . . . . 74.41 109.318 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.22 145.61 96.76 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 122.774 0.429 . . . . 61.32 110.359 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.61 ' HD3' HG22 ' C' ' 13' ' ' ILE . 23.8 Cg_exo -64.6 104.74 0.56 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.967 2.445 . . . . 75.14 112.455 -173.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 t -100.12 112.46 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.881 -1.155 . . . . 72.21 107.881 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -85.82 86.23 7.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.207 -1.405 . . . . 75.15 107.207 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 98.6 m-85 -60.71 -29.18 69.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.523 -0.762 . . . . 74.1 110.659 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.639 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.8 t70 . . . . . 0 C--N 1.356 0.87 0 C-N-CA 123.762 0.825 . . . . 41.14 109.377 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 25.3 m . . . . . 0 C--O 1.24 0.578 0 N-CA-C 106.935 -1.505 . . . . 74.04 106.935 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -139.74 130.69 26.22 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.25 -0.648 . . . . 75.12 109.25 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.532 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 2.6 pm0 -148.47 129.82 14.73 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.573 -0.528 . . . . 75.32 109.573 172.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.17 144.33 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 115.565 -0.743 . . . . 51.21 109.16 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -108.49 -47.49 3.49 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.456 -0.572 . . . . 74.43 109.456 169.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.825 ' HD2' HG21 ' A' ' 122' ' ' THR . 34.8 ttp180 -165.79 152.95 10.14 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.784 -0.644 . . . . 64.2 110.98 -170.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -131.73 139.25 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 107.343 -1.355 . . . . 64.41 107.343 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.59 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.6 p90 -161.46 168.69 23.27 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.785 0.803 . . . . 73.02 112.256 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.2 m -93.25 121.21 34.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.473 -1.239 . . . . 73.5 108.763 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.613 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 24.6 mtpp -87.66 -30.46 20.39 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.428 0.691 . . . . 75.25 110.614 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.86 145.6 18.58 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -174.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 28.3 mm -138.81 141.94 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.031 1.732 . . . . 70.04 109.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -150.45 117.4 5.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.181 -1.044 . . . . 71.31 108.181 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -131.81 116.18 16.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.259 -1.385 . . . . 74.11 107.259 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 157.56 27.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.405 0.682 . . . . 74.1 109.694 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -148.88 79.2 8.62 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.333 -1.358 . . . . 75.45 107.333 175.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.58 -9.81 20.09 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.006 2.471 . . . . 61.41 112.602 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.429 ' OD1' ' HB ' ' B' ' 72' ' ' THR . 3.0 m120 -116.63 11.25 14.64 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.214 1.006 . . . . 74.4 109.043 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.66 -54.51 26.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.779 1.232 . . . . 61.24 114.216 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.71 -23.27 14.63 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 121.696 1.597 . . . . 73.21 112.436 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.476 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 3.4 m-70 -90.33 -0.36 57.6 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.833 0.853 . . . . 62.54 112.044 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.95 -28.39 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.66 0.784 . . . . 72.31 111.857 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.0 -23.15 64.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.083 0.953 . . . . 65.31 112.146 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.623 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -70.0 -40.01 75.53 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.746 -0.465 . . . . 71.33 109.746 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.623 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 78.5 mttt -109.73 64.52 0.61 Allowed 'General case' 0 C--N 1.359 1.02 0 N-CA-C 108.434 -0.95 . . . . 73.14 108.434 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 9.4 p-10 -78.61 94.06 4.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.921 -0.581 . . . . 64.32 110.388 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' B' ' 35' ' ' ASP . 0.4 OUTLIER 173.93 -173.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.945 1.298 . . . . 75.13 111.024 159.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -55.08 117.99 16.22 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.037 1.335 . . . . 55.04 112.503 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.49 169.31 22.12 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.742 2.295 . . . . 74.31 111.166 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.55 102.01 3.73 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 106.882 -1.525 . . . . 74.53 106.882 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 m -89.95 140.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.807 -1.088 . . . . 71.44 108.976 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -119.1 130.57 55.66 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.239 -0.652 . . . . 73.54 109.239 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.65 HD21 HD11 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -86.04 136.91 33.05 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.032 -1.47 . . . . 63.45 107.032 168.305 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 18.4 t0 -142.88 128.36 19.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.77 -1.196 . . . . 75.43 107.77 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.471 HD22 ' HE1' ' B' ' 133' ' ' PHE . 1.4 mp -131.38 126.49 35.34 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.093 -1.077 . . . . 73.13 108.093 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.3 t70 -123.3 142.61 50.76 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.49 1.116 . . . . 75.23 108.371 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -117.39 119.26 34.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.088 0.555 . . . . 72.53 110.411 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.32 135.29 33.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.9 0.88 . . . . 64.34 108.912 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -134.62 169.91 16.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.318 0.647 . . . . 74.04 110.054 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -151.97 163.86 38.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.561 0.744 . . . . 70.33 110.232 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -108.58 120.08 41.39 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.812 -0.811 . . . . 71.32 108.812 170.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' B' ' 57' ' ' GLU . 17.6 mt -92.06 -46.03 8.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.847 0.859 . . . . 73.33 109.336 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.93 -178.86 6.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.3 -1.318 . . . . 74.03 108.803 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.52 122.39 18.94 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.956 -1.02 . . . . 73.22 108.825 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 71.59 -4.3 1.92 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.644 1.577 . . . . 73.11 112.699 -173.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.6 t -106.16 107.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.925 -0.769 . . . . 74.44 108.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.43 140.71 50.97 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.182 0.993 . . . . 61.44 109.586 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.597 ' HB2' HD11 ' B' ' 51' ' ' LEU . 40.2 tt0 -102.72 138.48 39.57 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.916 0.886 . . . . 55.11 109.369 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -115.08 122.94 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.309 1.044 . . . . 75.01 108.301 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.94 116.21 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.539 0.736 . . . . 62.3 109.479 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.59 108.44 19.96 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.907 -0.775 . . . . 74.23 108.907 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.534 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 55.0 ttt180 -86.89 106.19 17.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.828 0.851 . . . . 72.14 108.834 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.02 115.72 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.948 -0.76 . . . . 62.04 108.948 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 16.8 m -116.12 136.12 53.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.211 1.004 . . . . 73.1 109.302 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.404 HG11 HD13 ' B' ' 126' ' ' LEU . 54.1 t -120.0 125.03 73.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.811 1.245 . . . . 63.45 109.086 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -124.89 125.9 44.68 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.689 -0.486 . . . . 61.01 109.689 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.88 146.48 48.39 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.309 1.044 . . . . 44.41 109.335 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.2 p -149.16 128.93 13.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.443 0.535 . . . . 72.02 112.443 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' B' ' 34' ' ' LYS . 82.7 mt -97.32 108.4 21.12 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.396 1.079 . . . . 74.12 109.299 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.57 -124.2 7.96 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.002 -0.545 . . . . 72.43 111.784 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.9 1.96 46.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.378 0.671 . . . . 60.24 110.857 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -127.71 177.18 6.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.942 -0.474 . . . . 72.11 110.651 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 72' ' ' THR . . . . . 0.429 ' HB ' ' OD1' ' B' ' 27' ' ' ASN . 11.9 m -68.49 157.46 35.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.534 1.133 . . . . 65.45 110.709 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -111.59 -58.68 2.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.018 -0.734 . . . . 65.54 109.018 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -162.73 158.45 22.98 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.237 -1.347 . . . . 61.2 108.266 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -124.08 138.71 54.4 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.724 1.209 . . . . 74.31 108.589 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -146.88 149.47 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.274 -0.639 . . . . 71.22 109.274 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -165.34 133.76 3.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.535 0.734 . . . . 73.21 109.036 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 113' ' ' CYS . 96.6 t -127.02 145.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.526 1.13 . . . . 64.54 108.704 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.534 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 73.7 mt-30 -126.03 96.89 4.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.258 -1.015 . . . . 70.22 108.258 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -94.42 107.17 19.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.634 -0.712 . . . . 71.24 109.127 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.613 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -109.35 141.59 16.06 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.237 -0.745 . . . . 55.43 111.237 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.71 132.4 5.89 Favored Glycine 0 CA--C 1.503 -0.682 0 N-CA-C 110.35 -1.1 . . . . 73.45 110.35 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.469 HG23 HD12 ' B' ' 51' ' ' LEU . 80.5 mt -85.73 125.95 40.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 123.509 0.724 . . . . 75.44 109.164 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -133.06 160.93 35.75 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.421 1.088 . . . . 74.34 108.629 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.532 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 50.9 m -129.41 112.96 14.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.29 -1.004 . . . . 51.25 108.29 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.725 ' HB ' HD11 ' B' ' 89' ' ' ILE . 40.1 pt -119.31 144.45 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.228 1.011 . . . . 74.04 110.314 -173.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.57 156.65 33.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 72.25 109.092 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.72 -61.11 3.5 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.304 0.377 . . . . 72.34 112.542 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.725 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 133.59 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.524 0.73 . . . . 74.21 111.676 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -152.02 147.51 26.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.073 0.549 . . . . 74.14 110.433 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.42 -104.41 0.98 Allowed Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.468 -0.787 . . . . 53.35 112.506 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -78.58 -35.04 46.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 74.11 110.465 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -64.99 -41.71 95.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.329 0.652 . . . . 63.42 110.021 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 58.4 ttp -70.13 -37.43 75.3 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.813 -0.631 . . . . 73.4 110.66 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.19 75.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.066 0.547 . . . . 72.44 111.258 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.82 -41.8 59.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.504 0.722 . . . . 73.41 110.628 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.83 -65.53 0.73 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.85 -0.614 . . . . 53.35 110.235 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -34.42 78.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.277 1.031 . . . . 65.43 111.305 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.79 54.73 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.568 -0.573 . . . . 51.22 114.509 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.41 -57.84 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 117.824 0.812 . . . . 65.43 112.012 -173.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -61.88 -56.83 15.26 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.991 0.916 . . . . 72.05 112.036 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.422 ' HA ' HD12 ' B' ' 105' ' ' ILE . 61.9 m -62.39 -43.24 84.28 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 124.124 0.969 . . . . 72.53 112.808 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.38 -46.38 33.88 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.536 2.157 . . . . 74.43 112.757 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -61.78 -20.44 63.58 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 123.719 0.808 . . . . 54.11 112.743 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 102' ' ' CYS . 73.3 mt -71.58 -52.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.022 0.529 . . . . 64.31 110.311 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 pp -91.41 -6.18 53.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.554 -0.748 . . . . 63.04 112.166 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.22 -44.36 88.46 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.58 1.152 . . . . 75.35 112.684 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -53.21 -34.82 71.11 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.674 2.25 . . . . 70.04 113.802 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' D' ' 115' ' ' THR . 76.6 m-85 -73.46 -42.57 61.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.16 0.584 . . . . 74.15 110.515 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.31 98.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.132 0.573 . . . . 52.41 110.558 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.427 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 47.8 ttt-85 -57.27 -57.66 11.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.903 1.281 . . . . 72.32 111.089 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.03 -28.07 68.59 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.225 1.01 . . . . 75.45 110.876 -172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.1 t -74.0 -41.51 61.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.623 0.369 . . . . 73.41 110.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.428 HG21 HD22 ' B' ' 126' ' ' LEU . 63.1 mt -62.09 -41.68 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.375 -0.602 . . . . 61.34 109.375 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.592 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.5 m -62.28 -35.99 80.7 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.714 1.206 . . . . 64.52 111.449 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -70.01 -52.77 21.42 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.12 0.568 . . . . 73.21 109.875 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -65.43 -36.97 85.53 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.713 0.633 . . . . 74.14 112.028 -170.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' B' ' 123' ' ' PHE . 10.7 p -69.63 -34.12 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 122.481 0.312 . . . . 73.51 110.651 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -77.05 -21.73 54.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.341 0.656 . . . . 70.23 111.066 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -73.54 -34.65 65.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.13 0.572 . . . . 75.23 109.822 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.71 5.65 45.14 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.706 0.629 . . . . 62.24 112.549 169.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.4 p 59.43 46.83 11.87 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.614 1.965 . . . . 73.54 111.679 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.431 ' HB2' HG22 ' B' ' 118' ' ' VAL . 33.4 m-85 -119.48 157.05 52.64 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 113.898 -1.501 . . . . 75.01 109.781 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.57 143.89 76.73 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.902 2.401 . . . . 74.24 112.178 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.592 ' HB2' HG23 ' B' ' 115' ' ' THR . 24.7 pt20 -63.44 156.68 25.39 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.064 0.852 . . . . 64.54 111.993 -174.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.428 HD22 HG21 ' B' ' 114' ' ' ILE . 9.7 tt -125.23 105.01 8.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.353 -1.351 . . . . 75.32 107.353 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -91.44 115.72 28.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.997 -0.742 . . . . 70.44 108.997 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.65 HD11 HD21 ' B' ' 42' ' ' LEU . 1.1 mm? -67.16 107.56 2.37 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.197 -1.038 . . . . 72.31 108.197 166.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 158.05 54.68 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.127 0.971 . . . . 73.4 111.154 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -61.43 85.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 122.261 1.974 . . . . 74.12 112.153 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.07 110.79 22.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.269 -0.641 . . . . 75.45 109.269 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -82.3 104.22 12.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.256 -1.016 . . . . 73.15 108.256 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 133' ' ' PHE . . . . . 0.471 ' HE1' HD22 ' B' ' 44' ' ' LEU . 87.1 m-85 . . . . . 0 N--CA 1.481 1.11 0 C-N-CA 123.429 0.692 . . . . 74.41 111.306 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.638 ' HA ' HD12 ' C' ' 89' ' ' ILE . 58.0 ttp . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 113.133 0.79 . . . . 74.03 113.133 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 6.6 m -93.77 80.52 4.21 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.588 -0.893 . . . . 62.54 108.588 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -104.45 126.91 51.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.597 -0.729 . . . . 70.12 109.669 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' C' ' 85' ' ' SER . 1.6 pm0 -143.23 132.85 23.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.855 0.862 . . . . 63.23 109.808 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.61 HG22 ' HD3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -79.56 130.28 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.516 0.726 . . . . 61.52 109.213 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.6 mm100 -92.58 -54.2 3.88 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.398 -0.364 . . . . 72.5 110.104 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -169.02 126.84 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.825 0.45 . . . . 72.15 109.961 -173.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.602 HG13 HD11 ' C' ' 13' ' ' ILE . 80.0 mt -106.13 145.0 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.428 -1.323 . . . . 54.14 107.428 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.502 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 36.8 p90 -174.38 143.74 0.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.045 -0.724 . . . . 74.01 109.045 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -69.84 111.35 5.52 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.644 -0.873 . . . . 65.51 108.644 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -65.36 -42.18 93.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.594 0.711 . . . . 71.34 109.506 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -149.06 141.87 24.63 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.433 -1.258 . . . . 73.24 108.951 -176.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.1 mt -130.46 143.43 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.092 -1.447 . . . . 73.22 107.092 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -152.87 151.29 30.22 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.41 0.624 . . . . 70.52 110.897 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 73.1 t80 -152.41 121.19 6.51 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 107.101 -1.444 . . . . 73.15 107.101 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.3 mt-10 -122.85 112.08 17.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.23 80.96 67.18 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.032 -1.099 . . . . 64.12 108.032 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.2 -36.65 16.08 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.169 1.912 . . . . 75.44 111.135 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.461 ' O ' HG23 ' C' ' 31' ' ' VAL . 1.7 m-20 -85.07 14.25 5.24 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.465 1.106 . . . . 73.34 111.174 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.43 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -42.3 -56.99 4.88 Favored Pre-proline 0 N--CA 1.497 1.88 0 C-N-CA 125.773 1.629 . . . . 75.23 114.599 -171.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.4 -29.43 13.74 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.754 1.636 . . . . 74.11 111.997 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -69.76 -24.92 63.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.211 1.004 . . . . 74.53 112.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.567 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 58.4 t -64.4 -26.87 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.246 0.218 . . . . 61.2 111.226 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.02 0.0 12.61 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.875 0.695 . . . . 75.34 112.875 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -127.97 9.17 6.28 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.393 0.677 . . . . 72.24 110.959 170.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.698 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 3.4 ttmp? -87.9 151.92 22.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.335 1.054 . . . . 71.24 111.229 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.36 125.82 26.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.805 1.242 . . . . 73.15 109.617 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -82.78 70.84 9.85 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.277 0.631 . . . . 73.43 110.181 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -163.08 71.38 1.97 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.154 0.581 . . . . 73.02 109.924 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.04 154.14 8.37 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.86 2.374 . . . . 41.15 110.629 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.14 88.08 7.61 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.522 -1.288 . . . . 73.43 107.522 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -59.04 137.34 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 114.4 -1.273 . . . . 73.43 109.948 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 8.8 tmtt? -135.99 115.77 13.04 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.026 0.531 . . . . 70.43 109.771 -166.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.58 130.37 34.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.024 0.929 . . . . 75.21 108.591 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.2 t70 -142.78 106.34 4.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.827 0.451 . . . . 62.4 109.933 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.42 123.02 49.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.463 0.705 . . . . 74.31 110.315 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 2.5 m-20 -111.71 154.29 25.2 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.426 -0.953 . . . . 75.1 108.426 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -113.35 111.69 22.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.672 0.789 . . . . 74.13 109.379 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.21 136.49 53.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.159 0.984 . . . . 62.43 108.914 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.5 p -134.85 156.68 48.48 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.999 0.52 . . . . 73.33 110.283 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.28 126.82 15.08 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.257 1.023 . . . . 61.14 108.376 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -88.25 117.25 27.02 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.105 -1.072 . . . . 73.0 108.105 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.685 HD11 HD12 ' C' ' 83' ' ' ILE . 58.3 mt -87.71 -40.47 14.09 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.502 -0.772 . . . . 72.24 109.521 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.75 -173.01 3.07 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.718 -1.128 . . . . 73.54 110.101 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.56 120.56 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.719 -1.128 . . . . 61.23 109.049 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' C' ' 85' ' ' SER . 7.1 m-20 69.64 1.13 3.25 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.978 1.311 . . . . 63.02 112.831 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -112.01 95.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 107.757 -1.201 . . . . 61.31 107.757 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -119.64 125.59 49.1 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.759 0.824 . . . . 74.13 109.615 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.2 119.43 24.54 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.022 -0.99 . . . . 62.45 109.531 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.11 123.02 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.854 -1.165 . . . . 73.21 107.854 172.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.84 132.76 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.875 0.87 . . . . 63.3 108.699 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.78 112.23 23.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.38 -0.97 . . . . 73.24 108.38 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.672 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 1.6 tmm_? -82.53 104.18 12.61 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.847 -1.538 . . . . 72.44 106.847 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.22 133.22 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.264 -1.013 . . . . 54.42 108.264 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 94.3 m -128.77 133.88 48.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.159 -1.052 . . . . 71.02 108.159 175.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 39.1 t -121.43 112.2 34.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.751 -0.833 . . . . 71.04 108.751 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.532 HG23 HD23 ' C' ' 75' ' ' LEU . 2.2 m -99.74 148.72 24.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.704 -0.85 . . . . 72.52 108.704 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.96 108.43 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.342 -1.355 . . . . 63.53 107.342 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.0 m -146.67 139.85 25.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.06 -0.718 . . . . 73.33 109.06 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.92 45.99 0.94 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.131 0.972 . . . . 64.34 109.228 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.88 -116.61 4.05 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 114.795 -1.093 . . . . 73.31 111.043 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 -19.85 26.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.318 0.647 . . . . 73.31 110.024 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.698 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 12.4 tp10 -81.31 99.84 8.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.178 0.991 . . . . 60.34 109.252 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -87.96 131.25 34.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.984 0.421 . . . . 75.1 110.602 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.653 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -79.0 -64.0 1.29 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.616 1.166 . . . . 71.5 110.385 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -163.34 176.57 9.74 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.586 0.708 . . . . 62.41 110.149 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.532 HD23 HG23 ' C' ' 65' ' ' THR . 2.9 tm? -141.56 139.13 33.1 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.603 -1.628 . . . . 73.22 106.603 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 50.0 t -143.87 116.25 8.54 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.029 -0.73 . . . . 73.25 109.029 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -124.77 131.96 53.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.515 0.726 . . . . 72.0 109.414 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -132.99 115.73 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.233 1.013 . . . . 62.12 109.386 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.672 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 40.4 mt-30 -89.45 91.25 8.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.319 1.048 . . . . 64.22 108.209 172.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -88.79 119.04 28.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.321 -0.854 . . . . 75.2 110.122 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.39 159.3 15.04 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 123.588 0.555 . . . . 64.2 112.26 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.04 119.13 0.88 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.567 -1.013 . . . . 74.12 110.567 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.685 HD12 HD11 ' C' ' 51' ' ' LEU . 18.2 mm -79.78 122.08 34.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.607 -1.257 . . . . 72.52 107.607 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.72 124.79 36.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.548 0.739 . . . . 73.25 109.233 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.676 ' HB3' ' HG2' ' C' ' 12' ' ' GLN . 10.5 t -87.46 109.84 19.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.091 -1.077 . . . . 60.24 108.091 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.417 HD12 ' SD ' ' C' ' 94' ' ' MET . 22.6 pt -115.32 123.24 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.801 1.24 . . . . 73.14 109.205 -175.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -150.75 170.42 19.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.816 0.446 . . . . 72.34 111.726 -171.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.34 -48.34 1.92 Allowed Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.372 -0.831 . . . . 33.12 113.149 170.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.74 176.32 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.401 0.681 . . . . 62.15 110.929 -174.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.48 -171.23 3.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.028 0.931 . . . . 72.32 109.196 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.08 -147.98 47.02 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.527 0.517 . . . . 73.3 113.193 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 73.7 p -67.9 -18.69 64.86 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.007 0.923 . . . . 73.35 111.733 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -66.25 -43.95 85.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.684 0.794 . . . . 71.1 110.278 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.417 ' SD ' HD12 ' C' ' 86' ' ' ILE . 3.5 tmm? -81.32 -44.56 17.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.518 -0.765 . . . . 73.51 109.189 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.8 -25.67 67.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.237 1.015 . . . . 64.04 112.117 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 28.0 t-80 -58.56 -47.16 85.17 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.701 0.8 . . . . 71.14 110.334 171.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.86 -55.07 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.352 -0.386 . . . . 70.24 111.292 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tt -62.09 -35.83 79.87 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.014 0.525 . . . . 71.22 111.462 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.0 -4.86 62.91 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.045 -0.864 . . . . 61.22 114.437 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.35 -53.07 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 118.558 1.179 . . . . 62.15 112.681 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.76 -48.18 60.26 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.973 0.509 . . . . 74.35 112.121 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.28 -43.76 94.29 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.449 0.7 . . . . 72.22 111.988 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.94 -47.37 21.69 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.78 2.32 . . . . 65.43 113.909 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -62.37 -29.12 70.25 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.392 0.677 . . . . 34.24 112.178 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -75.1 -50.84 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.926 0.491 . . . . 62.11 110.252 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.14 -18.41 53.23 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.909 -0.587 . . . . 73.44 112.225 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.52 -54.6 53.27 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.677 -1.154 . . . . 71.31 112.702 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.79 -32.2 92.63 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.939 1.759 . . . . 75.1 112.843 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.402 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.0 m-85 -66.45 -47.32 73.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.541 0.737 . . . . 73.14 110.962 177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.91 84.62 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.122 0.569 . . . . 72.15 110.524 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.595 ' HG3' HD23 ' C' ' 128' ' ' LEU . 56.2 ttt180 -61.1 -49.17 78.4 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.907 1.283 . . . . 74.2 110.943 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.34 -29.99 69.69 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.619 0.574 . . . . 73.14 110.082 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.0 t -73.91 -36.56 64.73 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.182 0.593 . . . . 74.01 111.42 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.595 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 91.7 mt -68.63 -47.85 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.486 0.714 . . . . 74.04 109.754 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 98.7 m -60.45 -35.78 76.67 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.077 1.351 . . . . 71.34 111.306 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -41.68 80.67 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.51 0.724 . . . . 74.21 109.844 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.613 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.37 -35.09 78.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.334 0.654 . . . . 75.23 111.796 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.7 t -62.56 -44.11 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.407 0.683 . . . . 73.31 109.896 173.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.7 p -75.03 -25.78 58.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.549 -0.75 . . . . 51.13 112.223 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.526 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.2 mtt-85 -74.58 -40.17 61.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.69 0.796 . . . . 74.1 110.391 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 3.1 66.13 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.736 0.647 . . . . 64.22 112.56 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.0 p 61.31 24.32 14.44 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.154 1.781 . . . . 54.23 112.533 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -83.88 154.65 64.6 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.739 -1.119 . . . . 74.12 110.118 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -47.71 137.16 21.27 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.483 2.789 . . . . 75.12 113.154 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' B' ' 125' ' ' GLN . 23.7 mm-40 -60.95 147.26 43.91 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.205 1.187 . . . . 63.21 114.205 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 68.3 tp -125.14 96.1 4.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.483 -1.235 . . . . 74.44 108.693 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -100.8 105.1 16.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.489 -0.93 . . . . 74.42 108.489 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.595 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -71.15 151.26 44.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.699 0.8 . . . . 74.42 111.935 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.09 155.61 72.35 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 115.151 -0.931 . . . . 51.13 109.946 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' A' ' 13' ' ' ILE . 34.4 Cg_exo -60.54 102.63 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.375 2.05 . . . . 45.12 111.95 171.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.18 106.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 106.7 -1.592 . . . . 74.42 106.7 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -113.03 91.63 3.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.109 -0.951 . . . . 72.52 109.767 -169.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -64.35 -43.91 93.1 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 72.32 110.878 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t70 . . . . . 0 N--CA 1.47 0.548 0 CA-C-N 115.245 -0.889 . . . . 74.24 111.419 -176.642 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -157.79 98.62 1.65 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.057 -1.46 . . . . 73.0 107.057 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -130.18 128.1 41.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.652 -1.24 . . . . 74.43 107.652 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.421 HD13 HG21 ' D' ' 105' ' ' ILE . 17.5 mt -70.87 136.28 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 123.685 0.616 . . . . 63.42 110.329 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -94.71 -47.54 6.45 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.682 -0.69 . . . . 74.44 110.29 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.04 145.88 22.48 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.3 0.64 . . . . 71.32 110.558 -166.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 mp -133.23 137.02 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 105.033 -2.21 . . . . 75.24 105.033 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -169.22 153.3 5.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.634 0.73 . . . . 74.41 110.691 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -84.4 118.43 24.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.688 -0.856 . . . . 74.2 108.688 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.4 mtpt -80.2 -37.61 32.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 54.52 110.228 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 22.3 t70 -151.1 140.87 21.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.914 -1.039 . . . . 72.43 109.129 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.613 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.1 mt -135.98 145.65 30.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 124.252 1.021 . . . . 73.44 108.25 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 22' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 45.2 t -147.88 133.52 18.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 54.34 108.244 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.4 t80 -144.68 117.58 8.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.849 -1.908 . . . . 71.11 105.849 170.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.14 129.0 51.93 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.294 -0.632 . . . . 71.31 109.294 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.21 79.67 27.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.205 -1.035 . . . . 73.04 108.205 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.86 -28.28 20.15 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.66 2.24 . . . . 62.12 112.743 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -113.71 40.69 2.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.501 -0.925 . . . . 72.43 108.501 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.502 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.97 -65.08 2.22 Favored Pre-proline 0 CA--C 1.568 1.666 0 N-CA-C 114.139 1.163 . . . . 61.12 114.139 -167.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.82 -11.0 11.53 Favored 'Trans proline' 0 C--N 1.393 2.901 0 CA-C-N 122.624 1.973 . . . . 74.3 112.067 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -71.4 -42.9 67.78 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.931 1.292 . . . . 75.14 110.107 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.23 -35.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 N-CA-C 109.504 -0.554 . . . . 74.1 109.504 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -58.05 -12.13 3.12 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.395 1.078 . . . . 74.11 113.55 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.64 -36.55 51.42 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.181 0.593 . . . . 75.45 110.685 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 60.97 1.67 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.861 0.464 . . . . 75.21 111.399 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -98.6 101.23 12.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.675 . . . . 72.03 111.044 -169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -122.59 -158.98 0.81 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.195 0.998 . . . . 64.14 108.671 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -58.24 106.52 0.71 Allowed Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.539 0.736 . . . . 74.3 110.589 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.35 122.21 5.06 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.819 2.346 . . . . 71.52 110.515 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.96 111.28 6.22 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.902 -1.148 . . . . 61.44 107.902 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' D' ' 66' ' ' ALA . 29.3 m -100.9 144.86 12.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.318 0.647 . . . . 63.42 110.081 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -120.05 129.22 54.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 63.24 108.468 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.01 112.11 24.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.506 -0.553 . . . . 75.23 109.506 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.785 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 12.9 m-20 -108.07 132.05 53.96 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.994 0.918 . . . . 75.21 109.912 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -110.8 131.41 55.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.262 0.625 . . . . 73.12 109.434 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.8 t70 -133.55 131.46 39.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.487 -1.301 . . . . 52.41 107.487 172.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -105.52 141.81 36.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.98 0.512 . . . . 42.34 109.883 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.64 164.04 37.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.787 0.835 . . . . 54.12 109.071 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.1 p -174.92 161.04 2.94 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.376 0.67 . . . . 74.32 110.896 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 86.6 p -152.17 145.71 24.91 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.76 0.824 . . . . 73.43 109.474 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -81.92 130.93 35.22 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.284 -0.636 . . . . 64.31 109.284 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' D' ' 57' ' ' GLU . 54.6 mt -104.38 -34.93 8.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.134 0.573 . . . . 65.3 109.511 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.51 -174.88 4.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.159 0.584 . . . . 71.24 111.082 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.34 116.14 7.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.535 -1.211 . . . . 71.32 109.189 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 68.05 7.25 5.7 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.465 1.106 . . . . 64.14 112.126 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 88.1 t -113.51 119.06 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.322 1.049 . . . . 64.55 108.533 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.49 134.2 31.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.705 0.402 . . . . 75.12 110.055 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' D' ' 51' ' ' LEU . 11.0 tt0 -88.22 114.5 24.9 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.857 -1.164 . . . . 72.25 107.857 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.09 120.11 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.617 -1.253 . . . . 44.54 107.617 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.9 t -105.61 131.93 53.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.668 0.787 . . . . 53.33 109.064 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.24 108.15 13.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.497 -1.297 . . . . 74.25 107.497 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.3 ttm-85 -84.11 106.24 15.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.991 -0.744 . . . . 72.15 108.991 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.26 130.49 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.267 -1.012 . . . . 73.22 108.267 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 54.2 m -124.73 147.47 48.62 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.429 0.691 . . . . 72.5 109.15 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -135.95 115.74 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.666 1.186 . . . . 74.24 109.07 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.5 m -106.29 103.63 13.15 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 74.11 109.446 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.431 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -97.18 125.06 41.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.456 0.302 . . . . 62.42 110.386 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 52.2 p -125.55 125.47 43.27 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.001 0.92 . . . . 63.52 109.359 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' D' ' 73' ' ' ALA . 3.2 tm? -104.47 114.05 28.02 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.455 -0.943 . . . . 75.13 108.455 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -111.22 3.84 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.621 0.575 . . . . 34.52 111.998 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 8.38 19.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.12 0.968 . . . . 74.42 110.97 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 175.26 9.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.492 0.717 . . . . 64.44 110.119 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -80.28 137.06 36.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.495 0.718 . . . . 51.1 111.07 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' D' ' 68' ' ' LEU . . . -84.89 -63.97 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.718 -0.845 . . . . 71.03 108.718 170.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.46 168.67 24.75 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.423 -1.262 . . . . 73.21 109.994 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 97.7 mt -132.7 151.62 51.93 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.89 -1.152 . . . . 73.54 107.89 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.633 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -154.9 141.29 18.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.155 0.582 . . . . 71.21 109.939 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 33.3 tt0 -158.14 134.68 9.59 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 71.13 109.995 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.94 126.23 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.746 0.818 . . . . 74.42 109.302 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -97.22 87.22 4.12 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.678 -1.23 . . . . 72.01 107.678 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.89 98.76 8.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.847 -0.615 . . . . 70.12 109.562 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.49 144.36 17.13 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.596 -0.729 . . . . 45.55 111.698 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.49 131.05 3.74 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.314 -0.715 . . . . 71.05 111.314 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -90.33 126.98 43.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.376 -0.972 . . . . 61.24 108.376 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -126.96 144.39 51.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.01 0.924 . . . . 64.2 110.075 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -96.81 94.51 7.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.51 -0.922 . . . . 74.25 108.51 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 mt -108.78 101.06 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.361 -0.607 . . . . 71.35 109.361 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.42 1.088 . . . . 61.34 109.838 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.81 -11.33 59.97 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 114.343 0.497 . . . . 44.53 114.343 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.21 154.46 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.021 0.928 . . . . 70.21 110.781 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 -174.52 4.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.283 1.033 . . . . 75.33 110.043 172.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.54 -140.51 39.01 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 114.282 0.473 . . . . 65.01 114.282 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.9 p -70.84 -32.6 69.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.315 1.046 . . . . 75.12 112.037 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.19 -43.45 78.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.715 0.806 . . . . 70.22 110.649 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -74.06 -32.81 63.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.811 -0.631 . . . . 61.51 110.506 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.37 96.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.943 0.497 . . . . 53.3 110.461 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.09 -36.05 76.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.715 0.806 . . . . 74.4 110.884 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.54 -50.43 67.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.864 0.465 . . . . 75.43 111.498 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.485 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 2.9 pp -75.63 -23.35 56.35 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 111.974 0.361 . . . . 60.44 111.974 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.33 -0.98 56.84 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.53 -0.595 . . . . 72.4 114.361 -172.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.6 -60.69 0.51 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.241 0.52 . . . . 51.42 111.068 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -68.18 -45.71 72.71 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.577 0.751 . . . . 64.25 111.51 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 63.5 m -65.66 -45.76 67.06 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-O 118.695 -0.669 . . . . 72.13 112.018 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 84.0 Cg_exo -54.25 -34.93 81.62 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.665 2.243 . . . . 70.32 113.908 168.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -66.85 -26.43 66.9 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.85 0.46 . . . . 63.14 111.775 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.421 HG21 HD13 ' D' ' 13' ' ' ILE . 32.6 mm -75.71 -47.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.165 0.586 . . . . 74.55 109.775 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.02 -32.23 59.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.154 -0.93 . . . . 53.01 112.609 -169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -62.71 -44.57 86.75 Favored Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 118.177 -0.916 . . . . 65.22 113.042 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.98 -39.02 80.48 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.552 2.168 . . . . 53.24 113.996 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -79.87 -28.31 39.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.156 0.582 . . . . 75.53 111.906 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.21 66.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.798 -0.815 . . . . 65.43 108.798 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -60.84 -35.08 75.63 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.003 1.321 . . . . 71.1 111.396 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.526 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.0 tt0 -56.05 -53.54 55.74 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.021 0.928 . . . . 75.23 110.424 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' D' ' 21' ' ' ILE . 49.8 t -67.25 -42.3 84.14 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.806 -1.088 . . . . 62.1 111.306 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.633 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.7 mt -58.57 -60.05 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.822 0.849 . . . . 50.14 110.486 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.469 HG23 ' HB3' ' D' ' 125' ' ' GLN . 97.6 m -52.51 -43.56 65.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.512 1.125 . . . . 72.31 112.1 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.9 t -68.15 -36.96 80.49 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.501 -0.772 . . . . 73.02 111.014 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 77.7 mtm -67.87 -37.77 82.22 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.662 0.385 . . . . 45.13 111.315 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.9 t -65.41 -41.6 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.324 -0.853 . . . . 73.33 110.337 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 78.3 p -72.28 -30.47 64.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.162 0.585 . . . . 62.41 111.388 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.51 -29.95 65.38 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.927 0.491 . . . . 74.12 110.56 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 6.67 73.66 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.591 0.557 . . . . 45.24 112.456 174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 60.5 25.45 15.08 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 126.591 1.956 . . . . 74.33 113.342 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.18 159.68 31.57 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.575 1.15 . . . . 72.24 108.441 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.76 135.01 29.36 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.473 2.116 . . . . 73.2 111.021 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.469 ' HB3' HG23 ' D' ' 115' ' ' THR . 88.1 mt-30 -49.19 120.03 3.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.381 1.051 . . . . 74.15 110.842 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.02 94.05 5.03 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.501 -0.925 . . . . 73.02 108.501 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -100.65 104.23 15.54 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.207 -1.361 . . . . 73.32 107.946 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.37 143.76 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.863 -0.608 . . . . 62.34 111.459 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -63.46 133.3 95.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 114.968 -1.014 . . . . 63.45 110.757 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 9.7 Cg_endo -80.39 124.61 5.37 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.643 2.229 . . . . 62.12 111.119 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.72 109.36 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.628 -0.879 . . . . 50.14 108.628 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -72.63 96.37 1.98 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.043 -1.095 . . . . 71.24 108.043 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 N--CA 1.478 0.953 0 C-N-CA 123.302 0.641 . . . . 72.34 112.023 -174.418 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.702 -0.851 . . . . 72.44 108.702 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.476 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.1 t80 -137.7 134.42 35.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 73.2 110.139 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -154.54 136.0 14.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.101 -1.409 . . . . 74.3 107.396 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.535 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.0 mt -92.44 130.84 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.322 -0.622 . . . . 65.14 109.322 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -98.1 -41.33 7.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.779 -0.629 . . . . 71.31 110.537 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -177.89 123.5 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 112.926 0.713 . . . . 64.32 112.926 -170.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.592 HD13 ' HG3' ' C' ' 130' ' ' PRO . 4.0 mp -104.61 134.74 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.836 -1.172 . . . . 71.03 107.836 168.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -166.16 152.42 9.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.484 1.113 . . . . 71.31 109.416 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -75.51 118.28 18.2 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.871 -0.788 . . . . 64.23 108.871 172.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -80.56 -24.33 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.65 -0.5 . . . . 72.43 109.65 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -158.91 143.3 15.62 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.1 -0.954 . . . . 74.02 109.8 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.421 HD13 ' SD ' ' B' ' 117' ' ' MET . 86.0 mt -132.33 146.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.914 1.286 . . . . 63.31 107.972 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.89 135.13 15.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.491 0.717 . . . . 73.21 109.516 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.9 t80 -138.06 131.21 30.26 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.686 -1.598 . . . . 73.32 106.686 171.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -133.6 114.21 13.28 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.276 0.63 . . . . 64.1 109.556 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -107.39 83.03 1.37 Allowed Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.496 -1.668 . . . . 21.02 106.496 162.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.58 -31.94 16.04 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 122.605 2.203 . . . . 62.3 112.155 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -113.88 22.9 13.52 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.278 1.031 . . . . 62.41 109.053 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.494 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -43.54 -63.11 1.11 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-O 117.997 -1.002 . . . . 74.13 113.384 -168.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.51 -17.42 59.92 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.024 1.816 . . . . 73.24 113.354 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -85.9 -52.4 5.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.929 0.871 . . . . 64.23 109.995 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -70.52 -21.7 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.034 -1.439 . . . . 52.33 111.941 -160.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -64.42 -30.1 71.15 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.534 0.734 . . . . 74.44 112.22 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.83 -11.58 20.64 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.217 0.607 . . . . 75.21 112.423 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -78.64 171.74 14.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.01 0.524 . . . . 71.21 111.086 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.37 118.22 6.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.052 0.941 . . . . 62.23 110.741 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -79.84 82.37 5.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.573 0.702 . . . . 74.2 110.097 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -126.12 70.28 68.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.419 1.087 . . . . 74.03 108.948 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.74 127.67 8.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.609 2.206 . . . . 54.44 112.045 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -97.97 93.95 6.6 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.854 -1.536 . . . . 42.44 106.854 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.5 m -76.73 106.11 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.617 -1.174 . . . . 75.02 110.578 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 16.7 mtpp -81.73 134.96 35.5 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.959 -1.019 . . . . 74.34 110.402 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tt -110.74 106.45 15.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 106.154 -1.795 . . . . 63.13 106.154 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.3 m-20 -114.16 142.33 46.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.228 -1.397 . . . . 64.42 107.228 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.724 HD21 HD12 ' A' ' 60' ' ' LEU . 5.7 tt -141.46 128.64 20.93 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.948 -1.13 . . . . 74.12 107.948 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -117.15 134.28 54.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.581 1.153 . . . . 74.44 108.678 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.4 p -110.57 123.1 49.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.589 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.93 131.69 37.55 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.683 0.793 . . . . 71.23 110.477 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.55 152.56 51.92 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.035 0.445 . . . . 64.22 110.325 171.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 163.64 39.01 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.952 1.301 . . . . 71.1 108.233 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -112.54 146.56 38.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.206 0.602 . . . . 72.4 109.515 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -117.62 -43.75 2.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.878 0.871 . . . . 63.43 110.361 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.58 -168.52 3.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.204 0.601 . . . . 73.32 110.819 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.43 112.33 3.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.781 0.832 . . . . 71.55 110.346 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.4 0.39 2.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.516 1.527 . . . . 63.23 112.364 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -96.81 107.09 19.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.475 -1.306 . . . . 75.12 107.475 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.471 -0.937 . . . . 71.14 108.471 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -92.07 112.83 24.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.938 0.895 . . . . 70.01 109.396 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.14 111.32 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.619 -1.252 . . . . 65.33 107.619 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 32.1 t -106.7 129.54 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.621 0.768 . . . . 74.04 110.001 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.724 HD12 HD21 ' A' ' 44' ' ' LEU . 4.2 mm? -117.89 110.04 17.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.643 -0.873 . . . . 62.21 108.643 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.527 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 11.0 ttp180 -84.82 107.44 16.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.58 -0.896 . . . . 74.24 108.58 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 16.4 t -92.45 125.34 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 107.807 -1.183 . . . . 75.21 107.807 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.9 m -118.79 136.89 53.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.019 -0.734 . . . . 44.54 109.019 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.783 HG11 HD21 ' A' ' 126' ' ' LEU . 45.4 t -136.78 115.88 15.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 124.44 1.096 . . . . 73.21 108.068 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 7.1 m -105.25 148.02 27.43 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.912 -0.773 . . . . 74.42 108.912 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.23 106.65 7.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.086 -1.45 . . . . 73.21 107.086 168.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 17.9 t -116.8 126.97 53.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.682 -0.488 . . . . 73.22 109.682 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.551 HD22 HG22 ' A' ' 31' ' ' VAL . 7.7 mp -87.56 82.49 7.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 74.01 107.914 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.28 -84.72 0.83 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 114.976 -1.011 . . . . 54.43 111.881 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -111.92 -27.88 8.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.294 1.037 . . . . 71.13 111.686 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.7 125.15 54.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.564 0.346 . . . . 70.04 111.005 -169.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 63.7 m -73.7 129.3 37.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.573 0.749 . . . . 71.3 112.441 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -69.75 -65.64 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.868 -1.06 . . . . 54.33 109.911 169.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.13 167.77 27.46 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.289 -0.869 . . . . 65.1 111.607 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 tp -141.36 116.09 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.354 1.461 . . . . 65.35 107.728 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.6 m -105.66 131.79 52.6 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.332 0.653 . . . . 64.2 109.559 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 32.6 tt0 -146.59 115.38 6.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.58 -0.526 . . . . 64.34 109.58 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.74 114.27 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.97 0.908 . . . . 63.31 109.231 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 48.5 mt-30 -83.88 84.39 7.59 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.265 -1.013 . . . . 75.1 108.265 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.86 98.26 6.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.322 -0.992 . . . . 63.0 108.322 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.89 145.88 21.04 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.202 -0.759 . . . . 72.03 111.202 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.728 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.14 121.79 1.31 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 111.047 -0.821 . . . . 64.54 111.047 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -87.78 123.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 123.87 0.868 . . . . 54.34 108.736 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HD2' HG12 ' A' ' 13' ' ' ILE . 46.9 m-85 -131.71 120.26 22.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 m -77.78 90.91 4.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.551 0.74 . . . . 54.2 109.333 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.496 HG21 ' SG ' ' A' ' 97' ' ' CYS . 1.6 pp -118.69 133.26 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.806 0.842 . . . . 75.12 110.509 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.4 177.15 11.48 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.695 0.798 . . . . 61.4 111.125 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.52 86.68 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.758 0.662 . . . . 71.54 112.298 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.76 136.12 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.497 1.119 . . . . 73.02 109.936 -171.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -131.41 172.07 12.62 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.136 0.974 . . . . 74.51 108.863 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.42 4.59 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 115.001 0.761 . . . . 65.4 115.001 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.2 -18.74 58.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.953 0.901 . . . . 22.43 112.041 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -67.87 -48.88 64.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.176 0.591 . . . . 71.11 110.236 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.2 ttm -80.63 -18.56 47.77 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.592 -0.276 . . . . 64.51 110.454 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -66.38 -33.87 76.69 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.037 0.446 . . . . 73.12 110.428 169.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -68.66 -41.74 78.92 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.874 -0.603 . . . . 75.14 110.26 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 86' ' ' ILE . 47.3 t -64.26 -54.21 36.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.984 0.514 . . . . 72.41 111.959 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 mt -76.26 -35.94 58.69 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.409 0.443 . . . . 65.12 111.719 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.09 4.59 38.58 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 114.858 0.703 . . . . 70.4 114.858 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.6 -52.23 0.23 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.85 0.825 . . . . 43.23 112.436 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.564 ' HA ' ' HB3' ' A' ' 134' ' ' ASP . 66.4 t80 -79.81 -68.92 0.62 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.52 0.728 . . . . 63.55 111.939 -168.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.3 m -68.86 -32.36 3.45 Favored Pre-proline 0 CA--C 1.572 1.826 0 N-CA-C 114.844 1.424 . . . . 54.33 114.844 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 28.8 Cg_endo -61.45 -21.87 73.03 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 122.556 2.17 . . . . 65.13 113.458 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -68.12 -26.12 65.64 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.203 0.601 . . . . 75.23 110.034 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.453 HG21 HD13 ' A' ' 13' ' ' ILE . 39.5 mm -71.2 -36.01 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.477 0.711 . . . . 74.53 109.858 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.728 HD21 ' HA3' ' A' ' 82' ' ' GLY . 97.0 mt -83.48 -30.68 26.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.936 0.894 . . . . 73.54 112.883 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -62.9 -39.79 56.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 113.818 1.044 . . . . 55.21 113.818 -170.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.01 -37.67 51.58 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.387 2.058 . . . . 63.12 113.281 172.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -71.76 -38.62 70.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.14 0.576 . . . . 73.35 111.625 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -45.18 83.42 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.572 -0.529 . . . . 74.33 109.572 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.431 HH22 ' HB3' ' A' ' 130' ' ' PRO . 40.1 ttm180 -53.75 -50.45 65.97 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 124.646 1.216 . . . . 70.05 110.905 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.65 -41.6 75.36 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.204 0.94 . . . . 75.24 111.303 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 44.0 t -56.17 -42.21 76.69 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.576 0.547 . . . . 74.23 110.169 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 118' ' ' VAL . 92.8 mt -66.13 -50.33 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.593 -1.185 . . . . 75.13 110.296 175.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.445 HG23 ' HG3' ' A' ' 125' ' ' GLN . 63.0 m -52.8 -41.93 64.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.301 1.041 . . . . 44.51 111.375 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -69.17 -51.22 40.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.647 -1.161 . . . . 73.4 110.616 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.1 mtp -51.05 -42.91 60.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.026 0.931 . . . . 74.14 111.725 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -64.82 -50.96 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-N 114.376 -1.284 . . . . 72.34 110.718 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 93.2 p -70.38 -22.71 62.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.029 0.532 . . . . 54.12 111.947 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.61 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -75.19 -31.19 60.88 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.796 0.838 . . . . 73.2 110.048 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 -3.26 86.13 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 116.124 -0.489 . . . . 74.34 112.604 171.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.585 ' HB ' HH21 ' B' ' 15' ' ' ARG . 23.3 m 60.05 43.73 14.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.318 1.532 . . . . 65.3 110.133 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -99.53 163.9 17.65 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 113.029 -1.896 . . . . 64.04 108.888 169.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.12 136.46 37.76 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.766 2.311 . . . . 64.53 111.795 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.0 tt0 -48.31 124.37 7.82 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.584 1.177 . . . . 60.02 111.521 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.783 HD21 HG11 ' A' ' 64' ' ' VAL . 12.4 tp -108.13 100.54 9.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.695 0.798 . . . . 65.32 110.484 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.84 97.75 7.22 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.891 -1.152 . . . . 73.14 107.891 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.67 120.89 18.92 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.239 -0.437 . . . . 75.13 110.314 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 133.04 88.87 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.118 0.967 . . . . 72.34 111.934 -173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.431 ' HB3' HH22 ' A' ' 111' ' ' ARG . 18.0 Cg_endo -87.22 166.49 8.08 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.646 2.231 . . . . 74.43 113.351 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.58 142.51 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 106.779 -1.563 . . . . 71.12 106.779 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.45 75.46 6.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.907 -1.146 . . . . 72.54 107.907 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.5 -43.73 89.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.475 1.11 . . . . 74.21 111.843 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 101' ' ' TYR . 5.3 p-10 . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 123.994 0.917 . . . . 74.42 111.806 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 63.1 m . . . . . 0 C--O 1.237 0.422 0 N-CA-C 107.765 -1.198 . . . . 52.2 107.765 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.64 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 19.4 t80 -141.86 118.59 11.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.556 0.742 . . . . 72.02 109.312 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 7.3 pt20 -154.88 130.38 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.743 0.817 . . . . 72.02 109.155 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -81.31 132.53 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.142 0.577 . . . . 62.41 109.825 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -89.24 -48.54 7.31 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.884 -0.413 . . . . 74.24 109.884 168.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.585 HH21 ' HB ' ' A' ' 122' ' ' THR . 58.9 ttt180 -162.95 154.85 18.07 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 111.395 0.146 . . . . 74.22 111.395 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.408 ' HB ' HD21 ' D' ' 127' ' ' ASN . 87.3 mt -137.39 111.37 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.403 1.081 . . . . 75.22 108.083 171.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.406 ' HE1' HG13 ' B' ' 83' ' ' ILE . 24.9 p90 -137.2 147.92 46.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.853 0.461 . . . . 75.13 110.379 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -75.3 119.05 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.742 -0.663 . . . . 61.03 109.744 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -89.92 -23.15 21.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.68 0.792 . . . . 73.32 111.121 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.37 141.64 4.54 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.217 0.323 . . . . 73.5 111.789 -173.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -133.12 146.41 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.195 1.398 . . . . 73.02 109.084 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.0 t -149.08 151.94 35.32 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.881 0.872 . . . . 72.15 109.009 172.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -156.01 122.7 5.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.2 mt-10 -125.12 113.05 17.2 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.031 -0.729 . . . . 71.13 109.031 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.42 84.03 9.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.874 -1.158 . . . . 74.24 107.874 170.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.7 -22.96 17.31 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.661 2.241 . . . . 73.45 111.638 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -113.37 15.31 19.22 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.538 1.135 . . . . 73.1 110.576 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.686 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.68 -58.1 9.29 Favored Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 125.335 1.454 . . . . 62.52 114.607 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.76 -25.63 39.52 Favored 'Trans proline' 0 C--N 1.398 3.154 0 C-N-CA 121.903 1.735 . . . . 70.34 112.712 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.492 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 75.2 m80 -97.99 1.21 47.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.485 0.714 . . . . 73.3 112.876 -174.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.91 -22.66 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.227 0.611 . . . . 73.35 112.521 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -64.95 -30.77 71.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.941 0.897 . . . . 74.33 112.175 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.7 pt20 -65.49 -36.08 82.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 110.101 -0.333 . . . . 63.51 110.101 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.658 ' HB2' HD13 ' B' ' 68' ' ' LEU . 83.3 mttt -108.89 65.63 0.62 Allowed 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.616 0.722 . . . . 74.25 109.169 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -75.28 108.29 7.95 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.116 -0.947 . . . . 64.12 109.643 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.443 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 162.13 -171.69 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 127.61 2.364 . . . . 74.13 108.985 159.517 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -72.3 128.8 88.38 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 122.963 0.164 . . . . 72.42 110.838 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.52 -176.22 3.0 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.673 2.249 . . . . 75.43 111.05 168.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -76.04 106.78 7.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.796 -1.187 . . . . 72.0 107.796 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.13 136.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.079 -1.082 . . . . 74.35 108.079 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -150.98 142.41 23.43 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.279 0.631 . . . . 72.33 109.653 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -85.97 159.72 19.55 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.976 0.893 . . . . 71.1 110.505 171.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 33.7 t70 -140.09 110.46 6.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.448 -2.056 . . . . 64.42 105.448 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.87 134.63 47.66 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.885 -0.783 . . . . 71.43 108.885 -167.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.8 t70 -131.36 139.97 49.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.844 -0.799 . . . . 73.52 108.844 172.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -109.71 124.94 52.09 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.124 0.969 . . . . 72.4 109.605 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.61 43.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.699 0.8 . . . . 75.31 108.893 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -143.19 161.33 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.674 0.389 . . . . 73.14 110.198 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 84.9 p -153.06 150.76 29.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.786 0.834 . . . . 64.22 109.514 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -100.99 114.91 29.26 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.862 -0.792 . . . . 65.43 108.862 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 77.5 mt -77.75 -42.83 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.807 0.443 . . . . 64.23 110.343 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.11 -171.07 2.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.63 -0.714 . . . . 64.53 111.118 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.33 118.53 9.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.438 -1.256 . . . . 53.22 110.091 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.75 -3.94 1.3 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.296 1.438 . . . . 75.41 112.488 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.96 107.11 21.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.462 -0.94 . . . . 65.23 108.462 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.22 156.63 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.401 -0.818 . . . . 64.23 109.136 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.403 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 7.4 tm-20 -133.12 97.26 3.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.214 -1.402 . . . . 75.1 107.214 -167.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.4 128.83 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.341 1.056 . . . . 71.11 109.238 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.33 143.65 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.917 0.887 . . . . 72.03 109.401 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' B' ' 103' ' ' PRO . 58.6 mt -129.32 122.8 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.419 0.687 . . . . 74.12 109.406 170.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.639 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.8 ttm180 -92.19 108.57 20.04 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.469 -0.937 . . . . 71.31 108.469 172.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.12 103.14 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.197 -1.408 . . . . 73.4 107.197 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 10.8 m -104.53 124.43 49.28 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.228 -0.656 . . . . 74.25 109.228 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.565 HG21 HG21 ' B' ' 114' ' ' ILE . 90.8 t -103.09 104.72 17.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.626 0.77 . . . . 63.52 109.124 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.4 m -94.96 136.89 34.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.341 -0.845 . . . . 73.2 109.415 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.62 136.05 24.1 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.586 -0.894 . . . . 73.43 108.586 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.9 p -142.05 130.59 22.58 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.531 0.519 . . . . 55.04 111.532 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' B' ' 34' ' ' LYS . 46.5 mt -92.29 99.34 12.13 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -109.82 2.96 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.473 -0.785 . . . . 52.25 111.742 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.8 4.3 18.3 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.453 1.101 . . . . 65.11 111.564 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.66 170.88 9.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.609 0.764 . . . . 61.1 109.726 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -76.49 152.53 36.07 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.876 0.47 . . . . 63.04 110.903 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.575 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -104.98 -63.28 1.24 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.271 -1.011 . . . . 45.33 108.271 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.94 156.67 22.69 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.13 -1.396 . . . . 64.44 108.253 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 80.0 mt -132.77 148.82 52.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.532 1.133 . . . . 70.4 108.3 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.92 159.63 44.02 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.333 -0.988 . . . . 64.33 108.333 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.4 tt0 -163.34 137.78 6.14 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.671 0.388 . . . . 75.23 110.004 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.406 HG22 HD12 ' B' ' 21' ' ' ILE . 78.5 t -135.97 144.63 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.154 0.981 . . . . 64.45 109.202 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -122.56 105.43 10.11 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.5 -1.296 . . . . 72.41 107.5 169.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.522 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -99.59 108.75 21.23 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 149.94 20.55 Favored Glycine 0 C--O 1.242 0.605 0 N-CA-C 110.914 -0.874 . . . . 61.14 110.914 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.44 123.66 2.03 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.015 -0.834 . . . . 63.42 111.015 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.406 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.3 mt -88.11 126.78 41.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.691 -0.855 . . . . 62.1 108.691 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -135.36 134.38 39.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.483 1.113 . . . . 75.21 108.819 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.466 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 32.7 m -93.92 96.65 9.85 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.75 -0.833 . . . . 72.13 108.75 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -110.7 135.4 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.018 0.927 . . . . 61.43 110.668 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.16 164.47 37.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 74.15 109.296 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.67 -39.02 2.8 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 123.003 0.335 . . . . 70.42 113.776 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 28.9 pt -60.85 145.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.326 1.05 . . . . 73.31 111.587 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -166.28 163.1 17.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.663 0.785 . . . . 75.22 109.891 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.8 -123.19 32.65 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.87 0.732 . . . . 44.34 113.391 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -67.98 -36.21 79.66 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.407 1.083 . . . . 54.21 110.936 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.64 -29.97 67.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.794 -1.094 . . . . 74.31 110.674 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -49.66 60.33 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.358 -0.837 . . . . 75.43 109.632 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.3 73.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.123 0.969 . . . . 72.43 111.85 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -69.7 -34.22 73.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.89 0.876 . . . . 65.12 110.709 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -70.35 -66.88 0.54 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.043 -0.526 . . . . 73.41 111.112 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.548 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.0 OUTLIER -87.9 -14.47 39.27 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.339 0.496 . . . . 62.32 112.339 -169.151 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.401 ' N ' HD13 ' B' ' 98' ' ' LEU . . . -101.23 -4.22 53.66 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.896 -0.391 . . . . 63.01 113.379 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.82 -58.79 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 117.149 0.475 . . . . 63.34 111.66 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -73.41 -44.93 57.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 73.04 111.999 -172.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.64 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 35.2 m -68.01 -43.8 37.46 Favored Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 118.752 -0.642 . . . . 64.25 111.64 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.42 ' HB3' HD11 ' B' ' 60' ' ' LEU . 29.1 Cg_exo -44.94 -53.03 5.61 Favored 'Trans proline' 0 C--N 1.4 3.241 0 C-N-CA 123.038 2.492 . . . . 63.51 113.354 167.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -56.62 -23.65 42.52 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.219 1.008 . . . . 73.03 113.467 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.408 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.7 mt -78.81 -52.57 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.06 0.544 . . . . 72.44 110.929 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -87.38 -7.99 57.1 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -65.28 -45.02 70.61 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.669 1.188 . . . . 45.54 113.186 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.87 -37.66 66.79 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.627 2.218 . . . . 63.33 113.531 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.522 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 44.0 m-85 -68.96 -39.84 79.25 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.243 -0.89 . . . . 74.43 110.393 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.37 -45.49 79.93 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.669 0.388 . . . . 50.3 110.669 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -54.66 -56.13 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.329 1.452 . . . . 74.32 111.699 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.856 0.863 . . . . 75.14 110.791 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.61 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.0 t -66.86 -31.75 72.56 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.0 -0.545 . . . . 70.15 111.385 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.565 HG21 HG21 ' B' ' 64' ' ' VAL . 70.8 mt -67.53 -50.31 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.561 0.744 . . . . 73.04 110.314 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.5 m -61.84 -27.68 68.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 123.945 0.778 . . . . 73.35 111.245 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.14 -50.31 68.71 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.746 0.818 . . . . 64.34 110.295 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -72.49 -34.36 67.61 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.188 0.595 . . . . 62.01 111.653 -171.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.73 -38.55 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.469 0.708 . . . . 65.11 110.029 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t -72.94 -26.19 61.3 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.064 -0.971 . . . . 61.32 111.344 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.4 mtt-85 -73.81 -25.07 59.92 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.143 0.577 . . . . 52.41 110.5 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.24 14.71 32.33 Favored Glycine 0 C--N 1.357 1.697 0 O-C-N 123.541 0.525 . . . . 74.4 112.342 168.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 51.7 p 56.43 47.67 18.41 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.756 2.022 . . . . 63.24 112.612 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.08 151.96 46.17 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.205 -1.361 . . . . 74.12 109.658 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.26 -160.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.957 2.438 . . . . 54.44 113.33 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.648 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.43 125.69 25.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.347 1.059 . . . . 62.43 113.115 -170.548 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 59.5 tp -136.93 95.38 3.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.438 -0.949 . . . . 44.45 108.438 171.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -103.74 135.97 44.3 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.032 0.933 . . . . 73.41 110.547 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.3 tp -83.35 137.33 34.0 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.681 0.792 . . . . 71.5 109.709 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.51 152.82 95.34 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.278 1.031 . . . . 72.21 112.054 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.4 111.28 1.42 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.492 2.795 . . . . 61.41 112.863 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 t -106.6 110.28 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 61.41 109.341 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -97.25 100.25 11.71 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.355 -0.98 . . . . 72.5 108.355 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 123.464 0.706 . . . . 73.14 110.701 -178.782 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.5 ' HA ' HG13 ' C' ' 89' ' ' ILE . 59.6 ttp . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 113.573 0.953 . . . . 71.52 113.573 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 26.6 m -120.5 94.19 4.29 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.689 -1.226 . . . . 32.2 107.689 167.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -97.13 157.25 16.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.133 -0.939 . . . . 74.41 108.902 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -170.92 129.28 0.77 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.533 0.733 . . . . 75.52 110.155 175.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.667 HD13 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -90.88 107.88 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.7 0.8 . . . . 73.42 109.594 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.407 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.2 mm100 -76.52 -52.83 9.02 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.079 -0.388 . . . . 51.32 110.609 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -166.21 128.58 1.92 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.987 -0.375 . . . . 72.4 109.987 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -108.07 146.36 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.849 -1.167 . . . . 70.42 107.849 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.507 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -176.93 163.39 2.2 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.565 0.698 . . . . 73.34 110.912 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -85.08 117.44 24.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.108 -0.951 . . . . 75.24 108.892 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -68.82 -42.93 76.57 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.844 0.831 . . . . 63.11 108.772 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.27 141.18 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.092 -1.413 . . . . 71.41 109.155 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.9 mt -129.21 140.7 48.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.769 -1.567 . . . . 63.41 106.769 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -157.61 145.84 19.1 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.259 0.552 . . . . 51.2 110.611 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -146.45 105.65 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.236 -1.764 . . . . 74.41 106.236 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -114.73 110.19 19.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.069 -1.086 . . . . 74.21 108.069 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -124.55 80.06 61.38 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.342 1.057 . . . . 74.33 108.827 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.92 -4.18 13.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.491 2.127 . . . . 74.32 111.731 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -117.7 18.65 14.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.1 . . . . 72.25 109.617 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.424 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -58.07 -52.3 75.5 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 114.177 1.177 . . . . 63.05 114.177 -170.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.514 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 73.8 Cg_endo -75.92 -31.61 4.97 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.47 1.561 . . . . 71.44 112.009 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.61 -23.69 62.6 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.968 1.307 . . . . 64.34 112.734 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.457 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 9.5 p -79.51 -16.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.837 -0.54 . . . . 61.04 111.576 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' C' ' 29' ' ' PRO . 57.1 m-85 -67.39 -8.37 32.37 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.054 0.542 . . . . 64.33 112.251 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -116.09 25.18 10.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.784 0.834 . . . . 73.32 111.105 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.531 ' HG2' HD13 ' C' ' 68' ' ' LEU . 3.9 tppt? -91.83 172.69 8.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.002 0.521 . . . . 72.11 111.252 -173.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.64 130.31 35.32 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.729 -0.841 . . . . 72.14 108.729 168.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -70.18 85.15 0.55 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.642 1.177 . . . . 74.3 110.334 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -157.44 66.37 3.7 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.91 0.884 . . . . 61.44 108.967 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.34 109.16 2.84 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.667 2.244 . . . . 74.01 112.33 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -85.86 88.76 7.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.753 -1.573 . . . . 74.51 106.753 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.81 134.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.842 -1.072 . . . . 75.41 109.269 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' C' ' 43' ' ' ASP . 29.2 ttpt -114.97 129.18 56.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.141 -1.059 . . . . 74.21 108.141 169.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.47 HD22 HD11 ' C' ' 128' ' ' LEU . 49.4 tp -88.03 141.49 28.53 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.463 -1.31 . . . . 62.43 107.463 166.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.614 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 20.8 t70 -140.54 109.7 6.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.008 0.523 . . . . 61.34 109.692 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -105.64 145.73 30.63 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.245 -0.65 . . . . 71.14 109.245 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -143.29 149.76 38.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.519 1.127 . . . . 71.51 108.993 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.1 p -115.23 140.78 48.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.895 0.878 . . . . 72.11 110.257 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -143.11 151.31 40.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 73.24 109.527 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 24.3 m -141.29 155.96 45.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.937 0.495 . . . . 73.14 111.289 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -149.08 126.6 11.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.332 -0.988 . . . . 52.03 108.332 168.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -81.63 117.48 22.03 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 107.828 -1.175 . . . . 54.33 107.828 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.9 mt -97.07 -25.76 15.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.892 0.477 . . . . 73.12 110.549 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.44 -179.72 6.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.773 0.829 . . . . 73.11 110.119 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -62.67 122.35 15.64 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.937 -0.764 . . . . 75.51 108.937 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.8 21.19 12.64 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 124.447 1.092 . . . . 64.14 111.44 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.69 117.34 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 124.01 0.924 . . . . 62.04 108.63 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.66 130.42 43.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.931 0.892 . . . . 75.04 110.19 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.8 tt0 -82.02 109.28 16.2 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.527 -1.286 . . . . 64.44 107.527 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -96.39 114.12 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.031 -1.47 . . . . 52.43 107.031 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 48.9 t -111.88 131.28 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.455 0.702 . . . . 71.34 109.321 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.54 HD23 HD12 ' C' ' 106' ' ' LEU . 3.6 mm? -117.22 111.31 19.26 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.334 1.054 . . . . 74.14 108.312 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.4 ttm180 -81.99 114.76 20.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.912 -0.773 . . . . 74.12 108.912 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.28 117.03 50.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.854 -1.165 . . . . 73.14 107.854 173.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.0 m -123.74 139.83 53.59 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.417 1.087 . . . . 34.42 108.075 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.7 113.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.136 0.974 . . . . 74.11 108.971 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 45.8 m -98.24 137.09 37.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.278 -0.874 . . . . 74.14 108.658 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.29 112.9 10.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.878 -1.527 . . . . 42.25 106.878 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 48.7 m -145.35 127.6 15.77 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.052 -0.721 . . . . 64.44 109.052 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.531 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.8 mp -90.47 48.78 1.59 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.301 0.572 . . . . 62.33 110.543 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 -117.82 3.21 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.179 -1.168 . . . . 35.31 110.179 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.72 -33.19 16.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.134 0.974 . . . . 63.22 109.267 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.71 121.3 25.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.592 1.157 . . . . 60.53 110.851 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 91.7 m -78.77 137.84 37.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.081 0.952 . . . . 55.2 111.584 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.63 -66.11 0.74 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.106 0.963 . . . . 74.43 109.241 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -159.32 175.87 12.84 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.702 0.763 . . . . 60.54 110.858 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.4 143.36 51.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.982 -1.488 . . . . 73.25 106.982 171.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.44 140.21 41.13 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.659 -1.237 . . . . 74.3 107.659 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -151.46 119.74 6.36 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.373 0.533 . . . . 62.15 110.875 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -117.24 114.14 44.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.512 -0.922 . . . . 72.21 108.512 170.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 25.9 mt-30 -90.25 97.53 11.24 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.615 -1.254 . . . . 74.35 107.615 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -87.14 119.67 27.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.754 0.822 . . . . 64.12 109.806 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.23 148.95 18.28 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 123.188 0.305 . . . . 72.35 112.593 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.7 2.82 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 110.902 -0.879 . . . . 62.2 110.902 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.508 HD12 HD11 ' C' ' 51' ' ' LEU . 16.2 mm -81.26 119.85 31.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -129.41 142.89 50.69 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.418 -0.956 . . . . 72.03 108.418 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -105.98 123.31 47.78 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.124 -1.065 . . . . 73.24 108.124 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.87 100.66 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.914 0.886 . . . . 71.05 108.757 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 169.34 14.22 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.871 1.269 . . . . 75.23 108.818 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.18 -40.94 3.03 Favored Glycine 0 N--CA 1.466 0.7 0 CA-C-N 116.567 -0.288 . . . . 50.22 112.966 174.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.5 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.9 pp -124.86 165.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.041 0.937 . . . . 63.43 110.489 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' C' ' 91' ' ' GLY . 28.4 tt0 -152.97 166.0 33.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.417 0.687 . . . . 74.12 109.985 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 91' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' C' ' 90' ' ' GLU . . . 70.59 -118.44 7.74 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.565 -0.289 . . . . 75.2 113.71 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -77.96 -24.48 48.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.503 0.721 . . . . 55.13 111.194 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -41.01 69.23 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.567 -0.531 . . . . 70.14 109.567 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.406 ' HG2' ' N ' ' C' ' 91' ' ' GLY . 20.0 ptm -76.98 -28.34 55.08 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.12 -0.491 . . . . 64.21 110.755 176.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.2 69.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.149 0.58 . . . . 71.13 110.836 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -70.92 -36.07 72.51 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.656 0.782 . . . . 74.35 110.496 171.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -67.8 -62.13 1.56 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 51.34 110.568 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.57 -12.42 60.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.628 0.603 . . . . 75.11 112.628 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.48 -4.41 57.22 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.58 -0.567 . . . . 72.33 113.917 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.49 -50.87 0.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.761 0.781 . . . . 71.14 111.726 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -75.98 -54.2 7.23 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.293 0.637 . . . . 73.4 111.677 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.61 -42.32 71.78 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 123.766 0.827 . . . . 75.33 113.167 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.59 -30.84 79.66 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 122.209 1.94 . . . . 72.44 112.68 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.14 -33.77 73.97 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.232 0.613 . . . . 75.03 110.743 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -65.87 -50.49 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.055 0.542 . . . . 73.31 110.091 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.54 HD12 HD23 ' C' ' 60' ' ' LEU . 82.3 mt -79.52 -15.55 57.54 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.831 -0.622 . . . . 53.51 112.409 -172.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.438 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 87.8 t80 -56.41 -55.6 40.69 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.284 1.034 . . . . 72.5 113.131 -175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 21.0 Cg_exo -66.24 -29.87 46.43 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.914 1.743 . . . . 42.44 112.828 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.422 ' HE2' HG21 ' A' ' 115' ' ' THR . 86.1 m-85 -65.64 -45.78 81.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.364 0.666 . . . . 73.33 110.881 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.63 91.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.437 0.695 . . . . 75.23 110.651 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -60.92 -57.1 14.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.749 1.22 . . . . 72.04 111.484 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -33.38 75.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.415 0.447 . . . . 75.33 110.008 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.479 ' SG ' HG12 ' C' ' 21' ' ' ILE . 26.1 t -61.2 -43.87 98.19 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.978 0.511 . . . . 53.13 110.565 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -65.15 -43.98 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.177 0.591 . . . . 72.24 110.542 173.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -63.19 -33.15 74.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.441 0.697 . . . . 54.31 111.471 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.2 p -76.78 -41.61 43.95 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.84 -0.8 . . . . 70.24 108.84 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.724 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -54.95 -46.4 75.0 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.89 0.876 . . . . 62.53 112.111 178.043 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.81 -26.89 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.736 0.414 . . . . 72.12 111.126 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -70.88 -29.89 66.11 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.537 0.735 . . . . 72.55 111.416 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.405 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 50.6 mtt-85 -78.68 -33.17 47.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.744 0.818 . . . . 54.1 109.39 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.69 1.53 61.82 Favored Glycine 0 C--N 1.361 1.937 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.881 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 61.74 25.2 15.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.381 1.873 . . . . 40.25 113.069 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -103.4 156.44 35.46 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.35 1.06 . . . . 71.53 110.421 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 32.3 Cg_exo -40.66 118.9 0.67 Allowed 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 124.238 3.292 . . . . 72.51 113.779 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.16 139.55 57.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.54 -0.754 . . . . 71.4 111.743 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.18 105.7 15.86 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.029 -1.1 . . . . 64.01 108.029 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.18 112.66 22.98 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.211 -1.403 . . . . 72.44 107.211 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.47 HD11 HD22 ' C' ' 42' ' ' LEU . 20.4 tp -84.6 141.86 30.37 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 123.597 0.561 . . . . 74.23 110.039 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.35 145.29 63.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.686 -0.688 . . . . 71.24 112.095 -170.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.592 ' HG3' HD13 ' A' ' 16' ' ' ILE . 5.3 Cg_endo -46.8 102.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.977 3.118 . . . . 73.2 112.762 169.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -96.25 106.71 18.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.042 -1.466 . . . . 65.51 107.042 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -98.77 85.68 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.541 -1.281 . . . . 72.01 107.541 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -51.22 -38.3 51.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.342 1.057 . . . . 71.34 111.9 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 124.211 1.004 . . . . 71.55 111.811 -179.597 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 25.7 m . . . . . 0 C--O 1.238 0.486 0 N-CA-C 109.726 -0.472 . . . . 61.42 109.726 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -157.68 116.4 3.19 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.537 -1.283 . . . . 70.12 107.537 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.59 140.52 44.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.876 -1.157 . . . . 51.4 107.876 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.507 HG21 HD11 ' D' ' 16' ' ' ILE . 8.7 mt -97.46 124.77 50.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.017 -0.735 . . . . 60.24 109.017 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.82 -37.54 12.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.485 0.714 . . . . 64.24 110.344 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -161.12 148.34 15.17 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 75.14 110.675 -173.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.507 HD11 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -135.34 114.66 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.302 -2.11 . . . . 74.31 105.302 166.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -151.72 151.53 31.55 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.576 0.703 . . . . 65.44 111.081 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -77.32 109.89 11.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.761 -1.108 . . . . 64.2 109.134 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.514 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 34.9 mtpt -79.28 -33.16 43.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.041 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -141.33 142.2 33.82 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.371 -0.974 . . . . 72.42 108.371 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.724 HD13 ' HE3' ' C' ' 117' ' ' MET . 98.0 mt -133.06 140.91 46.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.574 -1.639 . . . . 75.31 106.574 173.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -146.7 136.47 23.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.605 0.762 . . . . 51.13 109.116 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 57.2 t80 -148.72 123.68 10.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.764 -1.939 . . . . 65.23 105.764 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.12 142.12 51.69 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.431 0.692 . . . . 75.21 109.298 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.66 80.36 66.55 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.913 -1.143 . . . . 64.45 107.913 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.79 -29.97 27.96 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.733 2.289 . . . . 62.22 111.784 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -114.47 40.74 2.47 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.959 1.304 . . . . 73.33 108.775 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.507 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -55.11 -66.41 1.0 Allowed Pre-proline 0 CA--C 1.563 1.453 0 N-CA-C 114.315 1.228 . . . . 74.44 114.315 -166.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -86.21 -3.92 8.66 Favored 'Trans proline' 0 C--N 1.387 2.578 0 CA-C-N 123.074 2.134 . . . . 63.3 112.123 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.25 -39.86 68.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.933 1.293 . . . . 74.33 109.901 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.29 -28.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.337 -0.392 . . . . 75.25 110.1 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.98 -2.33 3.89 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.235 1.198 . . . . 64.04 114.235 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -76.83 -38.18 54.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.145 0.578 . . . . 62.02 109.672 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.491 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -136.3 96.69 3.42 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.373 0.669 . . . . 73.23 112.303 173.011 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -107.13 98.03 7.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 164.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.636 ' H ' HD11 ' D' ' 68' ' ' LEU . 5.6 m-90 -122.31 -162.85 1.03 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.231 -1.766 . . . . 70.34 106.231 169.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -52.52 104.23 0.42 Allowed Pre-proline 0 N--CA 1.486 1.367 0 CA-C-N 118.66 0.664 . . . . 75.02 112.521 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.412 ' O ' HG13 ' D' ' 40' ' ' VAL . 5.9 Cg_exo -75.7 105.07 2.01 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.662 2.241 . . . . 52.12 109.892 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -61.23 111.0 1.56 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.701 -1.222 . . . . 74.44 107.701 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.544 HG11 HD11 ' D' ' 126' ' ' LEU . 2.2 m -104.61 149.42 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.797 -1.092 . . . . 71.14 110.876 -165.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.567 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.7 mmtt -109.17 133.05 53.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.069 0.947 . . . . 73.21 108.511 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -96.9 111.97 23.93 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.568 -1.271 . . . . 74.55 107.568 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.653 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -124.29 141.47 52.04 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.873 0.869 . . . . 72.22 108.79 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.74 167.14 22.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.22 0.533 . . . . 52.4 110.762 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' D' ' 61' ' ' ARG . 4.3 t70 -156.31 145.83 20.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.825 -1.176 . . . . 73.43 107.825 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.5 p -106.59 141.79 37.3 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.019 -0.734 . . . . 70.43 109.019 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.5 159.39 42.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.528 -0.915 . . . . 62.3 108.528 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 20.4 p -170.89 162.08 7.3 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.576 0.35 . . . . 63.43 110.931 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -152.0 152.24 32.2 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.212 0.605 . . . . 60.2 110.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -90.75 117.56 29.48 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.604 -0.887 . . . . 74.04 108.604 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.98 16.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.393 0.677 . . . . 72.41 109.434 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -166.94 177.11 6.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.319 1.048 . . . . 63.32 110.218 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.28 127.06 31.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.998 -1.112 . . . . 72.04 107.998 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 70.85 5.92 5.64 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.445 1.098 . . . . 74.22 111.856 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 86.3 t -125.51 115.22 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.252 1.021 . . . . 74.21 108.277 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -135.92 130.84 34.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.12 0.568 . . . . 72.23 109.553 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -90.26 136.12 33.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 73.0 109.881 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.12 114.55 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.654 1.182 . . . . 74.12 108.26 175.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -101.85 108.89 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.553 0.741 . . . . 64.35 109.339 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.86 111.25 23.57 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.25 -1.019 . . . . 73.22 108.25 175.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' D' ' 45' ' ' ASP . 14.7 ttm180 -83.91 114.34 21.6 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.324 0.65 . . . . 72.41 109.489 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.4 123.69 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.202 -1.036 . . . . 75.21 108.202 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -129.65 135.32 48.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.324 0.65 . . . . 71.33 109.817 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.9 109.27 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.974 0.91 . . . . 72.44 109.574 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 31.3 m -102.46 102.37 12.66 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.08 -0.711 . . . . 73.3 109.08 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.77 129.35 43.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 110.059 -0.348 . . . . 73.25 110.059 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -124.27 124.11 41.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 64.14 109.152 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.636 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.1 OUTLIER -90.9 96.57 10.7 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.512 -1.292 . . . . 74.23 107.512 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.14 -112.99 4.68 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.477 0.485 . . . . 64.14 112.548 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.95 6.43 48.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.306 1.042 . . . . 63.51 111.908 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -146.75 157.2 43.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.667 0.787 . . . . 62.32 109.336 -171.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -66.66 132.47 48.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.973 0.909 . . . . 70.02 111.909 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.08 -64.51 1.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.925 -0.769 . . . . 74.34 108.925 169.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.58 159.26 38.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.432 -1.258 . . . . 74.11 110.004 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.79 146.59 34.75 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 73.12 108.6 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.8 t -152.29 140.84 20.75 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.999 0.52 . . . . 72.32 110.171 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -157.95 145.79 18.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.712 0.805 . . . . 64.51 109.872 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.8 116.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.322 1.049 . . . . 62.14 109.018 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.75 90.58 8.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.847 -0.797 . . . . 75.13 108.847 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -82.4 98.23 8.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.353 -0.84 . . . . 73.13 109.819 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.63 144.68 17.52 Favored Glycine 0 C--N 1.342 0.917 0 N-CA-C 111.602 -0.599 . . . . 53.51 111.602 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.31 130.92 4.15 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 111.142 -0.783 . . . . 71.31 111.142 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.7 123.23 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.525 -0.917 . . . . 72.21 108.525 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.68 126.66 37.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.814 0.846 . . . . 72.02 110.024 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.3 m -76.26 98.01 4.34 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.82 -0.807 . . . . 74.25 108.82 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 63.6 mt -107.81 109.94 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.376 -0.972 . . . . 63.3 108.376 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -151.16 168.33 25.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.108 0.963 . . . . 54.22 110.133 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.52 -20.2 19.63 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.04 -0.527 . . . . 44.01 114.008 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 pt -124.22 162.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.938 0.895 . . . . 73.41 111.178 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 173.67 13.83 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.368 -0.833 . . . . 64.34 111.054 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.83 -118.62 12.39 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 124.156 0.91 . . . . 61.13 114.042 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.7 m -74.54 -31.05 61.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 74.25 111.684 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.52 -43.76 89.06 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.994 0.518 . . . . 75.51 110.987 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -34.91 60.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.012 -0.54 . . . . 61.02 110.363 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.36 -29.35 68.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.136 0.574 . . . . 74.11 111.504 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -71.49 -49.74 38.3 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.614 0.766 . . . . 70.43 109.492 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.73 -39.06 93.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.753 -0.658 . . . . 71.1 111.155 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -78.78 -37.08 41.87 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.499 1.12 . . . . 74.55 111.013 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.33 -23.28 24.79 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.089 -0.505 . . . . 55.0 113.901 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.86 -58.43 2.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.395 0.598 . . . . 54.3 111.635 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.63 -46.29 47.69 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.251 0.463 . . . . 71.31 112.251 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 76.1 m -64.91 -47.27 74.65 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.297 -0.858 . . . . 61.22 112.279 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.2 -34.27 97.49 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.444 2.096 . . . . 71.55 112.998 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.2 -30.11 69.96 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.093 0.957 . . . . 71.54 111.24 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.41 -43.58 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.267 0.627 . . . . 73.31 110.266 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.93 -34.57 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.301 -0.863 . . . . 74.41 112.214 -170.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.71 -42.6 92.24 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 114.372 1.249 . . . . 70.1 114.372 -168.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.65 -42.84 54.44 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.464 2.109 . . . . 74.4 113.858 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -76.5 -27.99 56.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.458 0.703 . . . . 75.33 111.493 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.01 -54.29 36.58 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.983 0.42 . . . . 70.02 109.955 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.408 ' NH2' HG23 ' B' ' 105' ' ' ILE . 40.9 ttp180 -62.51 -34.22 76.44 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.622 -1.172 . . . . 73.12 111.285 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.64 -52.87 58.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.357 1.063 . . . . 53.4 110.84 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.405 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 50.9 t -65.44 -43.68 89.7 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 114.841 -1.072 . . . . 73.42 111.377 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.3 mt -60.58 -56.7 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.752 0.821 . . . . 73.31 110.86 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.449 HG23 ' HB2' ' D' ' 125' ' ' GLN . 97.7 m -51.83 -42.71 62.75 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.32 1.048 . . . . 61.43 111.825 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.6 t -71.05 -28.4 64.35 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.399 -0.819 . . . . 54.24 111.645 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 77.0 mtm -77.99 -36.65 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.832 0.453 . . . . 75.3 111.391 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.499 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.7 t -64.5 -36.6 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.614 0.766 . . . . 73.45 110.752 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 84.9 p -69.71 -31.07 68.88 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.437 0.695 . . . . 62.21 111.322 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 68.8 mtt-85 -74.79 -26.06 59.48 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.559 0.743 . . . . 54.41 110.821 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.32 10.07 62.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.572 0.545 . . . . 65.21 112.538 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p 63.7 23.14 13.39 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.386 1.874 . . . . 74.0 113.287 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.44 163.83 18.94 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.487 1.115 . . . . 71.42 109.438 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.64 155.48 44.68 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.221 1.947 . . . . 55.22 110.555 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.449 ' HB2' HG23 ' D' ' 115' ' ' THR . 16.7 pt20 -55.57 147.27 18.36 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.513 0.725 . . . . 72.13 111.694 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.544 HD11 HG11 ' D' ' 40' ' ' VAL . 3.0 tt -126.39 106.19 9.32 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.059 -0.719 . . . . 74.35 109.059 -175.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.408 HD21 ' HB ' ' B' ' 16' ' ' ILE . 7.6 m-20 -112.52 110.38 20.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.233 1.013 . . . . 70.43 110.577 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.76 125.39 28.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.639 0.776 . . . . 73.53 108.993 171.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 145.54 99.01 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 122.395 0.278 . . . . 50.11 110.719 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.75 134.41 25.83 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.317 2.011 . . . . 71.42 111.378 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -108.89 120.23 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.152 -0.684 . . . . 41.12 109.152 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -86.41 82.42 7.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.395 0.678 . . . . 53.42 109.656 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.483 1.2 0 C-N-CA 124.174 0.99 . . . . 73.12 111.14 177.012 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 107.675 -1.231 . . . . 63.12 107.675 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.564 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.7 t80 -137.59 124.6 21.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.982 0.513 . . . . 73.02 109.984 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -153.38 112.02 3.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.731 -0.84 . . . . 73.13 108.731 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.585 HG12 ' HD2' ' A' ' 84' ' ' PHE . 67.8 mt -73.96 130.31 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.986 0.514 . . . . 72.13 110.418 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -91.55 -32.13 15.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.478 1.111 . . . . 63.24 111.068 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -164.69 140.71 5.86 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.752 0.421 . . . . 74.23 110.764 -172.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.78 123.73 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.935 -1.506 . . . . 70.3 106.935 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.657 ' HB3' HG23 ' B' ' 122' ' ' THR . 3.2 p90 -163.52 149.22 11.38 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.534 0.683 . . . . 71.54 112.703 -173.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.419 HG21 ' SG ' ' A' ' 113' ' ' CYS . 76.7 p -77.61 112.68 14.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.116 -0.947 . . . . 51.02 109.075 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -77.94 -25.97 48.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.362 -0.381 . . . . 63.41 110.522 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.4 t70 -152.42 144.12 23.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.245 0.966 . . . . 75.24 110.301 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -138.08 141.85 37.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 125.635 1.574 . . . . 73.25 107.055 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.32 119.01 4.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.594 0.559 . . . . 74.42 109.807 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 81.2 t80 -111.31 127.18 55.56 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 106.381 -1.711 . . . . 73.35 106.381 167.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.61 108.9 9.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.533 -0.544 . . . . 73.33 109.533 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.92 82.99 1.97 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.841 -1.17 . . . . 65.42 107.841 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.77 -35.84 26.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.006 2.471 . . . . 71.22 112.347 -169.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -116.4 33.8 5.36 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.142 -0.935 . . . . 53.33 108.867 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.66 -61.04 3.95 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.279 -0.867 . . . . 71.11 113.021 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 -0.2 8.18 Favored 'Trans proline' 0 C--N 1.386 2.522 0 CA-C-N 121.765 1.666 . . . . 50.55 113.812 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -99.59 -42.61 6.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.139 0.976 . . . . 75.32 110.916 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.4 p -77.1 -21.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.309 -0.859 . . . . 72.1 111.876 -163.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -76.8 0.57 20.17 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.126 0.57 . . . . 74.2 111.259 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -100.95 -22.57 14.75 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.631 1.173 . . . . 72.5 111.513 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.69 172.73 13.3 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.971 0.908 . . . . 75.22 113.24 -168.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 136.9 51.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.11 0.964 . . . . 71.14 111.249 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -82.17 75.71 9.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.718 0.807 . . . . 75.52 110.478 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.96 69.37 9.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.961 -1.018 . . . . 73.24 110.043 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.06 118.12 5.41 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.029 1.819 . . . . 65.54 111.107 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.72 118.66 31.7 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.601 -1.629 . . . . 74.51 106.601 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 65' ' ' THR . 43.9 t -104.9 116.45 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 122.855 0.462 . . . . 52.02 110.115 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 27.8 ttpp -100.19 123.52 44.52 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.217 1.007 . . . . 72.5 109.694 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.463 1.105 . . . . 75.3 108.204 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -111.65 115.39 29.04 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.466 -0.939 . . . . 62.34 108.466 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 tt -97.9 117.95 33.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.176 -1.416 . . . . 64.14 107.176 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.63 136.24 28.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.624 0.77 . . . . 75.1 109.197 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 m -149.3 150.91 33.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.793 0.437 . . . . 74.33 110.5 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.57 154.7 41.82 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.92 0.888 . . . . 60.35 110.142 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.8 p -120.48 161.59 21.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.848 0.459 . . . . 62.21 110.702 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -156.58 119.17 4.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 63.12 108.249 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -80.95 104.79 11.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.672 -0.862 . . . . 72.11 108.672 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 57' ' ' GLU . 60.1 mt -79.33 -41.95 26.79 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.682 0.793 . . . . 63.13 111.127 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.17 -172.65 4.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.777 0.831 . . . . 74.32 109.978 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -73.62 125.06 27.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.021 -0.733 . . . . 62.21 109.021 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 66.56 5.56 3.91 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.731 1.212 . . . . 61.23 113.15 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 84.2 t -121.94 120.59 61.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.678 0.791 . . . . 74.22 108.904 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.457 ' CE2' HG12 ' A' ' 86' ' ' ILE . 2.0 p90 -133.91 171.04 14.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.499 0.666 . . . . 72.41 110.061 172.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' A' ' 51' ' ' LEU . 34.4 tt0 -121.44 140.42 52.17 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.821 -1.536 . . . . 71.42 108.653 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -123.26 126.7 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 107.154 -1.424 . . . . 74.12 107.154 165.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.9 t -106.65 115.45 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.24 -0.652 . . . . 62.14 109.24 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 100.48 12.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.457 -1.312 . . . . 53.55 107.457 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.479 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 12.4 ttp180 -85.82 106.38 17.01 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.878 -0.786 . . . . 72.14 108.878 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.61 131.46 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.142 -1.429 . . . . 53.15 107.142 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.5 m -127.81 125.58 40.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.575 -0.898 . . . . 54.32 108.575 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.818 HG11 HD21 ' A' ' 126' ' ' LEU . 44.7 t -119.35 115.22 47.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.055 -0.975 . . . . 70.45 108.81 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.8 m -102.14 146.21 28.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.64 -0.874 . . . . 75.11 108.64 172.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.08 132.08 26.15 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.868 -1.16 . . . . 74.45 107.868 172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 m -142.78 128.01 18.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.52 0.513 . . . . 72.33 110.619 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 73' ' ' ALA . 10.3 mp -87.05 84.29 7.33 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.561 -1.274 . . . . 62.33 107.561 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.6 -116.4 4.88 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 114.708 -1.133 . . . . 64.1 111.757 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.26 -16.05 34.21 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.053 0.941 . . . . 71.11 110.823 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -95.27 116.29 28.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.279 1.032 . . . . 73.41 109.963 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.2 m -70.31 132.13 45.21 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.617 0.644 . . . . 74.24 111.05 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.49 -60.94 2.13 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.237 1.015 . . . . 73.33 109.416 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.08 170.17 21.82 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.19 -0.914 . . . . 63.35 111.22 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -141.99 112.42 7.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.196 -1.366 . . . . 63.23 107.368 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 70.7 m -111.93 104.4 12.68 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.469 0.708 . . . . 61.21 111.016 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.7 tt0 -113.4 115.74 28.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.406 1.082 . . . . 72.34 109.636 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.04 115.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.952 0.901 . . . . 73.44 109.399 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.2 mt-30 -84.86 85.62 7.45 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.966 -0.753 . . . . 73.35 108.966 169.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.39 96.2 4.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.515 0.726 . . . . 72.33 109.814 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.66 147.45 22.09 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 111.852 -0.499 . . . . 52.01 111.852 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.19 143.16 12.1 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.661 -0.975 . . . . 61.24 110.661 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -109.24 127.65 65.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.044 -1.095 . . . . 74.32 108.044 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.585 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.8 m-85 -128.72 120.17 25.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.14 -1.059 . . . . 63.44 108.14 -171.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -88.88 110.19 20.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.493 -0.929 . . . . 65.31 108.493 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.61 HD13 HD11 ' A' ' 89' ' ' ILE . 2.5 pp -124.76 162.47 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.089 1.356 . . . . 74.52 109.915 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.78 135.89 1.91 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.326 0.65 . . . . 64.14 109.659 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.97 8.77 27.28 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.218 -0.768 . . . . 65.12 114.076 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 86' ' ' ILE . 2.2 pp -120.91 154.09 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 117.931 0.865 . . . . 64.14 112.044 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.57 170.96 18.87 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.094 -0.957 . . . . 65.21 108.62 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.31 -119.02 9.29 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 115.962 1.145 . . . . 72.1 115.962 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -76.19 -20.29 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.424 0.689 . . . . 60.12 111.818 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.99 -50.35 23.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.098 0.559 . . . . 63.34 110.253 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -64.26 -35.69 81.67 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.504 0.502 . . . . 72.51 109.83 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.37 91.02 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.648 0.779 . . . . 50.25 111.004 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 53.5 t-80 -70.75 -28.93 65.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.3 -0.864 . . . . 70.25 110.75 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 32.6 t -73.43 -37.17 65.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.2 0.524 . . . . 61.34 110.292 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.2 mt -78.59 -36.01 44.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.13 0.972 . . . . 74.43 112.016 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.82 3.96 34.14 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.637 -0.535 . . . . 62.34 114.294 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.14 -63.88 0.25 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.623 0.711 . . . . 65.42 112.818 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.464 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 57.4 t80 -62.84 -61.28 2.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.435 1.094 . . . . 61.12 112.831 -169.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -70.78 -34.89 3.94 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.495 0.924 . . . . 71.31 113.495 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -46.12 -48.37 13.05 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.701 2.267 . . . . 75.34 113.881 162.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.65 -27.89 68.71 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.312 1.045 . . . . 73.42 111.013 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 13' ' ' ILE . 43.5 mm -70.07 -47.69 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.591 0.756 . . . . 73.11 110.593 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.455 HD21 ' HA3' ' A' ' 82' ' ' GLY . 89.4 mt -73.61 -31.25 63.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.335 -0.848 . . . . 50.45 112.177 -171.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.531 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 45.2 t80 -59.13 -44.18 98.22 Favored Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 113.866 1.062 . . . . 54.42 113.866 -170.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.81 -38.64 94.2 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.567 2.178 . . . . 74.21 114.359 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -71.41 -40.13 70.68 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.27 0.628 . . . . 74.45 111.64 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.23 -42.15 93.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.938 0.495 . . . . 75.22 109.951 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -53.39 -55.02 28.41 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 124.583 1.177 . . . . 73.52 110.41 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.55 -41.26 93.22 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.151 0.907 . . . . 75.54 110.662 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.419 ' SG ' HG21 ' A' ' 18' ' ' THR . 47.5 t -58.5 -36.29 73.55 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.104 0.478 . . . . 75.31 111.302 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 118' ' ' VAL . 24.2 mt -72.23 -51.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.963 0.905 . . . . 70.45 109.982 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.536 HG21 ' HE2' ' C' ' 109' ' ' TYR . 97.7 m -53.81 -40.69 66.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.765 1.226 . . . . 64.43 111.346 -173.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -62.29 -48.96 77.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.318 -1.31 . . . . 63.01 109.514 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.0 mtm -64.05 -40.66 96.79 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.563 0.745 . . . . 75.55 111.24 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.2 t -58.33 -48.63 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.058 0.943 . . . . 64.51 110.364 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.4 t -71.45 -28.99 64.34 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.331 -0.85 . . . . 73.32 111.253 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -71.11 -29.1 64.84 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.502 0.721 . . . . 65.22 110.195 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.58 2.79 66.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.65 0.594 . . . . 63.25 112.936 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.402 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 4.2 m 65.86 24.17 11.3 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.211 1.404 . . . . 73.5 110.521 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -94.45 140.54 22.75 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.538 -1.282 . . . . 74.41 107.538 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -44.5 134.46 9.55 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.079 2.519 . . . . 60.45 113.898 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.494 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -46.5 130.79 11.14 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.411 1.084 . . . . 73.15 112.864 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.818 HD21 HG11 ' A' ' 64' ' ' VAL . 23.1 tp -108.11 100.99 10.26 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.541 1.137 . . . . 72.22 109.48 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -101.94 103.2 13.83 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.926 -1.139 . . . . 64.21 107.926 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.531 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -68.18 124.55 23.75 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 108.635 -0.876 . . . . 60.33 108.635 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -60.09 130.7 89.26 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.384 0.674 . . . . 74.03 111.854 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.438 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 3.1 Cg_exo -76.56 146.17 27.01 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.988 2.459 . . . . 61.22 112.351 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.5 t -130.56 131.4 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.833 0.853 . . . . 70.42 109.408 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.09 96.03 2.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.977 -0.749 . . . . 71.13 108.977 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -72.47 -26.55 61.86 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.76 -0.654 . . . . 72.35 111.451 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.43 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.1 m-20 . . . . . 0 N--CA 1.476 0.838 0 C-N-CA 123.106 0.562 . . . . 62.34 110.225 176.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 C--O 1.237 0.401 0 N-CA-C 107.416 -1.327 . . . . 55.52 107.416 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -134.98 113.25 11.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.703 -0.481 . . . . 74.12 109.703 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.26 139.31 33.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.891 . . . . 65.53 108.678 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.428 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -87.46 134.94 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 109.026 -0.731 . . . . 74.32 109.026 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -93.24 -52.64 4.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.255 -0.646 . . . . 74.42 109.255 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.402 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 31.0 ttt180 -155.65 132.78 10.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.955 -0.566 . . . . 75.14 109.86 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.31 136.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.349 -1.723 . . . . 53.14 106.349 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.424 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.6 p90 -166.99 148.55 5.95 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.907 0.384 . . . . 62.24 110.961 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.456 HG21 HD11 ' B' ' 21' ' ' ILE . 94.8 m -77.28 129.21 35.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.964 -0.754 . . . . 71.14 108.964 171.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.413 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.7 mtpt -98.87 -31.13 12.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.641 0.776 . . . . 65.14 110.865 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -154.43 145.73 22.95 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.392 0.433 . . . . 75.43 111.662 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.456 HD11 HG21 ' B' ' 18' ' ' THR . 39.1 mm -137.18 148.18 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.199 1.399 . . . . 73.41 109.03 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.5 m -146.97 140.41 25.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.746 -1.116 . . . . 75.44 109.445 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.6 t80 -147.5 110.34 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 105.825 -1.917 . . . . 72.32 105.825 162.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.26 111.88 15.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.103 -1.073 . . . . 72.53 108.103 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -116.47 87.03 19.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 108.543 -0.91 . . . . 71.2 108.543 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.16 -25.17 19.34 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.443 2.095 . . . . 71.22 111.475 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -103.34 7.8 38.2 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.483 1.113 . . . . 64.42 110.457 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.642 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -40.86 -54.48 5.33 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 115.907 1.817 . . . . 52.41 115.907 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.3 Cg_exo -72.75 -50.25 0.22 Allowed 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.54 2.16 . . . . 50.02 111.955 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.542 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.3 m80 -85.37 5.51 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.724 -1.126 . . . . 74.3 112.133 -173.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.76 -16.72 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.197 0.599 . . . . 74.25 111.904 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -51.34 -32.72 26.53 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.787 0.835 . . . . 72.44 112.206 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.571 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.3 pt20 -73.21 -48.93 30.92 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.269 -0.423 . . . . 71.54 110.858 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.571 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 83.7 mttt -110.82 62.41 0.61 Allowed 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.937 0.875 . . . . 52.01 109.513 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -117.11 118.69 33.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.032 -1.84 . . . . 64.41 106.032 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 169.01 -168.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.64 1.976 . . . . 61.53 106.217 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.58 109.8 1.62 Allowed Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 122.977 0.511 . . . . 72.23 112.193 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HG2' HG13 ' B' ' 40' ' ' VAL . 91.6 Cg_endo -94.69 162.79 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.99 2.46 . . . . 51.31 112.099 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -80.52 103.53 10.44 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.293 -1.373 . . . . 54.44 107.293 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.465 HG13 ' HG2' ' B' ' 38' ' ' PRO . 5.4 m -99.3 143.2 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.149 -0.932 . . . . 35.33 109.576 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.99 132.67 32.61 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.609 -0.886 . . . . 53.45 108.609 -171.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 mt -99.92 123.9 44.66 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.899 -0.778 . . . . 73.45 108.899 173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.4 t70 -126.12 111.73 14.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.902 -0.777 . . . . 73.54 108.902 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 9.9 mp -100.33 131.65 46.14 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.69 -0.687 . . . . 71.11 109.302 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.6 t70 -120.7 125.97 49.01 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.464 -1.31 . . . . 71.13 107.464 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -109.2 103.69 12.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.305 -0.861 . . . . 72.53 109.506 -168.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 130.84 44.13 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.747 0.819 . . . . 65.42 109.159 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 74.9 p -142.45 162.8 34.54 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.962 0.505 . . . . 74.51 110.389 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 p -152.87 137.46 16.86 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.916 0.886 . . . . 74.03 109.346 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.95 122.99 28.48 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.013 0.525 . . . . 71.13 109.764 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.09 -43.2 16.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.058 0.543 . . . . 62.43 110.459 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -169.03 2.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.373 0.669 . . . . 72.3 111.082 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.89 112.32 2.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.488 1.115 . . . . 61.04 110.681 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.06 1.64 2.43 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.278 1.431 . . . . 71.51 112.805 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.1 t -105.26 110.89 32.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.563 -0.903 . . . . 64.43 108.563 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -115.16 160.23 19.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.779 0.832 . . . . 72.03 108.993 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -132.75 106.25 7.64 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.782 -1.562 . . . . 63.51 106.782 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -105.51 122.6 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.372 1.069 . . . . 73.44 109.817 -171.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.69 128.78 62.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.125 0.97 . . . . 71.53 108.846 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -118.7 111.77 18.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.464 -1.31 . . . . 70.31 107.464 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 38.6 ttm180 -87.16 132.51 33.84 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.669 0.788 . . . . 62.34 109.587 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.4 107.16 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.768 -1.197 . . . . 71.14 107.768 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 38.8 m -97.19 137.94 35.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.642 -0.873 . . . . 71.52 108.642 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.511 HG21 HG21 ' B' ' 114' ' ' ILE . 61.2 t -121.86 97.35 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -90.27 137.8 32.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.579 -0.737 . . . . 62.14 109.155 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -143.26 145.94 33.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.362 0.665 . . . . 71.25 109.753 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -159.31 135.97 9.32 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.816 0.698 . . . . 60.3 110.51 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.5 mp -113.45 137.96 50.78 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.558 -0.905 . . . . 75.33 108.558 168.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.1 -127.74 13.21 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.919 -0.473 . . . . 53.2 111.919 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -109.87 6.01 22.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.264 1.025 . . . . 75.43 110.412 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.01 167.12 12.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.559 0.743 . . . . 72.12 111.088 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.2 m -68.91 155.14 40.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.185 0.994 . . . . 75.24 110.542 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.469 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -109.88 -60.54 1.77 Allowed 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 61.41 108.581 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -164.27 156.17 16.41 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.767 -1.106 . . . . 70.32 108.336 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 mt -132.24 108.96 9.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.383 -1.339 . . . . 61.31 107.383 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.75 157.04 26.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.197 -1.038 . . . . 74.55 108.197 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.4 tt0 -164.9 142.49 6.23 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.153 0.581 . . . . 71.42 109.856 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' B' ' 113' ' ' CYS . 69.9 t -132.57 144.51 36.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.79 -1.189 . . . . 75.12 107.79 170.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -123.83 90.83 3.34 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.914 -1.143 . . . . 70.05 107.914 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -84.74 102.02 12.68 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 74.32 108.905 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.39 167.83 34.4 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.368 -0.833 . . . . 71.12 111.608 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.26 126.37 1.43 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.558 -0.353 . . . . 72.22 112.415 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.424 HG13 ' HE1' ' B' ' 17' ' ' TYR . 53.4 mt -85.37 128.09 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.56 -0.904 . . . . 75.25 108.56 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -135.8 135.11 39.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.626 1.171 . . . . 74.1 109.233 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.2 m -91.32 99.96 12.84 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.663 0.785 . . . . 74.13 108.99 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.414 ' HB ' HD11 ' B' ' 89' ' ' ILE . 29.5 pt -121.8 138.69 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.582 0.753 . . . . 74.32 110.439 -176.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.28 169.36 24.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.374 1.07 . . . . 70.24 109.89 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.84 -47.63 3.74 Favored Glycine 0 N--CA 1.478 1.45 0 C-N-CA 123.356 0.503 . . . . 51.12 112.668 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.414 HD11 ' HB ' ' B' ' 86' ' ' ILE . 16.9 pt -64.15 148.37 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.285 1.034 . . . . 74.22 111.73 173.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.588 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 42.6 tt0 -157.73 144.44 17.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.143 0.977 . . . . 72.11 109.909 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.51 -108.88 1.85 Allowed Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.381 -0.677 . . . . 72.5 113.602 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 36.5 m -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.386 0.675 . . . . 72.12 110.948 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.588 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.8 mt-30 -62.97 -45.22 93.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.598 0.759 . . . . 73.2 109.513 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ttt -73.71 -38.77 64.72 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.037 -0.983 . . . . 74.2 110.511 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.58 69.61 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.346 0.658 . . . . 70.3 111.161 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -79.2 -35.8 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.03 0.932 . . . . 63.51 110.124 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.15 -68.4 0.38 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.356 -0.384 . . . . 72.31 110.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.8 -8.27 56.45 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.462 0.541 . . . . 75.44 112.462 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.99 -9.19 46.12 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 114.303 0.481 . . . . 50.43 114.303 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.17 -54.72 0.4 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.49 0.645 . . . . 73.44 110.962 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -68.0 -55.75 11.48 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.879 0.872 . . . . 63.02 111.506 -172.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.59 -44.06 79.82 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.374 1.069 . . . . 55.04 112.286 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -48.75 -53.52 6.79 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.837 2.358 . . . . 72.31 112.601 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.14 -18.89 50.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.966 0.728 . . . . 64.35 112.966 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.404 ' HA ' HH21 ' D' ' 111' ' ' ARG . 71.7 mt -77.26 -57.09 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.189 0.596 . . . . 72.33 110.623 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.33 -4.83 59.29 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.093 0.557 . . . . 74.41 112.234 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.53 -46.74 47.61 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.48 1.112 . . . . 65.0 112.454 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.3 -34.78 94.77 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 121.875 1.717 . . . . 65.51 112.978 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.612 ' HE2' HG21 ' D' ' 115' ' ' THR . 57.2 m-85 -65.25 -52.57 53.63 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.122 0.969 . . . . 75.32 110.752 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.424 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.09 -43.19 91.83 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.501 0.72 . . . . 64.11 110.341 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -56.23 -56.33 22.27 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.926 1.291 . . . . 72.32 111.259 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -38.88 92.49 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.611 0.569 . . . . 74.33 109.602 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.5 t -64.97 -38.94 92.62 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 123.522 0.514 . . . . 73.4 111.719 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.511 HG21 HG21 ' B' ' 64' ' ' VAL . 57.6 mt -65.35 -52.66 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.242 0.617 . . . . 72.15 109.542 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.518 HG22 HE21 ' C' ' 125' ' ' GLN . 23.3 m -61.45 -29.02 69.69 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 115.089 -0.959 . . . . 72.11 111.475 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.9 t -63.14 -49.48 74.2 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.72 0.808 . . . . 65.21 109.326 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -69.96 -34.41 73.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.733 0.813 . . . . 74.44 111.16 -175.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.598 HG21 HD13 ' B' ' 126' ' ' LEU . 80.6 t -64.52 -39.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.669 0.788 . . . . 64.34 110.239 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 16.4 t -71.29 -31.28 67.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.222 0.609 . . . . 63.14 110.83 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.8 mtt-85 -67.87 -22.89 65.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.244 0.618 . . . . 72.31 110.279 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.71 17.98 56.48 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.504 0.502 . . . . 31.42 113.221 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.657 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.0 p 62.96 14.87 7.88 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.559 1.944 . . . . 73.15 113.7 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -92.47 148.7 36.88 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 122.921 0.488 . . . . 71.54 109.887 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' C' ' 125' ' ' GLN . 96.6 Cg_endo -74.21 -159.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.062 2.508 . . . . 34.43 113.059 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.4 122.74 17.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.368 -0.833 . . . . 71.42 113.153 -167.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.598 HD13 HG21 ' B' ' 118' ' ' VAL . 9.4 tt -109.89 127.42 54.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 106.018 -1.845 . . . . 72.11 106.018 166.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 106.67 9.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.313 -0.625 . . . . 64.1 109.313 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.65 107.88 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.005 -1.109 . . . . 75.3 108.005 169.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.39 135.07 88.76 Favored Pre-proline 0 CA--C 1.548 0.896 0 O-C-N 124.075 0.859 . . . . 73.31 110.256 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.28 109.25 0.39 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.278 2.652 . . . . 64.11 112.206 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.17 113.41 26.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.511 -0.922 . . . . 53.1 108.511 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.15 76.93 6.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.695 -0.854 . . . . 75.54 108.695 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 124.215 1.006 . . . . 62.43 111.017 -179.806 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.47 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 51.4 ttp . . . . . 0 CA--C 1.55 0.945 0 N-CA-C 112.773 0.657 . . . . 74.32 112.773 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -91.38 92.87 8.77 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.076 -1.453 . . . . 75.23 107.076 166.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 72.6 t80 -108.57 154.35 22.08 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.884 -1.053 . . . . 72.35 109.67 -175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -163.54 139.59 6.75 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.308 1.043 . . . . 74.41 109.017 173.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pp -80.89 141.32 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.447 0.699 . . . . 74.34 109.369 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -109.83 -51.25 2.89 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.777 0.431 . . . . 74.43 110.009 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -172.43 123.82 0.47 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.471 0.482 . . . . 74.32 109.846 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -109.01 136.02 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.012 -1.107 . . . . 64.51 108.012 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.509 ' HE1' HG12 ' C' ' 83' ' ' ILE . 19.5 p90 -168.68 162.92 11.99 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.861 0.839 . . . . 72.43 112.432 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.6 p -86.38 103.75 15.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.375 -1.284 . . . . 73.12 108.662 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -67.8 -35.21 78.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.64 0.733 . . . . 74.41 109.981 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.72 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.9 t70 -148.21 139.48 23.43 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.473 -1.24 . . . . 70.4 109.095 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.2 mt -133.55 141.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.077 -1.453 . . . . 45.13 107.077 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -152.87 146.34 24.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.411 -0.588 . . . . 72.13 109.411 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.95 113.63 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.131 -1.433 . . . . 72.33 107.131 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.48 111.26 20.49 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.297 -1.001 . . . . 64.33 108.297 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.75 80.21 55.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.356 1.063 . . . . 63.4 108.262 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.39 -16.78 24.44 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.172 1.915 . . . . 75.44 109.898 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.96 11.86 25.91 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.231 1.412 . . . . 52.01 110.041 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.55 97.72 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.028 1.122 . . . . 71.34 114.028 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.28 -36.15 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 121.404 1.402 . . . . 62.51 113.032 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -67.67 -25.68 65.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.884 1.274 . . . . 72.03 112.869 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.461 HG11 ' HE1' ' C' ' 123' ' ' PHE . 14.4 p -62.31 -27.13 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.455 1.102 . . . . 73.14 111.853 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.502 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 30.0 t80 -65.9 -26.76 67.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.588 -0.733 . . . . 72.43 111.96 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -99.0 6.12 46.84 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.455 0.539 . . . . 71.02 112.455 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -99.7 173.11 6.86 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.467 0.576 . . . . 75.23 110.054 175.543 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.26 123.38 25.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.455 -0.943 . . . . 70.05 108.455 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.502 ' HZ2' ' HA ' ' C' ' 32' ' ' PHE . 59.4 m95 -85.37 69.76 10.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.186 0.595 . . . . 72.21 110.683 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -163.17 60.1 0.91 Allowed Pre-proline 0 CA--C 1.56 1.344 0 CA-C-N 115.087 -0.96 . . . . 75.35 109.003 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.12 158.98 37.62 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.034 2.489 . . . . 63.33 111.61 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.43 88.84 6.58 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 106.664 -1.606 . . . . 75.55 106.664 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.93 102.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 113.61 -1.632 . . . . 74.33 109.749 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.1 110.82 22.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.553 -1.203 . . . . 74.22 108.537 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.15 130.57 34.58 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.366 -1.346 . . . . 60.13 107.366 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.9 t70 -119.36 103.81 9.81 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.882 1.273 . . . . 65.44 107.78 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 23.5 tp -100.16 112.53 24.84 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.348 -0.982 . . . . 63.53 108.348 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -114.67 139.62 49.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.763 1.225 . . . . 51.41 108.921 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -114.53 145.62 41.71 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.436 0.694 . . . . 55.21 110.361 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 150.5 29.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.607 0.763 . . . . 73.21 109.739 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.8 m -155.78 155.24 32.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.249 0.62 . . . . 74.01 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.3 p -148.85 140.42 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.53 0.732 . . . . 73.45 109.918 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.47 115.41 22.06 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.211 -1.033 . . . . 72.25 108.211 170.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.534 HD11 HD12 ' C' ' 83' ' ' ILE . 74.6 mt -88.88 -39.01 14.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.516 0.726 . . . . 63.22 110.343 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.08 -168.79 2.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.017 -0.992 . . . . 64.44 110.348 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.98 100.55 0.16 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.356 1.063 . . . . 52.02 110.654 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 66.94 10.69 7.85 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.497 1.519 . . . . 75.42 113.234 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -94.27 114.13 30.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.866 -1.161 . . . . 63.52 107.866 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.403 ' HB2' HD13 ' C' ' 86' ' ' ILE . 75.6 m-85 -123.23 124.23 42.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.108 0.963 . . . . 74.11 109.057 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.489 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.67 120.52 26.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.326 -0.852 . . . . 75.43 109.34 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -97.65 114.12 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.135 -1.061 . . . . 62.45 108.135 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.6 134.55 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.28 -1.007 . . . . 73.33 108.28 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -128.9 102.81 6.7 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.905 -1.146 . . . . 52.31 107.905 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.519 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 23.8 ttt180 -82.69 108.21 15.89 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.525 -0.761 . . . . 74.24 109.279 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.4 t -100.08 121.77 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 107.477 -1.305 . . . . 74.25 107.477 172.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.4 m -127.31 117.47 22.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.648 -0.871 . . . . 72.4 108.648 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.1 110.28 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.699 -0.852 . . . . 70.32 108.699 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.4 m -99.83 144.04 29.35 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.666 -0.865 . . . . 52.05 108.666 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.56 130.46 44.11 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.752 -1.203 . . . . 63.23 107.752 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.1 m -147.88 130.44 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.03 0.443 . . . . 74.23 110.965 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.07 58.1 4.86 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.016 1.326 . . . . 74.14 107.476 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.23 -118.0 5.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 114.732 -1.122 . . . . 51.02 110.567 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.06 -28.67 18.87 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.449 0.7 . . . . 54.31 109.308 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.68 102.63 0.76 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.939 0.896 . . . . 65.51 109.666 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -72.92 144.43 47.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.239 0.616 . . . . 74.22 111.021 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.65 -56.27 2.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.507 1.123 . . . . 63.22 109.455 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -158.03 172.01 19.21 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.99 -0.55 . . . . 74.54 110.923 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.442 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -136.37 146.16 46.2 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 106.9 -1.518 . . . . 74.51 106.9 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.442 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.76 113.58 4.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.13 0.572 . . . . 73.34 109.789 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -117.34 117.51 29.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.653 0.781 . . . . 74.24 110.04 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -121.84 122.24 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.504 -0.554 . . . . 71.4 109.504 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.72 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.8 mt-30 -99.04 91.34 4.97 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.043 -1.095 . . . . 73.44 108.043 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -83.14 104.86 13.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.235 -0.893 . . . . 63.33 110.062 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 146.6 18.3 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.108 -0.497 . . . . 74.14 112.015 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.05 116.85 1.11 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.07 -1.212 . . . . 32.14 110.07 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.534 HD12 HD11 ' C' ' 51' ' ' LEU . 15.5 mm -81.46 122.33 36.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.449 -0.945 . . . . 74.43 108.449 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -138.51 148.68 44.57 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.35 -0.981 . . . . 71.43 108.35 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.1 p -110.17 119.02 37.93 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.458 -0.941 . . . . 51.13 108.458 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' C' ' 56' ' ' TYR . 4.1 mp -114.88 120.68 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.267 -1.012 . . . . 73.1 108.267 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.47 165.02 30.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.132 0.973 . . . . 73.1 109.565 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.08 -46.68 1.14 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.965 -0.561 . . . . 63.43 112.242 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.502 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -121.81 171.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.24 0.616 . . . . 72.1 111.253 -177.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.74 -173.03 4.11 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.019 -0.991 . . . . 74.45 109.425 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.78 -139.72 39.3 Favored Glycine 0 C--N 1.344 1.011 0 O-C-N 123.529 0.518 . . . . 64.32 114.159 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -70.56 -21.72 62.66 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.117 0.967 . . . . 73.02 112.038 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -71.48 -38.01 71.25 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.537 0.735 . . . . 75.32 110.388 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.408 ' SD ' HD12 ' C' ' 98' ' ' LEU . 9.8 tmm? -71.99 -41.08 68.05 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.018 -0.734 . . . . 70.25 109.018 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.65 69.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.569 0.747 . . . . 51.52 111.262 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -70.64 -34.18 71.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.504 0.722 . . . . 74.21 110.491 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.47 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 40.6 t -68.21 -64.66 0.82 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.444 0.465 . . . . 53.2 110.398 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.408 HD12 ' SD ' ' C' ' 94' ' ' MET . 0.0 OUTLIER -84.04 -12.69 54.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.047 -0.408 . . . . 73.31 112.093 -172.411 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 -7.84 46.32 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 114.706 0.642 . . . . 73.5 114.706 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.33 -55.93 0.48 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.395 0.598 . . . . 75.22 110.847 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.438 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 81.0 t80 -69.12 -56.54 7.36 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.907 0.883 . . . . 71.15 111.822 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.76 -44.97 74.99 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.59 1.156 . . . . 72.42 112.951 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.94 -34.37 81.48 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 121.758 1.639 . . . . 75.21 111.995 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -28.5 67.28 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.317 0.647 . . . . 64.15 111.695 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 33.3 mm -66.24 -53.52 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.978 -0.378 . . . . 74.11 109.978 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -87.21 -8.35 56.95 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.412 0.523 . . . . 71.22 112.412 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.13 -50.09 89.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 124.21 1.004 . . . . 75.02 113.416 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.87 -25.74 74.47 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 121.489 1.459 . . . . 70.52 113.121 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.536 ' HE2' HG21 ' A' ' 115' ' ' THR . 70.1 m-85 -69.51 -46.07 67.4 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.285 0.634 . . . . 42.32 110.232 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.4 89.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.603 0.761 . . . . 73.4 110.396 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.521 ' HG3' HD23 ' C' ' 128' ' ' LEU . 39.5 ttt180 -58.38 -55.68 31.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 113.945 -1.48 . . . . 73.13 111.157 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.451 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -67.81 -27.46 66.75 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.979 0.512 . . . . 54.13 110.328 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.0 t -71.5 -36.57 71.15 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.744 0.418 . . . . 51.43 111.407 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.417 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.5 mt -72.67 -48.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.454 0.701 . . . . 74.35 110.025 174.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 49.1 m -60.92 -33.71 73.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.09 0.956 . . . . 74.53 111.36 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -62.2 -47.73 83.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.791 -0.64 . . . . 73.24 109.444 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.493 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.28 -37.5 87.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.709 1.203 . . . . 62.11 112.226 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.33 -42.21 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.181 0.592 . . . . 74.1 109.407 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.3 t -69.05 -28.99 67.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.641 0.777 . . . . 74.25 111.711 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -76.03 -28.8 57.84 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.694 0.797 . . . . 71.52 110.468 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.52 4.63 81.18 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.525 0.516 . . . . 74.31 112.433 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 20.8 p 62.38 33.04 16.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.044 1.738 . . . . 72.24 111.961 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' C' ' 31' ' ' VAL . 24.8 m-85 -102.17 154.05 37.64 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 115.004 -0.998 . . . . 64.35 110.608 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 75.4 Cg_exo -53.7 132.18 47.88 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.263 2.642 . . . . 71.12 112.949 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.536 ' HB2' ' HA ' ' B' ' 124' ' ' PRO . 14.6 mm-40 -59.63 142.74 52.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.026 0.829 . . . . 70.34 112.461 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -126.82 126.32 43.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.744 0.818 . . . . 74.44 108.863 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.43 127.28 48.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.206 1.003 . . . . 61.35 109.128 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.521 HD23 ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -80.48 141.36 35.28 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.697 0.623 . . . . 74.12 110.159 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.34 158.96 57.15 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 124.856 1.262 . . . . 63.14 111.183 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.34 107.45 2.46 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.102 2.535 . . . . 71.11 111.532 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.9 t -98.44 107.48 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.54 -0.911 . . . . 72.02 108.54 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -113.73 99.24 7.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.588 1.155 . . . . 75.02 108.83 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.51 -42.99 99.88 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.794 0.838 . . . . 74.25 111.337 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.478 0.927 0 CA-C-N 114.865 -1.061 . . . . 74.14 111.714 -179.273 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m . . . . . 0 C--O 1.239 0.505 0 N-CA-C 108.898 -0.779 . . . . 75.42 108.898 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -163.03 104.48 1.01 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.387 -1.338 . . . . 71.41 107.387 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -127.48 140.95 51.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.394 -0.965 . . . . 71.43 108.394 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.25 133.21 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.147 -1.057 . . . . 75.22 108.147 171.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -89.21 -39.6 13.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.345 0.403 . . . . 74.53 110.384 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 176.07 150.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.336 1.054 . . . . 72.25 110.6 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.26 134.45 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.444 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.0 p90 -147.73 162.53 39.0 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.267 1.027 . . . . 73.2 110.347 -176.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.43 HG21 HD11 ' D' ' 21' ' ' ILE . 75.6 p -95.44 119.68 34.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.764 -1.107 . . . . 71.42 109.52 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -90.56 -27.44 19.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.781 0.432 . . . . 72.31 110.585 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -154.76 140.27 17.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.087 -0.961 . . . . 74.11 108.696 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' C' ' 117' ' ' MET . 71.9 mt -137.95 143.05 34.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.081 -1.081 . . . . 74.31 108.081 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -148.07 123.36 10.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.142 0.977 . . . . 73.53 109.293 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.444 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -131.3 120.72 23.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.103 -1.814 . . . . 70.23 106.103 170.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.9 mt-10 -123.06 144.55 49.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.67 -0.492 . . . . 60.33 109.67 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.62 76.54 47.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 106.27 -1.752 . . . . 74.25 106.27 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.63 -25.26 24.78 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.695 2.263 . . . . 65.22 112.541 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -112.73 25.77 11.14 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.157 0.983 . . . . 65.43 109.169 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.501 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -49.02 -62.18 2.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 114.453 1.279 . . . . 72.44 114.453 -166.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.497 ' HB3' HD11 ' C' ' 83' ' ' ILE . 37.7 Cg_endo -83.14 -8.91 10.74 Favored 'Trans proline' 0 C--N 1.373 1.841 0 CA-C-N 122.358 1.878 . . . . 73.14 113.245 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -78.73 -36.78 42.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.67 1.188 . . . . 73.42 109.67 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.604 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.0 p -80.31 -21.66 11.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 CA-C-N 116.057 -0.52 . . . . 42.45 109.729 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -66.07 -6.51 13.27 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.427 0.899 . . . . 73.11 113.427 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -78.49 -36.22 45.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 74.33 109.541 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -131.38 61.36 1.64 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.122 0.969 . . . . 63.54 110.438 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -108.44 82.77 1.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.376 -0.828 . . . . 75.43 110.065 -172.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.605 ' H ' HD22 ' D' ' 68' ' ' LEU . 8.2 m95 -124.14 -159.71 0.88 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.987 -1.116 . . . . 73.31 107.987 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 37' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 45.8 tt0 -59.91 109.62 2.13 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.512 0.725 . . . . 74.25 111.763 -171.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 3.4 Cg_endo -84.76 150.87 11.33 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.093 2.528 . . . . 73.32 113.522 -175.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -73.73 120.46 19.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.093 -0.958 . . . . 71.24 109.253 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.36 129.05 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 124.104 0.962 . . . . 72.45 110.896 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -130.62 117.75 19.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.238 1.015 . . . . 73.12 110.113 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.732 HD12 HD12 ' D' ' 128' ' ' LEU . 8.8 tt -98.15 137.97 36.12 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.103 -0.703 . . . . 73.13 109.103 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.64 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.0 m-20 -127.68 147.34 50.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.189 0.996 . . . . 75.21 108.845 172.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.83 150.76 39.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.346 0.659 . . . . 73.32 109.614 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 14.5 t70 -149.56 125.25 10.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.487 1.115 . . . . 74.52 108.108 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -104.21 144.27 31.82 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.431 0.692 . . . . 75.2 110.638 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.35 156.94 31.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.936 0.894 . . . . 33.23 109.332 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -168.61 154.31 6.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.328 0.651 . . . . 72.13 110.292 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -155.63 136.24 13.37 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.635 0.774 . . . . 54.43 109.357 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -74.32 122.94 23.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.529 -0.545 . . . . 65.32 109.529 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.2 mt -90.58 -37.94 13.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.033 0.533 . . . . 73.13 110.58 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.17 -176.35 5.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.381 0.673 . . . . 70.44 111.023 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.11 119.21 7.4 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.932 -1.031 . . . . 50.43 110.365 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.87 19.18 10.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.343 1.057 . . . . 73.34 112.058 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.17 126.62 75.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.086 0.954 . . . . 72.45 109.076 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -132.85 129.93 39.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.008 -1.108 . . . . 72.11 108.008 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.1 tt0 -91.12 119.42 31.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.567 -0.901 . . . . 54.5 108.567 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.96 129.35 52.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.935 -1.135 . . . . 75.32 107.935 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.482 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.4 t -116.84 128.34 74.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.157 -1.053 . . . . 74.14 108.157 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -126.54 105.91 9.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.307 -1.368 . . . . 72.13 107.307 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.4 ttm180 -84.17 123.25 29.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.573 -0.74 . . . . 74.53 109.4 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -112.07 137.12 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.45 -0.944 . . . . 63.02 108.45 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.64 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.9 m -126.55 138.89 53.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.373 0.669 . . . . 72.01 109.515 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.561 HG11 ' HG ' ' D' ' 126' ' ' LEU . 75.5 t -127.72 108.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.244 1.018 . . . . 51.25 109.445 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.5 m -99.92 124.53 45.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.709 0.804 . . . . 74.32 109.013 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 126.69 54.45 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.485 0.714 . . . . 70.4 110.127 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 33.9 p -140.79 121.11 13.95 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 109.313 -0.625 . . . . 55.22 109.313 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.605 HD22 ' H ' ' D' ' 36' ' ' TRP . 1.0 OUTLIER -98.95 135.25 40.63 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.706 0.803 . . . . 63.3 110.104 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.35 -111.44 4.16 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.43 -0.668 . . . . 71.13 111.43 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.14 18.26 9.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.336 1.054 . . . . 61.21 109.961 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -124.15 143.75 50.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.839 1.256 . . . . 72.13 109.973 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -76.89 121.98 24.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.951 0.5 . . . . 63.35 110.979 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.604 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.39 -65.49 0.95 Allowed 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.395 0.678 . . . . 74.53 109.608 175.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.53 164.25 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.391 -1.277 . . . . 70.04 110.549 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 67.2 mt -126.47 142.54 51.5 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.245 -1.391 . . . . 73.02 107.245 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.2 t -147.87 139.06 23.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.33 -0.618 . . . . 71.53 109.33 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -157.74 139.86 14.31 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.896 0.878 . . . . 70.23 109.22 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.47 118.89 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.742 0.817 . . . . 71.31 109.334 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.97 82.74 6.12 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.174 -1.047 . . . . 65.3 108.174 173.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.46 102.48 12.11 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.463 -0.79 . . . . 71.22 109.9 -171.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 170.26 29.94 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 116.324 -0.398 . . . . 63.55 112.385 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.56 137.68 4.47 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.534 -0.627 . . . . 71.13 111.534 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.444 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.6 mt -90.28 135.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 109.175 -0.676 . . . . 74.02 109.175 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.01 126.08 29.47 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.443 0.697 . . . . 65.23 109.875 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -78.88 94.98 5.29 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.633 0.773 . . . . 63.42 109.092 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.593 HG22 HD11 ' D' ' 89' ' ' ILE . 21.8 mt -113.13 131.76 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.625 0.77 . . . . 75.22 110.142 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.45 169.25 23.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.075 0.95 . . . . 53.44 110.35 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.42 21.39 79.45 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.078 -0.51 . . . . 73.23 113.617 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.593 HD11 HG22 ' D' ' 86' ' ' ILE . 1.5 pp -135.46 160.55 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.565 1.146 . . . . 75.42 109.604 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -168.4 166.53 12.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.522 0.729 . . . . 74.13 110.515 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.69 -135.47 47.04 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.998 0.811 . . . . 54.13 114.149 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -77.0 -22.86 52.48 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.842 0.857 . . . . 73.42 111.066 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -62.31 -46.12 90.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.784 0.834 . . . . 72.45 110.444 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.3 ptm -77.75 -24.09 49.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.657 -0.701 . . . . 73.44 110.905 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -32.97 74.75 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.812 0.445 . . . . 73.23 111.148 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -77.59 -39.04 46.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.182 0.593 . . . . 73.22 111.276 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -63.66 -44.18 94.56 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.25 0.548 . . . . 71.21 110.963 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.04 -41.38 17.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.473 1.109 . . . . 72.23 111.11 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.62 -10.39 73.28 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 114.702 0.641 . . . . 60.54 114.702 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.29 -61.42 0.87 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.234 0.517 . . . . 75.12 111.232 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -65.25 -44.14 89.1 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.698 0.629 . . . . 73.3 112.698 -173.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 79.8 m -64.38 -44.68 76.45 Favored Pre-proline 0 CA--C 1.567 1.608 0 CA-C-O 118.824 -0.608 . . . . 70.34 112.498 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -48.19 -42.26 33.4 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.51 2.14 . . . . 72.43 114.093 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -64.75 -20.51 66.39 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.758 0.651 . . . . 73.45 112.758 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.3 mm -82.21 -46.8 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.398 0.618 . . . . 74.4 110.382 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -79.72 -28.85 40.53 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.169 -0.923 . . . . 54.35 111.826 -171.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -62.55 -42.56 80.13 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 124.205 1.002 . . . . 74.24 113.474 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -52.64 -39.98 74.47 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.48 2.12 . . . . 74.33 114.352 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -77.69 -32.69 53.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.522 0.729 . . . . 73.52 111.6 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.96 81.87 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.072 -0.714 . . . . 54.35 109.072 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.599 ' HA ' HD23 ' D' ' 128' ' ' LEU . 24.9 ttp180 -54.01 -55.37 27.89 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.899 1.374 . . . . 72.23 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -66.27 -39.71 89.63 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.142 0.901 . . . . 73.32 111.149 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.9 -44.1 97.61 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.31 0.381 . . . . 72.25 110.429 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.572 HG23 ' SG ' ' D' ' 76' ' ' CYS . 93.5 mt -59.03 -54.98 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.176 0.99 . . . . 72.04 110.238 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.612 HG21 ' HE2' ' B' ' 109' ' ' TYR . 71.7 m -52.08 -48.3 64.76 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 125.078 1.351 . . . . 63.33 111.595 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.81 -41.56 82.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.626 -1.17 . . . . 72.03 110.797 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.422 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -65.61 -36.68 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.709 0.404 . . . . 75.21 111.663 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.1 t -64.63 -44.74 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.605 -0.725 . . . . 62.45 109.969 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' D' ' 125' ' ' GLN . 88.1 p -69.62 -31.48 69.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.849 0.459 . . . . 71.2 111.614 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.79 -30.52 68.08 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.8 0.84 . . . . 75.22 110.488 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.01 11.55 59.97 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.375 -0.829 . . . . 15.0 112.281 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.3 p 60.67 14.57 5.1 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 127.092 2.157 . . . . 70.31 113.782 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -91.41 160.69 36.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.493 1.117 . . . . 72.14 108.495 173.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.54 115.66 4.41 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.429 2.086 . . . . 55.05 110.805 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' D' ' 119' ' ' SER . 3.9 pt20 -51.21 139.17 19.13 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.425 1.078 . . . . 73.24 112.407 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.561 ' HG ' HG11 ' D' ' 64' ' ' VAL . 0.7 OUTLIER -107.15 110.48 22.57 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.469 -0.567 . . . . 54.35 109.469 -165.701 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -98.59 102.57 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.468 0.707 . . . . 73.53 109.362 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.732 HD12 HD12 ' D' ' 42' ' ' LEU . 3.2 mm? -70.11 115.7 9.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.252 1.021 . . . . 63.21 109.912 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.1 137.55 95.81 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-O 119.581 -0.247 . . . . 54.52 110.376 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.23 133.06 23.84 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.131 1.888 . . . . 71.05 110.995 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -108.06 136.38 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.291 -1.003 . . . . 71.01 108.291 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -78.36 86.78 4.41 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.366 -0.605 . . . . 72.43 109.366 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 N--CA 1.476 0.848 0 CA-C-N 115.447 -0.797 . . . . 65.24 110.713 178.295 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.5 m . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 109.854 -0.424 . . . . 75.13 109.854 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.428 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 18.7 t80 -133.05 124.79 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 62.13 108.887 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -146.56 110.02 4.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.96 -0.756 . . . . 73.24 108.96 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.676 HG12 ' HD2' ' A' ' 84' ' ' PHE . 37.6 mt -69.65 128.69 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.639 -0.874 . . . . 71.14 108.639 173.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -97.73 -36.98 10.06 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 122.936 0.494 . . . . 74.14 110.461 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.8 ttt85 -166.86 142.99 4.46 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.885 -0.413 . . . . 75.33 109.885 -174.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.69 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.549 0.74 . . . . 72.14 109.027 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HE1' HG13 ' A' ' 83' ' ' ILE . 21.2 p90 -169.02 149.8 4.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.919 0.888 . . . . 63.24 110.299 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -79.33 119.81 22.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.899 -1.046 . . . . 74.52 108.83 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.2 mtpt -88.22 -17.93 29.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.847 0.356 . . . . 72.24 110.284 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.1 t70 -156.53 141.76 17.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.305 1.042 . . . . 72.45 109.141 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 64.4 mt -138.14 144.91 29.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 107.238 -1.393 . . . . 60.14 107.238 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.616 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 28.3 t -150.8 130.51 13.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.852 0.861 . . . . 61.11 108.935 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -132.64 136.44 46.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.406 -1.701 . . . . 70.52 106.406 167.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -133.91 140.13 46.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.414 -0.587 . . . . 74.42 109.414 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 69.23 10.92 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 106.065 -1.828 . . . . 74.25 106.065 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.46 -19.41 21.93 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.324 2.016 . . . . 73.24 112.453 -171.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -110.52 20.53 17.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.867 0.867 . . . . 64.11 109.798 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.74 -61.28 3.13 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.05 -0.976 . . . . 71.11 113.38 -167.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.4 -20.66 49.52 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.404 2.069 . . . . 71.52 113.912 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -83.85 -53.19 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.104 0.954 . . . . 73.34 109.906 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG11 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -77.43 -12.74 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-N 114.61 -1.177 . . . . 71.2 111.8 -162.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -74.18 -18.03 60.82 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.641 0.776 . . . . 64.43 112.606 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.07 -8.92 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.787 0.662 . . . . 73.41 112.787 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -79.9 168.95 18.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.957 0.503 . . . . 75.32 112.296 -174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.93 138.62 58.48 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.67 1.188 . . . . 73.34 111.153 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -86.84 80.43 8.49 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.483 0.659 . . . . 73.34 110.146 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -137.31 77.53 41.26 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 114.938 -1.028 . . . . 70.1 109.006 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -81.4 138.82 11.18 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.38 2.054 . . . . 62.35 111.762 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.56 84.32 3.39 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 106.006 -1.85 . . . . 64.42 106.006 164.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 65' ' ' THR . 12.0 p -81.91 123.39 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.748 -1.114 . . . . 60.2 109.153 -175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 18.0 pttp -123.6 127.62 48.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 74.24 110.591 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tt -98.55 109.49 22.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.629 -1.619 . . . . 70.33 106.629 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -106.34 147.89 28.69 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.792 0.837 . . . . 75.15 108.815 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -126.19 125.57 42.66 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.74 0.816 . . . . 61.44 109.342 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.5 t70 -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.093 0.957 . . . . 74.53 108.455 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -108.17 129.46 55.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.879 0.872 . . . . 72.21 111.597 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.16 130.72 17.83 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.705 0.802 . . . . 64.54 109.987 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -125.05 151.58 45.43 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.896 -0.779 . . . . 71.33 108.896 172.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 t -158.33 133.66 8.71 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.486 0.714 . . . . 72.24 109.857 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -78.32 125.53 29.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.227 0.611 . . . . 75.34 110.018 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.12 -34.28 13.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.453 0.701 . . . . 73.11 110.64 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -178.58 6.05 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.057 0.943 . . . . 34.22 109.707 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -69.26 125.34 26.39 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.902 -0.407 . . . . 71.35 109.902 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 68.58 -8.22 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.968 1.707 . . . . 64.44 112.805 -171.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -101.33 109.52 25.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.997 -0.742 . . . . 71.3 108.997 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.524 ' HB2' HD13 ' A' ' 86' ' ' ILE . 93.2 m-85 -123.64 127.19 47.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.965 0.906 . . . . 70.22 108.607 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.31 132.04 37.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.681 -1.145 . . . . 73.4 108.992 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.583 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 58.9 t -116.86 121.43 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.694 -1.224 . . . . 73.45 107.694 169.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.41 129.76 49.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.839 0.855 . . . . 73.21 108.711 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -120.57 100.5 7.17 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.547 -1.649 . . . . 74.55 106.547 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 6.6 ttm180 -87.35 131.22 34.34 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.843 -0.799 . . . . 74.35 108.843 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' A' ' 114' ' ' ILE . 47.9 t -117.84 130.61 72.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.328 -0.989 . . . . 72.43 108.328 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 69.2 m -113.72 140.97 47.82 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.635 0.584 . . . . 65.32 109.693 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.482 HG21 HD21 ' A' ' 126' ' ' LEU . 92.7 t -130.43 113.29 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.961 0.904 . . . . 50.13 108.747 174.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.5 m -112.73 131.49 55.65 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.114 -0.698 . . . . 71.11 109.114 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.27 105.74 8.75 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.316 -0.994 . . . . 72.12 108.316 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 51.6 m -110.58 122.92 48.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.29 0.495 . . . . 62.11 110.816 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 73' ' ' ALA . 10.4 mp -89.57 86.96 6.87 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.111 0.964 . . . . 74.11 109.012 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.1 -84.41 1.43 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.757 -1.111 . . . . 61.43 110.5 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -25.37 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.627 0.771 . . . . 60.31 110.446 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -98.4 129.87 45.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.312 1.045 . . . . 63.13 110.225 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.6 m -79.85 135.49 36.47 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.196 0.522 . . . . 73.53 112.19 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.611 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.64 -63.81 1.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.2 1.4 . . . . 72.03 109.766 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -147.09 159.75 43.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.104 -0.953 . . . . 75.12 111.645 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.65 117.26 11.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.399 -1.273 . . . . 72.32 108.335 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 63' ' ' THR . 83.9 m -110.61 136.72 49.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.392 0.677 . . . . 60.14 110.709 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 43.2 mp0 -135.9 131.27 35.02 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.618 -1.253 . . . . 71.21 107.618 169.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.27 115.2 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.6 -0.889 . . . . 53.14 108.6 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 42.3 mt-30 -90.23 86.98 6.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 172.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.71 93.11 4.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.727 -1.124 . . . . 73.3 108.62 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.01 148.24 22.3 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.264 -0.88 . . . . 71.12 111.082 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.74 123.27 2.01 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 111.349 -0.7 . . . . 50.15 111.349 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.492 HG13 ' HE1' ' A' ' 17' ' ' TYR . 56.3 mt -80.97 123.67 37.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.896 -1.149 . . . . 71.4 107.896 170.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.676 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.3 m-85 -133.83 162.9 30.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.263 -1.014 . . . . 63.23 108.263 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 t -118.43 102.47 8.95 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.489 -0.93 . . . . 74.55 108.489 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 56' ' ' TYR . 3.3 mp -112.82 137.13 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.568 0.747 . . . . 71.31 109.032 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.8 174.87 13.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.981 0.912 . . . . 60.42 109.876 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.21 16.14 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.742 0.657 . . . . 53.12 114.742 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 94' ' ' MET . 11.2 pt -121.29 157.07 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.918 0.887 . . . . 73.3 110.776 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 2.8 tt0 -140.31 174.63 10.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.96 0.904 . . . . 61.15 109.32 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.443 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 41.91 -116.11 0.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.927 1.131 . . . . 72.34 115.927 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.6 p -73.05 -28.58 62.4 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.7 1.2 . . . . 72.34 111.978 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -62.08 -46.74 87.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.383 0.673 . . . . 74.34 109.206 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.489 ' HA ' HD12 ' A' ' 89' ' ' ILE . 1.4 ppp? -83.59 -21.7 32.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.49 -0.777 . . . . 61.04 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -27.42 66.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.156 0.583 . . . . 70.02 110.692 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -64.52 -35.14 80.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.773 0.829 . . . . 75.24 110.597 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 45.1 t -72.33 -41.11 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.878 -0.601 . . . . 42.54 110.91 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.57 -51.1 21.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.3 0.24 . . . . 73.4 111.605 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.9 3.79 77.83 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 114.871 0.708 . . . . 54.45 114.871 -165.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.64 -58.26 0.2 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.013 0.907 . . . . 75.22 113.271 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 64.3 t80 -70.55 -59.21 2.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.692 -1.14 . . . . 61.11 112.086 -167.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.02 -32.48 2.91 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.546 0.943 . . . . 52.11 113.546 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.16 -45.58 25.25 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.732 2.288 . . . . 75.52 113.011 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.18 -27.76 69.29 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.747 0.819 . . . . 74.25 111.439 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 13' ' ' ILE . 47.9 mm -74.74 -47.59 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.634 0.774 . . . . 74.32 110.257 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.54 -29.68 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.623 0.769 . . . . 74.55 112.798 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -65.15 -38.65 29.79 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 113.599 0.962 . . . . 73.45 113.599 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.81 -40.68 79.34 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 122.14 1.893 . . . . 71.32 113.608 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -73.44 -40.56 64.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 75.2 111.636 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.87 84.0 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.814 0.446 . . . . 63.42 109.939 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -49.61 -53.75 22.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.096 1.498 . . . . 70.54 110.522 175.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.6 -41.11 93.16 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.178 0.924 . . . . 70.5 111.658 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.8 -31.59 72.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.034 0.533 . . . . 55.33 111.249 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 62' ' ' VAL . 89.7 mt -71.84 -51.78 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.555 0.742 . . . . 75.32 109.206 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.0 m -53.57 -40.04 65.27 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.705 1.202 . . . . 55.14 111.609 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -59.72 -55.2 37.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.719 -1.128 . . . . 22.0 110.386 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.4 mtm -60.75 -43.33 98.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.24 111.515 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 114' ' ' ILE . 78.5 t -57.38 -46.38 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.411 1.084 . . . . 50.21 110.691 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -70.67 -29.25 65.53 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.15 -0.932 . . . . 74.0 111.369 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.412 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.55 -30.74 66.22 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.788 0.835 . . . . 52.13 110.653 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.08 6.25 76.21 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.774 -0.459 . . . . 74.21 112.992 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.622 ' HB ' HH21 ' B' ' 15' ' ' ARG . 1.6 m 67.9 18.71 9.58 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.258 1.423 . . . . 75.32 111.681 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.92 151.57 64.2 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 109.284 -0.635 . . . . 72.44 109.284 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -58.97 146.01 95.43 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.795 2.33 . . . . 35.21 111.53 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.407 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.23 129.58 38.86 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.747 0.654 . . . . 75.25 111.393 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.482 HD21 HG21 ' A' ' 64' ' ' VAL . 48.0 tp -112.3 96.14 5.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.765 -1.107 . . . . 55.24 110.004 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.57 105.46 15.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.562 -1.273 . . . . 75.42 107.562 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 143.53 57.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.871 0.468 . . . . 72.35 110.045 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.17 130.51 94.24 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 122.95 0.5 . . . . 62.23 111.141 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 56.2 Cg_endo -72.37 104.9 1.77 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.241 1.961 . . . . 65.04 111.246 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.7 t -101.02 122.78 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.27 -1.011 . . . . 73.3 108.27 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -68.29 86.62 0.28 Allowed 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.65 -0.87 . . . . 62.15 108.65 170.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.467 -1.242 . . . . 73.32 109.922 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.695 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.2 t70 . . . . . 0 C--O 1.217 -0.652 0 CA-C-N 114.239 -1.346 . . . . 62.13 111.498 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.9 m . . . . . 0 C--O 1.24 0.561 0 N-CA-C 109.85 -0.426 . . . . 62.33 109.85 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.471 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 74.4 t80 -110.45 117.38 33.42 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.072 -1.084 . . . . 60.3 108.072 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -126.31 106.28 9.4 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.721 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -79.77 118.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 106.887 -1.523 . . . . 64.11 106.887 167.053 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -87.07 -53.61 4.77 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.472 -0.331 . . . . 73.5 110.188 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.622 HH21 ' HB ' ' A' ' 122' ' ' THR . 52.6 ttt180 -156.35 139.93 15.94 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.093 -0.336 . . . . 73.33 110.093 -172.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.721 HG13 HD11 ' B' ' 13' ' ' ILE . 92.5 mt -116.8 140.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 106.722 -1.584 . . . . 60.43 106.722 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -168.51 159.64 10.41 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 123.569 0.543 . . . . 71.54 110.552 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -85.93 120.26 27.13 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.403 -0.591 . . . . 74.05 109.403 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -87.81 -30.63 20.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.089 0.556 . . . . 71.25 110.689 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -158.86 146.81 17.96 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.715 0.293 . . . . 54.13 111.552 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 42.0 mm -132.46 141.61 44.76 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 125.281 1.432 . . . . 61.44 108.911 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.2 t -139.44 130.84 26.93 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.921 1.288 . . . . 71.13 107.655 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.482 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -148.13 125.17 11.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.462 -1.311 . . . . 50.0 107.462 168.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 45.9 mt-10 -122.92 144.99 48.86 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.623 -0.881 . . . . 53.12 108.623 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.856 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -142.22 74.88 20.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.6 -1.259 . . . . 75.31 107.6 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.31 -38.28 6.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.663 2.242 . . . . 53.02 112.566 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 71.9 m-20 -105.41 10.96 33.18 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.28 0.632 . . . . 74.22 111.01 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.856 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -44.59 -50.71 23.12 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 115.016 1.487 . . . . 71.45 115.016 -171.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.72 -30.35 17.94 Favored 'Trans proline' 0 C--N 1.383 2.384 0 CA-C-N 121.141 1.443 . . . . 42.35 112.829 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.426 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.0 m80 -97.61 -2.36 41.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.873 0.869 . . . . 64.41 112.956 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.53 -12.73 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.928 0.491 . . . . 72.24 110.492 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -61.36 -29.52 69.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.289 1.036 . . . . 71.42 111.735 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 pt20 -62.06 -31.98 72.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.193 0.597 . . . . 72.41 110.58 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 35.3 mmtp -97.05 64.98 2.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.311 -0.996 . . . . 74.25 108.311 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.91 99.72 11.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.802 -0.635 . . . . 75.13 110.324 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.402 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 163.89 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 126.953 2.101 . . . . 73.43 110.231 160.211 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -59.35 125.11 78.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.112 0.965 . . . . 63.13 112.589 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 87.9 Cg_endo -84.98 150.61 10.97 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.115 2.544 . . . . 74.32 112.56 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.44 106.45 3.94 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.015 -1.106 . . . . 74.25 108.015 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 65' ' ' THR . 91.9 t -93.13 128.69 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.62 0.768 . . . . 75.53 110.862 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.597 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.8 tttp -109.98 124.39 51.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.165 0.986 . . . . 61.35 109.478 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.21 152.51 22.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.43 0.692 . . . . 71.32 109.94 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.09 111.7 1.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.715 0.635 . . . . 54.14 109.525 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.402 ' HG ' HG22 ' B' ' 62' ' ' VAL . 10.1 mp -99.1 139.21 35.09 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.949 -1.13 . . . . 61.21 107.949 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.8 t70 -121.75 126.24 48.42 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.89 0.876 . . . . 75.3 108.841 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -106.96 103.93 13.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.17 0.988 . . . . 74.22 108.418 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 140.73 50.28 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.482 -0.781 . . . . 73.23 109.014 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 p -144.52 163.88 32.55 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.619 0.368 . . . . 62.34 111.28 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -153.06 140.38 19.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.04 0.936 . . . . 72.02 109.536 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -80.03 133.6 36.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.574 0.35 . . . . 75.53 110.527 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.84 -44.31 7.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.325 0.65 . . . . 70.44 110.592 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.62 -167.55 1.59 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.656 0.782 . . . . 63.15 110.965 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -63.9 106.08 0.96 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.884 -1.053 . . . . 60.35 110.784 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' B' ' 85' ' ' SER . 33.8 m-20 73.18 -1.72 2.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.303 1.841 . . . . 64.43 112.057 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.93 124.13 58.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.524 0 C-N-CA 124.182 0.993 . . . . 54.0 108.782 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -134.39 -178.62 5.13 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.512 0.725 . . . . 70.31 109.235 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.459 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.0 tm-20 -138.17 116.64 12.03 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.805 -1.554 . . . . 75.15 106.805 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.83 127.17 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.835 0.854 . . . . 73.53 110.309 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.6 t -102.48 112.89 37.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.297 1.039 . . . . 74.33 108.829 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.4 97.81 8.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.367 -1.346 . . . . 75.32 107.367 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 27.8 ttm180 -84.81 133.31 34.34 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.873 -0.788 . . . . 62.33 108.873 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' B' ' 44' ' ' LEU . 57.6 t -117.77 109.23 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.577 -1.268 . . . . 51.33 107.577 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -96.23 136.64 36.43 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.627 -0.879 . . . . 64.1 108.627 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -133.03 132.27 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.417 1.087 . . . . 61.41 108.455 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 59.7 m -123.19 144.08 49.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.686 -1.227 . . . . 72.04 107.686 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.04 135.14 39.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.953 -1.499 . . . . 70.11 106.953 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 14.8 p -145.77 139.03 26.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 122.982 0.513 . . . . 52.53 110.683 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 23.7 mt -129.46 104.67 7.61 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.853 1.261 . . . . 73.35 109.694 -171.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -135.92 19.79 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.542 -0.588 . . . . 65.04 111.953 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.7 11.08 18.56 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.546 0.673 . . . . 75.24 111.532 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.4 pt-20 -130.13 167.59 18.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.341 0.657 . . . . 62.12 110.936 -175.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -79.56 145.87 32.91 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.495 -0.775 . . . . 75.53 109.807 174.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.46 -67.11 0.88 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.947 0.499 . . . . 53.41 109.668 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -160.63 152.08 19.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.975 -1.011 . . . . 73.51 108.792 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 65.9 mt -128.07 137.1 52.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.56 1.144 . . . . 51.33 108.309 -174.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -146.49 147.03 30.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.522 -0.548 . . . . 74.24 109.522 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.3 tt0 -160.88 138.61 9.42 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' B' ' 113' ' ' CYS . 74.5 t -130.15 146.26 34.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.677 -1.231 . . . . 62.12 107.677 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.9 91.79 3.59 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.777 -1.194 . . . . 54.4 107.777 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 42.9 tp60 -88.04 100.07 12.65 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.343 -0.984 . . . . 71.25 108.343 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.34 162.11 30.52 Favored Glycine 0 C--O 1.241 0.574 0 N-CA-C 111.047 -0.821 . . . . 64.23 111.047 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.64 126.8 1.6 Allowed Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.938 -0.865 . . . . 34.05 110.938 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.459 HG12 ' HG2' ' B' ' 57' ' ' GLU . 59.0 mt -84.39 129.62 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.467 -0.938 . . . . 74.31 108.467 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -131.81 148.75 52.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.38 -0.6 . . . . 75.14 109.38 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 22.6 m -131.23 106.64 8.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.43 1.092 . . . . 73.22 109.161 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.459 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -117.69 145.02 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 122.946 0.498 . . . . 73.01 110.634 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.13 161.73 39.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.865 0.866 . . . . 32.01 109.986 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.47 -41.2 2.51 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.895 -0.593 . . . . 74.34 111.775 -178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' B' ' 94' ' ' MET . 11.0 pt -71.66 143.38 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.727 0.811 . . . . 72.21 110.574 173.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.18 145.0 24.36 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.857 -0.794 . . . . 60.24 108.857 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.73 -109.4 2.83 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.831 0.707 . . . . 74.41 113.68 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.09 -53.44 45.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.233 1.013 . . . . 73.33 111.487 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -66.55 -34.3 77.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.248 -1.342 . . . . 70.02 110.417 -172.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.609 ' HA ' HD12 ' B' ' 89' ' ' ILE . 52.2 ttp -65.86 -50.94 62.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.679 1.192 . . . . 75.3 110.606 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.9 77.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.14 0.976 . . . . 72.22 111.919 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -78.2 -36.02 47.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.215 0.606 . . . . 73.33 111.227 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -65.11 -52.18 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.07 0.548 . . . . 70.11 111.673 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.61 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.1 pp -86.75 -31.95 20.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.591 -0.277 . . . . 64.0 111.532 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.08 73.4 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.09 0.396 . . . . 35.13 114.09 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.75 -51.6 2.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.808 0.443 . . . . 74.15 111.801 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -75.54 -40.75 56.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.806 0.442 . . . . 71.33 111.99 -170.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.4 m -66.49 -43.89 53.88 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 113.466 0.913 . . . . 61.32 113.466 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.86 -37.09 97.61 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.359 2.039 . . . . 51.53 113.218 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.23 -19.7 66.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.497 0.719 . . . . 53.24 112.491 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.412 HG23 ' NH2' ' D' ' 111' ' ' ARG . 86.3 mt -81.68 -48.31 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.344 0.658 . . . . 72.24 110.75 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.24 -25.82 58.4 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.915 -0.584 . . . . 72.33 111.591 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -57.68 -52.54 73.61 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.066 1.136 . . . . 74.24 114.066 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.71 -41.42 61.96 Favored 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.439 2.093 . . . . 72.24 113.731 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -65.15 -48.13 74.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.8 0.84 . . . . 75.45 111.396 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.54 82.0 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.486 -0.779 . . . . 62.52 110.988 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 ttp-105 -65.71 -49.73 67.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.047 -1.433 . . . . 74.04 111.386 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -35.37 79.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.995 0.518 . . . . 74.31 110.232 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.6 t -67.21 -32.0 72.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.623 0.369 . . . . 71.23 111.405 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.63 -45.63 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.499 0.72 . . . . 52.54 109.651 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.728 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.8 m -60.51 -25.01 65.77 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.382 1.073 . . . . 74.22 111.521 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -75.24 -51.4 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.652 0.781 . . . . 72.45 110.136 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.31 -34.99 73.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.914 0.486 . . . . 72.03 111.933 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.55 -39.47 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.463 0.705 . . . . 44.02 110.039 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.3 t -72.92 -27.51 61.91 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.702 0.801 . . . . 62.5 111.605 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.4 mtt-85 -73.34 -33.34 65.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.413 0.685 . . . . 71.13 110.086 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.34 1.75 69.49 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 123.855 0.722 . . . . 52.42 112.305 168.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 63.33 38.61 10.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.85 2.06 . . . . 52.35 112.606 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.11 156.76 40.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.484 1.114 . . . . 64.32 109.869 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -66.58 143.42 68.53 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.428 2.085 . . . . 65.44 111.54 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.728 ' HB2' HG23 ' B' ' 115' ' ' THR . 13.5 pt20 -65.14 161.65 18.64 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.28 1.432 . . . . 74.51 114.566 -167.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 26.5 tp -135.29 104.38 5.86 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.345 -1.298 . . . . 73.05 109.876 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -92.2 107.43 19.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 106.48 -1.674 . . . . 70.02 106.48 167.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.1 tp -62.88 134.98 57.05 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.302 0.376 . . . . 65.02 110.153 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.25 156.46 50.42 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.775 1.23 . . . . 54.43 111.867 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.9 108.43 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.754 2.302 . . . . 72.01 111.992 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.14 108.57 18.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.775 -1.565 . . . . 54.21 106.775 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -90.23 88.99 7.45 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.854 -0.795 . . . . 75.03 108.854 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 . . . . . 0 N--CA 1.477 0.918 0 CA-C-N 115.199 -0.909 . . . . 74.54 110.466 178.431 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.3 tmm? . . . . . 0 CA--C 1.55 0.978 0 CA-C-O 121.325 0.584 . . . . 75.34 112.222 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.1 m -100.14 92.07 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.816 0.846 . . . . 73.32 109.36 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.716 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 49.0 t80 -92.01 145.78 24.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.799 -0.815 . . . . 60.13 108.799 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.01 132.2 4.8 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.844 -0.798 . . . . 72.12 108.844 167.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -70.88 134.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 109.17 -0.678 . . . . 70.04 109.17 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -103.19 -45.13 5.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.488 -0.56 . . . . 73.25 109.488 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 ttt85 -169.09 147.0 3.75 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.999 -0.546 . . . . 74.43 109.73 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -130.02 136.22 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.328 -1.36 . . . . 75.31 107.328 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.558 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.2 p90 -171.22 154.1 3.88 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.418 0.627 . . . . 71.41 111.258 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -77.95 109.26 11.84 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.237 -1.023 . . . . 72.34 108.237 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -70.28 -45.55 66.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.74 0.781 . . . . 72.42 108.945 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.9 t70 -138.09 141.53 40.24 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.362 -1.29 . . . . 71.23 109.318 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.9 mt -136.16 142.71 37.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.718 1.607 . . . . 72.2 106.686 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -155.92 150.91 26.4 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.298 0.57 . . . . 62.13 110.987 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.466 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -152.45 121.61 6.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.595 -1.184 . . . . 75.52 107.842 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 72.41 109.157 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -137.1 86.18 20.83 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.453 -0.943 . . . . 51.13 108.453 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.27 -39.08 10.72 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.386 2.057 . . . . 75.44 111.316 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -99.26 33.77 2.34 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.188 0.995 . . . . 75.31 110.035 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.483 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -59.78 -51.9 77.63 Favored Pre-proline 0 CA--C 1.569 1.689 0 C-N-CA 124.615 1.166 . . . . 62.22 114.128 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 4.4 Cg_exo -74.85 -26.95 10.74 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.718 1.612 . . . . 71.42 111.37 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -66.03 -18.34 65.28 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.138 1.375 . . . . 71.55 112.166 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -54.71 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 N-CA-C 113.324 0.861 . . . . 55.0 113.324 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -68.25 -26.4 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.974 0.416 . . . . 74.14 111.886 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.44 30.95 6.67 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.508 1.123 . . . . 70.11 109.683 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.631 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -95.32 137.07 34.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.175 0.99 . . . . 73.0 108.7 171.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.73 130.37 42.14 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.576 -0.898 . . . . 73.23 108.576 170.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -83.79 66.59 9.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.109 0.564 . . . . 74.54 111.238 -170.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -165.7 78.34 1.22 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.543 0.737 . . . . 53.5 109.824 172.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.411 ' HB2' HG23 ' C' ' 40' ' ' VAL . 12.3 Cg_exo -73.29 163.4 38.0 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.716 2.277 . . . . 74.2 112.941 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -86.85 76.61 9.41 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 107.269 -1.382 . . . . 74.51 107.269 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' C' ' 38' ' ' PRO . 64.1 t -73.7 97.96 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.234 -1.348 . . . . 71.34 108.468 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -133.22 128.21 35.42 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.105 0.962 . . . . 73.24 108.757 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.616 ' HG ' HD21 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -89.41 161.86 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.701 0.626 . . . . 75.53 109.999 175.494 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.5 t70 -139.12 141.58 38.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.307 1.043 . . . . 72.04 108.703 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -112.36 113.02 25.01 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.241 0.616 . . . . 75.02 109.455 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.4 t70 -114.89 142.01 47.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.484 -0.932 . . . . 71.34 108.484 172.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.4 p -128.39 136.94 51.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.915 0.486 . . . . 75.53 110.335 -172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 167.29 24.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 62.41 109.347 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -159.18 164.37 35.19 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.341 0.656 . . . . 65.03 111.365 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 92.3 p -145.91 155.23 42.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.008 0.923 . . . . 75.51 109.791 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -101.72 114.76 29.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.892 -0.781 . . . . 63.13 108.892 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.613 HD11 HD12 ' C' ' 83' ' ' ILE . 39.5 mt -94.06 -32.52 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.635 0.774 . . . . 74.11 110.456 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.92 -170.2 1.3 Allowed 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.001 0.92 . . . . 71.14 110.219 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.7 111.92 2.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.791 0.836 . . . . 73.31 109.417 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.3 -5.56 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.37 1.468 . . . . 73.54 112.88 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.19 94.87 5.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 106.935 -1.505 . . . . 75.33 106.935 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -114.0 124.36 51.94 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.72 -1.127 . . . . 74.33 108.442 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.2 tt0 -82.62 125.15 30.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.871 -0.788 . . . . 64.21 108.871 176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.99 118.52 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 73.34 108.669 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 72.5 t -102.9 127.76 56.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 107.696 -1.224 . . . . 74.41 107.696 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -129.44 94.5 3.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.993 -1.484 . . . . 70.03 106.993 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.47 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.9 ttm180 -82.67 121.69 27.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.717 -0.674 . . . . 70.31 109.211 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' C' ' 114' ' ' ILE . 18.3 t -115.72 117.63 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.735 -1.209 . . . . 42.14 107.735 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 41.1 m -110.35 137.76 47.63 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.259 -1.015 . . . . 73.43 108.259 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' C' ' 114' ' ' ILE . 97.8 t -120.64 109.93 26.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.332 -0.988 . . . . 71.41 108.332 170.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -99.55 140.64 33.43 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.863 -0.792 . . . . 73.23 108.863 171.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.64 97.28 3.23 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -141.64 146.25 35.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.169 0.588 . . . . 62.12 109.765 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.47 36.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.664 1.186 . . . . 70.1 108.819 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.48 -111.75 3.25 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.059 -1.216 . . . . 60.24 110.059 -168.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.77 -19.6 23.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.773 0.829 . . . . 71.12 110.415 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -78.0 84.43 4.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.298 1.039 . . . . 71.23 109.712 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -73.09 126.97 31.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.159 -0.473 . . . . 62.43 110.853 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.631 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -74.48 -52.14 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.748 0.819 . . . . 53.22 109.039 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -170.56 175.68 4.6 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.128 -1.396 . . . . 72.32 109.237 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.463 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.991 -1.485 . . . . 75.24 106.991 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.463 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.2 t -148.47 150.01 32.69 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.814 -0.81 . . . . 62.3 108.814 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -158.28 133.53 8.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.953 0.501 . . . . 71.34 109.829 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.07 115.45 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.939 0.896 . . . . 65.3 109.044 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.4 mt-30 -90.39 90.49 8.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.426 -0.953 . . . . 65.33 108.426 173.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -80.12 116.61 20.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.541 -1.209 . . . . 62.4 110.364 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 149.56 18.48 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 112.065 -0.414 . . . . 50.43 112.065 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.503 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.22 117.64 0.94 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.53 -1.028 . . . . 75.43 110.53 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.613 HD12 HD11 ' C' ' 51' ' ' LEU . 15.7 mm -80.89 114.66 22.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.963 -1.125 . . . . 72.14 107.963 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.66 147.54 49.92 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.87 0.468 . . . . 42.23 109.935 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.9 m -106.99 113.37 26.81 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.24 106.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 107.969 -1.123 . . . . 74.42 107.969 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -123.35 170.27 10.49 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.977 0.911 . . . . 74.13 110.659 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.12 -60.16 1.97 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.103 -0.499 . . . . 74.24 113.031 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' C' ' 94' ' ' MET . 1.3 pp -99.39 171.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.158 0.583 . . . . 63.43 111.966 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.93 -177.52 5.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.403 1.081 . . . . 73.15 109.026 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.46 -130.11 49.43 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 123.758 0.694 . . . . 74.42 114.747 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -70.13 -25.99 63.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.215 1.006 . . . . 53.31 111.543 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.48 -31.36 57.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.325 0.65 . . . . 71.3 110.251 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.594 ' HA ' HD13 ' C' ' 89' ' ' ILE . 0.7 OUTLIER -74.06 -42.29 60.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.326 -0.62 . . . . 65.14 109.326 172.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.94 67.9 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.181 0.926 . . . . 51.51 112.057 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -69.88 -51.12 35.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.661 0.384 . . . . 75.52 110.412 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.28 -32.43 68.67 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.266 0.626 . . . . 44.15 111.438 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.13 -53.83 10.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.087 0.955 . . . . 65.4 109.36 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 -29.0 64.48 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.506 -1.225 . . . . 41.14 114.118 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -114.0 -45.65 3.06 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.461 0.63 . . . . 72.31 111.569 -168.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.422 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 22.0 t80 -76.36 -43.55 40.38 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 111.567 0.21 . . . . 61.21 111.567 -174.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -66.23 -45.69 61.13 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-O 118.446 -0.788 . . . . 74.11 112.913 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.38 -35.11 99.06 Favored 'Trans proline' 0 C--N 1.401 3.292 0 C-N-CA 122.316 2.011 . . . . 74.25 113.417 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.86 -36.17 76.32 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.005 0.922 . . . . 72.4 110.725 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -74.76 -46.22 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.506 0.722 . . . . 74.5 111.091 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.503 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -78.7 -20.26 50.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.733 0.642 . . . . 72.34 112.733 -170.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.406 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.8 t80 -58.26 -52.68 72.82 Favored Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 124.5 1.12 . . . . 74.2 113.242 -175.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 33.0 Cg_exo -61.32 -37.09 75.47 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.976 1.784 . . . . 73.14 112.964 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.58 -39.55 80.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.578 0.751 . . . . 73.44 111.682 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.78 81.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.306 -0.406 . . . . 52.2 110.347 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -58.09 -63.26 1.32 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 62.34 111.469 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -30.99 72.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.334 0.397 . . . . 43.44 110.524 -173.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.435 ' O ' ' SD ' ' C' ' 117' ' ' MET . 34.3 t -66.52 -41.26 89.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.334 0.654 . . . . 74.13 111.362 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' C' ' 64' ' ' VAL . 67.1 mt -65.49 -48.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.231 0.613 . . . . 70.41 110.041 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.2 m -60.77 -29.36 69.36 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.87 -1.059 . . . . 72.02 110.848 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.81 -47.05 67.06 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.143 0.977 . . . . 74.01 110.356 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.522 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.59 -45.19 89.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.327 0.651 . . . . 75.31 111.905 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.51 -39.05 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.493 0.717 . . . . 60.53 110.534 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.654 ' HA ' HE22 ' B' ' 125' ' ' GLN . 80.6 p -74.01 -29.24 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.749 -0.66 . . . . 74.14 112.144 -176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.44 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 74.1 mtt-85 -75.44 -31.37 60.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.941 0.897 . . . . 72.12 110.75 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.09 -2.47 62.26 Favored Glycine 0 C--N 1.356 1.656 0 O-C-N 123.485 0.491 . . . . 65.32 112.427 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 63.74 27.93 14.78 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 126.692 1.997 . . . . 74.2 111.674 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -99.22 142.86 25.36 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 114.506 -1.225 . . . . 75.22 108.915 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.66 124.13 13.76 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.248 2.632 . . . . 63.42 112.768 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.553 HE21 ' HB3' ' C' ' 119' ' ' SER . 97.7 mt-30 -59.84 154.6 18.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.27 1.211 . . . . 61.2 114.27 -172.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp -127.89 119.98 26.75 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.531 -1.213 . . . . 74.11 108.635 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -98.97 130.12 45.31 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.111 -1.07 . . . . 65.04 108.111 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.616 HD21 ' HG ' ' C' ' 42' ' ' LEU . 0.2 OUTLIER -74.85 128.21 35.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 109.446 -0.576 . . . . 61.32 109.446 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.56 137.52 95.22 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.869 0.868 . . . . 44.2 110.708 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.64 103.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.38 2.72 . . . . 60.23 111.757 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.24 110.34 24.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.118 -1.067 . . . . 74.13 108.118 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -77.6 83.73 3.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.912 -1.04 . . . . 64.23 111.18 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.9 -43.55 71.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.303 -1.317 . . . . 70.15 107.803 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.636 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.4 p-10 . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 113.12 -1.855 . . . . 74.41 112.118 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.239 0.546 0 N-CA-C 108.888 -0.782 . . . . 62.34 108.888 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -164.57 91.7 0.59 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.144 -1.428 . . . . 74.01 107.144 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -119.73 115.39 23.8 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.869 -0.789 . . . . 74.22 108.869 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.435 HG21 HD11 ' D' ' 16' ' ' ILE . 13.5 mt -74.94 122.95 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.473 -0.936 . . . . 73.25 108.473 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -88.51 -49.02 7.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.935 0.334 . . . . 74.11 110.559 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -156.43 147.33 21.98 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.629 0.772 . . . . 74.33 109.837 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.435 HD11 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -117.81 122.82 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 105.582 -2.007 . . . . 72.32 105.582 161.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.483 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 32.8 p90 -152.23 162.08 41.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.926 0.869 . . . . 74.5 110.361 -171.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -90.02 114.64 26.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.184 -1.371 . . . . 63.51 109.424 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -82.69 -23.8 33.96 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.793 -0.64 . . . . 71.1 109.406 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -152.29 142.17 22.06 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.794 1.238 . . . . 65.11 109.11 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.522 HD13 ' HE3' ' C' ' 117' ' ' MET . 50.4 mt -138.69 142.13 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.187 1.395 . . . . 64.1 107.398 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.74 103.8 1.92 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.225 0.61 . . . . 73.53 110.476 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -109.68 120.37 42.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.114 -1.439 . . . . 75.04 107.114 166.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -124.72 120.02 30.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.457 0.703 . . . . 75.32 109.454 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 82.39 5.06 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 108.0 -1.111 . . . . 64.42 108.0 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -28.31 11.88 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.536 2.157 . . . . 65.42 112.77 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -116.52 40.85 2.8 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.21 1.004 . . . . 74.44 108.91 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.46 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -59.76 -68.99 0.6 Allowed Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 117.628 -1.177 . . . . 62.14 113.791 -170.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.26 -14.32 23.05 Favored 'Trans proline' 0 C--N 1.39 2.761 0 CA-C-N 123.144 2.159 . . . . 73.42 112.022 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -68.6 -43.48 76.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.004 1.322 . . . . 75.21 110.313 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.46 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.6 p -72.73 -33.08 43.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-O 119.136 -0.459 . . . . 61.32 110.245 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -61.83 -4.52 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.4 0.889 . . . . 71.31 113.4 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -84.28 -38.63 20.21 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.636 0.774 . . . . 73.44 110.578 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -128.58 61.0 1.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.374 1.07 . . . . 61.34 109.287 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 35' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' D' ' 31' ' ' VAL . 32.0 t0 -113.62 93.74 4.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.482 0.658 . . . . 60.31 110.858 -171.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.521 ' H ' HD11 ' D' ' 68' ' ' LEU . 40.3 m95 -126.09 -158.04 0.83 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 106.636 -1.616 . . . . 71.31 106.636 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.05 112.95 5.23 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-N 119.34 0.973 . . . . 72.13 110.934 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.25 135.14 20.18 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.715 1.61 . . . . 71.25 111.338 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -64.98 113.31 3.78 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 107.089 -1.448 . . . . 62.13 107.089 165.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -104.9 142.64 17.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.691 0.796 . . . . 55.44 110.42 -173.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.51 127.52 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.059 1.343 . . . . 61.12 108.006 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.43 111.87 23.95 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.721 -1.585 . . . . 55.42 106.721 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.79 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.3 m-20 -106.4 128.18 53.84 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.163 -1.051 . . . . 63.51 108.163 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.19 140.25 48.09 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.282 -0.636 . . . . 74.13 109.282 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.7 t70 -140.98 130.76 24.27 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.093 -1.077 . . . . 53.15 108.093 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -104.63 143.7 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.623 0.769 . . . . 65.52 110.808 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.678 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.77 151.87 30.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.632 0.773 . . . . 63.21 109.808 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.7 p -157.08 157.72 35.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.976 0.51 . . . . 43.1 109.745 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.2 p -153.06 154.29 34.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.665 0.786 . . . . 44.34 109.336 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -97.1 121.12 38.63 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.078 -1.453 . . . . 74.53 107.078 164.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.0 -30.05 17.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.77 0.428 . . . . 74.32 110.383 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.73 -173.99 1.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.59 0.756 . . . . 73.44 111.008 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.0 123.93 20.75 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.929 -1.032 . . . . 72.32 108.995 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 66.86 10.89 7.95 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.575 1.15 . . . . 73.21 112.09 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.9 t -123.5 123.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.151 -0.685 . . . . 61.31 109.151 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.68 149.61 51.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.801 0.84 . . . . 74.44 109.077 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -119.49 133.56 55.63 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.788 0.835 . . . . 75.34 109.733 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.49 112.63 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.689 -1.226 . . . . 64.44 107.689 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.0 t -101.76 127.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.774 -1.195 . . . . 72.23 107.774 172.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 59.3 tp -124.15 111.63 16.13 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.85 -0.796 . . . . 74.54 108.85 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.72 ' HB2' ' HG2' ' D' ' 79' ' ' GLN . 16.3 ttp180 -84.74 108.25 17.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.054 -0.976 . . . . 75.32 109.481 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.42 129.44 48.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.704 -1.221 . . . . 62.13 107.704 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.79 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.1 m -126.76 136.85 52.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.565 -0.902 . . . . 62.21 108.565 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.408 HG11 HD13 ' D' ' 126' ' ' LEU . 84.6 t -121.17 109.8 26.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.926 0.891 . . . . 52.35 108.706 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -93.03 118.99 31.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.161 -1.051 . . . . 71.11 108.161 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.29 129.49 56.64 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.658 -0.497 . . . . 75.45 109.658 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 68.1 m -134.75 128.12 32.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.842 0.857 . . . . 61.15 109.677 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.521 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.3 OUTLIER -92.04 92.38 8.25 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.019 0.528 . . . . 61.3 109.925 177.368 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.27 -125.48 10.74 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.332 -0.849 . . . . 73.14 111.351 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.05 9.08 18.24 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.578 0.751 . . . . 74.15 111.334 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -115.82 155.18 28.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.931 0.892 . . . . 72.14 109.918 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -82.32 136.21 35.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.556 -0.535 . . . . 74.4 109.556 168.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.433 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.59 -68.07 0.78 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -155.43 167.65 29.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.401 -1.272 . . . . 64.22 109.974 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.0 mt -133.05 142.99 49.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.946 1.299 . . . . 64.43 107.65 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.54 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.0 t -145.66 136.24 24.23 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.37 -0.604 . . . . 65.43 109.37 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.18 134.9 11.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.147 0.579 . . . . 74.23 110.514 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.69 122.99 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.658 0.783 . . . . 63.32 109.759 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.72 ' HG2' ' HB2' ' D' ' 61' ' ' ARG . 50.1 mt-30 -89.04 89.45 7.98 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.763 -0.829 . . . . 71.51 108.763 168.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.62 96.63 8.16 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.965 -1.016 . . . . 72.53 109.158 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.65 142.46 17.15 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.358 -0.697 . . . . 25.32 111.358 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.33 128.65 4.59 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.342 -1.103 . . . . 53.53 110.342 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.8 mt -90.73 128.23 42.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.846 -0.798 . . . . 74.34 108.846 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.406 ' HD2' HG12 ' D' ' 13' ' ' ILE . 27.4 m-85 -133.96 124.82 26.98 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.304 0.642 . . . . 70.33 109.606 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -77.4 93.94 4.16 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.855 -0.794 . . . . 73.34 108.855 171.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.11 125.94 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.555 0.742 . . . . 72.32 110.359 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.88 158.1 34.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.049 0.939 . . . . 71.44 109.924 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.97 -20.64 41.38 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-O 119.911 -0.383 . . . . 74.04 113.684 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.08 142.24 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.561 -0.903 . . . . 52.41 108.561 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -136.69 156.59 48.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.285 0.634 . . . . 72.32 111.883 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.61 -125.75 35.98 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 124.58 1.175 . . . . 75.33 115.055 166.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.33 -32.61 73.68 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.392 1.077 . . . . 71.52 112.127 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.68 -28.57 40.72 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.032 0.533 . . . . 75.22 110.499 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -33.28 54.18 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.069 -0.715 . . . . 74.2 109.069 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.94 -30.91 71.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.828 0.851 . . . . 72.3 110.695 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 10.5 t60 -66.09 -52.24 50.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 73.34 109.093 169.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.09 -35.27 78.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.849 0.46 . . . . 73.44 112.003 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.04 -40.33 16.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.046 0.938 . . . . 72.42 110.223 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.13 11.72 58.69 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.165 -0.47 . . . . 64.24 113.9 -173.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -144.44 -57.6 0.36 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.463 0.632 . . . . 70.14 112.073 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -73.66 -61.01 1.99 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.62 0.368 . . . . 75.15 111.287 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -56.04 -44.08 99.53 Favored Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 124.404 1.082 . . . . 64.53 113.758 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.3 -40.47 68.08 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 122.338 2.025 . . . . 74.35 112.691 173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -68.4 -26.57 65.61 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.576 0.75 . . . . 71.33 111.494 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -69.52 -50.87 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.948 0.499 . . . . 72.3 110.624 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.73 -12.89 52.84 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.759 -0.655 . . . . 44.41 112.243 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -62.24 -43.79 86.63 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.174 0.99 . . . . 63.31 113.635 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.67 -33.19 68.43 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.197 1.932 . . . . 61.54 113.912 172.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -79.14 -35.58 41.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.432 0.693 . . . . 74.32 110.708 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.97 82.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.439 0.696 . . . . 62.23 110.448 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.683 HH12 ' HB3' ' D' ' 130' ' ' PRO . 31.6 ttp180 -56.27 -50.37 71.56 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.322 -1.308 . . . . 53.22 110.627 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.17 -32.33 73.97 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.119 0.968 . . . . 74.21 111.501 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.44 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -70.35 -44.98 67.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.962 0.505 . . . . 63.13 111.021 176.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.54 HG23 ' SG ' ' D' ' 76' ' ' CYS . 61.8 mt -56.9 -54.79 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.408 1.083 . . . . 72.21 110.826 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -53.77 -45.72 70.75 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.083 1.353 . . . . 74.12 111.677 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.5 t -63.52 -43.39 97.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.429 -1.259 . . . . 64.13 110.842 -176.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.413 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 74.2 mtm -68.93 -36.04 77.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.879 0.472 . . . . 71.25 111.817 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.7 t -61.21 -45.14 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.76 -0.654 . . . . 72.43 109.897 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -71.25 -28.2 64.0 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.116 0.566 . . . . 75.13 111.498 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.0 mtt-85 -72.42 -28.69 63.12 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.709 0.804 . . . . 53.51 111.208 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.7 11.45 59.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.678 -0.512 . . . . 74.31 112.916 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.558 HG23 ' HB3' ' C' ' 17' ' ' TYR . 32.6 p 65.44 17.74 11.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 126.689 1.996 . . . . 62.03 113.215 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -93.52 159.39 35.1 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.197 0.999 . . . . 74.53 108.524 173.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.86 127.6 16.42 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.648 2.232 . . . . 75.43 111.342 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -53.38 120.81 6.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 123.761 0.663 . . . . 52.55 110.483 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.408 HD13 HG11 ' D' ' 64' ' ' VAL . 5.1 tt -104.04 102.52 12.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.427 -1.323 . . . . 62.24 107.427 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -94.84 85.09 4.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.195 -1.039 . . . . 72.24 108.195 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.538 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 33.0 tp -61.25 123.19 17.02 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.377 -1.738 . . . . 71.55 111.347 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.85 133.13 89.46 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 123.919 0.888 . . . . 64.13 111.645 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.683 ' HB3' HH12 ' D' ' 111' ' ' ARG . 90.3 Cg_endo -82.86 134.23 7.14 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.292 1.995 . . . . 74.25 112.478 -169.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.04 110.06 30.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.466 -0.939 . . . . 74.41 108.466 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -89.6 93.49 9.5 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.113 -0.699 . . . . 62.0 109.113 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.5 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 76.4 m-85 . . . . . 0 N--CA 1.472 0.642 0 CA-C-N 115.242 -0.89 . . . . 72.44 110.479 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 78.8 m . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.762 -0.459 . . . . 73.12 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.596 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.9 t80 -138.35 133.27 32.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.617 0.767 . . . . 74.23 109.954 170.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -160.58 116.32 2.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.813 0.845 . . . . 74.34 109.975 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.576 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.0 mt -76.17 125.68 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.536 -0.542 . . . . 70.51 109.536 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -97.3 -33.69 11.35 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.078 0.551 . . . . 74.12 111.13 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -172.24 128.41 0.57 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 110.079 -0.341 . . . . 74.33 110.079 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -121.79 126.9 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 123.664 0.785 . . . . 74.34 109.852 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 48.4 p90 -164.19 153.71 14.06 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.311 0.645 . . . . 72.22 111.202 -169.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.55 111.02 12.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.966 -1.015 . . . . 72.24 109.533 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 37.1 mtpt -76.43 -28.38 56.59 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.189 -0.459 . . . . 52.44 110.912 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -151.99 142.38 22.52 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.006 -0.997 . . . . 74.3 109.528 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.24 141.47 42.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 125.276 1.43 . . . . 45.12 107.293 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.78 130.4 14.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.966 -0.753 . . . . 72.44 108.966 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -133.5 120.48 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.482 -1.673 . . . . 62.32 106.482 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.1 114.29 20.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.773 0.429 . . . . 75.11 110.592 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 70.3 81.6 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 107.09 -1.448 . . . . 62.53 107.09 165.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.37 -3.56 13.48 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.246 1.964 . . . . 71.42 111.573 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -119.86 17.06 12.65 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.417 1.087 . . . . 62.41 109.317 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.98 -58.84 4.24 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.801 -1.095 . . . . 44.23 113.818 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.31 -25.71 71.6 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.376 2.051 . . . . 74.13 112.432 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.94 -48.1 17.08 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.5 -0.773 . . . . 72.1 109.914 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 6.2 p -77.29 -10.57 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.731 -0.668 . . . . 75.35 112.151 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.62 -18.23 61.61 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.159 0.583 . . . . 74.11 112.392 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.27 -8.54 21.17 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.339 0.866 . . . . 74.44 113.339 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 71' ' ' GLU . 8.7 mmpt? -55.11 164.07 0.95 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.13 1.159 . . . . 72.11 114.13 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.4 133.69 54.44 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.699 -1.137 . . . . 61.13 109.498 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -77.57 73.99 4.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.631 0.772 . . . . 74.53 111.791 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.66 79.05 24.9 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.299 1.039 . . . . 73.42 108.993 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 114.89 4.16 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.042 1.828 . . . . 70.21 111.867 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.22 83.96 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.333 -1.729 . . . . 75.1 106.333 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.8 t -98.08 102.69 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 113.983 -1.462 . . . . 60.35 108.441 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.12 144.19 32.26 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.85 0.86 . . . . 74.41 110.41 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tt -97.51 111.65 23.83 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.167 -1.42 . . . . 62.24 107.167 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.674 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.2 m-20 -102.9 112.49 25.33 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.86 -1.163 . . . . 71.44 107.86 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tt -110.05 129.09 55.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.588 0.355 . . . . 75.25 110.339 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -139.51 145.35 38.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.659 1.183 . . . . 71.25 108.583 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -136.64 153.22 50.98 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.265 0.626 . . . . 72.02 110.828 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -141.84 153.26 44.36 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.512 1.125 . . . . 71.51 110.423 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 p -119.47 172.46 7.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.709 0.804 . . . . 70.0 109.231 168.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.549 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.4 t -160.86 144.78 13.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.862 0.865 . . . . 74.33 109.467 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -114.82 109.79 18.71 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 74.4 109.292 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.1 mt -82.4 -40.32 21.45 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.529 0.732 . . . . 71.24 109.722 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.01 -178.12 7.13 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.682 1.193 . . . . 64.25 109.073 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 121.55 17.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.267 -0.642 . . . . 75.03 109.267 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.02 -8.5 1.12 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.904 1.682 . . . . 73.21 112.879 -171.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.05 103.42 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.135 -1.061 . . . . 42.42 108.135 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.08 163.56 18.17 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.232 -0.894 . . . . 72.01 108.615 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 29.2 tt0 -133.7 145.11 49.59 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.527 1.131 . . . . 64.42 108.737 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.83 133.86 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.876 -1.157 . . . . 53.32 107.876 168.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.5 t -111.39 139.04 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.585 1.154 . . . . 75.1 108.437 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.04 106.11 10.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.896 -1.15 . . . . 75.14 107.896 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -84.41 102.35 12.7 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.827 -0.805 . . . . 72.52 108.827 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.34 115.91 35.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.05 -1.092 . . . . 75.44 108.05 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 48.5 m -117.92 138.55 52.07 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.48 -0.933 . . . . 72.11 108.48 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.564 HG11 HD21 ' A' ' 126' ' ' LEU . 99.1 t -129.94 117.83 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 124.6 1.16 . . . . 64.2 108.209 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 20.8 m -101.88 136.61 41.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.332 -0.988 . . . . 71.5 108.332 171.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.34 125.34 21.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.741 -1.207 . . . . 54.12 107.741 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.0 m -146.02 127.76 15.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.582 0.551 . . . . 60.33 110.464 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.87 86.23 6.58 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.01 -1.108 . . . . 74.14 108.01 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.46 -123.22 6.05 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.569 -1.196 . . . . 74.34 110.613 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -88.1 -28.01 21.56 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.285 0.634 . . . . 64.13 111.094 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 34' ' ' LYS . 27.6 tt0 -90.03 126.14 35.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.977 0.511 . . . . 71.04 110.475 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 m -72.65 129.29 37.92 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.97 0.908 . . . . 75.05 111.744 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.5 -65.5 0.75 Allowed 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.162 0.913 . . . . 74.0 108.762 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.548 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 50.3 p90 -155.92 144.42 20.16 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.785 -0.643 . . . . 74.31 110.748 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -121.13 110.15 15.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.154 -1.054 . . . . 51.14 108.154 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.548 ' HG ' ' HD2' ' A' ' 74' ' ' PHE . 84.0 m -111.15 114.84 28.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.182 0.993 . . . . 74.41 110.892 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.5 124.98 39.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.5 -0.926 . . . . 60.23 108.5 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.3 t -132.81 108.52 13.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.844 -1.169 . . . . 71.41 107.844 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.2 mt-30 -85.28 80.19 9.26 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.299 -1.371 . . . . 62.31 107.299 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -76.46 96.54 4.09 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.176 -1.375 . . . . 70.12 108.651 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -94.1 166.18 27.05 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.955 -0.566 . . . . 63.43 112.124 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.21 128.41 1.73 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.933 -0.867 . . . . 63.44 110.933 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.7 mt -80.57 120.28 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.635 -0.876 . . . . 64.51 108.635 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.596 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.8 m-85 -125.7 117.3 23.18 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.739 -1.208 . . . . 75.41 107.739 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -79.67 86.77 5.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.92 -0.77 . . . . 71.21 108.92 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 pt -113.49 143.93 22.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.833 0.853 . . . . 73.31 110.496 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.09 161.37 12.53 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.706 -1.134 . . . . 72.33 109.806 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 2.75 58.81 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.59 -0.732 . . . . 64.51 114.15 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.56 137.35 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.192 0.597 . . . . 74.44 110.441 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -142.72 -177.59 5.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.724 1.21 . . . . 64.22 109.653 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.89 -125.15 29.93 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.459 0.475 . . . . 71.31 112.537 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.5 t -82.56 -19.42 38.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.053 0.541 . . . . 74.31 111.012 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -71.34 -39.2 71.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.063 0.545 . . . . 74.14 110.992 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 95' ' ' ALA . 3.8 ppp? -70.95 -32.09 68.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.055 0.222 . . . . 72.3 110.478 175.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' N ' ' SD ' ' A' ' 94' ' ' MET . . . -75.97 -23.91 55.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.314 0.646 . . . . 65.32 111.215 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -83.98 -32.52 24.94 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.335 0.654 . . . . 73.15 109.56 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.1 t -67.35 -43.56 81.18 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.182 0.593 . . . . 72.23 110.3 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.8 mt -88.42 -31.44 18.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.289 -0.869 . . . . 75.54 111.84 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.09 3.77 58.55 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-O 119.62 -0.545 . . . . 65.14 114.241 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 134' ' ' ASP . . . -149.25 -65.58 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.504 0.652 . . . . 70.4 111.699 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 74.3 t80 -64.36 -68.95 0.31 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.11 0.964 . . . . 61.41 112.974 -168.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.6 m -66.34 -33.52 6.81 Favored Pre-proline 0 CA--C 1.571 1.754 0 N-CA-C 114.26 1.207 . . . . 63.44 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 56.2 Cg_endo -69.49 -22.41 33.38 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 121.813 1.675 . . . . 73.41 113.083 169.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.13 -19.48 61.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.229 0.468 . . . . 70.2 110.804 173.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.639 -0.875 . . . . 64.21 108.639 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -78.66 -29.78 45.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.249 1.02 . . . . 74.44 112.547 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -60.39 -45.12 97.44 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.064 1.135 . . . . 74.32 114.064 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.28 -31.71 34.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.894 1.73 . . . . 70.11 113.204 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -72.0 -37.67 69.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.912 0.485 . . . . 64.14 110.907 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.56 79.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.228 0.611 . . . . 61.32 109.628 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.495 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.8 ttm180 -52.23 -51.39 58.58 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 124.803 1.314 . . . . 73.42 110.382 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.77 -45.36 86.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.036 0.934 . . . . 74.03 111.537 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.404 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -57.58 -41.89 82.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.816 0.698 . . . . 64.11 110.451 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 118' ' ' VAL . 85.1 mt -69.11 -45.7 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.177 -0.919 . . . . 74.44 110.072 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.5 m -54.95 -40.73 70.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.438 0.695 . . . . 34.31 110.802 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 t -68.87 -53.46 21.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.923 -1.035 . . . . 71.14 110.306 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 mtp -51.94 -47.09 64.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.282 1.033 . . . . 71.22 111.734 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.406 HG22 ' SG ' ' A' ' 76' ' ' CYS . 75.4 t -63.84 -45.68 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.544 -1.207 . . . . 73.4 110.813 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -66.72 -28.6 68.56 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.275 0.63 . . . . 73.33 111.396 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.538 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.0 mtt-85 -72.07 -31.16 65.84 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.433 0.693 . . . . 55.24 110.296 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.81 1.79 82.35 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.205 -0.452 . . . . 54.42 113.133 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.1 m 64.99 24.84 12.66 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 125.361 1.464 . . . . 73.31 110.711 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -93.42 160.13 33.73 Favored Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 114.559 -1.2 . . . . 74.24 110.263 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.54 137.52 57.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 124.398 3.399 . . . . 74.44 115.38 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -50.34 122.98 7.69 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.651 0.594 . . . . 61.5 110.549 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD21 HG11 ' A' ' 64' ' ' VAL . 21.4 tp -118.99 105.27 11.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.491 -1.232 . . . . 72.02 109.63 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -135.7 107.99 7.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.44 -1.254 . . . . 70.35 107.877 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.9 146.76 54.49 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.761 0.824 . . . . 73.42 111.893 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.25 148.18 96.09 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.734 0.813 . . . . 73.22 111.175 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.76 105.28 0.19 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.775 2.317 . . . . 71.51 112.834 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.35 116.91 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.998 -0.742 . . . . 52.33 108.998 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -93.14 77.97 4.58 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.369 1.068 . . . . 74.01 108.422 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -55.79 -34.89 65.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.7 1.2 . . . . 73.21 112.725 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB3' ' HB1' ' A' ' 100' ' ' ALA . 6.0 p-10 . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 123.849 0.86 . . . . 54.3 112.097 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 61.2 m . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 108.175 -1.046 . . . . 61.41 108.175 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.72 124.24 11.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.388 0.675 . . . . 71.34 109.274 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.5 132.94 21.98 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.885 0.474 . . . . 62.22 110.102 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.643 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -77.39 120.73 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.186 -0.915 . . . . 74.42 108.83 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -86.24 -50.26 7.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.329 -0.396 . . . . 74.42 111.055 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.52 140.02 5.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.467 0.307 . . . . 73.23 110.424 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.643 HG13 HD11 ' B' ' 13' ' ' ILE . 90.6 mt -115.53 139.48 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.107 0.963 . . . . 72.34 108.879 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -164.89 164.76 20.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.731 0.777 . . . . 74.12 112.219 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.449 HG21 HD11 ' B' ' 21' ' ' ILE . 97.3 m -93.74 124.69 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.99 -1.004 . . . . 70.51 108.474 171.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -88.9 -33.49 17.29 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.124 0.57 . . . . 61.1 110.677 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -155.31 142.29 19.14 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.164 0.431 . . . . 74.2 112.164 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.449 HD11 HG21 ' B' ' 18' ' ' THR . 47.5 mm -133.13 142.16 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.492 1.117 . . . . 72.52 109.301 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 58.6 m -143.13 131.67 22.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.597 -1.183 . . . . 51.52 108.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -144.12 107.6 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.808 -1.552 . . . . 72.0 106.808 167.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -119.23 115.46 24.25 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.844 -0.799 . . . . 75.14 108.844 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -107.17 88.28 3.72 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.583 1.153 . . . . 75.31 109.185 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.45 -44.1 1.77 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.722 2.281 . . . . 63.14 112.681 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -102.61 23.0 12.64 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.964 0.906 . . . . 71.32 109.705 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.864 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.5 -46.67 59.49 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 115.774 1.768 . . . . 72.41 115.774 -174.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.0 Cg_exo -75.79 -29.65 6.83 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.286 1.99 . . . . 53.42 112.325 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -94.36 1.0 55.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.39 1.076 . . . . 71.34 111.557 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 28' ' ' ALA . 4.5 p -83.57 -17.19 10.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 C-N-CA 123.38 0.672 . . . . 71.31 110.419 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.59 -28.66 63.82 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 118.481 0.582 . . . . 73.51 112.093 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -73.65 -45.77 50.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.446 0.698 . . . . 70.52 111.07 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.522 ' HB3' HD13 ' B' ' 68' ' ' LEU . 10.9 mmmm -107.37 62.62 0.62 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.288 1.035 . . . . 64.35 108.97 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -119.07 80.73 1.59 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.691 -0.855 . . . . 72.13 108.691 -171.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -152.64 -177.27 6.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.087 0.955 . . . . 74.0 109.511 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -59.53 109.19 1.75 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.509 0.724 . . . . 52.11 110.835 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -86.34 173.87 6.35 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.587 2.191 . . . . 72.04 112.902 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.28 103.77 4.09 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.385 -1.339 . . . . 65.13 107.385 164.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.41 151.9 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.699 -1.137 . . . . 50.44 110.492 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.413 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 55.5 mtpt -138.11 138.81 39.07 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.116 0.966 . . . . 72.41 109.393 175.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.76 126.25 45.79 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.992 -1.855 . . . . 70.45 105.992 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.1 t70 -124.7 139.95 53.39 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.423 -0.955 . . . . 72.34 108.423 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.446 ' H ' HD23 ' B' ' 44' ' ' LEU . 2.6 pt? -125.55 141.19 52.17 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.021 -0.733 . . . . 73.4 109.021 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.2 t70 -130.45 137.36 49.77 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.139 0.976 . . . . 60.24 108.575 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -108.69 103.11 12.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.841 0.857 . . . . 64.31 110.393 -172.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 141.07 50.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.218 1.007 . . . . 64.14 109.416 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 p -145.58 168.45 20.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.166 0.586 . . . . 53.13 110.903 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.72 138.64 18.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.11 0.564 . . . . 60.32 110.482 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -82.45 101.27 10.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.079 -0.711 . . . . 54.02 109.079 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 mt -74.54 -35.99 63.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.305 0.642 . . . . 74.54 109.996 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.23 -174.2 3.43 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.295 -1.32 . . . . 75.43 109.232 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.61 128.06 35.27 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.133 -0.94 . . . . 73.22 109.821 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 67.62 -5.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.437 1.495 . . . . 74.22 112.955 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.91 115.14 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.808 . . . . 72.43 109.146 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.91 143.38 50.77 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.369 0.668 . . . . 60.14 110.416 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -99.8 116.16 31.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.144 -1.058 . . . . 70.24 108.144 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -91.42 118.02 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.038 0.935 . . . . 64.44 109.001 172.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -114.42 112.64 40.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.053 0.941 . . . . 71.02 108.561 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.93 108.68 20.31 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.872 -1.158 . . . . 74.34 107.872 176.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.638 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 18.9 ttm-85 -85.58 112.41 20.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.78 -0.822 . . . . 73.22 108.78 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.35 103.02 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.872 -1.159 . . . . 61.32 107.872 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.0 m -100.96 130.95 47.04 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.055 -0.72 . . . . 70.13 109.055 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.462 HG11 HD21 ' B' ' 126' ' ' LEU . 68.9 t -117.53 115.86 49.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 85.8 m -92.57 141.67 28.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.147 0.979 . . . . 41.44 108.612 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.77 121.5 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.723 -0.843 . . . . 64.05 108.723 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 40.4 p -147.2 127.8 14.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.637 0.775 . . . . 43.44 109.456 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.721 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.3 OUTLIER -118.31 134.6 54.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.446 0.698 . . . . 54.52 109.305 -176.049 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.78 -118.28 6.43 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.206 -0.758 . . . . 74.14 111.206 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.17 11.35 12.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.874 0.87 . . . . 64.33 110.315 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -127.67 158.96 36.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.677 0.791 . . . . 74.12 110.682 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -78.81 135.99 37.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.942 -0.572 . . . . 74.21 110.328 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.721 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -83.72 -64.75 1.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.901 0.858 . . . . 75.43 108.993 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.83 152.95 16.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.563 -1.653 . . . . 44.21 108.094 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -123.74 137.02 54.77 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.324 -0.991 . . . . 63.33 108.324 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.0 t -134.18 148.18 50.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.809 -0.812 . . . . 54.11 108.809 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.7 tt0 -156.16 138.8 15.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.925 -0.768 . . . . 61.41 108.925 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -132.14 145.27 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.403 1.081 . . . . 74.5 108.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -118.82 97.1 5.54 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.285 -1.376 . . . . 60.23 107.285 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -87.74 100.11 12.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.043 -1.095 . . . . 74.02 108.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.37 157.65 25.92 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.392 -1.083 . . . . 63.41 110.392 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.93 125.65 1.37 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.177 -0.769 . . . . 42.23 111.177 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.7 130.91 35.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.825 -0.805 . . . . 53.22 108.825 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.72 165.63 22.48 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.109 0.963 . . . . 64.15 108.633 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.35 120.91 26.39 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.921 -0.77 . . . . 73.13 108.921 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 36.7 pt -119.13 145.81 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.584 1.153 . . . . 72.21 110.742 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.21 157.67 36.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.608 1.163 . . . . 73.25 108.682 172.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -42.39 2.57 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 116.856 -0.156 . . . . 55.21 112.889 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 35.5 pt -79.31 149.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.086 0.555 . . . . 72.22 110.655 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -170.64 160.08 6.97 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 70.3 109.376 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.77 -119.42 12.22 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.398 0.436 . . . . 73.21 112.452 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.0 m -73.69 -28.55 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.929 0.892 . . . . 74.23 111.292 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.97 -24.39 62.4 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 72.33 112.317 -167.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.5 ptp -67.25 -32.02 72.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.938 -0.574 . . . . 61.12 110.592 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -22.14 66.6 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.603 0.761 . . . . 73.54 112.027 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -83.83 -45.9 12.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.934 0.494 . . . . 74.12 109.907 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -74.95 -67.8 0.61 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.181 -0.463 . . . . 74.33 111.457 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.0 pp -80.73 -20.75 42.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 119.488 -0.291 . . . . 73.3 111.683 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.9 -32.57 26.29 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 113.887 0.315 . . . . 62.44 113.887 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.18 -59.23 2.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 71.51 110.899 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -67.17 -45.62 76.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.462 0.705 . . . . 74.44 112.779 -169.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 60.4 m -65.99 -45.07 63.28 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.606 -0.712 . . . . 63.42 112.761 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -34.48 98.29 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 122.303 2.002 . . . . 71.22 112.901 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -66.61 -27.63 67.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.117 0.567 . . . . 64.11 111.905 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.93 -45.41 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.221 0.608 . . . . 34.4 110.049 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.13 -17.42 49.94 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.478 -0.783 . . . . 74.14 111.692 -174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -61.17 -47.22 95.3 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.602 1.161 . . . . 72.33 113.944 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.41 -35.44 83.23 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.027 1.818 . . . . 51.34 112.978 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -68.9 -44.67 72.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.356 0.662 . . . . 74.41 110.618 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.36 0.664 . . . . 71.55 110.475 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.575 HH12 HD11 ' D' ' 16' ' ' ILE . 33.6 mtp180 -54.87 -60.46 3.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.191 0.996 . . . . 71.42 111.262 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.57 -31.71 70.83 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.244 0.965 . . . . 72.24 110.519 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.538 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.9 t -73.76 -37.74 64.94 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.967 -0.56 . . . . 44.24 111.344 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.441 HD13 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -67.09 -45.63 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 123.134 0.574 . . . . 74.33 109.836 174.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.515 HG21 ' OG ' ' C' ' 119' ' ' SER . 10.2 m -62.13 -39.67 93.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 73.51 111.385 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -61.68 -42.35 98.8 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.787 0.835 . . . . 71.22 110.516 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.516 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 10.0 mmt -72.48 -31.58 65.51 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.726 0.41 . . . . 55.24 111.186 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.624 HG21 HD23 ' B' ' 126' ' ' LEU . 92.8 t -65.83 -41.23 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.803 0.841 . . . . 75.44 110.221 172.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 53.0 m -64.31 -36.85 85.46 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.18 0.992 . . . . 55.02 111.05 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.516 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 84.0 mtt-85 -71.05 -27.58 63.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.815 -0.629 . . . . 71.03 110.714 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.04 14.51 61.86 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.513 -0.604 . . . . 74.32 113.082 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 55.05 45.69 25.73 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.397 1.479 . . . . 74.4 113.12 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -119.87 149.25 48.28 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.657 0.783 . . . . 74.21 110.253 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.59 -165.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.352 3.368 . . . . 74.13 114.945 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.465 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.7 tp60 -60.13 128.51 37.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.564 1.146 . . . . 72.34 113.587 -168.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.624 HD23 HG21 ' B' ' 118' ' ' VAL . 12.3 tp -136.05 108.86 7.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 71.22 108.59 165.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -128.46 135.75 49.89 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.382 -0.969 . . . . 74.4 108.382 167.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.25 139.27 34.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.924 -0.769 . . . . 73.52 108.924 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.94 148.18 98.43 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.698 0.799 . . . . 71.12 111.504 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.36 92.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.159 2.573 . . . . 72.13 111.504 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.86 108.34 19.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.804 -0.813 . . . . 73.42 108.804 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -83.16 109.18 16.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.34 -1.356 . . . . 71.22 107.34 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 122.53 0.332 . . . . 75.12 111.145 -178.533 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 56.9 ttp . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.165 0.507 . . . . 74.23 112.364 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.6 m -98.54 101.85 13.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.181 -1.044 . . . . 60.34 108.181 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -120.14 134.97 55.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.354 0.662 . . . . 74.05 110.03 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' C' ' 85' ' ' SER . 29.3 pt20 -154.92 144.48 21.38 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.998 0.919 . . . . 75.34 108.769 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -88.84 112.55 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.35 -50.53 10.71 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.078 -0.389 . . . . 75.1 111.02 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -166.91 125.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.335 -0.617 . . . . 53.12 109.335 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.19 141.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 107.865 -1.161 . . . . 61.5 107.865 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.518 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.2 p90 -173.23 159.88 3.92 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.644 0.735 . . . . 73.32 112.187 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.2 114.63 22.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.747 -0.834 . . . . 73.33 108.747 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -80.7 -33.87 35.04 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.128 0.49 . . . . 72.43 110.112 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 33.5 t70 -147.33 139.51 24.47 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.429 -0.805 . . . . 51.44 109.395 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -140.04 139.69 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.632 -1.247 . . . . 50.44 107.632 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 61.8 m -148.46 146.76 28.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.197 0.599 . . . . 55.42 110.54 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -145.08 107.62 4.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.472 -1.677 . . . . 71.5 106.472 165.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -118.82 109.63 16.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.165 -0.68 . . . . 75.44 109.165 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.28 80.7 12.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.137 -1.06 . . . . 74.34 108.137 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.98 -18.57 35.89 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.073 2.515 . . . . 64.41 112.041 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.94 32.69 5.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.052 0.941 . . . . 71.35 110.041 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -51.64 -51.31 71.09 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 113.813 1.042 . . . . 73.4 113.813 -175.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 11.5 Cg_exo -72.89 -30.76 10.86 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.175 1.916 . . . . 51.24 113.786 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -70.3 -40.1 74.45 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.14 0.576 . . . . 74.43 111.719 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 7.3 p -78.68 -20.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.665 0.786 . . . . 61.35 110.72 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -62.26 -20.79 64.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.948 1.299 . . . . 74.35 111.451 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -122.5 23.58 9.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 72.5 111.415 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 2.1 tppp? -98.0 146.79 25.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.2 0.6 . . . . 71.41 109.772 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.71 122.71 17.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.928 0.891 . . . . 74.3 110.276 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -72.07 90.32 1.18 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.842 0.857 . . . . 71.52 111.571 -166.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -127.67 64.11 62.57 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 124.078 0.951 . . . . 74.34 108.924 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.95 109.21 1.01 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.469 2.779 . . . . 71.52 113.302 -165.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -84.55 106.37 16.08 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.504 -0.925 . . . . 72.35 108.504 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -84.38 139.72 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.892 -1.049 . . . . 75.34 109.369 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.431 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 23.6 mtpp -131.87 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 71.1 109.038 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -91.72 120.31 32.35 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.255 -1.387 . . . . 74.1 107.255 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.726 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 2.1 m-20 -119.94 104.3 10.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.254 1.022 . . . . 53.43 108.421 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 110.97 23.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.506 -1.294 . . . . 61.32 107.506 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.7 t70 -116.35 149.25 39.63 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.36 1.464 . . . . 71.44 108.53 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.8 p -120.5 143.13 48.71 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.086 0.554 . . . . 73.45 109.756 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.22 145.92 33.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.178 0.991 . . . . 64.11 108.654 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -160.6 146.85 15.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.963 0.347 . . . . 64.22 111.213 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -154.35 144.01 21.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.836 0.854 . . . . 43.2 109.752 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.73 122.99 27.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.845 0.458 . . . . 73.13 109.813 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.3 mt -95.85 -36.4 11.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.485 0.714 . . . . 65.3 110.661 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -156.22 -177.51 6.64 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.172 -0.922 . . . . 54.12 109.976 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -65.22 116.65 6.79 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.013 -0.994 . . . . 75.52 109.592 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 54' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 23.6 m-20 67.05 12.12 8.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.953 1.301 . . . . 73.15 112.048 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 69.2 t -119.05 107.38 21.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.244 1.018 . . . . 72.53 109.096 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD13 ' C' ' 86' ' ' ILE . 89.7 m-85 -116.74 134.45 54.79 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.23 1.012 . . . . 74.24 108.62 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.616 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.7 tt0 -83.58 119.58 24.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.752 -0.658 . . . . 72.54 109.294 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.55 118.97 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.792 -1.188 . . . . 71.25 107.792 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.82 133.76 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.564 0.746 . . . . 74.43 109.168 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.573 HD23 HD12 ' C' ' 106' ' ' LEU . 4.1 mm? -118.96 106.38 12.4 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.324 1.05 . . . . 75.24 108.699 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.6 ttm-85 -81.07 106.51 13.13 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.855 -1.165 . . . . 73.13 107.855 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.72 119.51 50.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.766 -1.198 . . . . 71.15 107.766 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 55.9 m -116.39 141.08 48.63 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.951 -1.129 . . . . 62.21 107.951 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -135.34 128.0 47.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 71.34 107.671 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.0 m -122.57 125.84 46.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.705 -0.85 . . . . 72.11 108.705 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.49 123.64 48.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.535 -1.283 . . . . 63.23 107.535 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.8 m -143.44 123.9 13.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.877 0.471 . . . . 52.51 110.746 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.08 57.65 3.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.649 1.18 . . . . 75.35 109.798 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.45 -111.53 4.05 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 110.558 -1.017 . . . . 54.23 110.558 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -89.53 -28.09 19.85 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.732 0.813 . . . . 72.21 109.429 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.91 117.65 7.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.043 -0.98 . . . . 74.21 110.175 173.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 87.8 m -87.6 125.64 34.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.706 -0.849 . . . . 60.21 108.706 167.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.07 -63.02 1.36 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.572 -1.195 . . . . 71.54 109.806 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.34 177.11 11.83 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 114.85 -1.068 . . . . 62.13 111.217 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.416 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -135.98 147.51 48.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.83 -1.915 . . . . 54.34 105.83 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.3 t -150.48 113.08 4.71 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.148 -1.056 . . . . 54.31 108.148 176.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.4 126.78 31.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.207 -0.664 . . . . 72.33 109.207 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' C' ' 113' ' ' CYS . 80.2 t -130.21 113.74 26.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.917 0.887 . . . . 62.11 108.842 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.616 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -89.83 90.52 8.23 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.849 -1.167 . . . . 64.35 107.849 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -81.25 104.04 11.44 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.473 -1.239 . . . . 71.33 109.46 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.85 150.73 19.73 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 112.08 -0.408 . . . . 62.41 112.08 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.34 125.0 1.98 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.226 -1.15 . . . . 43.5 110.226 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.514 HD12 HD11 ' C' ' 51' ' ' LEU . 9.8 mm -81.93 126.52 39.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.759 -1.2 . . . . 71.23 107.759 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -136.51 154.72 50.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.419 0.688 . . . . 74.24 109.144 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 31.2 m -96.45 116.12 28.55 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.459 -0.941 . . . . 74.43 108.459 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' C' ' 56' ' ' TYR . 3.8 mp -116.73 118.16 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.503 -0.925 . . . . 75.51 108.503 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -153.21 170.51 20.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.134 0.974 . . . . 74.03 110.054 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.4 -59.39 0.4 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.54 -0.3 . . . . 65.22 113.434 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.23 -179.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.383 0.673 . . . . 63.43 112.176 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.93 -173.31 4.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 63.11 109.822 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.21 -140.76 38.13 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.533 0.521 . . . . 71.32 113.305 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -75.2 -17.64 60.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.856 0.863 . . . . 71.24 112.182 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -73.47 -36.58 65.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.025 0.53 . . . . 70.13 110.595 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -72.15 -41.63 66.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.373 -0.603 . . . . 74.22 109.373 174.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.89 66.07 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.854 -1.066 . . . . 64.52 111.568 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.575 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 39.9 t-80 -66.84 -41.66 87.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 74.32 111.254 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -77.74 -57.43 3.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.856 -0.424 . . . . 63.01 109.856 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.44 -39.65 94.03 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.366 1.066 . . . . 53.35 112.542 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.81 11.21 57.6 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.543 -0.587 . . . . 71.23 114.155 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -144.63 -63.41 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.59 0.695 . . . . 71.22 111.51 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -69.34 -55.12 11.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.723 0.409 . . . . 74.4 111.887 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.9 m -55.88 -44.77 99.84 Favored Pre-proline 0 CA--C 1.573 1.85 0 C-N-CA 123.581 0.752 . . . . 71.53 112.567 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -51.18 -43.46 48.5 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.062 2.508 . . . . 75.31 114.344 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 104' ' ' ASN . . . . . 0.421 HD22 ' N ' ' C' ' 104' ' ' ASN . 0.9 OUTLIER -74.24 -20.19 60.25 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.463 0.705 . . . . 63.11 111.715 -174.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.495 HD12 ' NH1' ' A' ' 111' ' ' ARG . 32.3 mm -76.88 -44.86 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.984 0.514 . . . . 73.42 110.061 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.573 HD12 HD23 ' C' ' 60' ' ' LEU . 73.1 mt -81.61 -18.72 43.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.044 -0.526 . . . . 74.03 112.004 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -57.11 -54.25 56.63 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 117.72 -1.133 . . . . 72.5 113.08 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.79 -27.45 84.84 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.026 1.818 . . . . 71.12 113.221 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -71.08 -45.98 62.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.208 0.603 . . . . 73.21 110.79 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.59 84.65 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.795 -0.638 . . . . 71.51 110.315 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.719 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 33.6 ttt180 -60.13 -47.88 84.07 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.489 1.516 . . . . 75.22 111.47 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -38.71 86.15 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.907 0.755 . . . . 75.51 109.765 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.512 ' HB3' HG21 ' C' ' 78' ' ' VAL . 12.2 m -58.5 -46.67 86.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.38 0.672 . . . . 51.02 112.357 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.53 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 86.9 mt -66.16 -48.43 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 122.916 0.486 . . . . 63.02 110.762 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.6 m -65.81 -32.71 74.39 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.088 0.555 . . . . 50.04 111.272 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -69.41 -37.99 77.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.325 0.65 . . . . 74.53 109.98 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.471 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -70.9 -35.97 72.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.661 0.784 . . . . 74.11 111.514 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.8 t -63.76 -37.31 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.543 -0.54 . . . . 61.13 109.543 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.515 ' OG ' HG21 ' B' ' 115' ' ' THR . 42.1 t -67.77 -35.34 78.52 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.85 0.86 . . . . 70.14 112.194 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.68 -32.46 65.81 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.2 0.6 . . . . 74.33 110.022 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.2 1.6 86.66 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.465 0.478 . . . . 71.41 112.612 171.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p 62.42 19.59 11.25 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.836 2.054 . . . . 70.45 113.17 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.64 150.04 45.31 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.09 0.956 . . . . 74.31 109.43 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.465 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 35.7 Cg_endo -62.54 113.25 1.87 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.722 2.281 . . . . 74.14 111.442 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -55.47 141.79 35.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.254 -1.339 . . . . 63.03 113.168 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.36 121.24 36.23 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.822 -1.548 . . . . 75.3 106.822 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.86 126.55 41.19 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.941 0.896 . . . . 72.42 108.653 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.719 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -63.92 145.02 56.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.218 0.607 . . . . 73.52 110.403 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.49 164.33 45.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.095 0.958 . . . . 53.12 111.232 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -66.52 117.26 4.59 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.064 1.842 . . . . 70.23 111.729 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.36 109.34 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.944 0.878 . . . . 73.44 108.964 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -107.9 94.4 5.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.044 -0.98 . . . . 75.14 109.708 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -75.9 -40.59 54.1 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.139 -0.689 . . . . 74.1 109.139 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.422 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 11.3 p-10 . . . . . 0 N--CA 1.47 0.548 0 C-N-CA 123.824 0.85 . . . . 74.13 110.91 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 72.52 107.989 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -154.66 98.36 2.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.01 -1.107 . . . . 65.33 108.01 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -131.26 125.9 34.04 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.604 -1.258 . . . . 54.42 107.604 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mt -69.59 124.42 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.504 -0.924 . . . . 62.43 108.504 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.483 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 19.7 mm-40 -74.31 -48.98 24.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.707 -0.479 . . . . 74.43 109.707 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -161.85 156.63 22.86 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.824 1.25 . . . . 75.02 109.845 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.575 HD11 HH12 ' B' ' 111' ' ' ARG . 0.2 OUTLIER -126.87 125.41 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 105.631 -1.988 . . . . 70.51 105.631 165.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.479 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 32.4 p90 -155.36 153.74 30.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.889 0.852 . . . . 74.05 110.707 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.77 110.75 12.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.172 -1.376 . . . . 52.03 108.438 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.479 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.7 mtpt -77.57 -36.54 51.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.061 -0.718 . . . . 74.12 109.061 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.5 t70 -140.49 137.86 34.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.537 -1.21 . . . . 74.15 109.324 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.471 HG21 ' HE2' ' C' ' 117' ' ' MET . 90.2 mt -132.81 142.95 41.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.821 1.249 . . . . 73.22 107.963 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -147.16 136.54 22.68 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.569 1.148 . . . . 74.31 108.653 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.404 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -143.36 123.58 13.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.592 -1.633 . . . . 75.52 106.592 167.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.3 mt-10 -127.37 127.03 43.54 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.397 0.679 . . . . 71.32 109.269 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.72 84.18 8.04 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.549 -1.649 . . . . 72.1 106.549 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.46 -30.22 12.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.823 2.349 . . . . 71.23 112.633 -167.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -115.26 36.36 3.95 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.266 1.026 . . . . 53.33 108.89 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.518 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -48.48 -61.54 3.1 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 115.076 1.51 . . . . 70.34 115.076 -165.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.487 ' HB3' HD11 ' C' ' 83' ' ' ILE . 33.0 Cg_endo -85.65 -4.03 9.13 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 122.671 1.99 . . . . 51.44 113.075 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -80.92 -42.0 22.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 74.0 109.414 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.744 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.0 p -76.27 -34.02 24.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.248 -0.887 . . . . 63.53 110.295 -173.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -57.23 -16.78 9.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.12 0.968 . . . . 72.43 113.403 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.59 -37.21 60.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.887 0.475 . . . . 75.33 110.535 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -130.85 57.93 1.72 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.461 0.304 . . . . 73.52 110.899 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -100.7 94.96 6.35 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.354 -0.841 . . . . 55.23 109.556 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.403 ' H ' HD22 ' D' ' 68' ' ' LEU . 16.4 m95 -124.08 -164.85 1.28 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.576 -1.638 . . . . 74.01 106.576 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 37' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 0.0 OUTLIER -51.41 106.65 0.68 Allowed Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 119.167 0.894 . . . . 74.34 112.172 -176.413 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 4.7 Cg_exo -78.35 144.82 20.77 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.589 2.193 . . . . 73.41 111.291 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -79.09 112.89 16.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.276 -1.379 . . . . 61.55 107.276 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.9 142.58 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.496 0.718 . . . . 72.34 110.099 -168.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -118.89 147.46 43.96 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.534 1.134 . . . . 71.33 109.421 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.44 HD21 HD21 ' D' ' 128' ' ' LEU . 95.1 mt -106.83 118.38 36.54 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.04 -1.096 . . . . 73.0 108.04 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.622 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.3 t70 -106.46 129.93 54.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.908 -1.145 . . . . 75.33 107.908 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.82 156.52 18.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.698 0.799 . . . . 75.32 111.106 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.3 t70 -168.16 129.29 1.37 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.274 -0.876 . . . . 70.01 109.265 172.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -106.09 148.49 27.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.647 0.779 . . . . 64.0 110.072 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.85 155.53 40.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.93 0.892 . . . . 50.25 108.789 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.0 p -163.17 153.91 16.53 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.275 0.63 . . . . 71.45 110.441 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.3 p -163.7 143.52 8.36 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.539 0.736 . . . . 61.45 110.079 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -78.4 122.59 25.99 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.463 -0.569 . . . . 71.22 109.463 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -93.05 -39.43 11.09 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.454 -0.573 . . . . 70.3 109.454 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -153.5 -176.67 5.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 75.04 110.49 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.34 119.85 13.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.201 -0.909 . . . . 50.33 109.594 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 64.03 7.02 3.12 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.811 1.245 . . . . 71.31 112.686 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 56.1 t -114.89 108.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.365 -0.976 . . . . 71.31 108.365 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -128.39 129.71 46.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.649 -1.16 . . . . 62.15 108.776 -169.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -96.69 129.26 44.13 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.267 1.027 . . . . 71.14 109.919 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.4 t -110.9 116.98 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.81 -1.182 . . . . 51.51 107.81 170.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.4 t -99.66 131.88 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.521 -0.918 . . . . 50.35 108.521 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.85 108.92 12.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.064 -1.087 . . . . 64.24 108.064 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.4 ttm180 -85.54 113.08 21.51 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.481 0.713 . . . . 73.22 109.796 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.49 103.43 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.26 -1.015 . . . . 74.42 108.26 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.4 m -102.37 138.87 38.73 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.097 -0.705 . . . . 65.25 109.097 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.63 122.61 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.203 1.001 . . . . 74.12 109.91 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 39.8 m -120.49 100.37 7.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.987 0.915 . . . . 51.32 109.59 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 133.7 42.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.333 0.653 . . . . 74.23 109.879 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 20.7 m -148.03 126.7 12.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.064 0.946 . . . . 75.52 109.636 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.0 pp -126.53 140.26 52.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.267 0.627 . . . . 72.53 111.404 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 -111.84 3.72 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.196 -1.161 . . . . 55.23 110.196 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 4.47 9.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 63.1 110.797 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.99 173.7 7.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.981 0.512 . . . . 54.21 110.542 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -82.09 139.15 34.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 52.13 109.638 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.744 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.7 -67.36 0.8 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.567 -0.901 . . . . 24.35 108.567 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -155.2 164.89 38.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.443 -1.253 . . . . 64.3 110.061 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 94.6 mt -134.38 151.68 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.229 1.412 . . . . 74.11 108.529 -176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.577 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.6 t -158.22 148.11 19.92 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.229 0.612 . . . . 52.14 110.097 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.59 126.05 6.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.476 0.71 . . . . 74.11 109.593 171.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.23 114.79 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.899 0.48 . . . . 71.43 109.772 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.8 mt-30 -90.56 88.78 7.27 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.949 -0.76 . . . . 74.5 108.949 173.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.34 96.39 6.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.657 -1.156 . . . . 72.32 109.328 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.01 141.64 17.81 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.046 -0.822 . . . . 63.13 111.046 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.41 128.59 4.56 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 110.537 -1.025 . . . . 61.15 110.537 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 29.5 mt -93.39 127.04 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.987 -1.116 . . . . 71.11 107.987 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -128.78 126.66 40.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.658 0.783 . . . . 63.21 110.18 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -82.99 93.4 7.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.602 -0.888 . . . . 63.23 108.602 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.9 mt -108.45 109.73 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.772 -0.825 . . . . 72.41 108.772 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.48 167.15 21.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.16 0.984 . . . . 62.31 110.428 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.94 0.78 57.32 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.787 0.675 . . . . 64.41 114.787 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 29.0 pt -137.92 162.21 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.513 1.125 . . . . 74.44 109.73 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.29 3.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.326 1.051 . . . . 73.34 109.501 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.41 -122.79 29.31 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 115.514 0.966 . . . . 75.32 115.514 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -60.31 -54.13 49.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.911 1.284 . . . . 54.22 112.137 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -70.94 -39.72 72.45 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.383 0.427 . . . . 71.45 111.752 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -42.89 59.23 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.908 0.483 . . . . 74.43 111.269 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.92 83.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.94 0.496 . . . . 72.34 110.817 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -74.7 -27.18 60.28 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.681 -0.69 . . . . 75.34 110.771 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.51 -50.76 64.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.036 0.534 . . . . 71.01 110.381 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.66 -17.51 53.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.404 0.282 . . . . 74.54 111.391 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.36 -5.7 84.81 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.327 0.392 . . . . 71.34 114.069 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.12 -59.03 0.31 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.908 0.354 . . . . 64.32 111.534 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -74.38 -53.71 9.07 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.413 0.685 . . . . 62.21 112.118 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.45 -43.27 88.55 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.053 1.131 . . . . 74.33 114.053 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.79 -29.15 50.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.823 1.682 . . . . 64.54 111.874 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.9 -22.32 59.74 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.191 0.996 . . . . 73.12 110.664 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.1 mm -76.95 -45.01 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.387 0.675 . . . . 74.03 109.95 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.7 mt -72.47 -30.98 65.04 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.576 -0.738 . . . . 71.5 111.807 -174.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.78 -41.96 60.14 Favored Pre-proline 0 CA--C 1.568 1.662 0 N-CA-C 114.405 1.261 . . . . 62.24 114.405 -169.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.48 -39.56 74.02 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.381 2.054 . . . . 61.11 113.578 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -75.72 -35.5 60.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.612 0.765 . . . . 74.3 110.913 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.8 79.01 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.234 0.614 . . . . 72.4 110.279 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -59.6 -46.17 89.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.626 1.17 . . . . 71.13 110.78 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.73 -44.78 96.24 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.141 0.901 . . . . 74.3 111.014 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.82 -45.14 93.3 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.864 0.728 . . . . 74.3 110.691 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.577 HG12 ' SG ' ' D' ' 76' ' ' CYS . 57.6 mt -59.53 -54.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.017 0.927 . . . . 74.24 110.686 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -47.62 66.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.481 1.112 . . . . 62.42 111.302 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.06 -42.8 93.87 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.425 -1.261 . . . . 51.53 110.809 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.416 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -70.68 -37.34 73.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.777 0.431 . . . . 53.22 111.812 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.442 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -65.15 -41.51 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.684 -0.689 . . . . 74.53 109.774 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -72.21 -29.04 63.58 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 122.985 0.514 . . . . 55.03 111.241 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -70.82 -29.07 65.13 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.397 0.679 . . . . 70.11 110.418 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 10.1 60.11 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.954 -0.566 . . . . 42.03 112.576 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.9 p 59.87 23.43 12.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.853 2.061 . . . . 74.13 112.985 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 51.5 m-85 -88.84 174.61 4.83 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 125.193 1.397 . . . . 65.33 108.831 170.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 33.9 Cg_endo -59.21 167.36 6.04 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.913 2.408 . . . . 75.31 113.929 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -73.82 131.28 41.37 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.937 -1.135 . . . . 74.45 107.937 164.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.46 93.59 4.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.706 -1.22 . . . . 64.51 107.706 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -98.23 99.01 10.2 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.539 -1.282 . . . . 71.21 107.539 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.44 HD21 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -71.08 136.03 48.04 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.768 -0.651 . . . . 73.24 109.664 -176.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.81 137.31 87.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.417 1.087 . . . . 73.21 111.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' B' ' 13' ' ' ILE . 16.9 Cg_exo -68.91 106.26 1.48 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.935 2.423 . . . . 44.23 111.921 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.81 109.16 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.554 0.741 . . . . 45.11 109.152 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -85.73 106.88 17.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.338 0.655 . . . . 44.41 109.795 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 124.148 0.979 . . . . 72.31 111.429 -179.718 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.241 0.633 0 N-CA-C 108.391 -0.966 . . . . 41.51 108.391 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -134.25 134.87 42.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.168 -0.678 . . . . 73.4 109.168 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -152.39 117.71 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.89 -1.152 . . . . 75.45 107.89 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.402 HG12 ' HD2' ' A' ' 84' ' ' PHE . 51.5 mt -75.07 126.78 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.123 -0.695 . . . . 63.24 109.123 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -92.04 -37.93 12.52 Favored 'General case' 0 C--O 1.243 0.758 0 O-C-N 123.829 0.705 . . . . 74.14 110.793 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -176.92 127.92 0.17 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.78 0.675 . . . . 72.4 111.629 -173.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.52 136.62 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.328 -0.99 . . . . 61.43 108.328 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 26.1 p90 -170.02 156.45 6.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 64.15 111.226 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -82.27 113.55 20.16 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.801 -0.814 . . . . 71.53 108.801 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -75.04 -31.23 61.26 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.66 -0.496 . . . . 74.52 109.66 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -150.88 141.13 22.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.008 -0.996 . . . . 61.52 109.889 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -134.67 143.86 36.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 125.503 1.521 . . . . 64.14 107.167 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 35.9 t -153.02 132.83 13.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.841 0.856 . . . . 64.13 108.738 174.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 82.4 t80 -139.87 119.21 12.91 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.78 -1.563 . . . . 72.42 106.78 174.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.19 131.09 54.85 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.147 0.579 . . . . 65.21 109.869 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.62 77.67 63.8 Favored Pre-proline 0 C--O 1.243 0.761 0 N-CA-C 106.709 -1.589 . . . . 63.35 106.709 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.75 -39.89 24.46 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.519 2.146 . . . . 74.02 111.764 -173.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.13 25.38 5.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.353 -0.84 . . . . 44.22 110.154 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -57.09 9.22 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 117.565 -1.207 . . . . 65.11 113.458 -169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.0 -21.78 68.33 Favored 'Trans proline' 0 C--N 1.398 3.135 0 CA-C-N 122.132 1.797 . . . . 44.13 112.804 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -85.07 -40.31 16.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.15 0.98 . . . . 74.4 110.643 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.9 p -76.92 -20.35 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.545 -0.752 . . . . 74.5 112.079 -159.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.002 0.521 . . . . 74.1 112.231 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -103.9 -11.13 17.67 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.43 0.692 . . . . 71.42 112.755 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HE3' ' HG2' ' A' ' 71' ' ' GLU . 20.9 mmtt -65.4 171.1 4.18 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.136 0.974 . . . . 73.13 113.598 -170.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.12 122.05 5.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.181 1.393 . . . . 71.44 111.948 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -86.95 63.26 7.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.085 0.554 . . . . 72.43 110.241 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -147.38 82.31 8.27 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 123.871 0.868 . . . . 50.44 109.082 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -84.47 165.52 12.39 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.98 2.454 . . . . 75.52 112.772 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.36 106.05 8.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.288 -1.375 . . . . 73.0 107.288 161.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 p -79.0 91.54 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 123.066 1.412 . . . . 74.24 108.467 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 40.6 tttm -83.7 118.15 23.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 113.924 -1.489 . . . . 52.23 109.89 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -97.22 111.35 23.63 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.388 -1.338 . . . . 70.42 107.388 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.67 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 19.6 m-20 -108.4 108.35 19.27 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.38 118.09 34.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.487 -1.301 . . . . 72.4 107.487 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.64 153.99 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.984 0.914 . . . . 64.43 109.074 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -135.16 156.61 48.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.07 0.948 . . . . 71.2 110.415 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -163.97 142.5 7.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 41.13 109.493 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.4 p -128.81 158.46 38.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.611 . . . . 60.43 109.532 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -154.85 136.77 14.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.933 0.893 . . . . 53.34 108.599 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -103.72 103.39 13.28 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.515 -0.92 . . . . 72.21 108.515 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.49 -31.21 37.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.339 0.655 . . . . 71.03 110.807 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -162.83 176.77 9.9 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.618 1.167 . . . . 72.12 109.243 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.69 135.91 54.75 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.091 -0.707 . . . . 74.3 109.091 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t70 69.36 -7.79 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.929 1.291 . . . . 65.43 111.975 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 90.9 t -119.88 98.24 6.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.667 0.787 . . . . 74.2 109.046 -172.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -120.57 125.28 47.4 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.734 -1.121 . . . . 74.11 108.386 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.78 131.48 39.1 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.921 0.888 . . . . 75.2 110.126 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.4 t -108.58 126.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.584 -1.265 . . . . 72.25 107.584 168.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 57.3 t -109.39 133.72 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.612 -0.884 . . . . 75.13 108.612 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -125.41 106.09 9.56 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.171 -1.418 . . . . 70.11 107.171 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.578 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 31.6 ttp180 -92.28 109.31 20.68 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 122.911 0.485 . . . . 61.32 109.745 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.69 126.84 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 106.934 -1.506 . . . . 53.11 106.934 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.67 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 98.0 m -123.82 123.26 40.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.498 -0.927 . . . . 54.53 108.498 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 69.8 t -116.51 108.25 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.184 0.994 . . . . 44.23 109.19 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 9.8 m -105.05 146.37 29.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.153 -0.684 . . . . 54.31 109.153 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 121.81 20.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.985 -1.117 . . . . 74.2 107.985 169.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.2 m -124.59 127.38 47.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.259 0.552 . . . . 73.32 110.86 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.67 85.26 7.05 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 126.134 1.773 . . . . 72.03 110.259 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.95 -80.88 1.55 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.897 -0.881 . . . . 72.1 110.897 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -130.75 -25.94 2.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.78 0.832 . . . . 65.03 110.83 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HG2' ' HE3' ' A' ' 34' ' ' LYS . 7.8 tp10 -82.96 134.91 35.04 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.648 0.779 . . . . 75.51 110.795 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 90.8 m -79.54 139.29 37.59 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 118.738 0.699 . . . . 63.25 111.893 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.838 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.79 -68.49 0.69 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.169 0.988 . . . . 71.51 110.512 170.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -152.82 167.28 29.58 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.492 -0.777 . . . . 72.25 111.126 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 tp -141.39 142.95 33.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.639 1.175 . . . . 65.2 108.65 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.2 m -142.37 104.53 4.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.633 0.373 . . . . 71.5 111.154 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 7.0 mp0 -103.5 132.86 49.39 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.259 -0.645 . . . . 71.31 109.259 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -140.4 110.38 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.16 -0.681 . . . . 62.44 109.16 173.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.7 mt-30 -85.27 85.39 7.46 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.139 -1.06 . . . . 74.24 108.139 171.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -77.23 97.03 4.69 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.102 -0.954 . . . . 74.34 108.887 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.71 146.16 20.52 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.434 -0.803 . . . . 73.13 111.5 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.597 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.39 120.82 1.25 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 110.397 -1.081 . . . . 73.44 110.397 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.0 mt -83.03 122.94 38.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.646 -0.872 . . . . 64.23 108.646 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.49 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 49.9 m-85 -126.37 120.49 29.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.133 -0.692 . . . . 73.31 109.133 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.7 t -81.67 104.48 12.1 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.001 -1.111 . . . . 72.32 108.001 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 pt -137.9 149.41 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 73.3 110.598 -171.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -173.75 177.99 2.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.988 1.315 . . . . 65.31 109.512 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.18 10.27 71.75 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.553 0.533 . . . . 74.2 114.061 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.19 138.08 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.89 0.876 . . . . 63.24 109.749 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -130.39 170.15 14.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.234 0.614 . . . . 62.22 110.841 -173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.42 -117.04 2.2 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.176 0.923 . . . . 75.33 115.22 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -64.25 -26.9 68.71 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.133 0.973 . . . . 73.23 112.261 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.06 -44.01 55.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.607 0.763 . . . . 71.44 110.828 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -71.17 -34.16 70.69 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.706 -0.479 . . . . 64.43 109.706 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.28 86.12 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.418 -0.81 . . . . 73.43 110.174 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -67.85 -29.6 68.77 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.154 -0.93 . . . . 75.21 110.444 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.544 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 29.6 t -66.79 -38.56 86.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.859 0.464 . . . . 74.33 110.957 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.6 mt -81.71 -43.57 18.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.493 0.317 . . . . 72.45 110.804 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.96 -20.69 77.5 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.709 0.644 . . . . 72.24 114.709 -171.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -141.58 -63.39 0.45 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.407 0.604 . . . . 44.31 112.56 -168.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 53.8 t80 -56.71 -64.45 0.87 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.529 1.532 . . . . 73.23 113.024 -167.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 90.9 m -77.42 -35.57 1.34 Allowed Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 114.426 1.269 . . . . 50.11 114.426 -173.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 55.6 Cg_endo -67.81 -20.08 46.22 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.022 1.815 . . . . 32.43 112.999 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 3.3 t30 -74.66 -18.09 60.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.217 0.607 . . . . 73.33 110.091 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.7 mm -74.85 -39.28 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.74 0.816 . . . . 70.31 109.281 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.597 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.1 mt -75.29 -37.87 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.294 1.038 . . . . 64.43 112.495 -173.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.411 ' HZ ' ' HG ' ' A' ' 128' ' ' LEU . 52.4 t80 -57.26 -43.13 99.01 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.04 1.126 . . . . 72.05 114.04 -169.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.99 -39.06 86.59 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.188 1.925 . . . . 72.35 113.726 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -76.77 -38.63 53.73 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.41 0.684 . . . . 73.21 111.904 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.67 94.9 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.847 -0.427 . . . . 71.53 109.847 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -57.71 -49.93 74.89 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.618 1.199 . . . . 73.42 110.278 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.74 -44.43 96.24 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.577 1.173 . . . . 75.01 110.905 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.6 t -56.72 -48.54 77.52 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.099 0.874 . . . . 71.2 110.23 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.2 mt -64.69 -42.26 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.263 0.977 . . . . 75.11 110.814 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.528 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.9 m -54.63 -48.04 72.75 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.562 0.745 . . . . 55.32 110.422 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.1 t -63.8 -46.05 86.9 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.306 -1.316 . . . . 74.35 109.838 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 20.1 mtp -57.64 -46.44 84.17 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.118 0.967 . . . . 54.44 112.115 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.0 t -63.27 -45.02 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.232 1.013 . . . . 71.01 110.283 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.2 t -66.19 -30.43 70.89 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.813 -1.085 . . . . 72.0 110.788 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.13 -28.6 60.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.702 0.801 . . . . 63.22 110.435 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 10.27 52.64 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 116.146 -0.479 . . . . 43.32 113.345 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.3 m 71.33 13.34 6.63 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.428 1.491 . . . . 71.11 112.122 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -96.16 145.8 30.19 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.732 -1.21 . . . . 73.14 107.732 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.05 157.59 28.83 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.722 2.281 . . . . 74.44 112.213 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.774 HE22 ' HB ' ' C' ' 16' ' ' ILE . 23.0 tt0 -50.71 125.39 13.09 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 124.195 0.934 . . . . 63.22 111.28 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 64' ' ' VAL . 17.9 tp -109.2 119.48 39.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.146 -0.934 . . . . 64.43 109.222 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.85 94.94 3.24 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.394 1.078 . . . . 65.22 108.18 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.411 ' HG ' ' HZ ' ' A' ' 107' ' ' PHE . 18.8 tp -62.12 131.78 50.64 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.027 -0.988 . . . . 74.42 109.723 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.91 129.27 47.57 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.266 1.027 . . . . 52.22 111.641 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.16 104.19 0.84 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.397 2.064 . . . . 72.32 111.034 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.71 117.6 43.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.026 -1.102 . . . . 73.54 108.026 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 33.5 t30 -63.48 99.65 0.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.409 1.068 . . . . 63.25 109.475 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -67.1 -24.21 65.91 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.176 -0.466 . . . . 72.44 111.247 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.408 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 10.2 t70 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.896 0.878 . . . . 74.43 110.654 173.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.727 HG22 HE22 ' B' ' 12' ' ' GLN . 41.4 m . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 108.923 -0.769 . . . . 74.44 108.923 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.96 138.61 51.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.525 0.73 . . . . 64.45 109.734 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.727 HE22 HG22 ' B' ' 10' ' ' THR . 0.0 OUTLIER -152.53 135.47 15.56 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.346 0.658 . . . . 63.4 110.116 168.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.46 118.38 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.331 1.053 . . . . 72.23 108.549 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -82.5 -39.12 22.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.659 0.384 . . . . 73.41 111.655 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.528 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 28.4 ttm180 -166.28 145.86 5.99 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.51 0.724 . . . . 73.33 110.258 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.444 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 86.6 mt -119.54 145.88 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.44 -1.689 . . . . 72.23 106.44 166.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.528 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 35.1 p90 -170.03 163.85 9.37 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.935 0.874 . . . . 75.32 111.977 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 71.5 m -92.01 122.79 34.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.612 -1.176 . . . . 75.4 109.072 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -89.12 -37.93 14.7 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.87 0.868 . . . . 74.21 110.043 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -155.82 143.77 19.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.102 -0.499 . . . . 73.44 110.766 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.4 mm -134.76 139.18 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.914 1.286 . . . . 74.15 108.201 176.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -140.72 132.08 26.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.018 -1.105 . . . . 72.01 108.018 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -147.03 114.81 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.608 -1.256 . . . . 70.44 107.608 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.58 130.72 56.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.851 0.86 . . . . 74.41 108.989 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.8 83.43 65.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 106.847 -1.538 . . . . 54.41 106.847 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -68.7 -32.81 22.92 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.923 2.415 . . . . 63.21 111.971 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -106.6 25.8 10.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.88 1.272 . . . . 72.15 110.206 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.475 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -46.68 -50.01 44.36 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 115.558 1.688 . . . . 63.55 115.558 -168.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.8 -33.98 4.45 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.232 1.476 . . . . 74.41 112.505 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.1 m80 -82.99 -22.51 33.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.645 0.778 . . . . 72.45 112.283 -169.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.43 HG11 ' HZ ' ' B' ' 123' ' ' PHE . 4.6 p -67.93 -4.38 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 124.391 1.076 . . . . 70.52 111.963 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -56.49 -27.49 57.27 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.758 0.823 . . . . 75.34 110.931 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.582 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -76.86 -34.99 57.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.65 0.38 . . . . 74.04 110.737 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.582 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 98.9 mttt -109.99 77.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.565 0.746 . . . . 72.31 112.313 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.12 82.76 1.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.628 -1.249 . . . . 71.15 107.628 163.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -148.62 160.15 43.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.156 -1.424 . . . . 75.42 107.156 -171.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 23.9 pt20 -53.6 102.22 0.3 Allowed Pre-proline 0 CA--C 1.564 1.494 0 O-C-N 124.376 1.047 . . . . 73.41 111.7 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.51 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 6.1 Cg_endo -85.93 170.21 8.67 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.807 2.338 . . . . 73.43 112.305 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -80.9 100.65 8.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 106.344 -1.724 . . . . 74.22 106.344 165.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -114.74 142.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.923 0.889 . . . . 74.23 108.72 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.599 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 27.9 ttpt -136.72 136.63 39.17 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.496 0.718 . . . . 73.15 109.377 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.624 HD12 HD11 ' B' ' 128' ' ' LEU . 4.6 tt -85.6 127.46 34.47 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 106.28 -1.748 . . . . 70.53 106.28 165.172 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.599 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 12.6 t70 -122.27 110.61 15.9 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.358 -1.349 . . . . 72.2 107.358 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 3.5 pp -100.22 137.45 38.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.438 0.695 . . . . 75.23 109.292 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 32.9 t70 -124.23 135.85 53.72 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.972 -0.751 . . . . 64.31 108.972 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.04 110.15 21.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.899 0.879 . . . . 72.12 110.402 -171.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.97 140.26 52.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.514 0.726 . . . . 25.14 109.213 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 75.6 m -144.07 165.2 28.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.777 0.831 . . . . 53.55 110.199 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.4 p -152.0 162.23 41.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.398 1.079 . . . . 43.23 109.033 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -106.78 112.88 26.06 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.346 -0.613 . . . . 74.32 109.346 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.99 -40.71 23.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.827 0.451 . . . . 60.52 110.327 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.95 -172.91 4.11 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.27 0.628 . . . . 43.22 110.575 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.06 116.03 4.98 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.442 -1.254 . . . . 75.42 109.774 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 71.33 -3.41 2.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.775 1.63 . . . . 65.1 112.636 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.438 HG22 ' OG ' ' B' ' 85' ' ' SER . 98.6 t -101.52 113.38 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.96 -0.755 . . . . 73.33 108.96 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.77 137.8 53.73 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.177 -0.919 . . . . 72.54 109.428 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -100.57 98.16 8.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.976 -1.49 . . . . 71.34 106.976 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.11 128.61 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.734 1.214 . . . . 30.23 109.644 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 36.3 t -119.21 143.06 31.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.757 1.223 . . . . 75.52 108.957 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -136.7 111.75 8.97 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.727 -1.212 . . . . 64.25 107.727 171.243 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -86.12 122.67 30.46 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.155 -0.683 . . . . 75.21 109.155 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.81 103.23 15.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.92 -1.141 . . . . 74.54 107.92 173.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.7 m -103.79 129.89 51.26 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.42 -0.585 . . . . 44.34 109.42 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.459 HG23 HD13 ' B' ' 114' ' ' ILE . 61.3 t -115.0 100.99 11.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 109.248 -0.649 . . . . 74.21 109.248 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.3 m -97.8 138.06 35.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.068 -0.969 . . . . 25.43 109.146 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.77 149.76 34.97 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.881 0.472 . . . . 63.31 110.347 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -149.18 141.92 24.57 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.541 -0.754 . . . . 71.04 110.544 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.0 mt -125.55 110.4 13.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.685 1.194 . . . . 71.21 108.663 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.23 -123.39 6.3 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.627 -0.715 . . . . 63.02 111.489 -174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -108.42 2.44 22.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.116 0.967 . . . . 73.32 109.983 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.23 -179.44 3.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.748 0.819 . . . . 74.02 110.344 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -77.09 155.21 32.59 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.744 1.218 . . . . 75.2 110.703 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.08 -50.3 3.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.611 -0.885 . . . . 74.32 108.611 167.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -166.83 152.79 8.17 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.822 -1.081 . . . . 72.24 108.812 167.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -123.54 124.45 42.86 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.165 -1.05 . . . . 72.13 108.165 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.2 t -142.08 157.14 45.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.219 0.608 . . . . 74.35 109.536 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.5 tt0 -164.42 141.56 6.53 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.851 0.86 . . . . 74.44 109.121 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.5 t -134.22 143.81 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.677 -1.231 . . . . 70.23 107.677 170.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.5 96.53 5.24 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.952 -1.129 . . . . 71.02 107.952 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 38.0 tp60 -91.34 101.59 14.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.367 -0.975 . . . . 61.14 108.367 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.38 167.55 32.77 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.143 -0.935 . . . . 60.22 110.881 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.16 127.56 1.65 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.562 -0.615 . . . . 74.22 111.562 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.8 mt -85.61 124.5 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 54.4 108.062 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.67 159.14 38.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.069 0.948 . . . . 54.52 108.699 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.438 ' OG ' HG22 ' B' ' 55' ' ' VAL . 17.1 m -132.14 120.38 22.2 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.379 -0.971 . . . . 70.31 108.379 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 pt -133.75 138.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.47 1.108 . . . . 55.43 109.367 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.4 155.65 39.06 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.649 0.78 . . . . 71.13 110.158 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.32 -71.17 0.2 Allowed Glycine 0 C--N 1.341 0.822 0 O-C-N 123.703 0.627 . . . . 63.14 112.469 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 32.6 pt -81.95 159.49 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 122.98 0.512 . . . . 72.5 110.942 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -153.56 156.93 38.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.666 -0.697 . . . . 63.23 110.16 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.47 -114.76 6.49 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.329 0.49 . . . . 73.23 113.539 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -67.14 -39.0 86.48 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.981 0.912 . . . . 62.23 111.536 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.87 -50.71 65.53 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.023 -0.989 . . . . 71.12 110.311 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -24.92 58.54 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.545 -0.752 . . . . 74.44 111.638 -175.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.7 -31.36 68.17 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.729 0.812 . . . . 63.33 111.792 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -69.75 -46.47 65.79 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.941 -0.572 . . . . 70.14 110.689 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -73.38 -32.52 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.327 0.651 . . . . 74.04 112.465 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -96.6 -39.23 9.62 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.858 0.863 . . . . 73.21 109.447 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.31 -25.57 43.18 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 114.693 0.637 . . . . 63.53 114.693 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -49.45 2.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.888 0.475 . . . . 33.13 111.334 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -79.21 -42.43 26.04 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.536 0.569 . . . . 74.15 112.536 -169.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.17 -45.46 79.17 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 118.416 -0.802 . . . . 52.41 112.016 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.435 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 47.2 Cg_exo -60.89 -31.44 91.58 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 122.427 2.084 . . . . 63.33 113.148 171.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.51 -34.87 77.75 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.707 0.803 . . . . 62.13 110.94 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.74 -44.47 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.431 0.692 . . . . 52.35 110.628 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.96 -24.99 59.71 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 123.607 0.567 . . . . 73.45 111.846 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -56.86 -52.68 72.01 Favored Pre-proline 0 CA--C 1.557 1.233 0 CA-C-O 117.029 -1.463 . . . . 74.05 113.494 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.92 -34.61 67.24 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.582 2.188 . . . . 52.01 113.976 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.628 ' HE2' HG21 ' D' ' 115' ' ' THR . 80.0 m-85 -72.76 -48.81 35.22 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.44 0.696 . . . . 73.12 110.218 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.16 80.99 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.749 -0.66 . . . . 54.31 110.439 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -63.38 -52.49 61.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.831 1.652 . . . . 71.22 110.987 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -38.44 89.89 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.973 0.796 . . . . 74.13 109.286 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.2 t -65.46 -37.63 87.43 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.042 0.537 . . . . 62.33 111.186 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.459 HD13 HG23 ' B' ' 64' ' ' VAL . 76.3 mt -64.08 -49.12 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.387 0.675 . . . . 63.34 109.587 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -61.44 -30.16 70.41 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.634 0.773 . . . . 71.33 111.231 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -69.47 -44.43 71.2 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.528 0.731 . . . . 34.21 109.146 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -68.1 -29.34 68.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.942 0.497 . . . . 74.22 111.124 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.471 HG21 HD23 ' B' ' 126' ' ' LEU . 78.7 t -69.34 -41.18 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.096 0.959 . . . . 75.25 110.015 173.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -67.66 -28.35 67.63 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.994 0.918 . . . . 30.45 111.724 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 73.5 mtt-85 -79.41 -35.72 40.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.52 0.728 . . . . 73.13 110.044 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.35 3.75 71.2 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.022 -0.536 . . . . 55.14 112.72 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 45.7 p 59.67 56.11 3.73 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.953 1.701 . . . . 65.4 112.744 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.43 ' HZ ' HG11 ' B' ' 31' ' ' VAL . 44.1 m-85 -119.49 157.9 50.48 Favored Pre-proline 0 N--CA 1.48 1.053 0 C-N-CA 124.192 0.997 . . . . 60.31 109.835 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.28 -173.83 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.78 2.32 . . . . 71.22 113.884 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.515 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -59.37 116.59 4.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.645 1.178 . . . . 74.12 112.41 -172.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.471 HD23 HG21 ' B' ' 118' ' ' VAL . 43.8 tp -123.06 93.7 4.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.473 0.709 . . . . 74.22 109.811 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -92.09 126.87 37.34 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.1 -1.074 . . . . 72.5 108.1 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.624 HD11 HD12 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -73.28 129.35 37.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.133 -1.062 . . . . 53.15 108.133 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.53 129.66 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.353 0.661 . . . . 62.44 111.073 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.58 ' HG3' HD11 ' D' ' 16' ' ' ILE . 68.0 Cg_endo -68.38 130.95 22.12 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.544 2.163 . . . . 74.41 112.115 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.71 114.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.532 0.733 . . . . 73.04 109.435 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -85.22 98.11 10.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.731 0.812 . . . . 65.24 110.811 178.79 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.1 tmm? . . . . . 0 CA--C 1.556 1.175 0 CA-C-O 121.48 0.657 . . . . 64.21 112.701 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -91.28 98.65 11.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.584 0.754 . . . . 75.02 109.926 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.613 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 50.0 t80 -97.13 142.14 29.41 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.322 0.649 . . . . 71.33 109.474 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -156.81 144.55 19.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.267 0.627 . . . . 73.32 109.327 166.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.91 137.57 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.298 -1.001 . . . . 73.12 108.298 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -95.89 -50.15 5.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.488 -0.56 . . . . 73.01 109.488 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -164.23 124.25 2.05 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.889 -0.596 . . . . 70.12 110.72 -169.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.774 ' HB ' HE22 ' A' ' 125' ' ' GLN . 64.9 mt -109.7 130.72 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.532 -1.285 . . . . 64.25 107.532 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.473 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 20.8 p90 -163.05 149.58 12.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.776 0.798 . . . . 74.04 111.947 -172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -77.93 103.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.933 -1.136 . . . . 71.21 107.933 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -70.87 -28.81 64.84 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.818 -0.438 . . . . 72.53 109.818 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.0 t70 -148.91 143.14 26.03 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.216 -0.902 . . . . 71.41 109.853 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -138.05 145.17 29.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.631 1.572 . . . . 72.12 106.76 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -158.4 152.19 23.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.279 0.562 . . . . 60.13 110.133 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -148.14 133.29 18.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.254 -1.388 . . . . 64.22 107.254 173.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 49.0 mt-10 -125.14 132.84 53.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.853 -0.795 . . . . 74.42 108.853 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.39 77.67 5.94 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.085 0.954 . . . . 74.12 108.806 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 -22.12 17.92 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.096 1.864 . . . . 65.31 111.319 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -99.91 28.58 4.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.51 1.124 . . . . 74.3 110.816 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.68 97.12 Favored Pre-proline 0 CA--C 1.569 1.673 0 C-N-CA 123.951 0.9 . . . . 71.33 112.925 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.97 -25.83 8.5 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 121.433 1.422 . . . . 72.52 112.048 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -69.41 -21.37 63.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.077 1.351 . . . . 73.04 112.063 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 p -51.4 -29.98 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 113.018 0.748 . . . . 72.23 113.018 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -70.94 -34.53 71.56 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.339 0.656 . . . . 73.35 111.842 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -93.62 6.05 49.57 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.448 0.699 . . . . 74.04 111.015 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 2.9 ttmp? -90.95 147.76 22.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.277 0.631 . . . . 75.13 111.486 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.77 135.76 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.795 1.638 . . . . 75.51 110.148 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -81.79 79.38 8.36 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 122.122 -0.362 . . . . 74.55 110.182 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.408 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 4.7 tp-100 -153.0 55.66 1.48 Allowed Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.693 0.397 . . . . 64.03 111.216 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' C' ' 37' ' ' GLN . 17.3 Cg_endo -90.47 144.23 3.85 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.06 1.84 . . . . 73.32 112.226 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -86.3 83.73 7.63 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.227 -1.397 . . . . 73.44 107.227 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 p -76.97 99.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.882 -1.053 . . . . 71.4 108.693 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -125.21 140.65 52.67 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.66 -1.154 . . . . 62.32 108.652 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.582 HD13 HD11 ' C' ' 128' ' ' LEU . 2.6 pt? -87.75 163.47 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.252 0.549 . . . . 74.43 110.089 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.1 t70 -148.18 145.41 28.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.36 1.064 . . . . 72.44 108.145 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 41.1 tp -130.78 135.51 47.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.734 -0.469 . . . . 72.4 109.734 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.69 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 3.9 m-20 -118.61 142.29 47.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.918 0.887 . . . . 73.41 108.82 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.8 p -114.26 113.98 25.34 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.132 0.973 . . . . 73.44 109.561 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.89 141.97 38.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.556 0.742 . . . . 65.55 110.171 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -145.78 154.29 41.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.251 0.621 . . . . 55.33 110.547 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.9 p -144.61 131.51 20.29 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.936 0.894 . . . . 62.41 108.644 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -79.21 116.67 19.62 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.268 -0.641 . . . . 65.24 109.268 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 57' ' ' GLU . 32.1 mt -93.3 -32.24 14.39 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.387 -0.824 . . . . 72.23 109.684 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.77 -177.03 5.28 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.153 -0.93 . . . . 54.44 110.387 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.98 128.05 34.5 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.638 -1.164 . . . . 70.03 108.97 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.48 -7.1 0.73 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.201 1.4 . . . . 73.31 113.183 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.94 112.93 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.607 0.763 . . . . 72.14 109.462 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -129.28 133.87 47.68 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.84 -1.073 . . . . 75.24 108.382 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.3 tt0 -83.31 115.67 22.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.919 -0.771 . . . . 72.05 108.919 173.749 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.52 118.11 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.017 -1.105 . . . . 71.14 108.017 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.73 127.75 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 122.867 0.467 . . . . 72.34 110.062 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.533 HD23 HD12 ' C' ' 106' ' ' LEU . 3.6 mm? -120.94 112.62 18.99 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.138 -1.06 . . . . 72.43 108.138 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.69 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 35.4 ttm180 -82.06 110.82 17.64 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.701 -0.851 . . . . 65.14 108.701 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.7 t -99.94 112.27 31.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.048 -1.093 . . . . 65.43 108.048 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.2 m -114.67 142.13 46.89 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.791 -1.095 . . . . 35.43 108.114 -175.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.412 HG21 HG21 ' C' ' 114' ' ' ILE . 87.4 t -136.02 108.34 7.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.817 -1.179 . . . . 64.04 107.817 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.0 m -108.68 142.31 39.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.287 -0.634 . . . . 73.52 109.287 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.81 113.12 11.92 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.705 -1.22 . . . . 65.4 107.705 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.7 m -142.46 150.7 40.9 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.236 0.541 . . . . 63.34 111.076 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.21 19.04 15.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.615 1.566 . . . . 74.15 109.849 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.48 -108.73 1.3 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 110.416 -1.074 . . . . 62.43 110.416 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -89.9 -33.09 16.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.282 -1.007 . . . . 74.52 108.282 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.85 102.83 0.38 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.975 1.31 . . . . 50.4 109.953 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -88.59 129.67 35.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.923 0.329 . . . . 65.13 110.255 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -73.54 -59.79 2.55 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 173.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -173.09 174.55 3.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.211 0.945 . . . . 75.12 110.534 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -134.96 145.27 47.99 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.047 -1.464 . . . . 71.14 107.047 172.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.433 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.3 t -151.71 121.45 7.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.884 -1.154 . . . . 73.11 107.884 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.41 130.3 18.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.902 0.382 . . . . 65.32 110.141 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.31 115.43 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.925 1.29 . . . . 63.11 108.716 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.574 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.0 mt-30 -89.09 88.78 7.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.849 -1.167 . . . . 72.23 107.849 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -80.49 112.35 17.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.623 -1.171 . . . . 71.45 109.664 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.39 148.32 18.31 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 111.269 -0.733 . . . . 44.5 111.269 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.3 130.97 4.17 Favored Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 111.398 -0.681 . . . . 74.24 111.398 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.512 HD12 HD11 ' C' ' 51' ' ' LEU . 13.7 mm -84.52 120.87 35.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.439 -0.949 . . . . 72.3 108.439 174.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -130.98 139.88 50.07 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.402 0.681 . . . . 74.14 109.474 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 m -110.49 109.03 19.23 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.765 -0.828 . . . . 60.33 108.765 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.33 122.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.141 -1.059 . . . . 71.12 108.141 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.78 170.32 12.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.188 0.995 . . . . 72.14 110.187 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.81 -60.61 0.33 Allowed Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.968 -0.56 . . . . 54.51 112.803 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.71 -176.65 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 117.084 0.442 . . . . 72.12 111.446 -176.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.93 -171.98 3.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.144 0.977 . . . . 70.32 109.472 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.36 -148.94 41.44 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 116.157 -0.474 . . . . 71.55 113.8 173.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.5 p -63.32 -26.98 69.02 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.382 1.073 . . . . 41.11 112.052 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -64.71 -54.29 33.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.352 1.061 . . . . 74.42 110.655 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.0 -38.14 75.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.283 -0.872 . . . . 73.32 109.974 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.47 -22.74 65.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 63.42 112.071 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 56.7 t-80 -71.79 -41.59 68.13 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.778 -0.453 . . . . 72.01 109.778 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.65 -31.5 69.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.137 0.494 . . . . 70.24 110.657 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.54 -48.73 12.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.427 1.091 . . . . 75.55 109.901 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.15 9.53 67.64 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.355 -0.839 . . . . 53.12 114.283 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -146.13 -51.72 0.24 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.442 0.621 . . . . 74.23 111.607 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -74.77 -41.98 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.534 0.333 . . . . 75.15 111.412 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.441 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 68.8 m -66.93 -45.14 53.57 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 118.373 -0.823 . . . . 64.15 111.726 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.404 ' HG3' HD21 ' C' ' 60' ' ' LEU . 92.7 Cg_exo -50.2 -38.93 52.11 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.933 2.422 . . . . 75.53 114.017 168.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -61.74 -34.41 75.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.294 0.638 . . . . 72.25 111.992 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.34 -42.77 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.927 -0.397 . . . . 73.33 109.927 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.533 HD12 HD23 ' C' ' 60' ' ' LEU . 85.5 mt -76.03 -26.9 57.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.69 -0.686 . . . . 72.5 112.015 -174.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.83 -52.75 69.77 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 117.703 -1.141 . . . . 74.34 113.493 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.61 -32.66 93.63 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.177 1.918 . . . . 62.04 113.327 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.528 ' HE2' HG21 ' A' ' 115' ' ' THR . 67.9 m-85 -70.88 -44.44 66.32 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 54.42 110.819 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.3 -45.6 93.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.811 -0.631 . . . . 62.11 109.691 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.6 ttt-85 -56.28 -47.21 79.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.055 1.342 . . . . 62.12 111.652 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.9 -36.51 78.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.668 0.605 . . . . 75.0 109.732 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.7 t -68.2 -35.13 77.51 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.391 0.676 . . . . 73.23 111.103 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.433 HG23 ' SG ' ' C' ' 76' ' ' CYS . 60.6 mt -72.15 -47.91 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.673 0.789 . . . . 74.1 109.974 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -64.4 -31.42 72.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.468 0.707 . . . . 74.12 110.825 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -66.38 -47.72 72.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.413 -0.812 . . . . 73.54 109.462 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.52 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.3 -36.61 84.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.45 0.7 . . . . 74.55 112.428 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.1 t -64.44 -37.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.21 0.604 . . . . 61.13 109.786 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.2 t -68.53 -35.1 76.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.437 0.695 . . . . 75.33 111.584 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -70.67 -35.58 72.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.731 0.812 . . . . 73.44 110.428 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.27 4.61 80.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.893 -0.594 . . . . 73.41 113.046 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.2 p 60.96 35.19 19.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.768 1.627 . . . . 72.52 112.372 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -105.01 150.75 39.1 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.557 1.143 . . . . 55.31 110.05 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.515 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 76.5 Cg_exo -53.92 110.31 0.49 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.397 2.731 . . . . 53.23 113.001 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -60.34 144.46 50.63 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.507 1.13 . . . . 64.24 111.224 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.99 124.14 11.47 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.72 -1.585 . . . . 73.43 106.72 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -90.76 130.41 36.74 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.892 -0.781 . . . . 71.04 108.892 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.582 HD11 HD13 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -64.62 131.74 47.82 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.427 -0.953 . . . . 74.5 108.427 177.714 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.06 140.19 90.74 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.971 0.909 . . . . 62.23 111.334 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 103.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.18 2.587 . . . . 73.53 112.708 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.28 108.33 21.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 N-CA-C 108.319 -0.993 . . . . 72.11 108.319 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.4 m-80 -96.49 92.2 6.16 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.319 -0.855 . . . . 74.55 109.156 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -61.51 -39.19 90.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.218 -0.901 . . . . 54.3 110.475 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 124.173 0.989 . . . . 75.42 112.031 -177.736 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 108.801 -0.814 . . . . 74.15 108.801 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.608 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 23.4 t80 -160.23 110.73 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.592 -2.003 . . . . 73.34 105.592 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -130.98 114.79 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.921 -0.77 . . . . 63.3 108.921 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.77 123.18 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.854 0.359 . . . . 74.05 110.141 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.08 -40.4 12.3 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.346 -0.843 . . . . 73.44 109.712 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.496 ' HB3' ' HD1' ' D' ' 17' ' ' TYR . 22.1 mmt-85 -156.87 150.52 24.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.408 0.683 . . . . 64.54 112.016 -170.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.58 HD11 ' HG3' ' B' ' 130' ' ' PRO . 0.3 OUTLIER -138.85 118.0 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 105.072 -2.196 . . . . 72.14 105.072 165.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' D' ' 15' ' ' ARG . 28.2 p90 -150.39 157.91 43.57 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.866 0.841 . . . . 71.5 111.657 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -93.71 113.65 25.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.033 -0.985 . . . . 65.24 108.76 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.4 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 35.4 mtpt -81.4 -35.65 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.171 0.51 . . . . 75.41 109.629 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -144.67 141.75 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.064 -0.971 . . . . 74.43 108.444 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' C' ' 117' ' ' MET . 95.7 mt -137.09 143.9 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.698 1.199 . . . . 75.45 107.845 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 99.1 p -147.76 141.9 26.08 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.702 0.801 . . . . 72.04 108.993 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.2 t80 -146.48 113.81 6.28 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 105.944 -1.872 . . . . 73.23 105.944 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -126.87 109.45 11.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 73.24 110.106 -173.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.97 91.18 3.45 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 107.412 -1.329 . . . . 62.33 107.412 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.02 -43.16 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.262 1.975 . . . . 72.44 112.416 -173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.75 37.63 1.37 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.916 -1.142 . . . . 64.32 107.916 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.473 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -51.32 -64.6 1.3 Allowed Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.786 -1.102 . . . . 73.52 113.858 -161.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' C' ' 83' ' ' ILE . 81.7 Cg_endo -78.21 -14.55 14.87 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 122.195 1.82 . . . . 64.03 113.002 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -67.25 -41.47 85.55 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.54 1.136 . . . . 72.53 109.395 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.41 -41.42 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 123.962 0.789 . . . . 74.51 110.126 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -69.61 -18.6 63.62 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.377 0.88 . . . . 55.32 113.377 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -84.99 -2.98 58.58 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.623 0.769 . . . . 71.51 111.999 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.405 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 47.6 mtpt -124.78 116.04 21.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.096 1.358 . . . . 62.14 108.571 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -89.34 97.42 11.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.877 0.871 . . . . 63.51 112.812 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.559 ' CH2' HD13 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -167.85 -179.39 4.2 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 124.165 0.986 . . . . 64.2 112.97 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -93.22 145.48 30.11 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.484 1.114 . . . . 52.45 112.755 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.509 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 76.9 Cg_endo -79.74 135.57 11.54 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.418 2.078 . . . . 73.11 112.765 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.73 111.61 7.15 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.504 -1.295 . . . . 73.13 107.504 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.78 144.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.157 0.583 . . . . 45.31 110.774 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 85.0 tttt -124.69 127.6 47.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.288 1.035 . . . . 74.02 109.109 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.15 120.76 39.12 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.002 -1.481 . . . . 75.45 107.002 173.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.49 143.04 50.91 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.527 -0.916 . . . . 65.53 108.527 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.19 148.76 50.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.097 0.475 . . . . 72.13 110.64 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.4 t70 -139.5 150.03 44.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.185 -1.042 . . . . 65.11 108.185 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 24.2 p -116.75 143.65 45.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.746 0.818 . . . . 72.52 109.785 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.88 155.88 32.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.511 1.124 . . . . 73.11 108.246 174.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 27.1 p -169.26 163.96 10.87 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.844 0.457 . . . . 53.43 110.733 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -159.57 132.71 6.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.668 0.787 . . . . 72.15 110.009 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -77.43 117.47 18.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.769 -0.826 . . . . 72.44 108.769 170.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' D' ' 57' ' ' GLU . 70.6 mt -90.29 -32.59 16.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.858 0.463 . . . . 74.34 110.508 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.92 -171.17 1.12 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.645 0.778 . . . . 43.23 110.632 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.93 114.79 4.78 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.779 -1.101 . . . . 70.25 109.391 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 68.3 2.18 3.18 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.147 1.379 . . . . 75.35 113.012 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.67 120.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.409 -0.96 . . . . 74.43 108.409 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -136.51 131.2 33.6 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.558 0.536 . . . . 74.23 109.884 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.7 tt0 -87.43 126.59 34.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.298 -1.001 . . . . 62.2 108.298 169.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.89 112.77 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.715 -1.217 . . . . 74.24 107.715 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.516 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.7 t -102.65 130.74 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.233 0.613 . . . . 73.41 109.618 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.01 109.03 13.02 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.143 -1.428 . . . . 75.32 107.143 171.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.0 ttm-85 -84.34 106.66 16.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.446 -0.797 . . . . 74.33 109.16 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.32 129.74 45.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.568 -0.901 . . . . 61.41 108.568 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 31.3 m -125.87 135.67 52.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.573 0.749 . . . . 72.41 109.544 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.474 HG23 HD13 ' D' ' 114' ' ' ILE . 91.2 t -124.81 111.99 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.041 0.936 . . . . 63.34 109.382 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 58.7 m -105.39 119.67 39.66 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.245 -0.65 . . . . 41.1 109.245 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.03 133.24 56.21 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.275 0.63 . . . . 73.45 110.635 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -141.93 125.18 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.143 0.977 . . . . 61.4 109.649 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.642 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -126.7 138.99 53.48 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.283 1.033 . . . . 62.32 110.841 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.85 -111.91 3.51 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.8 -0.52 . . . . 54.1 111.8 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.15 4.05 17.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.202 1.001 . . . . 54.21 110.023 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.17 168.58 21.3 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.212 0.529 . . . . 64.12 112.358 -157.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -84.56 126.58 33.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.143 -0.935 . . . . 74.32 110.428 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.642 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -71.78 -69.45 0.39 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.97 0.908 . . . . 64.45 109.706 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -158.67 147.5 18.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.543 -1.662 . . . . 63.1 109.953 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.92 152.93 20.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.194 -1.41 . . . . 70.34 107.194 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.5 t -154.27 135.78 14.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.955 -0.757 . . . . 65.21 108.955 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -153.54 134.44 13.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.522 -0.547 . . . . 70.21 109.522 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.5 t -136.52 116.79 17.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.745 -0.835 . . . . 52.04 108.745 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.81 86.54 7.17 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.843 -1.169 . . . . 60.42 107.843 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.54 92.89 5.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.951 -1.022 . . . . 60.45 109.254 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.67 148.27 19.43 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.104 -0.798 . . . . 64.01 111.104 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.63 131.53 3.69 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 110.961 -0.856 . . . . 64.2 110.961 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' D' ' 17' ' ' TYR . 68.2 mt -89.18 122.47 40.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.446 -0.946 . . . . 64.13 108.446 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.3 138.78 52.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.37 1.068 . . . . 72.03 108.996 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 19.4 m -90.69 97.34 11.13 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.207 -1.034 . . . . 62.21 108.207 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.98 123.03 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.547 -0.538 . . . . 74.32 109.547 -171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.23 170.95 20.09 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.56 1.144 . . . . 53.04 109.442 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.1 -18.48 51.23 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 116.301 -0.409 . . . . 74.41 113.222 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.35 159.05 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.439 1.095 . . . . 74.22 109.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 158.98 40.83 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.142 0.577 . . . . 75.41 110.795 -174.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.57 -97.48 0.01 OUTLIER Glycine 0 C--N 1.351 1.377 0 O-C-N 125.165 1.54 . . . . 75.3 115.793 161.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.3 p -58.89 -54.53 46.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.957 1.303 . . . . 74.13 112.597 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -82.12 -27.02 33.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.22 -0.445 . . . . 71.03 110.698 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 27.8 ttt -67.46 -35.05 78.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.831 -0.433 . . . . 74.43 109.831 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -53.87 51.98 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 123.615 0.766 . . . . 63.11 110.61 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -57.24 -45.27 84.07 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.229 0.956 . . . . 75.31 110.824 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.39 -33.13 75.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.446 0.699 . . . . 62.5 111.706 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.456 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.2 tp -75.41 -32.4 60.72 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 70.0 110.994 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.85 13.59 34.77 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.21 -0.45 . . . . 71.32 113.658 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -129.7 -61.2 1.01 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.172 0.486 . . . . 74.4 110.345 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -75.33 -46.51 32.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.4 0.68 . . . . 74.35 111.095 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.608 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 60.5 m -62.47 -48.94 85.67 Favored Pre-proline 0 CA--C 1.569 1.687 0 CA-C-O 118.306 -0.854 . . . . 54.54 112.114 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.63 -16.19 33.87 Favored 'Trans proline' 0 C--N 1.402 3.376 0 C-N-CA 122.1 1.867 . . . . 70.32 112.735 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.16 -24.48 62.26 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.833 0.453 . . . . 73.12 110.259 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.38 -39.29 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.281 0.632 . . . . 64.43 109.853 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 -37.0 64.22 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.765 0.826 . . . . 71.24 112.201 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.14 -40.9 57.49 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-O 117.787 -1.102 . . . . 75.32 113.515 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -53.93 -39.73 83.58 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.377 2.051 . . . . 71.22 113.816 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -80.26 -32.81 38.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.369 0.667 . . . . 74.33 111.368 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.69 81.3 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.168 -0.679 . . . . 44.1 109.168 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.515 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -53.53 -53.55 49.94 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.906 1.282 . . . . 74.15 110.771 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.65 -40.76 92.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.504 1.128 . . . . 74.13 110.698 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.62 -44.11 96.7 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.576 0.548 . . . . 75.24 110.757 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.599 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.1 mt -63.22 -53.19 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 64.2 109.884 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.628 HG21 ' HE2' ' B' ' 109' ' ' TYR . 95.9 m -52.8 -45.07 67.05 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.085 1.354 . . . . 51.12 111.923 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.39 -44.94 77.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.944 -1.025 . . . . 71.42 110.151 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 77.7 mtm -62.55 -37.79 87.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.857 0.463 . . . . 72.22 112.0 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.502 HG23 ' O ' ' D' ' 114' ' ' ILE . 85.7 t -61.59 -44.63 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 124.093 0.871 . . . . 61.33 110.014 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.57 -27.33 61.26 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.878 0.471 . . . . 62.21 111.718 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -72.39 -31.64 65.72 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.347 0.659 . . . . 73.22 110.076 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.25 10.81 62.48 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.445 -0.798 . . . . 61.22 112.368 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.405 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.6 p 65.75 15.04 9.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.964 2.105 . . . . 63.04 113.961 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.74 156.97 55.51 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 107.437 -1.319 . . . . 63.03 107.437 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.02 146.09 36.52 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.682 2.255 . . . . 54.32 111.588 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.457 ' HB2' HG23 ' D' ' 115' ' ' THR . 3.2 pt20 -51.3 127.71 20.34 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 124.275 0.985 . . . . 63.53 112.134 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -107.49 100.77 10.16 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.483 -0.932 . . . . 74.34 108.483 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.444 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 3.1 m-20 -98.89 107.1 19.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.298 1.039 . . . . 73.33 110.18 -166.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.515 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.7 mm? -72.22 116.01 12.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.069 0.948 . . . . 62.53 109.908 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.57 154.42 94.53 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.534 0.334 . . . . 72.32 111.494 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.78 123.87 14.5 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.499 2.133 . . . . 64.11 111.951 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 63.4 t -108.41 125.49 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.905 0.882 . . . . 63.34 108.773 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -72.17 93.88 1.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.171 0.588 . . . . 64.23 109.632 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 70.7 m-85 . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 115.583 -0.735 . . . . 74.2 111.352 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 109.602 -0.518 . . . . 65.43 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.621 ' HA ' HG22 ' A' ' 86' ' ' ILE . 54.1 t80 -136.2 132.16 35.53 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.495 -1.668 . . . . 72.03 106.495 164.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -150.82 120.3 6.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.855 -0.424 . . . . 75.1 109.855 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -77.81 128.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.929 -1.137 . . . . 71.24 107.929 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -101.78 -39.9 7.2 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.605 -0.517 . . . . 61.21 109.605 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -174.68 127.62 0.31 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.672 0.389 . . . . 71.31 109.961 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -112.48 145.94 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.02 -0.733 . . . . 72.42 109.02 175.74 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -165.39 174.64 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.716 0.807 . . . . 74.42 111.195 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -99.68 122.56 42.88 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.212 -0.662 . . . . 72.35 109.212 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.94 -24.6 23.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.738 0.415 . . . . 62.51 110.042 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.28 137.36 17.32 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.175 -0.921 . . . . 62.42 109.416 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -133.77 132.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.319 -1.363 . . . . 61.5 107.319 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -139.57 124.89 19.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 72.12 108.641 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -135.23 128.49 32.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.397 -1.705 . . . . 75.01 106.397 170.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -137.32 121.7 18.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.995 0.518 . . . . 72.23 109.666 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.11 77.57 67.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.599 -1.63 . . . . 71.21 106.599 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.77 -46.06 9.64 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.578 2.186 . . . . 71.3 111.36 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.22 23.37 3.88 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.653 -1.158 . . . . 74.41 109.704 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.03 -55.64 10.7 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.111 -0.947 . . . . 75.22 112.916 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.8 Cg_exo -61.18 -26.89 83.07 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.378 2.052 . . . . 71.03 113.305 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.97 -26.7 20.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.988 0.915 . . . . 72.42 110.763 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -82.52 -17.69 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 122.744 0.417 . . . . 72.31 111.281 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -79.81 -12.46 59.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.271 0.628 . . . . 73.45 111.78 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -101.94 -9.14 20.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.174 0.99 . . . . 74.3 110.933 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -71.94 158.62 35.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.3 0.64 . . . . 75.11 111.663 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.59 138.16 58.42 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.048 -0.978 . . . . 73.25 110.19 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -94.01 63.23 3.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.623 0.725 . . . . 73.01 111.645 -165.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.45 83.77 16.9 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.123 0.969 . . . . 72.14 109.188 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.92 167.04 8.36 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.643 2.229 . . . . 75.15 111.648 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.14 99.62 7.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.316 -1.364 . . . . 74.42 107.316 167.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 65' ' ' THR . 59.7 t -85.08 129.87 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.04 -0.726 . . . . 64.01 109.04 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -125.09 120.15 30.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.528 1.131 . . . . 72.51 109.296 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tt -96.71 109.07 21.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.281 -1.748 . . . . 51.33 106.281 170.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -127.1 128.2 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.906 -1.146 . . . . 72.3 107.906 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.73 162.13 14.74 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.269 0.556 . . . . 73.32 110.853 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 10.1 t70 -131.05 134.51 46.71 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.015 1.326 . . . . 64.23 108.081 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -115.76 125.08 52.3 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.018 0.927 . . . . 74.44 110.695 -171.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.38 124.06 11.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.23 0.612 . . . . 53.2 111.586 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.5 p -90.91 155.68 18.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.296 0.638 . . . . 70.52 109.568 168.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -150.58 150.56 31.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.223 1.009 . . . . 70.3 109.027 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -115.24 138.84 50.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.194 0.598 . . . . 60.23 110.228 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.04 -34.63 6.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.824 0.85 . . . . 71.24 109.856 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -166.75 -176.01 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 71.04 109.986 -176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.39 122.07 21.48 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.955 -0.758 . . . . 75.32 108.955 173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 72.75 -7.02 1.52 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.36 1.464 . . . . 74.32 112.468 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.5 t -114.86 111.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 107.506 -1.294 . . . . 51.43 107.506 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -128.68 170.96 12.65 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 123.65 0.78 . . . . 73.34 108.997 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -130.59 147.25 52.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.978 0.911 . . . . 74.12 109.076 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.98 122.33 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.923 -1.14 . . . . 71.11 107.923 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.2 t -105.35 129.68 57.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 109.239 -0.652 . . . . 75.43 109.239 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -118.61 100.41 7.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 106.482 -1.673 . . . . 64.22 106.482 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttp180 -84.96 109.0 17.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.764 -0.653 . . . . 61.52 109.276 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -92.81 132.59 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 107.966 -1.124 . . . . 73.34 107.966 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -120.27 138.39 53.7 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.485 -0.561 . . . . 63.15 109.485 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.56 108.98 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 124.874 1.27 . . . . 74.14 107.573 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 m -105.02 134.72 47.65 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 109.461 -0.57 . . . . 73.04 109.461 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.77 111.63 15.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.232 -1.396 . . . . 71.53 107.232 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 18.2 t -138.15 134.99 35.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.004 0.522 . . . . 71.01 110.464 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.42 52.06 2.01 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.078 1.351 . . . . 64.32 109.608 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.83 -90.69 1.46 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.61 -0.596 . . . . 60.25 111.61 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.62 -27.59 17.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.996 0.518 . . . . 73.04 112.381 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.31 125.13 53.54 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.662 -0.496 . . . . 70.05 109.662 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 43.5 m -81.26 135.3 35.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.571 0.748 . . . . 73.31 111.237 -177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.87 -65.08 0.88 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.466 0.706 . . . . 43.14 110.217 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -160.53 163.47 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.988 -1.006 . . . . 74.32 111.366 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.93 124.89 30.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.862 1.265 . . . . 61.51 108.371 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.411 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 54.7 m -123.88 105.61 9.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.115 0.966 . . . . 73.41 109.067 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.7 122.16 28.38 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.348 0.659 . . . . 61.32 109.718 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 113' ' ' CYS . 46.7 t -130.47 112.75 23.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.915 0.886 . . . . 74.1 109.458 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 37.6 mt-30 -84.87 89.16 7.49 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.466 0.706 . . . . 74.21 109.506 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -80.33 98.23 7.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.136 -0.938 . . . . 73.33 109.023 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -101.1 145.25 16.91 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.426 -0.67 . . . . 63.24 111.426 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.98 137.27 6.58 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 111.639 -0.585 . . . . 71.21 111.639 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mt -77.9 126.15 38.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.843 -0.799 . . . . 55.41 108.843 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -129.52 118.98 22.93 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.621 -0.881 . . . . 72.4 108.621 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -86.25 99.11 11.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.778 -0.823 . . . . 71.5 108.778 172.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.88 157.32 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.313 0.645 . . . . 73.25 110.512 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.88 161.6 15.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.941 -1.027 . . . . 65.14 110.476 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.3 8.04 83.09 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.287 0.367 . . . . 73.33 113.797 170.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 pt -111.45 143.69 20.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 123.956 0.902 . . . . 71.14 108.901 -176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.7 tt0 -159.13 174.92 14.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.834 0.454 . . . . 74.41 109.879 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.469 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 58.87 -127.91 46.41 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 123.904 0.764 . . . . 72.23 114.274 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -82.66 -15.19 52.98 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.296 0.638 . . . . 70.0 111.527 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.53 -40.31 61.81 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.353 0.661 . . . . 74.14 110.097 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.8 ptm -71.01 -29.5 65.47 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.272 -0.422 . . . . 72.41 110.065 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.14 -28.85 63.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.561 0.745 . . . . 64.41 111.131 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -81.6 -31.49 32.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.419 0.687 . . . . 73.01 110.494 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.12 -57.57 5.23 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.965 0.506 . . . . 74.32 109.925 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.8 -51.83 44.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.284 -0.871 . . . . 61.4 111.001 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.57 -6.09 88.16 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 115.147 0.819 . . . . 62.33 115.147 -167.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.39 -54.14 0.19 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.254 0.835 . . . . 74.33 113.254 -170.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -69.39 -46.91 65.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.611 0.365 . . . . 64.13 111.575 -171.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.9 m -67.98 -43.56 37.02 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.003 0.921 . . . . 64.33 112.609 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.69 -43.26 40.72 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 123.096 2.531 . . . . 72.43 113.148 168.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -63.25 -37.14 86.07 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.089 0.868 . . . . 70.34 110.837 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.0 -45.53 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.326 0.65 . . . . 74.43 111.015 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.33 -24.49 34.55 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.566 -0.743 . . . . 74.14 112.292 -170.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -61.29 -42.49 85.64 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 113.824 1.046 . . . . 54.42 113.824 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PRO . . . . . 0.427 ' HA ' HH11 ' A' ' 111' ' ' ARG . 76.6 Cg_exo -55.04 -41.8 75.26 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.47 2.114 . . . . 74.31 114.399 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.148 0.579 . . . . 62.31 111.62 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.87 97.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.032 0.533 . . . . 71.0 110.657 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.1 ttm105 -50.69 -57.67 7.73 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.776 1.298 . . . . 64.41 110.825 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.88 -40.76 95.62 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.991 0.807 . . . . 74.1 110.802 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.571 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.2 t -60.76 -33.21 72.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.659 0.599 . . . . 73.43 111.786 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.522 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 96.1 mt -74.01 -55.74 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.623 0.769 . . . . 64.33 109.843 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -51.41 -44.3 62.2 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.246 1.418 . . . . 62.21 112.64 -173.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 34.3 t -65.3 -42.75 92.77 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.93 -1.032 . . . . 74.14 110.106 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.522 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 51.4 mtm -64.63 -40.39 95.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.84 0.456 . . . . 72.21 111.05 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.1 t -57.27 -48.29 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.576 0.75 . . . . 65.5 109.945 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -71.16 -31.89 68.24 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.737 -0.665 . . . . 75.41 111.765 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 116' ' ' SER . 73.1 mtt-85 -67.58 -28.74 68.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.85 0.86 . . . . 71.42 110.885 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.87 23.85 8.61 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 119.627 -0.54 . . . . 74.24 113.972 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.415 HG23 ' HB3' ' B' ' 17' ' ' TYR . 75.4 p 50.13 26.08 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.809 1.644 . . . . 44.35 113.625 -173.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.36 149.17 36.26 Favored Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 108.83 -0.804 . . . . 63.22 108.83 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.02 139.3 84.76 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.818 2.346 . . . . 60.12 111.488 174.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.448 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.1 tt0 -54.71 132.6 46.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.13 0.894 . . . . 70.42 111.092 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.1 tp -111.92 118.3 35.11 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.85 -0.796 . . . . 72.5 108.85 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.595 ' HB2' HD13 ' C' ' 13' ' ' ILE . 89.9 m-20 -110.0 110.36 21.25 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.995 -1.113 . . . . 70.1 107.995 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 128' ' ' LEU . 2.1 mm? -73.15 117.33 14.76 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.932 -1.136 . . . . 54.22 107.932 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -60.12 140.27 90.93 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 118.406 0.548 . . . . 45.44 110.996 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 1.7 Cg_endo -74.03 109.84 2.96 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.027 1.818 . . . . 43.32 110.645 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.36 123.74 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.501 -0.925 . . . . 73.45 108.501 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -73.75 99.73 3.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.807 0.843 . . . . 73.54 109.929 -173.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -72.15 -46.31 56.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.475 0.71 . . . . 73.34 111.85 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.644 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.9 p-10 . . . . . 0 N--CA 1.479 1.007 0 O-C-N 123.425 0.453 . . . . 64.31 111.441 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.241 0.638 0 N-CA-C 108.012 -1.107 . . . . 75.35 108.012 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -151.68 128.6 11.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.936 0.494 . . . . 73.23 110.104 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -159.67 144.27 15.09 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.678 0.791 . . . . 64.44 108.942 161.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.561 HG22 ' HE2' ' B' ' 84' ' ' PHE . 2.7 pp -59.13 138.4 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.498 -0.774 . . . . 73.24 109.957 168.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.7 mm100 -100.47 -45.98 5.38 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.575 -0.898 . . . . 75.34 108.575 172.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -164.84 129.93 2.64 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.99 -1.004 . . . . 75.14 108.882 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -115.03 135.98 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 106.667 -1.605 . . . . 62.54 106.667 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 122' ' ' THR . 26.5 p90 -166.5 158.44 13.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.482 0.658 . . . . 73.2 111.331 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 78.2 m -85.46 119.71 26.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.162 -0.926 . . . . 74.04 108.962 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.524 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 44.3 mtpt -88.32 -34.68 17.57 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.273 0.629 . . . . 73.14 110.177 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.2 t70 -153.79 147.16 24.87 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.568 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 41.0 mm -139.76 142.94 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.86 1.664 . . . . 53.31 107.573 177.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -148.43 138.17 22.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.665 -0.865 . . . . 62.02 108.665 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -151.18 123.3 8.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.239 -1.393 . . . . 75.44 107.239 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -120.89 149.52 42.49 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.081 0.552 . . . . 75.31 109.542 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -143.72 80.26 12.92 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.11 -1.07 . . . . 40.54 108.11 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.41 -17.66 39.03 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.057 2.505 . . . . 73.01 111.872 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -122.87 27.84 7.53 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.501 1.121 . . . . 72.22 109.439 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.05 -50.05 47.87 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 124.275 1.03 . . . . 75.32 112.836 172.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 1.0 OUTLIER -85.21 -35.29 0.16 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.504 2.136 . . . . 62.34 112.709 178.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.1 m80 -90.84 2.35 56.2 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 75.31 112.908 -170.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.83 -28.59 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 125.075 1.35 . . . . 71.0 111.898 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -66.62 -13.82 61.62 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.753 1.221 . . . . 73.42 112.381 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.617 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 21.2 pt20 -73.34 -32.45 64.56 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.427 0.632 . . . . 74.3 110.253 174.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.617 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 29.3 mmtp -107.03 81.81 1.6 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.04 1.336 . . . . 51.25 108.922 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.39 77.17 8.29 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.547 -0.751 . . . . 71.13 111.644 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.6 ' HA ' ' CE3' ' B' ' 36' ' ' TRP 0.258 0.0 OUTLIER 160.56 -171.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 127.084 2.153 . . . . 71.33 111.141 156.19 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.423 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 12.4 pt20 -59.02 132.2 87.11 Favored Pre-proline 0 C--N 1.361 1.068 0 C-N-CA 124.755 1.222 . . . . 72.2 113.278 -168.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.42 171.77 15.48 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.418 2.746 . . . . 74.23 112.784 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -69.39 109.41 4.17 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 108.596 -0.89 . . . . 50.51 108.596 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 m -95.16 135.0 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.407 -0.815 . . . . 61.21 109.931 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -141.65 124.28 15.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.329 1.052 . . . . 65.41 108.294 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.65 HD22 HD21 ' B' ' 128' ' ' LEU . 64.7 tp -97.41 145.49 26.12 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.454 -0.573 . . . . 65.02 109.454 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -146.66 154.25 41.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.999 -1.112 . . . . 63.4 107.999 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -138.38 141.97 39.63 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.484 -0.932 . . . . 73.04 108.484 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.692 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 15.1 t70 -124.34 144.02 50.25 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.966 0.906 . . . . 61.31 108.699 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.3 p -112.23 112.08 23.43 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.423 -0.808 . . . . 74.3 110.225 -170.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.96 125.36 31.4 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.314 -0.995 . . . . 71.35 108.314 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.6 p -142.82 168.17 20.34 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.36 0.664 . . . . 64.32 109.621 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 57.8 p -150.99 141.06 22.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.129 0.572 . . . . 74.25 109.909 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -82.02 109.74 16.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.826 -0.805 . . . . 62.11 108.826 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' B' ' 57' ' ' GLU . 55.1 mt -75.83 -41.03 53.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.445 . . . . 75.54 110.245 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.75 -171.77 3.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.184 0.994 . . . . 65.23 110.062 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.88 111.37 1.44 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 115.555 -0.748 . . . . 63.11 110.446 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 65.55 12.53 8.27 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.637 1.175 . . . . 75.54 112.516 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.06 115.14 47.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.094 -1.076 . . . . 72.42 108.094 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -124.14 138.49 54.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.225 -0.657 . . . . 72.44 109.225 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.507 ' HB2' HD11 ' B' ' 51' ' ' LEU . 7.8 tm-20 -107.08 106.92 17.66 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.278 -1.379 . . . . 73.32 107.278 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.1 t -96.4 121.57 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.088 1.355 . . . . 74.34 110.04 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.494 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 30.0 t -105.39 120.19 55.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.437 0.695 . . . . 54.11 109.149 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' ' 103' ' ' PRO . 50.2 tp -95.16 99.16 11.18 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 73.24 108.605 172.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.692 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 65.2 ttt180 -88.48 107.94 19.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.813 -0.81 . . . . 71.53 108.813 177.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -104.9 102.87 14.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.177 0.991 . . . . 65.24 108.934 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -100.93 128.47 46.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.376 0.67 . . . . 72.43 109.836 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.43 135.29 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.333 1.053 . . . . 72.44 108.932 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.9 m -124.83 143.59 50.74 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.528 0.731 . . . . 30.32 109.571 174.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.74 130.25 24.0 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.915 -1.142 . . . . 64.22 107.915 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.411 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 8.4 m -135.14 126.53 28.47 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 120.81 0.338 . . . . 53.23 111.586 -176.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 56.9 mt -93.9 109.75 21.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.409 1.084 . . . . 73.24 108.467 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.9 -111.17 3.86 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.051 -0.82 . . . . 53.41 111.051 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -121.97 18.42 10.91 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.657 0.742 . . . . 73.22 110.214 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -122.2 142.79 50.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.529 -0.732 . . . . 75.21 109.132 178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.7 m -66.78 118.45 10.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.909 0.484 . . . . 75.4 110.983 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -68.03 -55.46 12.51 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.973 -0.751 . . . . 71.4 108.973 177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -164.4 164.98 21.96 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.203 -1.362 . . . . 75.24 109.214 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.76 151.91 42.75 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.439 1.096 . . . . 64.45 108.514 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.4 t -155.52 115.66 3.75 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.221 -0.659 . . . . 74.43 109.221 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -123.62 127.04 47.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.143 -1.058 . . . . 74.15 108.143 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.414 HG13 HD13 ' B' ' 21' ' ' ILE . 57.3 t -122.55 148.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.875 -0.787 . . . . 74.05 108.875 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.5 mt-30 -123.4 99.46 6.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.218 -1.031 . . . . 55.24 108.218 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 44.6 tp60 -93.71 100.45 12.67 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.35 -0.981 . . . . 72.23 108.35 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.94 162.0 29.7 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 123.677 0.61 . . . . 45.15 111.912 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.89 127.13 1.64 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.226 -0.75 . . . . 71.53 111.226 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 33.9 mt -83.98 133.81 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.057 -1.09 . . . . 64.25 108.057 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.561 ' HE2' HG22 ' B' ' 13' ' ' ILE . 49.2 m-85 -135.42 138.61 43.41 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.454 0.702 . . . . 75.13 109.45 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -91.86 103.74 16.25 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.791 -0.818 . . . . 74.33 108.791 169.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.475 ' HB ' HD11 ' B' ' 89' ' ' ILE . 26.1 pt -120.21 122.04 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.879 0.872 . . . . 72.2 110.007 -176.024 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.87 21.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.839 0.855 . . . . 54.23 109.876 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.36 -45.32 3.48 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.525 0.516 . . . . 74.13 113.108 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' B' ' 86' ' ' ILE . 20.9 pt -64.03 158.88 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.655 1.182 . . . . 61.45 112.439 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.418 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 11.1 pt-20 -170.21 166.57 8.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.581 1.152 . . . . 74.3 109.8 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -119.1 16.6 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.297 -0.411 . . . . 71.35 113.881 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -80.27 -18.87 48.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 71.42 111.345 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.418 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 94.5 mt-30 -60.89 -44.35 97.24 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 73.42 110.954 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -73.24 -32.7 64.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.661 0.384 . . . . 71.14 110.612 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.57 -33.7 76.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.721 0.808 . . . . 63.33 111.406 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -85.24 -26.64 26.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.667 0.787 . . . . 52.21 110.488 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.97 -67.18 0.53 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.562 0.345 . . . . 72.15 110.569 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.433 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -95.14 -6.48 41.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.517 0.562 . . . . 74.0 112.517 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.8 2.38 45.19 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.216 0.322 . . . . 71.5 113.036 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.76 -58.36 0.32 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.094 0.558 . . . . 63.43 111.037 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.41 -46.8 46.57 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.198 0.599 . . . . 73.2 111.963 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 68.8 m -66.04 -42.46 51.67 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.546 0.738 . . . . 53.02 111.781 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HA ' HD22 ' B' ' 60' ' ' LEU . 89.9 Cg_exo -50.87 -43.72 45.46 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.628 2.218 . . . . 74.11 112.893 166.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -65.87 -25.04 67.0 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.183 0.593 . . . . 71.44 112.523 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mt -76.8 -50.55 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.407 0.683 . . . . 64.1 110.346 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.36 -15.95 57.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.562 0.745 . . . . 70.43 111.521 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.466 ' HE1' HD13 ' B' ' 128' ' ' LEU . 37.8 t80 -62.5 -53.33 58.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.609 -1.186 . . . . 75.3 112.799 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 71.4 Cg_exo -54.26 -37.76 88.31 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.187 1.925 . . . . 75.15 113.59 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.518 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 80.0 m-85 -68.33 -51.38 45.22 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.737 0.815 . . . . 72.02 110.947 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.72 81.23 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.959 0.904 . . . . 61.02 111.33 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -64.95 -52.71 54.82 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.457 1.503 . . . . 73.21 110.296 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -34.84 78.4 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.903 0.752 . . . . 55.12 109.776 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.523 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.8 t -68.66 -43.29 76.53 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.904 0.482 . . . . 75.15 111.363 -177.708 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.85 -43.78 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 123.445 0.698 . . . . 75.14 110.338 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.723 HG23 ' HB2' ' B' ' 125' ' ' GLN . 44.5 m -64.02 -27.7 69.29 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.203 -0.908 . . . . 74.35 111.052 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.8 t -73.59 -45.01 55.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.458 0.703 . . . . 71.31 110.122 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -72.5 -37.78 68.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.991 0.517 . . . . 72.33 112.025 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.59 -31.07 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.002 0.43 . . . . 73.43 110.46 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.461 ' OG ' HG21 ' C' ' 115' ' ' THR . 21.5 t -70.98 -30.54 66.84 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.925 0.89 . . . . 72.01 111.611 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.571 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.7 mtt-85 -74.03 -31.16 62.78 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.213 -0.903 . . . . 75.11 109.683 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.4 0.7 68.09 Favored Glycine 0 C--N 1.362 2.027 0 O-C-N 123.911 0.757 . . . . 53.34 112.203 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.563 HG22 HH22 ' C' ' 111' ' ' ARG . 29.3 p 65.5 23.62 11.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.93 2.092 . . . . 75.44 113.244 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.59 150.85 39.53 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 122.893 0.477 . . . . 74.55 110.079 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -42.0 137.76 3.07 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.381 3.387 . . . . 72.14 113.226 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.723 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.0 pt20 -66.57 157.33 32.6 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.267 1.21 . . . . 75.51 114.267 -174.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.77 95.86 5.82 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.521 -1.659 . . . . 73.01 106.521 165.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -88.33 92.6 9.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.923 -1.51 . . . . 72.14 106.923 173.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.65 HD21 HD22 ' B' ' 42' ' ' LEU . 1.2 tt -63.44 133.91 54.76 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.785 -1.098 . . . . 72.42 110.892 -165.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.99 146.6 95.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.155 0.982 . . . . 74.04 111.051 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.77 116.16 3.11 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.682 2.254 . . . . 72.24 111.516 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.76 118.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.226 -0.657 . . . . 73.03 109.226 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -96.74 103.67 15.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.578 0.751 . . . . 71.5 109.823 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 123.625 0.77 . . . . 73.11 110.707 177.057 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.524 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 57.9 ttp . . . . . 0 CA--C 1.555 1.136 0 CA-C-O 121.926 0.87 . . . . 64.01 112.704 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 67.6 m -119.11 97.17 5.55 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.894 -1.521 . . . . 70.23 106.894 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.92 121.68 45.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.338 0.655 . . . . 65.43 109.633 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -137.84 145.13 41.87 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.363 0.665 . . . . 71.5 109.748 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 127' ' ' ASN . 2.6 pp -82.42 142.68 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.615 -0.883 . . . . 72.13 108.615 171.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -110.09 -50.19 3.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.855 -0.424 . . . . 75.14 109.855 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -169.71 130.95 1.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.245 0.341 . . . . 72.51 110.464 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 16' ' ' ILE . . . . . 0.435 ' H ' HD21 ' A' ' 127' ' ' ASN . 65.6 mt -109.61 140.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.826 1.25 . . . . 73.2 107.92 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG12 ' C' ' 83' ' ' ILE . 12.8 p90 -171.89 154.5 3.56 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.018 0.826 . . . . 74.42 112.212 -175.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -80.44 106.44 12.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.661 -1.154 . . . . 55.03 107.974 170.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -68.73 -48.16 64.51 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.872 0.844 . . . . 55.44 109.205 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.8 t70 -134.65 141.81 46.68 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.237 -1.347 . . . . 74.02 109.244 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.3 mt -135.63 145.33 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.353 1.461 . . . . 75.24 107.219 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -155.59 152.01 28.24 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.212 0.529 . . . . 53.14 110.355 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.3 t80 -147.94 119.11 7.74 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.298 -1.371 . . . . 72.04 107.298 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 41.4 mt-10 -118.7 118.23 31.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.163 0.585 . . . . 72.24 109.628 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 25' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -134.54 86.0 35.71 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.627 0.771 . . . . 72.02 109.313 175.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -71.25 -28.71 18.17 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.954 2.436 . . . . 65.24 111.781 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.99 19.81 12.2 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.397 1.079 . . . . 64.42 110.465 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' C' ' 25' ' ' ALA . . . -59.11 -47.0 99.34 Favored Pre-proline 0 CA--C 1.567 1.596 0 C-N-CA 124.812 1.245 . . . . 62.33 113.953 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.94 -31.06 6.62 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.775 1.65 . . . . 65.52 111.875 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -66.68 -21.84 66.09 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.896 1.278 . . . . 72.32 112.744 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 8.3 p -50.92 -33.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 113.856 1.058 . . . . 73.32 113.856 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -58.35 -30.8 67.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.569 0.748 . . . . 71.42 112.624 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.25 28.06 9.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.232 1.013 . . . . 73.33 110.593 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 14.1 ttmm -104.15 147.27 27.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.242 0.617 . . . . 64.35 109.739 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.25 130.74 42.83 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.347 0.659 . . . . 74.11 109.836 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -84.7 62.81 7.59 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 123.731 0.644 . . . . 72.35 111.246 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -156.28 77.66 4.33 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.361 1.065 . . . . 74.24 108.348 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.485 ' HB2' ' HB1' ' C' ' 66' ' ' ALA . 72.5 Cg_endo -88.45 140.2 4.4 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 122.454 2.103 . . . . 73.41 111.608 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.03 115.52 24.47 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.249 -1.019 . . . . 73.32 108.249 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.85 106.22 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.86 -0.793 . . . . 74.52 108.86 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -92.11 108.31 19.84 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.18 122.85 32.21 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.281 -1.377 . . . . 75.41 107.281 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.77 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.0 m-20 -119.88 118.27 30.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.769 0.827 . . . . 74.34 109.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.45 126.34 53.39 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.908 -0.775 . . . . 75.52 108.908 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 19.8 t70 -128.53 135.68 49.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.719 1.208 . . . . 75.03 108.107 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.0 p -113.73 126.58 55.39 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.946 0.498 . . . . 44.12 110.358 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -126.58 145.66 50.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.951 0.9 . . . . 74.15 110.081 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.4 p -144.04 148.68 35.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.256 0.622 . . . . 53.11 109.458 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -145.38 140.28 27.56 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.564 -0.902 . . . . 63.15 108.564 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -94.29 115.82 28.12 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.044 -1.095 . . . . 73.21 108.044 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 HD12 ' C' ' 83' ' ' ILE . 35.1 mt -87.92 -40.83 13.62 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.745 0.818 . . . . 71.43 109.618 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.81 -175.77 5.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.085 1.354 . . . . 63.14 108.371 175.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -62.45 122.94 16.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.389 0.431 . . . . 55.55 109.943 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 68.93 -7.09 0.8 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.67 1.588 . . . . 61.41 113.604 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.22 107.05 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.837 -1.171 . . . . 73.35 107.837 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' C' ' 86' ' ' ILE . 72.9 m-85 -118.18 122.87 44.12 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.927 -1.138 . . . . 74.11 107.927 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.22 120.77 26.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.158 0.983 . . . . 72.32 109.141 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.2 t -97.05 116.07 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 72.21 108.375 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 59.6 t -117.82 134.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.643 0.777 . . . . 63.34 109.132 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.91 111.02 19.06 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.2 ttm180 -79.96 105.83 11.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.041 -1.466 . . . . 62.41 107.041 167.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.25 114.07 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.09 -1.078 . . . . 75.13 108.09 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.77 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 64.2 m -114.71 137.73 51.57 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.715 0.806 . . . . 72.43 108.882 -174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.48 HG21 HG21 ' C' ' 114' ' ' ILE . 61.0 t -128.23 112.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.667 -1.234 . . . . 62.25 107.667 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -106.24 139.89 40.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.613 -0.884 . . . . 72.45 108.613 169.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 66' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' C' ' 38' ' ' PRO . . . -121.34 112.89 19.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.881 -1.526 . . . . 74.32 106.881 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.0 m -148.12 137.44 22.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.116 0.566 . . . . 72.05 110.354 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.5 58.79 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.391 1.076 . . . . 65.41 109.347 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 -117.78 5.3 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.808 -1.087 . . . . 73.2 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.53 -30.25 18.36 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.925 -0.769 . . . . 70.15 108.925 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -63.61 100.05 0.25 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 124.236 0.96 . . . . 63.24 109.476 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -85.56 134.96 34.0 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.053 0.541 . . . . 73.41 109.856 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.635 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -80.83 -61.05 2.08 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.995 0.918 . . . . 42.13 109.173 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -167.59 178.0 5.6 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.952 0.782 . . . . 74.31 110.934 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -138.49 144.85 40.2 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.548 -1.279 . . . . 75.01 107.548 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.465 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.0 t -148.98 142.92 25.78 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.792 -1.188 . . . . 74.2 107.792 174.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.64 134.54 11.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.896 0.316 . . . . 60.44 110.722 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -138.48 116.08 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.458 1.103 . . . . 43.55 110.027 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.505 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 2.2 mp0 -89.99 88.4 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.179 0.992 . . . . 71.34 108.426 174.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -79.39 103.41 9.29 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.061 -0.972 . . . . 62.41 110.081 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.54 153.11 20.86 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.784 -0.644 . . . . 63.21 111.763 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.08 117.37 0.82 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 110.225 -1.15 . . . . 54.41 110.225 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.577 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -81.2 122.31 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.11 -0.7 . . . . 54.23 109.11 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' C' ' 86' ' ' ILE . 60.3 m-85 -132.07 152.82 50.98 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.534 -0.914 . . . . 64.53 108.534 176.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -110.27 113.15 25.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.542 -0.91 . . . . 50.42 108.542 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' C' ' 84' ' ' PHE . 2.9 mp -115.75 103.15 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.204 -1.406 . . . . 45.03 107.204 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.52 169.83 10.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.339 0.656 . . . . 72.45 110.903 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.06 -50.69 2.8 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.913 -0.585 . . . . 43.21 112.484 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 170.32 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.002 0.521 . . . . 72.25 111.769 -171.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.22 -173.99 4.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.767 0.827 . . . . 71.3 109.823 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -138.63 39.12 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.738 -0.479 . . . . 53.4 113.627 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 92' ' ' THR . . . . . 0.527 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 35.7 p -68.54 -22.3 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.915 0.886 . . . . 52.43 111.818 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -67.41 -50.07 61.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 74.42 110.041 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -66.83 -38.21 85.98 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.871 -0.604 . . . . 64.34 109.985 172.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -60.88 -27.69 68.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.874 0.87 . . . . 62.44 112.331 -175.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 37.1 t-80 -74.91 -47.88 27.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.007 -0.368 . . . . 63.11 110.007 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.524 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 18.7 t -70.73 -22.3 62.45 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 111.984 0.364 . . . . 71.2 111.984 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.24 -43.48 5.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.084 0.954 . . . . 74.01 109.521 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.66 -5.36 64.85 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.56 -0.746 . . . . 73.24 114.139 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -133.87 -54.7 0.87 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.192 0.496 . . . . 54.31 111.361 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.422 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 33.4 t80 -67.13 -55.92 12.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.156 0.983 . . . . 71.35 112.079 -172.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.83 -45.49 87.59 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 113.044 0.757 . . . . 72.31 113.044 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -56.61 -39.89 88.24 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.715 2.277 . . . . 70.11 113.72 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -65.69 -28.7 69.26 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.937 0.895 . . . . 64.34 110.982 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.505 HD12 ' NH1' ' A' ' 111' ' ' ARG . 24.0 mm -72.79 -44.87 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.449 0.7 . . . . 72.21 110.592 173.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.08 -15.01 54.96 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.635 -0.711 . . . . 53.31 112.134 -173.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 78.1 t80 -57.11 -50.57 87.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 124.837 1.255 . . . . 71.52 113.139 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 34.4 Cg_exo -62.85 -32.79 77.2 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 122.129 1.886 . . . . 72.42 113.428 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.34 -44.88 86.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.688 0.795 . . . . 73.44 111.626 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.64 95.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.001 -0.545 . . . . 73.43 110.117 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.563 HH22 HG22 ' B' ' 122' ' ' THR . 48.2 ttt180 -56.44 -55.1 37.91 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.224 0.952 . . . . 72.2 111.255 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.41 -30.7 71.54 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.294 0.638 . . . . 71.4 110.69 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.74 -39.82 63.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.812 0.445 . . . . 55.33 111.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.48 HG21 HG21 ' C' ' 64' ' ' VAL . 66.5 mt -62.62 -47.0 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.958 0.903 . . . . 65.03 109.87 172.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 115' ' ' THR . . . . . 0.461 HG21 ' OG ' ' B' ' 119' ' ' SER . 86.8 m -67.62 -29.33 68.63 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 114.088 -1.414 . . . . 74.44 110.846 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -68.33 -46.26 70.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.384 0.674 . . . . 61.13 109.592 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.46 -42.71 95.79 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.302 1.041 . . . . 73.21 113.248 -176.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 22.8 m -66.65 -32.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.576 0.227 . . . . 64.32 110.438 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.53 -34.42 77.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.111 0.964 . . . . 74.11 111.473 174.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.4 mtt-85 -72.77 -33.25 66.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.743 0.817 . . . . 73.45 110.498 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.26 64.46 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 123.661 0.601 . . . . 45.13 112.465 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.409 ' OG1' ' HD3' ' D' ' 15' ' ' ARG . 69.3 p 58.04 31.36 20.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.152 1.781 . . . . 44.52 112.943 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.42 148.41 36.27 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.539 1.135 . . . . 65.42 108.771 174.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.46 138.58 47.5 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.416 2.744 . . . . 75.34 112.821 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.41 ' HB3' HG23 ' C' ' 115' ' ' THR . 95.9 mt-30 -63.36 149.3 46.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 113.865 1.061 . . . . 75.33 113.865 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.7 98.24 6.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 106.863 -1.532 . . . . 75.04 106.863 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -92.38 130.44 38.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.313 0.645 . . . . 72.25 109.603 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.05 136.64 37.23 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.594 0.758 . . . . 54.11 110.495 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.02 157.8 73.24 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.263 1.025 . . . . 61.15 109.963 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.76 98.9 0.31 Allowed 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 122.358 2.038 . . . . 53.23 113.075 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.57 109.28 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.482 -1.303 . . . . 74.13 107.482 170.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -110.45 101.35 10.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.221 -1.029 . . . . 44.11 108.221 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 64.0 m-85 -69.72 -30.09 67.63 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.454 -0.794 . . . . 72.41 110.923 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 123.671 0.788 . . . . 74.41 110.7 177.763 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 C--O 1.242 0.686 0 N-CA-C 108.436 -0.95 . . . . 72.14 108.436 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.587 ' HZ ' ' HG ' ' D' ' 102' ' ' CYS . 41.3 t80 -149.76 94.95 2.25 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.947 -1.131 . . . . 75.43 107.947 172.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -117.94 125.87 51.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.314 0.645 . . . . 65.22 109.421 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.37 124.89 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.713 -0.847 . . . . 51.31 108.713 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -87.42 -34.96 18.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.287 -0.634 . . . . 43.11 109.287 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HD3' ' OG1' ' C' ' 122' ' ' THR . 17.7 ttm180 -175.64 144.37 0.65 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.102 -0.953 . . . . 74.42 109.357 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.417 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -131.11 130.13 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 106.455 -1.683 . . . . 74.14 106.455 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 27.5 p90 -164.52 173.42 12.07 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.834 0.826 . . . . 72.15 111.249 -165.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.26 121.62 41.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.694 -1.139 . . . . 34.44 108.896 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.2 mtpt -85.46 -39.86 17.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.3 0.571 . . . . 61.41 109.732 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 19.9 t70 -149.78 126.76 11.19 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 114.67 -1.15 . . . . 70.04 108.984 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.574 HG21 ' HE2' ' C' ' 117' ' ' MET . 70.0 mt -118.87 147.1 22.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.429 -0.952 . . . . 64.33 108.429 175.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -143.77 136.01 26.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.21 1.004 . . . . 72.41 109.097 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.3 t80 -140.28 117.63 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.126 -1.805 . . . . 74.54 106.126 168.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -123.71 122.35 37.87 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.269 0.628 . . . . 74.44 109.811 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.38 81.26 3.9 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 107.181 -1.415 . . . . 74.13 107.181 168.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.2 -33.47 18.64 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.734 2.289 . . . . 43.23 112.116 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.425 ' HB2' HG23 ' D' ' 31' ' ' VAL . 4.1 m120 -111.66 29.76 7.57 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 108.768 -0.827 . . . . 63.0 108.768 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -61.52 2.57 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 114.989 1.477 . . . . 71.24 114.989 -166.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.1 Cg_endo -81.81 -13.03 10.73 Favored 'Trans proline' 0 C--N 1.378 2.089 0 CA-C-N 121.54 1.586 . . . . 74.51 113.329 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -69.35 -41.38 76.68 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.859 0.864 . . . . 72.42 109.249 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' D' ' 35' ' ' ASP . 36.1 t -70.8 -35.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 CA-C-N 114.909 -1.041 . . . . 65.42 109.98 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -64.36 -6.79 7.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.969 1.1 . . . . 73.1 113.969 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -84.62 -35.46 22.67 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.027 0.531 . . . . 74.12 109.915 170.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -128.7 60.09 1.53 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.114 0.966 . . . . 61.1 110.352 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 35' ' ' ASP . . . . . 0.509 ' HB2' HG12 ' D' ' 31' ' ' VAL . 5.7 t0 -110.08 94.56 5.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.737 . . . . 74.31 109.463 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.531 ' H ' HD22 ' D' ' 68' ' ' LEU . 10.8 m95 -124.4 -159.5 0.88 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.927 -1.508 . . . . 73.2 106.927 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -63.35 112.32 6.79 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 118.374 0.534 . . . . 73.32 111.558 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.54 151.78 13.36 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.111 2.541 . . . . 61.23 112.313 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.89 113.68 20.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.996 -0.742 . . . . 73.43 108.996 166.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' D' ' 66' ' ' ALA . 3.6 m -99.28 106.37 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.074 0.95 . . . . 61.32 109.602 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.0 mmtt -88.31 128.76 35.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.349 1.06 . . . . 74.23 108.952 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.05 113.05 24.8 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.532 -0.544 . . . . 75.51 109.532 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -122.94 115.75 22.45 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.892 -0.781 . . . . 63.24 108.892 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.96 145.75 31.88 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.28 0.632 . . . . 72.31 109.973 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -137.15 131.31 32.39 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.364 1.066 . . . . 73.31 108.511 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 56.6 p -105.71 144.67 32.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.469 0.708 . . . . 73.14 110.195 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.22 155.03 35.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.498 0.719 . . . . 43.13 109.885 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -164.07 153.27 13.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.781 0.832 . . . . 33.45 109.883 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.9 p -160.47 151.77 19.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 70.32 110.101 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -81.8 118.57 22.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.078 0.551 . . . . 71.03 109.688 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -31.3 15.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.339 0.656 . . . . 74.35 110.488 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.02 -179.34 7.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.277 0.631 . . . . 61.05 110.707 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.58 116.92 5.57 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.702 -1.135 . . . . 74.51 110.117 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 11.7 m-20 60.47 24.66 14.27 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.258 0.974 . . . . 65.41 111.539 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.48 116.54 44.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.053 -1.092 . . . . 75.45 108.053 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.544 ' HB2' HD12 ' D' ' 86' ' ' ILE . 96.8 m-85 -129.82 129.03 43.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.335 1.054 . . . . 74.32 108.738 -174.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -90.32 139.1 30.99 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.989 0.915 . . . . 70.52 109.744 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.45 117.28 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 107.354 -1.35 . . . . 64.11 107.354 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.7 t -100.18 128.82 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.279 -1.008 . . . . 64.32 108.279 172.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 107.23 12.55 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.769 -1.197 . . . . 70.34 107.769 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 16.1 ttm-85 -87.17 105.71 17.38 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.218 -0.901 . . . . 75.21 109.566 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.22 120.47 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.685 -0.857 . . . . 73.44 108.685 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.3 m -125.84 135.85 52.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.705 0.802 . . . . 74.44 109.137 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.587 HG11 HD11 ' D' ' 126' ' ' LEU . 44.0 t -129.95 117.95 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.436 1.094 . . . . 55.31 109.68 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 57.0 m -105.57 100.6 10.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.135 0.974 . . . . 54.21 110.093 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -96.71 125.15 40.97 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.234 -0.291 . . . . 41.34 110.773 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.5 m -138.94 123.32 18.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.841 0.856 . . . . 53.24 109.611 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.6 OUTLIER -103.07 128.09 50.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.354 0.662 . . . . 61.13 109.852 177.054 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.24 -111.73 3.95 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.95 -0.86 . . . . 71.05 110.95 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.81 5.68 11.49 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.56 0.744 . . . . 73.42 110.877 175.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.04 140.28 50.3 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.1 0.56 . . . . 61.55 110.449 -172.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.8 m -71.98 117.38 13.52 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.607 0.763 . . . . 73.14 111.115 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.601 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -68.45 -65.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.279 0.987 . . . . 70.44 109.914 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -154.51 156.64 37.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.408 -1.269 . . . . 75.52 110.406 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.84 145.93 47.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.747 1.219 . . . . 72.15 107.714 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.62 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.6 t -150.75 142.11 23.35 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.622 -0.51 . . . . 62.35 109.622 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.04 138.31 14.75 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.988 -0.745 . . . . 74.4 108.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.64 115.57 8.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.331 -0.989 . . . . 74.2 108.331 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 66.4 mt-30 -88.97 84.49 6.62 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.099 -1.074 . . . . 70.43 108.099 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -79.52 93.45 5.43 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.208 -0.906 . . . . 70.51 109.031 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.69 142.29 16.55 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.802 -0.919 . . . . 65.13 110.802 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.99 128.59 3.48 Favored Glycine 0 CA--C 1.499 -0.919 0 N-CA-C 110.327 -1.109 . . . . 62.1 110.327 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.93 132.3 35.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.701 0.801 . . . . 61.52 109.061 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -134.01 133.43 41.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.88 0.472 . . . . 73.33 110.157 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -79.11 98.88 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.486 0.714 . . . . 64.34 109.27 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' D' ' 56' ' ' TYR . 48.2 mt -109.08 106.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.907 0.883 . . . . 70.03 109.506 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -144.07 148.54 35.31 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.048 0.939 . . . . 33.32 110.092 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.48 -20.82 44.28 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.842 -0.421 . . . . 40.2 113.438 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.493 ' HB ' ' HG3' ' D' ' 94' ' ' MET . 0.4 OUTLIER -106.39 139.76 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.675 -1.231 . . . . 62.11 107.675 179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.77 157.85 41.72 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.15 0.58 . . . . 72.52 111.425 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -134.96 51.81 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.597 1.186 . . . . 63.13 115.782 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -63.82 -29.17 70.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.235 1.014 . . . . 74.25 111.841 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -40.5 77.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.624 0.77 . . . . 33.11 109.216 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.493 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 9.9 ttp -75.92 -41.99 50.21 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.813 -0.631 . . . . 73.44 110.773 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.21 69.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.884 0.874 . . . . 63.55 111.2 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -66.23 -46.63 76.52 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.143 -0.48 . . . . 64.02 109.996 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.62 -36.61 78.88 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.017 0.527 . . . . 63.33 111.276 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.569 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.1 tt -77.45 -30.75 53.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.394 0.678 . . . . 70.35 110.02 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.06 -16.44 55.96 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.127 -0.488 . . . . 72.12 113.663 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.09 -64.32 1.32 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.398 0.599 . . . . 72.22 111.289 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -66.03 -47.27 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.151 0.58 . . . . 63.45 111.414 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.587 ' HG ' ' HZ ' ' D' ' 11' ' ' PHE . 58.0 m -61.43 -48.47 90.72 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.348 -0.834 . . . . 65.44 112.731 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.2 Cg_exo -54.9 -39.41 90.45 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.76 2.306 . . . . 73.1 113.91 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -72.47 -14.04 61.58 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.298 0.639 . . . . 62.34 112.541 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -81.09 -40.95 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 121.597 0.713 . . . . 73.53 109.864 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.414 HD21 ' HA3' ' D' ' 82' ' ' GLY . 71.9 mt -78.46 -31.75 48.08 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.909 -1.041 . . . . 75.43 111.802 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -63.72 -42.1 69.39 Favored Pre-proline 0 CA--C 1.56 1.361 0 N-CA-C 114.146 1.165 . . . . 75.33 114.146 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.45 -43.67 55.57 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.152 1.901 . . . . 70.01 113.132 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -74.98 -31.71 61.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.662 0.785 . . . . 71.34 111.891 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.62 -54.53 34.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.068 0.547 . . . . 51.14 109.797 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -56.73 -46.57 81.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 114.091 -1.413 . . . . 62.44 110.899 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.63 -44.49 90.36 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.104 0.878 . . . . 72.33 111.214 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 113' ' ' CYS . . . . . 0.43 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.5 t -58.61 -41.36 85.69 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.533 0.52 . . . . 74.05 110.947 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.62 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -62.32 -53.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.939 0.896 . . . . 73.23 110.369 174.071 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -53.84 -42.95 69.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.725 1.21 . . . . 71.02 111.426 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -66.97 -44.65 79.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.754 -1.112 . . . . 64.42 110.654 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -66.32 -33.76 76.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.863 0.465 . . . . 73.35 111.656 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.3 t -67.78 -43.3 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.545 -0.752 . . . . 73.31 109.919 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.35 -28.9 64.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.751 0.42 . . . . 73.44 111.699 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -75.04 -32.06 61.46 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.924 0.89 . . . . 75.22 110.085 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.14 5.66 75.48 Favored Glycine 0 C--N 1.356 1.676 0 CA-C-N 115.586 -0.734 . . . . 62.43 111.853 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 65.54 14.15 9.31 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.488 2.315 . . . . 43.34 114.257 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -84.89 158.28 59.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.207 1.003 . . . . 74.1 108.867 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.11 136.74 49.26 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.871 2.381 . . . . 72.2 112.175 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -47.19 129.92 12.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.488 1.115 . . . . 74.05 112.135 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.587 HD11 HG11 ' D' ' 64' ' ' VAL . 5.1 tt -107.22 93.93 4.82 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.234 -1.024 . . . . 33.22 108.234 -170.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -105.09 100.47 10.07 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.9 -1.148 . . . . 73.22 107.9 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.413 HD12 ' H ' ' D' ' 129' ' ' ALA . 20.5 tp -75.86 141.46 42.4 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.004 0.522 . . . . 64.21 110.814 177.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.413 ' H ' HD12 ' D' ' 128' ' ' LEU . . . -56.24 132.84 75.5 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.447 1.099 . . . . 73.24 111.326 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.0 116.65 4.8 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.448 2.099 . . . . 75.32 110.363 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.48 138.44 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.477 0.711 . . . . 63.34 109.577 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -79.97 103.55 9.94 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.602 0.761 . . . . 72.24 110.02 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.478 0.972 0 C-N-CA 123.33 0.652 . . . . 74.23 111.406 177.693 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.9 m . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.104 -0.702 . . . . 73.34 109.104 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.466 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.4 t80 -137.2 122.84 19.79 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.623 -1.251 . . . . 72.42 107.623 166.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -146.74 129.61 16.27 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.161 -0.681 . . . . 60.55 109.161 173.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.661 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.7 mt -86.24 119.85 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 109.437 -0.579 . . . . 71.11 109.437 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.5 -40.38 13.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.062 0.945 . . . . 74.51 109.281 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -166.42 141.7 4.51 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.533 -166.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER -131.87 126.31 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.032 -1.47 . . . . 73.41 107.032 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.6 p90 -161.08 152.55 19.16 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.512 0.672 . . . . 70.25 111.491 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -76.57 107.87 9.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.614 -1.176 . . . . 71.52 108.161 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.5 mtpt -67.26 -33.15 74.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.198 0.523 . . . . 63.33 109.603 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.4 t70 -153.12 144.16 22.99 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.193 -1.367 . . . . 74.22 109.682 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -133.06 143.64 38.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.941 1.296 . . . . 53.42 107.863 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 44.0 t -147.21 126.89 13.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.855 0.862 . . . . 54.13 109.171 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 87.2 t80 -127.93 126.68 41.95 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.892 -1.892 . . . . 73.54 105.892 168.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -133.95 116.6 15.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.016 -0.735 . . . . 71.42 109.016 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -127.55 74.45 77.96 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.573 -1.269 . . . . 54.52 107.573 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.13 -43.63 2.25 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.553 2.169 . . . . 74.21 111.127 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -89.4 12.15 17.14 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 118.057 -0.973 . . . . 75.23 111.414 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.76 -56.26 9.0 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.136 -0.935 . . . . 62.05 112.372 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 35.3 Cg_exo -58.75 -22.97 64.15 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.579 2.186 . . . . 74.21 113.888 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 -31.58 12.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.746 0.818 . . . . 75.14 110.503 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.704 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.58 -17.02 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 120.895 0.379 . . . . 72.22 110.165 -170.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.437 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 21.9 m-85 -73.86 -30.4 62.63 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.61 0.764 . . . . 55.24 111.807 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -85.37 -12.86 51.15 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.485 0.314 . . . . 74.54 111.364 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 31.4 mmtp -79.16 152.24 30.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.311 0.644 . . . . 73.13 110.872 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.05 140.18 58.81 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.22 0.95 . . . . 63.12 109.623 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HH2' ' HA ' ' A' ' 32' ' ' PHE . 32.2 m95 -74.28 83.47 1.89 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.689 0.796 . . . . 71.35 110.912 -173.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -134.56 71.23 71.45 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.575 1.15 . . . . 71.45 109.609 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.32 127.76 5.3 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.009 1.806 . . . . 75.43 112.174 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.9 88.82 5.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 106.423 -1.695 . . . . 64.12 106.423 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -82.22 114.72 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.761 -1.109 . . . . 73.11 111.11 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 88.3 mttt -80.18 152.86 28.95 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.454 1.102 . . . . 73.41 110.84 167.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.1 tt -122.72 109.61 14.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.539 -2.022 . . . . 50.1 105.539 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.688 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -117.77 107.73 14.51 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.793 -0.817 . . . . 64.31 108.793 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -99.06 150.45 21.99 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.321 -0.622 . . . . 74.01 109.321 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 30.1 t70 -145.5 136.6 24.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.678 0.791 . . . . 63.3 109.39 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -121.76 126.76 49.61 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.684 0.794 . . . . 54.11 110.942 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.3 113.56 4.57 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.366 0.667 . . . . 64.41 110.193 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.9 p -98.77 162.3 13.18 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.683 -0.488 . . . . 71.24 109.683 173.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -152.94 158.07 41.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.321 1.048 . . . . 71.4 109.196 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -114.07 126.3 54.96 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.944 -1.132 . . . . 64.42 107.944 166.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -93.5 -41.53 9.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.011 0.525 . . . . 75.53 110.25 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -152.25 178.75 9.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.866 0.866 . . . . 74.42 109.702 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.85 123.13 18.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.991 -0.744 . . . . 73.14 108.991 171.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 73.02 -7.23 1.53 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.796 1.638 . . . . 64.3 112.237 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 44.9 t -106.7 111.45 35.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.286 -1.005 . . . . 64.24 108.286 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -123.38 161.06 25.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.274 -0.639 . . . . 65.43 109.274 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -131.56 138.99 49.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.859 -1.064 . . . . 74.54 108.784 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.9 t -126.22 117.02 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.849 -1.538 . . . . 55.21 106.849 169.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 t -101.23 130.45 50.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.986 -0.746 . . . . 72.43 108.986 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD23 HD12 ' A' ' 106' ' ' LEU . 3.8 mm? -117.57 109.78 17.12 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.212 -1.032 . . . . 75.12 108.212 170.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.637 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 13.2 ttp180 -85.57 112.64 21.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.108 -0.701 . . . . 74.31 109.108 172.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.0 t -94.2 128.62 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 107.359 -1.348 . . . . 74.44 107.359 170.576 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.688 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 47.3 m -127.05 126.5 43.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.213 -1.032 . . . . 74.3 108.213 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.826 HG11 HD21 ' A' ' 126' ' ' LEU . 44.9 t -118.75 109.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.46 -0.941 . . . . 73.3 108.46 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.3 m -103.71 133.28 48.98 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.292 -0.632 . . . . 51.14 109.292 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.37 31.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.439 -1.319 . . . . 72.22 107.439 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 55.6 m -135.93 127.91 29.56 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.819 0.447 . . . . 71.23 110.479 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -88.83 72.28 8.56 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.917 -1.142 . . . . 74.3 107.917 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.24 -84.46 0.83 Allowed Glycine 0 C--N 1.35 1.333 0 CA-C-N 114.934 -1.03 . . . . 45.25 110.713 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -110.88 -29.22 8.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 74.01 109.86 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 3.3 tp10 -82.89 91.48 7.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.721 0.809 . . . . 74.14 110.322 -173.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 86.5 m -64.71 130.89 45.26 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.284 0.564 . . . . 54.32 111.495 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.704 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.29 -63.36 1.42 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.91 -1.041 . . . . 73.42 110.011 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -162.04 170.94 18.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.467 -1.242 . . . . 73.04 110.97 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.4 tp -142.62 113.77 7.69 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.551 -1.204 . . . . 72.01 108.284 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 118' ' ' VAL . 76.4 m -113.42 100.87 8.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.387 0.675 . . . . 71.34 110.77 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 31.4 tt0 -119.16 118.65 31.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.285 1.034 . . . . 71.04 109.617 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.12 112.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.236 1.015 . . . . 72.23 109.224 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.637 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 49.7 mt-30 -84.24 84.47 7.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.686 -0.857 . . . . 71.41 108.686 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.85 97.89 7.59 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.775 -1.102 . . . . 71.21 108.592 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.22 146.64 18.34 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.723 -0.671 . . . . 71.14 111.524 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.23 137.87 9.11 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 110.716 -0.954 . . . . 61.11 110.716 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -93.02 123.72 45.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.806 -0.813 . . . . 61.22 108.806 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.8 m-85 -132.56 118.64 19.48 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.71 -1.219 . . . . 74.3 107.71 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.3 p -81.68 98.52 8.43 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.327 -0.62 . . . . 71.04 109.327 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' THR . 2.8 pp -113.24 160.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.417 0.687 . . . . 74.15 111.258 -175.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.37 174.58 2.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.001 1.32 . . . . 63.33 109.495 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.08 -6.48 49.36 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 115.514 0.966 . . . . 75.11 115.514 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -126.18 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.216 -1.031 . . . . 65.11 108.216 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -133.16 173.74 11.12 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.692 0.797 . . . . 75.34 109.461 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.34 -139.45 47.4 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.702 0.626 . . . . 43.32 113.737 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 15.1 t -72.9 -18.63 61.39 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.595 0.758 . . . . 54.31 111.208 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.47 -36.63 76.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.599 0.76 . . . . 64.52 110.323 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.78 -42.19 41.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.943 0.497 . . . . 74.24 109.777 173.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.09 -16.88 64.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.431 -0.804 . . . . 73.11 112.682 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.425 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 t-80 -68.9 -28.72 66.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.953 0.501 . . . . 73.5 110.15 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.2 t -78.01 -39.2 42.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.064 0.546 . . . . 60.34 110.008 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.66 -51.77 56.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.354 0.662 . . . . 73.11 112.081 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.56 4.91 47.46 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.424 -0.807 . . . . 74.31 114.33 -164.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.91 -63.8 0.35 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 117.281 0.541 . . . . 42.4 112.388 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 82.0 t80 -71.05 -57.1 4.86 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.901 0.704 . . . . 75.35 112.901 -169.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 88.5 m -67.4 -32.28 4.4 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 118.189 -0.91 . . . . 73.11 112.882 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.28 -50.12 12.79 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.413 2.075 . . . . 60.3 112.876 159.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -61.35 -25.01 66.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.656 0.782 . . . . 73.02 111.957 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.473 HG21 HD11 ' A' ' 13' ' ' ILE . 49.1 mm -76.68 -48.92 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 72.23 110.111 174.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 60' ' ' LEU . 95.8 mt -81.18 -23.01 38.48 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.446 0.698 . . . . 73.43 112.214 -170.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.4 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 55.3 t80 -65.34 -42.57 59.47 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.216 1.006 . . . . 73.24 112.957 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 -32.11 85.47 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.83 1.687 . . . . 63.11 113.077 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -74.22 -39.65 62.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.209 0.603 . . . . 74.41 111.618 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.47 78.32 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.419 -0.586 . . . . 72.13 109.419 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -54.37 -46.27 72.98 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.777 1.298 . . . . 71.11 110.728 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.54 -48.47 77.36 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.295 0.997 . . . . 72.43 110.552 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.54 -45.25 85.29 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.772 0.67 . . . . 40.33 110.697 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 118' ' ' VAL . 91.8 mt -60.29 -52.58 59.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 114.855 -1.066 . . . . 71.4 110.05 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 125' ' ' GLN . 78.4 m -53.19 -46.22 68.91 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.919 0.888 . . . . 74.21 111.515 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -64.88 -47.51 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.179 -0.919 . . . . 71.45 110.034 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.42 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 13.4 mtp -54.58 -43.7 72.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.09 0.956 . . . . 72.1 111.449 175.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 114' ' ' ILE . 67.5 t -65.9 -47.16 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.862 1.265 . . . . 72.25 111.312 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.5 p -66.69 -32.66 74.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.095 0.558 . . . . 75.44 111.264 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.17 -33.08 74.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.753 0.821 . . . . 62.24 110.49 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.58 20.43 18.61 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.08 -0.845 . . . . 72.31 114.28 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 48.39 47.35 20.04 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.366 1.466 . . . . 73.3 112.352 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -117.05 149.84 44.95 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 107.777 -1.194 . . . . 65.53 107.777 169.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.48 153.68 77.1 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.189 1.926 . . . . 72.41 110.392 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.8 tt0 -51.1 126.9 17.68 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.332 1.02 . . . . 75.14 111.995 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.826 HD21 HG11 ' A' ' 64' ' ' VAL . 33.3 tp -110.19 94.66 5.13 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.205 -0.907 . . . . 75.03 109.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -111.91 104.32 12.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.405 -1.27 . . . . 72.5 107.968 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.4 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 3.3 tt -63.74 128.04 34.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.943 -1.132 . . . . 64.23 107.943 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.26 144.13 8.7 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 124.208 1.003 . . . . 51.23 111.709 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 40.9 Cg_exo -58.52 110.0 0.59 Allowed 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.644 2.229 . . . . 73.51 112.064 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 t -101.07 112.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.737 -0.838 . . . . 73.32 108.737 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.98 85.21 5.61 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.662 0.785 . . . . 64.52 109.537 174.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -59.48 -32.86 70.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.666 0.787 . . . . 73.3 111.366 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 124.125 0.97 . . . . 53.31 111.184 177.634 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 82.2 m . . . . . 0 C--O 1.238 0.451 0 N-CA-C 107.858 -1.164 . . . . 61.45 107.858 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -132.94 136.74 46.29 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.558 -0.534 . . . . 65.24 109.558 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -152.05 139.52 19.57 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.281 1.032 . . . . 74.55 108.954 171.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -83.42 144.55 9.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.738 -0.838 . . . . 74.1 108.738 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -103.63 -43.35 5.39 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.17 0.588 . . . . 62.35 110.194 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -166.99 134.88 2.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.866 -0.606 . . . . 54.43 109.673 -171.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.5 mt -118.52 133.78 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 106.831 -1.544 . . . . 73.24 106.831 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -164.64 147.13 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.65 0.593 . . . . 73.53 112.098 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.8 m -73.25 124.47 25.72 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.343 -0.844 . . . . 73.1 108.879 170.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -97.95 -32.93 11.41 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.923 0.489 . . . . 73.42 110.89 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -152.81 140.99 20.44 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.338 -0.392 . . . . 72.42 110.361 -171.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.3 mm -132.88 137.33 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.212 1.005 . . . . 74.43 109.292 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.4 m -133.69 112.04 11.08 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.986 1.315 . . . . 74.42 108.444 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.7 t80 -130.5 110.02 11.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.053 -1.462 . . . . 73.13 107.053 167.306 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.66 111.9 18.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.431 -0.952 . . . . 64.11 108.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -115.92 85.56 14.96 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.296 -1.002 . . . . 63.01 108.296 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.91 -22.9 35.45 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.515 2.144 . . . . 70.2 111.388 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.83 13.84 25.99 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.653 1.181 . . . . 61.14 110.656 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -45.21 -51.62 24.16 Favored Pre-proline 0 CA--C 1.57 1.732 0 N-CA-C 114.3 1.222 . . . . 73.22 114.3 -175.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.5 -46.37 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 CA-C-N 121.511 1.575 . . . . 73.54 112.965 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -77.66 3.34 14.15 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.814 1.042 . . . . 70.4 113.814 -171.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.576 HG23 HD11 ' B' ' 68' ' ' LEU . 14.7 p -73.62 -30.64 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 109.63 -0.507 . . . . 63.32 109.63 171.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.54 -31.27 61.99 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 125.145 1.378 . . . . 75.3 112.993 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.42 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.5 pt20 -63.76 -50.37 69.32 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.367 0.417 . . . . 73.5 110.886 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.487 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 54.1 pttt -116.48 60.31 0.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.943 0.897 . . . . 75.45 110.501 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -101.27 119.74 39.21 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.762 -0.586 . . . . 74.12 109.648 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.35 -167.93 0.14 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.071 1.482 . . . . 75.42 108.984 163.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.91 105.45 0.49 Allowed Pre-proline 0 CA--C 1.566 1.581 0 C-N-CA 124.421 1.089 . . . . 65.22 112.783 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.02 169.66 2.89 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.526 2.818 . . . . 53.52 113.066 -173.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.86 107.84 5.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 45.41 108.652 172.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 65' ' ' THR . 16.2 m -105.71 141.01 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.678 -0.692 . . . . 75.11 110.77 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -126.79 121.96 33.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.984 0.914 . . . . 45.43 109.06 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 tp -98.44 124.59 43.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.683 0.793 . . . . 61.11 108.984 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.742 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.7 m-20 -125.47 118.73 26.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.982 0.913 . . . . 72.2 108.626 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.2 126.44 46.48 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.405 -1.331 . . . . 75.55 107.405 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.83 139.4 46.23 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 74.24 109.216 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -117.74 113.74 22.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.279 0.632 . . . . 70.11 110.787 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.61 147.78 42.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.39 1.076 . . . . 52.14 108.23 172.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.5 p -145.95 174.33 11.36 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 118.064 0.393 . . . . 60.34 111.546 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.9 p -153.32 145.11 23.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.385 1.074 . . . . 54.14 109.248 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -97.28 104.2 16.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.502 -0.555 . . . . 71.14 109.502 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.64 -42.49 51.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.16 0.584 . . . . 74.1 110.943 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.12 -179.95 7.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.111 0.965 . . . . 51.3 109.306 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.23 123.41 21.59 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.514 -0.766 . . . . 61.44 109.31 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 74.33 -3.1 2.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.82 1.648 . . . . 70.35 112.838 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -106.34 114.1 44.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.498 -0.927 . . . . 73.01 108.498 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -116.29 139.87 49.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.793 -0.818 . . . . 63.13 108.793 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -111.87 99.92 8.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.418 -1.327 . . . . 72.11 107.418 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.41 127.87 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.908 0.883 . . . . 43.45 110.277 -174.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.6 t -111.97 112.37 40.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 124.912 1.285 . . . . 75.42 108.738 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 106.0 18.17 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.667 -0.864 . . . . 63.33 108.667 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -86.03 123.85 31.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.576 -0.738 . . . . 70.11 109.535 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.44 105.76 19.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.709 -1.219 . . . . 52.5 107.709 168.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.742 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 32.4 m -94.42 137.49 33.49 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.659 -0.867 . . . . 74.23 108.659 176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.94 130.14 61.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.429 -1.323 . . . . 71.14 107.429 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 97.1 m -120.04 144.93 47.29 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.528 -0.915 . . . . 75.1 108.528 173.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.61 134.11 40.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.806 -1.183 . . . . 53.23 107.806 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 61.2 p -147.36 133.91 19.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.297 0.639 . . . . 74.45 109.976 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.689 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -125.48 138.27 53.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.564 0.746 . . . . 74.23 110.016 177.848 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -127.69 9.03 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.213 -0.903 . . . . 72.13 111.444 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.98 11.35 29.89 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.129 0.972 . . . . 74.35 111.932 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.487 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 17.0 pt-20 -154.88 -179.49 8.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.585 0.354 . . . . 75.24 110.986 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -64.18 154.39 34.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 72.23 112.424 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.689 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -103.91 -60.35 1.59 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.774 -1.195 . . . . 73.01 107.774 166.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -166.34 164.39 17.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.346 -1.297 . . . . 72.55 109.161 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 29.4 mt -123.65 135.84 54.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.129 -1.434 . . . . 74.1 107.129 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 48.7 t -144.96 131.58 19.91 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.083 -0.71 . . . . 53.2 109.083 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.7 tt0 -156.22 143.65 19.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.615 -0.883 . . . . 64.53 108.615 -170.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.452 HG21 ' HB3' ' B' ' 113' ' ' CYS . 93.3 t -135.69 146.9 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.555 -0.905 . . . . 64.12 108.555 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -121.58 95.61 4.74 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.628 -1.249 . . . . 73.13 107.628 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 46.3 tp60 -89.0 101.05 13.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.642 -0.873 . . . . 62.55 108.642 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.45 168.74 36.81 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.749 0.656 . . . . 64.45 111.874 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.54 127.74 1.48 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.574 -0.611 . . . . 71.14 111.574 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -84.46 128.86 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.053 -1.091 . . . . 71.03 108.053 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.64 163.51 29.59 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.835 1.254 . . . . 72.13 108.853 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -131.87 113.11 13.07 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.66 -0.867 . . . . 72.33 108.66 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.39 129.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.7 -0.852 . . . . 74.12 108.7 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.28 170.1 18.01 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.582 1.153 . . . . 63.43 108.857 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -70.8 3.02 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.803 -0.519 . . . . 52.53 111.803 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -87.55 152.22 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.166 0.586 . . . . 64.13 110.553 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 14.4 pt-20 -158.69 175.86 13.1 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.696 0.623 . . . . 74.02 111.822 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.69 -130.09 28.04 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.006 -0.997 . . . . 74.44 113.857 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.7 m -65.52 -32.9 74.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.158 0.983 . . . . 75.11 110.833 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -75.41 -31.09 60.29 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.922 -1.035 . . . . 75.12 109.933 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.506 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 26.3 ttt -70.13 -32.4 70.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.908 -0.405 . . . . 61.42 109.908 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 95' ' ' ALA . . . . . 0.413 ' HA ' HD11 ' B' ' 98' ' ' LEU . . . -58.33 -25.42 61.93 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.059 0.543 . . . . 61.33 112.133 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.51 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 55.5 t-80 -79.56 -26.49 41.35 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.481 0.713 . . . . 75.12 111.157 173.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -79.15 -65.66 0.97 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.755 0.422 . . . . 65.35 110.407 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.7 pp -63.53 -21.4 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.622 0.769 . . . . 73.45 112.776 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.49 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -107.06 3.62 35.53 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 114.431 0.532 . . . . 61.14 114.431 -172.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -151.32 -51.92 0.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.903 0.352 . . . . 73.2 111.725 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -68.65 -48.49 63.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.763 0.825 . . . . 74.3 110.646 -177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.468 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 56.1 m -68.89 -46.51 31.94 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.186 0.594 . . . . 65.14 111.466 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -55.38 -35.16 91.18 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 122.686 2.257 . . . . 54.21 114.003 168.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.64 -35.32 74.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.357 0.663 . . . . 73.31 110.881 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.6 -51.13 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.303 -0.862 . . . . 74.33 110.146 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.31 -23.94 54.33 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.564 0.746 . . . . 73.1 112.667 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.93 -50.71 79.84 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 117.567 -1.206 . . . . 65.33 113.125 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.77 -40.5 74.21 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.643 2.229 . . . . 71.51 113.911 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.5 m-85 -69.86 -45.58 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.411 0.684 . . . . 75.44 110.591 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.48 86.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.547 0.739 . . . . 65.31 110.859 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.647 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 32.1 ttt180 -63.28 -54.63 34.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.758 1.623 . . . . 65.23 110.994 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -36.98 81.66 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.226 0.954 . . . . 72.44 109.663 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -69.0 -38.95 79.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.756 -0.656 . . . . 72.02 111.951 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.41 HG23 ' SG ' ' B' ' 76' ' ' CYS . 58.3 mt -63.27 -51.94 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.129 0.572 . . . . 74.4 109.463 174.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.615 HG23 ' HB2' ' B' ' 125' ' ' GLN . 29.6 m -61.37 -28.25 69.1 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.323 -0.853 . . . . 74.11 111.498 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -69.47 -43.29 73.52 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.514 0.726 . . . . 65.33 110.22 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -73.27 -30.68 63.6 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.582 0.353 . . . . 74.24 111.129 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 114' ' ' ILE . 58.8 t -66.77 -39.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 64.23 109.704 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.4 t -62.99 -35.72 81.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.374 1.07 . . . . 73.5 111.294 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.43 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 82.3 mtt-85 -75.99 -31.04 58.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.831 0.852 . . . . 74.11 110.716 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -0.77 86.58 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 123.572 0.545 . . . . 54.13 112.469 171.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 48.9 p 62.57 32.68 16.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.512 1.925 . . . . 71.4 112.512 173.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' B' ' 31' ' ' VAL . 40.6 m-85 -101.71 151.94 38.0 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 115.095 -0.957 . . . . 74.31 110.479 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.55 119.0 5.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.67 2.247 . . . . 75.22 110.635 172.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.615 ' HB2' HG23 ' B' ' 115' ' ' THR . 12.8 pt20 -60.42 152.26 26.0 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.231 1.012 . . . . 74.24 113.175 -168.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 pp -112.26 120.81 43.01 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.544 -1.28 . . . . 72.21 107.544 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -93.33 104.37 16.53 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.469 -0.938 . . . . 72.44 108.469 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.647 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -58.25 118.41 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.67 -0.863 . . . . 63.55 108.67 175.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.03 144.89 59.95 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 109.837 -0.431 . . . . 71.0 109.837 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -64.12 110.36 1.33 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.954 2.436 . . . . 64.14 112.381 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.68 112.79 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.421 -1.326 . . . . 71.31 107.421 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -78.22 75.45 4.75 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.191 -1.04 . . . . 73.02 108.191 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 125.058 1.343 . . . . 74.54 111.581 -172.619 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.54 0.686 . . . . 75.13 112.129 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.485 HG22 HE22 ' C' ' 12' ' ' GLN . 88.3 m -125.68 107.91 11.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.883 -0.784 . . . . 53.23 108.883 177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.421 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 61.1 t80 -123.18 133.84 54.21 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.079 0.952 . . . . 74.14 108.432 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.485 HE22 HG22 ' C' ' 10' ' ' THR . 2.1 pm0 -155.18 144.49 21.08 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.42 0.688 . . . . 73.31 110.036 166.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.543 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.9 pp -65.23 141.35 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.073 -0.967 . . . . 73.53 109.313 171.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.534 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 18.2 mm100 -112.07 -50.62 2.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.681 -0.489 . . . . 73.43 109.681 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -168.24 123.7 0.99 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.175 -0.676 . . . . 71.41 109.175 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.28 145.61 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.262 -1.385 . . . . 72.21 107.262 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.401 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.0 p90 -176.88 168.49 2.49 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.842 0.83 . . . . 75.02 111.242 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -90.12 113.41 25.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.532 -1.213 . . . . 71.32 108.725 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.66 -38.61 89.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.354 0.662 . . . . 61.44 109.793 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.57 144.48 26.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.812 -1.086 . . . . 71.44 109.257 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.1 mt -134.83 137.89 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.006 -1.479 . . . . 62.24 107.006 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -149.5 150.73 32.77 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.31 0.644 . . . . 73.53 109.495 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -154.23 135.31 13.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.74 -1.207 . . . . 74.21 107.74 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.7 mt-10 -131.43 117.74 19.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.044 -0.724 . . . . 51.02 109.044 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.8 72.46 55.53 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.352 -0.981 . . . . 73.1 108.352 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.06 -15.68 25.83 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.576 2.184 . . . . 61.04 111.912 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 27' ' ' ASN . . . . . 0.457 ' O ' HG23 ' C' ' 31' ' ' VAL . 2.0 m-20 -105.18 18.4 22.39 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.356 1.062 . . . . 52.41 110.093 178.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.24 -48.82 54.67 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 114.356 1.243 . . . . 65.11 114.356 -171.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.428 ' HB3' HD13 ' D' ' 51' ' ' LEU . 13.5 Cg_exo -68.59 -38.35 11.05 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 121.818 1.679 . . . . 44.41 111.815 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -67.66 -22.68 65.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.406 1.482 . . . . 74.31 112.381 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.457 HG23 ' O ' ' C' ' 27' ' ' ASN . 78.2 t -65.91 -37.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.813 0.445 . . . . 61.1 111.952 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -69.65 -28.67 66.08 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 111.976 0.361 . . . . 72.2 111.976 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -87.8 12.92 11.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.208 0.603 . . . . 74.32 111.656 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.535 ' HD2' HD21 ' C' ' 68' ' ' LEU . 5.4 ttpm? -112.93 148.98 33.86 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.822 0.849 . . . . 65.44 110.915 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.97 130.24 39.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.147 0.979 . . . . 64.43 109.88 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -85.44 80.85 8.96 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.104 0.962 . . . . 75.12 111.721 -165.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 37' ' ' GLN . . . . . 0.488 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 1.0 OUTLIER -152.94 44.74 0.26 Allowed Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 114.0 1.111 . . . . 74.31 114.0 173.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' C' ' 68' ' ' LEU . 22.7 Cg_exo -67.0 149.0 82.75 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 122.253 1.968 . . . . 45.41 111.1 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.48 118.73 25.19 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 170.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.68 HG21 HD11 ' C' ' 126' ' ' LEU . 14.2 p -82.1 142.89 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.992 -1.004 . . . . 75.3 109.537 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -131.8 124.46 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.933 0.893 . . . . 50.43 108.934 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -88.77 129.98 35.45 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 105.764 -1.939 . . . . 75.52 105.764 164.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.8 t70 -130.01 108.43 10.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.933 -1.136 . . . . 70.42 107.933 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 43.5 tp -96.6 151.96 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.124 0.57 . . . . 44.51 110.265 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.9 t0 -131.15 154.44 48.35 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.908 0.883 . . . . 62.44 108.642 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.5 p -119.64 111.77 18.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.813 0.845 . . . . 61.55 109.586 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.81 146.5 43.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.966 0.906 . . . . 72.22 109.436 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -161.76 152.94 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.055 0.542 . . . . 75.22 110.505 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -149.52 146.03 27.17 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.196 0.598 . . . . 32.43 110.394 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -86.26 124.73 32.97 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.443 -0.576 . . . . 72.33 109.443 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.551 HD11 HD12 ' C' ' 83' ' ' ILE . 70.2 mt -96.53 -44.89 6.96 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.731 0.813 . . . . 74.44 109.78 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.38 -177.19 5.71 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.115 -0.948 . . . . 75.21 109.644 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.83 115.82 3.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.301 0.64 . . . . 64.14 109.886 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 64.48 0.96 1.19 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.205 1.402 . . . . 63.45 113.206 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 94.5 t -94.17 111.09 24.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.885 -1.154 . . . . 72.23 107.885 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -126.86 125.72 42.1 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.182 0.993 . . . . 71.43 109.112 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -84.65 122.62 29.33 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.318 -0.855 . . . . 73.12 109.193 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.13 124.59 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.993 -1.114 . . . . 52.11 107.993 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.64 131.16 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.963 0.905 . . . . 74.54 109.236 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.12 105.74 12.14 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.693 -1.225 . . . . 54.15 107.693 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.8 tmm_? -82.64 108.28 15.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.433 -1.321 . . . . 71.34 107.433 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.4 t -100.23 136.54 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.247 -1.02 . . . . 53.31 108.247 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 59.9 m -134.85 121.32 20.46 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.168 -0.679 . . . . 42.21 109.168 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.411 HG23 HD13 ' C' ' 114' ' ' ILE . 76.7 t -103.75 109.27 26.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.951 . . . . 61.52 108.434 174.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.451 HG23 HD23 ' C' ' 75' ' ' LEU . 6.2 m -99.28 150.21 22.34 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.2 -0.909 . . . . 64.32 109.792 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.97 110.09 8.32 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.419 0.688 . . . . 62.31 109.17 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.0 m -148.0 138.64 23.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.924 0.49 . . . . 61.45 110.32 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.617 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.7 OUTLIER -112.41 56.11 0.67 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.405 1.082 . . . . 74.12 108.764 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.44 -116.56 4.4 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.27 -1.332 . . . . 54.22 110.519 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -88.79 -29.03 20.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.195 0.598 . . . . 75.23 110.146 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -79.18 106.14 11.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.999 0.919 . . . . 75.52 110.056 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -78.74 126.01 30.14 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.715 -0.675 . . . . 72.22 109.778 171.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.32 -56.55 4.92 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.666 -1.152 . . . . 72.04 109.437 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -167.75 178.71 5.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.645 0.778 . . . . 72.11 110.691 173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -138.38 143.76 39.95 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.613 1.165 . . . . 75.41 107.956 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.2 t -140.2 137.51 34.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.612 -1.255 . . . . 73.21 107.612 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -152.88 134.55 14.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.667 0.387 . . . . 75.34 110.601 -173.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.05 120.76 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.684 1.194 . . . . 70.24 108.735 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 72.4 mt-30 -88.42 100.18 12.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.455 -1.313 . . . . 72.42 107.455 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -87.95 112.23 22.33 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.674 -0.491 . . . . 74.02 109.674 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.08 154.11 17.7 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.851 -0.5 . . . . 71.35 111.851 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.11 123.97 1.48 Allowed Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 110.69 -0.964 . . . . 52.33 110.69 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.551 HD12 HD11 ' C' ' 51' ' ' LEU . 9.4 mm -81.38 129.51 37.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 108.452 -0.944 . . . . 74.23 108.452 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.543 ' HE2' HG22 ' C' ' 13' ' ' ILE . 50.4 m-85 -138.02 151.73 48.17 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.399 -0.593 . . . . 62.24 109.399 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.9 p -110.36 117.08 32.66 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.364 -0.976 . . . . 71.53 108.364 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.99 116.71 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.157 0.983 . . . . 63.55 109.597 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.4 163.52 34.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.35 0.66 . . . . 54.3 111.439 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.77 -29.58 7.8 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.401 -0.818 . . . . 50.22 113.977 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.14 157.11 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.166 0.987 . . . . 70.22 111.013 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -149.91 159.67 44.19 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.134 0.974 . . . . 73.25 109.582 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.34 -144.58 17.98 Favored Glycine 0 C--N 1.348 1.246 0 C-N-CA 123.279 0.466 . . . . 71.05 112.458 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -64.5 -21.29 66.63 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.708 0.803 . . . . 71.52 111.677 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -65.8 -52.24 52.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.915 1.286 . . . . 71.2 109.747 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -77.76 -21.6 51.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.612 -0.722 . . . . 71.43 110.515 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.67 70.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.87 0.868 . . . . 73.02 111.82 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 40.3 t-80 -69.85 -34.28 73.4 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.058 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -69.59 -43.05 73.58 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.695 0.398 . . . . 62.51 110.73 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -55.09 5.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.969 0.907 . . . . 74.24 110.06 -174.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.03 11.46 69.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.519 -0.764 . . . . 75.42 114.639 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.577 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -148.23 -52.02 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.457 0.628 . . . . 21.34 111.84 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -76.27 -41.95 47.18 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.541 0.736 . . . . 74.53 111.203 -173.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.6 m -67.36 -47.71 48.01 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 118.517 -0.754 . . . . 64.03 111.478 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.6 Cg_exo -53.68 -35.8 79.3 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.756 2.304 . . . . 54.31 113.715 169.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.28 -40.23 81.37 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.672 0.789 . . . . 53.42 110.912 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.59 -46.25 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.632 0.773 . . . . 72.23 110.901 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.8 mt -82.46 -23.33 34.81 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.163 0.801 . . . . 62.12 113.163 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -57.06 -49.39 94.22 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.162 0.985 . . . . 73.35 112.842 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.21 -33.72 97.83 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.504 2.136 . . . . 71.2 113.982 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.457 ' HE2' HG21 ' A' ' 115' ' ' THR . 95.9 m-85 -70.66 -48.39 55.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.387 0.675 . . . . 64.14 111.285 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.13 89.95 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.472 0.482 . . . . 71.43 109.86 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.534 ' HA ' HD23 ' C' ' 128' ' ' LEU . 31.1 ttt-85 -52.64 -55.98 18.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.251 1.421 . . . . 72.22 111.78 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.11 -32.79 72.45 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.476 0.485 . . . . 71.21 110.546 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -69.39 -33.51 73.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.996 0.518 . . . . 74.14 111.257 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' C' ' 62' ' ' VAL . 90.1 mt -69.22 -52.29 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.73 0.812 . . . . 62.2 109.283 172.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.1 m -59.11 -33.79 71.25 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.272 1.029 . . . . 73.34 111.478 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.7 t -64.14 -48.72 74.95 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.614 0.766 . . . . 42.24 109.41 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.0 -38.24 90.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.392 1.077 . . . . 64.21 112.404 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.59 -42.37 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 O-C-N 123.559 0.537 . . . . 74.5 109.715 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -66.79 -32.99 74.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.034 0.934 . . . . 74.14 111.68 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.6 mtt-85 -72.12 -31.68 66.25 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.781 0.832 . . . . 73.41 110.76 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.03 8.48 70.12 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 119.521 -0.599 . . . . 71.23 112.715 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p 62.02 34.05 16.84 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.772 1.629 . . . . 65.2 112.408 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 123' ' ' PHE . . . . . 0.438 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 29.1 m-85 -104.84 163.05 17.98 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 124.803 1.241 . . . . 64.2 109.486 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 63.1 Cg_endo -68.51 162.57 40.24 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.015 2.477 . . . . 64.14 113.502 -173.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.513 HE21 ' HB3' ' B' ' 125' ' ' GLN . 64.9 mm-40 -60.85 128.05 34.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.116 -0.947 . . . . 75.21 112.721 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.68 HD11 HG21 ' C' ' 40' ' ' VAL . 6.3 tt -140.65 89.28 2.26 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.731 -1.211 . . . . 74.02 107.731 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -97.47 131.31 44.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.706 0.802 . . . . 74.25 109.128 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' C' ' 111' ' ' ARG . 3.5 mm? -70.88 135.59 48.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.743 0.817 . . . . 73.14 111.123 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.97 160.29 52.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 124.925 1.29 . . . . 73.32 112.156 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.88 102.57 0.77 Allowed 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 123.304 2.669 . . . . 63.32 112.343 -175.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -99.4 110.24 26.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.303 -0.999 . . . . 74.24 108.303 171.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -81.39 88.34 6.12 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.422 0.689 . . . . 75.33 110.613 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -65.26 -34.86 79.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.007 -0.997 . . . . 65.44 109.344 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.577 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.7 p-10 . . . . . 0 CA--C 1.545 0.78 0 CA-C-N 114.417 -1.265 . . . . 62.21 111.701 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.0 m . . . . . 0 C--O 1.235 0.328 0 N-CA-C 107.612 -1.255 . . . . 72.23 107.612 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -152.37 91.35 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.646 -1.242 . . . . 71.31 107.646 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 77.0 mt-30 -114.44 115.77 27.8 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.48 -0.933 . . . . 74.3 108.48 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -72.69 115.86 13.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.298 -1.001 . . . . 63.45 108.298 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -83.14 -50.06 8.85 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.062 -0.347 . . . . 64.22 110.062 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -172.83 151.28 2.22 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.792 0.33 . . . . 73.45 111.879 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.407 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -128.85 126.89 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.896 -1.52 . . . . 62.5 106.896 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -144.6 150.28 37.17 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.246 1.019 . . . . 73.24 109.645 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.5 p -83.97 109.03 17.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.839 -1.073 . . . . 74.22 108.909 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -76.28 -23.52 54.41 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.727 -0.67 . . . . 60.55 110.48 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -163.33 140.18 7.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.968 -1.014 . . . . 70.31 108.823 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.564 HD13 ' HE3' ' C' ' 117' ' ' MET . 85.2 mt -135.11 148.02 29.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 108.127 -1.064 . . . . 73.14 108.127 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -147.47 143.22 27.72 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.893 0.877 . . . . 44.35 109.769 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.8 t80 -153.56 126.77 8.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.969 -1.863 . . . . 71.24 105.969 169.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.65 153.66 45.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.651 . . . . 75.02 109.361 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.95 77.02 12.33 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.506 -0.924 . . . . 74.14 108.506 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.28 -31.18 23.19 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.922 2.415 . . . . 73.11 113.322 -172.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -116.06 36.32 4.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.473 0.709 . . . . 51.05 109.621 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.623 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.84 -64.12 1.4 Allowed Pre-proline 0 CA--C 1.568 1.646 0 N-CA-C 113.418 0.896 . . . . 72.21 113.418 -172.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.416 ' HB3' HD11 ' C' ' 83' ' ' ILE . 55.1 Cg_endo -78.39 -9.96 16.17 Favored 'Trans proline' 0 C--N 1.385 2.48 0 CA-C-N 121.73 1.654 . . . . 75.53 112.618 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -82.9 -38.69 22.54 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.896 1.679 . . . . 73.35 109.615 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 ' CZ2' ' D' ' 36' ' ' TRP . 2.0 p -85.56 -19.61 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.791 0.836 . . . . 74.51 110.886 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -68.85 -10.57 57.64 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.5 0.72 . . . . 64.42 112.33 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -83.62 3.07 34.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.065 0.946 . . . . 63.25 111.505 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -126.23 112.7 16.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.012 0.925 . . . . 71.05 109.347 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -90.51 97.6 11.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.666 0.786 . . . . 62.14 111.72 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.515 ' CZ2' HG22 ' D' ' 31' ' ' VAL . 0.0 OUTLIER -150.62 -173.93 4.61 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.805 0.842 . . . . 75.42 112.222 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.1 115.93 65.68 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-N 114.974 -1.012 . . . . 71.01 110.1 165.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.652 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.0 Cg_exo -63.3 131.04 30.56 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.164 2.576 . . . . 73.2 111.746 163.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.6 112.28 20.29 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.163 -1.791 . . . . 72.25 106.163 163.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.845 HG12 ' HB2' ' D' ' 66' ' ' ALA . 26.8 m -98.29 112.29 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.635 -1.246 . . . . 60.13 107.635 177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -84.2 124.33 31.07 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.45 -0.945 . . . . 50.15 108.45 -172.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.1 mt -97.21 112.77 24.42 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.284 -1.326 . . . . 73.53 109.145 -170.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 31.2 t70 -114.0 130.69 56.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.257 -1.016 . . . . 74.42 108.257 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.62 136.5 47.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.706 -0.85 . . . . 64.21 108.706 177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -132.64 127.94 35.98 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.865 -1.161 . . . . 73.52 107.865 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.2 p -105.54 151.96 23.66 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.249 0.62 . . . . 74.04 110.302 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.663 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.03 160.53 43.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.29 -0.868 . . . . 75.45 109.331 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 66.1 p -155.33 156.79 36.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.649 0.78 . . . . 75.34 109.535 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.6 m -150.63 146.85 26.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.419 -1.326 . . . . 74.41 107.419 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.34 116.56 32.61 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.207 -1.405 . . . . 72.55 107.207 162.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' C' ' 29' ' ' PRO . 40.9 mt -92.23 -29.55 16.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.801 0.441 . . . . 64.54 110.263 -176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.46 -178.73 7.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.647 0.779 . . . . 52.1 110.083 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.76 123.67 20.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.174 -0.921 . . . . 73.21 109.645 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 64.25 9.71 5.02 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.586 1.154 . . . . 54.22 112.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 96.7 t -118.63 117.29 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.305 -0.628 . . . . 72.12 109.305 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -128.36 128.33 44.34 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.118 0.967 . . . . 70.43 108.685 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.81 132.13 35.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.886 0.874 . . . . 62.53 108.795 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -117.03 122.26 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.047 -1.464 . . . . 65.11 107.047 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.663 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.9 t -112.86 129.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.317 -0.624 . . . . 74.34 109.317 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.493 HD23 HD12 ' D' ' 106' ' ' LEU . 3.8 mm? -116.76 107.52 14.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 64.12 108.994 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -88.29 112.35 22.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.489 -0.778 . . . . 74.13 109.071 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -99.88 120.65 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.038 -1.097 . . . . 75.13 108.038 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 33.6 m -115.4 140.01 49.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.792 0.837 . . . . 73.23 109.595 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.598 HG13 ' HB ' ' D' ' 40' ' ' VAL . 88.1 t -137.15 127.81 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.754 1.222 . . . . 54.21 108.764 -172.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.3 m -133.91 103.8 5.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.178 0.591 . . . . 73.51 109.648 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.845 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -102.06 130.42 48.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.577 0.751 . . . . 75.23 109.976 177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 16.2 p -154.43 124.37 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.996 -0.742 . . . . 70.22 108.996 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.652 HD11 ' HA ' ' D' ' 38' ' ' PRO . 3.0 mm? -114.85 134.07 55.44 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.971 0.508 . . . . 70.31 110.083 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.5 -110.24 3.06 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.902 0.751 . . . . 73.13 112.037 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.4 7.68 10.15 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.231 1.012 . . . . 70.14 110.85 -175.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -137.55 154.87 49.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 122.874 0.47 . . . . 74.25 110.697 -173.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.9 m -83.26 124.94 31.07 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.744 -0.662 . . . . 64.33 110.309 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.446 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -71.03 -65.73 0.7 Allowed 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.897 0.748 . . . . 64.1 109.555 176.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.34 158.49 37.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.962 -1.017 . . . . 72.14 110.765 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -120.69 151.94 38.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.502 -1.295 . . . . 62.23 107.502 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' D' ' 114' ' ' ILE . 33.7 t -159.52 136.12 9.21 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.978 -0.379 . . . . 72.04 109.978 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.66 139.86 15.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.746 0.418 . . . . 73.44 110.046 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.8 120.45 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.177 0.591 . . . . 74.33 110.087 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -89.03 88.27 7.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.658 -0.868 . . . . 72.41 108.658 168.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -84.36 92.21 7.97 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.019 -0.991 . . . . 64.51 108.738 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 143.93 18.97 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.946 -0.861 . . . . 62.22 110.946 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.86 129.59 3.23 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 110.808 -0.917 . . . . 54.34 110.808 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.7 mt -89.56 134.1 29.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 123.22 0.608 . . . . 72.44 109.505 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -132.0 129.59 40.31 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.177 0.991 . . . . 74.22 109.291 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 50.0 m -75.77 94.35 3.28 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.896 -0.779 . . . . 63.31 108.896 166.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 19.5 mt -107.05 123.32 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 107.824 -1.176 . . . . 64.04 107.824 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -148.22 161.98 40.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.759 0.824 . . . . 71.0 110.297 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.02 19.68 75.66 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.761 0.663 . . . . 43.21 113.875 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' D' ' 93' ' ' GLN . 16.2 tt -135.45 149.91 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.817 -0.808 . . . . 73.43 108.817 -169.489 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.03 156.96 44.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.068 0.547 . . . . 72.22 111.689 -170.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 33.87 -96.17 0.01 OUTLIER Glycine 0 C--N 1.357 1.73 0 N-CA-C 117.094 1.598 . . . . 61.52 117.094 153.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 44.0 p -64.89 -50.63 65.77 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.98 0.912 . . . . 74.3 112.529 -173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 93' ' ' GLN . . . . . 0.516 ' HG3' HD11 ' D' ' 89' ' ' ILE . 52.9 tp60 -79.78 -28.91 40.29 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 111.803 0.298 . . . . 73.5 111.803 -172.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -70.65 -34.02 71.59 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.746 -0.465 . . . . 74.31 109.746 176.416 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' D' D ' 95' ' ' ALA . . . . . 0.405 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -59.92 -35.99 76.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.634 0.774 . . . . 55.34 110.727 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.14 -36.57 72.13 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.873 -1.058 . . . . 75.02 110.712 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -73.02 -52.22 15.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.006 0.522 . . . . 52.21 112.366 -173.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.0 pp -94.84 -20.47 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.04 0.536 . . . . 74.42 111.912 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.45 -6.84 60.91 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.72 -0.489 . . . . 62.33 113.721 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.85 -58.66 0.47 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.161 0.48 . . . . 41.15 111.402 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.5 -45.47 68.84 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.221 0.608 . . . . 75.15 112.547 -171.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -43.06 57.26 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 123.56 0.744 . . . . 64.33 111.426 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.88 -43.47 35.1 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.831 2.354 . . . . 71.31 113.906 163.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.28 -21.19 65.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.402 0.681 . . . . 70.34 112.285 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.78 -42.2 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.948 0.499 . . . . 72.22 110.532 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.493 HD12 HD23 ' D' ' 60' ' ' LEU . 74.3 mt -91.13 -20.92 21.49 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.888 0.699 . . . . 70.05 112.888 -170.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -65.85 -41.67 48.12 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.152 -0.927 . . . . 65.11 112.715 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.19 -40.35 69.41 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.383 2.055 . . . . 50.14 113.399 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -73.97 -36.39 64.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.748 0.819 . . . . 74.42 111.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.95 -45.09 83.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.003 0.521 . . . . 61.55 110.219 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -60.75 -46.05 91.94 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.575 -1.193 . . . . 72.32 110.46 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.92 -47.23 87.37 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.238 0.961 . . . . 74.14 110.779 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.99 -41.06 86.69 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.682 0.614 . . . . 65.32 110.945 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.651 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.8 mt -66.3 -47.95 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.496 0.718 . . . . 63.44 110.243 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.47 HG23 ' HB3' ' D' ' 125' ' ' GLN . 99.4 m -53.17 -46.82 69.08 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.489 1.116 . . . . 74.35 111.229 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.5 t -66.84 -41.7 86.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.071 -0.968 . . . . 63.04 110.731 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.479 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 77.2 mtm -67.8 -45.26 75.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.86 0.464 . . . . 65.53 112.185 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 -32.03 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.313 -0.858 . . . . 52.31 110.082 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.9 p -72.22 -33.67 67.76 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.917 0.487 . . . . 64.33 110.819 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtt-85 -68.26 -26.68 65.79 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.744 0.817 . . . . 72.02 110.917 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.0 10.46 65.63 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.615 0.572 . . . . 63.41 112.889 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.401 HG23 ' HB3' ' C' ' 17' ' ' TYR . 58.1 p 57.57 19.85 5.71 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 126.524 1.929 . . . . 75.2 113.248 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.603 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 63.7 m-85 -91.4 178.06 1.95 Allowed Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.487 1.515 . . . . 73.44 107.688 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 83.1 Cg_endo -74.82 160.79 40.22 Favored 'Trans proline' 0 C--N 1.39 2.75 0 CA-C-N 121.843 1.694 . . . . 74.33 112.434 -174.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.47 ' HB3' HG23 ' D' ' 115' ' ' THR . 15.9 mt-30 -66.34 128.12 34.91 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.287 -1.005 . . . . 65.41 108.287 166.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.99 91.55 4.17 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.433 -1.321 . . . . 74.05 107.433 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -103.88 93.31 4.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.089 -1.414 . . . . 65.12 108.323 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.87 127.89 34.22 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.196 -0.668 . . . . 73.31 109.196 174.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -56.24 134.32 75.42 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 124.269 0.981 . . . . 73.13 110.554 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 5.8 Cg_exo -73.63 96.67 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.702 2.268 . . . . 61.55 109.876 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.69 110.06 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.712 -1.218 . . . . 60.24 107.712 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -68.99 114.76 7.58 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.048 -0.978 . . . . 34.23 109.94 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.01 111.356 -178.453 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 110.163 -0.31 . . . . 74.31 110.163 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.7 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 7.1 t80 -120.09 134.71 55.18 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.457 1.103 . . . . 72.45 108.488 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -155.28 117.17 4.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.978 -0.749 . . . . 61.42 108.978 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.57 HG21 ' HG2' ' C' ' 130' ' ' PRO . 24.4 mt -76.8 124.17 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.892 -0.41 . . . . 74.35 109.892 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -81.68 -43.65 18.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.775 0.83 . . . . 71.32 110.858 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -173.4 131.57 0.46 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.248 -0.278 . . . . 53.24 110.248 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -116.75 138.31 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.716 0.806 . . . . 71.22 108.867 174.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -171.19 166.48 7.21 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.775 0.798 . . . . 73.33 111.082 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -95.51 119.43 34.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.947 -1.024 . . . . 73.31 108.895 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.507 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 38.6 mtpt -82.71 -28.38 30.56 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.642 0.377 . . . . 54.51 110.125 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.21 145.95 21.05 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.062 -0.972 . . . . 52.54 109.631 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.9 mt -134.65 134.84 54.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.981 1.312 . . . . 64.22 107.652 176.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -136.18 123.84 22.38 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.49 -1.3 . . . . 71.01 107.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 84.5 t80 -136.85 126.5 25.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.896 -1.52 . . . . 74.04 106.896 173.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.4 139.12 43.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.824 -0.435 . . . . 74.24 109.824 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.22 70.59 9.98 Favored Pre-proline 0 C--O 1.245 0.833 0 N-CA-C 107.777 -1.194 . . . . 41.34 107.777 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.59 -21.98 38.79 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.226 1.95 . . . . 73.04 111.744 -173.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -118.33 23.42 11.57 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.825 0.85 . . . . 63.21 109.77 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.589 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -48.22 -54.56 24.21 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-O 118.318 -0.849 . . . . 62.15 113.222 -175.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.28 -34.25 97.98 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.536 2.157 . . . . 55.21 112.716 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -70.8 -42.02 70.84 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.456 -0.793 . . . . 73.33 110.148 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.87 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.78 -28.56 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.364 -0.835 . . . . 72.32 111.596 -170.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -60.85 -33.31 72.86 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.472 0.483 . . . . 64.03 112.019 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -88.83 -15.89 33.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.596 0.358 . . . . 74.32 111.541 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -68.01 163.89 21.25 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.328 0.585 . . . . 75.34 111.408 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.96 149.01 50.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.085 -0.961 . . . . 75.42 109.973 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -83.36 63.76 7.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.319 0.648 . . . . 75.04 109.955 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -148.05 70.19 11.0 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.597 0.759 . . . . 75.0 109.986 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -92.35 166.92 2.91 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.269 1.979 . . . . 65.23 111.585 163.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.5 104.4 16.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.336 -1.357 . . . . 73.1 107.336 167.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 66' ' ' ALA . 85.1 t -85.06 95.36 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.937 -0.764 . . . . 63.45 108.937 175.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -87.8 115.24 25.12 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.897 -0.779 . . . . 70.42 108.897 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mp -103.09 120.72 41.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.417 -0.586 . . . . 62.13 109.417 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.01 136.5 42.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.376 1.071 . . . . 73.12 108.583 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.0 tp -114.56 118.83 34.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.108 -1.071 . . . . 72.23 108.108 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 29.5 t70 -128.73 147.5 50.77 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.979 0.912 . . . . 71.1 108.969 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -149.15 136.92 20.45 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.242 -1.021 . . . . 71.34 108.242 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.25 134.5 38.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 63.41 109.01 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -129.26 151.44 49.91 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.616 0.644 . . . . 75.21 110.874 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -164.92 133.02 3.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.765 0.826 . . . . 73.14 109.767 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 48.3 tt0 -79.01 119.49 22.23 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.692 0.397 . . . . 72.52 110.933 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 57' ' ' GLU . 79.6 mt -84.07 -43.12 15.4 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.725 0.81 . . . . 60.12 111.281 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.9 -179.76 7.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.609 0.764 . . . . 65.42 110.012 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.24 116.73 5.25 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.252 -0.647 . . . . 73.31 109.252 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 68.25 19.36 9.07 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.564 1.145 . . . . 74.31 111.991 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.51 120.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.152 0.981 . . . . 50.44 108.758 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.526 ' HE2' HD12 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -128.46 171.13 12.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.328 -0.619 . . . . 71.01 109.328 169.829 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.2 tt0 -127.89 133.28 49.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.37 1.068 . . . . 75.05 108.253 176.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.4 121.4 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.031 -1.099 . . . . 73.35 108.031 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 56.2 t -97.85 136.85 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.503 1.121 . . . . 71.53 108.86 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HB2' HD13 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -116.03 99.71 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.327 -1.36 . . . . 72.33 107.327 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.3 ttp180 -89.05 101.83 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.106 -0.701 . . . . 72.5 109.106 174.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.2 t -93.6 127.76 45.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.8 -1.556 . . . . 72.41 106.8 170.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 77' ' ' GLU . 11.1 m -117.46 130.84 56.71 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.147 -0.686 . . . . 71.55 109.147 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.8 t -120.37 107.28 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.745 -1.206 . . . . 71.23 107.745 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.7 m -111.68 134.45 53.24 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.846 -0.798 . . . . 71.21 108.846 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -124.88 126.64 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.663 -1.236 . . . . 44.14 107.663 173.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -141.32 128.49 20.91 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.313 -0.625 . . . . 74.34 109.313 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.05 86.03 2.79 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.804 -1.184 . . . . 52.34 107.804 173.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -126.12 7.49 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.92 -1.036 . . . . 63.15 110.825 -171.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.36 -26.51 22.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.274 0.63 . . . . 71.31 110.452 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -77.78 120.16 22.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.584 0.353 . . . . 61.33 110.303 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -79.66 130.5 35.42 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.47 0.708 . . . . 72.14 110.163 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.87 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.96 -62.14 1.6 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.609 0.764 . . . . 62.33 110.485 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.479 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 39.0 p90 -160.25 171.03 19.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.127 -0.942 . . . . 63.32 111.332 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -138.14 131.88 31.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.995 -1.457 . . . . 72.5 107.443 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.8 m -135.51 97.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.748 0.819 . . . . 75.32 109.196 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.49 ' HB2' HG23 ' A' ' 63' ' ' THR . 42.0 tt0 -123.26 116.34 23.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.264 -1.014 . . . . 73.42 108.264 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.21 121.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.195 -0.669 . . . . 52.13 109.195 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 84.41 6.13 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.512 -0.922 . . . . 64.41 108.512 173.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -79.01 94.24 5.25 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.051 -0.977 . . . . 75.2 109.207 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.62 142.37 20.16 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.465 -0.654 . . . . 73.44 111.465 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.03 120.82 1.52 Allowed Glycine 0 CA--C 1.502 -0.736 0 N-CA-C 109.929 -1.269 . . . . 74.32 109.929 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -83.14 125.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.671 -0.863 . . . . 65.04 108.671 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.7 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.8 m-85 -124.63 127.39 47.26 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 109.297 -0.631 . . . . 63.53 109.297 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.9 t -83.82 119.1 24.43 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.394 0.678 . . . . 73.3 109.344 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.526 HD12 ' HE2' ' A' ' 56' ' ' TYR . 12.9 tt -103.4 146.59 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.194 0.997 . . . . 75.4 109.486 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 157.47 18.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.414 0.686 . . . . 74.12 109.892 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.29 -33.25 3.2 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.846 0.716 . . . . 61.45 114.413 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.78 164.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 117.571 0.685 . . . . 71.41 112.469 -172.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.48 -179.97 6.34 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.015 0.926 . . . . 72.25 109.545 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.47 22.36 Favored Glycine 0 N--CA 1.478 1.476 0 C-N-CA 123.116 0.389 . . . . 60.1 113.829 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -66.94 -28.24 68.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.947 1.299 . . . . 73.21 111.659 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -64.11 -51.31 64.58 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.35 -0.841 . . . . 63.04 110.322 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -73.93 -28.28 61.44 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.222 -0.899 . . . . 74.53 110.666 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.78 92.37 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.282 0.563 . . . . 73.32 111.0 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 39.2 t-80 -69.57 -36.49 76.32 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.154 -0.93 . . . . 72.32 110.036 173.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 23.7 t -73.68 -27.17 61.09 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.88 0.472 . . . . 74.12 111.276 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.06 -42.19 14.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.989 0.916 . . . . 74.32 110.988 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.09 4.78 52.49 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.59 0.556 . . . . 50.32 114.132 -168.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.819 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.51 -60.13 0.24 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 117.627 0.714 . . . . 63.22 112.493 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.6 t80 -68.2 -62.12 1.54 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.154 0.981 . . . . 53.12 112.125 -170.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 97.8 m -69.06 -32.85 3.61 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 114.315 1.228 . . . . 60.25 114.315 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.92 -42.74 20.22 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.985 2.456 . . . . 71.15 113.713 164.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.44 -26.19 64.48 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.762 0.825 . . . . 72.04 111.485 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -72.39 -45.34 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.599 0.76 . . . . 74.53 109.743 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 60' ' ' LEU . 48.9 mt -70.85 -35.68 72.53 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.409 -1.269 . . . . 71.11 112.394 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -59.75 -43.05 94.34 Favored Pre-proline 0 CA--C 1.572 1.791 0 C-N-CA 124.701 1.2 . . . . 74.01 114.227 -167.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -59.41 -37.34 90.51 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.27 1.98 . . . . 73.44 113.487 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.47 -35.92 68.34 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.294 0.638 . . . . 75.43 111.863 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.97 94.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 60.43 109.515 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -63.05 -35.83 81.54 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 124.287 0.992 . . . . 71.43 110.309 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 22.2 tt0 -56.64 -56.37 22.21 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.624 0.77 . . . . 75.15 110.91 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -63.35 -45.02 93.12 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 114.397 -1.274 . . . . 64.44 110.766 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 118' ' ' VAL . 66.2 mt -62.93 -59.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 123.987 0.804 . . . . 72.14 110.775 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.4 m -56.77 -32.8 65.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.181 0.593 . . . . 53.23 111.966 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.0 t -68.52 -46.45 69.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.86 -0.609 . . . . 52.4 110.529 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.402 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mtp -58.37 -42.87 87.95 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 75.33 111.049 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.3 t -62.3 -44.64 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.419 1.087 . . . . 74.1 110.225 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -73.56 -29.96 62.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.355 -0.384 . . . . 74.03 111.3 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -68.3 -37.12 80.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.418 0.687 . . . . 74.13 109.815 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.97 -3.42 89.39 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.811 -0.631 . . . . 72.21 113.033 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.78 HG21 HE21 ' D' ' 125' ' ' GLN . 24.3 p 54.56 48.8 19.62 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.167 1.787 . . . . 75.05 111.572 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -104.56 154.41 38.47 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 113.807 -1.542 . . . . 74.23 108.43 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -59.75 131.32 39.28 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.335 2.023 . . . . 75.14 110.615 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -47.84 133.69 13.91 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.472 1.108 . . . . 62.51 111.785 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.8 tp -107.17 110.31 22.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.296 -0.631 . . . . 71.51 109.296 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.67 84.02 1.95 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.851 -1.537 . . . . 71.42 106.851 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.5 tp -71.7 128.81 36.99 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.092 -0.958 . . . . 72.32 109.623 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -52.97 131.57 49.43 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 124.689 1.243 . . . . 54.14 111.517 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 3.4 Cg_endo -77.47 116.25 4.06 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.265 1.977 . . . . 65.53 109.866 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.41 123.96 53.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.643 -0.873 . . . . 63.21 108.643 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -76.79 86.83 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.211 -1.033 . . . . 71.03 108.211 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.994 . . . . 73.34 110.662 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 t70 . . . . . 0 C--N 1.348 0.542 0 CA-C-N 114.984 -1.007 . . . . 74.42 110.426 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 90.7 m . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.11 -0.33 . . . . 72.25 110.11 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.548 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 47.9 t80 -151.06 113.76 4.69 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.905 -0.776 . . . . 74.23 108.905 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -142.11 137.63 31.09 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.37 0.668 . . . . 72.3 109.935 170.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.508 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -82.3 128.0 39.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.825 -0.805 . . . . 74.24 108.825 174.182 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -98.39 -43.62 6.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.015 -0.539 . . . . 74.53 110.075 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -164.33 130.93 3.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.517 -0.31 . . . . 72.43 110.574 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -115.86 127.9 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.545 1.138 . . . . 72.32 108.902 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -162.49 147.59 12.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.982 0.42 . . . . 72.25 111.869 -171.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.6 m -73.95 123.42 24.25 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.984 0.913 . . . . 70.34 109.367 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -98.96 -27.56 13.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.098 0.559 . . . . 71.03 111.506 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.2 t70 -156.67 144.53 19.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.316 0.246 . . . . 72.13 110.641 -170.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 36.2 mm -144.66 141.43 23.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.326 1.451 . . . . 72.14 108.251 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -145.61 109.36 4.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 124.103 0.877 . . . . 74.45 108.699 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.0 t80 -118.0 117.48 29.34 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 107.186 -1.413 . . . . 75.24 107.186 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 39.3 mt-10 -119.95 133.01 55.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.372 0.669 . . . . 63.22 109.404 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.41 83.33 66.46 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.664 -1.236 . . . . 32.22 107.664 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.23 -29.53 46.88 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.902 2.402 . . . . 71.14 112.167 -174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -108.43 21.06 17.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 74.53 110.877 -177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -44.44 -57.67 6.21 Favored Pre-proline 0 CA--C 1.582 2.193 0 N-CA-C 114.743 1.386 . . . . 74.35 114.743 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 71.0 Cg_endo -80.24 -26.92 3.89 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 122.302 2.001 . . . . 64.34 113.11 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 2.3 m-70 -93.99 1.13 56.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.545 0.738 . . . . 71.44 112.344 -171.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.67 -28.1 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.036 0.534 . . . . 72.23 111.686 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -53.69 -26.02 20.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.589 1.156 . . . . 61.3 113.365 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 25.0 pt20 -66.6 -52.45 45.19 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.338 0.255 . . . . 72.35 110.781 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -118.13 68.15 0.77 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 123.552 0.741 . . . . 44.42 110.167 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.44 ' O ' ' HE3' ' B' ' 36' ' ' TRP . 11.0 t70 -98.53 118.16 34.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 106.932 -1.507 . . . . 75.22 106.932 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.44 ' HE3' ' O ' ' B' ' 35' ' ' ASP . 2.2 t-105 -176.1 175.29 1.93 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.832 -1.173 . . . . 72.14 107.832 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.55 112.07 3.81 Favored Pre-proline 0 CA--C 1.56 1.359 0 O-C-N 123.582 0.552 . . . . 73.53 110.996 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.77 164.84 15.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.62 2.213 . . . . 72.32 112.388 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.09 101.94 4.07 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.185 -1.042 . . . . 71.32 108.185 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.09 146.43 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.407 -0.815 . . . . 72.03 108.931 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.57 133.07 32.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.121 0.969 . . . . 74.04 109.307 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.482 HD21 HD11 ' B' ' 128' ' ' LEU . 4.6 mp -90.97 150.1 21.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.346 -0.843 . . . . 61.43 108.953 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.592 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.3 t70 -158.99 154.58 26.04 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.419 -0.956 . . . . 74.03 108.419 172.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.2 154.55 48.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.002 0.521 . . . . 74.24 110.582 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.5 t70 -140.02 124.62 18.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.419 -1.326 . . . . 53.12 107.419 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -110.21 104.76 13.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.023 0.929 . . . . 74.41 109.741 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.24 155.39 45.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.97 0.908 . . . . 41.44 109.984 -175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.6 m -144.11 172.64 12.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.296 0.639 . . . . 62.44 110.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.0 p -151.76 134.88 15.85 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.11 0.964 . . . . 63.11 108.647 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -84.47 114.68 22.1 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.86 -0.422 . . . . 74.33 109.86 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -80.49 -45.72 17.05 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.447 -0.575 . . . . 72.43 109.447 173.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.48 -173.43 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.666 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.14 119.43 18.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.872 . . . . 75.05 109.968 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 71.45 -6.4 1.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 125.965 1.706 . . . . 75.12 112.668 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -104.99 104.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 108.08 -1.082 . . . . 73.32 108.08 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.82 137.96 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -101.16 101.51 12.25 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.017 -1.475 . . . . 70.23 107.017 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.33 123.18 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.074 0.949 . . . . 33.24 109.879 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.446 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.0 t -102.95 144.4 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.085 0.954 . . . . 54.12 109.417 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' B' ' 103' ' ' PRO . 61.0 tp -129.77 115.02 16.68 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.555 -0.905 . . . . 55.12 108.555 170.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.583 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 37.3 ttm180 -92.85 125.86 37.65 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.373 -0.603 . . . . 70.33 109.373 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 92.9 t -111.25 104.55 17.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.305 -1.369 . . . . 64.44 107.305 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 36.4 m -97.0 136.96 36.82 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.481 -0.781 . . . . 65.21 109.437 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.11 129.32 67.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.947 -1.024 . . . . 73.54 108.476 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.5 m -124.82 137.87 54.29 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.406 0.682 . . . . 71.11 109.408 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.51 143.4 35.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.034 0.534 . . . . 65.22 109.63 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -158.09 140.37 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.698 0.624 . . . . 71.32 111.362 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.2 mp -103.24 118.92 37.87 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.45 -0.944 . . . . 33.44 108.45 167.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.63 -141.77 39.18 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.587 0.554 . . . . 75.31 112.882 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 9.43 12.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.327 1.051 . . . . 74.02 111.875 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -127.41 143.35 51.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.545 0.738 . . . . 73.31 110.147 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -70.78 140.47 51.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.574 0.75 . . . . 70.35 110.855 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -90.99 -62.58 1.42 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.97 0.908 . . . . 61.54 108.744 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -156.29 167.02 31.73 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.572 -1.195 . . . . 64.43 109.144 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.3 mt -137.08 131.03 32.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.802 -1.555 . . . . 62.42 106.802 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 37.7 t -141.33 132.7 26.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.759 -0.83 . . . . 53.1 108.759 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -154.19 135.37 13.99 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.009 -0.737 . . . . 72.2 109.009 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' B' ' 113' ' ' CYS . 61.9 t -133.33 146.44 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.637 0.775 . . . . 63.41 109.019 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -119.48 95.93 4.99 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.405 -1.331 . . . . 71.41 107.405 168.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -85.19 104.57 15.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.69 -0.855 . . . . 75.11 108.69 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.68 159.85 29.66 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 123.927 0.767 . . . . 75.33 111.186 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.29 126.34 1.57 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.922 -0.871 . . . . 64.31 110.922 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.26 119.11 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.12 -1.067 . . . . 75.22 108.12 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.11 134.26 54.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.752 0.821 . . . . 74.42 108.892 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -92.36 97.17 10.7 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.4 -0.963 . . . . 64.22 108.4 168.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.16 139.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.194 -0.912 . . . . 62.45 110.421 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.1 160.92 39.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.014 0.926 . . . . 71.23 109.555 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.95 -31.9 4.2 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.398 0.436 . . . . 72.12 114.072 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.405 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -75.63 136.5 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.296 0.638 . . . . 72.2 111.048 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.91 151.62 16.45 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.717 0.807 . . . . 63.51 109.695 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.54 -110.37 3.32 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 123.614 0.626 . . . . 44.43 113.189 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -74.59 -42.9 57.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.826 0.822 . . . . 72.22 110.088 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -67.64 -32.6 73.42 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.977 -1.465 . . . . 74.24 111.206 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.3 ptm -68.47 -37.37 80.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.957 -0.565 . . . . 74.23 110.748 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.88 -26.73 64.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.522 0.729 . . . . 63.42 110.721 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -89.39 -19.3 25.37 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.354 0.662 . . . . 54.45 110.839 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.5 t -86.69 -70.17 0.63 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.497 0.319 . . . . 33.43 111.436 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.516 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.2 pp -80.43 -24.83 39.32 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.431 0.292 . . . . 64.13 111.478 -175.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.29 1.82 56.18 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-O 119.66 -0.522 . . . . 64.13 114.153 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.03 -53.08 0.38 Allowed 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.548 0.674 . . . . 52.11 111.827 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -75.34 -45.17 41.11 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.086 0.554 . . . . 74.25 112.075 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.548 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 56.0 m -65.97 -43.71 58.7 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.161 0.584 . . . . 65.11 111.82 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HA ' HD22 ' B' ' 60' ' ' LEU . 65.2 Cg_exo -48.42 -42.97 33.89 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.868 2.378 . . . . 75.54 114.295 167.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -61.31 -30.24 70.37 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.552 0.741 . . . . 75.24 112.64 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.89 -43.79 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.152 0.581 . . . . 72.52 110.635 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.42 -20.5 47.4 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.062 -0.517 . . . . 64.43 111.571 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -61.15 -49.35 88.81 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.892 -1.052 . . . . 61.35 113.275 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.9 -46.38 30.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.938 2.426 . . . . 63.54 113.841 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -67.16 -44.88 78.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 71.43 111.32 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.58 96.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.284 0.634 . . . . 74.41 110.979 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 8.7 ttp-105 -71.75 -44.86 63.36 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.086 -0.961 . . . . 71.45 110.743 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.97 -34.04 77.47 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.872 0.732 . . . . 74.42 110.166 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.493 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.5 t -68.79 -36.5 78.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 122.877 0.471 . . . . 73.13 110.86 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.527 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 62.0 mt -62.84 -48.92 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.255 0.622 . . . . 74.41 109.773 172.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -62.03 -32.17 72.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.678 0.791 . . . . 74.13 111.527 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 30.9 t -65.78 -46.55 78.31 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.633 -0.712 . . . . 44.02 110.238 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -72.94 -38.1 66.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.802 0.441 . . . . 75.51 111.329 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.45 -38.49 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.396 0.678 . . . . 62.35 110.339 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -68.05 -34.58 76.72 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.892 -1.049 . . . . 63.24 111.19 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -71.27 -26.79 63.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.914 0.486 . . . . 73.12 110.458 176.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.92 1.39 63.17 Favored Glycine 0 C--N 1.358 1.796 0 O-C-N 123.446 0.467 . . . . 53.54 112.59 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 41.5 p 62.73 49.54 3.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.915 2.086 . . . . 74.12 112.22 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -119.98 154.46 55.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.393 -1.276 . . . . 75.25 109.924 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.37 -169.96 0.12 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.581 2.854 . . . . 74.33 114.143 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 15.4 tp60 -57.34 124.26 18.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.448 1.099 . . . . 72.22 112.771 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -141.49 83.35 1.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.864 -0.791 . . . . 71.25 108.864 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -104.5 131.42 51.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.385 -1.339 . . . . 72.14 107.385 165.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.482 HD11 HD21 ' B' ' 42' ' ' LEU . 33.1 tp -70.74 149.74 46.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.091 0.557 . . . . 43.41 110.253 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.2 149.4 87.05 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.894 0.878 . . . . 54.33 111.898 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.447 ' HG3' HD12 ' D' ' 16' ' ' ILE . 20.4 Cg_exo -63.45 93.51 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.925 2.417 . . . . 72.42 111.825 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 t -92.0 110.07 22.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.301 -1.0 . . . . 71.34 108.301 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -92.75 88.25 6.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.026 -1.101 . . . . 74.04 108.026 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 N--CA 1.479 0.993 0 CA-C-N 115.037 -0.983 . . . . 73.14 110.298 -177.886 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.412 ' HA ' HG13 ' C' ' 89' ' ' ILE . 56.3 ttp . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.333 0.587 . . . . 53.54 112.45 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 7.0 m -97.22 105.57 17.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.172 -1.047 . . . . 62.02 108.172 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.6 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.4 t80 -124.27 119.38 29.15 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.529 -0.545 . . . . 63.24 109.529 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.426 HE22 ' CG2' ' C' ' 10' ' ' THR . 25.5 mp0 -136.92 142.26 42.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.486 -0.931 . . . . 71.25 108.486 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.14 97.29 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -74.19 -28.25 61.19 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 122.423 0.289 . . . . 51.41 110.649 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 15' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' C' ' 15' ' ' ARG . 10.0 ttt180 -172.55 152.76 2.68 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 123.727 0.642 . . . . 62.51 110.94 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 89.3 mt -133.6 137.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.269 -1.382 . . . . 62.05 107.269 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG23 ' D' ' 122' ' ' THR . 18.6 p90 -175.52 166.24 3.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.88 0.472 . . . . 75.31 110.052 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -89.26 120.24 30.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.267 -0.642 . . . . 75.23 109.267 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 13.6 mmmm -66.49 -44.55 82.31 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.614 -0.884 . . . . 71.24 108.614 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.2 t70 -139.79 145.71 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.112 -0.949 . . . . 73.33 110.598 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.9 mt -135.53 142.83 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 125.587 1.555 . . . . 71.02 107.038 170.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -156.84 151.34 25.48 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.129 0.49 . . . . 72.42 110.702 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -149.36 112.14 4.81 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 106.895 -1.52 . . . . 72.14 106.895 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -116.24 125.71 52.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.286 0.634 . . . . 62.52 109.855 -176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.64 82.08 18.82 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.086 -1.079 . . . . 62.53 108.086 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.86 -28.16 75.46 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.522 2.148 . . . . 72.55 111.646 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.86 31.87 2.53 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.519 1.128 . . . . 54.53 110.47 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.511 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -58.13 -54.04 59.77 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.441 1.275 . . . . 63.44 114.441 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 58.8 Cg_endo -79.83 -25.99 4.86 Favored 'Trans proline' 0 C--N 1.385 2.464 0 CA-C-N 122.072 1.776 . . . . 61.04 112.654 172.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.06 -23.32 67.39 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.044 1.338 . . . . 65.52 111.997 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -18.75 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.88 1.272 . . . . 61.52 112.022 -174.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.04 -38.55 75.88 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.676 0.39 . . . . 73.34 111.461 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.99 34.42 1.1 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.424 0.69 . . . . 75.42 110.912 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.432 ' HD2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -98.0 150.9 20.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.181 0.992 . . . . 73.41 111.012 -175.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.81 138.95 58.25 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.952 1.301 . . . . 73.32 111.533 172.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -85.24 67.21 10.08 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.864 0.866 . . . . 72.11 110.784 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -162.94 71.0 2.01 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.118 0.567 . . . . 71.04 110.81 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -87.05 115.9 1.2 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.315 2.677 . . . . 71.15 112.015 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.87 112.77 22.08 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.352 -0.981 . . . . 65.52 108.352 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.89 104.51 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.726 -0.67 . . . . 73.34 109.355 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.416 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 58.7 tttm -95.03 103.25 15.09 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.616 -0.883 . . . . 65.12 108.616 173.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.78 138.05 31.87 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.153 -1.054 . . . . 72.41 108.153 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.4 t70 -128.89 141.55 51.24 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.42 1.088 . . . . 75.02 109.042 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 44' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 61.7 tp -134.29 132.01 39.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.111 -0.7 . . . . 72.05 109.111 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.777 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 17.1 t70 -123.27 141.76 51.65 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.106 0.963 . . . . 75.31 109.133 174.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -114.51 111.08 20.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.993 -0.743 . . . . 62.23 108.993 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -117.03 164.29 14.94 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.341 1.056 . . . . 42.02 110.09 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -146.83 155.49 42.38 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.391 0.676 . . . . 71.14 109.884 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.51 126.84 14.89 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 65.32 108.598 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -82.72 117.76 22.87 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.447 -0.946 . . . . 73.35 108.447 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.591 HD11 HD12 ' C' ' 83' ' ' ILE . 83.1 mt -90.89 -42.51 10.56 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.621 -0.718 . . . . 55.12 109.463 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.45 -177.85 6.84 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.802 -1.09 . . . . 71.41 109.728 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.4 126.62 30.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.991 -1.004 . . . . 75.43 109.182 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.7 10.51 7.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.622 1.169 . . . . 60.32 111.732 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -126.22 112.96 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.918 0.887 . . . . 72.11 109.206 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -131.14 125.54 33.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.889 0.876 . . . . 73.3 109.11 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -83.61 124.48 30.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.279 1.031 . . . . 75.12 109.66 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.49 130.09 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.572 -1.27 . . . . 51.43 107.572 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 86.0 t -123.44 139.91 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.505 0.722 . . . . 71.11 109.978 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.575 HD11 ' HA ' ' C' ' 103' ' ' PRO . 69.5 mt -128.76 118.72 23.27 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 124.283 1.033 . . . . 61.02 109.315 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.777 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 45.0 mtt180 -82.96 108.55 16.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.689 -0.856 . . . . 75.44 108.689 166.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -103.92 116.38 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.456 -1.313 . . . . 62.24 107.456 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 20.2 m -130.12 118.24 21.18 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.056 0.542 . . . . 50.23 109.594 -170.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.596 HG23 HD13 ' C' ' 114' ' ' ILE . 67.0 t -104.0 118.18 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 70.21 108.586 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 22.4 m -110.77 141.45 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.463 -0.94 . . . . 72.34 108.463 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.76 106.61 9.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.963 -1.865 . . . . 61.33 105.963 170.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.5 m -138.91 152.28 47.63 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.338 0.59 . . . . 74.44 109.71 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.432 HD13 ' HD2' ' C' ' 34' ' ' LYS . 4.3 mp -116.32 31.48 6.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.462 -1.244 . . . . 73.51 108.635 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.54 -117.63 4.02 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 109.802 -1.319 . . . . 75.13 109.802 -170.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -88.85 -30.61 18.8 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.433 -0.58 . . . . 63.24 109.433 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.68 95.12 1.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.223 1.009 . . . . 60.14 109.227 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 64.3 m -87.49 139.65 30.33 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.219 0.608 . . . . 72.11 110.737 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.6 -65.02 1.01 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.098 -0.955 . . . . 73.44 109.395 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -157.91 176.19 12.87 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.167 0.587 . . . . 75.13 110.784 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -140.79 147.47 39.12 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.671 1.188 . . . . 72.34 108.162 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 51.0 t -151.08 129.36 11.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.129 0.971 . . . . 50.13 108.596 175.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -136.86 134.58 37.06 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.976 0.51 . . . . 74.1 110.025 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' C' ' 110' ' ' ALA . 36.5 t -131.39 115.6 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 52.34 109.021 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.617 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 27.2 mt-30 -89.48 96.39 10.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.018 . . . . 63.15 108.25 169.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 66.2 tp60 -80.07 125.45 29.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.273 0.629 . . . . 64.34 109.86 176.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.23 154.19 16.81 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.831 -0.507 . . . . 40.14 111.831 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.25 120.24 1.05 Allowed Glycine 0 CA--C 1.504 -0.65 0 N-CA-C 111.865 -0.494 . . . . 71.13 111.865 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.591 HD12 HD11 ' C' ' 51' ' ' LEU . 9.0 mm -87.92 122.6 39.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 60.51 108.371 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -133.75 127.33 32.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.933 -0.766 . . . . 74.31 108.933 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -87.91 104.28 16.47 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.659 -0.867 . . . . 73.23 108.659 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' C' ' 10' ' ' THR . 21.9 pt -115.54 134.36 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.352 1.061 . . . . 73.1 110.234 -173.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.34 172.2 14.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 74.12 111.272 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.68 -49.15 2.3 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.648 -0.705 . . . . 72.21 113.054 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.412 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.8 pp -119.94 172.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.567 0.747 . . . . 73.12 110.828 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.81 -172.91 4.27 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.776 -0.647 . . . . 61.51 110.186 -171.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.85 -129.01 44.47 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.736 0.647 . . . . 62.25 113.835 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -69.75 -28.03 65.44 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.319 1.048 . . . . 64.13 111.916 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.8 -47.83 83.37 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.745 0.818 . . . . 73.22 109.838 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 36.6 ttp -83.38 -29.18 28.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.449 -0.796 . . . . 72.35 110.829 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.33 -30.86 71.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.981 0.513 . . . . 72.05 111.368 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -68.77 -34.53 75.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.285 0.634 . . . . 75.05 110.434 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -70.3 -61.86 1.61 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.159 -0.473 . . . . 65.43 110.761 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.542 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.9 OUTLIER -77.83 -13.5 59.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.819 0.674 . . . . 40.1 112.819 -176.009 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -7.35 49.9 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 119.757 -0.468 . . . . 41.02 113.875 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.56 -58.28 0.63 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.311 0.555 . . . . 73.33 110.951 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -70.99 -45.04 64.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.271 1.028 . . . . 74.34 112.089 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.6 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 33.4 m -70.45 -44.13 17.79 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.549 0.739 . . . . 73.21 111.739 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.575 ' HA ' HD11 ' C' ' 60' ' ' LEU . 86.9 Cg_exo -50.5 -41.57 51.94 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.459 2.106 . . . . 73.11 113.91 168.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -62.41 -26.81 68.68 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.64 0.776 . . . . 72.23 112.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -80.95 -45.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.139 0.576 . . . . 74.52 110.86 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.3 mt -78.12 -33.13 50.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.735 -0.666 . . . . 75.11 112.124 -171.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.557 ' HE1' HD23 ' C' ' 128' ' ' LEU . 25.0 t80 -51.36 -52.03 63.3 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.692 -1.147 . . . . 73.02 113.708 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 93.6 Cg_exo -48.89 -36.49 34.2 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.938 2.425 . . . . 72.33 114.685 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -72.9 -43.9 61.9 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.88 -0.6 . . . . 70.32 111.622 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.87 -39.4 93.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.744 0.418 . . . . 40.41 110.645 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -55.8 -57.06 13.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.481 1.513 . . . . 70.23 111.275 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -68.09 -31.73 71.56 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.514 0.725 . . . . 74.41 110.913 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.422 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.0 t -67.91 -37.93 82.32 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.255 0.622 . . . . 60.55 111.199 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.596 HD13 HG23 ' C' ' 64' ' ' VAL . 70.1 mt -64.78 -49.29 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.497 -0.774 . . . . 71.42 109.729 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -60.16 -34.45 73.59 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 123.882 0.739 . . . . 75.1 111.534 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -67.78 -38.84 83.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.256 -0.884 . . . . 75.22 110.083 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.618 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -69.43 -37.87 77.61 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.101 0.96 . . . . 73.22 112.273 178.372 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.06 -34.16 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.14 0.576 . . . . 73.23 109.498 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 39.5 t -65.19 -38.81 91.66 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-N 115.381 -0.827 . . . . 71.14 111.727 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.436 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.5 mtt-85 -72.21 -23.81 61.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.19 -0.914 . . . . 53.34 111.18 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.43 6.42 83.29 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 119.865 -0.408 . . . . 54.14 113.146 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.439 HG23 ' HB3' ' D' ' 17' ' ' TYR . 38.0 p 60.75 35.64 19.56 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.014 1.726 . . . . 54.41 112.18 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -115.06 148.12 39.88 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.534 0.734 . . . . 75.34 110.89 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -45.89 109.03 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.295 3.33 . . . . 42.44 112.822 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -60.06 131.55 51.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.304 -1.316 . . . . 70.53 111.967 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.3 tp -108.58 102.16 11.25 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.401 0.68 . . . . 74.24 109.443 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -90.97 111.89 23.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.952 -1.129 . . . . 64.13 107.952 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.557 HD23 ' HE1' ' C' ' 107' ' ' PHE . 16.9 tp -73.43 149.05 42.69 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.113 0.782 . . . . 71.14 113.113 -164.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.552 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -65.9 157.92 77.85 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.611 1.565 . . . . 74.31 112.784 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.57 ' HG2' HG21 ' A' ' 13' ' ' ILE . 8.2 Cg_exo -73.73 129.49 13.6 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.059 2.506 . . . . 74.41 112.56 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.53 107.66 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.751 -1.574 . . . . 53.05 106.751 168.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -102.78 103.64 13.87 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.234 -1.025 . . . . 73.33 108.234 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -62.25 -35.83 80.15 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.781 -0.645 . . . . 63.22 110.523 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 N--CA 1.476 0.832 0 C-N-CA 123.578 0.751 . . . . 73.54 112.092 176.371 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 57.5 m . . . . . 0 C--O 1.24 0.555 0 N-CA-C 108.031 -1.1 . . . . 72.43 108.031 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -157.59 93.32 1.28 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.728 -1.212 . . . . 74.0 107.728 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -117.56 115.88 26.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.87 -0.789 . . . . 63.25 108.87 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.402 HG12 ' HD2' ' D' ' 84' ' ' PHE . 22.0 mt -68.41 127.67 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.135 -1.061 . . . . 55.42 108.135 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.95 -42.47 14.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.65 -0.87 . . . . 72.11 108.65 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 178.92 150.6 0.28 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.312 1.045 . . . . 73.4 109.759 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.545 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -116.1 144.07 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.466 -1.309 . . . . 63.13 107.466 169.245 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.511 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 13.6 p90 -165.53 150.46 8.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.669 0.747 . . . . 74.2 111.108 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -78.02 109.76 12.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.623 -1.171 . . . . 62.33 109.228 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.579 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 46.6 mtpt -75.83 -32.86 59.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.819 -0.628 . . . . 73.34 109.435 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.4 t70 -149.23 137.42 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.697 -1.138 . . . . 64.43 109.452 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.618 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.0 mt -135.73 146.82 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.321 1.048 . . . . 71.41 108.674 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 m -147.66 138.3 23.25 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.161 0.984 . . . . 73.45 110.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.488 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.6 t80 -142.62 111.67 6.48 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 105.516 -2.031 . . . . 75.42 105.516 166.557 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.1 mt-10 -123.08 110.89 15.89 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.897 -0.779 . . . . 74.13 108.897 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.821 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -113.64 83.25 6.99 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.477 0.711 . . . . 71.35 109.336 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.27 -36.9 6.45 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.505 2.137 . . . . 71.24 111.807 -175.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 30.8 m-20 -112.41 22.77 14.32 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.041 0.936 . . . . 75.52 109.891 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.821 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.82 -60.48 4.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 114.394 1.257 . . . . 41.33 114.394 -168.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HE3' ' C' ' 19' ' ' LYS . 82.7 Cg_endo -75.12 -8.76 20.21 Favored 'Trans proline' 0 C--N 1.387 2.585 0 CA-C-N 121.751 1.661 . . . . 73.13 112.845 -175.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.428 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.3 t-160 -83.5 -37.17 23.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.43 1.492 . . . . 64.31 109.427 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' D' ' 73' ' ' ALA . 96.3 t -72.42 -32.49 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.777 . . . . 71.13 110.357 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -69.07 -3.1 11.87 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.528 0.936 . . . . 73.51 113.528 -176.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -83.94 -9.92 58.34 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.57 0.748 . . . . 72.23 111.306 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -110.4 114.29 27.61 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.672 1.189 . . . . 74.15 109.677 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.11 93.9 5.96 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.826 0.85 . . . . 73.21 112.106 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' D' ' 68' ' ' LEU . 0.0 OUTLIER -168.78 -164.48 0.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.684 0.794 . . . . 73.33 111.262 -177.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -89.12 122.08 69.05 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 124.193 0.997 . . . . 74.4 111.544 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.743 ' HB3' HD11 ' D' ' 68' ' ' LEU . 74.2 Cg_exo -56.43 134.52 64.79 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.51 2.807 . . . . 73.51 114.531 165.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.11 114.0 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.553 -1.647 . . . . 74.4 106.553 166.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.18 138.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.554 0.742 . . . . 55.22 109.852 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -130.92 153.18 49.43 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.424 1.09 . . . . 71.0 111.134 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.6 120.0 37.18 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.847 -1.168 . . . . 62.3 107.847 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.582 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -105.66 145.38 31.13 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.105 -1.072 . . . . 74.12 108.105 171.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.68 147.34 44.79 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.489 0.661 . . . . 63.51 111.93 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.67 146.85 27.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.328 1.451 . . . . 62.41 107.705 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -123.62 155.76 37.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.411 0.684 . . . . 73.22 110.757 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -159.25 158.37 32.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.506 0.722 . . . . 70.13 110.312 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 60.7 p -160.25 153.22 21.52 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.395 0.678 . . . . 74.11 109.434 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 26.7 p -157.56 123.31 4.66 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.521 0.728 . . . . 71.21 109.582 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -70.36 120.46 16.05 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.434 -0.58 . . . . 72.12 109.434 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -89.88 -38.35 13.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 71.33 110.138 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.0 -175.95 5.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 75.12 110.262 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -67.19 128.26 35.71 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.671 -0.695 . . . . 71.32 109.291 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 45.5 m-20 63.13 13.99 7.3 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.349 1.06 . . . . 75.22 112.135 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.28 119.9 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.238 1.015 . . . . 71.44 108.483 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -132.86 128.61 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.185 -1.043 . . . . 53.13 108.185 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -94.71 130.97 41.01 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.367 -0.605 . . . . 65.21 109.367 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.87 119.08 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.839 -1.171 . . . . 73.44 107.839 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.9 t -106.28 129.42 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.85 -0.796 . . . . 75.44 108.85 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.29 113.1 20.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.115 -1.069 . . . . 60.22 108.115 176.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -86.87 98.26 11.11 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.884 -0.784 . . . . 71.13 108.884 172.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -91.48 127.32 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.008 -1.108 . . . . 74.55 108.008 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 16.9 m -126.62 148.33 49.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.988 -0.745 . . . . 51.02 108.988 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.1 t -136.42 109.49 8.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 125.317 1.447 . . . . 72.43 108.192 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 122.27 44.78 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.994 0.518 . . . . 72.43 109.633 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' D' ' 73' ' ' ALA . . . -107.63 135.14 49.57 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.78 -0.822 . . . . 71.51 108.78 172.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -135.39 116.22 14.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.031 -1.47 . . . . 62.54 107.031 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' D' ' 38' ' ' PRO . 9.9 mp -122.42 115.45 22.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.555 -0.748 . . . . 64.41 110.662 -167.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.79 -111.32 3.27 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.799 -0.92 . . . . 53.35 110.799 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.59 6.61 8.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.067 0.947 . . . . 72.21 109.172 174.337 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.5 174.92 7.48 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.846 0.858 . . . . 72.21 110.035 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -84.18 135.29 34.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.249 0.619 . . . . 63.14 110.793 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' D' ' 68' ' ' LEU . . . -81.19 -73.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.725 . . . . 73.3 109.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -153.6 155.55 36.31 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.272 -1.331 . . . . 74.44 109.947 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.2 mt -123.08 110.93 15.94 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 107.928 -1.138 . . . . 53.24 107.928 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.4 t -115.78 133.74 55.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.966 -0.753 . . . . 62.15 108.966 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -153.86 132.87 12.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.637 0.375 . . . . 72.12 110.252 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.58 115.69 15.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.901 0.881 . . . . 74.13 109.327 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -88.7 86.82 7.06 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.723 -0.843 . . . . 71.31 108.723 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.21 95.13 6.19 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.704 -1.135 . . . . 73.43 109.468 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -91.96 143.35 16.5 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.208 -0.757 . . . . 61.43 111.208 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.57 130.03 3.92 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 110.274 -1.13 . . . . 74.34 110.274 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -89.8 127.1 42.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.816 . . . . 74.23 108.795 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.402 ' HD2' HG12 ' D' ' 13' ' ' ILE . 36.6 m-85 -130.21 125.41 34.85 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.602 -0.518 . . . . 75.51 109.602 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.3 m -79.33 95.24 5.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.471 0.709 . . . . 73.12 109.304 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 mt -108.4 123.32 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.721 0.808 . . . . 52.31 109.625 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -152.64 169.84 21.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.278 1.031 . . . . 62.33 109.711 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.63 2.01 73.79 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.9 0.72 . . . . 62.24 114.9 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 pt -135.93 148.5 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.005 0.922 . . . . 73.21 109.517 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.86 159.71 41.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.566 0.746 . . . . 63.21 110.813 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.82 -115.53 7.38 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 124.279 0.987 . . . . 63.43 115.372 167.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.4 m -68.68 -33.04 73.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.063 0.945 . . . . 64.44 111.891 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.08 -44.74 62.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.762 0.425 . . . . 72.35 111.025 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.82 67.68 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.979 -0.378 . . . . 51.42 109.979 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.19 82.35 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.547 0.739 . . . . 54.21 110.649 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -63.61 -42.27 98.24 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.849 0.46 . . . . 73.44 110.034 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.4 -47.77 80.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.848 0.459 . . . . 74.41 110.955 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -34.36 46.92 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.452 0.701 . . . . 63.14 110.576 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.82 -15.57 72.57 Favored Glycine 0 N--CA 1.466 0.677 0 CA-C-N 116.271 -0.422 . . . . 61.1 113.47 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.17 -63.89 0.83 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.618 0.599 . . . . 73.22 112.618 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -72.46 -48.02 44.21 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 112.634 0.605 . . . . 65.1 112.634 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.35 -46.23 90.13 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.556 0.742 . . . . 70.54 112.855 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.16 -31.19 54.7 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.043 1.828 . . . . 72.24 112.182 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -72.09 -17.99 61.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.703 0.801 . . . . 72.25 111.024 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.0 mm -80.2 -43.81 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.478 0.711 . . . . 50.12 110.051 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.81 -32.62 57.75 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.545 0.738 . . . . 71.11 112.571 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.06 -44.79 95.47 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 124.154 0.981 . . . . 54.01 113.095 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.85 -37.24 98.6 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.536 2.157 . . . . 74.25 114.075 172.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -79.91 -25.96 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.087 0.555 . . . . 62.13 111.838 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.22 -50.07 62.14 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.105 -0.702 . . . . 41.04 109.105 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.5 -35.59 76.29 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.564 1.165 . . . . 52.42 111.301 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 112' ' ' GLU . . . . . 0.436 ' HG2' HH12 ' C' ' 120' ' ' ARG . 26.8 tt0 -56.35 -52.13 65.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.151 0.98 . . . . 71.03 110.865 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.915 -1.039 . . . . 73.3 111.132 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.444 HG12 ' SG ' ' D' ' 76' ' ' CYS . 87.7 mt -58.74 -63.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.185 0.994 . . . . 64.51 110.508 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 34.9 m -52.03 -38.17 56.0 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.467 1.107 . . . . 75.21 112.206 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 25.9 t -66.41 -45.21 80.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.52 0.728 . . . . 73.34 111.04 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.95 -36.71 80.57 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.886 0.475 . . . . 70.33 111.554 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.9 t -64.4 -40.27 88.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 115.306 -0.861 . . . . 64.35 110.224 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -31.33 65.99 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.601 0.36 . . . . 73.35 111.202 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 93.8 mtt-85 -73.16 -23.52 60.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.286 0.634 . . . . 62.03 110.994 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.31 12.41 69.01 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.743 0.652 . . . . 60.51 112.861 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.493 HG23 ' HB3' ' C' ' 17' ' ' TYR . 54.3 p 59.78 22.21 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.277 1.831 . . . . 71.11 113.619 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.23 161.64 30.45 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.423 1.089 . . . . 70.52 109.387 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -74.9 144.34 30.5 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.256 1.971 . . . . 62.33 111.172 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.78 HE21 HG21 ' A' ' 122' ' ' THR . 5.0 pt20 -44.84 121.78 2.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.666 1.186 . . . . 73.34 111.934 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.78 95.42 5.72 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.616 -1.253 . . . . 74.15 107.616 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -103.77 109.26 20.91 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.303 -0.862 . . . . 72.3 109.134 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.83 118.97 11.77 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.614 -0.721 . . . . 35.44 109.057 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.2 138.66 97.49 Favored Pre-proline 0 CA--C 1.55 0.953 0 O-C-N 123.963 0.789 . . . . 53.25 111.15 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.45 132.12 10.97 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.429 2.086 . . . . 73.54 112.882 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.71 121.96 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.366 -0.976 . . . . 73.41 108.366 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -77.27 97.54 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.084 -0.71 . . . . 70.32 109.084 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 CA--C 1.542 0.659 0 CA-C-N 115.48 -0.782 . . . . 62.01 111.156 -179.404 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 109.665 -0.495 . . . . 63.31 109.665 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.7 t80 -135.89 122.33 20.67 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.908 -1.145 . . . . 73.55 107.908 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -144.78 102.71 3.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.099 -0.334 . . . . 72.52 110.099 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.706 HG21 ' HG2' ' C' ' 130' ' ' PRO . 58.2 mt -71.93 128.34 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.101 -0.703 . . . . 71.34 109.101 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -103.68 -37.55 7.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.917 0.487 . . . . 42.23 110.011 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -165.53 138.73 4.42 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 110.209 -0.293 . . . . 74.22 110.209 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -128.4 134.01 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.57 -0.9 . . . . 74.21 108.57 172.851 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' B' ' 122' ' ' THR . 22.9 p90 -165.07 147.02 7.87 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 65.43 110.961 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.44 110.48 11.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.79 -0.819 . . . . 75.3 108.79 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -76.05 -22.52 55.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.025 -0.534 . . . . 74.23 110.511 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.87 142.16 17.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.797 -1.092 . . . . 71.43 109.441 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.7 140.2 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 106.732 -1.581 . . . . 73.03 106.732 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 31.1 t -150.85 141.75 22.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.8 -0.815 . . . . 73.02 108.8 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.8 t80 -151.78 110.78 3.87 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 105.955 -1.869 . . . . 62.25 105.955 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -122.35 118.15 27.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.356 -0.609 . . . . 74.23 109.356 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.89 83.73 1.11 Allowed Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 107.802 -1.185 . . . . 55.53 107.802 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.88 -42.64 36.19 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.859 2.372 . . . . 71.4 112.929 -166.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -109.64 29.89 7.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 118.415 -0.803 . . . . 64.32 109.815 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.89 -57.06 5.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 117.583 -1.199 . . . . 70.32 113.669 -173.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.7 Cg_exo -64.42 -29.33 62.52 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.618 1.614 . . . . 62.31 112.348 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -79.8 -35.75 38.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.853 -1.067 . . . . 72.22 110.883 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.1 p -80.88 -13.49 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 115.749 -0.66 . . . . 73.05 111.879 -168.205 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -76.57 -11.72 59.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.174 0.59 . . . . 72.34 110.781 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -91.25 -12.5 35.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.495 1.118 . . . . 64.13 110.913 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 27.9 mmmt -81.62 166.2 20.4 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.671 0.788 . . . . 74.21 112.103 -173.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.14 139.18 39.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.254 -1.339 . . . . 75.3 108.576 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -81.31 69.35 7.92 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.579 0.704 . . . . 74.43 111.16 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -134.35 71.48 72.01 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.871 0.868 . . . . 54.12 108.93 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 67' ' ' SER . 92.4 Cg_endo -81.91 143.18 12.92 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.28 1.987 . . . . 62.34 111.704 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -104.65 102.37 11.97 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.79 -1.189 . . . . 65.35 107.79 164.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 65' ' ' THR . 42.4 t -74.43 94.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 60.1 tttm -80.85 113.84 19.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.129 0.972 . . . . 75.53 109.519 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.13 125.67 44.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.121 -1.066 . . . . 53.2 108.121 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -120.01 129.65 54.36 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.334 -0.987 . . . . 75.11 108.334 176.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.43 117.56 34.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.15 -0.685 . . . . 72.41 109.15 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.079 -1.082 . . . . 75.45 108.079 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -152.14 163.46 39.32 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 122.834 0.454 . . . . 75.05 111.15 -174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -160.91 153.23 20.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.099 0.96 . . . . 44.34 109.974 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -131.23 151.45 51.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.814 -0.81 . . . . 54.2 108.814 167.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -158.21 145.5 18.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.859 0.464 . . . . 73.24 110.675 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -88.19 113.62 23.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.504 0.722 . . . . 51.41 109.585 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.46 -35.81 24.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.836 0.455 . . . . 73.23 110.269 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.74 -174.61 4.7 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.364 1.066 . . . . 70.14 109.839 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.64 130.09 40.31 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.225 -0.658 . . . . 74.42 109.225 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 69.37 -9.89 0.6 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.819 1.648 . . . . 63.02 112.813 -170.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.57 109.41 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.649 0.78 . . . . 74.22 109.188 -170.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -126.81 157.2 39.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.039 -1.097 . . . . 73.34 108.039 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -132.51 146.08 51.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.027 0.931 . . . . 64.25 109.355 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.92 132.87 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.853 -1.166 . . . . 53.53 107.853 167.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.22 133.63 58.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.774 -0.824 . . . . 72.54 108.774 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 103' ' ' PRO . 75.5 mt -116.69 100.55 7.89 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.969 -1.122 . . . . 73.5 107.969 173.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -85.32 102.31 13.28 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.647 -0.871 . . . . 71.22 108.647 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.531 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.9 t -92.13 119.78 40.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.133 -1.062 . . . . 73.11 108.133 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -103.7 135.08 45.93 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.391 0.615 . . . . 71.54 110.207 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -131.12 114.17 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.589 -1.187 . . . . 74.13 108.738 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 1.1 m -115.35 138.72 50.68 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 108.627 -0.879 . . . . 53.43 108.627 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.27 129.08 42.82 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.105 -0.702 . . . . 73.54 109.105 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 64.1 m -134.18 124.34 25.86 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.589 -0.523 . . . . 72.32 109.589 173.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 73' ' ' ALA . 9.5 mp -88.4 85.14 6.82 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.398 -0.964 . . . . 75.22 108.398 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 -82.59 1.64 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.011 -0.995 . . . . 70.14 110.711 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -27.15 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.122 0.969 . . . . 72.21 111.612 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.32 127.18 45.3 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.086 0.555 . . . . 72.14 110.239 -172.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 65.8 m -74.05 138.36 43.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.471 0.709 . . . . 63.12 111.909 -175.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -87.3 -64.06 1.21 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.63 1.172 . . . . 72.13 110.56 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -153.76 172.56 17.12 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.264 -0.88 . . . . 64.02 111.781 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.0 tp -141.53 137.95 32.38 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.813 -1.539 . . . . 35.12 107.799 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.9 m -121.86 139.62 53.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.702 0.801 . . . . 52.15 109.864 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 22.3 mp0 -137.25 122.78 19.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.614 1.166 . . . . 65.14 108.068 169.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.95 108.03 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 108.184 -1.043 . . . . 63.52 108.184 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -86.01 81.76 8.37 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 124.296 0.998 . . . . 74.11 108.314 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -76.06 93.84 3.36 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.309 -0.997 . . . . 72.44 108.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.93 153.58 27.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.407 -0.815 . . . . 65.44 111.376 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.55 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.29 122.17 1.19 Allowed Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.083 -0.807 . . . . 43.43 111.083 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mt -82.78 116.3 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.397 0.679 . . . . 63.42 109.431 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HD2' HG12 ' A' ' 13' ' ' ILE . 31.6 m-85 -120.63 118.7 30.81 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 73.01 108.267 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 t -91.33 99.71 12.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.583 -0.895 . . . . 53.41 108.583 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.529 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -121.14 152.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.255 0.622 . . . . 40.4 111.191 -173.788 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 162.89 33.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.117 0.967 . . . . 72.14 109.843 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.61 -14.38 47.25 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.793 -0.448 . . . . 71.41 114.013 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.76 136.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.618 0.709 . . . . 74.12 109.676 177.233 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -145.56 175.28 10.46 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.99 1.316 . . . . 72.14 108.467 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.52 -121.45 26.63 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 123.439 0.462 . . . . 52.11 113.798 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -73.07 -25.7 61.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.285 0.634 . . . . 73.32 111.416 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -67.67 -47.11 70.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.446 0.698 . . . . 73.55 110.057 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.458 ' HA ' ' HB3' ' A' ' 97' ' ' CYS . 21.7 ttt -81.93 -19.47 40.68 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.571 -0.741 . . . . 75.45 110.518 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.22 73.67 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.599 0.36 . . . . 62.12 110.395 171.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -79.46 -37.56 36.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.357 0.663 . . . . 74.13 110.503 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.6 t -63.91 -44.76 92.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.228 0.611 . . . . 42.31 110.752 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.9 mt -92.39 -9.42 41.77 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.53 0.332 . . . . 54.2 111.049 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.65 -29.04 17.27 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.28 0.472 . . . . 64.42 114.28 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.42 -46.14 0.14 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.485 0.55 . . . . 75.2 112.485 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.0 t80 -60.88 -65.63 0.66 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.053 0.941 . . . . 73.42 112.699 -171.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.4 m -70.75 -34.04 3.42 Favored Pre-proline 0 CA--C 1.565 1.52 0 C-N-CA 123.72 0.808 . . . . 71.44 112.647 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.524 ' HA ' HD11 ' A' ' 60' ' ' LEU . 98.0 Cg_exo -49.5 -39.85 45.31 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.263 1.975 . . . . 71.35 113.874 162.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.28 -12.79 61.64 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.364 0.665 . . . . 70.32 111.802 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -78.11 -48.38 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.285 -0.635 . . . . 75.41 109.285 171.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.55 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.0 mt -82.31 -28.43 31.69 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.917 0.887 . . . . 72.42 113.103 -170.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.23 -41.5 69.35 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.169 -0.92 . . . . 75.0 113.425 -172.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.33 -36.51 87.18 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.93 1.753 . . . . 74.15 113.138 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -69.89 -42.38 73.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.062 0.545 . . . . 75.0 111.452 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.0 94.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.176 0.591 . . . . 42.41 109.846 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -54.02 -51.86 62.64 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.676 1.235 . . . . 71.14 110.425 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.12 -47.04 86.36 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.395 1.06 . . . . 72.54 110.979 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.406 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 36.4 t -57.61 -43.56 84.8 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.082 0.864 . . . . 72.43 110.763 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 ' HB ' ' A' ' 62' ' ' VAL . 81.2 mt -65.81 -51.19 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 124.074 0.859 . . . . 64.43 110.303 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.453 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.4 m -53.96 -41.88 68.31 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.094 0.871 . . . . 73.51 111.096 -176.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.9 t -68.93 -45.82 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.63 -1.168 . . . . 71.13 110.471 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 17.2 mtp -56.76 -41.86 78.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.648 0.779 . . . . 52.03 111.428 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.498 HG21 HD23 ' A' ' 126' ' ' LEU . 73.5 t -66.1 -45.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.655 1.182 . . . . 64.21 110.544 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.4 p -73.52 -26.72 61.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.331 -0.395 . . . . 44.11 111.181 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.7 mtt-85 -73.81 -33.12 64.05 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.668 0.787 . . . . 52.31 109.399 172.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' B' ' 18' ' ' THR . . . -74.95 -1.38 62.57 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 115.437 -0.801 . . . . 73.41 112.686 170.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.34 31.98 17.14 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.744 2.018 . . . . 74.32 112.433 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -94.01 154.91 40.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.758 -1.201 . . . . 53.51 107.758 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -51.78 142.19 42.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.776 2.318 . . . . 72.12 112.161 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.24 127.26 28.5 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.878 0.736 . . . . 73.12 111.516 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 118' ' ' VAL . 32.9 tp -111.05 95.18 5.38 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.608 -1.178 . . . . 64.4 109.294 -176.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -103.04 107.53 18.37 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.843 -1.169 . . . . 51.41 107.843 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.2 tp -72.39 134.15 45.28 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.381 -0.6 . . . . 65.32 109.381 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.63 141.24 97.9 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.578 0.751 . . . . 73.32 111.861 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 21.0 Cg_endo -87.21 110.91 0.81 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.562 2.174 . . . . 71.52 111.838 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.7 125.05 54.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.422 -0.955 . . . . 72.13 108.422 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -80.73 79.93 7.28 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -61.85 -34.21 75.57 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.6 -0.727 . . . . 73.23 110.041 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--N 1.351 0.655 0 CA-C-N 114.549 -1.205 . . . . 75.24 111.094 179.614 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.687 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 19.9 m . . . . . 0 C--O 1.24 0.554 0 N-CA-C 107.948 -1.13 . . . . 71.43 107.948 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -146.67 113.71 6.17 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.175 -0.676 . . . . 72.25 109.175 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.66 140.12 27.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.885 -0.783 . . . . 74.11 108.885 165.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.683 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -90.66 126.81 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.275 -0.875 . . . . 70.54 108.816 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.69 -52.6 5.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.52 0.676 . . . . 73.0 109.988 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -151.07 132.9 15.02 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.944 -0.472 . . . . 73.12 110.878 -169.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.683 HG13 HD11 ' B' ' 13' ' ' ILE . 96.5 mt -114.36 140.73 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.214 -1.773 . . . . 63.04 106.214 166.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.427 ' HE1' HG13 ' B' ' 83' ' ' ILE . 34.9 p90 -164.09 150.73 11.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.416 0.627 . . . . 75.12 111.333 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.424 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 96.3 m -74.18 126.83 31.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.589 -1.187 . . . . 71.1 108.246 167.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -91.91 -48.04 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.769 -1.197 . . . . 71.41 107.769 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 21.5 m-20 -138.88 143.0 38.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 115.091 -0.959 . . . . 75.22 110.471 -165.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.5 mm -136.23 144.44 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.939 1.296 . . . . 72.53 109.164 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 60.3 m -142.83 135.29 27.62 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.201 1.4 . . . . 73.14 108.166 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.36 107.95 3.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.364 -1.717 . . . . 74.44 106.364 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.73 124.02 47.45 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.993 -0.743 . . . . 75.12 108.993 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -125.02 82.11 61.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 106.917 -1.512 . . . . 61.24 106.917 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.33 -22.11 34.5 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.317 2.678 . . . . 75.22 112.164 -172.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -122.64 29.77 6.75 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.751 1.22 . . . . 52.24 109.392 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.3 -45.42 42.8 Favored Pre-proline 0 CA--C 1.576 1.944 0 N-CA-C 115.819 1.785 . . . . 72.42 115.819 -173.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 59.8 Cg_endo -75.51 -30.12 6.79 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.543 1.496 . . . . 42.35 113.137 172.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 71.0 m80 -90.92 -15.2 30.22 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.322 0.86 . . . . 72.32 113.322 -170.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -19.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.927 0.891 . . . . 70.24 111.819 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.26 -19.11 64.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.977 1.311 . . . . 71.14 112.295 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 23.8 pt20 -64.36 -36.92 85.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.811 0.444 . . . . 62.32 110.442 175.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' B' ' 68' ' ' LEU . 90.5 mttt -106.34 65.48 0.68 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.671 -0.863 . . . . 72.03 108.671 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.28 100.43 5.1 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.322 -0.399 . . . . 73.32 110.045 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.475 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 163.41 -177.36 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 127.643 2.377 . . . . 75.32 109.731 156.5 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.15 121.15 28.91 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.984 1.314 . . . . 61.51 114.175 -170.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.06 174.55 10.0 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.413 2.075 . . . . 75.34 110.816 163.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.57 103.23 6.45 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.481 -1.303 . . . . 73.53 107.481 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.72 141.13 14.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.864 -0.791 . . . . 72.31 108.864 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -132.65 130.85 40.7 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.355 -0.609 . . . . 72.12 109.355 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.409 HD22 HD11 ' B' ' 128' ' ' LEU . 4.4 pp -86.22 140.6 29.99 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.02 -1.104 . . . . 73.22 108.02 165.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.38 151.52 46.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.671 -1.233 . . . . 65.02 107.671 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.84 134.1 40.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.147 0.431 . . . . 73.35 110.171 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' B' ' 61' ' ' ARG . 7.8 m-20 -123.4 138.2 54.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.973 0.909 . . . . 63.31 109.06 173.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.2 p -109.62 146.75 34.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.207 0.603 . . . . 61.0 110.315 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.76 143.51 15.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.958 0.903 . . . . 70.35 108.933 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.2 p -141.75 160.93 39.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.895 0.316 . . . . 65.54 110.626 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.19 141.83 21.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.53 0.732 . . . . 64.43 110.446 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.44 121.83 30.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.438 0.695 . . . . 71.42 109.927 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 mt -94.17 -40.12 10.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 34.32 110.435 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.69 -168.33 1.78 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.728 -1.124 . . . . 71.24 109.716 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.66 112.77 14.82 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.164 -0.925 . . . . 60.02 109.387 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 65.26 3.95 2.45 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.184 1.394 . . . . 73.43 112.745 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 92.8 t -104.73 113.64 42.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.902 -1.148 . . . . 53.14 107.902 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.14 169.81 13.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.441 -0.8 . . . . 65.01 109.101 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -138.5 107.77 6.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.783 -0.821 . . . . 73.04 108.783 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.09 127.75 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.343 1.457 . . . . 62.21 109.577 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.69 132.29 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.888 0.875 . . . . 75.21 109.631 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' B' ' 103' ' ' PRO . 50.0 tp -124.5 118.3 26.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.942 -0.762 . . . . 75.54 108.942 171.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.455 ' HD2' ' HB2' ' B' ' 45' ' ' ASP . 28.9 ttm180 -84.17 133.22 34.61 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.127 -1.064 . . . . 74.11 108.127 169.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.97 116.58 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.193 -1.04 . . . . 74.34 108.193 169.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -104.98 146.43 29.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.808 1.243 . . . . 74.31 109.017 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.75 97.8 3.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 107.907 -1.146 . . . . 74.23 107.907 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.0 m -93.89 135.32 35.34 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.21 -0.663 . . . . 71.22 109.21 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.1 136.64 25.29 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.751 0.821 . . . . 51.13 108.887 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -147.66 130.3 15.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.154 0.582 . . . . 53.31 111.067 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 57.8 mt -98.99 104.85 16.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.374 1.069 . . . . 53.33 109.651 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.44 -110.23 3.2 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.908 -0.587 . . . . 71.32 111.643 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.94 4.71 14.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.73 0.812 . . . . 72.12 111.121 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.17 176.17 5.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.462 -0.569 . . . . 71.52 109.462 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 7.4 m -75.72 157.25 33.82 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.702 0.801 . . . . 65.52 110.34 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -110.18 -61.73 1.62 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.034 -0.728 . . . . 65.14 109.034 166.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -166.04 141.09 4.67 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.738 -1.119 . . . . 74.43 108.644 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.26 132.55 54.87 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.381 -0.97 . . . . 74.21 108.381 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.429 ' SG ' HG23 ' B' ' 114' ' ' ILE . 48.4 t -140.74 153.59 45.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.591 -0.892 . . . . 50.44 108.591 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.3 tt0 -166.18 141.59 4.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.134 -0.691 . . . . 75.54 109.134 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' B' ' 113' ' ' CYS . 86.2 t -129.45 146.29 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.257 -1.016 . . . . 75.4 108.257 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 49.2 mt-30 -122.54 96.93 5.23 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.96 -1.126 . . . . 72.03 107.96 171.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -92.85 106.85 18.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.877 -1.056 . . . . 72.04 108.811 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.34 171.58 35.34 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.632 -0.587 . . . . 73.02 111.632 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.83 126.99 1.54 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 112.056 -0.418 . . . . 70.02 112.056 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.8 mt -84.68 116.69 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.877 0.871 . . . . 73.2 109.038 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -124.0 146.83 48.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.467 1.107 . . . . 63.3 108.609 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 61.3 m -106.86 104.61 14.34 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.153 -0.684 . . . . 50.32 109.153 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -114.03 134.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.828 0.851 . . . . 73.14 109.693 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.5 167.9 29.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.522 1.129 . . . . 73.14 109.317 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.66 -50.21 4.32 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.323 0.389 . . . . 65.54 112.9 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -62.68 146.39 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.403 0.681 . . . . 72.12 111.504 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.3 178.46 6.21 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.731 0.813 . . . . 72.21 110.627 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -122.05 27.41 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 123.845 0.715 . . . . 63.05 113.536 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.7 m -78.3 -37.38 44.94 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.023 0.929 . . . . 72.12 110.569 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -76.03 -26.97 57.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.561 -0.745 . . . . 65.32 111.987 -166.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -66.11 -30.85 71.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.479 0.181 . . . . 74.14 110.693 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.52 75.72 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.868 0.73 . . . . 72.53 110.515 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 62.9 t-80 -76.01 -32.4 59.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.451 0.3 . . . . 73.0 110.896 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.47 -55.65 9.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.946 0.498 . . . . 72.44 110.629 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.75 -38.43 38.77 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.806 0.842 . . . . 72.52 110.0 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.68 -1.62 85.24 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.084 0.794 . . . . 55.25 115.084 -171.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -142.02 -56.88 0.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.909 0.855 . . . . 52.5 111.524 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.87 -46.03 47.27 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.451 0.537 . . . . 71.04 112.451 -170.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -62.04 -46.34 91.68 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.503 -0.761 . . . . 50.11 112.988 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.472 ' HB2' HD22 ' B' ' 60' ' ' LEU . 59.4 Cg_endo -68.9 -22.2 36.54 Favored 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 121.889 1.726 . . . . 74.23 112.849 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -71.76 -30.49 65.63 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.407 0.683 . . . . 71.41 111.13 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.52 -48.16 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 65.23 110.986 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.63 -10.78 57.03 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.866 -0.606 . . . . 72.22 111.941 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -56.5 -47.6 98.64 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-O 117.895 -1.05 . . . . 73.31 113.656 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.03 -31.3 53.03 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.531 2.154 . . . . 70.14 114.323 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -74.06 -43.64 57.08 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.12 0.568 . . . . 53.14 110.515 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.92 91.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.105 0.562 . . . . 62.04 110.4 174.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 111' ' ' ARG . . . . . 0.701 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 52.7 ttt-85 -51.35 -53.72 33.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.081 1.752 . . . . 74.43 112.215 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -70.59 -34.01 71.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.308 0.643 . . . . 75.31 110.703 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.6 t -71.13 -30.41 66.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.04 0.536 . . . . 62.45 111.446 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.429 HG23 ' SG ' ' B' ' 76' ' ' CYS . 63.7 mt -65.28 -52.18 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 109.525 -0.546 . . . . 75.0 109.525 173.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -60.06 -34.08 72.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.926 0.89 . . . . 75.24 111.854 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -57.98 -49.8 75.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.549 0.74 . . . . 75.32 110.493 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.0 mmt -72.22 -34.32 68.25 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.665 0.786 . . . . 74.24 111.563 -173.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.88 -37.19 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.776 0.83 . . . . 73.1 110.798 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 119' ' ' SER . . . . . 0.422 ' HB2' ' OE1' ' C' ' 125' ' ' GLN . 3.6 t -74.18 -30.85 62.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.628 0.771 . . . . 52.21 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' B' ' 116' ' ' SER . 87.6 mtt-85 -67.02 -30.09 70.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.326 0.65 . . . . 74.22 110.295 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.41 12.99 59.32 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-O 119.468 -0.629 . . . . 55.11 113.554 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 17' ' ' TYR . 60.3 p 58.23 27.08 14.65 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.843 1.657 . . . . 75.25 113.364 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -91.8 165.26 21.0 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.07 0.948 . . . . 71.3 110.736 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.55 177.48 0.44 Allowed 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.436 2.757 . . . . 70.15 115.696 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.757 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 67.3 tp60 -64.44 143.57 57.81 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.565 -1.198 . . . . 71.41 111.806 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 30.7 tp -134.77 93.02 2.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.998 -0.742 . . . . 74.41 108.998 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -92.86 98.89 11.67 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.46 -0.941 . . . . 74.22 108.46 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.701 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 42.8 tp -71.93 131.17 42.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.216 0.606 . . . . 60.51 109.764 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.25 151.5 56.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.835 0.854 . . . . 52.42 112.199 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -54.93 124.58 16.64 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.505 2.803 . . . . 75.12 113.297 171.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.61 112.64 40.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.633 -1.247 . . . . 65.21 107.633 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -79.94 83.44 5.85 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.657 -0.868 . . . . 70.23 108.657 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 N--CA 1.48 1.065 0 C-N-CA 123.979 0.911 . . . . 63.43 111.125 -177.87 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.408 ' HA ' HG13 ' C' ' 89' ' ' ILE . 56.8 ttp . . . . . 0 CA--C 1.551 1.015 0 CA-C-O 121.235 0.541 . . . . 73.33 111.508 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 28.6 m -87.6 97.65 10.98 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.253 -1.017 . . . . 45.0 108.253 172.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -124.51 140.58 52.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.623 -0.717 . . . . 65.14 109.971 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -161.05 140.63 10.61 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 125.174 1.39 . . . . 75.34 107.491 172.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.423 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.8 pp -74.59 130.25 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.249 -0.649 . . . . 64.43 109.249 176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -95.24 -46.52 6.72 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.314 -0.624 . . . . 64.52 109.314 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -169.78 151.47 4.23 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.666 0.604 . . . . 64.1 110.741 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.74 133.91 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.949 1.3 . . . . 70.24 107.546 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -171.0 157.05 5.1 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.433 0.635 . . . . 75.02 111.693 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.0 p -85.8 108.37 18.07 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.469 -0.787 . . . . 65.51 109.433 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 19' ' ' LYS . . . . . 0.423 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 13.0 mtmt -76.58 -35.95 57.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.441 0.639 . . . . 70.41 109.709 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.9 t70 -142.14 122.63 14.1 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.777 -1.102 . . . . 72.52 109.048 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -116.57 140.91 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.775 -1.565 . . . . 72.44 106.775 166.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -150.9 146.26 26.18 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.224 0.535 . . . . 72.21 110.203 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -152.43 109.8 3.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.491 -1.299 . . . . 74.43 107.491 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.7 116.27 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 74.52 108.551 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.01 89.78 10.16 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 106.914 -1.513 . . . . 73.24 106.914 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -49.99 0.92 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.595 2.196 . . . . 63.23 111.605 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.96 22.7 3.07 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 118.619 -0.705 . . . . 75.11 110.339 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.52 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -38.94 -53.3 3.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 115.524 1.676 . . . . 71.25 115.524 -171.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.7 Cg_exo -75.49 -39.41 1.06 Allowed 'Trans proline' 0 C--N 1.393 2.91 0 CA-C-N 121.472 1.561 . . . . 72.02 112.23 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.402 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.9 t60 -70.08 -26.23 63.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.643 1.177 . . . . 74.51 112.884 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -80.72 -22.71 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.754 0.422 . . . . 71.35 110.82 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 32' ' ' PHE . . . . . 0.494 ' HA ' ' CH2' ' C' ' 36' ' ' TRP . 19.0 m-30 -62.87 -32.87 74.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.759 0.424 . . . . 71.41 111.38 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 12.2 pt20 -86.24 6.28 30.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.052 0.541 . . . . 73.3 111.415 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -100.4 144.08 29.82 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.39 0.676 . . . . 65.31 110.505 -179.041 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.62 122.59 15.08 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.921 0.888 . . . . 62.41 110.011 171.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 36' ' ' TRP . . . . . 0.494 ' CH2' ' HA ' ' C' ' 32' ' ' PHE . 47.9 m95 -67.96 96.32 0.59 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.947 0.899 . . . . 71.23 112.147 -172.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -145.69 73.43 13.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.996 -0.547 . . . . 75.12 109.811 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -83.24 133.7 6.54 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.986 2.457 . . . . 72.54 112.41 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.7 91.66 8.36 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.253 -1.388 . . . . 73.44 107.253 167.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' C' ' 65' ' ' THR . 58.3 t -76.3 111.84 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.331 -0.849 . . . . 74.55 109.303 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 59.2 mttm -99.98 117.54 34.48 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.562 -0.903 . . . . 72.44 108.562 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.502 HD11 HD11 ' C' ' 128' ' ' LEU . 3.7 tt -86.6 122.34 30.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.333 -1.358 . . . . 73.43 107.333 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.514 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 18.9 m-20 -127.02 132.28 50.78 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.524 1.13 . . . . 64.12 109.13 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -128.45 124.47 36.28 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.943 0.897 . . . . 73.05 109.37 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 16.6 t70 -116.31 150.86 36.97 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.647 1.179 . . . . 70.43 108.902 172.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 41.7 p -130.78 118.38 20.74 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.834 0.854 . . . . 62.01 109.649 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -125.69 149.1 48.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.834 0.854 . . . . 72.34 110.206 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -154.38 153.46 31.64 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.237 0.615 . . . . 61.44 110.802 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 71.6 p -157.37 152.31 25.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.252 0.621 . . . . 62.03 110.573 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -89.36 119.53 29.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.647 0.779 . . . . 71.0 109.265 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.1 mt -95.87 -31.61 13.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.114 0.566 . . . . 71.52 110.342 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.49 -172.87 3.32 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.083 0.953 . . . . 53.43 109.687 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -77.23 119.33 20.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.594 0.757 . . . . 63.23 109.265 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 69.89 -3.17 1.79 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.714 1.605 . . . . 73.13 112.556 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 81.5 t -104.34 115.2 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.631 0.772 . . . . 61.41 109.536 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.8 125.53 33.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.805 0.842 . . . . 71.21 108.878 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.2 tt0 -81.77 123.84 29.12 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.392 -0.596 . . . . 74.02 109.392 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -102.65 115.74 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.881 -1.155 . . . . 62.13 107.881 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.2 t -104.8 132.19 52.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.845 -0.798 . . . . 60.34 108.845 172.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.7 102.34 10.16 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.936 -1.505 . . . . 74.14 106.936 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 30.0 ttm180 -83.34 125.7 31.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.788 -0.819 . . . . 74.42 108.788 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.4 t -115.52 131.41 67.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.442 -1.318 . . . . 73.41 107.442 172.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 24.1 m -127.85 125.45 39.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.292 -1.003 . . . . 72.45 108.292 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.427 HG21 HG21 ' C' ' 114' ' ' ILE . 50.3 t -120.37 115.1 46.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.026 -0.731 . . . . 72.3 109.026 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.1 m -99.29 148.39 24.2 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 109.425 -0.583 . . . . 72.24 109.425 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.09 106.81 4.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.071 -1.085 . . . . 64.23 108.071 171.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.8 m -135.9 127.49 28.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.081 -0.34 . . . . 72.15 110.081 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.429 HD12 ' N ' ' C' ' 68' ' ' LEU . 4.2 mp -86.78 56.43 4.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.365 1.466 . . . . 43.41 108.238 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.34 -108.19 3.45 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 109.728 -1.349 . . . . 74.41 109.728 -173.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -25.61 17.37 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.193 0.997 . . . . 71.43 109.318 168.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -68.03 83.85 0.22 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.416 1.486 . . . . 60.2 110.884 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.1 m -73.55 120.35 19.03 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 121.083 0.468 . . . . 73.01 111.136 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.79 -55.72 7.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.536 -1.211 . . . . 74.2 108.847 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -167.16 169.36 12.75 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.789 -1.096 . . . . 71.02 111.477 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.85 138.51 49.88 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 105.232 -2.136 . . . . 51.15 105.232 165.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.6 t -139.88 111.99 7.58 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.888 -0.782 . . . . 70.22 108.888 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.45 128.12 52.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.019 0.527 . . . . 72.03 109.907 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.84 114.5 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.836 0.854 . . . . 73.13 108.75 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -88.73 91.05 8.66 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.911 -1.144 . . . . 70.52 107.911 170.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -78.95 97.72 6.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.806 -1.088 . . . . 75.14 109.146 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.423 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -84.49 151.47 26.73 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.731 -0.668 . . . . 71.1 111.832 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.81 120.89 1.1 Allowed Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.823 -0.911 . . . . 53.52 110.823 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.452 HD12 HD11 ' C' ' 51' ' ' LEU . 17.7 mm -81.72 128.56 38.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.423 ' HE2' HG22 ' C' ' 13' ' ' ILE . 58.7 m-85 -137.62 151.62 48.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.38 -0.97 . . . . 44.41 108.38 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 34.9 m -111.31 121.49 45.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.824 -0.806 . . . . 53.53 108.824 172.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.555 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.9 mp -113.5 120.88 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.224 -1.399 . . . . 72.5 107.224 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.21 171.07 17.07 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.707 0.803 . . . . 61.44 110.326 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.51 -57.4 3.07 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.807 -0.633 . . . . 72.13 112.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' C' ' 9' ' ' MET . 2.6 pp -113.94 179.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.054 0.941 . . . . 71.3 111.013 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.44 -169.42 3.22 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.825 0.85 . . . . 75.24 109.706 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.73 -135.17 20.09 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.964 -0.353 . . . . 72.13 113.539 171.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -66.83 -28.6 68.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.767 0.827 . . . . 40.42 111.489 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -64.49 -43.13 95.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.202 0.601 . . . . 75.34 110.44 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.555 ' HG2' HG21 ' C' ' 86' ' ' ILE . 0.3 OUTLIER -72.73 -43.8 62.48 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.961 -0.563 . . . . 71.52 110.317 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.03 -30.94 71.97 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.433 0.693 . . . . 74.41 111.671 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -71.5 -41.81 68.81 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.657 0.783 . . . . 75.12 110.275 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.84 -40.63 91.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.83 0.452 . . . . 34.33 111.024 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.5 tp -73.67 -37.66 65.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.302 1.041 . . . . 60.34 110.875 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 -3.85 56.91 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 115.117 0.807 . . . . 70.44 115.117 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.3 -54.36 0.63 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.903 0.851 . . . . 52.21 112.052 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.84 -49.21 40.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.635 0.374 . . . . 72.13 111.978 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.1 m -68.8 -44.06 29.81 Favored Pre-proline 0 CA--C 1.569 1.674 0 CA-C-O 118.726 -0.654 . . . . 74.14 112.041 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -56.85 -37.65 97.65 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 122.703 2.269 . . . . 65.02 113.865 170.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -56.84 -38.69 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.892 0.877 . . . . 74.44 110.927 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -73.16 -47.16 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.177 -0.919 . . . . 74.33 111.2 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' C' ' 82' ' ' GLY . 98.0 mt -79.11 -24.33 43.47 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.923 0.712 . . . . 74.21 112.923 -170.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.68 -53.13 66.03 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.244 1.018 . . . . 71.24 113.568 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.7 -31.15 49.83 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.788 1.659 . . . . 62.34 112.809 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 115' ' ' THR . 79.8 m-85 -68.5 -38.52 81.04 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.241 0.616 . . . . 50.15 111.317 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.77 91.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.231 -0.441 . . . . 63.41 110.154 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -53.34 -59.89 3.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.084 0.954 . . . . 75.22 111.906 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 112' ' ' GLU . . . . . 0.44 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -65.27 -31.33 72.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 73.13 110.837 -172.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.482 ' SG ' HG12 ' C' ' 21' ' ' ILE . 47.5 t -69.09 -36.83 78.02 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.1 0.56 . . . . 71.32 111.457 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.532 HD11 ' HB ' ' C' ' 62' ' ' VAL . 96.7 mt -70.7 -50.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.638 0.775 . . . . 62.52 110.174 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.1 m -64.4 -29.14 70.21 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.574 0.749 . . . . 71.03 111.052 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 24.1 t -63.53 -49.94 71.53 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.596 0.758 . . . . 64.24 109.316 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.39 -40.34 82.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.569 1.148 . . . . 71.53 112.315 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.1 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.697 0.799 . . . . 72.52 109.852 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.455 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 41.4 t -65.92 -31.75 72.85 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.992 0.917 . . . . 62.3 112.188 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -73.98 -37.43 64.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.599 0.76 . . . . 73.53 110.817 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.18 6.08 64.77 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.469 0.481 . . . . 74.11 112.591 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.2 p 63.98 20.11 12.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.865 2.066 . . . . 73.23 113.145 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -84.82 141.2 38.01 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.292 1.037 . . . . 54.22 108.987 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.757 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 84.3 Cg_exo -53.07 140.16 60.56 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.811 3.008 . . . . 70.41 116.854 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.455 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 9.1 mm-40 -56.45 117.06 3.47 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.601 1.56 . . . . 72.41 113.175 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 66.6 tp -119.57 125.41 48.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.996 0.918 . . . . 52.1 108.91 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -121.55 132.58 54.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 71.35 109.388 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.502 HD11 HD11 ' C' ' 42' ' ' LEU . 0.1 OUTLIER -71.5 138.43 48.93 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.581 0.753 . . . . 74.11 109.808 179.019 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.54 161.02 79.41 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.25 1.02 . . . . 62.45 110.833 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.706 ' HG2' HG21 ' A' ' 13' ' ' ILE . 35.0 Cg_exo -59.58 108.64 0.48 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.275 1.983 . . . . 72.11 112.563 177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.48 108.52 21.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.526 -1.287 . . . . 74.12 107.526 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -91.34 99.37 12.35 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.004 -1.11 . . . . 74.3 108.004 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -64.36 -38.54 91.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.546 -0.752 . . . . 75.24 110.393 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 70.35 112.0 176.904 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 21.4 m . . . . . 0 C--O 1.238 0.473 0 N-CA-C 109.192 -0.67 . . . . 72.22 109.192 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.75 94.38 0.95 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.447 -1.316 . . . . 72.43 107.447 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.56 123.24 37.26 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.854 -0.795 . . . . 64.53 108.854 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.582 HD13 HG21 ' D' ' 105' ' ' ILE . 5.8 mt -82.16 119.32 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.206 -0.665 . . . . 60.45 109.206 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -86.3 -34.21 20.4 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.374 -0.376 . . . . 75.32 111.104 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -179.74 133.61 0.11 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.672 0.607 . . . . 61.34 110.094 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.475 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.2 mp -114.21 119.39 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.205 -1.776 . . . . 73.52 106.205 174.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.52 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 27.2 p90 -144.3 153.45 42.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 122.073 0.939 . . . . 74.22 110.16 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -85.27 113.69 21.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.235 -1.348 . . . . 71.35 108.766 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -78.79 -30.95 45.82 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.156 0.503 . . . . 74.55 109.769 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.0 142.3 24.21 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.482 -1.236 . . . . 54.53 109.89 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.3 mt -137.73 138.31 44.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.072 1.349 . . . . 74.01 107.96 173.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -139.4 136.82 35.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.301 1.04 . . . . 73.54 108.297 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -140.67 117.83 11.27 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.38 -1.711 . . . . 75.23 106.38 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 24' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.7 mt-10 -122.36 139.42 53.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.485 0.714 . . . . 65.51 109.158 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -127.29 79.91 72.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 106.906 -1.516 . . . . 73.21 106.906 173.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.25 -38.87 8.28 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.947 2.431 . . . . 41.21 113.036 -169.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -110.67 35.09 3.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.336 -0.987 . . . . 70.12 108.336 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.71 -66.53 0.6 Allowed Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 113.845 1.054 . . . . 24.13 113.845 -166.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' D' ' 28' ' ' ALA . 84.0 Cg_endo -74.69 -16.47 21.02 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 121.852 1.697 . . . . 71.21 112.653 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.46 -42.3 87.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.925 1.29 . . . . 64.13 110.26 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.06 -41.48 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.492 0.717 . . . . 73.21 110.594 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -67.25 -15.38 63.66 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 124.02 0.825 . . . . 65.24 112.571 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -86.09 -7.57 58.51 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.506 1.122 . . . . 75.13 112.703 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -127.31 114.62 17.82 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.678 1.191 . . . . 75.03 108.605 -172.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -98.42 95.26 7.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.428 1.013 . . . . 73.23 112.68 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.442 ' CH2' HD13 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -157.65 -179.54 8.26 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.859 0.864 . . . . 73.35 112.935 178.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.51 141.98 26.44 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 124.693 1.197 . . . . 54.5 112.185 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -91.74 124.5 0.8 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.578 2.852 . . . . 75.43 113.389 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.61 113.08 11.46 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.316 -0.994 . . . . 73.53 108.316 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -101.06 125.17 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.517 0.727 . . . . 74.1 110.498 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -109.56 144.33 38.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.1 0.96 . . . . 72.41 108.851 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tt -119.59 124.45 46.38 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.49 -0.93 . . . . 64.24 108.49 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -108.82 133.43 52.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.516 1.126 . . . . 75.03 108.805 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.62 130.95 55.59 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.973 -0.751 . . . . 52.31 108.973 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.69 146.44 43.78 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.815 0.846 . . . . 62.04 108.943 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -125.45 147.3 49.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.364 0.665 . . . . 70.22 110.651 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.42 164.02 36.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.745 1.218 . . . . 63.24 108.872 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -175.6 154.33 1.59 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.745 0.818 . . . . 63.23 110.708 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -165.76 138.79 4.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.368 0.667 . . . . 63.24 110.462 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.95 123.82 24.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.896 0.479 . . . . 72.53 109.926 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.32 -41.61 10.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.158 0.583 . . . . 64.35 110.593 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 52' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -152.22 -174.92 5.05 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.276 0.63 . . . . 65.01 110.541 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.59 111.4 3.6 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.209 -0.905 . . . . 71.45 109.87 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 67.37 21.61 9.7 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.415 1.086 . . . . 63.23 110.956 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 81.8 t -126.52 117.51 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.398 1.079 . . . . 70.24 108.614 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.61 ' HB2' HD12 ' D' ' 86' ' ' ILE . 54.1 m-85 -131.0 137.25 49.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.206 1.002 . . . . 74.02 108.503 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.47 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -92.24 136.24 33.35 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.832 0.853 . . . . 71.24 109.362 173.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -118.65 118.66 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.373 -1.343 . . . . 75.45 107.373 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 40.1 t -103.13 130.81 52.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.613 -0.884 . . . . 72.21 108.613 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -124.15 108.28 12.14 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.846 -1.168 . . . . 62.2 107.846 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.9 ttm180 -86.26 117.88 25.35 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.977 -0.556 . . . . 73.02 109.79 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.1 t -104.62 121.55 56.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.887 -1.153 . . . . 71.2 107.887 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -120.32 139.44 52.75 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.566 -0.531 . . . . 64.15 109.566 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 83.8 t -128.33 102.26 8.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 65.3 108.451 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.4 p -98.49 93.71 6.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.231 -1.026 . . . . 71.13 108.231 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.57 142.07 32.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.513 -1.221 . . . . 71.54 109.684 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 52.1 p -155.52 130.43 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 122.931 0.492 . . . . 54.51 110.717 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.672 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.2 OUTLIER -121.79 137.83 54.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.655 1.182 . . . . 54.1 109.461 177.214 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -113.43 4.0 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.392 0.433 . . . . 73.44 112.855 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.84 3.84 10.55 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.606 0.763 . . . . 74.45 110.288 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -130.69 173.5 10.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.144 0.578 . . . . 75.22 111.917 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 68.6 m -74.31 139.42 44.18 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.069 -0.969 . . . . 74.04 109.958 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.672 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -81.85 -70.66 0.53 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.802 -0.814 . . . . 44.32 108.802 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.54 139.78 18.48 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.155 -0.93 . . . . 72.23 109.552 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 75' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 96.3 mt -105.82 109.0 20.81 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.065 -1.087 . . . . 74.32 108.065 174.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.9 t -125.36 114.4 18.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.311 -0.626 . . . . 60.41 109.311 -174.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.17 122.24 17.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.14 -0.689 . . . . 53.34 109.14 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.86 117.61 48.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.836 0.854 . . . . 63.22 109.215 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.29 86.72 6.9 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.239 -1.023 . . . . 72.11 108.239 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.97 94.88 6.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.667 -1.151 . . . . 70.42 109.32 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.77 146.43 19.93 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.431 -0.668 . . . . 62.45 111.431 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.43 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -145.47 131.82 4.36 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.912 -0.875 . . . . 52.55 110.912 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 42.5 mt -90.24 131.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.897 -0.779 . . . . 62.33 108.897 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -132.51 139.93 48.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.24 0.616 . . . . 75.14 110.162 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -80.14 102.1 9.19 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 107.912 -1.144 . . . . 71.05 107.912 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' D' ' 56' ' ' TYR . 58.2 mt -106.6 110.31 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.378 -0.601 . . . . 63.33 109.378 -175.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -152.73 165.1 36.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.285 1.034 . . . . 72.13 110.18 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.33 44.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.733 0.653 . . . . 71.11 114.733 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.477 HD11 HG23 ' D' ' 86' ' ' ILE . 28.8 pt -124.94 147.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.907 1.283 . . . . 61.21 108.503 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.37 177.55 11.32 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 71.32 110.95 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.95 -137.44 46.12 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 123.596 0.56 . . . . 63.42 113.782 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -80.21 -15.77 56.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.515 0.726 . . . . 52.44 111.655 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.85 -51.13 66.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.303 0.641 . . . . 72.44 109.802 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -73.32 -28.79 62.27 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.612 -0.722 . . . . 63.15 110.303 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.66 72.53 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.831 0.453 . . . . 74.34 111.017 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -72.97 -40.68 65.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.807 0.843 . . . . 73.22 110.552 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -65.63 -44.66 85.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.267 0.627 . . . . 61.02 110.606 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.463 HD21 HD13 ' D' ' 86' ' ' ILE . 3.8 mm? -77.73 -20.18 53.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.078 0.951 . . . . 75.34 111.403 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 13.93 57.74 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.73 -0.483 . . . . 65.13 113.456 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.59 -64.04 0.09 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.031 0.416 . . . . 63.11 111.978 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -72.53 -48.96 36.12 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.418 0.687 . . . . 72.14 112.654 -167.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 59.9 m -63.58 -45.57 83.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.578 0.751 . . . . 43.24 112.506 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 43.7 Cg_exo -61.88 -30.97 84.74 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.261 1.974 . . . . 73.02 113.439 171.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -66.54 -28.24 68.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.768 0.827 . . . . 74.05 110.755 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.582 HG21 HD13 ' D' ' 13' ' ' ILE . 40.9 mm -67.82 -46.4 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.222 0.609 . . . . 75.23 110.478 174.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.43 HD21 ' HA3' ' D' ' 82' ' ' GLY . 64.9 mt -76.99 -23.37 52.27 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.231 -0.895 . . . . 74.03 111.734 -170.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -66.08 -44.22 59.42 Favored Pre-proline 0 CA--C 1.569 1.7 0 N-CA-C 113.572 0.953 . . . . 73.13 113.572 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.85 -32.46 95.37 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.42 2.08 . . . . 72.03 113.725 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.09 -31.68 50.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.206 0.602 . . . . 74.25 111.232 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.64 -51.6 58.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.333 -0.618 . . . . 50.44 109.333 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.15 -49.42 69.29 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.752 1.282 . . . . 64.11 111.069 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.53 -45.86 91.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.196 0.935 . . . . 75.32 110.783 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.1 -45.13 87.75 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.801 0.688 . . . . 73.3 110.997 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' D' ' 76' ' ' CYS . 73.5 mt -64.57 -53.41 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.021 0.928 . . . . 72.12 110.786 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -53.91 -42.97 69.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.347 1.059 . . . . 64.24 111.564 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.8 t -67.77 -32.07 72.4 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.275 -0.875 . . . . 64.32 111.666 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -80.04 -36.05 36.28 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.668 0.387 . . . . 65.32 111.999 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' D' ' 114' ' ' ILE . 47.4 t -67.14 -34.99 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 122.979 0.511 . . . . 61.05 110.025 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -69.42 -33.89 73.66 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.363 0.665 . . . . 72.14 111.27 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.8 mtt-85 -68.96 -34.14 74.86 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.282 0.633 . . . . 75.22 110.994 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.01 8.76 65.48 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.209 -0.45 . . . . 74.14 113.196 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p 61.93 20.86 11.86 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.616 1.966 . . . . 74.23 113.567 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 47.9 m-85 -87.83 167.16 21.17 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.653 1.181 . . . . 71.5 107.862 165.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 72.9 Cg_endo -67.82 -166.5 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.614 2.209 . . . . 70.15 113.875 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -75.24 156.6 35.57 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.679 -0.691 . . . . 70.21 110.851 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.6 tp -127.61 95.23 4.18 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.456 -1.313 . . . . 70.43 107.456 164.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.667 ' HB3' HD12 ' B' ' 13' ' ' ILE . 78.6 m-20 -99.2 89.55 4.27 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.187 -1.042 . . . . 74.23 108.187 -175.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 123.06 17.32 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.172 -0.922 . . . . 73.5 110.687 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.67 124.04 86.31 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.641 0.776 . . . . 71.22 110.405 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.31 127.36 11.84 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.284 1.99 . . . . 34.11 111.692 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.49 133.85 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.801 0.84 . . . . 72.12 109.165 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -76.64 85.18 3.3 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.966 -0.753 . . . . 53.41 108.966 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 N--CA 1.474 0.738 0 CA-C-N 115.744 -0.662 . . . . 63.34 110.791 178.296 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 96.8 m . . . . . 0 C--O 1.24 0.596 0 N-CA-C 108.483 -0.932 . . . . 62.23 108.483 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.663 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.1 t80 -139.63 135.56 33.43 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.717 0.636 . . . . 63.52 110.511 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -154.44 126.16 7.58 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.9 mt -81.32 113.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.604 -0.887 . . . . 74.2 108.604 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -79.13 -31.05 43.98 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.16 0.913 . . . . 64.43 109.771 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -173.25 143.64 1.12 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.361 0.664 . . . . 72.1 110.293 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.63 140.2 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.788 0.835 . . . . 74.3 109.161 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -173.63 175.68 2.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.955 0.902 . . . . 70.33 110.495 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.1 p -100.15 119.54 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.725 0.81 . . . . 44.11 109.009 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -84.48 -32.75 23.82 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.5 0.32 . . . . 64.25 110.405 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -148.93 139.44 22.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.695 -0.684 . . . . 73.41 109.641 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 89.2 mt -138.42 139.5 41.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.398 -1.704 . . . . 71.53 106.398 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 t -154.85 110.21 3.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.711 0.632 . . . . 71.44 109.636 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.666 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 74.1 t80 -110.54 113.65 26.45 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.268 -1.382 . . . . 73.32 107.268 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.44 118.27 31.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.21 0.604 . . . . 64.11 109.748 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.61 78.77 0.93 Allowed Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 107.271 -1.381 . . . . 74.34 107.271 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 -39.03 34.24 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.814 2.343 . . . . 70.11 112.464 -166.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 3.5 m120 -106.85 48.32 0.84 Allowed 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.998 -1.482 . . . . 74.54 106.998 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -54.39 -62.13 4.47 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.503 -1.237 . . . . 61.43 111.499 -176.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.7 Cg_exo -64.59 -21.95 65.2 Favored 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 121.578 1.599 . . . . 52.41 113.23 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 1.9 t60 -81.44 -55.78 4.47 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.489 0.715 . . . . 73.42 110.118 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 73' ' ' ALA . 5.0 p -67.99 -18.22 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.85 0.86 . . . . 71.14 111.626 -165.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 20.1 m-30 -62.87 -27.03 69.07 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.281 1.032 . . . . 74.23 112.718 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -96.83 -12.93 22.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.085 0.402 . . . . 74.11 112.085 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.4 tmtp? -74.59 141.62 44.72 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.213 0.605 . . . . 70.14 109.838 -173.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.512 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 25.1 t70 -51.03 128.16 20.79 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.408 1.483 . . . . 60.3 112.348 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.406 ' HH2' ' HA ' ' A' ' 32' ' ' PHE . 51.8 m95 -78.11 90.4 4.24 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.019 0.825 . . . . 74.22 111.262 -171.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -139.94 78.22 25.04 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 114.651 -1.159 . . . . 64.45 108.446 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.52 121.36 3.36 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.828 2.352 . . . . 63.35 112.662 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -96.39 95.39 8.02 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.006 -1.479 . . . . 72.3 107.006 171.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' THR . 20.0 t -84.27 97.94 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.318 -0.855 . . . . 74.42 110.075 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 55.8 tttm -82.53 125.83 31.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.626 0.77 . . . . 73.34 110.418 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -111.43 115.59 29.51 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.596 -0.89 . . . . 72.25 108.596 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.694 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -106.75 129.67 54.59 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 74.4 109.165 173.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -113.96 116.31 29.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.967 -0.753 . . . . 64.55 108.967 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -132.99 153.93 51.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.81 0.844 . . . . 75.44 109.292 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -151.43 163.47 38.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.322 0.649 . . . . 55.03 110.883 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -164.26 154.42 14.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.154 0.982 . . . . 42.13 109.838 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.5 p -131.16 159.85 36.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.97 0.35 . . . . 73.53 111.21 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -150.53 128.51 11.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.736 0.815 . . . . 44.34 109.46 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.54 110.74 12.58 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.05 -0.722 . . . . 72.23 109.05 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.529 HD12 HG23 ' A' ' 83' ' ' ILE . 74.1 mt -94.54 -38.67 10.78 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.78 -0.646 . . . . 64.11 109.571 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.62 -179.51 7.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.733 0.813 . . . . 53.01 110.042 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -73.3 126.52 30.31 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.846 -0.798 . . . . 45.23 108.846 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 68.78 1.78 3.22 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.318 1.447 . . . . 44.54 112.258 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 94.5 t -115.68 107.33 22.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.883 -0.784 . . . . 72.14 108.883 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.65 ' HB2' HD13 ' A' ' 86' ' ' ILE . 76.0 m-85 -126.85 126.87 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.184 -1.414 . . . . 74.53 107.184 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -84.47 133.1 34.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.191 -1.04 . . . . 75.34 108.191 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -113.06 127.06 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.343 -1.354 . . . . 73.43 107.343 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.2 t -100.65 138.02 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 172.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.63 109.35 12.0 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -95.31 124.02 39.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 73.1 110.326 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.74 132.14 57.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.409 -1.33 . . . . 74.24 107.409 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.9 m -120.29 121.46 38.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.037 -0.727 . . . . 64.04 109.037 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 114' ' ' ILE . 50.1 t -114.72 106.65 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.532 1.133 . . . . 72.31 108.679 -174.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 11.6 m -105.94 145.52 31.2 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 108.04 -1.096 . . . . 63.02 108.04 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.87 103.88 7.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.252 -1.388 . . . . 74.2 107.252 168.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 36.0 m -108.09 124.16 49.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.98 0.419 . . . . 71.0 109.992 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.52 80.54 2.23 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.658 -1.608 . . . . 74.43 106.658 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -117.81 5.46 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.212 -1.155 . . . . 55.41 110.212 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.09 -26.31 22.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.397 0.679 . . . . 73.33 109.972 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.1 100.35 11.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.24 0.616 . . . . 62.44 111.061 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.3 m -72.53 133.85 44.96 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 120.923 0.392 . . . . 73.25 110.298 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.5 -63.48 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.645 1.178 . . . . 73.02 110.183 177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -149.2 162.96 38.97 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.591 -1.186 . . . . 64.53 110.689 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 14.0 tp -141.29 140.6 33.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.613 -1.625 . . . . 63.41 106.613 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.666 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 16.3 m -145.51 99.08 3.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.186 -0.672 . . . . 64.3 109.186 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.01 116.68 29.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.661 -0.866 . . . . 74.12 108.661 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.49 110.39 20.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.715 0.806 . . . . 71.34 109.392 -174.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -84.85 89.21 7.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.302 -0.999 . . . . 73.11 108.302 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -76.71 97.21 4.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.118 -0.697 . . . . 75.52 109.118 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.3 143.25 16.81 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.552 -0.619 . . . . 73.21 111.552 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.47 122.91 2.15 Favored Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.44 -1.064 . . . . 73.21 110.44 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG23 HD12 ' A' ' 51' ' ' LEU . 43.5 mt -80.12 116.33 24.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.656 -1.238 . . . . 71.24 107.656 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.663 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -122.38 158.57 29.36 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.281 0.632 . . . . 63.11 109.416 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 42.8 m -104.57 98.76 8.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.226 -1.028 . . . . 65.24 108.226 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.65 HD13 ' HB2' ' A' ' 56' ' ' TYR . 3.9 mp -97.46 124.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.739 -1.208 . . . . 71.23 107.739 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -162.04 151.93 16.55 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.772 0.67 . . . . 42.43 110.714 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.55 -33.24 6.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.334 -0.848 . . . . 53.44 113.081 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.558 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -116.67 147.5 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.339 0.656 . . . . 53.11 111.467 -168.486 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.52 173.88 10.85 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.226 -0.897 . . . . 41.15 110.708 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -114.46 5.79 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.639 1.212 . . . . 52.43 115.011 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -65.42 -42.54 92.38 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.019 0.928 . . . . 61.0 111.551 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -70.39 -36.91 74.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.226 0.611 . . . . 53.52 111.042 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -65.19 -44.03 89.7 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.368 0.667 . . . . 62.12 109.799 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.83 88.74 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.044 0.938 . . . . 51.4 111.243 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -74.07 -31.09 62.7 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 65.14 110.79 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.76 -44.36 70.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.336 0.589 . . . . 74.51 110.055 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.34 -44.28 37.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.876 -1.056 . . . . 63.15 111.403 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.36 62.42 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.434 0.933 . . . . 72.12 115.434 -167.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.63 -61.23 0.21 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.708 0.754 . . . . 75.41 112.055 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.1 t80 -61.75 -59.33 5.32 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 74.21 112.625 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.41 -36.5 4.75 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 118.557 -0.735 . . . . 42.34 112.951 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.48 -40.96 45.1 Favored 'Trans proline' 0 C--N 1.387 2.59 0 C-N-CA 123.089 2.526 . . . . 74.42 114.287 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -60.04 -35.33 74.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.942 0.897 . . . . 74.44 111.108 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.8 mm -68.15 -42.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.638 0.775 . . . . 65.14 110.145 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.61 -33.09 60.51 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.582 -1.19 . . . . 52.02 112.547 -172.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.65 -43.76 96.14 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.032 1.123 . . . . 70.12 114.032 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.06 -38.23 96.34 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.483 2.122 . . . . 72.1 113.73 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.494 0.718 . . . . 73.32 111.845 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.52 87.28 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.728 0.411 . . . . 75.03 110.16 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -54.07 -52.43 60.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.637 1.175 . . . . 73.13 110.477 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -62.98 -46.13 89.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.809 0.844 . . . . 71.34 111.141 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 40.5 t -55.16 -47.12 75.59 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.855 0.722 . . . . 63.14 110.469 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -60.69 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.918 -1.037 . . . . 63.24 110.371 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 125' ' ' GLN . 99.3 m -52.41 -46.66 66.41 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 124.248 1.019 . . . . 62.13 112.18 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.04 -44.04 85.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.061 -0.972 . . . . 74.41 109.848 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 mtp -58.87 -42.08 88.61 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.785 0.834 . . . . 62.32 111.206 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.4 t -59.96 -49.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.788 0.835 . . . . 75.33 110.307 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.0 p -69.25 -28.97 66.79 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.866 0.467 . . . . 64.12 112.135 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -66.49 -28.34 68.49 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.813 0.845 . . . . 74.12 111.235 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.04 11.85 61.56 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.478 -0.623 . . . . 62.04 114.053 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.408 ' HB ' HH21 ' B' ' 15' ' ' ARG . 3.8 m 65.62 16.11 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.0 1.32 . . . . 45.1 111.192 -175.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -88.21 141.23 30.81 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.736 -0.838 . . . . 74.44 108.736 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 144.4 84.71 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.14 2.56 . . . . 50.21 112.71 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.8 tt0 -53.71 138.85 34.21 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.352 1.033 . . . . 64.44 111.958 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.46 114.92 18.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.632 -0.713 . . . . 74.4 109.398 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -112.0 118.89 36.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.462 -1.31 . . . . 74.3 107.462 172.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.36 122.64 20.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.274 -0.639 . . . . 65.54 109.274 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.18 134.91 94.75 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 123.399 0.437 . . . . 72.41 110.913 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.0 106.62 0.8 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.783 2.322 . . . . 64.24 111.975 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.15 117.77 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.716 -1.216 . . . . 63.23 107.716 175.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -80.98 73.22 8.03 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.668 0.747 . . . . 72.22 110.628 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -67.2 -33.75 76.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.78 -1.1 . . . . 74.52 108.997 169.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.652 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.4 p-10 . . . . . 0 C--O 1.24 0.577 0 CA-C-N 114.328 -1.306 . . . . 60.1 111.654 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.6 m . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 107.185 -1.413 . . . . 52.35 107.185 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -121.69 143.46 49.33 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.298 -0.63 . . . . 74.15 109.298 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.15 132.18 9.88 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.6 -0.889 . . . . 72.03 108.6 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.475 HG22 ' HE2' ' B' ' 84' ' ' PHE . 1.8 pp -76.4 104.33 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 122.112 0.958 . . . . 73.01 108.842 173.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLN . . . . . 0.418 ' HG3' ' OG ' ' B' ' 85' ' ' SER . 1.4 tm0? -76.71 -36.37 57.24 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.963 -0.754 . . . . 55.41 108.963 -170.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.408 HH21 ' HB ' ' A' ' 122' ' ' THR . 21.8 ttt180 -168.06 140.08 2.97 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 124.036 0.835 . . . . 74.43 109.199 173.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.0 mt -124.82 134.38 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.597 -1.26 . . . . 32.31 107.597 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.27 157.39 13.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.576 0.547 . . . . 70.24 111.813 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -83.0 127.9 33.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.407 -0.815 . . . . 54.52 109.039 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.564 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 25.4 mtpp -93.51 -41.05 9.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.549 -0.75 . . . . 75.33 110.095 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.5 t70 -152.4 145.63 24.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.827 -0.624 . . . . 74.34 111.4 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.8 mm -140.02 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 C-N-CA 125.291 1.437 . . . . 73.23 108.411 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -146.22 134.9 22.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.454 1.101 . . . . 73.4 108.325 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.447 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -148.2 120.14 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.061 -1.459 . . . . 73.23 107.061 170.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -119.08 142.91 47.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.153 -1.055 . . . . 71.33 108.153 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.976 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -139.25 77.59 29.82 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.635 -1.246 . . . . 72.42 107.635 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.62 -40.4 10.22 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.902 2.401 . . . . 64.33 112.509 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -109.03 21.06 17.69 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.255 -0.884 . . . . 71.22 110.072 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.976 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.44 -48.88 35.24 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 115.524 1.676 . . . . 72.01 115.524 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -38.44 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.539 2.16 . . . . 74.1 112.256 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 37.8 m80 -90.09 -4.98 57.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.147 0.795 . . . . 65.31 113.147 -171.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.466 HG23 HD11 ' B' ' 68' ' ' LEU . 7.6 p -69.99 -18.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.115 0.566 . . . . 64.43 111.082 -175.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' PHE . . . . . 0.4 ' HA ' ' HB3' ' B' ' 35' ' ' ASP . 55.2 t80 -66.47 -14.95 62.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.645 0.778 . . . . 73.31 111.865 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -69.15 -37.3 78.18 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.602 -0.518 . . . . 75.41 109.602 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.6 mttt -110.75 62.46 0.61 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.615 -0.883 . . . . 52.2 108.615 172.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.4 ' HB3' ' HA ' ' B' ' 32' ' ' PHE . 11.1 p-10 -88.17 98.44 11.56 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.03 -0.419 . . . . 73.24 110.662 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 172.36 -174.96 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.244 1.417 . . . . 63.04 111.429 163.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -49.03 110.1 1.41 Allowed Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.464 1.506 . . . . 65.35 113.494 -169.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.51 165.84 16.0 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.688 2.259 . . . . 71.54 110.836 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.86 104.46 4.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.205 -1.406 . . . . 75.22 107.205 169.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.65 143.53 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -138.96 116.75 11.5 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.231 0.612 . . . . 54.02 109.909 -170.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -86.78 125.72 34.13 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 74.44 108.55 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -133.83 107.41 7.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.814 -1.18 . . . . 64.35 107.814 177.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.39 127.37 53.52 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.72 -0.844 . . . . 63.21 108.72 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.1 t70 -123.14 136.91 54.98 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.801 -1.185 . . . . 73.11 107.801 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -109.19 115.05 29.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.325 0.65 . . . . 74.22 110.998 -168.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -119.63 144.57 47.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.909 0.884 . . . . 63.33 109.161 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.8 p -145.14 163.21 35.04 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.375 0.67 . . . . 75.51 109.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -151.26 167.28 28.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.525 0.73 . . . . 74.53 109.804 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -113.42 112.61 23.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.885 -0.783 . . . . 73.12 108.885 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.49 -40.21 23.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.894 0.477 . . . . 71.21 110.035 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.78 -173.32 4.32 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.28 -0.873 . . . . 74.32 110.706 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.2 106.62 0.45 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.645 -1.162 . . . . 75.35 109.73 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 73.49 5.22 4.94 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.197 1.399 . . . . 71.12 112.209 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.81 113.07 39.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 107.958 -1.127 . . . . 73.45 107.958 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -122.5 140.76 52.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.22 0.608 . . . . 71.15 110.119 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.629 ' HG2' HG12 ' B' ' 83' ' ' ILE . 3.9 tm-20 -108.15 98.31 7.88 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.58 -1.267 . . . . 71.42 107.58 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -93.96 119.87 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.703 1.201 . . . . 62.41 110.236 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 21.8 t -107.13 139.21 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.204 1.002 . . . . 53.13 109.981 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.815 HD11 ' HA ' ' B' ' 103' ' ' PRO . 84.9 mt -121.56 112.85 18.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.373 0.669 . . . . 74.24 109.376 174.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.2 ttm-85 -86.89 107.6 18.41 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.185 -1.043 . . . . 72.34 108.185 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.83 101.88 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.075 -1.454 . . . . 74.25 107.075 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 32.3 m -97.31 139.12 33.74 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.931 -1.486 . . . . 54.41 108.443 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.61 114.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.203 -1.036 . . . . 71.23 108.203 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -101.38 140.58 35.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.371 -0.974 . . . . 71.11 108.371 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.95 126.38 23.34 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.314 -0.995 . . . . 41.11 108.314 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.4 p -146.27 140.03 26.2 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.357 0.663 . . . . 74.21 110.514 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -133.36 140.87 47.63 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.992 0.917 . . . . 74.4 109.655 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.84 -111.75 3.66 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.434 -0.803 . . . . 30.12 111.429 -172.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -121.6 2.5 10.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 74.1 109.885 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -135.63 171.95 13.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.949 0.5 . . . . 70.2 110.877 -169.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -75.03 140.37 43.5 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.493 -0.776 . . . . 73.23 111.352 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.628 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.04 -62.2 1.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.247 -1.02 . . . . 71.51 108.247 172.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -163.07 167.08 22.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.475 -1.693 . . . . 74.25 107.917 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.63 143.31 49.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 71.33 108.013 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.7 t -143.33 144.34 32.05 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.372 -0.973 . . . . 62.13 108.372 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -160.12 139.01 10.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.97 -0.752 . . . . 60.43 108.97 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' B' ' 113' ' ' CYS . 69.7 t -135.43 145.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.547 -1.279 . . . . 72.22 107.547 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 76.2 mt-30 -124.88 92.78 3.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.939 -1.134 . . . . 64.02 107.939 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -89.38 104.42 16.97 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.956 -1.02 . . . . 61.41 108.848 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.21 156.65 25.3 Favored Glycine 0 C--O 1.244 0.767 0 N-CA-C 111.131 -0.788 . . . . 74.14 111.131 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.18 1.33 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.072 -0.811 . . . . 73.11 111.072 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.629 HG12 ' HG2' ' B' ' 57' ' ' GLU . 26.0 mt -85.99 134.55 27.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 108.076 -1.083 . . . . 60.32 108.076 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 84' ' ' PHE . . . . . 0.475 ' HE2' HG22 ' B' ' 13' ' ' ILE . 65.4 m-85 -133.64 135.08 43.94 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 71.34 108.343 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.418 ' OG ' ' HG3' ' B' ' 14' ' ' GLN . 65.5 m -107.61 91.85 3.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 172.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.555 ' HB ' HD11 ' B' ' 89' ' ' ILE . 35.2 pt -98.11 138.21 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.386 -0.825 . . . . 65.33 110.974 -169.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -145.01 167.77 21.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.28 1.032 . . . . 65.35 109.945 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.79 -63.72 4.42 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.696 -0.684 . . . . 75.42 112.006 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.555 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.3 pp -61.35 138.1 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.618 0.767 . . . . 73.13 112.123 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.12 149.66 16.08 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.477 -0.783 . . . . 73.41 109.197 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.08 -124.9 14.69 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.68 0.613 . . . . 42.33 112.793 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.0 m -67.19 -33.37 75.25 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.402 0.681 . . . . 62.11 110.964 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.88 -33.24 71.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.763 -0.653 . . . . 71.21 110.468 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -65.57 -45.57 82.8 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.024 0.53 . . . . 62.33 110.138 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.14 -31.87 70.5 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.812 0.845 . . . . 62.34 112.09 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -77.71 -43.92 29.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.168 0.587 . . . . 74.55 111.2 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.46 -47.26 56.82 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.37 0.605 . . . . 54.33 111.909 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.564 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.1 tm? -89.38 -37.61 14.73 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.112 0.965 . . . . 73.43 110.202 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.28 -26.32 57.68 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.34 0.4 . . . . 54.04 114.015 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.91 -48.99 2.23 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.985 0.514 . . . . 70.43 112.203 -173.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.512 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 67.2 t80 -77.84 -45.71 23.57 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.51 0.559 . . . . 73.51 112.51 -172.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 78.5 m -59.48 -42.55 92.82 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 112.981 0.734 . . . . 62.04 112.981 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.815 ' HA ' HD11 ' B' ' 60' ' ' LEU . 83.6 Cg_exo -52.08 -39.61 70.0 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.529 2.153 . . . . 73.31 114.818 168.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.54 -24.05 65.5 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.114 0.566 . . . . 61.42 112.062 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.534 HG23 ' NH2' ' D' ' 111' ' ' ARG . 92.8 mt -73.15 -47.39 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.778 0.831 . . . . 71.33 111.348 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.513 ' HB2' HD12 ' B' ' 60' ' ' LEU . 75.1 mt -79.72 -18.79 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.871 -0.604 . . . . 63.45 110.987 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.76 -50.55 86.42 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-O 117.699 -1.143 . . . . 73.53 113.733 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.1 -35.86 97.18 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.552 2.168 . . . . 71.2 113.959 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -69.44 -46.73 66.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.481 0.712 . . . . 73.53 110.575 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.3 -41.28 88.63 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.398 -0.819 . . . . 75.33 110.616 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -63.14 -50.43 70.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.557 1.543 . . . . 74.32 111.268 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.85 -37.99 89.47 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.95 0.781 . . . . 64.51 109.998 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.545 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -68.62 -39.21 80.91 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.508 0.505 . . . . 64.4 111.169 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.2 -49.69 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.062 0.545 . . . . 43.45 110.014 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -56.53 -39.37 73.25 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.301 -0.863 . . . . 71.14 111.168 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -68.05 -46.53 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.123 -0.944 . . . . 65.4 110.394 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -66.74 -39.48 87.95 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.006 0.523 . . . . 73.21 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.28 -39.47 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.867 0.467 . . . . 75.13 110.251 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -68.5 -28.57 67.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.071 0.948 . . . . 61.13 111.761 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.0 mtt-85 -73.58 -35.79 65.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.744 0.818 . . . . 73.14 110.101 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 3.4 55.0 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 123.757 0.661 . . . . 73.44 112.673 170.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 58.81 28.87 18.01 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.516 1.926 . . . . 61.21 112.304 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -98.77 153.03 38.07 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 114.849 -1.069 . . . . 75.45 109.645 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.2 102.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.13 2.553 . . . . 74.23 111.523 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.408 ' NE2' ' HB3' ' C' ' 119' ' ' SER . 4.6 pt20 -62.38 155.41 25.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.604 -1.18 . . . . 75.35 111.527 -171.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.6 tp -109.29 100.82 9.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.459 -0.791 . . . . 73.22 109.612 -168.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -89.37 92.85 9.31 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 106.44 -1.689 . . . . 73.14 106.44 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.25 150.1 46.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.959 -1.473 . . . . 63.51 111.19 -168.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.26 74.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 122.97 0.508 . . . . 71.1 110.779 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.08 111.8 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.942 2.428 . . . . 75.11 112.233 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.64 113.85 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.479 -0.934 . . . . 61.12 108.479 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.38 80.11 7.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.279 0.632 . . . . 74.11 109.375 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 N--CA 1.486 1.372 0 C-N-CA 123.653 0.781 . . . . 72.41 111.303 -179.73 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.531 ' HB2' HG21 ' C' ' 89' ' ' ILE . 46.9 ttp . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 121.435 0.636 . . . . 74.03 111.088 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.2 m -85.77 88.38 7.54 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.975 -1.12 . . . . 72.42 107.975 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 52.1 t80 -96.62 122.31 39.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.784 -0.821 . . . . 54.52 108.784 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -138.57 139.11 38.51 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.465 0.706 . . . . 73.35 110.472 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.58 96.79 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.764 -0.828 . . . . 73.41 108.764 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.452 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.5 mm100 -75.98 -43.47 44.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.69 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -169.84 122.99 0.73 Allowed 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.894 0.746 . . . . 72.52 109.892 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.84 133.54 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.347 -0.983 . . . . 44.12 108.347 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.463 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.0 p90 -169.67 158.72 7.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.697 0.761 . . . . 72.31 112.267 -173.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -81.56 110.37 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.518 -1.219 . . . . 70.41 108.864 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -79.47 -23.92 42.71 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 122.277 -0.264 . . . . 71.33 110.605 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -150.06 142.08 23.94 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.954 0.783 . . . . 74.34 109.467 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -137.26 144.26 32.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 106.916 -1.513 . . . . 74.21 106.916 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 22' ' ' SER . . . . . 0.551 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 40.3 t -151.82 147.71 26.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.482 0.713 . . . . 73.21 110.125 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -154.87 119.93 4.93 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.342 -1.355 . . . . 74.5 107.342 168.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.48 130.14 54.16 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.489 0.716 . . . . 75.54 109.236 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.31 77.36 76.3 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.652 -1.24 . . . . 72.33 107.652 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -68.02 -27.72 35.91 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.037 2.491 . . . . 62.44 112.051 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -109.91 41.96 1.61 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.496 1.118 . . . . 35.21 109.457 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.617 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.64 -54.94 49.83 Favored Pre-proline 0 CA--C 1.571 1.753 0 N-CA-C 114.47 1.285 . . . . 54.42 114.47 -175.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 12.5 Cg_exo -72.66 -28.42 14.11 Favored 'Trans proline' 0 C--N 1.386 2.533 0 CA-C-N 121.891 1.711 . . . . 73.41 111.775 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -68.7 -22.08 64.38 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.04 1.336 . . . . 74.0 111.953 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -72.2 -18.84 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.539 0.736 . . . . 72.23 111.497 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -68.79 -23.48 64.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.623 0.369 . . . . 65.05 111.201 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -109.52 24.04 13.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.51 0.724 . . . . 71.35 110.722 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.681 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -81.08 148.05 29.83 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.35 0.66 . . . . 73.43 110.046 -176.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 35' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' C' ' 68' ' ' LEU . 12.7 t70 -69.37 125.01 25.37 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.315 -0.994 . . . . 75.04 108.315 169.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -86.76 63.12 7.79 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.882 0.738 . . . . 74.24 110.372 -168.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -164.95 77.4 1.39 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.227 1.011 . . . . 61.25 108.403 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.97 156.11 26.62 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.77 2.313 . . . . 71.13 111.371 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.37 86.85 7.35 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.132 -1.433 . . . . 73.51 107.132 170.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -69.42 112.43 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.427 -1.26 . . . . 62.21 109.835 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -134.29 127.12 31.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.749 0.82 . . . . 74.31 109.852 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 42' ' ' LEU . . . . . 0.409 HD23 ' N ' ' C' ' 43' ' ' ASP . 6.1 tt -86.41 139.14 31.21 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 107.648 -1.241 . . . . 70.45 107.648 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.4 t70 -119.61 107.5 13.33 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.577 -1.268 . . . . 61.15 107.577 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.17 116.16 28.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.268 1.027 . . . . 74.42 109.059 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.9 t70 -115.08 143.94 44.41 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.606 -0.887 . . . . 64.42 108.606 172.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -131.19 134.96 47.0 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.614 0.766 . . . . 64.11 109.789 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -148.21 157.34 43.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.138 0.575 . . . . 54.35 110.628 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -161.28 145.75 13.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.87 0.868 . . . . 52.51 110.413 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -156.06 140.85 17.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 73.03 109.898 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -72.55 127.87 33.87 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' C' ' 57' ' ' GLU . 34.9 mt -96.06 -39.67 9.62 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 64.45 109.581 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.32 176.59 12.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.919 -1.491 . . . . 45.21 108.964 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -68.31 121.98 17.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.673 -0.694 . . . . 71.11 109.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 76.51 -8.37 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 126.401 1.881 . . . . 72.15 112.632 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.81 96.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 70.22 108.879 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.8 161.97 13.72 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.493 0.717 . . . . 74.34 109.378 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.667 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.0 tt0 -124.73 133.61 53.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.14 0.576 . . . . 73.52 109.768 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.426 HG22 HD12 ' C' ' 98' ' ' LEU . 77.2 t -110.69 129.22 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.402 -1.333 . . . . 52.04 107.402 169.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 96.7 t -114.18 136.76 49.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.257 -1.016 . . . . 74.53 108.257 173.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.13 101.76 5.95 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.324 -1.361 . . . . 74.25 107.324 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 8.1 ttm180 -87.29 135.13 33.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.262 0.625 . . . . 73.41 109.687 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.5 t -125.81 121.89 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.137 -1.431 . . . . 55.45 107.137 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 30.7 m -124.7 119.56 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.423 -0.584 . . . . 64.2 109.423 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 114' ' ' ILE . 59.1 t -100.35 116.43 43.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.635 -0.876 . . . . 74.33 108.635 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.5 m -106.21 137.71 43.68 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.688 0.618 . . . . 62.23 109.511 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.64 94.49 3.2 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.516 -1.291 . . . . 74.24 107.516 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -143.57 139.15 29.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.392 -0.966 . . . . 64.24 108.392 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.681 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 23.65 8.74 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.506 0.722 . . . . 74.02 110.329 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.94 -120.57 1.4 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.827 -1.309 . . . . 72.44 109.827 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.79 -28.47 21.66 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.56 -0.904 . . . . 75.31 108.56 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.0 99.2 0.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.466 1.106 . . . . 64.54 109.608 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.1 m -87.75 130.24 34.9 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.058 0.543 . . . . 64.0 110.644 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.66 5.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.495 -0.775 . . . . 72.24 109.256 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -167.21 169.75 12.33 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.827 0.851 . . . . 70.32 110.768 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.411 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -142.87 144.67 32.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.939 -1.134 . . . . 62.4 107.939 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.411 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.6 t -146.68 146.28 30.3 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.353 -0.98 . . . . 61.44 108.353 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 77' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 38.4 tt0 -153.76 137.49 16.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.25 0.62 . . . . 71.44 110.218 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 78' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.4 t -141.9 115.02 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.305 1.042 . . . . 74.33 108.615 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 73.2 mt-30 -95.03 97.69 10.14 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.889 -0.782 . . . . 64.12 108.889 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.1 102.32 14.32 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 44.25 110.009 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.16 151.82 21.8 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.918 -0.473 . . . . 73.43 111.918 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.97 128.59 2.82 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.645 -0.582 . . . . 32.03 111.645 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' D' ' 29' ' ' PRO . 8.3 mm -90.14 130.38 39.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 108.491 -0.929 . . . . 73.33 108.491 178.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.98 119.91 17.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.316 -0.624 . . . . 71.54 109.316 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.0 p -85.93 99.9 11.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.212 -1.033 . . . . 22.42 108.212 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.63 124.7 68.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.472 0.709 . . . . 62.13 109.645 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 169.06 25.23 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.029 -0.987 . . . . 72.22 110.228 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.69 -28.58 11.9 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.033 -0.985 . . . . 63.02 111.045 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.2 OUTLIER -119.14 167.51 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.943 0.897 . . . . 64.41 110.903 -173.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -160.1 -171.76 3.34 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.799 -1.092 . . . . 75.55 108.954 173.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.52 -124.44 33.43 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.824 0.703 . . . . 63.43 114.109 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.6 t -63.62 -32.19 73.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.103 0.961 . . . . 75.01 112.789 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -68.28 -57.52 5.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.249 0.62 . . . . 73.24 111.218 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.553 ' HB3' HG12 ' C' ' 89' ' ' ILE . 3.3 ppp? -73.92 -21.19 60.14 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.698 -0.683 . . . . 61.52 110.739 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.4 96.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.946 0.498 . . . . 73.45 110.414 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.29 -39.18 75.22 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.007 -0.542 . . . . 72.12 110.844 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 97' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 94.2 m -67.49 -52.98 32.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.028 -0.533 . . . . 63.43 110.232 175.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.426 HD12 HG22 ' C' ' 58' ' ' VAL . 52.2 tp -60.38 -53.98 51.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.072 0.949 . . . . 70.43 111.546 -168.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.53 11.29 59.64 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.433 -0.648 . . . . 75.23 114.687 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.23 -63.79 0.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.837 0.818 . . . . 74.31 112.477 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 38.5 t80 -72.76 -53.25 12.12 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.823 0.449 . . . . 62.54 111.919 -168.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.546 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 44.1 m -59.11 -47.39 98.58 Favored Pre-proline 0 CA--C 1.569 1.675 0 C-N-CA 123.969 0.908 . . . . 72.5 112.352 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 86.5 Cg_exo -54.55 -37.28 90.4 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.96 2.44 . . . . 64.35 113.711 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -66.58 -38.49 87.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.886 0.741 . . . . 61.33 110.286 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.1 mm -61.53 -44.6 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.05 0.54 . . . . 74.13 110.324 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.573 HD21 ' HA3' ' C' ' 82' ' ' GLY . 97.0 mt -75.31 -30.85 60.46 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.291 -0.868 . . . . 74.23 112.302 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 107' ' ' PHE . . . . . 0.407 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 61.5 t80 -53.94 -49.77 87.73 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.298 1.221 . . . . 73.34 114.298 -171.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.09 -31.85 94.12 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.299 1.999 . . . . 72.35 113.841 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.468 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.5 m-85 -71.98 -43.15 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.238 0.615 . . . . 64.25 110.64 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -65.3 -38.33 89.89 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 116.038 -0.528 . . . . 60.4 110.484 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.516 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 39.2 ttt-85 -56.66 -53.48 57.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.556 1.542 . . . . 64.41 111.797 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.35 -32.91 74.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.825 0.45 . . . . 71.21 110.307 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.13 -32.38 71.72 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.065 0.546 . . . . 73.14 111.269 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' C' ' 62' ' ' VAL . 59.3 mt -70.29 -56.06 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.408 0.683 . . . . 72.4 109.739 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -63.33 -27.14 69.12 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.563 0.745 . . . . 72.3 111.276 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.36 -48.83 68.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.422 0.689 . . . . 50.35 109.544 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -32.79 74.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.482 0.713 . . . . 72.34 112.16 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.65 -46.97 95.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.473 0.709 . . . . 65.33 109.549 174.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' B' ' 125' ' ' GLN . 58.9 p -73.73 -23.78 59.81 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.275 0.63 . . . . 72.14 112.185 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -72.76 -37.8 67.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.575 0.75 . . . . 74.34 110.192 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.16 1.86 73.26 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.524 0.515 . . . . 45.41 112.43 169.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 62.42 36.97 13.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.93 2.092 . . . . 70.34 112.665 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -94.94 154.15 39.77 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.781 -1.1 . . . . 73.42 109.44 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 -177.78 1.49 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.032 2.488 . . . . 43.25 113.591 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.71 133.9 56.33 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.133 1.16 . . . . 62.34 114.133 -169.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.3 tt -138.7 85.31 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.079 -1.822 . . . . 73.13 106.079 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.7 129.88 44.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.787 0.835 . . . . 55.03 109.493 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.516 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.6 mm? -80.47 143.89 33.0 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.642 0.589 . . . . 73.54 110.472 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.72 150.23 50.24 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.951 0.9 . . . . 72.22 111.376 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.06 130.08 7.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.174 2.583 . . . . 61.22 112.297 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 9.4 t -135.08 112.97 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 109.067 -0.716 . . . . 74.32 109.067 173.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -97.34 90.75 5.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.438 0.695 . . . . 73.11 110.128 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.63 -39.07 77.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.778 0.799 . . . . 73.15 109.705 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 N--CA 1.473 0.7 0 CA-C-N 113.984 -1.462 . . . . 75.23 112.193 -176.717 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.24 0.559 0 N-CA-C 108.897 -0.779 . . . . 65.33 108.897 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -171.87 104.46 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.164 -1.791 . . . . 71.41 106.164 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -156.07 138.39 14.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.826 0.851 . . . . 63.42 108.844 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.426 HG21 HD13 ' D' ' 16' ' ' ILE . 10.1 mt -76.4 137.28 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.536 0.522 . . . . 73.52 110.368 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -99.93 -40.56 7.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.64 0.776 . . . . 71.3 110.257 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -167.15 125.9 1.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.474 -0.33 . . . . 61.23 111.207 -170.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.426 HD13 HG21 ' D' ' 13' ' ' ILE . 1.3 mp -103.91 132.56 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.13 -1.433 . . . . 55.25 107.13 165.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.617 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 26.0 p90 -166.09 154.95 11.27 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.954 0.784 . . . . 74.53 110.475 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -80.22 121.31 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.218 -0.901 . . . . 70.32 109.05 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 42.4 mtpt -87.28 -30.51 20.84 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.767 -0.457 . . . . 71.32 109.767 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.17 135.33 17.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.891 -1.049 . . . . 62.45 109.018 -177.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.676 HG23 HG22 ' D' ' 78' ' ' VAL . 48.7 mt -134.84 144.26 35.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 107.991 -1.114 . . . . 74.43 107.991 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -151.82 137.78 18.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.359 0.664 . . . . 73.41 110.313 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 55.2 t80 -143.88 115.66 8.24 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 106.767 -1.568 . . . . 71.12 106.767 171.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.56 126.19 48.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.13 0.572 . . . . 75.42 109.601 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.56 80.35 22.8 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.578 -1.267 . . . . 64.23 107.578 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.24 -31.91 17.54 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.017 2.478 . . . . 65.15 112.672 -170.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -114.95 36.49 3.84 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.45 -0.944 . . . . 73.3 108.45 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.443 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -56.38 -62.48 4.8 Favored Pre-proline 0 CA--C 1.559 1.321 0 N-CA-C 113.919 1.081 . . . . 74.44 113.919 -167.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.509 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -78.07 -2.21 12.33 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 122.796 2.034 . . . . 64.1 113.318 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -84.35 -42.17 16.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.758 1.223 . . . . 71.15 109.75 174.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.0 p -76.6 -27.26 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.102 0.561 . . . . 72.14 111.049 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -68.2 -7.95 34.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.247 0.832 . . . . 72.21 113.247 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -82.72 -18.79 39.57 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.799 0.84 . . . . 74.31 111.19 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.99 99.46 8.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.101 0.96 . . . . 64.21 110.954 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -75.52 94.63 3.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.861 0.865 . . . . 74.21 111.743 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.481 ' CE3' HD23 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -155.84 175.02 14.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.71 0.804 . . . . 75.13 111.961 174.132 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -94.92 109.56 44.81 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 124.299 1.04 . . . . 70.41 110.942 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.407 ' HA ' HD22 ' D' ' 68' ' ' LEU . 19.0 Cg_exo -65.3 146.13 85.26 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.231 2.62 . . . . 33.04 111.85 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.27 156.17 38.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.903 -0.777 . . . . 65.14 108.903 164.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.526 HG23 HG13 ' D' ' 64' ' ' VAL . 1.3 p -136.3 118.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.775 -1.194 . . . . 75.34 107.775 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -106.1 125.69 51.3 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.104 0.962 . . . . 61.11 108.514 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.5 tt -95.89 126.54 41.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.277 -1.008 . . . . 75.2 108.277 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.9 t70 -114.95 125.87 54.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.879 -1.156 . . . . 64.45 107.879 169.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.06 130.85 46.26 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.1 -0.704 . . . . 63.23 109.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -134.01 143.29 48.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.723 -0.843 . . . . 73.21 108.723 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -121.47 147.74 45.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.139 0.976 . . . . 65.25 110.019 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.07 142.74 18.71 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.785 0.834 . . . . 63.44 109.261 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -160.64 153.4 21.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.889 0.476 . . . . 61.22 109.98 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -164.08 147.17 9.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.33 0.652 . . . . 63.04 109.948 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.8 122.13 25.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.162 -0.681 . . . . 72.55 109.162 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' C' ' 29' ' ' PRO . 71.6 mt -89.95 -34.61 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.549 0.74 . . . . 75.12 110.524 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 -177.8 6.43 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.349 -0.841 . . . . 71.55 109.667 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.43 116.25 5.92 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.75 -0.659 . . . . 72.32 110.495 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 62.4 24.59 14.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.435 1.094 . . . . 71.25 111.899 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.08 116.82 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.396 -0.964 . . . . 75.45 108.396 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.485 ' HB2' HD12 ' D' ' 86' ' ' ILE . 82.3 m-85 -131.91 129.05 39.8 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.745 1.218 . . . . 61.41 108.036 -173.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' D' ' 51' ' ' LEU . 34.6 tt0 -102.52 139.7 37.77 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.599 0.76 . . . . 73.02 109.803 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.476 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 96.6 t -118.72 122.82 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.617 -1.253 . . . . 72.35 107.617 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 39.1 t -108.55 131.99 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.329 -0.989 . . . . 64.15 108.329 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tt -116.43 116.96 28.64 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.373 -1.343 . . . . 64.14 107.373 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -97.63 108.69 21.47 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.116 -0.698 . . . . 73.22 109.116 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.92 129.09 43.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 107.645 -1.243 . . . . 72.13 107.645 166.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.0 m -120.41 134.06 55.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.243 0.544 . . . . 73.21 109.701 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 78.5 t -125.62 106.81 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.128 1.371 . . . . 71.42 108.199 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -113.21 106.75 15.01 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.465 -0.568 . . . . 75.51 109.465 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.87 123.93 48.75 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.209 0.604 . . . . 51.55 109.679 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.7 m -147.31 121.54 9.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.304 -0.998 . . . . 50.12 108.304 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.481 HD23 ' CE3' ' D' ' 36' ' ' TRP . 17.3 tp -137.55 136.85 38.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.808 0.443 . . . . 51.31 110.013 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 69' ' ' GLY . . . . . 0.417 ' H ' HD12 ' D' ' 68' ' ' LEU . . . 91.75 -136.11 13.11 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.336 -1.106 . . . . 74.54 110.336 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 16.4 23.65 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.316 0.558 . . . . 73.31 110.881 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -136.21 164.66 27.55 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.071 0.548 . . . . 65.11 111.562 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -79.85 129.74 34.73 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.874 -1.057 . . . . 64.44 109.764 170.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.526 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.91 -66.15 0.88 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.178 -0.675 . . . . 74.44 109.178 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.35 165.88 32.36 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.061 -0.972 . . . . 72.5 111.191 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -129.07 146.54 51.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.888 1.275 . . . . 74.12 108.481 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.647 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 5.4 m -148.66 138.23 21.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.015 0.926 . . . . 62.15 109.661 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.57 122.31 5.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.332 -0.988 . . . . 70.53 108.332 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.676 HG22 HG23 ' D' ' 21' ' ' ILE . 91.6 t -130.54 118.49 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.448 -0.575 . . . . 54.53 109.448 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 76.6 mt-30 -90.02 90.81 8.3 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.132 -0.94 . . . . 74.42 108.651 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.28 103.66 10.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.427 -0.806 . . . . 75.12 109.401 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 143.37 16.51 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.519 -0.633 . . . . 34.33 111.519 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.43 128.47 4.16 Favored Glycine 0 CA--C 1.506 -0.515 0 N-CA-C 109.942 -1.263 . . . . 52.13 109.942 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.27 131.68 36.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.12 -1.067 . . . . 71.2 108.12 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.476 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 18.7 m-85 -130.65 139.72 50.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.428 -0.582 . . . . 73.43 109.428 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.7 m -82.65 100.9 10.47 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 108.084 -1.08 . . . . 34.04 108.084 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' D' ' 56' ' ' TYR . 36.3 mt -117.28 138.65 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.294 0.638 . . . . 72.31 110.218 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 167.52 15.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.804 0.841 . . . . 65.54 110.456 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.8 -19.78 10.95 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 114.914 0.726 . . . . 53.41 114.914 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 pt -121.67 138.31 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.969 -1.122 . . . . 74.34 107.969 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -141.87 167.67 21.57 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.681 0.792 . . . . 64.3 110.809 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.87 -135.19 40.76 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.849 0.718 . . . . 44.32 113.054 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -66.08 -29.86 70.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.265 0.626 . . . . 64.04 111.324 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -63.77 -40.96 97.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.371 0.669 . . . . 74.32 110.728 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -81.34 -34.6 31.69 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.301 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.21 -23.92 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.64 0.776 . . . . 73.15 112.545 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 96' ' ' HIS . . . . . 0.565 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.6 t-80 -69.91 -38.55 76.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.695 0.398 . . . . 73.02 110.506 171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.18 -33.67 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 110.338 -0.245 . . . . 44.3 110.338 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.52 -54.16 11.47 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.475 1.11 . . . . 74.34 109.877 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.92 14.31 64.86 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.562 -0.745 . . . . 61.43 114.405 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 100' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -145.23 -56.42 0.32 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 117.405 0.603 . . . . 54.41 112.333 -175.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -75.63 -51.6 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.532 0.567 . . . . 72.42 112.532 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.9 m -59.14 -48.61 96.11 Favored Pre-proline 0 CA--C 1.568 1.653 0 C-N-CA 124.206 1.002 . . . . 72.1 112.93 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.81 -30.79 78.09 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 122.265 1.976 . . . . 70.03 112.852 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.94 -32.2 73.45 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.298 0.639 . . . . 74.44 111.126 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 13' ' ' ILE . 49.5 mm -74.21 -42.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.584 0.754 . . . . 64.21 110.678 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.16 -30.25 49.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.325 -0.852 . . . . 73.31 111.997 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.51 -44.4 97.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.187 1.18 . . . . 62.44 114.187 -170.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.42 -41.59 51.22 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.452 2.101 . . . . 63.12 114.159 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -75.92 -38.62 57.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.811 . . . . 75.3 111.756 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.67 99.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.476 0.71 . . . . 51.05 110.753 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.536 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.7 ttp180 -62.56 -49.91 73.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.542 -1.208 . . . . 72.22 110.59 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -58.4 -48.47 80.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.379 1.072 . . . . 71.35 111.531 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.69 -40.12 75.03 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.811 0.694 . . . . 73.35 111.224 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.492 HG21 HG21 ' D' ' 64' ' ' VAL . 93.7 mt -65.98 -50.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.132 -0.94 . . . . 74.43 110.582 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.6 m -53.9 -38.88 65.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.507 1.123 . . . . 75.42 111.759 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -70.54 -50.24 39.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.01 110.316 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -56.62 -43.16 79.95 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.453 0.701 . . . . 73.33 111.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.553 HG11 HD23 ' D' ' 126' ' ' LEU . 82.3 t -63.73 -42.28 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 114.441 -1.254 . . . . 64.22 110.814 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 59.6 p -68.8 -30.79 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 120.817 0.341 . . . . 61.11 110.965 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -69.63 -29.45 66.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.072 0.949 . . . . 73.44 110.525 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 121' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.45 11.42 69.97 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-N 115.579 -0.737 . . . . 71.12 112.905 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.463 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.7 p 61.31 16.04 7.02 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 126.771 2.028 . . . . 70.44 113.721 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -90.41 164.66 26.21 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.237 1.015 . . . . 75.23 108.359 170.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -86.65 150.77 8.77 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.655 2.237 . . . . 74.42 112.466 -172.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.17 133.21 28.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.949 0.9 . . . . 62.43 112.749 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.553 HD23 HG11 ' D' ' 118' ' ' VAL . 3.8 mm? -105.82 95.0 5.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.533 -0.914 . . . . 75.13 108.533 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -98.87 98.79 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.9 mm? -76.08 135.15 39.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.3 -0.864 . . . . 61.32 109.625 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.88 128.69 92.74 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-O 119.56 -0.257 . . . . 75.32 110.989 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.536 ' HB3' HH12 ' D' ' 111' ' ' ARG . 65.6 Cg_endo -74.65 117.48 4.96 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.508 2.139 . . . . 61.41 111.299 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.76 110.3 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.534 -0.913 . . . . 71.4 108.534 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -78.4 98.8 6.13 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.859 -0.793 . . . . 73.3 108.859 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' D' D ' 133' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 62.8 m-85 . . . . . 0 N--CA 1.473 0.678 0 CA-C-N 115.102 -0.953 . . . . 74.04 111.267 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 110.181 -0.303 . . . . 72.12 110.181 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 28.1 t80 -138.83 127.59 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.005 -0.739 . . . . 71.44 109.005 171.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -159.17 110.91 2.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.466 0.479 . . . . 71.52 110.143 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.688 HG12 ' HD2' ' A' ' 84' ' ' PHE . 56.6 mt -69.5 116.02 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.057 0.543 . . . . 60.22 110.329 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -81.43 -36.04 29.91 Favored 'General case' 0 C--O 1.248 0.996 0 O-C-N 124.159 0.912 . . . . 65.41 110.007 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -176.28 123.01 0.17 Allowed 'General case' 0 C--N 1.363 1.195 0 O-C-N 123.557 0.536 . . . . 64.53 111.025 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.06 142.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 123.614 0.766 . . . . 74.43 109.024 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -168.44 155.83 7.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.674 0.75 . . . . 75.11 111.71 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -86.6 114.99 23.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.953 -1.021 . . . . 32.45 109.193 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -79.3 -22.07 45.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.147 -0.479 . . . . 74.1 111.009 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -159.84 144.27 14.82 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.88 0.872 . . . . 62.11 109.357 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 84.3 mt -141.93 143.88 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.361 1.464 . . . . 75.22 107.806 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -145.73 128.29 16.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.525 0.73 . . . . 60.21 109.537 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 89.7 t80 -126.12 117.25 22.76 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 106.082 -1.821 . . . . 71.4 106.082 162.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 47.1 mt-10 -118.99 140.56 49.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.965 -0.754 . . . . 73.51 108.965 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.53 72.96 69.16 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 105.804 -1.925 . . . . 53.21 105.804 168.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.58 -20.27 41.24 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.798 2.332 . . . . 73.2 112.042 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 37.9 m-20 -119.42 23.43 11.24 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.242 1.017 . . . . 64.3 109.434 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -47.95 -57.45 10.2 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.625 -1.179 . . . . 24.34 113.485 -170.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 14.1 Cg_exo -65.9 -19.4 58.42 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 121.873 1.715 . . . . 61.11 112.572 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.61 -44.62 14.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.803 0.841 . . . . 64.41 109.889 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -78.99 -19.6 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.824 -1.08 . . . . 70.51 111.943 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.61 -6.25 42.88 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.497 0.719 . . . . 71.15 111.301 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -102.2 -12.55 17.94 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.661 1.185 . . . . 74.15 111.978 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -71.42 168.66 17.0 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.719 0.808 . . . . 75.24 113.016 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 68' ' ' LEU . 23.3 m-20 -69.97 135.19 49.14 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.182 -0.917 . . . . 64.31 109.368 169.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -82.77 67.18 8.73 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.491 1.116 . . . . 73.33 110.617 -169.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -141.75 71.0 25.01 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.137 0.975 . . . . 55.41 109.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -91.26 129.47 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.61 2.873 . . . . 75.4 112.217 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -96.63 110.5 22.91 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.034 -1.098 . . . . 73.24 108.034 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 t -79.22 136.64 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.672 0.789 . . . . 62.25 109.108 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -117.04 118.58 32.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.486 1.114 . . . . 75.01 108.136 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -102.37 107.72 18.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.109 -1.071 . . . . 61.33 108.109 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.701 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 14.8 m-20 -108.01 151.16 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.935 0.894 . . . . 73.54 108.982 172.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -139.0 134.58 33.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.202 1.001 . . . . 64.41 108.42 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 35.0 t70 -135.96 137.27 41.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.076 0.951 . . . . 73.14 109.354 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 p -124.86 134.9 52.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.339 1.056 . . . . 64.24 110.157 -172.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.95 143.09 25.0 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 61.24 109.77 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -132.18 161.1 34.2 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.28 0.632 . . . . 74.54 109.338 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -163.49 127.8 2.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.499 0.72 . . . . 74.15 109.74 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -74.23 114.06 12.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.845 -0.798 . . . . 54.4 108.845 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 57' ' ' GLU . 39.9 mt -79.42 -43.96 22.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.146 0.578 . . . . 63.11 109.629 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.64 -172.69 2.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.939 -1.028 . . . . 75.52 109.815 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.34 120.99 14.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.371 0.668 . . . . 64.35 109.387 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.37 16.55 9.6 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.668 1.187 . . . . 71.45 112.528 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.49 HG12 HD12 ' A' ' 51' ' ' LEU . 28.7 t -127.48 106.32 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.301 -1.0 . . . . 71.51 108.301 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -133.78 127.9 33.68 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.089 0.956 . . . . 74.12 108.479 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.7 tt0 -104.65 134.41 47.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.36 0.664 . . . . 70.32 109.762 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.61 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 97.2 t -122.82 123.79 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.967 -1.123 . . . . 71.43 107.967 169.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.551 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -99.68 135.48 34.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.357 1.063 . . . . 73.13 109.374 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.14 99.52 6.4 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.158 -1.423 . . . . 73.04 107.158 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.7 ttp180 -87.46 113.29 23.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.045 0.538 . . . . 73.31 109.806 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -93.76 143.33 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.498 -1.297 . . . . 74.11 107.498 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.701 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.5 m -131.56 133.86 45.47 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.42 -0.585 . . . . 62.53 109.42 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.8 t -131.19 111.02 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.1 1.36 . . . . 72.24 108.709 -173.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 m -120.69 121.64 38.71 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.326 0.512 . . . . 74.41 110.212 173.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.33 22.53 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.339 -1.356 . . . . 72.0 107.339 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 66.2 m -118.25 126.56 52.42 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.306 0.503 . . . . 73.42 110.485 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 35' ' ' ASP . 5.3 mp -90.22 85.72 6.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.879 -1.156 . . . . 74.14 107.879 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.15 -85.11 1.53 Allowed Glycine 0 C--N 1.343 0.94 0 CA-C-N 114.434 -1.257 . . . . 45.53 110.643 -173.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.13 -28.74 3.11 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.482 0.713 . . . . 64.3 110.872 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 30.4 tt0 -95.73 125.65 40.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.835 0.35 . . . . 65.15 110.307 -174.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 29.5 m -77.77 142.23 38.78 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.783 1.233 . . . . 71.11 112.805 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.686 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.04 -65.98 0.94 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.522 1.129 . . . . 53.32 109.199 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.414 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 50.6 p90 -146.1 148.94 33.15 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.513 -1.221 . . . . 74.35 111.865 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -109.29 143.08 39.25 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.22 -1.355 . . . . 71.32 107.904 167.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.3 m -143.06 109.7 5.45 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.6 119.54 17.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.755 -0.461 . . . . 70.45 109.755 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.09 114.37 32.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.382 1.073 . . . . 75.22 109.404 -171.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.86 84.22 7.65 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.38 -0.97 . . . . 72.44 108.38 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -79.57 91.7 5.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.811 -0.811 . . . . 60.42 108.811 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.09 167.27 37.69 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.39 -0.823 . . . . 52.43 111.715 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 124.95 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.186 -0.366 . . . . 75.34 112.186 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -81.98 115.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.964 -0.754 . . . . 41.32 108.964 171.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.7 m-85 -116.98 120.08 37.31 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.17 1.388 . . . . 75.55 107.81 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 t -75.57 94.17 3.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.797 -0.816 . . . . 71.41 108.797 171.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.681 HD13 HD21 ' A' ' 98' ' ' LEU . 50.8 pt -112.72 155.57 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.165 0.586 . . . . 53.5 110.708 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.76 167.69 11.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.456 -1.247 . . . . 71.45 109.111 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -11.65 57.6 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 114.511 0.564 . . . . 71.24 114.511 173.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.47 144.21 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.755 0.822 . . . . 45.14 110.3 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -162.06 173.31 14.55 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.785 -1.561 . . . . 65.31 106.785 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.25 -129.82 48.11 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 117.888 0.313 . . . . 61.04 113.543 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 71.3 p -75.09 -20.98 59.23 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.805 0.842 . . . . 74.43 111.826 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -69.82 -44.59 69.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.135 0.574 . . . . 74.14 109.619 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.4 ttm -68.95 -34.27 75.08 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.01 -0.541 . . . . 72.24 110.066 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -60.98 -28.34 68.94 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.188 0.595 . . . . 62.44 111.777 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.8 t-80 -88.47 -31.13 18.92 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.297 0.639 . . . . 71.43 111.065 171.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.11 -64.69 0.84 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.582 0.353 . . . . 72.33 111.149 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 86' ' ' ILE . 47.2 mt -90.09 -12.74 37.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.168 0.433 . . . . 72.52 112.168 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.78 -2.45 55.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.768 -0.462 . . . . 61.4 113.347 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.19 -53.17 0.17 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.365 0.582 . . . . 73.33 112.186 -174.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -77.3 -56.94 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 64.34 112.085 -168.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 80.5 m -74.97 -34.48 1.72 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.563 0.949 . . . . 73.32 113.563 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.6 Cg_endo -67.06 -23.01 46.8 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 121.958 1.772 . . . . 61.1 112.936 168.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -70.19 -33.76 72.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.3 0.64 . . . . 62.31 109.487 174.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 13' ' ' ILE . 45.3 mm -63.04 -42.17 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.799 0.84 . . . . 50.23 110.14 173.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.66 -32.62 69.97 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.982 -1.008 . . . . 64.34 111.981 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.27 -39.99 55.75 Favored Pre-proline 0 CA--C 1.575 1.927 0 N-CA-C 114.597 1.332 . . . . 74.41 114.597 -169.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.05 -41.75 73.69 Favored 'Trans proline' 0 C--N 1.392 2.835 0 C-N-CA 122.592 2.195 . . . . 73.32 113.489 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -71.97 -37.3 69.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.985 0.514 . . . . 64.25 111.376 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.46 88.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.785 0.434 . . . . 74.24 109.86 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.97 -53.38 56.44 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 124.726 1.266 . . . . 75.23 110.126 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.52 -42.75 95.59 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.044 0.84 . . . . 73.41 111.231 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.522 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.4 t -60.64 -34.52 74.39 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.504 0.722 . . . . 72.45 111.257 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.459 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 95.5 mt -73.44 -55.51 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.593 0.757 . . . . 71.21 109.867 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 125' ' ' GLN . 90.0 m -53.08 -40.33 63.98 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 125.199 1.4 . . . . 54.05 111.952 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -61.49 -50.78 71.33 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 60.03 110.303 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -61.17 -44.22 97.65 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.461 0.704 . . . . 71.44 111.527 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.4 t -55.83 -46.81 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 O-C-N 124.25 0.969 . . . . 63.02 110.299 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.6 t -69.87 -29.58 66.83 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.199 -0.91 . . . . 74.43 111.504 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -70.95 -27.67 63.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.363 0.665 . . . . 73.34 111.259 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.78 11.77 58.71 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.93 -0.372 . . . . 62.24 113.339 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.524 ' HB ' HH21 ' B' ' 15' ' ' ARG . 2.4 m 61.03 25.62 15.63 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 125.141 1.376 . . . . 71.4 111.022 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -94.01 146.23 31.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.825 -0.806 . . . . 74.24 108.825 171.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.73 149.55 90.55 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.66 2.24 . . . . 63.51 112.088 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.502 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.6 tt0 -58.37 133.16 55.49 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.295 0.997 . . . . 60.24 112.003 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.01 103.73 9.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.256 1.022 . . . . 55.5 108.783 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -105.97 110.89 23.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.127 -1.064 . . . . 73.23 108.127 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.55 135.5 54.27 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 123.404 0.44 . . . . 73.03 110.402 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.403 ' HA ' HD13 ' C' ' 13' ' ' ILE . . . -69.38 155.93 92.59 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.39 0.676 . . . . 63.3 110.312 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.24 125.33 14.94 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.524 2.149 . . . . 73.1 112.181 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -99.8 113.1 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.717 -1.586 . . . . 63.52 106.717 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -72.79 81.33 1.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 74.11 110.488 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.09 -44.26 97.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.449 0.7 . . . . 63.32 110.951 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.519 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.2 p-10 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 114.286 -1.325 . . . . 65.13 111.707 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 109.381 -0.6 . . . . 70.52 109.381 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.593 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 31.9 t80 -139.58 131.33 27.46 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.224 -0.658 . . . . 65.24 109.224 176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' B' ' 85' ' ' SER . 3.9 pp0? -152.29 140.9 20.81 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.055 0.542 . . . . 72.31 109.54 168.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.594 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -69.28 113.8 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.247 -0.888 . . . . 72.12 109.344 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -88.24 -35.31 17.38 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.008 -0.738 . . . . 62.32 109.008 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.524 HH21 ' HB ' ' A' ' 122' ' ' THR . 24.3 ttt180 -168.47 142.0 3.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.999 0.92 . . . . 72.32 109.726 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.11 137.66 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.007 -1.479 . . . . 72.04 107.007 172.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 36.2 p90 -166.28 159.24 14.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.687 0.756 . . . . 75.24 110.96 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.9 m -84.63 119.42 25.21 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.283 -1.006 . . . . 75.51 108.283 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.404 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 41.8 mtpt -87.03 -34.44 19.2 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.289 0.635 . . . . 75.51 111.142 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -158.84 146.26 17.64 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.322 -0.399 . . . . 73.52 110.746 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.7 mm -142.49 138.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 125.965 1.706 . . . . 73.22 107.619 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -140.1 118.9 12.44 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.522 -1.288 . . . . 63.31 107.522 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.5 t80 -131.59 136.42 47.77 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.08 -1.081 . . . . 73.33 108.08 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.76 145.28 38.05 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.131 0.972 . . . . 65.03 108.696 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -148.34 72.3 10.93 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 105.9 -1.889 . . . . 74.34 105.9 171.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.55 -14.71 30.65 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.79 2.327 . . . . 71.45 112.177 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -127.04 28.53 5.76 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.032 0.933 . . . . 60.14 109.502 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -46.69 -59.35 5.25 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.477 1.111 . . . . 63.2 113.305 -173.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.29 -18.97 34.16 Favored 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 121.926 1.751 . . . . 53.33 113.029 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -94.73 -21.81 18.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.439 0.696 . . . . 74.1 112.382 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -81.94 -28.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 110.051 -0.351 . . . . 71.44 110.051 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -62.47 -27.03 68.85 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.278 1.031 . . . . 72.04 113.216 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -72.77 -16.18 61.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.235 0.614 . . . . 71.11 112.204 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -107.55 113.34 26.59 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.149 0.98 . . . . 73.32 109.227 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -110.38 104.57 13.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 118.707 0.685 . . . . 62.15 112.605 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.473 ' HE3' ' N ' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 179.21 -177.38 0.3 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.384 1.474 . . . . 73.35 110.898 176.563 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.54 133.73 70.45 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.293 1.037 . . . . 74.41 111.956 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' PRO . . . . . 0.611 ' HB3' HD21 ' B' ' 68' ' ' LEU . 93.1 Cg_endo -93.43 170.6 2.08 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.329 2.686 . . . . 73.34 114.564 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -80.98 101.69 9.67 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.879 -1.526 . . . . 54.31 106.879 164.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -99.7 134.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.343 -0.984 . . . . 63.41 108.343 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.3 tttp -125.35 117.17 23.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.251 0.62 . . . . 74.33 110.195 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.88 136.57 33.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.968 -1.123 . . . . 71.53 107.968 169.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 15.4 t70 -145.93 154.72 42.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.19 0.596 . . . . 61.33 109.584 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.5 tp -135.42 128.32 31.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.228 1.011 . . . . 74.43 109.71 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.6 t70 -124.01 130.99 53.49 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.232 -1.025 . . . . 64.31 108.232 170.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -118.31 104.54 10.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.36 0.664 . . . . 74.43 109.947 -176.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.27 118.77 33.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.575 -0.898 . . . . 73.2 108.575 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 41.1 p -129.31 160.58 32.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.22 0.608 . . . . 52.41 110.53 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.1 p -165.69 138.37 4.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.972 0.909 . . . . 62.34 110.016 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 50.3 tt0 -81.16 115.46 20.59 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.477 0.711 . . . . 62.12 109.405 175.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' B' ' 57' ' ' GLU . 32.7 mt -75.5 -43.38 49.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.67 0.788 . . . . 70.23 110.538 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.65 -171.21 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.84 0.856 . . . . 53.51 110.481 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.62 116.49 4.05 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.36 0.664 . . . . 64.31 110.243 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 67.12 -3.36 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.568 1.547 . . . . 70.23 113.383 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -102.92 110.56 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.822 -1.177 . . . . 74.44 107.822 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 45.6 m-85 -111.68 172.04 7.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.379 -0.828 . . . . 71.32 108.996 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' B' ' 51' ' ' LEU . 20.3 tt0 -142.43 129.0 20.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.485 -0.931 . . . . 61.43 108.485 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -112.51 119.0 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.504 -1.295 . . . . 71.33 107.504 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -103.09 111.91 34.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 108.965 -0.754 . . . . 72.35 108.965 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.49 101.47 13.67 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.993 -1.003 . . . . 64.25 108.772 -176.883 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.7 ttm-85 -94.93 121.0 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.366 -0.605 . . . . 63.0 109.366 174.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 62' ' ' VAL . . . . . 0.43 HG11 HD21 ' B' ' 128' ' ' LEU . 41.3 t -115.75 125.48 72.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.222 -1.029 . . . . 61.0 108.222 172.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.6 m -111.96 140.34 46.71 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.616 0.722 . . . . 71.22 110.129 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.554 HG21 HG21 ' B' ' 114' ' ' ILE . 54.5 t -124.72 130.81 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 113.818 -1.537 . . . . 61.1 108.161 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.1 m -122.23 143.61 49.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.127 0.571 . . . . 70.33 109.466 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.05 125.77 13.42 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.524 -1.287 . . . . 70.55 107.524 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.8 p -140.82 140.08 34.61 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.303 0.641 . . . . 62.41 109.566 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' B' ' 73' ' ' ALA . 3.2 mm? -124.68 123.0 39.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.59 1.156 . . . . 55.21 109.974 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.89 -113.03 4.75 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.595 0.56 . . . . 63.35 112.057 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -113.02 4.16 16.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.856 0.863 . . . . 73.54 110.326 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 10.6 pt-20 -123.6 146.51 48.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.063 0.545 . . . . 75.53 110.282 -169.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -83.03 124.89 30.85 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.469 0.308 . . . . 74.22 110.341 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.63 ' HB2' HD23 ' B' ' 68' ' ' LEU . . . -71.45 -63.98 1.01 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.257 0.973 . . . . 63.44 109.262 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -157.03 149.44 23.17 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 121.657 0.741 . . . . 73.05 112.511 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.89 118.96 35.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.946 -1.501 . . . . 74.52 106.946 166.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 34.5 t -125.42 124.8 42.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.797 -0.816 . . . . 34.45 108.797 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -148.55 130.81 15.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.5 -0.926 . . . . 65.21 108.5 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -124.45 146.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 123.953 0.901 . . . . 74.11 109.512 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -121.66 96.49 5.09 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.193 -1.04 . . . . 63.25 108.193 170.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.529 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 45.2 tp60 -90.99 99.33 12.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.292 -1.003 . . . . 70.43 108.292 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.13 142.66 16.07 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 110.788 -0.925 . . . . 55.33 110.788 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.27 124.93 3.35 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.43 -1.068 . . . . 42.21 110.43 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -85.69 127.7 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.305 -1.369 . . . . 73.24 107.305 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.73 133.66 43.77 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.402 -0.962 . . . . 75.32 108.402 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.592 ' HB2' ' NE2' ' B' ' 12' ' ' GLN . 48.4 m -94.04 103.58 15.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.628 -1.249 . . . . 70.44 107.628 171.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.86 146.16 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.405 1.082 . . . . 73.52 110.265 -171.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.05 172.22 16.08 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.798 1.239 . . . . 40.44 109.198 172.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.0 -30.39 6.7 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.173 0.416 . . . . 71.51 114.003 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.36 162.79 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.343 0.657 . . . . 61.21 112.135 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -172.09 145.38 1.79 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.925 1.29 . . . . 62.2 109.04 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -111.3 3.3 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 114.74 0.656 . . . . 75.25 114.74 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -65.49 -44.02 88.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.833 0.853 . . . . 52.34 110.122 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -69.07 -29.77 67.95 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.693 -1.594 . . . . 75.31 110.545 -171.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.468 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 19.9 ptm -81.84 -34.09 30.35 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 116.496 -0.32 . . . . 71.21 111.016 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -34.75 74.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.515 0.726 . . . . 14.44 111.912 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -77.83 -34.02 52.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.238 0.615 . . . . 74.13 111.05 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.92 -65.84 0.63 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.698 0.399 . . . . 71.35 111.013 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.551 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.4 pp -70.95 -24.1 62.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.735 0.414 . . . . 72.21 111.961 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.453 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -84.4 -32.89 21.34 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.661 0.601 . . . . 54.14 113.729 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.7 -50.35 1.49 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.007 0.523 . . . . 70.43 111.564 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 101' ' ' TYR . . . . . 0.42 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 70.3 t80 -71.22 -40.8 70.9 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.361 0.664 . . . . 71.02 111.945 -172.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.593 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 55.6 m -72.21 -46.99 10.93 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.803 -0.618 . . . . 74.12 111.121 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.1 Cg_exo -57.62 -33.24 96.32 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.462 2.108 . . . . 53.41 113.708 168.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.78 -37.57 68.75 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.886 0.874 . . . . 54.41 110.919 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.19 -48.87 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.865 -1.062 . . . . 72.22 111.159 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.447 ' HB2' HD12 ' B' ' 60' ' ' LEU . 62.3 mt -77.72 -19.33 55.42 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.538 0.735 . . . . 74.33 112.405 -170.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.26 -45.56 85.12 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 114.164 1.172 . . . . 74.32 114.164 -170.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -57.02 -38.94 94.75 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 122.511 2.141 . . . . 55.33 113.351 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.529 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.1 m-85 -69.14 -40.11 78.45 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.153 -0.93 . . . . 71.24 109.858 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.99 93.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.523 0.729 . . . . 63.12 110.308 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -54.86 -57.59 11.0 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.623 1.169 . . . . 64.43 111.373 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.43 80.53 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.989 0.805 . . . . 74.2 110.244 -175.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.1 t -72.37 -32.58 66.56 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.868 0.467 . . . . 64.13 111.643 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.554 HG21 HG21 ' B' ' 64' ' ' VAL . 50.9 mt -65.3 -51.81 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.357 -0.979 . . . . 71.23 108.357 171.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 115' ' ' THR . . . . . 0.437 HG21 ' OG ' ' C' ' 119' ' ' SER . 24.8 m -61.28 -30.17 70.31 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.667 -1.152 . . . . 60.41 111.698 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.2 t -64.86 -46.7 80.74 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.789 0.836 . . . . 74.21 109.443 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 13.3 mmt -72.54 -30.54 64.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.217 0.607 . . . . 74.53 110.944 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.497 HG21 HD23 ' B' ' 126' ' ' LEU . 83.3 t -64.46 -41.16 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.911 0.884 . . . . 75.02 110.311 172.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -65.65 -35.11 79.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.058 0.943 . . . . 72.03 111.452 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.522 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.4 mtt-85 -73.03 -37.21 66.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.614 -0.721 . . . . 75.1 110.317 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.39 1.94 74.14 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.737 0.648 . . . . 71.21 112.59 173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p 63.93 18.32 11.11 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.581 1.952 . . . . 73.42 113.544 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.57 152.79 81.08 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.47 0.708 . . . . 73.5 109.433 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.54 -178.81 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 123.106 2.538 . . . . 73.43 114.236 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 7.6 tp-100 -65.37 113.48 4.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.753 -0.658 . . . . 63.12 112.445 -170.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.497 HD23 HG21 ' B' ' 118' ' ' VAL . 55.9 tp -114.35 93.78 4.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.05 -0.977 . . . . 72.23 108.855 171.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.08 128.5 36.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.591 -1.262 . . . . 74.41 107.591 166.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.43 HD21 HG11 ' B' ' 62' ' ' VAL . 30.2 tp -75.77 145.6 40.64 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.377 0.671 . . . . 73.31 110.51 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 127.49 85.02 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.817 0.847 . . . . 51.12 111.316 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.47 122.84 10.62 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.891 2.394 . . . . 54.35 111.594 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.91 116.85 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.409 0.684 . . . . 73.02 109.978 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.23 86.47 7.35 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.546 -0.909 . . . . 52.34 108.546 176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.474 0.736 0 CA-C-N 115.742 -0.663 . . . . 72.12 109.668 178.567 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 73.5 mtp . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 112.365 0.506 . . . . 53.01 112.365 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -86.26 99.5 11.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.677 -0.86 . . . . 54.03 108.677 169.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -124.33 126.76 46.55 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.789 -1.189 . . . . 71.03 107.789 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -151.85 144.09 23.99 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.918 0.487 . . . . 71.02 110.257 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.467 HG13 ' HE2' ' C' ' 84' ' ' PHE . 3.1 mp -82.63 115.73 25.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.219 -1.03 . . . . 62.44 108.219 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -80.93 -44.08 18.79 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.951 -0.388 . . . . 72.31 109.951 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -169.11 141.78 2.67 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.304 0.378 . . . . 75.11 110.098 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -125.45 135.52 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.053 -1.091 . . . . 70.2 108.053 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.595 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 32.6 p90 -173.77 155.9 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.914 0.387 . . . . 71.41 111.129 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -77.36 115.59 17.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.392 -0.822 . . . . 51.15 109.871 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -65.1 -41.02 95.34 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.995 -0.743 . . . . 74.22 108.995 171.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -149.34 150.11 31.96 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.316 -1.311 . . . . 74.14 110.353 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -142.14 145.28 24.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.501 1.92 . . . . 65.34 106.507 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -161.87 150.87 15.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.822 0.449 . . . . 64.25 110.053 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.86 106.67 2.68 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.436 -1.32 . . . . 62.33 107.436 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.39 120.22 36.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.747 0.819 . . . . 70.33 109.41 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.95 83.34 61.42 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.343 1.057 . . . . 70.31 108.496 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.92 -39.21 34.01 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.628 2.219 . . . . 73.13 112.081 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -97.13 20.9 10.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.957 0.903 . . . . 64.11 110.952 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.15 76.08 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.419 1.266 . . . . 70.25 114.419 -171.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.75 -26.35 8.32 Favored 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 121.235 1.477 . . . . 73.32 112.655 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.66 -30.37 65.65 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.336 1.054 . . . . 63.2 112.511 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' C' ' 73' ' ' ALA . 99.4 t -80.02 -20.17 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.32 0.648 . . . . 64.21 110.639 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -60.47 -28.97 68.75 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.072 0.549 . . . . 74.24 111.348 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.42 26.26 6.82 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.558 0.743 . . . . 74.34 110.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.25 152.36 37.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.605 0.762 . . . . 74.23 111.084 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.62 130.71 43.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.816 0.847 . . . . 71.5 110.449 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -76.34 98.14 4.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.838 0.855 . . . . 73.3 110.889 -172.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -156.59 75.82 4.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.397 -0.964 . . . . 74.41 108.397 173.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -86.63 130.09 3.17 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.391 2.06 . . . . 73.11 112.126 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.53 80.25 9.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.582 -1.636 . . . . 74.42 106.582 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.442 HG11 HD21 ' C' ' 126' ' ' LEU . 90.2 t -74.45 118.26 19.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.226 -1.352 . . . . 75.45 108.617 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -128.71 141.34 51.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.276 -1.379 . . . . 72.4 107.276 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.16 166.39 14.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.554 -0.906 . . . . 61.33 108.554 167.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.1 t70 -140.0 127.91 22.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.611 -1.255 . . . . 54.44 107.611 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 tp -104.85 140.62 37.86 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.691 0.796 . . . . 63.14 109.991 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 29.3 t70 -144.84 149.93 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.17 0.988 . . . . 73.4 108.676 172.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 66.3 p -126.77 141.09 51.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 62.05 109.928 -172.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -150.25 139.98 21.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.055 0.542 . . . . 63.32 110.104 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p -148.01 156.07 42.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.533 0.733 . . . . 64.51 109.529 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -152.68 165.55 34.93 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.282 0.633 . . . . 74.01 109.937 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -105.16 118.08 35.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.824 -0.806 . . . . 63.41 108.824 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.576 HD11 HD12 ' C' ' 83' ' ' ILE . 76.4 mt -89.04 -35.61 16.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.181 0.592 . . . . 73.2 110.366 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -171.3 2.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.036 0.934 . . . . 44.21 110.219 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.43 116.41 8.96 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.278 -0.874 . . . . 75.22 109.423 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 69.57 -0.46 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.371 1.468 . . . . 75.43 112.601 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.32 112.29 38.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 108.146 -1.057 . . . . 63.02 108.146 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' C' ' 86' ' ' ILE . 94.0 m-85 -129.56 144.13 51.13 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.889 0.876 . . . . 72.24 108.856 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -99.73 136.42 39.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.529 1.132 . . . . 74.52 110.021 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 58' ' ' VAL . . . . . 0.431 HG22 HD22 ' C' ' 98' ' ' LEU . 40.8 t -114.95 120.04 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.816 -1.179 . . . . 74.42 107.816 173.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 88.7 t -118.59 129.92 74.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.764 -0.828 . . . . 71.02 108.764 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -125.01 107.0 10.38 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.948 -1.501 . . . . 73.43 106.948 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 25.5 ttm180 -84.06 127.02 33.62 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.906 -0.588 . . . . 71.3 109.774 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.15 121.28 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.52 -1.218 . . . . 73.2 107.881 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 68.5 m -120.59 142.54 49.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.566 -0.902 . . . . 72.15 108.566 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.468 HG23 HD13 ' C' ' 114' ' ' ILE . 72.8 t -122.39 115.31 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.889 0.876 . . . . 74.31 109.421 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 28.2 m -99.31 135.79 40.21 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.879 -0.786 . . . . 43.35 108.879 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.29 107.29 7.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.082 -1.451 . . . . 60.52 107.082 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 67' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.3 m -143.44 128.36 18.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.286 0.634 . . . . 73.3 109.468 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' C' ' 73' ' ' ALA . 5.3 mp -85.8 56.71 4.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.469 1.507 . . . . 74.41 109.313 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.0 -82.33 0.44 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 109.893 -1.283 . . . . 71.54 109.893 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.12 -30.6 4.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.604 1.161 . . . . 71.02 109.104 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.19 91.79 0.08 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.191 1.397 . . . . 62.11 110.796 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 72' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 38.6 m -71.98 121.36 19.0 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.749 0.309 . . . . 63.05 111.389 -173.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.617 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -68.72 -62.67 1.29 Allowed 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.722 1.263 . . . . 60.13 109.646 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -163.48 175.66 10.52 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.442 -1.254 . . . . 73.11 109.794 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.431 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -140.41 145.71 37.4 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.251 -1.759 . . . . 73.11 106.251 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.431 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.0 t -144.92 149.61 35.56 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.325 -0.991 . . . . 64.11 108.325 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.88 121.03 3.93 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.61 -0.515 . . . . 62.42 109.61 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -119.64 114.41 44.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.869 -0.789 . . . . 73.42 108.869 170.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.1 96.79 10.84 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.628 -1.249 . . . . 74.51 107.628 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.564 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 67.1 tp60 -82.75 129.22 34.94 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.941 0.496 . . . . 53.44 109.678 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.16 154.84 16.72 Favored Glycine 0 N--CA 1.461 0.328 0 O-C-N 123.51 0.506 . . . . 61.43 112.051 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.462 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.47 122.25 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.147 -0.781 . . . . 73.43 111.147 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -89.25 127.08 42.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.468 -0.938 . . . . 71.32 108.468 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.467 ' HE2' HG13 ' C' ' 13' ' ' ILE . 83.8 m-85 -136.59 131.68 34.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 71.43 109.871 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -81.05 104.09 11.31 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.405 -0.961 . . . . 71.44 108.405 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.586 HD12 ' SD ' ' C' ' 94' ' ' MET . 10.5 pt -119.45 120.55 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.705 0.802 . . . . 65.44 109.867 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.35 168.05 25.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.715 0.806 . . . . 75.53 110.72 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.28 -61.17 3.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.048 -0.978 . . . . 71.55 111.411 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.17 142.52 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.789 0.328 . . . . 74.44 110.331 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 90' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 12.2 pt-20 -147.91 179.03 8.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.797 0.839 . . . . 63.23 109.397 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -122.43 29.81 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 123.687 0.617 . . . . 71.03 113.652 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -78.79 -22.99 45.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.93 0.892 . . . . 73.31 111.595 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -72.86 -31.7 64.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.882 0.473 . . . . 74.41 109.913 173.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.586 ' SD ' HD12 ' C' ' 86' ' ' ILE . 51.6 tpp -66.66 -40.52 88.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.659 -0.7 . . . . 71.34 110.114 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.11 70.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.934 0.894 . . . . 73.34 112.767 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 43.7 t-80 -69.27 -39.06 78.61 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.737 0.415 . . . . 65.43 111.426 177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -76.16 -41.47 49.71 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.168 0.509 . . . . 73.3 110.732 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.431 HD22 HG22 ' C' ' 58' ' ' VAL . 3.4 tm? -82.62 -53.38 5.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.995 1.318 . . . . 71.05 110.75 -168.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.7 -0.19 69.58 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.708 -0.678 . . . . 63.4 114.176 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -128.97 -66.81 0.81 Allowed 'General case' 0 C--N 1.35 0.598 0 CA-C-N 117.211 0.506 . . . . 45.2 111.503 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.15 -49.01 63.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.678 0.622 . . . . 73.4 112.678 -169.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.12 -42.67 77.87 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 118.237 -0.887 . . . . 70.34 112.477 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.57 -41.36 44.99 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.129 2.553 . . . . 61.11 113.691 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -67.62 -31.22 71.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.766 0.827 . . . . 75.41 111.467 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 39.6 mm -70.39 -44.23 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.16 0.584 . . . . 75.14 109.735 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.462 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.4 mt -79.24 -21.56 46.01 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.452 -0.794 . . . . 73.54 111.773 -173.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.42 -54.88 46.1 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.788 1.235 . . . . 74.44 113.199 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.67 -30.26 78.46 Favored 'Trans proline' 0 C--N 1.392 2.867 0 C-N-CA 122.024 1.816 . . . . 74.04 112.662 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.26 -48.75 64.23 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.574 0.75 . . . . 73.33 110.809 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.564 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.75 -37.22 86.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.426 0.69 . . . . 75.44 110.802 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -42.01 72.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.534 1.134 . . . . 74.22 110.568 -174.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.66 -36.45 73.36 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.616 0.766 . . . . 53.31 109.581 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.8 t -67.04 -35.18 79.3 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.69 0.796 . . . . 74.3 111.256 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.468 HD13 HG23 ' C' ' 64' ' ' VAL . 51.7 mt -68.61 -49.0 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.135 0.574 . . . . 62.01 110.083 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 30.4 m -61.01 -33.25 72.96 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.55 0.74 . . . . 74.41 111.249 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -61.26 -51.81 67.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.917 0.887 . . . . 71.53 109.359 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.521 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.68 -42.02 78.33 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.716 1.207 . . . . 64.13 112.622 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' C' ' 126' ' ' LEU . 61.2 t -65.62 -41.7 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.156 0.582 . . . . 60.44 110.595 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.437 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.1 t -68.16 -33.79 75.11 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.623 0.769 . . . . 73.24 111.218 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -64.92 -38.68 91.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.417 0.687 . . . . 73.34 110.282 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 7.86 55.58 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 123.8 0.688 . . . . 72.2 113.059 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 41.2 p 60.6 34.15 20.25 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.016 1.726 . . . . 62.12 112.195 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -108.41 152.82 42.2 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.808 1.243 . . . . 73.41 109.094 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.585 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 34.0 Cg_exo -60.99 158.82 32.23 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.684 2.923 . . . . 55.11 114.776 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -51.9 111.0 0.53 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.916 1.286 . . . . 63.22 112.477 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 126' ' ' LEU . . . . . 0.442 HD21 HG11 ' C' ' 40' ' ' VAL . 2.8 tm? -112.2 99.16 7.82 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.594 -1.261 . . . . 74.5 107.594 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.51 127.61 49.76 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.168 0.987 . . . . 71.41 108.709 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.413 HD23 ' N ' ' C' ' 129' ' ' ALA . 2.2 tt -71.74 143.03 49.75 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.763 0.825 . . . . 74.01 109.677 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.413 ' N ' HD23 ' C' ' 128' ' ' LEU . . . -72.2 146.9 90.16 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.278 1.031 . . . . 64.54 111.855 -177.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.0 124.61 16.35 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.24 2.627 . . . . 64.21 112.045 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 p -133.64 126.86 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.631 0.773 . . . . 75.22 109.746 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.98 90.83 7.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.452 0.701 . . . . 43.24 110.535 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -65.42 -30.41 71.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.536 -0.542 . . . . 71.2 109.536 169.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.676 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.9 t70 . . . . . 0 C--N 1.351 0.668 0 CA-C-N 114.755 -1.111 . . . . 71.52 111.28 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 23.5 m . . . . . 0 C--O 1.24 0.559 0 N-CA-C 110.17 -0.307 . . . . 64.25 110.17 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 11' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' D' ' 85' ' ' SER . 30.1 t80 -158.57 114.02 2.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.213 1.005 . . . . 71.15 108.474 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -135.07 131.14 36.62 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.905 -0.776 . . . . 73.53 108.905 175.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.48 132.95 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.652 . . . . 72.21 109.238 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 40.9 mt-30 -95.48 -35.04 11.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 122.562 0.345 . . . . 54.34 110.446 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 178.79 160.92 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.187 0.995 . . . . 75.11 110.766 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.24 118.61 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.542 -1.651 . . . . 54.22 106.542 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.438 ' HE1' HG13 ' D' ' 83' ' ' ILE . 9.9 p90 -140.7 141.88 34.91 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.298 0.639 . . . . 54.04 110.503 -173.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 41.1 p -76.85 119.68 20.94 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.658 -0.497 . . . . 72.33 109.658 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -93.84 -21.82 19.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.094 0.558 . . . . 62.11 109.928 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.72 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.4 t70 -153.91 137.06 15.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.378 1.071 . . . . 72.44 109.343 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.521 HD13 ' HE3' ' C' ' 117' ' ' MET . 30.1 mt -139.36 146.76 25.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 124.857 1.263 . . . . 74.54 107.682 174.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -154.13 137.9 16.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.328 0.651 . . . . 73.12 109.849 168.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 78.9 t80 -133.93 121.49 21.75 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 105.798 -1.927 . . . . 71.52 105.798 165.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -122.4 131.24 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.188 -0.671 . . . . 73.05 109.188 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.8 83.52 9.32 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 106.34 -1.726 . . . . 72.53 106.34 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.5 -37.54 69.93 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.732 2.288 . . . . 51.25 112.614 -167.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 0.7 OUTLIER -117.82 25.48 10.35 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.893 0.877 . . . . 74.21 109.247 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.595 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.42 -68.58 0.05 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 N-CA-C 117.413 2.375 . . . . 73.42 117.413 -167.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.74 -24.84 15.26 Favored 'Trans proline' 0 C--N 1.395 2.979 0 CA-C-N 122.777 2.028 . . . . 54.33 112.976 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 1.7 t60 -66.25 -35.11 79.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.894 1.277 . . . . 64.51 109.725 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' D' ' 73' ' ' ALA . 94.1 t -70.98 -39.9 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.707 -0.679 . . . . 73.24 111.604 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -65.71 -15.0 62.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.706 1.002 . . . . 64.35 113.706 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -66.73 -33.08 74.84 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.131 0.572 . . . . 74.41 110.581 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.459 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 44.9 mtpt -87.42 111.18 20.87 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.933 0.893 . . . . 65.21 108.594 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -99.7 99.32 10.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.256 1.023 . . . . 73.21 111.374 -173.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.595 ' CD2' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -156.7 -176.65 6.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.758 1.021 . . . . 74.35 113.758 -170.004 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -97.43 102.94 14.07 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 124.761 1.224 . . . . 75.31 112.975 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.536 ' HA ' HD21 ' D' ' 68' ' ' LEU . 75.2 Cg_exo -53.2 131.84 45.06 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 124.059 3.173 . . . . 73.24 115.32 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -98.15 115.44 28.29 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.048 -1.433 . . . . 62.54 107.177 170.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' D' ' 66' ' ' ALA . 31.9 m -98.64 143.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.605 0.762 . . . . 73.41 110.073 -176.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 83.1 tttt -107.22 130.54 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.168 0.987 . . . . 73.54 109.243 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -96.61 128.77 43.87 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.316 -1.364 . . . . 71.44 107.316 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.4 t70 -132.59 126.6 33.15 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.571 -1.27 . . . . 61.15 107.571 172.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.36 139.91 41.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.558 0.743 . . . . 64.03 110.764 -172.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.4 t70 -138.88 139.63 38.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.588 0.755 . . . . 63.43 109.003 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 46.6 p -108.11 144.07 35.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.691 0.796 . . . . 74.13 110.76 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.8 161.99 41.85 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.688 0.795 . . . . 61.43 109.653 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -170.9 156.41 4.97 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.113 0.965 . . . . 62.12 109.499 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 64.7 p -149.53 120.35 7.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.532 0.733 . . . . 44.55 109.154 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -69.99 118.35 12.72 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.389 -0.597 . . . . 75.23 109.389 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 -30.02 17.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.941 -0.572 . . . . 75.31 110.211 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.13 -179.89 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.6 -0.727 . . . . 53.42 110.601 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.35 130.44 40.74 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.926 -1.033 . . . . 63.45 108.538 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 69.21 2.24 3.57 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.395 1.478 . . . . 74.03 112.23 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.26 117.65 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.284 -0.636 . . . . 74.22 109.284 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.672 ' HB2' HD13 ' D' ' 86' ' ' ILE . 97.6 m-85 -128.37 130.13 47.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.036 -1.098 . . . . 74.11 108.036 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -90.91 135.85 33.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.68 -1.6 . . . . 41.44 106.68 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.95 131.67 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.042 0.937 . . . . 75.44 108.637 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 17.5 t -115.16 135.85 53.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.068 -0.716 . . . . 71.41 109.068 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.21 114.84 20.16 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.873 -1.158 . . . . 72.21 107.873 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.8 ttm180 -96.57 114.9 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.136 0.574 . . . . 73.31 110.01 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.49 122.26 55.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.638 -0.875 . . . . 73.44 108.638 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.8 m -115.32 128.65 56.24 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.276 0.631 . . . . 65.22 109.434 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.4 t -115.8 117.64 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.069 1.348 . . . . 73.21 109.342 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.5 m -119.03 95.21 4.72 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.741 -0.837 . . . . 74.4 108.741 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.572 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -98.05 135.0 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.998 -0.741 . . . . 75.45 108.998 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 39.9 p -163.82 135.73 4.88 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.869 0.731 . . . . 64.1 109.704 -173.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' D' ' 36' ' ' TRP . 4.7 mp -134.74 136.44 42.65 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.54 0.736 . . . . 72.03 110.701 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.66 -111.6 3.35 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.238 -0.745 . . . . 42.31 111.238 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.55 11.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.231 1.012 . . . . 75.5 109.588 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -139.82 144.11 37.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.04 0.536 . . . . 71.24 111.409 -163.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.1 m -67.53 140.54 57.0 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 124.298 1.039 . . . . 63.14 110.633 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.478 ' HA ' HG11 ' D' ' 31' ' ' VAL . . . -84.96 -69.48 0.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.748 -0.834 . . . . 72.35 108.748 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -154.91 148.45 25.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.623 -1.171 . . . . 73.51 109.074 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.2 mt -108.24 152.94 23.92 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.853 1.261 . . . . 55.13 108.979 172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.3 t -158.87 144.02 16.14 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.659 0.784 . . . . 52.33 109.002 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.857 -0.794 . . . . 44.22 108.857 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 78' ' ' VAL . . . . . 0.462 HG22 HG23 ' D' ' 21' ' ' ILE . 51.1 t -125.94 119.71 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.819 0.448 . . . . 74.3 110.054 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.72 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 62.0 mt-30 -89.5 91.79 8.85 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 109.02 -0.733 . . . . 75.21 109.02 166.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -81.1 101.64 9.74 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.889 -1.051 . . . . 63.41 108.391 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 171.39 44.16 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 111.442 -0.663 . . . . 41.03 111.442 175.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.56 131.59 1.96 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.433 -0.667 . . . . 71.11 111.433 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' D' ' 17' ' ' TYR . 32.7 mt -89.43 134.19 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 109.151 -0.685 . . . . 74.41 109.151 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.492 ' HB2' HD11 ' D' ' 86' ' ' ILE . 32.8 m-85 -133.63 162.29 32.33 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.3 0.64 . . . . 74.32 109.687 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 36.2 m -109.61 103.23 12.06 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.409 -0.96 . . . . 54.53 108.409 171.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.672 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.1 mp -107.15 117.57 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.999 0.92 . . . . 65.15 108.837 -176.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -149.8 164.55 35.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.738 0.815 . . . . 72.25 110.336 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.51 -0.98 59.11 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 116.103 1.201 . . . . 42.14 116.103 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.67 133.47 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.58 0.752 . . . . 73.11 109.737 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -133.61 154.23 51.05 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.866 0.866 . . . . 74.41 110.299 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.02 -110.59 2.75 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.23 0.956 . . . . 50.22 114.489 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 m -65.82 -41.04 92.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.359 1.064 . . . . 63.04 112.298 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -72.78 -36.73 67.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.781 0.432 . . . . 65.4 111.106 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -79.92 -23.93 41.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.531 0.205 . . . . 53.52 110.602 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -32.38 68.78 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.79 -0.448 . . . . 63.33 109.79 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -74.04 -45.45 49.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.546 0.738 . . . . 74.32 110.6 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -66.58 -51.6 54.67 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 122.743 0.417 . . . . 63.14 110.285 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.447 HD13 ' SG ' ' D' ' 102' ' ' CYS . 3.8 mm? -78.98 -19.11 52.44 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.959 0.503 . . . . 63.45 110.87 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.11 -1.98 64.59 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-O 119.775 -0.459 . . . . 74.22 114.154 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 -61.31 0.23 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.345 0.573 . . . . 73.51 111.135 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.41 -50.59 51.76 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.195 0.998 . . . . 74.24 113.278 -166.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 102' ' ' CYS . . . . . 0.447 ' SG ' HD13 ' D' ' 98' ' ' LEU . 22.1 m -68.1 -45.78 40.69 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.797 0.839 . . . . 63.11 112.202 -175.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.02 -24.28 45.51 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 121.54 1.494 . . . . 73.23 112.847 172.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -66.36 -32.62 74.12 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.457 0.703 . . . . 64.3 110.285 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.16 -46.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 54.04 110.193 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -75.9 -32.72 59.78 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.271 -0.877 . . . . 72.45 111.987 -172.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.629 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 75.7 t80 -59.76 -46.01 98.43 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.81 1.411 . . . . 65.31 114.81 -167.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.18 -33.11 91.15 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 121.919 1.746 . . . . 72.41 112.618 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -75.67 -34.91 60.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.645 0.778 . . . . 73.12 110.993 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.9 84.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.479 0.711 . . . . 61.51 110.06 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -60.66 -46.64 89.57 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.585 -1.189 . . . . 74.2 110.956 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.67 -38.33 83.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 62.24 111.117 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.49 -41.86 95.14 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.715 0.635 . . . . 62.4 110.14 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.59 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.5 mt -63.05 -56.19 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.21 0.944 . . . . 64.33 110.061 173.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.467 HG21 ' HE2' ' B' ' 109' ' ' TYR . 88.9 m -51.76 -45.13 63.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.971 1.308 . . . . 74.33 112.003 -172.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -66.4 -43.14 86.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.832 -1.076 . . . . 72.4 110.724 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 62.7 mtm -66.12 -34.61 78.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.945 0.498 . . . . 72.42 111.812 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -66.11 -42.75 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.155 -0.93 . . . . 71.43 109.913 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.9 p -72.49 -30.76 64.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.834 0.454 . . . . 74.45 111.392 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -69.83 -30.89 68.51 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.345 0.658 . . . . 63.54 110.167 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.06 11.16 65.79 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.492 -0.777 . . . . 64.14 112.613 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.409 HG23 ' HB3' ' C' ' 17' ' ' TYR . 75.7 p 59.27 13.98 3.38 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.865 2.066 . . . . 63.51 114.424 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -82.15 162.67 56.06 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 107.417 -1.327 . . . . 72.31 107.417 164.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.34 152.74 15.91 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.017 1.811 . . . . 74.12 112.444 -171.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -54.02 120.46 6.43 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.372 0.669 . . . . 51.52 110.906 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 48.7 tp -104.58 108.59 20.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.281 -1.007 . . . . 73.23 108.281 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 127' ' ' ASN . . . . . 0.465 ' HB3' HG13 ' B' ' 13' ' ' ILE . 57.9 m-20 -100.28 93.09 5.5 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.463 -0.94 . . . . 74.41 108.463 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.629 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.3 OUTLIER -61.61 137.48 58.25 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.079 1.352 . . . . 75.23 109.785 -178.545 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.28 129.3 83.23 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 123.902 0.881 . . . . 64.11 112.295 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.457 ' HD3' HD12 ' B' ' 13' ' ' ILE . 59.3 Cg_endo -76.13 117.63 4.72 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.717 1.612 . . . . 71.32 109.841 168.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 95.4 t -106.1 110.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.679 -0.86 . . . . 74.14 108.679 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 99.43 1.55 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.336 -0.847 . . . . 74.14 109.665 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 CA--C 1.538 0.514 0 CA-C-N 115.484 -0.78 . . . . 72.13 111.249 179.16 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.4 m . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 109.458 -0.571 . . . . 64.42 109.458 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 29.1 t80 -140.16 129.4 23.8 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.214 -1.032 . . . . 74.21 108.214 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -148.77 109.44 4.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.706 0.289 . . . . 75.54 110.744 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.669 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.2 mt -73.0 111.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.237 -0.653 . . . . 63.52 109.237 172.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -91.7 -27.46 18.07 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.82 0.7 . . . . 64.4 110.209 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -164.27 144.29 7.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 121.382 -0.127 . . . . 74.43 110.924 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -143.51 118.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.074 1.349 . . . . 71.14 108.72 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.8 p90 -166.63 176.66 7.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.864 0.84 . . . . 75.52 111.821 -163.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -103.55 112.36 25.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.712 -1.131 . . . . 62.22 108.582 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -76.83 -19.63 57.3 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 110.103 -0.332 . . . . 54.55 110.103 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.14 144.88 17.68 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.716 0.806 . . . . 65.45 109.646 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -135.22 145.47 31.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 124.993 1.317 . . . . 72.45 107.742 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.9 p -147.9 138.95 23.37 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.039 -0.726 . . . . 51.14 109.039 166.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 93.6 t80 -136.06 111.17 8.94 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.831 -1.914 . . . . 73.54 105.831 170.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.25 107.24 13.17 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.292 -0.633 . . . . 75.42 109.292 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.29 78.41 10.55 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 107.477 -1.305 . . . . 71.52 107.477 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.47 -34.74 5.48 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.155 1.903 . . . . 71.24 111.737 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -89.41 10.67 21.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.69 -0.686 . . . . 71.23 110.879 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.98 -57.59 9.9 Favored Pre-proline 0 CA--C 1.566 1.573 0 CA-C-O 117.455 -1.259 . . . . 73.32 113.426 -166.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -47.8 -41.88 31.24 Favored 'Trans proline' 0 C--N 1.403 3.411 0 C-N-CA 123.381 2.721 . . . . 63.33 113.885 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -100.95 -14.04 18.05 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.145 0.794 . . . . 74.22 113.145 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.529 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.6 -18.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.29 0.495 . . . . 73.52 110.582 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.25 -5.37 41.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.767 0.827 . . . . 72.44 111.689 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -99.95 -18.79 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.203 1.001 . . . . 71.41 111.18 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -67.57 150.19 49.13 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 75.21 111.912 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.39 134.83 55.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.581 0.753 . . . . 75.31 110.139 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -78.82 75.91 5.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.273 0.629 . . . . 75.01 112.101 -169.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -132.91 74.86 73.44 Favored Pre-proline 0 N--CA 1.48 1.033 0 N-CA-C 108.324 -0.991 . . . . 72.12 108.324 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.75 128.09 2.8 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.102 2.535 . . . . 74.43 112.113 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.72 98.47 11.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.312 -2.107 . . . . 72.1 105.312 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.8 t -91.78 102.04 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.312 -1.313 . . . . 75.52 108.997 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -78.91 148.08 32.84 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.572 0.749 . . . . 74.32 111.048 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.51 111.53 18.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.617 -1.253 . . . . 75.44 107.617 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.778 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -107.3 144.06 34.67 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.277 -1.008 . . . . 73.11 108.277 170.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.68 129.45 24.65 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.903 0.481 . . . . 54.54 109.918 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.65 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.1 m-20 -127.22 127.4 44.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.194 0.998 . . . . 74.45 109.317 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.9 p -118.17 122.83 44.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.56 1.144 . . . . 75.4 109.522 -175.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.97 147.28 31.52 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.082 0.553 . . . . 51.11 110.938 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 p -119.42 167.12 12.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.76 0.824 . . . . 74.35 110.014 170.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -156.07 153.16 28.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.617 1.167 . . . . 73.4 108.355 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -113.44 127.04 55.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.488 0.315 . . . . 64.03 110.349 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 57' ' ' GLU . 41.6 mt -93.65 -44.33 8.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.604 0.762 . . . . 64.34 110.495 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.1 -179.01 6.82 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.482 -1.235 . . . . 75.44 108.914 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.39 118.87 8.68 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 109.483 -0.562 . . . . 71.42 109.483 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 71.96 -4.61 1.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.707 1.603 . . . . 72.03 113.312 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 42.1 t -104.86 118.62 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.915 -0.772 . . . . 71.21 108.915 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -122.3 160.43 25.34 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.488 0.715 . . . . 73.14 110.676 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' HB2' HD11 ' A' ' 51' ' ' LEU . 8.1 tm-20 -132.71 136.87 46.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.318 -1.364 . . . . 73.51 107.318 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.418 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 86.3 t -126.49 125.88 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.449 -0.945 . . . . 73.3 108.449 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.4 t -101.71 136.94 31.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.159 0.584 . . . . 61.44 110.025 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -122.3 97.68 5.58 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.67 -1.604 . . . . 54.04 106.67 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.65 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 47.2 ttp180 -86.53 109.81 19.36 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 109.319 -0.622 . . . . 74.1 109.319 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.8 139.49 18.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.295 -1.372 . . . . 61.41 107.295 169.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.778 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 40.3 m -132.27 136.03 46.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.611 -0.885 . . . . 51.23 108.611 173.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.705 HG11 HD21 ' A' ' 126' ' ' LEU . 92.5 t -134.85 109.07 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.464 1.106 . . . . 72.44 108.421 -173.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.3 m -106.05 137.22 44.35 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 108.684 -0.858 . . . . 75.55 108.684 174.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.39 123.57 38.24 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.021 -0.733 . . . . 63.11 109.021 176.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 63.8 m -132.14 125.45 31.29 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.768 0.427 . . . . 72.13 110.143 175.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -89.39 84.41 6.44 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.239 -1.393 . . . . 75.01 107.239 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.98 -98.86 1.23 Allowed Glycine 0 C--N 1.344 1.011 0 CA-C-N 114.245 -1.343 . . . . 35.22 110.93 -170.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -104.88 -25.87 12.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.299 1.04 . . . . 64.51 110.253 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.88 106.13 17.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 75.14 110.277 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.77 130.31 42.46 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.506 0.669 . . . . 70.31 111.248 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.53 -60.76 2.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.898 -1.046 . . . . 73.13 109.724 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -155.82 162.98 40.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.956 -1.02 . . . . 72.4 111.478 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -135.9 111.32 9.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.55 1.14 . . . . 74.03 108.465 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.43 124.05 48.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.25 1.02 . . . . 64.11 109.865 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -135.54 119.01 16.87 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.211 -0.663 . . . . 65.44 109.211 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.96 110.36 21.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.912 0.885 . . . . 64.3 109.132 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -83.91 82.8 8.18 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.396 -1.335 . . . . 75.51 107.396 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 60.7 tp60 -76.91 94.51 3.94 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.624 -0.88 . . . . 53.25 108.624 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.15 149.79 19.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.3 -0.864 . . . . 73.01 111.754 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 134.76 5.12 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.802 -0.519 . . . . 63.22 111.802 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' B' ' 29' ' ' PRO . 63.8 mt -81.72 123.86 38.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.941 -0.763 . . . . 63.52 108.941 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.669 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.3 m-85 -132.78 117.14 17.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.792 -1.188 . . . . 75.52 107.792 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 t -77.93 93.84 4.48 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.565 -0.902 . . . . 71.45 108.565 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.5 mt -104.34 131.61 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.862 -0.792 . . . . 75.11 108.862 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -153.34 162.65 41.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.721 0.808 . . . . 63.25 110.133 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.2 -28.92 8.12 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.938 -0.573 . . . . 73.12 114.521 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.79 140.9 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.448 0.699 . . . . 70.21 111.636 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.19 176.03 10.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.15 0.98 . . . . 63.24 108.6 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.59 -135.82 23.93 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.561 -0.577 . . . . 33.54 112.055 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 48.1 p -71.85 -14.99 62.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 72.21 111.729 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -74.25 -57.43 3.95 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.173 0.989 . . . . 75.52 110.253 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.7 ttt -80.27 -15.32 57.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.821 -0.172 . . . . 71.42 110.648 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -62.57 -39.66 94.4 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.884 0.373 . . . . 71.15 110.108 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.559 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.7 t-80 -77.3 -19.54 56.29 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.878 -0.601 . . . . 63.54 110.988 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.6 -61.05 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.813 -0.554 . . . . 74.14 110.278 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.46 -45.5 72.29 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.873 0.869 . . . . 70.4 111.702 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.69 6.38 79.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.116 -0.825 . . . . 34.33 114.559 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.683 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.37 -61.71 0.22 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.117 0.958 . . . . 62.13 112.714 -175.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 87.5 t80 -78.32 -55.46 5.22 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.036 1.124 . . . . 71.54 114.036 -164.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.5 m -70.21 -33.06 3.1 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 114.048 1.129 . . . . 74.32 114.048 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.4 Cg_endo -63.8 -16.8 56.91 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.039 1.826 . . . . 62.43 113.149 167.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -71.98 -14.95 62.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.59 . . . . 53.21 110.825 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 13' ' ' ILE . 36.0 mm -84.11 -41.8 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.848 0.832 . . . . 72.33 109.855 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 76.0 mt -76.35 -44.38 36.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.251 -1.341 . . . . 74.01 111.598 -171.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -59.82 -41.35 85.13 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 113.706 1.002 . . . . 74.03 113.706 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.96 -44.73 33.01 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.12 1.88 . . . . 72.44 113.375 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' C' ' 108' ' ' PRO . 26.7 m-85 -73.7 -24.06 59.88 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.989 0.516 . . . . 72.45 111.997 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -51.69 23.28 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.832 -0.803 . . . . 61.24 108.832 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -50.91 -46.78 60.8 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.944 1.402 . . . . 73.01 110.488 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -65.36 -42.02 93.22 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 124.765 1.291 . . . . 74.04 111.073 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.5 t -62.26 -45.43 93.35 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.739 0.649 . . . . 73.15 110.188 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.56 -43.0 98.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 O-C-N 124.267 0.98 . . . . 74.55 110.105 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.5 m -57.14 -44.06 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.824 0.85 . . . . 65.25 110.552 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 14.6 t -67.77 -47.7 68.47 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.071 -0.968 . . . . 65.33 110.589 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.7 mtp -57.11 -48.58 78.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 71.44 111.502 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.81 -43.44 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.069 1.348 . . . . 54.15 110.859 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -67.51 -33.61 75.43 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.795 0.838 . . . . 75.32 111.59 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 116' ' ' SER . 37.0 mtt180 -72.13 -29.63 64.25 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.428 0.691 . . . . 74.33 110.659 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.87 14.25 38.6 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.498 -0.612 . . . . 75.5 113.555 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 57.51 22.48 8.13 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.105 1.762 . . . . 41.33 113.329 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.22 156.51 48.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 73.43 108.759 171.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.71 151.98 81.52 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.813 2.342 . . . . 53.45 111.755 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.592 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.9 tt0 -53.99 127.74 27.64 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.976 0.797 . . . . 53.43 111.569 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 64' ' ' VAL . 16.5 tp -110.71 101.15 9.81 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.21 -0.904 . . . . 73.43 109.825 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -107.48 100.07 9.53 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.377 -1.342 . . . . 74.12 107.377 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.77 121.38 14.43 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.492 -0.558 . . . . 64.12 109.492 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -50.63 129.82 27.0 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.119 0.968 . . . . 62.01 112.219 -170.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 46.5 Cg_endo -84.1 115.86 2.05 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.678 2.252 . . . . 61.34 113.07 -175.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.65 141.43 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.573 -0.899 . . . . 73.14 108.573 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.34 72.43 4.86 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.37 -0.974 . . . . 71.55 108.37 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.46 -35.74 75.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.818 1.247 . . . . 72.02 110.586 -172.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.683 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.0 p-10 . . . . . 0 CA--C 1.546 0.824 0 CA-C-N 114.655 -1.157 . . . . 72.43 111.511 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.241 0.639 0 N-CA-C 107.377 -1.342 . . . . 51.31 107.377 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.86 156.69 44.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.807 0.813 . . . . 74.02 110.957 161.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.1 pm0 -126.43 132.67 51.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 113.644 -1.616 . . . . 65.33 107.722 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.414 ' O ' HG13 ' B' ' 13' ' ' ILE . 35.5 pt -76.89 108.68 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.497 -0.774 . . . . 72.13 109.136 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -74.93 -46.68 34.04 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.611 -0.515 . . . . 73.31 109.611 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -162.04 135.62 6.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 110.28 -0.267 . . . . 70.45 110.28 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.9 mt -116.74 131.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 106.147 -1.797 . . . . 73.35 106.147 170.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -164.01 141.58 7.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.644 0.378 . . . . 65.32 110.975 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 45.2 m -72.34 116.89 13.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.726 -0.842 . . . . 74.13 108.726 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -84.99 -40.28 17.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.944 -0.571 . . . . 71.12 110.458 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 11.6 t70 -145.62 144.2 30.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.108 -0.496 . . . . 63.21 111.081 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.533 HD11 ' SG ' ' B' ' 113' ' ' CYS . 32.2 mm -137.15 145.85 29.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.277 1.431 . . . . 65.52 108.487 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.552 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 26.7 t -146.25 138.86 25.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.284 -1.326 . . . . 22.52 107.434 176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -155.92 143.12 19.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.024 -1.102 . . . . 73.53 108.024 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.3 mt-10 -143.6 155.59 44.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.733 1.213 . . . . 70.43 108.716 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -151.27 86.09 4.85 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 107.878 -1.156 . . . . 60.01 107.878 172.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.5 -43.22 4.31 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.779 2.319 . . . . 71.13 113.006 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -105.0 29.02 6.66 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.018 0.527 . . . . 70.34 109.893 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.54 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.55 -54.06 25.42 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.866 1.266 . . . . 42.44 113.233 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HA ' HD11 ' A' ' 83' ' ' ILE . 2.5 Cg_endo -80.35 -20.44 8.36 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 121.527 1.485 . . . . 60.22 112.77 -176.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 51.5 m-70 -97.41 2.66 50.68 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.405 1.082 . . . . 60.32 112.686 -175.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.25 -15.12 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.62 0.768 . . . . 75.2 112.08 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -84.94 -27.11 26.78 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.606 0.762 . . . . 73.12 112.836 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 2.9 pt20 -75.69 -29.43 59.01 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.591 0.356 . . . . 72.45 111.626 -172.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.433 ' HB2' ' CZ2' ' B' ' 36' ' ' TRP . 38.1 mtpt -108.85 117.44 34.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.726 1.21 . . . . 52.33 108.707 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -89.71 117.41 28.55 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.458 0.572 . . . . 75.23 110.857 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.472 ' CZ2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -171.39 162.5 6.72 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 123.982 0.913 . . . . 71.53 112.916 -178.398 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -93.24 132.72 29.89 Favored Pre-proline 0 N--CA 1.485 1.322 0 C-N-CA 124.328 1.051 . . . . 64.2 109.997 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.44 147.39 36.48 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.25 1.966 . . . . 73.21 112.83 171.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.23 109.65 16.7 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.845 -1.169 . . . . 62.4 107.845 163.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.24 123.21 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.731 -0.668 . . . . 61.21 109.422 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.3 142.24 35.41 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.776 0.83 . . . . 71.31 109.555 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.601 HD11 HD21 ' B' ' 128' ' ' LEU . 3.7 tt -106.52 134.98 48.83 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.962 -1.496 . . . . 61.1 106.962 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 4.7 m-20 -128.42 114.55 16.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.215 -1.032 . . . . 60.21 108.215 -177.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.17 127.2 46.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.239 -1.393 . . . . 73.53 107.239 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -137.66 147.12 44.62 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.453 0.701 . . . . 73.23 109.199 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.1 p -121.82 128.85 52.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.412 0.685 . . . . 63.41 110.217 -173.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' ALA . . . . . 0.41 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -131.57 137.3 48.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.044 -1.095 . . . . 63.44 108.044 174.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.7 p -144.6 163.17 34.72 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.132 0.491 . . . . 55.32 110.559 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.88 173.09 15.79 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.065 -0.97 . . . . 75.53 108.845 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -120.51 125.14 47.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.801 0.44 . . . . 73.51 110.25 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.1 mt -87.45 -46.56 9.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.397 0.679 . . . . 72.43 109.459 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.25 -174.33 4.93 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.209 -0.905 . . . . 54.24 111.059 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.79 120.72 13.01 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.5 -0.773 . . . . 72.22 110.197 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 70.02 -5.48 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.522 1.529 . . . . 75.21 112.542 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -102.43 111.62 32.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.728 -0.842 . . . . 73.31 108.728 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -119.79 139.93 51.56 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.597 -0.729 . . . . 64.32 109.861 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.581 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.9 tm-20 -104.05 97.13 7.15 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.694 -1.595 . . . . 70.22 106.694 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -92.62 118.72 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.864 0.866 . . . . 74.02 109.533 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.61 119.23 51.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 123.632 0.773 . . . . 64.31 110.033 176.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.23 109.14 20.97 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.096 -1.076 . . . . 64.34 108.096 172.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.7 122.95 33.91 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.351 -0.611 . . . . 74.42 109.351 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.43 124.99 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 107.985 -1.117 . . . . 71.43 107.985 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 12.4 m -119.7 138.53 53.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.579 0.752 . . . . 71.45 109.227 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.533 HG23 HD13 ' B' ' 114' ' ' ILE . 51.6 t -122.0 128.78 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 123.932 0.893 . . . . 62.13 109.164 175.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -118.84 144.28 46.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.576 -0.898 . . . . 75.02 108.576 171.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.81 133.79 30.86 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.66 -0.867 . . . . 71.23 108.66 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.4 p -149.88 140.11 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.883 0.473 . . . . 74.15 110.321 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -137.41 144.3 42.33 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.597 1.159 . . . . 71.33 109.228 -171.154 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.86 -108.06 1.95 Allowed Glycine 0 C--N 1.347 1.143 0 O-C-N 123.341 0.401 . . . . 74.14 113.81 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -116.05 1.17 13.2 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.226 1.01 . . . . 74.34 110.11 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.88 177.98 7.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.002 0.742 . . . . 72.24 113.002 -169.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 140.34 29.68 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.419 1.088 . . . . 55.12 109.808 171.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -80.44 -67.58 0.76 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.106 0.962 . . . . 71.22 109.477 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -159.3 157.79 31.19 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.146 -1.388 . . . . 62.53 109.472 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.98 150.51 47.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.608 1.163 . . . . 75.54 108.22 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.5 t -157.96 152.02 24.24 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.44 -0.578 . . . . 71.14 109.44 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -164.85 131.51 2.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.147 -0.686 . . . . 62.41 109.147 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -124.23 146.39 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.771 -0.826 . . . . 72.34 108.771 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -125.09 98.26 5.59 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.939 . . . . 75.32 108.463 171.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 63.4 tp60 -86.52 102.08 13.78 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.445 -0.798 . . . . 44.12 109.186 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.62 148.66 20.61 Favored Glycine 0 C--O 1.24 0.516 0 N-CA-C 111.189 -0.765 . . . . 62.02 111.189 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -152.38 125.46 1.82 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.889 -0.885 . . . . 71.2 110.889 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.581 HG12 ' HG2' ' B' ' 57' ' ' GLU . 38.0 mt -88.94 117.22 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.113 -0.699 . . . . 70.41 109.113 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -122.27 131.37 53.88 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.195 -1.409 . . . . 72.22 107.195 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.7 m -97.62 88.87 4.47 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.216 -1.031 . . . . 73.43 108.216 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' B' ' 89' ' ' ILE . 4.4 pt -95.67 121.98 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.24 -1.346 . . . . 75.42 110.028 -169.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.46 159.68 40.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.924 0.889 . . . . 45.42 109.89 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.19 -56.55 3.6 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.989 -0.55 . . . . 62.42 111.957 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.3 pp -58.5 153.04 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.152 0.981 . . . . 75.25 113.308 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -169.28 146.5 3.54 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.842 -1.072 . . . . 70.52 108.43 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -130.45 13.13 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 120.028 -0.318 . . . . 62.12 113.465 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -65.8 -33.22 75.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.479 1.111 . . . . 35.05 110.883 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.83 -40.54 97.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.202 -0.908 . . . . 74.3 110.561 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 23.0 ttt -76.93 -31.73 56.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.808 -0.633 . . . . 70.11 110.438 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.05 -21.3 66.37 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.877 -0.602 . . . . 65.32 111.517 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 33.7 t-80 -84.71 -37.0 21.47 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.22 0.608 . . . . 73.1 110.552 169.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.47 -67.2 0.45 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.482 0.313 . . . . 61.15 111.38 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -12.79 42.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.383 0.512 . . . . 72.51 112.383 -176.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.03 -4.97 53.9 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-O 119.715 -0.492 . . . . 53.43 113.82 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -141.43 -58.41 0.49 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.185 0.493 . . . . 74.31 111.753 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -75.28 -44.61 44.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.2 0.6 . . . . 72.1 111.922 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.9 m -67.21 -44.68 49.23 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 118.572 -0.728 . . . . 71.03 111.721 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -57.16 -36.27 99.1 Favored 'Trans proline' 0 C--N 1.397 3.088 0 C-N-CA 122.435 2.09 . . . . 64.14 113.143 168.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -61.87 -35.91 79.72 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.389 0.676 . . . . 60.44 110.429 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -48.02 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.328 0.651 . . . . 74.1 110.752 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.422 HD21 ' HA3' ' B' ' 82' ' ' GLY . 96.5 mt -74.26 -21.12 59.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.188 0.595 . . . . 65.02 112.24 -173.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.573 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 50.0 t80 -60.64 -52.32 73.48 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-O 117.143 -1.408 . . . . 65.22 113.578 -171.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.88 -35.58 80.34 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.204 1.936 . . . . 55.21 113.267 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -68.81 -49.87 54.9 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.683 0.793 . . . . 74.42 110.548 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.54 92.0 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.574 0.749 . . . . 50.41 111.087 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -57.23 -62.09 2.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.236 1.814 . . . . 73.34 111.7 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 112' ' ' GLU . . . . . 0.466 ' HG2' ' NH2' ' C' ' 120' ' ' ARG . 13.7 tp10 -70.34 -23.89 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.498 0.719 . . . . 72.41 110.709 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.533 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.1 t -69.97 -35.84 74.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.683 -0.199 . . . . 61.43 110.632 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.533 HD13 HG23 ' B' ' 64' ' ' VAL . 61.7 mt -63.82 -54.86 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.048 -0.723 . . . . 72.44 109.048 171.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.6 m -56.62 -34.69 67.5 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.382 1.073 . . . . 61.32 112.072 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -66.64 -45.01 80.41 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.644 -0.707 . . . . 71.04 110.43 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 13.7 mmt -71.2 -33.93 70.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.498 0.499 . . . . 52.03 111.165 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.61 -44.0 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.833 0.853 . . . . 63.22 109.746 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -72.0 -25.48 61.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.35 -0.841 . . . . 65.34 111.399 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -72.94 -27.51 61.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.877 0.471 . . . . 74.33 109.883 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.71 38.6 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.837 0.711 . . . . 52.11 112.756 169.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.9 p 54.86 46.6 24.13 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 125.888 1.675 . . . . 74.53 112.253 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -108.8 158.5 33.95 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.523 1.129 . . . . 63.1 109.099 174.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.93 -163.21 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.073 2.515 . . . . 71.21 113.696 -174.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 21.6 tp60 -64.08 130.38 43.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.724 0.81 . . . . 65.03 112.098 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 29.9 tp -130.5 85.09 2.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.141 0.576 . . . . 74.52 109.615 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -91.01 115.55 28.1 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.623 -0.88 . . . . 74.34 108.623 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.601 HD21 HD11 ' B' ' 42' ' ' LEU . 1.6 tt -77.12 140.22 40.18 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.841 -1.17 . . . . 71.44 107.841 173.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.77 148.31 79.13 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.143 0.577 . . . . 71.45 111.057 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.87 109.67 0.48 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.576 2.184 . . . . 65.4 112.354 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.84 110.37 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.747 -0.834 . . . . 42.12 108.747 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -90.31 85.44 6.21 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.724 -0.843 . . . . 64.13 108.724 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 123.921 0.889 . . . . 74.44 111.525 179.243 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.52 0.676 . . . . 72.21 112.379 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -122.45 97.12 5.32 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -105.59 129.3 53.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.446 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 12' ' ' GLN . . . . . 0.622 ' HG2' ' HB2' ' C' ' 85' ' ' SER . 0.7 OUTLIER -137.71 108.87 6.8 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.401 0.681 . . . . 63.14 109.254 173.521 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.7 120.07 13.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.222 -0.899 . . . . 63.32 108.626 171.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -86.15 -49.91 7.39 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.685 -0.689 . . . . 70.22 109.9 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -171.69 129.41 0.66 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.174 -0.467 . . . . 65.42 109.893 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.21 143.88 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.197 -1.409 . . . . 72.33 107.197 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.488 ' HE1' HG12 ' C' ' 83' ' ' ILE . 15.7 p90 -175.73 151.4 1.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.315 0.579 . . . . 71.55 110.444 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -76.6 107.12 8.67 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.622 -0.881 . . . . 72.12 108.622 171.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -70.48 -29.73 66.35 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.008 -0.738 . . . . 72.53 109.008 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.756 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -145.84 140.51 27.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.26 -0.882 . . . . 53.42 110.687 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.4 mt -134.66 144.98 33.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.275 -1.75 . . . . 62.32 106.275 170.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.0 t -159.68 151.77 20.71 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.484 0.659 . . . . 54.34 110.674 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 80.7 t80 -149.36 109.7 4.18 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.335 -1.357 . . . . 75.14 107.335 171.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.3 119.17 35.41 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.98 -0.748 . . . . 64.12 108.98 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.07 79.62 12.98 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.626 -0.879 . . . . 65.53 108.626 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.17 -12.53 25.62 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.815 2.343 . . . . 72.11 111.409 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -103.97 13.25 33.05 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.453 1.101 . . . . 51.41 109.357 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.02 96.0 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.613 1.338 . . . . 65.12 114.613 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.402 ' HA ' HH21 ' D' ' 15' ' ' ARG . 24.0 Cg_exo -65.24 -39.72 22.09 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.624 1.549 . . . . 62.43 112.181 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -68.76 -41.59 78.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.977 -1.011 . . . . 71.25 112.359 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.435 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 13.5 p -70.94 -25.83 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.065 0.394 . . . . 71.43 112.065 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -69.63 -12.16 61.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.668 0.787 . . . . 75.11 112.173 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -128.47 22.84 5.95 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.584 0.753 . . . . 71.45 110.635 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.6 ' HE3' HD21 ' C' ' 68' ' ' LEU . 31.9 ttpt -109.1 168.1 9.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.934 0.894 . . . . 75.35 110.626 -174.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.67 125.23 19.03 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.942 1.297 . . . . 65.02 112.243 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -85.53 68.21 10.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.955 0.902 . . . . 72.34 111.39 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -149.3 71.65 10.02 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 109.379 -0.6 . . . . 75.24 109.379 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.03 143.19 4.0 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.673 2.249 . . . . 63.02 112.023 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -88.06 91.6 8.83 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.61 -1.256 . . . . 75.53 107.61 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.41 129.02 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.662 -0.866 . . . . 55.3 108.662 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.77 118.24 22.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.394 0.678 . . . . 71.1 109.222 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -87.17 119.76 27.74 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.423 -1.325 . . . . 65.41 107.423 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.73 114.35 19.81 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.959 -0.756 . . . . 74.42 108.959 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.83 150.11 24.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.38 0.672 . . . . 73.32 109.284 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.729 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 6.5 t70 -148.02 150.93 34.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.345 1.058 . . . . 74.42 109.158 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -119.34 131.12 55.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.886 0.874 . . . . 54.42 110.272 -174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -134.57 145.77 49.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 64.13 109.509 174.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -151.89 146.05 25.36 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.734 . . . . 74.14 110.262 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.8 p -148.09 137.09 21.96 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.556 0.742 . . . . 75.43 109.93 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -83.58 116.62 22.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.096 -0.705 . . . . 70.32 109.096 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' C' ' 57' ' ' GLU . 43.7 mt -93.91 -34.02 13.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.453 0.701 . . . . 54.1 109.933 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.71 -173.99 4.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.896 . . . . 73.54 110.101 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.95 116.39 5.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.32 -0.854 . . . . 75.15 110.188 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 70.28 -5.85 1.26 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.559 1.543 . . . . 44.3 113.129 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -94.76 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.724 -0.843 . . . . 75.33 108.724 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -124.62 126.18 45.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.518 1.127 . . . . 75.53 108.748 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.593 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.1 tt0 -82.21 116.17 21.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.051 -0.977 . . . . 71.55 108.783 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -97.23 122.82 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.597 -1.26 . . . . 63.21 107.597 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 92.5 t -115.85 132.81 64.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.536 -0.912 . . . . 73.45 108.536 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.94 102.59 9.49 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.343 -1.354 . . . . 60.2 107.343 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.729 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.2 tmt_? -82.59 110.03 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.226 1.01 . . . . 74.13 108.481 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.5 t -102.57 136.88 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.92 -1.141 . . . . 64.35 107.92 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -140.03 116.54 10.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.217 -0.66 . . . . 72.12 109.217 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 78.4 t -102.35 109.09 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.793 -1.094 . . . . 71.22 108.1 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.0 m -98.67 150.68 21.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.623 -1.171 . . . . 71.34 109.301 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.94 111.24 7.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 74.24 107.141 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -144.39 127.08 16.16 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.621 -0.511 . . . . 33.32 109.621 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.645 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -90.29 60.5 4.76 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.283 1.039 . . . . 71.22 108.798 176.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 -122.7 6.41 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 114.063 -1.426 . . . . 43.15 110.517 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.86 -23.93 19.5 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.449 -0.945 . . . . 73.12 108.449 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.11 115.89 5.94 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.424 1.09 . . . . 72.21 109.722 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -85.73 140.19 30.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.427 . . . . 63.34 111.085 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.37 -61.54 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.962 0.905 . . . . 41.4 109.058 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -164.47 176.42 9.03 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.454 0.702 . . . . 71.12 110.653 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -141.57 143.9 33.96 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.934 -1.135 . . . . 54.14 107.934 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.501 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.7 t -147.17 129.83 16.02 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.558 0.743 . . . . 65.04 109.113 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -132.15 139.6 48.47 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.344 0.658 . . . . 71.13 110.407 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.97 114.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.526 1.13 . . . . 65.44 108.365 172.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.756 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -92.31 93.62 8.73 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 75.43 108.849 171.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 80' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 69.9 tp60 -80.04 105.39 11.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.407 -0.815 . . . . 75.53 110.073 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.06 155.0 27.06 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.917 -0.583 . . . . 73.24 112.08 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 82' ' ' GLY . . . . . 0.487 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.57 116.22 0.71 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.703 -0.959 . . . . 73.22 110.703 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.511 HD12 HD11 ' C' ' 51' ' ' LEU . 15.3 mm -81.41 122.73 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.192 -1.04 . . . . 75.03 108.192 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -132.68 142.07 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 85' ' ' SER . . . . . 0.622 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 38.3 m -109.8 121.47 45.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.633 -1.247 . . . . 72.2 107.633 169.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.505 ' HB ' HD11 ' C' ' 89' ' ' ILE . 1.9 pp -121.49 141.41 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.873 0.869 . . . . 75.44 110.852 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.76 164.22 36.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.003 0.921 . . . . 74.1 109.645 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.64 -19.11 34.56 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 114.092 0.397 . . . . 71.51 114.092 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' C' ' 86' ' ' ILE . 0.8 OUTLIER -101.91 141.88 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.76 1.224 . . . . 64.24 110.581 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -156.15 148.24 23.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.591 0.757 . . . . 74.02 110.068 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.18 -146.06 35.69 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.27 -0.423 . . . . 73.32 112.874 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -67.83 -21.54 65.2 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.481 0.712 . . . . 72.45 111.357 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -65.6 -36.74 84.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.588 0.755 . . . . 71.35 110.926 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.505 ' HG3' HD13 ' C' ' 89' ' ' ILE . 28.1 ttt -70.42 -29.92 66.65 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 116.288 -0.415 . . . . 62.2 110.883 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.82 69.02 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.313 0.645 . . . . 54.44 111.679 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 50.1 t-80 -74.14 -26.93 60.61 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.154 0.582 . . . . 72.52 110.816 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -81.18 -60.68 2.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.511 0.324 . . . . 33.42 110.712 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.487 HD23 ' HG2' ' C' ' 94' ' ' MET . 4.6 pp -73.23 -36.96 66.52 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.257 0.623 . . . . 63.12 111.695 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 99' ' ' GLY . . . . . 0.436 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -90.95 -14.65 57.54 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 114.3 0.48 . . . . 72.15 114.3 -170.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -127.09 -58.16 1.29 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.725 0.41 . . . . 64.12 111.579 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.8 -45.24 75.36 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.602 0.361 . . . . 44.41 111.935 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -63.94 -45.52 80.65 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.641 -0.695 . . . . 73.21 112.124 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.63 -39.73 81.97 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.559 2.173 . . . . 72.43 113.87 165.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.9 -18.75 65.55 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.826 0.451 . . . . 61.32 112.202 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mm -86.66 -45.94 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.254 0.622 . . . . 73.41 110.537 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.487 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.7 mt -79.85 -43.53 22.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.936 0.717 . . . . 60.31 112.936 -168.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.4 -42.08 89.87 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.239 1.016 . . . . 73.13 113.041 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 108' ' ' PRO . . . . . 0.586 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 69.9 Cg_exo -44.36 -46.97 11.34 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.628 2.219 . . . . 54.23 115.091 169.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 109' ' ' TYR . . . . . 0.417 ' HE2' HG21 ' A' ' 115' ' ' THR . 53.0 m-85 -69.64 -42.21 74.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.155 0.582 . . . . 72.31 111.252 -177.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 110' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.82 -29.8 69.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.705 -0.679 . . . . 60.12 111.354 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.619 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 34.7 ttp180 -56.08 -58.27 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 123.93 0.769 . . . . 74.22 111.179 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -73.5 -32.69 64.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.258 0.623 . . . . 75.2 110.338 -176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 113' ' ' CYS . . . . . 0.495 ' SG ' HG12 ' C' ' 21' ' ' ILE . 36.2 t -62.54 -34.68 77.42 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.396 0.678 . . . . 61.44 111.865 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' C' ' 62' ' ' VAL . 96.7 mt -71.36 -47.16 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.608 0.763 . . . . 75.02 110.206 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -64.7 -28.32 69.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.327 0.651 . . . . 63.52 111.852 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -68.28 -39.97 81.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.581 0.753 . . . . 72.13 110.011 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.636 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.06 -41.11 95.41 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.729 0.811 . . . . 73.34 111.105 175.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.24 -34.14 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.831 0.852 . . . . 72.32 110.246 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 119' ' ' SER . . . . . 0.461 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 42.0 t -65.59 -43.04 90.91 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.57 -0.741 . . . . 52.25 110.98 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.466 ' NH2' ' HG2' ' B' ' 112' ' ' GLU . 91.3 mtt-85 -72.28 -21.28 61.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.22 -0.9 . . . . 74.02 111.439 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.65 -1.04 87.7 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.79 -0.45 . . . . 24.51 113.365 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.444 HG23 ' HB3' ' D' ' 17' ' ' TYR . 30.2 p 59.66 43.09 16.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.507 1.523 . . . . 64.23 111.489 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -119.69 141.11 30.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.733 0.813 . . . . 71.41 110.033 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 13.1 Cg_endo -53.09 107.16 0.18 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.729 2.953 . . . . 71.21 112.898 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -55.74 143.21 31.63 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.058 1.343 . . . . 73.53 113.52 -170.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tt -134.61 114.65 12.99 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.787 -1.19 . . . . 71.21 107.787 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -92.12 126.24 37.13 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.395 -0.965 . . . . 75.52 108.395 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.619 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.0 mm? -66.67 148.33 52.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.667 0.787 . . . . 72.21 111.447 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.92 153.4 60.33 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 123.356 0.663 . . . . 74.42 110.86 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.529 ' HG2' HG21 ' A' ' 13' ' ' ILE . 6.3 Cg_exo -76.9 125.53 8.12 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.301 2.668 . . . . 75.24 112.295 -172.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.37 110.6 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.13 0.572 . . . . 65.23 109.493 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.3 93.89 9.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 62.32 109.451 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -76.57 -33.11 58.5 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.36 0.6 . . . . 75.31 109.592 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 N--CA 1.471 0.619 0 CA-C-N 114.885 -1.052 . . . . 51.42 111.503 -178.424 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' D' D ' 10' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 57.5 m . . . . . 0 C--O 1.237 0.427 0 N-CA-C 109.45 -0.574 . . . . 75.32 109.45 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -157.47 105.77 2.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.492 -1.299 . . . . 53.23 107.492 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -125.26 119.19 27.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 74.12 109.257 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mt -73.4 114.93 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 107.837 -1.171 . . . . 65.53 107.837 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.91 -45.54 16.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.27 -0.641 . . . . 74.05 109.27 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' C' ' 29' ' ' PRO . 16.6 ptt180 -174.04 159.73 3.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.025 0.93 . . . . 71.12 109.897 172.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.489 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -130.03 143.2 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.375 1.07 . . . . 65.2 108.128 174.583 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' C' ' 122' ' ' THR . 31.0 p90 -170.26 172.27 6.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.933 0.873 . . . . 75.14 110.988 -169.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.414 HG21 HD11 ' D' ' 21' ' ' ILE . 81.4 p -98.74 115.77 29.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.507 -1.224 . . . . 73.0 109.56 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -87.69 -23.42 24.19 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.356 -0.609 . . . . 74.15 109.356 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.1 t70 -151.23 134.56 16.11 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.553 -1.203 . . . . 63.11 109.338 175.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.636 HD13 ' HE3' ' C' ' 117' ' ' MET . 72.0 mt -129.45 138.39 54.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.562 -1.273 . . . . 64.22 107.562 171.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -143.08 128.47 18.91 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.107 -1.071 . . . . 72.23 108.107 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 56.6 t80 -138.0 113.63 9.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.653 -1.98 . . . . 72.3 105.653 167.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.36 138.54 54.21 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.373 -0.603 . . . . 74.31 109.373 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -143.53 77.06 15.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.436 -1.32 . . . . 55.14 107.436 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.46 -45.44 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.664 2.243 . . . . 51.02 111.901 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.48 30.09 1.82 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.442 1.097 . . . . 73.0 108.78 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -59.47 -57.45 26.81 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 124.112 0.965 . . . . 65.51 112.702 -172.374 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -76.88 -12.19 17.97 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.468 1.56 . . . . 71.43 112.163 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -78.19 -41.65 33.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.02 1.328 . . . . 72.31 109.982 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -79.32 -32.48 14.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-O 118.812 -0.613 . . . . 73.03 110.097 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -50.95 -28.67 10.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.094 0.872 . . . . 73.43 113.197 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.43 -38.01 89.48 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.442 0.697 . . . . 71.34 111.141 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.48 ' HD2' ' O ' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -132.5 64.07 1.61 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.639 0.776 . . . . 72.15 110.202 168.692 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -112.16 95.98 5.77 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.795 0.807 . . . . 74.22 110.152 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -123.01 -157.45 0.75 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.044 1.738 . . . . 63.14 106.804 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 37' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 15.9 pm0 -50.87 106.28 0.63 Allowed Pre-proline 0 CA--C 1.567 1.618 0 C-N-CA 123.386 0.674 . . . . 75.42 111.915 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 4.7 Cg_exo -78.06 147.32 23.66 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.737 2.291 . . . . 51.31 112.295 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.4 110.98 5.63 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 107.243 -1.392 . . . . 74.53 107.243 168.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.74 114.81 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.539 -0.755 . . . . 63.3 110.18 -169.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.56 138.49 32.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.109 0.964 . . . . 55.22 109.767 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 42' ' ' LEU . . . . . 0.47 HD12 HD21 ' D' ' 128' ' ' LEU . 6.2 tt -98.8 131.91 44.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.331 -1.359 . . . . 74.14 107.331 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -132.33 147.14 52.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.865 -0.791 . . . . 75.04 108.865 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.16 139.39 49.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.251 0.62 . . . . 73.45 110.394 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 12.1 t70 -137.43 135.27 36.74 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.109 -1.071 . . . . 75.51 108.109 170.549 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -113.42 144.4 42.87 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 65.13 109.584 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.16 155.1 39.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.355 0.662 . . . . 63.32 110.197 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 73.6 p -164.72 153.14 12.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.191 0.596 . . . . 74.25 110.649 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -154.31 137.06 15.26 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.356 0.663 . . . . 51.21 109.449 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.19 116.99 15.48 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.912 -0.773 . . . . 61.4 108.912 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.89 -32.12 15.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.674 0.39 . . . . 65.4 110.358 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.83 -175.25 5.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.785 -0.643 . . . . 75.21 111.361 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.67 118.08 7.16 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.598 -1.183 . . . . 74.21 109.749 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 13.0 m-20 65.09 11.05 6.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.508 1.123 . . . . 74.5 112.314 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.83 120.21 64.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 123.779 0.831 . . . . 75.12 109.239 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.614 ' HB2' HD13 ' D' ' 86' ' ' ILE . 73.8 m-85 -129.67 128.88 43.48 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.502 -1.295 . . . . 64.52 107.502 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -92.27 128.37 38.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.116 -0.698 . . . . 75.34 109.116 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.92 118.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.849 -1.167 . . . . 70.4 107.849 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 49.0 t -99.97 133.41 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.365 -0.976 . . . . 73.12 108.365 172.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.29 109.74 13.17 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.384 -0.969 . . . . 64.33 108.384 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -88.53 112.65 23.26 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.475 0.71 . . . . 74.41 110.051 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.7 t -101.27 126.31 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 74.5 108.564 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.0 m -129.42 134.3 47.77 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.97 0.508 . . . . 73.44 110.2 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.659 HG11 HD13 ' D' ' 126' ' ' LEU . 47.6 t -130.72 113.44 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.425 1.09 . . . . 60.41 108.892 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -103.87 101.12 10.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.465 0.706 . . . . 63.52 109.415 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.47 124.79 43.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.827 -0.435 . . . . 72.21 109.827 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.7 m -139.2 124.61 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.694 0.798 . . . . 73.05 108.894 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.6 103.36 15.96 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.771 -1.196 . . . . 75.44 107.771 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.19 -115.94 4.61 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.885 0.741 . . . . 75.24 112.465 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.47 5.0 51.75 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.741 0.816 . . . . 64.11 110.742 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -135.86 145.83 46.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.763 0.825 . . . . 63.34 110.473 -165.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -73.08 130.57 40.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.298 0.639 . . . . 61.13 111.334 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.477 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.36 -61.38 1.78 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.991 . . . . 30.21 108.679 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 74' ' ' PHE . . . . . 0.571 ' HE2' HD11 ' D' ' 126' ' ' LEU . 42.9 p90 -159.05 151.69 21.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.175 -1.375 . . . . 63.32 110.311 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 84.1 mt -113.65 151.49 31.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.489 1.116 . . . . 73.24 109.127 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.599 ' SG ' HG23 ' D' ' 114' ' ' ILE . 34.7 t -154.64 134.68 13.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.722 -0.473 . . . . 65.44 109.722 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.485 0.714 . . . . 73.31 109.832 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.44 121.09 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.61 0.764 . . . . 42.15 109.473 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.5 mt-30 -89.87 89.84 7.92 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.722 -0.844 . . . . 75.1 108.722 171.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -80.22 93.39 5.86 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.821 -1.081 . . . . 70.13 109.107 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.6 140.38 17.25 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.36 -0.696 . . . . 70.12 111.36 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.19 128.09 3.58 Favored Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 110.189 -1.164 . . . . 34.24 110.189 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.2 mt -90.85 129.23 41.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.834 -0.802 . . . . 71.12 108.834 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.516 ' HB2' HD11 ' D' ' 86' ' ' ILE . 22.1 m-85 -132.48 158.26 42.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.353 0.408 . . . . 63.0 110.368 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 25.4 m -107.14 102.29 11.63 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.504 -0.924 . . . . 75.32 108.504 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.0 mp -107.51 113.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.818 -1.179 . . . . 74.0 107.818 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -142.57 124.79 15.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.177 0.591 . . . . 71.13 110.492 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.19 5.65 57.09 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.421 -0.655 . . . . 52.13 114.577 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.408 HD13 HG23 ' D' ' 86' ' ' ILE . 2.4 mp -114.96 126.39 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.69 -0.856 . . . . 74.41 108.69 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 -177.83 4.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.776 0.83 . . . . 74.12 110.56 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.59 -141.06 39.83 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.501 -0.772 . . . . 75.1 113.799 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.2 p -84.31 -13.5 52.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.635 0.774 . . . . 73.14 111.656 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.89 0.476 . . . . 74.33 110.403 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.471 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -69.95 -31.84 69.79 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 110.421 -0.214 . . . . 74.24 110.421 175.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.62 68.6 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.866 0.729 . . . . 75.02 111.218 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -72.62 -35.67 67.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.224 0.61 . . . . 61.11 110.204 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.25 -51.45 52.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.859 0.464 . . . . 74.22 110.908 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 98' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' D' ' 94' ' ' MET . 2.9 pp -75.84 -19.74 58.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.755 0.422 . . . . 70.34 112.065 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -7.79 60.32 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.73 -0.483 . . . . 71.21 113.364 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.56 -62.6 0.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.342 0.571 . . . . 52.12 111.952 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -68.13 -52.33 36.02 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.424 0.527 . . . . 75.22 112.424 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 60.7 m -61.55 -43.81 89.9 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 123.673 0.789 . . . . 63.34 111.944 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.13 -46.52 32.08 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.13 1.887 . . . . 71.03 112.898 165.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -66.9 -15.79 63.89 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.442 0.697 . . . . 63.5 112.584 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -80.11 -49.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.464 -0.569 . . . . 72.42 109.464 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.3 mt -79.22 -28.91 42.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.73 0.812 . . . . 71.34 112.247 -169.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.93 -40.43 16.39 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.035 -0.983 . . . . 72.44 113.07 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -50.91 -43.52 46.83 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.282 1.988 . . . . 73.22 113.229 169.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -74.84 -37.08 62.35 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.477 0.711 . . . . 54.05 111.6 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.3 67.59 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.084 0.553 . . . . 74.22 110.281 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -43.6 79.72 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.905 1.378 . . . . 64.14 111.13 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -73.2 -36.48 66.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.779 0.832 . . . . 75.51 111.236 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -62.92 -44.92 94.77 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.893 0.477 . . . . 45.02 110.163 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.599 HG23 ' SG ' ' D' ' 76' ' ' CYS . 73.0 mt -61.83 -50.3 80.74 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.225 1.01 . . . . 71.52 110.213 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.568 HG23 ' HB3' ' D' ' 125' ' ' GLN . 30.4 m -50.84 -46.9 60.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.494 1.117 . . . . 73.33 111.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.8 t -73.53 -22.63 60.05 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.065 0.946 . . . . 35.2 112.635 -172.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.45 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.8 mtm -87.31 -43.46 12.14 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.062 0.458 . . . . 64.22 111.243 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.5 -34.45 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 114.691 -1.14 . . . . 72.02 110.382 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -66.55 -36.81 83.59 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.387 0.675 . . . . 74.23 111.405 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.5 mtt-85 -69.65 -26.74 64.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.143 0.577 . . . . 70.41 111.164 177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 11.04 60.71 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-O 119.689 -0.506 . . . . 74.43 113.316 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.479 HG23 ' HB3' ' C' ' 17' ' ' TYR . 25.6 p 65.42 16.36 10.48 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.581 1.952 . . . . 71.13 112.921 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -96.31 165.66 15.79 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.707 1.203 . . . . 72.44 108.406 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.64 150.58 24.59 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.258 1.972 . . . . 74.1 112.628 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 125' ' ' GLN . . . . . 0.568 ' HB3' HG23 ' D' ' 115' ' ' THR . 70.1 mt-30 -57.54 135.25 56.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.144 0.578 . . . . 74.55 111.092 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.659 HD13 HG11 ' D' ' 64' ' ' VAL . 88.4 mt -106.33 93.32 4.54 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.367 -0.605 . . . . 62.02 109.367 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -100.43 100.36 11.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.474 -0.936 . . . . 71.22 108.474 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.47 HD21 HD12 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.39 132.79 48.36 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.961 0.904 . . . . 70.44 109.136 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.21 146.95 87.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.815 0.846 . . . . 62.13 111.615 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.05 111.54 2.02 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 121.939 1.759 . . . . 65.41 111.393 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -106.65 124.99 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.375 -0.972 . . . . 75.31 108.375 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.02 92.41 5.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.242 0.617 . . . . 73.41 110.036 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.476 0.873 0 C-N-CA 124.023 0.929 . . . . 74.22 111.202 178.066 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.2 m . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 109.088 -0.708 . . . . 74.35 109.088 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.481 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 20.4 t80 -136.76 120.83 17.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.824 -1.176 . . . . 74.4 107.824 171.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 45.9 tp60 -142.83 108.25 5.04 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.087 -0.708 . . . . 71.11 109.087 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.521 HG12 ' HD2' ' A' ' 84' ' ' PHE . 20.0 mt -71.03 125.2 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.2 -0.455 . . . . 63.13 109.91 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -101.23 -31.89 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.975 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -179.27 132.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 119.369 -0.348 . . . . 72.35 110.996 -167.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.418 HD13 ' HG3' ' C' ' 130' ' ' PRO . 3.6 mp -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 107.417 -1.327 . . . . 61.31 107.417 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 23.5 p90 -164.06 167.53 20.22 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 122.218 1.009 . . . . 62.33 111.299 -174.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.5 109.09 21.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.038 -1.437 . . . . 65.22 108.674 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.9 mtpt -78.26 -29.97 48.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.105 0.479 . . . . 62.13 109.791 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.33 141.4 27.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.902 -1.045 . . . . 75.35 109.616 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 61.8 mt -137.54 136.68 46.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.077 -1.823 . . . . 73.22 106.077 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -148.08 125.59 11.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.66 -0.867 . . . . 75.02 108.66 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.0 t80 -127.18 140.15 52.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.18 -1.415 . . . . 71.31 107.18 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -134.74 151.58 51.09 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.752 -0.832 . . . . 65.11 108.752 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.24 73.96 11.87 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 105.682 -1.97 . . . . 73.31 105.682 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.66 -43.02 10.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.893 2.396 . . . . 75.32 113.197 -165.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.34 30.19 5.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.971 -0.751 . . . . 61.13 108.971 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.38 -57.92 7.62 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.595 -1.193 . . . . 75.14 113.052 -174.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 45.0 Cg_exo -55.74 -20.31 27.8 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.979 2.453 . . . . 75.12 113.722 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -98.96 -38.14 9.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.018 0.927 . . . . 73.13 110.798 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.85 -15.4 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.074 0.549 . . . . 72.45 111.444 -164.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.73 -30.95 71.97 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.081 0.553 . . . . 53.52 111.193 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -90.93 -7.12 52.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 112.363 0.505 . . . . 73.05 112.363 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -64.01 173.05 2.02 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.016 1.117 . . . . 72.11 114.016 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.45 159.12 30.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.928 1.291 . . . . 74.31 111.691 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -94.14 64.46 3.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.063 0.459 . . . . 74.32 110.166 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -142.81 82.84 11.95 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.918 0.887 . . . . 61.12 109.241 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.57 138.44 13.64 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 121.735 1.623 . . . . 64.42 110.891 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -92.57 82.58 4.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.978 -1.86 . . . . 71.25 105.978 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 65' ' ' THR . 10.2 m -82.53 114.65 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.993 -1.458 . . . . 42.32 109.382 -176.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -121.48 143.95 48.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.753 0.821 . . . . 74.21 109.96 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -112.97 118.91 36.15 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.865 0.866 . . . . 73.21 109.786 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -107.41 143.13 36.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.594 -1.261 . . . . 64.25 107.594 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.59 129.24 32.61 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.728 -0.842 . . . . 54.33 108.728 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.3 m-20 -117.74 120.81 39.09 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.738 -1.208 . . . . 74.52 107.738 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -107.29 121.81 45.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 75.33 108.627 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.0 140.33 28.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.991 0.517 . . . . 62.44 110.377 -173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 p -130.35 158.79 38.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.415 0.686 . . . . 74.22 110.616 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 154.98 39.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.336 1.054 . . . . 73.14 109.534 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -103.76 105.61 15.87 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.693 -0.855 . . . . 75.41 108.693 172.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.0 mt -79.22 -38.2 36.29 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.221 0.609 . . . . 74.23 110.55 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.62 -178.19 6.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.333 1.053 . . . . 63.23 109.246 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.47 123.15 18.89 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 71.18 -9.81 0.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.019 1.728 . . . . 75.53 112.771 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.67 110.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 N-CA-C 108.385 -0.969 . . . . 71.24 108.385 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -125.3 164.13 21.02 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.703 0.801 . . . . 70.14 109.536 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.0 tt0 -131.69 142.73 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.693 0.797 . . . . 65.15 109.449 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.36 132.52 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.601 -1.259 . . . . 74.24 107.601 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.2 t -125.08 131.36 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 123.625 0.77 . . . . 74.4 108.934 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 106' ' ' LEU . 3.9 mm? -117.99 106.0 12.47 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.106 -1.072 . . . . 73.12 108.106 177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.594 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 23.9 ttp180 -83.82 102.63 12.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.151 -1.055 . . . . 54.44 108.151 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.31 119.75 39.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.995 -1.483 . . . . 70.41 106.995 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 44.0 m -118.97 122.64 42.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.344 -0.613 . . . . 72.11 109.344 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.85 HG11 HD21 ' A' ' 126' ' ' LEU . 28.9 t -118.52 108.99 25.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.652 -0.87 . . . . 62.53 108.652 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.0 m -107.63 137.4 45.73 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.537 -0.542 . . . . 71.02 109.537 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.95 105.25 8.78 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.362 -0.977 . . . . 63.41 108.362 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -114.2 127.56 55.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.996 0.519 . . . . 72.24 110.796 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.12 85.19 2.09 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.91 -1.145 . . . . 65.43 107.91 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -111.29 3.23 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.562 -1.015 . . . . 73.15 110.562 -171.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -100.8 -8.49 22.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.058 0.543 . . . . 74.44 110.512 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -102.26 97.71 7.95 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.753 0.821 . . . . 60.43 110.383 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -66.86 124.29 22.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 122.911 0.484 . . . . 73.42 110.823 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -67.64 -57.3 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.203 1.001 . . . . 54.13 109.974 175.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -157.48 158.85 36.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.528 -1.215 . . . . 62.44 112.204 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.6 tp -126.89 135.17 50.57 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.95 1.3 . . . . 64.14 108.035 171.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 118' ' ' VAL . 51.2 m -130.64 97.75 4.45 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.404 -0.591 . . . . 71.33 109.404 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -116.9 116.28 27.12 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.021 0.929 . . . . 74.43 109.392 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -133.94 110.94 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.784 0.834 . . . . 70.42 109.215 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -84.93 89.31 7.55 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.684 -0.858 . . . . 74.45 108.684 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -80.86 96.69 7.09 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.506 -0.77 . . . . 70.32 109.048 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.99 151.52 22.21 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.48 -0.782 . . . . 72.45 111.92 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -153.19 124.55 1.61 Allowed Glycine 0 CA--C 1.509 -0.309 0 N-CA-C 111.302 -0.719 . . . . 44.45 111.302 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -85.14 124.59 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.208 0.603 . . . . 70.31 109.763 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HD2' HG12 ' A' ' 13' ' ' ILE . 37.9 m-85 -132.94 119.87 20.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.764 -1.198 . . . . 63.0 107.764 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 25.8 t -82.19 98.61 8.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 109.493 -0.558 . . . . 65.52 109.493 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.55 HD13 HD21 ' A' ' 98' ' ' LEU . 45.3 pt -103.49 147.46 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.999 0.919 . . . . 74.35 110.411 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -169.68 161.08 9.19 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.228 0.611 . . . . 41.11 111.863 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.31 -33.96 3.54 Favored Glycine 0 C--N 1.356 1.655 0 CA-C-N 115.605 -0.725 . . . . 75.24 113.964 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.422 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.1 pp -117.04 135.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.877 0.871 . . . . 64.34 109.432 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -139.56 175.86 9.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.376 0.67 . . . . 71.43 110.326 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -115.32 7.85 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.77 0.669 . . . . 65.3 112.831 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.1 t -74.58 -30.46 61.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.54 0.736 . . . . 74.33 111.567 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -67.32 -37.5 83.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.536 -0.757 . . . . 73.14 109.562 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.431 ' HG2' ' HG ' ' A' ' 98' ' ' LEU . 3.4 ttp -82.3 -24.45 34.65 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.311 -0.859 . . . . 74.45 110.833 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.48 -34.74 78.6 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.086 0.402 . . . . 75.44 112.086 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -77.28 -30.77 54.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.559 -0.292 . . . . 74.24 110.34 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.39 -65.05 0.76 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.582 0.353 . . . . 70.2 110.951 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.55 HD21 HD13 ' A' ' 86' ' ' ILE . 14.7 mt -75.66 -23.81 56.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.742 0.417 . . . . 65.41 111.739 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.94 -5.97 59.44 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.313 -0.715 . . . . 34.51 114.751 -172.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.41 -57.78 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.992 0.896 . . . . 72.13 112.319 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 89.8 t80 -68.4 -54.89 14.15 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.245 0.618 . . . . 73.42 112.066 -171.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.0 m -71.01 -33.16 2.71 Favored Pre-proline 0 CA--C 1.569 1.674 0 C-N-CA 123.673 0.789 . . . . 64.25 112.876 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.96 -41.96 60.87 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.493 2.128 . . . . 64.13 113.154 160.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -70.87 -14.03 62.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.384 0.674 . . . . 64.11 111.766 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -78.86 -41.39 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.98 -0.748 . . . . 75.32 108.98 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.9 mt -84.33 -30.21 25.69 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.059 0.944 . . . . 72.44 113.189 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -64.94 -38.63 30.97 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.037 -0.983 . . . . 75.43 113.537 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.54 -38.45 93.8 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.923 1.749 . . . . 74.24 113.25 171.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -73.84 -37.45 64.81 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.985 0.514 . . . . 75.45 111.141 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -44.6 91.55 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.777 -0.453 . . . . 45.12 109.777 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -52.51 -53.58 44.09 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.777 1.298 . . . . 74.11 110.72 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -68.19 -38.92 82.52 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.242 0.964 . . . . 73.4 111.374 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.5 t -61.79 -32.25 72.53 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.978 0.511 . . . . 74.1 110.648 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 118' ' ' VAL . 84.9 mt -74.34 -52.94 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.287 -0.869 . . . . 74.22 110.323 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.7 m -55.28 -41.56 72.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.223 1.009 . . . . 72.22 111.297 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -64.96 -44.86 88.0 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.72 -1.127 . . . . 72.34 110.776 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.4 mtm -64.52 -38.59 91.56 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.689 0.395 . . . . 75.15 111.492 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.2 t -64.36 -42.01 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.664 0.785 . . . . 74.52 110.704 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.3 p -72.4 -30.73 64.92 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.09 -0.505 . . . . 73.35 110.907 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -68.3 -25.32 65.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.594 0.758 . . . . 70.33 110.882 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 7.51 65.36 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.595 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 m 61.86 35.49 16.45 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.255 1.422 . . . . 73.01 110.945 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -107.31 160.89 24.87 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.064 0.946 . . . . 65.2 109.723 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.25 146.22 61.91 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.242 1.961 . . . . 73.13 111.522 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.11 148.19 48.63 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.775 0.322 . . . . 74.32 110.3 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.85 HD21 HG11 ' A' ' 64' ' ' VAL . 48.7 tp -113.72 113.48 25.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.004 0.522 . . . . 65.43 110.127 -177.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -114.17 114.19 25.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.653 -1.24 . . . . 71.23 107.653 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 128' ' ' LEU . 3.9 mm? -74.4 135.14 42.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.92 0.391 . . . . 70.34 110.152 174.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -71.87 132.23 85.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.935 -0.575 . . . . 51.24 110.368 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -77.54 116.95 4.17 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.505 2.136 . . . . 74.02 111.515 -177.012 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.76 135.36 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.189 0.596 . . . . 72.54 109.953 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -76.78 69.94 3.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.334 1.054 . . . . 74.54 110.605 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -56.08 -38.74 71.09 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.247 1.019 . . . . 75.1 111.749 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 114.487 -1.233 . . . . 53.53 111.917 179.922 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.9 m . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 108.536 -0.913 . . . . 72.53 108.536 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' PHE . . . . . 0.41 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 49.4 t80 -135.32 132.8 38.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.828 0.851 . . . . 74.35 109.492 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.423 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 9.3 pt20 -156.41 140.17 16.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.942 0.897 . . . . 71.44 109.022 173.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.71 135.42 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.834 -1.173 . . . . 61.15 107.834 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -93.19 -53.84 3.95 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.858 -0.423 . . . . 61.23 109.858 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -155.49 131.52 10.06 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.914 -0.402 . . . . 73.12 109.914 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.97 136.96 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.287 -1.746 . . . . 63.45 106.287 174.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -165.45 140.44 4.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.881 0.472 . . . . 74.25 111.142 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.0 m -73.47 117.85 15.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.873 0.869 . . . . 54.42 109.24 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -94.59 -22.41 18.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.471 0.708 . . . . 72.13 111.58 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.1 t70 -163.1 142.48 8.69 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.337 0.398 . . . . 65.05 110.473 -172.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.448 HD11 ' SG ' ' B' ' 113' ' ' CYS . 33.1 mm -137.27 141.59 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.975 1.31 . . . . 40.24 108.467 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.5 t -142.8 124.09 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.785 -1.191 . . . . 74.13 107.785 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -146.56 115.73 7.0 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 107.274 -1.38 . . . . 72.52 107.274 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -119.91 158.81 25.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.448 0.699 . . . . 64.55 109.513 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -149.99 78.19 8.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.664 -1.235 . . . . 70.33 107.664 175.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.88 -22.65 42.19 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.936 2.424 . . . . 53.31 112.675 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -122.97 24.55 8.92 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.959 . . . . 73.1 109.663 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.42 -50.16 59.26 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.744 1.387 . . . . 71.3 114.744 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -28.7 2.77 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 121.849 1.7 . . . . 54.54 112.789 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 51.5 m80 -96.18 4.67 52.27 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.354 1.061 . . . . 71.14 112.09 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.31 -26.25 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.632 0.773 . . . . 75.42 110.788 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' B' ' 35' ' ' ASP . 30.2 t80 -69.0 -16.09 63.64 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.104 0.779 . . . . 72.31 113.104 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.2 pt20 -73.16 -47.08 46.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.065 0.393 . . . . 75.53 110.73 176.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.52 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 45.4 pttt -112.62 66.79 0.65 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.548 -1.279 . . . . 75.21 107.548 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.57 ' HB2' ' HA ' ' B' ' 32' ' ' PHE . 39.1 t70 -96.86 108.47 21.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.275 -0.875 . . . . 73.51 111.563 -164.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.514 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.8 OUTLIER 177.74 -170.86 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.597 1.186 . . . . 73.03 109.437 163.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.89 116.77 7.59 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.096 0.958 . . . . 73.3 111.995 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.65 156.73 18.68 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.651 2.234 . . . . 72.43 111.464 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.03 102.19 0.47 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.123 -1.066 . . . . 73.13 108.123 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.4 151.16 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.066 -0.97 . . . . 61.22 109.632 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -139.12 137.42 36.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.34 0.656 . . . . 74.2 109.621 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' LEU . . . . . 0.511 HD12 HD11 ' B' ' 128' ' ' LEU . 2.4 tt -93.18 126.11 38.12 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.148 -1.427 . . . . 62.43 107.148 167.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.4 t0 -131.34 145.21 51.75 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 106.547 -1.649 . . . . 73.3 106.547 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.62 133.27 28.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.667 -0.864 . . . . 73.31 108.667 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.7 t70 -124.3 134.38 53.22 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.694 1.198 . . . . 74.44 108.701 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -107.9 108.25 19.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.455 0.702 . . . . 64.42 109.759 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.91 119.3 32.22 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.538 -0.912 . . . . 72.21 108.538 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.2 p -139.15 166.08 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.141 0.577 . . . . 73.13 110.688 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.2 p -151.16 165.99 32.22 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.136 0.974 . . . . 72.35 109.146 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -115.07 107.74 15.74 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.454 -0.943 . . . . 72.21 108.454 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.11 -42.52 84.39 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.585 0.754 . . . . 75.11 110.892 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.77 -170.98 3.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.667 0.787 . . . . 43.43 110.363 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.41 114.39 5.4 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.226 -0.897 . . . . 75.21 109.517 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 73.22 -6.69 1.67 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 126.332 1.853 . . . . 70.41 113.202 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.74 120.59 52.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 109.151 -0.685 . . . . 73.31 109.151 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -114.11 173.11 6.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.605 -0.725 . . . . 73.21 110.945 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -142.17 95.19 2.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 105.541 -2.022 . . . . 74.52 105.541 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.35 122.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.03 0.932 . . . . 62.12 109.09 -175.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -111.7 143.47 21.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.57 0.748 . . . . 75.31 109.454 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' B' ' 103' ' ' PRO . 93.6 mt -120.1 112.43 19.11 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.753 -0.462 . . . . 43.21 109.753 174.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.7 ttm-85 -86.6 107.24 18.07 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.155 -1.054 . . . . 73.43 108.155 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 105.54 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.27 -1.382 . . . . 75.01 107.27 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 63' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 28.6 m -96.48 137.79 35.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.447 -0.797 . . . . 74.43 108.994 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -134.62 101.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.887 -1.153 . . . . 64.23 107.887 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.5 m -98.08 141.58 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 72.1 109.516 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.73 148.44 52.58 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.02 -0.733 . . . . 75.31 109.02 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -157.39 128.61 6.76 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.368 0.417 . . . . 52.34 111.238 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.671 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -127.84 143.19 51.12 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.552 0.741 . . . . 63.31 109.917 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.25 -112.24 3.51 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.929 -0.869 . . . . 53.12 110.929 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -123.86 6.1 8.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.966 0.906 . . . . 73.34 109.922 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 71' ' ' GLU . . . . . 0.52 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 8.8 pt-20 -149.28 -178.98 6.71 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.625 0.37 . . . . 74.41 111.209 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -64.6 147.69 52.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.685 1.194 . . . . 72.33 111.674 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.671 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -96.34 -63.49 1.14 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.111 -1.07 . . . . 75.43 108.111 171.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -152.78 163.66 39.28 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.622 -1.626 . . . . 73.41 108.041 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -125.84 144.69 50.55 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.736 1.215 . . . . 75.4 108.543 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 76' ' ' CYS . . . . . 0.492 ' SG ' HG23 ' B' ' 114' ' ' ILE . 33.8 t -147.44 144.08 28.37 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.53 -0.915 . . . . 61.31 108.53 173.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.1 tt0 -164.95 138.98 4.95 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.171 -0.677 . . . . 71.43 109.171 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' B' ' 113' ' ' CYS . 97.4 t -132.07 148.07 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.675 0.79 . . . . 73.5 109.257 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 79' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 41.5 mt-30 -122.6 103.17 8.51 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.407 -0.96 . . . . 70.11 108.407 168.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.05 105.29 17.3 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.14 -1.059 . . . . 51.41 108.14 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 155.0 24.18 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.205 -0.758 . . . . 61.55 111.205 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 125.29 1.72 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.566 -0.614 . . . . 65.13 111.566 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.28 126.36 40.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.055 -1.091 . . . . 73.42 108.055 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.74 162.57 28.12 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 74.53 108.988 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 48.7 m -132.5 113.26 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.083 -0.71 . . . . 71.1 109.083 168.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.462 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.9 pt -119.17 137.85 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.919 0.888 . . . . 63.33 110.084 -177.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.23 164.0 39.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 71.44 109.743 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.63 -47.46 3.6 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.242 -0.435 . . . . 73.31 112.493 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' B' ' 94' ' ' MET . 19.9 pt -64.04 148.89 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.523 1.129 . . . . 74.42 113.211 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 15.4 pt-20 -157.36 162.7 39.07 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.306 1.042 . . . . 72.4 109.704 172.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.57 -115.07 6.61 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.398 0.436 . . . . 54.24 113.614 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.9 m -77.77 -28.88 50.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.413 0.685 . . . . 55.5 110.79 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 97.0 mt-30 -58.56 -42.15 87.26 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.053 0.541 . . . . 71.52 110.588 177.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.558 ' HA ' HD12 ' B' ' 89' ' ' ILE . 23.9 ttt -71.87 -41.54 67.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 74.43 110.767 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.55 82.54 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.783 0.677 . . . . 74.23 111.29 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 57.9 t-80 -79.54 -20.15 47.82 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.963 -1.017 . . . . 71.32 110.916 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -83.29 -67.05 0.82 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.293 0.237 . . . . 41.32 111.009 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.451 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.5 pp -83.92 -15.0 49.58 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.64 0.608 . . . . 75.12 112.64 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.64 -27.75 11.15 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.986 -0.341 . . . . 55.14 112.929 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -114.93 -60.24 1.91 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.252 0.621 . . . . 65.05 111.391 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.87 -46.0 66.46 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.195 0.598 . . . . 73.11 112.133 -170.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 62.6 m -68.38 -40.86 21.72 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.851 -0.595 . . . . 74.55 112.299 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.561 ' HA ' HD11 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -52.91 -39.9 77.16 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 122.273 1.982 . . . . 64.33 113.961 165.744 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.91 -16.43 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 111.715 0.265 . . . . 63.54 111.715 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.67 -55.76 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.368 0.667 . . . . 65.04 110.526 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' LEU . . . . . 0.435 ' HB2' HD12 ' B' ' 60' ' ' LEU . 91.0 mt -76.83 -25.32 53.09 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.265 0.626 . . . . 73.55 112.681 -169.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.7 -48.98 88.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 CA-C-O 117.72 -1.134 . . . . 70.41 113.628 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.92 -38.47 86.18 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.052 1.835 . . . . 51.44 113.374 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.469 ' HE2' HG21 ' D' ' 115' ' ' THR . 29.3 m-85 -65.3 -45.33 84.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.596 0.759 . . . . 74.02 110.296 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.19 79.82 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.791 -0.641 . . . . 65.21 111.044 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ttt-85 -61.2 -56.23 23.1 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.331 1.052 . . . . 55.15 111.106 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -36.86 85.03 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.517 0.511 . . . . 63.45 110.087 -176.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.0 t -69.44 -26.9 64.83 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 123.684 0.615 . . . . 74.42 111.503 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.492 HG23 ' SG ' ' B' ' 76' ' ' CYS . 81.7 mt -74.56 -52.35 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 122.889 0.475 . . . . 73.33 109.846 170.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 28.9 m -60.26 -27.74 67.49 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.053 0.941 . . . . 71.44 111.665 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.16 -48.73 64.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.632 0.773 . . . . 65.12 109.769 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -71.72 -32.2 67.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.921 0.488 . . . . 75.12 111.484 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.33 -38.94 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.228 0.611 . . . . 64.31 110.139 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.5 t -65.66 -38.99 90.87 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 71.33 111.166 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.435 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -67.66 -33.76 75.59 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.608 0.763 . . . . 62.33 110.356 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.82 11.66 61.59 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.875 -0.602 . . . . 73.13 112.963 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.2 p 56.97 29.69 16.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.735 1.614 . . . . 52.43 113.847 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -109.72 145.47 32.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.106 0.962 . . . . 74.12 109.045 172.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.571 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 61.6 Cg_exo -57.21 140.34 92.56 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.838 2.358 . . . . 65.12 113.843 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -65.43 160.01 22.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 113.476 -1.693 . . . . 74.21 112.695 -174.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.4 116.38 15.11 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.574 -1.269 . . . . 62.34 107.574 168.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -89.97 104.08 16.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 106.924 -1.51 . . . . 71.04 106.924 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 128' ' ' LEU . . . . . 0.511 HD11 HD12 ' B' ' 42' ' ' LEU . 16.0 tp -66.46 134.85 53.3 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.846 -0.616 . . . . 75.11 110.874 -172.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.14 137.97 94.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.228 1.011 . . . . 73.51 111.745 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.46 111.72 0.5 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.143 2.562 . . . . 72.34 112.013 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.15 108.13 18.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.14 -1.059 . . . . 61.24 108.14 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.47 77.24 2.6 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.436 -0.95 . . . . 61.42 108.436 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 t80 . . . . . 0 CA--C 1.55 0.951 0 CA-C-N 114.862 -1.063 . . . . 74.31 109.917 178.352 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.423 ' HB2' HG23 ' C' ' 89' ' ' ILE . 23.7 ttt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.34 0.59 . . . . 70.15 111.651 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 10' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 91.0 m -98.58 96.36 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.836 -0.801 . . . . 61.45 108.836 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 11' ' ' PHE . . . . . 0.596 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 57.1 t80 -99.38 128.38 45.49 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.652 -0.87 . . . . 74.35 108.652 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -152.79 136.74 16.31 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.262 -0.644 . . . . 60.35 109.262 175.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 66.7 mt -90.07 104.39 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.069 0.947 . . . . 74.14 109.745 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -73.56 -50.51 20.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.309 -0.256 . . . . 71.33 110.309 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -169.48 123.83 0.8 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.734 -0.469 . . . . 74.33 109.734 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -107.98 137.3 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.388 -0.967 . . . . 74.32 108.388 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.491 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 33.6 p90 -168.56 159.54 10.24 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.815 0.817 . . . . 72.35 111.09 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -77.5 114.32 16.21 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.138 -1.392 . . . . 72.33 108.763 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -68.89 -41.59 78.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.864 0.84 . . . . 61.24 109.469 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -145.23 140.85 28.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.033 -1.439 . . . . 75.53 109.058 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 65.6 mt -134.63 141.51 43.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.333 -1.358 . . . . 74.14 107.333 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -161.74 150.7 15.79 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.397 0.618 . . . . 72.41 111.276 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 88.4 t80 -141.86 131.0 23.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.584 -1.265 . . . . 53.41 107.584 173.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.2 mt-10 -123.73 123.73 41.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.351 0.66 . . . . 73.31 109.266 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.8 83.21 62.19 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 107.432 -1.321 . . . . 33.31 107.432 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.28 -35.45 62.69 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.708 2.272 . . . . 72.51 111.875 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -110.66 33.39 4.57 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.811 -1.086 . . . . 75.02 109.223 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.23 -50.19 48.8 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 114.299 1.222 . . . . 71.34 114.299 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 15.2 Cg_exo -66.47 -39.51 16.48 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 121.788 1.659 . . . . 75.33 112.971 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -67.2 -57.58 6.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.313 1.045 . . . . 62.2 112.333 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 31' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' C' ' 73' ' ' ALA . 46.0 t -54.91 -24.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 125.176 1.39 . . . . 73.12 112.877 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -51.95 -35.11 44.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.113 0.565 . . . . 62.32 112.05 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.48 45.9 0.95 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.666 0.787 . . . . 70.25 110.749 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -124.53 151.86 44.16 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.011 0.924 . . . . 71.13 110.82 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.37 131.84 33.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.384 1.074 . . . . 72.34 112.636 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -86.39 69.31 10.41 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.082 0.953 . . . . 74.22 111.253 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -158.13 77.87 3.44 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.313 0.645 . . . . 71.32 109.679 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.501 ' HA ' ' HB3' ' C' ' 68' ' ' LEU . 95.7 Cg_endo -90.83 154.13 4.06 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.814 2.342 . . . . 71.13 113.122 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.05 95.2 9.86 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.455 -1.313 . . . . 73.45 107.455 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.4 114.3 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.938 -1.028 . . . . 72.2 109.461 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.474 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 89.6 mttt -102.24 146.51 27.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.757 0.823 . . . . 61.13 109.752 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.34 123.42 39.36 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 106.836 -1.542 . . . . 72.34 106.836 171.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.53 104.19 7.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.832 -1.173 . . . . 74.25 107.832 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.42 154.5 17.17 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.036 0.534 . . . . 64.03 110.224 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 10.6 t70 -146.79 151.91 37.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.774 0.83 . . . . 75.25 109.036 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -121.52 122.01 38.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.296 0.638 . . . . 73.05 110.093 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.76 138.7 48.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.503 -0.925 . . . . 75.3 108.503 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 48' ' ' SER . . . . . 0.58 ' HB3' ' HE1' ' C' ' 56' ' ' TYR . 71.2 m -155.06 151.54 28.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.038 0.535 . . . . 72.43 110.692 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -152.91 138.07 17.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.077 0.551 . . . . 72.34 110.498 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.53 122.92 27.07 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.671 -0.492 . . . . 75.2 109.671 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' C' ' 57' ' ' GLU . 41.1 mt -95.44 -43.32 8.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.767 0.827 . . . . 73.12 111.103 -172.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -158.83 -168.1 2.3 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.676 0.79 . . . . 75.41 110.066 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.91 103.63 0.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.093 -0.958 . . . . 74.22 110.066 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 72.77 -6.35 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 126.126 1.77 . . . . 64.31 113.024 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 60.2 t -91.85 107.49 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.792 -1.188 . . . . 65.24 107.792 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 56' ' ' TYR . . . . . 0.58 ' HE1' ' HB3' ' C' ' 48' ' ' SER . 2.1 t80 -128.59 141.0 51.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.11 -1.07 . . . . 62.31 108.11 -173.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.2 tt0 -98.05 129.33 44.9 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.348 0.659 . . . . 70.14 110.829 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -110.35 114.69 47.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.08 -1.081 . . . . 74.44 108.08 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.21 135.84 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.831 -0.803 . . . . 55.43 108.831 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.16 109.38 12.81 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.945 -1.502 . . . . 74.52 106.945 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.2 ttm-85 -80.55 125.0 29.44 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.102 -0.703 . . . . 63.1 109.102 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' C' ' 114' ' ' ILE . 43.9 t -116.11 105.75 19.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.468 -1.308 . . . . 73.1 107.468 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.8 m -108.57 119.17 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.741 -0.837 . . . . 62.2 108.741 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.52 130.44 74.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.742 -0.836 . . . . 61.55 108.742 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 9.7 m -121.22 152.11 39.21 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.245 1.018 . . . . 61.51 109.309 -171.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.67 112.83 10.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.476 -1.305 . . . . 73.31 107.476 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -145.02 135.06 23.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.329 -0.619 . . . . 74.25 109.329 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.5 OUTLIER -120.23 57.01 0.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 122.216 1.008 . . . . 53.44 110.49 -173.76 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.29 -119.94 4.47 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.692 -1.594 . . . . 54.24 110.285 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.92 -30.59 18.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.855 -0.794 . . . . 65.25 108.855 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.436 ' HB3' HD12 ' C' ' 68' ' ' LEU . 11.7 tp10 -72.72 109.72 6.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.743 -1.117 . . . . 64.04 109.984 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -83.41 122.76 28.93 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.975 -0.75 . . . . 65.54 108.975 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.419 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -72.64 -54.77 8.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.407 1.067 . . . . 65.11 109.264 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -165.82 171.65 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.476 -0.784 . . . . 71.42 111.45 171.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -137.86 145.97 42.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.185 1.394 . . . . 74.53 107.242 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -152.85 121.39 6.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.044 0.537 . . . . 73.22 109.671 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.45 127.98 47.35 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.963 0.505 . . . . 73.3 110.285 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.91 124.46 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.895 -0.78 . . . . 74.2 108.895 169.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.551 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 23.3 mt-30 -96.62 105.52 17.63 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.988 -1.116 . . . . 71.33 107.988 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -92.24 112.05 23.84 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.724 0.41 . . . . 72.31 110.656 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 155.5 23.75 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.93 -0.577 . . . . 60.32 111.92 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.95 116.62 0.74 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.825 -1.31 . . . . 41.44 109.825 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.516 HD12 HD11 ' C' ' 51' ' ' LEU . 19.4 mm -81.71 119.51 31.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.322 -0.992 . . . . 70.55 108.322 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -126.93 119.18 26.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.661 -1.237 . . . . 74.24 107.661 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -84.65 98.61 10.29 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.505 -1.294 . . . . 74.14 107.505 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' C' ' 10' ' ' THR . 0.2 OUTLIER -121.34 142.29 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.169 0.509 . . . . 74.43 111.242 -175.439 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.58 168.38 27.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.547 1.139 . . . . 62.1 109.416 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.77 -45.67 2.71 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.939 -0.464 . . . . 61.12 111.939 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' C' ' 93' ' ' GLN . 1.6 pp -80.93 145.66 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.482 0.713 . . . . 75.21 111.021 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -162.04 148.32 13.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.791 0.837 . . . . 71.0 109.081 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 -117.22 10.79 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.603 0.564 . . . . 52.12 113.328 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 56.6 p -65.12 -35.66 81.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.875 . . . . 74.3 111.532 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 93' ' ' GLN . . . . . 0.6 ' HB3' HG22 ' C' ' 89' ' ' ILE . 78.2 mt-30 -67.64 -43.3 80.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.92 -0.582 . . . . 61.24 110.623 178.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.491 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.5 ttt -75.78 -23.51 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.32 110.801 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.49 96.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.038 0.535 . . . . 74.53 110.674 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.25 -34.19 74.41 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.433 -0.803 . . . . 71.44 110.745 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -65.74 -61.26 2.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.797 -0.638 . . . . 71.43 111.317 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 98' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -87.08 -12.97 45.62 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.502 0.556 . . . . 72.35 112.502 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.15 8.02 60.62 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-O 119.584 -0.564 . . . . 60.32 113.36 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -154.79 -59.95 0.11 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.93 0.492 . . . . 64.22 111.273 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.53 -49.59 21.4 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.556 0.742 . . . . 75.13 112.094 -168.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 102' ' ' CYS . . . . . 0.596 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -69.86 -44.52 22.68 Favored Pre-proline 0 CA--C 1.561 1.401 0 CA-C-O 118.156 -0.926 . . . . 73.11 113.223 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' C' ' 102' ' ' CYS . 28.7 Cg_endo -61.59 -38.42 62.26 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 121.722 1.615 . . . . 74.05 111.259 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -62.95 -22.74 67.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.591 0.756 . . . . 75.04 112.392 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -73.32 -54.46 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 110.224 -0.287 . . . . 74.13 110.224 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 pp -87.16 -8.51 56.86 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.955 -0.566 . . . . 62.12 112.517 -170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -58.44 -50.67 86.77 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.421 1.088 . . . . 64.24 113.303 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.51 -29.94 89.67 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 121.654 1.57 . . . . 63.15 113.189 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.68 -45.78 67.55 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.223 0.609 . . . . 74.32 110.462 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.63 91.95 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.547 0.739 . . . . 73.13 110.631 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 111' ' ' ARG . . . . . 0.533 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 36.1 ttt180 -61.78 -53.74 51.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.431 -1.713 . . . . 75.32 111.927 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.322 0.649 . . . . 71.1 110.315 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -67.91 -31.35 71.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.2 0.6 . . . . 73.43 111.449 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.431 HG23 ' SG ' ' C' ' 76' ' ' CYS . 83.2 mt -75.4 -49.97 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.617 0.767 . . . . 72.11 110.526 174.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -62.2 -29.37 70.33 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.515 0.726 . . . . 74.33 111.457 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -67.26 -49.69 63.41 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.56 -0.745 . . . . 74.14 109.622 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.672 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.04 -36.59 75.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.055 0.942 . . . . 63.43 112.615 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.4 t -64.88 -41.74 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.588 0.755 . . . . 75.01 110.346 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.1 p -74.91 -27.01 60.05 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.031 -0.532 . . . . 72.31 111.349 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -70.3 -39.44 74.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.835 0.854 . . . . 74.21 110.742 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 121' ' ' GLY . . . . . 0.491 ' HA2' ' H ' ' D' ' 18' ' ' THR . . . -83.89 10.06 61.23 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.045 -0.525 . . . . 61.43 113.461 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p 55.12 62.28 2.57 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 125.482 1.513 . . . . 73.35 111.718 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -126.59 154.39 75.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.867 1.267 . . . . 74.35 109.139 170.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.32 167.8 13.99 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.276 2.651 . . . . 72.01 113.759 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 125' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 10.9 mm100 -56.26 123.64 15.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.571 1.148 . . . . 74.14 113.912 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.97 84.18 1.91 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.117 -1.438 . . . . 70.12 107.117 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 127' ' ' ASN . . . . . 0.537 ' ND2' ' HB3' ' C' ' 125' ' ' GLN . 25.6 m-80 -91.77 102.11 14.71 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.248 -1.019 . . . . 63.05 108.248 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 128' ' ' LEU . . . . . 0.533 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 14.8 tp -68.08 137.15 54.76 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 64.53 110.382 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 129' ' ' ALA . . . . . 0.417 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -81.08 152.19 70.99 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.035 0.934 . . . . 64.03 111.146 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.418 ' HG3' HD13 ' A' ' 16' ' ' ILE . 41.3 Cg_exo -50.11 142.19 28.43 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.16 2.573 . . . . 74.21 113.111 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.11 110.29 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.779 -0.823 . . . . 72.14 108.779 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -97.98 85.65 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.389 0.676 . . . . 71.43 109.922 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 91.0 m-85 -69.59 -46.65 65.84 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.264 -0.426 . . . . 75.23 110.866 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.419 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 29.8 t70 . . . . . 0 N--CA 1.475 0.804 0 CA-C-N 115.72 -0.673 . . . . 72.45 110.801 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.242 0.707 0 N-CA-C 108.924 -0.769 . . . . 73.53 108.924 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -157.15 100.66 1.87 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.945 -1.131 . . . . 61.52 107.945 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.3 143.53 51.03 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.842 0.857 . . . . 71.33 109.221 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' D' ' 84' ' ' PHE . 47.7 mt -96.11 136.22 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.016 0.526 . . . . 51.15 109.754 175.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 14' ' ' GLN . . . . . 0.426 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.6 mt-30 -89.13 -42.1 11.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.978 -0.379 . . . . 62.15 109.978 172.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -176.03 153.64 1.34 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 65.31 110.919 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.842 -1.54 . . . . 73.32 106.842 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -149.43 170.81 17.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.173 0.987 . . . . 64.43 111.613 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 18' ' ' THR . . . . . 0.491 ' H ' ' HA2' ' C' ' 121' ' ' GLY . 68.4 p -105.09 117.65 34.54 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.312 -1.313 . . . . 71.11 109.726 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -85.6 -29.29 24.21 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.889 -0.596 . . . . 72.54 109.458 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 24.5 t70 -151.03 139.1 20.08 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.338 -1.301 . . . . 72.55 108.924 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.672 HD13 ' HE3' ' C' ' 117' ' ' MET . 92.1 mt -132.49 146.84 32.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.729 -1.211 . . . . 74.44 107.729 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.8 t -148.75 140.0 23.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.65 0.78 . . . . 53.11 109.715 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -149.35 117.67 6.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.372 -2.084 . . . . 74.23 105.372 167.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -121.88 135.64 54.9 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.966 -0.753 . . . . 70.21 108.966 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.04 83.45 55.66 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.371 -1.344 . . . . 72.11 107.371 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.38 -29.82 10.84 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.89 2.393 . . . . 63.01 113.558 -169.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -114.71 33.22 5.49 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.03 -0.73 . . . . 64.5 109.03 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.491 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -43.15 -62.33 1.39 Allowed Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.433 1.642 . . . . 61.33 115.433 -163.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.21 -15.61 7.69 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 121.794 1.676 . . . . 61.15 112.888 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -68.18 -34.29 76.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.815 1.246 . . . . 63.42 109.079 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.565 HG13 ' HH2' ' D' ' 36' ' ' TRP . 55.8 t -68.44 -38.97 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.81 0.844 . . . . 71.24 110.398 175.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -74.04 4.69 5.12 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.831 0.678 . . . . 72.42 112.831 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.04 -17.75 32.21 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.058 0.543 . . . . 73.03 111.181 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.648 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 29.5 mtpt -126.34 107.3 10.18 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.336 1.054 . . . . 73.54 110.656 -167.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.47 97.6 9.56 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 118.905 0.775 . . . . 65.33 111.295 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.648 ' HE1' ' HE2' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -136.4 176.67 8.48 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 71.02 110.4 175.397 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.43 111.82 39.63 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.046 0.938 . . . . 74.05 110.336 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.616 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.1 Cg_exo -64.35 140.07 68.47 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.049 2.499 . . . . 52.4 113.871 173.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 39' ' ' GLU . . . . . 0.45 ' H ' HD11 ' D' ' 68' ' ' LEU . 14.4 pt-20 -82.77 130.15 35.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.042 -1.095 . . . . 75.1 108.042 162.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.503 HG13 HG13 ' D' ' 64' ' ' VAL . 77.2 t -105.57 104.74 17.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 107.694 -1.224 . . . . 42.34 107.694 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.16 127.86 36.75 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.17 -0.307 . . . . 74.02 110.17 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -95.89 124.43 39.9 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.621 -1.251 . . . . 61.33 107.621 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -137.59 138.26 39.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.36 -0.978 . . . . 74.12 108.36 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.88 147.36 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.417 0.627 . . . . 75.2 110.945 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -133.07 137.52 46.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.823 -1.177 . . . . 72.52 107.823 170.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.1 p -105.16 144.16 32.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 51.23 110.205 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.33 145.08 23.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.462 0.705 . . . . 62.34 109.32 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -151.22 157.46 42.65 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.873 0.469 . . . . 74.24 109.973 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 6.4 m -147.82 149.62 32.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.98 -1.118 . . . . 71.22 107.98 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -101.1 118.03 36.18 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.56 -1.274 . . . . 55.11 107.56 161.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 mt -89.68 -34.02 16.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.805 -0.442 . . . . 62.41 109.805 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.68 -177.8 6.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.599 -0.728 . . . . 73.15 110.679 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.34 130.94 45.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.252 -0.885 . . . . 71.43 109.126 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 66.33 5.64 3.82 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.63 1.172 . . . . 72.52 112.4 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.86 123.32 71.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 C-N-CA 123.381 0.672 . . . . 63.44 109.937 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -128.11 127.34 42.86 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.316 -0.994 . . . . 61.21 108.316 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -88.15 143.0 27.31 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.776 0.831 . . . . 64.43 109.114 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 48.6 t -125.32 123.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.268 -1.012 . . . . 74.41 108.268 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 43.4 t -109.83 131.33 61.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.167 -1.049 . . . . 61.21 108.167 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -126.38 117.66 23.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.588 -0.893 . . . . 75.24 108.588 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.1 ttm-85 -95.64 106.93 19.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.78 0.832 . . . . 71.11 109.938 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -94.46 112.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.778 -0.823 . . . . 73.31 108.778 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -112.15 128.59 56.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.485 0.66 . . . . 70.44 109.868 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 64' ' ' VAL . . . . . 0.503 HG13 HG13 ' D' ' 40' ' ' VAL . 42.2 t -124.8 107.42 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.458 1.503 . . . . 72.14 108.649 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.9 m -106.02 117.46 34.09 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.904 0.881 . . . . 74.44 110.375 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.48 126.55 53.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.307 -0.627 . . . . 72.23 109.307 172.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.2 m -153.76 122.83 6.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.304 0.641 . . . . 52.11 109.344 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' D' ' 38' ' ' PRO . 2.5 mm? -130.49 135.46 47.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.795 0.838 . . . . 63.13 109.448 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 -116.39 4.93 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.972 -0.851 . . . . 45.12 110.972 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.03 8.3 8.64 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.998 -0.742 . . . . 63.01 108.998 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.46 155.87 33.98 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.651 0.78 . . . . 61.02 110.793 -173.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -82.64 129.14 34.9 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 72.23 110.529 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -69.33 -68.61 0.39 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.093 -1.077 . . . . 55.45 108.093 173.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.88 152.61 28.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.388 -0.824 . . . . 73.43 109.596 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 77.1 mt -110.64 150.27 29.23 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.426 1.09 . . . . 71.34 108.243 167.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.484 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.1 t -150.9 136.23 17.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.432 -0.951 . . . . 71.22 108.432 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -155.53 129.56 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.644 0.378 . . . . 74.13 110.313 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -134.43 120.1 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.049 0.539 . . . . 74.54 110.07 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 7.1 mt-30 -87.7 91.25 8.68 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.607 -0.886 . . . . 62.52 108.607 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.72 95.54 6.65 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.383 -0.969 . . . . 63.34 108.383 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 144.18 16.95 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.83 -0.623 . . . . 61.14 111.562 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.39 136.22 6.61 Favored Glycine 0 CA--C 1.507 -0.43 0 N-CA-C 110.515 -1.034 . . . . 50.12 110.515 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.8 mt -88.42 126.54 41.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.6 -0.889 . . . . 65.01 108.6 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 84' ' ' PHE . . . . . 0.404 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 52.6 m-85 -123.92 148.65 46.69 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.565 -0.532 . . . . 72.55 109.565 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 27.0 m -103.57 94.22 5.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.671 -1.233 . . . . 63.33 107.671 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.8 mt -110.17 116.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.999 0.919 . . . . 74.33 108.72 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.45 153.5 15.47 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.145 0.578 . . . . 75.11 110.33 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.05 59.97 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.127 -0.488 . . . . 71.45 112.738 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.65 129.1 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.736 -0.839 . . . . 53.35 108.736 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -134.5 168.07 19.62 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.883 0.873 . . . . 73.14 110.362 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.42 -135.61 23.95 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.855 -0.611 . . . . 70.24 114.177 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -70.61 -34.63 72.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.166 0.987 . . . . 55.11 112.056 -173.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.98 -38.76 83.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.971 0.508 . . . . 62.01 110.726 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -44.11 76.66 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.5 -0.555 . . . . 73.0 109.5 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.54 71.66 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.204 0.94 . . . . 71.33 111.508 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -72.01 -45.0 62.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.572 0.749 . . . . 64.45 110.646 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.44 -37.9 88.27 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.807 0.443 . . . . 61.22 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 41.3 tp -79.32 -37.77 36.81 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.262 1.025 . . . . 53.22 111.301 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -7.79 76.09 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.657 -0.524 . . . . 74.24 113.769 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 -54.98 0.73 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.763 0.782 . . . . 73.31 112.211 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -72.37 -49.02 37.16 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.064 0.393 . . . . 75.22 111.573 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.0 m -60.78 -48.47 92.89 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.252 -0.88 . . . . 75.34 112.531 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.24 -27.75 48.22 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 121.636 1.557 . . . . 74.31 112.604 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -71.99 -24.09 61.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.066 0.546 . . . . 74.11 111.099 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -80.64 -41.68 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.607 0.763 . . . . 62.54 110.455 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.77 -30.57 62.84 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.202 0.601 . . . . 64.04 111.547 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -63.87 -42.36 70.09 Favored Pre-proline 0 CA--C 1.564 1.508 0 N-CA-C 114.187 1.18 . . . . 75.31 114.187 -170.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.57 -45.09 32.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.413 2.076 . . . . 75.42 113.821 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -79.63 -30.98 41.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.357 0.663 . . . . 74.13 111.798 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.91 74.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.912 0.485 . . . . 73.42 109.863 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.85 -51.27 70.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.293 -1.321 . . . . 55.23 110.352 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.54 -42.17 91.72 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.218 0.949 . . . . 73.11 111.385 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -44.56 94.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.754 0.659 . . . . 65.21 110.793 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.484 HG23 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -62.46 -52.38 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.073 0.949 . . . . 73.11 110.697 175.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.469 HG21 ' HE2' ' B' ' 109' ' ' TYR . 32.0 m -56.36 -41.25 75.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.824 1.249 . . . . 63.25 111.135 -171.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -67.93 -43.58 78.84 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.549 -1.205 . . . . 74.12 110.507 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.9 mtm -66.64 -31.55 72.31 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.371 0.508 . . . . 62.05 112.371 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.5 t -68.34 -44.83 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.27 0.628 . . . . 73.12 109.712 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.0 p -70.37 -28.96 65.52 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.994 0.518 . . . . 74.02 111.45 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -73.38 -31.71 64.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.337 0.655 . . . . 74.52 110.186 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 3.0 86.12 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.959 -0.564 . . . . 73.32 112.851 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 122' ' ' THR . . . . . 0.406 HG23 ' HB3' ' C' ' 17' ' ' TYR . 69.3 p 63.29 14.43 7.81 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.794 2.038 . . . . 73.34 113.672 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.447 ' HE1' HG11 ' D' ' 31' ' ' VAL . 87.8 m-85 -80.29 158.83 71.34 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 165.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -70.88 134.29 25.32 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 121.61 1.54 . . . . 73.32 110.878 -168.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -48.72 116.94 1.81 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.333 1.021 . . . . 54.2 110.349 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -105.5 104.79 14.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.039 -0.726 . . . . 64.43 109.039 -164.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -99.0 94.24 6.44 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.513 -1.221 . . . . 74.23 107.998 -177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 127.48 32.43 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.121 0.969 . . . . 71.01 109.368 -175.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 129' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -59.88 128.63 87.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.58 0.752 . . . . 72.42 111.235 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HG2' ' HE2' ' B' ' 11' ' ' PHE . 1.2 Cg_endo -79.73 122.61 5.0 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.852 2.368 . . . . 73.03 111.391 -177.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.36 115.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.273 0.629 . . . . 74.53 109.448 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -76.55 105.28 7.52 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.143 -0.688 . . . . 65.44 109.143 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 123.798 0.839 . . . . 70.35 110.571 -177.202 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 C--O 1.24 0.562 0 N-CA-C 108.382 -0.97 . . . . 52.22 108.382 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 47.5 t80 -137.08 129.07 29.27 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.818 -1.178 . . . . 74.15 107.818 172.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -153.02 119.29 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.074 -0.713 . . . . 71.35 109.074 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.623 HG21 ' HG2' ' C' ' 130' ' ' PRO . 52.8 mt -65.69 133.24 31.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 114.922 -1.036 . . . . 73.44 110.026 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -115.66 -22.32 9.24 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.568 0.747 . . . . 74.23 112.447 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -176.12 122.81 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.192 0.451 . . . . 74.31 111.628 -175.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.524 HD13 ' HG2' ' C' ' 130' ' ' PRO . 1.4 mp -110.11 127.45 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.209 -1.034 . . . . 55.42 108.209 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 27.2 p90 -158.44 150.69 21.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.014 0.926 . . . . 74.21 110.284 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.422 HG21 ' SG ' ' A' ' 113' ' ' CYS . 82.2 p -76.81 119.02 20.01 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.834 -0.802 . . . . 73.55 108.834 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -81.68 -42.36 20.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 53.33 109.568 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.69 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 15.3 m-20 -136.26 137.31 40.64 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.724 -1.125 . . . . 64.43 109.053 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.3 mt -133.74 142.53 41.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.458 -1.312 . . . . 75.45 107.458 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -150.49 133.93 16.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.849 -0.797 . . . . 70.51 108.849 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.9 t80 -136.22 132.65 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.564 -1.643 . . . . 62.41 106.564 172.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.42 138.09 42.91 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.622 -0.881 . . . . 74.21 108.622 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.82 79.83 63.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.356 -1.72 . . . . 51.2 106.356 171.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.68 -40.81 76.69 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.297 2.664 . . . . 70.23 113.049 -164.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.37 38.5 3.97 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.748 -0.834 . . . . 54.51 108.748 -177.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.06 -57.63 7.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 117.935 -1.031 . . . . 50.31 113.262 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.5 Cg_exo -62.79 -20.25 70.67 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 122.073 1.849 . . . . 34.2 113.383 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -94.24 -31.87 13.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.178 0.991 . . . . 63.42 111.049 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.1 p -78.33 -19.45 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.716 0.807 . . . . 54.54 111.025 -169.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -73.78 -7.52 52.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.744 0.818 . . . . 73.44 111.397 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -98.33 -19.8 17.56 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 60.44 111.003 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -82.03 166.61 19.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.659 0.783 . . . . 72.44 111.546 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.94 149.18 49.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.996 0.918 . . . . 70.1 110.02 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -86.77 62.35 7.35 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.266 0.555 . . . . 74.3 111.948 -168.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -134.34 66.71 71.4 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.007 0.523 . . . . 75.02 111.298 173.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.18 126.65 2.81 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.008 1.805 . . . . 61.22 110.615 167.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -95.54 105.31 17.27 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.459 -0.941 . . . . 72.23 108.459 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.614 HG23 HG13 ' A' ' 64' ' ' VAL . 2.1 p -75.52 129.64 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.278 -1.328 . . . . 74.31 110.218 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -99.92 141.17 33.09 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 74.21 110.089 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' A' ' 128' ' ' LEU . 0.8 OUTLIER -100.65 118.67 37.26 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.954 -1.128 . . . . 64.5 107.954 173.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.54 145.05 33.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.012 0.525 . . . . 64.13 110.068 170.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.87 141.49 51.27 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.355 -0.979 . . . . 65.12 108.355 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.9 t70 -119.37 138.0 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.583 -1.266 . . . . 63.24 107.583 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -106.66 138.21 43.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.374 0.669 . . . . 75.41 110.629 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.16 110.45 0.91 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.17 0.588 . . . . 54.34 110.492 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -112.76 159.76 18.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.019 -0.734 . . . . 73.33 109.019 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -154.14 150.42 28.12 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.536 0.734 . . . . 53.12 109.716 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.46 143.45 30.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.403 -0.962 . . . . 65.31 108.403 171.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 57' ' ' GLU . 28.6 mt -115.94 -43.88 2.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.396 0.679 . . . . 75.14 109.719 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.86 -167.94 2.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.108 -0.951 . . . . 74.31 110.073 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.76 106.41 0.8 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.553 0.741 . . . . 73.51 110.132 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 23.9 m-20 67.34 13.87 9.5 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.727 1.211 . . . . 73.45 113.095 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.25 117.14 45.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.379 -0.971 . . . . 63.21 108.379 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 64.0 m-85 -125.06 123.39 39.68 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.512 -0.921 . . . . 64.54 108.512 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.589 ' HB2' HD11 ' A' ' 51' ' ' LEU . 27.4 tt0 -88.88 143.11 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.094 -0.957 . . . . 75.2 108.761 173.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.441 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.7 t -119.08 136.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.815 -1.18 . . . . 63.2 107.815 172.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.8 t -127.13 132.38 69.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.065 0.946 . . . . 74.4 108.762 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 106' ' ' LEU . 4.5 mm? -119.67 110.09 16.42 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.336 1.055 . . . . 73.25 108.344 175.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.727 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 26.3 ttp180 -83.81 99.55 10.37 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.012 -0.736 . . . . 62.44 109.012 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 117.35 34.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.313 -1.365 . . . . 72.43 107.313 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 m -116.03 122.24 44.6 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.911 0.862 . . . . 74.45 109.544 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.614 HG13 HG23 ' A' ' 40' ' ' VAL . 49.1 t -112.98 120.93 64.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.492 -1.685 . . . . 72.13 108.181 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -121.45 125.95 48.12 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.934 -0.765 . . . . 73.43 108.934 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.94 121.63 38.44 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.97 -1.122 . . . . 75.03 107.97 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -136.93 132.86 35.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.095 0.558 . . . . 70.15 110.344 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.24 85.18 3.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.003 0.921 . . . . 72.43 109.166 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -90.98 1.54 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-N 114.45 -1.25 . . . . 71.32 110.889 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -122.36 -30.2 4.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.637 0.775 . . . . 73.21 110.423 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.01 131.35 35.78 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.333 -0.617 . . . . 61.11 109.333 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 m -87.01 136.23 32.99 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.232 0.539 . . . . 53.03 111.156 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.776 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.61 -65.22 0.93 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.893 -1.049 . . . . 70.32 109.323 172.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.69 159.28 44.62 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.511 -1.222 . . . . 74.21 111.319 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.9 tp -132.14 115.4 15.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.173 1.389 . . . . 74.23 107.964 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 67.7 m -105.76 138.28 42.21 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.26 -1.015 . . . . 60.33 108.26 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -146.81 115.39 6.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.28 -1.007 . . . . 65.24 108.28 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.39 110.14 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.448 0.699 . . . . 45.32 109.501 -175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.727 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 39.5 mt-30 -84.64 83.19 8.1 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.894 -1.15 . . . . 52.34 107.894 169.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.22 102.22 5.73 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.443 -1.253 . . . . 41.33 107.884 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 156.31 24.77 Favored Glycine 0 C--O 1.243 0.685 0 CA-C-N 115.939 -0.573 . . . . 64.14 111.882 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.3 120.61 1.09 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.503 -1.039 . . . . 71.21 110.503 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.75 125.99 39.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 N-CA-C 108.267 -1.012 . . . . 34.42 108.267 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.553 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.7 m-85 -135.65 144.75 46.22 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.642 -1.244 . . . . 74.13 107.642 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -84.47 93.53 8.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.907 -1.145 . . . . 53.23 107.907 169.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 55.3 mt -100.08 117.92 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 108.56 -0.904 . . . . 62.2 108.56 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -151.03 158.33 43.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.679 0.791 . . . . 64.04 110.38 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.75 10.13 86.11 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.339 0.399 . . . . 65.13 113.788 171.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 pp -113.26 163.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.967 1.307 . . . . 73.44 110.299 -173.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.56 170.64 6.75 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.296 -1.001 . . . . 72.1 108.296 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.05 -126.53 26.88 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 124.07 0.843 . . . . 74.4 114.947 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -72.97 -22.47 60.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.086 0.955 . . . . 71.53 111.639 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.6 -43.96 65.31 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.926 0.491 . . . . 75.11 110.3 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.4 ttt -71.42 -38.52 71.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.759 -0.655 . . . . 64.14 109.358 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.93 72.93 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.49 -0.777 . . . . 65.35 111.233 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -78.98 -27.03 43.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.861 0.464 . . . . 74.0 110.695 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.1 t -73.95 -66.03 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.161 0.184 . . . . 54.33 110.519 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.65 -17.26 36.58 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.445 0.535 . . . . 73.32 112.445 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.85 1.33 44.97 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.43 -0.65 . . . . 50.42 114.265 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.96 -56.8 0.2 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.885 0.842 . . . . 44.24 113.25 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.482 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.6 t80 -76.04 -59.05 2.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.477 0.711 . . . . 75.13 111.221 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.82 -31.99 4.57 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.913 0.885 . . . . 62.42 113.105 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.54 -49.06 14.01 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.647 2.231 . . . . 74.13 113.192 160.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -68.67 -26.53 65.36 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.574 0.75 . . . . 74.23 110.437 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -69.62 -42.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.194 0.597 . . . . 73.25 110.196 172.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.53 HD12 HD23 ' A' ' 60' ' ' LEU . 96.7 mt -80.75 -17.42 51.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.733 0.813 . . . . 75.41 111.568 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.85 -45.8 65.17 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 118.075 -0.964 . . . . 72.44 113.277 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.25 -30.91 64.21 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.986 1.791 . . . . 65.41 112.616 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -78.89 -36.46 42.07 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.423 0.689 . . . . 73.1 111.356 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.53 74.67 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.853 -0.795 . . . . 72.22 108.853 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -51.25 -50.31 59.46 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 125.098 1.499 . . . . 70.23 110.757 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -72.81 -37.63 67.44 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.197 0.936 . . . . 63.4 111.106 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 18' ' ' THR . 41.8 t -62.9 -35.89 81.52 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.08 0.467 . . . . 71.55 110.651 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.467 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 97.0 mt -68.13 -52.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.333 -0.849 . . . . 71.33 109.527 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.481 HG23 ' HG3' ' A' ' 125' ' ' GLN . 92.6 m -52.25 -44.8 65.08 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.775 1.23 . . . . 71.0 111.422 -174.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -66.42 -45.8 78.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.412 -1.267 . . . . 71.24 110.546 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.3 mtm -61.91 -41.16 97.59 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.789 0.436 . . . . 72.53 111.147 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 114' ' ' ILE . 72.4 t -58.5 -49.46 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.227 1.011 . . . . 44.34 110.334 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -69.14 -27.45 65.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.847 0.459 . . . . 55.34 111.383 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.1 mtt-85 -73.61 -20.75 60.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.717 0.807 . . . . 74.44 110.837 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.95 10.83 64.18 Favored Glycine 0 C--N 1.354 1.568 0 CA-C-O 119.676 -0.513 . . . . 61.41 113.539 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m 56.94 32.74 22.08 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.171 1.389 . . . . 73.11 110.646 -173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -99.09 153.85 37.59 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-N 114.897 -1.047 . . . . 75.13 109.097 173.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.47 144.97 95.54 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.365 2.043 . . . . 72.31 110.944 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.1 tt0 -55.05 130.13 40.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.864 0.728 . . . . 73.14 111.298 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.4 tp -111.51 102.71 11.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.03 0.932 . . . . 63.4 109.516 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.36 102.63 14.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.753 -1.203 . . . . 64.31 107.753 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.65 116.97 6.17 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 107.765 -1.198 . . . . 62.5 107.765 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.61 135.92 94.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.428 0.691 . . . . 70.2 112.241 -172.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.24 137.81 49.01 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.763 2.308 . . . . 64.41 112.983 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.94 134.7 65.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.033 0.933 . . . . 71.4 109.258 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -84.01 77.61 9.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.201 1.0 . . . . 71.3 110.908 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -66.59 -40.79 89.06 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.45 0.643 . . . . 72.43 109.932 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.646 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.3 p-10 . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 125.036 1.334 . . . . 71.54 111.69 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 107.394 -1.336 . . . . 53.35 107.394 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -140.62 135.72 32.01 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.314 0.646 . . . . 70.11 109.314 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -152.99 140.59 19.86 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.146 0.903 . . . . 72.24 109.708 167.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 pp -80.51 140.21 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.333 -1.358 . . . . 75.24 107.333 169.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -98.02 -44.32 6.7 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.071 -0.714 . . . . 62.01 109.071 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -164.41 138.67 5.42 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.331 -0.85 . . . . 71.23 109.28 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.77 137.22 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 106.344 -1.724 . . . . 75.12 106.344 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -166.08 161.64 17.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.414 0.626 . . . . 74.44 111.88 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.9 m -90.24 117.66 29.16 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.017 -0.992 . . . . 71.31 108.818 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -87.67 -27.91 22.15 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.453 -0.794 . . . . 74.42 111.056 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -159.81 143.69 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.411 0.444 . . . . 70.42 111.928 -174.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' ILE . . . . . 0.474 HD11 ' SG ' ' B' ' 113' ' ' CYS . 44.9 mm -134.63 143.46 37.68 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 125.286 1.435 . . . . 74.13 109.055 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -144.37 130.53 19.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.757 -1.201 . . . . 53.43 107.757 173.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -145.59 114.45 6.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.352 -1.351 . . . . 71.03 107.352 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.1 mt-10 -118.78 137.51 53.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.131 0.572 . . . . 72.41 109.673 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.931 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -129.34 78.69 75.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.814 -1.18 . . . . 73.42 107.814 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.4 -18.24 38.78 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.471 2.781 . . . . 65.44 113.448 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -126.81 12.88 7.36 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.315 1.446 . . . . 71.0 110.739 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.931 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -44.71 -57.18 7.19 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 115.817 1.784 . . . . 71.22 115.817 -165.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.0 Cg_exo -66.01 -26.8 50.63 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.528 2.152 . . . . 62.21 112.336 -173.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.459 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.9 m80 -91.46 -43.79 9.5 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.129 -0.941 . . . . 71.32 111.465 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.7 -26.37 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.244 0.618 . . . . 73.03 112.389 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -58.8 -24.01 61.23 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.026 0.93 . . . . 71.32 113.029 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 24.2 pt20 -76.47 -6.52 52.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.224 0.61 . . . . 71.2 112.424 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -103.93 109.49 21.26 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.162 -0.681 . . . . 74.44 109.162 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -95.46 96.93 9.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.266 0.469 . . . . 74.55 112.266 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.18 177.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.18 1.392 . . . . 74.23 110.511 162.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -78.7 138.03 58.36 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.121 0.968 . . . . 75.14 112.082 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -84.41 158.3 12.72 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.796 2.33 . . . . 73.01 112.881 167.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.49 128.2 35.23 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.813 -1.18 . . . . 74.22 107.813 162.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.9 t -108.48 131.72 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.302 0.641 . . . . 74.25 109.891 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.74 135.6 46.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.603 1.161 . . . . 72.51 109.194 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -109.16 125.62 52.38 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.222 1.009 . . . . 72.54 108.331 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -141.01 118.55 11.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.217 0.607 . . . . 61.12 109.368 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 pp -99.75 165.31 11.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.789 -0.449 . . . . 60.14 109.789 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -146.82 136.52 23.1 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.805 1.242 . . . . 71.13 108.095 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -120.93 105.54 10.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.609 0.764 . . . . 62.45 111.189 -167.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.19 155.27 31.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.861 0.864 . . . . 72.21 109.984 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.2 p -146.85 169.04 19.95 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.272 1.029 . . . . 53.45 109.885 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -153.46 137.63 16.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.308 0.643 . . . . 62.0 109.523 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -83.54 111.69 19.31 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.716 -0.476 . . . . 71.45 109.716 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.24 -45.78 13.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.689 0.618 . . . . 74.23 110.257 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 -168.01 2.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.218 -0.901 . . . . 60.32 110.701 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.01 108.32 3.03 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.997 -1.001 . . . . 72.43 109.883 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.8 11.11 7.37 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.945 1.298 . . . . 72.14 112.641 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.42 113.63 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.646 -0.872 . . . . 51.52 108.646 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.92 139.87 53.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.438 0.695 . . . . 74.02 109.522 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -101.78 106.39 17.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.528 -1.286 . . . . 54.3 107.528 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.19 123.6 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.256 1.022 . . . . 64.25 110.213 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -103.39 113.47 40.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.003 0.921 . . . . 74.21 109.496 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.61 100.02 10.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.614 -1.254 . . . . 75.52 107.614 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.7 ttm180 -85.3 128.18 34.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.116 -0.698 . . . . 71.35 109.116 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.26 106.13 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.1 -1.074 . . . . 71.4 108.1 172.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -98.55 126.72 44.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.522 0.729 . . . . 75.52 109.375 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.621 HG21 HG21 ' B' ' 114' ' ' ILE . 93.7 t -118.33 116.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.889 -1.05 . . . . 64.15 108.575 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.7 m -116.32 140.48 49.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.653 -0.869 . . . . 75.23 108.653 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.92 142.73 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.81 -1.181 . . . . 52.0 107.81 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 38.9 p -150.31 141.96 23.59 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.074 0.55 . . . . 74.15 110.64 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -138.1 136.53 36.84 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.223 1.009 . . . . 62.23 110.534 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.4 -124.1 26.68 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.766 -0.652 . . . . 31.21 112.455 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -96.98 2.91 52.11 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.328 1.051 . . . . 73.42 111.066 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.65 -179.87 7.45 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.469 0.544 . . . . 63.33 112.469 -167.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -73.29 154.67 40.06 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.518 1.127 . . . . 53.2 111.235 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.533 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.77 -57.8 2.15 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.052 -1.092 . . . . 51.42 108.052 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -160.28 161.41 33.36 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.492 -1.231 . . . . 71.33 109.674 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 50.7 mt -116.95 131.34 56.98 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.273 -1.38 . . . . 72.31 107.273 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.09 150.46 39.54 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.09 -0.707 . . . . 75.35 109.09 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 77' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 45.0 tt0 -164.55 133.71 3.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.66 0.784 . . . . 63.32 108.975 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.3 t -130.61 145.7 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.276 1.03 . . . . 71.34 108.289 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -121.87 95.68 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.668 -1.234 . . . . 74.23 107.668 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 48.8 tp60 -90.4 99.69 12.67 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.28 -1.007 . . . . 74.25 108.28 177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 165.49 32.14 Favored Glycine 0 C--O 1.242 0.631 0 N-CA-C 111.165 -0.774 . . . . 72.42 111.165 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.51 127.18 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.025 -0.83 . . . . 10.43 111.025 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.58 129.09 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.961 -1.125 . . . . 63.41 107.961 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -133.02 134.79 44.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.074 0.95 . . . . 75.03 109.084 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.8 m -99.36 105.15 17.09 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 61.3 107.75 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.463 HD12 HD11 ' B' ' 89' ' ' ILE . 29.9 pt -119.75 142.88 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.631 0.772 . . . . 71.54 110.065 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.58 161.12 41.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.757 0.823 . . . . 44.21 109.984 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.49 -54.43 3.83 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 123.647 0.592 . . . . 71.23 112.13 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.463 HD11 HD12 ' B' ' 86' ' ' ILE . 28.6 pt -54.44 145.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.531 1.132 . . . . 53.43 112.026 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -165.99 152.5 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.553 0.533 . . . . 70.3 110.485 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.95 -128.29 34.19 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.869 0.73 . . . . 44.35 114.058 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.6 m -69.25 -29.94 67.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.726 0.811 . . . . 74.32 110.77 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.65 -26.81 58.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.919 0.888 . . . . 63.21 110.392 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 35.3 ttm -62.71 -32.96 74.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.826 0.85 . . . . 71.54 110.422 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.77 -29.01 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.96 0.904 . . . . 33.21 112.608 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 96' ' ' HIS . . . . . 0.476 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 51.4 t-80 -69.07 -26.55 65.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.522 0.329 . . . . 74.34 110.773 175.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -80.94 -63.17 1.46 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.179 -0.304 . . . . 64.33 110.179 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.481 HD12 ' N ' ' B' ' 99' ' ' GLY . 3.5 pp -67.12 -31.66 72.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.656 0.613 . . . . 74.3 112.656 -172.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 99' ' ' GLY . . . . . 0.481 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -108.32 3.08 32.94 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 119.718 -0.49 . . . . 61.42 114.284 -171.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 100' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -144.16 -57.64 0.38 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.377 0.588 . . . . 52.32 111.7 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.38 -53.75 11.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.312 0.645 . . . . 73.43 111.459 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 68.0 m -64.28 -45.05 78.27 Favored Pre-proline 0 CA--C 1.565 1.522 0 C-N-CA 123.956 0.903 . . . . 64.33 111.601 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.7 Cg_exo -55.6 -39.96 88.09 Favored 'Trans proline' 0 C--N 1.402 3.348 0 C-N-CA 122.649 2.233 . . . . 64.02 113.236 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -58.4 -29.17 65.86 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 123.579 0.752 . . . . 61.44 111.29 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 105' ' ' ILE . . . . . 0.403 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 73.1 mt -80.54 -53.42 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.786 0.834 . . . . 73.31 110.886 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.48 -24.54 56.95 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.367 0.667 . . . . 72.31 112.545 -170.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -63.53 -48.15 81.71 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.913 -1.041 . . . . 65.13 112.893 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 84.7 Cg_exo -51.9 -43.09 54.3 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.455 2.103 . . . . 53.42 113.966 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE2' HG21 ' D' ' 115' ' ' THR . 86.7 m-85 -67.1 -47.43 71.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.348 0.659 . . . . 75.25 110.888 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 110' ' ' ALA . . . . . 0.536 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.09 -48.27 80.67 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.813 0.696 . . . . 72.11 110.127 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -51.85 -52.27 50.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.806 1.642 . . . . 73.44 111.628 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.39 -35.0 78.43 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 123.657 0.598 . . . . 63.03 109.727 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.474 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.8 t -68.08 -31.0 70.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 122.93 0.492 . . . . 53.52 111.527 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.621 HG21 HG21 ' B' ' 64' ' ' VAL . 53.7 mt -70.14 -55.25 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.562 -0.903 . . . . 73.31 108.562 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -54.93 -33.91 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.88 1.363 . . . . 64.42 111.628 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -63.35 -51.56 65.4 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.398 -0.819 . . . . 62.13 109.552 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.76 -34.17 69.26 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.786 0.679 . . . . 75.2 111.318 -174.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 118' ' ' VAL . . . . . 0.422 HG21 HD23 ' B' ' 126' ' ' LEU . 85.0 t -62.64 -44.73 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.879 0.872 . . . . 72.5 110.011 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.8 t -68.6 -35.28 77.13 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.179 -0.919 . . . . 71.21 110.634 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.59 -29.42 69.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.026 0.53 . . . . 65.24 110.326 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.7 18.28 35.38 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.967 0.792 . . . . 54.35 112.629 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 35.5 p 54.51 44.98 27.94 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.876 1.67 . . . . 65.23 112.881 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 123' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' B' ' 124' ' ' PRO . 41.4 m-85 -112.78 147.32 36.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.403 0.681 . . . . 71.43 109.709 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 123' ' ' PHE . 10.6 Cg_exo -70.01 -165.63 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.41 2.74 . . . . 43.24 113.954 -175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.421 HE21 ' N ' ' B' ' 126' ' ' LEU . 22.9 tp60 -61.27 129.56 41.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.967 1.099 . . . . 71.11 113.967 -163.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 HG21 ' B' ' 118' ' ' VAL . 27.5 tp -136.3 118.35 15.37 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.609 1.163 . . . . 62.11 108.951 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -134.5 134.48 41.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.157 -1.053 . . . . 72.44 108.157 166.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.58 148.17 24.98 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.928 0.394 . . . . 74.34 111.342 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.07 147.94 55.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.204 1.002 . . . . 52.24 112.352 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 130' ' ' PRO . . . . . 0.454 ' HG3' ' CD1' ' D' ' 16' ' ' ILE . 85.0 Cg_endo -75.82 79.78 2.77 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.53 2.82 . . . . 75.13 111.306 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 58.4 t -88.99 111.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.781 -1.192 . . . . 74.21 107.781 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -71.54 94.52 1.31 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 124.162 0.914 . . . . 75.05 109.341 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 . . . . . 0 N--CA 1.483 1.179 0 C-N-CA 124.091 0.956 . . . . 74.03 111.391 -177.596 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.445 ' HG3' HD13 ' C' ' 89' ' ' ILE . 41.0 ttm . . . . . 0 CA--C 1.549 0.92 0 CA-C-O 121.384 0.611 . . . . 72.12 111.703 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.2 m -89.82 79.57 6.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.486 -0.931 . . . . 71.15 108.486 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -90.78 120.88 32.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -146.14 125.7 13.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.292 0.637 . . . . 74.22 109.594 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.29 138.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.433 -0.803 . . . . 72.3 110.395 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.86 -51.65 3.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.02 -0.363 . . . . 73.54 110.02 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -172.22 129.81 0.59 Allowed 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.276 0.36 . . . . 74.52 110.466 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.347 -0.982 . . . . 63.32 108.347 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG12 ' C' ' 83' ' ' ILE . 39.9 p90 -173.32 172.5 3.76 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.428 0.632 . . . . 74.34 111.417 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -92.16 114.95 27.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.647 -0.706 . . . . 61.24 110.103 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -64.48 -38.41 90.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.033 -0.728 . . . . 74.41 109.033 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.7 t70 -153.73 148.14 26.04 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.571 -1.195 . . . . 74.23 110.043 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -136.15 143.26 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 105.606 -1.998 . . . . 73.25 105.606 171.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -156.18 150.1 25.16 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.391 0.615 . . . . 62.32 109.868 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -152.59 118.19 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.481 -1.303 . . . . 71.45 107.481 173.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -115.44 139.43 50.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.655 -1.239 . . . . 75.42 107.655 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 84.25 53.48 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.66 -1.237 . . . . 75.1 107.66 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.32 -45.09 28.77 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.101 2.534 . . . . 72.23 112.226 -176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.27 50.73 0.79 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.591 -0.892 . . . . 72.21 108.591 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.59 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -55.73 -48.15 97.17 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 115.518 -0.764 . . . . 73.23 112.832 -175.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 1.9 Cg_endo -85.91 -33.7 0.2 Allowed 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.929 1.752 . . . . 74.02 112.836 169.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 55.8 t60 -70.23 -33.52 71.75 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.657 0.984 . . . . 72.05 113.657 -167.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -79.44 -14.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 122.815 0.446 . . . . 75.02 111.224 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -71.31 -14.91 62.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.624 0.77 . . . . 74.04 111.601 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 33' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.1 pt20 -105.14 12.51 31.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.525 0.73 . . . . 62.23 110.824 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.443 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 1.1 mptm? -97.45 176.71 5.77 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.021 0.915 . . . . 63.51 112.994 -170.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -87.91 128.5 35.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.384 -1.735 . . . . 72.03 108.938 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.648 0.592 . . . . 73.44 111.206 -168.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -148.24 58.89 4.06 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.247 0.619 . . . . 52.31 110.319 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.37 123.31 10.1 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.767 2.311 . . . . 64.54 112.387 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.98 77.57 8.42 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.551 -1.648 . . . . 64.43 106.551 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -73.83 97.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.838 -1.074 . . . . 65.32 108.4 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -93.49 122.08 35.55 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.95 -1.023 . . . . 74.31 109.01 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.31 121.51 28.98 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.308 -1.368 . . . . 64.03 107.308 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.0 t70 -121.85 135.43 54.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.691 -1.225 . . . . 74.03 107.691 176.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tt -137.21 120.12 16.43 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.335 -0.987 . . . . 71.23 108.335 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.547 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 5.6 t70 -113.46 148.11 36.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.056 0.942 . . . . 62.44 108.71 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 62.0 p -117.19 118.85 33.46 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.212 -0.904 . . . . 75.45 109.753 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -124.37 146.6 48.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.0 0.92 . . . . 34.42 109.5 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.6 p -151.48 157.4 42.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.687 0.395 . . . . 75.21 110.584 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 49' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 20.0 m -143.81 147.53 34.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.133 0.973 . . . . 71.14 108.635 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -101.93 115.76 31.23 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.953 -1.129 . . . . 74.34 107.953 168.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' C' ' 57' ' ' GLU . 28.5 mt -98.18 -27.6 14.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.324 0.65 . . . . 63.12 110.034 -175.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.72 -171.38 1.83 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.242 1.017 . . . . 70.32 110.334 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.51 124.76 25.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.254 -0.884 . . . . 71.14 109.237 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 69.85 -8.88 0.75 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.878 1.671 . . . . 74.41 112.728 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.91 112.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.407 -0.59 . . . . 64.31 109.407 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -127.54 126.08 41.52 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.476 1.11 . . . . 63.44 108.685 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.603 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.4 tt0 -82.52 118.53 23.33 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.809 0.843 . . . . 75.33 108.745 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.15 114.75 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.952 -1.129 . . . . 53.43 107.952 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 59' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 43.6 t -110.64 131.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.071 -0.714 . . . . 63.04 109.071 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.436 HD13 ' HB3' ' C' ' 103' ' ' PRO . 36.2 tp -111.97 103.14 11.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.971 -1.122 . . . . 64.12 107.971 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.547 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 55.1 ttm-85 -81.32 115.36 20.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.883 -1.154 . . . . 64.4 107.883 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -116.73 108.74 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.905 -1.146 . . . . 75.43 107.905 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.1 m -116.02 124.37 50.29 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.834 0.854 . . . . 71.11 108.755 -174.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 56.2 t -117.8 113.71 43.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.846 -0.798 . . . . 73.31 108.846 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -100.88 146.84 26.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.595 -0.73 . . . . 72.13 109.343 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.66 13.06 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.132 -0.692 . . . . 74.24 109.132 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -131.63 126.28 34.32 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.841 -0.799 . . . . 70.14 108.841 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' C' ' 73' ' ' ALA . 9.2 mp -84.56 57.32 4.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.894 0.878 . . . . 63.25 109.399 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.1 -114.03 4.2 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.072 -1.211 . . . . 73.52 110.072 -174.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -90.8 -22.83 20.83 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.87 0.868 . . . . 62.15 110.322 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 7.3 tp10 -87.87 117.83 26.98 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.433 0.693 . . . . 70.12 110.844 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -76.23 128.05 34.13 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.006 0.431 . . . . 73.33 110.647 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 73' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' C' ' 68' ' ' LEU . . . -77.32 -60.45 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.792 -1.094 . . . . 60.42 109.422 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.11 176.47 12.21 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.88 -1.055 . . . . 72.32 110.58 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -140.98 120.86 13.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 106.357 -1.72 . . . . 71.13 106.357 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -117.01 119.89 36.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.439 -0.949 . . . . 72.02 108.439 177.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.69 141.71 51.53 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.72 -0.844 . . . . 70.31 108.72 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -147.41 115.14 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.444 1.098 . . . . 73.41 108.823 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.1 mt-30 -89.41 97.84 11.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.988 -1.115 . . . . 71.15 107.988 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -88.97 100.86 13.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.719 -0.673 . . . . 52.33 109.328 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.21 147.24 18.5 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.146 -0.479 . . . . 64.21 112.366 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.38 125.57 2.37 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 111.008 -0.837 . . . . 75.21 111.008 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' D' ' 29' ' ' PRO . 13.4 mm -81.76 122.66 37.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.765 -0.828 . . . . 61.1 108.765 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.54 138.17 45.93 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.3 p -109.34 106.17 15.86 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.933 -0.765 . . . . 71.21 108.933 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.46 142.24 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.856 0.863 . . . . 72.42 110.709 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.8 163.18 35.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.942 0.897 . . . . 43.01 110.406 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.82 -21.13 34.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.833 -0.621 . . . . 64.51 113.406 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 89' ' ' ILE . . . . . 0.445 HD13 ' HG3' ' C' ' 9' ' ' MET . 36.4 pt -114.18 148.16 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.063 0.945 . . . . 54.35 109.914 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -160.22 148.19 16.61 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.494 0.497 . . . . 61.03 110.099 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.51 -112.66 4.49 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 124.293 0.996 . . . . 72.22 113.543 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -64.69 -37.22 86.85 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.062 0.945 . . . . 65.12 111.775 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -65.88 -46.73 77.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.135 0.574 . . . . 72.25 110.937 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 94' ' ' MET . . . . . 0.437 ' HA ' HD12 ' C' ' 89' ' ' ILE . 3.1 ppp? -74.53 -20.97 59.76 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.509 -0.769 . . . . 63.55 110.146 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.66 72.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.408 0.683 . . . . 64.12 111.074 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 53.1 t-80 -68.18 -46.86 69.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.247 -0.433 . . . . 74.32 110.596 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.98 -56.56 9.62 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.141 -0.481 . . . . 64.02 110.376 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.02 -40.43 96.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.449 1.1 . . . . 63.14 111.894 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.93 70.42 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.481 -0.622 . . . . 70.04 114.415 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -149.87 -59.76 0.2 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.808 0.804 . . . . 73.12 111.988 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -75.0 -50.93 14.91 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.244 -0.435 . . . . 72.15 112.008 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.66 -45.76 97.09 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.577 0.751 . . . . 63.45 112.95 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 103' ' ' PRO . . . . . 0.436 ' HB3' HD13 ' C' ' 60' ' ' LEU . 44.2 Cg_endo -67.65 -24.72 41.11 Favored 'Trans proline' 0 C--N 1.393 2.875 0 C-N-CA 121.983 1.788 . . . . 74.32 112.882 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.47 -40.49 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.257 0.623 . . . . 71.24 109.392 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.08 -46.76 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.634 -0.712 . . . . 71.41 110.195 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.07 -20.84 44.23 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.27 -0.877 . . . . 70.41 112.226 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.9 -54.74 48.78 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.109 -0.948 . . . . 73.55 113.538 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.49 -31.52 71.53 Favored 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.994 1.796 . . . . 53.44 112.972 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -66.1 -45.38 81.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.524 0.73 . . . . 63.21 110.756 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.13 -37.78 86.54 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.852 -0.613 . . . . 74.04 110.439 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -60.56 -54.11 49.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.298 1.439 . . . . 70.32 111.425 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -35.39 80.28 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.608 0.568 . . . . 74.12 110.172 -177.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.09 -38.87 86.46 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.079 0.552 . . . . 71.44 111.822 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -67.76 -50.94 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.436 0.694 . . . . 61.53 110.169 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.4 m -63.14 -28.79 70.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.368 0.667 . . . . 61.11 111.311 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.6 t -67.58 -47.85 68.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.18 -0.674 . . . . 61.53 109.18 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.555 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.45 -37.67 86.82 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.961 0.904 . . . . 75.41 112.325 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.52 -40.58 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.049 0.539 . . . . 61.32 109.918 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.33 -33.96 76.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.651 0.78 . . . . 75.24 111.229 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.474 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 71.4 mtt-85 -70.48 -27.11 63.96 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.9 0.88 . . . . 73.12 110.901 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.24 15.01 62.13 Favored Glycine 0 C--N 1.352 1.45 0 O-C-N 123.63 0.581 . . . . 44.24 112.817 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.534 HG23 ' HB3' ' D' ' 17' ' ' TYR . 49.6 p 55.0 26.39 7.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.901 1.681 . . . . 65.21 112.638 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -103.46 141.86 23.38 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 124.425 1.09 . . . . 72.21 108.887 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -40.6 111.77 0.16 Allowed 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 124.148 3.232 . . . . 75.15 113.893 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -57.23 123.67 16.13 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.148 0.905 . . . . 74.13 111.268 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -112.36 110.75 21.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.128 -1.064 . . . . 73.54 108.128 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -94.97 117.38 30.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.635 -0.876 . . . . 71.33 108.635 175.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.55 142.25 53.66 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.516 0.51 . . . . 61.32 110.268 175.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.2 160.84 81.73 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 115.099 -0.955 . . . . 63.32 111.065 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.623 ' HG2' HG21 ' A' ' 13' ' ' ILE . 26.0 Cg_exo -59.76 100.73 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.65 2.233 . . . . 63.42 112.455 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.2 t -98.85 107.12 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.399 -0.963 . . . . 74.01 108.399 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -114.34 106.25 14.09 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.232 1.013 . . . . 64.31 108.559 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' C' C ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 51.1 m-85 -63.91 -30.64 71.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.731 0.812 . . . . 72.43 111.429 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.482 1.126 0 C-N-CA 123.849 0.86 . . . . 63.22 110.515 173.844 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.5 m . . . . . 0 C--O 1.236 0.365 0 N-CA-C 107.735 -1.209 . . . . 54.42 107.735 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -156.8 92.93 1.32 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.05 -1.463 . . . . 55.25 107.05 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -122.02 156.44 33.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.674 0.79 . . . . 63.13 109.363 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.507 HD13 HG21 ' D' ' 105' ' ' ILE . 11.3 mt -102.0 122.48 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.983 -0.747 . . . . 42.15 108.983 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.25 -49.57 10.6 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.433 -0.58 . . . . 74.11 109.433 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 15' ' ' ARG . . . . . 0.513 ' HE ' HD12 ' D' ' 83' ' ' ILE . 19.4 ptt180 -173.65 152.67 2.11 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 112.171 0.434 . . . . 72.14 112.171 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.454 ' CD1' ' HG3' ' B' ' 130' ' ' PRO . 4.0 mp -114.36 139.35 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.621 -1.622 . . . . 72.42 106.621 167.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.59 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 41.2 p90 -162.56 157.67 22.43 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.833 0.853 . . . . 64.22 109.691 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -81.42 113.55 19.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.459 -1.246 . . . . 72.45 109.175 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.9 mtpt -83.33 -33.2 25.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.098 0.475 . . . . 63.14 109.812 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.6 t70 -144.93 135.54 24.45 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.537 -1.21 . . . . 71.34 109.038 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.555 HG21 ' HE2' ' C' ' 117' ' ' MET . 53.4 mt -133.43 140.89 45.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.351 -1.351 . . . . 64.05 107.351 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -154.44 102.32 2.41 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.675 0.79 . . . . 62.55 109.466 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.0 t80 -108.39 115.49 30.2 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 105.783 -1.932 . . . . 73.32 105.783 167.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -121.01 131.78 54.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.149 -0.686 . . . . 74.23 109.149 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.45 78.26 45.77 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.284 -1.376 . . . . 75.13 107.284 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.9 -35.15 36.49 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.675 2.25 . . . . 62.42 111.522 -172.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 6.7 m120 -109.91 22.29 15.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.775 0.83 . . . . 72.01 109.99 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.43 -64.82 0.31 Allowed Pre-proline 0 CA--C 1.571 1.773 0 N-CA-C 116.13 1.9 . . . . 74.13 116.13 -171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.508 ' HB3' HD11 ' C' ' 83' ' ' ILE . 40.0 Cg_endo -81.03 -14.5 10.91 Favored 'Trans proline' 0 C--N 1.39 2.744 0 CA-C-N 122.023 1.758 . . . . 74.41 113.339 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 30' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 1.3 t60 -71.35 -37.43 71.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.901 1.28 . . . . 71.44 109.06 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.633 HG13 HD11 ' D' ' 68' ' ' LEU . 76.1 t -74.12 -30.98 28.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 115.131 -0.94 . . . . 74.32 109.95 175.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -70.84 6.76 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.644 0.979 . . . . 73.21 113.644 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -84.48 -37.84 20.84 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.367 -0.605 . . . . 75.24 109.367 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 34' ' ' LYS . . . . . 0.426 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 30.4 pttt -132.45 95.87 3.72 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 124.23 1.012 . . . . 74.12 112.319 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -108.72 92.74 4.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 72.42 109.522 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 36' ' ' TRP . . . . . 0.426 ' HZ3' ' HA ' ' D' ' 34' ' ' LYS . 12.3 m-90 -125.86 -179.99 4.93 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.364 -1.347 . . . . 75.13 107.364 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -50.05 104.65 0.44 Allowed Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.476 0.71 . . . . 73.03 112.055 -163.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.69 109.72 2.91 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.958 2.438 . . . . 70.41 109.464 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.62 113.9 4.04 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.589 -0.893 . . . . 74.54 108.589 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 40' ' ' VAL . . . . . 0.418 HG11 HD11 ' D' ' 126' ' ' LEU . 1.2 m -104.78 114.2 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 114.436 -1.256 . . . . 45.44 110.64 -166.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 81.1 tttt -87.54 128.65 35.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.198 1.399 . . . . 73.4 108.945 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -101.77 114.17 27.99 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.382 0.673 . . . . 75.55 109.828 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.646 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -106.84 109.43 21.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.256 -1.387 . . . . 73.41 107.256 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.5 130.88 44.54 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.245 -1.02 . . . . 74.44 108.245 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -133.49 130.39 38.48 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.149 -1.056 . . . . 72.23 108.149 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -103.88 142.4 34.47 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.6 0.76 . . . . 63.14 109.781 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.24 150.65 27.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.549 0.74 . . . . 71.22 109.251 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.5 p -164.63 153.32 12.72 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.393 0.677 . . . . 41.53 109.332 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -158.65 142.55 15.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.063 0.545 . . . . 63.35 110.054 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -73.05 128.47 35.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.356 0.662 . . . . 71.22 109.393 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -100.88 -26.32 13.79 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.884 0.474 . . . . 73.32 110.552 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.52 -179.09 4.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.753 0.821 . . . . 61.21 110.82 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.04 119.82 12.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.852 -1.067 . . . . 62.51 108.858 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 54' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 40.5 m-20 66.39 16.79 10.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.044 1.338 . . . . 75.03 111.891 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.81 114.81 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.934 0.894 . . . . 72.23 108.969 175.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 56' ' ' TYR . . . . . 0.448 ' HB2' HD12 ' D' ' 86' ' ' ILE . 90.4 m-85 -132.81 129.45 38.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.352 1.061 . . . . 73.22 108.489 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -100.27 139.73 35.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.384 1.074 . . . . 50.5 109.789 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.58 118.8 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 73.45 108.305 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.5 t -104.99 131.4 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.442 -0.947 . . . . 72.51 108.442 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.93 109.76 12.84 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.991 -1.115 . . . . 70.24 107.991 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.2 ttm-85 -87.05 109.36 19.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.537 0.735 . . . . 74.12 109.838 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.56 104.25 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.591 -1.263 . . . . 50.22 107.591 166.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.8 m -100.0 136.51 39.8 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.433 -0.58 . . . . 65.31 109.433 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.06 110.12 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.46 1.104 . . . . 63.24 108.255 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 39.6 m -102.97 103.08 13.17 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.597 0.759 . . . . 63.5 109.244 175.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.59 135.99 36.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 29.5 p -148.36 124.28 10.64 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.641 0.588 . . . . 63.33 110.433 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.634 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.5 OUTLIER -113.04 126.7 55.78 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.422 -0.955 . . . . 54.01 108.422 172.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -134.03 28.11 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.474 -0.65 . . . . 65.32 111.474 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.26 4.2 54.38 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.979 0.512 . . . . 73.33 110.874 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -119.07 144.18 46.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 75.41 111.337 -168.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.8 m -74.72 120.1 19.81 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 123.469 0.708 . . . . 75.13 109.895 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.634 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -67.94 -61.53 1.82 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.252 0.97 . . . . 72.42 110.191 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.37 168.56 26.24 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.247 -1.342 . . . . 63.54 110.454 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.7 mt -127.45 139.57 52.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.65 -1.611 . . . . 72.31 106.65 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' HG23 ' D' ' 114' ' ' ILE . 36.2 t -153.38 110.21 3.42 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.415 -0.587 . . . . 70.32 109.415 -175.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -136.45 132.18 35.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.45 1.1 . . . . 71.43 108.998 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.39 121.79 20.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.117 0.567 . . . . 65.31 109.614 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -88.74 88.83 7.74 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.321 -0.992 . . . . 61.42 108.321 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -81.11 96.63 7.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.565 -1.198 . . . . 65.15 108.958 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.09 144.24 17.01 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.579 -0.608 . . . . 64.45 111.579 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.74 130.0 4.03 Favored Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 110.834 -0.906 . . . . 74.33 110.834 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 83' ' ' ILE . . . . . 0.513 HD12 ' HE ' ' D' ' 15' ' ' ARG . 48.0 mt -89.82 127.04 42.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.527 -0.916 . . . . 64.4 108.527 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -129.12 133.51 47.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.724 0.809 . . . . 74.24 109.759 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.1 m -80.92 94.98 6.61 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 108.901 -0.777 . . . . 55.11 108.901 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' D' ' 56' ' ' TYR . 40.1 mt -111.34 123.63 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.444 0.698 . . . . 62.13 110.202 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 87' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -149.67 165.01 33.63 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.767 0.827 . . . . 52.53 110.671 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.71 -19.44 24.73 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.411 0.925 . . . . 52.12 115.411 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 19.7 pt -129.2 134.73 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 117.835 0.817 . . . . 40.31 111.879 -170.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.33 -171.26 3.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.617 0.767 . . . . 63.04 110.061 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 -140.41 34.5 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.622 0.576 . . . . 61.04 112.18 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -78.19 -20.87 51.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.381 0.672 . . . . 70.31 111.57 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -60.44 -52.96 63.01 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.759 0.823 . . . . 75.21 110.17 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.27 -41.56 69.87 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 114.86 -1.063 . . . . 55.45 109.923 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.38 -26.92 68.68 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.476 0.71 . . . . 75.11 112.36 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.88 -42.04 25.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.347 0.659 . . . . 73.44 109.694 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.39 -31.03 71.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.068 0.547 . . . . 63.42 110.836 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -46.59 18.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 71.3 108.611 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.14 -20.05 79.41 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.97 -1.013 . . . . 75.2 114.377 -173.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.98 -61.71 1.22 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 117.17 0.485 . . . . 72.35 111.805 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -67.11 -40.89 86.95 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 112.677 0.621 . . . . 75.44 112.677 -170.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.5 m -63.76 -47.48 81.52 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-O 118.72 -0.657 . . . . 65.33 111.742 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.3 -40.2 35.43 Favored 'Trans proline' 0 C--N 1.4 3.269 0 C-N-CA 123.045 2.497 . . . . 63.11 114.196 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -59.78 -27.0 66.17 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 112.764 0.653 . . . . 64.11 112.764 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.507 HG21 HD13 ' D' ' 13' ' ' ILE . 41.6 mm -82.42 -44.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-O 121.157 0.503 . . . . 53.02 110.572 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.1 mt -76.29 -32.2 58.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.97 -1.014 . . . . 72.25 111.722 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 107' ' ' PHE . . . . . 0.408 ' HZ ' ' HG ' ' D' ' 128' ' ' LEU . 62.8 t80 -63.48 -42.86 76.36 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.566 1.146 . . . . 75.44 113.872 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.08 -42.65 45.37 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 122.386 2.058 . . . . 61.04 113.19 171.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -81.26 -27.67 35.07 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.58 0.752 . . . . 75.21 111.858 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.61 -53.54 49.97 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 173.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 39.1 ttp180 -58.74 -42.08 87.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.837 -1.529 . . . . 61.11 110.99 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.74 -49.92 74.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.771 0.828 . . . . 72.0 110.708 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -60.19 -44.2 95.28 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.843 0.714 . . . . 52.51 111.176 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.578 HG23 ' SG ' ' D' ' 76' ' ' CYS . 49.8 mt -58.57 -55.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 72.42 111.07 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 115' ' ' THR . . . . . 0.505 HG21 ' HE2' ' B' ' 109' ' ' TYR . 63.2 m -53.24 -47.46 69.01 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.239 1.016 . . . . 72.43 111.758 -174.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 46.7 t -62.14 -37.8 86.54 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.655 -1.157 . . . . 63.12 111.204 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 72.6 mtm -75.17 -32.14 61.19 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.871 0.469 . . . . 74.22 111.998 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.516 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -68.07 -36.93 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 116.066 -0.515 . . . . 54.41 109.733 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.2 p -72.54 -28.44 62.84 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.874 0.47 . . . . 65.24 111.085 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 120' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.4 mtt-85 -73.06 -27.23 61.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.673 0.789 . . . . 71.24 110.635 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.95 8.42 76.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.015 -0.538 . . . . 74.43 112.395 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p 66.54 13.67 9.39 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.084 2.154 . . . . 51.32 114.02 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 123' ' ' PHE . . . . . 0.489 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 76.5 m-85 -90.99 169.19 12.12 Favored Pre-proline 0 CA--C 1.568 1.647 0 C-N-CA 124.536 1.135 . . . . 70.02 107.964 169.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 124' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 93.0 Cg_endo -74.47 166.94 28.29 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.532 2.155 . . . . 61.45 112.92 -172.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.9 121.69 13.02 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.114 -0.494 . . . . 70.45 109.757 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 126' ' ' LEU . . . . . 0.418 HD11 HG11 ' D' ' 40' ' ' VAL . 7.5 tt -104.24 93.53 4.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.16 -1.422 . . . . 65.21 107.16 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -103.25 89.82 3.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.011 -1.45 . . . . 73.22 108.596 -171.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 23.1 tp -71.96 122.78 21.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.854 -0.612 . . . . 71.21 110.514 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.91 140.31 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.492 1.117 . . . . 44.15 112.223 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.67 114.42 3.67 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.661 2.241 . . . . 73.35 110.371 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.56 143.56 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.555 0.742 . . . . 34.44 109.682 -172.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -69.67 101.72 1.72 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.189 0.996 . . . . 73.34 110.302 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 N--CA 1.476 0.852 0 C-N-CA 123.262 0.625 . . . . 73.22 111.175 179.006 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 108.7 -0.852 . . . . 75.05 108.7 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.627 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.8 t80 -126.34 123.47 38.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.079 0.952 . . . . 65.43 108.646 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -143.3 103.5 4.13 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.423 0.452 . . . . 73.12 109.878 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.642 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.4 mt -64.9 121.57 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.041 -0.725 . . . . 72.04 109.041 174.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -87.61 -41.39 13.46 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.677 0.611 . . . . 75.43 109.656 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 59.0 ttt180 -168.28 144.01 3.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.996 -0.281 . . . . 74.42 111.428 -162.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -129.67 137.29 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.09 -1.078 . . . . 60.31 108.09 172.452 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.47 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 21.4 p90 -160.96 165.97 29.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.453 0.701 . . . . 71.21 110.996 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -100.24 117.57 34.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.651 -0.87 . . . . 43.45 108.651 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -77.83 -26.69 49.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.382 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.35 142.39 16.93 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 123.912 0.757 . . . . 70.31 109.223 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 95.9 mt -134.75 142.38 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 106.612 -1.625 . . . . 74.23 106.612 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -155.14 114.0 3.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.413 0.446 . . . . 34.52 110.045 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -109.08 117.89 35.36 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 106.766 -1.568 . . . . 73.34 106.766 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.81 137.1 52.44 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.273 -0.64 . . . . 65.03 109.273 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.45 72.2 12.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.818 -1.549 . . . . 73.22 106.818 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.16 -30.98 37.27 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.772 2.315 . . . . 64.24 111.577 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.04 28.31 8.62 Favored 'General case' 0 C--O 1.213 -0.842 0 C-N-CA 124.207 1.003 . . . . 53.35 108.381 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.29 -53.5 43.9 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.272 -0.871 . . . . 53.1 112.486 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 16.0 Cg_exo -66.63 -17.53 52.86 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 121.882 1.721 . . . . 73.44 112.696 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -95.9 -29.16 14.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 72.32 111.285 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -82.94 -25.39 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.791 0.436 . . . . 72.35 111.652 -172.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -72.49 -9.6 58.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.516 0.726 . . . . 71.15 112.277 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -102.71 -10.78 18.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.651 0.78 . . . . 54.31 111.472 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -77.73 165.44 24.2 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.152 0.581 . . . . 62.34 111.965 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.74 145.15 55.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.376 1.07 . . . . 72.52 110.922 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -81.13 90.3 6.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.516 0.726 . . . . 75.35 110.183 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tp60 -141.8 50.04 1.62 Allowed Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 114.729 -1.123 . . . . 71.11 109.261 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 37' ' ' GLN . 6.9 Cg_exo -74.99 96.43 1.02 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 122.539 2.159 . . . . 63.32 111.624 -172.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.14 98.0 10.67 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.279 -1.008 . . . . 64.34 108.279 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 65' ' ' THR . 2.6 p -93.33 104.94 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 114.055 -1.429 . . . . 72.21 110.616 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -83.17 137.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.007 1.323 . . . . 74.24 110.15 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 tt -105.72 127.56 53.15 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.122 -1.066 . . . . 74.34 108.122 174.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.8 m-20 -120.34 144.21 47.98 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.095 -1.076 . . . . 72.33 108.095 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.566 HD11 HD12 ' A' ' 60' ' ' LEU . 27.1 tp -139.31 124.61 19.1 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.73 -0.47 . . . . 62.54 109.73 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.3 m-20 -119.3 127.09 52.88 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.763 0.825 . . . . 74.12 109.042 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -106.33 121.42 44.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.053 0.941 . . . . 55.13 109.485 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.88 147.08 38.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.975 0.91 . . . . 72.31 109.544 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -133.08 168.57 18.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.693 0.797 . . . . 55.25 110.271 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -161.71 154.44 20.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.385 1.074 . . . . 74.42 109.506 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -111.25 121.87 46.38 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.152 -1.055 . . . . 54.21 108.152 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 57' ' ' GLU . 26.9 mt -97.43 -33.88 11.23 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.338 0.655 . . . . 74.22 110.599 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.14 -173.13 3.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.266 0.626 . . . . 72.23 110.729 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.04 112.35 3.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.229 1.012 . . . . 64.41 110.093 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' SER . 62.0 m-20 70.45 1.69 3.74 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.579 1.552 . . . . 75.53 113.323 -175.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -100.86 115.82 43.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.508 0.723 . . . . 64.32 109.382 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -131.64 124.76 30.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.535 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.4 tt0 -95.59 116.54 28.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.261 1.025 . . . . 64.04 109.408 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.1 124.11 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.418 -1.327 . . . . 73.04 107.418 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 t -112.7 129.84 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.595 0.758 . . . . 71.45 109.195 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.566 HD12 HD11 ' A' ' 44' ' ' LEU . 3.9 mm? -120.86 104.27 9.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.708 1.203 . . . . 73.22 108.443 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.604 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 30.4 ttp180 -84.49 104.55 14.59 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.743 -0.836 . . . . 74.2 108.743 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.9 120.48 43.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.393 -1.336 . . . . 74.0 107.393 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 36.9 m -122.07 130.6 53.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.225 -0.657 . . . . 71.52 109.225 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.689 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -123.47 116.46 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 124.932 1.293 . . . . 72.15 108.777 -174.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.9 m -118.61 130.15 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.249 0.477 . . . . 73.42 110.12 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.36 130.28 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.556 -0.905 . . . . 44.2 108.556 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.9 m -127.35 126.82 43.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.125 0.57 . . . . 61.35 109.704 176.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.685 HD13 ' HB2' ' A' ' 73' ' ' ALA . 11.0 mp -88.65 85.89 6.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.97 -1.122 . . . . 72.22 107.97 174.019 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.94 -88.29 1.17 Allowed Glycine 0 C--N 1.346 1.091 0 CA-C-N 114.924 -1.034 . . . . 50.14 111.488 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.21 -27.78 7.16 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.472 0.709 . . . . 71.14 111.357 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -102.75 132.93 48.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.188 0.595 . . . . 64.03 110.629 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 47.2 m -69.03 130.61 43.24 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.077 0.951 . . . . 74.32 111.315 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -74.63 -61.51 1.85 Allowed 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.998 0.919 . . . . 74.51 109.504 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.459 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 40.3 p90 -152.9 163.26 40.12 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.564 -1.198 . . . . 73.25 111.38 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 tp -130.67 137.5 49.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.149 -1.387 . . . . 75.11 107.274 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.689 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.2 m -137.03 98.99 3.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.557 0.743 . . . . 75.43 109.306 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -119.13 117.83 29.75 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.23 -1.026 . . . . 72.34 108.23 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.54 109.22 15.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.985 0.914 . . . . 72.41 109.148 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -84.59 81.24 8.94 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.593 -1.262 . . . . 70.33 107.593 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -76.63 93.56 3.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.718 -0.845 . . . . 74.14 108.718 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.16 147.26 21.56 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.073 -0.811 . . . . 71.32 111.073 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.635 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.68 122.97 1.41 Allowed Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 111.783 -0.527 . . . . 43.53 111.783 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.79 125.62 39.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.233 -0.654 . . . . 71.42 109.233 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.642 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.0 m-85 -132.17 148.76 52.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.767 -1.197 . . . . 71.21 107.767 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 41.9 t -102.51 110.84 22.9 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.425 -0.954 . . . . 63.25 108.425 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.55 HG21 ' HG2' ' A' ' 94' ' ' MET . 4.2 mp -112.95 125.27 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.97 44.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.559 0.744 . . . . 52.41 109.644 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.26 -32.55 7.34 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 123.72 0.637 . . . . 73.34 113.667 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.82 147.75 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.435 0.694 . . . . 73.25 110.287 -175.135 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -138.82 -179.08 5.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.706 0.802 . . . . 74.34 109.38 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.61 -132.88 32.35 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 119.623 -0.543 . . . . 62.24 112.897 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 18.6 p -74.96 -17.54 60.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.64 0.776 . . . . 55.55 111.977 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -72.01 -42.67 66.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.999 0.52 . . . . 71.51 109.668 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' MET . . . . . 0.55 ' HG2' HG21 ' A' ' 86' ' ' ILE . 1.1 tmt? -81.7 -24.84 35.94 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.637 0.775 . . . . 73.24 110.043 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.65 -37.18 79.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.368 0.667 . . . . 64.23 110.135 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.71 -34.47 77.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.357 0.663 . . . . 74.13 110.11 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.5 t -67.89 -42.42 81.24 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.016 -0.538 . . . . 64.24 110.999 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.0 mt -86.15 -29.19 23.46 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.912 0.708 . . . . 72.41 112.912 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.78 3.89 34.2 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.597 0.599 . . . . 50.14 114.597 -170.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -51.22 0.16 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.42 0.61 . . . . 71.02 111.745 -174.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 60.0 t80 -79.46 -66.84 0.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.445 1.098 . . . . 74.2 112.23 -169.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' CYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 67.2 m -70.72 -32.17 2.42 Favored Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 114.78 1.4 . . . . 70.44 114.78 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 36.3 Cg_endo -63.99 -20.66 68.13 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 122.055 1.77 . . . . 65.43 112.775 171.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -17.75 59.43 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.227 0.611 . . . . 74.04 109.981 175.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.532 HG21 HD13 ' A' ' 13' ' ' ILE . 42.2 mm -75.41 -39.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.961 -0.755 . . . . 72.52 108.961 170.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.635 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.5 mt -78.47 -33.02 48.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.953 0.901 . . . . 74.32 112.959 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -62.16 -43.75 86.88 Favored Pre-proline 0 CA--C 1.572 1.789 0 N-CA-C 113.758 1.022 . . . . 75.24 113.758 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.53 -28.08 22.01 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.113 1.875 . . . . 75.02 113.157 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -76.02 -34.56 59.68 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.084 0.553 . . . . 75.51 111.156 175.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.27 78.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.111 -0.699 . . . . 42.41 109.111 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.436 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.7 ttm180 -55.18 -49.86 70.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.594 1.184 . . . . 75.1 109.845 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.266 0.979 . . . . 71.34 110.738 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 28.3 t -59.51 -44.25 93.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.386 0.674 . . . . 44.32 110.558 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.4 mt -64.41 -54.13 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.818 0.847 . . . . 65.44 109.965 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 58.2 m -55.22 -39.77 70.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.126 0.97 . . . . 75.15 111.212 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -64.22 -51.35 64.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.824 -1.08 . . . . 60.14 109.793 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 21' ' ' ILE . 16.0 mtp -56.83 -44.49 82.12 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.376 1.07 . . . . 73.1 111.646 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.9 t -62.5 -45.82 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.324 1.05 . . . . 74.24 110.436 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.4 t -68.77 -31.68 70.88 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.402 -0.817 . . . . 62.4 110.881 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -70.63 -31.98 69.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.807 0.843 . . . . 74.51 110.11 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.68 2.68 78.11 Favored Glycine 0 C--N 1.355 1.629 0 O-C-N 123.858 0.724 . . . . 60.33 113.181 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m 65.69 32.86 8.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.824 1.25 . . . . 73.54 111.159 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -101.09 140.63 21.45 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 106.723 -1.584 . . . . 64.13 106.723 168.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -56.94 149.79 59.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.562 2.174 . . . . 41.22 111.672 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.5 tt0 -51.53 136.47 26.18 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.349 1.03 . . . . 73.11 113.202 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.517 HD21 HG11 ' A' ' 64' ' ' VAL . 10.3 tp -125.69 120.65 31.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.306 -1.315 . . . . 73.1 108.064 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.01 120.18 32.58 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.44 -0.948 . . . . 71.23 108.44 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.06 118.32 15.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.935 -0.765 . . . . 74.03 108.935 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.66 139.67 59.76 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 124.209 1.004 . . . . 74.14 111.98 -174.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 4.6 Cg_exo -72.25 110.17 2.89 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.835 1.69 . . . . 61.25 110.208 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.84 123.75 52.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -65.54 97.3 0.3 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.409 1.084 . . . . 63.33 110.835 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.2 -50.27 6.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.256 0.623 . . . . 74.31 109.556 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.0 p-10 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 124.704 1.201 . . . . 74.53 111.312 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.2 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.694 -0.484 . . . . 73.45 109.694 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -134.7 139.89 45.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.724 -1.213 . . . . 74.45 107.724 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 2.7 pp0? -163.39 139.61 6.93 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.057 -0.72 . . . . 71.4 109.057 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ILE . . . . . 0.624 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -91.79 134.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.378 -0.971 . . . . 64.15 108.378 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -97.97 -52.67 3.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.164 0.586 . . . . 65.14 110.566 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -151.3 134.52 16.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.609 -0.269 . . . . 75.13 110.45 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 16' ' ' ILE . . . . . 0.624 HG13 HD11 ' B' ' 13' ' ' ILE . 98.5 mt -114.4 136.12 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.072 -1.455 . . . . 71.02 107.072 167.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.2 p90 -166.21 144.98 5.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.943 0.497 . . . . 73.4 110.882 -172.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.5 m -76.67 120.52 21.97 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.484 -0.78 . . . . 72.33 109.295 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 19' ' ' LYS . . . . . 0.441 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 44.5 mtpt -92.1 -30.82 15.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.451 0.7 . . . . 63.14 111.34 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.6 142.18 17.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.59 0.233 . . . . 75.02 110.636 -173.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mm -141.1 139.35 33.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.633 1.573 . . . . 65.12 108.02 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -143.0 130.61 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.486 -1.302 . . . . 71.24 107.486 172.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 79.2 t80 -137.45 119.23 15.13 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.708 -1.589 . . . . 72.2 106.708 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -117.38 122.49 43.98 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.402 -0.962 . . . . 75.14 108.402 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -119.49 79.84 21.74 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 107.302 -1.369 . . . . 73.14 107.302 165.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.26 -18.25 34.76 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.207 1.938 . . . . 61.42 110.419 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -111.59 15.67 21.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.984 1.314 . . . . 73.31 110.821 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.1 -54.5 7.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 N-CA-C 114.396 1.258 . . . . 64.52 114.396 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' PRO . . . . . 0.465 ' HG2' ' ND1' ' B' ' 30' ' ' HIS . 95.0 Cg_endo -78.76 -31.75 2.32 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 121.765 1.643 . . . . 74.32 113.274 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' HIS . . . . . 0.465 ' ND1' ' HG2' ' B' ' 29' ' ' PRO . 77.0 m80 -92.35 4.11 54.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.096 0.959 . . . . 74.13 113.303 -169.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 7.7 p -79.06 -6.96 10.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 C-N-CA 123.516 0.726 . . . . 72.44 110.061 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.14 -33.04 74.57 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.797 0.439 . . . . 71.43 111.141 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -76.03 -41.85 49.66 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.358 0.663 . . . . 72.22 109.931 175.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' LYS . . . . . 0.618 ' HB3' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -108.42 64.34 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.584 1.154 . . . . 75.32 109.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 31' ' ' VAL . 13.6 t70 -118.82 118.55 31.88 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.565 -0.531 . . . . 73.34 109.565 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -179.81 179.43 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.029 1.732 . . . . 73.34 107.883 155.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -47.35 106.43 0.59 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.011 0.925 . . . . 74.2 110.92 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.23 169.1 7.42 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.723 2.282 . . . . 73.5 110.667 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.26 100.69 3.19 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 106.907 -1.516 . . . . 72.32 106.907 170.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.25 126.66 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.68 -1.145 . . . . 72.23 109.401 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -128.05 135.09 49.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.738 0.815 . . . . 74.23 109.477 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.41 151.79 19.6 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.337 -0.986 . . . . 73.11 108.337 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -148.2 109.9 4.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.419 -1.326 . . . . 75.01 107.419 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mp -103.72 129.63 51.11 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.136 0.574 . . . . 72.0 109.478 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.2 t70 -122.62 149.92 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.335 1.054 . . . . 74.02 110.192 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -118.07 128.57 54.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.631 -1.168 . . . . 74.22 109.438 -170.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.13 126.74 15.14 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.038 0.535 . . . . 72.04 110.175 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 56.5 p -136.49 160.78 37.75 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.348 . . . . 72.43 110.795 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -157.64 137.66 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.723 -0.671 . . . . 63.54 110.045 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.93 114.69 20.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.197 0.599 . . . . 74.42 110.263 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' B' ' 57' ' ' GLU . 23.5 mt -88.41 -34.55 17.5 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.603 0.761 . . . . 63.01 110.461 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.83 -167.93 1.5 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.654 0.782 . . . . 73.4 110.573 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.86 106.24 0.98 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.576 -1.193 . . . . 61.04 110.166 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.29 9.16 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.954 1.301 . . . . 72.3 113.044 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -103.89 108.46 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.262 -1.014 . . . . 71.32 108.262 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.14 140.13 51.55 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.168 0.987 . . . . 71.44 109.239 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' B' ' 51' ' ' LEU . 5.8 tm-20 -103.6 99.96 9.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.234 -1.024 . . . . 74.12 108.234 -174.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 77.0 t -88.68 125.93 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.354 1.462 . . . . 62.3 109.925 -175.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.3 t -118.7 131.26 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.874 0.869 . . . . 74.14 109.543 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.33 108.12 18.09 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.762 -1.199 . . . . 71.02 107.762 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.5 ttm180 -88.21 113.79 24.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.622 -0.881 . . . . 64.54 108.622 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.7 104.17 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.891 -1.151 . . . . 71.23 107.891 169.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -98.7 132.99 43.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.589 -0.522 . . . . 44.04 109.589 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 64' ' ' VAL . . . . . 0.403 HG21 HG21 ' B' ' 114' ' ' ILE . 95.8 t -122.09 120.22 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.347 1.059 . . . . 72.43 108.933 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -115.11 143.03 45.84 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.354 0.661 . . . . 70.42 109.305 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.3 136.58 38.14 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.75 -0.833 . . . . 74.34 108.75 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 52.1 p -147.1 139.01 24.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.879 0.472 . . . . 75.41 110.672 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 68' ' ' LEU . . . . . 0.618 HD13 ' HB3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -136.45 139.67 42.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.905 1.282 . . . . 73.51 108.615 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.09 -115.95 6.84 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.016 -0.834 . . . . 72.44 111.016 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -122.94 3.01 9.41 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.061 0.944 . . . . 72.13 108.853 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.1 168.96 9.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.338 0.59 . . . . 74.32 111.342 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 14.8 m -71.04 143.77 50.61 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.651 -1.158 . . . . 63.22 111.028 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -95.32 -60.02 1.76 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.27 -1.011 . . . . 64.05 108.27 169.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -164.68 155.52 14.76 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.339 -1.3 . . . . 74.14 108.401 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 62.9 mt -128.23 136.52 51.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -148.69 152.71 37.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.235 0.614 . . . . 71.12 109.357 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -160.39 129.19 4.84 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.952 -1.129 . . . . 63.33 107.952 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.9 t -124.04 142.37 41.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.676 -0.861 . . . . 52.42 108.676 176.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -125.32 93.23 3.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.138 -1.06 . . . . 71.23 108.138 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 80' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -83.52 102.8 12.37 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.23 -1.026 . . . . 41.2 108.23 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.29 166.85 35.25 Favored Glycine 0 C--O 1.244 0.724 0 N-CA-C 111.02 -0.832 . . . . 23.35 111.02 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.33 126.91 1.57 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.15 -0.78 . . . . 71.23 111.15 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' B' ' 17' ' ' TYR . 69.1 mt -83.68 118.51 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.67 -1.233 . . . . 64.35 107.67 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -124.34 166.84 15.23 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.358 1.063 . . . . 72.42 108.68 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 40.9 m -130.53 112.69 13.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.466 -0.939 . . . . 64.14 108.466 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 86' ' ' ILE . . . . . 0.712 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -117.36 133.77 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.985 0.914 . . . . 51.44 109.743 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 87' ' ' ALA . . . . . 0.658 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.37 158.35 38.54 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.107 0.963 . . . . 52.5 109.399 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.71 3.11 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.302 -0.408 . . . . 73.44 112.526 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 89' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' B' ' 86' ' ' ILE . 20.5 pt -68.5 150.12 10.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 123.041 0.536 . . . . 63.42 110.297 169.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 90' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 39.8 tt0 -164.31 146.32 8.74 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.537 -0.756 . . . . 61.03 109.818 -174.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.76 -103.75 1.5 Allowed Glycine 0 C--N 1.349 1.298 0 O-C-N 123.332 0.395 . . . . 45.21 113.109 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.4 m -88.3 -29.28 20.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.486 0.714 . . . . 50.43 110.947 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 47.9 mt-30 -58.66 -45.21 89.85 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.787 0.835 . . . . 73.13 110.986 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 94' ' ' MET . . . . . 0.637 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.8 ptt? -65.1 -39.56 93.33 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.214 -0.903 . . . . 63.24 110.864 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.33 82.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.738 0.815 . . . . 75.33 110.884 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -76.57 -33.56 58.48 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.591 0.757 . . . . 64.43 110.837 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -62.46 -63.11 1.33 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.89 0.476 . . . . 75.02 110.531 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.86 -3.43 54.08 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.102 0.408 . . . . 71.25 112.102 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.21 -1.78 56.9 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 119.648 -0.529 . . . . 63.04 113.49 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.26 0.18 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.477 0.639 . . . . 44.52 111.585 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -72.02 -55.54 7.22 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.377 0.671 . . . . 71.51 111.547 -170.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -65.43 -37.65 21.09 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 123.875 0.87 . . . . 72.21 112.583 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -49.6 -48.79 17.72 Favored 'Trans proline' 0 C--N 1.397 3.117 0 C-N-CA 122.885 2.39 . . . . 72.53 113.052 164.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -64.89 -15.89 62.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 112.52 0.563 . . . . 74.24 112.52 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -80.02 -49.86 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.92 0.488 . . . . 73.2 110.264 171.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.15 -19.52 39.8 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.396 0.678 . . . . 53.1 112.784 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' PHE . . . . . 0.41 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 84.3 t80 -66.49 -45.53 58.34 Favored Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.54 1.136 . . . . 72.33 113.423 -172.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.6 Cg_endo -57.58 -35.7 98.77 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 122.105 1.87 . . . . 64.32 113.256 176.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 109' ' ' TYR . . . . . 0.403 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.9 m-85 -68.05 -45.13 74.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.292 0.637 . . . . 73.05 110.418 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.57 84.47 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.925 -0.58 . . . . 71.43 110.813 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -59.84 -57.55 12.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.482 1.113 . . . . 64.35 110.254 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -31.69 71.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.697 0.799 . . . . 62.31 110.831 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.2 t -72.04 -43.56 64.77 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.931 0.492 . . . . 75.1 111.269 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 114' ' ' ILE . . . . . 0.403 HG21 HG21 ' B' ' 64' ' ' VAL . 87.4 mt -62.99 -44.74 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.347 0.659 . . . . 50.01 109.671 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -61.56 -30.83 70.91 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.995 -1.002 . . . . 75.52 111.344 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -73.58 -52.95 11.7 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.317 0.647 . . . . 73.32 110.07 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 36.4 mmt -59.31 -46.94 87.22 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.903 0.881 . . . . 75.34 111.641 -173.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.65 -34.9 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.25 110.879 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t -67.99 -30.76 70.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.357 -0.383 . . . . 74.32 110.74 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -68.76 -18.93 64.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.435 0.694 . . . . 73.13 110.823 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.1 15.71 42.42 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-O 119.533 -0.593 . . . . 74.41 112.488 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 17' ' ' TYR . 57.6 p 62.14 28.8 17.32 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.856 2.063 . . . . 70.25 112.809 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -97.16 150.93 37.36 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.817 0.447 . . . . 73.34 110.938 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.86 -165.06 0.11 Allowed 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 123.751 2.967 . . . . 72.1 113.579 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 125' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.3 tp60 -63.78 115.79 5.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.753 -0.658 . . . . 72.2 112.565 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -119.43 100.92 7.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.899 -1.148 . . . . 74.53 107.899 168.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.49 135.19 54.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 65.01 109.766 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.09 139.26 33.32 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 124.255 0.972 . . . . 72.24 110.39 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.37 147.26 52.68 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.101 0.961 . . . . 73.22 110.35 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.13 109.37 1.31 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.939 2.426 . . . . 74.4 111.489 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.24 131.5 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.896 0.879 . . . . 72.04 109.897 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -82.12 90.3 6.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.33 0.586 . . . . 60.04 109.771 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.48 1.073 0 CA-C-N 114.993 -1.003 . . . . 64.32 111.363 177.106 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' C' C ' 9' ' ' MET . . . . . 0.423 ' SD ' HG23 ' C' ' 86' ' ' ILE . 48.6 ttp . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 113.039 0.755 . . . . 74.21 113.039 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 3.8 m -84.77 85.12 7.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.333 -1.358 . . . . 71.3 107.333 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -93.77 120.17 33.69 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.635 -0.712 . . . . 72.23 109.875 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -138.79 142.64 38.75 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.464 0.706 . . . . 64.32 110.144 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 13' ' ' ILE . . . . . 0.406 HG22 ' CE2' ' C' ' 84' ' ' PHE . 2.7 pp -77.96 137.79 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.945 0.778 . . . . 52.12 109.279 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 14' ' ' GLN . . . . . 0.403 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.3 mm100 -101.78 -51.17 3.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.802 -0.444 . . . . 63.04 109.802 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -167.86 124.77 1.12 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.092 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.73 147.14 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -175.15 160.77 2.76 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.142 0.496 . . . . 73.23 110.807 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.8 p -78.87 115.03 18.3 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.005 -0.998 . . . . 75.14 108.534 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -66.6 -43.68 84.17 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.904 0.859 . . . . 71.14 109.415 172.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.1 t70 -150.52 145.94 26.28 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.959 -1.473 . . . . 75.42 109.211 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 21' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.2 mt -140.25 141.27 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.6 -1.629 . . . . 61.24 106.6 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.3 t -153.16 150.62 29.24 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.111 0.481 . . . . 54.41 110.116 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -151.14 115.42 5.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.579 -1.267 . . . . 72.13 107.579 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -116.22 116.1 27.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.966 -1.124 . . . . 63.21 107.966 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.19 85.53 5.5 Favored Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.285 -1.376 . . . . 73.01 107.285 170.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.31 -26.11 30.0 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.635 2.223 . . . . 64.31 112.025 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.31 36.83 4.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 124.142 0.977 . . . . 54.12 109.081 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -45.31 -52.77 20.25 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 124.613 1.165 . . . . 73.53 114.012 -177.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.22 -32.81 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 121.563 1.509 . . . . 72.54 113.345 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -70.06 -27.1 64.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.887 0.875 . . . . 63.31 113.071 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.22 -15.15 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.542 0.737 . . . . 65.23 110.271 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.06 -34.9 79.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.102 0.561 . . . . 74.55 111.3 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -89.75 7.49 36.62 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.964 0.906 . . . . 62.2 111.889 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 34' ' ' LYS . . . . . 0.442 ' HD2' HD11 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -98.73 147.25 25.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 63.21 111.202 -171.142 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.74 131.09 44.9 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.414 1.085 . . . . 52.51 109.832 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -80.06 71.33 6.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.737 0.815 . . . . 75.24 110.786 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -143.98 72.53 16.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 108.179 -1.045 . . . . 71.4 108.179 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 38' ' ' PRO . . . . . 0.613 ' HG2' HG13 ' C' ' 40' ' ' VAL . 69.4 Cg_endo -90.97 155.84 3.94 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.795 2.33 . . . . 75.22 111.18 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -87.1 81.39 8.05 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 106.893 -1.521 . . . . 71.32 106.893 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 40' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' C' ' 38' ' ' PRO . 12.6 m -68.35 123.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 CA-C-N 114.517 -1.219 . . . . 71.13 109.383 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 41' ' ' LYS . . . . . 0.422 ' HZ2' ' HB3' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -136.86 126.73 25.74 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.528 -0.916 . . . . 74.21 108.528 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.56 138.41 31.73 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.121 0.968 . . . . 74.33 108.637 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 43' ' ' ASP . . . . . 0.828 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.2 m-20 -119.01 119.1 33.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.114 0.965 . . . . 41.21 109.177 -175.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.02 125.54 52.6 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.125 -1.065 . . . . 70.52 108.125 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 45' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 7.3 t70 -137.12 142.67 42.29 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.698 0.799 . . . . 62.24 109.583 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -115.4 116.73 28.74 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.962 0.905 . . . . 62.31 110.836 -171.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.03 153.01 47.25 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.371 1.068 . . . . 72.34 110.072 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.3 p -166.13 159.05 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.985 0.514 . . . . 74.0 111.732 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -149.88 153.88 37.43 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.556 0.742 . . . . 63.42 111.08 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.2 122.75 33.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 108.991 -0.744 . . . . 73.1 108.991 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 51' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -96.58 -44.17 7.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.717 0.807 . . . . 54.1 110.205 -176.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.94 -165.31 1.71 Allowed 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.139 -0.937 . . . . 75.21 109.952 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -70.4 102.78 2.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.725 0.81 . . . . 74.03 109.601 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 71.62 -3.24 2.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.726 1.61 . . . . 42.03 113.444 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.5 t -92.09 113.48 27.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.242 -1.392 . . . . 35.11 107.242 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.34 149.17 49.36 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.074 0.95 . . . . 72.44 108.945 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 57' ' ' GLU . . . . . 0.637 ' HB2' HD11 ' C' ' 51' ' ' LEU . 45.9 tt0 -104.41 136.23 44.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.112 -0.699 . . . . 62.55 109.112 172.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.43 120.84 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.442 -1.688 . . . . 63.51 106.442 171.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.53 135.56 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.078 0.951 . . . . 33.31 109.048 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 60' ' ' LEU . . . . . 0.43 HD23 HD12 ' C' ' 106' ' ' LEU . 3.8 mm? -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.698 0.799 . . . . 73.45 109.072 172.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 61' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 17.2 ttm-85 -81.84 106.15 13.53 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.443 -0.947 . . . . 64.45 108.443 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.85 120.4 59.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.92 -1.141 . . . . 62.43 107.92 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 63' ' ' THR . . . . . 0.828 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 48.0 m -133.26 145.77 50.8 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.242 1.017 . . . . 74.2 108.405 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 64' ' ' VAL . . . . . 0.403 HG23 HD13 ' C' ' 114' ' ' ILE . 98.9 t -127.08 121.23 57.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.9 -0.778 . . . . 72.33 108.9 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -104.58 142.5 34.54 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.007 0.817 . . . . 74.43 109.514 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 100.42 4.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.137 -1.06 . . . . 63.2 108.137 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -139.23 126.59 21.51 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.888 -0.412 . . . . 71.14 109.888 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 68' ' ' LEU . . . . . 0.462 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.3 OUTLIER -100.82 60.04 0.95 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 122.172 0.987 . . . . 74.15 109.416 176.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -122.05 7.18 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 113.979 -1.464 . . . . 73.31 110.4 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -89.65 -16.96 29.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.498 0.719 . . . . 65.15 109.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -75.92 92.49 3.12 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.249 1.019 . . . . 73.11 109.091 170.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 84.9 m -83.35 121.7 27.49 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 109.036 -0.727 . . . . 73.31 109.036 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.7 -51.48 10.51 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.45 -1.25 . . . . 71.53 109.478 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -161.08 175.64 12.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.663 0.745 . . . . 62.23 110.976 168.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -145.12 144.36 30.87 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.403 -1.702 . . . . 62.13 106.403 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.3 t -146.21 112.03 5.64 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.158 -0.682 . . . . 75.05 109.158 175.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -118.38 117.39 28.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.06 0.544 . . . . 72.2 110.459 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.44 122.01 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.129 0.572 . . . . 73.25 109.554 172.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -99.68 105.04 16.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.956 -1.127 . . . . 75.23 107.956 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -93.2 112.96 25.05 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.516 0.727 . . . . 72.34 110.234 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.58 161.57 25.06 Favored Glycine 0 C--N 1.337 0.627 0 O-C-N 123.473 0.483 . . . . 62.21 112.782 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.81 120.58 0.98 Allowed Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.253 -0.739 . . . . 73.45 111.253 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 83' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 12.6 mm -84.31 122.76 38.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.207 -1.034 . . . . 65.52 108.207 176.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 84' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' C' ' 13' ' ' ILE . 70.6 m-85 -133.49 130.59 38.75 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 72.35 109.062 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -85.96 106.58 17.24 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.892 -0.781 . . . . 70.23 108.892 171.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 86' ' ' ILE . . . . . 0.423 HG23 ' SD ' ' C' ' 9' ' ' MET . 66.7 mt -116.32 107.93 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.954 0.902 . . . . 75.03 108.987 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.15 138.32 20.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.786 0.835 . . . . 73.31 109.458 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.33 -47.74 1.0 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.641 0.588 . . . . 75.1 112.366 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.89 172.68 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.147 0.579 . . . . 64.53 111.526 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.28 151.31 17.26 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.594 0.758 . . . . 75.42 110.585 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.11 -112.62 4.47 Favored Glycine 0 C--N 1.356 1.669 0 O-C-N 123.731 0.644 . . . . 52.21 114.191 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.3 p -64.3 -35.03 79.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.982 0.913 . . . . 71.24 111.842 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -77.86 -35.69 50.69 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.914 -0.585 . . . . 74.0 111.41 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -70.66 -23.66 62.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 110.333 -0.247 . . . . 63.54 110.333 175.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.75 92.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.762 0.425 . . . . 51.1 110.878 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 96' ' ' HIS . . . . . 0.485 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.3 t-80 -73.7 -32.45 63.93 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 116.203 -0.453 . . . . 51.21 111.305 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -81.81 -62.55 1.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.157 0.503 . . . . 65.41 110.628 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.42 -43.83 96.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.484 1.113 . . . . 70.52 111.817 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.57 5.27 82.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.295 -0.725 . . . . 72.12 114.876 -172.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 100' ' ' ALA . . . . . 0.589 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -149.39 -56.35 0.19 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.306 1.053 . . . . 64.13 112.908 -173.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 101' ' ' TYR . . . . . 0.417 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 89.3 t80 -71.13 -49.43 44.14 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.349 1.06 . . . . 75.44 111.543 -173.368 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.53 -44.42 65.83 Favored Pre-proline 0 CA--C 1.571 1.788 0 C-N-CA 124.144 0.977 . . . . 65.23 112.249 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.06 -40.64 67.73 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.948 2.432 . . . . 51.02 114.196 169.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -64.14 -31.64 72.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.787 0.679 . . . . 63.22 110.825 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 105' ' ' ILE . . . . . 0.436 HG23 ' NH1' ' A' ' 111' ' ' ARG . 39.9 mm -68.2 -41.55 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.82 0.448 . . . . 72.51 110.856 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 106' ' ' LEU . . . . . 0.43 HD12 HD23 ' C' ' 60' ' ' LEU . 86.4 mt -88.88 -22.22 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.701 0.8 . . . . 54.41 113.014 -172.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -56.36 -48.54 96.79 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 113.947 1.092 . . . . 52.44 113.947 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.8 -33.27 76.6 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 121.912 1.741 . . . . 60.13 113.64 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -48.04 69.4 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.432 0.693 . . . . 73.34 110.359 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.36 81.25 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.948 -1.023 . . . . 71.05 110.597 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.48 -52.47 64.6 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.938 -1.483 . . . . 75.45 112.003 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -33.27 73.91 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.607 0.363 . . . . 71.44 110.568 -173.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.46 -29.44 66.0 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 122.999 0.519 . . . . 75.43 110.839 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 114' ' ' ILE . . . . . 0.403 HD13 HG23 ' C' ' 64' ' ' VAL . 73.3 mt -72.04 -44.16 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.599 0.76 . . . . 74.24 109.768 170.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -64.34 -30.13 71.18 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.47 0.708 . . . . 72.21 111.174 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.9 t -71.76 -49.57 37.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.824 0.85 . . . . 74.1 109.002 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 117' ' ' MET . . . . . 0.528 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.0 -39.88 94.12 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.097 0.959 . . . . 74.05 113.041 -175.24 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.7 -34.78 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 109.944 -0.391 . . . . 60.41 109.944 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -72.71 -32.07 65.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.559 0.744 . . . . 60.54 111.587 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -68.16 -26.76 65.92 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.21 0.604 . . . . 60.12 110.42 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 11.52 68.35 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 119.246 -0.752 . . . . 74.03 113.271 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 122' ' ' THR . . . . . 0.495 HG23 ' HB3' ' D' ' 17' ' ' TYR . 52.7 p 58.76 26.86 15.21 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.91 1.684 . . . . 71.51 112.82 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -102.05 151.64 38.07 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.706 0.802 . . . . 75.31 109.922 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 124' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 35.3 Cg_exo -59.87 121.55 10.01 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.016 2.477 . . . . 71.53 113.108 -171.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -60.33 146.37 44.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.111 0.882 . . . . 73.43 112.496 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -141.66 127.58 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 108.316 -0.994 . . . . 65.34 108.316 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.13 114.88 25.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.587 -1.264 . . . . 70.24 107.587 172.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 29.9 tp -64.86 129.01 38.14 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.86 0.725 . . . . 60.21 110.532 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.2 151.09 97.46 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.98 1.312 . . . . 74.11 112.039 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 130' ' ' PRO . . . . . 0.474 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.1 Cg_exo -64.02 109.88 1.21 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.979 2.453 . . . . 60.05 112.28 -177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.16 108.67 21.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.619 -1.252 . . . . 42.24 107.619 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -82.23 101.39 10.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.557 -0.747 . . . . 75.14 110.239 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -80.02 -38.46 31.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.332 -0.988 . . . . 73.42 108.332 168.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' C' C ' 134' ' ' ASP . . . . . 0.589 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.1 p-10 . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 126.118 1.767 . . . . 52.15 112.856 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.245 0.863 0 CA-C-O 121.301 0.572 . . . . 72.1 109.611 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -143.87 112.11 6.34 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.233 -1.025 . . . . 54.41 108.233 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 12' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 71.3 mt-30 -131.59 154.54 48.76 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.467 -0.938 . . . . 75.32 108.467 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 13' ' ' ILE . . . . . 0.44 HD11 HG21 ' D' ' 105' ' ' ILE . 35.6 mt -104.02 132.94 49.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.913 -1.143 . . . . 53.13 107.913 168.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.36 -48.14 8.23 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.627 -0.509 . . . . 71.03 109.627 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -155.64 148.29 24.08 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.32 0.648 . . . . 70.15 109.873 -176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 16' ' ' ILE . . . . . 0.463 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -124.05 111.21 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.345 -1.354 . . . . 71.21 107.345 168.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HB3' HG23 ' C' ' 122' ' ' THR . 31.8 p90 -140.56 170.2 16.23 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.82 0.819 . . . . 73.51 111.764 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.4 p -101.2 121.31 41.61 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.556 -1.202 . . . . 65.03 108.883 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 19' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -88.23 -30.62 19.56 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.984 0.513 . . . . 73.43 110.346 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.6 t70 -152.86 127.02 9.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.142 -0.935 . . . . 73.22 108.573 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 21' ' ' ILE . . . . . 0.528 HG21 ' HE2' ' C' ' 117' ' ' MET . 82.7 mt -123.93 144.07 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.335 -1.357 . . . . 72.03 107.335 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -152.49 110.67 3.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 124.188 0.93 . . . . 62.21 109.494 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 23' ' ' PHE . . . . . 0.436 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 75.1 t80 -108.39 128.75 55.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.109 -1.812 . . . . 63.32 106.109 162.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -123.86 151.01 43.91 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.851 -0.796 . . . . 75.03 108.851 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 25' ' ' ALA . . . . . 0.778 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -132.82 76.59 70.55 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 106.616 -1.624 . . . . 74.21 106.616 170.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.5 -45.23 31.47 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.561 2.841 . . . . 71.43 113.113 -166.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 27' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' D' ' 31' ' ' VAL . 20.3 m-80 -114.59 25.99 10.57 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.232 -0.895 . . . . 63.42 110.101 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 28' ' ' ALA . . . . . 0.778 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -39.01 -60.02 1.27 Allowed Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 115.798 1.777 . . . . 63.11 115.798 -163.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 29' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 31.3 Cg_endo -81.94 -14.47 9.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 CA-C-N 122.282 1.851 . . . . 74.44 113.542 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.02 -38.77 69.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.36 1.064 . . . . 74.33 109.301 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 31' ' ' VAL . . . . . 0.607 HG13 HD11 ' D' ' 68' ' ' LEU . 52.8 t -63.35 -39.04 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.914 0.886 . . . . 61.42 109.991 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 32' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.9 m-30 -60.12 -9.22 2.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.378 1.251 . . . . 74.05 114.378 -173.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -77.77 -37.67 48.44 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.974 0.51 . . . . 75.34 111.108 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -132.8 62.83 1.65 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.847 0.859 . . . . 75.3 109.979 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' D' ' 32' ' ' PHE . 42.5 t0 -107.79 83.28 1.77 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.847 0.832 . . . . 65.31 110.706 -169.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -126.5 -178.53 4.39 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.713 -1.131 . . . . 71.44 108.062 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pm0 -48.56 100.59 0.24 Allowed Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 123.571 0.749 . . . . 60.23 112.728 -162.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 38' ' ' PRO . . . . . 0.475 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 59.9 Cg_endo -71.62 149.09 54.65 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.601 2.201 . . . . 62.13 111.107 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.63 111.45 4.79 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.873 -1.158 . . . . 73.42 107.873 173.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -103.54 106.27 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.919 0.888 . . . . 74.22 109.164 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -100.95 129.98 46.88 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.069 0.948 . . . . 63.23 109.952 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 tp -97.09 119.53 35.76 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.05 -0.722 . . . . 55.45 109.05 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 43' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.2 m-20 -120.32 130.82 54.61 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.782 0.833 . . . . 75.0 109.15 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.02 137.42 47.81 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.831 0.853 . . . . 54.13 109.155 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 45' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 6.3 t70 -135.83 132.27 36.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 44.4 p -104.94 143.61 32.93 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.717 0.807 . . . . 62.32 109.773 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 47' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.18 155.47 36.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.892 0.877 . . . . 71.03 110.025 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 28.6 p -158.99 162.8 36.82 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.219 0.533 . . . . 65.0 111.228 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -150.01 150.02 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.649 -1.16 . . . . 74.4 109.462 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -100.71 122.52 43.49 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.335 -1.358 . . . . 74.42 107.335 159.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 51' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.0 mt -96.3 -26.36 15.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.453 0.701 . . . . 52.11 109.38 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.33 173.46 5.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.758 1.223 . . . . 52.23 109.532 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.93 131.47 46.33 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.623 -0.88 . . . . 71.53 108.623 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 70.15 -2.05 2.23 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.112 1.365 . . . . 61.11 113.086 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.65 116.34 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.35 0.66 . . . . 72.04 109.29 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.01 162.13 31.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.979 -0.749 . . . . 72.51 108.979 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 57' ' ' GLU . . . . . 0.494 ' HB2' HD11 ' D' ' 51' ' ' LEU . 28.4 tt0 -130.42 118.31 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.084 0.954 . . . . 74.11 108.604 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 77.3 t -100.48 113.31 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.387 -1.338 . . . . 64.31 107.387 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.9 t -107.01 127.72 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.997 -1.112 . . . . 73.25 107.997 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HB3' HD22 ' D' ' 106' ' ' LEU . 0.9 OUTLIER -128.94 112.65 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.762 -1.199 . . . . 63.0 107.762 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 61' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.3 ttm180 -85.18 118.4 24.71 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.733 0.813 . . . . 75.41 109.459 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.59 122.0 62.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.943 -1.132 . . . . 74.1 107.943 170.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 63' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.4 m -119.36 137.27 53.83 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.561 0.745 . . . . 65.11 109.92 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 71.5 t -128.24 103.73 10.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 C-N-CA 125.146 1.378 . . . . 70.53 107.729 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.2 m -101.91 105.24 16.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.515 0.726 . . . . 61.25 109.454 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 66' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -99.28 128.5 45.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.276 0.63 . . . . 74.05 110.633 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -144.81 126.06 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.174 0.589 . . . . 65.41 110.443 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 68' ' ' LEU . . . . . 0.607 HD11 HG13 ' D' ' 31' ' ' VAL . 3.4 pp -124.96 139.81 53.49 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.723 0.809 . . . . 63.42 111.187 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.57 -111.47 3.34 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 110.479 -1.049 . . . . 32.21 110.479 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 3.35 8.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 75.02 110.446 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.78 167.76 14.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.109 0.564 . . . . 53.55 110.082 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.0 m -84.65 126.47 33.39 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.492 -0.777 . . . . 54.53 110.593 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 73' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -69.7 -64.95 0.78 Allowed 'General case' 0 C--O 1.242 0.668 0 O-C-N 124.259 0.974 . . . . 55.11 109.299 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.1 162.2 39.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.559 -1.201 . . . . 74.31 110.432 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -124.12 141.42 52.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.898 1.279 . . . . 72.03 108.012 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 76' ' ' CYS . . . . . 0.605 ' SG ' HG23 ' D' ' 114' ' ' ILE . 21.8 t -152.27 109.5 3.55 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.652 -0.499 . . . . 72.14 109.652 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 77' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' D' ' 63' ' ' THR . 38.7 tt0 -140.41 130.65 25.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.404 1.082 . . . . 74.53 108.848 -171.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.68 116.36 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.428 0.691 . . . . 73.53 109.788 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -88.04 83.93 6.99 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.851 -1.166 . . . . 74.15 107.851 166.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 80' ' ' GLN . . . . . 0.483 ' HB3' HD21 ' D' ' 106' ' ' LEU . 35.8 tp60 -79.84 114.82 19.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.44 -1.318 . . . . 71.15 107.44 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -109.16 142.03 16.11 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.194 -0.762 . . . . 61.23 111.194 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.9 5.92 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.058 -0.817 . . . . 65.33 111.058 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.31 126.06 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.062 -1.088 . . . . 72.32 108.062 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -123.65 127.96 48.97 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.593 1.157 . . . . 75.11 109.229 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 85' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 43.8 m -78.63 101.16 7.32 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.301 -1.0 . . . . 72.04 108.301 169.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 86' ' ' ILE . . . . . 0.442 HG23 HD11 ' D' ' 89' ' ' ILE . 61.4 mt -108.59 128.99 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.914 0.886 . . . . 63.13 109.725 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.24 159.15 25.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.973 0.909 . . . . 72.22 110.328 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.79 14.96 78.79 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 115.011 0.765 . . . . 71.35 115.011 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 89' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' D' ' 94' ' ' MET . 18.3 pt -136.67 134.93 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.355 -0.979 . . . . 52.12 108.355 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.98 157.66 45.93 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.949 -0.47 . . . . 73.51 111.202 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -118.51 14.5 Favored Glycine 0 C--N 1.355 1.605 0 O-C-N 124.658 1.224 . . . . 74.43 113.565 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 17.4 m -69.6 -31.36 69.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.738 0.815 . . . . 75.23 111.985 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -72.99 -42.33 63.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.828 0.451 . . . . 65.43 110.871 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 94' ' ' MET . . . . . 0.469 ' HA ' HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -72.04 -34.37 68.73 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.234 -0.284 . . . . 62.45 110.234 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.84 92.54 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.782 0.833 . . . . 54.22 110.893 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -67.7 -36.42 80.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 72.53 110.953 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.8 -51.41 34.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.582 0.353 . . . . 70.43 110.85 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.19 -20.48 44.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.649 0.379 . . . . 71.04 111.652 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.39 -2.98 55.59 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.608 -0.551 . . . . 63.21 114.007 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.82 -64.48 0.41 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.69 0.745 . . . . 65.41 111.251 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -64.23 -56.11 16.92 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.812 0.671 . . . . 72.52 112.812 -170.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.3 m -60.2 -45.41 97.76 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.31 1.044 . . . . 73.45 112.417 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.76 -40.2 80.91 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 122.65 2.234 . . . . 71.34 113.254 168.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.33 -22.81 57.35 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.465 0.706 . . . . 71.1 112.406 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 105' ' ' ILE . . . . . 0.44 HG21 HD11 ' D' ' 13' ' ' ILE . 29.0 mm -71.74 -42.77 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 122.302 1.048 . . . . 74.35 109.166 169.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 106' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' D' ' 80' ' ' GLN . 8.6 tt -76.55 -27.82 56.06 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 113.562 -1.653 . . . . 72.42 111.171 -173.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.91 -40.83 72.52 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 125.254 1.422 . . . . 61.41 113.905 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.38 -34.42 88.87 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.477 2.118 . . . . 41.05 114.272 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -79.55 -30.9 41.88 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.185 0.594 . . . . 72.52 111.055 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.35 79.14 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.363 -0.606 . . . . 74.13 109.363 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 111' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 25.2 ttp180 -54.52 -55.41 29.42 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.098 -1.41 . . . . 71.44 111.158 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -60.16 -43.93 95.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.027 0.829 . . . . 71.04 111.177 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -63.26 -45.44 91.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.804 0.442 . . . . 74.21 111.318 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 114' ' ' ILE . . . . . 0.605 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.2 mt -58.06 -59.39 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.877 0.871 . . . . 55.1 110.555 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 94.9 m -51.64 -43.57 62.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.569 1.548 . . . . 64.31 112.426 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.2 t -68.9 -39.33 79.79 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.204 -0.907 . . . . 74.33 110.741 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 117' ' ' MET . . . . . 0.422 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.8 mtm -71.33 -32.33 68.44 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.0 0.52 . . . . 60.41 111.721 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -63.65 -44.98 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 O-C-N 123.683 0.614 . . . . 74.12 109.432 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -73.02 -27.84 62.0 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.171 0.588 . . . . 44.42 111.808 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -73.4 -31.4 63.85 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.6 0.76 . . . . 74.21 110.499 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.94 5.44 75.85 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.599 0.562 . . . . 61.33 111.933 171.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p 61.5 14.67 6.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.128 2.171 . . . . 75.21 113.333 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -80.01 158.81 72.04 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.483 1.113 . . . . 72.43 108.585 169.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -67.42 124.5 12.13 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.746 2.297 . . . . 75.2 111.419 -168.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -53.3 116.8 2.61 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.298 0.999 . . . . 63.02 110.282 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -109.13 131.45 55.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.831 -1.174 . . . . 74.11 107.831 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -107.34 98.2 7.86 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.37 -0.974 . . . . 71.12 108.37 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 128' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 65.3 tp -56.73 115.7 2.71 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.874 1.27 . . . . 73.14 111.053 -176.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.13 95.85 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.933 0.893 . . . . 44.43 110.895 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.26 139.05 25.87 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.104 1.869 . . . . 62.24 111.719 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.48 111.27 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.727 -0.842 . . . . 74.31 108.727 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.41 81.39 4.76 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.402 -0.962 . . . . 72.33 108.402 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 31.2 t80 . . . . . 0 C--O 1.241 0.63 0 CA-C-N 114.862 -1.063 . . . . 75.41 111.44 -173.022 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.774 -0.454 . . . . 74.32 109.774 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 t -162.73 50.05 0.17 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.965 -0.754 . . . . 74.42 108.965 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.88 -38.87 76.53 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.084 0.954 . . . . 71.34 111.23 -173.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER 55.5 63.07 2.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.546 1.138 . . . . 54.51 110.481 165.283 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -80.13 80.23 6.58 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.545 0.688 . . . . 73.24 109.894 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' HB2' ' OE1' ' A' ' 4' ' ' GLN . 34.5 t-20 -97.53 162.04 13.49 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.842 -1.072 . . . . 73.53 108.282 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 p -72.93 8.31 1.61 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.976 0.91 . . . . 74.45 112.277 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.69 -175.21 0.37 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.14 0.976 . . . . 71.13 110.29 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.9 mtm 72.95 145.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.531 1.132 . . . . 70.12 111.56 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.3 m -142.47 142.33 32.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.675 0.79 . . . . 73.32 109.098 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.523 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -138.47 132.28 31.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.199 1.0 . . . . 72.51 109.76 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -153.56 109.11 3.23 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.153 0.581 . . . . 71.41 109.764 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 84' ' ' PHE . 45.5 mt -75.06 122.92 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.294 -0.632 . . . . 73.13 109.294 177.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -93.57 -35.34 12.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.598 0.561 . . . . 70.4 110.677 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -169.23 140.29 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.658 -0.246 . . . . 63.25 110.356 -170.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.63 HD12 ' HG3' ' C' ' 130' ' ' PRO . 0.2 OUTLIER -125.95 141.54 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.175 -1.046 . . . . 75.22 108.175 173.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.6 p90 -174.16 155.7 2.49 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.926 0.49 . . . . 73.13 111.365 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -78.36 121.29 24.29 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.808 -0.633 . . . . 72.51 109.569 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.5 mtpt -87.02 -25.2 24.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.625 0.37 . . . . 73.23 110.187 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.2 t70 -151.27 139.31 20.07 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.462 -0.79 . . . . 75.21 109.623 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.3 mt -131.38 139.47 50.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 106.77 -1.567 . . . . 75.41 106.77 176.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -147.59 127.4 13.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.235 -1.024 . . . . 65.5 108.235 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.2 t80 -135.63 113.12 10.73 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.227 -1.397 . . . . 64.0 107.227 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.82 130.03 55.55 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.797 -0.816 . . . . 63.03 108.797 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -121.1 78.52 33.38 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.222 -1.399 . . . . 62.23 107.222 174.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.05 -46.77 23.56 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 123.641 2.894 . . . . 62.31 113.272 -164.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.16 41.68 3.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.759 -0.83 . . . . 74.03 108.759 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -45.65 -53.5 19.41 Favored Pre-proline 0 CA--C 1.561 1.379 0 O-C-N 124.199 0.937 . . . . 61.44 112.322 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -63.96 -23.84 67.71 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 121.951 1.767 . . . . 72.41 113.173 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -95.35 -21.95 18.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.728 0.811 . . . . 65.41 111.342 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.2 t -80.79 -32.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.002 0.921 . . . . 63.54 112.424 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.08 -1.47 20.27 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.453 0.701 . . . . 74.51 112.863 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -105.71 -11.3 16.35 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.003 0.921 . . . . 64.12 112.236 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.17 170.96 15.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.567 0.951 . . . . 73.44 113.567 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.427 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.9 m-20 -61.01 134.36 57.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.766 1.226 . . . . 65.23 110.013 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -85.44 62.29 7.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 73.34 111.604 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -146.59 76.73 11.73 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.153 0.981 . . . . 73.11 109.906 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' E' ' 295' ' ' ALA . 59.4 Cg_endo -75.88 149.14 32.85 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.525 2.15 . . . . 73.03 112.428 163.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.49 102.12 13.81 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.707 -1.219 . . . . 75.42 107.707 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 t -84.92 95.44 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.746 -0.464 . . . . 72.41 109.746 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -85.32 119.74 26.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.087 -0.961 . . . . 70.41 109.605 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' E' ' 290' ' ' TRP . 2.1 pt? -97.58 146.18 25.54 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.382 0.61 . . . . 72.41 109.423 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.676 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.9 m-20 -136.84 146.8 46.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.41 1.084 . . . . 73.51 108.531 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 tt -141.32 125.34 17.22 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.715 -1.217 . . . . 70.21 107.715 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.9 m-20 -116.32 131.95 56.8 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.102 -1.073 . . . . 71.42 108.102 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -106.06 125.02 50.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.812 -1.085 . . . . 61.13 109.085 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.05 126.05 9.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.257 0.623 . . . . 74.34 109.352 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 p -110.57 162.67 14.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.638 0.775 . . . . 73.34 109.21 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 44.4 t -148.44 153.61 38.75 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.502 0.721 . . . . 44.02 109.665 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.532 ' HB2' ' HE3' ' E' ' 275' ' ' LYS . 45.4 tt0 -104.96 116.44 31.96 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.151 -1.055 . . . . 72.14 108.151 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.5 mt -96.36 -35.78 11.09 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.07 0.462 . . . . 65.34 109.96 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -153.87 -179.03 7.47 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.164 -0.925 . . . . 73.0 109.653 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.29 121.94 16.37 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.585 -0.895 . . . . 71.42 108.585 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 67.3 8.22 6.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.57 1.148 . . . . 53.1 112.515 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 67.8 t -113.51 106.2 20.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 107.929 -1.137 . . . . 72.05 107.929 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.98 125.27 50.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.772 -1.104 . . . . 71.12 108.593 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 34.9 tt0 -91.98 148.95 21.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.346 -0.843 . . . . 52.22 109.315 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.587 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 41.2 t -127.13 130.11 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.58 -1.267 . . . . 74.13 107.58 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.55 131.1 72.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.432 -0.951 . . . . 75.1 108.432 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 103' ' ' PRO . 2.7 mm? -119.52 114.9 22.97 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.842 -1.17 . . . . 73.4 107.842 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 21.5 ttp180 -85.18 100.35 11.69 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -93.99 110.1 23.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.522 -1.288 . . . . 44.41 107.522 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.676 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -109.12 126.91 53.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.962 -0.755 . . . . 72.54 108.962 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.6 t -116.03 124.17 72.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 106.906 -1.516 . . . . 63.01 106.906 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 2.6 m -127.16 129.65 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.351 -0.611 . . . . 42.44 109.351 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.65 124.16 37.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.814 -0.81 . . . . 72.22 108.814 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.9 m -134.03 127.42 32.23 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.298 0.639 . . . . 54.22 109.938 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 35' ' ' ASP . 5.2 mp -87.4 80.66 8.08 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.559 -1.275 . . . . 70.04 107.559 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.44 -83.49 1.32 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.232 -1.349 . . . . 35.22 111.286 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.34 -21.73 10.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 72.43 111.586 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.73 119.32 38.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.53 0.332 . . . . 73.23 111.207 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 25.0 m -70.47 133.24 46.64 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.75 0.648 . . . . 63.43 112.75 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.12 -63.62 1.36 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.885 1.274 . . . . 54.31 109.99 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -153.35 168.82 24.78 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 114.694 -1.139 . . . . 73.31 110.931 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -143.89 107.29 4.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.599 -1.637 . . . . 62.42 107.352 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.9 m -105.8 97.91 7.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.102 0.561 . . . . 64.03 110.525 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.99 115.48 29.0 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.859 0.863 . . . . 73.41 108.796 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.83 109.89 17.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.656 0.783 . . . . 71.12 109.317 -173.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.0 mt-30 -85.38 86.44 7.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.753 -0.832 . . . . 74.02 108.753 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.1 tp60 -78.49 104.6 9.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.806 -1.088 . . . . 72.44 108.876 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.73 160.11 28.6 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.797 -0.638 . . . . 62.22 112.106 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.02 123.33 1.23 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.115 -0.794 . . . . 45.43 111.115 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.364 0.666 . . . . 70.23 109.463 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.598 ' HD2' HG12 ' A' ' 13' ' ' ILE . 33.7 m-85 -134.44 118.89 17.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.445 -0.946 . . . . 61.22 108.445 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -83.48 100.69 10.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.77 -0.826 . . . . 72.41 108.77 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.39 140.53 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.328 0.651 . . . . 51.01 110.697 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.16 165.87 30.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.461 1.104 . . . . 63.22 109.534 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.89 86.61 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.086 0.395 . . . . 64.44 114.086 176.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -110.1 134.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.236 0.615 . . . . 51.42 109.522 -172.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -146.56 171.68 14.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.581 1.152 . . . . 74.34 108.6 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.44 -129.02 24.53 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 115.404 0.922 . . . . 43.34 115.404 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.585 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.44 -15.18 59.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.454 0.702 . . . . 72.24 111.922 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -67.64 -45.21 76.02 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.618 -0.512 . . . . 71.43 109.618 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -27.96 49.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.683 0.393 . . . . 45.11 110.625 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.65 -32.01 71.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.293 0.637 . . . . 63.22 111.718 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -87.31 -33.91 19.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.206 0.603 . . . . 61.43 110.209 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -61.65 -45.91 92.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.95 0.5 . . . . 70.44 110.355 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.02 -30.21 18.9 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.487 -0.779 . . . . 53.42 111.176 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.65 -3.27 81.0 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 114.846 0.698 . . . . 64.02 114.846 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.96 -60.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.937 0.868 . . . . 71.34 112.208 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.484 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 71.0 t80 -68.89 -70.68 0.26 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 113.101 0.778 . . . . 74.13 113.101 -168.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 79.3 m -63.71 -33.11 9.17 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.889 1.44 . . . . 64.33 114.889 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HA ' HD21 ' A' ' 60' ' ' LEU . 30.0 Cg_endo -62.64 -33.46 77.39 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 121.768 1.645 . . . . 50.25 112.98 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -74.54 -15.92 60.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.185 0.594 . . . . 73.43 111.097 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.72 -40.97 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.46 0.648 . . . . 54.14 109.527 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.97 -17.89 27.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.15 -0.932 . . . . 73.5 112.346 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.32 -45.37 99.09 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.243 -0.884 . . . . 72.43 113.156 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.99 -31.25 76.94 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.202 1.934 . . . . 73.32 113.509 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -76.64 -36.48 57.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.365 0.666 . . . . 72.23 111.911 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.77 77.91 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 109.133 -0.692 . . . . 63.15 109.133 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.548 HH12 HD12 ' C' ' 105' ' ' ILE . 31.6 ttm180 -52.62 -52.01 57.43 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.742 1.276 . . . . 72.15 109.932 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.81 -48.68 78.05 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.394 1.059 . . . . 75.15 110.601 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.436 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.2 t -57.59 -43.22 84.46 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.77 0.669 . . . . 70.43 111.252 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 76.9 mt -62.78 -56.9 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.164 -0.925 . . . . 74.5 109.785 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.427 HG21 ' HE2' ' C' ' 109' ' ' TYR . 89.7 m -50.55 -43.72 56.29 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.595 1.184 . . . . 64.11 111.667 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -62.72 -48.4 79.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.539 -1.209 . . . . 65.03 109.945 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.433 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 36.6 mtm -64.4 -40.41 95.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.163 0.585 . . . . 62.11 111.296 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.5 t -56.46 -48.18 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 123.906 0.754 . . . . 64.2 109.807 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.3 t -73.38 -26.87 61.18 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 114.955 -1.02 . . . . 73.13 111.438 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -73.06 -27.93 62.02 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.619 0.768 . . . . 73.12 110.59 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.86 3.6 74.62 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.779 0.674 . . . . 44.44 112.896 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.3 m 62.1 44.16 8.18 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.077 1.351 . . . . 70.11 110.272 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -116.97 145.42 35.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.201 -1.363 . . . . 75.02 108.068 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.54 131.82 0.39 Allowed 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 124.196 3.264 . . . . 61.21 114.263 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.95 133.6 56.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.033 0.833 . . . . 71.13 110.969 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.511 HD11 ' HH2' ' E' ' 290' ' ' TRP . 50.9 tp -110.06 110.67 21.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.254 -0.647 . . . . 74.35 109.254 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -99.57 108.69 21.16 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.284 -1.376 . . . . 75.54 107.284 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.31 117.43 7.85 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.647 -0.871 . . . . 72.53 108.647 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.95 98.14 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.314 0.646 . . . . 71.35 111.08 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 76.4 Cg_exo -54.78 109.42 0.4 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.119 2.546 . . . . 63.23 113.484 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.44 HG11 HG13 ' E' ' 288' ' ' VAL . 57.4 t -101.95 112.8 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.035 -1.469 . . . . 74.12 107.035 168.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 43.3 t30 -81.39 95.03 6.91 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.768 -0.827 . . . . 72.33 108.768 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -57.8 -32.48 67.6 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.735 -1.121 . . . . 62.31 111.45 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.69 -52.6 64.76 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.309 1.005 . . . . 65.25 110.741 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -62.1 -54.64 38.42 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.118 0.886 . . . . 74.23 111.339 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.56 -32.65 72.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.645 0.378 . . . . 75.35 111.357 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -71.32 -36.44 71.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.277 0.631 . . . . 64.51 109.828 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -38.56 90.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.389 0.676 . . . . 72.11 110.887 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -55.82 -30.41 61.36 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.105 0.562 . . . . 72.22 110.43 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -85.27 -52.48 5.87 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.03 -0.987 . . . . 75.12 110.923 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.53 -51.02 47.61 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.521 0.934 . . . . 74.22 113.521 -162.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -151.81 -4.16 0.27 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.095 0.405 . . . . 72.12 112.095 -169.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 69.63 123.3 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.556 1.143 . . . . 72.21 111.357 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -137.98 104.75 5.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.173 0.589 . . . . 72.24 110.452 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' C' ' 5' ' ' ASN . . . -177.35 144.89 0.42 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.908 1.283 . . . . 75.12 109.416 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.6 131.75 2.69 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 119.785 -0.453 . . . . 71.53 112.808 170.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -147.34 146.28 29.62 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.201 1.0 . . . . 54.03 110.497 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -95.25 57.38 1.72 Allowed Glycine 0 C--N 1.352 1.464 0 O-C-N 123.534 0.521 . . . . 52.03 112.939 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 42.9 p -95.53 109.54 21.75 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.305 0.642 . . . . 65.54 109.891 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.91 -49.52 0.09 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.768 0.285 . . . . 71.55 111.768 -174.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.74 145.15 31.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.904 0.881 . . . . 63.35 110.905 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -128.18 155.88 43.79 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.324 1.049 . . . . 55.51 108.93 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.85 105.36 0.45 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.56 0.744 . . . . 71.44 109.505 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.02 154.88 21.02 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.837 0.855 . . . . 70.41 109.753 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 123.678 0.791 . . . . 72.05 108.955 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.472 -0.566 . . . . 75.4 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m 62.65 43.61 7.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.247 1.019 . . . . 65.53 111.37 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -62.79 95.21 0.07 Allowed 'General case' 0 C--N 1.357 0.894 0 N-CA-C 109.612 -0.514 . . . . 45.32 109.612 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -71.59 91.29 1.07 Allowed 'General case' 0 C--N 1.348 0.534 0 CA-C-N 115.267 -0.879 . . . . 73.01 109.666 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -83.55 152.89 24.65 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.897 -1.047 . . . . 73.34 109.588 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -63.57 -37.15 86.23 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.438 0.695 . . . . 43.11 110.165 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 16.3 m -93.34 102.47 14.73 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.033 -0.985 . . . . 73.12 108.868 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.46 100.33 2.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.262 -1.384 . . . . 71.43 107.262 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.5 ptm 51.77 169.7 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.984 2.114 . . . . 64.25 114.378 -173.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 61.8 m -154.5 140.31 18.13 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.047 -1.464 . . . . 74.14 107.047 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.568 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 77.2 t80 -140.88 132.34 26.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.01 -0.737 . . . . 71.22 109.01 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -144.07 131.61 21.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.306 -0.998 . . . . 72.13 108.306 171.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -82.02 126.73 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.044 -0.724 . . . . 74.3 109.044 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.12 -42.44 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.25 0.62 . . . . 71.2 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -165.01 151.02 10.0 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.466 0.174 . . . . 75.31 110.764 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.71 135.16 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.244 -1.762 . . . . 63.35 106.244 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HE1' HG13 ' B' ' 83' ' ' ILE . 7.3 p90 -168.24 146.29 4.29 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.166 0.586 . . . . 75.23 109.962 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.5 m -76.97 122.55 25.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.511 -0.768 . . . . 53.24 108.982 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -98.08 -27.22 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 72.23 111.379 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.7 t70 -158.35 139.69 13.39 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.527 0.517 . . . . 72.41 111.261 -172.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.2 mm -140.88 141.86 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.423 1.489 . . . . 74.04 108.001 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -145.78 131.58 19.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.211 -1.403 . . . . 54.42 107.211 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.5 t80 -145.76 110.28 5.06 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.73 -1.211 . . . . 63.23 107.73 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.42 134.3 54.99 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.803 -0.814 . . . . 74.33 108.803 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.6 81.22 60.5 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 106.419 -1.696 . . . . 62.23 106.419 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.69 -32.62 37.5 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.371 2.714 . . . . 74.15 112.469 -171.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.45 31.56 6.66 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.605 1.162 . . . . 72.21 109.855 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -43.07 -48.4 14.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 115.818 1.784 . . . . 71.54 115.818 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.74 -25.02 4.6 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 121.843 1.696 . . . . 35.4 112.789 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.42 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 72.0 m80 -94.74 -16.19 23.25 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.024 0.75 . . . . 72.11 113.024 -171.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' B' ' 73' ' ' ALA . 12.0 p -64.23 -12.75 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.803 0.841 . . . . 75.15 111.96 175.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -56.37 -25.74 50.55 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.013 0.925 . . . . 73.15 112.637 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.423 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 24.8 pt20 -71.44 -29.13 64.52 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.42 111.108 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 32.2 mmtp -107.52 80.3 1.39 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.342 1.057 . . . . 74.33 108.691 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.71 109.19 18.54 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.408 -0.815 . . . . 62.42 110.283 -174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.436 ' O ' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER 161.69 -158.91 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.965 2.506 . . . . 74.33 109.262 157.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 15.0 mp0 -49.44 106.99 0.69 Allowed Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 124.679 1.192 . . . . 72.42 111.621 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.22 153.07 14.12 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.479 2.119 . . . . 62.42 110.944 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -71.1 102.33 2.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.269 -1.011 . . . . 62.45 108.269 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -88.9 140.61 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.481 -0.933 . . . . 74.43 108.481 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -134.56 125.61 27.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.35 1.06 . . . . 75.31 109.211 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.2 148.0 23.52 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.131 0.972 . . . . 64.34 109.17 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -158.69 112.5 2.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.903 -0.777 . . . . 72.34 108.903 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.18 134.04 43.68 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.127 -0.694 . . . . 70.14 109.127 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.06 142.06 51.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.13 0.972 . . . . 52.13 108.882 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -109.19 117.5 34.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.538 0.735 . . . . 61.11 110.427 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -124.68 140.25 53.1 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.248 1.019 . . . . 75.21 109.036 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.5 p -145.12 162.89 35.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.848 0.459 . . . . 53.33 111.102 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -158.89 145.81 17.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.301 1.04 . . . . 64.54 109.238 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -96.49 112.05 23.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.527 -0.916 . . . . 74.14 108.527 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.24 -45.12 50.02 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.424 0.69 . . . . 74.2 110.681 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.4 -174.1 4.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.669 -1.151 . . . . 40.13 109.584 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.59 116.92 11.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.353 -0.84 . . . . 73.43 109.065 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 70.6 -2.29 2.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.541 1.536 . . . . 71.14 112.978 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.9 t -104.52 113.52 41.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -117.63 169.16 9.78 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.745 . . . . 73.23 109.31 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.427 ' HG2' HG12 ' B' ' 83' ' ' ILE . 4.7 tm-20 -142.47 105.92 4.64 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.721 -1.214 . . . . 74.43 107.721 -174.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.08 121.15 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.515 1.126 . . . . 54.0 109.434 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.3 t -106.02 121.74 58.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 124.24 1.016 . . . . 64.25 108.694 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.51 114.36 28.13 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.795 -1.187 . . . . 73.41 107.795 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -93.38 129.92 39.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.306 -0.861 . . . . 74.43 109.442 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.21 104.27 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.707 -1.22 . . . . 73.42 107.707 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -98.99 131.09 45.3 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.578 -0.527 . . . . 74.03 109.578 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.411 HG23 HD13 ' B' ' 114' ' ' ILE . 91.4 t -122.53 122.12 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.41 1.084 . . . . 73.24 108.922 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -115.05 143.71 44.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.625 -0.88 . . . . 72.14 108.625 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.81 142.87 38.7 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.766 -0.827 . . . . 63.14 108.766 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.5 p -161.37 148.02 14.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.826 0.704 . . . . 62.42 111.041 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' B' ' 34' ' ' LYS . 2.7 mp -123.73 130.78 53.16 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.636 -0.875 . . . . 74.43 108.636 173.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.17 -119.02 7.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.723 -0.951 . . . . 71.01 110.723 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.41 4.93 14.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.046 0.538 . . . . 64.51 110.967 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.23 161.95 18.65 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.572 0.349 . . . . 71.34 110.259 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.8 m -78.53 152.35 32.01 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.112 0.965 . . . . 71.2 111.538 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -97.49 -62.21 1.28 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.859 -1.164 . . . . 65.42 107.859 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.97 153.29 22.15 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.439 -1.255 . . . . 61.43 109.657 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.1 mt -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.608 -1.256 . . . . 55.34 107.608 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.45 152.2 33.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.993 0.517 . . . . 70.13 109.811 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -163.39 132.14 3.89 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.384 -0.969 . . . . 44.01 108.384 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.94 146.63 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.558 -0.904 . . . . 73.33 108.558 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.9 mt-30 -124.08 95.39 4.54 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.545 -1.28 . . . . 74.43 107.545 170.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -86.61 102.57 14.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.827 -1.175 . . . . 74.4 107.827 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.57 159.48 29.5 Favored Glycine 0 C--O 1.242 0.64 0 N-CA-C 110.958 -0.857 . . . . 50.41 110.958 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 125.69 1.55 Allowed Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.025 -0.83 . . . . 73.3 111.025 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.446 HG13 ' HE1' ' B' ' 17' ' ' TYR . 52.3 mt -85.71 131.36 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.89 -1.152 . . . . 74.22 107.89 175.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -139.05 132.84 30.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.43 -0.952 . . . . 74.54 108.43 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.1 m -89.8 101.91 14.61 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 172.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' B' ' 11' ' ' PHE . 15.1 pt -125.69 138.45 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.014 0.926 . . . . 72.21 109.605 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.65 166.54 33.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.566 1.146 . . . . 44.2 108.941 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 -28.16 2.64 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-N 117.569 0.168 . . . . 62.1 113.438 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 40.6 pt -54.35 135.31 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.322 1.449 . . . . 61.13 111.249 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -151.7 140.65 21.07 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.94 -0.573 . . . . 75.2 110.41 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.96 -110.78 2.11 Favored Glycine 0 C--N 1.355 1.611 0 O-C-N 124.738 1.274 . . . . 71.44 113.402 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.456 HG23 HD13 ' B' ' 141' ' ' LEU . 63.4 m -66.48 -42.93 86.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.113 0.965 . . . . 62.14 111.196 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -68.88 -31.93 71.22 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.62 0.768 . . . . 71.14 111.137 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.609 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 24.6 ttt -67.28 -57.32 6.89 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 123.512 0.507 . . . . 73.2 110.026 173.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' H' ' 280' ' ' LEU . . . -57.96 -36.58 72.77 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.438 1.086 . . . . 74.52 111.95 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.85 -31.73 59.46 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.421 0.688 . . . . 65.45 111.188 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.97 -67.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.654 0.264 . . . . 42.25 110.593 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.468 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -83.62 -13.14 54.98 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.831 0.678 . . . . 74.44 112.831 -174.01 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.16 0.09 41.04 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.178 0.431 . . . . 74.51 114.178 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.606 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -144.24 -54.04 0.34 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 117.244 0.522 . . . . 74.02 110.954 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -71.33 -52.43 18.79 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.688 0.795 . . . . 75.43 111.181 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.568 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 33.4 m -67.03 -45.93 52.89 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 123.872 0.869 . . . . 55.41 112.538 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.9 Cg_exo -55.45 -38.25 94.13 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.544 2.163 . . . . 62.21 113.649 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -69.67 -22.41 63.44 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.874 0.734 . . . . 51.13 111.276 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.14 -46.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.172 0.589 . . . . 64.54 109.864 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.83 -26.64 60.7 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.484 -0.78 . . . . 73.54 111.586 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.4 -50.32 88.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.223 1.194 . . . . 71.02 114.223 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.43 -38.48 74.14 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.6 2.2 . . . . 75.53 114.138 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.486 ' HE2' HG21 ' D' ' 115' ' ' THR . 52.5 m-85 -70.79 -45.08 65.32 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.812 0.845 . . . . 73.04 110.562 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.38 85.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.39 -0.823 . . . . 64.55 110.901 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -63.62 -51.42 65.29 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.269 1.428 . . . . 71.3 110.207 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -68.24 -29.82 68.72 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.75 0.656 . . . . 72.14 110.301 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -67.82 -42.12 82.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.533 0.333 . . . . 60.43 110.427 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.411 HD13 HG23 ' B' ' 64' ' ' VAL . 76.5 mt -62.21 -48.18 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.42 0.688 . . . . 65.01 109.623 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.416 HG23 ' OE1' ' B' ' 125' ' ' GLN . 89.3 m -56.67 -34.71 67.64 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.369 1.068 . . . . 62.42 111.599 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.9 t -69.42 -48.19 61.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.289 0.636 . . . . 70.2 110.066 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -70.47 -33.51 71.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.031 0.532 . . . . 54.21 111.545 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.46 -39.06 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.446 0.698 . . . . 74.22 109.855 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.485 ' OG ' HG21 ' C' ' 115' ' ' THR . 11.9 t -69.93 -27.2 64.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.456 -0.793 . . . . 63.34 111.824 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.5 mtt-85 -76.61 -32.1 57.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.304 0.642 . . . . 72.54 109.84 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.73 0.2 82.71 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.547 0.529 . . . . 73.0 112.259 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.456 HG22 ' OD1' ' C' ' 127' ' ' ASN . 61.4 p 61.38 33.88 18.58 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.675 1.99 . . . . 52.35 112.518 171.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -94.68 155.85 38.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.237 -0.892 . . . . 71.23 109.801 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -55.62 167.02 2.31 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.54 2.827 . . . . 72.12 114.422 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.485 ' HG3' HD22 ' B' ' 127' ' ' ASN . 5.7 tp60 -59.56 134.03 56.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.835 -1.075 . . . . 74.21 113.413 -172.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.77 96.13 4.9 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.42 -1.263 . . . . 65.23 107.867 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.485 HD22 ' HG3' ' B' ' 125' ' ' GLN . 4.0 p30 -108.28 112.79 25.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.574 -0.899 . . . . 75.03 108.574 172.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.406 HD12 ' H ' ' B' ' 129' ' ' ALA . 20.5 tp -75.18 139.76 42.87 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.001 -0.545 . . . . 74.21 109.828 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.406 ' H ' HD12 ' B' ' 128' ' ' LEU . . . -63.05 148.05 93.33 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.48 1.112 . . . . 71.12 111.619 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' D' ' 16' ' ' ILE . 5.5 Cg_exo -71.09 110.41 2.81 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.24 1.96 . . . . 74.32 110.21 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.4 t -99.39 121.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.55 -1.278 . . . . 63.11 107.55 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -74.21 88.69 1.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.357 -0.979 . . . . 72.03 108.357 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -62.38 -32.36 73.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.479 0.712 . . . . 72.51 111.137 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.606 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 24.7 t70 -60.0 -59.05 6.05 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.522 1.129 . . . . 73.33 111.142 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.72 77.11 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.691 0.796 . . . . 41.55 111.203 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 55.1 tp -59.28 -39.36 82.67 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.948 0.899 . . . . 73.32 110.791 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -77.71 -30.23 51.7 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.686 -0.688 . . . . 64.42 110.838 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.2 mtt -62.94 -35.86 81.53 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.819 -0.437 . . . . 74.02 109.819 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -74.58 -31.94 62.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.158 0.983 . . . . 74.11 110.456 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -62.06 -36.39 81.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.802 0.841 . . . . 71.13 110.146 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.456 HD13 HG23 ' B' ' 92' ' ' THR . 58.1 mt -99.77 22.09 11.53 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.216 1.007 . . . . 61.31 110.914 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 67.84 -79.14 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.859 1.263 . . . . 71.11 109.554 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -153.13 150.41 29.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.646 1.179 . . . . 63.1 109.0 170.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.61 178.99 8.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.529 0.731 . . . . 64.32 110.76 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.11 139.22 30.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.809 0.843 . . . . 63.33 111.342 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.38 43.63 1.0 Allowed Glycine 0 N--CA 1.47 0.924 0 N-CA-C 110.8 -0.92 . . . . 62.42 110.8 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -151.35 137.6 18.43 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.21 1.004 . . . . 74.23 108.447 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.56 169.05 38.45 Favored Glycine 0 C--N 1.347 1.162 0 O-C-N 123.645 0.591 . . . . 35.33 112.522 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 35.2 m -93.75 134.54 35.97 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.653 0.781 . . . . 74.12 109.374 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.36 142.83 48.76 Favored 'General case' 0 C--O 1.24 0.604 0 O-C-N 123.845 0.716 . . . . 74.11 110.944 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -144.37 94.97 2.64 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.836 -1.172 . . . . 62.44 107.836 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -142.41 127.94 19.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.612 0.765 . . . . 60.23 110.715 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.35 154.51 14.5 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.386 -1.339 . . . . 73.35 107.386 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -52.68 124.78 14.69 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.9 0.88 . . . . 73.34 110.955 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.878 0 C-N-CA 123.899 0.88 . . . . 73.35 108.707 177.827 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.341 -0.615 . . . . 64.31 109.341 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 17.4 t -176.5 88.92 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.626 1.17 . . . . 54.41 108.58 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.96 128.14 3.66 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.522 0.729 . . . . 61.41 109.899 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -87.19 99.89 12.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.061 0.545 . . . . 73.11 110.688 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.641 ' HB2' ' HB1' ' A' ' 145' ' ' ALA . 65.7 t30 -87.18 127.93 35.14 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.674 -0.862 . . . . 74.1 108.674 173.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -154.98 118.78 4.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.513 -0.551 . . . . 74.02 109.513 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 75.3 m 66.25 80.91 0.21 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 122.267 1.032 . . . . 72.4 109.338 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.437 ' HG3' HD21 ' C' ' 5' ' ' ASN . 0.2 OUTLIER -139.36 24.2 2.5 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.786 -1.097 . . . . 71.21 110.145 -168.997 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' C' ' 97' ' ' CYS . 54.3 ttp 65.83 114.54 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.947 1.299 . . . . 73.3 111.081 -166.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -109.0 99.69 8.98 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.593 -1.262 . . . . 74.32 107.593 173.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -105.76 130.27 53.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.027 -0.988 . . . . 72.31 109.533 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -151.14 139.17 20.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.902 0.881 . . . . 75.4 109.575 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.422 ' O ' HG11 ' G' ' 306' ' ' VAL . 2.8 pp -86.94 142.5 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.661 0.784 . . . . 55.31 110.004 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 75.9 mt-30 -101.56 -49.89 3.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.596 0.358 . . . . 62.01 110.584 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.513 HH12 HD13 ' G' ' 301' ' ' ILE . 57.3 ttt180 -167.79 127.04 1.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.466 0.306 . . . . 65.34 110.824 -173.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -107.89 143.63 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.108 -1.071 . . . . 72.13 108.108 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -172.03 164.07 6.14 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.535 0.683 . . . . 72.41 111.139 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.4 p -85.33 109.69 18.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.382 -0.969 . . . . 55.13 108.382 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -33.12 74.9 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.177 0.513 . . . . 75.23 109.875 173.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -155.41 150.29 26.54 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.577 -1.192 . . . . 72.3 109.572 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 60.2 mt -138.63 149.09 23.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.506 -1.665 . . . . 63.42 106.506 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 21.2 t -160.67 152.08 19.33 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.332 0.587 . . . . 65.22 110.789 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -147.02 141.86 26.85 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.691 -1.226 . . . . 73.54 107.691 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 50.2 mt-10 -132.92 150.89 52.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.707 0.803 . . . . 75.42 109.189 170.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.73 80.7 7.38 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 106.957 -1.497 . . . . 72.32 106.957 170.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.07 -35.04 20.99 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.488 2.125 . . . . 75.44 111.741 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.39 32.03 3.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.266 1.027 . . . . 74.01 109.489 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' D' ' 17' ' ' TYR . . . -59.67 -51.2 82.68 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 114.512 1.301 . . . . 21.55 114.512 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 15.4 Cg_exo -71.46 -35.55 7.99 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 121.627 1.617 . . . . 71.33 111.073 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -62.68 -23.41 67.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.131 1.772 . . . . 73.21 112.85 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 4.0 p -61.28 -20.33 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.03 0.752 . . . . 72.31 113.03 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.52 -40.3 96.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.436 0.695 . . . . 74.11 110.826 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -97.48 23.19 7.92 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.864 0.866 . . . . 74.41 110.461 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 4.2 ttmp? -109.06 150.28 28.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.071 . . . . 73.03 109.913 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.75 125.96 30.07 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.889 -0.782 . . . . 51.51 108.889 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -84.74 75.59 10.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.331 0.586 . . . . 74.51 109.958 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -162.8 80.05 1.73 Allowed Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 107.895 -1.15 . . . . 73.01 107.895 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -87.65 154.2 7.57 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.901 2.4 . . . . 63.45 112.477 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.87 89.31 7.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 106.3 -1.741 . . . . 62.33 106.3 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.97 120.67 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.999 -1.001 . . . . 75.03 109.062 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -109.98 130.8 55.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.77 1.228 . . . . 53.32 109.592 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.472 HD21 HD21 ' C' ' 128' ' ' LEU . 16.9 mt -87.32 122.89 31.68 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.025 -0.731 . . . . 55.45 109.025 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.39 103.19 8.57 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.467 1.107 . . . . 64.42 108.167 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -111.71 146.51 37.4 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.483 0.713 . . . . 51.01 109.518 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 21.4 t70 -138.8 135.32 34.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.283 -1.377 . . . . 50.52 107.283 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 22.0 p -127.13 126.94 43.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.456 0.302 . . . . 43.32 111.05 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.47 164.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.915 0.886 . . . . 50.14 110.058 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -144.46 148.36 34.48 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.984 0.914 . . . . 51.12 108.974 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 16.0 p -147.64 129.02 14.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.12 0.568 . . . . 60.04 109.964 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -75.4 125.38 28.87 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 109.295 -0.632 . . . . 72.13 109.295 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.459 HD11 HD12 ' C' ' 83' ' ' ILE . 73.5 mt -99.65 -31.4 11.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.696 0.798 . . . . 71.41 110.547 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 -177.79 6.22 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.269 1.028 . . . . 73.32 109.644 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.84 121.85 13.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.603 -0.726 . . . . 64.33 109.506 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 69.0 -3.0 1.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.85 1.26 . . . . 54.33 112.791 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -100.38 112.66 33.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.844 -0.799 . . . . 63.43 108.844 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -126.89 124.47 39.64 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.201 -1.037 . . . . 72.23 108.201 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.63 119.48 23.87 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.969 -1.014 . . . . 75.13 108.434 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.8 t -96.16 124.55 48.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.119 -1.067 . . . . 41.24 108.119 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.35 129.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.057 -1.09 . . . . 75.3 108.057 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -122.68 95.67 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.931 -1.137 . . . . 75.45 107.931 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.524 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.7 tmt_? -86.05 114.12 22.67 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.822 -1.177 . . . . 72.1 107.822 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.9 t -113.28 132.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.107 -1.071 . . . . 63.35 108.107 175.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -128.81 124.2 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.493 -0.928 . . . . 53.23 108.493 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.5 HG11 HD13 ' C' ' 126' ' ' LEU . 39.0 t -106.55 110.48 31.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.928 -1.138 . . . . 55.31 107.928 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.452 HG23 HD23 ' C' ' 75' ' ' LEU . 8.0 m -106.71 127.03 53.04 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.113 -0.699 . . . . 71.02 109.113 175.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.9 20.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.065 -1.087 . . . . 63.33 108.065 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.7 m -148.15 126.7 12.44 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.966 0.506 . . . . 74.42 109.782 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.503 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.2 OUTLIER -87.44 58.6 5.05 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.727 0.811 . . . . 73.32 109.473 177.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 -119.18 5.86 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.877 -1.289 . . . . 64.43 109.877 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.71 -24.02 21.67 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.616 0.766 . . . . 74.33 109.512 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.624 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 14.7 tp10 -68.2 96.1 0.62 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.192 0.997 . . . . 71.24 110.553 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.2 m -83.12 126.52 32.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.738 0.78 . . . . 61.41 111.259 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -82.78 -53.67 5.71 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.174 1.39 . . . . 51.0 110.19 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.88 170.46 16.75 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.022 0.826 . . . . 74.0 110.379 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.8 tm? -136.99 137.9 39.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 106.507 -1.664 . . . . 71.32 106.507 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -146.8 143.04 28.34 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.284 -1.006 . . . . 74.05 108.284 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -155.32 135.53 13.09 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.061 0.544 . . . . 72.0 109.887 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -138.3 135.23 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.235 1.014 . . . . 63.33 108.355 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -105.92 89.15 2.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.944 -1.132 . . . . 75.12 107.944 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -81.21 107.73 14.25 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.045 -0.979 . . . . 74.24 109.749 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.62 145.67 16.23 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.98 -0.448 . . . . 74.31 111.98 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.05 127.71 3.34 Favored Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 110.416 -1.074 . . . . 61.32 110.416 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.459 HD12 HD11 ' C' ' 51' ' ' LEU . 10.2 mm -81.28 114.64 22.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.842 -1.17 . . . . 72.34 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -121.55 137.11 54.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.037 -0.727 . . . . 74.3 109.037 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 m -109.96 105.59 14.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.425 -0.954 . . . . 71.13 108.425 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.422 HG21 ' HG3' ' C' ' 94' ' ' MET . 2.2 mp -114.7 111.88 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.648 -1.612 . . . . 73.53 106.648 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.64 157.94 31.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.994 0.518 . . . . 62.23 111.726 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.07 -60.51 0.97 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.016 -0.993 . . . . 53.32 112.384 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.68 178.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.833 0.453 . . . . 72.33 111.726 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.462 ' HB2' ' H ' ' F' ' 277' ' ' LEU . 9.9 pt-20 -154.32 -171.07 3.74 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.631 -0.713 . . . . 72.43 110.419 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.45 -128.8 44.34 Favored Glycine 0 C--N 1.355 1.634 0 O-C-N 123.856 0.723 . . . . 60.01 114.166 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -68.18 -31.92 71.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.065 0.946 . . . . 63.14 111.743 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.88 -46.32 82.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.658 0.783 . . . . 74.14 110.117 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.736 ' HG2' HD23 ' C' ' 98' ' ' LEU . 27.9 ttt -78.32 -25.69 46.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.342 -0.845 . . . . 74.14 110.987 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -32.73 74.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.999 0.52 . . . . 72.14 111.003 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.503 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 38.9 t-80 -65.49 -36.75 84.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.644 -0.707 . . . . 65.33 111.073 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.404 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 53.9 t -76.17 -61.35 1.97 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.627 0.371 . . . . 64.52 111.143 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.736 HD23 ' HG2' ' C' ' 94' ' ' MET . 3.4 pp -70.71 -34.04 71.51 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.186 0.594 . . . . 74.24 110.989 -175.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.65 -2.47 75.84 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.65 0.62 . . . . 71.25 114.65 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -137.24 -57.86 0.7 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.349 0.575 . . . . 74.42 111.193 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.425 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 68.0 t80 -72.59 -48.95 35.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 122.897 0.479 . . . . 74.13 111.586 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.589 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 81.2 m -58.21 -45.03 99.76 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.383 0.883 . . . . 72.44 113.383 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 98' ' ' LEU . 50.3 Cg_exo -56.92 -36.5 99.1 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 122.548 2.165 . . . . 75.3 113.209 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -68.7 -22.53 64.35 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.714 0.805 . . . . 55.14 111.734 -178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.548 HD12 HH12 ' A' ' 111' ' ' ARG . 35.3 mm -83.33 -36.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.803 0.441 . . . . 50.41 110.052 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.52 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.4 mt -82.34 -24.89 34.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.75 0.82 . . . . 71.25 112.131 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.77 -48.84 96.08 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 113.571 0.952 . . . . 53.51 113.571 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.96 -40.03 75.26 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.066 1.844 . . . . 74.21 113.184 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.427 ' HE2' HG21 ' A' ' 115' ' ' THR . 97.0 m-85 -70.51 -42.91 70.69 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.405 -0.816 . . . . 74.44 111.519 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.88 -46.47 87.75 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.357 0.663 . . . . 73.41 109.215 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -55.93 -51.64 66.92 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.483 1.513 . . . . 64.5 111.827 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.68 -33.2 70.65 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.503 0.321 . . . . 75.43 110.163 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.2 t -70.59 -31.02 67.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.637 0.375 . . . . 64.04 111.013 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -72.05 -51.17 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.676 0.79 . . . . 74.54 109.76 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.485 HG21 ' OG ' ' B' ' 119' ' ' SER . 88.4 m -59.23 -41.27 88.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.626 0.77 . . . . 75.42 111.071 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 26.2 t -60.3 -44.38 95.45 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.064 0.853 . . . . 61.35 109.653 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.537 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.92 -39.95 91.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.312 0.645 . . . . 74.4 111.824 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 72.6 t -62.16 -40.66 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.022 0.529 . . . . 63.55 110.116 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.427 ' HB2' ' NE2' ' B' ' 125' ' ' GLN . 84.1 p -76.17 -26.41 56.21 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.568 -0.742 . . . . 71.45 111.742 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.9 mtt-85 -71.52 -34.58 70.21 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.758 0.823 . . . . 75.24 110.168 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.62 6.06 59.25 Favored Glycine 0 C--N 1.355 1.593 0 O-C-N 123.576 0.548 . . . . 50.15 112.384 170.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p 61.67 19.49 10.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.168 2.187 . . . . 75.2 113.314 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HE1' HG11 ' C' ' 31' ' ' VAL . 52.2 m-85 -85.88 156.27 58.18 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.136 0.974 . . . . 73.32 109.688 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' F' ' 300' ' ' ASN . 68.3 Cg_exo -51.68 120.58 7.24 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.033 2.489 . . . . 72.54 111.958 173.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' B' ' 125' ' ' GLN . 96.2 mt-30 -57.08 143.99 36.31 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.309 1.006 . . . . 73.11 112.477 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.754 HD21 ' HH2' ' F' ' 290' ' ' TRP . 5.9 tt -119.28 109.18 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.178 -1.045 . . . . 75.0 108.178 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.456 ' OD1' HG22 ' B' ' 122' ' ' THR . 1.0 OUTLIER -91.95 119.0 31.29 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.43 -0.952 . . . . 71.43 108.43 170.206 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.472 HD21 HD21 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -73.13 136.75 44.87 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.083 -0.71 . . . . 75.41 109.083 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.9 151.75 94.56 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.288 1.035 . . . . 62.13 111.574 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.63 ' HG3' HD12 ' A' ' 16' ' ' ILE . 15.0 Cg_exo -66.39 98.54 0.4 Allowed 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.486 2.124 . . . . 35.51 111.325 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.92 108.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.908 -1.145 . . . . 54.31 107.908 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -95.04 99.05 11.12 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.762 -0.829 . . . . 73.41 108.762 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -68.71 -37.0 79.16 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 71.12 109.949 176.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.9 -27.99 69.53 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.474 1.11 . . . . 75.44 112.265 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.46 91.16 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.789 0.836 . . . . 44.32 111.552 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.98 -46.38 87.95 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.176 0.59 . . . . 75.35 110.534 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 137' ' ' PHE . . . . . 0.461 ' HB3' ' HD2' ' C' ' 96' ' ' HIS . 55.0 m-85 -64.79 -31.58 72.88 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.321 -0.854 . . . . 74.42 111.146 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 48.1 ttm -66.97 -38.48 86.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.93 0.892 . . . . 53.3 110.822 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -68.57 -38.98 81.15 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 116.154 -0.476 . . . . 72.21 110.962 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -71.01 -88.27 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 O-C-N 123.568 0.542 . . . . 73.13 110.826 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 15.1 tp -177.63 176.2 1.28 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.971 0.908 . . . . 74.23 108.691 -171.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.431 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 25.1 mm-40 75.04 8.76 4.04 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.396 1.478 . . . . 71.12 111.277 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.77 -15.85 61.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.465 1.106 . . . . 61.24 111.211 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -65.27 115.63 5.78 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.499 1.12 . . . . 73.15 111.199 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.9 -178.22 6.24 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.892 0.877 . . . . 71.53 110.202 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.69 109.46 0.61 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 108.437 -1.865 . . . . 62.0 108.437 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.86 148.74 50.75 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.639 0.775 . . . . 70.54 112.295 -165.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.63 -114.38 0.42 Allowed Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.157 -0.929 . . . . 62.34 111.508 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 50.4 p -140.14 131.17 26.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.905 0.882 . . . . 71.32 111.278 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.52 166.98 12.56 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.239 0.616 . . . . 73.32 110.324 172.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -106.83 -70.85 0.77 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.005 0.522 . . . . 62.41 111.544 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 m170 61.54 72.63 0.5 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 124.157 0.911 . . . . 74.52 110.363 -166.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -143.75 10.31 1.59 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.186 -0.915 . . . . 72.45 109.248 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -133.05 102.28 5.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.849 0.859 . . . . 70.44 108.803 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.358 0 C-N-CA 124.107 0.963 . . . . 54.41 111.636 -173.652 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 108.805 -0.813 . . . . 64.15 108.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' SER . . . . . 0.505 ' H ' ' HA ' ' D' ' 150' ' ' GLU . 20.2 m -145.34 161.82 38.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.154 0.582 . . . . 72.11 111.001 -174.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.84 121.31 3.6 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.059 0.944 . . . . 51.52 109.805 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -128.13 105.08 8.13 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.907 0.883 . . . . 62.43 110.025 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -156.17 162.74 40.17 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 107.987 -1.116 . . . . 53.33 107.987 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -146.46 109.46 4.65 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.694 0.398 . . . . 72.13 110.186 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.756 ' HB ' ' HA2' ' D' ' 88' ' ' GLY . 32.1 m -80.88 166.91 20.47 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 108.352 -0.981 . . . . 51.01 108.352 169.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.09 94.12 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.338 0.655 . . . . 71.3 111.209 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.46 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 7.6 ttp -35.34 128.55 0.56 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.232 1.413 . . . . 72.42 113.416 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.1 m -139.72 140.31 36.76 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.094 -1.076 . . . . 62.53 108.094 171.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -161.63 99.39 1.14 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.39 -0.967 . . . . 73.22 108.39 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -136.42 131.26 33.88 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.544 -0.91 . . . . 53.14 108.544 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.444 HD11 HG21 ' D' ' 105' ' ' ILE . 22.8 mt -82.34 122.12 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.206 -0.665 . . . . 63.33 109.206 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.63 -31.78 19.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.819 0.448 . . . . 73.43 110.826 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -167.3 144.66 4.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 110.48 -0.193 . . . . 75.13 110.48 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.602 HD12 ' HG3' ' B' ' 130' ' ' PRO . 0.1 OUTLIER -133.56 133.15 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 106.357 -1.72 . . . . 74.52 106.357 173.038 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.472 ' CE2' ' HB1' ' C' ' 28' ' ' ALA . 21.6 p90 -168.31 166.79 12.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.793 0.806 . . . . 71.4 111.12 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -93.09 121.63 34.63 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.371 -1.286 . . . . 74.13 108.769 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -88.77 -31.26 18.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.884 0.474 . . . . 75.23 110.069 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.01 139.44 18.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.946 -1.024 . . . . 51.12 109.012 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.2 mt -139.59 151.3 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.771 -1.196 . . . . 63.3 107.771 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -158.68 121.67 3.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.663 0.785 . . . . 74.12 110.264 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.9 t80 -113.65 121.22 43.5 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 106.657 -1.609 . . . . 72.22 106.657 165.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.4 mt-10 -121.88 117.63 26.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.708 -0.478 . . . . 72.53 109.708 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.68 87.66 2.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.806 -1.183 . . . . 42.25 107.806 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.13 -36.77 5.35 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.739 2.293 . . . . 70.32 112.727 -170.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -113.0 40.1 2.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.27 1.028 . . . . 64.25 108.623 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -51.98 -65.09 1.1 Allowed Pre-proline 0 CA--C 1.563 1.468 0 CA-C-O 117.916 -1.04 . . . . 61.44 113.799 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.92 -9.81 11.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 122.6 1.964 . . . . 72.51 112.91 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -74.07 -42.44 60.18 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.688 1.195 . . . . 75.35 110.377 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.28 -33.69 14.29 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 115.951 -0.568 . . . . 61.15 109.909 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -56.16 -22.55 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 74.04 113.699 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -70.6 -36.16 73.37 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.015 0.526 . . . . 51.03 110.436 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 63.32 1.63 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.778 0.831 . . . . 64.41 111.381 171.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.509 ' HB3' HD12 ' G' ' 301' ' ' ILE . 9.6 t70 -107.47 97.93 7.61 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.529 0.732 . . . . 50.2 109.714 -175.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.453 ' O ' HD22 ' D' ' 68' ' ' LEU . 13.2 m95 -121.87 -155.12 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.037 -1.097 . . . . 62.32 108.037 -169.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' G' ' 297' ' ' TYR . 10.3 tt0 -54.45 109.04 1.32 Allowed Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.082 0.771 . . . . 72.11 113.082 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.709 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 9.8 Cg_exo -72.03 139.45 32.87 Favored 'Trans proline' 0 C--N 1.386 2.525 0 C-N-CA 123.102 2.535 . . . . 64.25 112.968 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.0 116.48 29.0 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.561 -1.274 . . . . 74.04 107.561 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.32 149.85 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.923 0.889 . . . . 74.45 112.21 -170.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -127.83 139.35 52.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.72 1.608 . . . . 73.14 108.473 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.509 HD13 HG11 ' G' ' 288' ' ' VAL . 1.2 tt -120.84 114.7 21.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.944 -0.762 . . . . 62.34 108.944 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -109.08 141.98 40.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.209 1.004 . . . . 74.34 108.501 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.546 HD22 ' SD ' ' G' ' 286' ' ' MET . 4.9 mp -122.04 145.03 48.54 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.335 -0.617 . . . . 61.21 109.335 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.04 159.55 44.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.177 0.991 . . . . 70.34 108.47 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -136.6 168.78 18.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.13 0.572 . . . . 74.1 110.501 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.32 154.31 36.48 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.603 1.161 . . . . 72.34 108.347 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.485 ' HB2' ' HG ' ' G' ' 278' ' ' LEU . 58.6 p -149.44 150.67 32.75 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.31 0.244 . . . . 73.42 111.117 -174.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -174.18 127.73 0.36 Allowed 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.34 1.056 . . . . 73.13 108.93 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.89 127.31 32.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.898 -0.779 . . . . 74.34 108.898 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' D' ' 57' ' ' GLU . 57.6 mt -92.55 -36.01 13.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.886 0.474 . . . . 65.5 111.147 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.61 -171.1 1.99 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.433 0.693 . . . . 65.04 111.115 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -58.13 114.31 2.32 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.869 -1.06 . . . . 65.44 110.785 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 62.29 13.01 5.61 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.591 1.156 . . . . 62.15 112.501 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 80.6 t -115.52 118.48 58.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.512 -0.921 . . . . 70.44 108.512 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.626 ' HB3' HD22 ' G' ' 278' ' ' LEU . 96.1 m-85 -131.25 132.54 44.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.657 1.183 . . . . 74.35 108.144 -174.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.5 tt0 -99.77 126.0 45.77 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.375 0.422 . . . . 72.12 110.596 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -107.36 117.75 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 107.248 -1.389 . . . . 73.5 107.248 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.0 t -100.27 132.25 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.649 -1.241 . . . . 72.3 107.649 172.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -124.26 110.81 15.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.555 -0.906 . . . . 73.45 108.555 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.07 118.4 29.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.272 1.029 . . . . 74.11 109.694 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' VAL . . . . . 0.455 HG13 HD21 ' D' ' 42' ' ' LEU . 65.3 t -102.42 130.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.867 -1.161 . . . . 72.23 107.867 166.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.3 m -121.4 131.2 54.04 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.449 0.642 . . . . 74.35 109.887 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.437 HG21 HG21 ' D' ' 114' ' ' ILE . 88.5 t -122.42 105.89 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.473 1.509 . . . . 63.21 108.938 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -107.45 108.84 20.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.847 0.859 . . . . 73.22 109.258 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.59 137.0 37.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.451 -0.574 . . . . 74.14 109.451 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -139.21 123.08 17.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.309 -0.996 . . . . 53.43 108.309 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.709 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.4 pp -129.1 137.55 51.3 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.711 -0.478 . . . . 74.03 109.711 174.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.38 -113.09 3.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.683 -0.689 . . . . 71.04 112.119 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -116.37 3.14 13.29 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.723 0.809 . . . . 72.23 111.21 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.78 176.05 13.12 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.071 0.462 . . . . 74.51 111.497 -168.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 78.1 m -66.78 138.13 57.13 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.918 -1.037 . . . . 55.21 111.015 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.4 -65.79 0.97 Allowed 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.06 -1.089 . . . . 65.25 108.06 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -156.52 164.72 37.89 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.787 -1.551 . . . . 74.24 109.231 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.6 mt -126.26 144.31 50.84 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.665 1.186 . . . . 71.22 107.842 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.406 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 0.7 OUTLIER -145.7 139.24 26.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.204 1.002 . . . . 54.12 108.348 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -157.79 130.1 7.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.52 -0.548 . . . . 74.12 109.52 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 55.3 t -137.6 119.52 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.4 0.68 . . . . 74.35 109.682 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -89.29 91.24 8.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.539 0.735 . . . . 62.44 109.083 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 65.2 tp60 -80.59 94.66 6.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.259 0.624 . . . . 72.01 109.491 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.7 141.73 18.11 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.524 -0.63 . . . . 52.23 111.524 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.447 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.23 129.83 5.05 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 110.953 -0.859 . . . . 63.43 110.953 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.417 HG23 HD12 ' D' ' 51' ' ' LEU . 45.8 mt -89.41 119.42 36.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.793 -1.188 . . . . 65.34 107.793 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -121.47 147.52 45.66 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.04 0.936 . . . . 73.11 109.199 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -99.57 93.3 5.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.173 -1.418 . . . . 74.2 107.173 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 71.9 mt -106.78 118.35 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.107 -0.701 . . . . 64.01 109.107 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -151.94 160.74 43.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.114 0.966 . . . . 71.35 109.447 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.756 ' HA2' ' HB ' ' D' ' 7' ' ' THR . . . 81.44 -23.16 4.91 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 115.696 1.038 . . . . 53.14 115.696 170.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.419 HG13 ' HG2' ' D' ' 94' ' ' MET . 26.2 pt -96.11 135.7 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.597 -0.89 . . . . 73.23 108.597 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.05 172.93 15.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.518 -0.765 . . . . 74.43 110.153 -169.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.528 ' H ' ' HG3' ' G' ' 276' ' ' PRO . . . 62.69 -137.28 44.39 Favored Glycine 0 C--N 1.35 1.309 0 O-C-N 123.492 0.495 . . . . 70.05 112.595 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -77.58 -20.41 54.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.861 0.864 . . . . 75.42 111.511 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -62.38 -47.38 84.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.77 0.828 . . . . 71.34 110.318 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.572 ' HG3' HD23 ' G' ' 277' ' ' LEU . 0.0 OUTLIER -64.69 -46.96 80.15 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.246 -0.888 . . . . 74.33 109.681 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.17 67.41 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.341 1.026 . . . . 71.3 112.182 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -67.25 -50.55 60.11 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.247 -0.888 . . . . 65.43 111.159 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.84 -35.54 78.55 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.058 0.543 . . . . 75.14 111.462 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.539 HD12 ' SD ' ' D' ' 94' ' ' MET . 4.1 tt -70.27 -45.64 65.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.94 1.296 . . . . 63.21 109.226 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.74 -22.39 72.31 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 72.55 113.831 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.33 -66.82 1.04 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.405 0.52 . . . . 74.34 112.405 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -72.92 -48.19 39.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.551 0.741 . . . . 74.51 112.51 -166.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -60.1 -48.71 93.77 Favored Pre-proline 0 CA--C 1.571 1.781 0 C-N-CA 123.89 0.876 . . . . 71.21 112.784 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.64 -21.72 18.86 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.964 1.776 . . . . 53.15 112.906 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.09 -31.58 72.15 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.226 0.61 . . . . 64.5 110.577 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.444 HG21 HD11 ' D' ' 13' ' ' ILE . 47.8 mm -68.0 -42.82 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.674 0.79 . . . . 74.01 110.332 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.447 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.1 mt -73.73 -29.9 62.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.235 -0.893 . . . . 74.0 111.716 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -59.98 -44.11 96.0 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.338 1.236 . . . . 74.33 114.338 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.48 -41.09 80.15 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.445 2.097 . . . . 74.11 114.03 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -74.29 -37.36 63.7 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.258 0.623 . . . . 74.11 111.371 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' ALA . . . . . 0.4 ' O ' HG13 ' D' ' 114' ' ' ILE . . . -63.71 -47.45 81.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.086 0.554 . . . . 71.54 109.975 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -53.9 -53.51 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.772 1.295 . . . . 60.41 110.562 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.56 -46.98 85.74 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 124.523 1.139 . . . . 74.44 110.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.3 t -59.44 -32.88 70.62 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.579 0.549 . . . . 75.45 111.708 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' D' ' 118' ' ' VAL . 73.3 mt -73.24 -49.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.157 0.583 . . . . 71.44 109.916 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.486 HG21 ' HE2' ' B' ' 109' ' ' TYR . 21.8 m -55.07 -40.99 70.95 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.719 1.208 . . . . 72.13 111.577 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -71.65 -37.51 70.81 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.335 -0.848 . . . . 72.11 110.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.3 mtm -63.37 -45.34 91.56 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 122.742 0.417 . . . . 75.03 111.287 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.6 t -63.05 -41.87 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.142 -0.936 . . . . 65.21 110.451 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.2 p -68.16 -31.86 71.72 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.207 0.603 . . . . 63.33 111.754 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -71.93 -30.1 64.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.74 0.816 . . . . 63.13 110.931 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.62 8.63 64.7 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.965 -0.561 . . . . 71.11 112.569 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.6 p 60.73 24.97 14.8 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.018 2.127 . . . . 72.4 113.036 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.23 161.17 27.02 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.836 1.255 . . . . 72.43 109.499 172.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 120.04 7.16 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.475 2.117 . . . . 73.44 111.102 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.87 139.68 50.66 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.689 0.618 . . . . 74.5 110.093 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tt -109.19 117.75 34.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.401 -0.592 . . . . 74.32 109.401 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -99.98 95.39 6.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.969 -1.014 . . . . 72.54 108.362 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.12 121.19 12.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.433 0.693 . . . . 74.02 110.08 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -66.95 140.7 96.25 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.38 0.672 . . . . 51.21 110.577 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -75.0 108.65 2.77 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.549 2.166 . . . . 73.34 110.777 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.94 138.88 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.443 0.697 . . . . 74.31 109.199 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -74.17 112.37 10.26 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 123.97 0.794 . . . . 74.25 110.428 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -74.83 -32.2 61.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.56 0.744 . . . . 72.53 110.988 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -49.77 -55.02 15.63 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.17 0.988 . . . . 73.55 111.445 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.41 -41.59 85.29 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.215 1.006 . . . . 51.13 112.63 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.4 HD22 ' HG2' ' G' ' 287' ' ' PRO . 73.5 mt -63.14 -40.15 96.74 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.18 -0.918 . . . . 74.0 111.055 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -78.76 -26.46 44.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.353 1.061 . . . . 72.41 112.991 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.1 mmt -46.74 -47.47 20.66 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.202 0.601 . . . . 73.45 110.99 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.98 -48.96 78.02 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.947 -1.024 . . . . 61.14 110.953 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.69 -35.98 75.57 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.114 0.966 . . . . 71.04 112.028 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.6 -28.67 62.92 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.873 0.869 . . . . 73.02 110.939 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -87.04 3.7 44.98 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.125 0.97 . . . . 73.31 111.059 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -130.84 51.1 2.16 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.244 1.018 . . . . 74.4 110.276 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -144.45 155.0 43.53 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.193 0.597 . . . . 73.31 109.786 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.31 89.81 1.07 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.548 -0.908 . . . . 62.25 108.548 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.7 65.24 0.02 OUTLIER Glycine 0 C--N 1.343 0.972 0 N-CA-C 110.44 -1.064 . . . . 42.5 110.44 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -81.57 169.67 16.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.821 0.848 . . . . 71.35 110.041 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.47 -24.73 73.81 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.784 0.677 . . . . 40.0 114.517 -172.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.3 t -161.5 177.74 9.77 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 123.374 0.67 . . . . 71.23 110.068 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 150' ' ' GLU . . . . . 0.505 ' HA ' ' H ' ' D' ' 2' ' ' SER . 34.3 tt0 -132.76 104.71 6.75 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.822 -0.807 . . . . 61.11 108.822 170.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -151.35 93.24 1.87 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.128 -1.064 . . . . 71.22 108.128 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -67.2 93.76 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.763 -1.108 . . . . 74.45 110.66 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -94.43 152.73 18.38 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.617 -0.883 . . . . 73.53 108.617 165.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -159.88 161.61 34.43 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.319 0.648 . . . . 72.11 109.705 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 123.45 0.7 . . . . 54.42 110.374 177.931 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.213 -0.292 . . . . 62.15 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -154.26 126.51 7.89 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.887 -0.783 . . . . 53.34 108.887 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.26 97.42 8.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.586 0.754 . . . . 72.35 109.436 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -78.56 104.9 9.47 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 275' ' ' LYS . . . . . 0.532 ' HE3' ' HB2' ' A' ' 50' ' ' GLN . 21.6 pttm -82.27 118.76 73.09 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.173 0.589 . . . . 73.31 110.37 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.39 -1.8 11.51 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.822 2.348 . . . . 74.35 113.559 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 78.9 mt -78.72 -35.78 44.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.655 0.782 . . . . 74.33 111.776 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.81 104.27 15.5 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.334 -1.358 . . . . 61.23 107.334 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -154.39 31.26 0.7 Allowed Glycine 0 C--N 1.343 0.955 0 O-C-N 123.631 0.582 . . . . 65.33 112.15 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 95' ' ' ALA . 4.5 tt -164.46 167.02 20.0 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 107.998 -1.112 . . . . 55.21 107.998 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 281' ' ' PHE . . . . . 0.405 ' CZ ' HG13 ' A' ' 58' ' ' VAL . 72.6 t80 73.94 30.15 1.33 Allowed 'General case' 0 CA--C 1.561 1.388 0 CA-C-O 122.862 1.315 . . . . 73.42 110.3 172.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -109.18 13.05 24.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.69 -1.141 . . . . 72.01 109.063 166.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -148.93 147.22 28.38 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.657 1.183 . . . . 65.14 109.398 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.71 100.03 0.35 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.558 -0.617 . . . . 54.42 111.558 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 285' ' ' ASN . . . . . 0.442 ' HB2' ' SD ' ' E' ' 286' ' ' MET . 41.9 m-80 -57.99 -51.08 71.12 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.157 0.983 . . . . 71.44 112.276 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 286' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' E' ' 285' ' ' ASN . 0.0 OUTLIER -145.28 146.09 29.03 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.595 0.758 . . . . 73.3 110.202 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.46 128.35 20.06 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.998 2.466 . . . . 74.52 112.258 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 288' ' ' VAL . . . . . 0.44 HG13 HG11 ' A' ' 131' ' ' VAL . 99.8 t -95.73 122.63 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.556 -0.905 . . . . 70.01 108.556 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -78.12 149.62 33.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.891 -0.781 . . . . 71.13 108.891 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 290' ' ' TRP . . . . . 0.511 ' HH2' HD11 ' A' ' 126' ' ' LEU . 5.0 t-105 -91.62 124.95 36.16 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.639 -0.504 . . . . 74.42 109.639 174.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.5 15.78 28.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.108 0.963 . . . . 73.1 110.846 -171.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -128.07 64.98 0.58 Allowed Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.404 -0.664 . . . . 52.22 112.475 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.52 177.29 9.01 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.385 2.057 . . . . 63.12 111.653 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt 67.77 12.77 9.0 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.308 1.043 . . . . 71.02 111.388 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 295' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . 68.52 153.97 0.1 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.342 1.457 . . . . 71.34 113.192 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 6.0 t -85.09 70.35 10.89 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 122.426 1.108 . . . . 42.22 110.421 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -151.94 -67.98 0.17 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.673 -1.148 . . . . 75.03 109.309 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 64.9 14.29 9.15 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.888 1.275 . . . . 73.45 110.826 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 159.51 -166.24 34.75 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 116.243 -0.435 . . . . 50.02 112.496 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -79.52 175.98 10.11 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.056 0.942 . . . . 75.05 110.103 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 20.7 pt -136.52 -153.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.59 0.756 . . . . 73.23 110.11 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.54 -172.78 0.08 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.161 0.984 . . . . 70.13 111.369 162.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -146.8 164.45 23.68 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 122.689 0.396 . . . . 54.24 110.872 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.49 55.13 4.1 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.835 2.357 . . . . 64.34 112.532 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -167.07 115.84 0.84 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.975 1.31 . . . . 73.42 108.152 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 95.3 t -73.89 -79.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.786 0.434 . . . . 55.22 110.338 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 307' ' ' THR . . . . . 0.41 HG22 ' HB3' ' G' ' 295' ' ' ALA . 20.2 p -141.15 -84.63 0.2 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.835 0.454 . . . . 64.41 110.703 -173.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 308' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' E' ' 310' ' ' PRO . 48.9 t -178.73 -176.96 0.49 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.442 1.097 . . . . 74.11 109.226 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 309' ' ' THR . . . . . 0.433 ' HA ' HD23 ' G' ' 291' ' ' LEU . 4.4 p -135.34 -45.52 0.02 OUTLIER Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.952 -1.023 . . . . 52.44 112.581 170.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 310' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' E' ' 308' ' ' CYS . 51.3 Cg_exo . . . . . 0 C--N 1.398 3.157 0 C-N-CA 122.382 2.054 . . . . 75.15 112.5 168.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.939 -0.393 . . . . 53.13 109.939 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -150.96 -77.97 0.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.821 -0.807 . . . . 74.5 108.821 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -146.13 -79.27 0.17 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.598 0.759 . . . . 65.13 109.87 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -109.51 125.08 52.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.704 0.802 . . . . 74.21 110.582 -170.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -113.93 96.66 42.32 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 108.172 -1.048 . . . . 74.24 108.172 172.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.05 146.46 97.68 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.899 2.4 . . . . 62.43 112.694 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 277' ' ' LEU . . . . . 0.515 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 96.0 mt 61.22 27.97 17.63 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.982 1.313 . . . . 71.01 112.594 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.591 HD12 HD22 ' C' ' 98' ' ' LEU . 8.9 tp -167.12 178.32 5.74 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.772 0.829 . . . . 72.31 109.027 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 155.61 37.1 0.02 OUTLIER Glycine 0 C--N 1.353 1.497 0 CA-C-O 119.793 -0.449 . . . . 63.14 113.677 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 280' ' ' LEU . . . . . 0.708 HD13 ' H ' ' F' ' 281' ' ' PHE . 0.2 OUTLIER -168.5 168.46 11.06 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.607 -1.257 . . . . 75.21 107.607 178.171 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 281' ' ' PHE . . . . . 0.708 ' H ' HD13 ' F' ' 280' ' ' LEU . 22.2 m-30 80.64 -62.16 0.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 126.265 1.826 . . . . 74.34 110.906 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.43 38.69 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.949 0.9 . . . . 73.31 111.59 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -68.77 -35.25 76.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.754 0.822 . . . . 63.12 110.803 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 165.13 4.68 0.04 OUTLIER Glycine 0 C--N 1.355 1.588 0 CA-C-O 118.729 -1.039 . . . . 70.14 114.444 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 67.8 117.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.969 1.308 . . . . 75.13 110.752 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 28.4 ttt -69.84 115.46 33.73 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 122.932 0.493 . . . . 53.44 110.506 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.45 142.71 26.84 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.467 2.112 . . . . 74.23 112.412 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.16 130.83 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.447 0.699 . . . . 72.1 109.145 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -105.83 145.97 30.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.923 0.889 . . . . 61.42 109.146 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 290' ' ' TRP . . . . . 0.754 ' HH2' HD21 ' C' ' 126' ' ' LEU . 47.8 m95 -76.84 162.11 27.9 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.842 0.83 . . . . 72.23 112.309 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 4.8 mp -93.25 -45.73 7.71 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 113.946 -1.479 . . . . 71.32 108.074 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.74 122.51 0.66 Allowed Glycine 0 CA--C 1.532 1.15 0 CA-C-N 114.996 -1.002 . . . . 53.4 111.387 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.26 -2.93 13.2 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.09 2.527 . . . . 71.21 112.798 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -61.67 -33.2 73.57 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.653 1.181 . . . . 65.02 112.029 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.51 -16.98 63.55 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.14 0.976 . . . . 63.24 112.552 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 27.1 m -125.22 151.92 45.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.675 0.79 . . . . 55.44 110.376 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.424 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 6.4 t80 70.31 51.87 0.37 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.387 1.075 . . . . 74.5 111.375 165.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -92.75 5.64 50.41 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.758 0.79 . . . . 62.43 109.876 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 115.68 139.65 6.8 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.676 -0.693 . . . . 61.11 111.987 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 300' ' ' ASN . . . . . 0.45 ' HB2' ' HG3' ' C' ' 124' ' ' PRO . 15.6 t-20 -132.01 -22.01 2.35 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.027 -0.731 . . . . 72.51 109.027 168.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' F' ' 305' ' ' ALA . 2.6 mp -115.88 78.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.931 0 C-N-CA 124.147 0.979 . . . . 71.41 109.645 -175.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -97.21 164.88 12.3 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.136 -1.061 . . . . 64.44 108.136 166.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 65.62 -164.8 0.01 OUTLIER Pre-proline 0 CA--C 1.576 1.968 0 CA-C-O 118.395 -0.812 . . . . 75.22 109.566 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -72.41 20.13 0.31 Allowed 'Trans proline' 0 C--N 1.389 2.705 0 CA-C-N 122.506 1.931 . . . . 73.13 113.977 165.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 305' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' F' ' 301' ' ' ILE . . . 67.36 -75.75 0.06 Allowed 'General case' 0 C--N 1.366 1.296 0 C-N-CA 125.658 1.583 . . . . 64.33 111.574 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 57.1 t -110.18 113.12 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.752 -1.944 . . . . 72.02 105.752 171.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 18.8 m -83.91 -24.35 30.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.801 0.44 . . . . 73.54 111.145 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 67.8 m -144.47 139.67 28.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.846 0.459 . . . . 74.22 111.075 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 309' ' ' THR . . . . . 0.442 HG23 ' O ' ' B' ' 130' ' ' PRO . 38.1 m -124.52 113.03 27.5 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.788 0.835 . . . . 63.43 109.984 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 C--N 1.379 2.184 0 C-N-CA 123.49 2.793 . . . . 73.14 111.501 175.404 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.484 -0.562 . . . . 52.12 109.484 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -163.12 109.8 1.18 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 107.458 -1.312 . . . . 61.25 107.458 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -142.43 166.16 25.42 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.349 -0.982 . . . . 74.3 108.349 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 274' ' ' GLN . . . . . 0.481 ' HA ' HD12 ' G' ' 277' ' ' LEU . 15.8 mt-30 69.5 38.73 1.71 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.4 1.08 . . . . 75.4 110.598 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 275' ' ' LYS . . . . . 0.51 ' HB2' ' HD3' ' G' ' 276' ' ' PRO . 18.9 mtmt -69.66 -52.43 14.05 Favored Pre-proline 0 CA--C 1.566 1.573 0 CA-C-N 115.137 -0.938 . . . . 72.41 111.442 -173.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 276' ' ' PRO . . . . . 0.528 ' HG3' ' H ' ' D' ' 91' ' ' GLY . 43.1 Cg_endo -90.37 -5.13 4.83 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 121.69 1.593 . . . . 75.13 112.572 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.572 HD23 ' HG3' ' D' ' 94' ' ' MET . 94.3 mt -74.96 93.66 2.72 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 123.007 0.523 . . . . 70.11 109.884 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 278' ' ' LEU . . . . . 0.626 HD22 ' HB3' ' D' ' 56' ' ' TYR . 22.6 tp 74.34 80.57 0.12 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 113.879 -1.509 . . . . 73.15 111.71 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 279' ' ' GLY . . . . . 0.437 ' H ' HD11 ' D' ' 98' ' ' LEU . . . 165.46 53.28 0.02 OUTLIER Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.591 -0.731 . . . . 72.15 112.09 174.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' D' ' 98' ' ' LEU . 2.9 tm? -92.78 -68.11 0.82 Allowed 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 109.609 -0.515 . . . . 63.32 109.609 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -110.07 142.99 40.75 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.922 0.489 . . . . 65.31 109.708 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -148.44 -31.68 0.26 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.707 0.803 . . . . 74.5 110.92 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -59.8 -49.61 77.04 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.413 1.085 . . . . 64.21 111.742 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.05 -166.17 29.65 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.849 -0.614 . . . . 61.41 113.166 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 19.6 m120 52.43 85.67 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.315 1.446 . . . . 74.25 111.743 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 286' ' ' MET . . . . . 0.546 ' SD ' HD22 ' D' ' 44' ' ' LEU . 64.0 mtt -76.07 161.19 76.32 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-N 115.398 -0.819 . . . . 74.41 109.528 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 287' ' ' PRO . . . . . 0.4 ' HG2' HD22 ' D' ' 136' ' ' LEU . 93.0 Cg_endo -75.48 38.04 0.54 Allowed 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.941 2.427 . . . . 73.41 113.764 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 288' ' ' VAL . . . . . 0.509 HG11 HD13 ' D' ' 42' ' ' LEU . 48.1 t -80.51 94.69 2.28 Favored 'Isoleucine or valine' 0 C--N 1.353 0.743 0 N-CA-C 108.568 -0.901 . . . . 75.1 108.568 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -92.21 27.03 2.32 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.32 1.048 . . . . 74.31 109.327 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 66.6 m95 63.6 172.39 0.17 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.93 1.292 . . . . 74.01 112.891 -171.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' E' ' 309' ' ' THR . 3.5 mp -104.99 -15.02 15.23 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.026 -1.443 . . . . 70.51 108.638 173.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -161.87 94.67 0.13 Allowed Glycine 0 C--N 1.349 1.279 0 N-CA-C 109.2 -1.56 . . . . 75.33 109.2 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.06 -23.21 59.59 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.523 2.815 . . . . 72.33 114.629 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -144.44 88.5 1.94 Allowed 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.16 -0.682 . . . . 75.22 109.16 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 295' ' ' ALA . . . . . 0.41 ' HB3' HG22 ' E' ' 307' ' ' THR . . . -169.03 99.51 0.37 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.083 -0.962 . . . . 74.22 109.138 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 296' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' D' ' 38' ' ' PRO . 5.6 m -146.48 -62.31 0.3 Allowed 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.015 0.526 . . . . 63.22 110.34 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' D' ' 37' ' ' GLN . 0.0 OUTLIER -157.97 163.88 37.37 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 123.107 0.563 . . . . 75.42 110.906 -177.133 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -161.36 134.46 6.33 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.637 -0.875 . . . . 63.24 108.637 170.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -161.49 -146.01 4.5 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-O 119.848 -0.418 . . . . 74.4 113.007 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -147.73 97.86 2.88 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.335 0.654 . . . . 65.53 109.369 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.513 HD13 HH12 ' C' ' 15' ' ' ARG . 80.6 mt -72.16 125.48 30.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.104 -0.953 . . . . 73.21 111.432 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -171.36 149.33 2.72 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 124.509 1.131 . . . . 73.13 108.619 163.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 303' ' ' LYS . . . . . 0.518 ' HD3' ' HB ' ' G' ' 306' ' ' VAL . 1.0 OUTLIER -60.61 141.97 91.75 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 123.894 0.878 . . . . 54.3 110.467 174.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.83 81.32 1.37 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.584 2.189 . . . . 64.41 112.545 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . 70.53 -68.07 0.22 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.954 1.701 . . . . 55.41 111.795 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.518 ' HB ' ' HD3' ' G' ' 303' ' ' LYS . 33.4 t 35.9 70.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 126.405 1.882 . . . . 54.14 112.698 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 40.9 p -90.63 -60.07 2.01 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.306 -0.861 . . . . 63.4 109.91 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 83.8 m -149.36 148.64 29.74 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.701 0.8 . . . . 61.22 110.139 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 309' ' ' THR . . . . . 0.504 ' N ' ' HD2' ' G' ' 310' ' ' PRO . 15.8 p -78.54 -32.82 0.86 Allowed Pre-proline 0 CA--C 1.572 1.824 0 CA-C-O 117.627 -1.178 . . . . 65.21 114.001 175.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 310' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' G' ' 309' ' ' THR . 11.2 Cg_endo . . . . . 0 C--N 1.408 3.705 0 C-N-CA 122.492 2.128 . . . . 51.34 112.976 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 109.841 -0.429 . . . . 61.14 109.841 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -72.33 -9.7 58.84 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.571 0.748 . . . . 74.34 111.27 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -63.36 93.84 0.07 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.276 1.03 . . . . 73.41 110.024 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -114.5 162.21 17.0 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.365 1.066 . . . . 74.53 109.463 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -147.33 103.19 3.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 122.905 0.482 . . . . 74.14 110.362 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.44 133.62 24.72 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 121.869 1.713 . . . . 74.41 109.993 165.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 9.7 tt -60.33 -36.53 78.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.071 0.548 . . . . 70.31 109.845 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.51 90.68 1.01 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.196 -0.668 . . . . 72.4 109.196 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 279' ' ' GLY . . . . . 0.448 ' H ' ' HE1' ' B' ' 94' ' ' MET . . . -116.52 -64.46 0.35 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 110.446 -1.061 . . . . 62.25 110.446 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 280' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' B' ' 95' ' ' ALA . 4.4 mm? -71.21 74.06 0.68 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.527 1.131 . . . . 70.44 111.625 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -176.49 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 123.619 0.768 . . . . 72.34 110.939 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -85.69 80.64 8.92 Favored 'General case' 0 C--N 1.357 0.917 0 CA-C-O 121.438 0.637 . . . . 65.53 109.903 -170.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -126.1 -36.26 2.36 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.691 -1.14 . . . . 71.14 108.951 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.85 148.95 19.76 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.032 -0.986 . . . . 62.45 111.053 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -73.12 165.63 24.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.274 0.63 . . . . 71.44 111.072 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 52.2 ttp -126.01 89.95 51.28 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.307 0.643 . . . . 43.33 109.554 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.65 111.96 2.93 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.8 2.334 . . . . 44.25 110.919 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 87.6 t -74.03 127.2 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.003 0.521 . . . . 52.41 109.658 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -64.91 112.64 3.38 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 108.761 -0.829 . . . . 63.42 108.761 173.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -61.05 124.05 19.39 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 124.118 0.886 . . . . 72.54 111.16 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.32 139.74 45.89 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.166 0.987 . . . . 64.44 108.598 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 178.83 85.31 0.06 OUTLIER Glycine 0 C--N 1.336 0.556 0 N-CA-C 110.333 -1.107 . . . . 34.4 110.333 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.36 -33.57 94.22 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.143 2.562 . . . . 74.53 113.167 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -81.06 -20.11 42.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.036 0.534 . . . . 61.2 111.308 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 65.24 -176.85 0.18 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.729 1.212 . . . . 75.51 112.678 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 43.9 m -94.05 -63.22 1.22 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.923 0.889 . . . . 61.22 110.262 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.68 148.14 28.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.076 -0.965 . . . . 73.11 109.531 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -136.96 -72.01 0.44 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.006 -0.739 . . . . 75.23 109.006 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.93 62.31 0.14 Allowed Glycine 0 C--N 1.352 1.454 0 C-N-CA 121.24 -0.505 . . . . 55.42 113.416 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -136.83 109.69 7.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.624 1.169 . . . . 71.32 108.334 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 301' ' ' ILE . . . . . 0.567 HG12 ' H ' ' H' ' 302' ' ' ASP . 10.7 tt -163.05 179.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 O-C-N 123.405 0.44 . . . . 62.45 110.653 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 302' ' ' ASP . . . . . 0.567 ' H ' HG12 ' H' ' 301' ' ' ILE . 5.4 m-20 -55.68 106.85 0.28 Allowed 'General case' 0 C--N 1.363 1.185 0 C-N-CA 124.943 1.297 . . . . 74.34 110.48 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 303' ' ' LYS . . . . . 0.617 ' HB3' ' HD3' ' H' ' 304' ' ' PRO . 37.6 ttpt -162.17 -54.57 0.01 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.219 -1.03 . . . . 75.42 108.219 171.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 304' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' H' ' 303' ' ' LYS . 10.4 Cg_endo -95.95 47.7 0.16 Allowed 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 122.689 2.259 . . . . 70.25 109.973 163.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.14 -171.34 1.68 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.364 1.065 . . . . 75.43 111.874 -174.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 19.5 t -79.97 76.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-O 122.144 0.973 . . . . 65.25 109.848 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 31.4 m -121.42 -38.22 2.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.133 0.973 . . . . 73.2 108.604 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 85.7 m -85.7 77.17 9.85 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.56 -0.746 . . . . 44.41 110.82 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 16.5 p -135.47 78.01 51.77 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.229 1.011 . . . . 71.34 108.554 172.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 C--N 1.377 2.073 0 C-N-CA 122.964 2.443 . . . . 71.33 111.636 178.758 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.652 -0.499 . . . . 62.31 109.652 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.5 t -160.07 -64.88 0.07 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.386 0.674 . . . . 41.43 109.548 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.29 -58.5 0.64 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.229 1.012 . . . . 62.14 110.079 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.08 -15.15 59.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.47 0.708 . . . . 71.2 112.807 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.8 t30 73.76 138.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.542 1.537 . . . . 72.32 111.451 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -105.33 -7.23 18.99 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.642 0.777 . . . . 62.44 111.961 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -92.78 25.45 3.13 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.899 0.48 . . . . 72.04 111.028 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.419 ' O ' ' HA3' ' A' ' 88' ' ' GLY . 40.7 tt0 -124.72 122.51 37.68 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.625 0.77 . . . . 72.41 109.633 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.517 ' HG3' HG23 ' A' ' 89' ' ' ILE . 1.9 mpp? -75.6 146.88 40.02 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.675 0.79 . . . . 71.4 110.0 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m -142.73 135.77 28.27 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.415 0.686 . . . . 63.13 109.932 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.451 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 21.7 t80 -137.08 131.69 33.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.784 0.834 . . . . 71.12 109.442 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -154.96 108.09 2.81 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.688 0.618 . . . . 64.51 109.904 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.684 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.4 mt -70.84 119.56 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 110.015 -0.365 . . . . 74.14 110.015 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.658 ' HA ' ' HA ' ' H' ' 307' ' ' THR . 1.5 tm0? -82.68 -33.01 27.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.646 0.778 . . . . 73.13 110.674 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -173.37 136.77 0.62 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.011 0.524 . . . . 64.25 110.182 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 16' ' ' ILE . 2.5 pp -122.59 139.39 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.058 -0.719 . . . . 74.32 109.058 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 12.4 p90 -173.91 172.28 3.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.422 0.63 . . . . 73.41 111.189 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -94.93 123.45 38.41 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.386 -0.825 . . . . 61.53 108.849 171.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.8 mtpt -83.24 -34.89 25.74 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 110.003 -0.369 . . . . 74.12 110.003 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 10.2 t70 -152.99 140.66 19.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.524 -0.762 . . . . 72.32 109.127 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.5 mt -129.96 143.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.268 1.027 . . . . 62.32 108.5 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.64 122.53 10.65 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.313 0.383 . . . . 74.22 110.41 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 91.6 t80 -123.58 140.72 52.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 107.721 -1.214 . . . . 72.34 107.721 166.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.36 133.93 31.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.828 0.451 . . . . 75.41 110.438 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -150.34 72.61 9.19 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.606 1.562 . . . . 75.24 107.414 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.42 -42.57 3.63 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.791 2.327 . . . . 73.31 111.465 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.94 27.7 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.631 -1.168 . . . . 63.45 110.803 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -49.24 -53.2 41.76 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 118.216 -0.897 . . . . 74.33 112.211 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.93 -30.41 83.61 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.945 1.763 . . . . 74.01 113.036 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -74.42 -50.03 20.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.58 0.705 . . . . 61.33 110.139 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.4 p -70.42 -22.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 114.49 -1.232 . . . . 73.21 112.168 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -64.74 -27.94 69.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.105 0.409 . . . . 63.41 112.105 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -100.94 -10.81 20.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.653 0.612 . . . . 74.12 112.653 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.641 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmtp -72.0 172.67 9.61 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.744 0.646 . . . . 73.23 112.744 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -50.79 117.56 2.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.599 1.16 . . . . 73.32 110.997 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -69.61 65.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.063 1.745 . . . . 73.21 110.691 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -148.63 68.96 10.13 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.603 1.161 . . . . 71.45 109.491 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.59 ' HG2' ' HB ' ' E' ' 296' ' ' THR . 56.6 Cg_endo -85.94 120.3 1.95 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.791 2.327 . . . . 72.2 112.706 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.93 105.16 17.19 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.651 -1.24 . . . . 53.53 107.651 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.1 p -85.09 124.98 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.487 -0.779 . . . . 72.01 109.932 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -102.82 117.77 35.35 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.552 1.141 . . . . 61.15 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HB2' ' NE1' ' E' ' 290' ' ' TRP . 1.1 tt -96.82 129.02 44.32 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.045 -1.094 . . . . 61.44 108.045 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.734 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.0 m-20 -134.51 140.01 45.87 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.669 0.788 . . . . 74.42 109.951 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.48 119.06 31.89 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.219 -1.03 . . . . 74.14 108.219 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 32.3 t70 -121.42 141.56 50.87 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.18 -1.415 . . . . 73.1 107.18 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -149.07 159.18 44.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.881 0.309 . . . . 74.0 111.518 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.44 116.12 1.08 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.697 0.623 . . . . 72.34 110.917 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.2 p -89.91 153.45 20.61 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.809 -0.811 . . . . 64.52 108.809 168.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -159.02 159.65 35.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.327 -0.99 . . . . 64.34 108.327 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.29 129.78 56.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.432 -0.581 . . . . 74.02 109.432 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 57' ' ' GLU . 77.4 mt -99.1 -39.43 8.5 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.947 0.899 . . . . 62.34 110.965 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -148.7 178.43 8.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.627 0.771 . . . . 72.24 109.556 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -62.07 117.64 6.26 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.952 -0.758 . . . . 70.42 108.952 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 71.51 0.72 3.58 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.275 1.43 . . . . 64.34 112.835 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 61.7 t -108.51 119.02 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.567 -0.901 . . . . 74.44 108.567 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -130.14 141.1 50.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.952 0.501 . . . . 75.52 110.108 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.649 ' HB2' HD11 ' A' ' 51' ' ' LEU . 39.9 tt0 -104.03 142.49 34.36 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.419 0.688 . . . . 72.32 109.899 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.83 128.28 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.423 -0.954 . . . . 64.04 108.423 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.88 131.13 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.137 -0.69 . . . . 70.44 109.137 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.523 HD23 HD12 ' A' ' 106' ' ' LEU . 4.1 mm? -110.94 100.8 9.44 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.767 -1.197 . . . . 62.3 107.767 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 37.6 ttp85 -84.01 100.52 11.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.423 -0.954 . . . . 71.43 108.423 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' A' ' 114' ' ' ILE . 35.7 t -95.08 121.62 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.414 -0.958 . . . . 71.34 108.414 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.4 m -108.52 131.38 54.89 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.66 -0.496 . . . . 72.11 109.66 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.41 HG21 HG21 ' A' ' 114' ' ' ILE . 67.0 t -128.86 109.27 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.824 1.249 . . . . 64.34 107.805 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.8 m -108.1 151.49 25.81 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.062 -1.088 . . . . 73.41 108.062 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.28 128.14 23.49 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.149 -1.056 . . . . 64.13 108.149 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.7 m -137.54 127.61 25.94 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.202 0.456 . . . . 51.54 111.594 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.75 80.45 6.55 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.837 1.255 . . . . 43.12 108.354 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.53 -84.04 0.88 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.22 -1.152 . . . . 63.45 110.22 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.95 -12.94 5.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.132 0.973 . . . . 65.21 111.387 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.641 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.5 tp10 -90.17 99.77 12.73 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.634 . . . . 72.34 110.553 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 87.4 m -67.58 129.58 40.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.206 0.526 . . . . 64.51 111.985 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.12 -64.07 1.18 Allowed 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.394 0.678 . . . . 54.03 110.077 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.11 158.92 41.16 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.179 -0.919 . . . . 72.33 111.854 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.29 107.54 9.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.622 -1.172 . . . . 54.25 107.882 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.47 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -108.98 110.53 21.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.327 1.051 . . . . 72.14 109.191 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -130.29 117.37 19.71 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 62.32 108.603 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.63 120.55 60.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.745 0.818 . . . . 72.33 110.241 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -90.68 82.49 5.76 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 124.217 1.007 . . . . 73.42 108.358 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -80.36 100.32 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.909 -1.041 . . . . 73.15 109.571 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.96 145.32 17.54 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.796 -0.521 . . . . 74.11 111.796 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.02 120.31 1.88 Allowed Glycine 0 CA--C 1.504 -0.624 0 N-CA-C 110.388 -1.085 . . . . 64.3 110.388 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 51' ' ' LEU . 55.7 mt -87.45 127.72 40.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.555 -0.905 . . . . 74.31 108.555 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.684 ' HD2' HG12 ' A' ' 13' ' ' ILE . 1.4 m-85 -133.54 162.78 30.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 74.13 108.959 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.4 t -119.73 113.47 20.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 63.22 108.494 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.473 HD12 ' SG ' ' A' ' 97' ' ' CYS . 11.5 tt -126.71 148.71 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 122.964 0.506 . . . . 74.43 110.529 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 165.83 22.93 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.02 0.928 . . . . 74.11 109.308 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 8' ' ' GLU . . . 88.49 11.78 65.84 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.883 -0.954 . . . . 71.31 114.693 171.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.517 HG23 ' HG3' ' A' ' 9' ' ' MET . 1.6 pp -141.61 161.77 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.92 0.86 . . . . 63.53 112.24 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.8 tt0 -160.59 -175.59 5.08 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 124.951 1.3 . . . . 74.41 107.689 167.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.52 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.43 -140.04 31.5 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 118.04 0.382 . . . . 72.02 113.348 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -72.6 -29.94 63.93 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.386 0.674 . . . . 74.31 111.116 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -61.64 -45.69 92.97 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.604 0.762 . . . . 50.54 111.027 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.516 ' SD ' HD21 ' A' ' 98' ' ' LEU . 9.0 tmm? -66.64 -51.22 58.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.452 -0.795 . . . . 64.04 110.116 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' E' ' 280' ' ' LEU . . . -60.7 -22.74 64.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.021 0.928 . . . . 71.04 112.528 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -77.23 -32.16 55.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.548 0.739 . . . . 72.11 110.846 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 86' ' ' ILE . 49.4 t -69.65 -64.52 0.86 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.375 0.27 . . . . 72.34 110.886 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -67.97 -27.14 66.34 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 119.09 -0.481 . . . . 72.22 110.671 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -8.99 71.02 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 114.913 0.725 . . . . 60.22 114.913 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.399 1.099 . . . . 74.02 111.821 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.451 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.0 t80 -63.33 -62.51 1.64 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.202 1.001 . . . . 75.12 112.442 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.9 m -65.53 -33.29 7.32 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 114.114 1.153 . . . . 55.02 114.114 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.17 -50.79 12.42 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.451 2.1 . . . . 73.11 112.405 161.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -64.92 -22.63 67.03 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.606 0.762 . . . . 64.21 112.069 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 13' ' ' ILE . 49.7 mm -71.16 -50.34 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.385 -0.598 . . . . 54.3 109.385 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.523 HD12 HD23 ' A' ' 60' ' ' LEU . 77.7 mt -82.87 -19.54 37.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.736 -0.666 . . . . 60.15 112.749 -171.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -62.3 -42.97 83.79 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.09 0.956 . . . . 72.13 112.785 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -37.73 91.75 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.106 1.871 . . . . 73.12 113.713 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -71.21 -39.72 71.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.218 0.607 . . . . 72.32 111.487 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.83 73.91 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.459 -0.571 . . . . 72.14 109.459 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 -51.61 -48.56 63.21 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.728 1.267 . . . . 71.31 110.891 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.95 -48.91 72.37 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.609 0.764 . . . . 64.41 110.906 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.16 -30.06 70.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.953 0.501 . . . . 64.31 111.958 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.4 mt -72.17 -59.16 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.375 -0.602 . . . . 72.33 109.375 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.7 m -51.48 -40.32 59.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.882 1.273 . . . . 72.1 112.676 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -66.4 -41.83 88.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.473 -0.785 . . . . 75.33 110.368 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 30.5 mtm -69.21 -35.62 76.4 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.468 0.307 . . . . 65.53 110.832 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.7 t -59.67 -44.27 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 O-C-N 123.848 0.717 . . . . 72.34 109.948 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -75.29 -32.25 60.94 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 116.059 -0.519 . . . . 72.11 111.411 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -68.84 -31.75 70.95 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.434 0.694 . . . . 72.13 110.528 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.3 7.15 68.91 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.531 0.519 . . . . 74.25 112.613 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 p 56.17 49.71 14.91 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 126.493 1.917 . . . . 64.42 112.483 175.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.42 161.61 23.89 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 113.028 -1.896 . . . . 73.34 108.329 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.8 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 33.5 Cg_endo -59.98 162.11 17.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.157 2.571 . . . . 73.01 111.982 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.55 137.7 46.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.535 0.684 . . . . 72.31 110.71 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.699 -1.137 . . . . 73.02 108.611 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -135.12 127.14 29.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.763 -0.828 . . . . 73.0 108.763 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.44 125.77 27.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.229 -0.656 . . . . 74.1 109.229 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.541 ' HB3' HD11 ' E' ' 291' ' ' LEU . . . -71.78 150.51 93.14 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 122.844 0.458 . . . . 72.14 111.382 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.2 Cg_exo -60.29 105.12 0.27 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.764 2.309 . . . . 60.52 111.931 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.36 116.16 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.132 -1.432 . . . . 70.21 107.132 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -77.86 83.05 4.21 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.691 0.62 . . . . 52.03 109.506 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -62.55 -33.39 74.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.088 -0.96 . . . . 70.32 110.555 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -56.74 -49.2 75.95 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.405 1.066 . . . . 73.13 110.41 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.73 80.32 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.151 0.907 . . . . 73.21 111.99 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.64 -46.03 70.4 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.324 0.65 . . . . 73.2 110.259 -176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -82.82 -35.61 26.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.553 0.741 . . . . 75.35 111.108 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.2 tpt -73.22 -32.09 64.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.202 0.601 . . . . 74.13 112.321 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.8 m-20 -64.4 -31.27 72.42 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.801 0.84 . . . . 73.13 111.238 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -82.48 -32.57 28.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.059 -0.973 . . . . 75.22 110.375 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 tp -67.05 -49.33 65.52 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.294 0.638 . . . . 74.35 110.765 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -169.74 -4.24 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 115.435 -0.802 . . . . 63.31 111.69 -174.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 29.1 tt0 69.33 147.93 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.523 1.529 . . . . 74.23 111.997 -169.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -72.24 133.45 45.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.049 0.54 . . . . 64.51 110.748 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.79 124.34 52.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.516 0.727 . . . . 72.42 109.354 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.51 66.12 0.41 Allowed Glycine 0 C--N 1.345 1.04 0 N-CA-C 111.672 -0.571 . . . . 74.0 111.672 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.82 145.72 28.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.473 0.709 . . . . 72.23 110.226 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.34 71.79 0.01 OUTLIER Glycine 0 C--N 1.346 1.136 0 N-CA-C 110.33 -1.108 . . . . 55.31 110.33 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.1 p -94.53 126.8 40.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.085 0.954 . . . . 51.43 111.749 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.756 ' H ' ' HG2' ' C' ' 90' ' ' GLU . 44.0 mt-10 -133.16 179.64 6.06 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.707 1.603 . . . . 73.04 107.597 170.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.92 133.27 50.91 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.72 -1.215 . . . . 65.31 107.72 172.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' F' ' 275' ' ' LYS . 31.8 p-80 -121.4 145.82 47.52 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.678 0.275 . . . . 61.14 111.695 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.516 ' HB3' ' HG3' ' F' ' 274' ' ' GLN . 8.5 pt20 -91.11 -178.4 5.16 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.526 0.73 . . . . 74.21 110.953 172.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.12 160.16 23.2 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.914 -1.039 . . . . 75.31 110.305 170.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.229 -0.891 . . . . 73.24 109.77 -178.117 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.041 0.448 . . . . 73.22 109.805 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -166.57 132.68 2.37 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.948 -1.13 . . . . 53.23 107.948 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -79.11 75.23 5.64 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 122.37 1.081 . . . . 74.51 110.094 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -82.04 89.12 6.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.698 -1.137 . . . . 55.41 109.042 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -102.47 150.04 23.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.478 0.711 . . . . 72.51 109.657 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -140.0 105.16 5.02 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.654 -0.869 . . . . 75.0 108.654 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p -114.15 169.37 9.07 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 124.814 1.246 . . . . 64.21 109.706 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -69.77 -20.56 63.48 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.764 0.826 . . . . 70.33 111.089 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.589 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.1 ptm 58.45 174.65 0.06 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.14 2.176 . . . . 62.11 113.905 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 52.1 m -149.88 121.9 8.25 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.187 0.995 . . . . 54.23 108.348 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -137.91 128.9 27.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.514 0.725 . . . . 74.52 109.824 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 3.1 pm0 -147.25 129.35 15.52 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.657 0.783 . . . . 63.31 109.568 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.32 143.19 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.01 108.987 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -105.48 -50.78 3.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.505 0.322 . . . . 63.23 110.136 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -159.39 135.6 8.96 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.802 -167.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.14 129.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 75.01 109.162 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.43 ' HE1' HG13 ' B' ' 83' ' ' ILE . 17.5 p90 -157.81 151.26 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.525 0.679 . . . . 73.44 111.366 -173.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.6 m -76.26 122.13 23.94 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.672 -1.149 . . . . 65.1 109.099 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.93 -17.64 19.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.961 0.504 . . . . 70.32 112.082 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -167.97 139.16 2.85 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.104 0.252 . . . . 73.02 111.031 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.467 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -134.35 141.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.713 1.205 . . . . 65.43 109.414 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.6 t -139.15 137.14 35.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.779 1.232 . . . . 74.51 107.811 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.466 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -143.76 119.61 10.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.904 -1.517 . . . . 73.43 106.904 169.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 31.6 mt-10 -120.61 117.87 28.68 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -121.92 83.45 43.7 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.012 -0.736 . . . . 44.44 109.012 170.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.11 -24.77 32.27 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.879 2.386 . . . . 75.34 111.215 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -114.91 24.5 11.69 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.502 1.121 . . . . 74.32 109.785 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.612 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.08 -55.48 9.38 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.014 1.325 . . . . 74.02 114.047 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -77.61 -33.74 2.22 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.235 1.957 . . . . 62.2 111.89 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.515 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 70.5 m80 -96.0 4.3 52.76 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 124.245 1.018 . . . . 73.04 112.83 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.14 -25.78 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.886 0.875 . . . . 71.15 111.889 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -66.29 -26.5 67.35 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.594 1.158 . . . . 65.24 112.281 -174.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 5.5 pt20 -67.83 -33.58 75.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 110.047 -0.353 . . . . 55.35 110.047 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.548 ' HB2' HD13 ' B' ' 68' ' ' LEU . 80.1 mttt -108.27 65.48 0.63 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.584 -0.895 . . . . 72.22 108.584 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.39 108.32 14.9 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.698 -0.482 . . . . 64.43 109.698 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.505 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 161.5 -171.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.842 2.457 . . . . 71.34 109.605 157.133 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -58.56 128.36 83.16 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 122.635 0.374 . . . . 61.52 111.758 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -88.19 161.55 7.08 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.069 2.513 . . . . 75.23 112.099 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -75.49 107.53 7.68 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.92 -0.77 . . . . 72.04 108.92 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 142.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.198 -0.91 . . . . 62.04 110.693 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.419 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.7 tttm -139.39 144.1 38.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 74.01 109.528 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 84.7 mt -105.24 156.09 18.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.215 0.606 . . . . 71.4 110.702 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.8 t70 -152.04 109.97 3.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.967 -1.015 . . . . 64.24 108.409 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.36 128.89 55.46 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.607 -0.886 . . . . 74.02 108.607 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -131.45 145.19 51.67 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.78 0.832 . . . . 74.44 109.331 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 75.3 p -116.0 119.45 35.93 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.308 0.643 . . . . 70.21 110.308 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.93 139.79 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.765 -0.828 . . . . 51.13 108.765 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 p -143.32 162.85 34.61 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 111.763 0.283 . . . . 71.14 111.763 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 63.7 p -165.55 153.6 11.15 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.018 0.824 . . . . 72.43 110.024 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.0 126.51 31.48 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.098 -0.704 . . . . 74.41 109.098 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' B' ' 57' ' ' GLU . 34.5 mt -93.66 -49.37 5.9 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.37 0.668 . . . . 73.44 109.495 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.57 -166.21 2.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.536 -0.756 . . . . 62.33 110.845 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.84 108.95 1.11 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.669 1.188 . . . . 73.0 111.062 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 66.35 6.75 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.273 1.429 . . . . 54.2 112.107 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.98 115.05 46.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.752 -0.832 . . . . 72.3 108.752 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.83 144.82 50.09 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.563 -0.903 . . . . 64.02 108.563 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.573 ' HB2' HD11 ' B' ' 51' ' ' LEU . 38.4 tt0 -99.53 127.61 45.61 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.489 0.715 . . . . 63.42 109.539 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.0 116.95 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 48.4 t -103.64 128.82 56.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 107.379 -1.341 . . . . 75.44 107.379 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.01 100.15 7.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.063 -1.458 . . . . 73.41 107.063 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -85.7 108.28 17.96 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.0 -1.0 . . . . 70.54 109.159 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 102.88 14.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.567 -1.272 . . . . 73.23 107.567 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.1 m -101.68 130.35 48.03 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.341 -0.845 . . . . 61.23 108.757 177.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.451 HG23 HD13 ' B' ' 114' ' ' ILE . 71.7 t -118.14 133.47 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 124.166 0.986 . . . . 70.45 108.594 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.5 m -118.88 144.45 46.39 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.927 0.891 . . . . 74.11 109.037 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.96 21.27 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.606 -1.257 . . . . 71.34 107.606 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.0 p -139.89 128.43 22.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.949 0.5 . . . . 70.45 111.825 -174.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' B' ' 34' ' ' LYS . 28.6 mt -95.48 100.96 12.64 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.563 1.145 . . . . 64.25 109.017 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.77 -125.44 10.02 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 112.007 -0.437 . . . . 65.33 112.007 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -99.06 18.69 16.74 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.763 0.825 . . . . 73.21 110.283 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -126.45 147.23 49.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.94 0.896 . . . . 71.01 109.888 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.9 m -70.12 133.13 46.83 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.568 0.747 . . . . 75.43 110.717 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.524 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.66 -62.19 1.56 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.054 -0.721 . . . . 72.31 109.054 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -162.95 154.93 18.16 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.45 -1.25 . . . . 72.42 108.737 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 87.6 mt -130.92 144.91 51.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 63.54 108.386 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.1 t -147.55 152.56 38.19 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.746 -0.835 . . . . 73.24 108.746 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.4 tt0 -159.53 132.16 6.71 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.606 -0.887 . . . . 64.12 108.606 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' B' ' 113' ' ' CYS . 75.5 t -128.59 144.41 38.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.427 -0.953 . . . . 75.05 108.427 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.64 91.87 3.59 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.938 -1.134 . . . . 72.23 107.938 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.95 101.85 12.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.738 -0.838 . . . . 74.41 108.738 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.77 142.83 16.8 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 111.124 -0.79 . . . . 64.31 111.124 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 126.31 3.21 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.741 -0.944 . . . . 41.23 110.741 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.432 HG23 HD12 ' B' ' 51' ' ' LEU . 65.2 mt -84.25 123.2 38.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 108.431 -0.951 . . . . 65.04 108.431 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.75 134.74 45.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.321 1.048 . . . . 71.31 108.309 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 16.4 m -103.85 99.81 9.59 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.564 -1.273 . . . . 53.55 107.564 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.537 ' HB ' HD11 ' B' ' 89' ' ' ILE . 34.2 pt -107.03 139.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.368 0.667 . . . . 45.44 110.521 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.52 161.49 40.0 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.11 0.964 . . . . 72.34 109.55 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.78 -59.17 4.94 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.259 -0.428 . . . . 74.42 113.298 176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.19 125.87 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.355 0.598 . . . . 71.33 110.691 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.73 167.86 29.19 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.672 -0.695 . . . . 73.42 110.877 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -118.04 12.97 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.18 -0.918 . . . . 73.23 113.191 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.2 m -71.72 -35.01 70.06 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.343 0.657 . . . . 64.13 110.945 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -66.58 -36.89 83.73 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.184 -0.916 . . . . 72.2 111.093 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.544 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 16.9 ptp -60.28 -43.32 96.32 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 123.576 0.547 . . . . 64.33 110.008 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.4 69.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.492 0.717 . . . . 71.44 111.383 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -75.4 -40.66 57.57 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.888 0.475 . . . . 74.4 110.65 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -68.32 -67.48 0.46 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.011 0.524 . . . . 61.41 110.945 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 94' ' ' MET . 4.0 pp -75.81 -12.62 60.21 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.917 0.487 . . . . 73.33 112.185 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -23.01 24.93 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.945 -0.364 . . . . 35.44 113.986 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.69 -58.7 1.16 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.2 0.5 . . . . 72.0 110.717 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.14 -50.78 72.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.489 1.115 . . . . 72.31 112.181 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.4 m -69.03 -47.27 30.12 Favored Pre-proline 0 CA--C 1.569 1.691 0 C-N-CA 123.481 0.712 . . . . 41.25 112.048 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.8 Cg_exo -53.71 -35.23 77.49 Favored 'Trans proline' 0 C--N 1.397 3.121 0 C-N-CA 122.721 2.28 . . . . 73.34 114.098 170.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -67.68 -24.57 65.43 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.399 0.68 . . . . 72.11 111.856 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.41 -45.24 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.997 0.519 . . . . 52.43 110.213 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.08 -21.92 49.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.732 -0.667 . . . . 71.35 112.066 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.457 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 75.5 t80 -56.67 -51.74 78.97 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 117.997 -1.001 . . . . 73.5 113.098 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.8 Cg_exo -58.25 -38.92 88.86 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.437 2.091 . . . . 74.51 113.584 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -67.5 -41.73 83.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.411 0.684 . . . . 74.4 111.191 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.24 88.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.018 0.527 . . . . 73.13 110.573 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.5 ttt180 -59.56 -60.27 4.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.69 1.596 . . . . 74.1 111.062 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.77 -31.12 70.49 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.38 1.072 . . . . 74.22 111.135 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.7 t -70.96 -36.65 72.66 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 122.483 -0.136 . . . . 60.11 111.022 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.451 HD13 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -68.18 -45.92 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.167 0.587 . . . . 73.2 109.448 173.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.3 m -56.92 -38.68 73.21 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.749 -1.114 . . . . 72.23 111.164 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.9 t -63.97 -47.79 79.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.582 0.753 . . . . 71.41 110.667 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.1 mmt -72.14 -34.73 68.75 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.972 0.509 . . . . 74.02 111.573 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.7 t -67.64 -38.46 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.186 0.594 . . . . 72.11 110.15 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -67.97 -30.92 70.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.913 0.885 . . . . 72.42 111.013 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -72.62 -34.18 67.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.624 0.77 . . . . 75.51 110.504 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.32 3.39 53.54 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.626 0.579 . . . . 74.05 112.3 170.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.8 p 58.21 54.56 5.7 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.445 1.898 . . . . 73.21 111.357 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -119.44 154.1 54.08 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.139 -1.391 . . . . 53.52 110.265 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -60.22 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.319 2.679 . . . . 63.21 114.776 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -64.98 129.89 41.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.167 -0.924 . . . . 62.34 112.814 -159.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.9 84.78 2.24 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.439 -1.689 . . . . 74.25 106.439 170.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -115.73 127.55 55.21 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.352 -0.981 . . . . 64.1 108.352 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.416 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 4.3 mm? -72.07 147.86 46.35 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.871 0.732 . . . . 71.1 110.311 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' H' ' 291' ' ' LEU . . . -79.67 150.79 73.42 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 115.464 -0.789 . . . . 63.04 109.205 175.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.03 102.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.63 2.22 . . . . 64.23 110.938 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.23 110.23 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 109.284 -0.635 . . . . 71.13 109.284 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 44.6 t30 -85.75 88.32 7.53 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 71.34 108.8 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.84 -26.03 68.56 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.438 -0.801 . . . . 64.43 111.378 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.28 -38.88 88.37 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.303 1.002 . . . . 74.1 110.641 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -58.92 -47.37 85.26 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.996 0.518 . . . . 75.32 110.689 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.87 -41.69 99.48 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.368 -0.833 . . . . 73.32 110.084 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -71.56 -28.39 63.81 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.922 -1.036 . . . . 72.01 111.296 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 19.2 mmt -69.22 -38.68 78.66 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.425 0.69 . . . . 61.35 110.012 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -79.49 -25.38 41.83 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.276 0.63 . . . . 62.02 111.111 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -63.62 -48.27 77.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.261 0.625 . . . . 74.04 111.144 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 pp -119.8 31.5 6.51 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.582 -0.735 . . . . 75.12 110.93 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.34 100.0 0.16 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.815 0.846 . . . . 63.44 110.777 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -155.14 109.94 2.99 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.336 -0.987 . . . . 65.53 108.336 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -104.86 147.18 28.02 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.684 -0.858 . . . . 73.51 108.684 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -134.95 137.63 43.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.68 0.792 . . . . 72.02 109.634 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.39 152.52 24.64 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.681 -0.568 . . . . 63.55 111.681 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -148.95 146.3 27.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.982 0.913 . . . . 72.21 109.239 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.37 86.53 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.27 -1.132 . . . . 71.23 110.27 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -135.78 140.32 44.19 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.488 0.715 . . . . 41.31 109.074 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -158.6 156.04 29.35 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.528 0.731 . . . . 64.31 110.495 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -166.04 135.41 3.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.285 1.034 . . . . 75.14 108.787 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -156.34 83.4 0.98 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.675 -0.861 . . . . 74.02 108.675 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -125.97 107.42 10.43 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 124.047 0.939 . . . . 74.1 108.899 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -138.04 110.27 7.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.898 0.879 . . . . 75.22 109.311 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.411 0.685 . . . . 63.12 109.986 -179.683 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.3 p -96.2 13.66 26.67 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.63 0.772 . . . . 73.42 112.016 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 65.9 109.12 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.818 1.247 . . . . 75.13 111.466 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -74.74 79.1 2.06 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-O 122.108 0.956 . . . . 75.41 110.575 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.72 93.83 0.27 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.089 -0.96 . . . . 74.34 109.279 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -141.84 118.46 11.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.696 -0.684 . . . . 60.21 109.616 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -148.13 5.11 0.74 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.007 0.923 . . . . 72.3 109.079 166.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -68.93 126.61 30.33 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.217 1.007 . . . . 70.01 108.368 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.563 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 50.2 ttp 66.23 119.2 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.801 1.313 . . . . 74.21 111.878 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -86.02 78.01 9.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.286 -1.005 . . . . 61.13 108.286 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.563 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 35.0 t80 -112.42 133.96 54.22 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.035 -0.984 . . . . 73.25 109.096 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -154.76 142.15 19.61 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.201 0.6 . . . . 65.04 109.646 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -77.21 97.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.317 -0.856 . . . . 53.05 109.308 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.7 mm-40 -75.06 -42.11 57.66 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.603 -0.517 . . . . 74.44 109.603 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.499 ' NH2' ' HB3' ' G' ' 302' ' ' ASP . 49.7 ttt180 -174.25 147.42 1.2 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.274 0.984 . . . . 73.24 109.561 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.1 mt -129.1 142.03 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 107.62 -1.252 . . . . 72.35 107.62 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -172.64 158.29 4.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.468 0.651 . . . . 74.4 111.418 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 18' ' ' THR . . . . . 0.407 HG21 ' SG ' ' C' ' 113' ' ' CYS . 66.7 p -83.22 106.35 14.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.804 -1.089 . . . . 64.41 108.387 173.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -65.93 -47.47 74.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.554 0.692 . . . . 62.42 109.268 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -135.51 140.42 44.76 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.611 -1.177 . . . . 50.5 109.204 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 69.9 mt -134.22 138.32 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.325 -1.361 . . . . 64.14 107.325 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -154.79 150.53 27.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.964 0.411 . . . . 72.03 110.034 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.14 108.59 3.62 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.912 -1.144 . . . . 63.4 107.912 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.77 108.82 16.83 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.148 0.579 . . . . 73.24 109.546 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.14 85.45 18.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.398 -0.964 . . . . 53.11 108.398 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -36.22 31.69 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.009 2.473 . . . . 71.41 112.368 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -107.6 34.29 3.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.516 0.726 . . . . 73.22 109.413 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.48 -50.76 63.72 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.223 1.194 . . . . 65.32 114.223 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.97 -32.96 8.2 Favored 'Trans proline' 0 C--N 1.388 2.625 0 CA-C-N 121.036 1.406 . . . . 71.43 112.78 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.18 -37.13 75.08 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.836 0.854 . . . . 73.32 112.642 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.36 -21.09 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.165 0.586 . . . . 75.3 110.608 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.474 ' HE2' ' HB ' ' F' ' 301' ' ' ILE . 2.3 t80 -75.47 -2.26 27.96 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.268 0.627 . . . . 74.11 111.095 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -124.12 26.28 7.54 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.417 1.087 . . . . 73.42 109.837 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 147.44 35.93 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.248 1.019 . . . . 70.44 109.947 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.44 131.13 49.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 73.42 111.114 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.425 ' HB3' ' HD2' ' F' ' 297' ' ' TYR . 20.4 m95 -71.61 93.57 1.24 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.148 0.979 . . . . 73.41 112.011 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -154.91 74.49 5.64 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.738 0.815 . . . . 70.34 108.991 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.787 ' HD2' ' HG2' ' F' ' 294' ' ' LYS . 55.7 Cg_endo -84.44 127.95 3.97 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.563 2.175 . . . . 74.21 112.357 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.56 97.22 10.4 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 106.502 -1.666 . . . . 74.13 106.502 166.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.96 117.05 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.57 -1.196 . . . . 73.01 109.8 -169.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -97.36 109.0 21.85 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.053 -1.091 . . . . 64.44 108.053 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tt -86.81 123.8 32.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.264 -1.754 . . . . 75.52 106.264 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.9 t70 -120.02 147.91 44.21 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.642 0.777 . . . . 75.21 109.462 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -134.54 131.85 38.44 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.396 1.078 . . . . 64.31 108.129 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.742 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.3 t70 -133.52 135.26 44.3 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.511 -0.551 . . . . 75.52 109.511 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -113.41 111.2 21.56 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.754 0.822 . . . . 64.33 109.559 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.79 157.62 35.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.204 1.002 . . . . 52.2 109.851 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 67.5 p -155.15 167.25 30.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.817 0.447 . . . . 63.52 110.95 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -164.86 127.34 2.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.661 0.785 . . . . 73.15 109.839 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.31 135.96 33.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.264 0.483 . . . . 75.42 109.784 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.653 HD11 HD12 ' C' ' 83' ' ' ILE . 41.2 mt -106.11 -47.01 3.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.03 0.932 . . . . 74.45 109.993 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.7 -178.01 5.45 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.138 0.975 . . . . 70.31 108.973 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.64 110.91 1.24 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.6 0.76 . . . . 71.31 111.019 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 19.1 m-20 62.85 30.75 16.6 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.493 1.117 . . . . 71.43 111.768 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -118.98 111.59 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.619 -1.252 . . . . 75.42 107.619 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.421 ' HB2' HD12 ' C' ' 86' ' ' ILE . 95.4 m-85 -123.51 125.85 45.65 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.772 0.829 . . . . 52.24 109.81 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.78 120.3 24.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 65.21 108.917 168.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -96.78 117.33 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.585 -1.265 . . . . 75.25 107.585 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.08 131.61 52.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.006 -1.109 . . . . 71.22 108.006 173.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.62 105.85 9.0 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.191 -1.04 . . . . 75.21 108.191 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.742 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 59.3 mtt180 -83.3 134.61 34.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.646 -0.502 . . . . 63.24 109.646 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.0 123.77 69.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.798 -1.556 . . . . 73.04 106.798 162.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.8 m -121.17 112.33 18.53 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.446 0.641 . . . . 72.54 109.321 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.455 HG21 HG21 ' C' ' 114' ' ' ILE . 51.5 t -101.13 117.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 54.23 108.586 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -115.13 141.89 47.4 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.667 -0.864 . . . . 65.01 108.667 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.07 123.0 22.54 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.941 -1.133 . . . . 70.52 107.941 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 127.07 16.97 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 122.852 0.461 . . . . 73.13 110.548 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.51 ' H ' HD12 ' C' ' 68' ' ' LEU . 1.5 mp -90.63 49.25 1.64 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.045 1.338 . . . . 53.54 109.121 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.01 -106.58 2.81 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.212 -0.903 . . . . 73.05 110.901 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -90.35 -30.88 17.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.962 0.905 . . . . 70.03 110.162 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -66.32 115.47 6.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.308 1.043 . . . . 65.42 109.891 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.2 m -89.82 125.6 35.38 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.714 0.688 . . . . 64.22 109.653 168.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' C' ' 68' ' ' LEU . . . -72.23 -64.02 1.03 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.79 -1.095 . . . . 65.1 109.502 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.59 170.16 23.02 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.564 -1.198 . . . . 73.32 110.814 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.426 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -133.69 146.61 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.562 -2.014 . . . . 72.24 105.562 172.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.426 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -151.47 145.26 25.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.394 -0.965 . . . . 54.23 108.394 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 77' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' C' ' 63' ' ' THR . 34.3 tt0 -157.56 136.37 11.5 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.294 -0.632 . . . . 73.42 109.294 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.58 123.7 49.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.114 -0.948 . . . . 74.32 108.927 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.732 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 29.1 mt-30 -92.33 87.56 6.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.656 -1.239 . . . . 75.41 107.656 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -79.08 96.88 5.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.317 -0.624 . . . . 73.12 109.317 -178.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.07 149.05 24.88 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 115.26 -0.882 . . . . 42.33 111.577 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.92 117.23 0.81 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 110.825 -0.91 . . . . 73.13 110.825 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.653 HD12 HD11 ' C' ' 51' ' ' LEU . 14.5 mm -80.98 121.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.398 -0.964 . . . . 75.33 108.398 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.97 126.73 29.16 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.596 -0.89 . . . . 53.15 108.596 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -69.61 119.26 13.58 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.344 -0.984 . . . . 44.33 108.344 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.611 HG23 HD11 ' C' ' 89' ' ' ILE . 59.1 mt -116.3 100.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.066 -0.716 . . . . 71.01 109.066 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -148.71 164.47 34.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.648 1.179 . . . . 73.31 109.031 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.34 32.5 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 123.13 0.269 . . . . 70.55 112.988 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.611 HD11 HG23 ' C' ' 86' ' ' ILE . 11.9 pt -114.45 156.18 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.598 1.159 . . . . 73.25 110.37 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.756 ' HG2' ' H ' ' A' ' 150' ' ' GLU . 9.1 tp10 -164.96 156.21 14.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.945 -1.025 . . . . 71.21 109.264 -176.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 63.08 -110.37 3.32 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.423 0.452 . . . . 73.45 114.006 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -83.1 -27.19 30.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.664 0.386 . . . . 72.13 111.797 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -42.07 75.25 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.476 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.2 ptt? -63.57 -35.78 81.62 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.67 -0.696 . . . . 73.33 110.004 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.64 93.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.708 0.803 . . . . 45.11 112.024 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 47.7 t-80 -78.76 -20.92 48.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.304 -0.407 . . . . 73.41 111.265 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.5 t -82.56 -63.25 1.41 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.154 -0.342 . . . . 64.55 111.27 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.566 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 4.6 pp -77.51 -32.16 53.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.847 0.459 . . . . 45.32 111.387 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.34 8.77 64.7 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.727 -0.485 . . . . 73.44 113.702 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -148.64 -56.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.246 0.523 . . . . 63.34 111.838 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -74.49 -40.27 61.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.193 0.442 . . . . 72.2 112.193 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 85.4 m -64.84 -47.24 75.14 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.723 -0.656 . . . . 63.31 111.176 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 55.3 Cg_exo -57.34 -37.24 98.21 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.123 1.882 . . . . 72.24 113.023 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.09 -37.97 81.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.787 0.835 . . . . 74.33 111.348 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -73.23 -46.78 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.242 0.617 . . . . 63.02 110.92 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.92 -20.56 49.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.552 -0.749 . . . . 73.34 112.298 -172.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 61.4 t80 -58.56 -51.86 78.77 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.747 -1.121 . . . . 72.45 113.192 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.3 Cg_exo -56.71 -38.57 95.37 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.036 1.824 . . . . 74.21 113.518 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -69.16 -42.64 75.63 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.322 0.649 . . . . 73.22 111.517 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.72 99.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.255 0.622 . . . . 74.33 109.637 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' C' ' 127' ' ' ASN . 41.1 ttt180 -58.43 -53.88 53.34 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.924 1.69 . . . . 75.24 111.469 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.57 -34.77 78.64 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.579 0.549 . . . . 70.33 110.321 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' C' ' 18' ' ' THR . 6.4 t -68.56 -32.91 73.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.034 0.534 . . . . 70.33 111.128 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' C' ' 62' ' ' VAL . 78.6 mt -71.52 -53.64 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.777 -0.647 . . . . 71.32 109.869 174.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.2 m -63.05 -28.87 70.38 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.258 0.623 . . . . 64.32 111.693 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -64.42 -51.51 62.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.498 0.719 . . . . 55.21 109.424 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.605 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.21 -38.9 81.05 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.325 1.05 . . . . 65.32 112.213 178.33 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.9 t -60.7 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.561 0.744 . . . . 71.33 109.749 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 41.1 t -67.08 -35.36 79.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.671 0.789 . . . . 73.31 112.083 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -69.3 -31.84 70.6 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.432 0.693 . . . . 75.34 110.551 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.61 12.18 70.08 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.559 0.537 . . . . 71.41 113.073 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.422 HG22 ' NH2' ' D' ' 15' ' ' ARG . 6.9 p 64.84 20.88 12.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.652 1.981 . . . . 74.31 113.423 173.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -89.1 151.1 46.38 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.267 -0.642 . . . . 62.53 109.267 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.693 ' HG2' ' HB3' ' F' ' 297' ' ' TYR . 31.9 Cg_exo -61.78 144.28 96.87 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.205 2.603 . . . . 75.42 113.282 -176.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.473 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -51.08 111.07 0.5 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 71.51 111.415 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.11 85.71 2.16 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.332 -0.988 . . . . 74.14 108.332 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.461 ' HB3' ' NH2' ' C' ' 111' ' ' ARG . 17.5 m120 -91.6 109.32 20.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.47 -1.241 . . . . 73.45 108.427 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.65 135.08 57.29 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.263 0.977 . . . . 52.43 111.929 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.24 157.85 88.93 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.281 1.032 . . . . 42.41 110.345 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.54 105.49 0.76 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.389 2.059 . . . . 72.25 112.171 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.445 HG22 HD11 ' F' ' 291' ' ' LEU . 46.4 t -99.59 107.85 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.488 -1.301 . . . . 74.31 107.488 171.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -105.72 93.91 4.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.432 -0.803 . . . . 73.21 110.004 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -63.7 -41.84 98.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.117 -0.697 . . . . 73.22 109.117 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.449 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.9 p-10 -53.32 -46.96 69.64 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.959 1.304 . . . . 63.23 111.822 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.43 -38.28 74.53 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 123.9 0.88 . . . . 43.42 111.416 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.6 mp -64.1 -37.04 86.02 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.454 0.702 . . . . 75.02 111.946 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.69 -42.81 73.59 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 122.86 0.464 . . . . 75.42 111.087 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 75.3 mtm -72.05 -28.59 63.45 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.272 0.629 . . . . 64.02 111.129 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -60.46 -37.02 79.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.966 1.306 . . . . 74.52 110.717 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -59.73 -82.87 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 O-C-N 124.019 0.825 . . . . 74.31 109.883 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 17.5 tp 65.85 -176.35 0.18 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.159 0.984 . . . . 72.13 110.565 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 142' ' ' GLN . . . . . 0.514 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 63.2 tt0 -150.78 -43.79 0.12 Allowed 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.844 -0.535 . . . . 73.32 109.995 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -131.02 155.42 46.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.13 0.572 . . . . 73.43 109.69 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -86.36 170.78 11.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.883 0.473 . . . . 53.44 111.048 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.15 166.16 13.11 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.749 -0.66 . . . . 75.11 110.877 174.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.92 -166.0 35.74 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.724 -0.671 . . . . 75.34 111.907 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -164.19 135.86 4.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.872 0.869 . . . . 60.12 108.905 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.55 156.61 28.34 Favored Glycine 0 C--N 1.345 1.06 0 C-N-CA 121.669 -0.3 . . . . 64.14 113.215 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 28.7 m -104.47 93.0 4.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.883 0.873 . . . . 74.23 108.865 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -82.98 101.27 10.97 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.122 -0.49 . . . . 73.41 110.72 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -81.32 122.34 27.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.819 0.848 . . . . 71.41 110.111 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -114.08 86.28 2.39 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.937 -1.134 . . . . 75.01 107.937 173.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -81.94 127.31 32.91 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.067 -0.97 . . . . 63.52 109.418 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.56 155.57 39.0 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.261 0.624 . . . . 74.2 111.162 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.973 0 CA-C-N 115.363 -0.835 . . . . 60.21 110.469 -176.253 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 111.583 0.216 . . . . 70.52 111.583 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -153.73 59.91 0.74 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.04 0.936 . . . . 65.22 109.401 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.72 81.39 7.78 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.229 -0.896 . . . . 72.34 109.286 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.13 110.92 13.52 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.541 -0.754 . . . . 70.14 109.522 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -141.46 90.08 2.27 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.658 -0.868 . . . . 64.54 108.658 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -135.78 16.33 3.33 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.518 0.727 . . . . 60.44 110.568 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -155.66 162.55 40.57 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.332 0.653 . . . . 64.15 110.324 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 66.46 -178.31 0.2 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.254 1.422 . . . . 75.02 111.814 -173.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.6 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 2.1 ptm -32.93 140.43 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.819 1.248 . . . . 64.0 113.88 170.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 95.1 m -112.6 119.89 39.69 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.185 0.594 . . . . 75.0 110.381 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.8 t80 -138.98 122.56 17.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.053 -1.462 . . . . 72.05 107.053 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.5 130.52 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.446 -0.576 . . . . 64.22 109.446 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.88 125.79 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.67 -1.233 . . . . 74.43 107.67 168.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -99.06 -43.6 6.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.766 0.426 . . . . 71.2 110.259 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.659 HH11 HG11 ' F' ' 306' ' ' VAL . 7.8 tpt180 -179.69 141.0 0.15 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.827 0.851 . . . . 72.35 110.627 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.95 141.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.15 -1.055 . . . . 70.51 108.15 171.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.1 p90 -156.55 173.39 16.99 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.847 0.832 . . . . 74.31 111.2 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -104.81 119.62 39.45 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.437 -1.256 . . . . 74.01 109.111 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -90.52 -26.87 19.54 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.279 -0.419 . . . . 62.42 110.42 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -159.71 110.72 1.97 Allowed 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.792 0.682 . . . . 72.24 109.278 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.605 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.0 mt -111.27 149.44 14.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.708 -0.849 . . . . 65.11 108.708 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -148.82 142.29 25.3 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.955 0.902 . . . . 51.54 109.82 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.441 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.0 t80 -152.55 120.08 6.01 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 106.406 -1.702 . . . . 44.15 106.406 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' D' ' 74' ' ' PHE . 45.0 mt-10 -128.32 120.28 26.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.499 0.72 . . . . 71.14 109.269 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.97 85.01 4.75 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.01 -1.107 . . . . 74.13 108.01 171.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.29 -28.68 8.49 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.114 2.543 . . . . 75.53 113.502 -167.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 14.5 m-80 -115.05 28.61 8.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.206 -0.664 . . . . 64.45 109.206 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.85 -66.1 0.47 Allowed Pre-proline 0 CA--C 1.566 1.569 0 N-CA-C 114.992 1.478 . . . . 44.42 114.992 -165.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.456 ' HB3' HD11 ' C' ' 83' ' ' ILE . 78.7 Cg_endo -77.22 -15.22 16.22 Favored 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.566 1.952 . . . . 75.42 113.199 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.411 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 19.5 t-160 -70.23 -38.87 75.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 74.12 109.609 174.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.61 -39.82 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.266 1.026 . . . . 64.44 110.66 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -75.85 -3.77 37.01 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.754 -1.112 . . . . 73.12 113.764 -168.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -85.33 -6.88 59.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.774 0.83 . . . . 75.42 111.305 172.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -121.92 115.21 22.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.386 1.474 . . . . 73.23 108.093 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.567 ' HA ' ' HB ' ' G' ' 301' ' ' ILE . 3.8 p-10 -92.83 93.94 8.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.556 0.743 . . . . 71.14 112.381 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.415 ' HE3' ' H ' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -165.22 -179.19 5.47 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.951 0.9 . . . . 73.31 111.848 177.765 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.86 140.58 26.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.603 0.761 . . . . 73.31 111.935 -176.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 58.6 Cg_endo -75.03 156.13 42.83 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.019 2.479 . . . . 73.33 114.152 168.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -89.17 140.68 29.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.354 -1.294 . . . . 61.21 108.058 164.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.66 HG23 ' HE1' ' G' ' 290' ' ' TRP . 4.6 m -119.78 119.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.337 0.655 . . . . 63.43 110.778 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 61.7 tttt -98.74 137.15 37.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.93 0.892 . . . . 71.0 109.339 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.61 123.51 44.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.589 0.756 . . . . 60.03 109.789 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.2 m-20 -118.84 127.49 53.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.15 0.98 . . . . 75.04 108.541 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' G' ' 286' ' ' MET . 3.8 mp -109.06 138.17 45.83 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.251 -0.648 . . . . 65.12 109.251 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.1 t70 -150.49 152.94 34.98 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.536 0.735 . . . . 60.32 109.082 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 20.6 p -140.94 160.88 39.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.008 0.923 . . . . 73.14 110.393 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.95 167.82 29.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.006 0.922 . . . . 73.33 109.593 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 42.2 p -159.07 153.01 23.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.176 0.59 . . . . 75.14 109.799 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 92.6 p -151.9 149.08 28.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.281 -0.637 . . . . 74.42 109.281 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -89.01 118.35 28.68 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.35 -0.611 . . . . 64.1 109.35 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.6 mt -92.02 -36.7 13.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.021 0.529 . . . . 73.32 110.152 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.33 -179.75 8.22 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.294 -0.867 . . . . 55.34 109.955 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.41 125.85 28.83 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.987 -0.746 . . . . 63.54 108.987 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 65.82 14.84 9.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.374 1.07 . . . . 74.34 111.773 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 41.9 t -129.57 124.74 60.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 124.125 0.97 . . . . 63.12 109.145 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.621 ' HB2' HD13 ' D' ' 86' ' ' ILE . 62.7 m-85 -136.1 141.18 44.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.342 0.591 . . . . 73.55 109.805 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.6 tt0 -91.83 132.66 36.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.471 -1.24 . . . . 74.32 109.792 173.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.57 125.85 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 107.541 -1.281 . . . . 63.44 107.541 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 34.1 t -110.15 129.58 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.039 -0.726 . . . . 72.2 109.039 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.504 HD23 HD12 ' D' ' 106' ' ' LEU . 1.8 mm? -118.65 106.21 12.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.529 0.731 . . . . 70.44 109.599 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.7 ttm180 -88.39 102.03 14.47 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.622 -0.717 . . . . 61.43 109.443 177.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -91.74 121.18 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.786 -1.19 . . . . 74.23 107.786 170.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.4 m -127.0 146.07 50.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.602 0.761 . . . . 52.4 109.298 -175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.505 HG11 HD21 ' D' ' 126' ' ' LEU . 54.0 t -139.5 111.74 5.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.997 1.319 . . . . 65.02 109.038 -172.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.2 m -96.75 95.63 8.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.768 -0.827 . . . . 51.11 108.768 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.82 44.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.35 -0.611 . . . . 73.4 109.35 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.503 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.0 m -142.33 141.1 32.32 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.361 0.665 . . . . 74.15 110.778 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -132.17 135.64 46.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.912 1.285 . . . . 63.32 110.17 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 -114.51 5.57 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.902 -0.879 . . . . 53.42 110.902 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.61 4.69 12.36 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.039 0.535 . . . . 65.54 110.418 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -127.36 161.84 27.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.074 0.55 . . . . 73.02 110.946 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -80.75 131.55 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.964 0.505 . . . . 65.01 111.469 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.718 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -72.68 -71.62 0.28 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.754 1.222 . . . . 74.14 108.379 173.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' D' ' 24' ' ' GLU . 51.4 p90 -153.93 140.32 18.68 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.746 -0.661 . . . . 73.04 111.033 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.37 110.2 22.17 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.272 -1.381 . . . . 44.5 107.272 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.584 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.2 t -119.0 132.89 56.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.478 -0.564 . . . . 74.51 109.478 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.412 ' HB2' HG23 ' D' ' 63' ' ' THR . 32.3 tt0 -152.08 132.13 13.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.14 0.576 . . . . 60.42 110.249 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.71 117.35 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.356 0.663 . . . . 61.43 109.669 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -87.28 87.33 7.4 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.852 -1.166 . . . . 73.51 107.852 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.33 91.17 5.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.289 -0.869 . . . . 63.35 108.796 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.94 143.61 17.61 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.071 -0.811 . . . . 53.14 111.071 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.92 132.13 5.08 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 111.209 -0.756 . . . . 62.45 111.209 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.495 HG13 ' HE1' ' D' ' 17' ' ' TYR . 49.1 mt -88.19 124.37 41.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 108.407 -0.96 . . . . 65.11 108.407 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -129.48 160.77 32.13 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.26 0.552 . . . . 74.1 110.112 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 35.5 m -104.9 117.19 33.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.992 -1.114 . . . . 74.51 107.992 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.4 mp -118.15 108.76 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.197 -0.668 . . . . 72.12 109.197 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.32 160.82 41.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.037 0.935 . . . . 74.01 110.014 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 79.01 -4.13 62.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.728 -0.669 . . . . 72.53 113.904 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.447 HD11 HG23 ' D' ' 86' ' ' ILE . 15.0 pt -126.65 142.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.123 0.969 . . . . 73.14 109.696 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.8 167.21 22.68 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.43 0.692 . . . . 74.34 110.114 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.17 -122.7 27.1 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 124.605 1.191 . . . . 72.05 114.606 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 m -66.27 -44.38 83.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.162 0.985 . . . . 61.0 112.128 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.69 -38.33 88.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.027 0.531 . . . . 70.43 110.873 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.67 -0.695 . . . . 72.44 110.199 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -28.7 67.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.748 0.819 . . . . 71.32 111.767 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 53.0 t-80 -78.69 -30.64 46.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.745 . . . . 74.12 110.513 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -76.61 -50.86 12.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.295 0.569 . . . . 54.12 110.071 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.601 HD12 HG12 ' D' ' 86' ' ' ILE . 6.3 tt -81.96 -23.28 36.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.654 -0.703 . . . . 62.43 111.124 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.18 57.09 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.447 -0.641 . . . . 44.5 114.145 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -141.01 -53.96 0.48 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.868 0.834 . . . . 73.55 111.782 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -73.89 -54.32 8.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 71.12 110.978 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 61.2 m -59.25 -44.95 99.14 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 113.895 1.072 . . . . 74.22 113.895 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.72 -35.49 94.51 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 121.915 1.743 . . . . 71.12 112.794 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -80.78 -7.57 59.43 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.518 0.727 . . . . 70.23 111.415 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.71 -37.38 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.491 0.662 . . . . 74.1 109.747 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.504 HD12 HD23 ' D' ' 60' ' ' LEU . 50.9 mt -81.79 -32.02 31.55 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.129 -0.941 . . . . 53.11 111.409 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.54 -44.21 98.84 Favored Pre-proline 0 CA--C 1.572 1.805 0 N-CA-C 114.195 1.183 . . . . 63.41 114.195 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.56 -39.99 78.09 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.317 2.011 . . . . 72.11 113.421 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -74.9 -33.61 62.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.295 0.638 . . . . 65.13 110.97 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.35 88.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.217 0.607 . . . . 72.35 109.994 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.4 ttp180 -59.42 -52.19 66.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 114.412 -1.267 . . . . 73.33 110.754 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.72 -45.34 94.39 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.176 0.923 . . . . 74.23 110.925 -175.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.3 -41.47 84.51 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.761 0.663 . . . . 75.43 110.953 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.584 HG23 ' SG ' ' D' ' 76' ' ' CYS . 47.6 mt -63.29 -55.66 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.612 -0.722 . . . . 74.52 110.39 174.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -53.49 -39.68 64.76 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.337 1.055 . . . . 64.43 111.47 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 20.6 t -65.95 -45.91 80.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.987 -1.006 . . . . 74.22 110.501 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.9 mtm -67.39 -35.89 80.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.967 0.507 . . . . 73.02 111.776 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.7 t -64.04 -43.59 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 123.838 0.711 . . . . 71.33 109.399 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.0 p -71.62 -29.32 64.53 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.007 0.523 . . . . 73.51 111.87 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' D' ' 116' ' ' SER . 86.3 mtt-85 -72.86 -34.28 66.64 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.574 0.75 . . . . 74.21 110.473 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 9.01 63.96 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.759 0.662 . . . . 24.04 112.202 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.4 p 62.14 18.7 10.29 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.935 2.094 . . . . 64.35 113.544 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -83.34 165.46 40.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 107.557 -1.275 . . . . 75.05 107.557 162.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -84.05 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.284 1.989 . . . . 63.45 113.549 -165.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -74.44 120.57 20.18 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 122.442 0.297 . . . . 74.1 110.891 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.505 HD21 HG11 ' D' ' 64' ' ' VAL . 63.1 tp -116.51 95.0 4.85 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 42.24 108.184 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.27 104.26 13.61 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.508 -0.923 . . . . 62.21 108.508 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.495 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.5 mm? -62.99 113.87 3.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.607 0.763 . . . . 75.12 109.372 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -64.16 137.12 97.02 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 122.946 0.499 . . . . 64.13 110.477 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 15.8 Cg_exo -65.3 131.63 28.92 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.939 2.426 . . . . 72.45 112.273 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.621 HG22 HD21 ' G' ' 291' ' ' LEU . 65.1 t -109.28 130.92 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.23 0.612 . . . . 73.34 109.788 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -86.6 85.51 7.3 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.428 -0.953 . . . . 43.14 108.428 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -63.46 -22.49 66.92 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.377 -0.829 . . . . 72.43 111.185 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.88 -53.85 53.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.924 1.29 . . . . 73.14 111.566 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.421 ' HA ' ' CE ' ' D' ' 138' ' ' MET . . . -64.32 -43.25 95.27 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.344 -0.844 . . . . 63.2 111.468 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 65.4 mt -62.53 -37.88 87.79 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 124.208 0.942 . . . . 71.24 111.261 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -67.55 -47.26 70.38 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.44 -0.8 . . . . 70.33 110.517 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.47 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 71.4 mtm -62.89 -41.99 99.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.121 0.568 . . . . 64.1 110.894 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -59.7 -27.32 66.33 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.769 0.828 . . . . 72.53 112.425 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -65.37 -48.98 71.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.91 0.484 . . . . 74.35 110.561 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.03 -27.05 68.85 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.667 0.787 . . . . 75.01 111.352 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' D' ' 138' ' ' MET . 82.2 mt-30 -74.72 1.98 11.08 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.979 0.912 . . . . 75.11 112.795 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -143.92 44.44 1.47 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.141 0.496 . . . . 75.21 111.433 178.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.75 167.64 18.73 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.894 0.877 . . . . 73.4 109.92 173.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.47 25.28 9.22 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.741 0.816 . . . . 75.03 112.139 -171.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.9 -69.49 3.36 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.211 -0.449 . . . . 55.13 112.543 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.59 122.96 21.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.166 0.986 . . . . 65.23 110.581 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.22 -145.03 4.9 Favored Glycine 0 C--N 1.346 1.087 0 C-N-CA 121.169 -0.539 . . . . 73.32 113.281 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 44.8 m -63.98 106.33 1.02 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.406 0.683 . . . . 75.3 110.48 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 150' ' ' GLU . . . . . 0.589 ' HB2' HE21 ' G' ' 274' ' ' GLN . 17.0 pt-20 -147.28 137.91 23.49 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.434 -0.803 . . . . 73.33 109.139 -176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -86.58 141.1 29.26 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.339 -0.846 . . . . 74.21 110.576 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -70.45 108.35 4.24 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.594 -0.891 . . . . 55.45 108.594 173.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 153' ' ' GLN . . . . . 0.451 ' HG3' ' HA2' ' G' ' 279' ' ' GLY . 0.0 OUTLIER -84.9 116.36 23.29 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.244 -1.391 . . . . 65.34 107.244 176.621 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.1 87.72 3.0 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.944 0.778 . . . . 61.14 110.075 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 N-CA-C 107.621 -1.252 . . . . 63.5 107.621 178.054 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.934 0.397 . . . . 62.04 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -70.7 91.03 0.79 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.904 0.859 . . . . 54.51 110.278 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.08 -138.01 0.27 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.37 1.068 . . . . 73.44 109.522 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -74.73 81.16 2.06 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.028 0.918 . . . . 75.51 110.239 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -82.69 147.87 56.53 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 113.905 -1.498 . . . . 71.04 108.515 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -40.94 98.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 123.148 2.566 . . . . 54.42 112.91 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.56 -48.49 7.54 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 113.59 -1.641 . . . . 70.24 109.964 -168.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 278' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 98' ' ' LEU . 89.1 mt -72.36 126.35 29.6 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.78 0.832 . . . . 51.33 111.802 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -160.47 143.47 9.04 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 118.82 -0.989 . . . . 64.43 110.861 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.43 HD23 ' HB1' ' A' ' 95' ' ' ALA . 59.0 tp 66.1 107.84 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.754 1.221 . . . . 75.32 110.844 -175.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -171.7 -57.87 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 CA-C-O 121.154 0.502 . . . . 74.41 111.802 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -82.9 27.4 0.54 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.254 1.022 . . . . 61.24 112.092 -173.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -99.83 142.1 31.76 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.142 0.977 . . . . 73.24 108.994 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.55 70.86 1.9 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 111.286 -0.726 . . . . 74.41 111.286 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -102.79 -22.46 13.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.896 1.278 . . . . 44.04 109.375 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 286' ' ' MET . . . . . 0.612 ' HB3' HG23 ' E' ' 288' ' ' VAL . 64.9 mtt -100.54 114.59 65.78 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.235 1.014 . . . . 72.4 110.351 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -92.63 38.5 0.24 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.458 2.772 . . . . 71.14 112.249 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 288' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' E' ' 286' ' ' MET . 66.4 t -66.05 128.72 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.799 0.839 . . . . 54.34 111.353 -171.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -149.92 -166.1 2.45 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 124.525 1.13 . . . . 74.21 108.555 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 290' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 42' ' ' LEU . 98.6 m95 -77.32 118.39 19.76 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.339 -0.615 . . . . 74.3 109.339 172.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.682 ' H ' HD13 ' E' ' 291' ' ' LEU . 0.0 OUTLIER -82.86 -11.43 58.23 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.446 1.098 . . . . 64.32 110.602 178.899 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 292' ' ' GLY . . . . . 0.463 ' HA2' ' SG ' ' G' ' 308' ' ' CYS . . . -126.99 177.48 17.33 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 115.328 -0.851 . . . . 73.34 112.472 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.15 147.22 66.28 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.202 2.601 . . . . 63.42 112.67 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.94 82.96 6.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.524 0.73 . . . . 54.32 109.434 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 295' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' G' ' 305' ' ' ALA . . . -71.33 -77.83 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.265 -0.643 . . . . 64.33 109.265 175.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 296' ' ' THR . . . . . 0.59 ' HB ' ' HG2' ' A' ' 38' ' ' PRO . 1.9 m 58.59 12.1 2.0 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 125.005 1.322 . . . . 74.52 112.7 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.8 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 0.6 OUTLIER -151.31 -171.67 4.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.761 1.624 . . . . 61.21 108.664 176.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 54.9 m80 74.85 28.95 1.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.383 1.473 . . . . 74.02 111.433 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 299' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 124' ' ' PRO . . . -148.76 11.5 1.1 Allowed Glycine 0 C--N 1.357 1.727 0 N-CA-C 115.956 1.143 . . . . 71.4 115.956 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -169.58 -165.4 0.5 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.263 -1.014 . . . . 74.31 108.263 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 68.3 mt 66.94 96.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.291 1.436 . . . . 71.05 109.269 -176.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.52 -68.67 0.79 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.322 -0.853 . . . . 55.32 111.279 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 303' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' E' ' 304' ' ' PRO . 65.6 tttp -175.34 127.78 0.39 Allowed Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.395 0.678 . . . . 72.14 109.54 -174.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 304' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' E' ' 303' ' ' LYS . 2.9 Cg_endo -83.35 50.06 3.16 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.481 2.787 . . . . 65.43 111.944 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -171.03 127.52 0.71 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.001 0.92 . . . . 70.51 109.305 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 83.0 t -127.62 142.37 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.611 0.764 . . . . 75.33 109.232 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 307' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' G' ' 293' ' ' PRO . 18.9 m -70.4 128.38 35.97 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.35 0.66 . . . . 65.12 110.024 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 29.7 p -76.43 172.47 12.88 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.324 0.65 . . . . 62.14 111.162 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 34.3 p -65.27 113.3 10.84 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.489 0.716 . . . . 55.44 110.16 173.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 C--N 1.381 2.286 0 C-N-CA 123.322 2.682 . . . . 71.14 111.434 177.892 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 110.161 -0.311 . . . . 63.2 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -153.22 170.18 21.2 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.201 1.0 . . . . 74.24 108.472 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -73.24 79.94 1.31 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.669 0.747 . . . . 63.01 109.532 175.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 274' ' ' GLN . . . . . 0.516 ' HG3' ' HB3' ' A' ' 153' ' ' GLN . 6.5 tp-100 -133.17 -11.58 2.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.673 1.189 . . . . 64.55 108.821 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 275' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 152' ' ' HIS . 25.5 tptp 68.22 99.81 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 124.257 1.023 . . . . 73.42 111.507 166.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.91 156.89 8.67 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.319 2.012 . . . . 73.3 111.287 167.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.6 -40.2 95.09 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.419 0.628 . . . . 74.33 110.16 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' F' ' 281' ' ' PHE . 3.0 mm? -98.34 66.04 1.72 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.372 0.669 . . . . 71.43 109.267 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -99.29 -60.41 0.86 Allowed Glycine 0 C--N 1.356 1.649 0 CA-C-N 115.695 -0.684 . . . . 52.32 112.029 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -68.04 -19.14 64.87 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.6 0.76 . . . . 64.13 111.217 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 281' ' ' PHE . . . . . 0.41 ' CD2' HD12 ' F' ' 278' ' ' LEU . 24.2 t80 -74.73 -11.22 60.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.538 1.135 . . . . 74.3 111.668 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.36 68.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.51 0.724 . . . . 53.03 110.554 172.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -137.7 96.33 3.22 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.9 0.88 . . . . 74.21 109.473 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -94.61 61.68 1.71 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.017 -0.833 . . . . 70.43 111.017 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -72.4 87.36 1.16 Allowed 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.079 0.552 . . . . 73.32 109.852 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 51.4 tpp -97.04 123.69 52.36 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 107.427 -1.323 . . . . 71.43 107.427 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.88 74.86 2.26 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.61 2.207 . . . . 74.45 112.286 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 45.3 t -80.84 96.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 108.138 -1.06 . . . . 71.32 108.138 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -95.52 34.07 1.52 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.165 0.986 . . . . 74.51 110.543 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 290' ' ' TRP . . . . . 0.524 ' HE3' ' H ' ' F' ' 291' ' ' LEU . 7.0 m95 61.37 162.99 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.529 1.531 . . . . 74.13 113.05 -173.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.524 ' H ' ' HE3' ' F' ' 290' ' ' TRP . 51.7 mt -118.47 -21.54 7.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 113.807 -1.542 . . . . 73.31 109.282 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 292' ' ' GLY . . . . . 0.419 ' H ' ' HE3' ' F' ' 290' ' ' TRP . . . -149.16 96.62 0.17 Allowed Glycine 0 C--N 1.358 1.766 0 C-N-CA 124.252 0.93 . . . . 51.42 111.163 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.66 -65.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 123.066 2.511 . . . . 72.22 114.114 -170.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 294' ' ' LYS . . . . . 0.787 ' HG2' ' HD2' ' C' ' 38' ' ' PRO . 0.0 OUTLIER -96.99 14.83 24.18 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.692 0.758 . . . . 62.51 110.081 -174.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.04 -14.96 63.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.863 0.865 . . . . 74.23 112.625 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 32.5 m -59.73 -55.78 30.05 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.458 0.703 . . . . 73.15 110.854 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.693 ' HB3' ' HG2' ' C' ' 124' ' ' PRO . 16.4 p90 -146.82 106.31 3.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.476 0.655 . . . . 75.3 111.448 169.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 298' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' H' ' 300' ' ' ASN . 62.1 t60 -80.92 -41.14 23.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.673 -1.148 . . . . 72.42 108.808 167.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 165.25 50.94 0.02 OUTLIER Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.548 -0.751 . . . . 45.13 112.506 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 300' ' ' ASN . . . . . 0.563 ' HB2' ' HB2' ' H' ' 300' ' ' ASN . 2.7 t-20 -84.26 -51.71 6.8 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.323 0.583 . . . . 71.14 110.064 176.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.474 ' HB ' ' HE2' ' C' ' 32' ' ' PHE . 47.6 pt -87.14 37.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 115.18 -0.918 . . . . 62.42 109.982 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.33 -25.79 68.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.067 1.347 . . . . 74.12 111.649 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -99.86 129.38 28.71 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.58 0.752 . . . . 71.33 109.569 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -84.4 23.25 0.85 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.669 2.913 . . . . 72.34 113.957 -172.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -158.5 141.38 14.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.676 0.79 . . . . 73.25 109.346 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 306' ' ' VAL . . . . . 0.659 HG11 HH11 ' D' ' 15' ' ' ARG . 17.4 m -88.81 -51.57 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 123.107 0.255 . . . . 72.01 110.338 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 307' ' ' THR . . . . . 0.642 HG21 ' HB3' ' H' ' 291' ' ' LEU . 64.1 m -161.65 125.81 3.32 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.676 -1.231 . . . . 74.33 107.676 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 60.7 m -85.31 82.8 8.19 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.863 -0.791 . . . . 74.12 108.863 172.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' F' F ' 309' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' F' ' 310' ' ' PRO . 8.0 t -115.36 134.52 22.58 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 123.104 0.562 . . . . 43.23 110.753 -174.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' F' F ' 310' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' F' ' 309' ' ' THR . 6.9 Cg_endo . . . . . 0 C--N 1.375 1.974 0 C-N-CA 122.861 2.374 . . . . 75.53 111.124 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.992 -0.373 . . . . 75.51 109.992 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -99.81 159.71 14.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.546 0.738 . . . . 71.03 109.931 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -114.09 26.85 9.96 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.143 0.973 . . . . 70.25 109.57 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 274' ' ' GLN . . . . . 0.589 HE21 ' HB2' ' D' ' 150' ' ' GLU . 62.6 mt-30 -89.6 -163.94 1.08 Allowed 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.152 -0.931 . . . . 61.0 109.933 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -63.06 134.45 95.81 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 118.518 -0.753 . . . . 74.43 109.047 171.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -49.81 -43.24 41.55 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.946 2.431 . . . . 74.22 113.033 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.455 HD21 HG22 ' D' ' 86' ' ' ILE . 3.2 tm? -106.88 111.63 24.22 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.127 -1.064 . . . . 72.04 108.127 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 70.06 166.8 0.29 Allowed 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.593 1.183 . . . . 71.42 112.992 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 279' ' ' GLY . . . . . 0.451 ' HA2' ' HG3' ' D' ' 153' ' ' GLN . . . 158.29 -73.11 0.23 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 114.791 -1.095 . . . . 43.32 111.235 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.22 137.43 33.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.069 0.548 . . . . 74.34 111.073 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 22.1 t80 176.88 174.78 0.39 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.641 1.577 . . . . 74.43 108.459 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . 77.27 89.18 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.598 1.559 . . . . 53.14 111.845 171.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -150.87 145.03 25.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.99 1.316 . . . . 72.15 108.606 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -120.96 0.76 11.84 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.842 -0.421 . . . . 51.52 113.074 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -94.88 58.79 2.28 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.377 0.589 . . . . 51.4 109.865 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 286' ' ' MET . . . . . 0.546 ' HB2' HD22 ' D' ' 44' ' ' LEU . 94.8 mmm -102.64 98.71 11.57 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 109.064 -0.717 . . . . 62.45 109.064 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.3 97.6 1.14 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.841 2.361 . . . . 73.23 111.087 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 10.4 p -99.79 5.14 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 C-N-CA 123.585 0.754 . . . . 72.35 110.187 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? 71.54 4.32 5.0 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.911 1.284 . . . . 73.42 111.352 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.66 ' HE1' HG23 ' D' ' 40' ' ' VAL . 0.1 OUTLIER 62.15 27.4 16.49 Favored 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 124.595 1.158 . . . . 75.25 110.349 -173.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.621 HD21 HG22 ' D' ' 131' ' ' VAL . 4.8 mp 53.54 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.727 1.611 . . . . 64.43 112.889 173.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -163.52 139.89 6.15 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.509 -1.036 . . . . 63.01 110.509 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 293' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' E' ' 307' ' ' THR . 72.9 Cg_endo -76.68 117.54 4.56 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.693 2.262 . . . . 72.22 112.707 -173.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -76.64 140.86 41.12 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.417 -0.957 . . . . 74.15 108.417 165.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -68.49 139.02 55.66 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 123.519 0.512 . . . . 61.33 109.75 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 8.3 p -98.79 -65.35 0.97 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.598 0.759 . . . . 70.24 109.819 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -118.72 140.91 49.18 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.353 -0.61 . . . . 74.32 109.353 172.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.74 -42.71 63.78 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.046 0.538 . . . . 73.21 109.941 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 175.53 54.47 0.06 OUTLIER Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.134 -0.786 . . . . 75.04 111.134 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 300' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 9.8 p30 -157.19 -174.21 4.8 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.323 0.649 . . . . 54.32 109.837 -176.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' D' ' 35' ' ' ASP . 10.2 tp -155.44 9.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.749 0.42 . . . . 74.41 111.051 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 302' ' ' ASP . . . . . 0.499 ' HB3' ' NH2' ' C' ' 15' ' ' ARG . 31.0 t70 70.16 98.88 0.06 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.556 1.543 . . . . 73.15 110.765 -167.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -134.29 85.72 37.86 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 107.58 -1.267 . . . . 74.25 107.58 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.91 120.37 7.6 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.238 1.959 . . . . 72.44 110.092 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 305' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' E' ' 295' ' ' ALA . . . -66.59 83.76 0.1 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.315 0.646 . . . . 75.14 110.534 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 61.5 t -116.5 89.98 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 106.187 -1.783 . . . . 71.44 106.187 174.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 25.9 p -117.76 12.0 13.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.935 0.894 . . . . 75.23 111.143 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 308' ' ' CYS . . . . . 0.463 ' SG ' ' HA2' ' E' ' 292' ' ' GLY . 21.2 p -166.69 126.49 1.54 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.609 0.764 . . . . 72.42 110.287 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 39.0 m -142.99 69.55 18.45 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.455 1.102 . . . . 74.22 108.218 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.381 2.285 0 C-N-CA 123.365 2.71 . . . . 72.44 110.905 -179.378 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.512 0.196 . . . . 71.23 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -122.24 119.26 30.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.638 0.775 . . . . 63.24 108.989 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -76.68 178.58 6.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.731 0.812 . . . . 43.45 109.645 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 274' ' ' GLN . . . . . 0.418 ' NE2' ' HB1' ' B' ' 87' ' ' ALA . 79.2 mt-30 -58.21 -49.23 77.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.94 0.496 . . . . 71.2 110.377 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -168.83 163.39 7.88 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 125.406 1.482 . . . . 75.24 109.053 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.96 -31.34 56.26 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.603 2.202 . . . . 75.23 112.793 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 277' ' ' LEU . . . . . 0.463 ' HG ' ' HE2' ' B' ' 94' ' ' MET . 9.2 mp 62.24 -165.56 0.23 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.299 1.04 . . . . 73.0 111.27 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 8.0 mp 68.99 -159.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.983 0.913 . . . . 63.31 111.36 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 117.6 -45.72 1.24 Allowed Glycine 0 C--N 1.352 1.426 0 N-CA-C 112.087 -0.405 . . . . 72.41 112.087 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.3 -23.89 64.79 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.335 0.654 . . . . 74.05 110.507 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -72.95 173.53 9.12 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.585 -0.734 . . . . 75.32 111.424 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . 59.0 28.18 17.35 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 124.039 0.837 . . . . 75.4 109.874 -170.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -165.34 -89.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.154 -1.385 . . . . 64.24 107.602 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 56.37 30.38 58.34 Favored Glycine 0 C--N 1.353 1.474 0 C-N-CA 123.05 0.357 . . . . 74.42 112.783 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -77.71 80.37 4.17 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.811 0.844 . . . . 71.24 109.949 -174.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 286' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' H' ' 287' ' ' PRO . 73.8 mtm -115.66 132.22 23.26 Favored Pre-proline 0 C--O 1.238 0.493 0 N-CA-C 107.268 -1.382 . . . . 63.01 107.268 171.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 287' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' H' ' 286' ' ' MET . 12.8 Cg_exo -67.98 90.15 0.37 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.438 2.092 . . . . 73.31 111.667 -175.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 82.0 t -75.35 -55.11 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.29 -1.004 . . . . 72.33 108.29 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 59.58 -82.67 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 O-C-N 124.796 1.31 . . . . 73.14 110.066 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -172.02 157.13 4.27 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 126.364 1.866 . . . . 65.13 106.31 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.642 ' HB3' HG21 ' F' ' 307' ' ' THR . 6.8 mp -92.42 41.4 1.07 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.384 -0.969 . . . . 62.12 108.384 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 102.55 143.43 13.23 Favored Glycine 0 C--N 1.358 1.759 0 CA-C-N 114.656 -1.156 . . . . 62.34 111.426 -170.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.08 116.98 4.03 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.981 2.454 . . . . 64.15 111.227 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -92.64 146.37 23.71 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 110.088 -0.338 . . . . 75.24 110.088 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.26 67.06 9.65 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.488 0.715 . . . . 71.54 110.181 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 89.8 m -71.21 145.69 49.51 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.236 1.015 . . . . 74.53 109.093 174.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 43.1 t80 74.37 -64.34 0.39 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.713 1.205 . . . . 74.41 108.91 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 36.3 t60 62.55 -82.4 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.461 1.504 . . . . 44.14 111.747 167.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 164.76 69.62 0.02 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.36 -1.096 . . . . 63.01 110.36 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 300' ' ' ASN . . . . . 0.563 ' HB2' ' HB2' ' F' ' 300' ' ' ASN . 7.0 t30 -113.16 0.61 14.98 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.201 0.6 . . . . 74.1 110.496 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 48.6 mt -68.23 85.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.77 0 N-CA-C 107.412 -1.329 . . . . 74.24 107.412 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.94 -64.31 0.95 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.899 0.88 . . . . 71.22 111.042 -170.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -139.67 158.73 67.5 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.781 0.832 . . . . 73.45 109.392 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.48 73.08 0.2 Allowed 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.131 2.554 . . . . 72.34 111.461 169.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -88.07 -57.9 2.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.785 -1.098 . . . . 61.43 112.367 -166.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 5.2 p -65.39 -34.81 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.203 -0.908 . . . . 64.05 111.484 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 307' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 12.0 t -69.99 -21.64 63.2 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.319 0.647 . . . . 72.13 111.999 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 308' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' H' ' 307' ' ' THR . 57.4 m -131.84 76.9 1.73 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.335 0.654 . . . . 71.33 109.323 -177.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 23.3 p -69.91 110.13 6.03 Favored Pre-proline 0 CA--C 1.558 1.284 0 O-C-N 123.464 0.477 . . . . 70.13 109.746 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo . . . . . 0 C--N 1.379 2.18 0 C-N-CA 123.044 2.496 . . . . 61.52 111.628 -177.535 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.396 -0.594 . . . . 64.25 109.396 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 t -72.31 95.58 1.74 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.515 0.726 . . . . 64.01 109.179 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.65 140.96 48.7 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.97 0.908 . . . . 73.2 110.226 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.47 174.36 7.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.483 0.713 . . . . 73.24 110.663 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -165.86 139.36 4.34 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.292 1.037 . . . . 75.44 109.14 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -166.45 150.9 7.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.417 0.687 . . . . 74.12 109.542 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p -66.86 92.83 0.24 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.651 0.78 . . . . 64.01 111.299 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.78 5.47 15.78 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.769 1.228 . . . . 72.31 111.544 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.8 mtt -61.75 133.4 55.49 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.822 0.849 . . . . 63.32 110.629 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -153.37 137.06 16.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.958 0.903 . . . . 60.44 109.442 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 27.2 t80 -137.81 126.13 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.214 1.005 . . . . 71.15 108.712 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -151.06 128.51 11.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.307 0.643 . . . . 72.03 109.502 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CD1' HG21 ' A' ' 105' ' ' ILE . 56.4 mt -85.12 129.03 38.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 120.921 0.391 . . . . 73.15 109.955 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -88.6 -42.71 11.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.108 -0.951 . . . . 73.43 110.255 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' HB3' HD12 ' A' ' 83' ' ' ILE . 60.1 ttt180 -169.83 140.75 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.314 -0.403 . . . . 74.2 110.714 -170.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -122.81 137.95 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.221 -1.029 . . . . 74.34 108.221 172.014 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -168.23 143.58 3.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.388 0.675 . . . . 73.44 110.463 -171.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -76.59 111.01 11.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.735 -0.839 . . . . 70.43 108.735 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 40.4 mtpt -77.27 -25.28 51.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.969 0.508 . . . . 74.03 110.565 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.24 146.71 24.94 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.941 -1.027 . . . . 72.25 109.895 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.4 mt -140.24 145.2 26.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 125.06 1.344 . . . . 54.42 107.498 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 36.5 t -154.7 138.39 16.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.634 0.774 . . . . 61.2 109.103 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -143.58 131.63 21.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.565 -1.643 . . . . 74.52 106.565 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -134.51 128.81 34.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.006 -0.739 . . . . 74.14 109.006 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 78.65 72.94 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 107.33 -1.359 . . . . 73.44 107.33 171.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.73 -26.07 19.75 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.68 2.253 . . . . 70.24 112.055 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -109.39 24.22 13.38 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.773 0.829 . . . . 62.35 109.019 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.21 -61.17 2.48 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 117.879 -1.057 . . . . 70.22 112.595 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.7 Cg_exo -63.21 -24.3 72.5 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 122.28 1.987 . . . . 73.15 113.008 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.407 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 16.2 m-70 -77.95 -47.37 18.75 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.673 0.789 . . . . 45.34 110.442 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -73.9 -20.02 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 CA-C-N 115.16 -0.927 . . . . 75.12 110.949 -163.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.9 -19.22 62.62 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.354 1.062 . . . . 75.41 112.765 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -102.53 -10.28 19.47 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.696 0.398 . . . . 55.32 111.979 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 30' ' ' HIS . 36.6 mtpt -82.12 167.63 18.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.875 0.47 . . . . 74.44 112.248 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -61.53 141.33 57.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.457 1.103 . . . . 71.34 111.933 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' E' ' 297' ' ' TYR . 48.4 m95 -91.87 64.08 4.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.07 0.548 . . . . 74.12 110.68 -172.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -127.07 73.68 76.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.393 0.677 . . . . 75.54 110.054 175.384 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -89.72 118.44 0.78 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.619 2.213 . . . . 74.45 112.187 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.73 101.1 12.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.901 -1.518 . . . . 72.14 106.901 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.3 t -76.46 114.89 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.355 -0.839 . . . . 54.04 110.133 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.35 134.41 35.57 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.355 0.662 . . . . 53.53 109.565 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.2 mt -103.28 108.61 19.9 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.527 -0.916 . . . . 71.01 108.527 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -104.26 113.9 27.77 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.004 0.922 . . . . 64.35 108.735 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.48 135.87 39.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.312 0.645 . . . . 64.42 109.586 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.57 134.44 30.56 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.397 -0.964 . . . . 75.03 108.397 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.454 HG23 HD22 ' A' ' 60' ' ' LEU . 11.5 m -148.63 140.57 23.84 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.64 0.376 . . . . 63.12 110.092 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.06 135.07 13.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.369 0.668 . . . . 74.31 110.644 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.416 ' OG ' HD11 ' E' ' 278' ' ' LEU . 45.7 p -96.45 164.09 12.77 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.859 0.864 . . . . 63.33 111.013 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -162.09 119.99 2.2 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.45 1.1 . . . . 73.32 108.752 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.39 118.69 18.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.958 -0.386 . . . . 74.33 109.958 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -89.25 -33.1 17.1 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.487 0.715 . . . . 75.13 111.137 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.53 -174.07 4.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.414 0.686 . . . . 72.35 110.765 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.24 116.66 5.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.425 0.69 . . . . 72.12 110.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 66.16 -0.14 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.403 1.481 . . . . 70.05 113.091 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.91 106.57 19.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.334 -0.987 . . . . 74.35 108.334 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -119.57 124.04 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.801 -1.185 . . . . 74.2 107.801 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -88.77 136.16 33.15 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.563 1.145 . . . . 71.42 108.532 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 99.0 t -122.76 125.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.644 -1.243 . . . . 74.02 107.644 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.516 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.6 t -104.97 128.02 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.023 0.529 . . . . 62.34 109.875 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.75 HD23 HD12 ' A' ' 106' ' ' LEU . 3.9 mm? -106.28 98.17 7.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 73.42 108.906 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 17.2 ttp180 -87.18 100.88 12.99 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.651 -0.87 . . . . 73.14 108.651 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.5 t -93.64 122.66 45.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.999 -1.482 . . . . 65.32 106.999 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.3 m -116.35 121.38 41.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.531 0.681 . . . . 71.44 109.281 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 t -111.18 109.84 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.95 1.3 . . . . 72.32 108.672 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.7 m -103.56 140.07 38.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 108.31 -0.996 . . . . 73.11 108.31 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.16 121.22 37.33 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.182 -0.673 . . . . 71.14 109.182 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -122.73 124.82 44.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.245 0.545 . . . . 60.51 110.768 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 5.1 mp -88.81 77.08 7.87 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.351 1.46 . . . . 71.43 107.578 173.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.01 -86.78 0.88 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.865 -1.061 . . . . 62.44 111.15 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -113.9 -27.89 7.58 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.882 0.873 . . . . 52.52 110.65 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -86.07 133.71 33.87 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.351 0.66 . . . . 71.13 111.042 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.4 m -78.26 147.24 34.43 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.127 0.421 . . . . 74.32 110.526 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.734 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -96.8 -63.25 1.15 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.971 0.908 . . . . 71.44 108.964 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -151.6 163.86 38.15 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.154 -1.384 . . . . 74.4 110.548 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.7 tp -132.89 121.26 22.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.498 1.119 . . . . 72.22 108.461 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.657 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.2 m -105.79 141.03 37.92 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.603 1.161 . . . . 43.51 108.719 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.4 tt0 -146.66 115.35 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.091 -1.077 . . . . 54.31 108.091 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 113' ' ' CYS . 46.4 t -131.32 109.96 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.102 -0.703 . . . . 75.31 109.102 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 64.5 mt-30 -87.7 81.79 7.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.3 -0.864 . . . . 55.24 109.086 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.7 tp60 -75.87 93.11 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.108 -0.951 . . . . 74.13 108.633 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.55 145.4 21.92 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.317 -0.713 . . . . 65.31 111.317 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.07 142.82 12.15 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.539 -1.024 . . . . 64.15 110.539 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 15' ' ' ARG . 54.8 mt -106.9 126.41 62.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.578 -0.897 . . . . 73.25 108.578 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.48 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 14.5 m-85 -131.45 117.43 18.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.393 0.677 . . . . 71.43 109.199 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 t -78.55 90.63 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.889 0.876 . . . . 51.35 108.661 168.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 89' ' ' ILE . 48.5 pt -106.44 143.94 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.654 0.782 . . . . 61.02 110.286 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.22 154.88 28.0 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.809 0.844 . . . . 61.31 109.544 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.66 5.37 88.27 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 115.155 0.822 . . . . 61.21 115.155 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.6 134.51 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.392 -0.966 . . . . 74.35 108.392 174.079 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -142.47 171.93 13.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.227 1.011 . . . . 70.23 108.946 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.06 -120.18 14.27 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.459 0.543 . . . . 61.3 114.459 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -80.21 -24.17 40.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.01 0.924 . . . . 72.22 111.593 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -36.91 75.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.348 0.659 . . . . 64.43 109.949 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.57 ' SD ' HD23 ' E' ' 277' ' ' LEU . 52.1 ttp -65.98 -43.06 88.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.915 0.886 . . . . 51.44 110.193 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.93 82.39 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.347 -0.842 . . . . 73.15 111.426 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.731 0.813 . . . . 72.33 110.763 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.46 -49.56 68.67 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.01 0.524 . . . . 53.24 110.836 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 mt -85.03 -32.2 23.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.037 -0.529 . . . . 64.02 111.512 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.58 -1.88 63.69 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 114.823 0.689 . . . . 74.25 114.823 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.75 -54.65 0.19 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.998 0.899 . . . . 62.25 112.445 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -71.31 -64.4 0.92 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.318 1.047 . . . . 71.31 112.629 -167.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.9 m -70.37 -34.25 3.84 Favored Pre-proline 0 CA--C 1.574 1.87 0 N-CA-C 113.933 1.086 . . . . 55.43 113.933 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.61 ' HB3' HD21 ' A' ' 60' ' ' LEU . 26.2 Cg_endo -64.03 -31.53 65.8 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.249 1.966 . . . . 55.35 113.319 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -62.05 -34.93 77.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.246 0.618 . . . . 72.23 109.666 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.532 HG21 ' CD1' ' A' ' 13' ' ' ILE . 45.6 mm -60.03 -47.3 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.855 0.862 . . . . 73.44 110.603 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.75 HD12 HD23 ' A' ' 60' ' ' LEU . 98.4 mt -76.27 -25.62 55.1 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.454 -0.793 . . . . 60.25 112.091 -171.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.16 -44.58 98.74 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.003 1.112 . . . . 62.33 114.003 -170.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.92 -33.98 95.48 Favored 'Trans proline' 0 C--N 1.392 2.818 0 C-N-CA 122.117 1.878 . . . . 53.21 113.7 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.16 -35.27 56.12 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 75.23 110.98 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.27 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.504 -0.554 . . . . 30.02 109.504 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HG23 ' C' ' 105' ' ' ILE . 38.1 ttm180 -54.28 -53.91 47.35 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 124.663 1.227 . . . . 74.54 110.116 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.48 -43.4 98.92 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.542 1.151 . . . . 75.42 110.98 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.488 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 48.0 t -60.15 -40.51 90.11 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.581 0.551 . . . . 44.13 111.002 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 94.7 mt -65.49 -54.76 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.901 0.751 . . . . 72.23 109.669 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.584 HG21 ' HE2' ' C' ' 109' ' ' TYR . 93.5 m -53.17 -39.06 63.31 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.936 1.397 . . . . 71.12 111.343 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.8 t -65.94 -47.63 74.05 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.546 -1.206 . . . . 64.42 109.257 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.554 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 44.4 mtm -61.85 -42.94 99.65 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.194 0.598 . . . . 73.31 111.066 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.9 t -56.21 -50.48 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 124.388 1.055 . . . . 55.2 109.957 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -72.0 -32.29 67.06 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.222 -0.899 . . . . 61.21 111.588 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.511 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 61.6 mtt-85 -72.16 -27.43 62.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.5 0.72 . . . . 75.03 110.036 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.67 12.36 56.67 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.749 -0.659 . . . . 73.52 113.182 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.5 p 57.99 17.77 4.63 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.808 2.043 . . . . 53.52 113.393 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.28 145.75 49.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.245 -1.391 . . . . 73.43 107.245 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 141.74 80.89 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.494 2.129 . . . . 74.45 111.149 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -48.03 123.16 5.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.619 1.199 . . . . 72.32 111.336 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.47 118.94 38.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.256 0.622 . . . . 54.25 109.387 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -115.48 114.85 25.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.153 -0.684 . . . . 71.31 109.153 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.63 122.09 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.644 0.778 . . . . 70.22 109.939 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.545 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -64.12 132.28 95.25 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 109.276 -0.639 . . . . 63.0 109.276 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.432 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 4.3 Cg_endo -76.72 113.49 3.66 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.119 1.879 . . . . 74.33 110.569 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -98.99 123.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.713 -1.217 . . . . 51.33 107.713 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -76.72 89.98 3.41 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.425 -0.954 . . . . 75.31 108.425 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -62.66 -31.91 72.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.881 0.873 . . . . 73.21 110.902 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.406 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.6 m-20 -59.93 -48.93 79.69 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.672 0.789 . . . . 64.03 110.566 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.72 89.45 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.23 0.956 . . . . 62.53 111.027 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.66 -50.94 69.2 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.038 0.836 . . . . 73.14 110.145 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -64.95 -38.86 92.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.44 0.696 . . . . 74.31 110.466 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.623 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 12.5 tpt -66.68 -44.79 80.83 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 115.413 -0.812 . . . . 71.15 110.146 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.52 -36.89 64.72 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.464 0.706 . . . . 75.25 112.006 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -70.31 -40.62 74.09 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.094 0.558 . . . . 74.4 110.555 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.458 HD23 ' SD ' ' A' ' 138' ' ' MET . 35.2 tp -65.97 -16.57 64.0 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.88 1.272 . . . . 73.3 112.289 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.707 ' HB2' ' HA ' ' C' ' 2' ' ' SER . 4.0 pt20 -144.74 29.36 1.24 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.925 0.89 . . . . 71.52 110.293 -173.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -59.74 98.18 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.564 1.146 . . . . 65.03 113.775 -171.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 174.1 158.04 0.15 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.775 1.63 . . . . 70.5 109.055 164.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.47 102.98 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.333 1.021 . . . . 72.43 110.929 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' C' ' 3' ' ' GLU . . . -86.89 133.62 11.93 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.617 -0.72 . . . . 34.32 112.209 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.68 122.88 12.95 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.196 -1.039 . . . . 74.54 108.196 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.74 126.19 1.02 Allowed Glycine 0 C--N 1.343 0.958 0 O-C-N 123.556 0.535 . . . . 63.54 111.834 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.2 t -145.91 120.55 9.81 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.503 0.721 . . . . 71.05 109.604 173.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -91.29 84.85 5.68 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.877 -0.786 . . . . 70.24 108.877 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -99.49 107.56 19.79 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.274 -0.876 . . . . 72.32 108.769 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -125.22 109.22 12.58 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.924 0.889 . . . . 70.43 108.947 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.76 87.02 2.21 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.655 -0.868 . . . . 74.41 108.655 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -85.59 118.43 25.1 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.972 -0.751 . . . . 63.42 108.972 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 N-CA-C 109.141 -0.688 . . . . 73.14 109.141 -177.058 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.363 -0.606 . . . . 73.2 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 39.9 m -66.77 98.71 0.55 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.757 -0.831 . . . . 73.22 108.757 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' B' ' 151' ' ' GLU . 23.7 tt0 -124.77 127.58 47.43 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.724 -0.671 . . . . 42.42 111.981 -169.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.4 ' HG2' ' HG3' ' B' ' 151' ' ' GLU . 9.9 pt20 -159.18 161.8 36.24 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.195 1.398 . . . . 64.23 108.821 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -144.97 136.08 24.91 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.033 0.533 . . . . 75.31 109.972 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -164.9 106.25 0.82 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.173 0.989 . . . . 74.12 109.216 175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.599 HG21 ' HB2' ' E' ' 310' ' ' PRO . 41.1 p -118.26 100.77 7.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.395 0.678 . . . . 54.55 109.601 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -80.86 163.3 23.5 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.126 -0.488 . . . . 74.25 110.626 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.567 ' HB3' HG23 ' B' ' 89' ' ' ILE . 24.2 ptm 49.43 -174.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.261 1.824 . . . . 74.33 113.874 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.8 m -135.95 123.47 22.16 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.295 -1.002 . . . . 70.54 108.295 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.463 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 56.6 t80 -127.68 112.61 15.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.736 -1.209 . . . . 74.33 107.736 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.557 ' HG2' HG23 ' E' ' 309' ' ' THR . 0.0 OUTLIER -131.83 135.29 46.61 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.008 -1.108 . . . . 73.03 108.008 -178.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.476 ' O ' HD12 ' B' ' 13' ' ' ILE . 2.4 pp -94.99 130.52 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.397 0.679 . . . . 71.02 110.277 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -99.12 -50.83 4.02 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.807 -0.558 . . . . 63.34 110.06 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.459 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 41.8 ttt180 -162.59 134.23 5.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.998 -0.546 . . . . 74.3 110.452 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -113.91 142.55 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.71 -1.589 . . . . 53.31 106.71 172.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -168.9 149.35 4.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.615 0.643 . . . . 73.04 112.733 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.661 HG21 HD11 ' B' ' 21' ' ' ILE . 37.9 m -79.71 120.1 23.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.345 -0.843 . . . . 72.53 109.529 172.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.579 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 9.3 mtpt -89.14 -28.88 19.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.4 0.68 . . . . 74.45 110.835 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.7 136.92 14.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.846 -0.616 . . . . 72.24 110.406 -169.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.661 HD11 HG21 ' B' ' 18' ' ' THR . 31.2 mm -124.99 148.88 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.398 1.079 . . . . 75.25 108.155 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.7 t -154.15 141.37 19.51 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.789 -0.641 . . . . 71.51 109.576 170.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -152.71 109.0 3.39 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.26 -1.385 . . . . 65.35 107.26 171.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -118.08 111.53 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.456 -1.313 . . . . 74.53 107.456 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.79 88.23 6.42 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 108.313 -0.995 . . . . 43.12 108.313 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.74 -24.33 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.095 2.53 . . . . 61.34 111.938 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -121.6 24.14 9.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.936 0.895 . . . . 73.25 110.391 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -41.69 -54.41 6.74 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 124.788 1.235 . . . . 72.31 114.16 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.9 Cg_endo -66.17 -32.93 41.74 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.317 2.011 . . . . 74.3 113.157 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -94.42 -15.5 24.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.877 0.695 . . . . 65.22 112.877 -169.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.64 -23.25 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.743 1.217 . . . . 71.42 113.682 -169.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -66.57 -21.72 66.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.122 0.969 . . . . 54.21 112.149 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.421 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.6 pt20 -61.98 -29.06 70.0 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.879 0.472 . . . . 51.03 110.619 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 32.8 mmtp -105.1 67.65 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.536 -1.283 . . . . 74.04 107.536 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.02 79.5 6.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.546 0.738 . . . . 73.0 111.93 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 164.79 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.899 2.079 . . . . 71.33 110.647 160.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.2 126.25 67.2 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.553 1.141 . . . . 72.21 112.335 -170.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.71 176.15 9.33 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.752 2.301 . . . . 62.23 111.597 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.04 104.22 7.4 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.11 -1.441 . . . . 74.24 107.11 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.46 154.91 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.503 0.721 . . . . 70.02 109.197 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -147.18 138.7 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.813 0.845 . . . . 71.13 109.801 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.658 HD21 HD11 ' B' ' 128' ' ' LEU . 5.5 mp -85.4 141.11 30.21 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.052 -1.092 . . . . 75.14 108.052 165.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.8 t70 -141.18 109.99 6.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.35 -1.352 . . . . 72.13 107.35 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.33 131.6 48.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.846 0.458 . . . . 75.33 109.886 -173.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.3 135.41 54.73 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.968 1.307 . . . . 72.54 107.895 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -109.97 145.87 36.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.385 0.674 . . . . 72.53 110.195 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.83 148.3 25.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 54.32 109.282 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.2 m -144.69 167.89 21.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.365 0.666 . . . . 73.55 110.784 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -157.63 154.17 27.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.161 0.985 . . . . 71.05 109.599 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -102.85 130.5 49.89 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.974 -0.75 . . . . 74.43 108.974 171.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 67.2 mt -97.74 -38.05 9.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.194 0.597 . . . . 64.42 110.459 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.7 -171.95 2.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.437 0.695 . . . . 73.52 110.808 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.7 114.48 4.47 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.631 -1.168 . . . . 71.42 110.123 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 72.08 -3.81 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.691 1.597 . . . . 60.21 112.589 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.08 110.74 31.22 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 N-CA-C 107.859 -1.163 . . . . 71.12 107.859 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -122.11 173.24 7.69 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.038 -0.727 . . . . 74.25 109.038 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -142.87 109.98 5.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.022 -1.103 . . . . 71.43 108.022 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -101.65 134.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.331 1.052 . . . . 70.31 109.965 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.532 1.133 . . . . 73.31 109.059 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.44 112.32 17.39 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.931 -0.766 . . . . 53.33 108.931 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.76 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 28.0 ttm180 -89.92 124.93 35.14 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.607 0.763 . . . . 72.53 109.62 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -111.61 126.56 69.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.76 -1.2 . . . . 44.13 107.76 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.4 m -121.11 122.1 39.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.775 0.798 . . . . 62.13 109.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.662 HG11 HD21 ' B' ' 126' ' ' LEU . 87.8 t -102.05 95.99 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.29 1.436 . . . . 63.3 108.331 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 24.7 m -85.48 137.06 33.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.749 -0.834 . . . . 75.53 108.749 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.99 127.3 13.04 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.652 -0.499 . . . . 55.41 109.652 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 64.3 p -145.89 144.72 30.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.203 0.601 . . . . 63.24 110.809 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -133.54 102.31 5.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 50.11 109.406 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.73 -132.97 11.43 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.949 -0.569 . . . . 20.12 112.594 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.81 8.77 24.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.172 0.589 . . . . 63.14 110.744 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.19 154.68 49.13 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.522 0.729 . . . . 71.35 110.675 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' THR . . . . . 0.434 HG21 ' HG ' ' B' ' 75' ' ' LEU . 66.4 m -83.79 138.67 33.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.301 0.64 . . . . 62.23 110.273 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -76.61 -60.24 2.43 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.894 0.878 . . . . 64.32 108.974 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -165.69 153.01 10.36 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 113.656 -1.611 . . . . 71.03 109.054 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.434 ' HG ' HG21 ' B' ' 72' ' ' THR . 94.8 mt -124.1 112.78 17.52 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.562 -1.273 . . . . 70.21 107.562 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.8 t -115.98 143.43 45.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.776 -1.194 . . . . 61.21 107.776 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.4 tt0 -157.26 124.2 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 -173.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.78 142.02 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.215 0.606 . . . . 74.44 109.574 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 42.1 mt-30 -108.1 114.58 28.58 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.739 -1.208 . . . . 74.43 107.739 166.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.4 tp-100 -103.11 110.86 22.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.297 -1.001 . . . . 70.14 108.297 172.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.96 166.9 19.32 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.682 0.613 . . . . 65.22 111.719 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.84 127.56 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.446 -0.661 . . . . 63.31 111.446 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.17 125.05 40.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.605 0.762 . . . . 71.1 109.066 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.69 132.56 42.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.227 1.011 . . . . 74.33 108.959 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 49.6 m -96.59 97.98 9.83 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.732 0.813 . . . . 62.31 108.908 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.06 132.9 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.398 0.679 . . . . 52.34 110.09 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.24 172.86 16.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.004 0.922 . . . . 63.12 110.605 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -62.46 1.04 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.045 -0.525 . . . . 52.23 112.346 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.2 OUTLIER -90.48 170.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.915 0.886 . . . . 74.34 111.126 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.58 171.91 16.36 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.19 0.596 . . . . 72.54 111.089 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.28 42.91 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.121 -0.945 . . . . 43.42 113.286 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -70.73 -28.06 64.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.139 0.976 . . . . 71.42 111.689 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.82 -37.93 89.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.221 0.608 . . . . 54.33 109.822 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.504 ' HG2' HD23 ' B' ' 98' ' ' LEU . 22.9 ttt -80.32 -33.99 37.09 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 73.43 110.133 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -28.07 69.51 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.922 0.889 . . . . 62.53 111.814 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -62.0 -43.31 99.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.602 0.761 . . . . 65.22 110.247 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -70.72 -64.04 0.98 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.577 -0.738 . . . . 72.03 110.81 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.504 HD23 ' HG2' ' B' ' 94' ' ' MET . 4.5 pp -71.04 -30.84 67.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.569 0.747 . . . . 72.43 112.496 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -33.67 11.13 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.575 0.547 . . . . 74.41 113.264 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.88 -67.17 1.02 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.887 0.475 . . . . 61.43 111.33 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -60.18 -46.76 88.61 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.586 0.754 . . . . 71.42 112.898 -172.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.504 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.7 m -63.86 -51.41 64.63 Favored Pre-proline 0 CA--C 1.569 1.678 0 C-N-CA 123.932 0.893 . . . . 75.15 112.292 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.3 Cg_exo -58.94 -30.12 92.33 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.659 2.239 . . . . 53.12 113.733 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -27.98 62.78 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.301 0.64 . . . . 62.03 111.437 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.48 -40.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.543 0.737 . . . . 73.1 109.902 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' B' ' 80' ' ' GLN . 86.4 mt -75.39 -29.34 59.81 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.943 -1.026 . . . . 73.22 111.709 -173.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -55.52 -47.55 98.39 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-O 117.66 -1.162 . . . . 71.23 113.782 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.58 -43.36 33.74 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.131 2.554 . . . . 74.44 114.622 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE2' HG21 ' D' ' 115' ' ' THR . 81.4 m-85 -70.6 -42.58 70.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.382 0.673 . . . . 72.2 110.325 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -65.54 -32.17 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.702 -0.681 . . . . 53.01 110.888 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.76 -58.09 10.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.292 1.037 . . . . 71.12 110.482 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.533 0.52 . . . . 75.21 109.878 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' B' ' 21' ' ' ILE . 0.0 OUTLIER -67.4 -40.13 85.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.232 0.613 . . . . 74.52 110.776 177.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.457 HG21 HG21 ' B' ' 64' ' ' VAL . 78.5 mt -67.37 -54.3 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 75.24 109.868 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -60.15 -33.0 71.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.222 1.009 . . . . 62.32 111.55 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -60.69 -49.79 76.11 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.47 0.708 . . . . 64.12 110.124 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.7 mmt -71.26 -34.89 71.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.57 0.748 . . . . 75.25 111.584 -172.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.503 HG21 HD23 ' B' ' 126' ' ' LEU . 97.0 t -66.33 -40.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 75.33 110.153 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.6 t -68.67 -28.13 66.6 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.288 -0.869 . . . . 74.31 111.024 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.488 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 88.9 mtt-85 -72.64 -25.11 61.17 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.187 0.595 . . . . 65.33 110.753 176.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.23 13.8 43.2 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 123.346 0.404 . . . . 50.34 112.557 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 61.45 31.48 19.05 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 126.903 2.081 . . . . 74.22 112.227 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -95.79 148.36 34.44 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 115.575 -0.739 . . . . 75.23 110.175 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.459 ' HG2' ' H ' ' H' ' 297' ' ' TYR . 36.4 Cg_endo -63.76 -171.23 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.597 2.865 . . . . 64.33 114.252 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.501 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 17.7 tp60 -59.13 113.44 2.12 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.385 -1.279 . . . . 72.23 112.011 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.662 HD21 HG11 ' B' ' 64' ' ' VAL . 66.5 tp -111.09 100.58 9.23 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.614 -0.884 . . . . 63.2 108.614 171.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.21 123.26 41.82 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.95 0.9 . . . . 62.34 109.875 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.658 HD11 HD21 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -87.28 144.33 26.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.789 0.836 . . . . 73.43 109.011 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.428 ' N ' HD13 ' B' ' 128' ' ' LEU . . . -64.61 143.36 98.63 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.34 1.056 . . . . 43.04 111.568 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 5.8 Cg_exo -75.05 90.53 1.08 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.797 2.331 . . . . 70.11 111.311 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.512 HG11 HG11 ' H' ' 288' ' ' VAL . 37.7 t -91.33 111.33 23.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.983 -0.747 . . . . 42.11 108.983 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -93.01 91.97 7.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.568 -0.901 . . . . 73.12 108.568 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -63.65 -29.51 70.74 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.764 0.826 . . . . 74.13 111.319 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -67.0 -36.83 83.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.76 0.824 . . . . 71.01 110.994 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.58 81.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.905 0.882 . . . . 61.14 111.256 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.47 -25.76 54.67 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.022 -0.535 . . . . 65.22 110.585 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -74.97 -17.45 60.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.944 0.498 . . . . 52.25 111.356 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.0 mtm -58.18 -29.51 65.68 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.959 0.504 . . . . 74.11 111.171 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -78.26 -6.56 55.34 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.27 1.028 . . . . 54.35 112.155 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -88.93 -31.59 18.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.656 -0.498 . . . . 72.24 109.656 166.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 68.4 mt -88.73 6.2 39.76 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.662 0.785 . . . . 71.34 111.968 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -65.27 103.49 0.8 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.214 1.006 . . . . 73.22 111.23 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -142.07 -96.66 0.13 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.067 -1.457 . . . . 74.14 107.067 169.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -157.51 157.27 33.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.058 1.743 . . . . 75.12 106.726 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.39 177.49 10.93 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.822 0.449 . . . . 62.54 110.377 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -175.29 55.49 0.12 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 112.192 -0.363 . . . . 73.41 112.192 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -78.71 145.91 34.25 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 122.612 0.365 . . . . 75.21 110.435 176.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.83 134.38 34.92 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 124.166 0.916 . . . . 75.04 112.432 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 36.7 m -76.55 155.04 33.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.683 0.793 . . . . 72.32 109.85 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 150' ' ' GLU . . . . . 0.662 ' H ' HD13 ' D' ' 136' ' ' LEU . 23.5 mm-40 -82.2 43.0 0.77 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.75 0.82 . . . . 61.12 111.535 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.6 pt-20 -90.06 83.33 6.07 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 108.185 -1.043 . . . . 73.14 108.185 170.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -154.4 139.98 17.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.342 0.657 . . . . 62.33 109.32 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.11 134.93 52.78 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.018 -1.104 . . . . 71.35 108.018 172.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' G' ' 289' ' ' ARG . 38.6 t70 -153.44 119.17 5.31 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.807 -1.182 . . . . 73.1 107.807 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 107.946 -1.131 . . . . 71.43 107.946 177.568 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.401 -0.222 . . . . 72.3 110.401 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.707 ' HA ' ' HB2' ' A' ' 142' ' ' GLN . 55.9 p -164.83 157.01 15.93 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.647 0.779 . . . . 75.51 111.357 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 3' ' ' GLU . . . . . 0.589 ' HA ' ' HA3' ' A' ' 146' ' ' GLY . 28.9 tt0 -168.95 149.82 4.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.98 0.912 . . . . 73.31 109.628 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -167.12 104.79 0.55 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.13 -0.692 . . . . 62.41 109.13 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -83.92 132.83 34.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.81 -0.811 . . . . 60.42 108.81 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -67.62 -60.88 2.19 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.46 0.704 . . . . 62.4 111.746 -173.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.9 p -153.67 97.91 2.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.742 1.217 . . . . 75.03 108.247 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -128.24 144.19 51.1 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.901 0.881 . . . . 73.0 109.792 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.3 ttm 64.5 114.49 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.336 1.455 . . . . 72.43 112.492 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 63.6 m -103.76 92.8 4.58 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.826 -1.175 . . . . 74.21 107.826 166.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.478 ' CE1' ' SG ' ' C' ' 102' ' ' CYS . 87.8 t80 -112.43 132.66 54.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.248 -1.019 . . . . 74.21 108.248 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.53 ' HG2' ' HA ' ' G' ' 307' ' ' THR . 50.1 tp60 -147.35 144.59 28.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.034 0.445 . . . . 75.02 111.209 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.472 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.3 pp -93.7 139.76 17.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.09 -0.959 . . . . 70.15 108.451 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -110.55 -51.09 2.9 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.863 -0.421 . . . . 63.03 109.863 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -166.79 128.86 1.75 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.777 -0.647 . . . . 71.12 110.312 -170.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.55 143.05 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 106.838 -1.541 . . . . 73.25 106.838 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.493 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.2 p90 -174.34 158.67 2.95 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.575 0.625 . . . . 72.44 111.291 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -81.29 119.26 23.43 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.09 -0.708 . . . . 71.32 109.09 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.7 mmmm -73.39 -42.0 62.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 169.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 32.3 t70 -143.95 142.33 30.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.777 -1.101 . . . . 61.13 110.526 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -139.74 143.65 30.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.521 1.528 . . . . 74.02 107.2 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 30.8 t -158.76 151.38 21.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.275 0.559 . . . . 72.11 110.283 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -150.41 125.66 10.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.767 -1.198 . . . . 72.43 107.767 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.26 140.53 49.67 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.291 0.636 . . . . 52.01 110.215 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.59 77.65 22.61 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.787 -1.56 . . . . 75.33 106.787 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.94 -32.78 65.3 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.064 2.51 . . . . 65.44 112.467 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' C' ' 30' ' ' HIS . 9.2 p30 -112.22 45.49 1.27 Allowed 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.815 0.846 . . . . 44.44 109.677 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.574 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -53.31 -41.34 85.94 Favored Pre-proline 0 CA--C 1.577 1.995 0 N-CA-C 114.697 1.369 . . . . 65.34 114.697 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.7 -37.9 1.1 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 121.744 1.63 . . . . 64.24 112.97 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.714 ' HB3' ' HB2' ' C' ' 27' ' ' ASN . 75.5 t60 -69.19 -21.9 63.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.317 1.047 . . . . 65.12 112.338 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.69 -13.84 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.667 0.787 . . . . 74.43 112.566 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.55 -15.45 60.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.563 -0.71 . . . . 71.15 112.301 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -109.1 21.67 16.88 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.578 0.751 . . . . 71.33 110.355 172.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.548 ' HZ3' ' HB2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -82.69 136.96 34.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.223 1.009 . . . . 71.32 109.028 175.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.17 123.56 19.41 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.058 -0.719 . . . . 60.21 109.058 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.479 ' HZ2' ' HB3' ' F' ' 302' ' ' ASP . 22.7 m95 -85.16 58.94 5.32 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.55 0.34 . . . . 71.23 111.04 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -156.51 53.91 0.81 Allowed Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 124.367 1.067 . . . . 71.13 109.448 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.08 153.3 36.68 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.927 1.751 . . . . 70.24 112.208 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -84.29 115.59 22.56 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.362 -1.347 . . . . 75.53 107.362 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.24 133.82 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.505 -0.554 . . . . 64.01 109.505 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -123.57 112.13 17.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.205 1.002 . . . . 74.01 108.416 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.432 HD21 HD22 ' C' ' 128' ' ' LEU . 8.4 mp -86.06 133.93 33.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.241 -1.392 . . . . 75.44 107.241 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.447 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.5 t70 -117.36 103.11 9.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.176 -1.416 . . . . 62.1 107.176 172.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.34 112.63 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.876 -1.528 . . . . 73.13 106.876 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.3 t70 -127.8 135.1 49.63 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.157 -0.683 . . . . 51.44 109.157 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -114.94 123.62 49.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.84 0.856 . . . . 74.42 109.952 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.11 34.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.32 0.648 . . . . 71.25 110.168 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.9 p -163.38 152.4 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.185 0.594 . . . . 53.11 110.438 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.2 p -151.25 159.35 44.41 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.81 0.844 . . . . 74.52 109.406 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -75.21 120.61 20.94 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.612 -0.722 . . . . 74.31 110.479 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' C' ' 57' ' ' GLU . 83.3 mt -84.95 -46.32 11.36 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.87 -0.789 . . . . 62.22 108.87 169.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.33 178.27 9.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.532 -1.213 . . . . 72.33 108.88 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -66.05 122.37 17.26 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.34 -0.391 . . . . 73.3 110.052 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 74.55 -5.6 2.08 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.813 1.645 . . . . 64.34 112.599 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -104.9 116.62 49.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 124.035 0.934 . . . . 64.41 109.475 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 135.58 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.411 -0.959 . . . . 73.22 108.411 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.2 tt0 -87.52 120.24 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.799 -0.815 . . . . 53.41 108.799 173.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.31 111.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.399 -0.963 . . . . 74.11 108.399 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.8 t -106.57 127.26 62.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.838 -1.171 . . . . 70.14 107.838 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -130.4 105.48 7.9 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.758 -1.201 . . . . 72.23 107.758 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 24.0 ttm180 -82.65 125.12 30.84 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.855 -0.611 . . . . 71.45 109.614 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -116.71 106.97 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.791 -1.559 . . . . 71.11 106.791 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.4 m -116.29 114.05 23.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.521 0.677 . . . . 64.23 109.618 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.93 111.36 35.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 114.619 -1.173 . . . . 65.12 108.486 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 13.8 m -111.33 125.86 54.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.471 0.708 . . . . 71.02 110.238 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.86 116.83 31.92 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.338 -1.356 . . . . 60.43 107.338 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.5 m -148.39 152.65 37.36 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.827 0.451 . . . . 64.41 110.78 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.497 HD23 ' HD2' ' C' ' 34' ' ' LYS . 4.1 mm? -95.37 26.98 3.53 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.63 1.172 . . . . 73.02 110.203 172.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.85 -104.95 0.95 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.36 -25.47 21.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.359 0.664 . . . . 72.51 110.261 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.54 113.62 21.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.056 0.942 . . . . 65.13 109.679 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.3 m -88.88 129.65 35.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.944 0.497 . . . . 51.24 111.525 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 -57.83 4.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.961 . . . . 44.14 109.728 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.73 155.04 29.21 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.503 -0.771 . . . . 72.02 109.941 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.455 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -117.02 145.28 43.78 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.367 -1.345 . . . . 73.43 107.367 171.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.455 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.9 t -150.07 131.86 15.05 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 173.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -139.79 132.88 29.6 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.526 0.73 . . . . 74.12 110.24 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.62 138.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.867 0.867 . . . . 71.42 109.07 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -113.21 96.65 6.03 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.983 -1.488 . . . . 72.14 106.983 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.7 tp-100 -83.52 107.36 15.94 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.044 -0.526 . . . . 71.0 109.631 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 145.94 18.27 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.788 -0.642 . . . . 71.13 111.68 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.76 117.44 0.91 Allowed Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.518 -1.033 . . . . 23.2 110.518 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.403 HD12 HD11 ' C' ' 51' ' ' LEU . 15.9 mm -81.56 119.73 31.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.627 -0.879 . . . . 71.11 108.627 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.472 ' HE2' HG22 ' C' ' 13' ' ' ILE . 97.3 m-85 -132.52 145.29 51.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.837 0.855 . . . . 63.11 109.552 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 65.9 m -110.69 112.43 24.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.781 0.833 . . . . 41.15 109.287 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.513 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.5 mp -116.11 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.895 -1.15 . . . . 72.12 107.895 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.41 162.75 34.95 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.357 1.063 . . . . 65.51 109.843 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.08 -58.51 4.25 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.944 -0.571 . . . . 53.43 112.258 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.51 168.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.622 0.769 . . . . 54.41 111.536 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.28 -177.22 5.88 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.867 1.267 . . . . 64.42 109.012 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.79 -124.45 36.16 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.772 0.67 . . . . 73.33 113.683 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 49.0 p -70.22 -36.57 74.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.491 1.116 . . . . 73.41 111.953 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -66.16 -36.23 82.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.097 0.559 . . . . 72.13 110.858 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.513 ' HG2' HG21 ' C' ' 86' ' ' ILE . 0.1 OUTLIER -83.14 -33.83 26.18 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.426 0.69 . . . . 75.43 109.971 178.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' F' ' 280' ' ' LEU . . . -60.41 -44.46 95.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.075 0.95 . . . . 72.1 111.263 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -76.8 -26.44 54.42 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.642 -0.708 . . . . 71.22 111.079 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' C' ' 101' ' ' TYR . 47.2 t -73.86 -61.84 1.7 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.739 0.416 . . . . 71.1 110.491 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.66 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 8.4 tt -79.89 -25.5 40.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.404 0.282 . . . . 55.22 110.791 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.547 ' HA3' HD22 ' F' ' 280' ' ' LEU . . . -86.75 -7.16 78.86 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 115.083 0.793 . . . . 51.32 115.083 -174.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -55.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.491 0.646 . . . . 75.12 111.369 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.468 ' O ' HG12 ' C' ' 105' ' ' ILE . 82.8 t80 -65.89 -39.11 90.35 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.998 0.919 . . . . 72.32 111.734 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.66 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 38.3 m -76.37 -47.19 3.39 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.474 -0.774 . . . . 61.44 112.288 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.7 Cg_exo -53.14 -40.36 77.27 Favored 'Trans proline' 0 C--N 1.399 3.206 0 C-N-CA 122.761 2.307 . . . . 54.21 112.891 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.27 -29.34 67.5 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.692 0.797 . . . . 71.23 112.52 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.484 HG23 ' NH1' ' A' ' 111' ' ' ARG . 29.4 mm -75.6 -43.66 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.096 0.558 . . . . 75.25 110.943 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 pp -93.29 -11.07 33.35 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 112.738 0.644 . . . . 73.42 112.738 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -57.44 -49.47 93.66 Favored Pre-proline 0 N--CA 1.491 1.604 0 CA-C-O 117.968 -1.015 . . . . 75.41 112.776 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.99 -31.29 89.5 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 121.94 1.76 . . . . 71.11 112.755 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.584 ' HE2' HG21 ' A' ' 115' ' ' THR . 92.8 m-85 -68.37 -48.5 64.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.951 0.9 . . . . 64.34 111.147 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -58.72 -41.22 85.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 61.41 110.539 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -69.57 -47.73 62.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.954 -1.476 . . . . 74.33 111.252 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.06 -31.92 72.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.161 0.584 . . . . 64.43 109.95 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.417 ' O ' ' SD ' ' C' ' 117' ' ' MET . 43.0 t -63.99 -40.96 97.54 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.551 0.532 . . . . 73.34 110.589 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.419 ' O ' HG23 ' C' ' 118' ' ' VAL . 86.6 mt -68.02 -41.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.329 0.651 . . . . 75.44 110.823 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.469 HG23 ' HB3' ' C' ' 125' ' ' GLN . 30.8 m -62.98 -30.16 71.37 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.432 0.693 . . . . 54.33 110.684 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -74.16 -46.23 43.59 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.922 0.889 . . . . 73.1 109.973 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.469 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.69 -42.71 84.21 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.923 0.889 . . . . 60.33 111.642 177.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.9 t -70.91 -33.99 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.86 0.864 . . . . 74.35 110.185 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.501 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 38.5 t -65.59 -33.02 74.94 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.389 0.676 . . . . 53.21 111.464 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.539 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 73.4 mtt-85 -81.66 -31.89 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.07 0.948 . . . . 73.55 110.618 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 -1.56 86.45 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.791 -0.641 . . . . 73.2 112.29 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 49.6 p 61.88 31.72 18.16 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 126.075 1.75 . . . . 64.55 112.262 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.0 150.06 37.88 Favored Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 114.495 -1.23 . . . . 71.14 109.385 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.533 ' HG2' ' HA ' ' F' ' 297' ' ' TYR . 23.9 Cg_exo -40.3 109.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 124.365 3.377 . . . . 71.35 113.908 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.469 ' HB3' HG23 ' C' ' 115' ' ' THR . 50.6 mt-30 -60.54 142.54 55.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.755 1.222 . . . . 63.43 111.99 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp -121.2 106.5 11.57 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.306 0.642 . . . . 60.14 109.553 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.34 108.44 20.48 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.458 -1.312 . . . . 71.22 107.458 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.432 HD22 HD21 ' C' ' 42' ' ' LEU . 85.2 mt -63.24 144.69 56.71 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.687 0.795 . . . . 73.25 111.868 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.407 ' HB3' HD22 ' F' ' 291' ' ' LEU . . . -67.54 159.57 77.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.838 1.255 . . . . 74.31 111.475 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.418 ' HG2' HG21 ' A' ' 13' ' ' ILE . 22.4 Cg_exo -63.8 104.22 0.45 Allowed 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.528 2.152 . . . . 74.23 111.76 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.97 109.35 23.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.445 -0.946 . . . . 72.15 108.445 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -104.04 88.62 3.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.818 -1.083 . . . . 75.21 109.576 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.62 -37.98 83.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.099 -0.955 . . . . 72.53 108.763 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -67.05 -50.33 62.24 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.895 -1.048 . . . . 65.25 111.83 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' C' ' 138' ' ' MET . . . -66.0 -33.56 76.09 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.113 0.965 . . . . 63.53 112.172 -169.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 94.1 mt -52.27 -47.66 65.7 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.436 1.085 . . . . 71.11 110.8 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -76.3 -38.7 55.71 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.477 -0.783 . . . . 73.24 111.14 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' C' ' 135' ' ' ALA . 88.1 mtp -56.11 -26.66 50.78 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.332 1.053 . . . . 73.51 113.434 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -47.31 -30.88 3.43 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.246 1.019 . . . . 71.11 113.288 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -152.72 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 123.714 0.806 . . . . 75.24 111.8 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 42.4 tp 74.1 119.8 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.801 1.241 . . . . 71.11 111.845 167.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -107.19 125.15 50.74 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.653 0.781 . . . . 73.24 108.925 176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -61.8 127.41 31.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.06 -0.719 . . . . 64.33 109.06 172.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -88.36 -169.99 2.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.562 0.745 . . . . 75.2 111.24 -173.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.86 166.85 10.1 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.968 0.907 . . . . 71.04 109.985 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.35 142.19 8.86 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.431 -0.349 . . . . 62.13 112.75 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -176.35 105.94 0.07 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.487 1.115 . . . . 74.34 108.432 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.45 82.75 0.11 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.95 -0.46 . . . . 32.03 111.95 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p -135.68 96.82 3.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.824 0.85 . . . . 74.53 110.731 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -122.29 111.47 16.95 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.784 -1.191 . . . . 75.35 107.784 167.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -151.47 132.47 14.28 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.234 0.614 . . . . 72.03 109.595 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -154.98 85.69 1.1 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.701 0.8 . . . . 63.34 109.474 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -101.39 88.52 3.48 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.79 -0.819 . . . . 73.43 108.79 170.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -121.38 103.66 9.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.48 0.712 . . . . 72.31 109.391 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.796 0.838 . . . . 62.11 109.113 -177.267 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.406 -0.59 . . . . 74.52 109.406 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 31.3 m 58.69 56.03 4.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.663 0.785 . . . . 63.22 110.486 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -75.12 169.85 17.2 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.123 -0.944 . . . . 74.34 111.861 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -99.96 105.36 17.04 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.718 0.807 . . . . 75.51 110.509 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -173.34 115.07 0.25 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.073 0.949 . . . . 64.13 109.236 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -103.41 87.16 2.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.034 0.534 . . . . 74.25 110.022 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m -67.12 153.04 44.64 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.131 0.573 . . . . 54.02 110.829 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.46 161.24 17.57 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.243 0.617 . . . . 74.52 109.946 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -28.47 122.17 0.12 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 125.922 1.689 . . . . 61.32 114.685 -166.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m -146.49 143.76 29.18 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.141 0.976 . . . . 50.22 108.83 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -174.07 97.1 0.1 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.848 -1.538 . . . . 73.44 106.848 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -133.13 119.81 20.43 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.198 -0.91 . . . . 64.25 108.658 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mt -70.55 107.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 114.711 -1.132 . . . . 71.0 109.482 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.87 -37.64 62.12 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.203 -0.295 . . . . 75.22 110.203 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.42 HH22 ' HB ' ' F' ' 301' ' ' ILE . 7.7 ttt85 -170.5 143.89 2.33 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.963 0.79 . . . . 73.54 109.95 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.622 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.1 OUTLIER -120.29 108.36 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.468 1.107 . . . . 72.4 108.205 175.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -138.25 158.69 43.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.447 1.118 . . . . 63.14 111.195 -170.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -92.56 110.31 21.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.768 -1.56 . . . . 74.51 108.873 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.574 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 41.3 mtpt -74.05 -31.69 62.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.149 0.5 . . . . 73.14 110.124 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -150.61 141.66 23.03 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.781 -1.1 . . . . 63.53 109.367 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.469 HD13 ' HE3' ' C' ' 117' ' ' MET . 28.8 mt -136.55 141.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.825 1.25 . . . . 74.32 107.802 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.2 t -146.55 137.5 24.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.988 0.915 . . . . 72.12 109.656 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -149.32 121.06 8.09 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 106.127 -1.805 . . . . 64.43 106.127 167.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -131.1 124.78 31.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -127.48 82.45 68.23 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.106 -1.072 . . . . 73.13 108.106 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.58 -34.34 5.76 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.866 2.377 . . . . 73.55 112.327 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.47 ' O ' HG23 ' D' ' 31' ' ' VAL . 14.7 m120 -106.98 23.55 14.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.403 1.081 . . . . 75.14 109.573 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.589 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -45.57 -59.77 4.14 Favored Pre-proline 0 CA--C 1.571 1.751 0 C-N-CA 125.194 1.398 . . . . 73.43 114.492 -168.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.19 -16.73 15.45 Favored 'Trans proline' 0 C--N 1.392 2.86 0 CA-C-N 121.886 1.709 . . . . 63.44 113.133 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 12.4 t-160 -68.52 -43.55 76.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.082 0.953 . . . . 73.11 109.972 174.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' D' ' 73' ' ' ALA . 99.0 t -65.62 -34.82 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.857 0.863 . . . . 73.22 110.533 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.28 -7.98 46.67 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.871 1.063 . . . . 70.31 113.871 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.2 mt-30 -84.81 -29.33 25.46 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.102 0.561 . . . . 73.14 111.274 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -109.9 114.26 27.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.76 1.224 . . . . 62.24 108.7 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' G' ' 300' ' ' ASN . 7.2 p-10 -91.11 95.09 9.9 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.312 0.577 . . . . 73.41 112.081 -177.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.406 ' HE3' ' H ' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -146.86 171.29 15.43 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.639 0.776 . . . . 72.52 112.333 175.07 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' G' ' 297' ' ' TYR . 21.8 mp0 -84.22 134.34 43.46 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.094 1.358 . . . . 64.43 111.388 -169.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' G' ' 297' ' ' TYR . 16.6 Cg_exo -68.23 117.55 5.02 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.13 114.301 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.91 114.37 10.98 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.19 -1.411 . . . . 52.44 107.19 163.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.85 123.24 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.65 0.738 . . . . 50.5 110.216 -170.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.625 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 51.7 tttp -93.44 125.59 38.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.841 1.256 . . . . 70.12 109.132 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.451 ' HB2' ' NE1' ' G' ' 290' ' ' TRP . 4.8 tt -97.66 114.62 26.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.662 -1.607 . . . . 72.45 106.662 173.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 15.8 t70 -127.89 129.85 47.55 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.665 -0.865 . . . . 65.31 108.665 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 64.0 tp -122.71 135.61 54.63 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.558 0.743 . . . . 72.04 110.118 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -134.51 148.88 50.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.682 1.193 . . . . 75.54 108.165 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -124.08 149.07 46.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.295 0.638 . . . . 55.44 110.674 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.651 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.39 152.09 35.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.971 0.908 . . . . 64.24 109.266 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.702 ' HB2' HD21 ' G' ' 278' ' ' LEU . 16.6 p -174.8 154.17 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.319 0.648 . . . . 72.14 111.373 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 55.2 p -171.46 158.57 5.26 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.369 1.068 . . . . 41.32 109.81 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -87.5 125.61 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.397 -0.594 . . . . 64.3 109.397 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.4 mt -91.36 -42.23 10.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.363 0.665 . . . . 44.23 110.456 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.15 -172.36 4.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.431 -0.804 . . . . 64.11 110.31 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.73 118.2 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.022 -0.99 . . . . 72.11 109.895 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 66.65 0.81 1.96 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.772 1.629 . . . . 73.23 112.661 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -108.49 124.82 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.048 0.539 . . . . 75.21 109.988 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -127.15 159.88 32.93 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.317 1.047 . . . . 75.24 109.403 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' D' ' 51' ' ' LEU . 39.6 tt0 -118.27 137.29 53.15 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.889 0.876 . . . . 72.43 108.715 174.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.471 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 69.3 t -121.11 121.43 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.509 -1.293 . . . . 71.24 107.509 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.651 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 31.2 t -117.89 129.77 73.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.965 -0.754 . . . . 74.1 108.965 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.33 110.93 20.11 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.636 -0.875 . . . . 72.24 108.636 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 13.7 ttm180 -84.16 99.71 10.69 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.717 -0.846 . . . . 74.24 108.717 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.27 122.38 45.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.116 -0.947 . . . . 73.31 108.487 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.1 m -129.28 130.29 46.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.367 -0.833 . . . . 75.14 109.908 -171.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 82.2 t -124.01 126.43 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.665 1.586 . . . . 72.42 108.146 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 89.2 m -126.42 110.63 13.54 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.76 -0.459 . . . . 61.31 109.76 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.84 124.19 49.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.068 0.547 . . . . 64.35 109.948 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' D' ' 72' ' ' THR . 58.8 m -135.91 119.61 17.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.571 -1.27 . . . . 53.52 107.571 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' D' ' 73' ' ' ALA . 6.8 mp -123.35 133.78 54.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.838 0.855 . . . . 74.21 109.734 -170.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.6 -116.87 5.9 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -112.26 3.76 17.32 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.201 0.6 . . . . 64.3 110.52 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -127.54 164.57 21.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.681 0.792 . . . . 62.53 110.814 -174.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 72' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' D' ' 67' ' ' SER . 53.4 m -86.46 129.98 34.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.147 0.579 . . . . 73.31 110.278 169.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.737 ' HB2' HD13 ' D' ' 68' ' ' LEU . . . -72.39 -68.61 0.46 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.325 0.65 . . . . 64.54 109.47 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.8 152.03 31.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.906 -1.043 . . . . 72.1 111.947 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -119.63 116.64 26.43 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.572 1.549 . . . . 71.54 107.574 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.601 ' SG ' HG23 ' D' ' 114' ' ' ILE . 17.1 t -127.83 134.94 49.45 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.784 -0.451 . . . . 72.21 109.784 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.7 133.71 13.22 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.189 0.596 . . . . 75.4 109.941 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.63 119.78 22.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.656 0.782 . . . . 74.05 109.324 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.506 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 64.6 mt-30 -90.53 88.52 7.18 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 174.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 65.3 tp60 -79.33 97.95 6.51 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.451 -0.795 . . . . 75.13 109.118 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 143.88 16.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.183 -0.767 . . . . 53.45 111.183 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.79 130.96 3.8 Favored Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.224 -1.15 . . . . 70.31 110.224 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.3 mt -90.02 131.82 36.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.94 -0.763 . . . . 74.05 108.94 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.471 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 30.0 m-85 -134.02 125.31 27.85 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.889 -0.782 . . . . 74.41 108.889 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -76.14 103.42 6.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.878 -1.156 . . . . 62.54 107.878 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.533 HG23 HD11 ' D' ' 89' ' ' ILE . 75.0 mt -107.8 132.18 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.358 1.063 . . . . 64.44 109.475 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.66 164.86 19.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.431 0.692 . . . . 62.45 110.948 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.81 47.75 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 115.262 0.865 . . . . 73.14 115.262 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.533 HD11 HG23 ' D' ' 86' ' ' ILE . 15.9 pt -123.97 128.43 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.628 1.171 . . . . 73.42 108.036 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -137.29 159.7 41.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.115 0.566 . . . . 73.1 111.352 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -123.42 31.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 115.46 -0.791 . . . . 73.05 113.201 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -69.19 -25.74 64.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 74.21 111.685 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -72.9 -39.74 66.1 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.385 0.674 . . . . 75.2 110.133 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -31.83 56.18 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.528 -0.545 . . . . 73.43 109.528 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.44 90.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.901 0.88 . . . . 71.5 111.89 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.47 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 17.6 t-80 -61.53 -48.13 82.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.582 -0.736 . . . . 74.02 110.34 172.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.17 -29.36 62.79 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.927 -0.579 . . . . 72.31 112.128 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 29.7 tp -95.52 -51.21 4.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.217 1.007 . . . . 71.34 110.834 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.77 5.18 66.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.702 -0.681 . . . . 44.53 114.057 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.537 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -136.86 -55.96 0.73 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.064 0.432 . . . . 74.22 110.696 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -75.61 -41.24 54.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.809 0.67 . . . . 73.3 112.809 -173.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.24 -46.98 90.85 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.834 -0.603 . . . . 51.14 111.026 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.63 -40.0 87.85 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 122.299 1.999 . . . . 72.44 113.061 165.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -60.98 -28.08 68.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.406 0.682 . . . . 74.11 111.4 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -79.42 -50.54 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.842 0.857 . . . . 74.25 110.921 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.11 -28.63 32.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.057 0.762 . . . . 71.33 113.057 -167.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -65.83 -42.57 54.48 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.21 1.004 . . . . 61.32 112.873 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.19 -37.41 94.26 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 121.922 1.748 . . . . 73.12 113.087 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -77.2 -31.04 55.03 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 64.34 111.887 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.55 -51.91 63.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.299 0.64 . . . . 71.44 109.67 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.502 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.3 ttp180 -55.83 -54.32 45.96 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.074 -1.421 . . . . 74.25 110.396 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.8 -39.22 84.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 75.31 111.58 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -62.21 -47.54 83.99 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.029 0.532 . . . . 64.22 111.02 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.601 HG23 ' SG ' ' D' ' 76' ' ' CYS . 85.5 mt -60.11 -51.73 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.099 0.96 . . . . 73.24 110.225 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.505 HG21 ' HE2' ' B' ' 109' ' ' TYR . 87.0 m -54.71 -43.66 72.78 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.881 1.672 . . . . 64.42 112.452 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.1 t -66.65 -38.49 86.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.486 0.714 . . . . 71.54 110.718 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.1 mtm -72.1 -29.78 64.44 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.771 0.428 . . . . 64.02 111.842 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -64.49 -44.32 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.376 0.67 . . . . 71.33 109.73 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.1 p -72.27 -29.95 64.37 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.07 0.548 . . . . 74.32 111.417 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -69.69 -32.39 70.96 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.583 0.753 . . . . 64.24 110.574 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.76 81.44 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 115.908 -0.587 . . . . 43.43 112.818 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 60.09 21.38 10.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 126.819 2.048 . . . . 65.42 113.311 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -86.74 163.06 42.73 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.957 1.303 . . . . 75.11 109.627 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.71 133.69 20.73 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.114 1.876 . . . . 75.04 110.68 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.8 135.51 56.82 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.752 0.658 . . . . 72.11 111.455 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.65 107.75 18.86 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.134 -1.432 . . . . 55.23 107.134 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 75.8 m-20 -97.81 93.27 6.27 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.069 -1.456 . . . . 74.23 107.069 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -74.18 120.08 19.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.24 -0.891 . . . . 62.4 109.507 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.65 123.22 78.45 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.618 0.767 . . . . 73.53 111.781 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.502 ' HB3' HH12 ' D' ' 111' ' ' ARG . 18.7 Cg_endo -86.86 115.31 1.21 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.082 2.521 . . . . 64.25 111.58 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.8 110.13 30.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.668 -1.234 . . . . 73.52 107.668 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 57.5 t30 -79.03 87.99 4.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.021 0.528 . . . . 74.05 110.208 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -72.39 -19.13 61.66 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.658 -0.701 . . . . 73.22 111.06 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.537 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 20.7 t70 -61.75 -35.55 78.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.629 0.772 . . . . 64.2 111.28 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -59.35 -37.25 77.39 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 124.338 1.024 . . . . 72.12 113.023 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.662 HD13 ' H ' ' B' ' 150' ' ' GLU . 24.5 mt -59.66 -47.71 84.54 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.93 0.892 . . . . 64.1 111.173 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -77.45 -31.03 53.61 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.018 -0.992 . . . . 74.32 110.897 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 33.4 ttm -59.76 -39.41 84.74 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.423 1.489 . . . . 72.44 110.606 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -58.54 -21.84 53.78 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.682 1.239 . . . . 73.12 112.827 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -84.63 -35.95 22.33 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.647 0.779 . . . . 72.1 110.932 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.66 -30.25 46.14 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.014 0.376 . . . . 51.24 112.014 -176.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -88.96 44.5 1.22 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.967 0.507 . . . . 73.24 111.484 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -120.44 46.03 2.08 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.764 0.826 . . . . 41.51 109.829 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -162.31 -81.84 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.412 0.285 . . . . 75.44 111.115 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.97 162.29 31.84 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.503 0.721 . . . . 61.11 111.835 -169.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.25 138.19 3.04 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.796 -0.522 . . . . 53.12 111.796 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -113.63 137.59 51.38 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.694 0.747 . . . . 74.31 110.215 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.82 160.77 11.1 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.554 -0.618 . . . . 63.32 111.554 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 76.4 m -143.88 -90.25 0.12 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.447 0.699 . . . . 74.42 109.252 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.51 152.19 10.07 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.655 -1.239 . . . . 63.32 107.655 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -98.08 118.88 35.68 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.587 -0.894 . . . . 72.43 108.587 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -79.55 82.59 5.65 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.807 -1.183 . . . . 72.23 107.807 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -66.06 90.85 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.515 -1.22 . . . . 74.24 110.619 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -142.96 115.3 8.47 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.411 -1.268 . . . . 71.4 108.583 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 C-N-CA 123.771 0.828 . . . . 70.13 109.792 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 110.377 -0.231 . . . . 61.33 110.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.52 130.83 35.38 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.941 -0.763 . . . . 62.04 108.941 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -96.04 166.75 11.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.33 0.652 . . . . 73.41 110.561 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -167.11 164.23 15.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.04 0.936 . . . . 74.4 110.048 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.15 102.32 1.56 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.25 0.62 . . . . 71.34 110.067 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -71.91 125.71 11.24 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.672 2.248 . . . . 75.01 112.861 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 277' ' ' LEU . . . . . 0.57 HD23 ' SD ' ' A' ' 94' ' ' MET . 0.6 OUTLIER -96.79 31.37 2.36 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.553 -0.906 . . . . 72.25 108.553 170.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 278' ' ' LEU . . . . . 0.416 HD11 ' OG ' ' A' ' 48' ' ' SER . 15.5 tp -164.38 37.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.208 1.003 . . . . 73.11 108.386 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -66.85 -26.93 73.15 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 114.726 -1.125 . . . . 51.34 114.571 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.86 142.72 27.95 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 122.749 0.419 . . . . 75.12 111.002 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -176.92 -21.72 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 O-C-N 124.61 1.194 . . . . 74.32 110.424 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.04 -7.0 31.59 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.657 0.783 . . . . 74.23 112.735 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.82 89.79 0.58 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.992 0.917 . . . . 61.22 110.488 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -99.42 -131.04 7.17 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.335 -0.706 . . . . 52.41 111.335 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.28 74.69 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.711 1.204 . . . . 71.53 111.751 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 65.4 mtt -118.43 142.74 31.91 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 123.739 0.816 . . . . 54.25 109.344 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.78 33.94 0.54 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.218 2.612 . . . . 54.14 113.444 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.61 88.0 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 108.71 -0.848 . . . . 72.11 108.71 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -128.34 44.35 2.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.42 1.088 . . . . 74.23 108.88 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 96.9 m95 73.83 158.36 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.794 1.637 . . . . 75.25 112.979 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 129' ' ' ALA . 3.9 mp -109.42 66.13 0.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.119 -1.4 . . . . 75.03 108.777 -171.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 106.47 -152.3 16.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.224 -0.898 . . . . 71.02 112.626 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.09 120.79 6.19 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.25 2.633 . . . . 64.42 112.748 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 294' ' ' LYS . . . . . 0.555 ' HD3' ' H ' ' E' ' 294' ' ' LYS . 0.0 OUTLIER -114.64 88.21 2.81 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.784 0.802 . . . . 74.44 110.24 -178.49 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.96 83.69 4.78 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.486 -0.931 . . . . 73.24 108.486 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 47.2 m -59.54 -58.09 10.11 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 115.277 -0.874 . . . . 74.43 108.879 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 21.5 m-30 -67.75 89.95 0.27 Allowed 'General case' 0 C--N 1.35 0.624 0 N-CA-C 108.464 -0.939 . . . . 75.12 108.464 168.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -78.67 -2.5 39.47 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.243 -1.344 . . . . 63.32 112.712 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 172.03 -168.66 41.76 Favored Glycine 0 C--O 1.247 0.922 0 N-CA-C 110.748 -0.941 . . . . 42.01 110.748 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -70.94 108.38 4.51 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.077 0.551 . . . . 74.42 109.876 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.442 HG21 HH22 ' B' ' 15' ' ' ARG . 13.8 mt -75.78 -64.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.71 -1.218 . . . . 64.2 107.71 171.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 32.3 t70 58.26 -80.38 0.02 OUTLIER 'General case' 0 C--N 1.359 0.979 0 C-N-CA 125.67 1.588 . . . . 52.23 111.304 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 17.1 pttp 169.0 156.94 0.17 Allowed Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 126.966 2.106 . . . . 52.03 107.841 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.0 120.83 9.02 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.1 1.867 . . . . 71.32 110.928 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 305' ' ' ALA . . . . . 0.815 ' HB3' ' HB3' ' G' ' 295' ' ' ALA . . . -70.41 86.54 0.61 Allowed 'General case' 0 C--N 1.352 0.699 0 CA-C-O 121.786 0.803 . . . . 70.42 110.236 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 306' ' ' VAL . . . . . 0.694 ' HA ' ' HD2' ' G' ' 293' ' ' PRO . 6.6 m -131.51 135.38 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.712 1.605 . . . . 61.23 106.804 170.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 15.4 t -163.22 20.85 0.08 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.753 0.311 . . . . 73.4 111.062 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.52 128.38 33.23 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 122.111 -0.368 . . . . 62.04 110.434 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' E' E ' 309' ' ' THR . . . . . 0.559 HG22 HD23 ' G' ' 291' ' ' LEU . 23.1 p -130.49 158.46 74.47 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.698 1.199 . . . . 63.32 109.304 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' E' E ' 310' ' ' PRO . . . . . 0.599 ' HB2' HG21 ' B' ' 7' ' ' THR . 19.2 Cg_endo . . . . . 0 C--N 1.377 2.039 0 C-N-CA 122.595 2.197 . . . . 70.22 111.412 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 109.533 -0.543 . . . . 62.53 109.533 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -98.24 119.41 36.86 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.654 0.781 . . . . 75.55 109.169 178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -82.0 77.27 8.84 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.354 0.662 . . . . 75.01 111.177 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.68 -33.28 68.69 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.73 0.812 . . . . 73.42 109.982 167.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -64.1 129.16 93.82 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.09 -0.959 . . . . 65.31 109.245 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.27 107.31 0.47 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.978 1.786 . . . . 72.31 109.998 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 277' ' ' LEU . . . . . 0.412 ' HG ' ' HG3' ' C' ' 94' ' ' MET . 17.0 tp -69.72 2.59 3.15 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 125.06 1.344 . . . . 73.23 112.809 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.517 HD22 HD22 ' C' ' 98' ' ' LEU . 19.6 mt -71.3 161.79 30.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.979 1.312 . . . . 71.34 111.602 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -154.87 25.33 0.63 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.8 -0.636 . . . . 65.34 112.023 173.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 280' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' C' ' 95' ' ' ALA . 8.7 tt -165.6 -62.61 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.339 0.656 . . . . 74.14 109.282 -173.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 281' ' ' PHE . . . . . 0.45 ' HB2' ' HA2' ' C' ' 99' ' ' GLY . 38.6 t80 -65.05 133.76 52.35 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.185 -0.916 . . . . 62.35 110.132 -173.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 71.95 147.2 0.08 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.894 1.371 . . . . 61.22 111.288 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 68.45 -72.3 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.002 1.321 . . . . 63.45 111.218 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -86.01 60.08 4.65 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 112.182 -0.367 . . . . 73.24 112.182 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -82.52 144.08 30.65 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.028 0.531 . . . . 73.33 110.395 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 63.9 ttp -102.38 103.6 32.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 108.253 -1.018 . . . . 74.24 108.253 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.11 108.58 2.5 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.479 2.12 . . . . 62.3 111.981 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 58.9 t -74.33 90.38 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 108.818 -0.808 . . . . 72.45 108.818 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 36.8 ttp-105 -84.14 80.19 9.27 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.719 -1.128 . . . . 75.22 108.541 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 13.2 m95 65.96 168.07 0.21 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 114.098 -1.41 . . . . 74.3 113.821 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' C' ' 129' ' ' ALA . 4.8 mp -119.85 -33.09 4.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.229 -1.35 . . . . 65.32 109.905 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -159.21 -100.94 0.17 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-O 118.961 -0.911 . . . . 63.12 112.198 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.75 154.25 63.92 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.019 2.479 . . . . 65.02 112.24 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.5 14.92 4.08 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.519 0.727 . . . . 74.54 112.454 -176.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -102.19 155.53 18.15 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.963 0.505 . . . . 71.32 110.923 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 72.7 m -134.96 163.69 29.28 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.69 1.196 . . . . 55.22 108.168 173.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.533 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 48.9 m-85 69.36 -89.08 0.03 OUTLIER 'General case' 0 C--N 1.353 0.72 0 C-N-CA 125.219 1.408 . . . . 74.52 109.532 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 51.77 32.96 10.3 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.81 1.244 . . . . 72.04 111.248 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -164.58 144.25 9.22 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 114.826 -1.079 . . . . 71.53 111.424 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -73.72 77.82 1.55 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.237 1.015 . . . . 71.15 110.739 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.42 ' HB ' HH22 ' D' ' 15' ' ' ARG . 32.0 pt -78.44 -13.16 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 116.304 -0.407 . . . . 74.42 110.813 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 302' ' ' ASP . . . . . 0.479 ' HB3' ' HZ2' ' C' ' 36' ' ' TRP . 3.9 p30 -57.24 -26.58 60.97 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.308 1.043 . . . . 72.43 112.288 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -66.75 115.03 20.61 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 123.958 0.786 . . . . 74.34 109.821 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.5 97.34 1.14 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.201 1.934 . . . . 71.32 111.889 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -87.28 17.64 4.25 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.814 0.846 . . . . 51.1 111.031 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 93.1 t -102.22 -68.34 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.596 1.158 . . . . 63.01 109.031 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 77.5 p 43.59 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.795 1.638 . . . . 74.03 113.184 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 18.0 p -161.75 168.71 22.75 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.703 -1.221 . . . . 73.23 107.703 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 9.6 m -128.43 68.54 77.66 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-N 117.934 0.334 . . . . 74.44 110.598 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--N 1.389 2.672 0 C-N-CA 123.954 3.103 . . . . 52.33 111.631 175.371 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.681 -0.488 . . . . 55.54 109.681 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -64.5 91.67 0.08 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.88 0.472 . . . . 73.34 110.061 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -82.09 94.63 7.25 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.09 -1.078 . . . . 71.23 108.09 170.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -162.64 170.72 18.03 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-N 114.24 -1.345 . . . . 74.22 108.514 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 12.8 mptt 68.91 145.57 0.11 Allowed Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 124.69 1.196 . . . . 73.11 110.644 -173.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.87 177.0 1.53 Allowed 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.036 1.824 . . . . 73.22 111.659 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 36.9 mt -85.01 38.0 0.69 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.565 0.698 . . . . 62.01 110.447 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 278' ' ' LEU . . . . . 0.702 HD21 ' HB2' ' D' ' 48' ' ' SER . 0.4 OUTLIER -156.35 136.82 13.11 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.231 -1.396 . . . . 74.33 107.231 -175.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 165.22 -49.38 0.28 Allowed Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.88 -0.2 . . . . 71.43 113.269 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.37 77.58 3.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.519 0.728 . . . . 73.25 111.645 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -143.38 2.52 1.27 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.859 1.264 . . . . 72.14 110.379 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -102.8 153.78 19.84 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.536 0.734 . . . . 52.34 110.396 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -71.0 95.76 1.22 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.349 0.66 . . . . 71.03 109.854 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.57 -75.1 0.37 Allowed Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.825 -0.51 . . . . 74.33 111.825 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -157.52 23.31 0.29 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 107.945 -1.131 . . . . 71.41 107.945 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 72.9 mmm -90.02 117.33 67.99 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.337 1.055 . . . . 75.14 110.262 -170.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -93.02 154.72 2.66 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.888 2.392 . . . . 75.24 112.426 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.93 -61.82 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 107.855 -1.165 . . . . 75.33 107.855 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 289' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' B' ' 154' ' ' ASP . 71.2 mtp180 60.5 -86.54 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 125.454 1.502 . . . . 62.44 110.725 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.631 ' HE3' ' H ' ' G' ' 291' ' ' LEU . 0.8 OUTLIER -179.68 159.57 0.88 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.397 1.479 . . . . 74.11 108.905 -176.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.631 ' H ' ' HE3' ' G' ' 290' ' ' TRP . 4.7 mp -125.21 143.67 50.83 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.226 1.01 . . . . 63.3 108.929 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 82.9 167.65 41.47 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 116.304 -0.407 . . . . 61.44 113.582 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 293' ' ' PRO . . . . . 0.694 ' HD2' ' HA ' ' E' ' 306' ' ' VAL . 61.2 Cg_endo -69.9 -20.26 34.39 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.877 2.385 . . . . 64.42 112.57 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 294' ' ' LYS . . . . . 0.472 ' HD3' ' CG ' ' G' ' 290' ' ' TRP . 7.1 mtmp? 68.39 89.85 0.1 Allowed 'General case' 0 C--N 1.362 1.109 0 C-N-CA 125.097 1.359 . . . . 71.11 111.333 174.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 295' ' ' ALA . . . . . 0.815 ' HB3' ' HB3' ' E' ' 305' ' ' ALA . . . -141.13 78.42 1.64 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.998 -1.112 . . . . 31.04 107.998 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m -62.26 -37.73 86.56 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.729 -1.123 . . . . 71.32 111.497 -171.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.593 ' HB2' ' HD3' ' D' ' 38' ' ' PRO . 0.1 OUTLIER -91.11 115.32 27.93 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.607 -1.257 . . . . 73.11 107.607 171.513 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -97.08 10.58 38.93 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.582 0.23 . . . . 61.13 110.632 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -167.51 -155.84 9.52 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.587 -0.279 . . . . 44.43 113.627 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 300' ' ' ASN . . . . . 0.427 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 23.8 t-20 -68.58 151.1 47.21 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.061 0.945 . . . . 73.43 111.242 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 301' ' ' ILE . . . . . . . . . . . . . 16.9 tt -98.08 -38.06 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.47 0.708 . . . . 72.15 112.315 -173.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.68 157.09 32.05 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.33 0.652 . . . . 51.33 110.02 -173.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -113.21 102.79 55.26 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.536 0.734 . . . . 75.21 109.882 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.59 80.02 0.86 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.841 2.36 . . . . 74.14 111.114 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -83.71 177.38 8.39 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.183 -0.917 . . . . 63.01 110.406 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.445 HG23 ' NE2' ' C' ' 12' ' ' GLN . 9.3 m -59.18 149.98 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.276 0.631 . . . . 72.54 110.943 174.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 307' ' ' THR . . . . . 0.53 ' HA ' ' HG2' ' C' ' 12' ' ' GLN . 11.5 t -151.09 18.69 0.77 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.75 0.42 . . . . 74.43 111.358 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 31.4 m -126.28 80.3 1.91 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.744 0.418 . . . . 72.34 110.915 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' G' G ' 309' ' ' THR . . . . . 0.4 ' OG1' ' HD3' ' G' ' 310' ' ' PRO . 0.8 OUTLIER -91.37 -51.03 0.31 Allowed Pre-proline 0 CA--C 1.567 1.618 0 CA-C-O 118.258 -0.877 . . . . 75.53 111.892 172.172 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' G' G ' 310' ' ' PRO . . . . . 0.4 ' HD3' ' OG1' ' G' ' 309' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.396 3.068 0 C-N-CA 122.454 2.103 . . . . 61.53 111.705 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.874 0.368 . . . . 65.11 110.419 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -121.16 109.43 14.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.04 -1.096 . . . . 74.34 108.04 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -173.16 124.14 0.41 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.724 0.81 . . . . 74.15 109.08 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -147.57 131.19 16.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.312 0.645 . . . . 73.25 109.534 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.23 133.54 21.98 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 123.765 0.826 . . . . 61.52 109.711 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.95 155.14 15.05 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.752 2.301 . . . . 75.44 111.377 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.89 -10.36 59.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.415 0.686 . . . . 73.13 112.239 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 278' ' ' LEU . . . . . 0.438 HD22 HD22 ' B' ' 98' ' ' LEU . 71.9 mt -58.86 -45.02 91.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.469 0.708 . . . . 74.14 111.226 -177.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 75.89 -76.39 1.4 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.253 -0.885 . . . . 54.34 112.088 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 280' ' ' LEU . . . . . 0.411 HD13 ' H ' ' H' ' 283' ' ' ASP . 3.3 pp -153.46 157.55 40.04 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.464 1.106 . . . . 71.53 109.311 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -100.77 91.94 4.85 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.938 -0.764 . . . . 74.35 108.938 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . 48.35 69.23 0.57 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.858 1.263 . . . . 43.4 112.591 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 283' ' ' ASP . . . . . 0.411 ' H ' HD13 ' H' ' 280' ' ' LEU . 36.2 t70 -94.16 143.17 26.61 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.317 -0.401 . . . . 75.33 111.124 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 138.17 -164.69 25.56 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.607 -0.724 . . . . 32.34 112.379 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -133.54 139.54 46.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.187 0.995 . . . . 74.41 109.407 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 54.8 ttp -165.31 102.43 0.77 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.049 0.939 . . . . 75.32 108.738 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.57 98.03 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.346 2.698 . . . . 64.53 113.48 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 288' ' ' VAL . . . . . 0.512 HG11 HG11 ' B' ' 131' ' ' VAL . 56.1 t -126.69 95.61 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.643 1.177 . . . . 65.22 108.566 176.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -125.49 -156.46 0.73 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.176 0.99 . . . . 74.13 108.596 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -64.89 122.05 16.07 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-N 118.098 0.408 . . . . 72.1 110.993 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -25.64 63.44 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.107 0.88 . . . . 55.51 111.16 168.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -178.62 96.64 0.1 Allowed Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.018 -0.833 . . . . 52.14 111.018 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.31 34.72 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.696 2.931 . . . . 70.2 112.972 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.15 3.71 41.37 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.163 0.985 . . . . 62.25 110.53 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.21 159.28 28.63 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.668 0.787 . . . . 71.32 110.494 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 9.0 m 72.4 155.32 0.15 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.657 1.183 . . . . 61.2 111.507 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.459 ' H ' ' HG2' ' B' ' 124' ' ' PRO . 15.3 m-85 67.99 7.76 6.03 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.161 1.384 . . . . 63.22 112.081 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -95.84 76.29 3.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.997 -1.112 . . . . 70.43 107.997 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 119.7 170.55 14.49 Favored Glycine 0 C--O 1.247 0.923 0 CA-C-N 114.215 -1.357 . . . . 74.23 111.085 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 23.3 m120 65.77 -176.93 0.18 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.688 1.195 . . . . 71.34 111.027 -173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 25.8 pt 46.94 25.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 126.038 1.735 . . . . 55.13 112.923 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -67.21 -37.86 84.33 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 124.697 1.199 . . . . 62.41 110.717 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 303' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' H' ' 303' ' ' LYS . 0.1 OUTLIER -136.08 92.26 16.32 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.01 -0.995 . . . . 62.41 108.997 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.85 157.13 55.72 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.525 2.15 . . . . 73.43 110.826 169.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 70.69 122.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.768 1.227 . . . . 62.24 111.172 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 52.6 t -61.66 -41.38 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.36 0.664 . . . . 71.41 110.163 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 5.7 m 54.89 80.39 0.13 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.318 1.447 . . . . 72.2 111.917 173.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 57.7 m 69.51 139.44 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.166 1.386 . . . . 73.4 112.34 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 24.6 p -112.99 94.55 30.36 Favored Pre-proline 0 N--CA 1.476 0.837 0 N-CA-C 108.619 -0.882 . . . . 72.14 108.619 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--N 1.379 2.171 0 C-N-CA 123.095 2.53 . . . . 75.05 112.144 -178.564 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.77 ' HA ' ' HA ' ' C' ' 149' ' ' THR . 61.9 mtt . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 109.614 -0.513 . . . . 75.11 109.614 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.6 m 66.9 37.54 3.96 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.199 1.0 . . . . 62.53 113.569 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -87.71 173.83 8.77 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.933 -0.766 . . . . 74.53 108.933 166.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.55 91.86 7.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 106.62 -1.622 . . . . 63.04 106.62 167.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -109.54 117.27 33.52 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.359 0.664 . . . . 73.21 109.884 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -143.98 121.52 11.76 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.208 -1.034 . . . . 72.22 108.208 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' C' ' 144' ' ' GLN . 31.5 p -116.93 162.04 18.39 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.62 0.768 . . . . 64.04 110.922 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -65.22 125.45 25.07 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.96 0.904 . . . . 71.3 110.05 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 82.1 mtp -116.09 161.63 18.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.524 0.73 . . . . 62.43 109.622 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.3 m -141.23 126.69 18.79 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.731 -1.211 . . . . 75.04 107.731 172.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.738 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.4 t80 -135.63 132.82 37.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.725 0.41 . . . . 73.33 110.028 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' NE2' ' HA ' ' H' ' 307' ' ' THR . 53.6 tp60 -152.9 114.31 4.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.824 . . . . 73.52 108.794 172.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.639 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -83.13 119.79 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.797 -0.446 . . . . 74.32 109.797 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -87.19 -31.05 20.55 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.463 0.705 . . . . 74.0 109.651 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -163.43 142.17 8.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.757 -0.201 . . . . 53.33 110.999 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -130.94 140.27 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 124.553 1.141 . . . . 53.21 108.166 170.083 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 40.3 p90 -172.76 167.95 5.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.662 0.744 . . . . 72.14 111.023 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -95.88 119.04 33.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.961 -1.018 . . . . 75.45 108.729 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 29.7 mtpt -81.87 -23.46 36.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.111 0.481 . . . . 63.12 110.464 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.2 t70 -154.58 144.15 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.97 -1.014 . . . . 72.45 110.026 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.7 mt -137.26 144.36 32.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.887 1.675 . . . . 72.25 106.987 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -153.71 125.99 7.99 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.258 0.551 . . . . 63.11 110.033 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 90.1 t80 -124.1 120.85 33.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.939 -1.874 . . . . 74.2 105.939 168.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 35.4 mt-10 -126.95 108.41 10.94 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.715 0.689 . . . . 74.41 110.702 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -112.18 79.02 2.64 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 106.424 -1.695 . . . . 55.03 106.424 168.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.4 -46.12 3.1 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.388 2.058 . . . . 72.13 111.192 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.8 m-20 -100.81 28.38 5.24 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.914 -1.039 . . . . 74.02 108.874 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -41.47 -56.77 4.28 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.038 -0.982 . . . . 63.42 113.093 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -63.19 -30.32 74.49 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 121.794 1.663 . . . . 62.21 112.878 178.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.5 m80 -79.53 -30.2 41.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.748 0.819 . . . . 74.11 111.279 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -82.25 -18.39 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.55 0.34 . . . . 54.2 110.939 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -75.96 -31.07 58.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.203 0.601 . . . . 73.11 110.498 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -82.19 -18.96 40.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.768 0.427 . . . . 75.2 110.595 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -68.82 142.09 54.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.873 0.469 . . . . 71.41 110.166 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.47 139.46 58.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.156 0.582 . . . . 64.33 109.847 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.419 ' CZ2' ' HA ' ' E' ' 300' ' ' ASN . 8.1 m95 -66.66 90.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.078 0.861 . . . . 71.41 109.889 -171.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 94.1 mt-30 -133.81 63.11 61.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.365 1.066 . . . . 74.51 108.389 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.452 ' HG3' ' HB3' ' E' ' 297' ' ' TYR . 91.4 Cg_endo -81.47 133.29 8.35 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.212 1.941 . . . . 43.31 112.063 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.47 91.96 6.05 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.523 -1.288 . . . . 75.12 107.523 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.5 t -78.38 107.56 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -94.27 156.78 16.36 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.317 1.047 . . . . 72.33 109.69 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 128' ' ' LEU . 3.5 tt -137.82 109.01 6.81 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.363 -0.977 . . . . 74.54 108.363 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.4 m-20 -125.46 141.88 51.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.178 0.991 . . . . 73.22 109.252 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.24 126.67 37.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 63.34 109.245 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -118.82 129.08 55.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.675 1.19 . . . . 75.05 108.622 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.8 p -110.38 144.9 38.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.859 0.864 . . . . 70.35 110.339 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.22 131.78 12.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.166 0.586 . . . . 74.12 110.55 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -133.81 151.92 51.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.235 0.614 . . . . 70.41 109.994 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.3 t -154.71 162.19 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.652 0.781 . . . . 72.11 109.672 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -109.22 113.17 25.78 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.762 0.825 . . . . 72.01 108.784 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB2' HG12 ' A' ' 55' ' ' VAL . 65.5 mt -82.79 -33.63 27.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.259 0.624 . . . . 64.24 110.301 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -170.91 -174.42 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.337 1.055 . . . . 73.04 109.989 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.98 123.2 19.18 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.084 0.554 . . . . 65.45 109.738 173.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 67.52 -4.43 0.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.455 1.502 . . . . 74.22 112.943 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.3 t -112.1 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.241 -1.022 . . . . 63.53 108.241 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.82 167.14 16.2 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.103 0.961 . . . . 64.2 108.611 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -129.58 138.8 51.49 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.427 0.691 . . . . 74.51 109.326 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -126.66 129.07 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.415 -1.328 . . . . 73.34 107.415 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.65 131.6 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.118 0.967 . . . . 75.31 109.068 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.6 103.45 9.71 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.987 -1.116 . . . . 70.34 107.987 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.645 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 9.8 ttp180 -84.74 110.51 18.84 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.453 -0.573 . . . . 72.51 109.453 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 114' ' ' ILE . 12.4 t -92.92 128.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.394 -1.336 . . . . 72.23 107.394 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 16.8 m -123.9 126.83 47.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.471 -0.566 . . . . 61.35 109.471 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.762 HG11 HD21 ' A' ' 126' ' ' LEU . 47.2 t -125.0 131.72 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.767 1.227 . . . . 73.22 107.823 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.6 m -116.38 151.64 35.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.702 -0.851 . . . . 63.34 108.702 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.54 115.69 11.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.926 -1.509 . . . . 64.14 106.926 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.8 t -130.02 128.21 41.52 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.99 0.424 . . . . 55.2 110.228 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD21 ' HE2' ' E' ' 297' ' ' TYR . 8.2 mp -90.3 85.74 6.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.687 1.195 . . . . 64.43 107.984 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.43 -98.28 2.08 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 114.822 -1.081 . . . . 65.45 110.534 -172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.68 -5.03 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.4 0.68 . . . . 74.41 110.01 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -85.83 100.8 12.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.005 -1.109 . . . . 73.31 108.005 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 59.8 m -71.21 129.66 39.46 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.269 0.556 . . . . 72.23 111.671 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.24 -59.74 2.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.06 -1.427 . . . . 74.22 109.897 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.594 ' HE2' HD22 ' A' ' 126' ' ' LEU . 43.1 p90 -159.57 136.9 9.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.322 -0.854 . . . . 72.11 111.4 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 tp -112.54 107.85 16.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.054 1.342 . . . . 74.52 107.495 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.614 ' HB3' HG23 ' A' ' 114' ' ' ILE . 72.6 m -107.93 106.05 16.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.809 0.844 . . . . 61.45 111.156 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 63' ' ' THR . 40.8 tt0 -127.64 125.04 39.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.928 1.291 . . . . 71.31 109.186 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.43 115.32 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.872 0.869 . . . . 52.12 109.752 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.645 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 73.4 mt-30 -83.36 89.33 7.01 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.378 -0.971 . . . . 63.52 108.378 168.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.8 tp60 -83.12 106.4 14.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.444 -0.947 . . . . 73.4 108.444 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.2 -177.38 19.13 Favored Glycine 0 N--CA 1.465 0.614 0 O-C-N 123.528 0.518 . . . . 41.35 112.422 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.3 155.71 15.65 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 112.443 -0.263 . . . . 51.23 112.443 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -90.34 115.84 30.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.873 -0.788 . . . . 65.02 108.873 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.738 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -121.1 119.67 33.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.946 0.899 . . . . 75.42 109.564 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 t -83.33 97.94 9.19 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.685 -0.858 . . . . 64.45 108.685 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.6 pt -112.53 142.9 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.603 0.761 . . . . 71.05 110.386 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -154.81 164.33 38.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.098 0.959 . . . . 55.44 110.184 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.36 -5.89 83.33 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.86 -0.609 . . . . 71.22 113.925 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 94' ' ' MET . 18.8 pt -114.57 144.79 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.008 0.923 . . . . 75.13 111.118 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -163.18 172.18 15.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.754 0.822 . . . . 72.33 108.783 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.47 -124.6 11.9 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.692 0.637 . . . . 73.22 114.692 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -74.8 -23.62 58.52 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.867 0.867 . . . . 72.45 111.399 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -68.04 -36.98 80.81 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 63.15 109.411 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG3' HD12 ' A' ' 89' ' ' ILE . 24.8 ttt -81.55 -24.68 36.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.715 -0.675 . . . . 72.53 110.822 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.05 85.48 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.852 0.461 . . . . 72.32 111.115 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -68.25 -37.17 80.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.404 -0.816 . . . . 65.22 110.781 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.3 t -73.82 -42.33 61.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 53.4 111.647 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.38 -47.3 20.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.365 0.666 . . . . 62.14 110.264 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.4 -2.69 88.99 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 115.077 0.791 . . . . 55.04 115.077 -170.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.11 -56.75 0.23 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 117.91 0.855 . . . . 74.3 112.279 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.8 t80 -64.78 -47.76 76.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.731 1.213 . . . . 72.14 113.065 -168.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.32 -35.5 1.17 Allowed Pre-proline 0 CA--C 1.57 1.727 0 CA-C-O 118.851 -0.595 . . . . 62.43 112.502 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.85 -39.68 48.64 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.77 2.314 . . . . 60.41 113.295 161.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -61.1 -25.93 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.42 0.688 . . . . 64.14 111.419 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.451 HG21 ' CD1' ' A' ' 13' ' ' ILE . 36.1 mm -78.95 -55.42 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.695 0.798 . . . . 72.05 110.227 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.95 -24.46 33.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.75 1.018 . . . . 72.45 113.75 -165.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -64.13 -41.57 62.49 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.382 -0.818 . . . . 71.31 112.68 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.34 -43.17 61.15 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 122.095 1.863 . . . . 73.52 113.225 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -67.95 -38.62 83.03 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.441 0.696 . . . . 74.0 112.092 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 -45.96 76.3 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.684 -0.487 . . . . 61.1 109.684 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -53.71 -46.49 70.79 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.576 1.173 . . . . 75.34 110.755 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.23 -49.37 72.2 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.43 1.081 . . . . 73.42 111.148 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.7 t -58.22 -41.47 84.13 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.834 0.709 . . . . 70.25 110.735 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 76' ' ' CYS . 78.7 mt -64.94 -48.49 83.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 O-C-N 124.097 0.873 . . . . 52.51 109.958 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.648 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.0 m -51.76 -49.98 61.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.133 0.973 . . . . 74.21 111.768 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -64.02 -42.94 96.94 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.088 0.867 . . . . 64.32 110.409 -175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.432 ' SD ' HG23 ' A' ' 21' ' ' ILE . 5.7 mtp -56.38 -46.76 79.95 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.835 0.854 . . . . 72.02 111.442 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 126' ' ' LEU . 77.5 t -65.69 -44.2 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.195 0.998 . . . . 71.24 111.68 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.7 p -67.66 -31.35 71.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.981 0.513 . . . . 72.21 111.346 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 88.3 mtt-85 -68.02 -29.6 68.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.602 0.761 . . . . 54.21 110.858 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.47 3.04 80.2 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.177 -0.465 . . . . 54.2 113.547 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.423 ' HB ' HH21 ' B' ' 15' ' ' ARG . 6.8 m 63.74 35.75 11.09 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.808 1.243 . . . . 75.34 110.045 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.419 ' HD1' ' HE1' ' E' ' 297' ' ' TYR . 93.6 m-85 -105.58 151.66 39.86 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 114.547 -1.206 . . . . 72.12 108.386 170.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.05 147.87 91.38 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.431 2.087 . . . . 70.35 111.94 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.648 ' HG3' HG23 ' A' ' 115' ' ' THR . 24.2 tt0 -52.9 128.67 27.83 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.772 0.829 . . . . 63.35 112.472 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.762 HD21 HG11 ' A' ' 64' ' ' VAL . 38.4 tp -108.48 118.44 36.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.256 0.623 . . . . 74.54 109.419 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -140.05 109.05 6.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.162 0.985 . . . . 62.35 108.939 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 42' ' ' LEU . 17.9 tp -67.48 135.74 53.54 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.198 0.599 . . . . 63.42 110.544 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -53.52 133.29 54.2 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.647 1.179 . . . . 63.41 112.293 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD3' HD12 ' C' ' 13' ' ' ILE . 6.0 Cg_exo -78.3 92.88 1.11 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.039 2.493 . . . . 75.01 110.864 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 66.9 t -100.54 126.85 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.222 -1.029 . . . . 65.33 108.222 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 40.9 t-20 -73.28 98.69 2.72 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.357 0.663 . . . . 71.4 110.143 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.08 -27.15 62.48 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.928 0.891 . . . . 75.31 110.756 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 7.1 t70 -63.55 -42.04 98.39 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.904 0.881 . . . . 74.31 110.587 175.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.31 -35.11 69.43 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.01 0.819 . . . . 64.31 111.639 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.05 -51.46 66.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.114 0.565 . . . . 71.52 109.521 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -66.98 -29.2 68.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.751 0.82 . . . . 43.31 112.472 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 82.0 mmm -78.87 -39.22 35.81 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 119.606 -0.235 . . . . 75.45 110.737 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 95.0 m-20 -60.17 -42.63 95.37 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.066 0.546 . . . . 74.42 109.834 174.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -56.71 -41.64 77.79 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.717 1.207 . . . . 72.35 111.449 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.58 -54.22 15.1 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.128 0.268 . . . . 64.24 111.62 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.87 28.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.202 1.001 . . . . 71.22 108.863 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.9 OUTLIER 63.02 -91.35 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.011 -1.107 . . . . 73.41 108.011 -172.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -156.49 133.44 10.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.255 1.422 . . . . 72.15 107.613 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.46 148.93 38.66 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.455 -0.572 . . . . 34.41 109.455 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.57 65.41 3.14 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 123.3 0.375 . . . . 52.34 113.119 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -97.36 124.4 41.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.067 0.947 . . . . 74.41 108.58 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -124.39 75.53 0.39 Allowed Glycine 0 C--N 1.342 0.866 0 N-CA-C 111.212 -0.755 . . . . 72.11 111.212 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.0 p -87.81 124.1 33.28 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.896 0.478 . . . . 72.43 110.801 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -132.39 152.46 51.45 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.394 1.077 . . . . 75.25 109.313 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -149.41 173.22 13.78 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.736 0.814 . . . . 72.31 110.265 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -146.39 125.78 13.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.16 0.984 . . . . 64.42 109.161 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -68.02 109.22 3.38 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.309 0.576 . . . . 61.44 110.061 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.36 -22.0 61.22 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.628 0.771 . . . . 64.1 110.574 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.471 1.109 . . . . 74.34 108.668 176.419 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttm . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.953 -0.388 . . . . 61.24 109.953 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -120.34 109.66 15.62 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.67 -0.863 . . . . 73.44 108.67 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.52 -37.74 80.27 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.697 0.799 . . . . 73.22 110.19 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -75.79 102.87 5.63 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.456 -0.793 . . . . 61.1 108.984 176.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -127.22 153.97 45.43 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.279 1.032 . . . . 63.51 110.047 -170.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.492 HD21 ' HG2' ' B' ' 93' ' ' GLN . 4.9 m-80 -100.24 -179.18 4.05 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.55 -0.907 . . . . 75.23 108.55 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 48.1 m -138.93 -85.8 0.25 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.906 -0.496 . . . . 62.23 110.772 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -102.38 -37.8 7.88 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.154 0.582 . . . . 75.22 110.591 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.565 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 27.8 ttt 65.68 168.4 0.2 Allowed 'General case' 0 CA--C 1.563 1.449 0 O-C-N 124.845 1.341 . . . . 62.14 111.18 -171.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 94.0 m -150.6 101.62 2.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.334 -1.358 . . . . 73.51 107.334 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -116.59 114.71 24.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.0 -1.111 . . . . 72.52 108.0 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -134.75 141.0 46.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.235 0.614 . . . . 74.23 110.344 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -86.2 102.18 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.884 -1.053 . . . . 74.2 110.656 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -77.38 -32.02 54.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 122.019 -0.425 . . . . 62.14 110.055 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.423 HH21 ' HB ' ' A' ' 122' ' ' THR . 37.6 ttt180 -173.75 134.13 0.47 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.19 -0.67 . . . . 63.45 109.19 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.7 mt -113.8 134.62 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 106.915 -1.513 . . . . 74.14 106.915 171.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -166.17 151.24 8.29 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.679 0.752 . . . . 73.52 112.163 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.7 m -77.45 122.12 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.905 -1.043 . . . . 63.31 109.027 170.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.511 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 43.7 mtpt -89.71 -39.33 13.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.141 0.576 . . . . 60.41 111.105 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.3 t70 -150.09 136.04 18.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.57 -0.286 . . . . 74.21 110.632 -169.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.471 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.9 mm -128.59 139.13 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.477 1.111 . . . . 43.24 108.687 173.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -141.56 121.55 13.68 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.719 -1.215 . . . . 50.21 107.719 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.2 t80 -136.19 137.33 40.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.664 -0.865 . . . . 75.14 108.664 172.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.4 mt-10 -136.42 153.35 51.1 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.862 1.265 . . . . 74.03 108.833 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 82.49 7.15 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.833 -1.543 . . . . 74.55 106.833 172.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.62 -46.44 7.01 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.882 2.388 . . . . 73.1 111.712 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -96.89 28.21 3.61 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.928 0.891 . . . . 75.23 109.641 -178.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.582 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -46.86 -51.71 37.26 Favored Pre-proline 0 CA--C 1.568 1.655 0 N-CA-C 114.22 1.193 . . . . 53.21 114.22 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 9.3 Cg_endo -79.56 -24.21 6.49 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.715 1.61 . . . . 73.31 112.538 176.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.463 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.4 m80 -97.09 2.18 50.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.225 1.01 . . . . 74.5 112.81 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.539 HG23 HD11 ' B' ' 68' ' ' LEU . 11.1 p -71.51 -19.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.053 0.941 . . . . 75.21 111.334 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -67.08 -23.12 65.82 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.516 1.127 . . . . 73.03 111.938 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.614 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 28.4 pt20 -69.91 -34.04 72.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.373 0.669 . . . . 71.13 110.44 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.635 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.9 mmtp -107.67 63.71 0.62 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.329 -0.989 . . . . 63.51 108.329 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.05 105.21 14.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.147 -0.686 . . . . 74.13 109.147 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.445 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 162.65 -165.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 127.39 2.276 . . . . 74.24 109.216 159.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.414 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 28.7 pt20 -61.08 127.35 87.74 Favored Pre-proline 0 C--N 1.363 1.159 0 O-C-N 123.248 0.342 . . . . 75.1 111.18 -171.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.11 160.86 15.55 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.542 2.161 . . . . 71.1 112.112 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.19 106.25 3.23 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.999 -1.112 . . . . 71.25 107.999 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.95 158.33 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.346 0.659 . . . . 73.23 111.705 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.0 tttm -143.64 108.84 5.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.377 1.071 . . . . 72.05 109.058 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 tt -86.59 135.47 33.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 106.772 -1.566 . . . . 73.3 106.772 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 16.9 t70 -144.51 147.45 33.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.944 -0.761 . . . . 74.23 108.944 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.4 140.01 53.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.294 -0.632 . . . . 51.23 109.294 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 8.7 t70 -123.49 140.95 52.48 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.403 1.081 . . . . 73.22 108.615 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.0 p -108.81 115.53 30.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.281 -0.872 . . . . 61.33 109.977 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -136.22 133.68 37.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.743 0.817 . . . . 72.3 108.892 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.5 p -144.7 167.68 21.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.326 0.65 . . . . 53.22 110.032 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -150.56 137.38 19.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.19 0.596 . . . . 75.11 110.089 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -90.81 94.73 9.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.455 0.702 . . . . 61.14 109.401 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' B' ' 57' ' ' GLU . 38.5 mt -69.87 -39.41 76.35 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.38 0.609 . . . . 71.05 110.102 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -157.44 -179.59 8.32 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.648 -1.16 . . . . 71.41 109.413 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -67.08 120.43 13.67 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.357 -0.609 . . . . 60.22 109.357 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 73.9 -4.79 2.18 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.375 1.47 . . . . 64.22 112.394 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 87.9 t -104.51 111.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 N-CA-C 108.05 -1.093 . . . . 72.03 108.05 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -126.51 137.6 53.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.602 . . . . 75.33 109.706 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' B' ' 51' ' ' LEU . 6.1 tm-20 -101.64 102.01 12.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.738 -1.579 . . . . 75.21 106.738 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.7 t -95.54 121.92 46.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.67 1.188 . . . . 74.11 110.219 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.1 t -104.95 120.79 56.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 124.731 1.213 . . . . 23.01 109.633 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' B' ' 103' ' ' PRO . 61.7 tp -104.39 104.66 14.57 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.811 -0.811 . . . . 70.24 108.811 172.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 38.5 ttm180 -88.67 114.09 24.92 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.356 -0.609 . . . . 73.22 109.356 173.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.4 t -106.43 112.03 37.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.084 -1.08 . . . . 62.43 108.084 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.9 m -98.2 138.36 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.992 0.917 . . . . 62.42 110.038 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.679 HG21 HG21 ' B' ' 114' ' ' ILE . 55.5 t -127.34 124.3 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.822 1.249 . . . . 55.44 108.355 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 85.0 m -119.18 145.61 45.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.008 -1.108 . . . . 74.33 108.008 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.1 131.72 17.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.673 -0.862 . . . . 73.54 108.673 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.6 p -152.98 126.91 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.088 0.555 . . . . 64.03 110.433 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.1 OUTLIER -104.65 123.75 48.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.816 0.847 . . . . 73.25 109.188 -176.095 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -111.49 3.26 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.14 -1.184 . . . . 60.05 110.14 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.46 6.25 6.93 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 72.25 109.798 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -113.52 143.4 44.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.531 . . . . 72.31 109.745 -176.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 54.4 m -70.0 133.71 47.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.104 0.562 . . . . 71.21 111.932 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -88.55 -59.46 2.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.303 1.041 . . . . 72.12 109.426 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.02 150.4 9.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.896 -1.502 . . . . 75.21 109.242 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.32 123.66 39.89 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 124.819 1.248 . . . . 70.42 107.695 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.7 t -129.85 149.91 51.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.257 -0.645 . . . . 73.42 109.257 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -162.78 132.53 4.39 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.026 -0.731 . . . . 60.12 109.026 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' B' ' 113' ' ' CYS . 85.3 t -126.83 145.62 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.612 0.765 . . . . 35.32 109.505 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -118.01 103.24 9.71 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.288 -1.375 . . . . 72.51 107.288 167.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 32.3 tp60 -93.21 99.48 12.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.378 -1.341 . . . . 61.43 107.378 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 171.62 38.79 Favored Glycine 0 C--O 1.248 1.024 0 N-CA-C 110.724 -0.95 . . . . 72.33 110.724 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.18 126.66 1.16 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.915 -0.659 . . . . 52.41 112.022 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 28.4 mt -84.73 129.0 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.042 -1.096 . . . . 70.43 108.042 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -133.74 150.59 51.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.602 1.161 . . . . 74.01 108.222 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -114.46 114.8 26.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.074 -1.084 . . . . 74.33 108.074 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' B' ' 10' ' ' THR . 46.3 pt -121.02 130.69 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.348 0.659 . . . . 75.03 110.712 -174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.66 171.11 19.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.311 1.045 . . . . 71.25 109.79 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.7 -47.08 3.79 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.091 0.377 . . . . 64.52 112.391 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.425 ' HA ' ' OD1' ' B' ' 6' ' ' ASN . 1.8 pp -70.18 152.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.691 0.797 . . . . 73.33 111.154 169.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -150.41 143.28 24.71 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 111.726 0.269 . . . . 63.4 111.726 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.55 -111.1 2.95 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.99 0.805 . . . . 63.02 113.934 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.448 HG22 HD23 ' B' ' 141' ' ' LEU . 2.8 m -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.97 0.908 . . . . 71.25 110.144 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.492 ' HG2' HD21 ' B' ' 6' ' ' ASN . 25.3 mp0 -76.02 -25.82 56.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.049 0.939 . . . . 73.12 110.327 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 43.7 ttp -73.32 -34.8 65.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.913 0.885 . . . . 73.44 110.307 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.38 68.75 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.604 -0.726 . . . . 71.32 110.814 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.463 ' HB2' HD21 ' B' ' 141' ' ' LEU . 57.1 t-80 -73.56 -24.12 60.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.419 0.687 . . . . 74.43 111.198 173.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -73.59 -63.54 1.18 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.672 0.389 . . . . 64.01 111.024 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.716 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -87.02 -19.23 28.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.577 0.584 . . . . 73.12 112.577 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.71 2.8 52.81 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.83 -0.428 . . . . 63.11 113.972 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -146.39 -46.8 0.19 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.034 0.417 . . . . 64.32 111.43 -177.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -83.23 -38.39 22.31 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 111.577 0.214 . . . . 72.24 111.577 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.716 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.7 m -62.1 -46.54 91.43 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.47 -0.776 . . . . 74.33 111.077 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.652 ' HA ' HD22 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -49.26 -42.2 40.7 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 122.547 2.165 . . . . 62.22 113.878 166.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -58.01 -36.86 73.29 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.547 0.739 . . . . 72.14 111.68 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.402 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 47.3 mt -80.49 -48.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.591 0.756 . . . . 73.35 111.484 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.38 -21.13 53.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.258 0.623 . . . . 74.22 112.167 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.5 -47.73 67.77 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 117.665 -1.159 . . . . 71.3 113.064 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 97.2 Cg_exo -49.98 -45.89 30.57 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.741 2.294 . . . . 73.01 113.917 172.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.8 m-85 -65.61 -43.45 89.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.3 0.64 . . . . 71.25 110.893 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.413 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -66.4 -34.41 77.9 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 115.877 -0.602 . . . . 55.52 110.623 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -59.42 -57.27 13.72 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.152 0.981 . . . . 73.43 110.466 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.18 -33.05 74.64 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.807 0.692 . . . . 71.01 110.307 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.6 t -74.03 -36.44 64.43 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.193 -0.458 . . . . 74.42 111.427 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.679 HG21 HG21 ' B' ' 64' ' ' VAL . 81.6 mt -67.83 -51.77 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 74.01 109.05 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.674 HG23 ' HB2' ' B' ' 125' ' ' GLN . 66.6 m -62.19 -28.33 69.59 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 114.359 -1.292 . . . . 64.23 111.194 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -65.3 -46.34 80.77 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.344 0.658 . . . . 63.52 109.7 174.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.79 -33.02 68.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.999 0.52 . . . . 55.12 111.249 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.41 -41.61 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.407 0.683 . . . . 73.44 109.909 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.1 t -68.68 -31.07 69.92 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.321 -0.854 . . . . 61.12 111.515 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -74.53 -32.27 62.41 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.319 0.648 . . . . 43.2 110.227 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.73 -3.32 83.49 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.443 0.464 . . . . 72.24 112.432 170.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 59.45 51.17 6.8 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 126.424 1.89 . . . . 75.45 111.819 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.85 145.76 40.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.013 -1.449 . . . . 75.05 109.01 170.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.16 130.05 27.11 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.31 2.673 . . . . 72.42 112.432 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.674 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.7 pt20 -65.43 156.94 30.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.849 -1.069 . . . . 72.13 113.148 -171.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.46 114.05 25.29 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.503 -1.295 . . . . 41.35 107.503 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -91.47 108.65 20.04 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.959 -1.126 . . . . 45.43 107.959 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.87 150.2 45.4 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.821 0.849 . . . . 70.31 112.326 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.22 138.46 71.96 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.849 -1.069 . . . . 65.3 109.789 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.599 ' HG3' HD11 ' D' ' 16' ' ' ILE . 60.5 Cg_endo -71.48 97.22 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.499 2.133 . . . . 73.44 110.811 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.73 109.34 20.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.261 -1.014 . . . . 65.3 108.261 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.461 ' HB3' ' HB3' ' B' ' 135' ' ' ALA . 9.5 m120 -76.29 87.34 3.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.705 0.802 . . . . 75.34 109.871 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -64.51 -37.77 88.69 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.467 -0.568 . . . . 54.43 109.467 171.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.493 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 5.7 p-10 -57.43 -61.49 2.45 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.501 1.12 . . . . 73.23 111.411 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' B' ' 132' ' ' ASN . . . -66.51 -34.87 78.89 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.666 0.786 . . . . 75.44 111.83 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.55 -49.55 70.8 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.676 0.791 . . . . 62.21 110.953 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -73.72 -15.24 61.22 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.373 -0.831 . . . . 74.02 111.348 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 88.5 mtp -62.25 -35.98 80.61 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.983 0.513 . . . . 71.01 110.851 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -75.02 -20.72 59.49 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.371 0.668 . . . . 71.14 111.275 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -68.63 -42.56 77.9 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.766 0.826 . . . . 74.13 110.626 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' B' ' 96' ' ' HIS . 1.4 pp -118.89 36.71 4.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.741 1.216 . . . . 74.33 110.147 -174.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -58.46 99.72 0.05 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.748 0.819 . . . . 54.23 111.541 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -94.82 116.87 29.26 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.268 1.027 . . . . 74.32 109.321 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -74.22 120.35 19.67 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.912 0.885 . . . . 74.21 109.962 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.29 176.42 5.38 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.777 0.831 . . . . 74.54 110.548 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.32 134.83 13.18 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.981 -0.554 . . . . 62.45 112.149 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -82.03 -61.09 2.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.551 0.74 . . . . 71.22 110.117 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.84 -155.29 26.39 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.583 -0.735 . . . . 64.42 111.336 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 t -135.27 147.75 49.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.353 0.661 . . . . 64.21 109.688 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.7 142.26 51.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.953 0.901 . . . . 72.22 109.772 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -104.21 97.96 7.84 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.907 0.883 . . . . 75.15 109.72 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -100.18 101.8 12.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.999 -0.741 . . . . 71.41 108.999 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -66.67 99.91 0.64 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.088 0.955 . . . . 60.44 110.68 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.77 139.44 58.33 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.259 1.023 . . . . 73.53 111.861 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.879 0 C-N-CA 123.875 0.87 . . . . 74.1 109.184 179.394 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.948 -0.39 . . . . 63.32 109.948 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -109.02 71.72 0.78 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.165 0.586 . . . . 42.04 109.952 -175.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -83.07 126.43 32.56 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.447 -0.797 . . . . 62.52 109.606 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -58.3 -45.43 88.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.94 0.896 . . . . 73.54 110.301 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.96 155.24 35.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.52 -1.218 . . . . 64.2 109.22 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -161.27 132.11 5.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.733 -0.84 . . . . 75.45 108.733 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.9 p -108.88 115.54 30.27 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.372 -0.973 . . . . 63.51 108.372 171.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -75.78 -21.16 57.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.388 0.675 . . . . 71.31 110.978 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.514 ' HG3' HD12 ' C' ' 89' ' ' ILE . 26.9 ttt 64.48 113.99 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.104 1.361 . . . . 70.4 111.512 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.1 m -92.35 88.74 6.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.573 0.749 . . . . 63.15 109.116 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -119.61 126.55 51.45 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.711 -0.848 . . . . 53.53 108.711 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -150.75 131.04 13.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.872 0.869 . . . . 72.4 108.995 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.418 HD12 ' HD3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -78.52 132.02 33.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.768 -0.827 . . . . 74.34 108.768 174.267 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.0 mm100 -93.57 -46.04 7.47 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.077 0.551 . . . . 63.33 109.553 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -176.31 126.0 0.19 Allowed 'General case' 0 C--N 1.356 0.891 0 O-C-N 124.168 0.917 . . . . 75.23 110.192 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.01 142.99 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.636 -1.246 . . . . 75.2 107.636 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.443 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -176.79 156.01 1.34 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.617 0.644 . . . . 74.54 111.806 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -75.94 121.79 23.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.786 0.834 . . . . 74.32 109.061 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 12.6 mmmm -76.15 -47.99 22.23 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.305 1.05 . . . . 73.32 108.875 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -140.59 146.0 37.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 113.772 -1.558 . . . . 62.1 109.198 -173.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.7 mt -140.91 144.84 26.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.096 1.358 . . . . 63.44 107.482 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -156.22 151.14 26.2 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.573 0.702 . . . . 73.44 110.433 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -148.89 127.58 12.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.531 -1.285 . . . . 75.42 107.531 171.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.1 mt-10 -120.84 133.89 55.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.789 0.835 . . . . 75.43 109.411 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.53 79.36 24.76 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.335 -0.987 . . . . 74.23 108.335 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.87 -25.13 12.45 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.679 2.253 . . . . 71.14 112.112 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.441 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 96.9 m-20 -106.87 34.96 3.18 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.444 1.098 . . . . 73.02 109.504 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.38 -55.6 43.58 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.388 -0.815 . . . . 51.54 112.997 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 26.0 Cg_exo -65.53 -30.09 52.3 Favored 'Trans proline' 0 C--N 1.394 2.932 0 CA-C-N 121.421 1.543 . . . . 72.45 112.204 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.441 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.1 t60 -62.76 -23.51 67.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.784 1.234 . . . . 71.45 112.001 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' C' ' 34' ' ' LYS . 8.8 p -52.67 -25.34 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 N-CA-C 112.828 0.677 . . . . 75.33 112.828 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -79.7 -24.56 41.62 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.583 -0.698 . . . . 74.2 112.305 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -102.24 17.63 22.92 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.274 0.559 . . . . 53.31 110.503 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.73 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.07 138.26 33.15 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.085 0.954 . . . . 62.25 110.333 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -77.04 129.17 35.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 72.51 108.927 170.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' F' ' 300' ' ' ASN . 29.7 m95 -80.2 77.55 6.92 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.334 0.588 . . . . 75.14 110.667 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' C' ' 68' ' ' LEU . 36.6 tt0 -160.45 63.64 1.98 Allowed Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 115.048 -0.978 . . . . 64.54 109.293 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.72 126.67 6.01 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.216 1.944 . . . . 74.34 111.416 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -85.88 99.11 11.17 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.609 -1.626 . . . . 75.22 106.609 169.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.437 HG11 HD13 ' C' ' 126' ' ' LEU . 43.2 t -73.19 122.93 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.794 -1.094 . . . . 70.12 109.038 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -124.62 112.34 16.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.345 1.058 . . . . 63.2 109.254 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 145.66 26.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.839 0.856 . . . . 62.45 109.156 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.5 t70 -132.95 143.63 49.59 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.909 -1.145 . . . . 63.33 107.909 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -135.08 115.01 12.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.247 -0.649 . . . . 72.4 109.247 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.0 t70 -111.44 143.39 42.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.104 -1.072 . . . . 73.1 108.104 175.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -115.05 117.39 30.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.728 0.811 . . . . 75.55 110.224 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -112.74 141.98 45.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 71.21 108.824 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -151.32 158.1 43.36 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.134 0.574 . . . . 73.32 110.518 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -167.62 131.88 1.81 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.858 0.863 . . . . 52.45 109.434 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.63 117.91 24.81 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.82 -0.807 . . . . 73.44 108.82 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.515 HD11 HD12 ' C' ' 83' ' ' ILE . 56.6 mt -86.33 -38.97 16.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.022 0.929 . . . . 74.04 111.354 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -171.19 3.08 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.669 -0.696 . . . . 73.53 110.572 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -57.5 110.39 0.86 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.983 -1.008 . . . . 75.31 110.104 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 70.26 -2.19 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.927 1.291 . . . . 63.11 112.781 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -94.28 103.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 71.34 108.859 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -115.48 126.15 53.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.084 0.954 . . . . 60.51 109.534 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -84.43 119.26 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.44 -0.578 . . . . 63.15 109.44 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.407 HG13 ' CZ ' ' F' ' 281' ' ' PHE . 87.0 t -98.23 128.43 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.495 1.118 . . . . 74.35 108.244 172.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 70.2 t -131.7 137.38 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.441 0.696 . . . . 65.24 109.413 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' C' ' 103' ' ' PRO . 92.9 mt -125.51 112.42 16.2 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.741 0.816 . . . . 75.13 109.917 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 27.4 ttm180 -82.61 105.79 13.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.024 -0.732 . . . . 75.12 109.024 168.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.658 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.3 t -101.19 125.36 55.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.968 -1.123 . . . . 62.12 107.968 171.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 15.5 m -124.41 113.29 17.97 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.795 -0.817 . . . . 73.02 108.795 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.502 HG21 HG21 ' C' ' 114' ' ' ILE . 60.2 t -102.19 114.22 40.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.681 0.792 . . . . 73.03 109.065 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -102.41 150.71 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.535 -0.913 . . . . 71.23 108.535 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.5 106.09 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.48 -1.674 . . . . 73.31 106.48 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -148.39 146.22 28.38 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.913 0.485 . . . . 62.45 110.544 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.73 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.3 OUTLIER -110.78 55.79 0.64 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.095 0.958 . . . . 71.53 108.544 174.04 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.95 -113.72 4.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.48 -1.237 . . . . 40.32 111.131 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.36 -17.78 29.83 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.457 0.703 . . . . 74.13 110.301 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -88.96 99.35 12.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.072 0.949 . . . . 74.54 109.529 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -85.57 132.78 34.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.94 0.496 . . . . 60.45 111.096 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -77.47 -64.25 1.19 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.146 0.979 . . . . 63.41 109.591 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -163.58 175.67 10.43 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.416 -0.811 . . . . 73.43 110.324 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -139.27 144.21 38.29 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 107.901 -1.148 . . . . 74.51 107.901 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.435 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.5 t -143.87 149.13 36.46 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.27 -1.011 . . . . 70.11 108.27 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.25 136.46 11.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.922 0.489 . . . . 53.12 110.056 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -138.08 134.79 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.237 1.015 . . . . 71.4 108.456 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 63.3 mt-30 -110.57 91.22 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.951 -1.129 . . . . 64.14 107.951 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -80.05 117.43 20.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.626 -0.715 . . . . 71.53 110.55 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.37 162.52 20.75 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 123.517 0.51 . . . . 61.24 112.556 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.524 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -166.94 118.19 0.78 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.306 -0.718 . . . . 62.44 111.306 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.515 HD12 HD11 ' C' ' 51' ' ' LEU . 13.6 mm -83.21 122.73 37.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.764 -0.828 . . . . 71.22 108.764 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -132.78 132.25 42.03 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.65 0.78 . . . . 73.21 109.417 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 47.8 m -94.18 114.36 26.46 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.594 -0.891 . . . . 72.04 108.594 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 50.8 mt -115.08 119.26 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.554 1.142 . . . . 74.52 107.994 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.55 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.246 1.019 . . . . 63.55 109.923 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.78 -34.3 4.59 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.271 -0.422 . . . . 52.05 112.772 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.525 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -121.9 165.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 71.32 110.176 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -156.46 -179.9 8.61 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.41 0.684 . . . . 61.03 110.42 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' C' ' 94' ' ' MET . . . 68.81 -130.35 25.16 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.384 -0.371 . . . . 73.01 113.052 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -78.95 -20.72 48.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.254 0.622 . . . . 72.43 111.272 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.21 -44.52 95.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.392 0.677 . . . . 75.15 110.184 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.58 ' HG2' HD22 ' F' ' 277' ' ' LEU . 0.0 OUTLIER -76.58 -26.32 54.93 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 116.029 -0.532 . . . . 70.43 110.785 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.66 -32.13 70.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.892 0.477 . . . . 75.41 111.087 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 60.1 t-80 -73.73 -24.3 59.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.288 0.635 . . . . 54.45 110.73 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -81.67 -58.57 2.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.205 0.602 . . . . 54.35 110.324 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.33 -48.37 42.52 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.19 1.396 . . . . 72.23 110.826 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.83 11.46 72.05 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.547 -0.585 . . . . 61.42 114.111 -171.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -148.61 -59.3 0.23 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.554 0.677 . . . . 71.04 112.217 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -74.85 -38.88 61.86 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.981 0.512 . . . . 75.33 112.243 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.9 -45.46 74.41 Favored Pre-proline 0 CA--C 1.557 1.249 0 CA-C-O 118.833 -0.603 . . . . 55.21 111.277 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HA ' HD11 ' C' ' 60' ' ' LEU . 69.9 Cg_exo -48.8 -42.8 36.45 Favored 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.647 2.232 . . . . 73.2 114.457 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -60.7 -40.21 91.39 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.784 0.833 . . . . 74.44 110.798 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.11 -48.21 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.919 0.488 . . . . 75.02 110.72 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.524 HD21 ' HA3' ' C' ' 82' ' ' GLY . 80.3 mt -80.11 -19.57 47.05 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.76 -0.655 . . . . 74.14 112.53 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -58.64 -48.42 96.92 Favored Pre-proline 0 CA--C 1.566 1.593 0 CA-C-O 118.061 -0.971 . . . . 71.04 113.29 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.94 -36.64 96.52 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.358 2.039 . . . . 73.45 113.463 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -66.69 -45.18 79.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.425 0.69 . . . . 75.42 111.146 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.77 88.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.282 0.633 . . . . 74.12 109.64 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -53.7 -49.23 68.49 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.639 1.576 . . . . 72.02 112.091 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.94 -39.01 72.88 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.81 0.694 . . . . 65.53 110.163 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.49 -33.6 74.44 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.994 0.517 . . . . 65.45 111.274 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.658 HD11 ' HB ' ' C' ' 62' ' ' VAL . 81.3 mt -66.27 -52.29 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.597 0.759 . . . . 72.13 109.53 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 29.1 m -65.28 -29.08 69.82 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.049 -0.978 . . . . 61.44 110.75 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -66.84 -43.75 82.85 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.694 0.798 . . . . 50.34 109.925 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.562 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.44 -37.64 85.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.524 0.73 . . . . 74.03 111.646 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.03 -37.78 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.253 0.621 . . . . 63.13 109.811 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.0 t -66.24 -35.9 81.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.229 1.012 . . . . 74.12 111.829 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.4 mtt-85 -74.35 -35.76 63.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.614 0.766 . . . . 74.22 110.332 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.17 1.14 76.85 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.622 0.576 . . . . 74.13 112.592 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.3 p 61.36 24.05 14.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.035 1.734 . . . . 61.01 112.656 172.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -90.42 155.24 46.46 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.127 0.971 . . . . 73.03 110.03 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.08 122.43 11.8 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.058 2.505 . . . . 71.52 112.38 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -61.13 153.59 25.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.311 1.045 . . . . 62.45 112.881 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' F' ' 294' ' ' LYS . 5.1 tt -141.52 114.01 8.27 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 106.68 -1.6 . . . . 75.11 106.68 171.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -90.9 131.73 36.35 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.799 0.84 . . . . 65.43 109.749 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.43 141.69 56.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.444 0.698 . . . . 70.24 110.964 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.512 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -83.76 148.89 55.65 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.025 0.93 . . . . 72.1 110.907 -176.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.542 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.9 Cg_exo -64.52 94.69 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.144 2.563 . . . . 71.23 112.465 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.38 106.71 19.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.938 -1.134 . . . . 71.23 107.938 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.89 102.42 11.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.609 -1.256 . . . . 63.35 107.609 173.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -63.06 -42.3 99.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.454 0.645 . . . . 61.24 109.308 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.67 -49.01 76.83 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.195 1.398 . . . . 73.2 112.382 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.26 -23.15 60.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.328 0.651 . . . . 52.14 111.133 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tt -69.61 -40.02 76.89 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.552 0.741 . . . . 74.31 109.374 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -64.27 -34.78 78.91 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.928 0.491 . . . . 65.51 110.973 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 91.0 mtp -77.51 -30.82 53.13 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.686 0.795 . . . . 71.42 111.204 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.69 -36.17 82.85 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.811 1.244 . . . . 53.33 111.555 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -42.36 -84.72 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 125.304 1.442 . . . . 71.14 112.956 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 5.1 tt -81.94 115.24 21.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.161 -0.681 . . . . 73.22 109.161 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -147.28 90.76 1.91 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.594 1.158 . . . . 51.04 109.016 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -73.03 160.63 31.77 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.04 0.536 . . . . 63.21 109.588 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -115.15 93.28 4.23 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.859 -0.793 . . . . 74.03 108.859 178.09 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -174.9 104.63 0.09 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.821 1.249 . . . . 61.01 109.218 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.96 161.3 11.0 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.562 -0.29 . . . . 34.42 112.44 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.4 -52.37 2.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.167 0.987 . . . . 74.1 109.186 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.36 175.55 14.38 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.27 -0.877 . . . . 73.04 111.824 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 95.2 m -68.96 -51.83 35.45 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.095 -0.705 . . . . 65.41 109.095 169.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 58.7 103.0 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.113 1.365 . . . . 70.31 112.519 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.49 140.49 4.98 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.223 -1.399 . . . . 74.23 107.223 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -63.31 128.69 36.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.921 0.488 . . . . 54.44 110.526 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -79.81 97.67 6.74 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.983 0.897 . . . . 62.4 109.752 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.07 31.72 4.4 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.293 1.037 . . . . 61.55 109.557 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 C-N-CA 123.671 0.788 . . . . 71.42 110.14 179.89 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.734 0.302 . . . . 75.11 110.761 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 82.1 p -162.1 171.17 17.91 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.055 0.942 . . . . 53.12 109.665 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.04 64.69 4.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.58 0.705 . . . . 45.0 109.528 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.14 97.95 11.49 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.49 -1.3 . . . . 74.34 107.49 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -141.31 94.44 2.7 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.473 -0.936 . . . . 73.34 108.473 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -148.92 -174.69 4.7 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.174 0.99 . . . . 64.11 108.367 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -51.43 100.82 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 121.766 0.793 . . . . 74.44 111.136 170.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -83.08 -174.76 5.48 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.04 -0.982 . . . . 74.52 111.422 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 1.4 ptm -30.13 145.32 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.422 1.489 . . . . 72.02 113.407 165.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.5 m -105.09 143.88 32.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 64.4 110.299 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -159.88 90.62 0.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.629 -1.619 . . . . 62.31 106.629 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.85 114.97 28.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.066 -1.087 . . . . 70.24 108.066 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.505 ' O ' ' HB ' ' F' ' 306' ' ' VAL . 14.5 mt -77.13 104.5 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 108.203 -1.036 . . . . 72.21 108.203 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.96 -45.48 60.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.769 -0.456 . . . . 75.43 109.769 -170.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' D' ' 15' ' ' ARG . 3.4 mmp_? -157.66 147.75 20.54 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.374 1.07 . . . . 73.21 110.138 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.599 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.7 mp -120.04 113.38 40.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 106.496 -1.668 . . . . 74.54 106.496 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.577 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 42.0 p90 -145.93 150.73 36.62 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.759 0.79 . . . . 63.34 111.282 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -81.38 115.28 20.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.897 -1.047 . . . . 43.45 109.549 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.53 -33.14 28.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.424 0.631 . . . . 74.22 109.885 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -144.26 137.2 27.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.483 -1.235 . . . . 51.24 109.524 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.562 HD13 ' HE3' ' C' ' 117' ' ' MET . 93.3 mt -132.05 140.52 47.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.68 1.192 . . . . 73.21 107.885 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 38.6 t -142.34 133.74 26.44 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.562 1.145 . . . . 73.32 108.053 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -147.91 124.7 11.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.754 -1.573 . . . . 73.21 106.754 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -129.19 137.09 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.488 1.115 . . . . 74.01 108.898 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.11 85.36 59.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.703 -1.591 . . . . 53.22 106.703 172.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.39 -61.59 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.901 2.401 . . . . 74.02 112.547 -172.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.76 41.83 1.09 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.0 -1.111 . . . . 72.32 108.0 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -49.07 -59.72 5.93 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 114.389 1.255 . . . . 53.4 114.389 -167.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.54 -12.86 15.13 Favored 'Trans proline' 0 C--N 1.385 2.462 0 CA-C-N 121.727 1.652 . . . . 54.01 112.772 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -75.2 -41.4 57.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.122 1.369 . . . . 62.32 109.597 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.06 -40.69 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.746 -1.116 . . . . 64.44 110.471 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.588 ' HA ' HG21 ' G' ' 301' ' ' ILE . 20.9 m-85 -67.68 -18.37 64.91 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.146 -0.933 . . . . 71.22 113.064 -174.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -78.79 -14.65 59.15 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.386 0.674 . . . . 71.35 112.222 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -109.04 114.51 28.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.06 0.944 . . . . 61.11 108.593 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -88.14 96.17 10.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.627 0.603 . . . . 64.4 112.627 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.475 ' CZ3' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -169.42 -174.26 1.89 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.097 0.777 . . . . 73.04 113.097 171.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' G' ' 298' ' ' HIS . 12.0 mt-30 -92.1 126.5 52.9 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 125.05 1.34 . . . . 72.03 111.509 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.588 ' HB3' HD23 ' D' ' 68' ' ' LEU . 56.0 Cg_endo -75.31 150.59 37.09 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.928 2.419 . . . . 74.2 113.783 172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -83.21 135.59 34.72 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.504 1.122 . . . . 65.22 108.392 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 67.8 t -118.82 138.82 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.381 0.672 . . . . 54.33 109.262 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 47.9 tttm -125.81 121.26 32.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.186 0.994 . . . . 73.43 108.653 -172.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.47 HD11 HD11 ' D' ' 128' ' ' LEU . 0.4 OUTLIER -97.62 112.68 24.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.586 0.754 . . . . 41.45 109.062 -172.524 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.609 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.9 m-20 -111.75 127.8 55.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.277 1.031 . . . . 74.23 108.848 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.17 140.02 49.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.376 0.67 . . . . 75.32 109.431 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.6 t70 -142.0 136.47 30.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.107 0.963 . . . . 74.31 108.723 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -105.47 143.9 32.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.461 0.704 . . . . 70.42 110.193 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.69 159.02 44.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.694 0.798 . . . . 23.23 109.772 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.2 p -168.27 166.68 12.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.119 0.568 . . . . 64.04 111.166 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -158.84 145.56 17.17 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.368 1.067 . . . . 62.35 109.107 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.0 117.71 25.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.942 -0.762 . . . . 71.23 108.942 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' D' ' 57' ' ' GLU . 31.5 mt -92.85 -24.78 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.598 0.359 . . . . 53.34 110.281 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.87 -178.84 3.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.125 0.97 . . . . 74.35 110.608 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.56 118.92 9.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.914 -1.039 . . . . 74.24 108.937 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 70.07 5.17 5.16 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.696 1.198 . . . . 64.45 112.088 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.26 114.91 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.767 -0.827 . . . . 70.41 108.767 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.59 129.8 39.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.356 1.062 . . . . 63.11 108.883 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.457 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.4 tt0 -88.42 124.79 34.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.428 -0.953 . . . . 74.03 108.428 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.495 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 47.4 t -108.77 122.99 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.039 -1.467 . . . . 62.13 107.039 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 23.3 t -106.28 128.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.724 -0.843 . . . . 65.42 108.724 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.64 HD23 HD12 ' D' ' 106' ' ' LEU . 4.1 mm? -112.06 114.21 26.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.677 -0.49 . . . . 74.3 109.677 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -86.93 106.08 17.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.633 -0.712 . . . . 73.11 109.152 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.95 127.73 48.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.895 -1.15 . . . . 70.51 107.895 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 39.6 m -125.66 130.13 50.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.382 -0.826 . . . . 61.51 108.793 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -120.42 121.27 65.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.785 1.234 . . . . 61.35 108.474 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 87.6 m -120.63 100.43 7.12 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.054 0.942 . . . . 74.34 109.099 -170.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.15 137.47 37.63 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.187 -0.46 . . . . 65.22 110.098 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 53.4 p -150.47 140.12 21.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.603 0.761 . . . . 71.14 109.598 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.652 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -136.22 136.4 39.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.501 1.12 . . . . 75.12 110.135 -174.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.67 3.78 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.337 -0.705 . . . . 73.54 111.337 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.52 4.2 8.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.703 0.801 . . . . 74.12 110.346 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.63 166.85 13.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.15 0.58 . . . . 72.13 110.821 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 87.1 m -80.97 139.14 35.99 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.821 -0.627 . . . . 63.33 110.483 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.652 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -80.56 -72.02 0.43 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.027 -1.101 . . . . 75.44 108.027 172.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.45 146.46 25.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.17 -0.923 . . . . 63.21 108.928 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -110.34 130.06 55.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.57 -1.271 . . . . 74.11 107.57 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.554 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.4 t -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 72.31 108.871 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 41.9 tt0 -154.59 121.8 5.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.085 0.554 . . . . 63.33 110.065 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -130.21 118.11 42.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.068 -0.715 . . . . 75.14 109.068 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -87.8 86.78 7.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.612 -1.255 . . . . 63.44 107.612 169.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.98 97.38 6.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.184 -1.371 . . . . 64.32 108.565 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.52 144.0 18.82 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.453 -0.659 . . . . 53.14 111.453 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.28 4.58 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 109.826 -1.31 . . . . 71.44 109.826 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.75 130.23 38.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.173 . . . . 63.3 107.834 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.495 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 42.3 m-85 -129.0 136.16 49.94 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.483 0.49 . . . . 64.02 109.98 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.9 m -86.52 93.32 9.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.924 -1.139 . . . . 74.02 107.924 167.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 14.9 mt -106.58 114.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 109.437 -0.579 . . . . 73.43 109.437 -172.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.4 163.0 35.06 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.915 0.886 . . . . 63.32 109.679 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -6.3 83.76 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.508 -0.607 . . . . 51.2 114.568 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 pt -129.11 147.97 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.639 0.719 . . . . 73.42 111.716 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 173.57 13.18 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.823 1.249 . . . . 53.12 109.426 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.24 -127.28 43.08 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 115.258 0.863 . . . . 74.42 115.258 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 90.1 m -66.23 -38.46 87.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.68 1.192 . . . . 74.14 111.642 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -69.2 -36.77 77.63 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.881 0.873 . . . . 75.13 110.75 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.683 ' SD ' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -72.12 -42.52 65.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.508 -0.553 . . . . 72.11 109.508 176.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.82 88.46 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.588 0.755 . . . . 64.22 110.805 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 15.0 t-80 -64.91 -36.55 84.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.158 -0.928 . . . . 71.42 110.669 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -68.03 -50.53 54.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.513 0.325 . . . . 74.44 111.236 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.683 HD23 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -71.18 -30.3 66.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.9 0.48 . . . . 74.31 111.305 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.24 7.5 56.66 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.61 -0.55 . . . . 75.0 114.06 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.05 -57.82 0.24 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.465 0.633 . . . . 54.25 111.762 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -70.62 -52.94 18.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.211 0.604 . . . . 75.21 111.238 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.436 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 34.0 m -60.58 -45.7 97.2 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.873 0.869 . . . . 34.45 112.127 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 75.0 Cg_exo -53.93 -45.59 39.9 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.747 2.298 . . . . 72.2 113.156 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.03 -26.31 68.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.559 0.743 . . . . 71.12 111.725 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.0 mm -73.51 -49.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.373 0.669 . . . . 61.24 110.962 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.64 HD12 HD23 ' D' ' 60' ' ' LEU . 83.2 mt -87.13 -13.95 42.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.13 0.572 . . . . 73.41 112.46 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -67.51 -45.69 47.29 Favored Pre-proline 0 CA--C 1.559 1.326 0 CA-C-O 118.188 -0.91 . . . . 72.31 112.328 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.79 -33.43 96.87 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.21 1.94 . . . . 72.35 113.408 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -78.96 -34.96 43.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.533 0.733 . . . . 73.33 112.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.56 -50.05 68.81 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.933 -0.766 . . . . 74.12 108.933 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -54.18 -48.01 71.4 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.991 1.432 . . . . 71.43 110.574 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.34 -50.1 74.29 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.169 0.918 . . . . 74.13 110.911 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.422 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.6 t -55.32 -43.29 74.76 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.973 0.795 . . . . 73.51 110.913 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.554 HG12 ' SG ' ' D' ' 76' ' ' CYS . 86.1 mt -65.8 -51.91 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 124.355 1.034 . . . . 50.0 110.624 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.458 HG23 ' HB2' ' D' ' 125' ' ' GLN . 68.9 m -51.03 -44.45 61.04 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.986 1.315 . . . . 72.54 111.658 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -69.41 -45.61 68.8 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.849 -1.069 . . . . 72.44 110.812 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.98 -36.96 85.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.741 0.416 . . . . 65.03 111.981 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.2 t -66.79 -44.33 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.097 -0.956 . . . . 70.31 109.998 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -69.73 -27.31 64.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.817 0.447 . . . . 73.15 111.414 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -73.21 -29.72 63.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 73.42 110.205 175.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.89 11.48 66.69 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.69 -0.686 . . . . 43.11 112.438 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.428 HG23 ' HB3' ' C' ' 17' ' ' TYR . 59.9 p 57.87 14.11 2.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.725 2.01 . . . . 74.23 113.518 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.02 162.91 55.55 Favored Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.482 1.113 . . . . 43.35 108.342 169.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.6 ' HG2' HG22 ' G' ' 296' ' ' THR . 90.1 Cg_endo -75.32 127.02 10.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.212 1.941 . . . . 74.43 111.41 -174.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.458 ' HB2' HG23 ' D' ' 115' ' ' THR . 1.6 pp0? -54.12 142.8 24.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.319 0.648 . . . . 64.11 111.291 -176.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.89 103.79 13.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.021 -0.733 . . . . 55.13 109.021 -161.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -97.05 91.92 5.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.98 -1.118 . . . . 74.41 107.98 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.47 HD11 HD11 ' D' ' 42' ' ' LEU . 0.1 OUTLIER -73.82 126.81 31.23 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.453 -0.943 . . . . 64.13 108.453 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.17 141.52 95.95 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.6 0.76 . . . . 64.45 111.374 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.31 122.8 11.65 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.408 2.072 . . . . 60.22 111.261 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.17 117.9 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.217 -1.031 . . . . 71.42 108.217 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -72.09 84.29 1.0 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.448 0.699 . . . . 72.5 109.686 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -62.6 -29.76 70.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.654 0.782 . . . . 74.52 110.903 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.44 -59.62 5.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.841 0.857 . . . . 72.43 111.233 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.99 -37.91 84.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.559 0.744 . . . . 73.43 111.969 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.97 -41.76 74.06 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.342 -0.844 . . . . 65.22 111.75 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' D' ' 140' ' ' TYR . 64.6 t80 -75.04 -40.58 60.32 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.884 0.474 . . . . 74.31 111.199 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 51.1 mtm -63.08 -38.97 93.3 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.832 0.453 . . . . 73.55 110.395 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 18.8 t-20 -69.58 -27.63 65.28 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.618 -0.719 . . . . 74.35 110.745 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' D' ' 137' ' ' PHE . 45.1 t80 -60.26 -33.71 72.7 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.438 0.695 . . . . 72.4 111.708 176.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mp -62.32 -34.66 77.06 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.294 0.638 . . . . 62.21 111.754 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -91.96 21.85 4.68 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.707 0.403 . . . . 75.11 112.07 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 89.0 mt-30 -120.39 88.5 2.95 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.48 0.712 . . . . 73.0 109.524 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -172.3 66.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.945 0.898 . . . . 63.31 109.149 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.76 -40.16 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.768 -0.651 . . . . 72.54 111.347 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.59 -79.66 0.55 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 112.213 -0.355 . . . . 41.12 112.213 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.3 -177.43 6.44 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.849 0.86 . . . . 72.15 110.558 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.44 137.23 3.43 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 111.62 -0.592 . . . . 72.42 111.62 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.9 t -131.86 142.1 49.59 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.737 0.78 . . . . 61.45 111.307 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -129.18 74.61 1.59 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.861 1.265 . . . . 71.34 107.714 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -87.14 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.092 -0.958 . . . . 74.45 110.848 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 m170 65.08 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.708 1.203 . . . . 71.02 112.899 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -121.26 159.6 25.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.035 0.934 . . . . 73.43 110.669 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -74.07 137.51 43.39 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.663 -0.699 . . . . 62.22 110.124 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 108.81 -0.811 . . . . 73.21 108.81 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.348 -0.241 . . . . 41.51 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -94.35 103.62 15.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.714 -0.846 . . . . 73.13 108.714 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 27.7 mp0 -75.58 162.81 27.96 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.115 0.484 . . . . 64.52 110.107 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -95.98 14.01 25.07 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.939 0.896 . . . . 74.44 111.079 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 57.22 80.91 0.27 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.385 1.474 . . . . 73.55 112.502 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.8 27.54 0.57 Allowed 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.082 2.522 . . . . 73.51 111.896 169.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.59 76.13 6.22 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.394 -0.965 . . . . 61.54 108.394 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 176.2 143.54 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.137 -1.431 . . . . 71.11 107.137 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . 177.31 -120.01 0.71 Allowed Glycine 0 C--N 1.343 0.949 0 C-N-CA 121.546 -0.359 . . . . 51.31 112.947 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.649 ' H ' HD23 ' E' ' 280' ' ' LEU . 1.5 pt? -64.87 86.26 0.05 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.667 1.187 . . . . 72.13 111.981 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 67.5 t80 179.03 -26.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.094 1.358 . . . . 71.45 109.608 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -71.74 -1.48 14.1 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 121.486 0.66 . . . . 74.11 110.711 168.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -137.56 -168.66 2.36 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.536 1.934 . . . . 73.12 108.069 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 85.84 72.77 1.29 Allowed Glycine 0 C--N 1.343 0.946 0 CA-C-O 120.964 0.202 . . . . 74.33 113.053 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.82 99.76 1.43 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.811 0.845 . . . . 70.31 109.419 173.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 85.6 mtp -70.41 117.1 51.73 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.485 0.714 . . . . 74.45 110.305 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.83 90.58 0.94 Allowed 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.985 2.457 . . . . 62.34 110.815 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.4 107.07 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.947 -1.131 . . . . 71.2 107.947 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.01 160.46 14.3 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.015 0.926 . . . . 73.03 110.631 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 290' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 93.8 m95 -72.46 144.37 48.11 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.691 -0.686 . . . . 74.54 109.621 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.476 HD22 ' H ' ' E' ' 291' ' ' LEU . 0.0 OUTLIER -109.14 -11.22 14.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.7 1.2 . . . . 73.33 110.672 -177.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -149.47 72.34 0.3 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.277 -0.729 . . . . 74.44 111.277 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.62 175.48 11.04 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.291 2.661 . . . . 44.11 112.848 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? 77.8 -29.45 0.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.424 1.489 . . . . 75.34 111.191 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -66.2 170.86 5.27 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.91 0.884 . . . . 72.23 111.599 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 5.1 m 70.75 21.35 5.26 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.208 1.003 . . . . 74.34 110.751 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.487 ' HE2' HD21 ' A' ' 68' ' ' LEU . 11.0 t80 -168.69 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.125 0.488 . . . . 72.3 110.959 -175.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -92.36 -2.57 56.28 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.87 0.468 . . . . 72.52 110.796 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.14 130.51 9.87 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.817 -0.435 . . . . 72.43 112.743 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 300' ' ' ASN . . . . . 0.419 ' HA ' ' CZ2' ' A' ' 36' ' ' TRP . 4.4 m-20 -72.78 85.14 1.22 Allowed 'General case' 0 C--N 1.355 0.83 0 C-N-CA 123.062 0.545 . . . . 75.14 110.225 174.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 14.0 pt -78.56 79.48 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 122.291 1.043 . . . . 60.14 109.041 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 302' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' G' ' 298' ' ' HIS . 12.6 t70 -118.73 -155.65 0.61 Allowed 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 114.211 -1.359 . . . . 61.24 108.635 -169.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' E' E ' 303' ' ' LYS . . . . . 0.485 ' HE3' ' N ' ' E' ' 303' ' ' LYS . 0.6 OUTLIER -73.11 142.4 82.39 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.332 0.653 . . . . 62.22 110.459 -178.473 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -84.89 -165.21 0.28 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.292 2.662 . . . . 70.22 111.685 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -89.9 25.81 1.99 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.606 0.763 . . . . 73.53 112.309 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 21.8 m -69.68 147.11 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.13 0.572 . . . . 61.14 109.694 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 5.0 t -154.58 -48.71 0.09 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.667 0.387 . . . . 63.33 110.974 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 79.2 m -155.09 119.26 4.66 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.879 0.872 . . . . 75.41 108.989 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 29.6 m -145.03 116.07 5.15 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 108.377 -0.971 . . . . 64.35 108.377 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 C--N 1.38 2.2 0 C-N-CA 123.307 2.671 . . . . 74.51 112.367 179.876 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 108.578 -0.897 . . . . 64.31 108.578 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -137.38 -66.68 0.5 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.783 0.833 . . . . 74.44 109.644 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 53.01 -107.95 0.38 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.994 0.918 . . . . 55.14 109.522 -166.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -171.27 110.08 0.31 Allowed 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.557 -1.275 . . . . 63.23 107.557 168.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -139.83 115.74 8.08 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 107.763 -1.199 . . . . 64.34 107.763 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.83 94.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.756 2.304 . . . . 63.33 111.833 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 277' ' ' LEU . . . . . 0.58 HD22 ' HG2' ' C' ' 94' ' ' MET . 51.4 mt -78.41 75.75 4.92 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.933 0.873 . . . . 54.13 108.756 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.66 89.93 1.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 106.467 -1.679 . . . . 74.21 106.467 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -128.14 -59.79 0.12 Allowed Glycine 0 N--CA 1.471 0.998 0 N-CA-C 111.152 -0.779 . . . . 65.2 111.152 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.4 116.32 31.72 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.473 -1.306 . . . . 73.15 107.473 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 281' ' ' PHE . . . . . 0.407 ' CZ ' HG13 ' C' ' 58' ' ' VAL . 61.9 t80 -164.46 -54.57 0.03 OUTLIER 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.669 0.606 . . . . 71.14 110.495 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.75 -74.01 0.06 Allowed 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.486 1.117 . . . . 73.1 111.999 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -171.39 170.42 5.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.343 0.657 . . . . 74.13 110.714 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 176.13 -63.25 0.1 OUTLIER Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.603 -1.399 . . . . 55.43 109.603 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -175.25 108.19 0.1 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.514 1.126 . . . . 72.33 108.882 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 14.9 tpt -148.24 113.74 3.85 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.141 0.577 . . . . 64.34 109.468 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.83 83.76 2.04 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.812 2.342 . . . . 62.14 112.78 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 66.4 t -141.14 99.72 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.605 -0.887 . . . . 70.5 108.605 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -117.75 -71.08 0.75 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.006 -1.109 . . . . 73.42 108.006 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 27.6 m95 -147.3 130.0 16.04 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.691 0.796 . . . . 63.54 110.305 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' C' ' 129' ' ' ALA . 4.7 mp -79.75 79.91 6.2 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.314 1.009 . . . . 64.22 108.857 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.09 132.66 4.98 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.116 -0.824 . . . . 62.32 111.562 -172.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.16 122.9 11.28 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.581 2.187 . . . . 73.42 111.201 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 294' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' C' ' 126' ' ' LEU . 0.1 OUTLIER -141.16 161.9 36.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.553 0.741 . . . . 71.13 110.957 -174.227 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -132.03 144.9 51.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.097 -0.956 . . . . 55.4 109.724 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 35.4 p -70.73 -52.84 18.23 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.534 0.521 . . . . 64.54 110.002 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -73.42 89.86 1.66 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.024 -0.732 . . . . 75.21 109.024 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -83.55 66.08 8.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.287 1.035 . . . . 64.42 109.103 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 101.09 -162.35 18.25 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.61 -0.723 . . . . 35.23 112.413 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 300' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' C' ' 36' ' ' TRP . 2.2 m-20 -80.07 98.35 7.22 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.652 0.781 . . . . 75.14 110.135 -176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 12.4 pt -81.68 -5.55 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 112.634 0.605 . . . . 64.21 112.634 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -40.96 115.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.097 1.759 . . . . 74.33 113.855 -165.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -158.09 116.14 1.82 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.629 0.771 . . . . 41.2 109.913 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.91 -12.44 17.87 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.591 2.194 . . . . 55.15 110.673 161.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 65.52 -87.8 0.03 OUTLIER 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.691 1.597 . . . . 62.25 112.279 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 306' ' ' VAL . . . . . 0.532 HG21 ' HD2' ' B' ' 130' ' ' PRO . 16.4 t -96.49 60.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 123.064 1.412 . . . . 71.11 109.645 -172.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 12.7 t -117.29 -10.82 10.7 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 113.384 -1.735 . . . . 75.22 108.446 165.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 25.4 t -135.57 87.4 2.32 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.984 1.313 . . . . 74.4 107.627 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' F' F ' 309' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' F' ' 310' ' ' PRO . 97.5 m -155.64 -52.63 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.655 1.182 . . . . 71.35 110.24 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' F' F ' 310' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' F' ' 309' ' ' THR . 6.4 Cg_exo . . . . . 0 C--N 1.403 3.4 0 C-N-CA 122.116 1.877 . . . . 54.44 111.535 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.903 -0.406 . . . . 43.42 109.903 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -74.38 83.57 1.94 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.585 0.754 . . . . 62.23 110.084 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -108.54 76.87 1.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.672 -1.232 . . . . 44.33 107.672 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -105.1 23.63 13.31 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.944 -1.025 . . . . 74.24 110.457 -172.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -60.83 126.69 86.06 Favored Pre-proline 0 N--CA 1.482 1.139 0 N-CA-C 108.058 -1.09 . . . . 65.01 108.058 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.06 -49.6 14.91 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.782 2.322 . . . . 71.24 111.967 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.416 HD23 ' N ' ' G' ' 278' ' ' LEU . 8.2 tt -178.05 153.83 0.83 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.044 -1.465 . . . . 65.21 107.044 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 278' ' ' LEU . . . . . 0.56 HD22 HD22 ' D' ' 98' ' ' LEU . 0.2 OUTLIER 74.85 125.12 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.758 1.223 . . . . 73.44 109.812 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.88 -99.44 0.21 Allowed Glycine 0 C--N 1.346 1.108 0 N-CA-C 111.435 -0.666 . . . . 75.1 111.435 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.84 96.6 1.68 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.845 -1.169 . . . . 74.25 107.845 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -137.53 90.84 2.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.512 0.672 . . . . 74.01 109.292 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -161.12 -172.13 3.32 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 114.305 -1.316 . . . . 54.24 108.615 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.71 94.58 1.38 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.497 0.665 . . . . 72.42 109.342 173.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -74.05 -110.35 0.08 OUTLIER Glycine 0 C--N 1.352 1.469 0 CA-C-N 115.515 -0.766 . . . . 63.41 111.412 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -93.88 98.28 10.95 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.936 -1.135 . . . . 64.4 107.936 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 18.8 mmt -114.86 86.84 13.86 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.754 0.822 . . . . 74.31 109.264 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -91.46 27.99 0.4 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.046 2.497 . . . . 54.15 111.335 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 29.2 t -76.65 82.54 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.886 -0.783 . . . . 63.34 108.886 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -98.51 19.2 14.96 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.961 -1.018 . . . . 72.54 110.761 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 43.6 m95 70.64 153.89 0.12 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.266 1.426 . . . . 73.41 112.446 -170.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.2 9.36 21.81 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.574 -1.193 . . . . 71.43 110.013 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 120.95 88.37 1.01 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 111.374 -0.69 . . . . 62.43 111.374 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -98.91 11.87 0.72 Allowed 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.627 2.885 . . . . 71.14 113.531 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -89.52 49.16 1.7 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.982 0.513 . . . . 73.52 112.154 -174.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -168.62 35.69 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.284 1.034 . . . . 71.01 109.179 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 296' ' ' THR . . . . . 0.6 HG22 ' HG2' ' D' ' 124' ' ' PRO . 11.5 m -61.85 -56.6 17.66 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.379 -0.828 . . . . 74.31 110.846 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.79 -46.2 15.76 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.332 -0.618 . . . . 64.43 109.332 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 298' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' E' ' 302' ' ' ASP . 62.6 t-80 68.43 -75.99 0.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.278 1.431 . . . . 75.44 111.331 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.58 70.31 3.09 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.248 -0.433 . . . . 65.25 113.693 -174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.21 -162.28 0.25 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.796 0.838 . . . . 75.12 111.878 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' D' ' 32' ' ' PHE . 11.2 mt -128.42 92.19 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.423 -1.325 . . . . 71.14 107.423 165.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -87.94 153.69 21.1 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.99 -0.55 . . . . 74.15 110.611 -177.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -136.06 150.46 71.32 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.82 1.248 . . . . 74.41 109.088 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.28 -60.68 0.25 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.136 1.891 . . . . 71.11 111.441 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . 51.85 85.65 0.04 OUTLIER 'General case' 0 C--N 1.364 1.23 0 C-N-CA 124.704 1.202 . . . . 73.0 112.299 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.68 62.12 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 122.447 1.118 . . . . 53.12 110.339 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 11.0 m -89.93 58.92 4.37 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.304 1.049 . . . . 71.55 109.799 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 34.3 m -129.55 -10.08 4.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.767 -1.106 . . . . 65.54 110.743 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 70.0 p -67.36 165.4 29.16 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.826 0.85 . . . . 75.43 110.193 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo . . . . . 0 C--N 1.39 2.717 0 C-N-CA 123.641 2.894 . . . . 64.34 114.217 178.21 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.393 -0.225 . . . . 72.34 110.393 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -85.81 132.99 34.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.357 0.663 . . . . 75.21 109.955 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -89.11 -32.57 17.45 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.976 0.91 . . . . 73.43 110.452 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -73.26 86.36 1.44 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.749 0.82 . . . . 62.41 110.665 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -138.97 168.0 17.18 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 124.252 1.021 . . . . 75.32 109.97 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.13 173.41 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.596 2.197 . . . . 62.2 113.232 168.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 19.7 tp -84.08 41.7 0.83 Allowed 'General case' 0 CA--C 1.566 1.59 0 CA-C-O 122.019 0.914 . . . . 73.15 111.086 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.1 -60.79 1.82 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.53 -1.285 . . . . 73.31 107.53 168.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 82.98 -55.54 5.04 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 115.304 -0.862 . . . . 71.43 112.827 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 280' ' ' LEU . . . . . 0.622 ' HG ' ' H ' ' H' ' 281' ' ' PHE . 15.6 tp -128.61 -167.37 1.76 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.257 1.023 . . . . 42.2 108.658 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 281' ' ' PHE . . . . . 0.622 ' H ' ' HG ' ' H' ' 280' ' ' LEU . 23.8 t80 81.63 0.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.407 1.483 . . . . 73.33 111.952 170.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -100.25 86.25 3.17 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.032 -1.47 . . . . 72.13 107.032 168.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 21.6 t70 74.21 134.76 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.011 1.325 . . . . 73.54 110.664 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -168.83 144.35 8.69 Favored Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.677 -0.569 . . . . 71.42 111.677 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -122.83 127.71 49.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.276 0.63 . . . . 75.3 110.435 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -135.22 152.49 76.97 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.634 1.174 . . . . 74.23 108.252 173.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.79 70.48 2.12 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.847 2.365 . . . . 73.31 112.064 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 15.3 t -130.5 24.77 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 124.025 0.93 . . . . 74.0 109.014 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -55.99 -60.14 3.9 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.809 -0.811 . . . . 72.33 108.809 169.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -166.26 -179.9 5.31 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.508 1.523 . . . . 73.32 108.637 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 -169.01 1.63 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.365 1.066 . . . . 72.15 108.835 172.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.62 114.54 5.31 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 118.553 -1.137 . . . . 61.21 111.206 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.99 117.54 5.21 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.756 2.304 . . . . 74.32 113.535 -169.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -90.26 139.2 30.88 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.877 -1.157 . . . . 71.43 107.877 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -56.26 109.86 0.67 Allowed 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.088 0.867 . . . . 65.1 110.801 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 94.0 m -78.01 -51.38 10.44 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.908 0.883 . . . . 64.23 111.506 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -67.38 -75.98 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.481 -0.781 . . . . 72.41 111.614 -165.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 70.57 -56.23 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.868 1.267 . . . . 64.24 111.451 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 154.55 171.39 21.35 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 112.262 -0.335 . . . . 72.22 112.262 171.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -171.14 -46.47 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 106.378 -1.712 . . . . 74.03 106.378 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 29.5 pt -61.62 150.65 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 113.449 -1.705 . . . . 71.12 110.124 165.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -165.09 171.87 13.31 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.191 -0.67 . . . . 61.52 109.191 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 303' ' ' LYS . . . . . 0.423 ' HB2' ' HD3' ' H' ' 304' ' ' PRO . 52.2 mtpt -76.18 -54.66 1.95 Allowed Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 118.672 -0.68 . . . . 71.11 111.548 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 304' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' H' ' 303' ' ' LYS . 42.0 Cg_endo -84.12 44.06 1.48 Allowed 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.14 1.893 . . . . 71.41 111.747 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.75 -71.82 0.08 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.236 1.014 . . . . 72.12 111.619 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 306' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' C' ' 129' ' ' ALA . 15.6 m -144.4 123.96 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.197 0.599 . . . . 74.43 110.202 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 307' ' ' THR . . . . . 0.453 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 2.0 p -151.52 117.38 5.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.907 1.283 . . . . 54.44 108.908 172.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 57.9 m 62.43 173.31 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.612 1.165 . . . . 75.32 112.389 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 64.5 p -113.56 94.06 30.55 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.062 0.545 . . . . 74.33 109.982 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 C--N 1.377 2.045 0 C-N-CA 122.671 2.247 . . . . 53.53 109.897 167.133 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.954 0.407 . . . . 71.4 110.017 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.6 m -91.26 -69.19 0.75 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.652 0.781 . . . . 73.15 109.51 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 58.39 26.14 13.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.34 1.056 . . . . 71.43 112.93 174.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -86.42 165.32 16.42 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.235 0.614 . . . . 65.52 109.56 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -170.62 133.43 1.0 Allowed 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.989 0.916 . . . . 64.34 108.884 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 9' ' ' MET . 44.3 t-20 -87.81 108.83 19.34 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.939 -1.134 . . . . 74.42 107.939 176.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 p -66.21 -28.18 68.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.361 0.664 . . . . 65.15 111.743 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.28 -17.55 51.83 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.565 0.746 . . . . 52.42 111.622 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.458 ' HG3' HD12 ' A' ' 89' ' ' ILE . 57.3 ttp -60.8 134.23 56.88 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.304 0.573 . . . . 75.54 110.3 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m -143.04 117.48 9.68 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 114.611 -1.177 . . . . 72.43 108.384 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.72 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.2 t80 -123.83 117.69 25.44 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.527 -0.916 . . . . 73.01 108.527 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -141.62 112.67 7.37 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.832 -0.803 . . . . 74.5 108.832 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.662 HG21 ' HG2' ' C' ' 130' ' ' PRO . 66.5 mt -69.91 130.64 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 122.844 0.458 . . . . 73.05 109.986 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.519 ' O ' ' HB1' ' H' ' 305' ' ' ALA . 63.9 tt0 -96.47 -38.29 10.08 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.954 -0.546 . . . . 74.5 110.567 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -173.01 123.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.196 0.907 . . . . 73.34 112.686 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.83 133.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.582 -0.896 . . . . 70.55 108.582 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -167.88 158.5 10.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.243 1.017 . . . . 62.34 110.653 -172.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -91.73 115.24 27.89 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.347 -0.842 . . . . 72.05 109.425 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -85.56 -18.87 32.12 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.381 -0.372 . . . . 75.25 110.405 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.5 t70 -155.9 140.84 17.25 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.906 0.882 . . . . 75.14 109.735 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -140.73 135.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.447 1.499 . . . . 64.14 107.301 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 39.6 t -141.45 125.77 17.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.423 -0.955 . . . . 45.3 108.423 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -136.42 110.13 8.08 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.639 -1.245 . . . . 74.42 107.639 171.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.13 120.14 35.35 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.813 0.445 . . . . 55.02 109.945 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.78 80.79 14.45 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 107.633 -1.247 . . . . 34.34 107.633 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.75 -24.74 29.36 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.825 2.35 . . . . 73.53 113.061 -170.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -107.02 12.98 28.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.395 0.678 . . . . 54.23 111.269 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.08 4.24 Favored Pre-proline 0 CA--C 1.565 1.53 0 N-CA-C 114.964 1.468 . . . . 72.42 114.964 -165.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HB3' HD22 ' B' ' 51' ' ' LEU . 26.1 Cg_exo -56.74 -46.51 29.1 Favored 'Trans proline' 0 C--N 1.396 3.037 0 CA-C-N 122.107 1.788 . . . . 64.11 113.045 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -98.7 -6.99 28.54 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.94 0.896 . . . . 72.11 112.911 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.5 p -79.88 -20.18 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.615 -0.678 . . . . 52.22 111.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -86.52 -3.86 59.08 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.446 0.698 . . . . 74.14 112.016 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -100.64 -7.73 23.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.653 0.781 . . . . 73.33 111.0 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -70.29 163.92 25.52 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.738 0.815 . . . . 71.32 112.469 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.39 144.22 51.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.216 1.006 . . . . 64.24 110.049 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -87.24 73.98 9.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.703 0.764 . . . . 74.23 111.404 -169.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -143.41 84.1 10.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 114.614 -1.175 . . . . 74.4 108.066 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.26 136.28 11.29 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.335 2.023 . . . . 43.42 112.131 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -95.13 93.88 7.6 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.765 -1.569 . . . . 62.22 106.765 170.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 34.0 t -92.46 96.51 6.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.983 -1.008 . . . . 52.52 111.061 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.9 tttm -80.47 111.53 16.97 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.1 -0.955 . . . . 73.52 108.938 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.408 HD13 ' O ' ' E' ' 289' ' ' ARG . 10.5 tt -98.74 121.9 41.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.343 -0.984 . . . . 64.22 108.343 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.55 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 24.0 m-20 -116.72 150.32 38.4 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.356 1.062 . . . . 61.43 108.849 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -130.52 133.47 46.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.946 -0.761 . . . . 64.24 108.946 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -132.97 144.14 49.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.076 0.95 . . . . 73.51 108.769 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.501 ' HB ' ' CZ ' ' E' ' 281' ' ' PHE . 41.6 p -136.36 136.38 39.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.778 0.831 . . . . 63.11 109.466 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.6 111.03 5.59 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.977 0.511 . . . . 43.41 110.079 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -92.05 152.07 20.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.501 -0.555 . . . . 74.1 109.501 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -151.96 154.98 37.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.435 -1.32 . . . . 73.41 107.435 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -117.46 130.97 56.8 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.962 -0.755 . . . . 73.33 108.962 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -93.45 -40.48 10.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.513 0.725 . . . . 73.45 110.539 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.26 -177.23 6.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.904 0.882 . . . . 54.22 110.077 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.25 123.61 20.41 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.386 -0.598 . . . . 63.52 109.386 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 69.0 -8.1 0.71 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.809 1.643 . . . . 73.11 112.963 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.36 109.77 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.032 -0.729 . . . . 73.32 109.032 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.73 153.53 32.22 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.947 0.899 . . . . 64.53 108.67 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -129.73 118.95 22.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.337 1.055 . . . . 73.54 108.852 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.77 118.92 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.205 -1.035 . . . . 70.01 108.205 174.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 95.3 t -98.28 128.22 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 108.848 -0.797 . . . . 61.44 108.848 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.24 97.92 6.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.401 -1.703 . . . . 73.44 106.401 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 16.8 ttp180 -88.41 109.13 19.76 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.375 -0.602 . . . . 73.55 109.375 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 11.1 t -93.87 130.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.266 -1.383 . . . . 71.12 107.266 171.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -120.87 128.57 52.94 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.73 -0.841 . . . . 75.44 108.73 176.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.831 HG11 HD21 ' A' ' 126' ' ' LEU . 52.9 t -130.73 107.72 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.349 0.66 . . . . 75.3 109.874 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 13.5 m -102.81 141.23 35.97 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.465 -0.939 . . . . 61.44 108.465 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.53 46.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.004 -1.109 . . . . 73.3 108.004 173.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -142.76 127.46 18.1 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.858 0.463 . . . . 74.2 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 73' ' ' ALA . 9.2 mp -95.17 84.93 4.17 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.471 -1.307 . . . . 64.31 107.471 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -127.13 8.29 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.268 -1.333 . . . . 54.34 111.281 -171.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.28 -25.09 22.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 75.24 110.028 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.21 117.53 20.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.277 1.031 . . . . 72.41 110.296 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -66.79 128.4 36.16 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.122 0.889 . . . . 74.43 110.749 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -70.89 -62.91 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.393 -0.966 . . . . 72.13 108.393 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.22 166.07 33.29 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.713 -1.13 . . . . 73.03 110.183 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -132.41 135.8 46.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.163 -1.421 . . . . 71.12 107.163 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.1 m -134.96 101.05 4.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.562 0.745 . . . . 73.12 109.829 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 34.7 tt0 -125.81 116.01 20.91 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.207 -0.664 . . . . 62.0 109.207 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -128.88 111.63 23.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.088 0.955 . . . . 52.51 108.94 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.6 mt-30 -84.39 84.28 7.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.316 -0.994 . . . . 71.13 108.316 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.78 93.33 3.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.784 -1.098 . . . . 71.4 108.391 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.49 145.29 21.06 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.379 -0.828 . . . . 74.13 111.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -146.74 121.46 1.43 Allowed Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 111.188 -0.765 . . . . 63.41 111.188 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.2 mt -82.09 116.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.624 -0.88 . . . . 61.32 108.624 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.72 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.3 m-85 -121.83 121.55 37.44 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.335 1.054 . . . . 63.0 108.32 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -79.72 99.84 7.62 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.603 -0.888 . . . . 72.13 108.603 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.94 121.04 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.061 0.944 . . . . 65.45 109.375 -174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.27 161.53 42.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.387 0.675 . . . . 55.12 110.063 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 94.33 -29.81 8.47 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.69 0.636 . . . . 53.12 114.69 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.67 170.19 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.423 0.689 . . . . 71.14 109.976 178.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -152.74 172.29 16.92 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 123.553 0.533 . . . . 73.1 110.225 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.41 -116.31 3.49 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.422 1.487 . . . . 55.55 115.544 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 t -57.07 -31.74 65.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.31 1.444 . . . . 51.2 112.445 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -75.42 -39.15 59.28 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.482 0.713 . . . . 70.01 110.437 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mtp -77.4 -21.18 53.54 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.266 0.354 . . . . 75.53 110.617 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.484 ' HB1' HD12 ' E' ' 280' ' ' LEU . . . -72.28 -33.45 67.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.124 0.57 . . . . 73.22 109.708 172.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 44.1 t-80 -76.16 -35.15 59.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.199 -0.91 . . . . 65.33 110.204 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -70.25 -47.52 60.95 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 122.234 -0.291 . . . . 74.53 110.226 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.16 -40.48 62.54 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.878 -0.601 . . . . 75.44 110.942 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.69 4.25 59.49 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.239 -0.756 . . . . 43.31 114.781 -168.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.41 -68.51 0.27 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.178 0.989 . . . . 61.04 112.434 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 92.1 t80 -68.84 -51.37 41.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.87 0.868 . . . . 75.12 113.065 -167.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.8 m -73.57 -31.74 1.44 Allowed Pre-proline 0 CA--C 1.563 1.48 0 CA-C-O 118.402 -0.808 . . . . 63.23 113.081 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.4 -42.64 34.24 Favored 'Trans proline' 0 C--N 1.395 3.01 0 C-N-CA 122.594 2.196 . . . . 72.11 112.799 159.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.559 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 91.9 m-20 -64.63 -19.51 65.74 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.646 0.778 . . . . 71.23 112.093 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.1 mm -81.6 -46.43 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.307 -0.627 . . . . 63.11 109.307 173.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.509 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.3 mt -78.67 -30.56 46.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.049 0.94 . . . . 61.11 113.073 -171.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -69.78 -38.36 9.47 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.005 -0.997 . . . . 72.11 112.6 -169.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -41.93 71.07 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 122.277 1.984 . . . . 64.32 113.543 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -76.53 -32.37 58.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.146 0.578 . . . . 72.52 111.848 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.23 68.44 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.296 -0.631 . . . . 71.1 109.296 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -54.86 -47.19 74.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.651 1.18 . . . . 74.14 110.623 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.38 -47.14 74.33 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.161 0.913 . . . . 63.52 110.809 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -57.6 -43.79 84.95 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.382 0.673 . . . . 75.41 110.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.431 HG23 ' HB3' ' A' ' 76' ' ' CYS . 87.0 mt -64.69 -46.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 O-C-N 124.255 0.972 . . . . 74.32 110.142 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.7 m -52.89 -45.75 67.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.651 0.78 . . . . 61.4 111.28 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -69.37 -44.92 70.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.887 -1.051 . . . . 75.42 110.511 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -55.86 -44.59 78.19 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.654 0.781 . . . . 73.0 111.362 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 123' ' ' PHE . 41.0 t -61.9 -48.25 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.971 1.308 . . . . 74.21 110.59 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 77.9 p -68.02 -32.26 72.52 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.001 0.52 . . . . 63.45 111.628 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.29 -33.82 75.04 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.688 0.795 . . . . 74.04 110.366 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 9.53 66.54 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.462 -0.79 . . . . 61.32 113.308 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.825 HG21 ' HD2' ' B' ' 15' ' ' ARG . 17.9 m 73.2 9.13 5.28 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.388 1.075 . . . . 64.25 112.782 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.427 ' HB2' HG13 ' A' ' 118' ' ' VAL . 96.1 m-85 -85.47 138.5 36.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 107.762 -1.199 . . . . 74.32 107.762 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 24.5 Cg_endo -62.24 160.2 31.87 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.702 2.268 . . . . 75.51 112.622 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.1 tt0 -45.44 121.95 3.27 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 124.795 1.31 . . . . 71.43 112.507 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.831 HD21 HG11 ' A' ' 64' ' ' VAL . 48.8 tp -108.4 115.49 30.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.885 -1.052 . . . . 75.13 108.374 174.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -129.28 124.15 33.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.641 -1.163 . . . . 62.21 107.977 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.77 138.86 46.72 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.318 -0.623 . . . . 74.41 109.318 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.735 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -63.22 145.61 96.76 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 122.774 0.429 . . . . 61.32 110.359 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.61 ' HD3' HG22 ' C' ' 13' ' ' ILE . 23.8 Cg_exo -64.6 104.74 0.56 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.967 2.445 . . . . 75.14 112.455 -173.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.658 HG22 HD21 ' E' ' 291' ' ' LEU . 14.5 t -100.12 112.46 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.881 -1.155 . . . . 72.21 107.881 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -85.82 86.23 7.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.207 -1.405 . . . . 75.15 107.207 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 98.6 m-85 -60.71 -29.18 69.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.523 -0.762 . . . . 74.1 110.659 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.639 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.8 t70 -65.54 -50.73 64.13 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 123.762 0.825 . . . . 41.14 109.377 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.54 -38.73 88.5 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 124.773 1.295 . . . . 74.44 111.252 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -58.73 -47.41 84.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.734 0.814 . . . . 70.24 111.022 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -79.22 -24.21 43.26 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.133 0.573 . . . . 72.44 110.593 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.449 ' SD ' HD23 ' A' ' 141' ' ' LEU . 51.9 tpp -68.82 -30.72 69.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.494 0.718 . . . . 74.01 110.354 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 64.4 m-80 -69.63 -25.52 63.97 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.169 -0.469 . . . . 61.35 111.665 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -80.8 -36.84 31.19 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.993 0.517 . . . . 72.55 109.98 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.449 HD23 ' SD ' ' A' ' 138' ' ' MET . 29.8 tp -67.36 -48.36 67.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.254 1.022 . . . . 44.33 111.884 -174.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.29 11.82 0.11 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.085 0.554 . . . . 74.13 112.387 -172.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 20.6 tt0 64.84 -110.24 0.22 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.604 1.162 . . . . 63.33 110.081 -171.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -176.78 125.43 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.678 0.672 . . . . 65.32 109.79 -177.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.53 86.17 5.96 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.123 0.569 . . . . 65.03 109.914 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.62 138.78 16.65 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.76 -0.655 . . . . 71.33 112.626 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -162.42 144.22 10.68 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.195 0.598 . . . . 74.41 110.004 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.93 171.74 44.66 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.712 -0.676 . . . . 60.12 111.948 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 t -158.88 -175.16 5.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.4 0.68 . . . . 62.42 109.937 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.43 176.54 8.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.134 0.974 . . . . 74.43 109.503 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -151.68 125.01 8.8 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.854 -0.425 . . . . 63.5 109.854 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -89.07 157.01 18.48 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.95 0.5 . . . . 74.44 111.076 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -139.33 140.24 37.48 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.94 0.896 . . . . 74.44 109.119 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -123.42 174.98 7.01 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.442 0.697 . . . . 74.23 110.24 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.845 0.858 . . . . 61.2 109.41 179.249 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 109.576 -0.527 . . . . 75.12 109.576 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.1 m -131.98 7.17 4.33 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.166 0.987 . . . . 71.32 110.224 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 56.19 22.9 6.5 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.954 1.301 . . . . 70.51 112.061 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -141.03 127.71 20.23 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.223 1.409 . . . . 74.42 107.489 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' D' ' 148' ' ' GLY . 27.7 m120 -99.47 114.37 27.29 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.166 0.432 . . . . 64.32 112.166 -168.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -166.02 -72.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 44.31 109.885 171.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m 70.08 122.42 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.55 1.54 . . . . 74.55 112.29 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -124.7 -55.85 1.6 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.515 1.126 . . . . 64.43 109.274 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 13.8 ptm 52.52 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.084 2.553 . . . . 74.32 113.522 -164.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 25.3 m -159.02 123.82 4.11 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 106.935 -1.505 . . . . 74.04 106.935 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -139.74 130.69 26.22 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.25 -0.648 . . . . 75.12 109.25 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.532 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 2.6 pm0 -148.47 129.82 14.73 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.573 -0.528 . . . . 75.32 109.573 172.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.17 144.33 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 115.565 -0.743 . . . . 51.21 109.16 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -108.49 -47.49 3.49 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.456 -0.572 . . . . 74.43 109.456 169.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.825 ' HD2' HG21 ' A' ' 122' ' ' THR . 34.8 ttp180 -165.79 152.95 10.14 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.784 -0.644 . . . . 64.2 110.98 -170.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -131.73 139.25 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 107.343 -1.355 . . . . 64.41 107.343 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.59 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.6 p90 -161.46 168.69 23.27 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.785 0.803 . . . . 73.02 112.256 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.2 m -93.25 121.21 34.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.473 -1.239 . . . . 73.5 108.763 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.613 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 24.6 mtpp -87.66 -30.46 20.39 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.428 0.691 . . . . 75.25 110.614 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.86 145.6 18.58 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -174.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 28.3 mm -138.81 141.94 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.031 1.732 . . . . 70.04 109.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -150.45 117.4 5.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.181 -1.044 . . . . 71.31 108.181 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -131.81 116.18 16.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.259 -1.385 . . . . 74.11 107.259 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 157.56 27.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.405 0.682 . . . . 74.1 109.694 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -148.88 79.2 8.62 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.333 -1.358 . . . . 75.45 107.333 175.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.58 -9.81 20.09 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.006 2.471 . . . . 61.41 112.602 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.429 ' OD1' ' HB ' ' B' ' 72' ' ' THR . 3.0 m120 -116.63 11.25 14.64 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.214 1.006 . . . . 74.4 109.043 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.66 -54.51 26.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.779 1.232 . . . . 61.24 114.216 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.71 -23.27 14.63 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 121.696 1.597 . . . . 73.21 112.436 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.476 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 3.4 m-70 -90.33 -0.36 57.6 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.833 0.853 . . . . 62.54 112.044 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.95 -28.39 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.66 0.784 . . . . 72.31 111.857 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.0 -23.15 64.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.083 0.953 . . . . 65.31 112.146 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.623 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -70.0 -40.01 75.53 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.746 -0.465 . . . . 71.33 109.746 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.623 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 78.5 mttt -109.73 64.52 0.61 Allowed 'General case' 0 C--N 1.359 1.02 0 N-CA-C 108.434 -0.95 . . . . 73.14 108.434 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 9.4 p-10 -78.61 94.06 4.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.921 -0.581 . . . . 64.32 110.388 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' B' ' 35' ' ' ASP . 0.4 OUTLIER 173.93 -173.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.945 1.298 . . . . 75.13 111.024 159.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -55.08 117.99 16.22 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.037 1.335 . . . . 55.04 112.503 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.49 169.31 22.12 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.742 2.295 . . . . 74.31 111.166 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.55 102.01 3.73 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 106.882 -1.525 . . . . 74.53 106.882 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' H' ' 295' ' ' ALA . 13.7 m -89.95 140.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.807 -1.088 . . . . 71.44 108.976 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -119.1 130.57 55.66 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.239 -0.652 . . . . 73.54 109.239 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.65 HD21 HD11 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -86.04 136.91 33.05 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.032 -1.47 . . . . 63.45 107.032 168.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 18.4 t0 -142.88 128.36 19.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.77 -1.196 . . . . 75.43 107.77 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.471 HD22 ' HE1' ' B' ' 133' ' ' PHE . 1.4 mp -131.38 126.49 35.34 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.093 -1.077 . . . . 73.13 108.093 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.3 t70 -123.3 142.61 50.76 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.49 1.116 . . . . 75.23 108.371 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -117.39 119.26 34.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.088 0.555 . . . . 72.53 110.411 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.32 135.29 33.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.9 0.88 . . . . 64.34 108.912 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -134.62 169.91 16.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.318 0.647 . . . . 74.04 110.054 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -151.97 163.86 38.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.561 0.744 . . . . 70.33 110.232 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -108.58 120.08 41.39 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.812 -0.811 . . . . 71.32 108.812 170.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' B' ' 57' ' ' GLU . 17.6 mt -92.06 -46.03 8.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.847 0.859 . . . . 73.33 109.336 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.93 -178.86 6.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.3 -1.318 . . . . 74.03 108.803 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.52 122.39 18.94 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.956 -1.02 . . . . 73.22 108.825 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 71.59 -4.3 1.92 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.644 1.577 . . . . 73.11 112.699 -173.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.6 t -106.16 107.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.925 -0.769 . . . . 74.44 108.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' H' ' 278' ' ' LEU . 92.5 m-85 -120.43 140.71 50.97 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.182 0.993 . . . . 61.44 109.586 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.597 ' HB2' HD11 ' B' ' 51' ' ' LEU . 40.2 tt0 -102.72 138.48 39.57 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.916 0.886 . . . . 55.11 109.369 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -115.08 122.94 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.309 1.044 . . . . 75.01 108.301 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.94 116.21 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.539 0.736 . . . . 62.3 109.479 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.59 108.44 19.96 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.907 -0.775 . . . . 74.23 108.907 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.534 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 55.0 ttt180 -86.89 106.19 17.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.828 0.851 . . . . 72.14 108.834 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.02 115.72 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.948 -0.76 . . . . 62.04 108.948 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 16.8 m -116.12 136.12 53.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.211 1.004 . . . . 73.1 109.302 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.404 HG11 HD13 ' B' ' 126' ' ' LEU . 54.1 t -120.0 125.03 73.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.811 1.245 . . . . 63.45 109.086 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -124.89 125.9 44.68 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.689 -0.486 . . . . 61.01 109.689 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.88 146.48 48.39 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.309 1.044 . . . . 44.41 109.335 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.2 p -149.16 128.93 13.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.443 0.535 . . . . 72.02 112.443 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' B' ' 34' ' ' LYS . 82.7 mt -97.32 108.4 21.12 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.396 1.079 . . . . 74.12 109.299 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.57 -124.2 7.96 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.002 -0.545 . . . . 72.43 111.784 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.9 1.96 46.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.378 0.671 . . . . 60.24 110.857 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -127.71 177.18 6.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.942 -0.474 . . . . 72.11 110.651 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 72' ' ' THR . . . . . 0.429 ' HB ' ' OD1' ' B' ' 27' ' ' ASN . 11.9 m -68.49 157.46 35.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.534 1.133 . . . . 65.45 110.709 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -111.59 -58.68 2.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.018 -0.734 . . . . 65.54 109.018 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -162.73 158.45 22.98 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.237 -1.347 . . . . 61.2 108.266 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -124.08 138.71 54.4 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.724 1.209 . . . . 74.31 108.589 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -146.88 149.47 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.274 -0.639 . . . . 71.22 109.274 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -165.34 133.76 3.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.535 0.734 . . . . 73.21 109.036 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 113' ' ' CYS . 96.6 t -127.02 145.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.526 1.13 . . . . 64.54 108.704 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.534 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 73.7 mt-30 -126.03 96.89 4.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.258 -1.015 . . . . 70.22 108.258 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 42.8 tp60 -94.42 107.17 19.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.634 -0.712 . . . . 71.24 109.127 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.613 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -109.35 141.59 16.06 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.237 -0.745 . . . . 55.43 111.237 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.71 132.4 5.89 Favored Glycine 0 CA--C 1.503 -0.682 0 N-CA-C 110.35 -1.1 . . . . 73.45 110.35 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.469 HG23 HD12 ' B' ' 51' ' ' LEU . 80.5 mt -85.73 125.95 40.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 123.509 0.724 . . . . 75.44 109.164 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -133.06 160.93 35.75 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.421 1.088 . . . . 74.34 108.629 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.532 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 50.9 m -129.41 112.96 14.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.29 -1.004 . . . . 51.25 108.29 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.725 ' HB ' HD11 ' B' ' 89' ' ' ILE . 40.1 pt -119.31 144.45 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.228 1.011 . . . . 74.04 110.314 -173.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.57 156.65 33.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 72.25 109.092 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.72 -61.11 3.5 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.304 0.377 . . . . 72.34 112.542 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.725 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 133.59 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.524 0.73 . . . . 74.21 111.676 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -152.02 147.51 26.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.073 0.549 . . . . 74.14 110.433 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.42 -104.41 0.98 Allowed Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.468 -0.787 . . . . 53.35 112.506 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -78.58 -35.04 46.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 74.11 110.465 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -64.99 -41.71 95.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.329 0.652 . . . . 63.42 110.021 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 58.4 ttp -70.13 -37.43 75.3 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.813 -0.631 . . . . 73.4 110.66 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.19 75.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.066 0.547 . . . . 72.44 111.258 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.82 -41.8 59.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.504 0.722 . . . . 73.41 110.628 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.83 -65.53 0.73 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.85 -0.614 . . . . 53.35 110.235 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -34.42 78.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.277 1.031 . . . . 65.43 111.305 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.79 54.73 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.568 -0.573 . . . . 51.22 114.509 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.41 -57.84 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 117.824 0.812 . . . . 65.43 112.012 -173.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -61.88 -56.83 15.26 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.991 0.916 . . . . 72.05 112.036 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.422 ' HA ' HD12 ' B' ' 105' ' ' ILE . 61.9 m -62.39 -43.24 84.28 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 124.124 0.969 . . . . 72.53 112.808 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.38 -46.38 33.88 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.536 2.157 . . . . 74.43 112.757 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -61.78 -20.44 63.58 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 123.719 0.808 . . . . 54.11 112.743 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 102' ' ' CYS . 73.3 mt -71.58 -52.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.022 0.529 . . . . 64.31 110.311 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 pp -91.41 -6.18 53.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.554 -0.748 . . . . 63.04 112.166 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.22 -44.36 88.46 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.58 1.152 . . . . 75.35 112.684 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -53.21 -34.82 71.11 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.674 2.25 . . . . 70.04 113.802 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' D' ' 115' ' ' THR . 76.6 m-85 -73.46 -42.57 61.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.16 0.584 . . . . 74.15 110.515 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.31 98.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.132 0.573 . . . . 52.41 110.558 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.427 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 47.8 ttt-85 -57.27 -57.66 11.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.903 1.281 . . . . 72.32 111.089 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.03 -28.07 68.59 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.225 1.01 . . . . 75.45 110.876 -172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.1 t -74.0 -41.51 61.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.623 0.369 . . . . 73.41 110.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.428 HG21 HD22 ' B' ' 126' ' ' LEU . 63.1 mt -62.09 -41.68 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.375 -0.602 . . . . 61.34 109.375 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.592 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.5 m -62.28 -35.99 80.7 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.714 1.206 . . . . 64.52 111.449 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -70.01 -52.77 21.42 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.12 0.568 . . . . 73.21 109.875 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -65.43 -36.97 85.53 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.713 0.633 . . . . 74.14 112.028 -170.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' B' ' 123' ' ' PHE . 10.7 p -69.63 -34.12 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 122.481 0.312 . . . . 73.51 110.651 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -77.05 -21.73 54.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.341 0.656 . . . . 70.23 111.066 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -73.54 -34.65 65.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.13 0.572 . . . . 75.23 109.822 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.71 5.65 45.14 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.706 0.629 . . . . 62.24 112.549 169.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.4 p 59.43 46.83 11.87 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.614 1.965 . . . . 73.54 111.679 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.431 ' HB2' HG22 ' B' ' 118' ' ' VAL . 33.4 m-85 -119.48 157.05 52.64 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 113.898 -1.501 . . . . 75.01 109.781 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.46 ' HG3' ' O ' ' H' ' 300' ' ' ASN . 50.3 Cg_exo -55.57 143.89 76.73 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.902 2.401 . . . . 74.24 112.178 173.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.592 ' HB2' HG23 ' B' ' 115' ' ' THR . 24.7 pt20 -63.44 156.68 25.39 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.064 0.852 . . . . 64.54 111.993 -174.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.428 HD22 HG21 ' B' ' 114' ' ' ILE . 9.7 tt -125.23 105.01 8.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.353 -1.351 . . . . 75.32 107.353 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -91.44 115.72 28.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.997 -0.742 . . . . 70.44 108.997 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.65 HD11 HD21 ' B' ' 42' ' ' LEU . 1.1 mm? -67.16 107.56 2.37 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.197 -1.038 . . . . 72.31 108.197 166.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 158.05 54.68 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.127 0.971 . . . . 73.4 111.154 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -61.43 85.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 122.261 1.974 . . . . 74.12 112.153 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.07 110.79 22.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.269 -0.641 . . . . 75.45 109.269 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 22.8 t30 -82.3 104.22 12.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.256 -1.016 . . . . 73.15 108.256 173.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 133' ' ' PHE . . . . . 0.471 ' HE1' HD22 ' B' ' 44' ' ' LEU . 87.1 m-85 -58.94 -37.05 75.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.429 0.692 . . . . 74.41 111.306 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.74 -27.98 69.27 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.758 0.823 . . . . 73.22 111.68 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.436 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -64.74 -35.65 81.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.689 0.396 . . . . 71.42 110.902 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.9 mp -67.69 -45.49 75.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.302 0.641 . . . . 74.23 109.743 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -65.67 -35.63 81.34 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.018 -0.537 . . . . 71.42 111.391 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -70.8 -40.51 72.48 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.314 0.645 . . . . 75.01 110.39 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -75.48 -8.09 55.81 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.399 0.279 . . . . 72.53 111.6 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -79.05 -49.95 11.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.748 0.419 . . . . 75.24 110.946 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.8 -4.64 16.74 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.362 0.505 . . . . 71.32 112.362 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -136.82 139.56 41.83 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.327 0.584 . . . . 54.32 110.316 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.22 -178.26 6.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.279 1.032 . . . . 75.42 110.71 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -65.18 132.47 49.19 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.898 -0.592 . . . . 75.41 109.544 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.82 126.97 13.78 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.832 -0.803 . . . . 71.21 108.832 174.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.613 ' HA3' ' HG2' ' D' ' 8' ' ' GLU . . . -88.24 54.75 4.24 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.584 0.553 . . . . 32.11 112.539 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.36 170.94 9.02 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.922 0.889 . . . . 72.34 110.603 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.02 172.04 39.61 Favored Glycine 0 C--O 1.24 0.511 0 N-CA-C 110.912 -0.875 . . . . 52.24 110.912 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.2 m -142.55 142.77 32.25 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.201 -0.666 . . . . 61.44 109.201 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.15 107.63 19.72 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.861 0.864 . . . . 72.01 109.438 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.11 110.31 16.5 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.016 0.526 . . . . 72.42 110.116 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -85.42 141.69 29.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.196 -0.911 . . . . 65.21 109.983 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -149.43 131.71 15.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.988 0.915 . . . . 62.13 109.397 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -115.64 93.4 4.25 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.217 -1.031 . . . . 75.42 108.217 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.116 0 C-N-CA 124.113 0.965 . . . . 72.0 110.547 -176.552 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.689 -0.486 . . . . 75.45 109.689 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.6 p -170.04 177.24 4.36 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.702 0.801 . . . . 70.02 110.707 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.36 -176.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.656 1.182 . . . . 74.3 112.196 177.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -136.95 136.24 38.41 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.858 -0.423 . . . . 74.41 109.858 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 23.3 m-80 -83.18 110.29 17.92 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.238 1.015 . . . . 73.4 110.33 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.436 ' OD1' ' HG2' ' C' ' 8' ' ' GLU . 23.2 t-20 -66.59 135.83 54.72 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.46 0.704 . . . . 73.51 109.457 170.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -118.55 78.0 1.22 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.567 0.747 . . . . 41.32 110.781 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.436 ' HG2' ' OD1' ' C' ' 6' ' ' ASN . 62.1 mm-40 -71.78 144.09 49.31 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.702 -0.681 . . . . 73.41 109.853 168.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.638 ' HA ' HD12 ' C' ' 89' ' ' ILE . 58.0 ttp 65.47 115.76 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.912 1.285 . . . . 74.03 113.133 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 6.6 m -93.77 80.52 4.21 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.588 -0.893 . . . . 62.54 108.588 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -104.45 126.91 51.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.597 -0.729 . . . . 70.12 109.669 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' C' ' 85' ' ' SER . 1.6 pm0 -143.23 132.85 23.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.855 0.862 . . . . 63.23 109.808 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.61 HG22 ' HD3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -79.56 130.28 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.516 0.726 . . . . 61.52 109.213 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.6 mm100 -92.58 -54.2 3.88 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.398 -0.364 . . . . 72.5 110.104 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -169.02 126.84 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.825 0.45 . . . . 72.15 109.961 -173.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.602 HG13 HD11 ' C' ' 13' ' ' ILE . 80.0 mt -106.13 145.0 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.428 -1.323 . . . . 54.14 107.428 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.502 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 36.8 p90 -174.38 143.74 0.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.045 -0.724 . . . . 74.01 109.045 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -69.84 111.35 5.52 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.644 -0.873 . . . . 65.51 108.644 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -65.36 -42.18 93.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.594 0.711 . . . . 71.34 109.506 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -149.06 141.87 24.63 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.433 -1.258 . . . . 73.24 108.951 -176.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.1 mt -130.46 143.43 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.092 -1.447 . . . . 73.22 107.092 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -152.87 151.29 30.22 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.41 0.624 . . . . 70.52 110.897 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 73.1 t80 -152.41 121.19 6.51 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 107.101 -1.444 . . . . 73.15 107.101 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.3 mt-10 -122.85 112.08 17.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.23 80.96 67.18 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.032 -1.099 . . . . 64.12 108.032 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.2 -36.65 16.08 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.169 1.912 . . . . 75.44 111.135 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.461 ' O ' HG23 ' C' ' 31' ' ' VAL . 1.7 m-20 -85.07 14.25 5.24 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.465 1.106 . . . . 73.34 111.174 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.43 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -42.3 -56.99 4.88 Favored Pre-proline 0 N--CA 1.497 1.88 0 C-N-CA 125.773 1.629 . . . . 75.23 114.599 -171.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.4 -29.43 13.74 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.754 1.636 . . . . 74.11 111.997 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -69.76 -24.92 63.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.211 1.004 . . . . 74.53 112.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.567 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 58.4 t -64.4 -26.87 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.246 0.218 . . . . 61.2 111.226 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.02 0.0 12.61 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.875 0.695 . . . . 75.34 112.875 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -127.97 9.17 6.28 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.393 0.677 . . . . 72.24 110.959 170.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.698 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 3.4 ttmp? -87.9 151.92 22.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.335 1.054 . . . . 71.24 111.229 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.36 125.82 26.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.805 1.242 . . . . 73.15 109.617 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -82.78 70.84 9.85 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.277 0.631 . . . . 73.43 110.181 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -163.08 71.38 1.97 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.154 0.581 . . . . 73.02 109.924 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.04 154.14 8.37 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.86 2.374 . . . . 41.15 110.629 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.14 88.08 7.61 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.522 -1.288 . . . . 73.43 107.522 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.525 HG23 ' NE1' ' F' ' 290' ' ' TRP . 3.5 m -59.04 137.34 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 114.4 -1.273 . . . . 73.43 109.948 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 8.8 tmtt? -135.99 115.77 13.04 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.026 0.531 . . . . 70.43 109.771 -166.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.58 130.37 34.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.024 0.929 . . . . 75.21 108.591 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.2 t70 -142.78 106.34 4.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.827 0.451 . . . . 62.4 109.933 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.42 123.02 49.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.463 0.705 . . . . 74.31 110.315 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 2.5 m-20 -111.71 154.29 25.2 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.426 -0.953 . . . . 75.1 108.426 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -113.35 111.69 22.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.672 0.789 . . . . 74.13 109.379 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.21 136.49 53.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.159 0.984 . . . . 62.43 108.914 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.5 p -134.85 156.68 48.48 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.999 0.52 . . . . 73.33 110.283 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.28 126.82 15.08 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.257 1.023 . . . . 61.14 108.376 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -88.25 117.25 27.02 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.105 -1.072 . . . . 73.0 108.105 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.685 HD11 HD12 ' C' ' 83' ' ' ILE . 58.3 mt -87.71 -40.47 14.09 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.502 -0.772 . . . . 72.24 109.521 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.75 -173.01 3.07 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.718 -1.128 . . . . 73.54 110.101 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.56 120.56 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.719 -1.128 . . . . 61.23 109.049 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' C' ' 85' ' ' SER . 7.1 m-20 69.64 1.13 3.25 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.978 1.311 . . . . 63.02 112.831 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -112.01 95.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 107.757 -1.201 . . . . 61.31 107.757 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -119.64 125.59 49.1 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.759 0.824 . . . . 74.13 109.615 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.2 119.43 24.54 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.022 -0.99 . . . . 62.45 109.531 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.401 HG13 ' CZ ' ' F' ' 281' ' ' PHE . 98.0 t -100.11 123.02 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.854 -1.165 . . . . 73.21 107.854 172.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.84 132.76 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.875 0.87 . . . . 63.3 108.699 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.78 112.23 23.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.38 -0.97 . . . . 73.24 108.38 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.672 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 1.6 tmm_? -82.53 104.18 12.61 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.847 -1.538 . . . . 72.44 106.847 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.22 133.22 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.264 -1.013 . . . . 54.42 108.264 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 94.3 m -128.77 133.88 48.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.159 -1.052 . . . . 71.02 108.159 175.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 39.1 t -121.43 112.2 34.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.751 -0.833 . . . . 71.04 108.751 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.532 HG23 HD23 ' C' ' 75' ' ' LEU . 2.2 m -99.74 148.72 24.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.704 -0.85 . . . . 72.52 108.704 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.96 108.43 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.342 -1.355 . . . . 63.53 107.342 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.0 m -146.67 139.85 25.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.06 -0.718 . . . . 73.33 109.06 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.92 45.99 0.94 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.131 0.972 . . . . 64.34 109.228 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.88 -116.61 4.05 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 114.795 -1.093 . . . . 73.31 111.043 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 -19.85 26.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.318 0.647 . . . . 73.31 110.024 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.698 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 12.4 tp10 -81.31 99.84 8.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.178 0.991 . . . . 60.34 109.252 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -87.96 131.25 34.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.984 0.421 . . . . 75.1 110.602 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.653 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -79.0 -64.0 1.29 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.616 1.166 . . . . 71.5 110.385 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -163.34 176.57 9.74 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.586 0.708 . . . . 62.41 110.149 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.532 HD23 HG23 ' C' ' 65' ' ' THR . 2.9 tm? -141.56 139.13 33.1 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.603 -1.628 . . . . 73.22 106.603 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 50.0 t -143.87 116.25 8.54 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.029 -0.73 . . . . 73.25 109.029 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -124.77 131.96 53.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.515 0.726 . . . . 72.0 109.414 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -132.99 115.73 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.233 1.013 . . . . 62.12 109.386 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.672 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 40.4 mt-30 -89.45 91.25 8.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.319 1.048 . . . . 64.22 108.209 172.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -88.79 119.04 28.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.321 -0.854 . . . . 75.2 110.122 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.39 159.3 15.04 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 123.588 0.555 . . . . 64.2 112.26 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.04 119.13 0.88 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.567 -1.013 . . . . 74.12 110.567 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.685 HD12 HD11 ' C' ' 51' ' ' LEU . 18.2 mm -79.78 122.08 34.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.607 -1.257 . . . . 72.52 107.607 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.72 124.79 36.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.548 0.739 . . . . 73.25 109.233 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.676 ' HB3' ' HG2' ' C' ' 12' ' ' GLN . 10.5 t -87.46 109.84 19.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.091 -1.077 . . . . 60.24 108.091 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.417 HD12 ' SD ' ' C' ' 94' ' ' MET . 22.6 pt -115.32 123.24 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.801 1.24 . . . . 73.14 109.205 -175.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -150.75 170.42 19.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.816 0.446 . . . . 72.34 111.726 -171.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.34 -48.34 1.92 Allowed Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.372 -0.831 . . . . 33.12 113.149 170.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.74 176.32 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.401 0.681 . . . . 62.15 110.929 -174.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.48 -171.23 3.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.028 0.931 . . . . 72.32 109.196 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' HB2' ' F' ' 275' ' ' LYS . . . 69.08 -147.98 47.02 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.527 0.517 . . . . 73.3 113.193 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 73.7 p -67.9 -18.69 64.86 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.007 0.923 . . . . 73.35 111.733 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.57 ' HG3' ' HB3' ' F' ' 272' ' ' ASN . 88.3 mt-30 -66.25 -43.95 85.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.684 0.794 . . . . 71.1 110.278 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.417 ' SD ' HD12 ' C' ' 86' ' ' ILE . 3.5 tmm? -81.32 -44.56 17.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.518 -0.765 . . . . 73.51 109.189 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' F' ' 280' ' ' LEU . . . -61.8 -25.67 67.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.237 1.015 . . . . 64.04 112.117 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 28.0 t-80 -58.56 -47.16 85.17 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.701 0.8 . . . . 71.14 110.334 171.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.86 -55.07 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.352 -0.386 . . . . 70.24 111.292 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tt -62.09 -35.83 79.87 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.014 0.525 . . . . 71.22 111.462 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.0 -4.86 62.91 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.045 -0.864 . . . . 61.22 114.437 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.35 -53.07 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 118.558 1.179 . . . . 62.15 112.681 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.76 -48.18 60.26 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.973 0.509 . . . . 74.35 112.121 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.28 -43.76 94.29 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.449 0.7 . . . . 72.22 111.988 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.94 -47.37 21.69 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.78 2.32 . . . . 65.43 113.909 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -62.37 -29.12 70.25 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.392 0.677 . . . . 34.24 112.178 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -75.1 -50.84 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.926 0.491 . . . . 62.11 110.252 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.14 -18.41 53.23 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.909 -0.587 . . . . 73.44 112.225 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.52 -54.6 53.27 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.677 -1.154 . . . . 71.31 112.702 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.79 -32.2 92.63 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.939 1.759 . . . . 75.1 112.843 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.402 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.0 m-85 -66.45 -47.32 73.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.541 0.737 . . . . 73.14 110.962 177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.91 84.62 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.122 0.569 . . . . 72.15 110.524 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.595 ' HG3' HD23 ' C' ' 128' ' ' LEU . 56.2 ttt180 -61.1 -49.17 78.4 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.907 1.283 . . . . 74.2 110.943 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.34 -29.99 69.69 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.619 0.574 . . . . 73.14 110.082 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.0 t -73.91 -36.56 64.73 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.182 0.593 . . . . 74.01 111.42 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.595 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 91.7 mt -68.63 -47.85 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.486 0.714 . . . . 74.04 109.754 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 98.7 m -60.45 -35.78 76.67 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.077 1.351 . . . . 71.34 111.306 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -41.68 80.67 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.51 0.724 . . . . 74.21 109.844 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.613 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.37 -35.09 78.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.334 0.654 . . . . 75.23 111.796 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.7 t -62.56 -44.11 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.407 0.683 . . . . 73.31 109.896 173.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.7 p -75.03 -25.78 58.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.549 -0.75 . . . . 51.13 112.223 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.526 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.2 mtt-85 -74.58 -40.17 61.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.69 0.796 . . . . 74.1 110.391 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 3.1 66.13 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.736 0.647 . . . . 64.22 112.56 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.0 p 61.31 24.32 14.44 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.154 1.781 . . . . 54.23 112.533 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -83.88 154.65 64.6 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.739 -1.119 . . . . 74.12 110.118 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.771 ' HD3' HD13 ' F' ' 301' ' ' ILE . 92.9 Cg_exo -47.71 137.16 21.27 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.483 2.789 . . . . 75.12 113.154 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' B' ' 125' ' ' GLN . 23.7 mm-40 -60.95 147.26 43.91 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.205 1.187 . . . . 63.21 114.205 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 68.3 tp -125.14 96.1 4.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.483 -1.235 . . . . 74.44 108.693 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 -100.8 105.1 16.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.489 -0.93 . . . . 74.42 108.489 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.595 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -71.15 151.26 44.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.699 0.8 . . . . 74.42 111.935 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.09 155.61 72.35 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 115.151 -0.931 . . . . 51.13 109.946 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' A' ' 13' ' ' ILE . 34.4 Cg_exo -60.54 102.63 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.375 2.05 . . . . 45.12 111.95 171.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.18 106.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 106.7 -1.592 . . . . 74.42 106.7 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -113.03 91.63 3.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.109 -0.951 . . . . 72.52 109.767 -169.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.521 ' HD1' ' SD ' ' F' ' 286' ' ' MET . 89.9 m-85 -64.35 -43.91 93.1 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 72.32 110.878 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.75 -38.77 70.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.245 -0.889 . . . . 74.24 111.419 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.59 -28.84 68.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.413 -0.812 . . . . 70.51 111.63 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 61.9 tp -54.45 -45.57 73.11 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.693 0.797 . . . . 73.54 110.668 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -64.58 -43.07 95.03 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.772 -0.649 . . . . 74.13 111.008 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 59.5 mtt -60.35 -42.96 96.81 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.076 0.95 . . . . 72.51 112.714 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -60.31 -36.56 78.18 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.601 0.76 . . . . 72.04 112.57 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -61.85 -83.35 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.188 0.995 . . . . 73.23 112.238 -171.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.87 105.58 5.2 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.28 0.632 . . . . 62.51 110.878 -173.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.39 130.4 36.48 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.552 -1.277 . . . . 60.12 107.552 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -78.71 -73.63 0.32 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.153 0.581 . . . . 72.35 110.09 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -172.76 -179.7 2.17 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.861 0.865 . . . . 64.33 110.059 -173.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.53 140.73 42.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.136 0.974 . . . . 55.25 108.774 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.97 -134.86 5.38 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.121 -0.792 . . . . 75.23 111.121 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -111.46 175.47 5.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.294 0.638 . . . . 75.33 110.569 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.13 -154.43 11.6 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.012 -0.995 . . . . 71.1 110.964 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.2 m 51.51 53.8 12.16 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.795 1.238 . . . . 64.24 111.943 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -123.36 94.13 4.16 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 108.674 -0.862 . . . . 71.41 108.674 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.57 106.93 15.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.994 -1.003 . . . . 74.13 110.358 -177.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -109.57 136.67 48.57 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.72 -0.844 . . . . 73.5 108.72 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -145.92 137.77 25.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.686 0.794 . . . . 73.52 109.507 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -153.68 155.98 37.01 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.133 0.973 . . . . 65.35 109.308 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 N-CA-C 108.985 -0.746 . . . . 55.12 108.985 -178.101 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.918 -0.401 . . . . 63.32 109.918 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.4 t -132.13 81.66 1.98 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.448 -1.316 . . . . 72.22 107.448 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -79.02 -52.98 7.49 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.153 -0.93 . . . . 73.1 111.689 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 69.05 -66.84 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.416 1.486 . . . . 74.51 110.813 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.76 39.25 8.63 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.113 1.365 . . . . 62.01 110.843 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -119.76 -64.64 1.24 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.078 0.951 . . . . 53.32 108.908 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -153.2 83.22 1.2 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.121 0.968 . . . . 71.35 109.547 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.613 ' HG2' ' HA3' ' B' ' 146' ' ' GLY . 4.6 mp0 -90.2 -165.32 1.32 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.365 0.666 . . . . 70.13 109.796 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.1 ttp -33.28 125.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.249 1.02 . . . . 74.12 111.961 167.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.8 m -129.96 137.53 50.38 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 175.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -157.79 98.62 1.65 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.057 -1.46 . . . . 73.0 107.057 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -130.18 128.1 41.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.652 -1.24 . . . . 74.43 107.652 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.421 HD13 HG21 ' D' ' 105' ' ' ILE . 17.5 mt -70.87 136.28 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 123.685 0.616 . . . . 63.42 110.329 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.612 ' HA ' ' HB3' ' F' ' 304' ' ' PRO . 21.2 mt-30 -94.71 -47.54 6.45 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.682 -0.69 . . . . 74.44 110.29 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.04 145.88 22.48 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.3 0.64 . . . . 71.32 110.558 -166.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 mp -133.23 137.02 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 105.033 -2.21 . . . . 75.24 105.033 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -169.22 153.3 5.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.634 0.73 . . . . 74.41 110.691 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -84.4 118.43 24.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.688 -0.856 . . . . 74.2 108.688 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.4 mtpt -80.2 -37.61 32.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 54.52 110.228 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 22.3 t70 -151.1 140.87 21.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.914 -1.039 . . . . 72.43 109.129 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.613 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.1 mt -135.98 145.65 30.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 124.252 1.021 . . . . 73.44 108.25 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 22' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 45.2 t -147.88 133.52 18.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 54.34 108.244 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.4 t80 -144.68 117.58 8.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.849 -1.908 . . . . 71.11 105.849 170.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.14 129.0 51.93 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.294 -0.632 . . . . 71.31 109.294 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.21 79.67 27.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.205 -1.035 . . . . 73.04 108.205 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.86 -28.28 20.15 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.66 2.24 . . . . 62.12 112.743 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -113.71 40.69 2.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.501 -0.925 . . . . 72.43 108.501 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.502 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.97 -65.08 2.22 Favored Pre-proline 0 CA--C 1.568 1.666 0 N-CA-C 114.139 1.163 . . . . 61.12 114.139 -167.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.82 -11.0 11.53 Favored 'Trans proline' 0 C--N 1.393 2.901 0 CA-C-N 122.624 1.973 . . . . 74.3 112.067 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -71.4 -42.9 67.78 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.931 1.292 . . . . 75.14 110.107 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.23 -35.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 N-CA-C 109.504 -0.554 . . . . 74.1 109.504 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -58.05 -12.13 3.12 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.395 1.078 . . . . 74.11 113.55 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.64 -36.55 51.42 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.181 0.593 . . . . 75.45 110.685 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 60.97 1.67 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.861 0.464 . . . . 75.21 111.399 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -98.6 101.23 12.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.675 . . . . 72.03 111.044 -169.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -122.59 -158.98 0.81 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.195 0.998 . . . . 64.14 108.671 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -58.24 106.52 0.71 Allowed Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.539 0.736 . . . . 74.3 110.589 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.35 122.21 5.06 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.819 2.346 . . . . 71.52 110.515 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.96 111.28 6.22 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.902 -1.148 . . . . 61.44 107.902 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.611 HG23 ' HE1' ' G' ' 290' ' ' TRP . 29.3 m -100.9 144.86 12.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.318 0.647 . . . . 63.42 110.081 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -120.05 129.22 54.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 63.24 108.468 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.01 112.11 24.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.506 -0.553 . . . . 75.23 109.506 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.785 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 12.9 m-20 -108.07 132.05 53.96 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.994 0.918 . . . . 75.21 109.912 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.613 HD11 HG12 ' G' ' 288' ' ' VAL . 5.0 mp -110.8 131.41 55.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.262 0.625 . . . . 73.12 109.434 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.8 t70 -133.55 131.46 39.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.487 -1.301 . . . . 52.41 107.487 172.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -105.52 141.81 36.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.98 0.512 . . . . 42.34 109.883 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.64 164.04 37.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.787 0.835 . . . . 54.12 109.071 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.55 ' HB2' HD11 ' G' ' 278' ' ' LEU . 51.1 p -174.92 161.04 2.94 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.376 0.67 . . . . 74.32 110.896 -178.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 86.6 p -152.17 145.71 24.91 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.76 0.824 . . . . 73.43 109.474 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -81.92 130.93 35.22 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.284 -0.636 . . . . 64.31 109.284 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' D' ' 57' ' ' GLU . 54.6 mt -104.38 -34.93 8.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.134 0.573 . . . . 65.3 109.511 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.51 -174.88 4.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.159 0.584 . . . . 71.24 111.082 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.34 116.14 7.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.535 -1.211 . . . . 71.32 109.189 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 68.05 7.25 5.7 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.465 1.106 . . . . 64.14 112.126 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 88.1 t -113.51 119.06 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.322 1.049 . . . . 64.55 108.533 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.49 134.2 31.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.705 0.402 . . . . 75.12 110.055 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' D' ' 51' ' ' LEU . 11.0 tt0 -88.22 114.5 24.9 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.857 -1.164 . . . . 72.25 107.857 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.09 120.11 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.617 -1.253 . . . . 44.54 107.617 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.9 t -105.61 131.93 53.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.668 0.787 . . . . 53.33 109.064 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.24 108.15 13.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.497 -1.297 . . . . 74.25 107.497 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.3 ttm-85 -84.11 106.24 15.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.991 -0.744 . . . . 72.15 108.991 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.26 130.49 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.267 -1.012 . . . . 73.22 108.267 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 54.2 m -124.73 147.47 48.62 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.429 0.691 . . . . 72.5 109.15 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -135.95 115.74 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.666 1.186 . . . . 74.24 109.07 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.5 m -106.29 103.63 13.15 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 74.11 109.446 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.431 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -97.18 125.06 41.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.456 0.302 . . . . 62.42 110.386 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 52.2 p -125.55 125.47 43.27 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.001 0.92 . . . . 63.52 109.359 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' D' ' 73' ' ' ALA . 3.2 tm? -104.47 114.05 28.02 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.455 -0.943 . . . . 75.13 108.455 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -111.22 3.84 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.621 0.575 . . . . 34.52 111.998 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 8.38 19.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.12 0.968 . . . . 74.42 110.97 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 175.26 9.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.492 0.717 . . . . 64.44 110.119 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -80.28 137.06 36.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.495 0.718 . . . . 51.1 111.07 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' D' ' 68' ' ' LEU . . . -84.89 -63.97 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.718 -0.845 . . . . 71.03 108.718 170.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.46 168.67 24.75 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.423 -1.262 . . . . 73.21 109.994 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 97.7 mt -132.7 151.62 51.93 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.89 -1.152 . . . . 73.54 107.89 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.633 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -154.9 141.29 18.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.155 0.582 . . . . 71.21 109.939 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 33.3 tt0 -158.14 134.68 9.59 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 71.13 109.995 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.94 126.23 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.746 0.818 . . . . 74.42 109.302 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -97.22 87.22 4.12 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.678 -1.23 . . . . 72.01 107.678 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.89 98.76 8.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.847 -0.615 . . . . 70.12 109.562 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.49 144.36 17.13 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.596 -0.729 . . . . 45.55 111.698 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.49 131.05 3.74 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.314 -0.715 . . . . 71.05 111.314 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -90.33 126.98 43.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.376 -0.972 . . . . 61.24 108.376 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -126.96 144.39 51.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.01 0.924 . . . . 64.2 110.075 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -96.81 94.51 7.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.51 -0.922 . . . . 74.25 108.51 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 mt -108.78 101.06 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.361 -0.607 . . . . 71.35 109.361 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.42 1.088 . . . . 61.34 109.838 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.81 -11.33 59.97 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 114.343 0.497 . . . . 44.53 114.343 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.21 154.46 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.021 0.928 . . . . 70.21 110.781 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 -174.52 4.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.283 1.033 . . . . 75.33 110.043 172.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.54 -140.51 39.01 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 114.282 0.473 . . . . 65.01 114.282 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.9 p -70.84 -32.6 69.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.315 1.046 . . . . 75.12 112.037 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.19 -43.45 78.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.715 0.806 . . . . 70.22 110.649 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -74.06 -32.81 63.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.811 -0.631 . . . . 61.51 110.506 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' G' ' 280' ' ' LEU . . . -60.38 -43.37 96.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.943 0.497 . . . . 53.3 110.461 174.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.09 -36.05 76.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.715 0.806 . . . . 74.4 110.884 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.54 -50.43 67.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.864 0.465 . . . . 75.43 111.498 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.485 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 2.9 pp -75.63 -23.35 56.35 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 111.974 0.361 . . . . 60.44 111.974 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 99' ' ' GLY . . . . . 0.463 ' HA3' HD23 ' G' ' 280' ' ' LEU . . . -99.33 -0.98 56.84 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.53 -0.595 . . . . 72.4 114.361 -172.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.6 -60.69 0.51 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.241 0.52 . . . . 51.42 111.068 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -68.18 -45.71 72.71 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.577 0.751 . . . . 64.25 111.51 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 63.5 m -65.66 -45.76 67.06 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-O 118.695 -0.669 . . . . 72.13 112.018 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 84.0 Cg_exo -54.25 -34.93 81.62 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.665 2.243 . . . . 70.32 113.908 168.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -66.85 -26.43 66.9 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.85 0.46 . . . . 63.14 111.775 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.421 HG21 HD13 ' D' ' 13' ' ' ILE . 32.6 mm -75.71 -47.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.165 0.586 . . . . 74.55 109.775 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.02 -32.23 59.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.154 -0.93 . . . . 53.01 112.609 -169.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -62.71 -44.57 86.75 Favored Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 118.177 -0.916 . . . . 65.22 113.042 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.98 -39.02 80.48 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.552 2.168 . . . . 53.24 113.996 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -79.87 -28.31 39.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.156 0.582 . . . . 75.53 111.906 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.21 66.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.798 -0.815 . . . . 65.43 108.798 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -60.84 -35.08 75.63 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.003 1.321 . . . . 71.1 111.396 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.526 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.0 tt0 -56.05 -53.54 55.74 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.021 0.928 . . . . 75.23 110.424 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' D' ' 21' ' ' ILE . 49.8 t -67.25 -42.3 84.14 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.806 -1.088 . . . . 62.1 111.306 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.633 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.7 mt -58.57 -60.05 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.822 0.849 . . . . 50.14 110.486 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.469 HG23 ' HB3' ' D' ' 125' ' ' GLN . 97.6 m -52.51 -43.56 65.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.512 1.125 . . . . 72.31 112.1 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.9 t -68.15 -36.96 80.49 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.501 -0.772 . . . . 73.02 111.014 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 77.7 mtm -67.87 -37.77 82.22 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.662 0.385 . . . . 45.13 111.315 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.9 t -65.41 -41.6 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.324 -0.853 . . . . 73.33 110.337 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 78.3 p -72.28 -30.47 64.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.162 0.585 . . . . 62.41 111.388 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.51 -29.95 65.38 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.927 0.491 . . . . 74.12 110.56 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 6.67 73.66 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.591 0.557 . . . . 45.24 112.456 174.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 60.5 25.45 15.08 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 126.591 1.956 . . . . 74.33 113.342 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.18 159.68 31.57 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.575 1.15 . . . . 72.24 108.441 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' G' ' 297' ' ' TYR . 61.5 Cg_endo -69.76 135.01 29.36 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.473 2.116 . . . . 73.2 111.021 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.469 ' HB3' HG23 ' D' ' 115' ' ' THR . 88.1 mt-30 -49.19 120.03 3.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.381 1.051 . . . . 74.15 110.842 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.02 94.05 5.03 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.501 -0.925 . . . . 73.02 108.501 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -100.65 104.23 15.54 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.207 -1.361 . . . . 73.32 107.946 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.37 143.76 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.863 -0.608 . . . . 62.34 111.459 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' E' ' 306' ' ' VAL . . . -63.46 133.3 95.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 114.968 -1.014 . . . . 63.45 110.757 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 9.7 Cg_endo -80.39 124.61 5.37 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.643 2.229 . . . . 62.12 111.119 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.524 HG22 HD21 ' G' ' 291' ' ' LEU . 60.3 t -107.72 109.36 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.628 -0.879 . . . . 50.14 108.628 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.63 96.37 1.98 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.043 -1.095 . . . . 71.24 108.043 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -62.19 -31.1 71.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.302 0.641 . . . . 72.34 112.023 -174.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -54.84 -37.3 66.01 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.844 0.857 . . . . 75.53 111.346 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.36 97.39 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.536 0.735 . . . . 63.53 110.707 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.03 -42.28 94.47 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.919 0.762 . . . . 54.32 110.631 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -64.83 -41.86 95.41 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.812 -0.631 . . . . 63.42 111.211 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.5 mtm -72.83 -30.42 64.02 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.994 0.518 . . . . 63.21 111.52 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 79.6 m-20 -60.19 -37.72 81.08 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.542 0.737 . . . . 72.02 110.426 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -56.86 -31.7 65.08 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.121 0.969 . . . . 75.11 111.055 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.9 -48.84 8.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.015 0.526 . . . . 74.3 111.583 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.472 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 13.8 pt20 -89.02 33.33 0.79 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.293 0.849 . . . . 75.11 113.293 -164.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -116.62 48.63 1.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.733 -1.21 . . . . 72.22 107.733 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -143.52 -55.11 0.38 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.208 -1.815 . . . . 65.05 107.188 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.45 111.43 10.72 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.678 -0.86 . . . . 62.31 108.678 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.14 120.47 5.62 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.817 0.698 . . . . 61.34 111.789 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.67 110.43 11.37 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.911 -1.144 . . . . 52.34 107.911 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 148' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' B' ' 5' ' ' ASN . . . -158.83 143.58 9.42 Favored Glycine 0 C--N 1.34 0.75 0 N-CA-C 110.781 -0.928 . . . . 51.34 110.781 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 72.1 p -86.2 -13.17 47.71 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 117.585 0.693 . . . . 64.44 112.04 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -78.92 151.83 31.48 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.184 0.994 . . . . 72.11 109.44 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.01 -164.51 1.15 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.074 0.949 . . . . 75.03 113.15 -168.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 152' ' ' HIS . . . . . 0.615 ' HE1' ' HB3' ' D' ' 155' ' ' ALA . 52.9 t-80 -126.75 147.45 49.98 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 124.58 1.152 . . . . 75.41 109.033 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -73.65 -179.47 3.6 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.684 0.794 . . . . 50.25 111.911 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.25 93.69 1.12 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.834 0.454 . . . . 65.1 110.768 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' D' D ' 155' ' ' ALA . . . . . 0.615 ' HB3' ' HE1' ' D' ' 152' ' ' HIS . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 124.568 1.147 . . . . 74.2 108.106 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 109.074 -0.713 . . . . 52.32 109.074 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' E' E ' 272' ' ' ASN . . . . . 0.439 ' HA ' HE22 ' E' ' 274' ' ' GLN . 88.2 m-20 -117.03 75.88 1.0 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.508 0.723 . . . . 71.5 110.46 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -120.11 22.09 11.55 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.126 -0.943 . . . . 74.54 109.301 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 274' ' ' GLN . . . . . 0.439 HE22 ' HA ' ' E' ' 272' ' ' ASN . 1.6 mp0 -74.26 118.18 16.92 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 124.198 0.999 . . . . 71.42 109.759 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -107.65 98.38 24.17 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.139 0.976 . . . . 72.23 108.381 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.7 88.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.906 2.404 . . . . 74.1 112.368 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 41.4 tp -73.45 -24.28 60.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.706 -1.134 . . . . 71.12 109.75 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 pp -76.56 169.43 18.28 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.093 -0.958 . . . . 73.32 110.896 172.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -158.63 -68.29 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.294 -0.722 . . . . 24.44 111.294 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.484 HD12 ' HB1' ' A' ' 95' ' ' ALA . 3.2 tm? -74.12 123.21 24.0 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.802 0.441 . . . . 62.31 110.535 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 281' ' ' PHE . . . . . 0.501 ' CZ ' ' HB ' ' A' ' 46' ' ' THR . 1.6 t80 -167.9 13.91 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.601 1.188 . . . . 72.24 109.406 170.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -79.44 -16.44 56.13 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.704 0.801 . . . . 41.34 112.037 -173.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.25 -72.89 0.14 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.608 -0.886 . . . . 72.53 108.608 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 67.16 -80.59 0.14 Allowed Glycine 0 C--N 1.352 1.435 0 O-C-N 123.882 0.739 . . . . 72.05 114.789 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -78.22 105.79 9.69 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.878 0.871 . . . . 73.33 109.762 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -78.53 143.85 64.43 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.767 -0.827 . . . . 65.21 108.767 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.55 40.92 1.04 Allowed 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.493 2.796 . . . . 72.04 113.278 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 98.4 t -71.25 -52.87 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.896 0.879 . . . . 53.13 110.3 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 289' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 42' ' ' LEU . 32.4 mmt180 62.16 -77.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.153 1.381 . . . . 61.32 109.984 -170.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -134.18 144.55 48.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.571 0.748 . . . . 74.51 109.754 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 129' ' ' ALA . 5.2 mp -83.24 -46.01 13.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.996 0.918 . . . . 71.11 109.879 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -157.14 144.8 11.06 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.041 -0.866 . . . . 41.3 111.152 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.62 133.29 29.36 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.74 2.293 . . . . 71.43 111.198 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 294' ' ' LYS . . . . . 0.572 ' HB3' ' HA ' ' G' ' 306' ' ' VAL . 0.0 OUTLIER -155.91 15.68 0.35 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.86 0.864 . . . . 73.0 111.359 -176.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 66.3 157.05 0.11 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.173 1.389 . . . . 71.22 112.483 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 27.9 m -99.62 -43.87 6.34 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.525 -0.917 . . . . 53.34 108.525 171.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.45 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 51.0 m-85 -78.79 110.59 14.09 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.965 -1.016 . . . . 74.43 110.58 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -116.65 8.14 13.74 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.638 1.175 . . . . 65.01 111.393 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 299' ' ' GLY . . . . . 0.492 ' HA3' ' HB ' ' G' ' 301' ' ' ILE . . . 108.86 101.01 2.67 Favored Glycine 0 C--N 1.361 1.944 0 N-CA-C 115.05 0.78 . . . . 74.24 115.05 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -162.05 -110.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.191 -1.411 . . . . 53.13 107.191 168.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 48.1 mm 68.02 -14.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.883 0 C-N-CA 125.956 1.702 . . . . 63.32 114.713 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 48.93 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.563 1.545 . . . . 64.43 112.389 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -71.77 129.65 88.03 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 119.123 -0.465 . . . . 74.41 109.958 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -41.68 110.89 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 123.911 3.074 . . . . 32.44 113.991 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -109.9 -176.53 3.03 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.27 1.028 . . . . 61.15 109.616 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 306' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' D' ' 129' ' ' ALA . 59.2 t 68.69 126.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 124.672 1.189 . . . . 70.33 111.844 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 307' ' ' THR . . . . . 0.526 ' H ' ' HA3' ' G' ' 292' ' ' GLY . 62.3 m -74.58 -66.71 0.71 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.21 -0.663 . . . . 72.54 109.21 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 91.0 m -159.35 160.47 35.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.603 0.761 . . . . 60.14 110.941 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 7.0 m -128.33 84.21 63.87 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 107.647 -1.242 . . . . 63.0 107.647 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 C--N 1.377 2.048 0 C-N-CA 123.289 2.659 . . . . 75.31 111.035 174.369 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.01 -0.367 . . . . 53.44 110.01 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' F' F ' 272' ' ' ASN . . . . . 0.57 ' HB3' ' HG3' ' C' ' 93' ' ' GLN . 85.1 m-20 74.25 -67.47 0.26 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.169 1.788 . . . . 74.12 112.914 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -73.09 -158.35 0.05 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.556 1.142 . . . . 73.04 112.289 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 76.06 11.26 3.01 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.255 1.422 . . . . 71.42 109.89 -172.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 275' ' ' LYS . . . . . 0.621 ' HB2' ' HA2' ' C' ' 91' ' ' GLY . 97.1 mttt -132.29 134.22 24.7 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 124.502 1.121 . . . . 74.14 108.564 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.73 160.64 14.22 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.745 2.297 . . . . 72.02 112.446 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.39 -60.1 4.15 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.61 0.764 . . . . 72.22 110.817 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.49 93.2 0.34 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.039 0.535 . . . . 60.51 110.088 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -166.02 158.11 30.87 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.751 -0.94 . . . . 64.14 110.751 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 280' ' ' LEU . . . . . 0.44 ' HB3' ' HB1' ' C' ' 95' ' ' ALA . 5.2 tt 60.85 75.99 0.39 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.366 1.066 . . . . 73.21 108.795 -176.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 281' ' ' PHE . . . . . 0.401 ' CZ ' HG13 ' C' ' 58' ' ' VAL . 12.4 t80 -170.96 45.11 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.773 0.797 . . . . 74.32 109.621 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -151.95 97.2 2.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.689 0.796 . . . . 73.44 109.485 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 57.49 77.31 0.28 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.757 1.223 . . . . 74.01 111.511 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -148.59 30.95 1.26 Allowed Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.297 -0.865 . . . . 64.34 112.207 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -74.22 137.63 43.17 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.921 -0.77 . . . . 73.13 108.921 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 286' ' ' MET . . . . . 0.521 ' SD ' ' HD1' ' C' ' 133' ' ' PHE . 1.0 OUTLIER -64.43 158.27 67.26 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.365 1.066 . . . . 63.43 109.953 178.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.21 77.88 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.641 2.227 . . . . 54.44 112.517 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 64.0 t -104.17 84.87 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.522 1.129 . . . . 75.11 108.775 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -82.83 -76.34 0.28 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 106.198 -1.778 . . . . 71.42 106.198 168.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 290' ' ' TRP . . . . . 0.525 ' NE1' HG23 ' C' ' 40' ' ' VAL . 54.2 m95 -152.66 -177.62 6.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.346 1.058 . . . . 74.03 109.872 170.054 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.84 86.34 2.17 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.709 -1.589 . . . . 74.54 106.709 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 108.21 136.49 7.9 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 114.922 -1.035 . . . . 73.53 110.601 -167.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.38 122.27 11.25 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 123.158 2.572 . . . . 71.13 112.563 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 294' ' ' LYS . . . . . 0.492 ' HB2' ' NZ ' ' F' ' 294' ' ' LYS . 7.9 mtmp? 68.38 176.01 0.27 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.338 1.455 . . . . 74.21 112.656 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -169.69 135.66 1.52 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 113.823 -1.535 . . . . 61.32 107.378 170.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 296' ' ' THR . . . . . 0.608 HG22 ' HD1' ' F' ' 297' ' ' TYR . 56.0 m 73.01 159.91 0.23 Allowed 'General case' 0 CA--C 1.568 1.648 0 O-C-N 123.73 0.644 . . . . 74.1 112.696 169.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.608 ' HD1' HG22 ' F' ' 296' ' ' THR . 5.1 m-85 65.83 78.16 0.28 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.936 1.294 . . . . 75.3 112.072 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -153.36 157.44 40.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.086 0.955 . . . . 74.42 109.043 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 299' ' ' GLY . . . . . 0.436 ' HA3' ' HA3' ' H' ' 299' ' ' GLY . . . 86.43 -131.75 10.72 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.906 -0.588 . . . . 54.23 112.16 -174.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.57 129.81 11.24 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.135 0.574 . . . . 73.13 110.121 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.771 HD13 ' HD3' ' C' ' 124' ' ' PRO . 38.7 pt -117.45 14.99 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 124.284 1.033 . . . . 62.32 110.347 173.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -93.9 -174.24 3.37 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.488 1.115 . . . . 71.5 109.455 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? 74.23 108.24 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.412 1.485 . . . . 72.24 111.833 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 304' ' ' PRO . . . . . 0.612 ' HB3' ' HA ' ' D' ' 14' ' ' GLN . 35.5 Cg_exo -60.5 104.73 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.02 2.48 . . . . 74.34 111.739 173.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -92.84 -5.71 50.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.898 0.479 . . . . 74.44 111.141 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 306' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' H' ' 291' ' ' LEU . 19.3 t -76.93 -13.34 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 123.715 0.806 . . . . 74.24 111.017 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 8.3 t -70.23 78.12 0.53 Allowed 'General case' 0 CA--C 1.563 1.475 0 CA-C-O 122.08 0.943 . . . . 73.4 111.11 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 52.3 t -172.44 -36.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.427 1.091 . . . . 54.23 109.509 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 3.3 t -104.65 106.32 54.14 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.027 0.931 . . . . 51.23 109.933 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 CA--C 1.565 2.067 0 C-N-CA 122.698 2.265 . . . . 61.04 110.846 169.682 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.451 -0.203 . . . . 42.44 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -159.34 -30.15 0.07 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.236 0.615 . . . . 73.0 111.265 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -62.95 -33.01 74.46 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.74 0.816 . . . . 72.1 111.744 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -69.8 155.63 40.25 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.498 -0.556 . . . . 74.5 109.498 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 275' ' ' LYS . . . . . 0.642 ' H ' ' HD3' ' G' ' 275' ' ' LYS . 0.0 OUTLIER -104.21 141.19 22.01 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 122.888 0.475 . . . . 74.14 110.017 -178.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.55 142.55 71.83 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.786 2.324 . . . . 73.04 111.609 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 69.7 mt 67.62 22.05 9.21 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.884 1.274 . . . . 51.21 112.227 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 278' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' D' ' 48' ' ' SER . 14.6 tp -159.45 98.25 1.39 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.896 -0.779 . . . . 55.2 108.896 174.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -174.42 -140.29 3.23 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.799 -0.637 . . . . 63.14 112.232 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.463 HD23 ' HA3' ' D' ' 99' ' ' GLY . 43.4 tp 67.59 -58.55 0.43 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 126.879 2.071 . . . . 74.21 112.61 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -44.19 -58.53 2.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.731 1.213 . . . . 64.03 111.379 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . 57.04 -86.95 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.621 1.169 . . . . 61.41 111.022 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -96.3 -40.1 9.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.51 0.724 . . . . 75.25 109.387 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.36 173.63 34.94 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.461 -0.791 . . . . 72.35 111.674 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -93.5 -179.88 5.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.33 0.652 . . . . 72.03 110.248 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.98 125.76 89.81 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-N 115.801 -0.636 . . . . 63.22 110.628 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.66 133.71 43.73 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.633 2.222 . . . . 72.53 111.525 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 288' ' ' VAL . . . . . 0.613 HG12 HD11 ' D' ' 44' ' ' LEU . 11.6 p -64.9 -27.98 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.355 0.662 . . . . 70.14 111.396 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 66.37 -83.69 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.898 1.279 . . . . 64.04 109.196 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.672 ' HE3' ' H ' ' G' ' 291' ' ' LEU . 0.1 OUTLIER -176.31 176.96 1.58 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.456 1.502 . . . . 72.04 107.869 173.239 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.672 ' H ' ' HE3' ' G' ' 290' ' ' TRP . 3.7 mp -126.02 6.69 7.25 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.042 0.937 . . . . 61.13 110.683 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 292' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' E' ' 307' ' ' THR . . . 153.64 -152.88 24.44 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-O 119.234 -0.759 . . . . 74.25 112.649 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.97 151.77 69.51 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.699 2.933 . . . . 71.42 113.392 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 294' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' G' ' 294' ' ' LYS . 8.6 mptt -105.57 12.83 30.8 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.735 1.214 . . . . 75.15 110.023 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.96 84.78 0.51 Allowed 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.077 0.951 . . . . 74.3 110.518 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m -91.94 -32.25 15.33 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.191 -0.913 . . . . 65.02 110.226 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.453 ' CZ ' ' HD3' ' D' ' 124' ' ' PRO . 1.5 m-85 -78.06 141.0 39.13 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.769 -0.456 . . . . 72.24 109.769 169.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -98.46 7.46 46.14 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.469 0.708 . . . . 74.31 110.035 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 85.72 -156.13 29.89 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.051 -1.22 . . . . 74.03 110.051 -163.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 52.46 64.23 1.93 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.647 1.179 . . . . 52.35 111.252 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.492 ' HB ' ' HA3' ' E' ' 299' ' ' GLY . 0.0 OUTLIER -155.6 132.53 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 113.858 -1.519 . . . . 65.54 108.299 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -164.36 -174.57 3.55 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 108.537 -0.912 . . . . 73.23 108.537 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -67.35 122.58 83.65 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.107 -1.072 . . . . 71.54 108.107 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -62.22 104.23 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.394 2.062 . . . . 44.5 110.469 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -77.03 79.74 3.56 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.823 0.849 . . . . 41.11 110.477 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' E' ' 294' ' ' LYS . 5.3 t -74.56 107.28 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.503 -0.925 . . . . 71.24 108.503 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 25.8 m -61.67 -67.98 0.36 Allowed 'General case' 0 CA--C 1.545 0.783 0 O-C-N 124.061 0.851 . . . . 72.41 110.65 -174.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 84.7 m -160.57 134.79 7.23 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.669 0.788 . . . . 75.53 109.683 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' G' G ' 309' ' ' THR . . . . . 0.501 ' HB ' ' HD3' ' G' ' 310' ' ' PRO . 94.1 m -71.89 -50.59 9.45 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 118.732 -0.651 . . . . 74.32 109.896 166.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' G' G ' 310' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' G' ' 309' ' ' THR . 3.7 Cg_endo . . . . . 0 C--N 1.406 3.569 0 C-N-CA 122.738 2.292 . . . . 63.13 111.679 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 110.513 -0.18 . . . . 52.02 110.513 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -85.22 85.56 7.45 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.266 -1.013 . . . . 74.42 108.266 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -126.83 120.3 28.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.888 0.875 . . . . 74.01 109.564 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.89 23.35 0.84 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.933 0.893 . . . . 74.43 111.568 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -134.34 82.77 45.89 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.595 1.158 . . . . 55.25 109.14 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -99.79 -166.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 123.625 2.883 . . . . 64.32 112.261 173.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 90.4 mt -103.48 43.06 1.11 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.024 0.93 . . . . 73.42 109.369 171.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 278' ' ' LEU . . . . . 0.423 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 17.9 tp -149.55 153.25 36.86 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.204 -0.907 . . . . 71.34 109.375 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 146.01 164.66 11.0 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-O 119.405 -0.664 . . . . 54.22 111.536 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 61.4 tp 77.52 -51.28 0.53 Allowed 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.709 1.604 . . . . 75.1 112.353 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -85.8 47.93 1.52 Allowed 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.104 1.362 . . . . 73.12 110.392 -173.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -121.92 -6.11 9.03 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.053 0.941 . . . . 64.2 110.599 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -147.65 -77.42 0.17 Allowed 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.432 -0.951 . . . . 74.13 108.432 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 56.78 -89.29 0.01 OUTLIER Glycine 0 C--N 1.357 1.742 0 O-C-N 123.971 0.794 . . . . 62.31 113.646 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 285' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' B' ' 44' ' ' LEU . 3.5 t-20 59.64 87.66 0.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.576 1.551 . . . . 72.15 111.541 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 286' ' ' MET . . . . . 0.432 ' HB3' HG23 ' H' ' 288' ' ' VAL . 1.2 mpt? -68.37 119.36 67.54 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 115.445 -0.798 . . . . 75.31 109.959 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.21 37.91 0.71 Allowed 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.927 3.084 . . . . 71.31 112.709 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 288' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' H' ' 286' ' ' MET . 53.2 t -68.12 115.6 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.519 0.727 . . . . 73.54 109.177 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -65.03 -68.61 0.35 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.701 -0.851 . . . . 72.12 108.701 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -175.11 169.58 3.29 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.921 1.688 . . . . 64.33 109.588 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' F' ' 306' ' ' VAL . 5.9 mp -100.84 78.07 1.92 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.98 -1.489 . . . . 70.41 106.98 167.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 74.72 172.0 28.37 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 114.64 -1.163 . . . . 71.44 112.96 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.32 32.35 0.52 Allowed 'Trans proline' 0 CA--C 1.557 1.631 0 C-N-CA 122.951 2.434 . . . . 75.31 112.151 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -93.72 31.39 1.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.454 1.101 . . . . 75.12 110.533 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 295' ' ' ALA . . . . . 0.62 ' HB3' HG21 ' B' ' 40' ' ' VAL . . . -92.47 -80.64 0.36 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.069 0.548 . . . . 64.34 110.159 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 296' ' ' THR . . . . . 0.412 ' OG1' HD12 ' B' ' 126' ' ' LEU . 21.2 m -104.99 149.14 26.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.634 0.774 . . . . 62.22 110.551 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.558 ' HE1' HD12 ' H' ' 301' ' ' ILE . 74.1 m-85 57.66 83.82 0.11 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.797 1.239 . . . . 65.02 111.69 -176.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -88.1 26.41 1.39 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.414 -0.812 . . . . 64.25 109.925 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 299' ' ' GLY . . . . . 0.436 ' HA3' ' HA3' ' F' ' 299' ' ' GLY . . . 87.85 -26.3 7.67 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 120.174 -0.237 . . . . 63.04 112.97 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 300' ' ' ASN . . . . . 0.46 ' O ' ' HG3' ' B' ' 124' ' ' PRO . 8.6 t30 -67.72 93.49 0.39 Allowed 'General case' 0 C--N 1.352 0.713 0 C-N-CA 123.693 0.797 . . . . 64.2 110.898 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 301' ' ' ILE . . . . . 0.558 HD12 ' HE1' ' H' ' 297' ' ' TYR . 13.2 tt -138.97 12.59 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 107.458 -1.312 . . . . 75.03 107.458 169.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.44 83.37 1.97 Allowed 'General case' 0 C--N 1.362 1.124 0 CA-C-N 114.828 -1.078 . . . . 73.51 110.463 -169.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 303' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' H' ' 303' ' ' LYS . 0.7 OUTLIER 169.68 93.38 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.117 2.167 . . . . 70.1 105.284 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.74 77.4 1.07 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.611 2.207 . . . . 71.3 111.58 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 305' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 14' ' ' GLN . . . 60.04 -151.56 0.41 Allowed 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.346 1.058 . . . . 71.5 110.482 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.81 -24.76 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.161 0.584 . . . . 74.1 110.171 168.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 49.1 m 65.98 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.967 1.307 . . . . 75.32 110.274 -172.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 42.7 t -165.35 137.29 4.16 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.214 -1.032 . . . . 64.41 108.214 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 6.7 m -102.5 104.98 41.39 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 108.723 -0.843 . . . . 74.42 108.723 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 C--N 1.381 2.259 0 C-N-CA 122.899 2.399 . . . . 62.15 112.367 -177.047 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.613 -0.514 . . . . 72.23 109.613 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m 68.65 148.47 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.788 1.635 . . . . 41.44 113.562 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -101.51 108.33 19.88 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.131 0.972 . . . . 73.11 109.773 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -141.29 55.75 1.54 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.195 0.998 . . . . 74.01 110.325 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.504 ' HB3' ' NE2' ' A' ' 93' ' ' GLN . 12.9 m120 -117.24 33.02 5.83 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.951 -1.022 . . . . 64.13 109.373 172.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -78.15 79.91 4.58 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.289 -1.004 . . . . 75.32 108.289 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -99.98 154.95 17.97 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.688 0.795 . . . . 64.04 110.34 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -33.29 73.04 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.822 0.701 . . . . 64.2 110.699 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.443 ' SD ' ' HB3' ' A' ' 147' ' ' GLU . 46.9 mtt 63.53 172.3 0.16 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.779 1.632 . . . . 55.25 112.593 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 m -140.99 134.52 29.99 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.702 -0.851 . . . . 72.44 108.702 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.59 ' HB3' HG22 ' A' ' 149' ' ' THR . 3.1 t80 -137.7 134.42 35.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 73.2 110.139 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -154.54 136.0 14.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.101 -1.409 . . . . 74.3 107.396 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.535 HG12 ' HD2' ' A' ' 84' ' ' PHE . 32.0 mt -92.44 130.84 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.322 -0.622 . . . . 65.14 109.322 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' H' ' 307' ' ' THR . 33.0 tt0 -98.1 -41.33 7.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.779 -0.629 . . . . 71.31 110.537 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.573 ' HA ' HG12 ' H' ' 306' ' ' VAL . 18.2 ttt180 -177.89 123.5 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 112.926 0.713 . . . . 64.32 112.926 -170.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.592 HD13 ' HG3' ' C' ' 130' ' ' PRO . 4.0 mp -104.61 134.74 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.836 -1.172 . . . . 71.03 107.836 168.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -166.16 152.42 9.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.484 1.113 . . . . 71.31 109.416 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -75.51 118.28 18.2 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.871 -0.788 . . . . 64.23 108.871 172.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -80.56 -24.33 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.65 -0.5 . . . . 72.43 109.65 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -158.91 143.3 15.62 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.1 -0.954 . . . . 74.02 109.8 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.421 HD13 ' SD ' ' B' ' 117' ' ' MET . 86.0 mt -132.33 146.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.914 1.286 . . . . 63.31 107.972 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.89 135.13 15.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.491 0.717 . . . . 73.21 109.516 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.9 t80 -138.06 131.21 30.26 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.686 -1.598 . . . . 73.32 106.686 171.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -133.6 114.21 13.28 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.276 0.63 . . . . 64.1 109.556 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -107.39 83.03 1.37 Allowed Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.496 -1.668 . . . . 21.02 106.496 162.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.58 -31.94 16.04 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 122.605 2.203 . . . . 62.3 112.155 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -113.88 22.9 13.52 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.278 1.031 . . . . 62.41 109.053 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -43.54 -63.11 1.11 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-O 117.997 -1.002 . . . . 74.13 113.384 -168.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.51 -17.42 59.92 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.024 1.816 . . . . 73.24 113.354 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -85.9 -52.4 5.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.929 0.871 . . . . 64.23 109.995 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -70.52 -21.7 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.034 -1.439 . . . . 52.33 111.941 -160.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -64.42 -30.1 71.15 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.534 0.734 . . . . 74.44 112.22 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.83 -11.58 20.64 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.217 0.607 . . . . 75.21 112.423 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -78.64 171.74 14.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.01 0.524 . . . . 71.21 111.086 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.37 118.22 6.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.052 0.941 . . . . 62.23 110.741 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CE2' HD11 ' E' ' 301' ' ' ILE . 20.9 m0 -79.84 82.37 5.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.573 0.702 . . . . 74.2 110.097 -177.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -126.12 70.28 68.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.419 1.087 . . . . 74.03 108.948 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.717 ' HG3' ' HB3' ' E' ' 297' ' ' TYR . 94.8 Cg_endo -78.74 127.67 8.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.609 2.206 . . . . 54.44 112.045 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -97.97 93.95 6.6 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.854 -1.536 . . . . 42.44 106.854 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.5 m -76.73 106.11 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.617 -1.174 . . . . 75.02 110.578 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 16.7 mtpp -81.73 134.96 35.5 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.959 -1.019 . . . . 74.34 110.402 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tt -110.74 106.45 15.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 106.154 -1.795 . . . . 63.13 106.154 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.3 m-20 -114.16 142.33 46.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.228 -1.397 . . . . 64.42 107.228 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.76 ' HB3' ' HA ' ' E' ' 287' ' ' PRO . 5.7 tt -141.46 128.64 20.93 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.948 -1.13 . . . . 74.12 107.948 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -117.15 134.28 54.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.581 1.153 . . . . 74.44 108.678 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.4 p -110.57 123.1 49.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.589 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.93 131.69 37.55 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.683 0.793 . . . . 71.23 110.477 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.55 152.56 51.92 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.035 0.445 . . . . 64.22 110.325 171.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 163.64 39.01 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.952 1.301 . . . . 71.1 108.233 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -112.54 146.56 38.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.206 0.602 . . . . 72.4 109.515 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -117.62 -43.75 2.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.878 0.871 . . . . 63.43 110.361 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.58 -168.52 3.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.204 0.601 . . . . 73.32 110.819 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.507 ' HA ' ' HG2' ' C' ' 150' ' ' GLU . 4.6 m-20 -64.43 112.33 3.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.781 0.832 . . . . 71.55 110.346 178.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.4 0.39 2.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.516 1.527 . . . . 63.23 112.364 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -96.81 107.09 19.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.475 -1.306 . . . . 75.12 107.475 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.471 -0.937 . . . . 71.14 108.471 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -92.07 112.83 24.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.938 0.895 . . . . 70.01 109.396 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.14 111.32 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.619 -1.252 . . . . 65.33 107.619 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 32.1 t -106.7 129.54 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.621 0.768 . . . . 74.04 110.001 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.724 HD12 HD21 ' A' ' 44' ' ' LEU . 4.2 mm? -117.89 110.04 17.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.643 -0.873 . . . . 62.21 108.643 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.527 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 11.0 ttp180 -84.82 107.44 16.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.58 -0.896 . . . . 74.24 108.58 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 16.4 t -92.45 125.34 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 107.807 -1.183 . . . . 75.21 107.807 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.9 m -118.79 136.89 53.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.019 -0.734 . . . . 44.54 109.019 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.783 HG11 HD21 ' A' ' 126' ' ' LEU . 45.4 t -136.78 115.88 15.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 124.44 1.096 . . . . 73.21 108.068 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 7.1 m -105.25 148.02 27.43 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.912 -0.773 . . . . 74.42 108.912 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.23 106.65 7.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.086 -1.45 . . . . 73.21 107.086 168.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 17.9 t -116.8 126.97 53.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.682 -0.488 . . . . 73.22 109.682 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.551 HD22 HG22 ' A' ' 31' ' ' VAL . 7.7 mp -87.56 82.49 7.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 74.01 107.914 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.28 -84.72 0.83 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 114.976 -1.011 . . . . 54.43 111.881 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -111.92 -27.88 8.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.294 1.037 . . . . 71.13 111.686 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.7 125.15 54.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.564 0.346 . . . . 70.04 111.005 -169.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 63.7 m -73.7 129.3 37.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.573 0.749 . . . . 71.3 112.441 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -69.75 -65.64 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.868 -1.06 . . . . 54.33 109.911 169.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.13 167.77 27.46 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.289 -0.869 . . . . 65.1 111.607 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 tp -141.36 116.09 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.354 1.461 . . . . 65.35 107.728 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.6 m -105.66 131.79 52.6 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.332 0.653 . . . . 64.2 109.559 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 32.6 tt0 -146.59 115.38 6.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.58 -0.526 . . . . 64.34 109.58 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.74 114.27 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.97 0.908 . . . . 63.31 109.231 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 48.5 mt-30 -83.88 84.39 7.59 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.265 -1.013 . . . . 75.1 108.265 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.86 98.26 6.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.322 -0.992 . . . . 63.0 108.322 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.89 145.88 21.04 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.202 -0.759 . . . . 72.03 111.202 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.728 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.14 121.79 1.31 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 111.047 -0.821 . . . . 64.54 111.047 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -87.78 123.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 123.87 0.868 . . . . 54.34 108.736 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HD2' HG12 ' A' ' 13' ' ' ILE . 46.9 m-85 -131.71 120.26 22.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 m -77.78 90.91 4.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.551 0.74 . . . . 54.2 109.333 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.496 HG21 ' SG ' ' A' ' 97' ' ' CYS . 1.6 pp -118.69 133.26 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.806 0.842 . . . . 75.12 110.509 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.4 177.15 11.48 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.695 0.798 . . . . 61.4 111.125 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.52 86.68 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.758 0.662 . . . . 71.54 112.298 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.76 136.12 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.497 1.119 . . . . 73.02 109.936 -171.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -131.41 172.07 12.62 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.136 0.974 . . . . 74.51 108.863 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.42 4.59 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 115.001 0.761 . . . . 65.4 115.001 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.2 -18.74 58.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.953 0.901 . . . . 22.43 112.041 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.504 ' NE2' ' HB3' ' A' ' 5' ' ' ASN . 98.4 mt-30 -67.87 -48.88 64.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.176 0.591 . . . . 71.11 110.236 175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.723 ' SD ' ' HB3' ' E' ' 277' ' ' LEU . 50.2 ttm -80.63 -18.56 47.77 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.592 -0.276 . . . . 64.51 110.454 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -66.38 -33.87 76.69 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.037 0.446 . . . . 73.12 110.428 169.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.2 t60 -68.66 -41.74 78.92 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.874 -0.603 . . . . 75.14 110.26 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 86' ' ' ILE . 47.3 t -64.26 -54.21 36.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.984 0.514 . . . . 72.41 111.959 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 mt -76.26 -35.94 58.69 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.409 0.443 . . . . 65.12 111.719 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.09 4.59 38.58 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 114.858 0.703 . . . . 70.4 114.858 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.6 -52.23 0.23 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.85 0.825 . . . . 43.23 112.436 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.564 ' HA ' ' HB3' ' A' ' 134' ' ' ASP . 66.4 t80 -79.81 -68.92 0.62 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.52 0.728 . . . . 63.55 111.939 -168.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.3 m -68.86 -32.36 3.45 Favored Pre-proline 0 CA--C 1.572 1.826 0 N-CA-C 114.844 1.424 . . . . 54.33 114.844 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 28.8 Cg_endo -61.45 -21.87 73.03 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 122.556 2.17 . . . . 65.13 113.458 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -68.12 -26.12 65.64 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.203 0.601 . . . . 75.23 110.034 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.453 HG21 HD13 ' A' ' 13' ' ' ILE . 39.5 mm -71.2 -36.01 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.477 0.711 . . . . 74.53 109.858 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.728 HD21 ' HA3' ' A' ' 82' ' ' GLY . 97.0 mt -83.48 -30.68 26.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.936 0.894 . . . . 73.54 112.883 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -62.9 -39.79 56.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 113.818 1.044 . . . . 55.21 113.818 -170.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.01 -37.67 51.58 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.387 2.058 . . . . 63.12 113.281 172.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -71.76 -38.62 70.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.14 0.576 . . . . 73.35 111.625 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -45.18 83.42 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.572 -0.529 . . . . 74.33 109.572 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.431 HH22 ' HB3' ' A' ' 130' ' ' PRO . 40.1 ttm180 -53.75 -50.45 65.97 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 124.646 1.216 . . . . 70.05 110.905 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.65 -41.6 75.36 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.204 0.94 . . . . 75.24 111.303 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 44.0 t -56.17 -42.21 76.69 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.576 0.547 . . . . 74.23 110.169 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 118' ' ' VAL . 92.8 mt -66.13 -50.33 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.593 -1.185 . . . . 75.13 110.296 175.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.445 HG23 ' HG3' ' A' ' 125' ' ' GLN . 63.0 m -52.8 -41.93 64.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.301 1.041 . . . . 44.51 111.375 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -69.17 -51.22 40.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.647 -1.161 . . . . 73.4 110.616 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.1 mtp -51.05 -42.91 60.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.026 0.931 . . . . 74.14 111.725 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -64.82 -50.96 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-N 114.376 -1.284 . . . . 72.34 110.718 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 93.2 p -70.38 -22.71 62.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.029 0.532 . . . . 54.12 111.947 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.61 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -75.19 -31.19 60.88 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.796 0.838 . . . . 73.2 110.048 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 -3.26 86.13 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 116.124 -0.489 . . . . 74.34 112.604 171.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.585 ' HB ' HH21 ' B' ' 15' ' ' ARG . 23.3 m 60.05 43.73 14.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.318 1.532 . . . . 65.3 110.133 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.51 ' HA ' HG22 ' E' ' 301' ' ' ILE . 69.1 m-85 -99.53 163.9 17.65 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 113.029 -1.896 . . . . 64.04 108.888 169.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 17.4 Cg_exo -68.12 136.46 37.76 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.766 2.311 . . . . 64.53 111.795 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.0 tt0 -48.31 124.37 7.82 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.584 1.177 . . . . 60.02 111.521 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.783 HD21 HG11 ' A' ' 64' ' ' VAL . 12.4 tp -108.13 100.54 9.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.695 0.798 . . . . 65.32 110.484 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.84 97.75 7.22 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.891 -1.152 . . . . 73.14 107.891 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.67 120.89 18.92 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.239 -0.437 . . . . 75.13 110.314 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 133.04 88.87 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.118 0.967 . . . . 72.34 111.934 -173.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.431 ' HB3' HH22 ' A' ' 111' ' ' ARG . 18.0 Cg_endo -87.22 166.49 8.08 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.646 2.231 . . . . 74.43 113.351 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.58 142.51 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 106.779 -1.563 . . . . 71.12 106.779 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.45 75.46 6.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.907 -1.146 . . . . 72.54 107.907 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.5 -43.73 89.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.475 1.11 . . . . 74.21 111.843 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 101' ' ' TYR . 5.3 p-10 -61.12 -45.26 95.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.994 0.917 . . . . 74.42 111.806 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.75 87.86 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.76 0.662 . . . . 62.11 110.982 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.3 tp -68.45 -39.41 81.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.823 0.702 . . . . 51.42 111.124 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -70.35 -36.9 74.48 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.44 -0.578 . . . . 74.43 109.44 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.0 mmt -64.46 -56.92 11.02 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 123.408 0.443 . . . . 55.02 110.59 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -62.75 -27.72 69.48 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.017 0.527 . . . . 75.14 111.835 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -73.33 -42.24 62.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.694 0.798 . . . . 61.01 111.156 173.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.8 tp -69.19 -56.71 6.8 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-O 119.211 -0.423 . . . . 54.12 111.144 -174.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.447 ' H ' ' H ' ' A' ' 143' ' ' GLN . 51.8 mt-30 -168.42 -12.92 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.348 1.459 . . . . 72.4 111.154 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.447 ' H ' ' H ' ' A' ' 142' ' ' GLN . 0.1 OUTLIER 69.44 72.42 0.25 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.588 1.555 . . . . 51.14 108.867 -177.029 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -157.79 116.01 3.11 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.58 0.752 . . . . 54.15 109.899 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.24 156.47 48.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.289 1.036 . . . . 62.13 109.73 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.46 40.39 0.02 OUTLIER Glycine 0 N--CA 1.47 0.914 0 N-CA-C 111.818 -0.513 . . . . 54.44 111.818 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.443 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 1.7 pm0 -68.96 125.68 27.42 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.849 0.86 . . . . 72.23 111.167 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.66 140.91 27.75 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.75 -0.659 . . . . 64.02 112.363 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.59 HG22 ' HB3' ' A' ' 11' ' ' PHE . 25.5 p -113.84 125.71 54.37 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.857 0.863 . . . . 74.13 110.285 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.74 138.18 10.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.6 0.76 . . . . 71.24 109.666 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.01 156.1 23.59 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.428 0.691 . . . . 74.21 112.81 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -173.49 140.94 0.84 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.073 1.349 . . . . 51.32 107.747 164.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.29 107.8 5.58 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.897 -1.149 . . . . 63.02 107.897 -178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -105.61 -35.56 7.38 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.777 0.831 . . . . 75.12 111.182 -176.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 124.806 1.243 . . . . 71.22 112.229 176.659 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 110.497 -0.186 . . . . 73.32 110.497 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 43.5 p -72.77 101.41 3.1 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 123.928 0.767 . . . . 72.01 109.308 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.59 154.86 19.99 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.734 -0.839 . . . . 71.43 108.734 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -60.71 100.64 0.11 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.805 0.842 . . . . 74.42 110.419 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 59.4 t30 55.54 98.75 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.326 1.45 . . . . 70.2 111.818 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -58.73 -61.4 2.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.645 0.778 . . . . 74.32 111.196 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m 51.36 45.3 28.16 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.369 1.08 . . . . 72.43 110.154 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.65 174.38 9.84 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.616 -1.175 . . . . 64.42 110.331 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.431 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 9.5 ptt? 54.49 -166.62 0.09 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 126.079 1.751 . . . . 63.4 112.966 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 63.1 m -148.7 125.65 11.29 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.765 -1.198 . . . . 52.2 107.765 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.64 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 19.4 t80 -141.86 118.59 11.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.556 0.742 . . . . 72.02 109.312 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.476 ' HB3' ' HB ' ' E' ' 309' ' ' THR . 7.3 pt20 -154.88 130.38 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.743 0.817 . . . . 72.02 109.155 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -81.31 132.53 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.142 0.577 . . . . 62.41 109.825 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -89.24 -48.54 7.31 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.884 -0.413 . . . . 74.24 109.884 168.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.585 HH21 ' HB ' ' A' ' 122' ' ' THR . 58.9 ttt180 -162.95 154.85 18.07 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 111.395 0.146 . . . . 74.22 111.395 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.408 ' HB ' HD21 ' D' ' 127' ' ' ASN . 87.3 mt -137.39 111.37 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.403 1.081 . . . . 75.22 108.083 171.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.406 ' HE1' HG13 ' B' ' 83' ' ' ILE . 24.9 p90 -137.2 147.92 46.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.853 0.461 . . . . 75.13 110.379 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -75.3 119.05 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.742 -0.663 . . . . 61.03 109.744 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -89.92 -23.15 21.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.68 0.792 . . . . 73.32 111.121 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.37 141.64 4.54 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.217 0.323 . . . . 73.5 111.789 -173.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -133.12 146.41 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.195 1.398 . . . . 73.02 109.084 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.0 t -149.08 151.94 35.32 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.881 0.872 . . . . 72.15 109.009 172.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -156.01 122.7 5.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.2 mt-10 -125.12 113.05 17.2 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.031 -0.729 . . . . 71.13 109.031 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.42 84.03 9.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.874 -1.158 . . . . 74.24 107.874 170.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.7 -22.96 17.31 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.661 2.241 . . . . 73.45 111.638 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -113.37 15.31 19.22 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.538 1.135 . . . . 73.1 110.576 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.686 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.68 -58.1 9.29 Favored Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 125.335 1.454 . . . . 62.52 114.607 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.76 -25.63 39.52 Favored 'Trans proline' 0 C--N 1.398 3.154 0 C-N-CA 121.903 1.735 . . . . 70.34 112.712 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.492 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 75.2 m80 -97.99 1.21 47.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.485 0.714 . . . . 73.3 112.876 -174.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.91 -22.66 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.227 0.611 . . . . 73.35 112.521 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -64.95 -30.77 71.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.941 0.897 . . . . 74.33 112.175 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.7 pt20 -65.49 -36.08 82.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 110.101 -0.333 . . . . 63.51 110.101 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.658 ' HB2' HD13 ' B' ' 68' ' ' LEU . 83.3 mttt -108.89 65.63 0.62 Allowed 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.616 0.722 . . . . 74.25 109.169 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -75.28 108.29 7.95 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.116 -0.947 . . . . 64.12 109.643 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.443 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 162.13 -171.69 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 127.61 2.364 . . . . 74.13 108.985 159.517 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.611 ' HB3' ' H ' ' H' ' 297' ' ' TYR . 14.8 pt20 -72.3 128.8 88.38 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 122.963 0.164 . . . . 72.42 110.838 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.52 -176.22 3.0 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.673 2.249 . . . . 75.43 111.05 168.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -76.04 106.78 7.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.796 -1.187 . . . . 72.0 107.796 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.13 136.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.079 -1.082 . . . . 74.35 108.079 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -150.98 142.41 23.43 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.279 0.631 . . . . 72.33 109.653 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -85.97 159.72 19.55 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.976 0.893 . . . . 71.1 110.505 171.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 33.7 t70 -140.09 110.46 6.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.448 -2.056 . . . . 64.42 105.448 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.87 134.63 47.66 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.885 -0.783 . . . . 71.43 108.885 -167.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.8 t70 -131.36 139.97 49.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.844 -0.799 . . . . 73.52 108.844 172.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -109.71 124.94 52.09 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.124 0.969 . . . . 72.4 109.605 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.61 43.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.699 0.8 . . . . 75.31 108.893 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -143.19 161.33 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.674 0.389 . . . . 73.14 110.198 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 84.9 p -153.06 150.76 29.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.786 0.834 . . . . 64.22 109.514 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -100.99 114.91 29.26 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.862 -0.792 . . . . 65.43 108.862 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 77.5 mt -77.75 -42.83 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.807 0.443 . . . . 64.23 110.343 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.11 -171.07 2.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.63 -0.714 . . . . 64.53 111.118 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.33 118.53 9.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.438 -1.256 . . . . 53.22 110.091 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.75 -3.94 1.3 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.296 1.438 . . . . 75.41 112.488 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.96 107.11 21.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.462 -0.94 . . . . 65.23 108.462 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.22 156.63 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.401 -0.818 . . . . 64.23 109.136 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.403 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 7.4 tm-20 -133.12 97.26 3.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.214 -1.402 . . . . 75.1 107.214 -167.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.4 128.83 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.341 1.056 . . . . 71.11 109.238 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.33 143.65 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.917 0.887 . . . . 72.03 109.401 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' B' ' 103' ' ' PRO . 58.6 mt -129.32 122.8 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.419 0.687 . . . . 74.12 109.406 170.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.639 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.8 ttm180 -92.19 108.57 20.04 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.469 -0.937 . . . . 71.31 108.469 172.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.12 103.14 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.197 -1.408 . . . . 73.4 107.197 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 10.8 m -104.53 124.43 49.28 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.228 -0.656 . . . . 74.25 109.228 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.565 HG21 HG21 ' B' ' 114' ' ' ILE . 90.8 t -103.09 104.72 17.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.626 0.77 . . . . 63.52 109.124 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.4 m -94.96 136.89 34.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.341 -0.845 . . . . 73.2 109.415 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.62 136.05 24.1 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.586 -0.894 . . . . 73.43 108.586 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.9 p -142.05 130.59 22.58 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.531 0.519 . . . . 55.04 111.532 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' B' ' 34' ' ' LYS . 46.5 mt -92.29 99.34 12.13 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -109.82 2.96 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.473 -0.785 . . . . 52.25 111.742 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.8 4.3 18.3 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.453 1.101 . . . . 65.11 111.564 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.66 170.88 9.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.609 0.764 . . . . 61.1 109.726 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -76.49 152.53 36.07 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.876 0.47 . . . . 63.04 110.903 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.575 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -104.98 -63.28 1.24 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.271 -1.011 . . . . 45.33 108.271 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.94 156.67 22.69 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.13 -1.396 . . . . 64.44 108.253 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 80.0 mt -132.77 148.82 52.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.532 1.133 . . . . 70.4 108.3 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.92 159.63 44.02 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.333 -0.988 . . . . 64.33 108.333 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.4 tt0 -163.34 137.78 6.14 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.671 0.388 . . . . 75.23 110.004 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.406 HG22 HD12 ' B' ' 21' ' ' ILE . 78.5 t -135.97 144.63 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.154 0.981 . . . . 64.45 109.202 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -122.56 105.43 10.11 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.5 -1.296 . . . . 72.41 107.5 169.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.522 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -99.59 108.75 21.23 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 149.94 20.55 Favored Glycine 0 C--O 1.242 0.605 0 N-CA-C 110.914 -0.874 . . . . 61.14 110.914 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.44 123.66 2.03 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.015 -0.834 . . . . 63.42 111.015 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.406 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.3 mt -88.11 126.78 41.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.691 -0.855 . . . . 62.1 108.691 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -135.36 134.38 39.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.483 1.113 . . . . 75.21 108.819 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.466 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 32.7 m -93.92 96.65 9.85 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.75 -0.833 . . . . 72.13 108.75 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -110.7 135.4 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.018 0.927 . . . . 61.43 110.668 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.16 164.47 37.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 74.15 109.296 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.67 -39.02 2.8 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 123.003 0.335 . . . . 70.42 113.776 175.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.605 HG13 HD11 ' H' ' 277' ' ' LEU . 28.9 pt -60.85 145.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.326 1.05 . . . . 73.31 111.587 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -166.28 163.1 17.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.663 0.785 . . . . 75.22 109.891 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.8 -123.19 32.65 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.87 0.732 . . . . 44.34 113.391 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -67.98 -36.21 79.66 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.407 1.083 . . . . 54.21 110.936 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.64 -29.97 67.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.794 -1.094 . . . . 74.31 110.674 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -49.66 60.33 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.358 -0.837 . . . . 75.43 109.632 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.3 73.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.123 0.969 . . . . 72.43 111.85 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -69.7 -34.22 73.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.89 0.876 . . . . 65.12 110.709 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -70.35 -66.88 0.54 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.043 -0.526 . . . . 73.41 111.112 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.548 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.0 OUTLIER -87.9 -14.47 39.27 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.339 0.496 . . . . 62.32 112.339 -169.151 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.401 ' N ' HD13 ' B' ' 98' ' ' LEU . . . -101.23 -4.22 53.66 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.896 -0.391 . . . . 63.01 113.379 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.82 -58.79 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 117.149 0.475 . . . . 63.34 111.66 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -73.41 -44.93 57.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 73.04 111.999 -172.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.64 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 35.2 m -68.01 -43.8 37.46 Favored Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 118.752 -0.642 . . . . 64.25 111.64 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.42 ' HB3' HD11 ' B' ' 60' ' ' LEU . 29.1 Cg_exo -44.94 -53.03 5.61 Favored 'Trans proline' 0 C--N 1.4 3.241 0 C-N-CA 123.038 2.492 . . . . 63.51 113.354 167.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -56.62 -23.65 42.52 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.219 1.008 . . . . 73.03 113.467 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.408 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.7 mt -78.81 -52.57 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.06 0.544 . . . . 72.44 110.929 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -87.38 -7.99 57.1 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -65.28 -45.02 70.61 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.669 1.188 . . . . 45.54 113.186 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.87 -37.66 66.79 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.627 2.218 . . . . 63.33 113.531 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.522 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 44.0 m-85 -68.96 -39.84 79.25 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.243 -0.89 . . . . 74.43 110.393 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.37 -45.49 79.93 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.669 0.388 . . . . 50.3 110.669 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -54.66 -56.13 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.329 1.452 . . . . 74.32 111.699 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.856 0.863 . . . . 75.14 110.791 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.61 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.0 t -66.86 -31.75 72.56 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.0 -0.545 . . . . 70.15 111.385 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.565 HG21 HG21 ' B' ' 64' ' ' VAL . 70.8 mt -67.53 -50.31 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.561 0.744 . . . . 73.04 110.314 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.5 m -61.84 -27.68 68.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 123.945 0.778 . . . . 73.35 111.245 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.14 -50.31 68.71 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.746 0.818 . . . . 64.34 110.295 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -72.49 -34.36 67.61 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.188 0.595 . . . . 62.01 111.653 -171.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.73 -38.55 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.469 0.708 . . . . 65.11 110.029 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t -72.94 -26.19 61.3 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.064 -0.971 . . . . 61.32 111.344 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.4 mtt-85 -73.81 -25.07 59.92 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.143 0.577 . . . . 52.41 110.5 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.24 14.71 32.33 Favored Glycine 0 C--N 1.357 1.697 0 O-C-N 123.541 0.525 . . . . 74.4 112.342 168.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 51.7 p 56.43 47.67 18.41 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.756 2.022 . . . . 63.24 112.612 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.08 151.96 46.17 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.205 -1.361 . . . . 74.12 109.658 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.26 -160.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.957 2.438 . . . . 54.44 113.33 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.648 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.43 125.69 25.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.347 1.059 . . . . 62.43 113.115 -170.548 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 59.5 tp -136.93 95.38 3.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.438 -0.949 . . . . 44.45 108.438 171.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -103.74 135.97 44.3 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.032 0.933 . . . . 73.41 110.547 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.3 tp -83.35 137.33 34.0 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.681 0.792 . . . . 71.5 109.709 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.459 ' HB3' HD13 ' H' ' 291' ' ' LEU . . . -70.51 152.82 95.34 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.278 1.031 . . . . 72.21 112.054 -173.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.4 111.28 1.42 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.492 2.795 . . . . 61.41 112.863 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.502 HG22 HD11 ' H' ' 291' ' ' LEU . 35.4 t -106.6 110.28 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 61.41 109.341 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 52.8 t30 -97.25 100.25 11.71 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.355 -0.98 . . . . 72.5 108.355 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -68.4 -31.31 70.57 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.464 0.706 . . . . 73.14 110.701 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.23 -33.91 75.48 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.528 -0.76 . . . . 75.33 111.475 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.43 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -55.94 -55.6 30.78 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.919 0.762 . . . . 62.3 111.353 -175.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.63 -38.99 84.68 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.996 0.518 . . . . 64.43 110.598 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.58 -36.34 83.47 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.803 0.841 . . . . 72.23 111.088 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 95.1 mmm -85.31 -36.32 20.9 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.211 0.604 . . . . 75.42 110.868 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -73.23 -13.18 61.1 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 117.672 0.215 . . . . 64.23 111.394 -178.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -62.18 -48.66 79.05 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 123.774 0.671 . . . . 65.34 110.607 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 pp -115.71 -4.5 12.17 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.845 0.858 . . . . 74.22 112.336 -168.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -147.26 95.6 2.58 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.671 0.788 . . . . 74.52 109.023 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -86.39 -8.36 57.72 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.987 -1.006 . . . . 65.32 111.624 -176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -70.14 -30.05 67.13 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.02 0.928 . . . . 64.31 111.687 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.31 87.98 2.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.369 0.668 . . . . 73.34 110.038 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 156.76 -160.36 30.25 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.833 -0.621 . . . . 61.24 111.872 177.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -142.44 160.93 39.31 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.798 0.839 . . . . 73.14 110.016 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.48 61.34 4.21 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.122 -0.945 . . . . 74.42 111.113 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 58.6 p -67.21 143.79 56.34 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 123.355 0.662 . . . . 74.23 111.265 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 69.63 138.05 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.736 1.614 . . . . 62.4 111.371 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -60.36 110.17 1.18 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 107.774 -1.195 . . . . 63.34 107.774 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -60.91 108.14 0.82 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.09 0.869 . . . . 65.04 110.593 -170.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -68.72 95.75 0.69 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.258 0.974 . . . . 72.11 110.393 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -102.74 -26.09 13.29 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.017 -0.992 . . . . 74.3 110.004 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 C-N-CA 125.49 1.516 . . . . 53.51 112.109 170.407 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.153 -0.684 . . . . 73.45 109.153 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' C' C ' 2' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 143' ' ' GLN . 49.6 m -144.18 131.53 20.85 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.25 0.62 . . . . 44.24 109.563 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.2 122.12 33.18 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.471 0.709 . . . . 72.32 109.118 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -152.15 133.59 14.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.867 0.867 . . . . 63.25 110.325 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -125.29 81.37 1.96 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.475 -1.305 . . . . 62.34 107.475 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.53 -61.19 1.75 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.397 -0.819 . . . . 71.54 108.844 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -104.09 127.56 51.68 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.053 0.941 . . . . 52.42 110.03 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' C' ' 9' ' ' MET . 4.4 pt-20 -97.15 -51.13 4.32 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.5 0.32 . . . . 52.25 110.279 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.5 ' HA ' HG13 ' C' ' 89' ' ' ILE . 59.6 ttp 63.38 128.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.601 1.56 . . . . 71.52 113.573 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 26.6 m -120.5 94.19 4.29 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.689 -1.226 . . . . 32.2 107.689 167.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -97.13 157.25 16.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.133 -0.939 . . . . 74.41 108.902 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.531 ' HB2' HG23 ' G' ' 306' ' ' VAL . 10.9 pt20 -170.92 129.28 0.77 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.533 0.733 . . . . 75.52 110.155 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.667 HD13 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -90.88 107.88 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.7 0.8 . . . . 73.42 109.594 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.407 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.2 mm100 -76.52 -52.83 9.02 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.079 -0.388 . . . . 51.32 110.609 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.738 HH12 HD13 ' G' ' 301' ' ' ILE . 63.3 ttt180 -166.21 128.58 1.92 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.987 -0.375 . . . . 72.4 109.987 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -108.07 146.36 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.849 -1.167 . . . . 70.42 107.849 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.507 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -176.93 163.39 2.2 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.565 0.698 . . . . 73.34 110.912 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -85.08 117.44 24.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.108 -0.951 . . . . 75.24 108.892 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -68.82 -42.93 76.57 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.844 0.831 . . . . 63.11 108.772 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.27 141.18 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.092 -1.413 . . . . 71.41 109.155 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.9 mt -129.21 140.7 48.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.769 -1.567 . . . . 63.41 106.769 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -157.61 145.84 19.1 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.259 0.552 . . . . 51.2 110.611 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -146.45 105.65 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.236 -1.764 . . . . 74.41 106.236 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -114.73 110.19 19.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.069 -1.086 . . . . 74.21 108.069 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -124.55 80.06 61.38 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.342 1.057 . . . . 74.33 108.827 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.92 -4.18 13.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.491 2.127 . . . . 74.32 111.731 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -117.7 18.65 14.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.1 . . . . 72.25 109.617 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.424 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -58.07 -52.3 75.5 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 114.177 1.177 . . . . 63.05 114.177 -170.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.514 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 73.8 Cg_endo -75.92 -31.61 4.97 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.47 1.561 . . . . 71.44 112.009 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.61 -23.69 62.6 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.968 1.307 . . . . 64.34 112.734 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.541 HG22 ' HA2' ' F' ' 299' ' ' GLY . 9.5 p -79.51 -16.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.837 -0.54 . . . . 61.04 111.576 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' C' ' 29' ' ' PRO . 57.1 m-85 -67.39 -8.37 32.37 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.054 0.542 . . . . 64.33 112.251 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -116.09 25.18 10.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.784 0.834 . . . . 73.32 111.105 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.531 ' HG2' HD13 ' C' ' 68' ' ' LEU . 3.9 tppt? -91.83 172.69 8.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.002 0.521 . . . . 72.11 111.252 -173.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.64 130.31 35.32 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.729 -0.841 . . . . 72.14 108.729 168.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -70.18 85.15 0.55 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.642 1.177 . . . . 74.3 110.334 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -157.44 66.37 3.7 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.91 0.884 . . . . 61.44 108.967 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.34 109.16 2.84 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.667 2.244 . . . . 74.01 112.33 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -85.86 88.76 7.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.753 -1.573 . . . . 74.51 106.753 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.81 134.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.842 -1.072 . . . . 75.41 109.269 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' C' ' 43' ' ' ASP . 29.2 ttpt -114.97 129.18 56.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.141 -1.059 . . . . 74.21 108.141 169.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.47 HD22 HD11 ' C' ' 128' ' ' LEU . 49.4 tp -88.03 141.49 28.53 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.463 -1.31 . . . . 62.43 107.463 166.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.614 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 20.8 t70 -140.54 109.7 6.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.008 0.523 . . . . 61.34 109.692 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -105.64 145.73 30.63 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.245 -0.65 . . . . 71.14 109.245 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -143.29 149.76 38.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.519 1.127 . . . . 71.51 108.993 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' F' ' 282' ' ' ALA . 34.1 p -115.23 140.78 48.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.895 0.878 . . . . 72.11 110.257 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -143.11 151.31 40.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 73.24 109.527 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 24.3 m -141.29 155.96 45.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.937 0.495 . . . . 73.14 111.289 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -149.08 126.6 11.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.332 -0.988 . . . . 52.03 108.332 168.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -81.63 117.48 22.03 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 107.828 -1.175 . . . . 54.33 107.828 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.9 mt -97.07 -25.76 15.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.892 0.477 . . . . 73.12 110.549 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.44 -179.72 6.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.773 0.829 . . . . 73.11 110.119 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -62.67 122.35 15.64 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.937 -0.764 . . . . 75.51 108.937 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.8 21.19 12.64 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 124.447 1.092 . . . . 64.14 111.44 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.69 117.34 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 124.01 0.924 . . . . 62.04 108.63 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.66 130.42 43.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.931 0.892 . . . . 75.04 110.19 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.8 tt0 -82.02 109.28 16.2 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.527 -1.286 . . . . 64.44 107.527 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -96.39 114.12 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.031 -1.47 . . . . 52.43 107.031 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 48.9 t -111.88 131.28 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.455 0.702 . . . . 71.34 109.321 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.54 HD23 HD12 ' C' ' 106' ' ' LEU . 3.6 mm? -117.22 111.31 19.26 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.334 1.054 . . . . 74.14 108.312 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.4 ttm180 -81.99 114.76 20.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.912 -0.773 . . . . 74.12 108.912 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.28 117.03 50.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.854 -1.165 . . . . 73.14 107.854 173.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.0 m -123.74 139.83 53.59 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.417 1.087 . . . . 34.42 108.075 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.7 113.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.136 0.974 . . . . 74.11 108.971 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 45.8 m -98.24 137.09 37.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.278 -0.874 . . . . 74.14 108.658 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.29 112.9 10.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.878 -1.527 . . . . 42.25 106.878 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 48.7 m -145.35 127.6 15.77 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.052 -0.721 . . . . 64.44 109.052 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.531 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.8 mp -90.47 48.78 1.59 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.301 0.572 . . . . 62.33 110.543 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 -117.82 3.21 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.179 -1.168 . . . . 35.31 110.179 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.72 -33.19 16.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.134 0.974 . . . . 63.22 109.267 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.71 121.3 25.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.592 1.157 . . . . 60.53 110.851 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 91.7 m -78.77 137.84 37.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.081 0.952 . . . . 55.2 111.584 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.63 -66.11 0.74 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.106 0.963 . . . . 74.43 109.241 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -159.32 175.87 12.84 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.702 0.763 . . . . 60.54 110.858 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.4 143.36 51.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.982 -1.488 . . . . 73.25 106.982 171.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.44 140.21 41.13 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.659 -1.237 . . . . 74.3 107.659 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -151.46 119.74 6.36 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.373 0.533 . . . . 62.15 110.875 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -117.24 114.14 44.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.512 -0.922 . . . . 72.21 108.512 170.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 25.9 mt-30 -90.25 97.53 11.24 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.615 -1.254 . . . . 74.35 107.615 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.4 tp60 -87.14 119.67 27.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.754 0.822 . . . . 64.12 109.806 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.23 148.95 18.28 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 123.188 0.305 . . . . 72.35 112.593 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.7 2.82 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 110.902 -0.879 . . . . 62.2 110.902 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.508 HD12 HD11 ' C' ' 51' ' ' LEU . 16.2 mm -81.26 119.85 31.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -129.41 142.89 50.69 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.418 -0.956 . . . . 72.03 108.418 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -105.98 123.31 47.78 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.124 -1.065 . . . . 73.24 108.124 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.87 100.66 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.914 0.886 . . . . 71.05 108.757 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 169.34 14.22 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.871 1.269 . . . . 75.23 108.818 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.18 -40.94 3.03 Favored Glycine 0 N--CA 1.466 0.7 0 CA-C-N 116.567 -0.288 . . . . 50.22 112.966 174.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.5 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.9 pp -124.86 165.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.041 0.937 . . . . 63.43 110.489 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' C' ' 91' ' ' GLY . 28.4 tt0 -152.97 166.0 33.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.417 0.687 . . . . 74.12 109.985 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 91' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' C' ' 90' ' ' GLU . . . 70.59 -118.44 7.74 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.565 -0.289 . . . . 75.2 113.71 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -77.96 -24.48 48.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.503 0.721 . . . . 55.13 111.194 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -41.01 69.23 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.567 -0.531 . . . . 70.14 109.567 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' F' ' 277' ' ' LEU . 20.0 ptm -76.98 -28.34 55.08 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.12 -0.491 . . . . 64.21 110.755 176.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' F' ' 280' ' ' LEU . . . -66.46 -29.2 69.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.149 0.58 . . . . 71.13 110.836 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -70.92 -36.07 72.51 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.656 0.782 . . . . 74.35 110.496 171.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -67.8 -62.13 1.56 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 51.34 110.568 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.57 -12.42 60.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.628 0.603 . . . . 75.11 112.628 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.48 -4.41 57.22 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.58 -0.567 . . . . 72.33 113.917 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.49 -50.87 0.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.761 0.781 . . . . 71.14 111.726 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -75.98 -54.2 7.23 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.293 0.637 . . . . 73.4 111.677 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.61 -42.32 71.78 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 123.766 0.827 . . . . 75.33 113.167 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.59 -30.84 79.66 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 122.209 1.94 . . . . 72.44 112.68 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.14 -33.77 73.97 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.232 0.613 . . . . 75.03 110.743 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -65.87 -50.49 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.055 0.542 . . . . 73.31 110.091 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.54 HD12 HD23 ' C' ' 60' ' ' LEU . 82.3 mt -79.52 -15.55 57.54 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.831 -0.622 . . . . 53.51 112.409 -172.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.438 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 87.8 t80 -56.41 -55.6 40.69 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.284 1.034 . . . . 72.5 113.131 -175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 21.0 Cg_exo -66.24 -29.87 46.43 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.914 1.743 . . . . 42.44 112.828 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.422 ' HE2' HG21 ' A' ' 115' ' ' THR . 86.1 m-85 -65.64 -45.78 81.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.364 0.666 . . . . 73.33 110.881 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.63 91.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.437 0.695 . . . . 75.23 110.651 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -60.92 -57.1 14.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.749 1.22 . . . . 72.04 111.484 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -33.38 75.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.415 0.447 . . . . 75.33 110.008 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.479 ' SG ' HG12 ' C' ' 21' ' ' ILE . 26.1 t -61.2 -43.87 98.19 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.978 0.511 . . . . 53.13 110.565 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -65.15 -43.98 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.177 0.591 . . . . 72.24 110.542 173.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -63.19 -33.15 74.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.441 0.697 . . . . 54.31 111.471 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.2 p -76.78 -41.61 43.95 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.84 -0.8 . . . . 70.24 108.84 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.724 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -54.95 -46.4 75.0 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.89 0.876 . . . . 62.53 112.111 178.043 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.81 -26.89 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.736 0.414 . . . . 72.12 111.126 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -70.88 -29.89 66.11 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.537 0.735 . . . . 72.55 111.416 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.405 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 50.6 mtt-85 -78.68 -33.17 47.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.744 0.818 . . . . 54.1 109.39 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.69 1.53 61.82 Favored Glycine 0 C--N 1.361 1.937 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.881 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 61.74 25.2 15.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.381 1.873 . . . . 40.25 113.069 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -103.4 156.44 35.46 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.35 1.06 . . . . 71.53 110.421 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 32.3 Cg_exo -40.66 118.9 0.67 Allowed 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 124.238 3.292 . . . . 72.51 113.779 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.16 139.55 57.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.54 -0.754 . . . . 71.4 111.743 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.18 105.7 15.86 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.029 -1.1 . . . . 64.01 108.029 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.18 112.66 22.98 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.211 -1.403 . . . . 72.44 107.211 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.47 HD11 HD22 ' C' ' 42' ' ' LEU . 20.4 tp -84.6 141.86 30.37 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 123.597 0.561 . . . . 74.23 110.039 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' H' ' 309' ' ' THR . . . -79.35 145.29 63.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.686 -0.688 . . . . 71.24 112.095 -170.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.592 ' HG3' HD13 ' A' ' 16' ' ' ILE . 5.3 Cg_endo -46.8 102.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.977 3.118 . . . . 73.2 112.762 169.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -96.25 106.71 18.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.042 -1.466 . . . . 65.51 107.042 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -98.77 85.68 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.541 -1.281 . . . . 72.01 107.541 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -51.22 -38.3 51.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.342 1.057 . . . . 71.34 111.9 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.48 -38.47 62.9 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.211 1.004 . . . . 71.55 111.811 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.93 -28.86 67.03 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.935 0.494 . . . . 60.23 111.078 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 mp -56.13 -41.02 74.68 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.821 0.701 . . . . 65.21 110.888 171.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -66.48 -29.92 70.14 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.088 0.555 . . . . 75.22 111.883 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 65.1 mtt -74.07 -31.59 62.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.186 0.594 . . . . 64.33 110.843 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -69.64 -38.09 77.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.529 0.732 . . . . 60.21 109.897 174.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -66.56 -82.52 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.57 0.748 . . . . 74.3 110.068 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 41.7 tp -115.17 93.06 4.14 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.001 0.52 . . . . 73.32 110.586 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.17 -98.97 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.421 -1.326 . . . . 75.3 107.421 168.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -156.62 112.82 3.01 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.656 1.182 . . . . 63.53 108.411 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -90.83 93.93 9.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.652 -1.24 . . . . 44.43 107.652 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.74 141.62 15.81 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.623 0.769 . . . . 50.4 110.352 -170.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -174.76 144.94 7.68 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.806 -0.634 . . . . 61.31 112.088 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -167.4 148.76 5.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.713 0.405 . . . . 54.14 110.735 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.17 -89.7 0.08 OUTLIER Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.773 -0.931 . . . . 73.55 110.773 174.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' A' ' 53' ' ' ASP . 33.6 p 61.6 128.43 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.079 2.152 . . . . 73.22 111.71 -175.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 16.0 pt-20 -135.85 -175.06 3.84 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.524 0.73 . . . . 74.44 110.787 -171.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.26 111.54 10.32 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.027 -1.842 . . . . 63.1 106.027 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 33.9 t-80 -167.89 112.4 0.66 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.431 -0.952 . . . . 71.1 108.431 -174.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -83.26 120.9 26.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.409 0.684 . . . . 70.3 109.927 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -119.19 147.08 44.62 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.176 0.59 . . . . 74.31 111.078 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.306 0 C-N-CA 123.992 0.917 . . . . 74.55 110.66 -178.886 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.844 -0.428 . . . . 72.33 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -84.14 76.07 10.12 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.261 0.625 . . . . 55.13 109.836 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -86.0 93.68 9.03 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.775 -0.648 . . . . 64.42 110.188 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -76.46 176.58 8.12 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.614 -0.721 . . . . 72.54 110.588 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -156.04 -60.8 0.1 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.301 0.64 . . . . 74.12 109.454 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -143.31 124.46 14.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.808 0.843 . . . . 70.54 109.196 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -123.21 -12.72 7.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.597 0.759 . . . . 54.1 110.274 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.29 -0.48 56.7 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.156 0.982 . . . . 75.01 111.013 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 8.1 ttp -30.88 127.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.457 1.503 . . . . 71.3 113.583 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 25.7 m -118.83 139.34 51.77 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.437 0.695 . . . . 61.42 109.726 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -157.68 116.4 3.19 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.537 -1.283 . . . . 70.12 107.537 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -135.59 140.52 44.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.876 -1.157 . . . . 51.4 107.876 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.507 HG21 HD11 ' D' ' 16' ' ' ILE . 8.7 mt -97.46 124.77 50.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.017 -0.735 . . . . 60.24 109.017 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.82 -37.54 12.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.485 0.714 . . . . 64.24 110.344 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -161.12 148.34 15.17 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 75.14 110.675 -173.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.507 HD11 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -135.34 114.66 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.302 -2.11 . . . . 74.31 105.302 166.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -151.72 151.53 31.55 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.576 0.703 . . . . 65.44 111.081 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -77.32 109.89 11.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.761 -1.108 . . . . 64.2 109.134 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.514 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 34.9 mtpt -79.28 -33.16 43.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.041 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -141.33 142.2 33.82 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.371 -0.974 . . . . 72.42 108.371 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.724 HD13 ' HE3' ' C' ' 117' ' ' MET . 98.0 mt -133.06 140.91 46.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.574 -1.639 . . . . 75.31 106.574 173.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -146.7 136.47 23.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.605 0.762 . . . . 51.13 109.116 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 57.2 t80 -148.72 123.68 10.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.764 -1.939 . . . . 65.23 105.764 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.12 142.12 51.69 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.431 0.692 . . . . 75.21 109.298 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.66 80.36 66.55 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.913 -1.143 . . . . 64.45 107.913 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.79 -29.97 27.96 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.733 2.289 . . . . 62.22 111.784 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -114.47 40.74 2.47 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.959 1.304 . . . . 73.33 108.775 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.507 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -55.11 -66.41 1.0 Allowed Pre-proline 0 CA--C 1.563 1.453 0 N-CA-C 114.315 1.228 . . . . 74.44 114.315 -166.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -86.21 -3.92 8.66 Favored 'Trans proline' 0 C--N 1.387 2.578 0 CA-C-N 123.074 2.134 . . . . 63.3 112.123 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.25 -39.86 68.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.933 1.293 . . . . 74.33 109.901 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.29 -28.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.337 -0.392 . . . . 75.25 110.1 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.98 -2.33 3.89 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.235 1.198 . . . . 64.04 114.235 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -76.83 -38.18 54.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.145 0.578 . . . . 62.02 109.672 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.491 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -136.3 96.69 3.42 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.373 0.669 . . . . 73.23 112.303 173.011 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -107.13 98.03 7.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 164.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.636 ' H ' HD11 ' D' ' 68' ' ' LEU . 5.6 m-90 -122.31 -162.85 1.03 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.231 -1.766 . . . . 70.34 106.231 169.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.608 ' HB3' ' HB3' ' G' ' 295' ' ' ALA . 26.6 mt-30 -52.52 104.23 0.42 Allowed Pre-proline 0 N--CA 1.486 1.367 0 CA-C-N 118.66 0.664 . . . . 75.02 112.521 -168.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.412 ' O ' HG13 ' D' ' 40' ' ' VAL . 5.9 Cg_exo -75.7 105.07 2.01 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.662 2.241 . . . . 52.12 109.892 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -61.23 111.0 1.56 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.701 -1.222 . . . . 74.44 107.701 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.544 HG11 HD11 ' D' ' 126' ' ' LEU . 2.2 m -104.61 149.42 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.797 -1.092 . . . . 71.14 110.876 -165.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.567 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.7 mmtt -109.17 133.05 53.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.069 0.947 . . . . 73.21 108.511 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -96.9 111.97 23.93 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.568 -1.271 . . . . 74.55 107.568 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.653 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -124.29 141.47 52.04 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.873 0.869 . . . . 72.22 108.79 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.74 167.14 22.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.22 0.533 . . . . 52.4 110.762 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' D' ' 61' ' ' ARG . 4.3 t70 -156.31 145.83 20.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.825 -1.176 . . . . 73.43 107.825 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.5 p -106.59 141.79 37.3 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.019 -0.734 . . . . 70.43 109.019 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.5 159.39 42.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.528 -0.915 . . . . 62.3 108.528 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 20.4 p -170.89 162.08 7.3 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.576 0.35 . . . . 63.43 110.931 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -152.0 152.24 32.2 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.212 0.605 . . . . 60.2 110.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -90.75 117.56 29.48 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.604 -0.887 . . . . 74.04 108.604 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.98 16.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.393 0.677 . . . . 72.41 109.434 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -166.94 177.11 6.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.319 1.048 . . . . 63.32 110.218 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.28 127.06 31.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.998 -1.112 . . . . 72.04 107.998 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 70.85 5.92 5.64 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.445 1.098 . . . . 74.22 111.856 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 86.3 t -125.51 115.22 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.252 1.021 . . . . 74.21 108.277 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -135.92 130.84 34.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.12 0.568 . . . . 72.23 109.553 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -90.26 136.12 33.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 73.0 109.881 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.12 114.55 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.654 1.182 . . . . 74.12 108.26 175.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -101.85 108.89 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.553 0.741 . . . . 64.35 109.339 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.86 111.25 23.57 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.25 -1.019 . . . . 73.22 108.25 175.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' D' ' 45' ' ' ASP . 14.7 ttm180 -83.91 114.34 21.6 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.324 0.65 . . . . 72.41 109.489 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.4 123.69 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.202 -1.036 . . . . 75.21 108.202 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -129.65 135.32 48.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.324 0.65 . . . . 71.33 109.817 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.9 109.27 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.974 0.91 . . . . 72.44 109.574 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 31.3 m -102.46 102.37 12.66 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.08 -0.711 . . . . 73.3 109.08 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.77 129.35 43.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 110.059 -0.348 . . . . 73.25 110.059 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -124.27 124.11 41.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 64.14 109.152 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.636 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.1 OUTLIER -90.9 96.57 10.7 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.512 -1.292 . . . . 74.23 107.512 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.14 -112.99 4.68 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.477 0.485 . . . . 64.14 112.548 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.95 6.43 48.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.306 1.042 . . . . 63.51 111.908 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -146.75 157.2 43.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.667 0.787 . . . . 62.32 109.336 -171.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -66.66 132.47 48.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.973 0.909 . . . . 70.02 111.909 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.08 -64.51 1.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.925 -0.769 . . . . 74.34 108.925 169.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.58 159.26 38.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.432 -1.258 . . . . 74.11 110.004 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.79 146.59 34.75 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 73.12 108.6 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.8 t -152.29 140.84 20.75 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.999 0.52 . . . . 72.32 110.171 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -157.95 145.79 18.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.712 0.805 . . . . 64.51 109.872 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.8 116.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.322 1.049 . . . . 62.14 109.018 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.75 90.58 8.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.847 -0.797 . . . . 75.13 108.847 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -82.4 98.23 8.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.353 -0.84 . . . . 73.13 109.819 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.63 144.68 17.52 Favored Glycine 0 C--N 1.342 0.917 0 N-CA-C 111.602 -0.599 . . . . 53.51 111.602 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.31 130.92 4.15 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 111.142 -0.783 . . . . 71.31 111.142 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.7 123.23 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.525 -0.917 . . . . 72.21 108.525 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.68 126.66 37.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.814 0.846 . . . . 72.02 110.024 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.3 m -76.26 98.01 4.34 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.82 -0.807 . . . . 74.25 108.82 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 63.6 mt -107.81 109.94 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.376 -0.972 . . . . 63.3 108.376 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -151.16 168.33 25.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.108 0.963 . . . . 54.22 110.133 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.52 -20.2 19.63 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.04 -0.527 . . . . 44.01 114.008 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 pt -124.22 162.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.938 0.895 . . . . 73.41 111.178 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 173.67 13.83 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.368 -0.833 . . . . 64.34 111.054 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.83 -118.62 12.39 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 124.156 0.91 . . . . 61.13 114.042 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.7 m -74.54 -31.05 61.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 74.25 111.684 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 37.5 mm-40 -65.52 -43.76 89.06 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.994 0.518 . . . . 75.51 110.987 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' G' ' 276' ' ' PRO . 0.0 OUTLIER -75.55 -34.91 60.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.012 -0.54 . . . . 61.02 110.363 177.263 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.36 -29.35 68.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.136 0.574 . . . . 74.11 111.504 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.446 ' HD1' ' HD2' ' D' ' 137' ' ' PHE . 18.4 t60 -71.49 -49.74 38.3 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.614 0.766 . . . . 70.43 109.492 175.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.73 -39.06 93.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.753 -0.658 . . . . 71.1 111.155 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.463 HD21 HD13 ' G' ' 278' ' ' LEU . 58.5 tp -78.78 -37.08 41.87 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.499 1.12 . . . . 74.55 111.013 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.33 -23.28 24.79 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.089 -0.505 . . . . 55.0 113.901 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.86 -58.43 2.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.395 0.598 . . . . 54.3 111.635 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.63 -46.29 47.69 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.251 0.463 . . . . 71.31 112.251 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 76.1 m -64.91 -47.27 74.65 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.297 -0.858 . . . . 61.22 112.279 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.2 -34.27 97.49 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.444 2.096 . . . . 71.55 112.998 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.2 -30.11 69.96 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.093 0.957 . . . . 71.54 111.24 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.41 -43.58 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.267 0.627 . . . . 73.31 110.266 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.93 -34.57 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.301 -0.863 . . . . 74.41 112.214 -170.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.71 -42.6 92.24 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 114.372 1.249 . . . . 70.1 114.372 -168.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.65 -42.84 54.44 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.464 2.109 . . . . 74.4 113.858 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -76.5 -27.99 56.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.458 0.703 . . . . 75.33 111.493 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.01 -54.29 36.58 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.983 0.42 . . . . 70.02 109.955 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.408 ' NH2' HG23 ' B' ' 105' ' ' ILE . 40.9 ttp180 -62.51 -34.22 76.44 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.622 -1.172 . . . . 73.12 111.285 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.64 -52.87 58.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.357 1.063 . . . . 53.4 110.84 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.405 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 50.9 t -65.44 -43.68 89.7 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 114.841 -1.072 . . . . 73.42 111.377 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.3 mt -60.58 -56.7 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.752 0.821 . . . . 73.31 110.86 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.449 HG23 ' HB2' ' D' ' 125' ' ' GLN . 97.7 m -51.83 -42.71 62.75 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.32 1.048 . . . . 61.43 111.825 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.6 t -71.05 -28.4 64.35 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.399 -0.819 . . . . 54.24 111.645 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 77.0 mtm -77.99 -36.65 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.832 0.453 . . . . 75.3 111.391 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.499 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.7 t -64.5 -36.6 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.614 0.766 . . . . 73.45 110.752 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 84.9 p -69.71 -31.07 68.88 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.437 0.695 . . . . 62.21 111.322 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 68.8 mtt-85 -74.79 -26.06 59.48 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.559 0.743 . . . . 54.41 110.821 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.32 10.07 62.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.572 0.545 . . . . 65.21 112.538 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p 63.7 23.14 13.39 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.386 1.874 . . . . 74.0 113.287 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.44 163.83 18.94 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.487 1.115 . . . . 71.42 109.438 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.64 155.48 44.68 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.221 1.947 . . . . 55.22 110.555 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.449 ' HB2' HG23 ' D' ' 115' ' ' THR . 16.7 pt20 -55.57 147.27 18.36 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.513 0.725 . . . . 72.13 111.694 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.544 HD11 HG11 ' D' ' 40' ' ' VAL . 3.0 tt -126.39 106.19 9.32 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.059 -0.719 . . . . 74.35 109.059 -175.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.408 HD21 ' HB ' ' B' ' 16' ' ' ILE . 7.6 m-20 -112.52 110.38 20.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.233 1.013 . . . . 70.43 110.577 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.76 125.39 28.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.639 0.776 . . . . 73.53 108.993 171.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.427 ' HB3' HD13 ' G' ' 291' ' ' LEU . . . -66.02 145.54 99.01 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 122.395 0.278 . . . . 50.11 110.719 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.75 134.41 25.83 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.317 2.011 . . . . 71.42 111.378 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.402 HG22 HD21 ' G' ' 291' ' ' LEU . 41.5 t -108.89 120.23 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.152 -0.684 . . . . 41.12 109.152 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -86.41 82.42 7.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.395 0.678 . . . . 53.42 109.656 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -62.38 -28.57 69.86 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.174 0.99 . . . . 73.12 111.14 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -49.32 77.73 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 125.068 1.347 . . . . 73.25 110.439 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.83 94.44 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.944 0.898 . . . . 64.45 111.783 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.63 -34.42 77.84 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.197 -0.91 . . . . 75.41 111.683 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.446 ' HD2' ' HD1' ' D' ' 96' ' ' HIS . 71.5 t80 -80.3 -44.24 19.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.31 0.644 . . . . 64.42 110.738 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.7 ptp -64.38 -26.38 68.44 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.876 0.47 . . . . 71.55 111.736 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -54.66 -49.35 70.81 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.432 1.093 . . . . 73.31 111.199 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -59.06 -36.42 75.02 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.937 0.895 . . . . 74.24 111.77 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.58 -31.73 62.16 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.435 0.694 . . . . 44.4 112.254 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -90.76 12.53 18.9 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.16 0.43 . . . . 62.23 112.16 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -116.68 75.52 0.97 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.641 0.734 . . . . 73.52 109.153 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.06 -25.36 0.08 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.523 -1.217 . . . . 74.31 110.652 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.24 132.48 23.22 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.671 -1.233 . . . . 60.22 107.671 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.22 73.49 2.47 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 123.734 0.646 . . . . 70.13 112.454 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -79.41 118.67 21.51 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.263 0.625 . . . . 73.54 109.347 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.05 57.51 0.12 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 123.489 0.493 . . . . 63.55 112.963 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 82.0 m -64.54 89.93 0.07 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.803 0.841 . . . . 73.34 110.038 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -179.17 166.23 1.52 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.365 1.466 . . . . 65.11 109.655 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -152.99 -59.24 0.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.103 0.961 . . . . 74.13 108.421 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 84.5 t60 42.5 75.38 0.09 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.83 1.652 . . . . 71.1 112.115 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -65.32 108.3 1.89 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.936 -0.575 . . . . 72.42 109.857 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -156.33 28.71 0.34 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.751 -0.658 . . . . 70.24 109.352 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 C-N-CA 124.033 0.933 . . . . 62.34 111.165 -174.68 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.873 -0.417 . . . . 53.42 109.873 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -169.12 154.09 5.83 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.216 1.006 . . . . 72.34 109.724 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -168.35 -85.22 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.811 0.845 . . . . 64.24 108.833 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -144.54 102.05 3.76 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.109 -1.071 . . . . 74.15 108.109 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -78.45 150.0 76.03 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.144 0.578 . . . . 63.14 111.11 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.84 132.08 36.04 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 123.953 3.102 . . . . 64.03 113.608 -173.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 277' ' ' LEU . . . . . 0.723 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 40.5 mt -73.73 -60.82 2.07 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.817 -1.083 . . . . 63.31 110.095 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.33 51.03 1.42 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.004 0.921 . . . . 64.33 109.568 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -102.8 16.81 54.16 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.099 -0.5 . . . . 73.12 112.643 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 95' ' ' ALA . 64.3 tp -92.66 -65.37 1.01 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.122 0.569 . . . . 64.15 111.43 -173.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -67.48 -36.48 81.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.639 0.776 . . . . 75.45 110.805 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.05 -29.01 70.0 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.6 -1.182 . . . . 73.24 111.225 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.34 -54.87 4.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.859 0.864 . . . . 63.33 110.767 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -141.59 120.82 1.73 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.598 -0.728 . . . . 72.32 112.128 -171.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -80.07 120.77 24.67 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.423 1.089 . . . . 72.0 108.894 174.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 28.3 ttt -112.45 104.58 56.03 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.116 0.567 . . . . 72.21 111.118 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 287' ' ' PRO . . . . . 0.76 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 65.7 Cg_endo -85.04 176.04 6.21 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.724 2.283 . . . . 74.41 112.532 168.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.19 151.34 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.097 0.959 . . . . 74.04 109.105 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -103.57 156.24 17.93 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.568 0.747 . . . . 73.14 109.438 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -63.51 143.26 57.97 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.258 0.623 . . . . 72.25 110.844 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 6.9 mp -89.15 81.61 6.73 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.47 0.708 . . . . 61.52 109.992 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.25 -113.28 5.05 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-O 118.619 -1.101 . . . . 71.11 113.691 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.39 107.59 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.1 2.533 . . . . 73.33 111.688 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -115.37 19.68 15.34 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.667 1.187 . . . . 63.54 110.753 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.09 72.85 5.65 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.94 0.876 . . . . 31.13 110.337 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 43.9 m -86.8 -34.31 19.59 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.469 -1.241 . . . . 60.34 110.622 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.717 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 45.7 t80 -85.13 91.08 8.03 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.231 -0.895 . . . . 63.15 110.382 -172.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -93.72 -166.63 1.54 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.421 1.088 . . . . 60.31 109.977 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.25 67.72 0.22 Allowed Glycine 0 C--N 1.344 1.008 0 C-N-CA 122.796 0.236 . . . . 72.43 113.682 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -107.09 7.54 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.035 -0.728 . . . . 62.44 109.035 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 123' ' ' PHE . 25.2 pt -81.69 48.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.217 1.407 . . . . 71.55 110.397 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -108.24 -179.69 3.96 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.434 -0.803 . . . . 72.34 109.988 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -100.61 136.28 19.94 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-N 114.92 -1.037 . . . . 63.03 108.782 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 304' ' ' PRO . . . . . 0.442 ' HG3' ' HG3' ' D' ' 125' ' ' GLN . 74.1 Cg_exo -49.22 -41.41 41.97 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.476 2.117 . . . . 52.02 110.91 160.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 305' ' ' ALA . . . . . 0.534 ' HB3' ' HG2' ' G' ' 294' ' ' LYS . . . 50.14 47.73 23.12 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 125.468 1.73 . . . . 43.22 110.956 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 p -68.56 81.35 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-O 123.233 1.492 . . . . 65.52 108.566 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 11.6 t -101.4 175.4 5.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 112.908 -1.951 . . . . 70.11 109.205 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 53.9 m 63.46 20.84 12.47 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.079 0.952 . . . . 74.21 111.703 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' E' E ' 309' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' B' ' 12' ' ' GLN . 36.7 m -70.54 142.54 89.1 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.249 1.019 . . . . 65.44 108.548 171.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo . . . . . 0 C--N 1.379 2.159 0 C-N-CA 122.819 2.346 . . . . 70.21 112.315 172.063 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 110.198 -0.297 . . . . 34.45 110.198 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.8 -176.29 4.0 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.709 0.804 . . . . 71.33 109.398 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -84.93 -171.3 3.56 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.17 0.588 . . . . 65.11 109.651 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.76 99.07 0.08 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.832 0.853 . . . . 72.51 108.859 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -45.55 -40.54 14.1 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 115.073 1.509 . . . . 64.41 115.073 -168.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.43 61.23 6.7 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 121.364 1.376 . . . . 71.14 111.873 163.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 277' ' ' LEU . . . . . 0.503 ' HB3' ' SD ' ' C' ' 94' ' ' MET . 5.5 mp -61.5 101.86 0.21 Allowed 'General case' 0 C--N 1.363 1.195 0 C-N-CA 122.916 0.486 . . . . 73.33 110.16 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 15.6 tp -168.66 168.17 10.93 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.226 0.61 . . . . 61.22 109.785 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -171.15 -126.84 0.9 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 111.358 -0.697 . . . . 44.22 111.358 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 280' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' C' ' 95' ' ' ALA . 8.0 tt -63.97 108.5 1.52 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.276 1.03 . . . . 73.21 109.562 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -162.5 -69.72 0.05 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.256 0.622 . . . . 75.41 110.787 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 282' ' ' ALA . . . . . 0.476 ' HA ' ' OG1' ' C' ' 46' ' ' THR . . . -68.24 -46.55 70.18 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.358 0.663 . . . . 64.24 111.314 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -86.57 -0.0 55.27 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.507 -0.77 . . . . 71.0 110.712 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -91.15 15.65 60.56 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 115.908 -0.587 . . . . 42.02 113.508 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -71.43 95.3 1.34 Allowed 'General case' 0 C--N 1.351 0.64 0 N-CA-C 108.333 -0.988 . . . . 74.23 108.333 174.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 69.7 mtm -67.24 133.11 93.35 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.25 -0.886 . . . . 74.12 109.617 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.74 84.29 0.23 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.74 2.294 . . . . 75.42 112.233 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 84.6 t -90.28 -51.84 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 114.72 -1.127 . . . . 63.02 108.251 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 67.24 -75.27 0.06 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.322 1.449 . . . . 64.22 109.992 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -137.89 124.25 20.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.321 -0.992 . . . . 74.33 108.321 169.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.692 HD13 ' H ' ' F' ' 291' ' ' LEU . 0.0 OUTLIER -74.93 -14.97 60.7 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.252 0.621 . . . . 74.25 110.563 174.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -173.77 97.81 0.12 Allowed Glycine 0 C--N 1.35 1.323 0 CA-C-O 118.884 -0.953 . . . . 73.41 111.035 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.47 -174.7 1.1 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.807 2.338 . . . . 50.43 111.439 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 294' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' F' ' 294' ' ' LYS . 0.6 OUTLIER 62.0 29.47 17.72 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.113 0.958 . . . . 75.43 109.944 -176.301 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' F' F ' 295' ' ' ALA . . . . . 0.699 ' HA ' ' HB3' ' H' ' 303' ' ' LYS . . . -117.77 117.98 30.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.209 1.004 . . . . 75.12 110.877 -172.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 41.4 m 63.58 98.88 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.14 1.376 . . . . 62.13 111.867 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -77.16 156.43 31.59 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.637 0.375 . . . . 74.54 110.37 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -149.67 102.27 3.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.824 1.25 . . . . 74.13 108.49 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 299' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' C' ' 31' ' ' VAL . . . -167.14 -139.28 2.63 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.8 -0.444 . . . . 74.45 112.341 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -71.44 141.22 50.27 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.114 -0.699 . . . . 64.25 109.114 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 30.5 mm -116.33 147.75 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.772 0.429 . . . . 74.44 110.117 -170.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.88 91.35 0.09 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.687 -0.486 . . . . 74.41 109.687 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 42.4 tptt 49.45 82.77 0.23 Allowed Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 126.229 1.812 . . . . 73.33 112.54 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.23 9.03 3.54 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.833 2.355 . . . . 63.3 114.425 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -83.23 145.43 29.14 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.069 0.548 . . . . 64.21 110.927 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.68 151.49 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.016 -0.735 . . . . 71.14 109.016 172.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 5.0 m -80.59 62.6 4.73 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.756 0.822 . . . . 45.1 110.807 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 82.9 m 51.75 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.813 1.645 . . . . 72.54 113.518 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 20.5 p -73.21 146.63 87.13 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 119.036 -0.507 . . . . 73.13 110.664 173.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 C--N 1.38 2.189 0 C-N-CA 122.957 2.438 . . . . 61.31 111.904 -179.537 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.674 0.273 . . . . 71.43 110.661 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -145.39 174.54 11.04 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.841 -0.8 . . . . 74.12 108.841 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 73.61 128.64 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.165 1.386 . . . . 63.12 110.717 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.89 139.92 58.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.027 0.931 . . . . 71.03 111.882 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -95.34 101.28 7.25 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 107.549 -1.278 . . . . 71.1 107.549 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 276' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' D' ' 94' ' ' MET . 71.3 Cg_exo -53.12 -44.48 48.52 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.475 2.783 . . . . 44.52 113.135 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.58 144.52 51.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.954 0.902 . . . . 75.12 108.888 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 278' ' ' LEU . . . . . 0.463 HD13 HD21 ' D' ' 98' ' ' LEU . 3.8 mm? 64.78 41.81 4.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.064 0.946 . . . . 74.43 111.354 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -102.56 -1.37 50.0 Favored Glycine 0 N--CA 1.472 1.087 0 CA-C-N 115.427 -0.806 . . . . 62.42 113.398 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 4.6 tt -163.96 114.81 1.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.088 -1.078 . . . . 70.4 108.088 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -163.82 -70.8 0.04 OUTLIER 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.565 0.746 . . . . 74.11 110.77 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.54 68.78 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.408 0.683 . . . . 74.14 111.692 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -78.28 -4.96 50.5 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.393 1.077 . . . . 65.45 111.669 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.78 80.73 0.33 Allowed Glycine 0 C--N 1.352 1.448 0 O-C-N 123.886 0.741 . . . . 75.31 112.371 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -76.69 91.07 3.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.414 1.085 . . . . 72.01 110.144 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 88.9 mtp -118.56 90.57 39.75 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 107.568 -1.271 . . . . 72.33 107.568 170.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.92 101.98 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.137 2.558 . . . . 74.13 112.742 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 51.8 t -84.69 108.64 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.565 0.746 . . . . 72.23 109.401 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -69.22 159.14 33.58 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.637 0.775 . . . . 71.5 110.783 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 103.76 6.25 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 107.139 -1.43 . . . . 70.32 107.139 171.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.476 HD22 HG23 ' E' ' 309' ' ' THR . 0.3 OUTLIER -82.49 25.11 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.273 1.029 . . . . 75.42 112.246 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -150.84 91.98 0.14 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 110.627 -0.989 . . . . 41.34 110.627 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.03 -15.36 29.18 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.166 2.577 . . . . 75.13 112.407 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 294' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' E' ' 305' ' ' ALA . 17.4 tppt? -78.81 123.94 27.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.395 0.678 . . . . 75.34 109.665 174.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 295' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' D' ' 37' ' ' GLN . . . -89.65 131.49 35.61 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.263 -1.014 . . . . 72.54 108.263 172.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 5.5 t -62.7 96.08 0.08 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.81 0.844 . . . . 62.35 113.232 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' D' ' 37' ' ' GLN . 0.2 OUTLIER 179.12 163.17 0.83 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.775 1.63 . . . . 71.11 108.21 171.058 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -159.29 -37.52 0.06 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.303 1.041 . . . . 74.11 109.381 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -88.74 -125.14 2.43 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.815 -0.63 . . . . 52.3 112.271 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -168.23 151.82 5.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.351 0.66 . . . . 63.24 111.489 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.738 HD13 HH12 ' C' ' 15' ' ' ARG . 2.8 pp -125.64 146.47 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.95 -1.13 . . . . 55.25 107.95 158.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -132.53 169.48 16.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.522 -0.918 . . . . 75.25 108.522 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -55.42 110.66 2.38 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.716 1.206 . . . . 60.14 110.859 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.61 144.6 22.52 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.134 1.89 . . . . 61.34 110.625 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -138.27 86.16 2.14 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.853 0.461 . . . . 64.33 109.888 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' C' ' 12' ' ' GLN . 26.6 m -91.69 153.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.118 -1.067 . . . . 74.4 108.118 169.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 30.1 m -149.05 149.42 31.08 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.947 0.499 . . . . 75.13 109.814 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 53.8 t 67.13 87.17 0.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.995 1.318 . . . . 64.41 112.16 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 96.8 m -122.86 103.87 36.59 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 108.126 -1.064 . . . . 55.11 108.126 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 C--N 1.378 2.084 0 C-N-CA 123.573 2.849 . . . . 73.14 111.796 176.351 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.544 -0.169 . . . . 65.42 110.544 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -157.23 -81.9 0.06 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.604 0.762 . . . . 54.44 109.189 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 63.69 127.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.043 1.337 . . . . 53.32 111.908 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.29 136.48 47.93 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.649 0.379 . . . . 72.21 110.735 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -107.51 102.37 44.1 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.519 0.727 . . . . 62.1 109.204 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.82 -65.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.575 2.183 . . . . 74.42 110.467 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 277' ' ' LEU . . . . . 0.605 HD11 HG13 ' B' ' 89' ' ' ILE . 35.6 tp -160.82 46.45 0.21 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.849 -1.537 . . . . 64.22 106.849 172.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 26.3 tp -167.51 136.11 2.56 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.253 -1.34 . . . . 63.14 108.399 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 173.1 -43.69 0.16 Allowed Glycine 0 C--N 1.345 1.071 0 O-C-N 123.178 0.299 . . . . 62.21 112.794 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 97.4 mt -96.04 109.45 21.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.417 0.687 . . . . 72.24 110.068 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -163.12 -66.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.151 0.581 . . . . 75.45 109.973 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -84.43 12.76 6.3 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.248 1.019 . . . . 75.12 112.261 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.31 -46.56 10.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.079 0.952 . . . . 74.23 110.26 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -85.6 74.05 2.49 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.927 -0.579 . . . . 72.54 111.756 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -78.61 78.74 5.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.321 0.648 . . . . 54.44 109.593 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 72.8 mtm -77.31 119.82 79.02 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.738 -1.208 . . . . 62.25 107.738 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.99 81.8 0.48 Allowed 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.763 2.309 . . . . 65.12 112.002 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.52 81.62 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 108.497 -0.927 . . . . 73.11 108.497 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -78.92 -67.82 0.71 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.747 -1.115 . . . . 60.3 109.272 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -159.85 155.46 25.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.626 1.17 . . . . 71.32 110.16 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.502 HD11 HG22 ' B' ' 131' ' ' VAL . 4.9 mp -97.33 76.61 2.6 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.095 -0.957 . . . . 73.22 108.546 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 82.4 177.35 51.85 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.106 -0.952 . . . . 73.11 113.798 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.45 126.41 20.66 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.844 3.03 . . . . 60.23 111.405 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.0 114.3 14.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.67 0.271 . . . . 71.52 110.821 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 295' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' H' ' 298' ' ' HIS . . . -77.25 102.49 6.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.758 0.823 . . . . 72.12 110.276 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 11.3 m -64.45 -49.55 70.99 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.818 0.818 . . . . 63.34 109.977 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.611 ' H ' ' HB3' ' B' ' 37' ' ' GLN . 28.0 m-85 -128.32 -20.31 3.72 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.191 -1.368 . . . . 73.54 110.1 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 298' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' H' ' 295' ' ' ALA . 55.3 t-80 60.29 -83.21 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.921 1.288 . . . . 73.01 110.074 -171.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -174.88 28.65 0.08 OUTLIER Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.642 -1.383 . . . . 65.45 109.642 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -132.01 53.76 1.98 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.284 1.034 . . . . 74.33 109.804 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 21.5 pt -78.1 69.38 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 107.022 -1.473 . . . . 70.13 107.022 163.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -46.32 -56.08 6.34 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 113.544 -1.662 . . . . 72.31 112.195 -163.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 303' ' ' LYS . . . . . 0.699 ' HB3' ' HA ' ' F' ' 295' ' ' ALA . 39.6 ttmt -175.23 111.65 0.27 Allowed Pre-proline 0 C--O 1.243 0.721 0 O-C-N 124.825 1.328 . . . . 72.14 108.035 166.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.99 94.8 0.41 Allowed 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.07 1.847 . . . . 74.33 108.809 165.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 305' ' ' ALA . . . . . 0.414 ' HB2' ' HB1' ' F' ' 295' ' ' ALA . . . -65.56 84.78 0.07 Allowed 'General case' 0 C--N 1.35 0.599 0 O-C-N 123.831 0.707 . . . . 73.43 109.91 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 306' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 15' ' ' ARG . 70.7 t -154.85 -34.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.276 2.23 . . . . 74.32 106.468 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 307' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 37.7 p -59.58 110.91 1.23 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.318 -1.31 . . . . 62.25 112.36 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 85.9 m 69.43 95.04 0.07 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.485 1.514 . . . . 73.13 112.105 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' H' H ' 309' ' ' THR . . . . . 0.426 HG21 ' HB1' ' C' ' 129' ' ' ALA . 36.4 p -132.19 135.48 26.52 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.43 1.092 . . . . 72.53 109.684 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo . . . . . 0 CA--C 1.568 2.188 0 C-N-CA 123.073 2.515 . . . . 43.43 111.756 175.855 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.142 0.02 . . . . 60.32 110.98 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -82.8 102.3 11.5 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.316 0.646 . . . . 73.32 110.618 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -138.31 30.98 2.39 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.385 1.074 . . . . 63.41 109.648 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -79.12 106.9 11.49 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.904 0.482 . . . . 72.12 110.082 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -76.25 165.11 25.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.16 0.984 . . . . 70.41 109.223 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.2 t30 67.49 42.11 2.22 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.573 1.178 . . . . 72.5 108.799 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 t -74.47 92.85 2.39 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.547 -1.206 . . . . 63.33 109.261 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' C' ' 144' ' ' GLN . 39.6 tt0 -62.17 -57.79 10.2 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.041 -0.981 . . . . 72.1 112.123 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.62 ' H ' ' HA3' ' A' ' 88' ' ' GLY . 44.7 ttp 63.08 133.69 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 113.646 -1.615 . . . . 63.53 111.815 -170.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m -151.59 143.08 23.53 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.675 -1.231 . . . . 63.12 107.675 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.564 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.7 t80 -137.59 124.6 21.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.982 0.513 . . . . 73.02 109.984 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -153.38 112.02 3.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.731 -0.84 . . . . 73.13 108.731 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.585 HG12 ' HD2' ' A' ' 84' ' ' PHE . 67.8 mt -73.96 130.31 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.986 0.514 . . . . 72.13 110.418 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -91.55 -32.13 15.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.478 1.111 . . . . 63.24 111.068 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -164.69 140.71 5.86 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.752 0.421 . . . . 74.23 110.764 -172.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.78 123.73 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.935 -1.506 . . . . 70.3 106.935 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.657 ' HB3' HG23 ' B' ' 122' ' ' THR . 3.2 p90 -163.52 149.22 11.38 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.534 0.683 . . . . 71.54 112.703 -173.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.419 HG21 ' SG ' ' A' ' 113' ' ' CYS . 76.7 p -77.61 112.68 14.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.116 -0.947 . . . . 51.02 109.075 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -77.94 -25.97 48.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.362 -0.381 . . . . 63.41 110.522 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.4 t70 -152.42 144.12 23.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.245 0.966 . . . . 75.24 110.301 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -138.08 141.85 37.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 125.635 1.574 . . . . 73.25 107.055 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.32 119.01 4.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.594 0.559 . . . . 74.42 109.807 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 81.2 t80 -111.31 127.18 55.56 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 106.381 -1.711 . . . . 73.35 106.381 167.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.61 108.9 9.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.533 -0.544 . . . . 73.33 109.533 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.92 82.99 1.97 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.841 -1.17 . . . . 65.42 107.841 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.77 -35.84 26.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.006 2.471 . . . . 71.22 112.347 -169.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -116.4 33.8 5.36 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.142 -0.935 . . . . 53.33 108.867 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.66 -61.04 3.95 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.279 -0.867 . . . . 71.11 113.021 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 -0.2 8.18 Favored 'Trans proline' 0 C--N 1.386 2.522 0 CA-C-N 121.765 1.666 . . . . 50.55 113.812 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -99.59 -42.61 6.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.139 0.976 . . . . 75.32 110.916 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.4 p -77.1 -21.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.309 -0.859 . . . . 72.1 111.876 -163.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -76.8 0.57 20.17 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.126 0.57 . . . . 74.2 111.259 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -100.95 -22.57 14.75 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.631 1.173 . . . . 72.5 111.513 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.69 172.73 13.3 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.971 0.908 . . . . 75.22 113.24 -168.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 136.9 51.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.11 0.964 . . . . 71.14 111.249 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.401 ' HB3' ' O ' ' E' ' 298' ' ' HIS . 19.2 m95 -82.17 75.71 9.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.718 0.807 . . . . 75.52 110.478 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.96 69.37 9.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.961 -1.018 . . . . 73.24 110.043 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.622 ' HG3' ' HB3' ' E' ' 297' ' ' TYR . 60.0 Cg_endo -73.06 118.12 5.41 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.029 1.819 . . . . 65.54 111.107 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.72 118.66 31.7 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.601 -1.629 . . . . 74.51 106.601 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.681 ' HB ' ' HE1' ' E' ' 290' ' ' TRP . 43.9 t -104.9 116.45 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 122.855 0.462 . . . . 52.02 110.115 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 27.8 ttpp -100.19 123.52 44.52 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.217 1.007 . . . . 72.5 109.694 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.463 1.105 . . . . 75.3 108.204 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -111.65 115.39 29.04 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.466 -0.939 . . . . 62.34 108.466 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 tt -97.9 117.95 33.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.176 -1.416 . . . . 64.14 107.176 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.63 136.24 28.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.624 0.77 . . . . 75.1 109.197 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 m -149.3 150.91 33.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.793 0.437 . . . . 74.33 110.5 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.57 154.7 41.82 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.92 0.888 . . . . 60.35 110.142 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.8 p -120.48 161.59 21.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.848 0.459 . . . . 62.21 110.702 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -156.58 119.17 4.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 63.12 108.249 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -80.95 104.79 11.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.672 -0.862 . . . . 72.11 108.672 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 57' ' ' GLU . 60.1 mt -79.33 -41.95 26.79 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.682 0.793 . . . . 63.13 111.127 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.17 -172.65 4.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.777 0.831 . . . . 74.32 109.978 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' C' ' 150' ' ' GLU . 7.8 p-10 -73.62 125.06 27.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.021 -0.733 . . . . 62.21 109.021 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 66.56 5.56 3.91 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.731 1.212 . . . . 61.23 113.15 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 84.2 t -121.94 120.59 61.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.678 0.791 . . . . 74.22 108.904 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.457 ' CE2' HG12 ' A' ' 86' ' ' ILE . 2.0 p90 -133.91 171.04 14.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.499 0.666 . . . . 72.41 110.061 172.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' A' ' 51' ' ' LEU . 34.4 tt0 -121.44 140.42 52.17 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.821 -1.536 . . . . 71.42 108.653 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -123.26 126.7 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 107.154 -1.424 . . . . 74.12 107.154 165.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.9 t -106.65 115.45 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.24 -0.652 . . . . 62.14 109.24 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 100.48 12.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.457 -1.312 . . . . 53.55 107.457 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.479 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 12.4 ttp180 -85.82 106.38 17.01 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.878 -0.786 . . . . 72.14 108.878 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.61 131.46 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.142 -1.429 . . . . 53.15 107.142 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.5 m -127.81 125.58 40.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.575 -0.898 . . . . 54.32 108.575 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.818 HG11 HD21 ' A' ' 126' ' ' LEU . 44.7 t -119.35 115.22 47.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.055 -0.975 . . . . 70.45 108.81 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.8 m -102.14 146.21 28.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.64 -0.874 . . . . 75.11 108.64 172.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.08 132.08 26.15 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.868 -1.16 . . . . 74.45 107.868 172.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 m -142.78 128.01 18.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.52 0.513 . . . . 72.33 110.619 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 73' ' ' ALA . 10.3 mp -87.05 84.29 7.33 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.561 -1.274 . . . . 62.33 107.561 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.6 -116.4 4.88 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 114.708 -1.133 . . . . 64.1 111.757 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.26 -16.05 34.21 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.053 0.941 . . . . 71.11 110.823 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -95.27 116.29 28.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.279 1.032 . . . . 73.41 109.963 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.2 m -70.31 132.13 45.21 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.617 0.644 . . . . 74.24 111.05 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.49 -60.94 2.13 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.237 1.015 . . . . 73.33 109.416 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.08 170.17 21.82 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.19 -0.914 . . . . 63.35 111.22 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -141.99 112.42 7.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.196 -1.366 . . . . 63.23 107.368 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 70.7 m -111.93 104.4 12.68 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.469 0.708 . . . . 61.21 111.016 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.7 tt0 -113.4 115.74 28.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.406 1.082 . . . . 72.34 109.636 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.04 115.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.952 0.901 . . . . 73.44 109.399 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.2 mt-30 -84.86 85.62 7.45 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.966 -0.753 . . . . 73.35 108.966 169.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.39 96.2 4.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.515 0.726 . . . . 72.33 109.814 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.66 147.45 22.09 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 111.852 -0.499 . . . . 52.01 111.852 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.19 143.16 12.1 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.661 -0.975 . . . . 61.24 110.661 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -109.24 127.65 65.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.044 -1.095 . . . . 74.32 108.044 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.585 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.8 m-85 -128.72 120.17 25.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.14 -1.059 . . . . 63.44 108.14 -171.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -88.88 110.19 20.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.493 -0.929 . . . . 65.31 108.493 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.61 HD13 HD11 ' A' ' 89' ' ' ILE . 2.5 pp -124.76 162.47 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.089 1.356 . . . . 74.52 109.915 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.78 135.89 1.91 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.326 0.65 . . . . 64.14 109.659 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.62 ' HA3' ' H ' ' A' ' 9' ' ' MET . . . 108.97 8.77 27.28 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.218 -0.768 . . . . 65.12 114.076 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 86' ' ' ILE . 2.2 pp -120.91 154.09 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 117.931 0.865 . . . . 64.14 112.044 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.57 170.96 18.87 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.094 -0.957 . . . . 65.21 108.62 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.31 -119.02 9.29 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 115.962 1.145 . . . . 72.1 115.962 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -76.19 -20.29 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.424 0.689 . . . . 60.12 111.818 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -72.99 -50.35 23.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.098 0.559 . . . . 63.34 110.253 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -64.26 -35.69 81.67 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.504 0.502 . . . . 72.51 109.83 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' E' ' 280' ' ' LEU . . . -61.02 -46.37 91.02 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.648 0.779 . . . . 50.25 111.004 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 53.5 t-80 -70.75 -28.93 65.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.3 -0.864 . . . . 70.25 110.75 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 32.6 t -73.43 -37.17 65.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.2 0.524 . . . . 61.34 110.292 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.536 HD11 HD22 ' E' ' 278' ' ' LEU . 82.2 mt -78.59 -36.01 44.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.13 0.972 . . . . 74.43 112.016 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.82 3.96 34.14 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.637 -0.535 . . . . 62.34 114.294 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.14 -63.88 0.25 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.623 0.711 . . . . 65.42 112.818 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.464 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 57.4 t80 -62.84 -61.28 2.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.435 1.094 . . . . 61.12 112.831 -169.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -70.78 -34.89 3.94 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.495 0.924 . . . . 71.31 113.495 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -46.12 -48.37 13.05 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.701 2.267 . . . . 75.34 113.881 162.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.65 -27.89 68.71 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.312 1.045 . . . . 73.42 111.013 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 13' ' ' ILE . 43.5 mm -70.07 -47.69 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.591 0.756 . . . . 73.11 110.593 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.455 HD21 ' HA3' ' A' ' 82' ' ' GLY . 89.4 mt -73.61 -31.25 63.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.335 -0.848 . . . . 50.45 112.177 -171.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.531 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 45.2 t80 -59.13 -44.18 98.22 Favored Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 113.866 1.062 . . . . 54.42 113.866 -170.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.81 -38.64 94.2 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.567 2.178 . . . . 74.21 114.359 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -71.41 -40.13 70.68 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.27 0.628 . . . . 74.45 111.64 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.23 -42.15 93.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.938 0.495 . . . . 75.22 109.951 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -53.39 -55.02 28.41 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 124.583 1.177 . . . . 73.52 110.41 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.55 -41.26 93.22 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.151 0.907 . . . . 75.54 110.662 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.419 ' SG ' HG21 ' A' ' 18' ' ' THR . 47.5 t -58.5 -36.29 73.55 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.104 0.478 . . . . 75.31 111.302 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 118' ' ' VAL . 24.2 mt -72.23 -51.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.963 0.905 . . . . 70.45 109.982 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.536 HG21 ' HE2' ' C' ' 109' ' ' TYR . 97.7 m -53.81 -40.69 66.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.765 1.226 . . . . 64.43 111.346 -173.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -62.29 -48.96 77.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.318 -1.31 . . . . 63.01 109.514 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.0 mtm -64.05 -40.66 96.79 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.563 0.745 . . . . 75.55 111.24 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.2 t -58.33 -48.63 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.058 0.943 . . . . 64.51 110.364 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.4 t -71.45 -28.99 64.34 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.331 -0.85 . . . . 73.32 111.253 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -71.11 -29.1 64.84 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.502 0.721 . . . . 65.22 110.195 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.58 2.79 66.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.65 0.594 . . . . 63.25 112.936 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.402 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 4.2 m 65.86 24.17 11.3 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.211 1.404 . . . . 73.5 110.521 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -94.45 140.54 22.75 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.538 -1.282 . . . . 74.41 107.538 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.411 ' HG2' ' CD1' ' E' ' 297' ' ' TYR . 64.2 Cg_exo -44.5 134.46 9.55 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.079 2.519 . . . . 60.45 113.898 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.494 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -46.5 130.79 11.14 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.411 1.084 . . . . 73.15 112.864 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.818 HD21 HG11 ' A' ' 64' ' ' VAL . 23.1 tp -108.11 100.99 10.26 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.541 1.137 . . . . 72.22 109.48 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -101.94 103.2 13.83 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.926 -1.139 . . . . 64.21 107.926 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.531 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -68.18 124.55 23.75 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 108.635 -0.876 . . . . 60.33 108.635 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.487 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -60.09 130.7 89.26 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.384 0.674 . . . . 74.03 111.854 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' G' ' 309' ' ' THR . 3.1 Cg_exo -76.56 146.17 27.01 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.988 2.459 . . . . 61.22 112.351 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.5 t -130.56 131.4 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.833 0.853 . . . . 70.42 109.408 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.09 96.03 2.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.977 -0.749 . . . . 71.13 108.977 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -72.47 -26.55 61.86 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.76 -0.654 . . . . 72.35 111.451 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.43 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.1 m-20 -62.0 -35.37 78.32 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.106 0.562 . . . . 62.34 110.225 176.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.5 -55.88 7.89 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.22 -0.9 . . . . 72.4 110.61 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 mt -65.3 -28.14 69.11 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.115 0.783 . . . . 71.34 113.115 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.05 -45.87 91.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.395 0.678 . . . . 73.31 109.567 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.71 -36.33 75.82 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.473 -0.785 . . . . 54.41 110.87 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -68.94 -26.94 65.32 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.237 -0.892 . . . . 71.21 111.838 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -95.3 -44.1 7.74 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.535 0.334 . . . . 70.41 111.233 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 68.0 tp -60.46 -45.2 94.56 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.532 0.733 . . . . 63.34 112.149 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -147.55 5.52 0.81 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.902 0.481 . . . . 71.23 111.986 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 63.56 22.16 13.05 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.583 1.153 . . . . 72.03 112.642 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -161.81 159.01 26.47 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.89 0.876 . . . . 72.55 109.132 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.25 -179.88 7.52 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.775 0.43 . . . . 14.25 110.625 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.59 -144.29 4.22 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 119.312 -0.715 . . . . 11.14 111.907 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 63.79 92.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.745 1.218 . . . . 64.03 110.815 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.83 128.47 1.43 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.7 -0.56 . . . . 71.55 111.7 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.8 p -119.19 123.76 45.12 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.754 0.822 . . . . 72.53 109.982 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.13 91.24 8.37 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.505 0.722 . . . . 73.35 110.286 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -86.33 141.24 29.36 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.553 -0.536 . . . . 72.54 109.553 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -118.01 118.82 32.98 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.483 0.713 . . . . 75.15 109.651 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -83.79 110.44 18.34 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.398 0.679 . . . . 75.12 109.734 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -105.77 159.11 16.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.155 0.982 . . . . 71.32 110.327 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.816 0.847 . . . . 73.31 109.218 -177.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.026 -0.361 . . . . 71.32 110.026 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.455 ' O ' ' HA3' ' B' ' 91' ' ' GLY . 61.7 m -127.41 -83.17 0.61 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.868 0.467 . . . . 74.52 110.1 175.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 59.65 175.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.72 0.808 . . . . 63.41 112.427 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -162.26 142.34 9.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.018 0.527 . . . . 53.43 110.528 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -169.73 93.4 0.25 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.291 -1.374 . . . . 72.3 107.291 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -56.57 112.44 1.28 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.834 0.854 . . . . 73.44 111.064 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.623 HG22 ' H ' ' B' ' 9' ' ' MET . 32.0 m -137.55 148.82 46.24 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.477 -0.935 . . . . 61.5 108.477 177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.54 -12.29 56.97 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.231 1.012 . . . . 73.35 112.293 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.623 ' H ' HG22 ' B' ' 7' ' ' THR . 19.6 ptm 55.91 -173.75 0.06 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.766 2.026 . . . . 54.41 113.245 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.6 m -138.77 118.74 13.33 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.416 -1.327 . . . . 55.52 107.416 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -134.98 113.25 11.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.703 -0.481 . . . . 74.12 109.703 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.26 139.31 33.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.891 . . . . 65.53 108.678 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.428 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -87.46 134.94 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 109.026 -0.731 . . . . 74.32 109.026 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -93.24 -52.64 4.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.255 -0.646 . . . . 74.42 109.255 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.402 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 31.0 ttt180 -155.65 132.78 10.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.955 -0.566 . . . . 75.14 109.86 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.31 136.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.349 -1.723 . . . . 53.14 106.349 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.424 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.6 p90 -166.99 148.55 5.95 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.907 0.384 . . . . 62.24 110.961 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.456 HG21 HD11 ' B' ' 21' ' ' ILE . 94.8 m -77.28 129.21 35.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.964 -0.754 . . . . 71.14 108.964 171.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.413 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.7 mtpt -98.87 -31.13 12.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.641 0.776 . . . . 65.14 110.865 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -154.43 145.73 22.95 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.392 0.433 . . . . 75.43 111.662 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.456 HD11 HG21 ' B' ' 18' ' ' THR . 39.1 mm -137.18 148.18 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.199 1.399 . . . . 73.41 109.03 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.5 m -146.97 140.41 25.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.746 -1.116 . . . . 75.44 109.445 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.6 t80 -147.5 110.34 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 105.825 -1.917 . . . . 72.32 105.825 162.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.26 111.88 15.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.103 -1.073 . . . . 72.53 108.103 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -116.47 87.03 19.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 108.543 -0.91 . . . . 71.2 108.543 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.16 -25.17 19.34 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.443 2.095 . . . . 71.22 111.475 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -103.34 7.8 38.2 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.483 1.113 . . . . 64.42 110.457 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.642 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -40.86 -54.48 5.33 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 115.907 1.817 . . . . 52.41 115.907 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.3 Cg_exo -72.75 -50.25 0.22 Allowed 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.54 2.16 . . . . 50.02 111.955 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.542 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.3 m80 -85.37 5.51 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.724 -1.126 . . . . 74.3 112.133 -173.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.76 -16.72 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.197 0.599 . . . . 74.25 111.904 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -51.34 -32.72 26.53 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.787 0.835 . . . . 72.44 112.206 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.571 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.3 pt20 -73.21 -48.93 30.92 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.269 -0.423 . . . . 71.54 110.858 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.571 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 83.7 mttt -110.82 62.41 0.61 Allowed 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.937 0.875 . . . . 52.01 109.513 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -117.11 118.69 33.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.032 -1.84 . . . . 64.41 106.032 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 169.01 -168.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.64 1.976 . . . . 61.53 106.217 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.58 109.8 1.62 Allowed Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 122.977 0.511 . . . . 72.23 112.193 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HG2' HG13 ' B' ' 40' ' ' VAL . 91.6 Cg_endo -94.69 162.79 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.99 2.46 . . . . 51.31 112.099 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -80.52 103.53 10.44 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.293 -1.373 . . . . 54.44 107.293 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.465 HG13 ' HG2' ' B' ' 38' ' ' PRO . 5.4 m -99.3 143.2 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.149 -0.932 . . . . 35.33 109.576 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.99 132.67 32.61 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.609 -0.886 . . . . 53.45 108.609 -171.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' H' ' 288' ' ' VAL . 51.4 mt -99.92 123.9 44.66 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.899 -0.778 . . . . 73.45 108.899 173.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.4 t70 -126.12 111.73 14.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.902 -0.777 . . . . 73.54 108.902 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 9.9 mp -100.33 131.65 46.14 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.69 -0.687 . . . . 71.11 109.302 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.6 t70 -120.7 125.97 49.01 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.464 -1.31 . . . . 71.13 107.464 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -109.2 103.69 12.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.305 -0.861 . . . . 72.53 109.506 -168.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 130.84 44.13 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.747 0.819 . . . . 65.42 109.159 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 74.9 p -142.45 162.8 34.54 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.962 0.505 . . . . 74.51 110.389 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 p -152.87 137.46 16.86 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.916 0.886 . . . . 74.03 109.346 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.95 122.99 28.48 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.013 0.525 . . . . 71.13 109.764 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.09 -43.2 16.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.058 0.543 . . . . 62.43 110.459 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -169.03 2.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.373 0.669 . . . . 72.3 111.082 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.89 112.32 2.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.488 1.115 . . . . 61.04 110.681 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.06 1.64 2.43 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.278 1.431 . . . . 71.51 112.805 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.1 t -105.26 110.89 32.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.563 -0.903 . . . . 64.43 108.563 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -115.16 160.23 19.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.779 0.832 . . . . 72.03 108.993 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -132.75 106.25 7.64 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.782 -1.562 . . . . 63.51 106.782 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -105.51 122.6 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.372 1.069 . . . . 73.44 109.817 -171.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.69 128.78 62.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.125 0.97 . . . . 71.53 108.846 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -118.7 111.77 18.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.464 -1.31 . . . . 70.31 107.464 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 38.6 ttm180 -87.16 132.51 33.84 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.669 0.788 . . . . 62.34 109.587 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.4 107.16 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.768 -1.197 . . . . 71.14 107.768 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 38.8 m -97.19 137.94 35.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.642 -0.873 . . . . 71.52 108.642 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.511 HG21 HG21 ' B' ' 114' ' ' ILE . 61.2 t -121.86 97.35 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -90.27 137.8 32.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.579 -0.737 . . . . 62.14 109.155 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -143.26 145.94 33.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.362 0.665 . . . . 71.25 109.753 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -159.31 135.97 9.32 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.816 0.698 . . . . 60.3 110.51 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.5 mp -113.45 137.96 50.78 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.558 -0.905 . . . . 75.33 108.558 168.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.1 -127.74 13.21 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.919 -0.473 . . . . 53.2 111.919 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -109.87 6.01 22.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.264 1.025 . . . . 75.43 110.412 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.01 167.12 12.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.559 0.743 . . . . 72.12 111.088 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.2 m -68.91 155.14 40.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.185 0.994 . . . . 75.24 110.542 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.469 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -109.88 -60.54 1.77 Allowed 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 61.41 108.581 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -164.27 156.17 16.41 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.767 -1.106 . . . . 70.32 108.336 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 mt -132.24 108.96 9.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.383 -1.339 . . . . 61.31 107.383 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.75 157.04 26.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.197 -1.038 . . . . 74.55 108.197 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.4 tt0 -164.9 142.49 6.23 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.153 0.581 . . . . 71.42 109.856 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' B' ' 113' ' ' CYS . 69.9 t -132.57 144.51 36.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.79 -1.189 . . . . 75.12 107.79 170.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -123.83 90.83 3.34 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.914 -1.143 . . . . 70.05 107.914 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -84.74 102.02 12.68 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 74.32 108.905 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.39 167.83 34.4 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.368 -0.833 . . . . 71.12 111.608 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.26 126.37 1.43 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.558 -0.353 . . . . 72.22 112.415 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.424 HG13 ' HE1' ' B' ' 17' ' ' TYR . 53.4 mt -85.37 128.09 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.56 -0.904 . . . . 75.25 108.56 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -135.8 135.11 39.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.626 1.171 . . . . 74.1 109.233 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.2 m -91.32 99.96 12.84 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.663 0.785 . . . . 74.13 108.99 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.414 ' HB ' HD11 ' B' ' 89' ' ' ILE . 29.5 pt -121.8 138.69 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.582 0.753 . . . . 74.32 110.439 -176.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.28 169.36 24.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.374 1.07 . . . . 70.24 109.89 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.84 -47.63 3.74 Favored Glycine 0 N--CA 1.478 1.45 0 C-N-CA 123.356 0.503 . . . . 51.12 112.668 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.428 ' O ' HD11 ' H' ' 277' ' ' LEU . 16.9 pt -64.15 148.37 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.285 1.034 . . . . 74.22 111.73 173.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.588 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 42.6 tt0 -157.73 144.44 17.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.143 0.977 . . . . 72.11 109.909 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 91' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 2' ' ' SER . . . 59.51 -108.88 1.85 Allowed Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.381 -0.677 . . . . 72.5 113.602 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 36.5 m -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.386 0.675 . . . . 72.12 110.948 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.588 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.8 mt-30 -62.97 -45.22 93.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.598 0.759 . . . . 73.2 109.513 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.602 ' SD ' ' HG ' ' H' ' 277' ' ' LEU . 25.9 ttt -73.71 -38.77 64.72 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.037 -0.983 . . . . 74.2 110.511 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.58 69.61 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.346 0.658 . . . . 70.3 111.161 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -79.2 -35.8 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.03 0.932 . . . . 63.51 110.124 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.15 -68.4 0.38 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.356 -0.384 . . . . 72.31 110.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' H' ' 280' ' ' LEU . 1.6 pp -75.8 -8.27 56.45 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.462 0.541 . . . . 75.44 112.462 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.99 -9.19 46.12 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 114.303 0.481 . . . . 50.43 114.303 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.17 -54.72 0.4 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.49 0.645 . . . . 73.44 110.962 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -68.0 -55.75 11.48 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.879 0.872 . . . . 63.02 111.506 -172.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.59 -44.06 79.82 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.374 1.069 . . . . 55.04 112.286 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -48.75 -53.52 6.79 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.837 2.358 . . . . 72.31 112.601 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.14 -18.89 50.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.966 0.728 . . . . 64.35 112.966 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.404 ' HA ' HH21 ' D' ' 111' ' ' ARG . 71.7 mt -77.26 -57.09 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.189 0.596 . . . . 72.33 110.623 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.33 -4.83 59.29 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.093 0.557 . . . . 74.41 112.234 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.53 -46.74 47.61 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.48 1.112 . . . . 65.0 112.454 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.3 -34.78 94.77 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 121.875 1.717 . . . . 65.51 112.978 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.612 ' HE2' HG21 ' D' ' 115' ' ' THR . 57.2 m-85 -65.25 -52.57 53.63 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.122 0.969 . . . . 75.32 110.752 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.424 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.09 -43.19 91.83 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.501 0.72 . . . . 64.11 110.341 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -56.23 -56.33 22.27 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.926 1.291 . . . . 72.32 111.259 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -38.88 92.49 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.611 0.569 . . . . 74.33 109.602 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.5 t -64.97 -38.94 92.62 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 123.522 0.514 . . . . 73.4 111.719 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.511 HG21 HG21 ' B' ' 64' ' ' VAL . 57.6 mt -65.35 -52.66 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.242 0.617 . . . . 72.15 109.542 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.518 HG22 HE21 ' C' ' 125' ' ' GLN . 23.3 m -61.45 -29.02 69.69 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 115.089 -0.959 . . . . 72.11 111.475 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.9 t -63.14 -49.48 74.2 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.72 0.808 . . . . 65.21 109.326 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -69.96 -34.41 73.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.733 0.813 . . . . 74.44 111.16 -175.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.598 HG21 HD13 ' B' ' 126' ' ' LEU . 80.6 t -64.52 -39.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.669 0.788 . . . . 64.34 110.239 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 16.4 t -71.29 -31.28 67.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.222 0.609 . . . . 63.14 110.83 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.8 mtt-85 -67.87 -22.89 65.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.244 0.618 . . . . 72.31 110.279 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.71 17.98 56.48 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.504 0.502 . . . . 31.42 113.221 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.657 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.0 p 62.96 14.87 7.88 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.559 1.944 . . . . 73.15 113.7 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -92.47 148.7 36.88 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 122.921 0.488 . . . . 71.54 109.887 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' C' ' 125' ' ' GLN . 96.6 Cg_endo -74.21 -159.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.062 2.508 . . . . 34.43 113.059 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.4 122.74 17.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.368 -0.833 . . . . 71.42 113.153 -167.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.598 HD13 HG21 ' B' ' 118' ' ' VAL . 9.4 tt -109.89 127.42 54.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 106.018 -1.845 . . . . 72.11 106.018 166.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 106.67 9.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.313 -0.625 . . . . 64.1 109.313 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.65 107.88 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.005 -1.109 . . . . 75.3 108.005 169.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.39 135.07 88.76 Favored Pre-proline 0 CA--C 1.548 0.896 0 O-C-N 124.075 0.859 . . . . 73.31 110.256 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.28 109.25 0.39 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.278 2.652 . . . . 64.11 112.206 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.17 113.41 26.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.511 -0.922 . . . . 53.1 108.511 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.15 76.93 6.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.695 -0.854 . . . . 75.54 108.695 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -54.47 -36.27 63.95 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.215 1.006 . . . . 62.43 111.017 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.67 -52.0 66.11 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.152 -1.386 . . . . 64.32 111.127 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.16 83.24 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.659 0.784 . . . . 72.32 111.762 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.48 -31.84 73.22 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.52 0.728 . . . . 74.13 111.098 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.37 -26.49 22.16 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.299 0.64 . . . . 51.42 109.989 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 39.5 ttm -70.29 -37.05 74.72 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.98 0.912 . . . . 62.02 111.295 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -74.08 -26.15 60.22 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.079 0.551 . . . . 62.12 110.781 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -68.13 -32.89 73.49 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.106 0.479 . . . . 74.4 110.377 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.2 mt -103.82 14.59 30.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.227 1.011 . . . . 64.24 111.649 -174.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -76.6 147.66 37.48 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.12 0.568 . . . . 75.34 111.615 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -91.51 176.64 6.48 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.241 1.017 . . . . 53.23 110.815 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -74.47 -74.6 0.19 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.028 0.531 . . . . 75.24 110.527 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.47 -174.1 1.84 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.274 0.63 . . . . 53.02 111.383 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.15 -168.71 16.72 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 110.826 -0.91 . . . . 72.34 110.826 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -160.38 142.55 12.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.992 0.517 . . . . 70.35 110.752 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.77 131.95 10.75 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.529 -0.628 . . . . 61.12 111.529 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 17.7 p -97.93 143.03 28.94 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.275 0.63 . . . . 70.23 110.466 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -146.62 98.22 3.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.744 -0.836 . . . . 64.23 108.744 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.67 149.92 27.08 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.372 1.069 . . . . 75.45 110.864 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -126.58 159.11 34.46 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.028 0.931 . . . . 71.15 110.013 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -147.35 98.29 2.98 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.56 1.144 . . . . 70.15 108.617 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.9 147.36 25.81 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.77 -0.456 . . . . 70.31 109.77 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.593 -0.718 . . . . 74.53 110.463 -179.722 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 120.656 0.265 . . . . 74.31 111.394 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -148.68 18.56 1.02 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.674 0.79 . . . . 70.21 110.612 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.96 128.24 48.46 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.222 0.609 . . . . 74.21 110.803 -168.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -126.03 138.78 53.75 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.433 -1.321 . . . . 74.03 107.433 168.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -68.15 109.45 3.55 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.014 -0.736 . . . . 74.22 109.014 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -66.04 127.06 30.6 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 109.429 -0.582 . . . . 75.42 109.429 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -87.61 35.94 0.74 Allowed 'General case' 0 CA--C 1.556 1.189 0 CA-C-O 121.999 0.905 . . . . 63.22 110.031 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -143.44 118.03 9.78 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.073 0.949 . . . . 74.53 108.595 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.47 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 51.4 ttp 63.58 112.02 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.984 1.714 . . . . 74.32 112.773 175.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -91.38 92.87 8.77 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.076 -1.453 . . . . 75.23 107.076 166.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 72.6 t80 -108.57 154.35 22.08 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.884 -1.053 . . . . 72.35 109.67 -175.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -163.54 139.59 6.75 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.308 1.043 . . . . 74.41 109.017 173.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pp -80.89 141.32 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.447 0.699 . . . . 74.34 109.369 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -109.83 -51.25 2.89 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.777 0.431 . . . . 74.43 110.009 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.546 ' NH1' HD12 ' G' ' 301' ' ' ILE . 72.0 ttt180 -172.43 123.82 0.47 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.471 0.482 . . . . 74.32 109.846 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -109.01 136.02 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.012 -1.107 . . . . 64.51 108.012 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.509 ' HE1' HG12 ' C' ' 83' ' ' ILE . 19.5 p90 -168.68 162.92 11.99 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.861 0.839 . . . . 72.43 112.432 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.6 p -86.38 103.75 15.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.375 -1.284 . . . . 73.12 108.662 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -67.8 -35.21 78.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.64 0.733 . . . . 74.41 109.981 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.72 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.9 t70 -148.21 139.48 23.43 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.473 -1.24 . . . . 70.4 109.095 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.2 mt -133.55 141.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.077 -1.453 . . . . 45.13 107.077 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -152.87 146.34 24.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.411 -0.588 . . . . 72.13 109.411 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.95 113.63 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.131 -1.433 . . . . 72.33 107.131 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.48 111.26 20.49 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.297 -1.001 . . . . 64.33 108.297 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.75 80.21 55.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.356 1.063 . . . . 63.4 108.262 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.39 -16.78 24.44 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.172 1.915 . . . . 75.44 109.898 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.96 11.86 25.91 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.231 1.412 . . . . 52.01 110.041 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.55 97.72 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.028 1.122 . . . . 71.34 114.028 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.28 -36.15 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 121.404 1.402 . . . . 62.51 113.032 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -67.67 -25.68 65.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.884 1.274 . . . . 72.03 112.869 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.461 HG11 ' HE1' ' C' ' 123' ' ' PHE . 14.4 p -62.31 -27.13 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.455 1.102 . . . . 73.14 111.853 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.507 ' HZ ' ' HA ' ' F' ' 303' ' ' LYS . 30.0 t80 -65.9 -26.76 67.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.588 -0.733 . . . . 72.43 111.96 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -99.0 6.12 46.84 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.455 0.539 . . . . 71.02 112.455 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -99.7 173.11 6.86 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.467 0.576 . . . . 75.23 110.054 175.543 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.26 123.38 25.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.455 -0.943 . . . . 70.05 108.455 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.502 ' HZ2' ' HA ' ' C' ' 32' ' ' PHE . 59.4 m95 -85.37 69.76 10.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.186 0.595 . . . . 72.21 110.683 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -163.17 60.1 0.91 Allowed Pre-proline 0 CA--C 1.56 1.344 0 CA-C-N 115.087 -0.96 . . . . 75.35 109.003 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.12 158.98 37.62 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.034 2.489 . . . . 63.33 111.61 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.43 88.84 6.58 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 106.664 -1.606 . . . . 75.55 106.664 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.93 102.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 113.61 -1.632 . . . . 74.33 109.749 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.1 110.82 22.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.553 -1.203 . . . . 74.22 108.537 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.15 130.57 34.58 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.366 -1.346 . . . . 60.13 107.366 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.9 t70 -119.36 103.81 9.81 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.882 1.273 . . . . 65.44 107.78 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 23.5 tp -100.16 112.53 24.84 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.348 -0.982 . . . . 63.53 108.348 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -114.67 139.62 49.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.763 1.225 . . . . 51.41 108.921 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -114.53 145.62 41.71 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.436 0.694 . . . . 55.21 110.361 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 150.5 29.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.607 0.763 . . . . 73.21 109.739 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.8 m -155.78 155.24 32.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.249 0.62 . . . . 74.01 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.3 p -148.85 140.42 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.53 0.732 . . . . 73.45 109.918 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.47 115.41 22.06 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.211 -1.033 . . . . 72.25 108.211 170.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.534 HD11 HD12 ' C' ' 83' ' ' ILE . 74.6 mt -88.88 -39.01 14.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.516 0.726 . . . . 63.22 110.343 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.08 -168.79 2.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.017 -0.992 . . . . 64.44 110.348 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.98 100.55 0.16 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.356 1.063 . . . . 52.02 110.654 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 66.94 10.69 7.85 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.497 1.519 . . . . 75.42 113.234 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -94.27 114.13 30.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.866 -1.161 . . . . 63.52 107.866 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.403 ' HB2' HD13 ' C' ' 86' ' ' ILE . 75.6 m-85 -123.23 124.23 42.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.108 0.963 . . . . 74.11 109.057 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.489 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.67 120.52 26.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.326 -0.852 . . . . 75.43 109.34 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -97.65 114.12 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.135 -1.061 . . . . 62.45 108.135 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.6 134.55 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.28 -1.007 . . . . 73.33 108.28 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -128.9 102.81 6.7 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.905 -1.146 . . . . 52.31 107.905 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.519 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 23.8 ttt180 -82.69 108.21 15.89 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.525 -0.761 . . . . 74.24 109.279 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.4 t -100.08 121.77 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 107.477 -1.305 . . . . 74.25 107.477 172.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.4 m -127.31 117.47 22.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.648 -0.871 . . . . 72.4 108.648 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.1 110.28 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.699 -0.852 . . . . 70.32 108.699 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.4 m -99.83 144.04 29.35 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.666 -0.865 . . . . 52.05 108.666 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.56 130.46 44.11 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.752 -1.203 . . . . 63.23 107.752 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.1 m -147.88 130.44 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.03 0.443 . . . . 74.23 110.965 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.07 58.1 4.86 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.016 1.326 . . . . 74.14 107.476 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.23 -118.0 5.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 114.732 -1.122 . . . . 51.02 110.567 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.06 -28.67 18.87 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.449 0.7 . . . . 54.31 109.308 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.68 102.63 0.76 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.939 0.896 . . . . 65.51 109.666 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -72.92 144.43 47.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.239 0.616 . . . . 74.22 111.021 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.409 ' HB1' ' CE2' ' F' ' 297' ' ' TYR . . . -97.65 -56.27 2.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.507 1.123 . . . . 63.22 109.455 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -158.03 172.01 19.21 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.99 -0.55 . . . . 74.54 110.923 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.442 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -136.37 146.16 46.2 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 106.9 -1.518 . . . . 74.51 106.9 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.442 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.76 113.58 4.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.13 0.572 . . . . 73.34 109.789 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -117.34 117.51 29.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.653 0.781 . . . . 74.24 110.04 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -121.84 122.24 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.504 -0.554 . . . . 71.4 109.504 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.72 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.8 mt-30 -99.04 91.34 4.97 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.043 -1.095 . . . . 73.44 108.043 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -83.14 104.86 13.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.235 -0.893 . . . . 63.33 110.062 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 146.6 18.3 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.108 -0.497 . . . . 74.14 112.015 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.05 116.85 1.11 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.07 -1.212 . . . . 32.14 110.07 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.534 HD12 HD11 ' C' ' 51' ' ' LEU . 15.5 mm -81.46 122.33 36.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.449 -0.945 . . . . 74.43 108.449 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -138.51 148.68 44.57 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.35 -0.981 . . . . 71.43 108.35 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.1 p -110.17 119.02 37.93 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.458 -0.941 . . . . 51.13 108.458 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' C' ' 56' ' ' TYR . 4.1 mp -114.88 120.68 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.267 -1.012 . . . . 73.1 108.267 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.47 165.02 30.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.132 0.973 . . . . 73.1 109.565 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.08 -46.68 1.14 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.965 -0.561 . . . . 63.43 112.242 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.502 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -121.81 171.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.24 0.616 . . . . 72.1 111.253 -177.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.74 -173.03 4.11 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.019 -0.991 . . . . 74.45 109.425 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.78 -139.72 39.3 Favored Glycine 0 C--N 1.344 1.011 0 O-C-N 123.529 0.518 . . . . 64.32 114.159 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -70.56 -21.72 62.66 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.117 0.967 . . . . 73.02 112.038 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 81.6 mt-30 -71.48 -38.01 71.25 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.537 0.735 . . . . 75.32 110.388 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.408 ' SD ' HD12 ' C' ' 98' ' ' LEU . 9.8 tmm? -71.99 -41.08 68.05 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.018 -0.734 . . . . 70.25 109.018 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.65 69.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.569 0.747 . . . . 51.52 111.262 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -70.64 -34.18 71.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.504 0.722 . . . . 74.21 110.491 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.47 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 40.6 t -68.21 -64.66 0.82 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.444 0.465 . . . . 53.2 110.398 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.408 HD12 ' SD ' ' C' ' 94' ' ' MET . 0.0 OUTLIER -84.04 -12.69 54.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.047 -0.408 . . . . 73.31 112.093 -172.411 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 -7.84 46.32 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 114.706 0.642 . . . . 73.5 114.706 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.33 -55.93 0.48 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.395 0.598 . . . . 75.22 110.847 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.438 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 81.0 t80 -69.12 -56.54 7.36 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.907 0.883 . . . . 71.15 111.822 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.76 -44.97 74.99 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.59 1.156 . . . . 72.42 112.951 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.94 -34.37 81.48 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 121.758 1.639 . . . . 75.21 111.995 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -28.5 67.28 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.317 0.647 . . . . 64.15 111.695 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 33.3 mm -66.24 -53.52 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.978 -0.378 . . . . 74.11 109.978 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -87.21 -8.35 56.95 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.412 0.523 . . . . 71.22 112.412 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.13 -50.09 89.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 124.21 1.004 . . . . 75.02 113.416 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.87 -25.74 74.47 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 121.489 1.459 . . . . 70.52 113.121 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.536 ' HE2' HG21 ' A' ' 115' ' ' THR . 70.1 m-85 -69.51 -46.07 67.4 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.285 0.634 . . . . 42.32 110.232 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.4 89.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.603 0.761 . . . . 73.4 110.396 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.521 ' HG3' HD23 ' C' ' 128' ' ' LEU . 39.5 ttt180 -58.38 -55.68 31.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 113.945 -1.48 . . . . 73.13 111.157 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.451 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -67.81 -27.46 66.75 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.979 0.512 . . . . 54.13 110.328 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.0 t -71.5 -36.57 71.15 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.744 0.418 . . . . 51.43 111.407 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.417 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.5 mt -72.67 -48.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.454 0.701 . . . . 74.35 110.025 174.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 49.1 m -60.92 -33.71 73.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.09 0.956 . . . . 74.53 111.36 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -62.2 -47.73 83.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.791 -0.64 . . . . 73.24 109.444 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.493 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.28 -37.5 87.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.709 1.203 . . . . 62.11 112.226 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.33 -42.21 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.181 0.592 . . . . 74.1 109.407 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.3 t -69.05 -28.99 67.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.641 0.777 . . . . 74.25 111.711 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -76.03 -28.8 57.84 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.694 0.797 . . . . 71.52 110.468 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.52 4.63 81.18 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.525 0.516 . . . . 74.31 112.433 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 20.8 p 62.38 33.04 16.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.044 1.738 . . . . 72.24 111.961 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' C' ' 31' ' ' VAL . 24.8 m-85 -102.17 154.05 37.64 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 115.004 -0.998 . . . . 64.35 110.608 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.484 ' HD3' HD11 ' F' ' 301' ' ' ILE . 75.4 Cg_exo -53.7 132.18 47.88 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.263 2.642 . . . . 71.12 112.949 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.536 ' HB2' ' HA ' ' B' ' 124' ' ' PRO . 14.6 mm-40 -59.63 142.74 52.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.026 0.829 . . . . 70.34 112.461 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.616 HD11 ' HH2' ' F' ' 290' ' ' TRP . 3.0 tm? -126.82 126.32 43.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.744 0.818 . . . . 74.44 108.863 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.43 127.28 48.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.206 1.003 . . . . 61.35 109.128 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.521 HD23 ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -80.48 141.36 35.28 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.697 0.623 . . . . 74.12 110.159 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.594 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -85.34 158.96 57.15 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 124.856 1.262 . . . . 63.14 111.183 -177.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.34 107.45 2.46 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.102 2.535 . . . . 71.11 111.532 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.499 HG22 HD11 ' F' ' 291' ' ' LEU . 44.9 t -98.44 107.48 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.54 -0.911 . . . . 72.02 108.54 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -113.73 99.24 7.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.588 1.155 . . . . 75.02 108.83 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.51 -42.99 99.88 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.794 0.838 . . . . 74.25 111.337 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -66.85 -37.69 84.94 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.865 -1.061 . . . . 74.14 111.714 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.35 -33.83 75.48 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.831 0.707 . . . . 72.21 111.246 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.0 -36.14 82.57 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.294 0.638 . . . . 61.22 110.99 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -71.5 -33.39 69.21 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.269 0.627 . . . . 74.24 110.989 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 29.9 mmt -72.42 -34.54 67.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.342 0.657 . . . . 64.44 110.98 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -72.27 -35.68 68.82 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.199 0.999 . . . . 64.45 110.432 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -54.13 -80.74 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.316 1.047 . . . . 70.55 111.037 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 34.3 tp -73.28 85.15 1.42 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.3 0.571 . . . . 64.13 110.866 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -142.65 168.36 19.91 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.786 1.234 . . . . 61.42 108.869 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.32 87.84 1.06 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 105.964 -1.865 . . . . 75.51 105.964 172.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 8' ' ' GLU . 85.4 mm-40 -145.66 156.87 43.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.788 0.835 . . . . 65.31 111.338 -173.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.46 65.64 0.33 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.894 0.878 . . . . 64.43 109.615 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 8' ' ' GLU . . . -89.55 -146.63 14.56 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.548 -0.751 . . . . 73.21 112.892 -176.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.91 145.33 44.17 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.152 0.501 . . . . 73.53 111.839 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.91 131.36 10.34 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.668 -1.151 . . . . 62.22 110.372 167.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 58.3 m -101.56 138.28 38.77 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.02 0.928 . . . . 74.23 111.178 -171.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 12.2 pt-20 -70.83 140.81 51.27 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.368 -0.604 . . . . 72.41 109.368 172.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' E' ' 277' ' ' LEU . 3.1 mm-40 -161.9 161.62 28.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.342 -0.39 . . . . 51.01 111.224 -173.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -176.54 141.75 0.41 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.984 1.314 . . . . 74.21 109.213 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -156.8 117.64 3.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.431 -1.322 . . . . 75.52 107.431 174.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.77 152.7 45.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.548 0.739 . . . . 63.44 111.75 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.553 -0.737 . . . . 52.0 109.344 -179.155 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.456 -0.572 . . . . 64.2 109.456 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 42.3 t -156.36 143.14 18.69 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.196 0.998 . . . . 74.12 108.784 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -71.14 -64.43 0.91 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.302 -0.999 . . . . 73.33 108.302 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -176.82 -68.47 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.662 -1.607 . . . . 73.25 106.662 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -165.71 143.86 5.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.295 1.038 . . . . 64.33 109.092 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -168.43 154.44 6.99 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.616 1.167 . . . . 74.45 108.494 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 37.5 p -69.65 83.41 0.44 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.893 0.877 . . . . 73.12 110.919 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.91 131.47 35.81 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.331 -1.359 . . . . 74.25 107.331 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.411 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 4.9 ttp 16.37 119.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 127.448 2.299 . . . . 63.32 115.718 -169.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m -129.27 143.37 50.83 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.898 -0.779 . . . . 75.42 108.898 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -163.03 104.48 1.01 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.387 -1.338 . . . . 71.41 107.387 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -127.48 140.95 51.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.394 -0.965 . . . . 71.43 108.394 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.25 133.21 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.147 -1.057 . . . . 75.22 108.147 171.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -89.21 -39.6 13.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.345 0.403 . . . . 74.53 110.384 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 176.07 150.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.336 1.054 . . . . 72.25 110.6 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.26 134.45 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.444 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.0 p90 -147.73 162.53 39.0 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.267 1.027 . . . . 73.2 110.347 -176.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.43 HG21 HD11 ' D' ' 21' ' ' ILE . 75.6 p -95.44 119.68 34.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.764 -1.107 . . . . 71.42 109.52 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -90.56 -27.44 19.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.781 0.432 . . . . 72.31 110.585 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -154.76 140.27 17.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.087 -0.961 . . . . 74.11 108.696 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' C' ' 117' ' ' MET . 71.9 mt -137.95 143.05 34.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.081 -1.081 . . . . 74.31 108.081 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -148.07 123.36 10.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.142 0.977 . . . . 73.53 109.293 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.444 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -131.3 120.72 23.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.103 -1.814 . . . . 70.23 106.103 170.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.9 mt-10 -123.06 144.55 49.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.67 -0.492 . . . . 60.33 109.67 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.62 76.54 47.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 106.27 -1.752 . . . . 74.25 106.27 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.63 -25.26 24.78 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.695 2.263 . . . . 65.22 112.541 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -112.73 25.77 11.14 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.157 0.983 . . . . 65.43 109.169 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.501 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -49.02 -62.18 2.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 114.453 1.279 . . . . 72.44 114.453 -166.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.497 ' HB3' HD11 ' C' ' 83' ' ' ILE . 37.7 Cg_endo -83.14 -8.91 10.74 Favored 'Trans proline' 0 C--N 1.373 1.841 0 CA-C-N 122.358 1.878 . . . . 73.14 113.245 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -78.73 -36.78 42.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.67 1.188 . . . . 73.42 109.67 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.604 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.0 p -80.31 -21.66 11.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 CA-C-N 116.057 -0.52 . . . . 42.45 109.729 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -66.07 -6.51 13.27 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.427 0.899 . . . . 73.11 113.427 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -78.49 -36.22 45.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 74.33 109.541 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -131.38 61.36 1.64 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.122 0.969 . . . . 63.54 110.438 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.708 ' HB3' HD13 ' G' ' 301' ' ' ILE . 20.6 t0 -108.44 82.77 1.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.376 -0.828 . . . . 75.43 110.065 -172.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.605 ' H ' HD22 ' D' ' 68' ' ' LEU . 8.2 m95 -124.14 -159.71 0.88 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.987 -1.116 . . . . 73.31 107.987 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 45.8 tt0 -59.91 109.62 2.13 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.512 0.725 . . . . 74.25 111.763 -171.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' G' ' 297' ' ' TYR . 3.4 Cg_endo -84.76 150.87 11.33 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.093 2.528 . . . . 73.32 113.522 -175.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -73.73 120.46 19.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.093 -0.958 . . . . 71.24 109.253 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.677 HG23 ' HE1' ' G' ' 290' ' ' TRP . 16.4 m -99.36 129.05 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 124.104 0.962 . . . . 72.45 110.896 -172.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -130.62 117.75 19.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.238 1.015 . . . . 73.12 110.113 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.732 HD12 HD12 ' D' ' 128' ' ' LEU . 8.8 tt -98.15 137.97 36.12 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.103 -0.703 . . . . 73.13 109.103 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.64 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.0 m-20 -127.68 147.34 50.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.189 0.996 . . . . 75.21 108.845 172.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.83 150.76 39.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.346 0.659 . . . . 73.32 109.614 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 14.5 t70 -149.56 125.25 10.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.487 1.115 . . . . 74.52 108.108 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -104.21 144.27 31.82 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.431 0.692 . . . . 75.2 110.638 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.35 156.94 31.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.936 0.894 . . . . 33.23 109.332 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -168.61 154.31 6.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.328 0.651 . . . . 72.13 110.292 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -155.63 136.24 13.37 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.635 0.774 . . . . 54.43 109.357 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -74.32 122.94 23.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.529 -0.545 . . . . 65.32 109.529 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.2 mt -90.58 -37.94 13.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.033 0.533 . . . . 73.13 110.58 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.17 -176.35 5.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.381 0.673 . . . . 70.44 111.023 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.11 119.21 7.4 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.932 -1.031 . . . . 50.43 110.365 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.87 19.18 10.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.343 1.057 . . . . 73.34 112.058 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.17 126.62 75.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.086 0.954 . . . . 72.45 109.076 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -132.85 129.93 39.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.008 -1.108 . . . . 72.11 108.008 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.1 tt0 -91.12 119.42 31.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.567 -0.901 . . . . 54.5 108.567 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.96 129.35 52.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.935 -1.135 . . . . 75.32 107.935 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.482 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.4 t -116.84 128.34 74.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.157 -1.053 . . . . 74.14 108.157 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -126.54 105.91 9.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.307 -1.368 . . . . 72.13 107.307 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.4 ttm180 -84.17 123.25 29.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.573 -0.74 . . . . 74.53 109.4 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -112.07 137.12 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.45 -0.944 . . . . 63.02 108.45 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.64 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.9 m -126.55 138.89 53.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.373 0.669 . . . . 72.01 109.515 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.561 HG11 ' HG ' ' D' ' 126' ' ' LEU . 75.5 t -127.72 108.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.244 1.018 . . . . 51.25 109.445 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.5 m -99.92 124.53 45.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.709 0.804 . . . . 74.32 109.013 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 126.69 54.45 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.485 0.714 . . . . 70.4 110.127 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 33.9 p -140.79 121.11 13.95 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 109.313 -0.625 . . . . 55.22 109.313 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.605 HD22 ' H ' ' D' ' 36' ' ' TRP . 1.0 OUTLIER -98.95 135.25 40.63 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.706 0.803 . . . . 63.3 110.104 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.35 -111.44 4.16 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.43 -0.668 . . . . 71.13 111.43 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.14 18.26 9.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.336 1.054 . . . . 61.21 109.961 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -124.15 143.75 50.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.839 1.256 . . . . 72.13 109.973 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -76.89 121.98 24.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.951 0.5 . . . . 63.35 110.979 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.604 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.39 -65.49 0.95 Allowed 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.395 0.678 . . . . 74.53 109.608 175.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.53 164.25 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.391 -1.277 . . . . 70.04 110.549 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 67.2 mt -126.47 142.54 51.5 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.245 -1.391 . . . . 73.02 107.245 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.2 t -147.87 139.06 23.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.33 -0.618 . . . . 71.53 109.33 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -157.74 139.86 14.31 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.896 0.878 . . . . 70.23 109.22 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.47 118.89 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.742 0.817 . . . . 71.31 109.334 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.97 82.74 6.12 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.174 -1.047 . . . . 65.3 108.174 173.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.46 102.48 12.11 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.463 -0.79 . . . . 71.22 109.9 -171.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 170.26 29.94 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 116.324 -0.398 . . . . 63.55 112.385 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.56 137.68 4.47 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.534 -0.627 . . . . 71.13 111.534 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.444 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.6 mt -90.28 135.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 109.175 -0.676 . . . . 74.02 109.175 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.01 126.08 29.47 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.443 0.697 . . . . 65.23 109.875 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -78.88 94.98 5.29 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.633 0.773 . . . . 63.42 109.092 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.593 HG22 HD11 ' D' ' 89' ' ' ILE . 21.8 mt -113.13 131.76 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.625 0.77 . . . . 75.22 110.142 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.45 169.25 23.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.075 0.95 . . . . 53.44 110.35 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 72.42 21.39 79.45 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.078 -0.51 . . . . 73.23 113.617 173.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.593 HD11 HG22 ' D' ' 86' ' ' ILE . 1.5 pp -135.46 160.55 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.565 1.146 . . . . 75.42 109.604 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -168.4 166.53 12.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.522 0.729 . . . . 74.13 110.515 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.69 -135.47 47.04 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.998 0.811 . . . . 54.13 114.149 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -77.0 -22.86 52.48 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.842 0.857 . . . . 73.42 111.066 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -62.31 -46.12 90.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.784 0.834 . . . . 72.45 110.444 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.3 ptm -77.75 -24.09 49.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.657 -0.701 . . . . 73.44 110.905 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -32.97 74.75 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.812 0.445 . . . . 73.23 111.148 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -77.59 -39.04 46.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.182 0.593 . . . . 73.22 111.276 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -63.66 -44.18 94.56 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.25 0.548 . . . . 71.21 110.963 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.578 ' HB3' ' HE2' ' G' ' 281' ' ' PHE . 4.6 mm? -84.04 -41.38 17.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.473 1.109 . . . . 72.23 111.11 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.62 -10.39 73.28 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 114.702 0.641 . . . . 60.54 114.702 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.29 -61.42 0.87 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.234 0.517 . . . . 75.12 111.232 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -65.25 -44.14 89.1 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.698 0.629 . . . . 73.3 112.698 -173.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 79.8 m -64.38 -44.68 76.45 Favored Pre-proline 0 CA--C 1.567 1.608 0 CA-C-O 118.824 -0.608 . . . . 70.34 112.498 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -48.19 -42.26 33.4 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.51 2.14 . . . . 72.43 114.093 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -64.75 -20.51 66.39 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.758 0.651 . . . . 73.45 112.758 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.3 mm -82.21 -46.8 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.398 0.618 . . . . 74.4 110.382 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -79.72 -28.85 40.53 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.169 -0.923 . . . . 54.35 111.826 -171.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -62.55 -42.56 80.13 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 124.205 1.002 . . . . 74.24 113.474 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -52.64 -39.98 74.47 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.48 2.12 . . . . 74.33 114.352 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -77.69 -32.69 53.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.522 0.729 . . . . 73.52 111.6 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.96 81.87 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.072 -0.714 . . . . 54.35 109.072 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.599 ' HA ' HD23 ' D' ' 128' ' ' LEU . 24.9 ttp180 -54.01 -55.37 27.89 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.899 1.374 . . . . 72.23 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -66.27 -39.71 89.63 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.142 0.901 . . . . 73.32 111.149 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.9 -44.1 97.61 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.31 0.381 . . . . 72.25 110.429 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.572 HG23 ' SG ' ' D' ' 76' ' ' CYS . 93.5 mt -59.03 -54.98 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.176 0.99 . . . . 72.04 110.238 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.612 HG21 ' HE2' ' B' ' 109' ' ' TYR . 71.7 m -52.08 -48.3 64.76 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 125.078 1.351 . . . . 63.33 111.595 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.81 -41.56 82.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.626 -1.17 . . . . 72.03 110.797 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.422 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -65.61 -36.68 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.709 0.404 . . . . 75.21 111.663 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.1 t -64.63 -44.74 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.605 -0.725 . . . . 62.45 109.969 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' D' ' 125' ' ' GLN . 88.1 p -69.62 -31.48 69.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.849 0.459 . . . . 71.2 111.614 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.79 -30.52 68.08 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.8 0.84 . . . . 75.22 110.488 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.01 11.55 59.97 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.375 -0.829 . . . . 15.0 112.281 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.3 p 60.67 14.57 5.1 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 127.092 2.157 . . . . 70.31 113.782 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -91.41 160.69 36.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.493 1.117 . . . . 72.14 108.495 173.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.424 ' HG2' ' HB ' ' G' ' 296' ' ' THR . 86.5 Cg_endo -73.54 115.66 4.41 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.429 2.086 . . . . 55.05 110.805 -175.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' D' ' 119' ' ' SER . 3.9 pt20 -51.21 139.17 19.13 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.425 1.078 . . . . 73.24 112.407 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.561 ' HG ' HG11 ' D' ' 64' ' ' VAL . 0.7 OUTLIER -107.15 110.48 22.57 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.469 -0.567 . . . . 54.35 109.469 -165.701 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -98.59 102.57 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.468 0.707 . . . . 73.53 109.362 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.732 HD12 HD12 ' D' ' 42' ' ' LEU . 3.2 mm? -70.11 115.7 9.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.252 1.021 . . . . 63.21 109.912 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.715 ' HB3' HD11 ' G' ' 291' ' ' LEU . . . -66.1 137.55 95.81 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-O 119.581 -0.247 . . . . 54.52 110.376 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.23 133.06 23.84 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.131 1.888 . . . . 71.05 110.995 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -108.06 136.38 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.291 -1.003 . . . . 71.01 108.291 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -78.36 86.78 4.41 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.366 -0.605 . . . . 72.43 109.366 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -64.76 -31.63 72.95 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.447 -0.797 . . . . 65.24 110.713 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' D' ' 138' ' ' MET . 6.1 m-20 -63.52 -58.43 7.03 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.221 1.008 . . . . 73.51 111.245 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.9 91.17 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.503 0.721 . . . . 74.02 112.339 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.48 -37.56 87.75 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.076 -0.966 . . . . 75.01 110.965 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -77.39 -30.76 53.81 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.642 -0.708 . . . . 72.13 111.512 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 57.4 mtt -59.81 -28.38 67.41 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.572 0.749 . . . . 54.45 111.603 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.402 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 88.8 m-20 -60.14 -35.86 76.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.186 0.595 . . . . 74.45 111.359 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -64.93 -41.76 95.26 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.928 0.891 . . . . 75.0 110.863 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.74 -35.16 77.28 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.035 0.534 . . . . 74.44 110.579 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -80.42 9.2 6.2 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.968 0.907 . . . . 61.05 111.63 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 69.8 mt-30 -121.99 46.98 1.98 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.739 1.216 . . . . 64.33 108.541 176.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -161.97 111.29 1.51 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.588 -0.733 . . . . 74.13 109.593 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.48 146.98 31.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.029 0.532 . . . . 60.51 110.384 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.66 54.31 4.79 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.326 0.391 . . . . 34.14 112.631 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -105.24 27.71 7.99 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.218 1.007 . . . . 75.35 109.196 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.37 64.96 3.92 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.713 -0.676 . . . . 53.35 112.526 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 35.3 p -76.14 85.54 2.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.074 0.95 . . . . 64.12 108.613 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.0 85.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.613 1.565 . . . . 72.11 113.253 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -83.85 87.83 7.1 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.087 -1.449 . . . . 71.32 107.087 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -140.48 150.19 43.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.774 0.83 . . . . 73.01 109.849 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -67.05 149.64 50.31 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 124.035 0.834 . . . . 74.23 110.718 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.05 141.17 58.25 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.787 0.679 . . . . 70.32 110.787 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 N-CA-C 107.929 -1.138 . . . . 72.15 107.929 -178.94 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.66 0.267 . . . . 75.14 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -62.7 138.24 58.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.327 0.651 . . . . 75.02 109.396 172.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.05 -37.96 72.52 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.416 -0.587 . . . . 75.22 109.416 178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 58.35 76.17 0.35 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.896 1.278 . . . . 72.23 109.103 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 275' ' ' LYS . . . . . 0.406 ' HZ2' ' HB3' ' E' ' 278' ' ' LEU . 9.4 ptmm? -115.62 137.61 23.3 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 114.371 -1.286 . . . . 74.33 109.538 -171.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.21 9.11 4.24 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.431 2.754 . . . . 74.3 114.307 -172.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 277' ' ' LEU . . . . . 0.492 ' HB3' ' HG3' ' C' ' 151' ' ' GLU . 3.8 tt -166.36 144.58 5.48 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 106.545 -1.65 . . . . 60.1 106.545 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 278' ' ' LEU . . . . . 0.536 HD22 HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER 66.82 42.89 2.45 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.463 1.105 . . . . 73.13 109.939 176.088 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -71.63 -25.05 75.94 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 115.615 -0.72 . . . . 53.25 113.754 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 95' ' ' ALA . 3.6 pp -149.74 -174.45 4.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.997 0.919 . . . . 52.41 110.016 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 281' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 98' ' ' LEU . 76.8 t80 -140.39 123.61 16.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.83 0.852 . . . . 75.01 109.642 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 61.96 -172.7 0.15 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.415 1.086 . . . . 65.34 112.614 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -106.63 -33.85 7.51 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.741 0.817 . . . . 73.21 110.533 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -175.68 -157.48 17.05 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 111.681 -0.568 . . . . 73.13 111.681 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -116.54 148.09 41.18 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.584 0.754 . . . . 62.44 109.965 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -119.68 92.23 46.0 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.704 0.802 . . . . 65.41 109.944 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.5 107.4 0.7 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.69 2.26 . . . . 74.44 110.791 166.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.69 134.66 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.41 1.084 . . . . 65.4 109.135 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -83.31 -63.94 1.26 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.273 0.629 . . . . 64.24 109.579 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 290' ' ' TRP . . . . . 0.681 ' HE1' ' HB ' ' A' ' 40' ' ' VAL . 28.4 m95 -153.7 -173.17 4.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.268 1.027 . . . . 75.15 110.508 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 129' ' ' ALA . 5.1 mp -106.34 31.4 5.19 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.94 1.296 . . . . 74.25 109.023 177.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 132.45 162.82 10.45 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.074 -0.811 . . . . 54.31 111.074 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.22 90.34 0.46 Allowed 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.837 2.358 . . . . 51.11 111.275 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 294' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' G' ' 304' ' ' PRO . 5.1 ptmm? -146.24 128.2 15.48 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.99 -0.55 . . . . 74.41 110.871 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -86.65 -166.38 1.54 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.52 0.728 . . . . 61.2 109.542 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 25.2 m -120.05 -14.02 8.92 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 121.327 0.584 . . . . 35.51 110.147 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.622 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 51.2 t80 -147.82 154.35 40.35 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.898 0.879 . . . . 72.14 110.091 -172.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 298' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 36' ' ' TRP . 9.1 t60 -162.06 -76.04 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 106.434 -1.691 . . . . 74.14 106.434 167.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.55 120.49 6.55 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 119.212 -0.771 . . . . 61.03 111.364 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 300' ' ' ASN . . . . . 0.503 ' HB3' ' HE1' ' E' ' 297' ' ' TYR . 10.8 t-20 173.72 -174.4 0.06 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.736 1.614 . . . . 55.23 107.507 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 72.6 mt 73.41 100.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.03 1.332 . . . . 74.22 110.067 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -74.49 156.17 37.2 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.153 -0.684 . . . . 72.13 109.153 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -88.02 105.26 8.64 Favored Pre-proline 0 C--O 1.242 0.71 0 C-N-CA 123.964 0.905 . . . . 71.54 109.569 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.65 91.04 0.89 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.291 1.994 . . . . 42.23 111.229 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -82.09 -56.62 3.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.539 -0.912 . . . . 70.44 108.539 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 10.9 t 48.26 64.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 125.359 1.463 . . . . 64.21 110.51 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 33.4 p -105.93 116.99 32.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.229 -0.896 . . . . 73.25 109.67 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 48.4 t 65.17 102.36 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.261 1.424 . . . . 52.3 112.062 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 97.7 m -68.66 -46.59 34.66 Favored Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.132 0.973 . . . . 71.11 112.297 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 C--N 1.394 2.959 0 C-N-CA 122.069 1.846 . . . . 72.14 112.558 178.813 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.774 -0.454 . . . . 51.52 109.774 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -164.18 35.24 0.08 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.782 -1.192 . . . . 74.21 107.782 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.77 114.03 19.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.726 -1.125 . . . . 73.14 110.038 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -165.22 144.88 6.8 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.985 0.914 . . . . 60.52 109.312 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.56 157.88 34.01 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.098 0.959 . . . . 72.23 109.33 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -63.29 -155.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.29 2.66 . . . . 44.13 113.176 172.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 66.3 tp -58.3 -40.13 81.2 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.741 -0.466 . . . . 62.52 109.741 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 45.1 tp -71.03 138.83 50.17 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.167 -0.924 . . . . 65.33 110.655 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -156.69 -86.92 0.06 OUTLIER Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.494 -0.642 . . . . 65.42 111.494 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 tt -83.57 121.92 27.88 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.737 -0.838 . . . . 73.22 108.737 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -92.41 -86.62 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.294 -1.373 . . . . 72.31 107.294 172.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -160.02 -166.75 1.78 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.727 0.811 . . . . 64.51 109.378 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 26.0 t70 71.23 174.74 0.3 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.528 1.131 . . . . 71.54 110.891 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 106.78 -74.21 0.22 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.668 -0.973 . . . . 74.21 110.668 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -73.29 -24.71 60.45 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.999 0.519 . . . . 72.15 109.879 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -119.23 95.81 49.56 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.995 0.918 . . . . 71.41 110.391 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.39 89.66 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.148 1.899 . . . . 74.3 109.628 166.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.82 91.39 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.645 -0.707 . . . . 65.12 110.396 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.35 -41.54 10.3 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.153 -0.93 . . . . 70.44 109.493 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 290' ' ' TRP . . . . . 0.616 ' HH2' HD11 ' C' ' 126' ' ' LEU . 13.6 m95 179.68 175.6 0.74 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.85 2.06 . . . . 73.55 109.081 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.594 HD13 ' HB3' ' C' ' 129' ' ' ALA . 5.2 mp -118.93 -1.46 10.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.752 0.821 . . . . 74.41 110.722 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -148.6 -175.38 21.1 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.335 -0.703 . . . . 34.41 112.608 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.81 -68.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.901 2.401 . . . . 54.23 112.496 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -175.83 153.5 1.39 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.125 0.97 . . . . 71.13 109.237 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -150.95 -36.5 0.14 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.014 0.526 . . . . 63.2 111.773 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 4.3 m -62.93 136.17 57.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.46 0.704 . . . . 64.21 111.435 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.409 ' CE2' ' HB1' ' C' ' 73' ' ' ALA . 5.1 m-30 74.55 -19.56 0.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.098 1.359 . . . . 54.12 113.633 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -65.87 96.92 0.32 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.419 0.687 . . . . 64.43 109.232 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 161.05 -20.27 0.21 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-N 114.423 -1.262 . . . . 63.3 111.026 -170.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 300' ' ' ASN . . . . . 0.444 ' HA ' ' HB2' ' C' ' 36' ' ' TRP . 26.5 t-20 81.22 -43.14 0.18 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.441 1.497 . . . . 41.02 113.388 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.484 HD11 ' HD3' ' C' ' 124' ' ' PRO . 53.7 mt 66.27 108.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 124.524 1.13 . . . . 75.11 109.344 -168.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.22 -73.8 0.08 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.619 0.768 . . . . 72.35 110.609 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 303' ' ' LYS . . . . . 0.507 ' HA ' ' HZ ' ' C' ' 32' ' ' PHE . 98.2 mttt -147.86 161.01 36.54 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 124.287 1.035 . . . . 73.35 109.611 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.64 102.02 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.478 2.119 . . . . 62.24 110.28 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 305' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' H' ' 294' ' ' LYS . . . -56.59 -31.56 64.36 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.89 1.276 . . . . 32.45 112.85 -173.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 t -70.7 101.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.892 -0.781 . . . . 74.44 108.892 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 307' ' ' THR . . . . . 0.402 ' H ' ' H ' ' F' ' 308' ' ' CYS . 15.1 t -160.97 -2.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.587 0.755 . . . . 73.04 110.338 173.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 308' ' ' CYS . . . . . 0.402 ' H ' ' H ' ' F' ' 307' ' ' THR . 60.8 m -97.19 24.3 6.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.471 0.708 . . . . 72.24 110.769 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 3.4 t -154.12 79.17 5.15 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.574 0.749 . . . . 73.53 110.072 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo . . . . . 0 C--N 1.374 1.894 0 C-N-CA 122.544 2.163 . . . . 64.43 111.276 172.178 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.379 0.609 . . . . 55.32 111.054 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -125.34 83.56 2.18 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.164 1.386 . . . . 65.34 107.575 172.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -71.85 90.73 1.13 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.291 -0.868 . . . . 72.15 111.013 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -156.26 95.62 1.61 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.361 1.064 . . . . 74.24 109.373 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -118.37 97.82 50.97 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.17 0.588 . . . . 64.32 109.446 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.15 90.93 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.618 2.212 . . . . 65.13 110.095 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.52 144.65 49.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.33 0.652 . . . . 72.32 110.161 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 34.4 tp 69.82 71.46 0.23 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.526 1.13 . . . . 44.13 109.988 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -100.72 41.75 2.08 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 114.848 -1.069 . . . . 75.33 111.822 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -153.76 -176.78 5.99 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.943 0.897 . . . . 70.54 109.917 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 281' ' ' PHE . . . . . 0.578 ' HE2' ' HB3' ' D' ' 98' ' ' LEU . 72.6 m-85 71.69 82.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.033 1.333 . . . . 63.1 110.33 -171.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -166.69 -35.65 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.765 1.226 . . . . 75.13 108.689 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.33 131.83 34.84 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.365 1.066 . . . . 71.22 108.763 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -127.89 61.27 0.65 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.725 0.641 . . . . 75.23 112.422 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -73.82 81.19 1.61 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.407 0.622 . . . . 70.45 110.053 171.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 49.7 tpp -103.99 120.02 52.49 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.242 1.017 . . . . 73.5 108.364 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -70.38 80.79 1.03 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.907 2.405 . . . . 75.22 111.831 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 288' ' ' VAL . . . . . 0.606 HG11 HD22 ' D' ' 42' ' ' LEU . 67.0 t -85.45 96.59 5.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.562 -1.273 . . . . 52.34 107.562 174.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -69.4 -31.85 70.48 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.01 -0.995 . . . . 71.14 110.716 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.677 ' HE1' HG23 ' D' ' 40' ' ' VAL . 57.9 t-105 69.09 161.25 0.2 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.903 1.281 . . . . 61.35 112.083 175.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' D' ' 129' ' ' ALA . 5.7 mp -74.91 112.56 11.27 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.336 -0.847 . . . . 74.45 109.712 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.53 -57.87 15.91 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 123.813 0.695 . . . . 72.34 111.724 165.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.68 123.79 12.97 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.462 2.108 . . . . 54.25 112.984 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -99.87 142.27 31.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.192 0.997 . . . . 74.43 109.938 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -144.7 88.88 1.94 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.031 -0.729 . . . . 74.33 109.031 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 296' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' D' ' 124' ' ' PRO . 4.4 p -150.2 -88.13 0.07 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.653 0.781 . . . . 63.3 110.796 -173.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.483 ' HB2' ' HD3' ' D' ' 38' ' ' PRO . 0.1 OUTLIER -102.3 179.8 4.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.995 0.918 . . . . 75.24 109.166 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -166.14 -38.77 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.168 -0.679 . . . . 72.15 109.168 171.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 176.02 163.41 28.61 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.881 -0.6 . . . . 42.42 113.195 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 62.35 109.61 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.385 1.474 . . . . 72.15 112.524 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.708 HD13 ' HB3' ' D' ' 35' ' ' ASP . 10.5 pt -122.46 11.43 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.303 1.041 . . . . 63.11 109.797 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.95 136.59 34.08 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.068 -0.969 . . . . 70.3 111.171 -163.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 303' ' ' LYS . . . . . 0.46 ' HZ1' ' HB3' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -104.47 131.1 22.19 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.86 -1.163 . . . . 74.42 107.86 173.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' G' G ' 304' ' ' PRO . . . . . 0.419 ' HB2' ' HB2' ' E' ' 294' ' ' LYS . 85.3 Cg_exo -49.67 128.93 22.39 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.1 2.534 . . . . 74.03 113.127 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -69.91 148.3 49.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.691 0.796 . . . . 65.12 111.898 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 15.4 t -87.54 146.95 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.391 -0.966 . . . . 52.43 108.391 175.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 73.9 p -68.08 -65.95 0.63 Allowed 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.03 0.532 . . . . 72.41 109.75 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 66.9 m -154.67 109.76 3.08 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.326 -1.361 . . . . 71.13 107.326 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' G' G ' 309' ' ' THR . . . . . 0.469 HG21 ' HD2' ' A' ' 130' ' ' PRO . 67.7 p -74.69 120.63 82.46 Favored Pre-proline 0 C--N 1.351 0.662 0 N-CA-C 108.154 -1.054 . . . . 75.21 108.154 171.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo . . . . . 0 C--N 1.374 1.88 0 C-N-CA 122.129 1.886 . . . . 72.3 110.613 174.06 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.214 -0.291 . . . . 63.22 110.214 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.4 -72.72 0.11 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.384 1.474 . . . . 71.23 111.958 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.1 104.99 0.63 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.391 0.676 . . . . 73.11 110.603 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -100.37 -44.45 5.91 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.586 0.754 . . . . 74.24 109.999 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -151.5 135.73 9.81 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.617 1.167 . . . . 71.02 108.889 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.98 -172.41 0.6 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.744 2.296 . . . . 73.51 111.773 169.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 277' ' ' LEU . . . . . 0.602 ' HG ' ' SD ' ' B' ' 94' ' ' MET . 23.3 tp -58.55 -42.61 88.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.394 0.678 . . . . 53.43 110.204 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 38.5 tp -69.93 89.99 0.61 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.367 -1.288 . . . . 74.22 110.094 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -94.94 -24.53 17.03 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.011 -0.995 . . . . 64.54 113.213 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 280' ' ' LEU . . . . . 0.442 ' HB3' HD11 ' B' ' 98' ' ' LEU . 13.4 tp -117.86 170.21 8.99 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.173 0.589 . . . . 64.34 109.43 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 67.42 45.03 1.66 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.526 1.13 . . . . 73.43 111.875 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -114.48 -2.34 13.22 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.791 -1.095 . . . . 73.51 111.189 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -153.78 -93.94 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.773 0.429 . . . . 74.12 111.035 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 142.87 99.95 0.34 Allowed Glycine 0 C--N 1.356 1.669 0 CA-C-N 118.21 0.459 . . . . 65.33 112.348 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -118.68 67.25 0.77 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.049 0.94 . . . . 72.32 109.548 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 48.1 ttm -163.34 84.3 1.39 Allowed Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 116.401 -0.363 . . . . 73.13 110.973 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.4 89.31 1.27 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.331 2.687 . . . . 73.31 109.516 166.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 288' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' B' ' 42' ' ' LEU . 60.0 t -69.76 112.72 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.554 0.742 . . . . 72.21 111.261 -172.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -78.64 138.81 38.5 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 107.059 -1.46 . . . . 74.25 107.059 164.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -57.37 151.75 15.63 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.697 0.76 . . . . 73.41 112.726 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.57 7.57 38.46 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.401 -1.272 . . . . 72.22 110.299 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 292' ' ' GLY . . . . . 0.438 ' HA3' ' HB1' ' F' ' 305' ' ' ALA . . . 148.67 84.15 0.05 OUTLIER Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.831 -1.308 . . . . 50.1 109.831 -176.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.3 -51.41 2.69 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.557 2.171 . . . . 54.23 113.075 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 294' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' H' ' 294' ' ' LYS . 8.3 mmpt? 55.02 31.08 15.38 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.682 1.193 . . . . 72.1 113.448 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 65.55 101.39 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.395 1.078 . . . . 74.03 112.183 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 80.5 m -63.56 -27.77 69.48 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.619 -0.718 . . . . 74.52 111.171 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.415 ' OH ' ' HB1' ' B' ' 73' ' ' ALA . 3.9 m-30 -86.25 176.45 7.93 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.229 1.011 . . . . 74.25 111.947 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -68.28 117.89 10.67 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 114.861 -1.063 . . . . 72.23 110.113 -172.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -66.24 -23.63 71.66 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.854 0.721 . . . . 63.12 112.033 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -143.7 129.15 19.02 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.439 1.096 . . . . 71.24 110.33 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 98.8 mt -121.62 125.36 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.623 -1.251 . . . . 64.33 107.623 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -132.48 -73.26 0.51 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.846 -0.798 . . . . 74.52 108.846 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -138.59 151.2 68.44 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 123.87 0.868 . . . . 73.34 109.739 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.06 166.38 23.2 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.64 2.226 . . . . 74.03 112.624 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.03 8.47 8.45 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.462 0.705 . . . . 71.23 111.482 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.51 136.95 32.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 C-N-CA 124.38 1.072 . . . . 62.01 109.482 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 9.9 t -168.7 -34.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.132 0.973 . . . . 71.52 110.69 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 64.4 m -144.11 110.74 5.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.933 0.893 . . . . 74.24 108.992 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' H' H ' 309' ' ' THR . . . . . 0.572 HG22 HD23 ' F' ' 291' ' ' LEU . 32.1 p -64.45 142.8 98.46 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 123.024 0.529 . . . . 74.32 110.323 175.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' H' H ' 310' ' ' PRO . . . . . 0.51 ' HD3' ' HG ' ' F' ' 291' ' ' LEU . 55.0 Cg_endo . . . . . 0 C--N 1.379 2.154 0 C-N-CA 123.104 2.536 . . . . 64.53 112.43 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.732 -0.47 . . . . 54.43 109.732 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.4 p -78.48 82.68 4.73 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.791 0.805 . . . . 72.21 109.64 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -125.95 -53.36 1.53 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.376 1.071 . . . . 74.5 108.826 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -88.91 126.52 35.42 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.179 -1.045 . . . . 74.25 108.179 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -70.12 111.14 5.55 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.474 -0.936 . . . . 72.42 108.474 175.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.453 ' HB3' HG22 ' A' ' 89' ' ' ILE . 72.1 m-20 -84.22 58.38 4.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.467 0.707 . . . . 63.22 111.214 -172.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 m 62.03 -74.89 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.533 1.533 . . . . 62.24 110.6 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -151.98 -53.58 0.12 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.172 1.389 . . . . 72.01 107.645 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 71.39 137.03 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.902 1.681 . . . . 74.31 111.163 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.5 m -142.41 138.32 31.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.571 0.748 . . . . 75.13 109.854 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.428 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 18.7 t80 -133.05 124.79 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 62.13 108.887 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -146.56 110.02 4.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.96 -0.756 . . . . 73.24 108.96 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.676 HG12 ' HD2' ' A' ' 84' ' ' PHE . 37.6 mt -69.65 128.69 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.639 -0.874 . . . . 71.14 108.639 173.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.519 ' O ' ' HB3' ' H' ' 305' ' ' ALA . 21.1 mm-40 -97.73 -36.98 10.06 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 122.936 0.494 . . . . 74.14 110.461 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.563 HH11 ' HB2' ' H' ' 305' ' ' ALA . 40.8 ttt85 -166.86 142.99 4.46 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.885 -0.413 . . . . 75.33 109.885 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.69 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.549 0.74 . . . . 72.14 109.027 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HE1' HG13 ' A' ' 83' ' ' ILE . 21.2 p90 -169.02 149.8 4.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.919 0.888 . . . . 63.24 110.299 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -79.33 119.81 22.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.899 -1.046 . . . . 74.52 108.83 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.2 mtpt -88.22 -17.93 29.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.847 0.356 . . . . 72.24 110.284 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.1 t70 -156.53 141.76 17.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.305 1.042 . . . . 72.45 109.141 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 64.4 mt -138.14 144.91 29.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 107.238 -1.393 . . . . 60.14 107.238 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.616 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 28.3 t -150.8 130.51 13.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.852 0.861 . . . . 61.11 108.935 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -132.64 136.44 46.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.406 -1.701 . . . . 70.52 106.406 167.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -133.91 140.13 46.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.414 -0.587 . . . . 74.42 109.414 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 69.23 10.92 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 106.065 -1.828 . . . . 74.25 106.065 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.46 -19.41 21.93 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.324 2.016 . . . . 73.24 112.453 -171.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -110.52 20.53 17.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.867 0.867 . . . . 64.11 109.798 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.74 -61.28 3.13 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.05 -0.976 . . . . 71.11 113.38 -167.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.4 -20.66 49.52 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.404 2.069 . . . . 71.52 113.912 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -83.85 -53.19 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.104 0.954 . . . . 73.34 109.906 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG11 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -77.43 -12.74 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-N 114.61 -1.177 . . . . 71.2 111.8 -162.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -74.18 -18.03 60.82 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.641 0.776 . . . . 64.43 112.606 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.07 -8.92 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.787 0.662 . . . . 73.41 112.787 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -79.9 168.95 18.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.957 0.503 . . . . 75.32 112.296 -174.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.93 138.62 58.48 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.67 1.188 . . . . 73.34 111.153 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -86.84 80.43 8.49 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.483 0.659 . . . . 73.34 110.146 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -137.31 77.53 41.26 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 114.938 -1.028 . . . . 70.1 109.006 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -81.4 138.82 11.18 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.38 2.054 . . . . 62.35 111.762 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.56 84.32 3.39 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 106.006 -1.85 . . . . 64.42 106.006 164.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 65' ' ' THR . 12.0 p -81.91 123.39 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.748 -1.114 . . . . 60.2 109.153 -175.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 18.0 pttp -123.6 127.62 48.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 74.24 110.591 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tt -98.55 109.49 22.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.629 -1.619 . . . . 70.33 106.629 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -106.34 147.89 28.69 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.792 0.837 . . . . 75.15 108.815 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -126.19 125.57 42.66 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.74 0.816 . . . . 61.44 109.342 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.5 t70 -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.093 0.957 . . . . 74.53 108.455 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -108.17 129.46 55.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.879 0.872 . . . . 72.21 111.597 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.16 130.72 17.83 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.705 0.802 . . . . 64.54 109.987 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -125.05 151.58 45.43 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.896 -0.779 . . . . 71.33 108.896 172.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 t -158.33 133.66 8.71 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.486 0.714 . . . . 72.24 109.857 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -78.32 125.53 29.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.227 0.611 . . . . 75.34 110.018 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.12 -34.28 13.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.453 0.701 . . . . 73.11 110.64 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -178.58 6.05 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.057 0.943 . . . . 34.22 109.707 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -69.26 125.34 26.39 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.902 -0.407 . . . . 71.35 109.902 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 68.58 -8.22 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.968 1.707 . . . . 64.44 112.805 -171.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -101.33 109.52 25.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.997 -0.742 . . . . 71.3 108.997 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.524 ' HB2' HD13 ' A' ' 86' ' ' ILE . 93.2 m-85 -123.64 127.19 47.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.965 0.906 . . . . 70.22 108.607 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.31 132.04 37.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.681 -1.145 . . . . 73.4 108.992 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.583 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 58.9 t -116.86 121.43 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.694 -1.224 . . . . 73.45 107.694 169.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.41 129.76 49.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.839 0.855 . . . . 73.21 108.711 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -120.57 100.5 7.17 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.547 -1.649 . . . . 74.55 106.547 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 6.6 ttm180 -87.35 131.22 34.34 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.843 -0.799 . . . . 74.35 108.843 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' A' ' 114' ' ' ILE . 47.9 t -117.84 130.61 72.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.328 -0.989 . . . . 72.43 108.328 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 69.2 m -113.72 140.97 47.82 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.635 0.584 . . . . 65.32 109.693 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG21 HD21 ' A' ' 126' ' ' LEU . 92.7 t -130.43 113.29 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.961 0.904 . . . . 50.13 108.747 174.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.5 m -112.73 131.49 55.65 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.114 -0.698 . . . . 71.11 109.114 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.27 105.74 8.75 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.316 -0.994 . . . . 72.12 108.316 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 51.6 m -110.58 122.92 48.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.29 0.495 . . . . 62.11 110.816 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 73' ' ' ALA . 10.4 mp -89.57 86.96 6.87 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.111 0.964 . . . . 74.11 109.012 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.1 -84.41 1.43 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.757 -1.111 . . . . 61.43 110.5 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -25.37 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.627 0.771 . . . . 60.31 110.446 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -98.4 129.87 45.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.312 1.045 . . . . 63.13 110.225 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.6 m -79.85 135.49 36.47 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.196 0.522 . . . . 73.53 112.19 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.611 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.64 -63.81 1.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.2 1.4 . . . . 72.03 109.766 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -147.09 159.75 43.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.104 -0.953 . . . . 75.12 111.645 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.65 117.26 11.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.399 -1.273 . . . . 72.32 108.335 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 63' ' ' THR . 83.9 m -110.61 136.72 49.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.392 0.677 . . . . 60.14 110.709 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 43.2 mp0 -135.9 131.27 35.02 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.618 -1.253 . . . . 71.21 107.618 169.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.27 115.2 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.6 -0.889 . . . . 53.14 108.6 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 42.3 mt-30 -90.23 86.98 6.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 172.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.71 93.11 4.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.727 -1.124 . . . . 73.3 108.62 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.01 148.24 22.3 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.264 -0.88 . . . . 71.12 111.082 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.74 123.27 2.01 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 111.349 -0.7 . . . . 50.15 111.349 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.492 HG13 ' HE1' ' A' ' 17' ' ' TYR . 56.3 mt -80.97 123.67 37.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.896 -1.149 . . . . 71.4 107.896 170.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.676 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.3 m-85 -133.83 162.9 30.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.263 -1.014 . . . . 63.23 108.263 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 t -118.43 102.47 8.95 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.489 -0.93 . . . . 74.55 108.489 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 56' ' ' TYR . 3.3 mp -112.82 137.13 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.568 0.747 . . . . 71.31 109.032 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.8 174.87 13.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.981 0.912 . . . . 60.42 109.876 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.21 16.14 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.742 0.657 . . . . 53.12 114.742 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 94' ' ' MET . 11.2 pt -121.29 157.07 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.918 0.887 . . . . 73.3 110.776 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 2.8 tt0 -140.31 174.63 10.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.96 0.904 . . . . 61.15 109.32 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.443 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 41.91 -116.11 0.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.927 1.131 . . . . 72.34 115.927 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.6 p -73.05 -28.58 62.4 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.7 1.2 . . . . 72.34 111.978 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -62.08 -46.74 87.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.383 0.673 . . . . 74.34 109.206 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.514 ' HE1' HD23 ' E' ' 278' ' ' LEU . 1.4 ppp? -83.59 -21.7 32.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.49 -0.777 . . . . 61.04 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -27.42 66.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.156 0.583 . . . . 70.02 110.692 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -64.52 -35.14 80.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.773 0.829 . . . . 75.24 110.597 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 45.1 t -72.33 -41.11 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.878 -0.601 . . . . 42.54 110.91 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.57 -51.1 21.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.3 0.24 . . . . 73.4 111.605 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.9 3.79 77.83 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 114.871 0.708 . . . . 54.45 114.871 -165.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.64 -58.26 0.2 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.013 0.907 . . . . 75.22 113.271 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 64.3 t80 -70.55 -59.21 2.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.692 -1.14 . . . . 61.11 112.086 -167.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.02 -32.48 2.91 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.546 0.943 . . . . 52.11 113.546 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.16 -45.58 25.25 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.732 2.288 . . . . 75.52 113.011 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.18 -27.76 69.29 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.747 0.819 . . . . 74.25 111.439 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 13' ' ' ILE . 47.9 mm -74.74 -47.59 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.634 0.774 . . . . 74.32 110.257 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.54 -29.68 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.623 0.769 . . . . 74.55 112.798 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -65.15 -38.65 29.79 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 113.599 0.962 . . . . 73.45 113.599 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.81 -40.68 79.34 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 122.14 1.893 . . . . 71.32 113.608 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -73.44 -40.56 64.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 75.2 111.636 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.87 84.0 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.814 0.446 . . . . 63.42 109.939 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -49.61 -53.75 22.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.096 1.498 . . . . 70.54 110.522 175.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.6 -41.11 93.16 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.178 0.924 . . . . 70.5 111.658 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.8 -31.59 72.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.034 0.533 . . . . 55.33 111.249 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 62' ' ' VAL . 89.7 mt -71.84 -51.78 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.555 0.742 . . . . 75.32 109.206 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.0 m -53.57 -40.04 65.27 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.705 1.202 . . . . 55.14 111.609 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -59.72 -55.2 37.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.719 -1.128 . . . . 22.0 110.386 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.4 mtm -60.75 -43.33 98.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.24 111.515 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 114' ' ' ILE . 78.5 t -57.38 -46.38 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.411 1.084 . . . . 50.21 110.691 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -70.67 -29.25 65.53 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.15 -0.932 . . . . 74.0 111.369 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.412 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.55 -30.74 66.22 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.788 0.835 . . . . 52.13 110.653 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.08 6.25 76.21 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.774 -0.459 . . . . 74.21 112.992 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.622 ' HB ' HH21 ' B' ' 15' ' ' ARG . 1.6 m 67.9 18.71 9.58 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.258 1.423 . . . . 75.32 111.681 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.92 151.57 64.2 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 109.284 -0.635 . . . . 72.44 109.284 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -58.97 146.01 95.43 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.795 2.33 . . . . 35.21 111.53 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.407 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.23 129.58 38.86 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.747 0.654 . . . . 75.25 111.393 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.482 HD21 HG21 ' A' ' 64' ' ' VAL . 48.0 tp -112.3 96.14 5.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.765 -1.107 . . . . 55.24 110.004 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.57 105.46 15.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.562 -1.273 . . . . 75.42 107.562 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 143.53 57.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.871 0.468 . . . . 72.35 110.045 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.625 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -63.17 130.51 94.24 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 122.95 0.5 . . . . 62.23 111.141 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 56.2 Cg_endo -72.37 104.9 1.77 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.241 1.961 . . . . 65.04 111.246 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.487 HG22 HD21 ' E' ' 291' ' ' LEU . 32.7 t -101.02 122.78 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.27 -1.011 . . . . 73.3 108.27 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 51.3 t30 -68.29 86.62 0.28 Allowed 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.65 -0.87 . . . . 62.15 108.65 170.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.467 -1.242 . . . . 73.32 109.922 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.695 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.2 t70 -66.27 -36.31 82.64 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 114.239 -1.346 . . . . 62.13 111.498 -174.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -66.91 -53.4 32.4 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 120.568 0.223 . . . . 73.33 110.606 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.4 mt -65.64 -28.07 68.84 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.894 0.478 . . . . 71.04 112.277 -173.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -81.98 -50.44 9.13 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.929 -0.578 . . . . 64.51 110.167 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -72.03 -39.98 68.74 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.481 0.712 . . . . 61.11 110.979 -169.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.637 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 87.1 m-20 -53.94 -41.06 67.34 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.226 0.611 . . . . 72.32 110.675 174.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -78.28 -31.94 49.23 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.901 -0.59 . . . . 74.41 111.459 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.54 -51.18 53.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.322 0.649 . . . . 41.42 111.465 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -166.59 18.21 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.517 0.727 . . . . 75.1 110.015 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.637 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 64.0 tt0 67.49 135.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.101 1.361 . . . . 74.13 111.052 -171.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -83.36 43.28 0.87 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.948 0.88 . . . . 62.5 110.311 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.49 104.62 9.21 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.196 0.998 . . . . 74.14 109.694 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -145.19 121.97 1.63 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.648 -0.706 . . . . 73.41 111.517 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -161.19 103.29 1.27 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.713 0.805 . . . . 72.4 108.925 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.15 77.23 0.23 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.33 -0.708 . . . . 71.11 111.33 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.6 p -73.16 86.09 1.38 Allowed 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 121.613 0.72 . . . . 62.01 109.421 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -85.15 141.48 30.16 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.433 1.093 . . . . 75.3 111.615 -170.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.01 151.08 20.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.545 0.738 . . . . 73.31 109.724 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -145.69 89.37 1.9 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.232 1.013 . . . . 74.01 110.003 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -162.66 102.41 1.04 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 107.208 -1.404 . . . . 71.4 107.208 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -86.23 -45.43 11.31 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.571 0.748 . . . . 55.0 111.937 -171.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.798 0 C-N-CA 123.593 0.757 . . . . 73.44 109.097 -172.948 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 110.362 -0.236 . . . . 73.4 110.362 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 61.3 p -163.82 57.15 0.17 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.909 1.284 . . . . 65.11 108.458 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -105.9 171.82 7.13 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.763 -1.108 . . . . 73.33 111.374 -167.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 70.36 107.77 0.06 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.273 1.429 . . . . 64.13 111.965 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -65.21 133.09 50.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.435 0.694 . . . . 74.32 110.376 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -139.92 145.11 37.55 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.166 0.986 . . . . 71.3 108.762 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 56.3 m 74.42 129.62 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.197 1.399 . . . . 73.43 112.011 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -83.54 -157.59 0.25 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.122 0.969 . . . . 71.25 109.565 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.449 ' HB2' HG23 ' B' ' 89' ' ' ILE . 17.1 ptm 59.46 -177.8 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 126.137 1.775 . . . . 75.53 113.368 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.9 m -148.09 113.31 5.55 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.28 0.632 . . . . 62.33 109.85 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.471 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 74.4 t80 -110.45 117.38 33.42 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.072 -1.084 . . . . 60.3 108.072 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -126.31 106.28 9.4 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.721 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -79.77 118.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 106.887 -1.523 . . . . 64.11 106.887 167.053 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -87.07 -53.61 4.77 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.472 -0.331 . . . . 73.5 110.188 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.622 HH21 ' HB ' ' A' ' 122' ' ' THR . 52.6 ttt180 -156.35 139.93 15.94 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.093 -0.336 . . . . 73.33 110.093 -172.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.721 HG13 HD11 ' B' ' 13' ' ' ILE . 92.5 mt -116.8 140.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 106.722 -1.584 . . . . 60.43 106.722 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -168.51 159.64 10.41 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 123.569 0.543 . . . . 71.54 110.552 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -85.93 120.26 27.13 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.403 -0.591 . . . . 74.05 109.403 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -87.81 -30.63 20.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.089 0.556 . . . . 71.25 110.689 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -158.86 146.81 17.96 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.715 0.293 . . . . 54.13 111.552 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 42.0 mm -132.46 141.61 44.76 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 125.281 1.432 . . . . 61.44 108.911 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.2 t -139.44 130.84 26.93 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.921 1.288 . . . . 71.13 107.655 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.482 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -148.13 125.17 11.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.462 -1.311 . . . . 50.0 107.462 168.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 45.9 mt-10 -122.92 144.99 48.86 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.623 -0.881 . . . . 53.12 108.623 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.856 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -142.22 74.88 20.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.6 -1.259 . . . . 75.31 107.6 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.31 -38.28 6.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.663 2.242 . . . . 53.02 112.566 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 71.9 m-20 -105.41 10.96 33.18 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.28 0.632 . . . . 74.22 111.01 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.856 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -44.59 -50.71 23.12 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 115.016 1.487 . . . . 71.45 115.016 -171.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.72 -30.35 17.94 Favored 'Trans proline' 0 C--N 1.383 2.384 0 CA-C-N 121.141 1.443 . . . . 42.35 112.829 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.426 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.0 m80 -97.61 -2.36 41.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.873 0.869 . . . . 64.41 112.956 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.53 -12.73 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.928 0.491 . . . . 72.24 110.492 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.585 ' HZ ' ' HG2' ' H' ' 303' ' ' LYS . 71.8 t80 -61.36 -29.52 69.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.289 1.036 . . . . 71.42 111.735 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 pt20 -62.06 -31.98 72.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.193 0.597 . . . . 72.41 110.58 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 35.3 mmtp -97.05 64.98 2.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.311 -0.996 . . . . 74.25 108.311 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.91 99.72 11.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.802 -0.635 . . . . 75.13 110.324 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.52 ' HZ3' HG21 ' H' ' 301' ' ' ILE . 0.0 OUTLIER 163.89 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 126.953 2.101 . . . . 73.43 110.231 160.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' H' ' 297' ' ' TYR . 26.6 pt20 -59.35 125.11 78.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.112 0.965 . . . . 63.13 112.589 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 87.9 Cg_endo -84.98 150.61 10.97 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.115 2.544 . . . . 74.32 112.56 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.44 106.45 3.94 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.015 -1.106 . . . . 74.25 108.015 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 65' ' ' THR . 91.9 t -93.13 128.69 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.62 0.768 . . . . 75.53 110.862 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.597 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.8 tttp -109.98 124.39 51.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.165 0.986 . . . . 61.35 109.478 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.21 152.51 22.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.43 0.692 . . . . 71.32 109.94 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.09 111.7 1.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.715 0.635 . . . . 54.14 109.525 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.402 ' HG ' HG22 ' B' ' 62' ' ' VAL . 10.1 mp -99.1 139.21 35.09 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.949 -1.13 . . . . 61.21 107.949 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.8 t70 -121.75 126.24 48.42 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.89 0.876 . . . . 75.3 108.841 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -106.96 103.93 13.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.17 0.988 . . . . 74.22 108.418 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 140.73 50.28 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.482 -0.781 . . . . 73.23 109.014 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 p -144.52 163.88 32.55 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.619 0.368 . . . . 62.34 111.28 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -153.06 140.38 19.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.04 0.936 . . . . 72.02 109.536 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -80.03 133.6 36.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.574 0.35 . . . . 75.53 110.527 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.84 -44.31 7.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.325 0.65 . . . . 70.44 110.592 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.62 -167.55 1.59 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.656 0.782 . . . . 63.15 110.965 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -63.9 106.08 0.96 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.884 -1.053 . . . . 60.35 110.784 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' B' ' 85' ' ' SER . 33.8 m-20 73.18 -1.72 2.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.303 1.841 . . . . 64.43 112.057 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.93 124.13 58.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.524 0 C-N-CA 124.182 0.993 . . . . 54.0 108.782 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -134.39 -178.62 5.13 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.512 0.725 . . . . 70.31 109.235 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.459 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.0 tm-20 -138.17 116.64 12.03 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.805 -1.554 . . . . 75.15 106.805 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.83 127.17 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.835 0.854 . . . . 73.53 110.309 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.6 t -102.48 112.89 37.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.297 1.039 . . . . 74.33 108.829 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.4 97.81 8.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.367 -1.346 . . . . 75.32 107.367 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 27.8 ttm180 -84.81 133.31 34.34 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.873 -0.788 . . . . 62.33 108.873 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' B' ' 44' ' ' LEU . 57.6 t -117.77 109.23 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.577 -1.268 . . . . 51.33 107.577 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -96.23 136.64 36.43 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.627 -0.879 . . . . 64.1 108.627 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -133.03 132.27 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.417 1.087 . . . . 61.41 108.455 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 59.7 m -123.19 144.08 49.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.686 -1.227 . . . . 72.04 107.686 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.04 135.14 39.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.953 -1.499 . . . . 70.11 106.953 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 14.8 p -145.77 139.03 26.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 122.982 0.513 . . . . 52.53 110.683 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 23.7 mt -129.46 104.67 7.61 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.853 1.261 . . . . 73.35 109.694 -171.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -135.92 19.79 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.542 -0.588 . . . . 65.04 111.953 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.7 11.08 18.56 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.546 0.673 . . . . 75.24 111.532 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.4 pt-20 -130.13 167.59 18.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.341 0.657 . . . . 62.12 110.936 -175.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -79.56 145.87 32.91 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.495 -0.775 . . . . 75.53 109.807 174.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.46 -67.11 0.88 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.947 0.499 . . . . 53.41 109.668 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -160.63 152.08 19.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.975 -1.011 . . . . 73.51 108.792 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 65.9 mt -128.07 137.1 52.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.56 1.144 . . . . 51.33 108.309 -174.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -146.49 147.03 30.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.522 -0.548 . . . . 74.24 109.522 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.3 tt0 -160.88 138.61 9.42 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' B' ' 113' ' ' CYS . 74.5 t -130.15 146.26 34.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.677 -1.231 . . . . 62.12 107.677 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.9 91.79 3.59 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.777 -1.194 . . . . 54.4 107.777 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 42.9 tp60 -88.04 100.07 12.65 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.343 -0.984 . . . . 71.25 108.343 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.34 162.11 30.52 Favored Glycine 0 C--O 1.241 0.574 0 N-CA-C 111.047 -0.821 . . . . 64.23 111.047 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.64 126.8 1.6 Allowed Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.938 -0.865 . . . . 34.05 110.938 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.459 HG12 ' HG2' ' B' ' 57' ' ' GLU . 59.0 mt -84.39 129.62 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.467 -0.938 . . . . 74.31 108.467 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -131.81 148.75 52.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.38 -0.6 . . . . 75.14 109.38 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 22.6 m -131.23 106.64 8.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.43 1.092 . . . . 73.22 109.161 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.459 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -117.69 145.02 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 122.946 0.498 . . . . 73.01 110.634 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.13 161.73 39.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.865 0.866 . . . . 32.01 109.986 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.47 -41.2 2.51 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.895 -0.593 . . . . 74.34 111.775 -178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' B' ' 94' ' ' MET . 11.0 pt -71.66 143.38 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.727 0.811 . . . . 72.21 110.574 173.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.18 145.0 24.36 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.857 -0.794 . . . . 60.24 108.857 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.73 -109.4 2.83 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.831 0.707 . . . . 74.41 113.68 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.09 -53.44 45.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.233 1.013 . . . . 73.33 111.487 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -66.55 -34.3 77.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.248 -1.342 . . . . 70.02 110.417 -172.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.609 ' HA ' HD12 ' B' ' 89' ' ' ILE . 52.2 ttp -65.86 -50.94 62.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.679 1.192 . . . . 75.3 110.606 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.9 77.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.14 0.976 . . . . 72.22 111.919 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -78.2 -36.02 47.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.215 0.606 . . . . 73.33 111.227 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -65.11 -52.18 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.07 0.548 . . . . 70.11 111.673 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.61 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.1 pp -86.75 -31.95 20.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.591 -0.277 . . . . 64.0 111.532 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.08 73.4 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.09 0.396 . . . . 35.13 114.09 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.75 -51.6 2.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.808 0.443 . . . . 74.15 111.801 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -75.54 -40.75 56.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.806 0.442 . . . . 71.33 111.99 -170.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.4 m -66.49 -43.89 53.88 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 113.466 0.913 . . . . 61.32 113.466 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.86 -37.09 97.61 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.359 2.039 . . . . 51.53 113.218 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.23 -19.7 66.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.497 0.719 . . . . 53.24 112.491 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.412 HG23 ' NH2' ' D' ' 111' ' ' ARG . 86.3 mt -81.68 -48.31 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.344 0.658 . . . . 72.24 110.75 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.24 -25.82 58.4 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.915 -0.584 . . . . 72.33 111.591 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -57.68 -52.54 73.61 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.066 1.136 . . . . 74.24 114.066 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.71 -41.42 61.96 Favored 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.439 2.093 . . . . 72.24 113.731 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -65.15 -48.13 74.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.8 0.84 . . . . 75.45 111.396 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.54 82.0 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.486 -0.779 . . . . 62.52 110.988 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 ttp-105 -65.71 -49.73 67.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.047 -1.433 . . . . 74.04 111.386 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -35.37 79.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.995 0.518 . . . . 74.31 110.232 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.6 t -67.21 -32.0 72.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.623 0.369 . . . . 71.23 111.405 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.63 -45.63 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.499 0.72 . . . . 52.54 109.651 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.728 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.8 m -60.51 -25.01 65.77 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.382 1.073 . . . . 74.22 111.521 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -75.24 -51.4 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.652 0.781 . . . . 72.45 110.136 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.31 -34.99 73.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.914 0.486 . . . . 72.03 111.933 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.55 -39.47 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.463 0.705 . . . . 44.02 110.039 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.3 t -72.92 -27.51 61.91 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.702 0.801 . . . . 62.5 111.605 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.4 mtt-85 -73.34 -33.34 65.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.413 0.685 . . . . 71.13 110.086 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.34 1.75 69.49 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 123.855 0.722 . . . . 52.42 112.305 168.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 63.33 38.61 10.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.85 2.06 . . . . 52.35 112.606 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.11 156.76 40.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.484 1.114 . . . . 64.32 109.869 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.522 ' HG3' ' HB2' ' H' ' 300' ' ' ASN . 11.8 Cg_exo -66.58 143.42 68.53 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.428 2.085 . . . . 65.44 111.54 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.728 ' HB2' HG23 ' B' ' 115' ' ' THR . 13.5 pt20 -65.14 161.65 18.64 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.28 1.432 . . . . 74.51 114.566 -167.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.633 HD11 ' HH2' ' H' ' 290' ' ' TRP . 26.5 tp -135.29 104.38 5.86 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.345 -1.298 . . . . 73.05 109.876 168.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -92.2 107.43 19.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 106.48 -1.674 . . . . 70.02 106.48 167.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.1 tp -62.88 134.98 57.05 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.302 0.376 . . . . 65.02 110.153 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' H' ' 292' ' ' GLY . . . -61.25 156.46 50.42 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.775 1.23 . . . . 54.43 111.867 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.9 108.43 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.754 2.302 . . . . 72.01 111.992 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.466 HG22 HD11 ' H' ' 291' ' ' LEU . 38.2 t -88.14 108.57 18.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.775 -1.565 . . . . 54.21 106.775 176.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' B' ' 134' ' ' ASP . 64.9 t30 -90.23 88.99 7.45 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.854 -0.795 . . . . 75.03 108.854 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -63.33 -28.62 70.13 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.199 -0.909 . . . . 74.54 110.466 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.424 ' HB3' ' OD1' ' B' ' 132' ' ' ASN . 7.6 t70 -51.5 -51.07 58.23 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.49 1.116 . . . . 71.32 111.398 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.409 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -65.44 -32.43 74.05 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 123.877 0.736 . . . . 74.55 112.221 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.74 -45.61 93.18 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.873 0.869 . . . . 75.54 110.686 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 71.4 m-85 -78.53 -34.91 46.87 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.8 -0.636 . . . . 71.4 110.853 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -36.96 85.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.657 0.783 . . . . 52.23 110.528 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -77.53 -7.66 56.62 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.368 -0.833 . . . . 71.15 111.35 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -89.0 -29.23 19.65 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 109.356 -0.609 . . . . 74.04 109.356 168.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 62.9 mt -86.81 26.3 1.15 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.983 0.913 . . . . 73.32 111.792 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -71.21 95.67 1.3 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.373 -0.602 . . . . 62.52 109.373 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.23 162.82 26.29 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.669 0.787 . . . . 70.52 111.68 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -87.56 173.29 9.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.171 0.988 . . . . 63.44 111.433 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.28 134.84 20.93 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.919 0.888 . . . . 72.52 109.339 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.58 148.8 18.68 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 111.759 -0.537 . . . . 53.52 111.759 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -165.75 112.42 0.91 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.534 0.734 . . . . 73.24 110.116 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -94.81 -149.18 25.3 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.159 -0.377 . . . . 71.44 112.159 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 88.3 m -146.95 126.47 13.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.288 0.635 . . . . 63.04 110.478 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.59 103.77 5.85 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.743 -0.836 . . . . 73.11 108.743 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -80.38 166.16 21.55 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.79 0.805 . . . . 74.04 112.741 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -118.81 106.99 13.08 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 113.854 -1.521 . . . . 71.33 109.39 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -87.56 89.28 7.93 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.2 0.524 . . . . 64.24 110.056 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.8 155.59 20.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.167 0.987 . . . . 72.13 110.581 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 123.721 0.808 . . . . 75.41 109.721 -177.146 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.789 -0.449 . . . . 70.14 109.789 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.7 m -154.36 169.09 24.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.872 0.869 . . . . 71.42 110.26 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -138.9 88.49 2.29 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.332 -1.358 . . . . 52.54 107.332 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.19 142.3 45.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.547 0.739 . . . . 72.43 109.592 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -60.63 -41.41 94.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.189 0.596 . . . . 73.33 111.669 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -70.41 128.19 35.34 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.22 0.325 . . . . 62.14 110.216 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 35.4 p -132.36 94.8 3.51 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.485 1.114 . . . . 71.04 108.581 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.57 139.84 45.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.97 0.908 . . . . 72.04 110.365 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.3 tmm? 65.7 115.23 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.391 1.476 . . . . 75.34 112.222 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.1 m -100.14 92.07 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.816 0.846 . . . . 73.32 109.36 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.716 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 49.0 t80 -92.01 145.78 24.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.799 -0.815 . . . . 60.13 108.799 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.01 132.2 4.8 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.844 -0.798 . . . . 72.12 108.844 167.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -70.88 134.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 109.17 -0.678 . . . . 70.04 109.17 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -103.19 -45.13 5.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.488 -0.56 . . . . 73.25 109.488 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.536 HH12 HG23 ' G' ' 301' ' ' ILE . 29.8 ttt85 -169.09 147.0 3.75 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.999 -0.546 . . . . 74.43 109.73 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -130.02 136.22 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.328 -1.36 . . . . 75.31 107.328 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.558 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.2 p90 -171.22 154.1 3.88 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.418 0.627 . . . . 71.41 111.258 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -77.95 109.26 11.84 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.237 -1.023 . . . . 72.34 108.237 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -70.28 -45.55 66.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.74 0.781 . . . . 72.42 108.945 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.9 t70 -138.09 141.53 40.24 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.362 -1.29 . . . . 71.23 109.318 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.9 mt -136.16 142.71 37.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.718 1.607 . . . . 72.2 106.686 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -155.92 150.91 26.4 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.298 0.57 . . . . 62.13 110.987 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.466 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -152.45 121.61 6.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.595 -1.184 . . . . 75.52 107.842 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 72.41 109.157 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -137.1 86.18 20.83 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.453 -0.943 . . . . 51.13 108.453 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.27 -39.08 10.72 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.386 2.057 . . . . 75.44 111.316 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -99.26 33.77 2.34 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.188 0.995 . . . . 75.31 110.035 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.483 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -59.78 -51.9 77.63 Favored Pre-proline 0 CA--C 1.569 1.689 0 C-N-CA 124.615 1.166 . . . . 62.22 114.128 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 4.4 Cg_exo -74.85 -26.95 10.74 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.718 1.612 . . . . 71.42 111.37 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -66.03 -18.34 65.28 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.138 1.375 . . . . 71.55 112.166 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -54.71 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 N-CA-C 113.324 0.861 . . . . 55.0 113.324 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -68.25 -26.4 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.974 0.416 . . . . 74.14 111.886 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.44 30.95 6.67 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.508 1.123 . . . . 70.11 109.683 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.631 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -95.32 137.07 34.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.175 0.99 . . . . 73.0 108.7 171.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.73 130.37 42.14 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.576 -0.898 . . . . 73.23 108.576 170.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -83.79 66.59 9.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.109 0.564 . . . . 74.54 111.238 -170.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -165.7 78.34 1.22 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.543 0.737 . . . . 53.5 109.824 172.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' F' ' 295' ' ' ALA . 12.3 Cg_exo -73.29 163.4 38.0 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.716 2.277 . . . . 74.2 112.941 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -86.85 76.61 9.41 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 107.269 -1.382 . . . . 74.51 107.269 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.651 HG21 ' H ' ' F' ' 296' ' ' THR . 64.1 t -73.7 97.96 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.234 -1.348 . . . . 71.34 108.468 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' F' ' 290' ' ' TRP . 98.8 mttt -133.22 128.21 35.42 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.105 0.962 . . . . 73.24 108.757 -175.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.616 ' HG ' HD21 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -89.41 161.86 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.701 0.626 . . . . 75.53 109.999 175.494 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.5 t70 -139.12 141.58 38.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.307 1.043 . . . . 72.04 108.703 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -112.36 113.02 25.01 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.241 0.616 . . . . 75.02 109.455 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.4 t70 -114.89 142.01 47.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.484 -0.932 . . . . 71.34 108.484 172.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.4 p -128.39 136.94 51.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.915 0.486 . . . . 75.53 110.335 -172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 167.29 24.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 62.41 109.347 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -159.18 164.37 35.19 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.341 0.656 . . . . 65.03 111.365 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 92.3 p -145.91 155.23 42.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.008 0.923 . . . . 75.51 109.791 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -101.72 114.76 29.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.892 -0.781 . . . . 63.13 108.892 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.613 HD11 HD12 ' C' ' 83' ' ' ILE . 39.5 mt -94.06 -32.52 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.635 0.774 . . . . 74.11 110.456 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.92 -170.2 1.3 Allowed 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.001 0.92 . . . . 71.14 110.219 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.7 111.92 2.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.791 0.836 . . . . 73.31 109.417 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.3 -5.56 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.37 1.468 . . . . 73.54 112.88 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.19 94.87 5.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 106.935 -1.505 . . . . 75.33 106.935 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -114.0 124.36 51.94 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.72 -1.127 . . . . 74.33 108.442 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.2 tt0 -82.62 125.15 30.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.871 -0.788 . . . . 64.21 108.871 176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.99 118.52 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 73.34 108.669 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 72.5 t -102.9 127.76 56.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 107.696 -1.224 . . . . 74.41 107.696 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -129.44 94.5 3.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.993 -1.484 . . . . 70.03 106.993 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.47 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.9 ttm180 -82.67 121.69 27.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.717 -0.674 . . . . 70.31 109.211 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' C' ' 114' ' ' ILE . 18.3 t -115.72 117.63 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.735 -1.209 . . . . 42.14 107.735 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 41.1 m -110.35 137.76 47.63 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.259 -1.015 . . . . 73.43 108.259 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' C' ' 114' ' ' ILE . 97.8 t -120.64 109.93 26.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.332 -0.988 . . . . 71.41 108.332 170.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -99.55 140.64 33.43 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.863 -0.792 . . . . 73.23 108.863 171.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.64 97.28 3.23 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -141.64 146.25 35.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.169 0.588 . . . . 62.12 109.765 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.47 36.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.664 1.186 . . . . 70.1 108.819 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.48 -111.75 3.25 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.059 -1.216 . . . . 60.24 110.059 -168.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.77 -19.6 23.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.773 0.829 . . . . 71.12 110.415 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -78.0 84.43 4.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.298 1.039 . . . . 71.23 109.712 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -73.09 126.97 31.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.159 -0.473 . . . . 62.43 110.853 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.631 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -74.48 -52.14 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.748 0.819 . . . . 53.22 109.039 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.426 ' HZ ' HG21 ' F' ' 296' ' ' THR . 55.8 p90 -170.56 175.68 4.6 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.128 -1.396 . . . . 72.32 109.237 173.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.463 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.991 -1.485 . . . . 75.24 106.991 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.463 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.2 t -148.47 150.01 32.69 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.814 -0.81 . . . . 62.3 108.814 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -158.28 133.53 8.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.953 0.501 . . . . 71.34 109.829 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.07 115.45 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.939 0.896 . . . . 65.3 109.044 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.4 mt-30 -90.39 90.49 8.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.426 -0.953 . . . . 65.33 108.426 173.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.1 tp60 -80.12 116.61 20.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.541 -1.209 . . . . 62.4 110.364 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 149.56 18.48 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 112.065 -0.414 . . . . 50.43 112.065 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.503 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.22 117.64 0.94 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.53 -1.028 . . . . 75.43 110.53 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.613 HD12 HD11 ' C' ' 51' ' ' LEU . 15.7 mm -80.89 114.66 22.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.963 -1.125 . . . . 72.14 107.963 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.66 147.54 49.92 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.87 0.468 . . . . 42.23 109.935 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.9 m -106.99 113.37 26.81 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.24 106.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 107.969 -1.123 . . . . 74.42 107.969 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -123.35 170.27 10.49 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.977 0.911 . . . . 74.13 110.659 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.12 -60.16 1.97 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.103 -0.499 . . . . 74.24 113.031 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' C' ' 94' ' ' MET . 1.3 pp -99.39 171.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.158 0.583 . . . . 63.43 111.966 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.93 -177.52 5.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.403 1.081 . . . . 73.15 109.026 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.46 -130.11 49.43 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 123.758 0.694 . . . . 74.42 114.747 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -70.13 -25.99 63.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.215 1.006 . . . . 53.31 111.543 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.48 -31.36 57.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.325 0.65 . . . . 71.3 110.251 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.594 ' HA ' HD13 ' C' ' 89' ' ' ILE . 0.7 OUTLIER -74.06 -42.29 60.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.326 -0.62 . . . . 65.14 109.326 172.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' F' ' 280' ' ' LEU . . . -64.04 -24.94 67.9 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.181 0.926 . . . . 51.51 112.057 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -69.88 -51.12 35.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.661 0.384 . . . . 75.52 110.412 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.28 -32.43 68.67 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.266 0.626 . . . . 44.15 111.438 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.13 -53.83 10.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.087 0.955 . . . . 65.4 109.36 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 -29.0 64.48 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.506 -1.225 . . . . 41.14 114.118 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -114.0 -45.65 3.06 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.461 0.63 . . . . 72.31 111.569 -168.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.422 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 22.0 t80 -76.36 -43.55 40.38 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 111.567 0.21 . . . . 61.21 111.567 -174.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -66.23 -45.69 61.13 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-O 118.446 -0.788 . . . . 74.11 112.913 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.38 -35.11 99.06 Favored 'Trans proline' 0 C--N 1.401 3.292 0 C-N-CA 122.316 2.011 . . . . 74.25 113.417 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.86 -36.17 76.32 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.005 0.922 . . . . 72.4 110.725 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -74.76 -46.22 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.506 0.722 . . . . 74.5 111.091 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.503 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -78.7 -20.26 50.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.733 0.642 . . . . 72.34 112.733 -170.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.406 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.8 t80 -58.26 -52.68 72.82 Favored Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 124.5 1.12 . . . . 74.2 113.242 -175.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 33.0 Cg_exo -61.32 -37.09 75.47 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.976 1.784 . . . . 73.14 112.964 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.58 -39.55 80.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.578 0.751 . . . . 73.44 111.682 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.78 81.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.306 -0.406 . . . . 52.2 110.347 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -58.09 -63.26 1.32 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 62.34 111.469 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -30.99 72.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.334 0.397 . . . . 43.44 110.524 -173.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.435 ' O ' ' SD ' ' C' ' 117' ' ' MET . 34.3 t -66.52 -41.26 89.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.334 0.654 . . . . 74.13 111.362 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' C' ' 64' ' ' VAL . 67.1 mt -65.49 -48.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.231 0.613 . . . . 70.41 110.041 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.2 m -60.77 -29.36 69.36 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.87 -1.059 . . . . 72.02 110.848 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.81 -47.05 67.06 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.143 0.977 . . . . 74.01 110.356 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.522 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.59 -45.19 89.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.327 0.651 . . . . 75.31 111.905 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.51 -39.05 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.493 0.717 . . . . 60.53 110.534 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.654 ' HA ' HE22 ' B' ' 125' ' ' GLN . 80.6 p -74.01 -29.24 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.749 -0.66 . . . . 74.14 112.144 -176.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.44 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 74.1 mtt-85 -75.44 -31.37 60.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.941 0.897 . . . . 72.12 110.75 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.09 -2.47 62.26 Favored Glycine 0 C--N 1.356 1.656 0 O-C-N 123.485 0.491 . . . . 65.32 112.427 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 63.74 27.93 14.78 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 126.692 1.997 . . . . 74.2 111.674 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -99.22 142.86 25.36 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 114.506 -1.225 . . . . 75.22 108.915 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.66 124.13 13.76 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.248 2.632 . . . . 63.42 112.768 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.553 HE21 ' HB3' ' C' ' 119' ' ' SER . 97.7 mt-30 -59.84 154.6 18.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.27 1.211 . . . . 61.2 114.27 -172.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp -127.89 119.98 26.75 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.531 -1.213 . . . . 74.11 108.635 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -98.97 130.12 45.31 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.111 -1.07 . . . . 65.04 108.111 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.616 HD21 ' HG ' ' C' ' 42' ' ' LEU . 0.2 OUTLIER -74.85 128.21 35.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 109.446 -0.576 . . . . 61.32 109.446 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' H' ' 306' ' ' VAL . . . -66.56 137.52 95.22 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.869 0.868 . . . . 44.2 110.708 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.498 ' HG2' HG21 ' H' ' 306' ' ' VAL . 10.0 Cg_endo -51.64 103.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.38 2.72 . . . . 60.23 111.757 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.24 110.34 24.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.118 -1.067 . . . . 74.13 108.118 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.621 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 11.2 m120 -77.6 83.73 3.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.912 -1.04 . . . . 64.23 111.18 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.504 ' CZ ' ' HG3' ' F' ' 286' ' ' MET . 0.3 OUTLIER -69.9 -43.55 71.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.303 -1.317 . . . . 70.15 107.803 171.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.636 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.4 p-10 -54.39 -50.33 67.82 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.12 -1.855 . . . . 74.41 112.118 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -67.63 -35.26 78.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.384 0.673 . . . . 74.52 112.002 -171.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 tp -55.36 -43.93 75.52 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 124.112 0.883 . . . . 74.44 110.395 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -80.65 -18.6 47.56 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.098 -0.956 . . . . 72.3 112.329 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 67.1 mtt -75.24 -50.34 16.44 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.751 0.42 . . . . 73.52 110.692 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -70.76 -36.89 73.32 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.344 0.402 . . . . 73.02 111.048 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -66.44 -84.36 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.632 0.773 . . . . 72.01 111.019 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.21 96.17 6.46 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.573 -0.899 . . . . 74.04 108.573 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -76.62 122.62 24.9 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.873 0.869 . . . . 45.35 110.079 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -126.13 174.55 8.41 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.371 1.069 . . . . 75.21 109.615 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -69.19 122.17 18.27 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.543 -0.91 . . . . 74.0 108.543 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.37 90.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.136 0.974 . . . . 73.04 112.725 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.03 117.84 2.19 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 120.293 -0.171 . . . . 71.53 112.9 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -114.22 153.52 29.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.166 0.986 . . . . 74.21 109.17 173.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.54 37.37 0.03 OUTLIER Glycine 0 C--N 1.344 0.989 0 CA-C-O 120.109 -0.273 . . . . 65.42 112.621 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 89.0 m -75.32 95.79 3.26 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 121.507 0.67 . . . . 63.31 109.89 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.37 148.55 51.84 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.422 1.089 . . . . 64.35 109.971 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -149.74 112.53 4.8 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.389 0.676 . . . . 71.24 109.576 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -132.77 118.84 19.54 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.523 -1.288 . . . . 74.33 107.523 168.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -120.45 130.17 54.2 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.138 -1.06 . . . . 74.52 108.138 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -117.08 112.38 20.82 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.454 -0.943 . . . . 63.42 108.454 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 N-CA-C 108.306 -0.998 . . . . 65.1 108.306 174.04 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.024 -0.362 . . . . 65.23 110.024 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 57.6 m -86.09 54.0 2.99 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.572 0.749 . . . . 73.14 110.916 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -138.11 176.96 8.25 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.242 1.017 . . . . 74.35 108.419 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -160.74 142.38 12.22 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.652 -1.24 . . . . 73.45 107.652 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -132.96 168.69 18.0 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.868 0.467 . . . . 54.31 111.476 -172.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -168.53 142.64 3.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.484 1.114 . . . . 63.33 108.607 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -86.04 -59.56 2.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.327 0.651 . . . . 64.35 110.018 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.78 -31.63 1.03 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.833 0.853 . . . . 74.21 109.9 172.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 7.9 ttp -33.87 134.29 0.17 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.126 1.37 . . . . 72.12 112.342 167.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.3 m -139.39 137.95 36.13 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.888 -0.782 . . . . 62.34 108.888 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -164.57 91.7 0.59 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.144 -1.428 . . . . 74.01 107.144 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -119.73 115.39 23.8 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.869 -0.789 . . . . 74.22 108.869 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.435 HG21 HD11 ' D' ' 16' ' ' ILE . 13.5 mt -74.94 122.95 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.473 -0.936 . . . . 73.25 108.473 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.455 ' HA ' HG11 ' F' ' 306' ' ' VAL . 74.8 mt-30 -88.51 -49.02 7.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.935 0.334 . . . . 74.11 110.559 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -156.43 147.33 21.98 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.629 0.772 . . . . 74.33 109.837 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.435 HD11 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -117.81 122.82 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 105.582 -2.007 . . . . 72.32 105.582 161.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.483 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 32.8 p90 -152.23 162.08 41.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.926 0.869 . . . . 74.5 110.361 -171.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -90.02 114.64 26.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.184 -1.371 . . . . 63.51 109.424 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -82.69 -23.8 33.96 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.793 -0.64 . . . . 71.1 109.406 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -152.29 142.17 22.06 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.794 1.238 . . . . 65.11 109.11 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.522 HD13 ' HE3' ' C' ' 117' ' ' MET . 50.4 mt -138.69 142.13 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.187 1.395 . . . . 64.1 107.398 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.74 103.8 1.92 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.225 0.61 . . . . 73.53 110.476 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -109.68 120.37 42.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.114 -1.439 . . . . 75.04 107.114 166.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -124.72 120.02 30.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.457 0.703 . . . . 75.32 109.454 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 82.39 5.06 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 108.0 -1.111 . . . . 64.42 108.0 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -28.31 11.88 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.536 2.157 . . . . 65.42 112.77 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -116.52 40.85 2.8 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.21 1.004 . . . . 74.44 108.91 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.46 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -59.76 -68.99 0.6 Allowed Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 117.628 -1.177 . . . . 62.14 113.791 -170.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.26 -14.32 23.05 Favored 'Trans proline' 0 C--N 1.39 2.761 0 CA-C-N 123.144 2.159 . . . . 73.42 112.022 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -68.6 -43.48 76.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.004 1.322 . . . . 75.21 110.313 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.46 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.6 p -72.73 -33.08 43.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-O 119.136 -0.459 . . . . 61.32 110.245 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -61.83 -4.52 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.4 0.889 . . . . 71.31 113.4 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -84.28 -38.63 20.21 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.636 0.774 . . . . 73.44 110.578 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -128.58 61.0 1.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.374 1.07 . . . . 61.34 109.287 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' D' ' 31' ' ' VAL . 32.0 t0 -113.62 93.74 4.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.482 0.658 . . . . 60.31 110.858 -171.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.521 ' H ' HD11 ' D' ' 68' ' ' LEU . 40.3 m95 -126.09 -158.04 0.83 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 106.636 -1.616 . . . . 71.31 106.636 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' G' ' 297' ' ' TYR . 0.0 OUTLIER -57.05 112.95 5.23 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-N 119.34 0.973 . . . . 72.13 110.934 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' G' ' 296' ' ' THR . 54.2 Cg_endo -74.25 135.14 20.18 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.715 1.61 . . . . 71.25 111.338 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -64.98 113.31 3.78 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 107.089 -1.448 . . . . 62.13 107.089 165.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -104.9 142.64 17.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.691 0.796 . . . . 55.44 110.42 -173.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.51 127.52 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.059 1.343 . . . . 61.12 108.006 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.43 111.87 23.95 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.721 -1.585 . . . . 55.42 106.721 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.79 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.3 m-20 -106.4 128.18 53.84 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.163 -1.051 . . . . 63.51 108.163 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.19 140.25 48.09 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.282 -0.636 . . . . 74.13 109.282 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.7 t70 -140.98 130.76 24.27 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.093 -1.077 . . . . 53.15 108.093 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -104.63 143.7 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.623 0.769 . . . . 65.52 110.808 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.678 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.77 151.87 30.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.632 0.773 . . . . 63.21 109.808 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.7 p -157.08 157.72 35.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.976 0.51 . . . . 43.1 109.745 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.2 p -153.06 154.29 34.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.665 0.786 . . . . 44.34 109.336 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -97.1 121.12 38.63 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.078 -1.453 . . . . 74.53 107.078 164.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.0 -30.05 17.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.77 0.428 . . . . 74.32 110.383 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.73 -173.99 1.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.59 0.756 . . . . 73.44 111.008 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.0 123.93 20.75 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.929 -1.032 . . . . 72.32 108.995 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 66.86 10.89 7.95 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.575 1.15 . . . . 73.21 112.09 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.9 t -123.5 123.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.151 -0.685 . . . . 61.31 109.151 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.68 149.61 51.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.801 0.84 . . . . 74.44 109.077 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -119.49 133.56 55.63 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.788 0.835 . . . . 75.34 109.733 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.49 112.63 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.689 -1.226 . . . . 64.44 107.689 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.0 t -101.76 127.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.774 -1.195 . . . . 72.23 107.774 172.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 59.3 tp -124.15 111.63 16.13 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.85 -0.796 . . . . 74.54 108.85 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.72 ' HB2' ' HG2' ' D' ' 79' ' ' GLN . 16.3 ttp180 -84.74 108.25 17.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.054 -0.976 . . . . 75.32 109.481 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.42 129.44 48.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.704 -1.221 . . . . 62.13 107.704 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.79 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.1 m -126.76 136.85 52.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.565 -0.902 . . . . 62.21 108.565 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.408 HG11 HD13 ' D' ' 126' ' ' LEU . 84.6 t -121.17 109.8 26.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.926 0.891 . . . . 52.35 108.706 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -93.03 118.99 31.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.161 -1.051 . . . . 71.11 108.161 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.29 129.49 56.64 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.658 -0.497 . . . . 75.45 109.658 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 68.1 m -134.75 128.12 32.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.842 0.857 . . . . 61.15 109.677 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.521 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.3 OUTLIER -92.04 92.38 8.25 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.019 0.528 . . . . 61.3 109.925 177.368 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.27 -125.48 10.74 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.332 -0.849 . . . . 73.14 111.351 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.05 9.08 18.24 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.578 0.751 . . . . 74.15 111.334 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -115.82 155.18 28.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.931 0.892 . . . . 72.14 109.918 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.1 m -82.32 136.21 35.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.556 -0.535 . . . . 74.4 109.556 168.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.433 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.59 -68.07 0.78 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -155.43 167.65 29.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.401 -1.272 . . . . 64.22 109.974 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.0 mt -133.05 142.99 49.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.946 1.299 . . . . 64.43 107.65 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.54 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.0 t -145.66 136.24 24.23 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.37 -0.604 . . . . 65.43 109.37 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.18 134.9 11.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.147 0.579 . . . . 74.23 110.514 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.69 122.99 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.658 0.783 . . . . 63.32 109.759 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.72 ' HG2' ' HB2' ' D' ' 61' ' ' ARG . 50.1 mt-30 -89.04 89.45 7.98 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.763 -0.829 . . . . 71.51 108.763 168.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.62 96.63 8.16 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.965 -1.016 . . . . 72.53 109.158 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.65 142.46 17.15 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.358 -0.697 . . . . 25.32 111.358 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.33 128.65 4.59 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.342 -1.103 . . . . 53.53 110.342 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.8 mt -90.73 128.23 42.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.846 -0.798 . . . . 74.34 108.846 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.406 ' HD2' HG12 ' D' ' 13' ' ' ILE . 27.4 m-85 -133.96 124.82 26.98 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.304 0.642 . . . . 70.33 109.606 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -77.4 93.94 4.16 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.855 -0.794 . . . . 73.34 108.855 171.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.11 125.94 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.555 0.742 . . . . 72.32 110.359 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.88 158.1 34.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.049 0.939 . . . . 71.44 109.924 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.97 -20.64 41.38 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-O 119.911 -0.383 . . . . 74.04 113.684 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.08 142.24 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.561 -0.903 . . . . 52.41 108.561 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -136.69 156.59 48.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.285 0.634 . . . . 72.32 111.883 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.61 -125.75 35.98 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 124.58 1.175 . . . . 75.33 115.055 166.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.33 -32.61 73.68 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.392 1.077 . . . . 71.52 112.127 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.68 -28.57 40.72 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.032 0.533 . . . . 75.22 110.499 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.616 ' HG3' ' HB3' ' G' ' 277' ' ' LEU . 0.1 OUTLIER -77.55 -33.28 54.18 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.069 -0.715 . . . . 74.2 109.069 173.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' G' ' 280' ' ' LEU . . . -65.94 -30.91 71.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.828 0.851 . . . . 72.3 110.695 173.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 10.5 t60 -66.09 -52.24 50.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 73.34 109.093 169.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.09 -35.27 78.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.849 0.46 . . . . 73.44 112.003 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' G' ' 281' ' ' PHE . 1.1 tm? -85.04 -40.33 16.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.046 0.938 . . . . 72.42 110.223 -173.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.13 11.72 58.69 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.165 -0.47 . . . . 64.24 113.9 -173.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -144.44 -57.6 0.36 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.463 0.632 . . . . 70.14 112.073 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -73.66 -61.01 1.99 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.62 0.368 . . . . 75.15 111.287 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -56.04 -44.08 99.53 Favored Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 124.404 1.082 . . . . 64.53 113.758 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.3 -40.47 68.08 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 122.338 2.025 . . . . 74.35 112.691 173.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.5 t30 -68.4 -26.57 65.61 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.576 0.75 . . . . 71.33 111.494 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -69.52 -50.87 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.948 0.499 . . . . 72.3 110.624 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.73 -12.89 52.84 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.759 -0.655 . . . . 44.41 112.243 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -62.24 -43.79 86.63 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.174 0.99 . . . . 63.31 113.635 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.67 -33.19 68.43 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.197 1.932 . . . . 61.54 113.912 172.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -79.14 -35.58 41.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.432 0.693 . . . . 74.32 110.708 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.97 82.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.439 0.696 . . . . 62.23 110.448 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.683 HH12 ' HB3' ' D' ' 130' ' ' PRO . 31.6 ttp180 -56.27 -50.37 71.56 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.322 -1.308 . . . . 53.22 110.627 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.17 -32.33 73.97 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.119 0.968 . . . . 74.21 111.501 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.44 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -70.35 -44.98 67.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.962 0.505 . . . . 63.13 111.021 176.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.54 HG23 ' SG ' ' D' ' 76' ' ' CYS . 61.8 mt -56.9 -54.79 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.408 1.083 . . . . 72.21 110.826 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -53.77 -45.72 70.75 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.083 1.353 . . . . 74.12 111.677 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.5 t -63.52 -43.39 97.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.429 -1.259 . . . . 64.13 110.842 -176.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.413 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 74.2 mtm -68.93 -36.04 77.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.879 0.472 . . . . 71.25 111.817 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.7 t -61.21 -45.14 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.76 -0.654 . . . . 72.43 109.897 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -71.25 -28.2 64.0 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.116 0.566 . . . . 75.13 111.498 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.0 mtt-85 -72.42 -28.69 63.12 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.709 0.804 . . . . 53.51 111.208 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.7 11.45 59.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.678 -0.512 . . . . 74.31 112.916 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.558 HG23 ' HB3' ' C' ' 17' ' ' TYR . 32.6 p 65.44 17.74 11.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 126.689 1.996 . . . . 62.03 113.215 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -93.52 159.39 35.1 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.197 0.999 . . . . 74.53 108.524 173.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.902 ' HG3' ' HA ' ' G' ' 297' ' ' TYR . 71.8 Cg_endo -67.86 127.6 16.42 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.648 2.232 . . . . 75.43 111.342 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -53.38 120.81 6.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 123.761 0.663 . . . . 52.55 110.483 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.408 HD13 HG11 ' D' ' 64' ' ' VAL . 5.1 tt -104.04 102.52 12.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.427 -1.323 . . . . 62.24 107.427 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -94.84 85.09 4.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.195 -1.039 . . . . 72.24 108.195 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.538 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 33.0 tp -61.25 123.19 17.02 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.377 -1.738 . . . . 71.55 111.347 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.85 133.13 89.46 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 123.919 0.888 . . . . 64.13 111.645 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.683 ' HB3' HH12 ' D' ' 111' ' ' ARG . 90.3 Cg_endo -82.86 134.23 7.14 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.292 1.995 . . . . 74.25 112.478 -169.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.428 HG22 HD11 ' G' ' 291' ' ' LEU . 44.3 t -108.04 110.06 30.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.466 -0.939 . . . . 74.41 108.466 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 50.8 t30 -89.6 93.49 9.5 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.113 -0.699 . . . . 62.0 109.113 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.5 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 76.4 m-85 -65.86 -30.5 71.12 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.242 -0.89 . . . . 72.44 110.479 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.439 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.4 t70 -58.6 -42.22 87.62 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.103 0.961 . . . . 71.01 110.284 -178.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.495 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -60.55 -46.57 89.71 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.717 -1.128 . . . . 41.05 111.25 175.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 72.7 mt -56.62 -47.59 79.33 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.819 0.699 . . . . 75.32 111.593 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -69.29 -39.58 78.24 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 122.904 0.482 . . . . 71.24 112.085 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 18.5 ptp -73.74 -29.74 62.41 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 117.839 0.29 . . . . 75.02 111.283 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -75.33 -9.59 58.69 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.083 0.953 . . . . 65.24 111.781 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -65.07 -38.78 91.91 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 109.474 -0.565 . . . . 70.02 109.474 164.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 mp -83.39 -55.64 4.2 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.934 0.894 . . . . 73.41 112.297 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -91.93 35.98 0.97 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.266 1.21 . . . . 74.13 114.266 -162.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -117.64 75.49 0.99 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.0 0.905 . . . . 63.44 109.345 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -160.46 19.34 0.14 Allowed 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 113.921 -1.49 . . . . 65.21 109.263 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.3 108.29 7.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.775 0.83 . . . . 53.41 110.43 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.0 106.77 1.48 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 109.932 -1.267 . . . . 23.32 109.932 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -118.87 -84.08 0.65 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 117.201 0.501 . . . . 74.13 111.773 -170.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.71 89.28 0.57 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.346 -0.388 . . . . 73.14 112.841 -166.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.9 t -155.8 93.77 1.49 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.867 0.841 . . . . 60.44 110.017 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.45 -31.27 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.299 -0.864 . . . . 65.1 111.065 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -97.84 48.52 1.01 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.386 0.612 . . . . 72.25 109.933 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -73.42 100.52 3.24 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.196 -0.911 . . . . 61.22 108.733 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -59.3 136.87 58.1 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.043 0.937 . . . . 63.34 110.759 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.48 -43.26 99.25 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.961 0.788 . . . . 71.21 109.998 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-N 114.602 -1.181 . . . . 54.14 107.909 176.312 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.947 -0.39 . . . . 73.4 109.947 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 49.5 t30 65.48 -76.05 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.417 1.487 . . . . 61.02 111.507 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 60.76 75.43 0.41 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 124.945 1.298 . . . . 74.13 110.845 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -103.2 128.44 50.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.827 -1.175 . . . . 64.42 107.827 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -80.03 167.09 36.12 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.787 0.835 . . . . 73.11 109.949 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.57 143.83 97.86 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 121.776 1.651 . . . . 71.43 109.885 164.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 277' ' ' LEU . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 7.9 mp -71.51 -177.44 1.84 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.778 0.431 . . . . 41.15 110.681 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 278' ' ' LEU . . . . . 0.514 HD23 ' HE1' ' A' ' 94' ' ' MET . 40.1 mt 75.88 -172.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.675 1.59 . . . . 73.53 110.022 -174.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . 125.65 -49.67 0.9 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.558 -0.617 . . . . 64.33 111.558 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.496 ' H ' HD23 ' E' ' 280' ' ' LEU . 2.2 pt? -121.08 125.14 46.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.584 0.753 . . . . 61.33 109.369 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -172.7 48.33 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.48 1.112 . . . . 73.4 108.531 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -132.77 172.19 12.89 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.015 -0.993 . . . . 73.44 110.325 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 28.1 t70 67.27 131.1 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.47 1.508 . . . . 74.54 111.25 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -59.73 107.16 1.17 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.358 -0.697 . . . . 70.34 111.358 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 285' ' ' ASN . . . . . 0.463 ' HB2' ' SD ' ' E' ' 286' ' ' MET . 14.3 m120 -62.81 -35.54 80.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.046 0.938 . . . . 74.32 111.306 -176.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 286' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' E' ' 285' ' ' ASN . 0.0 OUTLIER -143.73 134.89 12.55 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.457 1.103 . . . . 75.51 108.861 174.309 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.53 92.95 0.67 Allowed 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.474 2.116 . . . . 73.3 110.394 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.17 -55.81 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.113 -0.949 . . . . 61.52 110.614 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 56.92 -83.68 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.915 1.286 . . . . 73.32 110.292 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -168.83 155.28 6.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.333 1.853 . . . . 74.43 107.846 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.625 HD13 ' HB3' ' A' ' 129' ' ' ALA . 5.5 mp -106.22 119.9 40.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.794 0.438 . . . . 73.14 110.007 -175.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.48 162.45 33.19 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.517 -0.765 . . . . 64.34 111.475 -169.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.29 83.91 1.2 Allowed 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 122.355 2.037 . . . . 65.41 111.153 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt 62.09 107.59 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.31 1.444 . . . . 63.45 110.448 -174.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -100.29 -1.01 37.37 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.179 0.807 . . . . 55.52 113.179 -173.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 40.8 m -147.46 142.79 27.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.643 0.377 . . . . 64.32 110.887 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 1.1 t80 71.29 95.38 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.022 1.329 . . . . 74.52 110.296 168.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -131.7 -43.09 1.01 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.103 0.561 . . . . 75.33 111.236 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -154.65 62.53 0.36 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 110.631 -0.988 . . . . 71.22 110.631 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 300' ' ' ASN . . . . . 0.405 HD21 ' HB2' ' G' ' 302' ' ' ASP . 17.1 m120 -125.68 166.03 17.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.548 0.739 . . . . 74.14 111.085 -170.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 68.4 mt 70.97 138.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 125.638 1.575 . . . . 75.31 111.301 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 302' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' G' ' 298' ' ' HIS . 38.6 t70 -153.2 169.55 22.73 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 122.748 0.419 . . . . 65.43 110.094 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 303' ' ' LYS . . . . . 0.566 ' HD2' ' H ' ' E' ' 303' ' ' LYS . 10.3 mptt -60.08 141.14 90.45 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 125.361 1.464 . . . . 73.12 110.665 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -67.48 -51.59 0.7 Allowed 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.347 2.032 . . . . 71.34 112.611 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . 46.84 67.95 0.7 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.123 1.369 . . . . 62.15 112.057 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.3 28.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 122.778 1.275 . . . . 72.54 108.484 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 31.3 p -73.66 87.01 1.66 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.541 -1.209 . . . . 74.13 109.293 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 26.7 p -157.72 -22.1 0.09 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.145 -0.934 . . . . 65.25 110.79 -171.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' E' E ' 309' ' ' THR . . . . . 0.542 HG22 HD13 ' G' ' 291' ' ' LEU . 17.0 p -66.8 151.31 96.92 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.034 1.334 . . . . 64.42 111.797 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo . . . . . 0 C--N 1.378 2.122 0 C-N-CA 123.507 2.805 . . . . 74.43 112.874 176.129 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.035 -0.358 . . . . 71.02 110.035 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -66.52 132.5 48.37 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.738 0.815 . . . . 64.33 110.946 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -108.3 157.66 18.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.868 0.867 . . . . 64.34 109.385 173.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -119.42 -55.57 2.12 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.469 0.707 . . . . 63.42 110.635 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -159.35 87.05 2.13 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.496 0.718 . . . . 74.5 109.432 -170.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -89.28 141.67 4.17 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.469 2.113 . . . . 74.12 112.324 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 277' ' ' LEU . . . . . 0.519 ' HB3' ' HG3' ' C' ' 94' ' ' MET . 6.2 mp -70.19 -24.42 63.12 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.66 0.784 . . . . 74.13 109.097 170.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.37 123.07 17.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.346 1.458 . . . . 74.53 110.813 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -177.89 90.74 0.08 OUTLIER Glycine 0 C--N 1.351 1.411 0 O-C-N 123.35 0.406 . . . . 63.31 113.169 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 280' ' ' LEU . . . . . 0.48 HD12 ' HB1' ' C' ' 95' ' ' ALA . 6.8 tt -171.49 -58.31 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.395 -0.965 . . . . 62.11 108.395 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -71.35 86.36 0.82 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.294 -0.867 . . . . 73.44 111.729 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -169.34 -61.22 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.493 -1.299 . . . . 75.54 107.493 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.76 -34.66 11.83 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.051 -0.977 . . . . 54.42 110.262 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.05 71.0 2.97 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.641 0.588 . . . . 55.35 112.945 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -68.64 -41.85 78.82 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.447 1.099 . . . . 73.43 111.489 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 286' ' ' MET . . . . . 0.504 ' HG3' ' CZ ' ' C' ' 133' ' ' PHE . 20.3 mmt 60.39 89.23 0.11 Allowed Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.705 1.202 . . . . 73.31 109.124 -167.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.02 84.31 0.25 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.966 2.444 . . . . 75.32 112.516 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.05 120.88 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.878 -1.156 . . . . 62.35 107.878 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -123.56 175.94 6.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.109 0.964 . . . . 75.23 108.739 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 290' ' ' TRP . . . . . 0.501 ' HB2' ' HA ' ' C' ' 41' ' ' LYS . 2.0 t-105 -55.84 130.64 44.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.128 0.971 . . . . 74.33 111.556 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.07 -0.28 27.42 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.424 0.898 . . . . 71.11 113.424 -165.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 169.01 -134.61 3.27 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.395 -0.67 . . . . 42.52 112.446 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -87.64 -161.9 0.13 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.443 2.762 . . . . 74.31 112.406 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 11.3 mptt 76.2 164.37 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.035 1.334 . . . . 63.33 112.419 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 295' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' C' ' 38' ' ' PRO . . . -158.42 173.1 17.16 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.997 -1.001 . . . . 64.23 110.132 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 296' ' ' THR . . . . . 0.651 ' H ' HG21 ' C' ' 40' ' ' VAL . 40.5 p -66.04 -52.99 44.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.753 0.821 . . . . 61.23 110.748 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -77.01 82.62 3.53 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.905 -1.146 . . . . 62.55 107.905 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -75.07 -46.14 36.74 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.184 0.594 . . . . 72.53 110.831 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 178.63 -52.64 0.09 OUTLIER Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.969 -0.559 . . . . 63.11 112.572 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -81.61 82.14 7.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.482 0.658 . . . . 72.22 111.13 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 6.1 tt -167.52 118.22 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.493 1.517 . . . . 73.1 107.042 169.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -134.57 -79.13 0.45 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.418 0.687 . . . . 64.05 109.441 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -116.98 152.67 48.99 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.994 0.918 . . . . 65.4 109.528 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.5 109.27 2.81 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.171 1.914 . . . . 54.02 111.853 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 305' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' H' ' 293' ' ' PRO . . . -75.33 93.52 2.9 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.177 -1.046 . . . . 73.55 108.177 169.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 306' ' ' VAL . . . . . 0.455 HG11 ' HA ' ' D' ' 14' ' ' GLN . 3.4 p -134.52 -29.15 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.436 1.094 . . . . 64.35 109.567 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 40.1 p -88.9 28.02 1.24 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.36 1.064 . . . . 73.24 111.336 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.28 13.48 13.33 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.099 0.96 . . . . 55.55 110.401 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 16.7 p -64.49 147.62 97.26 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 125.108 1.363 . . . . 73.15 112.56 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.39 2.747 0 C-N-CA 124.547 3.498 . . . . 74.12 114.409 -178.851 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.544 -0.169 . . . . 44.15 110.544 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -85.76 120.86 27.65 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.223 -0.658 . . . . 73.3 109.223 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -158.81 90.94 1.02 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.546 0.738 . . . . 75.51 109.963 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -85.26 64.06 8.45 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.388 0.613 . . . . 62.14 110.122 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -91.14 146.4 33.49 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.542 0.737 . . . . 63.42 110.01 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.66 87.99 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.764 2.31 . . . . 71.22 110.067 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.616 ' HB3' ' HG3' ' D' ' 94' ' ' MET . 71.6 mt -59.93 -48.17 82.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.486 0.714 . . . . 74.23 111.164 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.59 173.47 9.53 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.586 -0.734 . . . . 71.11 110.917 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 171.39 -57.13 0.18 Allowed Glycine 0 C--N 1.344 1.007 0 N-CA-C 110.845 -0.902 . . . . 74.31 110.845 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.548 ' HB3' ' HB1' ' D' ' 95' ' ' ALA . 7.2 tt -76.38 113.05 13.53 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.672 -0.862 . . . . 71.35 108.672 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 281' ' ' PHE . . . . . 0.462 ' HB2' HD12 ' D' ' 98' ' ' LEU . 39.2 t80 -170.92 -60.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.319 1.048 . . . . 64.24 108.328 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -97.66 25.55 5.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.888 -1.051 . . . . 50.0 109.306 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -123.29 138.23 54.67 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.997 0.919 . . . . 62.12 109.417 -171.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 73.87 -110.87 3.24 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.269 -0.732 . . . . 75.45 111.269 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -165.69 134.55 3.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.996 0.918 . . . . 55.4 109.739 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 96.5 mmm -123.51 80.64 54.14 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 124.463 1.105 . . . . 62.33 108.461 173.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -88.27 125.78 1.88 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.022 2.481 . . . . 72.44 113.627 -173.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.82 -26.43 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.111 0.964 . . . . 70.41 109.959 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 60.17 -88.8 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.461 1.504 . . . . 75.23 109.986 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.6 124.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 105.456 -2.053 . . . . 72.02 105.456 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.542 HD13 HG22 ' E' ' 309' ' ' THR . 89.7 mt -66.59 -50.37 63.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.564 0.346 . . . . 64.24 110.61 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -156.58 99.28 0.18 Allowed Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.369 -0.684 . . . . 72.52 112.208 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -83.94 -177.73 3.21 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.75 2.3 . . . . 74.45 111.367 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 69.04 168.34 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.842 1.257 . . . . 65.22 112.242 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . 58.88 9.65 1.27 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.375 1.47 . . . . 61.0 112.715 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 296' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' D' ' 38' ' ' PRO . 26.5 m -62.57 -24.52 67.59 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.383 1.073 . . . . 74.04 113.327 -163.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.902 ' HA ' ' HG3' ' D' ' 124' ' ' PRO . 2.5 t80 -74.6 -75.53 0.16 Allowed 'General case' 0 C--N 1.359 0.993 0 CA-C-N 117.921 0.328 . . . . 75.23 110.789 -175.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 298' ' ' HIS . . . . . 0.571 ' HB3' ' HB3' ' E' ' 302' ' ' ASP . 78.7 m-70 73.46 -53.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.794 1.238 . . . . 54.05 113.089 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -64.63 -33.68 87.89 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 116.006 1.162 . . . . 75.04 116.006 -168.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 300' ' ' ASN . . . . . 0.468 ' H ' ' HD1' ' G' ' 297' ' ' TYR . 49.6 t30 66.32 149.07 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.823 1.249 . . . . 63.02 112.769 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.536 HG23 HH12 ' C' ' 15' ' ' ARG . 2.8 mp -77.12 125.39 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.919 0.887 . . . . 74.21 109.37 177.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 302' ' ' ASP . . . . . 0.405 ' HB2' HD21 ' E' ' 300' ' ' ASN . 12.2 t70 -96.98 145.5 25.87 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.275 -0.639 . . . . 74.24 109.275 170.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' G' G ' 303' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' G' ' 303' ' ' LYS . 0.1 OUTLIER -103.44 122.16 45.98 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.837 0.855 . . . . 61.2 108.871 -175.413 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.64 113.58 3.22 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.641 2.227 . . . . 62.02 111.26 176.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.82 22.72 0.73 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.778 0.831 . . . . 74.11 111.695 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.07 84.66 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 124.728 1.211 . . . . 73.23 110.987 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 28.8 m -82.72 100.42 10.24 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.369 -0.832 . . . . 75.4 110.253 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 59.6 m 63.67 87.73 0.11 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.871 1.268 . . . . 70.32 111.698 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 8.4 t -134.21 101.21 12.47 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 123.629 0.772 . . . . 60.32 109.51 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo . . . . . 0 C--N 1.383 2.367 0 C-N-CA 123.481 2.787 . . . . 71.2 112.69 -175.764 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.893 -0.41 . . . . 73.44 109.893 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -168.88 126.84 1.02 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.838 0.855 . . . . 71.53 109.896 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -84.08 171.89 12.48 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.852 0.861 . . . . 61.44 109.594 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -78.29 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.092 0.557 . . . . 70.33 109.953 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 47.8 tttt 178.03 149.28 0.38 Allowed Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.163 0.985 . . . . 73.43 108.633 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.48 170.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.853 3.035 . . . . 62.25 115.245 170.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 8.4 tt -57.68 -53.09 62.08 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.787 1.235 . . . . 74.54 109.621 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 22.6 tp -89.51 52.1 2.26 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.405 -0.961 . . . . 71.21 108.405 176.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -83.49 56.02 5.04 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.182 -0.917 . . . . 71.34 111.784 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 34.0 tp 165.55 161.97 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.867 2.067 . . . . 65.41 105.915 -169.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 1.6 t80 79.95 -49.83 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.692 1.197 . . . . 71.21 111.76 168.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.24 67.85 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.202 -0.666 . . . . 73.34 109.202 159.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -135.99 120.44 18.1 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 107.696 -1.224 . . . . 62.01 107.696 167.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 169.97 78.44 0.04 OUTLIER Glycine 0 C--O 1.243 0.677 0 O-C-N 121.873 -0.517 . . . . 72.1 111.847 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.22 130.1 42.07 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.881 0.872 . . . . 60.2 110.09 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 14.9 ptp -139.38 125.38 12.16 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.441 0.696 . . . . 72.51 110.423 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.08 123.54 5.7 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.636 2.224 . . . . 34.44 111.524 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.62 -53.51 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.928 -0.578 . . . . 74.43 109.619 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 69.48 153.96 0.11 Allowed 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.689 1.243 . . . . 73.33 110.265 -172.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 290' ' ' TRP . . . . . 0.633 ' HH2' HD11 ' B' ' 126' ' ' LEU . 0.0 OUTLIER -74.97 76.17 2.19 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.252 -1.018 . . . . 74.42 108.252 177.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.466 HD11 HG22 ' B' ' 131' ' ' VAL . 2.3 pp -91.73 -11.06 37.85 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.289 -0.869 . . . . 71.05 112.47 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 292' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' B' ' 129' ' ' ALA . . . -97.51 -166.29 32.24 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 123.525 0.516 . . . . 32.42 114.295 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 293' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' F' ' 305' ' ' ALA . 46.1 Cg_endo -68.12 100.84 0.66 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.03 2.487 . . . . 74.4 111.872 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -77.54 57.68 1.62 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.352 1.061 . . . . 72.22 110.015 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -160.04 35.55 0.18 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.878 1.271 . . . . 73.42 108.766 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 296' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 126' ' ' LEU . 36.8 m -45.87 -50.77 14.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.67 1.588 . . . . 51.31 111.786 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.582 ' HE1' ' HB ' ' H' ' 301' ' ' ILE . 0.3 OUTLIER -81.06 91.53 6.11 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.032 -0.985 . . . . 74.24 108.597 177.118 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -79.62 14.72 1.55 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.047 0.939 . . . . 71.44 112.327 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 93.82 -4.83 72.45 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.625 -0.542 . . . . 62.13 113.088 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 300' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 1.8 m-20 -73.99 92.46 2.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.443 0.64 . . . . 73.15 109.291 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 301' ' ' ILE . . . . . 0.582 ' HB ' ' HE1' ' H' ' 297' ' ' TYR . 13.1 tt -149.58 132.46 6.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.492 1.117 . . . . 74.23 108.593 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 302' ' ' ASP . . . . . 0.524 ' HB2' HH12 ' A' ' 15' ' ' ARG . 3.0 m-20 -119.81 129.3 54.38 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.104 -0.702 . . . . 73.01 109.104 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 303' ' ' LYS . . . . . 0.585 ' HG2' ' HZ ' ' B' ' 32' ' ' PHE . 40.1 mtmt -78.68 -51.39 1.44 Allowed Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 123.208 0.603 . . . . 63.13 110.712 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 304' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' H' ' 303' ' ' LYS . 33.3 Cg_endo -93.4 -21.08 0.38 Allowed 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 121.916 1.744 . . . . 60.22 113.181 170.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 305' ' ' ALA . . . . . 0.563 ' HB2' HH11 ' A' ' 15' ' ' ARG . . . 52.49 -80.36 0.01 OUTLIER 'General case' 0 C--N 1.363 1.155 0 C-N-CA 125.608 1.563 . . . . 51.31 111.771 -166.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 306' ' ' VAL . . . . . 0.499 HG22 ' HB1' ' C' ' 129' ' ' ALA . 18.6 t -88.16 98.27 7.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.177 -1.046 . . . . 74.32 108.177 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 68.8 m -55.56 -58.61 7.07 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.164 0.985 . . . . 60.54 110.586 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 30.6 t -172.24 165.92 5.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.474 1.11 . . . . 74.54 109.277 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 68.7 p -126.99 152.95 76.35 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 124.002 0.921 . . . . 74.24 109.871 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo . . . . . 0 C--N 1.379 2.141 0 C-N-CA 122.762 2.308 . . . . 74.3 111.85 173.102 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 109.174 -0.676 . . . . 74.21 109.174 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m -116.8 9.48 13.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.852 0.861 . . . . 64.21 113.01 -170.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -55.29 8.28 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 119.296 -0.383 . . . . 73.33 110.802 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 59.35 116.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.148 1.379 . . . . 71.1 112.987 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -109.67 -62.81 1.44 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.176 0.59 . . . . 72.34 109.751 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -173.03 155.64 3.08 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.857 0.863 . . . . 64.31 109.319 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -138.63 159.99 40.71 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.301 0.64 . . . . 72.04 109.642 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.02 -39.05 90.96 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.138 0.975 . . . . 62.32 111.076 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.1 mtm 71.18 144.73 0.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.619 1.568 . . . . 74.31 111.639 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 78.8 m -140.95 135.4 31.18 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.823 0.849 . . . . 73.12 109.762 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.596 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.9 t80 -138.35 133.27 32.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.617 0.767 . . . . 74.23 109.954 170.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -160.58 116.32 2.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.813 0.845 . . . . 74.34 109.975 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.576 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.0 mt -76.17 125.68 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.536 -0.542 . . . . 70.51 109.536 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -97.3 -33.69 11.35 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.078 0.551 . . . . 74.12 111.13 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -172.24 128.41 0.57 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 110.079 -0.341 . . . . 74.33 110.079 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -121.79 126.9 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 123.664 0.785 . . . . 74.34 109.852 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 48.4 p90 -164.19 153.71 14.06 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.311 0.645 . . . . 72.22 111.202 -169.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.55 111.02 12.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.966 -1.015 . . . . 72.24 109.533 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 37.1 mtpt -76.43 -28.38 56.59 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.189 -0.459 . . . . 52.44 110.912 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -151.99 142.38 22.52 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.006 -0.997 . . . . 74.3 109.528 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.24 141.47 42.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 125.276 1.43 . . . . 45.12 107.293 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.78 130.4 14.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.966 -0.753 . . . . 72.44 108.966 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -133.5 120.48 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.482 -1.673 . . . . 62.32 106.482 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.1 114.29 20.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.773 0.429 . . . . 75.11 110.592 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 70.3 81.6 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 107.09 -1.448 . . . . 62.53 107.09 165.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.37 -3.56 13.48 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.246 1.964 . . . . 71.42 111.573 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -119.86 17.06 12.65 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.417 1.087 . . . . 62.41 109.317 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.98 -58.84 4.24 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.801 -1.095 . . . . 44.23 113.818 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.31 -25.71 71.6 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.376 2.051 . . . . 74.13 112.432 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.94 -48.1 17.08 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.5 -0.773 . . . . 72.1 109.914 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 6.2 p -77.29 -10.57 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.731 -0.668 . . . . 75.35 112.151 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' HA ' HD11 ' E' ' 301' ' ' ILE . 22.5 m-85 -72.62 -18.23 61.61 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.159 0.583 . . . . 74.11 112.392 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.27 -8.54 21.17 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.339 0.866 . . . . 74.44 113.339 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 71' ' ' GLU . 8.7 mmpt? -55.11 164.07 0.95 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.13 1.159 . . . . 72.11 114.13 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.4 133.69 54.44 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.699 -1.137 . . . . 61.13 109.498 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -77.57 73.99 4.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.631 0.772 . . . . 74.53 111.791 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.66 79.05 24.9 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.299 1.039 . . . . 73.42 108.993 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 114.89 4.16 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.042 1.828 . . . . 70.21 111.867 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.22 83.96 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.333 -1.729 . . . . 75.1 106.333 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.8 t -98.08 102.69 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 113.983 -1.462 . . . . 60.35 108.441 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.12 144.19 32.26 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.85 0.86 . . . . 74.41 110.41 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tt -97.51 111.65 23.83 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.167 -1.42 . . . . 62.24 107.167 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.674 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.2 m-20 -102.9 112.49 25.33 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.86 -1.163 . . . . 71.44 107.86 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tt -110.05 129.09 55.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.588 0.355 . . . . 75.25 110.339 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -139.51 145.35 38.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.659 1.183 . . . . 71.25 108.583 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -136.64 153.22 50.98 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.265 0.626 . . . . 72.02 110.828 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' E' ' 282' ' ' ALA . . . -141.84 153.26 44.36 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.512 1.125 . . . . 71.51 110.423 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 p -119.47 172.46 7.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.709 0.804 . . . . 70.0 109.231 168.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.549 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.4 t -160.86 144.78 13.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.862 0.865 . . . . 74.33 109.467 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -114.82 109.79 18.71 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 74.4 109.292 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.1 mt -82.4 -40.32 21.45 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.529 0.732 . . . . 71.24 109.722 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.01 -178.12 7.13 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.682 1.193 . . . . 64.25 109.073 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 121.55 17.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.267 -0.642 . . . . 75.03 109.267 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.02 -8.5 1.12 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.904 1.682 . . . . 73.21 112.879 -171.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.05 103.42 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.135 -1.061 . . . . 42.42 108.135 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.08 163.56 18.17 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.232 -0.894 . . . . 72.01 108.615 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 29.2 tt0 -133.7 145.11 49.59 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.527 1.131 . . . . 64.42 108.737 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.83 133.86 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.876 -1.157 . . . . 53.32 107.876 168.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.5 t -111.39 139.04 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.585 1.154 . . . . 75.1 108.437 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.04 106.11 10.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.896 -1.15 . . . . 75.14 107.896 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -84.41 102.35 12.7 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.827 -0.805 . . . . 72.52 108.827 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.34 115.91 35.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.05 -1.092 . . . . 75.44 108.05 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 48.5 m -117.92 138.55 52.07 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.48 -0.933 . . . . 72.11 108.48 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.564 HG11 HD21 ' A' ' 126' ' ' LEU . 99.1 t -129.94 117.83 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 124.6 1.16 . . . . 64.2 108.209 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 20.8 m -101.88 136.61 41.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.332 -0.988 . . . . 71.5 108.332 171.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.34 125.34 21.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.741 -1.207 . . . . 54.12 107.741 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.0 m -146.02 127.76 15.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.582 0.551 . . . . 60.33 110.464 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.87 86.23 6.58 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.01 -1.108 . . . . 74.14 108.01 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.46 -123.22 6.05 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.569 -1.196 . . . . 74.34 110.613 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -88.1 -28.01 21.56 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.285 0.634 . . . . 64.13 111.094 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 34' ' ' LYS . 27.6 tt0 -90.03 126.14 35.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.977 0.511 . . . . 71.04 110.475 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 m -72.65 129.29 37.92 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.97 0.908 . . . . 75.05 111.744 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.5 -65.5 0.75 Allowed 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.162 0.913 . . . . 74.0 108.762 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.548 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 50.3 p90 -155.92 144.42 20.16 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.785 -0.643 . . . . 74.31 110.748 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -121.13 110.15 15.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.154 -1.054 . . . . 51.14 108.154 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.548 ' HG ' ' HD2' ' A' ' 74' ' ' PHE . 84.0 m -111.15 114.84 28.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.182 0.993 . . . . 74.41 110.892 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.5 124.98 39.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.5 -0.926 . . . . 60.23 108.5 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.3 t -132.81 108.52 13.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.844 -1.169 . . . . 71.41 107.844 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.2 mt-30 -85.28 80.19 9.26 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.299 -1.371 . . . . 62.31 107.299 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.4 tp60 -76.46 96.54 4.09 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.176 -1.375 . . . . 70.12 108.651 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -94.1 166.18 27.05 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.955 -0.566 . . . . 63.43 112.124 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.21 128.41 1.73 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.933 -0.867 . . . . 63.44 110.933 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.7 mt -80.57 120.28 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.635 -0.876 . . . . 64.51 108.635 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.596 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.8 m-85 -125.7 117.3 23.18 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.739 -1.208 . . . . 75.41 107.739 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -79.67 86.77 5.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.92 -0.77 . . . . 71.21 108.92 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 pt -113.49 143.93 22.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.833 0.853 . . . . 73.31 110.496 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.09 161.37 12.53 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.706 -1.134 . . . . 72.33 109.806 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 2.75 58.81 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.59 -0.732 . . . . 64.51 114.15 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.56 137.35 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.192 0.597 . . . . 74.44 110.441 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -142.72 -177.59 5.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.724 1.21 . . . . 64.22 109.653 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.89 -125.15 29.93 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.459 0.475 . . . . 71.31 112.537 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.5 t -82.56 -19.42 38.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.053 0.541 . . . . 74.31 111.012 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -71.34 -39.2 71.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.063 0.545 . . . . 74.14 110.992 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 95' ' ' ALA . 3.8 ppp? -70.95 -32.09 68.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.055 0.222 . . . . 72.3 110.478 175.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' E' ' 280' ' ' LEU . . . -75.97 -23.91 55.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.314 0.646 . . . . 65.32 111.215 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -83.98 -32.52 24.94 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.335 0.654 . . . . 73.15 109.56 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.1 t -67.35 -43.56 81.18 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.182 0.593 . . . . 72.23 110.3 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.8 mt -88.42 -31.44 18.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.289 -0.869 . . . . 75.54 111.84 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.09 3.77 58.55 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-O 119.62 -0.545 . . . . 65.14 114.241 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 134' ' ' ASP . . . -149.25 -65.58 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.504 0.652 . . . . 70.4 111.699 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 74.3 t80 -64.36 -68.95 0.31 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.11 0.964 . . . . 61.41 112.974 -168.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.6 m -66.34 -33.52 6.81 Favored Pre-proline 0 CA--C 1.571 1.754 0 N-CA-C 114.26 1.207 . . . . 63.44 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 56.2 Cg_endo -69.49 -22.41 33.38 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 121.813 1.675 . . . . 73.41 113.083 169.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -72.13 -19.48 61.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.229 0.468 . . . . 70.2 110.804 173.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.639 -0.875 . . . . 64.21 108.639 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -78.66 -29.78 45.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.249 1.02 . . . . 74.44 112.547 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -60.39 -45.12 97.44 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.064 1.135 . . . . 74.32 114.064 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.28 -31.71 34.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.894 1.73 . . . . 70.11 113.204 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -72.0 -37.67 69.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.912 0.485 . . . . 64.14 110.907 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.56 79.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.228 0.611 . . . . 61.32 109.628 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.495 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.8 ttm180 -52.23 -51.39 58.58 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 124.803 1.314 . . . . 73.42 110.382 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.77 -45.36 86.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.036 0.934 . . . . 74.03 111.537 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.404 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -57.58 -41.89 82.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.816 0.698 . . . . 64.11 110.451 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 118' ' ' VAL . 85.1 mt -69.11 -45.7 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.177 -0.919 . . . . 74.44 110.072 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.5 m -54.95 -40.73 70.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.438 0.695 . . . . 34.31 110.802 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 t -68.87 -53.46 21.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.923 -1.035 . . . . 71.14 110.306 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 mtp -51.94 -47.09 64.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.282 1.033 . . . . 71.22 111.734 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG22 ' SG ' ' A' ' 76' ' ' CYS . 75.4 t -63.84 -45.68 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.544 -1.207 . . . . 73.4 110.813 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -66.72 -28.6 68.56 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.275 0.63 . . . . 73.33 111.396 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.0 mtt-85 -72.07 -31.16 65.84 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.433 0.693 . . . . 55.24 110.296 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.81 1.79 82.35 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.205 -0.452 . . . . 54.42 113.133 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.1 m 64.99 24.84 12.66 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 125.361 1.464 . . . . 73.31 110.711 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -93.42 160.13 33.73 Favored Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 114.559 -1.2 . . . . 74.24 110.263 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.815 ' HB3' ' H ' ' E' ' 298' ' ' HIS . 12.1 Cg_endo -52.54 137.52 57.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 124.398 3.399 . . . . 74.44 115.38 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -50.34 122.98 7.69 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.651 0.594 . . . . 61.5 110.549 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD21 HG11 ' A' ' 64' ' ' VAL . 21.4 tp -118.99 105.27 11.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.491 -1.232 . . . . 72.02 109.63 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -135.7 107.99 7.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.44 -1.254 . . . . 70.35 107.877 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.9 146.76 54.49 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.761 0.824 . . . . 73.42 111.893 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.25 148.18 96.09 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.734 0.813 . . . . 73.22 111.175 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.76 105.28 0.19 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.775 2.317 . . . . 71.51 112.834 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.35 116.91 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.998 -0.742 . . . . 52.33 108.998 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -93.14 77.97 4.58 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.369 1.068 . . . . 74.01 108.422 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -55.79 -34.89 65.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.7 1.2 . . . . 73.21 112.725 -173.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB3' ' HB1' ' A' ' 100' ' ' ALA . 6.0 p-10 -66.62 -32.51 73.88 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.849 0.86 . . . . 54.3 112.097 -176.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.75 -52.63 55.98 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.576 0.35 . . . . 54.22 110.314 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 tt -57.3 -42.03 80.99 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.97 0.794 . . . . 74.54 110.002 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -62.04 -42.62 99.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.759 0.823 . . . . 70.35 111.491 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.4 mmt -68.81 -44.38 73.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.597 0.359 . . . . 75.45 110.344 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -64.54 -34.41 78.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.841 0.856 . . . . 75.01 111.105 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -74.0 -39.44 63.64 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.165 -0.925 . . . . 71.53 110.546 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.81 -55.72 26.96 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.522 0.514 . . . . 74.32 110.725 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.475 ' HB3' ' HG2' ' A' ' 144' ' ' GLN . 11.6 mm-40 -166.47 -17.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.859 0.864 . . . . 70.33 111.258 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 55.23 26.29 8.3 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.048 1.339 . . . . 43.32 111.605 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.475 ' HG2' ' HB3' ' A' ' 142' ' ' GLN . 9.2 pt20 -134.96 170.11 16.38 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.046 0.539 . . . . 55.33 111.047 -175.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.92 135.9 8.63 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.397 1.079 . . . . 54.3 109.139 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.31 163.15 29.46 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 123.388 0.43 . . . . 71.32 112.164 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.99 149.68 44.76 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.981 0.512 . . . . 75.05 109.877 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.32 69.77 0.05 OUTLIER Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.291 -0.724 . . . . 72.4 111.291 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -162.94 159.1 23.21 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.178 0.591 . . . . 62.44 110.659 -176.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.48 134.39 4.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.641 1.176 . . . . 64.31 108.855 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -95.01 88.47 5.26 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.338 -1.356 . . . . 61.14 107.338 168.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -133.46 145.23 50.03 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.643 1.177 . . . . 75.12 108.113 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -76.24 74.39 3.05 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.438 0.637 . . . . 73.12 110.307 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -93.91 79.58 4.15 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.159 -1.052 . . . . 51.04 108.159 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 118.535 -0.745 . . . . 62.32 109.185 -179.394 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.03 -0.73 . . . . 73.43 109.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.6 m -145.77 125.41 13.32 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.847 -0.797 . . . . 73.41 108.847 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.67 83.82 1.59 Allowed 'General case' 0 C--N 1.346 0.454 0 N-CA-C 108.532 -0.914 . . . . 75.33 108.532 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.89 70.33 9.87 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.696 -0.853 . . . . 71.14 108.696 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -148.41 125.97 11.72 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.804 -1.089 . . . . 73.52 108.167 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ASN . . . . . 0.719 ' HB2' HE22 ' B' ' 93' ' ' GLN . 3.2 p-10 -89.91 12.07 18.5 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.608 1.163 . . . . 74.55 112.448 -170.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -117.58 -60.07 1.86 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.222 0.609 . . . . 70.33 110.969 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -71.68 -41.87 68.16 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.311 0.645 . . . . 62.4 111.547 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.6 ptm 47.28 -163.04 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 125.692 1.597 . . . . 74.24 112.765 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 61.2 m -143.14 122.68 13.21 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.175 -1.046 . . . . 61.41 108.175 174.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.72 124.24 11.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.388 0.675 . . . . 71.34 109.274 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.5 132.94 21.98 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.885 0.474 . . . . 62.22 110.102 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.643 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -77.39 120.73 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.186 -0.915 . . . . 74.42 108.83 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -86.24 -50.26 7.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.329 -0.396 . . . . 74.42 111.055 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.52 140.02 5.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.467 0.307 . . . . 73.23 110.424 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.643 HG13 HD11 ' B' ' 13' ' ' ILE . 90.6 mt -115.53 139.48 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.107 0.963 . . . . 72.34 108.879 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -164.89 164.76 20.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.731 0.777 . . . . 74.12 112.219 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.449 HG21 HD11 ' B' ' 21' ' ' ILE . 97.3 m -93.74 124.69 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.99 -1.004 . . . . 70.51 108.474 171.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -88.9 -33.49 17.29 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.124 0.57 . . . . 61.1 110.677 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -155.31 142.29 19.14 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.164 0.431 . . . . 74.2 112.164 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.449 HD11 HG21 ' B' ' 18' ' ' THR . 47.5 mm -133.13 142.16 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.492 1.117 . . . . 72.52 109.301 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 58.6 m -143.13 131.67 22.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.597 -1.183 . . . . 51.52 108.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -144.12 107.6 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.808 -1.552 . . . . 72.0 106.808 167.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -119.23 115.46 24.25 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.844 -0.799 . . . . 75.14 108.844 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -107.17 88.28 3.72 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.583 1.153 . . . . 75.31 109.185 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.45 -44.1 1.77 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.722 2.281 . . . . 63.14 112.681 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -102.61 23.0 12.64 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.964 0.906 . . . . 71.32 109.705 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.864 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.5 -46.67 59.49 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 115.774 1.768 . . . . 72.41 115.774 -174.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.0 Cg_exo -75.79 -29.65 6.83 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.286 1.99 . . . . 53.42 112.325 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -94.36 1.0 55.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.39 1.076 . . . . 71.34 111.557 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 28' ' ' ALA . 4.5 p -83.57 -17.19 10.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 C-N-CA 123.38 0.672 . . . . 71.31 110.419 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.59 -28.66 63.82 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 118.481 0.582 . . . . 73.51 112.093 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -73.65 -45.77 50.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.446 0.698 . . . . 70.52 111.07 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.522 ' HB3' HD13 ' B' ' 68' ' ' LEU . 10.9 mmmm -107.37 62.62 0.62 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.288 1.035 . . . . 64.35 108.97 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.53 ' HB3' HD11 ' H' ' 301' ' ' ILE . 6.9 t70 -119.07 80.73 1.59 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.691 -0.855 . . . . 72.13 108.691 -171.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -152.64 -177.27 6.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.087 0.955 . . . . 74.0 109.511 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -59.53 109.19 1.75 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.509 0.724 . . . . 52.11 110.835 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -86.34 173.87 6.35 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.587 2.191 . . . . 72.04 112.902 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.28 103.77 4.09 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.385 -1.339 . . . . 65.13 107.385 164.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.457 HG21 ' HB ' ' H' ' 296' ' ' THR . 44.4 t -101.41 151.9 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.699 -1.137 . . . . 50.44 110.492 -173.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.413 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 55.5 mtpt -138.11 138.81 39.07 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.116 0.966 . . . . 72.41 109.393 175.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.76 126.25 45.79 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.992 -1.855 . . . . 70.45 105.992 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.1 t70 -124.7 139.95 53.39 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.423 -0.955 . . . . 72.34 108.423 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.446 ' H ' HD23 ' B' ' 44' ' ' LEU . 2.6 pt? -125.55 141.19 52.17 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.021 -0.733 . . . . 73.4 109.021 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.2 t70 -130.45 137.36 49.77 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.139 0.976 . . . . 60.24 108.575 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -108.69 103.11 12.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.841 0.857 . . . . 64.31 110.393 -172.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 141.07 50.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.218 1.007 . . . . 64.14 109.416 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 p -145.58 168.45 20.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.166 0.586 . . . . 53.13 110.903 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.72 138.64 18.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.11 0.564 . . . . 60.32 110.482 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -82.45 101.27 10.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.079 -0.711 . . . . 54.02 109.079 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 mt -74.54 -35.99 63.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.305 0.642 . . . . 74.54 109.996 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.23 -174.2 3.43 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.295 -1.32 . . . . 75.43 109.232 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.61 128.06 35.27 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.133 -0.94 . . . . 73.22 109.821 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 67.62 -5.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.437 1.495 . . . . 74.22 112.955 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.91 115.14 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.808 . . . . 72.43 109.146 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.91 143.38 50.77 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.369 0.668 . . . . 60.14 110.416 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -99.8 116.16 31.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.144 -1.058 . . . . 70.24 108.144 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -91.42 118.02 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.038 0.935 . . . . 64.44 109.001 172.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -114.42 112.64 40.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.053 0.941 . . . . 71.02 108.561 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.93 108.68 20.31 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.872 -1.158 . . . . 74.34 107.872 176.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.638 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 18.9 ttm-85 -85.58 112.41 20.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.78 -0.822 . . . . 73.22 108.78 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.35 103.02 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.872 -1.159 . . . . 61.32 107.872 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.0 m -100.96 130.95 47.04 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.055 -0.72 . . . . 70.13 109.055 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.462 HG11 HD21 ' B' ' 126' ' ' LEU . 68.9 t -117.53 115.86 49.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 85.8 m -92.57 141.67 28.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.147 0.979 . . . . 41.44 108.612 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.77 121.5 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.723 -0.843 . . . . 64.05 108.723 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 40.4 p -147.2 127.8 14.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.637 0.775 . . . . 43.44 109.456 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.721 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.3 OUTLIER -118.31 134.6 54.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.446 0.698 . . . . 54.52 109.305 -176.049 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.78 -118.28 6.43 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.206 -0.758 . . . . 74.14 111.206 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.17 11.35 12.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.874 0.87 . . . . 64.33 110.315 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 pm0 -127.67 158.96 36.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.677 0.791 . . . . 74.12 110.682 -176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -78.81 135.99 37.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.942 -0.572 . . . . 74.21 110.328 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.721 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -83.72 -64.75 1.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.901 0.858 . . . . 75.43 108.993 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.83 152.95 16.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.563 -1.653 . . . . 44.21 108.094 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -123.74 137.02 54.77 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.324 -0.991 . . . . 63.33 108.324 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.0 t -134.18 148.18 50.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.809 -0.812 . . . . 54.11 108.809 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.7 tt0 -156.16 138.8 15.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.925 -0.768 . . . . 61.41 108.925 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -132.14 145.27 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.403 1.081 . . . . 74.5 108.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -118.82 97.1 5.54 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.285 -1.376 . . . . 60.23 107.285 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 45.5 tp60 -87.74 100.11 12.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.043 -1.095 . . . . 74.02 108.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.37 157.65 25.92 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.392 -1.083 . . . . 63.41 110.392 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.93 125.65 1.37 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.177 -0.769 . . . . 42.23 111.177 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.7 130.91 35.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.825 -0.805 . . . . 53.22 108.825 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.72 165.63 22.48 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.109 0.963 . . . . 64.15 108.633 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.35 120.91 26.39 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.921 -0.77 . . . . 73.13 108.921 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 36.7 pt -119.13 145.81 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.584 1.153 . . . . 72.21 110.742 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.21 157.67 36.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.608 1.163 . . . . 73.25 108.682 172.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -42.39 2.57 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 116.856 -0.156 . . . . 55.21 112.889 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 35.5 pt -79.31 149.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.086 0.555 . . . . 72.22 110.655 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -170.64 160.08 6.97 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 70.3 109.376 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.77 -119.42 12.22 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.398 0.436 . . . . 73.21 112.452 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.0 m -73.69 -28.55 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.929 0.892 . . . . 74.23 111.292 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.719 HE22 ' HB2' ' B' ' 6' ' ' ASN . 18.2 tt0 -70.97 -24.39 62.4 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 72.33 112.317 -167.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.5 ptp -67.25 -32.02 72.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.938 -0.574 . . . . 61.12 110.592 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.595 ' HA ' HD22 ' H' ' 280' ' ' LEU . . . -62.97 -22.14 66.6 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.603 0.761 . . . . 73.54 112.027 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -83.83 -45.9 12.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.934 0.494 . . . . 74.12 109.907 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -74.95 -67.8 0.61 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.181 -0.463 . . . . 74.33 111.457 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.0 pp -80.73 -20.75 42.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 119.488 -0.291 . . . . 73.3 111.683 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.9 -32.57 26.29 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 113.887 0.315 . . . . 62.44 113.887 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.18 -59.23 2.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 71.51 110.899 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -67.17 -45.62 76.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.462 0.705 . . . . 74.44 112.779 -169.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 60.4 m -65.99 -45.07 63.28 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.606 -0.712 . . . . 63.42 112.761 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -34.48 98.29 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 122.303 2.002 . . . . 71.22 112.901 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -66.61 -27.63 67.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.117 0.567 . . . . 64.11 111.905 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.93 -45.41 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.221 0.608 . . . . 34.4 110.049 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.13 -17.42 49.94 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.478 -0.783 . . . . 74.14 111.692 -174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -61.17 -47.22 95.3 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.602 1.161 . . . . 72.33 113.944 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.41 -35.44 83.23 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.027 1.818 . . . . 51.34 112.978 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -68.9 -44.67 72.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.356 0.662 . . . . 74.41 110.618 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.36 0.664 . . . . 71.55 110.475 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.575 HH12 HD11 ' D' ' 16' ' ' ILE . 33.6 mtp180 -54.87 -60.46 3.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.191 0.996 . . . . 71.42 111.262 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.57 -31.71 70.83 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.244 0.965 . . . . 72.24 110.519 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.538 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.9 t -73.76 -37.74 64.94 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.967 -0.56 . . . . 44.24 111.344 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.441 HD13 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -67.09 -45.63 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 123.134 0.574 . . . . 74.33 109.836 174.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.515 HG21 ' OG ' ' C' ' 119' ' ' SER . 10.2 m -62.13 -39.67 93.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 73.51 111.385 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -61.68 -42.35 98.8 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.787 0.835 . . . . 71.22 110.516 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.516 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 10.0 mmt -72.48 -31.58 65.51 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.726 0.41 . . . . 55.24 111.186 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.624 HG21 HD23 ' B' ' 126' ' ' LEU . 92.8 t -65.83 -41.23 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.803 0.841 . . . . 75.44 110.221 172.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 53.0 m -64.31 -36.85 85.46 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.18 0.992 . . . . 55.02 111.05 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.516 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 84.0 mtt-85 -71.05 -27.58 63.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.815 -0.629 . . . . 71.03 110.714 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.04 14.51 61.86 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.513 -0.604 . . . . 74.32 113.082 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 55.05 45.69 25.73 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.397 1.479 . . . . 74.4 113.12 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -119.87 149.25 48.28 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.657 0.783 . . . . 74.21 110.253 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.59 -165.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.352 3.368 . . . . 74.13 114.945 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.465 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.7 tp60 -60.13 128.51 37.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.564 1.146 . . . . 72.34 113.587 -168.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.624 HD23 HG21 ' B' ' 118' ' ' VAL . 12.3 tp -136.05 108.86 7.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 71.22 108.59 165.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -128.46 135.75 49.89 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.382 -0.969 . . . . 74.4 108.382 167.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.25 139.27 34.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.924 -0.769 . . . . 73.52 108.924 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.433 ' HB1' HG13 ' F' ' 306' ' ' VAL . . . -67.94 148.18 98.43 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.698 0.799 . . . . 71.12 111.504 -175.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.36 92.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.159 2.573 . . . . 72.13 111.504 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.86 108.34 19.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.804 -0.813 . . . . 73.42 108.804 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -83.16 109.18 16.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.34 -1.356 . . . . 71.22 107.34 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -63.89 -31.51 72.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.53 0.332 . . . . 75.12 111.145 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.41 -34.38 75.27 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.729 0.643 . . . . 75.5 111.385 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.48 85.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.029 0.531 . . . . 65.41 109.926 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.57 -34.42 75.57 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.513 0.725 . . . . 61.34 111.233 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -64.86 -53.17 50.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.903 0.481 . . . . 65.34 110.445 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.461 ' O ' ' HG2' ' B' ' 142' ' ' GLN . 70.5 mtm -68.39 -40.28 81.43 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.368 0.507 . . . . 75.41 112.368 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -76.15 -12.11 60.05 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 122.768 0.427 . . . . 74.13 111.289 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -87.46 -43.77 11.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.136 -0.691 . . . . 62.02 109.136 171.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.11 -5.76 58.91 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.623 -0.717 . . . . 73.14 112.615 -172.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 138' ' ' MET . 8.7 pt20 -163.13 152.31 14.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.399 0.68 . . . . 73.05 110.07 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -98.93 5.82 47.07 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.748 0.819 . . . . 71.33 111.021 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -81.87 85.21 6.7 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.22 0.608 . . . . 73.34 109.506 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.8 -46.19 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.066 1.346 . . . . 74.01 108.792 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.64 85.89 0.71 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 109.834 -1.306 . . . . 64.32 109.834 -171.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.93 119.21 5.07 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.445 0.698 . . . . 73.01 110.305 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.58 29.0 3.35 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.242 -0.436 . . . . 73.3 113.855 -171.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' THR . . . . . 0.417 ' HA ' ' SG ' ' F' ' 308' ' ' CYS . 42.6 p -79.12 82.92 5.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.083 0.953 . . . . 74.12 110.887 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -92.82 93.88 8.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.375 -0.829 . . . . 73.23 108.919 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.81 176.67 10.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.988 0.915 . . . . 62.2 110.774 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -164.85 67.09 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.679 -1.6 . . . . 73.35 106.679 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -63.45 96.47 0.11 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.975 -1.011 . . . . 64.12 111.494 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -88.54 149.28 23.69 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.681 0.792 . . . . 71.33 110.534 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 C-N-CA 124.143 0.977 . . . . 70.24 108.699 -178.113 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.701 -0.481 . . . . 72.41 109.701 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 24.1 p -120.48 86.67 2.61 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.837 -0.801 . . . . 74.05 108.837 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.46 73.27 8.51 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.933 -1.03 . . . . 71.32 109.072 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -109.91 46.65 1.0 Allowed 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.741 -1.118 . . . . 72.32 108.694 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.09 133.39 50.64 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.413 -0.812 . . . . 73.02 110.618 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -117.31 142.17 47.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.376 1.07 . . . . 64.11 108.366 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.0 m -139.72 45.87 1.9 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.898 0.856 . . . . 53.01 109.422 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.66 153.31 38.98 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.604 -0.726 . . . . 63.31 109.825 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 56.9 ttp 65.44 115.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.163 1.385 . . . . 74.23 112.364 -174.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.6 m -98.54 101.85 13.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.181 -1.044 . . . . 60.34 108.181 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -120.14 134.97 55.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.354 0.662 . . . . 74.05 110.03 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' C' ' 85' ' ' SER . 29.3 pt20 -154.92 144.48 21.38 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.998 0.919 . . . . 75.34 108.769 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -88.84 112.55 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.35 -50.53 10.71 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.078 -0.389 . . . . 75.1 111.02 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -166.91 125.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.335 -0.617 . . . . 53.12 109.335 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.19 141.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 107.865 -1.161 . . . . 61.5 107.865 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.518 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.2 p90 -173.23 159.88 3.92 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.644 0.735 . . . . 73.32 112.187 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.2 114.63 22.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.747 -0.834 . . . . 73.33 108.747 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -80.7 -33.87 35.04 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.128 0.49 . . . . 72.43 110.112 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 33.5 t70 -147.33 139.51 24.47 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.429 -0.805 . . . . 51.44 109.395 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -140.04 139.69 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.632 -1.247 . . . . 50.44 107.632 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 61.8 m -148.46 146.76 28.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.197 0.599 . . . . 55.42 110.54 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -145.08 107.62 4.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.472 -1.677 . . . . 71.5 106.472 165.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -118.82 109.63 16.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.165 -0.68 . . . . 75.44 109.165 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.28 80.7 12.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.137 -1.06 . . . . 74.34 108.137 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.98 -18.57 35.89 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.073 2.515 . . . . 64.41 112.041 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.94 32.69 5.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.052 0.941 . . . . 71.35 110.041 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -51.64 -51.31 71.09 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 113.813 1.042 . . . . 73.4 113.813 -175.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 11.5 Cg_exo -72.89 -30.76 10.86 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.175 1.916 . . . . 51.24 113.786 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -70.3 -40.1 74.45 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.14 0.576 . . . . 74.43 111.719 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 7.3 p -78.68 -20.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.665 0.786 . . . . 61.35 110.72 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -62.26 -20.79 64.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.948 1.299 . . . . 74.35 111.451 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -122.5 23.58 9.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 72.5 111.415 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 2.1 tppp? -98.0 146.79 25.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.2 0.6 . . . . 71.41 109.772 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.71 122.71 17.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.928 0.891 . . . . 74.3 110.276 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -72.07 90.32 1.18 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.842 0.857 . . . . 71.52 111.571 -166.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -127.67 64.11 62.57 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 124.078 0.951 . . . . 74.34 108.924 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.95 109.21 1.01 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.469 2.779 . . . . 71.52 113.302 -165.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -84.55 106.37 16.08 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.504 -0.925 . . . . 72.35 108.504 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -84.38 139.72 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.892 -1.049 . . . . 75.34 109.369 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.431 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 23.6 mtpp -131.87 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 71.1 109.038 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -91.72 120.31 32.35 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.255 -1.387 . . . . 74.1 107.255 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.726 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 2.1 m-20 -119.94 104.3 10.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.254 1.022 . . . . 53.43 108.421 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 110.97 23.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.506 -1.294 . . . . 61.32 107.506 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.7 t70 -116.35 149.25 39.63 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.36 1.464 . . . . 71.44 108.53 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.8 p -120.5 143.13 48.71 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.086 0.554 . . . . 73.45 109.756 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.22 145.92 33.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.178 0.991 . . . . 64.11 108.654 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -160.6 146.85 15.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.963 0.347 . . . . 64.22 111.213 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -154.35 144.01 21.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.836 0.854 . . . . 43.2 109.752 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.73 122.99 27.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.845 0.458 . . . . 73.13 109.813 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.3 mt -95.85 -36.4 11.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.485 0.714 . . . . 65.3 110.661 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -156.22 -177.51 6.64 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.172 -0.922 . . . . 54.12 109.976 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -65.22 116.65 6.79 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.013 -0.994 . . . . 75.52 109.592 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 54' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 23.6 m-20 67.05 12.12 8.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.953 1.301 . . . . 73.15 112.048 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 69.2 t -119.05 107.38 21.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.244 1.018 . . . . 72.53 109.096 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD13 ' C' ' 86' ' ' ILE . 89.7 m-85 -116.74 134.45 54.79 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.23 1.012 . . . . 74.24 108.62 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.616 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.7 tt0 -83.58 119.58 24.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.752 -0.658 . . . . 72.54 109.294 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.55 118.97 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.792 -1.188 . . . . 71.25 107.792 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.82 133.76 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.564 0.746 . . . . 74.43 109.168 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.573 HD23 HD12 ' C' ' 106' ' ' LEU . 4.1 mm? -118.96 106.38 12.4 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.324 1.05 . . . . 75.24 108.699 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.6 ttm-85 -81.07 106.51 13.13 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.855 -1.165 . . . . 73.13 107.855 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.72 119.51 50.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.766 -1.198 . . . . 71.15 107.766 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 55.9 m -116.39 141.08 48.63 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.951 -1.129 . . . . 62.21 107.951 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -135.34 128.0 47.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 71.34 107.671 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.0 m -122.57 125.84 46.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.705 -0.85 . . . . 72.11 108.705 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.49 123.64 48.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.535 -1.283 . . . . 63.23 107.535 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.8 m -143.44 123.9 13.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.877 0.471 . . . . 52.51 110.746 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.08 57.65 3.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.649 1.18 . . . . 75.35 109.798 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.45 -111.53 4.05 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 110.558 -1.017 . . . . 54.23 110.558 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -89.53 -28.09 19.85 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.732 0.813 . . . . 72.21 109.429 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.91 117.65 7.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.043 -0.98 . . . . 74.21 110.175 173.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 87.8 m -87.6 125.64 34.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.706 -0.849 . . . . 60.21 108.706 167.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.07 -63.02 1.36 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.572 -1.195 . . . . 71.54 109.806 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.34 177.11 11.83 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 114.85 -1.068 . . . . 62.13 111.217 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.416 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -135.98 147.51 48.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.83 -1.915 . . . . 54.34 105.83 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.3 t -150.48 113.08 4.71 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.148 -1.056 . . . . 54.31 108.148 176.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.4 126.78 31.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.207 -0.664 . . . . 72.33 109.207 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' C' ' 113' ' ' CYS . 80.2 t -130.21 113.74 26.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.917 0.887 . . . . 62.11 108.842 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.616 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -89.83 90.52 8.23 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.849 -1.167 . . . . 64.35 107.849 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 63.8 tp60 -81.25 104.04 11.44 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.473 -1.239 . . . . 71.33 109.46 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.85 150.73 19.73 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 112.08 -0.408 . . . . 62.41 112.08 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.34 125.0 1.98 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.226 -1.15 . . . . 43.5 110.226 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.514 HD12 HD11 ' C' ' 51' ' ' LEU . 9.8 mm -81.93 126.52 39.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.759 -1.2 . . . . 71.23 107.759 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -136.51 154.72 50.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.419 0.688 . . . . 74.24 109.144 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 31.2 m -96.45 116.12 28.55 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.459 -0.941 . . . . 74.43 108.459 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' C' ' 56' ' ' TYR . 3.8 mp -116.73 118.16 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.503 -0.925 . . . . 75.51 108.503 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -153.21 170.51 20.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.134 0.974 . . . . 74.03 110.054 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.4 -59.39 0.4 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.54 -0.3 . . . . 65.22 113.434 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.23 -179.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.383 0.673 . . . . 63.43 112.176 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.93 -173.31 4.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 63.11 109.822 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.21 -140.76 38.13 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.533 0.521 . . . . 71.32 113.305 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -75.2 -17.64 60.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.856 0.863 . . . . 71.24 112.182 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -73.47 -36.58 65.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.025 0.53 . . . . 70.13 110.595 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.546 ' HE3' HD12 ' F' ' 278' ' ' LEU . 1.2 tmt? -72.15 -41.63 66.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.373 -0.603 . . . . 74.22 109.373 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.89 66.07 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.854 -1.066 . . . . 64.52 111.568 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.575 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 70.4 t60 -66.84 -41.66 87.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 74.32 111.254 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -77.74 -57.43 3.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.856 -0.424 . . . . 63.01 109.856 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.44 -39.65 94.03 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.366 1.066 . . . . 53.35 112.542 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.81 11.21 57.6 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.543 -0.587 . . . . 71.23 114.155 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -144.63 -63.41 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.59 0.695 . . . . 71.22 111.51 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -69.34 -55.12 11.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.723 0.409 . . . . 74.4 111.887 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.9 m -55.88 -44.77 99.84 Favored Pre-proline 0 CA--C 1.573 1.85 0 C-N-CA 123.581 0.752 . . . . 71.53 112.567 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -51.18 -43.46 48.5 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.062 2.508 . . . . 75.31 114.344 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 104' ' ' ASN . . . . . 0.421 HD22 ' N ' ' C' ' 104' ' ' ASN . 0.9 OUTLIER -74.24 -20.19 60.25 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.463 0.705 . . . . 63.11 111.715 -174.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.495 HD12 ' NH1' ' A' ' 111' ' ' ARG . 32.3 mm -76.88 -44.86 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.984 0.514 . . . . 73.42 110.061 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.573 HD12 HD23 ' C' ' 60' ' ' LEU . 73.1 mt -81.61 -18.72 43.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.044 -0.526 . . . . 74.03 112.004 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -57.11 -54.25 56.63 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 117.72 -1.133 . . . . 72.5 113.08 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.79 -27.45 84.84 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.026 1.818 . . . . 71.12 113.221 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -71.08 -45.98 62.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.208 0.603 . . . . 73.21 110.79 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.59 84.65 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.795 -0.638 . . . . 71.51 110.315 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.719 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 33.6 ttt180 -60.13 -47.88 84.07 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.489 1.516 . . . . 75.22 111.47 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -38.71 86.15 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.907 0.755 . . . . 75.51 109.765 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.512 ' HB3' HG21 ' C' ' 78' ' ' VAL . 12.2 m -58.5 -46.67 86.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.38 0.672 . . . . 51.02 112.357 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.53 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 86.9 mt -66.16 -48.43 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 122.916 0.486 . . . . 63.02 110.762 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.6 m -65.81 -32.71 74.39 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.088 0.555 . . . . 50.04 111.272 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -69.41 -37.99 77.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.325 0.65 . . . . 74.53 109.98 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.471 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -70.9 -35.97 72.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.661 0.784 . . . . 74.11 111.514 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.8 t -63.76 -37.31 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.543 -0.54 . . . . 61.13 109.543 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.515 ' OG ' HG21 ' B' ' 115' ' ' THR . 42.1 t -67.77 -35.34 78.52 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.85 0.86 . . . . 70.14 112.194 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.68 -32.46 65.81 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.2 0.6 . . . . 74.33 110.022 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.2 1.6 86.66 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.465 0.478 . . . . 71.41 112.612 171.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p 62.42 19.59 11.25 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.836 2.054 . . . . 70.45 113.17 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.64 150.04 45.31 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.09 0.956 . . . . 74.31 109.43 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.523 ' HD3' HG21 ' F' ' 301' ' ' ILE . 35.7 Cg_endo -62.54 113.25 1.87 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.722 2.281 . . . . 74.14 111.442 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -55.47 141.79 35.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.254 -1.339 . . . . 63.03 113.168 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.36 121.24 36.23 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.822 -1.548 . . . . 75.3 106.822 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.86 126.55 41.19 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.941 0.896 . . . . 72.42 108.653 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.719 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -63.92 145.02 56.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.218 0.607 . . . . 73.52 110.403 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.512 ' HB2' ' HE2' ' F' ' 294' ' ' LYS . . . -83.49 164.33 45.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.095 0.958 . . . . 53.12 111.232 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -66.52 117.26 4.59 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.064 1.842 . . . . 70.23 111.729 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.36 109.34 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.944 0.878 . . . . 73.44 108.964 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 9.1 m120 -107.9 94.4 5.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.044 -0.98 . . . . 75.14 109.708 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -75.9 -40.59 54.1 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.139 -0.689 . . . . 74.1 109.139 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' C' ' 138' ' ' MET . 11.3 p-10 -60.64 -41.54 95.13 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.824 0.85 . . . . 74.13 110.91 -176.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -71.82 -24.97 61.8 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.039 0.935 . . . . 63.33 111.691 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 98.8 mt -74.43 -40.13 62.15 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.187 0.595 . . . . 64.03 109.801 172.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -80.74 -11.45 59.61 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.912 0.885 . . . . 63.44 112.736 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 66.3 mtt -62.11 -32.92 73.54 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.092 0.557 . . . . 74.34 110.704 170.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -64.16 -33.73 76.46 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.295 1.038 . . . . 74.04 111.342 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -58.75 -83.74 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.048 0.939 . . . . 64.2 111.519 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.48 125.54 15.37 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.35 -0.982 . . . . 64.44 108.35 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -124.5 121.59 35.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.056 0.943 . . . . 74.34 109.177 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -97.58 169.53 9.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.65 0.78 . . . . 71.04 110.202 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -87.65 89.72 8.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.684 -0.858 . . . . 73.24 108.684 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.21 146.52 54.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.98 0.912 . . . . 75.04 112.454 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.54 132.44 11.08 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.682 -0.69 . . . . 63.13 111.63 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -147.48 142.52 27.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.445 0.698 . . . . 73.11 109.85 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.25 -169.59 35.14 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.178 -0.769 . . . . 64.4 111.178 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 51.8 m -147.99 81.0 1.49 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.328 -0.619 . . . . 61.51 109.328 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' G' ' 310' ' ' PRO . 3.0 tm-20 -74.48 102.76 4.58 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.289 -1.374 . . . . 71.0 107.289 170.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -68.62 108.94 3.54 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.119 -0.697 . . . . 75.21 109.119 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -125.12 137.71 54.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.043 0.937 . . . . 74.42 109.957 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -142.69 133.18 25.01 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.351 1.06 . . . . 74.55 109.099 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -137.41 131.31 31.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.968 -1.123 . . . . 75.51 107.968 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.817 0 N-CA-C 108.862 -0.792 . . . . 37.97 108.862 -177.132 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.148 -0.686 . . . . 63.05 109.148 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 62.2 m -154.3 96.78 1.96 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.793 -1.188 . . . . 65.52 107.793 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.7 151.17 40.78 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.482 0.713 . . . . 64.35 110.149 -172.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -129.2 102.5 6.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.632 0.773 . . . . 73.2 109.909 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -92.53 139.12 30.9 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.896 0.878 . . . . 64.33 110.852 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -150.18 112.38 4.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.785 0.834 . . . . 50.25 109.257 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -179.62 -40.31 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.966 1.307 . . . . 72.11 109.51 171.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -98.83 -29.23 13.09 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.239 1.016 . . . . 64.02 110.095 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.451 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.4 ptm -34.21 142.53 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.284 1.587 . . . . 74.14 115.284 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m -143.89 142.93 31.05 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 72.52 107.989 169.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -154.66 98.36 2.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.01 -1.107 . . . . 65.33 108.01 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -131.26 125.9 34.04 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.604 -1.258 . . . . 54.42 107.604 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mt -69.59 124.42 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.504 -0.924 . . . . 62.43 108.504 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.483 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 19.7 mm-40 -74.31 -48.98 24.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.707 -0.479 . . . . 74.43 109.707 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -161.85 156.63 22.86 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.824 1.25 . . . . 75.02 109.845 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.575 HD11 HH12 ' B' ' 111' ' ' ARG . 0.2 OUTLIER -126.87 125.41 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 105.631 -1.988 . . . . 70.51 105.631 165.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.479 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 32.4 p90 -155.36 153.74 30.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.889 0.852 . . . . 74.05 110.707 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.77 110.75 12.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.172 -1.376 . . . . 52.03 108.438 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.479 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.7 mtpt -77.57 -36.54 51.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.061 -0.718 . . . . 74.12 109.061 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.5 t70 -140.49 137.86 34.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.537 -1.21 . . . . 74.15 109.324 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.471 HG21 ' HE2' ' C' ' 117' ' ' MET . 90.2 mt -132.81 142.95 41.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.821 1.249 . . . . 73.22 107.963 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -147.16 136.54 22.68 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.569 1.148 . . . . 74.31 108.653 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.404 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -143.36 123.58 13.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.592 -1.633 . . . . 75.52 106.592 167.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.3 mt-10 -127.37 127.03 43.54 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.397 0.679 . . . . 71.32 109.269 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.72 84.18 8.04 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.549 -1.649 . . . . 72.1 106.549 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.46 -30.22 12.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.823 2.349 . . . . 71.23 112.633 -167.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -115.26 36.36 3.95 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.266 1.026 . . . . 53.33 108.89 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.518 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -48.48 -61.54 3.1 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 115.076 1.51 . . . . 70.34 115.076 -165.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.487 ' HB3' HD11 ' C' ' 83' ' ' ILE . 33.0 Cg_endo -85.65 -4.03 9.13 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 122.671 1.99 . . . . 51.44 113.075 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -80.92 -42.0 22.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 74.0 109.414 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.744 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.0 p -76.27 -34.02 24.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.248 -0.887 . . . . 63.53 110.295 -173.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -57.23 -16.78 9.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.12 0.968 . . . . 72.43 113.403 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.59 -37.21 60.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.887 0.475 . . . . 75.33 110.535 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -130.85 57.93 1.72 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.461 0.304 . . . . 73.52 110.899 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' G' ' 301' ' ' ILE . 12.0 t70 -100.7 94.96 6.35 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.354 -0.841 . . . . 55.23 109.556 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.403 ' H ' HD22 ' D' ' 68' ' ' LEU . 16.4 m95 -124.08 -164.85 1.28 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.576 -1.638 . . . . 74.01 106.576 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' G' ' 297' ' ' TYR . 0.0 OUTLIER -51.41 106.65 0.68 Allowed Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 119.167 0.894 . . . . 74.34 112.172 -176.413 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 4.7 Cg_exo -78.35 144.82 20.77 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.589 2.193 . . . . 73.41 111.291 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -79.09 112.89 16.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.276 -1.379 . . . . 61.55 107.276 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.9 142.58 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.496 0.718 . . . . 72.34 110.099 -168.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -118.89 147.46 43.96 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.534 1.134 . . . . 71.33 109.421 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.44 HD21 HD21 ' D' ' 128' ' ' LEU . 95.1 mt -106.83 118.38 36.54 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.04 -1.096 . . . . 73.0 108.04 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.622 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.3 t70 -106.46 129.93 54.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.908 -1.145 . . . . 75.33 107.908 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.82 156.52 18.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.698 0.799 . . . . 75.32 111.106 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.3 t70 -168.16 129.29 1.37 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.274 -0.876 . . . . 70.01 109.265 172.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -106.09 148.49 27.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.647 0.779 . . . . 64.0 110.072 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.85 155.53 40.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.93 0.892 . . . . 50.25 108.789 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.0 p -163.17 153.91 16.53 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.275 0.63 . . . . 71.45 110.441 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.3 p -163.7 143.52 8.36 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.539 0.736 . . . . 61.45 110.079 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -78.4 122.59 25.99 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.463 -0.569 . . . . 71.22 109.463 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -93.05 -39.43 11.09 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.454 -0.573 . . . . 70.3 109.454 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -153.5 -176.67 5.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 75.04 110.49 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.34 119.85 13.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.201 -0.909 . . . . 50.33 109.594 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 64.03 7.02 3.12 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.811 1.245 . . . . 71.31 112.686 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 56.1 t -114.89 108.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.365 -0.976 . . . . 71.31 108.365 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -128.39 129.71 46.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.649 -1.16 . . . . 62.15 108.776 -169.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -96.69 129.26 44.13 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.267 1.027 . . . . 71.14 109.919 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.4 t -110.9 116.98 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.81 -1.182 . . . . 51.51 107.81 170.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.4 t -99.66 131.88 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.521 -0.918 . . . . 50.35 108.521 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.85 108.92 12.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.064 -1.087 . . . . 64.24 108.064 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.4 ttm180 -85.54 113.08 21.51 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.481 0.713 . . . . 73.22 109.796 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.49 103.43 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.26 -1.015 . . . . 74.42 108.26 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.4 m -102.37 138.87 38.73 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.097 -0.705 . . . . 65.25 109.097 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.63 122.61 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.203 1.001 . . . . 74.12 109.91 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 39.8 m -120.49 100.37 7.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.987 0.915 . . . . 51.32 109.59 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 133.7 42.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.333 0.653 . . . . 74.23 109.879 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 20.7 m -148.03 126.7 12.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.064 0.946 . . . . 75.52 109.636 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.0 pp -126.53 140.26 52.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.267 0.627 . . . . 72.53 111.404 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 -111.84 3.72 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.196 -1.161 . . . . 55.23 110.196 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 4.47 9.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 63.1 110.797 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.99 173.7 7.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.981 0.512 . . . . 54.21 110.542 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -82.09 139.15 34.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 52.13 109.638 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.744 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.7 -67.36 0.8 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.567 -0.901 . . . . 24.35 108.567 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -155.2 164.89 38.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.443 -1.253 . . . . 64.3 110.061 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 94.6 mt -134.38 151.68 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.229 1.412 . . . . 74.11 108.529 -176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.577 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.6 t -158.22 148.11 19.92 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.229 0.612 . . . . 52.14 110.097 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.59 126.05 6.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.476 0.71 . . . . 74.11 109.593 171.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.23 114.79 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.899 0.48 . . . . 71.43 109.772 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.8 mt-30 -90.56 88.78 7.27 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.949 -0.76 . . . . 74.5 108.949 173.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.34 96.39 6.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.657 -1.156 . . . . 72.32 109.328 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.01 141.64 17.81 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.046 -0.822 . . . . 63.13 111.046 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.41 128.59 4.56 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 110.537 -1.025 . . . . 61.15 110.537 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 29.5 mt -93.39 127.04 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.987 -1.116 . . . . 71.11 107.987 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -128.78 126.66 40.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.658 0.783 . . . . 63.21 110.18 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -82.99 93.4 7.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.602 -0.888 . . . . 63.23 108.602 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.9 mt -108.45 109.73 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.772 -0.825 . . . . 72.41 108.772 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.48 167.15 21.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.16 0.984 . . . . 62.31 110.428 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.94 0.78 57.32 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.787 0.675 . . . . 64.41 114.787 170.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 29.0 pt -137.92 162.21 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.513 1.125 . . . . 74.44 109.73 -178.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.29 3.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.326 1.051 . . . . 73.34 109.501 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.41 -122.79 29.31 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 115.514 0.966 . . . . 75.32 115.514 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -60.31 -54.13 49.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.911 1.284 . . . . 54.22 112.137 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -70.94 -39.72 72.45 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.383 0.427 . . . . 71.45 111.752 -172.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -42.89 59.23 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.908 0.483 . . . . 74.43 111.269 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.92 83.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.94 0.496 . . . . 72.34 110.817 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -74.7 -27.18 60.28 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.681 -0.69 . . . . 75.34 110.771 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.51 -50.76 64.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.036 0.534 . . . . 71.01 110.381 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' G' ' 278' ' ' LEU . 4.3 pp -79.66 -17.51 53.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.404 0.282 . . . . 74.54 111.391 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.36 -5.7 84.81 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.327 0.392 . . . . 71.34 114.069 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.12 -59.03 0.31 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.908 0.354 . . . . 64.32 111.534 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -74.38 -53.71 9.07 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.413 0.685 . . . . 62.21 112.118 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.45 -43.27 88.55 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.053 1.131 . . . . 74.33 114.053 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.79 -29.15 50.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.823 1.682 . . . . 64.54 111.874 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.9 -22.32 59.74 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.191 0.996 . . . . 73.12 110.664 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.1 mm -76.95 -45.01 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.387 0.675 . . . . 74.03 109.95 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.7 mt -72.47 -30.98 65.04 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.576 -0.738 . . . . 71.5 111.807 -174.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.78 -41.96 60.14 Favored Pre-proline 0 CA--C 1.568 1.662 0 N-CA-C 114.405 1.261 . . . . 62.24 114.405 -169.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.48 -39.56 74.02 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.381 2.054 . . . . 61.11 113.578 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -75.72 -35.5 60.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.612 0.765 . . . . 74.3 110.913 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.8 79.01 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.234 0.614 . . . . 72.4 110.279 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -59.6 -46.17 89.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.626 1.17 . . . . 71.13 110.78 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.73 -44.78 96.24 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.141 0.901 . . . . 74.3 111.014 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.82 -45.14 93.3 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.864 0.728 . . . . 74.3 110.691 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.577 HG12 ' SG ' ' D' ' 76' ' ' CYS . 57.6 mt -59.53 -54.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.017 0.927 . . . . 74.24 110.686 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -47.62 66.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.481 1.112 . . . . 62.42 111.302 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.06 -42.8 93.87 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.425 -1.261 . . . . 51.53 110.809 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.416 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -70.68 -37.34 73.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.777 0.431 . . . . 53.22 111.812 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.442 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -65.15 -41.51 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.684 -0.689 . . . . 74.53 109.774 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -72.21 -29.04 63.58 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 122.985 0.514 . . . . 55.03 111.241 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -70.82 -29.07 65.13 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.397 0.679 . . . . 70.11 110.418 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 10.1 60.11 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.954 -0.566 . . . . 42.03 112.576 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.9 p 59.87 23.43 12.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.853 2.061 . . . . 74.13 112.985 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 51.5 m-85 -88.84 174.61 4.83 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 125.193 1.397 . . . . 65.33 108.831 170.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 33.9 Cg_endo -59.21 167.36 6.04 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.913 2.408 . . . . 75.31 113.929 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -73.82 131.28 41.37 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.937 -1.135 . . . . 74.45 107.937 164.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.46 93.59 4.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.706 -1.22 . . . . 64.51 107.706 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -98.23 99.01 10.2 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.539 -1.282 . . . . 71.21 107.539 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.44 HD21 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -71.08 136.03 48.04 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.768 -0.651 . . . . 73.24 109.664 -176.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.81 137.31 87.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.417 1.087 . . . . 73.21 111.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' B' ' 13' ' ' ILE . 16.9 Cg_exo -68.91 106.26 1.48 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.935 2.423 . . . . 44.23 111.921 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.81 109.16 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.554 0.741 . . . . 45.11 109.152 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -85.73 106.88 17.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.338 0.655 . . . . 44.41 109.795 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -64.42 -31.84 73.22 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.148 0.979 . . . . 72.31 111.429 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -62.72 -46.78 86.52 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.106 -0.952 . . . . 74.21 110.772 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.5 92.95 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.288 0.993 . . . . 72.44 111.815 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.16 -48.58 67.58 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.423 0.689 . . . . 73.43 111.513 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -71.86 -32.12 67.17 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.097 0.559 . . . . 74.45 111.059 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 43.7 ttm -58.68 -37.57 76.34 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.558 1.143 . . . . 63.05 111.379 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.21 -35.46 78.95 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.022 -0.99 . . . . 61.41 111.695 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -57.84 -43.74 86.03 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.351 0.661 . . . . 74.24 110.921 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.2 mp -67.14 -43.15 83.08 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.771 -0.65 . . . . 71.21 111.336 -177.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.421 ' OE1' ' HG3' ' D' ' 143' ' ' GLN . 0.0 OUTLIER -90.34 4.24 51.37 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.92 0.711 . . . . 71.12 112.92 -174.454 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.421 ' HG3' ' OE1' ' D' ' 142' ' ' GLN . 75.6 mt-30 -119.62 46.95 1.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.345 0.593 . . . . 73.34 109.889 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -159.05 19.76 0.19 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.527 -0.761 . . . . 64.15 110.919 173.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.62 6.72 8.21 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.503 0.721 . . . . 73.02 111.224 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.78 -84.24 0.47 Allowed Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.02 -0.832 . . . . 75.01 111.02 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -130.17 -59.0 1.06 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.017 -1.105 . . . . 72.11 108.017 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.27 -77.06 1.58 Allowed Glycine 0 C--N 1.346 1.111 0 CA-C-N 114.83 -1.077 . . . . 72.21 111.696 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.7 t -151.29 157.88 43.12 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.977 0.911 . . . . 73.52 109.293 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -175.96 5.0 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.495 0.718 . . . . 73.31 109.974 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -131.63 -64.4 0.79 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.223 0.609 . . . . 73.11 109.389 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -84.33 84.75 7.52 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.737 -0.838 . . . . 72.11 108.737 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -64.35 108.83 1.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.468 0.707 . . . . 72.31 111.688 -170.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -160.74 86.08 0.71 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.482 -0.932 . . . . 75.34 108.482 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 123.879 0.872 . . . . 73.41 109.188 178.715 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 119.267 -0.397 . . . . 72.44 110.186 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 66.1 t30 79.86 -12.21 1.08 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.683 1.593 . . . . 72.12 111.818 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 67.18 -73.11 0.08 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 126.168 1.787 . . . . 74.34 111.878 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -60.95 -74.58 0.08 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.664 1.186 . . . . 54.4 111.459 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -125.08 88.9 53.49 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 122.809 0.443 . . . . 60.2 110.504 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.14 -32.11 7.13 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.408 2.739 . . . . 74.03 114.406 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.13 -30.4 70.39 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.702 0.401 . . . . 72.25 110.427 -173.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.31 55.88 0.84 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.078 0.551 . . . . 72.34 110.182 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -75.86 -38.21 36.82 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.97 -0.559 . . . . 62.53 112.226 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 95' ' ' ALA . 1.0 OUTLIER -133.17 -168.62 2.12 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.016 0.926 . . . . 73.12 109.634 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 85.3 t80 73.41 132.95 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.839 1.656 . . . . 65.52 110.096 -171.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 282' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . . . 72.87 5.38 5.19 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.215 1.406 . . . . 64.45 111.457 -169.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.1 -9.11 49.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.612 0.765 . . . . 73.5 110.611 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -157.97 -58.61 0.01 OUTLIER Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.963 -0.455 . . . . 65.54 111.963 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 70.08 172.58 0.31 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.474 1.51 . . . . 75.31 111.904 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 286' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' E' ' 287' ' ' PRO . 0.0 OUTLIER -131.45 122.84 19.13 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.399 0.679 . . . . 75.54 110.171 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' E' E ' 287' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' E' ' 286' ' ' MET . 2.0 Cg_endo -82.15 115.32 2.62 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.702 2.268 . . . . 74.55 111.169 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 84.1 t -86.09 125.36 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.569 -0.9 . . . . 70.23 108.569 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -89.23 172.74 8.84 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.554 0.741 . . . . 45.24 109.747 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -72.27 150.01 43.99 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.314 0.578 . . . . 62.12 111.556 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.23 11.12 17.33 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.603 -1.181 . . . . 72.54 110.932 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -159.49 -176.74 31.89 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.978 -0.556 . . . . 65.15 112.42 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -87.89 -155.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.893 3.062 . . . . 74.31 113.842 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -56.75 87.31 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.565 1.146 . . . . 51.34 110.597 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 295' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' G' ' 304' ' ' PRO . . . -142.15 -168.64 2.76 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.472 -0.786 . . . . 60.53 109.815 -172.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 46.6 m 79.22 -28.47 0.15 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.93 1.692 . . . . 75.33 112.114 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.728 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 21.7 t80 -77.0 86.3 3.52 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.784 0.834 . . . . 70.41 111.691 -170.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 298' ' ' HIS . . . . . 0.815 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 1.2 p-80 -145.76 54.69 1.17 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 125.067 1.347 . . . . 73.53 111.279 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.06 166.5 19.04 Favored Glycine 0 N--CA 1.482 1.708 0 CA-C-O 119.062 -0.854 . . . . 53.13 112.016 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 300' ' ' ASN . . . . . 0.534 ' HA ' ' ND2' ' G' ' 300' ' ' ASN . 27.6 t-20 -64.42 96.48 0.16 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.97 0.508 . . . . 74.12 110.224 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 32' ' ' PHE . 15.4 tt -133.54 4.76 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.859 0.864 . . . . 70.33 110.446 -172.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -52.79 -63.99 0.96 Allowed 'General case' 0 C--N 1.363 1.163 0 C-N-CA 124.5 1.12 . . . . 61.34 111.495 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 53.73 70.02 1.95 Allowed Pre-proline 0 CA--C 1.558 1.286 0 O-C-N 124.785 1.303 . . . . 74.41 110.432 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.35 -63.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.265 1.977 . . . . 73.11 112.468 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -171.82 124.56 0.55 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.923 0.889 . . . . 63.22 109.352 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 86.4 t -100.46 122.13 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.822 -0.807 . . . . 74.42 108.822 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 27.0 m -77.02 132.53 39.0 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.171 0.588 . . . . 74.22 110.34 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 53.9 m -66.76 159.63 27.54 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.054 0.941 . . . . 51.01 111.133 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 6.1 p -68.67 -40.77 19.24 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-O 117.887 -1.054 . . . . 73.33 113.364 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.399 3.234 0 CA-C-N 121.733 1.655 . . . . 73.45 111.573 170.05 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.219 -0.289 . . . . 53.31 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -80.68 142.82 33.54 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.789 0.836 . . . . 73.54 111.859 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -113.85 -50.81 2.82 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.904 0.882 . . . . 72.31 109.504 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -155.91 129.14 8.16 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.66 0.784 . . . . 74.35 109.65 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.78 -50.3 71.81 Favored Pre-proline 0 N--CA 1.49 1.542 0 CA-C-O 118.422 -0.799 . . . . 70.31 112.927 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.63 -174.0 0.97 Allowed 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 121.623 1.549 . . . . 72.31 112.423 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.27 168.63 5.37 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.435 -0.802 . . . . 70.22 110.304 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.546 HD12 ' HE3' ' C' ' 94' ' ' MET . 5.4 mp 79.15 95.18 0.06 Allowed 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 125.211 1.404 . . . . 74.55 109.874 -170.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -139.54 43.78 1.13 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.058 -0.519 . . . . 74.33 113.104 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 10.5 tt -178.98 -53.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.938 -1.134 . . . . 72.42 107.938 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -80.9 172.0 14.29 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.133 -1.394 . . . . 73.11 110.549 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 72.04 20.55 4.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.001 1.32 . . . . 61.12 109.664 -171.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -140.82 134.49 30.23 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.973 1.709 . . . . 61.5 108.001 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -80.07 64.63 3.91 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 112.007 -0.437 . . . . 42.01 112.007 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -67.91 -49.89 59.28 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.709 0.804 . . . . 73.31 110.724 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 65.6 mtt -103.36 106.32 51.0 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.884 0.874 . . . . 73.31 109.284 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.97 -38.16 23.71 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.32 2.68 . . . . 74.51 112.817 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 17.6 t 56.42 55.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.986 1.314 . . . . 72.4 110.548 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -79.62 71.01 6.21 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.511 -0.768 . . . . 55.55 110.724 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 98.6 m95 61.17 91.85 0.06 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.962 1.705 . . . . 75.24 114.144 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 91.66 0.17 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.75 -1.114 . . . . 75.44 108.808 163.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.89 108.68 0.98 Allowed Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.493 -1.17 . . . . 71.12 110.517 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.16 113.51 1.56 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.528 2.819 . . . . 71.11 112.539 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 294' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' C' ' 129' ' ' ALA . 60.7 mttp -126.87 86.31 2.49 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.849 0.859 . . . . 72.44 109.165 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -77.32 142.32 39.46 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.303 -0.862 . . . . 62.43 111.778 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 296' ' ' THR . . . . . 0.483 HG22 ' H ' ' F' ' 297' ' ' TYR . 4.6 m -80.17 178.45 8.25 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 108.132 -1.062 . . . . 75.04 108.132 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.483 ' H ' HG22 ' F' ' 296' ' ' THR . 94.1 m-85 64.4 19.67 11.88 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.882 0.873 . . . . 71.41 112.596 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -68.15 116.64 8.99 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 108.439 -0.948 . . . . 64.4 108.439 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 90.0 123.89 2.59 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.629 -0.989 . . . . 44.24 110.629 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -60.78 116.53 4.49 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.195 0.998 . . . . 64.12 110.734 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.523 HG21 ' HD3' ' C' ' 124' ' ' PRO . 2.7 pp -114.92 14.83 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.49 0.716 . . . . 42.14 111.796 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -55.36 -27.84 49.94 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.318 1.047 . . . . 73.02 111.306 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 303' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' F' ' 303' ' ' LYS . 0.3 OUTLIER -78.28 123.11 85.92 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 114.779 -1.101 . . . . 71.32 108.762 175.033 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.59 -31.29 48.86 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 124.081 3.188 . . . . 71.4 114.072 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 76.21 -47.13 0.55 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.579 1.552 . . . . 63.41 112.017 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 306' ' ' VAL . . . . . 0.433 HG13 ' HB1' ' B' ' 129' ' ' ALA . 57.5 t -71.85 101.83 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.058 -0.719 . . . . 63.42 109.058 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 15.0 t -162.17 -175.59 4.67 Favored 'General case' 0 C--O 1.247 0.933 0 C-N-CA 125.164 1.386 . . . . 73.45 107.399 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 308' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' B' ' 149' ' ' THR . 52.0 t 64.69 30.45 12.51 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.768 0.794 . . . . 52.1 110.455 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 40.4 p -88.48 119.96 70.25 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.028 0.931 . . . . 71.13 109.773 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 C--N 1.38 2.186 0 C-N-CA 122.764 2.31 . . . . 72.2 111.311 174.542 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 110.308 -0.256 . . . . 73.23 110.308 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -79.33 86.38 5.07 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.342 -0.614 . . . . 71.52 109.342 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -121.48 154.46 36.58 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.22 0.608 . . . . 62.43 109.781 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -123.7 149.53 45.4 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.218 1.007 . . . . 65.21 109.209 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 57.9 mttp 55.27 65.54 4.64 Favored Pre-proline 0 CA--C 1.562 1.429 0 C-N-CA 124.486 1.114 . . . . 65.52 110.306 -171.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.12 80.08 2.97 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.51 2.14 . . . . 64.23 110.706 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 50.7 mt 66.29 170.57 0.23 Allowed 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.838 1.255 . . . . 73.32 111.241 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 278' ' ' LEU . . . . . 0.609 ' HA ' HD21 ' D' ' 98' ' ' LEU . 3.8 mm? 67.06 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.246 1.418 . . . . 62.32 112.3 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 67.84 -97.46 0.42 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 111.903 -0.479 . . . . 75.43 111.903 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.5 HD13 ' H ' ' G' ' 283' ' ' ASP . 2.8 pp -165.18 168.88 16.69 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.272 1.029 . . . . 65.23 110.204 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -76.76 -70.32 0.46 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.392 0.433 . . . . 72.54 110.023 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -158.26 43.5 0.29 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.32 -0.622 . . . . 63.42 109.32 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 283' ' ' ASP . . . . . 0.5 ' H ' HD13 ' G' ' 280' ' ' LEU . 6.3 m-20 58.25 78.06 0.26 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.728 1.211 . . . . 55.34 110.126 -176.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.64 -159.77 25.05 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.428 -0.806 . . . . 72.22 111.549 -170.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -95.82 145.53 25.27 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.663 0.785 . . . . 73.24 110.111 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 54.7 tpp -65.82 128.16 93.62 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.671 0.789 . . . . 70.05 110.05 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -65.97 86.47 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.43 2.086 . . . . 71.34 112.018 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 89.7 t -79.23 114.22 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.596 0.758 . . . . 63.21 109.409 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -121.07 147.51 45.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.902 0.881 . . . . 73.33 109.697 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.428 ' NE1' ' HG ' ' D' ' 42' ' ' LEU . 15.5 m95 -70.84 115.1 9.59 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.046 0.539 . . . . 72.12 110.407 173.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.79 -48.92 77.04 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.404 0.682 . . . . 73.41 109.248 173.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -127.5 99.78 0.53 Allowed Glycine 0 C--N 1.345 1.047 0 CA-C-O 118.763 -1.02 . . . . 62.25 110.672 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.94 -11.88 23.38 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.545 2.83 . . . . 63.24 114.085 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -138.78 25.78 2.54 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.043 0.937 . . . . 73.31 110.571 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -73.32 -1.61 18.7 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.67 0.788 . . . . 75.04 112.554 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 77.4 m -124.02 130.93 53.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.12 1.368 . . . . 73.24 109.462 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' D' ' 37' ' ' GLN . 0.6 OUTLIER 75.43 160.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.035 1.334 . . . . 73.54 112.165 172.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.38 -42.61 0.12 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.247 1.419 . . . . 71.52 107.776 170.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 152.58 112.23 0.5 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.555 -0.618 . . . . 45.21 111.555 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 300' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' E' ' 300' ' ' ASN . 38.2 m-80 -115.67 -2.71 12.4 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 117.166 0.483 . . . . 71.12 111.187 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.418 ' CD1' ' HB3' ' D' ' 35' ' ' ASP . 63.0 mt -72.86 89.16 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-O 121.976 0.893 . . . . 74.04 109.498 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -161.36 175.52 12.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.941 1.696 . . . . 70.23 106.852 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 67.14 127.04 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.895 0 C-N-CA 124.144 0.978 . . . . 64.21 111.913 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 304' ' ' PRO . . . . . 0.41 ' O ' ' HB1' ' E' ' 295' ' ' ALA . 34.4 Cg_exo -61.52 156.37 47.4 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.702 2.268 . . . . 64.1 112.687 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -154.04 125.32 7.42 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.955 -0.757 . . . . 61.34 108.955 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 99.9 t 67.17 136.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.887 1.275 . . . . 62.21 111.885 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 38.8 m -140.58 143.87 35.53 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.453 -0.943 . . . . 72.32 108.453 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 11.3 p -58.55 140.27 54.47 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.811 0.844 . . . . 40.25 110.575 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 24.8 p -55.2 103.69 0.38 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.929 1.291 . . . . 62.15 112.192 -172.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' G' G ' 310' ' ' PRO . . . . . 0.429 ' HB2' ' HB3' ' C' ' 150' ' ' GLU . 60.1 Cg_endo . . . . . 0 C--N 1.38 2.207 0 C-N-CA 123.204 2.603 . . . . 64.52 111.551 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.588 -0.523 . . . . 74.33 109.588 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 14.4 m120 60.31 36.49 20.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.397 1.079 . . . . 60.24 112.021 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -61.83 -24.25 66.76 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.216 0.607 . . . . 74.32 111.314 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -92.54 134.22 35.19 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 107.494 -1.298 . . . . 74.12 107.494 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -109.19 93.16 12.49 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.953 -0.758 . . . . 71.53 108.953 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -85.03 112.78 1.47 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.543 2.162 . . . . 75.23 111.401 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.17 -44.52 92.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.326 0.65 . . . . 74.34 110.23 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 278' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' H' ' 281' ' ' PHE . 1.9 tm? -58.48 118.07 5.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.156 0.982 . . . . 73.33 111.257 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -144.74 50.66 0.64 Allowed Glycine 0 C--N 1.345 1.06 0 O-C-N 123.842 0.714 . . . . 74.44 111.694 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 280' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' B' ' 95' ' ' ALA . 47.8 tp -146.11 -59.64 0.31 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.828 0.451 . . . . 63.14 110.85 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 281' ' ' PHE . . . . . 0.573 ' HB2' HD11 ' H' ' 278' ' ' LEU . 38.4 m-85 -61.89 103.42 0.35 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.064 0.546 . . . . 75.45 110.926 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.81 -73.29 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.836 0.854 . . . . 35.42 108.714 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -133.89 -34.05 1.02 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.034 0.934 . . . . 70.34 110.297 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.63 93.24 0.37 Allowed Glycine 0 C--N 1.348 1.245 0 O-C-N 123.568 0.543 . . . . 74.03 112.739 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -124.27 154.18 40.61 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.83 0.852 . . . . 65.15 109.043 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -72.54 121.11 84.02 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.213 0.605 . . . . 70.33 109.502 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.45 99.87 0.45 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.28 1.987 . . . . 62.53 111.267 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.02 -33.23 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.335 1.054 . . . . 75.12 111.043 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 76.93 -20.03 0.4 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 125.086 1.354 . . . . 74.02 112.535 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 66.98 124.31 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.187 1.395 . . . . 74.01 109.845 -167.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.56 155.24 30.09 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.239 1.016 . . . . 62.23 112.105 -168.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -52.84 -59.59 9.1 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 124.653 1.221 . . . . 51.13 113.881 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.97 127.28 10.58 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.565 2.177 . . . . 73.51 111.474 170.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -94.12 112.66 24.5 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.612 -0.884 . . . . 72.3 108.612 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.14 -9.89 59.38 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.708 0.803 . . . . 71.44 112.169 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 296' ' ' THR . . . . . 0.457 ' HB ' HG21 ' B' ' 40' ' ' VAL . 4.7 m -70.92 130.24 41.12 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.396 1.078 . . . . 73.22 111.556 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 1.7 t80 59.62 98.94 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.398 1.479 . . . . 73.42 111.305 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -131.52 131.63 43.56 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.449 0.7 . . . . 73.21 109.384 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 109.39 170.41 20.49 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.476 -1.05 . . . . 62.44 110.476 -167.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -132.75 161.96 32.69 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.983 0.913 . . . . 75.11 108.981 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 301' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' B' ' 35' ' ' ASP . 67.9 mt -63.58 -58.91 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.628 -0.878 . . . . 72.33 108.628 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 37.3 t70 61.94 -76.93 0.03 OUTLIER 'General case' 0 C--N 1.356 0.89 0 C-N-CA 126.005 1.722 . . . . 62.43 112.021 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -106.06 119.79 51.04 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.895 0.878 . . . . 60.1 109.202 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.33 85.97 0.16 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.73 2.287 . . . . 63.22 111.021 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.41 -9.96 59.04 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.962 0.905 . . . . 72.44 112.574 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.72 78.82 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 108.505 -0.924 . . . . 74.12 108.505 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 21.5 p -110.31 -178.14 3.43 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 114.289 -1.323 . . . . 74.13 109.957 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 74.6 m -58.43 120.17 8.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.182 0.593 . . . . 74.22 109.979 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 41.2 p -55.54 113.79 6.2 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.771 1.229 . . . . 74.43 111.429 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--N 1.38 2.233 0 C-N-CA 122.88 2.386 . . . . 41.52 112.509 -175.923 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.111 -0.7 . . . . 63.21 109.111 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 m -64.9 119.58 10.96 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.069 0.948 . . . . 74.4 111.118 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -87.9 0.08 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 106.908 -1.516 . . . . 60.24 106.908 170.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 61.04 11.67 3.53 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 114.758 1.392 . . . . 54.44 114.758 167.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -74.81 -28.68 60.81 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.873 0.469 . . . . 63.12 110.693 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.521 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 87.2 m-20 59.75 47.92 9.82 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.085 0.866 . . . . 73.44 111.608 172.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 p -78.13 -67.26 0.75 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.714 0.805 . . . . 64.13 111.798 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -90.67 3.18 54.91 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.339 0.656 . . . . 72.25 112.187 -171.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.521 ' SD ' ' HB3' ' A' ' 6' ' ' ASN . 17.7 ptm -58.28 133.78 55.98 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-O 121.526 0.679 . . . . 74.42 111.883 -172.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.9 m -151.06 140.17 21.15 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.7 -1.136 . . . . 41.51 108.391 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -134.25 134.87 42.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.168 -0.678 . . . . 73.4 109.168 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -152.39 117.71 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.89 -1.152 . . . . 75.45 107.89 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.402 HG12 ' HD2' ' A' ' 84' ' ' PHE . 51.5 mt -75.07 126.78 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.123 -0.695 . . . . 63.24 109.123 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -92.04 -37.93 12.52 Favored 'General case' 0 C--O 1.243 0.758 0 O-C-N 123.829 0.705 . . . . 74.14 110.793 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -176.92 127.92 0.17 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.78 0.675 . . . . 72.4 111.629 -173.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.52 136.62 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.328 -0.99 . . . . 61.43 108.328 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 26.1 p90 -170.02 156.45 6.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 64.15 111.226 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -82.27 113.55 20.16 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.801 -0.814 . . . . 71.53 108.801 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -75.04 -31.23 61.26 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.66 -0.496 . . . . 74.52 109.66 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -150.88 141.13 22.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.008 -0.996 . . . . 61.52 109.889 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -134.67 143.86 36.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 125.503 1.521 . . . . 64.14 107.167 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 35.9 t -153.02 132.83 13.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.841 0.856 . . . . 64.13 108.738 174.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 82.4 t80 -139.87 119.21 12.91 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.78 -1.563 . . . . 72.42 106.78 174.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.19 131.09 54.85 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.147 0.579 . . . . 65.21 109.869 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.62 77.67 63.8 Favored Pre-proline 0 C--O 1.243 0.761 0 N-CA-C 106.709 -1.589 . . . . 63.35 106.709 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.75 -39.89 24.46 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.519 2.146 . . . . 74.02 111.764 -173.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.13 25.38 5.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.353 -0.84 . . . . 44.22 110.154 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -57.09 9.22 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 117.565 -1.207 . . . . 65.11 113.458 -169.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.0 -21.78 68.33 Favored 'Trans proline' 0 C--N 1.398 3.135 0 CA-C-N 122.132 1.797 . . . . 44.13 112.804 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -85.07 -40.31 16.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.15 0.98 . . . . 74.4 110.643 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.9 p -76.92 -20.35 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.545 -0.752 . . . . 74.5 112.079 -159.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.5 ' HA ' HD11 ' E' ' 301' ' ' ILE . 38.5 m-85 -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.002 0.521 . . . . 74.1 112.231 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -103.9 -11.13 17.67 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.43 0.692 . . . . 71.42 112.755 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HE3' ' HG2' ' A' ' 71' ' ' GLU . 20.9 mmtt -65.4 171.1 4.18 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.136 0.974 . . . . 73.13 113.598 -170.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.12 122.05 5.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.181 1.393 . . . . 71.44 111.948 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -86.95 63.26 7.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.085 0.554 . . . . 72.43 110.241 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -147.38 82.31 8.27 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 123.871 0.868 . . . . 50.44 109.082 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' E' ' 294' ' ' LYS . 5.2 Cg_endo -84.47 165.52 12.39 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.98 2.454 . . . . 75.52 112.772 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.36 106.05 8.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.288 -1.375 . . . . 73.0 107.288 161.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' E' ' 294' ' ' LYS . 10.3 p -79.0 91.54 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 123.066 1.412 . . . . 74.24 108.467 176.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 40.6 tttm -83.7 118.15 23.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 113.924 -1.489 . . . . 52.23 109.89 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -97.22 111.35 23.63 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.388 -1.338 . . . . 70.42 107.388 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.67 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 19.6 m-20 -108.4 108.35 19.27 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.38 118.09 34.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.487 -1.301 . . . . 72.4 107.487 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.64 153.99 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.984 0.914 . . . . 64.43 109.074 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -135.16 156.61 48.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.07 0.948 . . . . 71.2 110.415 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -163.97 142.5 7.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 41.13 109.493 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.535 ' HB2' HD13 ' E' ' 278' ' ' LEU . 37.4 p -128.81 158.46 38.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.611 . . . . 60.43 109.532 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -154.85 136.77 14.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.933 0.893 . . . . 53.34 108.599 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -103.72 103.39 13.28 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.515 -0.92 . . . . 72.21 108.515 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.49 -31.21 37.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.339 0.655 . . . . 71.03 110.807 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -162.83 176.77 9.9 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.618 1.167 . . . . 72.12 109.243 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.69 135.91 54.75 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.091 -0.707 . . . . 74.3 109.091 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t70 69.36 -7.79 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.929 1.291 . . . . 65.43 111.975 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 90.9 t -119.88 98.24 6.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.667 0.787 . . . . 74.2 109.046 -172.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -120.57 125.28 47.4 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.734 -1.121 . . . . 74.11 108.386 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.78 131.48 39.1 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.921 0.888 . . . . 75.2 110.126 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.4 t -108.58 126.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.584 -1.265 . . . . 72.25 107.584 168.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 57.3 t -109.39 133.72 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.612 -0.884 . . . . 75.13 108.612 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -125.41 106.09 9.56 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.171 -1.418 . . . . 70.11 107.171 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.578 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 31.6 ttp180 -92.28 109.31 20.68 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 122.911 0.485 . . . . 61.32 109.745 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.69 126.84 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 106.934 -1.506 . . . . 53.11 106.934 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.67 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 98.0 m -123.82 123.26 40.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.498 -0.927 . . . . 54.53 108.498 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 69.8 t -116.51 108.25 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.184 0.994 . . . . 44.23 109.19 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 9.8 m -105.05 146.37 29.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.153 -0.684 . . . . 54.31 109.153 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 121.81 20.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.985 -1.117 . . . . 74.2 107.985 169.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.2 m -124.59 127.38 47.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.259 0.552 . . . . 73.32 110.86 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.67 85.26 7.05 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 126.134 1.773 . . . . 72.03 110.259 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.95 -80.88 1.55 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.897 -0.881 . . . . 72.1 110.897 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -130.75 -25.94 2.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.78 0.832 . . . . 65.03 110.83 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HG2' ' HE3' ' A' ' 34' ' ' LYS . 7.8 tp10 -82.96 134.91 35.04 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.648 0.779 . . . . 75.51 110.795 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 90.8 m -79.54 139.29 37.59 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 118.738 0.699 . . . . 63.25 111.893 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.838 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.79 -68.49 0.69 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.169 0.988 . . . . 71.51 110.512 170.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -152.82 167.28 29.58 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.492 -0.777 . . . . 72.25 111.126 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 tp -141.39 142.95 33.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.639 1.175 . . . . 65.2 108.65 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.2 m -142.37 104.53 4.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.633 0.373 . . . . 71.5 111.154 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 7.0 mp0 -103.5 132.86 49.39 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.259 -0.645 . . . . 71.31 109.259 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -140.4 110.38 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.16 -0.681 . . . . 62.44 109.16 173.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.7 mt-30 -85.27 85.39 7.46 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.139 -1.06 . . . . 74.24 108.139 171.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -77.23 97.03 4.69 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.102 -0.954 . . . . 74.34 108.887 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.71 146.16 20.52 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.434 -0.803 . . . . 73.13 111.5 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.597 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.39 120.82 1.25 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 110.397 -1.081 . . . . 73.44 110.397 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.0 mt -83.03 122.94 38.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.646 -0.872 . . . . 64.23 108.646 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.49 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 49.9 m-85 -126.37 120.49 29.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.133 -0.692 . . . . 73.31 109.133 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.7 t -81.67 104.48 12.1 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.001 -1.111 . . . . 72.32 108.001 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 pt -137.9 149.41 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 73.3 110.598 -171.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' MET . . . -173.75 177.99 2.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.988 1.315 . . . . 65.31 109.512 173.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.18 10.27 71.75 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.553 0.533 . . . . 74.2 114.061 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.19 138.08 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.89 0.876 . . . . 63.24 109.749 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -130.39 170.15 14.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.234 0.614 . . . . 62.22 110.841 -173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.42 -117.04 2.2 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.176 0.923 . . . . 75.33 115.22 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -64.25 -26.9 68.71 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.133 0.973 . . . . 73.23 112.261 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.06 -44.01 55.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.607 0.763 . . . . 71.44 110.828 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -71.17 -34.16 70.69 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.706 -0.479 . . . . 64.43 109.706 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.415 ' HB1' HD22 ' E' ' 280' ' ' LEU . . . -67.28 -40.28 86.12 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.418 -0.81 . . . . 73.43 110.174 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -67.85 -29.6 68.77 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.154 -0.93 . . . . 75.21 110.444 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.544 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 29.6 t -66.79 -38.56 86.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.859 0.464 . . . . 74.33 110.957 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.675 HD21 HD22 ' E' ' 278' ' ' LEU . 74.6 mt -81.71 -43.57 18.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.493 0.317 . . . . 72.45 110.804 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.96 -20.69 77.5 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.709 0.644 . . . . 72.24 114.709 -171.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -141.58 -63.39 0.45 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.407 0.604 . . . . 44.31 112.56 -168.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 53.8 t80 -56.71 -64.45 0.87 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.529 1.532 . . . . 73.23 113.024 -167.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 90.9 m -77.42 -35.57 1.34 Allowed Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 114.426 1.269 . . . . 50.11 114.426 -173.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 55.6 Cg_endo -67.81 -20.08 46.22 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.022 1.815 . . . . 32.43 112.999 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 3.3 t30 -74.66 -18.09 60.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.217 0.607 . . . . 73.33 110.091 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.7 mm -74.85 -39.28 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.74 0.816 . . . . 70.31 109.281 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.597 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.1 mt -75.29 -37.87 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.294 1.038 . . . . 64.43 112.495 -173.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.411 ' HZ ' ' HG ' ' A' ' 128' ' ' LEU . 52.4 t80 -57.26 -43.13 99.01 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.04 1.126 . . . . 72.05 114.04 -169.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.99 -39.06 86.59 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.188 1.925 . . . . 72.35 113.726 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -76.77 -38.63 53.73 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.41 0.684 . . . . 73.21 111.904 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.67 94.9 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.847 -0.427 . . . . 71.53 109.847 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -57.71 -49.93 74.89 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.618 1.199 . . . . 73.42 110.278 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.74 -44.43 96.24 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.577 1.173 . . . . 75.01 110.905 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.6 t -56.72 -48.54 77.52 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.099 0.874 . . . . 71.2 110.23 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.2 mt -64.69 -42.26 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.263 0.977 . . . . 75.11 110.814 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.528 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.9 m -54.63 -48.04 72.75 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.562 0.745 . . . . 55.32 110.422 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.1 t -63.8 -46.05 86.9 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.306 -1.316 . . . . 74.35 109.838 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 20.1 mtp -57.64 -46.44 84.17 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.118 0.967 . . . . 54.44 112.115 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.0 t -63.27 -45.02 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.232 1.013 . . . . 71.01 110.283 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.2 t -66.19 -30.43 70.89 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.813 -1.085 . . . . 72.0 110.788 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.13 -28.6 60.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.702 0.801 . . . . 63.22 110.435 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 10.27 52.64 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 116.146 -0.479 . . . . 43.32 113.345 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.3 m 71.33 13.34 6.63 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.428 1.491 . . . . 71.11 112.122 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -96.16 145.8 30.19 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.732 -1.21 . . . . 73.14 107.732 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' G' ' 303' ' ' LYS . 36.7 Cg_endo -59.05 157.59 28.83 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.722 2.281 . . . . 74.44 112.213 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.774 HE22 ' HB ' ' C' ' 16' ' ' ILE . 23.0 tt0 -50.71 125.39 13.09 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 124.195 0.934 . . . . 63.22 111.28 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 64' ' ' VAL . 17.9 tp -109.2 119.48 39.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.146 -0.934 . . . . 64.43 109.222 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -134.85 94.94 3.24 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.394 1.078 . . . . 65.22 108.18 179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.411 ' HG ' ' HZ ' ' A' ' 107' ' ' PHE . 18.8 tp -62.12 131.78 50.64 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.027 -0.988 . . . . 74.42 109.723 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.91 129.27 47.57 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.266 1.027 . . . . 52.22 111.641 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.16 104.19 0.84 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.397 2.064 . . . . 72.32 111.034 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.57 HG21 HG13 ' E' ' 288' ' ' VAL . 85.3 t -98.71 117.6 43.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.026 -1.102 . . . . 73.54 108.026 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.421 HD22 ' HB2' ' A' ' 135' ' ' ALA . 33.5 t30 -63.48 99.65 0.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.409 1.068 . . . . 63.25 109.475 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -67.1 -24.21 65.91 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.176 -0.466 . . . . 72.44 111.247 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.408 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 10.2 t70 -56.09 -47.79 77.35 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.896 0.878 . . . . 74.43 110.654 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.537 ' HB1' HG21 ' C' ' 7' ' ' THR . . . -57.82 -37.66 74.2 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.503 1.127 . . . . 50.0 112.679 -172.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.46 -37.9 85.3 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 120.925 0.393 . . . . 74.15 111.324 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -86.22 -29.9 22.8 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.548 0.739 . . . . 60.42 111.425 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 59.6 tpp -74.01 -39.89 63.31 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.826 0.851 . . . . 75.14 111.231 -171.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -56.13 -39.95 73.03 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.98 0.8 . . . . 72.15 110.458 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -76.27 -38.92 55.53 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.295 -0.866 . . . . 74.54 111.004 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.68 -50.95 69.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.87 0.468 . . . . 75.34 111.427 -170.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -178.31 12.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.237 0.961 . . . . 65.04 112.085 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 65.74 144.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.967 1.307 . . . . 75.35 112.562 -173.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.04 143.66 32.32 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.73 0.812 . . . . 72.33 112.059 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -168.86 177.88 4.82 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 125.34 1.456 . . . . 53.23 108.647 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.53 174.92 21.31 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 116.125 -0.489 . . . . 25.54 112.421 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -137.76 -173.44 3.5 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.13 0.972 . . . . 74.45 109.03 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.46 67.58 0.55 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.654 -0.978 . . . . 54.0 110.654 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.3 t -76.31 151.58 36.68 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.052 0.541 . . . . 74.12 110.17 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -70.75 125.42 26.78 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.279 0.632 . . . . 71.1 110.456 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -81.83 68.05 8.05 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.18 0.99 . . . . 63.42 110.859 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -132.23 106.17 7.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.608 0.763 . . . . 65.41 109.56 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -158.88 52.14 0.4 Allowed 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.901 -1.148 . . . . 74.53 107.901 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -160.45 133.64 6.69 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.48 -0.782 . . . . 63.2 110.878 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.988 0 C-N-CA 123.488 0.715 . . . . 44.34 109.095 170.721 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.9 ttp . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.643 -0.502 . . . . 75.31 109.643 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -150.28 123.99 9.18 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.935 0.894 . . . . 55.4 109.593 -174.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -95.0 -60.26 1.72 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.198 0.599 . . . . 73.1 109.977 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -74.68 81.14 2.04 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.613 0.765 . . . . 71.33 109.778 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -155.15 144.02 20.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.042 0.937 . . . . 73.42 108.903 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -78.63 76.4 5.13 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.417 0.687 . . . . 52.43 110.122 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -106.8 -34.04 7.38 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.183 0.993 . . . . 54.42 110.832 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.3 -25.73 61.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.316 0.647 . . . . 71.02 110.615 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.596 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.9 OUTLIER 56.25 -165.85 0.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 126.005 1.722 . . . . 61.11 113.106 177.275 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 41.4 m -149.28 120.83 7.98 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.111 0.964 . . . . 74.44 108.923 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.96 138.61 51.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.525 0.73 . . . . 64.45 109.734 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.709 HE21 ' HB2' ' B' ' 85' ' ' SER . 4.4 pm0 -152.53 135.47 15.56 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.346 0.658 . . . . 63.4 110.116 168.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.46 118.38 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.331 1.053 . . . . 72.23 108.549 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.578 ' HB3' ' HB3' ' E' ' 304' ' ' PRO . 76.4 mm-40 -82.5 -39.12 22.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.659 0.384 . . . . 73.41 111.655 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.528 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 28.4 ttm180 -166.28 145.86 5.99 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.51 0.724 . . . . 73.33 110.258 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.444 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 86.6 mt -119.54 145.88 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.44 -1.689 . . . . 72.23 106.44 166.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.528 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 35.1 p90 -170.03 163.85 9.37 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.935 0.874 . . . . 75.32 111.977 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 71.5 m -92.01 122.79 34.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.612 -1.176 . . . . 75.4 109.072 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -89.12 -37.93 14.7 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.87 0.868 . . . . 74.21 110.043 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -155.82 143.77 19.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.102 -0.499 . . . . 73.44 110.766 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.4 mm -134.76 139.18 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.914 1.286 . . . . 74.15 108.201 176.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -140.72 132.08 26.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.018 -1.105 . . . . 72.01 108.018 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -147.03 114.81 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.608 -1.256 . . . . 70.44 107.608 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.58 130.72 56.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.851 0.86 . . . . 74.41 108.989 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.8 83.43 65.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 106.847 -1.538 . . . . 54.41 106.847 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -68.7 -32.81 22.92 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.923 2.415 . . . . 63.21 111.971 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -106.6 25.8 10.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.88 1.272 . . . . 72.15 110.206 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.475 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -46.68 -50.01 44.36 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 115.558 1.688 . . . . 63.55 115.558 -168.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.8 -33.98 4.45 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.232 1.476 . . . . 74.41 112.505 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.1 m80 -82.99 -22.51 33.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.645 0.778 . . . . 72.45 112.283 -169.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.43 HG11 ' HZ ' ' B' ' 123' ' ' PHE . 4.6 p -67.93 -4.38 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 124.391 1.076 . . . . 70.52 111.963 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -56.49 -27.49 57.27 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.758 0.823 . . . . 75.34 110.931 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.582 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -76.86 -34.99 57.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.65 0.38 . . . . 74.04 110.737 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.582 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 98.9 mttt -109.99 77.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.565 0.746 . . . . 72.31 112.313 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.449 ' HB3' HD13 ' H' ' 301' ' ' ILE . 15.2 t70 -117.12 82.76 1.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.628 -1.249 . . . . 71.15 107.628 163.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -148.62 160.15 43.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.156 -1.424 . . . . 75.42 107.156 -171.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 23.9 pt20 -53.6 102.22 0.3 Allowed Pre-proline 0 CA--C 1.564 1.494 0 O-C-N 124.376 1.047 . . . . 73.41 111.7 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.51 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 6.1 Cg_endo -85.93 170.21 8.67 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.807 2.338 . . . . 73.43 112.305 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -80.9 100.65 8.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 106.344 -1.724 . . . . 74.22 106.344 165.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -114.74 142.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.923 0.889 . . . . 74.23 108.72 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.599 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 27.9 ttpt -136.72 136.63 39.17 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.496 0.718 . . . . 73.15 109.377 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.624 HD12 HD11 ' B' ' 128' ' ' LEU . 4.6 tt -85.6 127.46 34.47 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 106.28 -1.748 . . . . 70.53 106.28 165.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.599 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 12.6 t70 -122.27 110.61 15.9 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.358 -1.349 . . . . 72.2 107.358 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 3.5 pp -100.22 137.45 38.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.438 0.695 . . . . 75.23 109.292 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 32.9 t70 -124.23 135.85 53.72 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.972 -0.751 . . . . 64.31 108.972 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.04 110.15 21.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.899 0.879 . . . . 72.12 110.402 -171.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.97 140.26 52.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.514 0.726 . . . . 25.14 109.213 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 75.6 m -144.07 165.2 28.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.777 0.831 . . . . 53.55 110.199 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.4 p -152.0 162.23 41.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.398 1.079 . . . . 43.23 109.033 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -106.78 112.88 26.06 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.346 -0.613 . . . . 74.32 109.346 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.99 -40.71 23.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.827 0.451 . . . . 60.52 110.327 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.95 -172.91 4.11 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.27 0.628 . . . . 43.22 110.575 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.06 116.03 4.98 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.442 -1.254 . . . . 75.42 109.774 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 71.33 -3.41 2.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.775 1.63 . . . . 65.1 112.636 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.438 HG22 ' OG ' ' B' ' 85' ' ' SER . 98.6 t -101.52 113.38 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.96 -0.755 . . . . 73.33 108.96 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.77 137.8 53.73 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.177 -0.919 . . . . 72.54 109.428 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -100.57 98.16 8.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.976 -1.49 . . . . 71.34 106.976 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.11 128.61 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.734 1.214 . . . . 30.23 109.644 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 36.3 t -119.21 143.06 31.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.757 1.223 . . . . 75.52 108.957 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -136.7 111.75 8.97 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.727 -1.212 . . . . 64.25 107.727 171.243 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -86.12 122.67 30.46 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.155 -0.683 . . . . 75.21 109.155 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.81 103.23 15.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.92 -1.141 . . . . 74.54 107.92 173.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.7 m -103.79 129.89 51.26 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.42 -0.585 . . . . 44.34 109.42 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.459 HG23 HD13 ' B' ' 114' ' ' ILE . 61.3 t -115.0 100.99 11.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 109.248 -0.649 . . . . 74.21 109.248 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.3 m -97.8 138.06 35.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.068 -0.969 . . . . 25.43 109.146 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.77 149.76 34.97 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.881 0.472 . . . . 63.31 110.347 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -149.18 141.92 24.57 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.541 -0.754 . . . . 71.04 110.544 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.0 mt -125.55 110.4 13.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.685 1.194 . . . . 71.21 108.663 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.23 -123.39 6.3 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.627 -0.715 . . . . 63.02 111.489 -174.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -108.42 2.44 22.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.116 0.967 . . . . 73.32 109.983 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.23 -179.44 3.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.748 0.819 . . . . 74.02 110.344 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -77.09 155.21 32.59 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.744 1.218 . . . . 75.2 110.703 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.08 -50.3 3.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.611 -0.885 . . . . 74.32 108.611 167.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -166.83 152.79 8.17 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.822 -1.081 . . . . 72.24 108.812 167.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -123.54 124.45 42.86 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.165 -1.05 . . . . 72.13 108.165 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.2 t -142.08 157.14 45.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.219 0.608 . . . . 74.35 109.536 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.5 tt0 -164.42 141.56 6.53 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.851 0.86 . . . . 74.44 109.121 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.5 t -134.22 143.81 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.677 -1.231 . . . . 70.23 107.677 170.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.5 96.53 5.24 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.952 -1.129 . . . . 71.02 107.952 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 38.0 tp60 -91.34 101.59 14.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.367 -0.975 . . . . 61.14 108.367 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.38 167.55 32.77 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.143 -0.935 . . . . 60.22 110.881 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.16 127.56 1.65 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.562 -0.615 . . . . 74.22 111.562 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.8 mt -85.61 124.5 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 54.4 108.062 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.67 159.14 38.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.069 0.948 . . . . 54.52 108.699 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.709 ' HB2' HE21 ' B' ' 12' ' ' GLN . 17.1 m -132.14 120.38 22.2 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.379 -0.971 . . . . 70.31 108.379 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 pt -133.75 138.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.47 1.108 . . . . 55.43 109.367 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -151.4 155.65 39.06 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.649 0.78 . . . . 71.13 110.158 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.32 -71.17 0.2 Allowed Glycine 0 C--N 1.341 0.822 0 O-C-N 123.703 0.627 . . . . 63.14 112.469 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.596 HG23 ' HB3' ' B' ' 9' ' ' MET . 32.6 pt -81.95 159.49 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 122.98 0.512 . . . . 72.5 110.942 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -153.56 156.93 38.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.666 -0.697 . . . . 63.23 110.16 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.47 -114.76 6.49 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.329 0.49 . . . . 73.23 113.539 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -67.14 -39.0 86.48 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.981 0.912 . . . . 62.23 111.536 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.87 -50.71 65.53 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.023 -0.989 . . . . 71.12 110.311 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.431 ' HG3' HD23 ' H' ' 277' ' ' LEU . 0.0 OUTLIER -74.96 -24.92 58.54 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.545 -0.752 . . . . 74.44 111.638 -175.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.431 ' HB2' HD21 ' H' ' 280' ' ' LEU . . . -58.7 -31.36 68.17 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.729 0.812 . . . . 63.33 111.792 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -69.75 -46.47 65.79 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.941 -0.572 . . . . 70.14 110.689 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -73.38 -32.52 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.327 0.651 . . . . 74.04 112.465 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -96.6 -39.23 9.62 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.858 0.863 . . . . 73.21 109.447 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.31 -25.57 43.18 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 114.693 0.637 . . . . 63.53 114.693 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -49.45 2.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.888 0.475 . . . . 33.13 111.334 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -79.21 -42.43 26.04 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.536 0.569 . . . . 74.15 112.536 -169.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.17 -45.46 79.17 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 118.416 -0.802 . . . . 52.41 112.016 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.435 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 47.2 Cg_exo -60.89 -31.44 91.58 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 122.427 2.084 . . . . 63.33 113.148 171.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.51 -34.87 77.75 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.707 0.803 . . . . 62.13 110.94 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.74 -44.47 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.431 0.692 . . . . 52.35 110.628 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.96 -24.99 59.71 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 123.607 0.567 . . . . 73.45 111.846 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -56.86 -52.68 72.01 Favored Pre-proline 0 CA--C 1.557 1.233 0 CA-C-O 117.029 -1.463 . . . . 74.05 113.494 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.92 -34.61 67.24 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.582 2.188 . . . . 52.01 113.976 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.628 ' HE2' HG21 ' D' ' 115' ' ' THR . 80.0 m-85 -72.76 -48.81 35.22 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.44 0.696 . . . . 73.12 110.218 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.16 80.99 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.749 -0.66 . . . . 54.31 110.439 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -63.38 -52.49 61.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.831 1.652 . . . . 71.22 110.987 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -38.44 89.89 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.973 0.796 . . . . 74.13 109.286 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.2 t -65.46 -37.63 87.43 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.042 0.537 . . . . 62.33 111.186 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.459 HD13 HG23 ' B' ' 64' ' ' VAL . 76.3 mt -64.08 -49.12 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.387 0.675 . . . . 63.34 109.587 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -61.44 -30.16 70.41 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.634 0.773 . . . . 71.33 111.231 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -69.47 -44.43 71.2 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.528 0.731 . . . . 34.21 109.146 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -68.1 -29.34 68.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.942 0.497 . . . . 74.22 111.124 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.471 HG21 HD23 ' B' ' 126' ' ' LEU . 78.7 t -69.34 -41.18 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.096 0.959 . . . . 75.25 110.015 173.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -67.66 -28.35 67.63 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.994 0.918 . . . . 30.45 111.724 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 73.5 mtt-85 -79.41 -35.72 40.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.52 0.728 . . . . 73.13 110.044 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.35 3.75 71.2 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.022 -0.536 . . . . 55.14 112.72 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 45.7 p 59.67 56.11 3.73 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.953 1.701 . . . . 65.4 112.744 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.43 ' HZ ' HG11 ' B' ' 31' ' ' VAL . 44.1 m-85 -119.49 157.9 50.48 Favored Pre-proline 0 N--CA 1.48 1.053 0 C-N-CA 124.192 0.997 . . . . 60.31 109.835 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.28 -173.83 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.78 2.32 . . . . 71.22 113.884 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.515 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -59.37 116.59 4.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.645 1.178 . . . . 74.12 112.41 -172.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.471 HD23 HG21 ' B' ' 118' ' ' VAL . 43.8 tp -123.06 93.7 4.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.473 0.709 . . . . 74.22 109.811 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -92.09 126.87 37.34 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.1 -1.074 . . . . 72.5 108.1 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.624 HD11 HD12 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -73.28 129.35 37.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.133 -1.062 . . . . 53.15 108.133 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.53 129.66 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.353 0.661 . . . . 62.44 111.073 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.58 ' HG3' HD11 ' D' ' 16' ' ' ILE . 68.0 Cg_endo -68.38 130.95 22.12 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.544 2.163 . . . . 74.41 112.115 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.438 HG22 HD11 ' H' ' 291' ' ' LEU . 21.8 t -115.71 114.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.532 0.733 . . . . 73.04 109.435 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -85.22 98.11 10.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -74.52 -34.14 62.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.731 0.812 . . . . 65.24 110.811 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.42 -51.63 69.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.857 1.263 . . . . 73.43 111.194 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -43.76 98.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.454 1.102 . . . . 62.51 111.466 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.11 -43.66 97.83 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.033 0.933 . . . . 64.12 110.238 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -69.41 -24.82 63.89 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.964 0.906 . . . . 72.24 111.803 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.45 ' HA ' ' HE2' ' B' ' 138' ' ' MET . 31.3 mmt -67.67 -31.99 72.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.846 0.458 . . . . 75.03 111.668 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -74.76 -29.02 61.0 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.097 0.559 . . . . 71.13 110.199 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.89 -28.58 69.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.491 0.716 . . . . 74.14 111.07 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.95 16.52 23.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.477 0.711 . . . . 64.52 111.727 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -73.1 111.73 8.49 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.9 0.48 . . . . 64.04 111.533 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -169.12 138.07 2.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.45 1.1 . . . . 64.53 108.799 171.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -108.31 -55.68 2.35 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.238 0.615 . . . . 74.34 110.405 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.55 -175.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.704 1.202 . . . . 62.35 112.819 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.08 92.59 0.2 Allowed Glycine 0 C--N 1.353 1.488 0 N-CA-C 112.109 -0.397 . . . . 52.42 112.109 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.78 161.32 39.77 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.693 0.797 . . . . 72.11 110.928 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.23 107.55 3.2 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.359 -0.837 . . . . 42.24 112.234 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 3.6 p -133.84 102.47 5.46 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.193 0.997 . . . . 61.42 109.406 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -80.77 88.68 5.79 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.69 -0.856 . . . . 75.11 108.69 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.0 -17.7 59.58 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.242 -0.89 . . . . 75.44 111.1 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -64.18 131.21 46.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.924 0.89 . . . . 73.43 110.608 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -156.4 116.3 3.58 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.279 -1.008 . . . . 74.45 108.279 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -154.29 163.59 39.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.483 0.713 . . . . 70.24 109.838 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.886 0 N-CA-C 108.44 -0.948 . . . . 75.32 108.44 178.368 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.583 -0.525 . . . . 73.43 109.583 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 34.6 p -80.2 94.49 6.06 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.122 -0.696 . . . . 72.43 109.122 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.55 116.1 6.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.121 -0.945 . . . . 62.1 110.426 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -65.3 152.36 43.96 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.478 0.711 . . . . 50.43 111.185 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -120.42 163.21 18.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.449 0.7 . . . . 72.31 109.906 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 46.6 m-20 -112.52 97.54 6.67 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.138 -1.06 . . . . 71.31 108.138 177.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.537 HG21 ' HB1' ' A' ' 135' ' ' ALA . 80.6 p -76.59 -66.09 0.85 Allowed 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.721 -0.672 . . . . 64.42 109.268 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 177.74 143.11 0.1 Allowed 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.017 1.727 . . . . 75.01 107.72 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.1 tmm? 64.71 115.48 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.587 1.155 . . . . 64.21 112.701 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -91.28 98.65 11.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.584 0.754 . . . . 75.02 109.926 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.613 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 50.0 t80 -97.13 142.14 29.41 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.322 0.649 . . . . 71.33 109.474 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -156.81 144.55 19.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.267 0.627 . . . . 73.32 109.327 166.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.91 137.57 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.298 -1.001 . . . . 73.12 108.298 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -95.89 -50.15 5.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.488 -0.56 . . . . 73.01 109.488 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -164.23 124.25 2.05 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.889 -0.596 . . . . 70.12 110.72 -169.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.774 ' HB ' HE22 ' A' ' 125' ' ' GLN . 64.9 mt -109.7 130.72 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.532 -1.285 . . . . 64.25 107.532 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.473 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 20.8 p90 -163.05 149.58 12.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.776 0.798 . . . . 74.04 111.947 -172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -77.93 103.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.933 -1.136 . . . . 71.21 107.933 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -70.87 -28.81 64.84 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.818 -0.438 . . . . 72.53 109.818 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.0 t70 -148.91 143.14 26.03 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.216 -0.902 . . . . 71.41 109.853 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -138.05 145.17 29.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.631 1.572 . . . . 72.12 106.76 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -158.4 152.19 23.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.279 0.562 . . . . 60.13 110.133 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -148.14 133.29 18.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.254 -1.388 . . . . 64.22 107.254 173.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 49.0 mt-10 -125.14 132.84 53.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.853 -0.795 . . . . 74.42 108.853 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.39 77.67 5.94 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.085 0.954 . . . . 74.12 108.806 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 -22.12 17.92 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.096 1.864 . . . . 65.31 111.319 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -99.91 28.58 4.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.51 1.124 . . . . 74.3 110.816 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.68 97.12 Favored Pre-proline 0 CA--C 1.569 1.673 0 C-N-CA 123.951 0.9 . . . . 71.33 112.925 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.97 -25.83 8.5 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 121.433 1.422 . . . . 72.52 112.048 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 65.1 t-80 -69.41 -21.37 63.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.077 1.351 . . . . 73.04 112.063 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 p -51.4 -29.98 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 113.018 0.748 . . . . 72.23 113.018 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -70.94 -34.53 71.56 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.339 0.656 . . . . 73.35 111.842 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -93.62 6.05 49.57 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.448 0.699 . . . . 74.04 111.015 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 2.9 ttmp? -90.95 147.76 22.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.277 0.631 . . . . 75.13 111.486 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.77 135.76 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.795 1.638 . . . . 75.51 110.148 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -81.79 79.38 8.36 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 122.122 -0.362 . . . . 74.55 110.182 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.408 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 4.7 tp-100 -153.0 55.66 1.48 Allowed Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.693 0.397 . . . . 64.03 111.216 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' C' ' 37' ' ' GLN . 17.3 Cg_endo -90.47 144.23 3.85 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.06 1.84 . . . . 73.32 112.226 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -86.3 83.73 7.63 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.227 -1.397 . . . . 73.44 107.227 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 p -76.97 99.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.882 -1.053 . . . . 71.4 108.693 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -125.21 140.65 52.67 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.66 -1.154 . . . . 62.32 108.652 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.582 HD13 HD11 ' C' ' 128' ' ' LEU . 2.6 pt? -87.75 163.47 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.252 0.549 . . . . 74.43 110.089 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.1 t70 -148.18 145.41 28.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.36 1.064 . . . . 72.44 108.145 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 41.1 tp -130.78 135.51 47.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.734 -0.469 . . . . 72.4 109.734 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.69 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 3.9 m-20 -118.61 142.29 47.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.918 0.887 . . . . 73.41 108.82 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.8 p -114.26 113.98 25.34 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.132 0.973 . . . . 73.44 109.561 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.89 141.97 38.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.556 0.742 . . . . 65.55 110.171 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -145.78 154.29 41.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.251 0.621 . . . . 55.33 110.547 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.9 p -144.61 131.51 20.29 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.936 0.894 . . . . 62.41 108.644 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 50' ' ' GLN . . . . . 0.443 ' HB3' ' HA ' ' F' ' 271' ' ' ALA . 59.5 tt0 -79.21 116.67 19.62 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.268 -0.641 . . . . 65.24 109.268 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 57' ' ' GLU . 32.1 mt -93.3 -32.24 14.39 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.387 -0.824 . . . . 72.23 109.684 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.77 -177.03 5.28 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.153 -0.93 . . . . 54.44 110.387 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.98 128.05 34.5 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.638 -1.164 . . . . 70.03 108.97 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.48 -7.1 0.73 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.201 1.4 . . . . 73.31 113.183 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.94 112.93 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.607 0.763 . . . . 72.14 109.462 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -129.28 133.87 47.68 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.84 -1.073 . . . . 75.24 108.382 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.3 tt0 -83.31 115.67 22.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.919 -0.771 . . . . 72.05 108.919 173.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.52 118.11 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.017 -1.105 . . . . 71.14 108.017 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.73 127.75 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 122.867 0.467 . . . . 72.34 110.062 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.533 HD23 HD12 ' C' ' 106' ' ' LEU . 3.6 mm? -120.94 112.62 18.99 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.138 -1.06 . . . . 72.43 108.138 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.69 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 35.4 ttm180 -82.06 110.82 17.64 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.701 -0.851 . . . . 65.14 108.701 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.7 t -99.94 112.27 31.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.048 -1.093 . . . . 65.43 108.048 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.2 m -114.67 142.13 46.89 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.791 -1.095 . . . . 35.43 108.114 -175.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.412 HG21 HG21 ' C' ' 114' ' ' ILE . 87.4 t -136.02 108.34 7.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.817 -1.179 . . . . 64.04 107.817 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.0 m -108.68 142.31 39.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.287 -0.634 . . . . 73.52 109.287 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.81 113.12 11.92 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.705 -1.22 . . . . 65.4 107.705 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.7 m -142.46 150.7 40.9 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.236 0.541 . . . . 63.34 111.076 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.21 19.04 15.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.615 1.566 . . . . 74.15 109.849 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.48 -108.73 1.3 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 110.416 -1.074 . . . . 62.43 110.416 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -89.9 -33.09 16.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.282 -1.007 . . . . 74.52 108.282 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.85 102.83 0.38 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.975 1.31 . . . . 50.4 109.953 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -88.59 129.67 35.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.923 0.329 . . . . 65.13 110.255 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -73.54 -59.79 2.55 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 173.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -173.09 174.55 3.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.211 0.945 . . . . 75.12 110.534 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -134.96 145.27 47.99 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.047 -1.464 . . . . 71.14 107.047 172.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.433 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.3 t -151.71 121.45 7.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.884 -1.154 . . . . 73.11 107.884 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.41 130.3 18.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.902 0.382 . . . . 65.32 110.141 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.31 115.43 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.925 1.29 . . . . 63.11 108.716 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.574 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.0 mt-30 -89.09 88.78 7.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.849 -1.167 . . . . 72.23 107.849 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 66.3 tp60 -80.49 112.35 17.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.623 -1.171 . . . . 71.45 109.664 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.39 148.32 18.31 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 111.269 -0.733 . . . . 44.5 111.269 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.3 130.97 4.17 Favored Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 111.398 -0.681 . . . . 74.24 111.398 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.512 HD12 HD11 ' C' ' 51' ' ' LEU . 13.7 mm -84.52 120.87 35.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.439 -0.949 . . . . 72.3 108.439 174.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -130.98 139.88 50.07 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.402 0.681 . . . . 74.14 109.474 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 m -110.49 109.03 19.23 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.765 -0.828 . . . . 60.33 108.765 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.33 122.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.141 -1.059 . . . . 71.12 108.141 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.78 170.32 12.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.188 0.995 . . . . 72.14 110.187 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.81 -60.61 0.33 Allowed Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.968 -0.56 . . . . 54.51 112.803 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.71 -176.65 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 117.084 0.442 . . . . 72.12 111.446 -176.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.93 -171.98 3.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.144 0.977 . . . . 70.32 109.472 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.36 -148.94 41.44 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 116.157 -0.474 . . . . 71.55 113.8 173.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.5 p -63.32 -26.98 69.02 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.382 1.073 . . . . 41.11 112.052 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -64.71 -54.29 33.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.352 1.061 . . . . 74.42 110.655 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.0 -38.14 75.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.283 -0.872 . . . . 73.32 109.974 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.539 ' HB1' ' HB3' ' F' ' 280' ' ' LEU . . . -67.47 -22.74 65.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 63.42 112.071 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 56.7 t-80 -71.79 -41.59 68.13 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.778 -0.453 . . . . 72.01 109.778 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.65 -31.5 69.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.137 0.494 . . . . 70.24 110.657 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.542 ' HG ' ' HG ' ' F' ' 278' ' ' LEU . 1.3 tm? -80.54 -48.73 12.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.427 1.091 . . . . 75.55 109.901 -176.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.15 9.53 67.64 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.355 -0.839 . . . . 53.12 114.283 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -146.13 -51.72 0.24 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.442 0.621 . . . . 74.23 111.607 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -74.77 -41.98 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.534 0.333 . . . . 75.15 111.412 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.441 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 68.8 m -66.93 -45.14 53.57 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 118.373 -0.823 . . . . 64.15 111.726 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.404 ' HG3' HD21 ' C' ' 60' ' ' LEU . 92.7 Cg_exo -50.2 -38.93 52.11 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.933 2.422 . . . . 75.53 114.017 168.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -61.74 -34.41 75.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.294 0.638 . . . . 72.25 111.992 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.34 -42.77 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.927 -0.397 . . . . 73.33 109.927 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.533 HD12 HD23 ' C' ' 60' ' ' LEU . 85.5 mt -76.03 -26.9 57.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.69 -0.686 . . . . 72.5 112.015 -174.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.83 -52.75 69.77 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 117.703 -1.141 . . . . 74.34 113.493 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.61 -32.66 93.63 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.177 1.918 . . . . 62.04 113.327 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.528 ' HE2' HG21 ' A' ' 115' ' ' THR . 67.9 m-85 -70.88 -44.44 66.32 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 54.42 110.819 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.3 -45.6 93.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.811 -0.631 . . . . 62.11 109.691 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.6 ttt-85 -56.28 -47.21 79.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.055 1.342 . . . . 62.12 111.652 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.9 -36.51 78.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.668 0.605 . . . . 75.0 109.732 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.7 t -68.2 -35.13 77.51 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.391 0.676 . . . . 73.23 111.103 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.433 HG23 ' SG ' ' C' ' 76' ' ' CYS . 60.6 mt -72.15 -47.91 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.673 0.789 . . . . 74.1 109.974 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -64.4 -31.42 72.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.468 0.707 . . . . 74.12 110.825 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -66.38 -47.72 72.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.413 -0.812 . . . . 73.54 109.462 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.52 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.3 -36.61 84.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.45 0.7 . . . . 74.55 112.428 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.1 t -64.44 -37.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.21 0.604 . . . . 61.13 109.786 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.2 t -68.53 -35.1 76.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.437 0.695 . . . . 75.33 111.584 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -70.67 -35.58 72.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.731 0.812 . . . . 73.44 110.428 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.27 4.61 80.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.893 -0.594 . . . . 73.41 113.046 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.2 p 60.96 35.19 19.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.768 1.627 . . . . 72.52 112.372 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -105.01 150.75 39.1 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.557 1.143 . . . . 55.31 110.05 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' F' ' 297' ' ' TYR . 76.5 Cg_exo -53.92 110.31 0.49 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.397 2.731 . . . . 53.23 113.001 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -60.34 144.46 50.63 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.507 1.13 . . . . 64.24 111.224 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.99 124.14 11.47 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.72 -1.585 . . . . 73.43 106.72 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -90.76 130.41 36.74 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.892 -0.781 . . . . 71.04 108.892 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.582 HD11 HD13 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -64.62 131.74 47.82 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.427 -0.953 . . . . 74.5 108.427 177.714 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.482 ' HB1' HG13 ' H' ' 306' ' ' VAL . . . -60.06 140.19 90.74 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.971 0.909 . . . . 62.23 111.334 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 103.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.18 2.587 . . . . 73.53 112.708 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.28 108.33 21.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 N-CA-C 108.319 -0.993 . . . . 72.11 108.319 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 14.4 m-80 -96.49 92.2 6.16 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.319 -0.855 . . . . 74.55 109.156 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -61.51 -39.19 90.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.218 -0.901 . . . . 54.3 110.475 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -69.32 -38.85 78.41 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.173 0.989 . . . . 75.42 112.031 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -77.66 -26.22 50.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.126 -0.943 . . . . 75.42 111.768 -173.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.423 HD12 ' HG3' ' F' ' 286' ' ' MET . 76.2 mt -59.75 -36.96 77.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 123.854 0.721 . . . . 74.22 111.837 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -62.39 -44.12 97.21 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.033 0.533 . . . . 71.13 111.333 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 59.4 mtt -73.61 -29.38 62.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.892 0.877 . . . . 74.4 111.032 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -68.28 -40.62 81.78 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.022 1.329 . . . . 73.34 111.111 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -70.67 -88.23 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.345 -0.613 . . . . 62.43 109.345 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.17 120.27 41.88 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 109.111 -0.7 . . . . 65.31 109.111 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -82.65 172.58 12.78 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.441 0.696 . . . . 74.5 110.832 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.2 pm0 -135.41 151.43 50.44 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.432 0.693 . . . . 75.22 110.441 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -83.79 157.08 22.21 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.481 -0.782 . . . . 63.03 110.187 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.47 166.01 13.64 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.859 0.863 . . . . 53.54 109.597 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.32 -179.44 23.32 Favored Glycine 0 N--CA 1.472 1.064 0 CA-C-O 120.151 -0.249 . . . . 64.23 113.048 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 66.99 155.09 0.1 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.263 1.425 . . . . 60.42 111.567 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.15 151.88 23.2 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 112.083 -0.407 . . . . 71.44 112.083 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -156.76 154.62 30.26 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.804 0.842 . . . . 73.43 109.334 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.65 98.26 1.92 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.309 0.643 . . . . 73.43 110.276 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.37 130.15 18.13 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.586 -1.264 . . . . 73.12 107.586 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -160.65 66.81 0.32 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.929 -1.137 . . . . 71.02 107.929 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -64.44 95.25 0.13 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.581 -0.736 . . . . 61.32 110.145 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.44 98.08 11.18 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 109.022 -0.732 . . . . 73.52 109.022 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 N-CA-C 108.17 -1.048 . . . . 52.4 108.17 178.874 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' D' D ' 1' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' D' ' 138' ' ' MET . 53.4 ttp . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.097 -0.705 . . . . 72.25 109.097 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 69.33 -167.04 0.18 Allowed 'General case' 0 C--O 1.253 1.279 0 C-N-CA 124.891 1.276 . . . . 72.42 110.253 -172.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 64.48 -153.92 0.3 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.824 0.85 . . . . 71.34 110.79 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 76.29 0.6 3.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.096 1.358 . . . . 71.01 110.843 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -82.13 134.63 35.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.953 0.901 . . . . 74.43 109.321 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.49 95.24 6.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.434 0.694 . . . . 75.34 110.637 -174.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 90.6 m -74.07 72.89 1.69 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.532 0.733 . . . . 73.32 109.562 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 56.31 12.89 1.1 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.662 1.185 . . . . 54.23 112.362 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ttp -33.93 126.24 0.43 Allowed 'General case' 0 C--N 1.365 1.242 0 C-N-CA 126.115 1.766 . . . . 61.34 112.968 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.7 m -106.35 136.85 45.37 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.801 -0.814 . . . . 74.15 108.801 173.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.608 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 23.4 t80 -160.23 110.73 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.592 -2.003 . . . . 73.34 105.592 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -130.98 114.79 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.921 -0.77 . . . . 63.3 108.921 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.77 123.18 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.854 0.359 . . . . 74.05 110.141 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.08 -40.4 12.3 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.346 -0.843 . . . . 73.44 109.712 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.496 ' HB3' ' HD1' ' D' ' 17' ' ' TYR . 22.1 mmt-85 -156.87 150.52 24.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.408 0.683 . . . . 64.54 112.016 -170.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.58 HD11 ' HG3' ' B' ' 130' ' ' PRO . 0.3 OUTLIER -138.85 118.0 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 105.072 -2.196 . . . . 72.14 105.072 165.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' D' ' 15' ' ' ARG . 28.2 p90 -150.39 157.91 43.57 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.866 0.841 . . . . 71.5 111.657 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -93.71 113.65 25.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.033 -0.985 . . . . 65.24 108.76 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.4 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 35.4 mtpt -81.4 -35.65 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.171 0.51 . . . . 75.41 109.629 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -144.67 141.75 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.064 -0.971 . . . . 74.43 108.444 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' C' ' 117' ' ' MET . 95.7 mt -137.09 143.9 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.698 1.199 . . . . 75.45 107.845 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 99.1 p -147.76 141.9 26.08 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.702 0.801 . . . . 72.04 108.993 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.2 t80 -146.48 113.81 6.28 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 105.944 -1.872 . . . . 73.23 105.944 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -126.87 109.45 11.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 73.24 110.106 -173.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.97 91.18 3.45 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 107.412 -1.329 . . . . 62.33 107.412 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.02 -43.16 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.262 1.975 . . . . 72.44 112.416 -173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -97.75 37.63 1.37 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.916 -1.142 . . . . 64.32 107.916 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.473 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -51.32 -64.6 1.3 Allowed Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.786 -1.102 . . . . 73.52 113.858 -161.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' C' ' 83' ' ' ILE . 81.7 Cg_endo -78.21 -14.55 14.87 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 122.195 1.82 . . . . 64.03 113.002 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -67.25 -41.47 85.55 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.54 1.136 . . . . 72.53 109.395 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.41 -41.42 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 123.962 0.789 . . . . 74.51 110.126 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -69.61 -18.6 63.62 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.377 0.88 . . . . 55.32 113.377 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -84.99 -2.98 58.58 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.623 0.769 . . . . 71.51 111.999 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.405 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 47.6 mtpt -124.78 116.04 21.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.096 1.358 . . . . 62.14 108.571 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -89.34 97.42 11.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.877 0.871 . . . . 63.51 112.812 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.559 ' CH2' HD13 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -167.85 -179.39 4.2 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 124.165 0.986 . . . . 64.2 112.97 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.496 ' HB2' ' HB3' ' G' ' 295' ' ' ALA . 11.6 pt20 -93.22 145.48 30.11 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.484 1.114 . . . . 52.45 112.755 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.509 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 76.9 Cg_endo -79.74 135.57 11.54 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.418 2.078 . . . . 73.11 112.765 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.73 111.61 7.15 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.504 -1.295 . . . . 73.13 107.504 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.78 144.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.157 0.583 . . . . 45.31 110.774 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 85.0 tttt -124.69 127.6 47.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.288 1.035 . . . . 74.02 109.109 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.15 120.76 39.12 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.002 -1.481 . . . . 75.45 107.002 173.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.49 143.04 50.91 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.527 -0.916 . . . . 65.53 108.527 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.19 148.76 50.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.097 0.475 . . . . 72.13 110.64 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.4 t70 -139.5 150.03 44.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.185 -1.042 . . . . 65.11 108.185 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 24.2 p -116.75 143.65 45.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.746 0.818 . . . . 72.52 109.785 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.88 155.88 32.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.511 1.124 . . . . 73.11 108.246 174.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 27.1 p -169.26 163.96 10.87 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.844 0.457 . . . . 53.43 110.733 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -159.57 132.71 6.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.668 0.787 . . . . 72.15 110.009 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -77.43 117.47 18.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.769 -0.826 . . . . 72.44 108.769 170.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' D' ' 57' ' ' GLU . 70.6 mt -90.29 -32.59 16.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.858 0.463 . . . . 74.34 110.508 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.92 -171.17 1.12 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.645 0.778 . . . . 43.23 110.632 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.93 114.79 4.78 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.779 -1.101 . . . . 70.25 109.391 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 68.3 2.18 3.18 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.147 1.379 . . . . 75.35 113.012 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.67 120.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.409 -0.96 . . . . 74.43 108.409 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -136.51 131.2 33.6 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.558 0.536 . . . . 74.23 109.884 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.7 tt0 -87.43 126.59 34.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.298 -1.001 . . . . 62.2 108.298 169.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.89 112.77 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.715 -1.217 . . . . 74.24 107.715 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.516 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.7 t -102.65 130.74 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.233 0.613 . . . . 73.41 109.618 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.01 109.03 13.02 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.143 -1.428 . . . . 75.32 107.143 171.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.0 ttm-85 -84.34 106.66 16.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.446 -0.797 . . . . 74.33 109.16 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.32 129.74 45.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.568 -0.901 . . . . 61.41 108.568 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 31.3 m -125.87 135.67 52.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.573 0.749 . . . . 72.41 109.544 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.474 HG23 HD13 ' D' ' 114' ' ' ILE . 91.2 t -124.81 111.99 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.041 0.936 . . . . 63.34 109.382 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 58.7 m -105.39 119.67 39.66 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.245 -0.65 . . . . 41.1 109.245 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.03 133.24 56.21 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.275 0.63 . . . . 73.45 110.635 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -141.93 125.18 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.143 0.977 . . . . 61.4 109.649 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.642 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -126.7 138.99 53.48 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.283 1.033 . . . . 62.32 110.841 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.85 -111.91 3.51 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.8 -0.52 . . . . 54.1 111.8 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.15 4.05 17.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.202 1.001 . . . . 54.21 110.023 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.17 168.58 21.3 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.212 0.529 . . . . 64.12 112.358 -157.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -84.56 126.58 33.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.143 -0.935 . . . . 74.32 110.428 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.642 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -71.78 -69.45 0.39 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.97 0.908 . . . . 64.45 109.706 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -158.67 147.5 18.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.543 -1.662 . . . . 63.1 109.953 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.92 152.93 20.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.194 -1.41 . . . . 70.34 107.194 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.5 t -154.27 135.78 14.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.955 -0.757 . . . . 65.21 108.955 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -153.54 134.44 13.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.522 -0.547 . . . . 70.21 109.522 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.5 t -136.52 116.79 17.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.745 -0.835 . . . . 52.04 108.745 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.81 86.54 7.17 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.843 -1.169 . . . . 60.42 107.843 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.54 92.89 5.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.951 -1.022 . . . . 60.45 109.254 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.67 148.27 19.43 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.104 -0.798 . . . . 64.01 111.104 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.63 131.53 3.69 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 110.961 -0.856 . . . . 64.2 110.961 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' D' ' 17' ' ' TYR . 68.2 mt -89.18 122.47 40.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.446 -0.946 . . . . 64.13 108.446 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.3 138.78 52.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.37 1.068 . . . . 72.03 108.996 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 19.4 m -90.69 97.34 11.13 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.207 -1.034 . . . . 62.21 108.207 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.98 123.03 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.547 -0.538 . . . . 74.32 109.547 -171.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.23 170.95 20.09 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.56 1.144 . . . . 53.04 109.442 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.1 -18.48 51.23 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 116.301 -0.409 . . . . 74.41 113.222 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.35 159.05 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.439 1.095 . . . . 74.22 109.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 158.98 40.83 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.142 0.577 . . . . 75.41 110.795 -174.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.57 -97.48 0.01 OUTLIER Glycine 0 C--N 1.351 1.377 0 O-C-N 125.165 1.54 . . . . 75.3 115.793 161.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.3 p -58.89 -54.53 46.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.957 1.303 . . . . 74.13 112.597 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -82.12 -27.02 33.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.22 -0.445 . . . . 71.03 110.698 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' G' ' 277' ' ' LEU . 27.8 ttt -67.46 -35.05 78.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.831 -0.433 . . . . 74.43 109.831 173.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -53.87 51.98 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 123.615 0.766 . . . . 63.11 110.61 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -57.24 -45.27 84.07 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.229 0.956 . . . . 75.31 110.824 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.39 -33.13 75.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.446 0.699 . . . . 62.5 111.706 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.456 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.2 tp -75.41 -32.4 60.72 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 70.0 110.994 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.85 13.59 34.77 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.21 -0.45 . . . . 71.32 113.658 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -129.7 -61.2 1.01 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.172 0.486 . . . . 74.4 110.345 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -75.33 -46.51 32.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.4 0.68 . . . . 74.35 111.095 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.608 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 60.5 m -62.47 -48.94 85.67 Favored Pre-proline 0 CA--C 1.569 1.687 0 CA-C-O 118.306 -0.854 . . . . 54.54 112.114 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.63 -16.19 33.87 Favored 'Trans proline' 0 C--N 1.402 3.376 0 C-N-CA 122.1 1.867 . . . . 70.32 112.735 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.16 -24.48 62.26 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.833 0.453 . . . . 73.12 110.259 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.38 -39.29 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.281 0.632 . . . . 64.43 109.853 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 -37.0 64.22 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.765 0.826 . . . . 71.24 112.201 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.14 -40.9 57.49 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-O 117.787 -1.102 . . . . 75.32 113.515 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -53.93 -39.73 83.58 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.377 2.051 . . . . 71.22 113.816 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -80.26 -32.81 38.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.369 0.667 . . . . 74.33 111.368 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.69 81.3 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.168 -0.679 . . . . 44.1 109.168 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.515 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -53.53 -53.55 49.94 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.906 1.282 . . . . 74.15 110.771 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.65 -40.76 92.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.504 1.128 . . . . 74.13 110.698 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.62 -44.11 96.7 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.576 0.548 . . . . 75.24 110.757 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.599 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.1 mt -63.22 -53.19 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 64.2 109.884 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.628 HG21 ' HE2' ' B' ' 109' ' ' TYR . 95.9 m -52.8 -45.07 67.05 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.085 1.354 . . . . 51.12 111.923 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.39 -44.94 77.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.944 -1.025 . . . . 71.42 110.151 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 77.7 mtm -62.55 -37.79 87.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.857 0.463 . . . . 72.22 112.0 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.502 HG23 ' O ' ' D' ' 114' ' ' ILE . 85.7 t -61.59 -44.63 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 124.093 0.871 . . . . 61.33 110.014 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.57 -27.33 61.26 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.878 0.471 . . . . 62.21 111.718 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -72.39 -31.64 65.72 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.347 0.659 . . . . 73.22 110.076 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.25 10.81 62.48 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.445 -0.798 . . . . 61.22 112.368 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.405 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.6 p 65.75 15.04 9.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.964 2.105 . . . . 63.04 113.961 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.74 156.97 55.51 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 107.437 -1.319 . . . . 63.03 107.437 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.699 ' HG2' HG23 ' G' ' 296' ' ' THR . 71.7 Cg_endo -74.02 146.09 36.52 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.682 2.255 . . . . 54.32 111.588 -177.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.457 ' HB2' HG23 ' D' ' 115' ' ' THR . 3.2 pt20 -51.3 127.71 20.34 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 124.275 0.985 . . . . 63.53 112.134 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -107.49 100.77 10.16 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.483 -0.932 . . . . 74.34 108.483 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.444 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 3.1 m-20 -98.89 107.1 19.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.298 1.039 . . . . 73.33 110.18 -166.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.515 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.7 mm? -72.22 116.01 12.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.069 0.948 . . . . 62.53 109.908 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' G' ' 291' ' ' LEU . . . -68.57 154.42 94.53 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.534 0.334 . . . . 72.32 111.494 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.78 123.87 14.5 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.499 2.133 . . . . 64.11 111.951 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 63.4 t -108.41 125.49 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.905 0.882 . . . . 63.34 108.773 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -72.17 93.88 1.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.171 0.588 . . . . 64.23 109.632 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 70.7 m-85 -72.82 -21.89 60.89 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.583 -0.735 . . . . 74.2 111.352 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' D' ' 138' ' ' MET . 12.7 m-20 -56.19 -57.25 12.98 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.585 0.754 . . . . 72.51 111.38 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.54 95.25 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.078 0.861 . . . . 54.21 112.493 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 85.6 mt -71.37 -48.82 47.68 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.498 -0.774 . . . . 64.32 111.25 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -72.28 -26.92 62.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 74.24 111.089 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 33.7 ttm -55.06 -35.76 64.87 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.035 0.934 . . . . 71.32 111.157 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -79.53 -13.1 59.78 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.093 0.957 . . . . 75.05 112.071 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -79.03 -37.08 39.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.703 0.801 . . . . 71.24 110.201 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.66 -34.78 79.1 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.474 0.71 . . . . 75.55 112.217 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -78.2 0.89 23.33 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.053 0.541 . . . . 71.54 112.072 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -135.05 82.05 1.93 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.641 0.776 . . . . 73.44 109.348 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.96 125.29 1.94 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.524 -0.917 . . . . 65.5 108.524 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.97 136.18 36.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.333 0.653 . . . . 62.2 109.835 176.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.38 59.15 5.0 Favored Glycine 0 C--N 1.344 0.997 0 C-N-CA 122.723 0.201 . . . . 63.33 112.683 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.93 112.63 24.48 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.331 -0.989 . . . . 63.43 108.331 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.91 68.03 0.33 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 111.532 -0.627 . . . . 43.22 111.532 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -117.06 157.6 25.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.984 0.914 . . . . 72.34 109.706 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -132.88 133.51 43.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.768 0.827 . . . . 72.41 109.808 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -115.87 135.23 54.19 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.651 0.78 . . . . 64.23 110.96 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -136.94 135.01 37.36 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.557 1.143 . . . . 74.31 107.946 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -130.23 112.65 13.55 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.009 -0.737 . . . . 62.41 109.009 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -67.61 146.37 53.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.652 0.781 . . . . 72.23 110.581 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 124.067 0.947 . . . . 75.25 108.76 179.677 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 110.018 -0.364 . . . . 74.24 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -76.07 87.26 2.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.336 0.655 . . . . 71.24 109.313 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -82.98 178.53 8.11 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.204 -0.907 . . . . 71.0 109.399 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -77.06 82.74 3.57 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.079 -0.712 . . . . 74.34 109.079 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -150.7 139.55 13.09 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.384 0.674 . . . . 70.1 111.066 -172.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.19 106.3 1.35 Allowed 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.009 1.806 . . . . 72.12 110.573 163.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 10.2 tt -66.67 -24.6 66.3 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.381 0.672 . . . . 73.54 110.182 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 278' ' ' LEU . . . . . 0.675 HD22 HD21 ' A' ' 98' ' ' LEU . 25.0 mt -84.16 144.62 28.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.08 0.952 . . . . 75.2 110.548 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . 175.65 40.24 0.05 OUTLIER Glycine 0 C--N 1.35 1.312 0 N-CA-C 114.109 0.404 . . . . 42.24 114.109 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 95' ' ' ALA . 62.5 tp -159.5 107.4 1.76 Allowed 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 117.323 0.562 . . . . 55.24 109.876 172.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -173.75 176.35 2.71 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.558 1.543 . . . . 74.32 110.159 168.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.38 -70.82 0.12 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.625 1.57 . . . . 53.44 111.534 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.54 108.67 2.94 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.648 0.779 . . . . 73.34 109.623 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 168.65 102.55 0.16 Allowed Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.554 0.534 . . . . 74.03 112.496 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -71.14 92.16 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 107.792 -1.188 . . . . 73.44 107.792 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 286' ' ' MET . . . . . 0.553 ' HG3' HG23 ' E' ' 288' ' ' VAL . 14.1 tpt -82.23 116.55 64.23 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.829 0.852 . . . . 73.1 110.841 -169.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 287' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' E' ' 286' ' ' MET . 6.2 Cg_exo -77.07 85.85 1.71 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.133 2.555 . . . . 64.24 111.762 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 288' ' ' VAL . . . . . 0.57 HG13 HG21 ' A' ' 131' ' ' VAL . 88.7 t -125.52 -83.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 115.603 -0.726 . . . . 64.41 109.053 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 54.89 -165.24 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.176 0.991 . . . . 72.01 111.455 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -101.46 121.29 41.67 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.678 -0.639 . . . . 75.24 110.077 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.42 52.8 2.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.482 1.113 . . . . 74.11 109.704 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 171.22 -148.65 11.34 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.7 -1.055 . . . . 53.22 111.309 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 293' ' ' PRO . . . . . 0.416 ' HG3' ' HB2' ' G' ' 304' ' ' PRO . 64.4 Cg_endo -81.41 -172.59 1.53 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.915 2.41 . . . . 74.53 112.62 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 294' ' ' LYS . . . . . 0.427 ' HA ' HG12 ' A' ' 40' ' ' VAL . 11.7 mptt -78.16 -52.69 8.32 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.434 -0.803 . . . . 55.13 108.868 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 69.73 -73.33 0.09 Allowed 'General case' 0 CA--C 1.553 1.078 0 O-C-N 125.033 1.458 . . . . 75.11 113.343 168.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 43.7 m -56.69 99.8 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.251 1.421 . . . . 73.12 113.103 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 51.7 t80 179.83 -60.7 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.069 1.348 . . . . 73.12 108.923 170.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -78.3 135.14 37.46 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.615 0.572 . . . . 71.04 110.106 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.63 -92.84 0.11 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.22 -0.752 . . . . 62.24 111.22 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -93.36 16.88 12.3 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 65.33 110.793 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 32' ' ' PHE . 5.6 tt -104.76 142.8 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.714 1.205 . . . . 71.21 110.864 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -174.0 171.61 3.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 63.04 108.682 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -77.05 157.07 81.8 Favored Pre-proline 0 CA--C 1.568 1.664 0 C-N-CA 123.558 0.743 . . . . 75.13 109.546 167.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 304' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' B' ' 14' ' ' GLN . 87.1 Cg_exo -47.63 136.97 20.99 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 123.507 2.804 . . . . 73.23 114.313 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -147.0 22.17 1.23 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.109 0.564 . . . . 71.34 111.841 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 97.9 t -82.25 114.63 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 120.934 0.397 . . . . 73.42 110.413 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 14.7 m -65.51 -9.0 22.34 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 125.572 1.549 . . . . 64.43 114.332 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 36.3 t 78.14 147.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.107 1.363 . . . . 70.13 112.152 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' E' E ' 309' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' E' ' 310' ' ' PRO . 40.7 m -65.17 116.14 27.66 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.751 0.821 . . . . 73.22 109.826 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' E' E ' 310' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' E' ' 309' ' ' THR . 5.2 Cg_endo . . . . . 0 C--N 1.374 1.883 0 C-N-CA 122.925 2.417 . . . . 52.32 111.051 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 271' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' C' ' 50' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 110.204 -0.295 . . . . 64.3 110.204 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -78.81 80.94 5.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.376 0.67 . . . . 60.41 109.361 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 64.08 176.51 0.18 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.797 1.239 . . . . 71.22 111.508 -172.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 62.59 104.51 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.525 1.13 . . . . 75.03 111.487 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 275' ' ' LYS . . . . . 0.587 ' HD2' HD22 ' F' ' 278' ' ' LEU . 46.0 mtmt -105.57 92.69 6.22 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.715 0.806 . . . . 73.31 109.248 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.88 -36.34 97.1 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.53 2.82 . . . . 74.2 114.021 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 8.0 mp -83.86 -33.05 24.92 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.904 0.482 . . . . 75.42 111.491 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' F' ' 275' ' ' LYS . 8.0 mp -89.34 106.24 18.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.543 0.737 . . . . 75.13 110.656 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 279' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' C' ' 95' ' ' ALA . . . -97.39 -6.31 57.61 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.938 -0.574 . . . . 74.43 112.153 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 280' ' ' LEU . . . . . 0.539 ' HB3' ' HB1' ' C' ' 95' ' ' ALA . 9.1 tt -158.23 110.05 2.26 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.754 0.821 . . . . 64.43 109.578 -172.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -175.94 54.8 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.877 1.271 . . . . 63.41 109.172 162.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -167.13 99.71 0.53 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.899 -1.046 . . . . 71.01 108.346 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.95 17.65 10.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.659 1.184 . . . . 75.25 111.866 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -95.99 104.64 3.13 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.558 -0.579 . . . . 22.23 112.39 -172.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 16.2 m120 69.46 176.62 0.27 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.895 1.278 . . . . 74.25 113.089 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 286' ' ' MET . . . . . 0.423 ' HG3' HD12 ' C' ' 136' ' ' LEU . 4.9 mpp? 52.73 78.54 0.39 Allowed Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.112 1.365 . . . . 72.44 112.186 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -78.52 64.33 8.56 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.766 2.31 . . . . 54.41 110.653 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 63.6 t -71.85 113.67 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 114.973 -1.012 . . . . 71.14 110.674 -173.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -119.93 160.07 23.44 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.247 -1.02 . . . . 74.23 108.247 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -60.68 137.3 58.2 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.093 0.557 . . . . 71.32 111.875 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.563 HD13 ' H ' ' F' ' 291' ' ' LEU . 0.0 OUTLIER -100.1 155.4 17.75 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.686 1.194 . . . . 70.21 110.634 -174.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' F' F ' 292' ' ' GLY . . . . . 0.414 ' N ' HG21 ' H' ' 307' ' ' THR . . . 76.7 -167.62 54.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.203 -0.776 . . . . 52.12 112.573 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.26 -72.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.213 1.942 . . . . 61.31 110.796 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -155.36 -56.2 0.09 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.607 1.163 . . . . 64.31 109.035 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . 63.04 -165.15 0.24 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.972 0.909 . . . . 34.15 109.73 -169.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 11.1 m 64.92 150.56 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.416 1.086 . . . . 74.14 111.486 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.535 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 3.4 m-30 65.7 14.16 9.37 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.906 0.883 . . . . 74.13 112.698 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 298' ' ' HIS . . . . . 0.46 ' HE1' ' HA ' ' H' ' 302' ' ' ASP . 32.2 p80 -95.33 119.01 33.1 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.989 -1.115 . . . . 75.42 107.989 170.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 138.33 163.89 9.75 Favored Glycine 0 N--CA 1.469 0.878 0 N-CA-C 112.086 -0.405 . . . . 52.14 112.086 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.73 88.75 7.74 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.292 0.637 . . . . 70.43 109.89 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.44 18.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.301 1.041 . . . . 74.51 111.279 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -81.31 -72.41 0.43 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 109.145 -0.687 . . . . 65.25 109.145 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 178.38 91.95 0.15 Allowed Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 123.924 0.89 . . . . 74.54 109.653 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.54 -56.63 0.4 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.939 1.759 . . . . 45.12 110.833 169.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -174.61 128.35 0.33 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.851 1.261 . . . . 71.41 108.354 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 7.7 p -169.74 -39.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.349 1.06 . . . . 61.51 110.383 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 23.7 m -75.53 80.64 2.55 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.443 1.097 . . . . 75.1 110.437 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 48.9 m -146.71 3.44 0.85 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.513 -1.221 . . . . 74.33 110.421 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 9.3 t -140.65 149.12 55.8 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 123.671 0.788 . . . . 73.41 110.468 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 C--N 1.372 1.77 0 C-N-CA 122.329 2.019 . . . . 74.34 113.329 167.961 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.492 -0.559 . . . . 65.45 109.492 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -73.3 85.9 1.45 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.989 -0.745 . . . . 72.52 108.989 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -56.68 120.05 7.16 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.26 1.024 . . . . 62.43 110.598 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -77.22 135.0 38.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.109 0.564 . . . . 72.41 110.873 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.77 118.08 7.22 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.381 0.672 . . . . 74.12 110.21 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -89.77 101.93 0.33 Allowed 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.721 2.281 . . . . 75.11 111.162 170.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.538 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 5.7 mp -82.0 -17.43 46.89 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 120.827 0.346 . . . . 61.22 110.338 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.82 114.79 28.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.117 0.967 . . . . 72.14 108.864 -176.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 279' ' ' GLY . . . . . 0.488 ' H ' HD23 ' G' ' 280' ' ' LEU . . . 164.27 78.91 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.852 -0.899 . . . . 41.03 110.852 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.488 HD23 ' H ' ' G' ' 279' ' ' GLY . 1.1 pt? -154.62 -38.79 0.09 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.77 0.828 . . . . 52.11 111.304 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -61.97 101.24 0.2 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.332 0.653 . . . . 72.41 110.982 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -90.06 -151.36 0.23 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.354 1.062 . . . . 54.4 108.421 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -75.45 75.44 2.52 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.722 -0.844 . . . . 44.34 108.722 166.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -86.52 58.85 4.66 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.31 -0.859 . . . . 51.45 113.021 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -78.47 97.04 5.56 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.985 -1.117 . . . . 73.21 107.985 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 71.5 mtm -78.18 140.79 61.65 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.815 -0.612 . . . . 61.31 109.396 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.86 83.86 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.919 2.413 . . . . 64.44 111.964 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 81.7 t -101.38 119.13 49.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.95 0.9 . . . . 72.3 108.632 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -104.59 153.53 21.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.173 0.989 . . . . 74.51 109.503 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.409 ' CH2' HD13 ' D' ' 128' ' ' LEU . 53.1 m95 -65.65 169.26 6.48 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.211 1.005 . . . . 74.32 111.89 171.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' D' ' 129' ' ' ALA . 5.5 mp -76.21 -41.55 49.01 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 113.706 -1.588 . . . . 65.1 110.333 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -171.97 173.52 45.14 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.701 -0.681 . . . . 72.01 113.621 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.62 -25.75 10.61 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 123.772 2.981 . . . . 61.13 113.332 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -69.04 92.52 0.53 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.919 0.487 . . . . 71.43 109.836 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 295' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' D' ' 37' ' ' GLN . . . -75.52 173.67 10.68 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.322 -0.854 . . . . 73.53 111.295 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 296' ' ' THR . . . . . 0.699 HG23 ' HG2' ' D' ' 124' ' ' PRO . 4.4 t -72.16 -14.38 61.8 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 115.083 -0.962 . . . . 61.34 113.071 -173.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.529 ' HA ' ' HG3' ' D' ' 124' ' ' PRO . 0.1 OUTLIER -84.08 76.85 10.03 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 118.612 0.642 . . . . 74.43 110.793 -177.608 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -121.45 143.46 49.23 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.161 0.985 . . . . 74.53 108.447 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.73 -77.78 0.35 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.376 -1.089 . . . . 53.41 110.376 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.78 160.89 3.01 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.447 1.499 . . . . 72.23 108.114 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 301' ' ' ILE . . . . . . . . . . . . . 6.0 tt -80.97 -25.87 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.387 -0.821 . . . . 72.33 111.873 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -155.95 -161.33 1.13 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.604 -0.517 . . . . 64.15 109.604 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 303' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 124' ' ' PRO . 0.9 OUTLIER -124.1 163.96 32.56 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.627 1.171 . . . . 65.43 108.448 175.203 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' G' G ' 304' ' ' PRO . . . . . 0.416 ' HB2' ' HG3' ' E' ' 293' ' ' PRO . 31.5 Cg_exo -63.51 132.42 35.57 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.38 2.053 . . . . 73.41 112.093 172.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.66 161.56 30.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.358 0.663 . . . . 63.44 111.034 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 34.6 m -75.23 166.49 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.099 0.56 . . . . 64.14 111.079 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 65.9 p -77.19 -66.87 0.77 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.739 -0.664 . . . . 73.13 110.728 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 84.0 m -157.28 146.45 20.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.637 0.775 . . . . 72.31 110.212 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 40.5 m -140.93 82.24 15.38 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 108.777 -0.823 . . . . 52.34 108.777 171.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_endo . . . . . 0 C--N 1.38 2.193 0 C-N-CA 123.605 2.87 . . . . 72.35 111.417 171.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.059 -0.348 . . . . 63.21 110.059 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -164.82 -38.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.53 1.132 . . . . 73.42 109.226 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -142.18 47.76 1.6 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.905 1.282 . . . . 72.21 109.406 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -84.01 18.78 1.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.608 1.163 . . . . 72.3 110.812 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -93.37 109.62 41.48 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.222 1.409 . . . . 72.43 108.615 -173.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.2 173.07 9.15 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.079 1.853 . . . . 71.42 111.323 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 277' ' ' LEU . . . . . 0.431 HD23 ' HG3' ' B' ' 94' ' ' MET . 9.7 tt -68.48 -37.82 80.47 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.278 -1.008 . . . . 71.01 108.278 170.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 61.0 tp -79.17 73.9 5.75 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.189 0.996 . . . . 70.41 110.038 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -74.55 -33.3 56.31 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.266 -0.424 . . . . 72.42 112.256 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 280' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' B' ' 95' ' ' ALA . 2.2 pt? -154.55 175.11 14.04 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.2 1.4 . . . . 63.1 108.455 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -98.18 -88.51 0.31 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.219 -1.4 . . . . 71.44 107.219 170.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -114.13 -47.26 2.95 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.343 -0.984 . . . . 62.44 108.343 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 17.0 t70 65.15 -161.99 0.27 Allowed 'General case' 0 CA--C 1.567 1.626 0 O-C-N 124.6 1.188 . . . . 74.22 110.636 171.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 74.69 -109.43 2.78 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 110.231 -1.148 . . . . 71.13 110.231 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -173.15 133.98 0.53 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.119 0.968 . . . . 53.35 108.705 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 286' ' ' MET . . . . . 0.535 ' HB3' HG23 ' H' ' 288' ' ' VAL . 63.1 mtt -126.69 95.22 38.24 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.869 0.867 . . . . 74.2 109.703 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -82.01 53.36 4.54 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.116 2.544 . . . . 65.51 111.577 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 288' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' H' ' 286' ' ' MET . 87.3 t -71.13 130.39 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.777 0.831 . . . . 63.22 110.638 -174.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -122.83 -88.07 0.62 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.002 -1.11 . . . . 70.43 108.002 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -151.79 162.06 41.65 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.051 0.94 . . . . 72.32 110.328 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.438 HD11 HG22 ' B' ' 131' ' ' VAL . 5.6 mp -90.98 -10.75 41.19 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.541 -1.209 . . . . 72.32 110.023 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 176.46 82.05 0.06 OUTLIER Glycine 0 C--N 1.351 1.401 0 N-CA-C 111.474 -0.65 . . . . 43.02 111.474 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.87 80.08 2.93 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.048 2.498 . . . . 74.14 111.371 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -154.24 -29.94 0.12 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.655 -0.702 . . . . 73.23 110.996 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.76 88.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.696 0.798 . . . . 55.25 111.38 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 9.3 m -62.23 114.99 3.77 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.928 0.891 . . . . 71.33 110.012 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 69.28 -69.63 0.16 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.15 1.38 . . . . 72.33 111.439 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 31.1 t60 79.73 -60.25 0.33 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.46 1.904 . . . . 70.44 110.611 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 161.54 46.72 0.02 OUTLIER Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.27 -0.739 . . . . 63.5 113.496 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -160.78 117.47 2.33 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.053 0.926 . . . . 74.42 111.199 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 301' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' B' ' 35' ' ' ASP . 26.1 mm -64.63 147.76 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.369 0 C-N-CA 124.283 1.033 . . . . 75.52 110.448 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 302' ' ' ASP . . . . . 0.46 ' HA ' ' HE1' ' F' ' 298' ' ' HIS . 14.4 p-10 -58.27 -53.21 60.91 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.115 0.966 . . . . 74.52 110.862 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -153.64 139.23 12.0 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.839 1.656 . . . . 74.54 106.904 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.08 -25.02 80.57 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.327 2.018 . . . . 75.31 112.433 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -163.67 177.45 8.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.568 1.147 . . . . 64.4 109.144 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 306' ' ' VAL . . . . . 0.482 HG13 ' HB1' ' C' ' 129' ' ' ALA . 3.6 t -62.99 -31.15 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 122.995 0.518 . . . . 62.01 110.803 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 307' ' ' THR . . . . . 0.414 HG21 ' N ' ' F' ' 292' ' ' GLY . 24.2 m 84.76 141.65 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.326 1.85 . . . . 70.14 110.76 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 15.3 p -66.59 131.31 45.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.886 0.874 . . . . 63.33 111.382 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 35.8 p -120.28 88.7 42.32 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.461 1.104 . . . . 71.23 109.151 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 C--N 1.378 2.084 0 C-N-CA 123.23 2.62 . . . . 64.31 112.018 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.1 mmm . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.252 -0.647 . . . . 52.33 109.252 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 m -76.06 86.27 2.95 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.536 0.734 . . . . 60.31 110.865 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -155.64 -71.34 0.12 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.961 -0.755 . . . . 72.55 108.961 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.705 ' HG2' HE22 ' E' ' 273' ' ' GLN . 82.8 mm-40 -86.67 62.28 7.31 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.723 0.773 . . . . 63.41 109.431 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -85.03 -18.46 34.32 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.017 -0.992 . . . . 74.32 111.05 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -70.73 123.84 22.87 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.555 -0.535 . . . . 74.21 109.555 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 m -87.8 -3.53 58.94 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.258 1.023 . . . . 64.1 111.368 -171.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -99.1 141.31 32.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.009 0.524 . . . . 72.23 111.188 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.2 mtm -88.07 159.66 18.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.002 0.921 . . . . 42.1 110.278 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -147.18 135.94 22.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.921 0.888 . . . . 65.43 109.602 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.621 ' HA ' HG22 ' A' ' 86' ' ' ILE . 54.1 t80 -136.2 132.16 35.53 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.495 -1.668 . . . . 72.03 106.495 164.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -150.82 120.3 6.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.855 -0.424 . . . . 75.1 109.855 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -77.81 128.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.929 -1.137 . . . . 71.24 107.929 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -101.78 -39.9 7.2 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.605 -0.517 . . . . 61.21 109.605 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -174.68 127.62 0.31 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.672 0.389 . . . . 71.31 109.961 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -112.48 145.94 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.02 -0.733 . . . . 72.42 109.02 175.74 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -165.39 174.64 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.716 0.807 . . . . 74.42 111.195 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -99.68 122.56 42.88 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.212 -0.662 . . . . 72.35 109.212 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.94 -24.6 23.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.738 0.415 . . . . 62.51 110.042 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.28 137.36 17.32 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.175 -0.921 . . . . 62.42 109.416 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -133.77 132.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.319 -1.363 . . . . 61.5 107.319 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -139.57 124.89 19.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 72.12 108.641 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -135.23 128.49 32.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.397 -1.705 . . . . 75.01 106.397 170.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -137.32 121.7 18.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.995 0.518 . . . . 72.23 109.666 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.11 77.57 67.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.599 -1.63 . . . . 71.21 106.599 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.77 -46.06 9.64 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.578 2.186 . . . . 71.3 111.36 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.22 23.37 3.88 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.653 -1.158 . . . . 74.41 109.704 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.03 -55.64 10.7 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.111 -0.947 . . . . 75.22 112.916 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.8 Cg_exo -61.18 -26.89 83.07 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.378 2.052 . . . . 71.03 113.305 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.97 -26.7 20.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.988 0.915 . . . . 72.42 110.763 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -82.52 -17.69 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 122.744 0.417 . . . . 72.31 111.281 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -79.81 -12.46 59.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.271 0.628 . . . . 73.45 111.78 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -101.94 -9.14 20.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.174 0.99 . . . . 74.3 110.933 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -71.94 158.62 35.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.3 0.64 . . . . 75.11 111.663 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.59 138.16 58.42 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.048 -0.978 . . . . 73.25 110.19 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -94.01 63.23 3.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.623 0.725 . . . . 73.01 111.645 -165.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.45 83.77 16.9 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.123 0.969 . . . . 72.14 109.188 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.92 167.04 8.36 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.643 2.229 . . . . 75.15 111.648 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.14 99.62 7.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.316 -1.364 . . . . 74.42 107.316 167.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 65' ' ' THR . 59.7 t -85.08 129.87 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.04 -0.726 . . . . 64.01 109.04 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -125.09 120.15 30.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.528 1.131 . . . . 72.51 109.296 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tt -96.71 109.07 21.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.281 -1.748 . . . . 51.33 106.281 170.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -127.1 128.2 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.906 -1.146 . . . . 72.3 107.906 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.73 162.13 14.74 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.269 0.556 . . . . 73.32 110.853 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 10.1 t70 -131.05 134.51 46.71 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.015 1.326 . . . . 64.23 108.081 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' E' ' 281' ' ' PHE . 26.8 p -115.76 125.08 52.3 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.018 0.927 . . . . 74.44 110.695 -171.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.38 124.06 11.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.23 0.612 . . . . 53.2 111.586 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.54 ' HB2' HD11 ' E' ' 278' ' ' LEU . 6.5 p -90.91 155.68 18.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.296 0.638 . . . . 70.52 109.568 168.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -150.58 150.56 31.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.223 1.009 . . . . 70.3 109.027 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -115.24 138.84 50.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.194 0.598 . . . . 60.23 110.228 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.04 -34.63 6.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.824 0.85 . . . . 71.24 109.856 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -166.75 -176.01 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 71.04 109.986 -176.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.39 122.07 21.48 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.955 -0.758 . . . . 75.32 108.955 173.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 72.75 -7.02 1.52 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.36 1.464 . . . . 74.32 112.468 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.5 t -114.86 111.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 107.506 -1.294 . . . . 51.43 107.506 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -128.68 170.96 12.65 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 123.65 0.78 . . . . 73.34 108.997 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -130.59 147.25 52.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.978 0.911 . . . . 74.12 109.076 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.424 HG13 ' HE2' ' E' ' 281' ' ' PHE . 96.4 t -125.98 122.33 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.923 -1.14 . . . . 71.11 107.923 171.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.2 t -105.35 129.68 57.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 109.239 -0.652 . . . . 75.43 109.239 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -118.61 100.41 7.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 106.482 -1.673 . . . . 64.22 106.482 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttp180 -84.96 109.0 17.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.764 -0.653 . . . . 61.52 109.276 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -92.81 132.59 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 107.966 -1.124 . . . . 73.34 107.966 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -120.27 138.39 53.7 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.485 -0.561 . . . . 63.15 109.485 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.56 108.98 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 124.874 1.27 . . . . 74.14 107.573 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 m -105.02 134.72 47.65 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 109.461 -0.57 . . . . 73.04 109.461 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.77 111.63 15.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.232 -1.396 . . . . 71.53 107.232 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 18.2 t -138.15 134.99 35.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.004 0.522 . . . . 71.01 110.464 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.42 52.06 2.01 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.078 1.351 . . . . 64.32 109.608 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.83 -90.69 1.46 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.61 -0.596 . . . . 60.25 111.61 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.62 -27.59 17.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.996 0.518 . . . . 73.04 112.381 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.31 125.13 53.54 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.662 -0.496 . . . . 70.05 109.662 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 43.5 m -81.26 135.3 35.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.571 0.748 . . . . 73.31 111.237 -177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.87 -65.08 0.88 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.466 0.706 . . . . 43.14 110.217 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -160.53 163.47 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.988 -1.006 . . . . 74.32 111.366 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.93 124.89 30.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.862 1.265 . . . . 61.51 108.371 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.411 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 54.7 m -123.88 105.61 9.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.115 0.966 . . . . 73.41 109.067 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.7 122.16 28.38 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.348 0.659 . . . . 61.32 109.718 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 113' ' ' CYS . 46.7 t -130.47 112.75 23.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.915 0.886 . . . . 74.1 109.458 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 37.6 mt-30 -84.87 89.16 7.49 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.466 0.706 . . . . 74.21 109.506 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 67.5 tp60 -80.33 98.23 7.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.136 -0.938 . . . . 73.33 109.023 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -101.1 145.25 16.91 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.426 -0.67 . . . . 63.24 111.426 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.98 137.27 6.58 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 111.639 -0.585 . . . . 71.21 111.639 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mt -77.9 126.15 38.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.843 -0.799 . . . . 55.41 108.843 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -129.52 118.98 22.93 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.621 -0.881 . . . . 72.4 108.621 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -86.25 99.11 11.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.778 -0.823 . . . . 71.5 108.778 172.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.88 157.32 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.313 0.645 . . . . 73.25 110.512 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HA ' HD21 ' E' ' 277' ' ' LEU . . . -166.88 161.6 15.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.941 -1.027 . . . . 65.14 110.476 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.3 8.04 83.09 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.287 0.367 . . . . 73.33 113.797 170.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 pt -111.45 143.69 20.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 123.956 0.902 . . . . 71.14 108.901 -176.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.7 tt0 -159.13 174.92 14.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.834 0.454 . . . . 74.41 109.879 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 58.87 -127.91 46.41 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 123.904 0.764 . . . . 72.23 114.274 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -82.66 -15.19 52.98 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.296 0.638 . . . . 70.0 111.527 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.53 -40.31 61.81 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.353 0.661 . . . . 74.14 110.097 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.8 ptm -71.01 -29.5 65.47 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.272 -0.422 . . . . 72.41 110.065 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.14 -28.85 63.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.561 0.745 . . . . 64.41 111.131 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -81.6 -31.49 32.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.419 0.687 . . . . 73.01 110.494 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.12 -57.57 5.23 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.965 0.506 . . . . 74.32 109.925 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.8 -51.83 44.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.284 -0.871 . . . . 61.4 111.001 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.57 -6.09 88.16 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 115.147 0.819 . . . . 62.33 115.147 -167.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.39 -54.14 0.19 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.254 0.835 . . . . 74.33 113.254 -170.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -69.39 -46.91 65.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.611 0.365 . . . . 64.13 111.575 -171.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.9 m -67.98 -43.56 37.02 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.003 0.921 . . . . 64.33 112.609 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.69 -43.26 40.72 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 123.096 2.531 . . . . 72.43 113.148 168.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -63.25 -37.14 86.07 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.089 0.868 . . . . 70.34 110.837 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.0 -45.53 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.326 0.65 . . . . 74.43 111.015 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.33 -24.49 34.55 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.566 -0.743 . . . . 74.14 112.292 -170.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -61.29 -42.49 85.64 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 113.824 1.046 . . . . 54.42 113.824 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.427 ' HA ' HH11 ' A' ' 111' ' ' ARG . 76.6 Cg_exo -55.04 -41.8 75.26 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.47 2.114 . . . . 74.31 114.399 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.148 0.579 . . . . 62.31 111.62 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.87 97.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.032 0.533 . . . . 71.0 110.657 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.1 ttm105 -50.69 -57.67 7.73 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.776 1.298 . . . . 64.41 110.825 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.88 -40.76 95.62 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.991 0.807 . . . . 74.1 110.802 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.571 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.2 t -60.76 -33.21 72.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.659 0.599 . . . . 73.43 111.786 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.522 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 96.1 mt -74.01 -55.74 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.623 0.769 . . . . 64.33 109.843 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -51.41 -44.3 62.2 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.246 1.418 . . . . 62.21 112.64 -173.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 34.3 t -65.3 -42.75 92.77 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.93 -1.032 . . . . 74.14 110.106 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.522 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 51.4 mtm -64.63 -40.39 95.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.84 0.456 . . . . 72.21 111.05 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.1 t -57.27 -48.29 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.576 0.75 . . . . 65.5 109.945 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -71.16 -31.89 68.24 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.737 -0.665 . . . . 75.41 111.765 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 116' ' ' SER . 73.1 mtt-85 -67.58 -28.74 68.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.85 0.86 . . . . 71.42 110.885 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.87 23.85 8.61 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 119.627 -0.54 . . . . 74.24 113.972 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.415 HG23 ' HB3' ' B' ' 17' ' ' TYR . 75.4 p 50.13 26.08 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.809 1.644 . . . . 44.35 113.625 -173.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.36 149.17 36.26 Favored Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 108.83 -0.804 . . . . 63.22 108.83 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.541 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 50.3 Cg_exo -56.02 139.3 84.76 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.818 2.346 . . . . 60.12 111.488 174.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.448 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.1 tt0 -54.71 132.6 46.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.13 0.894 . . . . 70.42 111.092 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.1 tp -111.92 118.3 35.11 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.85 -0.796 . . . . 72.5 108.85 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.595 ' HB2' HD13 ' C' ' 13' ' ' ILE . 89.9 m-20 -110.0 110.36 21.25 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.995 -1.113 . . . . 70.1 107.995 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 128' ' ' LEU . 2.1 mm? -73.15 117.33 14.76 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.932 -1.136 . . . . 54.22 107.932 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -60.12 140.27 90.93 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 118.406 0.548 . . . . 45.44 110.996 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 1.7 Cg_endo -74.03 109.84 2.96 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.027 1.818 . . . . 43.32 110.645 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.36 123.74 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.501 -0.925 . . . . 73.45 108.501 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -73.75 99.73 3.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.807 0.843 . . . . 73.54 109.929 -173.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -72.15 -46.31 56.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.475 0.71 . . . . 73.34 111.85 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.644 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.9 p-10 -63.25 -41.63 99.09 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.425 0.453 . . . . 64.31 111.441 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.33 -51.98 60.73 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.449 0.468 . . . . 52.45 109.991 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.37 -42.62 67.04 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.988 1.43 . . . . 74.33 110.969 -173.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -61.28 -44.87 96.51 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.22 0.95 . . . . 73.34 110.198 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 84.1 mmm -71.38 -42.71 68.06 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.058 0.543 . . . . 71.35 112.22 -173.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 1.4 p-10 -71.05 -26.43 63.08 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.69 0.223 . . . . 53.21 111.096 178.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -76.36 -35.25 58.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.986 0.514 . . . . 72.52 110.423 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.8 tp -68.73 -51.76 37.97 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 74.33 112.059 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -169.78 19.33 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.716 -0.674 . . . . 74.21 110.615 -168.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 62.0 mm-40 64.98 -80.24 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.414 1.086 . . . . 61.33 110.828 -174.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -88.72 131.72 34.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.491 1.116 . . . . 73.53 111.08 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.42 165.03 20.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.021 0.928 . . . . 73.41 111.463 174.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.66 170.46 48.23 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.169 -0.469 . . . . 74.44 113.805 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.46 130.45 56.32 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.211 1.005 . . . . 64.44 110.445 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.9 69.73 2.83 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 111.493 -0.643 . . . . 73.42 111.493 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.6 p -89.31 129.9 35.78 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.706 0.802 . . . . 63.51 111.865 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -89.77 145.65 25.03 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 107.909 -1.145 . . . . 65.1 107.909 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -136.22 -12.98 1.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.745 0.418 . . . . 73.03 111.67 -169.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -86.24 109.48 18.96 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.785 -0.572 . . . . 65.14 111.818 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.09 118.53 21.89 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.379 1.072 . . . . 74.33 108.682 171.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.07 -49.14 76.76 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.957 0.903 . . . . 75.04 111.693 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 N-CA-C 108.782 -0.821 . . . . 73.31 108.782 177.385 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.736 -0.468 . . . . 62.23 109.736 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -141.32 97.78 3.23 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.889 0.875 . . . . 51.03 109.898 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -107.72 159.87 16.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.741 0.816 . . . . 73.31 109.76 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -142.01 171.41 14.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.748 1.219 . . . . 73.14 109.501 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -68.94 157.99 35.55 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.232 0.613 . . . . 61.41 110.772 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -67.96 145.07 54.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.478 0.711 . . . . 70.43 112.123 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.427 HG22 ' HB2' ' E' ' 310' ' ' PRO . 14.9 t -133.62 -160.09 1.02 Allowed 'General case' 0 C--O 1.246 0.904 0 C-N-CA 124.528 1.131 . . . . 72.52 108.504 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -55.6 115.65 2.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.07 0.548 . . . . 71.2 110.298 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.565 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 15.2 ptm 58.46 177.79 0.07 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.472 1.909 . . . . 72.13 114.267 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m -152.48 130.32 11.69 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.797 1.239 . . . . 75.35 108.012 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -151.68 128.6 11.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.936 0.494 . . . . 73.23 110.104 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -159.67 144.27 15.09 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.678 0.791 . . . . 64.44 108.942 161.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.561 HG22 ' HE2' ' B' ' 84' ' ' PHE . 2.7 pp -59.13 138.4 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.498 -0.774 . . . . 73.24 109.957 168.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.7 mm100 -100.47 -45.98 5.38 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.575 -0.898 . . . . 75.34 108.575 172.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -164.84 129.93 2.64 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.99 -1.004 . . . . 75.14 108.882 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -115.03 135.98 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 106.667 -1.605 . . . . 62.54 106.667 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 122' ' ' THR . 26.5 p90 -166.5 158.44 13.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.482 0.658 . . . . 73.2 111.331 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 78.2 m -85.46 119.71 26.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.162 -0.926 . . . . 74.04 108.962 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.524 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 44.3 mtpt -88.32 -34.68 17.57 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.273 0.629 . . . . 73.14 110.177 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.2 t70 -153.79 147.16 24.87 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.568 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 41.0 mm -139.76 142.94 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.86 1.664 . . . . 53.31 107.573 177.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -148.43 138.17 22.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.665 -0.865 . . . . 62.02 108.665 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -151.18 123.3 8.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.239 -1.393 . . . . 75.44 107.239 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -120.89 149.52 42.49 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.081 0.552 . . . . 75.31 109.542 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -143.72 80.26 12.92 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.11 -1.07 . . . . 40.54 108.11 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.41 -17.66 39.03 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.057 2.505 . . . . 73.01 111.872 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -122.87 27.84 7.53 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.501 1.121 . . . . 72.22 109.439 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.05 -50.05 47.87 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 124.275 1.03 . . . . 75.32 112.836 172.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 1.0 OUTLIER -85.21 -35.29 0.16 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.504 2.136 . . . . 62.34 112.709 178.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.1 m80 -90.84 2.35 56.2 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 75.31 112.908 -170.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.83 -28.59 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 125.075 1.35 . . . . 71.0 111.898 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -66.62 -13.82 61.62 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.753 1.221 . . . . 73.42 112.381 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.617 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 21.2 pt20 -73.34 -32.45 64.56 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.427 0.632 . . . . 74.3 110.253 174.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.617 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 29.3 mmtp -107.03 81.81 1.6 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.04 1.336 . . . . 51.25 108.922 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.39 77.17 8.29 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.547 -0.751 . . . . 71.13 111.644 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.6 ' HA ' ' CE3' ' B' ' 36' ' ' TRP 0.258 0.0 OUTLIER 160.56 -171.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 127.084 2.153 . . . . 71.33 111.141 156.19 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.59 ' HA ' ' HB3' ' H' ' 297' ' ' TYR . 12.4 pt20 -59.02 132.2 87.11 Favored Pre-proline 0 C--N 1.361 1.068 0 C-N-CA 124.755 1.222 . . . . 72.2 113.278 -168.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.42 171.77 15.48 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.418 2.746 . . . . 74.23 112.784 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -69.39 109.41 4.17 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 108.596 -0.89 . . . . 50.51 108.596 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' H' ' 295' ' ' ALA . 9.3 m -95.16 135.0 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.407 -0.815 . . . . 61.21 109.931 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -141.65 124.28 15.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.329 1.052 . . . . 65.41 108.294 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.65 HD22 HD21 ' B' ' 128' ' ' LEU . 64.7 tp -97.41 145.49 26.12 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.454 -0.573 . . . . 65.02 109.454 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -146.66 154.25 41.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.999 -1.112 . . . . 63.4 107.999 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -138.38 141.97 39.63 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.484 -0.932 . . . . 73.04 108.484 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.692 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 15.1 t70 -124.34 144.02 50.25 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.966 0.906 . . . . 61.31 108.699 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.3 p -112.23 112.08 23.43 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.423 -0.808 . . . . 74.3 110.225 -170.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.96 125.36 31.4 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.314 -0.995 . . . . 71.35 108.314 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.6 p -142.82 168.17 20.34 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.36 0.664 . . . . 64.32 109.621 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 57.8 p -150.99 141.06 22.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.129 0.572 . . . . 74.25 109.909 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -82.02 109.74 16.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.826 -0.805 . . . . 62.11 108.826 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' B' ' 57' ' ' GLU . 55.1 mt -75.83 -41.03 53.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.445 . . . . 75.54 110.245 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.75 -171.77 3.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.184 0.994 . . . . 65.23 110.062 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.88 111.37 1.44 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 115.555 -0.748 . . . . 63.11 110.446 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 65.55 12.53 8.27 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.637 1.175 . . . . 75.54 112.516 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.06 115.14 47.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.094 -1.076 . . . . 72.42 108.094 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' H' ' 278' ' ' LEU . 78.7 m-85 -124.14 138.49 54.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.225 -0.657 . . . . 72.44 109.225 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.507 ' HB2' HD11 ' B' ' 51' ' ' LEU . 7.8 tm-20 -107.08 106.92 17.66 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.278 -1.379 . . . . 73.32 107.278 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.1 t -96.4 121.57 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.088 1.355 . . . . 74.34 110.04 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.494 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 30.0 t -105.39 120.19 55.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.437 0.695 . . . . 54.11 109.149 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' ' 103' ' ' PRO . 50.2 tp -95.16 99.16 11.18 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 73.24 108.605 172.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.692 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 65.2 ttt180 -88.48 107.94 19.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.813 -0.81 . . . . 71.53 108.813 177.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -104.9 102.87 14.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.177 0.991 . . . . 65.24 108.934 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -100.93 128.47 46.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.376 0.67 . . . . 72.43 109.836 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.43 135.29 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.333 1.053 . . . . 72.44 108.932 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.9 m -124.83 143.59 50.74 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.528 0.731 . . . . 30.32 109.571 174.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.74 130.25 24.0 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.915 -1.142 . . . . 64.22 107.915 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.411 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 8.4 m -135.14 126.53 28.47 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 120.81 0.338 . . . . 53.23 111.586 -176.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 56.9 mt -93.9 109.75 21.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.409 1.084 . . . . 73.24 108.467 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.9 -111.17 3.86 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.051 -0.82 . . . . 53.41 111.051 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -121.97 18.42 10.91 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.657 0.742 . . . . 73.22 110.214 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -122.2 142.79 50.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.529 -0.732 . . . . 75.21 109.132 178.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.7 m -66.78 118.45 10.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.909 0.484 . . . . 75.4 110.983 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -68.03 -55.46 12.51 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.973 -0.751 . . . . 71.4 108.973 177.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 74' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' H' ' 296' ' ' THR . 50.4 p90 -164.4 164.98 21.96 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.203 -1.362 . . . . 75.24 109.214 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.76 151.91 42.75 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.439 1.096 . . . . 64.45 108.514 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.4 t -155.52 115.66 3.75 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.221 -0.659 . . . . 74.43 109.221 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -123.62 127.04 47.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.143 -1.058 . . . . 74.15 108.143 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.414 HG13 HD13 ' B' ' 21' ' ' ILE . 57.3 t -122.55 148.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.875 -0.787 . . . . 74.05 108.875 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.5 mt-30 -123.4 99.46 6.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.218 -1.031 . . . . 55.24 108.218 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 44.6 tp60 -93.71 100.45 12.67 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.35 -0.981 . . . . 72.23 108.35 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.94 162.0 29.7 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 123.677 0.61 . . . . 45.15 111.912 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.89 127.13 1.64 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.226 -0.75 . . . . 71.53 111.226 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 33.9 mt -83.98 133.81 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.057 -1.09 . . . . 64.25 108.057 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.561 ' HE2' HG22 ' B' ' 13' ' ' ILE . 49.2 m-85 -135.42 138.61 43.41 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.454 0.702 . . . . 75.13 109.45 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -91.86 103.74 16.25 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.791 -0.818 . . . . 74.33 108.791 169.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.475 ' HB ' HD11 ' B' ' 89' ' ' ILE . 26.1 pt -120.21 122.04 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.879 0.872 . . . . 72.2 110.007 -176.024 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.87 21.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.839 0.855 . . . . 54.23 109.876 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.36 -45.32 3.48 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.525 0.516 . . . . 74.13 113.108 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' B' ' 86' ' ' ILE . 20.9 pt -64.03 158.88 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.655 1.182 . . . . 61.45 112.439 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.418 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 11.1 pt-20 -170.21 166.57 8.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.581 1.152 . . . . 74.3 109.8 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -119.1 16.6 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.297 -0.411 . . . . 71.35 113.881 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -80.27 -18.87 48.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 71.42 111.345 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.418 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 94.5 mt-30 -60.89 -44.35 97.24 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 73.42 110.954 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.414 ' HE3' ' O ' ' H' ' 277' ' ' LEU . 3.3 ppp? -73.24 -32.7 64.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.661 0.384 . . . . 71.14 110.612 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.57 -33.7 76.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.721 0.808 . . . . 63.33 111.406 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -85.24 -26.64 26.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.667 0.787 . . . . 52.21 110.488 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.97 -67.18 0.53 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.562 0.345 . . . . 72.15 110.569 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.433 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -95.14 -6.48 41.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.517 0.562 . . . . 74.0 112.517 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.8 2.38 45.19 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.216 0.322 . . . . 71.5 113.036 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.76 -58.36 0.32 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.094 0.558 . . . . 63.43 111.037 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.41 -46.8 46.57 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.198 0.599 . . . . 73.2 111.963 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 68.8 m -66.04 -42.46 51.67 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.546 0.738 . . . . 53.02 111.781 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HA ' HD22 ' B' ' 60' ' ' LEU . 89.9 Cg_exo -50.87 -43.72 45.46 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.628 2.218 . . . . 74.11 112.893 166.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -65.87 -25.04 67.0 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.183 0.593 . . . . 71.44 112.523 179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mt -76.8 -50.55 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.407 0.683 . . . . 64.1 110.346 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.36 -15.95 57.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.562 0.745 . . . . 70.43 111.521 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.466 ' HE1' HD13 ' B' ' 128' ' ' LEU . 37.8 t80 -62.5 -53.33 58.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.609 -1.186 . . . . 75.3 112.799 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 71.4 Cg_exo -54.26 -37.76 88.31 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.187 1.925 . . . . 75.15 113.59 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.518 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 80.0 m-85 -68.33 -51.38 45.22 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.737 0.815 . . . . 72.02 110.947 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.72 81.23 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.959 0.904 . . . . 61.02 111.33 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -64.95 -52.71 54.82 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.457 1.503 . . . . 73.21 110.296 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -34.84 78.4 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.903 0.752 . . . . 55.12 109.776 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.523 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.8 t -68.66 -43.29 76.53 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.904 0.482 . . . . 75.15 111.363 -177.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.85 -43.78 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 123.445 0.698 . . . . 75.14 110.338 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.723 HG23 ' HB2' ' B' ' 125' ' ' GLN . 44.5 m -64.02 -27.7 69.29 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.203 -0.908 . . . . 74.35 111.052 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.8 t -73.59 -45.01 55.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.458 0.703 . . . . 71.31 110.122 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -72.5 -37.78 68.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.991 0.517 . . . . 72.33 112.025 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.59 -31.07 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.002 0.43 . . . . 73.43 110.46 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.461 ' OG ' HG21 ' C' ' 115' ' ' THR . 21.5 t -70.98 -30.54 66.84 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.925 0.89 . . . . 72.01 111.611 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.571 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.7 mtt-85 -74.03 -31.16 62.78 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.213 -0.903 . . . . 75.11 109.683 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.4 0.7 68.09 Favored Glycine 0 C--N 1.362 2.027 0 O-C-N 123.911 0.757 . . . . 53.34 112.203 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.563 HG22 HH22 ' C' ' 111' ' ' ARG . 29.3 p 65.5 23.62 11.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.93 2.092 . . . . 75.44 113.244 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.59 150.85 39.53 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 122.893 0.477 . . . . 74.55 110.079 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.521 ' O ' HG22 ' H' ' 296' ' ' THR . 91.9 Cg_exo -42.0 137.76 3.07 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.381 3.387 . . . . 72.14 113.226 173.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.723 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.0 pt20 -66.57 157.33 32.6 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.267 1.21 . . . . 75.51 114.267 -174.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.48 ' HB2' HG23 ' H' ' 296' ' ' THR . 2.1 tt -110.77 95.86 5.82 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.521 -1.659 . . . . 73.01 106.521 165.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 127' ' ' ASN . . . . . 0.407 HD22 ' HG3' ' B' ' 125' ' ' GLN . 3.5 p30 -88.33 92.6 9.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.923 -1.51 . . . . 72.14 106.923 173.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.65 HD21 HD22 ' B' ' 42' ' ' LEU . 1.2 tt -63.44 133.91 54.76 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.785 -1.098 . . . . 72.42 110.892 -165.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.561 ' HB3' HD22 ' H' ' 291' ' ' LEU . . . -62.99 146.6 95.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.155 0.982 . . . . 74.04 111.051 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.77 116.16 3.11 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.682 2.254 . . . . 72.24 111.516 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.568 HG22 HD21 ' H' ' 291' ' ' LEU . 12.7 t -90.76 118.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.226 -0.657 . . . . 73.03 109.226 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.533 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 59.7 t30 -96.74 103.67 15.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.578 0.751 . . . . 71.5 109.823 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -87.08 -23.31 24.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.625 0.77 . . . . 73.11 110.707 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -60.25 -34.86 74.29 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.509 -0.768 . . . . 74.31 110.685 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.533 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -51.52 -40.19 59.13 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.087 0.955 . . . . 75.32 113.193 -176.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 57.0 tp -72.08 -52.26 17.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.74 0.416 . . . . 54.3 110.835 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -69.37 -29.52 67.32 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.274 0.63 . . . . 73.4 112.682 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.7 -41.52 65.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.521 0.728 . . . . 63.32 109.438 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -78.73 -25.08 44.54 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.231 -1.35 . . . . 41.31 110.112 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -65.52 -38.38 89.52 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.215 -0.902 . . . . 74.14 110.358 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.1 mt -91.01 3.09 55.64 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.301 -0.863 . . . . 63.35 111.51 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -81.02 98.05 7.78 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-O 121.304 0.573 . . . . 75.35 109.986 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -139.46 -31.56 0.68 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.505 1.122 . . . . 75.35 110.137 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -92.23 163.53 13.88 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.687 0.795 . . . . 75.0 110.456 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.1 111.14 8.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.621 0.768 . . . . 71.13 110.361 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -175.49 39.83 0.11 Allowed Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.347 -0.701 . . . . 35.44 111.347 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.54 -153.6 0.53 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.242 1.017 . . . . 74.45 109.358 -174.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.96 55.1 1.66 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 110.289 -1.124 . . . . 31.54 110.289 -173.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -152.19 166.65 31.05 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 124.364 1.066 . . . . 70.41 109.727 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -68.93 115.87 8.74 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.71 0.804 . . . . 72.32 109.597 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -75.75 73.44 2.7 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.294 -1.002 . . . . 70.12 108.294 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -69.25 129.42 39.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.862 -1.063 . . . . 71.41 111.051 -171.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -173.93 166.82 4.35 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.233 1.413 . . . . 73.52 109.646 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.49 76.09 0.81 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.977 -0.749 . . . . 70.45 108.977 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.836 -1.074 . . . . 74.15 109.024 177.107 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.193 -0.669 . . . . 73.3 109.193 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.5 t 63.0 81.44 0.2 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.95 1.3 . . . . 61.54 110.945 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.72 16.98 5.06 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.212 1.005 . . . . 71.44 112.439 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 66.32 125.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.33 1.452 . . . . 74.34 112.082 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -155.68 142.29 18.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.273 0.629 . . . . 74.42 110.218 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -151.21 172.74 15.35 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.24 1.016 . . . . 43.3 108.637 173.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 87.0 m -129.29 -71.81 0.61 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.295 -1.002 . . . . 73.43 108.295 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.18 64.89 1.61 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.745 1.218 . . . . 63.54 109.904 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.524 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 57.9 ttp 65.89 144.43 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.001 1.32 . . . . 64.01 112.704 -170.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 67.6 m -119.11 97.17 5.55 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.894 -1.521 . . . . 70.23 106.894 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.92 121.68 45.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.338 0.655 . . . . 65.43 109.633 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.413 ' HB3' ' HB3' ' G' ' 310' ' ' PRO . 4.1 pt20 -137.84 145.13 41.87 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.363 0.665 . . . . 71.5 109.748 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 127' ' ' ASN . 2.6 pp -82.42 142.68 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.615 -0.883 . . . . 72.13 108.615 171.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -110.09 -50.19 3.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.855 -0.424 . . . . 75.14 109.855 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.643 HH12 HD11 ' G' ' 301' ' ' ILE . 62.7 ttt180 -169.71 130.95 1.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.245 0.341 . . . . 72.51 110.464 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 16' ' ' ILE . . . . . 0.435 ' H ' HD21 ' A' ' 127' ' ' ASN . 65.6 mt -109.61 140.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.826 1.25 . . . . 73.2 107.92 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG12 ' C' ' 83' ' ' ILE . 12.8 p90 -171.89 154.5 3.56 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.018 0.826 . . . . 74.42 112.212 -175.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -80.44 106.44 12.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.661 -1.154 . . . . 55.03 107.974 170.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -68.73 -48.16 64.51 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.872 0.844 . . . . 55.44 109.205 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.8 t70 -134.65 141.81 46.68 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.237 -1.347 . . . . 74.02 109.244 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.3 mt -135.63 145.33 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.353 1.461 . . . . 75.24 107.219 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -155.59 152.01 28.24 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.212 0.529 . . . . 53.14 110.355 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.3 t80 -147.94 119.11 7.74 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.298 -1.371 . . . . 72.04 107.298 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 41.4 mt-10 -118.7 118.23 31.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.163 0.585 . . . . 72.24 109.628 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 25' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -134.54 86.0 35.71 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.627 0.771 . . . . 72.02 109.313 175.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -71.25 -28.71 18.17 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.954 2.436 . . . . 65.24 111.781 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.99 19.81 12.2 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.397 1.079 . . . . 64.42 110.465 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' C' ' 25' ' ' ALA . . . -59.11 -47.0 99.34 Favored Pre-proline 0 CA--C 1.567 1.596 0 C-N-CA 124.812 1.245 . . . . 62.33 113.953 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.94 -31.06 6.62 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.775 1.65 . . . . 65.52 111.875 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -66.68 -21.84 66.09 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.896 1.278 . . . . 72.32 112.744 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 8.3 p -50.92 -33.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 113.856 1.058 . . . . 73.32 113.856 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -58.35 -30.8 67.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.569 0.748 . . . . 71.42 112.624 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.25 28.06 9.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.232 1.013 . . . . 73.33 110.593 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 14.1 ttmm -104.15 147.27 27.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.242 0.617 . . . . 64.35 109.739 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.25 130.74 42.83 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.347 0.659 . . . . 74.11 109.836 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -84.7 62.81 7.59 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 123.731 0.644 . . . . 72.35 111.246 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -156.28 77.66 4.33 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.361 1.065 . . . . 74.24 108.348 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.485 ' HB2' ' HB1' ' C' ' 66' ' ' ALA . 72.5 Cg_endo -88.45 140.2 4.4 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 122.454 2.103 . . . . 73.41 111.608 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.03 115.52 24.47 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.249 -1.019 . . . . 73.32 108.249 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.85 106.22 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.86 -0.793 . . . . 74.52 108.86 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -92.11 108.31 19.84 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.18 122.85 32.21 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.281 -1.377 . . . . 75.41 107.281 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.77 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.0 m-20 -119.88 118.27 30.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.769 0.827 . . . . 74.34 109.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.45 126.34 53.39 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.908 -0.775 . . . . 75.52 108.908 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 19.8 t70 -128.53 135.68 49.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.719 1.208 . . . . 75.03 108.107 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.0 p -113.73 126.58 55.39 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.946 0.498 . . . . 44.12 110.358 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -126.58 145.66 50.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.951 0.9 . . . . 74.15 110.081 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.4 p -144.04 148.68 35.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.256 0.622 . . . . 53.11 109.458 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -145.38 140.28 27.56 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.564 -0.902 . . . . 63.15 108.564 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -94.29 115.82 28.12 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.044 -1.095 . . . . 73.21 108.044 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 HD12 ' C' ' 83' ' ' ILE . 35.1 mt -87.92 -40.83 13.62 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.745 0.818 . . . . 71.43 109.618 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.81 -175.77 5.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.085 1.354 . . . . 63.14 108.371 175.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -62.45 122.94 16.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.389 0.431 . . . . 55.55 109.943 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 68.93 -7.09 0.8 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.67 1.588 . . . . 61.41 113.604 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.22 107.05 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.837 -1.171 . . . . 73.35 107.837 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' C' ' 86' ' ' ILE . 72.9 m-85 -118.18 122.87 44.12 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.927 -1.138 . . . . 74.11 107.927 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.22 120.77 26.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.158 0.983 . . . . 72.32 109.141 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.2 t -97.05 116.07 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 72.21 108.375 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 59.6 t -117.82 134.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.643 0.777 . . . . 63.34 109.132 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.91 111.02 19.06 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.2 ttm180 -79.96 105.83 11.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.041 -1.466 . . . . 62.41 107.041 167.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.25 114.07 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.09 -1.078 . . . . 75.13 108.09 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.77 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 64.2 m -114.71 137.73 51.57 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.715 0.806 . . . . 72.43 108.882 -174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.48 HG21 HG21 ' C' ' 114' ' ' ILE . 61.0 t -128.23 112.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.667 -1.234 . . . . 62.25 107.667 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -106.24 139.89 40.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.613 -0.884 . . . . 72.45 108.613 169.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 66' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' C' ' 38' ' ' PRO . . . -121.34 112.89 19.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.881 -1.526 . . . . 74.32 106.881 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.0 m -148.12 137.44 22.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.116 0.566 . . . . 72.05 110.354 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.5 58.79 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.391 1.076 . . . . 65.41 109.347 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 -117.78 5.3 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.808 -1.087 . . . . 73.2 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.53 -30.25 18.36 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.925 -0.769 . . . . 70.15 108.925 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -63.61 100.05 0.25 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 124.236 0.96 . . . . 63.24 109.476 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -85.56 134.96 34.0 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.053 0.541 . . . . 73.41 109.856 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.635 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -80.83 -61.05 2.08 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.995 0.918 . . . . 42.13 109.173 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -167.59 178.0 5.6 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.952 0.782 . . . . 74.31 110.934 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -138.49 144.85 40.2 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.548 -1.279 . . . . 75.01 107.548 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.465 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.0 t -148.98 142.92 25.78 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.792 -1.188 . . . . 74.2 107.792 174.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.64 134.54 11.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.896 0.316 . . . . 60.44 110.722 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -138.48 116.08 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.458 1.103 . . . . 43.55 110.027 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.505 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 2.2 mp0 -89.99 88.4 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.179 0.992 . . . . 71.34 108.426 174.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.6 tp60 -79.39 103.41 9.29 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.061 -0.972 . . . . 62.41 110.081 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.54 153.11 20.86 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.784 -0.644 . . . . 63.21 111.763 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.08 117.37 0.82 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 110.225 -1.15 . . . . 54.41 110.225 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.577 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -81.2 122.31 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.11 -0.7 . . . . 54.23 109.11 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' C' ' 86' ' ' ILE . 60.3 m-85 -132.07 152.82 50.98 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.534 -0.914 . . . . 64.53 108.534 176.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -110.27 113.15 25.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.542 -0.91 . . . . 50.42 108.542 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' C' ' 84' ' ' PHE . 2.9 mp -115.75 103.15 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.204 -1.406 . . . . 45.03 107.204 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.52 169.83 10.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.339 0.656 . . . . 72.45 110.903 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.06 -50.69 2.8 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.913 -0.585 . . . . 43.21 112.484 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 170.32 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.002 0.521 . . . . 72.25 111.769 -171.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.22 -173.99 4.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.767 0.827 . . . . 71.3 109.823 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -138.63 39.12 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.738 -0.479 . . . . 53.4 113.627 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 92' ' ' THR . . . . . 0.527 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 35.7 p -68.54 -22.3 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.915 0.886 . . . . 52.43 111.818 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -67.41 -50.07 61.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 74.42 110.041 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -66.83 -38.21 85.98 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.871 -0.604 . . . . 64.34 109.985 172.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -60.88 -27.69 68.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.874 0.87 . . . . 62.44 112.331 -175.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 37.1 t-80 -74.91 -47.88 27.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.007 -0.368 . . . . 63.11 110.007 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.524 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 18.7 t -70.73 -22.3 62.45 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 111.984 0.364 . . . . 71.2 111.984 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.24 -43.48 5.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.084 0.954 . . . . 74.01 109.521 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.66 -5.36 64.85 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.56 -0.746 . . . . 73.24 114.139 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -133.87 -54.7 0.87 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.192 0.496 . . . . 54.31 111.361 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.422 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 33.4 t80 -67.13 -55.92 12.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.156 0.983 . . . . 71.35 112.079 -172.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.83 -45.49 87.59 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 113.044 0.757 . . . . 72.31 113.044 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -56.61 -39.89 88.24 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.715 2.277 . . . . 70.11 113.72 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -65.69 -28.7 69.26 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.937 0.895 . . . . 64.34 110.982 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.505 HD12 ' NH1' ' A' ' 111' ' ' ARG . 24.0 mm -72.79 -44.87 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.449 0.7 . . . . 72.21 110.592 173.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.08 -15.01 54.96 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.635 -0.711 . . . . 53.31 112.134 -173.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 78.1 t80 -57.11 -50.57 87.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 124.837 1.255 . . . . 71.52 113.139 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 34.4 Cg_exo -62.85 -32.79 77.2 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 122.129 1.886 . . . . 72.42 113.428 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.34 -44.88 86.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.688 0.795 . . . . 73.44 111.626 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.64 95.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.001 -0.545 . . . . 73.43 110.117 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.563 HH22 HG22 ' B' ' 122' ' ' THR . 48.2 ttt180 -56.44 -55.1 37.91 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.224 0.952 . . . . 72.2 111.255 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.41 -30.7 71.54 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.294 0.638 . . . . 71.4 110.69 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.74 -39.82 63.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.812 0.445 . . . . 55.33 111.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.48 HG21 HG21 ' C' ' 64' ' ' VAL . 66.5 mt -62.62 -47.0 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.958 0.903 . . . . 65.03 109.87 172.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 115' ' ' THR . . . . . 0.461 HG21 ' OG ' ' B' ' 119' ' ' SER . 86.8 m -67.62 -29.33 68.63 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 114.088 -1.414 . . . . 74.44 110.846 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -68.33 -46.26 70.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.384 0.674 . . . . 61.13 109.592 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.46 -42.71 95.79 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.302 1.041 . . . . 73.21 113.248 -176.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 22.8 m -66.65 -32.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.576 0.227 . . . . 64.32 110.438 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.53 -34.42 77.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.111 0.964 . . . . 74.11 111.473 174.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.4 mtt-85 -72.77 -33.25 66.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.743 0.817 . . . . 73.45 110.498 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.26 64.46 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 123.661 0.601 . . . . 45.13 112.465 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.409 ' OG1' ' HD3' ' D' ' 15' ' ' ARG . 69.3 p 58.04 31.36 20.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.152 1.781 . . . . 44.52 112.943 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.42 148.41 36.27 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.539 1.135 . . . . 65.42 108.771 174.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.403 ' HG2' ' HA ' ' F' ' 297' ' ' TYR . 77.6 Cg_exo -51.46 138.58 47.5 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.416 2.744 . . . . 75.34 112.821 176.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.41 ' HB3' HG23 ' C' ' 115' ' ' THR . 95.9 mt-30 -63.36 149.3 46.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 113.865 1.061 . . . . 75.33 113.865 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.7 98.24 6.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 106.863 -1.532 . . . . 75.04 106.863 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -92.38 130.44 38.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.313 0.645 . . . . 72.25 109.603 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.05 136.64 37.23 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.594 0.758 . . . . 54.11 110.495 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' F' ' 291' ' ' LEU . . . -80.02 157.8 73.24 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.263 1.025 . . . . 61.15 109.963 177.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.76 98.9 0.31 Allowed 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 122.358 2.038 . . . . 53.23 113.075 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.425 HG11 HG21 ' F' ' 288' ' ' VAL . 56.0 t -99.57 109.28 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.482 -1.303 . . . . 74.13 107.482 170.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -110.45 101.35 10.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.221 -1.029 . . . . 44.11 108.221 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 64.0 m-85 -69.72 -30.09 67.63 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.454 -0.794 . . . . 72.41 110.923 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.39 -52.0 67.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.671 0.788 . . . . 74.41 110.7 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.19 72.83 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.007 1.323 . . . . 53.21 111.734 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 tt -51.65 -57.84 8.05 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.53 1.144 . . . . 74.11 110.275 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.37 -18.34 49.26 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.076 0.55 . . . . 74.33 111.77 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 27.8 ttt -75.79 -26.59 57.46 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.587 1.155 . . . . 63.11 111.024 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -51.47 -45.87 62.91 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.446 0.698 . . . . 64.4 110.688 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -71.15 -87.08 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 108.868 -0.79 . . . . 73.15 108.868 169.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 56.1 tp 53.22 120.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.838 1.655 . . . . 65.44 113.85 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -140.45 11.79 2.33 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.354 0.597 . . . . 63.14 110.062 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.18 -79.72 0.32 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.921 -1.14 . . . . 72.43 107.921 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 49.86 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.118 1.367 . . . . 71.0 112.791 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.95 -54.73 2.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.839 -0.8 . . . . 54.45 108.839 173.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.08 71.71 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.1 -0.955 . . . . 65.43 113.593 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.24 -165.69 1.28 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.954 0.902 . . . . 63.12 108.939 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.41 98.38 0.19 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.738 -0.945 . . . . 51.31 110.738 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 98.3 m -139.97 137.35 34.65 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.427 0.691 . . . . 61.15 109.789 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.12 139.71 26.17 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.664 -1.236 . . . . 64.54 107.664 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' C' ' 153' ' ' GLN . 40.9 tt0 -95.81 110.45 22.61 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.522 -0.918 . . . . 74.42 108.522 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -87.72 73.69 9.28 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.765 0.793 . . . . 71.1 109.009 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.427 ' HB2' ' HG2' ' C' ' 151' ' ' GLU . 17.6 tm0? -113.16 100.93 8.96 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.623 -1.251 . . . . 74.11 107.623 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -135.08 177.77 7.55 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.061 0.945 . . . . 74.33 109.727 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 C-N-CA 123.71 0.804 . . . . 60.11 109.226 -179.565 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 108.776 -0.824 . . . . 74.43 108.776 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -88.27 -65.65 1.0 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.136 -0.69 . . . . 62.23 109.136 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -175.94 99.02 0.07 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.437 1.095 . . . . 74.42 109.39 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -78.38 89.59 4.39 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -91.22 -64.41 1.13 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.259 1.024 . . . . 72.2 110.685 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -134.26 -156.61 0.75 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.648 0.779 . . . . 72.33 110.431 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 38.0 p -55.03 102.2 0.06 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.948 0.899 . . . . 65.51 111.35 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -132.98 -140.97 0.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.077 1.351 . . . . 63.41 108.419 -176.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.414 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.2 tmt? -29.69 129.7 0.09 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.828 1.651 . . . . 72.23 114.518 173.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m -148.44 139.58 23.23 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.384 1.474 . . . . 72.14 108.436 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.587 ' HZ ' ' HG ' ' D' ' 102' ' ' CYS . 41.3 t80 -149.76 94.95 2.25 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.947 -1.131 . . . . 75.43 107.947 172.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -117.94 125.87 51.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.314 0.645 . . . . 65.22 109.421 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.37 124.89 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.713 -0.847 . . . . 51.31 108.713 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' F' ' 305' ' ' ALA . 56.2 mt-30 -87.42 -34.96 18.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.287 -0.634 . . . . 43.11 109.287 175.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.78 HH22 HD12 ' F' ' 301' ' ' ILE . 17.7 ttm180 -175.64 144.37 0.65 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.102 -0.953 . . . . 74.42 109.357 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.417 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -131.11 130.13 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 106.455 -1.683 . . . . 74.14 106.455 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 27.5 p90 -164.52 173.42 12.07 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.834 0.826 . . . . 72.15 111.249 -165.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.26 121.62 41.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.694 -1.139 . . . . 34.44 108.896 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.2 mtpt -85.46 -39.86 17.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.3 0.571 . . . . 61.41 109.732 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 19.9 t70 -149.78 126.76 11.19 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 114.67 -1.15 . . . . 70.04 108.984 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.574 HG21 ' HE2' ' C' ' 117' ' ' MET . 70.0 mt -118.87 147.1 22.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.429 -0.952 . . . . 64.33 108.429 175.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -143.77 136.01 26.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.21 1.004 . . . . 72.41 109.097 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.3 t80 -140.28 117.63 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.126 -1.805 . . . . 74.54 106.126 168.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -123.71 122.35 37.87 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.269 0.628 . . . . 74.44 109.811 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.38 81.26 3.9 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 107.181 -1.415 . . . . 74.13 107.181 168.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.2 -33.47 18.64 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.734 2.289 . . . . 43.23 112.116 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.425 ' HB2' HG23 ' D' ' 31' ' ' VAL . 4.1 m120 -111.66 29.76 7.57 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 108.768 -0.827 . . . . 63.0 108.768 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -61.52 2.57 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 114.989 1.477 . . . . 71.24 114.989 -166.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.1 Cg_endo -81.81 -13.03 10.73 Favored 'Trans proline' 0 C--N 1.378 2.089 0 CA-C-N 121.54 1.586 . . . . 74.51 113.329 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -69.35 -41.38 76.68 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.859 0.864 . . . . 72.42 109.249 170.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' D' ' 35' ' ' ASP . 36.1 t -70.8 -35.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 CA-C-N 114.909 -1.041 . . . . 65.42 109.98 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -64.36 -6.79 7.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.969 1.1 . . . . 73.1 113.969 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -84.62 -35.46 22.67 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.027 0.531 . . . . 74.12 109.915 170.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -128.7 60.09 1.53 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.114 0.966 . . . . 61.1 110.352 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.623 ' HB3' HD12 ' G' ' 301' ' ' ILE . 5.7 t0 -110.08 94.56 5.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.737 . . . . 74.31 109.463 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.531 ' H ' HD22 ' D' ' 68' ' ' LEU . 10.8 m95 -124.4 -159.5 0.88 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.927 -1.508 . . . . 73.2 106.927 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -63.35 112.32 6.79 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 118.374 0.534 . . . . 73.32 111.558 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.54 151.78 13.36 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.111 2.541 . . . . 61.23 112.313 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.89 113.68 20.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.996 -0.742 . . . . 73.43 108.996 166.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.54 HG23 ' NE1' ' G' ' 290' ' ' TRP . 3.6 m -99.28 106.37 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.074 0.95 . . . . 61.32 109.602 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.0 mmtt -88.31 128.76 35.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.349 1.06 . . . . 74.23 108.952 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.05 113.05 24.8 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.532 -0.544 . . . . 75.51 109.532 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -122.94 115.75 22.45 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.892 -0.781 . . . . 63.24 108.892 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.96 145.75 31.88 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.28 0.632 . . . . 72.31 109.973 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -137.15 131.31 32.39 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.364 1.066 . . . . 73.31 108.511 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 56.6 p -105.71 144.67 32.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.469 0.708 . . . . 73.14 110.195 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.22 155.03 35.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.498 0.719 . . . . 43.13 109.885 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -164.07 153.27 13.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.781 0.832 . . . . 33.45 109.883 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.9 p -160.47 151.77 19.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 70.32 110.101 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -81.8 118.57 22.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.078 0.551 . . . . 71.03 109.688 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -31.3 15.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.339 0.656 . . . . 74.35 110.488 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.02 -179.34 7.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.277 0.631 . . . . 61.05 110.707 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.58 116.92 5.57 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.702 -1.135 . . . . 74.51 110.117 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 11.7 m-20 60.47 24.66 14.27 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.258 0.974 . . . . 65.41 111.539 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.48 116.54 44.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.053 -1.092 . . . . 75.45 108.053 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.544 ' HB2' HD12 ' D' ' 86' ' ' ILE . 96.8 m-85 -129.82 129.03 43.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.335 1.054 . . . . 74.32 108.738 -174.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -90.32 139.1 30.99 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.989 0.915 . . . . 70.52 109.744 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.45 117.28 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 107.354 -1.35 . . . . 64.11 107.354 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.7 t -100.18 128.82 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.279 -1.008 . . . . 64.32 108.279 172.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 107.23 12.55 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.769 -1.197 . . . . 70.34 107.769 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 16.1 ttm-85 -87.17 105.71 17.38 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.218 -0.901 . . . . 75.21 109.566 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.22 120.47 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.685 -0.857 . . . . 73.44 108.685 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.3 m -125.84 135.85 52.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.705 0.802 . . . . 74.44 109.137 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.587 HG11 HD11 ' D' ' 126' ' ' LEU . 44.0 t -129.95 117.95 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.436 1.094 . . . . 55.31 109.68 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 57.0 m -105.57 100.6 10.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.135 0.974 . . . . 54.21 110.093 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -96.71 125.15 40.97 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.234 -0.291 . . . . 41.34 110.773 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.5 m -138.94 123.32 18.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.841 0.856 . . . . 53.24 109.611 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.6 OUTLIER -103.07 128.09 50.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.354 0.662 . . . . 61.13 109.852 177.054 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.24 -111.73 3.95 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.95 -0.86 . . . . 71.05 110.95 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.81 5.68 11.49 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.56 0.744 . . . . 73.42 110.877 175.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.04 140.28 50.3 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.1 0.56 . . . . 61.55 110.449 -172.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.8 m -71.98 117.38 13.52 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.607 0.763 . . . . 73.14 111.115 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.601 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -68.45 -65.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.279 0.987 . . . . 70.44 109.914 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -154.51 156.64 37.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.408 -1.269 . . . . 75.52 110.406 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.84 145.93 47.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.747 1.219 . . . . 72.15 107.714 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.62 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.6 t -150.75 142.11 23.35 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.622 -0.51 . . . . 62.35 109.622 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.04 138.31 14.75 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.988 -0.745 . . . . 74.4 108.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.64 115.57 8.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.331 -0.989 . . . . 74.2 108.331 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 66.4 mt-30 -88.97 84.49 6.62 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.099 -1.074 . . . . 70.43 108.099 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -79.52 93.45 5.43 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.208 -0.906 . . . . 70.51 109.031 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.69 142.29 16.55 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.802 -0.919 . . . . 65.13 110.802 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.99 128.59 3.48 Favored Glycine 0 CA--C 1.499 -0.919 0 N-CA-C 110.327 -1.109 . . . . 62.1 110.327 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.93 132.3 35.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.701 0.801 . . . . 61.52 109.061 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -134.01 133.43 41.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.88 0.472 . . . . 73.33 110.157 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -79.11 98.88 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.486 0.714 . . . . 64.34 109.27 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' D' ' 56' ' ' TYR . 48.2 mt -109.08 106.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.907 0.883 . . . . 70.03 109.506 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -144.07 148.54 35.31 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.048 0.939 . . . . 33.32 110.092 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 93.48 -20.82 44.28 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.842 -0.421 . . . . 40.2 113.438 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.493 ' HB ' ' HG3' ' D' ' 94' ' ' MET . 0.4 OUTLIER -106.39 139.76 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.675 -1.231 . . . . 62.11 107.675 179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.77 157.85 41.72 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.15 0.58 . . . . 72.52 111.425 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -134.96 51.81 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.597 1.186 . . . . 63.13 115.782 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -63.82 -29.17 70.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.235 1.014 . . . . 74.25 111.841 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -40.5 77.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.624 0.77 . . . . 33.11 109.216 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.493 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 9.9 ttp -75.92 -41.99 50.21 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.813 -0.631 . . . . 73.44 110.773 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.21 69.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.884 0.874 . . . . 63.55 111.2 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -66.23 -46.63 76.52 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.143 -0.48 . . . . 64.02 109.996 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.62 -36.61 78.88 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.017 0.527 . . . . 63.33 111.276 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.569 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.1 tt -77.45 -30.75 53.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.394 0.678 . . . . 70.35 110.02 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.06 -16.44 55.96 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.127 -0.488 . . . . 72.12 113.663 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.09 -64.32 1.32 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.398 0.599 . . . . 72.22 111.289 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -66.03 -47.27 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.151 0.58 . . . . 63.45 111.414 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.587 ' HG ' ' HZ ' ' D' ' 11' ' ' PHE . 58.0 m -61.43 -48.47 90.72 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.348 -0.834 . . . . 65.44 112.731 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.2 Cg_exo -54.9 -39.41 90.45 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.76 2.306 . . . . 73.1 113.91 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -72.47 -14.04 61.58 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.298 0.639 . . . . 62.34 112.541 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -81.09 -40.95 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 121.597 0.713 . . . . 73.53 109.864 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.414 HD21 ' HA3' ' D' ' 82' ' ' GLY . 71.9 mt -78.46 -31.75 48.08 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.909 -1.041 . . . . 75.43 111.802 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -63.72 -42.1 69.39 Favored Pre-proline 0 CA--C 1.56 1.361 0 N-CA-C 114.146 1.165 . . . . 75.33 114.146 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.45 -43.67 55.57 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.152 1.901 . . . . 70.01 113.132 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -74.98 -31.71 61.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.662 0.785 . . . . 71.34 111.891 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.62 -54.53 34.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.068 0.547 . . . . 51.14 109.797 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -56.73 -46.57 81.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 114.091 -1.413 . . . . 62.44 110.899 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.63 -44.49 90.36 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.104 0.878 . . . . 72.33 111.214 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 113' ' ' CYS . . . . . 0.43 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.5 t -58.61 -41.36 85.69 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.533 0.52 . . . . 74.05 110.947 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.62 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -62.32 -53.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.939 0.896 . . . . 73.23 110.369 174.071 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -53.84 -42.95 69.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.725 1.21 . . . . 71.02 111.426 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -66.97 -44.65 79.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.754 -1.112 . . . . 64.42 110.654 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -66.32 -33.76 76.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.863 0.465 . . . . 73.35 111.656 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.3 t -67.78 -43.3 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.545 -0.752 . . . . 73.31 109.919 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.35 -28.9 64.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.751 0.42 . . . . 73.44 111.699 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -75.04 -32.06 61.46 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.924 0.89 . . . . 75.22 110.085 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.14 5.66 75.48 Favored Glycine 0 C--N 1.356 1.676 0 CA-C-N 115.586 -0.734 . . . . 62.43 111.853 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 65.54 14.15 9.31 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.488 2.315 . . . . 43.34 114.257 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -84.89 158.28 59.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.207 1.003 . . . . 74.1 108.867 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.525 ' HG3' ' HB2' ' G' ' 297' ' ' TYR . 55.4 Cg_endo -65.11 136.74 49.26 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.871 2.381 . . . . 72.2 112.175 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -47.19 129.92 12.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.488 1.115 . . . . 74.05 112.135 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.587 HD11 HG11 ' D' ' 64' ' ' VAL . 5.1 tt -107.22 93.93 4.82 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.234 -1.024 . . . . 33.22 108.234 -170.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -105.09 100.47 10.07 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.9 -1.148 . . . . 73.22 107.9 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.413 HD12 ' H ' ' D' ' 129' ' ' ALA . 20.5 tp -75.86 141.46 42.4 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.004 0.522 . . . . 64.21 110.814 177.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.413 ' H ' HD12 ' D' ' 128' ' ' LEU . . . -56.24 132.84 75.5 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.447 1.099 . . . . 73.24 111.326 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.0 116.65 4.8 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.448 2.099 . . . . 75.32 110.363 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.48 138.44 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.477 0.711 . . . . 63.34 109.577 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -79.97 103.55 9.94 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.602 0.761 . . . . 72.24 110.02 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -77.25 -20.99 54.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.33 0.652 . . . . 74.23 111.406 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -59.46 -46.38 88.95 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.611 0.764 . . . . 62.35 110.577 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.28 99.63 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.269 0.981 . . . . 74.43 111.804 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 69.7 mt -61.12 -39.96 91.98 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 124.375 1.047 . . . . 53.41 111.121 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.464 ' O ' HD13 ' D' ' 141' ' ' LEU . 27.9 m-85 -78.71 -34.75 45.79 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.592 0.757 . . . . 63.33 111.543 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.21 -30.0 71.23 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.984 0.514 . . . . 71.24 111.273 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -57.43 -43.31 83.74 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.771 0.828 . . . . 73.41 110.616 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -69.65 -33.74 73.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.834 0.854 . . . . 71.21 111.447 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.464 HD13 ' O ' ' D' ' 137' ' ' PHE . 7.6 mp -62.98 -29.16 70.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.751 0.82 . . . . 71.42 111.135 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -87.6 10.28 18.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.965 0.906 . . . . 74.45 111.813 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.69 52.06 1.2 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.919 0.888 . . . . 71.51 110.433 -173.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -151.53 141.01 21.59 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.253 -0.885 . . . . 73.32 109.651 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.13 162.55 18.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.984 0.913 . . . . 70.33 110.058 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -171.56 178.58 43.8 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.192 -0.458 . . . . 43.02 112.314 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -117.48 168.84 10.02 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.15 0.98 . . . . 70.23 110.503 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.74 75.18 0.25 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.492 -0.643 . . . . 71.14 111.492 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -78.06 128.1 33.32 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.212 0.605 . . . . 73.02 109.672 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.54 87.33 5.13 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 106.888 -1.523 . . . . 71.31 106.888 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -76.18 114.15 14.51 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.831 -0.622 . . . . 70.14 110.092 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -122.4 80.82 1.77 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.582 -0.896 . . . . 75.3 108.582 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -127.33 133.16 50.12 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.151 0.98 . . . . 73.33 108.883 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.7 167.4 12.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.148 0.579 . . . . 73.35 110.948 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 N-CA-C 109.192 -0.67 . . . . 71.14 109.192 177.687 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.525 -0.176 . . . . 64.13 110.525 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -76.39 142.3 41.18 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.533 -0.543 . . . . 75.1 109.533 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 273' ' ' GLN . . . . . 0.705 HE22 ' HG2' ' A' ' 4' ' ' GLN . 25.1 tt0 -83.24 107.35 15.72 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.656 -0.868 . . . . 75.23 108.656 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -67.01 -24.65 66.04 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.086 0.954 . . . . 73.31 111.728 -170.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -107.65 91.45 7.32 Favored Pre-proline 0 N--CA 1.475 0.794 0 N-CA-C 107.221 -1.4 . . . . 73.42 107.221 166.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.96 -57.37 1.17 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.671 2.247 . . . . 70.51 110.463 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 277' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 87' ' ' ALA . 5.5 tt -179.45 -46.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 105.054 -2.202 . . . . 75.24 105.054 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 278' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 48' ' ' SER . 20.1 tp -86.57 147.22 26.03 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 114.559 -1.201 . . . . 45.33 108.593 170.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -178.46 160.32 26.22 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.612 -0.995 . . . . 62.14 110.612 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 45.59 -167.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.87 1.668 . . . . 74.12 112.432 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 281' ' ' PHE . . . . . 0.493 ' CE1' ' HB ' ' A' ' 46' ' ' THR . 56.4 t80 68.37 19.69 8.84 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 123.997 0.919 . . . . 61.43 111.867 171.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -72.8 -33.53 66.31 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.437 -0.949 . . . . 60.11 108.437 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -122.68 -170.75 2.15 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 114.66 -1.155 . . . . 73.41 108.93 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 154.89 -80.25 0.18 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.663 -0.575 . . . . 63.41 111.663 175.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 59.95 85.48 0.11 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 124.26 1.024 . . . . 75.02 109.488 -173.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 96.2 mmm -57.42 130.93 81.31 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.556 0.743 . . . . 74.43 110.408 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.19 78.17 0.83 Allowed 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.199 2.599 . . . . 74.3 111.847 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 92.2 t -98.75 101.93 12.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 108.137 -1.06 . . . . 54.13 108.137 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -70.82 125.79 27.8 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.282 -0.872 . . . . 75.51 109.242 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -64.56 131.53 47.31 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.024 0.916 . . . . 75.33 110.733 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.655 ' HB3' ' HB ' ' G' ' 309' ' ' THR . 0.0 OUTLIER -100.82 4.7 43.07 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.972 -1.467 . . . . 64.14 112.005 -169.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.91 127.24 43.8 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-O 118.203 -1.332 . . . . 75.44 111.924 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.94 -70.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.934 2.423 . . . . 72.25 113.144 -171.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -147.0 -46.97 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.349 1.06 . . . . 73.42 108.905 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -144.22 166.95 23.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.249 -0.887 . . . . 62.4 110.143 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 47.7 m -114.35 -30.8 6.47 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.061 0.945 . . . . 65.43 110.423 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 22.8 m-85 -72.18 125.98 28.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.123 -0.49 . . . . 73.33 109.89 174.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 298' ' ' HIS . . . . . 0.435 ' HA ' ' HB2' ' G' ' 302' ' ' ASP . 32.9 p80 -82.11 57.25 3.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.549 0.69 . . . . 74.1 109.773 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 62.2 -136.01 45.59 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.208 -1.157 . . . . 62.34 110.208 -168.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 300' ' ' ASN . . . . . 0.412 ' HB2' ' ND1' ' G' ' 298' ' ' HIS . 0.8 OUTLIER -68.82 125.49 26.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.489 0.645 . . . . 61.2 109.552 175.273 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 122' ' ' THR . 65.2 mt -61.61 -57.95 9.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.113 -1.069 . . . . 64.15 108.113 170.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -146.79 167.73 23.15 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.677 -1.601 . . . . 75.42 108.469 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 303' ' ' LYS . . . . . 0.614 ' H ' ' HD2' ' E' ' 304' ' ' PRO . 13.3 tmtt? -154.26 -52.69 0.02 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 CA-C-O 117.901 -1.047 . . . . 73.04 110.061 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 304' ' ' PRO . . . . . 0.614 ' HD2' ' H ' ' E' ' 303' ' ' LYS . 55.5 Cg_endo -65.62 89.43 0.22 Allowed 'Trans proline' 0 C--N 1.4 3.272 0 C-N-CA 121.642 1.562 . . . . 74.01 112.385 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -75.9 154.45 36.0 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.89 -1.05 . . . . 22.42 110.557 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.35 163.51 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.936 -0.574 . . . . 74.1 111.466 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 34.6 p -92.99 -164.54 1.19 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.045 0.938 . . . . 75.03 111.057 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 10.9 p -59.23 -55.18 38.2 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 124.492 1.117 . . . . 75.22 112.075 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 95.8 m 56.14 80.55 0.29 Allowed Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 124.477 1.111 . . . . 62.55 110.965 -174.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' E' E ' 310' ' ' PRO . . . . . 0.427 ' HB2' HG22 ' B' ' 7' ' ' THR . 29.5 Cg_endo . . . . . 0 CA--C 1.555 1.566 0 C-N-CA 123.505 2.803 . . . . 62.15 111.717 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 119.569 -0.253 . . . . 72.23 111.403 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 69.07 -74.16 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.785 1.234 . . . . 73.12 111.315 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -79.59 -178.2 6.22 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.336 0.655 . . . . 71.31 110.37 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -64.54 170.27 4.14 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.473 0.654 . . . . 64.31 111.222 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 275' ' ' LYS . . . . . 0.776 ' HB2' ' HB3' ' F' ' 278' ' ' LEU . 17.7 mmtp -90.54 131.56 37.75 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 107.302 -1.37 . . . . 74.3 107.302 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -36.66 -64.68 0.17 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 124.783 3.655 . . . . 73.23 115.988 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.17 -3.59 44.15 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.865 0.466 . . . . 63.42 111.795 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.776 ' HB3' ' HB2' ' F' ' 275' ' ' LYS . 6.9 tt -118.78 102.66 8.99 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.98 0.912 . . . . 71.1 108.802 -169.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -112.94 16.75 22.93 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 116.084 -0.507 . . . . 54.15 112.795 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 10.3 tt -154.25 146.16 23.51 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.109 -1.071 . . . . 70.32 108.109 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 67.9 t80 88.94 -22.44 0.12 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.982 2.113 . . . . 64.21 111.05 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.2 -25.55 68.12 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.115 0.566 . . . . 73.12 111.18 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -111.31 148.51 32.78 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.55 1.14 . . . . 51.13 109.358 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.21 73.26 1.1 Allowed Glycine 0 C--N 1.355 1.639 0 O-C-N 123.764 0.665 . . . . 64.0 112.457 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -99.24 3.73 46.38 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.358 1.063 . . . . 65.44 110.515 -174.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 97.7 mmm -120.85 83.9 37.39 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.578 0.751 . . . . 54.44 109.799 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -97.26 92.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.326 2.684 . . . . 61.54 112.92 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 288' ' ' VAL . . . . . 0.425 HG21 HG11 ' C' ' 131' ' ' VAL . 96.0 t -81.83 96.43 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-O 121.243 0.544 . . . . 64.2 109.819 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -89.43 60.76 5.34 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.349 0.66 . . . . 65.22 109.684 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 44.0 m95 63.12 -172.9 0.16 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.65 -1.159 . . . . 73.44 112.544 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.531 HD11 ' HB3' ' C' ' 129' ' ' ALA . 0.0 OUTLIER -130.15 16.77 5.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.409 -1.269 . . . . 62.42 109.842 178.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 147.64 -147.15 17.62 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-O 118.989 -0.895 . . . . 63.13 110.927 -176.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.23 174.26 13.06 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.982 2.455 . . . . 73.34 111.277 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -159.22 -63.58 0.08 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.279 -0.638 . . . . 70.11 109.279 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . 65.11 -178.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.781 1.233 . . . . 74.32 111.407 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 96.0 m -142.94 -67.38 0.37 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.956 0.502 . . . . 73.23 109.747 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.403 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 22.8 m-30 -66.09 109.29 2.53 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 122.769 0.428 . . . . 74.24 110.295 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -143.31 148.82 36.91 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.868 -1.16 . . . . 73.05 107.868 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.28 -144.86 22.77 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.631 0.582 . . . . 60.53 112.116 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -137.71 128.91 27.67 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.787 0.435 . . . . 72.34 110.899 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.78 HD12 HH22 ' D' ' 15' ' ' ARG . 41.0 pt -129.19 15.33 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.385 1.074 . . . . 71.14 108.935 167.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.07 90.13 4.22 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.664 1.186 . . . . 71.53 109.167 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -150.97 130.04 6.37 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.374 -0.973 . . . . 55.32 108.374 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.42 -32.18 71.65 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.148 2.566 . . . . 73.43 113.672 -173.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 305' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' D' ' 14' ' ' GLN . . . -162.01 167.65 24.09 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.358 0.663 . . . . 71.45 110.183 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 36.4 t -79.17 71.09 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 108.3 -1.0 . . . . 71.32 108.3 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 5.7 m -93.71 73.02 4.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.462 -1.31 . . . . 70.22 107.462 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' F' F ' 308' ' ' CYS . . . . . 0.597 ' SG ' ' HD2' ' H' ' 293' ' ' PRO . 85.5 m -149.56 -55.08 0.17 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.667 -1.152 . . . . 75.11 108.608 -173.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 309' ' ' THR . . . . . 0.417 ' OG1' HD23 ' H' ' 291' ' ' LEU . 7.8 m -67.47 137.58 93.54 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 114.779 -1.1 . . . . 64.34 110.805 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo . . . . . 0 CA--C 1.556 1.608 0 C-N-CA 122.741 2.294 . . . . 63.33 111.038 164.373 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 110.039 -0.356 . . . . 71.05 110.039 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -86.84 138.81 31.26 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.594 0.757 . . . . 73.01 109.326 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -124.81 82.02 2.01 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.298 0.639 . . . . 51.24 109.862 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.07 109.93 6.97 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.67 -0.863 . . . . 63.35 108.67 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -136.56 154.82 77.01 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 109.947 -0.39 . . . . 74.23 109.947 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -65.54 159.34 48.45 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.003 2.469 . . . . 64.01 112.759 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 68.9 mt -91.9 -77.56 0.43 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.286 -0.635 . . . . 73.31 109.286 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 45.9 tp -78.66 119.51 22.01 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.68 0.792 . . . . 74.11 109.939 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -169.11 61.68 0.19 Allowed Glycine 0 C--N 1.348 1.23 0 O-C-N 123.359 0.412 . . . . 72.31 112.352 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.461 HD21 HD22 ' D' ' 98' ' ' LEU . 2.2 pt? -156.28 -172.06 3.95 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.605 0.762 . . . . 71.32 110.017 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 66.09 81.93 0.19 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.633 1.173 . . . . 63.23 111.279 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -154.6 -52.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.398 -0.964 . . . . 62.31 108.398 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -146.7 173.47 12.33 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.695 -1.139 . . . . 74.44 109.334 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 157.23 143.78 3.75 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.59 -1.004 . . . . 55.44 110.59 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -71.59 91.21 1.06 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.157 0.583 . . . . 71.24 109.662 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 26.5 mmt -100.5 99.16 9.25 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.378 1.071 . . . . 62.2 109.762 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 287' ' ' PRO . . . . . 0.439 ' HA ' ' NH1' ' G' ' 289' ' ' ARG . 43.5 Cg_endo -94.1 35.05 0.19 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.469 2.779 . . . . 72.11 111.772 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.17 79.64 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.759 0.79 . . . . 72.13 110.371 -172.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 289' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' G' ' 287' ' ' PRO . 1.4 mpt_? -121.12 178.27 4.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 107.507 -1.294 . . . . 72.03 107.507 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.54 ' NE1' HG23 ' D' ' 40' ' ' VAL . 85.9 m95 -70.71 123.48 22.01 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 110.177 -0.305 . . . . 73.42 110.177 176.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.35 -60.86 1.86 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.688 0.795 . . . . 71.23 108.95 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -86.84 -178.03 49.17 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.289 -0.869 . . . . 34.21 112.447 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.68 175.35 1.25 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.575 2.85 . . . . 70.1 113.712 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -107.49 103.55 12.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.321 0.648 . . . . 73.13 110.235 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -87.08 98.31 11.21 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.957 -0.757 . . . . 44.24 108.957 173.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 1.3 p -150.26 -70.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.277 1.031 . . . . 75.2 110.085 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.525 ' HB2' ' HG3' ' D' ' 124' ' ' PRO . 0.3 OUTLIER -130.82 123.49 29.21 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.349 -0.982 . . . . 74.03 108.349 -169.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' G' G ' 298' ' ' HIS . . . . . 0.412 ' ND1' ' HB2' ' E' ' 300' ' ' ASN . 50.5 t-80 -83.16 -50.68 8.21 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.849 -0.426 . . . . 62.24 109.849 174.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 153.66 -177.95 30.89 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 115.475 -0.784 . . . . 44.44 112.148 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 64.35 148.7 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.572 1.549 . . . . 54.12 111.596 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.643 HD11 HH12 ' C' ' 15' ' ' ARG . 15.2 tt -141.24 29.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 122.13 0.967 . . . . 60.33 110.116 -171.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 302' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' E' ' 298' ' ' HIS . 7.8 m-20 -61.88 104.73 0.48 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.589 -1.187 . . . . 63.24 110.371 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -98.44 163.7 18.59 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.28 1.432 . . . . 71.24 109.895 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.84 81.09 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.473 2.115 . . . . 75.32 111.729 171.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -78.09 97.33 5.39 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.766 -0.827 . . . . 72.05 108.766 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.574 HG22 HD23 ' E' ' 291' ' ' LEU . 98.9 t -69.33 82.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.991 0.916 . . . . 55.04 110.319 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 43.5 p -106.91 -26.27 11.29 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.893 -1.049 . . . . 74.4 110.125 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 58.9 m -68.24 -38.02 81.4 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.76 0.824 . . . . 72.02 111.48 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' G' G ' 309' ' ' THR . . . . . 0.655 ' HB ' ' HB3' ' E' ' 291' ' ' LEU . 96.8 m -147.05 78.58 10.37 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.473 0.709 . . . . 65.22 109.737 177.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' G' G ' 310' ' ' PRO . . . . . 0.413 ' HB3' ' HB3' ' C' ' 12' ' ' GLN . 37.1 Cg_endo . . . . . 0 CA--C 1.564 2.011 0 C-N-CA 123.362 2.708 . . . . 72.44 112.293 174.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 110.256 -0.276 . . . . 52.01 110.256 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -75.43 85.32 2.55 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.592 0.757 . . . . 71.1 109.296 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -165.52 175.57 8.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.308 1.043 . . . . 64.12 110.238 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -120.45 29.28 7.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.18 0.992 . . . . 75.03 110.044 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 73.46 166.94 0.12 Allowed Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 124.347 1.059 . . . . 73.52 111.369 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.28 -152.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 122.202 1.935 . . . . 71.22 111.543 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 277' ' ' LEU . . . . . 0.454 HD11 HG13 ' B' ' 89' ' ' ILE . 45.1 tp -59.94 -37.25 78.97 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 110.316 -0.253 . . . . 43.44 110.316 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 278' ' ' LEU . . . . . 0.41 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 31.3 tp -80.2 81.9 6.36 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.074 0.55 . . . . 74.51 110.078 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -93.37 -40.79 4.69 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.149 -0.932 . . . . 32.45 111.56 174.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.81 -175.31 3.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.75 0.82 . . . . 74.42 109.178 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 12.4 t80 70.27 63.99 0.22 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.111 0.964 . . . . 74.23 110.894 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -149.49 115.78 5.78 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.61 -1.177 . . . . 71.12 108.78 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 67.84 8.65 6.58 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.736 1.214 . . . . 63.43 113.444 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 167.45 155.33 9.13 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 112.116 -0.394 . . . . 72.2 112.116 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -117.48 -57.82 2.1 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.199 1.0 . . . . 65.43 108.361 178.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 22.6 ptp -171.77 145.02 1.61 Allowed Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 124.07 0.948 . . . . 75.13 110.061 -176.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.81 105.61 0.67 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.149 2.566 . . . . 71.2 111.625 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.44 -43.71 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.238 0.615 . . . . 63.12 109.916 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 66.16 -74.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.552 1.541 . . . . 74.3 110.558 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 290' ' ' TRP . . . . . 0.556 ' NE1' HG23 ' B' ' 40' ' ' VAL . 1.5 t-105 -170.13 139.64 1.83 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.983 1.313 . . . . 72.12 107.523 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.568 HD21 HG22 ' B' ' 131' ' ' VAL . 6.5 mp -69.17 -41.94 76.56 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.679 0.792 . . . . 64.25 110.725 -173.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 150.38 -149.67 21.58 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-O 119.049 -0.861 . . . . 52.51 112.926 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 293' ' ' PRO . . . . . 0.597 ' HD2' ' SG ' ' F' ' 308' ' ' CYS . 75.2 Cg_exo -51.56 95.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.246 3.297 . . . . 72.24 113.761 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 294' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' H' ' 294' ' ' LYS . 0.5 OUTLIER -167.1 33.68 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.549 0.74 . . . . 70.21 109.851 -175.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' H' H ' 295' ' ' ALA . . . . . 0.615 ' HA ' HG21 ' B' ' 40' ' ' VAL . . . -60.23 142.29 54.75 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.894 0.378 . . . . 65.43 111.869 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 296' ' ' THR . . . . . 0.521 HG22 ' O ' ' B' ' 124' ' ' PRO . 5.2 m -58.06 -49.81 75.61 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.333 -1.303 . . . . 55.51 111.672 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.59 ' HB3' ' HA ' ' B' ' 37' ' ' GLN . 10.8 t80 -90.37 41.98 1.08 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.407 -1.269 . . . . 73.53 111.546 -165.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 298' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' H' ' 295' ' ' ALA . 11.8 m80 -87.63 -37.14 17.04 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.254 0.622 . . . . 72.03 110.178 172.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.59 -165.74 3.8 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.644 0.59 . . . . 61.11 113.9 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -73.17 120.39 18.72 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.664 -0.315 . . . . 72.35 110.658 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 9.1 tt -61.28 -31.03 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.391 0.676 . . . . 65.2 109.903 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 28.0 t70 73.28 115.01 0.06 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.986 1.714 . . . . 72.24 111.232 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -138.97 80.67 23.56 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 106.661 -1.607 . . . . 74.11 106.661 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -90.06 -7.14 4.54 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.174 2.583 . . . . 74.53 112.05 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 49.35 77.73 0.1 Allowed 'General case' 0 C--N 1.368 1.401 0 C-N-CA 125.557 1.543 . . . . 60.31 110.572 -172.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.42 105.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 123.9 0.75 . . . . 43.34 109.997 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 11.3 t -110.54 176.24 5.12 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.168 0.987 . . . . 63.53 108.816 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 49.0 t -68.32 83.95 0.25 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.002 0.921 . . . . 74.23 110.61 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 4.7 t -94.32 120.91 64.71 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.996 0.919 . . . . 73.21 110.664 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo . . . . . 0 C--N 1.378 2.097 0 C-N-CA 122.932 2.421 . . . . 73.53 110.494 171.933 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 109.679 -0.489 . . . . 73.33 109.679 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 p -95.28 3.8 54.15 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.25 0.62 . . . . 73.21 111.592 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -65.23 124.91 23.42 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.6 0.76 . . . . 73.32 110.215 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -166.3 170.94 12.63 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.59 0.756 . . . . 74.41 109.565 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -117.84 106.84 13.42 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.125 -1.435 . . . . 73.42 107.125 170.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -172.65 169.78 4.93 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 124.3 1.0 . . . . 72.02 108.771 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 m 82.95 -63.27 0.12 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.723 1.609 . . . . 71.31 112.291 167.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.78 79.16 1.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.451 0.7 . . . . 73.42 110.049 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.447 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 23.9 ptm -87.98 153.14 21.53 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.49 -0.777 . . . . 71.13 111.252 -173.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.9 m -142.95 139.01 30.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.745 -1.116 . . . . 73.34 109.104 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.466 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.4 t80 -137.2 122.84 19.79 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.623 -1.251 . . . . 72.42 107.623 166.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -146.74 129.61 16.27 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.161 -0.681 . . . . 60.55 109.161 173.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.661 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.7 mt -86.24 119.85 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 109.437 -0.579 . . . . 71.11 109.437 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.5 -40.38 13.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.062 0.945 . . . . 74.51 109.281 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -166.42 141.7 4.51 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.533 -166.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER -131.87 126.31 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.032 -1.47 . . . . 73.41 107.032 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.6 p90 -161.08 152.55 19.16 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.512 0.672 . . . . 70.25 111.491 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -76.57 107.87 9.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.614 -1.176 . . . . 71.52 108.161 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.5 mtpt -67.26 -33.15 74.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.198 0.523 . . . . 63.33 109.603 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.4 t70 -153.12 144.16 22.99 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.193 -1.367 . . . . 74.22 109.682 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -133.06 143.64 38.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.941 1.296 . . . . 53.42 107.863 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 44.0 t -147.21 126.89 13.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.855 0.862 . . . . 54.13 109.171 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 87.2 t80 -127.93 126.68 41.95 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.892 -1.892 . . . . 73.54 105.892 168.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -133.95 116.6 15.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.016 -0.735 . . . . 71.42 109.016 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -127.55 74.45 77.96 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.573 -1.269 . . . . 54.52 107.573 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.13 -43.63 2.25 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.553 2.169 . . . . 74.21 111.127 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -89.4 12.15 17.14 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 118.057 -0.973 . . . . 75.23 111.414 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.76 -56.26 9.0 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.136 -0.935 . . . . 62.05 112.372 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 35.3 Cg_exo -58.75 -22.97 64.15 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.579 2.186 . . . . 74.21 113.888 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 -31.58 12.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.746 0.818 . . . . 75.14 110.503 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.704 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.58 -17.02 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 120.895 0.379 . . . . 72.22 110.165 -170.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.437 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 21.9 m-85 -73.86 -30.4 62.63 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.61 0.764 . . . . 55.24 111.807 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -85.37 -12.86 51.15 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.485 0.314 . . . . 74.54 111.364 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 31.4 mmtp -79.16 152.24 30.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.311 0.644 . . . . 73.13 110.872 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.05 140.18 58.81 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.22 0.95 . . . . 63.12 109.623 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.764 ' HB3' ' HB3' ' E' ' 297' ' ' TYR . 32.2 m95 -74.28 83.47 1.89 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.689 0.796 . . . . 71.35 110.912 -173.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -134.56 71.23 71.45 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.575 1.15 . . . . 71.45 109.609 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.32 127.76 5.3 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.009 1.806 . . . . 75.43 112.174 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.9 88.82 5.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 106.423 -1.695 . . . . 64.12 106.423 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -82.22 114.72 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.761 -1.109 . . . . 73.11 111.11 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 88.3 mttt -80.18 152.86 28.95 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.454 1.102 . . . . 73.41 110.84 167.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.1 tt -122.72 109.61 14.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.539 -2.022 . . . . 50.1 105.539 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.688 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -117.77 107.73 14.51 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.793 -0.817 . . . . 64.31 108.793 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -99.06 150.45 21.99 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.321 -0.622 . . . . 74.01 109.321 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 30.1 t70 -145.5 136.6 24.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.678 0.791 . . . . 63.3 109.39 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -121.76 126.76 49.61 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.684 0.794 . . . . 54.11 110.942 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.3 113.56 4.57 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.366 0.667 . . . . 64.41 110.193 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.9 p -98.77 162.3 13.18 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.683 -0.488 . . . . 71.24 109.683 173.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -152.94 158.07 41.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.321 1.048 . . . . 71.4 109.196 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -114.07 126.3 54.96 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.944 -1.132 . . . . 64.42 107.944 166.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -93.5 -41.53 9.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.011 0.525 . . . . 75.53 110.25 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -152.25 178.75 9.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.866 0.866 . . . . 74.42 109.702 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.85 123.13 18.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.991 -0.744 . . . . 73.14 108.991 171.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 73.02 -7.23 1.53 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.796 1.638 . . . . 64.3 112.237 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 44.9 t -106.7 111.45 35.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.286 -1.005 . . . . 64.24 108.286 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -123.38 161.06 25.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.274 -0.639 . . . . 65.43 109.274 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -131.56 138.99 49.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.859 -1.064 . . . . 74.54 108.784 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.9 t -126.22 117.02 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.849 -1.538 . . . . 55.21 106.849 169.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 t -101.23 130.45 50.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.986 -0.746 . . . . 72.43 108.986 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD23 HD12 ' A' ' 106' ' ' LEU . 3.8 mm? -117.57 109.78 17.12 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.212 -1.032 . . . . 75.12 108.212 170.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.637 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 13.2 ttp180 -85.57 112.64 21.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.108 -0.701 . . . . 74.31 109.108 172.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.0 t -94.2 128.62 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 107.359 -1.348 . . . . 74.44 107.359 170.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.688 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 47.3 m -127.05 126.5 43.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.213 -1.032 . . . . 74.3 108.213 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.826 HG11 HD21 ' A' ' 126' ' ' LEU . 44.9 t -118.75 109.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.46 -0.941 . . . . 73.3 108.46 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.3 m -103.71 133.28 48.98 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.292 -0.632 . . . . 51.14 109.292 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.37 31.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.439 -1.319 . . . . 72.22 107.439 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 55.6 m -135.93 127.91 29.56 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.819 0.447 . . . . 71.23 110.479 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -88.83 72.28 8.56 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.917 -1.142 . . . . 74.3 107.917 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.24 -84.46 0.83 Allowed Glycine 0 C--N 1.35 1.333 0 CA-C-N 114.934 -1.03 . . . . 45.25 110.713 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -110.88 -29.22 8.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 74.01 109.86 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 3.3 tp10 -82.89 91.48 7.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.721 0.809 . . . . 74.14 110.322 -173.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 86.5 m -64.71 130.89 45.26 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.284 0.564 . . . . 54.32 111.495 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.704 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.29 -63.36 1.42 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.91 -1.041 . . . . 73.42 110.011 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -162.04 170.94 18.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.467 -1.242 . . . . 73.04 110.97 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.4 tp -142.62 113.77 7.69 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.551 -1.204 . . . . 72.01 108.284 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 118' ' ' VAL . 76.4 m -113.42 100.87 8.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.387 0.675 . . . . 71.34 110.77 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 31.4 tt0 -119.16 118.65 31.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.285 1.034 . . . . 71.04 109.617 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.12 112.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.236 1.015 . . . . 72.23 109.224 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.637 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 49.7 mt-30 -84.24 84.47 7.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.686 -0.857 . . . . 71.41 108.686 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.85 97.89 7.59 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.775 -1.102 . . . . 71.21 108.592 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.22 146.64 18.34 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.723 -0.671 . . . . 71.14 111.524 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.23 137.87 9.11 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 110.716 -0.954 . . . . 61.11 110.716 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -93.02 123.72 45.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.806 -0.813 . . . . 61.22 108.806 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.8 m-85 -132.56 118.64 19.48 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.71 -1.219 . . . . 74.3 107.71 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.3 p -81.68 98.52 8.43 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.327 -0.62 . . . . 71.04 109.327 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' THR . 2.8 pp -113.24 160.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.417 0.687 . . . . 74.15 111.258 -175.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.37 174.58 2.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.001 1.32 . . . . 63.33 109.495 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 78.08 -6.48 49.36 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 115.514 0.966 . . . . 75.11 115.514 169.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -126.18 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.216 -1.031 . . . . 65.11 108.216 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.567 ' HB3' ' HG2' ' E' ' 276' ' ' PRO . 19.2 mp0 -133.16 173.74 11.12 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.692 0.797 . . . . 75.34 109.461 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.34 -139.45 47.4 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.702 0.626 . . . . 43.32 113.737 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 15.1 t -72.9 -18.63 61.39 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.595 0.758 . . . . 54.31 111.208 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.47 -36.63 76.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.599 0.76 . . . . 64.52 110.323 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.78 -42.19 41.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.943 0.497 . . . . 74.24 109.777 173.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.09 -16.88 64.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.431 -0.804 . . . . 73.11 112.682 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.425 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 t-80 -68.9 -28.72 66.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.953 0.501 . . . . 73.5 110.15 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.2 t -78.01 -39.2 42.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.064 0.546 . . . . 60.34 110.008 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.66 -51.77 56.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.354 0.662 . . . . 73.11 112.081 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.56 4.91 47.46 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.424 -0.807 . . . . 74.31 114.33 -164.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.91 -63.8 0.35 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 117.281 0.541 . . . . 42.4 112.388 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 82.0 t80 -71.05 -57.1 4.86 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.901 0.704 . . . . 75.35 112.901 -169.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 88.5 m -67.4 -32.28 4.4 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 118.189 -0.91 . . . . 73.11 112.882 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.28 -50.12 12.79 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.413 2.075 . . . . 60.3 112.876 159.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -61.35 -25.01 66.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.656 0.782 . . . . 73.02 111.957 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.473 HG21 HD11 ' A' ' 13' ' ' ILE . 49.1 mm -76.68 -48.92 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 72.23 110.111 174.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 60' ' ' LEU . 95.8 mt -81.18 -23.01 38.48 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.446 0.698 . . . . 73.43 112.214 -170.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.4 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 55.3 t80 -65.34 -42.57 59.47 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.216 1.006 . . . . 73.24 112.957 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 -32.11 85.47 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.83 1.687 . . . . 63.11 113.077 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -74.22 -39.65 62.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.209 0.603 . . . . 74.41 111.618 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.47 78.32 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.419 -0.586 . . . . 72.13 109.419 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -54.37 -46.27 72.98 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.777 1.298 . . . . 71.11 110.728 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.54 -48.47 77.36 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.295 0.997 . . . . 72.43 110.552 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.54 -45.25 85.29 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.772 0.67 . . . . 40.33 110.697 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 118' ' ' VAL . 91.8 mt -60.29 -52.58 59.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 114.855 -1.066 . . . . 71.4 110.05 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 125' ' ' GLN . 78.4 m -53.19 -46.22 68.91 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.919 0.888 . . . . 74.21 111.515 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -64.88 -47.51 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.179 -0.919 . . . . 71.45 110.034 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.42 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 13.4 mtp -54.58 -43.7 72.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.09 0.956 . . . . 72.1 111.449 175.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 114' ' ' ILE . 67.5 t -65.9 -47.16 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.862 1.265 . . . . 72.25 111.312 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.5 p -66.69 -32.66 74.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.095 0.558 . . . . 75.44 111.264 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.17 -33.08 74.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.753 0.821 . . . . 62.24 110.49 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.58 20.43 18.61 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.08 -0.845 . . . . 72.31 114.28 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 48.39 47.35 20.04 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.366 1.466 . . . . 73.3 112.352 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.482 ' HA ' HD13 ' E' ' 301' ' ' ILE . 61.8 m-85 -117.05 149.84 44.95 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 107.777 -1.194 . . . . 65.53 107.777 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.567 ' HB3' ' HB2' ' E' ' 300' ' ' ASN . 44.8 Cg_endo -65.48 153.68 77.1 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.189 1.926 . . . . 72.41 110.392 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.8 tt0 -51.1 126.9 17.68 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.332 1.02 . . . . 75.14 111.995 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.826 HD21 HG11 ' A' ' 64' ' ' VAL . 33.3 tp -110.19 94.66 5.13 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.205 -0.907 . . . . 75.03 109.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -111.91 104.32 12.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.405 -1.27 . . . . 72.5 107.968 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.4 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 3.3 tt -63.74 128.04 34.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.943 -1.132 . . . . 64.23 107.943 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.26 144.13 8.7 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 124.208 1.003 . . . . 51.23 111.709 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 40.9 Cg_exo -58.52 110.0 0.59 Allowed 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.644 2.229 . . . . 73.51 112.064 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 t -101.07 112.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.737 -0.838 . . . . 73.32 108.737 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.98 85.21 5.61 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.662 0.785 . . . . 64.52 109.537 174.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -59.48 -32.86 70.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.666 0.787 . . . . 73.3 111.366 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -67.03 -40.72 87.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.125 0.97 . . . . 53.31 111.184 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.73 -37.44 67.75 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.758 0.661 . . . . 64.23 111.173 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.51 -42.99 81.94 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.061 0.545 . . . . 65.35 110.906 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -62.02 -38.18 87.69 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.27 -0.877 . . . . 73.4 109.97 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.531 ' SD ' ' HG2' ' A' ' 144' ' ' GLN . 36.7 tpp -68.5 -38.64 81.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.886 0.874 . . . . 64.24 111.073 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -58.84 -35.25 72.61 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.161 0.585 . . . . 72.1 110.756 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -81.08 -36.14 30.82 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.271 0.628 . . . . 71.11 110.952 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.91 -51.62 68.52 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.006 0.923 . . . . 74.45 110.827 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 178.7 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.883 1.273 . . . . 61.32 109.471 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 138' ' ' MET . 0.0 OUTLIER 69.9 118.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.042 1.737 . . . . 74.32 110.668 178.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.531 ' HG2' ' SD ' ' A' ' 138' ' ' MET . 2.4 pt20 -133.0 107.51 8.31 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.278 1.031 . . . . 62.24 109.162 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.23 172.24 18.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.743 0.817 . . . . 72.1 110.568 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.81 169.25 13.21 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.648 -0.705 . . . . 55.35 112.045 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -140.08 142.53 36.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.083 0.553 . . . . 74.51 110.69 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.81 41.75 62.48 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.945 -0.571 . . . . 62.42 111.744 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.1 p -62.42 -56.32 19.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.713 0.805 . . . . 63.42 109.772 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -172.46 129.45 0.55 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.557 -1.646 . . . . 74.45 106.557 165.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -77.89 -67.03 0.77 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.222 1.009 . . . . 71.04 110.072 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -178.26 111.01 0.06 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.642 0.777 . . . . 64.02 110.862 -172.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' C' ' 90' ' ' GLU . 0.2 OUTLIER -143.51 92.57 2.38 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.991 0.9 . . . . 71.52 109.8 167.481 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -79.2 78.4 5.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.787 0.804 . . . . 75.34 109.992 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.318 0 CA-C-N 115.219 -0.901 . . . . 62.04 110.558 -176.353 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.237 -0.653 . . . . 64.51 109.237 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.2 m -101.27 -176.02 3.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.159 0.984 . . . . 51.24 110.732 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.43 4.02 33.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.106 0.962 . . . . 73.45 112.314 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 63.52 -78.42 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.559 1.143 . . . . 70.52 110.896 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 51.0 t30 64.25 106.68 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.418 1.487 . . . . 63.33 111.292 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -127.11 79.66 1.9 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.964 -0.754 . . . . 73.04 108.964 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 39.6 p -134.56 135.82 42.56 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.412 0.685 . . . . 73.05 110.498 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.05 -63.4 1.39 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.441 -0.948 . . . . 72.45 108.441 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ptm 49.36 171.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 127.144 2.178 . . . . 74.44 115.08 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 82.2 m -155.3 111.15 3.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.858 -1.164 . . . . 61.45 107.858 173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -132.94 136.74 46.29 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.558 -0.534 . . . . 65.24 109.558 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.635 ' HB3' HG23 ' E' ' 309' ' ' THR . 0.6 OUTLIER -152.05 139.52 19.57 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.281 1.032 . . . . 74.55 108.954 171.127 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -83.42 144.55 9.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.738 -0.838 . . . . 74.1 108.738 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' E' ' 306' ' ' VAL . 69.3 mt-30 -103.63 -43.35 5.39 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.17 0.588 . . . . 62.35 110.194 173.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -166.99 134.88 2.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.866 -0.606 . . . . 54.43 109.673 -171.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.5 mt -118.52 133.78 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 106.831 -1.544 . . . . 73.24 106.831 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -164.64 147.13 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.65 0.593 . . . . 73.53 112.098 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.8 m -73.25 124.47 25.72 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.343 -0.844 . . . . 73.1 108.879 170.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -97.95 -32.93 11.41 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.923 0.489 . . . . 73.42 110.89 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -152.81 140.99 20.44 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.338 -0.392 . . . . 72.42 110.361 -171.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.3 mm -132.88 137.33 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.212 1.005 . . . . 74.43 109.292 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.4 m -133.69 112.04 11.08 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.986 1.315 . . . . 74.42 108.444 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.7 t80 -130.5 110.02 11.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.053 -1.462 . . . . 73.13 107.053 167.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.66 111.9 18.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.431 -0.952 . . . . 64.11 108.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -115.92 85.56 14.96 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.296 -1.002 . . . . 63.01 108.296 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.91 -22.9 35.45 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.515 2.144 . . . . 70.2 111.388 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.83 13.84 25.99 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.653 1.181 . . . . 61.14 110.656 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -45.21 -51.62 24.16 Favored Pre-proline 0 CA--C 1.57 1.732 0 N-CA-C 114.3 1.222 . . . . 73.22 114.3 -175.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.5 -46.37 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 CA-C-N 121.511 1.575 . . . . 73.54 112.965 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -77.66 3.34 14.15 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.814 1.042 . . . . 70.4 113.814 -171.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.576 HG23 HD11 ' B' ' 68' ' ' LEU . 14.7 p -73.62 -30.64 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 109.63 -0.507 . . . . 63.32 109.63 171.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.54 -31.27 61.99 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 125.145 1.378 . . . . 75.3 112.993 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.42 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.5 pt20 -63.76 -50.37 69.32 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.367 0.417 . . . . 73.5 110.886 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.487 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 54.1 pttt -116.48 60.31 0.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.943 0.897 . . . . 75.45 110.501 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -101.27 119.74 39.21 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.762 -0.586 . . . . 74.12 109.648 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.35 -167.93 0.14 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.071 1.482 . . . . 75.42 108.984 163.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.91 105.45 0.49 Allowed Pre-proline 0 CA--C 1.566 1.581 0 C-N-CA 124.421 1.089 . . . . 65.22 112.783 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.02 169.66 2.89 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.526 2.818 . . . . 53.52 113.066 -173.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.86 107.84 5.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 45.41 108.652 172.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 65' ' ' THR . 16.2 m -105.71 141.01 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.678 -0.692 . . . . 75.11 110.77 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -126.79 121.96 33.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.984 0.914 . . . . 45.43 109.06 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 tp -98.44 124.59 43.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.683 0.793 . . . . 61.11 108.984 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.742 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.7 m-20 -125.47 118.73 26.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.982 0.913 . . . . 72.2 108.626 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.2 126.44 46.48 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.405 -1.331 . . . . 75.55 107.405 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.83 139.4 46.23 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 74.24 109.216 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -117.74 113.74 22.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.279 0.632 . . . . 70.11 110.787 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.61 147.78 42.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.39 1.076 . . . . 52.14 108.23 172.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.5 p -145.95 174.33 11.36 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 118.064 0.393 . . . . 60.34 111.546 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.9 p -153.32 145.11 23.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.385 1.074 . . . . 54.14 109.248 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -97.28 104.2 16.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.502 -0.555 . . . . 71.14 109.502 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.64 -42.49 51.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.16 0.584 . . . . 74.1 110.943 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.12 -179.95 7.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.111 0.965 . . . . 51.3 109.306 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.23 123.41 21.59 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.514 -0.766 . . . . 61.44 109.31 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 74.33 -3.1 2.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.82 1.648 . . . . 70.35 112.838 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -106.34 114.1 44.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.498 -0.927 . . . . 73.01 108.498 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -116.29 139.87 49.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.793 -0.818 . . . . 63.13 108.793 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -111.87 99.92 8.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.418 -1.327 . . . . 72.11 107.418 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.41 127.87 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.908 0.883 . . . . 43.45 110.277 -174.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.6 t -111.97 112.37 40.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 124.912 1.285 . . . . 75.42 108.738 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 106.0 18.17 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.667 -0.864 . . . . 63.33 108.667 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -86.03 123.85 31.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.576 -0.738 . . . . 70.11 109.535 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.44 105.76 19.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.709 -1.219 . . . . 52.5 107.709 168.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.742 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 32.4 m -94.42 137.49 33.49 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.659 -0.867 . . . . 74.23 108.659 176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.94 130.14 61.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.429 -1.323 . . . . 71.14 107.429 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 97.1 m -120.04 144.93 47.29 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.528 -0.915 . . . . 75.1 108.528 173.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.61 134.11 40.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.806 -1.183 . . . . 53.23 107.806 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 61.2 p -147.36 133.91 19.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.297 0.639 . . . . 74.45 109.976 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.689 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -125.48 138.27 53.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.564 0.746 . . . . 74.23 110.016 177.848 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -127.69 9.03 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.213 -0.903 . . . . 72.13 111.444 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.98 11.35 29.89 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.129 0.972 . . . . 74.35 111.932 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.487 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 17.0 pt-20 -154.88 -179.49 8.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.585 0.354 . . . . 75.24 110.986 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -64.18 154.39 34.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 72.23 112.424 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.689 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -103.91 -60.35 1.59 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.774 -1.195 . . . . 73.01 107.774 166.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -166.34 164.39 17.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.346 -1.297 . . . . 72.55 109.161 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 29.4 mt -123.65 135.84 54.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.129 -1.434 . . . . 74.1 107.129 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 48.7 t -144.96 131.58 19.91 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.083 -0.71 . . . . 53.2 109.083 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.7 tt0 -156.22 143.65 19.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.615 -0.883 . . . . 64.53 108.615 -170.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.452 HG21 ' HB3' ' B' ' 113' ' ' CYS . 93.3 t -135.69 146.9 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.555 -0.905 . . . . 64.12 108.555 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -121.58 95.61 4.74 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.628 -1.249 . . . . 73.13 107.628 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 46.3 tp60 -89.0 101.05 13.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.642 -0.873 . . . . 62.55 108.642 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.45 168.74 36.81 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.749 0.656 . . . . 64.45 111.874 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.54 127.74 1.48 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.574 -0.611 . . . . 71.14 111.574 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -84.46 128.86 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.053 -1.091 . . . . 71.03 108.053 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.64 163.51 29.59 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.835 1.254 . . . . 72.13 108.853 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -131.87 113.11 13.07 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.66 -0.867 . . . . 72.33 108.66 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.39 129.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.7 -0.852 . . . . 74.12 108.7 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.28 170.1 18.01 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.582 1.153 . . . . 63.43 108.857 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -70.8 3.02 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.803 -0.519 . . . . 52.53 111.803 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -87.55 152.22 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.166 0.586 . . . . 64.13 110.553 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 14.4 pt-20 -158.69 175.86 13.1 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.696 0.623 . . . . 74.02 111.822 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.69 -130.09 28.04 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.006 -0.997 . . . . 74.44 113.857 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.432 ' HA ' HD21 ' H' ' 280' ' ' LEU . 17.7 m -65.52 -32.9 74.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.158 0.983 . . . . 75.11 110.833 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -75.41 -31.09 60.29 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.922 -1.035 . . . . 75.12 109.933 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.506 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 26.3 ttt -70.13 -32.4 70.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.908 -0.405 . . . . 61.42 109.908 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.413 ' HA ' HD11 ' B' ' 98' ' ' LEU . . . -58.33 -25.42 61.93 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.059 0.543 . . . . 61.33 112.133 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.51 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 55.5 t-80 -79.56 -26.49 41.35 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.481 0.713 . . . . 75.12 111.157 173.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -79.15 -65.66 0.97 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.755 0.422 . . . . 65.35 110.407 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.7 pp -63.53 -21.4 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.622 0.769 . . . . 73.45 112.776 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.49 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -107.06 3.62 35.53 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 114.431 0.532 . . . . 61.14 114.431 -172.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -151.32 -51.92 0.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.903 0.352 . . . . 73.2 111.725 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -68.65 -48.49 63.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.763 0.825 . . . . 74.3 110.646 -177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.468 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 56.1 m -68.89 -46.51 31.94 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.186 0.594 . . . . 65.14 111.466 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -55.38 -35.16 91.18 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 122.686 2.257 . . . . 54.21 114.003 168.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.64 -35.32 74.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.357 0.663 . . . . 73.31 110.881 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.6 -51.13 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.303 -0.862 . . . . 74.33 110.146 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.31 -23.94 54.33 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.564 0.746 . . . . 73.1 112.667 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.93 -50.71 79.84 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 117.567 -1.206 . . . . 65.33 113.125 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.77 -40.5 74.21 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.643 2.229 . . . . 71.51 113.911 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.5 m-85 -69.86 -45.58 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.411 0.684 . . . . 75.44 110.591 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.48 86.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.547 0.739 . . . . 65.31 110.859 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.647 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 32.1 ttt180 -63.28 -54.63 34.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.758 1.623 . . . . 65.23 110.994 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -36.98 81.66 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.226 0.954 . . . . 72.44 109.663 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -69.0 -38.95 79.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.756 -0.656 . . . . 72.02 111.951 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.41 HG23 ' SG ' ' B' ' 76' ' ' CYS . 58.3 mt -63.27 -51.94 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.129 0.572 . . . . 74.4 109.463 174.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.615 HG23 ' HB2' ' B' ' 125' ' ' GLN . 29.6 m -61.37 -28.25 69.1 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.323 -0.853 . . . . 74.11 111.498 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -69.47 -43.29 73.52 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.514 0.726 . . . . 65.33 110.22 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -73.27 -30.68 63.6 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.582 0.353 . . . . 74.24 111.129 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 114' ' ' ILE . 58.8 t -66.77 -39.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 64.23 109.704 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.4 t -62.99 -35.72 81.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.374 1.07 . . . . 73.5 111.294 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.43 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 82.3 mtt-85 -75.99 -31.04 58.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.831 0.852 . . . . 74.11 110.716 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -0.77 86.58 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 123.572 0.545 . . . . 54.13 112.469 171.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 48.9 p 62.57 32.68 16.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.512 1.925 . . . . 71.4 112.512 173.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' B' ' 31' ' ' VAL . 40.6 m-85 -101.71 151.94 38.0 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 115.095 -0.957 . . . . 74.31 110.479 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.641 ' HB2' ' HA ' ' H' ' 297' ' ' TYR . 36.3 Cg_exo -57.55 119.0 5.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.67 2.247 . . . . 75.22 110.635 172.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.615 ' HB2' HG23 ' B' ' 115' ' ' THR . 12.8 pt20 -60.42 152.26 26.0 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.231 1.012 . . . . 74.24 113.175 -168.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.526 ' HB3' HG23 ' H' ' 296' ' ' THR . 3.4 pp -112.26 120.81 43.01 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.544 -1.28 . . . . 72.21 107.544 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -93.33 104.37 16.53 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.469 -0.938 . . . . 72.44 108.469 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.647 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -58.25 118.41 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.67 -0.863 . . . . 63.55 108.67 175.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' H' ' 291' ' ' LEU . . . -80.03 144.89 59.95 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 109.837 -0.431 . . . . 71.0 109.837 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.446 ' HD2' HG21 ' F' ' 309' ' ' THR . 14.4 Cg_exo -64.12 110.36 1.33 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.954 2.436 . . . . 64.14 112.381 -173.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.68 112.79 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.421 -1.326 . . . . 71.31 107.421 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -78.22 75.45 4.75 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.191 -1.04 . . . . 73.02 108.191 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -54.9 -47.21 74.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.058 1.343 . . . . 74.54 111.581 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.31 -49.86 73.94 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 113.944 -1.48 . . . . 74.41 112.395 -174.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.86 96.26 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.871 0.732 . . . . 71.54 110.959 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.528 HD12 ' SD ' ' H' ' 286' ' ' MET . 2.1 tm? -65.08 -43.86 90.8 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.927 0.891 . . . . 64.54 110.034 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -67.04 -27.52 67.46 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.416 0.686 . . . . 73.44 111.536 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 94.2 mtp -66.94 -29.92 69.92 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.857 0.463 . . . . 73.32 111.204 176.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -77.63 -20.24 54.17 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.392 0.677 . . . . 61.23 111.177 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.78 -34.94 79.04 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.936 -0.394 . . . . 75.11 109.936 173.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.77 33.91 0.92 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.059 0.944 . . . . 74.43 109.973 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? 63.24 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.159 1.383 . . . . 61.42 108.792 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -169.15 141.47 2.59 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.189 0.995 . . . . 73.21 109.842 164.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -177.85 145.14 0.38 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.884 1.274 . . . . 74.33 108.643 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.94 109.84 3.88 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.777 0.831 . . . . 74.32 108.941 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.34 150.93 5.95 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 111.754 -0.538 . . . . 54.34 111.754 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -92.27 -3.46 55.43 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.109 0.564 . . . . 64.03 112.226 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.53 44.98 61.65 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.643 0.589 . . . . 51.35 112.574 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.3 m -140.82 85.03 1.97 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.454 0.701 . . . . 73.24 109.327 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -174.17 117.18 0.22 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.473 1.109 . . . . 74.5 109.297 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.16 118.97 11.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.777 0.831 . . . . 61.45 110.436 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -137.01 164.87 27.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.988 1.315 . . . . 73.21 107.635 163.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -68.66 112.51 5.46 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.667 0.746 . . . . 75.13 110.679 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -64.54 118.11 8.34 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.149 -0.932 . . . . 63.41 109.603 174.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.096 0.559 . . . . 75.03 110.316 -173.369 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.487 -0.56 . . . . 64.25 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.1 t -150.27 -52.62 0.14 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.565 -0.902 . . . . 44.34 108.565 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.35 92.79 1.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 106.417 -1.698 . . . . 65.54 106.417 170.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -165.77 122.77 1.42 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.488 0.315 . . . . 61.14 110.878 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -86.68 -68.06 0.77 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.199 -1.408 . . . . 55.1 107.199 167.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -149.79 160.35 43.62 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.659 1.184 . . . . 74.2 109.083 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 86.4 m -152.03 95.81 2.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.502 0.321 . . . . 64.05 111.309 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 67.93 155.42 0.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.804 1.241 . . . . 63.43 113.43 165.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ttt 65.09 121.72 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.132 1.373 . . . . 75.13 112.129 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.3 m -125.68 107.91 11.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.883 -0.784 . . . . 53.23 108.883 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.421 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 61.1 t80 -123.18 133.84 54.21 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.079 0.952 . . . . 74.14 108.432 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.18 144.49 21.08 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.42 0.688 . . . . 73.31 110.036 166.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.543 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.9 pp -65.23 141.35 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.073 -0.967 . . . . 73.53 109.313 171.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.534 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.3 mm-40 -112.07 -50.62 2.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.681 -0.489 . . . . 73.43 109.681 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -168.24 123.7 0.99 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.175 -0.676 . . . . 71.41 109.175 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.28 145.61 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.262 -1.385 . . . . 72.21 107.262 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.401 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.0 p90 -176.88 168.49 2.49 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.842 0.83 . . . . 75.02 111.242 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -90.12 113.41 25.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.532 -1.213 . . . . 71.32 108.725 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.66 -38.61 89.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.354 0.662 . . . . 61.44 109.793 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.57 144.48 26.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.812 -1.086 . . . . 71.44 109.257 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.1 mt -134.83 137.89 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.006 -1.479 . . . . 62.24 107.006 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -149.5 150.73 32.77 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.31 0.644 . . . . 73.53 109.495 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -154.23 135.31 13.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.74 -1.207 . . . . 74.21 107.74 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.7 mt-10 -131.43 117.74 19.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.044 -0.724 . . . . 51.02 109.044 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.8 72.46 55.53 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.352 -0.981 . . . . 73.1 108.352 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.06 -15.68 25.83 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.576 2.184 . . . . 61.04 111.912 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 27' ' ' ASN . . . . . 0.457 ' O ' HG23 ' C' ' 31' ' ' VAL . 2.0 m-20 -105.18 18.4 22.39 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.356 1.062 . . . . 52.41 110.093 178.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.24 -48.82 54.67 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 114.356 1.243 . . . . 65.11 114.356 -171.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.428 ' HB3' HD13 ' D' ' 51' ' ' LEU . 13.5 Cg_exo -68.59 -38.35 11.05 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 121.818 1.679 . . . . 44.41 111.815 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -67.66 -22.68 65.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.406 1.482 . . . . 74.31 112.381 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.457 HG23 ' O ' ' C' ' 27' ' ' ASN . 78.2 t -65.91 -37.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.813 0.445 . . . . 61.1 111.952 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -69.65 -28.67 66.08 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 111.976 0.361 . . . . 72.2 111.976 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -87.8 12.92 11.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.208 0.603 . . . . 74.32 111.656 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.535 ' HD2' HD21 ' C' ' 68' ' ' LEU . 5.4 ttpm? -112.93 148.98 33.86 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.822 0.849 . . . . 65.44 110.915 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.97 130.24 39.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.147 0.979 . . . . 64.43 109.88 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -85.44 80.85 8.96 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.104 0.962 . . . . 75.12 111.721 -165.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 37' ' ' GLN . . . . . 0.488 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 1.0 OUTLIER -152.94 44.74 0.26 Allowed Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 114.0 1.111 . . . . 74.31 114.0 173.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' C' ' 68' ' ' LEU . 22.7 Cg_exo -67.0 149.0 82.75 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 122.253 1.968 . . . . 45.41 111.1 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.48 118.73 25.19 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 170.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.68 HG21 HD11 ' C' ' 126' ' ' LEU . 14.2 p -82.1 142.89 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.992 -1.004 . . . . 75.3 109.537 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -131.8 124.46 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.933 0.893 . . . . 50.43 108.934 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -88.77 129.98 35.45 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 105.764 -1.939 . . . . 75.52 105.764 164.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.8 t70 -130.01 108.43 10.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.933 -1.136 . . . . 70.42 107.933 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 43.5 tp -96.6 151.96 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.124 0.57 . . . . 44.51 110.265 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.9 t0 -131.15 154.44 48.35 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.908 0.883 . . . . 62.44 108.642 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.5 p -119.64 111.77 18.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.813 0.845 . . . . 61.55 109.586 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.81 146.5 43.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.966 0.906 . . . . 72.22 109.436 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -161.76 152.94 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.055 0.542 . . . . 75.22 110.505 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -149.52 146.03 27.17 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.196 0.598 . . . . 32.43 110.394 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -86.26 124.73 32.97 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.443 -0.576 . . . . 72.33 109.443 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.551 HD11 HD12 ' C' ' 83' ' ' ILE . 70.2 mt -96.53 -44.89 6.96 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.731 0.813 . . . . 74.44 109.78 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.38 -177.19 5.71 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.115 -0.948 . . . . 75.21 109.644 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.83 115.82 3.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.301 0.64 . . . . 64.14 109.886 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 64.48 0.96 1.19 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.205 1.402 . . . . 63.45 113.206 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 94.5 t -94.17 111.09 24.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.885 -1.154 . . . . 72.23 107.885 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -126.86 125.72 42.1 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.182 0.993 . . . . 71.43 109.112 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -84.65 122.62 29.33 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.318 -0.855 . . . . 73.12 109.193 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.13 124.59 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.993 -1.114 . . . . 52.11 107.993 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.64 131.16 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.963 0.905 . . . . 74.54 109.236 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.12 105.74 12.14 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.693 -1.225 . . . . 54.15 107.693 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.8 tmm_? -82.64 108.28 15.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.433 -1.321 . . . . 71.34 107.433 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.4 t -100.23 136.54 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.247 -1.02 . . . . 53.31 108.247 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 59.9 m -134.85 121.32 20.46 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.168 -0.679 . . . . 42.21 109.168 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.411 HG23 HD13 ' C' ' 114' ' ' ILE . 76.7 t -103.75 109.27 26.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.951 . . . . 61.52 108.434 174.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.451 HG23 HD23 ' C' ' 75' ' ' LEU . 6.2 m -99.28 150.21 22.34 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.2 -0.909 . . . . 64.32 109.792 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.97 110.09 8.32 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.419 0.688 . . . . 62.31 109.17 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.0 m -148.0 138.64 23.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.924 0.49 . . . . 61.45 110.32 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.617 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.7 OUTLIER -112.41 56.11 0.67 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.405 1.082 . . . . 74.12 108.764 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.44 -116.56 4.4 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.27 -1.332 . . . . 54.22 110.519 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -88.79 -29.03 20.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.195 0.598 . . . . 75.23 110.146 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -79.18 106.14 11.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.999 0.919 . . . . 75.52 110.056 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -78.74 126.01 30.14 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.715 -0.675 . . . . 72.22 109.778 171.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.32 -56.55 4.92 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.666 -1.152 . . . . 72.04 109.437 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -167.75 178.71 5.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.645 0.778 . . . . 72.11 110.691 173.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -138.38 143.76 39.95 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.613 1.165 . . . . 75.41 107.956 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.2 t -140.2 137.51 34.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.612 -1.255 . . . . 73.21 107.612 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -152.88 134.55 14.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.667 0.387 . . . . 75.34 110.601 -173.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.05 120.76 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.684 1.194 . . . . 70.24 108.735 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 72.4 mt-30 -88.42 100.18 12.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.455 -1.313 . . . . 72.42 107.455 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.0 tp60 -87.95 112.23 22.33 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.674 -0.491 . . . . 74.02 109.674 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.08 154.11 17.7 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.851 -0.5 . . . . 71.35 111.851 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.11 123.97 1.48 Allowed Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 110.69 -0.964 . . . . 52.33 110.69 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.551 HD12 HD11 ' C' ' 51' ' ' LEU . 9.4 mm -81.38 129.51 37.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 108.452 -0.944 . . . . 74.23 108.452 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.543 ' HE2' HG22 ' C' ' 13' ' ' ILE . 50.4 m-85 -138.02 151.73 48.17 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.399 -0.593 . . . . 62.24 109.399 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.9 p -110.36 117.08 32.66 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.364 -0.976 . . . . 71.53 108.364 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.99 116.71 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.157 0.983 . . . . 63.55 109.597 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.4 163.52 34.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.35 0.66 . . . . 54.3 111.439 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.77 -29.58 7.8 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.401 -0.818 . . . . 50.22 113.977 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.14 157.11 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.166 0.987 . . . . 70.22 111.013 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 153' ' ' GLN . 7.3 tp10 -149.91 159.67 44.19 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.134 0.974 . . . . 73.25 109.582 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.34 -144.58 17.98 Favored Glycine 0 C--N 1.348 1.246 0 C-N-CA 123.279 0.466 . . . . 71.05 112.458 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -64.5 -21.29 66.63 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.708 0.803 . . . . 71.52 111.677 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -65.8 -52.24 52.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.915 1.286 . . . . 71.2 109.747 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' F' ' 279' ' ' GLY . 3.5 ppp? -77.76 -21.6 51.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.612 -0.722 . . . . 71.43 110.515 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.67 70.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.87 0.868 . . . . 73.02 111.82 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 81.5 t60 -69.85 -34.28 73.4 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.058 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -69.59 -43.05 73.58 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.695 0.398 . . . . 62.51 110.73 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.503 HD11 HD22 ' F' ' 278' ' ' LEU . 0.8 OUTLIER -79.79 -55.09 5.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.969 0.907 . . . . 74.24 110.06 -174.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.03 11.46 69.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.519 -0.764 . . . . 75.42 114.639 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.577 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -148.23 -52.02 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.457 0.628 . . . . 21.34 111.84 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -76.27 -41.95 47.18 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.541 0.736 . . . . 74.53 111.203 -173.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.6 m -67.36 -47.71 48.01 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 118.517 -0.754 . . . . 64.03 111.478 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.6 Cg_exo -53.68 -35.8 79.3 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.756 2.304 . . . . 54.31 113.715 169.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.28 -40.23 81.37 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.672 0.789 . . . . 53.42 110.912 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.59 -46.25 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.632 0.773 . . . . 72.23 110.901 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.8 mt -82.46 -23.33 34.81 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.163 0.801 . . . . 62.12 113.163 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -57.06 -49.39 94.22 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.162 0.985 . . . . 73.35 112.842 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.21 -33.72 97.83 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.504 2.136 . . . . 71.2 113.982 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.457 ' HE2' HG21 ' A' ' 115' ' ' THR . 95.9 m-85 -70.66 -48.39 55.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.387 0.675 . . . . 64.14 111.285 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.13 89.95 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.472 0.482 . . . . 71.43 109.86 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.534 ' HA ' HD23 ' C' ' 128' ' ' LEU . 31.1 ttt-85 -52.64 -55.98 18.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.251 1.421 . . . . 72.22 111.78 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.11 -32.79 72.45 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.476 0.485 . . . . 71.21 110.546 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -69.39 -33.51 73.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.996 0.518 . . . . 74.14 111.257 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' C' ' 62' ' ' VAL . 90.1 mt -69.22 -52.29 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.73 0.812 . . . . 62.2 109.283 172.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.1 m -59.11 -33.79 71.25 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.272 1.029 . . . . 73.34 111.478 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.7 t -64.14 -48.72 74.95 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.614 0.766 . . . . 42.24 109.41 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.0 -38.24 90.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.392 1.077 . . . . 64.21 112.404 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.59 -42.37 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 O-C-N 123.559 0.537 . . . . 74.5 109.715 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -66.79 -32.99 74.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.034 0.934 . . . . 74.14 111.68 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.6 mtt-85 -72.12 -31.68 66.25 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.781 0.832 . . . . 73.41 110.76 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.03 8.48 70.12 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 119.521 -0.599 . . . . 71.23 112.715 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p 62.02 34.05 16.84 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.772 1.629 . . . . 65.2 112.408 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.438 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 29.1 m-85 -104.84 163.05 17.98 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 124.803 1.241 . . . . 64.2 109.486 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 63.1 Cg_endo -68.51 162.57 40.24 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.015 2.477 . . . . 64.14 113.502 -173.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.513 HE21 ' HB3' ' B' ' 125' ' ' GLN . 64.9 mm-40 -60.85 128.05 34.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.116 -0.947 . . . . 75.21 112.721 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.68 HD11 HG21 ' C' ' 40' ' ' VAL . 6.3 tt -140.65 89.28 2.26 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.731 -1.211 . . . . 74.02 107.731 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -97.47 131.31 44.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.706 0.802 . . . . 74.25 109.128 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' C' ' 111' ' ' ARG . 3.5 mm? -70.88 135.59 48.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.743 0.817 . . . . 73.14 111.123 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.447 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -85.97 160.29 52.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 124.925 1.29 . . . . 73.32 112.156 -173.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.88 102.57 0.77 Allowed 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 123.304 2.669 . . . . 63.32 112.343 -175.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -99.4 110.24 26.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.303 -0.999 . . . . 74.24 108.303 171.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -81.39 88.34 6.12 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.422 0.689 . . . . 75.33 110.613 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -65.26 -34.86 79.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.007 -0.997 . . . . 65.44 109.344 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.577 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.7 p-10 -65.38 -46.78 78.77 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.417 -1.265 . . . . 62.21 111.701 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.82 -31.21 71.68 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.567 0.747 . . . . 72.54 111.623 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -54.34 -52.02 62.89 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.322 1.014 . . . . 71.32 109.288 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -73.07 -16.44 61.48 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.795 0.838 . . . . 74.23 112.365 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 32.2 mmt -75.48 -27.37 58.8 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.987 0.515 . . . . 72.42 111.704 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -54.15 -34.16 59.7 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.525 0.73 . . . . 73.44 111.71 172.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -57.84 -85.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.309 1.044 . . . . 75.34 111.323 171.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.539 HD13 HE22 ' C' ' 143' ' ' GLN . 1.3 pp -76.28 159.3 30.72 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.684 0.624 . . . . 74.51 112.684 -168.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -148.37 108.21 4.02 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.287 1.035 . . . . 63.42 109.188 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.539 HE22 HD13 ' C' ' 141' ' ' LEU . 1.7 mp0 -94.62 83.47 4.1 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.686 -0.487 . . . . 74.32 109.686 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -85.84 86.09 7.37 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.14 -0.689 . . . . 74.24 109.14 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.46 -174.77 3.29 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.006 0.922 . . . . 75.14 109.731 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.03 -126.19 22.99 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-O 118.952 -0.915 . . . . 53.32 112.45 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 62.84 102.38 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.972 1.309 . . . . 75.55 111.726 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.97 120.91 0.6 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.816 -0.435 . . . . 71.24 112.698 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 15.7 p -137.46 164.46 28.62 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.056 0.942 . . . . 70.12 110.444 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 69.72 117.14 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.544 1.538 . . . . 74.43 110.681 170.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -98.62 9.31 43.55 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.155 0.982 . . . . 72.11 111.65 -170.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 59.47 67.2 0.92 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.969 1.308 . . . . 71.2 109.155 -168.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -72.08 108.72 5.43 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.311 -0.859 . . . . 62.53 110.653 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -159.93 150.01 18.47 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.727 0.811 . . . . 75.34 109.453 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.132 0 N-CA-C 108.549 -0.908 . . . . 55.45 108.549 176.056 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.226 -0.657 . . . . 74.11 109.226 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -134.59 -165.01 1.59 Allowed 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.568 -0.901 . . . . 54.53 108.568 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.43 159.81 44.21 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.897 0.879 . . . . 74.35 109.027 169.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -170.73 129.44 0.8 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.276 -0.638 . . . . 74.33 109.276 179.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -127.5 78.63 1.83 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 108.984 -0.747 . . . . 62.32 108.984 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -93.5 134.01 36.21 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.788 -0.449 . . . . 73.13 109.788 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 27.0 m -63.18 -35.5 80.5 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.025 -0.731 . . . . 72.34 109.025 164.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.07 175.5 2.05 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.896 -1.047 . . . . 63.45 111.133 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.0 ttp -33.3 124.6 0.4 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.902 1.281 . . . . 62.22 113.403 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.0 m -132.18 141.91 49.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.612 -1.255 . . . . 72.23 107.612 175.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -152.37 91.35 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.646 -1.242 . . . . 71.31 107.646 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 77.0 mt-30 -114.44 115.77 27.8 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.48 -0.933 . . . . 74.3 108.48 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -72.69 115.86 13.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.298 -1.001 . . . . 63.45 108.298 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -83.14 -50.06 8.85 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.062 -0.347 . . . . 64.22 110.062 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -172.83 151.28 2.22 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.792 0.33 . . . . 73.45 111.879 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.407 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -128.85 126.89 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.896 -1.52 . . . . 62.5 106.896 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -144.6 150.28 37.17 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.246 1.019 . . . . 73.24 109.645 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.5 p -83.97 109.03 17.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.839 -1.073 . . . . 74.22 108.909 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -76.28 -23.52 54.41 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.727 -0.67 . . . . 60.55 110.48 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -163.33 140.18 7.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.968 -1.014 . . . . 70.31 108.823 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.564 HD13 ' HE3' ' C' ' 117' ' ' MET . 85.2 mt -135.11 148.02 29.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 108.127 -1.064 . . . . 73.14 108.127 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -147.47 143.22 27.72 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.893 0.877 . . . . 44.35 109.769 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.8 t80 -153.56 126.77 8.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.969 -1.863 . . . . 71.24 105.969 169.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.65 153.66 45.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.651 . . . . 75.02 109.361 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.95 77.02 12.33 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.506 -0.924 . . . . 74.14 108.506 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.28 -31.18 23.19 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.922 2.415 . . . . 73.11 113.322 -172.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -116.06 36.32 4.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.473 0.709 . . . . 51.05 109.621 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.623 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.84 -64.12 1.4 Allowed Pre-proline 0 CA--C 1.568 1.646 0 N-CA-C 113.418 0.896 . . . . 72.21 113.418 -172.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.416 ' HB3' HD11 ' C' ' 83' ' ' ILE . 55.1 Cg_endo -78.39 -9.96 16.17 Favored 'Trans proline' 0 C--N 1.385 2.48 0 CA-C-N 121.73 1.654 . . . . 75.53 112.618 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -82.9 -38.69 22.54 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.896 1.679 . . . . 73.35 109.615 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 ' CZ2' ' D' ' 36' ' ' TRP . 2.0 p -85.56 -19.61 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.791 0.836 . . . . 74.51 110.886 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.421 ' HA ' HD12 ' G' ' 301' ' ' ILE . 20.1 m-85 -68.85 -10.57 57.64 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.5 0.72 . . . . 64.42 112.33 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -83.62 3.07 34.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.065 0.946 . . . . 63.25 111.505 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -126.23 112.7 16.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.012 0.925 . . . . 71.05 109.347 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -90.51 97.6 11.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.666 0.786 . . . . 62.14 111.72 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.515 ' CZ2' HG22 ' D' ' 31' ' ' VAL . 0.0 OUTLIER -150.62 -173.93 4.61 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.805 0.842 . . . . 75.42 112.222 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.1 115.93 65.68 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-N 114.974 -1.012 . . . . 71.01 110.1 165.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.652 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.0 Cg_exo -63.3 131.04 30.56 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.164 2.576 . . . . 73.2 111.746 163.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.6 112.28 20.29 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.163 -1.791 . . . . 72.25 106.163 163.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.845 HG12 ' HB2' ' D' ' 66' ' ' ALA . 26.8 m -98.29 112.29 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.635 -1.246 . . . . 60.13 107.635 177.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -84.2 124.33 31.07 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.45 -0.945 . . . . 50.15 108.45 -172.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.1 mt -97.21 112.77 24.42 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.284 -1.326 . . . . 73.53 109.145 -170.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 31.2 t70 -114.0 130.69 56.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.257 -1.016 . . . . 74.42 108.257 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.62 136.5 47.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.706 -0.85 . . . . 64.21 108.706 177.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -132.64 127.94 35.98 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.865 -1.161 . . . . 73.52 107.865 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.2 p -105.54 151.96 23.66 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.249 0.62 . . . . 74.04 110.302 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.663 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.03 160.53 43.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.29 -0.868 . . . . 75.45 109.331 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 66.1 p -155.33 156.79 36.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.649 0.78 . . . . 75.34 109.535 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.6 m -150.63 146.85 26.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.419 -1.326 . . . . 74.41 107.419 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.34 116.56 32.61 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.207 -1.405 . . . . 72.55 107.207 162.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' C' ' 29' ' ' PRO . 40.9 mt -92.23 -29.55 16.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.801 0.441 . . . . 64.54 110.263 -176.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.46 -178.73 7.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.647 0.779 . . . . 52.1 110.083 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.76 123.67 20.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.174 -0.921 . . . . 73.21 109.645 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 64.25 9.71 5.02 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.586 1.154 . . . . 54.22 112.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 96.7 t -118.63 117.29 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.305 -0.628 . . . . 72.12 109.305 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -128.36 128.33 44.34 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.118 0.967 . . . . 70.43 108.685 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.81 132.13 35.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.886 0.874 . . . . 62.53 108.795 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.577 HG13 ' HZ ' ' G' ' 281' ' ' PHE . 97.9 t -117.03 122.26 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.047 -1.464 . . . . 65.11 107.047 176.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.663 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.9 t -112.86 129.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.317 -0.624 . . . . 74.34 109.317 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.493 HD23 HD12 ' D' ' 106' ' ' LEU . 3.8 mm? -116.76 107.52 14.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 64.12 108.994 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -88.29 112.35 22.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.489 -0.778 . . . . 74.13 109.071 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -99.88 120.65 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.038 -1.097 . . . . 75.13 108.038 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 33.6 m -115.4 140.01 49.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.792 0.837 . . . . 73.23 109.595 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.598 HG13 ' HB ' ' D' ' 40' ' ' VAL . 88.1 t -137.15 127.81 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.754 1.222 . . . . 54.21 108.764 -172.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.3 m -133.91 103.8 5.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.178 0.591 . . . . 73.51 109.648 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.845 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -102.06 130.42 48.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.577 0.751 . . . . 75.23 109.976 177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 16.2 p -154.43 124.37 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.996 -0.742 . . . . 70.22 108.996 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.652 HD11 ' HA ' ' D' ' 38' ' ' PRO . 3.0 mm? -114.85 134.07 55.44 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.971 0.508 . . . . 70.31 110.083 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.5 -110.24 3.06 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.902 0.751 . . . . 73.13 112.037 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.4 7.68 10.15 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.231 1.012 . . . . 70.14 110.85 -175.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -137.55 154.87 49.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 122.874 0.47 . . . . 74.25 110.697 -173.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.9 m -83.26 124.94 31.07 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.744 -0.662 . . . . 64.33 110.309 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.446 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -71.03 -65.73 0.7 Allowed 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.897 0.748 . . . . 64.1 109.555 176.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.34 158.49 37.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.962 -1.017 . . . . 72.14 110.765 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -120.69 151.94 38.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.502 -1.295 . . . . 62.23 107.502 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' D' ' 114' ' ' ILE . 33.7 t -159.52 136.12 9.21 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.978 -0.379 . . . . 72.04 109.978 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.66 139.86 15.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.746 0.418 . . . . 73.44 110.046 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.8 120.45 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.177 0.591 . . . . 74.33 110.087 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -89.03 88.27 7.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.658 -0.868 . . . . 72.41 108.658 168.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -84.36 92.21 7.97 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.019 -0.991 . . . . 64.51 108.738 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 143.93 18.97 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.946 -0.861 . . . . 62.22 110.946 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.86 129.59 3.23 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 110.808 -0.917 . . . . 54.34 110.808 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.7 mt -89.56 134.1 29.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 123.22 0.608 . . . . 72.44 109.505 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -132.0 129.59 40.31 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.177 0.991 . . . . 74.22 109.291 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 50.0 m -75.77 94.35 3.28 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.896 -0.779 . . . . 63.31 108.896 166.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 19.5 mt -107.05 123.32 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 107.824 -1.176 . . . . 64.04 107.824 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -148.22 161.98 40.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.759 0.824 . . . . 71.0 110.297 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.02 19.68 75.66 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.761 0.663 . . . . 43.21 113.875 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' D' ' 93' ' ' GLN . 16.2 tt -135.45 149.91 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.817 -0.808 . . . . 73.43 108.817 -169.489 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.03 156.96 44.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.068 0.547 . . . . 72.22 111.689 -170.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 33.87 -96.17 0.01 OUTLIER Glycine 0 C--N 1.357 1.73 0 N-CA-C 117.094 1.598 . . . . 61.52 117.094 153.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 44.0 p -64.89 -50.63 65.77 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.98 0.912 . . . . 74.3 112.529 -173.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 93' ' ' GLN . . . . . 0.516 ' HG3' HD11 ' D' ' 89' ' ' ILE . 52.9 tp60 -79.78 -28.91 40.29 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 111.803 0.298 . . . . 73.5 111.803 -172.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -70.65 -34.02 71.59 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.746 -0.465 . . . . 74.31 109.746 176.416 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.47 ' HB1' HD22 ' G' ' 280' ' ' LEU . . . -59.92 -35.99 76.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.634 0.774 . . . . 55.34 110.727 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.14 -36.57 72.13 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.873 -1.058 . . . . 75.02 110.712 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -73.02 -52.22 15.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.006 0.522 . . . . 52.21 112.366 -173.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.0 pp -94.84 -20.47 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.04 0.536 . . . . 74.42 111.912 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.45 -6.84 60.91 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.72 -0.489 . . . . 62.33 113.721 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.85 -58.66 0.47 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.161 0.48 . . . . 41.15 111.402 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.5 -45.47 68.84 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.221 0.608 . . . . 75.15 112.547 -171.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -43.06 57.26 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 123.56 0.744 . . . . 64.33 111.426 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.88 -43.47 35.1 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.831 2.354 . . . . 71.31 113.906 163.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.28 -21.19 65.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.402 0.681 . . . . 70.34 112.285 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.78 -42.2 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.948 0.499 . . . . 72.22 110.532 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.493 HD12 HD23 ' D' ' 60' ' ' LEU . 74.3 mt -91.13 -20.92 21.49 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.888 0.699 . . . . 70.05 112.888 -170.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -65.85 -41.67 48.12 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.152 -0.927 . . . . 65.11 112.715 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.19 -40.35 69.41 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.383 2.055 . . . . 50.14 113.399 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -73.97 -36.39 64.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.748 0.819 . . . . 74.42 111.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.95 -45.09 83.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.003 0.521 . . . . 61.55 110.219 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -60.75 -46.05 91.94 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.575 -1.193 . . . . 72.32 110.46 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.92 -47.23 87.37 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.238 0.961 . . . . 74.14 110.779 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.99 -41.06 86.69 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.682 0.614 . . . . 65.32 110.945 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.651 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.8 mt -66.3 -47.95 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.496 0.718 . . . . 63.44 110.243 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.47 HG23 ' HB3' ' D' ' 125' ' ' GLN . 99.4 m -53.17 -46.82 69.08 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.489 1.116 . . . . 74.35 111.229 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.5 t -66.84 -41.7 86.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.071 -0.968 . . . . 63.04 110.731 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.479 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 77.2 mtm -67.8 -45.26 75.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.86 0.464 . . . . 65.53 112.185 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 -32.03 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.313 -0.858 . . . . 52.31 110.082 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.9 p -72.22 -33.67 67.76 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.917 0.487 . . . . 64.33 110.819 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtt-85 -68.26 -26.68 65.79 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.744 0.817 . . . . 72.02 110.917 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.0 10.46 65.63 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.615 0.572 . . . . 63.41 112.889 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.401 HG23 ' HB3' ' C' ' 17' ' ' TYR . 58.1 p 57.57 19.85 5.71 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 126.524 1.929 . . . . 75.2 113.248 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.603 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 63.7 m-85 -91.4 178.06 1.95 Allowed Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.487 1.515 . . . . 73.44 107.688 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 83.1 Cg_endo -74.82 160.79 40.22 Favored 'Trans proline' 0 C--N 1.39 2.75 0 CA-C-N 121.843 1.694 . . . . 74.33 112.434 -174.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.47 ' HB3' HG23 ' D' ' 115' ' ' THR . 15.9 mt-30 -66.34 128.12 34.91 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.287 -1.005 . . . . 65.41 108.287 166.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.99 91.55 4.17 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.433 -1.321 . . . . 74.05 107.433 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -103.88 93.31 4.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.089 -1.414 . . . . 65.12 108.323 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.87 127.89 34.22 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.196 -0.668 . . . . 73.31 109.196 174.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -56.24 134.32 75.42 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 124.269 0.981 . . . . 73.13 110.554 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 5.8 Cg_exo -73.63 96.67 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.702 2.268 . . . . 61.55 109.876 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.69 110.06 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.712 -1.218 . . . . 60.24 107.712 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -68.99 114.76 7.58 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.048 -0.978 . . . . 34.23 109.94 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -63.2 -36.63 84.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.01 111.356 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.14 -44.02 92.04 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.121 0.968 . . . . 70.25 110.217 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.88 67.36 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 114.961 -1.018 . . . . 74.45 110.313 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 79.8 mt -57.66 -40.23 78.85 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.758 0.423 . . . . 73.02 111.929 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -63.29 -52.6 61.32 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.895 -1.048 . . . . 70.2 110.728 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.6 ptp -73.64 -32.85 64.24 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.022 0.529 . . . . 70.43 111.007 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.664 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 4.7 m-80 -66.44 -32.5 73.91 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.776 0.83 . . . . 75.34 111.043 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -61.07 -39.24 89.13 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.452 0.47 . . . . 63.41 110.964 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.45 -37.64 31.56 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.173 0.589 . . . . 51.44 111.104 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.664 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 12.0 pt20 -89.6 0.58 56.83 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.758 0.651 . . . . 64.42 112.758 -171.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -119.29 87.56 2.76 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.426 -0.953 . . . . 72.44 108.426 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -145.48 103.27 3.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.439 -1.255 . . . . 72.31 107.99 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.37 141.68 19.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.012 0.925 . . . . 74.14 110.252 -174.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.61 -157.7 33.85 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.376 0.423 . . . . 61.13 112.31 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -163.24 122.78 2.15 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.954 -1.128 . . . . 64.43 107.954 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.69 82.0 1.12 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.691 -0.564 . . . . 54.03 111.691 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 49.4 m -58.75 129.38 41.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.623 0.769 . . . . 74.31 110.573 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -127.5 147.15 50.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.962 0.905 . . . . 74.43 108.568 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.67 -172.4 3.23 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.057 0.943 . . . . 75.31 110.255 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -134.76 105.28 6.37 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.735 -0.839 . . . . 74.54 108.735 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -62.51 111.65 2.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.302 0.641 . . . . 74.3 110.125 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -97.19 123.35 40.94 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.42 -0.956 . . . . 74.11 108.42 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.946 0 CA-C-O 118.484 -0.769 . . . . 44.04 109.632 -178.757 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.888 -0.412 . . . . 64.25 109.888 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -68.76 137.27 53.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.58 0.752 . . . . 74.23 109.758 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -77.59 74.63 4.15 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.632 0.73 . . . . 74.13 110.073 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -151.32 -0.38 0.36 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.778 -1.101 . . . . 55.14 109.472 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 56.6 84.03 0.21 Allowed Pre-proline 0 C--N 1.361 1.069 0 C-N-CA 124.7 1.2 . . . . 72.23 109.744 -170.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 276' ' ' PRO . . . . . 0.567 ' HG2' ' HB3' ' A' ' 90' ' ' GLU . 38.9 Cg_endo -66.6 77.91 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.003 2.469 . . . . 63.12 112.334 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 277' ' ' LEU . . . . . 0.42 ' HB2' HD22 ' E' ' 278' ' ' LEU . 62.2 mt -103.16 -63.46 1.17 Allowed 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 108.022 -1.103 . . . . 73.02 108.022 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 278' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' E' ' 277' ' ' LEU . 0.8 OUTLIER -96.5 87.2 4.34 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.316 -0.994 . . . . 53.42 108.316 176.482 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.98 -60.5 0.02 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.309 -0.717 . . . . 72.32 111.309 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 56.0 tp -88.29 61.66 6.31 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.838 0.855 . . . . 73.44 109.901 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -176.58 91.5 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.241 -0.89 . . . . 71.24 109.89 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -160.55 -55.64 0.05 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.261 -1.014 . . . . 64.12 108.261 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.4 125.45 49.12 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.26 -0.882 . . . . 71.31 109.511 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -120.1 81.81 0.34 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.413 -1.075 . . . . 51.14 110.413 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -77.87 71.55 4.35 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.592 0.711 . . . . 71.11 109.227 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 90.6 mtp -131.14 84.57 56.97 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.56 1.144 . . . . 70.31 108.757 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.36 90.83 0.99 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.801 2.334 . . . . 64.13 111.003 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.4 -46.82 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.69 0.796 . . . . 74.44 110.175 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 61.07 31.75 19.78 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.1 0.96 . . . . 74.44 111.075 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 69.4 m95 67.02 170.87 0.25 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.371 1.081 . . . . 74.41 112.618 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 3.1 mp -117.35 1.58 12.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.061 -1.427 . . . . 74.44 109.959 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -147.47 167.6 28.57 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 118.972 -0.904 . . . . 70.25 112.06 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.58 -75.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.371 2.714 . . . . 64.1 113.237 -175.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -123.77 -63.2 1.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.883 -0.784 . . . . 63.45 108.883 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 73.73 -55.5 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.373 1.469 . . . . 70.32 111.108 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 23.7 m -65.12 143.09 58.11 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.758 0.823 . . . . 53.34 110.18 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.764 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 16.7 m-30 68.97 26.4 5.72 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.097 1.359 . . . . 72.11 111.964 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -91.07 63.12 5.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.277 -1.008 . . . . 64.23 108.277 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 86.4 -151.59 24.56 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.454 -1.248 . . . . 72.33 113.372 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 300' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 124' ' ' PRO . 3.3 m-20 73.14 -63.52 0.43 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.213 1.805 . . . . 74.23 111.742 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 123' ' ' PHE . 20.0 pt -105.42 154.49 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.375 0.607 . . . . 63.13 111.608 -177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 302' ' ' ASP . . . . . 0.529 ' HA ' ' HZ2' ' A' ' 36' ' ' TRP . 21.7 t70 -157.54 -176.87 6.19 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.527 -1.215 . . . . 71.44 107.867 167.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -48.52 150.49 2.38 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 125.228 1.411 . . . . 72.33 113.023 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -53.18 124.08 14.76 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.403 2.735 . . . . 65.12 113.423 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 305' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' G' ' 295' ' ' ALA . . . -80.28 -64.53 1.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.034 0.934 . . . . 74.42 110.97 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 306' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 16.7 m -66.86 133.58 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.709 -0.678 . . . . 62.34 109.735 174.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 13.6 t -166.03 7.0 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.219 0.607 . . . . 63.51 110.95 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' E' E ' 308' ' ' CYS . . . . . 0.479 ' HB2' ' HG3' ' G' ' 293' ' ' PRO . 66.7 m -144.41 152.42 40.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.989 0.515 . . . . 71.43 111.074 -173.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 309' ' ' THR . . . . . 0.635 HG23 ' HB3' ' B' ' 12' ' ' GLN . 16.2 p -126.69 130.59 23.81 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.407 1.083 . . . . 54.25 109.614 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.376 1.983 0 C-N-CA 122.784 2.323 . . . . 72.24 111.451 177.031 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.924 0.392 . . . . 72.12 110.219 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -86.06 149.82 24.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.344 0.658 . . . . 74.13 109.289 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -88.8 -29.91 19.38 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.682 0.793 . . . . 71.53 111.887 -171.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.55 -74.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.432 1.493 . . . . 63.24 111.044 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 63.32 73.76 0.48 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.191 1.396 . . . . 70.32 110.267 -170.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -66.72 -38.47 17.98 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.819 2.346 . . . . 73.03 112.111 175.589 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 2.5 tt -149.36 69.43 1.05 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.468 -1.308 . . . . 74.44 107.468 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.503 HD22 HD11 ' C' ' 98' ' ' LEU . 96.4 mt -140.54 122.95 16.0 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.22 1.008 . . . . 61.43 109.249 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 279' ' ' GLY . . . . . 0.45 ' N ' ' SD ' ' C' ' 94' ' ' MET . . . -112.0 132.89 11.08 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-O 119.148 -0.807 . . . . 61.34 111.219 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . 0.28 2.3 pp 40.07 -127.32 0.4 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.229 1.812 . . . . 73.42 113.388 -175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 34.0 t80 72.41 31.81 1.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.917 1.287 . . . . 75.51 109.84 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -139.68 -86.22 0.22 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.799 -1.091 . . . . 41.42 108.237 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 54.91 26.88 8.35 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.524 1.129 . . . . 53.35 111.591 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 85.21 -73.27 2.64 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 109.824 -1.31 . . . . 62.51 109.824 -167.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -176.29 147.91 0.73 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.863 1.265 . . . . 73.52 108.512 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 53.7 ttm -93.91 100.91 5.29 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 108.65 -0.87 . . . . 72.51 108.65 171.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.66 91.15 1.21 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.525 2.15 . . . . 54.01 111.995 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 68.5 t -97.95 104.05 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.491 -0.929 . . . . 65.23 108.491 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -92.15 -90.44 0.17 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.984 -0.747 . . . . 74.13 108.984 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -140.18 155.91 46.74 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.401 0.62 . . . . 73.53 111.799 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' C' ' 129' ' ' ALA . 3.9 mp -92.81 -43.84 8.81 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.193 -1.367 . . . . 65.32 110.346 -173.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -151.31 -96.17 0.14 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 118.871 -0.96 . . . . 70.51 111.747 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.37 129.22 22.11 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.705 2.27 . . . . 73.21 112.46 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -115.34 -150.63 0.47 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.423 1.089 . . . . 74.15 109.12 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . 71.08 128.28 0.03 OUTLIER 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.053 1.341 . . . . 72.01 110.766 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 9.3 m -71.43 -53.32 14.41 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.332 0.587 . . . . 73.11 111.09 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.63 52.41 2.04 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.943 0.878 . . . . 73.42 108.657 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -65.65 -32.27 73.74 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 113.295 -1.775 . . . . 60.2 109.37 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.24 115.32 4.88 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 114.624 -1.171 . . . . 62.21 110.386 165.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -71.35 94.31 1.21 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.306 0.642 . . . . 43.44 110.354 -175.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.405 HD13 ' HD3' ' C' ' 124' ' ' PRO . 46.7 pt -81.14 15.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.15 0.58 . . . . 72.02 111.545 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -69.77 76.78 0.45 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.546 1.138 . . . . 74.34 110.902 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -153.41 139.84 12.58 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 126.065 1.746 . . . . 71.1 106.63 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -48.39 -42.58 34.24 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.914 2.409 . . . . 74.25 112.181 169.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 54.92 -91.83 0.03 OUTLIER 'General case' 0 C--N 1.361 1.099 0 C-N-CA 125.514 1.526 . . . . 64.35 112.383 171.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.37 110.35 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 108.49 -0.93 . . . . 73.55 108.49 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 9.6 t -179.62 -35.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.154 1.382 . . . . 72.22 108.443 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.51 42.07 1.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.332 1.053 . . . . 70.34 109.575 171.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' F' F ' 309' ' ' THR . . . . . 0.446 HG21 ' HD2' ' B' ' 130' ' ' PRO . 92.5 m -69.48 -51.74 16.05 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 114.21 -1.359 . . . . 75.43 112.182 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' F' F ' 310' ' ' PRO . . . . . 0.43 ' HD3' ' HB ' ' F' ' 309' ' ' THR . 13.2 Cg_exo . . . . . 0 C--N 1.394 2.96 0 C-N-CA 121.866 1.711 . . . . 72.31 111.284 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.244 -0.65 . . . . 75.51 109.244 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -68.71 94.29 0.58 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.667 -0.864 . . . . 71.24 108.667 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.51 43.26 1.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.451 1.119 . . . . 62.51 109.152 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -71.18 -33.69 70.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.503 -1.226 . . . . 74.14 110.514 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -88.15 127.48 57.17 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 109.08 -0.711 . . . . 73.44 109.08 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.22 -176.44 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.335 2.69 . . . . 74.44 113.508 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.438 HD23 ' O ' ' G' ' 277' ' ' LEU . 6.1 tt -74.47 -32.21 62.5 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.606 -0.724 . . . . 64.2 110.372 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 27.4 tp -112.01 111.02 21.64 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.693 -0.63 . . . . 73.44 109.381 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -150.9 -96.33 0.14 Allowed Glycine 0 C--N 1.351 1.384 0 N-CA-C 111.467 -0.653 . . . . 72.23 111.467 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.47 HD22 ' HB1' ' D' ' 95' ' ' ALA . 7.5 tt -65.38 115.87 6.1 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.589 -0.893 . . . . 73.23 108.589 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 281' ' ' PHE . . . . . 0.577 ' HZ ' HG13 ' D' ' 58' ' ' VAL . 2.9 t80 -125.53 102.44 7.38 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.327 -0.99 . . . . 65.33 108.327 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . 66.04 103.43 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.61 1.164 . . . . 62.44 111.528 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -132.2 161.35 33.61 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.384 0.673 . . . . 71.3 109.729 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 108.23 -23.14 25.73 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-O 119.38 -0.678 . . . . 73.23 112.18 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 50.37 80.61 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.92 1.288 . . . . 55.52 111.723 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 38.0 mtm -89.46 126.33 58.65 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.431 0.693 . . . . 71.43 109.527 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.04 -29.85 48.13 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.109 2.54 . . . . 74.15 113.004 -175.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 86.6 t 70.76 -66.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.646 1.578 . . . . 60.53 110.963 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 65.92 -93.59 0.03 OUTLIER 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.02 1.328 . . . . 74.01 109.15 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.464 ' HE1' HG23 ' D' ' 40' ' ' VAL . 0.0 OUTLIER 178.4 28.65 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.629 1.171 . . . . 74.41 108.86 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.411 HD23 HG22 ' E' ' 309' ' ' THR . 6.3 mp 63.03 -83.75 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.375 1.07 . . . . 63.34 109.706 -171.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -170.75 -77.37 0.04 OUTLIER Glycine 0 C--N 1.348 1.243 0 N-CA-C 111.342 -0.703 . . . . 44.41 111.342 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 293' ' ' PRO . . . . . 0.479 ' HG3' ' HB2' ' E' ' 308' ' ' CYS . 91.0 Cg_endo -78.43 71.19 6.92 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.267 2.644 . . . . 74.42 111.791 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 294' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' G' ' 295' ' ' ALA . 35.0 pttt -67.52 -82.07 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.239 1.016 . . . . 74.45 110.998 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 295' ' ' ALA . . . . . 0.537 ' HB3' ' HB1' ' E' ' 305' ' ' ALA . . . 52.58 39.63 28.48 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 124.474 1.11 . . . . 65.21 112.887 173.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 18.4 m -47.37 -42.9 22.69 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.429 1.492 . . . . 65.21 114.012 -167.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.648 ' HB2' ' HD2' ' D' ' 38' ' ' PRO . 0.3 OUTLIER -87.29 -69.29 0.69 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.069 -0.715 . . . . 74.41 109.069 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 55.48 24.11 6.49 Favored 'General case' 0 CA--C 1.569 1.674 0 O-C-N 124.74 1.275 . . . . 71.44 110.143 -168.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -81.57 119.07 4.76 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 114.917 -1.038 . . . . 74.52 111.836 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -81.15 52.44 1.8 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.092 0.957 . . . . 74.13 110.454 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' D' ' 32' ' ' PHE . 22.2 pt -72.45 152.42 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.194 0.998 . . . . 70.32 111.478 -174.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -154.28 169.09 24.48 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.689 0.795 . . . . 74.11 109.042 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -57.86 144.36 74.68 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 123.437 0.695 . . . . 53.35 110.444 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 304' ' ' PRO . . . . . 0.468 ' HG2' ' HB3' ' C' ' 14' ' ' GLN . 24.1 Cg_exo -65.41 122.46 10.16 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.427 2.084 . . . . 73.12 111.311 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -87.29 9.31 20.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.604 0.761 . . . . 71.25 111.438 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 20.1 t -77.19 95.02 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 108.073 -1.084 . . . . 72.15 108.073 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 10.4 t -124.64 0.43 8.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.471 0.708 . . . . 72.5 110.5 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 19.2 p -124.95 99.65 6.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.557 0.743 . . . . 71.12 110.388 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' G' G ' 309' ' ' THR . . . . . 0.435 ' N ' ' HD3' ' G' ' 310' ' ' PRO . 21.7 m -150.59 62.97 5.66 Favored Pre-proline 0 CA--C 1.564 1.51 0 N-CA-C 108.7 -0.852 . . . . 62.13 108.7 165.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' G' G ' 310' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' G' ' 309' ' ' THR . 58.9 Cg_endo . . . . . 0 C--N 1.385 2.473 0 C-N-CA 123.472 2.781 . . . . 72.34 111.981 172.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.796 -0.446 . . . . 64.2 109.796 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -75.28 144.56 42.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.591 0.756 . . . . 73.53 109.919 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -81.57 146.8 29.95 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.595 0.758 . . . . 62.5 110.805 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -74.44 133.98 42.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.558 0.743 . . . . 74.34 110.055 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -151.1 110.88 3.06 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 123.482 0.489 . . . . 52.41 109.97 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.72 -164.79 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.555 2.17 . . . . 63.32 110.168 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 277' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' B' ' 90' ' ' GLU . 6.5 tt 78.34 -47.97 0.45 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 124.409 1.084 . . . . 73.2 110.067 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 278' ' ' LEU . . . . . 0.482 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 1.6 tm? -50.04 -59.39 3.94 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.156 1.382 . . . . 71.34 109.748 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 75.43 -79.1 1.09 Allowed Glycine 0 C--N 1.352 1.417 0 CA-C-N 115.267 -0.879 . . . . 71.43 112.27 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 280' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' B' ' 92' ' ' THR . 2.3 pt? -143.83 146.55 33.15 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.291 1.036 . . . . 71.34 109.193 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -96.58 -178.11 4.15 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.478 -0.783 . . . . 71.21 109.229 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.9 81.99 0.2 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.881 0.872 . . . . 75.33 110.906 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -123.33 154.21 39.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.021 0.928 . . . . 71.54 108.59 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 133.61 -22.92 3.84 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 111.299 -0.72 . . . . 35.1 111.299 -173.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 60.57 88.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.749 1.22 . . . . 53.33 111.012 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 286' ' ' MET . . . . . 0.528 ' SD ' HD12 ' B' ' 136' ' ' LEU . 62.6 mtm -81.1 109.76 15.08 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 109.284 -0.635 . . . . 71.45 109.284 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.41 87.57 1.07 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.905 2.404 . . . . 74.43 111.241 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.21 -38.44 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.716 -0.674 . . . . 72.25 109.641 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 59.08 33.14 22.74 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.172 1.389 . . . . 75.03 111.207 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 43.0 m95 65.53 162.45 0.14 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.075 1.35 . . . . 75.14 112.163 -170.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . 0.5 OUTLIER -117.88 11.81 13.61 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.969 -1.014 . . . . 74.22 109.091 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 169.75 70.65 0.04 OUTLIER Glycine 0 C--N 1.342 0.893 0 N-CA-C 109.74 -1.344 . . . . 73.42 109.74 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.58 -21.77 59.14 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.185 2.59 . . . . 73.11 113.092 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -95.23 0.8 54.31 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.89 1.276 . . . . 73.45 112.299 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.48 12.51 18.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.72 0.808 . . . . 74.22 111.567 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 296' ' ' THR . . . . . 0.526 HG23 ' HB3' ' B' ' 126' ' ' LEU . 20.6 m -78.1 -82.44 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.557 0.743 . . . . 64.41 110.65 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.641 ' HA ' ' HB2' ' B' ' 124' ' ' PRO . 3.3 m-30 -84.09 102.0 12.21 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 121.758 -0.589 . . . . 74.35 109.547 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -77.88 -11.31 59.88 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.527 -1.215 . . . . 72.23 109.904 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 91.94 169.77 41.26 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.673 -0.694 . . . . 24.31 111.559 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 66.0 t30 173.81 -27.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.275 1.43 . . . . 75.53 108.844 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.9 104.99 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.113 0.965 . . . . 64.22 110.444 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -168.39 98.21 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.102 -1.814 . . . . 73.15 106.102 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt 61.52 74.17 0.52 Allowed Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 107.677 -1.231 . . . . 72.13 107.677 -162.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.78 4.46 6.69 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.634 2.89 . . . . 72.05 113.624 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -127.09 138.39 53.19 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.797 0.839 . . . . 74.44 109.234 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 15.5 m -71.27 119.92 18.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.811 -0.811 . . . . 73.44 108.811 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 40.5 p -74.23 89.84 2.05 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.342 -0.845 . . . . 74.4 109.839 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 63.4 m 71.35 108.32 0.06 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.378 1.471 . . . . 73.41 112.153 175.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 4.7 p -79.92 157.79 73.49 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.593 1.157 . . . . 62.14 110.073 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.387 2.595 0 C-N-CA 123.667 2.912 . . . . 71.41 114.111 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.402 -0.592 . . . . 75.12 109.402 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m -81.9 145.97 30.06 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.999 0.92 . . . . 73.34 110.302 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 76.97 -4.02 2.42 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.441 1.496 . . . . 74.41 112.647 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -86.8 68.59 10.16 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.944 0.498 . . . . 75.24 110.841 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -103.93 177.32 4.88 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.9 0.88 . . . . 71.02 110.441 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.8 t30 62.27 14.86 7.1 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.608 1.163 . . . . 73.33 111.558 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -100.89 23.67 10.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.605 1.162 . . . . 72.55 109.038 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.76 -160.4 0.84 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.078 1.351 . . . . 63.43 109.637 -167.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.551 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 4.5 ppp? -71.43 158.5 36.19 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.011 0.524 . . . . 74.24 111.017 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m -142.03 135.78 29.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.089 0.556 . . . . 74.31 110.163 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.7 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 7.1 t80 -120.09 134.71 55.18 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.457 1.103 . . . . 72.45 108.488 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -155.28 117.17 4.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.978 -0.749 . . . . 61.42 108.978 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.57 HG21 ' HG2' ' C' ' 130' ' ' PRO . 24.4 mt -76.8 124.17 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.892 -0.41 . . . . 74.35 109.892 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.9 tp60 -81.68 -43.65 18.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.775 0.83 . . . . 71.32 110.858 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -173.4 131.57 0.46 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.248 -0.278 . . . . 53.24 110.248 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -116.75 138.31 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.716 0.806 . . . . 71.22 108.867 174.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -171.19 166.48 7.21 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.775 0.798 . . . . 73.33 111.082 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -95.51 119.43 34.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.947 -1.024 . . . . 73.31 108.895 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.507 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 38.6 mtpt -82.71 -28.38 30.56 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.642 0.377 . . . . 54.51 110.125 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.21 145.95 21.05 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.062 -0.972 . . . . 52.54 109.631 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.9 mt -134.65 134.84 54.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.981 1.312 . . . . 64.22 107.652 176.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -136.18 123.84 22.38 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.49 -1.3 . . . . 71.01 107.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 84.5 t80 -136.85 126.5 25.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.896 -1.52 . . . . 74.04 106.896 173.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.4 139.12 43.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.824 -0.435 . . . . 74.24 109.824 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.22 70.59 9.98 Favored Pre-proline 0 C--O 1.245 0.833 0 N-CA-C 107.777 -1.194 . . . . 41.34 107.777 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.59 -21.98 38.79 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.226 1.95 . . . . 73.04 111.744 -173.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -118.33 23.42 11.57 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.825 0.85 . . . . 63.21 109.77 -177.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.589 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -48.22 -54.56 24.21 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-O 118.318 -0.849 . . . . 62.15 113.222 -175.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.28 -34.25 97.98 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.536 2.157 . . . . 55.21 112.716 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.1 m80 -70.8 -42.02 70.84 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.456 -0.793 . . . . 73.33 110.148 -179.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.87 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.78 -28.56 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.364 -0.835 . . . . 72.32 111.596 -170.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -60.85 -33.31 72.86 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.472 0.483 . . . . 64.03 112.019 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -88.83 -15.89 33.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.596 0.358 . . . . 74.32 111.541 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -68.01 163.89 21.25 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.328 0.585 . . . . 75.34 111.408 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.96 149.01 50.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.085 -0.961 . . . . 75.42 109.973 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -83.36 63.76 7.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.319 0.648 . . . . 75.04 109.955 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -148.05 70.19 11.0 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.597 0.759 . . . . 75.0 109.986 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -92.35 166.92 2.91 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.269 1.979 . . . . 65.23 111.585 163.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.5 104.4 16.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.336 -1.357 . . . . 73.1 107.336 167.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 66' ' ' ALA . 85.1 t -85.06 95.36 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.937 -0.764 . . . . 63.45 108.937 175.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -87.8 115.24 25.12 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.897 -0.779 . . . . 70.42 108.897 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mp -103.09 120.72 41.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.417 -0.586 . . . . 62.13 109.417 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.01 136.5 42.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.376 1.071 . . . . 73.12 108.583 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' E' ' 286' ' ' MET . 34.0 tp -114.56 118.83 34.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.108 -1.071 . . . . 72.23 108.108 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 29.5 t70 -128.73 147.5 50.77 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.979 0.912 . . . . 71.1 108.969 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -149.15 136.92 20.45 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.242 -1.021 . . . . 71.34 108.242 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.25 134.5 38.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 63.41 109.01 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -129.26 151.44 49.91 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.616 0.644 . . . . 75.21 110.874 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -164.92 133.02 3.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.765 0.826 . . . . 73.14 109.767 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 48.3 tt0 -79.01 119.49 22.23 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.692 0.397 . . . . 72.52 110.933 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 57' ' ' GLU . 79.6 mt -84.07 -43.12 15.4 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.725 0.81 . . . . 60.12 111.281 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.9 -179.76 7.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.609 0.764 . . . . 65.42 110.012 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.24 116.73 5.25 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.252 -0.647 . . . . 73.31 109.252 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 68.25 19.36 9.07 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.564 1.145 . . . . 74.31 111.991 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.51 120.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.152 0.981 . . . . 50.44 108.758 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.526 ' HE2' HD12 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -128.46 171.13 12.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.328 -0.619 . . . . 71.01 109.328 169.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.2 tt0 -127.89 133.28 49.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.37 1.068 . . . . 75.05 108.253 176.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.4 121.4 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.031 -1.099 . . . . 73.35 108.031 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 56.2 t -97.85 136.85 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.503 1.121 . . . . 71.53 108.86 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HB2' HD13 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -116.03 99.71 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.327 -1.36 . . . . 72.33 107.327 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.3 ttp180 -89.05 101.83 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.106 -0.701 . . . . 72.5 109.106 174.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.2 t -93.6 127.76 45.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.8 -1.556 . . . . 72.41 106.8 170.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 77' ' ' GLU . 11.1 m -117.46 130.84 56.71 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.147 -0.686 . . . . 71.55 109.147 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.8 t -120.37 107.28 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.745 -1.206 . . . . 71.23 107.745 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.7 m -111.68 134.45 53.24 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.846 -0.798 . . . . 71.21 108.846 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -124.88 126.64 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.663 -1.236 . . . . 44.14 107.663 173.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -141.32 128.49 20.91 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.313 -0.625 . . . . 74.34 109.313 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.05 86.03 2.79 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.804 -1.184 . . . . 52.34 107.804 173.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -126.12 7.49 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.92 -1.036 . . . . 63.15 110.825 -171.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.36 -26.51 22.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.274 0.63 . . . . 71.31 110.452 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -77.78 120.16 22.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.584 0.353 . . . . 61.33 110.303 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -79.66 130.5 35.42 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.47 0.708 . . . . 72.14 110.163 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.87 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.96 -62.14 1.6 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.609 0.764 . . . . 62.33 110.485 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.479 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 39.0 p90 -160.25 171.03 19.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.127 -0.942 . . . . 63.32 111.332 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -138.14 131.88 31.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.995 -1.457 . . . . 72.5 107.443 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.8 m -135.51 97.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.748 0.819 . . . . 75.32 109.196 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.49 ' HB2' HG23 ' A' ' 63' ' ' THR . 42.0 tt0 -123.26 116.34 23.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.264 -1.014 . . . . 73.42 108.264 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.21 121.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.195 -0.669 . . . . 52.13 109.195 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 84.41 6.13 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.512 -0.922 . . . . 64.41 108.512 173.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -79.01 94.24 5.25 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.051 -0.977 . . . . 75.2 109.207 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.62 142.37 20.16 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.465 -0.654 . . . . 73.44 111.465 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.03 120.82 1.52 Allowed Glycine 0 CA--C 1.502 -0.736 0 N-CA-C 109.929 -1.269 . . . . 74.32 109.929 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -83.14 125.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.671 -0.863 . . . . 65.04 108.671 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.7 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.8 m-85 -124.63 127.39 47.26 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 109.297 -0.631 . . . . 63.53 109.297 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.9 t -83.82 119.1 24.43 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.394 0.678 . . . . 73.3 109.344 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.526 HD12 ' HE2' ' A' ' 56' ' ' TYR . 12.9 tt -103.4 146.59 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.194 0.997 . . . . 75.4 109.486 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 157.47 18.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.414 0.686 . . . . 74.12 109.892 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 84.29 -33.25 3.2 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.846 0.716 . . . . 61.45 114.413 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 9' ' ' MET . 2.8 pp -128.78 164.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 117.571 0.685 . . . . 71.41 112.469 -172.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.48 -179.97 6.34 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.015 0.926 . . . . 72.25 109.545 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.47 22.36 Favored Glycine 0 N--CA 1.478 1.476 0 C-N-CA 123.116 0.389 . . . . 60.1 113.829 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -66.94 -28.24 68.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.947 1.299 . . . . 73.21 111.659 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -64.11 -51.31 64.58 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.35 -0.841 . . . . 63.04 110.322 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -73.93 -28.28 61.44 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.222 -0.899 . . . . 74.53 110.666 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.78 92.37 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.282 0.563 . . . . 73.32 111.0 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 39.2 t-80 -69.57 -36.49 76.32 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.154 -0.93 . . . . 72.32 110.036 173.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 23.7 t -73.68 -27.17 61.09 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.88 0.472 . . . . 74.12 111.276 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.06 -42.19 14.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.989 0.916 . . . . 74.32 110.988 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.09 4.78 52.49 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.59 0.556 . . . . 50.32 114.132 -168.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.819 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.51 -60.13 0.24 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 117.627 0.714 . . . . 63.22 112.493 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.6 t80 -68.2 -62.12 1.54 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.154 0.981 . . . . 53.12 112.125 -170.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 97.8 m -69.06 -32.85 3.61 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 114.315 1.228 . . . . 60.25 114.315 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.92 -42.74 20.22 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.985 2.456 . . . . 71.15 113.713 164.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.44 -26.19 64.48 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.762 0.825 . . . . 72.04 111.485 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -72.39 -45.34 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.599 0.76 . . . . 74.53 109.743 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 60' ' ' LEU . 48.9 mt -70.85 -35.68 72.53 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.409 -1.269 . . . . 71.11 112.394 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -59.75 -43.05 94.34 Favored Pre-proline 0 CA--C 1.572 1.791 0 C-N-CA 124.701 1.2 . . . . 74.01 114.227 -167.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -59.41 -37.34 90.51 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.27 1.98 . . . . 73.44 113.487 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.47 -35.92 68.34 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.294 0.638 . . . . 75.43 111.863 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.97 94.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 60.43 109.515 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -63.05 -35.83 81.54 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 124.287 0.992 . . . . 71.43 110.309 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 22.2 tt0 -56.64 -56.37 22.21 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.624 0.77 . . . . 75.15 110.91 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -63.35 -45.02 93.12 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 114.397 -1.274 . . . . 64.44 110.766 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 118' ' ' VAL . 66.2 mt -62.93 -59.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 123.987 0.804 . . . . 72.14 110.775 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.4 m -56.77 -32.8 65.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.181 0.593 . . . . 53.23 111.966 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.0 t -68.52 -46.45 69.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.86 -0.609 . . . . 52.4 110.529 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.402 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mtp -58.37 -42.87 87.95 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 75.33 111.049 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.3 t -62.3 -44.64 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.419 1.087 . . . . 74.1 110.225 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -73.56 -29.96 62.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.355 -0.384 . . . . 74.03 111.3 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -68.3 -37.12 80.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.418 0.687 . . . . 74.13 109.815 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.97 -3.42 89.39 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.811 -0.631 . . . . 72.21 113.033 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.78 HG21 HE21 ' D' ' 125' ' ' GLN . 24.3 p 54.56 48.8 19.62 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.167 1.787 . . . . 75.05 111.572 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.599 ' HA ' HD13 ' E' ' 301' ' ' ILE . 74.5 m-85 -104.56 154.41 38.47 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 113.807 -1.542 . . . . 74.23 108.43 169.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.5 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 26.4 Cg_exo -59.75 131.32 39.28 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.335 2.023 . . . . 75.14 110.615 -172.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -47.84 133.69 13.91 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.472 1.108 . . . . 62.51 111.785 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.8 tp -107.17 110.31 22.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.296 -0.631 . . . . 71.51 109.296 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.67 84.02 1.95 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.851 -1.537 . . . . 71.42 106.851 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.5 tp -71.7 128.81 36.99 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.092 -0.958 . . . . 72.32 109.623 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -52.97 131.57 49.43 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 124.689 1.243 . . . . 54.14 111.517 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 3.4 Cg_endo -77.47 116.25 4.06 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.265 1.977 . . . . 65.53 109.866 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.41 123.96 53.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.643 -0.873 . . . . 63.21 108.643 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -76.79 86.83 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.211 -1.033 . . . . 71.03 108.211 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.994 . . . . 73.34 110.662 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 t70 -65.42 -44.21 88.13 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.984 -1.007 . . . . 74.42 110.426 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.79 94.64 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.357 -0.838 . . . . 63.15 111.182 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.28 -48.3 80.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.236 0.614 . . . . 53.23 111.223 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -67.37 -31.18 71.24 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.161 -0.927 . . . . 71.31 110.427 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.4 tpp -69.45 -41.95 75.58 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.055 0.542 . . . . 65.44 110.506 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.57 -26.5 68.62 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.724 0.809 . . . . 70.31 110.933 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -90.87 -31.83 16.28 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.776 0.83 . . . . 53.25 111.457 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.18 -45.58 92.77 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.112 0.965 . . . . 75.44 110.528 -172.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLN . . . . . 0.46 HE21 ' HA2' ' C' ' 146' ' ' GLY . 8.0 pt20 173.57 -13.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 125.942 1.697 . . . . 54.04 110.122 167.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 63.05 31.18 16.1 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 124.269 1.027 . . . . 74.41 110.387 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -149.97 144.83 26.1 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.921 -0.581 . . . . 73.13 109.724 -170.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.93 143.65 31.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.511 0.724 . . . . 33.42 110.461 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.34 118.69 5.85 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.147 -0.781 . . . . 35.22 111.147 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -80.51 134.58 35.97 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 117.17 0.485 . . . . 70.11 110.726 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.8 121.46 7.12 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.662 -0.575 . . . . 75.42 111.662 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.0 m -82.8 135.44 34.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.63 0.772 . . . . 72.32 110.459 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.06 178.59 5.55 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.634 0.773 . . . . 72.3 110.932 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -153.59 110.18 3.37 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.054 -0.721 . . . . 63.31 109.054 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -112.63 131.19 55.75 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.16 -0.682 . . . . 72.14 109.16 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -106.39 120.51 42.08 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.988 -1.116 . . . . 51.51 107.988 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.49 134.88 37.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.934 0.494 . . . . 72.25 109.754 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 C-N-CA 123.137 0.575 . . . . 44.2 110.401 -177.251 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tmm? . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.472 -0.566 . . . . 72.23 109.472 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.0 t -153.83 130.58 10.82 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.34 0.656 . . . . 73.02 109.735 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -95.29 100.72 12.46 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.602 -0.888 . . . . 72.42 108.602 173.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -84.41 171.58 12.48 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.714 -0.476 . . . . 72.1 109.714 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -64.63 131.12 46.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.951 0.501 . . . . 71.11 110.613 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -65.14 156.74 30.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.406 0.682 . . . . 70.15 111.027 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 61.4 m -72.28 151.14 43.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.61 0.764 . . . . 63.02 110.023 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' B' ' 9' ' ' MET . 35.1 mt-10 -64.64 -175.06 0.16 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.083 0.953 . . . . 73.42 111.655 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.0 OUTLIER 51.38 -150.98 0.26 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.145 1.378 . . . . 63.23 110.146 -171.05 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.591 ' N ' ' SD ' ' B' ' 9' ' ' MET . 90.7 m -152.78 128.6 10.22 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.922 1.237 . . . . 72.25 110.11 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.548 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 47.9 t80 -151.06 113.76 4.69 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.905 -0.776 . . . . 74.23 108.905 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -142.11 137.63 31.09 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.37 0.668 . . . . 72.3 109.935 170.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.508 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -82.3 128.0 39.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.825 -0.805 . . . . 74.24 108.825 174.182 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' E' ' 305' ' ' ALA . 11.9 mm-40 -98.39 -43.62 6.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.015 -0.539 . . . . 74.53 110.075 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.535 HH22 ' HB ' ' E' ' 301' ' ' ILE . 23.2 ttt180 -164.33 130.93 3.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.517 -0.31 . . . . 72.43 110.574 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -115.86 127.9 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.545 1.138 . . . . 72.32 108.902 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -162.49 147.59 12.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.982 0.42 . . . . 72.25 111.869 -171.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.6 m -73.95 123.42 24.25 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.984 0.913 . . . . 70.34 109.367 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -98.96 -27.56 13.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.098 0.559 . . . . 71.03 111.506 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.2 t70 -156.67 144.53 19.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.316 0.246 . . . . 72.13 110.641 -170.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 36.2 mm -144.66 141.43 23.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.326 1.451 . . . . 72.14 108.251 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -145.61 109.36 4.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 124.103 0.877 . . . . 74.45 108.699 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.0 t80 -118.0 117.48 29.34 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 107.186 -1.413 . . . . 75.24 107.186 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 39.3 mt-10 -119.95 133.01 55.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.372 0.669 . . . . 63.22 109.404 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.41 83.33 66.46 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.664 -1.236 . . . . 32.22 107.664 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -66.23 -29.53 46.88 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.902 2.402 . . . . 71.14 112.167 -174.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -108.43 21.06 17.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 74.53 110.877 -177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -44.44 -57.67 6.21 Favored Pre-proline 0 CA--C 1.582 2.193 0 N-CA-C 114.743 1.386 . . . . 74.35 114.743 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 71.0 Cg_endo -80.24 -26.92 3.89 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 122.302 2.001 . . . . 64.34 113.11 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 2.3 m-70 -93.99 1.13 56.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.545 0.738 . . . . 71.44 112.344 -171.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.67 -28.1 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.036 0.534 . . . . 72.23 111.686 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -53.69 -26.02 20.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.589 1.156 . . . . 61.3 113.365 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 25.0 pt20 -66.6 -52.45 45.19 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.338 0.255 . . . . 72.35 110.781 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -118.13 68.15 0.77 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 123.552 0.741 . . . . 44.42 110.167 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.44 ' O ' ' HE3' ' B' ' 36' ' ' TRP . 11.0 t70 -98.53 118.16 34.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 106.932 -1.507 . . . . 75.22 106.932 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.44 ' HE3' ' O ' ' B' ' 35' ' ' ASP . 2.2 t-105 -176.1 175.29 1.93 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.832 -1.173 . . . . 72.14 107.832 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.55 112.07 3.81 Favored Pre-proline 0 CA--C 1.56 1.359 0 O-C-N 123.582 0.552 . . . . 73.53 110.996 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.77 164.84 15.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.62 2.213 . . . . 72.32 112.388 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.09 101.94 4.07 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.185 -1.042 . . . . 71.32 108.185 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.09 146.43 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.407 -0.815 . . . . 72.03 108.931 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.57 133.07 32.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.121 0.969 . . . . 74.04 109.307 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.482 HD21 HD11 ' B' ' 128' ' ' LEU . 4.6 mp -90.97 150.1 21.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.346 -0.843 . . . . 61.43 108.953 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.592 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.3 t70 -158.99 154.58 26.04 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.419 -0.956 . . . . 74.03 108.419 172.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.2 154.55 48.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.002 0.521 . . . . 74.24 110.582 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.5 t70 -140.02 124.62 18.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.419 -1.326 . . . . 53.12 107.419 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -110.21 104.76 13.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.023 0.929 . . . . 74.41 109.741 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.24 155.39 45.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.97 0.908 . . . . 41.44 109.984 -175.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.6 m -144.11 172.64 12.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.296 0.639 . . . . 62.44 110.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.0 p -151.76 134.88 15.85 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.11 0.964 . . . . 63.11 108.647 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -84.47 114.68 22.1 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.86 -0.422 . . . . 74.33 109.86 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -80.49 -45.72 17.05 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.447 -0.575 . . . . 72.43 109.447 173.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.48 -173.43 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.666 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.14 119.43 18.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.872 . . . . 75.05 109.968 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 71.45 -6.4 1.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 125.965 1.706 . . . . 75.12 112.668 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -104.99 104.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 108.08 -1.082 . . . . 73.32 108.08 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.82 137.96 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -101.16 101.51 12.25 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.017 -1.475 . . . . 70.23 107.017 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.33 123.18 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.074 0.949 . . . . 33.24 109.879 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.446 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.0 t -102.95 144.4 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.085 0.954 . . . . 54.12 109.417 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' B' ' 103' ' ' PRO . 61.0 tp -129.77 115.02 16.68 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.555 -0.905 . . . . 55.12 108.555 170.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.583 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 37.3 ttm180 -92.85 125.86 37.65 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.373 -0.603 . . . . 70.33 109.373 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 92.9 t -111.25 104.55 17.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.305 -1.369 . . . . 64.44 107.305 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 36.4 m -97.0 136.96 36.82 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.481 -0.781 . . . . 65.21 109.437 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.11 129.32 67.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.947 -1.024 . . . . 73.54 108.476 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.5 m -124.82 137.87 54.29 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.406 0.682 . . . . 71.11 109.408 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.51 143.4 35.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.034 0.534 . . . . 65.22 109.63 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -158.09 140.37 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.698 0.624 . . . . 71.32 111.362 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.2 mp -103.24 118.92 37.87 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.45 -0.944 . . . . 33.44 108.45 167.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.63 -141.77 39.18 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.587 0.554 . . . . 75.31 112.882 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 9.43 12.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.327 1.051 . . . . 74.02 111.875 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -127.41 143.35 51.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.545 0.738 . . . . 73.31 110.147 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -70.78 140.47 51.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.574 0.75 . . . . 70.35 110.855 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -90.99 -62.58 1.42 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.97 0.908 . . . . 61.54 108.744 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -156.29 167.02 31.73 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.572 -1.195 . . . . 64.43 109.144 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.3 mt -137.08 131.03 32.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.802 -1.555 . . . . 62.42 106.802 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 37.7 t -141.33 132.7 26.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.759 -0.83 . . . . 53.1 108.759 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -154.19 135.37 13.99 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.009 -0.737 . . . . 72.2 109.009 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' B' ' 113' ' ' CYS . 61.9 t -133.33 146.44 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.637 0.775 . . . . 63.41 109.019 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -119.48 95.93 4.99 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.405 -1.331 . . . . 71.41 107.405 168.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -85.19 104.57 15.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.69 -0.855 . . . . 75.11 108.69 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.68 159.85 29.66 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 123.927 0.767 . . . . 75.33 111.186 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.29 126.34 1.57 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.922 -0.871 . . . . 64.31 110.922 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.26 119.11 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.12 -1.067 . . . . 75.22 108.12 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.11 134.26 54.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.752 0.821 . . . . 74.42 108.892 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -92.36 97.17 10.7 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.4 -0.963 . . . . 64.22 108.4 168.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.16 139.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.194 -0.912 . . . . 62.45 110.421 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.1 160.92 39.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.014 0.926 . . . . 71.23 109.555 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.95 -31.9 4.2 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.398 0.436 . . . . 72.12 114.072 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.405 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -75.63 136.5 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.296 0.638 . . . . 72.2 111.048 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.91 151.62 16.45 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.717 0.807 . . . . 63.51 109.695 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.54 -110.37 3.32 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 123.614 0.626 . . . . 44.43 113.189 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -74.59 -42.9 57.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.826 0.822 . . . . 72.22 110.088 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -67.64 -32.6 73.42 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.977 -1.465 . . . . 74.24 111.206 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.3 ptm -68.47 -37.37 80.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.957 -0.565 . . . . 74.23 110.748 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.88 -26.73 64.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.522 0.729 . . . . 63.42 110.721 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.416 ' HD2' ' HB2' ' B' ' 137' ' ' PHE . 41.9 t-80 -89.39 -19.3 25.37 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.354 0.662 . . . . 54.45 110.839 175.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.5 t -86.69 -70.17 0.63 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.497 0.319 . . . . 33.43 111.436 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.516 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.2 pp -80.43 -24.83 39.32 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.431 0.292 . . . . 64.13 111.478 -175.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.29 1.82 56.18 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-O 119.66 -0.522 . . . . 64.13 114.153 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.739 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -143.03 -53.08 0.38 Allowed 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.548 0.674 . . . . 52.11 111.827 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -75.34 -45.17 41.11 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.086 0.554 . . . . 74.25 112.075 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.548 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 56.0 m -65.97 -43.71 58.7 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.161 0.584 . . . . 65.11 111.82 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HA ' HD22 ' B' ' 60' ' ' LEU . 65.2 Cg_exo -48.42 -42.97 33.89 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.868 2.378 . . . . 75.54 114.295 167.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -61.31 -30.24 70.37 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.552 0.741 . . . . 75.24 112.64 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.89 -43.79 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.152 0.581 . . . . 72.52 110.635 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.42 -20.5 47.4 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.062 -0.517 . . . . 64.43 111.571 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -61.15 -49.35 88.81 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.892 -1.052 . . . . 61.35 113.275 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.9 -46.38 30.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.938 2.426 . . . . 63.54 113.841 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -67.16 -44.88 78.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 71.43 111.32 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.58 96.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.284 0.634 . . . . 74.41 110.979 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 8.7 ttp-105 -71.75 -44.86 63.36 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.086 -0.961 . . . . 71.45 110.743 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.97 -34.04 77.47 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.872 0.732 . . . . 74.42 110.166 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.493 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.5 t -68.79 -36.5 78.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 122.877 0.471 . . . . 73.13 110.86 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.527 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 62.0 mt -62.84 -48.92 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.255 0.622 . . . . 74.41 109.773 172.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -62.03 -32.17 72.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.678 0.791 . . . . 74.13 111.527 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 30.9 t -65.78 -46.55 78.31 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.633 -0.712 . . . . 44.02 110.238 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -72.94 -38.1 66.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.802 0.441 . . . . 75.51 111.329 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.45 -38.49 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.396 0.678 . . . . 62.35 110.339 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -68.05 -34.58 76.72 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.892 -1.049 . . . . 63.24 111.19 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -71.27 -26.79 63.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.914 0.486 . . . . 73.12 110.458 176.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.92 1.39 63.17 Favored Glycine 0 C--N 1.358 1.796 0 O-C-N 123.446 0.467 . . . . 53.54 112.59 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 41.5 p 62.73 49.54 3.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.915 2.086 . . . . 74.12 112.22 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -119.98 154.46 55.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.393 -1.276 . . . . 75.25 109.924 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.37 -169.96 0.12 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.581 2.854 . . . . 74.33 114.143 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 15.4 tp60 -57.34 124.26 18.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.448 1.099 . . . . 72.22 112.771 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -141.49 83.35 1.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.864 -0.791 . . . . 71.25 108.864 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -104.5 131.42 51.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.385 -1.339 . . . . 72.14 107.385 165.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.482 HD11 HD21 ' B' ' 42' ' ' LEU . 33.1 tp -70.74 149.74 46.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.091 0.557 . . . . 43.41 110.253 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.2 149.4 87.05 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.894 0.878 . . . . 54.33 111.898 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.447 ' HG3' HD12 ' D' ' 16' ' ' ILE . 20.4 Cg_exo -63.45 93.51 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.925 2.417 . . . . 72.42 111.825 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 t -92.0 110.07 22.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.301 -1.0 . . . . 71.34 108.301 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -92.75 88.25 6.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.026 -1.101 . . . . 74.04 108.026 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -61.36 -37.32 82.95 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.037 -0.983 . . . . 73.14 110.298 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.739 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 15.5 t70 -59.67 -44.75 93.46 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.794 -1.093 . . . . 60.23 111.768 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.27 -33.0 72.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.173 0.589 . . . . 60.21 111.446 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.23 -55.03 39.97 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.327 0.651 . . . . 62.13 109.806 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 137' ' ' PHE . . . . . 0.416 ' HB2' ' HD2' ' B' ' 96' ' ' HIS . 89.1 m-85 -68.31 -31.76 71.42 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.732 -0.667 . . . . 73.3 111.343 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 55.2 ttm -64.78 -37.76 88.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.493 0.317 . . . . 42.25 111.184 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -75.22 -28.16 59.82 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.812 0.445 . . . . 75.12 110.779 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -69.11 -36.3 77.37 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.037 0.446 . . . . 70.14 110.196 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.6 mt -93.86 -5.35 48.24 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.555 0.742 . . . . 61.35 111.304 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -77.0 93.1 3.77 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.098 0.559 . . . . 54.41 109.797 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -138.74 -28.87 0.8 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.108 0.963 . . . . 75.4 109.059 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -83.35 126.46 32.74 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.775 -0.648 . . . . 73.4 110.431 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.78 3.55 54.88 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.255 1.022 . . . . 65.32 111.324 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 100.92 153.87 26.61 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 111.819 -0.512 . . . . 44.53 111.819 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.85 139.59 50.9 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.762 0.425 . . . . 71.23 110.153 175.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.72 147.6 18.73 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 123.807 0.692 . . . . 72.4 112.282 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 72.8 p -93.71 -159.97 0.73 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.216 1.006 . . . . 74.24 109.227 172.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.29 177.58 5.33 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.496 -0.927 . . . . 73.22 108.496 163.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -165.24 157.28 15.25 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.308 0.575 . . . . 74.23 111.691 172.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -147.91 92.99 2.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.203 -1.406 . . . . 64.44 107.203 165.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -78.36 110.3 13.27 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.132 0.573 . . . . 61.5 109.704 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -102.68 169.65 8.5 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.884 0.874 . . . . 62.53 110.539 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.907 1.283 . . . . 73.44 111.131 174.581 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.738 -0.468 . . . . 64.41 109.738 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 60.2 m -156.29 169.47 24.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.202 1.001 . . . . 60.43 109.748 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.32 73.39 8.36 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 122.12 0.962 . . . . 72.11 109.119 170.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -77.22 126.7 31.36 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.228 -0.896 . . . . 71.22 109.042 -177.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -71.78 96.63 1.66 Allowed 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.767 -0.827 . . . . 63.24 108.767 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -66.83 160.19 26.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.354 0.662 . . . . 73.31 110.049 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 66.3 p -58.15 126.48 27.68 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.383 0.673 . . . . 62.33 110.388 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.76 -76.11 0.09 Allowed 'General case' 0 CA--C 1.549 0.904 0 O-C-N 123.84 0.713 . . . . 73.3 109.45 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.412 ' HA ' HG13 ' C' ' 89' ' ' ILE . 56.3 ttp 57.95 111.22 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.326 1.45 . . . . 53.54 112.45 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.453 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 7.0 m -97.22 105.57 17.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.172 -1.047 . . . . 62.02 108.172 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.6 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.4 t80 -124.27 119.38 29.15 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.529 -0.545 . . . . 63.24 109.529 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.426 HE22 ' CG2' ' C' ' 10' ' ' THR . 25.5 mp0 -136.92 142.26 42.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.486 -0.931 . . . . 71.25 108.486 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.14 97.29 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -74.19 -28.25 61.19 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 122.423 0.289 . . . . 51.41 110.649 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' C' ' 15' ' ' ARG . 10.0 ttt180 -172.55 152.76 2.68 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 123.727 0.642 . . . . 62.51 110.94 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 89.3 mt -133.6 137.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.269 -1.382 . . . . 62.05 107.269 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG23 ' D' ' 122' ' ' THR . 18.6 p90 -175.52 166.24 3.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.88 0.472 . . . . 75.31 110.052 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -89.26 120.24 30.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.267 -0.642 . . . . 75.23 109.267 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 13.6 mmmm -66.49 -44.55 82.31 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.614 -0.884 . . . . 71.24 108.614 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.2 t70 -139.79 145.71 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.112 -0.949 . . . . 73.33 110.598 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.9 mt -135.53 142.83 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 125.587 1.555 . . . . 71.02 107.038 170.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -156.84 151.34 25.48 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.129 0.49 . . . . 72.42 110.702 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -149.36 112.14 4.81 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 106.895 -1.52 . . . . 72.14 106.895 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -116.24 125.71 52.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.286 0.634 . . . . 62.52 109.855 -176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.64 82.08 18.82 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.086 -1.079 . . . . 62.53 108.086 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.86 -28.16 75.46 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.522 2.148 . . . . 72.55 111.646 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.86 31.87 2.53 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.519 1.128 . . . . 54.53 110.47 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.511 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -58.13 -54.04 59.77 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.441 1.275 . . . . 63.44 114.441 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 58.8 Cg_endo -79.83 -25.99 4.86 Favored 'Trans proline' 0 C--N 1.385 2.464 0 CA-C-N 122.072 1.776 . . . . 61.04 112.654 172.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.06 -23.32 67.39 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.044 1.338 . . . . 65.52 111.997 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -18.75 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.88 1.272 . . . . 61.52 112.022 -174.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.04 -38.55 75.88 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.676 0.39 . . . . 73.34 111.461 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.99 34.42 1.1 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.424 0.69 . . . . 75.42 110.912 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.432 ' HD2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -98.0 150.9 20.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.181 0.992 . . . . 73.41 111.012 -175.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.81 138.95 58.25 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.952 1.301 . . . . 73.32 111.533 172.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -85.24 67.21 10.08 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.864 0.866 . . . . 72.11 110.784 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -162.94 71.0 2.01 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.118 0.567 . . . . 71.04 110.81 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -87.05 115.9 1.2 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.315 2.677 . . . . 71.15 112.015 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.87 112.77 22.08 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.352 -0.981 . . . . 65.52 108.352 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.89 104.51 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.726 -0.67 . . . . 73.34 109.355 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.416 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 58.7 tttm -95.03 103.25 15.09 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.616 -0.883 . . . . 65.12 108.616 173.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.78 138.05 31.87 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.153 -1.054 . . . . 72.41 108.153 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.4 t70 -128.89 141.55 51.24 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.42 1.088 . . . . 75.02 109.042 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 61.7 tp -134.29 132.01 39.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.111 -0.7 . . . . 72.05 109.111 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.777 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 17.1 t70 -123.27 141.76 51.65 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.106 0.963 . . . . 75.31 109.133 174.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -114.51 111.08 20.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.993 -0.743 . . . . 62.23 108.993 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -117.03 164.29 14.94 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.341 1.056 . . . . 42.02 110.09 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -146.83 155.49 42.38 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.391 0.676 . . . . 71.14 109.884 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.51 126.84 14.89 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 65.32 108.598 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -82.72 117.76 22.87 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.447 -0.946 . . . . 73.35 108.447 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.591 HD11 HD12 ' C' ' 83' ' ' ILE . 83.1 mt -90.89 -42.51 10.56 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.621 -0.718 . . . . 55.12 109.463 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.45 -177.85 6.84 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.802 -1.09 . . . . 71.41 109.728 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.4 126.62 30.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.991 -1.004 . . . . 75.43 109.182 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.7 10.51 7.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.622 1.169 . . . . 60.32 111.732 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -126.22 112.96 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.918 0.887 . . . . 72.11 109.206 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -131.14 125.54 33.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.889 0.876 . . . . 73.3 109.11 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -83.61 124.48 30.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.279 1.031 . . . . 75.12 109.66 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.49 130.09 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.572 -1.27 . . . . 51.43 107.572 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 86.0 t -123.44 139.91 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.505 0.722 . . . . 71.11 109.978 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.575 HD11 ' HA ' ' C' ' 103' ' ' PRO . 69.5 mt -128.76 118.72 23.27 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 124.283 1.033 . . . . 61.02 109.315 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.777 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 45.0 mtt180 -82.96 108.55 16.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.689 -0.856 . . . . 75.44 108.689 166.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -103.92 116.38 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.456 -1.313 . . . . 62.24 107.456 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 20.2 m -130.12 118.24 21.18 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.056 0.542 . . . . 50.23 109.594 -170.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.596 HG23 HD13 ' C' ' 114' ' ' ILE . 67.0 t -104.0 118.18 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 70.21 108.586 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 22.4 m -110.77 141.45 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.463 -0.94 . . . . 72.34 108.463 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.76 106.61 9.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.963 -1.865 . . . . 61.33 105.963 170.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.5 m -138.91 152.28 47.63 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.338 0.59 . . . . 74.44 109.71 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.432 HD13 ' HD2' ' C' ' 34' ' ' LYS . 4.3 mp -116.32 31.48 6.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.462 -1.244 . . . . 73.51 108.635 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.54 -117.63 4.02 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 109.802 -1.319 . . . . 75.13 109.802 -170.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -88.85 -30.61 18.8 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.433 -0.58 . . . . 63.24 109.433 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.68 95.12 1.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.223 1.009 . . . . 60.14 109.227 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 64.3 m -87.49 139.65 30.33 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.219 0.608 . . . . 72.11 110.737 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.6 -65.02 1.01 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.098 -0.955 . . . . 73.44 109.395 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 74' ' ' PHE . . . . . 0.603 ' HE1' ' HB2' ' F' ' 297' ' ' TYR . 40.7 p90 -157.91 176.19 12.87 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.167 0.587 . . . . 75.13 110.784 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -140.79 147.47 39.12 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.671 1.188 . . . . 72.34 108.162 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 51.0 t -151.08 129.36 11.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.129 0.971 . . . . 50.13 108.596 175.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -136.86 134.58 37.06 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.976 0.51 . . . . 74.1 110.025 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' C' ' 110' ' ' ALA . 36.5 t -131.39 115.6 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 52.34 109.021 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.617 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 27.2 mt-30 -89.48 96.39 10.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.018 . . . . 63.15 108.25 169.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 66.2 tp60 -80.07 125.45 29.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.273 0.629 . . . . 64.34 109.86 176.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.23 154.19 16.81 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.831 -0.507 . . . . 40.14 111.831 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.25 120.24 1.05 Allowed Glycine 0 CA--C 1.504 -0.65 0 N-CA-C 111.865 -0.494 . . . . 71.13 111.865 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.591 HD12 HD11 ' C' ' 51' ' ' LEU . 9.0 mm -87.92 122.6 39.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 60.51 108.371 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -133.75 127.33 32.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.933 -0.766 . . . . 74.31 108.933 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -87.91 104.28 16.47 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.659 -0.867 . . . . 73.23 108.659 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' C' ' 10' ' ' THR . 21.9 pt -115.54 134.36 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.352 1.061 . . . . 73.1 110.234 -173.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.34 172.2 14.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 74.12 111.272 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.68 -49.15 2.3 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.648 -0.705 . . . . 72.21 113.054 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.412 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.8 pp -119.94 172.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.567 0.747 . . . . 73.12 110.828 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.81 -172.91 4.27 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.776 -0.647 . . . . 61.51 110.186 -171.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.85 -129.01 44.47 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.736 0.647 . . . . 62.25 113.835 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -69.75 -28.03 65.44 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.319 1.048 . . . . 64.13 111.916 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.8 -47.83 83.37 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.745 0.818 . . . . 73.22 109.838 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 36.6 ttp -83.38 -29.18 28.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.449 -0.796 . . . . 72.35 110.829 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 95' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' F' ' 280' ' ' LEU . . . -65.33 -30.86 71.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.981 0.513 . . . . 72.05 111.368 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -68.77 -34.53 75.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.285 0.634 . . . . 75.05 110.434 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -70.3 -61.86 1.61 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.159 -0.473 . . . . 65.43 110.761 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.542 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.9 OUTLIER -77.83 -13.5 59.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.819 0.674 . . . . 40.1 112.819 -176.009 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -7.35 49.9 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 119.757 -0.468 . . . . 41.02 113.875 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.56 -58.28 0.63 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.311 0.555 . . . . 73.33 110.951 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -70.99 -45.04 64.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.271 1.028 . . . . 74.34 112.089 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.6 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 33.4 m -70.45 -44.13 17.79 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.549 0.739 . . . . 73.21 111.739 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.575 ' HA ' HD11 ' C' ' 60' ' ' LEU . 86.9 Cg_exo -50.5 -41.57 51.94 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.459 2.106 . . . . 73.11 113.91 168.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -62.41 -26.81 68.68 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.64 0.776 . . . . 72.23 112.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -80.95 -45.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.139 0.576 . . . . 74.52 110.86 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.3 mt -78.12 -33.13 50.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.735 -0.666 . . . . 75.11 112.124 -171.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.557 ' HE1' HD23 ' C' ' 128' ' ' LEU . 25.0 t80 -51.36 -52.03 63.3 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.692 -1.147 . . . . 73.02 113.708 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 93.6 Cg_exo -48.89 -36.49 34.2 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.938 2.425 . . . . 72.33 114.685 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -72.9 -43.9 61.9 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.88 -0.6 . . . . 70.32 111.622 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.87 -39.4 93.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.744 0.418 . . . . 40.41 110.645 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -55.8 -57.06 13.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.481 1.513 . . . . 70.23 111.275 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -68.09 -31.73 71.56 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.514 0.725 . . . . 74.41 110.913 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.422 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.0 t -67.91 -37.93 82.32 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.255 0.622 . . . . 60.55 111.199 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.596 HD13 HG23 ' C' ' 64' ' ' VAL . 70.1 mt -64.78 -49.29 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.497 -0.774 . . . . 71.42 109.729 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -60.16 -34.45 73.59 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 123.882 0.739 . . . . 75.1 111.534 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -67.78 -38.84 83.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.256 -0.884 . . . . 75.22 110.083 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.618 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -69.43 -37.87 77.61 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.101 0.96 . . . . 73.22 112.273 178.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.06 -34.16 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.14 0.576 . . . . 73.23 109.498 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 39.5 t -65.19 -38.81 91.66 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-N 115.381 -0.827 . . . . 71.14 111.727 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.436 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.5 mtt-85 -72.21 -23.81 61.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.19 -0.914 . . . . 53.34 111.18 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.43 6.42 83.29 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 119.865 -0.408 . . . . 54.14 113.146 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.439 HG23 ' HB3' ' D' ' 17' ' ' TYR . 38.0 p 60.75 35.64 19.56 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.014 1.726 . . . . 54.41 112.18 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -115.06 148.12 39.88 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.534 0.734 . . . . 75.34 110.89 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -45.89 109.03 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.295 3.33 . . . . 42.44 112.822 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -60.06 131.55 51.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.304 -1.316 . . . . 70.53 111.967 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.3 tp -108.58 102.16 11.25 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.401 0.68 . . . . 74.24 109.443 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 25.8 m-80 -90.97 111.89 23.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.952 -1.129 . . . . 64.13 107.952 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.557 HD23 ' HE1' ' C' ' 107' ' ' PHE . 16.9 tp -73.43 149.05 42.69 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.113 0.782 . . . . 71.14 113.113 -164.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.552 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -65.9 157.92 77.85 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.611 1.565 . . . . 74.31 112.784 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.57 ' HG2' HG21 ' A' ' 13' ' ' ILE . 8.2 Cg_exo -73.73 129.49 13.6 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.059 2.506 . . . . 74.41 112.56 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.53 107.66 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.751 -1.574 . . . . 53.05 106.751 168.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -102.78 103.64 13.87 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.234 -1.025 . . . . 73.33 108.234 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.468 ' HD1' ' SD ' ' F' ' 286' ' ' MET . 65.8 m-85 -62.25 -35.83 80.15 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.781 -0.645 . . . . 63.22 110.523 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' C' ' 138' ' ' MET . 14.0 m-20 -66.17 -35.28 80.04 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.578 0.751 . . . . 73.54 112.092 176.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.06 -30.46 71.01 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.925 0.49 . . . . 64.41 111.405 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.92 -42.79 97.29 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.194 -0.912 . . . . 74.13 110.868 171.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -73.65 -23.68 59.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.538 0.735 . . . . 65.31 112.064 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 138' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 64.5 mtt -69.01 -29.42 67.6 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.584 0.754 . . . . 72.02 110.605 177.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -60.18 -36.32 77.34 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.417 1.087 . . . . 74.12 111.219 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -57.48 -83.15 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.346 1.058 . . . . 74.32 110.959 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.43 ' O ' HD12 ' C' ' 141' ' ' LEU . 1.8 pp -132.47 122.8 25.47 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.075 0.398 . . . . 54.1 110.678 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -179.2 89.28 0.02 OUTLIER 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.041 1.337 . . . . 70.24 107.654 173.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -93.78 142.48 27.31 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.863 -0.608 . . . . 73.02 110.534 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -99.83 104.37 16.04 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.176 -1.046 . . . . 61.03 108.176 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.63 112.25 5.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.187 0.595 . . . . 74.42 109.535 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 146' ' ' GLY . . . . . 0.46 ' HA2' HE21 ' A' ' 142' ' ' GLN . . . 148.4 -172.76 28.57 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.308 0.38 . . . . 44.13 113.971 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -137.91 168.34 19.9 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.934 1.293 . . . . 72.14 109.43 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.05 146.65 8.52 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 120.139 -0.256 . . . . 72.33 112.694 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 12.8 t -159.43 129.7 5.71 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.688 0.795 . . . . 74.43 109.89 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -121.47 178.23 4.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.054 0.542 . . . . 73.41 111.06 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -155.68 81.12 1.02 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.429 0.691 . . . . 74.12 109.314 174.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -154.06 121.48 5.8 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.169 -1.049 . . . . 65.51 108.169 172.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -111.93 91.56 3.7 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.71 -0.848 . . . . 64.04 108.71 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -161.26 159.73 29.01 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.753 0.821 . . . . 73.51 110.195 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 C-N-CA 124.687 1.195 . . . . 73.02 108.585 179.706 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.58 -0.526 . . . . 62.44 109.58 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -114.59 100.26 8.14 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.519 0.728 . . . . 73.53 109.682 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.89 97.97 8.3 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.383 0.611 . . . . 72.2 109.42 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -80.68 136.29 36.17 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 108.603 -0.888 . . . . 64.15 108.603 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -125.71 145.39 50.2 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.908 0.883 . . . . 65.33 109.479 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -83.8 6.89 19.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.145 0.578 . . . . 64.34 111.133 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -65.69 86.5 0.08 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.559 0.744 . . . . 62.23 109.947 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.46 178.63 7.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.71 0.804 . . . . 64.54 110.171 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.6 ttp -32.75 124.61 0.35 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.763 1.225 . . . . 72.34 113.61 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 57.5 m -108.69 140.81 41.56 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.031 -1.1 . . . . 72.43 108.031 165.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -157.59 93.32 1.28 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.728 -1.212 . . . . 74.0 107.728 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -117.56 115.88 26.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.87 -0.789 . . . . 63.25 108.87 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.402 HG12 ' HD2' ' D' ' 84' ' ' PHE . 22.0 mt -68.41 127.67 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.135 -1.061 . . . . 55.42 108.135 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.95 -42.47 14.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.65 -0.87 . . . . 72.11 108.65 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 178.92 150.6 0.28 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.312 1.045 . . . . 73.4 109.759 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.545 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -116.1 144.07 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.466 -1.309 . . . . 63.13 107.466 169.245 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.511 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 13.6 p90 -165.53 150.46 8.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.669 0.747 . . . . 74.2 111.108 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -78.02 109.76 12.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.623 -1.171 . . . . 62.33 109.228 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.579 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 46.6 mtpt -75.83 -32.86 59.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.819 -0.628 . . . . 73.34 109.435 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.4 t70 -149.23 137.42 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.697 -1.138 . . . . 64.43 109.452 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.618 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.0 mt -135.73 146.82 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.321 1.048 . . . . 71.41 108.674 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 m -147.66 138.3 23.25 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.161 0.984 . . . . 73.45 110.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.488 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.6 t80 -142.62 111.67 6.48 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 105.516 -2.031 . . . . 75.42 105.516 166.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.1 mt-10 -123.08 110.89 15.89 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.897 -0.779 . . . . 74.13 108.897 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.821 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -113.64 83.25 6.99 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.477 0.711 . . . . 71.35 109.336 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.27 -36.9 6.45 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.505 2.137 . . . . 71.24 111.807 -175.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 30.8 m-20 -112.41 22.77 14.32 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.041 0.936 . . . . 75.52 109.891 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.821 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.82 -60.48 4.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 114.394 1.257 . . . . 41.33 114.394 -168.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HE3' ' C' ' 19' ' ' LYS . 82.7 Cg_endo -75.12 -8.76 20.21 Favored 'Trans proline' 0 C--N 1.387 2.585 0 CA-C-N 121.751 1.661 . . . . 73.13 112.845 -175.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.428 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.3 t-160 -83.5 -37.17 23.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.43 1.492 . . . . 64.31 109.427 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' D' ' 73' ' ' ALA . 96.3 t -72.42 -32.49 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.777 . . . . 71.13 110.357 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.465 ' HA ' HG12 ' G' ' 301' ' ' ILE . 21.9 m-85 -69.07 -3.1 11.87 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.528 0.936 . . . . 73.51 113.528 -176.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -83.94 -9.92 58.34 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.57 0.748 . . . . 72.23 111.306 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -110.4 114.29 27.61 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.672 1.189 . . . . 74.15 109.677 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' G' ' 300' ' ' ASN . 12.1 p-10 -100.11 93.9 5.96 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.826 0.85 . . . . 73.21 112.106 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' D' ' 68' ' ' LEU . 0.0 OUTLIER -168.78 -164.48 0.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.684 0.794 . . . . 73.33 111.262 -177.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -89.12 122.08 69.05 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 124.193 0.997 . . . . 74.4 111.544 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.743 ' HB3' HD11 ' D' ' 68' ' ' LEU . 74.2 Cg_exo -56.43 134.52 64.79 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.51 2.807 . . . . 73.51 114.531 165.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.11 114.0 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.553 -1.647 . . . . 74.4 106.553 166.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.18 138.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.554 0.742 . . . . 55.22 109.852 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -130.92 153.18 49.43 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.424 1.09 . . . . 71.0 111.134 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.6 120.0 37.18 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.847 -1.168 . . . . 62.3 107.847 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.582 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -105.66 145.38 31.13 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.105 -1.072 . . . . 74.12 108.105 171.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.68 147.34 44.79 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.489 0.661 . . . . 63.51 111.93 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.67 146.85 27.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.328 1.451 . . . . 62.41 107.705 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -123.62 155.76 37.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.411 0.684 . . . . 73.22 110.757 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -159.25 158.37 32.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.506 0.722 . . . . 70.13 110.312 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 60.7 p -160.25 153.22 21.52 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.395 0.678 . . . . 74.11 109.434 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 26.7 p -157.56 123.31 4.66 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.521 0.728 . . . . 71.21 109.582 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -70.36 120.46 16.05 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.434 -0.58 . . . . 72.12 109.434 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -89.88 -38.35 13.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 71.33 110.138 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.0 -175.95 5.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 75.12 110.262 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -67.19 128.26 35.71 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.671 -0.695 . . . . 71.32 109.291 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 45.5 m-20 63.13 13.99 7.3 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.349 1.06 . . . . 75.22 112.135 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.28 119.9 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.238 1.015 . . . . 71.44 108.483 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -132.86 128.61 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.185 -1.043 . . . . 53.13 108.185 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -94.71 130.97 41.01 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.367 -0.605 . . . . 65.21 109.367 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.87 119.08 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.839 -1.171 . . . . 73.44 107.839 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.9 t -106.28 129.42 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.85 -0.796 . . . . 75.44 108.85 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.29 113.1 20.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.115 -1.069 . . . . 60.22 108.115 176.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -86.87 98.26 11.11 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.884 -0.784 . . . . 71.13 108.884 172.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -91.48 127.32 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.008 -1.108 . . . . 74.55 108.008 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 16.9 m -126.62 148.33 49.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.988 -0.745 . . . . 51.02 108.988 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.1 t -136.42 109.49 8.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 125.317 1.447 . . . . 72.43 108.192 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 122.27 44.78 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.994 0.518 . . . . 72.43 109.633 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' D' ' 73' ' ' ALA . . . -107.63 135.14 49.57 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.78 -0.822 . . . . 71.51 108.78 172.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -135.39 116.22 14.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.031 -1.47 . . . . 62.54 107.031 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' D' ' 38' ' ' PRO . 9.9 mp -122.42 115.45 22.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.555 -0.748 . . . . 64.41 110.662 -167.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.79 -111.32 3.27 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.799 -0.92 . . . . 53.35 110.799 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.59 6.61 8.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.067 0.947 . . . . 72.21 109.172 174.337 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.5 174.92 7.48 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.846 0.858 . . . . 72.21 110.035 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -84.18 135.29 34.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.249 0.619 . . . . 63.14 110.793 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' D' ' 68' ' ' LEU . . . -81.19 -73.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.725 . . . . 73.3 109.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -153.6 155.55 36.31 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.272 -1.331 . . . . 74.44 109.947 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.2 mt -123.08 110.93 15.94 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 107.928 -1.138 . . . . 53.24 107.928 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.4 t -115.78 133.74 55.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.966 -0.753 . . . . 62.15 108.966 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -153.86 132.87 12.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.637 0.375 . . . . 72.12 110.252 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.58 115.69 15.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.901 0.881 . . . . 74.13 109.327 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -88.7 86.82 7.06 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.723 -0.843 . . . . 71.31 108.723 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.21 95.13 6.19 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.704 -1.135 . . . . 73.43 109.468 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -91.96 143.35 16.5 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.208 -0.757 . . . . 61.43 111.208 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.57 130.03 3.92 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 110.274 -1.13 . . . . 74.34 110.274 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -89.8 127.1 42.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.816 . . . . 74.23 108.795 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.402 ' HD2' HG12 ' D' ' 13' ' ' ILE . 36.6 m-85 -130.21 125.41 34.85 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.602 -0.518 . . . . 75.51 109.602 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.3 m -79.33 95.24 5.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.471 0.709 . . . . 73.12 109.304 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 mt -108.4 123.32 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.721 0.808 . . . . 52.31 109.625 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -152.64 169.84 21.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.278 1.031 . . . . 62.33 109.711 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.63 2.01 73.79 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.9 0.72 . . . . 62.24 114.9 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 pt -135.93 148.5 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.005 0.922 . . . . 73.21 109.517 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.86 159.71 41.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.566 0.746 . . . . 63.21 110.813 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.82 -115.53 7.38 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 124.279 0.987 . . . . 63.43 115.372 167.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.4 m -68.68 -33.04 73.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.063 0.945 . . . . 64.44 111.891 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.08 -44.74 62.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.762 0.425 . . . . 72.35 111.025 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.82 67.68 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.979 -0.378 . . . . 51.42 109.979 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.417 ' HB1' HD22 ' G' ' 280' ' ' LEU . . . -68.24 -39.19 82.35 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.547 0.739 . . . . 54.21 110.649 176.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -63.61 -42.27 98.24 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.849 0.46 . . . . 73.44 110.034 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.4 -47.77 80.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.848 0.459 . . . . 74.41 110.955 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -34.36 46.92 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.452 0.701 . . . . 63.14 110.576 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.82 -15.57 72.57 Favored Glycine 0 N--CA 1.466 0.677 0 CA-C-N 116.271 -0.422 . . . . 61.1 113.47 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.17 -63.89 0.83 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.618 0.599 . . . . 73.22 112.618 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -72.46 -48.02 44.21 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 112.634 0.605 . . . . 65.1 112.634 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.35 -46.23 90.13 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.556 0.742 . . . . 70.54 112.855 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.16 -31.19 54.7 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.043 1.828 . . . . 72.24 112.182 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -72.09 -17.99 61.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.703 0.801 . . . . 72.25 111.024 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.0 mm -80.2 -43.81 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.478 0.711 . . . . 50.12 110.051 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.81 -32.62 57.75 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.545 0.738 . . . . 71.11 112.571 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.06 -44.79 95.47 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 124.154 0.981 . . . . 54.01 113.095 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.85 -37.24 98.6 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.536 2.157 . . . . 74.25 114.075 172.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -79.91 -25.96 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.087 0.555 . . . . 62.13 111.838 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.22 -50.07 62.14 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.105 -0.702 . . . . 41.04 109.105 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.5 -35.59 76.29 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.564 1.165 . . . . 52.42 111.301 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 112' ' ' GLU . . . . . 0.436 ' HG2' HH12 ' C' ' 120' ' ' ARG . 26.8 tt0 -56.35 -52.13 65.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.151 0.98 . . . . 71.03 110.865 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.915 -1.039 . . . . 73.3 111.132 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.444 HG12 ' SG ' ' D' ' 76' ' ' CYS . 87.7 mt -58.74 -63.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.185 0.994 . . . . 64.51 110.508 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 34.9 m -52.03 -38.17 56.0 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.467 1.107 . . . . 75.21 112.206 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 25.9 t -66.41 -45.21 80.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.52 0.728 . . . . 73.34 111.04 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.95 -36.71 80.57 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.886 0.475 . . . . 70.33 111.554 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.9 t -64.4 -40.27 88.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 115.306 -0.861 . . . . 64.35 110.224 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -31.33 65.99 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.601 0.36 . . . . 73.35 111.202 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 93.8 mtt-85 -73.16 -23.52 60.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.286 0.634 . . . . 62.03 110.994 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.31 12.41 69.01 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.743 0.652 . . . . 60.51 112.861 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.493 HG23 ' HB3' ' C' ' 17' ' ' TYR . 54.3 p 59.78 22.21 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.277 1.831 . . . . 71.11 113.619 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.23 161.64 30.45 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.423 1.089 . . . . 70.52 109.387 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -74.9 144.34 30.5 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.256 1.971 . . . . 62.33 111.172 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.78 HE21 HG21 ' A' ' 122' ' ' THR . 5.0 pt20 -44.84 121.78 2.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.666 1.186 . . . . 73.34 111.934 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.78 95.42 5.72 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.616 -1.253 . . . . 74.15 107.616 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -103.77 109.26 20.91 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.303 -0.862 . . . . 72.3 109.134 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.83 118.97 11.77 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.614 -0.721 . . . . 35.44 109.057 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HB2' HG11 ' E' ' 306' ' ' VAL . . . -64.2 138.66 97.49 Favored Pre-proline 0 CA--C 1.55 0.953 0 O-C-N 123.963 0.789 . . . . 53.25 111.15 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.45 132.12 10.97 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.429 2.086 . . . . 73.54 112.882 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.71 121.96 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.366 -0.976 . . . . 73.41 108.366 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 53.9 t30 -77.27 97.54 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.084 -0.71 . . . . 70.32 109.084 175.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -71.1 -32.9 69.62 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.48 -0.782 . . . . 62.01 111.156 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -56.21 -38.8 71.5 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.101 0.96 . . . . 71.52 112.135 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -73.38 -27.89 61.72 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.825 0.703 . . . . 74.34 112.086 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' G' ' 287' ' ' PRO . 74.7 mt -67.29 -43.9 80.61 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.62 0.768 . . . . 75.52 110.244 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -75.58 -32.05 60.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.634 0.774 . . . . 75.12 111.191 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 34.8 ttm -59.02 -32.35 69.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.415 1.086 . . . . 54.13 111.819 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -58.59 -39.0 79.17 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.291 -0.868 . . . . 71.43 111.18 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -65.79 -39.51 91.02 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.138 0.575 . . . . 75.31 111.411 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.98 -34.53 78.65 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.896 0.878 . . . . 62.42 112.376 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.07 25.29 2.19 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.146 0.579 . . . . 73.11 112.223 -177.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -116.79 48.13 1.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 122.271 1.034 . . . . 32.33 108.215 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -151.52 151.04 31.07 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.049 -1.432 . . . . 61.21 107.796 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.71 146.77 54.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.842 0.457 . . . . 73.43 111.433 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.42 70.98 0.3 Allowed Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.578 -1.009 . . . . 33.43 110.578 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.73 109.79 0.88 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.515 1.126 . . . . 62.43 110.684 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.65 68.64 0.23 Allowed Glycine 0 C--N 1.342 0.884 0 N-CA-C 110.815 -0.914 . . . . 43.43 110.815 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 26.9 m -60.56 112.96 2.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.521 0.728 . . . . 60.34 111.066 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.96 155.41 40.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.22 1.008 . . . . 52.13 110.89 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.77 141.19 21.55 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.454 0.702 . . . . 74.45 110.061 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -149.81 166.13 30.42 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.091 1.356 . . . . 71.2 108.8 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -152.53 149.53 28.61 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.894 0.877 . . . . 60.11 109.611 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -105.59 117.99 35.44 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.133 -1.062 . . . . 75.2 108.133 172.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 N-CA-C 109.094 -0.706 . . . . 52.32 109.094 179.13 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.525 -0.546 . . . . 74.34 109.525 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -70.27 103.15 2.29 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.966 -0.753 . . . . 75.3 108.966 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.62 -9.24 58.84 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.512 0.725 . . . . 72.41 112.207 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 274' ' ' GLN . . . . . 0.635 ' HG3' ' HA3' ' E' ' 279' ' ' GLY . 34.3 tt0 -85.52 53.88 2.92 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 121.924 0.869 . . . . 74.34 109.745 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -89.0 -46.16 0.43 Allowed Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.703 0.801 . . . . 74.41 110.445 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.15 176.92 9.43 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.53 1.487 . . . . 74.41 111.79 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.05 66.08 9.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.736 0.814 . . . . 75.42 109.844 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -169.81 97.27 0.3 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 105.961 -1.866 . . . . 51.33 105.961 175.318 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 279' ' ' GLY . . . . . 0.635 ' HA3' ' HG3' ' E' ' 274' ' ' GLN . . . -153.49 17.41 0.67 Allowed Glycine 0 C--N 1.348 1.232 0 N-CA-C 114.302 0.481 . . . . 72.31 114.302 -174.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 5.0 tt -163.59 100.49 0.91 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.893 -1.521 . . . . 71.02 106.893 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -166.98 131.31 1.97 Allowed 'General case' 0 CA--C 1.542 0.672 0 O-C-N 123.797 0.686 . . . . 64.12 110.263 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -98.76 151.42 20.8 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.624 0.769 . . . . 74.23 109.461 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.79 91.53 3.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.416 0.687 . . . . 73.31 110.067 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 74.24 -81.49 0.81 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.833 -0.621 . . . . 50.23 111.743 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 17.3 t30 74.8 -62.33 0.46 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.946 1.698 . . . . 64.55 113.109 171.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 286' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 43.2 ttm -67.63 113.29 13.48 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.831 0.852 . . . . 54.41 110.617 -177.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -91.52 108.72 0.29 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.501 2.134 . . . . 72.2 110.269 171.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.51 -27.06 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.276 0.23 . . . . 64.12 110.794 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 61.95 -88.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.023 1.329 . . . . 75.43 111.77 172.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 290' ' ' TRP . . . . . 0.54 ' HE3' ' H ' ' E' ' 291' ' ' LEU . 0.0 OUTLIER -167.24 146.94 5.28 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.515 1.126 . . . . 72.23 109.468 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.54 ' H ' ' HE3' ' E' ' 290' ' ' TRP . 3.1 mp -126.76 82.68 2.1 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.516 -0.92 . . . . 74.31 108.516 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 114.14 -94.86 0.71 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.974 -0.903 . . . . 62.14 112.758 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -70.0 175.05 8.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.03 2.486 . . . . 74.45 113.012 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -106.18 -16.63 14.54 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.225 1.01 . . . . 64.32 110.483 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -156.23 163.75 39.19 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.242 0.544 . . . . 71.13 111.527 -172.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 12.1 t -90.64 -19.56 23.51 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.098 -0.956 . . . . 71.41 109.967 171.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.5 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 6.2 m-85 -72.54 139.51 47.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.488 0.715 . . . . 73.41 111.92 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 298' ' ' HIS . . . . . 0.784 ' HB3' ' HB3' ' G' ' 303' ' ' LYS . 80.6 t60 -175.7 -41.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 O-C-N 125.058 1.473 . . . . 73.31 107.16 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.44 -140.86 3.24 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.354 -0.839 . . . . 75.35 112.075 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 300' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' G' ' 302' ' ' ASP . 3.3 t-20 82.59 -16.08 0.62 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.938 1.695 . . . . 65.35 113.576 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.599 HD13 ' HA ' ' A' ' 123' ' ' PHE . 9.3 pt -137.03 48.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 113.309 0.855 . . . . 73.51 113.309 -170.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 302' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' G' ' 297' ' ' TYR . 76.6 m-20 -68.93 144.97 54.03 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 121.557 -0.714 . . . . 62.14 109.876 170.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 303' ' ' LYS . . . . . 0.582 ' H ' ' HD3' ' E' ' 303' ' ' LYS . 0.0 OUTLIER -70.44 137.04 86.17 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 123.329 0.651 . . . . 75.12 111.142 -178.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.15 -57.88 0.45 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.127 2.551 . . . . 54.3 112.806 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 305' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' B' ' 14' ' ' GLN . . . 55.29 85.04 0.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.821 1.248 . . . . 71.24 111.658 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 306' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' D' ' 129' ' ' ALA . 57.6 t -73.18 122.45 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.965 0.506 . . . . 72.23 110.2 -176.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 15.2 t -70.27 154.67 41.64 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.784 0.833 . . . . 74.12 111.2 -174.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 28.1 p -66.42 138.36 57.5 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.313 0.645 . . . . 60.54 111.11 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 17.7 p -65.55 152.46 92.46 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.841 1.256 . . . . 62.14 112.022 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.387 2.59 0 C-N-CA 123.768 2.979 . . . . 71.44 113.48 -175.021 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.864 -0.421 . . . . 71.24 109.864 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -77.36 -13.27 59.96 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.359 0.664 . . . . 71.54 111.306 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 273' ' ' GLN . . . . . 0.619 ' HG2' ' HG3' ' F' ' 274' ' ' GLN . 53.7 tt0 -67.26 130.34 42.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.04 0.936 . . . . 73.1 111.999 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 274' ' ' GLN . . . . . 0.619 ' HG3' ' HG2' ' F' ' 273' ' ' GLN . 92.5 mt-30 65.59 111.99 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.498 1.519 . . . . 64.31 111.94 175.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -104.86 98.92 16.55 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 108.19 -1.041 . . . . 75.04 108.19 170.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.16 -67.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.852 2.368 . . . . 75.24 112.995 -171.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 62.2 mt -102.05 123.31 45.72 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.828 -0.434 . . . . 70.52 109.828 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 70.65 81.52 0.16 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.519 1.528 . . . . 75.02 109.511 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -114.17 -84.99 1.31 Allowed Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.008 -0.997 . . . . 43.42 110.648 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 280' ' ' LEU . . . . . 0.495 ' HB3' ' HB1' ' C' ' 95' ' ' ALA . 2.4 tt -78.92 78.33 5.37 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.444 -0.947 . . . . 72.43 108.444 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -179.89 84.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.093 0.957 . . . . 70.43 109.771 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -167.62 106.2 0.54 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.183 -1.043 . . . . 73.24 108.183 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 37.3 t70 63.77 23.59 13.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.097 0.873 . . . . 74.3 110.481 -177.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.9 89.34 0.39 Allowed Glycine 0 C--N 1.354 1.571 0 CA-C-N 115.37 -0.832 . . . . 44.43 113.159 -171.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -98.78 106.22 18.46 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.739 0.816 . . . . 65.34 109.135 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 286' ' ' MET . . . . . 0.468 ' SD ' ' HD1' ' C' ' 133' ' ' PHE . 58.9 mtt -73.7 157.12 87.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-O 118.907 -0.568 . . . . 64.45 109.476 171.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.48 79.77 0.24 Allowed 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.592 2.194 . . . . 72.14 112.609 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.16 84.54 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.853 -1.165 . . . . 73.31 107.853 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.13 130.46 40.94 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.787 -1.19 . . . . 72.52 107.787 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 290' ' ' TRP . . . . . 0.404 ' HE1' ' HG3' ' F' ' 294' ' ' LYS . 15.1 t-105 -62.73 129.12 39.1 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 123.639 0.587 . . . . 62.3 110.542 -177.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.86 -175.06 3.07 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.012 1.325 . . . . 52.32 111.268 -167.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 73.25 173.96 26.81 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 114.995 -1.002 . . . . 51.23 113.672 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.81 133.5 15.48 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 122.682 2.255 . . . . 75.5 110.964 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 294' ' ' LYS . . . . . 0.404 ' HG3' ' HE1' ' F' ' 290' ' ' TRP . 0.0 OUTLIER -88.97 30.85 0.9 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.102 0.961 . . . . 72.33 110.93 -177.692 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -76.22 78.5 3.01 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.994 0.902 . . . . 73.44 108.9 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 31.5 m -136.78 149.43 47.78 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.404 1.481 . . . . 64.23 107.14 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.603 ' HB2' ' HE1' ' C' ' 74' ' ' PHE . 18.9 t80 68.33 -73.61 0.08 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.298 1.039 . . . . 71.32 111.303 -177.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -103.41 26.95 7.78 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.09 0.556 . . . . 65.12 110.147 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -78.95 70.82 2.69 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.046 -0.822 . . . . 34.4 111.046 167.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 300' ' ' ASN . . . . . 0.61 ' HB2' ' HA2' ' H' ' 299' ' ' GLY . 40.6 m-80 61.97 82.16 0.18 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.605 1.562 . . . . 71.53 112.282 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 36.5 pt -102.73 170.65 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.67 0.748 . . . . 74.13 110.257 170.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -151.44 -179.81 7.7 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 107.255 -1.387 . . . . 55.33 107.255 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -64.84 133.35 95.72 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 108.428 -0.953 . . . . 73.42 108.428 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.33 11.58 0.45 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.49 2.793 . . . . 73.12 115.226 -168.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.03 27.13 8.83 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.57 1.148 . . . . 74.11 111.539 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 306' ' ' VAL . . . . . 0.416 HG13 ' HD2' ' B' ' 130' ' ' PRO . 55.8 t -102.53 122.38 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.569 0.748 . . . . 64.04 109.189 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 62.4 m -142.02 155.09 45.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.004 0.921 . . . . 54.11 108.557 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 53.2 t -63.05 126.58 27.82 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.817 0.447 . . . . 73.3 110.461 175.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 3.6 t -134.05 103.44 11.79 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.937 0.895 . . . . 55.3 108.678 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 CA--C 1.564 1.981 0 C-N-CA 122.419 2.079 . . . . 73.23 112.375 174.028 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 110.599 -0.149 . . . . 72.25 110.599 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 65.44 30.01 11.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.832 1.253 . . . . 61.23 111.697 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -78.95 102.15 8.13 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.776 0.831 . . . . 60.34 109.343 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -115.22 -54.45 2.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.194 0.998 . . . . 74.24 112.061 -168.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -69.92 154.17 94.88 Favored Pre-proline 0 N--CA 1.485 1.287 0 CA-C-O 119.092 -0.48 . . . . 61.03 111.202 -168.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -37.38 116.65 0.19 Allowed 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 124.473 3.449 . . . . 70.34 115.666 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.07 -11.09 48.16 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 114.584 -1.189 . . . . 64.32 108.59 169.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 34.2 tp -135.7 118.75 16.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.4 1.08 . . . . 54.52 108.194 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 167.27 65.66 0.03 OUTLIER Glycine 0 C--N 1.35 1.315 0 O-C-N 123.074 0.234 . . . . 74.12 113.554 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' G' ' 281' ' ' PHE . 13.4 tp -166.74 -162.84 0.52 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.864 -1.162 . . . . 75.24 107.864 170.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 281' ' ' PHE . . . . . 0.673 ' H ' ' HG ' ' G' ' 280' ' ' LEU . 9.4 t80 87.77 -48.84 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.969 1.708 . . . . 75.42 111.925 163.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -75.28 77.33 2.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.075 0.55 . . . . 74.4 109.905 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.87 -52.67 0.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.658 0.783 . . . . 75.13 110.833 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 67.25 40.43 92.22 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 111.629 -0.588 . . . . 71.21 111.629 -172.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -71.06 -32.94 69.75 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.267 1.027 . . . . 75.02 110.939 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.73 125.99 84.18 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 115.533 -0.758 . . . . 75.43 109.73 171.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 287' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' D' ' 136' ' ' LEU . 14.8 Cg_endo -54.44 -63.69 0.2 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.185 2.59 . . . . 64.31 112.859 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 60.0 t 60.84 -75.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 124.638 1.175 . . . . 62.31 110.958 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 74.23 -12.07 0.93 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.433 1.493 . . . . 75.41 112.553 172.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 73.91 123.8 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.72 1.608 . . . . 65.34 109.705 -164.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 3.3 mp -88.68 19.21 4.1 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.491 1.116 . . . . 71.41 112.288 -161.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 141.51 101.65 0.44 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.123 -0.821 . . . . 61.02 112.09 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.95 168.6 24.26 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.595 2.197 . . . . 74.1 111.835 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 294' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' D' ' 38' ' ' PRO . 6.9 mtmp? 67.71 11.63 8.47 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.322 1.049 . . . . 74.04 112.532 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.35 60.46 6.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.75 0.82 . . . . 74.0 109.96 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.63 132.4 6.74 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.502 1.521 . . . . 73.11 107.992 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.777 ' HA ' ' HB2' ' E' ' 302' ' ' ASP . 5.2 m-85 57.11 -175.37 0.07 Allowed 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.352 1.061 . . . . 42.12 113.374 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -143.89 -56.5 0.38 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.08 -0.963 . . . . 71.24 109.087 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -164.91 30.44 0.23 Allowed Glycine 0 C--N 1.35 1.327 0 N-CA-C 114.48 0.552 . . . . 62.34 114.48 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 300' ' ' ASN . . . . . 0.427 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 12.1 p30 -148.67 155.78 41.5 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.266 0.533 . . . . 74.22 109.837 168.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' D' ' 32' ' ' PHE . 6.9 tp -113.27 -39.91 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.847 0.859 . . . . 72.23 110.886 -175.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 302' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' E' ' 300' ' ' ASN . 3.5 p30 -166.77 -165.19 0.71 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.965 0.888 . . . . 71.42 113.115 -175.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' G' G ' 303' ' ' LYS . . . . . 0.784 ' HB3' ' HB3' ' E' ' 298' ' ' HIS . 0.0 OUTLIER -136.62 125.15 15.12 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 126.025 1.73 . . . . 74.52 108.375 172.239 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.9 -42.11 12.28 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.3 2.0 . . . . 71.42 111.171 168.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . 60.37 -84.84 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.425 1.49 . . . . 41.14 112.089 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 20.2 m -90.17 113.41 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.371 0.605 . . . . 74.35 109.646 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 33.0 m -142.18 -32.4 0.51 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.19 0.996 . . . . 55.21 108.801 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 73.8 m -116.1 76.38 1.01 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.92 0.888 . . . . 73.42 108.739 168.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 90.6 m -65.07 -53.58 40.27 Favored Pre-proline 0 CA--C 1.563 1.461 0 CA-C-N 115.487 -0.779 . . . . 65.2 112.098 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo . . . . . 0 C--N 1.396 3.032 0 C-N-CA 122.356 2.038 . . . . 74.53 111.407 -178.19 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.5 0.19 . . . . 55.41 110.575 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -81.37 -14.51 57.12 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.244 0.618 . . . . 72.04 111.408 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.69 158.01 34.24 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.721 0.808 . . . . 71.05 109.634 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -123.97 144.55 49.74 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.69 0.796 . . . . 71.33 109.249 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -51.43 51.57 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 123.7 0.8 . . . . 63.12 111.07 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -83.68 172.97 9.76 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 121.519 1.479 . . . . 74.43 112.238 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 85.8 mt 64.99 175.13 0.2 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.739 1.216 . . . . 64.15 112.343 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 62.51 18.87 10.79 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.257 1.023 . . . . 74.43 112.535 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -79.39 129.49 9.2 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-O 119.477 -0.624 . . . . 70.22 112.651 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 2.2 tt 56.46 75.94 0.32 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.166 1.386 . . . . 74.34 109.645 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -167.18 -43.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.775 -0.648 . . . . 71.35 110.482 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.66 -27.37 68.63 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.156 0.582 . . . . 63.21 111.272 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -78.64 -82.72 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.844 0.857 . . . . 54.22 110.249 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 73.79 108.81 0.07 OUTLIER Glycine 0 CA--C 1.54 1.639 0 CA-C-N 118.304 0.502 . . . . 72.42 113.999 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -136.22 -101.05 0.21 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 108.193 -1.04 . . . . 44.13 108.193 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 44.8 ttp 46.62 84.8 0.19 Allowed Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 124.93 1.292 . . . . 73.24 112.797 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.57 111.86 2.46 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.858 2.372 . . . . 64.31 111.466 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.71 -33.98 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.662 0.785 . . . . 61.03 110.633 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 65.59 -170.01 0.2 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.792 1.237 . . . . 73.42 110.876 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -102.69 138.97 38.88 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.237 0.541 . . . . 72.12 110.49 171.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.43 -14.54 30.39 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.584 -1.189 . . . . 54.21 109.887 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.23 177.57 41.83 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 116.007 -0.542 . . . . 31.12 112.656 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.94 145.59 25.21 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 123.278 2.652 . . . . 73.22 112.578 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -104.82 130.01 53.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.229 0.611 . . . . 73.12 111.5 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.64 101.19 13.73 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 108.423 -0.955 . . . . 74.13 108.423 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 296' ' ' THR . . . . . 0.411 HG22 ' HD1' ' H' ' 297' ' ' TYR . 3.0 m -132.52 160.8 35.48 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.946 -1.131 . . . . 72.23 107.946 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.411 ' HD1' HG22 ' H' ' 296' ' ' THR . 2.8 m-85 70.84 -67.26 0.26 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.614 1.166 . . . . 73.22 111.007 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -63.26 94.09 0.07 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.438 0.695 . . . . 73.54 110.517 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 299' ' ' GLY . . . . . 0.61 ' HA2' ' HB2' ' F' ' 300' ' ' ASN . . . -154.45 -64.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.909 -1.276 . . . . 51.03 109.909 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -125.62 79.95 1.86 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.493 -1.299 . . . . 73.43 107.493 172.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 10.1 tt -139.84 108.41 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 115.271 -0.877 . . . . 74.43 110.156 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -169.53 -67.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.465 -1.309 . . . . 70.54 107.465 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -123.56 87.72 52.07 Favored Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 108.027 -1.101 . . . . 64.43 108.027 170.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.46 3.03 7.15 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.581 2.187 . . . . 75.22 112.511 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -70.61 121.26 17.56 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.425 1.09 . . . . 73.45 111.001 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 306' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 13' ' ' ILE . 58.1 t -77.4 86.83 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.923 -1.14 . . . . 74.14 107.923 168.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 32.4 p -86.9 135.8 33.18 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.294 -0.866 . . . . 55.24 109.327 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 63.7 m 71.42 142.62 0.06 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.555 1.542 . . . . 64.3 111.059 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 94.0 m 67.99 109.53 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.883 1.273 . . . . 72.5 111.303 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.377 2.066 0 C-N-CA 122.311 2.007 . . . . 74.32 111.494 173.326 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtm . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 108.791 -0.818 . . . . 73.4 108.791 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.4 t -121.36 153.72 37.4 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.268 -0.641 . . . . 73.14 109.268 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.52 102.56 3.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.139 -0.689 . . . . 73.04 109.139 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -73.76 85.5 1.67 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.577 0.703 . . . . 64.31 111.977 -171.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -78.68 128.59 33.66 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.912 -1.04 . . . . 63.12 109.661 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.89 -27.17 60.92 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.534 0.734 . . . . 73.24 110.864 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.5 p 54.18 -170.64 0.05 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.491 1.516 . . . . 62.2 112.802 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -100.21 168.81 9.56 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.213 0.605 . . . . 70.31 109.721 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -59.63 133.52 56.17 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.611 0.764 . . . . 75.4 110.733 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.9 m -144.52 142.35 30.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.62 0.768 . . . . 63.31 109.665 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.7 t80 -135.89 122.33 20.67 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.908 -1.145 . . . . 73.55 107.908 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -144.78 102.71 3.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.099 -0.334 . . . . 72.52 110.099 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.706 HG21 ' HG2' ' C' ' 130' ' ' PRO . 58.2 mt -71.93 128.34 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.101 -0.703 . . . . 71.34 109.101 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -103.68 -37.55 7.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.917 0.487 . . . . 42.23 110.011 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -165.53 138.73 4.42 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 110.209 -0.293 . . . . 74.22 110.209 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -128.4 134.01 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.57 -0.9 . . . . 74.21 108.57 172.851 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' B' ' 122' ' ' THR . 22.9 p90 -165.07 147.02 7.87 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 65.43 110.961 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.44 110.48 11.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.79 -0.819 . . . . 75.3 108.79 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -76.05 -22.52 55.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.025 -0.534 . . . . 74.23 110.511 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.87 142.16 17.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.797 -1.092 . . . . 71.43 109.441 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.7 140.2 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 106.732 -1.581 . . . . 73.03 106.732 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 31.1 t -150.85 141.75 22.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.8 -0.815 . . . . 73.02 108.8 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.8 t80 -151.78 110.78 3.87 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 105.955 -1.869 . . . . 62.25 105.955 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -122.35 118.15 27.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.356 -0.609 . . . . 74.23 109.356 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.89 83.73 1.11 Allowed Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 107.802 -1.185 . . . . 55.53 107.802 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.88 -42.64 36.19 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.859 2.372 . . . . 71.4 112.929 -166.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -109.64 29.89 7.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 118.415 -0.803 . . . . 64.32 109.815 -175.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.89 -57.06 5.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 117.583 -1.199 . . . . 70.32 113.669 -173.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.7 Cg_exo -64.42 -29.33 62.52 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.618 1.614 . . . . 62.31 112.348 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -79.8 -35.75 38.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.853 -1.067 . . . . 72.22 110.883 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.1 p -80.88 -13.49 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 115.749 -0.66 . . . . 73.05 111.879 -168.205 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -76.57 -11.72 59.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.174 0.59 . . . . 72.34 110.781 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -91.25 -12.5 35.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.495 1.118 . . . . 64.13 110.913 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 27.9 mmmt -81.62 166.2 20.4 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.671 0.788 . . . . 74.21 112.103 -173.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.14 139.18 39.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.254 -1.339 . . . . 75.3 108.576 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -81.31 69.35 7.92 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.579 0.704 . . . . 74.43 111.16 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -134.35 71.48 72.01 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.871 0.868 . . . . 54.12 108.93 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' E' ' 295' ' ' ALA . 92.4 Cg_endo -81.91 143.18 12.92 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.28 1.987 . . . . 62.34 111.704 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -104.65 102.37 11.97 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.79 -1.189 . . . . 65.35 107.79 164.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 65' ' ' THR . 42.4 t -74.43 94.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 60.1 tttm -80.85 113.84 19.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.129 0.972 . . . . 75.53 109.519 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.13 125.67 44.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.121 -1.066 . . . . 53.2 108.121 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -120.01 129.65 54.36 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.334 -0.987 . . . . 75.11 108.334 176.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.43 117.56 34.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.15 -0.685 . . . . 72.41 109.15 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.079 -1.082 . . . . 75.45 108.079 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -152.14 163.46 39.32 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 122.834 0.454 . . . . 75.05 111.15 -174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -160.91 153.23 20.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.099 0.96 . . . . 44.34 109.974 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -131.23 151.45 51.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.814 -0.81 . . . . 54.2 108.814 167.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -158.21 145.5 18.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.859 0.464 . . . . 73.24 110.675 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -88.19 113.62 23.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.504 0.722 . . . . 51.41 109.585 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.46 -35.81 24.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.836 0.455 . . . . 73.23 110.269 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.74 -174.61 4.7 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.364 1.066 . . . . 70.14 109.839 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.64 130.09 40.31 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.225 -0.658 . . . . 74.42 109.225 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 69.37 -9.89 0.6 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.819 1.648 . . . . 63.02 112.813 -170.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.57 109.41 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.649 0.78 . . . . 74.22 109.188 -170.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -126.81 157.2 39.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.039 -1.097 . . . . 73.34 108.039 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -132.51 146.08 51.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.027 0.931 . . . . 64.25 109.355 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.92 132.87 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.853 -1.166 . . . . 53.53 107.853 167.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.22 133.63 58.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.774 -0.824 . . . . 72.54 108.774 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 103' ' ' PRO . 75.5 mt -116.69 100.55 7.89 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.969 -1.122 . . . . 73.5 107.969 173.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -85.32 102.31 13.28 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.647 -0.871 . . . . 71.22 108.647 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.531 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.9 t -92.13 119.78 40.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.133 -1.062 . . . . 73.11 108.133 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -103.7 135.08 45.93 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.391 0.615 . . . . 71.54 110.207 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -131.12 114.17 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.589 -1.187 . . . . 74.13 108.738 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 1.1 m -115.35 138.72 50.68 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 108.627 -0.879 . . . . 53.43 108.627 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.27 129.08 42.82 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.105 -0.702 . . . . 73.54 109.105 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 64.1 m -134.18 124.34 25.86 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.589 -0.523 . . . . 72.32 109.589 173.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 73' ' ' ALA . 9.5 mp -88.4 85.14 6.82 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.398 -0.964 . . . . 75.22 108.398 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 -82.59 1.64 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.011 -0.995 . . . . 70.14 110.711 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -27.15 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.122 0.969 . . . . 72.21 111.612 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -99.32 127.18 45.3 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.086 0.555 . . . . 72.14 110.239 -172.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 65.8 m -74.05 138.36 43.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.471 0.709 . . . . 63.12 111.909 -175.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -87.3 -64.06 1.21 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.63 1.172 . . . . 72.13 110.56 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -153.76 172.56 17.12 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.264 -0.88 . . . . 64.02 111.781 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.0 tp -141.53 137.95 32.38 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.813 -1.539 . . . . 35.12 107.799 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.9 m -121.86 139.62 53.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.702 0.801 . . . . 52.15 109.864 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 22.3 mp0 -137.25 122.78 19.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.614 1.166 . . . . 65.14 108.068 169.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.95 108.03 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 108.184 -1.043 . . . . 63.52 108.184 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -86.01 81.76 8.37 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 124.296 0.998 . . . . 74.11 108.314 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 69.5 tp60 -76.06 93.84 3.36 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.309 -0.997 . . . . 72.44 108.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.93 153.58 27.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.407 -0.815 . . . . 65.44 111.376 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.55 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.29 122.17 1.19 Allowed Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.083 -0.807 . . . . 43.43 111.083 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mt -82.78 116.3 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.397 0.679 . . . . 63.42 109.431 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HD2' HG12 ' A' ' 13' ' ' ILE . 31.6 m-85 -120.63 118.7 30.81 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 73.01 108.267 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 t -91.33 99.71 12.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.583 -0.895 . . . . 53.41 108.583 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.529 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -121.14 152.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.255 0.622 . . . . 40.4 111.191 -173.788 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 162.89 33.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.117 0.967 . . . . 72.14 109.843 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.61 -14.38 47.25 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.793 -0.448 . . . . 71.41 114.013 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.76 136.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.618 0.709 . . . . 74.12 109.676 177.233 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -145.56 175.28 10.46 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.99 1.316 . . . . 72.14 108.467 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.52 -121.45 26.63 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 123.439 0.462 . . . . 52.11 113.798 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -73.07 -25.7 61.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.285 0.634 . . . . 73.32 111.416 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -67.67 -47.11 70.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.446 0.698 . . . . 73.55 110.057 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.458 ' HA ' ' HB3' ' A' ' 97' ' ' CYS . 21.7 ttt -81.93 -19.47 40.68 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.571 -0.741 . . . . 75.45 110.518 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.22 73.67 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.599 0.36 . . . . 62.12 110.395 171.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -79.46 -37.56 36.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.357 0.663 . . . . 74.13 110.503 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.6 t -63.91 -44.76 92.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.228 0.611 . . . . 42.31 110.752 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.615 HD12 ' H ' ' E' ' 279' ' ' GLY . 15.9 mt -92.39 -9.42 41.77 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.53 0.332 . . . . 54.2 111.049 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.558 ' HA2' HD11 ' E' ' 280' ' ' LEU . . . -89.65 -29.04 17.27 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.28 0.472 . . . . 64.42 114.28 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.42 -46.14 0.14 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.485 0.55 . . . . 75.2 112.485 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.0 t80 -60.88 -65.63 0.66 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.053 0.941 . . . . 73.42 112.699 -171.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.4 m -70.75 -34.04 3.42 Favored Pre-proline 0 CA--C 1.565 1.52 0 C-N-CA 123.72 0.808 . . . . 71.44 112.647 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.524 ' HA ' HD11 ' A' ' 60' ' ' LEU . 98.0 Cg_exo -49.5 -39.85 45.31 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.263 1.975 . . . . 71.35 113.874 162.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.28 -12.79 61.64 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.364 0.665 . . . . 70.32 111.802 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -78.11 -48.38 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.285 -0.635 . . . . 75.41 109.285 171.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.55 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.0 mt -82.31 -28.43 31.69 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.917 0.887 . . . . 72.42 113.103 -170.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.23 -41.5 69.35 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.169 -0.92 . . . . 75.0 113.425 -172.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.33 -36.51 87.18 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.93 1.753 . . . . 74.15 113.138 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -69.89 -42.38 73.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.062 0.545 . . . . 75.0 111.452 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.0 94.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.176 0.591 . . . . 42.41 109.846 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -54.02 -51.86 62.64 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.676 1.235 . . . . 71.14 110.425 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.12 -47.04 86.36 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.395 1.06 . . . . 72.54 110.979 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.406 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 36.4 t -57.61 -43.56 84.8 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.082 0.864 . . . . 72.43 110.763 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 ' HB ' ' A' ' 62' ' ' VAL . 81.2 mt -65.81 -51.19 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 124.074 0.859 . . . . 64.43 110.303 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.453 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.4 m -53.96 -41.88 68.31 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.094 0.871 . . . . 73.51 111.096 -176.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.9 t -68.93 -45.82 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.63 -1.168 . . . . 71.13 110.471 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 17.2 mtp -56.76 -41.86 78.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.648 0.779 . . . . 52.03 111.428 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.498 HG21 HD23 ' A' ' 126' ' ' LEU . 73.5 t -66.1 -45.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.655 1.182 . . . . 64.21 110.544 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.4 p -73.52 -26.72 61.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.331 -0.395 . . . . 44.11 111.181 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.7 mtt-85 -73.81 -33.12 64.05 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.668 0.787 . . . . 52.31 109.399 172.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' B' ' 18' ' ' THR . . . -74.95 -1.38 62.57 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 115.437 -0.801 . . . . 73.41 112.686 170.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.34 31.98 17.14 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.744 2.018 . . . . 74.32 112.433 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -94.01 154.91 40.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.758 -1.201 . . . . 53.51 107.758 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.595 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 70.5 Cg_exo -51.78 142.19 42.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.776 2.318 . . . . 72.12 112.161 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.24 127.26 28.5 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.878 0.736 . . . . 73.12 111.516 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 118' ' ' VAL . 32.9 tp -111.05 95.18 5.38 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.608 -1.178 . . . . 64.4 109.294 -176.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -103.04 107.53 18.37 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.843 -1.169 . . . . 51.41 107.843 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.2 tp -72.39 134.15 45.28 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.381 -0.6 . . . . 65.32 109.381 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.475 ' HB2' HG21 ' G' ' 306' ' ' VAL . . . -63.63 141.24 97.9 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.578 0.751 . . . . 73.32 111.861 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 21.0 Cg_endo -87.21 110.91 0.81 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.562 2.174 . . . . 71.52 111.838 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.7 125.05 54.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.422 -0.955 . . . . 72.13 108.422 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -80.73 79.93 7.28 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -61.85 -34.21 75.57 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.6 -0.727 . . . . 73.23 110.041 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.08 -34.66 72.24 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.549 -1.205 . . . . 75.24 111.094 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -57.45 11.82 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 123.894 0.746 . . . . 75.44 111.245 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.99 -41.64 97.44 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.315 0.646 . . . . 73.11 110.281 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.3 -43.12 92.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.272 1.029 . . . . 74.11 110.31 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.68 -48.69 63.28 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 115.058 -0.974 . . . . 61.24 111.015 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -57.97 -44.5 87.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 123.921 0.763 . . . . 70.42 111.573 -174.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -65.8 -37.06 85.26 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.14 0.9 . . . . 72.21 110.87 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.31 -45.84 75.33 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.466 0.479 . . . . 73.11 111.472 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 179.53 -13.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.919 0.711 . . . . 73.33 112.919 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -76.02 146.56 39.39 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.196 0.443 . . . . 52.41 112.196 -168.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -168.53 -179.83 4.04 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.724 1.21 . . . . 73.22 109.476 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.13 97.06 0.08 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.196 0.598 . . . . 74.44 110.459 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.6 64.94 0.18 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.345 -1.102 . . . . 65.12 110.345 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.608 ' HG2' ' H ' ' C' ' 144' ' ' GLN . 36.6 mt-10 -60.34 125.41 23.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.113 0.965 . . . . 75.3 110.856 -176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.33 60.38 4.56 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.765 -0.534 . . . . 72.33 111.765 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.2 p -75.68 98.48 4.08 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.642 0.777 . . . . 60.43 110.656 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -147.96 136.86 21.95 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.872 0.869 . . . . 73.33 108.717 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 153' ' ' GLN . 30.3 tt0 -84.21 -67.16 0.82 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.726 0.81 . . . . 70.52 109.278 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.6 t60 57.0 16.85 3.04 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.483 1.113 . . . . 65.25 112.097 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.506 ' H ' ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -96.43 82.74 3.42 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.499 -1.297 . . . . 73.13 107.499 -176.209 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.73 141.68 32.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.699 -1.137 . . . . 64.33 109.393 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 C-N-CA 123.632 0.773 . . . . 75.23 110.024 -174.306 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.465 ' HB3' ' SD ' ' B' ' 138' ' ' MET . 25.1 mmt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.48 -0.563 . . . . 73.32 109.48 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 40.2 m -74.15 102.83 4.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.225 -0.898 . . . . 64.42 110.855 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -112.17 148.78 33.3 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.613 -0.514 . . . . 72.45 109.613 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -148.82 124.85 10.69 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.31 1.044 . . . . 72.41 108.69 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -105.27 70.71 0.9 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.782 0.801 . . . . 72.34 109.068 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -73.51 77.9 1.44 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.427 -1.26 . . . . 74.11 109.771 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' THR . . . . . 0.448 HG22 ' HB3' ' B' ' 9' ' ' MET . 36.3 m -154.55 124.22 6.59 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.177 0.991 . . . . 74.25 108.332 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.76 -48.76 80.33 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.987 0.915 . . . . 75.11 109.771 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.448 ' HB3' HG22 ' B' ' 7' ' ' THR . 21.5 ptm 47.87 -169.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 126.57 1.948 . . . . 71.11 114.529 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.687 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 19.9 m -140.22 123.25 16.65 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.948 -1.13 . . . . 71.43 107.948 173.344 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -146.67 113.71 6.17 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.175 -0.676 . . . . 72.25 109.175 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.66 140.12 27.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.885 -0.783 . . . . 74.11 108.885 165.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.683 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -90.66 126.81 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.275 -0.875 . . . . 70.54 108.816 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.69 -52.6 5.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.52 0.676 . . . . 73.0 109.988 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -151.07 132.9 15.02 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.944 -0.472 . . . . 73.12 110.878 -169.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.683 HG13 HD11 ' B' ' 13' ' ' ILE . 96.5 mt -114.36 140.73 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.214 -1.773 . . . . 63.04 106.214 166.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.427 ' HE1' HG13 ' B' ' 83' ' ' ILE . 34.9 p90 -164.09 150.73 11.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.416 0.627 . . . . 75.12 111.333 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.424 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 96.3 m -74.18 126.83 31.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.589 -1.187 . . . . 71.1 108.246 167.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -91.91 -48.04 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.769 -1.197 . . . . 71.41 107.769 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 21.5 m-20 -138.88 143.0 38.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 115.091 -0.959 . . . . 75.22 110.471 -165.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.5 mm -136.23 144.44 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.939 1.296 . . . . 72.53 109.164 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 60.3 m -142.83 135.29 27.62 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.201 1.4 . . . . 73.14 108.166 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.36 107.95 3.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.364 -1.717 . . . . 74.44 106.364 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.73 124.02 47.45 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.993 -0.743 . . . . 75.12 108.993 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -125.02 82.11 61.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 106.917 -1.512 . . . . 61.24 106.917 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.33 -22.11 34.5 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.317 2.678 . . . . 75.22 112.164 -172.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -122.64 29.77 6.75 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.751 1.22 . . . . 52.24 109.392 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.3 -45.42 42.8 Favored Pre-proline 0 CA--C 1.576 1.944 0 N-CA-C 115.819 1.785 . . . . 72.42 115.819 -173.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 59.8 Cg_endo -75.51 -30.12 6.79 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.543 1.496 . . . . 42.35 113.137 172.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 71.0 m80 -90.92 -15.2 30.22 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.322 0.86 . . . . 72.32 113.322 -170.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -19.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.927 0.891 . . . . 70.24 111.819 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.26 -19.11 64.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.977 1.311 . . . . 71.14 112.295 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 23.8 pt20 -64.36 -36.92 85.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.811 0.444 . . . . 62.32 110.442 175.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' B' ' 68' ' ' LEU . 90.5 mttt -106.34 65.48 0.68 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.671 -0.863 . . . . 72.03 108.671 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.28 100.43 5.1 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.322 -0.399 . . . . 73.32 110.045 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.475 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 163.41 -177.36 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 127.643 2.377 . . . . 75.32 109.731 156.5 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.547 ' HA ' ' HB3' ' H' ' 297' ' ' TYR . 0.0 OUTLIER -54.15 121.15 28.91 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.984 1.314 . . . . 61.51 114.175 -170.811 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.06 174.55 10.0 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.413 2.075 . . . . 75.34 110.816 163.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.57 103.23 6.45 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.481 -1.303 . . . . 73.53 107.481 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.72 141.13 14.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.864 -0.791 . . . . 72.31 108.864 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -132.65 130.85 40.7 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.355 -0.609 . . . . 72.12 109.355 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.409 HD22 HD11 ' B' ' 128' ' ' LEU . 4.4 pp -86.22 140.6 29.99 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.02 -1.104 . . . . 73.22 108.02 165.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.38 151.52 46.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.671 -1.233 . . . . 65.02 107.671 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.84 134.1 40.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.147 0.431 . . . . 73.35 110.171 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' B' ' 61' ' ' ARG . 7.8 m-20 -123.4 138.2 54.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.973 0.909 . . . . 63.31 109.06 173.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.2 p -109.62 146.75 34.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.207 0.603 . . . . 61.0 110.315 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.76 143.51 15.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.958 0.903 . . . . 70.35 108.933 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.2 p -141.75 160.93 39.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.895 0.316 . . . . 65.54 110.626 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.19 141.83 21.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.53 0.732 . . . . 64.43 110.446 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.44 121.83 30.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.438 0.695 . . . . 71.42 109.927 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 mt -94.17 -40.12 10.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 34.32 110.435 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.69 -168.33 1.78 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.728 -1.124 . . . . 71.24 109.716 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.66 112.77 14.82 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.164 -0.925 . . . . 60.02 109.387 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 65.26 3.95 2.45 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.184 1.394 . . . . 73.43 112.745 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 92.8 t -104.73 113.64 42.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.902 -1.148 . . . . 53.14 107.902 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.14 169.81 13.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.441 -0.8 . . . . 65.01 109.101 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -138.5 107.77 6.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.783 -0.821 . . . . 73.04 108.783 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.09 127.75 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.343 1.457 . . . . 62.21 109.577 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.69 132.29 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.888 0.875 . . . . 75.21 109.631 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' B' ' 103' ' ' PRO . 50.0 tp -124.5 118.3 26.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.942 -0.762 . . . . 75.54 108.942 171.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.455 ' HD2' ' HB2' ' B' ' 45' ' ' ASP . 28.9 ttm180 -84.17 133.22 34.61 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.127 -1.064 . . . . 74.11 108.127 169.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.97 116.58 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.193 -1.04 . . . . 74.34 108.193 169.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -104.98 146.43 29.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.808 1.243 . . . . 74.31 109.017 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.75 97.8 3.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 107.907 -1.146 . . . . 74.23 107.907 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.0 m -93.89 135.32 35.34 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.21 -0.663 . . . . 71.22 109.21 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.1 136.64 25.29 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.751 0.821 . . . . 51.13 108.887 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -147.66 130.3 15.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.154 0.582 . . . . 53.31 111.067 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 57.8 mt -98.99 104.85 16.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.374 1.069 . . . . 53.33 109.651 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.44 -110.23 3.2 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.908 -0.587 . . . . 71.32 111.643 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.94 4.71 14.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.73 0.812 . . . . 72.12 111.121 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.17 176.17 5.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.462 -0.569 . . . . 71.52 109.462 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 7.4 m -75.72 157.25 33.82 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.702 0.801 . . . . 65.52 110.34 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -110.18 -61.73 1.62 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.034 -0.728 . . . . 65.14 109.034 166.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -166.04 141.09 4.67 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.738 -1.119 . . . . 74.43 108.644 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.26 132.55 54.87 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.381 -0.97 . . . . 74.21 108.381 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.429 ' SG ' HG23 ' B' ' 114' ' ' ILE . 48.4 t -140.74 153.59 45.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.591 -0.892 . . . . 50.44 108.591 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.3 tt0 -166.18 141.59 4.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.134 -0.691 . . . . 75.54 109.134 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' B' ' 113' ' ' CYS . 86.2 t -129.45 146.29 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.257 -1.016 . . . . 75.4 108.257 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 49.2 mt-30 -122.54 96.93 5.23 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.96 -1.126 . . . . 72.03 107.96 171.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -92.85 106.85 18.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.877 -1.056 . . . . 72.04 108.811 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.34 171.58 35.34 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.632 -0.587 . . . . 73.02 111.632 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.83 126.99 1.54 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 112.056 -0.418 . . . . 70.02 112.056 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.8 mt -84.68 116.69 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.877 0.871 . . . . 73.2 109.038 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -124.0 146.83 48.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.467 1.107 . . . . 63.3 108.609 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 61.3 m -106.86 104.61 14.34 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.153 -0.684 . . . . 50.32 109.153 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -114.03 134.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.828 0.851 . . . . 73.14 109.693 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.5 167.9 29.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.522 1.129 . . . . 73.14 109.317 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.66 -50.21 4.32 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.323 0.389 . . . . 65.54 112.9 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -62.68 146.39 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.403 0.681 . . . . 72.12 111.504 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.3 178.46 6.21 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.731 0.813 . . . . 72.21 110.627 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -122.05 27.41 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 123.845 0.715 . . . . 63.05 113.536 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 92' ' ' THR . . . . . 0.482 HG22 HD13 ' B' ' 141' ' ' LEU . 4.7 m -78.3 -37.38 44.94 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.023 0.929 . . . . 72.12 110.569 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -76.03 -26.97 57.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.561 -0.745 . . . . 65.32 111.987 -166.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -66.11 -30.85 71.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.479 0.181 . . . . 74.14 110.693 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.52 75.72 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.868 0.73 . . . . 72.53 110.515 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 62.9 t-80 -76.01 -32.4 59.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.451 0.3 . . . . 73.0 110.896 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.47 -55.65 9.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.946 0.498 . . . . 72.44 110.629 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.75 -38.43 38.77 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.806 0.842 . . . . 72.52 110.0 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' H' ' 281' ' ' PHE . . . -86.68 -1.62 85.24 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.084 0.794 . . . . 55.25 115.084 -171.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -142.02 -56.88 0.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.909 0.855 . . . . 52.5 111.524 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.87 -46.03 47.27 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.451 0.537 . . . . 71.04 112.451 -170.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -62.04 -46.34 91.68 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.503 -0.761 . . . . 50.11 112.988 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.472 ' HB2' HD22 ' B' ' 60' ' ' LEU . 59.4 Cg_endo -68.9 -22.2 36.54 Favored 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 121.889 1.726 . . . . 74.23 112.849 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -71.76 -30.49 65.63 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.407 0.683 . . . . 71.41 111.13 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.52 -48.16 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 65.23 110.986 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.63 -10.78 57.03 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.866 -0.606 . . . . 72.22 111.941 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -56.5 -47.6 98.64 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-O 117.895 -1.05 . . . . 73.31 113.656 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.03 -31.3 53.03 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.531 2.154 . . . . 70.14 114.323 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -74.06 -43.64 57.08 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.12 0.568 . . . . 53.14 110.515 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.92 91.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.105 0.562 . . . . 62.04 110.4 174.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.701 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 52.7 ttt-85 -51.35 -53.72 33.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.081 1.752 . . . . 74.43 112.215 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -70.59 -34.01 71.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.308 0.643 . . . . 75.31 110.703 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.6 t -71.13 -30.41 66.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.04 0.536 . . . . 62.45 111.446 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.429 HG23 ' SG ' ' B' ' 76' ' ' CYS . 63.7 mt -65.28 -52.18 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 109.525 -0.546 . . . . 75.0 109.525 173.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -60.06 -34.08 72.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.926 0.89 . . . . 75.24 111.854 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -57.98 -49.8 75.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.549 0.74 . . . . 75.32 110.493 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.0 mmt -72.22 -34.32 68.25 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.665 0.786 . . . . 74.24 111.563 -173.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.88 -37.19 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.776 0.83 . . . . 73.1 110.798 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 119' ' ' SER . . . . . 0.422 ' HB2' ' OE1' ' C' ' 125' ' ' GLN . 3.6 t -74.18 -30.85 62.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.628 0.771 . . . . 52.21 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' B' ' 116' ' ' SER . 87.6 mtt-85 -67.02 -30.09 70.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.326 0.65 . . . . 74.22 110.295 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.41 12.99 59.32 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-O 119.468 -0.629 . . . . 55.11 113.554 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 17' ' ' TYR . 60.3 p 58.23 27.08 14.65 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.843 1.657 . . . . 75.25 113.364 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -91.8 165.26 21.0 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.07 0.948 . . . . 71.3 110.736 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.683 ' HG2' ' HA ' ' H' ' 297' ' ' TYR . 51.2 Cg_exo -59.55 177.48 0.44 Allowed 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.436 2.757 . . . . 70.15 115.696 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.757 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 67.3 tp60 -64.44 143.57 57.81 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.565 -1.198 . . . . 71.41 111.806 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 30.7 tp -134.77 93.02 2.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.998 -0.742 . . . . 74.41 108.998 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -92.86 98.89 11.67 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.46 -0.941 . . . . 74.22 108.46 173.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.701 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 42.8 tp -71.93 131.17 42.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.216 0.606 . . . . 60.51 109.764 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.25 151.5 56.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.835 0.854 . . . . 52.42 112.199 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -54.93 124.58 16.64 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.505 2.803 . . . . 75.12 113.297 171.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.61 112.64 40.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.633 -1.247 . . . . 65.21 107.633 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -79.94 83.44 5.85 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.657 -0.868 . . . . 70.23 108.657 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -62.05 -37.52 85.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.979 0.911 . . . . 63.43 111.125 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.42 -40.65 95.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.278 1.031 . . . . 72.11 111.649 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.37 -50.88 63.87 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.009 0.524 . . . . 42.44 111.223 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.32 -45.0 81.78 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.96 0.904 . . . . 72.34 110.934 -173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -71.14 -27.31 63.47 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.3 0.64 . . . . 71.31 111.226 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.465 ' SD ' ' HB3' ' B' ' 1' ' ' MET . 1.2 tmt? -62.89 -35.8 81.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.106 0.562 . . . . 53.31 110.518 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -75.78 -20.02 58.55 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.207 0.603 . . . . 75.04 111.023 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -75.22 -30.16 60.5 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.787 -0.449 . . . . 75.3 109.787 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 141' ' ' LEU . . . . . 0.482 HD13 HG22 ' B' ' 92' ' ' THR . 61.7 mt -99.92 31.41 3.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.704 0.802 . . . . 65.54 110.311 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -61.54 120.76 11.18 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.364 0.602 . . . . 74.11 111.515 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -161.85 171.83 17.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.115 1.366 . . . . 73.12 108.836 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -124.06 136.88 54.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.732 0.413 . . . . 62.24 110.262 -176.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.82 157.31 25.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.761 0.825 . . . . 50.21 111.458 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.72 -147.96 7.8 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.243 -0.743 . . . . 74.43 111.243 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.22 165.26 31.82 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.481 0.641 . . . . 70.22 111.109 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.4 43.31 1.33 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.915 -0.874 . . . . 72.44 110.915 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -76.63 158.57 30.98 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.445 0.698 . . . . 72.3 110.807 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.59 148.74 26.98 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.459 0.704 . . . . 74.4 110.379 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.512 ' HG2' ' H ' ' B' ' 152' ' ' HIS . 23.6 tt0 -164.19 176.32 9.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.582 -0.896 . . . . 73.45 108.582 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 152' ' ' HIS . . . . . 0.512 ' H ' ' HG2' ' B' ' 151' ' ' GLU . 55.4 p-80 -62.88 106.62 0.84 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.446 0.698 . . . . 64.02 111.075 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -80.35 74.98 7.18 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.25 -1.018 . . . . 64.03 108.25 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -66.14 130.17 42.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.917 -1.038 . . . . 72.4 110.601 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 C-N-CA 123.956 0.902 . . . . 73.11 109.06 -175.819 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.519 -0.548 . . . . 72.1 109.519 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m 59.78 -170.44 0.14 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.281 1.032 . . . . 61.15 112.565 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.8 149.74 30.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.889 0.876 . . . . 72.54 109.078 176.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 4' ' ' GLN . . . . . 0.427 HE21 ' HG2' ' C' ' 8' ' ' GLU . 8.4 tt0 -84.76 110.97 19.19 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.475 0.31 . . . . 74.31 110.181 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -62.01 -46.98 86.84 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.384 -0.826 . . . . 55.23 109.578 164.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 6' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' C' ' 7' ' ' THR . 8.7 p30 179.19 -17.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.599 1.159 . . . . 71.12 110.153 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 7' ' ' THR . . . . . 0.401 ' H ' ' H ' ' C' ' 6' ' ' ASN . 23.7 p -90.19 123.45 34.02 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.846 1.258 . . . . 75.15 111.76 -171.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 8' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' C' ' 149' ' ' THR . 7.0 pt-20 -161.39 -45.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.962 0.505 . . . . 74.1 111.859 175.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' C' ' 8' ' ' GLU . 56.8 ttp 63.81 112.63 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.565 1.546 . . . . 73.33 111.508 -164.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 28.6 m -87.6 97.65 10.98 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.253 -1.017 . . . . 45.0 108.253 172.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -124.51 140.58 52.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.623 -0.717 . . . . 65.14 109.971 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' C' ' 85' ' ' SER . 0.1 OUTLIER -161.05 140.63 10.61 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 125.174 1.39 . . . . 75.34 107.491 172.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.423 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.8 pp -74.59 130.25 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.249 -0.649 . . . . 64.43 109.249 176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -95.24 -46.52 6.72 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.314 -0.624 . . . . 64.52 109.314 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.488 ' NH1' ' HA ' ' G' ' 302' ' ' ASP . 28.4 ttt85 -169.78 151.47 4.23 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.666 0.604 . . . . 64.1 110.741 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.74 133.91 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.949 1.3 . . . . 70.24 107.546 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -171.0 157.05 5.1 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.433 0.635 . . . . 75.02 111.693 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.0 p -85.8 108.37 18.07 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.469 -0.787 . . . . 65.51 109.433 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 19' ' ' LYS . . . . . 0.423 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 13.0 mtmt -76.58 -35.95 57.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.441 0.639 . . . . 70.41 109.709 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.9 t70 -142.14 122.63 14.1 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.777 -1.102 . . . . 72.52 109.048 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -116.57 140.91 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.775 -1.565 . . . . 72.44 106.775 166.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -150.9 146.26 26.18 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.224 0.535 . . . . 72.21 110.203 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -152.43 109.8 3.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.491 -1.299 . . . . 74.43 107.491 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.7 116.27 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 74.52 108.551 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.01 89.78 10.16 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 106.914 -1.513 . . . . 73.24 106.914 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -49.99 0.92 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.595 2.196 . . . . 63.23 111.605 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.96 22.7 3.07 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 118.619 -0.705 . . . . 75.11 110.339 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.52 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -38.94 -53.3 3.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 115.524 1.676 . . . . 71.25 115.524 -171.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.7 Cg_exo -75.49 -39.41 1.06 Allowed 'Trans proline' 0 C--N 1.393 2.91 0 CA-C-N 121.472 1.561 . . . . 72.02 112.23 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.402 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.9 t60 -70.08 -26.23 63.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.643 1.177 . . . . 74.51 112.884 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -80.72 -22.71 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.754 0.422 . . . . 71.35 110.82 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.494 ' HA ' ' CH2' ' C' ' 36' ' ' TRP . 19.0 m-30 -62.87 -32.87 74.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.759 0.424 . . . . 71.41 111.38 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 12.2 pt20 -86.24 6.28 30.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.052 0.541 . . . . 73.3 111.415 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -100.4 144.08 29.82 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.39 0.676 . . . . 65.31 110.505 -179.041 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.62 122.59 15.08 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.921 0.888 . . . . 62.41 110.011 171.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.494 ' CH2' ' HA ' ' C' ' 32' ' ' PHE . 47.9 m95 -67.96 96.32 0.59 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.947 0.899 . . . . 71.23 112.147 -172.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -145.69 73.43 13.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.996 -0.547 . . . . 75.12 109.811 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -83.24 133.7 6.54 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.986 2.457 . . . . 72.54 112.41 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.7 91.66 8.36 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.253 -1.388 . . . . 73.44 107.253 167.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' C' ' 65' ' ' THR . 58.3 t -76.3 111.84 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.331 -0.849 . . . . 74.55 109.303 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 59.2 mttm -99.98 117.54 34.48 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.562 -0.903 . . . . 72.44 108.562 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.502 HD11 HD11 ' C' ' 128' ' ' LEU . 3.7 tt -86.6 122.34 30.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.333 -1.358 . . . . 73.43 107.333 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.514 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 18.9 m-20 -127.02 132.28 50.78 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.524 1.13 . . . . 64.12 109.13 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 44' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' F' ' 288' ' ' VAL . 33.5 mt -128.45 124.47 36.28 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.943 0.897 . . . . 73.05 109.37 174.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 16.6 t70 -116.31 150.86 36.97 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.647 1.179 . . . . 70.43 108.902 172.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 41.7 p -130.78 118.38 20.74 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.834 0.854 . . . . 62.01 109.649 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -125.69 149.1 48.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.834 0.854 . . . . 72.34 110.206 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -154.38 153.46 31.64 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.237 0.615 . . . . 61.44 110.802 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 71.6 p -157.37 152.31 25.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.252 0.621 . . . . 62.03 110.573 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -89.36 119.53 29.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.647 0.779 . . . . 71.0 109.265 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.1 mt -95.87 -31.61 13.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.114 0.566 . . . . 71.52 110.342 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.49 -172.87 3.32 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.083 0.953 . . . . 53.43 109.687 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -77.23 119.33 20.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.594 0.757 . . . . 63.23 109.265 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 69.89 -3.17 1.79 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.714 1.605 . . . . 73.13 112.556 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 81.5 t -104.34 115.2 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.631 0.772 . . . . 61.41 109.536 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.8 125.53 33.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.805 0.842 . . . . 71.21 108.878 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.2 tt0 -81.77 123.84 29.12 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.392 -0.596 . . . . 74.02 109.392 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -102.65 115.74 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.881 -1.155 . . . . 62.13 107.881 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.2 t -104.8 132.19 52.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.845 -0.798 . . . . 60.34 108.845 172.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.7 102.34 10.16 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.936 -1.505 . . . . 74.14 106.936 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 30.0 ttm180 -83.34 125.7 31.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.788 -0.819 . . . . 74.42 108.788 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.4 t -115.52 131.41 67.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.442 -1.318 . . . . 73.41 107.442 172.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 24.1 m -127.85 125.45 39.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.292 -1.003 . . . . 72.45 108.292 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.427 HG21 HG21 ' C' ' 114' ' ' ILE . 50.3 t -120.37 115.1 46.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.026 -0.731 . . . . 72.3 109.026 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.1 m -99.29 148.39 24.2 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 109.425 -0.583 . . . . 72.24 109.425 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.09 106.81 4.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.071 -1.085 . . . . 64.23 108.071 171.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.8 m -135.9 127.49 28.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.081 -0.34 . . . . 72.15 110.081 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.429 HD12 ' N ' ' C' ' 68' ' ' LEU . 4.2 mp -86.78 56.43 4.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.365 1.466 . . . . 43.41 108.238 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.34 -108.19 3.45 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 109.728 -1.349 . . . . 74.41 109.728 -173.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -25.61 17.37 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.193 0.997 . . . . 71.43 109.318 168.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -68.03 83.85 0.22 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.416 1.486 . . . . 60.2 110.884 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.1 m -73.55 120.35 19.03 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 121.083 0.468 . . . . 73.01 111.136 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.79 -55.72 7.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.536 -1.211 . . . . 74.2 108.847 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -167.16 169.36 12.75 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.789 -1.096 . . . . 71.02 111.477 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.85 138.51 49.88 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 105.232 -2.136 . . . . 51.15 105.232 165.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.6 t -139.88 111.99 7.58 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.888 -0.782 . . . . 70.22 108.888 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.45 128.12 52.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.019 0.527 . . . . 72.03 109.907 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.84 114.5 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.836 0.854 . . . . 73.13 108.75 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -88.73 91.05 8.66 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.911 -1.144 . . . . 70.52 107.911 170.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 69.7 tp60 -78.95 97.72 6.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.806 -1.088 . . . . 75.14 109.146 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.423 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -84.49 151.47 26.73 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.731 -0.668 . . . . 71.1 111.832 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.81 120.89 1.1 Allowed Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.823 -0.911 . . . . 53.52 110.823 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.452 HD12 HD11 ' C' ' 51' ' ' LEU . 17.7 mm -81.72 128.56 38.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.423 ' HE2' HG22 ' C' ' 13' ' ' ILE . 58.7 m-85 -137.62 151.62 48.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.38 -0.97 . . . . 44.41 108.38 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.544 ' HB2' ' NE2' ' C' ' 12' ' ' GLN . 34.9 m -111.31 121.49 45.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.824 -0.806 . . . . 53.53 108.824 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.555 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.9 mp -113.5 120.88 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.224 -1.399 . . . . 72.5 107.224 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.21 171.07 17.07 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.707 0.803 . . . . 61.44 110.326 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.51 -57.4 3.07 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.807 -0.633 . . . . 72.13 112.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' C' ' 9' ' ' MET . 2.6 pp -113.94 179.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.054 0.941 . . . . 71.3 111.013 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.44 -169.42 3.22 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.825 0.85 . . . . 75.24 109.706 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.73 -135.17 20.09 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.964 -0.353 . . . . 72.13 113.539 171.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -66.83 -28.6 68.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.767 0.827 . . . . 40.42 111.489 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -64.49 -43.13 95.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.202 0.601 . . . . 75.34 110.44 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.555 ' HG2' HG21 ' C' ' 86' ' ' ILE . 0.3 OUTLIER -72.73 -43.8 62.48 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.961 -0.563 . . . . 71.52 110.317 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.03 -30.94 71.97 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.433 0.693 . . . . 74.41 111.671 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -71.5 -41.81 68.81 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.657 0.783 . . . . 75.12 110.275 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.84 -40.63 91.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.83 0.452 . . . . 34.33 111.024 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.5 tp -73.67 -37.66 65.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.302 1.041 . . . . 60.34 110.875 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 -3.85 56.91 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 115.117 0.807 . . . . 70.44 115.117 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.3 -54.36 0.63 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.903 0.851 . . . . 52.21 112.052 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.84 -49.21 40.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.635 0.374 . . . . 72.13 111.978 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.1 m -68.8 -44.06 29.81 Favored Pre-proline 0 CA--C 1.569 1.674 0 CA-C-O 118.726 -0.654 . . . . 74.14 112.041 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.489 ' HG3' ' HZ ' ' F' ' 281' ' ' PHE . 61.3 Cg_exo -56.85 -37.65 97.65 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 122.703 2.269 . . . . 65.02 113.865 170.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -56.84 -38.69 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.892 0.877 . . . . 74.44 110.927 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -73.16 -47.16 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.177 -0.919 . . . . 74.33 111.2 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' C' ' 82' ' ' GLY . 98.0 mt -79.11 -24.33 43.47 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.923 0.712 . . . . 74.21 112.923 -170.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.68 -53.13 66.03 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.244 1.018 . . . . 71.24 113.568 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.7 -31.15 49.83 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.788 1.659 . . . . 62.34 112.809 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 115' ' ' THR . 79.8 m-85 -68.5 -38.52 81.04 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.241 0.616 . . . . 50.15 111.317 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.77 91.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.231 -0.441 . . . . 63.41 110.154 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -53.34 -59.89 3.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.084 0.954 . . . . 75.22 111.906 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 112' ' ' GLU . . . . . 0.44 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -65.27 -31.33 72.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 73.13 110.837 -172.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.482 ' SG ' HG12 ' C' ' 21' ' ' ILE . 47.5 t -69.09 -36.83 78.02 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.1 0.56 . . . . 71.32 111.457 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.532 HD11 ' HB ' ' C' ' 62' ' ' VAL . 96.7 mt -70.7 -50.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.638 0.775 . . . . 62.52 110.174 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.1 m -64.4 -29.14 70.21 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.574 0.749 . . . . 71.03 111.052 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 24.1 t -63.53 -49.94 71.53 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.596 0.758 . . . . 64.24 109.316 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.39 -40.34 82.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.569 1.148 . . . . 71.53 112.315 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.1 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.697 0.799 . . . . 72.52 109.852 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.455 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 41.4 t -65.92 -31.75 72.85 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.992 0.917 . . . . 62.3 112.188 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -73.98 -37.43 64.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.599 0.76 . . . . 73.53 110.817 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.18 6.08 64.77 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.469 0.481 . . . . 74.11 112.591 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 46.2 p 63.98 20.11 12.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.865 2.066 . . . . 73.23 113.145 174.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 123' ' ' PHE . . . . . 0.465 ' HA ' HD12 ' F' ' 301' ' ' ILE . 71.1 m-85 -84.82 141.2 38.01 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.292 1.037 . . . . 54.22 108.987 173.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.757 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 84.3 Cg_exo -53.07 140.16 60.56 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.811 3.008 . . . . 70.41 116.854 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.455 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 9.1 mm-40 -56.45 117.06 3.47 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.601 1.56 . . . . 72.41 113.175 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 66.6 tp -119.57 125.41 48.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.996 0.918 . . . . 52.1 108.91 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -121.55 132.58 54.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 71.35 109.388 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.502 HD11 HD11 ' C' ' 42' ' ' LEU . 0.1 OUTLIER -71.5 138.43 48.93 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.581 0.753 . . . . 74.11 109.808 179.019 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.54 161.02 79.41 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.25 1.02 . . . . 62.45 110.833 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.706 ' HG2' HG21 ' A' ' 13' ' ' ILE . 35.0 Cg_exo -59.58 108.64 0.48 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.275 1.983 . . . . 72.11 112.563 177.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.48 108.52 21.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.526 -1.287 . . . . 74.12 107.526 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -91.34 99.37 12.35 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.004 -1.11 . . . . 74.3 108.004 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -64.36 -38.54 91.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.546 -0.752 . . . . 75.24 110.393 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.8 -40.75 80.66 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 70.35 112.0 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.45 -42.28 95.8 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.886 0.741 . . . . 63.55 111.562 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.03 -46.01 92.47 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.154 0.982 . . . . 73.4 110.226 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -75.79 -22.58 56.24 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.393 0.677 . . . . 74.34 111.888 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 27.0 ttt -76.36 -32.79 58.82 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.832 0.853 . . . . 72.52 110.254 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -56.87 -38.52 72.85 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.602 0.761 . . . . 64.24 110.281 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -70.04 -87.2 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.093 0.957 . . . . 75.33 110.798 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.18 141.44 51.74 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.097 0.959 . . . . 64.51 108.985 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -107.98 110.17 21.82 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.845 0.858 . . . . 73.25 110.219 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 47.9 mt-30 -85.1 137.87 32.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.408 -0.814 . . . . 51.12 109.914 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.608 ' H ' ' HG2' ' A' ' 147' ' ' GLU . 43.3 mt-30 -125.17 100.27 6.47 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.037 0.935 . . . . 72.54 108.598 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -173.92 158.42 3.18 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.944 1.298 . . . . 53.34 109.359 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.96 53.99 0.05 OUTLIER Glycine 0 N--CA 1.47 0.918 0 N-CA-C 111.242 -0.743 . . . . 61.23 111.242 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.11 -38.26 85.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.665 1.186 . . . . 72.42 111.551 -171.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.66 159.79 10.02 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.294 -0.867 . . . . 74.0 111.389 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' C' ' 8' ' ' GLU . 9.3 t -78.08 133.62 37.87 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.047 0.539 . . . . 73.44 109.71 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -175.79 104.49 0.08 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.768 -1.197 . . . . 52.32 107.768 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.13 96.19 0.8 Allowed 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 108.477 -0.934 . . . . 74.41 108.477 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -146.02 -69.39 0.27 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.481 0.712 . . . . 74.3 109.561 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 58.46 89.58 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.219 1.407 . . . . 55.42 112.002 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -86.15 -49.41 7.78 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.043 -0.526 . . . . 74.53 110.458 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 C-N-CA 123.52 0.728 . . . . 74.23 109.704 -175.66 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.906 -0.405 . . . . 71.23 109.906 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 16.2 p -167.78 144.78 4.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.088 0.955 . . . . 54.44 109.135 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -81.76 72.28 8.8 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.647 0.737 . . . . 74.3 111.775 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -71.04 91.92 0.92 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.494 0.664 . . . . 70.04 109.944 173.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -67.99 86.3 0.24 Allowed 'General case' 0 C--N 1.355 0.838 0 N-CA-C 108.53 -0.915 . . . . 54.25 108.53 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -158.55 171.41 20.18 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 125.267 1.427 . . . . 53.42 107.443 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.9 p -79.53 68.44 5.57 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.55 0.69 . . . . 53.24 110.023 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -69.44 -54.51 13.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.285 1.034 . . . . 44.35 108.802 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 7.6 ttp 18.65 121.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 128.187 2.595 . . . . 72.51 116.14 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 21.4 m -118.44 139.32 51.6 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.192 -0.67 . . . . 72.22 109.192 169.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.75 94.38 0.95 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.447 -1.316 . . . . 72.43 107.447 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.56 123.24 37.26 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.854 -0.795 . . . . 64.53 108.854 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.582 HD13 HG21 ' D' ' 105' ' ' ILE . 5.8 mt -82.16 119.32 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.206 -0.665 . . . . 60.45 109.206 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' F' ' 304' ' ' PRO . 24.8 mt-30 -86.3 -34.21 20.4 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.374 -0.376 . . . . 75.32 111.104 -173.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -179.74 133.61 0.11 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.672 0.607 . . . . 61.34 110.094 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.475 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.2 mp -114.21 119.39 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.205 -1.776 . . . . 73.52 106.205 174.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.52 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 27.2 p90 -144.3 153.45 42.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 122.073 0.939 . . . . 74.22 110.16 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -85.27 113.69 21.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.235 -1.348 . . . . 71.35 108.766 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -78.79 -30.95 45.82 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.156 0.503 . . . . 74.55 109.769 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.0 142.3 24.21 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.482 -1.236 . . . . 54.53 109.89 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.3 mt -137.73 138.31 44.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.072 1.349 . . . . 74.01 107.96 173.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -139.4 136.82 35.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.301 1.04 . . . . 73.54 108.297 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -140.67 117.83 11.27 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.38 -1.711 . . . . 75.23 106.38 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 24' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.7 mt-10 -122.36 139.42 53.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.485 0.714 . . . . 65.51 109.158 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -127.29 79.91 72.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 106.906 -1.516 . . . . 73.21 106.906 173.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.25 -38.87 8.28 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.947 2.431 . . . . 41.21 113.036 -169.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -110.67 35.09 3.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.336 -0.987 . . . . 70.12 108.336 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.71 -66.53 0.6 Allowed Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 113.845 1.054 . . . . 24.13 113.845 -166.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' D' ' 28' ' ' ALA . 84.0 Cg_endo -74.69 -16.47 21.02 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 121.852 1.697 . . . . 71.21 112.653 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.6 t-160 -66.46 -42.3 87.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.925 1.29 . . . . 64.13 110.26 172.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.06 -41.48 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.492 0.717 . . . . 73.21 110.594 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -67.25 -15.38 63.66 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 124.02 0.825 . . . . 65.24 112.571 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -86.09 -7.57 58.51 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.506 1.122 . . . . 75.13 112.703 177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -127.31 114.62 17.82 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.678 1.191 . . . . 75.03 108.605 -172.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -98.42 95.26 7.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.428 1.013 . . . . 73.23 112.68 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.442 ' CH2' HD13 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -157.65 -179.54 8.26 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.859 0.864 . . . . 73.35 112.935 178.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -91.51 141.98 26.44 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 124.693 1.197 . . . . 54.5 112.185 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -91.74 124.5 0.8 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.578 2.852 . . . . 75.43 113.389 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.61 113.08 11.46 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.316 -0.994 . . . . 73.53 108.316 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -101.06 125.17 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.517 0.727 . . . . 74.1 110.498 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -109.56 144.33 38.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.1 0.96 . . . . 72.41 108.851 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.418 HD13 HG11 ' G' ' 288' ' ' VAL . 3.7 tt -119.59 124.45 46.38 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.49 -0.93 . . . . 64.24 108.49 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -108.82 133.43 52.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.516 1.126 . . . . 75.03 108.805 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.62 130.95 55.59 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.973 -0.751 . . . . 52.31 108.973 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.69 146.44 43.78 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.815 0.846 . . . . 62.04 108.943 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -125.45 147.3 49.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.364 0.665 . . . . 70.22 110.651 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.42 164.02 36.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.745 1.218 . . . . 63.24 108.872 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -175.6 154.33 1.59 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.745 0.818 . . . . 63.23 110.708 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -165.76 138.79 4.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.368 0.667 . . . . 63.24 110.462 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.95 123.82 24.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.896 0.479 . . . . 72.53 109.926 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.32 -41.61 10.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.158 0.583 . . . . 64.35 110.593 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 52' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -152.22 -174.92 5.05 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.276 0.63 . . . . 65.01 110.541 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.59 111.4 3.6 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.209 -0.905 . . . . 71.45 109.87 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 67.37 21.61 9.7 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.415 1.086 . . . . 63.23 110.956 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 81.8 t -126.52 117.51 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.398 1.079 . . . . 70.24 108.614 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.61 ' HB2' HD12 ' D' ' 86' ' ' ILE . 54.1 m-85 -131.0 137.25 49.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.206 1.002 . . . . 74.02 108.503 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.47 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -92.24 136.24 33.35 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.832 0.853 . . . . 71.24 109.362 173.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -118.65 118.66 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.373 -1.343 . . . . 75.45 107.373 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 40.1 t -103.13 130.81 52.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.613 -0.884 . . . . 72.21 108.613 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -124.15 108.28 12.14 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.846 -1.168 . . . . 62.2 107.846 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.9 ttm180 -86.26 117.88 25.35 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.977 -0.556 . . . . 73.02 109.79 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.1 t -104.62 121.55 56.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.887 -1.153 . . . . 71.2 107.887 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -120.32 139.44 52.75 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.566 -0.531 . . . . 64.15 109.566 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 83.8 t -128.33 102.26 8.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 65.3 108.451 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.4 p -98.49 93.71 6.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.231 -1.026 . . . . 71.13 108.231 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.57 142.07 32.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.513 -1.221 . . . . 71.54 109.684 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 52.1 p -155.52 130.43 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 122.931 0.492 . . . . 54.51 110.717 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.672 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.2 OUTLIER -121.79 137.83 54.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.655 1.182 . . . . 54.1 109.461 177.214 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -113.43 4.0 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.392 0.433 . . . . 73.44 112.855 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.84 3.84 10.55 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.606 0.763 . . . . 74.45 110.288 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -130.69 173.5 10.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.144 0.578 . . . . 75.22 111.917 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 68.6 m -74.31 139.42 44.18 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.069 -0.969 . . . . 74.04 109.958 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.672 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -81.85 -70.66 0.53 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.802 -0.814 . . . . 44.32 108.802 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.54 139.78 18.48 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.155 -0.93 . . . . 72.23 109.552 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 75' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 96.3 mt -105.82 109.0 20.81 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.065 -1.087 . . . . 74.32 108.065 174.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.9 t -125.36 114.4 18.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.311 -0.626 . . . . 60.41 109.311 -174.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.17 122.24 17.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.14 -0.689 . . . . 53.34 109.14 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.86 117.61 48.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.836 0.854 . . . . 63.22 109.215 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.29 86.72 6.9 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.239 -1.023 . . . . 72.11 108.239 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.97 94.88 6.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.667 -1.151 . . . . 70.42 109.32 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.77 146.43 19.93 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.431 -0.668 . . . . 62.45 111.431 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.43 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -145.47 131.82 4.36 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.912 -0.875 . . . . 52.55 110.912 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 42.5 mt -90.24 131.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.897 -0.779 . . . . 62.33 108.897 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -132.51 139.93 48.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.24 0.616 . . . . 75.14 110.162 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -80.14 102.1 9.19 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 107.912 -1.144 . . . . 71.05 107.912 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' D' ' 56' ' ' TYR . 58.2 mt -106.6 110.31 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.378 -0.601 . . . . 63.33 109.378 -175.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -152.73 165.1 36.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.285 1.034 . . . . 72.13 110.18 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.33 44.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.733 0.653 . . . . 71.11 114.733 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.477 HD11 HG23 ' D' ' 86' ' ' ILE . 28.8 pt -124.94 147.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.907 1.283 . . . . 61.21 108.503 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.37 177.55 11.32 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 71.32 110.95 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.95 -137.44 46.12 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 123.596 0.56 . . . . 63.42 113.782 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -80.21 -15.77 56.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.515 0.726 . . . . 52.44 111.655 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.85 -51.13 66.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.303 0.641 . . . . 72.44 109.802 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -73.32 -28.79 62.27 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.612 -0.722 . . . . 63.15 110.303 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' G' ' 279' ' ' GLY . . . -68.81 -32.66 72.53 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.831 0.453 . . . . 74.34 111.017 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -72.97 -40.68 65.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.807 0.843 . . . . 73.22 110.552 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -65.63 -44.66 85.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.267 0.627 . . . . 61.02 110.606 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.481 ' HB3' ' HE1' ' G' ' 281' ' ' PHE . 3.8 mm? -77.73 -20.18 53.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.078 0.951 . . . . 75.34 111.403 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 13.93 57.74 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.73 -0.483 . . . . 65.13 113.456 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.59 -64.04 0.09 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.031 0.416 . . . . 63.11 111.978 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -72.53 -48.96 36.12 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.418 0.687 . . . . 72.14 112.654 -167.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 59.9 m -63.58 -45.57 83.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.578 0.751 . . . . 43.24 112.506 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 43.7 Cg_exo -61.88 -30.97 84.74 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.261 1.974 . . . . 73.02 113.439 171.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -66.54 -28.24 68.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.768 0.827 . . . . 74.05 110.755 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.582 HG21 HD13 ' D' ' 13' ' ' ILE . 40.9 mm -67.82 -46.4 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.222 0.609 . . . . 75.23 110.478 174.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.43 HD21 ' HA3' ' D' ' 82' ' ' GLY . 64.9 mt -76.99 -23.37 52.27 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.231 -0.895 . . . . 74.03 111.734 -170.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -66.08 -44.22 59.42 Favored Pre-proline 0 CA--C 1.569 1.7 0 N-CA-C 113.572 0.953 . . . . 73.13 113.572 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.85 -32.46 95.37 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.42 2.08 . . . . 72.03 113.725 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.09 -31.68 50.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.206 0.602 . . . . 74.25 111.232 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.64 -51.6 58.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.333 -0.618 . . . . 50.44 109.333 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.15 -49.42 69.29 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.752 1.282 . . . . 64.11 111.069 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.53 -45.86 91.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.196 0.935 . . . . 75.32 110.783 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.1 -45.13 87.75 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.801 0.688 . . . . 73.3 110.997 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' D' ' 76' ' ' CYS . 73.5 mt -64.57 -53.41 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.021 0.928 . . . . 72.12 110.786 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -53.91 -42.97 69.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.347 1.059 . . . . 64.24 111.564 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.8 t -67.77 -32.07 72.4 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.275 -0.875 . . . . 64.32 111.666 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -80.04 -36.05 36.28 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.668 0.387 . . . . 65.32 111.999 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' D' ' 114' ' ' ILE . 47.4 t -67.14 -34.99 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 122.979 0.511 . . . . 61.05 110.025 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -69.42 -33.89 73.66 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.363 0.665 . . . . 72.14 111.27 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.8 mtt-85 -68.96 -34.14 74.86 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.282 0.633 . . . . 75.22 110.994 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.01 8.76 65.48 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.209 -0.45 . . . . 74.14 113.196 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p 61.93 20.86 11.86 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.616 1.966 . . . . 74.23 113.567 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 47.9 m-85 -87.83 167.16 21.17 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.653 1.181 . . . . 71.5 107.862 165.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.561 ' HB3' ' HB3' ' G' ' 297' ' ' TYR . 72.9 Cg_endo -67.82 -166.5 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.614 2.209 . . . . 70.15 113.875 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -75.24 156.6 35.57 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.679 -0.691 . . . . 70.21 110.851 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.6 tp -127.61 95.23 4.18 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.456 -1.313 . . . . 70.43 107.456 164.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.667 ' HB3' HD12 ' B' ' 13' ' ' ILE . 78.6 m-20 -99.2 89.55 4.27 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.187 -1.042 . . . . 74.23 108.187 -175.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 123.06 17.32 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.172 -0.922 . . . . 73.5 110.687 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.67 124.04 86.31 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.641 0.776 . . . . 71.22 110.405 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.31 127.36 11.84 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.284 1.99 . . . . 34.11 111.692 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.49 133.85 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.801 0.84 . . . . 72.12 109.165 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -76.64 85.18 3.3 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.966 -0.753 . . . . 53.41 108.966 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -65.09 -33.45 76.06 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.744 -0.662 . . . . 63.34 110.791 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' D' ' 138' ' ' MET . 3.7 t70 -60.21 -57.63 11.98 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.604 1.161 . . . . 64.25 110.856 -173.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.33 96.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.292 1.037 . . . . 53.03 112.657 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 91.9 mt -70.17 -34.09 72.56 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.361 0.664 . . . . 73.44 111.704 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -65.77 -32.27 73.71 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.089 0.956 . . . . 71.55 111.027 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 48.3 mtt -61.27 -42.63 98.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.037 0.935 . . . . 71.35 111.032 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.58 -31.28 71.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.889 0.876 . . . . 71.1 111.759 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -69.71 -36.22 75.74 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.54 -0.755 . . . . 71.25 111.053 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.7 mp -68.86 -24.51 64.35 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.197 0.999 . . . . 71.43 112.205 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -71.29 2.56 4.59 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.984 0.914 . . . . 72.24 112.337 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -116.7 92.49 3.88 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.874 -1.158 . . . . 74.35 107.874 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -143.54 165.87 26.38 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.555 0.742 . . . . 72.2 110.203 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.14 145.4 29.55 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.089 0.555 . . . . 72.34 109.524 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.93 64.33 3.92 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.544 0.528 . . . . 40.22 111.923 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.1 130.73 43.06 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.17 -1.419 . . . . 72.31 107.17 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.72 58.58 0.43 Allowed Glycine 0 C--N 1.344 1.004 0 O-C-N 123.081 0.238 . . . . 44.22 112.802 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.0 p -66.63 96.85 0.41 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.909 0.385 . . . . 74.12 110.368 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.51 -39.96 9.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.76 0.824 . . . . 72.43 109.862 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 64.62 131.8 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.898 1.679 . . . . 73.55 113.867 170.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -117.38 147.12 42.94 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.484 1.113 . . . . 64.22 109.801 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -156.77 159.58 38.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.522 0.729 . . . . 71.01 110.618 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -116.21 164.68 14.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.049 0.94 . . . . 54.25 111.57 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 124.57 1.148 . . . . 44.24 108.572 173.849 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.965 -0.383 . . . . 74.24 109.965 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -84.4 132.46 34.58 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.24 0.616 . . . . 73.11 109.808 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -79.75 -58.44 3.18 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.078 -0.712 . . . . 74.31 109.078 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 58.38 -171.81 0.1 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.75 1.22 . . . . 72.25 111.757 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt 52.89 84.23 0.21 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.751 1.22 . . . . 70.44 111.401 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.63 103.05 0.37 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 121.755 1.637 . . . . 75.53 109.761 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tt -75.9 73.05 2.81 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.578 -1.267 . . . . 73.14 107.578 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 90.4 mt -142.64 -170.03 3.12 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 125.689 1.596 . . . . 72.45 108.17 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 279' ' ' GLY . . . . . 0.615 ' H ' HD12 ' A' ' 98' ' ' LEU . . . -106.35 -120.68 4.68 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 111.596 -0.602 . . . . 75.13 111.596 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.558 HD11 ' HA2' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -95.53 -117.59 0.11 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 118.414 -0.803 . . . . 33.41 110.77 177.814 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 76.93 -43.65 0.45 Allowed 'General case' 0 C--N 1.37 1.484 0 C-N-CA 125.946 1.699 . . . . 71.13 111.13 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.26 86.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.509 0.723 . . . . 74.34 110.686 168.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -125.72 173.22 9.18 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.007 0.923 . . . . 74.01 110.434 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 72.79 83.17 0.28 Allowed Glycine 0 C--N 1.349 1.257 0 O-C-N 123.919 0.762 . . . . 42.21 112.247 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -39.77 87.45 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.157 0.983 . . . . 50.23 110.862 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 5.8 tpt 64.68 93.73 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.642 1.177 . . . . 74.15 110.577 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.34 101.13 0.29 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.726 2.284 . . . . 71.22 111.806 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 90.7 t -82.73 -63.49 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.889 0.875 . . . . 74.11 110.32 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 66.05 145.88 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.224 1.41 . . . . 75.41 111.616 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.6 135.31 37.22 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.413 -0.588 . . . . 73.5 109.413 173.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.5 109.45 19.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.483 0.713 . . . . 74.4 109.716 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.35 -167.99 54.33 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 115.569 -0.742 . . . . 63.22 112.619 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.05 120.41 7.39 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.326 2.018 . . . . 72.11 111.471 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 294' ' ' LYS . . . . . 0.599 ' HD3' ' H ' ' E' ' 294' ' ' LYS . 0.0 OUTLIER -84.44 68.68 10.36 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.551 0.741 . . . . 71.03 110.783 -177.515 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 295' ' ' ALA . . . . . 0.563 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . . . -134.57 86.71 2.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.195 0.598 . . . . 74.43 110.946 -174.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 296' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 124' ' ' PRO . 25.7 m -66.35 -42.15 88.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.993 0.917 . . . . 73.14 112.447 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.595 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -75.66 140.16 42.38 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.617 0.767 . . . . 75.33 110.051 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -163.42 23.73 0.08 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.707 0.803 . . . . 74.25 110.143 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 110.23 -136.29 13.48 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.039 -0.867 . . . . 52.0 111.353 -170.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 68.65 -67.79 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.685 1.594 . . . . 64.31 110.613 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 40.8 pt -78.87 23.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.913 0.885 . . . . 71.12 112.658 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.42 -65.85 0.59 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.682 1.593 . . . . 43.13 112.109 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -110.41 101.71 49.28 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.169 0.588 . . . . 75.42 110.372 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -91.9 5.92 3.55 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.1 2.533 . . . . 72.11 113.593 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.6 76.36 1.5 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.871 0.469 . . . . 73.31 110.419 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.42 -36.17 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.913 0.885 . . . . 71.43 111.826 -171.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 41.0 m -145.33 135.73 24.13 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.067 0.547 . . . . 75.3 110.536 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 77.2 m -104.04 85.47 2.4 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.906 0.882 . . . . 73.42 109.833 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 68.5 p -78.19 169.55 20.35 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 123.638 0.775 . . . . 71.15 110.206 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo . . . . . 0 C--N 1.381 2.286 0 C-N-CA 122.171 1.914 . . . . 74.43 112.468 167.659 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 110.466 -0.198 . . . . 51.4 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -101.52 -173.87 2.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.83 0.852 . . . . 62.34 110.133 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -159.86 -57.93 0.06 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.724 0.81 . . . . 73.44 109.039 176.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -111.14 152.36 27.09 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.931 0.893 . . . . 55.31 110.263 -177.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 275' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' F' ' 278' ' ' LEU . 5.8 ttpm? -151.12 79.52 6.84 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.465 -0.939 . . . . 52.12 108.465 175.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.12 -16.46 17.79 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.137 2.558 . . . . 60.02 112.92 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 277' ' ' LEU . . . . . 0.521 ' HA ' ' HG3' ' C' ' 94' ' ' MET . 49.8 mt -96.96 42.77 1.08 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.526 0.731 . . . . 74.44 110.707 -175.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.532 ' HB3' ' HE2' ' F' ' 275' ' ' LYS . 0.3 OUTLIER -172.29 92.44 0.12 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 106.791 -1.559 . . . . 53.24 106.791 175.337 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -133.15 25.77 3.63 Favored Glycine 0 N--CA 1.478 1.444 0 CA-C-N 116.392 -0.367 . . . . 70.53 112.367 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 22.0 tp -163.82 167.5 20.74 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.051 -1.092 . . . . 71.1 108.051 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 281' ' ' PHE . . . . . 0.489 ' HZ ' ' HG3' ' C' ' 103' ' ' PRO . 2.6 m-85 67.74 -168.65 0.19 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.925 0.89 . . . . 73.13 111.004 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 64.91 97.78 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.705 1.202 . . . . 64.31 111.448 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 28.2 t70 63.61 42.01 6.76 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.665 1.186 . . . . 75.24 110.755 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -138.45 156.22 23.95 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 114.863 -1.062 . . . . 73.12 111.383 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -122.36 171.49 9.02 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.917 0.887 . . . . 74.55 110.061 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 90.7 mtp -125.6 136.9 28.96 Favored Pre-proline 0 N--CA 1.474 0.773 0 N-CA-C 108.57 -0.9 . . . . 70.24 108.57 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.62 44.93 1.79 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.397 2.731 . . . . 74.41 112.582 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 288' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' C' ' 44' ' ' LEU . 97.5 t -77.48 103.18 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.479 -0.934 . . . . 74.01 108.479 174.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 65.1 mtt-85 -98.0 -179.45 4.41 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.95 0.9 . . . . 72.23 109.463 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -69.22 155.44 40.39 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.343 0.592 . . . . 70.41 110.699 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.87 -7.32 57.36 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.882 -1.054 . . . . 61.14 110.305 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -140.28 -174.42 13.86 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.681 -0.968 . . . . 70.53 110.681 173.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.6 -61.62 0.12 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.828 2.352 . . . . 73.45 112.026 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -173.84 150.77 1.7 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.167 0.987 . . . . 63.35 109.543 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -173.78 87.86 0.06 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.768 0.827 . . . . 71.21 109.405 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 296' ' ' THR . . . . . 0.538 HG22 ' HD2' ' F' ' 297' ' ' TYR . 3.5 m -149.6 162.26 40.55 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.113 -0.699 . . . . 71.31 109.113 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.538 ' HD2' HG22 ' F' ' 296' ' ' THR . 2.2 m-85 71.02 -159.92 0.13 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.782 1.233 . . . . 72.24 110.786 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 71.15 17.03 6.17 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.192 0.997 . . . . 71.22 110.778 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.1 -127.81 5.7 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.966 -0.561 . . . . 35.24 112.577 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -106.34 110.49 22.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.783 0.833 . . . . 72.42 109.598 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' C' ' 123' ' ' PHE . 16.7 tt -162.71 152.45 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 124.244 1.018 . . . . 72.44 108.969 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 36.5 t70 70.31 -174.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.266 1.026 . . . . 55.55 110.283 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 80.15 137.2 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 126.098 1.759 . . . . 71.54 111.159 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 304' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' D' ' 14' ' ' GLN . 55.3 Cg_endo -71.03 101.03 1.03 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.97 2.447 . . . . 71.13 111.578 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.4 -53.44 8.15 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.596 0.758 . . . . 63.44 111.603 -176.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 306' ' ' VAL . . . . . 0.661 HG13 HG23 ' F' ' 309' ' ' THR . 91.5 t -72.84 96.46 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.695 0.798 . . . . 64.13 109.762 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 40.2 p -129.67 -36.36 1.63 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.859 1.264 . . . . 65.21 110.252 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 43.6 t -88.54 -2.78 58.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.056 0.943 . . . . 73.5 112.059 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' F' F ' 309' ' ' THR . . . . . 0.661 HG23 HG13 ' F' ' 306' ' ' VAL . 6.2 t -141.14 149.92 57.05 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.989 0.916 . . . . 73.14 108.835 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 C--N 1.379 2.14 0 C-N-CA 122.182 1.921 . . . . 75.44 111.542 171.137 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.975 -0.38 . . . . 61.04 109.975 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -85.62 -57.37 3.08 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.615 0.766 . . . . 74.31 109.408 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -167.53 108.14 0.59 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.458 1.103 . . . . 72.43 108.972 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -169.74 150.29 3.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.528 0.731 . . . . 72.51 109.46 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 275' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' G' ' 275' ' ' LYS . 0.1 OUTLIER -76.45 107.92 5.45 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.322 -0.992 . . . . 73.32 108.322 176.581 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.77 -39.77 24.79 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.14 2.56 . . . . 63.53 112.727 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 97.2 mt -128.78 84.71 2.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.467 0.707 . . . . 71.33 110.704 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.34 17.45 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.939 0.896 . . . . 71.41 109.476 168.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 279' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' D' ' 95' ' ' ALA . . . 62.86 -106.92 1.43 Allowed Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.182 -0.463 . . . . 44.31 113.366 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.31 17.74 0.34 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.74 0.816 . . . . 72.21 110.684 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 281' ' ' PHE . . . . . 0.481 ' HE1' ' HB3' ' D' ' 98' ' ' LEU . 77.6 m-85 -64.45 -18.2 64.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.571 0.748 . . . . 64.11 112.274 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.95 79.0 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.899 0.88 . . . . 50.12 111.479 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -157.24 99.53 1.79 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.44 0.696 . . . . 63.12 109.296 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.19 111.41 0.24 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.39 -0.368 . . . . 64.54 112.816 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -139.28 162.8 34.11 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.219 1.408 . . . . 60.43 108.715 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 18.1 ptm -143.2 103.5 5.13 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 122.928 0.491 . . . . 72.44 109.948 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.55 108.48 1.85 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.651 2.234 . . . . 73.01 110.458 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 288' ' ' VAL . . . . . 0.418 HG11 HD13 ' D' ' 42' ' ' LEU . 13.9 p -62.55 -31.16 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.318 0.647 . . . . 72.0 111.218 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 67.24 3.08 3.07 Favored 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 124.414 1.086 . . . . 74.54 112.196 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.418 ' H ' HG13 ' G' ' 288' ' ' VAL . 87.6 m95 70.45 153.81 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.29 1.436 . . . . 65.31 111.459 -163.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.407 ' N ' HD12 ' G' ' 291' ' ' LEU . 3.0 mp -97.44 28.9 3.48 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.546 0.738 . . . . 75.51 109.795 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 89.34 83.53 1.31 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.311 -0.716 . . . . 70.05 112.423 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.14 153.34 46.29 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.626 2.217 . . . . 73.34 112.661 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -130.92 84.76 2.21 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.402 0.681 . . . . 64.3 109.217 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . 62.02 -172.32 0.15 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.916 0.887 . . . . 70.22 110.825 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 2.0 m -146.94 -32.18 0.31 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.284 -1.006 . . . . 70.23 108.284 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.564 ' HE1' HG12 ' G' ' 301' ' ' ILE . 3.5 p90 -153.61 169.38 23.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.671 0.789 . . . . 74.43 110.228 169.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -154.63 138.46 16.23 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.827 0.851 . . . . 75.24 108.823 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 121.83 -172.38 15.46 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 110.46 -1.056 . . . . 71.21 110.46 -174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.02 138.0 40.61 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.926 -0.398 . . . . 63.34 109.926 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.564 HG12 ' HE1' ' G' ' 297' ' ' TYR . 7.5 mt -78.55 -47.4 23.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.697 -0.853 . . . . 73.01 108.697 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 302' ' ' ASP . . . . . 0.488 ' HA ' ' NH1' ' C' ' 15' ' ' ARG . 7.0 p-10 -72.82 172.58 10.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.024 -1.443 . . . . 71.1 110.744 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -147.68 103.17 3.68 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.143 -0.688 . . . . 74.25 109.143 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.99 139.58 8.52 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.868 2.379 . . . . 75.25 112.171 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -170.12 -60.16 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.778 0.831 . . . . 71.34 110.154 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 129' ' ' ALA . 42.1 t -95.92 108.58 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.406 0.682 . . . . 73.21 110.19 -174.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 6.2 p -111.96 121.06 43.98 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.362 -0.977 . . . . 52.52 108.362 171.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 22.8 t 59.63 -164.73 0.21 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.977 1.311 . . . . 54.02 110.42 -172.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 51.4 m -132.35 72.82 78.03 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 108.148 -1.056 . . . . 60.32 108.148 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 C--N 1.384 2.434 0 C-N-CA 123.321 2.681 . . . . 73.42 111.74 177.86 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.451 -0.574 . . . . 61.05 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 66.8 156.21 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.105 1.362 . . . . 62.04 113.445 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.72 124.04 48.14 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.724 -1.126 . . . . 74.13 109.098 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -114.89 129.73 56.76 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.764 -0.828 . . . . 74.2 108.764 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -124.49 86.04 55.56 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.87 0.868 . . . . 61.12 109.905 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 276' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' H' ' 278' ' ' LEU . 92.0 Cg_endo -88.67 -174.76 1.1 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.269 1.979 . . . . 73.33 111.129 165.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.77 32.63 1.59 Allowed 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.456 0.646 . . . . 73.33 109.822 175.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 278' ' ' LEU . . . . . 0.607 HD13 ' H ' ' H' ' 279' ' ' GLY . 0.4 OUTLIER -153.9 156.36 37.4 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 106.971 -1.492 . . . . 74.35 106.971 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' H' H ' 279' ' ' GLY . . . . . 0.607 ' H ' HD13 ' H' ' 278' ' ' LEU . . . 122.9 6.55 7.69 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.535 -0.626 . . . . 72.55 111.535 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 6.8 tt -138.86 161.88 36.18 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 107.332 -1.358 . . . . 52.43 107.332 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 281' ' ' PHE . . . . . 0.48 ' CD1' ' HA2' ' B' ' 99' ' ' GLY . 57.1 t80 74.24 75.6 0.12 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.072 0.949 . . . . 72.54 109.245 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -152.97 3.39 0.32 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.889 -1.05 . . . . 65.24 111.256 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -127.37 123.6 36.63 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.812 -0.81 . . . . 75.51 108.812 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.42 -84.49 0.11 Allowed Glycine 0 C--N 1.347 1.147 0 O-C-N 123.598 0.561 . . . . 73.15 112.045 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 71.69 -15.65 0.43 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.613 1.165 . . . . 75.35 113.452 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 63.9 mtt -61.72 107.41 1.12 Allowed Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.007 0.923 . . . . 63.21 111.366 -167.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.23 61.44 2.37 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.174 2.583 . . . . 53.22 110.962 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.22 117.71 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.735 -0.839 . . . . 65.03 108.735 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -87.36 43.65 1.12 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.923 0.889 . . . . 73.41 109.757 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 4.2 m95 64.36 175.16 0.19 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.702 1.201 . . . . 61.21 112.546 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 78.3 mt -130.53 43.43 3.11 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.732 -1.577 . . . . 74.4 107.546 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -170.11 -172.25 36.39 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 115.242 -0.89 . . . . 72.23 113.501 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.34 -10.79 27.35 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.666 2.911 . . . . 41.4 114.853 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? 59.32 22.84 11.23 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.583 1.153 . . . . 73.55 111.477 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -131.36 65.43 1.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.627 1.171 . . . . 63.23 108.831 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 84.2 m -63.53 -45.57 89.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.19 0.996 . . . . 73.15 111.862 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.683 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 0.8 OUTLIER -84.49 69.3 10.54 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.78 1.232 . . . . 71.43 109.796 -175.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -72.4 -82.2 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.908 -0.587 . . . . 54.42 109.89 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -158.58 19.5 0.31 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-O 119.536 -0.591 . . . . 25.23 113.791 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -87.59 63.61 7.67 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.291 1.043 . . . . 71.12 108.52 170.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 14.4 tt -116.16 -24.32 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.924 1.29 . . . . 74.41 107.66 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.55 91.93 1.87 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.463 -1.244 . . . . 73.44 108.925 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -97.21 144.21 27.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.317 -1.364 . . . . 64.42 107.317 165.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.1 79.13 2.09 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.177 1.918 . . . . 51.34 110.356 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -71.83 172.76 9.27 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 114.555 -1.202 . . . . 73.43 110.365 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 306' ' ' VAL . . . . . 0.563 HG13 HG23 ' H' ' 309' ' ' THR . 48.7 t -64.96 97.76 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 109.32 -0.622 . . . . 71.04 109.32 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 25.0 m -72.85 -49.18 31.7 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.31 -0.996 . . . . 60.0 108.31 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 42.2 t -172.61 119.69 0.38 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.215 -1.357 . . . . 71.54 108.472 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' H' H ' 309' ' ' THR . . . . . 0.563 HG23 HG13 ' H' ' 306' ' ' VAL . 11.7 p -78.99 149.62 73.78 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.19 0.596 . . . . 73.12 110.019 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 C--N 1.378 2.101 0 C-N-CA 123.037 2.492 . . . . 55.01 111.455 173.763 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 108.608 -0.886 . . . . 74.43 108.608 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 m 61.0 78.68 0.28 Allowed 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.257 0.973 . . . . 65.12 111.395 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.31 67.42 8.32 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.259 0.624 . . . . 74.13 110.082 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -156.7 113.3 3.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.752 -1.203 . . . . 33.31 107.752 171.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 93' ' ' GLN . 29.9 p30 -166.43 -12.14 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.472 -0.786 . . . . 75.44 111.416 -169.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -101.28 97.59 8.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.962 0.905 . . . . 54.23 110.759 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -120.2 -71.26 0.74 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.79 0.836 . . . . 72.43 108.957 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -164.18 175.06 10.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.567 1.147 . . . . 72.42 108.987 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 90.6 mtp -136.33 150.44 48.86 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.891 0.477 . . . . 74.14 110.643 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 96.8 m -142.25 126.32 17.37 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.291 1.036 . . . . 62.23 108.483 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.663 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.1 t80 -139.63 135.56 33.43 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.717 0.636 . . . . 63.52 110.511 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -154.44 126.16 7.58 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.9 mt -81.32 113.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.604 -0.887 . . . . 74.2 108.604 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -79.13 -31.05 43.98 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.16 0.913 . . . . 64.43 109.771 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -173.25 143.64 1.12 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.361 0.664 . . . . 72.1 110.293 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.63 140.2 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.788 0.835 . . . . 74.3 109.161 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -173.63 175.68 2.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.955 0.902 . . . . 70.33 110.495 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.1 p -100.15 119.54 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.725 0.81 . . . . 44.11 109.009 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -84.48 -32.75 23.82 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.5 0.32 . . . . 64.25 110.405 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -148.93 139.44 22.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.695 -0.684 . . . . 73.41 109.641 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 89.2 mt -138.42 139.5 41.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.398 -1.704 . . . . 71.53 106.398 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 t -154.85 110.21 3.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.711 0.632 . . . . 71.44 109.636 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.666 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 74.1 t80 -110.54 113.65 26.45 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.268 -1.382 . . . . 73.32 107.268 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.44 118.27 31.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.21 0.604 . . . . 64.11 109.748 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.61 78.77 0.93 Allowed Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 107.271 -1.381 . . . . 74.34 107.271 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 -39.03 34.24 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.814 2.343 . . . . 70.11 112.464 -166.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 3.5 m120 -106.85 48.32 0.84 Allowed 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.998 -1.482 . . . . 74.54 106.998 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -54.39 -62.13 4.47 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.503 -1.237 . . . . 61.43 111.499 -176.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.7 Cg_exo -64.59 -21.95 65.2 Favored 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 121.578 1.599 . . . . 52.41 113.23 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 1.9 t60 -81.44 -55.78 4.47 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.489 0.715 . . . . 73.42 110.118 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 73' ' ' ALA . 5.0 p -67.99 -18.22 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.85 0.86 . . . . 71.14 111.626 -165.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 20.1 m-30 -62.87 -27.03 69.07 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.281 1.032 . . . . 74.23 112.718 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -96.83 -12.93 22.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.085 0.402 . . . . 74.11 112.085 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.4 tmtp? -74.59 141.62 44.72 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.213 0.605 . . . . 70.14 109.838 -173.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.512 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 25.1 t70 -51.03 128.16 20.79 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.408 1.483 . . . . 60.3 112.348 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.406 ' HH2' ' HA ' ' A' ' 32' ' ' PHE . 51.8 m95 -78.11 90.4 4.24 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.019 0.825 . . . . 74.22 111.262 -171.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -139.94 78.22 25.04 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 114.651 -1.159 . . . . 64.45 108.446 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.52 121.36 3.36 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.828 2.352 . . . . 63.35 112.662 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -96.39 95.39 8.02 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.006 -1.479 . . . . 72.3 107.006 171.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' THR . 20.0 t -84.27 97.94 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.318 -0.855 . . . . 74.42 110.075 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 55.8 tttm -82.53 125.83 31.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.626 0.77 . . . . 73.34 110.418 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -111.43 115.59 29.51 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.596 -0.89 . . . . 72.25 108.596 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.694 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -106.75 129.67 54.59 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 74.4 109.165 173.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -113.96 116.31 29.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.967 -0.753 . . . . 64.55 108.967 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -132.99 153.93 51.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.81 0.844 . . . . 75.44 109.292 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -151.43 163.47 38.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.322 0.649 . . . . 55.03 110.883 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -164.26 154.42 14.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.154 0.982 . . . . 42.13 109.838 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.5 p -131.16 159.85 36.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.97 0.35 . . . . 73.53 111.21 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -150.53 128.51 11.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.736 0.815 . . . . 44.34 109.46 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.54 110.74 12.58 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.05 -0.722 . . . . 72.23 109.05 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.529 HD12 HG23 ' A' ' 83' ' ' ILE . 74.1 mt -94.54 -38.67 10.78 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.78 -0.646 . . . . 64.11 109.571 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.62 -179.51 7.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.733 0.813 . . . . 53.01 110.042 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -73.3 126.52 30.31 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.846 -0.798 . . . . 45.23 108.846 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 68.78 1.78 3.22 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.318 1.447 . . . . 44.54 112.258 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 94.5 t -115.68 107.33 22.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.883 -0.784 . . . . 72.14 108.883 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.65 ' HB2' HD13 ' A' ' 86' ' ' ILE . 76.0 m-85 -126.85 126.87 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.184 -1.414 . . . . 74.53 107.184 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -84.47 133.1 34.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.191 -1.04 . . . . 75.34 108.191 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -113.06 127.06 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.343 -1.354 . . . . 73.43 107.343 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.2 t -100.65 138.02 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 172.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.63 109.35 12.0 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -95.31 124.02 39.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 73.1 110.326 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.74 132.14 57.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.409 -1.33 . . . . 74.24 107.409 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.9 m -120.29 121.46 38.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.037 -0.727 . . . . 64.04 109.037 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 114' ' ' ILE . 50.1 t -114.72 106.65 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.532 1.133 . . . . 72.31 108.679 -174.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 11.6 m -105.94 145.52 31.2 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 108.04 -1.096 . . . . 63.02 108.04 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.87 103.88 7.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.252 -1.388 . . . . 74.2 107.252 168.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 36.0 m -108.09 124.16 49.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.98 0.419 . . . . 71.0 109.992 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.52 80.54 2.23 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.658 -1.608 . . . . 74.43 106.658 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -117.81 5.46 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.212 -1.155 . . . . 55.41 110.212 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.09 -26.31 22.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.397 0.679 . . . . 73.33 109.972 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.1 100.35 11.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.24 0.616 . . . . 62.44 111.061 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.3 m -72.53 133.85 44.96 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 120.923 0.392 . . . . 73.25 110.298 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.5 -63.48 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.645 1.178 . . . . 73.02 110.183 177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -149.2 162.96 38.97 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.591 -1.186 . . . . 64.53 110.689 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 14.0 tp -141.29 140.6 33.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.613 -1.625 . . . . 63.41 106.613 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.666 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 16.3 m -145.51 99.08 3.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.186 -0.672 . . . . 64.3 109.186 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.01 116.68 29.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.661 -0.866 . . . . 74.12 108.661 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.49 110.39 20.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.715 0.806 . . . . 71.34 109.392 -174.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -84.85 89.21 7.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.302 -0.999 . . . . 73.11 108.302 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -76.71 97.21 4.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.118 -0.697 . . . . 75.52 109.118 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.3 143.25 16.81 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.552 -0.619 . . . . 73.21 111.552 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.47 122.91 2.15 Favored Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.44 -1.064 . . . . 73.21 110.44 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG23 HD12 ' A' ' 51' ' ' LEU . 43.5 mt -80.12 116.33 24.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.656 -1.238 . . . . 71.24 107.656 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.663 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -122.38 158.57 29.36 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.281 0.632 . . . . 63.11 109.416 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 42.8 m -104.57 98.76 8.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.226 -1.028 . . . . 65.24 108.226 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.65 HD13 ' HB2' ' A' ' 56' ' ' TYR . 3.9 mp -97.46 124.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.739 -1.208 . . . . 71.23 107.739 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -162.04 151.93 16.55 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.772 0.67 . . . . 42.43 110.714 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.55 -33.24 6.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.334 -0.848 . . . . 53.44 113.081 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.558 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -116.67 147.5 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.339 0.656 . . . . 53.11 111.467 -168.486 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.52 173.88 10.85 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.226 -0.897 . . . . 41.15 110.708 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -114.46 5.79 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.639 1.212 . . . . 52.43 115.011 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -65.42 -42.54 92.38 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.019 0.928 . . . . 61.0 111.551 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' A' ' 5' ' ' ASN . 82.9 mm-40 -70.39 -36.91 74.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.226 0.611 . . . . 53.52 111.042 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -65.19 -44.03 89.7 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.368 0.667 . . . . 62.12 109.799 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.83 88.74 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.044 0.938 . . . . 51.4 111.243 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -74.07 -31.09 62.7 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 65.14 110.79 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.76 -44.36 70.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.336 0.589 . . . . 74.51 110.055 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.34 -44.28 37.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.876 -1.056 . . . . 63.15 111.403 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.36 62.42 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.434 0.933 . . . . 72.12 115.434 -167.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.63 -61.23 0.21 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.708 0.754 . . . . 75.41 112.055 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.1 t80 -61.75 -59.33 5.32 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 74.21 112.625 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.41 -36.5 4.75 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 118.557 -0.735 . . . . 42.34 112.951 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.48 -40.96 45.1 Favored 'Trans proline' 0 C--N 1.387 2.59 0 C-N-CA 123.089 2.526 . . . . 74.42 114.287 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -60.04 -35.33 74.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.942 0.897 . . . . 74.44 111.108 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.8 mm -68.15 -42.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.638 0.775 . . . . 65.14 110.145 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.61 -33.09 60.51 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.582 -1.19 . . . . 52.02 112.547 -172.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.65 -43.76 96.14 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.032 1.123 . . . . 70.12 114.032 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.06 -38.23 96.34 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.483 2.122 . . . . 72.1 113.73 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.494 0.718 . . . . 73.32 111.845 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.52 87.28 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.728 0.411 . . . . 75.03 110.16 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -54.07 -52.43 60.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.637 1.175 . . . . 73.13 110.477 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -62.98 -46.13 89.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.809 0.844 . . . . 71.34 111.141 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 40.5 t -55.16 -47.12 75.59 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.855 0.722 . . . . 63.14 110.469 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -60.69 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.918 -1.037 . . . . 63.24 110.371 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 125' ' ' GLN . 99.3 m -52.41 -46.66 66.41 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 124.248 1.019 . . . . 62.13 112.18 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.04 -44.04 85.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.061 -0.972 . . . . 74.41 109.848 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 mtp -58.87 -42.08 88.61 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.785 0.834 . . . . 62.32 111.206 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.4 t -59.96 -49.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.788 0.835 . . . . 75.33 110.307 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.0 p -69.25 -28.97 66.79 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.866 0.467 . . . . 64.12 112.135 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -66.49 -28.34 68.49 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.813 0.845 . . . . 74.12 111.235 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.04 11.85 61.56 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.478 -0.623 . . . . 62.04 114.053 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.408 ' HB ' HH21 ' B' ' 15' ' ' ARG . 3.8 m 65.62 16.11 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.0 1.32 . . . . 45.1 111.192 -175.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -88.21 141.23 30.81 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.736 -0.838 . . . . 74.44 108.736 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 144.4 84.71 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.14 2.56 . . . . 50.21 112.71 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.8 tt0 -53.71 138.85 34.21 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.352 1.033 . . . . 64.44 111.958 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.46 114.92 18.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.632 -0.713 . . . . 74.4 109.398 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -112.0 118.89 36.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.462 -1.31 . . . . 74.3 107.462 172.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.36 122.64 20.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.274 -0.639 . . . . 65.54 109.274 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.18 134.91 94.75 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 123.399 0.437 . . . . 72.41 110.913 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.0 106.62 0.8 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.783 2.322 . . . . 64.24 111.975 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.15 117.77 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.716 -1.216 . . . . 63.23 107.716 175.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 12.2 m120 -80.98 73.22 8.03 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.668 0.747 . . . . 72.22 110.628 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -67.2 -33.75 76.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.78 -1.1 . . . . 74.52 108.997 169.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.652 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.4 p-10 -60.19 -43.16 96.11 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.328 -1.306 . . . . 60.1 111.654 176.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -72.75 -38.73 67.27 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.474 0.71 . . . . 51.13 110.594 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.496 HD22 ' HG2' ' E' ' 286' ' ' MET . 8.9 tt -55.25 -52.86 62.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.398 1.061 . . . . 50.41 109.988 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PHE . . . . . 0.464 ' HB2' ' SD ' ' E' ' 286' ' ' MET . 10.9 t80 -69.04 -23.45 64.06 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.607 -1.178 . . . . 73.35 110.883 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -46.4 19.37 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.681 0.792 . . . . 72.24 111.291 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -71.06 -19.77 62.45 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 120.879 0.371 . . . . 62.13 111.206 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -82.98 -30.59 28.09 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.531 0.732 . . . . 72.23 110.345 170.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 26.5 tp -63.48 -51.27 66.32 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.318 1.047 . . . . 70.35 112.848 -173.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -158.29 22.06 0.24 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.385 0.674 . . . . 45.5 109.563 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' C' ' 144' ' ' GLN . 18.6 tp60 68.69 -70.52 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.875 1.27 . . . . 73.02 110.354 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.416 ' HB2' ' HG2' ' C' ' 144' ' ' GLN . 1.1 mm-40 -171.79 168.34 6.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.982 1.713 . . . . 70.04 108.547 170.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.16 -59.79 0.31 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.381 -0.97 . . . . 71.25 108.381 176.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.42 -146.3 50.22 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 114.954 -1.021 . . . . 73.21 112.866 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 63.61 109.06 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.451 1.501 . . . . 70.33 110.412 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.11 60.53 0.54 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.869 -0.892 . . . . 61.15 110.869 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.6 m -77.71 -59.17 2.89 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.6 0.76 . . . . 74.41 110.546 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 57.49 87.61 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.509 1.123 . . . . 71.13 111.598 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.62 120.98 3.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.695 -0.854 . . . . 74.11 108.695 176.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -166.21 28.7 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.72 0.808 . . . . 71.01 110.14 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.78 107.76 2.71 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.297 0.57 . . . . 64.35 110.521 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -110.28 141.98 42.52 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.41 1.084 . . . . 64.0 109.773 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.5 0 O-C-N 124.068 0.855 . . . . 64.5 110.541 178.33 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.668 ' HG2' ' HA ' ' D' ' 141' ' ' LEU . 66.0 mtm . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.501 -0.926 . . . . 72.54 108.501 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.555 ' HB3' ' HG2' ' B' ' 4' ' ' GLN . 23.1 t -165.18 175.76 9.03 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.977 -0.749 . . . . 71.31 108.977 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -16.03 61.5 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.859 0.464 . . . . 73.21 111.21 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.555 ' HG2' ' HB3' ' B' ' 2' ' ' SER . 20.9 pt20 -74.35 164.45 26.58 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.489 1.115 . . . . 72.23 111.993 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -137.42 178.96 6.7 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.364 -0.835 . . . . 74.52 108.913 169.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -147.95 177.88 8.98 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.224 0.61 . . . . 74.41 109.698 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 53.6 p -63.45 118.81 8.64 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.416 -0.587 . . . . 63.13 109.416 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -86.69 34.25 0.65 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.574 1.15 . . . . 61.21 110.256 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.572 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 10.1 ptt? 51.48 -170.05 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 126.811 2.044 . . . . 75.41 113.347 -172.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.6 m -155.39 108.64 2.78 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.185 -1.413 . . . . 52.35 107.185 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -121.69 143.46 49.33 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.298 -0.63 . . . . 74.15 109.298 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.6 ' NE2' ' HB ' ' E' ' 306' ' ' VAL . 0.0 OUTLIER -156.15 132.18 9.88 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.6 -0.889 . . . . 72.03 108.6 175.577 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.475 HG22 ' HE2' ' B' ' 84' ' ' PHE . 1.8 pp -76.4 104.33 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 122.112 0.958 . . . . 73.01 108.842 173.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLN . . . . . 0.418 ' HG3' ' OG ' ' B' ' 85' ' ' SER . 1.4 tm0? -76.71 -36.37 57.24 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.963 -0.754 . . . . 55.41 108.963 -170.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.408 HH21 ' HB ' ' A' ' 122' ' ' THR . 21.8 ttt180 -168.06 140.08 2.97 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 124.036 0.835 . . . . 74.43 109.199 173.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.0 mt -124.82 134.38 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.597 -1.26 . . . . 32.31 107.597 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.27 157.39 13.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.576 0.547 . . . . 70.24 111.813 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -83.0 127.9 33.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.407 -0.815 . . . . 54.52 109.039 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.564 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 25.4 mtpp -93.51 -41.05 9.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.549 -0.75 . . . . 75.33 110.095 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.5 t70 -152.4 145.63 24.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.827 -0.624 . . . . 74.34 111.4 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.8 mm -140.02 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 C-N-CA 125.291 1.437 . . . . 73.23 108.411 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -146.22 134.9 22.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.454 1.101 . . . . 73.4 108.325 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.447 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -148.2 120.14 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.061 -1.459 . . . . 73.23 107.061 170.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -119.08 142.91 47.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.153 -1.055 . . . . 71.33 108.153 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.976 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -139.25 77.59 29.82 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.635 -1.246 . . . . 72.42 107.635 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.62 -40.4 10.22 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.902 2.401 . . . . 64.33 112.509 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -109.03 21.06 17.69 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.255 -0.884 . . . . 71.22 110.072 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.976 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.44 -48.88 35.24 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 115.524 1.676 . . . . 72.01 115.524 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -38.44 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.539 2.16 . . . . 74.1 112.256 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 37.8 m80 -90.09 -4.98 57.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.147 0.795 . . . . 65.31 113.147 -171.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.466 HG23 HD11 ' B' ' 68' ' ' LEU . 7.6 p -69.99 -18.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.115 0.566 . . . . 64.43 111.082 -175.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.4 ' HA ' ' HB3' ' B' ' 35' ' ' ASP . 55.2 t80 -66.47 -14.95 62.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.645 0.778 . . . . 73.31 111.865 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -69.15 -37.3 78.18 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.602 -0.518 . . . . 75.41 109.602 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.6 mttt -110.75 62.46 0.61 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.615 -0.883 . . . . 52.2 108.615 172.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.4 ' HB3' ' HA ' ' B' ' 32' ' ' PHE . 11.1 p-10 -88.17 98.44 11.56 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.03 -0.419 . . . . 73.24 110.662 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 172.36 -174.96 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.244 1.417 . . . . 63.04 111.429 163.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.535 ' HA ' ' HB2' ' H' ' 297' ' ' TYR . 29.4 pt20 -49.03 110.1 1.41 Allowed Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.464 1.506 . . . . 65.35 113.494 -169.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.51 165.84 16.0 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.688 2.259 . . . . 71.54 110.836 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.86 104.46 4.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.205 -1.406 . . . . 75.22 107.205 169.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.65 143.53 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -138.96 116.75 11.5 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.231 0.612 . . . . 54.02 109.909 -170.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -86.78 125.72 34.13 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 74.44 108.55 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -133.83 107.41 7.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.814 -1.18 . . . . 64.35 107.814 177.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.39 127.37 53.52 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.72 -0.844 . . . . 63.21 108.72 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.1 t70 -123.14 136.91 54.98 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.801 -1.185 . . . . 73.11 107.801 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -109.19 115.05 29.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.325 0.65 . . . . 74.22 110.998 -168.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -119.63 144.57 47.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.909 0.884 . . . . 63.33 109.161 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.8 p -145.14 163.21 35.04 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.375 0.67 . . . . 75.51 109.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -151.26 167.28 28.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.525 0.73 . . . . 74.53 109.804 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -113.42 112.61 23.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.885 -0.783 . . . . 73.12 108.885 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.49 -40.21 23.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.894 0.477 . . . . 71.21 110.035 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.78 -173.32 4.32 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.28 -0.873 . . . . 74.32 110.706 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.2 106.62 0.45 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.645 -1.162 . . . . 75.35 109.73 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 73.49 5.22 4.94 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.197 1.399 . . . . 71.12 112.209 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.81 113.07 39.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 107.958 -1.127 . . . . 73.45 107.958 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -122.5 140.76 52.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.22 0.608 . . . . 71.15 110.119 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.629 ' HG2' HG12 ' B' ' 83' ' ' ILE . 3.9 tm-20 -108.15 98.31 7.88 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.58 -1.267 . . . . 71.42 107.58 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -93.96 119.87 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.703 1.201 . . . . 62.41 110.236 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 21.8 t -107.13 139.21 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.204 1.002 . . . . 53.13 109.981 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.815 HD11 ' HA ' ' B' ' 103' ' ' PRO . 84.9 mt -121.56 112.85 18.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.373 0.669 . . . . 74.24 109.376 174.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.2 ttm-85 -86.89 107.6 18.41 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.185 -1.043 . . . . 72.34 108.185 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.83 101.88 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.075 -1.454 . . . . 74.25 107.075 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 32.3 m -97.31 139.12 33.74 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.931 -1.486 . . . . 54.41 108.443 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.61 114.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.203 -1.036 . . . . 71.23 108.203 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -101.38 140.58 35.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.371 -0.974 . . . . 71.11 108.371 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.95 126.38 23.34 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.314 -0.995 . . . . 41.11 108.314 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.4 p -146.27 140.03 26.2 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.357 0.663 . . . . 74.21 110.514 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -133.36 140.87 47.63 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.992 0.917 . . . . 74.4 109.655 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.84 -111.75 3.66 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.434 -0.803 . . . . 30.12 111.429 -172.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -121.6 2.5 10.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 74.1 109.885 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -135.63 171.95 13.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.949 0.5 . . . . 70.2 110.877 -169.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -75.03 140.37 43.5 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.493 -0.776 . . . . 73.23 111.352 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.628 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.04 -62.2 1.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.247 -1.02 . . . . 71.51 108.247 172.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -163.07 167.08 22.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.475 -1.693 . . . . 74.25 107.917 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.63 143.31 49.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 71.33 108.013 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.7 t -143.33 144.34 32.05 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.372 -0.973 . . . . 62.13 108.372 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -160.12 139.01 10.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.97 -0.752 . . . . 60.43 108.97 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' B' ' 113' ' ' CYS . 69.7 t -135.43 145.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.547 -1.279 . . . . 72.22 107.547 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 76.2 mt-30 -124.88 92.78 3.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.939 -1.134 . . . . 64.02 107.939 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 45.8 tp60 -89.38 104.42 16.97 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.956 -1.02 . . . . 61.41 108.848 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.21 156.65 25.3 Favored Glycine 0 C--O 1.244 0.767 0 N-CA-C 111.131 -0.788 . . . . 74.14 111.131 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.18 1.33 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.072 -0.811 . . . . 73.11 111.072 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.629 HG12 ' HG2' ' B' ' 57' ' ' GLU . 26.0 mt -85.99 134.55 27.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 108.076 -1.083 . . . . 60.32 108.076 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 84' ' ' PHE . . . . . 0.475 ' HE2' HG22 ' B' ' 13' ' ' ILE . 65.4 m-85 -133.64 135.08 43.94 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 71.34 108.343 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.418 ' OG ' ' HG3' ' B' ' 14' ' ' GLN . 65.5 m -107.61 91.85 3.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 172.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.555 ' HB ' HD11 ' B' ' 89' ' ' ILE . 35.2 pt -98.11 138.21 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.386 -0.825 . . . . 65.33 110.974 -169.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -145.01 167.77 21.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.28 1.032 . . . . 65.35 109.945 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.79 -63.72 4.42 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.696 -0.684 . . . . 75.42 112.006 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.555 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.3 pp -61.35 138.1 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.618 0.767 . . . . 73.13 112.123 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.12 149.66 16.08 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.477 -0.783 . . . . 73.41 109.197 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.08 -124.9 14.69 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.68 0.613 . . . . 42.33 112.793 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.0 m -67.19 -33.37 75.25 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.402 0.681 . . . . 62.11 110.964 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.88 -33.24 71.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.763 -0.653 . . . . 71.21 110.468 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -65.57 -45.57 82.8 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.024 0.53 . . . . 62.33 110.138 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.14 -31.87 70.5 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.812 0.845 . . . . 62.34 112.09 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -77.71 -43.92 29.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.168 0.587 . . . . 74.55 111.2 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.46 -47.26 56.82 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.37 0.605 . . . . 54.33 111.909 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.564 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.1 tm? -89.38 -37.61 14.73 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.112 0.965 . . . . 73.43 110.202 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.28 -26.32 57.68 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.34 0.4 . . . . 54.04 114.015 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.615 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -120.91 -48.99 2.23 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.985 0.514 . . . . 70.43 112.203 -173.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.512 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 67.2 t80 -77.84 -45.71 23.57 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.51 0.559 . . . . 73.51 112.51 -172.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 78.5 m -59.48 -42.55 92.82 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 112.981 0.734 . . . . 62.04 112.981 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.815 ' HA ' HD11 ' B' ' 60' ' ' LEU . 83.6 Cg_exo -52.08 -39.61 70.0 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.529 2.153 . . . . 73.31 114.818 168.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.54 -24.05 65.5 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.114 0.566 . . . . 61.42 112.062 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.534 HG23 ' NH2' ' D' ' 111' ' ' ARG . 92.8 mt -73.15 -47.39 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.778 0.831 . . . . 71.33 111.348 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.513 ' HB2' HD12 ' B' ' 60' ' ' LEU . 75.1 mt -79.72 -18.79 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.871 -0.604 . . . . 63.45 110.987 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.76 -50.55 86.42 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-O 117.699 -1.143 . . . . 73.53 113.733 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.1 -35.86 97.18 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.552 2.168 . . . . 71.2 113.959 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -69.44 -46.73 66.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.481 0.712 . . . . 73.53 110.575 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.3 -41.28 88.63 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.398 -0.819 . . . . 75.33 110.616 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -63.14 -50.43 70.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.557 1.543 . . . . 74.32 111.268 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.85 -37.99 89.47 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.95 0.781 . . . . 64.51 109.998 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.545 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -68.62 -39.21 80.91 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.508 0.505 . . . . 64.4 111.169 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.2 -49.69 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.062 0.545 . . . . 43.45 110.014 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -56.53 -39.37 73.25 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.301 -0.863 . . . . 71.14 111.168 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -68.05 -46.53 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.123 -0.944 . . . . 65.4 110.394 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -66.74 -39.48 87.95 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.006 0.523 . . . . 73.21 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.28 -39.47 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.867 0.467 . . . . 75.13 110.251 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -68.5 -28.57 67.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.071 0.948 . . . . 61.13 111.761 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.0 mtt-85 -73.58 -35.79 65.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.744 0.818 . . . . 73.14 110.101 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 3.4 55.0 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 123.757 0.661 . . . . 73.44 112.673 170.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 58.81 28.87 18.01 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.516 1.926 . . . . 61.21 112.304 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -98.77 153.03 38.07 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 114.849 -1.069 . . . . 75.45 109.645 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.61 ' HG2' ' HA ' ' H' ' 297' ' ' TYR . 54.0 Cg_exo -51.2 102.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.13 2.553 . . . . 74.23 111.523 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.408 ' NE2' ' HB3' ' C' ' 119' ' ' SER . 4.6 pt20 -62.38 155.41 25.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.604 -1.18 . . . . 75.35 111.527 -171.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.6 tp -109.29 100.82 9.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.459 -0.791 . . . . 73.22 109.612 -168.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 53.2 m-20 -89.37 92.85 9.31 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 106.44 -1.689 . . . . 73.14 106.44 176.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.25 150.1 46.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.959 -1.473 . . . . 63.51 111.19 -168.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.26 74.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 122.97 0.508 . . . . 71.1 110.779 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.08 111.8 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.942 2.428 . . . . 75.11 112.233 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.64 113.85 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.479 -0.934 . . . . 61.12 108.479 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.38 80.11 7.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.279 0.632 . . . . 74.11 109.375 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -59.64 -34.68 73.11 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.653 0.781 . . . . 72.41 111.303 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.615 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 12.3 t70 -63.0 -44.72 95.23 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.781 -1.099 . . . . 74.11 111.671 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.92 -36.73 75.59 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.295 0.638 . . . . 74.05 111.276 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.82 -30.87 71.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.007 0.523 . . . . 44.33 110.737 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -76.76 -32.09 57.51 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.397 0.679 . . . . 72.2 110.077 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 63.2 mtt -67.49 -25.43 65.86 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.336 0.654 . . . . 72.35 110.951 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -74.76 -29.86 61.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.381 0.672 . . . . 53.55 110.532 175.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -72.7 -36.43 67.85 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.244 0.617 . . . . 73.33 109.71 174.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 53.7 mt -100.08 22.16 11.74 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.705 0.802 . . . . 73.42 110.868 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -70.74 100.14 1.83 Allowed 'General case' 0 C--N 1.351 0.64 0 CA-C-O 121.2 0.524 . . . . 72.02 110.675 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -151.23 96.44 2.3 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 106.568 -1.642 . . . . 74.33 106.568 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -138.97 151.37 46.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.681 0.793 . . . . 45.42 110.059 -173.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.39 -44.98 49.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.878 0.871 . . . . 71.41 111.372 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.13 88.16 0.9 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.892 -0.595 . . . . 51.04 112.517 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -139.32 138.73 36.94 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.831 0.852 . . . . 74.23 109.346 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.23 101.51 0.15 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.761 -1.336 . . . . 75.52 109.761 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 72.6 p -64.57 169.54 4.79 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.37 0.668 . . . . 65.45 111.443 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.64 44.23 2.44 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.6 0.76 . . . . 63.53 109.423 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.91 102.91 0.18 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.966 0.888 . . . . 74.25 109.862 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -128.62 58.56 1.56 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.869 -1.06 . . . . 65.24 109.661 -172.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -72.78 -46.74 51.69 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.338 -1.356 . . . . 74.51 107.338 158.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 68.5 -68.24 0.18 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.552 1.541 . . . . 73.24 111.971 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.364 0 C-N-CA 124.175 0.99 . . . . 72.33 108.576 174.782 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.568 -0.53 . . . . 55.25 109.568 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -151.83 101.84 2.79 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.664 -0.495 . . . . 63.54 109.664 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -160.5 104.64 1.42 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.296 -1.001 . . . . 63.21 108.296 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.42 109.43 4.47 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.625 0.77 . . . . 64.05 109.82 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -155.73 69.51 0.68 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.611 -1.255 . . . . 74.01 107.611 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -154.03 147.92 25.5 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.013 -0.994 . . . . 63.13 110.493 -170.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.9 p -80.89 120.54 24.85 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.769 -0.826 . . . . 73.11 108.769 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -58.44 -25.57 62.35 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.13 0.972 . . . . 74.42 112.412 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.531 ' HB2' HG21 ' C' ' 89' ' ' ILE . 46.9 ttp 67.29 115.93 0.03 OUTLIER 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.385 1.474 . . . . 74.03 111.088 -172.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.2 m -85.77 88.38 7.54 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.975 -1.12 . . . . 72.42 107.975 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 52.1 t80 -96.62 122.31 39.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.784 -0.821 . . . . 54.52 108.784 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -138.57 139.11 38.51 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.465 0.706 . . . . 73.35 110.472 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.58 96.79 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.764 -0.828 . . . . 73.41 108.764 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.452 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.5 mm100 -75.98 -43.47 44.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.69 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.418 ' NH1' ' H ' ' G' ' 302' ' ' ASP . 24.4 ttt85 -169.84 122.99 0.73 Allowed 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.894 0.746 . . . . 72.52 109.892 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.84 133.54 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.347 -0.983 . . . . 44.12 108.347 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.463 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.0 p90 -169.67 158.72 7.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.697 0.761 . . . . 72.31 112.267 -173.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -81.56 110.37 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.518 -1.219 . . . . 70.41 108.864 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -79.47 -23.92 42.71 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 122.277 -0.264 . . . . 71.33 110.605 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -150.06 142.08 23.94 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.954 0.783 . . . . 74.34 109.467 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -137.26 144.26 32.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 106.916 -1.513 . . . . 74.21 106.916 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 22' ' ' SER . . . . . 0.551 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 40.3 t -151.82 147.71 26.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.482 0.713 . . . . 73.21 110.125 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -154.87 119.93 4.93 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.342 -1.355 . . . . 74.5 107.342 168.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.48 130.14 54.16 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.489 0.716 . . . . 75.54 109.236 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.31 77.36 76.3 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.652 -1.24 . . . . 72.33 107.652 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -68.02 -27.72 35.91 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.037 2.491 . . . . 62.44 112.051 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -109.91 41.96 1.61 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.496 1.118 . . . . 35.21 109.457 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.617 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.64 -54.94 49.83 Favored Pre-proline 0 CA--C 1.571 1.753 0 N-CA-C 114.47 1.285 . . . . 54.42 114.47 -175.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 12.5 Cg_exo -72.66 -28.42 14.11 Favored 'Trans proline' 0 C--N 1.386 2.533 0 CA-C-N 121.891 1.711 . . . . 73.41 111.775 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -68.7 -22.08 64.38 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.04 1.336 . . . . 74.0 111.953 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -72.2 -18.84 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.539 0.736 . . . . 72.23 111.497 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -68.79 -23.48 64.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.623 0.369 . . . . 65.05 111.201 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -109.52 24.04 13.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.51 0.724 . . . . 71.35 110.722 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.681 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -81.08 148.05 29.83 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.35 0.66 . . . . 73.43 110.046 -176.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 35' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' C' ' 68' ' ' LEU . 12.7 t70 -69.37 125.01 25.37 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.315 -0.994 . . . . 75.04 108.315 169.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -86.76 63.12 7.79 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.882 0.738 . . . . 74.24 110.372 -168.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -164.95 77.4 1.39 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.227 1.011 . . . . 61.25 108.403 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.97 156.11 26.62 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.77 2.313 . . . . 71.13 111.371 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.37 86.85 7.35 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.132 -1.433 . . . . 73.51 107.132 170.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -69.42 112.43 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.427 -1.26 . . . . 62.21 109.835 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -134.29 127.12 31.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.749 0.82 . . . . 74.31 109.852 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 42' ' ' LEU . . . . . 0.409 HD23 ' N ' ' C' ' 43' ' ' ASP . 6.1 tt -86.41 139.14 31.21 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 107.648 -1.241 . . . . 70.45 107.648 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.4 t70 -119.61 107.5 13.33 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.577 -1.268 . . . . 61.15 107.577 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.17 116.16 28.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.268 1.027 . . . . 74.42 109.059 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.9 t70 -115.08 143.94 44.41 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.606 -0.887 . . . . 64.42 108.606 172.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -131.19 134.96 47.0 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.614 0.766 . . . . 64.11 109.789 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -148.21 157.34 43.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.138 0.575 . . . . 54.35 110.628 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.419 ' HB3' ' HE2' ' F' ' 281' ' ' PHE . 57.6 p -161.28 145.75 13.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.87 0.868 . . . . 52.51 110.413 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -156.06 140.85 17.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 73.03 109.898 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -72.55 127.87 33.87 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' C' ' 57' ' ' GLU . 34.9 mt -96.06 -39.67 9.62 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 64.45 109.581 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.32 176.59 12.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.919 -1.491 . . . . 45.21 108.964 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -68.31 121.98 17.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.673 -0.694 . . . . 71.11 109.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 76.51 -8.37 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 126.401 1.881 . . . . 72.15 112.632 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.81 96.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 70.22 108.879 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.8 161.97 13.72 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.493 0.717 . . . . 74.34 109.378 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.667 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.0 tt0 -124.73 133.61 53.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.14 0.576 . . . . 73.52 109.768 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.426 HG22 HD12 ' C' ' 98' ' ' LEU . 77.2 t -110.69 129.22 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.402 -1.333 . . . . 52.04 107.402 169.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 96.7 t -114.18 136.76 49.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.257 -1.016 . . . . 74.53 108.257 173.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.13 101.76 5.95 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.324 -1.361 . . . . 74.25 107.324 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 8.1 ttm180 -87.29 135.13 33.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.262 0.625 . . . . 73.41 109.687 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.5 t -125.81 121.89 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.137 -1.431 . . . . 55.45 107.137 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 30.7 m -124.7 119.56 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.423 -0.584 . . . . 64.2 109.423 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 114' ' ' ILE . 59.1 t -100.35 116.43 43.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.635 -0.876 . . . . 74.33 108.635 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.5 m -106.21 137.71 43.68 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.688 0.618 . . . . 62.23 109.511 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.64 94.49 3.2 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.516 -1.291 . . . . 74.24 107.516 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -143.57 139.15 29.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.392 -0.966 . . . . 64.24 108.392 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.681 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 23.65 8.74 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.506 0.722 . . . . 74.02 110.329 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.94 -120.57 1.4 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.827 -1.309 . . . . 72.44 109.827 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.79 -28.47 21.66 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.56 -0.904 . . . . 75.31 108.56 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.0 99.2 0.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.466 1.106 . . . . 64.54 109.608 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.1 m -87.75 130.24 34.9 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.058 0.543 . . . . 64.0 110.644 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.66 5.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.495 -0.775 . . . . 72.24 109.256 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -167.21 169.75 12.33 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.827 0.851 . . . . 70.32 110.768 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.411 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -142.87 144.67 32.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.939 -1.134 . . . . 62.4 107.939 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.411 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.6 t -146.68 146.28 30.3 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.353 -0.98 . . . . 61.44 108.353 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 77' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 38.4 tt0 -153.76 137.49 16.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.25 0.62 . . . . 71.44 110.218 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 78' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.4 t -141.9 115.02 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.305 1.042 . . . . 74.33 108.615 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 73.2 mt-30 -95.03 97.69 10.14 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.889 -0.782 . . . . 64.12 108.889 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.1 102.32 14.32 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 44.25 110.009 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.16 151.82 21.8 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.918 -0.473 . . . . 73.43 111.918 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.97 128.59 2.82 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.645 -0.582 . . . . 32.03 111.645 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' D' ' 29' ' ' PRO . 8.3 mm -90.14 130.38 39.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 108.491 -0.929 . . . . 73.33 108.491 178.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.98 119.91 17.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.316 -0.624 . . . . 71.54 109.316 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.0 p -85.93 99.9 11.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.212 -1.033 . . . . 22.42 108.212 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.63 124.7 68.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.472 0.709 . . . . 62.13 109.645 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 169.06 25.23 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.029 -0.987 . . . . 72.22 110.228 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.69 -28.58 11.9 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.033 -0.985 . . . . 63.02 111.045 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.2 OUTLIER -119.14 167.51 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.943 0.897 . . . . 64.41 110.903 -173.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -160.1 -171.76 3.34 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.799 -1.092 . . . . 75.55 108.954 173.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.52 -124.44 33.43 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.824 0.703 . . . . 63.43 114.109 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.6 t -63.62 -32.19 73.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.103 0.961 . . . . 75.01 112.789 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -68.28 -57.52 5.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.249 0.62 . . . . 73.24 111.218 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.553 ' HB3' HG12 ' C' ' 89' ' ' ILE . 3.3 ppp? -73.92 -21.19 60.14 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.698 -0.683 . . . . 61.52 110.739 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.4 96.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.946 0.498 . . . . 73.45 110.414 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.29 -39.18 75.22 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.007 -0.542 . . . . 72.12 110.844 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 97' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 94.2 m -67.49 -52.98 32.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.028 -0.533 . . . . 63.43 110.232 175.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.426 HD12 HG22 ' C' ' 58' ' ' VAL . 52.2 tp -60.38 -53.98 51.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.072 0.949 . . . . 70.43 111.546 -168.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.441 ' HA3' HD23 ' F' ' 280' ' ' LEU . . . -100.53 11.29 59.64 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.433 -0.648 . . . . 75.23 114.687 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.23 -63.79 0.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.837 0.818 . . . . 74.31 112.477 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 38.5 t80 -72.76 -53.25 12.12 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.823 0.449 . . . . 62.54 111.919 -168.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.546 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 44.1 m -59.11 -47.39 98.58 Favored Pre-proline 0 CA--C 1.569 1.675 0 C-N-CA 123.969 0.908 . . . . 72.5 112.352 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 86.5 Cg_exo -54.55 -37.28 90.4 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.96 2.44 . . . . 64.35 113.711 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -66.58 -38.49 87.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.886 0.741 . . . . 61.33 110.286 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.1 mm -61.53 -44.6 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.05 0.54 . . . . 74.13 110.324 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.573 HD21 ' HA3' ' C' ' 82' ' ' GLY . 97.0 mt -75.31 -30.85 60.46 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.291 -0.868 . . . . 74.23 112.302 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 107' ' ' PHE . . . . . 0.407 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 61.5 t80 -53.94 -49.77 87.73 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.298 1.221 . . . . 73.34 114.298 -171.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.09 -31.85 94.12 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.299 1.999 . . . . 72.35 113.841 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.468 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.5 m-85 -71.98 -43.15 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.238 0.615 . . . . 64.25 110.64 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -65.3 -38.33 89.89 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 116.038 -0.528 . . . . 60.4 110.484 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.516 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 39.2 ttt-85 -56.66 -53.48 57.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.556 1.542 . . . . 64.41 111.797 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.35 -32.91 74.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.825 0.45 . . . . 71.21 110.307 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.13 -32.38 71.72 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.065 0.546 . . . . 73.14 111.269 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' C' ' 62' ' ' VAL . 59.3 mt -70.29 -56.06 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.408 0.683 . . . . 72.4 109.739 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -63.33 -27.14 69.12 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.563 0.745 . . . . 72.3 111.276 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.36 -48.83 68.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.422 0.689 . . . . 50.35 109.544 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -32.79 74.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.482 0.713 . . . . 72.34 112.16 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.65 -46.97 95.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.473 0.709 . . . . 65.33 109.549 174.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.408 ' HB3' ' NE2' ' B' ' 125' ' ' GLN . 58.9 p -73.73 -23.78 59.81 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.275 0.63 . . . . 72.14 112.185 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -72.76 -37.8 67.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.575 0.75 . . . . 74.34 110.192 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.16 1.86 73.26 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.524 0.515 . . . . 45.41 112.43 169.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 62.42 36.97 13.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.93 2.092 . . . . 70.34 112.665 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -94.94 154.15 39.77 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.781 -1.1 . . . . 73.42 109.44 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 -177.78 1.49 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.032 2.488 . . . . 43.25 113.591 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.71 133.9 56.33 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.133 1.16 . . . . 62.34 114.133 -169.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.3 tt -138.7 85.31 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.079 -1.822 . . . . 73.13 106.079 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.7 129.88 44.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.787 0.835 . . . . 55.03 109.493 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.516 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.6 mm? -80.47 143.89 33.0 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.642 0.589 . . . . 73.54 110.472 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.575 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -86.72 150.23 50.24 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.951 0.9 . . . . 72.22 111.376 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.06 130.08 7.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.174 2.583 . . . . 61.22 112.297 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.535 HG22 HD21 ' F' ' 291' ' ' LEU . 9.4 t -135.08 112.97 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 109.067 -0.716 . . . . 74.32 109.067 173.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -97.34 90.75 5.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.438 0.695 . . . . 73.11 110.128 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.63 -39.07 77.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.778 0.799 . . . . 73.15 109.705 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -65.21 -42.46 93.49 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.984 -1.462 . . . . 75.23 112.193 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.54 92.48 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.685 0.794 . . . . 62.31 110.551 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.4 tt -64.66 -38.27 90.42 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.297 0.998 . . . . 63.42 110.817 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -70.93 -30.06 66.28 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.532 0.733 . . . . 74.12 110.734 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 72.5 mtm -81.44 -30.05 33.61 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.099 0.56 . . . . 74.24 111.274 170.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -64.77 -39.62 93.92 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.223 1.009 . . . . 72.54 111.817 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -68.16 -85.93 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 117.696 -1.145 . . . . 73.44 108.083 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 141' ' ' LEU . . . . . 0.664 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 15.6 tp 48.41 -179.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.281 1.432 . . . . 53.23 114.073 173.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -164.49 15.77 0.05 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.654 0.782 . . . . 71.21 110.114 163.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.664 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 78.3 mt-30 -111.32 178.43 4.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.406 1.082 . . . . 73.41 110.997 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -135.42 143.68 46.08 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.068 -1.086 . . . . 73.11 108.068 177.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.91 138.11 35.36 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.946 0.899 . . . . 73.43 109.899 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.24 173.49 25.29 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.654 0.596 . . . . 74.42 113.069 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -84.9 145.85 27.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.738 0.815 . . . . 72.11 109.643 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -120.3 -167.23 13.4 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 112.012 -0.435 . . . . 75.55 112.012 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 37.8 m -152.06 142.58 22.66 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.492 0.717 . . . . 71.43 110.067 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 150' ' ' GLU . . . . . 0.564 ' H ' ' HG2' ' G' ' 310' ' ' PRO . 2.3 mm-40 -130.4 84.17 2.18 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.026 1.33 . . . . 71.4 107.591 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -121.75 103.55 8.95 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.677 -0.692 . . . . 74.13 109.685 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -167.44 138.26 2.99 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.928 0.891 . . . . 63.15 109.318 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -153.06 108.53 3.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.973 0.909 . . . . 52.33 108.814 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -154.0 105.81 2.77 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.1 -1.074 . . . . 60.23 108.1 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 108.813 -0.81 . . . . 74.34 108.813 176.441 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 110.111 -0.329 . . . . 75.24 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 24.3 t -141.32 21.61 2.22 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.69 0.796 . . . . 63.15 108.945 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.65 105.95 5.19 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 115.772 -0.649 . . . . 64.41 109.658 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -71.18 86.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.195 -1.039 . . . . 62.54 108.195 168.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -68.31 176.23 2.9 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.696 -1.138 . . . . 74.43 109.787 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -48.77 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.73 0.812 . . . . 72.01 110.549 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.9 m -84.71 69.66 10.7 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-O 122.439 1.114 . . . . 73.24 108.487 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -83.27 -10.89 58.27 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 113.995 -1.457 . . . . 74.32 109.917 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.503 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 5.4 ttp -29.86 126.0 0.14 Allowed 'General case' 0 C--N 1.375 1.695 0 C-N-CA 126.039 1.736 . . . . 61.42 113.117 172.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m -114.09 146.36 40.35 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.897 -0.779 . . . . 65.33 108.897 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -171.87 104.46 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.164 -1.791 . . . . 71.41 106.164 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -156.07 138.39 14.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.826 0.851 . . . . 63.42 108.844 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.426 HG21 HD13 ' D' ' 16' ' ' ILE . 10.1 mt -76.4 137.28 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.536 0.522 . . . . 73.52 110.368 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -99.93 -40.56 7.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.64 0.776 . . . . 71.3 110.257 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -167.15 125.9 1.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.474 -0.33 . . . . 61.23 111.207 -170.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.426 HD13 HG21 ' D' ' 13' ' ' ILE . 1.3 mp -103.91 132.56 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.13 -1.433 . . . . 55.25 107.13 165.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.617 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 26.0 p90 -166.09 154.95 11.27 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.954 0.784 . . . . 74.53 110.475 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -80.22 121.31 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.218 -0.901 . . . . 70.32 109.05 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 42.4 mtpt -87.28 -30.51 20.84 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.767 -0.457 . . . . 71.32 109.767 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.17 135.33 17.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.891 -1.049 . . . . 62.45 109.018 -177.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.676 HG23 HG22 ' D' ' 78' ' ' VAL . 48.7 mt -134.84 144.26 35.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 107.991 -1.114 . . . . 74.43 107.991 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -151.82 137.78 18.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.359 0.664 . . . . 73.41 110.313 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 55.2 t80 -143.88 115.66 8.24 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 106.767 -1.568 . . . . 71.12 106.767 171.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.56 126.19 48.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.13 0.572 . . . . 75.42 109.601 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.56 80.35 22.8 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.578 -1.267 . . . . 64.23 107.578 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.24 -31.91 17.54 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.017 2.478 . . . . 65.15 112.672 -170.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 9.7 m120 -114.95 36.49 3.84 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.45 -0.944 . . . . 73.3 108.45 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.443 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -56.38 -62.48 4.8 Favored Pre-proline 0 CA--C 1.559 1.321 0 N-CA-C 113.919 1.081 . . . . 74.44 113.919 -167.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.509 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -78.07 -2.21 12.33 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 122.796 2.034 . . . . 64.1 113.318 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -84.35 -42.17 16.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.758 1.223 . . . . 71.15 109.75 174.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.0 p -76.6 -27.26 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.102 0.561 . . . . 72.14 111.049 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.533 ' HA ' HG13 ' G' ' 301' ' ' ILE . 21.5 m-85 -68.2 -7.95 34.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.247 0.832 . . . . 72.21 113.247 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -82.72 -18.79 39.57 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.799 0.84 . . . . 74.31 111.19 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.99 99.46 8.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.101 0.96 . . . . 64.21 110.954 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -75.52 94.63 3.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.861 0.865 . . . . 74.21 111.743 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.481 ' CE3' HD23 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -155.84 175.02 14.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.71 0.804 . . . . 75.13 111.961 174.132 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.615 ' HA ' ' HB2' ' G' ' 297' ' ' TYR . 1.9 mp0 -94.92 109.56 44.81 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 124.299 1.04 . . . . 70.41 110.942 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.542 ' HD3' ' HD2' ' G' ' 297' ' ' TYR . 19.0 Cg_exo -65.3 146.13 85.26 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.231 2.62 . . . . 33.04 111.85 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.27 156.17 38.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.903 -0.777 . . . . 65.14 108.903 164.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.526 HG23 HG13 ' D' ' 64' ' ' VAL . 1.3 p -136.3 118.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.775 -1.194 . . . . 75.34 107.775 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -106.1 125.69 51.3 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.104 0.962 . . . . 61.11 108.514 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.5 tt -95.89 126.54 41.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.277 -1.008 . . . . 75.2 108.277 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.9 t70 -114.95 125.87 54.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.879 -1.156 . . . . 64.45 107.879 169.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.06 130.85 46.26 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.1 -0.704 . . . . 63.23 109.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -134.01 143.29 48.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.723 -0.843 . . . . 73.21 108.723 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -121.47 147.74 45.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.139 0.976 . . . . 65.25 110.019 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.07 142.74 18.71 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.785 0.834 . . . . 63.44 109.261 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -160.64 153.4 21.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.889 0.476 . . . . 61.22 109.98 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -164.08 147.17 9.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.33 0.652 . . . . 63.04 109.948 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.8 122.13 25.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.162 -0.681 . . . . 72.55 109.162 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' C' ' 29' ' ' PRO . 71.6 mt -89.95 -34.61 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.549 0.74 . . . . 75.12 110.524 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 -177.8 6.43 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.349 -0.841 . . . . 71.55 109.667 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.43 116.25 5.92 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.75 -0.659 . . . . 72.32 110.495 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 62.4 24.59 14.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.435 1.094 . . . . 71.25 111.899 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.08 116.82 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.396 -0.964 . . . . 75.45 108.396 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.485 ' HB2' HD12 ' D' ' 86' ' ' ILE . 82.3 m-85 -131.91 129.05 39.8 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.745 1.218 . . . . 61.41 108.036 -173.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' D' ' 51' ' ' LEU . 34.6 tt0 -102.52 139.7 37.77 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.599 0.76 . . . . 73.02 109.803 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.476 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 96.6 t -118.72 122.82 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.617 -1.253 . . . . 72.35 107.617 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 39.1 t -108.55 131.99 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.329 -0.989 . . . . 64.15 108.329 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tt -116.43 116.96 28.64 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.373 -1.343 . . . . 64.14 107.373 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -97.63 108.69 21.47 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.116 -0.698 . . . . 73.22 109.116 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.92 129.09 43.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 107.645 -1.243 . . . . 72.13 107.645 166.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.0 m -120.41 134.06 55.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.243 0.544 . . . . 73.21 109.701 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 78.5 t -125.62 106.81 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.128 1.371 . . . . 71.42 108.199 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -113.21 106.75 15.01 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.465 -0.568 . . . . 75.51 109.465 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.87 123.93 48.75 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.209 0.604 . . . . 51.55 109.679 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.7 m -147.31 121.54 9.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.304 -0.998 . . . . 50.12 108.304 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.481 HD23 ' CE3' ' D' ' 36' ' ' TRP . 17.3 tp -137.55 136.85 38.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.808 0.443 . . . . 51.31 110.013 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 69' ' ' GLY . . . . . 0.417 ' H ' HD12 ' D' ' 68' ' ' LEU . . . 91.75 -136.11 13.11 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.336 -1.106 . . . . 74.54 110.336 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 16.4 23.65 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.316 0.558 . . . . 73.31 110.881 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -136.21 164.66 27.55 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.071 0.548 . . . . 65.11 111.562 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -79.85 129.74 34.73 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.874 -1.057 . . . . 64.44 109.764 170.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.526 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.91 -66.15 0.88 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.178 -0.675 . . . . 74.44 109.178 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.35 165.88 32.36 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.061 -0.972 . . . . 72.5 111.191 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -129.07 146.54 51.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.888 1.275 . . . . 74.12 108.481 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.647 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 5.4 m -148.66 138.23 21.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.015 0.926 . . . . 62.15 109.661 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.57 122.31 5.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.332 -0.988 . . . . 70.53 108.332 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.676 HG22 HG23 ' D' ' 21' ' ' ILE . 91.6 t -130.54 118.49 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.448 -0.575 . . . . 54.53 109.448 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 76.6 mt-30 -90.02 90.81 8.3 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.132 -0.94 . . . . 74.42 108.651 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.28 103.66 10.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.427 -0.806 . . . . 75.12 109.401 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 143.37 16.51 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.519 -0.633 . . . . 34.33 111.519 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.43 128.47 4.16 Favored Glycine 0 CA--C 1.506 -0.515 0 N-CA-C 109.942 -1.263 . . . . 52.13 109.942 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.27 131.68 36.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.12 -1.067 . . . . 71.2 108.12 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.476 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 18.7 m-85 -130.65 139.72 50.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.428 -0.582 . . . . 73.43 109.428 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.7 m -82.65 100.9 10.47 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 108.084 -1.08 . . . . 34.04 108.084 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' D' ' 56' ' ' TYR . 36.3 mt -117.28 138.65 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.294 0.638 . . . . 72.31 110.218 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 167.52 15.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.804 0.841 . . . . 65.54 110.456 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.8 -19.78 10.95 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 114.914 0.726 . . . . 53.41 114.914 169.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.446 HG23 ' HG3' ' D' ' 9' ' ' MET . 13.1 pt -121.67 138.31 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.969 -1.122 . . . . 74.34 107.969 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HA ' ' G' ' 272' ' ' ASN . 40.9 mt-10 -141.87 167.67 21.57 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.681 0.792 . . . . 64.3 110.809 -176.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.87 -135.19 40.76 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.849 0.718 . . . . 44.32 113.054 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -66.08 -29.86 70.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.265 0.626 . . . . 64.04 111.324 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.8 tp60 -63.77 -40.96 97.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.371 0.669 . . . . 74.32 110.728 -178.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -81.34 -34.6 31.69 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.301 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 95' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' G' ' 280' ' ' LEU . . . -63.21 -23.92 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.64 0.776 . . . . 73.15 112.545 -177.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 96' ' ' HIS . . . . . 0.565 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.6 t-80 -69.91 -38.55 76.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.695 0.398 . . . . 73.02 110.506 171.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.18 -33.67 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 110.338 -0.245 . . . . 44.3 110.338 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.52 -54.16 11.47 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.475 1.11 . . . . 74.34 109.877 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.92 14.31 64.86 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.562 -0.745 . . . . 61.43 114.405 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -145.23 -56.42 0.32 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 117.405 0.603 . . . . 54.41 112.333 -175.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -75.63 -51.6 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.532 0.567 . . . . 72.42 112.532 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.9 m -59.14 -48.61 96.11 Favored Pre-proline 0 CA--C 1.568 1.653 0 C-N-CA 124.206 1.002 . . . . 72.1 112.93 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.81 -30.79 78.09 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 122.265 1.976 . . . . 70.03 112.852 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.94 -32.2 73.45 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.298 0.639 . . . . 74.44 111.126 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 13' ' ' ILE . 49.5 mm -74.21 -42.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.584 0.754 . . . . 64.21 110.678 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.16 -30.25 49.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.325 -0.852 . . . . 73.31 111.997 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.51 -44.4 97.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.187 1.18 . . . . 62.44 114.187 -170.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.42 -41.59 51.22 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.452 2.101 . . . . 63.12 114.159 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -75.92 -38.62 57.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.811 . . . . 75.3 111.756 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.67 99.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.476 0.71 . . . . 51.05 110.753 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.536 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.7 ttp180 -62.56 -49.91 73.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.542 -1.208 . . . . 72.22 110.59 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -58.4 -48.47 80.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.379 1.072 . . . . 71.35 111.531 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.69 -40.12 75.03 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.811 0.694 . . . . 73.35 111.224 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.492 HG21 HG21 ' D' ' 64' ' ' VAL . 93.7 mt -65.98 -50.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.132 -0.94 . . . . 74.43 110.582 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.6 m -53.9 -38.88 65.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.507 1.123 . . . . 75.42 111.759 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -70.54 -50.24 39.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.01 110.316 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -56.62 -43.16 79.95 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.453 0.701 . . . . 73.33 111.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.553 HG11 HD23 ' D' ' 126' ' ' LEU . 82.3 t -63.73 -42.28 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 114.441 -1.254 . . . . 64.22 110.814 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 59.6 p -68.8 -30.79 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 120.817 0.341 . . . . 61.11 110.965 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -69.63 -29.45 66.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.072 0.949 . . . . 73.44 110.525 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 121' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.45 11.42 69.97 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-N 115.579 -0.737 . . . . 71.12 112.905 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.463 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.7 p 61.31 16.04 7.02 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 126.771 2.028 . . . . 70.44 113.721 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -90.41 164.66 26.21 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.237 1.015 . . . . 75.23 108.359 170.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.643 ' HG3' ' HA ' ' G' ' 297' ' ' TYR . 37.8 Cg_endo -86.65 150.77 8.77 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.655 2.237 . . . . 74.42 112.466 -172.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.17 133.21 28.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.949 0.9 . . . . 62.43 112.749 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.553 HD23 HG11 ' D' ' 118' ' ' VAL . 3.8 mm? -105.82 95.0 5.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.533 -0.914 . . . . 75.13 108.533 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -98.87 98.79 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.9 mm? -76.08 135.15 39.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.3 -0.864 . . . . 61.32 109.625 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' G' ' 291' ' ' LEU . . . -68.88 128.69 92.74 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-O 119.56 -0.257 . . . . 75.32 110.989 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.536 ' HB3' HH12 ' D' ' 111' ' ' ARG . 65.6 Cg_endo -74.65 117.48 4.96 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.508 2.139 . . . . 61.41 111.299 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.76 110.3 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.534 -0.913 . . . . 71.4 108.534 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.538 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 32.9 t30 -78.4 98.8 6.13 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.859 -0.793 . . . . 73.3 108.859 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 133' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 62.8 m-85 -70.09 -28.54 65.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.102 -0.953 . . . . 74.04 111.267 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 134' ' ' ASP . . . . . 0.425 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 1.9 t70 -63.95 -38.12 89.9 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.272 0.629 . . . . 71.04 110.52 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.538 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -61.76 -40.94 96.92 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.544 1.152 . . . . 31.24 112.181 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 82.3 mt -55.31 -48.38 74.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.01 0.924 . . . . 63.51 112.312 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -75.72 -36.4 59.98 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.353 0.661 . . . . 72.51 110.631 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.422 ' O ' ' HG2' ' D' ' 142' ' ' GLN . 32.2 ttm -58.96 -33.16 70.32 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.717 1.207 . . . . 74.32 111.417 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 85.2 m-20 -57.51 -35.2 69.95 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.424 1.09 . . . . 72.11 111.669 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -64.55 -40.67 96.0 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.375 0.67 . . . . 75.02 110.695 175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.668 ' HA ' ' HG2' ' B' ' 1' ' ' MET . 8.6 mp -70.73 -42.81 70.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.624 0.77 . . . . 75.53 111.674 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' D' ' 138' ' ' MET . 13.6 pt20 -89.91 43.95 1.18 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.917 0.887 . . . . 73.1 111.684 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 19.6 mm-40 -125.76 93.76 3.93 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.595 0.758 . . . . 74.34 111.496 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -162.22 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.037 1.335 . . . . 65.41 108.181 172.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.62 103.31 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.403 1.081 . . . . 61.43 108.516 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.9 82.27 0.29 Allowed Glycine 0 C--N 1.342 0.874 0 O-C-N 123.295 0.372 . . . . 75.03 112.404 -174.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -164.38 123.26 1.86 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.789 0.836 . . . . 62.52 109.34 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.1 151.58 19.44 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 110.904 -0.878 . . . . 73.24 110.904 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 31.8 p -78.61 97.74 5.91 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.027 0.531 . . . . 63.33 110.856 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -86.81 116.56 24.98 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.98 0.512 . . . . 72.33 109.941 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -122.34 140.9 52.13 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.667 -1.234 . . . . 70.3 107.667 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -71.31 144.44 49.95 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.743 0.417 . . . . 63.44 110.492 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -74.47 132.65 42.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.551 0.741 . . . . 73.44 109.32 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -49.89 121.98 6.01 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.979 1.312 . . . . 74.32 111.645 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 123.733 0.813 . . . . 72.22 110.247 -176.143 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.226 -0.657 . . . . 52.13 109.226 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -71.93 -64.09 1.0 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.002 0.814 . . . . 71.02 109.042 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -168.71 172.9 7.6 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.762 0.825 . . . . 61.21 110.728 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -174.22 118.37 0.24 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.382 1.073 . . . . 74.44 108.223 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.57 104.79 50.01 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.598 0.759 . . . . 63.12 109.97 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.75 89.35 1.34 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.241 1.961 . . . . 55.43 110.934 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.52 -45.33 76.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 108.151 -1.055 . . . . 71.23 108.151 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.46 91.57 7.4 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.23 -1.35 . . . . 72.43 107.666 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -131.12 -78.96 0.18 Allowed Glycine 0 C--N 1.35 1.34 0 N-CA-C 112.652 -0.179 . . . . 50.45 112.652 -172.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.57 100.93 2.88 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.88 -0.785 . . . . 54.3 108.88 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -170.47 120.9 0.6 Allowed 'General case' 0 C--N 1.35 0.616 0 O-C-N 124.122 0.889 . . . . 72.23 110.481 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -151.4 -65.88 0.18 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 124.201 0.938 . . . . 60.04 108.897 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -157.97 -163.02 1.24 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.926 0.89 . . . . 63.11 109.085 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -151.85 176.67 30.1 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 111.728 -0.549 . . . . 74.34 111.728 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -87.13 25.91 1.27 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.712 0.805 . . . . 43.12 110.817 176.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 286' ' ' MET . . . . . 0.496 ' HG2' HD22 ' A' ' 136' ' ' LEU . 32.9 mtm -99.03 106.44 38.08 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.307 -1.368 . . . . 74.31 107.307 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.76 -58.82 0.35 Allowed 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.992 2.461 . . . . 74.34 112.825 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 12.5 t 54.34 37.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 123.616 1.674 . . . . 71.45 109.512 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -96.03 50.04 1.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 113.834 -1.53 . . . . 64.41 108.372 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 53.6 m95 69.25 174.47 0.29 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.132 1.373 . . . . 74.43 113.08 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.435 ' N ' HD12 ' E' ' 291' ' ' LEU . 2.2 mp -112.7 -52.8 2.76 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 113.28 -1.782 . . . . 64.2 106.376 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -154.31 114.01 0.6 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-N 114.316 -1.311 . . . . 74.42 110.257 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.11 177.17 5.38 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.771 2.314 . . . . 33.22 112.443 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? 64.23 103.18 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.42 1.088 . . . . 74.45 110.36 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -160.26 -34.29 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.606 1.162 . . . . 74.1 108.226 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 11.6 m -66.87 145.34 55.57 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 114.581 -1.19 . . . . 70.11 109.909 171.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 74.38 175.12 0.26 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.749 1.619 . . . . 74.32 110.772 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -163.4 -50.68 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.64 0.376 . . . . 72.41 109.998 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -125.49 -81.57 0.44 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.494 -0.642 . . . . 71.55 111.494 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -152.87 132.35 12.96 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.156 0.582 . . . . 72.13 110.498 178.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.659 ' HA ' ' HB3' ' G' ' 298' ' ' HIS . 24.4 pt -96.73 10.02 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.419 0.288 . . . . 45.24 111.103 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.65 165.35 35.7 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.03 0.932 . . . . 73.22 110.633 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 303' ' ' LYS . . . . . 0.561 ' HB3' ' HD3' ' E' ' 304' ' ' PRO 0.268 57.2 tttm 104.3 -68.49 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.654 0 C-N-CA 128.385 2.674 . . . . 73.33 111.761 174.701 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' E' E ' 304' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' E' ' 303' ' ' LYS . 13.7 Cg_exo -72.57 97.6 0.89 Allowed 'Trans proline' 0 C--N 1.391 2.779 0 CA-C-N 122.381 1.886 . . . . 75.3 111.85 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -92.04 -170.45 2.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.813 0.845 . . . . 64.13 111.474 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 306' ' ' VAL . . . . . 0.6 ' HB ' ' NE2' ' B' ' 12' ' ' GLN . 21.5 t -86.36 144.94 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.867 0.867 . . . . 65.43 110.393 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 40.2 p -72.28 149.58 44.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.378 0.671 . . . . 63.22 110.857 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 35.6 m -107.7 163.11 13.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.69 0.796 . . . . 75.43 110.642 -175.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 12.1 t -147.62 147.54 27.96 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.194 0.597 . . . . 73.11 109.818 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 C--N 1.372 1.788 0 C-N-CA 122.539 2.159 . . . . 72.14 112.855 167.442 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 111.578 0.214 . . . . 74.35 111.578 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -89.1 146.87 24.54 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.267 0.627 . . . . 75.3 110.151 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 57.97 85.39 0.09 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 124.824 1.328 . . . . 74.54 110.52 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.74 177.75 10.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.281 0.632 . . . . 74.41 111.167 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -141.14 164.45 35.57 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.322 1.449 . . . . 75.42 108.351 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.57 -7.87 6.27 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.301 2.667 . . . . 72.21 114.271 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.85 -56.3 24.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.149 0.58 . . . . 62.43 109.487 169.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.66 122.09 17.8 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.111 -0.95 . . . . 75.15 110.387 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 159.07 94.15 0.1 OUTLIER Glycine 0 C--N 1.348 1.201 0 O-C-N 123.43 0.457 . . . . 43.34 111.999 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 280' ' ' LEU . . . . . 0.441 HD23 ' HA3' ' C' ' 99' ' ' GLY . 27.9 tp -163.97 -22.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.192 0.597 . . . . 61.43 110.658 176.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 281' ' ' PHE . . . . . 0.419 ' HE2' ' HB3' ' C' ' 48' ' ' SER . 12.1 m-85 -70.23 -49.29 51.61 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.288 0.635 . . . . 73.41 112.37 -177.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 64.33 -156.85 0.31 Allowed 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.314 1.009 . . . . 73.23 109.58 -167.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.7 -19.7 63.56 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.683 0.393 . . . . 64.04 110.266 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 164.41 151.96 6.77 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 110.352 -1.099 . . . . 62.33 110.352 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -148.39 146.88 28.67 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.833 -0.803 . . . . 72.03 108.833 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 61.8 mtt 59.15 69.43 1.35 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.593 1.157 . . . . 70.35 110.91 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.89 94.81 0.55 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.457 2.105 . . . . 54.2 110.859 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.52 107.57 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.183 -0.917 . . . . 72.23 109.826 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.51 37.6 0.83 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.391 1.077 . . . . 72.43 110.677 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 94.6 m95 68.32 164.91 0.24 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.221 1.408 . . . . 75.22 112.1 -169.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.575 HD13 ' HB3' ' C' ' 129' ' ' ALA . 4.5 mp -107.33 64.86 0.64 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.168 -1.419 . . . . 70.22 107.168 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.58 88.65 0.77 Allowed Glycine 0 C--N 1.347 1.18 0 CA-C-N 114.716 -1.129 . . . . 53.22 110.623 -167.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.38 115.54 1.62 Allowed 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 123.914 3.076 . . . . 71.11 113.226 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -82.32 142.35 32.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.695 -0.684 . . . . 72.22 110.548 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.8 72.55 7.78 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.338 -0.616 . . . . 64.3 109.338 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 86.7 m -60.67 -53.87 52.17 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.999 -1.0 . . . . 74.11 110.352 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -82.3 74.88 9.25 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.916 0.865 . . . . 75.45 109.364 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -78.28 -37.31 45.26 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.891 -1.504 . . . . 71.13 111.131 -172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 120.09 -141.77 15.59 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.019 -0.832 . . . . 74.33 111.019 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 14.2 m120 71.7 -2.55 2.44 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.286 1.434 . . . . 75.3 112.666 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 35.9 pt -102.7 22.85 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.584 1.153 . . . . 74.32 109.232 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.73 2.51 11.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.705 1.202 . . . . 64.41 112.394 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.49 148.51 67.78 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.052 0.941 . . . . 32.32 110.021 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.24 147.58 29.62 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.878 2.385 . . . . 65.12 111.32 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -124.44 -167.21 1.62 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.618 0.767 . . . . 63.2 108.988 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 4.3 t 67.58 3.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 124.738 1.215 . . . . 75.04 111.953 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 37.1 p -77.52 11.98 1.8 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.24 1.016 . . . . 52.42 112.836 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 308' ' ' CYS . . . . . 0.453 ' HB2' ' HG ' ' H' ' 291' ' ' LEU . 60.9 m -97.66 1.53 48.77 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.105 0.962 . . . . 51.53 111.129 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 14.5 t -139.29 134.52 16.62 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 122.675 0.39 . . . . 74.4 110.455 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 CA--C 1.564 2.017 0 C-N-CA 123.417 2.745 . . . . 73.33 111.707 170.644 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 110.481 -0.192 . . . . 61.44 110.481 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' G' G ' 272' ' ' ASN . . . . . 0.591 ' HA ' ' HB2' ' D' ' 90' ' ' GLU . 26.1 t-20 -86.67 146.84 26.14 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.833 0.453 . . . . 73.01 110.655 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -153.02 78.26 1.17 Allowed 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.463 -0.94 . . . . 65.3 108.463 172.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 65.92 126.17 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.936 1.294 . . . . 73.32 112.162 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 275' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' G' ' 276' ' ' PRO . 0.1 OUTLIER 68.83 168.58 0.12 Allowed Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 124.048 0.939 . . . . 54.23 112.068 177.282 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' G' G ' 276' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' G' ' 275' ' ' LYS . 46.0 Cg_endo -65.57 -164.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.278 1.986 . . . . 60.03 113.643 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 6.1 mp -67.27 -37.17 83.02 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.893 0.877 . . . . 75.12 112.057 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.17 107.4 11.9 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.147 -0.686 . . . . 75.0 109.147 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -137.59 -101.57 0.57 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.534 0.521 . . . . 62.25 112.137 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.578 ' HB3' ' HB1' ' D' ' 95' ' ' ALA . 6.7 tt -72.09 122.25 20.63 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.937 0.895 . . . . 61.45 109.079 178.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -163.26 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.502 1.126 . . . . 74.04 109.349 170.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -79.66 -18.69 50.86 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.104 -0.498 . . . . 63.32 110.763 175.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 283' ' ' ASP . . . . . 0.543 ' HB3' ' HG ' ' G' ' 280' ' ' LEU . 25.5 t70 -66.94 99.96 0.69 Allowed 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.528 0.731 . . . . 64.34 109.487 174.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.36 73.92 2.3 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.562 -0.745 . . . . 63.11 111.504 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -57.0 -36.75 70.77 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.85 0.86 . . . . 63.34 110.697 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 286' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' G' ' 286' ' ' MET . 0.0 OUTLIER -122.9 101.58 38.98 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.192 0.997 . . . . 71.22 109.698 177.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.48 85.68 1.25 Allowed 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.303 2.002 . . . . 62.4 110.418 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.44 -52.38 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.153 -0.93 . . . . 70.31 110.283 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 63.7 -77.39 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.8 1.24 . . . . 73.15 111.226 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.527 ' HE3' ' H ' ' G' ' 291' ' ' LEU . 3.6 m95 -150.98 175.79 11.74 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.726 1.21 . . . . 64.23 109.681 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.527 ' H ' ' HE3' ' G' ' 290' ' ' TRP . 5.1 mp -93.71 -32.93 13.83 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.313 1.045 . . . . 73.25 108.894 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 155.36 -161.25 30.38 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 114.842 -1.072 . . . . 55.43 111.496 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.0 167.03 25.83 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.629 2.219 . . . . 72.5 112.147 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 294' ' ' LYS . . . . . 0.468 ' HE3' HG11 ' D' ' 40' ' ' VAL . 22.1 pttp -160.24 149.7 17.66 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 122.911 0.485 . . . . 73.15 109.919 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -74.53 96.32 2.92 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.295 -1.002 . . . . 74.44 108.295 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 296' ' ' THR . . . . . 0.508 HG22 ' HG2' ' D' ' 124' ' ' PRO . 78.7 m -73.3 -58.95 2.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.801 -0.636 . . . . 73.24 110.967 -173.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.643 ' HA ' ' HG3' ' D' ' 124' ' ' PRO . 0.2 OUTLIER -71.09 135.51 47.75 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.004 0.431 . . . . 74.23 111.22 -178.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' G' G ' 298' ' ' HIS . . . . . 0.659 ' HB3' ' HA ' ' E' ' 301' ' ' ILE . 42.1 m-70 -151.36 -41.62 0.12 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.728 -1.124 . . . . 61.34 110.295 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.02 -89.43 0.02 OUTLIER Glycine 0 CA--C 1.533 1.206 0 O-C-N 123.792 0.682 . . . . 74.4 113.144 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -160.57 143.8 13.39 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.79 -0.818 . . . . 45.25 108.79 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' D' ' 32' ' ' PHE . 9.9 tt -148.23 102.55 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.726 0 C-N-CA 124.928 1.291 . . . . 74.1 108.059 174.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 302' ' ' ASP . . . . . 0.418 ' H ' ' NH1' ' C' ' 15' ' ' ARG . 0.7 OUTLIER -159.92 159.19 32.05 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.378 -0.971 . . . . 53.32 108.378 -175.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 5.8 tmtp? -95.89 -54.11 0.22 Allowed Pre-proline 0 CA--C 1.57 1.732 0 CA-C-O 118.821 -0.609 . . . . 71.33 110.761 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -90.22 159.56 4.69 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.077 1.851 . . . . 73.52 112.88 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -100.18 -70.39 0.74 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.37 0.668 . . . . 55.41 109.993 177.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.02 176.98 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.734 0.813 . . . . 74.25 110.345 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 27.0 m -87.09 -60.04 2.09 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.497 0.719 . . . . 75.04 111.18 -176.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 60.1 m -127.28 158.08 38.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.195 0.998 . . . . 72.32 110.047 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' G' G ' 309' ' ' THR . . . . . 0.488 ' HB ' ' HD3' ' G' ' 310' ' ' PRO . 28.1 m -73.4 -52.04 5.35 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-O 118.877 -0.583 . . . . 75.14 109.604 167.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' G' G ' 310' ' ' PRO . . . . . 0.564 ' HG2' ' H ' ' C' ' 150' ' ' GLU . 98.3 Cg_endo . . . . . 0 C--N 1.394 2.962 0 C-N-CA 122.221 1.947 . . . . 53.54 111.504 172.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.062 -0.347 . . . . 70.41 110.062 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -132.47 145.41 51.16 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.938 -0.764 . . . . 71.44 108.938 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -104.38 32.19 4.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.48 0.712 . . . . 61.0 109.978 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -60.84 -36.09 78.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.932 0.893 . . . . 74.04 110.815 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 275' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' H' ' 275' ' ' LYS . 0.0 OUTLIER -98.98 130.95 26.36 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 107.521 -1.289 . . . . 71.52 107.521 171.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.26 -58.41 1.65 Allowed 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.945 3.096 . . . . 74.01 114.556 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.97 -46.41 9.88 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.283 -0.636 . . . . 74.33 109.283 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 278' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' H' ' 275' ' ' LYS . 39.0 tp -76.99 74.67 3.57 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-O 122.098 0.951 . . . . 71.2 111.05 -176.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -111.98 -4.77 25.79 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 114.767 -1.106 . . . . 70.02 111.669 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.65 129.76 12.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.017 0.927 . . . . 72.22 108.944 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -158.94 22.19 0.21 Allowed 'General case' 0 CA--C 1.559 1.311 0 O-C-N 124.245 0.966 . . . . 73.12 109.179 171.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -148.54 131.56 16.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.305 0.642 . . . . 74.41 110.213 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.11 -74.65 0.39 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.283 0.633 . . . . 75.24 110.331 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 159.48 -54.27 0.36 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.577 -0.609 . . . . 73.11 111.577 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -148.62 109.01 4.14 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.018 0.527 . . . . 65.53 109.841 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 55.6 ttp -169.69 89.17 0.56 Allowed Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 108.165 -1.05 . . . . 73.42 108.165 172.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -73.62 148.64 42.37 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.746 2.298 . . . . 60.32 111.96 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 61.9 t -77.1 89.98 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.652 -0.87 . . . . 54.2 108.652 175.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -75.23 148.49 39.44 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.769 -1.105 . . . . 61.42 109.78 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -66.13 131.54 46.41 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.259 0.552 . . . . 73.1 111.947 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.453 ' HG ' ' HB2' ' F' ' 308' ' ' CYS . 4.5 mp -88.65 1.24 55.4 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.513 -1.221 . . . . 75.21 109.917 171.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -178.27 95.47 0.1 OUTLIER Glycine 0 C--N 1.345 1.056 0 N-CA-C 109.255 -1.538 . . . . 63.02 109.255 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -58.59 -28.89 87.44 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.11 2.54 . . . . 52.43 112.945 -173.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -93.05 116.02 28.65 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.669 -0.863 . . . . 65.43 108.669 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -148.74 -59.94 0.23 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.911 0.485 . . . . 74.32 110.616 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 296' ' ' THR . . . . . 0.542 HG22 ' HD2' ' H' ' 297' ' ' TYR . 7.8 m -84.09 145.04 28.66 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.196 0.598 . . . . 71.53 110.534 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.61 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 27.2 m-85 59.99 103.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.081 1.352 . . . . 73.14 112.161 -174.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -148.4 -50.82 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.427 -0.806 . . . . 61.54 110.252 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -165.94 123.85 1.19 Allowed Glycine 0 C--N 1.347 1.144 0 C-N-CA 120.732 -0.747 . . . . 54.42 113.965 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 300' ' ' ASN . . . . . 0.48 ' OD1' ' HG3' ' B' ' 124' ' ' PRO . 28.7 p-10 171.44 -40.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.807 1.643 . . . . 72.14 108.861 174.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 33.3 pt -94.35 18.32 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.093 0.957 . . . . 61.03 111.568 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.47 -43.31 77.25 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.951 0.9 . . . . 44.15 108.983 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -126.14 85.01 60.47 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.88 -1.156 . . . . 75.23 107.88 165.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -87.65 -161.77 0.13 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.266 2.644 . . . . 71.43 111.434 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 70.46 157.33 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.655 1.182 . . . . 72.53 113.188 171.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.35 120.5 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.361 -1.348 . . . . 72.5 107.361 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 13.4 t -160.28 168.66 24.84 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.256 0.622 . . . . 71.42 110.067 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 43.9 t 61.55 34.17 18.01 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.455 1.102 . . . . 72.51 110.335 -176.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 47.6 m -64.69 111.95 6.85 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 114.986 -1.007 . . . . 54.03 109.989 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.375 1.922 0 C-N-CA 122.465 2.11 . . . . 64.44 111.325 178.564 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.062 -0.718 . . . . 72.2 109.062 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.3 m -147.74 39.67 0.96 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.446 1.098 . . . . 34.23 109.102 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.32 95.86 7.13 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.912 0.485 . . . . 72.02 110.839 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -80.99 124.24 28.99 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.78 -0.822 . . . . 73.1 108.78 168.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -89.68 157.57 17.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.51 0.724 . . . . 75.54 109.876 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -69.4 90.34 0.52 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.864 0.866 . . . . 63.34 109.765 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.3 p -141.89 164.47 30.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.672 1.189 . . . . 65.34 110.411 -171.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.63 122.63 32.27 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.478 0.711 . . . . 61.33 109.316 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.4 mpt? -67.76 134.01 50.26 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.982 -0.747 . . . . 55.23 108.982 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m -140.69 137.4 33.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.294 0.638 . . . . 72.12 110.181 -173.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 28.1 t80 -138.83 127.59 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.005 -0.739 . . . . 71.44 109.005 171.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -159.17 110.91 2.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.466 0.479 . . . . 71.52 110.143 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.688 HG12 ' HD2' ' A' ' 84' ' ' PHE . 56.6 mt -69.5 116.02 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.057 0.543 . . . . 60.22 110.329 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' H' ' 307' ' ' THR . 22.7 tm0? -81.43 -36.04 29.91 Favored 'General case' 0 C--O 1.248 0.996 0 O-C-N 124.159 0.912 . . . . 65.41 110.007 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -176.28 123.01 0.17 Allowed 'General case' 0 C--N 1.363 1.195 0 O-C-N 123.557 0.536 . . . . 64.53 111.025 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.06 142.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 123.614 0.766 . . . . 74.43 109.024 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -168.44 155.83 7.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.674 0.75 . . . . 75.11 111.71 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -86.6 114.99 23.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.953 -1.021 . . . . 32.45 109.193 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -79.3 -22.07 45.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.147 -0.479 . . . . 74.1 111.009 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -159.84 144.27 14.82 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.88 0.872 . . . . 62.11 109.357 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 84.3 mt -141.93 143.88 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.361 1.464 . . . . 75.22 107.806 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -145.73 128.29 16.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.525 0.73 . . . . 60.21 109.537 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 89.7 t80 -126.12 117.25 22.76 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 106.082 -1.821 . . . . 71.4 106.082 162.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 47.1 mt-10 -118.99 140.56 49.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.965 -0.754 . . . . 73.51 108.965 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.53 72.96 69.16 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 105.804 -1.925 . . . . 53.21 105.804 168.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.58 -20.27 41.24 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.798 2.332 . . . . 73.2 112.042 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 37.9 m-20 -119.42 23.43 11.24 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.242 1.017 . . . . 64.3 109.434 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -47.95 -57.45 10.2 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.625 -1.179 . . . . 24.34 113.485 -170.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 14.1 Cg_exo -65.9 -19.4 58.42 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 121.873 1.715 . . . . 61.11 112.572 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.61 -44.62 14.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.803 0.841 . . . . 64.41 109.889 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -78.99 -19.6 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.824 -1.08 . . . . 70.51 111.943 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.61 -6.25 42.88 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.497 0.719 . . . . 71.15 111.301 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -102.2 -12.55 17.94 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.661 1.185 . . . . 74.15 111.978 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -71.42 168.66 17.0 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.719 0.808 . . . . 75.24 113.016 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 68' ' ' LEU . 23.3 m-20 -69.97 135.19 49.14 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.182 -0.917 . . . . 64.31 109.368 169.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -82.77 67.18 8.73 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.491 1.116 . . . . 73.33 110.617 -169.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -141.75 71.0 25.01 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.137 0.975 . . . . 55.41 109.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.642 ' HG2' ' HB3' ' E' ' 297' ' ' TYR . 2.0 Cg_endo -91.26 129.47 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.61 2.873 . . . . 75.4 112.217 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -96.63 110.5 22.91 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.034 -1.098 . . . . 73.24 108.034 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 t -79.22 136.64 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.672 0.789 . . . . 62.25 109.108 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -117.04 118.58 32.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.486 1.114 . . . . 75.01 108.136 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.702 HD13 HG11 ' E' ' 288' ' ' VAL . 4.0 tt -102.37 107.72 18.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.109 -1.071 . . . . 61.33 108.109 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.701 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 14.8 m-20 -108.01 151.16 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.935 0.894 . . . . 73.54 108.982 172.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -139.0 134.58 33.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.202 1.001 . . . . 64.41 108.42 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 35.0 t70 -135.96 137.27 41.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.076 0.951 . . . . 73.14 109.354 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 p -124.86 134.9 52.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.339 1.056 . . . . 64.24 110.157 -172.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.95 143.09 25.0 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 61.24 109.77 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -132.18 161.1 34.2 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.28 0.632 . . . . 74.54 109.338 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -163.49 127.8 2.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.499 0.72 . . . . 74.15 109.74 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -74.23 114.06 12.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.845 -0.798 . . . . 54.4 108.845 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 57' ' ' GLU . 39.9 mt -79.42 -43.96 22.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.146 0.578 . . . . 63.11 109.629 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.64 -172.69 2.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.939 -1.028 . . . . 75.52 109.815 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.34 120.99 14.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.371 0.668 . . . . 64.35 109.387 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.37 16.55 9.6 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.668 1.187 . . . . 71.45 112.528 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.49 HG12 HD12 ' A' ' 51' ' ' LEU . 28.7 t -127.48 106.32 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.301 -1.0 . . . . 71.51 108.301 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -133.78 127.9 33.68 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.089 0.956 . . . . 74.12 108.479 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.7 tt0 -104.65 134.41 47.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.36 0.664 . . . . 70.32 109.762 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.61 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 97.2 t -122.82 123.79 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.967 -1.123 . . . . 71.43 107.967 169.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.551 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -99.68 135.48 34.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.357 1.063 . . . . 73.13 109.374 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.14 99.52 6.4 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.158 -1.423 . . . . 73.04 107.158 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.7 ttp180 -87.46 113.29 23.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.045 0.538 . . . . 73.31 109.806 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -93.76 143.33 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.498 -1.297 . . . . 74.11 107.498 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.701 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.5 m -131.56 133.86 45.47 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.42 -0.585 . . . . 62.53 109.42 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.8 t -131.19 111.02 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.1 1.36 . . . . 72.24 108.709 -173.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 m -120.69 121.64 38.71 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.326 0.512 . . . . 74.41 110.212 173.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.33 22.53 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.339 -1.356 . . . . 72.0 107.339 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 66.2 m -118.25 126.56 52.42 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.306 0.503 . . . . 73.42 110.485 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 35' ' ' ASP . 5.3 mp -90.22 85.72 6.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.879 -1.156 . . . . 74.14 107.879 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.15 -85.11 1.53 Allowed Glycine 0 C--N 1.343 0.94 0 CA-C-N 114.434 -1.257 . . . . 45.53 110.643 -173.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.13 -28.74 3.11 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.482 0.713 . . . . 64.3 110.872 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 30.4 tt0 -95.73 125.65 40.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.835 0.35 . . . . 65.15 110.307 -174.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 29.5 m -77.77 142.23 38.78 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.783 1.233 . . . . 71.11 112.805 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.686 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.04 -65.98 0.94 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.522 1.129 . . . . 53.32 109.199 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.414 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 50.6 p90 -146.1 148.94 33.15 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.513 -1.221 . . . . 74.35 111.865 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -109.29 143.08 39.25 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.22 -1.355 . . . . 71.32 107.904 167.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.3 m -143.06 109.7 5.45 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.6 119.54 17.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.755 -0.461 . . . . 70.45 109.755 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.09 114.37 32.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.382 1.073 . . . . 75.22 109.404 -171.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.86 84.22 7.65 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.38 -0.97 . . . . 72.44 108.38 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 37.2 tp60 -79.57 91.7 5.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.811 -0.811 . . . . 60.42 108.811 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.09 167.27 37.69 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.39 -0.823 . . . . 52.43 111.715 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 124.95 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.186 -0.366 . . . . 75.34 112.186 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -81.98 115.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.964 -0.754 . . . . 41.32 108.964 171.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.7 m-85 -116.98 120.08 37.31 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.17 1.388 . . . . 75.55 107.81 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 t -75.57 94.17 3.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.797 -0.816 . . . . 71.41 108.797 171.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.681 HD13 HD21 ' A' ' 98' ' ' LEU . 50.8 pt -112.72 155.57 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.165 0.586 . . . . 53.5 110.708 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.76 167.69 11.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.456 -1.247 . . . . 71.45 109.111 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -11.65 57.6 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 114.511 0.564 . . . . 71.24 114.511 173.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.47 144.21 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.755 0.822 . . . . 45.14 110.3 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -162.06 173.31 14.55 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.785 -1.561 . . . . 65.31 106.785 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.25 -129.82 48.11 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 117.888 0.313 . . . . 61.04 113.543 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 71.3 p -75.09 -20.98 59.23 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.805 0.842 . . . . 74.43 111.826 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -69.82 -44.59 69.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.135 0.574 . . . . 74.14 109.619 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.712 ' SD ' ' HA ' ' E' ' 278' ' ' LEU . 50.4 ttm -68.95 -34.27 75.08 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.01 -0.541 . . . . 72.24 110.066 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.513 ' HA ' HD22 ' E' ' 280' ' ' LEU . . . -60.98 -28.34 68.94 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.188 0.595 . . . . 62.44 111.777 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.8 t-80 -88.47 -31.13 18.92 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.297 0.639 . . . . 71.43 111.065 171.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.11 -64.69 0.84 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.582 0.353 . . . . 72.33 111.149 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 86' ' ' ILE . 47.2 mt -90.09 -12.74 37.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.168 0.433 . . . . 72.52 112.168 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.78 -2.45 55.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.768 -0.462 . . . . 61.4 113.347 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.19 -53.17 0.17 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.365 0.582 . . . . 73.33 112.186 -174.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -77.3 -56.94 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 64.34 112.085 -168.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 80.5 m -74.97 -34.48 1.72 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.563 0.949 . . . . 73.32 113.563 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.6 Cg_endo -67.06 -23.01 46.8 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 121.958 1.772 . . . . 61.1 112.936 168.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -70.19 -33.76 72.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.3 0.64 . . . . 62.31 109.487 174.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 13' ' ' ILE . 45.3 mm -63.04 -42.17 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.799 0.84 . . . . 50.23 110.14 173.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.66 -32.62 69.97 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.982 -1.008 . . . . 64.34 111.981 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.27 -39.99 55.75 Favored Pre-proline 0 CA--C 1.575 1.927 0 N-CA-C 114.597 1.332 . . . . 74.41 114.597 -169.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.05 -41.75 73.69 Favored 'Trans proline' 0 C--N 1.392 2.835 0 C-N-CA 122.592 2.195 . . . . 73.32 113.489 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -71.97 -37.3 69.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.985 0.514 . . . . 64.25 111.376 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.46 88.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.785 0.434 . . . . 74.24 109.86 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.97 -53.38 56.44 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 124.726 1.266 . . . . 75.23 110.126 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.52 -42.75 95.59 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.044 0.84 . . . . 73.41 111.231 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.522 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.4 t -60.64 -34.52 74.39 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.504 0.722 . . . . 72.45 111.257 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.459 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 95.5 mt -73.44 -55.51 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.593 0.757 . . . . 71.21 109.867 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 125' ' ' GLN . 90.0 m -53.08 -40.33 63.98 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 125.199 1.4 . . . . 54.05 111.952 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -61.49 -50.78 71.33 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 60.03 110.303 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -61.17 -44.22 97.65 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.461 0.704 . . . . 71.44 111.527 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.4 t -55.83 -46.81 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 O-C-N 124.25 0.969 . . . . 63.02 110.299 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.6 t -69.87 -29.58 66.83 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.199 -0.91 . . . . 74.43 111.504 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -70.95 -27.67 63.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.363 0.665 . . . . 73.34 111.259 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.78 11.77 58.71 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.93 -0.372 . . . . 62.24 113.339 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.524 ' HB ' HH21 ' B' ' 15' ' ' ARG . 2.4 m 61.03 25.62 15.63 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 125.141 1.376 . . . . 71.4 111.022 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -94.01 146.23 31.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.825 -0.806 . . . . 74.24 108.825 171.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.73 149.55 90.55 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.66 2.24 . . . . 63.51 112.088 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.502 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.6 tt0 -58.37 133.16 55.49 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.295 0.997 . . . . 60.24 112.003 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.01 103.73 9.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.256 1.022 . . . . 55.5 108.783 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -105.97 110.89 23.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.127 -1.064 . . . . 73.23 108.127 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.55 135.5 54.27 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 123.404 0.44 . . . . 73.03 110.402 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' E' ' 291' ' ' LEU . . . -69.38 155.93 92.59 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.39 0.676 . . . . 63.3 110.312 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.24 125.33 14.94 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.524 2.149 . . . . 73.1 112.181 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -99.8 113.1 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.717 -1.586 . . . . 63.52 106.717 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 135' ' ' ALA . 2.3 p-10 -72.79 81.33 1.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 74.11 110.488 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.09 -44.26 97.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.449 0.7 . . . . 63.32 110.951 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.519 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.2 p-10 -71.92 -40.33 68.86 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.286 -1.325 . . . . 65.13 111.707 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 132' ' ' ASN . . . -72.44 -41.58 65.97 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.61 0.569 . . . . 34.02 111.16 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.13 -51.09 65.59 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.441 0.696 . . . . 74.02 109.794 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.98 -36.09 82.83 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.699 0.624 . . . . 61.01 110.979 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.5 tpt -63.26 -43.95 96.51 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.573 0.545 . . . . 62.21 110.104 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 43.5 m-80 -62.89 -38.79 92.31 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.786 0.679 . . . . 64.21 111.368 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -69.12 -39.33 79.0 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.944 -0.571 . . . . 71.12 110.852 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.0 tp -69.15 -50.87 43.83 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.117 0.567 . . . . 72.41 111.72 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -178.43 21.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.016 0.526 . . . . 71.5 111.416 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 40.3 mt-30 58.47 -75.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.384 1.874 . . . . 65.42 114.66 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -135.2 34.07 3.07 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.803 0.811 . . . . 71.22 109.093 -174.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.97 -169.15 3.25 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.051 -0.977 . . . . 71.0 110.195 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.85 137.38 8.82 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.854 -0.898 . . . . 52.13 110.854 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -72.74 129.26 37.8 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.083 0.553 . . . . 75.31 110.908 -174.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.98 124.63 6.72 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.981 -0.554 . . . . 55.13 112.354 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.5 p -81.75 138.7 35.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.885 0.874 . . . . 74.25 111.195 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -107.45 118.0 35.58 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.733 0.813 . . . . 53.5 109.912 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.9 128.32 34.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.316 0.646 . . . . 73.02 110.293 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -176.53 123.5 0.16 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.658 1.183 . . . . 60.32 108.013 168.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.39 66.88 8.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.855 0.862 . . . . 53.34 110.288 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.1 86.9 7.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.424 -0.954 . . . . 51.11 108.424 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 N-CA-C 108.401 -0.963 . . . . 74.25 108.401 174.998 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.756 -0.461 . . . . 52.53 109.756 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' D' ' 137' ' ' PHE . 47.3 m -74.61 85.43 2.09 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.246 0.618 . . . . 61.22 110.181 175.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -75.51 168.39 20.1 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.292 -0.867 . . . . 71.24 112.15 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 63.03 -161.9 0.29 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 124.546 1.139 . . . . 62.45 110.555 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -157.14 145.06 19.16 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.713 -1.217 . . . . 75.15 107.713 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.47 137.35 42.51 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.818 -0.808 . . . . 72.43 108.818 171.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.8 m -72.0 78.35 0.92 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.528 -0.916 . . . . 65.32 108.528 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -108.64 103.25 12.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.256 -1.387 . . . . 73.31 107.256 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 21.2 ptm 48.84 -171.77 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.729 1.612 . . . . 75.55 113.76 -175.102 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 52.6 m -137.35 116.69 12.71 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.537 0.735 . . . . 70.52 109.381 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.593 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 31.9 t80 -139.58 131.33 27.46 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.224 -0.658 . . . . 65.24 109.224 176.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' B' ' 85' ' ' SER . 3.9 pp0? -152.29 140.9 20.81 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.055 0.542 . . . . 72.31 109.54 168.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.594 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -69.28 113.8 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.247 -0.888 . . . . 72.12 109.344 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -88.24 -35.31 17.38 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.008 -0.738 . . . . 62.32 109.008 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.524 HH21 ' HB ' ' A' ' 122' ' ' THR . 24.3 ttt180 -168.47 142.0 3.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.999 0.92 . . . . 72.32 109.726 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.11 137.66 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.007 -1.479 . . . . 72.04 107.007 172.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 36.2 p90 -166.28 159.24 14.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.687 0.756 . . . . 75.24 110.96 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.9 m -84.63 119.42 25.21 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.283 -1.006 . . . . 75.51 108.283 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.404 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 41.8 mtpt -87.03 -34.44 19.2 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.289 0.635 . . . . 75.51 111.142 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -158.84 146.26 17.64 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.322 -0.399 . . . . 73.52 110.746 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.7 mm -142.49 138.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 125.965 1.706 . . . . 73.22 107.619 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -140.1 118.9 12.44 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.522 -1.288 . . . . 63.31 107.522 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.5 t80 -131.59 136.42 47.77 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.08 -1.081 . . . . 73.33 108.08 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.76 145.28 38.05 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.131 0.972 . . . . 65.03 108.696 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -148.34 72.3 10.93 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 105.9 -1.889 . . . . 74.34 105.9 171.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.55 -14.71 30.65 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.79 2.327 . . . . 71.45 112.177 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -127.04 28.53 5.76 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.032 0.933 . . . . 60.14 109.502 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -46.69 -59.35 5.25 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.477 1.111 . . . . 63.2 113.305 -173.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.29 -18.97 34.16 Favored 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 121.926 1.751 . . . . 53.33 113.029 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -94.73 -21.81 18.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.439 0.696 . . . . 74.1 112.382 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -81.94 -28.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 110.051 -0.351 . . . . 71.44 110.051 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -62.47 -27.03 68.85 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.278 1.031 . . . . 72.04 113.216 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -72.77 -16.18 61.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.235 0.614 . . . . 71.11 112.204 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -107.55 113.34 26.59 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.149 0.98 . . . . 73.32 109.227 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -110.38 104.57 13.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 118.707 0.685 . . . . 62.15 112.605 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.473 ' HE3' ' N ' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 179.21 -177.38 0.3 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.384 1.474 . . . . 73.35 110.898 176.563 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.54 133.73 70.45 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.293 1.037 . . . . 74.41 111.956 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' PRO . . . . . 0.611 ' HB3' HD21 ' B' ' 68' ' ' LEU . 93.1 Cg_endo -93.43 170.6 2.08 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.329 2.686 . . . . 73.34 114.564 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -80.98 101.69 9.67 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.879 -1.526 . . . . 54.31 106.879 164.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.497 ' H ' ' HE3' ' H' ' 294' ' ' LYS . 10.9 t -99.7 134.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.343 -0.984 . . . . 63.41 108.343 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.3 tttp -125.35 117.17 23.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.251 0.62 . . . . 74.33 110.195 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.88 136.57 33.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.968 -1.123 . . . . 71.53 107.968 169.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 15.4 t70 -145.93 154.72 42.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.19 0.596 . . . . 61.33 109.584 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.5 tp -135.42 128.32 31.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.228 1.011 . . . . 74.43 109.71 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.6 t70 -124.01 130.99 53.49 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.232 -1.025 . . . . 64.31 108.232 170.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -118.31 104.54 10.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.36 0.664 . . . . 74.43 109.947 -176.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.27 118.77 33.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.575 -0.898 . . . . 73.2 108.575 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 41.1 p -129.31 160.58 32.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.22 0.608 . . . . 52.41 110.53 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.1 p -165.69 138.37 4.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.972 0.909 . . . . 62.34 110.016 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 50.3 tt0 -81.16 115.46 20.59 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.477 0.711 . . . . 62.12 109.405 175.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' B' ' 57' ' ' GLU . 32.7 mt -75.5 -43.38 49.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.67 0.788 . . . . 70.23 110.538 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.65 -171.21 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.84 0.856 . . . . 53.51 110.481 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.62 116.49 4.05 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.36 0.664 . . . . 64.31 110.243 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 67.12 -3.36 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.568 1.547 . . . . 70.23 113.383 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -102.92 110.56 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.822 -1.177 . . . . 74.44 107.822 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 45.6 m-85 -111.68 172.04 7.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.379 -0.828 . . . . 71.32 108.996 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' B' ' 51' ' ' LEU . 20.3 tt0 -142.43 129.0 20.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.485 -0.931 . . . . 61.43 108.485 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -112.51 119.0 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.504 -1.295 . . . . 71.33 107.504 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -103.09 111.91 34.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 108.965 -0.754 . . . . 72.35 108.965 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.49 101.47 13.67 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.993 -1.003 . . . . 64.25 108.772 -176.883 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.7 ttm-85 -94.93 121.0 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.366 -0.605 . . . . 63.0 109.366 174.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 62' ' ' VAL . . . . . 0.43 HG11 HD21 ' B' ' 128' ' ' LEU . 41.3 t -115.75 125.48 72.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.222 -1.029 . . . . 61.0 108.222 172.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.6 m -111.96 140.34 46.71 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.616 0.722 . . . . 71.22 110.129 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.554 HG21 HG21 ' B' ' 114' ' ' ILE . 54.5 t -124.72 130.81 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 113.818 -1.537 . . . . 61.1 108.161 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.1 m -122.23 143.61 49.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.127 0.571 . . . . 70.33 109.466 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.05 125.77 13.42 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.524 -1.287 . . . . 70.55 107.524 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.8 p -140.82 140.08 34.61 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.303 0.641 . . . . 62.41 109.566 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' B' ' 73' ' ' ALA . 3.2 mm? -124.68 123.0 39.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.59 1.156 . . . . 55.21 109.974 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.89 -113.03 4.75 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.595 0.56 . . . . 63.35 112.057 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -113.02 4.16 16.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.856 0.863 . . . . 73.54 110.326 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 10.6 pt-20 -123.6 146.51 48.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.063 0.545 . . . . 75.53 110.282 -169.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -83.03 124.89 30.85 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.469 0.308 . . . . 74.22 110.341 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.63 ' HB2' HD23 ' B' ' 68' ' ' LEU . . . -71.45 -63.98 1.01 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.257 0.973 . . . . 63.44 109.262 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -157.03 149.44 23.17 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 121.657 0.741 . . . . 73.05 112.511 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.89 118.96 35.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.946 -1.501 . . . . 74.52 106.946 166.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 34.5 t -125.42 124.8 42.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.797 -0.816 . . . . 34.45 108.797 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -148.55 130.81 15.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.5 -0.926 . . . . 65.21 108.5 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -124.45 146.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 123.953 0.901 . . . . 74.11 109.512 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -121.66 96.49 5.09 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.193 -1.04 . . . . 63.25 108.193 170.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.529 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 45.2 tp60 -90.99 99.33 12.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.292 -1.003 . . . . 70.43 108.292 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.13 142.66 16.07 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 110.788 -0.925 . . . . 55.33 110.788 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.27 124.93 3.35 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.43 -1.068 . . . . 42.21 110.43 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -85.69 127.7 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.305 -1.369 . . . . 73.24 107.305 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.73 133.66 43.77 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.402 -0.962 . . . . 75.32 108.402 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.592 ' HB2' ' NE2' ' B' ' 12' ' ' GLN . 48.4 m -94.04 103.58 15.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.628 -1.249 . . . . 70.44 107.628 171.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.86 146.16 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.405 1.082 . . . . 73.52 110.265 -171.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.05 172.22 16.08 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.798 1.239 . . . . 40.44 109.198 172.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.0 -30.39 6.7 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.173 0.416 . . . . 71.51 114.003 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.36 162.79 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.343 0.657 . . . . 61.21 112.135 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -172.09 145.38 1.79 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.925 1.29 . . . . 62.2 109.04 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -111.3 3.3 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 114.74 0.656 . . . . 75.25 114.74 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -65.49 -44.02 88.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.833 0.853 . . . . 52.34 110.122 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -69.07 -29.77 67.95 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.693 -1.594 . . . . 75.31 110.545 -171.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.468 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 19.9 ptm -81.84 -34.09 30.35 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 116.496 -0.32 . . . . 71.21 111.016 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -34.75 74.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.515 0.726 . . . . 14.44 111.912 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -77.83 -34.02 52.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.238 0.615 . . . . 74.13 111.05 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.92 -65.84 0.63 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.698 0.399 . . . . 71.35 111.013 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.551 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.4 pp -70.95 -24.1 62.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.735 0.414 . . . . 72.21 111.961 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.453 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -84.4 -32.89 21.34 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.661 0.601 . . . . 54.14 113.729 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.7 -50.35 1.49 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.007 0.523 . . . . 70.43 111.564 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 101' ' ' TYR . . . . . 0.42 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 70.3 t80 -71.22 -40.8 70.9 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.361 0.664 . . . . 71.02 111.945 -172.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.593 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 55.6 m -72.21 -46.99 10.93 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.803 -0.618 . . . . 74.12 111.121 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.1 Cg_exo -57.62 -33.24 96.32 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.462 2.108 . . . . 53.41 113.708 168.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.78 -37.57 68.75 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.886 0.874 . . . . 54.41 110.919 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.19 -48.87 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.865 -1.062 . . . . 72.22 111.159 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.447 ' HB2' HD12 ' B' ' 60' ' ' LEU . 62.3 mt -77.72 -19.33 55.42 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.538 0.735 . . . . 74.33 112.405 -170.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.26 -45.56 85.12 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 114.164 1.172 . . . . 74.32 114.164 -170.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -57.02 -38.94 94.75 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 122.511 2.141 . . . . 55.33 113.351 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.529 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.1 m-85 -69.14 -40.11 78.45 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.153 -0.93 . . . . 71.24 109.858 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.99 93.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.523 0.729 . . . . 63.12 110.308 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -54.86 -57.59 11.0 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.623 1.169 . . . . 64.43 111.373 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.43 80.53 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.989 0.805 . . . . 74.2 110.244 -175.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.1 t -72.37 -32.58 66.56 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.868 0.467 . . . . 64.13 111.643 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.554 HG21 HG21 ' B' ' 64' ' ' VAL . 50.9 mt -65.3 -51.81 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.357 -0.979 . . . . 71.23 108.357 171.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' THR . . . . . 0.437 HG21 ' OG ' ' C' ' 119' ' ' SER . 24.8 m -61.28 -30.17 70.31 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.667 -1.152 . . . . 60.41 111.698 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.2 t -64.86 -46.7 80.74 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.789 0.836 . . . . 74.21 109.443 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 13.3 mmt -72.54 -30.54 64.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.217 0.607 . . . . 74.53 110.944 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.497 HG21 HD23 ' B' ' 126' ' ' LEU . 83.3 t -64.46 -41.16 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.911 0.884 . . . . 75.02 110.311 172.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -65.65 -35.11 79.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.058 0.943 . . . . 72.03 111.452 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.522 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.4 mtt-85 -73.03 -37.21 66.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.614 -0.721 . . . . 75.1 110.317 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.39 1.94 74.14 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.737 0.648 . . . . 71.21 112.59 173.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p 63.93 18.32 11.11 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.581 1.952 . . . . 73.42 113.544 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.57 152.79 81.08 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.47 0.708 . . . . 73.5 109.433 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.444 ' HG2' ' HA ' ' H' ' 297' ' ' TYR . 32.1 Cg_exo -60.54 -178.81 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 123.106 2.538 . . . . 73.43 114.236 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 7.6 tp-100 -65.37 113.48 4.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.753 -0.658 . . . . 63.12 112.445 -170.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.497 HD23 HG21 ' B' ' 118' ' ' VAL . 55.9 tp -114.35 93.78 4.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.05 -0.977 . . . . 72.23 108.855 171.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.08 128.5 36.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.591 -1.262 . . . . 74.41 107.591 166.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.43 HD21 HG11 ' B' ' 62' ' ' VAL . 30.2 tp -75.77 145.6 40.64 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.377 0.671 . . . . 73.31 110.51 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 127.49 85.02 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.817 0.847 . . . . 51.12 111.316 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.47 122.84 10.62 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.891 2.394 . . . . 54.35 111.594 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.423 HG22 HD11 ' H' ' 291' ' ' LEU . 29.1 t -111.91 116.85 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.409 0.684 . . . . 73.02 109.978 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -86.23 86.47 7.35 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.546 -0.909 . . . . 52.34 108.546 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -73.31 -32.17 64.45 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.742 -0.663 . . . . 72.12 109.668 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -58.63 -51.01 71.73 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.55 1.14 . . . . 74.2 111.502 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.74 -39.98 73.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.623 0.769 . . . . 70.14 111.364 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.34 -47.7 84.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.424 0.69 . . . . 73.34 109.514 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -73.79 -24.77 59.87 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.132 -0.94 . . . . 71.1 111.086 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.4 ttt -67.67 -37.98 83.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.357 0.663 . . . . 61.44 110.485 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -79.49 -26.12 41.69 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 115.906 -0.588 . . . . 71.42 110.739 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -63.88 -39.1 93.4 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.918 0.887 . . . . 72.2 110.108 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.11 -6.4 55.46 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.479 -0.782 . . . . 61.43 112.124 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 68.0 135.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.802 1.241 . . . . 64.31 111.629 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -76.6 85.56 3.27 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.184 0.516 . . . . 50.41 111.166 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -167.36 115.05 0.78 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.269 1.028 . . . . 64.11 108.265 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.41 97.55 1.35 Allowed 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.185 -0.672 . . . . 64.41 109.185 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.56 66.03 4.0 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.717 -0.553 . . . . 71.14 111.717 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.25 139.0 49.88 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.215 1.006 . . . . 75.54 110.757 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.85 86.27 0.08 OUTLIER Glycine 0 C--N 1.342 0.882 0 N-CA-C 110.325 -1.11 . . . . 73.15 110.325 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 24.0 p -74.51 84.15 2.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.659 0.784 . . . . 75.23 111.347 -176.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.26 147.3 32.6 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.551 -0.749 . . . . 73.22 109.265 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -156.45 132.38 9.72 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.914 0.388 . . . . 71.31 111.522 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -128.9 105.61 8.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.498 1.119 . . . . 75.14 108.795 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.31 91.28 2.17 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.088 -0.708 . . . . 62.43 109.088 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.54 139.92 35.53 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.373 1.069 . . . . 73.42 110.318 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.916 0 C-N-CA 123.64 0.776 . . . . 73.2 109.234 177.582 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.373 -0.603 . . . . 75.02 109.373 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 17.6 m -76.24 76.41 3.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.395 0.678 . . . . 63.11 109.618 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.25 -44.88 82.44 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.395 0.617 . . . . 71.52 110.499 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -153.19 130.5 11.28 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.854 -1.066 . . . . 63.41 109.469 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.494 ' HA ' ' OG1' ' C' ' 149' ' ' THR . 52.5 m-80 -132.31 127.5 35.71 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.66 -1.237 . . . . 54.51 107.66 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -153.55 118.71 5.12 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.132 -0.692 . . . . 73.53 109.132 -168.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 51.1 m -103.24 101.47 11.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.291 1.036 . . . . 72.34 110.337 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.05 117.88 30.93 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.154 -1.054 . . . . 65.13 108.154 167.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 73.5 mtp 64.71 117.33 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.364 1.466 . . . . 53.01 112.365 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.497 ' HA ' ' SG ' ' G' ' 308' ' ' CYS . 89.3 m -86.26 99.5 11.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.677 -0.86 . . . . 54.03 108.677 169.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -124.33 126.76 46.55 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.789 -1.189 . . . . 71.03 107.789 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' G' ' 306' ' ' VAL . 13.0 pt20 -151.85 144.09 23.99 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.918 0.487 . . . . 71.02 110.257 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.467 HG13 ' HE2' ' C' ' 84' ' ' PHE . 3.1 mp -82.63 115.73 25.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.219 -1.03 . . . . 62.44 108.219 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -80.93 -44.08 18.79 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.951 -0.388 . . . . 72.31 109.951 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -169.11 141.78 2.67 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.304 0.378 . . . . 75.11 110.098 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -125.45 135.52 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.053 -1.091 . . . . 70.2 108.053 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.595 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 32.6 p90 -173.77 155.9 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.914 0.387 . . . . 71.41 111.129 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -77.36 115.59 17.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.392 -0.822 . . . . 51.15 109.871 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -65.1 -41.02 95.34 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.995 -0.743 . . . . 74.22 108.995 171.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -149.34 150.11 31.96 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.316 -1.311 . . . . 74.14 110.353 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -142.14 145.28 24.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.501 1.92 . . . . 65.34 106.507 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -161.87 150.87 15.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.822 0.449 . . . . 64.25 110.053 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.86 106.67 2.68 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.436 -1.32 . . . . 62.33 107.436 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.39 120.22 36.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.747 0.819 . . . . 70.33 109.41 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.95 83.34 61.42 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.343 1.057 . . . . 70.31 108.496 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.92 -39.21 34.01 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.628 2.219 . . . . 73.13 112.081 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -97.13 20.9 10.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.957 0.903 . . . . 64.11 110.952 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.15 76.08 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.419 1.266 . . . . 70.25 114.419 -171.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.75 -26.35 8.32 Favored 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 121.235 1.477 . . . . 73.32 112.655 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.66 -30.37 65.65 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.336 1.054 . . . . 63.2 112.511 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' C' ' 73' ' ' ALA . 99.4 t -80.02 -20.17 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.32 0.648 . . . . 64.21 110.639 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -60.47 -28.97 68.75 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.072 0.549 . . . . 74.24 111.348 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.42 26.26 6.82 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.558 0.743 . . . . 74.34 110.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.25 152.36 37.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.605 0.762 . . . . 74.23 111.084 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.62 130.71 43.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.816 0.847 . . . . 71.5 110.449 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.504 ' HE1' ' ND2' ' F' ' 300' ' ' ASN . 18.0 m95 -76.34 98.14 4.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.838 0.855 . . . . 73.3 110.889 -172.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -156.59 75.82 4.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.397 -0.964 . . . . 74.41 108.397 173.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -86.63 130.09 3.17 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.391 2.06 . . . . 73.11 112.126 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.53 80.25 9.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.582 -1.636 . . . . 74.42 106.582 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.442 HG11 HD21 ' C' ' 126' ' ' LEU . 90.2 t -74.45 118.26 19.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.226 -1.352 . . . . 75.45 108.617 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -128.71 141.34 51.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.276 -1.379 . . . . 72.4 107.276 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.16 166.39 14.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.554 -0.906 . . . . 61.33 108.554 167.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.1 t70 -140.0 127.91 22.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.611 -1.255 . . . . 54.44 107.611 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 tp -104.85 140.62 37.86 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.691 0.796 . . . . 63.14 109.991 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 29.3 t70 -144.84 149.93 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.17 0.988 . . . . 73.4 108.676 172.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 66.3 p -126.77 141.09 51.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 62.05 109.928 -172.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -150.25 139.98 21.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.055 0.542 . . . . 63.32 110.104 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p -148.01 156.07 42.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.533 0.733 . . . . 64.51 109.529 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -152.68 165.55 34.93 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.282 0.633 . . . . 74.01 109.937 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -105.16 118.08 35.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.824 -0.806 . . . . 63.41 108.824 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.576 HD11 HD12 ' C' ' 83' ' ' ILE . 76.4 mt -89.04 -35.61 16.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.181 0.592 . . . . 73.2 110.366 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -171.3 2.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.036 0.934 . . . . 44.21 110.219 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.43 116.41 8.96 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.278 -0.874 . . . . 75.22 109.423 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 69.57 -0.46 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.371 1.468 . . . . 75.43 112.601 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.32 112.29 38.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 108.146 -1.057 . . . . 63.02 108.146 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' C' ' 86' ' ' ILE . 94.0 m-85 -129.56 144.13 51.13 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.889 0.876 . . . . 72.24 108.856 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -99.73 136.42 39.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.529 1.132 . . . . 74.52 110.021 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 58' ' ' VAL . . . . . 0.431 HG22 HD22 ' C' ' 98' ' ' LEU . 40.8 t -114.95 120.04 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.816 -1.179 . . . . 74.42 107.816 173.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 88.7 t -118.59 129.92 74.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.764 -0.828 . . . . 71.02 108.764 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -125.01 107.0 10.38 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.948 -1.501 . . . . 73.43 106.948 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 25.5 ttm180 -84.06 127.02 33.62 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.906 -0.588 . . . . 71.3 109.774 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.15 121.28 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.52 -1.218 . . . . 73.2 107.881 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 68.5 m -120.59 142.54 49.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.566 -0.902 . . . . 72.15 108.566 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.468 HG23 HD13 ' C' ' 114' ' ' ILE . 72.8 t -122.39 115.31 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.889 0.876 . . . . 74.31 109.421 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 28.2 m -99.31 135.79 40.21 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.879 -0.786 . . . . 43.35 108.879 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.29 107.29 7.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.082 -1.451 . . . . 60.52 107.082 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 67' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.3 m -143.44 128.36 18.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.286 0.634 . . . . 73.3 109.468 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' C' ' 73' ' ' ALA . 5.3 mp -85.8 56.71 4.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.469 1.507 . . . . 74.41 109.313 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.0 -82.33 0.44 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 109.893 -1.283 . . . . 71.54 109.893 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.12 -30.6 4.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.604 1.161 . . . . 71.02 109.104 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.19 91.79 0.08 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.191 1.397 . . . . 62.11 110.796 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 72' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 38.6 m -71.98 121.36 19.0 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.749 0.309 . . . . 63.05 111.389 -173.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.617 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -68.72 -62.67 1.29 Allowed 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.722 1.263 . . . . 60.13 109.646 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -163.48 175.66 10.52 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.442 -1.254 . . . . 73.11 109.794 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.431 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -140.41 145.71 37.4 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.251 -1.759 . . . . 73.11 106.251 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.431 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.0 t -144.92 149.61 35.56 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.325 -0.991 . . . . 64.11 108.325 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.88 121.03 3.93 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.61 -0.515 . . . . 62.42 109.61 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -119.64 114.41 44.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.869 -0.789 . . . . 73.42 108.869 170.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.1 96.79 10.84 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.628 -1.249 . . . . 74.51 107.628 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.564 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 67.1 tp60 -82.75 129.22 34.94 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.941 0.496 . . . . 53.44 109.678 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.16 154.84 16.72 Favored Glycine 0 N--CA 1.461 0.328 0 O-C-N 123.51 0.506 . . . . 61.43 112.051 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.462 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.47 122.25 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.147 -0.781 . . . . 73.43 111.147 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -89.25 127.08 42.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.468 -0.938 . . . . 71.32 108.468 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.467 ' HE2' HG13 ' C' ' 13' ' ' ILE . 83.8 m-85 -136.59 131.68 34.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 71.43 109.871 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -81.05 104.09 11.31 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.405 -0.961 . . . . 71.44 108.405 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.586 HD12 ' SD ' ' C' ' 94' ' ' MET . 10.5 pt -119.45 120.55 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.705 0.802 . . . . 65.44 109.867 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.35 168.05 25.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.715 0.806 . . . . 75.53 110.72 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.28 -61.17 3.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.048 -0.978 . . . . 71.55 111.411 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.17 142.52 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.789 0.328 . . . . 74.44 110.331 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 12.2 pt-20 -147.91 179.03 8.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.797 0.839 . . . . 63.23 109.397 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -122.43 29.81 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 123.687 0.617 . . . . 71.03 113.652 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -78.79 -22.99 45.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.93 0.892 . . . . 73.31 111.595 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -72.86 -31.7 64.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.882 0.473 . . . . 74.41 109.913 173.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.586 ' SD ' HD12 ' C' ' 86' ' ' ILE . 51.6 tpp -66.66 -40.52 88.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.659 -0.7 . . . . 71.34 110.114 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.11 70.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.934 0.894 . . . . 73.34 112.767 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 43.7 t-80 -69.27 -39.06 78.61 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.737 0.415 . . . . 65.43 111.426 177.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -76.16 -41.47 49.71 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.168 0.509 . . . . 73.3 110.732 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.431 HD22 HG22 ' C' ' 58' ' ' VAL . 3.4 tm? -82.62 -53.38 5.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.995 1.318 . . . . 71.05 110.75 -168.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.7 -0.19 69.58 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.708 -0.678 . . . . 63.4 114.176 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -128.97 -66.81 0.81 Allowed 'General case' 0 C--N 1.35 0.598 0 CA-C-N 117.211 0.506 . . . . 45.2 111.503 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.15 -49.01 63.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.678 0.622 . . . . 73.4 112.678 -169.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.12 -42.67 77.87 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 118.237 -0.887 . . . . 70.34 112.477 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.57 -41.36 44.99 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.129 2.553 . . . . 61.11 113.691 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -67.62 -31.22 71.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.766 0.827 . . . . 75.41 111.467 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 39.6 mm -70.39 -44.23 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.16 0.584 . . . . 75.14 109.735 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.462 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.4 mt -79.24 -21.56 46.01 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.452 -0.794 . . . . 73.54 111.773 -173.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.42 -54.88 46.1 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.788 1.235 . . . . 74.44 113.199 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.67 -30.26 78.46 Favored 'Trans proline' 0 C--N 1.392 2.867 0 C-N-CA 122.024 1.816 . . . . 74.04 112.662 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.26 -48.75 64.23 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.574 0.75 . . . . 73.33 110.809 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.564 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.75 -37.22 86.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.426 0.69 . . . . 75.44 110.802 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -42.01 72.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.534 1.134 . . . . 74.22 110.568 -174.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.66 -36.45 73.36 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.616 0.766 . . . . 53.31 109.581 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.8 t -67.04 -35.18 79.3 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.69 0.796 . . . . 74.3 111.256 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.468 HD13 HG23 ' C' ' 64' ' ' VAL . 51.7 mt -68.61 -49.0 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.135 0.574 . . . . 62.01 110.083 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 30.4 m -61.01 -33.25 72.96 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.55 0.74 . . . . 74.41 111.249 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -61.26 -51.81 67.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.917 0.887 . . . . 71.53 109.359 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.521 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.68 -42.02 78.33 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.716 1.207 . . . . 64.13 112.622 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' C' ' 126' ' ' LEU . 61.2 t -65.62 -41.7 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.156 0.582 . . . . 60.44 110.595 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.437 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.1 t -68.16 -33.79 75.11 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.623 0.769 . . . . 73.24 111.218 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -64.92 -38.68 91.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.417 0.687 . . . . 73.34 110.282 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 7.86 55.58 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 123.8 0.688 . . . . 72.2 113.059 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 41.2 p 60.6 34.15 20.25 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.016 1.726 . . . . 62.12 112.195 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -108.41 152.82 42.2 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.808 1.243 . . . . 73.41 109.094 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.631 ' HD3' HG22 ' F' ' 301' ' ' ILE . 34.0 Cg_exo -60.99 158.82 32.23 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.684 2.923 . . . . 55.11 114.776 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -51.9 111.0 0.53 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.916 1.286 . . . . 63.22 112.477 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.497 HD23 HG23 ' F' ' 296' ' ' THR . 2.8 tm? -112.2 99.16 7.82 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.594 -1.261 . . . . 74.5 107.594 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.51 127.61 49.76 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.168 0.987 . . . . 71.41 108.709 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.413 HD23 ' N ' ' C' ' 129' ' ' ALA . 2.2 tt -71.74 143.03 49.75 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.763 0.825 . . . . 74.01 109.677 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.545 ' HB3' HD22 ' F' ' 291' ' ' LEU . . . -72.2 146.9 90.16 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.278 1.031 . . . . 64.54 111.855 -177.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.0 124.61 16.35 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.24 2.627 . . . . 64.21 112.045 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.664 ' HB ' HD21 ' F' ' 291' ' ' LEU . 5.8 p -133.64 126.86 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.631 0.773 . . . . 75.22 109.746 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.98 90.83 7.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.452 0.701 . . . . 43.24 110.535 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -65.42 -30.41 71.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.536 -0.542 . . . . 71.2 109.536 169.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.676 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.9 t70 -66.28 -47.11 74.74 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.755 -1.111 . . . . 71.52 111.28 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.21 79.91 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.099 0.875 . . . . 31.52 111.428 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.62 -51.54 69.46 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.029 0.932 . . . . 71.14 109.621 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -73.45 -15.1 61.35 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.723 0.809 . . . . 75.55 112.336 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 90.3 mmm -81.86 -29.42 32.49 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 123.475 0.71 . . . . 72.44 112.552 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -53.22 -35.63 60.14 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.211 1.004 . . . . 73.14 113.351 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.62 -88.7 0.0 OUTLIER 'General case' 0 CA--C 1.587 2.392 0 C-N-CA 125.2 1.4 . . . . 70.13 113.507 -170.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -134.95 88.79 2.46 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.792 1.637 . . . . 70.12 106.648 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -81.38 89.04 6.08 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.544 0.688 . . . . 71.4 109.379 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -130.03 22.88 5.3 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.251 1.02 . . . . 72.1 111.256 -173.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -132.26 115.4 15.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.915 0.486 . . . . 64.21 110.435 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.48 102.54 6.2 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.429 1.091 . . . . 63.15 108.272 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.4 -173.44 25.03 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-O 121.457 0.476 . . . . 54.21 114.287 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -107.66 133.25 52.35 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.273 1.029 . . . . 75.22 109.509 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.34 99.55 0.21 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 109.998 -1.241 . . . . 72.34 109.998 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.494 ' OG1' ' HA ' ' C' ' 5' ' ' ASN . 39.1 p -104.77 -173.51 2.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.593 0.757 . . . . 62.02 110.975 -175.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -159.12 168.52 26.4 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.511 0.724 . . . . 72.13 110.823 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -167.8 -76.45 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 O-C-N 123.912 0.758 . . . . 73.34 109.631 170.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -174.0 32.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.415 0.686 . . . . 72.11 110.478 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -73.43 125.67 28.42 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.074 -0.391 . . . . 73.14 110.338 -175.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' C' C ' 154' ' ' ASP . . . . . 0.629 ' HA ' ' HD3' ' E' ' 293' ' ' PRO . 6.6 m-20 -83.68 95.23 8.32 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.099 -0.955 . . . . 75.25 110.0 -175.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' C' C ' 155' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' G' ' 307' ' ' THR . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.527 -0.749 . . . . 52.02 109.903 174.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.513 -0.551 . . . . 70.35 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 33.9 m -80.57 75.78 7.44 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.669 0.788 . . . . 73.45 109.435 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.49 115.4 18.18 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.643 -1.162 . . . . 55.44 108.296 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 tm0? -126.46 99.3 5.77 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.951 -1.129 . . . . 73.32 107.951 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -85.18 -21.14 29.29 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.012 0.525 . . . . 75.4 111.23 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -79.62 77.56 6.22 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 121.747 0.784 . . . . 74.33 110.413 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 22.4 m -138.82 113.99 9.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.787 -1.19 . . . . 44.5 107.787 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.36 116.56 4.74 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.977 0.911 . . . . 71.55 111.165 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -32.76 127.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.694 1.197 . . . . 74.14 113.093 168.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 23.5 m -144.48 140.59 29.01 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.054 0.541 . . . . 64.25 110.17 173.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 11' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' D' ' 85' ' ' SER . 30.1 t80 -158.57 114.02 2.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.213 1.005 . . . . 71.15 108.474 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -135.07 131.14 36.62 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.905 -0.776 . . . . 73.53 108.905 175.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.48 132.95 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.652 . . . . 72.21 109.238 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 40.9 mt-30 -95.48 -35.04 11.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 122.562 0.345 . . . . 54.34 110.446 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 178.79 160.92 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.187 0.995 . . . . 75.11 110.766 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.24 118.61 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.542 -1.651 . . . . 54.22 106.542 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.438 ' HE1' HG13 ' D' ' 83' ' ' ILE . 9.9 p90 -140.7 141.88 34.91 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.298 0.639 . . . . 54.04 110.503 -173.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 41.1 p -76.85 119.68 20.94 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.658 -0.497 . . . . 72.33 109.658 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -93.84 -21.82 19.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.094 0.558 . . . . 62.11 109.928 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.72 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.4 t70 -153.91 137.06 15.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.378 1.071 . . . . 72.44 109.343 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.521 HD13 ' HE3' ' C' ' 117' ' ' MET . 30.1 mt -139.36 146.76 25.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 124.857 1.263 . . . . 74.54 107.682 174.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -154.13 137.9 16.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.328 0.651 . . . . 73.12 109.849 168.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 78.9 t80 -133.93 121.49 21.75 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 105.798 -1.927 . . . . 71.52 105.798 165.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -122.4 131.24 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.188 -0.671 . . . . 73.05 109.188 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.8 83.52 9.32 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 106.34 -1.726 . . . . 72.53 106.34 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.5 -37.54 69.93 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.732 2.288 . . . . 51.25 112.614 -167.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 0.7 OUTLIER -117.82 25.48 10.35 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.893 0.877 . . . . 74.21 109.247 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.595 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.42 -68.58 0.05 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 N-CA-C 117.413 2.375 . . . . 73.42 117.413 -167.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.74 -24.84 15.26 Favored 'Trans proline' 0 C--N 1.395 2.979 0 CA-C-N 122.777 2.028 . . . . 54.33 112.976 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 1.7 t60 -66.25 -35.11 79.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.894 1.277 . . . . 64.51 109.725 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' D' ' 73' ' ' ALA . 94.1 t -70.98 -39.9 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.707 -0.679 . . . . 73.24 111.604 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -65.71 -15.0 62.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.706 1.002 . . . . 64.35 113.706 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -66.73 -33.08 74.84 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.131 0.572 . . . . 74.41 110.581 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.459 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 44.9 mtpt -87.42 111.18 20.87 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.933 0.893 . . . . 65.21 108.594 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.561 ' HB2' ' H ' ' G' ' 301' ' ' ILE . 11.9 p-10 -99.7 99.32 10.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.256 1.023 . . . . 73.21 111.374 -173.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.595 ' CD2' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -156.7 -176.65 6.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.758 1.021 . . . . 74.35 113.758 -170.004 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' G' ' 297' ' ' TYR . 51.5 tt0 -97.43 102.94 14.07 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 124.761 1.224 . . . . 75.31 112.975 175.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.536 ' HA ' HD21 ' D' ' 68' ' ' LEU . 75.2 Cg_exo -53.2 131.84 45.06 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 124.059 3.173 . . . . 73.24 115.32 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.689 ' HG2' ' HG2' ' G' ' 294' ' ' LYS . 36.7 mt-10 -98.15 115.44 28.29 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.048 -1.433 . . . . 62.54 107.177 170.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' D' ' 66' ' ' ALA . 31.9 m -98.64 143.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.605 0.762 . . . . 73.41 110.073 -176.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 83.1 tttt -107.22 130.54 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.168 0.987 . . . . 73.54 109.243 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -96.61 128.77 43.87 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.316 -1.364 . . . . 71.44 107.316 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.4 t70 -132.59 126.6 33.15 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.571 -1.27 . . . . 61.15 107.571 172.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.36 139.91 41.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.558 0.743 . . . . 64.03 110.764 -172.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.4 t70 -138.88 139.63 38.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.588 0.755 . . . . 63.43 109.003 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 46' ' ' THR . . . . . 0.48 ' HB ' ' HD1' ' G' ' 281' ' ' PHE . 46.6 p -108.11 144.07 35.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.691 0.796 . . . . 74.13 110.76 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.8 161.99 41.85 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.688 0.795 . . . . 61.43 109.653 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -170.9 156.41 4.97 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.113 0.965 . . . . 62.12 109.499 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 64.7 p -149.53 120.35 7.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.532 0.733 . . . . 44.55 109.154 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -69.99 118.35 12.72 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.389 -0.597 . . . . 75.23 109.389 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 -30.02 17.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.941 -0.572 . . . . 75.31 110.211 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.13 -179.89 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.6 -0.727 . . . . 53.42 110.601 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.35 130.44 40.74 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.926 -1.033 . . . . 63.45 108.538 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 69.21 2.24 3.57 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.395 1.478 . . . . 74.03 112.23 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.26 117.65 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.284 -0.636 . . . . 74.22 109.284 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.672 ' HB2' HD13 ' D' ' 86' ' ' ILE . 97.6 m-85 -128.37 130.13 47.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.036 -1.098 . . . . 74.11 108.036 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -90.91 135.85 33.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.68 -1.6 . . . . 41.44 106.68 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.95 131.67 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.042 0.937 . . . . 75.44 108.637 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 17.5 t -115.16 135.85 53.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.068 -0.716 . . . . 71.41 109.068 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.21 114.84 20.16 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.873 -1.158 . . . . 72.21 107.873 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.8 ttm180 -96.57 114.9 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.136 0.574 . . . . 73.31 110.01 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.49 122.26 55.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.638 -0.875 . . . . 73.44 108.638 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.8 m -115.32 128.65 56.24 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.276 0.631 . . . . 65.22 109.434 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.4 t -115.8 117.64 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.069 1.348 . . . . 73.21 109.342 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.5 m -119.03 95.21 4.72 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.741 -0.837 . . . . 74.4 108.741 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.572 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -98.05 135.0 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.998 -0.741 . . . . 75.45 108.998 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 39.9 p -163.82 135.73 4.88 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.869 0.731 . . . . 64.1 109.704 -173.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' D' ' 36' ' ' TRP . 4.7 mp -134.74 136.44 42.65 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.54 0.736 . . . . 72.03 110.701 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.66 -111.6 3.35 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.238 -0.745 . . . . 42.31 111.238 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.55 11.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.231 1.012 . . . . 75.5 109.588 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -139.82 144.11 37.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.04 0.536 . . . . 71.24 111.409 -163.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.1 m -67.53 140.54 57.0 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 124.298 1.039 . . . . 63.14 110.633 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.478 ' HA ' HG11 ' D' ' 31' ' ' VAL . . . -84.96 -69.48 0.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.748 -0.834 . . . . 72.35 108.748 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -154.91 148.45 25.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.623 -1.171 . . . . 73.51 109.074 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.2 mt -108.24 152.94 23.92 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.853 1.261 . . . . 55.13 108.979 172.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.3 t -158.87 144.02 16.14 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.659 0.784 . . . . 52.33 109.002 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.857 -0.794 . . . . 44.22 108.857 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 78' ' ' VAL . . . . . 0.462 HG22 HG23 ' D' ' 21' ' ' ILE . 51.1 t -125.94 119.71 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.819 0.448 . . . . 74.3 110.054 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.72 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 62.0 mt-30 -89.5 91.79 8.85 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 109.02 -0.733 . . . . 75.21 109.02 166.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -81.1 101.64 9.74 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.889 -1.051 . . . . 63.41 108.391 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 171.39 44.16 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 111.442 -0.663 . . . . 41.03 111.442 175.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.56 131.59 1.96 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.433 -0.667 . . . . 71.11 111.433 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' D' ' 17' ' ' TYR . 32.7 mt -89.43 134.19 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 109.151 -0.685 . . . . 74.41 109.151 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.492 ' HB2' HD11 ' D' ' 86' ' ' ILE . 32.8 m-85 -133.63 162.29 32.33 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.3 0.64 . . . . 74.32 109.687 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 36.2 m -109.61 103.23 12.06 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.409 -0.96 . . . . 54.53 108.409 171.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.672 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.1 mp -107.15 117.57 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.999 0.92 . . . . 65.15 108.837 -176.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -149.8 164.55 35.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.738 0.815 . . . . 72.25 110.336 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.51 -0.98 59.11 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 116.103 1.201 . . . . 42.14 116.103 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.67 133.47 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.58 0.752 . . . . 73.11 109.737 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -133.61 154.23 51.05 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.866 0.866 . . . . 74.41 110.299 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.02 -110.59 2.75 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.23 0.956 . . . . 50.22 114.489 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 m -65.82 -41.04 92.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.359 1.064 . . . . 63.04 112.298 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -72.78 -36.73 67.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.781 0.432 . . . . 65.4 111.106 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.807 ' SD ' ' HB2' ' G' ' 277' ' ' LEU . 20.4 ptt? -79.92 -23.93 41.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.531 0.205 . . . . 53.52 110.602 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -32.38 68.78 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.79 -0.448 . . . . 63.33 109.79 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -74.04 -45.45 49.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.546 0.738 . . . . 74.32 110.6 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -66.58 -51.6 54.67 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 122.743 0.417 . . . . 63.14 110.285 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.667 ' HG ' HD13 ' G' ' 278' ' ' LEU . 3.8 mm? -78.98 -19.11 52.44 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.959 0.503 . . . . 63.45 110.87 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.11 -1.98 64.59 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-O 119.775 -0.459 . . . . 74.22 114.154 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 -61.31 0.23 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.345 0.573 . . . . 73.51 111.135 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.41 -50.59 51.76 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.195 0.998 . . . . 74.24 113.278 -166.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 102' ' ' CYS . . . . . 0.447 ' SG ' HD13 ' D' ' 98' ' ' LEU . 22.1 m -68.1 -45.78 40.69 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.797 0.839 . . . . 63.11 112.202 -175.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.02 -24.28 45.51 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 121.54 1.494 . . . . 73.23 112.847 172.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -66.36 -32.62 74.12 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.457 0.703 . . . . 64.3 110.285 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.16 -46.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 54.04 110.193 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -75.9 -32.72 59.78 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.271 -0.877 . . . . 72.45 111.987 -172.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.629 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 75.7 t80 -59.76 -46.01 98.43 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.81 1.411 . . . . 65.31 114.81 -167.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.18 -33.11 91.15 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 121.919 1.746 . . . . 72.41 112.618 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -75.67 -34.91 60.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.645 0.778 . . . . 73.12 110.993 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.9 84.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.479 0.711 . . . . 61.51 110.06 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -60.66 -46.64 89.57 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.585 -1.189 . . . . 74.2 110.956 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.67 -38.33 83.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 62.24 111.117 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.49 -41.86 95.14 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.715 0.635 . . . . 62.4 110.14 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.59 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.5 mt -63.05 -56.19 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.21 0.944 . . . . 64.33 110.061 173.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.467 HG21 ' HE2' ' B' ' 109' ' ' TYR . 88.9 m -51.76 -45.13 63.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.971 1.308 . . . . 74.33 112.003 -172.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -66.4 -43.14 86.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.832 -1.076 . . . . 72.4 110.724 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 62.7 mtm -66.12 -34.61 78.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.945 0.498 . . . . 72.42 111.812 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -66.11 -42.75 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.155 -0.93 . . . . 71.43 109.913 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.9 p -72.49 -30.76 64.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.834 0.454 . . . . 74.45 111.392 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -69.83 -30.89 68.51 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.345 0.658 . . . . 63.54 110.167 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.06 11.16 65.79 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.492 -0.777 . . . . 64.14 112.613 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.409 HG23 ' HB3' ' C' ' 17' ' ' TYR . 75.7 p 59.27 13.98 3.38 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.865 2.066 . . . . 63.51 114.424 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -82.15 162.67 56.06 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 107.417 -1.327 . . . . 72.31 107.417 164.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.535 ' HG2' ' HB ' ' G' ' 296' ' ' THR . 62.1 Cg_endo -82.34 152.74 15.91 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.017 1.811 . . . . 74.12 112.444 -171.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 79.8 mt-30 -54.02 120.46 6.43 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.372 0.669 . . . . 51.52 110.906 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 48.7 tp -104.58 108.59 20.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.281 -1.007 . . . . 73.23 108.281 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 127' ' ' ASN . . . . . 0.465 ' HB3' HG13 ' B' ' 13' ' ' ILE . 57.9 m-20 -100.28 93.09 5.5 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.463 -0.94 . . . . 74.41 108.463 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.629 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.3 OUTLIER -61.61 137.48 58.25 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.079 1.352 . . . . 75.23 109.785 -178.545 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.28 129.3 83.23 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 123.902 0.881 . . . . 64.11 112.295 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.457 ' HD3' HD12 ' B' ' 13' ' ' ILE . 59.3 Cg_endo -76.13 117.63 4.72 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.717 1.612 . . . . 71.32 109.841 168.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 95.4 t -106.1 110.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.679 -0.86 . . . . 74.14 108.679 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 44.2 t30 -70.33 99.43 1.55 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.336 -0.847 . . . . 74.14 109.665 178.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -71.36 -21.85 61.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.484 -0.78 . . . . 72.13 111.249 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.68 -51.27 70.08 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 123.083 0.553 . . . . 73.01 111.042 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.403 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -52.75 -53.76 43.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.831 0.852 . . . . 65.41 112.002 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.7 pp -75.45 -25.74 57.7 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.964 -0.562 . . . . 60.21 112.335 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 137' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' B' ' 2' ' ' SER . 44.0 t80 -74.83 -53.93 8.22 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.772 -0.455 . . . . 62.32 109.772 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 69.6 mtm -58.5 -25.95 62.92 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 124.144 0.978 . . . . 63.54 111.115 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.46 -36.24 71.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.639 0.776 . . . . 74.33 111.25 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -73.35 -38.12 65.85 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.711 0.804 . . . . 75.3 110.528 174.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 141' ' ' LEU . . . . . 0.408 HD13 ' O ' ' D' ' 137' ' ' PHE . 7.6 mp -76.23 -30.13 57.82 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.023 0.929 . . . . 73.14 112.985 -174.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -83.91 25.68 0.79 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.066 0.546 . . . . 50.44 112.155 -170.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -113.96 46.64 1.29 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.384 1.088 . . . . 75.12 108.772 -170.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -147.12 146.2 29.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.64 -1.618 . . . . 74.41 107.277 168.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.83 102.72 1.29 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.471 -0.566 . . . . 72.54 109.471 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.89 57.08 5.07 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.151 0.405 . . . . 63.34 112.112 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.81 102.99 1.66 Allowed 'General case' 0 C--N 1.351 0.659 0 C-N-CA 123.928 0.891 . . . . 73.44 109.651 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -164.64 41.32 0.3 Allowed Glycine 0 C--O 1.238 0.399 0 N-CA-C 109.963 -1.255 . . . . 53.43 109.963 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 48.3 p -64.73 97.62 0.23 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.825 0.85 . . . . 54.31 110.154 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -86.79 148.88 25.21 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.514 0.726 . . . . 73.34 109.811 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -146.52 124.58 12.1 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.702 -0.851 . . . . 73.45 108.702 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -157.65 80.52 0.88 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 122.24 1.019 . . . . 72.35 109.298 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -119.77 121.02 38.22 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.86 -1.163 . . . . 73.54 107.86 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.7 166.72 28.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.096 0.958 . . . . 74.44 109.009 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 C-N-CA 123.484 0.714 . . . . 74.3 109.636 176.256 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.804 -0.443 . . . . 62.21 109.804 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -67.81 139.82 56.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.938 0.895 . . . . 73.23 110.063 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -74.68 143.45 44.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.318 0.647 . . . . 73.22 110.461 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -122.45 77.21 1.39 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.584 0.753 . . . . 64.24 109.524 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -145.15 113.49 4.85 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.052 -0.976 . . . . 73.41 108.628 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.14 174.45 10.02 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.154 1.903 . . . . 60.2 111.941 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 4.9 tt -155.01 -58.29 0.1 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.689 -1.597 . . . . 71.43 106.689 174.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 278' ' ' LEU . . . . . 0.712 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 5.6 mp -81.15 78.3 7.96 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.882 -0.784 . . . . 63.13 108.882 175.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -84.95 61.48 4.67 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.598 -0.728 . . . . 50.13 112.177 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 95' ' ' ALA . 42.7 tp -168.79 170.45 9.25 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.101 0.961 . . . . 72.43 109.035 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 70.76 -177.35 0.21 Allowed 'General case' 0 C--N 1.367 1.334 0 C-N-CA 125.205 1.402 . . . . 72.42 110.158 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.27 -69.78 0.14 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.496 1.118 . . . . 63.42 109.554 -171.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.04 94.68 5.99 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.385 -0.969 . . . . 73.01 108.385 166.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 171.02 125.66 0.83 Allowed Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.731 -0.668 . . . . 71.3 111.689 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -111.07 -52.74 2.77 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.539 0.736 . . . . 74.44 111.358 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 20.7 mmt 60.12 77.94 0.35 Allowed Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 124.058 0.943 . . . . 73.01 110.489 -166.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.49 129.12 9.97 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.221 2.614 . . . . 65.23 112.199 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 288' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 42' ' ' LEU . 50.3 t -116.45 124.86 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.696 -0.853 . . . . 74.21 108.696 173.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 19.5 mmt85 -103.82 -3.27 25.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.434 1.094 . . . . 73.52 111.429 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 64.7 m95 78.04 149.6 0.1 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.67 1.588 . . . . 75.34 111.414 -167.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 129' ' ' ALA . 29.9 mt -90.69 -7.49 52.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 113.518 -1.674 . . . . 71.34 111.151 -172.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 169.87 -150.93 15.73 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-O 119.221 -0.766 . . . . 53.22 112.737 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 293' ' ' PRO . . . . . 0.629 ' HD3' ' HA ' ' C' ' 154' ' ' ASP . 88.5 Cg_endo -77.17 173.06 14.98 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 123.399 2.733 . . . . 73.21 113.561 -177.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -83.2 176.95 8.78 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.412 1.085 . . . . 75.34 110.621 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -175.92 -25.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.636 1.174 . . . . 71.13 110.007 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 19.8 m -60.8 124.89 21.78 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.641 1.177 . . . . 50.53 111.157 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.642 ' HB3' ' HG2' ' A' ' 38' ' ' PRO . 22.8 t80 71.31 10.54 6.68 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.292 1.437 . . . . 75.55 112.7 173.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -80.35 101.08 8.75 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.04 -1.467 . . . . 75.2 107.04 166.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -169.36 -141.92 3.38 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-O 119.872 -0.404 . . . . 74.32 112.268 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -143.64 125.45 15.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.359 0.664 . . . . 74.04 110.015 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 74.1 mt -122.79 100.85 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 108.2 -1.037 . . . . 75.44 108.2 169.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -133.59 -179.77 5.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.557 1.143 . . . . 42.42 108.53 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 65.03 134.31 0.04 OUTLIER Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 125.283 1.433 . . . . 60.2 113.556 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.71 -177.67 3.55 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.966 1.777 . . . . 74.35 111.395 170.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -131.38 144.52 51.28 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.108 0.563 . . . . 42.44 110.185 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 17.9 t 60.76 29.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 124.458 1.103 . . . . 75.24 111.528 173.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 3.0 m -87.71 37.76 0.81 Allowed 'General case' 0 CA--C 1.567 1.605 0 O-C-N 120.995 -1.066 . . . . 74.44 110.842 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 70.7 m -112.23 -0.81 15.38 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.577 1.151 . . . . 72.03 110.468 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 24.2 m -75.1 133.64 75.18 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.574 0.749 . . . . 71.24 110.512 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo . . . . . 0 C--N 1.394 2.97 0 C-N-CA 124.383 3.389 . . . . 71.5 114.776 177.301 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.533 0.206 . . . . 74.41 110.496 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.9 -47.48 58.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.95 0.9 . . . . 60.42 109.953 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -115.97 171.21 7.93 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.24 1.016 . . . . 72.22 109.734 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.94 -64.5 1.17 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.038 -1.097 . . . . 74.53 108.038 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -143.08 140.39 17.85 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.708 -1.219 . . . . 75.01 107.708 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.46 131.12 40.81 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.72 2.28 . . . . 72.51 112.804 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 10.5 tt -58.54 -36.54 74.02 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.979 0.912 . . . . 74.22 109.955 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 6.3 tt -122.73 117.68 26.29 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.919 -1.511 . . . . 75.41 106.919 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -146.22 33.46 1.47 Allowed Glycine 0 C--N 1.343 0.926 0 O-C-N 123.355 0.41 . . . . 32.31 112.897 -174.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 4.1 pp -161.23 -172.73 3.53 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.011 0.924 . . . . 64.52 109.878 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -145.43 -90.06 0.1 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.101 -1.074 . . . . 71.13 108.101 169.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -94.32 176.82 6.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.498 0.719 . . . . 74.51 110.074 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.56 -35.47 80.58 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.72 0.808 . . . . 73.24 110.968 175.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.98 -43.12 2.59 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.928 -0.578 . . . . 73.34 112.243 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -93.46 47.39 1.24 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.947 0.899 . . . . 74.44 110.001 -175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 90.6 mtp -125.89 87.68 55.56 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.116 0.966 . . . . 44.51 109.238 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.8 100.73 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.84 2.36 . . . . 73.44 111.101 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.04 -42.01 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.089 0.556 . . . . 65.13 110.074 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 62.94 -81.43 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.515 1.526 . . . . 73.04 111.657 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -173.57 125.7 0.39 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.35 -1.352 . . . . 73.33 107.35 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.664 HD21 ' HB ' ' C' ' 131' ' ' VAL . 7.4 mp -65.96 -23.71 66.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.961 0.905 . . . . 63.22 113.145 -166.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -162.99 -175.95 34.55 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-O 119.291 -0.727 . . . . 71.42 111.835 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -83.38 46.68 2.16 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.309 2.673 . . . . 52.23 111.613 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -91.31 83.77 5.53 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.452 0.701 . . . . 74.11 109.574 -173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -100.06 154.23 18.58 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.581 -0.736 . . . . 71.31 110.365 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 296' ' ' THR . . . . . 0.497 HG23 HD23 ' C' ' 126' ' ' LEU . 14.2 p -88.59 -165.72 1.41 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.872 0.869 . . . . 74.11 110.512 174.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.494 ' OH ' ' HB1' ' C' ' 73' ' ' ALA . 50.0 m-85 62.76 14.31 7.18 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.802 1.241 . . . . 71.32 112.567 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -72.64 130.13 39.86 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.664 0.786 . . . . 72.31 109.822 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 299' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' H' ' 298' ' ' HIS . . . 85.54 -83.34 1.63 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.347 -1.101 . . . . 73.32 110.347 -169.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 300' ' ' ASN . . . . . 0.504 ' ND2' ' HE1' ' C' ' 36' ' ' TRP . 3.9 t-20 -177.38 163.39 2.0 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.12 0.968 . . . . 64.22 108.867 177.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.631 HG22 ' HD3' ' C' ' 124' ' ' PRO . 30.4 pt -104.29 24.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 123.428 0.691 . . . . 62.42 109.965 171.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -48.51 -43.99 35.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.598 1.959 . . . . 74.53 114.713 -168.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.33 76.87 0.5 Allowed Pre-proline 0 CA--C 1.561 1.368 0 O-C-N 124.348 1.03 . . . . 63.2 109.53 -174.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 304' ' ' PRO . . . . . 0.527 ' HB2' ' HD2' ' H' ' 293' ' ' PRO . 75.0 Cg_endo -86.38 -31.13 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.668 2.245 . . . . 74.45 114.149 -173.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -77.66 86.71 3.95 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.196 0.598 . . . . 74.31 109.548 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 7.6 p 168.1 -24.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 125.785 1.634 . . . . 75.42 109.076 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 75.5 p -75.12 12.69 0.84 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.55 0.945 . . . . 53.53 113.55 -170.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 36.9 t -144.7 37.14 1.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.568 0.747 . . . . 70.43 110.199 176.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 17.4 p -69.74 128.88 91.69 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.12 0.568 . . . . 72.41 110.642 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--N 1.382 2.295 0 C-N-CA 122.801 2.334 . . . . 74.23 111.844 176.613 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.835 -0.432 . . . . 61.44 109.835 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.17 -58.81 3.07 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.341 -0.614 . . . . 63.03 109.341 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -122.23 -70.7 0.76 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.428 -0.952 . . . . 61.33 108.428 169.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 274' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' G' ' 275' ' ' LYS . 62.1 tt0 64.79 179.09 0.18 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.899 1.28 . . . . 73.14 111.032 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 275' ' ' LYS . . . . . 0.455 ' H ' ' HG2' ' G' ' 274' ' ' GLN . 32.1 mtmt 71.72 83.08 0.15 Allowed Pre-proline 0 C--N 1.362 1.126 0 C-N-CA 125.11 1.364 . . . . 64.01 109.251 170.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.74 89.88 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.421 2.081 . . . . 64.1 111.063 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.807 ' HB2' ' SD ' ' D' ' 94' ' ' MET . 2.7 pt? -79.6 -174.86 4.5 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.357 -0.838 . . . . 75.13 110.005 176.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 278' ' ' LEU . . . . . 0.667 HD13 ' HG ' ' D' ' 98' ' ' LEU . 40.1 tp 66.4 94.45 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.368 1.067 . . . . 74.12 110.426 -171.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -102.66 4.64 50.48 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.588 -0.733 . . . . 73.23 112.389 173.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 280' ' ' LEU . . . . . 0.42 ' H ' HD12 ' G' ' 278' ' ' LEU . 78.0 mt -101.83 175.88 5.4 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.943 0.897 . . . . 75.42 111.257 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 281' ' ' PHE . . . . . 0.48 ' HD1' ' HB ' ' D' ' 46' ' ' THR . 90.3 m-85 65.16 6.19 3.41 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.292 1.437 . . . . 54.41 112.208 -175.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -105.96 86.9 2.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.232 1.013 . . . . 74.33 108.781 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 62.55 19.33 11.17 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.458 1.103 . . . . 71.23 112.573 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -89.94 91.25 1.68 Allowed Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.314 -0.403 . . . . 64.23 112.25 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -70.45 109.16 4.63 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.517 0.727 . . . . 75.54 110.031 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 286' ' ' MET . . . . . 0.429 ' SD ' ' HD2' ' G' ' 287' ' ' PRO . 16.0 tpt -91.34 123.88 62.82 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 108.575 -0.898 . . . . 60.41 108.575 172.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 287' ' ' PRO . . . . . 0.429 ' HD2' ' SD ' ' G' ' 286' ' ' MET . 72.7 Cg_endo -74.25 72.09 4.24 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.5 2.133 . . . . 75.42 112.442 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 57.0 t -82.44 95.34 3.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.94 -0.763 . . . . 63.22 108.94 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -71.46 135.55 47.23 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.306 -0.861 . . . . 73.22 110.374 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.472 ' NE1' ' HA ' ' G' ' 293' ' ' PRO . 1.3 t-105 -82.07 120.03 24.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.625 0.77 . . . . 72.5 110.486 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.441 ' H ' HD12 ' G' ' 291' ' ' LEU . 1.8 mp -88.01 91.08 8.63 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.456 1.102 . . . . 64.13 109.903 -173.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 81.03 86.91 0.64 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.269 -0.74 . . . . 75.53 112.838 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 293' ' ' PRO . . . . . 0.472 ' HA ' ' NE1' ' G' ' 290' ' ' TRP . 34.8 Cg_endo -63.21 -27.62 72.62 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.034 2.489 . . . . 64.13 113.148 176.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 294' ' ' LYS . . . . . 0.689 ' HG2' ' HG2' ' D' ' 39' ' ' GLU . 42.8 mtmt -88.66 92.51 9.23 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.291 0.636 . . . . 74.04 109.621 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -162.05 65.94 0.24 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.291 0.567 . . . . 70.43 110.822 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 296' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' D' ' 124' ' ' PRO . 7.9 p -142.04 -97.79 0.13 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.962 0.905 . . . . 63.03 109.973 -177.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.448 ' HB2' ' HA ' ' D' ' 37' ' ' GLN . 31.6 m-85 -73.42 166.37 23.33 Favored 'General case' 0 C--N 1.371 1.542 0 N-CA-C 108.767 -0.827 . . . . 73.24 108.767 170.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -143.97 14.66 1.7 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.428 -0.953 . . . . 72.34 108.428 165.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -155.24 -172.38 22.83 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.321 -0.854 . . . . 64.1 111.745 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -82.31 154.06 25.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.703 0.801 . . . . 73.34 112.233 -174.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.561 ' H ' ' HB2' ' D' ' 35' ' ' ASP . 41.3 mt -90.74 -5.73 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 125.1 1.36 . . . . 75.21 110.452 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -57.37 97.42 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.83 1.252 . . . . 70.21 112.658 -170.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -143.5 96.62 5.68 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 106.671 -1.603 . . . . 72.23 106.671 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -59.94 -63.04 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.562 2.175 . . . . 74.11 113.092 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -175.06 164.76 3.38 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.086 0.955 . . . . 55.13 109.779 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' C' ' 12' ' ' GLN . 10.4 p -80.24 143.48 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 107.357 -1.349 . . . . 74.24 107.357 162.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 307' ' ' THR . . . . . 0.479 HG23 ' HB3' ' C' ' 155' ' ' ALA . 14.0 m -74.43 138.36 43.25 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.841 0.456 . . . . 55.33 111.259 -173.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 308' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' C' ' 10' ' ' THR . 41.5 t -68.48 162.05 26.43 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.819 0.848 . . . . 63.23 111.094 174.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 36.0 p -65.42 113.57 12.1 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.149 0.98 . . . . 73.21 111.061 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 C--N 1.377 2.034 0 C-N-CA 123.212 2.608 . . . . 72.51 112.066 175.77 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.697 -0.483 . . . . 71.34 109.697 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' H' H ' 272' ' ' ASN . . . . . 0.432 ' N ' HD21 ' H' ' 272' ' ' ASN . 0.0 OUTLIER -168.19 154.54 7.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.581 0.753 . . . . 73.41 110.404 -177.587 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -140.75 -35.64 0.48 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.524 0.73 . . . . 54.34 111.112 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 274' ' ' GLN . . . . . 0.424 ' OE1' ' HB2' ' H' ' 272' ' ' ASN . 1.8 mp0 55.28 88.37 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.633 1.173 . . . . 73.52 110.65 -175.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -66.93 135.55 94.17 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.591 -0.731 . . . . 74.14 109.994 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.51 158.31 41.87 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.104 2.536 . . . . 61.23 112.46 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.44 -32.95 74.17 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.116 -0.698 . . . . 63.13 109.116 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 278' ' ' LEU . . . . . 0.419 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 39.3 tp -58.99 127.04 30.21 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 123.8 0.687 . . . . 65.52 111.432 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -170.89 148.96 11.77 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.13 -0.788 . . . . 54.54 111.13 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 46.6 mt 67.08 161.91 0.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.191 1.396 . . . . 75.33 112.298 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -165.67 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.436 -0.95 . . . . 73.21 108.436 172.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -173.92 127.36 0.38 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.362 1.065 . . . . 72.15 109.962 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -98.95 163.82 12.44 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.595 -0.891 . . . . 73.41 108.595 173.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.22 26.12 1.25 Allowed Glycine 0 CA--C 1.54 1.651 0 N-CA-C 115.996 1.159 . . . . 74.53 115.996 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -68.39 -20.18 64.67 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 117.727 0.764 . . . . 64.42 111.212 173.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -128.47 90.84 45.49 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.43 1.092 . . . . 64.34 109.29 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.3 121.55 7.28 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.87 2.38 . . . . 62.41 112.994 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 85.3 t -86.33 91.96 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 121.812 0.815 . . . . 73.25 109.635 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -117.22 -173.91 2.5 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.156 1.382 . . . . 61.43 108.312 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -59.83 134.78 57.36 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.519 0.6 . . . . 74.24 112.167 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.423 HD11 HG22 ' B' ' 131' ' ' VAL . 5.1 mp -93.88 41.45 1.09 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.256 1.023 . . . . 61.54 110.091 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 158.93 -173.56 35.84 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 114.293 -1.321 . . . . 41.34 110.612 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 293' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' F' ' 304' ' ' PRO . 80.3 Cg_endo -81.64 68.87 7.92 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.672 2.248 . . . . 73.31 112.584 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 294' ' ' LYS . . . . . 0.497 ' HE3' ' H ' ' B' ' 40' ' ' VAL . 50.2 mttp 60.6 -158.43 0.33 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.087 0.955 . . . . 73.31 112.297 173.332 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -158.54 -173.71 4.42 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 125.199 1.4 . . . . 72.01 107.975 168.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 1.4 m 72.06 164.64 0.28 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.308 1.043 . . . . 72.41 112.346 168.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.444 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 5.9 m-85 60.51 29.75 19.25 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.146 1.378 . . . . 72.43 113.126 176.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 298' ' ' HIS . . . . . 0.595 ' HB3' ' HA3' ' F' ' 299' ' ' GLY . 2.2 m80 -73.46 88.6 1.62 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.074 0.55 . . . . 74.25 110.856 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 70.3 23.87 77.07 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-N 115.359 -0.837 . . . . 64.41 113.583 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -166.4 136.75 3.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.908 0.385 . . . . 65.1 111.36 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 15.3 tt -134.45 -33.03 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.86 1.264 . . . . 74.0 108.27 165.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.37 -170.78 3.35 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.939 1.696 . . . . 74.41 107.48 -177.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 303' ' ' LYS . . . . . 0.415 ' HB2' ' HD3' ' H' ' 304' ' ' PRO 0.266 42.9 mtmt 108.61 -57.26 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.204 0 C-N-CA 127.706 2.403 . . . . 71.02 112.392 171.083 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' H' H ' 304' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' H' ' 303' ' ' LYS . 8.2 Cg_exo -74.88 -53.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.395 2.987 0 CA-C-N 122.034 1.762 . . . . 55.13 110.656 166.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 41.51 -106.53 0.07 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 125.377 1.471 . . . . 75.54 111.82 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 34.6 m -144.6 29.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.559 1.144 . . . . 74.53 108.428 168.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 307' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 29.4 p -39.25 -66.56 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.577 1.951 . . . . 64.44 114.922 -162.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 27.2 p -154.2 151.4 29.15 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.921 0.391 . . . . 71.24 111.61 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 3.8 t -144.07 110.35 5.1 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.286 1.034 . . . . 74.53 108.473 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo . . . . . 0 C--N 1.379 2.154 0 C-N-CA 122.453 2.102 . . . . 53.12 111.21 175.42 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 110.331 -0.248 . . . . 65.33 110.331 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.3 t 68.42 173.94 0.28 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.001 1.32 . . . . 51.44 111.972 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.84 124.29 24.51 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.414 0.685 . . . . 72.52 110.651 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -79.15 120.13 23.23 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.26 0.624 . . . . 72.04 110.759 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.58 ' H ' ' HB1' ' C' ' 145' ' ' ALA . 21.8 m120 -93.53 163.86 13.4 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.103 0.961 . . . . 62.34 110.819 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -136.59 -71.41 0.45 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.431 0.692 . . . . 70.14 110.987 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 m -79.24 -12.82 59.96 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.646 0.778 . . . . 74.22 111.687 -171.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -85.05 69.2 10.77 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.425 0.69 . . . . 75.0 109.789 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.7 mtm -149.58 133.56 17.08 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.063 -1.088 . . . . 71.52 108.063 170.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.4 m -149.05 130.26 14.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.345 0.658 . . . . 64.42 109.458 172.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 29.1 t80 -140.16 129.4 23.8 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.214 -1.032 . . . . 74.21 108.214 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -148.77 109.44 4.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.706 0.289 . . . . 75.54 110.744 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.669 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.2 mt -73.0 111.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.237 -0.653 . . . . 63.52 109.237 172.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -91.7 -27.46 18.07 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.82 0.7 . . . . 64.4 110.209 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -164.27 144.29 7.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 121.382 -0.127 . . . . 74.43 110.924 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -143.51 118.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.074 1.349 . . . . 71.14 108.72 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.8 p90 -166.63 176.66 7.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.864 0.84 . . . . 75.52 111.821 -163.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -103.55 112.36 25.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.712 -1.131 . . . . 62.22 108.582 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -76.83 -19.63 57.3 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 110.103 -0.332 . . . . 54.55 110.103 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.14 144.88 17.68 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.716 0.806 . . . . 65.45 109.646 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -135.22 145.47 31.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 124.993 1.317 . . . . 72.45 107.742 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.9 p -147.9 138.95 23.37 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.039 -0.726 . . . . 51.14 109.039 166.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 93.6 t80 -136.06 111.17 8.94 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.831 -1.914 . . . . 73.54 105.831 170.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.25 107.24 13.17 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.292 -0.633 . . . . 75.42 109.292 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.29 78.41 10.55 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 107.477 -1.305 . . . . 71.52 107.477 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.47 -34.74 5.48 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.155 1.903 . . . . 71.24 111.737 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -89.41 10.67 21.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.69 -0.686 . . . . 71.23 110.879 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.98 -57.59 9.9 Favored Pre-proline 0 CA--C 1.566 1.573 0 CA-C-O 117.455 -1.259 . . . . 73.32 113.426 -166.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -47.8 -41.88 31.24 Favored 'Trans proline' 0 C--N 1.403 3.411 0 C-N-CA 123.381 2.721 . . . . 63.33 113.885 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -100.95 -14.04 18.05 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.145 0.794 . . . . 74.22 113.145 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.529 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.6 -18.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.29 0.495 . . . . 73.52 110.582 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.25 -5.37 41.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.767 0.827 . . . . 72.44 111.689 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -99.95 -18.79 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.203 1.001 . . . . 71.41 111.18 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -67.57 150.19 49.13 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 75.21 111.912 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.39 134.83 55.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.581 0.753 . . . . 75.31 110.139 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -78.82 75.91 5.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.273 0.629 . . . . 75.01 112.101 -169.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -132.91 74.86 73.44 Favored Pre-proline 0 N--CA 1.48 1.033 0 N-CA-C 108.324 -0.991 . . . . 72.12 108.324 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.75 128.09 2.8 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.102 2.535 . . . . 74.43 112.113 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.72 98.47 11.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.312 -2.107 . . . . 72.1 105.312 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.618 ' H ' ' HD3' ' E' ' 294' ' ' LYS . 39.8 t -91.78 102.04 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.312 -1.313 . . . . 75.52 108.997 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -78.91 148.08 32.84 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.572 0.749 . . . . 74.32 111.048 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.51 111.53 18.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.617 -1.253 . . . . 75.44 107.617 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.778 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -107.3 144.06 34.67 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.277 -1.008 . . . . 73.11 108.277 170.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.68 129.45 24.65 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.903 0.481 . . . . 54.54 109.918 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.65 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.1 m-20 -127.22 127.4 44.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.194 0.998 . . . . 74.45 109.317 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' E' ' 281' ' ' PHE . 44.9 p -118.17 122.83 44.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.56 1.144 . . . . 75.4 109.522 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.97 147.28 31.52 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.082 0.553 . . . . 51.11 110.938 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 p -119.42 167.12 12.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.76 0.824 . . . . 74.35 110.014 170.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -156.07 153.16 28.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.617 1.167 . . . . 73.4 108.355 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -113.44 127.04 55.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.488 0.315 . . . . 64.03 110.349 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 57' ' ' GLU . 41.6 mt -93.65 -44.33 8.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.604 0.762 . . . . 64.34 110.495 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' C' ' 155' ' ' ALA . . . -150.1 -179.01 6.82 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.482 -1.235 . . . . 75.44 108.914 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.39 118.87 8.68 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 109.483 -0.562 . . . . 71.42 109.483 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 71.96 -4.61 1.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.707 1.603 . . . . 72.03 113.312 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 42.1 t -104.86 118.62 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.915 -0.772 . . . . 71.21 108.915 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -122.3 160.43 25.34 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.488 0.715 . . . . 73.14 110.676 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' HB2' HD11 ' A' ' 51' ' ' LEU . 8.1 tm-20 -132.71 136.87 46.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.318 -1.364 . . . . 73.51 107.318 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.418 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 86.3 t -126.49 125.88 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.449 -0.945 . . . . 73.3 108.449 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.4 t -101.71 136.94 31.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.159 0.584 . . . . 61.44 110.025 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -122.3 97.68 5.58 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.67 -1.604 . . . . 54.04 106.67 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.65 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 47.2 ttp180 -86.53 109.81 19.36 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 109.319 -0.622 . . . . 74.1 109.319 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.8 139.49 18.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.295 -1.372 . . . . 61.41 107.295 169.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.778 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 40.3 m -132.27 136.03 46.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.611 -0.885 . . . . 51.23 108.611 173.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.705 HG11 HD21 ' A' ' 126' ' ' LEU . 92.5 t -134.85 109.07 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.464 1.106 . . . . 72.44 108.421 -173.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.3 m -106.05 137.22 44.35 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 108.684 -0.858 . . . . 75.55 108.684 174.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.39 123.57 38.24 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.021 -0.733 . . . . 63.11 109.021 176.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 63.8 m -132.14 125.45 31.29 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.768 0.427 . . . . 72.13 110.143 175.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -89.39 84.41 6.44 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.239 -1.393 . . . . 75.01 107.239 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.98 -98.86 1.23 Allowed Glycine 0 C--N 1.344 1.011 0 CA-C-N 114.245 -1.343 . . . . 35.22 110.93 -170.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -104.88 -25.87 12.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.299 1.04 . . . . 64.51 110.253 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.88 106.13 17.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 75.14 110.277 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.77 130.31 42.46 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.506 0.669 . . . . 70.31 111.248 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.53 -60.76 2.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.898 -1.046 . . . . 73.13 109.724 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -155.82 162.98 40.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.956 -1.02 . . . . 72.4 111.478 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -135.9 111.32 9.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.55 1.14 . . . . 74.03 108.465 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.43 124.05 48.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.25 1.02 . . . . 64.11 109.865 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -135.54 119.01 16.87 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.211 -0.663 . . . . 65.44 109.211 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.96 110.36 21.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.912 0.885 . . . . 64.3 109.132 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -83.91 82.8 8.18 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.396 -1.335 . . . . 75.51 107.396 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 60.7 tp60 -76.91 94.51 3.94 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.624 -0.88 . . . . 53.25 108.624 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.15 149.79 19.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.3 -0.864 . . . . 73.01 111.754 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 134.76 5.12 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.802 -0.519 . . . . 63.22 111.802 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' B' ' 29' ' ' PRO . 63.8 mt -81.72 123.86 38.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.941 -0.763 . . . . 63.52 108.941 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.669 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.3 m-85 -132.78 117.14 17.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.792 -1.188 . . . . 75.52 107.792 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 t -77.93 93.84 4.48 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.565 -0.902 . . . . 71.45 108.565 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.5 mt -104.34 131.61 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.862 -0.792 . . . . 75.11 108.862 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -153.34 162.65 41.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.721 0.808 . . . . 63.25 110.133 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' C' ' 147' ' ' GLU . . . 92.2 -28.92 8.12 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.938 -0.573 . . . . 73.12 114.521 168.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.79 140.9 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.448 0.699 . . . . 70.21 111.636 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.677 ' HB2' ' HA3' ' C' ' 148' ' ' GLY . 0.4 OUTLIER -147.19 176.03 10.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.15 0.98 . . . . 63.24 108.6 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.59 -135.82 23.93 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.561 -0.577 . . . . 33.54 112.055 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 48.1 p -71.85 -14.99 62.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 72.21 111.729 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.706 ' HG3' ' HB3' ' C' ' 144' ' ' GLN . 23.2 mp0 -74.25 -57.43 3.95 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.173 0.989 . . . . 75.52 110.253 -176.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.567 ' SD ' ' HB3' ' E' ' 277' ' ' LEU . 25.7 ttt -80.27 -15.32 57.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.821 -0.172 . . . . 71.42 110.648 175.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -62.57 -39.66 94.4 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.884 0.373 . . . . 71.15 110.108 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.559 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.7 t-80 -77.3 -19.54 56.29 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.878 -0.601 . . . . 63.54 110.988 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.6 -61.05 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.813 -0.554 . . . . 74.14 110.278 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.46 -45.5 72.29 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.873 0.869 . . . . 70.4 111.702 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.69 6.38 79.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.116 -0.825 . . . . 34.33 114.559 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.683 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.37 -61.71 0.22 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.117 0.958 . . . . 62.13 112.714 -175.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 87.5 t80 -78.32 -55.46 5.22 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.036 1.124 . . . . 71.54 114.036 -164.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.5 m -70.21 -33.06 3.1 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 114.048 1.129 . . . . 74.32 114.048 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.4 Cg_endo -63.8 -16.8 56.91 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.039 1.826 . . . . 62.43 113.149 167.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -71.98 -14.95 62.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.59 . . . . 53.21 110.825 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 13' ' ' ILE . 36.0 mm -84.11 -41.8 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.848 0.832 . . . . 72.33 109.855 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 76.0 mt -76.35 -44.38 36.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.251 -1.341 . . . . 74.01 111.598 -171.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -59.82 -41.35 85.13 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 113.706 1.002 . . . . 74.03 113.706 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.96 -44.73 33.01 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.12 1.88 . . . . 72.44 113.375 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' C' ' 108' ' ' PRO . 26.7 m-85 -73.7 -24.06 59.88 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.989 0.516 . . . . 72.45 111.997 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -51.69 23.28 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.832 -0.803 . . . . 61.24 108.832 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -50.91 -46.78 60.8 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.944 1.402 . . . . 73.01 110.488 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -65.36 -42.02 93.22 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 124.765 1.291 . . . . 74.04 111.073 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.5 t -62.26 -45.43 93.35 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.739 0.649 . . . . 73.15 110.188 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.56 -43.0 98.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 O-C-N 124.267 0.98 . . . . 74.55 110.105 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.5 m -57.14 -44.06 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.824 0.85 . . . . 65.25 110.552 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 14.6 t -67.77 -47.7 68.47 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.071 -0.968 . . . . 65.33 110.589 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.7 mtp -57.11 -48.58 78.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 71.44 111.502 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.81 -43.44 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.069 1.348 . . . . 54.15 110.859 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -67.51 -33.61 75.43 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.795 0.838 . . . . 75.32 111.59 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 116' ' ' SER . 37.0 mtt180 -72.13 -29.63 64.25 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.428 0.691 . . . . 74.33 110.659 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.87 14.25 38.6 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.498 -0.612 . . . . 75.5 113.555 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 57.51 22.48 8.13 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.105 1.762 . . . . 41.33 113.329 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PHE . . . . . 0.503 ' HA ' HD11 ' E' ' 301' ' ' ILE . 91.4 m-85 -89.22 156.51 48.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 73.43 108.759 171.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.646 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 60.1 Cg_endo -66.71 151.98 81.52 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.813 2.342 . . . . 53.45 111.755 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.592 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.9 tt0 -53.99 127.74 27.64 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.976 0.797 . . . . 53.43 111.569 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 64' ' ' VAL . 16.5 tp -110.71 101.15 9.81 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.21 -0.904 . . . . 73.43 109.825 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -107.48 100.07 9.53 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.377 -1.342 . . . . 74.12 107.377 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.77 121.38 14.43 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.492 -0.558 . . . . 64.12 109.492 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -50.63 129.82 27.0 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.119 0.968 . . . . 62.01 112.219 -170.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 46.5 Cg_endo -84.1 115.86 2.05 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.678 2.252 . . . . 61.34 113.07 -175.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.65 141.43 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.573 -0.899 . . . . 73.14 108.573 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.34 72.43 4.86 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.37 -0.974 . . . . 71.55 108.37 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.46 -35.74 75.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.818 1.247 . . . . 72.02 110.586 -172.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.683 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.0 p-10 -62.03 -38.87 90.31 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.655 -1.157 . . . . 72.43 111.511 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.75 -27.55 36.75 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.442 0.697 . . . . 74.35 111.336 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.01 -38.35 90.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.965 0.906 . . . . 75.25 109.946 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.82 -31.55 72.57 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.214 -0.448 . . . . 65.41 111.051 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 93.5 mmm -74.66 -31.21 61.86 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.719 0.408 . . . . 74.43 111.201 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 50.0 m-80 -65.48 -38.94 91.25 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 116.351 -0.386 . . . . 62.21 110.118 172.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.15 -36.91 72.23 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.396 0.679 . . . . 71.33 110.783 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.45 -49.1 75.02 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.633 0.773 . . . . 72.45 110.911 -172.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -169.36 18.07 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.497 0.498 . . . . 73.13 110.758 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 34.3 tt0 59.86 34.82 21.82 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.325 1.05 . . . . 61.25 111.11 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -98.12 116.45 30.37 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.435 -0.802 . . . . 63.42 109.69 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.78 -49.3 6.34 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.123 0.569 . . . . 55.42 109.601 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.82 -163.94 49.75 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.246 -0.888 . . . . 63.51 113.571 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.453 ' HB3' ' ND2' ' C' ' 5' ' ' ASN . 8.2 pt-20 -161.45 165.84 28.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.128 0.971 . . . . 63.44 110.012 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 163.63 97.02 0.11 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 112.301 -0.32 . . . . 72.02 112.301 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.0 p -126.75 150.25 49.19 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.912 0.885 . . . . 71.41 110.576 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.85 108.56 19.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.746 0.818 . . . . 73.22 110.336 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HG2' ' HG3' ' A' ' 153' ' ' GLN . 27.4 tt0 -98.24 78.16 2.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.266 -1.013 . . . . 73.54 108.266 169.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -83.34 -17.16 43.39 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 116.384 -0.371 . . . . 74.13 111.12 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.409 ' HG3' ' HG2' ' A' ' 151' ' ' GLU . 94.4 mt-30 61.59 78.57 0.28 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.807 1.243 . . . . 63.12 112.193 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -173.03 -73.15 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.778 0.831 . . . . 64.05 108.981 170.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 C-N-CA 123.787 0.835 . . . . 71.34 109.171 177.704 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.258 -0.275 . . . . 64.23 110.258 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t -159.58 113.67 2.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.354 0.662 . . . . 43.13 109.331 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -102.42 107.19 18.09 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.343 0.592 . . . . 55.4 109.822 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -82.86 82.6 8.09 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.463 0.705 . . . . 71.41 110.098 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -164.67 -172.46 2.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.389 -0.967 . . . . 64.35 108.389 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -49.3 111.8 0.54 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.812 0.845 . . . . 72.1 112.748 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 89.8 m -67.15 -50.61 60.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.196 0.998 . . . . 75.21 110.341 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 73.57 -56.99 0.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.698 1.599 . . . . 75.04 112.795 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 12.1 ptm 56.83 166.17 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.072 2.549 . . . . 73.21 113.564 -168.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -163.87 139.59 6.38 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.377 -1.342 . . . . 51.31 107.377 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.86 156.69 44.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.807 0.813 . . . . 74.02 110.957 161.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.604 ' HB2' HG12 ' E' ' 306' ' ' VAL . 17.1 pm0 -126.43 132.67 51.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 113.644 -1.616 . . . . 65.33 107.722 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.414 ' O ' HG13 ' B' ' 13' ' ' ILE . 35.5 pt -76.89 108.68 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.497 -0.774 . . . . 72.13 109.136 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -74.93 -46.68 34.04 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.611 -0.515 . . . . 73.31 109.611 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.757 HH22 HG23 ' E' ' 301' ' ' ILE . 18.2 ttt85 -162.04 135.62 6.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 110.28 -0.267 . . . . 70.45 110.28 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.9 mt -116.74 131.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 106.147 -1.797 . . . . 73.35 106.147 170.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -164.01 141.58 7.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.644 0.378 . . . . 65.32 110.975 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 45.2 m -72.34 116.89 13.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.726 -0.842 . . . . 74.13 108.726 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -84.99 -40.28 17.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.944 -0.571 . . . . 71.12 110.458 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 11.6 t70 -145.62 144.2 30.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.108 -0.496 . . . . 63.21 111.081 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.533 HD11 ' SG ' ' B' ' 113' ' ' CYS . 32.2 mm -137.15 145.85 29.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.277 1.431 . . . . 65.52 108.487 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.552 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 26.7 t -146.25 138.86 25.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.284 -1.326 . . . . 22.52 107.434 176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -155.92 143.12 19.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.024 -1.102 . . . . 73.53 108.024 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.3 mt-10 -143.6 155.59 44.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.733 1.213 . . . . 70.43 108.716 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -151.27 86.09 4.85 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 107.878 -1.156 . . . . 60.01 107.878 172.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.5 -43.22 4.31 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.779 2.319 . . . . 71.13 113.006 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -105.0 29.02 6.66 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.018 0.527 . . . . 70.34 109.893 179.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.54 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.55 -54.06 25.42 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.866 1.266 . . . . 42.44 113.233 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HA ' HD11 ' A' ' 83' ' ' ILE . 2.5 Cg_endo -80.35 -20.44 8.36 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 121.527 1.485 . . . . 60.22 112.77 -176.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 51.5 m-70 -97.41 2.66 50.68 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.405 1.082 . . . . 60.32 112.686 -175.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.25 -15.12 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.62 0.768 . . . . 75.2 112.08 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -84.94 -27.11 26.78 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.606 0.762 . . . . 73.12 112.836 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 2.9 pt20 -75.69 -29.43 59.01 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.591 0.356 . . . . 72.45 111.626 -172.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.433 ' HB2' ' CZ2' ' B' ' 36' ' ' TRP . 38.1 mtpt -108.85 117.44 34.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.726 1.21 . . . . 52.33 108.707 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -89.71 117.41 28.55 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.458 0.572 . . . . 75.23 110.857 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.472 ' CZ2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -171.39 162.5 6.72 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 123.982 0.913 . . . . 71.53 112.916 -178.398 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -93.24 132.72 29.89 Favored Pre-proline 0 N--CA 1.485 1.322 0 C-N-CA 124.328 1.051 . . . . 64.2 109.997 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.44 147.39 36.48 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.25 1.966 . . . . 73.21 112.83 171.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.23 109.65 16.7 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.845 -1.169 . . . . 62.4 107.845 163.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.439 HG12 ' HE1' ' H' ' 290' ' ' TRP . 60.8 t -100.24 123.21 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.731 -0.668 . . . . 61.21 109.422 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.3 142.24 35.41 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.776 0.83 . . . . 71.31 109.555 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.601 HD11 HD21 ' B' ' 128' ' ' LEU . 3.7 tt -106.52 134.98 48.83 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.962 -1.496 . . . . 61.1 106.962 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 4.7 m-20 -128.42 114.55 16.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.215 -1.032 . . . . 60.21 108.215 -177.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.17 127.2 46.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.239 -1.393 . . . . 73.53 107.239 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -137.66 147.12 44.62 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.453 0.701 . . . . 73.23 109.199 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.1 p -121.82 128.85 52.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.412 0.685 . . . . 63.41 110.217 -173.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' ALA . . . . . 0.41 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -131.57 137.3 48.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.044 -1.095 . . . . 63.44 108.044 174.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.7 p -144.6 163.17 34.72 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.132 0.491 . . . . 55.32 110.559 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.88 173.09 15.79 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.065 -0.97 . . . . 75.53 108.845 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -120.51 125.14 47.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.801 0.44 . . . . 73.51 110.25 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.1 mt -87.45 -46.56 9.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.397 0.679 . . . . 72.43 109.459 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.25 -174.33 4.93 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.209 -0.905 . . . . 54.24 111.059 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.79 120.72 13.01 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.5 -0.773 . . . . 72.22 110.197 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 70.02 -5.48 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.522 1.529 . . . . 75.21 112.542 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -102.43 111.62 32.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.728 -0.842 . . . . 73.31 108.728 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.4 ' HE1' HD23 ' H' ' 277' ' ' LEU . 78.3 m-85 -119.79 139.93 51.56 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.597 -0.729 . . . . 64.32 109.861 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.581 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.9 tm-20 -104.05 97.13 7.15 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.694 -1.595 . . . . 70.22 106.694 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -92.62 118.72 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.864 0.866 . . . . 74.02 109.533 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.61 119.23 51.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 123.632 0.773 . . . . 64.31 110.033 176.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.23 109.14 20.97 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.096 -1.076 . . . . 64.34 108.096 172.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.7 122.95 33.91 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.351 -0.611 . . . . 74.42 109.351 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.43 124.99 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 107.985 -1.117 . . . . 71.43 107.985 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 12.4 m -119.7 138.53 53.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.579 0.752 . . . . 71.45 109.227 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.533 HG23 HD13 ' B' ' 114' ' ' ILE . 51.6 t -122.0 128.78 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 123.932 0.893 . . . . 62.13 109.164 175.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -118.84 144.28 46.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.576 -0.898 . . . . 75.02 108.576 171.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.81 133.79 30.86 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.66 -0.867 . . . . 71.23 108.66 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.4 p -149.88 140.11 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.883 0.473 . . . . 74.15 110.321 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -137.41 144.3 42.33 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.597 1.159 . . . . 71.33 109.228 -171.154 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.86 -108.06 1.95 Allowed Glycine 0 C--N 1.347 1.143 0 O-C-N 123.341 0.401 . . . . 74.14 113.81 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -116.05 1.17 13.2 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.226 1.01 . . . . 74.34 110.11 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.88 177.98 7.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.002 0.742 . . . . 72.24 113.002 -169.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 140.34 29.68 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.419 1.088 . . . . 55.12 109.808 171.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -80.44 -67.58 0.76 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.106 0.962 . . . . 71.22 109.477 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -159.3 157.79 31.19 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.146 -1.388 . . . . 62.53 109.472 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.98 150.51 47.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.608 1.163 . . . . 75.54 108.22 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.5 t -157.96 152.02 24.24 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.44 -0.578 . . . . 71.14 109.44 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -164.85 131.51 2.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.147 -0.686 . . . . 62.41 109.147 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -124.23 146.39 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.771 -0.826 . . . . 72.34 108.771 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -125.09 98.26 5.59 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.939 . . . . 75.32 108.463 171.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 63.4 tp60 -86.52 102.08 13.78 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.445 -0.798 . . . . 44.12 109.186 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.62 148.66 20.61 Favored Glycine 0 C--O 1.24 0.516 0 N-CA-C 111.189 -0.765 . . . . 62.02 111.189 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -152.38 125.46 1.82 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.889 -0.885 . . . . 71.2 110.889 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.581 HG12 ' HG2' ' B' ' 57' ' ' GLU . 38.0 mt -88.94 117.22 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.113 -0.699 . . . . 70.41 109.113 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -122.27 131.37 53.88 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.195 -1.409 . . . . 72.22 107.195 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.7 m -97.62 88.87 4.47 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.216 -1.031 . . . . 73.43 108.216 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' B' ' 89' ' ' ILE . 4.4 pt -95.67 121.98 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.24 -1.346 . . . . 75.42 110.028 -169.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.46 159.68 40.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.924 0.889 . . . . 45.42 109.89 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.19 -56.55 3.6 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.989 -0.55 . . . . 62.42 111.957 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.3 pp -58.5 153.04 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.152 0.981 . . . . 75.25 113.308 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -169.28 146.5 3.54 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.842 -1.072 . . . . 70.52 108.43 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -130.45 13.13 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 120.028 -0.318 . . . . 62.12 113.465 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -65.8 -33.22 75.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.479 1.111 . . . . 35.05 110.883 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.83 -40.54 97.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.202 -0.908 . . . . 74.3 110.561 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.425 ' SD ' ' O ' ' H' ' 277' ' ' LEU . 23.0 ttt -76.93 -31.73 56.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.808 -0.633 . . . . 70.11 110.438 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.05 -21.3 66.37 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.877 -0.602 . . . . 65.32 111.517 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 33.7 t-80 -84.71 -37.0 21.47 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.22 0.608 . . . . 73.1 110.552 169.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.47 -67.2 0.45 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.482 0.313 . . . . 61.15 111.38 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -12.79 42.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.383 0.512 . . . . 72.51 112.383 -176.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.03 -4.97 53.9 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-O 119.715 -0.492 . . . . 53.43 113.82 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -141.43 -58.41 0.49 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.185 0.493 . . . . 74.31 111.753 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -75.28 -44.61 44.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.2 0.6 . . . . 72.1 111.922 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.9 m -67.21 -44.68 49.23 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 118.572 -0.728 . . . . 71.03 111.721 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -57.16 -36.27 99.1 Favored 'Trans proline' 0 C--N 1.397 3.088 0 C-N-CA 122.435 2.09 . . . . 64.14 113.143 168.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -61.87 -35.91 79.72 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.389 0.676 . . . . 60.44 110.429 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -48.02 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.328 0.651 . . . . 74.1 110.752 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.422 HD21 ' HA3' ' B' ' 82' ' ' GLY . 96.5 mt -74.26 -21.12 59.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.188 0.595 . . . . 65.02 112.24 -173.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.573 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 50.0 t80 -60.64 -52.32 73.48 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-O 117.143 -1.408 . . . . 65.22 113.578 -171.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.88 -35.58 80.34 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.204 1.936 . . . . 55.21 113.267 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -68.81 -49.87 54.9 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.683 0.793 . . . . 74.42 110.548 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.54 92.0 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.574 0.749 . . . . 50.41 111.087 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -57.23 -62.09 2.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.236 1.814 . . . . 73.34 111.7 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' GLU . . . . . 0.466 ' HG2' ' NH2' ' C' ' 120' ' ' ARG . 13.7 tp10 -70.34 -23.89 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.498 0.719 . . . . 72.41 110.709 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.533 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.1 t -69.97 -35.84 74.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.683 -0.199 . . . . 61.43 110.632 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.533 HD13 HG23 ' B' ' 64' ' ' VAL . 61.7 mt -63.82 -54.86 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.048 -0.723 . . . . 72.44 109.048 171.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.6 m -56.62 -34.69 67.5 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.382 1.073 . . . . 61.32 112.072 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -66.64 -45.01 80.41 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.644 -0.707 . . . . 71.04 110.43 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 13.7 mmt -71.2 -33.93 70.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.498 0.499 . . . . 52.03 111.165 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.61 -44.0 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.833 0.853 . . . . 63.22 109.746 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -72.0 -25.48 61.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.35 -0.841 . . . . 65.34 111.399 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -72.94 -27.51 61.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.877 0.471 . . . . 74.33 109.883 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.71 38.6 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.837 0.711 . . . . 52.11 112.756 169.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.9 p 54.86 46.6 24.13 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 125.888 1.675 . . . . 74.53 112.253 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.566 ' HD1' ' HH ' ' H' ' 297' ' ' TYR . 60.9 m-85 -108.8 158.5 33.95 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.523 1.129 . . . . 63.1 109.099 174.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.407 ' HG2' HG22 ' H' ' 296' ' ' THR . 89.8 Cg_endo -72.93 -163.21 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.073 2.515 . . . . 71.21 113.696 -174.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 21.6 tp60 -64.08 130.38 43.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.724 0.81 . . . . 65.03 112.098 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.425 ' HB2' HG23 ' H' ' 296' ' ' THR . 29.9 tp -130.5 85.09 2.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.141 0.576 . . . . 74.52 109.615 171.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -91.01 115.55 28.1 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.623 -0.88 . . . . 74.34 108.623 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.601 HD21 HD11 ' B' ' 42' ' ' LEU . 1.6 tt -77.12 140.22 40.18 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.841 -1.17 . . . . 71.44 107.841 173.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.483 ' HB3' HD13 ' H' ' 291' ' ' LEU . . . -76.77 148.31 79.13 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.143 0.577 . . . . 71.45 111.057 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.87 109.67 0.48 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.576 2.184 . . . . 65.4 112.354 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.84 110.37 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.747 -0.834 . . . . 42.12 108.747 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -90.31 85.44 6.21 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.724 -0.843 . . . . 64.13 108.724 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -59.05 -36.37 74.91 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.921 0.889 . . . . 74.44 111.525 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 134' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' B' ' 138' ' ' MET . 4.2 m-20 -61.05 -47.81 84.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.874 -1.057 . . . . 73.33 110.391 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.62 -37.01 83.96 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.679 0.612 . . . . 64.54 111.466 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.76 -41.98 98.4 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 123.659 0.6 . . . . 74.0 110.888 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -74.27 -31.7 62.64 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.704 -0.68 . . . . 72.33 110.486 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 138' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 24.2 mmt -67.48 -38.84 84.99 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.763 -0.458 . . . . 61.32 109.763 173.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 139' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' B' ' 142' ' ' GLN . 4.3 m-20 -75.04 -8.05 55.42 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.387 0.675 . . . . 55.14 111.567 -175.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -69.3 -38.79 78.46 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 110.101 -0.333 . . . . 74.44 110.101 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.17 4.57 10.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.209 0.818 . . . . 73.54 113.209 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 142' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' B' ' 139' ' ' ASN . 58.1 tt0 -143.38 141.38 30.88 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.028 0.531 . . . . 52.03 110.443 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -124.0 171.01 10.07 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.193 0.597 . . . . 74.14 110.078 173.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -115.42 172.65 6.96 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.931 0.892 . . . . 74.14 109.254 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.46 74.33 0.46 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.325 0.65 . . . . 53.43 109.275 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 146' ' ' GLY . . . . . 0.555 ' HA2' HG23 ' D' ' 7' ' ' THR . . . -95.26 120.11 6.39 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.731 -0.548 . . . . 73.41 111.731 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -166.4 98.11 0.59 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.081 0.552 . . . . 75.04 110.181 -173.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.39 -120.22 1.62 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.059 -0.817 . . . . 50.4 111.059 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 10.2 t -173.65 129.59 0.42 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.931 0.892 . . . . 43.03 109.076 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.17 127.93 1.86 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.425 -0.583 . . . . 72.34 109.425 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -133.04 105.83 7.29 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.099 -1.445 . . . . 73.3 107.099 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -114.55 109.34 18.11 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.616 0.367 . . . . 72.42 110.92 -168.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -111.62 100.17 8.76 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.869 -1.16 . . . . 63.32 107.869 170.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.95 158.13 29.45 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.945 0.498 . . . . 72.1 110.802 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 C-N-CA 124.073 0.949 . . . . 72.33 108.618 179.926 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 108.654 -0.869 . . . . 65.51 108.654 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 54.3 m -151.81 112.19 4.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.855 0.862 . . . . 51.13 108.985 171.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.49 151.04 25.63 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.292 0.637 . . . . 73.04 110.499 177.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -148.83 140.04 23.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.192 0.597 . . . . 73.43 109.922 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 5' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 147' ' ' GLU . 5.2 p30 -112.08 141.72 45.41 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.459 1.103 . . . . 73.55 109.408 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -86.51 73.34 10.12 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.639 0.733 . . . . 64.2 109.508 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.1 m -120.82 95.2 4.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.057 0.943 . . . . 72.45 108.616 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -80.45 -40.97 25.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.874 -0.603 . . . . 72.33 110.737 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 89.3 mtp 59.69 115.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.065 1.346 . . . . 72.21 112.379 -173.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -122.45 97.12 5.32 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -105.59 129.3 53.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.446 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.663 ' HB3' ' H ' ' G' ' 308' ' ' CYS . 0.7 OUTLIER -137.71 108.87 6.8 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.401 0.681 . . . . 63.14 109.254 173.521 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.7 120.07 13.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.222 -0.899 . . . . 63.32 108.626 171.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -86.15 -49.91 7.39 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.685 -0.689 . . . . 70.22 109.9 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 15' ' ' ARG . . . . . 0.635 HH12 HD13 ' G' ' 301' ' ' ILE . 58.7 ttt180 -171.69 129.41 0.66 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.174 -0.467 . . . . 65.42 109.893 -176.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.21 143.88 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.197 -1.409 . . . . 72.33 107.197 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.488 ' HE1' HG12 ' C' ' 83' ' ' ILE . 15.7 p90 -175.73 151.4 1.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.315 0.579 . . . . 71.55 110.444 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -76.6 107.12 8.67 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.622 -0.881 . . . . 72.12 108.622 171.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -70.48 -29.73 66.35 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.008 -0.738 . . . . 72.53 109.008 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.756 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -145.84 140.51 27.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.26 -0.882 . . . . 53.42 110.687 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.4 mt -134.66 144.98 33.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.275 -1.75 . . . . 62.32 106.275 170.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.0 t -159.68 151.77 20.71 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.484 0.659 . . . . 54.34 110.674 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 80.7 t80 -149.36 109.7 4.18 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.335 -1.357 . . . . 75.14 107.335 171.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.3 119.17 35.41 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.98 -0.748 . . . . 64.12 108.98 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.07 79.62 12.98 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.626 -0.879 . . . . 65.53 108.626 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.17 -12.53 25.62 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.815 2.343 . . . . 72.11 111.409 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -103.97 13.25 33.05 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.453 1.101 . . . . 51.41 109.357 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.02 96.0 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.613 1.338 . . . . 65.12 114.613 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.402 ' HA ' HH21 ' D' ' 15' ' ' ARG . 24.0 Cg_exo -65.24 -39.72 22.09 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.624 1.549 . . . . 62.43 112.181 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -68.76 -41.59 78.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.977 -1.011 . . . . 71.25 112.359 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.435 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 13.5 p -70.94 -25.83 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.065 0.394 . . . . 71.43 112.065 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 32' ' ' PHE . . . . . 0.434 ' HE2' ' HD3' ' F' ' 304' ' ' PRO . 67.9 t80 -69.63 -12.16 61.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.668 0.787 . . . . 75.11 112.173 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -128.47 22.84 5.95 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.584 0.753 . . . . 71.45 110.635 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.6 ' HE3' HD21 ' C' ' 68' ' ' LEU . 31.9 ttpt -109.1 168.1 9.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.934 0.894 . . . . 75.35 110.626 -174.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.67 125.23 19.03 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.942 1.297 . . . . 65.02 112.243 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -85.53 68.21 10.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.955 0.902 . . . . 72.34 111.39 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -149.3 71.65 10.02 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 109.379 -0.6 . . . . 75.24 109.379 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.03 143.19 4.0 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.673 2.249 . . . . 63.02 112.023 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -88.06 91.6 8.83 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.61 -1.256 . . . . 75.53 107.61 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.41 129.02 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.662 -0.866 . . . . 55.3 108.662 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.77 118.24 22.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.394 0.678 . . . . 71.1 109.222 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -87.17 119.76 27.74 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.423 -1.325 . . . . 65.41 107.423 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.73 114.35 19.81 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.959 -0.756 . . . . 74.42 108.959 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.83 150.11 24.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.38 0.672 . . . . 73.32 109.284 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.729 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 6.5 t70 -148.02 150.93 34.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.345 1.058 . . . . 74.42 109.158 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -119.34 131.12 55.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.886 0.874 . . . . 54.42 110.272 -174.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -134.57 145.77 49.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 64.13 109.509 174.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -151.89 146.05 25.36 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.734 . . . . 74.14 110.262 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.8 p -148.09 137.09 21.96 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.556 0.742 . . . . 75.43 109.93 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -83.58 116.62 22.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.096 -0.705 . . . . 70.32 109.096 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' C' ' 57' ' ' GLU . 43.7 mt -93.91 -34.02 13.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.453 0.701 . . . . 54.1 109.933 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.71 -173.99 4.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.896 . . . . 73.54 110.101 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.95 116.39 5.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.32 -0.854 . . . . 75.15 110.188 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 70.28 -5.85 1.26 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.559 1.543 . . . . 44.3 113.129 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -94.76 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.724 -0.843 . . . . 75.33 108.724 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -124.62 126.18 45.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.518 1.127 . . . . 75.53 108.748 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.593 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.1 tt0 -82.21 116.17 21.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.051 -0.977 . . . . 71.55 108.783 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -97.23 122.82 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.597 -1.26 . . . . 63.21 107.597 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 92.5 t -115.85 132.81 64.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.536 -0.912 . . . . 73.45 108.536 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.94 102.59 9.49 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.343 -1.354 . . . . 60.2 107.343 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.729 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.2 tmt_? -82.59 110.03 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.226 1.01 . . . . 74.13 108.481 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.5 t -102.57 136.88 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.92 -1.141 . . . . 64.35 107.92 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -140.03 116.54 10.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.217 -0.66 . . . . 72.12 109.217 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 78.4 t -102.35 109.09 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.793 -1.094 . . . . 71.22 108.1 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.0 m -98.67 150.68 21.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.623 -1.171 . . . . 71.34 109.301 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.94 111.24 7.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 74.24 107.141 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -144.39 127.08 16.16 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.621 -0.511 . . . . 33.32 109.621 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.645 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -90.29 60.5 4.76 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.283 1.039 . . . . 71.22 108.798 176.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 -122.7 6.41 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 114.063 -1.426 . . . . 43.15 110.517 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.86 -23.93 19.5 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.449 -0.945 . . . . 73.12 108.449 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.11 115.89 5.94 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.424 1.09 . . . . 72.21 109.722 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -85.73 140.19 30.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.427 . . . . 63.34 111.085 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.37 -61.54 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.962 0.905 . . . . 41.4 109.058 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -164.47 176.42 9.03 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.454 0.702 . . . . 71.12 110.653 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -141.57 143.9 33.96 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.934 -1.135 . . . . 54.14 107.934 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.501 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.7 t -147.17 129.83 16.02 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.558 0.743 . . . . 65.04 109.113 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -132.15 139.6 48.47 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.344 0.658 . . . . 71.13 110.407 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.97 114.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.526 1.13 . . . . 65.44 108.365 172.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.756 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -92.31 93.62 8.73 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 75.43 108.849 171.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 80' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 69.9 tp60 -80.04 105.39 11.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.407 -0.815 . . . . 75.53 110.073 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.06 155.0 27.06 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.917 -0.583 . . . . 73.24 112.08 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 82' ' ' GLY . . . . . 0.487 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.57 116.22 0.71 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.703 -0.959 . . . . 73.22 110.703 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.511 HD12 HD11 ' C' ' 51' ' ' LEU . 15.3 mm -81.41 122.73 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.192 -1.04 . . . . 75.03 108.192 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -132.68 142.07 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 85' ' ' SER . . . . . 0.622 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 38.3 m -109.8 121.47 45.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.633 -1.247 . . . . 72.2 107.633 169.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.505 ' HB ' HD11 ' C' ' 89' ' ' ILE . 1.9 pp -121.49 141.41 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.873 0.869 . . . . 75.44 110.852 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.76 164.22 36.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.003 0.921 . . . . 74.1 109.645 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.64 -19.11 34.56 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 114.092 0.397 . . . . 71.51 114.092 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' C' ' 86' ' ' ILE . 0.8 OUTLIER -101.91 141.88 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.76 1.224 . . . . 64.24 110.581 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -156.15 148.24 23.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.591 0.757 . . . . 74.02 110.068 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.18 -146.06 35.69 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.27 -0.423 . . . . 73.32 112.874 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -67.83 -21.54 65.2 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.481 0.712 . . . . 72.45 111.357 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.6 -36.74 84.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.588 0.755 . . . . 71.35 110.926 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.505 ' HG3' HD13 ' C' ' 89' ' ' ILE . 28.1 ttt -70.42 -29.92 66.65 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 116.288 -0.415 . . . . 62.2 110.883 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.82 69.02 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.313 0.645 . . . . 54.44 111.679 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 50.1 t-80 -74.14 -26.93 60.61 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.154 0.582 . . . . 72.52 110.816 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -81.18 -60.68 2.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.511 0.324 . . . . 33.42 110.712 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.638 HD22 HD22 ' F' ' 278' ' ' LEU . 4.6 pp -73.23 -36.96 66.52 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.257 0.623 . . . . 63.12 111.695 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 99' ' ' GLY . . . . . 0.436 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -90.95 -14.65 57.54 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 114.3 0.48 . . . . 72.15 114.3 -170.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -127.09 -58.16 1.29 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.725 0.41 . . . . 64.12 111.579 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.8 -45.24 75.36 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.602 0.361 . . . . 44.41 111.935 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -63.94 -45.52 80.65 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.641 -0.695 . . . . 73.21 112.124 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.63 -39.73 81.97 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.559 2.173 . . . . 72.43 113.87 165.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.9 -18.75 65.55 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.826 0.451 . . . . 61.32 112.202 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mm -86.66 -45.94 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.254 0.622 . . . . 73.41 110.537 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.487 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.7 mt -79.85 -43.53 22.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.936 0.717 . . . . 60.31 112.936 -168.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.4 -42.08 89.87 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.239 1.016 . . . . 73.13 113.041 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 108' ' ' PRO . . . . . 0.586 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 69.9 Cg_exo -44.36 -46.97 11.34 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.628 2.219 . . . . 54.23 115.091 169.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 109' ' ' TYR . . . . . 0.417 ' HE2' HG21 ' A' ' 115' ' ' THR . 53.0 m-85 -69.64 -42.21 74.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.155 0.582 . . . . 72.31 111.252 -177.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 110' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.82 -29.8 69.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.705 -0.679 . . . . 60.12 111.354 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.619 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 34.7 ttp180 -56.08 -58.27 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 123.93 0.769 . . . . 74.22 111.179 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -73.5 -32.69 64.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.258 0.623 . . . . 75.2 110.338 -176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 113' ' ' CYS . . . . . 0.495 ' SG ' HG12 ' C' ' 21' ' ' ILE . 36.2 t -62.54 -34.68 77.42 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.396 0.678 . . . . 61.44 111.865 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' C' ' 62' ' ' VAL . 96.7 mt -71.36 -47.16 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.608 0.763 . . . . 75.02 110.206 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -64.7 -28.32 69.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.327 0.651 . . . . 63.52 111.852 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -68.28 -39.97 81.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.581 0.753 . . . . 72.13 110.011 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.636 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.06 -41.11 95.41 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.729 0.811 . . . . 73.34 111.105 175.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.24 -34.14 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.831 0.852 . . . . 72.32 110.246 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 119' ' ' SER . . . . . 0.461 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 42.0 t -65.59 -43.04 90.91 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.57 -0.741 . . . . 52.25 110.98 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.466 ' NH2' ' HG2' ' B' ' 112' ' ' GLU . 91.3 mtt-85 -72.28 -21.28 61.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.22 -0.9 . . . . 74.02 111.439 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.65 -1.04 87.7 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.79 -0.45 . . . . 24.51 113.365 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.444 HG23 ' HB3' ' D' ' 17' ' ' TYR . 30.2 p 59.66 43.09 16.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.507 1.523 . . . . 64.23 111.489 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -119.69 141.11 30.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.733 0.813 . . . . 71.41 110.033 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 13.1 Cg_endo -53.09 107.16 0.18 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.729 2.953 . . . . 71.21 112.898 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -55.74 143.21 31.63 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.058 1.343 . . . . 73.53 113.52 -170.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tt -134.61 114.65 12.99 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.787 -1.19 . . . . 71.21 107.787 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -92.12 126.24 37.13 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.395 -0.965 . . . . 75.52 108.395 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.619 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.0 mm? -66.67 148.33 52.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.667 0.787 . . . . 72.21 111.447 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' F' ' 291' ' ' LEU . . . -84.92 153.4 60.33 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 123.356 0.663 . . . . 74.42 110.86 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.529 ' HG2' HG21 ' A' ' 13' ' ' ILE . 6.3 Cg_exo -76.9 125.53 8.12 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.301 2.668 . . . . 75.24 112.295 -172.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.37 110.6 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.13 0.572 . . . . 65.23 109.493 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -91.3 93.89 9.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 62.32 109.451 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -76.57 -33.11 58.5 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.36 0.6 . . . . 75.31 109.592 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -70.69 -40.78 72.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.885 -1.052 . . . . 51.42 111.503 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.26 83.35 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.107 0.879 . . . . 63.24 111.842 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.32 -23.22 57.27 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 123.937 0.773 . . . . 72.25 111.372 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -80.63 -33.61 35.62 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.176 0.59 . . . . 75.4 111.097 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 95.0 mmm -74.05 -30.91 62.64 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.698 -0.482 . . . . 75.22 109.698 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -53.73 -37.07 62.96 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.411 1.484 . . . . 63.43 111.076 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -52.96 -83.75 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.502 1.521 . . . . 74.21 112.342 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 95.0 mt -95.34 10.63 35.54 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.448 0.907 . . . . 63.43 113.448 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -122.94 150.0 43.52 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.165 0.439 . . . . 61.51 110.418 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -160.46 163.08 33.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.049 0.94 . . . . 74.51 110.634 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 144' ' ' GLN . . . . . 0.706 ' HB3' ' HG3' ' A' ' 93' ' ' GLN . 51.3 mt-30 -130.62 147.07 52.26 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.13 0.972 . . . . 71.23 108.711 170.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 145' ' ' ALA . . . . . 0.58 ' HB1' ' H ' ' A' ' 5' ' ' ASN . . . -132.71 119.71 20.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.257 0.623 . . . . 53.24 110.696 -173.02 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.5 98.82 0.13 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.36 -1.096 . . . . 62.33 110.36 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 147' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 88' ' ' GLY . 15.1 pt-20 -72.96 164.89 26.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.446 0.641 . . . . 73.42 112.468 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 148' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 90' ' ' GLU . . . -177.27 141.21 5.21 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 114.653 -1.158 . . . . 43.44 110.817 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.7 t -171.33 163.3 6.97 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.21 0.604 . . . . 65.32 110.592 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -170.13 119.8 0.61 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.7 -1.592 . . . . 75.35 106.7 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.63 89.06 0.24 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.321 0.649 . . . . 54.23 109.436 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -77.36 153.19 33.99 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.731 0.812 . . . . 65.41 112.362 -168.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -61.06 130.79 48.15 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.165 . . . . 75.24 111.105 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.6 t70 72.04 132.7 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.571 1.549 . . . . 75.34 111.576 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' C' C ' 155' ' ' ALA . . . . . 0.636 ' HA ' ' HB1' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.508 0.723 . . . . 74.31 109.749 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.123 -0.695 . . . . 74.02 109.123 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.9 t -78.98 105.93 10.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.289 0.635 . . . . 72.4 110.691 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -112.38 107.87 16.84 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.993 -1.114 . . . . 75.3 107.993 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -102.92 173.85 6.13 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.93 0.892 . . . . 74.54 109.046 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -161.18 93.69 0.97 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.576 0.703 . . . . 64.34 110.645 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 6' ' ' ASN . . . . . 0.455 ' HB3' ' HG2' ' D' ' 8' ' ' GLU . 61.3 t30 -163.03 175.02 11.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.427 0.691 . . . . 74.21 109.327 177.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 7' ' ' THR . . . . . 0.555 HG23 ' HA2' ' B' ' 146' ' ' GLY . 8.1 t -82.78 59.16 4.64 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 122.411 1.1 . . . . 70.12 110.76 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 8' ' ' GLU . . . . . 0.455 ' HG2' ' HB3' ' D' ' 6' ' ' ASN . 11.1 mm-40 -85.75 -2.01 57.78 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.901 -1.045 . . . . 75.23 110.927 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.5 ttp -30.65 127.96 0.14 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.332 1.853 . . . . 72.41 113.698 170.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 10' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 57.5 m -135.65 138.26 42.67 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.608 0.763 . . . . 75.32 109.45 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -157.47 105.77 2.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.492 -1.299 . . . . 53.23 107.492 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -125.26 119.19 27.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 74.12 109.257 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mt -73.4 114.93 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 107.837 -1.171 . . . . 65.53 107.837 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.91 -45.54 16.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.27 -0.641 . . . . 74.05 109.27 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' C' ' 29' ' ' PRO . 16.6 ptt180 -174.04 159.73 3.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.025 0.93 . . . . 71.12 109.897 172.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.489 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -130.03 143.2 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.375 1.07 . . . . 65.2 108.128 174.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' C' ' 122' ' ' THR . 31.0 p90 -170.26 172.27 6.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.933 0.873 . . . . 75.14 110.988 -169.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.414 HG21 HD11 ' D' ' 21' ' ' ILE . 81.4 p -98.74 115.77 29.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.507 -1.224 . . . . 73.0 109.56 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -87.69 -23.42 24.19 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.356 -0.609 . . . . 74.15 109.356 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.1 t70 -151.23 134.56 16.11 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.553 -1.203 . . . . 63.11 109.338 175.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.636 HD13 ' HE3' ' C' ' 117' ' ' MET . 72.0 mt -129.45 138.39 54.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.562 -1.273 . . . . 64.22 107.562 171.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -143.08 128.47 18.91 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.107 -1.071 . . . . 72.23 108.107 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 56.6 t80 -138.0 113.63 9.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.653 -1.98 . . . . 72.3 105.653 167.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.36 138.54 54.21 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.373 -0.603 . . . . 74.31 109.373 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -143.53 77.06 15.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.436 -1.32 . . . . 55.14 107.436 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.46 -45.44 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.664 2.243 . . . . 51.02 111.901 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -93.48 30.09 1.82 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.442 1.097 . . . . 73.0 108.78 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -59.47 -57.45 26.81 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 124.112 0.965 . . . . 65.51 112.702 -172.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -76.88 -12.19 17.97 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.468 1.56 . . . . 71.43 112.163 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -78.19 -41.65 33.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.02 1.328 . . . . 72.31 109.982 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -79.32 -32.48 14.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-O 118.812 -0.613 . . . . 73.03 110.097 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -50.95 -28.67 10.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.094 0.872 . . . . 73.43 113.197 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.43 -38.01 89.48 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.442 0.697 . . . . 71.34 111.141 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.48 ' HD2' ' O ' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -132.5 64.07 1.61 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.639 0.776 . . . . 72.15 110.202 168.692 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.511 ' HB3' HD11 ' G' ' 301' ' ' ILE . 17.5 t70 -112.16 95.98 5.77 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.795 0.807 . . . . 74.22 110.152 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -123.01 -157.45 0.75 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.044 1.738 . . . . 63.14 106.804 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 37' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 15.9 pm0 -50.87 106.28 0.63 Allowed Pre-proline 0 CA--C 1.567 1.618 0 C-N-CA 123.386 0.674 . . . . 75.42 111.915 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 4.7 Cg_exo -78.06 147.32 23.66 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.737 2.291 . . . . 51.31 112.295 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.4 110.98 5.63 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 107.243 -1.392 . . . . 74.53 107.243 168.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.74 114.81 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.539 -0.755 . . . . 63.3 110.18 -169.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.56 138.49 32.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.109 0.964 . . . . 55.22 109.767 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 42' ' ' LEU . . . . . 0.47 HD12 HD21 ' D' ' 128' ' ' LEU . 6.2 tt -98.8 131.91 44.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.331 -1.359 . . . . 74.14 107.331 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -132.33 147.14 52.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.865 -0.791 . . . . 75.04 108.865 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.16 139.39 49.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.251 0.62 . . . . 73.45 110.394 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 12.1 t70 -137.43 135.27 36.74 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.109 -1.071 . . . . 75.51 108.109 170.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -113.42 144.4 42.87 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 65.13 109.584 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.16 155.1 39.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.355 0.662 . . . . 63.32 110.197 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 73.6 p -164.72 153.14 12.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.191 0.596 . . . . 74.25 110.649 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -154.31 137.06 15.26 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.356 0.663 . . . . 51.21 109.449 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.19 116.99 15.48 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.912 -0.773 . . . . 61.4 108.912 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.89 -32.12 15.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.674 0.39 . . . . 65.4 110.358 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.83 -175.25 5.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.785 -0.643 . . . . 75.21 111.361 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.67 118.08 7.16 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.598 -1.183 . . . . 74.21 109.749 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 13.0 m-20 65.09 11.05 6.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.508 1.123 . . . . 74.5 112.314 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.83 120.21 64.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 123.779 0.831 . . . . 75.12 109.239 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.614 ' HB2' HD13 ' D' ' 86' ' ' ILE . 73.8 m-85 -129.67 128.88 43.48 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.502 -1.295 . . . . 64.52 107.502 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -92.27 128.37 38.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.116 -0.698 . . . . 75.34 109.116 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.92 118.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.849 -1.167 . . . . 70.4 107.849 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 49.0 t -99.97 133.41 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.365 -0.976 . . . . 73.12 108.365 172.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.29 109.74 13.17 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.384 -0.969 . . . . 64.33 108.384 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -88.53 112.65 23.26 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.475 0.71 . . . . 74.41 110.051 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.7 t -101.27 126.31 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 74.5 108.564 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.0 m -129.42 134.3 47.77 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.97 0.508 . . . . 73.44 110.2 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.659 HG11 HD13 ' D' ' 126' ' ' LEU . 47.6 t -130.72 113.44 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.425 1.09 . . . . 60.41 108.892 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -103.87 101.12 10.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.465 0.706 . . . . 63.52 109.415 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.47 124.79 43.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.827 -0.435 . . . . 72.21 109.827 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.7 m -139.2 124.61 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.694 0.798 . . . . 73.05 108.894 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.6 103.36 15.96 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.771 -1.196 . . . . 75.44 107.771 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.19 -115.94 4.61 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.885 0.741 . . . . 75.24 112.465 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.47 5.0 51.75 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.741 0.816 . . . . 64.11 110.742 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -135.86 145.83 46.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.763 0.825 . . . . 63.34 110.473 -165.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -73.08 130.57 40.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.298 0.639 . . . . 61.13 111.334 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.477 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.36 -61.38 1.78 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.991 . . . . 30.21 108.679 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 74' ' ' PHE . . . . . 0.571 ' HE2' HD11 ' D' ' 126' ' ' LEU . 42.9 p90 -159.05 151.69 21.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.175 -1.375 . . . . 63.32 110.311 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 84.1 mt -113.65 151.49 31.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.489 1.116 . . . . 73.24 109.127 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.599 ' SG ' HG23 ' D' ' 114' ' ' ILE . 34.7 t -154.64 134.68 13.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.722 -0.473 . . . . 65.44 109.722 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.485 0.714 . . . . 73.31 109.832 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.44 121.09 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.61 0.764 . . . . 42.15 109.473 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.5 mt-30 -89.87 89.84 7.92 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.722 -0.844 . . . . 75.1 108.722 171.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 66.9 tp60 -80.22 93.39 5.86 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.821 -1.081 . . . . 70.13 109.107 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.6 140.38 17.25 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.36 -0.696 . . . . 70.12 111.36 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.19 128.09 3.58 Favored Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 110.189 -1.164 . . . . 34.24 110.189 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.2 mt -90.85 129.23 41.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.834 -0.802 . . . . 71.12 108.834 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.516 ' HB2' HD11 ' D' ' 86' ' ' ILE . 22.1 m-85 -132.48 158.26 42.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.353 0.408 . . . . 63.0 110.368 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 25.4 m -107.14 102.29 11.63 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.504 -0.924 . . . . 75.32 108.504 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.0 mp -107.51 113.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.818 -1.179 . . . . 74.0 107.818 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.608 ' HA ' HD11 ' G' ' 277' ' ' LEU . . . -142.57 124.79 15.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.177 0.591 . . . . 71.13 110.492 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.19 5.65 57.09 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.421 -0.655 . . . . 52.13 114.577 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.408 HD13 HG23 ' D' ' 86' ' ' ILE . 2.4 mp -114.96 126.39 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.69 -0.856 . . . . 74.41 108.69 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 -177.83 4.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.776 0.83 . . . . 74.12 110.56 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.59 -141.06 39.83 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.501 -0.772 . . . . 75.1 113.799 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.2 p -84.31 -13.5 52.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.635 0.774 . . . . 73.14 111.656 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.89 0.476 . . . . 74.33 110.403 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.471 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -69.95 -31.84 69.79 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 110.421 -0.214 . . . . 74.24 110.421 175.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.62 68.6 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.866 0.729 . . . . 75.02 111.218 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -72.62 -35.67 67.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.224 0.61 . . . . 61.11 110.204 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.25 -51.45 52.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.859 0.464 . . . . 74.22 110.908 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' G' ' 281' ' ' PHE . 2.9 pp -75.84 -19.74 58.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.755 0.422 . . . . 70.34 112.065 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -7.79 60.32 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.73 -0.483 . . . . 71.21 113.364 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.56 -62.6 0.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.342 0.571 . . . . 52.12 111.952 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -68.13 -52.33 36.02 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.424 0.527 . . . . 75.22 112.424 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 60.7 m -61.55 -43.81 89.9 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 123.673 0.789 . . . . 63.34 111.944 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.13 -46.52 32.08 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.13 1.887 . . . . 71.03 112.898 165.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -66.9 -15.79 63.89 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.442 0.697 . . . . 63.5 112.584 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -80.11 -49.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.464 -0.569 . . . . 72.42 109.464 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.3 mt -79.22 -28.91 42.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.73 0.812 . . . . 71.34 112.247 -169.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.93 -40.43 16.39 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.035 -0.983 . . . . 72.44 113.07 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -50.91 -43.52 46.83 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.282 1.988 . . . . 73.22 113.229 169.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -74.84 -37.08 62.35 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.477 0.711 . . . . 54.05 111.6 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.3 67.59 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.084 0.553 . . . . 74.22 110.281 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -43.6 79.72 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.905 1.378 . . . . 64.14 111.13 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -73.2 -36.48 66.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.779 0.832 . . . . 75.51 111.236 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -62.92 -44.92 94.77 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.893 0.477 . . . . 45.02 110.163 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.599 HG23 ' SG ' ' D' ' 76' ' ' CYS . 73.0 mt -61.83 -50.3 80.74 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.225 1.01 . . . . 71.52 110.213 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.568 HG23 ' HB3' ' D' ' 125' ' ' GLN . 30.4 m -50.84 -46.9 60.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.494 1.117 . . . . 73.33 111.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.8 t -73.53 -22.63 60.05 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.065 0.946 . . . . 35.2 112.635 -172.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.45 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.8 mtm -87.31 -43.46 12.14 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.062 0.458 . . . . 64.22 111.243 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.5 -34.45 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 114.691 -1.14 . . . . 72.02 110.382 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -66.55 -36.81 83.59 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.387 0.675 . . . . 74.23 111.405 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.5 mtt-85 -69.65 -26.74 64.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.143 0.577 . . . . 70.41 111.164 177.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 11.04 60.71 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-O 119.689 -0.506 . . . . 74.43 113.316 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.479 HG23 ' HB3' ' C' ' 17' ' ' TYR . 25.6 p 65.42 16.36 10.48 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.581 1.952 . . . . 71.13 112.921 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -96.31 165.66 15.79 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.707 1.203 . . . . 72.44 108.406 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.64 150.58 24.59 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.258 1.972 . . . . 74.1 112.628 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 125' ' ' GLN . . . . . 0.568 ' HB3' HG23 ' D' ' 115' ' ' THR . 70.1 mt-30 -57.54 135.25 56.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.144 0.578 . . . . 74.55 111.092 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.659 HD13 HG11 ' D' ' 64' ' ' VAL . 88.4 mt -106.33 93.32 4.54 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.367 -0.605 . . . . 62.02 109.367 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -100.43 100.36 11.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.474 -0.936 . . . . 71.22 108.474 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.47 HD21 HD12 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.39 132.79 48.36 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.961 0.904 . . . . 70.44 109.136 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.21 146.95 87.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.815 0.846 . . . . 62.13 111.615 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.05 111.54 2.02 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 121.939 1.759 . . . . 65.41 111.393 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 131' ' ' VAL . . . . . 0.511 HG22 HD22 ' G' ' 291' ' ' LEU . 77.1 t -106.65 124.99 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.375 -0.972 . . . . 75.31 108.375 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.02 92.41 5.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.242 0.617 . . . . 73.41 110.036 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -64.01 -33.11 74.99 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.023 0.929 . . . . 74.22 111.202 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -59.68 -54.04 50.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.862 0.865 . . . . 73.44 111.071 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.3 88.57 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.133 0.896 . . . . 71.42 111.592 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.92 -42.38 99.78 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.174 0.921 . . . . 73.42 111.536 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -69.74 -52.31 26.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.093 0.557 . . . . 75.03 110.272 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.0 mtm -66.2 -19.86 65.96 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.873 0.869 . . . . 73.32 111.825 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -66.27 -42.28 88.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.706 0.802 . . . . 52.51 109.877 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -63.97 -34.94 79.11 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.329 1.051 . . . . 75.25 111.322 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp -62.57 -28.55 69.95 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.821 0.848 . . . . 74.52 111.082 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -90.27 9.11 29.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.946 0.899 . . . . 62.31 111.63 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -126.71 45.83 2.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.499 0.72 . . . . 74.33 109.682 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -154.49 145.81 22.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.241 0.616 . . . . 71.12 110.138 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.31 19.66 2.76 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.19 0.596 . . . . 64.22 110.657 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.82 69.9 2.62 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.023 -0.831 . . . . 73.42 111.023 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.9 -48.71 80.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.014 0.925 . . . . 70.2 111.087 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 79.78 -49.73 3.73 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.015 -0.538 . . . . 65.22 114.281 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 79.0 p 55.52 89.2 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.565 1.546 . . . . 75.21 111.976 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -143.68 152.61 41.54 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.92 0.888 . . . . 74.45 109.28 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -73.19 164.27 26.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.414 0.686 . . . . 64.41 111.248 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -166.82 155.07 9.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.378 1.071 . . . . 73.22 108.415 -175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.62 146.34 53.95 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.766 -0.457 . . . . 74.53 109.766 171.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -116.84 154.49 30.66 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.496 0.718 . . . . 72.11 109.882 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.158 0 C-N-CA 124.531 1.132 . . . . 72.41 108.422 177.435 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.327 0.584 . . . . 73.54 110.143 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -86.83 123.2 31.71 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.315 -0.857 . . . . 71.33 108.997 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -78.18 81.1 4.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.031 0.92 . . . . 63.52 109.259 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -106.26 -161.89 0.82 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.35 -1.295 . . . . 74.04 108.186 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 275' ' ' LYS . . . . . 0.405 ' HG2' ' HA2' ' E' ' 279' ' ' GLY . 11.9 mptt -65.6 124.62 87.82 Favored Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 108.983 -0.747 . . . . 63.12 108.983 170.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.49 -49.73 6.89 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.74 2.294 . . . . 71.43 112.141 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 277' ' ' LEU . . . . . 0.567 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 52.2 mt -154.64 -43.71 0.09 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.067 1.747 . . . . 75.43 107.531 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 77.2 mt -66.26 88.54 0.12 Allowed 'General case' 0 C--N 1.358 0.953 0 C-N-CA 123.525 0.73 . . . . 51.15 110.76 174.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 279' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' E' ' 275' ' ' LYS . . . -96.0 -67.58 0.98 Allowed Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.757 -0.656 . . . . 73.5 111.922 177.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 40.0 tp -91.38 122.08 33.66 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.728 0.411 . . . . 63.42 111.865 -175.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 281' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 46' ' ' THR . 0.8 OUTLIER -177.74 138.5 0.21 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.363 1.865 . . . . 65.22 107.906 158.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -152.85 -161.67 1.34 Allowed 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.199 1.0 . . . . 74.54 108.795 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.19 78.49 0.7 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.875 -0.787 . . . . 62.14 108.875 173.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 57.63 -136.85 50.32 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 115.867 -0.606 . . . . 73.22 112.103 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -176.37 -61.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 107.036 -1.468 . . . . 72.01 107.036 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -83.86 124.22 75.06 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.933 -1.136 . . . . 64.3 107.933 170.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -26.52 62.32 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.55 2.167 . . . . 73.14 112.938 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 58.7 t 64.19 -76.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 125.154 1.382 . . . . 73.43 110.144 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 62.02 33.16 17.4 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.17 0.988 . . . . 72.2 110.363 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 72.0 m95 69.18 152.79 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.419 1.487 . . . . 72.34 111.402 -165.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.43 HD23 HG21 ' G' ' 309' ' ' THR . 9.8 mp -69.78 -40.31 76.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.313 -0.858 . . . . 75.23 110.826 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.58 -70.38 0.11 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.657 -0.977 . . . . 71.44 110.657 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 293' ' ' PRO . . . . . 0.445 ' HB2' HG12 ' G' ' 306' ' ' VAL . 6.6 Cg_exo -75.02 167.79 26.26 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.658 2.239 . . . . 73.21 111.362 172.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 294' ' ' LYS . . . . . 0.618 ' HD3' ' H ' ' A' ' 40' ' ' VAL . 22.1 ttmm -138.18 -62.18 0.59 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.774 0.83 . . . . 72.02 108.879 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 57.61 -87.16 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.077 1.351 . . . . 74.0 112.487 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 296' ' ' THR . . . . . 0.412 HG23 HD13 ' A' ' 126' ' ' LEU . 11.9 m 68.51 -65.17 0.28 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.552 1.541 . . . . 54.53 112.561 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.646 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 3.1 m-85 -85.7 -84.83 0.16 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.326 0.861 . . . . 65.04 113.326 -174.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 70.65 -55.77 0.62 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.381 1.472 . . . . 73.52 111.22 -164.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 299' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' G' ' 300' ' ' ASN . . . -160.26 -113.24 0.32 Allowed Glycine 0 C--N 1.345 1.067 0 CA-C-O 119.497 -0.613 . . . . 73.4 112.003 173.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 26.8 t30 69.04 -66.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.632 1.573 . . . . 74.13 111.522 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.757 HG23 HH22 ' B' ' 15' ' ' ARG . 27.4 mt -74.36 144.91 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.622 0.769 . . . . 71.44 111.451 -172.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 302' ' ' ASP . . . . . 0.415 ' HB2' ' HB2' ' G' ' 298' ' ' HIS . 44.0 t0 -156.93 169.93 23.67 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.924 1.29 . . . . 64.34 107.73 169.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -72.23 117.35 57.72 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 108.787 -0.82 . . . . 54.41 108.787 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -81.95 91.27 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.225 1.95 . . . . 71.33 109.99 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.62 76.51 3.3 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.41 -0.814 . . . . 63.3 110.79 -176.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 306' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' B' ' 12' ' ' GLN . 47.6 t -89.73 121.0 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.495 -0.928 . . . . 64.21 108.495 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 72.0 p -103.96 168.16 9.3 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.4 0.68 . . . . 75.32 111.325 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 78.8 m -58.65 99.99 0.06 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 124.17 0.988 . . . . 73.42 110.909 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' E' E ' 309' ' ' THR . . . . . 0.408 HG21 ' HB3' ' G' ' 291' ' ' LEU . 91.0 m -68.42 122.29 83.88 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.403 -1.271 . . . . 72.33 112.069 -171.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo . . . . . 0 C--N 1.38 2.189 0 C-N-CA 122.548 2.165 . . . . 70.44 111.021 166.824 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.491 -0.559 . . . . 74.41 109.491 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -68.85 -67.56 0.46 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.329 0.652 . . . . 72.24 109.843 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 67.11 -71.71 0.1 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.924 1.29 . . . . 75.2 112.011 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -131.79 161.9 31.8 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.072 0.949 . . . . 74.45 111.422 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -128.31 169.35 12.92 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.331 1.452 . . . . 63.4 108.808 171.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.68 -156.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.124 1.883 . . . . 62.12 111.966 169.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 35.9 tp -77.63 66.23 3.29 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-O 122.347 1.07 . . . . 74.12 108.487 173.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.638 HD22 HD22 ' C' ' 98' ' ' LEU . 1.6 tm? -175.35 97.24 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 105.891 -1.892 . . . . 74.42 105.891 -171.212 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -138.19 154.71 23.01 Favored Glycine 0 N--CA 1.47 0.962 0 CA-C-O 119.414 -0.659 . . . . 64.02 111.551 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 4.8 tt 57.53 77.27 0.28 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.108 0.963 . . . . 73.02 108.926 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -154.37 43.37 0.52 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.626 -0.716 . . . . 75.03 109.763 -176.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -129.94 125.32 35.19 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.554 0.742 . . . . 41.24 109.659 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -75.2 157.24 34.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.219 0.608 . . . . 74.0 109.994 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 147.71 -1.36 0.7 Allowed Glycine 0 N--CA 1.469 0.898 0 CA-C-N 116.003 -0.544 . . . . 62.04 112.102 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -124.17 137.43 54.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.204 1.002 . . . . 75.54 108.306 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 51.6 ttp 64.24 94.14 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.317 0 O-C-N 124.299 1.0 . . . . 72.43 110.091 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.26 94.32 0.2 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.621 2.214 . . . . 75.1 113.465 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 44.5 t -81.99 78.09 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.246 -1.02 . . . . 61.02 108.246 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -79.55 -64.58 1.15 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.688 -1.142 . . . . 62.12 110.187 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 290' ' ' TRP . . . . . 0.453 ' HE3' ' H ' ' F' ' 291' ' ' LEU . 0.8 OUTLIER -155.8 155.99 33.97 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.424 -0.807 . . . . 74.11 110.297 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.453 ' H ' ' HE3' ' F' ' 290' ' ' TRP . 2.4 mp -118.41 26.72 9.4 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.449 -1.25 . . . . 55.42 108.567 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -173.47 105.18 0.21 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 110.653 -0.979 . . . . 75.03 110.653 -173.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -85.23 98.62 0.66 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.863 2.375 . . . . 63.13 112.779 -168.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 294' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' F' ' 294' ' ' LYS . 35.0 mtmt 63.98 42.92 5.51 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.353 1.061 . . . . 72.32 111.388 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.59 41.03 0.61 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.905 0.482 . . . . 70.12 111.733 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 37.2 m -134.1 138.8 45.51 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.522 1.129 . . . . 61.11 109.418 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.455 ' H ' ' HG2' ' C' ' 124' ' ' PRO . 22.8 m-30 63.26 -97.16 0.06 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.256 1.422 . . . . 63.2 112.282 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 19.2 m170 56.42 -85.65 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.503 1.121 . . . . 74.25 113.156 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -91.39 38.33 3.23 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.477 -0.624 . . . . 73.4 114.086 -171.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 10.1 t30 67.74 143.05 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.754 1.221 . . . . 73.05 112.166 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 46.7 mt -71.91 -68.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.258 0.551 . . . . 75.24 109.787 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 11.9 t70 176.64 175.11 0.36 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.929 1.692 . . . . 73.14 107.388 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -135.21 148.79 67.92 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.48 0.712 . . . . 65.33 109.244 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 304' ' ' PRO . . . . . 0.434 ' HD3' ' HE2' ' C' ' 32' ' ' PHE . 30.1 Cg_endo -61.14 85.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 123.212 2.608 . . . . 71.01 113.448 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -103.11 3.97 36.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.148 0.979 . . . . 65.32 110.03 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 23.9 m -78.13 12.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.567 1.147 . . . . 71.34 112.688 -174.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 7.6 t -84.07 29.45 0.56 Allowed 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 125.162 1.385 . . . . 65.1 111.783 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 49.0 t -142.35 94.99 2.72 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.58 -0.7 . . . . 74.05 109.95 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 17.7 p -91.37 -47.48 0.35 Allowed Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 118.169 -0.919 . . . . 75.45 112.627 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 C--N 1.397 3.13 0 C-N-CA 122.77 2.313 . . . . 54.24 112.152 -177.135 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.709 0.29 . . . . 70.14 110.933 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -86.62 -4.92 59.24 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.565 0.746 . . . . 60.14 111.617 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -123.59 83.16 2.1 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.513 0.725 . . . . 74.34 109.295 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -86.29 140.68 29.87 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.895 -1.15 . . . . 61.03 107.895 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -120.06 152.97 55.05 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.22 -1.03 . . . . 64.41 108.22 177.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.71 82.32 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.405 2.07 . . . . 74.53 110.649 175.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' D' ' 87' ' ' ALA . 5.4 tt 66.26 -84.82 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.161 1.384 . . . . 75.41 110.121 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.9 112.39 25.0 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.861 -1.162 . . . . 54.32 107.861 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -164.1 26.93 0.21 Allowed Glycine 0 C--N 1.345 1.067 0 C-N-CA 121.589 -0.338 . . . . 64.02 113.76 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.49 80.29 1.66 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.77 -1.196 . . . . 70.52 107.77 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 281' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' D' ' 98' ' ' LEU . 2.3 t80 -147.49 43.22 1.1 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.847 -1.168 . . . . 72.01 107.847 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -82.36 -166.78 1.36 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.934 -1.485 . . . . 71.2 110.88 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.86 149.05 9.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.766 0.826 . . . . 74.32 112.409 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 142.34 -54.14 0.61 Allowed Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.809 -0.632 . . . . 65.32 111.678 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 61.79 -169.23 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.278 1.031 . . . . 64.35 111.395 -175.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 95.9 mmm -111.85 133.11 21.67 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.791 -0.818 . . . . 74.44 108.791 173.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.81 79.41 2.86 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.29 1.993 . . . . 65.53 111.012 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.74 -30.84 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.405 0.682 . . . . 74.44 110.602 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 64.74 -81.81 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.955 1.302 . . . . 62.02 111.196 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.91 -60.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.482 -0.933 . . . . 74.02 108.482 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 291' ' ' LEU . . . . . 0.511 HD22 HG22 ' D' ' 131' ' ' VAL . 10.2 mp 65.44 22.91 11.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.082 1.353 . . . . 74.24 113.17 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -132.34 140.62 11.97 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.011 -0.883 . . . . 74.43 112.197 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 293' ' ' PRO . . . . . 0.5 ' HG3' ' HA ' ' E' ' 306' ' ' VAL . 57.0 Cg_endo -71.77 119.97 6.57 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.68 2.253 . . . . 70.45 111.087 175.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -78.05 73.67 4.61 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.656 1.217 . . . . 75.44 110.904 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -142.24 33.44 1.51 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.733 -1.576 . . . . 72.43 107.786 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 8.3 m -63.66 -30.19 71.33 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.096 -1.411 . . . . 62.11 112.465 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.58 142.15 49.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 120.705 0.288 . . . . 74.35 111.087 -174.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 298' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' E' ' 302' ' ' ASP . 70.9 t60 -95.04 -15.39 23.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.549 0.739 . . . . 54.43 110.347 175.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 71.36 -132.47 20.83 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 119.334 -0.703 . . . . 74.43 112.627 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 300' ' ' ASN . . . . . 0.565 ' HB2' ' HA3' ' E' ' 299' ' ' GLY . 30.6 m-80 61.45 34.02 18.33 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.309 1.044 . . . . 75.41 111.322 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.635 HD13 HH12 ' C' ' 15' ' ' ARG . 1.9 pp -120.73 10.21 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 114.684 -1.144 . . . . 74.11 111.015 -176.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.57 -16.25 64.02 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.127 1.371 . . . . 72.32 112.341 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 303' ' ' LYS . . . . . 0.568 ' HD2' ' H ' ' G' ' 303' ' ' LYS . 0.0 OUTLIER -103.46 151.92 38.72 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.472 1.109 . . . . 63.44 109.695 178.304 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.25 179.78 6.19 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 123.035 2.49 . . . . 64.43 113.854 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -75.44 -56.13 5.01 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.812 0.845 . . . . 64.33 110.199 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' E' ' 293' ' ' PRO . 26.9 m -134.91 160.69 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.692 0.797 . . . . 71.13 110.157 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 4.5 t -145.31 95.3 2.65 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.663 0.785 . . . . 55.5 109.066 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' G' G ' 308' ' ' CYS . . . . . 0.663 ' H ' ' HB3' ' C' ' 12' ' ' GLN . 52.9 t 66.05 160.46 0.13 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.566 1.546 . . . . 63.51 112.346 -175.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 309' ' ' THR . . . . . 0.43 HG21 HD23 ' E' ' 291' ' ' LEU . 6.0 t -159.7 97.66 1.55 Allowed Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.283 0.633 . . . . 60.45 110.556 175.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 CA--C 1.562 1.895 0 C-N-CA 122.829 2.353 . . . . 73.35 111.665 168.187 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.67 0.271 . . . . 60.31 110.936 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -72.96 163.73 27.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.994 0.918 . . . . 62.41 110.365 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 75.36 -33.48 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.722 1.609 . . . . 61.14 111.818 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -64.77 156.26 31.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.852 0.861 . . . . 53.02 110.062 166.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -65.43 144.14 98.89 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 109.787 -0.449 . . . . 73.41 109.787 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.92 172.69 9.32 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.025 1.817 . . . . 74.53 110.917 167.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 277' ' ' LEU . . . . . 0.425 ' O ' ' SD ' ' B' ' 94' ' ' MET . 36.7 tp -58.19 -49.33 77.42 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.552 -0.536 . . . . 72.5 109.552 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.71 94.99 5.18 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.154 -1.054 . . . . 65.43 108.154 168.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -72.87 -49.51 17.02 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.958 -0.857 . . . . 64.12 110.958 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 3.8 pp -147.78 163.75 35.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.48 1.112 . . . . 64.51 109.234 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -82.16 -64.73 1.12 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.303 -0.628 . . . . 75.43 109.303 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -165.7 138.64 4.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.048 0.939 . . . . 72.41 108.775 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.63 125.11 39.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.369 -0.604 . . . . 75.23 109.369 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 155.84 -115.69 0.68 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.087 -1.205 . . . . 54.51 110.087 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -174.59 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.994 0.917 . . . . 54.52 108.622 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 61.96 76.92 0.37 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.445 1.098 . . . . 74.05 109.869 -168.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.77 65.93 8.69 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.914 2.409 . . . . 64.01 110.806 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.24 89.0 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.041 -0.981 . . . . 65.33 109.415 -175.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -94.89 173.71 7.45 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.148 -1.387 . . . . 75.42 107.669 170.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 290' ' ' TRP . . . . . 0.509 ' HZ3' ' HA ' ' B' ' 128' ' ' LEU . 94.9 m95 -58.02 113.73 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.421 0.629 . . . . 72.52 111.932 176.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' B' ' 129' ' ' ALA . 3.0 mp -77.34 -13.01 60.02 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.321 -1.308 . . . . 73.45 110.884 -173.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -156.13 -82.0 0.04 OUTLIER Glycine 0 C--N 1.353 1.506 0 CA-C-O 118.921 -0.933 . . . . 61.51 112.888 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -58.51 129.58 33.22 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.629 2.886 . . . . 64.14 113.366 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.1 99.91 12.83 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.72 -0.845 . . . . 65.34 108.72 176.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 72.07 172.57 0.31 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.3 1.44 . . . . 72.34 113.232 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 296' ' ' THR . . . . . 0.425 HG23 ' HB2' ' B' ' 126' ' ' LEU . 8.8 m -71.85 -39.97 69.36 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.971 -1.013 . . . . 63.33 110.382 177.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.566 ' HH ' ' HD1' ' B' ' 123' ' ' PHE . 87.1 m-85 -87.21 91.71 8.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.006 -0.997 . . . . 72.1 110.523 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -82.53 -54.86 4.84 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.677 -0.692 . . . . 53.31 109.59 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.29 49.97 1.48 Allowed Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.235 -0.439 . . . . 63.52 112.761 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 64.27 178.11 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.928 1.291 . . . . 54.24 112.881 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 20.2 tt -82.06 -12.9 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 115.57 -0.741 . . . . 71.12 110.632 171.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.66 93.76 0.39 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.765 0.826 . . . . 73.3 112.213 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -115.7 148.75 41.81 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.231 -1.396 . . . . 70.43 107.231 158.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.82 -1.52 5.18 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.752 2.301 . . . . 64.11 114.686 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 68.26 -172.58 0.19 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.961 1.304 . . . . 55.22 111.337 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 20.4 m -84.55 133.8 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.224 0.535 . . . . 71.01 110.034 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 54.4 m -82.34 143.66 31.1 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.864 0.866 . . . . 73.1 110.865 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 26.5 p -66.01 111.89 3.57 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 108.392 -0.966 . . . . 70.52 108.392 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 33.1 p -62.41 117.34 29.74 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.221 0.608 . . . . 74.5 110.456 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.381 2.259 0 C-N-CA 122.683 2.256 . . . . 71.33 112.394 -177.216 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.062 -0.018 . . . . 74.32 110.999 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 p -62.39 115.16 3.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.342 0.657 . . . . 74.4 110.389 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.566 ' HG3' ' H ' ' A' ' 5' ' ' ASN . 10.5 tp10 -80.72 143.27 33.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.685 0.794 . . . . 75.52 112.983 -166.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.41 1.37 25.64 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.681 1.192 . . . . 70.22 111.553 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASN . . . . . 0.566 ' H ' ' HG3' ' A' ' 3' ' ' GLU . 45.7 t-20 -67.76 112.81 5.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.266 0.626 . . . . 64.51 110.115 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -91.79 132.95 36.05 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.533 -0.758 . . . . 44.33 109.092 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 m -76.33 82.28 3.08 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.473 0.654 . . . . 54.15 110.804 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -124.04 101.02 7.01 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.358 -1.349 . . . . 73.22 107.358 173.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 9' ' ' MET . 2.0 mpp? -64.47 133.89 53.38 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.45 0.468 . . . . 55.14 110.592 -171.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.2 m -140.22 124.02 17.34 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.088 -0.708 . . . . 74.35 109.088 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.481 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 20.4 t80 -136.76 120.83 17.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.824 -1.176 . . . . 74.4 107.824 171.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 45.9 tp60 -142.83 108.25 5.04 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.087 -0.708 . . . . 71.11 109.087 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.521 HG12 ' HD2' ' A' ' 84' ' ' PHE . 20.0 mt -71.03 125.2 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.2 -0.455 . . . . 63.13 109.91 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -101.23 -31.89 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.975 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -179.27 132.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 119.369 -0.348 . . . . 72.35 110.996 -167.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.418 HD13 ' HG3' ' C' ' 130' ' ' PRO . 3.6 mp -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 107.417 -1.327 . . . . 61.31 107.417 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 23.5 p90 -164.06 167.53 20.22 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 122.218 1.009 . . . . 62.33 111.299 -174.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.5 109.09 21.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.038 -1.437 . . . . 65.22 108.674 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.9 mtpt -78.26 -29.97 48.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.105 0.479 . . . . 62.13 109.791 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.33 141.4 27.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.902 -1.045 . . . . 75.35 109.616 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 61.8 mt -137.54 136.68 46.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.077 -1.823 . . . . 73.22 106.077 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -148.08 125.59 11.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.66 -0.867 . . . . 75.02 108.66 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.0 t80 -127.18 140.15 52.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.18 -1.415 . . . . 71.31 107.18 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -134.74 151.58 51.09 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.752 -0.832 . . . . 65.11 108.752 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.24 73.96 11.87 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 105.682 -1.97 . . . . 73.31 105.682 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.66 -43.02 10.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.893 2.396 . . . . 75.32 113.197 -165.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.34 30.19 5.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.971 -0.751 . . . . 61.13 108.971 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.38 -57.92 7.62 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.595 -1.193 . . . . 75.14 113.052 -174.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 45.0 Cg_exo -55.74 -20.31 27.8 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.979 2.453 . . . . 75.12 113.722 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -98.96 -38.14 9.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.018 0.927 . . . . 73.13 110.798 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.85 -15.4 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.074 0.549 . . . . 72.45 111.444 -164.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.73 -30.95 71.97 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.081 0.553 . . . . 53.52 111.193 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -90.93 -7.12 52.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 112.363 0.505 . . . . 73.05 112.363 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -64.01 173.05 2.02 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.016 1.117 . . . . 72.11 114.016 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.45 159.12 30.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.928 1.291 . . . . 74.31 111.691 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -94.14 64.46 3.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.063 0.459 . . . . 74.32 110.166 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -142.81 82.84 11.95 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.918 0.887 . . . . 61.12 109.241 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.57 138.44 13.64 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 121.735 1.623 . . . . 64.42 110.891 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -92.57 82.58 4.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.978 -1.86 . . . . 71.25 105.978 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 65' ' ' THR . 10.2 m -82.53 114.65 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.993 -1.458 . . . . 42.32 109.382 -176.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -121.48 143.95 48.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.753 0.821 . . . . 74.21 109.96 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -112.97 118.91 36.15 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.865 0.866 . . . . 73.21 109.786 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -107.41 143.13 36.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.594 -1.261 . . . . 64.25 107.594 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.59 129.24 32.61 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.728 -0.842 . . . . 54.33 108.728 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.3 m-20 -117.74 120.81 39.09 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.738 -1.208 . . . . 74.52 107.738 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -107.29 121.81 45.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 75.33 108.627 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.0 140.33 28.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.991 0.517 . . . . 62.44 110.377 -173.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 p -130.35 158.79 38.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.415 0.686 . . . . 74.22 110.616 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 154.98 39.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.336 1.054 . . . . 73.14 109.534 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -103.76 105.61 15.87 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.693 -0.855 . . . . 75.41 108.693 172.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.0 mt -79.22 -38.2 36.29 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.221 0.609 . . . . 74.23 110.55 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.62 -178.19 6.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.333 1.053 . . . . 63.23 109.246 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.47 123.15 18.89 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 71.18 -9.81 0.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.019 1.728 . . . . 75.53 112.771 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.67 110.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 N-CA-C 108.385 -0.969 . . . . 71.24 108.385 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -125.3 164.13 21.02 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.703 0.801 . . . . 70.14 109.536 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.0 tt0 -131.69 142.73 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.693 0.797 . . . . 65.15 109.449 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.36 132.52 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.601 -1.259 . . . . 74.24 107.601 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.2 t -125.08 131.36 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 123.625 0.77 . . . . 74.4 108.934 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 106' ' ' LEU . 3.9 mm? -117.99 106.0 12.47 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.106 -1.072 . . . . 73.12 108.106 177.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.594 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 23.9 ttp180 -83.82 102.63 12.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.151 -1.055 . . . . 54.44 108.151 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.31 119.75 39.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.995 -1.483 . . . . 70.41 106.995 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 44.0 m -118.97 122.64 42.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.344 -0.613 . . . . 72.11 109.344 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.85 HG11 HD21 ' A' ' 126' ' ' LEU . 28.9 t -118.52 108.99 25.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.652 -0.87 . . . . 62.53 108.652 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.0 m -107.63 137.4 45.73 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.537 -0.542 . . . . 71.02 109.537 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.95 105.25 8.78 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.362 -0.977 . . . . 63.41 108.362 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -114.2 127.56 55.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.996 0.519 . . . . 72.24 110.796 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.12 85.19 2.09 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.91 -1.145 . . . . 65.43 107.91 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -111.29 3.23 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.562 -1.015 . . . . 73.15 110.562 -171.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -100.8 -8.49 22.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.058 0.543 . . . . 74.44 110.512 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -102.26 97.71 7.95 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.753 0.821 . . . . 60.43 110.383 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -66.86 124.29 22.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 122.911 0.484 . . . . 73.42 110.823 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -67.64 -57.3 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.203 1.001 . . . . 54.13 109.974 175.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -157.48 158.85 36.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.528 -1.215 . . . . 62.44 112.204 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.6 tp -126.89 135.17 50.57 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.95 1.3 . . . . 64.14 108.035 171.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 118' ' ' VAL . 51.2 m -130.64 97.75 4.45 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.404 -0.591 . . . . 71.33 109.404 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -116.9 116.28 27.12 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.021 0.929 . . . . 74.43 109.392 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -133.94 110.94 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.784 0.834 . . . . 70.42 109.215 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -84.93 89.31 7.55 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.684 -0.858 . . . . 74.45 108.684 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 61.0 tp60 -80.86 96.69 7.09 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.506 -0.77 . . . . 70.32 109.048 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.99 151.52 22.21 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.48 -0.782 . . . . 72.45 111.92 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -153.19 124.55 1.61 Allowed Glycine 0 CA--C 1.509 -0.309 0 N-CA-C 111.302 -0.719 . . . . 44.45 111.302 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -85.14 124.59 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.208 0.603 . . . . 70.31 109.763 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HD2' HG12 ' A' ' 13' ' ' ILE . 37.9 m-85 -132.94 119.87 20.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.764 -1.198 . . . . 63.0 107.764 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 25.8 t -82.19 98.61 8.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 109.493 -0.558 . . . . 65.52 109.493 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.55 HD13 HD21 ' A' ' 98' ' ' LEU . 45.3 pt -103.49 147.46 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.999 0.919 . . . . 74.35 110.411 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -169.68 161.08 9.19 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.228 0.611 . . . . 41.11 111.863 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.31 -33.96 3.54 Favored Glycine 0 C--N 1.356 1.655 0 CA-C-N 115.605 -0.725 . . . . 75.24 113.964 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.422 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.1 pp -117.04 135.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.877 0.871 . . . . 64.34 109.432 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -139.56 175.86 9.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.376 0.67 . . . . 71.43 110.326 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' E' ' 275' ' ' LYS . . . 62.59 -115.32 7.85 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.77 0.669 . . . . 65.3 112.831 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.1 t -74.58 -30.46 61.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.54 0.736 . . . . 74.33 111.567 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -67.32 -37.5 83.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.536 -0.757 . . . . 73.14 109.562 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.431 ' HG2' ' HG ' ' A' ' 98' ' ' LEU . 3.4 ttp -82.3 -24.45 34.65 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.311 -0.859 . . . . 74.45 110.833 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.731 ' HA ' HD22 ' E' ' 280' ' ' LEU . . . -66.48 -34.74 78.6 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.086 0.402 . . . . 75.44 112.086 -177.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -77.28 -30.77 54.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.559 -0.292 . . . . 74.24 110.34 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.39 -65.05 0.76 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.582 0.353 . . . . 70.2 110.951 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.55 HD21 HD13 ' A' ' 86' ' ' ILE . 14.7 mt -75.66 -23.81 56.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.742 0.417 . . . . 65.41 111.739 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.94 -5.97 59.44 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.313 -0.715 . . . . 34.51 114.751 -172.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.41 -57.78 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.992 0.896 . . . . 72.13 112.319 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 89.8 t80 -68.4 -54.89 14.15 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.245 0.618 . . . . 73.42 112.066 -171.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.0 m -71.01 -33.16 2.71 Favored Pre-proline 0 CA--C 1.569 1.674 0 C-N-CA 123.673 0.789 . . . . 64.25 112.876 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.96 -41.96 60.87 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.493 2.128 . . . . 64.13 113.154 160.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -70.87 -14.03 62.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.384 0.674 . . . . 64.11 111.766 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -78.86 -41.39 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.98 -0.748 . . . . 75.32 108.98 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.9 mt -84.33 -30.21 25.69 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.059 0.944 . . . . 72.44 113.189 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -64.94 -38.63 30.97 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.037 -0.983 . . . . 75.43 113.537 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.54 -38.45 93.8 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.923 1.749 . . . . 74.24 113.25 171.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -73.84 -37.45 64.81 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.985 0.514 . . . . 75.45 111.141 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -44.6 91.55 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.777 -0.453 . . . . 45.12 109.777 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -52.51 -53.58 44.09 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.777 1.298 . . . . 74.11 110.72 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -68.19 -38.92 82.52 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.242 0.964 . . . . 73.4 111.374 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.5 t -61.79 -32.25 72.53 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.978 0.511 . . . . 74.1 110.648 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 118' ' ' VAL . 84.9 mt -74.34 -52.94 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.287 -0.869 . . . . 74.22 110.323 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.7 m -55.28 -41.56 72.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.223 1.009 . . . . 72.22 111.297 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -64.96 -44.86 88.0 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.72 -1.127 . . . . 72.34 110.776 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.4 mtm -64.52 -38.59 91.56 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.689 0.395 . . . . 75.15 111.492 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.2 t -64.36 -42.01 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.664 0.785 . . . . 74.52 110.704 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.3 p -72.4 -30.73 64.92 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.09 -0.505 . . . . 73.35 110.907 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -68.3 -25.32 65.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.594 0.758 . . . . 70.33 110.882 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 7.51 65.36 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.595 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 m 61.86 35.49 16.45 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.255 1.422 . . . . 73.01 110.945 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -107.31 160.89 24.87 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.064 0.946 . . . . 65.2 109.723 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.25 146.22 61.91 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.242 1.961 . . . . 73.13 111.522 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.11 148.19 48.63 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.775 0.322 . . . . 74.32 110.3 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.85 HD21 HG11 ' A' ' 64' ' ' VAL . 48.7 tp -113.72 113.48 25.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.004 0.522 . . . . 65.43 110.127 -177.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -114.17 114.19 25.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.653 -1.24 . . . . 71.23 107.653 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 128' ' ' LEU . 3.9 mm? -74.4 135.14 42.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.92 0.391 . . . . 70.34 110.152 174.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -71.87 132.23 85.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.935 -0.575 . . . . 51.24 110.368 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -77.54 116.95 4.17 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.505 2.136 . . . . 74.02 111.515 -177.012 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.512 HG22 HD21 ' E' ' 291' ' ' LEU . 48.3 t -101.76 135.36 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.189 0.596 . . . . 72.54 109.953 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -76.78 69.94 3.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.334 1.054 . . . . 74.54 110.605 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -56.08 -38.74 71.09 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.247 1.019 . . . . 75.1 111.749 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -65.51 -35.36 80.66 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.487 -1.233 . . . . 53.53 111.917 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -71.19 -34.17 70.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.049 0.54 . . . . 34.14 111.307 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.3 mp -61.72 -42.89 99.55 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.81 0.444 . . . . 75.43 110.204 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -63.04 -31.55 72.72 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.038 0.935 . . . . 73.03 110.345 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.3 mmt -75.93 -35.25 59.8 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 116.009 -0.541 . . . . 72.54 111.398 175.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 30.2 m-80 -61.31 -39.68 91.37 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.506 0.322 . . . . 73.33 110.933 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CE2' ' HB ' ' C' ' 149' ' ' THR . 83.9 t80 -67.3 -43.98 80.34 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.377 0.423 . . . . 62.23 110.406 171.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.4 tp -57.67 -51.57 69.0 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.106 0.879 . . . . 71.11 111.569 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 175.31 30.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 125.259 1.423 . . . . 72.31 109.843 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.5 OUTLIER 65.41 -83.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.713 1.205 . . . . 64.1 108.238 -169.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -158.83 164.45 35.74 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.948 1.299 . . . . 74.41 109.155 173.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.5 114.97 17.43 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.956 0.903 . . . . 74.43 108.785 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.5 156.08 38.5 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.766 -0.533 . . . . 61.24 111.766 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -74.92 0.08 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 122.973 0.509 . . . . 74.12 110.258 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 56.46 29.39 57.17 Favored Glycine 0 C--N 1.361 1.962 0 N-CA-C 113.972 0.349 . . . . 72.31 113.972 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -119.25 102.6 8.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.497 1.119 . . . . 53.42 110.111 -171.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -95.36 132.33 40.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.309 0.644 . . . . 75.21 109.422 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.97 150.22 43.27 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.761 0.824 . . . . 61.21 109.534 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -85.09 125.2 32.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.824 0.45 . . . . 65.21 109.865 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -66.03 -61.29 2.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.99 0.916 . . . . 72.22 112.394 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -157.52 141.91 16.33 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.97 0.508 . . . . 73.43 109.885 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 C-N-CA 123.454 0.702 . . . . 61.34 109.652 179.66 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.765 -0.457 . . . . 74.24 109.765 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.3 p -167.19 142.86 4.16 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.39 1.076 . . . . 72.13 109.178 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -167.39 153.68 7.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.97 0.908 . . . . 73.45 109.786 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.417 ' H ' ' HD1' ' D' ' 140' ' ' TYR . 74.6 mt-30 -79.31 77.12 5.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.998 -1.112 . . . . 64.31 107.998 169.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.52 115.13 8.41 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.014 -0.993 . . . . 70.31 111.202 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -163.21 142.54 8.59 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.383 1.073 . . . . 70.42 108.306 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -110.06 143.25 40.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.1 0.56 . . . . 70.4 109.61 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.3 176.87 7.73 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.862 0.865 . . . . 71.22 110.446 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 21.9 ptm 43.86 -153.04 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 125.575 1.55 . . . . 73.04 111.969 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.9 m -143.52 114.94 8.02 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.536 -0.913 . . . . 72.53 108.536 167.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PHE . . . . . 0.41 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 49.4 t80 -135.32 132.8 38.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.828 0.851 . . . . 74.35 109.492 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.583 ' HB3' ' HB ' ' E' ' 309' ' ' THR . 9.3 pt20 -156.41 140.17 16.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.942 0.897 . . . . 71.44 109.022 173.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.71 135.42 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.834 -1.173 . . . . 61.15 107.834 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -93.19 -53.84 3.95 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.858 -0.423 . . . . 61.23 109.858 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' E' ' 304' ' ' PRO . 20.9 ttt180 -155.49 131.52 10.06 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.914 -0.402 . . . . 73.12 109.914 -172.037 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 83.7 mt -114.97 136.96 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.287 -1.746 . . . . 63.45 106.287 174.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -165.45 140.44 4.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.881 0.472 . . . . 74.25 111.142 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.0 m -73.47 117.85 15.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.873 0.869 . . . . 54.42 109.24 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -94.59 -22.41 18.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.471 0.708 . . . . 72.13 111.58 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.1 t70 -163.1 142.48 8.69 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.337 0.398 . . . . 65.05 110.473 -172.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.448 HD11 ' SG ' ' B' ' 113' ' ' CYS . 33.1 mm -137.27 141.59 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.975 1.31 . . . . 40.24 108.467 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.5 t -142.8 124.09 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.785 -1.191 . . . . 74.13 107.785 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -146.56 115.73 7.0 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 107.274 -1.38 . . . . 72.52 107.274 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -119.91 158.81 25.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.448 0.699 . . . . 64.55 109.513 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -149.99 78.19 8.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.664 -1.235 . . . . 70.33 107.664 175.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.88 -22.65 42.19 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.936 2.424 . . . . 53.31 112.675 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -122.97 24.55 8.92 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.959 . . . . 73.1 109.663 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.42 -50.16 59.26 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.744 1.387 . . . . 71.3 114.744 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -28.7 2.77 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 121.849 1.7 . . . . 54.54 112.789 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 51.5 m80 -96.18 4.67 52.27 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.354 1.061 . . . . 71.14 112.09 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.31 -26.25 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.632 0.773 . . . . 75.42 110.788 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' B' ' 35' ' ' ASP . 30.2 t80 -69.0 -16.09 63.64 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.104 0.779 . . . . 72.31 113.104 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.2 pt20 -73.16 -47.08 46.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.065 0.393 . . . . 75.53 110.73 176.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.52 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 45.4 pttt -112.62 66.79 0.65 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.548 -1.279 . . . . 75.21 107.548 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.57 ' HB2' ' HA ' ' B' ' 32' ' ' PHE . 39.1 t70 -96.86 108.47 21.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.275 -0.875 . . . . 73.51 111.563 -164.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.514 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.8 OUTLIER 177.74 -170.86 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.597 1.186 . . . . 73.03 109.437 163.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.89 116.77 7.59 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.096 0.958 . . . . 73.3 111.995 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.65 156.73 18.68 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.651 2.234 . . . . 72.43 111.464 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.03 102.19 0.47 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.123 -1.066 . . . . 73.13 108.123 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.4 151.16 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.066 -0.97 . . . . 61.22 109.632 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -139.12 137.42 36.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.34 0.656 . . . . 74.2 109.621 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.511 HD12 HD11 ' B' ' 128' ' ' LEU . 2.4 tt -93.18 126.11 38.12 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.148 -1.427 . . . . 62.43 107.148 167.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.4 t0 -131.34 145.21 51.75 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 106.547 -1.649 . . . . 73.3 106.547 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.62 133.27 28.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.667 -0.864 . . . . 73.31 108.667 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.7 t70 -124.3 134.38 53.22 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.694 1.198 . . . . 74.44 108.701 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -107.9 108.25 19.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.455 0.702 . . . . 64.42 109.759 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.91 119.3 32.22 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.538 -0.912 . . . . 72.21 108.538 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.2 p -139.15 166.08 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.141 0.577 . . . . 73.13 110.688 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.2 p -151.16 165.99 32.22 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.136 0.974 . . . . 72.35 109.146 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -115.07 107.74 15.74 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.454 -0.943 . . . . 72.21 108.454 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.11 -42.52 84.39 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.585 0.754 . . . . 75.11 110.892 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.77 -170.98 3.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.667 0.787 . . . . 43.43 110.363 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.41 114.39 5.4 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.226 -0.897 . . . . 75.21 109.517 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 73.22 -6.69 1.67 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 126.332 1.853 . . . . 70.41 113.202 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.74 120.59 52.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 109.151 -0.685 . . . . 73.31 109.151 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' TYR . . . . . 0.528 ' HE2' ' HB2' ' H' ' 278' ' ' LEU . 36.9 m-85 -114.11 173.11 6.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.605 -0.725 . . . . 73.21 110.945 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -142.17 95.19 2.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 105.541 -2.022 . . . . 74.52 105.541 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.35 122.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.03 0.932 . . . . 62.12 109.09 -175.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -111.7 143.47 21.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.57 0.748 . . . . 75.31 109.454 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' B' ' 103' ' ' PRO . 93.6 mt -120.1 112.43 19.11 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.753 -0.462 . . . . 43.21 109.753 174.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.7 ttm-85 -86.6 107.24 18.07 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.155 -1.054 . . . . 73.43 108.155 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 105.54 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.27 -1.382 . . . . 75.01 107.27 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 63' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 28.6 m -96.48 137.79 35.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.447 -0.797 . . . . 74.43 108.994 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -134.62 101.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.887 -1.153 . . . . 64.23 107.887 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.5 m -98.08 141.58 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 72.1 109.516 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.73 148.44 52.58 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.02 -0.733 . . . . 75.31 109.02 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -157.39 128.61 6.76 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.368 0.417 . . . . 52.34 111.238 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.671 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -127.84 143.19 51.12 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.552 0.741 . . . . 63.31 109.917 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.25 -112.24 3.51 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.929 -0.869 . . . . 53.12 110.929 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -123.86 6.1 8.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.966 0.906 . . . . 73.34 109.922 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 71' ' ' GLU . . . . . 0.52 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 8.8 pt-20 -149.28 -178.98 6.71 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.625 0.37 . . . . 74.41 111.209 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -64.6 147.69 52.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.685 1.194 . . . . 72.33 111.674 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.671 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -96.34 -63.49 1.14 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.111 -1.07 . . . . 75.43 108.111 171.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -152.78 163.66 39.28 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.622 -1.626 . . . . 73.41 108.041 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -125.84 144.69 50.55 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.736 1.215 . . . . 75.4 108.543 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' CYS . . . . . 0.492 ' SG ' HG23 ' B' ' 114' ' ' ILE . 33.8 t -147.44 144.08 28.37 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.53 -0.915 . . . . 61.31 108.53 173.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.1 tt0 -164.95 138.98 4.95 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.171 -0.677 . . . . 71.43 109.171 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' B' ' 113' ' ' CYS . 97.4 t -132.07 148.07 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.675 0.79 . . . . 73.5 109.257 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 79' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 41.5 mt-30 -122.6 103.17 8.51 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.407 -0.96 . . . . 70.11 108.407 168.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.05 105.29 17.3 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.14 -1.059 . . . . 51.41 108.14 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 155.0 24.18 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.205 -0.758 . . . . 61.55 111.205 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 125.29 1.72 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.566 -0.614 . . . . 65.13 111.566 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.28 126.36 40.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.055 -1.091 . . . . 73.42 108.055 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.74 162.57 28.12 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 74.53 108.988 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 48.7 m -132.5 113.26 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.083 -0.71 . . . . 71.1 109.083 168.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.462 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.9 pt -119.17 137.85 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.919 0.888 . . . . 63.33 110.084 -177.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.23 164.0 39.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 71.44 109.743 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.63 -47.46 3.6 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.242 -0.435 . . . . 73.31 112.493 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' B' ' 94' ' ' MET . 19.9 pt -64.04 148.89 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.523 1.129 . . . . 74.42 113.211 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 15.4 pt-20 -157.36 162.7 39.07 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.306 1.042 . . . . 72.4 109.704 172.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.57 -115.07 6.61 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.398 0.436 . . . . 54.24 113.614 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.9 m -77.77 -28.88 50.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.413 0.685 . . . . 55.5 110.79 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 97.0 mt-30 -58.56 -42.15 87.26 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.053 0.541 . . . . 71.52 110.588 177.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.558 ' HA ' HD12 ' B' ' 89' ' ' ILE . 23.9 ttt -71.87 -41.54 67.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 74.43 110.767 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.55 82.54 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.783 0.677 . . . . 74.23 111.29 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 57.9 t-80 -79.54 -20.15 47.82 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.963 -1.017 . . . . 71.32 110.916 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -83.29 -67.05 0.82 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.293 0.237 . . . . 41.32 111.009 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.451 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.5 pp -83.92 -15.0 49.58 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.64 0.608 . . . . 75.12 112.64 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.64 -27.75 11.15 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.986 -0.341 . . . . 55.14 112.929 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -114.93 -60.24 1.91 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.252 0.621 . . . . 65.05 111.391 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.87 -46.0 66.46 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.195 0.598 . . . . 73.11 112.133 -170.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 62.6 m -68.38 -40.86 21.72 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.851 -0.595 . . . . 74.55 112.299 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.561 ' HA ' HD11 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -52.91 -39.9 77.16 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 122.273 1.982 . . . . 64.33 113.961 165.744 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -65.91 -16.43 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 111.715 0.265 . . . . 63.54 111.715 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.67 -55.76 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.368 0.667 . . . . 65.04 110.526 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' LEU . . . . . 0.435 ' HB2' HD12 ' B' ' 60' ' ' LEU . 91.0 mt -76.83 -25.32 53.09 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.265 0.626 . . . . 73.55 112.681 -169.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.7 -48.98 88.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 CA-C-O 117.72 -1.134 . . . . 70.41 113.628 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.92 -38.47 86.18 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.052 1.835 . . . . 51.44 113.374 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.469 ' HE2' HG21 ' D' ' 115' ' ' THR . 29.3 m-85 -65.3 -45.33 84.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.596 0.759 . . . . 74.02 110.296 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.19 79.82 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.791 -0.641 . . . . 65.21 111.044 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ttt-85 -61.2 -56.23 23.1 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.331 1.052 . . . . 55.15 111.106 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -36.86 85.03 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.517 0.511 . . . . 63.45 110.087 -176.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.0 t -69.44 -26.9 64.83 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 123.684 0.615 . . . . 74.42 111.503 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.492 HG23 ' SG ' ' B' ' 76' ' ' CYS . 81.7 mt -74.56 -52.35 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 122.889 0.475 . . . . 73.33 109.846 170.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 28.9 m -60.26 -27.74 67.49 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.053 0.941 . . . . 71.44 111.665 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.16 -48.73 64.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.632 0.773 . . . . 65.12 109.769 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -71.72 -32.2 67.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.921 0.488 . . . . 75.12 111.484 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.33 -38.94 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.228 0.611 . . . . 64.31 110.139 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.5 t -65.66 -38.99 90.87 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 71.33 111.166 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.435 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -67.66 -33.76 75.59 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.608 0.763 . . . . 62.33 110.356 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.82 11.66 61.59 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.875 -0.602 . . . . 73.13 112.963 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.2 p 56.97 29.69 16.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.735 1.614 . . . . 52.43 113.847 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -109.72 145.47 32.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.106 0.962 . . . . 74.12 109.045 172.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.571 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 61.6 Cg_exo -57.21 140.34 92.56 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.838 2.358 . . . . 65.12 113.843 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -65.43 160.01 22.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 113.476 -1.693 . . . . 74.21 112.695 -174.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.4 116.38 15.11 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.574 -1.269 . . . . 62.34 107.574 168.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -89.97 104.08 16.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 106.924 -1.51 . . . . 71.04 106.924 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 128' ' ' LEU . . . . . 0.511 HD11 HD12 ' B' ' 42' ' ' LEU . 16.0 tp -66.46 134.85 53.3 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.846 -0.616 . . . . 75.11 110.874 -172.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.14 137.97 94.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.228 1.011 . . . . 73.51 111.745 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.46 111.72 0.5 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.143 2.562 . . . . 72.34 112.013 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.15 108.13 18.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.14 -1.059 . . . . 61.24 108.14 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.47 77.24 2.6 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.436 -0.95 . . . . 61.42 108.436 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -70.74 -21.41 62.53 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.862 -1.063 . . . . 74.31 109.917 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.79 -46.07 86.87 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.815 0.846 . . . . 73.44 109.087 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.84 -32.59 70.81 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 114.838 -1.074 . . . . 74.23 112.011 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 136' ' ' LEU . . . . . 0.478 HD21 ' SD ' ' H' ' 286' ' ' MET . 7.3 tt -57.07 -50.43 72.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.544 0.737 . . . . 73.1 110.31 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -67.4 -33.56 75.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.278 0.631 . . . . 61.43 111.758 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.2 mmt -69.51 -33.77 73.31 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.139 0.576 . . . . 75.52 111.44 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -82.85 -14.81 53.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.453 0.701 . . . . 74.01 110.896 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -72.95 -29.71 63.3 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.247 -0.649 . . . . 74.51 109.247 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 58.2 mt -104.86 33.69 3.5 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.186 0.994 . . . . 74.21 109.957 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.72 93.71 1.68 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.077 0.951 . . . . 70.13 111.85 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -166.47 109.88 0.75 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.59 0.756 . . . . 65.24 109.35 171.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -156.66 130.67 8.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.361 0.665 . . . . 63.42 109.658 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.07 145.36 32.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.08 0.552 . . . . 52.54 110.76 173.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.41 139.71 14.58 Favored Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.487 -0.645 . . . . 73.13 111.487 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -97.8 130.84 44.71 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.465 0.706 . . . . 73.34 110.242 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.8 160.35 41.02 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.515 0.509 . . . . 71.41 112.189 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 50.2 m -103.04 108.8 20.11 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.477 -0.934 . . . . 74.45 108.477 172.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.6 104.83 2.92 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.822 -0.807 . . . . 61.13 108.822 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.33 90.16 0.1 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.821 -0.807 . . . . 51.41 108.821 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -68.24 102.45 1.37 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.52 -0.764 . . . . 72.11 109.933 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 17.4 tm0? -68.99 115.92 8.85 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.635 -1.617 . . . . 64.12 106.635 168.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.76 137.42 54.01 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.514 0.509 . . . . 73.11 110.522 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 123.429 0.692 . . . . 63.54 110.548 -178.023 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' C' C ' 1' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' C' ' 1' ' ' MET . 2.7 mpp? . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 109.023 -0.732 . . . . 70.22 109.023 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -67.63 126.28 28.86 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 122.991 0.516 . . . . 53.45 110.244 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.38 79.42 1.38 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.731 0.812 . . . . 71.0 110.079 175.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.18 89.59 5.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.828 -0.804 . . . . 73.22 108.828 -178.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -168.03 126.32 1.19 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.556 1.142 . . . . 75.42 108.726 178.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -161.81 125.68 3.22 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.982 0.913 . . . . 72.4 109.178 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 16.9 p -142.46 179.29 7.04 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.237 1.015 . . . . 72.11 110.101 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.47 159.37 34.61 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.13 0.572 . . . . 64.34 109.527 167.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.423 ' HB2' HG23 ' C' ' 89' ' ' ILE . 23.7 ttt 64.25 114.84 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.319 1.047 . . . . 70.15 111.651 -174.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 10' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 91.0 m -98.58 96.36 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.836 -0.801 . . . . 61.45 108.836 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 11' ' ' PHE . . . . . 0.596 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 57.1 t80 -99.38 128.38 45.49 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.652 -0.87 . . . . 74.35 108.652 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -152.79 136.74 16.31 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.262 -0.644 . . . . 60.35 109.262 175.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.409 ' HB ' HG21 ' G' ' 306' ' ' VAL . 66.7 mt -90.07 104.39 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.069 0.947 . . . . 74.14 109.745 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -73.56 -50.51 20.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.309 -0.256 . . . . 71.33 110.309 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -169.48 123.83 0.8 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.734 -0.469 . . . . 74.33 109.734 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -107.98 137.3 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.388 -0.967 . . . . 74.32 108.388 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.491 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 33.6 p90 -168.56 159.54 10.24 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.815 0.817 . . . . 72.35 111.09 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -77.5 114.32 16.21 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.138 -1.392 . . . . 72.33 108.763 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -68.89 -41.59 78.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.864 0.84 . . . . 61.24 109.469 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -145.23 140.85 28.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.033 -1.439 . . . . 75.53 109.058 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 65.6 mt -134.63 141.51 43.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.333 -1.358 . . . . 74.14 107.333 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -161.74 150.7 15.79 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.397 0.618 . . . . 72.41 111.276 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 88.4 t80 -141.86 131.0 23.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.584 -1.265 . . . . 53.41 107.584 173.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.2 mt-10 -123.73 123.73 41.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.351 0.66 . . . . 73.31 109.266 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.8 83.21 62.19 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 107.432 -1.321 . . . . 33.31 107.432 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.28 -35.45 62.69 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.708 2.272 . . . . 72.51 111.875 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -110.66 33.39 4.57 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.811 -1.086 . . . . 75.02 109.223 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.23 -50.19 48.8 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 114.299 1.222 . . . . 71.34 114.299 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 15.2 Cg_exo -66.47 -39.51 16.48 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 121.788 1.659 . . . . 75.33 112.971 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -67.2 -57.58 6.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.313 1.045 . . . . 62.2 112.333 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 31' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' C' ' 73' ' ' ALA . 46.0 t -54.91 -24.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 125.176 1.39 . . . . 73.12 112.877 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -51.95 -35.11 44.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.113 0.565 . . . . 62.32 112.05 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.48 45.9 0.95 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.666 0.787 . . . . 70.25 110.749 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -124.53 151.86 44.16 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.011 0.924 . . . . 71.13 110.82 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.37 131.84 33.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.384 1.074 . . . . 72.34 112.636 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -86.39 69.31 10.41 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.082 0.953 . . . . 74.22 111.253 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -158.13 77.87 3.44 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.313 0.645 . . . . 71.32 109.679 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.754 ' HG3' ' HB3' ' F' ' 297' ' ' TYR . 95.7 Cg_endo -90.83 154.13 4.06 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.814 2.342 . . . . 71.13 113.122 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.05 95.2 9.86 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.455 -1.313 . . . . 73.45 107.455 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.4 114.3 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.938 -1.028 . . . . 72.2 109.461 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.474 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 89.6 mttt -102.24 146.51 27.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.757 0.823 . . . . 61.13 109.752 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.34 123.42 39.36 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 106.836 -1.542 . . . . 72.34 106.836 171.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.53 104.19 7.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.832 -1.173 . . . . 74.25 107.832 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.42 154.5 17.17 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.036 0.534 . . . . 64.03 110.224 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 10.6 t70 -146.79 151.91 37.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.774 0.83 . . . . 75.25 109.036 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -121.52 122.01 38.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.296 0.638 . . . . 73.05 110.093 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.76 138.7 48.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.503 -0.925 . . . . 75.3 108.503 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 48' ' ' SER . . . . . 0.58 ' HB3' ' HE1' ' C' ' 56' ' ' TYR . 71.2 m -155.06 151.54 28.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.038 0.535 . . . . 72.43 110.692 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -152.91 138.07 17.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.077 0.551 . . . . 72.34 110.498 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.53 122.92 27.07 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.671 -0.492 . . . . 75.2 109.671 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' C' ' 57' ' ' GLU . 41.1 mt -95.44 -43.32 8.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.767 0.827 . . . . 73.12 111.103 -172.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -158.83 -168.1 2.3 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.676 0.79 . . . . 75.41 110.066 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.91 103.63 0.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.093 -0.958 . . . . 74.22 110.066 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 72.77 -6.35 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 126.126 1.77 . . . . 64.31 113.024 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 60.2 t -91.85 107.49 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.792 -1.188 . . . . 65.24 107.792 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 56' ' ' TYR . . . . . 0.58 ' HE1' ' HB3' ' C' ' 48' ' ' SER . 2.1 t80 -128.59 141.0 51.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.11 -1.07 . . . . 62.31 108.11 -173.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.2 tt0 -98.05 129.33 44.9 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.348 0.659 . . . . 70.14 110.829 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -110.35 114.69 47.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.08 -1.081 . . . . 74.44 108.08 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.21 135.84 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.831 -0.803 . . . . 55.43 108.831 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.16 109.38 12.81 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.945 -1.502 . . . . 74.52 106.945 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.2 ttm-85 -80.55 125.0 29.44 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.102 -0.703 . . . . 63.1 109.102 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' C' ' 114' ' ' ILE . 43.9 t -116.11 105.75 19.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.468 -1.308 . . . . 73.1 107.468 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.8 m -108.57 119.17 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.741 -0.837 . . . . 62.2 108.741 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.52 130.44 74.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.742 -0.836 . . . . 61.55 108.742 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 9.7 m -121.22 152.11 39.21 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.245 1.018 . . . . 61.51 109.309 -171.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.67 112.83 10.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.476 -1.305 . . . . 73.31 107.476 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -145.02 135.06 23.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.329 -0.619 . . . . 74.25 109.329 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.5 OUTLIER -120.23 57.01 0.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 122.216 1.008 . . . . 53.44 110.49 -173.76 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.29 -119.94 4.47 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.692 -1.594 . . . . 54.24 110.285 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.92 -30.59 18.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.855 -0.794 . . . . 65.25 108.855 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.436 ' HB3' HD12 ' C' ' 68' ' ' LEU . 11.7 tp10 -72.72 109.72 6.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.743 -1.117 . . . . 64.04 109.984 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -83.41 122.76 28.93 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.975 -0.75 . . . . 65.54 108.975 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.419 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -72.64 -54.77 8.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.407 1.067 . . . . 65.11 109.264 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -165.82 171.65 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.476 -0.784 . . . . 71.42 111.45 171.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -137.86 145.97 42.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.185 1.394 . . . . 74.53 107.242 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -152.85 121.39 6.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.044 0.537 . . . . 73.22 109.671 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.45 127.98 47.35 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.963 0.505 . . . . 73.3 110.285 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.91 124.46 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.895 -0.78 . . . . 74.2 108.895 169.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.551 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 23.3 mt-30 -96.62 105.52 17.63 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.988 -1.116 . . . . 71.33 107.988 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 68.7 tp60 -92.24 112.05 23.84 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.724 0.41 . . . . 72.31 110.656 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 155.5 23.75 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.93 -0.577 . . . . 60.32 111.92 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.95 116.62 0.74 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.825 -1.31 . . . . 41.44 109.825 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.516 HD12 HD11 ' C' ' 51' ' ' LEU . 19.4 mm -81.71 119.51 31.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.322 -0.992 . . . . 70.55 108.322 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -126.93 119.18 26.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.661 -1.237 . . . . 74.24 107.661 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -84.65 98.61 10.29 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.505 -1.294 . . . . 74.14 107.505 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' C' ' 10' ' ' THR . 0.2 OUTLIER -121.34 142.29 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.169 0.509 . . . . 74.43 111.242 -175.439 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.58 168.38 27.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.547 1.139 . . . . 62.1 109.416 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.77 -45.67 2.71 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.939 -0.464 . . . . 61.12 111.939 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' C' ' 93' ' ' GLN . 1.6 pp -80.93 145.66 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.482 0.713 . . . . 75.21 111.021 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -162.04 148.32 13.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.791 0.837 . . . . 71.0 109.081 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 -117.22 10.79 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.603 0.564 . . . . 52.12 113.328 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 56.6 p -65.12 -35.66 81.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.875 . . . . 74.3 111.532 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 93' ' ' GLN . . . . . 0.6 ' HB3' HG22 ' C' ' 89' ' ' ILE . 78.2 mt-30 -67.64 -43.3 80.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.92 -0.582 . . . . 61.24 110.623 178.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.491 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.5 ttt -75.78 -23.51 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.32 110.801 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.49 96.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.038 0.535 . . . . 74.53 110.674 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.25 -34.19 74.41 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.433 -0.803 . . . . 71.44 110.745 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -65.74 -61.26 2.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.797 -0.638 . . . . 71.43 111.317 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -87.08 -12.97 45.62 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.502 0.556 . . . . 72.35 112.502 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.15 8.02 60.62 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-O 119.584 -0.564 . . . . 60.32 113.36 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -154.79 -59.95 0.11 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.93 0.492 . . . . 64.22 111.273 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.53 -49.59 21.4 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.556 0.742 . . . . 75.13 112.094 -168.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 102' ' ' CYS . . . . . 0.596 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -69.86 -44.52 22.68 Favored Pre-proline 0 CA--C 1.561 1.401 0 CA-C-O 118.156 -0.926 . . . . 73.11 113.223 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' C' ' 102' ' ' CYS . 28.7 Cg_endo -61.59 -38.42 62.26 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 121.722 1.615 . . . . 74.05 111.259 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -62.95 -22.74 67.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.591 0.756 . . . . 75.04 112.392 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -73.32 -54.46 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 110.224 -0.287 . . . . 74.13 110.224 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 pp -87.16 -8.51 56.86 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.955 -0.566 . . . . 62.12 112.517 -170.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -58.44 -50.67 86.77 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.421 1.088 . . . . 64.24 113.303 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.51 -29.94 89.67 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 121.654 1.57 . . . . 63.15 113.189 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.68 -45.78 67.55 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.223 0.609 . . . . 74.32 110.462 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.63 91.95 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.547 0.739 . . . . 73.13 110.631 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 111' ' ' ARG . . . . . 0.533 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 36.1 ttt180 -61.78 -53.74 51.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.431 -1.713 . . . . 75.32 111.927 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.322 0.649 . . . . 71.1 110.315 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -67.91 -31.35 71.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.2 0.6 . . . . 73.43 111.449 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.431 HG23 ' SG ' ' C' ' 76' ' ' CYS . 83.2 mt -75.4 -49.97 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.617 0.767 . . . . 72.11 110.526 174.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -62.2 -29.37 70.33 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.515 0.726 . . . . 74.33 111.457 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -67.26 -49.69 63.41 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.56 -0.745 . . . . 74.14 109.622 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.672 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.04 -36.59 75.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.055 0.942 . . . . 63.43 112.615 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.4 t -64.88 -41.74 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.588 0.755 . . . . 75.01 110.346 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.1 p -74.91 -27.01 60.05 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.031 -0.532 . . . . 72.31 111.349 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -70.3 -39.44 74.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.835 0.854 . . . . 74.21 110.742 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 121' ' ' GLY . . . . . 0.491 ' HA2' ' H ' ' D' ' 18' ' ' THR . . . -83.89 10.06 61.23 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.045 -0.525 . . . . 61.43 113.461 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p 55.12 62.28 2.57 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 125.482 1.513 . . . . 73.35 111.718 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -126.59 154.39 75.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.867 1.267 . . . . 74.35 109.139 170.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.435 ' HD3' HD13 ' F' ' 301' ' ' ILE . 23.4 Cg_exo -64.32 167.8 13.99 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.276 2.651 . . . . 72.01 113.759 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 125' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 10.9 mm100 -56.26 123.64 15.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.571 1.148 . . . . 74.14 113.912 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.97 84.18 1.91 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.117 -1.438 . . . . 70.12 107.117 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 127' ' ' ASN . . . . . 0.537 ' ND2' ' HB3' ' C' ' 125' ' ' GLN . 25.6 m-80 -91.77 102.11 14.71 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.248 -1.019 . . . . 63.05 108.248 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 128' ' ' LEU . . . . . 0.533 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 14.8 tp -68.08 137.15 54.76 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 64.53 110.382 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.417 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -81.08 152.19 70.99 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.035 0.934 . . . . 64.03 111.146 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.467 ' O ' HG11 ' H' ' 306' ' ' VAL . 41.3 Cg_exo -50.11 142.19 28.43 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.16 2.573 . . . . 74.21 113.111 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.552 ' HA ' HG21 ' H' ' 309' ' ' THR . 22.0 t -123.11 110.29 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.779 -0.823 . . . . 72.14 108.779 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.615 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 3.5 m-20 -97.98 85.65 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.389 0.676 . . . . 71.43 109.922 -176.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 91.0 m-85 -69.59 -46.65 65.84 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.264 -0.426 . . . . 75.23 110.866 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.419 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 29.8 t70 -65.98 -48.35 71.53 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.72 -0.673 . . . . 72.45 110.801 -176.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 135' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -58.39 -21.02 48.87 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.147 0.904 . . . . 73.14 112.958 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.11 -56.66 4.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.913 0.885 . . . . 42.34 109.638 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -72.53 -47.31 49.37 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.041 0.756 . . . . 73.44 113.041 -171.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -25.75 60.6 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.911 0.885 . . . . 71.03 113.224 -170.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -50.79 -37.52 42.9 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.488 1.115 . . . . 74.22 113.767 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -34.09 -80.5 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 126.262 1.825 . . . . 61.34 114.365 -168.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.25 117.36 7.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 106.816 -1.55 . . . . 73.13 106.816 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 177.98 10.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.286 1.034 . . . . 63.13 109.617 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -152.65 150.66 29.72 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.171 0.588 . . . . 73.15 109.821 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -155.04 136.55 14.22 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.032 -0.729 . . . . 70.31 109.032 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.69 -167.94 1.96 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.342 0.657 . . . . 63.34 110.929 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.43 121.32 1.57 Allowed Glycine 0 C--N 1.35 1.324 0 C-N-CA 121.457 -0.402 . . . . 75.03 113.928 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -173.61 104.54 0.12 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.256 1.422 . . . . 75.31 107.965 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.46 75.42 2.14 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.968 -0.56 . . . . 70.54 113.706 -168.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 149' ' ' THR . . . . . 0.437 ' HB ' ' CE2' ' A' ' 140' ' ' TYR . 47.2 m -147.0 153.91 40.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.95 0.9 . . . . 62.53 108.572 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.48 179.2 9.35 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.851 0.86 . . . . 73.12 108.831 173.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -109.99 133.4 53.23 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.909 0.385 . . . . 54.33 110.456 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -89.92 134.59 34.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.6 0.76 . . . . 75.21 109.697 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' E' ' 287' ' ' PRO . 59.5 tt0 -123.66 93.41 3.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.477 -0.934 . . . . 42.44 108.477 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -75.67 96.27 3.56 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.951 -1.022 . . . . 71.24 109.741 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.03 0 CA-C-N 115.649 -0.705 . . . . 54.42 109.68 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.92 -0.4 . . . . 62.45 109.92 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 46.7 m -64.08 92.25 0.08 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.567 0.747 . . . . 72.34 111.304 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.57 74.22 8.58 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.682 -1.229 . . . . 72.43 107.682 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -176.76 150.59 0.83 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.987 -1.46 . . . . 51.55 108.772 -172.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -71.08 84.58 0.72 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.381 0.61 . . . . 70.42 110.223 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -146.61 -165.48 2.24 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.554 1.142 . . . . 63.05 109.616 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -78.17 70.62 4.56 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 121.88 0.848 . . . . 74.34 111.724 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -169.63 -166.31 0.58 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.965 1.706 . . . . 73.54 108.414 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -32.43 123.58 0.33 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.674 1.19 . . . . 71.23 113.383 168.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -149.39 141.53 23.98 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.841 0.857 . . . . 73.53 108.924 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -157.15 100.66 1.87 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.945 -1.131 . . . . 61.52 107.945 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.3 143.53 51.03 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.842 0.857 . . . . 71.33 109.221 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' D' ' 84' ' ' PHE . 47.7 mt -96.11 136.22 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.016 0.526 . . . . 51.15 109.754 175.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 14' ' ' GLN . . . . . 0.426 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.6 mt-30 -89.13 -42.1 11.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.978 -0.379 . . . . 62.15 109.978 172.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -176.03 153.64 1.34 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 65.31 110.919 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.842 -1.54 . . . . 73.32 106.842 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -149.43 170.81 17.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.173 0.987 . . . . 64.43 111.613 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 18' ' ' THR . . . . . 0.491 ' H ' ' HA2' ' C' ' 121' ' ' GLY . 68.4 p -105.09 117.65 34.54 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.312 -1.313 . . . . 71.11 109.726 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -85.6 -29.29 24.21 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.889 -0.596 . . . . 72.54 109.458 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 24.5 t70 -151.03 139.1 20.08 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.338 -1.301 . . . . 72.55 108.924 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.672 HD13 ' HE3' ' C' ' 117' ' ' MET . 92.1 mt -132.49 146.84 32.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.729 -1.211 . . . . 74.44 107.729 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.8 t -148.75 140.0 23.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.65 0.78 . . . . 53.11 109.715 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -149.35 117.67 6.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.372 -2.084 . . . . 74.23 105.372 167.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -121.88 135.64 54.9 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.966 -0.753 . . . . 70.21 108.966 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.04 83.45 55.66 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.371 -1.344 . . . . 72.11 107.371 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.38 -29.82 10.84 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.89 2.393 . . . . 63.01 113.558 -169.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -114.71 33.22 5.49 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.03 -0.73 . . . . 64.5 109.03 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.491 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -43.15 -62.33 1.39 Allowed Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.433 1.642 . . . . 61.33 115.433 -163.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.21 -15.61 7.69 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 121.794 1.676 . . . . 61.15 112.888 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 18.6 t-160 -68.18 -34.29 76.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.815 1.246 . . . . 63.42 109.079 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.565 HG13 ' HH2' ' D' ' 36' ' ' TRP . 55.8 t -68.44 -38.97 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.81 0.844 . . . . 71.24 110.398 175.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.416 ' HD1' HG12 ' G' ' 301' ' ' ILE . 24.5 m-85 -74.04 4.69 5.12 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.831 0.678 . . . . 72.42 112.831 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -87.04 -17.75 32.21 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.058 0.543 . . . . 73.03 111.181 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.648 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 29.5 mtpt -126.34 107.3 10.18 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.336 1.054 . . . . 73.54 110.656 -167.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.47 97.6 9.56 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 118.905 0.775 . . . . 65.33 111.295 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.648 ' HE1' ' HE2' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -136.4 176.67 8.48 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 71.02 110.4 175.397 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.43 111.82 39.63 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.046 0.938 . . . . 74.05 110.336 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.616 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.1 Cg_exo -64.35 140.07 68.47 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.049 2.499 . . . . 52.4 113.871 173.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 39' ' ' GLU . . . . . 0.45 ' H ' HD11 ' D' ' 68' ' ' LEU . 14.4 pt-20 -82.77 130.15 35.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.042 -1.095 . . . . 75.1 108.042 162.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.503 HG13 HG13 ' D' ' 64' ' ' VAL . 77.2 t -105.57 104.74 17.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 107.694 -1.224 . . . . 42.34 107.694 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.16 127.86 36.75 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.17 -0.307 . . . . 74.02 110.17 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -95.89 124.43 39.9 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.621 -1.251 . . . . 61.33 107.621 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -137.59 138.26 39.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.36 -0.978 . . . . 74.12 108.36 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.88 147.36 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.417 0.627 . . . . 75.2 110.945 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -133.07 137.52 46.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.823 -1.177 . . . . 72.52 107.823 170.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.1 p -105.16 144.16 32.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 51.23 110.205 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.33 145.08 23.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.462 0.705 . . . . 62.34 109.32 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -151.22 157.46 42.65 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.873 0.469 . . . . 74.24 109.973 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 6.4 m -147.82 149.62 32.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.98 -1.118 . . . . 71.22 107.98 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -101.1 118.03 36.18 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.56 -1.274 . . . . 55.11 107.56 161.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 mt -89.68 -34.02 16.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.805 -0.442 . . . . 62.41 109.805 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.68 -177.8 6.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.599 -0.728 . . . . 73.15 110.679 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.34 130.94 45.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.252 -0.885 . . . . 71.43 109.126 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 66.33 5.64 3.82 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.63 1.172 . . . . 72.52 112.4 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.86 123.32 71.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 C-N-CA 123.381 0.672 . . . . 63.44 109.937 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -128.11 127.34 42.86 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.316 -0.994 . . . . 61.21 108.316 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -88.15 143.0 27.31 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.776 0.831 . . . . 64.43 109.114 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 48.6 t -125.32 123.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.268 -1.012 . . . . 74.41 108.268 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 43.4 t -109.83 131.33 61.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.167 -1.049 . . . . 61.21 108.167 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -126.38 117.66 23.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.588 -0.893 . . . . 75.24 108.588 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.1 ttm-85 -95.64 106.93 19.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.78 0.832 . . . . 71.11 109.938 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -94.46 112.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.778 -0.823 . . . . 73.31 108.778 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -112.15 128.59 56.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.485 0.66 . . . . 70.44 109.868 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 64' ' ' VAL . . . . . 0.503 HG13 HG13 ' D' ' 40' ' ' VAL . 42.2 t -124.8 107.42 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.458 1.503 . . . . 72.14 108.649 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.9 m -106.02 117.46 34.09 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.904 0.881 . . . . 74.44 110.375 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.48 126.55 53.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.307 -0.627 . . . . 72.23 109.307 172.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.2 m -153.76 122.83 6.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.304 0.641 . . . . 52.11 109.344 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' D' ' 38' ' ' PRO . 2.5 mm? -130.49 135.46 47.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.795 0.838 . . . . 63.13 109.448 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 -116.39 4.93 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.972 -0.851 . . . . 45.12 110.972 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.03 8.3 8.64 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.998 -0.742 . . . . 63.01 108.998 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.46 155.87 33.98 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.651 0.78 . . . . 61.02 110.793 -173.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -82.64 129.14 34.9 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 72.23 110.529 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -69.33 -68.61 0.39 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.093 -1.077 . . . . 55.45 108.093 173.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.88 152.61 28.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.388 -0.824 . . . . 73.43 109.596 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 77.1 mt -110.64 150.27 29.23 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.426 1.09 . . . . 71.34 108.243 167.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.484 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.1 t -150.9 136.23 17.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.432 -0.951 . . . . 71.22 108.432 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -155.53 129.56 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.644 0.378 . . . . 74.13 110.313 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -134.43 120.1 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.049 0.539 . . . . 74.54 110.07 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 7.1 mt-30 -87.7 91.25 8.68 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.607 -0.886 . . . . 62.52 108.607 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.72 95.54 6.65 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.383 -0.969 . . . . 63.34 108.383 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 144.18 16.95 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.83 -0.623 . . . . 61.14 111.562 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.39 136.22 6.61 Favored Glycine 0 CA--C 1.507 -0.43 0 N-CA-C 110.515 -1.034 . . . . 50.12 110.515 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.8 mt -88.42 126.54 41.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.6 -0.889 . . . . 65.01 108.6 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 84' ' ' PHE . . . . . 0.404 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 52.6 m-85 -123.92 148.65 46.69 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.565 -0.532 . . . . 72.55 109.565 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 27.0 m -103.57 94.22 5.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.671 -1.233 . . . . 63.33 107.671 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.8 mt -110.17 116.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.999 0.919 . . . . 74.33 108.72 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.45 153.5 15.47 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.145 0.578 . . . . 75.11 110.33 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.05 59.97 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.127 -0.488 . . . . 71.45 112.738 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.65 129.1 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.736 -0.839 . . . . 53.35 108.736 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -134.5 168.07 19.62 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.883 0.873 . . . . 73.14 110.362 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 91' ' ' GLY . . . . . 0.411 ' HA2' ' HD2' ' G' ' 276' ' ' PRO . . . 71.42 -135.61 23.95 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.855 -0.611 . . . . 70.24 114.177 174.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -70.61 -34.63 72.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.166 0.987 . . . . 55.11 112.056 -173.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.98 -38.76 83.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.971 0.508 . . . . 62.01 110.726 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -44.11 76.66 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.5 -0.555 . . . . 73.0 109.5 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.54 71.66 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.204 0.94 . . . . 71.33 111.508 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -72.01 -45.0 62.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.572 0.749 . . . . 64.45 110.646 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.44 -37.9 88.27 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.807 0.443 . . . . 61.22 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' G' ' 281' ' ' PHE . 41.3 tp -79.32 -37.77 36.81 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.262 1.025 . . . . 53.22 111.301 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -7.79 76.09 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.657 -0.524 . . . . 74.24 113.769 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 -54.98 0.73 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.763 0.782 . . . . 73.31 112.211 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -72.37 -49.02 37.16 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.064 0.393 . . . . 75.22 111.573 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.0 m -60.78 -48.47 92.89 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.252 -0.88 . . . . 75.34 112.531 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.24 -27.75 48.22 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 121.636 1.557 . . . . 74.31 112.604 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -71.99 -24.09 61.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.066 0.546 . . . . 74.11 111.099 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -80.64 -41.68 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.607 0.763 . . . . 62.54 110.455 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.77 -30.57 62.84 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.202 0.601 . . . . 64.04 111.547 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -63.87 -42.36 70.09 Favored Pre-proline 0 CA--C 1.564 1.508 0 N-CA-C 114.187 1.18 . . . . 75.31 114.187 -170.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.57 -45.09 32.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.413 2.076 . . . . 75.42 113.821 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -79.63 -30.98 41.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.357 0.663 . . . . 74.13 111.798 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.91 74.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.912 0.485 . . . . 73.42 109.863 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.85 -51.27 70.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.293 -1.321 . . . . 55.23 110.352 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.54 -42.17 91.72 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.218 0.949 . . . . 73.11 111.385 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -44.56 94.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.754 0.659 . . . . 65.21 110.793 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.484 HG23 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -62.46 -52.38 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.073 0.949 . . . . 73.11 110.697 175.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.469 HG21 ' HE2' ' B' ' 109' ' ' TYR . 32.0 m -56.36 -41.25 75.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.824 1.249 . . . . 63.25 111.135 -171.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -67.93 -43.58 78.84 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.549 -1.205 . . . . 74.12 110.507 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.9 mtm -66.64 -31.55 72.31 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.371 0.508 . . . . 62.05 112.371 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.5 t -68.34 -44.83 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.27 0.628 . . . . 73.12 109.712 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.0 p -70.37 -28.96 65.52 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.994 0.518 . . . . 74.02 111.45 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -73.38 -31.71 64.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.337 0.655 . . . . 74.52 110.186 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 3.0 86.12 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.959 -0.564 . . . . 73.32 112.851 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 122' ' ' THR . . . . . 0.406 HG23 ' HB3' ' C' ' 17' ' ' TYR . 69.3 p 63.29 14.43 7.81 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.794 2.038 . . . . 73.34 113.672 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.447 ' HE1' HG11 ' D' ' 31' ' ' VAL . 87.8 m-85 -80.29 158.83 71.34 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 165.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -70.88 134.29 25.32 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 121.61 1.54 . . . . 73.32 110.878 -168.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -48.72 116.94 1.81 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.333 1.021 . . . . 54.2 110.349 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -105.5 104.79 14.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.039 -0.726 . . . . 64.43 109.039 -164.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -99.0 94.24 6.44 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.513 -1.221 . . . . 74.23 107.998 -177.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 127.48 32.43 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.121 0.969 . . . . 71.01 109.368 -175.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 129' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -59.88 128.63 87.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.58 0.752 . . . . 72.42 111.235 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HG2' ' HE2' ' B' ' 11' ' ' PHE . 1.2 Cg_endo -79.73 122.61 5.0 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.852 2.368 . . . . 73.03 111.391 -177.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.36 115.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.273 0.629 . . . . 74.53 109.448 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 132' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 28.1 t30 -76.55 105.28 7.52 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.143 -0.688 . . . . 65.44 109.143 174.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -68.21 -37.75 81.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.798 0.839 . . . . 70.35 110.571 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.73 -46.52 77.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.998 0.919 . . . . 72.23 111.282 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 135' ' ' ALA . . . . . 0.52 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -53.45 -48.21 69.02 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.985 1.428 . . . . 70.32 111.006 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 66.0 mt -55.99 -49.37 73.79 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 124.719 1.262 . . . . 53.42 112.206 -176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -72.43 -42.24 65.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.267 -0.879 . . . . 75.11 112.127 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 24.4 ptp -73.13 -25.85 60.99 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 120.619 0.247 . . . . 73.0 110.813 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' D' ' 143' ' ' GLN . 0.4 OUTLIER -68.9 -35.72 77.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.258 1.023 . . . . 73.33 111.398 178.787 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' D' D ' 140' ' ' TYR . . . . . 0.417 ' HD1' ' H ' ' B' ' 4' ' ' GLN . 75.3 t80 -48.68 -36.87 17.03 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.613 0.765 . . . . 73.55 111.27 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.24 -57.88 3.66 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.318 -0.856 . . . . 61.24 110.39 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.4 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 4.3 pt20 -88.38 38.86 0.88 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.185 0.994 . . . . 63.04 112.409 -169.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 143' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' D' ' 139' ' ' ASN . 9.2 tt0 -116.18 91.52 3.62 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.927 -0.768 . . . . 53.13 108.927 -174.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -155.73 26.2 0.39 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.893 -1.049 . . . . 72.1 109.828 -178.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.8 169.04 16.79 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.709 0.804 . . . . 71.13 110.695 -174.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.62 118.91 1.26 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.422 -1.071 . . . . 62.23 110.422 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.46 148.86 24.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.316 0.646 . . . . 71.31 111.045 -176.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.16 81.12 0.26 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 124.345 1.028 . . . . 54.13 113.6 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 44.3 m -84.05 98.71 10.01 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.793 0.837 . . . . 61.54 109.947 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -100.25 139.62 35.66 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.065 0.546 . . . . 75.14 109.595 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -141.28 134.73 29.79 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.124 -1.065 . . . . 63.42 108.124 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -99.73 103.51 15.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.816 0.446 . . . . 74.14 111.076 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -139.35 139.23 37.17 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.304 -0.999 . . . . 75.34 108.304 171.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -107.71 108.75 20.12 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.131 -0.692 . . . . 74.44 109.131 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 C-N-CA 123.893 0.877 . . . . 65.11 108.782 172.77 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.341 -0.614 . . . . 61.14 109.341 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -170.66 46.53 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.76 1.224 . . . . 70.23 107.767 -174.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -68.75 96.23 0.72 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.575 -0.739 . . . . 61.32 109.783 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -102.76 37.4 1.94 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.277 1.031 . . . . 70.31 111.466 -173.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 275' ' ' LYS . . . . . 0.449 ' HE3' ' HA3' ' E' ' 279' ' ' GLY . 61.4 tttp -144.73 86.17 8.05 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.604 -0.888 . . . . 72.14 108.604 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.34 79.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 124.684 3.59 . . . . 74.11 115.489 -165.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 61.4 mt 50.21 -82.38 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.405 1.882 . . . . 75.35 113.181 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.44 90.73 0.25 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.451 0.7 . . . . 71.31 111.894 -172.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 279' ' ' GLY . . . . . 0.449 ' HA3' ' HE3' ' E' ' 275' ' ' LYS . . . -135.05 34.36 2.33 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 109.859 -1.297 . . . . 71.22 109.859 169.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 95' ' ' ALA . 39.5 tp -134.69 167.97 19.87 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.85 1.26 . . . . 45.43 108.91 -173.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 281' ' ' PHE . . . . . 0.425 ' N ' ' HG ' ' E' ' 280' ' ' LEU . 21.8 m-30 79.11 -26.71 0.17 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.534 1.534 . . . . 75.41 111.87 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -47.24 -43.84 22.22 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.188 0.995 . . . . 72.22 110.763 168.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -130.92 102.68 6.16 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.716 -1.216 . . . . 72.1 107.716 164.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -163.59 38.06 0.32 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.667 -0.697 . . . . 74.14 112.663 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.9 102.55 5.59 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.726 -0.842 . . . . 71.31 108.726 170.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 13.0 mmt -65.14 143.73 98.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 116.119 -0.491 . . . . 73.53 111.461 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 287' ' ' PRO . . . . . 0.594 ' HB3' ' HB3' ' C' ' 153' ' ' GLN . 22.3 Cg_exo -66.98 77.82 0.4 Allowed 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.571 2.181 . . . . 74.14 111.347 168.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 11.2 t -89.83 65.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 122.665 1.221 . . . . 64.43 108.689 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -88.2 128.96 35.46 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 113.706 -1.588 . . . . 74.42 107.135 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -53.2 124.53 14.76 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.449 0.7 . . . . 72.4 111.785 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 129' ' ' ALA . 3.2 mp -83.82 76.51 10.01 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.134 -1.432 . . . . 74.25 107.134 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 292' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' G' ' 307' ' ' THR . . . 80.44 90.29 0.51 Allowed Glycine 0 C--N 1.347 1.151 0 CA-C-N 114.459 -1.246 . . . . 33.34 111.552 -165.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.9 27.67 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.57 2.847 . . . . 75.42 114.162 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -133.92 91.9 2.89 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.647 -0.872 . . . . 55.31 108.647 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 295' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' G' ' 305' ' ' ALA . . . -164.92 174.1 10.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.214 1.006 . . . . 64.34 109.112 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 83.9 m 64.98 -86.62 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.774 0.671 . . . . 65.5 110.615 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -97.83 92.55 5.89 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.227 -0.657 . . . . 62.44 109.227 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -157.58 10.69 0.19 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.589 -0.522 . . . . 73.0 109.589 170.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.68 174.81 24.96 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.762 -0.654 . . . . 62.02 112.137 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -70.42 117.54 12.09 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.827 -0.805 . . . . 71.54 108.827 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 10.4 tp -52.63 134.12 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.139 0.976 . . . . 71.34 111.583 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -65.16 126.41 28.01 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.992 -0.373 . . . . 73.23 109.992 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -78.95 139.65 57.47 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 114.787 -1.097 . . . . 72.42 110.054 -174.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 304' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 4.8 Cg_endo -46.5 -25.56 3.5 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 124.042 3.162 . . . . 23.52 114.692 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . 74.3 -66.0 0.32 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.332 1.453 . . . . 43.4 112.314 172.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 306' ' ' VAL . . . . . 0.561 ' HA ' ' HD2' ' G' ' 293' ' ' PRO . 20.9 m -79.22 40.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 124.491 1.116 . . . . 72.42 111.915 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 2.5 m -79.59 1.23 26.82 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.382 1.073 . . . . 73.31 111.178 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 80.0 m -144.57 118.78 9.51 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.189 0.996 . . . . 73.22 109.396 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' E' E ' 309' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' B' ' 12' ' ' GLN . 94.7 m -141.08 94.72 7.74 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 107.503 -1.295 . . . . 52.52 107.503 170.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 C--N 1.379 2.158 0 C-N-CA 123.335 2.69 . . . . 73.44 113.461 -172.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.549 -0.537 . . . . 74.03 109.549 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -79.17 80.75 5.5 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.551 0.691 . . . . 74.51 111.42 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -79.2 70.06 5.51 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.06 -0.719 . . . . 75.33 109.06 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -82.77 147.16 28.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.4 -0.818 . . . . 74.43 110.122 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.92 77.09 30.24 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 108.571 -0.9 . . . . 74.14 108.571 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.27 178.23 7.83 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.455 2.103 . . . . 63.53 111.401 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.61 109.63 3.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.238 -0.653 . . . . 73.15 109.238 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.432 HD12 HD22 ' C' ' 98' ' ' LEU . 13.7 tp -161.36 -81.9 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.842 -0.429 . . . . 73.44 109.842 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 87.16 -82.3 1.62 Allowed Glycine 0 C--N 1.352 1.435 0 N-CA-C 114.995 0.758 . . . . 52.43 114.995 171.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 280' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' C' ' 98' ' ' LEU . 9.8 tt -62.1 -28.52 69.68 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.482 0.713 . . . . 70.01 112.405 -169.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -73.53 79.51 1.45 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.676 0.751 . . . . 75.25 109.891 173.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -170.12 35.36 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.355 1.462 . . . . 72.43 108.478 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 27.4 t70 77.18 131.78 0.05 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.752 1.621 . . . . 71.41 111.727 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -128.75 157.27 21.43 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 123.161 0.41 . . . . 72.13 112.307 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -85.62 77.4 9.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.283 0.633 . . . . 55.54 110.259 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 17.2 ptp -156.49 89.26 2.72 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.232 -0.894 . . . . 75.12 109.588 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.72 -60.07 1.0 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.3 2.666 . . . . 72.45 113.621 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 46.4 t 50.55 -83.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 124.852 1.261 . . . . 70.24 112.176 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 57.75 -88.15 0.02 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.429 1.492 . . . . 64.23 111.282 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -137.07 157.29 47.03 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.461 0.648 . . . . 62.44 111.523 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.472 HD22 HG12 ' H' ' 306' ' ' VAL . 5.3 mp -118.93 -4.44 10.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.685 -1.143 . . . . 70.15 110.173 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -170.37 154.62 23.47 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.45 -0.639 . . . . 71.24 112.341 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.88 -39.95 47.81 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.61 2.873 . . . . 41.22 114.163 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 294' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' F' ' 294' ' ' LYS . 0.1 OUTLIER 70.28 173.19 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.914 1.286 . . . . 73.33 111.271 178.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' F' F ' 295' ' ' ALA . . . . . 0.423 ' H ' ' HG3' ' F' ' 294' ' ' LYS . . . -78.29 6.69 7.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.169 0.988 . . . . 74.52 112.761 177.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 34.0 m -60.67 105.23 0.42 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.685 1.194 . . . . 62.34 111.483 -176.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.754 ' HB3' ' HG3' ' C' ' 38' ' ' PRO . 68.7 t80 55.73 38.91 30.69 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.75 1.22 . . . . 71.52 111.215 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -118.79 143.59 46.83 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.696 -0.628 . . . . 73.53 109.564 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.02 -81.37 1.74 Allowed Glycine 0 C--N 1.35 1.313 0 N-CA-C 111.69 -0.564 . . . . 70.1 111.69 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -170.01 164.53 9.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.445 1.098 . . . . 64.04 109.629 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.435 HD13 ' HD3' ' C' ' 124' ' ' PRO . 40.4 mm -62.18 -70.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.634 0.774 . . . . 71.22 109.92 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 174.79 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.826 1.651 . . . . 74.13 107.803 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 140.69 29.45 Favored Pre-proline 0 N--CA 1.48 1.064 0 N-CA-C 109.497 -0.557 . . . . 62.22 109.497 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.4 -32.58 3.79 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.724 2.283 . . . . 65.31 111.509 166.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -164.29 169.56 17.35 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.505 1.122 . . . . 62.23 109.36 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.47 129.41 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.444 -0.947 . . . . 52.12 108.444 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 307' ' ' THR . . . . . 0.545 HG21 ' HA3' ' H' ' 292' ' ' GLY . 18.5 m -82.27 100.13 9.73 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.458 0.703 . . . . 74.23 111.516 -168.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 75.3 m 75.46 -63.71 0.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.702 1.601 . . . . 70.25 113.107 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' F' F ' 309' ' ' THR . . . . . 0.718 HG21 HD23 ' H' ' 291' ' ' LEU . 10.1 t -61.91 145.51 92.54 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 123.427 0.691 . . . . 75.14 110.732 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo . . . . . 0 CA--C 1.561 1.863 0 C-N-CA 121.613 1.542 . . . . 62.14 110.301 168.391 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.795 0.331 . . . . 71.52 110.59 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -146.07 156.92 43.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.905 0.882 . . . . 64.13 109.891 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -29.86 70.38 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.121 -0.945 . . . . 55.14 111.51 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -75.99 -60.84 2.15 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.327 0.651 . . . . 71.11 111.866 -174.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 56.35 84.99 0.2 Allowed Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 123.984 0.914 . . . . 74.22 111.276 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 276' ' ' PRO . . . . . 0.411 ' HD2' ' HA2' ' D' ' 91' ' ' GLY . 91.8 Cg_endo -80.77 150.29 18.56 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.54 2.16 . . . . 74.31 113.582 -173.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.24 21.45 6.94 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.021 0.928 . . . . 64.31 108.993 173.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 43.4 tp -168.85 118.07 0.7 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.189 1.396 . . . . 74.24 107.396 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 178.06 169.63 39.2 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 114.199 0.44 . . . . 55.33 114.199 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 67.7 tp 78.07 -48.11 0.47 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 126.378 1.871 . . . . 60.13 112.18 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 281' ' ' PHE . . . . . 0.524 ' HB2' ' HG ' ' D' ' 98' ' ' LEU . 16.3 t80 -59.58 -30.31 68.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.446 1.098 . . . . 65.3 112.344 -172.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.32 88.36 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.319 0.647 . . . . 75.12 111.078 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -77.98 -40.38 39.41 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.739 0.816 . . . . 74.23 109.847 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 87.59 -60.66 4.23 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.592 -0.731 . . . . 70.34 112.511 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 5.4 t30 53.14 68.07 0.9 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.744 1.218 . . . . 75.43 110.154 -170.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 21.9 mmt -133.24 89.85 31.84 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.79 0.836 . . . . 63.33 110.143 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -93.06 50.38 0.4 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.629 2.886 . . . . 70.3 111.1 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.16 -39.61 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.855 1.262 . . . . 71.33 112.762 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 61.68 -155.9 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.304 1.042 . . . . 71.54 110.61 -174.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -128.21 132.08 48.82 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.417 -0.957 . . . . 72.53 108.417 165.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.96 3.11 11.54 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.705 0.802 . . . . 73.12 111.79 -175.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -87.62 124.64 7.19 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 119.045 -0.864 . . . . 53.53 112.181 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 293' ' ' PRO . . . . . 0.561 ' HD2' ' HA ' ' E' ' 306' ' ' VAL . 52.4 Cg_exo -57.22 127.82 27.2 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.672 2.248 . . . . 51.3 112.388 174.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.72 84.49 1.63 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.258 1.023 . . . . 71.12 109.91 -175.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -147.03 34.74 0.9 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.953 0.901 . . . . 71.01 110.187 -174.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 296' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' D' ' 38' ' ' PRO . 2.4 m -66.28 -63.7 1.02 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.921 0.888 . . . . 63.0 111.588 -169.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.567 ' H ' ' HD2' ' D' ' 38' ' ' PRO . 16.7 m-85 -73.28 162.87 28.87 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.943 -0.762 . . . . 62.13 108.943 165.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -153.84 -20.28 0.14 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.084 -0.507 . . . . 72.4 109.976 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 166.44 65.1 0.03 OUTLIER Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.999 -0.44 . . . . 73.35 111.999 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -118.01 -40.74 2.95 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.728 0.811 . . . . 74.03 110.158 -175.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.416 HG12 ' HD1' ' D' ' 32' ' ' PHE . 18.2 mt -65.22 -36.9 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.211 1.004 . . . . 53.43 110.963 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -80.46 15.55 1.61 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.873 0.694 . . . . 73.24 112.873 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 303' ' ' LYS . . . . . 0.703 ' HA ' ' HE3' ' G' ' 303' ' ' LYS . 0.6 OUTLIER -143.11 103.05 5.17 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 110.003 -0.369 . . . . 62.54 110.003 165.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.79 -174.28 2.09 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.942 2.428 . . . . 63.12 112.388 170.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 305' ' ' ALA . . . . . 0.594 ' HA ' ' HB1' ' E' ' 295' ' ' ALA . . . -113.39 167.82 10.26 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.778 0.831 . . . . 74.33 109.773 174.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.409 HG21 ' HB ' ' C' ' 13' ' ' ILE . 58.6 t 53.31 98.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 124.725 1.21 . . . . 61.22 112.371 -177.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 307' ' ' THR . . . . . 0.489 ' HB ' ' HA3' ' E' ' 292' ' ' GLY . 18.2 m -68.39 156.73 37.23 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 115.546 -0.752 . . . . 73.21 109.924 177.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 28.5 p -51.4 114.31 1.2 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.573 1.149 . . . . 62.53 112.933 -174.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 60.3 m -118.07 96.17 49.28 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.087 0.955 . . . . 73.54 109.871 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.378 2.114 0 C-N-CA 123.448 2.765 . . . . 74.43 112.259 171.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.799 -0.445 . . . . 61.41 109.799 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -163.21 147.79 11.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.827 0.851 . . . . 71.54 109.5 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -73.29 86.29 1.45 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.113 -1.069 . . . . 74.34 108.113 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -85.69 32.99 0.57 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.686 1.194 . . . . 74.41 113.497 -162.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -159.8 102.76 1.45 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.316 0.646 . . . . 64.14 109.405 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.99 128.61 9.26 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.755 2.303 . . . . 62.33 110.067 168.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 54.6 tp -66.09 -28.65 68.98 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.916 -0.402 . . . . 75.03 109.916 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 278' ' ' LEU . . . . . 0.528 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 32.9 tp -65.48 96.38 0.25 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.588 0.755 . . . . 70.44 110.014 175.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -92.38 -17.06 47.56 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.733 -0.667 . . . . 65.24 113.494 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 92.7 mt -131.2 -169.73 2.23 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.273 1.029 . . . . 73.42 109.93 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 28.2 t80 80.5 -29.4 0.13 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 125.091 1.357 . . . . 74.44 113.599 167.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.98 -26.5 65.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.305 0.642 . . . . 42.12 112.534 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.4 -24.74 34.24 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.516 0.726 . . . . 73.33 110.46 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 73.53 -92.51 0.69 Allowed Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.435 -0.666 . . . . 72.04 111.435 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 69.09 163.05 0.23 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.278 1.431 . . . . 64.23 112.236 175.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 286' ' ' MET . . . . . 0.478 ' SD ' HD21 ' B' ' 136' ' ' LEU . 66.6 mtm 64.23 77.95 0.29 Allowed Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.072 1.349 . . . . 53.3 110.358 -177.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.2 131.77 46.76 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.385 2.723 . . . . 70.42 113.293 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.08 -45.99 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 O-C-N 123.848 0.718 . . . . 70.23 110.2 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 65.94 -78.42 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.956 1.302 . . . . 72.41 111.267 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -171.26 142.47 1.74 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.366 1.066 . . . . 72.24 108.559 175.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.718 HD23 HG21 ' F' ' 309' ' ' THR . 5.6 mp -93.85 56.48 2.31 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.983 -1.117 . . . . 61.42 107.983 172.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 292' ' ' GLY . . . . . 0.545 ' HA3' HG21 ' F' ' 307' ' ' THR . . . 74.0 165.37 11.67 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 115.351 -0.84 . . . . 64.24 113.318 -174.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.24 151.54 30.04 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.525 2.15 . . . . 61.12 112.215 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -124.42 158.72 32.09 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 108.898 -0.779 . . . . 71.22 108.898 169.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.63 72.25 7.55 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.515 1.126 . . . . 70.14 111.282 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 17.0 m -85.17 148.21 26.22 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.28 1.032 . . . . 74.31 109.311 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 64.14 30.55 13.72 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.979 0.912 . . . . 72.54 111.666 -173.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -100.83 162.88 12.6 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 120.726 0.298 . . . . 63.14 110.265 173.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 90.15 -160.74 28.56 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.693 -0.685 . . . . 73.25 111.694 -171.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -89.57 88.93 7.61 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.022 -0.733 . . . . 74.42 109.022 176.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 301' ' ' ILE . . . . . 0.545 HG22 ' HG2' ' B' ' 124' ' ' PRO . 8.8 pt -71.1 -18.22 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.298 0.57 . . . . 71.45 111.091 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -86.17 -159.85 0.5 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.558 1.143 . . . . 72.54 110.334 174.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 303' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' H' ' 304' ' ' PRO . 39.8 mttp 63.12 50.79 1.32 Allowed Pre-proline 0 CA--C 1.577 1.997 0 C-N-CA 124.639 1.175 . . . . 73.01 111.84 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 304' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' H' ' 303' ' ' LYS . 64.8 Cg_endo -101.95 6.22 0.51 Allowed 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 123.167 2.578 . . . . 75.43 112.813 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -98.78 157.16 16.47 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.246 1.018 . . . . 72.3 111.772 -170.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 306' ' ' VAL . . . . . 0.472 HG12 HD22 ' F' ' 291' ' ' LEU . 13.9 m -124.98 110.33 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.593 -0.731 . . . . 74.22 109.557 173.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 14.8 p -66.09 -53.53 37.03 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.012 -0.994 . . . . 73.14 110.092 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' H' H ' 308' ' ' CYS . . . . . 0.434 ' O ' ' HD3' ' H' ' 310' ' ' PRO . 47.5 t -172.05 150.28 2.49 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.531 1.133 . . . . 74.32 108.656 172.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 309' ' ' THR . . . . . 0.552 HG21 ' HA ' ' C' ' 131' ' ' VAL . 29.5 p -109.58 85.0 3.46 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.636 0.774 . . . . 44.2 109.961 175.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' H' H ' 310' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' H' ' 308' ' ' CYS . 37.8 Cg_endo . . . . . 0 C--N 1.38 2.219 0 C-N-CA 123.697 2.932 . . . . 61.3 111.359 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.924 -0.398 . . . . 63.35 109.924 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 p -164.83 97.14 0.74 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.496 1.118 . . . . 63.33 108.179 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.1 158.23 23.52 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.069 0.947 . . . . 74.34 111.402 -172.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 64.11 32.86 12.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.317 1.047 . . . . 72.12 112.703 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -151.45 91.15 1.64 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.945 0.498 . . . . 62.12 110.129 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -167.92 33.5 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 123.596 0.758 . . . . 53.12 110.027 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.557 ' HA ' ' HG2' ' C' ' 143' ' ' GLN . 73.3 m -142.86 -57.34 0.43 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.139 -0.689 . . . . 43.33 109.139 174.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -172.86 4.38 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.992 -1.004 . . . . 74.25 109.891 173.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.488 ' HG3' HG23 ' A' ' 89' ' ' ILE . 54.8 ttm 68.86 133.31 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.319 1.447 . . . . 74.4 111.511 -176.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.8 m -148.85 131.22 15.64 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.164 0.986 . . . . 52.22 108.382 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 47.5 t80 -137.08 129.07 29.27 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.818 -1.178 . . . . 74.15 107.818 172.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -153.02 119.29 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.074 -0.713 . . . . 71.35 109.074 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.623 HG21 ' HG2' ' C' ' 130' ' ' PRO . 52.8 mt -65.69 133.24 31.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 114.922 -1.036 . . . . 73.44 110.026 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -115.66 -22.32 9.24 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.568 0.747 . . . . 74.23 112.447 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.558 ' HD2' ' HG3' ' H' ' 304' ' ' PRO . 24.6 ttt85 -176.12 122.81 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.192 0.451 . . . . 74.31 111.628 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.524 HD13 ' HG2' ' C' ' 130' ' ' PRO . 1.4 mp -110.11 127.45 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.209 -1.034 . . . . 55.42 108.209 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 27.2 p90 -158.44 150.69 21.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.014 0.926 . . . . 74.21 110.284 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.422 HG21 ' SG ' ' A' ' 113' ' ' CYS . 82.2 p -76.81 119.02 20.01 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.834 -0.802 . . . . 73.55 108.834 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -81.68 -42.36 20.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 53.33 109.568 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.69 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 15.3 m-20 -136.26 137.31 40.64 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.724 -1.125 . . . . 64.43 109.053 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.3 mt -133.74 142.53 41.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.458 -1.312 . . . . 75.45 107.458 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -150.49 133.93 16.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.849 -0.797 . . . . 70.51 108.849 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.9 t80 -136.22 132.65 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.564 -1.643 . . . . 62.41 106.564 172.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.42 138.09 42.91 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.622 -0.881 . . . . 74.21 108.622 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.82 79.83 63.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.356 -1.72 . . . . 51.2 106.356 171.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.68 -40.81 76.69 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.297 2.664 . . . . 70.23 113.049 -164.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.37 38.5 3.97 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.748 -0.834 . . . . 54.51 108.748 -177.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.06 -57.63 7.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 117.935 -1.031 . . . . 50.31 113.262 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.5 Cg_exo -62.79 -20.25 70.67 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 122.073 1.849 . . . . 34.2 113.383 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -94.24 -31.87 13.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.178 0.991 . . . . 63.42 111.049 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.1 p -78.33 -19.45 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.716 0.807 . . . . 54.54 111.025 -169.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -73.78 -7.52 52.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.744 0.818 . . . . 73.44 111.397 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 81.2 mt-30 -98.33 -19.8 17.56 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 60.44 111.003 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -82.03 166.61 19.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.659 0.783 . . . . 72.44 111.546 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.94 149.18 49.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.996 0.918 . . . . 70.1 110.02 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -86.77 62.35 7.35 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.266 0.555 . . . . 74.3 111.948 -168.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -134.34 66.71 71.4 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.007 0.523 . . . . 75.02 111.298 173.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.18 126.65 2.81 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.008 1.805 . . . . 61.22 110.615 167.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -95.54 105.31 17.27 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.459 -0.941 . . . . 72.23 108.459 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.614 HG23 HG13 ' A' ' 64' ' ' VAL . 2.1 p -75.52 129.64 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.278 -1.328 . . . . 74.31 110.218 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -99.92 141.17 33.09 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 74.21 110.089 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' A' ' 128' ' ' LEU . 0.8 OUTLIER -100.65 118.67 37.26 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.954 -1.128 . . . . 64.5 107.954 173.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.54 145.05 33.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.012 0.525 . . . . 64.13 110.068 170.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.87 141.49 51.27 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.355 -0.979 . . . . 65.12 108.355 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.9 t70 -119.37 138.0 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.583 -1.266 . . . . 63.24 107.583 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' E' ' 282' ' ' ALA . 72.4 p -106.66 138.21 43.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.374 0.669 . . . . 75.41 110.629 -167.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.16 110.45 0.91 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.17 0.588 . . . . 54.34 110.492 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -112.76 159.76 18.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.019 -0.734 . . . . 73.33 109.019 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -154.14 150.42 28.12 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.536 0.734 . . . . 53.12 109.716 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.46 143.45 30.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.403 -0.962 . . . . 65.31 108.403 171.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 57' ' ' GLU . 28.6 mt -115.94 -43.88 2.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.396 0.679 . . . . 75.14 109.719 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.86 -167.94 2.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.108 -0.951 . . . . 74.31 110.073 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.76 106.41 0.8 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.553 0.741 . . . . 73.51 110.132 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 23.9 m-20 67.34 13.87 9.5 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.727 1.211 . . . . 73.45 113.095 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.25 117.14 45.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.379 -0.971 . . . . 63.21 108.379 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 64.0 m-85 -125.06 123.39 39.68 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.512 -0.921 . . . . 64.54 108.512 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.589 ' HB2' HD11 ' A' ' 51' ' ' LEU . 27.4 tt0 -88.88 143.11 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.094 -0.957 . . . . 75.2 108.761 173.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.441 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.7 t -119.08 136.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.815 -1.18 . . . . 63.2 107.815 172.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.8 t -127.13 132.38 69.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.065 0.946 . . . . 74.4 108.762 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 106' ' ' LEU . 4.5 mm? -119.67 110.09 16.42 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.336 1.055 . . . . 73.25 108.344 175.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.727 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 26.3 ttp180 -83.81 99.55 10.37 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.012 -0.736 . . . . 62.44 109.012 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 117.35 34.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.313 -1.365 . . . . 72.43 107.313 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 m -116.03 122.24 44.6 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.911 0.862 . . . . 74.45 109.544 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.614 HG13 HG23 ' A' ' 40' ' ' VAL . 49.1 t -112.98 120.93 64.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.492 -1.685 . . . . 72.13 108.181 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -121.45 125.95 48.12 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.934 -0.765 . . . . 73.43 108.934 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.94 121.63 38.44 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.97 -1.122 . . . . 75.03 107.97 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -136.93 132.86 35.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.095 0.558 . . . . 70.15 110.344 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.24 85.18 3.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.003 0.921 . . . . 72.43 109.166 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -90.98 1.54 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-N 114.45 -1.25 . . . . 71.32 110.889 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -122.36 -30.2 4.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.637 0.775 . . . . 73.21 110.423 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.01 131.35 35.78 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.333 -0.617 . . . . 61.11 109.333 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 m -87.01 136.23 32.99 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.232 0.539 . . . . 53.03 111.156 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.776 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.61 -65.22 0.93 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.893 -1.049 . . . . 70.32 109.323 172.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.69 159.28 44.62 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.511 -1.222 . . . . 74.21 111.319 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.9 tp -132.14 115.4 15.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.173 1.389 . . . . 74.23 107.964 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 67.7 m -105.76 138.28 42.21 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.26 -1.015 . . . . 60.33 108.26 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -146.81 115.39 6.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.28 -1.007 . . . . 65.24 108.28 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.39 110.14 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.448 0.699 . . . . 45.32 109.501 -175.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.727 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 39.5 mt-30 -84.64 83.19 8.1 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.894 -1.15 . . . . 52.34 107.894 169.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.22 102.22 5.73 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.443 -1.253 . . . . 41.33 107.884 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 156.31 24.77 Favored Glycine 0 C--O 1.243 0.685 0 CA-C-N 115.939 -0.573 . . . . 64.14 111.882 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.3 120.61 1.09 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.503 -1.039 . . . . 71.21 110.503 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.75 125.99 39.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 N-CA-C 108.267 -1.012 . . . . 34.42 108.267 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.553 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.7 m-85 -135.65 144.75 46.22 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.642 -1.244 . . . . 74.13 107.642 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -84.47 93.53 8.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.907 -1.145 . . . . 53.23 107.907 169.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 55.3 mt -100.08 117.92 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 108.56 -0.904 . . . . 62.2 108.56 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -151.03 158.33 43.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.679 0.791 . . . . 64.04 110.38 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.404 ' HA3' ' H ' ' A' ' 9' ' ' MET . . . 76.75 10.13 86.11 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.339 0.399 . . . . 65.13 113.788 171.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.488 HG23 ' HG3' ' A' ' 9' ' ' MET . 1.2 pp -113.26 163.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.967 1.307 . . . . 73.44 110.299 -173.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.56 170.64 6.75 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.296 -1.001 . . . . 72.1 108.296 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.05 -126.53 26.88 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 124.07 0.843 . . . . 74.4 114.947 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -72.97 -22.47 60.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.086 0.955 . . . . 71.53 111.639 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.6 -43.96 65.31 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.926 0.491 . . . . 75.11 110.3 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.4 ttt -71.42 -38.52 71.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.759 -0.655 . . . . 64.14 109.358 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.93 72.93 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.49 -0.777 . . . . 65.35 111.233 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -78.98 -27.03 43.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.861 0.464 . . . . 74.0 110.695 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.1 t -73.95 -66.03 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.161 0.184 . . . . 54.33 110.519 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.65 -17.26 36.58 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.445 0.535 . . . . 73.32 112.445 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.85 1.33 44.97 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.43 -0.65 . . . . 50.42 114.265 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.96 -56.8 0.2 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.885 0.842 . . . . 44.24 113.25 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.482 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.6 t80 -76.04 -59.05 2.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.477 0.711 . . . . 75.13 111.221 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.82 -31.99 4.57 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.913 0.885 . . . . 62.42 113.105 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.54 -49.06 14.01 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.647 2.231 . . . . 74.13 113.192 160.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -68.67 -26.53 65.36 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.574 0.75 . . . . 74.23 110.437 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -69.62 -42.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.194 0.597 . . . . 73.25 110.196 172.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.53 HD12 HD23 ' A' ' 60' ' ' LEU . 96.7 mt -80.75 -17.42 51.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.733 0.813 . . . . 75.41 111.568 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.85 -45.8 65.17 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 118.075 -0.964 . . . . 72.44 113.277 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.25 -30.91 64.21 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.986 1.791 . . . . 65.41 112.616 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -78.89 -36.46 42.07 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.423 0.689 . . . . 73.1 111.356 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.53 74.67 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.853 -0.795 . . . . 72.22 108.853 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -51.25 -50.31 59.46 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 125.098 1.499 . . . . 70.23 110.757 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -72.81 -37.63 67.44 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.197 0.936 . . . . 63.4 111.106 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 18' ' ' THR . 41.8 t -62.9 -35.89 81.52 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.08 0.467 . . . . 71.55 110.651 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.467 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 97.0 mt -68.13 -52.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.333 -0.849 . . . . 71.33 109.527 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.481 HG23 ' HG3' ' A' ' 125' ' ' GLN . 92.6 m -52.25 -44.8 65.08 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.775 1.23 . . . . 71.0 111.422 -174.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -66.42 -45.8 78.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.412 -1.267 . . . . 71.24 110.546 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.3 mtm -61.91 -41.16 97.59 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.789 0.436 . . . . 72.53 111.147 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 114' ' ' ILE . 72.4 t -58.5 -49.46 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.227 1.011 . . . . 44.34 110.334 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -69.14 -27.45 65.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.847 0.459 . . . . 55.34 111.383 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.1 mtt-85 -73.61 -20.75 60.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.717 0.807 . . . . 74.44 110.837 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.95 10.83 64.18 Favored Glycine 0 C--N 1.354 1.568 0 CA-C-O 119.676 -0.513 . . . . 61.41 113.539 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m 56.94 32.74 22.08 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.171 1.389 . . . . 73.11 110.646 -173.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -99.09 153.85 37.59 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-N 114.897 -1.047 . . . . 75.13 109.097 173.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 36.4 Cg_endo -62.47 144.97 95.54 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.365 2.043 . . . . 72.31 110.944 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.1 tt0 -55.05 130.13 40.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.864 0.728 . . . . 73.14 111.298 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.4 tp -111.51 102.71 11.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.03 0.932 . . . . 63.4 109.516 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.36 102.63 14.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.753 -1.203 . . . . 64.31 107.753 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.65 116.97 6.17 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 107.765 -1.198 . . . . 62.5 107.765 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.61 135.92 94.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.428 0.691 . . . . 70.2 112.241 -172.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.24 137.81 49.01 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.763 2.308 . . . . 64.41 112.983 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.94 134.7 65.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.033 0.933 . . . . 71.4 109.258 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 135' ' ' ALA . 15.9 p-10 -84.01 77.61 9.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.201 1.0 . . . . 71.3 110.908 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -66.59 -40.79 89.06 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.45 0.643 . . . . 72.43 109.932 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.646 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.3 p-10 -61.28 -40.75 95.26 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.036 1.334 . . . . 71.54 111.69 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 132' ' ' ASN . . . -79.11 -34.64 43.25 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.844 0.858 . . . . 74.1 110.582 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.3 tt -53.12 -48.47 67.84 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.962 0.905 . . . . 75.31 110.285 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -60.36 -42.76 96.42 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.095 -0.957 . . . . 75.23 111.734 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 mmt -73.07 -33.76 65.84 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 112.691 0.626 . . . . 71.42 112.691 -175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -61.82 -31.41 71.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.462 0.705 . . . . 74.1 110.247 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -88.43 -37.44 15.85 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.029 -0.987 . . . . 74.31 110.814 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.6 tp -68.84 -49.68 56.35 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.277 0.631 . . . . 72.2 111.927 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -157.52 14.39 0.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.902 -0.59 . . . . 70.13 111.55 -172.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 68.75 -72.75 0.1 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.866 1.266 . . . . 72.14 110.211 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 71.99 127.0 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.835 1.254 . . . . 74.1 110.298 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.9 143.5 14.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.158 0.583 . . . . 60.5 109.804 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.34 153.99 15.43 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.942 -0.463 . . . . 71.21 111.942 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -123.42 -172.44 2.51 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.217 1.007 . . . . 61.11 110.629 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.66 93.09 0.19 Allowed Glycine 0 C--N 1.348 1.213 0 N-CA-C 110.332 -1.107 . . . . 64.3 110.332 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.3 p -139.07 107.41 5.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.175 0.99 . . . . 73.23 110.502 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.02 -36.21 64.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.684 0.794 . . . . 74.53 109.981 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 75.67 15.18 2.67 Favored 'General case' 0 C--N 1.367 1.369 0 O-C-N 125.35 1.656 . . . . 72.22 110.338 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -87.7 85.66 7.09 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.058 0.943 . . . . 64.25 110.42 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -174.96 99.37 0.08 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.582 1.153 . . . . 51.45 108.956 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.63 132.01 35.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.17 0.988 . . . . 61.44 110.161 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.472 ' HA ' HD22 ' F' ' 285' ' ' ASN . . . . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.461 0.704 . . . . 75.43 110.363 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.795 -0.446 . . . . 75.14 109.795 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 33.2 t -166.18 94.5 0.55 Allowed 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.114 -1.069 . . . . 63.3 108.114 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -77.65 78.82 4.16 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.746 0.784 . . . . 73.23 109.237 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -135.09 28.74 3.44 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.88 -1.055 . . . . 74.33 110.109 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -77.1 83.23 3.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.985 -0.746 . . . . 71.03 108.985 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -175.51 98.66 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.093 -1.077 . . . . 74.25 108.093 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -146.15 94.38 2.46 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.869 0.842 . . . . 44.4 110.683 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -167.69 -59.35 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.845 -1.168 . . . . 71.41 107.845 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.465 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 5.0 ptt? 53.62 -171.67 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.239 1.816 . . . . 74.3 113.352 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m -154.97 132.15 11.0 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.394 -1.336 . . . . 53.35 107.394 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -140.62 135.72 32.01 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.314 0.646 . . . . 70.11 109.314 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.572 ' HG3' ' HA ' ' E' ' 308' ' ' CYS . 3.1 mm-40 -152.99 140.59 19.86 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.146 0.903 . . . . 72.24 109.708 167.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' E' ' 306' ' ' VAL . 2.4 pp -80.51 140.21 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.333 -1.358 . . . . 75.24 107.333 169.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -98.02 -44.32 6.7 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.071 -0.714 . . . . 62.01 109.071 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -164.41 138.67 5.42 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.331 -0.85 . . . . 71.23 109.28 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.77 137.22 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 106.344 -1.724 . . . . 75.12 106.344 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -166.08 161.64 17.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.414 0.626 . . . . 74.44 111.88 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.9 m -90.24 117.66 29.16 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.017 -0.992 . . . . 71.31 108.818 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -87.67 -27.91 22.15 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.453 -0.794 . . . . 74.42 111.056 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -159.81 143.69 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.411 0.444 . . . . 70.42 111.928 -174.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' ILE . . . . . 0.474 HD11 ' SG ' ' B' ' 113' ' ' CYS . 44.9 mm -134.63 143.46 37.68 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 125.286 1.435 . . . . 74.13 109.055 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -144.37 130.53 19.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.757 -1.201 . . . . 53.43 107.757 173.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -145.59 114.45 6.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.352 -1.351 . . . . 71.03 107.352 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.1 mt-10 -118.78 137.51 53.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.131 0.572 . . . . 72.41 109.673 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.931 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -129.34 78.69 75.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.814 -1.18 . . . . 73.42 107.814 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.4 -18.24 38.78 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.471 2.781 . . . . 65.44 113.448 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -126.81 12.88 7.36 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.315 1.446 . . . . 71.0 110.739 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.931 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -44.71 -57.18 7.19 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 115.817 1.784 . . . . 71.22 115.817 -165.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.0 Cg_exo -66.01 -26.8 50.63 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.528 2.152 . . . . 62.21 112.336 -173.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.459 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.9 m80 -91.46 -43.79 9.5 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.129 -0.941 . . . . 71.32 111.465 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.7 -26.37 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.244 0.618 . . . . 73.03 112.389 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' PHE . . . . . 0.513 ' HA ' HG21 ' H' ' 301' ' ' ILE . 21.9 m-30 -58.8 -24.01 61.23 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.026 0.93 . . . . 71.32 113.029 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.651 ' HA ' ' HE2' ' H' ' 303' ' ' LYS . 24.2 pt20 -76.47 -6.52 52.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.224 0.61 . . . . 71.2 112.424 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.687 ' HG2' ' HB2' ' C' ' 153' ' ' GLN . 31.0 mtpt -103.93 109.49 21.26 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.162 -0.681 . . . . 74.44 109.162 -177.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -95.46 96.93 9.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.266 0.469 . . . . 74.55 112.266 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.18 177.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.18 1.392 . . . . 74.23 110.511 162.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -78.7 138.03 58.36 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.121 0.968 . . . . 75.14 112.082 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -84.41 158.3 12.72 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.796 2.33 . . . . 73.01 112.881 167.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.49 128.2 35.23 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.813 -1.18 . . . . 74.22 107.813 162.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.9 t -108.48 131.72 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.302 0.641 . . . . 74.25 109.891 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.74 135.6 46.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.603 1.161 . . . . 72.51 109.194 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -109.16 125.62 52.38 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.222 1.009 . . . . 72.54 108.331 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -141.01 118.55 11.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.217 0.607 . . . . 61.12 109.368 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 pp -99.75 165.31 11.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.789 -0.449 . . . . 60.14 109.789 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -146.82 136.52 23.1 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.805 1.242 . . . . 71.13 108.095 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -120.93 105.54 10.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.609 0.764 . . . . 62.45 111.189 -167.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.19 155.27 31.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.861 0.864 . . . . 72.21 109.984 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.2 p -146.85 169.04 19.95 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.272 1.029 . . . . 53.45 109.885 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -153.46 137.63 16.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.308 0.643 . . . . 62.0 109.523 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -83.54 111.69 19.31 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.716 -0.476 . . . . 71.45 109.716 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.24 -45.78 13.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.689 0.618 . . . . 74.23 110.257 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 -168.01 2.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.218 -0.901 . . . . 60.32 110.701 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.01 108.32 3.03 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.997 -1.001 . . . . 72.43 109.883 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.8 11.11 7.37 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.945 1.298 . . . . 72.14 112.641 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.42 113.63 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.646 -0.872 . . . . 51.52 108.646 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.92 139.87 53.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.438 0.695 . . . . 74.02 109.522 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -101.78 106.39 17.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.528 -1.286 . . . . 54.3 107.528 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.19 123.6 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.256 1.022 . . . . 64.25 110.213 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -103.39 113.47 40.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.003 0.921 . . . . 74.21 109.496 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.61 100.02 10.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.614 -1.254 . . . . 75.52 107.614 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.7 ttm180 -85.3 128.18 34.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.116 -0.698 . . . . 71.35 109.116 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.26 106.13 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.1 -1.074 . . . . 71.4 108.1 172.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -98.55 126.72 44.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.522 0.729 . . . . 75.52 109.375 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.621 HG21 HG21 ' B' ' 114' ' ' ILE . 93.7 t -118.33 116.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.889 -1.05 . . . . 64.15 108.575 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.7 m -116.32 140.48 49.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.653 -0.869 . . . . 75.23 108.653 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.92 142.73 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.81 -1.181 . . . . 52.0 107.81 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 38.9 p -150.31 141.96 23.59 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.074 0.55 . . . . 74.15 110.64 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -138.1 136.53 36.84 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.223 1.009 . . . . 62.23 110.534 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.4 -124.1 26.68 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.766 -0.652 . . . . 31.21 112.455 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -96.98 2.91 52.11 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.328 1.051 . . . . 73.42 111.066 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.65 -179.87 7.45 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.469 0.544 . . . . 63.33 112.469 -167.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -73.29 154.67 40.06 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.518 1.127 . . . . 53.2 111.235 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.533 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.77 -57.8 2.15 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.052 -1.092 . . . . 51.42 108.052 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -160.28 161.41 33.36 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.492 -1.231 . . . . 71.33 109.674 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 50.7 mt -116.95 131.34 56.98 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.273 -1.38 . . . . 72.31 107.273 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.09 150.46 39.54 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.09 -0.707 . . . . 75.35 109.09 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 45.0 tt0 -164.55 133.71 3.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.66 0.784 . . . . 63.32 108.975 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.3 t -130.61 145.7 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.276 1.03 . . . . 71.34 108.289 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -121.87 95.68 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.668 -1.234 . . . . 74.23 107.668 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 48.8 tp60 -90.4 99.69 12.67 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.28 -1.007 . . . . 74.25 108.28 177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 165.49 32.14 Favored Glycine 0 C--O 1.242 0.631 0 N-CA-C 111.165 -0.774 . . . . 72.42 111.165 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.51 127.18 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.025 -0.83 . . . . 10.43 111.025 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.58 129.09 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.961 -1.125 . . . . 63.41 107.961 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -133.02 134.79 44.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.074 0.95 . . . . 75.03 109.084 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.8 m -99.36 105.15 17.09 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 61.3 107.75 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.463 HD12 HD11 ' B' ' 89' ' ' ILE . 29.9 pt -119.75 142.88 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.631 0.772 . . . . 71.54 110.065 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.58 161.12 41.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.757 0.823 . . . . 44.21 109.984 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 88' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 89.49 -54.43 3.83 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 123.647 0.592 . . . . 71.23 112.13 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.463 HD11 HD12 ' B' ' 86' ' ' ILE . 28.6 pt -54.44 145.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.531 1.132 . . . . 53.43 112.026 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -165.99 152.5 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.553 0.533 . . . . 70.3 110.485 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.95 -128.29 34.19 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.869 0.73 . . . . 44.35 114.058 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.6 m -69.25 -29.94 67.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.726 0.811 . . . . 74.32 110.77 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.65 -26.81 58.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.919 0.888 . . . . 63.21 110.392 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 35.3 ttm -62.71 -32.96 74.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.826 0.85 . . . . 71.54 110.422 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 95' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' H' ' 280' ' ' LEU . . . -64.77 -29.01 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.96 0.904 . . . . 33.21 112.608 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 96' ' ' HIS . . . . . 0.476 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 51.4 t-80 -69.07 -26.55 65.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.522 0.329 . . . . 74.34 110.773 175.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -80.94 -63.17 1.46 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.179 -0.304 . . . . 64.33 110.179 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.491 HD13 ' CD1' ' H' ' 281' ' ' PHE . 3.5 pp -67.12 -31.66 72.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.656 0.613 . . . . 74.3 112.656 -172.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 99' ' ' GLY . . . . . 0.481 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -108.32 3.08 32.94 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 119.718 -0.49 . . . . 61.42 114.284 -171.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -144.16 -57.64 0.38 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.377 0.588 . . . . 52.32 111.7 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.38 -53.75 11.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.312 0.645 . . . . 73.43 111.459 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 68.0 m -64.28 -45.05 78.27 Favored Pre-proline 0 CA--C 1.565 1.522 0 C-N-CA 123.956 0.903 . . . . 64.33 111.601 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.7 Cg_exo -55.6 -39.96 88.09 Favored 'Trans proline' 0 C--N 1.402 3.348 0 C-N-CA 122.649 2.233 . . . . 64.02 113.236 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -58.4 -29.17 65.86 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 123.579 0.752 . . . . 61.44 111.29 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 105' ' ' ILE . . . . . 0.403 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 73.1 mt -80.54 -53.42 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.786 0.834 . . . . 73.31 110.886 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.48 -24.54 56.95 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.367 0.667 . . . . 72.31 112.545 -170.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -63.53 -48.15 81.71 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.913 -1.041 . . . . 65.13 112.893 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 84.7 Cg_exo -51.9 -43.09 54.3 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.455 2.103 . . . . 53.42 113.966 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE2' HG21 ' D' ' 115' ' ' THR . 86.7 m-85 -67.1 -47.43 71.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.348 0.659 . . . . 75.25 110.888 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' ALA . . . . . 0.536 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.09 -48.27 80.67 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.813 0.696 . . . . 72.11 110.127 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -51.85 -52.27 50.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.806 1.642 . . . . 73.44 111.628 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.39 -35.0 78.43 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 123.657 0.598 . . . . 63.03 109.727 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.474 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.8 t -68.08 -31.0 70.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 122.93 0.492 . . . . 53.52 111.527 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.621 HG21 HG21 ' B' ' 64' ' ' VAL . 53.7 mt -70.14 -55.25 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.562 -0.903 . . . . 73.31 108.562 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -54.93 -33.91 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.88 1.363 . . . . 64.42 111.628 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -63.35 -51.56 65.4 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.398 -0.819 . . . . 62.13 109.552 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.76 -34.17 69.26 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.786 0.679 . . . . 75.2 111.318 -174.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 118' ' ' VAL . . . . . 0.422 HG21 HD23 ' B' ' 126' ' ' LEU . 85.0 t -62.64 -44.73 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.879 0.872 . . . . 72.5 110.011 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.8 t -68.6 -35.28 77.13 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.179 -0.919 . . . . 71.21 110.634 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.59 -29.42 69.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.026 0.53 . . . . 65.24 110.326 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.7 18.28 35.38 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.967 0.792 . . . . 54.35 112.629 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 35.5 p 54.51 44.98 27.94 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.876 1.67 . . . . 65.23 112.881 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 123' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' B' ' 124' ' ' PRO . 41.4 m-85 -112.78 147.32 36.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.403 0.681 . . . . 71.43 109.709 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 123' ' ' PHE . 10.6 Cg_exo -70.01 -165.63 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.41 2.74 . . . . 43.24 113.954 -175.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.421 HE21 ' N ' ' B' ' 126' ' ' LEU . 22.9 tp60 -61.27 129.56 41.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.967 1.099 . . . . 71.11 113.967 -163.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 126' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' H' ' 296' ' ' THR . 27.5 tp -136.3 118.35 15.37 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.609 1.163 . . . . 62.11 108.951 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -134.5 134.48 41.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.157 -1.053 . . . . 72.44 108.157 166.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.58 148.17 24.98 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.928 0.394 . . . . 74.34 111.342 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.07 147.94 55.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.204 1.002 . . . . 52.24 112.352 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 130' ' ' PRO . . . . . 0.454 ' HG3' ' CD1' ' D' ' 16' ' ' ILE . 85.0 Cg_endo -75.82 79.78 2.77 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.53 2.82 . . . . 75.13 111.306 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 58.4 t -88.99 111.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.781 -1.192 . . . . 74.21 107.781 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.54 94.52 1.31 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 124.162 0.914 . . . . 75.05 109.341 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -62.65 -27.46 69.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.091 0.956 . . . . 74.03 111.391 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.45 -44.26 89.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.624 1.169 . . . . 53.31 109.683 175.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.79 -42.92 76.72 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.737 -1.119 . . . . 75.23 110.658 -178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 82.9 mt -60.81 -36.92 80.29 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.535 0.734 . . . . 73.41 111.772 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -85.32 -46.82 10.62 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.221 -0.445 . . . . 71.1 111.04 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.92 -33.24 75.37 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.711 0.404 . . . . 53.44 111.971 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -75.81 -22.31 56.48 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.359 0.663 . . . . 72.1 111.779 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -65.63 -37.46 86.63 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.785 0.802 . . . . 65.34 109.535 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.11 6.48 48.43 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.345 -1.298 . . . . 65.15 110.414 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 69.58 112.34 0.05 OUTLIER 'General case' 0 C--N 1.363 1.163 0 C-N-CA 125.107 1.363 . . . . 72.33 109.569 -168.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -67.49 124.94 24.6 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.143 0.577 . . . . 72.03 110.936 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -104.46 130.02 52.4 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.195 -1.039 . . . . 62.43 108.195 167.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.52 -73.92 0.56 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.983 0.513 . . . . 75.51 109.752 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.91 61.64 3.94 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.477 -0.649 . . . . 75.21 111.477 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.84 117.85 13.94 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.525 0.73 . . . . 73.33 109.74 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.75 121.96 3.41 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.904 -0.479 . . . . 75.24 111.904 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 31.6 p -107.05 95.87 6.03 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.579 0.752 . . . . 74.44 109.708 177.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -83.39 146.56 28.39 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.806 -0.633 . . . . 71.04 110.179 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 151' ' ' GLU . . . . . 0.727 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 47.2 mt-10 -140.77 95.94 2.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.109 0.964 . . . . 63.31 108.897 174.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -104.69 130.93 52.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.065 0.546 . . . . 73.31 109.675 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.91 84.04 2.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.453 0.701 . . . . 72.45 109.825 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -163.78 -170.23 2.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.707 0.803 . . . . 72.11 109.717 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.595 0.758 . . . . 50.35 109.187 -178.486 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 111.744 0.275 . . . . 63.15 111.744 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -63.98 111.02 2.32 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.126 0.571 . . . . 54.43 109.635 177.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -130.63 151.16 51.39 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.586 0.754 . . . . 62.02 109.673 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -60.12 135.86 57.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.616 0.766 . . . . 63.0 110.659 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -148.34 -66.45 0.24 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.207 0.603 . . . . 73.45 109.65 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -87.48 67.45 9.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.826 0.822 . . . . 63.35 110.219 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -156.1 81.82 1.0 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.332 -1.359 . . . . 70.51 107.332 175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.72 150.31 27.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.253 -0.885 . . . . 74.33 109.235 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.445 ' HG3' HD13 ' C' ' 89' ' ' ILE . 41.0 ttm 65.24 113.52 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.977 1.311 . . . . 72.12 111.703 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.2 m -89.82 79.57 6.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.486 -0.931 . . . . 71.15 108.486 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -90.78 120.88 32.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 12' ' ' GLN . . . . . 0.632 ' HB2' ' HB ' ' G' ' 306' ' ' VAL . 12.5 pt20 -146.14 125.7 13.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.292 0.637 . . . . 74.22 109.594 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.29 138.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.433 -0.803 . . . . 72.3 110.395 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.86 -51.65 3.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.02 -0.363 . . . . 73.54 110.02 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -172.22 129.81 0.59 Allowed 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.276 0.36 . . . . 74.52 110.466 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.347 -0.982 . . . . 63.32 108.347 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG12 ' C' ' 83' ' ' ILE . 39.9 p90 -173.32 172.5 3.76 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.428 0.632 . . . . 74.34 111.417 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -92.16 114.95 27.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.647 -0.706 . . . . 61.24 110.103 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -64.48 -38.41 90.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.033 -0.728 . . . . 74.41 109.033 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.7 t70 -153.73 148.14 26.04 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.571 -1.195 . . . . 74.23 110.043 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -136.15 143.26 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 105.606 -1.998 . . . . 73.25 105.606 171.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -156.18 150.1 25.16 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.391 0.615 . . . . 62.32 109.868 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -152.59 118.19 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.481 -1.303 . . . . 71.45 107.481 173.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -115.44 139.43 50.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.655 -1.239 . . . . 75.42 107.655 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 84.25 53.48 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.66 -1.237 . . . . 75.1 107.66 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.32 -45.09 28.77 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.101 2.534 . . . . 72.23 112.226 -176.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.27 50.73 0.79 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.591 -0.892 . . . . 72.21 108.591 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.59 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -55.73 -48.15 97.17 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 115.518 -0.764 . . . . 73.23 112.832 -175.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 1.9 Cg_endo -85.91 -33.7 0.2 Allowed 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.929 1.752 . . . . 74.02 112.836 169.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 55.8 t60 -70.23 -33.52 71.75 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.657 0.984 . . . . 72.05 113.657 -167.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -79.44 -14.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 122.815 0.446 . . . . 75.02 111.224 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -71.31 -14.91 62.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.624 0.77 . . . . 74.04 111.601 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 33' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.1 pt20 -105.14 12.51 31.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.525 0.73 . . . . 62.23 110.824 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.443 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 1.1 mptm? -97.45 176.71 5.77 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.021 0.915 . . . . 63.51 112.994 -170.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -87.91 128.5 35.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.384 -1.735 . . . . 72.03 108.938 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.648 0.592 . . . . 73.44 111.206 -168.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -148.24 58.89 4.06 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.247 0.619 . . . . 52.31 110.319 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.37 123.31 10.1 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.767 2.311 . . . . 64.54 112.387 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.98 77.57 8.42 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.551 -1.648 . . . . 64.43 106.551 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -73.83 97.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.838 -1.074 . . . . 65.32 108.4 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -93.49 122.08 35.55 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.95 -1.023 . . . . 74.31 109.01 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.31 121.51 28.98 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.308 -1.368 . . . . 64.03 107.308 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.0 t70 -121.85 135.43 54.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.691 -1.225 . . . . 74.03 107.691 176.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tt -137.21 120.12 16.43 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.335 -0.987 . . . . 71.23 108.335 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.557 ' HA ' ' HA2' ' F' ' 284' ' ' GLY . 5.6 t70 -113.46 148.11 36.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.056 0.942 . . . . 62.44 108.71 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 46' ' ' THR . . . . . 0.48 ' HB ' ' CG ' ' F' ' 281' ' ' PHE . 62.0 p -117.19 118.85 33.46 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.212 -0.904 . . . . 75.45 109.753 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -124.37 146.6 48.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.0 0.92 . . . . 34.42 109.5 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.6 p -151.48 157.4 42.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.687 0.395 . . . . 75.21 110.584 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 49' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 20.0 m -143.81 147.53 34.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.133 0.973 . . . . 71.14 108.635 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -101.93 115.76 31.23 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.953 -1.129 . . . . 74.34 107.953 168.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' C' ' 57' ' ' GLU . 28.5 mt -98.18 -27.6 14.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.324 0.65 . . . . 63.12 110.034 -175.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.72 -171.38 1.83 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.242 1.017 . . . . 70.32 110.334 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.51 124.76 25.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.254 -0.884 . . . . 71.14 109.237 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 69.85 -8.88 0.75 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.878 1.671 . . . . 74.41 112.728 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.91 112.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.407 -0.59 . . . . 64.31 109.407 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -127.54 126.08 41.52 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.476 1.11 . . . . 63.44 108.685 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.603 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.4 tt0 -82.52 118.53 23.33 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.809 0.843 . . . . 75.33 108.745 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.15 114.75 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.952 -1.129 . . . . 53.43 107.952 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 59' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 43.6 t -110.64 131.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.071 -0.714 . . . . 63.04 109.071 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.436 HD13 ' HB3' ' C' ' 103' ' ' PRO . 36.2 tp -111.97 103.14 11.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.971 -1.122 . . . . 64.12 107.971 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.547 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 55.1 ttm-85 -81.32 115.36 20.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.883 -1.154 . . . . 64.4 107.883 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -116.73 108.74 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.905 -1.146 . . . . 75.43 107.905 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.1 m -116.02 124.37 50.29 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.834 0.854 . . . . 71.11 108.755 -174.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 56.2 t -117.8 113.71 43.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.846 -0.798 . . . . 73.31 108.846 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -100.88 146.84 26.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.595 -0.73 . . . . 72.13 109.343 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.66 13.06 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.132 -0.692 . . . . 74.24 109.132 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -131.63 126.28 34.32 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.841 -0.799 . . . . 70.14 108.841 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' C' ' 73' ' ' ALA . 9.2 mp -84.56 57.32 4.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.894 0.878 . . . . 63.25 109.399 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.1 -114.03 4.2 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.072 -1.211 . . . . 73.52 110.072 -174.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -90.8 -22.83 20.83 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.87 0.868 . . . . 62.15 110.322 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 7.3 tp10 -87.87 117.83 26.98 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.433 0.693 . . . . 70.12 110.844 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -76.23 128.05 34.13 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.006 0.431 . . . . 73.33 110.647 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 73' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' C' ' 68' ' ' LEU . . . -77.32 -60.45 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.792 -1.094 . . . . 60.42 109.422 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.11 176.47 12.21 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.88 -1.055 . . . . 72.32 110.58 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -140.98 120.86 13.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 106.357 -1.72 . . . . 71.13 106.357 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -117.01 119.89 36.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.439 -0.949 . . . . 72.02 108.439 177.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.69 141.71 51.53 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.72 -0.844 . . . . 70.31 108.72 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -147.41 115.14 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.444 1.098 . . . . 73.41 108.823 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.1 mt-30 -89.41 97.84 11.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.988 -1.115 . . . . 71.15 107.988 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -88.97 100.86 13.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.719 -0.673 . . . . 52.33 109.328 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.21 147.24 18.5 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.146 -0.479 . . . . 64.21 112.366 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.38 125.57 2.37 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 111.008 -0.837 . . . . 75.21 111.008 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' D' ' 29' ' ' PRO . 13.4 mm -81.76 122.66 37.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.765 -0.828 . . . . 61.1 108.765 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.54 138.17 45.93 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.3 p -109.34 106.17 15.86 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.933 -0.765 . . . . 71.21 108.933 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.46 142.24 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.856 0.863 . . . . 72.42 110.709 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.8 163.18 35.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.942 0.897 . . . . 43.01 110.406 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.82 -21.13 34.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.833 -0.621 . . . . 64.51 113.406 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 89' ' ' ILE . . . . . 0.445 HD13 ' HG3' ' C' ' 9' ' ' MET . 36.4 pt -114.18 148.16 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.063 0.945 . . . . 54.35 109.914 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 90' ' ' GLU . . . . . 0.547 ' HG3' ' HA ' ' F' ' 277' ' ' LEU . 35.6 tt0 -160.22 148.19 16.61 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.494 0.497 . . . . 61.03 110.099 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.51 -112.66 4.49 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 124.293 0.996 . . . . 72.22 113.543 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -64.69 -37.22 86.85 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.062 0.945 . . . . 65.12 111.775 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 76.6 mt-30 -65.88 -46.73 77.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.135 0.574 . . . . 72.25 110.937 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.437 ' HA ' HD12 ' C' ' 89' ' ' ILE . 3.1 ppp? -74.53 -20.97 59.76 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.509 -0.769 . . . . 63.55 110.146 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.66 72.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.408 0.683 . . . . 64.12 111.074 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 53.1 t-80 -68.18 -46.86 69.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.247 -0.433 . . . . 74.32 110.596 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.98 -56.56 9.62 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.141 -0.481 . . . . 64.02 110.376 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.02 -40.43 96.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.449 1.1 . . . . 63.14 111.894 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.93 70.42 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.481 -0.622 . . . . 70.04 114.415 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -149.87 -59.76 0.2 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.808 0.804 . . . . 73.12 111.988 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -75.0 -50.93 14.91 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.244 -0.435 . . . . 72.15 112.008 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.66 -45.76 97.09 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.577 0.751 . . . . 63.45 112.95 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 103' ' ' PRO . . . . . 0.436 ' HB3' HD13 ' C' ' 60' ' ' LEU . 44.2 Cg_endo -67.65 -24.72 41.11 Favored 'Trans proline' 0 C--N 1.393 2.875 0 C-N-CA 121.983 1.788 . . . . 74.32 112.882 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.47 -40.49 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.257 0.623 . . . . 71.24 109.392 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.08 -46.76 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.634 -0.712 . . . . 71.41 110.195 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.07 -20.84 44.23 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.27 -0.877 . . . . 70.41 112.226 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.9 -54.74 48.78 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.109 -0.948 . . . . 73.55 113.538 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.49 -31.52 71.53 Favored 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.994 1.796 . . . . 53.44 112.972 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -66.1 -45.38 81.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.524 0.73 . . . . 63.21 110.756 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.13 -37.78 86.54 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.852 -0.613 . . . . 74.04 110.439 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -60.56 -54.11 49.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.298 1.439 . . . . 70.32 111.425 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -35.39 80.28 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.608 0.568 . . . . 74.12 110.172 -177.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.09 -38.87 86.46 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.079 0.552 . . . . 71.44 111.822 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -67.76 -50.94 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.436 0.694 . . . . 61.53 110.169 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.4 m -63.14 -28.79 70.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.368 0.667 . . . . 61.11 111.311 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.6 t -67.58 -47.85 68.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.18 -0.674 . . . . 61.53 109.18 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.555 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.45 -37.67 86.82 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.961 0.904 . . . . 75.41 112.325 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.52 -40.58 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.049 0.539 . . . . 61.32 109.918 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.33 -33.96 76.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.651 0.78 . . . . 75.24 111.229 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.474 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 71.4 mtt-85 -70.48 -27.11 63.96 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.9 0.88 . . . . 73.12 110.901 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.24 15.01 62.13 Favored Glycine 0 C--N 1.352 1.45 0 O-C-N 123.63 0.581 . . . . 44.24 112.817 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.534 HG23 ' HB3' ' D' ' 17' ' ' TYR . 49.6 p 55.0 26.39 7.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.901 1.681 . . . . 65.21 112.638 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -103.46 141.86 23.38 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 124.425 1.09 . . . . 72.21 108.887 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -40.6 111.77 0.16 Allowed 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 124.148 3.232 . . . . 75.15 113.893 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -57.23 123.67 16.13 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.148 0.905 . . . . 74.13 111.268 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 126' ' ' LEU . . . . . 0.487 HD11 ' HH2' ' F' ' 290' ' ' TRP . 3.1 tm? -112.36 110.75 21.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.128 -1.064 . . . . 73.54 108.128 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -94.97 117.38 30.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.635 -0.876 . . . . 71.33 108.635 175.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.55 142.25 53.66 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.516 0.51 . . . . 61.32 110.268 175.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.2 160.84 81.73 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 115.099 -0.955 . . . . 63.32 111.065 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.623 ' HG2' HG21 ' A' ' 13' ' ' ILE . 26.0 Cg_exo -59.76 100.73 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.65 2.233 . . . . 63.42 112.455 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.452 HG11 HG21 ' F' ' 288' ' ' VAL . 61.2 t -98.85 107.12 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.399 -0.963 . . . . 74.01 108.399 175.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -114.34 106.25 14.09 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.232 1.013 . . . . 64.31 108.559 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 51.1 m-85 -63.91 -30.64 71.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.731 0.812 . . . . 72.43 111.429 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.43 -50.57 73.42 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.849 0.86 . . . . 63.22 110.515 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.46 87.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.213 -0.903 . . . . 53.34 110.693 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.12 -41.37 96.58 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.199 1.0 . . . . 74.3 110.401 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -64.05 -33.4 75.67 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.352 0.661 . . . . 73.21 111.333 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 62.3 mtt -77.71 -45.37 24.97 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.228 0.611 . . . . 74.15 111.046 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -59.69 -33.74 71.97 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.198 0.999 . . . . 54.2 111.766 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -29.54 -82.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.112 1.765 . . . . 65.12 112.548 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 50.1 tp -107.21 87.47 2.51 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.417 -0.586 . . . . 71.11 109.417 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -145.73 -168.85 3.09 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.7 1.2 . . . . 71.51 109.261 172.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 143' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 7' ' ' THR . 7.5 tp-100 -117.34 131.29 56.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.062 0.945 . . . . 73.51 109.66 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -118.97 127.34 53.38 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.953 0.901 . . . . 63.53 109.577 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.85 -70.82 0.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.184 0.593 . . . . 70.52 109.797 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.15 176.94 40.65 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 116.153 -0.476 . . . . 43.04 112.117 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.96 -65.67 1.12 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.529 0.732 . . . . 73.42 111.386 -172.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 142.62 -145.97 16.47 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.335 -0.848 . . . . 64.51 111.327 -173.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 99.8 m -148.96 150.13 32.35 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.398 1.079 . . . . 73.32 108.464 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -172.86 0.99 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 122.98 0.512 . . . . 63.34 110.723 174.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 151' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' C' ' 152' ' ' HIS . 23.0 tt0 -133.44 -174.96 3.65 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.887 -0.783 . . . . 72.23 108.887 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 152' ' ' HIS . . . . . 0.453 ' H ' ' HG2' ' C' ' 151' ' ' GLU . 8.2 p80 -152.04 138.41 18.5 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.12 0.418 . . . . 55.23 111.642 -177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 153' ' ' GLN . . . . . 0.687 ' HB2' ' HG2' ' B' ' 34' ' ' LYS . 90.2 mt-30 -114.76 118.54 33.88 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.021 -1.103 . . . . 75.21 108.021 169.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -97.84 120.67 38.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.627 0.771 . . . . 73.25 109.646 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 C-N-CA 123.505 0.722 . . . . 72.51 109.227 176.124 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.951 -0.389 . . . . 55.3 109.951 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -163.86 86.76 0.5 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.273 -1.01 . . . . 72.15 108.273 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.98 63.21 6.95 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.171 0.986 . . . . 54.33 111.192 -175.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -138.71 118.04 12.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.335 1.054 . . . . 74.21 109.044 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -149.68 84.02 1.41 Allowed 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.337 -1.357 . . . . 65.41 107.337 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -84.29 161.03 20.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.075 -0.966 . . . . 72.34 111.31 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -155.4 151.8 28.28 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.104 0.962 . . . . 72.32 109.77 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -139.7 71.5 1.38 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.635 -1.246 . . . . 74.32 107.635 164.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.8 ttp -34.58 126.34 0.5 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.67 -1.15 . . . . 74.34 111.713 166.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.5 m -136.79 139.87 42.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.735 -1.209 . . . . 54.42 107.735 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -156.8 92.93 1.32 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.05 -1.463 . . . . 55.25 107.05 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -122.02 156.44 33.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.674 0.79 . . . . 63.13 109.363 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.507 HD13 HG21 ' D' ' 105' ' ' ILE . 11.3 mt -102.0 122.48 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.983 -0.747 . . . . 42.15 108.983 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.25 -49.57 10.6 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.433 -0.58 . . . . 74.11 109.433 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 15' ' ' ARG . . . . . 0.513 ' HE ' HD12 ' D' ' 83' ' ' ILE . 19.4 ptt180 -173.65 152.67 2.11 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 112.171 0.434 . . . . 72.14 112.171 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.454 ' CD1' ' HG3' ' B' ' 130' ' ' PRO . 4.0 mp -114.36 139.35 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.621 -1.622 . . . . 72.42 106.621 167.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.59 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 41.2 p90 -162.56 157.67 22.43 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.833 0.853 . . . . 64.22 109.691 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -81.42 113.55 19.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.459 -1.246 . . . . 72.45 109.175 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.9 mtpt -83.33 -33.2 25.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.098 0.475 . . . . 63.14 109.812 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.6 t70 -144.93 135.54 24.45 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.537 -1.21 . . . . 71.34 109.038 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.555 HG21 ' HE2' ' C' ' 117' ' ' MET . 53.4 mt -133.43 140.89 45.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.351 -1.351 . . . . 64.05 107.351 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -154.44 102.32 2.41 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.675 0.79 . . . . 62.55 109.466 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.0 t80 -108.39 115.49 30.2 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 105.783 -1.932 . . . . 73.32 105.783 167.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -121.01 131.78 54.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.149 -0.686 . . . . 74.23 109.149 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.45 78.26 45.77 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.284 -1.376 . . . . 75.13 107.284 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.9 -35.15 36.49 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.675 2.25 . . . . 62.42 111.522 -172.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 6.7 m120 -109.91 22.29 15.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.775 0.83 . . . . 72.01 109.99 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.43 -64.82 0.31 Allowed Pre-proline 0 CA--C 1.571 1.773 0 N-CA-C 116.13 1.9 . . . . 74.13 116.13 -171.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.508 ' HB3' HD11 ' C' ' 83' ' ' ILE . 40.0 Cg_endo -81.03 -14.5 10.91 Favored 'Trans proline' 0 C--N 1.39 2.744 0 CA-C-N 122.023 1.758 . . . . 74.41 113.339 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 30' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 1.3 t60 -71.35 -37.43 71.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.901 1.28 . . . . 71.44 109.06 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.633 HG13 HD11 ' D' ' 68' ' ' LEU . 76.1 t -74.12 -30.98 28.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 115.131 -0.94 . . . . 74.32 109.95 175.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -70.84 6.76 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.644 0.979 . . . . 73.21 113.644 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -84.48 -37.84 20.84 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.367 -0.605 . . . . 75.24 109.367 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 34' ' ' LYS . . . . . 0.426 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 30.4 pttt -132.45 95.87 3.72 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 124.23 1.012 . . . . 74.12 112.319 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.427 ' CG ' HD11 ' G' ' 301' ' ' ILE . 92.2 m-20 -108.72 92.74 4.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 72.42 109.522 170.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 36' ' ' TRP . . . . . 0.426 ' HZ3' ' HA ' ' D' ' 34' ' ' LYS . 12.3 m-90 -125.86 -179.99 4.93 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.364 -1.347 . . . . 75.13 107.364 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 18.4 tm0? -50.05 104.65 0.44 Allowed Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.476 0.71 . . . . 73.03 112.055 -163.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.69 109.72 2.91 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.958 2.438 . . . . 70.41 109.464 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.62 113.9 4.04 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.589 -0.893 . . . . 74.54 108.589 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.418 HG11 HD11 ' D' ' 126' ' ' LEU . 1.2 m -104.78 114.2 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 114.436 -1.256 . . . . 45.44 110.64 -166.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 81.1 tttt -87.54 128.65 35.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.198 1.399 . . . . 73.4 108.945 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -101.77 114.17 27.99 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.382 0.673 . . . . 75.55 109.828 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.646 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -106.84 109.43 21.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.256 -1.387 . . . . 73.41 107.256 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 44' ' ' LEU . . . . . 0.419 ' HG ' ' HG2' ' G' ' 286' ' ' MET . 3.0 mm? -97.5 130.88 44.54 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.245 -1.02 . . . . 74.44 108.245 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -133.49 130.39 38.48 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.149 -1.056 . . . . 72.23 108.149 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -103.88 142.4 34.47 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.6 0.76 . . . . 63.14 109.781 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.24 150.65 27.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.549 0.74 . . . . 71.22 109.251 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.5 p -164.63 153.32 12.72 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.393 0.677 . . . . 41.53 109.332 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -158.65 142.55 15.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.063 0.545 . . . . 63.35 110.054 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -73.05 128.47 35.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.356 0.662 . . . . 71.22 109.393 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -100.88 -26.32 13.79 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.884 0.474 . . . . 73.32 110.552 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.52 -179.09 4.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.753 0.821 . . . . 61.21 110.82 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.04 119.82 12.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.852 -1.067 . . . . 62.51 108.858 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 54' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 40.5 m-20 66.39 16.79 10.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.044 1.338 . . . . 75.03 111.891 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.81 114.81 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.934 0.894 . . . . 72.23 108.969 175.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 56' ' ' TYR . . . . . 0.448 ' HB2' HD12 ' D' ' 86' ' ' ILE . 90.4 m-85 -132.81 129.45 38.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.352 1.061 . . . . 73.22 108.489 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -100.27 139.73 35.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.384 1.074 . . . . 50.5 109.789 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.58 118.8 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 73.45 108.305 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.5 t -104.99 131.4 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.442 -0.947 . . . . 72.51 108.442 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.93 109.76 12.84 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.991 -1.115 . . . . 70.24 107.991 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.2 ttm-85 -87.05 109.36 19.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.537 0.735 . . . . 74.12 109.838 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.56 104.25 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.591 -1.263 . . . . 50.22 107.591 166.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.8 m -100.0 136.51 39.8 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.433 -0.58 . . . . 65.31 109.433 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.06 110.12 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.46 1.104 . . . . 63.24 108.255 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 39.6 m -102.97 103.08 13.17 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.597 0.759 . . . . 63.5 109.244 175.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.59 135.99 36.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 29.5 p -148.36 124.28 10.64 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.641 0.588 . . . . 63.33 110.433 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.634 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.5 OUTLIER -113.04 126.7 55.78 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.422 -0.955 . . . . 54.01 108.422 172.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -134.03 28.11 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.474 -0.65 . . . . 65.32 111.474 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.26 4.2 54.38 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.979 0.512 . . . . 73.33 110.874 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -119.07 144.18 46.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 75.41 111.337 -168.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.8 m -74.72 120.1 19.81 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 123.469 0.708 . . . . 75.13 109.895 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.634 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -67.94 -61.53 1.82 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.252 0.97 . . . . 72.42 110.191 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.37 168.56 26.24 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.247 -1.342 . . . . 63.54 110.454 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.7 mt -127.45 139.57 52.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.65 -1.611 . . . . 72.31 106.65 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' HG23 ' D' ' 114' ' ' ILE . 36.2 t -153.38 110.21 3.42 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.415 -0.587 . . . . 70.32 109.415 -175.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -136.45 132.18 35.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.45 1.1 . . . . 71.43 108.998 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.39 121.79 20.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.117 0.567 . . . . 65.31 109.614 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -88.74 88.83 7.74 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.321 -0.992 . . . . 61.42 108.321 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -81.11 96.63 7.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.565 -1.198 . . . . 65.15 108.958 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.09 144.24 17.01 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.579 -0.608 . . . . 64.45 111.579 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.74 130.0 4.03 Favored Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 110.834 -0.906 . . . . 74.33 110.834 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 83' ' ' ILE . . . . . 0.513 HD12 ' HE ' ' D' ' 15' ' ' ARG . 48.0 mt -89.82 127.04 42.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.527 -0.916 . . . . 64.4 108.527 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -129.12 133.51 47.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.724 0.809 . . . . 74.24 109.759 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.1 m -80.92 94.98 6.61 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 108.901 -0.777 . . . . 55.11 108.901 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' D' ' 56' ' ' TYR . 40.1 mt -111.34 123.63 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.444 0.698 . . . . 62.13 110.202 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 87' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -149.67 165.01 33.63 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.767 0.827 . . . . 52.53 110.671 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.71 -19.44 24.73 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.411 0.925 . . . . 52.12 115.411 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.552 ' O ' HD23 ' G' ' 277' ' ' LEU . 19.7 pt -129.2 134.73 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 117.835 0.817 . . . . 40.31 111.879 -170.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.33 -171.26 3.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.617 0.767 . . . . 63.04 110.061 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 -140.41 34.5 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.622 0.576 . . . . 61.04 112.18 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -78.19 -20.87 51.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.381 0.672 . . . . 70.31 111.57 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -60.44 -52.96 63.01 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.759 0.823 . . . . 75.21 110.17 177.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.27 -41.56 69.87 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 114.86 -1.063 . . . . 55.45 109.923 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.38 -26.92 68.68 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.476 0.71 . . . . 75.11 112.36 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.88 -42.04 25.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.347 0.659 . . . . 73.44 109.694 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.39 -31.03 71.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.068 0.547 . . . . 63.42 110.836 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -46.59 18.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 71.3 108.611 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.14 -20.05 79.41 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.97 -1.013 . . . . 75.2 114.377 -173.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.98 -61.71 1.22 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 117.17 0.485 . . . . 72.35 111.805 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -67.11 -40.89 86.95 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 112.677 0.621 . . . . 75.44 112.677 -170.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.5 m -63.76 -47.48 81.52 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-O 118.72 -0.657 . . . . 65.33 111.742 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.3 -40.2 35.43 Favored 'Trans proline' 0 C--N 1.4 3.269 0 C-N-CA 123.045 2.497 . . . . 63.11 114.196 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -59.78 -27.0 66.17 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 112.764 0.653 . . . . 64.11 112.764 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.507 HG21 HD13 ' D' ' 13' ' ' ILE . 41.6 mm -82.42 -44.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-O 121.157 0.503 . . . . 53.02 110.572 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.1 mt -76.29 -32.2 58.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.97 -1.014 . . . . 72.25 111.722 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 107' ' ' PHE . . . . . 0.408 ' HZ ' ' HG ' ' D' ' 128' ' ' LEU . 62.8 t80 -63.48 -42.86 76.36 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.566 1.146 . . . . 75.44 113.872 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.08 -42.65 45.37 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 122.386 2.058 . . . . 61.04 113.19 171.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -81.26 -27.67 35.07 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.58 0.752 . . . . 75.21 111.858 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.61 -53.54 49.97 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 173.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 39.1 ttp180 -58.74 -42.08 87.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.837 -1.529 . . . . 61.11 110.99 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.74 -49.92 74.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.771 0.828 . . . . 72.0 110.708 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -60.19 -44.2 95.28 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.843 0.714 . . . . 52.51 111.176 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.578 HG23 ' SG ' ' D' ' 76' ' ' CYS . 49.8 mt -58.57 -55.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 72.42 111.07 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 115' ' ' THR . . . . . 0.505 HG21 ' HE2' ' B' ' 109' ' ' TYR . 63.2 m -53.24 -47.46 69.01 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.239 1.016 . . . . 72.43 111.758 -174.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 46.7 t -62.14 -37.8 86.54 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.655 -1.157 . . . . 63.12 111.204 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 72.6 mtm -75.17 -32.14 61.19 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.871 0.469 . . . . 74.22 111.998 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.516 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -68.07 -36.93 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 116.066 -0.515 . . . . 54.41 109.733 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.2 p -72.54 -28.44 62.84 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.874 0.47 . . . . 65.24 111.085 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 120' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.4 mtt-85 -73.06 -27.23 61.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.673 0.789 . . . . 71.24 110.635 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.95 8.42 76.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.015 -0.538 . . . . 74.43 112.395 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p 66.54 13.67 9.39 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.084 2.154 . . . . 51.32 114.02 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 123' ' ' PHE . . . . . 0.489 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 76.5 m-85 -90.99 169.19 12.12 Favored Pre-proline 0 CA--C 1.568 1.647 0 C-N-CA 124.536 1.135 . . . . 70.02 107.964 169.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 124' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 93.0 Cg_endo -74.47 166.94 28.29 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.532 2.155 . . . . 61.45 112.92 -172.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 76.9 mt-30 -60.9 121.69 13.02 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.114 -0.494 . . . . 70.45 109.757 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 126' ' ' LEU . . . . . 0.418 HD11 HG11 ' D' ' 40' ' ' VAL . 7.5 tt -104.24 93.53 4.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.16 -1.422 . . . . 65.21 107.16 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -103.25 89.82 3.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.011 -1.45 . . . . 73.22 108.596 -171.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 23.1 tp -71.96 122.78 21.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.854 -0.612 . . . . 71.21 110.514 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.91 140.31 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.492 1.117 . . . . 44.15 112.223 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.67 114.42 3.67 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.661 2.241 . . . . 73.35 110.371 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.56 143.56 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.555 0.742 . . . . 34.44 109.682 -172.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -69.67 101.72 1.72 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.189 0.996 . . . . 73.34 110.302 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -71.24 -33.31 69.73 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.262 0.625 . . . . 73.22 111.175 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.07 -57.57 12.01 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.467 0.707 . . . . 74.24 111.799 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.91 89.86 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.911 0.757 . . . . 52.45 111.674 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' G' ' 287' ' ' PRO . 87.5 mt -64.78 -36.47 84.42 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.57 -0.741 . . . . 73.52 111.246 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -71.63 -41.43 68.87 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.701 -0.681 . . . . 70.14 110.579 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 138' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 78.3 mtm -69.51 -31.68 70.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.015 0.526 . . . . 73.35 110.852 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 139' ' ' ASN . . . . . 0.562 ' HA ' HE21 ' D' ' 142' ' ' GLN . 32.0 m-80 -75.68 -25.4 56.72 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 119.083 -0.484 . . . . 72.24 111.82 174.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -59.9 -43.37 94.87 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 120.896 0.379 . . . . 71.23 110.735 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.57 -31.06 71.81 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.891 0.876 . . . . 75.33 111.32 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 142' ' ' GLN . . . . . 0.727 ' HG2' ' HA ' ' B' ' 151' ' ' GLU . 42.0 mt-30 -83.08 3.26 31.24 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.688 0.795 . . . . 74.4 112.311 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -117.27 53.48 0.92 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.917 0.865 . . . . 74.34 108.779 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -159.54 151.41 20.51 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 113.859 -1.519 . . . . 65.41 109.073 173.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.31 150.64 36.89 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.492 -0.558 . . . . 64.21 109.492 173.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.88 56.55 4.94 Favored Glycine 0 C--N 1.345 1.064 0 O-C-N 123.35 0.406 . . . . 40.31 112.113 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.21 112.97 9.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.542 0.737 . . . . 74.53 109.051 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.94 127.49 27.83 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.795 0.684 . . . . 74.13 112.903 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 149' ' ' THR . . . . . 0.428 HG22 ' HG3' ' D' ' 151' ' ' GLU . 38.8 m -106.82 111.89 24.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.253 1.021 . . . . 73.41 108.559 175.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -98.82 94.33 6.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.325 -0.62 . . . . 74.04 109.325 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 151' ' ' GLU . . . . . 0.428 ' HG3' HG22 ' D' ' 149' ' ' THR . 46.1 mt-10 -112.1 154.75 24.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.929 0.892 . . . . 74.21 109.673 172.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -158.55 126.01 5.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.236 1.014 . . . . 75.32 109.083 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -65.29 -53.26 46.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.962 0.905 . . . . 73.34 111.304 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 73.42 177.07 0.25 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.229 1.412 . . . . 62.01 111.482 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.327 0 C-N-CA 123.843 0.857 . . . . 70.45 109.036 176.962 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.768 0.318 . . . . 73.11 110.898 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -104.16 126.14 51.04 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.684 -0.858 . . . . 74.42 108.684 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -70.13 98.31 1.31 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.128 0.571 . . . . 73.45 109.963 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -163.55 166.02 22.95 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.643 1.177 . . . . 72.02 108.164 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.77 68.88 0.94 Allowed Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 124.474 1.11 . . . . 72.22 109.765 -172.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.19 110.58 2.29 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.662 2.241 . . . . 72.05 110.902 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 60.0 tp -54.47 -39.79 67.81 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.962 0.905 . . . . 63.44 110.374 175.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.89 107.23 17.61 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.839 -1.073 . . . . 72.45 109.721 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.92 26.37 1.29 Allowed Glycine 0 C--N 1.347 1.155 0 O-C-N 123.701 0.625 . . . . 65.22 112.356 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -153.14 76.17 1.1 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.532 -0.914 . . . . 74.32 108.532 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 5.0 t80 176.42 -176.26 0.12 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.042 1.337 . . . . 73.45 108.107 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 282' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 46' ' ' THR . . . 72.29 105.97 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.665 1.186 . . . . 60.21 110.741 171.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 16.8 t70 72.92 136.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.043 1.337 . . . . 62.15 110.451 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 110.48 80.63 1.15 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.149 -0.78 . . . . 71.31 111.149 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -75.97 153.44 36.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.337 0.655 . . . . 65.11 110.875 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 62.5 mtt -88.85 141.27 29.67 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.777 -0.647 . . . . 71.31 109.429 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.7 70.7 5.69 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.85 2.367 . . . . 70.11 110.925 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 62.3 t -76.54 134.31 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 114.787 -1.097 . . . . 73.35 109.859 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -62.49 142.61 57.84 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.835 0.709 . . . . 63.04 109.907 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 290' ' ' TRP . . . . . 0.485 ' HE1' HG13 ' A' ' 40' ' ' VAL . 1.7 t-105 -92.27 109.08 20.45 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.831 -1.174 . . . . 72.32 107.831 170.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.516 ' HB3' HG13 ' G' ' 306' ' ' VAL . 4.9 mp -74.12 -16.33 61.01 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.818 -1.083 . . . . 54.55 111.769 -172.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -118.75 82.12 0.33 Allowed Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.183 -0.787 . . . . 62.4 111.925 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.57 46.44 2.26 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.316 2.677 . . . . 71.42 111.14 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -111.71 132.99 54.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.258 1.423 . . . . 71.2 108.0 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -64.14 123.29 18.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.026 -0.731 . . . . 64.24 109.026 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 20.9 m -55.29 -49.37 72.3 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 124.179 0.924 . . . . 72.13 111.611 -172.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.458 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 21.6 m-85 -68.19 87.31 0.28 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.437 0.636 . . . . 73.21 110.719 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -136.86 -42.61 0.59 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.642 1.177 . . . . 75.02 108.327 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -72.69 -132.37 0.16 Allowed Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.549 -0.75 . . . . 55.33 113.15 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 300' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' D' ' 124' ' ' PRO . 2.4 p-10 -72.21 120.89 18.46 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 117.136 0.468 . . . . 63.15 110.472 -174.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 9.4 tp -153.69 -45.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 122.604 0.362 . . . . 72.43 110.453 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 302' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' G' ' 298' ' ' HIS . 9.0 t70 63.6 -178.83 0.15 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 124.727 1.211 . . . . 62.15 112.07 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 303' ' ' LYS . . . . . 0.595 ' H ' ' HD2' ' E' ' 304' ' ' PRO . 39.8 ttmt -162.72 -48.66 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.417 0 C-N-CA 124.57 1.148 . . . . 73.1 111.241 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 304' ' ' PRO . . . . . 0.595 ' HD2' ' H ' ' E' ' 303' ' ' LYS . 4.6 Cg_endo -45.52 -39.3 17.13 Favored 'Trans proline' 0 C--N 1.406 3.563 0 C-N-CA 123.51 2.806 . . . . 63.11 115.064 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.32 162.7 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.719 1.208 . . . . 73.22 111.855 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 306' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' B' ' 13' ' ' ILE . 58.5 t -74.34 127.75 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 122.879 0.472 . . . . 62.2 110.114 -174.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 24.4 m -74.7 141.35 44.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.761 0.824 . . . . 64.34 111.11 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' E' E ' 308' ' ' CYS . . . . . 0.572 ' HA ' ' HG3' ' B' ' 12' ' ' GLN . 67.3 m -64.48 152.29 42.08 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.311 1.044 . . . . 62.14 111.731 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 309' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' E' ' 310' ' ' PRO . 9.0 t -144.62 140.01 16.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.145 0.578 . . . . 74.44 110.454 -178.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' E' E ' 310' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' E' ' 309' ' ' THR . 7.9 Cg_exo . . . . . 0 C--N 1.373 1.834 0 C-N-CA 122.978 2.452 . . . . 61.04 111.155 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 110.882 -0.044 . . . . 74.33 110.882 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 65.97 -169.44 0.2 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.678 1.191 . . . . 72.02 110.268 -171.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 61.71 35.05 17.12 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.091 0.956 . . . . 75.12 110.435 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -87.56 59.88 5.7 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.997 0.904 . . . . 74.42 109.733 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -121.25 79.56 35.66 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 124.306 1.042 . . . . 73.33 108.682 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -92.38 -84.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.021 2.48 . . . . 71.34 110.894 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 277' ' ' LEU . . . . . 0.547 ' HA ' ' HG3' ' C' ' 90' ' ' GLU . 7.9 tt -88.56 -41.11 12.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.616 -1.253 . . . . 72.11 107.616 168.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 278' ' ' LEU . . . . . 0.409 HD12 ' HE1' ' C' ' 94' ' ' MET . 45.8 tp -67.01 112.02 4.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.66 1.184 . . . . 75.11 110.248 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -97.49 -80.72 1.55 Allowed Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.237 -0.438 . . . . 73.31 113.216 -175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.12 -172.41 1.08 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.581 0.752 . . . . 65.35 111.755 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 281' ' ' PHE . . . . . 0.48 ' CG ' ' HB ' ' C' ' 46' ' ' THR . 4.1 m-85 67.85 93.13 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.477 1.111 . . . . 74.1 111.22 177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -161.4 -34.29 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.452 0.701 . . . . 72.14 111.432 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -132.71 -171.84 2.76 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.787 0.835 . . . . 74.33 109.957 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 284' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' C' ' 45' ' ' ASP . . . -95.24 124.15 7.88 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-O 119.897 -0.39 . . . . 73.42 112.316 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 285' ' ' ASN . . . . . 0.472 HD22 ' HA ' ' A' ' 155' ' ' ALA . 10.5 t-20 -163.5 177.85 8.51 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.243 1.017 . . . . 60.5 108.263 174.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 286' ' ' MET . . . . . 0.452 ' N ' ' HD3' ' F' ' 287' ' ' PRO . 17.8 mmt 62.74 47.29 0.9 Allowed Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 124.455 1.102 . . . . 75.15 111.094 -170.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 287' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' F' ' 286' ' ' MET . 20.3 Cg_exo -65.29 -34.95 42.86 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 122.083 1.855 . . . . 72.32 112.244 -174.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 288' ' ' VAL . . . . . 0.452 HG21 HG11 ' C' ' 131' ' ' VAL . 60.6 t 70.53 124.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.131 1.373 . . . . 74.25 110.371 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -72.34 -81.44 0.05 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.736 0.414 . . . . 73.42 110.62 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 290' ' ' TRP . . . . . 0.487 ' HH2' HD11 ' C' ' 126' ' ' LEU . 0.5 OUTLIER -175.62 148.81 0.93 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.987 1.315 . . . . 73.42 108.157 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' H' ' 306' ' ' VAL . 0.0 OUTLIER -103.44 -3.82 24.9 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.13 0.972 . . . . 71.23 110.725 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -163.92 168.32 38.38 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.439 -0.8 . . . . 72.43 111.303 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.05 42.8 1.38 Allowed 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.855 3.037 . . . . 75.3 112.791 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 69.86 115.28 0.04 OUTLIER 'General case' 0 C--N 1.364 1.235 0 C-N-CA 125.385 1.474 . . . . 65.04 112.187 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.84 -10.48 57.11 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.554 0.741 . . . . 25.25 111.133 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 3.7 m -68.68 121.41 16.4 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.809 0.844 . . . . 55.4 109.654 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 64.28 48.31 2.89 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.539 1.136 . . . . 71.2 111.687 -173.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -67.85 -27.43 66.68 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 107.912 -1.144 . . . . 71.22 107.912 165.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -129.06 149.54 18.55 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 110.316 -1.114 . . . . 73.34 110.316 166.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -75.48 151.03 38.08 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.551 0.74 . . . . 74.3 110.236 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.456 ' HB ' ' HG3' ' F' ' 304' ' ' PRO . 36.1 pt -90.57 43.23 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.547 0.689 . . . . 64.51 111.883 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.91 86.86 2.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.468 -0.938 . . . . 72.42 108.468 169.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 303' ' ' LYS . . . . . 0.56 ' HE2' ' SG ' ' F' ' 308' ' ' CYS . 0.1 OUTLIER 64.88 70.39 0.61 Allowed Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 125.598 1.559 . . . . 64.41 111.05 -178.526 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' F' F ' 304' ' ' PRO . . . . . 0.462 ' HD2' ' OG1' ' F' ' 307' ' ' THR . 24.0 Cg_exo -60.36 -40.39 58.72 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.256 2.637 . . . . 75.05 112.36 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -169.07 -76.6 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.647 1.217 . . . . 40.31 109.372 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 306' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' D' ' 15' ' ' ARG . 5.6 t -93.44 97.2 6.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.098 -1.075 . . . . 73.31 108.098 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 307' ' ' THR . . . . . 0.462 ' OG1' ' HD2' ' F' ' 304' ' ' PRO . 82.0 m -149.82 -46.74 0.13 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.729 0.411 . . . . 65.35 111.517 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 308' ' ' CYS . . . . . 0.56 ' SG ' ' HE2' ' F' ' 303' ' ' LYS . 85.2 m -136.11 104.08 5.55 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.787 0.327 . . . . 75.4 111.443 -172.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 48.7 p -88.37 117.95 68.94 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 107.346 -1.353 . . . . 74.03 107.346 162.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--N 1.377 2.03 0 C-N-CA 123.389 2.726 . . . . 70.42 113.189 -176.535 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 121.018 0.437 . . . . 32.32 110.286 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -88.59 109.64 20.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.131 -0.692 . . . . 64.11 109.131 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -111.5 70.49 0.71 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.719 -0.845 . . . . 71.01 108.719 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -116.16 178.12 4.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.695 -1.139 . . . . 53.55 110.203 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 275' ' ' LYS . . . . . 0.548 ' H ' ' HD3' ' G' ' 275' ' ' LYS . 0.3 OUTLIER -121.38 149.04 51.31 Favored Pre-proline 0 C--O 1.247 0.935 0 CA-C-N 115.241 -0.89 . . . . 72.31 109.539 -174.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.37 -178.85 3.18 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.635 2.223 . . . . 74.1 111.945 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.552 HD23 ' O ' ' D' ' 89' ' ' ILE . 56.5 mt 62.62 22.49 13.35 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.792 0.837 . . . . 72.13 111.304 -176.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 29.2 tp -161.33 -66.04 0.06 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.014 -1.106 . . . . 65.25 108.014 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 72.34 -83.47 0.54 Allowed Glycine 0 C--N 1.348 1.198 0 CA-C-N 115.606 -0.724 . . . . 75.24 112.781 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 pp -158.17 157.1 32.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.723 0.809 . . . . 65.01 110.977 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -159.81 86.82 0.79 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.509 -1.293 . . . . 60.23 107.509 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -148.67 -160.44 1.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.957 -1.02 . . . . 73.35 109.406 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 22.6 t70 76.75 148.2 0.1 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.455 1.502 . . . . 74.01 111.455 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -114.98 12.98 19.89 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.935 -0.925 . . . . 72.14 114.615 -170.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -79.21 92.64 5.11 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.26 1.03 . . . . 75.01 109.303 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 286' ' ' MET . . . . . 0.419 ' HG2' ' HG ' ' D' ' 44' ' ' LEU . 0.3 OUTLIER -134.98 94.33 16.36 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.102 -1.074 . . . . 72.0 108.102 176.301 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' G' G ' 287' ' ' PRO . . . . . 0.504 ' HD2' HD13 ' D' ' 136' ' ' LEU . 32.1 Cg_exo -63.79 15.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 124.113 3.209 . . . . 72.25 116.227 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.09 86.56 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.874 -0.787 . . . . 73.43 108.874 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -121.07 29.24 7.44 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.191 0.996 . . . . 75.13 108.631 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.414 ' NE1' HG23 ' D' ' 40' ' ' VAL . 94.7 m95 67.97 113.11 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.087 1.355 . . . . 75.41 110.961 -168.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.41 7.06 37.82 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 114.858 -1.065 . . . . 61.0 110.661 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -179.26 68.45 0.07 OUTLIER Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.387 -0.685 . . . . 63.12 111.387 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.65 -142.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.327 2.684 . . . . 71.13 111.719 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt 65.22 28.3 12.08 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.211 1.005 . . . . 65.02 111.61 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -160.33 112.37 1.98 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.927 -1.033 . . . . 74.55 109.948 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -68.0 0.06 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.003 1.321 . . . . 73.15 107.667 173.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 297' ' ' TYR . . . . . 0.471 ' CD2' ' HD3' ' D' ' 124' ' ' PRO . 0.3 OUTLIER -122.35 71.69 1.02 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.856 -0.424 . . . . 73.33 109.856 -173.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' G' G ' 298' ' ' HIS . . . . . 0.434 ' HB3' ' HA ' ' E' ' 302' ' ' ASP . 71.6 t60 -88.35 74.26 8.68 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.492 -1.299 . . . . 73.4 107.492 164.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -115.39 -140.26 7.05 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 114.997 -1.001 . . . . 72.41 111.145 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -156.26 -37.71 0.08 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.663 0.385 . . . . 71.12 111.046 -176.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.427 HD11 ' CG ' ' D' ' 35' ' ' ASP . 97.0 mt 73.37 -71.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 125.148 1.379 . . . . 71.41 110.188 -166.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 35.7 t70 62.99 118.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.949 1.3 . . . . 72.3 110.363 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -49.98 122.25 14.02 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.517 0.727 . . . . 71.24 112.477 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.61 170.34 14.44 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.02 2.48 . . . . 60.22 110.892 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -163.48 -37.68 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.014 0.525 . . . . 52.34 111.287 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' C' ' 12' ' ' GLN . 62.2 t 68.46 147.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 124.092 0.957 . . . . 73.42 110.517 -172.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 44.8 p -64.1 -70.99 0.19 Allowed 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 109.569 -0.53 . . . . 70.42 109.569 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 49.3 t 169.33 158.29 0.05 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.352 1.461 . . . . 72.22 109.199 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 21.8 p -77.92 141.87 64.1 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.417 0.687 . . . . 44.33 109.869 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.38 2.206 0 C-N-CA 123.651 2.901 . . . . 73.12 113.434 -179.121 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 110.39 -0.226 . . . . 65.25 110.39 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -71.41 -57.45 4.43 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.967 0.507 . . . . 61.24 109.901 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 60.34 90.76 0.06 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.216 1.007 . . . . 72.33 111.099 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -73.27 82.76 1.37 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.978 0.894 . . . . 73.21 111.736 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -91.79 134.49 28.95 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-N 115.224 -0.898 . . . . 75.53 109.171 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.79 -42.66 24.09 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.185 2.59 . . . . 63.01 113.229 -175.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 58.3 mt -118.52 167.14 11.89 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.121 0.569 . . . . 63.21 110.54 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.12 19.58 9.18 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.416 1.486 . . . . 64.25 112.458 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -87.49 39.14 3.11 Favored Glycine 0 C--N 1.353 1.472 0 C-N-CA 122.676 0.179 . . . . 42.03 112.789 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 280' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' B' ' 95' ' ' ALA . 18.1 tp -165.17 33.67 0.06 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.852 1.261 . . . . 61.34 107.833 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 281' ' ' PHE . . . . . 0.491 ' CD1' HD13 ' B' ' 98' ' ' LEU . 6.6 t80 -147.23 113.99 6.07 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.045 -0.979 . . . . 70.45 109.574 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -166.53 -54.4 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.724 0.64 . . . . 32.41 110.541 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -148.77 147.53 28.91 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.077 0.951 . . . . 63.41 109.304 -174.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 153.06 61.06 0.01 OUTLIER Glycine 0 C--N 1.346 1.133 0 O-C-N 123.077 0.236 . . . . 61.22 112.628 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -73.06 128.9 36.8 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.584 -0.524 . . . . 75.32 109.584 172.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 286' ' ' MET . . . . . 0.402 ' N ' ' SD ' ' H' ' 286' ' ' MET . 1.5 mpt? -71.47 135.88 83.89 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.211 -1.033 . . . . 65.52 108.211 172.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.45 80.25 1.09 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.415 2.077 . . . . 71.15 110.857 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.4 102.91 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.448 -0.796 . . . . 74.43 109.427 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -95.27 24.31 5.12 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.414 1.086 . . . . 71.13 109.505 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 97.4 m95 69.95 -175.41 0.19 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.492 1.517 . . . . 74.54 111.758 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 5.5 mp -71.13 -18.79 62.5 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.016 0.926 . . . . 74.42 111.563 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 152.69 -66.87 0.33 Allowed Glycine 0 C--N 1.34 0.755 0 N-CA-C 109.555 -1.418 . . . . 64.32 109.555 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.16 144.88 23.92 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.456 2.104 . . . . 52.54 110.909 167.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 132.73 49.86 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.603 -0.726 . . . . 74.01 110.384 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -107.36 -176.7 3.14 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.595 0.758 . . . . 71.32 111.365 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 296' ' ' THR . . . . . 0.58 HG22 ' HD1' ' H' ' 297' ' ' TYR . 3.8 m 74.71 146.26 0.09 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.415 1.486 . . . . 62.42 111.135 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 297' ' ' TYR . . . . . 0.58 ' HD1' HG22 ' H' ' 296' ' ' THR . 2.7 m-85 64.16 -82.73 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.612 1.165 . . . . 72.32 110.617 -173.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 61.18 99.98 0.03 OUTLIER 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.913 1.285 . . . . 73.13 110.353 -168.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 125.77 -96.76 0.5 Allowed Glycine 0 C--N 1.339 0.701 0 CA-C-N 114.521 -1.218 . . . . 62.31 110.081 -173.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -171.31 -175.44 1.66 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.235 1.014 . . . . 74.3 109.239 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 301' ' ' ILE . . . . . 0.513 HG21 ' HA ' ' B' ' 32' ' ' PHE . 37.7 mt -78.87 108.34 12.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 N-CA-C 108.197 -1.038 . . . . 64.54 108.197 170.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.39 128.77 37.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.016 -0.735 . . . . 64.35 109.016 176.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 303' ' ' LYS . . . . . 0.651 ' HE2' ' HA ' ' B' ' 33' ' ' GLN . 98.5 mttt -88.01 157.56 51.15 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.92 0.888 . . . . 71.11 112.23 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 304' ' ' PRO . . . . . 0.558 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 52.1 Cg_exo -54.98 123.23 13.28 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 123.46 2.773 . . . . 74.23 113.009 176.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.41 79.91 0.96 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.519 0.728 . . . . 72.42 110.325 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 306' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' F' ' 291' ' ' LEU . 81.6 t -114.35 98.35 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 108.336 -0.987 . . . . 62.33 108.336 173.185 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 8.7 m -93.12 158.51 15.73 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.484 0.713 . . . . 52.32 110.036 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 56.0 m -55.27 104.3 0.12 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.384 1.074 . . . . 74.33 110.694 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 4.3 t -118.23 103.45 49.52 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.504 0.722 . . . . 61.23 111.038 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 CA--C 1.559 1.765 0 C-N-CA 122.861 2.374 . . . . 65.32 109.594 162.931 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 108.955 -0.757 . . . . 63.03 108.955 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.4 p -152.89 121.28 6.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.566 0.746 . . . . 73.22 109.252 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -86.72 83.68 7.53 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.273 -0.64 . . . . 71.15 109.273 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -75.37 83.66 2.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.603 0.761 . . . . 63.13 109.012 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -100.55 91.34 4.62 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.977 -1.011 . . . . 64.11 110.328 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -130.12 64.18 1.53 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 106.853 -1.536 . . . . 74.23 106.853 168.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -83.55 105.43 14.47 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.02 -1.446 . . . . 71.33 110.191 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -69.81 85.5 0.49 Allowed 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.992 -0.744 . . . . 72.12 108.992 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.593 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 25.5 ptp -90.82 153.28 20.35 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.679 -0.691 . . . . 54.33 110.774 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m -144.29 131.46 20.64 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.045 0.938 . . . . 75.05 108.7 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.627 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.8 t80 -126.34 123.47 38.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.079 0.952 . . . . 65.43 108.646 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -143.3 103.5 4.13 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.423 0.452 . . . . 73.12 109.878 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.642 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.4 mt -64.9 121.57 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.041 -0.725 . . . . 72.04 109.041 174.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -87.61 -41.39 13.46 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.677 0.611 . . . . 75.43 109.656 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 59.0 ttt180 -168.28 144.01 3.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.996 -0.281 . . . . 74.42 111.428 -162.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -129.67 137.29 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.09 -1.078 . . . . 60.31 108.09 172.452 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.47 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 21.4 p90 -160.96 165.97 29.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.453 0.701 . . . . 71.21 110.996 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -100.24 117.57 34.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.651 -0.87 . . . . 43.45 108.651 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -77.83 -26.69 49.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.382 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.35 142.39 16.93 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 123.912 0.757 . . . . 70.31 109.223 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 95.9 mt -134.75 142.38 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 106.612 -1.625 . . . . 74.23 106.612 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -155.14 114.0 3.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.413 0.446 . . . . 34.52 110.045 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -109.08 117.89 35.36 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 106.766 -1.568 . . . . 73.34 106.766 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.81 137.1 52.44 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.273 -0.64 . . . . 65.03 109.273 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.45 72.2 12.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.818 -1.549 . . . . 73.22 106.818 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.16 -30.98 37.27 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.772 2.315 . . . . 64.24 111.577 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.04 28.31 8.62 Favored 'General case' 0 C--O 1.213 -0.842 0 C-N-CA 124.207 1.003 . . . . 53.35 108.381 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.29 -53.5 43.9 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.272 -0.871 . . . . 53.1 112.486 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 16.0 Cg_exo -66.63 -17.53 52.86 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 121.882 1.721 . . . . 73.44 112.696 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -95.9 -29.16 14.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 72.32 111.285 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -82.94 -25.39 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.791 0.436 . . . . 72.35 111.652 -172.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' O ' HG12 ' E' ' 301' ' ' ILE . 23.5 m-85 -72.49 -9.6 58.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.516 0.726 . . . . 71.15 112.277 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -102.71 -10.78 18.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.651 0.78 . . . . 54.31 111.472 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -77.73 165.44 24.2 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.152 0.581 . . . . 62.34 111.965 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.74 145.15 55.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.376 1.07 . . . . 72.52 110.922 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -81.13 90.3 6.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.516 0.726 . . . . 75.35 110.183 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tp60 -141.8 50.04 1.62 Allowed Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 114.729 -1.123 . . . . 71.11 109.261 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.595 ' HG2' ' HB2' ' E' ' 297' ' ' TYR . 6.9 Cg_exo -74.99 96.43 1.02 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 122.539 2.159 . . . . 63.32 111.624 -172.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.14 98.0 10.67 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.279 -1.008 . . . . 64.34 108.279 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 65' ' ' THR . 2.6 p -93.33 104.94 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 114.055 -1.429 . . . . 72.21 110.616 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -83.17 137.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.007 1.323 . . . . 74.24 110.15 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.566 HD22 ' HB ' ' E' ' 288' ' ' VAL . 4.6 tt -105.72 127.56 53.15 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.122 -1.066 . . . . 74.34 108.122 174.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.8 m-20 -120.34 144.21 47.98 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.095 -1.076 . . . . 72.33 108.095 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.566 HD11 HD12 ' A' ' 60' ' ' LEU . 27.1 tp -139.31 124.61 19.1 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.73 -0.47 . . . . 62.54 109.73 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.3 m-20 -119.3 127.09 52.88 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.763 0.825 . . . . 74.12 109.042 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -106.33 121.42 44.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.053 0.941 . . . . 55.13 109.485 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.88 147.08 38.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.975 0.91 . . . . 72.31 109.544 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -133.08 168.57 18.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.693 0.797 . . . . 55.25 110.271 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -161.71 154.44 20.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.385 1.074 . . . . 74.42 109.506 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -111.25 121.87 46.38 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.152 -1.055 . . . . 54.21 108.152 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 57' ' ' GLU . 26.9 mt -97.43 -33.88 11.23 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.338 0.655 . . . . 74.22 110.599 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.14 -173.13 3.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.266 0.626 . . . . 72.23 110.729 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.04 112.35 3.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.229 1.012 . . . . 64.41 110.093 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' SER . 62.0 m-20 70.45 1.69 3.74 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.579 1.552 . . . . 75.53 113.323 -175.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -100.86 115.82 43.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.508 0.723 . . . . 64.32 109.382 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -131.64 124.76 30.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.535 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.4 tt0 -95.59 116.54 28.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.261 1.025 . . . . 64.04 109.408 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.1 124.11 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.418 -1.327 . . . . 73.04 107.418 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 t -112.7 129.84 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.595 0.758 . . . . 71.45 109.195 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.566 HD12 HD11 ' A' ' 44' ' ' LEU . 3.9 mm? -120.86 104.27 9.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.708 1.203 . . . . 73.22 108.443 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.604 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 30.4 ttp180 -84.49 104.55 14.59 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.743 -0.836 . . . . 74.2 108.743 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.9 120.48 43.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.393 -1.336 . . . . 74.0 107.393 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 36.9 m -122.07 130.6 53.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.225 -0.657 . . . . 71.52 109.225 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.689 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -123.47 116.46 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 124.932 1.293 . . . . 72.15 108.777 -174.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.9 m -118.61 130.15 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.249 0.477 . . . . 73.42 110.12 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.36 130.28 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.556 -0.905 . . . . 44.2 108.556 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.9 m -127.35 126.82 43.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.125 0.57 . . . . 61.35 109.704 176.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.685 HD13 ' HB2' ' A' ' 73' ' ' ALA . 11.0 mp -88.65 85.89 6.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.97 -1.122 . . . . 72.22 107.97 174.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.94 -88.29 1.17 Allowed Glycine 0 C--N 1.346 1.091 0 CA-C-N 114.924 -1.034 . . . . 50.14 111.488 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.21 -27.78 7.16 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.472 0.709 . . . . 71.14 111.357 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -102.75 132.93 48.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.188 0.595 . . . . 64.03 110.629 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 47.2 m -69.03 130.61 43.24 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.077 0.951 . . . . 74.32 111.315 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -74.63 -61.51 1.85 Allowed 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.998 0.919 . . . . 74.51 109.504 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.459 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 40.3 p90 -152.9 163.26 40.12 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.564 -1.198 . . . . 73.25 111.38 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 tp -130.67 137.5 49.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.149 -1.387 . . . . 75.11 107.274 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.689 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.2 m -137.03 98.99 3.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.557 0.743 . . . . 75.43 109.306 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -119.13 117.83 29.75 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.23 -1.026 . . . . 72.34 108.23 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.54 109.22 15.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.985 0.914 . . . . 72.41 109.148 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -84.59 81.24 8.94 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.593 -1.262 . . . . 70.33 107.593 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -76.63 93.56 3.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.718 -0.845 . . . . 74.14 108.718 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.16 147.26 21.56 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.073 -0.811 . . . . 71.32 111.073 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.635 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.68 122.97 1.41 Allowed Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 111.783 -0.527 . . . . 43.53 111.783 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.79 125.62 39.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.233 -0.654 . . . . 71.42 109.233 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.642 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.0 m-85 -132.17 148.76 52.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.767 -1.197 . . . . 71.21 107.767 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 41.9 t -102.51 110.84 22.9 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.425 -0.954 . . . . 63.25 108.425 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.55 HG21 ' HG2' ' A' ' 94' ' ' MET . 4.2 mp -112.95 125.27 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.97 44.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.559 0.744 . . . . 52.41 109.644 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 101.26 -32.55 7.34 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 123.72 0.637 . . . . 73.34 113.667 175.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.82 147.75 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.435 0.694 . . . . 73.25 110.287 -175.135 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' E' ' 275' ' ' LYS . 32.4 mt-10 -138.82 -179.08 5.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.706 0.802 . . . . 74.34 109.38 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.61 -132.88 32.35 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 119.623 -0.543 . . . . 62.24 112.897 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 18.6 p -74.96 -17.54 60.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.64 0.776 . . . . 55.55 111.977 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -72.01 -42.67 66.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.999 0.52 . . . . 71.51 109.668 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' MET . . . . . 0.55 ' HG2' HG21 ' A' ' 86' ' ' ILE . 1.1 tmt? -81.7 -24.84 35.94 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.637 0.775 . . . . 73.24 110.043 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.529 ' HB1' HD13 ' E' ' 280' ' ' LEU . . . -68.65 -37.18 79.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.368 0.667 . . . . 64.23 110.135 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.71 -34.47 77.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.357 0.663 . . . . 74.13 110.11 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.5 t -67.89 -42.42 81.24 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.016 -0.538 . . . . 64.24 110.999 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.0 mt -86.15 -29.19 23.46 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.912 0.708 . . . . 72.41 112.912 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.78 3.89 34.2 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.597 0.599 . . . . 50.14 114.597 -170.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -51.22 0.16 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.42 0.61 . . . . 71.02 111.745 -174.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 60.0 t80 -79.46 -66.84 0.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.445 1.098 . . . . 74.2 112.23 -169.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' CYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 67.2 m -70.72 -32.17 2.42 Favored Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 114.78 1.4 . . . . 70.44 114.78 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 36.3 Cg_endo -63.99 -20.66 68.13 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 122.055 1.77 . . . . 65.43 112.775 171.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -76.14 -17.75 59.43 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.227 0.611 . . . . 74.04 109.981 175.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.532 HG21 HD13 ' A' ' 13' ' ' ILE . 42.2 mm -75.41 -39.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.961 -0.755 . . . . 72.52 108.961 170.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.635 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.5 mt -78.47 -33.02 48.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.953 0.901 . . . . 74.32 112.959 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -62.16 -43.75 86.88 Favored Pre-proline 0 CA--C 1.572 1.789 0 N-CA-C 113.758 1.022 . . . . 75.24 113.758 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.53 -28.08 22.01 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.113 1.875 . . . . 75.02 113.157 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -76.02 -34.56 59.68 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.084 0.553 . . . . 75.51 111.156 175.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.27 78.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.111 -0.699 . . . . 42.41 109.111 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.436 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.7 ttm180 -55.18 -49.86 70.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.594 1.184 . . . . 75.1 109.845 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.266 0.979 . . . . 71.34 110.738 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 28.3 t -59.51 -44.25 93.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.386 0.674 . . . . 44.32 110.558 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.4 mt -64.41 -54.13 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.818 0.847 . . . . 65.44 109.965 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 58.2 m -55.22 -39.77 70.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.126 0.97 . . . . 75.15 111.212 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -64.22 -51.35 64.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.824 -1.08 . . . . 60.14 109.793 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 21' ' ' ILE . 16.0 mtp -56.83 -44.49 82.12 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.376 1.07 . . . . 73.1 111.646 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.9 t -62.5 -45.82 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.324 1.05 . . . . 74.24 110.436 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.4 t -68.77 -31.68 70.88 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.402 -0.817 . . . . 62.4 110.881 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -70.63 -31.98 69.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.807 0.843 . . . . 74.51 110.11 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.68 2.68 78.11 Favored Glycine 0 C--N 1.355 1.629 0 O-C-N 123.858 0.724 . . . . 60.33 113.181 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m 65.69 32.86 8.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.824 1.25 . . . . 73.54 111.159 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -101.09 140.63 21.45 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 106.723 -1.584 . . . . 64.13 106.723 168.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' E' ' 299' ' ' GLY . 25.0 Cg_endo -56.94 149.79 59.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.562 2.174 . . . . 41.22 111.672 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.5 tt0 -51.53 136.47 26.18 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.349 1.03 . . . . 73.11 113.202 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.517 HD21 HG11 ' A' ' 64' ' ' VAL . 10.3 tp -125.69 120.65 31.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.306 -1.315 . . . . 73.1 108.064 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.01 120.18 32.58 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.44 -0.948 . . . . 71.23 108.44 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.06 118.32 15.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.935 -0.765 . . . . 74.03 108.935 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.66 139.67 59.76 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 124.209 1.004 . . . . 74.14 111.98 -174.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 4.6 Cg_exo -72.25 110.17 2.89 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.835 1.69 . . . . 61.25 110.208 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.84 123.75 52.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 7.1 m-20 -65.54 97.3 0.3 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.409 1.084 . . . . 63.33 110.835 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.2 -50.27 6.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.256 0.623 . . . . 74.31 109.556 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.0 p-10 -61.59 -45.22 95.03 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.704 1.201 . . . . 74.53 111.312 -177.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -66.07 -52.73 46.15 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.07 0.856 . . . . 52.24 110.545 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.71 -50.61 65.53 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.687 1.242 . . . . 62.33 110.449 -174.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -58.14 -37.16 74.09 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.073 0.858 . . . . 72.42 110.848 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . 0.485 ' HB3' ' HB3' ' A' ' 144' ' ' GLN . 17.2 mmt -73.86 -50.58 19.64 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.108 0.563 . . . . 71.35 111.909 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 1.2 p-10 -69.94 -24.19 63.31 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 111.54 0.2 . . . . 65.11 111.54 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -79.61 -44.33 21.21 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.559 0.744 . . . . 62.13 110.913 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.13 -49.74 66.42 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.523 0.515 . . . . 62.32 111.259 -172.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -162.69 27.14 0.1 Allowed 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.384 0.428 . . . . 65.11 111.156 -174.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 41.1 mt-30 56.95 34.58 25.12 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.595 0.758 . . . . 60.3 110.862 176.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 6.0 tp-100 -60.87 116.15 4.24 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.006 0.922 . . . . 71.24 111.664 -172.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.36 137.76 24.58 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.407 1.083 . . . . 73.01 109.243 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.42 -97.32 1.06 Allowed Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.522 -0.631 . . . . 62.24 111.522 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 66.21 137.16 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.291 1.436 . . . . 64.11 111.964 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 136.27 -170.64 23.19 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 116.394 -0.366 . . . . 71.31 112.203 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.3 t -164.64 162.59 21.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.036 0.934 . . . . 70.13 109.703 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.26 153.83 47.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 74.1 109.967 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -178.06 97.85 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.44 1.096 . . . . 73.11 108.518 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -147.33 103.53 3.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.883 0.473 . . . . 63.34 110.17 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -93.75 150.33 20.49 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.155 0.982 . . . . 73.21 109.428 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.97 -63.31 1.29 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.692 0.797 . . . . 53.3 109.72 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.213 0 C-N-CA 124.272 1.029 . . . . 73.23 108.477 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.534 0.207 . . . . 75.13 111.521 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 40.8 m -74.25 77.31 1.82 Allowed 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.595 0.712 . . . . 75.4 109.822 174.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' B' ' 4' ' ' GLN . 8.5 pt-20 -158.14 -28.69 0.08 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.98 0.912 . . . . 62.22 110.544 -172.88 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLN . . . . . 0.499 ' HG2' ' HG3' ' B' ' 3' ' ' GLU . 9.2 pt20 -134.19 88.92 2.5 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.513 0.725 . . . . 71.24 110.32 -177.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -168.81 175.26 6.06 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.197 0.999 . . . . 74.25 108.627 175.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -66.26 95.52 0.3 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.845 0.858 . . . . 71.04 109.748 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -66.89 141.42 57.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.796 0.839 . . . . 62.11 111.269 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 76.23 -44.57 0.49 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.173 1.789 . . . . 64.04 113.512 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' MET . . . . . 0.679 ' SD ' HG23 ' B' ' 89' ' ' ILE . 1.9 ptt? 51.68 -159.12 0.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.613 1.565 . . . . 70.14 112.341 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.2 m -146.04 124.71 12.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.303 0.641 . . . . 73.45 109.694 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -134.7 139.89 45.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.724 -1.213 . . . . 74.45 107.724 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 2.7 pp0? -163.39 139.61 6.93 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.057 -0.72 . . . . 71.4 109.057 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ILE . . . . . 0.624 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -91.79 134.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.378 -0.971 . . . . 64.15 108.378 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -97.97 -52.67 3.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.164 0.586 . . . . 65.14 110.566 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -151.3 134.52 16.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.609 -0.269 . . . . 75.13 110.45 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' ILE . . . . . 0.624 HG13 HD11 ' B' ' 13' ' ' ILE . 98.5 mt -114.4 136.12 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.072 -1.455 . . . . 71.02 107.072 167.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.2 p90 -166.21 144.98 5.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.943 0.497 . . . . 73.4 110.882 -172.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.5 m -76.67 120.52 21.97 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.484 -0.78 . . . . 72.33 109.295 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' LYS . . . . . 0.441 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 44.5 mtpt -92.1 -30.82 15.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.451 0.7 . . . . 63.14 111.34 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.6 142.18 17.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.59 0.233 . . . . 75.02 110.636 -173.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mm -141.1 139.35 33.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.633 1.573 . . . . 65.12 108.02 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -143.0 130.61 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.486 -1.302 . . . . 71.24 107.486 172.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 79.2 t80 -137.45 119.23 15.13 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.708 -1.589 . . . . 72.2 106.708 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -117.38 122.49 43.98 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.402 -0.962 . . . . 75.14 108.402 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -119.49 79.84 21.74 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 107.302 -1.369 . . . . 73.14 107.302 165.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.26 -18.25 34.76 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.207 1.938 . . . . 61.42 110.419 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -111.59 15.67 21.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.984 1.314 . . . . 73.31 110.821 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.1 -54.5 7.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 N-CA-C 114.396 1.258 . . . . 64.52 114.396 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PRO . . . . . 0.465 ' HG2' ' ND1' ' B' ' 30' ' ' HIS . 95.0 Cg_endo -78.76 -31.75 2.32 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 121.765 1.643 . . . . 74.32 113.274 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' HIS . . . . . 0.465 ' ND1' ' HG2' ' B' ' 29' ' ' PRO . 77.0 m80 -92.35 4.11 54.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.096 0.959 . . . . 74.13 113.303 -169.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 7.7 p -79.06 -6.96 10.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 C-N-CA 123.516 0.726 . . . . 72.44 110.061 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.14 -33.04 74.57 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.797 0.439 . . . . 71.43 111.141 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -76.03 -41.85 49.66 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.358 0.663 . . . . 72.22 109.931 175.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' LYS . . . . . 0.618 ' HB3' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -108.42 64.34 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.584 1.154 . . . . 75.32 109.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 31' ' ' VAL . 13.6 t70 -118.82 118.55 31.88 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.565 -0.531 . . . . 73.34 109.565 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -179.81 179.43 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.029 1.732 . . . . 73.34 107.883 155.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -47.35 106.43 0.59 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.011 0.925 . . . . 74.2 110.92 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.23 169.1 7.42 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.723 2.282 . . . . 73.5 110.667 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.26 100.69 3.19 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 106.907 -1.516 . . . . 72.32 106.907 170.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.25 126.66 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.68 -1.145 . . . . 72.23 109.401 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -128.05 135.09 49.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.738 0.815 . . . . 74.23 109.477 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' H' ' 288' ' ' VAL . 22.5 mt -97.41 151.79 19.6 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.337 -0.986 . . . . 73.11 108.337 172.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -148.2 109.9 4.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.419 -1.326 . . . . 75.01 107.419 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mp -103.72 129.63 51.11 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.136 0.574 . . . . 72.0 109.478 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ASP . . . . . 0.723 ' HA ' ' HA3' ' H' ' 284' ' ' GLY . 9.2 t70 -122.62 149.92 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.335 1.054 . . . . 74.02 110.192 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -118.07 128.57 54.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.631 -1.168 . . . . 74.22 109.438 -170.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.13 126.74 15.14 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.038 0.535 . . . . 72.04 110.175 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 56.5 p -136.49 160.78 37.75 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.348 . . . . 72.43 110.795 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -157.64 137.66 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.723 -0.671 . . . . 63.54 110.045 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.93 114.69 20.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.197 0.599 . . . . 74.42 110.263 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' B' ' 57' ' ' GLU . 23.5 mt -88.41 -34.55 17.5 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.603 0.761 . . . . 63.01 110.461 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.83 -167.93 1.5 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.654 0.782 . . . . 73.4 110.573 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.86 106.24 0.98 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.576 -1.193 . . . . 61.04 110.166 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.29 9.16 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.954 1.301 . . . . 72.3 113.044 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -103.89 108.46 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.262 -1.014 . . . . 71.32 108.262 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.14 140.13 51.55 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.168 0.987 . . . . 71.44 109.239 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' B' ' 51' ' ' LEU . 5.8 tm-20 -103.6 99.96 9.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.234 -1.024 . . . . 74.12 108.234 -174.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' H' ' 281' ' ' PHE . 77.0 t -88.68 125.93 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.354 1.462 . . . . 62.3 109.925 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.3 t -118.7 131.26 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.874 0.869 . . . . 74.14 109.543 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.33 108.12 18.09 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.762 -1.199 . . . . 71.02 107.762 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.5 ttm180 -88.21 113.79 24.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.622 -0.881 . . . . 64.54 108.622 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.7 104.17 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.891 -1.151 . . . . 71.23 107.891 169.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -98.7 132.99 43.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.589 -0.522 . . . . 44.04 109.589 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 64' ' ' VAL . . . . . 0.403 HG21 HG21 ' B' ' 114' ' ' ILE . 95.8 t -122.09 120.22 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.347 1.059 . . . . 72.43 108.933 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -115.11 143.03 45.84 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.354 0.661 . . . . 70.42 109.305 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.3 136.58 38.14 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.75 -0.833 . . . . 74.34 108.75 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 52.1 p -147.1 139.01 24.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.879 0.472 . . . . 75.41 110.672 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 68' ' ' LEU . . . . . 0.618 HD13 ' HB3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -136.45 139.67 42.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.905 1.282 . . . . 73.51 108.615 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.09 -115.95 6.84 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.016 -0.834 . . . . 72.44 111.016 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -122.94 3.01 9.41 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.061 0.944 . . . . 72.13 108.853 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.1 168.96 9.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.338 0.59 . . . . 74.32 111.342 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 14.8 m -71.04 143.77 50.61 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.651 -1.158 . . . . 63.22 111.028 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -95.32 -60.02 1.76 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.27 -1.011 . . . . 64.05 108.27 169.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -164.68 155.52 14.76 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.339 -1.3 . . . . 74.14 108.401 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 62.9 mt -128.23 136.52 51.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -148.69 152.71 37.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.235 0.614 . . . . 71.12 109.357 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -160.39 129.19 4.84 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.952 -1.129 . . . . 63.33 107.952 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.9 t -124.04 142.37 41.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.676 -0.861 . . . . 52.42 108.676 176.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -125.32 93.23 3.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.138 -1.06 . . . . 71.23 108.138 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 80' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -83.52 102.8 12.37 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.23 -1.026 . . . . 41.2 108.23 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.29 166.85 35.25 Favored Glycine 0 C--O 1.244 0.724 0 N-CA-C 111.02 -0.832 . . . . 23.35 111.02 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.33 126.91 1.57 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.15 -0.78 . . . . 71.23 111.15 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' B' ' 17' ' ' TYR . 69.1 mt -83.68 118.51 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.67 -1.233 . . . . 64.35 107.67 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -124.34 166.84 15.23 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.358 1.063 . . . . 72.42 108.68 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 40.9 m -130.53 112.69 13.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.466 -0.939 . . . . 64.14 108.466 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 86' ' ' ILE . . . . . 0.712 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -117.36 133.77 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.985 0.914 . . . . 51.44 109.743 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 87' ' ' ALA . . . . . 0.658 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.37 158.35 38.54 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.107 0.963 . . . . 52.5 109.399 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.71 3.11 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.302 -0.408 . . . . 73.44 112.526 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 89' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' B' ' 86' ' ' ILE . 20.5 pt -68.5 150.12 10.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 123.041 0.536 . . . . 63.42 110.297 169.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 90' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 39.8 tt0 -164.31 146.32 8.74 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.537 -0.756 . . . . 61.03 109.818 -174.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.76 -103.75 1.5 Allowed Glycine 0 C--N 1.349 1.298 0 O-C-N 123.332 0.395 . . . . 45.21 113.109 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.4 m -88.3 -29.28 20.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.486 0.714 . . . . 50.43 110.947 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 47.9 mt-30 -58.66 -45.21 89.85 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.787 0.835 . . . . 73.13 110.986 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 94' ' ' MET . . . . . 0.637 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.8 ptt? -65.1 -39.56 93.33 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.214 -0.903 . . . . 63.24 110.864 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.33 82.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.738 0.815 . . . . 75.33 110.884 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -76.57 -33.56 58.48 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.591 0.757 . . . . 64.43 110.837 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -62.46 -63.11 1.33 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.89 0.476 . . . . 75.02 110.531 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.86 -3.43 54.08 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.102 0.408 . . . . 71.25 112.102 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.21 -1.78 56.9 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 119.648 -0.529 . . . . 63.04 113.49 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.26 0.18 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.477 0.639 . . . . 44.52 111.585 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -72.02 -55.54 7.22 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.377 0.671 . . . . 71.51 111.547 -170.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -65.43 -37.65 21.09 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 123.875 0.87 . . . . 72.21 112.583 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -49.6 -48.79 17.72 Favored 'Trans proline' 0 C--N 1.397 3.117 0 C-N-CA 122.885 2.39 . . . . 72.53 113.052 164.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -64.89 -15.89 62.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 112.52 0.563 . . . . 74.24 112.52 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -80.02 -49.86 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.92 0.488 . . . . 73.2 110.264 171.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.15 -19.52 39.8 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.396 0.678 . . . . 53.1 112.784 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' PHE . . . . . 0.41 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 84.3 t80 -66.49 -45.53 58.34 Favored Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.54 1.136 . . . . 72.33 113.423 -172.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.6 Cg_endo -57.58 -35.7 98.77 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 122.105 1.87 . . . . 64.32 113.256 176.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 109' ' ' TYR . . . . . 0.403 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.9 m-85 -68.05 -45.13 74.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.292 0.637 . . . . 73.05 110.418 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.57 84.47 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.925 -0.58 . . . . 71.43 110.813 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -59.84 -57.55 12.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.482 1.113 . . . . 64.35 110.254 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -31.69 71.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.697 0.799 . . . . 62.31 110.831 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.2 t -72.04 -43.56 64.77 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.931 0.492 . . . . 75.1 111.269 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 114' ' ' ILE . . . . . 0.403 HG21 HG21 ' B' ' 64' ' ' VAL . 87.4 mt -62.99 -44.74 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.347 0.659 . . . . 50.01 109.671 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -61.56 -30.83 70.91 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.995 -1.002 . . . . 75.52 111.344 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -73.58 -52.95 11.7 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.317 0.647 . . . . 73.32 110.07 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 36.4 mmt -59.31 -46.94 87.22 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.903 0.881 . . . . 75.34 111.641 -173.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.65 -34.9 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.25 110.879 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t -67.99 -30.76 70.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.357 -0.383 . . . . 74.32 110.74 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -68.76 -18.93 64.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.435 0.694 . . . . 73.13 110.823 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.1 15.71 42.42 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-O 119.533 -0.593 . . . . 74.41 112.488 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 17' ' ' TYR . 57.6 p 62.14 28.8 17.32 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.856 2.063 . . . . 70.25 112.809 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -97.16 150.93 37.36 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.817 0.447 . . . . 73.34 110.938 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.86 -165.06 0.11 Allowed 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 123.751 2.967 . . . . 72.1 113.579 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 125' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.3 tp60 -63.78 115.79 5.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.753 -0.658 . . . . 72.2 112.565 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -119.43 100.92 7.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.899 -1.148 . . . . 74.53 107.899 168.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.49 135.19 54.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 65.01 109.766 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.09 139.26 33.32 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 124.255 0.972 . . . . 72.24 110.39 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 129' ' ' ALA . . . . . 0.523 ' HB3' HD13 ' H' ' 291' ' ' LEU . . . -83.37 147.26 52.68 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.101 0.961 . . . . 73.22 110.35 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.13 109.37 1.31 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.939 2.426 . . . . 74.4 111.489 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 131' ' ' VAL . . . . . 0.479 HG22 HD11 ' H' ' 291' ' ' LEU . 56.0 t -95.24 131.5 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.896 0.879 . . . . 72.04 109.897 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 132' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 57.1 t30 -82.12 90.3 6.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.33 0.586 . . . . 60.04 109.771 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -69.83 -25.01 63.55 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.993 -1.003 . . . . 64.32 111.363 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -59.95 -38.62 82.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.852 0.861 . . . . 55.34 110.727 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 135' ' ' ALA . . . . . 0.459 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -63.55 -38.49 91.32 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.725 0.81 . . . . 62.12 112.289 -178.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.2 -42.64 81.66 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 123.955 0.784 . . . . 70.53 110.596 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -77.34 -42.23 37.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.584 -1.189 . . . . 70.3 111.462 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -58.97 -35.71 73.64 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.423 1.089 . . . . 71.05 112.292 -170.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -73.29 -38.75 65.76 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.338 -0.392 . . . . 74.0 110.284 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -70.4 -30.68 67.63 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.07 0.462 . . . . 73.52 111.17 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 42.2 mt -99.58 9.3 43.43 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.125 0.97 . . . . 73.43 111.261 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -68.29 114.92 7.17 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.491 0.717 . . . . 74.1 110.734 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -122.71 131.98 54.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.676 0.79 . . . . 75.14 110.592 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -99.93 140.76 33.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.777 0.831 . . . . 63.51 110.02 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.84 152.29 38.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.439 1.096 . . . . 61.21 109.458 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.89 -159.38 9.58 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.472 -0.331 . . . . 64.12 112.995 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.93 -173.63 2.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.797 0.839 . . . . 73.21 109.891 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.96 135.88 13.28 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.475 -0.625 . . . . 62.13 111.573 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 38.7 p -65.32 106.88 1.46 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.558 0.743 . . . . 64.42 110.542 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -88.84 121.74 31.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.983 0.513 . . . . 70.43 110.52 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -81.73 174.93 10.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.24 0.616 . . . . 73.44 110.583 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -131.22 147.91 52.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.226 0.61 . . . . 71.41 110.104 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -80.6 121.48 25.88 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.245 -0.65 . . . . 71.31 109.245 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -129.35 119.67 24.28 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.572 -1.27 . . . . 71.13 107.572 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.004 0.922 . . . . 74.44 110.001 -172.062 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.484 1.225 0 CA-C-O 120.788 0.328 . . . . 71.04 110.127 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -162.38 151.99 15.98 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.55 0.74 . . . . 73.14 109.374 -173.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.75 114.45 28.67 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.097 -0.705 . . . . 73.05 109.097 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -77.25 172.2 13.64 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.407 0.623 . . . . 73.01 111.497 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 70.6 m-20 -144.73 151.23 38.57 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.824 1.25 . . . . 72.53 108.817 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -167.85 158.13 10.54 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.334 0.654 . . . . 73.55 109.438 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 73.4 p -117.76 72.9 0.86 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.235 0.614 . . . . 71.51 111.871 -170.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -138.59 89.68 2.39 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.736 0.814 . . . . 73.41 109.667 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 9' ' ' MET . . . . . 0.423 ' SD ' HG23 ' C' ' 86' ' ' ILE . 48.6 ttp 65.28 119.35 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.91 1.284 . . . . 74.21 113.039 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 3.8 m -84.77 85.12 7.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.333 -1.358 . . . . 71.3 107.333 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -93.77 120.17 33.69 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.635 -0.712 . . . . 72.23 109.875 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -138.79 142.64 38.75 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.464 0.706 . . . . 64.32 110.144 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 13' ' ' ILE . . . . . 0.406 HG22 ' CE2' ' C' ' 84' ' ' PHE . 2.7 pp -77.96 137.79 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.945 0.778 . . . . 52.12 109.279 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 14' ' ' GLN . . . . . 0.431 ' HA ' ' HB3' ' G' ' 304' ' ' PRO . 15.3 mm100 -101.78 -51.17 3.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.802 -0.444 . . . . 63.04 109.802 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -167.86 124.77 1.12 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.092 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.73 147.14 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -175.15 160.77 2.76 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.142 0.496 . . . . 73.23 110.807 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.8 p -78.87 115.03 18.3 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.005 -0.998 . . . . 75.14 108.534 173.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -66.6 -43.68 84.17 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.904 0.859 . . . . 71.14 109.415 172.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.1 t70 -150.52 145.94 26.28 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.959 -1.473 . . . . 75.42 109.211 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 21' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.2 mt -140.25 141.27 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.6 -1.629 . . . . 61.24 106.6 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.3 t -153.16 150.62 29.24 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.111 0.481 . . . . 54.41 110.116 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -151.14 115.42 5.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.579 -1.267 . . . . 72.13 107.579 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -116.22 116.1 27.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.966 -1.124 . . . . 63.21 107.966 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.19 85.53 5.5 Favored Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.285 -1.376 . . . . 73.01 107.285 170.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.31 -26.11 30.0 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.635 2.223 . . . . 64.31 112.025 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.31 36.83 4.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 124.142 0.977 . . . . 54.12 109.081 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -45.31 -52.77 20.25 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 124.613 1.165 . . . . 73.53 114.012 -177.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.22 -32.81 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 121.563 1.509 . . . . 72.54 113.345 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -70.06 -27.1 64.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.887 0.875 . . . . 63.31 113.071 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.22 -15.15 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.542 0.737 . . . . 65.23 110.271 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.06 -34.9 79.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.102 0.561 . . . . 74.55 111.3 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -89.75 7.49 36.62 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.964 0.906 . . . . 62.2 111.889 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 34' ' ' LYS . . . . . 0.442 ' HD2' HD11 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -98.73 147.25 25.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 63.21 111.202 -171.142 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.74 131.09 44.9 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.414 1.085 . . . . 52.51 109.832 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 36' ' ' TRP . . . . . 0.605 ' HB3' ' HB3' ' F' ' 297' ' ' TYR . 26.7 m95 -80.06 71.33 6.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.737 0.815 . . . . 75.24 110.786 -174.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -143.98 72.53 16.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 108.179 -1.045 . . . . 71.4 108.179 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 38' ' ' PRO . . . . . 0.716 ' HG3' ' HD2' ' F' ' 297' ' ' TYR . 69.4 Cg_endo -90.97 155.84 3.94 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.795 2.33 . . . . 75.22 111.18 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -87.1 81.39 8.05 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 106.893 -1.521 . . . . 71.32 106.893 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 40' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' C' ' 38' ' ' PRO . 12.6 m -68.35 123.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 CA-C-N 114.517 -1.219 . . . . 71.13 109.383 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 41' ' ' LYS . . . . . 0.422 ' HZ2' ' HB3' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -136.86 126.73 25.74 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.528 -0.916 . . . . 74.21 108.528 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.56 138.41 31.73 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.121 0.968 . . . . 74.33 108.637 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 43' ' ' ASP . . . . . 0.828 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.2 m-20 -119.01 119.1 33.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.114 0.965 . . . . 41.21 109.177 -175.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.02 125.54 52.6 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.125 -1.065 . . . . 70.52 108.125 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 45' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 7.3 t70 -137.12 142.67 42.29 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.698 0.799 . . . . 62.24 109.583 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -115.4 116.73 28.74 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.962 0.905 . . . . 62.31 110.836 -171.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.03 153.01 47.25 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.371 1.068 . . . . 72.34 110.072 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.3 p -166.13 159.05 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.985 0.514 . . . . 74.0 111.732 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -149.88 153.88 37.43 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.556 0.742 . . . . 63.42 111.08 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.2 122.75 33.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 108.991 -0.744 . . . . 73.1 108.991 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 51' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -96.58 -44.17 7.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.717 0.807 . . . . 54.1 110.205 -176.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.94 -165.31 1.71 Allowed 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.139 -0.937 . . . . 75.21 109.952 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -70.4 102.78 2.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.725 0.81 . . . . 74.03 109.601 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 71.62 -3.24 2.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.726 1.61 . . . . 42.03 113.444 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.5 t -92.09 113.48 27.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.242 -1.392 . . . . 35.11 107.242 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.34 149.17 49.36 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.074 0.95 . . . . 72.44 108.945 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 57' ' ' GLU . . . . . 0.637 ' HB2' HD11 ' C' ' 51' ' ' LEU . 45.9 tt0 -104.41 136.23 44.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.112 -0.699 . . . . 62.55 109.112 172.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.43 120.84 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.442 -1.688 . . . . 63.51 106.442 171.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.53 135.56 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.078 0.951 . . . . 33.31 109.048 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 60' ' ' LEU . . . . . 0.43 HD23 HD12 ' C' ' 106' ' ' LEU . 3.8 mm? -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.698 0.799 . . . . 73.45 109.072 172.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 61' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 17.2 ttm-85 -81.84 106.15 13.53 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.443 -0.947 . . . . 64.45 108.443 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.85 120.4 59.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.92 -1.141 . . . . 62.43 107.92 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 63' ' ' THR . . . . . 0.828 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 48.0 m -133.26 145.77 50.8 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.242 1.017 . . . . 74.2 108.405 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 64' ' ' VAL . . . . . 0.403 HG23 HD13 ' C' ' 114' ' ' ILE . 98.9 t -127.08 121.23 57.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.9 -0.778 . . . . 72.33 108.9 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -104.58 142.5 34.54 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.007 0.817 . . . . 74.43 109.514 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 100.42 4.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.137 -1.06 . . . . 63.2 108.137 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -139.23 126.59 21.51 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.888 -0.412 . . . . 71.14 109.888 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 68' ' ' LEU . . . . . 0.462 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.3 OUTLIER -100.82 60.04 0.95 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 122.172 0.987 . . . . 74.15 109.416 176.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -122.05 7.18 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 113.979 -1.464 . . . . 73.31 110.4 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -89.65 -16.96 29.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.498 0.719 . . . . 65.15 109.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -75.92 92.49 3.12 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.249 1.019 . . . . 73.11 109.091 170.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 84.9 m -83.35 121.7 27.49 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 109.036 -0.727 . . . . 73.31 109.036 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.7 -51.48 10.51 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.45 -1.25 . . . . 71.53 109.478 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -161.08 175.64 12.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.663 0.745 . . . . 62.23 110.976 168.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -145.12 144.36 30.87 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.403 -1.702 . . . . 62.13 106.403 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.3 t -146.21 112.03 5.64 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.158 -0.682 . . . . 75.05 109.158 175.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -118.38 117.39 28.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.06 0.544 . . . . 72.2 110.459 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.44 122.01 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.129 0.572 . . . . 73.25 109.554 172.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -99.68 105.04 16.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.956 -1.127 . . . . 75.23 107.956 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 67.7 tp60 -93.2 112.96 25.05 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.516 0.727 . . . . 72.34 110.234 -176.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.58 161.57 25.06 Favored Glycine 0 C--N 1.337 0.627 0 O-C-N 123.473 0.483 . . . . 62.21 112.782 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.81 120.58 0.98 Allowed Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.253 -0.739 . . . . 73.45 111.253 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 83' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 12.6 mm -84.31 122.76 38.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.207 -1.034 . . . . 65.52 108.207 176.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 84' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' C' ' 13' ' ' ILE . 70.6 m-85 -133.49 130.59 38.75 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 72.35 109.062 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -85.96 106.58 17.24 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.892 -0.781 . . . . 70.23 108.892 171.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 86' ' ' ILE . . . . . 0.423 HG23 ' SD ' ' C' ' 9' ' ' MET . 66.7 mt -116.32 107.93 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.954 0.902 . . . . 75.03 108.987 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.15 138.32 20.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.786 0.835 . . . . 73.31 109.458 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.33 -47.74 1.0 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.641 0.588 . . . . 75.1 112.366 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.89 172.68 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.147 0.579 . . . . 64.53 111.526 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.28 151.31 17.26 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.594 0.758 . . . . 75.42 110.585 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.11 -112.62 4.47 Favored Glycine 0 C--N 1.356 1.669 0 O-C-N 123.731 0.644 . . . . 52.21 114.191 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.3 p -64.3 -35.03 79.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.982 0.913 . . . . 71.24 111.842 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -77.86 -35.69 50.69 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.914 -0.585 . . . . 74.0 111.41 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 94' ' ' MET . . . . . 0.645 ' SD ' ' HA ' ' F' ' 277' ' ' LEU . 12.6 ptt? -70.66 -23.66 62.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 110.333 -0.247 . . . . 63.54 110.333 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.75 92.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.762 0.425 . . . . 51.1 110.878 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 96' ' ' HIS . . . . . 0.485 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.3 t-80 -73.7 -32.45 63.93 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 116.203 -0.453 . . . . 51.21 111.305 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -81.81 -62.55 1.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.157 0.503 . . . . 65.41 110.628 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.42 -43.83 96.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.484 1.113 . . . . 70.52 111.817 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.57 5.27 82.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.295 -0.725 . . . . 72.12 114.876 -172.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.589 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -149.39 -56.35 0.19 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.306 1.053 . . . . 64.13 112.908 -173.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 101' ' ' TYR . . . . . 0.417 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 89.3 t80 -71.13 -49.43 44.14 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.349 1.06 . . . . 75.44 111.543 -173.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.53 -44.42 65.83 Favored Pre-proline 0 CA--C 1.571 1.788 0 C-N-CA 124.144 0.977 . . . . 65.23 112.249 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.06 -40.64 67.73 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.948 2.432 . . . . 51.02 114.196 169.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -64.14 -31.64 72.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.787 0.679 . . . . 63.22 110.825 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 105' ' ' ILE . . . . . 0.436 HG23 ' NH1' ' A' ' 111' ' ' ARG . 39.9 mm -68.2 -41.55 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.82 0.448 . . . . 72.51 110.856 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 106' ' ' LEU . . . . . 0.43 HD12 HD23 ' C' ' 60' ' ' LEU . 86.4 mt -88.88 -22.22 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.701 0.8 . . . . 54.41 113.014 -172.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -56.36 -48.54 96.79 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 113.947 1.092 . . . . 52.44 113.947 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.8 -33.27 76.6 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 121.912 1.741 . . . . 60.13 113.64 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -48.04 69.4 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.432 0.693 . . . . 73.34 110.359 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.36 81.25 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.948 -1.023 . . . . 71.05 110.597 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.48 -52.47 64.6 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.938 -1.483 . . . . 75.45 112.003 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -33.27 73.91 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.607 0.363 . . . . 71.44 110.568 -173.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.46 -29.44 66.0 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 122.999 0.519 . . . . 75.43 110.839 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 114' ' ' ILE . . . . . 0.403 HD13 HG23 ' C' ' 64' ' ' VAL . 73.3 mt -72.04 -44.16 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.599 0.76 . . . . 74.24 109.768 170.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -64.34 -30.13 71.18 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.47 0.708 . . . . 72.21 111.174 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.9 t -71.76 -49.57 37.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.824 0.85 . . . . 74.1 109.002 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 117' ' ' MET . . . . . 0.528 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.0 -39.88 94.12 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.097 0.959 . . . . 74.05 113.041 -175.24 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.7 -34.78 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 109.944 -0.391 . . . . 60.41 109.944 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -72.71 -32.07 65.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.559 0.744 . . . . 60.54 111.587 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -68.16 -26.76 65.92 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.21 0.604 . . . . 60.12 110.42 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 11.52 68.35 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 119.246 -0.752 . . . . 74.03 113.271 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 122' ' ' THR . . . . . 0.495 HG23 ' HB3' ' D' ' 17' ' ' TYR . 52.7 p 58.76 26.86 15.21 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.91 1.684 . . . . 71.51 112.82 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -102.05 151.64 38.07 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.706 0.802 . . . . 75.31 109.922 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 124' ' ' PRO . . . . . 0.542 ' HD3' HD11 ' F' ' 301' ' ' ILE . 35.3 Cg_exo -59.87 121.55 10.01 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.016 2.477 . . . . 71.53 113.108 -171.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -60.33 146.37 44.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.111 0.882 . . . . 73.43 112.496 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -141.66 127.58 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 108.316 -0.994 . . . . 65.34 108.316 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.13 114.88 25.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.587 -1.264 . . . . 70.24 107.587 172.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 29.9 tp -64.86 129.01 38.14 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.86 0.725 . . . . 60.21 110.532 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 129' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -68.2 151.09 97.46 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.98 1.312 . . . . 74.11 112.039 -171.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 130' ' ' PRO . . . . . 0.474 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.1 Cg_exo -64.02 109.88 1.21 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.979 2.453 . . . . 60.05 112.28 -177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 131' ' ' VAL . . . . . 0.429 HG22 HD21 ' F' ' 291' ' ' LEU . 61.3 t -97.16 108.67 21.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.619 -1.252 . . . . 42.24 107.619 175.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 132' ' ' ASN . . . . . 0.443 ' O ' HD23 ' C' ' 136' ' ' LEU . 14.7 m120 -82.23 101.39 10.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.557 -0.747 . . . . 75.14 110.239 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -80.02 -38.46 31.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.332 -0.988 . . . . 73.42 108.332 168.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 134' ' ' ASP . . . . . 0.589 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.1 p-10 -55.71 -44.74 77.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.118 1.767 . . . . 52.15 112.856 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.04 -37.85 75.69 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.013 0.925 . . . . 73.05 111.798 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 136' ' ' LEU . . . . . 0.443 HD23 ' O ' ' C' ' 132' ' ' ASN . 4.5 mm? -66.51 -46.38 76.4 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.548 -0.751 . . . . 63.25 110.953 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -74.4 -18.65 60.63 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.414 0.686 . . . . 73.51 112.433 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 55.6 ttp -66.75 -38.41 86.55 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.478 0.711 . . . . 73.33 109.926 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.75 -37.33 86.95 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.025 -0.989 . . . . 43.33 110.594 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -69.78 -84.94 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.079 0.952 . . . . 75.44 110.218 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.5 90.64 3.47 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.736 0.814 . . . . 63.11 109.966 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.36 97.23 6.25 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.73 -1.211 . . . . 74.24 107.73 169.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -161.29 132.51 5.41 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 108.454 -0.943 . . . . 75.43 108.454 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -70.65 150.92 45.51 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 123.619 0.574 . . . . 65.1 111.365 178.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.46 130.63 1.71 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.668 1.187 . . . . 64.32 108.717 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.31 -39.47 0.55 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 111.082 -0.807 . . . . 72.44 111.082 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.82 134.95 36.36 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.016 -1.105 . . . . 72.31 108.016 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.21 66.36 0.39 Allowed Glycine 0 N--CA 1.476 1.343 0 CA-C-N 118.686 0.675 . . . . 75.03 112.516 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.0 m -83.41 73.34 10.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.611 0.764 . . . . 75.12 111.445 -174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -136.83 140.07 42.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.611 0.764 . . . . 71.45 110.137 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -135.9 179.26 6.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.187 1.395 . . . . 73.13 109.46 -177.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 63.7 112.24 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.907 1.283 . . . . 72.44 111.642 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -97.92 173.82 6.88 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 116.099 -0.5 . . . . 71.54 110.158 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -136.15 125.71 25.26 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.133 0.973 . . . . 74.33 109.116 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 123.523 0.729 . . . . 72.43 109.152 178.199 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 110.441 -0.207 . . . . 75.3 110.441 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -63.82 138.09 58.33 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.651 0.78 . . . . 71.54 111.056 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.57 -72.82 0.26 Allowed 'General case' 0 CA--C 1.551 1.006 0 O-C-N 123.869 0.731 . . . . 74.44 110.768 -174.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 73.08 -36.26 0.35 Allowed 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 125.413 1.485 . . . . 71.12 111.966 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 73.58 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.329 1.852 . . . . 73.14 110.132 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 178.5 15.22 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.859 1.264 . . . . 71.25 109.844 -172.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 55.8 p -73.27 -16.52 61.39 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.447 0.699 . . . . 73.33 111.926 -170.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -99.25 -66.19 0.92 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.356 -0.979 . . . . 74.34 108.356 166.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 9' ' ' MET . . . . . 0.559 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER 23.11 170.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 129.178 2.991 . . . . 60.22 118.858 -170.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.7 m -141.92 136.64 30.63 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.631 -1.168 . . . . 72.1 109.611 172.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -143.87 112.11 6.34 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.233 -1.025 . . . . 54.41 108.233 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 12' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 71.3 mt-30 -131.59 154.54 48.76 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.467 -0.938 . . . . 75.32 108.467 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 13' ' ' ILE . . . . . 0.44 HD11 HG21 ' D' ' 105' ' ' ILE . 35.6 mt -104.02 132.94 49.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.913 -1.143 . . . . 53.13 107.913 168.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.36 -48.14 8.23 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.627 -0.509 . . . . 71.03 109.627 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -155.64 148.29 24.08 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.32 0.648 . . . . 70.15 109.873 -176.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 16' ' ' ILE . . . . . 0.463 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -124.05 111.21 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.345 -1.354 . . . . 71.21 107.345 168.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HB3' HG23 ' C' ' 122' ' ' THR . 31.8 p90 -140.56 170.2 16.23 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.82 0.819 . . . . 73.51 111.764 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.4 p -101.2 121.31 41.61 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.556 -1.202 . . . . 65.03 108.883 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 19' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -88.23 -30.62 19.56 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.984 0.513 . . . . 73.43 110.346 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.6 t70 -152.86 127.02 9.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.142 -0.935 . . . . 73.22 108.573 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 21' ' ' ILE . . . . . 0.528 HG21 ' HE2' ' C' ' 117' ' ' MET . 82.7 mt -123.93 144.07 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.335 -1.357 . . . . 72.03 107.335 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -152.49 110.67 3.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 124.188 0.93 . . . . 62.21 109.494 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 23' ' ' PHE . . . . . 0.436 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 75.1 t80 -108.39 128.75 55.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.109 -1.812 . . . . 63.32 106.109 162.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -123.86 151.01 43.91 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.851 -0.796 . . . . 75.03 108.851 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 25' ' ' ALA . . . . . 0.778 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -132.82 76.59 70.55 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 106.616 -1.624 . . . . 74.21 106.616 170.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.5 -45.23 31.47 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.561 2.841 . . . . 71.43 113.113 -166.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 27' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' D' ' 31' ' ' VAL . 20.3 m-80 -114.59 25.99 10.57 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.232 -0.895 . . . . 63.42 110.101 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 28' ' ' ALA . . . . . 0.778 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -39.01 -60.02 1.27 Allowed Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 115.798 1.777 . . . . 63.11 115.798 -163.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 29' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 31.3 Cg_endo -81.94 -14.47 9.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 CA-C-N 122.282 1.851 . . . . 74.44 113.542 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -72.02 -38.77 69.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.36 1.064 . . . . 74.33 109.301 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 31' ' ' VAL . . . . . 0.607 HG13 HD11 ' D' ' 68' ' ' LEU . 52.8 t -63.35 -39.04 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.914 0.886 . . . . 61.42 109.991 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 32' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.9 m-30 -60.12 -9.22 2.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.378 1.251 . . . . 74.05 114.378 -173.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -77.77 -37.67 48.44 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.974 0.51 . . . . 75.34 111.108 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -132.8 62.83 1.65 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.847 0.859 . . . . 75.3 109.979 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 35' ' ' ASP . . . . . 0.527 ' HB3' HD12 ' G' ' 301' ' ' ILE . 42.5 t0 -107.79 83.28 1.77 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.847 0.832 . . . . 65.31 110.706 -169.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -126.5 -178.53 4.39 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.713 -1.131 . . . . 71.44 108.062 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pm0 -48.56 100.59 0.24 Allowed Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 123.571 0.749 . . . . 60.23 112.728 -162.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 38' ' ' PRO . . . . . 0.475 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 59.9 Cg_endo -71.62 149.09 54.65 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.601 2.201 . . . . 62.13 111.107 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.63 111.45 4.79 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.873 -1.158 . . . . 73.42 107.873 173.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 40' ' ' VAL . . . . . 0.452 HG23 ' NE1' ' G' ' 290' ' ' TRP . 2.8 m -103.54 106.27 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.919 0.888 . . . . 74.22 109.164 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -100.95 129.98 46.88 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.069 0.948 . . . . 63.23 109.952 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 tp -97.09 119.53 35.76 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.05 -0.722 . . . . 55.45 109.05 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 43' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.2 m-20 -120.32 130.82 54.61 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.782 0.833 . . . . 75.0 109.15 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.02 137.42 47.81 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.831 0.853 . . . . 54.13 109.155 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 45' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 6.3 t70 -135.83 132.27 36.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 44.4 p -104.94 143.61 32.93 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.717 0.807 . . . . 62.32 109.773 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 47' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.18 155.47 36.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.892 0.877 . . . . 71.03 110.025 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 48' ' ' SER . . . . . 0.426 ' HB2' HD21 ' G' ' 278' ' ' LEU . 28.6 p -158.99 162.8 36.82 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.219 0.533 . . . . 65.0 111.228 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -150.01 150.02 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.649 -1.16 . . . . 74.4 109.462 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -100.71 122.52 43.49 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.335 -1.358 . . . . 74.42 107.335 159.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 51' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.0 mt -96.3 -26.36 15.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.453 0.701 . . . . 52.11 109.38 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.33 173.46 5.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.758 1.223 . . . . 52.23 109.532 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.93 131.47 46.33 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.623 -0.88 . . . . 71.53 108.623 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 70.15 -2.05 2.23 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.112 1.365 . . . . 61.11 113.086 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.65 116.34 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.35 0.66 . . . . 72.04 109.29 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.01 162.13 31.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.979 -0.749 . . . . 72.51 108.979 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 57' ' ' GLU . . . . . 0.494 ' HB2' HD11 ' D' ' 51' ' ' LEU . 28.4 tt0 -130.42 118.31 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.084 0.954 . . . . 74.11 108.604 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 58' ' ' VAL . . . . . 0.52 HG13 ' HZ ' ' G' ' 281' ' ' PHE . 77.3 t -100.48 113.31 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.387 -1.338 . . . . 64.31 107.387 175.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.9 t -107.01 127.72 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.997 -1.112 . . . . 73.25 107.997 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HB3' HD22 ' D' ' 106' ' ' LEU . 0.9 OUTLIER -128.94 112.65 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.762 -1.199 . . . . 63.0 107.762 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 61' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.3 ttm180 -85.18 118.4 24.71 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.733 0.813 . . . . 75.41 109.459 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.59 122.0 62.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.943 -1.132 . . . . 74.1 107.943 170.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 63' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.4 m -119.36 137.27 53.83 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.561 0.745 . . . . 65.11 109.92 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 71.5 t -128.24 103.73 10.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 C-N-CA 125.146 1.378 . . . . 70.53 107.729 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.2 m -101.91 105.24 16.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.515 0.726 . . . . 61.25 109.454 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 66' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -99.28 128.5 45.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.276 0.63 . . . . 74.05 110.633 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -144.81 126.06 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.174 0.589 . . . . 65.41 110.443 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 68' ' ' LEU . . . . . 0.607 HD11 HG13 ' D' ' 31' ' ' VAL . 3.4 pp -124.96 139.81 53.49 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.723 0.809 . . . . 63.42 111.187 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.57 -111.47 3.34 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 110.479 -1.049 . . . . 32.21 110.479 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 3.35 8.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 75.02 110.446 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.78 167.76 14.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.109 0.564 . . . . 53.55 110.082 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.0 m -84.65 126.47 33.39 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.492 -0.777 . . . . 54.53 110.593 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 73' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -69.7 -64.95 0.78 Allowed 'General case' 0 C--O 1.242 0.668 0 O-C-N 124.259 0.974 . . . . 55.11 109.299 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.1 162.2 39.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.559 -1.201 . . . . 74.31 110.432 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -124.12 141.42 52.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.898 1.279 . . . . 72.03 108.012 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 76' ' ' CYS . . . . . 0.605 ' SG ' HG23 ' D' ' 114' ' ' ILE . 21.8 t -152.27 109.5 3.55 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.652 -0.499 . . . . 72.14 109.652 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 77' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' D' ' 63' ' ' THR . 38.7 tt0 -140.41 130.65 25.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.404 1.082 . . . . 74.53 108.848 -171.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.68 116.36 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.428 0.691 . . . . 73.53 109.788 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -88.04 83.93 6.99 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.851 -1.166 . . . . 74.15 107.851 166.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 80' ' ' GLN . . . . . 0.483 ' HB3' HD21 ' D' ' 106' ' ' LEU . 35.8 tp60 -79.84 114.82 19.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.44 -1.318 . . . . 71.15 107.44 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -109.16 142.03 16.11 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.194 -0.762 . . . . 61.23 111.194 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.9 5.92 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.058 -0.817 . . . . 65.33 111.058 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.31 126.06 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.062 -1.088 . . . . 72.32 108.062 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -123.65 127.96 48.97 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.593 1.157 . . . . 75.11 109.229 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 85' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 43.8 m -78.63 101.16 7.32 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.301 -1.0 . . . . 72.04 108.301 169.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 86' ' ' ILE . . . . . 0.509 HG22 HD22 ' G' ' 277' ' ' LEU . 61.4 mt -108.59 128.99 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.914 0.886 . . . . 63.13 109.725 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.24 159.15 25.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.973 0.909 . . . . 72.22 110.328 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 88' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.79 14.96 78.79 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 115.011 0.765 . . . . 71.35 115.011 169.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 89' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' D' ' 94' ' ' MET . 18.3 pt -136.67 134.93 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.355 -0.979 . . . . 52.12 108.355 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.98 157.66 45.93 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.949 -0.47 . . . . 73.51 111.202 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -118.51 14.5 Favored Glycine 0 C--N 1.355 1.605 0 O-C-N 124.658 1.224 . . . . 74.43 113.565 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 17.4 m -69.6 -31.36 69.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.738 0.815 . . . . 75.23 111.985 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -72.99 -42.33 63.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.828 0.451 . . . . 65.43 110.871 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 94' ' ' MET . . . . . 0.469 ' HA ' HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -72.04 -34.37 68.73 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.234 -0.284 . . . . 62.45 110.234 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.84 92.54 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.782 0.833 . . . . 54.22 110.893 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -67.7 -36.42 80.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 72.53 110.953 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.8 -51.41 34.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.582 0.353 . . . . 70.43 110.85 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.429 HD21 ' H ' ' G' ' 279' ' ' GLY . 4.5 pp -80.19 -20.48 44.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.649 0.379 . . . . 71.04 111.652 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.39 -2.98 55.59 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.608 -0.551 . . . . 63.21 114.007 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.82 -64.48 0.41 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.69 0.745 . . . . 65.41 111.251 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -64.23 -56.11 16.92 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.812 0.671 . . . . 72.52 112.812 -170.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.3 m -60.2 -45.41 97.76 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.31 1.044 . . . . 73.45 112.417 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.76 -40.2 80.91 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 122.65 2.234 . . . . 71.34 113.254 168.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.33 -22.81 57.35 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.465 0.706 . . . . 71.1 112.406 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 105' ' ' ILE . . . . . 0.44 HG21 HD11 ' D' ' 13' ' ' ILE . 29.0 mm -71.74 -42.77 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 122.302 1.048 . . . . 74.35 109.166 169.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 106' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' D' ' 80' ' ' GLN . 8.6 tt -76.55 -27.82 56.06 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 113.562 -1.653 . . . . 72.42 111.171 -173.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.91 -40.83 72.52 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 125.254 1.422 . . . . 61.41 113.905 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.38 -34.42 88.87 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.477 2.118 . . . . 41.05 114.272 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -79.55 -30.9 41.88 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.185 0.594 . . . . 72.52 111.055 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.35 79.14 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.363 -0.606 . . . . 74.13 109.363 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 111' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 25.2 ttp180 -54.52 -55.41 29.42 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.098 -1.41 . . . . 71.44 111.158 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -60.16 -43.93 95.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.027 0.829 . . . . 71.04 111.177 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -63.26 -45.44 91.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.804 0.442 . . . . 74.21 111.318 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 114' ' ' ILE . . . . . 0.605 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.2 mt -58.06 -59.39 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.877 0.871 . . . . 55.1 110.555 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 94.9 m -51.64 -43.57 62.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.569 1.548 . . . . 64.31 112.426 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.2 t -68.9 -39.33 79.79 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.204 -0.907 . . . . 74.33 110.741 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 117' ' ' MET . . . . . 0.422 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.8 mtm -71.33 -32.33 68.44 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.0 0.52 . . . . 60.41 111.721 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -63.65 -44.98 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 O-C-N 123.683 0.614 . . . . 74.12 109.432 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -73.02 -27.84 62.0 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.171 0.588 . . . . 44.42 111.808 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -73.4 -31.4 63.85 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.6 0.76 . . . . 74.21 110.499 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.94 5.44 75.85 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.599 0.562 . . . . 61.33 111.933 171.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p 61.5 14.67 6.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.128 2.171 . . . . 75.21 113.333 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -80.01 158.81 72.04 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.483 1.113 . . . . 72.43 108.585 169.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -67.42 124.5 12.13 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.746 2.297 . . . . 75.2 111.419 -168.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -53.3 116.8 2.61 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.298 0.999 . . . . 63.02 110.282 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -109.13 131.45 55.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.831 -1.174 . . . . 74.11 107.831 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -107.34 98.2 7.86 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.37 -0.974 . . . . 71.12 108.37 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 128' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 65.3 tp -56.73 115.7 2.71 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.874 1.27 . . . . 73.14 111.053 -176.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.13 95.85 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.933 0.893 . . . . 44.43 110.895 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.26 139.05 25.87 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.104 1.869 . . . . 62.24 111.719 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.48 111.27 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.727 -0.842 . . . . 74.31 108.727 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.41 81.39 4.76 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.402 -0.962 . . . . 72.33 108.402 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -77.04 -29.28 55.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.862 -1.063 . . . . 75.41 111.44 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.84 -46.45 74.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.813 0.445 . . . . 75.43 111.497 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.98 -60.77 2.9 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.014 0.926 . . . . 63.13 112.367 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 136' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' G' ' 285' ' ' ASN . 3.3 pp -64.97 -27.04 68.56 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.404 -0.816 . . . . 63.42 112.197 -175.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.67 -40.6 33.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.402 0.681 . . . . 63.22 110.565 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.0 mtm -72.7 -26.85 61.75 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.486 0.714 . . . . 73.54 111.297 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -56.15 -40.02 73.2 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.679 0.612 . . . . 74.32 110.666 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.46 -43.72 96.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.312 1.045 . . . . 73.33 111.179 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.94 -29.29 70.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.264 1.026 . . . . 73.53 111.561 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -83.06 4.54 25.79 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.757 0.823 . . . . 72.34 112.419 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -118.63 88.55 2.95 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.173 -0.677 . . . . 75.24 109.173 -174.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.58 112.95 1.73 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.685 -1.143 . . . . 73.54 107.997 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.48 101.5 6.21 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.43 0.692 . . . . 63.22 109.312 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -127.28 76.43 0.4 Allowed Glycine 0 C--N 1.343 0.921 0 N-CA-C 110.492 -1.043 . . . . 62.15 110.492 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.68 142.9 50.62 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.493 0.717 . . . . 74.22 110.628 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.92 152.49 11.29 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.573 -0.74 . . . . 65.24 111.85 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.0 t -146.61 174.86 11.05 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.227 0.611 . . . . 35.34 110.14 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.99 -77.89 0.12 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.219 -2.141 . . . . 65.04 105.219 169.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -174.26 94.87 0.09 Allowed 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.957 -1.127 . . . . 62.42 107.957 173.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -159.35 66.76 0.4 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.413 -0.958 . . . . 73.34 108.413 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -18.83 57.87 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.866 -1.061 . . . . 74.51 111.303 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -76.16 167.22 22.25 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.037 0.935 . . . . 74.24 110.097 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 123.731 0.812 . . . . 74.21 109.01 176.373 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.66 -0.496 . . . . 53.53 109.66 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -81.0 156.01 26.11 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.286 -0.635 . . . . 64.24 109.286 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -60.03 113.05 2.12 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.03 0.932 . . . . 63.22 108.746 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -69.45 -66.86 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.882 0.739 . . . . 62.53 110.069 -168.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 275' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 90' ' ' GLU . 26.9 mtmt -161.1 148.52 12.16 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 124.408 1.083 . . . . 65.12 108.936 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -43.21 129.7 6.13 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 124.421 3.414 . . . . 64.53 114.763 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 67.0 mt -54.43 140.53 33.72 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.858 1.263 . . . . 74.42 110.666 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 7.3 mp 76.61 2.18 3.38 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.04 1.336 . . . . 64.24 112.003 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -76.72 89.86 0.95 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.872 -0.491 . . . . 71.24 111.872 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 280' ' ' LEU . . . . . 0.529 HD13 ' HB1' ' A' ' 95' ' ' ALA . 47.9 tp -159.98 -67.34 0.07 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.494 0.718 . . . . 53.53 110.174 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -53.78 -70.17 0.1 Allowed 'General case' 0 C--N 1.359 0.994 0 O-C-N 124.376 1.047 . . . . 65.42 112.641 -163.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 57.77 -82.83 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.158 0.983 . . . . 70.05 110.52 -171.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -113.91 148.01 37.51 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.391 1.076 . . . . 72.1 109.141 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.59 68.48 3.18 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 111.461 -0.656 . . . . 74.42 111.461 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -80.56 -8.34 59.56 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.848 0.859 . . . . 74.02 112.029 -169.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 52.3 mtm -118.73 87.96 33.87 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.129 0.572 . . . . 74.32 109.674 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -86.27 135.62 4.56 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.787 2.325 . . . . 73.23 110.058 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 288' ' ' VAL . . . . . 0.566 ' HB ' HD22 ' A' ' 42' ' ' LEU . 80.4 t -69.25 103.63 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 109.597 -0.52 . . . . 60.44 109.597 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -58.07 137.4 56.93 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.26 -1.015 . . . . 71.4 108.26 170.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -74.28 74.93 1.84 Allowed 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.708 0.63 . . . . 74.02 111.536 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 291' ' ' LEU . . . . . 0.445 HD13 ' HB ' ' G' ' 306' ' ' VAL . 24.0 mt 51.7 25.69 3.01 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.732 1.613 . . . . 74.21 113.824 163.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.06 -137.23 20.27 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-O 119.173 -0.793 . . . . 51.32 112.428 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.45 87.76 1.43 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.69 2.26 . . . . 75.31 112.45 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -143.17 167.21 22.65 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.778 0.831 . . . . 71.53 110.997 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -149.16 175.89 10.97 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.296 1.038 . . . . 72.25 110.653 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 99.0 m -133.69 113.08 11.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.475 0.71 . . . . 65.24 110.22 176.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 297' ' ' TYR . . . . . 0.595 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . 58.3 t80 -167.34 146.56 5.09 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.438 -1.319 . . . . 75.24 107.438 171.228 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -134.68 -49.26 0.76 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.145 -1.057 . . . . 72.54 108.145 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 299' ' ' GLY . . . . . 0.551 ' H ' ' HG3' ' A' ' 124' ' ' PRO . . . 148.44 129.86 1.88 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.669 -0.696 . . . . 60.21 111.603 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -152.55 7.74 0.44 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.326 1.05 . . . . 63.52 110.221 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 301' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 32' ' ' PHE . 4.1 mp -117.31 137.68 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.522 0.729 . . . . 72.13 109.652 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -169.42 -89.79 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.646 -1.242 . . . . 73.42 107.646 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -175.15 75.29 0.3 Allowed Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 105.993 -1.855 . . . . 71.2 105.993 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.35 121.05 6.55 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 121.596 1.53 . . . . 73.25 109.285 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -160.1 137.9 9.86 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.914 0.486 . . . . 63.24 109.98 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.59 1.07 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 124.146 0.978 . . . . 74.0 110.001 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 71.6 p 67.05 -69.85 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.715 2.006 . . . . 62.24 111.459 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 74.3 m -154.6 136.07 14.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.419 1.087 . . . . 74.45 109.051 171.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 63.3 m -74.26 -41.03 4.84 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 124.528 1.131 . . . . 74.14 110.992 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 C--N 1.402 3.366 0 C-N-CA 122.057 1.838 . . . . 53.3 111.167 166.842 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.022 0.439 . . . . 55.2 110.154 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -96.85 120.78 37.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.2 -1.037 . . . . 71.02 108.2 175.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -71.62 -14.74 62.15 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.72 0.638 . . . . 53.21 111.935 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -57.55 -32.58 67.25 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.184 0.594 . . . . 73.25 110.65 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -73.47 113.47 22.74 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 109.051 -0.722 . . . . 45.42 109.051 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.44 -151.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 123.238 2.625 . . . . 71.13 110.706 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 277' ' ' LEU . . . . . 0.645 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 59.1 mt -50.14 137.67 17.34 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 123.586 0.754 . . . . 43.44 111.987 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 77.65 -173.02 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 O-C-N 125.05 1.469 . . . . 53.22 110.816 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 87.69 -57.59 4.4 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.473 -0.651 . . . . 73.41 111.473 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -75.71 77.01 2.68 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 108.193 -1.04 . . . . 74.43 108.193 175.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -165.82 33.66 0.05 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.698 1.199 . . . . 73.24 108.332 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -141.42 89.97 2.26 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.988 -0.745 . . . . 64.03 108.988 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -168.56 151.17 5.2 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.297 -1.001 . . . . 74.21 108.297 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -84.93 57.84 4.99 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.588 0.555 . . . . 65.11 112.744 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -69.34 127.09 31.82 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.986 0.915 . . . . 74.04 109.929 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 4.4 mpp? 55.27 88.66 0.12 Allowed Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.75 1.22 . . . . 51.21 111.11 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.62 -42.71 18.77 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.92 3.08 . . . . 75.24 114.493 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 48.7 t 46.31 84.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.957 1.303 . . . . 53.43 111.772 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -59.27 2.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.956 -1.498 . . . . 73.33 106.956 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -152.21 178.15 9.79 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.953 1.301 . . . . 73.44 109.234 165.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 291' ' ' LEU . . . . . 0.593 ' HG ' HG23 ' H' ' 309' ' ' THR . 4.7 mp -114.64 16.07 17.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.745 0.818 . . . . 73.13 110.973 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -166.32 162.09 35.72 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 119.275 -0.736 . . . . 73.25 111.898 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.82 1.4 8.15 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.347 2.698 . . . . 71.01 113.244 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -87.66 -178.86 6.19 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.933 1.293 . . . . 62.53 112.524 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 295' ' ' ALA . . . . . 0.524 ' HA ' HG21 ' C' ' 40' ' ' VAL . . . -143.65 155.95 44.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.171 0.988 . . . . 53.22 110.313 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 296' ' ' THR . . . . . 0.577 ' H ' HG11 ' C' ' 40' ' ' VAL . 7.5 m -63.31 -33.6 75.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.512 0.725 . . . . 73.34 111.064 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 297' ' ' TYR . . . . . 0.716 ' HD2' ' HG3' ' C' ' 38' ' ' PRO . 42.3 m-85 -87.39 60.79 6.26 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.65 0.738 . . . . 65.32 110.455 169.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.43 109.92 3.39 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.776 -1.564 . . . . 63.31 106.776 158.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -61.73 79.78 0.02 OUTLIER Glycine 0 C--N 1.353 1.485 0 O-C-N 124.788 1.305 . . . . 61.11 115.348 -165.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -100.0 -21.73 15.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.216 1.006 . . . . 64.31 109.493 173.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 301' ' ' ILE . . . . . 0.542 HD11 ' HD3' ' C' ' 124' ' ' PRO . 46.9 mt -69.35 96.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.119 0 N-CA-C 109.035 -0.728 . . . . 75.11 109.035 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -155.92 -42.35 0.08 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.955 -1.021 . . . . 74.33 108.669 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -96.92 127.33 39.4 Favored Pre-proline 0 N--CA 1.476 0.838 0 N-CA-C 108.783 -0.821 . . . . 71.51 108.783 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.27 163.08 39.75 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.914 2.41 . . . . 72.14 112.317 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -95.61 -32.63 12.71 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.371 0.668 . . . . 70.21 110.893 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.98 116.53 52.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 C-N-CA 123.956 0.902 . . . . 71.03 108.989 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 91.5 m -133.66 93.82 3.19 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 107.676 -1.231 . . . . 64.34 107.676 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 56.0 m 65.63 175.02 0.22 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.985 1.314 . . . . 35.21 111.783 -173.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 16.3 p -132.69 156.97 79.49 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.832 1.253 . . . . 61.33 109.029 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' F' F ' 310' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' B' ' 132' ' ' ASN . 9.5 Cg_endo . . . . . 0 C--N 1.387 2.587 0 C-N-CA 123.014 2.476 . . . . 74.41 112.331 174.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.743 -0.466 . . . . 65.11 109.743 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -158.38 177.12 11.6 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.152 0.581 . . . . 72.12 109.961 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -67.5 106.14 2.05 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.469 0.652 . . . . 41.45 109.736 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -160.71 -175.29 4.88 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.666 0.786 . . . . 61.13 109.36 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 275' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' G' ' 278' ' ' LEU . 2.4 mppt? -110.65 89.47 9.13 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.898 -1.149 . . . . 55.21 107.898 174.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 276' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' D' ' 94' ' ' MET . 88.8 Cg_endo -78.41 -2.66 12.7 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.579 2.186 . . . . 73.42 112.119 -177.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 277' ' ' LEU . . . . . 0.509 HD22 HG22 ' D' ' 86' ' ' ILE . 96.1 mt -131.16 17.85 4.99 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.858 1.263 . . . . 75.11 110.832 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 278' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' G' ' 275' ' ' LYS . 0.4 OUTLIER -153.69 101.38 2.46 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.803 -0.443 . . . . 72.35 109.803 -179.241 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' G' G ' 279' ' ' GLY . . . . . 0.429 ' H ' HD21 ' D' ' 98' ' ' LEU . . . -173.58 143.93 7.41 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.008 -0.885 . . . . 73.44 111.4 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 65.5 tp 62.29 106.95 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.038 1.335 . . . . 74.02 111.77 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 281' ' ' PHE . . . . . 0.52 ' HZ ' HG13 ' D' ' 58' ' ' VAL . 0.1 OUTLIER -134.31 -45.42 0.77 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.664 0.385 . . . . 75.33 110.209 -174.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' G' G ' 282' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' G' ' 286' ' ' MET . . . -123.87 72.32 1.15 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.255 0.622 . . . . 73.44 111.499 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -171.12 116.48 0.44 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.167 0.987 . . . . 70.13 109.343 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 151.02 -75.86 0.24 Allowed Glycine 0 C--N 1.346 1.089 0 N-CA-C 110.721 -0.951 . . . . 74.41 110.721 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 285' ' ' ASN . . . . . 0.516 ' HB3' HD13 ' D' ' 136' ' ' LEU . 17.0 t-20 -159.93 31.68 0.18 Allowed 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 122.37 1.081 . . . . 72.31 109.192 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 286' ' ' MET . . . . . 0.648 ' HG2' ' HA ' ' G' ' 282' ' ' ALA . 1.5 mpt? -69.18 -31.77 2.92 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 115.478 1.658 . . . . 75.54 115.478 -172.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.23 77.2 0.33 Allowed 'Trans proline' 0 C--N 1.4 3.251 0 CA-C-N 122.424 1.901 . . . . 74.53 112.541 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.19 121.14 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.457 0.703 . . . . 70.02 109.42 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -69.36 165.48 20.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.322 1.049 . . . . 72.24 110.753 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 290' ' ' TRP . . . . . 0.452 ' NE1' HG23 ' D' ' 40' ' ' VAL . 20.2 t-105 -73.82 123.99 25.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.844 0.458 . . . . 71.41 110.161 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.74 129.19 35.6 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.585 0.754 . . . . 64.52 109.935 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 86.12 166.02 41.62 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.62 0.575 . . . . 61.14 114.028 175.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.57 162.59 19.21 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.239 2.626 . . . . 74.32 112.513 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -80.39 74.79 7.24 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.472 1.13 . . . . 71.14 109.364 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.71 24.77 3.4 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.726 -1.124 . . . . 73.25 110.636 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 16.0 p -68.27 -76.8 0.08 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.444 1.098 . . . . 74.24 112.186 -173.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.52 111.35 21.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.509 0.324 . . . . 61.34 111.218 -167.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -145.68 107.14 4.22 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.857 0.863 . . . . 72.23 109.155 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 177.12 -141.15 5.23 Favored Glycine 0 C--N 1.337 0.607 0 O-C-N 123.835 0.71 . . . . 64.21 111.693 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -150.5 109.21 3.84 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.193 0.997 . . . . 74.25 109.047 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 301' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' D' ' 35' ' ' ASP . 50.3 mt -93.12 61.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-O 122.52 1.152 . . . . 72.43 109.446 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -165.47 72.48 0.18 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.731 -1.581 . . . . 62.14 106.731 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -168.11 74.95 0.89 Allowed Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.557 -0.747 . . . . 74.21 110.36 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 304' ' ' PRO . . . . . 0.453 ' HG2' ' HA ' ' G' ' 307' ' ' THR . 37.3 Cg_endo -70.29 133.74 25.28 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.835 1.69 . . . . 62.14 110.972 171.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.72 -33.65 68.65 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.833 0.853 . . . . 70.13 110.801 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 306' ' ' VAL . . . . . 0.445 ' HB ' HD13 ' E' ' 291' ' ' LEU . 5.1 p -114.04 100.56 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.43 -0.952 . . . . 72.41 108.43 164.397 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 307' ' ' THR . . . . . 0.453 ' HA ' ' HG2' ' G' ' 304' ' ' PRO . 9.4 m -73.18 -32.21 64.69 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.531 -0.759 . . . . 73.04 110.538 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 19.3 p -162.17 125.5 3.03 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 124.539 1.136 . . . . 73.43 108.735 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 61.7 m -76.46 130.18 77.74 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-O 118.101 -0.952 . . . . 75.21 109.222 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo . . . . . 0 C--N 1.398 3.134 1 C-N-CA 125.406 4.07 . . . . 53.43 115.892 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.432 -0.21 . . . . 50.02 110.432 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -115.4 -48.95 2.77 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.483 1.113 . . . . 75.02 108.524 174.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.94 78.38 8.28 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.205 -0.907 . . . . 71.34 109.149 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -68.58 -33.8 74.69 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.774 -0.648 . . . . 60.11 110.747 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -114.14 87.34 13.0 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 109.165 -0.68 . . . . 65.13 109.165 172.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -88.2 128.33 2.23 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.545 2.163 . . . . 44.15 111.328 172.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 277' ' ' LEU . . . . . 0.508 HD23 ' SD ' ' B' ' 94' ' ' MET . 1.2 tt -81.31 65.97 6.66 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.755 -1.202 . . . . 64.24 107.755 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 47.8 tp -175.59 136.6 0.34 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.131 1.372 . . . . 74.3 107.98 -174.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.55 -69.11 0.03 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.517 -1.033 . . . . 61.33 110.517 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.74 -176.92 6.52 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.476 0.711 . . . . 72.22 109.633 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 281' ' ' PHE . . . . . 0.424 ' CZ ' HG13 ' B' ' 58' ' ' VAL . 38.4 t80 69.39 85.09 0.14 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.26 1.024 . . . . 63.14 110.203 176.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -174.09 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.585 1.154 . . . . 63.41 108.97 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -112.71 100.17 8.49 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.237 -1.023 . . . . 70.42 108.237 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 284' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' B' ' 45' ' ' ASP . . . -81.84 91.36 1.49 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.812 -0.515 . . . . 62.32 111.812 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -117.61 28.24 8.57 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.068 0.947 . . . . 60.2 110.552 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -105.54 96.74 12.59 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 109.312 -0.625 . . . . 72.32 109.312 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.62 94.26 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.674 2.25 . . . . 64.52 110.208 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 288' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' B' ' 42' ' ' LEU . 57.3 t -61.03 111.4 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.728 -0.669 . . . . 64.32 110.32 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -82.28 150.15 27.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.796 -0.816 . . . . 75.1 108.796 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -61.03 142.98 56.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.165 0.586 . . . . 74.53 111.225 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 291' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' B' ' 129' ' ' ALA . 5.6 mp -82.23 81.26 8.19 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.206 1.002 . . . . 71.03 108.949 -174.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 80.19 -130.53 9.85 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.834 -0.981 . . . . 72.4 111.19 -172.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.82 179.24 4.39 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.812 2.341 . . . . 75.24 113.013 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -155.48 -65.16 0.12 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.064 -0.971 . . . . 73.51 109.46 172.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 63.91 109.93 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.07 1.348 . . . . 71.54 111.794 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 25.9 m -77.68 -59.76 2.65 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.879 0.472 . . . . 72.24 109.861 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -109.05 111.05 22.49 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 108.27 -1.011 . . . . 74.34 108.27 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -154.92 150.02 26.96 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.784 0.433 . . . . 63.02 110.166 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 69.35 -95.97 0.46 Allowed Glycine 0 C--N 1.35 1.343 0 O-C-N 124.068 0.855 . . . . 62.3 111.912 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -120.53 111.02 17.17 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.1 -1.074 . . . . 73.12 108.1 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 301' ' ' ILE . . . . . 0.506 HG23 ' O ' ' H' ' 302' ' ' ASP . 1.2 tt -68.36 -24.35 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.357 1.063 . . . . 75.22 111.612 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 302' ' ' ASP . . . . . 0.506 ' O ' HG23 ' H' ' 301' ' ' ILE . 2.5 t70 85.82 -161.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 126.573 1.949 . . . . 71.23 107.162 -163.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -158.12 101.39 1.75 Allowed Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 108.301 -1.0 . . . . 73.24 108.301 165.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.96 77.92 0.77 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.556 2.17 . . . . 73.55 110.628 172.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -144.28 81.05 1.66 Allowed 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.441 -1.254 . . . . 75.45 108.976 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 306' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 13' ' ' ILE . 45.3 t -65.29 114.1 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 115.42 -0.809 . . . . 74.43 109.023 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 5.0 m -123.62 6.16 8.87 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.57 0.748 . . . . 73.44 109.815 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 24.6 p -168.04 164.71 13.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.246 1.019 . . . . 63.22 109.727 -174.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' H' H ' 309' ' ' THR . . . . . 0.593 HG23 ' HG ' ' F' ' 291' ' ' LEU . 17.5 m -145.64 61.79 7.93 Favored Pre-proline 0 CA--C 1.565 1.542 0 C-N-CA 123.507 0.723 . . . . 71.43 109.302 170.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 C--N 1.38 2.192 0 C-N-CA 122.3 2.0 . . . . 71.11 111.102 178.753 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.3 m . . . . . 0 N--CA 1.472 0.628 0 N-CA-C 109.098 -0.704 . . . . 73.32 109.098 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.523 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -138.47 132.28 31.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.199 1.0 . . . . 72.51 109.76 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -153.56 109.11 3.23 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.153 0.581 . . . . 71.41 109.764 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 84' ' ' PHE . 45.5 mt -75.06 122.92 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.294 -0.632 . . . . 73.13 109.294 177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -93.57 -35.34 12.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.598 0.561 . . . . 70.4 110.677 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -169.23 140.29 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.658 -0.246 . . . . 63.25 110.356 -170.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.63 HD12 ' HG3' ' C' ' 130' ' ' PRO . 0.2 OUTLIER -125.95 141.54 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.175 -1.046 . . . . 75.22 108.175 173.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.6 p90 -174.16 155.7 2.49 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.926 0.49 . . . . 73.13 111.365 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -78.36 121.29 24.29 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.808 -0.633 . . . . 72.51 109.569 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.5 mtpt -87.02 -25.2 24.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.625 0.37 . . . . 73.23 110.187 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.2 t70 -151.27 139.31 20.07 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.462 -0.79 . . . . 75.21 109.623 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.3 mt -131.38 139.47 50.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 106.77 -1.567 . . . . 75.41 106.77 176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -147.59 127.4 13.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.235 -1.024 . . . . 65.5 108.235 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.2 t80 -135.63 113.12 10.73 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.227 -1.397 . . . . 64.0 107.227 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.82 130.03 55.55 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.797 -0.816 . . . . 63.03 108.797 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -121.1 78.52 33.38 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.222 -1.399 . . . . 62.23 107.222 174.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.05 -46.77 23.56 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 123.641 2.894 . . . . 62.31 113.272 -164.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.16 41.68 3.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.759 -0.83 . . . . 74.03 108.759 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -45.65 -53.5 19.41 Favored Pre-proline 0 CA--C 1.561 1.379 0 O-C-N 124.199 0.937 . . . . 61.44 112.322 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -63.96 -23.84 67.71 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 121.951 1.767 . . . . 72.41 113.173 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -95.35 -21.95 18.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.728 0.811 . . . . 65.41 111.342 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.2 t -80.79 -32.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.002 0.921 . . . . 63.54 112.424 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.08 -1.47 20.27 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.453 0.701 . . . . 74.51 112.863 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -105.71 -11.3 16.35 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.003 0.921 . . . . 64.12 112.236 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.17 170.96 15.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.567 0.951 . . . . 73.44 113.567 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.427 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.9 m-20 -61.01 134.36 57.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.766 1.226 . . . . 65.23 110.013 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -85.44 62.29 7.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 73.34 111.604 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -146.59 76.73 11.73 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.153 0.981 . . . . 73.11 109.906 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.88 149.14 32.85 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.525 2.15 . . . . 73.03 112.428 163.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.49 102.12 13.81 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.707 -1.219 . . . . 75.42 107.707 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 t -84.92 95.44 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.746 -0.464 . . . . 72.41 109.746 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -85.32 119.74 26.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.087 -0.961 . . . . 70.41 109.605 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -97.58 146.18 25.54 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.382 0.61 . . . . 72.41 109.423 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.676 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.9 m-20 -136.84 146.8 46.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.41 1.084 . . . . 73.51 108.531 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 tt -141.32 125.34 17.22 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.715 -1.217 . . . . 70.21 107.715 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.9 m-20 -116.32 131.95 56.8 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.102 -1.073 . . . . 71.42 108.102 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -106.06 125.02 50.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.812 -1.085 . . . . 61.13 109.085 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.05 126.05 9.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.257 0.623 . . . . 74.34 109.352 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 p -110.57 162.67 14.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.638 0.775 . . . . 73.34 109.21 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 44.4 t -148.44 153.61 38.75 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.502 0.721 . . . . 44.02 109.665 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -104.96 116.44 31.96 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.151 -1.055 . . . . 72.14 108.151 172.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.5 mt -96.36 -35.78 11.09 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.07 0.462 . . . . 65.34 109.96 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -153.87 -179.03 7.47 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.164 -0.925 . . . . 73.0 109.653 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.29 121.94 16.37 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.585 -0.895 . . . . 71.42 108.585 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 67.3 8.22 6.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.57 1.148 . . . . 53.1 112.515 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 67.8 t -113.51 106.2 20.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 107.929 -1.137 . . . . 72.05 107.929 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.98 125.27 50.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.772 -1.104 . . . . 71.12 108.593 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 34.9 tt0 -91.98 148.95 21.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.346 -0.843 . . . . 52.22 109.315 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.587 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 41.2 t -127.13 130.11 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.58 -1.267 . . . . 74.13 107.58 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.55 131.1 72.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.432 -0.951 . . . . 75.1 108.432 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 103' ' ' PRO . 2.7 mm? -119.52 114.9 22.97 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.842 -1.17 . . . . 73.4 107.842 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 21.5 ttp180 -85.18 100.35 11.69 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -93.99 110.1 23.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.522 -1.288 . . . . 44.41 107.522 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.676 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -109.12 126.91 53.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.962 -0.755 . . . . 72.54 108.962 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.6 t -116.03 124.17 72.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 106.906 -1.516 . . . . 63.01 106.906 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 2.6 m -127.16 129.65 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.351 -0.611 . . . . 42.44 109.351 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.65 124.16 37.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.814 -0.81 . . . . 72.22 108.814 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.9 m -134.03 127.42 32.23 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.298 0.639 . . . . 54.22 109.938 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 35' ' ' ASP . 5.2 mp -87.4 80.66 8.08 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.559 -1.275 . . . . 70.04 107.559 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.44 -83.49 1.32 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.232 -1.349 . . . . 35.22 111.286 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.34 -21.73 10.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 72.43 111.586 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.73 119.32 38.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.53 0.332 . . . . 73.23 111.207 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 25.0 m -70.47 133.24 46.64 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.75 0.648 . . . . 63.43 112.75 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.12 -63.62 1.36 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.885 1.274 . . . . 54.31 109.99 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -153.35 168.82 24.78 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 114.694 -1.139 . . . . 73.31 110.931 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -143.89 107.29 4.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.599 -1.637 . . . . 62.42 107.352 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.9 m -105.8 97.91 7.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.102 0.561 . . . . 64.03 110.525 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.99 115.48 29.0 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.859 0.863 . . . . 73.41 108.796 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.83 109.89 17.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.656 0.783 . . . . 71.12 109.317 -173.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.0 mt-30 -85.38 86.44 7.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.753 -0.832 . . . . 74.02 108.753 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.49 104.6 9.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.806 -1.088 . . . . 72.44 108.876 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.73 160.11 28.6 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.797 -0.638 . . . . 62.22 112.106 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.02 123.33 1.23 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.115 -0.794 . . . . 45.43 111.115 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.364 0.666 . . . . 70.23 109.463 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.598 ' HD2' HG12 ' A' ' 13' ' ' ILE . 33.7 m-85 -134.44 118.89 17.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.445 -0.946 . . . . 61.22 108.445 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -83.48 100.69 10.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.77 -0.826 . . . . 72.41 108.77 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.39 140.53 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.328 0.651 . . . . 51.01 110.697 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.16 165.87 30.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.461 1.104 . . . . 63.22 109.534 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.89 86.61 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.086 0.395 . . . . 64.44 114.086 176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -110.1 134.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.236 0.615 . . . . 51.42 109.522 -172.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -146.56 171.68 14.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.581 1.152 . . . . 74.34 108.6 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.44 -129.02 24.53 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 115.404 0.922 . . . . 43.34 115.404 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.585 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.44 -15.18 59.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.454 0.702 . . . . 72.24 111.922 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -67.64 -45.21 76.02 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.618 -0.512 . . . . 71.43 109.618 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -27.96 49.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.683 0.393 . . . . 45.11 110.625 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.65 -32.01 71.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.293 0.637 . . . . 63.22 111.718 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -87.31 -33.91 19.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.206 0.603 . . . . 61.43 110.209 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -61.65 -45.91 92.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.95 0.5 . . . . 70.44 110.355 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.02 -30.21 18.9 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.487 -0.779 . . . . 53.42 111.176 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.65 -3.27 81.0 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 114.846 0.698 . . . . 64.02 114.846 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.96 -60.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.937 0.868 . . . . 71.34 112.208 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.484 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 71.0 t80 -68.89 -70.68 0.26 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 113.101 0.778 . . . . 74.13 113.101 -168.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 79.3 m -63.71 -33.11 9.17 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.889 1.44 . . . . 64.33 114.889 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HA ' HD21 ' A' ' 60' ' ' LEU . 30.0 Cg_endo -62.64 -33.46 77.39 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 121.768 1.645 . . . . 50.25 112.98 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -74.54 -15.92 60.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.185 0.594 . . . . 73.43 111.097 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.72 -40.97 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.46 0.648 . . . . 54.14 109.527 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.97 -17.89 27.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.15 -0.932 . . . . 73.5 112.346 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.32 -45.37 99.09 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.243 -0.884 . . . . 72.43 113.156 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.99 -31.25 76.94 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.202 1.934 . . . . 73.32 113.509 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -76.64 -36.48 57.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.365 0.666 . . . . 72.23 111.911 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.77 77.91 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 109.133 -0.692 . . . . 63.15 109.133 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.548 HH12 HD12 ' C' ' 105' ' ' ILE . 31.6 ttm180 -52.62 -52.01 57.43 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.742 1.276 . . . . 72.15 109.932 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.81 -48.68 78.05 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.394 1.059 . . . . 75.15 110.601 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.436 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.2 t -57.59 -43.22 84.46 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.77 0.669 . . . . 70.43 111.252 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 76.9 mt -62.78 -56.9 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.164 -0.925 . . . . 74.5 109.785 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.427 HG21 ' HE2' ' C' ' 109' ' ' TYR . 89.7 m -50.55 -43.72 56.29 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.595 1.184 . . . . 64.11 111.667 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -62.72 -48.4 79.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.539 -1.209 . . . . 65.03 109.945 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.433 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 36.6 mtm -64.4 -40.41 95.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.163 0.585 . . . . 62.11 111.296 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.5 t -56.46 -48.18 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 123.906 0.754 . . . . 64.2 109.807 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.3 t -73.38 -26.87 61.18 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 114.955 -1.02 . . . . 73.13 111.438 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -73.06 -27.93 62.02 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.619 0.768 . . . . 73.12 110.59 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.86 3.6 74.62 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.779 0.674 . . . . 44.44 112.896 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.3 m 62.1 44.16 8.18 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.077 1.351 . . . . 70.11 110.272 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -116.97 145.42 35.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.201 -1.363 . . . . 75.02 108.068 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.54 131.82 0.39 Allowed 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 124.196 3.264 . . . . 61.21 114.263 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.95 133.6 56.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.033 0.833 . . . . 71.13 110.969 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 50.9 tp -110.06 110.67 21.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.254 -0.647 . . . . 74.35 109.254 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -99.57 108.69 21.16 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.284 -1.376 . . . . 75.54 107.284 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.31 117.43 7.85 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.647 -0.871 . . . . 72.53 108.647 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.95 98.14 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.314 0.646 . . . . 71.35 111.08 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 76.4 Cg_exo -54.78 109.42 0.4 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.119 2.546 . . . . 63.23 113.484 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -101.95 112.8 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.035 -1.469 . . . . 74.12 107.035 168.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -81.39 95.03 6.91 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.768 -0.827 . . . . 72.33 108.768 178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -57.8 -32.48 67.6 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.735 -1.121 . . . . 62.31 111.45 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t70 . . . . . 0 N--CA 1.473 0.702 0 O-C-N 124.309 1.005 . . . . 65.25 110.741 177.225 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 61.8 m . . . . . 0 C--O 1.243 0.719 0 N-CA-C 107.047 -1.464 . . . . 74.14 107.047 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.568 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 77.2 t80 -140.88 132.34 26.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.01 -0.737 . . . . 71.22 109.01 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.468 HE21 ' HB2' ' B' ' 85' ' ' SER . 8.6 tt0 -144.07 131.61 21.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.306 -0.998 . . . . 72.13 108.306 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -82.02 126.73 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.044 -0.724 . . . . 74.3 109.044 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.12 -42.44 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.25 0.62 . . . . 71.2 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -165.01 151.02 10.0 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.466 0.174 . . . . 75.31 110.764 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.71 135.16 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.244 -1.762 . . . . 63.35 106.244 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HE1' HG13 ' B' ' 83' ' ' ILE . 7.3 p90 -168.24 146.29 4.29 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.166 0.586 . . . . 75.23 109.962 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.5 m -76.97 122.55 25.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.511 -0.768 . . . . 53.24 108.982 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -98.08 -27.22 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 72.23 111.379 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.7 t70 -158.35 139.69 13.39 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.527 0.517 . . . . 72.41 111.261 -172.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.2 mm -140.88 141.86 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.423 1.489 . . . . 74.04 108.001 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -145.78 131.58 19.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.211 -1.403 . . . . 54.42 107.211 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.5 t80 -145.76 110.28 5.06 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.73 -1.211 . . . . 63.23 107.73 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.42 134.3 54.99 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.803 -0.814 . . . . 74.33 108.803 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.6 81.22 60.5 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 106.419 -1.696 . . . . 62.23 106.419 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.69 -32.62 37.5 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.371 2.714 . . . . 74.15 112.469 -171.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.45 31.56 6.66 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.605 1.162 . . . . 72.21 109.855 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -43.07 -48.4 14.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 115.818 1.784 . . . . 71.54 115.818 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.74 -25.02 4.6 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 121.843 1.696 . . . . 35.4 112.789 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.42 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 72.0 m80 -94.74 -16.19 23.25 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.024 0.75 . . . . 72.11 113.024 -171.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' B' ' 73' ' ' ALA . 12.0 p -64.23 -12.75 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.803 0.841 . . . . 75.15 111.96 175.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -56.37 -25.74 50.55 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.013 0.925 . . . . 73.15 112.637 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.423 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 24.8 pt20 -71.44 -29.13 64.52 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.42 111.108 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 32.2 mmtp -107.52 80.3 1.39 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.342 1.057 . . . . 74.33 108.691 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.71 109.19 18.54 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.408 -0.815 . . . . 62.42 110.283 -174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.436 ' O ' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER 161.69 -158.91 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.965 2.506 . . . . 74.33 109.262 157.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 15.0 mp0 -49.44 106.99 0.69 Allowed Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 124.679 1.192 . . . . 72.42 111.621 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.22 153.07 14.12 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.479 2.119 . . . . 62.42 110.944 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -71.1 102.33 2.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.269 -1.011 . . . . 62.45 108.269 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -88.9 140.61 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.481 -0.933 . . . . 74.43 108.481 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -134.56 125.61 27.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.35 1.06 . . . . 75.31 109.211 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.2 148.0 23.52 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.131 0.972 . . . . 64.34 109.17 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -158.69 112.5 2.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.903 -0.777 . . . . 72.34 108.903 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.18 134.04 43.68 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.127 -0.694 . . . . 70.14 109.127 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.06 142.06 51.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.13 0.972 . . . . 52.13 108.882 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -109.19 117.5 34.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.538 0.735 . . . . 61.11 110.427 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -124.68 140.25 53.1 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.248 1.019 . . . . 75.21 109.036 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.5 p -145.12 162.89 35.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.848 0.459 . . . . 53.33 111.102 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -158.89 145.81 17.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.301 1.04 . . . . 64.54 109.238 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -96.49 112.05 23.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.527 -0.916 . . . . 74.14 108.527 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.24 -45.12 50.02 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.424 0.69 . . . . 74.2 110.681 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.4 -174.1 4.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.669 -1.151 . . . . 40.13 109.584 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.59 116.92 11.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.353 -0.84 . . . . 73.43 109.065 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 70.6 -2.29 2.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.541 1.536 . . . . 71.14 112.978 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.9 t -104.52 113.52 41.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -117.63 169.16 9.78 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.745 . . . . 73.23 109.31 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.427 ' HG2' HG12 ' B' ' 83' ' ' ILE . 4.7 tm-20 -142.47 105.92 4.64 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.721 -1.214 . . . . 74.43 107.721 -174.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.08 121.15 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.515 1.126 . . . . 54.0 109.434 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.3 t -106.02 121.74 58.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 124.24 1.016 . . . . 64.25 108.694 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.51 114.36 28.13 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.795 -1.187 . . . . 73.41 107.795 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -93.38 129.92 39.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.306 -0.861 . . . . 74.43 109.442 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.21 104.27 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.707 -1.22 . . . . 73.42 107.707 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -98.99 131.09 45.3 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.578 -0.527 . . . . 74.03 109.578 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.411 HG23 HD13 ' B' ' 114' ' ' ILE . 91.4 t -122.53 122.12 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.41 1.084 . . . . 73.24 108.922 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -115.05 143.71 44.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.625 -0.88 . . . . 72.14 108.625 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.81 142.87 38.7 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.766 -0.827 . . . . 63.14 108.766 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.5 p -161.37 148.02 14.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.826 0.704 . . . . 62.42 111.041 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' B' ' 34' ' ' LYS . 2.7 mp -123.73 130.78 53.16 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.636 -0.875 . . . . 74.43 108.636 173.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.17 -119.02 7.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.723 -0.951 . . . . 71.01 110.723 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.41 4.93 14.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.046 0.538 . . . . 64.51 110.967 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.23 161.95 18.65 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.572 0.349 . . . . 71.34 110.259 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.8 m -78.53 152.35 32.01 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.112 0.965 . . . . 71.2 111.538 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -97.49 -62.21 1.28 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.859 -1.164 . . . . 65.42 107.859 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.97 153.29 22.15 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.439 -1.255 . . . . 61.43 109.657 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.1 mt -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.608 -1.256 . . . . 55.34 107.608 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.45 152.2 33.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.993 0.517 . . . . 70.13 109.811 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -163.39 132.14 3.89 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.384 -0.969 . . . . 44.01 108.384 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.94 146.63 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.558 -0.904 . . . . 73.33 108.558 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.9 mt-30 -124.08 95.39 4.54 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.545 -1.28 . . . . 74.43 107.545 170.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -86.61 102.57 14.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.827 -1.175 . . . . 74.4 107.827 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.57 159.48 29.5 Favored Glycine 0 C--O 1.242 0.64 0 N-CA-C 110.958 -0.857 . . . . 50.41 110.958 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 125.69 1.55 Allowed Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.025 -0.83 . . . . 73.3 111.025 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.446 HG13 ' HE1' ' B' ' 17' ' ' TYR . 52.3 mt -85.71 131.36 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.89 -1.152 . . . . 74.22 107.89 175.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -139.05 132.84 30.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.43 -0.952 . . . . 74.54 108.43 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.468 ' HB2' HE21 ' B' ' 12' ' ' GLN . 66.1 m -89.8 101.91 14.61 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' B' ' 11' ' ' PHE . 15.1 pt -125.69 138.45 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.014 0.926 . . . . 72.21 109.605 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.65 166.54 33.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.566 1.146 . . . . 44.2 108.941 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 -28.16 2.64 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-N 117.569 0.168 . . . . 62.1 113.438 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 40.6 pt -54.35 135.31 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.322 1.449 . . . . 61.13 111.249 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -151.7 140.65 21.07 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.94 -0.573 . . . . 75.2 110.41 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.96 -110.78 2.11 Favored Glycine 0 C--N 1.355 1.611 0 O-C-N 124.738 1.274 . . . . 71.44 113.402 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 63.4 m -66.48 -42.93 86.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.113 0.965 . . . . 62.14 111.196 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -68.88 -31.93 71.22 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.62 0.768 . . . . 71.14 111.137 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.609 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 24.6 ttt -67.28 -57.32 6.89 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 123.512 0.507 . . . . 73.2 110.026 173.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.96 -36.58 72.77 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.438 1.086 . . . . 74.52 111.95 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.85 -31.73 59.46 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.421 0.688 . . . . 65.45 111.188 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.97 -67.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.654 0.264 . . . . 42.25 110.593 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.468 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -83.62 -13.14 54.98 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.831 0.678 . . . . 74.44 112.831 -174.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.16 0.09 41.04 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.178 0.431 . . . . 74.51 114.178 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.24 -54.04 0.34 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 117.244 0.522 . . . . 74.02 110.954 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -71.33 -52.43 18.79 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.688 0.795 . . . . 75.43 111.181 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.568 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 33.4 m -67.03 -45.93 52.89 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 123.872 0.869 . . . . 55.41 112.538 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.9 Cg_exo -55.45 -38.25 94.13 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.544 2.163 . . . . 62.21 113.649 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -69.67 -22.41 63.44 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.874 0.734 . . . . 51.13 111.276 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.14 -46.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.172 0.589 . . . . 64.54 109.864 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.83 -26.64 60.7 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.484 -0.78 . . . . 73.54 111.586 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.4 -50.32 88.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.223 1.194 . . . . 71.02 114.223 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.43 -38.48 74.14 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.6 2.2 . . . . 75.53 114.138 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.486 ' HE2' HG21 ' D' ' 115' ' ' THR . 52.5 m-85 -70.79 -45.08 65.32 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.812 0.845 . . . . 73.04 110.562 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.38 85.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.39 -0.823 . . . . 64.55 110.901 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -63.62 -51.42 65.29 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.269 1.428 . . . . 71.3 110.207 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -68.24 -29.82 68.72 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.75 0.656 . . . . 72.14 110.301 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -67.82 -42.12 82.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.533 0.333 . . . . 60.43 110.427 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.411 HD13 HG23 ' B' ' 64' ' ' VAL . 76.5 mt -62.21 -48.18 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.42 0.688 . . . . 65.01 109.623 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.416 HG23 ' OE1' ' B' ' 125' ' ' GLN . 89.3 m -56.67 -34.71 67.64 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.369 1.068 . . . . 62.42 111.599 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.9 t -69.42 -48.19 61.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.289 0.636 . . . . 70.2 110.066 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -70.47 -33.51 71.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.031 0.532 . . . . 54.21 111.545 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.46 -39.06 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.446 0.698 . . . . 74.22 109.855 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.485 ' OG ' HG21 ' C' ' 115' ' ' THR . 11.9 t -69.93 -27.2 64.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.456 -0.793 . . . . 63.34 111.824 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.5 mtt-85 -76.61 -32.1 57.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.304 0.642 . . . . 72.54 109.84 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.73 0.2 82.71 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.547 0.529 . . . . 73.0 112.259 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.456 HG22 ' OD1' ' C' ' 127' ' ' ASN . 61.4 p 61.38 33.88 18.58 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.675 1.99 . . . . 52.35 112.518 171.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -94.68 155.85 38.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.237 -0.892 . . . . 71.23 109.801 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -55.62 167.02 2.31 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.54 2.827 . . . . 72.12 114.422 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.485 ' HG3' HD22 ' B' ' 127' ' ' ASN . 5.7 tp60 -59.56 134.03 56.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.835 -1.075 . . . . 74.21 113.413 -172.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.77 96.13 4.9 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.42 -1.263 . . . . 65.23 107.867 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.485 HD22 ' HG3' ' B' ' 125' ' ' GLN . 4.0 p30 -108.28 112.79 25.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.574 -0.899 . . . . 75.03 108.574 172.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.406 HD12 ' H ' ' B' ' 129' ' ' ALA . 20.5 tp -75.18 139.76 42.87 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.001 -0.545 . . . . 74.21 109.828 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.406 ' H ' HD12 ' B' ' 128' ' ' LEU . . . -63.05 148.05 93.33 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.48 1.112 . . . . 71.12 111.619 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' D' ' 16' ' ' ILE . 5.5 Cg_exo -71.09 110.41 2.81 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.24 1.96 . . . . 74.32 110.21 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.4 t -99.39 121.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.55 -1.278 . . . . 63.11 107.55 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -74.21 88.69 1.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.357 -0.979 . . . . 72.03 108.357 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 . . . . . 0 N--CA 1.484 1.236 0 C-N-CA 123.479 0.712 . . . . 72.51 111.137 -177.459 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' C' ' 97' ' ' CYS . 54.3 ttp . . . . . 0 N--CA 1.484 1.241 0 CA-C-O 121.259 0.552 . . . . 73.3 111.081 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -109.0 99.69 8.98 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.593 -1.262 . . . . 74.32 107.593 173.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -105.76 130.27 53.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.027 -0.988 . . . . 72.31 109.533 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -151.14 139.17 20.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.902 0.881 . . . . 75.4 109.575 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -86.94 142.5 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.661 0.784 . . . . 55.31 110.004 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 75.9 mt-30 -101.56 -49.89 3.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.596 0.358 . . . . 62.01 110.584 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -167.79 127.04 1.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.466 0.306 . . . . 65.34 110.824 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -107.89 143.63 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.108 -1.071 . . . . 72.13 108.108 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -172.03 164.07 6.14 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.535 0.683 . . . . 72.41 111.139 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.4 p -85.33 109.69 18.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.382 -0.969 . . . . 55.13 108.382 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -33.12 74.9 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.177 0.513 . . . . 75.23 109.875 173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -155.41 150.29 26.54 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.577 -1.192 . . . . 72.3 109.572 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 60.2 mt -138.63 149.09 23.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.506 -1.665 . . . . 63.42 106.506 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 21.2 t -160.67 152.08 19.33 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.332 0.587 . . . . 65.22 110.789 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -147.02 141.86 26.85 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.691 -1.226 . . . . 73.54 107.691 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 50.2 mt-10 -132.92 150.89 52.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.707 0.803 . . . . 75.42 109.189 170.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.73 80.7 7.38 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 106.957 -1.497 . . . . 72.32 106.957 170.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.07 -35.04 20.99 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.488 2.125 . . . . 75.44 111.741 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.39 32.03 3.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.266 1.027 . . . . 74.01 109.489 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' D' ' 17' ' ' TYR . . . -59.67 -51.2 82.68 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 114.512 1.301 . . . . 21.55 114.512 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 15.4 Cg_exo -71.46 -35.55 7.99 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 121.627 1.617 . . . . 71.33 111.073 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -62.68 -23.41 67.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.131 1.772 . . . . 73.21 112.85 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 4.0 p -61.28 -20.33 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.03 0.752 . . . . 72.31 113.03 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.52 -40.3 96.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.436 0.695 . . . . 74.11 110.826 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -97.48 23.19 7.92 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.864 0.866 . . . . 74.41 110.461 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 4.2 ttmp? -109.06 150.28 28.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.071 . . . . 73.03 109.913 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.75 125.96 30.07 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.889 -0.782 . . . . 51.51 108.889 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -84.74 75.59 10.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.331 0.586 . . . . 74.51 109.958 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -162.8 80.05 1.73 Allowed Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 107.895 -1.15 . . . . 73.01 107.895 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -87.65 154.2 7.57 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.901 2.4 . . . . 63.45 112.477 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.87 89.31 7.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 106.3 -1.741 . . . . 62.33 106.3 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.97 120.67 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.999 -1.001 . . . . 75.03 109.062 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -109.98 130.8 55.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.77 1.228 . . . . 53.32 109.592 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.472 HD21 HD21 ' C' ' 128' ' ' LEU . 16.9 mt -87.32 122.89 31.68 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.025 -0.731 . . . . 55.45 109.025 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.39 103.19 8.57 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.467 1.107 . . . . 64.42 108.167 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -111.71 146.51 37.4 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.483 0.713 . . . . 51.01 109.518 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 21.4 t70 -138.8 135.32 34.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.283 -1.377 . . . . 50.52 107.283 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 22.0 p -127.13 126.94 43.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.456 0.302 . . . . 43.32 111.05 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.47 164.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.915 0.886 . . . . 50.14 110.058 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -144.46 148.36 34.48 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.984 0.914 . . . . 51.12 108.974 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 16.0 p -147.64 129.02 14.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.12 0.568 . . . . 60.04 109.964 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -75.4 125.38 28.87 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 109.295 -0.632 . . . . 72.13 109.295 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.459 HD11 HD12 ' C' ' 83' ' ' ILE . 73.5 mt -99.65 -31.4 11.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.696 0.798 . . . . 71.41 110.547 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 -177.79 6.22 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.269 1.028 . . . . 73.32 109.644 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.84 121.85 13.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.603 -0.726 . . . . 64.33 109.506 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 69.0 -3.0 1.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.85 1.26 . . . . 54.33 112.791 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -100.38 112.66 33.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.844 -0.799 . . . . 63.43 108.844 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -126.89 124.47 39.64 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.201 -1.037 . . . . 72.23 108.201 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.63 119.48 23.87 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.969 -1.014 . . . . 75.13 108.434 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.8 t -96.16 124.55 48.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.119 -1.067 . . . . 41.24 108.119 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.35 129.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.057 -1.09 . . . . 75.3 108.057 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -122.68 95.67 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.931 -1.137 . . . . 75.45 107.931 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.524 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.7 tmt_? -86.05 114.12 22.67 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.822 -1.177 . . . . 72.1 107.822 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.9 t -113.28 132.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.107 -1.071 . . . . 63.35 108.107 175.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -128.81 124.2 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.493 -0.928 . . . . 53.23 108.493 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.5 HG11 HD13 ' C' ' 126' ' ' LEU . 39.0 t -106.55 110.48 31.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.928 -1.138 . . . . 55.31 107.928 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.452 HG23 HD23 ' C' ' 75' ' ' LEU . 8.0 m -106.71 127.03 53.04 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.113 -0.699 . . . . 71.02 109.113 175.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.9 20.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.065 -1.087 . . . . 63.33 108.065 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.7 m -148.15 126.7 12.44 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.966 0.506 . . . . 74.42 109.782 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.503 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.2 OUTLIER -87.44 58.6 5.05 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.727 0.811 . . . . 73.32 109.473 177.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 -119.18 5.86 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.877 -1.289 . . . . 64.43 109.877 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.71 -24.02 21.67 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.616 0.766 . . . . 74.33 109.512 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.624 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 14.7 tp10 -68.2 96.1 0.62 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.192 0.997 . . . . 71.24 110.553 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.2 m -83.12 126.52 32.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.738 0.78 . . . . 61.41 111.259 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -82.78 -53.67 5.71 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.174 1.39 . . . . 51.0 110.19 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.88 170.46 16.75 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.022 0.826 . . . . 74.0 110.379 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.8 tm? -136.99 137.9 39.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 106.507 -1.664 . . . . 71.32 106.507 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -146.8 143.04 28.34 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.284 -1.006 . . . . 74.05 108.284 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -155.32 135.53 13.09 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.061 0.544 . . . . 72.0 109.887 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -138.3 135.23 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.235 1.014 . . . . 63.33 108.355 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -105.92 89.15 2.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.944 -1.132 . . . . 75.12 107.944 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -81.21 107.73 14.25 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.045 -0.979 . . . . 74.24 109.749 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.62 145.67 16.23 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.98 -0.448 . . . . 74.31 111.98 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.05 127.71 3.34 Favored Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 110.416 -1.074 . . . . 61.32 110.416 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.459 HD12 HD11 ' C' ' 51' ' ' LEU . 10.2 mm -81.28 114.64 22.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.842 -1.17 . . . . 72.34 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -121.55 137.11 54.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.037 -0.727 . . . . 74.3 109.037 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 m -109.96 105.59 14.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.425 -0.954 . . . . 71.13 108.425 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.422 HG21 ' HG3' ' C' ' 94' ' ' MET . 2.2 mp -114.7 111.88 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.648 -1.612 . . . . 73.53 106.648 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.64 157.94 31.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.994 0.518 . . . . 62.23 111.726 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.07 -60.51 0.97 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.016 -0.993 . . . . 53.32 112.384 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.68 178.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.833 0.453 . . . . 72.33 111.726 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -154.32 -171.07 3.74 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.631 -0.713 . . . . 72.43 110.419 -176.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.45 -128.8 44.34 Favored Glycine 0 C--N 1.355 1.634 0 O-C-N 123.856 0.723 . . . . 60.01 114.166 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -68.18 -31.92 71.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.065 0.946 . . . . 63.14 111.743 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.88 -46.32 82.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.658 0.783 . . . . 74.14 110.117 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.736 ' HG2' HD23 ' C' ' 98' ' ' LEU . 27.9 ttt -78.32 -25.69 46.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.342 -0.845 . . . . 74.14 110.987 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -32.73 74.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.999 0.52 . . . . 72.14 111.003 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.503 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 38.9 t-80 -65.49 -36.75 84.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.644 -0.707 . . . . 65.33 111.073 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.404 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 53.9 t -76.17 -61.35 1.97 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.627 0.371 . . . . 64.52 111.143 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.736 HD23 ' HG2' ' C' ' 94' ' ' MET . 3.4 pp -70.71 -34.04 71.51 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.186 0.594 . . . . 74.24 110.989 -175.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.65 -2.47 75.84 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.65 0.62 . . . . 71.25 114.65 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -137.24 -57.86 0.7 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.349 0.575 . . . . 74.42 111.193 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.425 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 68.0 t80 -72.59 -48.95 35.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 122.897 0.479 . . . . 74.13 111.586 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.589 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 81.2 m -58.21 -45.03 99.76 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.383 0.883 . . . . 72.44 113.383 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 98' ' ' LEU . 50.3 Cg_exo -56.92 -36.5 99.1 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 122.548 2.165 . . . . 75.3 113.209 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.459 HD21 ' HD2' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -68.7 -22.53 64.35 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.714 0.805 . . . . 55.14 111.734 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.548 HD12 HH12 ' A' ' 111' ' ' ARG . 35.3 mm -83.33 -36.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.803 0.441 . . . . 50.41 110.052 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.52 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.4 mt -82.34 -24.89 34.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.75 0.82 . . . . 71.25 112.131 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.77 -48.84 96.08 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 113.571 0.952 . . . . 53.51 113.571 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.96 -40.03 75.26 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.066 1.844 . . . . 74.21 113.184 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.427 ' HE2' HG21 ' A' ' 115' ' ' THR . 97.0 m-85 -70.51 -42.91 70.69 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.405 -0.816 . . . . 74.44 111.519 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.88 -46.47 87.75 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.357 0.663 . . . . 73.41 109.215 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -55.93 -51.64 66.92 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.483 1.513 . . . . 64.5 111.827 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.68 -33.2 70.65 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.503 0.321 . . . . 75.43 110.163 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.2 t -70.59 -31.02 67.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.637 0.375 . . . . 64.04 111.013 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -72.05 -51.17 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.676 0.79 . . . . 74.54 109.76 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.485 HG21 ' OG ' ' B' ' 119' ' ' SER . 88.4 m -59.23 -41.27 88.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.626 0.77 . . . . 75.42 111.071 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 26.2 t -60.3 -44.38 95.45 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.064 0.853 . . . . 61.35 109.653 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.537 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.92 -39.95 91.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.312 0.645 . . . . 74.4 111.824 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 72.6 t -62.16 -40.66 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.022 0.529 . . . . 63.55 110.116 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.427 ' HB2' ' NE2' ' B' ' 125' ' ' GLN . 84.1 p -76.17 -26.41 56.21 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.568 -0.742 . . . . 71.45 111.742 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.9 mtt-85 -71.52 -34.58 70.21 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.758 0.823 . . . . 75.24 110.168 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.62 6.06 59.25 Favored Glycine 0 C--N 1.355 1.593 0 O-C-N 123.576 0.548 . . . . 50.15 112.384 170.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p 61.67 19.49 10.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.168 2.187 . . . . 75.2 113.314 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HE1' HG11 ' C' ' 31' ' ' VAL . 52.2 m-85 -85.88 156.27 58.18 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.136 0.974 . . . . 73.32 109.688 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -51.68 120.58 7.24 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.033 2.489 . . . . 72.54 111.958 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' B' ' 125' ' ' GLN . 96.2 mt-30 -57.08 143.99 36.31 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.309 1.006 . . . . 73.11 112.477 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.5 HD13 HG11 ' C' ' 64' ' ' VAL . 5.9 tt -119.28 109.18 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.178 -1.045 . . . . 75.0 108.178 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.456 ' OD1' HG22 ' B' ' 122' ' ' THR . 1.0 OUTLIER -91.95 119.0 31.29 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.43 -0.952 . . . . 71.43 108.43 170.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.472 HD21 HD21 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -73.13 136.75 44.87 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.083 -0.71 . . . . 75.41 109.083 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.9 151.75 94.56 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.288 1.035 . . . . 62.13 111.574 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.63 ' HG3' HD12 ' A' ' 16' ' ' ILE . 15.0 Cg_exo -66.39 98.54 0.4 Allowed 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.486 2.124 . . . . 35.51 111.325 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.92 108.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.908 -1.145 . . . . 54.31 107.908 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -95.04 99.05 11.12 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.762 -0.829 . . . . 73.41 108.762 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.459 ' HD2' HD21 ' C' ' 104' ' ' ASN . 78.1 m-85 -68.71 -37.0 79.16 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 71.12 109.949 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 31.3 t70 . . . . . 0 N--CA 1.477 0.907 0 C-N-CA 124.474 1.11 . . . . 75.44 112.265 -175.513 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.1 m . . . . . 0 C--O 1.243 0.759 0 N-CA-C 108.094 -1.076 . . . . 62.53 108.094 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -161.63 99.39 1.14 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.39 -0.967 . . . . 73.22 108.39 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -136.42 131.26 33.88 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.544 -0.91 . . . . 53.14 108.544 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.444 HD11 HG21 ' D' ' 105' ' ' ILE . 22.8 mt -82.34 122.12 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.206 -0.665 . . . . 63.33 109.206 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.63 -31.78 19.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.819 0.448 . . . . 73.43 110.826 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -167.3 144.66 4.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 110.48 -0.193 . . . . 75.13 110.48 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.602 HD12 ' HG3' ' B' ' 130' ' ' PRO . 0.1 OUTLIER -133.56 133.15 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 106.357 -1.72 . . . . 74.52 106.357 173.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.472 ' CE2' ' HB1' ' C' ' 28' ' ' ALA . 21.6 p90 -168.31 166.79 12.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.793 0.806 . . . . 71.4 111.12 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -93.09 121.63 34.63 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.371 -1.286 . . . . 74.13 108.769 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -88.77 -31.26 18.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.884 0.474 . . . . 75.23 110.069 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.01 139.44 18.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.946 -1.024 . . . . 51.12 109.012 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.2 mt -139.59 151.3 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.771 -1.196 . . . . 63.3 107.771 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -158.68 121.67 3.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.663 0.785 . . . . 74.12 110.264 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.9 t80 -113.65 121.22 43.5 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 106.657 -1.609 . . . . 72.22 106.657 165.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.4 mt-10 -121.88 117.63 26.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.708 -0.478 . . . . 72.53 109.708 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.68 87.66 2.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.806 -1.183 . . . . 42.25 107.806 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.13 -36.77 5.35 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.739 2.293 . . . . 70.32 112.727 -170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -113.0 40.1 2.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.27 1.028 . . . . 64.25 108.623 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -51.98 -65.09 1.1 Allowed Pre-proline 0 CA--C 1.563 1.468 0 CA-C-O 117.916 -1.04 . . . . 61.44 113.799 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.92 -9.81 11.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 122.6 1.964 . . . . 72.51 112.91 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -74.07 -42.44 60.18 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.688 1.195 . . . . 75.35 110.377 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.28 -33.69 14.29 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 115.951 -0.568 . . . . 61.15 109.909 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -56.16 -22.55 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 74.04 113.699 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -70.6 -36.16 73.37 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.015 0.526 . . . . 51.03 110.436 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 63.32 1.63 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.778 0.831 . . . . 64.41 111.381 171.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . 0.431 ' OD2' HD21 ' D' ' 68' ' ' LEU . 9.6 t70 -107.47 97.93 7.61 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.529 0.732 . . . . 50.2 109.714 -175.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.453 ' O ' HD22 ' D' ' 68' ' ' LEU . 13.2 m95 -121.87 -155.12 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.037 -1.097 . . . . 62.32 108.037 -169.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -54.45 109.04 1.32 Allowed Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.082 0.771 . . . . 72.11 113.082 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.709 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 9.8 Cg_exo -72.03 139.45 32.87 Favored 'Trans proline' 0 C--N 1.386 2.525 0 C-N-CA 123.102 2.535 . . . . 64.25 112.968 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.0 116.48 29.0 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.561 -1.274 . . . . 74.04 107.561 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.32 149.85 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.923 0.889 . . . . 74.45 112.21 -170.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -127.83 139.35 52.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.72 1.608 . . . . 73.14 108.473 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.455 HD21 HG13 ' D' ' 62' ' ' VAL . 1.2 tt -120.84 114.7 21.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.944 -0.762 . . . . 62.34 108.944 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -109.08 141.98 40.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.209 1.004 . . . . 74.34 108.501 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -122.04 145.03 48.54 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.335 -0.617 . . . . 61.21 109.335 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.04 159.55 44.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.177 0.991 . . . . 70.34 108.47 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -136.6 168.78 18.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.13 0.572 . . . . 74.1 110.501 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.32 154.31 36.48 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.603 1.161 . . . . 72.34 108.347 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 58.6 p -149.44 150.67 32.75 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.31 0.244 . . . . 73.42 111.117 -174.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -174.18 127.73 0.36 Allowed 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.34 1.056 . . . . 73.13 108.93 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.89 127.31 32.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.898 -0.779 . . . . 74.34 108.898 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' D' ' 57' ' ' GLU . 57.6 mt -92.55 -36.01 13.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.886 0.474 . . . . 65.5 111.147 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.61 -171.1 1.99 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.433 0.693 . . . . 65.04 111.115 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -58.13 114.31 2.32 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.869 -1.06 . . . . 65.44 110.785 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 62.29 13.01 5.61 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.591 1.156 . . . . 62.15 112.501 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 80.6 t -115.52 118.48 58.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.512 -0.921 . . . . 70.44 108.512 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -131.25 132.54 44.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.657 1.183 . . . . 74.35 108.144 -174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.5 tt0 -99.77 126.0 45.77 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.375 0.422 . . . . 72.12 110.596 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -107.36 117.75 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 107.248 -1.389 . . . . 73.5 107.248 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.0 t -100.27 132.25 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.649 -1.241 . . . . 72.3 107.649 172.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -124.26 110.81 15.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.555 -0.906 . . . . 73.45 108.555 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.07 118.4 29.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.272 1.029 . . . . 74.11 109.694 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . 0.455 HG13 HD21 ' D' ' 42' ' ' LEU . 65.3 t -102.42 130.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.867 -1.161 . . . . 72.23 107.867 166.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.3 m -121.4 131.2 54.04 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.449 0.642 . . . . 74.35 109.887 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.437 HG21 HG21 ' D' ' 114' ' ' ILE . 88.5 t -122.42 105.89 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.473 1.509 . . . . 63.21 108.938 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -107.45 108.84 20.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.847 0.859 . . . . 73.22 109.258 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.59 137.0 37.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.451 -0.574 . . . . 74.14 109.451 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -139.21 123.08 17.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.309 -0.996 . . . . 53.43 108.309 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.709 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.4 pp -129.1 137.55 51.3 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.711 -0.478 . . . . 74.03 109.711 174.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.38 -113.09 3.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.683 -0.689 . . . . 71.04 112.119 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -116.37 3.14 13.29 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.723 0.809 . . . . 72.23 111.21 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.78 176.05 13.12 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.071 0.462 . . . . 74.51 111.497 -168.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 78.1 m -66.78 138.13 57.13 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.918 -1.037 . . . . 55.21 111.015 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.4 -65.79 0.97 Allowed 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.06 -1.089 . . . . 65.25 108.06 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -156.52 164.72 37.89 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.787 -1.551 . . . . 74.24 109.231 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.6 mt -126.26 144.31 50.84 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.665 1.186 . . . . 71.22 107.842 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.406 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 0.7 OUTLIER -145.7 139.24 26.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.204 1.002 . . . . 54.12 108.348 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -157.79 130.1 7.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.52 -0.548 . . . . 74.12 109.52 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 55.3 t -137.6 119.52 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.4 0.68 . . . . 74.35 109.682 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -89.29 91.24 8.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.539 0.735 . . . . 62.44 109.083 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.59 94.66 6.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.259 0.624 . . . . 72.01 109.491 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.7 141.73 18.11 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.524 -0.63 . . . . 52.23 111.524 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.447 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.23 129.83 5.05 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 110.953 -0.859 . . . . 63.43 110.953 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.417 HG23 HD12 ' D' ' 51' ' ' LEU . 45.8 mt -89.41 119.42 36.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.793 -1.188 . . . . 65.34 107.793 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -121.47 147.52 45.66 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.04 0.936 . . . . 73.11 109.199 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -99.57 93.3 5.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.173 -1.418 . . . . 74.2 107.173 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 71.9 mt -106.78 118.35 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.107 -0.701 . . . . 64.01 109.107 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -151.94 160.74 43.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.114 0.966 . . . . 71.35 109.447 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 81.44 -23.16 4.91 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 115.696 1.038 . . . . 53.14 115.696 170.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.419 HG13 ' HG2' ' D' ' 94' ' ' MET . 26.2 pt -96.11 135.7 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.597 -0.89 . . . . 73.23 108.597 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.05 172.93 15.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.518 -0.765 . . . . 74.43 110.153 -169.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.69 -137.28 44.39 Favored Glycine 0 C--N 1.35 1.309 0 O-C-N 123.492 0.495 . . . . 70.05 112.595 -172.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -77.58 -20.41 54.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.861 0.864 . . . . 75.42 111.511 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -62.38 -47.38 84.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.77 0.828 . . . . 71.34 110.318 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.539 ' SD ' HD12 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -64.69 -46.96 80.15 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.246 -0.888 . . . . 74.33 109.681 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.17 67.41 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.341 1.026 . . . . 71.3 112.182 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -67.25 -50.55 60.11 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.247 -0.888 . . . . 65.43 111.159 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.84 -35.54 78.55 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.058 0.543 . . . . 75.14 111.462 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.539 HD12 ' SD ' ' D' ' 94' ' ' MET . 4.1 tt -70.27 -45.64 65.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.94 1.296 . . . . 63.21 109.226 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.74 -22.39 72.31 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 72.55 113.831 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.33 -66.82 1.04 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.405 0.52 . . . . 74.34 112.405 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -72.92 -48.19 39.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.551 0.741 . . . . 74.51 112.51 -166.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -60.1 -48.71 93.77 Favored Pre-proline 0 CA--C 1.571 1.781 0 C-N-CA 123.89 0.876 . . . . 71.21 112.784 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.64 -21.72 18.86 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.964 1.776 . . . . 53.15 112.906 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.09 -31.58 72.15 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.226 0.61 . . . . 64.5 110.577 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.444 HG21 HD11 ' D' ' 13' ' ' ILE . 47.8 mm -68.0 -42.82 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.674 0.79 . . . . 74.01 110.332 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.447 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.1 mt -73.73 -29.9 62.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.235 -0.893 . . . . 74.0 111.716 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -59.98 -44.11 96.0 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.338 1.236 . . . . 74.33 114.338 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.48 -41.09 80.15 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.445 2.097 . . . . 74.11 114.03 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -74.29 -37.36 63.7 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.258 0.623 . . . . 74.11 111.371 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . 0.4 ' O ' HG13 ' D' ' 114' ' ' ILE . . . -63.71 -47.45 81.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.086 0.554 . . . . 71.54 109.975 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -53.9 -53.51 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.772 1.295 . . . . 60.41 110.562 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.56 -46.98 85.74 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 124.523 1.139 . . . . 74.44 110.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.3 t -59.44 -32.88 70.62 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.579 0.549 . . . . 75.45 111.708 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' D' ' 118' ' ' VAL . 73.3 mt -73.24 -49.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.157 0.583 . . . . 71.44 109.916 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.486 HG21 ' HE2' ' B' ' 109' ' ' TYR . 21.8 m -55.07 -40.99 70.95 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.719 1.208 . . . . 72.13 111.577 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -71.65 -37.51 70.81 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.335 -0.848 . . . . 72.11 110.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.3 mtm -63.37 -45.34 91.56 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 122.742 0.417 . . . . 75.03 111.287 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.6 t -63.05 -41.87 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.142 -0.936 . . . . 65.21 110.451 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.2 p -68.16 -31.86 71.72 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.207 0.603 . . . . 63.33 111.754 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -71.93 -30.1 64.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.74 0.816 . . . . 63.13 110.931 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.62 8.63 64.7 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.965 -0.561 . . . . 71.11 112.569 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.6 p 60.73 24.97 14.8 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.018 2.127 . . . . 72.4 113.036 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.23 161.17 27.02 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.836 1.255 . . . . 72.43 109.499 172.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 120.04 7.16 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.475 2.117 . . . . 73.44 111.102 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.87 139.68 50.66 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.689 0.618 . . . . 74.5 110.093 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tt -109.19 117.75 34.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.401 -0.592 . . . . 74.32 109.401 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -99.98 95.39 6.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.969 -1.014 . . . . 72.54 108.362 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.12 121.19 12.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.433 0.693 . . . . 74.02 110.08 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -66.95 140.7 96.25 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.38 0.672 . . . . 51.21 110.577 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -75.0 108.65 2.77 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.549 2.166 . . . . 73.34 110.777 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.94 138.88 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.443 0.697 . . . . 74.31 109.199 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -74.17 112.37 10.26 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 123.97 0.794 . . . . 74.25 110.428 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 . . . . . 0 N--CA 1.476 0.868 0 C-N-CA 123.56 0.744 . . . . 72.53 110.988 177.794 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m . . . . . 0 N--CA 1.479 0.987 0 N-CA-C 109.932 -0.395 . . . . 63.13 109.932 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.451 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 21.7 t80 -137.08 131.69 33.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.784 0.834 . . . . 71.12 109.442 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -154.96 108.09 2.81 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.688 0.618 . . . . 64.51 109.904 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.684 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.4 mt -70.84 119.56 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 110.015 -0.365 . . . . 74.14 110.015 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -82.68 -33.01 27.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.646 0.778 . . . . 73.13 110.674 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -173.37 136.77 0.62 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.011 0.524 . . . . 64.25 110.182 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 16' ' ' ILE . 2.5 pp -122.59 139.39 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.058 -0.719 . . . . 74.32 109.058 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 12.4 p90 -173.91 172.28 3.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.422 0.63 . . . . 73.41 111.189 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -94.93 123.45 38.41 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.386 -0.825 . . . . 61.53 108.849 171.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.8 mtpt -83.24 -34.89 25.74 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 110.003 -0.369 . . . . 74.12 110.003 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 10.2 t70 -152.99 140.66 19.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.524 -0.762 . . . . 72.32 109.127 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.5 mt -129.96 143.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.268 1.027 . . . . 62.32 108.5 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.64 122.53 10.65 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.313 0.383 . . . . 74.22 110.41 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 91.6 t80 -123.58 140.72 52.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 107.721 -1.214 . . . . 72.34 107.721 166.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.36 133.93 31.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.828 0.451 . . . . 75.41 110.438 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -150.34 72.61 9.19 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.606 1.562 . . . . 75.24 107.414 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.42 -42.57 3.63 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.791 2.327 . . . . 73.31 111.465 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.94 27.7 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.631 -1.168 . . . . 63.45 110.803 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -49.24 -53.2 41.76 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 118.216 -0.897 . . . . 74.33 112.211 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.93 -30.41 83.61 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.945 1.763 . . . . 74.01 113.036 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -74.42 -50.03 20.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.58 0.705 . . . . 61.33 110.139 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.4 p -70.42 -22.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 114.49 -1.232 . . . . 73.21 112.168 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -64.74 -27.94 69.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.105 0.409 . . . . 63.41 112.105 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -100.94 -10.81 20.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.653 0.612 . . . . 74.12 112.653 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.641 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmtp -72.0 172.67 9.61 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.744 0.646 . . . . 73.23 112.744 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -50.79 117.56 2.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.599 1.16 . . . . 73.32 110.997 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -69.61 65.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.063 1.745 . . . . 73.21 110.691 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -148.63 68.96 10.13 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.603 1.161 . . . . 71.45 109.491 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -85.94 120.3 1.95 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.791 2.327 . . . . 72.2 112.706 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.93 105.16 17.19 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.651 -1.24 . . . . 53.53 107.651 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.1 p -85.09 124.98 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.487 -0.779 . . . . 72.01 109.932 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -102.82 117.77 35.35 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.552 1.141 . . . . 61.15 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.1 tt -96.82 129.02 44.32 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.045 -1.094 . . . . 61.44 108.045 -179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.734 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.0 m-20 -134.51 140.01 45.87 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.669 0.788 . . . . 74.42 109.951 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.48 119.06 31.89 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.219 -1.03 . . . . 74.14 108.219 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 32.3 t70 -121.42 141.56 50.87 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.18 -1.415 . . . . 73.1 107.18 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -149.07 159.18 44.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.881 0.309 . . . . 74.0 111.518 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.44 116.12 1.08 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.697 0.623 . . . . 72.34 110.917 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.2 p -89.91 153.45 20.61 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.809 -0.811 . . . . 64.52 108.809 168.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -159.02 159.65 35.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.327 -0.99 . . . . 64.34 108.327 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.29 129.78 56.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.432 -0.581 . . . . 74.02 109.432 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 57' ' ' GLU . 77.4 mt -99.1 -39.43 8.5 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.947 0.899 . . . . 62.34 110.965 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -148.7 178.43 8.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.627 0.771 . . . . 72.24 109.556 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -62.07 117.64 6.26 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.952 -0.758 . . . . 70.42 108.952 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 71.51 0.72 3.58 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.275 1.43 . . . . 64.34 112.835 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 61.7 t -108.51 119.02 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.567 -0.901 . . . . 74.44 108.567 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -130.14 141.1 50.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.952 0.501 . . . . 75.52 110.108 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.649 ' HB2' HD11 ' A' ' 51' ' ' LEU . 39.9 tt0 -104.03 142.49 34.36 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.419 0.688 . . . . 72.32 109.899 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.83 128.28 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.423 -0.954 . . . . 64.04 108.423 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.88 131.13 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.137 -0.69 . . . . 70.44 109.137 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.523 HD23 HD12 ' A' ' 106' ' ' LEU . 4.1 mm? -110.94 100.8 9.44 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.767 -1.197 . . . . 62.3 107.767 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 37.6 ttp85 -84.01 100.52 11.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.423 -0.954 . . . . 71.43 108.423 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' A' ' 114' ' ' ILE . 35.7 t -95.08 121.62 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.414 -0.958 . . . . 71.34 108.414 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.4 m -108.52 131.38 54.89 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.66 -0.496 . . . . 72.11 109.66 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.41 HG21 HG21 ' A' ' 114' ' ' ILE . 67.0 t -128.86 109.27 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.824 1.249 . . . . 64.34 107.805 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.8 m -108.1 151.49 25.81 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.062 -1.088 . . . . 73.41 108.062 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.28 128.14 23.49 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.149 -1.056 . . . . 64.13 108.149 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.7 m -137.54 127.61 25.94 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.202 0.456 . . . . 51.54 111.594 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.75 80.45 6.55 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.837 1.255 . . . . 43.12 108.354 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.53 -84.04 0.88 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.22 -1.152 . . . . 63.45 110.22 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.95 -12.94 5.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.132 0.973 . . . . 65.21 111.387 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.641 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.5 tp10 -90.17 99.77 12.73 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.634 . . . . 72.34 110.553 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 87.4 m -67.58 129.58 40.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.206 0.526 . . . . 64.51 111.985 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.12 -64.07 1.18 Allowed 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.394 0.678 . . . . 54.03 110.077 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.11 158.92 41.16 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.179 -0.919 . . . . 72.33 111.854 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.29 107.54 9.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.622 -1.172 . . . . 54.25 107.882 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.47 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -108.98 110.53 21.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.327 1.051 . . . . 72.14 109.191 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -130.29 117.37 19.71 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 62.32 108.603 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.63 120.55 60.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.745 0.818 . . . . 72.33 110.241 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -90.68 82.49 5.76 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 124.217 1.007 . . . . 73.42 108.358 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.36 100.32 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.909 -1.041 . . . . 73.15 109.571 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.96 145.32 17.54 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.796 -0.521 . . . . 74.11 111.796 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.02 120.31 1.88 Allowed Glycine 0 CA--C 1.504 -0.624 0 N-CA-C 110.388 -1.085 . . . . 64.3 110.388 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 51' ' ' LEU . 55.7 mt -87.45 127.72 40.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.555 -0.905 . . . . 74.31 108.555 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.684 ' HD2' HG12 ' A' ' 13' ' ' ILE . 1.4 m-85 -133.54 162.78 30.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 74.13 108.959 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.4 t -119.73 113.47 20.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 63.22 108.494 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.473 HD12 ' SG ' ' A' ' 97' ' ' CYS . 11.5 tt -126.71 148.71 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 122.964 0.506 . . . . 74.43 110.529 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 165.83 22.93 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.02 0.928 . . . . 74.11 109.308 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.49 11.78 65.84 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.883 -0.954 . . . . 71.31 114.693 171.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -141.61 161.77 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.92 0.86 . . . . 63.53 112.24 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.8 tt0 -160.59 -175.59 5.08 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 124.951 1.3 . . . . 74.41 107.689 167.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.52 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.43 -140.04 31.5 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 118.04 0.382 . . . . 72.02 113.348 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -72.6 -29.94 63.93 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.386 0.674 . . . . 74.31 111.116 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -61.64 -45.69 92.97 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.604 0.762 . . . . 50.54 111.027 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.516 ' SD ' HD21 ' A' ' 98' ' ' LEU . 9.0 tmm? -66.64 -51.22 58.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.452 -0.795 . . . . 64.04 110.116 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.7 -22.74 64.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.021 0.928 . . . . 71.04 112.528 -176.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -77.23 -32.16 55.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.548 0.739 . . . . 72.11 110.846 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 86' ' ' ILE . 49.4 t -69.65 -64.52 0.86 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.375 0.27 . . . . 72.34 110.886 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -67.97 -27.14 66.34 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 119.09 -0.481 . . . . 72.22 110.671 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -8.99 71.02 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 114.913 0.725 . . . . 60.22 114.913 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.399 1.099 . . . . 74.02 111.821 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.451 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.0 t80 -63.33 -62.51 1.64 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.202 1.001 . . . . 75.12 112.442 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.9 m -65.53 -33.29 7.32 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 114.114 1.153 . . . . 55.02 114.114 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.17 -50.79 12.42 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.451 2.1 . . . . 73.11 112.405 161.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -64.92 -22.63 67.03 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.606 0.762 . . . . 64.21 112.069 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 13' ' ' ILE . 49.7 mm -71.16 -50.34 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.385 -0.598 . . . . 54.3 109.385 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.523 HD12 HD23 ' A' ' 60' ' ' LEU . 77.7 mt -82.87 -19.54 37.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.736 -0.666 . . . . 60.15 112.749 -171.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -62.3 -42.97 83.79 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.09 0.956 . . . . 72.13 112.785 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -37.73 91.75 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.106 1.871 . . . . 73.12 113.713 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -71.21 -39.72 71.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.218 0.607 . . . . 72.32 111.487 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.83 73.91 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.459 -0.571 . . . . 72.14 109.459 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 -51.61 -48.56 63.21 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.728 1.267 . . . . 71.31 110.891 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.95 -48.91 72.37 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.609 0.764 . . . . 64.41 110.906 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.16 -30.06 70.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.953 0.501 . . . . 64.31 111.958 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.4 mt -72.17 -59.16 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.375 -0.602 . . . . 72.33 109.375 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.7 m -51.48 -40.32 59.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.882 1.273 . . . . 72.1 112.676 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -66.4 -41.83 88.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.473 -0.785 . . . . 75.33 110.368 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 30.5 mtm -69.21 -35.62 76.4 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.468 0.307 . . . . 65.53 110.832 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.7 t -59.67 -44.27 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 O-C-N 123.848 0.717 . . . . 72.34 109.948 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -75.29 -32.25 60.94 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 116.059 -0.519 . . . . 72.11 111.411 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -68.84 -31.75 70.95 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.434 0.694 . . . . 72.13 110.528 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.3 7.15 68.91 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.531 0.519 . . . . 74.25 112.613 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 p 56.17 49.71 14.91 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 126.493 1.917 . . . . 64.42 112.483 175.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.42 161.61 23.89 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 113.028 -1.896 . . . . 73.34 108.329 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -59.98 162.11 17.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.157 2.571 . . . . 73.01 111.982 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.55 137.7 46.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.535 0.684 . . . . 72.31 110.71 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.699 -1.137 . . . . 73.02 108.611 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -135.12 127.14 29.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.763 -0.828 . . . . 73.0 108.763 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.44 125.77 27.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.229 -0.656 . . . . 74.1 109.229 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -71.78 150.51 93.14 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 122.844 0.458 . . . . 72.14 111.382 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.2 Cg_exo -60.29 105.12 0.27 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.764 2.309 . . . . 60.52 111.931 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.36 116.16 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.132 -1.432 . . . . 70.21 107.132 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -77.86 83.05 4.21 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.691 0.62 . . . . 52.03 109.506 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -62.55 -33.39 74.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.088 -0.96 . . . . 70.32 110.555 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 N--CA 1.474 0.762 0 O-C-N 124.405 1.066 . . . . 73.13 110.41 177.003 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 52.1 m . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 108.348 -0.982 . . . . 54.23 108.348 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -137.91 128.9 27.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.514 0.725 . . . . 74.52 109.824 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 3.1 pm0 -147.25 129.35 15.52 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.657 0.783 . . . . 63.31 109.568 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.32 143.19 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.01 108.987 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -105.48 -50.78 3.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.505 0.322 . . . . 63.23 110.136 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -159.39 135.6 8.96 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.802 -167.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.14 129.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 75.01 109.162 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.43 ' HE1' HG13 ' B' ' 83' ' ' ILE . 17.5 p90 -157.81 151.26 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.525 0.679 . . . . 73.44 111.366 -173.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.6 m -76.26 122.13 23.94 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.672 -1.149 . . . . 65.1 109.099 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.93 -17.64 19.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.961 0.504 . . . . 70.32 112.082 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -167.97 139.16 2.85 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.104 0.252 . . . . 73.02 111.031 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.467 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -134.35 141.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.713 1.205 . . . . 65.43 109.414 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.6 t -139.15 137.14 35.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.779 1.232 . . . . 74.51 107.811 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.466 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -143.76 119.61 10.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.904 -1.517 . . . . 73.43 106.904 169.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 31.6 mt-10 -120.61 117.87 28.68 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -121.92 83.45 43.7 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.012 -0.736 . . . . 44.44 109.012 170.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.11 -24.77 32.27 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.879 2.386 . . . . 75.34 111.215 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -114.91 24.5 11.69 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.502 1.121 . . . . 74.32 109.785 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.612 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.08 -55.48 9.38 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.014 1.325 . . . . 74.02 114.047 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -77.61 -33.74 2.22 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.235 1.957 . . . . 62.2 111.89 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.515 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 70.5 m80 -96.0 4.3 52.76 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 124.245 1.018 . . . . 73.04 112.83 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.14 -25.78 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.886 0.875 . . . . 71.15 111.889 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -66.29 -26.5 67.35 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.594 1.158 . . . . 65.24 112.281 -174.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 24.4 pt20 -67.83 -33.58 75.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 110.047 -0.353 . . . . 55.35 110.047 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.548 ' HB2' HD13 ' B' ' 68' ' ' LEU . 80.1 mttt -108.27 65.48 0.63 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.584 -0.895 . . . . 72.22 108.584 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.39 108.32 14.9 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.698 -0.482 . . . . 64.43 109.698 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.505 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 161.5 -171.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.842 2.457 . . . . 71.34 109.605 157.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -58.56 128.36 83.16 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 122.635 0.374 . . . . 61.52 111.758 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -88.19 161.55 7.08 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.069 2.513 . . . . 75.23 112.099 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -75.49 107.53 7.68 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.92 -0.77 . . . . 72.04 108.92 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 142.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.198 -0.91 . . . . 62.04 110.693 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.419 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.7 tttm -139.39 144.1 38.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 74.01 109.528 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 84.7 mt -105.24 156.09 18.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.215 0.606 . . . . 71.4 110.702 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.8 t70 -152.04 109.97 3.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.967 -1.015 . . . . 64.24 108.409 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.36 128.89 55.46 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.607 -0.886 . . . . 74.02 108.607 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -131.45 145.19 51.67 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.78 0.832 . . . . 74.44 109.331 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 75.3 p -116.0 119.45 35.93 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.308 0.643 . . . . 70.21 110.308 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.93 139.79 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.765 -0.828 . . . . 51.13 108.765 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 p -143.32 162.85 34.61 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 111.763 0.283 . . . . 71.14 111.763 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 63.7 p -165.55 153.6 11.15 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.018 0.824 . . . . 72.43 110.024 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.0 126.51 31.48 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.098 -0.704 . . . . 74.41 109.098 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' B' ' 57' ' ' GLU . 34.5 mt -93.66 -49.37 5.9 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.37 0.668 . . . . 73.44 109.495 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.57 -166.21 2.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.536 -0.756 . . . . 62.33 110.845 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.84 108.95 1.11 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.669 1.188 . . . . 73.0 111.062 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 66.35 6.75 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.273 1.429 . . . . 54.2 112.107 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.98 115.05 46.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.752 -0.832 . . . . 72.3 108.752 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.83 144.82 50.09 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.563 -0.903 . . . . 64.02 108.563 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.573 ' HB2' HD11 ' B' ' 51' ' ' LEU . 38.4 tt0 -99.53 127.61 45.61 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.489 0.715 . . . . 63.42 109.539 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.0 116.95 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 48.4 t -103.64 128.82 56.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 107.379 -1.341 . . . . 75.44 107.379 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.01 100.15 7.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.063 -1.458 . . . . 73.41 107.063 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -85.7 108.28 17.96 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.0 -1.0 . . . . 70.54 109.159 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 102.88 14.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.567 -1.272 . . . . 73.23 107.567 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.1 m -101.68 130.35 48.03 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.341 -0.845 . . . . 61.23 108.757 177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.451 HG23 HD13 ' B' ' 114' ' ' ILE . 71.7 t -118.14 133.47 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 124.166 0.986 . . . . 70.45 108.594 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.5 m -118.88 144.45 46.39 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.927 0.891 . . . . 74.11 109.037 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.96 21.27 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.606 -1.257 . . . . 71.34 107.606 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.0 p -139.89 128.43 22.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.949 0.5 . . . . 70.45 111.825 -174.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' B' ' 34' ' ' LYS . 28.6 mt -95.48 100.96 12.64 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.563 1.145 . . . . 64.25 109.017 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.77 -125.44 10.02 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 112.007 -0.437 . . . . 65.33 112.007 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -99.06 18.69 16.74 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.763 0.825 . . . . 73.21 110.283 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -126.45 147.23 49.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.94 0.896 . . . . 71.01 109.888 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.9 m -70.12 133.13 46.83 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.568 0.747 . . . . 75.43 110.717 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.524 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.66 -62.19 1.56 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.054 -0.721 . . . . 72.31 109.054 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -162.95 154.93 18.16 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.45 -1.25 . . . . 72.42 108.737 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 87.6 mt -130.92 144.91 51.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 63.54 108.386 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.1 t -147.55 152.56 38.19 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.746 -0.835 . . . . 73.24 108.746 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.4 tt0 -159.53 132.16 6.71 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.606 -0.887 . . . . 64.12 108.606 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' B' ' 113' ' ' CYS . 75.5 t -128.59 144.41 38.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.427 -0.953 . . . . 75.05 108.427 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.64 91.87 3.59 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.938 -1.134 . . . . 72.23 107.938 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.95 101.85 12.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.738 -0.838 . . . . 74.41 108.738 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.77 142.83 16.8 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 111.124 -0.79 . . . . 64.31 111.124 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 126.31 3.21 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.741 -0.944 . . . . 41.23 110.741 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.432 HG23 HD12 ' B' ' 51' ' ' LEU . 65.2 mt -84.25 123.2 38.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 108.431 -0.951 . . . . 65.04 108.431 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.75 134.74 45.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.321 1.048 . . . . 71.31 108.309 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 16.4 m -103.85 99.81 9.59 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.564 -1.273 . . . . 53.55 107.564 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.537 ' HB ' HD11 ' B' ' 89' ' ' ILE . 34.2 pt -107.03 139.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.368 0.667 . . . . 45.44 110.521 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.52 161.49 40.0 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.11 0.964 . . . . 72.34 109.55 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.78 -59.17 4.94 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.259 -0.428 . . . . 74.42 113.298 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.19 125.87 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.355 0.598 . . . . 71.33 110.691 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.73 167.86 29.19 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.672 -0.695 . . . . 73.42 110.877 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -118.04 12.97 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.18 -0.918 . . . . 73.23 113.191 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.2 m -71.72 -35.01 70.06 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.343 0.657 . . . . 64.13 110.945 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -66.58 -36.89 83.73 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.184 -0.916 . . . . 72.2 111.093 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.544 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 16.9 ptp -60.28 -43.32 96.32 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 123.576 0.547 . . . . 64.33 110.008 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.4 69.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.492 0.717 . . . . 71.44 111.383 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -75.4 -40.66 57.57 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.888 0.475 . . . . 74.4 110.65 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -68.32 -67.48 0.46 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.011 0.524 . . . . 61.41 110.945 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 94' ' ' MET . 4.0 pp -75.81 -12.62 60.21 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.917 0.487 . . . . 73.33 112.185 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -23.01 24.93 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.945 -0.364 . . . . 35.44 113.986 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.69 -58.7 1.16 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.2 0.5 . . . . 72.0 110.717 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.14 -50.78 72.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.489 1.115 . . . . 72.31 112.181 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.4 m -69.03 -47.27 30.12 Favored Pre-proline 0 CA--C 1.569 1.691 0 C-N-CA 123.481 0.712 . . . . 41.25 112.048 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.8 Cg_exo -53.71 -35.23 77.49 Favored 'Trans proline' 0 C--N 1.397 3.121 0 C-N-CA 122.721 2.28 . . . . 73.34 114.098 170.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . 0.59 HD21 ' HD1' ' B' ' 133' ' ' PHE . 0.9 OUTLIER -67.68 -24.57 65.43 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.399 0.68 . . . . 72.11 111.856 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.41 -45.24 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.997 0.519 . . . . 52.43 110.213 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.08 -21.92 49.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.732 -0.667 . . . . 71.35 112.066 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.457 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 75.5 t80 -56.67 -51.74 78.97 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 117.997 -1.001 . . . . 73.5 113.098 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.8 Cg_exo -58.25 -38.92 88.86 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.437 2.091 . . . . 74.51 113.584 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -67.5 -41.73 83.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.411 0.684 . . . . 74.4 111.191 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.24 88.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.018 0.527 . . . . 73.13 110.573 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.5 ttt180 -59.56 -60.27 4.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.69 1.596 . . . . 74.1 111.062 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.77 -31.12 70.49 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.38 1.072 . . . . 74.22 111.135 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.7 t -70.96 -36.65 72.66 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 122.483 -0.136 . . . . 60.11 111.022 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.451 HD13 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -68.18 -45.92 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.167 0.587 . . . . 73.2 109.448 173.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.3 m -56.92 -38.68 73.21 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.749 -1.114 . . . . 72.23 111.164 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.9 t -63.97 -47.79 79.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.582 0.753 . . . . 71.41 110.667 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.1 mmt -72.14 -34.73 68.75 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.972 0.509 . . . . 74.02 111.573 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.7 t -67.64 -38.46 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.186 0.594 . . . . 72.11 110.15 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -67.97 -30.92 70.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.913 0.885 . . . . 72.42 111.013 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -72.62 -34.18 67.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.624 0.77 . . . . 75.51 110.504 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.32 3.39 53.54 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.626 0.579 . . . . 74.05 112.3 170.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.8 p 58.21 54.56 5.7 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.445 1.898 . . . . 73.21 111.357 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -119.44 154.1 54.08 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.139 -1.391 . . . . 53.52 110.265 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -60.22 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.319 2.679 . . . . 63.21 114.776 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 15.6 tp60 -64.98 129.89 41.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.167 -0.924 . . . . 62.34 112.814 -159.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.9 84.78 2.24 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.439 -1.689 . . . . 74.25 106.439 170.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -115.73 127.55 55.21 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.352 -0.981 . . . . 64.1 108.352 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.416 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 4.3 mm? -72.07 147.86 46.35 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.871 0.732 . . . . 71.1 110.311 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.67 150.79 73.42 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 115.464 -0.789 . . . . 63.04 109.205 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.03 102.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.63 2.22 . . . . 64.23 110.938 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.23 110.23 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 109.284 -0.635 . . . . 71.13 109.284 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.6 t30 -85.75 88.32 7.53 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 71.34 108.8 176.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.59 ' HD1' HD21 ' B' ' 104' ' ' ASN . 98.7 m-85 . . . . . 0 N--CA 1.481 1.093 0 CA-C-N 115.438 -0.801 . . . . 64.43 111.378 179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.563 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 50.2 ttp . . . . . 0 CA--C 1.55 0.959 0 CA-C-O 121.304 0.573 . . . . 74.21 111.878 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -86.02 78.01 9.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.286 -1.005 . . . . 61.13 108.286 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.563 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 35.0 t80 -112.42 133.96 54.22 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.035 -0.984 . . . . 73.25 109.096 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -154.76 142.15 19.61 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.201 0.6 . . . . 65.04 109.646 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -77.21 97.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.317 -0.856 . . . . 53.05 109.308 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.7 mm-40 -75.06 -42.11 57.66 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.603 -0.517 . . . . 74.44 109.603 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 49.7 ttt180 -174.25 147.42 1.2 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.274 0.984 . . . . 73.24 109.561 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.1 mt -129.1 142.03 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 107.62 -1.252 . . . . 72.35 107.62 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -172.64 158.29 4.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.468 0.651 . . . . 74.4 111.418 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.507 HG22 HE22 ' C' ' 80' ' ' GLN . 66.7 p -83.22 106.35 14.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.804 -1.089 . . . . 64.41 108.387 173.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -65.93 -47.47 74.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.554 0.692 . . . . 62.42 109.268 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -135.51 140.42 44.76 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.611 -1.177 . . . . 50.5 109.204 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 69.9 mt -134.22 138.32 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.325 -1.361 . . . . 64.14 107.325 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -154.79 150.53 27.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.964 0.411 . . . . 72.03 110.034 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.14 108.59 3.62 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.912 -1.144 . . . . 63.4 107.912 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.77 108.82 16.83 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.148 0.579 . . . . 73.24 109.546 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.14 85.45 18.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.398 -0.964 . . . . 53.11 108.398 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -36.22 31.69 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.009 2.473 . . . . 71.41 112.368 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -107.6 34.29 3.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.516 0.726 . . . . 73.22 109.413 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.48 -50.76 63.72 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.223 1.194 . . . . 65.32 114.223 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.97 -32.96 8.2 Favored 'Trans proline' 0 C--N 1.388 2.625 0 CA-C-N 121.036 1.406 . . . . 71.43 112.78 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.18 -37.13 75.08 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.836 0.854 . . . . 73.32 112.642 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.36 -21.09 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.165 0.586 . . . . 75.3 110.608 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.47 -2.26 27.96 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.268 0.627 . . . . 74.11 111.095 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -124.12 26.28 7.54 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.417 1.087 . . . . 73.42 109.837 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 147.44 35.93 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.248 1.019 . . . . 70.44 109.947 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.44 131.13 49.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 73.42 111.114 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -71.61 93.57 1.24 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.148 0.979 . . . . 73.41 112.011 -171.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -154.91 74.49 5.64 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.738 0.815 . . . . 70.34 108.991 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -84.44 127.95 3.97 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.563 2.175 . . . . 74.21 112.357 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.56 97.22 10.4 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 106.502 -1.666 . . . . 74.13 106.502 166.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.96 117.05 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.57 -1.196 . . . . 73.01 109.8 -169.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -97.36 109.0 21.85 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.053 -1.091 . . . . 64.44 108.053 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tt -86.81 123.8 32.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.264 -1.754 . . . . 75.52 106.264 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.9 t70 -120.02 147.91 44.21 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.642 0.777 . . . . 75.21 109.462 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -134.54 131.85 38.44 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.396 1.078 . . . . 64.31 108.129 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.742 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.3 t70 -133.52 135.26 44.3 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.511 -0.551 . . . . 75.52 109.511 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -113.41 111.2 21.56 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.754 0.822 . . . . 64.33 109.559 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.79 157.62 35.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.204 1.002 . . . . 52.2 109.851 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 67.5 p -155.15 167.25 30.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.817 0.447 . . . . 63.52 110.95 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -164.86 127.34 2.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.661 0.785 . . . . 73.15 109.839 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.31 135.96 33.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.264 0.483 . . . . 75.42 109.784 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.653 HD11 HD12 ' C' ' 83' ' ' ILE . 41.2 mt -106.11 -47.01 3.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.03 0.932 . . . . 74.45 109.993 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.7 -178.01 5.45 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.138 0.975 . . . . 70.31 108.973 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.64 110.91 1.24 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.6 0.76 . . . . 71.31 111.019 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 19.1 m-20 62.85 30.75 16.6 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.493 1.117 . . . . 71.43 111.768 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -118.98 111.59 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.619 -1.252 . . . . 75.42 107.619 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.421 ' HB2' HD12 ' C' ' 86' ' ' ILE . 95.4 m-85 -123.51 125.85 45.65 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.772 0.829 . . . . 52.24 109.81 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.78 120.3 24.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 65.21 108.917 168.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -96.78 117.33 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.585 -1.265 . . . . 75.25 107.585 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.08 131.61 52.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.006 -1.109 . . . . 71.22 108.006 173.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.62 105.85 9.0 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.191 -1.04 . . . . 75.21 108.191 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.742 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 59.3 mtt180 -83.3 134.61 34.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.646 -0.502 . . . . 63.24 109.646 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.0 123.77 69.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.798 -1.556 . . . . 73.04 106.798 162.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.8 m -121.17 112.33 18.53 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.446 0.641 . . . . 72.54 109.321 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.455 HG21 HG21 ' C' ' 114' ' ' ILE . 51.5 t -101.13 117.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 54.23 108.586 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -115.13 141.89 47.4 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.667 -0.864 . . . . 65.01 108.667 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.07 123.0 22.54 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.941 -1.133 . . . . 70.52 107.941 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 127.07 16.97 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 122.852 0.461 . . . . 73.13 110.548 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.51 ' H ' HD12 ' C' ' 68' ' ' LEU . 1.5 mp -90.63 49.25 1.64 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.045 1.338 . . . . 53.54 109.121 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.01 -106.58 2.81 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.212 -0.903 . . . . 73.05 110.901 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -90.35 -30.88 17.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.962 0.905 . . . . 70.03 110.162 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -66.32 115.47 6.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.308 1.043 . . . . 65.42 109.891 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.2 m -89.82 125.6 35.38 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.714 0.688 . . . . 64.22 109.653 168.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' C' ' 68' ' ' LEU . . . -72.23 -64.02 1.03 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.79 -1.095 . . . . 65.1 109.502 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.59 170.16 23.02 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.564 -1.198 . . . . 73.32 110.814 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.426 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -133.69 146.61 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.562 -2.014 . . . . 72.24 105.562 172.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.426 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -151.47 145.26 25.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.394 -0.965 . . . . 54.23 108.394 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' C' ' 63' ' ' THR . 34.3 tt0 -157.56 136.37 11.5 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.294 -0.632 . . . . 73.42 109.294 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.58 123.7 49.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.114 -0.948 . . . . 74.32 108.927 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.732 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 29.1 mt-30 -92.33 87.56 6.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.656 -1.239 . . . . 75.41 107.656 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.507 HE22 HG22 ' C' ' 18' ' ' THR . 9.5 tp-100 -79.08 96.88 5.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.317 -0.624 . . . . 73.12 109.317 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.07 149.05 24.88 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 115.26 -0.882 . . . . 42.33 111.577 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.92 117.23 0.81 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 110.825 -0.91 . . . . 73.13 110.825 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.653 HD12 HD11 ' C' ' 51' ' ' LEU . 14.5 mm -80.98 121.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.398 -0.964 . . . . 75.33 108.398 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.97 126.73 29.16 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.596 -0.89 . . . . 53.15 108.596 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -69.61 119.26 13.58 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.344 -0.984 . . . . 44.33 108.344 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.611 HG23 HD11 ' C' ' 89' ' ' ILE . 59.1 mt -116.3 100.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.066 -0.716 . . . . 71.01 109.066 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -148.71 164.47 34.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.648 1.179 . . . . 73.31 109.031 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.34 32.5 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 123.13 0.269 . . . . 70.55 112.988 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.611 HD11 HG23 ' C' ' 86' ' ' ILE . 11.9 pt -114.45 156.18 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.598 1.159 . . . . 73.25 110.37 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -164.96 156.21 14.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.945 -1.025 . . . . 71.21 109.264 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 63.08 -110.37 3.32 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.423 0.452 . . . . 73.45 114.006 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -83.1 -27.19 30.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.664 0.386 . . . . 72.13 111.797 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -42.07 75.25 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.476 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.2 ptt? -63.57 -35.78 81.62 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.67 -0.696 . . . . 73.33 110.004 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.64 93.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.708 0.803 . . . . 45.11 112.024 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 47.7 t-80 -78.76 -20.92 48.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.304 -0.407 . . . . 73.41 111.265 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.5 t -82.56 -63.25 1.41 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.154 -0.342 . . . . 64.55 111.27 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.566 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 4.6 pp -77.51 -32.16 53.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.847 0.459 . . . . 45.32 111.387 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.34 8.77 64.7 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.727 -0.485 . . . . 73.44 113.702 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -148.64 -56.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.246 0.523 . . . . 63.34 111.838 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -74.49 -40.27 61.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.193 0.442 . . . . 72.2 112.193 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 85.4 m -64.84 -47.24 75.14 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.723 -0.656 . . . . 63.31 111.176 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 55.3 Cg_exo -57.34 -37.24 98.21 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.123 1.882 . . . . 72.24 113.023 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.09 -37.97 81.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.787 0.835 . . . . 74.33 111.348 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -73.23 -46.78 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.242 0.617 . . . . 63.02 110.92 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.92 -20.56 49.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.552 -0.749 . . . . 73.34 112.298 -172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 61.4 t80 -58.56 -51.86 78.77 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.747 -1.121 . . . . 72.45 113.192 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.3 Cg_exo -56.71 -38.57 95.37 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.036 1.824 . . . . 74.21 113.518 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -69.16 -42.64 75.63 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.322 0.649 . . . . 73.22 111.517 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.72 99.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.255 0.622 . . . . 74.33 109.637 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' C' ' 127' ' ' ASN . 41.1 ttt180 -58.43 -53.88 53.34 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.924 1.69 . . . . 75.24 111.469 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.57 -34.77 78.64 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.579 0.549 . . . . 70.33 110.321 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' C' ' 18' ' ' THR . 6.4 t -68.56 -32.91 73.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.034 0.534 . . . . 70.33 111.128 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' C' ' 62' ' ' VAL . 78.6 mt -71.52 -53.64 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.777 -0.647 . . . . 71.32 109.869 174.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.2 m -63.05 -28.87 70.38 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.258 0.623 . . . . 64.32 111.693 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -64.42 -51.51 62.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.498 0.719 . . . . 55.21 109.424 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.605 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.21 -38.9 81.05 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.325 1.05 . . . . 65.32 112.213 178.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.9 t -60.7 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.561 0.744 . . . . 71.33 109.749 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 41.1 t -67.08 -35.36 79.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.671 0.789 . . . . 73.31 112.083 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -69.3 -31.84 70.6 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.432 0.693 . . . . 75.34 110.551 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.61 12.18 70.08 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.559 0.537 . . . . 71.41 113.073 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.422 HG22 ' NH2' ' D' ' 15' ' ' ARG . 6.9 p 64.84 20.88 12.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.652 1.981 . . . . 74.31 113.423 173.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -89.1 151.1 46.38 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.267 -0.642 . . . . 62.53 109.267 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -61.78 144.28 96.87 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.205 2.603 . . . . 75.42 113.282 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.473 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -51.08 111.07 0.5 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 71.51 111.415 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.11 85.71 2.16 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.332 -0.988 . . . . 74.14 108.332 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.461 ' HB3' ' NH2' ' C' ' 111' ' ' ARG . 17.5 m120 -91.6 109.32 20.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.47 -1.241 . . . . 73.45 108.427 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.65 135.08 57.29 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.263 0.977 . . . . 52.43 111.929 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.24 157.85 88.93 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.281 1.032 . . . . 42.41 110.345 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.54 105.49 0.76 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.389 2.059 . . . . 72.25 112.171 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 46.4 t -99.59 107.85 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.488 -1.301 . . . . 74.31 107.488 171.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -105.72 93.91 4.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.432 -0.803 . . . . 73.21 110.004 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -63.7 -41.84 98.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.117 -0.697 . . . . 73.22 109.117 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.449 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.9 p-10 . . . . . 0 N--CA 1.476 0.865 0 C-N-CA 124.959 1.304 . . . . 63.23 111.822 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 95.1 m . . . . . 0 C--O 1.237 0.403 0 CA-C-O 121.113 0.483 . . . . 75.0 110.381 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.8 t80 -138.98 122.56 17.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.053 -1.462 . . . . 72.05 107.053 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.5 130.52 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.446 -0.576 . . . . 64.22 109.446 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.88 125.79 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.67 -1.233 . . . . 74.43 107.67 168.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -99.06 -43.6 6.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.766 0.426 . . . . 71.2 110.259 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.422 ' NH2' HG22 ' C' ' 122' ' ' THR . 7.8 tpt180 -179.69 141.0 0.15 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.827 0.851 . . . . 72.35 110.627 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.95 141.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.15 -1.055 . . . . 70.51 108.15 171.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.1 p90 -156.55 173.39 16.99 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.847 0.832 . . . . 74.31 111.2 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -104.81 119.62 39.45 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.437 -1.256 . . . . 74.01 109.111 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -90.52 -26.87 19.54 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.279 -0.419 . . . . 62.42 110.42 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -159.71 110.72 1.97 Allowed 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.792 0.682 . . . . 72.24 109.278 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.605 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.0 mt -111.27 149.44 14.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.708 -0.849 . . . . 65.11 108.708 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -148.82 142.29 25.3 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.955 0.902 . . . . 51.54 109.82 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.441 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.0 t80 -152.55 120.08 6.01 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 106.406 -1.702 . . . . 44.15 106.406 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' D' ' 74' ' ' PHE . 45.0 mt-10 -128.32 120.28 26.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.499 0.72 . . . . 71.14 109.269 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.97 85.01 4.75 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.01 -1.107 . . . . 74.13 108.01 171.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.29 -28.68 8.49 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.114 2.543 . . . . 75.53 113.502 -167.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 14.5 m-80 -115.05 28.61 8.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.206 -0.664 . . . . 64.45 109.206 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.85 -66.1 0.47 Allowed Pre-proline 0 CA--C 1.566 1.569 0 N-CA-C 114.992 1.478 . . . . 44.42 114.992 -165.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.456 ' HB3' HD11 ' C' ' 83' ' ' ILE . 78.7 Cg_endo -77.22 -15.22 16.22 Favored 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.566 1.952 . . . . 75.42 113.199 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.537 ' HA ' HE21 ' D' ' 33' ' ' GLN . 19.5 t-160 -70.23 -38.87 75.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 74.12 109.609 174.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.61 -39.82 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.266 1.026 . . . . 64.44 110.66 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -75.85 -3.77 37.01 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.754 -1.112 . . . . 73.12 113.764 -168.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' D' ' 30' ' ' HIS . 43.4 mt-30 -85.33 -6.88 59.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.774 0.83 . . . . 75.42 111.305 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -121.92 115.21 22.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.386 1.474 . . . . 73.23 108.093 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -92.83 93.94 8.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.556 0.743 . . . . 71.14 112.381 -179.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.415 ' HE3' ' H ' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -165.22 -179.19 5.47 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.951 0.9 . . . . 73.31 111.848 177.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.86 140.58 26.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.603 0.761 . . . . 73.31 111.935 -176.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 58.6 Cg_endo -75.03 156.13 42.83 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.019 2.479 . . . . 73.33 114.152 168.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -89.17 140.68 29.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.354 -1.294 . . . . 61.21 108.058 164.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.6 m -119.78 119.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.337 0.655 . . . . 63.43 110.778 -175.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 61.7 tttt -98.74 137.15 37.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.93 0.892 . . . . 71.0 109.339 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.61 123.51 44.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.589 0.756 . . . . 60.03 109.789 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.2 m-20 -118.84 127.49 53.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.15 0.98 . . . . 75.04 108.541 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.8 mp -109.06 138.17 45.83 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.251 -0.648 . . . . 65.12 109.251 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.1 t70 -150.49 152.94 34.98 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.536 0.735 . . . . 60.32 109.082 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 20.6 p -140.94 160.88 39.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.008 0.923 . . . . 73.14 110.393 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.95 167.82 29.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.006 0.922 . . . . 73.33 109.593 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 42.2 p -159.07 153.01 23.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.176 0.59 . . . . 75.14 109.799 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 92.6 p -151.9 149.08 28.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.281 -0.637 . . . . 74.42 109.281 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -89.01 118.35 28.68 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.35 -0.611 . . . . 64.1 109.35 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.6 mt -92.02 -36.7 13.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.021 0.529 . . . . 73.32 110.152 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.33 -179.75 8.22 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.294 -0.867 . . . . 55.34 109.955 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.41 125.85 28.83 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.987 -0.746 . . . . 63.54 108.987 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 65.82 14.84 9.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.374 1.07 . . . . 74.34 111.773 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 41.9 t -129.57 124.74 60.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 124.125 0.97 . . . . 63.12 109.145 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.621 ' HB2' HD13 ' D' ' 86' ' ' ILE . 62.7 m-85 -136.1 141.18 44.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.342 0.591 . . . . 73.55 109.805 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.6 tt0 -91.83 132.66 36.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.471 -1.24 . . . . 74.32 109.792 173.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.57 125.85 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 107.541 -1.281 . . . . 63.44 107.541 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 34.1 t -110.15 129.58 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.039 -0.726 . . . . 72.2 109.039 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.504 HD23 HD12 ' D' ' 106' ' ' LEU . 1.8 mm? -118.65 106.21 12.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.529 0.731 . . . . 70.44 109.599 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.7 ttm180 -88.39 102.03 14.47 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.622 -0.717 . . . . 61.43 109.443 177.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -91.74 121.18 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.786 -1.19 . . . . 74.23 107.786 170.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.4 m -127.0 146.07 50.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.602 0.761 . . . . 52.4 109.298 -175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.505 HG11 HD21 ' D' ' 126' ' ' LEU . 54.0 t -139.5 111.74 5.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.997 1.319 . . . . 65.02 109.038 -172.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.2 m -96.75 95.63 8.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.768 -0.827 . . . . 51.11 108.768 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.82 44.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.35 -0.611 . . . . 73.4 109.35 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.503 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.0 m -142.33 141.1 32.32 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.361 0.665 . . . . 74.15 110.778 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -132.17 135.64 46.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.912 1.285 . . . . 63.32 110.17 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 -114.51 5.57 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.902 -0.879 . . . . 53.42 110.902 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.61 4.69 12.36 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.039 0.535 . . . . 65.54 110.418 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -127.36 161.84 27.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.074 0.55 . . . . 73.02 110.946 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -80.75 131.55 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.964 0.505 . . . . 65.01 111.469 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.718 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -72.68 -71.62 0.28 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.754 1.222 . . . . 74.14 108.379 173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' D' ' 24' ' ' GLU . 51.4 p90 -153.93 140.32 18.68 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.746 -0.661 . . . . 73.04 111.033 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.37 110.2 22.17 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.272 -1.381 . . . . 44.5 107.272 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.584 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.2 t -119.0 132.89 56.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.478 -0.564 . . . . 74.51 109.478 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.412 ' HB2' HG23 ' D' ' 63' ' ' THR . 32.3 tt0 -152.08 132.13 13.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.14 0.576 . . . . 60.42 110.249 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.71 117.35 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.356 0.663 . . . . 61.43 109.669 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -87.28 87.33 7.4 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.852 -1.166 . . . . 73.51 107.852 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.33 91.17 5.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.289 -0.869 . . . . 63.35 108.796 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.94 143.61 17.61 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.071 -0.811 . . . . 53.14 111.071 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.92 132.13 5.08 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 111.209 -0.756 . . . . 62.45 111.209 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.495 HG13 ' HE1' ' D' ' 17' ' ' TYR . 49.1 mt -88.19 124.37 41.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 108.407 -0.96 . . . . 65.11 108.407 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -129.48 160.77 32.13 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.26 0.552 . . . . 74.1 110.112 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 35.5 m -104.9 117.19 33.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.992 -1.114 . . . . 74.51 107.992 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.4 mp -118.15 108.76 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.197 -0.668 . . . . 72.12 109.197 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.32 160.82 41.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.037 0.935 . . . . 74.01 110.014 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 79.01 -4.13 62.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.728 -0.669 . . . . 72.53 113.904 176.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.447 HD11 HG23 ' D' ' 86' ' ' ILE . 15.0 pt -126.65 142.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.123 0.969 . . . . 73.14 109.696 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.8 167.21 22.68 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.43 0.692 . . . . 74.34 110.114 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.17 -122.7 27.1 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 124.605 1.191 . . . . 72.05 114.606 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 m -66.27 -44.38 83.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.162 0.985 . . . . 61.0 112.128 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.69 -38.33 88.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.027 0.531 . . . . 70.43 110.873 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.67 -0.695 . . . . 72.44 110.199 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -28.7 67.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.748 0.819 . . . . 71.32 111.767 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 53.0 t-80 -78.69 -30.64 46.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.745 . . . . 74.12 110.513 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -76.61 -50.86 12.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.295 0.569 . . . . 54.12 110.071 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.601 HD12 HG12 ' D' ' 86' ' ' ILE . 6.3 tt -81.96 -23.28 36.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.654 -0.703 . . . . 62.43 111.124 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.18 57.09 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.447 -0.641 . . . . 44.5 114.145 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -141.01 -53.96 0.48 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.868 0.834 . . . . 73.55 111.782 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -73.89 -54.32 8.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 71.12 110.978 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 61.2 m -59.25 -44.95 99.14 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 113.895 1.072 . . . . 74.22 113.895 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.72 -35.49 94.51 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 121.915 1.743 . . . . 71.12 112.794 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -80.78 -7.57 59.43 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.518 0.727 . . . . 70.23 111.415 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.71 -37.38 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.491 0.662 . . . . 74.1 109.747 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.504 HD12 HD23 ' D' ' 60' ' ' LEU . 50.9 mt -81.79 -32.02 31.55 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.129 -0.941 . . . . 53.11 111.409 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.54 -44.21 98.84 Favored Pre-proline 0 CA--C 1.572 1.805 0 N-CA-C 114.195 1.183 . . . . 63.41 114.195 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.56 -39.99 78.09 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.317 2.011 . . . . 72.11 113.421 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -74.9 -33.61 62.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.295 0.638 . . . . 65.13 110.97 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.35 88.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.217 0.607 . . . . 72.35 109.994 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.4 ttp180 -59.42 -52.19 66.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 114.412 -1.267 . . . . 73.33 110.754 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.72 -45.34 94.39 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.176 0.923 . . . . 74.23 110.925 -175.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.3 -41.47 84.51 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.761 0.663 . . . . 75.43 110.953 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.584 HG23 ' SG ' ' D' ' 76' ' ' CYS . 47.6 mt -63.29 -55.66 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.612 -0.722 . . . . 74.52 110.39 174.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -53.49 -39.68 64.76 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.337 1.055 . . . . 64.43 111.47 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 20.6 t -65.95 -45.91 80.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.987 -1.006 . . . . 74.22 110.501 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.9 mtm -67.39 -35.89 80.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.967 0.507 . . . . 73.02 111.776 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.7 t -64.04 -43.59 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 123.838 0.711 . . . . 71.33 109.399 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.0 p -71.62 -29.32 64.53 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.007 0.523 . . . . 73.51 111.87 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' D' ' 116' ' ' SER . 86.3 mtt-85 -72.86 -34.28 66.64 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.574 0.75 . . . . 74.21 110.473 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 9.01 63.96 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.759 0.662 . . . . 24.04 112.202 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.4 p 62.14 18.7 10.29 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.935 2.094 . . . . 64.35 113.544 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -83.34 165.46 40.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 107.557 -1.275 . . . . 75.05 107.557 162.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -84.05 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.284 1.989 . . . . 63.45 113.549 -165.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -74.44 120.57 20.18 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 122.442 0.297 . . . . 74.1 110.891 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.505 HD21 HG11 ' D' ' 64' ' ' VAL . 63.1 tp -116.51 95.0 4.85 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 42.24 108.184 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.27 104.26 13.61 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.508 -0.923 . . . . 62.21 108.508 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.495 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.5 mm? -62.99 113.87 3.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.607 0.763 . . . . 75.12 109.372 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -64.16 137.12 97.02 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 122.946 0.499 . . . . 64.13 110.477 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 15.8 Cg_exo -65.3 131.63 28.92 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.939 2.426 . . . . 72.45 112.273 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 65.1 t -109.28 130.92 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.23 0.612 . . . . 73.34 109.788 -176.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -86.6 85.51 7.3 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.428 -0.953 . . . . 43.14 108.428 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 . . . . . 0 N--CA 1.484 1.272 0 CA-C-N 115.377 -0.829 . . . . 72.43 111.185 177.27 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 109.442 -0.577 . . . . 60.44 109.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 27.2 t80 -137.81 126.13 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.214 1.005 . . . . 71.15 108.712 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -151.06 128.51 11.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.307 0.643 . . . . 72.03 109.502 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CD1' HG21 ' A' ' 105' ' ' ILE . 56.4 mt -85.12 129.03 38.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 120.921 0.391 . . . . 73.15 109.955 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -88.6 -42.71 11.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.108 -0.951 . . . . 73.43 110.255 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' HB3' HD12 ' A' ' 83' ' ' ILE . 60.1 ttt180 -169.83 140.75 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.314 -0.403 . . . . 74.2 110.714 -170.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -122.81 137.95 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.221 -1.029 . . . . 74.34 108.221 172.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -168.23 143.58 3.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.388 0.675 . . . . 73.44 110.463 -171.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -76.59 111.01 11.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.735 -0.839 . . . . 70.43 108.735 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 40.4 mtpt -77.27 -25.28 51.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.969 0.508 . . . . 74.03 110.565 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.24 146.71 24.94 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.941 -1.027 . . . . 72.25 109.895 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.4 mt -140.24 145.2 26.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 125.06 1.344 . . . . 54.42 107.498 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 36.5 t -154.7 138.39 16.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.634 0.774 . . . . 61.2 109.103 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -143.58 131.63 21.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.565 -1.643 . . . . 74.52 106.565 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -134.51 128.81 34.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.006 -0.739 . . . . 74.14 109.006 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 78.65 72.94 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 107.33 -1.359 . . . . 73.44 107.33 171.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.73 -26.07 19.75 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.68 2.253 . . . . 70.24 112.055 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -109.39 24.22 13.38 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.773 0.829 . . . . 62.35 109.019 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.21 -61.17 2.48 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 117.879 -1.057 . . . . 70.22 112.595 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.7 Cg_exo -63.21 -24.3 72.5 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 122.28 1.987 . . . . 73.15 113.008 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.407 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 16.2 m-70 -77.95 -47.37 18.75 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.673 0.789 . . . . 45.34 110.442 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -73.9 -20.02 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 CA-C-N 115.16 -0.927 . . . . 75.12 110.949 -163.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.9 -19.22 62.62 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.354 1.062 . . . . 75.41 112.765 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -102.53 -10.28 19.47 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.696 0.398 . . . . 55.32 111.979 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 30' ' ' HIS . 36.6 mtpt -82.12 167.63 18.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.875 0.47 . . . . 74.44 112.248 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -61.53 141.33 57.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.457 1.103 . . . . 71.34 111.933 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 48.4 m95 -91.87 64.08 4.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.07 0.548 . . . . 74.12 110.68 -172.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -127.07 73.68 76.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.393 0.677 . . . . 75.54 110.054 175.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -89.72 118.44 0.78 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.619 2.213 . . . . 74.45 112.187 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.73 101.1 12.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.901 -1.518 . . . . 72.14 106.901 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.3 t -76.46 114.89 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.355 -0.839 . . . . 54.04 110.133 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.35 134.41 35.57 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.355 0.662 . . . . 53.53 109.565 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.2 mt -103.28 108.61 19.9 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.527 -0.916 . . . . 71.01 108.527 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -104.26 113.9 27.77 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.004 0.922 . . . . 64.35 108.735 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.48 135.87 39.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.312 0.645 . . . . 64.42 109.586 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.57 134.44 30.56 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.397 -0.964 . . . . 75.03 108.397 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.454 HG23 HD22 ' A' ' 60' ' ' LEU . 11.5 m -148.63 140.57 23.84 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.64 0.376 . . . . 63.12 110.092 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.06 135.07 13.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.369 0.668 . . . . 74.31 110.644 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 45.7 p -96.45 164.09 12.77 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.859 0.864 . . . . 63.33 111.013 176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -162.09 119.99 2.2 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.45 1.1 . . . . 73.32 108.752 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.39 118.69 18.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.958 -0.386 . . . . 74.33 109.958 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -89.25 -33.1 17.1 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.487 0.715 . . . . 75.13 111.137 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.53 -174.07 4.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.414 0.686 . . . . 72.35 110.765 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.24 116.66 5.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.425 0.69 . . . . 72.12 110.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 66.16 -0.14 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.403 1.481 . . . . 70.05 113.091 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.91 106.57 19.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.334 -0.987 . . . . 74.35 108.334 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -119.57 124.04 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.801 -1.185 . . . . 74.2 107.801 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -88.77 136.16 33.15 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.563 1.145 . . . . 71.42 108.532 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 99.0 t -122.76 125.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.644 -1.243 . . . . 74.02 107.644 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.516 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.6 t -104.97 128.02 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.023 0.529 . . . . 62.34 109.875 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.75 HD23 HD12 ' A' ' 106' ' ' LEU . 3.9 mm? -106.28 98.17 7.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 73.42 108.906 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 17.2 ttp180 -87.18 100.88 12.99 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.651 -0.87 . . . . 73.14 108.651 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.5 t -93.64 122.66 45.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.999 -1.482 . . . . 65.32 106.999 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.3 m -116.35 121.38 41.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.531 0.681 . . . . 71.44 109.281 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 t -111.18 109.84 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.95 1.3 . . . . 72.32 108.672 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.7 m -103.56 140.07 38.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 108.31 -0.996 . . . . 73.11 108.31 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.16 121.22 37.33 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.182 -0.673 . . . . 71.14 109.182 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -122.73 124.82 44.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.245 0.545 . . . . 60.51 110.768 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 5.1 mp -88.81 77.08 7.87 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.351 1.46 . . . . 71.43 107.578 173.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.01 -86.78 0.88 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.865 -1.061 . . . . 62.44 111.15 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -113.9 -27.89 7.58 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.882 0.873 . . . . 52.52 110.65 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -86.07 133.71 33.87 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.351 0.66 . . . . 71.13 111.042 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.4 m -78.26 147.24 34.43 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.127 0.421 . . . . 74.32 110.526 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.734 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -96.8 -63.25 1.15 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.971 0.908 . . . . 71.44 108.964 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -151.6 163.86 38.15 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.154 -1.384 . . . . 74.4 110.548 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.7 tp -132.89 121.26 22.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.498 1.119 . . . . 72.22 108.461 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.657 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.2 m -105.79 141.03 37.92 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.603 1.161 . . . . 43.51 108.719 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.4 tt0 -146.66 115.35 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.091 -1.077 . . . . 54.31 108.091 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 113' ' ' CYS . 46.4 t -131.32 109.96 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.102 -0.703 . . . . 75.31 109.102 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 64.5 mt-30 -87.7 81.79 7.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.3 -0.864 . . . . 55.24 109.086 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -75.87 93.11 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.108 -0.951 . . . . 74.13 108.633 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.55 145.4 21.92 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.317 -0.713 . . . . 65.31 111.317 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.07 142.82 12.15 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.539 -1.024 . . . . 64.15 110.539 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 15' ' ' ARG . 54.8 mt -106.9 126.41 62.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.578 -0.897 . . . . 73.25 108.578 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.48 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 14.5 m-85 -131.45 117.43 18.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.393 0.677 . . . . 71.43 109.199 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 t -78.55 90.63 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.889 0.876 . . . . 51.35 108.661 168.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 89' ' ' ILE . 48.5 pt -106.44 143.94 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.654 0.782 . . . . 61.02 110.286 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.22 154.88 28.0 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.809 0.844 . . . . 61.31 109.544 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.66 5.37 88.27 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 115.155 0.822 . . . . 61.21 115.155 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.6 134.51 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.392 -0.966 . . . . 74.35 108.392 174.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -142.47 171.93 13.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.227 1.011 . . . . 70.23 108.946 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.06 -120.18 14.27 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.459 0.543 . . . . 61.3 114.459 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -80.21 -24.17 40.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.01 0.924 . . . . 72.22 111.593 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -36.91 75.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.348 0.659 . . . . 64.43 109.949 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 52.1 ttp -65.98 -43.06 88.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.915 0.886 . . . . 51.44 110.193 171.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.93 82.39 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.347 -0.842 . . . . 73.15 111.426 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.731 0.813 . . . . 72.33 110.763 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.46 -49.56 68.67 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.01 0.524 . . . . 53.24 110.836 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 mt -85.03 -32.2 23.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.037 -0.529 . . . . 64.02 111.512 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.58 -1.88 63.69 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 114.823 0.689 . . . . 74.25 114.823 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.75 -54.65 0.19 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.998 0.899 . . . . 62.25 112.445 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -71.31 -64.4 0.92 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.318 1.047 . . . . 71.31 112.629 -167.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.9 m -70.37 -34.25 3.84 Favored Pre-proline 0 CA--C 1.574 1.87 0 N-CA-C 113.933 1.086 . . . . 55.43 113.933 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.61 ' HB3' HD21 ' A' ' 60' ' ' LEU . 26.2 Cg_endo -64.03 -31.53 65.8 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.249 1.966 . . . . 55.35 113.319 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -62.05 -34.93 77.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.246 0.618 . . . . 72.23 109.666 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.532 HG21 ' CD1' ' A' ' 13' ' ' ILE . 45.6 mm -60.03 -47.3 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.855 0.862 . . . . 73.44 110.603 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.75 HD12 HD23 ' A' ' 60' ' ' LEU . 98.4 mt -76.27 -25.62 55.1 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.454 -0.793 . . . . 60.25 112.091 -171.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.16 -44.58 98.74 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.003 1.112 . . . . 62.33 114.003 -170.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.92 -33.98 95.48 Favored 'Trans proline' 0 C--N 1.392 2.818 0 C-N-CA 122.117 1.878 . . . . 53.21 113.7 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.16 -35.27 56.12 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 75.23 110.98 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.27 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.504 -0.554 . . . . 30.02 109.504 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HG23 ' C' ' 105' ' ' ILE . 38.1 ttm180 -54.28 -53.91 47.35 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 124.663 1.227 . . . . 74.54 110.116 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.48 -43.4 98.92 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.542 1.151 . . . . 75.42 110.98 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.488 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 48.0 t -60.15 -40.51 90.11 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.581 0.551 . . . . 44.13 111.002 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 94.7 mt -65.49 -54.76 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.901 0.751 . . . . 72.23 109.669 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.584 HG21 ' HE2' ' C' ' 109' ' ' TYR . 93.5 m -53.17 -39.06 63.31 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.936 1.397 . . . . 71.12 111.343 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.8 t -65.94 -47.63 74.05 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.546 -1.206 . . . . 64.42 109.257 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.554 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 44.4 mtm -61.85 -42.94 99.65 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.194 0.598 . . . . 73.31 111.066 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.9 t -56.21 -50.48 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 124.388 1.055 . . . . 55.2 109.957 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -72.0 -32.29 67.06 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.222 -0.899 . . . . 61.21 111.588 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.511 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 61.6 mtt-85 -72.16 -27.43 62.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.5 0.72 . . . . 75.03 110.036 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.67 12.36 56.67 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.749 -0.659 . . . . 73.52 113.182 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.5 p 57.99 17.77 4.63 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.808 2.043 . . . . 53.52 113.393 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.28 145.75 49.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.245 -1.391 . . . . 73.43 107.245 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 141.74 80.89 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.494 2.129 . . . . 74.45 111.149 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -48.03 123.16 5.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.619 1.199 . . . . 72.32 111.336 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.47 118.94 38.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.256 0.622 . . . . 54.25 109.387 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -115.48 114.85 25.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.153 -0.684 . . . . 71.31 109.153 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.63 122.09 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.644 0.778 . . . . 70.22 109.939 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.12 132.28 95.25 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 109.276 -0.639 . . . . 63.0 109.276 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.432 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 4.3 Cg_endo -76.72 113.49 3.66 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.119 1.879 . . . . 74.33 110.569 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -98.99 123.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.713 -1.217 . . . . 51.33 107.713 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -76.72 89.98 3.41 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.425 -0.954 . . . . 75.31 108.425 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -62.66 -31.91 72.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.881 0.873 . . . . 73.21 110.902 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.406 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.6 m-20 . . . . . 0 N--CA 1.472 0.656 0 C-N-CA 123.672 0.789 . . . . 64.03 110.566 175.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.8 m . . . . . 0 C--O 1.233 0.212 0 N-CA-C 108.295 -1.002 . . . . 70.54 108.295 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.463 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 56.6 t80 -127.68 112.61 15.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.736 -1.209 . . . . 74.33 107.736 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.423 ' HB3' ' HB2' ' B' ' 85' ' ' SER . 0.0 OUTLIER -131.83 135.29 46.61 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.008 -1.108 . . . . 73.03 108.008 -178.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.476 ' O ' HD12 ' B' ' 13' ' ' ILE . 2.4 pp -94.99 130.52 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.397 0.679 . . . . 71.02 110.277 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -99.12 -50.83 4.02 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.807 -0.558 . . . . 63.34 110.06 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.459 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 41.8 ttt180 -162.59 134.23 5.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.998 -0.546 . . . . 74.3 110.452 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -113.91 142.55 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.71 -1.589 . . . . 53.31 106.71 172.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -168.9 149.35 4.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.615 0.643 . . . . 73.04 112.733 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.661 HG21 HD11 ' B' ' 21' ' ' ILE . 37.9 m -79.71 120.1 23.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.345 -0.843 . . . . 72.53 109.529 172.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.579 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 9.3 mtpt -89.14 -28.88 19.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.4 0.68 . . . . 74.45 110.835 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.7 136.92 14.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.846 -0.616 . . . . 72.24 110.406 -169.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.661 HD11 HG21 ' B' ' 18' ' ' THR . 31.2 mm -124.99 148.88 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.398 1.079 . . . . 75.25 108.155 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.7 t -154.15 141.37 19.51 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.789 -0.641 . . . . 71.51 109.576 170.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -152.71 109.0 3.39 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.26 -1.385 . . . . 65.35 107.26 171.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -118.08 111.53 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.456 -1.313 . . . . 74.53 107.456 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.79 88.23 6.42 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 108.313 -0.995 . . . . 43.12 108.313 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.74 -24.33 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.095 2.53 . . . . 61.34 111.938 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -121.6 24.14 9.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.936 0.895 . . . . 73.25 110.391 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -41.69 -54.41 6.74 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 124.788 1.235 . . . . 72.31 114.16 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.9 Cg_endo -66.17 -32.93 41.74 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.317 2.011 . . . . 74.3 113.157 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -94.42 -15.5 24.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.877 0.695 . . . . 65.22 112.877 -169.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.64 -23.25 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.743 1.217 . . . . 71.42 113.682 -169.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -66.57 -21.72 66.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.122 0.969 . . . . 54.21 112.149 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.421 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.6 pt20 -61.98 -29.06 70.0 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.879 0.472 . . . . 51.03 110.619 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 32.8 mmtp -105.1 67.65 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.536 -1.283 . . . . 74.04 107.536 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.02 79.5 6.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.546 0.738 . . . . 73.0 111.93 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 164.79 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.899 2.079 . . . . 71.33 110.647 160.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.2 126.25 67.2 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.553 1.141 . . . . 72.21 112.335 -170.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.71 176.15 9.33 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.752 2.301 . . . . 62.23 111.597 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.04 104.22 7.4 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.11 -1.441 . . . . 74.24 107.11 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.46 154.91 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.503 0.721 . . . . 70.02 109.197 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -147.18 138.7 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.813 0.845 . . . . 71.13 109.801 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.658 HD21 HD11 ' B' ' 128' ' ' LEU . 5.5 mp -85.4 141.11 30.21 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.052 -1.092 . . . . 75.14 108.052 165.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.8 t70 -141.18 109.99 6.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.35 -1.352 . . . . 72.13 107.35 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.33 131.6 48.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.846 0.458 . . . . 75.33 109.886 -173.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.3 135.41 54.73 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.968 1.307 . . . . 72.54 107.895 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -109.97 145.87 36.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.385 0.674 . . . . 72.53 110.195 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.83 148.3 25.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 54.32 109.282 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.2 m -144.69 167.89 21.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.365 0.666 . . . . 73.55 110.784 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -157.63 154.17 27.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.161 0.985 . . . . 71.05 109.599 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -102.85 130.5 49.89 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.974 -0.75 . . . . 74.43 108.974 171.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 67.2 mt -97.74 -38.05 9.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.194 0.597 . . . . 64.42 110.459 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.7 -171.95 2.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.437 0.695 . . . . 73.52 110.808 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.7 114.48 4.47 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.631 -1.168 . . . . 71.42 110.123 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 72.08 -3.81 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.691 1.597 . . . . 60.21 112.589 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.08 110.74 31.22 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 N-CA-C 107.859 -1.163 . . . . 71.12 107.859 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -122.11 173.24 7.69 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.038 -0.727 . . . . 74.25 109.038 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -142.87 109.98 5.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.022 -1.103 . . . . 71.43 108.022 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -101.65 134.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.331 1.052 . . . . 70.31 109.965 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.532 1.133 . . . . 73.31 109.059 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.44 112.32 17.39 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.931 -0.766 . . . . 53.33 108.931 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.76 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 28.0 ttm180 -89.92 124.93 35.14 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.607 0.763 . . . . 72.53 109.62 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -111.61 126.56 69.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.76 -1.2 . . . . 44.13 107.76 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.4 m -121.11 122.1 39.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.775 0.798 . . . . 62.13 109.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.662 HG11 HD21 ' B' ' 126' ' ' LEU . 87.8 t -102.05 95.99 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.29 1.436 . . . . 63.3 108.331 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 24.7 m -85.48 137.06 33.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.749 -0.834 . . . . 75.53 108.749 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.99 127.3 13.04 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.652 -0.499 . . . . 55.41 109.652 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 64.3 p -145.89 144.72 30.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.203 0.601 . . . . 63.24 110.809 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -133.54 102.31 5.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 50.11 109.406 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.73 -132.97 11.43 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.949 -0.569 . . . . 20.12 112.594 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.81 8.77 24.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.172 0.589 . . . . 63.14 110.744 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.19 154.68 49.13 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.522 0.729 . . . . 71.35 110.675 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . 0.434 HG21 ' HG ' ' B' ' 75' ' ' LEU . 66.4 m -83.79 138.67 33.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.301 0.64 . . . . 62.23 110.273 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -76.61 -60.24 2.43 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.894 0.878 . . . . 64.32 108.974 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -165.69 153.01 10.36 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 113.656 -1.611 . . . . 71.03 109.054 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.434 ' HG ' HG21 ' B' ' 72' ' ' THR . 94.8 mt -124.1 112.78 17.52 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.562 -1.273 . . . . 70.21 107.562 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.8 t -115.98 143.43 45.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.776 -1.194 . . . . 61.21 107.776 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.4 tt0 -157.26 124.2 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 -173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.78 142.02 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.215 0.606 . . . . 74.44 109.574 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 42.1 mt-30 -108.1 114.58 28.58 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.739 -1.208 . . . . 74.43 107.739 166.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.4 tp-100 -103.11 110.86 22.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.297 -1.001 . . . . 70.14 108.297 172.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.96 166.9 19.32 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.682 0.613 . . . . 65.22 111.719 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.84 127.56 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.446 -0.661 . . . . 63.31 111.446 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.17 125.05 40.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.605 0.762 . . . . 71.1 109.066 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.69 132.56 42.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.227 1.011 . . . . 74.33 108.959 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 49.6 m -96.59 97.98 9.83 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.732 0.813 . . . . 62.31 108.908 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.06 132.9 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.398 0.679 . . . . 52.34 110.09 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.24 172.86 16.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.004 0.922 . . . . 63.12 110.605 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -62.46 1.04 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.045 -0.525 . . . . 52.23 112.346 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.439 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -90.48 170.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.915 0.886 . . . . 74.34 111.126 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.58 171.91 16.36 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.19 0.596 . . . . 72.54 111.089 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.28 42.91 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.121 -0.945 . . . . 43.42 113.286 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -70.73 -28.06 64.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.139 0.976 . . . . 71.42 111.689 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.82 -37.93 89.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.221 0.608 . . . . 54.33 109.822 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.504 ' HG2' HD23 ' B' ' 98' ' ' LEU . 22.9 ttt -80.32 -33.99 37.09 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 73.43 110.133 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -28.07 69.51 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.922 0.889 . . . . 62.53 111.814 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -62.0 -43.31 99.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.602 0.761 . . . . 65.22 110.247 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -70.72 -64.04 0.98 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.577 -0.738 . . . . 72.03 110.81 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.504 HD23 ' HG2' ' B' ' 94' ' ' MET . 4.5 pp -71.04 -30.84 67.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.569 0.747 . . . . 72.43 112.496 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -33.67 11.13 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.575 0.547 . . . . 74.41 113.264 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.88 -67.17 1.02 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.887 0.475 . . . . 61.43 111.33 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -60.18 -46.76 88.61 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.586 0.754 . . . . 71.42 112.898 -172.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.504 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.7 m -63.86 -51.41 64.63 Favored Pre-proline 0 CA--C 1.569 1.678 0 C-N-CA 123.932 0.893 . . . . 75.15 112.292 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.3 Cg_exo -58.94 -30.12 92.33 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.659 2.239 . . . . 53.12 113.733 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -27.98 62.78 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.301 0.64 . . . . 62.03 111.437 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.48 -40.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.543 0.737 . . . . 73.1 109.902 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' B' ' 80' ' ' GLN . 86.4 mt -75.39 -29.34 59.81 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.943 -1.026 . . . . 73.22 111.709 -173.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -55.52 -47.55 98.39 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-O 117.66 -1.162 . . . . 71.23 113.782 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.58 -43.36 33.74 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.131 2.554 . . . . 74.44 114.622 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE2' HG21 ' D' ' 115' ' ' THR . 81.4 m-85 -70.6 -42.58 70.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.382 0.673 . . . . 72.2 110.325 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -65.54 -32.17 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.702 -0.681 . . . . 53.01 110.888 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.76 -58.09 10.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.292 1.037 . . . . 71.12 110.482 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.533 0.52 . . . . 75.21 109.878 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' B' ' 21' ' ' ILE . 0.0 OUTLIER -67.4 -40.13 85.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.232 0.613 . . . . 74.52 110.776 177.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.457 HG21 HG21 ' B' ' 64' ' ' VAL . 78.5 mt -67.37 -54.3 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 75.24 109.868 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -60.15 -33.0 71.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.222 1.009 . . . . 62.32 111.55 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -60.69 -49.79 76.11 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.47 0.708 . . . . 64.12 110.124 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.7 mmt -71.26 -34.89 71.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.57 0.748 . . . . 75.25 111.584 -172.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.503 HG21 HD23 ' B' ' 126' ' ' LEU . 97.0 t -66.33 -40.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 75.33 110.153 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.6 t -68.67 -28.13 66.6 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.288 -0.869 . . . . 74.31 111.024 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.488 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 88.9 mtt-85 -72.64 -25.11 61.17 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.187 0.595 . . . . 65.33 110.753 176.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.23 13.8 43.2 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 123.346 0.404 . . . . 50.34 112.557 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 61.45 31.48 19.05 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 126.903 2.081 . . . . 74.22 112.227 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -95.79 148.36 34.44 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 115.575 -0.739 . . . . 75.23 110.175 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -63.76 -171.23 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.597 2.865 . . . . 64.33 114.252 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.501 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 17.7 tp60 -59.13 113.44 2.12 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.385 -1.279 . . . . 72.23 112.011 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.662 HD21 HG11 ' B' ' 64' ' ' VAL . 66.5 tp -111.09 100.58 9.23 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.614 -0.884 . . . . 63.2 108.614 171.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.21 123.26 41.82 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.95 0.9 . . . . 62.34 109.875 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.658 HD11 HD21 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -87.28 144.33 26.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.789 0.836 . . . . 73.43 109.011 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . 0.428 ' N ' HD13 ' B' ' 128' ' ' LEU . . . -64.61 143.36 98.63 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.34 1.056 . . . . 43.04 111.568 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 5.8 Cg_exo -75.05 90.53 1.08 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.797 2.331 . . . . 70.11 111.311 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 37.7 t -91.33 111.33 23.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.983 -0.747 . . . . 42.11 108.983 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -93.01 91.97 7.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.568 -0.901 . . . . 73.12 108.568 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 . . . . . 0 N--CA 1.483 1.203 0 C-N-CA 123.764 0.826 . . . . 74.13 111.319 -179.771 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.3 ttm . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 121.461 0.648 . . . . 72.43 112.492 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 63.6 m -103.76 92.8 4.58 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.826 -1.175 . . . . 74.21 107.826 166.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.478 ' CE1' ' SG ' ' C' ' 102' ' ' CYS . 87.8 t80 -112.43 132.66 54.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.248 -1.019 . . . . 74.21 108.248 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 50.1 tp60 -147.35 144.59 28.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.034 0.445 . . . . 75.02 111.209 177.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.472 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.3 pp -93.7 139.76 17.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.09 -0.959 . . . . 70.15 108.451 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -110.55 -51.09 2.9 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.863 -0.421 . . . . 63.03 109.863 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -166.79 128.86 1.75 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.777 -0.647 . . . . 71.12 110.312 -170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.55 143.05 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 106.838 -1.541 . . . . 73.25 106.838 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.493 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.2 p90 -174.34 158.67 2.95 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.575 0.625 . . . . 72.44 111.291 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -81.29 119.26 23.43 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.09 -0.708 . . . . 71.32 109.09 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.7 mmmm -73.39 -42.0 62.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 169.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 32.3 t70 -143.95 142.33 30.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.777 -1.101 . . . . 61.13 110.526 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -139.74 143.65 30.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.521 1.528 . . . . 74.02 107.2 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 30.8 t -158.76 151.38 21.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.275 0.559 . . . . 72.11 110.283 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -150.41 125.66 10.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.767 -1.198 . . . . 72.43 107.767 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.26 140.53 49.67 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.291 0.636 . . . . 52.01 110.215 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.59 77.65 22.61 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.787 -1.56 . . . . 75.33 106.787 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.94 -32.78 65.3 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.064 2.51 . . . . 65.44 112.467 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' C' ' 30' ' ' HIS . 9.2 p30 -112.22 45.49 1.27 Allowed 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.815 0.846 . . . . 44.44 109.677 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.574 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -53.31 -41.34 85.94 Favored Pre-proline 0 CA--C 1.577 1.995 0 N-CA-C 114.697 1.369 . . . . 65.34 114.697 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.7 -37.9 1.1 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 121.744 1.63 . . . . 64.24 112.97 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.714 ' HB3' ' HB2' ' C' ' 27' ' ' ASN . 75.5 t60 -69.19 -21.9 63.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.317 1.047 . . . . 65.12 112.338 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.69 -13.84 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.667 0.787 . . . . 74.43 112.566 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.55 -15.45 60.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.563 -0.71 . . . . 71.15 112.301 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -109.1 21.67 16.88 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.578 0.751 . . . . 71.33 110.355 172.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.548 ' HZ3' ' HB2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -82.69 136.96 34.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.223 1.009 . . . . 71.32 109.028 175.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.17 123.56 19.41 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.058 -0.719 . . . . 60.21 109.058 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.7 m95 -85.16 58.94 5.32 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.55 0.34 . . . . 71.23 111.04 -173.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -156.51 53.91 0.81 Allowed Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 124.367 1.067 . . . . 71.13 109.448 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.08 153.3 36.68 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.927 1.751 . . . . 70.24 112.208 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -84.29 115.59 22.56 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.362 -1.347 . . . . 75.53 107.362 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.24 133.82 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.505 -0.554 . . . . 64.01 109.505 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -123.57 112.13 17.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.205 1.002 . . . . 74.01 108.416 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.432 HD21 HD22 ' C' ' 128' ' ' LEU . 8.4 mp -86.06 133.93 33.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.241 -1.392 . . . . 75.44 107.241 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.447 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.5 t70 -117.36 103.11 9.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.176 -1.416 . . . . 62.1 107.176 172.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.34 112.63 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.876 -1.528 . . . . 73.13 106.876 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.3 t70 -127.8 135.1 49.63 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.157 -0.683 . . . . 51.44 109.157 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -114.94 123.62 49.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.84 0.856 . . . . 74.42 109.952 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.11 34.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.32 0.648 . . . . 71.25 110.168 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.9 p -163.38 152.4 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.185 0.594 . . . . 53.11 110.438 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.2 p -151.25 159.35 44.41 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.81 0.844 . . . . 74.52 109.406 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -75.21 120.61 20.94 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.612 -0.722 . . . . 74.31 110.479 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' C' ' 57' ' ' GLU . 83.3 mt -84.95 -46.32 11.36 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.87 -0.789 . . . . 62.22 108.87 169.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.33 178.27 9.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.532 -1.213 . . . . 72.33 108.88 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -66.05 122.37 17.26 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.34 -0.391 . . . . 73.3 110.052 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 74.55 -5.6 2.08 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.813 1.645 . . . . 64.34 112.599 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -104.9 116.62 49.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 124.035 0.934 . . . . 64.41 109.475 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 135.58 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.411 -0.959 . . . . 73.22 108.411 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.2 tt0 -87.52 120.24 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.799 -0.815 . . . . 53.41 108.799 173.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.31 111.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.399 -0.963 . . . . 74.11 108.399 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.8 t -106.57 127.26 62.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.838 -1.171 . . . . 70.14 107.838 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -130.4 105.48 7.9 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.758 -1.201 . . . . 72.23 107.758 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 24.0 ttm180 -82.65 125.12 30.84 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.855 -0.611 . . . . 71.45 109.614 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -116.71 106.97 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.791 -1.559 . . . . 71.11 106.791 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.4 m -116.29 114.05 23.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.521 0.677 . . . . 64.23 109.618 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.93 111.36 35.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 114.619 -1.173 . . . . 65.12 108.486 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 13.8 m -111.33 125.86 54.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.471 0.708 . . . . 71.02 110.238 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.86 116.83 31.92 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.338 -1.356 . . . . 60.43 107.338 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.5 m -148.39 152.65 37.36 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.827 0.451 . . . . 64.41 110.78 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.497 HD23 ' HD2' ' C' ' 34' ' ' LYS . 4.1 mm? -95.37 26.98 3.53 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.63 1.172 . . . . 73.02 110.203 172.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.85 -104.95 0.95 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.36 -25.47 21.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.359 0.664 . . . . 72.51 110.261 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.54 113.62 21.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.056 0.942 . . . . 65.13 109.679 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.3 m -88.88 129.65 35.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.944 0.497 . . . . 51.24 111.525 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 -57.83 4.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.961 . . . . 44.14 109.728 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.73 155.04 29.21 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.503 -0.771 . . . . 72.02 109.941 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.455 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -117.02 145.28 43.78 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.367 -1.345 . . . . 73.43 107.367 171.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.455 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.9 t -150.07 131.86 15.05 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 173.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -139.79 132.88 29.6 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.526 0.73 . . . . 74.12 110.24 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.62 138.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.867 0.867 . . . . 71.42 109.07 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -113.21 96.65 6.03 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.983 -1.488 . . . . 72.14 106.983 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.7 tp-100 -83.52 107.36 15.94 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.044 -0.526 . . . . 71.0 109.631 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 145.94 18.27 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.788 -0.642 . . . . 71.13 111.68 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.76 117.44 0.91 Allowed Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.518 -1.033 . . . . 23.2 110.518 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.403 HD12 HD11 ' C' ' 51' ' ' LEU . 15.9 mm -81.56 119.73 31.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.627 -0.879 . . . . 71.11 108.627 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.472 ' HE2' HG22 ' C' ' 13' ' ' ILE . 97.3 m-85 -132.52 145.29 51.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.837 0.855 . . . . 63.11 109.552 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 65.9 m -110.69 112.43 24.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.781 0.833 . . . . 41.15 109.287 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.513 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.5 mp -116.11 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.895 -1.15 . . . . 72.12 107.895 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.41 162.75 34.95 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.357 1.063 . . . . 65.51 109.843 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.08 -58.51 4.25 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.944 -0.571 . . . . 53.43 112.258 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.51 168.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.622 0.769 . . . . 54.41 111.536 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.28 -177.22 5.88 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.867 1.267 . . . . 64.42 109.012 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.79 -124.45 36.16 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.772 0.67 . . . . 73.33 113.683 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 49.0 p -70.22 -36.57 74.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.491 1.116 . . . . 73.41 111.953 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -66.16 -36.23 82.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.097 0.559 . . . . 72.13 110.858 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.513 ' HG2' HG21 ' C' ' 86' ' ' ILE . 0.1 OUTLIER -83.14 -33.83 26.18 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.426 0.69 . . . . 75.43 109.971 178.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.41 -44.46 95.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.075 0.95 . . . . 72.1 111.263 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -76.8 -26.44 54.42 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.642 -0.708 . . . . 71.22 111.079 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' C' ' 101' ' ' TYR . 47.2 t -73.86 -61.84 1.7 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.739 0.416 . . . . 71.1 110.491 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.66 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 8.4 tt -79.89 -25.5 40.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.404 0.282 . . . . 55.22 110.791 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.75 -7.16 78.86 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 115.083 0.793 . . . . 51.32 115.083 -174.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -55.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.491 0.646 . . . . 75.12 111.369 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.468 ' O ' HG12 ' C' ' 105' ' ' ILE . 82.8 t80 -65.89 -39.11 90.35 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.998 0.919 . . . . 72.32 111.734 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.66 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 38.3 m -76.37 -47.19 3.39 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.474 -0.774 . . . . 61.44 112.288 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.7 Cg_exo -53.14 -40.36 77.27 Favored 'Trans proline' 0 C--N 1.399 3.206 0 C-N-CA 122.761 2.307 . . . . 54.21 112.891 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.27 -29.34 67.5 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.692 0.797 . . . . 71.23 112.52 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.484 HG23 ' NH1' ' A' ' 111' ' ' ARG . 29.4 mm -75.6 -43.66 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.096 0.558 . . . . 75.25 110.943 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 pp -93.29 -11.07 33.35 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 112.738 0.644 . . . . 73.42 112.738 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -57.44 -49.47 93.66 Favored Pre-proline 0 N--CA 1.491 1.604 0 CA-C-O 117.968 -1.015 . . . . 75.41 112.776 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.99 -31.29 89.5 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 121.94 1.76 . . . . 71.11 112.755 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.584 ' HE2' HG21 ' A' ' 115' ' ' THR . 92.8 m-85 -68.37 -48.5 64.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.951 0.9 . . . . 64.34 111.147 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -58.72 -41.22 85.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 61.41 110.539 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -69.57 -47.73 62.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.954 -1.476 . . . . 74.33 111.252 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.06 -31.92 72.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.161 0.584 . . . . 64.43 109.95 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.417 ' O ' ' SD ' ' C' ' 117' ' ' MET . 43.0 t -63.99 -40.96 97.54 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.551 0.532 . . . . 73.34 110.589 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.419 ' O ' HG23 ' C' ' 118' ' ' VAL . 86.6 mt -68.02 -41.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.329 0.651 . . . . 75.44 110.823 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.469 HG23 ' HB3' ' C' ' 125' ' ' GLN . 30.8 m -62.98 -30.16 71.37 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.432 0.693 . . . . 54.33 110.684 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -74.16 -46.23 43.59 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.922 0.889 . . . . 73.1 109.973 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.469 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.69 -42.71 84.21 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.923 0.889 . . . . 60.33 111.642 177.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.9 t -70.91 -33.99 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.86 0.864 . . . . 74.35 110.185 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.501 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 38.5 t -65.59 -33.02 74.94 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.389 0.676 . . . . 53.21 111.464 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.539 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 73.4 mtt-85 -81.66 -31.89 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.07 0.948 . . . . 73.55 110.618 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 -1.56 86.45 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.791 -0.641 . . . . 73.2 112.29 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 49.6 p 61.88 31.72 18.16 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 126.075 1.75 . . . . 64.55 112.262 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.0 150.06 37.88 Favored Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 114.495 -1.23 . . . . 71.14 109.385 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -40.3 109.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 124.365 3.377 . . . . 71.35 113.908 170.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.469 ' HB3' HG23 ' C' ' 115' ' ' THR . 50.6 mt-30 -60.54 142.54 55.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.755 1.222 . . . . 63.43 111.99 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp -121.2 106.5 11.57 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.306 0.642 . . . . 60.14 109.553 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.34 108.44 20.48 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.458 -1.312 . . . . 71.22 107.458 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.432 HD22 HD21 ' C' ' 42' ' ' LEU . 85.2 mt -63.24 144.69 56.71 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.687 0.795 . . . . 73.25 111.868 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.54 159.57 77.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.838 1.255 . . . . 74.31 111.475 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.418 ' HG2' HG21 ' A' ' 13' ' ' ILE . 22.4 Cg_exo -63.8 104.22 0.45 Allowed 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.528 2.152 . . . . 74.23 111.76 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.97 109.35 23.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.445 -0.946 . . . . 72.15 108.445 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -104.04 88.62 3.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.818 -1.083 . . . . 75.21 109.576 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.62 -37.98 83.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.099 -0.955 . . . . 72.53 108.763 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 . . . . . 0 CA--C 1.541 0.623 0 CA-C-N 114.895 -1.048 . . . . 65.25 111.83 -178.471 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m . . . . . 0 C--O 1.243 0.736 0 N-CA-C 108.83 -0.804 . . . . 50.22 108.83 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -174.07 97.1 0.1 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.848 -1.538 . . . . 73.44 106.848 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -133.13 119.81 20.43 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.198 -0.91 . . . . 64.25 108.658 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mt -70.55 107.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 114.711 -1.132 . . . . 71.0 109.482 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.87 -37.64 62.12 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.203 -0.295 . . . . 75.22 110.203 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 7.7 ttt85 -170.5 143.89 2.33 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.963 0.79 . . . . 73.54 109.95 -177.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.622 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.1 OUTLIER -120.29 108.36 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.468 1.107 . . . . 72.4 108.205 175.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -138.25 158.69 43.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.447 1.118 . . . . 63.14 111.195 -170.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -92.56 110.31 21.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.768 -1.56 . . . . 74.51 108.873 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.574 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 41.3 mtpt -74.05 -31.69 62.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.149 0.5 . . . . 73.14 110.124 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -150.61 141.66 23.03 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.781 -1.1 . . . . 63.53 109.367 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.469 HD13 ' HE3' ' C' ' 117' ' ' MET . 28.8 mt -136.55 141.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.825 1.25 . . . . 74.32 107.802 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.2 t -146.55 137.5 24.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.988 0.915 . . . . 72.12 109.656 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -149.32 121.06 8.09 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 106.127 -1.805 . . . . 64.43 106.127 167.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -131.1 124.78 31.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -127.48 82.45 68.23 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.106 -1.072 . . . . 73.13 108.106 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.58 -34.34 5.76 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.866 2.377 . . . . 73.55 112.327 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 64.7 m-20 -106.98 23.55 14.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.403 1.081 . . . . 75.14 109.573 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.589 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -45.57 -59.77 4.14 Favored Pre-proline 0 CA--C 1.571 1.751 0 C-N-CA 125.194 1.398 . . . . 73.43 114.492 -168.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.19 -16.73 15.45 Favored 'Trans proline' 0 C--N 1.392 2.86 0 CA-C-N 121.886 1.709 . . . . 63.44 113.133 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.478 ' HA ' HE21 ' D' ' 33' ' ' GLN . 12.4 t-160 -68.52 -43.55 76.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.082 0.953 . . . . 73.11 109.972 174.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' D' ' 73' ' ' ALA . 99.0 t -65.62 -34.82 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.857 0.863 . . . . 73.22 110.533 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.28 -7.98 46.67 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.871 1.063 . . . . 70.31 113.871 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' D' ' 30' ' ' HIS . 38.6 mt-30 -84.81 -29.33 25.46 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.102 0.561 . . . . 73.14 111.274 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -109.9 114.26 27.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.76 1.224 . . . . 62.24 108.7 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -91.11 95.09 9.9 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.312 0.577 . . . . 73.41 112.081 -177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.406 ' HE3' ' H ' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -146.86 171.29 15.43 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.639 0.776 . . . . 72.52 112.333 175.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -84.22 134.34 43.46 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.094 1.358 . . . . 64.43 111.388 -169.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' D' ' 68' ' ' LEU . 16.6 Cg_exo -68.23 117.55 5.02 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.13 114.301 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.91 114.37 10.98 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.19 -1.411 . . . . 52.44 107.19 163.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.85 123.24 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.65 0.738 . . . . 50.5 110.216 -170.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.625 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 51.7 tttp -93.44 125.59 38.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.841 1.256 . . . . 70.12 109.132 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tt -97.66 114.62 26.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.662 -1.607 . . . . 72.45 106.662 173.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 15.8 t70 -127.89 129.85 47.55 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.665 -0.865 . . . . 65.31 108.665 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 64.0 tp -122.71 135.61 54.63 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.558 0.743 . . . . 72.04 110.118 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -134.51 148.88 50.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.682 1.193 . . . . 75.54 108.165 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -124.08 149.07 46.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.295 0.638 . . . . 55.44 110.674 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.651 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.39 152.09 35.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.971 0.908 . . . . 64.24 109.266 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 16.6 p -174.8 154.17 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.319 0.648 . . . . 72.14 111.373 -176.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 55.2 p -171.46 158.57 5.26 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.369 1.068 . . . . 41.32 109.81 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -87.5 125.61 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.397 -0.594 . . . . 64.3 109.397 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.4 mt -91.36 -42.23 10.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.363 0.665 . . . . 44.23 110.456 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.15 -172.36 4.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.431 -0.804 . . . . 64.11 110.31 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.73 118.2 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.022 -0.99 . . . . 72.11 109.895 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 66.65 0.81 1.96 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.772 1.629 . . . . 73.23 112.661 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -108.49 124.82 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.048 0.539 . . . . 75.21 109.988 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -127.15 159.88 32.93 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.317 1.047 . . . . 75.24 109.403 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' D' ' 51' ' ' LEU . 39.6 tt0 -118.27 137.29 53.15 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.889 0.876 . . . . 72.43 108.715 174.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.471 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 69.3 t -121.11 121.43 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.509 -1.293 . . . . 71.24 107.509 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.651 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 31.2 t -117.89 129.77 73.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.965 -0.754 . . . . 74.1 108.965 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.33 110.93 20.11 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.636 -0.875 . . . . 72.24 108.636 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 13.7 ttm180 -84.16 99.71 10.69 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.717 -0.846 . . . . 74.24 108.717 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.27 122.38 45.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.116 -0.947 . . . . 73.31 108.487 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.1 m -129.28 130.29 46.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.367 -0.833 . . . . 75.14 109.908 -171.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 82.2 t -124.01 126.43 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.665 1.586 . . . . 72.42 108.146 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 89.2 m -126.42 110.63 13.54 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.76 -0.459 . . . . 61.31 109.76 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.84 124.19 49.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.068 0.547 . . . . 64.35 109.948 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' D' ' 72' ' ' THR . 58.8 m -135.91 119.61 17.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.571 -1.27 . . . . 53.52 107.571 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' D' ' 73' ' ' ALA . 6.8 mp -123.35 133.78 54.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.838 0.855 . . . . 74.21 109.734 -170.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.6 -116.87 5.9 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -112.26 3.76 17.32 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.201 0.6 . . . . 64.3 110.52 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . 0.502 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 9.7 pm0 -127.54 164.57 21.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.681 0.792 . . . . 62.53 110.814 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' D' ' 67' ' ' SER . 53.4 m -86.46 129.98 34.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.147 0.579 . . . . 73.31 110.278 169.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.737 ' HB2' HD13 ' D' ' 68' ' ' LEU . . . -72.39 -68.61 0.46 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.325 0.65 . . . . 64.54 109.47 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.8 152.03 31.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.906 -1.043 . . . . 72.1 111.947 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -119.63 116.64 26.43 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.572 1.549 . . . . 71.54 107.574 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.601 ' SG ' HG23 ' D' ' 114' ' ' ILE . 17.1 t -127.83 134.94 49.45 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.784 -0.451 . . . . 72.21 109.784 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.7 133.71 13.22 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.189 0.596 . . . . 75.4 109.941 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.63 119.78 22.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.656 0.782 . . . . 74.05 109.324 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.506 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 64.6 mt-30 -90.53 88.52 7.18 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 174.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -79.33 97.95 6.51 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.451 -0.795 . . . . 75.13 109.118 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 143.88 16.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.183 -0.767 . . . . 53.45 111.183 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.79 130.96 3.8 Favored Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.224 -1.15 . . . . 70.31 110.224 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.3 mt -90.02 131.82 36.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.94 -0.763 . . . . 74.05 108.94 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.471 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 30.0 m-85 -134.02 125.31 27.85 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.889 -0.782 . . . . 74.41 108.889 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -76.14 103.42 6.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.878 -1.156 . . . . 62.54 107.878 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.533 HG23 HD11 ' D' ' 89' ' ' ILE . 75.0 mt -107.8 132.18 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.358 1.063 . . . . 64.44 109.475 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.66 164.86 19.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.431 0.692 . . . . 62.45 110.948 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.81 47.75 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 115.262 0.865 . . . . 73.14 115.262 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.533 HD11 HG23 ' D' ' 86' ' ' ILE . 15.9 pt -123.97 128.43 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.628 1.171 . . . . 73.42 108.036 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -137.29 159.7 41.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.115 0.566 . . . . 73.1 111.352 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -123.42 31.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 115.46 -0.791 . . . . 73.05 113.201 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -69.19 -25.74 64.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 74.21 111.685 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -72.9 -39.74 66.1 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.385 0.674 . . . . 75.2 110.133 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -31.83 56.18 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.528 -0.545 . . . . 73.43 109.528 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.44 90.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.901 0.88 . . . . 71.5 111.89 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.47 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 17.6 t-80 -61.53 -48.13 82.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.582 -0.736 . . . . 74.02 110.34 172.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.17 -29.36 62.79 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.927 -0.579 . . . . 72.31 112.128 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 29.7 tp -95.52 -51.21 4.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.217 1.007 . . . . 71.34 110.834 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.77 5.18 66.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.702 -0.681 . . . . 44.53 114.057 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -136.86 -55.96 0.73 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.064 0.432 . . . . 74.22 110.696 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -75.61 -41.24 54.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.809 0.67 . . . . 73.3 112.809 -173.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.24 -46.98 90.85 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.834 -0.603 . . . . 51.14 111.026 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.63 -40.0 87.85 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 122.299 1.999 . . . . 72.44 113.061 165.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -60.98 -28.08 68.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.406 0.682 . . . . 74.11 111.4 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -79.42 -50.54 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.842 0.857 . . . . 74.25 110.921 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.11 -28.63 32.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.057 0.762 . . . . 71.33 113.057 -167.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -65.83 -42.57 54.48 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.21 1.004 . . . . 61.32 112.873 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.19 -37.41 94.26 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 121.922 1.748 . . . . 73.12 113.087 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -77.2 -31.04 55.03 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 64.34 111.887 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.55 -51.91 63.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.299 0.64 . . . . 71.44 109.67 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.502 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.3 ttp180 -55.83 -54.32 45.96 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.074 -1.421 . . . . 74.25 110.396 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.8 -39.22 84.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 75.31 111.58 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -62.21 -47.54 83.99 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.029 0.532 . . . . 64.22 111.02 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.601 HG23 ' SG ' ' D' ' 76' ' ' CYS . 85.5 mt -60.11 -51.73 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.099 0.96 . . . . 73.24 110.225 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.505 HG21 ' HE2' ' B' ' 109' ' ' TYR . 87.0 m -54.71 -43.66 72.78 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.881 1.672 . . . . 64.42 112.452 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.1 t -66.65 -38.49 86.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.486 0.714 . . . . 71.54 110.718 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.1 mtm -72.1 -29.78 64.44 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.771 0.428 . . . . 64.02 111.842 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -64.49 -44.32 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.376 0.67 . . . . 71.33 109.73 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.1 p -72.27 -29.95 64.37 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.07 0.548 . . . . 74.32 111.417 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -69.69 -32.39 70.96 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.583 0.753 . . . . 64.24 110.574 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.76 81.44 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 115.908 -0.587 . . . . 43.43 112.818 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 60.09 21.38 10.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 126.819 2.048 . . . . 65.42 113.311 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -86.74 163.06 42.73 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.957 1.303 . . . . 75.11 109.627 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.71 133.69 20.73 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.114 1.876 . . . . 75.04 110.68 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.8 135.51 56.82 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.752 0.658 . . . . 72.11 111.455 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.65 107.75 18.86 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.134 -1.432 . . . . 55.23 107.134 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 75.8 m-20 -97.81 93.27 6.27 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.069 -1.456 . . . . 74.23 107.069 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -74.18 120.08 19.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.24 -0.891 . . . . 62.4 109.507 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.65 123.22 78.45 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.618 0.767 . . . . 73.53 111.781 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.502 ' HB3' HH12 ' D' ' 111' ' ' ARG . 18.7 Cg_endo -86.86 115.31 1.21 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.082 2.521 . . . . 64.25 111.58 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.8 110.13 30.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.668 -1.234 . . . . 73.52 107.668 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -79.03 87.99 4.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.021 0.528 . . . . 74.05 110.208 -176.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 . . . . . 0 N--CA 1.476 0.827 0 CA-C-N 115.658 -0.701 . . . . 73.22 111.06 174.063 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.3 m . . . . . 0 C--O 1.237 0.402 0 N-CA-C 107.731 -1.211 . . . . 75.04 107.731 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.738 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.4 t80 -135.63 132.82 37.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.725 0.41 . . . . 73.33 110.028 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 53.6 tp60 -152.9 114.31 4.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.824 . . . . 73.52 108.794 172.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.639 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -83.13 119.79 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.797 -0.446 . . . . 74.32 109.797 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -87.19 -31.05 20.55 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.463 0.705 . . . . 74.0 109.651 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -163.43 142.17 8.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.757 -0.201 . . . . 53.33 110.999 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -130.94 140.27 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 124.553 1.141 . . . . 53.21 108.166 170.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 40.3 p90 -172.76 167.95 5.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.662 0.744 . . . . 72.14 111.023 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -95.88 119.04 33.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.961 -1.018 . . . . 75.45 108.729 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 29.7 mtpt -81.87 -23.46 36.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.111 0.481 . . . . 63.12 110.464 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.2 t70 -154.58 144.15 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.97 -1.014 . . . . 72.45 110.026 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.7 mt -137.26 144.36 32.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.887 1.675 . . . . 72.25 106.987 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -153.71 125.99 7.99 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.258 0.551 . . . . 63.11 110.033 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 90.1 t80 -124.1 120.85 33.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.939 -1.874 . . . . 74.2 105.939 168.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 35.4 mt-10 -126.95 108.41 10.94 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.715 0.689 . . . . 74.41 110.702 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -112.18 79.02 2.64 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 106.424 -1.695 . . . . 55.03 106.424 168.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.4 -46.12 3.1 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.388 2.058 . . . . 72.13 111.192 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.8 m-20 -100.81 28.38 5.24 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.914 -1.039 . . . . 74.02 108.874 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -41.47 -56.77 4.28 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.038 -0.982 . . . . 63.42 113.093 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HG2' ' HD2' ' A' ' 30' ' ' HIS . 36.3 Cg_endo -63.19 -30.32 74.49 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 121.794 1.663 . . . . 62.21 112.878 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.527 ' HD2' ' HG2' ' A' ' 29' ' ' PRO . 9.3 m-70 -79.53 -30.2 41.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.748 0.819 . . . . 74.11 111.279 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -82.25 -18.39 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.55 0.34 . . . . 54.2 110.939 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -75.96 -31.07 58.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.203 0.601 . . . . 73.11 110.498 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -82.19 -18.96 40.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.768 0.427 . . . . 75.2 110.595 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -68.82 142.09 54.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.873 0.469 . . . . 71.41 110.166 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.47 139.46 58.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.156 0.582 . . . . 64.33 109.847 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -66.66 90.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.078 0.861 . . . . 71.41 109.889 -171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 94.1 mt-30 -133.81 63.11 61.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.365 1.066 . . . . 74.51 108.389 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -81.47 133.29 8.35 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.212 1.941 . . . . 43.31 112.063 -172.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.47 91.96 6.05 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.523 -1.288 . . . . 75.12 107.523 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.5 t -78.38 107.56 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -94.27 156.78 16.36 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.317 1.047 . . . . 72.33 109.69 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 128' ' ' LEU . 3.5 tt -137.82 109.01 6.81 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.363 -0.977 . . . . 74.54 108.363 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.4 m-20 -125.46 141.88 51.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.178 0.991 . . . . 73.22 109.252 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.24 126.67 37.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 63.34 109.245 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -118.82 129.08 55.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.675 1.19 . . . . 75.05 108.622 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.8 p -110.38 144.9 38.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.859 0.864 . . . . 70.35 110.339 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.22 131.78 12.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.166 0.586 . . . . 74.12 110.55 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -133.81 151.92 51.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.235 0.614 . . . . 70.41 109.994 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.3 t -154.71 162.19 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.652 0.781 . . . . 72.11 109.672 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -109.22 113.17 25.78 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.762 0.825 . . . . 72.01 108.784 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB2' HG12 ' A' ' 55' ' ' VAL . 65.5 mt -82.79 -33.63 27.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.259 0.624 . . . . 64.24 110.301 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -170.91 -174.42 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.337 1.055 . . . . 73.04 109.989 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.98 123.2 19.18 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.084 0.554 . . . . 65.45 109.738 173.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 67.52 -4.43 0.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.455 1.502 . . . . 74.22 112.943 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.3 t -112.1 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.241 -1.022 . . . . 63.53 108.241 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.82 167.14 16.2 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.103 0.961 . . . . 64.2 108.611 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -129.58 138.8 51.49 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.427 0.691 . . . . 74.51 109.326 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -126.66 129.07 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.415 -1.328 . . . . 73.34 107.415 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.65 131.6 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.118 0.967 . . . . 75.31 109.068 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.6 103.45 9.71 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.987 -1.116 . . . . 70.34 107.987 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.645 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 9.8 ttp180 -84.74 110.51 18.84 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.453 -0.573 . . . . 72.51 109.453 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 114' ' ' ILE . 12.4 t -92.92 128.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.394 -1.336 . . . . 72.23 107.394 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 16.8 m -123.9 126.83 47.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.471 -0.566 . . . . 61.35 109.471 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.762 HG11 HD21 ' A' ' 126' ' ' LEU . 47.2 t -125.0 131.72 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.767 1.227 . . . . 73.22 107.823 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.6 m -116.38 151.64 35.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.702 -0.851 . . . . 63.34 108.702 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.54 115.69 11.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.926 -1.509 . . . . 64.14 106.926 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.8 t -130.02 128.21 41.52 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.99 0.424 . . . . 55.2 110.228 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 73' ' ' ALA . 8.2 mp -90.3 85.74 6.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.687 1.195 . . . . 64.43 107.984 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.43 -98.28 2.08 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 114.822 -1.081 . . . . 65.45 110.534 -172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.68 -5.03 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.4 0.68 . . . . 74.41 110.01 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -85.83 100.8 12.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.005 -1.109 . . . . 73.31 108.005 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 59.8 m -71.21 129.66 39.46 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.269 0.556 . . . . 72.23 111.671 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.24 -59.74 2.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.06 -1.427 . . . . 74.22 109.897 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.594 ' HE2' HD22 ' A' ' 126' ' ' LEU . 43.1 p90 -159.57 136.9 9.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.322 -0.854 . . . . 72.11 111.4 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 tp -112.54 107.85 16.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.054 1.342 . . . . 74.52 107.495 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.614 ' HB3' HG23 ' A' ' 114' ' ' ILE . 72.6 m -107.93 106.05 16.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.809 0.844 . . . . 61.45 111.156 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 63' ' ' THR . 40.8 tt0 -127.64 125.04 39.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.928 1.291 . . . . 71.31 109.186 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.43 115.32 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.872 0.869 . . . . 52.12 109.752 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.645 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 73.4 mt-30 -83.36 89.33 7.01 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.378 -0.971 . . . . 63.52 108.378 168.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -83.12 106.4 14.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.444 -0.947 . . . . 73.4 108.444 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.2 -177.38 19.13 Favored Glycine 0 N--CA 1.465 0.614 0 O-C-N 123.528 0.518 . . . . 41.35 112.422 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.3 155.71 15.65 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 112.443 -0.263 . . . . 51.23 112.443 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -90.34 115.84 30.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.873 -0.788 . . . . 65.02 108.873 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.738 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -121.1 119.67 33.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.946 0.899 . . . . 75.42 109.564 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 t -83.33 97.94 9.19 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.685 -0.858 . . . . 64.45 108.685 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.6 pt -112.53 142.9 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.603 0.761 . . . . 71.05 110.386 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -154.81 164.33 38.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.098 0.959 . . . . 55.44 110.184 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.36 -5.89 83.33 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.86 -0.609 . . . . 71.22 113.925 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 94' ' ' MET . 18.8 pt -114.57 144.79 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.008 0.923 . . . . 75.13 111.118 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -163.18 172.18 15.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.754 0.822 . . . . 72.33 108.783 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.47 -124.6 11.9 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.692 0.637 . . . . 73.22 114.692 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -74.8 -23.62 58.52 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.867 0.867 . . . . 72.45 111.399 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -68.04 -36.98 80.81 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 63.15 109.411 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG3' HD12 ' A' ' 89' ' ' ILE . 24.8 ttt -81.55 -24.68 36.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.715 -0.675 . . . . 72.53 110.822 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.05 85.48 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.852 0.461 . . . . 72.32 111.115 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -68.25 -37.17 80.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.404 -0.816 . . . . 65.22 110.781 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.3 t -73.82 -42.33 61.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 53.4 111.647 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.38 -47.3 20.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.365 0.666 . . . . 62.14 110.264 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.4 -2.69 88.99 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 115.077 0.791 . . . . 55.04 115.077 -170.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.11 -56.75 0.23 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 117.91 0.855 . . . . 74.3 112.279 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.8 t80 -64.78 -47.76 76.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.731 1.213 . . . . 72.14 113.065 -168.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.32 -35.5 1.17 Allowed Pre-proline 0 CA--C 1.57 1.727 0 CA-C-O 118.851 -0.595 . . . . 62.43 112.502 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.85 -39.68 48.64 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.77 2.314 . . . . 60.41 113.295 161.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -61.1 -25.93 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.42 0.688 . . . . 64.14 111.419 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.451 HG21 ' CD1' ' A' ' 13' ' ' ILE . 36.1 mm -78.95 -55.42 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.695 0.798 . . . . 72.05 110.227 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.95 -24.46 33.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.75 1.018 . . . . 72.45 113.75 -165.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -64.13 -41.57 62.49 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.382 -0.818 . . . . 71.31 112.68 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.34 -43.17 61.15 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 122.095 1.863 . . . . 73.52 113.225 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -67.95 -38.62 83.03 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.441 0.696 . . . . 74.0 112.092 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 -45.96 76.3 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.684 -0.487 . . . . 61.1 109.684 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -53.71 -46.49 70.79 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.576 1.173 . . . . 75.34 110.755 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.23 -49.37 72.2 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.43 1.081 . . . . 73.42 111.148 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.7 t -58.22 -41.47 84.13 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.834 0.709 . . . . 70.25 110.735 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 76' ' ' CYS . 78.7 mt -64.94 -48.49 83.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 O-C-N 124.097 0.873 . . . . 52.51 109.958 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.648 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.0 m -51.76 -49.98 61.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.133 0.973 . . . . 74.21 111.768 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -64.02 -42.94 96.94 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.088 0.867 . . . . 64.32 110.409 -175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.432 ' SD ' HG23 ' A' ' 21' ' ' ILE . 5.7 mtp -56.38 -46.76 79.95 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.835 0.854 . . . . 72.02 111.442 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 126' ' ' LEU . 77.5 t -65.69 -44.2 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.195 0.998 . . . . 71.24 111.68 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.7 p -67.66 -31.35 71.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.981 0.513 . . . . 72.21 111.346 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 88.3 mtt-85 -68.02 -29.6 68.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.602 0.761 . . . . 54.21 110.858 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.47 3.04 80.2 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.177 -0.465 . . . . 54.2 113.547 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.423 ' HB ' HH21 ' B' ' 15' ' ' ARG . 6.8 m 63.74 35.75 11.09 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.808 1.243 . . . . 75.34 110.045 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -105.58 151.66 39.86 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 114.547 -1.206 . . . . 72.12 108.386 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.05 147.87 91.38 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.431 2.087 . . . . 70.35 111.94 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.648 ' HG3' HG23 ' A' ' 115' ' ' THR . 24.2 tt0 -52.9 128.67 27.83 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.772 0.829 . . . . 63.35 112.472 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.762 HD21 HG11 ' A' ' 64' ' ' VAL . 38.4 tp -108.48 118.44 36.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.256 0.623 . . . . 74.54 109.419 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -140.05 109.05 6.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.162 0.985 . . . . 62.35 108.939 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 42' ' ' LEU . 17.9 tp -67.48 135.74 53.54 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.198 0.599 . . . . 63.42 110.544 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -53.52 133.29 54.2 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.647 1.179 . . . . 63.41 112.293 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD3' HD12 ' C' ' 13' ' ' ILE . 6.0 Cg_exo -78.3 92.88 1.11 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.039 2.493 . . . . 75.01 110.864 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 66.9 t -100.54 126.85 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.222 -1.029 . . . . 65.33 108.222 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 40.9 t-20 -73.28 98.69 2.72 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.357 0.663 . . . . 71.4 110.143 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.08 -27.15 62.48 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.928 0.891 . . . . 75.31 110.756 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.456 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 7.1 t70 . . . . . 0 N--CA 1.477 0.886 0 C-N-CA 123.904 0.881 . . . . 74.31 110.587 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 94.0 m . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 107.334 -1.358 . . . . 73.51 107.334 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -116.59 114.71 24.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.0 -1.111 . . . . 72.52 108.0 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -134.75 141.0 46.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.235 0.614 . . . . 74.23 110.344 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -86.2 102.18 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.884 -1.053 . . . . 74.2 110.656 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -77.38 -32.02 54.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 122.019 -0.425 . . . . 62.14 110.055 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.423 HH21 ' HB ' ' A' ' 122' ' ' THR . 37.6 ttt180 -173.75 134.13 0.47 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.19 -0.67 . . . . 63.45 109.19 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.7 mt -113.8 134.62 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 106.915 -1.513 . . . . 74.14 106.915 171.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -166.17 151.24 8.29 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.679 0.752 . . . . 73.52 112.163 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.7 m -77.45 122.12 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.905 -1.043 . . . . 63.31 109.027 170.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.511 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 43.7 mtpt -89.71 -39.33 13.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.141 0.576 . . . . 60.41 111.105 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.3 t70 -150.09 136.04 18.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.57 -0.286 . . . . 74.21 110.632 -169.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.471 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.9 mm -128.59 139.13 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.477 1.111 . . . . 43.24 108.687 173.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -141.56 121.55 13.68 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.719 -1.215 . . . . 50.21 107.719 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.2 t80 -136.19 137.33 40.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.664 -0.865 . . . . 75.14 108.664 172.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.4 mt-10 -136.42 153.35 51.1 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.862 1.265 . . . . 74.03 108.833 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 82.49 7.15 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.833 -1.543 . . . . 74.55 106.833 172.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.62 -46.44 7.01 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.882 2.388 . . . . 73.1 111.712 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 53.8 m-20 -96.89 28.21 3.61 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.928 0.891 . . . . 75.23 109.641 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.582 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -46.86 -51.71 37.26 Favored Pre-proline 0 CA--C 1.568 1.655 0 N-CA-C 114.22 1.193 . . . . 53.21 114.22 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 9.3 Cg_endo -79.56 -24.21 6.49 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.715 1.61 . . . . 73.31 112.538 176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.463 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.4 m80 -97.09 2.18 50.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.225 1.01 . . . . 74.5 112.81 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.539 HG23 HD11 ' B' ' 68' ' ' LEU . 11.1 p -71.51 -19.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.053 0.941 . . . . 75.21 111.334 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -67.08 -23.12 65.82 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.516 1.127 . . . . 73.03 111.938 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.614 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 28.4 pt20 -69.91 -34.04 72.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.373 0.669 . . . . 71.13 110.44 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.635 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.9 mmtp -107.67 63.71 0.62 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.329 -0.989 . . . . 63.51 108.329 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.05 105.21 14.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.147 -0.686 . . . . 74.13 109.147 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.445 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 162.65 -165.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 127.39 2.276 . . . . 74.24 109.216 159.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.414 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 28.7 pt20 -61.08 127.35 87.74 Favored Pre-proline 0 C--N 1.363 1.159 0 O-C-N 123.248 0.342 . . . . 75.1 111.18 -171.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.11 160.86 15.55 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.542 2.161 . . . . 71.1 112.112 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.19 106.25 3.23 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.999 -1.112 . . . . 71.25 107.999 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.95 158.33 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.346 0.659 . . . . 73.23 111.705 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.0 tttm -143.64 108.84 5.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.377 1.071 . . . . 72.05 109.058 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 tt -86.59 135.47 33.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 106.772 -1.566 . . . . 73.3 106.772 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 16.9 t70 -144.51 147.45 33.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.944 -0.761 . . . . 74.23 108.944 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.4 140.01 53.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.294 -0.632 . . . . 51.23 109.294 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 8.7 t70 -123.49 140.95 52.48 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.403 1.081 . . . . 73.22 108.615 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.0 p -108.81 115.53 30.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.281 -0.872 . . . . 61.33 109.977 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -136.22 133.68 37.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.743 0.817 . . . . 72.3 108.892 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.5 p -144.7 167.68 21.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.326 0.65 . . . . 53.22 110.032 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -150.56 137.38 19.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.19 0.596 . . . . 75.11 110.089 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -90.81 94.73 9.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.455 0.702 . . . . 61.14 109.401 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' B' ' 57' ' ' GLU . 38.5 mt -69.87 -39.41 76.35 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.38 0.609 . . . . 71.05 110.102 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -157.44 -179.59 8.32 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.648 -1.16 . . . . 71.41 109.413 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -67.08 120.43 13.67 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.357 -0.609 . . . . 60.22 109.357 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 73.9 -4.79 2.18 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.375 1.47 . . . . 64.22 112.394 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 87.9 t -104.51 111.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 N-CA-C 108.05 -1.093 . . . . 72.03 108.05 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -126.51 137.6 53.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.602 . . . . 75.33 109.706 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' B' ' 51' ' ' LEU . 6.1 tm-20 -101.64 102.01 12.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.738 -1.579 . . . . 75.21 106.738 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.7 t -95.54 121.92 46.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.67 1.188 . . . . 74.11 110.219 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.1 t -104.95 120.79 56.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 124.731 1.213 . . . . 23.01 109.633 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' B' ' 103' ' ' PRO . 61.7 tp -104.39 104.66 14.57 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.811 -0.811 . . . . 70.24 108.811 172.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 38.5 ttm180 -88.67 114.09 24.92 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.356 -0.609 . . . . 73.22 109.356 173.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.4 t -106.43 112.03 37.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.084 -1.08 . . . . 62.43 108.084 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.9 m -98.2 138.36 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.992 0.917 . . . . 62.42 110.038 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.679 HG21 HG21 ' B' ' 114' ' ' ILE . 55.5 t -127.34 124.3 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.822 1.249 . . . . 55.44 108.355 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 85.0 m -119.18 145.61 45.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.008 -1.108 . . . . 74.33 108.008 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.1 131.72 17.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.673 -0.862 . . . . 73.54 108.673 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.6 p -152.98 126.91 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.088 0.555 . . . . 64.03 110.433 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.1 OUTLIER -104.65 123.75 48.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.816 0.847 . . . . 73.25 109.188 -176.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -111.49 3.26 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.14 -1.184 . . . . 60.05 110.14 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.46 6.25 6.93 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 72.25 109.798 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.525 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 10.8 pt-20 -113.52 143.4 44.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.531 . . . . 72.31 109.745 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 54.4 m -70.0 133.71 47.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.104 0.562 . . . . 71.21 111.932 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -88.55 -59.46 2.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.303 1.041 . . . . 72.12 109.426 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.02 150.4 9.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.896 -1.502 . . . . 75.21 109.242 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.32 123.66 39.89 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 124.819 1.248 . . . . 70.42 107.695 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.7 t -129.85 149.91 51.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.257 -0.645 . . . . 73.42 109.257 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -162.78 132.53 4.39 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.026 -0.731 . . . . 60.12 109.026 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' B' ' 113' ' ' CYS . 85.3 t -126.83 145.62 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.612 0.765 . . . . 35.32 109.505 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -118.01 103.24 9.71 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.288 -1.375 . . . . 72.51 107.288 167.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 5.8 tp-100 -93.21 99.48 12.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.378 -1.341 . . . . 61.43 107.378 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 171.62 38.79 Favored Glycine 0 C--O 1.248 1.024 0 N-CA-C 110.724 -0.95 . . . . 72.33 110.724 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.18 126.66 1.16 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.915 -0.659 . . . . 52.41 112.022 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 28.4 mt -84.73 129.0 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.042 -1.096 . . . . 70.43 108.042 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -133.74 150.59 51.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.602 1.161 . . . . 74.01 108.222 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -114.46 114.8 26.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.074 -1.084 . . . . 74.33 108.074 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' B' ' 10' ' ' THR . 46.3 pt -121.02 130.69 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.348 0.659 . . . . 75.03 110.712 -174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.66 171.11 19.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.311 1.045 . . . . 71.25 109.79 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.7 -47.08 3.79 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.091 0.377 . . . . 64.52 112.391 -179.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.403 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.8 pp -70.18 152.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.691 0.797 . . . . 73.33 111.154 169.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -150.41 143.28 24.71 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 111.726 0.269 . . . . 63.4 111.726 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.55 -111.1 2.95 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.99 0.805 . . . . 63.02 113.934 173.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 2.8 m -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.97 0.908 . . . . 71.25 110.144 -178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mp0 -76.02 -25.82 56.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.049 0.939 . . . . 73.12 110.327 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 43.7 ttp -73.32 -34.8 65.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.913 0.885 . . . . 73.44 110.307 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.38 68.75 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.604 -0.726 . . . . 71.32 110.814 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 57.1 t-80 -73.56 -24.12 60.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.419 0.687 . . . . 74.43 111.198 173.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -73.59 -63.54 1.18 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.672 0.389 . . . . 64.01 111.024 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.716 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -87.02 -19.23 28.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.577 0.584 . . . . 73.12 112.577 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.71 2.8 52.81 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.83 -0.428 . . . . 63.11 113.972 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -146.39 -46.8 0.19 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.034 0.417 . . . . 64.32 111.43 -177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -83.23 -38.39 22.31 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 111.577 0.214 . . . . 72.24 111.577 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.716 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.7 m -62.1 -46.54 91.43 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.47 -0.776 . . . . 74.33 111.077 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.652 ' HA ' HD22 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -49.26 -42.2 40.7 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 122.547 2.165 . . . . 62.22 113.878 166.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -58.01 -36.86 73.29 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.547 0.739 . . . . 72.14 111.68 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.402 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 47.3 mt -80.49 -48.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.591 0.756 . . . . 73.35 111.484 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.38 -21.13 53.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.258 0.623 . . . . 74.22 112.167 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.5 -47.73 67.77 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 117.665 -1.159 . . . . 71.3 113.064 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 97.2 Cg_exo -49.98 -45.89 30.57 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.741 2.294 . . . . 73.01 113.917 172.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.8 m-85 -65.61 -43.45 89.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.3 0.64 . . . . 71.25 110.893 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.413 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -66.4 -34.41 77.9 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 115.877 -0.602 . . . . 55.52 110.623 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -59.42 -57.27 13.72 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.152 0.981 . . . . 73.43 110.466 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.18 -33.05 74.64 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.807 0.692 . . . . 71.01 110.307 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.6 t -74.03 -36.44 64.43 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.193 -0.458 . . . . 74.42 111.427 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.679 HG21 HG21 ' B' ' 64' ' ' VAL . 81.6 mt -67.83 -51.77 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 74.01 109.05 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.674 HG23 ' HB2' ' B' ' 125' ' ' GLN . 66.6 m -62.19 -28.33 69.59 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 114.359 -1.292 . . . . 64.23 111.194 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -65.3 -46.34 80.77 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.344 0.658 . . . . 63.52 109.7 174.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.79 -33.02 68.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.999 0.52 . . . . 55.12 111.249 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.41 -41.61 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.407 0.683 . . . . 73.44 109.909 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.1 t -68.68 -31.07 69.92 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.321 -0.854 . . . . 61.12 111.515 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -74.53 -32.27 62.41 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.319 0.648 . . . . 43.2 110.227 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.73 -3.32 83.49 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.443 0.464 . . . . 72.24 112.432 170.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 59.45 51.17 6.8 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 126.424 1.89 . . . . 75.45 111.819 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.85 145.76 40.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.013 -1.449 . . . . 75.05 109.01 170.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.16 130.05 27.11 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.31 2.673 . . . . 72.42 112.432 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.674 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.7 pt20 -65.43 156.94 30.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.849 -1.069 . . . . 72.13 113.148 -171.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.46 114.05 25.29 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.503 -1.295 . . . . 41.35 107.503 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -91.47 108.65 20.04 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.959 -1.126 . . . . 45.43 107.959 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.87 150.2 45.4 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.821 0.849 . . . . 70.31 112.326 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.22 138.46 71.96 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.849 -1.069 . . . . 65.3 109.789 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.599 ' HG3' HD11 ' D' ' 16' ' ' ILE . 60.5 Cg_endo -71.48 97.22 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.499 2.133 . . . . 73.44 110.811 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.73 109.34 20.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.261 -1.014 . . . . 65.3 108.261 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -76.29 87.34 3.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.705 0.802 . . . . 75.34 109.871 177.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 109.467 -0.568 . . . . 54.43 109.467 171.174 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.514 ' HG3' HD12 ' C' ' 89' ' ' ILE . 26.9 ttt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 121.188 0.518 . . . . 70.4 111.512 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.1 m -92.35 88.74 6.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.573 0.749 . . . . 63.15 109.116 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -119.61 126.55 51.45 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.711 -0.848 . . . . 53.53 108.711 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -150.75 131.04 13.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.872 0.869 . . . . 72.4 108.995 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.418 HD12 ' HD3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -78.52 132.02 33.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.768 -0.827 . . . . 74.34 108.768 174.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 85.6 mm-40 -93.57 -46.04 7.47 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.077 0.551 . . . . 63.33 109.553 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -176.31 126.0 0.19 Allowed 'General case' 0 C--N 1.356 0.891 0 O-C-N 124.168 0.917 . . . . 75.23 110.192 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.01 142.99 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.636 -1.246 . . . . 75.2 107.636 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.443 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -176.79 156.01 1.34 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.617 0.644 . . . . 74.54 111.806 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -75.94 121.79 23.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.786 0.834 . . . . 74.32 109.061 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 12.6 mmmm -76.15 -47.99 22.23 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.305 1.05 . . . . 73.32 108.875 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -140.59 146.0 37.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 113.772 -1.558 . . . . 62.1 109.198 -173.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.7 mt -140.91 144.84 26.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.096 1.358 . . . . 63.44 107.482 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -156.22 151.14 26.2 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.573 0.702 . . . . 73.44 110.433 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -148.89 127.58 12.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.531 -1.285 . . . . 75.42 107.531 171.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.1 mt-10 -120.84 133.89 55.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.789 0.835 . . . . 75.43 109.411 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.53 79.36 24.76 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.335 -0.987 . . . . 74.23 108.335 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.87 -25.13 12.45 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.679 2.253 . . . . 71.14 112.112 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.441 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 96.9 m-20 -106.87 34.96 3.18 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.444 1.098 . . . . 73.02 109.504 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.38 -55.6 43.58 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.388 -0.815 . . . . 51.54 112.997 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 26.0 Cg_exo -65.53 -30.09 52.3 Favored 'Trans proline' 0 C--N 1.394 2.932 0 CA-C-N 121.421 1.543 . . . . 72.45 112.204 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.441 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.1 t60 -62.76 -23.51 67.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.784 1.234 . . . . 71.45 112.001 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' C' ' 34' ' ' LYS . 8.8 p -52.67 -25.34 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 N-CA-C 112.828 0.677 . . . . 75.33 112.828 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -79.7 -24.56 41.62 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.583 -0.698 . . . . 74.2 112.305 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -102.24 17.63 22.92 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.274 0.559 . . . . 53.31 110.503 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.73 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.07 138.26 33.15 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.085 0.954 . . . . 62.25 110.333 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -77.04 129.17 35.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 72.51 108.927 170.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -80.2 77.55 6.92 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.334 0.588 . . . . 75.14 110.667 -174.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' C' ' 68' ' ' LEU . 36.6 tt0 -160.45 63.64 1.98 Allowed Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 115.048 -0.978 . . . . 64.54 109.293 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.72 126.67 6.01 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.216 1.944 . . . . 74.34 111.416 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -85.88 99.11 11.17 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.609 -1.626 . . . . 75.22 106.609 169.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.437 HG11 HD13 ' C' ' 126' ' ' LEU . 43.2 t -73.19 122.93 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.794 -1.094 . . . . 70.12 109.038 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -124.62 112.34 16.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.345 1.058 . . . . 63.2 109.254 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 145.66 26.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.839 0.856 . . . . 62.45 109.156 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.5 t70 -132.95 143.63 49.59 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.909 -1.145 . . . . 63.33 107.909 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -135.08 115.01 12.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.247 -0.649 . . . . 72.4 109.247 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.0 t70 -111.44 143.39 42.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.104 -1.072 . . . . 73.1 108.104 175.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -115.05 117.39 30.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.728 0.811 . . . . 75.55 110.224 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -112.74 141.98 45.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 71.21 108.824 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -151.32 158.1 43.36 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.134 0.574 . . . . 73.32 110.518 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -167.62 131.88 1.81 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.858 0.863 . . . . 52.45 109.434 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.63 117.91 24.81 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.82 -0.807 . . . . 73.44 108.82 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.515 HD11 HD12 ' C' ' 83' ' ' ILE . 56.6 mt -86.33 -38.97 16.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.022 0.929 . . . . 74.04 111.354 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -171.19 3.08 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.669 -0.696 . . . . 73.53 110.572 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -57.5 110.39 0.86 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.983 -1.008 . . . . 75.31 110.104 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 70.26 -2.19 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.927 1.291 . . . . 63.11 112.781 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -94.28 103.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 71.34 108.859 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -115.48 126.15 53.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.084 0.954 . . . . 60.51 109.534 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -84.43 119.26 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.44 -0.578 . . . . 63.15 109.44 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 87.0 t -98.23 128.43 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.495 1.118 . . . . 74.35 108.244 172.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 70.2 t -131.7 137.38 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.441 0.696 . . . . 65.24 109.413 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' C' ' 103' ' ' PRO . 92.9 mt -125.51 112.42 16.2 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.741 0.816 . . . . 75.13 109.917 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 27.4 ttm180 -82.61 105.79 13.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.024 -0.732 . . . . 75.12 109.024 168.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.658 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.3 t -101.19 125.36 55.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.968 -1.123 . . . . 62.12 107.968 171.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 15.5 m -124.41 113.29 17.97 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.795 -0.817 . . . . 73.02 108.795 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.502 HG21 HG21 ' C' ' 114' ' ' ILE . 60.2 t -102.19 114.22 40.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.681 0.792 . . . . 73.03 109.065 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -102.41 150.71 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.535 -0.913 . . . . 71.23 108.535 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.5 106.09 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.48 -1.674 . . . . 73.31 106.48 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -148.39 146.22 28.38 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.913 0.485 . . . . 62.45 110.544 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.73 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.3 OUTLIER -110.78 55.79 0.64 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.095 0.958 . . . . 71.53 108.544 174.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.95 -113.72 4.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.48 -1.237 . . . . 40.32 111.131 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.36 -17.78 29.83 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.457 0.703 . . . . 74.13 110.301 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -88.96 99.35 12.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.072 0.949 . . . . 74.54 109.529 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -85.57 132.78 34.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.94 0.496 . . . . 60.45 111.096 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -77.47 -64.25 1.19 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.146 0.979 . . . . 63.41 109.591 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -163.58 175.67 10.43 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.416 -0.811 . . . . 73.43 110.324 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -139.27 144.21 38.29 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 107.901 -1.148 . . . . 74.51 107.901 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.435 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.5 t -143.87 149.13 36.46 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.27 -1.011 . . . . 70.11 108.27 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.25 136.46 11.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.922 0.489 . . . . 53.12 110.056 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -138.08 134.79 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.237 1.015 . . . . 71.4 108.456 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 63.3 mt-30 -110.57 91.22 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.951 -1.129 . . . . 64.14 107.951 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.05 117.43 20.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.626 -0.715 . . . . 71.53 110.55 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.37 162.52 20.75 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 123.517 0.51 . . . . 61.24 112.556 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.524 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -166.94 118.19 0.78 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.306 -0.718 . . . . 62.44 111.306 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.515 HD12 HD11 ' C' ' 51' ' ' LEU . 13.6 mm -83.21 122.73 37.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.764 -0.828 . . . . 71.22 108.764 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -132.78 132.25 42.03 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.65 0.78 . . . . 73.21 109.417 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 47.8 m -94.18 114.36 26.46 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.594 -0.891 . . . . 72.04 108.594 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 50.8 mt -115.08 119.26 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.554 1.142 . . . . 74.52 107.994 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.55 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.246 1.019 . . . . 63.55 109.923 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.78 -34.3 4.59 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.271 -0.422 . . . . 52.05 112.772 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.525 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -121.9 165.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 71.32 110.176 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -156.46 -179.9 8.61 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.41 0.684 . . . . 61.03 110.42 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' C' ' 94' ' ' MET . . . 68.81 -130.35 25.16 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.384 -0.371 . . . . 73.01 113.052 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -78.95 -20.72 48.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.254 0.622 . . . . 72.43 111.272 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.21 -44.52 95.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.392 0.677 . . . . 75.15 110.184 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.428 ' HG3' ' O ' ' C' ' 91' ' ' GLY . 0.0 OUTLIER -76.58 -26.32 54.93 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 116.029 -0.532 . . . . 70.43 110.785 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.66 -32.13 70.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.892 0.477 . . . . 75.41 111.087 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 60.1 t-80 -73.73 -24.3 59.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.288 0.635 . . . . 54.45 110.73 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -81.67 -58.57 2.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.205 0.602 . . . . 54.35 110.324 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.33 -48.37 42.52 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.19 1.396 . . . . 72.23 110.826 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.83 11.46 72.05 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.547 -0.585 . . . . 61.42 114.111 -171.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -148.61 -59.3 0.23 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.554 0.677 . . . . 71.04 112.217 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -74.85 -38.88 61.86 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.981 0.512 . . . . 75.33 112.243 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.9 -45.46 74.41 Favored Pre-proline 0 CA--C 1.557 1.249 0 CA-C-O 118.833 -0.603 . . . . 55.21 111.277 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HA ' HD11 ' C' ' 60' ' ' LEU . 69.9 Cg_exo -48.8 -42.8 36.45 Favored 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.647 2.232 . . . . 73.2 114.457 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -60.7 -40.21 91.39 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.784 0.833 . . . . 74.44 110.798 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.11 -48.21 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.919 0.488 . . . . 75.02 110.72 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.524 HD21 ' HA3' ' C' ' 82' ' ' GLY . 80.3 mt -80.11 -19.57 47.05 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.76 -0.655 . . . . 74.14 112.53 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -58.64 -48.42 96.92 Favored Pre-proline 0 CA--C 1.566 1.593 0 CA-C-O 118.061 -0.971 . . . . 71.04 113.29 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.94 -36.64 96.52 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.358 2.039 . . . . 73.45 113.463 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -66.69 -45.18 79.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.425 0.69 . . . . 75.42 111.146 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.77 88.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.282 0.633 . . . . 74.12 109.64 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -53.7 -49.23 68.49 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.639 1.576 . . . . 72.02 112.091 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.94 -39.01 72.88 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.81 0.694 . . . . 65.53 110.163 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.49 -33.6 74.44 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.994 0.517 . . . . 65.45 111.274 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.658 HD11 ' HB ' ' C' ' 62' ' ' VAL . 81.3 mt -66.27 -52.29 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.597 0.759 . . . . 72.13 109.53 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 29.1 m -65.28 -29.08 69.82 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.049 -0.978 . . . . 61.44 110.75 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -66.84 -43.75 82.85 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.694 0.798 . . . . 50.34 109.925 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.562 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.44 -37.64 85.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.524 0.73 . . . . 74.03 111.646 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.03 -37.78 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.253 0.621 . . . . 63.13 109.811 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.0 t -66.24 -35.9 81.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.229 1.012 . . . . 74.12 111.829 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.4 mtt-85 -74.35 -35.76 63.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.614 0.766 . . . . 74.22 110.332 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.17 1.14 76.85 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.622 0.576 . . . . 74.13 112.592 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.3 p 61.36 24.05 14.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.035 1.734 . . . . 61.01 112.656 172.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -90.42 155.24 46.46 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.127 0.971 . . . . 73.03 110.03 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.08 122.43 11.8 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.058 2.505 . . . . 71.52 112.38 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.13 153.59 25.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.311 1.045 . . . . 62.45 112.881 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.437 HD13 HG11 ' C' ' 40' ' ' VAL . 5.1 tt -141.52 114.01 8.27 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 106.68 -1.6 . . . . 75.11 106.68 171.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -90.9 131.73 36.35 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.799 0.84 . . . . 65.43 109.749 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.43 141.69 56.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.444 0.698 . . . . 70.24 110.964 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.76 148.89 55.65 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.025 0.93 . . . . 72.1 110.907 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.542 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.9 Cg_exo -64.52 94.69 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.144 2.563 . . . . 71.23 112.465 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.38 106.71 19.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.938 -1.134 . . . . 71.23 107.938 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.89 102.42 11.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.609 -1.256 . . . . 63.35 107.609 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -63.06 -42.3 99.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.454 0.645 . . . . 61.24 109.308 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 . . . . . 0 N--CA 1.474 0.725 0 C-N-CA 125.195 1.398 . . . . 73.2 112.382 179.117 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.5 m . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 121.14 0.495 . . . . 64.4 110.299 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -159.88 90.62 0.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.629 -1.619 . . . . 62.31 106.629 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.85 114.97 28.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.066 -1.087 . . . . 70.24 108.066 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.5 mt -77.13 104.5 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 108.203 -1.036 . . . . 72.21 108.203 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.96 -45.48 60.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.769 -0.456 . . . . 75.43 109.769 -170.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' D' ' 15' ' ' ARG . 3.4 mmp_? -157.66 147.75 20.54 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.374 1.07 . . . . 73.21 110.138 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.599 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.7 mp -120.04 113.38 40.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 106.496 -1.668 . . . . 74.54 106.496 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.577 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 42.0 p90 -145.93 150.73 36.62 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.759 0.79 . . . . 63.34 111.282 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -81.38 115.28 20.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.897 -1.047 . . . . 43.45 109.549 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.53 -33.14 28.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.424 0.631 . . . . 74.22 109.885 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -144.26 137.2 27.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.483 -1.235 . . . . 51.24 109.524 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.562 HD13 ' HE3' ' C' ' 117' ' ' MET . 93.3 mt -132.05 140.52 47.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.68 1.192 . . . . 73.21 107.885 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 38.6 t -142.34 133.74 26.44 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.562 1.145 . . . . 73.32 108.053 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -147.91 124.7 11.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.754 -1.573 . . . . 73.21 106.754 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -129.19 137.09 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.488 1.115 . . . . 74.01 108.898 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.11 85.36 59.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.703 -1.591 . . . . 53.22 106.703 172.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.39 -61.59 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.901 2.401 . . . . 74.02 112.547 -172.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.76 41.83 1.09 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.0 -1.111 . . . . 72.32 108.0 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -49.07 -59.72 5.93 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 114.389 1.255 . . . . 53.4 114.389 -167.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.54 -12.86 15.13 Favored 'Trans proline' 0 C--N 1.385 2.462 0 CA-C-N 121.727 1.652 . . . . 54.01 112.772 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.409 ' HA ' HE21 ' D' ' 33' ' ' GLN . 8.1 t-160 -75.2 -41.4 57.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.122 1.369 . . . . 62.32 109.597 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.06 -40.69 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.746 -1.116 . . . . 64.44 110.471 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -67.68 -18.37 64.91 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.146 -0.933 . . . . 71.22 113.064 -174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' D' ' 30' ' ' HIS . 45.0 mt-30 -78.79 -14.65 59.15 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.386 0.674 . . . . 71.35 112.222 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -109.04 114.51 28.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.06 0.944 . . . . 61.11 108.593 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -88.14 96.17 10.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.627 0.603 . . . . 64.4 112.627 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.475 ' CZ3' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -169.42 -174.26 1.89 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.097 0.777 . . . . 73.04 113.097 171.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -92.1 126.5 52.9 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 125.05 1.34 . . . . 72.03 111.509 -173.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.588 ' HB3' HD23 ' D' ' 68' ' ' LEU . 56.0 Cg_endo -75.31 150.59 37.09 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.928 2.419 . . . . 74.2 113.783 172.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -83.21 135.59 34.72 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.504 1.122 . . . . 65.22 108.392 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 67.8 t -118.82 138.82 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.381 0.672 . . . . 54.33 109.262 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 47.9 tttm -125.81 121.26 32.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.186 0.994 . . . . 73.43 108.653 -172.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.47 HD11 HD11 ' D' ' 128' ' ' LEU . 0.4 OUTLIER -97.62 112.68 24.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.586 0.754 . . . . 41.45 109.062 -172.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.609 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.9 m-20 -111.75 127.8 55.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.277 1.031 . . . . 74.23 108.848 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.17 140.02 49.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.376 0.67 . . . . 75.32 109.431 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.6 t70 -142.0 136.47 30.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.107 0.963 . . . . 74.31 108.723 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -105.47 143.9 32.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.461 0.704 . . . . 70.42 110.193 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.69 159.02 44.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.694 0.798 . . . . 23.23 109.772 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.2 p -168.27 166.68 12.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.119 0.568 . . . . 64.04 111.166 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -158.84 145.56 17.17 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.368 1.067 . . . . 62.35 109.107 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.0 117.71 25.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.942 -0.762 . . . . 71.23 108.942 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' D' ' 57' ' ' GLU . 31.5 mt -92.85 -24.78 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.598 0.359 . . . . 53.34 110.281 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.87 -178.84 3.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.125 0.97 . . . . 74.35 110.608 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.56 118.92 9.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.914 -1.039 . . . . 74.24 108.937 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 70.07 5.17 5.16 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.696 1.198 . . . . 64.45 112.088 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.26 114.91 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.767 -0.827 . . . . 70.41 108.767 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.59 129.8 39.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.356 1.062 . . . . 63.11 108.883 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.457 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.4 tt0 -88.42 124.79 34.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.428 -0.953 . . . . 74.03 108.428 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.495 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 47.4 t -108.77 122.99 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.039 -1.467 . . . . 62.13 107.039 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 23.3 t -106.28 128.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.724 -0.843 . . . . 65.42 108.724 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.64 HD23 HD12 ' D' ' 106' ' ' LEU . 4.1 mm? -112.06 114.21 26.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.677 -0.49 . . . . 74.3 109.677 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -86.93 106.08 17.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.633 -0.712 . . . . 73.11 109.152 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.95 127.73 48.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.895 -1.15 . . . . 70.51 107.895 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 39.6 m -125.66 130.13 50.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.382 -0.826 . . . . 61.51 108.793 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -120.42 121.27 65.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.785 1.234 . . . . 61.35 108.474 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 87.6 m -120.63 100.43 7.12 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.054 0.942 . . . . 74.34 109.099 -170.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.15 137.47 37.63 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.187 -0.46 . . . . 65.22 110.098 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 53.4 p -150.47 140.12 21.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.603 0.761 . . . . 71.14 109.598 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.652 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -136.22 136.4 39.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.501 1.12 . . . . 75.12 110.135 -174.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.67 3.78 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.337 -0.705 . . . . 73.54 111.337 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.52 4.2 8.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.703 0.801 . . . . 74.12 110.346 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.63 166.85 13.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.15 0.58 . . . . 72.13 110.821 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 87.1 m -80.97 139.14 35.99 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.821 -0.627 . . . . 63.33 110.483 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.652 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -80.56 -72.02 0.43 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.027 -1.101 . . . . 75.44 108.027 172.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.45 146.46 25.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.17 -0.923 . . . . 63.21 108.928 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -110.34 130.06 55.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.57 -1.271 . . . . 74.11 107.57 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.554 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.4 t -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 72.31 108.871 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 41.9 tt0 -154.59 121.8 5.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.085 0.554 . . . . 63.33 110.065 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -130.21 118.11 42.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.068 -0.715 . . . . 75.14 109.068 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -87.8 86.78 7.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.612 -1.255 . . . . 63.44 107.612 169.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.98 97.38 6.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.184 -1.371 . . . . 64.32 108.565 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.52 144.0 18.82 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.453 -0.659 . . . . 53.14 111.453 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.28 4.58 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 109.826 -1.31 . . . . 71.44 109.826 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.75 130.23 38.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.173 . . . . 63.3 107.834 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.495 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 42.3 m-85 -129.0 136.16 49.94 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.483 0.49 . . . . 64.02 109.98 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.9 m -86.52 93.32 9.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.924 -1.139 . . . . 74.02 107.924 167.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 14.9 mt -106.58 114.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 109.437 -0.579 . . . . 73.43 109.437 -172.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.4 163.0 35.06 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.915 0.886 . . . . 63.32 109.679 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -6.3 83.76 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.508 -0.607 . . . . 51.2 114.568 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 pt -129.11 147.97 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.639 0.719 . . . . 73.42 111.716 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 173.57 13.18 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.823 1.249 . . . . 53.12 109.426 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.24 -127.28 43.08 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 115.258 0.863 . . . . 74.42 115.258 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 90.1 m -66.23 -38.46 87.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.68 1.192 . . . . 74.14 111.642 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -69.2 -36.77 77.63 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.881 0.873 . . . . 75.13 110.75 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.683 ' SD ' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -72.12 -42.52 65.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.508 -0.553 . . . . 72.11 109.508 176.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.82 88.46 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.588 0.755 . . . . 64.22 110.805 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 15.0 t-80 -64.91 -36.55 84.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.158 -0.928 . . . . 71.42 110.669 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -68.03 -50.53 54.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.513 0.325 . . . . 74.44 111.236 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.683 HD23 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -71.18 -30.3 66.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.9 0.48 . . . . 74.31 111.305 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.24 7.5 56.66 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.61 -0.55 . . . . 75.0 114.06 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.05 -57.82 0.24 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.465 0.633 . . . . 54.25 111.762 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -70.62 -52.94 18.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.211 0.604 . . . . 75.21 111.238 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.436 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 34.0 m -60.58 -45.7 97.2 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.873 0.869 . . . . 34.45 112.127 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 75.0 Cg_exo -53.93 -45.59 39.9 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.747 2.298 . . . . 72.2 113.156 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.03 -26.31 68.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.559 0.743 . . . . 71.12 111.725 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.0 mm -73.51 -49.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.373 0.669 . . . . 61.24 110.962 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.64 HD12 HD23 ' D' ' 60' ' ' LEU . 83.2 mt -87.13 -13.95 42.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.13 0.572 . . . . 73.41 112.46 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -67.51 -45.69 47.29 Favored Pre-proline 0 CA--C 1.559 1.326 0 CA-C-O 118.188 -0.91 . . . . 72.31 112.328 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.79 -33.43 96.87 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.21 1.94 . . . . 72.35 113.408 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -78.96 -34.96 43.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.533 0.733 . . . . 73.33 112.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.56 -50.05 68.81 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.933 -0.766 . . . . 74.12 108.933 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -54.18 -48.01 71.4 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.991 1.432 . . . . 71.43 110.574 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.34 -50.1 74.29 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.169 0.918 . . . . 74.13 110.911 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.422 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.6 t -55.32 -43.29 74.76 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.973 0.795 . . . . 73.51 110.913 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.554 HG12 ' SG ' ' D' ' 76' ' ' CYS . 86.1 mt -65.8 -51.91 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 124.355 1.034 . . . . 50.0 110.624 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.458 HG23 ' HB2' ' D' ' 125' ' ' GLN . 68.9 m -51.03 -44.45 61.04 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.986 1.315 . . . . 72.54 111.658 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -69.41 -45.61 68.8 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.849 -1.069 . . . . 72.44 110.812 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.98 -36.96 85.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.741 0.416 . . . . 65.03 111.981 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.2 t -66.79 -44.33 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.097 -0.956 . . . . 70.31 109.998 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -69.73 -27.31 64.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.817 0.447 . . . . 73.15 111.414 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -73.21 -29.72 63.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 73.42 110.205 175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.89 11.48 66.69 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.69 -0.686 . . . . 43.11 112.438 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.428 HG23 ' HB3' ' C' ' 17' ' ' TYR . 59.9 p 57.87 14.11 2.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.725 2.01 . . . . 74.23 113.518 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.02 162.91 55.55 Favored Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.482 1.113 . . . . 43.35 108.342 169.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -75.32 127.02 10.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.212 1.941 . . . . 74.43 111.41 -174.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.458 ' HB2' HG23 ' D' ' 115' ' ' THR . 0.0 OUTLIER -54.12 142.8 24.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.319 0.648 . . . . 64.11 111.291 -176.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.89 103.79 13.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.021 -0.733 . . . . 55.13 109.021 -161.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -97.05 91.92 5.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.98 -1.118 . . . . 74.41 107.98 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.47 HD11 HD11 ' D' ' 42' ' ' LEU . 0.1 OUTLIER -73.82 126.81 31.23 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.453 -0.943 . . . . 64.13 108.453 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.17 141.52 95.95 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.6 0.76 . . . . 64.45 111.374 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.31 122.8 11.65 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.408 2.072 . . . . 60.22 111.261 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.17 117.9 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.217 -1.031 . . . . 71.42 108.217 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -72.09 84.29 1.0 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.448 0.699 . . . . 72.5 109.686 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 N--CA 1.478 0.968 0 C-N-CA 123.654 0.782 . . . . 74.52 110.903 179.52 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 C--O 1.238 0.476 0 N-CA-C 108.384 -0.969 . . . . 72.43 108.384 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.72 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.2 t80 -123.83 117.69 25.44 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.527 -0.916 . . . . 73.01 108.527 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -141.62 112.67 7.37 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.832 -0.803 . . . . 74.5 108.832 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.662 HG21 ' HG2' ' C' ' 130' ' ' PRO . 66.5 mt -69.91 130.64 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 122.844 0.458 . . . . 73.05 109.986 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -96.47 -38.29 10.08 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.954 -0.546 . . . . 74.5 110.567 177.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -173.01 123.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.196 0.907 . . . . 73.34 112.686 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.83 133.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.582 -0.896 . . . . 70.55 108.582 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -167.88 158.5 10.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.243 1.017 . . . . 62.34 110.653 -172.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -91.73 115.24 27.89 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.347 -0.842 . . . . 72.05 109.425 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -85.56 -18.87 32.12 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.381 -0.372 . . . . 75.25 110.405 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.5 t70 -155.9 140.84 17.25 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.906 0.882 . . . . 75.14 109.735 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -140.73 135.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.447 1.499 . . . . 64.14 107.301 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 39.6 t -141.45 125.77 17.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.423 -0.955 . . . . 45.3 108.423 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -136.42 110.13 8.08 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.639 -1.245 . . . . 74.42 107.639 171.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.13 120.14 35.35 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.813 0.445 . . . . 55.02 109.945 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.78 80.79 14.45 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 107.633 -1.247 . . . . 34.34 107.633 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.75 -24.74 29.36 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.825 2.35 . . . . 73.53 113.061 -170.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.02 12.98 28.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.395 0.678 . . . . 54.23 111.269 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.08 4.24 Favored Pre-proline 0 CA--C 1.565 1.53 0 N-CA-C 114.964 1.468 . . . . 72.42 114.964 -165.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HB3' HD22 ' B' ' 51' ' ' LEU . 26.1 Cg_exo -56.74 -46.51 29.1 Favored 'Trans proline' 0 C--N 1.396 3.037 0 CA-C-N 122.107 1.788 . . . . 64.11 113.045 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -98.7 -6.99 28.54 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.94 0.896 . . . . 72.11 112.911 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.5 p -79.88 -20.18 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.615 -0.678 . . . . 52.22 111.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -86.52 -3.86 59.08 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.446 0.698 . . . . 74.14 112.016 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -100.64 -7.73 23.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.653 0.781 . . . . 73.33 111.0 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -70.29 163.92 25.52 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.738 0.815 . . . . 71.32 112.469 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.39 144.22 51.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.216 1.006 . . . . 64.24 110.049 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -87.24 73.98 9.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.703 0.764 . . . . 74.23 111.404 -169.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -143.41 84.1 10.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 114.614 -1.175 . . . . 74.4 108.066 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.26 136.28 11.29 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.335 2.023 . . . . 43.42 112.131 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -95.13 93.88 7.6 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.765 -1.569 . . . . 62.22 106.765 170.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 34.0 t -92.46 96.51 6.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.983 -1.008 . . . . 52.52 111.061 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.9 tttm -80.47 111.53 16.97 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.1 -0.955 . . . . 73.52 108.938 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 tt -98.74 121.9 41.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.343 -0.984 . . . . 64.22 108.343 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.55 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 24.0 m-20 -116.72 150.32 38.4 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.356 1.062 . . . . 61.43 108.849 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -130.52 133.47 46.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.946 -0.761 . . . . 64.24 108.946 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -132.97 144.14 49.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.076 0.95 . . . . 73.51 108.769 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.6 p -136.36 136.38 39.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.778 0.831 . . . . 63.11 109.466 -173.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.6 111.03 5.59 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.977 0.511 . . . . 43.41 110.079 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -92.05 152.07 20.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.501 -0.555 . . . . 74.1 109.501 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -151.96 154.98 37.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.435 -1.32 . . . . 73.41 107.435 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -117.46 130.97 56.8 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.962 -0.755 . . . . 73.33 108.962 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -93.45 -40.48 10.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.513 0.725 . . . . 73.45 110.539 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.26 -177.23 6.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.904 0.882 . . . . 54.22 110.077 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.25 123.61 20.41 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.386 -0.598 . . . . 63.52 109.386 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 69.0 -8.1 0.71 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.809 1.643 . . . . 73.11 112.963 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.36 109.77 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.032 -0.729 . . . . 73.32 109.032 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.73 153.53 32.22 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.947 0.899 . . . . 64.53 108.67 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -129.73 118.95 22.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.337 1.055 . . . . 73.54 108.852 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.77 118.92 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.205 -1.035 . . . . 70.01 108.205 174.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 95.3 t -98.28 128.22 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 108.848 -0.797 . . . . 61.44 108.848 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.24 97.92 6.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.401 -1.703 . . . . 73.44 106.401 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 16.8 ttp180 -88.41 109.13 19.76 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.375 -0.602 . . . . 73.55 109.375 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 11.1 t -93.87 130.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.266 -1.383 . . . . 71.12 107.266 171.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -120.87 128.57 52.94 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.73 -0.841 . . . . 75.44 108.73 176.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.831 HG11 HD21 ' A' ' 126' ' ' LEU . 52.9 t -130.73 107.72 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.349 0.66 . . . . 75.3 109.874 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 13.5 m -102.81 141.23 35.97 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.465 -0.939 . . . . 61.44 108.465 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.53 46.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.004 -1.109 . . . . 73.3 108.004 173.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -142.76 127.46 18.1 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.858 0.463 . . . . 74.2 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 73' ' ' ALA . 9.2 mp -95.17 84.93 4.17 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.471 -1.307 . . . . 64.31 107.471 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -127.13 8.29 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.268 -1.333 . . . . 54.34 111.281 -171.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.28 -25.09 22.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 75.24 110.028 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.21 117.53 20.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.277 1.031 . . . . 72.41 110.296 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -66.79 128.4 36.16 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.122 0.889 . . . . 74.43 110.749 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -70.89 -62.91 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.393 -0.966 . . . . 72.13 108.393 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.22 166.07 33.29 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.713 -1.13 . . . . 73.03 110.183 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -132.41 135.8 46.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.163 -1.421 . . . . 71.12 107.163 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.1 m -134.96 101.05 4.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.562 0.745 . . . . 73.12 109.829 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 34.7 tt0 -125.81 116.01 20.91 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.207 -0.664 . . . . 62.0 109.207 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -128.88 111.63 23.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.088 0.955 . . . . 52.51 108.94 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.6 mt-30 -84.39 84.28 7.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.316 -0.994 . . . . 71.13 108.316 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.78 93.33 3.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.784 -1.098 . . . . 71.4 108.391 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.49 145.29 21.06 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.379 -0.828 . . . . 74.13 111.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -146.74 121.46 1.43 Allowed Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 111.188 -0.765 . . . . 63.41 111.188 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.2 mt -82.09 116.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.624 -0.88 . . . . 61.32 108.624 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.72 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.3 m-85 -121.83 121.55 37.44 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.335 1.054 . . . . 63.0 108.32 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -79.72 99.84 7.62 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.603 -0.888 . . . . 72.13 108.603 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.94 121.04 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.061 0.944 . . . . 65.45 109.375 -174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.27 161.53 42.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.387 0.675 . . . . 55.12 110.063 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.33 -29.81 8.47 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.69 0.636 . . . . 53.12 114.69 171.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.67 170.19 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.423 0.689 . . . . 71.14 109.976 178.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -152.74 172.29 16.92 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 123.553 0.533 . . . . 73.1 110.225 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.41 -116.31 3.49 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.422 1.487 . . . . 55.55 115.544 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 t -57.07 -31.74 65.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.31 1.444 . . . . 51.2 112.445 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -75.42 -39.15 59.28 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.482 0.713 . . . . 70.01 110.437 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mtp -77.4 -21.18 53.54 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.266 0.354 . . . . 75.53 110.617 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.28 -33.45 67.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.124 0.57 . . . . 73.22 109.708 172.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 44.1 t-80 -76.16 -35.15 59.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.199 -0.91 . . . . 65.33 110.204 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -70.25 -47.52 60.95 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 122.234 -0.291 . . . . 74.53 110.226 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.16 -40.48 62.54 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.878 -0.601 . . . . 75.44 110.942 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.69 4.25 59.49 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.239 -0.756 . . . . 43.31 114.781 -168.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.41 -68.51 0.27 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.178 0.989 . . . . 61.04 112.434 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 92.1 t80 -68.84 -51.37 41.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.87 0.868 . . . . 75.12 113.065 -167.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.8 m -73.57 -31.74 1.44 Allowed Pre-proline 0 CA--C 1.563 1.48 0 CA-C-O 118.402 -0.808 . . . . 63.23 113.081 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.4 -42.64 34.24 Favored 'Trans proline' 0 C--N 1.395 3.01 0 C-N-CA 122.594 2.196 . . . . 72.11 112.799 159.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.559 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 91.9 m-20 -64.63 -19.51 65.74 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.646 0.778 . . . . 71.23 112.093 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.414 HD12 ' ND2' ' C' ' 132' ' ' ASN . 39.1 mm -81.6 -46.43 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.307 -0.627 . . . . 63.11 109.307 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.509 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.3 mt -78.67 -30.56 46.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.049 0.94 . . . . 61.11 113.073 -171.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -69.78 -38.36 9.47 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.005 -0.997 . . . . 72.11 112.6 -169.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -41.93 71.07 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 122.277 1.984 . . . . 64.32 113.543 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -76.53 -32.37 58.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.146 0.578 . . . . 72.52 111.848 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.23 68.44 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.296 -0.631 . . . . 71.1 109.296 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -54.86 -47.19 74.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.651 1.18 . . . . 74.14 110.623 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.38 -47.14 74.33 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.161 0.913 . . . . 63.52 110.809 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -57.6 -43.79 84.95 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.382 0.673 . . . . 75.41 110.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.431 HG23 ' HB3' ' A' ' 76' ' ' CYS . 87.0 mt -64.69 -46.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 O-C-N 124.255 0.972 . . . . 74.32 110.142 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.7 m -52.89 -45.75 67.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.651 0.78 . . . . 61.4 111.28 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -69.37 -44.92 70.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.887 -1.051 . . . . 75.42 110.511 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -55.86 -44.59 78.19 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.654 0.781 . . . . 73.0 111.362 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 123' ' ' PHE . 41.0 t -61.9 -48.25 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.971 1.308 . . . . 74.21 110.59 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 77.9 p -68.02 -32.26 72.52 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.001 0.52 . . . . 63.45 111.628 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.29 -33.82 75.04 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.688 0.795 . . . . 74.04 110.366 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 9.53 66.54 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.462 -0.79 . . . . 61.32 113.308 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.825 HG21 ' HD2' ' B' ' 15' ' ' ARG . 17.9 m 73.2 9.13 5.28 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.388 1.075 . . . . 64.25 112.782 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . 0.427 ' HB2' HG13 ' A' ' 118' ' ' VAL . 96.1 m-85 -85.47 138.5 36.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 107.762 -1.199 . . . . 74.32 107.762 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.24 160.2 31.87 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.702 2.268 . . . . 75.51 112.622 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.1 tt0 -45.44 121.95 3.27 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 124.795 1.31 . . . . 71.43 112.507 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.831 HD21 HG11 ' A' ' 64' ' ' VAL . 48.8 tp -108.4 115.49 30.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.885 -1.052 . . . . 75.13 108.374 174.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -129.28 124.15 33.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.641 -1.163 . . . . 62.21 107.977 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.77 138.86 46.72 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.318 -0.623 . . . . 74.41 109.318 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.22 145.61 96.76 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 122.774 0.429 . . . . 61.32 110.359 -178.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.61 ' HD3' HG22 ' C' ' 13' ' ' ILE . 23.8 Cg_exo -64.6 104.74 0.56 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.967 2.445 . . . . 75.14 112.455 -173.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 14.5 t -100.12 112.46 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.881 -1.155 . . . . 72.21 107.881 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -85.82 86.23 7.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.207 -1.405 . . . . 75.15 107.207 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 98.6 m-85 -60.71 -29.18 69.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.523 -0.762 . . . . 74.1 110.659 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.639 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.8 t70 . . . . . 0 C--N 1.356 0.87 0 C-N-CA 123.762 0.825 . . . . 41.14 109.377 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 25.3 m . . . . . 0 C--O 1.24 0.578 0 N-CA-C 106.935 -1.505 . . . . 74.04 106.935 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -139.74 130.69 26.22 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.25 -0.648 . . . . 75.12 109.25 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.532 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 2.6 pm0 -148.47 129.82 14.73 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.573 -0.528 . . . . 75.32 109.573 172.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.17 144.33 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 115.565 -0.743 . . . . 51.21 109.16 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -108.49 -47.49 3.49 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.456 -0.572 . . . . 74.43 109.456 169.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.825 ' HD2' HG21 ' A' ' 122' ' ' THR . 34.8 ttp180 -165.79 152.95 10.14 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.784 -0.644 . . . . 64.2 110.98 -170.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -131.73 139.25 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 107.343 -1.355 . . . . 64.41 107.343 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.59 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.6 p90 -161.46 168.69 23.27 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.785 0.803 . . . . 73.02 112.256 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.2 m -93.25 121.21 34.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.473 -1.239 . . . . 73.5 108.763 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.613 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 24.6 mtpp -87.66 -30.46 20.39 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.428 0.691 . . . . 75.25 110.614 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.86 145.6 18.58 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -174.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 28.3 mm -138.81 141.94 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.031 1.732 . . . . 70.04 109.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -150.45 117.4 5.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.181 -1.044 . . . . 71.31 108.181 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -131.81 116.18 16.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.259 -1.385 . . . . 74.11 107.259 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 157.56 27.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.405 0.682 . . . . 74.1 109.694 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -148.88 79.2 8.62 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.333 -1.358 . . . . 75.45 107.333 175.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.58 -9.81 20.09 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.006 2.471 . . . . 61.41 112.602 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.429 ' OD1' ' HB ' ' B' ' 72' ' ' THR . 3.0 m120 -116.63 11.25 14.64 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.214 1.006 . . . . 74.4 109.043 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.66 -54.51 26.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.779 1.232 . . . . 61.24 114.216 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.71 -23.27 14.63 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 121.696 1.597 . . . . 73.21 112.436 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.476 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 3.4 m-70 -90.33 -0.36 57.6 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.833 0.853 . . . . 62.54 112.044 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.95 -28.39 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.66 0.784 . . . . 72.31 111.857 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.0 -23.15 64.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.083 0.953 . . . . 65.31 112.146 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.623 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -70.0 -40.01 75.53 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.746 -0.465 . . . . 71.33 109.746 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.623 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 78.5 mttt -109.73 64.52 0.61 Allowed 'General case' 0 C--N 1.359 1.02 0 N-CA-C 108.434 -0.95 . . . . 73.14 108.434 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 9.4 p-10 -78.61 94.06 4.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.921 -0.581 . . . . 64.32 110.388 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' B' ' 35' ' ' ASP . 0.4 OUTLIER 173.93 -173.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.945 1.298 . . . . 75.13 111.024 159.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -55.08 117.99 16.22 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.037 1.335 . . . . 55.04 112.503 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.49 169.31 22.12 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.742 2.295 . . . . 74.31 111.166 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.55 102.01 3.73 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 106.882 -1.525 . . . . 74.53 106.882 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 13.7 m -89.95 140.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.807 -1.088 . . . . 71.44 108.976 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -119.1 130.57 55.66 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.239 -0.652 . . . . 73.54 109.239 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.65 HD21 HD11 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -86.04 136.91 33.05 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.032 -1.47 . . . . 63.45 107.032 168.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 18.4 t0 -142.88 128.36 19.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.77 -1.196 . . . . 75.43 107.77 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.471 HD22 ' HE1' ' B' ' 133' ' ' PHE . 1.4 mp -131.38 126.49 35.34 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.093 -1.077 . . . . 73.13 108.093 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.3 t70 -123.3 142.61 50.76 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.49 1.116 . . . . 75.23 108.371 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -117.39 119.26 34.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.088 0.555 . . . . 72.53 110.411 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.32 135.29 33.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.9 0.88 . . . . 64.34 108.912 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -134.62 169.91 16.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.318 0.647 . . . . 74.04 110.054 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -151.97 163.86 38.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.561 0.744 . . . . 70.33 110.232 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -108.58 120.08 41.39 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.812 -0.811 . . . . 71.32 108.812 170.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' B' ' 57' ' ' GLU . 17.6 mt -92.06 -46.03 8.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.847 0.859 . . . . 73.33 109.336 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.93 -178.86 6.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.3 -1.318 . . . . 74.03 108.803 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.52 122.39 18.94 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.956 -1.02 . . . . 73.22 108.825 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 71.59 -4.3 1.92 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.644 1.577 . . . . 73.11 112.699 -173.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.6 t -106.16 107.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.925 -0.769 . . . . 74.44 108.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -120.43 140.71 50.97 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.182 0.993 . . . . 61.44 109.586 -176.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.597 ' HB2' HD11 ' B' ' 51' ' ' LEU . 40.2 tt0 -102.72 138.48 39.57 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.916 0.886 . . . . 55.11 109.369 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -115.08 122.94 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.309 1.044 . . . . 75.01 108.301 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.94 116.21 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.539 0.736 . . . . 62.3 109.479 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.59 108.44 19.96 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.907 -0.775 . . . . 74.23 108.907 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.534 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 55.0 ttt180 -86.89 106.19 17.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.828 0.851 . . . . 72.14 108.834 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.02 115.72 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.948 -0.76 . . . . 62.04 108.948 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 16.8 m -116.12 136.12 53.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.211 1.004 . . . . 73.1 109.302 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.404 HG11 HD13 ' B' ' 126' ' ' LEU . 54.1 t -120.0 125.03 73.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.811 1.245 . . . . 63.45 109.086 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -124.89 125.9 44.68 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.689 -0.486 . . . . 61.01 109.689 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.88 146.48 48.39 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.309 1.044 . . . . 44.41 109.335 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.2 p -149.16 128.93 13.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.443 0.535 . . . . 72.02 112.443 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' B' ' 34' ' ' LYS . 82.7 mt -97.32 108.4 21.12 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.396 1.079 . . . . 74.12 109.299 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.57 -124.2 7.96 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.002 -0.545 . . . . 72.43 111.784 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.9 1.96 46.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.378 0.671 . . . . 60.24 110.857 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -127.71 177.18 6.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.942 -0.474 . . . . 72.11 110.651 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . 0.429 ' HB ' ' OD1' ' B' ' 27' ' ' ASN . 11.9 m -68.49 157.46 35.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.534 1.133 . . . . 65.45 110.709 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -111.59 -58.68 2.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.018 -0.734 . . . . 65.54 109.018 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -162.73 158.45 22.98 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.237 -1.347 . . . . 61.2 108.266 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -124.08 138.71 54.4 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.724 1.209 . . . . 74.31 108.589 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -146.88 149.47 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.274 -0.639 . . . . 71.22 109.274 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -165.34 133.76 3.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.535 0.734 . . . . 73.21 109.036 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 113' ' ' CYS . 96.6 t -127.02 145.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.526 1.13 . . . . 64.54 108.704 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.534 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.1 mt-30 -126.03 96.89 4.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.258 -1.015 . . . . 70.22 108.258 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -94.42 107.17 19.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.634 -0.712 . . . . 71.24 109.127 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.613 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -109.35 141.59 16.06 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.237 -0.745 . . . . 55.43 111.237 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.71 132.4 5.89 Favored Glycine 0 CA--C 1.503 -0.682 0 N-CA-C 110.35 -1.1 . . . . 73.45 110.35 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.469 HG23 HD12 ' B' ' 51' ' ' LEU . 80.5 mt -85.73 125.95 40.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 123.509 0.724 . . . . 75.44 109.164 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -133.06 160.93 35.75 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.421 1.088 . . . . 74.34 108.629 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.532 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 50.9 m -129.41 112.96 14.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.29 -1.004 . . . . 51.25 108.29 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.725 ' HB ' HD11 ' B' ' 89' ' ' ILE . 40.1 pt -119.31 144.45 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.228 1.011 . . . . 74.04 110.314 -173.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.57 156.65 33.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 72.25 109.092 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.72 -61.11 3.5 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.304 0.377 . . . . 72.34 112.542 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.725 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 133.59 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.524 0.73 . . . . 74.21 111.676 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -152.02 147.51 26.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.073 0.549 . . . . 74.14 110.433 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.42 -104.41 0.98 Allowed Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.468 -0.787 . . . . 53.35 112.506 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -78.58 -35.04 46.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 74.11 110.465 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -64.99 -41.71 95.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.329 0.652 . . . . 63.42 110.021 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 58.4 ttp -70.13 -37.43 75.3 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.813 -0.631 . . . . 73.4 110.66 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.19 75.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.066 0.547 . . . . 72.44 111.258 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.82 -41.8 59.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.504 0.722 . . . . 73.41 110.628 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.83 -65.53 0.73 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.85 -0.614 . . . . 53.35 110.235 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -34.42 78.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.277 1.031 . . . . 65.43 111.305 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.79 54.73 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.568 -0.573 . . . . 51.22 114.509 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.41 -57.84 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 117.824 0.812 . . . . 65.43 112.012 -173.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -61.88 -56.83 15.26 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.991 0.916 . . . . 72.05 112.036 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.422 ' HA ' HD12 ' B' ' 105' ' ' ILE . 61.9 m -62.39 -43.24 84.28 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 124.124 0.969 . . . . 72.53 112.808 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.38 -46.38 33.88 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.536 2.157 . . . . 74.43 112.757 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -20.44 63.58 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 123.719 0.808 . . . . 54.11 112.743 -177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 102' ' ' CYS . 73.3 mt -71.58 -52.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.022 0.529 . . . . 64.31 110.311 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 pp -91.41 -6.18 53.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.554 -0.748 . . . . 63.04 112.166 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.22 -44.36 88.46 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.58 1.152 . . . . 75.35 112.684 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -53.21 -34.82 71.11 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.674 2.25 . . . . 70.04 113.802 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' D' ' 115' ' ' THR . 76.6 m-85 -73.46 -42.57 61.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.16 0.584 . . . . 74.15 110.515 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.31 98.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.132 0.573 . . . . 52.41 110.558 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.427 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 47.8 ttt-85 -57.27 -57.66 11.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.903 1.281 . . . . 72.32 111.089 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.03 -28.07 68.59 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.225 1.01 . . . . 75.45 110.876 -172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.1 t -74.0 -41.51 61.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.623 0.369 . . . . 73.41 110.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.428 HG21 HD22 ' B' ' 126' ' ' LEU . 63.1 mt -62.09 -41.68 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.375 -0.602 . . . . 61.34 109.375 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.592 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.5 m -62.28 -35.99 80.7 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.714 1.206 . . . . 64.52 111.449 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -70.01 -52.77 21.42 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.12 0.568 . . . . 73.21 109.875 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -65.43 -36.97 85.53 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.713 0.633 . . . . 74.14 112.028 -170.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' B' ' 123' ' ' PHE . 10.7 p -69.63 -34.12 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 122.481 0.312 . . . . 73.51 110.651 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -77.05 -21.73 54.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.341 0.656 . . . . 70.23 111.066 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -73.54 -34.65 65.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.13 0.572 . . . . 75.23 109.822 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.71 5.65 45.14 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.706 0.629 . . . . 62.24 112.549 169.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.4 p 59.43 46.83 11.87 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.614 1.965 . . . . 73.54 111.679 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.431 ' HB2' HG22 ' B' ' 118' ' ' VAL . 33.4 m-85 -119.48 157.05 52.64 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 113.898 -1.501 . . . . 75.01 109.781 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.57 143.89 76.73 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.902 2.401 . . . . 74.24 112.178 173.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.592 ' HB2' HG23 ' B' ' 115' ' ' THR . 3.4 pt20 -63.44 156.68 25.39 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.064 0.852 . . . . 64.54 111.993 -174.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.428 HD22 HG21 ' B' ' 114' ' ' ILE . 9.7 tt -125.23 105.01 8.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.353 -1.351 . . . . 75.32 107.353 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -91.44 115.72 28.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.997 -0.742 . . . . 70.44 108.997 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.65 HD11 HD21 ' B' ' 42' ' ' LEU . 1.1 mm? -67.16 107.56 2.37 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.197 -1.038 . . . . 72.31 108.197 166.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 158.05 54.68 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.127 0.971 . . . . 73.4 111.154 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -61.43 85.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 122.261 1.974 . . . . 74.12 112.153 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.07 110.79 22.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.269 -0.641 . . . . 75.45 109.269 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -82.3 104.22 12.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.256 -1.016 . . . . 73.15 108.256 173.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . 0.471 ' HE1' HD22 ' B' ' 44' ' ' LEU . 87.1 m-85 . . . . . 0 N--CA 1.481 1.11 0 C-N-CA 123.429 0.692 . . . . 74.41 111.306 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.638 ' HA ' HD12 ' C' ' 89' ' ' ILE . 58.0 ttp . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 113.133 0.79 . . . . 74.03 113.133 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 6.6 m -93.77 80.52 4.21 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.588 -0.893 . . . . 62.54 108.588 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -104.45 126.91 51.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.597 -0.729 . . . . 70.12 109.669 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' C' ' 85' ' ' SER . 1.6 pm0 -143.23 132.85 23.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.855 0.862 . . . . 63.23 109.808 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.61 HG22 ' HD3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -79.56 130.28 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.516 0.726 . . . . 61.52 109.213 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.6 mm100 -92.58 -54.2 3.88 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.398 -0.364 . . . . 72.5 110.104 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -169.02 126.84 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.825 0.45 . . . . 72.15 109.961 -173.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.602 HG13 HD11 ' C' ' 13' ' ' ILE . 80.0 mt -106.13 145.0 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.428 -1.323 . . . . 54.14 107.428 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.502 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 36.8 p90 -174.38 143.74 0.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.045 -0.724 . . . . 74.01 109.045 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -69.84 111.35 5.52 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.644 -0.873 . . . . 65.51 108.644 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -65.36 -42.18 93.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.594 0.711 . . . . 71.34 109.506 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -149.06 141.87 24.63 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.433 -1.258 . . . . 73.24 108.951 -176.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.1 mt -130.46 143.43 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.092 -1.447 . . . . 73.22 107.092 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -152.87 151.29 30.22 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.41 0.624 . . . . 70.52 110.897 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 73.1 t80 -152.41 121.19 6.51 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 107.101 -1.444 . . . . 73.15 107.101 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.3 mt-10 -122.85 112.08 17.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.23 80.96 67.18 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.032 -1.099 . . . . 64.12 108.032 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.2 -36.65 16.08 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.169 1.912 . . . . 75.44 111.135 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.461 ' O ' HG23 ' C' ' 31' ' ' VAL . 1.7 m-20 -85.07 14.25 5.24 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.465 1.106 . . . . 73.34 111.174 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.43 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -42.3 -56.99 4.88 Favored Pre-proline 0 N--CA 1.497 1.88 0 C-N-CA 125.773 1.629 . . . . 75.23 114.599 -171.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.4 -29.43 13.74 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.754 1.636 . . . . 74.11 111.997 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -69.76 -24.92 63.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.211 1.004 . . . . 74.53 112.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.567 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 58.4 t -64.4 -26.87 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.246 0.218 . . . . 61.2 111.226 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.02 0.0 12.61 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.875 0.695 . . . . 75.34 112.875 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -127.97 9.17 6.28 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.393 0.677 . . . . 72.24 110.959 170.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.698 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 3.4 ttmp? -87.9 151.92 22.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.335 1.054 . . . . 71.24 111.229 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.36 125.82 26.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.805 1.242 . . . . 73.15 109.617 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -82.78 70.84 9.85 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.277 0.631 . . . . 73.43 110.181 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -163.08 71.38 1.97 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.154 0.581 . . . . 73.02 109.924 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.04 154.14 8.37 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.86 2.374 . . . . 41.15 110.629 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.14 88.08 7.61 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.522 -1.288 . . . . 73.43 107.522 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 3.5 m -59.04 137.34 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 114.4 -1.273 . . . . 73.43 109.948 175.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 8.8 tmtt? -135.99 115.77 13.04 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.026 0.531 . . . . 70.43 109.771 -166.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.58 130.37 34.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.024 0.929 . . . . 75.21 108.591 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.2 t70 -142.78 106.34 4.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.827 0.451 . . . . 62.4 109.933 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.42 123.02 49.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.463 0.705 . . . . 74.31 110.315 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 2.5 m-20 -111.71 154.29 25.2 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.426 -0.953 . . . . 75.1 108.426 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -113.35 111.69 22.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.672 0.789 . . . . 74.13 109.379 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.21 136.49 53.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.159 0.984 . . . . 62.43 108.914 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.5 p -134.85 156.68 48.48 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.999 0.52 . . . . 73.33 110.283 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.28 126.82 15.08 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.257 1.023 . . . . 61.14 108.376 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -88.25 117.25 27.02 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.105 -1.072 . . . . 73.0 108.105 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.685 HD11 HD12 ' C' ' 83' ' ' ILE . 58.3 mt -87.71 -40.47 14.09 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.502 -0.772 . . . . 72.24 109.521 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.75 -173.01 3.07 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.718 -1.128 . . . . 73.54 110.101 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.56 120.56 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.719 -1.128 . . . . 61.23 109.049 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' C' ' 85' ' ' SER . 7.1 m-20 69.64 1.13 3.25 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.978 1.311 . . . . 63.02 112.831 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -112.01 95.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 107.757 -1.201 . . . . 61.31 107.757 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -119.64 125.59 49.1 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.759 0.824 . . . . 74.13 109.615 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.2 119.43 24.54 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.022 -0.99 . . . . 62.45 109.531 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.0 t -100.11 123.02 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.854 -1.165 . . . . 73.21 107.854 172.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.84 132.76 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.875 0.87 . . . . 63.3 108.699 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.78 112.23 23.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.38 -0.97 . . . . 73.24 108.38 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.672 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 1.6 tmm_? -82.53 104.18 12.61 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.847 -1.538 . . . . 72.44 106.847 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.22 133.22 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.264 -1.013 . . . . 54.42 108.264 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 94.3 m -128.77 133.88 48.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.159 -1.052 . . . . 71.02 108.159 175.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 39.1 t -121.43 112.2 34.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.751 -0.833 . . . . 71.04 108.751 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.532 HG23 HD23 ' C' ' 75' ' ' LEU . 2.2 m -99.74 148.72 24.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.704 -0.85 . . . . 72.52 108.704 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.96 108.43 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.342 -1.355 . . . . 63.53 107.342 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.0 m -146.67 139.85 25.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.06 -0.718 . . . . 73.33 109.06 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.92 45.99 0.94 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.131 0.972 . . . . 64.34 109.228 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.88 -116.61 4.05 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 114.795 -1.093 . . . . 73.31 111.043 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 -19.85 26.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.318 0.647 . . . . 73.31 110.024 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.698 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 12.4 tp10 -81.31 99.84 8.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.178 0.991 . . . . 60.34 109.252 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -87.96 131.25 34.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.984 0.421 . . . . 75.1 110.602 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.653 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -79.0 -64.0 1.29 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.616 1.166 . . . . 71.5 110.385 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -163.34 176.57 9.74 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.586 0.708 . . . . 62.41 110.149 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.532 HD23 HG23 ' C' ' 65' ' ' THR . 2.9 tm? -141.56 139.13 33.1 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.603 -1.628 . . . . 73.22 106.603 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 50.0 t -143.87 116.25 8.54 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.029 -0.73 . . . . 73.25 109.029 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -124.77 131.96 53.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.515 0.726 . . . . 72.0 109.414 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -132.99 115.73 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.233 1.013 . . . . 62.12 109.386 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.672 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 40.4 mt-30 -89.45 91.25 8.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.319 1.048 . . . . 64.22 108.209 172.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -88.79 119.04 28.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.321 -0.854 . . . . 75.2 110.122 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.39 159.3 15.04 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 123.588 0.555 . . . . 64.2 112.26 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.04 119.13 0.88 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.567 -1.013 . . . . 74.12 110.567 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.685 HD12 HD11 ' C' ' 51' ' ' LEU . 18.2 mm -79.78 122.08 34.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.607 -1.257 . . . . 72.52 107.607 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.72 124.79 36.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.548 0.739 . . . . 73.25 109.233 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.676 ' HB3' ' HG2' ' C' ' 12' ' ' GLN . 10.5 t -87.46 109.84 19.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.091 -1.077 . . . . 60.24 108.091 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.417 HD12 ' SD ' ' C' ' 94' ' ' MET . 22.6 pt -115.32 123.24 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.801 1.24 . . . . 73.14 109.205 -175.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -150.75 170.42 19.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.816 0.446 . . . . 72.34 111.726 -171.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.34 -48.34 1.92 Allowed Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.372 -0.831 . . . . 33.12 113.149 170.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.74 176.32 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.401 0.681 . . . . 62.15 110.929 -174.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.48 -171.23 3.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.028 0.931 . . . . 72.32 109.196 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.08 -147.98 47.02 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.527 0.517 . . . . 73.3 113.193 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 73.7 p -67.9 -18.69 64.86 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.007 0.923 . . . . 73.35 111.733 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -66.25 -43.95 85.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.684 0.794 . . . . 71.1 110.278 178.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.417 ' SD ' HD12 ' C' ' 86' ' ' ILE . 3.5 tmm? -81.32 -44.56 17.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.518 -0.765 . . . . 73.51 109.189 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.8 -25.67 67.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.237 1.015 . . . . 64.04 112.117 -177.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 28.0 t-80 -58.56 -47.16 85.17 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.701 0.8 . . . . 71.14 110.334 171.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.86 -55.07 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.352 -0.386 . . . . 70.24 111.292 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tt -62.09 -35.83 79.87 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.014 0.525 . . . . 71.22 111.462 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.0 -4.86 62.91 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.045 -0.864 . . . . 61.22 114.437 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.35 -53.07 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 118.558 1.179 . . . . 62.15 112.681 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.76 -48.18 60.26 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.973 0.509 . . . . 74.35 112.121 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.28 -43.76 94.29 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.449 0.7 . . . . 72.22 111.988 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.94 -47.37 21.69 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.78 2.32 . . . . 65.43 113.909 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -62.37 -29.12 70.25 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.392 0.677 . . . . 34.24 112.178 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -75.1 -50.84 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.926 0.491 . . . . 62.11 110.252 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.14 -18.41 53.23 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.909 -0.587 . . . . 73.44 112.225 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.52 -54.6 53.27 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.677 -1.154 . . . . 71.31 112.702 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.79 -32.2 92.63 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.939 1.759 . . . . 75.1 112.843 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.402 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.0 m-85 -66.45 -47.32 73.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.541 0.737 . . . . 73.14 110.962 177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.91 84.62 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.122 0.569 . . . . 72.15 110.524 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.595 ' HG3' HD23 ' C' ' 128' ' ' LEU . 56.2 ttt180 -61.1 -49.17 78.4 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.907 1.283 . . . . 74.2 110.943 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.34 -29.99 69.69 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.619 0.574 . . . . 73.14 110.082 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.0 t -73.91 -36.56 64.73 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.182 0.593 . . . . 74.01 111.42 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.595 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 91.7 mt -68.63 -47.85 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.486 0.714 . . . . 74.04 109.754 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 98.7 m -60.45 -35.78 76.67 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.077 1.351 . . . . 71.34 111.306 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -41.68 80.67 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.51 0.724 . . . . 74.21 109.844 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.613 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.37 -35.09 78.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.334 0.654 . . . . 75.23 111.796 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.7 t -62.56 -44.11 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.407 0.683 . . . . 73.31 109.896 173.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.7 p -75.03 -25.78 58.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.549 -0.75 . . . . 51.13 112.223 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.526 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.2 mtt-85 -74.58 -40.17 61.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.69 0.796 . . . . 74.1 110.391 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 3.1 66.13 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.736 0.647 . . . . 64.22 112.56 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.0 p 61.31 24.32 14.44 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.154 1.781 . . . . 54.23 112.533 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -83.88 154.65 64.6 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.739 -1.119 . . . . 74.12 110.118 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -47.71 137.16 21.27 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.483 2.789 . . . . 75.12 113.154 175.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' B' ' 125' ' ' GLN . 23.7 mm-40 -60.95 147.26 43.91 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.205 1.187 . . . . 63.21 114.205 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 68.3 tp -125.14 96.1 4.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.483 -1.235 . . . . 74.44 108.693 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.8 105.1 16.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.489 -0.93 . . . . 74.42 108.489 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.595 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -71.15 151.26 44.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.699 0.8 . . . . 74.42 111.935 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.09 155.61 72.35 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 115.151 -0.931 . . . . 51.13 109.946 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' A' ' 13' ' ' ILE . 34.4 Cg_exo -60.54 102.63 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.375 2.05 . . . . 45.12 111.95 171.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.18 106.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 106.7 -1.592 . . . . 74.42 106.7 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.414 ' ND2' HD12 ' A' ' 105' ' ' ILE . 78.7 m-20 -113.03 91.63 3.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.109 -0.951 . . . . 72.52 109.767 -169.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -64.35 -43.91 93.1 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 72.32 110.878 -177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t70 . . . . . 0 N--CA 1.47 0.548 0 CA-C-N 115.245 -0.889 . . . . 74.24 111.419 -176.642 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.8 m . . . . . 0 C--O 1.237 0.396 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -157.79 98.62 1.65 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.057 -1.46 . . . . 73.0 107.057 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -130.18 128.1 41.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.652 -1.24 . . . . 74.43 107.652 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.421 HD13 HG21 ' D' ' 105' ' ' ILE . 17.5 mt -70.87 136.28 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 123.685 0.616 . . . . 63.42 110.329 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -94.71 -47.54 6.45 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.682 -0.69 . . . . 74.44 110.29 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.04 145.88 22.48 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.3 0.64 . . . . 71.32 110.558 -166.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 mp -133.23 137.02 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 105.033 -2.21 . . . . 75.24 105.033 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -169.22 153.3 5.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.634 0.73 . . . . 74.41 110.691 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -84.4 118.43 24.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.688 -0.856 . . . . 74.2 108.688 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.4 mtpt -80.2 -37.61 32.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 54.52 110.228 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 22.3 t70 -151.1 140.87 21.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.914 -1.039 . . . . 72.43 109.129 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.613 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.1 mt -135.98 145.65 30.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 124.252 1.021 . . . . 73.44 108.25 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 45.2 t -147.88 133.52 18.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 54.34 108.244 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.4 t80 -144.68 117.58 8.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.849 -1.908 . . . . 71.11 105.849 170.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.14 129.0 51.93 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.294 -0.632 . . . . 71.31 109.294 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.21 79.67 27.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.205 -1.035 . . . . 73.04 108.205 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.86 -28.28 20.15 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.66 2.24 . . . . 62.12 112.743 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -113.71 40.69 2.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.501 -0.925 . . . . 72.43 108.501 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.502 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.97 -65.08 2.22 Favored Pre-proline 0 CA--C 1.568 1.666 0 N-CA-C 114.139 1.163 . . . . 61.12 114.139 -167.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.82 -11.0 11.53 Favored 'Trans proline' 0 C--N 1.393 2.901 0 CA-C-N 122.624 1.973 . . . . 74.3 112.067 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -71.4 -42.9 67.78 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.931 1.292 . . . . 75.14 110.107 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.23 -35.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 N-CA-C 109.504 -0.554 . . . . 74.1 109.504 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -58.05 -12.13 3.12 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.395 1.078 . . . . 74.11 113.55 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.64 -36.55 51.42 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.181 0.593 . . . . 75.45 110.685 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 60.97 1.67 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.861 0.464 . . . . 75.21 111.399 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -98.6 101.23 12.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.675 . . . . 72.03 111.044 -169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -122.59 -158.98 0.81 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.195 0.998 . . . . 64.14 108.671 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -58.24 106.52 0.71 Allowed Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.539 0.736 . . . . 74.3 110.589 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.35 122.21 5.06 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.819 2.346 . . . . 71.52 110.515 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.96 111.28 6.22 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.902 -1.148 . . . . 61.44 107.902 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' D' ' 66' ' ' ALA . 29.3 m -100.9 144.86 12.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.318 0.647 . . . . 63.42 110.081 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -120.05 129.22 54.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 63.24 108.468 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.01 112.11 24.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.506 -0.553 . . . . 75.23 109.506 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.785 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 12.9 m-20 -108.07 132.05 53.96 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.994 0.918 . . . . 75.21 109.912 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 mp -110.8 131.41 55.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.262 0.625 . . . . 73.12 109.434 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.8 t70 -133.55 131.46 39.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.487 -1.301 . . . . 52.41 107.487 172.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -105.52 141.81 36.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.98 0.512 . . . . 42.34 109.883 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.64 164.04 37.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.787 0.835 . . . . 54.12 109.071 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.1 p -174.92 161.04 2.94 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.376 0.67 . . . . 74.32 110.896 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 86.6 p -152.17 145.71 24.91 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.76 0.824 . . . . 73.43 109.474 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -81.92 130.93 35.22 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.284 -0.636 . . . . 64.31 109.284 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' D' ' 57' ' ' GLU . 54.6 mt -104.38 -34.93 8.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.134 0.573 . . . . 65.3 109.511 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.51 -174.88 4.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.159 0.584 . . . . 71.24 111.082 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.34 116.14 7.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.535 -1.211 . . . . 71.32 109.189 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 68.05 7.25 5.7 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.465 1.106 . . . . 64.14 112.126 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 88.1 t -113.51 119.06 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.322 1.049 . . . . 64.55 108.533 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.49 134.2 31.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.705 0.402 . . . . 75.12 110.055 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' D' ' 51' ' ' LEU . 11.0 tt0 -88.22 114.5 24.9 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.857 -1.164 . . . . 72.25 107.857 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.09 120.11 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.617 -1.253 . . . . 44.54 107.617 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.9 t -105.61 131.93 53.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.668 0.787 . . . . 53.33 109.064 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.24 108.15 13.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.497 -1.297 . . . . 74.25 107.497 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.3 ttm-85 -84.11 106.24 15.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.991 -0.744 . . . . 72.15 108.991 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.26 130.49 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.267 -1.012 . . . . 73.22 108.267 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 54.2 m -124.73 147.47 48.62 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.429 0.691 . . . . 72.5 109.15 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -135.95 115.74 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.666 1.186 . . . . 74.24 109.07 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.5 m -106.29 103.63 13.15 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 74.11 109.446 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.431 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -97.18 125.06 41.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.456 0.302 . . . . 62.42 110.386 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 52.2 p -125.55 125.47 43.27 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.001 0.92 . . . . 63.52 109.359 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' D' ' 73' ' ' ALA . 3.2 tm? -104.47 114.05 28.02 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.455 -0.943 . . . . 75.13 108.455 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -111.22 3.84 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.621 0.575 . . . . 34.52 111.998 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 8.38 19.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.12 0.968 . . . . 74.42 110.97 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 175.26 9.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.492 0.717 . . . . 64.44 110.119 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -80.28 137.06 36.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.495 0.718 . . . . 51.1 111.07 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' D' ' 68' ' ' LEU . . . -84.89 -63.97 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.718 -0.845 . . . . 71.03 108.718 170.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.46 168.67 24.75 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.423 -1.262 . . . . 73.21 109.994 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 97.7 mt -132.7 151.62 51.93 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.89 -1.152 . . . . 73.54 107.89 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.633 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -154.9 141.29 18.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.155 0.582 . . . . 71.21 109.939 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 33.3 tt0 -158.14 134.68 9.59 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 71.13 109.995 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.94 126.23 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.746 0.818 . . . . 74.42 109.302 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -97.22 87.22 4.12 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.678 -1.23 . . . . 72.01 107.678 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.89 98.76 8.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.847 -0.615 . . . . 70.12 109.562 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.49 144.36 17.13 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.596 -0.729 . . . . 45.55 111.698 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.49 131.05 3.74 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.314 -0.715 . . . . 71.05 111.314 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -90.33 126.98 43.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.376 -0.972 . . . . 61.24 108.376 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -126.96 144.39 51.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.01 0.924 . . . . 64.2 110.075 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -96.81 94.51 7.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.51 -0.922 . . . . 74.25 108.51 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 mt -108.78 101.06 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.361 -0.607 . . . . 71.35 109.361 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.42 1.088 . . . . 61.34 109.838 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.81 -11.33 59.97 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 114.343 0.497 . . . . 44.53 114.343 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.21 154.46 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.021 0.928 . . . . 70.21 110.781 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 -174.52 4.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.283 1.033 . . . . 75.33 110.043 172.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.54 -140.51 39.01 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 114.282 0.473 . . . . 65.01 114.282 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.9 p -70.84 -32.6 69.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.315 1.046 . . . . 75.12 112.037 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.19 -43.45 78.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.715 0.806 . . . . 70.22 110.649 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -74.06 -32.81 63.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.811 -0.631 . . . . 61.51 110.506 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.37 96.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.943 0.497 . . . . 53.3 110.461 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.09 -36.05 76.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.715 0.806 . . . . 74.4 110.884 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.54 -50.43 67.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.864 0.465 . . . . 75.43 111.498 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.485 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 2.9 pp -75.63 -23.35 56.35 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 111.974 0.361 . . . . 60.44 111.974 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.33 -0.98 56.84 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.53 -0.595 . . . . 72.4 114.361 -172.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.6 -60.69 0.51 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.241 0.52 . . . . 51.42 111.068 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -68.18 -45.71 72.71 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.577 0.751 . . . . 64.25 111.51 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 63.5 m -65.66 -45.76 67.06 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-O 118.695 -0.669 . . . . 72.13 112.018 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 84.0 Cg_exo -54.25 -34.93 81.62 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.665 2.243 . . . . 70.32 113.908 168.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -66.85 -26.43 66.9 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.85 0.46 . . . . 63.14 111.775 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.421 HG21 HD13 ' D' ' 13' ' ' ILE . 32.6 mm -75.71 -47.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.165 0.586 . . . . 74.55 109.775 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.02 -32.23 59.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.154 -0.93 . . . . 53.01 112.609 -169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -62.71 -44.57 86.75 Favored Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 118.177 -0.916 . . . . 65.22 113.042 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.98 -39.02 80.48 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.552 2.168 . . . . 53.24 113.996 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -79.87 -28.31 39.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.156 0.582 . . . . 75.53 111.906 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.21 66.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.798 -0.815 . . . . 65.43 108.798 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -60.84 -35.08 75.63 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.003 1.321 . . . . 71.1 111.396 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.526 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.0 tt0 -56.05 -53.54 55.74 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.021 0.928 . . . . 75.23 110.424 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' D' ' 21' ' ' ILE . 49.8 t -67.25 -42.3 84.14 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.806 -1.088 . . . . 62.1 111.306 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.633 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.7 mt -58.57 -60.05 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.822 0.849 . . . . 50.14 110.486 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.469 HG23 ' HB3' ' D' ' 125' ' ' GLN . 97.6 m -52.51 -43.56 65.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.512 1.125 . . . . 72.31 112.1 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.9 t -68.15 -36.96 80.49 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.501 -0.772 . . . . 73.02 111.014 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 77.7 mtm -67.87 -37.77 82.22 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.662 0.385 . . . . 45.13 111.315 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.9 t -65.41 -41.6 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.324 -0.853 . . . . 73.33 110.337 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 78.3 p -72.28 -30.47 64.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.162 0.585 . . . . 62.41 111.388 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.51 -29.95 65.38 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.927 0.491 . . . . 74.12 110.56 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 6.67 73.66 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.591 0.557 . . . . 45.24 112.456 174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 60.5 25.45 15.08 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 126.591 1.956 . . . . 74.33 113.342 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.18 159.68 31.57 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.575 1.15 . . . . 72.24 108.441 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.76 135.01 29.36 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.473 2.116 . . . . 73.2 111.021 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.469 ' HB3' HG23 ' D' ' 115' ' ' THR . 26.7 mt-30 -49.19 120.03 3.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.381 1.051 . . . . 74.15 110.842 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.02 94.05 5.03 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.501 -0.925 . . . . 73.02 108.501 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -100.65 104.23 15.54 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.207 -1.361 . . . . 73.32 107.946 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.37 143.76 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.863 -0.608 . . . . 62.34 111.459 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -63.46 133.3 95.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 114.968 -1.014 . . . . 63.45 110.757 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 9.7 Cg_endo -80.39 124.61 5.37 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.643 2.229 . . . . 62.12 111.119 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 60.3 t -107.72 109.36 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.628 -0.879 . . . . 50.14 108.628 -179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -72.63 96.37 1.98 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.043 -1.095 . . . . 71.24 108.043 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 N--CA 1.478 0.953 0 C-N-CA 123.302 0.641 . . . . 72.34 112.023 -174.418 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 108.702 -0.851 . . . . 72.44 108.702 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.476 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 3.1 t80 -137.7 134.42 35.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 73.2 110.139 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -154.54 136.0 14.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.101 -1.409 . . . . 74.3 107.396 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.58 HD12 HD21 ' C' ' 132' ' ' ASN . 32.0 mt -92.44 130.84 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.322 -0.622 . . . . 65.14 109.322 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -98.1 -41.33 7.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.779 -0.629 . . . . 71.31 110.537 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 ttt180 -177.89 123.5 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 112.926 0.713 . . . . 64.32 112.926 -170.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.592 HD13 ' HG3' ' C' ' 130' ' ' PRO . 4.0 mp -104.61 134.74 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.836 -1.172 . . . . 71.03 107.836 168.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -166.16 152.42 9.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.484 1.113 . . . . 71.31 109.416 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -75.51 118.28 18.2 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.871 -0.788 . . . . 64.23 108.871 172.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -80.56 -24.33 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.65 -0.5 . . . . 72.43 109.65 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -158.91 143.3 15.62 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.1 -0.954 . . . . 74.02 109.8 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.421 HD13 ' SD ' ' B' ' 117' ' ' MET . 86.0 mt -132.33 146.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.914 1.286 . . . . 63.31 107.972 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.89 135.13 15.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.491 0.717 . . . . 73.21 109.516 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.9 t80 -138.06 131.21 30.26 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.686 -1.598 . . . . 73.32 106.686 171.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -133.6 114.21 13.28 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.276 0.63 . . . . 64.1 109.556 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -107.39 83.03 1.37 Allowed Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.496 -1.668 . . . . 21.02 106.496 162.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.58 -31.94 16.04 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 122.605 2.203 . . . . 62.3 112.155 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -113.88 22.9 13.52 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.278 1.031 . . . . 62.41 109.053 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.494 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -43.54 -63.11 1.11 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-O 117.997 -1.002 . . . . 74.13 113.384 -168.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.51 -17.42 59.92 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.024 1.816 . . . . 73.24 113.354 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -85.9 -52.4 5.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.929 0.871 . . . . 64.23 109.995 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -70.52 -21.7 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.034 -1.439 . . . . 52.33 111.941 -160.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -64.42 -30.1 71.15 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.534 0.734 . . . . 74.44 112.22 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.83 -11.58 20.64 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.217 0.607 . . . . 75.21 112.423 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -78.64 171.74 14.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.01 0.524 . . . . 71.21 111.086 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.37 118.22 6.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.052 0.941 . . . . 62.23 110.741 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -79.84 82.37 5.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.573 0.702 . . . . 74.2 110.097 -177.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -126.12 70.28 68.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.419 1.087 . . . . 74.03 108.948 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -78.74 127.67 8.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.609 2.206 . . . . 54.44 112.045 -172.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -97.97 93.95 6.6 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.854 -1.536 . . . . 42.44 106.854 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.5 m -76.73 106.11 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.617 -1.174 . . . . 75.02 110.578 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 16.7 mtpp -81.73 134.96 35.5 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.959 -1.019 . . . . 74.34 110.402 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tt -110.74 106.45 15.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 106.154 -1.795 . . . . 63.13 106.154 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.3 m-20 -114.16 142.33 46.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.228 -1.397 . . . . 64.42 107.228 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.724 HD21 HD12 ' A' ' 60' ' ' LEU . 5.7 tt -141.46 128.64 20.93 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.948 -1.13 . . . . 74.12 107.948 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -117.15 134.28 54.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.581 1.153 . . . . 74.44 108.678 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.4 p -110.57 123.1 49.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.589 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.93 131.69 37.55 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.683 0.793 . . . . 71.23 110.477 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.55 152.56 51.92 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.035 0.445 . . . . 64.22 110.325 171.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 163.64 39.01 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.952 1.301 . . . . 71.1 108.233 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -112.54 146.56 38.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.206 0.602 . . . . 72.4 109.515 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -117.62 -43.75 2.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.878 0.871 . . . . 63.43 110.361 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.58 -168.52 3.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.204 0.601 . . . . 73.32 110.819 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.43 112.33 3.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.781 0.832 . . . . 71.55 110.346 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.4 0.39 2.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.516 1.527 . . . . 63.23 112.364 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -96.81 107.09 19.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.475 -1.306 . . . . 75.12 107.475 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.471 -0.937 . . . . 71.14 108.471 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -92.07 112.83 24.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.938 0.895 . . . . 70.01 109.396 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.14 111.32 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.619 -1.252 . . . . 65.33 107.619 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 32.1 t -106.7 129.54 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.621 0.768 . . . . 74.04 110.001 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.724 HD12 HD21 ' A' ' 44' ' ' LEU . 4.2 mm? -117.89 110.04 17.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.643 -0.873 . . . . 62.21 108.643 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.527 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 11.0 ttp180 -84.82 107.44 16.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.58 -0.896 . . . . 74.24 108.58 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 16.4 t -92.45 125.34 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 107.807 -1.183 . . . . 75.21 107.807 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.9 m -118.79 136.89 53.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.019 -0.734 . . . . 44.54 109.019 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.783 HG11 HD21 ' A' ' 126' ' ' LEU . 45.4 t -136.78 115.88 15.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 124.44 1.096 . . . . 73.21 108.068 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 7.1 m -105.25 148.02 27.43 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.912 -0.773 . . . . 74.42 108.912 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.23 106.65 7.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.086 -1.45 . . . . 73.21 107.086 168.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 17.9 t -116.8 126.97 53.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.682 -0.488 . . . . 73.22 109.682 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.551 HD22 HG22 ' A' ' 31' ' ' VAL . 7.7 mp -87.56 82.49 7.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 74.01 107.914 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.28 -84.72 0.83 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 114.976 -1.011 . . . . 54.43 111.881 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -111.92 -27.88 8.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.294 1.037 . . . . 71.13 111.686 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.7 125.15 54.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.564 0.346 . . . . 70.04 111.005 -169.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 63.7 m -73.7 129.3 37.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.573 0.749 . . . . 71.3 112.441 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -69.75 -65.64 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.868 -1.06 . . . . 54.33 109.911 169.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.13 167.77 27.46 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.289 -0.869 . . . . 65.1 111.607 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 tp -141.36 116.09 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.354 1.461 . . . . 65.35 107.728 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.6 m -105.66 131.79 52.6 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.332 0.653 . . . . 64.2 109.559 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 32.6 tt0 -146.59 115.38 6.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.58 -0.526 . . . . 64.34 109.58 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.74 114.27 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.97 0.908 . . . . 63.31 109.231 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 48.5 mt-30 -83.88 84.39 7.59 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.265 -1.013 . . . . 75.1 108.265 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.86 98.26 6.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.322 -0.992 . . . . 63.0 108.322 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.89 145.88 21.04 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.202 -0.759 . . . . 72.03 111.202 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.728 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.14 121.79 1.31 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 111.047 -0.821 . . . . 64.54 111.047 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -87.78 123.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 123.87 0.868 . . . . 54.34 108.736 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HD2' HG12 ' A' ' 13' ' ' ILE . 46.9 m-85 -131.71 120.26 22.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 m -77.78 90.91 4.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.551 0.74 . . . . 54.2 109.333 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.496 HG21 ' SG ' ' A' ' 97' ' ' CYS . 1.6 pp -118.69 133.26 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.806 0.842 . . . . 75.12 110.509 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.4 177.15 11.48 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.695 0.798 . . . . 61.4 111.125 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.52 86.68 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.758 0.662 . . . . 71.54 112.298 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.76 136.12 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.497 1.119 . . . . 73.02 109.936 -171.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -131.41 172.07 12.62 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.136 0.974 . . . . 74.51 108.863 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.42 4.59 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 115.001 0.761 . . . . 65.4 115.001 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.2 -18.74 58.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.953 0.901 . . . . 22.43 112.041 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -67.87 -48.88 64.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.176 0.591 . . . . 71.11 110.236 175.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.2 ttm -80.63 -18.56 47.77 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.592 -0.276 . . . . 64.51 110.454 177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -66.38 -33.87 76.69 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.037 0.446 . . . . 73.12 110.428 169.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -68.66 -41.74 78.92 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.874 -0.603 . . . . 75.14 110.26 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 86' ' ' ILE . 47.3 t -64.26 -54.21 36.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.984 0.514 . . . . 72.41 111.959 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 mt -76.26 -35.94 58.69 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.409 0.443 . . . . 65.12 111.719 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.09 4.59 38.58 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 114.858 0.703 . . . . 70.4 114.858 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.6 -52.23 0.23 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.85 0.825 . . . . 43.23 112.436 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.564 ' HA ' ' HB3' ' A' ' 134' ' ' ASP . 66.4 t80 -79.81 -68.92 0.62 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.52 0.728 . . . . 63.55 111.939 -168.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.3 m -68.86 -32.36 3.45 Favored Pre-proline 0 CA--C 1.572 1.826 0 N-CA-C 114.844 1.424 . . . . 54.33 114.844 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 28.8 Cg_endo -61.45 -21.87 73.03 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 122.556 2.17 . . . . 65.13 113.458 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -68.12 -26.12 65.64 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.203 0.601 . . . . 75.23 110.034 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.453 HG21 HD13 ' A' ' 13' ' ' ILE . 39.5 mm -71.2 -36.01 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.477 0.711 . . . . 74.53 109.858 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.728 HD21 ' HA3' ' A' ' 82' ' ' GLY . 97.0 mt -83.48 -30.68 26.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.936 0.894 . . . . 73.54 112.883 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -62.9 -39.79 56.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 113.818 1.044 . . . . 55.21 113.818 -170.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.01 -37.67 51.58 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.387 2.058 . . . . 63.12 113.281 172.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -71.76 -38.62 70.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.14 0.576 . . . . 73.35 111.625 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -45.18 83.42 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.572 -0.529 . . . . 74.33 109.572 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.431 HH22 ' HB3' ' A' ' 130' ' ' PRO . 40.1 ttm180 -53.75 -50.45 65.97 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 124.646 1.216 . . . . 70.05 110.905 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.65 -41.6 75.36 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.204 0.94 . . . . 75.24 111.303 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 44.0 t -56.17 -42.21 76.69 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.576 0.547 . . . . 74.23 110.169 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 118' ' ' VAL . 92.8 mt -66.13 -50.33 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.593 -1.185 . . . . 75.13 110.296 175.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.445 HG23 ' HG3' ' A' ' 125' ' ' GLN . 63.0 m -52.8 -41.93 64.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.301 1.041 . . . . 44.51 111.375 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -69.17 -51.22 40.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.647 -1.161 . . . . 73.4 110.616 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.1 mtp -51.05 -42.91 60.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.026 0.931 . . . . 74.14 111.725 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -64.82 -50.96 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-N 114.376 -1.284 . . . . 72.34 110.718 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 93.2 p -70.38 -22.71 62.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.029 0.532 . . . . 54.12 111.947 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.61 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -75.19 -31.19 60.88 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.796 0.838 . . . . 73.2 110.048 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 -3.26 86.13 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 116.124 -0.489 . . . . 74.34 112.604 171.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.585 ' HB ' HH21 ' B' ' 15' ' ' ARG . 23.3 m 60.05 43.73 14.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.318 1.532 . . . . 65.3 110.133 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -99.53 163.9 17.65 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 113.029 -1.896 . . . . 64.04 108.888 169.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -68.12 136.46 37.76 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.766 2.311 . . . . 64.53 111.795 -178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.0 tt0 -48.31 124.37 7.82 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.584 1.177 . . . . 60.02 111.521 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.783 HD21 HG11 ' A' ' 64' ' ' VAL . 12.4 tp -108.13 100.54 9.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.695 0.798 . . . . 65.32 110.484 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.84 97.75 7.22 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.891 -1.152 . . . . 73.14 107.891 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.67 120.89 18.92 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.239 -0.437 . . . . 75.13 110.314 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 133.04 88.87 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.118 0.967 . . . . 72.34 111.934 -173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.431 ' HB3' HH22 ' A' ' 111' ' ' ARG . 18.0 Cg_endo -87.22 166.49 8.08 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.646 2.231 . . . . 74.43 113.351 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.58 142.51 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 106.779 -1.563 . . . . 71.12 106.779 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.45 75.46 6.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.907 -1.146 . . . . 72.54 107.907 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.5 -43.73 89.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.475 1.11 . . . . 74.21 111.843 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 101' ' ' TYR . 5.3 p-10 . . . . . 0 N--CA 1.476 0.867 0 C-N-CA 123.994 0.917 . . . . 74.42 111.806 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 63.1 m . . . . . 0 C--O 1.237 0.422 0 N-CA-C 107.765 -1.198 . . . . 52.2 107.765 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.64 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 19.4 t80 -141.86 118.59 11.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.556 0.742 . . . . 72.02 109.312 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.466 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 7.3 pt20 -154.88 130.38 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.743 0.817 . . . . 72.02 109.155 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -81.31 132.53 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.142 0.577 . . . . 62.41 109.825 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -89.24 -48.54 7.31 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.884 -0.413 . . . . 74.24 109.884 168.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.585 HH21 ' HB ' ' A' ' 122' ' ' THR . 58.9 ttt180 -162.95 154.85 18.07 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 111.395 0.146 . . . . 74.22 111.395 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.408 ' HB ' HD21 ' D' ' 127' ' ' ASN . 87.3 mt -137.39 111.37 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.403 1.081 . . . . 75.22 108.083 171.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.406 ' HE1' HG13 ' B' ' 83' ' ' ILE . 24.9 p90 -137.2 147.92 46.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.853 0.461 . . . . 75.13 110.379 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -75.3 119.05 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.742 -0.663 . . . . 61.03 109.744 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -89.92 -23.15 21.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.68 0.792 . . . . 73.32 111.121 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.37 141.64 4.54 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.217 0.323 . . . . 73.5 111.789 -173.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -133.12 146.41 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.195 1.398 . . . . 73.02 109.084 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.0 t -149.08 151.94 35.32 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.881 0.872 . . . . 72.15 109.009 172.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -156.01 122.7 5.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.2 mt-10 -125.12 113.05 17.2 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.031 -0.729 . . . . 71.13 109.031 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.42 84.03 9.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.874 -1.158 . . . . 74.24 107.874 170.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.7 -22.96 17.31 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.661 2.241 . . . . 73.45 111.638 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -113.37 15.31 19.22 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.538 1.135 . . . . 73.1 110.576 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.686 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.68 -58.1 9.29 Favored Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 125.335 1.454 . . . . 62.52 114.607 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.76 -25.63 39.52 Favored 'Trans proline' 0 C--N 1.398 3.154 0 C-N-CA 121.903 1.735 . . . . 70.34 112.712 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.492 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 75.2 m80 -97.99 1.21 47.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.485 0.714 . . . . 73.3 112.876 -174.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.91 -22.66 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.227 0.611 . . . . 73.35 112.521 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -64.95 -30.77 71.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.941 0.897 . . . . 74.33 112.175 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.7 pt20 -65.49 -36.08 82.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 110.101 -0.333 . . . . 63.51 110.101 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.658 ' HB2' HD13 ' B' ' 68' ' ' LEU . 83.3 mttt -108.89 65.63 0.62 Allowed 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.616 0.722 . . . . 74.25 109.169 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -75.28 108.29 7.95 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.116 -0.947 . . . . 64.12 109.643 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.443 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 162.13 -171.69 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 127.61 2.364 . . . . 74.13 108.985 159.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -72.3 128.8 88.38 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 122.963 0.164 . . . . 72.42 110.838 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.52 -176.22 3.0 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.673 2.249 . . . . 75.43 111.05 168.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -76.04 106.78 7.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.796 -1.187 . . . . 72.0 107.796 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.13 136.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.079 -1.082 . . . . 74.35 108.079 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -150.98 142.41 23.43 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.279 0.631 . . . . 72.33 109.653 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -85.97 159.72 19.55 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.976 0.893 . . . . 71.1 110.505 171.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 33.7 t70 -140.09 110.46 6.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.448 -2.056 . . . . 64.42 105.448 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.87 134.63 47.66 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.885 -0.783 . . . . 71.43 108.885 -167.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.8 t70 -131.36 139.97 49.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.844 -0.799 . . . . 73.52 108.844 172.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -109.71 124.94 52.09 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.124 0.969 . . . . 72.4 109.605 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.61 43.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.699 0.8 . . . . 75.31 108.893 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -143.19 161.33 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.674 0.389 . . . . 73.14 110.198 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 84.9 p -153.06 150.76 29.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.786 0.834 . . . . 64.22 109.514 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.99 114.91 29.26 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.862 -0.792 . . . . 65.43 108.862 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 77.5 mt -77.75 -42.83 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.807 0.443 . . . . 64.23 110.343 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.11 -171.07 2.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.63 -0.714 . . . . 64.53 111.118 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.33 118.53 9.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.438 -1.256 . . . . 53.22 110.091 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.75 -3.94 1.3 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.296 1.438 . . . . 75.41 112.488 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.96 107.11 21.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.462 -0.94 . . . . 65.23 108.462 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.22 156.63 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.401 -0.818 . . . . 64.23 109.136 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.403 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 7.4 tm-20 -133.12 97.26 3.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.214 -1.402 . . . . 75.1 107.214 -167.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.4 128.83 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.341 1.056 . . . . 71.11 109.238 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.33 143.65 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.917 0.887 . . . . 72.03 109.401 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' B' ' 103' ' ' PRO . 58.6 mt -129.32 122.8 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.419 0.687 . . . . 74.12 109.406 170.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.639 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.8 ttm180 -92.19 108.57 20.04 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.469 -0.937 . . . . 71.31 108.469 172.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.12 103.14 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.197 -1.408 . . . . 73.4 107.197 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 10.8 m -104.53 124.43 49.28 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.228 -0.656 . . . . 74.25 109.228 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.565 HG21 HG21 ' B' ' 114' ' ' ILE . 90.8 t -103.09 104.72 17.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.626 0.77 . . . . 63.52 109.124 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.4 m -94.96 136.89 34.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.341 -0.845 . . . . 73.2 109.415 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.62 136.05 24.1 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.586 -0.894 . . . . 73.43 108.586 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.9 p -142.05 130.59 22.58 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.531 0.519 . . . . 55.04 111.532 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' B' ' 34' ' ' LYS . 46.5 mt -92.29 99.34 12.13 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -109.82 2.96 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.473 -0.785 . . . . 52.25 111.742 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.8 4.3 18.3 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.453 1.101 . . . . 65.11 111.564 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.66 170.88 9.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.609 0.764 . . . . 61.1 109.726 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -76.49 152.53 36.07 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.876 0.47 . . . . 63.04 110.903 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.575 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -104.98 -63.28 1.24 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.271 -1.011 . . . . 45.33 108.271 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.94 156.67 22.69 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.13 -1.396 . . . . 64.44 108.253 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 80.0 mt -132.77 148.82 52.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.532 1.133 . . . . 70.4 108.3 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.92 159.63 44.02 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.333 -0.988 . . . . 64.33 108.333 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.4 tt0 -163.34 137.78 6.14 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.671 0.388 . . . . 75.23 110.004 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.406 HG22 HD12 ' B' ' 21' ' ' ILE . 78.5 t -135.97 144.63 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.154 0.981 . . . . 64.45 109.202 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -122.56 105.43 10.11 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.5 -1.296 . . . . 72.41 107.5 169.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.522 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -99.59 108.75 21.23 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 149.94 20.55 Favored Glycine 0 C--O 1.242 0.605 0 N-CA-C 110.914 -0.874 . . . . 61.14 110.914 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.44 123.66 2.03 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.015 -0.834 . . . . 63.42 111.015 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.406 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.3 mt -88.11 126.78 41.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.691 -0.855 . . . . 62.1 108.691 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -135.36 134.38 39.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.483 1.113 . . . . 75.21 108.819 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.466 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 32.7 m -93.92 96.65 9.85 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.75 -0.833 . . . . 72.13 108.75 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -110.7 135.4 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.018 0.927 . . . . 61.43 110.668 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.16 164.47 37.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 74.15 109.296 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 83.67 -39.02 2.8 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 123.003 0.335 . . . . 70.42 113.776 175.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 28.9 pt -60.85 145.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.326 1.05 . . . . 73.31 111.587 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -166.28 163.1 17.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.663 0.785 . . . . 75.22 109.891 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.8 -123.19 32.65 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.87 0.732 . . . . 44.34 113.391 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -67.98 -36.21 79.66 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.407 1.083 . . . . 54.21 110.936 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.64 -29.97 67.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.794 -1.094 . . . . 74.31 110.674 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -49.66 60.33 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.358 -0.837 . . . . 75.43 109.632 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.3 73.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.123 0.969 . . . . 72.43 111.85 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -69.7 -34.22 73.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.89 0.876 . . . . 65.12 110.709 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -70.35 -66.88 0.54 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.043 -0.526 . . . . 73.41 111.112 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.548 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.0 OUTLIER -87.9 -14.47 39.27 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.339 0.496 . . . . 62.32 112.339 -169.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.401 ' N ' HD13 ' B' ' 98' ' ' LEU . . . -101.23 -4.22 53.66 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.896 -0.391 . . . . 63.01 113.379 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.82 -58.79 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 117.149 0.475 . . . . 63.34 111.66 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -73.41 -44.93 57.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 73.04 111.999 -172.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.64 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 35.2 m -68.01 -43.8 37.46 Favored Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 118.752 -0.642 . . . . 64.25 111.64 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.42 ' HB3' HD11 ' B' ' 60' ' ' LEU . 29.1 Cg_exo -44.94 -53.03 5.61 Favored 'Trans proline' 0 C--N 1.4 3.241 0 C-N-CA 123.038 2.492 . . . . 63.51 113.354 167.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -56.62 -23.65 42.52 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.219 1.008 . . . . 73.03 113.467 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.408 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.7 mt -78.81 -52.57 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.06 0.544 . . . . 72.44 110.929 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -87.38 -7.99 57.1 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -65.28 -45.02 70.61 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.669 1.188 . . . . 45.54 113.186 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.87 -37.66 66.79 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.627 2.218 . . . . 63.33 113.531 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.522 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 44.0 m-85 -68.96 -39.84 79.25 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.243 -0.89 . . . . 74.43 110.393 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.37 -45.49 79.93 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.669 0.388 . . . . 50.3 110.669 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -54.66 -56.13 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.329 1.452 . . . . 74.32 111.699 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.856 0.863 . . . . 75.14 110.791 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.61 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.0 t -66.86 -31.75 72.56 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.0 -0.545 . . . . 70.15 111.385 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.565 HG21 HG21 ' B' ' 64' ' ' VAL . 70.8 mt -67.53 -50.31 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.561 0.744 . . . . 73.04 110.314 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.5 m -61.84 -27.68 68.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 123.945 0.778 . . . . 73.35 111.245 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.14 -50.31 68.71 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.746 0.818 . . . . 64.34 110.295 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -72.49 -34.36 67.61 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.188 0.595 . . . . 62.01 111.653 -171.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.73 -38.55 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.469 0.708 . . . . 65.11 110.029 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t -72.94 -26.19 61.3 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.064 -0.971 . . . . 61.32 111.344 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.4 mtt-85 -73.81 -25.07 59.92 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.143 0.577 . . . . 52.41 110.5 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.24 14.71 32.33 Favored Glycine 0 C--N 1.357 1.697 0 O-C-N 123.541 0.525 . . . . 74.4 112.342 168.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 51.7 p 56.43 47.67 18.41 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.756 2.022 . . . . 63.24 112.612 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.08 151.96 46.17 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.205 -1.361 . . . . 74.12 109.658 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.26 -160.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.957 2.438 . . . . 54.44 113.33 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.648 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.43 125.69 25.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.347 1.059 . . . . 62.43 113.115 -170.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 59.5 tp -136.93 95.38 3.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.438 -0.949 . . . . 44.45 108.438 171.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -103.74 135.97 44.3 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.032 0.933 . . . . 73.41 110.547 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.3 tp -83.35 137.33 34.0 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.681 0.792 . . . . 71.5 109.709 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.51 152.82 95.34 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.278 1.031 . . . . 72.21 112.054 -173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.4 111.28 1.42 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.492 2.795 . . . . 61.41 112.863 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 t -106.6 110.28 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 61.41 109.341 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -97.25 100.25 11.71 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.355 -0.98 . . . . 72.5 108.355 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 . . . . . 0 N--CA 1.476 0.858 0 C-N-CA 123.464 0.706 . . . . 73.14 110.701 -178.782 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.5 ' HA ' HG13 ' C' ' 89' ' ' ILE . 59.6 ttp . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 113.573 0.953 . . . . 71.52 113.573 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 26.6 m -120.5 94.19 4.29 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.689 -1.226 . . . . 32.2 107.689 167.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -97.13 157.25 16.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.133 -0.939 . . . . 74.41 108.902 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.41 ' HG3' HE21 ' C' ' 14' ' ' GLN . 10.9 pt20 -170.92 129.28 0.77 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.533 0.733 . . . . 75.52 110.155 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.667 HD13 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -90.88 107.88 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.7 0.8 . . . . 73.42 109.594 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.41 HE21 ' HG3' ' C' ' 12' ' ' GLN . 79.7 mm-40 -76.52 -52.83 9.02 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.079 -0.388 . . . . 51.32 110.609 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 63.3 ttt180 -166.21 128.58 1.92 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.987 -0.375 . . . . 72.4 109.987 -176.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -108.07 146.36 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.849 -1.167 . . . . 70.42 107.849 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.507 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -176.93 163.39 2.2 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.565 0.698 . . . . 73.34 110.912 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -85.08 117.44 24.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.108 -0.951 . . . . 75.24 108.892 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -68.82 -42.93 76.57 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.844 0.831 . . . . 63.11 108.772 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.27 141.18 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.092 -1.413 . . . . 71.41 109.155 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.9 mt -129.21 140.7 48.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.769 -1.567 . . . . 63.41 106.769 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -157.61 145.84 19.1 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.259 0.552 . . . . 51.2 110.611 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -146.45 105.65 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.236 -1.764 . . . . 74.41 106.236 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -114.73 110.19 19.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.069 -1.086 . . . . 74.21 108.069 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -124.55 80.06 61.38 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.342 1.057 . . . . 74.33 108.827 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.92 -4.18 13.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.491 2.127 . . . . 74.32 111.731 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -117.7 18.65 14.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.1 . . . . 72.25 109.617 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.424 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -58.07 -52.3 75.5 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 114.177 1.177 . . . . 63.05 114.177 -170.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.514 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 73.8 Cg_endo -75.92 -31.61 4.97 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.47 1.561 . . . . 71.44 112.009 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.61 -23.69 62.6 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.968 1.307 . . . . 64.34 112.734 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.457 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 9.5 p -79.51 -16.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.837 -0.54 . . . . 61.04 111.576 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' C' ' 29' ' ' PRO . 57.1 m-85 -67.39 -8.37 32.37 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.054 0.542 . . . . 64.33 112.251 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -116.09 25.18 10.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.784 0.834 . . . . 73.32 111.105 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.531 ' HG2' HD13 ' C' ' 68' ' ' LEU . 3.9 tppt? -91.83 172.69 8.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.002 0.521 . . . . 72.11 111.252 -173.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.64 130.31 35.32 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.729 -0.841 . . . . 72.14 108.729 168.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -70.18 85.15 0.55 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.642 1.177 . . . . 74.3 110.334 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -157.44 66.37 3.7 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.91 0.884 . . . . 61.44 108.967 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.34 109.16 2.84 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.667 2.244 . . . . 74.01 112.33 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -85.86 88.76 7.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.753 -1.573 . . . . 74.51 106.753 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.81 134.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.842 -1.072 . . . . 75.41 109.269 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' C' ' 43' ' ' ASP . 29.2 ttpt -114.97 129.18 56.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.141 -1.059 . . . . 74.21 108.141 169.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.47 HD22 HD11 ' C' ' 128' ' ' LEU . 49.4 tp -88.03 141.49 28.53 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.463 -1.31 . . . . 62.43 107.463 166.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.614 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 20.8 t70 -140.54 109.7 6.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.008 0.523 . . . . 61.34 109.692 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -105.64 145.73 30.63 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.245 -0.65 . . . . 71.14 109.245 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -143.29 149.76 38.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.519 1.127 . . . . 71.51 108.993 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.1 p -115.23 140.78 48.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.895 0.878 . . . . 72.11 110.257 -178.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -143.11 151.31 40.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 73.24 109.527 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 24.3 m -141.29 155.96 45.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.937 0.495 . . . . 73.14 111.289 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -149.08 126.6 11.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.332 -0.988 . . . . 52.03 108.332 168.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -81.63 117.48 22.03 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 107.828 -1.175 . . . . 54.33 107.828 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.9 mt -97.07 -25.76 15.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.892 0.477 . . . . 73.12 110.549 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.44 -179.72 6.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.773 0.829 . . . . 73.11 110.119 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -62.67 122.35 15.64 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.937 -0.764 . . . . 75.51 108.937 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.8 21.19 12.64 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 124.447 1.092 . . . . 64.14 111.44 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.69 117.34 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 124.01 0.924 . . . . 62.04 108.63 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.66 130.42 43.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.931 0.892 . . . . 75.04 110.19 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.8 tt0 -82.02 109.28 16.2 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.527 -1.286 . . . . 64.44 107.527 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -96.39 114.12 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.031 -1.47 . . . . 52.43 107.031 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 48.9 t -111.88 131.28 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.455 0.702 . . . . 71.34 109.321 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.54 HD23 HD12 ' C' ' 106' ' ' LEU . 3.6 mm? -117.22 111.31 19.26 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.334 1.054 . . . . 74.14 108.312 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.4 ttm180 -81.99 114.76 20.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.912 -0.773 . . . . 74.12 108.912 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.28 117.03 50.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.854 -1.165 . . . . 73.14 107.854 173.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.0 m -123.74 139.83 53.59 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.417 1.087 . . . . 34.42 108.075 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.7 113.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.136 0.974 . . . . 74.11 108.971 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 45.8 m -98.24 137.09 37.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.278 -0.874 . . . . 74.14 108.658 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.29 112.9 10.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.878 -1.527 . . . . 42.25 106.878 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 48.7 m -145.35 127.6 15.77 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.052 -0.721 . . . . 64.44 109.052 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.531 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.8 mp -90.47 48.78 1.59 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.301 0.572 . . . . 62.33 110.543 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 -117.82 3.21 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.179 -1.168 . . . . 35.31 110.179 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.72 -33.19 16.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.134 0.974 . . . . 63.22 109.267 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.71 121.3 25.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.592 1.157 . . . . 60.53 110.851 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 91.7 m -78.77 137.84 37.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.081 0.952 . . . . 55.2 111.584 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.63 -66.11 0.74 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.106 0.963 . . . . 74.43 109.241 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -159.32 175.87 12.84 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.702 0.763 . . . . 60.54 110.858 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.4 143.36 51.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.982 -1.488 . . . . 73.25 106.982 171.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.44 140.21 41.13 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.659 -1.237 . . . . 74.3 107.659 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -151.46 119.74 6.36 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.373 0.533 . . . . 62.15 110.875 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -117.24 114.14 44.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.512 -0.922 . . . . 72.21 108.512 170.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 25.9 mt-30 -90.25 97.53 11.24 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.615 -1.254 . . . . 74.35 107.615 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -87.14 119.67 27.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.754 0.822 . . . . 64.12 109.806 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.23 148.95 18.28 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 123.188 0.305 . . . . 72.35 112.593 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.7 2.82 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 110.902 -0.879 . . . . 62.2 110.902 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.508 HD12 HD11 ' C' ' 51' ' ' LEU . 16.2 mm -81.26 119.85 31.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -129.41 142.89 50.69 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.418 -0.956 . . . . 72.03 108.418 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -105.98 123.31 47.78 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.124 -1.065 . . . . 73.24 108.124 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.87 100.66 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.914 0.886 . . . . 71.05 108.757 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 169.34 14.22 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.871 1.269 . . . . 75.23 108.818 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.18 -40.94 3.03 Favored Glycine 0 N--CA 1.466 0.7 0 CA-C-N 116.567 -0.288 . . . . 50.22 112.966 174.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.5 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.9 pp -124.86 165.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.041 0.937 . . . . 63.43 110.489 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' C' ' 91' ' ' GLY . 28.4 tt0 -152.97 166.0 33.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.417 0.687 . . . . 74.12 109.985 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' C' ' 90' ' ' GLU . . . 70.59 -118.44 7.74 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.565 -0.289 . . . . 75.2 113.71 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -77.96 -24.48 48.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.503 0.721 . . . . 55.13 111.194 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -41.01 69.23 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.567 -0.531 . . . . 70.14 109.567 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.406 ' HG2' ' N ' ' C' ' 91' ' ' GLY . 20.0 ptm -76.98 -28.34 55.08 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.12 -0.491 . . . . 64.21 110.755 176.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.46 -29.2 69.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.149 0.58 . . . . 71.13 110.836 176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -70.92 -36.07 72.51 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.656 0.782 . . . . 74.35 110.496 171.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -67.8 -62.13 1.56 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 51.34 110.568 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.57 -12.42 60.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.628 0.603 . . . . 75.11 112.628 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.48 -4.41 57.22 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.58 -0.567 . . . . 72.33 113.917 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.49 -50.87 0.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.761 0.781 . . . . 71.14 111.726 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -75.98 -54.2 7.23 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.293 0.637 . . . . 73.4 111.677 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.61 -42.32 71.78 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 123.766 0.827 . . . . 75.33 113.167 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.59 -30.84 79.66 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 122.209 1.94 . . . . 72.44 112.68 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.14 -33.77 73.97 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.232 0.613 . . . . 75.03 110.743 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -65.87 -50.49 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.055 0.542 . . . . 73.31 110.091 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.54 HD12 HD23 ' C' ' 60' ' ' LEU . 82.3 mt -79.52 -15.55 57.54 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.831 -0.622 . . . . 53.51 112.409 -172.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.438 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 87.8 t80 -56.41 -55.6 40.69 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.284 1.034 . . . . 72.5 113.131 -175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 21.0 Cg_exo -66.24 -29.87 46.43 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.914 1.743 . . . . 42.44 112.828 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.422 ' HE2' HG21 ' A' ' 115' ' ' THR . 86.1 m-85 -65.64 -45.78 81.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.364 0.666 . . . . 73.33 110.881 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.63 91.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.437 0.695 . . . . 75.23 110.651 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -60.92 -57.1 14.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.749 1.22 . . . . 72.04 111.484 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -33.38 75.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.415 0.447 . . . . 75.33 110.008 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.479 ' SG ' HG12 ' C' ' 21' ' ' ILE . 26.1 t -61.2 -43.87 98.19 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.978 0.511 . . . . 53.13 110.565 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -65.15 -43.98 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.177 0.591 . . . . 72.24 110.542 173.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -63.19 -33.15 74.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.441 0.697 . . . . 54.31 111.471 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.2 p -76.78 -41.61 43.95 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.84 -0.8 . . . . 70.24 108.84 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.724 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -54.95 -46.4 75.0 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.89 0.876 . . . . 62.53 112.111 178.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.81 -26.89 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.736 0.414 . . . . 72.12 111.126 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -70.88 -29.89 66.11 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.537 0.735 . . . . 72.55 111.416 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.405 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 50.6 mtt-85 -78.68 -33.17 47.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.744 0.818 . . . . 54.1 109.39 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.69 1.53 61.82 Favored Glycine 0 C--N 1.361 1.937 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.881 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 61.74 25.2 15.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.381 1.873 . . . . 40.25 113.069 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -103.4 156.44 35.46 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.35 1.06 . . . . 71.53 110.421 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 32.3 Cg_exo -40.66 118.9 0.67 Allowed 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 124.238 3.292 . . . . 72.51 113.779 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.16 139.55 57.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.54 -0.754 . . . . 71.4 111.743 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.18 105.7 15.86 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.029 -1.1 . . . . 64.01 108.029 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.18 112.66 22.98 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.211 -1.403 . . . . 72.44 107.211 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.47 HD11 HD22 ' C' ' 42' ' ' LEU . 20.4 tp -84.6 141.86 30.37 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 123.597 0.561 . . . . 74.23 110.039 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -79.35 145.29 63.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.686 -0.688 . . . . 71.24 112.095 -170.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.592 ' HG3' HD13 ' A' ' 16' ' ' ILE . 5.3 Cg_endo -46.8 102.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.977 3.118 . . . . 73.2 112.762 169.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -96.25 106.71 18.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.042 -1.466 . . . . 65.51 107.042 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.58 HD21 HD12 ' A' ' 13' ' ' ILE . 77.6 m-20 -98.77 85.68 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.541 -1.281 . . . . 72.01 107.541 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -51.22 -38.3 51.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.342 1.057 . . . . 71.34 111.9 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t70 . . . . . 0 CA--C 1.549 0.939 0 C-N-CA 124.211 1.004 . . . . 71.55 111.811 -179.597 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 25.7 m . . . . . 0 C--O 1.238 0.486 0 N-CA-C 109.726 -0.472 . . . . 61.42 109.726 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -157.68 116.4 3.19 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.537 -1.283 . . . . 70.12 107.537 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.59 140.52 44.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.876 -1.157 . . . . 51.4 107.876 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.507 HG21 HD11 ' D' ' 16' ' ' ILE . 8.7 mt -97.46 124.77 50.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.017 -0.735 . . . . 60.24 109.017 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.82 -37.54 12.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.485 0.714 . . . . 64.24 110.344 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -161.12 148.34 15.17 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 75.14 110.675 -173.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.507 HD11 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -135.34 114.66 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.302 -2.11 . . . . 74.31 105.302 166.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -151.72 151.53 31.55 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.576 0.703 . . . . 65.44 111.081 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -77.32 109.89 11.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.761 -1.108 . . . . 64.2 109.134 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.514 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 34.9 mtpt -79.28 -33.16 43.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.041 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -141.33 142.2 33.82 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.371 -0.974 . . . . 72.42 108.371 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.724 HD13 ' HE3' ' C' ' 117' ' ' MET . 98.0 mt -133.06 140.91 46.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.574 -1.639 . . . . 75.31 106.574 173.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -146.7 136.47 23.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.605 0.762 . . . . 51.13 109.116 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 57.2 t80 -148.72 123.68 10.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.764 -1.939 . . . . 65.23 105.764 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.12 142.12 51.69 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.431 0.692 . . . . 75.21 109.298 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.66 80.36 66.55 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.913 -1.143 . . . . 64.45 107.913 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.79 -29.97 27.96 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.733 2.289 . . . . 62.22 111.784 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -114.47 40.74 2.47 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.959 1.304 . . . . 73.33 108.775 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.507 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -55.11 -66.41 1.0 Allowed Pre-proline 0 CA--C 1.563 1.453 0 N-CA-C 114.315 1.228 . . . . 74.44 114.315 -166.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -86.21 -3.92 8.66 Favored 'Trans proline' 0 C--N 1.387 2.578 0 CA-C-N 123.074 2.134 . . . . 63.3 112.123 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.25 -39.86 68.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.933 1.293 . . . . 74.33 109.901 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.29 -28.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.337 -0.392 . . . . 75.25 110.1 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.98 -2.33 3.89 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.235 1.198 . . . . 64.04 114.235 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -76.83 -38.18 54.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.145 0.578 . . . . 62.02 109.672 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.491 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -136.3 96.69 3.42 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.373 0.669 . . . . 73.23 112.303 173.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -107.13 98.03 7.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 164.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.636 ' H ' HD11 ' D' ' 68' ' ' LEU . 5.6 m-90 -122.31 -162.85 1.03 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.231 -1.766 . . . . 70.34 106.231 169.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -52.52 104.23 0.42 Allowed Pre-proline 0 N--CA 1.486 1.367 0 CA-C-N 118.66 0.664 . . . . 75.02 112.521 -168.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.412 ' O ' HG13 ' D' ' 40' ' ' VAL . 5.9 Cg_exo -75.7 105.07 2.01 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.662 2.241 . . . . 52.12 109.892 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -61.23 111.0 1.56 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.701 -1.222 . . . . 74.44 107.701 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.544 HG11 HD11 ' D' ' 126' ' ' LEU . 2.2 m -104.61 149.42 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.797 -1.092 . . . . 71.14 110.876 -165.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.567 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.7 mmtt -109.17 133.05 53.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.069 0.947 . . . . 73.21 108.511 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -96.9 111.97 23.93 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.568 -1.271 . . . . 74.55 107.568 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.653 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -124.29 141.47 52.04 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.873 0.869 . . . . 72.22 108.79 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.74 167.14 22.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.22 0.533 . . . . 52.4 110.762 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' D' ' 61' ' ' ARG . 4.3 t70 -156.31 145.83 20.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.825 -1.176 . . . . 73.43 107.825 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.5 p -106.59 141.79 37.3 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.019 -0.734 . . . . 70.43 109.019 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.5 159.39 42.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.528 -0.915 . . . . 62.3 108.528 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 20.4 p -170.89 162.08 7.3 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.576 0.35 . . . . 63.43 110.931 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -152.0 152.24 32.2 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.212 0.605 . . . . 60.2 110.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -90.75 117.56 29.48 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.604 -0.887 . . . . 74.04 108.604 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.98 16.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.393 0.677 . . . . 72.41 109.434 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -166.94 177.11 6.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.319 1.048 . . . . 63.32 110.218 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.28 127.06 31.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.998 -1.112 . . . . 72.04 107.998 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 70.85 5.92 5.64 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.445 1.098 . . . . 74.22 111.856 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 86.3 t -125.51 115.22 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.252 1.021 . . . . 74.21 108.277 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -135.92 130.84 34.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.12 0.568 . . . . 72.23 109.553 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -90.26 136.12 33.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 73.0 109.881 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.12 114.55 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.654 1.182 . . . . 74.12 108.26 175.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -101.85 108.89 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.553 0.741 . . . . 64.35 109.339 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.86 111.25 23.57 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.25 -1.019 . . . . 73.22 108.25 175.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' D' ' 45' ' ' ASP . 14.7 ttm180 -83.91 114.34 21.6 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.324 0.65 . . . . 72.41 109.489 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.4 123.69 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.202 -1.036 . . . . 75.21 108.202 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -129.65 135.32 48.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.324 0.65 . . . . 71.33 109.817 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.9 109.27 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.974 0.91 . . . . 72.44 109.574 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 31.3 m -102.46 102.37 12.66 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.08 -0.711 . . . . 73.3 109.08 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.77 129.35 43.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 110.059 -0.348 . . . . 73.25 110.059 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -124.27 124.11 41.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 64.14 109.152 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.636 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.1 OUTLIER -90.9 96.57 10.7 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.512 -1.292 . . . . 74.23 107.512 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.14 -112.99 4.68 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.477 0.485 . . . . 64.14 112.548 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.95 6.43 48.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.306 1.042 . . . . 63.51 111.908 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -146.75 157.2 43.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.667 0.787 . . . . 62.32 109.336 -171.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -66.66 132.47 48.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.973 0.909 . . . . 70.02 111.909 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.08 -64.51 1.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.925 -0.769 . . . . 74.34 108.925 169.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.58 159.26 38.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.432 -1.258 . . . . 74.11 110.004 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.79 146.59 34.75 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 73.12 108.6 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.8 t -152.29 140.84 20.75 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.999 0.52 . . . . 72.32 110.171 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -157.95 145.79 18.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.712 0.805 . . . . 64.51 109.872 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.8 116.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.322 1.049 . . . . 62.14 109.018 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.75 90.58 8.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.847 -0.797 . . . . 75.13 108.847 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -82.4 98.23 8.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.353 -0.84 . . . . 73.13 109.819 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.63 144.68 17.52 Favored Glycine 0 C--N 1.342 0.917 0 N-CA-C 111.602 -0.599 . . . . 53.51 111.602 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.31 130.92 4.15 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 111.142 -0.783 . . . . 71.31 111.142 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.7 123.23 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.525 -0.917 . . . . 72.21 108.525 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.68 126.66 37.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.814 0.846 . . . . 72.02 110.024 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.3 m -76.26 98.01 4.34 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.82 -0.807 . . . . 74.25 108.82 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 63.6 mt -107.81 109.94 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.376 -0.972 . . . . 63.3 108.376 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -151.16 168.33 25.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.108 0.963 . . . . 54.22 110.133 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.52 -20.2 19.63 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.04 -0.527 . . . . 44.01 114.008 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 pt -124.22 162.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.938 0.895 . . . . 73.41 111.178 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 173.67 13.83 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.368 -0.833 . . . . 64.34 111.054 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.83 -118.62 12.39 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 124.156 0.91 . . . . 61.13 114.042 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.7 m -74.54 -31.05 61.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 74.25 111.684 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.52 -43.76 89.06 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.994 0.518 . . . . 75.51 110.987 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.55 -34.91 60.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.012 -0.54 . . . . 61.02 110.363 177.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.36 -29.35 68.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.136 0.574 . . . . 74.11 111.504 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -71.49 -49.74 38.3 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.614 0.766 . . . . 70.43 109.492 175.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.73 -39.06 93.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.753 -0.658 . . . . 71.1 111.155 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 58.5 tp -78.78 -37.08 41.87 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.499 1.12 . . . . 74.55 111.013 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.33 -23.28 24.79 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.089 -0.505 . . . . 55.0 113.901 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.86 -58.43 2.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.395 0.598 . . . . 54.3 111.635 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.63 -46.29 47.69 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.251 0.463 . . . . 71.31 112.251 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 76.1 m -64.91 -47.27 74.65 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.297 -0.858 . . . . 61.22 112.279 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.2 -34.27 97.49 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.444 2.096 . . . . 71.55 112.998 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.2 -30.11 69.96 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.093 0.957 . . . . 71.54 111.24 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.41 -43.58 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.267 0.627 . . . . 73.31 110.266 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.93 -34.57 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.301 -0.863 . . . . 74.41 112.214 -170.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.71 -42.6 92.24 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 114.372 1.249 . . . . 70.1 114.372 -168.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.65 -42.84 54.44 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.464 2.109 . . . . 74.4 113.858 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -76.5 -27.99 56.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.458 0.703 . . . . 75.33 111.493 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.01 -54.29 36.58 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.983 0.42 . . . . 70.02 109.955 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.408 ' NH2' HG23 ' B' ' 105' ' ' ILE . 40.9 ttp180 -62.51 -34.22 76.44 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.622 -1.172 . . . . 73.12 111.285 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.64 -52.87 58.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.357 1.063 . . . . 53.4 110.84 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.405 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 50.9 t -65.44 -43.68 89.7 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 114.841 -1.072 . . . . 73.42 111.377 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.3 mt -60.58 -56.7 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.752 0.821 . . . . 73.31 110.86 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.449 HG23 ' HB2' ' D' ' 125' ' ' GLN . 97.7 m -51.83 -42.71 62.75 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.32 1.048 . . . . 61.43 111.825 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.6 t -71.05 -28.4 64.35 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.399 -0.819 . . . . 54.24 111.645 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 77.0 mtm -77.99 -36.65 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.832 0.453 . . . . 75.3 111.391 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.499 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.7 t -64.5 -36.6 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.614 0.766 . . . . 73.45 110.752 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 84.9 p -69.71 -31.07 68.88 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.437 0.695 . . . . 62.21 111.322 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 68.8 mtt-85 -74.79 -26.06 59.48 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.559 0.743 . . . . 54.41 110.821 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.32 10.07 62.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.572 0.545 . . . . 65.21 112.538 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p 63.7 23.14 13.39 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.386 1.874 . . . . 74.0 113.287 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.44 163.83 18.94 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.487 1.115 . . . . 71.42 109.438 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.64 155.48 44.68 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.221 1.947 . . . . 55.22 110.555 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.449 ' HB2' HG23 ' D' ' 115' ' ' THR . 16.7 pt20 -55.57 147.27 18.36 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.513 0.725 . . . . 72.13 111.694 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.544 HD11 HG11 ' D' ' 40' ' ' VAL . 3.0 tt -126.39 106.19 9.32 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.059 -0.719 . . . . 74.35 109.059 -175.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.408 HD21 ' HB ' ' B' ' 16' ' ' ILE . 7.6 m-20 -112.52 110.38 20.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.233 1.013 . . . . 70.43 110.577 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.76 125.39 28.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.639 0.776 . . . . 73.53 108.993 171.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.02 145.54 99.01 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 122.395 0.278 . . . . 50.11 110.719 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.75 134.41 25.83 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.317 2.011 . . . . 71.42 111.378 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.5 t -108.89 120.23 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.152 -0.684 . . . . 41.12 109.152 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -86.41 82.42 7.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.395 0.678 . . . . 53.42 109.656 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 . . . . . 0 N--CA 1.483 1.2 0 C-N-CA 124.174 0.99 . . . . 73.12 111.14 177.012 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m . . . . . 0 N--CA 1.469 0.522 0 N-CA-C 107.675 -1.231 . . . . 63.12 107.675 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.564 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.7 t80 -137.59 124.6 21.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.982 0.513 . . . . 73.02 109.984 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -153.38 112.02 3.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.731 -0.84 . . . . 73.13 108.731 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.585 HG12 ' HD2' ' A' ' 84' ' ' PHE . 67.8 mt -73.96 130.31 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.986 0.514 . . . . 72.13 110.418 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -91.55 -32.13 15.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.478 1.111 . . . . 63.24 111.068 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -164.69 140.71 5.86 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.752 0.421 . . . . 74.23 110.764 -172.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.78 123.73 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.935 -1.506 . . . . 70.3 106.935 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.657 ' HB3' HG23 ' B' ' 122' ' ' THR . 3.2 p90 -163.52 149.22 11.38 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.534 0.683 . . . . 71.54 112.703 -173.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.419 HG21 ' SG ' ' A' ' 113' ' ' CYS . 76.7 p -77.61 112.68 14.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.116 -0.947 . . . . 51.02 109.075 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -77.94 -25.97 48.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.362 -0.381 . . . . 63.41 110.522 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.4 t70 -152.42 144.12 23.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.245 0.966 . . . . 75.24 110.301 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -138.08 141.85 37.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 125.635 1.574 . . . . 73.25 107.055 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.32 119.01 4.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.594 0.559 . . . . 74.42 109.807 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 81.2 t80 -111.31 127.18 55.56 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 106.381 -1.711 . . . . 73.35 106.381 167.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.61 108.9 9.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.533 -0.544 . . . . 73.33 109.533 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.92 82.99 1.97 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.841 -1.17 . . . . 65.42 107.841 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.77 -35.84 26.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.006 2.471 . . . . 71.22 112.347 -169.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -116.4 33.8 5.36 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.142 -0.935 . . . . 53.33 108.867 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.66 -61.04 3.95 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.279 -0.867 . . . . 71.11 113.021 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 -0.2 8.18 Favored 'Trans proline' 0 C--N 1.386 2.522 0 CA-C-N 121.765 1.666 . . . . 50.55 113.812 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -99.59 -42.61 6.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.139 0.976 . . . . 75.32 110.916 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.4 p -77.1 -21.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.309 -0.859 . . . . 72.1 111.876 -163.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -76.8 0.57 20.17 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.126 0.57 . . . . 74.2 111.259 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -100.95 -22.57 14.75 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.631 1.173 . . . . 72.5 111.513 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.69 172.73 13.3 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.971 0.908 . . . . 75.22 113.24 -168.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 136.9 51.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.11 0.964 . . . . 71.14 111.249 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -82.17 75.71 9.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.718 0.807 . . . . 75.52 110.478 -173.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.96 69.37 9.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.961 -1.018 . . . . 73.24 110.043 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.06 118.12 5.41 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.029 1.819 . . . . 65.54 111.107 175.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.72 118.66 31.7 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.601 -1.629 . . . . 74.51 106.601 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 65' ' ' THR . 43.9 t -104.9 116.45 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 122.855 0.462 . . . . 52.02 110.115 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 27.8 ttpp -100.19 123.52 44.52 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.217 1.007 . . . . 72.5 109.694 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.463 1.105 . . . . 75.3 108.204 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -111.65 115.39 29.04 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.466 -0.939 . . . . 62.34 108.466 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 tt -97.9 117.95 33.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.176 -1.416 . . . . 64.14 107.176 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.63 136.24 28.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.624 0.77 . . . . 75.1 109.197 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 m -149.3 150.91 33.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.793 0.437 . . . . 74.33 110.5 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.57 154.7 41.82 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.92 0.888 . . . . 60.35 110.142 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.8 p -120.48 161.59 21.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.848 0.459 . . . . 62.21 110.702 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -156.58 119.17 4.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 63.12 108.249 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -80.95 104.79 11.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.672 -0.862 . . . . 72.11 108.672 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 57' ' ' GLU . 60.1 mt -79.33 -41.95 26.79 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.682 0.793 . . . . 63.13 111.127 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.17 -172.65 4.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.777 0.831 . . . . 74.32 109.978 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -73.62 125.06 27.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.021 -0.733 . . . . 62.21 109.021 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 66.56 5.56 3.91 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.731 1.212 . . . . 61.23 113.15 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 84.2 t -121.94 120.59 61.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.678 0.791 . . . . 74.22 108.904 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.457 ' CE2' HG12 ' A' ' 86' ' ' ILE . 2.0 p90 -133.91 171.04 14.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.499 0.666 . . . . 72.41 110.061 172.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' A' ' 51' ' ' LEU . 34.4 tt0 -121.44 140.42 52.17 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.821 -1.536 . . . . 71.42 108.653 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -123.26 126.7 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 107.154 -1.424 . . . . 74.12 107.154 165.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.9 t -106.65 115.45 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.24 -0.652 . . . . 62.14 109.24 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 100.48 12.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.457 -1.312 . . . . 53.55 107.457 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.479 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 12.4 ttp180 -85.82 106.38 17.01 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.878 -0.786 . . . . 72.14 108.878 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.61 131.46 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.142 -1.429 . . . . 53.15 107.142 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.5 m -127.81 125.58 40.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.575 -0.898 . . . . 54.32 108.575 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.818 HG11 HD21 ' A' ' 126' ' ' LEU . 44.7 t -119.35 115.22 47.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.055 -0.975 . . . . 70.45 108.81 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.8 m -102.14 146.21 28.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.64 -0.874 . . . . 75.11 108.64 172.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.08 132.08 26.15 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.868 -1.16 . . . . 74.45 107.868 172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 m -142.78 128.01 18.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.52 0.513 . . . . 72.33 110.619 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 73' ' ' ALA . 10.3 mp -87.05 84.29 7.33 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.561 -1.274 . . . . 62.33 107.561 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.6 -116.4 4.88 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 114.708 -1.133 . . . . 64.1 111.757 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.26 -16.05 34.21 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.053 0.941 . . . . 71.11 110.823 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -95.27 116.29 28.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.279 1.032 . . . . 73.41 109.963 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.2 m -70.31 132.13 45.21 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.617 0.644 . . . . 74.24 111.05 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.49 -60.94 2.13 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.237 1.015 . . . . 73.33 109.416 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.08 170.17 21.82 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.19 -0.914 . . . . 63.35 111.22 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -141.99 112.42 7.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.196 -1.366 . . . . 63.23 107.368 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 70.7 m -111.93 104.4 12.68 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.469 0.708 . . . . 61.21 111.016 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.7 tt0 -113.4 115.74 28.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.406 1.082 . . . . 72.34 109.636 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.04 115.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.952 0.901 . . . . 73.44 109.399 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.2 mt-30 -84.86 85.62 7.45 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.966 -0.753 . . . . 73.35 108.966 169.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.39 96.2 4.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.515 0.726 . . . . 72.33 109.814 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.66 147.45 22.09 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 111.852 -0.499 . . . . 52.01 111.852 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.19 143.16 12.1 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.661 -0.975 . . . . 61.24 110.661 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -109.24 127.65 65.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.044 -1.095 . . . . 74.32 108.044 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.585 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.8 m-85 -128.72 120.17 25.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.14 -1.059 . . . . 63.44 108.14 -171.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -88.88 110.19 20.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.493 -0.929 . . . . 65.31 108.493 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.61 HD13 HD11 ' A' ' 89' ' ' ILE . 2.5 pp -124.76 162.47 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.089 1.356 . . . . 74.52 109.915 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.78 135.89 1.91 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.326 0.65 . . . . 64.14 109.659 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 108.97 8.77 27.28 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.218 -0.768 . . . . 65.12 114.076 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 86' ' ' ILE . 2.2 pp -120.91 154.09 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 117.931 0.865 . . . . 64.14 112.044 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.57 170.96 18.87 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.094 -0.957 . . . . 65.21 108.62 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.31 -119.02 9.29 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 115.962 1.145 . . . . 72.1 115.962 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -76.19 -20.29 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.424 0.689 . . . . 60.12 111.818 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.99 -50.35 23.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.098 0.559 . . . . 63.34 110.253 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -64.26 -35.69 81.67 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.504 0.502 . . . . 72.51 109.83 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.02 -46.37 91.02 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.648 0.779 . . . . 50.25 111.004 177.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 53.5 t-80 -70.75 -28.93 65.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.3 -0.864 . . . . 70.25 110.75 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 32.6 t -73.43 -37.17 65.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.2 0.524 . . . . 61.34 110.292 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.2 mt -78.59 -36.01 44.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.13 0.972 . . . . 74.43 112.016 -179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.82 3.96 34.14 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.637 -0.535 . . . . 62.34 114.294 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.14 -63.88 0.25 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.623 0.711 . . . . 65.42 112.818 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.464 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 57.4 t80 -62.84 -61.28 2.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.435 1.094 . . . . 61.12 112.831 -169.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -70.78 -34.89 3.94 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.495 0.924 . . . . 71.31 113.495 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -46.12 -48.37 13.05 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.701 2.267 . . . . 75.34 113.881 162.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.65 -27.89 68.71 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.312 1.045 . . . . 73.42 111.013 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 13' ' ' ILE . 43.5 mm -70.07 -47.69 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.591 0.756 . . . . 73.11 110.593 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.455 HD21 ' HA3' ' A' ' 82' ' ' GLY . 89.4 mt -73.61 -31.25 63.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.335 -0.848 . . . . 50.45 112.177 -171.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.531 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 45.2 t80 -59.13 -44.18 98.22 Favored Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 113.866 1.062 . . . . 54.42 113.866 -170.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.81 -38.64 94.2 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.567 2.178 . . . . 74.21 114.359 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -71.41 -40.13 70.68 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.27 0.628 . . . . 74.45 111.64 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.23 -42.15 93.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.938 0.495 . . . . 75.22 109.951 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -53.39 -55.02 28.41 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 124.583 1.177 . . . . 73.52 110.41 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.55 -41.26 93.22 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.151 0.907 . . . . 75.54 110.662 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.419 ' SG ' HG21 ' A' ' 18' ' ' THR . 47.5 t -58.5 -36.29 73.55 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.104 0.478 . . . . 75.31 111.302 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 118' ' ' VAL . 24.2 mt -72.23 -51.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.963 0.905 . . . . 70.45 109.982 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.536 HG21 ' HE2' ' C' ' 109' ' ' TYR . 97.7 m -53.81 -40.69 66.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.765 1.226 . . . . 64.43 111.346 -173.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -62.29 -48.96 77.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.318 -1.31 . . . . 63.01 109.514 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.0 mtm -64.05 -40.66 96.79 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.563 0.745 . . . . 75.55 111.24 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.2 t -58.33 -48.63 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.058 0.943 . . . . 64.51 110.364 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.4 t -71.45 -28.99 64.34 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.331 -0.85 . . . . 73.32 111.253 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -71.11 -29.1 64.84 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.502 0.721 . . . . 65.22 110.195 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.58 2.79 66.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.65 0.594 . . . . 63.25 112.936 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.402 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 4.2 m 65.86 24.17 11.3 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.211 1.404 . . . . 73.5 110.521 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -94.45 140.54 22.75 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.538 -1.282 . . . . 74.41 107.538 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -44.5 134.46 9.55 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.079 2.519 . . . . 60.45 113.898 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.494 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -46.5 130.79 11.14 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.411 1.084 . . . . 73.15 112.864 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.818 HD21 HG11 ' A' ' 64' ' ' VAL . 23.1 tp -108.11 100.99 10.26 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.541 1.137 . . . . 72.22 109.48 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -101.94 103.2 13.83 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.926 -1.139 . . . . 64.21 107.926 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.531 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -68.18 124.55 23.75 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 108.635 -0.876 . . . . 60.33 108.635 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -60.09 130.7 89.26 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.384 0.674 . . . . 74.03 111.854 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.438 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 3.1 Cg_exo -76.56 146.17 27.01 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.988 2.459 . . . . 61.22 112.351 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.5 t -130.56 131.4 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.833 0.853 . . . . 70.42 109.408 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.09 96.03 2.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.977 -0.749 . . . . 71.13 108.977 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -72.47 -26.55 61.86 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.76 -0.654 . . . . 72.35 111.451 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.43 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.1 m-20 . . . . . 0 N--CA 1.476 0.838 0 C-N-CA 123.106 0.562 . . . . 62.34 110.225 176.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.6 m . . . . . 0 C--O 1.237 0.401 0 N-CA-C 107.416 -1.327 . . . . 55.52 107.416 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -134.98 113.25 11.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.703 -0.481 . . . . 74.12 109.703 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.26 139.31 33.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.891 . . . . 65.53 108.678 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.428 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -87.46 134.94 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 109.026 -0.731 . . . . 74.32 109.026 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -93.24 -52.64 4.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.255 -0.646 . . . . 74.42 109.255 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.402 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 31.0 ttt180 -155.65 132.78 10.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.955 -0.566 . . . . 75.14 109.86 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.31 136.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.349 -1.723 . . . . 53.14 106.349 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.424 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.6 p90 -166.99 148.55 5.95 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.907 0.384 . . . . 62.24 110.961 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.456 HG21 HD11 ' B' ' 21' ' ' ILE . 94.8 m -77.28 129.21 35.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.964 -0.754 . . . . 71.14 108.964 171.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.413 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.7 mtpt -98.87 -31.13 12.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.641 0.776 . . . . 65.14 110.865 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -154.43 145.73 22.95 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.392 0.433 . . . . 75.43 111.662 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.456 HD11 HG21 ' B' ' 18' ' ' THR . 39.1 mm -137.18 148.18 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.199 1.399 . . . . 73.41 109.03 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.5 m -146.97 140.41 25.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.746 -1.116 . . . . 75.44 109.445 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.6 t80 -147.5 110.34 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 105.825 -1.917 . . . . 72.32 105.825 162.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.26 111.88 15.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.103 -1.073 . . . . 72.53 108.103 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -116.47 87.03 19.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 108.543 -0.91 . . . . 71.2 108.543 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.16 -25.17 19.34 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.443 2.095 . . . . 71.22 111.475 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -103.34 7.8 38.2 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.483 1.113 . . . . 64.42 110.457 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.642 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -40.86 -54.48 5.33 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 115.907 1.817 . . . . 52.41 115.907 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.3 Cg_exo -72.75 -50.25 0.22 Allowed 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.54 2.16 . . . . 50.02 111.955 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.542 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.3 m80 -85.37 5.51 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.724 -1.126 . . . . 74.3 112.133 -173.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.76 -16.72 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.197 0.599 . . . . 74.25 111.904 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -51.34 -32.72 26.53 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.787 0.835 . . . . 72.44 112.206 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.571 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.3 pt20 -73.21 -48.93 30.92 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.269 -0.423 . . . . 71.54 110.858 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.571 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 83.7 mttt -110.82 62.41 0.61 Allowed 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.937 0.875 . . . . 52.01 109.513 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -117.11 118.69 33.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.032 -1.84 . . . . 64.41 106.032 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 169.01 -168.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.64 1.976 . . . . 61.53 106.217 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.58 109.8 1.62 Allowed Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 122.977 0.511 . . . . 72.23 112.193 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HG2' HG13 ' B' ' 40' ' ' VAL . 91.6 Cg_endo -94.69 162.79 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.99 2.46 . . . . 51.31 112.099 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -80.52 103.53 10.44 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.293 -1.373 . . . . 54.44 107.293 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.465 HG13 ' HG2' ' B' ' 38' ' ' PRO . 5.4 m -99.3 143.2 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.149 -0.932 . . . . 35.33 109.576 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.99 132.67 32.61 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.609 -0.886 . . . . 53.45 108.609 -171.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 mt -99.92 123.9 44.66 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.899 -0.778 . . . . 73.45 108.899 173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.4 t70 -126.12 111.73 14.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.902 -0.777 . . . . 73.54 108.902 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 9.9 mp -100.33 131.65 46.14 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.69 -0.687 . . . . 71.11 109.302 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.6 t70 -120.7 125.97 49.01 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.464 -1.31 . . . . 71.13 107.464 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -109.2 103.69 12.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.305 -0.861 . . . . 72.53 109.506 -168.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 130.84 44.13 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.747 0.819 . . . . 65.42 109.159 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 74.9 p -142.45 162.8 34.54 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.962 0.505 . . . . 74.51 110.389 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 p -152.87 137.46 16.86 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.916 0.886 . . . . 74.03 109.346 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.95 122.99 28.48 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.013 0.525 . . . . 71.13 109.764 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.09 -43.2 16.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.058 0.543 . . . . 62.43 110.459 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -169.03 2.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.373 0.669 . . . . 72.3 111.082 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.89 112.32 2.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.488 1.115 . . . . 61.04 110.681 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.06 1.64 2.43 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.278 1.431 . . . . 71.51 112.805 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.1 t -105.26 110.89 32.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.563 -0.903 . . . . 64.43 108.563 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -115.16 160.23 19.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.779 0.832 . . . . 72.03 108.993 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -132.75 106.25 7.64 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.782 -1.562 . . . . 63.51 106.782 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -105.51 122.6 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.372 1.069 . . . . 73.44 109.817 -171.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.69 128.78 62.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.125 0.97 . . . . 71.53 108.846 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -118.7 111.77 18.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.464 -1.31 . . . . 70.31 107.464 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 38.6 ttm180 -87.16 132.51 33.84 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.669 0.788 . . . . 62.34 109.587 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.4 107.16 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.768 -1.197 . . . . 71.14 107.768 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 38.8 m -97.19 137.94 35.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.642 -0.873 . . . . 71.52 108.642 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.511 HG21 HG21 ' B' ' 114' ' ' ILE . 61.2 t -121.86 97.35 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -90.27 137.8 32.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.579 -0.737 . . . . 62.14 109.155 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -143.26 145.94 33.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.362 0.665 . . . . 71.25 109.753 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -159.31 135.97 9.32 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.816 0.698 . . . . 60.3 110.51 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.5 mp -113.45 137.96 50.78 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.558 -0.905 . . . . 75.33 108.558 168.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.1 -127.74 13.21 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.919 -0.473 . . . . 53.2 111.919 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -109.87 6.01 22.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.264 1.025 . . . . 75.43 110.412 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.01 167.12 12.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.559 0.743 . . . . 72.12 111.088 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.2 m -68.91 155.14 40.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.185 0.994 . . . . 75.24 110.542 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.469 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -109.88 -60.54 1.77 Allowed 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 61.41 108.581 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -164.27 156.17 16.41 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.767 -1.106 . . . . 70.32 108.336 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 mt -132.24 108.96 9.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.383 -1.339 . . . . 61.31 107.383 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.75 157.04 26.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.197 -1.038 . . . . 74.55 108.197 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.4 tt0 -164.9 142.49 6.23 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.153 0.581 . . . . 71.42 109.856 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' B' ' 113' ' ' CYS . 69.9 t -132.57 144.51 36.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.79 -1.189 . . . . 75.12 107.79 170.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -123.83 90.83 3.34 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.914 -1.143 . . . . 70.05 107.914 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -84.74 102.02 12.68 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 74.32 108.905 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.39 167.83 34.4 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.368 -0.833 . . . . 71.12 111.608 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.26 126.37 1.43 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.558 -0.353 . . . . 72.22 112.415 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.424 HG13 ' HE1' ' B' ' 17' ' ' TYR . 53.4 mt -85.37 128.09 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.56 -0.904 . . . . 75.25 108.56 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -135.8 135.11 39.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.626 1.171 . . . . 74.1 109.233 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.2 m -91.32 99.96 12.84 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.663 0.785 . . . . 74.13 108.99 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.414 ' HB ' HD11 ' B' ' 89' ' ' ILE . 29.5 pt -121.8 138.69 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.582 0.753 . . . . 74.32 110.439 -176.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.28 169.36 24.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.374 1.07 . . . . 70.24 109.89 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.84 -47.63 3.74 Favored Glycine 0 N--CA 1.478 1.45 0 C-N-CA 123.356 0.503 . . . . 51.12 112.668 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.414 HD11 ' HB ' ' B' ' 86' ' ' ILE . 16.9 pt -64.15 148.37 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.285 1.034 . . . . 74.22 111.73 173.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.588 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 42.6 tt0 -157.73 144.44 17.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.143 0.977 . . . . 72.11 109.909 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.51 -108.88 1.85 Allowed Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.381 -0.677 . . . . 72.5 113.602 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 36.5 m -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.386 0.675 . . . . 72.12 110.948 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.588 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.8 mt-30 -62.97 -45.22 93.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.598 0.759 . . . . 73.2 109.513 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 25.9 ttt -73.71 -38.77 64.72 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.037 -0.983 . . . . 74.2 110.511 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.58 69.61 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.346 0.658 . . . . 70.3 111.161 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -79.2 -35.8 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.03 0.932 . . . . 63.51 110.124 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.15 -68.4 0.38 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.356 -0.384 . . . . 72.31 110.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.6 pp -75.8 -8.27 56.45 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.462 0.541 . . . . 75.44 112.462 -178.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.99 -9.19 46.12 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 114.303 0.481 . . . . 50.43 114.303 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.17 -54.72 0.4 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.49 0.645 . . . . 73.44 110.962 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -68.0 -55.75 11.48 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.879 0.872 . . . . 63.02 111.506 -172.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.59 -44.06 79.82 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.374 1.069 . . . . 55.04 112.286 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -48.75 -53.52 6.79 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.837 2.358 . . . . 72.31 112.601 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.14 -18.89 50.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.966 0.728 . . . . 64.35 112.966 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.404 ' HA ' HH21 ' D' ' 111' ' ' ARG . 71.7 mt -77.26 -57.09 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.189 0.596 . . . . 72.33 110.623 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.33 -4.83 59.29 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.093 0.557 . . . . 74.41 112.234 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.53 -46.74 47.61 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.48 1.112 . . . . 65.0 112.454 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.3 -34.78 94.77 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 121.875 1.717 . . . . 65.51 112.978 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.612 ' HE2' HG21 ' D' ' 115' ' ' THR . 57.2 m-85 -65.25 -52.57 53.63 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.122 0.969 . . . . 75.32 110.752 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.424 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.09 -43.19 91.83 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.501 0.72 . . . . 64.11 110.341 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -56.23 -56.33 22.27 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.926 1.291 . . . . 72.32 111.259 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -38.88 92.49 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.611 0.569 . . . . 74.33 109.602 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.5 t -64.97 -38.94 92.62 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 123.522 0.514 . . . . 73.4 111.719 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.511 HG21 HG21 ' B' ' 64' ' ' VAL . 57.6 mt -65.35 -52.66 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.242 0.617 . . . . 72.15 109.542 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.518 HG22 HE21 ' C' ' 125' ' ' GLN . 23.3 m -61.45 -29.02 69.69 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 115.089 -0.959 . . . . 72.11 111.475 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.9 t -63.14 -49.48 74.2 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.72 0.808 . . . . 65.21 109.326 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -69.96 -34.41 73.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.733 0.813 . . . . 74.44 111.16 -175.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.598 HG21 HD13 ' B' ' 126' ' ' LEU . 80.6 t -64.52 -39.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.669 0.788 . . . . 64.34 110.239 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 16.4 t -71.29 -31.28 67.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.222 0.609 . . . . 63.14 110.83 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.8 mtt-85 -67.87 -22.89 65.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.244 0.618 . . . . 72.31 110.279 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.71 17.98 56.48 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.504 0.502 . . . . 31.42 113.221 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.657 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.0 p 62.96 14.87 7.88 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.559 1.944 . . . . 73.15 113.7 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -92.47 148.7 36.88 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 122.921 0.488 . . . . 71.54 109.887 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' C' ' 125' ' ' GLN . 96.6 Cg_endo -74.21 -159.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.062 2.508 . . . . 34.43 113.059 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.4 122.74 17.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.368 -0.833 . . . . 71.42 113.153 -167.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.598 HD13 HG21 ' B' ' 118' ' ' VAL . 9.4 tt -109.89 127.42 54.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 106.018 -1.845 . . . . 72.11 106.018 166.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 106.67 9.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.313 -0.625 . . . . 64.1 109.313 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.65 107.88 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.005 -1.109 . . . . 75.3 108.005 169.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.39 135.07 88.76 Favored Pre-proline 0 CA--C 1.548 0.896 0 O-C-N 124.075 0.859 . . . . 73.31 110.256 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.28 109.25 0.39 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.278 2.652 . . . . 64.11 112.206 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.17 113.41 26.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.511 -0.922 . . . . 53.1 108.511 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.15 76.93 6.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.695 -0.854 . . . . 75.54 108.695 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 . . . . . 0 N--CA 1.487 1.388 0 C-N-CA 124.215 1.006 . . . . 62.43 111.017 -179.806 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.47 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 51.4 ttp . . . . . 0 CA--C 1.55 0.945 0 N-CA-C 112.773 0.657 . . . . 74.32 112.773 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -91.38 92.87 8.77 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.076 -1.453 . . . . 75.23 107.076 166.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 72.6 t80 -108.57 154.35 22.08 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.884 -1.053 . . . . 72.35 109.67 -175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -163.54 139.59 6.75 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.308 1.043 . . . . 74.41 109.017 173.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pp -80.89 141.32 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.447 0.699 . . . . 74.34 109.369 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -109.83 -51.25 2.89 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.777 0.431 . . . . 74.43 110.009 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -172.43 123.82 0.47 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.471 0.482 . . . . 74.32 109.846 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -109.01 136.02 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.012 -1.107 . . . . 64.51 108.012 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.509 ' HE1' HG12 ' C' ' 83' ' ' ILE . 19.5 p90 -168.68 162.92 11.99 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.861 0.839 . . . . 72.43 112.432 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.6 p -86.38 103.75 15.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.375 -1.284 . . . . 73.12 108.662 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -67.8 -35.21 78.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.64 0.733 . . . . 74.41 109.981 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.72 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.9 t70 -148.21 139.48 23.43 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.473 -1.24 . . . . 70.4 109.095 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.2 mt -133.55 141.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.077 -1.453 . . . . 45.13 107.077 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -152.87 146.34 24.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.411 -0.588 . . . . 72.13 109.411 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.95 113.63 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.131 -1.433 . . . . 72.33 107.131 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.48 111.26 20.49 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.297 -1.001 . . . . 64.33 108.297 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.75 80.21 55.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.356 1.063 . . . . 63.4 108.262 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.39 -16.78 24.44 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.172 1.915 . . . . 75.44 109.898 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.96 11.86 25.91 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.231 1.412 . . . . 52.01 110.041 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.55 97.72 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.028 1.122 . . . . 71.34 114.028 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.28 -36.15 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 121.404 1.402 . . . . 62.51 113.032 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -67.67 -25.68 65.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.884 1.274 . . . . 72.03 112.869 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.461 HG11 ' HE1' ' C' ' 123' ' ' PHE . 14.4 p -62.31 -27.13 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.455 1.102 . . . . 73.14 111.853 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.502 ' HA ' ' HZ2' ' C' ' 36' ' ' TRP . 30.0 t80 -65.9 -26.76 67.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.588 -0.733 . . . . 72.43 111.96 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -99.0 6.12 46.84 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.455 0.539 . . . . 71.02 112.455 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -99.7 173.11 6.86 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.467 0.576 . . . . 75.23 110.054 175.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.26 123.38 25.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.455 -0.943 . . . . 70.05 108.455 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.502 ' HZ2' ' HA ' ' C' ' 32' ' ' PHE . 59.4 m95 -85.37 69.76 10.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.186 0.595 . . . . 72.21 110.683 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -163.17 60.1 0.91 Allowed Pre-proline 0 CA--C 1.56 1.344 0 CA-C-N 115.087 -0.96 . . . . 75.35 109.003 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.12 158.98 37.62 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.034 2.489 . . . . 63.33 111.61 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.43 88.84 6.58 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 106.664 -1.606 . . . . 75.55 106.664 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.93 102.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 113.61 -1.632 . . . . 74.33 109.749 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.1 110.82 22.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.553 -1.203 . . . . 74.22 108.537 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.15 130.57 34.58 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.366 -1.346 . . . . 60.13 107.366 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.9 t70 -119.36 103.81 9.81 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.882 1.273 . . . . 65.44 107.78 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 23.5 tp -100.16 112.53 24.84 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.348 -0.982 . . . . 63.53 108.348 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -114.67 139.62 49.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.763 1.225 . . . . 51.41 108.921 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -114.53 145.62 41.71 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.436 0.694 . . . . 55.21 110.361 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 150.5 29.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.607 0.763 . . . . 73.21 109.739 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.8 m -155.78 155.24 32.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.249 0.62 . . . . 74.01 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.3 p -148.85 140.42 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.53 0.732 . . . . 73.45 109.918 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.47 115.41 22.06 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.211 -1.033 . . . . 72.25 108.211 170.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.534 HD11 HD12 ' C' ' 83' ' ' ILE . 74.6 mt -88.88 -39.01 14.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.516 0.726 . . . . 63.22 110.343 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.08 -168.79 2.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.017 -0.992 . . . . 64.44 110.348 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.98 100.55 0.16 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.356 1.063 . . . . 52.02 110.654 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 66.94 10.69 7.85 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.497 1.519 . . . . 75.42 113.234 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -94.27 114.13 30.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.866 -1.161 . . . . 63.52 107.866 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.403 ' HB2' HD13 ' C' ' 86' ' ' ILE . 75.6 m-85 -123.23 124.23 42.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.108 0.963 . . . . 74.11 109.057 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.489 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.67 120.52 26.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.326 -0.852 . . . . 75.43 109.34 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -97.65 114.12 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.135 -1.061 . . . . 62.45 108.135 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.6 134.55 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.28 -1.007 . . . . 73.33 108.28 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -128.9 102.81 6.7 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.905 -1.146 . . . . 52.31 107.905 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.519 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 23.8 ttt180 -82.69 108.21 15.89 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.525 -0.761 . . . . 74.24 109.279 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.4 t -100.08 121.77 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 107.477 -1.305 . . . . 74.25 107.477 172.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.4 m -127.31 117.47 22.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.648 -0.871 . . . . 72.4 108.648 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.1 110.28 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.699 -0.852 . . . . 70.32 108.699 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.4 m -99.83 144.04 29.35 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.666 -0.865 . . . . 52.05 108.666 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.56 130.46 44.11 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.752 -1.203 . . . . 63.23 107.752 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.1 m -147.88 130.44 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.03 0.443 . . . . 74.23 110.965 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.07 58.1 4.86 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.016 1.326 . . . . 74.14 107.476 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.23 -118.0 5.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 114.732 -1.122 . . . . 51.02 110.567 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.06 -28.67 18.87 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.449 0.7 . . . . 54.31 109.308 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.68 102.63 0.76 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.939 0.896 . . . . 65.51 109.666 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -72.92 144.43 47.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.239 0.616 . . . . 74.22 111.021 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.65 -56.27 2.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.507 1.123 . . . . 63.22 109.455 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -158.03 172.01 19.21 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.99 -0.55 . . . . 74.54 110.923 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.442 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -136.37 146.16 46.2 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 106.9 -1.518 . . . . 74.51 106.9 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.442 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.76 113.58 4.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.13 0.572 . . . . 73.34 109.789 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -117.34 117.51 29.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.653 0.781 . . . . 74.24 110.04 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -121.84 122.24 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.504 -0.554 . . . . 71.4 109.504 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.72 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.8 mt-30 -99.04 91.34 4.97 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.043 -1.095 . . . . 73.44 108.043 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -83.14 104.86 13.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.235 -0.893 . . . . 63.33 110.062 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 146.6 18.3 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.108 -0.497 . . . . 74.14 112.015 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.05 116.85 1.11 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.07 -1.212 . . . . 32.14 110.07 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.534 HD12 HD11 ' C' ' 51' ' ' LEU . 15.5 mm -81.46 122.33 36.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.449 -0.945 . . . . 74.43 108.449 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -138.51 148.68 44.57 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.35 -0.981 . . . . 71.43 108.35 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.1 p -110.17 119.02 37.93 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.458 -0.941 . . . . 51.13 108.458 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' C' ' 56' ' ' TYR . 4.1 mp -114.88 120.68 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.267 -1.012 . . . . 73.1 108.267 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.47 165.02 30.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.132 0.973 . . . . 73.1 109.565 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.08 -46.68 1.14 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.965 -0.561 . . . . 63.43 112.242 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.502 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -121.81 171.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.24 0.616 . . . . 72.1 111.253 -177.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.74 -173.03 4.11 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.019 -0.991 . . . . 74.45 109.425 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.78 -139.72 39.3 Favored Glycine 0 C--N 1.344 1.011 0 O-C-N 123.529 0.518 . . . . 64.32 114.159 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -70.56 -21.72 62.66 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.117 0.967 . . . . 73.02 112.038 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -71.48 -38.01 71.25 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.537 0.735 . . . . 75.32 110.388 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.408 ' SD ' HD12 ' C' ' 98' ' ' LEU . 9.8 tmm? -71.99 -41.08 68.05 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.018 -0.734 . . . . 70.25 109.018 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.65 69.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.569 0.747 . . . . 51.52 111.262 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -70.64 -34.18 71.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.504 0.722 . . . . 74.21 110.491 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.47 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 40.6 t -68.21 -64.66 0.82 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.444 0.465 . . . . 53.2 110.398 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.408 HD12 ' SD ' ' C' ' 94' ' ' MET . 0.0 OUTLIER -84.04 -12.69 54.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.047 -0.408 . . . . 73.31 112.093 -172.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 -7.84 46.32 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 114.706 0.642 . . . . 73.5 114.706 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.33 -55.93 0.48 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.395 0.598 . . . . 75.22 110.847 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.438 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 81.0 t80 -69.12 -56.54 7.36 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.907 0.883 . . . . 71.15 111.822 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.76 -44.97 74.99 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.59 1.156 . . . . 72.42 112.951 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.94 -34.37 81.48 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 121.758 1.639 . . . . 75.21 111.995 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -28.5 67.28 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.317 0.647 . . . . 64.15 111.695 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 33.3 mm -66.24 -53.52 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.978 -0.378 . . . . 74.11 109.978 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -87.21 -8.35 56.95 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.412 0.523 . . . . 71.22 112.412 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.13 -50.09 89.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 124.21 1.004 . . . . 75.02 113.416 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.87 -25.74 74.47 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 121.489 1.459 . . . . 70.52 113.121 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.536 ' HE2' HG21 ' A' ' 115' ' ' THR . 70.1 m-85 -69.51 -46.07 67.4 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.285 0.634 . . . . 42.32 110.232 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.4 89.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.603 0.761 . . . . 73.4 110.396 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.521 ' HG3' HD23 ' C' ' 128' ' ' LEU . 39.5 ttt180 -58.38 -55.68 31.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 113.945 -1.48 . . . . 73.13 111.157 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.451 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -67.81 -27.46 66.75 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.979 0.512 . . . . 54.13 110.328 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.0 t -71.5 -36.57 71.15 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.744 0.418 . . . . 51.43 111.407 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.417 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.5 mt -72.67 -48.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.454 0.701 . . . . 74.35 110.025 174.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 49.1 m -60.92 -33.71 73.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.09 0.956 . . . . 74.53 111.36 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -62.2 -47.73 83.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.791 -0.64 . . . . 73.24 109.444 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.493 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.28 -37.5 87.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.709 1.203 . . . . 62.11 112.226 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.33 -42.21 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.181 0.592 . . . . 74.1 109.407 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.3 t -69.05 -28.99 67.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.641 0.777 . . . . 74.25 111.711 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -76.03 -28.8 57.84 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.694 0.797 . . . . 71.52 110.468 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.52 4.63 81.18 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.525 0.516 . . . . 74.31 112.433 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 20.8 p 62.38 33.04 16.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.044 1.738 . . . . 72.24 111.961 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' C' ' 31' ' ' VAL . 24.8 m-85 -102.17 154.05 37.64 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 115.004 -0.998 . . . . 64.35 110.608 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.442 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 75.4 Cg_exo -53.7 132.18 47.88 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.263 2.642 . . . . 71.12 112.949 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.536 ' HB2' ' HA ' ' B' ' 124' ' ' PRO . 14.6 mm-40 -59.63 142.74 52.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.026 0.829 . . . . 70.34 112.461 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -126.82 126.32 43.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.744 0.818 . . . . 74.44 108.863 -178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.43 127.28 48.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.206 1.003 . . . . 61.35 109.128 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.521 HD23 ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -80.48 141.36 35.28 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.697 0.623 . . . . 74.12 110.159 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.34 158.96 57.15 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 124.856 1.262 . . . . 63.14 111.183 -177.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.34 107.45 2.46 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.102 2.535 . . . . 71.11 111.532 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 44.9 t -98.44 107.48 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.54 -0.911 . . . . 72.02 108.54 178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -113.73 99.24 7.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.588 1.155 . . . . 75.02 108.83 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.51 -42.99 99.88 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.794 0.838 . . . . 74.25 111.337 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 . . . . . 0 N--CA 1.478 0.927 0 CA-C-N 114.865 -1.061 . . . . 74.14 111.714 -179.273 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m . . . . . 0 C--O 1.239 0.505 0 N-CA-C 108.898 -0.779 . . . . 75.42 108.898 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -163.03 104.48 1.01 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.387 -1.338 . . . . 71.41 107.387 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -127.48 140.95 51.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.394 -0.965 . . . . 71.43 108.394 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.25 133.21 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.147 -1.057 . . . . 75.22 108.147 171.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -89.21 -39.6 13.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.345 0.403 . . . . 74.53 110.384 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 176.07 150.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.336 1.054 . . . . 72.25 110.6 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.26 134.45 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.444 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.0 p90 -147.73 162.53 39.0 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.267 1.027 . . . . 73.2 110.347 -176.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.43 HG21 HD11 ' D' ' 21' ' ' ILE . 75.6 p -95.44 119.68 34.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.764 -1.107 . . . . 71.42 109.52 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -90.56 -27.44 19.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.781 0.432 . . . . 72.31 110.585 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -154.76 140.27 17.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.087 -0.961 . . . . 74.11 108.696 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' C' ' 117' ' ' MET . 71.9 mt -137.95 143.05 34.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.081 -1.081 . . . . 74.31 108.081 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -148.07 123.36 10.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.142 0.977 . . . . 73.53 109.293 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.444 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -131.3 120.72 23.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.103 -1.814 . . . . 70.23 106.103 170.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.9 mt-10 -123.06 144.55 49.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.67 -0.492 . . . . 60.33 109.67 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.62 76.54 47.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 106.27 -1.752 . . . . 74.25 106.27 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.63 -25.26 24.78 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.695 2.263 . . . . 65.22 112.541 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -112.73 25.77 11.14 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.157 0.983 . . . . 65.43 109.169 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.501 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -49.02 -62.18 2.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 114.453 1.279 . . . . 72.44 114.453 -166.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.497 ' HB3' HD11 ' C' ' 83' ' ' ILE . 37.7 Cg_endo -83.14 -8.91 10.74 Favored 'Trans proline' 0 C--N 1.373 1.841 0 CA-C-N 122.358 1.878 . . . . 73.14 113.245 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -78.73 -36.78 42.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.67 1.188 . . . . 73.42 109.67 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.604 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.0 p -80.31 -21.66 11.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 CA-C-N 116.057 -0.52 . . . . 42.45 109.729 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -66.07 -6.51 13.27 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.427 0.899 . . . . 73.11 113.427 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -78.49 -36.22 45.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 74.33 109.541 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -131.38 61.36 1.64 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.122 0.969 . . . . 63.54 110.438 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -108.44 82.77 1.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.376 -0.828 . . . . 75.43 110.065 -172.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.605 ' H ' HD22 ' D' ' 68' ' ' LEU . 8.2 m95 -124.14 -159.71 0.88 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.987 -1.116 . . . . 73.31 107.987 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 45.8 tt0 -59.91 109.62 2.13 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.512 0.725 . . . . 74.25 111.763 -171.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 3.4 Cg_endo -84.76 150.87 11.33 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.093 2.528 . . . . 73.32 113.522 -175.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -73.73 120.46 19.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.093 -0.958 . . . . 71.24 109.253 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 m -99.36 129.05 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 124.104 0.962 . . . . 72.45 110.896 -172.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -130.62 117.75 19.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.238 1.015 . . . . 73.12 110.113 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.732 HD12 HD12 ' D' ' 128' ' ' LEU . 8.8 tt -98.15 137.97 36.12 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.103 -0.703 . . . . 73.13 109.103 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.64 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.0 m-20 -127.68 147.34 50.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.189 0.996 . . . . 75.21 108.845 172.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.83 150.76 39.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.346 0.659 . . . . 73.32 109.614 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 14.5 t70 -149.56 125.25 10.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.487 1.115 . . . . 74.52 108.108 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -104.21 144.27 31.82 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.431 0.692 . . . . 75.2 110.638 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.35 156.94 31.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.936 0.894 . . . . 33.23 109.332 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -168.61 154.31 6.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.328 0.651 . . . . 72.13 110.292 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -155.63 136.24 13.37 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.635 0.774 . . . . 54.43 109.357 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -74.32 122.94 23.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.529 -0.545 . . . . 65.32 109.529 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.2 mt -90.58 -37.94 13.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.033 0.533 . . . . 73.13 110.58 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.17 -176.35 5.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.381 0.673 . . . . 70.44 111.023 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.11 119.21 7.4 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.932 -1.031 . . . . 50.43 110.365 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.87 19.18 10.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.343 1.057 . . . . 73.34 112.058 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.17 126.62 75.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.086 0.954 . . . . 72.45 109.076 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -132.85 129.93 39.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.008 -1.108 . . . . 72.11 108.008 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.1 tt0 -91.12 119.42 31.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.567 -0.901 . . . . 54.5 108.567 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.96 129.35 52.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.935 -1.135 . . . . 75.32 107.935 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.482 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.4 t -116.84 128.34 74.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.157 -1.053 . . . . 74.14 108.157 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -126.54 105.91 9.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.307 -1.368 . . . . 72.13 107.307 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.4 ttm180 -84.17 123.25 29.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.573 -0.74 . . . . 74.53 109.4 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -112.07 137.12 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.45 -0.944 . . . . 63.02 108.45 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.64 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.9 m -126.55 138.89 53.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.373 0.669 . . . . 72.01 109.515 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.561 HG11 ' HG ' ' D' ' 126' ' ' LEU . 75.5 t -127.72 108.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.244 1.018 . . . . 51.25 109.445 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.5 m -99.92 124.53 45.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.709 0.804 . . . . 74.32 109.013 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 126.69 54.45 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.485 0.714 . . . . 70.4 110.127 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 33.9 p -140.79 121.11 13.95 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 109.313 -0.625 . . . . 55.22 109.313 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.605 HD22 ' H ' ' D' ' 36' ' ' TRP . 1.0 OUTLIER -98.95 135.25 40.63 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.706 0.803 . . . . 63.3 110.104 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.35 -111.44 4.16 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.43 -0.668 . . . . 71.13 111.43 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.14 18.26 9.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.336 1.054 . . . . 61.21 109.961 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -124.15 143.75 50.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.839 1.256 . . . . 72.13 109.973 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -76.89 121.98 24.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.951 0.5 . . . . 63.35 110.979 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.604 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.39 -65.49 0.95 Allowed 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.395 0.678 . . . . 74.53 109.608 175.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.53 164.25 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.391 -1.277 . . . . 70.04 110.549 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 67.2 mt -126.47 142.54 51.5 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.245 -1.391 . . . . 73.02 107.245 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.2 t -147.87 139.06 23.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.33 -0.618 . . . . 71.53 109.33 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -157.74 139.86 14.31 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.896 0.878 . . . . 70.23 109.22 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.47 118.89 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.742 0.817 . . . . 71.31 109.334 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.97 82.74 6.12 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.174 -1.047 . . . . 65.3 108.174 173.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.46 102.48 12.11 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.463 -0.79 . . . . 71.22 109.9 -171.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 170.26 29.94 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 116.324 -0.398 . . . . 63.55 112.385 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.56 137.68 4.47 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.534 -0.627 . . . . 71.13 111.534 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.444 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.6 mt -90.28 135.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 109.175 -0.676 . . . . 74.02 109.175 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.01 126.08 29.47 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.443 0.697 . . . . 65.23 109.875 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -78.88 94.98 5.29 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.633 0.773 . . . . 63.42 109.092 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.593 HG22 HD11 ' D' ' 89' ' ' ILE . 21.8 mt -113.13 131.76 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.625 0.77 . . . . 75.22 110.142 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.45 169.25 23.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.075 0.95 . . . . 53.44 110.35 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 72.42 21.39 79.45 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.078 -0.51 . . . . 73.23 113.617 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.593 HD11 HG22 ' D' ' 86' ' ' ILE . 1.5 pp -135.46 160.55 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.565 1.146 . . . . 75.42 109.604 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -168.4 166.53 12.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.522 0.729 . . . . 74.13 110.515 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.69 -135.47 47.04 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.998 0.811 . . . . 54.13 114.149 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -77.0 -22.86 52.48 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.842 0.857 . . . . 73.42 111.066 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -62.31 -46.12 90.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.784 0.834 . . . . 72.45 110.444 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.3 ptm -77.75 -24.09 49.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.657 -0.701 . . . . 73.44 110.905 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -32.97 74.75 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.812 0.445 . . . . 73.23 111.148 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -77.59 -39.04 46.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.182 0.593 . . . . 73.22 111.276 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -63.66 -44.18 94.56 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.25 0.548 . . . . 71.21 110.963 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -84.04 -41.38 17.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.473 1.109 . . . . 72.23 111.11 -176.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.62 -10.39 73.28 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 114.702 0.641 . . . . 60.54 114.702 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.29 -61.42 0.87 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.234 0.517 . . . . 75.12 111.232 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -65.25 -44.14 89.1 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.698 0.629 . . . . 73.3 112.698 -173.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 79.8 m -64.38 -44.68 76.45 Favored Pre-proline 0 CA--C 1.567 1.608 0 CA-C-O 118.824 -0.608 . . . . 70.34 112.498 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -48.19 -42.26 33.4 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.51 2.14 . . . . 72.43 114.093 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -64.75 -20.51 66.39 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.758 0.651 . . . . 73.45 112.758 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.3 mm -82.21 -46.8 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.398 0.618 . . . . 74.4 110.382 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -79.72 -28.85 40.53 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.169 -0.923 . . . . 54.35 111.826 -171.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -62.55 -42.56 80.13 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 124.205 1.002 . . . . 74.24 113.474 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -52.64 -39.98 74.47 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.48 2.12 . . . . 74.33 114.352 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -77.69 -32.69 53.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.522 0.729 . . . . 73.52 111.6 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.96 81.87 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.072 -0.714 . . . . 54.35 109.072 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.599 ' HA ' HD23 ' D' ' 128' ' ' LEU . 24.9 ttp180 -54.01 -55.37 27.89 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.899 1.374 . . . . 72.23 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -66.27 -39.71 89.63 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.142 0.901 . . . . 73.32 111.149 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.9 -44.1 97.61 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.31 0.381 . . . . 72.25 110.429 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.572 HG23 ' SG ' ' D' ' 76' ' ' CYS . 93.5 mt -59.03 -54.98 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.176 0.99 . . . . 72.04 110.238 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.612 HG21 ' HE2' ' B' ' 109' ' ' TYR . 71.7 m -52.08 -48.3 64.76 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 125.078 1.351 . . . . 63.33 111.595 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.81 -41.56 82.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.626 -1.17 . . . . 72.03 110.797 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.422 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -65.61 -36.68 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.709 0.404 . . . . 75.21 111.663 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.1 t -64.63 -44.74 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.605 -0.725 . . . . 62.45 109.969 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' D' ' 125' ' ' GLN . 88.1 p -69.62 -31.48 69.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.849 0.459 . . . . 71.2 111.614 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.79 -30.52 68.08 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.8 0.84 . . . . 75.22 110.488 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.01 11.55 59.97 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.375 -0.829 . . . . 15.0 112.281 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.3 p 60.67 14.57 5.1 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 127.092 2.157 . . . . 70.31 113.782 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -91.41 160.69 36.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.493 1.117 . . . . 72.14 108.495 173.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -73.54 115.66 4.41 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.429 2.086 . . . . 55.05 110.805 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' D' ' 119' ' ' SER . 12.6 pt20 -51.21 139.17 19.13 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.425 1.078 . . . . 73.24 112.407 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.561 ' HG ' HG11 ' D' ' 64' ' ' VAL . 0.7 OUTLIER -107.15 110.48 22.57 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.469 -0.567 . . . . 54.35 109.469 -165.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -98.59 102.57 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.468 0.707 . . . . 73.53 109.362 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.732 HD12 HD12 ' D' ' 42' ' ' LEU . 3.2 mm? -70.11 115.7 9.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.252 1.021 . . . . 63.21 109.912 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.1 137.55 95.81 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-O 119.581 -0.247 . . . . 54.52 110.376 177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.23 133.06 23.84 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.131 1.888 . . . . 71.05 110.995 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -108.06 136.38 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.291 -1.003 . . . . 71.01 108.291 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -78.36 86.78 4.41 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.366 -0.605 . . . . 72.43 109.366 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 . . . . . 0 N--CA 1.476 0.848 0 CA-C-N 115.447 -0.797 . . . . 65.24 110.713 178.295 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.5 m . . . . . 0 N--CA 1.47 0.55 0 N-CA-C 109.854 -0.424 . . . . 75.13 109.854 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.428 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 18.7 t80 -133.05 124.79 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 62.13 108.887 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -146.56 110.02 4.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.96 -0.756 . . . . 73.24 108.96 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.676 HG12 ' HD2' ' A' ' 84' ' ' PHE . 37.6 mt -69.65 128.69 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.639 -0.874 . . . . 71.14 108.639 173.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.631 ' HA ' HE21 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -97.73 -36.98 10.06 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 122.936 0.494 . . . . 74.14 110.461 177.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 40.8 ttt85 -166.86 142.99 4.46 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.885 -0.413 . . . . 75.33 109.885 -174.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.69 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.549 0.74 . . . . 72.14 109.027 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HE1' HG13 ' A' ' 83' ' ' ILE . 21.2 p90 -169.02 149.8 4.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.919 0.888 . . . . 63.24 110.299 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -79.33 119.81 22.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.899 -1.046 . . . . 74.52 108.83 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.2 mtpt -88.22 -17.93 29.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.847 0.356 . . . . 72.24 110.284 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.1 t70 -156.53 141.76 17.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.305 1.042 . . . . 72.45 109.141 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 64.4 mt -138.14 144.91 29.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 107.238 -1.393 . . . . 60.14 107.238 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.616 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 28.3 t -150.8 130.51 13.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.852 0.861 . . . . 61.11 108.935 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -132.64 136.44 46.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.406 -1.701 . . . . 70.52 106.406 167.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -133.91 140.13 46.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.414 -0.587 . . . . 74.42 109.414 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 69.23 10.92 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 106.065 -1.828 . . . . 74.25 106.065 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.46 -19.41 21.93 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.324 2.016 . . . . 73.24 112.453 -171.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -110.52 20.53 17.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.867 0.867 . . . . 64.11 109.798 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.74 -61.28 3.13 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.05 -0.976 . . . . 71.11 113.38 -167.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.4 -20.66 49.52 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.404 2.069 . . . . 71.52 113.912 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -83.85 -53.19 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.104 0.954 . . . . 73.34 109.906 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.611 HG11 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -77.43 -12.74 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-N 114.61 -1.177 . . . . 71.2 111.8 -162.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -74.18 -18.03 60.82 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.641 0.776 . . . . 64.43 112.606 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.07 -8.92 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.787 0.662 . . . . 73.41 112.787 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -79.9 168.95 18.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.957 0.503 . . . . 75.32 112.296 -174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.93 138.62 58.48 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.67 1.188 . . . . 73.34 111.153 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -86.84 80.43 8.49 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.483 0.659 . . . . 73.34 110.146 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -137.31 77.53 41.26 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 114.938 -1.028 . . . . 70.1 109.006 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -81.4 138.82 11.18 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.38 2.054 . . . . 62.35 111.762 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.56 84.32 3.39 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 106.006 -1.85 . . . . 64.42 106.006 164.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 65' ' ' THR . 12.0 p -81.91 123.39 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.748 -1.114 . . . . 60.2 109.153 -175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 18.0 pttp -123.6 127.62 48.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 74.24 110.591 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tt -98.55 109.49 22.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.629 -1.619 . . . . 70.33 106.629 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -106.34 147.89 28.69 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.792 0.837 . . . . 75.15 108.815 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -126.19 125.57 42.66 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.74 0.816 . . . . 61.44 109.342 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.5 t70 -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.093 0.957 . . . . 74.53 108.455 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -108.17 129.46 55.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.879 0.872 . . . . 72.21 111.597 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.16 130.72 17.83 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.705 0.802 . . . . 64.54 109.987 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -125.05 151.58 45.43 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.896 -0.779 . . . . 71.33 108.896 172.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 t -158.33 133.66 8.71 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.486 0.714 . . . . 72.24 109.857 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -78.32 125.53 29.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.227 0.611 . . . . 75.34 110.018 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.12 -34.28 13.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.453 0.701 . . . . 73.11 110.64 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -178.58 6.05 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.057 0.943 . . . . 34.22 109.707 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -69.26 125.34 26.39 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.902 -0.407 . . . . 71.35 109.902 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 68.58 -8.22 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.968 1.707 . . . . 64.44 112.805 -171.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -101.33 109.52 25.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.997 -0.742 . . . . 71.3 108.997 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.524 ' HB2' HD13 ' A' ' 86' ' ' ILE . 93.2 m-85 -123.64 127.19 47.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.965 0.906 . . . . 70.22 108.607 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.31 132.04 37.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.681 -1.145 . . . . 73.4 108.992 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.583 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 58.9 t -116.86 121.43 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.694 -1.224 . . . . 73.45 107.694 169.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.41 129.76 49.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.839 0.855 . . . . 73.21 108.711 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -120.57 100.5 7.17 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.547 -1.649 . . . . 74.55 106.547 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 6.6 ttm180 -87.35 131.22 34.34 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.843 -0.799 . . . . 74.35 108.843 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' A' ' 114' ' ' ILE . 47.9 t -117.84 130.61 72.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.328 -0.989 . . . . 72.43 108.328 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 69.2 m -113.72 140.97 47.82 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.635 0.584 . . . . 65.32 109.693 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.482 HG21 HD21 ' A' ' 126' ' ' LEU . 92.7 t -130.43 113.29 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.961 0.904 . . . . 50.13 108.747 174.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.5 m -112.73 131.49 55.65 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.114 -0.698 . . . . 71.11 109.114 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.27 105.74 8.75 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.316 -0.994 . . . . 72.12 108.316 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 51.6 m -110.58 122.92 48.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.29 0.495 . . . . 62.11 110.816 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 73' ' ' ALA . 10.4 mp -89.57 86.96 6.87 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.111 0.964 . . . . 74.11 109.012 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.1 -84.41 1.43 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.757 -1.111 . . . . 61.43 110.5 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -25.37 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.627 0.771 . . . . 60.31 110.446 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -98.4 129.87 45.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.312 1.045 . . . . 63.13 110.225 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.6 m -79.85 135.49 36.47 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.196 0.522 . . . . 73.53 112.19 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.611 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.64 -63.81 1.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.2 1.4 . . . . 72.03 109.766 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -147.09 159.75 43.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.104 -0.953 . . . . 75.12 111.645 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.65 117.26 11.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.399 -1.273 . . . . 72.32 108.335 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 63' ' ' THR . 83.9 m -110.61 136.72 49.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.392 0.677 . . . . 60.14 110.709 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 43.2 mp0 -135.9 131.27 35.02 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.618 -1.253 . . . . 71.21 107.618 169.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.27 115.2 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.6 -0.889 . . . . 53.14 108.6 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 42.3 mt-30 -90.23 86.98 6.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 172.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.71 93.11 4.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.727 -1.124 . . . . 73.3 108.62 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.01 148.24 22.3 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.264 -0.88 . . . . 71.12 111.082 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.74 123.27 2.01 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 111.349 -0.7 . . . . 50.15 111.349 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.492 HG13 ' HE1' ' A' ' 17' ' ' TYR . 56.3 mt -80.97 123.67 37.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.896 -1.149 . . . . 71.4 107.896 170.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.676 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.3 m-85 -133.83 162.9 30.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.263 -1.014 . . . . 63.23 108.263 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 t -118.43 102.47 8.95 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.489 -0.93 . . . . 74.55 108.489 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 56' ' ' TYR . 3.3 mp -112.82 137.13 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.568 0.747 . . . . 71.31 109.032 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.8 174.87 13.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.981 0.912 . . . . 60.42 109.876 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.21 16.14 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.742 0.657 . . . . 53.12 114.742 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 94' ' ' MET . 11.2 pt -121.29 157.07 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.918 0.887 . . . . 73.3 110.776 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 2.8 tt0 -140.31 174.63 10.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.96 0.904 . . . . 61.15 109.32 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.443 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 41.91 -116.11 0.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.927 1.131 . . . . 72.34 115.927 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.6 p -73.05 -28.58 62.4 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.7 1.2 . . . . 72.34 111.978 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.08 -46.74 87.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.383 0.673 . . . . 74.34 109.206 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.489 ' HA ' HD12 ' A' ' 89' ' ' ILE . 1.4 ppp? -83.59 -21.7 32.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.49 -0.777 . . . . 61.04 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -27.42 66.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.156 0.583 . . . . 70.02 110.692 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -64.52 -35.14 80.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.773 0.829 . . . . 75.24 110.597 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 45.1 t -72.33 -41.11 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.878 -0.601 . . . . 42.54 110.91 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.57 -51.1 21.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.3 0.24 . . . . 73.4 111.605 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.9 3.79 77.83 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 114.871 0.708 . . . . 54.45 114.871 -165.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.64 -58.26 0.2 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.013 0.907 . . . . 75.22 113.271 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 64.3 t80 -70.55 -59.21 2.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.692 -1.14 . . . . 61.11 112.086 -167.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.02 -32.48 2.91 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.546 0.943 . . . . 52.11 113.546 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.16 -45.58 25.25 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.732 2.288 . . . . 75.52 113.011 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.18 -27.76 69.29 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.747 0.819 . . . . 74.25 111.439 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 13' ' ' ILE . 47.9 mm -74.74 -47.59 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.634 0.774 . . . . 74.32 110.257 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.54 -29.68 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.623 0.769 . . . . 74.55 112.798 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -65.15 -38.65 29.79 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 113.599 0.962 . . . . 73.45 113.599 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.81 -40.68 79.34 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 122.14 1.893 . . . . 71.32 113.608 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -73.44 -40.56 64.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 75.2 111.636 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.87 84.0 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.814 0.446 . . . . 63.42 109.939 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -49.61 -53.75 22.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.096 1.498 . . . . 70.54 110.522 175.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.6 -41.11 93.16 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.178 0.924 . . . . 70.5 111.658 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.8 -31.59 72.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.034 0.533 . . . . 55.33 111.249 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 62' ' ' VAL . 89.7 mt -71.84 -51.78 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.555 0.742 . . . . 75.32 109.206 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.0 m -53.57 -40.04 65.27 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.705 1.202 . . . . 55.14 111.609 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -59.72 -55.2 37.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.719 -1.128 . . . . 22.0 110.386 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.4 mtm -60.75 -43.33 98.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.24 111.515 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 114' ' ' ILE . 78.5 t -57.38 -46.38 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.411 1.084 . . . . 50.21 110.691 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -70.67 -29.25 65.53 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.15 -0.932 . . . . 74.0 111.369 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.412 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.55 -30.74 66.22 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.788 0.835 . . . . 52.13 110.653 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.08 6.25 76.21 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.774 -0.459 . . . . 74.21 112.992 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.622 ' HB ' HH21 ' B' ' 15' ' ' ARG . 1.6 m 67.9 18.71 9.58 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.258 1.423 . . . . 75.32 111.681 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.92 151.57 64.2 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 109.284 -0.635 . . . . 72.44 109.284 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -58.97 146.01 95.43 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.795 2.33 . . . . 35.21 111.53 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.407 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.23 129.58 38.86 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.747 0.654 . . . . 75.25 111.393 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.482 HD21 HG21 ' A' ' 64' ' ' VAL . 48.0 tp -112.3 96.14 5.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.765 -1.107 . . . . 55.24 110.004 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.57 105.46 15.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.562 -1.273 . . . . 75.42 107.562 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 143.53 57.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.871 0.468 . . . . 72.35 110.045 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -63.17 130.51 94.24 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 122.95 0.5 . . . . 62.23 111.141 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 56.2 Cg_endo -72.37 104.9 1.77 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.241 1.961 . . . . 65.04 111.246 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.7 t -101.02 122.78 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.27 -1.011 . . . . 73.3 108.27 -178.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -68.29 86.62 0.28 Allowed 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.65 -0.87 . . . . 62.15 108.65 170.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.467 -1.242 . . . . 73.32 109.922 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.695 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.2 t70 . . . . . 0 C--O 1.217 -0.652 0 CA-C-N 114.239 -1.346 . . . . 62.13 111.498 -174.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.9 m . . . . . 0 C--O 1.24 0.561 0 N-CA-C 109.85 -0.426 . . . . 62.33 109.85 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.471 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 74.4 t80 -110.45 117.38 33.42 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.072 -1.084 . . . . 60.3 108.072 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -126.31 106.28 9.4 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.721 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -79.77 118.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 106.887 -1.523 . . . . 64.11 106.887 167.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -87.07 -53.61 4.77 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.472 -0.331 . . . . 73.5 110.188 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.622 HH21 ' HB ' ' A' ' 122' ' ' THR . 52.6 ttt180 -156.35 139.93 15.94 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.093 -0.336 . . . . 73.33 110.093 -172.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.721 HG13 HD11 ' B' ' 13' ' ' ILE . 92.5 mt -116.8 140.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 106.722 -1.584 . . . . 60.43 106.722 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -168.51 159.64 10.41 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 123.569 0.543 . . . . 71.54 110.552 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -85.93 120.26 27.13 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.403 -0.591 . . . . 74.05 109.403 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -87.81 -30.63 20.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.089 0.556 . . . . 71.25 110.689 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -158.86 146.81 17.96 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.715 0.293 . . . . 54.13 111.552 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 42.0 mm -132.46 141.61 44.76 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 125.281 1.432 . . . . 61.44 108.911 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.2 t -139.44 130.84 26.93 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.921 1.288 . . . . 71.13 107.655 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.482 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -148.13 125.17 11.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.462 -1.311 . . . . 50.0 107.462 168.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 45.9 mt-10 -122.92 144.99 48.86 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.623 -0.881 . . . . 53.12 108.623 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.856 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -142.22 74.88 20.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.6 -1.259 . . . . 75.31 107.6 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.31 -38.28 6.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.663 2.242 . . . . 53.02 112.566 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 71.9 m-20 -105.41 10.96 33.18 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.28 0.632 . . . . 74.22 111.01 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.856 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -44.59 -50.71 23.12 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 115.016 1.487 . . . . 71.45 115.016 -171.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.72 -30.35 17.94 Favored 'Trans proline' 0 C--N 1.383 2.384 0 CA-C-N 121.141 1.443 . . . . 42.35 112.829 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.426 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.0 m80 -97.61 -2.36 41.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.873 0.869 . . . . 64.41 112.956 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.53 -12.73 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.928 0.491 . . . . 72.24 110.492 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 71.8 t80 -61.36 -29.52 69.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.289 1.036 . . . . 71.42 111.735 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 pt20 -62.06 -31.98 72.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.193 0.597 . . . . 72.41 110.58 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 35.3 mmtp -97.05 64.98 2.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.311 -0.996 . . . . 74.25 108.311 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.91 99.72 11.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.802 -0.635 . . . . 75.13 110.324 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.402 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 163.89 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 126.953 2.101 . . . . 73.43 110.231 160.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -59.35 125.11 78.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.112 0.965 . . . . 63.13 112.589 -174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 87.9 Cg_endo -84.98 150.61 10.97 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.115 2.544 . . . . 74.32 112.56 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.44 106.45 3.94 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.015 -1.106 . . . . 74.25 108.015 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 65' ' ' THR . 91.9 t -93.13 128.69 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.62 0.768 . . . . 75.53 110.862 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.597 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.8 tttp -109.98 124.39 51.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.165 0.986 . . . . 61.35 109.478 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.21 152.51 22.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.43 0.692 . . . . 71.32 109.94 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.09 111.7 1.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.715 0.635 . . . . 54.14 109.525 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.402 ' HG ' HG22 ' B' ' 62' ' ' VAL . 10.1 mp -99.1 139.21 35.09 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.949 -1.13 . . . . 61.21 107.949 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.8 t70 -121.75 126.24 48.42 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.89 0.876 . . . . 75.3 108.841 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -106.96 103.93 13.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.17 0.988 . . . . 74.22 108.418 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 140.73 50.28 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.482 -0.781 . . . . 73.23 109.014 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 p -144.52 163.88 32.55 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.619 0.368 . . . . 62.34 111.28 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -153.06 140.38 19.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.04 0.936 . . . . 72.02 109.536 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -80.03 133.6 36.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.574 0.35 . . . . 75.53 110.527 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.84 -44.31 7.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.325 0.65 . . . . 70.44 110.592 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.62 -167.55 1.59 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.656 0.782 . . . . 63.15 110.965 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -63.9 106.08 0.96 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.884 -1.053 . . . . 60.35 110.784 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' B' ' 85' ' ' SER . 33.8 m-20 73.18 -1.72 2.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.303 1.841 . . . . 64.43 112.057 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.93 124.13 58.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.524 0 C-N-CA 124.182 0.993 . . . . 54.0 108.782 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -134.39 -178.62 5.13 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.512 0.725 . . . . 70.31 109.235 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.459 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.0 tm-20 -138.17 116.64 12.03 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.805 -1.554 . . . . 75.15 106.805 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.83 127.17 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.835 0.854 . . . . 73.53 110.309 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.6 t -102.48 112.89 37.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.297 1.039 . . . . 74.33 108.829 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.4 97.81 8.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.367 -1.346 . . . . 75.32 107.367 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 27.8 ttm180 -84.81 133.31 34.34 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.873 -0.788 . . . . 62.33 108.873 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' B' ' 44' ' ' LEU . 57.6 t -117.77 109.23 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.577 -1.268 . . . . 51.33 107.577 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -96.23 136.64 36.43 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.627 -0.879 . . . . 64.1 108.627 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -133.03 132.27 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.417 1.087 . . . . 61.41 108.455 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 59.7 m -123.19 144.08 49.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.686 -1.227 . . . . 72.04 107.686 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.04 135.14 39.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.953 -1.499 . . . . 70.11 106.953 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 14.8 p -145.77 139.03 26.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 122.982 0.513 . . . . 52.53 110.683 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 23.7 mt -129.46 104.67 7.61 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.853 1.261 . . . . 73.35 109.694 -171.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -135.92 19.79 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.542 -0.588 . . . . 65.04 111.953 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.7 11.08 18.56 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.546 0.673 . . . . 75.24 111.532 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.4 pt-20 -130.13 167.59 18.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.341 0.657 . . . . 62.12 110.936 -175.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -79.56 145.87 32.91 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.495 -0.775 . . . . 75.53 109.807 174.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.46 -67.11 0.88 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.947 0.499 . . . . 53.41 109.668 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -160.63 152.08 19.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.975 -1.011 . . . . 73.51 108.792 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 65.9 mt -128.07 137.1 52.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.56 1.144 . . . . 51.33 108.309 -174.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -146.49 147.03 30.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.522 -0.548 . . . . 74.24 109.522 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.3 tt0 -160.88 138.61 9.42 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' B' ' 113' ' ' CYS . 74.5 t -130.15 146.26 34.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.677 -1.231 . . . . 62.12 107.677 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.9 91.79 3.59 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.777 -1.194 . . . . 54.4 107.777 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.8 tp-100 -88.04 100.07 12.65 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.343 -0.984 . . . . 71.25 108.343 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.34 162.11 30.52 Favored Glycine 0 C--O 1.241 0.574 0 N-CA-C 111.047 -0.821 . . . . 64.23 111.047 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.64 126.8 1.6 Allowed Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.938 -0.865 . . . . 34.05 110.938 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.459 HG12 ' HG2' ' B' ' 57' ' ' GLU . 59.0 mt -84.39 129.62 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.467 -0.938 . . . . 74.31 108.467 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -131.81 148.75 52.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.38 -0.6 . . . . 75.14 109.38 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 22.6 m -131.23 106.64 8.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.43 1.092 . . . . 73.22 109.161 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.459 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -117.69 145.02 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 122.946 0.498 . . . . 73.01 110.634 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.13 161.73 39.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.865 0.866 . . . . 32.01 109.986 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.47 -41.2 2.51 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.895 -0.593 . . . . 74.34 111.775 -178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' B' ' 94' ' ' MET . 11.0 pt -71.66 143.38 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.727 0.811 . . . . 72.21 110.574 173.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.18 145.0 24.36 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.857 -0.794 . . . . 60.24 108.857 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.73 -109.4 2.83 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.831 0.707 . . . . 74.41 113.68 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.09 -53.44 45.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.233 1.013 . . . . 73.33 111.487 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -66.55 -34.3 77.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.248 -1.342 . . . . 70.02 110.417 -172.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.609 ' HA ' HD12 ' B' ' 89' ' ' ILE . 52.2 ttp -65.86 -50.94 62.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.679 1.192 . . . . 75.3 110.606 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.9 77.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.14 0.976 . . . . 72.22 111.919 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -78.2 -36.02 47.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.215 0.606 . . . . 73.33 111.227 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -65.11 -52.18 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.07 0.548 . . . . 70.11 111.673 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.61 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.1 pp -86.75 -31.95 20.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.591 -0.277 . . . . 64.0 111.532 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.08 73.4 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.09 0.396 . . . . 35.13 114.09 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.75 -51.6 2.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.808 0.443 . . . . 74.15 111.801 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -75.54 -40.75 56.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.806 0.442 . . . . 71.33 111.99 -170.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.4 m -66.49 -43.89 53.88 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 113.466 0.913 . . . . 61.32 113.466 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.86 -37.09 97.61 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.359 2.039 . . . . 51.53 113.218 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.23 -19.7 66.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.497 0.719 . . . . 53.24 112.491 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.412 HG23 ' NH2' ' D' ' 111' ' ' ARG . 86.3 mt -81.68 -48.31 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.344 0.658 . . . . 72.24 110.75 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.24 -25.82 58.4 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.915 -0.584 . . . . 72.33 111.591 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -57.68 -52.54 73.61 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.066 1.136 . . . . 74.24 114.066 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.71 -41.42 61.96 Favored 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.439 2.093 . . . . 72.24 113.731 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -65.15 -48.13 74.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.8 0.84 . . . . 75.45 111.396 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.54 82.0 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.486 -0.779 . . . . 62.52 110.988 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 ttp-105 -65.71 -49.73 67.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.047 -1.433 . . . . 74.04 111.386 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -35.37 79.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.995 0.518 . . . . 74.31 110.232 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.6 t -67.21 -32.0 72.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.623 0.369 . . . . 71.23 111.405 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.63 -45.63 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.499 0.72 . . . . 52.54 109.651 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.728 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.8 m -60.51 -25.01 65.77 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.382 1.073 . . . . 74.22 111.521 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -75.24 -51.4 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.652 0.781 . . . . 72.45 110.136 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.31 -34.99 73.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.914 0.486 . . . . 72.03 111.933 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.55 -39.47 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.463 0.705 . . . . 44.02 110.039 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.3 t -72.92 -27.51 61.91 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.702 0.801 . . . . 62.5 111.605 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.4 mtt-85 -73.34 -33.34 65.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.413 0.685 . . . . 71.13 110.086 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.34 1.75 69.49 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 123.855 0.722 . . . . 52.42 112.305 168.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 63.33 38.61 10.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.85 2.06 . . . . 52.35 112.606 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.11 156.76 40.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.484 1.114 . . . . 64.32 109.869 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -66.58 143.42 68.53 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.428 2.085 . . . . 65.44 111.54 177.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.728 ' HB2' HG23 ' B' ' 115' ' ' THR . 16.7 pt20 -65.14 161.65 18.64 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.28 1.432 . . . . 74.51 114.566 -167.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 26.5 tp -135.29 104.38 5.86 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.345 -1.298 . . . . 73.05 109.876 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.516 HD21 ' NE2' ' B' ' 125' ' ' GLN . 6.1 m-80 -92.2 107.43 19.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 106.48 -1.674 . . . . 70.02 106.48 167.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.1 tp -62.88 134.98 57.05 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.302 0.376 . . . . 65.02 110.153 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.25 156.46 50.42 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.775 1.23 . . . . 54.43 111.867 -177.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.9 108.43 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.754 2.302 . . . . 72.01 111.992 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 38.2 t -88.14 108.57 18.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.775 -1.565 . . . . 54.21 106.775 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -90.23 88.99 7.45 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.854 -0.795 . . . . 75.03 108.854 -177.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 . . . . . 0 N--CA 1.477 0.918 0 CA-C-N 115.199 -0.909 . . . . 74.54 110.466 178.431 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.3 tmm? . . . . . 0 CA--C 1.55 0.978 0 CA-C-O 121.325 0.584 . . . . 75.34 112.222 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.1 m -100.14 92.07 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.816 0.846 . . . . 73.32 109.36 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.716 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 49.0 t80 -92.01 145.78 24.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.799 -0.815 . . . . 60.13 108.799 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.01 132.2 4.8 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.844 -0.798 . . . . 72.12 108.844 167.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -70.88 134.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 109.17 -0.678 . . . . 70.04 109.17 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -103.19 -45.13 5.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.488 -0.56 . . . . 73.25 109.488 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 ttt85 -169.09 147.0 3.75 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.999 -0.546 . . . . 74.43 109.73 -178.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -130.02 136.22 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.328 -1.36 . . . . 75.31 107.328 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.558 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.2 p90 -171.22 154.1 3.88 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.418 0.627 . . . . 71.41 111.258 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -77.95 109.26 11.84 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.237 -1.023 . . . . 72.34 108.237 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -70.28 -45.55 66.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.74 0.781 . . . . 72.42 108.945 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.9 t70 -138.09 141.53 40.24 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.362 -1.29 . . . . 71.23 109.318 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.9 mt -136.16 142.71 37.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.718 1.607 . . . . 72.2 106.686 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -155.92 150.91 26.4 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.298 0.57 . . . . 62.13 110.987 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.466 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -152.45 121.61 6.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.595 -1.184 . . . . 75.52 107.842 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 72.41 109.157 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -137.1 86.18 20.83 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.453 -0.943 . . . . 51.13 108.453 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.27 -39.08 10.72 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.386 2.057 . . . . 75.44 111.316 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -99.26 33.77 2.34 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.188 0.995 . . . . 75.31 110.035 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.483 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -59.78 -51.9 77.63 Favored Pre-proline 0 CA--C 1.569 1.689 0 C-N-CA 124.615 1.166 . . . . 62.22 114.128 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 4.4 Cg_exo -74.85 -26.95 10.74 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.718 1.612 . . . . 71.42 111.37 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -66.03 -18.34 65.28 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.138 1.375 . . . . 71.55 112.166 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -54.71 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 N-CA-C 113.324 0.861 . . . . 55.0 113.324 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -68.25 -26.4 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.974 0.416 . . . . 74.14 111.886 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.44 30.95 6.67 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.508 1.123 . . . . 70.11 109.683 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.631 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -95.32 137.07 34.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.175 0.99 . . . . 73.0 108.7 171.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.73 130.37 42.14 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.576 -0.898 . . . . 73.23 108.576 170.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -83.79 66.59 9.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.109 0.564 . . . . 74.54 111.238 -170.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -165.7 78.34 1.22 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.543 0.737 . . . . 53.5 109.824 172.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.411 ' HB2' HG23 ' C' ' 40' ' ' VAL . 12.3 Cg_exo -73.29 163.4 38.0 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.716 2.277 . . . . 74.2 112.941 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -86.85 76.61 9.41 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 107.269 -1.382 . . . . 74.51 107.269 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.411 HG23 ' HB2' ' C' ' 38' ' ' PRO . 64.1 t -73.7 97.96 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.234 -1.348 . . . . 71.34 108.468 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -133.22 128.21 35.42 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.105 0.962 . . . . 73.24 108.757 -175.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.616 ' HG ' HD21 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -89.41 161.86 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.701 0.626 . . . . 75.53 109.999 175.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.5 t70 -139.12 141.58 38.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.307 1.043 . . . . 72.04 108.703 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -112.36 113.02 25.01 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.241 0.616 . . . . 75.02 109.455 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.4 t70 -114.89 142.01 47.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.484 -0.932 . . . . 71.34 108.484 172.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.4 p -128.39 136.94 51.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.915 0.486 . . . . 75.53 110.335 -172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 167.29 24.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 62.41 109.347 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -159.18 164.37 35.19 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.341 0.656 . . . . 65.03 111.365 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 92.3 p -145.91 155.23 42.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.008 0.923 . . . . 75.51 109.791 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -101.72 114.76 29.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.892 -0.781 . . . . 63.13 108.892 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.613 HD11 HD12 ' C' ' 83' ' ' ILE . 39.5 mt -94.06 -32.52 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.635 0.774 . . . . 74.11 110.456 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.92 -170.2 1.3 Allowed 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.001 0.92 . . . . 71.14 110.219 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.7 111.92 2.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.791 0.836 . . . . 73.31 109.417 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.3 -5.56 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.37 1.468 . . . . 73.54 112.88 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.19 94.87 5.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 106.935 -1.505 . . . . 75.33 106.935 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -114.0 124.36 51.94 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.72 -1.127 . . . . 74.33 108.442 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.2 tt0 -82.62 125.15 30.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.871 -0.788 . . . . 64.21 108.871 176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.99 118.52 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 73.34 108.669 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 72.5 t -102.9 127.76 56.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 107.696 -1.224 . . . . 74.41 107.696 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -129.44 94.5 3.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.993 -1.484 . . . . 70.03 106.993 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.47 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.9 ttm180 -82.67 121.69 27.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.717 -0.674 . . . . 70.31 109.211 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' C' ' 114' ' ' ILE . 18.3 t -115.72 117.63 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.735 -1.209 . . . . 42.14 107.735 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 41.1 m -110.35 137.76 47.63 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.259 -1.015 . . . . 73.43 108.259 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' C' ' 114' ' ' ILE . 97.8 t -120.64 109.93 26.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.332 -0.988 . . . . 71.41 108.332 170.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -99.55 140.64 33.43 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.863 -0.792 . . . . 73.23 108.863 171.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.64 97.28 3.23 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -141.64 146.25 35.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.169 0.588 . . . . 62.12 109.765 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.47 36.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.664 1.186 . . . . 70.1 108.819 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.48 -111.75 3.25 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.059 -1.216 . . . . 60.24 110.059 -168.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.77 -19.6 23.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.773 0.829 . . . . 71.12 110.415 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -78.0 84.43 4.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.298 1.039 . . . . 71.23 109.712 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -73.09 126.97 31.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.159 -0.473 . . . . 62.43 110.853 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.631 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -74.48 -52.14 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.748 0.819 . . . . 53.22 109.039 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 55.8 p90 -170.56 175.68 4.6 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.128 -1.396 . . . . 72.32 109.237 173.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.463 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.991 -1.485 . . . . 75.24 106.991 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.463 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.2 t -148.47 150.01 32.69 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.814 -0.81 . . . . 62.3 108.814 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -158.28 133.53 8.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.953 0.501 . . . . 71.34 109.829 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.07 115.45 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.939 0.896 . . . . 65.3 109.044 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.4 mt-30 -90.39 90.49 8.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.426 -0.953 . . . . 65.33 108.426 173.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.12 116.61 20.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.541 -1.209 . . . . 62.4 110.364 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 149.56 18.48 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 112.065 -0.414 . . . . 50.43 112.065 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.503 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.22 117.64 0.94 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.53 -1.028 . . . . 75.43 110.53 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.613 HD12 HD11 ' C' ' 51' ' ' LEU . 15.7 mm -80.89 114.66 22.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.963 -1.125 . . . . 72.14 107.963 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.66 147.54 49.92 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.87 0.468 . . . . 42.23 109.935 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.9 m -106.99 113.37 26.81 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.24 106.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 107.969 -1.123 . . . . 74.42 107.969 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -123.35 170.27 10.49 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.977 0.911 . . . . 74.13 110.659 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.12 -60.16 1.97 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.103 -0.499 . . . . 74.24 113.031 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' C' ' 94' ' ' MET . 1.3 pp -99.39 171.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.158 0.583 . . . . 63.43 111.966 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.93 -177.52 5.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.403 1.081 . . . . 73.15 109.026 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.46 -130.11 49.43 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 123.758 0.694 . . . . 74.42 114.747 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -70.13 -25.99 63.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.215 1.006 . . . . 53.31 111.543 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -76.48 -31.36 57.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.325 0.65 . . . . 71.3 110.251 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.594 ' HA ' HD13 ' C' ' 89' ' ' ILE . 0.7 OUTLIER -74.06 -42.29 60.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.326 -0.62 . . . . 65.14 109.326 172.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.04 -24.94 67.9 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.181 0.926 . . . . 51.51 112.057 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -69.88 -51.12 35.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.661 0.384 . . . . 75.52 110.412 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.28 -32.43 68.67 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.266 0.626 . . . . 44.15 111.438 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.13 -53.83 10.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.087 0.955 . . . . 65.4 109.36 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 -29.0 64.48 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.506 -1.225 . . . . 41.14 114.118 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -114.0 -45.65 3.06 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.461 0.63 . . . . 72.31 111.569 -168.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.422 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 22.0 t80 -76.36 -43.55 40.38 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 111.567 0.21 . . . . 61.21 111.567 -174.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -66.23 -45.69 61.13 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-O 118.446 -0.788 . . . . 74.11 112.913 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.38 -35.11 99.06 Favored 'Trans proline' 0 C--N 1.401 3.292 0 C-N-CA 122.316 2.011 . . . . 74.25 113.417 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.86 -36.17 76.32 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.005 0.922 . . . . 72.4 110.725 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -74.76 -46.22 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.506 0.722 . . . . 74.5 111.091 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.503 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -78.7 -20.26 50.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.733 0.642 . . . . 72.34 112.733 -170.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.406 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.8 t80 -58.26 -52.68 72.82 Favored Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 124.5 1.12 . . . . 74.2 113.242 -175.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 33.0 Cg_exo -61.32 -37.09 75.47 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.976 1.784 . . . . 73.14 112.964 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.58 -39.55 80.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.578 0.751 . . . . 73.44 111.682 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.78 81.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.306 -0.406 . . . . 52.2 110.347 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -58.09 -63.26 1.32 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 62.34 111.469 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -30.99 72.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.334 0.397 . . . . 43.44 110.524 -173.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.435 ' O ' ' SD ' ' C' ' 117' ' ' MET . 34.3 t -66.52 -41.26 89.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.334 0.654 . . . . 74.13 111.362 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' C' ' 64' ' ' VAL . 67.1 mt -65.49 -48.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.231 0.613 . . . . 70.41 110.041 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.2 m -60.77 -29.36 69.36 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.87 -1.059 . . . . 72.02 110.848 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.81 -47.05 67.06 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.143 0.977 . . . . 74.01 110.356 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.522 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.59 -45.19 89.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.327 0.651 . . . . 75.31 111.905 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.51 -39.05 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.493 0.717 . . . . 60.53 110.534 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.553 ' HB3' HE21 ' C' ' 125' ' ' GLN . 80.6 p -74.01 -29.24 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.749 -0.66 . . . . 74.14 112.144 -176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.44 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 74.1 mtt-85 -75.44 -31.37 60.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.941 0.897 . . . . 72.12 110.75 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.09 -2.47 62.26 Favored Glycine 0 C--N 1.356 1.656 0 O-C-N 123.485 0.491 . . . . 65.32 112.427 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 63.74 27.93 14.78 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 126.692 1.997 . . . . 74.2 111.674 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -99.22 142.86 25.36 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 114.506 -1.225 . . . . 75.22 108.915 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.66 124.13 13.76 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.248 2.632 . . . . 63.42 112.768 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.553 HE21 ' HB3' ' C' ' 119' ' ' SER . 97.7 mt-30 -59.84 154.6 18.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.27 1.211 . . . . 61.2 114.27 -172.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp -127.89 119.98 26.75 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.531 -1.213 . . . . 74.11 108.635 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -98.97 130.12 45.31 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.111 -1.07 . . . . 65.04 108.111 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.616 HD21 ' HG ' ' C' ' 42' ' ' LEU . 0.2 OUTLIER -74.85 128.21 35.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 109.446 -0.576 . . . . 61.32 109.446 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.56 137.52 95.22 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.869 0.868 . . . . 44.2 110.708 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.64 103.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.38 2.72 . . . . 60.23 111.757 176.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.24 110.34 24.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.118 -1.067 . . . . 74.13 108.118 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -77.6 83.73 3.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.912 -1.04 . . . . 64.23 111.18 -176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.9 -43.55 71.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.303 -1.317 . . . . 70.15 107.803 171.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.636 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.4 p-10 . . . . . 0 CA--C 1.542 0.657 0 CA-C-N 113.12 -1.855 . . . . 74.41 112.118 175.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 C--O 1.239 0.546 0 N-CA-C 108.888 -0.782 . . . . 62.34 108.888 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -164.57 91.7 0.59 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.144 -1.428 . . . . 74.01 107.144 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -119.73 115.39 23.8 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.869 -0.789 . . . . 74.22 108.869 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.435 HG21 HD11 ' D' ' 16' ' ' ILE . 13.5 mt -74.94 122.95 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.473 -0.936 . . . . 73.25 108.473 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -88.51 -49.02 7.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.935 0.334 . . . . 74.11 110.559 178.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -156.43 147.33 21.98 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.629 0.772 . . . . 74.33 109.837 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.435 HD11 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -117.81 122.82 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 105.582 -2.007 . . . . 72.32 105.582 161.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.483 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 32.8 p90 -152.23 162.08 41.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.926 0.869 . . . . 74.5 110.361 -171.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -90.02 114.64 26.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.184 -1.371 . . . . 63.51 109.424 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -82.69 -23.8 33.96 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.793 -0.64 . . . . 71.1 109.406 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -152.29 142.17 22.06 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.794 1.238 . . . . 65.11 109.11 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.522 HD13 ' HE3' ' C' ' 117' ' ' MET . 50.4 mt -138.69 142.13 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.187 1.395 . . . . 64.1 107.398 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.74 103.8 1.92 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.225 0.61 . . . . 73.53 110.476 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -109.68 120.37 42.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.114 -1.439 . . . . 75.04 107.114 166.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -124.72 120.02 30.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.457 0.703 . . . . 75.32 109.454 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 82.39 5.06 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 108.0 -1.111 . . . . 64.42 108.0 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -28.31 11.88 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.536 2.157 . . . . 65.42 112.77 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.532 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 43.1 m-20 -116.52 40.85 2.8 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.21 1.004 . . . . 74.44 108.91 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.46 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -59.76 -68.99 0.6 Allowed Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 117.628 -1.177 . . . . 62.14 113.791 -170.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.26 -14.32 23.05 Favored 'Trans proline' 0 C--N 1.39 2.761 0 CA-C-N 123.144 2.159 . . . . 73.42 112.022 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -68.6 -43.48 76.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.004 1.322 . . . . 75.21 110.313 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.46 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.6 p -72.73 -33.08 43.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-O 119.136 -0.459 . . . . 61.32 110.245 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -61.83 -4.52 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.4 0.889 . . . . 71.31 113.4 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -84.28 -38.63 20.21 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.636 0.774 . . . . 73.44 110.578 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -128.58 61.0 1.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.374 1.07 . . . . 61.34 109.287 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' D' ' 31' ' ' VAL . 32.0 t0 -113.62 93.74 4.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.482 0.658 . . . . 60.31 110.858 -171.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.521 ' H ' HD11 ' D' ' 68' ' ' LEU . 40.3 m95 -126.09 -158.04 0.83 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 106.636 -1.616 . . . . 71.31 106.636 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.05 112.95 5.23 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-N 119.34 0.973 . . . . 72.13 110.934 179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -74.25 135.14 20.18 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.715 1.61 . . . . 71.25 111.338 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -64.98 113.31 3.78 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 107.089 -1.448 . . . . 62.13 107.089 165.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -104.9 142.64 17.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.691 0.796 . . . . 55.44 110.42 -173.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.51 127.52 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.059 1.343 . . . . 61.12 108.006 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.43 111.87 23.95 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.721 -1.585 . . . . 55.42 106.721 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.79 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.3 m-20 -106.4 128.18 53.84 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.163 -1.051 . . . . 63.51 108.163 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.19 140.25 48.09 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.282 -0.636 . . . . 74.13 109.282 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.7 t70 -140.98 130.76 24.27 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.093 -1.077 . . . . 53.15 108.093 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -104.63 143.7 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.623 0.769 . . . . 65.52 110.808 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.678 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.77 151.87 30.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.632 0.773 . . . . 63.21 109.808 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.7 p -157.08 157.72 35.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.976 0.51 . . . . 43.1 109.745 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.2 p -153.06 154.29 34.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.665 0.786 . . . . 44.34 109.336 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -97.1 121.12 38.63 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.078 -1.453 . . . . 74.53 107.078 164.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.0 -30.05 17.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.77 0.428 . . . . 74.32 110.383 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.73 -173.99 1.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.59 0.756 . . . . 73.44 111.008 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.0 123.93 20.75 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.929 -1.032 . . . . 72.32 108.995 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 66.86 10.89 7.95 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.575 1.15 . . . . 73.21 112.09 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.9 t -123.5 123.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.151 -0.685 . . . . 61.31 109.151 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.68 149.61 51.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.801 0.84 . . . . 74.44 109.077 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -119.49 133.56 55.63 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.788 0.835 . . . . 75.34 109.733 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.49 112.63 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.689 -1.226 . . . . 64.44 107.689 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.0 t -101.76 127.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.774 -1.195 . . . . 72.23 107.774 172.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 59.3 tp -124.15 111.63 16.13 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.85 -0.796 . . . . 74.54 108.85 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.72 ' HB2' ' HG2' ' D' ' 79' ' ' GLN . 16.3 ttp180 -84.74 108.25 17.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.054 -0.976 . . . . 75.32 109.481 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.42 129.44 48.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.704 -1.221 . . . . 62.13 107.704 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.79 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.1 m -126.76 136.85 52.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.565 -0.902 . . . . 62.21 108.565 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.408 HG11 HD13 ' D' ' 126' ' ' LEU . 84.6 t -121.17 109.8 26.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.926 0.891 . . . . 52.35 108.706 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -93.03 118.99 31.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.161 -1.051 . . . . 71.11 108.161 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.29 129.49 56.64 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.658 -0.497 . . . . 75.45 109.658 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 68.1 m -134.75 128.12 32.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.842 0.857 . . . . 61.15 109.677 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.521 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.3 OUTLIER -92.04 92.38 8.25 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.019 0.528 . . . . 61.3 109.925 177.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.27 -125.48 10.74 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.332 -0.849 . . . . 73.14 111.351 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.05 9.08 18.24 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.578 0.751 . . . . 74.15 111.334 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -115.82 155.18 28.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.931 0.892 . . . . 72.14 109.918 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . 0.532 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 94.1 m -82.32 136.21 35.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.556 -0.535 . . . . 74.4 109.556 168.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.433 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.59 -68.07 0.78 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -155.43 167.65 29.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.401 -1.272 . . . . 64.22 109.974 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.0 mt -133.05 142.99 49.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.946 1.299 . . . . 64.43 107.65 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.54 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.0 t -145.66 136.24 24.23 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.37 -0.604 . . . . 65.43 109.37 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.18 134.9 11.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.147 0.579 . . . . 74.23 110.514 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.69 122.99 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.658 0.783 . . . . 63.32 109.759 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.72 ' HG2' ' HB2' ' D' ' 61' ' ' ARG . 50.1 mt-30 -89.04 89.45 7.98 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.763 -0.829 . . . . 71.51 108.763 168.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.62 96.63 8.16 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.965 -1.016 . . . . 72.53 109.158 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.65 142.46 17.15 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.358 -0.697 . . . . 25.32 111.358 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.33 128.65 4.59 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.342 -1.103 . . . . 53.53 110.342 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.8 mt -90.73 128.23 42.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.846 -0.798 . . . . 74.34 108.846 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.406 ' HD2' HG12 ' D' ' 13' ' ' ILE . 27.4 m-85 -133.96 124.82 26.98 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.304 0.642 . . . . 70.33 109.606 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -77.4 93.94 4.16 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.855 -0.794 . . . . 73.34 108.855 171.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.11 125.94 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.555 0.742 . . . . 72.32 110.359 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.88 158.1 34.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.049 0.939 . . . . 71.44 109.924 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.97 -20.64 41.38 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-O 119.911 -0.383 . . . . 74.04 113.684 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.08 142.24 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.561 -0.903 . . . . 52.41 108.561 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -136.69 156.59 48.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.285 0.634 . . . . 72.32 111.883 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.61 -125.75 35.98 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 124.58 1.175 . . . . 75.33 115.055 166.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.33 -32.61 73.68 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.392 1.077 . . . . 71.52 112.127 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.68 -28.57 40.72 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.032 0.533 . . . . 75.22 110.499 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -77.55 -33.28 54.18 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.069 -0.715 . . . . 74.2 109.069 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.94 -30.91 71.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.828 0.851 . . . . 72.3 110.695 173.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 10.5 t60 -66.09 -52.24 50.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 73.34 109.093 169.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.09 -35.27 78.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.849 0.46 . . . . 73.44 112.003 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -85.04 -40.33 16.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.046 0.938 . . . . 72.42 110.223 -173.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.13 11.72 58.69 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.165 -0.47 . . . . 64.24 113.9 -173.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -144.44 -57.6 0.36 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.463 0.632 . . . . 70.14 112.073 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -73.66 -61.01 1.99 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.62 0.368 . . . . 75.15 111.287 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -56.04 -44.08 99.53 Favored Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 124.404 1.082 . . . . 64.53 113.758 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.3 -40.47 68.08 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 122.338 2.025 . . . . 74.35 112.691 173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -68.4 -26.57 65.61 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.576 0.75 . . . . 71.33 111.494 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -69.52 -50.87 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.948 0.499 . . . . 72.3 110.624 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.73 -12.89 52.84 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.759 -0.655 . . . . 44.41 112.243 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -62.24 -43.79 86.63 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.174 0.99 . . . . 63.31 113.635 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.67 -33.19 68.43 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.197 1.932 . . . . 61.54 113.912 172.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -79.14 -35.58 41.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.432 0.693 . . . . 74.32 110.708 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.97 82.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.439 0.696 . . . . 62.23 110.448 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.683 HH12 ' HB3' ' D' ' 130' ' ' PRO . 31.6 ttp180 -56.27 -50.37 71.56 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.322 -1.308 . . . . 53.22 110.627 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.17 -32.33 73.97 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.119 0.968 . . . . 74.21 111.501 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.44 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -70.35 -44.98 67.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.962 0.505 . . . . 63.13 111.021 176.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.54 HG23 ' SG ' ' D' ' 76' ' ' CYS . 61.8 mt -56.9 -54.79 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.408 1.083 . . . . 72.21 110.826 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -53.77 -45.72 70.75 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.083 1.353 . . . . 74.12 111.677 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.5 t -63.52 -43.39 97.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.429 -1.259 . . . . 64.13 110.842 -176.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.413 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 74.2 mtm -68.93 -36.04 77.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.879 0.472 . . . . 71.25 111.817 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.7 t -61.21 -45.14 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.76 -0.654 . . . . 72.43 109.897 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -71.25 -28.2 64.0 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.116 0.566 . . . . 75.13 111.498 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.0 mtt-85 -72.42 -28.69 63.12 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.709 0.804 . . . . 53.51 111.208 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.7 11.45 59.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.678 -0.512 . . . . 74.31 112.916 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.558 HG23 ' HB3' ' C' ' 17' ' ' TYR . 32.6 p 65.44 17.74 11.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 126.689 1.996 . . . . 62.03 113.215 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -93.52 159.39 35.1 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.197 0.999 . . . . 74.53 108.524 173.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.86 127.6 16.42 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.648 2.232 . . . . 75.43 111.342 -175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -53.38 120.81 6.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 123.761 0.663 . . . . 52.55 110.483 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.408 HD13 HG11 ' D' ' 64' ' ' VAL . 5.1 tt -104.04 102.52 12.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.427 -1.323 . . . . 62.24 107.427 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -94.84 85.09 4.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.195 -1.039 . . . . 72.24 108.195 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.538 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 33.0 tp -61.25 123.19 17.02 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.377 -1.738 . . . . 71.55 111.347 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.85 133.13 89.46 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 123.919 0.888 . . . . 64.13 111.645 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.683 ' HB3' HH12 ' D' ' 111' ' ' ARG . 90.3 Cg_endo -82.86 134.23 7.14 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.292 1.995 . . . . 74.25 112.478 -169.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.3 t -108.04 110.06 30.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.466 -0.939 . . . . 74.41 108.466 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -89.6 93.49 9.5 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.113 -0.699 . . . . 62.0 109.113 177.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.5 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 76.4 m-85 . . . . . 0 N--CA 1.472 0.642 0 CA-C-N 115.242 -0.89 . . . . 72.44 110.479 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 78.8 m . . . . . 0 N--CA 1.471 0.601 0 N-CA-C 109.762 -0.459 . . . . 73.12 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.596 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.9 t80 -138.35 133.27 32.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.617 0.767 . . . . 74.23 109.954 170.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -160.58 116.32 2.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.813 0.845 . . . . 74.34 109.975 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.576 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.0 mt -76.17 125.68 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.536 -0.542 . . . . 70.51 109.536 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -97.3 -33.69 11.35 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.078 0.551 . . . . 74.12 111.13 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -172.24 128.41 0.57 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 110.079 -0.341 . . . . 74.33 110.079 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -121.79 126.9 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 123.664 0.785 . . . . 74.34 109.852 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 48.4 p90 -164.19 153.71 14.06 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.311 0.645 . . . . 72.22 111.202 -169.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.55 111.02 12.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.966 -1.015 . . . . 72.24 109.533 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 37.1 mtpt -76.43 -28.38 56.59 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.189 -0.459 . . . . 52.44 110.912 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -151.99 142.38 22.52 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.006 -0.997 . . . . 74.3 109.528 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.24 141.47 42.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 125.276 1.43 . . . . 45.12 107.293 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.78 130.4 14.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.966 -0.753 . . . . 72.44 108.966 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -133.5 120.48 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.482 -1.673 . . . . 62.32 106.482 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.1 114.29 20.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.773 0.429 . . . . 75.11 110.592 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 70.3 81.6 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 107.09 -1.448 . . . . 62.53 107.09 165.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.37 -3.56 13.48 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.246 1.964 . . . . 71.42 111.573 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -119.86 17.06 12.65 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.417 1.087 . . . . 62.41 109.317 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.98 -58.84 4.24 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.801 -1.095 . . . . 44.23 113.818 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.31 -25.71 71.6 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.376 2.051 . . . . 74.13 112.432 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.94 -48.1 17.08 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.5 -0.773 . . . . 72.1 109.914 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 6.2 p -77.29 -10.57 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.731 -0.668 . . . . 75.35 112.151 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -72.62 -18.23 61.61 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.159 0.583 . . . . 74.11 112.392 176.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.27 -8.54 21.17 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.339 0.866 . . . . 74.44 113.339 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 71' ' ' GLU . 8.7 mmpt? -55.11 164.07 0.95 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.13 1.159 . . . . 72.11 114.13 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.4 133.69 54.44 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.699 -1.137 . . . . 61.13 109.498 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -77.57 73.99 4.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.631 0.772 . . . . 74.53 111.791 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.66 79.05 24.9 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.299 1.039 . . . . 73.42 108.993 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 114.89 4.16 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.042 1.828 . . . . 70.21 111.867 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.22 83.96 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.333 -1.729 . . . . 75.1 106.333 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.8 t -98.08 102.69 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 113.983 -1.462 . . . . 60.35 108.441 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.12 144.19 32.26 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.85 0.86 . . . . 74.41 110.41 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tt -97.51 111.65 23.83 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.167 -1.42 . . . . 62.24 107.167 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.674 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.2 m-20 -102.9 112.49 25.33 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.86 -1.163 . . . . 71.44 107.86 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tt -110.05 129.09 55.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.588 0.355 . . . . 75.25 110.339 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -139.51 145.35 38.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.659 1.183 . . . . 71.25 108.583 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -136.64 153.22 50.98 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.265 0.626 . . . . 72.02 110.828 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -141.84 153.26 44.36 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.512 1.125 . . . . 71.51 110.423 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 p -119.47 172.46 7.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.709 0.804 . . . . 70.0 109.231 168.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.549 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.4 t -160.86 144.78 13.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.862 0.865 . . . . 74.33 109.467 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -114.82 109.79 18.71 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 74.4 109.292 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.1 mt -82.4 -40.32 21.45 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.529 0.732 . . . . 71.24 109.722 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.01 -178.12 7.13 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.682 1.193 . . . . 64.25 109.073 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 121.55 17.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.267 -0.642 . . . . 75.03 109.267 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.02 -8.5 1.12 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.904 1.682 . . . . 73.21 112.879 -171.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.05 103.42 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.135 -1.061 . . . . 42.42 108.135 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.08 163.56 18.17 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.232 -0.894 . . . . 72.01 108.615 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 29.2 tt0 -133.7 145.11 49.59 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.527 1.131 . . . . 64.42 108.737 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.83 133.86 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.876 -1.157 . . . . 53.32 107.876 168.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.5 t -111.39 139.04 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.585 1.154 . . . . 75.1 108.437 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.04 106.11 10.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.896 -1.15 . . . . 75.14 107.896 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -84.41 102.35 12.7 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.827 -0.805 . . . . 72.52 108.827 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.34 115.91 35.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.05 -1.092 . . . . 75.44 108.05 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 48.5 m -117.92 138.55 52.07 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.48 -0.933 . . . . 72.11 108.48 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.564 HG11 HD21 ' A' ' 126' ' ' LEU . 99.1 t -129.94 117.83 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 124.6 1.16 . . . . 64.2 108.209 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 20.8 m -101.88 136.61 41.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.332 -0.988 . . . . 71.5 108.332 171.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.34 125.34 21.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.741 -1.207 . . . . 54.12 107.741 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.0 m -146.02 127.76 15.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.582 0.551 . . . . 60.33 110.464 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.87 86.23 6.58 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.01 -1.108 . . . . 74.14 108.01 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.46 -123.22 6.05 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.569 -1.196 . . . . 74.34 110.613 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -88.1 -28.01 21.56 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.285 0.634 . . . . 64.13 111.094 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 34' ' ' LYS . 27.6 tt0 -90.03 126.14 35.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.977 0.511 . . . . 71.04 110.475 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 m -72.65 129.29 37.92 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.97 0.908 . . . . 75.05 111.744 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.5 -65.5 0.75 Allowed 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.162 0.913 . . . . 74.0 108.762 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.548 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 50.3 p90 -155.92 144.42 20.16 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.785 -0.643 . . . . 74.31 110.748 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -121.13 110.15 15.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.154 -1.054 . . . . 51.14 108.154 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.548 ' HG ' ' HD2' ' A' ' 74' ' ' PHE . 84.0 m -111.15 114.84 28.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.182 0.993 . . . . 74.41 110.892 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.5 124.98 39.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.5 -0.926 . . . . 60.23 108.5 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.3 t -132.81 108.52 13.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.844 -1.169 . . . . 71.41 107.844 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.2 mt-30 -85.28 80.19 9.26 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.299 -1.371 . . . . 62.31 107.299 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -76.46 96.54 4.09 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.176 -1.375 . . . . 70.12 108.651 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -94.1 166.18 27.05 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.955 -0.566 . . . . 63.43 112.124 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.21 128.41 1.73 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.933 -0.867 . . . . 63.44 110.933 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.7 mt -80.57 120.28 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.635 -0.876 . . . . 64.51 108.635 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.596 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.8 m-85 -125.7 117.3 23.18 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.739 -1.208 . . . . 75.41 107.739 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -79.67 86.77 5.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.92 -0.77 . . . . 71.21 108.92 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 pt -113.49 143.93 22.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.833 0.853 . . . . 73.31 110.496 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.09 161.37 12.53 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.706 -1.134 . . . . 72.33 109.806 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 2.75 58.81 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.59 -0.732 . . . . 64.51 114.15 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.56 137.35 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.192 0.597 . . . . 74.44 110.441 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -142.72 -177.59 5.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.724 1.21 . . . . 64.22 109.653 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.89 -125.15 29.93 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.459 0.475 . . . . 71.31 112.537 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.5 t -82.56 -19.42 38.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.053 0.541 . . . . 74.31 111.012 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -71.34 -39.2 71.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.063 0.545 . . . . 74.14 110.992 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 95' ' ' ALA . 3.8 ppp? -70.95 -32.09 68.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.055 0.222 . . . . 72.3 110.478 175.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.441 ' N ' ' SD ' ' A' ' 94' ' ' MET . . . -75.97 -23.91 55.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.314 0.646 . . . . 65.32 111.215 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -83.98 -32.52 24.94 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.335 0.654 . . . . 73.15 109.56 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.1 t -67.35 -43.56 81.18 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.182 0.593 . . . . 72.23 110.3 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.8 mt -88.42 -31.44 18.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.289 -0.869 . . . . 75.54 111.84 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.09 3.77 58.55 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-O 119.62 -0.545 . . . . 65.14 114.241 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 134' ' ' ASP . . . -149.25 -65.58 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.504 0.652 . . . . 70.4 111.699 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 74.3 t80 -64.36 -68.95 0.31 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.11 0.964 . . . . 61.41 112.974 -168.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.6 m -66.34 -33.52 6.81 Favored Pre-proline 0 CA--C 1.571 1.754 0 N-CA-C 114.26 1.207 . . . . 63.44 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 56.2 Cg_endo -69.49 -22.41 33.38 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 121.813 1.675 . . . . 73.41 113.083 169.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.403 HD21 ' HD2' ' A' ' 133' ' ' PHE . 1.3 m-80 -72.13 -19.48 61.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.229 0.468 . . . . 70.2 110.804 173.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.639 -0.875 . . . . 64.21 108.639 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -78.66 -29.78 45.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.249 1.02 . . . . 74.44 112.547 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -60.39 -45.12 97.44 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.064 1.135 . . . . 74.32 114.064 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.28 -31.71 34.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.894 1.73 . . . . 70.11 113.204 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -72.0 -37.67 69.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.912 0.485 . . . . 64.14 110.907 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.56 79.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.228 0.611 . . . . 61.32 109.628 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.495 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.8 ttm180 -52.23 -51.39 58.58 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 124.803 1.314 . . . . 73.42 110.382 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.77 -45.36 86.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.036 0.934 . . . . 74.03 111.537 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.404 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -57.58 -41.89 82.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.816 0.698 . . . . 64.11 110.451 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 118' ' ' VAL . 85.1 mt -69.11 -45.7 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.177 -0.919 . . . . 74.44 110.072 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.5 m -54.95 -40.73 70.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.438 0.695 . . . . 34.31 110.802 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 t -68.87 -53.46 21.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.923 -1.035 . . . . 71.14 110.306 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 mtp -51.94 -47.09 64.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.282 1.033 . . . . 71.22 111.734 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.406 HG22 ' SG ' ' A' ' 76' ' ' CYS . 75.4 t -63.84 -45.68 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.544 -1.207 . . . . 73.4 110.813 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -66.72 -28.6 68.56 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.275 0.63 . . . . 73.33 111.396 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.538 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.0 mtt-85 -72.07 -31.16 65.84 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.433 0.693 . . . . 55.24 110.296 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.81 1.79 82.35 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.205 -0.452 . . . . 54.42 113.133 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.1 m 64.99 24.84 12.66 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 125.361 1.464 . . . . 73.31 110.711 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -93.42 160.13 33.73 Favored Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 114.559 -1.2 . . . . 74.24 110.263 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -52.54 137.52 57.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 124.398 3.399 . . . . 74.44 115.38 -177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -50.34 122.98 7.69 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.651 0.594 . . . . 61.5 110.549 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.564 HD21 HG11 ' A' ' 64' ' ' VAL . 21.4 tp -118.99 105.27 11.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.491 -1.232 . . . . 72.02 109.63 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -135.7 107.99 7.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.44 -1.254 . . . . 70.35 107.877 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.9 146.76 54.49 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.761 0.824 . . . . 73.42 111.893 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.25 148.18 96.09 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.734 0.813 . . . . 73.22 111.175 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.76 105.28 0.19 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.775 2.317 . . . . 71.51 112.834 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.35 116.91 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.998 -0.742 . . . . 52.33 108.998 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -93.14 77.97 4.58 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.369 1.068 . . . . 74.01 108.422 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.403 ' HD2' HD21 ' A' ' 104' ' ' ASN . 91.2 m-85 -55.79 -34.89 65.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.7 1.2 . . . . 73.21 112.725 -173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB3' ' HB1' ' A' ' 100' ' ' ALA . 6.0 p-10 . . . . . 0 N--CA 1.471 0.624 0 C-N-CA 123.849 0.86 . . . . 54.3 112.097 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 61.2 m . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 108.175 -1.046 . . . . 61.41 108.175 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.72 124.24 11.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.388 0.675 . . . . 71.34 109.274 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.5 132.94 21.98 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.885 0.474 . . . . 62.22 110.102 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.643 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -77.39 120.73 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.186 -0.915 . . . . 74.42 108.83 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -86.24 -50.26 7.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.329 -0.396 . . . . 74.42 111.055 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.52 140.02 5.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.467 0.307 . . . . 73.23 110.424 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.643 HG13 HD11 ' B' ' 13' ' ' ILE . 90.6 mt -115.53 139.48 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.107 0.963 . . . . 72.34 108.879 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -164.89 164.76 20.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.731 0.777 . . . . 74.12 112.219 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.449 HG21 HD11 ' B' ' 21' ' ' ILE . 97.3 m -93.74 124.69 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.99 -1.004 . . . . 70.51 108.474 171.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -88.9 -33.49 17.29 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.124 0.57 . . . . 61.1 110.677 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -155.31 142.29 19.14 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.164 0.431 . . . . 74.2 112.164 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.449 HD11 HG21 ' B' ' 18' ' ' THR . 47.5 mm -133.13 142.16 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.492 1.117 . . . . 72.52 109.301 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 58.6 m -143.13 131.67 22.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.597 -1.183 . . . . 51.52 108.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -144.12 107.6 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.808 -1.552 . . . . 72.0 106.808 167.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -119.23 115.46 24.25 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.844 -0.799 . . . . 75.14 108.844 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -107.17 88.28 3.72 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.583 1.153 . . . . 75.31 109.185 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.45 -44.1 1.77 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.722 2.281 . . . . 63.14 112.681 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 77.1 m-20 -102.61 23.0 12.64 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.964 0.906 . . . . 71.32 109.705 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.864 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.5 -46.67 59.49 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 115.774 1.768 . . . . 72.41 115.774 -174.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.0 Cg_exo -75.79 -29.65 6.83 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.286 1.99 . . . . 53.42 112.325 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -94.36 1.0 55.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.39 1.076 . . . . 71.34 111.557 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 28' ' ' ALA . 4.5 p -83.57 -17.19 10.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 C-N-CA 123.38 0.672 . . . . 71.31 110.419 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.59 -28.66 63.82 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 118.481 0.582 . . . . 73.51 112.093 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -73.65 -45.77 50.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.446 0.698 . . . . 70.52 111.07 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.522 ' HB3' HD13 ' B' ' 68' ' ' LEU . 10.9 mmmm -107.37 62.62 0.62 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.288 1.035 . . . . 64.35 108.97 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -119.07 80.73 1.59 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.691 -0.855 . . . . 72.13 108.691 -171.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -152.64 -177.27 6.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.087 0.955 . . . . 74.0 109.511 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -59.53 109.19 1.75 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.509 0.724 . . . . 52.11 110.835 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -86.34 173.87 6.35 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.587 2.191 . . . . 72.04 112.902 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.28 103.77 4.09 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.385 -1.339 . . . . 65.13 107.385 164.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 44.4 t -101.41 151.9 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.699 -1.137 . . . . 50.44 110.492 -173.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.413 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 55.5 mtpt -138.11 138.81 39.07 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.116 0.966 . . . . 72.41 109.393 175.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.76 126.25 45.79 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.992 -1.855 . . . . 70.45 105.992 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.1 t70 -124.7 139.95 53.39 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.423 -0.955 . . . . 72.34 108.423 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.446 ' H ' HD23 ' B' ' 44' ' ' LEU . 2.6 pt? -125.55 141.19 52.17 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.021 -0.733 . . . . 73.4 109.021 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.2 t70 -130.45 137.36 49.77 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.139 0.976 . . . . 60.24 108.575 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -108.69 103.11 12.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.841 0.857 . . . . 64.31 110.393 -172.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 141.07 50.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.218 1.007 . . . . 64.14 109.416 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 p -145.58 168.45 20.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.166 0.586 . . . . 53.13 110.903 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.72 138.64 18.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.11 0.564 . . . . 60.32 110.482 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -82.45 101.27 10.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.079 -0.711 . . . . 54.02 109.079 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 mt -74.54 -35.99 63.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.305 0.642 . . . . 74.54 109.996 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.23 -174.2 3.43 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.295 -1.32 . . . . 75.43 109.232 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.61 128.06 35.27 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.133 -0.94 . . . . 73.22 109.821 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 67.62 -5.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.437 1.495 . . . . 74.22 112.955 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.91 115.14 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.808 . . . . 72.43 109.146 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.91 143.38 50.77 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.369 0.668 . . . . 60.14 110.416 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -99.8 116.16 31.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.144 -1.058 . . . . 70.24 108.144 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -91.42 118.02 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.038 0.935 . . . . 64.44 109.001 172.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -114.42 112.64 40.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.053 0.941 . . . . 71.02 108.561 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.93 108.68 20.31 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.872 -1.158 . . . . 74.34 107.872 176.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.638 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 18.9 ttm-85 -85.58 112.41 20.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.78 -0.822 . . . . 73.22 108.78 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.35 103.02 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.872 -1.159 . . . . 61.32 107.872 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.0 m -100.96 130.95 47.04 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.055 -0.72 . . . . 70.13 109.055 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.462 HG11 HD21 ' B' ' 126' ' ' LEU . 68.9 t -117.53 115.86 49.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 85.8 m -92.57 141.67 28.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.147 0.979 . . . . 41.44 108.612 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.77 121.5 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.723 -0.843 . . . . 64.05 108.723 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 40.4 p -147.2 127.8 14.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.637 0.775 . . . . 43.44 109.456 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.721 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.3 OUTLIER -118.31 134.6 54.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.446 0.698 . . . . 54.52 109.305 -176.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.78 -118.28 6.43 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.206 -0.758 . . . . 74.14 111.206 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.17 11.35 12.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.874 0.87 . . . . 64.33 110.315 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.442 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 3.7 pm0 -127.67 158.96 36.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.677 0.791 . . . . 74.12 110.682 -176.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -78.81 135.99 37.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.942 -0.572 . . . . 74.21 110.328 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.721 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -83.72 -64.75 1.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.901 0.858 . . . . 75.43 108.993 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.83 152.95 16.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.563 -1.653 . . . . 44.21 108.094 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -123.74 137.02 54.77 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.324 -0.991 . . . . 63.33 108.324 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.0 t -134.18 148.18 50.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.809 -0.812 . . . . 54.11 108.809 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.7 tt0 -156.16 138.8 15.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.925 -0.768 . . . . 61.41 108.925 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -132.14 145.27 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.403 1.081 . . . . 74.5 108.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -118.82 97.1 5.54 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.285 -1.376 . . . . 60.23 107.285 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -87.74 100.11 12.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.043 -1.095 . . . . 74.02 108.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.37 157.65 25.92 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.392 -1.083 . . . . 63.41 110.392 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.93 125.65 1.37 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.177 -0.769 . . . . 42.23 111.177 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.7 130.91 35.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.825 -0.805 . . . . 53.22 108.825 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.72 165.63 22.48 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.109 0.963 . . . . 64.15 108.633 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.35 120.91 26.39 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.921 -0.77 . . . . 73.13 108.921 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 36.7 pt -119.13 145.81 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.584 1.153 . . . . 72.21 110.742 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.21 157.67 36.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.608 1.163 . . . . 73.25 108.682 172.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -42.39 2.57 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 116.856 -0.156 . . . . 55.21 112.889 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 35.5 pt -79.31 149.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.086 0.555 . . . . 72.22 110.655 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -170.64 160.08 6.97 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 70.3 109.376 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.77 -119.42 12.22 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.398 0.436 . . . . 73.21 112.452 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.0 m -73.69 -28.55 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.929 0.892 . . . . 74.23 111.292 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -70.97 -24.39 62.4 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 72.33 112.317 -167.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.5 ptp -67.25 -32.02 72.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.938 -0.574 . . . . 61.12 110.592 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -22.14 66.6 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.603 0.761 . . . . 73.54 112.027 -178.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -83.83 -45.9 12.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.934 0.494 . . . . 74.12 109.907 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -74.95 -67.8 0.61 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.181 -0.463 . . . . 74.33 111.457 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.0 pp -80.73 -20.75 42.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 119.488 -0.291 . . . . 73.3 111.683 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.9 -32.57 26.29 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 113.887 0.315 . . . . 62.44 113.887 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.18 -59.23 2.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 71.51 110.899 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -67.17 -45.62 76.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.462 0.705 . . . . 74.44 112.779 -169.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 60.4 m -65.99 -45.07 63.28 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.606 -0.712 . . . . 63.42 112.761 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -34.48 98.29 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 122.303 2.002 . . . . 71.22 112.901 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -66.61 -27.63 67.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.117 0.567 . . . . 64.11 111.905 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.93 -45.41 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.221 0.608 . . . . 34.4 110.049 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.13 -17.42 49.94 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.478 -0.783 . . . . 74.14 111.692 -174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -61.17 -47.22 95.3 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.602 1.161 . . . . 72.33 113.944 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.41 -35.44 83.23 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.027 1.818 . . . . 51.34 112.978 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -68.9 -44.67 72.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.356 0.662 . . . . 74.41 110.618 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.36 0.664 . . . . 71.55 110.475 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.575 HH12 HD11 ' D' ' 16' ' ' ILE . 33.6 mtp180 -54.87 -60.46 3.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.191 0.996 . . . . 71.42 111.262 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.57 -31.71 70.83 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.244 0.965 . . . . 72.24 110.519 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.538 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.9 t -73.76 -37.74 64.94 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.967 -0.56 . . . . 44.24 111.344 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.441 HD13 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -67.09 -45.63 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 123.134 0.574 . . . . 74.33 109.836 174.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.515 HG21 ' OG ' ' C' ' 119' ' ' SER . 10.2 m -62.13 -39.67 93.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 73.51 111.385 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -61.68 -42.35 98.8 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.787 0.835 . . . . 71.22 110.516 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.516 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 10.0 mmt -72.48 -31.58 65.51 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.726 0.41 . . . . 55.24 111.186 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.624 HG21 HD23 ' B' ' 126' ' ' LEU . 92.8 t -65.83 -41.23 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.803 0.841 . . . . 75.44 110.221 172.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 53.0 m -64.31 -36.85 85.46 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.18 0.992 . . . . 55.02 111.05 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.516 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 84.0 mtt-85 -71.05 -27.58 63.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.815 -0.629 . . . . 71.03 110.714 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.04 14.51 61.86 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.513 -0.604 . . . . 74.32 113.082 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 55.05 45.69 25.73 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.397 1.479 . . . . 74.4 113.12 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -119.87 149.25 48.28 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.657 0.783 . . . . 74.21 110.253 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.59 -165.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.352 3.368 . . . . 74.13 114.945 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.465 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.7 tp60 -60.13 128.51 37.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.564 1.146 . . . . 72.34 113.587 -168.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.624 HD23 HG21 ' B' ' 118' ' ' VAL . 12.3 tp -136.05 108.86 7.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 71.22 108.59 165.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -128.46 135.75 49.89 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.382 -0.969 . . . . 74.4 108.382 167.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.25 139.27 34.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.924 -0.769 . . . . 73.52 108.924 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.94 148.18 98.43 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.698 0.799 . . . . 71.12 111.504 -175.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.36 92.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.159 2.573 . . . . 72.13 111.504 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.86 108.34 19.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.804 -0.813 . . . . 73.42 108.804 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -83.16 109.18 16.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.34 -1.356 . . . . 71.22 107.34 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 122.53 0.332 . . . . 75.12 111.145 -178.533 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 56.9 ttp . . . . . 0 N--CA 1.482 1.131 0 CA-C-O 121.165 0.507 . . . . 74.23 112.364 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.6 m -98.54 101.85 13.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.181 -1.044 . . . . 60.34 108.181 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -120.14 134.97 55.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.354 0.662 . . . . 74.05 110.03 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' C' ' 85' ' ' SER . 29.3 pt20 -154.92 144.48 21.38 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.998 0.919 . . . . 75.34 108.769 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -88.84 112.55 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.35 -50.53 10.71 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.078 -0.389 . . . . 75.1 111.02 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -166.91 125.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.335 -0.617 . . . . 53.12 109.335 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.19 141.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 107.865 -1.161 . . . . 61.5 107.865 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.518 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.2 p90 -173.23 159.88 3.92 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.644 0.735 . . . . 73.32 112.187 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.2 114.63 22.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.747 -0.834 . . . . 73.33 108.747 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -80.7 -33.87 35.04 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.128 0.49 . . . . 72.43 110.112 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 33.5 t70 -147.33 139.51 24.47 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.429 -0.805 . . . . 51.44 109.395 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -140.04 139.69 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.632 -1.247 . . . . 50.44 107.632 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 61.8 m -148.46 146.76 28.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.197 0.599 . . . . 55.42 110.54 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -145.08 107.62 4.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.472 -1.677 . . . . 71.5 106.472 165.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -118.82 109.63 16.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.165 -0.68 . . . . 75.44 109.165 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.28 80.7 12.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.137 -1.06 . . . . 74.34 108.137 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.98 -18.57 35.89 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.073 2.515 . . . . 64.41 112.041 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.94 32.69 5.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.052 0.941 . . . . 71.35 110.041 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -51.64 -51.31 71.09 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 113.813 1.042 . . . . 73.4 113.813 -175.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 11.5 Cg_exo -72.89 -30.76 10.86 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.175 1.916 . . . . 51.24 113.786 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -70.3 -40.1 74.45 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.14 0.576 . . . . 74.43 111.719 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 7.3 p -78.68 -20.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.665 0.786 . . . . 61.35 110.72 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -62.26 -20.79 64.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.948 1.299 . . . . 74.35 111.451 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -122.5 23.58 9.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 72.5 111.415 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 2.1 tppp? -98.0 146.79 25.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.2 0.6 . . . . 71.41 109.772 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.71 122.71 17.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.928 0.891 . . . . 74.3 110.276 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -72.07 90.32 1.18 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.842 0.857 . . . . 71.52 111.571 -166.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -127.67 64.11 62.57 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 124.078 0.951 . . . . 74.34 108.924 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.95 109.21 1.01 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.469 2.779 . . . . 71.52 113.302 -165.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -84.55 106.37 16.08 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.504 -0.925 . . . . 72.35 108.504 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -84.38 139.72 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.892 -1.049 . . . . 75.34 109.369 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.431 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 23.6 mtpp -131.87 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 71.1 109.038 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -91.72 120.31 32.35 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.255 -1.387 . . . . 74.1 107.255 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.726 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 2.1 m-20 -119.94 104.3 10.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.254 1.022 . . . . 53.43 108.421 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 110.97 23.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.506 -1.294 . . . . 61.32 107.506 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.7 t70 -116.35 149.25 39.63 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.36 1.464 . . . . 71.44 108.53 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.8 p -120.5 143.13 48.71 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.086 0.554 . . . . 73.45 109.756 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.22 145.92 33.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.178 0.991 . . . . 64.11 108.654 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -160.6 146.85 15.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.963 0.347 . . . . 64.22 111.213 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -154.35 144.01 21.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.836 0.854 . . . . 43.2 109.752 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.73 122.99 27.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.845 0.458 . . . . 73.13 109.813 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.3 mt -95.85 -36.4 11.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.485 0.714 . . . . 65.3 110.661 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -156.22 -177.51 6.64 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.172 -0.922 . . . . 54.12 109.976 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -65.22 116.65 6.79 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.013 -0.994 . . . . 75.52 109.592 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 23.6 m-20 67.05 12.12 8.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.953 1.301 . . . . 73.15 112.048 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 69.2 t -119.05 107.38 21.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.244 1.018 . . . . 72.53 109.096 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD13 ' C' ' 86' ' ' ILE . 89.7 m-85 -116.74 134.45 54.79 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.23 1.012 . . . . 74.24 108.62 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.616 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.7 tt0 -83.58 119.58 24.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.752 -0.658 . . . . 72.54 109.294 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.55 118.97 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.792 -1.188 . . . . 71.25 107.792 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.82 133.76 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.564 0.746 . . . . 74.43 109.168 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.573 HD23 HD12 ' C' ' 106' ' ' LEU . 4.1 mm? -118.96 106.38 12.4 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.324 1.05 . . . . 75.24 108.699 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.6 ttm-85 -81.07 106.51 13.13 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.855 -1.165 . . . . 73.13 107.855 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.72 119.51 50.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.766 -1.198 . . . . 71.15 107.766 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 55.9 m -116.39 141.08 48.63 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.951 -1.129 . . . . 62.21 107.951 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -135.34 128.0 47.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 71.34 107.671 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.0 m -122.57 125.84 46.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.705 -0.85 . . . . 72.11 108.705 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.49 123.64 48.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.535 -1.283 . . . . 63.23 107.535 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.8 m -143.44 123.9 13.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.877 0.471 . . . . 52.51 110.746 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.08 57.65 3.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.649 1.18 . . . . 75.35 109.798 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.45 -111.53 4.05 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 110.558 -1.017 . . . . 54.23 110.558 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -89.53 -28.09 19.85 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.732 0.813 . . . . 72.21 109.429 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.91 117.65 7.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.043 -0.98 . . . . 74.21 110.175 173.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 87.8 m -87.6 125.64 34.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.706 -0.849 . . . . 60.21 108.706 167.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.07 -63.02 1.36 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.572 -1.195 . . . . 71.54 109.806 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.34 177.11 11.83 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 114.85 -1.068 . . . . 62.13 111.217 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.416 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -135.98 147.51 48.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.83 -1.915 . . . . 54.34 105.83 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.3 t -150.48 113.08 4.71 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.148 -1.056 . . . . 54.31 108.148 176.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.4 126.78 31.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.207 -0.664 . . . . 72.33 109.207 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' C' ' 113' ' ' CYS . 80.2 t -130.21 113.74 26.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.917 0.887 . . . . 62.11 108.842 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.616 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -89.83 90.52 8.23 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.849 -1.167 . . . . 64.35 107.849 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -81.25 104.04 11.44 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.473 -1.239 . . . . 71.33 109.46 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.85 150.73 19.73 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 112.08 -0.408 . . . . 62.41 112.08 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.34 125.0 1.98 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.226 -1.15 . . . . 43.5 110.226 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.514 HD12 HD11 ' C' ' 51' ' ' LEU . 9.8 mm -81.93 126.52 39.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.759 -1.2 . . . . 71.23 107.759 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -136.51 154.72 50.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.419 0.688 . . . . 74.24 109.144 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 31.2 m -96.45 116.12 28.55 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.459 -0.941 . . . . 74.43 108.459 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' C' ' 56' ' ' TYR . 3.8 mp -116.73 118.16 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.503 -0.925 . . . . 75.51 108.503 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -153.21 170.51 20.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.134 0.974 . . . . 74.03 110.054 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.4 -59.39 0.4 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.54 -0.3 . . . . 65.22 113.434 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.23 -179.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.383 0.673 . . . . 63.43 112.176 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.93 -173.31 4.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 63.11 109.822 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.21 -140.76 38.13 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.533 0.521 . . . . 71.32 113.305 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -75.2 -17.64 60.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.856 0.863 . . . . 71.24 112.182 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -73.47 -36.58 65.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.025 0.53 . . . . 70.13 110.595 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -72.15 -41.63 66.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.373 -0.603 . . . . 74.22 109.373 174.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.89 66.07 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.854 -1.066 . . . . 64.52 111.568 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.575 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 39.9 t-80 -66.84 -41.66 87.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 74.32 111.254 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -77.74 -57.43 3.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.856 -0.424 . . . . 63.01 109.856 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.44 -39.65 94.03 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.366 1.066 . . . . 53.35 112.542 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.81 11.21 57.6 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.543 -0.587 . . . . 71.23 114.155 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -144.63 -63.41 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.59 0.695 . . . . 71.22 111.51 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -69.34 -55.12 11.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.723 0.409 . . . . 74.4 111.887 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.9 m -55.88 -44.77 99.84 Favored Pre-proline 0 CA--C 1.573 1.85 0 C-N-CA 123.581 0.752 . . . . 71.53 112.567 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -51.18 -43.46 48.5 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.062 2.508 . . . . 75.31 114.344 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.421 HD22 ' N ' ' C' ' 104' ' ' ASN . 0.9 OUTLIER -74.24 -20.19 60.25 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.463 0.705 . . . . 63.11 111.715 -174.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.495 HD12 ' NH1' ' A' ' 111' ' ' ARG . 32.3 mm -76.88 -44.86 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.984 0.514 . . . . 73.42 110.061 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.573 HD12 HD23 ' C' ' 60' ' ' LEU . 73.1 mt -81.61 -18.72 43.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.044 -0.526 . . . . 74.03 112.004 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -57.11 -54.25 56.63 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 117.72 -1.133 . . . . 72.5 113.08 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.79 -27.45 84.84 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.026 1.818 . . . . 71.12 113.221 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -71.08 -45.98 62.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.208 0.603 . . . . 73.21 110.79 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.59 84.65 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.795 -0.638 . . . . 71.51 110.315 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.719 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 33.6 ttt180 -60.13 -47.88 84.07 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.489 1.516 . . . . 75.22 111.47 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -38.71 86.15 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.907 0.755 . . . . 75.51 109.765 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.512 ' HB3' HG21 ' C' ' 78' ' ' VAL . 12.2 m -58.5 -46.67 86.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.38 0.672 . . . . 51.02 112.357 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.53 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 86.9 mt -66.16 -48.43 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 122.916 0.486 . . . . 63.02 110.762 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.6 m -65.81 -32.71 74.39 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.088 0.555 . . . . 50.04 111.272 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -69.41 -37.99 77.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.325 0.65 . . . . 74.53 109.98 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.471 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -70.9 -35.97 72.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.661 0.784 . . . . 74.11 111.514 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.8 t -63.76 -37.31 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.543 -0.54 . . . . 61.13 109.543 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.515 ' OG ' HG21 ' B' ' 115' ' ' THR . 42.1 t -67.77 -35.34 78.52 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.85 0.86 . . . . 70.14 112.194 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.68 -32.46 65.81 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.2 0.6 . . . . 74.33 110.022 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.2 1.6 86.66 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.465 0.478 . . . . 71.41 112.612 171.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p 62.42 19.59 11.25 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.836 2.054 . . . . 70.45 113.17 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.64 150.04 45.31 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.09 0.956 . . . . 74.31 109.43 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.465 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 35.7 Cg_endo -62.54 113.25 1.87 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.722 2.281 . . . . 74.14 111.442 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -55.47 141.79 35.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.254 -1.339 . . . . 63.03 113.168 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.36 121.24 36.23 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.822 -1.548 . . . . 75.3 106.822 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.86 126.55 41.19 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.941 0.896 . . . . 72.42 108.653 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.719 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -63.92 145.02 56.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.218 0.607 . . . . 73.52 110.403 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.49 164.33 45.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.095 0.958 . . . . 53.12 111.232 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -66.52 117.26 4.59 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.064 1.842 . . . . 70.23 111.729 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.36 109.34 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.944 0.878 . . . . 73.44 108.964 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -107.9 94.4 5.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.044 -0.98 . . . . 75.14 109.708 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -75.9 -40.59 54.1 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.139 -0.689 . . . . 74.1 109.139 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.422 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 11.3 p-10 . . . . . 0 N--CA 1.47 0.548 0 C-N-CA 123.824 0.85 . . . . 74.13 110.91 -176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 72.52 107.989 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -154.66 98.36 2.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.01 -1.107 . . . . 65.33 108.01 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -131.26 125.9 34.04 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.604 -1.258 . . . . 54.42 107.604 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mt -69.59 124.42 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.504 -0.924 . . . . 62.43 108.504 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.483 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 19.7 mm-40 -74.31 -48.98 24.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.707 -0.479 . . . . 74.43 109.707 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -161.85 156.63 22.86 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.824 1.25 . . . . 75.02 109.845 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.575 HD11 HH12 ' B' ' 111' ' ' ARG . 0.2 OUTLIER -126.87 125.41 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 105.631 -1.988 . . . . 70.51 105.631 165.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.479 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 32.4 p90 -155.36 153.74 30.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.889 0.852 . . . . 74.05 110.707 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.77 110.75 12.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.172 -1.376 . . . . 52.03 108.438 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.479 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.7 mtpt -77.57 -36.54 51.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.061 -0.718 . . . . 74.12 109.061 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.5 t70 -140.49 137.86 34.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.537 -1.21 . . . . 74.15 109.324 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.471 HG21 ' HE2' ' C' ' 117' ' ' MET . 90.2 mt -132.81 142.95 41.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.821 1.249 . . . . 73.22 107.963 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -147.16 136.54 22.68 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.569 1.148 . . . . 74.31 108.653 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.404 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -143.36 123.58 13.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.592 -1.633 . . . . 75.52 106.592 167.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.3 mt-10 -127.37 127.03 43.54 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.397 0.679 . . . . 71.32 109.269 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.72 84.18 8.04 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.549 -1.649 . . . . 72.1 106.549 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.46 -30.22 12.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.823 2.349 . . . . 71.23 112.633 -167.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -115.26 36.36 3.95 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.266 1.026 . . . . 53.33 108.89 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.518 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -48.48 -61.54 3.1 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 115.076 1.51 . . . . 70.34 115.076 -165.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.487 ' HB3' HD11 ' C' ' 83' ' ' ILE . 33.0 Cg_endo -85.65 -4.03 9.13 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 122.671 1.99 . . . . 51.44 113.075 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -80.92 -42.0 22.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 74.0 109.414 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.744 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.0 p -76.27 -34.02 24.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.248 -0.887 . . . . 63.53 110.295 -173.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -57.23 -16.78 9.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.12 0.968 . . . . 72.43 113.403 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.59 -37.21 60.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.887 0.475 . . . . 75.33 110.535 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -130.85 57.93 1.72 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.461 0.304 . . . . 73.52 110.899 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -100.7 94.96 6.35 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.354 -0.841 . . . . 55.23 109.556 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.403 ' H ' HD22 ' D' ' 68' ' ' LEU . 16.4 m95 -124.08 -164.85 1.28 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.576 -1.638 . . . . 74.01 106.576 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.431 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 0.0 OUTLIER -51.41 106.65 0.68 Allowed Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 119.167 0.894 . . . . 74.34 112.172 -176.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 4.7 Cg_exo -78.35 144.82 20.77 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.589 2.193 . . . . 73.41 111.291 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -79.09 112.89 16.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.276 -1.379 . . . . 61.55 107.276 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.9 142.58 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.496 0.718 . . . . 72.34 110.099 -168.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -118.89 147.46 43.96 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.534 1.134 . . . . 71.33 109.421 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.44 HD21 HD21 ' D' ' 128' ' ' LEU . 95.1 mt -106.83 118.38 36.54 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.04 -1.096 . . . . 73.0 108.04 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.622 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.3 t70 -106.46 129.93 54.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.908 -1.145 . . . . 75.33 107.908 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.82 156.52 18.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.698 0.799 . . . . 75.32 111.106 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.3 t70 -168.16 129.29 1.37 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.274 -0.876 . . . . 70.01 109.265 172.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -106.09 148.49 27.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.647 0.779 . . . . 64.0 110.072 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.85 155.53 40.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.93 0.892 . . . . 50.25 108.789 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.0 p -163.17 153.91 16.53 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.275 0.63 . . . . 71.45 110.441 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.3 p -163.7 143.52 8.36 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.539 0.736 . . . . 61.45 110.079 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -78.4 122.59 25.99 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.463 -0.569 . . . . 71.22 109.463 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -93.05 -39.43 11.09 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.454 -0.573 . . . . 70.3 109.454 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -153.5 -176.67 5.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 75.04 110.49 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.34 119.85 13.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.201 -0.909 . . . . 50.33 109.594 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 64.03 7.02 3.12 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.811 1.245 . . . . 71.31 112.686 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 56.1 t -114.89 108.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.365 -0.976 . . . . 71.31 108.365 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -128.39 129.71 46.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.649 -1.16 . . . . 62.15 108.776 -169.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -96.69 129.26 44.13 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.267 1.027 . . . . 71.14 109.919 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.4 t -110.9 116.98 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.81 -1.182 . . . . 51.51 107.81 170.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.4 t -99.66 131.88 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.521 -0.918 . . . . 50.35 108.521 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.85 108.92 12.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.064 -1.087 . . . . 64.24 108.064 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.4 ttm180 -85.54 113.08 21.51 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.481 0.713 . . . . 73.22 109.796 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.49 103.43 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.26 -1.015 . . . . 74.42 108.26 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.4 m -102.37 138.87 38.73 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.097 -0.705 . . . . 65.25 109.097 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.63 122.61 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.203 1.001 . . . . 74.12 109.91 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 39.8 m -120.49 100.37 7.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.987 0.915 . . . . 51.32 109.59 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 133.7 42.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.333 0.653 . . . . 74.23 109.879 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 20.7 m -148.03 126.7 12.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.064 0.946 . . . . 75.52 109.636 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.0 pp -126.53 140.26 52.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.267 0.627 . . . . 72.53 111.404 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 -111.84 3.72 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.196 -1.161 . . . . 55.23 110.196 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 4.47 9.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 63.1 110.797 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.99 173.7 7.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.981 0.512 . . . . 54.21 110.542 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -82.09 139.15 34.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 52.13 109.638 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.744 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.7 -67.36 0.8 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.567 -0.901 . . . . 24.35 108.567 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -155.2 164.89 38.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.443 -1.253 . . . . 64.3 110.061 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 94.6 mt -134.38 151.68 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.229 1.412 . . . . 74.11 108.529 -176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.577 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.6 t -158.22 148.11 19.92 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.229 0.612 . . . . 52.14 110.097 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.59 126.05 6.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.476 0.71 . . . . 74.11 109.593 171.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.23 114.79 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.899 0.48 . . . . 71.43 109.772 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.8 mt-30 -90.56 88.78 7.27 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.949 -0.76 . . . . 74.5 108.949 173.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.34 96.39 6.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.657 -1.156 . . . . 72.32 109.328 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.01 141.64 17.81 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.046 -0.822 . . . . 63.13 111.046 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.41 128.59 4.56 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 110.537 -1.025 . . . . 61.15 110.537 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 29.5 mt -93.39 127.04 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.987 -1.116 . . . . 71.11 107.987 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -128.78 126.66 40.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.658 0.783 . . . . 63.21 110.18 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -82.99 93.4 7.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.602 -0.888 . . . . 63.23 108.602 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.9 mt -108.45 109.73 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.772 -0.825 . . . . 72.41 108.772 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.48 167.15 21.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.16 0.984 . . . . 62.31 110.428 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.94 0.78 57.32 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.787 0.675 . . . . 64.41 114.787 170.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.498 HG21 HE21 ' D' ' 93' ' ' GLN . 29.0 pt -137.92 162.21 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.513 1.125 . . . . 74.44 109.73 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.29 3.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.326 1.051 . . . . 73.34 109.501 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.41 -122.79 29.31 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 115.514 0.966 . . . . 75.32 115.514 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -60.31 -54.13 49.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.911 1.284 . . . . 54.22 112.137 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.498 HE21 HG21 ' D' ' 89' ' ' ILE . 29.3 tt0 -70.94 -39.72 72.45 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.383 0.427 . . . . 71.45 111.752 -172.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -42.89 59.23 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.908 0.483 . . . . 74.43 111.269 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.92 83.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.94 0.496 . . . . 72.34 110.817 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -74.7 -27.18 60.28 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.681 -0.69 . . . . 75.34 110.771 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.51 -50.76 64.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.036 0.534 . . . . 71.01 110.381 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 pp -79.66 -17.51 53.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.404 0.282 . . . . 74.54 111.391 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.36 -5.7 84.81 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.327 0.392 . . . . 71.34 114.069 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.12 -59.03 0.31 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.908 0.354 . . . . 64.32 111.534 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -74.38 -53.71 9.07 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.413 0.685 . . . . 62.21 112.118 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.45 -43.27 88.55 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.053 1.131 . . . . 74.33 114.053 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.79 -29.15 50.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.823 1.682 . . . . 64.54 111.874 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.9 -22.32 59.74 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.191 0.996 . . . . 73.12 110.664 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.1 mm -76.95 -45.01 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.387 0.675 . . . . 74.03 109.95 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.7 mt -72.47 -30.98 65.04 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.576 -0.738 . . . . 71.5 111.807 -174.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.78 -41.96 60.14 Favored Pre-proline 0 CA--C 1.568 1.662 0 N-CA-C 114.405 1.261 . . . . 62.24 114.405 -169.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.48 -39.56 74.02 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.381 2.054 . . . . 61.11 113.578 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -75.72 -35.5 60.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.612 0.765 . . . . 74.3 110.913 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.8 79.01 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.234 0.614 . . . . 72.4 110.279 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -59.6 -46.17 89.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.626 1.17 . . . . 71.13 110.78 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.73 -44.78 96.24 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.141 0.901 . . . . 74.3 111.014 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.82 -45.14 93.3 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.864 0.728 . . . . 74.3 110.691 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.577 HG12 ' SG ' ' D' ' 76' ' ' CYS . 57.6 mt -59.53 -54.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.017 0.927 . . . . 74.24 110.686 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -47.62 66.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.481 1.112 . . . . 62.42 111.302 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.06 -42.8 93.87 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.425 -1.261 . . . . 51.53 110.809 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.416 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -70.68 -37.34 73.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.777 0.431 . . . . 53.22 111.812 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.442 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -65.15 -41.51 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.684 -0.689 . . . . 74.53 109.774 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -72.21 -29.04 63.58 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 122.985 0.514 . . . . 55.03 111.241 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -70.82 -29.07 65.13 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.397 0.679 . . . . 70.11 110.418 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 10.1 60.11 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.954 -0.566 . . . . 42.03 112.576 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.9 p 59.87 23.43 12.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.853 2.061 . . . . 74.13 112.985 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 51.5 m-85 -88.84 174.61 4.83 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 125.193 1.397 . . . . 65.33 108.831 170.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 33.9 Cg_endo -59.21 167.36 6.04 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.913 2.408 . . . . 75.31 113.929 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.496 ' NE2' HD21 ' D' ' 127' ' ' ASN . 3.5 pt20 -73.82 131.28 41.37 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.937 -1.135 . . . . 74.45 107.937 164.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.46 93.59 4.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.706 -1.22 . . . . 64.51 107.706 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.496 HD21 ' NE2' ' D' ' 125' ' ' GLN . 50.3 m-20 -98.23 99.01 10.2 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.539 -1.282 . . . . 71.21 107.539 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.44 HD21 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -71.08 136.03 48.04 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.768 -0.651 . . . . 73.24 109.664 -176.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.81 137.31 87.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.417 1.087 . . . . 73.21 111.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' B' ' 13' ' ' ILE . 16.9 Cg_exo -68.91 106.26 1.48 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.935 2.423 . . . . 44.23 111.921 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.81 109.16 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.554 0.741 . . . . 45.11 109.152 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -85.73 106.88 17.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.338 0.655 . . . . 44.41 109.795 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 . . . . . 0 N--CA 1.481 1.1 0 C-N-CA 124.148 0.979 . . . . 72.31 111.429 -179.718 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.9 m . . . . . 0 C--O 1.241 0.633 0 N-CA-C 108.391 -0.966 . . . . 41.51 108.391 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.49 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -134.25 134.87 42.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.168 -0.678 . . . . 73.4 109.168 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -152.39 117.71 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.89 -1.152 . . . . 75.45 107.89 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.402 HG12 ' HD2' ' A' ' 84' ' ' PHE . 51.5 mt -75.07 126.78 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.123 -0.695 . . . . 63.24 109.123 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -92.04 -37.93 12.52 Favored 'General case' 0 C--O 1.243 0.758 0 O-C-N 123.829 0.705 . . . . 74.14 110.793 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -176.92 127.92 0.17 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.78 0.675 . . . . 72.4 111.629 -173.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.52 136.62 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.328 -0.99 . . . . 61.43 108.328 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 26.1 p90 -170.02 156.45 6.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 64.15 111.226 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -82.27 113.55 20.16 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.801 -0.814 . . . . 71.53 108.801 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -75.04 -31.23 61.26 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.66 -0.496 . . . . 74.52 109.66 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -150.88 141.13 22.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.008 -0.996 . . . . 61.52 109.889 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -134.67 143.86 36.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 125.503 1.521 . . . . 64.14 107.167 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 35.9 t -153.02 132.83 13.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.841 0.856 . . . . 64.13 108.738 174.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 82.4 t80 -139.87 119.21 12.91 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.78 -1.563 . . . . 72.42 106.78 174.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.19 131.09 54.85 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.147 0.579 . . . . 65.21 109.869 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.62 77.67 63.8 Favored Pre-proline 0 C--O 1.243 0.761 0 N-CA-C 106.709 -1.589 . . . . 63.35 106.709 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.75 -39.89 24.46 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.519 2.146 . . . . 74.02 111.764 -173.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.13 25.38 5.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.353 -0.84 . . . . 44.22 110.154 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -57.09 9.22 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 117.565 -1.207 . . . . 65.11 113.458 -169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.0 -21.78 68.33 Favored 'Trans proline' 0 C--N 1.398 3.135 0 CA-C-N 122.132 1.797 . . . . 44.13 112.804 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -85.07 -40.31 16.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.15 0.98 . . . . 74.4 110.643 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.9 p -76.92 -20.35 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.545 -0.752 . . . . 74.5 112.079 -159.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.002 0.521 . . . . 74.1 112.231 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -103.9 -11.13 17.67 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.43 0.692 . . . . 71.42 112.755 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HE3' ' HG2' ' A' ' 71' ' ' GLU . 20.9 mmtt -65.4 171.1 4.18 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.136 0.974 . . . . 73.13 113.598 -170.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.12 122.05 5.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.181 1.393 . . . . 71.44 111.948 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -86.95 63.26 7.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.085 0.554 . . . . 72.43 110.241 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -147.38 82.31 8.27 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 123.871 0.868 . . . . 50.44 109.082 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -84.47 165.52 12.39 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.98 2.454 . . . . 75.52 112.772 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.36 106.05 8.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.288 -1.375 . . . . 73.0 107.288 161.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 10.3 p -79.0 91.54 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 123.066 1.412 . . . . 74.24 108.467 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 40.6 tttm -83.7 118.15 23.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 113.924 -1.489 . . . . 52.23 109.89 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -97.22 111.35 23.63 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.388 -1.338 . . . . 70.42 107.388 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.67 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 19.6 m-20 -108.4 108.35 19.27 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.38 118.09 34.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.487 -1.301 . . . . 72.4 107.487 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.64 153.99 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.984 0.914 . . . . 64.43 109.074 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -135.16 156.61 48.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.07 0.948 . . . . 71.2 110.415 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -163.97 142.5 7.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 41.13 109.493 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 37.4 p -128.81 158.46 38.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.611 . . . . 60.43 109.532 173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -154.85 136.77 14.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.933 0.893 . . . . 53.34 108.599 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -103.72 103.39 13.28 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.515 -0.92 . . . . 72.21 108.515 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.49 -31.21 37.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.339 0.655 . . . . 71.03 110.807 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -162.83 176.77 9.9 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.618 1.167 . . . . 72.12 109.243 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.69 135.91 54.75 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.091 -0.707 . . . . 74.3 109.091 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t70 69.36 -7.79 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.929 1.291 . . . . 65.43 111.975 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 90.9 t -119.88 98.24 6.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.667 0.787 . . . . 74.2 109.046 -172.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -120.57 125.28 47.4 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.734 -1.121 . . . . 74.11 108.386 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.78 131.48 39.1 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.921 0.888 . . . . 75.2 110.126 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.4 t -108.58 126.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.584 -1.265 . . . . 72.25 107.584 168.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 57.3 t -109.39 133.72 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.612 -0.884 . . . . 75.13 108.612 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -125.41 106.09 9.56 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.171 -1.418 . . . . 70.11 107.171 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.578 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 31.6 ttp180 -92.28 109.31 20.68 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 122.911 0.485 . . . . 61.32 109.745 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.69 126.84 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 106.934 -1.506 . . . . 53.11 106.934 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.67 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 98.0 m -123.82 123.26 40.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.498 -0.927 . . . . 54.53 108.498 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 69.8 t -116.51 108.25 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.184 0.994 . . . . 44.23 109.19 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 9.8 m -105.05 146.37 29.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.153 -0.684 . . . . 54.31 109.153 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 121.81 20.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.985 -1.117 . . . . 74.2 107.985 169.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.2 m -124.59 127.38 47.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.259 0.552 . . . . 73.32 110.86 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.67 85.26 7.05 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 126.134 1.773 . . . . 72.03 110.259 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.95 -80.88 1.55 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.897 -0.881 . . . . 72.1 110.897 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -130.75 -25.94 2.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.78 0.832 . . . . 65.03 110.83 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HG2' ' HE3' ' A' ' 34' ' ' LYS . 7.8 tp10 -82.96 134.91 35.04 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.648 0.779 . . . . 75.51 110.795 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 90.8 m -79.54 139.29 37.59 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 118.738 0.699 . . . . 63.25 111.893 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.838 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.79 -68.49 0.69 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.169 0.988 . . . . 71.51 110.512 170.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -152.82 167.28 29.58 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.492 -0.777 . . . . 72.25 111.126 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 tp -141.39 142.95 33.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.639 1.175 . . . . 65.2 108.65 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.2 m -142.37 104.53 4.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.633 0.373 . . . . 71.5 111.154 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 7.0 mp0 -103.5 132.86 49.39 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.259 -0.645 . . . . 71.31 109.259 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -140.4 110.38 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.16 -0.681 . . . . 62.44 109.16 173.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.7 mt-30 -85.27 85.39 7.46 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.139 -1.06 . . . . 74.24 108.139 171.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -77.23 97.03 4.69 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.102 -0.954 . . . . 74.34 108.887 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.71 146.16 20.52 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.434 -0.803 . . . . 73.13 111.5 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.597 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.39 120.82 1.25 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 110.397 -1.081 . . . . 73.44 110.397 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.0 mt -83.03 122.94 38.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.646 -0.872 . . . . 64.23 108.646 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.49 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 49.9 m-85 -126.37 120.49 29.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.133 -0.692 . . . . 73.31 109.133 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.7 t -81.67 104.48 12.1 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.001 -1.111 . . . . 72.32 108.001 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 pt -137.9 149.41 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 73.3 110.598 -171.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -173.75 177.99 2.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.988 1.315 . . . . 65.31 109.512 173.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.18 10.27 71.75 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.553 0.533 . . . . 74.2 114.061 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.19 138.08 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.89 0.876 . . . . 63.24 109.749 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -130.39 170.15 14.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.234 0.614 . . . . 62.22 110.841 -173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.42 -117.04 2.2 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.176 0.923 . . . . 75.33 115.22 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -64.25 -26.9 68.71 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.133 0.973 . . . . 73.23 112.261 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.06 -44.01 55.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.607 0.763 . . . . 71.44 110.828 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -71.17 -34.16 70.69 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.706 -0.479 . . . . 64.43 109.706 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.28 -40.28 86.12 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.418 -0.81 . . . . 73.43 110.174 177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -67.85 -29.6 68.77 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.154 -0.93 . . . . 75.21 110.444 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.544 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 29.6 t -66.79 -38.56 86.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.859 0.464 . . . . 74.33 110.957 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.6 mt -81.71 -43.57 18.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.493 0.317 . . . . 72.45 110.804 175.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.96 -20.69 77.5 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.709 0.644 . . . . 72.24 114.709 -171.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -141.58 -63.39 0.45 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.407 0.604 . . . . 44.31 112.56 -168.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 53.8 t80 -56.71 -64.45 0.87 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.529 1.532 . . . . 73.23 113.024 -167.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 90.9 m -77.42 -35.57 1.34 Allowed Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 114.426 1.269 . . . . 50.11 114.426 -173.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 55.6 Cg_endo -67.81 -20.08 46.22 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.022 1.815 . . . . 32.43 112.999 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 3.3 t30 -74.66 -18.09 60.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.217 0.607 . . . . 73.33 110.091 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.7 mm -74.85 -39.28 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.74 0.816 . . . . 70.31 109.281 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.597 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.1 mt -75.29 -37.87 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.294 1.038 . . . . 64.43 112.495 -173.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.411 ' HZ ' ' HG ' ' A' ' 128' ' ' LEU . 52.4 t80 -57.26 -43.13 99.01 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.04 1.126 . . . . 72.05 114.04 -169.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.99 -39.06 86.59 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.188 1.925 . . . . 72.35 113.726 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -76.77 -38.63 53.73 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.41 0.684 . . . . 73.21 111.904 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.67 94.9 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.847 -0.427 . . . . 71.53 109.847 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -57.71 -49.93 74.89 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.618 1.199 . . . . 73.42 110.278 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.74 -44.43 96.24 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.577 1.173 . . . . 75.01 110.905 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.6 t -56.72 -48.54 77.52 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.099 0.874 . . . . 71.2 110.23 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.2 mt -64.69 -42.26 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.263 0.977 . . . . 75.11 110.814 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.528 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.9 m -54.63 -48.04 72.75 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.562 0.745 . . . . 55.32 110.422 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.1 t -63.8 -46.05 86.9 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.306 -1.316 . . . . 74.35 109.838 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 20.1 mtp -57.64 -46.44 84.17 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.118 0.967 . . . . 54.44 112.115 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.0 t -63.27 -45.02 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.232 1.013 . . . . 71.01 110.283 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.2 t -66.19 -30.43 70.89 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.813 -1.085 . . . . 72.0 110.788 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.13 -28.6 60.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.702 0.801 . . . . 63.22 110.435 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 10.27 52.64 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 116.146 -0.479 . . . . 43.32 113.345 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.3 m 71.33 13.34 6.63 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.428 1.491 . . . . 71.11 112.122 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -96.16 145.8 30.19 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.732 -1.21 . . . . 73.14 107.732 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.05 157.59 28.83 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.722 2.281 . . . . 74.44 112.213 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.4 tt0 -50.71 125.39 13.09 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 124.195 0.934 . . . . 63.22 111.28 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 64' ' ' VAL . 17.9 tp -109.2 119.48 39.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.146 -0.934 . . . . 64.43 109.222 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -134.85 94.94 3.24 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.394 1.078 . . . . 65.22 108.18 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.411 ' HG ' ' HZ ' ' A' ' 107' ' ' PHE . 18.8 tp -62.12 131.78 50.64 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.027 -0.988 . . . . 74.42 109.723 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.91 129.27 47.57 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.266 1.027 . . . . 52.22 111.641 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.16 104.19 0.84 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.397 2.064 . . . . 72.32 111.034 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.3 t -98.71 117.6 43.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.026 -1.102 . . . . 73.54 108.026 -179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.408 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 33.5 t30 -63.48 99.65 0.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.409 1.068 . . . . 63.25 109.475 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -67.1 -24.21 65.91 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.176 -0.466 . . . . 72.44 111.247 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.408 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 10.2 t70 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 123.896 0.878 . . . . 74.43 110.654 173.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.727 HG22 HE22 ' B' ' 12' ' ' GLN . 41.4 m . . . . . 0 CA--C 1.545 0.771 0 N-CA-C 108.923 -0.769 . . . . 74.44 108.923 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.96 138.61 51.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.525 0.73 . . . . 64.45 109.734 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.727 HE22 HG22 ' B' ' 10' ' ' THR . 0.0 OUTLIER -152.53 135.47 15.56 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.346 0.658 . . . . 63.4 110.116 168.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.46 118.38 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.331 1.053 . . . . 72.23 108.549 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mm-40 -82.5 -39.12 22.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.659 0.384 . . . . 73.41 111.655 179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.528 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 28.4 ttm180 -166.28 145.86 5.99 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.51 0.724 . . . . 73.33 110.258 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.444 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 86.6 mt -119.54 145.88 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.44 -1.689 . . . . 72.23 106.44 166.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.528 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 35.1 p90 -170.03 163.85 9.37 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.935 0.874 . . . . 75.32 111.977 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 71.5 m -92.01 122.79 34.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.612 -1.176 . . . . 75.4 109.072 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -89.12 -37.93 14.7 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.87 0.868 . . . . 74.21 110.043 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -155.82 143.77 19.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.102 -0.499 . . . . 73.44 110.766 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.4 mm -134.76 139.18 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.914 1.286 . . . . 74.15 108.201 176.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -140.72 132.08 26.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.018 -1.105 . . . . 72.01 108.018 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -147.03 114.81 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.608 -1.256 . . . . 70.44 107.608 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.58 130.72 56.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.851 0.86 . . . . 74.41 108.989 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.8 83.43 65.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 106.847 -1.538 . . . . 54.41 106.847 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -68.7 -32.81 22.92 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.923 2.415 . . . . 63.21 111.971 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -106.6 25.8 10.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.88 1.272 . . . . 72.15 110.206 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.475 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -46.68 -50.01 44.36 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 115.558 1.688 . . . . 63.55 115.558 -168.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.8 -33.98 4.45 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.232 1.476 . . . . 74.41 112.505 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.1 m80 -82.99 -22.51 33.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.645 0.778 . . . . 72.45 112.283 -169.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.43 HG11 ' HZ ' ' B' ' 123' ' ' PHE . 4.6 p -67.93 -4.38 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 124.391 1.076 . . . . 70.52 111.963 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -56.49 -27.49 57.27 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.758 0.823 . . . . 75.34 110.931 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.582 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -76.86 -34.99 57.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.65 0.38 . . . . 74.04 110.737 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.582 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 98.9 mttt -109.99 77.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.565 0.746 . . . . 72.31 112.313 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -117.12 82.76 1.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.628 -1.249 . . . . 71.15 107.628 163.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -148.62 160.15 43.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.156 -1.424 . . . . 75.42 107.156 -171.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 23.9 pt20 -53.6 102.22 0.3 Allowed Pre-proline 0 CA--C 1.564 1.494 0 O-C-N 124.376 1.047 . . . . 73.41 111.7 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.51 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 6.1 Cg_endo -85.93 170.21 8.67 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.807 2.338 . . . . 73.43 112.305 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -80.9 100.65 8.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 106.344 -1.724 . . . . 74.22 106.344 165.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -114.74 142.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.923 0.889 . . . . 74.23 108.72 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.599 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 27.9 ttpt -136.72 136.63 39.17 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.496 0.718 . . . . 73.15 109.377 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.624 HD12 HD11 ' B' ' 128' ' ' LEU . 4.6 tt -85.6 127.46 34.47 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 106.28 -1.748 . . . . 70.53 106.28 165.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.599 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 12.6 t70 -122.27 110.61 15.9 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.358 -1.349 . . . . 72.2 107.358 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 3.5 pp -100.22 137.45 38.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.438 0.695 . . . . 75.23 109.292 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 32.9 t70 -124.23 135.85 53.72 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.972 -0.751 . . . . 64.31 108.972 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.04 110.15 21.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.899 0.879 . . . . 72.12 110.402 -171.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.97 140.26 52.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.514 0.726 . . . . 25.14 109.213 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 75.6 m -144.07 165.2 28.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.777 0.831 . . . . 53.55 110.199 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.4 p -152.0 162.23 41.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.398 1.079 . . . . 43.23 109.033 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -106.78 112.88 26.06 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.346 -0.613 . . . . 74.32 109.346 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.99 -40.71 23.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.827 0.451 . . . . 60.52 110.327 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.95 -172.91 4.11 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.27 0.628 . . . . 43.22 110.575 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.06 116.03 4.98 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.442 -1.254 . . . . 75.42 109.774 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 71.33 -3.41 2.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.775 1.63 . . . . 65.1 112.636 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.438 HG22 ' OG ' ' B' ' 85' ' ' SER . 98.6 t -101.52 113.38 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.96 -0.755 . . . . 73.33 108.96 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.77 137.8 53.73 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.177 -0.919 . . . . 72.54 109.428 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -100.57 98.16 8.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.976 -1.49 . . . . 71.34 106.976 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.11 128.61 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.734 1.214 . . . . 30.23 109.644 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 36.3 t -119.21 143.06 31.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.757 1.223 . . . . 75.52 108.957 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -136.7 111.75 8.97 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.727 -1.212 . . . . 64.25 107.727 171.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -86.12 122.67 30.46 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.155 -0.683 . . . . 75.21 109.155 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.81 103.23 15.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.92 -1.141 . . . . 74.54 107.92 173.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.7 m -103.79 129.89 51.26 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.42 -0.585 . . . . 44.34 109.42 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.459 HG23 HD13 ' B' ' 114' ' ' ILE . 61.3 t -115.0 100.99 11.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 109.248 -0.649 . . . . 74.21 109.248 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.3 m -97.8 138.06 35.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.068 -0.969 . . . . 25.43 109.146 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.77 149.76 34.97 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.881 0.472 . . . . 63.31 110.347 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -149.18 141.92 24.57 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.541 -0.754 . . . . 71.04 110.544 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.0 mt -125.55 110.4 13.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.685 1.194 . . . . 71.21 108.663 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.23 -123.39 6.3 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.627 -0.715 . . . . 63.02 111.489 -174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -108.42 2.44 22.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.116 0.967 . . . . 73.32 109.983 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.23 -179.44 3.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.748 0.819 . . . . 74.02 110.344 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -77.09 155.21 32.59 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.744 1.218 . . . . 75.2 110.703 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.08 -50.3 3.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.611 -0.885 . . . . 74.32 108.611 167.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -166.83 152.79 8.17 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.822 -1.081 . . . . 72.24 108.812 167.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -123.54 124.45 42.86 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.165 -1.05 . . . . 72.13 108.165 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.2 t -142.08 157.14 45.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.219 0.608 . . . . 74.35 109.536 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.5 tt0 -164.42 141.56 6.53 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.851 0.86 . . . . 74.44 109.121 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.5 t -134.22 143.81 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.677 -1.231 . . . . 70.23 107.677 170.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.5 96.53 5.24 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.952 -1.129 . . . . 71.02 107.952 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.5 tp-100 -91.34 101.59 14.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.367 -0.975 . . . . 61.14 108.367 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.38 167.55 32.77 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.143 -0.935 . . . . 60.22 110.881 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.16 127.56 1.65 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.562 -0.615 . . . . 74.22 111.562 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.8 mt -85.61 124.5 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 54.4 108.062 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.67 159.14 38.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.069 0.948 . . . . 54.52 108.699 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.438 ' OG ' HG22 ' B' ' 55' ' ' VAL . 17.1 m -132.14 120.38 22.2 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.379 -0.971 . . . . 70.31 108.379 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 pt -133.75 138.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.47 1.108 . . . . 55.43 109.367 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.4 155.65 39.06 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.649 0.78 . . . . 71.13 110.158 -178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.32 -71.17 0.2 Allowed Glycine 0 C--N 1.341 0.822 0 O-C-N 123.703 0.627 . . . . 63.14 112.469 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 32.6 pt -81.95 159.49 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 122.98 0.512 . . . . 72.5 110.942 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -153.56 156.93 38.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.666 -0.697 . . . . 63.23 110.16 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.47 -114.76 6.49 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.329 0.49 . . . . 73.23 113.539 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -67.14 -39.0 86.48 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.981 0.912 . . . . 62.23 111.536 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.87 -50.71 65.53 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.023 -0.989 . . . . 71.12 110.311 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.96 -24.92 58.54 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.545 -0.752 . . . . 74.44 111.638 -175.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.7 -31.36 68.17 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.729 0.812 . . . . 63.33 111.792 178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -69.75 -46.47 65.79 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.941 -0.572 . . . . 70.14 110.689 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -73.38 -32.52 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.327 0.651 . . . . 74.04 112.465 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -96.6 -39.23 9.62 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.858 0.863 . . . . 73.21 109.447 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.31 -25.57 43.18 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 114.693 0.637 . . . . 63.53 114.693 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -49.45 2.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.888 0.475 . . . . 33.13 111.334 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -79.21 -42.43 26.04 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.536 0.569 . . . . 74.15 112.536 -169.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.17 -45.46 79.17 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 118.416 -0.802 . . . . 52.41 112.016 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.435 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 47.2 Cg_exo -60.89 -31.44 91.58 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 122.427 2.084 . . . . 63.33 113.148 171.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.51 -34.87 77.75 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.707 0.803 . . . . 62.13 110.94 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.74 -44.47 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.431 0.692 . . . . 52.35 110.628 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.96 -24.99 59.71 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 123.607 0.567 . . . . 73.45 111.846 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -56.86 -52.68 72.01 Favored Pre-proline 0 CA--C 1.557 1.233 0 CA-C-O 117.029 -1.463 . . . . 74.05 113.494 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.92 -34.61 67.24 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.582 2.188 . . . . 52.01 113.976 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.628 ' HE2' HG21 ' D' ' 115' ' ' THR . 80.0 m-85 -72.76 -48.81 35.22 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.44 0.696 . . . . 73.12 110.218 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.16 80.99 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.749 -0.66 . . . . 54.31 110.439 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -63.38 -52.49 61.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.831 1.652 . . . . 71.22 110.987 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -38.44 89.89 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.973 0.796 . . . . 74.13 109.286 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.2 t -65.46 -37.63 87.43 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.042 0.537 . . . . 62.33 111.186 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.459 HD13 HG23 ' B' ' 64' ' ' VAL . 76.3 mt -64.08 -49.12 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.387 0.675 . . . . 63.34 109.587 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -61.44 -30.16 70.41 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.634 0.773 . . . . 71.33 111.231 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -69.47 -44.43 71.2 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.528 0.731 . . . . 34.21 109.146 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -68.1 -29.34 68.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.942 0.497 . . . . 74.22 111.124 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.471 HG21 HD23 ' B' ' 126' ' ' LEU . 78.7 t -69.34 -41.18 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.096 0.959 . . . . 75.25 110.015 173.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -67.66 -28.35 67.63 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.994 0.918 . . . . 30.45 111.724 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 73.5 mtt-85 -79.41 -35.72 40.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.52 0.728 . . . . 73.13 110.044 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.35 3.75 71.2 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.022 -0.536 . . . . 55.14 112.72 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 45.7 p 59.67 56.11 3.73 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.953 1.701 . . . . 65.4 112.744 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.43 ' HZ ' HG11 ' B' ' 31' ' ' VAL . 44.1 m-85 -119.49 157.9 50.48 Favored Pre-proline 0 N--CA 1.48 1.053 0 C-N-CA 124.192 0.997 . . . . 60.31 109.835 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.28 -173.83 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.78 2.32 . . . . 71.22 113.884 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.515 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -59.37 116.59 4.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.645 1.178 . . . . 74.12 112.41 -172.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.471 HD23 HG21 ' B' ' 118' ' ' VAL . 43.8 tp -123.06 93.7 4.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.473 0.709 . . . . 74.22 109.811 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -92.09 126.87 37.34 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.1 -1.074 . . . . 72.5 108.1 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.624 HD11 HD12 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -73.28 129.35 37.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.133 -1.062 . . . . 53.15 108.133 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.53 129.66 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.353 0.661 . . . . 62.44 111.073 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.58 ' HG3' HD11 ' D' ' 16' ' ' ILE . 68.0 Cg_endo -68.38 130.95 22.12 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.544 2.163 . . . . 74.41 112.115 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -115.71 114.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.532 0.733 . . . . 73.04 109.435 -177.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -85.22 98.11 10.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 . . . . . 0 N--CA 1.478 0.962 0 C-N-CA 123.731 0.812 . . . . 65.24 110.811 178.79 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.1 tmm? . . . . . 0 CA--C 1.556 1.175 0 CA-C-O 121.48 0.657 . . . . 64.21 112.701 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -91.28 98.65 11.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.584 0.754 . . . . 75.02 109.926 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.613 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 50.0 t80 -97.13 142.14 29.41 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.322 0.649 . . . . 71.33 109.474 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -156.81 144.55 19.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.267 0.627 . . . . 73.32 109.327 166.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.91 137.57 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.298 -1.001 . . . . 73.12 108.298 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -95.89 -50.15 5.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.488 -0.56 . . . . 73.01 109.488 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -164.23 124.25 2.05 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.889 -0.596 . . . . 70.12 110.72 -169.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.409 ' HB ' ' OE1' ' A' ' 125' ' ' GLN . 64.9 mt -109.7 130.72 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.532 -1.285 . . . . 64.25 107.532 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.473 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 20.8 p90 -163.05 149.58 12.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.776 0.798 . . . . 74.04 111.947 -172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -77.93 103.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.933 -1.136 . . . . 71.21 107.933 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -70.87 -28.81 64.84 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.818 -0.438 . . . . 72.53 109.818 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.0 t70 -148.91 143.14 26.03 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.216 -0.902 . . . . 71.41 109.853 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -138.05 145.17 29.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.631 1.572 . . . . 72.12 106.76 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -158.4 152.19 23.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.279 0.562 . . . . 60.13 110.133 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -148.14 133.29 18.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.254 -1.388 . . . . 64.22 107.254 173.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 49.0 mt-10 -125.14 132.84 53.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.853 -0.795 . . . . 74.42 108.853 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.39 77.67 5.94 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.085 0.954 . . . . 74.12 108.806 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 -22.12 17.92 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.096 1.864 . . . . 65.31 111.319 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -99.91 28.58 4.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.51 1.124 . . . . 74.3 110.816 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.68 97.12 Favored Pre-proline 0 CA--C 1.569 1.673 0 C-N-CA 123.951 0.9 . . . . 71.33 112.925 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.97 -25.83 8.5 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 121.433 1.422 . . . . 72.52 112.048 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -69.41 -21.37 63.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.077 1.351 . . . . 73.04 112.063 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 p -51.4 -29.98 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 113.018 0.748 . . . . 72.23 113.018 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -70.94 -34.53 71.56 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.339 0.656 . . . . 73.35 111.842 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -93.62 6.05 49.57 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.448 0.699 . . . . 74.04 111.015 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 2.9 ttmp? -90.95 147.76 22.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.277 0.631 . . . . 75.13 111.486 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.77 135.76 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.795 1.638 . . . . 75.51 110.148 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -81.79 79.38 8.36 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 122.122 -0.362 . . . . 74.55 110.182 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.408 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 4.7 tp-100 -153.0 55.66 1.48 Allowed Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.693 0.397 . . . . 64.03 111.216 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' C' ' 37' ' ' GLN . 17.3 Cg_endo -90.47 144.23 3.85 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.06 1.84 . . . . 73.32 112.226 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -86.3 83.73 7.63 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.227 -1.397 . . . . 73.44 107.227 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 p -76.97 99.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.882 -1.053 . . . . 71.4 108.693 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -125.21 140.65 52.67 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.66 -1.154 . . . . 62.32 108.652 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.582 HD13 HD11 ' C' ' 128' ' ' LEU . 2.6 pt? -87.75 163.47 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.252 0.549 . . . . 74.43 110.089 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.1 t70 -148.18 145.41 28.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.36 1.064 . . . . 72.44 108.145 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 41.1 tp -130.78 135.51 47.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.734 -0.469 . . . . 72.4 109.734 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.69 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 3.9 m-20 -118.61 142.29 47.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.918 0.887 . . . . 73.41 108.82 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.8 p -114.26 113.98 25.34 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.132 0.973 . . . . 73.44 109.561 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.89 141.97 38.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.556 0.742 . . . . 65.55 110.171 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -145.78 154.29 41.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.251 0.621 . . . . 55.33 110.547 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.9 p -144.61 131.51 20.29 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.936 0.894 . . . . 62.41 108.644 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 -79.21 116.67 19.62 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.268 -0.641 . . . . 65.24 109.268 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 57' ' ' GLU . 32.1 mt -93.3 -32.24 14.39 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.387 -0.824 . . . . 72.23 109.684 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.77 -177.03 5.28 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.153 -0.93 . . . . 54.44 110.387 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.98 128.05 34.5 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.638 -1.164 . . . . 70.03 108.97 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.48 -7.1 0.73 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.201 1.4 . . . . 73.31 113.183 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.94 112.93 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.607 0.763 . . . . 72.14 109.462 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -129.28 133.87 47.68 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.84 -1.073 . . . . 75.24 108.382 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.3 tt0 -83.31 115.67 22.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.919 -0.771 . . . . 72.05 108.919 173.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.52 118.11 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.017 -1.105 . . . . 71.14 108.017 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.73 127.75 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 122.867 0.467 . . . . 72.34 110.062 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.533 HD23 HD12 ' C' ' 106' ' ' LEU . 3.6 mm? -120.94 112.62 18.99 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.138 -1.06 . . . . 72.43 108.138 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.69 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 35.4 ttm180 -82.06 110.82 17.64 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.701 -0.851 . . . . 65.14 108.701 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.7 t -99.94 112.27 31.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.048 -1.093 . . . . 65.43 108.048 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.2 m -114.67 142.13 46.89 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.791 -1.095 . . . . 35.43 108.114 -175.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.412 HG21 HG21 ' C' ' 114' ' ' ILE . 87.4 t -136.02 108.34 7.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.817 -1.179 . . . . 64.04 107.817 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.0 m -108.68 142.31 39.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.287 -0.634 . . . . 73.52 109.287 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.81 113.12 11.92 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.705 -1.22 . . . . 65.4 107.705 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.7 m -142.46 150.7 40.9 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.236 0.541 . . . . 63.34 111.076 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.21 19.04 15.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.615 1.566 . . . . 74.15 109.849 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.48 -108.73 1.3 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 110.416 -1.074 . . . . 62.43 110.416 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -89.9 -33.09 16.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.282 -1.007 . . . . 74.52 108.282 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.85 102.83 0.38 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.975 1.31 . . . . 50.4 109.953 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -88.59 129.67 35.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.923 0.329 . . . . 65.13 110.255 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -73.54 -59.79 2.55 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 173.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -173.09 174.55 3.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.211 0.945 . . . . 75.12 110.534 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -134.96 145.27 47.99 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.047 -1.464 . . . . 71.14 107.047 172.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.433 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.3 t -151.71 121.45 7.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.884 -1.154 . . . . 73.11 107.884 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.41 130.3 18.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.902 0.382 . . . . 65.32 110.141 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.31 115.43 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.925 1.29 . . . . 63.11 108.716 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.574 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.0 mt-30 -89.09 88.78 7.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.849 -1.167 . . . . 72.23 107.849 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.49 112.35 17.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.623 -1.171 . . . . 71.45 109.664 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.39 148.32 18.31 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 111.269 -0.733 . . . . 44.5 111.269 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.3 130.97 4.17 Favored Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 111.398 -0.681 . . . . 74.24 111.398 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.512 HD12 HD11 ' C' ' 51' ' ' LEU . 13.7 mm -84.52 120.87 35.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.439 -0.949 . . . . 72.3 108.439 174.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -130.98 139.88 50.07 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.402 0.681 . . . . 74.14 109.474 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 m -110.49 109.03 19.23 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.765 -0.828 . . . . 60.33 108.765 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.33 122.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.141 -1.059 . . . . 71.12 108.141 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.78 170.32 12.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.188 0.995 . . . . 72.14 110.187 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.81 -60.61 0.33 Allowed Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.968 -0.56 . . . . 54.51 112.803 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.71 -176.65 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 117.084 0.442 . . . . 72.12 111.446 -176.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.93 -171.98 3.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.144 0.977 . . . . 70.32 109.472 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.36 -148.94 41.44 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 116.157 -0.474 . . . . 71.55 113.8 173.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.5 p -63.32 -26.98 69.02 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.382 1.073 . . . . 41.11 112.052 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -64.71 -54.29 33.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.352 1.061 . . . . 74.42 110.655 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.0 -38.14 75.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.283 -0.872 . . . . 73.32 109.974 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.47 -22.74 65.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 63.42 112.071 179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 56.7 t-80 -71.79 -41.59 68.13 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.778 -0.453 . . . . 72.01 109.778 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.65 -31.5 69.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.137 0.494 . . . . 70.24 110.657 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -80.54 -48.73 12.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.427 1.091 . . . . 75.55 109.901 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.15 9.53 67.64 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.355 -0.839 . . . . 53.12 114.283 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -146.13 -51.72 0.24 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.442 0.621 . . . . 74.23 111.607 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -74.77 -41.98 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.534 0.333 . . . . 75.15 111.412 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.441 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 68.8 m -66.93 -45.14 53.57 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 118.373 -0.823 . . . . 64.15 111.726 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.404 ' HG3' HD21 ' C' ' 60' ' ' LEU . 92.7 Cg_exo -50.2 -38.93 52.11 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.933 2.422 . . . . 75.53 114.017 168.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -61.74 -34.41 75.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.294 0.638 . . . . 72.25 111.992 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.34 -42.77 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.927 -0.397 . . . . 73.33 109.927 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.533 HD12 HD23 ' C' ' 60' ' ' LEU . 85.5 mt -76.03 -26.9 57.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.69 -0.686 . . . . 72.5 112.015 -174.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.83 -52.75 69.77 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 117.703 -1.141 . . . . 74.34 113.493 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.61 -32.66 93.63 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.177 1.918 . . . . 62.04 113.327 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.528 ' HE2' HG21 ' A' ' 115' ' ' THR . 67.9 m-85 -70.88 -44.44 66.32 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 54.42 110.819 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.3 -45.6 93.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.811 -0.631 . . . . 62.11 109.691 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.6 ttt-85 -56.28 -47.21 79.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.055 1.342 . . . . 62.12 111.652 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.9 -36.51 78.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.668 0.605 . . . . 75.0 109.732 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.7 t -68.2 -35.13 77.51 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.391 0.676 . . . . 73.23 111.103 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.433 HG23 ' SG ' ' C' ' 76' ' ' CYS . 60.6 mt -72.15 -47.91 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.673 0.789 . . . . 74.1 109.974 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -64.4 -31.42 72.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.468 0.707 . . . . 74.12 110.825 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -66.38 -47.72 72.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.413 -0.812 . . . . 73.54 109.462 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.52 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.3 -36.61 84.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.45 0.7 . . . . 74.55 112.428 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.1 t -64.44 -37.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.21 0.604 . . . . 61.13 109.786 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.2 t -68.53 -35.1 76.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.437 0.695 . . . . 75.33 111.584 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -70.67 -35.58 72.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.731 0.812 . . . . 73.44 110.428 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.27 4.61 80.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.893 -0.594 . . . . 73.41 113.046 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.2 p 60.96 35.19 19.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.768 1.627 . . . . 72.52 112.372 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -105.01 150.75 39.1 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.557 1.143 . . . . 55.31 110.05 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.515 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 76.5 Cg_exo -53.92 110.31 0.49 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.397 2.731 . . . . 53.23 113.001 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -60.34 144.46 50.63 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.507 1.13 . . . . 64.24 111.224 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.99 124.14 11.47 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.72 -1.585 . . . . 73.43 106.72 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -90.76 130.41 36.74 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.892 -0.781 . . . . 71.04 108.892 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.582 HD11 HD13 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -64.62 131.74 47.82 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.427 -0.953 . . . . 74.5 108.427 177.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -60.06 140.19 90.74 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.971 0.909 . . . . 62.23 111.334 -178.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 103.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.18 2.587 . . . . 73.53 112.708 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.28 108.33 21.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 N-CA-C 108.319 -0.993 . . . . 72.11 108.319 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -96.49 92.2 6.16 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.319 -0.855 . . . . 74.55 109.156 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -61.51 -39.19 90.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.218 -0.901 . . . . 54.3 110.475 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 . . . . . 0 N--CA 1.477 0.894 0 C-N-CA 124.173 0.989 . . . . 75.42 112.031 -177.736 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.7 m . . . . . 0 CA--C 1.537 0.451 0 N-CA-C 108.801 -0.814 . . . . 74.15 108.801 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.608 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 23.4 t80 -160.23 110.73 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.592 -2.003 . . . . 73.34 105.592 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -130.98 114.79 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.921 -0.77 . . . . 63.3 108.921 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.77 123.18 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.854 0.359 . . . . 74.05 110.141 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.08 -40.4 12.3 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.346 -0.843 . . . . 73.44 109.712 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.496 ' HB3' ' HD1' ' D' ' 17' ' ' TYR . 22.1 mmt-85 -156.87 150.52 24.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.408 0.683 . . . . 64.54 112.016 -170.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.58 HD11 ' HG3' ' B' ' 130' ' ' PRO . 0.3 OUTLIER -138.85 118.0 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 105.072 -2.196 . . . . 72.14 105.072 165.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' D' ' 15' ' ' ARG . 28.2 p90 -150.39 157.91 43.57 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.866 0.841 . . . . 71.5 111.657 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -93.71 113.65 25.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.033 -0.985 . . . . 65.24 108.76 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.4 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 35.4 mtpt -81.4 -35.65 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.171 0.51 . . . . 75.41 109.629 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -144.67 141.75 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.064 -0.971 . . . . 74.43 108.444 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' C' ' 117' ' ' MET . 95.7 mt -137.09 143.9 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.698 1.199 . . . . 75.45 107.845 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 99.1 p -147.76 141.9 26.08 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.702 0.801 . . . . 72.04 108.993 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.2 t80 -146.48 113.81 6.28 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 105.944 -1.872 . . . . 73.23 105.944 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -126.87 109.45 11.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 73.24 110.106 -173.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.97 91.18 3.45 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 107.412 -1.329 . . . . 62.33 107.412 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.02 -43.16 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.262 1.975 . . . . 72.44 112.416 -173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -97.75 37.63 1.37 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.916 -1.142 . . . . 64.32 107.916 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.473 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -51.32 -64.6 1.3 Allowed Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.786 -1.102 . . . . 73.52 113.858 -161.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' C' ' 83' ' ' ILE . 81.7 Cg_endo -78.21 -14.55 14.87 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 122.195 1.82 . . . . 64.03 113.002 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -67.25 -41.47 85.55 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.54 1.136 . . . . 72.53 109.395 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.41 -41.42 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 123.962 0.789 . . . . 74.51 110.126 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -69.61 -18.6 63.62 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.377 0.88 . . . . 55.32 113.377 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.99 -2.98 58.58 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.623 0.769 . . . . 71.51 111.999 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.405 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 47.6 mtpt -124.78 116.04 21.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.096 1.358 . . . . 62.14 108.571 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -89.34 97.42 11.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.877 0.871 . . . . 63.51 112.812 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.559 ' CH2' HD13 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -167.85 -179.39 4.2 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 124.165 0.986 . . . . 64.2 112.97 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -93.22 145.48 30.11 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.484 1.114 . . . . 52.45 112.755 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.509 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 76.9 Cg_endo -79.74 135.57 11.54 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.418 2.078 . . . . 73.11 112.765 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.73 111.61 7.15 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.504 -1.295 . . . . 73.13 107.504 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.78 144.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.157 0.583 . . . . 45.31 110.774 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 85.0 tttt -124.69 127.6 47.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.288 1.035 . . . . 74.02 109.109 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.15 120.76 39.12 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.002 -1.481 . . . . 75.45 107.002 173.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.49 143.04 50.91 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.527 -0.916 . . . . 65.53 108.527 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.19 148.76 50.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.097 0.475 . . . . 72.13 110.64 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.4 t70 -139.5 150.03 44.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.185 -1.042 . . . . 65.11 108.185 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 24.2 p -116.75 143.65 45.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.746 0.818 . . . . 72.52 109.785 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.88 155.88 32.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.511 1.124 . . . . 73.11 108.246 174.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 27.1 p -169.26 163.96 10.87 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.844 0.457 . . . . 53.43 110.733 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -159.57 132.71 6.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.668 0.787 . . . . 72.15 110.009 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -77.43 117.47 18.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.769 -0.826 . . . . 72.44 108.769 170.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' D' ' 57' ' ' GLU . 70.6 mt -90.29 -32.59 16.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.858 0.463 . . . . 74.34 110.508 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.92 -171.17 1.12 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.645 0.778 . . . . 43.23 110.632 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.93 114.79 4.78 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.779 -1.101 . . . . 70.25 109.391 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 68.3 2.18 3.18 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.147 1.379 . . . . 75.35 113.012 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.67 120.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.409 -0.96 . . . . 74.43 108.409 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -136.51 131.2 33.6 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.558 0.536 . . . . 74.23 109.884 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.7 tt0 -87.43 126.59 34.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.298 -1.001 . . . . 62.2 108.298 169.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.89 112.77 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.715 -1.217 . . . . 74.24 107.715 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.516 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.7 t -102.65 130.74 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.233 0.613 . . . . 73.41 109.618 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.01 109.03 13.02 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.143 -1.428 . . . . 75.32 107.143 171.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.0 ttm-85 -84.34 106.66 16.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.446 -0.797 . . . . 74.33 109.16 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.32 129.74 45.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.568 -0.901 . . . . 61.41 108.568 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 31.3 m -125.87 135.67 52.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.573 0.749 . . . . 72.41 109.544 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.474 HG23 HD13 ' D' ' 114' ' ' ILE . 91.2 t -124.81 111.99 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.041 0.936 . . . . 63.34 109.382 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 58.7 m -105.39 119.67 39.66 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.245 -0.65 . . . . 41.1 109.245 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.03 133.24 56.21 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.275 0.63 . . . . 73.45 110.635 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -141.93 125.18 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.143 0.977 . . . . 61.4 109.649 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.642 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -126.7 138.99 53.48 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.283 1.033 . . . . 62.32 110.841 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.85 -111.91 3.51 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.8 -0.52 . . . . 54.1 111.8 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.15 4.05 17.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.202 1.001 . . . . 54.21 110.023 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.17 168.58 21.3 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.212 0.529 . . . . 64.12 112.358 -157.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -84.56 126.58 33.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.143 -0.935 . . . . 74.32 110.428 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.642 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -71.78 -69.45 0.39 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.97 0.908 . . . . 64.45 109.706 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -158.67 147.5 18.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.543 -1.662 . . . . 63.1 109.953 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.92 152.93 20.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.194 -1.41 . . . . 70.34 107.194 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.5 t -154.27 135.78 14.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.955 -0.757 . . . . 65.21 108.955 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -153.54 134.44 13.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.522 -0.547 . . . . 70.21 109.522 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.5 t -136.52 116.79 17.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.745 -0.835 . . . . 52.04 108.745 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.81 86.54 7.17 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.843 -1.169 . . . . 60.42 107.843 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.54 92.89 5.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.951 -1.022 . . . . 60.45 109.254 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.67 148.27 19.43 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.104 -0.798 . . . . 64.01 111.104 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.63 131.53 3.69 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 110.961 -0.856 . . . . 64.2 110.961 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' D' ' 17' ' ' TYR . 68.2 mt -89.18 122.47 40.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.446 -0.946 . . . . 64.13 108.446 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.3 138.78 52.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.37 1.068 . . . . 72.03 108.996 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 19.4 m -90.69 97.34 11.13 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.207 -1.034 . . . . 62.21 108.207 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.98 123.03 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.547 -0.538 . . . . 74.32 109.547 -171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.23 170.95 20.09 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.56 1.144 . . . . 53.04 109.442 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.1 -18.48 51.23 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 116.301 -0.409 . . . . 74.41 113.222 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.35 159.05 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.439 1.095 . . . . 74.22 109.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 158.98 40.83 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.142 0.577 . . . . 75.41 110.795 -174.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.57 -97.48 0.01 OUTLIER Glycine 0 C--N 1.351 1.377 0 O-C-N 125.165 1.54 . . . . 75.3 115.793 161.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.3 p -58.89 -54.53 46.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.957 1.303 . . . . 74.13 112.597 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -82.12 -27.02 33.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.22 -0.445 . . . . 71.03 110.698 -173.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 27.8 ttt -67.46 -35.05 78.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.831 -0.433 . . . . 74.43 109.831 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -53.87 51.98 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 123.615 0.766 . . . . 63.11 110.61 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -57.24 -45.27 84.07 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.229 0.956 . . . . 75.31 110.824 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.39 -33.13 75.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.446 0.699 . . . . 62.5 111.706 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.456 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.2 tp -75.41 -32.4 60.72 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 70.0 110.994 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.85 13.59 34.77 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.21 -0.45 . . . . 71.32 113.658 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -129.7 -61.2 1.01 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.172 0.486 . . . . 74.4 110.345 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -75.33 -46.51 32.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.4 0.68 . . . . 74.35 111.095 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.608 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 60.5 m -62.47 -48.94 85.67 Favored Pre-proline 0 CA--C 1.569 1.687 0 CA-C-O 118.306 -0.854 . . . . 54.54 112.114 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.63 -16.19 33.87 Favored 'Trans proline' 0 C--N 1.402 3.376 0 C-N-CA 122.1 1.867 . . . . 70.32 112.735 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.16 -24.48 62.26 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.833 0.453 . . . . 73.12 110.259 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.38 -39.29 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.281 0.632 . . . . 64.43 109.853 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 -37.0 64.22 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.765 0.826 . . . . 71.24 112.201 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.14 -40.9 57.49 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-O 117.787 -1.102 . . . . 75.32 113.515 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -53.93 -39.73 83.58 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.377 2.051 . . . . 71.22 113.816 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -80.26 -32.81 38.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.369 0.667 . . . . 74.33 111.368 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.69 81.3 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.168 -0.679 . . . . 44.1 109.168 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.515 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -53.53 -53.55 49.94 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.906 1.282 . . . . 74.15 110.771 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.65 -40.76 92.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.504 1.128 . . . . 74.13 110.698 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.62 -44.11 96.7 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.576 0.548 . . . . 75.24 110.757 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.599 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.1 mt -63.22 -53.19 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 64.2 109.884 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.628 HG21 ' HE2' ' B' ' 109' ' ' TYR . 95.9 m -52.8 -45.07 67.05 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.085 1.354 . . . . 51.12 111.923 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.39 -44.94 77.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.944 -1.025 . . . . 71.42 110.151 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 77.7 mtm -62.55 -37.79 87.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.857 0.463 . . . . 72.22 112.0 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.502 HG23 ' O ' ' D' ' 114' ' ' ILE . 85.7 t -61.59 -44.63 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 124.093 0.871 . . . . 61.33 110.014 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.57 -27.33 61.26 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.878 0.471 . . . . 62.21 111.718 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -72.39 -31.64 65.72 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.347 0.659 . . . . 73.22 110.076 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.25 10.81 62.48 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.445 -0.798 . . . . 61.22 112.368 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.405 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.6 p 65.75 15.04 9.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.964 2.105 . . . . 63.04 113.961 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.74 156.97 55.51 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 107.437 -1.319 . . . . 63.03 107.437 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.02 146.09 36.52 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.682 2.255 . . . . 54.32 111.588 -177.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.457 ' HB2' HG23 ' D' ' 115' ' ' THR . 20.2 pt20 -51.3 127.71 20.34 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 124.275 0.985 . . . . 63.53 112.134 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -107.49 100.77 10.16 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.483 -0.932 . . . . 74.34 108.483 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.444 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 3.1 m-20 -98.89 107.1 19.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.298 1.039 . . . . 73.33 110.18 -166.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.515 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.7 mm? -72.22 116.01 12.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.069 0.948 . . . . 62.53 109.908 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.57 154.42 94.53 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.534 0.334 . . . . 72.32 111.494 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.78 123.87 14.5 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.499 2.133 . . . . 64.11 111.951 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 63.4 t -108.41 125.49 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.905 0.882 . . . . 63.34 108.773 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -72.17 93.88 1.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.171 0.588 . . . . 64.23 109.632 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 70.7 m-85 . . . . . 0 N--CA 1.474 0.768 0 CA-C-N 115.583 -0.735 . . . . 74.2 111.352 -179.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 CA--C 1.541 0.611 0 N-CA-C 109.602 -0.518 . . . . 65.43 109.602 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.621 ' HA ' HG22 ' A' ' 86' ' ' ILE . 54.1 t80 -136.2 132.16 35.53 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.495 -1.668 . . . . 72.03 106.495 164.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -150.82 120.3 6.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.855 -0.424 . . . . 75.1 109.855 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -77.81 128.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.929 -1.137 . . . . 71.24 107.929 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -101.78 -39.9 7.2 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.605 -0.517 . . . . 61.21 109.605 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -174.68 127.62 0.31 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.672 0.389 . . . . 71.31 109.961 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -112.48 145.94 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.02 -0.733 . . . . 72.42 109.02 175.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -165.39 174.64 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.716 0.807 . . . . 74.42 111.195 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -99.68 122.56 42.88 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.212 -0.662 . . . . 72.35 109.212 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.94 -24.6 23.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.738 0.415 . . . . 62.51 110.042 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.28 137.36 17.32 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.175 -0.921 . . . . 62.42 109.416 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -133.77 132.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.319 -1.363 . . . . 61.5 107.319 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -139.57 124.89 19.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 72.12 108.641 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -135.23 128.49 32.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.397 -1.705 . . . . 75.01 106.397 170.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -137.32 121.7 18.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.995 0.518 . . . . 72.23 109.666 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.11 77.57 67.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.599 -1.63 . . . . 71.21 106.599 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.77 -46.06 9.64 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.578 2.186 . . . . 71.3 111.36 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.22 23.37 3.88 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.653 -1.158 . . . . 74.41 109.704 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.03 -55.64 10.7 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.111 -0.947 . . . . 75.22 112.916 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.8 Cg_exo -61.18 -26.89 83.07 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.378 2.052 . . . . 71.03 113.305 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.97 -26.7 20.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.988 0.915 . . . . 72.42 110.763 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -82.52 -17.69 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 122.744 0.417 . . . . 72.31 111.281 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -79.81 -12.46 59.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.271 0.628 . . . . 73.45 111.78 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -101.94 -9.14 20.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.174 0.99 . . . . 74.3 110.933 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -71.94 158.62 35.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.3 0.64 . . . . 75.11 111.663 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.59 138.16 58.42 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.048 -0.978 . . . . 73.25 110.19 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -94.01 63.23 3.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.623 0.725 . . . . 73.01 111.645 -165.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.45 83.77 16.9 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.123 0.969 . . . . 72.14 109.188 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.92 167.04 8.36 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.643 2.229 . . . . 75.15 111.648 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.14 99.62 7.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.316 -1.364 . . . . 74.42 107.316 167.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 65' ' ' THR . 59.7 t -85.08 129.87 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.04 -0.726 . . . . 64.01 109.04 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -125.09 120.15 30.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.528 1.131 . . . . 72.51 109.296 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tt -96.71 109.07 21.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.281 -1.748 . . . . 51.33 106.281 170.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -127.1 128.2 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.906 -1.146 . . . . 72.3 107.906 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.73 162.13 14.74 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.269 0.556 . . . . 73.32 110.853 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 10.1 t70 -131.05 134.51 46.71 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.015 1.326 . . . . 64.23 108.081 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.8 p -115.76 125.08 52.3 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.018 0.927 . . . . 74.44 110.695 -171.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.38 124.06 11.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.23 0.612 . . . . 53.2 111.586 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 6.5 p -90.91 155.68 18.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.296 0.638 . . . . 70.52 109.568 168.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -150.58 150.56 31.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.223 1.009 . . . . 70.3 109.027 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -115.24 138.84 50.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.194 0.598 . . . . 60.23 110.228 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.04 -34.63 6.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.824 0.85 . . . . 71.24 109.856 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -166.75 -176.01 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 71.04 109.986 -176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.39 122.07 21.48 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.955 -0.758 . . . . 75.32 108.955 173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 72.75 -7.02 1.52 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.36 1.464 . . . . 74.32 112.468 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.5 t -114.86 111.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 107.506 -1.294 . . . . 51.43 107.506 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -128.68 170.96 12.65 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 123.65 0.78 . . . . 73.34 108.997 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -130.59 147.25 52.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.978 0.911 . . . . 74.12 109.076 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.98 122.33 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.923 -1.14 . . . . 71.11 107.923 171.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.2 t -105.35 129.68 57.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 109.239 -0.652 . . . . 75.43 109.239 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -118.61 100.41 7.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 106.482 -1.673 . . . . 64.22 106.482 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttp180 -84.96 109.0 17.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.764 -0.653 . . . . 61.52 109.276 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -92.81 132.59 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 107.966 -1.124 . . . . 73.34 107.966 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -120.27 138.39 53.7 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.485 -0.561 . . . . 63.15 109.485 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.56 108.98 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 124.874 1.27 . . . . 74.14 107.573 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 m -105.02 134.72 47.65 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 109.461 -0.57 . . . . 73.04 109.461 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.77 111.63 15.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.232 -1.396 . . . . 71.53 107.232 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 18.2 t -138.15 134.99 35.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.004 0.522 . . . . 71.01 110.464 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.42 52.06 2.01 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.078 1.351 . . . . 64.32 109.608 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.83 -90.69 1.46 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.61 -0.596 . . . . 60.25 111.61 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.62 -27.59 17.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.996 0.518 . . . . 73.04 112.381 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.31 125.13 53.54 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.662 -0.496 . . . . 70.05 109.662 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 43.5 m -81.26 135.3 35.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.571 0.748 . . . . 73.31 111.237 -177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.87 -65.08 0.88 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.466 0.706 . . . . 43.14 110.217 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -160.53 163.47 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.988 -1.006 . . . . 74.32 111.366 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.93 124.89 30.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.862 1.265 . . . . 61.51 108.371 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.411 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 54.7 m -123.88 105.61 9.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.115 0.966 . . . . 73.41 109.067 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.7 122.16 28.38 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.348 0.659 . . . . 61.32 109.718 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 113' ' ' CYS . 46.7 t -130.47 112.75 23.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.915 0.886 . . . . 74.1 109.458 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 44.4 mt-30 -84.87 89.16 7.49 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.466 0.706 . . . . 74.21 109.506 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.23 7.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.136 -0.938 . . . . 73.33 109.023 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -101.1 145.25 16.91 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.426 -0.67 . . . . 63.24 111.426 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.98 137.27 6.58 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 111.639 -0.585 . . . . 71.21 111.639 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mt -77.9 126.15 38.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.843 -0.799 . . . . 55.41 108.843 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -129.52 118.98 22.93 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.621 -0.881 . . . . 72.4 108.621 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -86.25 99.11 11.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.778 -0.823 . . . . 71.5 108.778 172.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.88 157.32 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.313 0.645 . . . . 73.25 110.512 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.88 161.6 15.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.941 -1.027 . . . . 65.14 110.476 -177.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.3 8.04 83.09 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.287 0.367 . . . . 73.33 113.797 170.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 pt -111.45 143.69 20.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 123.956 0.902 . . . . 71.14 108.901 -176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.7 tt0 -159.13 174.92 14.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.834 0.454 . . . . 74.41 109.879 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.469 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 58.87 -127.91 46.41 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 123.904 0.764 . . . . 72.23 114.274 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -82.66 -15.19 52.98 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.296 0.638 . . . . 70.0 111.527 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.53 -40.31 61.81 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.353 0.661 . . . . 74.14 110.097 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.8 ptm -71.01 -29.5 65.47 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.272 -0.422 . . . . 72.41 110.065 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.14 -28.85 63.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.561 0.745 . . . . 64.41 111.131 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -81.6 -31.49 32.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.419 0.687 . . . . 73.01 110.494 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.12 -57.57 5.23 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.965 0.506 . . . . 74.32 109.925 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.8 -51.83 44.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.284 -0.871 . . . . 61.4 111.001 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.57 -6.09 88.16 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 115.147 0.819 . . . . 62.33 115.147 -167.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.39 -54.14 0.19 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.254 0.835 . . . . 74.33 113.254 -170.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -69.39 -46.91 65.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.611 0.365 . . . . 64.13 111.575 -171.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.9 m -67.98 -43.56 37.02 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.003 0.921 . . . . 64.33 112.609 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.69 -43.26 40.72 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 123.096 2.531 . . . . 72.43 113.148 168.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -63.25 -37.14 86.07 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.089 0.868 . . . . 70.34 110.837 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.0 -45.53 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.326 0.65 . . . . 74.43 111.015 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.33 -24.49 34.55 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.566 -0.743 . . . . 74.14 112.292 -170.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -61.29 -42.49 85.64 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 113.824 1.046 . . . . 54.42 113.824 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . 0.427 ' HA ' HH11 ' A' ' 111' ' ' ARG . 76.6 Cg_exo -55.04 -41.8 75.26 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.47 2.114 . . . . 74.31 114.399 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.148 0.579 . . . . 62.31 111.62 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.87 97.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.032 0.533 . . . . 71.0 110.657 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.1 ttm105 -50.69 -57.67 7.73 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.776 1.298 . . . . 64.41 110.825 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.88 -40.76 95.62 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.991 0.807 . . . . 74.1 110.802 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.571 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.2 t -60.76 -33.21 72.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.659 0.599 . . . . 73.43 111.786 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.522 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 96.1 mt -74.01 -55.74 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.623 0.769 . . . . 64.33 109.843 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -51.41 -44.3 62.2 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.246 1.418 . . . . 62.21 112.64 -173.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 34.3 t -65.3 -42.75 92.77 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.93 -1.032 . . . . 74.14 110.106 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.522 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 51.4 mtm -64.63 -40.39 95.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.84 0.456 . . . . 72.21 111.05 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.1 t -57.27 -48.29 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.576 0.75 . . . . 65.5 109.945 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -71.16 -31.89 68.24 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.737 -0.665 . . . . 75.41 111.765 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 116' ' ' SER . 73.1 mtt-85 -67.58 -28.74 68.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.85 0.86 . . . . 71.42 110.885 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.87 23.85 8.61 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 119.627 -0.54 . . . . 74.24 113.972 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.415 HG23 ' HB3' ' B' ' 17' ' ' TYR . 75.4 p 50.13 26.08 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.809 1.644 . . . . 44.35 113.625 -173.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.36 149.17 36.26 Favored Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 108.83 -0.804 . . . . 63.22 108.83 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.02 139.3 84.76 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.818 2.346 . . . . 60.12 111.488 174.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.448 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.1 tt0 -54.71 132.6 46.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.13 0.894 . . . . 70.42 111.092 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.1 tp -111.92 118.3 35.11 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.85 -0.796 . . . . 72.5 108.85 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.595 ' HB2' HD13 ' C' ' 13' ' ' ILE . 89.9 m-20 -110.0 110.36 21.25 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.995 -1.113 . . . . 70.1 107.995 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 128' ' ' LEU . 2.1 mm? -73.15 117.33 14.76 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.932 -1.136 . . . . 54.22 107.932 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -60.12 140.27 90.93 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 118.406 0.548 . . . . 45.44 110.996 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 1.7 Cg_endo -74.03 109.84 2.96 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.027 1.818 . . . . 43.32 110.645 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.36 123.74 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.501 -0.925 . . . . 73.45 108.501 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -73.75 99.73 3.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.807 0.843 . . . . 73.54 109.929 -173.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -72.15 -46.31 56.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.475 0.71 . . . . 73.34 111.85 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.644 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.9 p-10 . . . . . 0 N--CA 1.479 1.007 0 O-C-N 123.425 0.453 . . . . 64.31 111.441 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m . . . . . 0 C--O 1.241 0.638 0 N-CA-C 108.012 -1.107 . . . . 75.35 108.012 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -151.68 128.6 11.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.936 0.494 . . . . 73.23 110.104 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -159.67 144.27 15.09 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.678 0.791 . . . . 64.44 108.942 161.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.561 HG22 ' HE2' ' B' ' 84' ' ' PHE . 2.7 pp -59.13 138.4 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.498 -0.774 . . . . 73.24 109.957 168.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.7 mm100 -100.47 -45.98 5.38 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.575 -0.898 . . . . 75.34 108.575 172.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -164.84 129.93 2.64 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.99 -1.004 . . . . 75.14 108.882 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -115.03 135.98 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 106.667 -1.605 . . . . 62.54 106.667 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 122' ' ' THR . 26.5 p90 -166.5 158.44 13.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.482 0.658 . . . . 73.2 111.331 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 78.2 m -85.46 119.71 26.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.162 -0.926 . . . . 74.04 108.962 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.524 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 44.3 mtpt -88.32 -34.68 17.57 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.273 0.629 . . . . 73.14 110.177 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.2 t70 -153.79 147.16 24.87 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.568 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 41.0 mm -139.76 142.94 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.86 1.664 . . . . 53.31 107.573 177.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -148.43 138.17 22.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.665 -0.865 . . . . 62.02 108.665 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -151.18 123.3 8.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.239 -1.393 . . . . 75.44 107.239 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -120.89 149.52 42.49 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.081 0.552 . . . . 75.31 109.542 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -143.72 80.26 12.92 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.11 -1.07 . . . . 40.54 108.11 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.41 -17.66 39.03 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.057 2.505 . . . . 73.01 111.872 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -122.87 27.84 7.53 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.501 1.121 . . . . 72.22 109.439 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.05 -50.05 47.87 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 124.275 1.03 . . . . 75.32 112.836 172.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 1.0 OUTLIER -85.21 -35.29 0.16 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.504 2.136 . . . . 62.34 112.709 178.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.1 m80 -90.84 2.35 56.2 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 75.31 112.908 -170.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.83 -28.59 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 125.075 1.35 . . . . 71.0 111.898 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -66.62 -13.82 61.62 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.753 1.221 . . . . 73.42 112.381 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.617 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 10.3 pt20 -73.34 -32.45 64.56 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.427 0.632 . . . . 74.3 110.253 174.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.617 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 29.3 mmtp -107.03 81.81 1.6 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.04 1.336 . . . . 51.25 108.922 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.39 77.17 8.29 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.547 -0.751 . . . . 71.13 111.644 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.6 ' HA ' ' CE3' ' B' ' 36' ' ' TRP 0.258 0.0 OUTLIER 160.56 -171.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 127.084 2.153 . . . . 71.33 111.141 156.19 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.423 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 12.4 pt20 -59.02 132.2 87.11 Favored Pre-proline 0 C--N 1.361 1.068 0 C-N-CA 124.755 1.222 . . . . 72.2 113.278 -168.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.42 171.77 15.48 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.418 2.746 . . . . 74.23 112.784 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -69.39 109.41 4.17 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 108.596 -0.89 . . . . 50.51 108.596 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 9.3 m -95.16 135.0 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.407 -0.815 . . . . 61.21 109.931 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -141.65 124.28 15.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.329 1.052 . . . . 65.41 108.294 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.65 HD22 HD21 ' B' ' 128' ' ' LEU . 64.7 tp -97.41 145.49 26.12 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.454 -0.573 . . . . 65.02 109.454 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -146.66 154.25 41.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.999 -1.112 . . . . 63.4 107.999 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -138.38 141.97 39.63 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.484 -0.932 . . . . 73.04 108.484 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.692 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 15.1 t70 -124.34 144.02 50.25 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.966 0.906 . . . . 61.31 108.699 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.3 p -112.23 112.08 23.43 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.423 -0.808 . . . . 74.3 110.225 -170.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.96 125.36 31.4 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.314 -0.995 . . . . 71.35 108.314 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.6 p -142.82 168.17 20.34 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.36 0.664 . . . . 64.32 109.621 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 57.8 p -150.99 141.06 22.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.129 0.572 . . . . 74.25 109.909 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -82.02 109.74 16.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.826 -0.805 . . . . 62.11 108.826 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' B' ' 57' ' ' GLU . 55.1 mt -75.83 -41.03 53.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.445 . . . . 75.54 110.245 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.75 -171.77 3.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.184 0.994 . . . . 65.23 110.062 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.88 111.37 1.44 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 115.555 -0.748 . . . . 63.11 110.446 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 65.55 12.53 8.27 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.637 1.175 . . . . 75.54 112.516 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.06 115.14 47.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.094 -1.076 . . . . 72.42 108.094 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -124.14 138.49 54.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.225 -0.657 . . . . 72.44 109.225 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.507 ' HB2' HD11 ' B' ' 51' ' ' LEU . 7.8 tm-20 -107.08 106.92 17.66 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.278 -1.379 . . . . 73.32 107.278 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.1 t -96.4 121.57 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.088 1.355 . . . . 74.34 110.04 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.494 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 30.0 t -105.39 120.19 55.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.437 0.695 . . . . 54.11 109.149 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' ' 103' ' ' PRO . 50.2 tp -95.16 99.16 11.18 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 73.24 108.605 172.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.692 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 65.2 ttt180 -88.48 107.94 19.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.813 -0.81 . . . . 71.53 108.813 177.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -104.9 102.87 14.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.177 0.991 . . . . 65.24 108.934 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -100.93 128.47 46.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.376 0.67 . . . . 72.43 109.836 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.43 135.29 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.333 1.053 . . . . 72.44 108.932 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.9 m -124.83 143.59 50.74 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.528 0.731 . . . . 30.32 109.571 174.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.74 130.25 24.0 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.915 -1.142 . . . . 64.22 107.915 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.411 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 8.4 m -135.14 126.53 28.47 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 120.81 0.338 . . . . 53.23 111.586 -176.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 56.9 mt -93.9 109.75 21.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.409 1.084 . . . . 73.24 108.467 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.9 -111.17 3.86 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.051 -0.82 . . . . 53.41 111.051 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -121.97 18.42 10.91 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.657 0.742 . . . . 73.22 110.214 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -122.2 142.79 50.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.529 -0.732 . . . . 75.21 109.132 178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.7 m -66.78 118.45 10.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.909 0.484 . . . . 75.4 110.983 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -68.03 -55.46 12.51 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.973 -0.751 . . . . 71.4 108.973 177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -164.4 164.98 21.96 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.203 -1.362 . . . . 75.24 109.214 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.76 151.91 42.75 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.439 1.096 . . . . 64.45 108.514 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.4 t -155.52 115.66 3.75 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.221 -0.659 . . . . 74.43 109.221 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -123.62 127.04 47.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.143 -1.058 . . . . 74.15 108.143 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.414 HG13 HD13 ' B' ' 21' ' ' ILE . 57.3 t -122.55 148.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.875 -0.787 . . . . 74.05 108.875 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.5 mt-30 -123.4 99.46 6.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.218 -1.031 . . . . 55.24 108.218 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -93.71 100.45 12.67 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.35 -0.981 . . . . 72.23 108.35 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.94 162.0 29.7 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 123.677 0.61 . . . . 45.15 111.912 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.89 127.13 1.64 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.226 -0.75 . . . . 71.53 111.226 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 33.9 mt -83.98 133.81 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.057 -1.09 . . . . 64.25 108.057 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.561 ' HE2' HG22 ' B' ' 13' ' ' ILE . 49.2 m-85 -135.42 138.61 43.41 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.454 0.702 . . . . 75.13 109.45 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -91.86 103.74 16.25 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.791 -0.818 . . . . 74.33 108.791 169.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.475 ' HB ' HD11 ' B' ' 89' ' ' ILE . 26.1 pt -120.21 122.04 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.879 0.872 . . . . 72.2 110.007 -176.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.87 21.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.839 0.855 . . . . 54.23 109.876 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.36 -45.32 3.48 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.525 0.516 . . . . 74.13 113.108 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' B' ' 86' ' ' ILE . 20.9 pt -64.03 158.88 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.655 1.182 . . . . 61.45 112.439 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.418 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 11.1 pt-20 -170.21 166.57 8.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.581 1.152 . . . . 74.3 109.8 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -119.1 16.6 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.297 -0.411 . . . . 71.35 113.881 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -80.27 -18.87 48.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 71.42 111.345 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.418 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 94.5 mt-30 -60.89 -44.35 97.24 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 73.42 110.954 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 3.3 ppp? -73.24 -32.7 64.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.661 0.384 . . . . 71.14 110.612 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.57 -33.7 76.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.721 0.808 . . . . 63.33 111.406 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -85.24 -26.64 26.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.667 0.787 . . . . 52.21 110.488 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.97 -67.18 0.53 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.562 0.345 . . . . 72.15 110.569 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.433 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -95.14 -6.48 41.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.517 0.562 . . . . 74.0 112.517 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.8 2.38 45.19 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.216 0.322 . . . . 71.5 113.036 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.76 -58.36 0.32 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.094 0.558 . . . . 63.43 111.037 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.41 -46.8 46.57 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.198 0.599 . . . . 73.2 111.963 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 68.8 m -66.04 -42.46 51.67 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.546 0.738 . . . . 53.02 111.781 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HA ' HD22 ' B' ' 60' ' ' LEU . 89.9 Cg_exo -50.87 -43.72 45.46 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.628 2.218 . . . . 74.11 112.893 166.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.87 -25.04 67.0 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.183 0.593 . . . . 71.44 112.523 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mt -76.8 -50.55 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.407 0.683 . . . . 64.1 110.346 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.36 -15.95 57.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.562 0.745 . . . . 70.43 111.521 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.466 ' HE1' HD13 ' B' ' 128' ' ' LEU . 37.8 t80 -62.5 -53.33 58.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.609 -1.186 . . . . 75.3 112.799 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 71.4 Cg_exo -54.26 -37.76 88.31 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.187 1.925 . . . . 75.15 113.59 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.518 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 80.0 m-85 -68.33 -51.38 45.22 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.737 0.815 . . . . 72.02 110.947 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.72 81.23 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.959 0.904 . . . . 61.02 111.33 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -64.95 -52.71 54.82 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.457 1.503 . . . . 73.21 110.296 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -34.84 78.4 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.903 0.752 . . . . 55.12 109.776 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.523 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.8 t -68.66 -43.29 76.53 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.904 0.482 . . . . 75.15 111.363 -177.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.85 -43.78 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 123.445 0.698 . . . . 75.14 110.338 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.723 HG23 ' HB2' ' B' ' 125' ' ' GLN . 44.5 m -64.02 -27.7 69.29 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.203 -0.908 . . . . 74.35 111.052 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.8 t -73.59 -45.01 55.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.458 0.703 . . . . 71.31 110.122 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -72.5 -37.78 68.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.991 0.517 . . . . 72.33 112.025 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.59 -31.07 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.002 0.43 . . . . 73.43 110.46 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.461 ' OG ' HG21 ' C' ' 115' ' ' THR . 21.5 t -70.98 -30.54 66.84 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.925 0.89 . . . . 72.01 111.611 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.571 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.7 mtt-85 -74.03 -31.16 62.78 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.213 -0.903 . . . . 75.11 109.683 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.4 0.7 68.09 Favored Glycine 0 C--N 1.362 2.027 0 O-C-N 123.911 0.757 . . . . 53.34 112.203 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.563 HG22 HH22 ' C' ' 111' ' ' ARG . 29.3 p 65.5 23.62 11.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.93 2.092 . . . . 75.44 113.244 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.59 150.85 39.53 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 122.893 0.477 . . . . 74.55 110.079 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_exo -42.0 137.76 3.07 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.381 3.387 . . . . 72.14 113.226 173.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.723 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.0 pt20 -66.57 157.33 32.6 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.267 1.21 . . . . 75.51 114.267 -174.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 2.1 tt -110.77 95.86 5.82 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.521 -1.659 . . . . 73.01 106.521 165.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.407 HD22 ' HG3' ' B' ' 125' ' ' GLN . 3.5 p30 -88.33 92.6 9.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.923 -1.51 . . . . 72.14 106.923 173.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.65 HD21 HD22 ' B' ' 42' ' ' LEU . 1.2 tt -63.44 133.91 54.76 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.785 -1.098 . . . . 72.42 110.892 -165.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.99 146.6 95.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.155 0.982 . . . . 74.04 111.051 178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.77 116.16 3.11 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.682 2.254 . . . . 72.24 111.516 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 12.7 t -90.76 118.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.226 -0.657 . . . . 73.03 109.226 -179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -96.74 103.67 15.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.578 0.751 . . . . 71.5 109.823 -178.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 . . . . . 0 N--CA 1.48 1.043 0 C-N-CA 123.625 0.77 . . . . 73.11 110.707 177.057 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.524 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 57.9 ttp . . . . . 0 CA--C 1.555 1.136 0 CA-C-O 121.926 0.87 . . . . 64.01 112.704 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 67.6 m -119.11 97.17 5.55 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.894 -1.521 . . . . 70.23 106.894 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.92 121.68 45.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.338 0.655 . . . . 65.43 109.633 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -137.84 145.13 41.87 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.363 0.665 . . . . 71.5 109.748 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 127' ' ' ASN . 2.6 pp -82.42 142.68 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.615 -0.883 . . . . 72.13 108.615 171.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -110.09 -50.19 3.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.855 -0.424 . . . . 75.14 109.855 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 62.7 ttt180 -169.71 130.95 1.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.245 0.341 . . . . 72.51 110.464 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . 0.435 ' H ' HD21 ' A' ' 127' ' ' ASN . 65.6 mt -109.61 140.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.826 1.25 . . . . 73.2 107.92 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG12 ' C' ' 83' ' ' ILE . 12.8 p90 -171.89 154.5 3.56 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.018 0.826 . . . . 74.42 112.212 -175.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -80.44 106.44 12.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.661 -1.154 . . . . 55.03 107.974 170.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -68.73 -48.16 64.51 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.872 0.844 . . . . 55.44 109.205 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.8 t70 -134.65 141.81 46.68 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.237 -1.347 . . . . 74.02 109.244 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.3 mt -135.63 145.33 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.353 1.461 . . . . 75.24 107.219 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -155.59 152.01 28.24 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.212 0.529 . . . . 53.14 110.355 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.3 t80 -147.94 119.11 7.74 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.298 -1.371 . . . . 72.04 107.298 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 41.4 mt-10 -118.7 118.23 31.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.163 0.585 . . . . 72.24 109.628 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -134.54 86.0 35.71 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.627 0.771 . . . . 72.02 109.313 175.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -71.25 -28.71 18.17 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.954 2.436 . . . . 65.24 111.781 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.99 19.81 12.2 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.397 1.079 . . . . 64.42 110.465 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' C' ' 25' ' ' ALA . . . -59.11 -47.0 99.34 Favored Pre-proline 0 CA--C 1.567 1.596 0 C-N-CA 124.812 1.245 . . . . 62.33 113.953 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.94 -31.06 6.62 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.775 1.65 . . . . 65.52 111.875 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -66.68 -21.84 66.09 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.896 1.278 . . . . 72.32 112.744 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 8.3 p -50.92 -33.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 113.856 1.058 . . . . 73.32 113.856 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -58.35 -30.8 67.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.569 0.748 . . . . 71.42 112.624 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.25 28.06 9.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.232 1.013 . . . . 73.33 110.593 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 14.1 ttmm -104.15 147.27 27.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.242 0.617 . . . . 64.35 109.739 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.25 130.74 42.83 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.347 0.659 . . . . 74.11 109.836 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -84.7 62.81 7.59 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 123.731 0.644 . . . . 72.35 111.246 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -156.28 77.66 4.33 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.361 1.065 . . . . 74.24 108.348 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.485 ' HB2' ' HB1' ' C' ' 66' ' ' ALA . 72.5 Cg_endo -88.45 140.2 4.4 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 122.454 2.103 . . . . 73.41 111.608 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.03 115.52 24.47 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.249 -1.019 . . . . 73.32 108.249 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.85 106.22 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.86 -0.793 . . . . 74.52 108.86 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -92.11 108.31 19.84 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.18 122.85 32.21 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.281 -1.377 . . . . 75.41 107.281 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.77 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.0 m-20 -119.88 118.27 30.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.769 0.827 . . . . 74.34 109.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.45 126.34 53.39 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.908 -0.775 . . . . 75.52 108.908 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 19.8 t70 -128.53 135.68 49.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.719 1.208 . . . . 75.03 108.107 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.0 p -113.73 126.58 55.39 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.946 0.498 . . . . 44.12 110.358 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -126.58 145.66 50.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.951 0.9 . . . . 74.15 110.081 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.4 p -144.04 148.68 35.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.256 0.622 . . . . 53.11 109.458 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -145.38 140.28 27.56 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.564 -0.902 . . . . 63.15 108.564 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -94.29 115.82 28.12 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.044 -1.095 . . . . 73.21 108.044 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 HD12 ' C' ' 83' ' ' ILE . 35.1 mt -87.92 -40.83 13.62 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.745 0.818 . . . . 71.43 109.618 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.81 -175.77 5.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.085 1.354 . . . . 63.14 108.371 175.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -62.45 122.94 16.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.389 0.431 . . . . 55.55 109.943 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 68.93 -7.09 0.8 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.67 1.588 . . . . 61.41 113.604 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.22 107.05 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.837 -1.171 . . . . 73.35 107.837 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' C' ' 86' ' ' ILE . 72.9 m-85 -118.18 122.87 44.12 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.927 -1.138 . . . . 74.11 107.927 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.22 120.77 26.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.158 0.983 . . . . 72.32 109.141 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.2 t -97.05 116.07 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 72.21 108.375 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 59.6 t -117.82 134.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.643 0.777 . . . . 63.34 109.132 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.91 111.02 19.06 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.2 ttm180 -79.96 105.83 11.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.041 -1.466 . . . . 62.41 107.041 167.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.25 114.07 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.09 -1.078 . . . . 75.13 108.09 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.77 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 64.2 m -114.71 137.73 51.57 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.715 0.806 . . . . 72.43 108.882 -174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.48 HG21 HG21 ' C' ' 114' ' ' ILE . 61.0 t -128.23 112.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.667 -1.234 . . . . 62.25 107.667 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -106.24 139.89 40.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.613 -0.884 . . . . 72.45 108.613 169.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' C' ' 38' ' ' PRO . . . -121.34 112.89 19.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.881 -1.526 . . . . 74.32 106.881 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.0 m -148.12 137.44 22.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.116 0.566 . . . . 72.05 110.354 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.5 58.79 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.391 1.076 . . . . 65.41 109.347 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 -117.78 5.3 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.808 -1.087 . . . . 73.2 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.53 -30.25 18.36 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.925 -0.769 . . . . 70.15 108.925 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -63.61 100.05 0.25 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 124.236 0.96 . . . . 63.24 109.476 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -85.56 134.96 34.0 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.053 0.541 . . . . 73.41 109.856 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.635 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -80.83 -61.05 2.08 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.995 0.918 . . . . 42.13 109.173 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -167.59 178.0 5.6 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.952 0.782 . . . . 74.31 110.934 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -138.49 144.85 40.2 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.548 -1.279 . . . . 75.01 107.548 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.465 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.0 t -148.98 142.92 25.78 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.792 -1.188 . . . . 74.2 107.792 174.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.64 134.54 11.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.896 0.316 . . . . 60.44 110.722 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -138.48 116.08 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.458 1.103 . . . . 43.55 110.027 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.505 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 2.2 mp0 -89.99 88.4 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.179 0.992 . . . . 71.34 108.426 174.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.39 103.41 9.29 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.061 -0.972 . . . . 62.41 110.081 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.54 153.11 20.86 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.784 -0.644 . . . . 63.21 111.763 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.08 117.37 0.82 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 110.225 -1.15 . . . . 54.41 110.225 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.577 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -81.2 122.31 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.11 -0.7 . . . . 54.23 109.11 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' C' ' 86' ' ' ILE . 60.3 m-85 -132.07 152.82 50.98 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.534 -0.914 . . . . 64.53 108.534 176.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -110.27 113.15 25.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.542 -0.91 . . . . 50.42 108.542 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' C' ' 84' ' ' PHE . 2.9 mp -115.75 103.15 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.204 -1.406 . . . . 45.03 107.204 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.52 169.83 10.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.339 0.656 . . . . 72.45 110.903 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.06 -50.69 2.8 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.913 -0.585 . . . . 43.21 112.484 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 170.32 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.002 0.521 . . . . 72.25 111.769 -171.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.22 -173.99 4.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.767 0.827 . . . . 71.3 109.823 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -138.63 39.12 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.738 -0.479 . . . . 53.4 113.627 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . 0.527 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 35.7 p -68.54 -22.3 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.915 0.886 . . . . 52.43 111.818 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.41 -50.07 61.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 74.42 110.041 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -66.83 -38.21 85.98 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.871 -0.604 . . . . 64.34 109.985 172.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -60.88 -27.69 68.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.874 0.87 . . . . 62.44 112.331 -175.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 37.1 t-80 -74.91 -47.88 27.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.007 -0.368 . . . . 63.11 110.007 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.524 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 18.7 t -70.73 -22.3 62.45 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 111.984 0.364 . . . . 71.2 111.984 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.24 -43.48 5.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.084 0.954 . . . . 74.01 109.521 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.66 -5.36 64.85 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.56 -0.746 . . . . 73.24 114.139 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -133.87 -54.7 0.87 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.192 0.496 . . . . 54.31 111.361 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.422 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 33.4 t80 -67.13 -55.92 12.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.156 0.983 . . . . 71.35 112.079 -172.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.83 -45.49 87.59 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 113.044 0.757 . . . . 72.31 113.044 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -56.61 -39.89 88.24 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.715 2.277 . . . . 70.11 113.72 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.69 -28.7 69.26 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.937 0.895 . . . . 64.34 110.982 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.505 HD12 ' NH1' ' A' ' 111' ' ' ARG . 24.0 mm -72.79 -44.87 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.449 0.7 . . . . 72.21 110.592 173.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.08 -15.01 54.96 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.635 -0.711 . . . . 53.31 112.134 -173.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 78.1 t80 -57.11 -50.57 87.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 124.837 1.255 . . . . 71.52 113.139 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 34.4 Cg_exo -62.85 -32.79 77.2 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 122.129 1.886 . . . . 72.42 113.428 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.34 -44.88 86.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.688 0.795 . . . . 73.44 111.626 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.64 95.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.001 -0.545 . . . . 73.43 110.117 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.563 HH22 HG22 ' B' ' 122' ' ' THR . 48.2 ttt180 -56.44 -55.1 37.91 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.224 0.952 . . . . 72.2 111.255 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.41 -30.7 71.54 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.294 0.638 . . . . 71.4 110.69 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.74 -39.82 63.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.812 0.445 . . . . 55.33 111.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.48 HG21 HG21 ' C' ' 64' ' ' VAL . 66.5 mt -62.62 -47.0 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.958 0.903 . . . . 65.03 109.87 172.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . 0.461 HG21 ' OG ' ' B' ' 119' ' ' SER . 86.8 m -67.62 -29.33 68.63 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 114.088 -1.414 . . . . 74.44 110.846 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -68.33 -46.26 70.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.384 0.674 . . . . 61.13 109.592 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.46 -42.71 95.79 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.302 1.041 . . . . 73.21 113.248 -176.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 22.8 m -66.65 -32.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.576 0.227 . . . . 64.32 110.438 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.53 -34.42 77.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.111 0.964 . . . . 74.11 111.473 174.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.4 mtt-85 -72.77 -33.25 66.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.743 0.817 . . . . 73.45 110.498 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.26 64.46 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 123.661 0.601 . . . . 45.13 112.465 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.409 ' OG1' ' HD3' ' D' ' 15' ' ' ARG . 69.3 p 58.04 31.36 20.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.152 1.781 . . . . 44.52 112.943 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.42 148.41 36.27 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.539 1.135 . . . . 65.42 108.771 174.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 77.6 Cg_exo -51.46 138.58 47.5 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.416 2.744 . . . . 75.34 112.821 176.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.41 ' HB3' HG23 ' C' ' 115' ' ' THR . 95.9 mt-30 -63.36 149.3 46.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 113.865 1.061 . . . . 75.33 113.865 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.7 98.24 6.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 106.863 -1.532 . . . . 75.04 106.863 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -92.38 130.44 38.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.313 0.645 . . . . 72.25 109.603 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.05 136.64 37.23 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.594 0.758 . . . . 54.11 110.495 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.02 157.8 73.24 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.263 1.025 . . . . 61.15 109.963 177.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.76 98.9 0.31 Allowed 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 122.358 2.038 . . . . 53.23 113.075 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 56.0 t -99.57 109.28 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.482 -1.303 . . . . 74.13 107.482 170.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -110.45 101.35 10.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.221 -1.029 . . . . 44.11 108.221 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 64.0 m-85 -69.72 -30.09 67.63 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.454 -0.794 . . . . 72.41 110.923 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 . . . . . 0 N--CA 1.477 0.885 0 C-N-CA 123.671 0.788 . . . . 74.41 110.7 177.763 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m . . . . . 0 C--O 1.242 0.686 0 N-CA-C 108.436 -0.95 . . . . 72.14 108.436 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.587 ' HZ ' ' HG ' ' D' ' 102' ' ' CYS . 41.3 t80 -149.76 94.95 2.25 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.947 -1.131 . . . . 75.43 107.947 172.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -117.94 125.87 51.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.314 0.645 . . . . 65.22 109.421 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.37 124.89 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.713 -0.847 . . . . 51.31 108.713 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 56.2 mt-30 -87.42 -34.96 18.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.287 -0.634 . . . . 43.11 109.287 175.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.409 ' HD3' ' OG1' ' C' ' 122' ' ' THR . 17.7 ttm180 -175.64 144.37 0.65 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.102 -0.953 . . . . 74.42 109.357 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.417 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -131.11 130.13 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 106.455 -1.683 . . . . 74.14 106.455 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 27.5 p90 -164.52 173.42 12.07 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.834 0.826 . . . . 72.15 111.249 -165.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.26 121.62 41.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.694 -1.139 . . . . 34.44 108.896 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.2 mtpt -85.46 -39.86 17.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.3 0.571 . . . . 61.41 109.732 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 19.9 t70 -149.78 126.76 11.19 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 114.67 -1.15 . . . . 70.04 108.984 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.574 HG21 ' HE2' ' C' ' 117' ' ' MET . 70.0 mt -118.87 147.1 22.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.429 -0.952 . . . . 64.33 108.429 175.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -143.77 136.01 26.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.21 1.004 . . . . 72.41 109.097 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.3 t80 -140.28 117.63 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.126 -1.805 . . . . 74.54 106.126 168.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -123.71 122.35 37.87 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.269 0.628 . . . . 74.44 109.811 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.38 81.26 3.9 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 107.181 -1.415 . . . . 74.13 107.181 168.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.2 -33.47 18.64 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.734 2.289 . . . . 43.23 112.116 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.425 ' HB2' HG23 ' D' ' 31' ' ' VAL . 3.7 m-80 -111.66 29.76 7.57 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 108.768 -0.827 . . . . 63.0 108.768 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -61.52 2.57 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 114.989 1.477 . . . . 71.24 114.989 -166.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.1 Cg_endo -81.81 -13.03 10.73 Favored 'Trans proline' 0 C--N 1.378 2.089 0 CA-C-N 121.54 1.586 . . . . 74.51 113.329 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.44 ' HA ' HE21 ' D' ' 33' ' ' GLN . 17.7 t-160 -69.35 -41.38 76.68 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.859 0.864 . . . . 72.42 109.249 170.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' D' ' 35' ' ' ASP . 36.1 t -70.8 -35.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 CA-C-N 114.909 -1.041 . . . . 65.42 109.98 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -64.36 -6.79 7.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.969 1.1 . . . . 73.1 113.969 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' D' ' 30' ' ' HIS . 42.7 mt-30 -84.62 -35.46 22.67 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.027 0.531 . . . . 74.12 109.915 170.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -128.7 60.09 1.53 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.114 0.966 . . . . 61.1 110.352 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . 0.509 ' HB2' HG12 ' D' ' 31' ' ' VAL . 5.7 t0 -110.08 94.56 5.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.737 . . . . 74.31 109.463 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.531 ' H ' HD22 ' D' ' 68' ' ' LEU . 10.8 m95 -124.4 -159.5 0.88 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.927 -1.508 . . . . 73.2 106.927 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -63.35 112.32 6.79 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 118.374 0.534 . . . . 73.32 111.558 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.54 151.78 13.36 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.111 2.541 . . . . 61.23 112.313 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.89 113.68 20.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.996 -0.742 . . . . 73.43 108.996 166.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.459 HG12 ' HB2' ' D' ' 66' ' ' ALA . 3.6 m -99.28 106.37 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.074 0.95 . . . . 61.32 109.602 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.0 mmtt -88.31 128.76 35.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.349 1.06 . . . . 74.23 108.952 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.05 113.05 24.8 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.532 -0.544 . . . . 75.51 109.532 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -122.94 115.75 22.45 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.892 -0.781 . . . . 63.24 108.892 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.96 145.75 31.88 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.28 0.632 . . . . 72.31 109.973 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -137.15 131.31 32.39 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.364 1.066 . . . . 73.31 108.511 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 56.6 p -105.71 144.67 32.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.469 0.708 . . . . 73.14 110.195 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.22 155.03 35.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.498 0.719 . . . . 43.13 109.885 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -164.07 153.27 13.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.781 0.832 . . . . 33.45 109.883 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.9 p -160.47 151.77 19.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 70.32 110.101 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -81.8 118.57 22.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.078 0.551 . . . . 71.03 109.688 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -31.3 15.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.339 0.656 . . . . 74.35 110.488 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.02 -179.34 7.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.277 0.631 . . . . 61.05 110.707 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.58 116.92 5.57 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.702 -1.135 . . . . 74.51 110.117 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 11.7 m-20 60.47 24.66 14.27 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.258 0.974 . . . . 65.41 111.539 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.48 116.54 44.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.053 -1.092 . . . . 75.45 108.053 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.544 ' HB2' HD12 ' D' ' 86' ' ' ILE . 96.8 m-85 -129.82 129.03 43.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.335 1.054 . . . . 74.32 108.738 -174.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -90.32 139.1 30.99 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.989 0.915 . . . . 70.52 109.744 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.45 117.28 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 107.354 -1.35 . . . . 64.11 107.354 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.7 t -100.18 128.82 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.279 -1.008 . . . . 64.32 108.279 172.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 107.23 12.55 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.769 -1.197 . . . . 70.34 107.769 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 16.1 ttm-85 -87.17 105.71 17.38 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.218 -0.901 . . . . 75.21 109.566 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.22 120.47 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.685 -0.857 . . . . 73.44 108.685 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.3 m -125.84 135.85 52.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.705 0.802 . . . . 74.44 109.137 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.587 HG11 HD11 ' D' ' 126' ' ' LEU . 44.0 t -129.95 117.95 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.436 1.094 . . . . 55.31 109.68 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 57.0 m -105.57 100.6 10.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.135 0.974 . . . . 54.21 110.093 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -96.71 125.15 40.97 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.234 -0.291 . . . . 41.34 110.773 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.5 m -138.94 123.32 18.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.841 0.856 . . . . 53.24 109.611 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.6 OUTLIER -103.07 128.09 50.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.354 0.662 . . . . 61.13 109.852 177.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.24 -111.73 3.95 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.95 -0.86 . . . . 71.05 110.95 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.81 5.68 11.49 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.56 0.744 . . . . 73.42 110.877 175.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.04 140.28 50.3 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.1 0.56 . . . . 61.55 110.449 -172.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.8 m -71.98 117.38 13.52 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.607 0.763 . . . . 73.14 111.115 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.601 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -68.45 -65.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.279 0.987 . . . . 70.44 109.914 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -154.51 156.64 37.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.408 -1.269 . . . . 75.52 110.406 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.84 145.93 47.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.747 1.219 . . . . 72.15 107.714 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.62 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.6 t -150.75 142.11 23.35 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.622 -0.51 . . . . 62.35 109.622 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.04 138.31 14.75 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.988 -0.745 . . . . 74.4 108.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.64 115.57 8.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.331 -0.989 . . . . 74.2 108.331 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 66.4 mt-30 -88.97 84.49 6.62 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.099 -1.074 . . . . 70.43 108.099 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.52 93.45 5.43 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.208 -0.906 . . . . 70.51 109.031 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.69 142.29 16.55 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.802 -0.919 . . . . 65.13 110.802 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.99 128.59 3.48 Favored Glycine 0 CA--C 1.499 -0.919 0 N-CA-C 110.327 -1.109 . . . . 62.1 110.327 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.93 132.3 35.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.701 0.801 . . . . 61.52 109.061 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -134.01 133.43 41.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.88 0.472 . . . . 73.33 110.157 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -79.11 98.88 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.486 0.714 . . . . 64.34 109.27 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' D' ' 56' ' ' TYR . 48.2 mt -109.08 106.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.907 0.883 . . . . 70.03 109.506 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -144.07 148.54 35.31 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.048 0.939 . . . . 33.32 110.092 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.48 -20.82 44.28 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.842 -0.421 . . . . 40.2 113.438 177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.493 ' HB ' ' HG3' ' D' ' 94' ' ' MET . 0.4 OUTLIER -106.39 139.76 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.675 -1.231 . . . . 62.11 107.675 179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.77 157.85 41.72 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.15 0.58 . . . . 72.52 111.425 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -134.96 51.81 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.597 1.186 . . . . 63.13 115.782 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -63.82 -29.17 70.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.235 1.014 . . . . 74.25 111.841 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -40.5 77.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.624 0.77 . . . . 33.11 109.216 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.493 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 9.9 ttp -75.92 -41.99 50.21 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.813 -0.631 . . . . 73.44 110.773 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.21 69.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.884 0.874 . . . . 63.55 111.2 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -66.23 -46.63 76.52 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.143 -0.48 . . . . 64.02 109.996 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.62 -36.61 78.88 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.017 0.527 . . . . 63.33 111.276 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.569 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.1 tt -77.45 -30.75 53.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.394 0.678 . . . . 70.35 110.02 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.06 -16.44 55.96 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.127 -0.488 . . . . 72.12 113.663 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.09 -64.32 1.32 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.398 0.599 . . . . 72.22 111.289 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -66.03 -47.27 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.151 0.58 . . . . 63.45 111.414 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.587 ' HG ' ' HZ ' ' D' ' 11' ' ' PHE . 58.0 m -61.43 -48.47 90.72 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.348 -0.834 . . . . 65.44 112.731 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.2 Cg_exo -54.9 -39.41 90.45 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.76 2.306 . . . . 73.1 113.91 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -72.47 -14.04 61.58 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.298 0.639 . . . . 62.34 112.541 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -81.09 -40.95 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 121.597 0.713 . . . . 73.53 109.864 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.414 HD21 ' HA3' ' D' ' 82' ' ' GLY . 71.9 mt -78.46 -31.75 48.08 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.909 -1.041 . . . . 75.43 111.802 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -63.72 -42.1 69.39 Favored Pre-proline 0 CA--C 1.56 1.361 0 N-CA-C 114.146 1.165 . . . . 75.33 114.146 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.45 -43.67 55.57 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.152 1.901 . . . . 70.01 113.132 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -74.98 -31.71 61.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.662 0.785 . . . . 71.34 111.891 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.62 -54.53 34.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.068 0.547 . . . . 51.14 109.797 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -56.73 -46.57 81.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 114.091 -1.413 . . . . 62.44 110.899 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.63 -44.49 90.36 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.104 0.878 . . . . 72.33 111.214 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . 0.43 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.5 t -58.61 -41.36 85.69 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.533 0.52 . . . . 74.05 110.947 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.62 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -62.32 -53.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.939 0.896 . . . . 73.23 110.369 174.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -53.84 -42.95 69.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.725 1.21 . . . . 71.02 111.426 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -66.97 -44.65 79.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.754 -1.112 . . . . 64.42 110.654 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -66.32 -33.76 76.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.863 0.465 . . . . 73.35 111.656 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.3 t -67.78 -43.3 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.545 -0.752 . . . . 73.31 109.919 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.35 -28.9 64.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.751 0.42 . . . . 73.44 111.699 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -75.04 -32.06 61.46 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.924 0.89 . . . . 75.22 110.085 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.14 5.66 75.48 Favored Glycine 0 C--N 1.356 1.676 0 CA-C-N 115.586 -0.734 . . . . 62.43 111.853 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 65.54 14.15 9.31 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.488 2.315 . . . . 43.34 114.257 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -84.89 158.28 59.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.207 1.003 . . . . 74.1 108.867 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -65.11 136.74 49.26 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.871 2.381 . . . . 72.2 112.175 -177.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -47.19 129.92 12.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.488 1.115 . . . . 74.05 112.135 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.587 HD11 HG11 ' D' ' 64' ' ' VAL . 5.1 tt -107.22 93.93 4.82 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.234 -1.024 . . . . 33.22 108.234 -170.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -105.09 100.47 10.07 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.9 -1.148 . . . . 73.22 107.9 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.413 HD12 ' H ' ' D' ' 129' ' ' ALA . 20.5 tp -75.86 141.46 42.4 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.004 0.522 . . . . 64.21 110.814 177.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.413 ' H ' HD12 ' D' ' 128' ' ' LEU . . . -56.24 132.84 75.5 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.447 1.099 . . . . 73.24 111.326 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.0 116.65 4.8 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.448 2.099 . . . . 75.32 110.363 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.48 138.44 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.477 0.711 . . . . 63.34 109.577 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -79.97 103.55 9.94 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.602 0.761 . . . . 72.24 110.02 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.478 0.972 0 C-N-CA 123.33 0.652 . . . . 74.23 111.406 177.693 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.9 m . . . . . 0 C--O 1.233 0.226 0 N-CA-C 109.104 -0.702 . . . . 73.34 109.104 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.466 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.4 t80 -137.2 122.84 19.79 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.623 -1.251 . . . . 72.42 107.623 166.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -146.74 129.61 16.27 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.161 -0.681 . . . . 60.55 109.161 173.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.661 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.7 mt -86.24 119.85 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 109.437 -0.579 . . . . 71.11 109.437 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.5 -40.38 13.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.062 0.945 . . . . 74.51 109.281 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -166.42 141.7 4.51 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.533 -166.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER -131.87 126.31 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.032 -1.47 . . . . 73.41 107.032 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.6 p90 -161.08 152.55 19.16 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.512 0.672 . . . . 70.25 111.491 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -76.57 107.87 9.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.614 -1.176 . . . . 71.52 108.161 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.5 mtpt -67.26 -33.15 74.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.198 0.523 . . . . 63.33 109.603 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.4 t70 -153.12 144.16 22.99 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.193 -1.367 . . . . 74.22 109.682 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -133.06 143.64 38.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.941 1.296 . . . . 53.42 107.863 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 44.0 t -147.21 126.89 13.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.855 0.862 . . . . 54.13 109.171 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 87.2 t80 -127.93 126.68 41.95 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.892 -1.892 . . . . 73.54 105.892 168.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -133.95 116.6 15.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.016 -0.735 . . . . 71.42 109.016 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -127.55 74.45 77.96 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.573 -1.269 . . . . 54.52 107.573 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.13 -43.63 2.25 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.553 2.169 . . . . 74.21 111.127 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -89.4 12.15 17.14 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 118.057 -0.973 . . . . 75.23 111.414 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.76 -56.26 9.0 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.136 -0.935 . . . . 62.05 112.372 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 35.3 Cg_exo -58.75 -22.97 64.15 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.579 2.186 . . . . 74.21 113.888 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 -31.58 12.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.746 0.818 . . . . 75.14 110.503 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.704 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.58 -17.02 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 120.895 0.379 . . . . 72.22 110.165 -170.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.437 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 21.9 m-85 -73.86 -30.4 62.63 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.61 0.764 . . . . 55.24 111.807 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -85.37 -12.86 51.15 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.485 0.314 . . . . 74.54 111.364 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 31.4 mmtp -79.16 152.24 30.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.311 0.644 . . . . 73.13 110.872 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.05 140.18 58.81 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.22 0.95 . . . . 63.12 109.623 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.437 ' HH2' ' HA ' ' A' ' 32' ' ' PHE . 32.2 m95 -74.28 83.47 1.89 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.689 0.796 . . . . 71.35 110.912 -173.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -134.56 71.23 71.45 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.575 1.15 . . . . 71.45 109.609 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.32 127.76 5.3 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.009 1.806 . . . . 75.43 112.174 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.9 88.82 5.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 106.423 -1.695 . . . . 64.12 106.423 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -82.22 114.72 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.761 -1.109 . . . . 73.11 111.11 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 88.3 mttt -80.18 152.86 28.95 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.454 1.102 . . . . 73.41 110.84 167.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.1 tt -122.72 109.61 14.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.539 -2.022 . . . . 50.1 105.539 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.688 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -117.77 107.73 14.51 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.793 -0.817 . . . . 64.31 108.793 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -99.06 150.45 21.99 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.321 -0.622 . . . . 74.01 109.321 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 30.1 t70 -145.5 136.6 24.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.678 0.791 . . . . 63.3 109.39 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -121.76 126.76 49.61 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.684 0.794 . . . . 54.11 110.942 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.3 113.56 4.57 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.366 0.667 . . . . 64.41 110.193 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.9 p -98.77 162.3 13.18 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.683 -0.488 . . . . 71.24 109.683 173.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -152.94 158.07 41.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.321 1.048 . . . . 71.4 109.196 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -114.07 126.3 54.96 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.944 -1.132 . . . . 64.42 107.944 166.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -93.5 -41.53 9.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.011 0.525 . . . . 75.53 110.25 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -152.25 178.75 9.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.866 0.866 . . . . 74.42 109.702 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.85 123.13 18.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.991 -0.744 . . . . 73.14 108.991 171.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 73.02 -7.23 1.53 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.796 1.638 . . . . 64.3 112.237 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 44.9 t -106.7 111.45 35.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.286 -1.005 . . . . 64.24 108.286 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -123.38 161.06 25.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.274 -0.639 . . . . 65.43 109.274 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -131.56 138.99 49.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.859 -1.064 . . . . 74.54 108.784 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.471 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.9 t -126.22 117.02 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.849 -1.538 . . . . 55.21 106.849 169.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 t -101.23 130.45 50.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.986 -0.746 . . . . 72.43 108.986 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.617 HD23 HD12 ' A' ' 106' ' ' LEU . 3.8 mm? -117.57 109.78 17.12 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.212 -1.032 . . . . 75.12 108.212 170.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.637 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 13.2 ttp180 -85.57 112.64 21.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.108 -0.701 . . . . 74.31 109.108 172.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.0 t -94.2 128.62 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 107.359 -1.348 . . . . 74.44 107.359 170.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.688 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 47.3 m -127.05 126.5 43.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.213 -1.032 . . . . 74.3 108.213 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.826 HG11 HD21 ' A' ' 126' ' ' LEU . 44.9 t -118.75 109.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.46 -0.941 . . . . 73.3 108.46 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.3 m -103.71 133.28 48.98 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.292 -0.632 . . . . 51.14 109.292 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.37 31.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.439 -1.319 . . . . 72.22 107.439 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 55.6 m -135.93 127.91 29.56 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.819 0.447 . . . . 71.23 110.479 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -88.83 72.28 8.56 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.917 -1.142 . . . . 74.3 107.917 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.24 -84.46 0.83 Allowed Glycine 0 C--N 1.35 1.333 0 CA-C-N 114.934 -1.03 . . . . 45.25 110.713 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -110.88 -29.22 8.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 74.01 109.86 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 3.3 tp10 -82.89 91.48 7.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.721 0.809 . . . . 74.14 110.322 -173.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 86.5 m -64.71 130.89 45.26 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.284 0.564 . . . . 54.32 111.495 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.704 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.29 -63.36 1.42 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.91 -1.041 . . . . 73.42 110.011 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -162.04 170.94 18.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.467 -1.242 . . . . 73.04 110.97 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.4 tp -142.62 113.77 7.69 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.551 -1.204 . . . . 72.01 108.284 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 118' ' ' VAL . 76.4 m -113.42 100.87 8.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.387 0.675 . . . . 71.34 110.77 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 31.4 tt0 -119.16 118.65 31.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.285 1.034 . . . . 71.04 109.617 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.12 112.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.236 1.015 . . . . 72.23 109.224 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.637 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 49.7 mt-30 -84.24 84.47 7.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.686 -0.857 . . . . 71.41 108.686 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.85 97.89 7.59 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.775 -1.102 . . . . 71.21 108.592 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.22 146.64 18.34 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.723 -0.671 . . . . 71.14 111.524 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.23 137.87 9.11 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 110.716 -0.954 . . . . 61.11 110.716 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -93.02 123.72 45.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.806 -0.813 . . . . 61.22 108.806 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.8 m-85 -132.56 118.64 19.48 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.71 -1.219 . . . . 74.3 107.71 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.3 p -81.68 98.52 8.43 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.327 -0.62 . . . . 71.04 109.327 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' THR . 2.8 pp -113.24 160.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.417 0.687 . . . . 74.15 111.258 -175.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.37 174.58 2.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.001 1.32 . . . . 63.33 109.495 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.08 -6.48 49.36 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 115.514 0.966 . . . . 75.11 115.514 169.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -126.18 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.216 -1.031 . . . . 65.11 108.216 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -133.16 173.74 11.12 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.692 0.797 . . . . 75.34 109.461 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.34 -139.45 47.4 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.702 0.626 . . . . 43.32 113.737 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 15.1 t -72.9 -18.63 61.39 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.595 0.758 . . . . 54.31 111.208 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.47 -36.63 76.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.599 0.76 . . . . 64.52 110.323 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.78 -42.19 41.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.943 0.497 . . . . 74.24 109.777 173.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.09 -16.88 64.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.431 -0.804 . . . . 73.11 112.682 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.425 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 t-80 -68.9 -28.72 66.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.953 0.501 . . . . 73.5 110.15 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.2 t -78.01 -39.2 42.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.064 0.546 . . . . 60.34 110.008 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.66 -51.77 56.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.354 0.662 . . . . 73.11 112.081 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.56 4.91 47.46 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.424 -0.807 . . . . 74.31 114.33 -164.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.91 -63.8 0.35 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 117.281 0.541 . . . . 42.4 112.388 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 82.0 t80 -71.05 -57.1 4.86 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.901 0.704 . . . . 75.35 112.901 -169.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 88.5 m -67.4 -32.28 4.4 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 118.189 -0.91 . . . . 73.11 112.882 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.28 -50.12 12.79 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.413 2.075 . . . . 60.3 112.876 159.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -61.35 -25.01 66.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.656 0.782 . . . . 73.02 111.957 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.473 HG21 HD11 ' A' ' 13' ' ' ILE . 49.1 mm -76.68 -48.92 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 72.23 110.111 174.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 60' ' ' LEU . 95.8 mt -81.18 -23.01 38.48 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.446 0.698 . . . . 73.43 112.214 -170.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.4 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 55.3 t80 -65.34 -42.57 59.47 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.216 1.006 . . . . 73.24 112.957 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 -32.11 85.47 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.83 1.687 . . . . 63.11 113.077 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -74.22 -39.65 62.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.209 0.603 . . . . 74.41 111.618 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.47 78.32 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.419 -0.586 . . . . 72.13 109.419 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -54.37 -46.27 72.98 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.777 1.298 . . . . 71.11 110.728 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.54 -48.47 77.36 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.295 0.997 . . . . 72.43 110.552 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.54 -45.25 85.29 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.772 0.67 . . . . 40.33 110.697 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 118' ' ' VAL . 91.8 mt -60.29 -52.58 59.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 114.855 -1.066 . . . . 71.4 110.05 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 125' ' ' GLN . 78.4 m -53.19 -46.22 68.91 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.919 0.888 . . . . 74.21 111.515 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -64.88 -47.51 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.179 -0.919 . . . . 71.45 110.034 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.42 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 13.4 mtp -54.58 -43.7 72.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.09 0.956 . . . . 72.1 111.449 175.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 114' ' ' ILE . 67.5 t -65.9 -47.16 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.862 1.265 . . . . 72.25 111.312 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.5 p -66.69 -32.66 74.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.095 0.558 . . . . 75.44 111.264 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.17 -33.08 74.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.753 0.821 . . . . 62.24 110.49 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.58 20.43 18.61 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.08 -0.845 . . . . 72.31 114.28 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 48.39 47.35 20.04 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.366 1.466 . . . . 73.3 112.352 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -117.05 149.84 44.95 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 107.777 -1.194 . . . . 65.53 107.777 169.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -65.48 153.68 77.1 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.189 1.926 . . . . 72.41 110.392 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.8 tt0 -51.1 126.9 17.68 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.332 1.02 . . . . 75.14 111.995 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.826 HD21 HG11 ' A' ' 64' ' ' VAL . 33.3 tp -110.19 94.66 5.13 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.205 -0.907 . . . . 75.03 109.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -111.91 104.32 12.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.405 -1.27 . . . . 72.5 107.968 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.4 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 3.3 tt -63.74 128.04 34.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.943 -1.132 . . . . 64.23 107.943 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.26 144.13 8.7 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 124.208 1.003 . . . . 51.23 111.709 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 40.9 Cg_exo -58.52 110.0 0.59 Allowed 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.644 2.229 . . . . 73.51 112.064 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 t -101.07 112.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.737 -0.838 . . . . 73.32 108.737 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.98 85.21 5.61 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.662 0.785 . . . . 64.52 109.537 174.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -59.48 -32.86 70.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.666 0.787 . . . . 73.3 111.366 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 124.125 0.97 . . . . 53.31 111.184 177.634 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.555 HG22 HE22 ' B' ' 12' ' ' GLN . 82.2 m . . . . . 0 C--O 1.238 0.451 0 N-CA-C 107.858 -1.164 . . . . 61.45 107.858 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -132.94 136.74 46.29 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.558 -0.534 . . . . 65.24 109.558 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.555 HE22 HG22 ' B' ' 10' ' ' THR . 0.2 OUTLIER -152.05 139.52 19.57 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.281 1.032 . . . . 74.55 108.954 171.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -83.42 144.55 9.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.738 -0.838 . . . . 74.1 108.738 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -103.63 -43.35 5.39 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.17 0.588 . . . . 62.35 110.194 173.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -166.99 134.88 2.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.866 -0.606 . . . . 54.43 109.673 -171.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.5 mt -118.52 133.78 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 106.831 -1.544 . . . . 73.24 106.831 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -164.64 147.13 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.65 0.593 . . . . 73.53 112.098 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.8 m -73.25 124.47 25.72 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.343 -0.844 . . . . 73.1 108.879 170.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -97.95 -32.93 11.41 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.923 0.489 . . . . 73.42 110.89 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -152.81 140.99 20.44 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.338 -0.392 . . . . 72.42 110.361 -171.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.3 mm -132.88 137.33 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.212 1.005 . . . . 74.43 109.292 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.4 m -133.69 112.04 11.08 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.986 1.315 . . . . 74.42 108.444 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.7 t80 -130.5 110.02 11.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.053 -1.462 . . . . 73.13 107.053 167.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.66 111.9 18.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.431 -0.952 . . . . 64.11 108.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -115.92 85.56 14.96 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.296 -1.002 . . . . 63.01 108.296 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.91 -22.9 35.45 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.515 2.144 . . . . 70.2 111.388 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.83 13.84 25.99 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.653 1.181 . . . . 61.14 110.656 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -45.21 -51.62 24.16 Favored Pre-proline 0 CA--C 1.57 1.732 0 N-CA-C 114.3 1.222 . . . . 73.22 114.3 -175.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.5 -46.37 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 CA-C-N 121.511 1.575 . . . . 73.54 112.965 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -77.66 3.34 14.15 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.814 1.042 . . . . 70.4 113.814 -171.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.576 HG23 HD11 ' B' ' 68' ' ' LEU . 14.7 p -73.62 -30.64 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 109.63 -0.507 . . . . 63.32 109.63 171.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.54 -31.27 61.99 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 125.145 1.378 . . . . 75.3 112.993 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.42 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.5 pt20 -63.76 -50.37 69.32 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.367 0.417 . . . . 73.5 110.886 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.487 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 54.1 pttt -116.48 60.31 0.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.943 0.897 . . . . 75.45 110.501 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -101.27 119.74 39.21 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.762 -0.586 . . . . 74.12 109.648 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.35 -167.93 0.14 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.071 1.482 . . . . 75.42 108.984 163.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.91 105.45 0.49 Allowed Pre-proline 0 CA--C 1.566 1.581 0 C-N-CA 124.421 1.089 . . . . 65.22 112.783 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.02 169.66 2.89 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.526 2.818 . . . . 53.52 113.066 -173.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.86 107.84 5.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 45.41 108.652 172.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 65' ' ' THR . 16.2 m -105.71 141.01 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.678 -0.692 . . . . 75.11 110.77 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -126.79 121.96 33.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.984 0.914 . . . . 45.43 109.06 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 tp -98.44 124.59 43.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.683 0.793 . . . . 61.11 108.984 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.742 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.7 m-20 -125.47 118.73 26.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.982 0.913 . . . . 72.2 108.626 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.2 126.44 46.48 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.405 -1.331 . . . . 75.55 107.405 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.83 139.4 46.23 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 74.24 109.216 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -117.74 113.74 22.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.279 0.632 . . . . 70.11 110.787 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.61 147.78 42.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.39 1.076 . . . . 52.14 108.23 172.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.5 p -145.95 174.33 11.36 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 118.064 0.393 . . . . 60.34 111.546 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.9 p -153.32 145.11 23.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.385 1.074 . . . . 54.14 109.248 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -97.28 104.2 16.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.502 -0.555 . . . . 71.14 109.502 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.64 -42.49 51.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.16 0.584 . . . . 74.1 110.943 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.12 -179.95 7.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.111 0.965 . . . . 51.3 109.306 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.23 123.41 21.59 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.514 -0.766 . . . . 61.44 109.31 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 74.33 -3.1 2.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.82 1.648 . . . . 70.35 112.838 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -106.34 114.1 44.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.498 -0.927 . . . . 73.01 108.498 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -116.29 139.87 49.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.793 -0.818 . . . . 63.13 108.793 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -111.87 99.92 8.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.418 -1.327 . . . . 72.11 107.418 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.41 127.87 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.908 0.883 . . . . 43.45 110.277 -174.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.6 t -111.97 112.37 40.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 124.912 1.285 . . . . 75.42 108.738 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 106.0 18.17 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.667 -0.864 . . . . 63.33 108.667 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -86.03 123.85 31.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.576 -0.738 . . . . 70.11 109.535 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.44 105.76 19.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.709 -1.219 . . . . 52.5 107.709 168.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.742 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 32.4 m -94.42 137.49 33.49 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.659 -0.867 . . . . 74.23 108.659 176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.94 130.14 61.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.429 -1.323 . . . . 71.14 107.429 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 97.1 m -120.04 144.93 47.29 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.528 -0.915 . . . . 75.1 108.528 173.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.61 134.11 40.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.806 -1.183 . . . . 53.23 107.806 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 61.2 p -147.36 133.91 19.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.297 0.639 . . . . 74.45 109.976 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.689 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -125.48 138.27 53.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.564 0.746 . . . . 74.23 110.016 177.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -127.69 9.03 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.213 -0.903 . . . . 72.13 111.444 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.98 11.35 29.89 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.129 0.972 . . . . 74.35 111.932 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.487 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 17.0 pt-20 -154.88 -179.49 8.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.585 0.354 . . . . 75.24 110.986 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -64.18 154.39 34.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 72.23 112.424 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.689 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -103.91 -60.35 1.59 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.774 -1.195 . . . . 73.01 107.774 166.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -166.34 164.39 17.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.346 -1.297 . . . . 72.55 109.161 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 29.4 mt -123.65 135.84 54.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.129 -1.434 . . . . 74.1 107.129 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 48.7 t -144.96 131.58 19.91 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.083 -0.71 . . . . 53.2 109.083 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.7 tt0 -156.22 143.65 19.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.615 -0.883 . . . . 64.53 108.615 -170.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.452 HG21 ' HB3' ' B' ' 113' ' ' CYS . 93.3 t -135.69 146.9 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.555 -0.905 . . . . 64.12 108.555 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -121.58 95.61 4.74 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.628 -1.249 . . . . 73.13 107.628 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.3 tp-100 -89.0 101.05 13.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.642 -0.873 . . . . 62.55 108.642 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.45 168.74 36.81 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.749 0.656 . . . . 64.45 111.874 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.54 127.74 1.48 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.574 -0.611 . . . . 71.14 111.574 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -84.46 128.86 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.053 -1.091 . . . . 71.03 108.053 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.64 163.51 29.59 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.835 1.254 . . . . 72.13 108.853 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -131.87 113.11 13.07 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.66 -0.867 . . . . 72.33 108.66 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.39 129.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.7 -0.852 . . . . 74.12 108.7 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.28 170.1 18.01 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.582 1.153 . . . . 63.43 108.857 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -70.8 3.02 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.803 -0.519 . . . . 52.53 111.803 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -87.55 152.22 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.166 0.586 . . . . 64.13 110.553 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 14.4 pt-20 -158.69 175.86 13.1 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.696 0.623 . . . . 74.02 111.822 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.69 -130.09 28.04 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.006 -0.997 . . . . 74.44 113.857 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.7 m -65.52 -32.9 74.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.158 0.983 . . . . 75.11 110.833 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -75.41 -31.09 60.29 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.922 -1.035 . . . . 75.12 109.933 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.506 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 26.3 ttt -70.13 -32.4 70.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.908 -0.405 . . . . 61.42 109.908 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . 0.413 ' HA ' HD11 ' B' ' 98' ' ' LEU . . . -58.33 -25.42 61.93 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.059 0.543 . . . . 61.33 112.133 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.51 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 55.5 t-80 -79.56 -26.49 41.35 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.481 0.713 . . . . 75.12 111.157 173.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -79.15 -65.66 0.97 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.755 0.422 . . . . 65.35 110.407 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.7 pp -63.53 -21.4 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.622 0.769 . . . . 73.45 112.776 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.49 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -107.06 3.62 35.53 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 114.431 0.532 . . . . 61.14 114.431 -172.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -151.32 -51.92 0.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.903 0.352 . . . . 73.2 111.725 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -68.65 -48.49 63.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.763 0.825 . . . . 74.3 110.646 -177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.468 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 56.1 m -68.89 -46.51 31.94 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.186 0.594 . . . . 65.14 111.466 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -55.38 -35.16 91.18 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 122.686 2.257 . . . . 54.21 114.003 168.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.64 -35.32 74.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.357 0.663 . . . . 73.31 110.881 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.6 -51.13 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.303 -0.862 . . . . 74.33 110.146 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.31 -23.94 54.33 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.564 0.746 . . . . 73.1 112.667 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.93 -50.71 79.84 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 117.567 -1.206 . . . . 65.33 113.125 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.77 -40.5 74.21 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.643 2.229 . . . . 71.51 113.911 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.5 m-85 -69.86 -45.58 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.411 0.684 . . . . 75.44 110.591 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.48 86.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.547 0.739 . . . . 65.31 110.859 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.647 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 32.1 ttt180 -63.28 -54.63 34.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.758 1.623 . . . . 65.23 110.994 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -36.98 81.66 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.226 0.954 . . . . 72.44 109.663 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -69.0 -38.95 79.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.756 -0.656 . . . . 72.02 111.951 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.41 HG23 ' SG ' ' B' ' 76' ' ' CYS . 58.3 mt -63.27 -51.94 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.129 0.572 . . . . 74.4 109.463 174.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.615 HG23 ' HB2' ' B' ' 125' ' ' GLN . 29.6 m -61.37 -28.25 69.1 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.323 -0.853 . . . . 74.11 111.498 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -69.47 -43.29 73.52 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.514 0.726 . . . . 65.33 110.22 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -73.27 -30.68 63.6 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.582 0.353 . . . . 74.24 111.129 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 114' ' ' ILE . 58.8 t -66.77 -39.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 64.23 109.704 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.4 t -62.99 -35.72 81.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.374 1.07 . . . . 73.5 111.294 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.43 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 82.3 mtt-85 -75.99 -31.04 58.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.831 0.852 . . . . 74.11 110.716 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -0.77 86.58 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 123.572 0.545 . . . . 54.13 112.469 171.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 48.9 p 62.57 32.68 16.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.512 1.925 . . . . 71.4 112.512 173.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' B' ' 31' ' ' VAL . 40.6 m-85 -101.71 151.94 38.0 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 115.095 -0.957 . . . . 74.31 110.479 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_exo -57.55 119.0 5.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.67 2.247 . . . . 75.22 110.635 172.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.615 ' HB2' HG23 ' B' ' 115' ' ' THR . 19.9 pt20 -60.42 152.26 26.0 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.231 1.012 . . . . 74.24 113.175 -168.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 pp -112.26 120.81 43.01 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.544 -1.28 . . . . 72.21 107.544 179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -93.33 104.37 16.53 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.469 -0.938 . . . . 72.44 108.469 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.647 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -58.25 118.41 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.67 -0.863 . . . . 63.55 108.67 175.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -80.03 144.89 59.95 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 109.837 -0.431 . . . . 71.0 109.837 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -64.12 110.36 1.33 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.954 2.436 . . . . 64.14 112.381 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.68 112.79 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.421 -1.326 . . . . 71.31 107.421 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.22 75.45 4.75 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.191 -1.04 . . . . 73.02 108.191 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 . . . . . 0 N--CA 1.486 1.352 0 C-N-CA 125.058 1.343 . . . . 74.54 111.581 -172.619 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.54 0.686 . . . . 75.13 112.129 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.3 m -125.68 107.91 11.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.883 -0.784 . . . . 53.23 108.883 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.421 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 61.1 t80 -123.18 133.84 54.21 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.079 0.952 . . . . 74.14 108.432 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.18 144.49 21.08 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.42 0.688 . . . . 73.31 110.036 166.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.543 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.9 pp -65.23 141.35 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.073 -0.967 . . . . 73.53 109.313 171.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.534 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.3 mm-40 -112.07 -50.62 2.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.681 -0.489 . . . . 73.43 109.681 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -168.24 123.7 0.99 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.175 -0.676 . . . . 71.41 109.175 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.28 145.61 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.262 -1.385 . . . . 72.21 107.262 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.401 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.0 p90 -176.88 168.49 2.49 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.842 0.83 . . . . 75.02 111.242 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -90.12 113.41 25.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.532 -1.213 . . . . 71.32 108.725 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.66 -38.61 89.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.354 0.662 . . . . 61.44 109.793 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.57 144.48 26.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.812 -1.086 . . . . 71.44 109.257 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.1 mt -134.83 137.89 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.006 -1.479 . . . . 62.24 107.006 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -149.5 150.73 32.77 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.31 0.644 . . . . 73.53 109.495 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -154.23 135.31 13.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.74 -1.207 . . . . 74.21 107.74 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.7 mt-10 -131.43 117.74 19.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.044 -0.724 . . . . 51.02 109.044 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.8 72.46 55.53 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.352 -0.981 . . . . 73.1 108.352 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.06 -15.68 25.83 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.576 2.184 . . . . 61.04 111.912 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . 0.457 ' O ' HG23 ' C' ' 31' ' ' VAL . 2.0 m-20 -105.18 18.4 22.39 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.356 1.062 . . . . 52.41 110.093 178.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.24 -48.82 54.67 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 114.356 1.243 . . . . 65.11 114.356 -171.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.428 ' HB3' HD13 ' D' ' 51' ' ' LEU . 13.5 Cg_exo -68.59 -38.35 11.05 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 121.818 1.679 . . . . 44.41 111.815 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -67.66 -22.68 65.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.406 1.482 . . . . 74.31 112.381 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.457 HG23 ' O ' ' C' ' 27' ' ' ASN . 78.2 t -65.91 -37.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.813 0.445 . . . . 61.1 111.952 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -69.65 -28.67 66.08 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 111.976 0.361 . . . . 72.2 111.976 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -87.8 12.92 11.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.208 0.603 . . . . 74.32 111.656 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.535 ' HD2' HD21 ' C' ' 68' ' ' LEU . 5.4 ttpm? -112.93 148.98 33.86 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.822 0.849 . . . . 65.44 110.915 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.97 130.24 39.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.147 0.979 . . . . 64.43 109.88 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -85.44 80.85 8.96 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.104 0.962 . . . . 75.12 111.721 -165.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . 0.488 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 1.0 OUTLIER -152.94 44.74 0.26 Allowed Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 114.0 1.111 . . . . 74.31 114.0 173.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' C' ' 68' ' ' LEU . 22.7 Cg_exo -67.0 149.0 82.75 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 122.253 1.968 . . . . 45.41 111.1 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.48 118.73 25.19 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 170.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.68 HG21 HD11 ' C' ' 126' ' ' LEU . 14.2 p -82.1 142.89 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.992 -1.004 . . . . 75.3 109.537 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -131.8 124.46 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.933 0.893 . . . . 50.43 108.934 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -88.77 129.98 35.45 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 105.764 -1.939 . . . . 75.52 105.764 164.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.8 t70 -130.01 108.43 10.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.933 -1.136 . . . . 70.42 107.933 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 43.5 tp -96.6 151.96 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.124 0.57 . . . . 44.51 110.265 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.9 t0 -131.15 154.44 48.35 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.908 0.883 . . . . 62.44 108.642 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.5 p -119.64 111.77 18.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.813 0.845 . . . . 61.55 109.586 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.81 146.5 43.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.966 0.906 . . . . 72.22 109.436 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -161.76 152.94 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.055 0.542 . . . . 75.22 110.505 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -149.52 146.03 27.17 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.196 0.598 . . . . 32.43 110.394 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -86.26 124.73 32.97 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.443 -0.576 . . . . 72.33 109.443 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.551 HD11 HD12 ' C' ' 83' ' ' ILE . 70.2 mt -96.53 -44.89 6.96 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.731 0.813 . . . . 74.44 109.78 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.38 -177.19 5.71 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.115 -0.948 . . . . 75.21 109.644 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.83 115.82 3.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.301 0.64 . . . . 64.14 109.886 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 64.48 0.96 1.19 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.205 1.402 . . . . 63.45 113.206 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 94.5 t -94.17 111.09 24.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.885 -1.154 . . . . 72.23 107.885 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -126.86 125.72 42.1 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.182 0.993 . . . . 71.43 109.112 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -84.65 122.62 29.33 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.318 -0.855 . . . . 73.12 109.193 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.13 124.59 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.993 -1.114 . . . . 52.11 107.993 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.64 131.16 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.963 0.905 . . . . 74.54 109.236 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.12 105.74 12.14 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.693 -1.225 . . . . 54.15 107.693 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.8 tmm_? -82.64 108.28 15.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.433 -1.321 . . . . 71.34 107.433 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.4 t -100.23 136.54 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.247 -1.02 . . . . 53.31 108.247 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 59.9 m -134.85 121.32 20.46 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.168 -0.679 . . . . 42.21 109.168 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.411 HG23 HD13 ' C' ' 114' ' ' ILE . 76.7 t -103.75 109.27 26.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.951 . . . . 61.52 108.434 174.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.451 HG23 HD23 ' C' ' 75' ' ' LEU . 6.2 m -99.28 150.21 22.34 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.2 -0.909 . . . . 64.32 109.792 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.97 110.09 8.32 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.419 0.688 . . . . 62.31 109.17 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.0 m -148.0 138.64 23.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.924 0.49 . . . . 61.45 110.32 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.617 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.7 OUTLIER -112.41 56.11 0.67 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.405 1.082 . . . . 74.12 108.764 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.44 -116.56 4.4 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.27 -1.332 . . . . 54.22 110.519 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -88.79 -29.03 20.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.195 0.598 . . . . 75.23 110.146 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -79.18 106.14 11.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.999 0.919 . . . . 75.52 110.056 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -78.74 126.01 30.14 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.715 -0.675 . . . . 72.22 109.778 171.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.32 -56.55 4.92 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.666 -1.152 . . . . 72.04 109.437 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -167.75 178.71 5.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.645 0.778 . . . . 72.11 110.691 173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -138.38 143.76 39.95 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.613 1.165 . . . . 75.41 107.956 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.2 t -140.2 137.51 34.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.612 -1.255 . . . . 73.21 107.612 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -152.88 134.55 14.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.667 0.387 . . . . 75.34 110.601 -173.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.05 120.76 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.684 1.194 . . . . 70.24 108.735 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 72.4 mt-30 -88.42 100.18 12.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.455 -1.313 . . . . 72.42 107.455 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -87.95 112.23 22.33 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.674 -0.491 . . . . 74.02 109.674 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.08 154.11 17.7 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.851 -0.5 . . . . 71.35 111.851 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.11 123.97 1.48 Allowed Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 110.69 -0.964 . . . . 52.33 110.69 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.551 HD12 HD11 ' C' ' 51' ' ' LEU . 9.4 mm -81.38 129.51 37.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 108.452 -0.944 . . . . 74.23 108.452 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.543 ' HE2' HG22 ' C' ' 13' ' ' ILE . 50.4 m-85 -138.02 151.73 48.17 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.399 -0.593 . . . . 62.24 109.399 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.9 p -110.36 117.08 32.66 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.364 -0.976 . . . . 71.53 108.364 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.99 116.71 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.157 0.983 . . . . 63.55 109.597 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.4 163.52 34.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.35 0.66 . . . . 54.3 111.439 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.77 -29.58 7.8 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.401 -0.818 . . . . 50.22 113.977 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.14 157.11 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.166 0.987 . . . . 70.22 111.013 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -149.91 159.67 44.19 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.134 0.974 . . . . 73.25 109.582 178.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.34 -144.58 17.98 Favored Glycine 0 C--N 1.348 1.246 0 C-N-CA 123.279 0.466 . . . . 71.05 112.458 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -64.5 -21.29 66.63 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.708 0.803 . . . . 71.52 111.677 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -65.8 -52.24 52.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.915 1.286 . . . . 71.2 109.747 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 3.5 ppp? -77.76 -21.6 51.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.612 -0.722 . . . . 71.43 110.515 178.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.67 70.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.87 0.868 . . . . 73.02 111.82 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 40.3 t-80 -69.85 -34.28 73.4 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.058 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -69.59 -43.05 73.58 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.695 0.398 . . . . 62.51 110.73 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.79 -55.09 5.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.969 0.907 . . . . 74.24 110.06 -174.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.03 11.46 69.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.519 -0.764 . . . . 75.42 114.639 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.577 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -148.23 -52.02 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.457 0.628 . . . . 21.34 111.84 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -76.27 -41.95 47.18 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.541 0.736 . . . . 74.53 111.203 -173.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.6 m -67.36 -47.71 48.01 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 118.517 -0.754 . . . . 64.03 111.478 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.6 Cg_exo -53.68 -35.8 79.3 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.756 2.304 . . . . 54.31 113.715 169.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.28 -40.23 81.37 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.672 0.789 . . . . 53.42 110.912 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.59 -46.25 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.632 0.773 . . . . 72.23 110.901 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.8 mt -82.46 -23.33 34.81 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.163 0.801 . . . . 62.12 113.163 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -57.06 -49.39 94.22 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.162 0.985 . . . . 73.35 112.842 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.21 -33.72 97.83 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.504 2.136 . . . . 71.2 113.982 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.457 ' HE2' HG21 ' A' ' 115' ' ' THR . 95.9 m-85 -70.66 -48.39 55.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.387 0.675 . . . . 64.14 111.285 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.13 89.95 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.472 0.482 . . . . 71.43 109.86 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.534 ' HA ' HD23 ' C' ' 128' ' ' LEU . 31.1 ttt-85 -52.64 -55.98 18.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.251 1.421 . . . . 72.22 111.78 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.11 -32.79 72.45 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.476 0.485 . . . . 71.21 110.546 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -69.39 -33.51 73.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.996 0.518 . . . . 74.14 111.257 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' C' ' 62' ' ' VAL . 90.1 mt -69.22 -52.29 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.73 0.812 . . . . 62.2 109.283 172.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.1 m -59.11 -33.79 71.25 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.272 1.029 . . . . 73.34 111.478 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.7 t -64.14 -48.72 74.95 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.614 0.766 . . . . 42.24 109.41 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.0 -38.24 90.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.392 1.077 . . . . 64.21 112.404 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.59 -42.37 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 O-C-N 123.559 0.537 . . . . 74.5 109.715 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -66.79 -32.99 74.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.034 0.934 . . . . 74.14 111.68 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.6 mtt-85 -72.12 -31.68 66.25 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.781 0.832 . . . . 73.41 110.76 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.03 8.48 70.12 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 119.521 -0.599 . . . . 71.23 112.715 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p 62.02 34.05 16.84 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.772 1.629 . . . . 65.2 112.408 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . 0.438 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 29.1 m-85 -104.84 163.05 17.98 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 124.803 1.241 . . . . 64.2 109.486 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 63.1 Cg_endo -68.51 162.57 40.24 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.015 2.477 . . . . 64.14 113.502 -173.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.513 HE21 ' HB3' ' B' ' 125' ' ' GLN . 64.9 mm-40 -60.85 128.05 34.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.116 -0.947 . . . . 75.21 112.721 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.68 HD11 HG21 ' C' ' 40' ' ' VAL . 6.3 tt -140.65 89.28 2.26 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.731 -1.211 . . . . 74.02 107.731 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -97.47 131.31 44.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.706 0.802 . . . . 74.25 109.128 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' C' ' 111' ' ' ARG . 3.5 mm? -70.88 135.59 48.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.743 0.817 . . . . 73.14 111.123 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.97 160.29 52.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 124.925 1.29 . . . . 73.32 112.156 -173.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.88 102.57 0.77 Allowed 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 123.304 2.669 . . . . 63.32 112.343 -175.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -99.4 110.24 26.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.303 -0.999 . . . . 74.24 108.303 171.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -81.39 88.34 6.12 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.422 0.689 . . . . 75.33 110.613 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -65.26 -34.86 79.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.007 -0.997 . . . . 65.44 109.344 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.577 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.7 p-10 . . . . . 0 CA--C 1.545 0.78 0 CA-C-N 114.417 -1.265 . . . . 62.21 111.701 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.0 m . . . . . 0 C--O 1.235 0.328 0 N-CA-C 107.612 -1.255 . . . . 72.23 107.612 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -152.37 91.35 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.646 -1.242 . . . . 71.31 107.646 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 77.0 mt-30 -114.44 115.77 27.8 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.48 -0.933 . . . . 74.3 108.48 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -72.69 115.86 13.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.298 -1.001 . . . . 63.45 108.298 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -83.14 -50.06 8.85 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.062 -0.347 . . . . 64.22 110.062 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -172.83 151.28 2.22 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.792 0.33 . . . . 73.45 111.879 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.407 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -128.85 126.89 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.896 -1.52 . . . . 62.5 106.896 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -144.6 150.28 37.17 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.246 1.019 . . . . 73.24 109.645 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.5 p -83.97 109.03 17.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.839 -1.073 . . . . 74.22 108.909 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -76.28 -23.52 54.41 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.727 -0.67 . . . . 60.55 110.48 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -163.33 140.18 7.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.968 -1.014 . . . . 70.31 108.823 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.564 HD13 ' HE3' ' C' ' 117' ' ' MET . 85.2 mt -135.11 148.02 29.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 108.127 -1.064 . . . . 73.14 108.127 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -147.47 143.22 27.72 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.893 0.877 . . . . 44.35 109.769 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.8 t80 -153.56 126.77 8.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.969 -1.863 . . . . 71.24 105.969 169.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.65 153.66 45.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.651 . . . . 75.02 109.361 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.95 77.02 12.33 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.506 -0.924 . . . . 74.14 108.506 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.28 -31.18 23.19 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.922 2.415 . . . . 73.11 113.322 -172.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -116.06 36.32 4.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.473 0.709 . . . . 51.05 109.621 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.623 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.84 -64.12 1.4 Allowed Pre-proline 0 CA--C 1.568 1.646 0 N-CA-C 113.418 0.896 . . . . 72.21 113.418 -172.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.416 ' HB3' HD11 ' C' ' 83' ' ' ILE . 55.1 Cg_endo -78.39 -9.96 16.17 Favored 'Trans proline' 0 C--N 1.385 2.48 0 CA-C-N 121.73 1.654 . . . . 75.53 112.618 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -82.9 -38.69 22.54 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.896 1.679 . . . . 73.35 109.615 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 ' CZ2' ' D' ' 36' ' ' TRP . 2.0 p -85.56 -19.61 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.791 0.836 . . . . 74.51 110.886 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -68.85 -10.57 57.64 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.5 0.72 . . . . 64.42 112.33 176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -83.62 3.07 34.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.065 0.946 . . . . 63.25 111.505 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -126.23 112.7 16.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.012 0.925 . . . . 71.05 109.347 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -90.51 97.6 11.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.666 0.786 . . . . 62.14 111.72 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.515 ' CZ2' HG22 ' D' ' 31' ' ' VAL . 0.0 OUTLIER -150.62 -173.93 4.61 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.805 0.842 . . . . 75.42 112.222 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.1 115.93 65.68 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-N 114.974 -1.012 . . . . 71.01 110.1 165.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.652 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.0 Cg_exo -63.3 131.04 30.56 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.164 2.576 . . . . 73.2 111.746 163.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.6 112.28 20.29 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.163 -1.791 . . . . 72.25 106.163 163.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.845 HG12 ' HB2' ' D' ' 66' ' ' ALA . 26.8 m -98.29 112.29 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.635 -1.246 . . . . 60.13 107.635 177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -84.2 124.33 31.07 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.45 -0.945 . . . . 50.15 108.45 -172.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.1 mt -97.21 112.77 24.42 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.284 -1.326 . . . . 73.53 109.145 -170.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 31.2 t70 -114.0 130.69 56.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.257 -1.016 . . . . 74.42 108.257 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.62 136.5 47.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.706 -0.85 . . . . 64.21 108.706 177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -132.64 127.94 35.98 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.865 -1.161 . . . . 73.52 107.865 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.2 p -105.54 151.96 23.66 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.249 0.62 . . . . 74.04 110.302 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.663 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.03 160.53 43.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.29 -0.868 . . . . 75.45 109.331 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 66.1 p -155.33 156.79 36.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.649 0.78 . . . . 75.34 109.535 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.6 m -150.63 146.85 26.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.419 -1.326 . . . . 74.41 107.419 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.34 116.56 32.61 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.207 -1.405 . . . . 72.55 107.207 162.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' C' ' 29' ' ' PRO . 40.9 mt -92.23 -29.55 16.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.801 0.441 . . . . 64.54 110.263 -176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.46 -178.73 7.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.647 0.779 . . . . 52.1 110.083 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.76 123.67 20.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.174 -0.921 . . . . 73.21 109.645 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 64.25 9.71 5.02 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.586 1.154 . . . . 54.22 112.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 96.7 t -118.63 117.29 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.305 -0.628 . . . . 72.12 109.305 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -128.36 128.33 44.34 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.118 0.967 . . . . 70.43 108.685 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.81 132.13 35.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.886 0.874 . . . . 62.53 108.795 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -117.03 122.26 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.047 -1.464 . . . . 65.11 107.047 176.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.663 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.9 t -112.86 129.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.317 -0.624 . . . . 74.34 109.317 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.493 HD23 HD12 ' D' ' 106' ' ' LEU . 3.8 mm? -116.76 107.52 14.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 64.12 108.994 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -88.29 112.35 22.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.489 -0.778 . . . . 74.13 109.071 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -99.88 120.65 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.038 -1.097 . . . . 75.13 108.038 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 33.6 m -115.4 140.01 49.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.792 0.837 . . . . 73.23 109.595 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.598 HG13 ' HB ' ' D' ' 40' ' ' VAL . 88.1 t -137.15 127.81 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.754 1.222 . . . . 54.21 108.764 -172.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.3 m -133.91 103.8 5.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.178 0.591 . . . . 73.51 109.648 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.845 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -102.06 130.42 48.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.577 0.751 . . . . 75.23 109.976 177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 16.2 p -154.43 124.37 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.996 -0.742 . . . . 70.22 108.996 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.652 HD11 ' HA ' ' D' ' 38' ' ' PRO . 3.0 mm? -114.85 134.07 55.44 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.971 0.508 . . . . 70.31 110.083 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.5 -110.24 3.06 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.902 0.751 . . . . 73.13 112.037 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.4 7.68 10.15 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.231 1.012 . . . . 70.14 110.85 -175.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -137.55 154.87 49.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 122.874 0.47 . . . . 74.25 110.697 -173.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.9 m -83.26 124.94 31.07 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.744 -0.662 . . . . 64.33 110.309 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.446 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -71.03 -65.73 0.7 Allowed 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.897 0.748 . . . . 64.1 109.555 176.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.34 158.49 37.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.962 -1.017 . . . . 72.14 110.765 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -120.69 151.94 38.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.502 -1.295 . . . . 62.23 107.502 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' D' ' 114' ' ' ILE . 33.7 t -159.52 136.12 9.21 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.978 -0.379 . . . . 72.04 109.978 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.66 139.86 15.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.746 0.418 . . . . 73.44 110.046 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.8 120.45 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.177 0.591 . . . . 74.33 110.087 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -89.03 88.27 7.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.658 -0.868 . . . . 72.41 108.658 168.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -84.36 92.21 7.97 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.019 -0.991 . . . . 64.51 108.738 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 143.93 18.97 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.946 -0.861 . . . . 62.22 110.946 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.86 129.59 3.23 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 110.808 -0.917 . . . . 54.34 110.808 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.7 mt -89.56 134.1 29.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 123.22 0.608 . . . . 72.44 109.505 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -132.0 129.59 40.31 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.177 0.991 . . . . 74.22 109.291 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 50.0 m -75.77 94.35 3.28 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.896 -0.779 . . . . 63.31 108.896 166.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 19.5 mt -107.05 123.32 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 107.824 -1.176 . . . . 64.04 107.824 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -148.22 161.98 40.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.759 0.824 . . . . 71.0 110.297 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.02 19.68 75.66 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.761 0.663 . . . . 43.21 113.875 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' D' ' 93' ' ' GLN . 16.2 tt -135.45 149.91 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.817 -0.808 . . . . 73.43 108.817 -169.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.03 156.96 44.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.068 0.547 . . . . 72.22 111.689 -170.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 33.87 -96.17 0.01 OUTLIER Glycine 0 C--N 1.357 1.73 0 N-CA-C 117.094 1.598 . . . . 61.52 117.094 153.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 44.0 p -64.89 -50.63 65.77 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.98 0.912 . . . . 74.3 112.529 -173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.516 ' HG3' HD11 ' D' ' 89' ' ' ILE . 52.9 tp60 -79.78 -28.91 40.29 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 111.803 0.298 . . . . 73.5 111.803 -172.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -70.65 -34.02 71.59 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.746 -0.465 . . . . 74.31 109.746 176.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . 0.405 ' N ' ' SD ' ' D' ' 94' ' ' MET . . . -59.92 -35.99 76.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.634 0.774 . . . . 55.34 110.727 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.14 -36.57 72.13 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.873 -1.058 . . . . 75.02 110.712 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -73.02 -52.22 15.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.006 0.522 . . . . 52.21 112.366 -173.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.0 pp -94.84 -20.47 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.04 0.536 . . . . 74.42 111.912 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.45 -6.84 60.91 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.72 -0.489 . . . . 62.33 113.721 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.85 -58.66 0.47 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.161 0.48 . . . . 41.15 111.402 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.5 -45.47 68.84 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.221 0.608 . . . . 75.15 112.547 -171.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -43.06 57.26 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 123.56 0.744 . . . . 64.33 111.426 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.88 -43.47 35.1 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.831 2.354 . . . . 71.31 113.906 163.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.28 -21.19 65.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.402 0.681 . . . . 70.34 112.285 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.78 -42.2 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.948 0.499 . . . . 72.22 110.532 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.493 HD12 HD23 ' D' ' 60' ' ' LEU . 74.3 mt -91.13 -20.92 21.49 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.888 0.699 . . . . 70.05 112.888 -170.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -65.85 -41.67 48.12 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.152 -0.927 . . . . 65.11 112.715 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.19 -40.35 69.41 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.383 2.055 . . . . 50.14 113.399 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -73.97 -36.39 64.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.748 0.819 . . . . 74.42 111.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.95 -45.09 83.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.003 0.521 . . . . 61.55 110.219 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -60.75 -46.05 91.94 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.575 -1.193 . . . . 72.32 110.46 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.92 -47.23 87.37 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.238 0.961 . . . . 74.14 110.779 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.99 -41.06 86.69 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.682 0.614 . . . . 65.32 110.945 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.651 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.8 mt -66.3 -47.95 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.496 0.718 . . . . 63.44 110.243 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.47 HG23 ' HB3' ' D' ' 125' ' ' GLN . 99.4 m -53.17 -46.82 69.08 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.489 1.116 . . . . 74.35 111.229 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.5 t -66.84 -41.7 86.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.071 -0.968 . . . . 63.04 110.731 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.479 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 77.2 mtm -67.8 -45.26 75.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.86 0.464 . . . . 65.53 112.185 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 -32.03 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.313 -0.858 . . . . 52.31 110.082 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.9 p -72.22 -33.67 67.76 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.917 0.487 . . . . 64.33 110.819 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtt-85 -68.26 -26.68 65.79 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.744 0.817 . . . . 72.02 110.917 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.0 10.46 65.63 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.615 0.572 . . . . 63.41 112.889 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.401 HG23 ' HB3' ' C' ' 17' ' ' TYR . 58.1 p 57.57 19.85 5.71 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 126.524 1.929 . . . . 75.2 113.248 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.603 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 63.7 m-85 -91.4 178.06 1.95 Allowed Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.487 1.515 . . . . 73.44 107.688 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 83.1 Cg_endo -74.82 160.79 40.22 Favored 'Trans proline' 0 C--N 1.39 2.75 0 CA-C-N 121.843 1.694 . . . . 74.33 112.434 -174.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.47 ' HB3' HG23 ' D' ' 115' ' ' THR . 15.9 mt-30 -66.34 128.12 34.91 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.287 -1.005 . . . . 65.41 108.287 166.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.99 91.55 4.17 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.433 -1.321 . . . . 74.05 107.433 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -103.88 93.31 4.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.089 -1.414 . . . . 65.12 108.323 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.87 127.89 34.22 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.196 -0.668 . . . . 73.31 109.196 174.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -56.24 134.32 75.42 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 124.269 0.981 . . . . 73.13 110.554 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 5.8 Cg_exo -73.63 96.67 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.702 2.268 . . . . 61.55 109.876 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.69 110.06 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.712 -1.218 . . . . 60.24 107.712 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -68.99 114.76 7.58 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.048 -0.978 . . . . 34.23 109.94 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 . . . . . 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.01 111.356 -178.453 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 110.163 -0.31 . . . . 74.31 110.163 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.7 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 7.1 t80 -120.09 134.71 55.18 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.457 1.103 . . . . 72.45 108.488 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -155.28 117.17 4.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.978 -0.749 . . . . 61.42 108.978 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.57 HG21 ' HG2' ' C' ' 130' ' ' PRO . 24.4 mt -76.8 124.17 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.892 -0.41 . . . . 74.35 109.892 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.68 -43.65 18.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.775 0.83 . . . . 71.32 110.858 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -173.4 131.57 0.46 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.248 -0.278 . . . . 53.24 110.248 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -116.75 138.31 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.716 0.806 . . . . 71.22 108.867 174.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -171.19 166.48 7.21 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.775 0.798 . . . . 73.33 111.082 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -95.51 119.43 34.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.947 -1.024 . . . . 73.31 108.895 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.507 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 38.6 mtpt -82.71 -28.38 30.56 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.642 0.377 . . . . 54.51 110.125 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.21 145.95 21.05 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.062 -0.972 . . . . 52.54 109.631 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.9 mt -134.65 134.84 54.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.981 1.312 . . . . 64.22 107.652 176.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -136.18 123.84 22.38 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.49 -1.3 . . . . 71.01 107.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 84.5 t80 -136.85 126.5 25.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.896 -1.52 . . . . 74.04 106.896 173.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.4 139.12 43.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.824 -0.435 . . . . 74.24 109.824 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.22 70.59 9.98 Favored Pre-proline 0 C--O 1.245 0.833 0 N-CA-C 107.777 -1.194 . . . . 41.34 107.777 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.59 -21.98 38.79 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.226 1.95 . . . . 73.04 111.744 -173.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.474 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 16.5 m-20 -118.33 23.42 11.57 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.825 0.85 . . . . 63.21 109.77 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.589 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -48.22 -54.56 24.21 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-O 118.318 -0.849 . . . . 62.15 113.222 -175.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HG2' ' HD2' ' A' ' 30' ' ' HIS . 17.9 Cg_endo -59.28 -34.25 97.98 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.536 2.157 . . . . 55.21 112.716 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.403 ' HD2' ' HG2' ' A' ' 29' ' ' PRO . 15.7 m-70 -70.8 -42.02 70.84 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.456 -0.793 . . . . 73.33 110.148 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.87 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.78 -28.56 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.364 -0.835 . . . . 72.32 111.596 -170.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -60.85 -33.31 72.86 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.472 0.483 . . . . 64.03 112.019 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -88.83 -15.89 33.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.596 0.358 . . . . 74.32 111.541 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -68.01 163.89 21.25 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.328 0.585 . . . . 75.34 111.408 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.96 149.01 50.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.085 -0.961 . . . . 75.42 109.973 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -83.36 63.76 7.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.319 0.648 . . . . 75.04 109.955 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -148.05 70.19 11.0 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.597 0.759 . . . . 75.0 109.986 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -92.35 166.92 2.91 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.269 1.979 . . . . 65.23 111.585 163.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.5 104.4 16.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.336 -1.357 . . . . 73.1 107.336 167.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 66' ' ' ALA . 85.1 t -85.06 95.36 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.937 -0.764 . . . . 63.45 108.937 175.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -87.8 115.24 25.12 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.897 -0.779 . . . . 70.42 108.897 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mp -103.09 120.72 41.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.417 -0.586 . . . . 62.13 109.417 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.01 136.5 42.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.376 1.071 . . . . 73.12 108.583 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 34.0 tp -114.56 118.83 34.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.108 -1.071 . . . . 72.23 108.108 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 29.5 t70 -128.73 147.5 50.77 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.979 0.912 . . . . 71.1 108.969 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -149.15 136.92 20.45 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.242 -1.021 . . . . 71.34 108.242 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.25 134.5 38.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 63.41 109.01 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -129.26 151.44 49.91 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.616 0.644 . . . . 75.21 110.874 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -164.92 133.02 3.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.765 0.826 . . . . 73.14 109.767 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 48.3 tt0 -79.01 119.49 22.23 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.692 0.397 . . . . 72.52 110.933 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 57' ' ' GLU . 79.6 mt -84.07 -43.12 15.4 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.725 0.81 . . . . 60.12 111.281 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.9 -179.76 7.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.609 0.764 . . . . 65.42 110.012 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.24 116.73 5.25 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.252 -0.647 . . . . 73.31 109.252 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 68.25 19.36 9.07 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.564 1.145 . . . . 74.31 111.991 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.51 120.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.152 0.981 . . . . 50.44 108.758 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.526 ' HE2' HD12 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -128.46 171.13 12.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.328 -0.619 . . . . 71.01 109.328 169.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.2 tt0 -127.89 133.28 49.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.37 1.068 . . . . 75.05 108.253 176.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.4 121.4 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.031 -1.099 . . . . 73.35 108.031 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 56.2 t -97.85 136.85 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.503 1.121 . . . . 71.53 108.86 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HB2' HD13 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -116.03 99.71 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.327 -1.36 . . . . 72.33 107.327 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.3 ttp180 -89.05 101.83 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.106 -0.701 . . . . 72.5 109.106 174.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.2 t -93.6 127.76 45.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.8 -1.556 . . . . 72.41 106.8 170.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 77' ' ' GLU . 11.1 m -117.46 130.84 56.71 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.147 -0.686 . . . . 71.55 109.147 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.8 t -120.37 107.28 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.745 -1.206 . . . . 71.23 107.745 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.7 m -111.68 134.45 53.24 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.846 -0.798 . . . . 71.21 108.846 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -124.88 126.64 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.663 -1.236 . . . . 44.14 107.663 173.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -141.32 128.49 20.91 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.313 -0.625 . . . . 74.34 109.313 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.05 86.03 2.79 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.804 -1.184 . . . . 52.34 107.804 173.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -126.12 7.49 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.92 -1.036 . . . . 63.15 110.825 -171.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.36 -26.51 22.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.274 0.63 . . . . 71.31 110.452 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 29.9 tt0 -77.78 120.16 22.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.584 0.353 . . . . 61.33 110.303 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -79.66 130.5 35.42 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.47 0.708 . . . . 72.14 110.163 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.87 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.96 -62.14 1.6 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.609 0.764 . . . . 62.33 110.485 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.479 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 39.0 p90 -160.25 171.03 19.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.127 -0.942 . . . . 63.32 111.332 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -138.14 131.88 31.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.995 -1.457 . . . . 72.5 107.443 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.8 m -135.51 97.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.748 0.819 . . . . 75.32 109.196 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.49 ' HB2' HG23 ' A' ' 63' ' ' THR . 42.0 tt0 -123.26 116.34 23.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.264 -1.014 . . . . 73.42 108.264 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.21 121.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.195 -0.669 . . . . 52.13 109.195 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 84.41 6.13 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.512 -0.922 . . . . 64.41 108.512 173.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.01 94.24 5.25 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.051 -0.977 . . . . 75.2 109.207 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.62 142.37 20.16 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.465 -0.654 . . . . 73.44 111.465 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.03 120.82 1.52 Allowed Glycine 0 CA--C 1.502 -0.736 0 N-CA-C 109.929 -1.269 . . . . 74.32 109.929 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -83.14 125.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.671 -0.863 . . . . 65.04 108.671 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.7 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.8 m-85 -124.63 127.39 47.26 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 109.297 -0.631 . . . . 63.53 109.297 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.9 t -83.82 119.1 24.43 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.394 0.678 . . . . 73.3 109.344 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.526 HD12 ' HE2' ' A' ' 56' ' ' TYR . 12.9 tt -103.4 146.59 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.194 0.997 . . . . 75.4 109.486 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 157.47 18.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.414 0.686 . . . . 74.12 109.892 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.29 -33.25 3.2 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.846 0.716 . . . . 61.45 114.413 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.8 pp -128.78 164.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 117.571 0.685 . . . . 71.41 112.469 -172.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.48 -179.97 6.34 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.015 0.926 . . . . 72.25 109.545 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.47 22.36 Favored Glycine 0 N--CA 1.478 1.476 0 C-N-CA 123.116 0.389 . . . . 60.1 113.829 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -66.94 -28.24 68.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.947 1.299 . . . . 73.21 111.659 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -64.11 -51.31 64.58 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.35 -0.841 . . . . 63.04 110.322 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -73.93 -28.28 61.44 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.222 -0.899 . . . . 74.53 110.666 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.78 92.37 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.282 0.563 . . . . 73.32 111.0 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 39.2 t-80 -69.57 -36.49 76.32 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.154 -0.93 . . . . 72.32 110.036 173.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 23.7 t -73.68 -27.17 61.09 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.88 0.472 . . . . 74.12 111.276 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.06 -42.19 14.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.989 0.916 . . . . 74.32 110.988 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.09 4.78 52.49 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.59 0.556 . . . . 50.32 114.132 -168.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.819 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.51 -60.13 0.24 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 117.627 0.714 . . . . 63.22 112.493 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.6 t80 -68.2 -62.12 1.54 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.154 0.981 . . . . 53.12 112.125 -170.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 97.8 m -69.06 -32.85 3.61 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 114.315 1.228 . . . . 60.25 114.315 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.92 -42.74 20.22 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.985 2.456 . . . . 71.15 113.713 164.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.44 -26.19 64.48 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.762 0.825 . . . . 72.04 111.485 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -72.39 -45.34 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.599 0.76 . . . . 74.53 109.743 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 60' ' ' LEU . 48.9 mt -70.85 -35.68 72.53 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.409 -1.269 . . . . 71.11 112.394 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -59.75 -43.05 94.34 Favored Pre-proline 0 CA--C 1.572 1.791 0 C-N-CA 124.701 1.2 . . . . 74.01 114.227 -167.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -59.41 -37.34 90.51 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.27 1.98 . . . . 73.44 113.487 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.47 -35.92 68.34 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.294 0.638 . . . . 75.43 111.863 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.97 94.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 60.43 109.515 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -63.05 -35.83 81.54 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 124.287 0.992 . . . . 71.43 110.309 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 22.2 tt0 -56.64 -56.37 22.21 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.624 0.77 . . . . 75.15 110.91 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -63.35 -45.02 93.12 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 114.397 -1.274 . . . . 64.44 110.766 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 118' ' ' VAL . 66.2 mt -62.93 -59.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 123.987 0.804 . . . . 72.14 110.775 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.4 m -56.77 -32.8 65.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.181 0.593 . . . . 53.23 111.966 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.0 t -68.52 -46.45 69.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.86 -0.609 . . . . 52.4 110.529 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.402 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mtp -58.37 -42.87 87.95 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 75.33 111.049 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.3 t -62.3 -44.64 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.419 1.087 . . . . 74.1 110.225 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -73.56 -29.96 62.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.355 -0.384 . . . . 74.03 111.3 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -68.3 -37.12 80.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.418 0.687 . . . . 74.13 109.815 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.97 -3.42 89.39 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.811 -0.631 . . . . 72.21 113.033 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.78 HG21 HE21 ' D' ' 125' ' ' GLN . 24.3 p 54.56 48.8 19.62 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.167 1.787 . . . . 75.05 111.572 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -104.56 154.41 38.47 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 113.807 -1.542 . . . . 74.23 108.43 169.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -59.75 131.32 39.28 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.335 2.023 . . . . 75.14 110.615 -172.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -47.84 133.69 13.91 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.472 1.108 . . . . 62.51 111.785 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.8 tp -107.17 110.31 22.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.296 -0.631 . . . . 71.51 109.296 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.67 84.02 1.95 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.851 -1.537 . . . . 71.42 106.851 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.5 tp -71.7 128.81 36.99 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.092 -0.958 . . . . 72.32 109.623 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -52.97 131.57 49.43 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 124.689 1.243 . . . . 54.14 111.517 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 3.4 Cg_endo -77.47 116.25 4.06 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.265 1.977 . . . . 65.53 109.866 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.41 123.96 53.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.643 -0.873 . . . . 63.21 108.643 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -76.79 86.83 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.211 -1.033 . . . . 71.03 108.211 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.994 . . . . 73.34 110.662 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 t70 . . . . . 0 C--N 1.348 0.542 0 CA-C-N 114.984 -1.007 . . . . 74.42 110.426 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 90.7 m . . . . . 0 N--CA 1.481 1.12 0 N-CA-C 110.11 -0.33 . . . . 72.25 110.11 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.548 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 47.9 t80 -151.06 113.76 4.69 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.905 -0.776 . . . . 74.23 108.905 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -142.11 137.63 31.09 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.37 0.668 . . . . 72.3 109.935 170.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.508 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -82.3 128.0 39.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.825 -0.805 . . . . 74.24 108.825 174.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 11.9 mm-40 -98.39 -43.62 6.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.015 -0.539 . . . . 74.53 110.075 179.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -164.33 130.93 3.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.517 -0.31 . . . . 72.43 110.574 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -115.86 127.9 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.545 1.138 . . . . 72.32 108.902 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -162.49 147.59 12.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.982 0.42 . . . . 72.25 111.869 -171.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.6 m -73.95 123.42 24.25 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.984 0.913 . . . . 70.34 109.367 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -98.96 -27.56 13.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.098 0.559 . . . . 71.03 111.506 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.2 t70 -156.67 144.53 19.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.316 0.246 . . . . 72.13 110.641 -170.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 36.2 mm -144.66 141.43 23.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.326 1.451 . . . . 72.14 108.251 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -145.61 109.36 4.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 124.103 0.877 . . . . 74.45 108.699 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.0 t80 -118.0 117.48 29.34 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 107.186 -1.413 . . . . 75.24 107.186 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 39.3 mt-10 -119.95 133.01 55.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.372 0.669 . . . . 63.22 109.404 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.41 83.33 66.46 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.664 -1.236 . . . . 32.22 107.664 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . 0.435 ' HG2' HD22 ' B' ' 27' ' ' ASN . 44.9 Cg_endo -66.23 -29.53 46.88 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.902 2.402 . . . . 71.14 112.167 -174.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.435 HD22 ' HG2' ' B' ' 26' ' ' PRO . 27.6 m-80 -108.43 21.06 17.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 74.53 110.877 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -44.44 -57.67 6.21 Favored Pre-proline 0 CA--C 1.582 2.193 0 N-CA-C 114.743 1.386 . . . . 74.35 114.743 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 71.0 Cg_endo -80.24 -26.92 3.89 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 122.302 2.001 . . . . 64.34 113.11 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 2.3 m-70 -93.99 1.13 56.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.545 0.738 . . . . 71.44 112.344 -171.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.67 -28.1 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.036 0.534 . . . . 72.23 111.686 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -53.69 -26.02 20.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.589 1.156 . . . . 61.3 113.365 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 25.0 pt20 -66.6 -52.45 45.19 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.338 0.255 . . . . 72.35 110.781 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -118.13 68.15 0.77 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 123.552 0.741 . . . . 44.42 110.167 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.44 ' O ' ' HE3' ' B' ' 36' ' ' TRP . 11.0 t70 -98.53 118.16 34.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 106.932 -1.507 . . . . 75.22 106.932 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.44 ' HE3' ' O ' ' B' ' 35' ' ' ASP . 2.2 t-105 -176.1 175.29 1.93 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.832 -1.173 . . . . 72.14 107.832 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.55 112.07 3.81 Favored Pre-proline 0 CA--C 1.56 1.359 0 O-C-N 123.582 0.552 . . . . 73.53 110.996 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.77 164.84 15.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.62 2.213 . . . . 72.32 112.388 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.09 101.94 4.07 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.185 -1.042 . . . . 71.32 108.185 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.09 146.43 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.407 -0.815 . . . . 72.03 108.931 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.57 133.07 32.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.121 0.969 . . . . 74.04 109.307 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.482 HD21 HD11 ' B' ' 128' ' ' LEU . 4.6 mp -90.97 150.1 21.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.346 -0.843 . . . . 61.43 108.953 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.592 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.3 t70 -158.99 154.58 26.04 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.419 -0.956 . . . . 74.03 108.419 172.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.2 154.55 48.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.002 0.521 . . . . 74.24 110.582 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.5 t70 -140.02 124.62 18.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.419 -1.326 . . . . 53.12 107.419 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -110.21 104.76 13.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.023 0.929 . . . . 74.41 109.741 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.24 155.39 45.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.97 0.908 . . . . 41.44 109.984 -175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.6 m -144.11 172.64 12.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.296 0.639 . . . . 62.44 110.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.0 p -151.76 134.88 15.85 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.11 0.964 . . . . 63.11 108.647 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -84.47 114.68 22.1 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.86 -0.422 . . . . 74.33 109.86 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -80.49 -45.72 17.05 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.447 -0.575 . . . . 72.43 109.447 173.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.48 -173.43 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.666 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.14 119.43 18.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.872 . . . . 75.05 109.968 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 71.45 -6.4 1.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 125.965 1.706 . . . . 75.12 112.668 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -104.99 104.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 108.08 -1.082 . . . . 73.32 108.08 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.82 137.96 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -101.16 101.51 12.25 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.017 -1.475 . . . . 70.23 107.017 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.33 123.18 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.074 0.949 . . . . 33.24 109.879 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.446 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.0 t -102.95 144.4 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.085 0.954 . . . . 54.12 109.417 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' B' ' 103' ' ' PRO . 61.0 tp -129.77 115.02 16.68 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.555 -0.905 . . . . 55.12 108.555 170.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.583 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 37.3 ttm180 -92.85 125.86 37.65 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.373 -0.603 . . . . 70.33 109.373 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 92.9 t -111.25 104.55 17.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.305 -1.369 . . . . 64.44 107.305 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 36.4 m -97.0 136.96 36.82 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.481 -0.781 . . . . 65.21 109.437 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.11 129.32 67.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.947 -1.024 . . . . 73.54 108.476 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.5 m -124.82 137.87 54.29 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.406 0.682 . . . . 71.11 109.408 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.51 143.4 35.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.034 0.534 . . . . 65.22 109.63 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -158.09 140.37 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.698 0.624 . . . . 71.32 111.362 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.2 mp -103.24 118.92 37.87 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.45 -0.944 . . . . 33.44 108.45 167.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.63 -141.77 39.18 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.587 0.554 . . . . 75.31 112.882 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 9.43 12.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.327 1.051 . . . . 74.02 111.875 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -127.41 143.35 51.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.545 0.738 . . . . 73.31 110.147 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -70.78 140.47 51.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.574 0.75 . . . . 70.35 110.855 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -90.99 -62.58 1.42 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.97 0.908 . . . . 61.54 108.744 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -156.29 167.02 31.73 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.572 -1.195 . . . . 64.43 109.144 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.3 mt -137.08 131.03 32.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.802 -1.555 . . . . 62.42 106.802 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 37.7 t -141.33 132.7 26.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.759 -0.83 . . . . 53.1 108.759 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -154.19 135.37 13.99 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.009 -0.737 . . . . 72.2 109.009 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' B' ' 113' ' ' CYS . 61.9 t -133.33 146.44 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.637 0.775 . . . . 63.41 109.019 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -119.48 95.93 4.99 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.405 -1.331 . . . . 71.41 107.405 168.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -85.19 104.57 15.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.69 -0.855 . . . . 75.11 108.69 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.68 159.85 29.66 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 123.927 0.767 . . . . 75.33 111.186 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.29 126.34 1.57 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.922 -0.871 . . . . 64.31 110.922 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.26 119.11 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.12 -1.067 . . . . 75.22 108.12 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.11 134.26 54.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.752 0.821 . . . . 74.42 108.892 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -92.36 97.17 10.7 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.4 -0.963 . . . . 64.22 108.4 168.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.16 139.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.194 -0.912 . . . . 62.45 110.421 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.1 160.92 39.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.014 0.926 . . . . 71.23 109.555 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.95 -31.9 4.2 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.398 0.436 . . . . 72.12 114.072 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.405 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -75.63 136.5 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.296 0.638 . . . . 72.2 111.048 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.91 151.62 16.45 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.717 0.807 . . . . 63.51 109.695 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.54 -110.37 3.32 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 123.614 0.626 . . . . 44.43 113.189 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -74.59 -42.9 57.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.826 0.822 . . . . 72.22 110.088 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -67.64 -32.6 73.42 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.977 -1.465 . . . . 74.24 111.206 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.3 ptm -68.47 -37.37 80.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.957 -0.565 . . . . 74.23 110.748 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.88 -26.73 64.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.522 0.729 . . . . 63.42 110.721 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.9 t-80 -89.39 -19.3 25.37 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.354 0.662 . . . . 54.45 110.839 175.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.5 t -86.69 -70.17 0.63 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.497 0.319 . . . . 33.43 111.436 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.516 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.2 pp -80.43 -24.83 39.32 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.431 0.292 . . . . 64.13 111.478 -175.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.29 1.82 56.18 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-O 119.66 -0.522 . . . . 64.13 114.153 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.03 -53.08 0.38 Allowed 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.548 0.674 . . . . 52.11 111.827 -177.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -75.34 -45.17 41.11 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.086 0.554 . . . . 74.25 112.075 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.548 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 56.0 m -65.97 -43.71 58.7 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.161 0.584 . . . . 65.11 111.82 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HA ' HD22 ' B' ' 60' ' ' LEU . 65.2 Cg_exo -48.42 -42.97 33.89 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.868 2.378 . . . . 75.54 114.295 167.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -61.31 -30.24 70.37 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.552 0.741 . . . . 75.24 112.64 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.89 -43.79 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.152 0.581 . . . . 72.52 110.635 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.42 -20.5 47.4 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.062 -0.517 . . . . 64.43 111.571 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -61.15 -49.35 88.81 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.892 -1.052 . . . . 61.35 113.275 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.9 -46.38 30.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.938 2.426 . . . . 63.54 113.841 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -67.16 -44.88 78.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 71.43 111.32 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.58 96.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.284 0.634 . . . . 74.41 110.979 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 8.7 ttp-105 -71.75 -44.86 63.36 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.086 -0.961 . . . . 71.45 110.743 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.97 -34.04 77.47 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.872 0.732 . . . . 74.42 110.166 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.493 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.5 t -68.79 -36.5 78.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 122.877 0.471 . . . . 73.13 110.86 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.527 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 62.0 mt -62.84 -48.92 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.255 0.622 . . . . 74.41 109.773 172.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -62.03 -32.17 72.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.678 0.791 . . . . 74.13 111.527 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 30.9 t -65.78 -46.55 78.31 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.633 -0.712 . . . . 44.02 110.238 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -72.94 -38.1 66.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.802 0.441 . . . . 75.51 111.329 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.45 -38.49 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.396 0.678 . . . . 62.35 110.339 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -68.05 -34.58 76.72 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.892 -1.049 . . . . 63.24 111.19 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -71.27 -26.79 63.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.914 0.486 . . . . 73.12 110.458 176.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.92 1.39 63.17 Favored Glycine 0 C--N 1.358 1.796 0 O-C-N 123.446 0.467 . . . . 53.54 112.59 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 41.5 p 62.73 49.54 3.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.915 2.086 . . . . 74.12 112.22 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -119.98 154.46 55.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.393 -1.276 . . . . 75.25 109.924 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.37 -169.96 0.12 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.581 2.854 . . . . 74.33 114.143 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 15.4 tp60 -57.34 124.26 18.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.448 1.099 . . . . 72.22 112.771 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -141.49 83.35 1.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.864 -0.791 . . . . 71.25 108.864 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -104.5 131.42 51.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.385 -1.339 . . . . 72.14 107.385 165.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.482 HD11 HD21 ' B' ' 42' ' ' LEU . 33.1 tp -70.74 149.74 46.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.091 0.557 . . . . 43.41 110.253 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.2 149.4 87.05 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.894 0.878 . . . . 54.33 111.898 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.447 ' HG3' HD12 ' D' ' 16' ' ' ILE . 20.4 Cg_exo -63.45 93.51 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.925 2.417 . . . . 72.42 111.825 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 t -92.0 110.07 22.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.301 -1.0 . . . . 71.34 108.301 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -92.75 88.25 6.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.026 -1.101 . . . . 74.04 108.026 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 . . . . . 0 N--CA 1.479 0.993 0 CA-C-N 115.037 -0.983 . . . . 73.14 110.298 -177.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.412 ' HA ' HG13 ' C' ' 89' ' ' ILE . 56.3 ttp . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 121.333 0.587 . . . . 53.54 112.45 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.721 HG22 HE22 ' C' ' 12' ' ' GLN . 7.0 m -97.22 105.57 17.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.172 -1.047 . . . . 62.02 108.172 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.6 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.4 t80 -124.27 119.38 29.15 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.529 -0.545 . . . . 63.24 109.529 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.721 HE22 HG22 ' C' ' 10' ' ' THR . 1.6 mp0 -136.92 142.26 42.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.486 -0.931 . . . . 71.25 108.486 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.14 97.29 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -74.19 -28.25 61.19 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 122.423 0.289 . . . . 51.41 110.649 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' C' ' 15' ' ' ARG . 10.0 ttt180 -172.55 152.76 2.68 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 123.727 0.642 . . . . 62.51 110.94 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 89.3 mt -133.6 137.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.269 -1.382 . . . . 62.05 107.269 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG23 ' D' ' 122' ' ' THR . 18.6 p90 -175.52 166.24 3.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.88 0.472 . . . . 75.31 110.052 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -89.26 120.24 30.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.267 -0.642 . . . . 75.23 109.267 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 13.6 mmmm -66.49 -44.55 82.31 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.614 -0.884 . . . . 71.24 108.614 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.2 t70 -139.79 145.71 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.112 -0.949 . . . . 73.33 110.598 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.9 mt -135.53 142.83 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 125.587 1.555 . . . . 71.02 107.038 170.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -156.84 151.34 25.48 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.129 0.49 . . . . 72.42 110.702 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -149.36 112.14 4.81 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 106.895 -1.52 . . . . 72.14 106.895 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -116.24 125.71 52.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.286 0.634 . . . . 62.52 109.855 -176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.64 82.08 18.82 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.086 -1.079 . . . . 62.53 108.086 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.86 -28.16 75.46 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.522 2.148 . . . . 72.55 111.646 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.86 31.87 2.53 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.519 1.128 . . . . 54.53 110.47 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.511 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -58.13 -54.04 59.77 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.441 1.275 . . . . 63.44 114.441 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 58.8 Cg_endo -79.83 -25.99 4.86 Favored 'Trans proline' 0 C--N 1.385 2.464 0 CA-C-N 122.072 1.776 . . . . 61.04 112.654 172.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.06 -23.32 67.39 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.044 1.338 . . . . 65.52 111.997 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -18.75 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.88 1.272 . . . . 61.52 112.022 -174.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.04 -38.55 75.88 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.676 0.39 . . . . 73.34 111.461 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.99 34.42 1.1 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.424 0.69 . . . . 75.42 110.912 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.432 ' HD2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -98.0 150.9 20.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.181 0.992 . . . . 73.41 111.012 -175.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.81 138.95 58.25 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.952 1.301 . . . . 73.32 111.533 172.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -85.24 67.21 10.08 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.864 0.866 . . . . 72.11 110.784 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -162.94 71.0 2.01 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.118 0.567 . . . . 71.04 110.81 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -87.05 115.9 1.2 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.315 2.677 . . . . 71.15 112.015 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.87 112.77 22.08 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.352 -0.981 . . . . 65.52 108.352 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.89 104.51 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.726 -0.67 . . . . 73.34 109.355 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.416 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 58.7 tttm -95.03 103.25 15.09 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.616 -0.883 . . . . 65.12 108.616 173.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.78 138.05 31.87 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.153 -1.054 . . . . 72.41 108.153 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.4 t70 -128.89 141.55 51.24 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.42 1.088 . . . . 75.02 109.042 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 61.7 tp -134.29 132.01 39.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.111 -0.7 . . . . 72.05 109.111 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.777 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 17.1 t70 -123.27 141.76 51.65 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.106 0.963 . . . . 75.31 109.133 174.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -114.51 111.08 20.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.993 -0.743 . . . . 62.23 108.993 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -117.03 164.29 14.94 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.341 1.056 . . . . 42.02 110.09 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -146.83 155.49 42.38 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.391 0.676 . . . . 71.14 109.884 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.51 126.84 14.89 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 65.32 108.598 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -82.72 117.76 22.87 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.447 -0.946 . . . . 73.35 108.447 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.591 HD11 HD12 ' C' ' 83' ' ' ILE . 83.1 mt -90.89 -42.51 10.56 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.621 -0.718 . . . . 55.12 109.463 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.45 -177.85 6.84 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.802 -1.09 . . . . 71.41 109.728 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.4 126.62 30.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.991 -1.004 . . . . 75.43 109.182 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.7 10.51 7.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.622 1.169 . . . . 60.32 111.732 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -126.22 112.96 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.918 0.887 . . . . 72.11 109.206 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -131.14 125.54 33.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.889 0.876 . . . . 73.3 109.11 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -83.61 124.48 30.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.279 1.031 . . . . 75.12 109.66 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.49 130.09 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.572 -1.27 . . . . 51.43 107.572 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 86.0 t -123.44 139.91 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.505 0.722 . . . . 71.11 109.978 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.575 HD11 ' HA ' ' C' ' 103' ' ' PRO . 69.5 mt -128.76 118.72 23.27 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 124.283 1.033 . . . . 61.02 109.315 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.777 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 45.0 mtt180 -82.96 108.55 16.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.689 -0.856 . . . . 75.44 108.689 166.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -103.92 116.38 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.456 -1.313 . . . . 62.24 107.456 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 20.2 m -130.12 118.24 21.18 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.056 0.542 . . . . 50.23 109.594 -170.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.596 HG23 HD13 ' C' ' 114' ' ' ILE . 67.0 t -104.0 118.18 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 70.21 108.586 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 22.4 m -110.77 141.45 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.463 -0.94 . . . . 72.34 108.463 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.76 106.61 9.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.963 -1.865 . . . . 61.33 105.963 170.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.5 m -138.91 152.28 47.63 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.338 0.59 . . . . 74.44 109.71 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.432 HD13 ' HD2' ' C' ' 34' ' ' LYS . 4.3 mp -116.32 31.48 6.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.462 -1.244 . . . . 73.51 108.635 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.54 -117.63 4.02 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 109.802 -1.319 . . . . 75.13 109.802 -170.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -88.85 -30.61 18.8 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.433 -0.58 . . . . 63.24 109.433 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.68 95.12 1.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.223 1.009 . . . . 60.14 109.227 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 64.3 m -87.49 139.65 30.33 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.219 0.608 . . . . 72.11 110.737 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.6 -65.02 1.01 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.098 -0.955 . . . . 73.44 109.395 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -157.91 176.19 12.87 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.167 0.587 . . . . 75.13 110.784 176.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -140.79 147.47 39.12 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.671 1.188 . . . . 72.34 108.162 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 51.0 t -151.08 129.36 11.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.129 0.971 . . . . 50.13 108.596 175.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -136.86 134.58 37.06 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.976 0.51 . . . . 74.1 110.025 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' C' ' 110' ' ' ALA . 36.5 t -131.39 115.6 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 52.34 109.021 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.617 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 27.2 mt-30 -89.48 96.39 10.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.018 . . . . 63.15 108.25 169.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.7 tp-100 -80.07 125.45 29.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.273 0.629 . . . . 64.34 109.86 176.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.23 154.19 16.81 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.831 -0.507 . . . . 40.14 111.831 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.25 120.24 1.05 Allowed Glycine 0 CA--C 1.504 -0.65 0 N-CA-C 111.865 -0.494 . . . . 71.13 111.865 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.591 HD12 HD11 ' C' ' 51' ' ' LEU . 9.0 mm -87.92 122.6 39.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 60.51 108.371 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -133.75 127.33 32.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.933 -0.766 . . . . 74.31 108.933 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -87.91 104.28 16.47 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.659 -0.867 . . . . 73.23 108.659 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' C' ' 10' ' ' THR . 21.9 pt -115.54 134.36 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.352 1.061 . . . . 73.1 110.234 -173.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.34 172.2 14.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 74.12 111.272 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.68 -49.15 2.3 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.648 -0.705 . . . . 72.21 113.054 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.412 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.8 pp -119.94 172.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.567 0.747 . . . . 73.12 110.828 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.81 -172.91 4.27 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.776 -0.647 . . . . 61.51 110.186 -171.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.85 -129.01 44.47 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.736 0.647 . . . . 62.25 113.835 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -69.75 -28.03 65.44 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.319 1.048 . . . . 64.13 111.916 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.8 -47.83 83.37 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.745 0.818 . . . . 73.22 109.838 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 36.6 ttp -83.38 -29.18 28.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.449 -0.796 . . . . 72.35 110.829 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.33 -30.86 71.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.981 0.513 . . . . 72.05 111.368 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -68.77 -34.53 75.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.285 0.634 . . . . 75.05 110.434 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -70.3 -61.86 1.61 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.159 -0.473 . . . . 65.43 110.761 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.542 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.9 OUTLIER -77.83 -13.5 59.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.819 0.674 . . . . 40.1 112.819 -176.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -7.35 49.9 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 119.757 -0.468 . . . . 41.02 113.875 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.56 -58.28 0.63 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.311 0.555 . . . . 73.33 110.951 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -70.99 -45.04 64.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.271 1.028 . . . . 74.34 112.089 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.6 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 33.4 m -70.45 -44.13 17.79 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.549 0.739 . . . . 73.21 111.739 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.575 ' HA ' HD11 ' C' ' 60' ' ' LEU . 86.9 Cg_exo -50.5 -41.57 51.94 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.459 2.106 . . . . 73.11 113.91 168.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -62.41 -26.81 68.68 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.64 0.776 . . . . 72.23 112.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -80.95 -45.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.139 0.576 . . . . 74.52 110.86 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.3 mt -78.12 -33.13 50.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.735 -0.666 . . . . 75.11 112.124 -171.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.557 ' HE1' HD23 ' C' ' 128' ' ' LEU . 25.0 t80 -51.36 -52.03 63.3 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.692 -1.147 . . . . 73.02 113.708 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 93.6 Cg_exo -48.89 -36.49 34.2 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.938 2.425 . . . . 72.33 114.685 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -72.9 -43.9 61.9 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.88 -0.6 . . . . 70.32 111.622 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.87 -39.4 93.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.744 0.418 . . . . 40.41 110.645 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -55.8 -57.06 13.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.481 1.513 . . . . 70.23 111.275 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -68.09 -31.73 71.56 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.514 0.725 . . . . 74.41 110.913 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.422 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.0 t -67.91 -37.93 82.32 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.255 0.622 . . . . 60.55 111.199 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.596 HD13 HG23 ' C' ' 64' ' ' VAL . 70.1 mt -64.78 -49.29 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.497 -0.774 . . . . 71.42 109.729 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -60.16 -34.45 73.59 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 123.882 0.739 . . . . 75.1 111.534 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -67.78 -38.84 83.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.256 -0.884 . . . . 75.22 110.083 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.618 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -69.43 -37.87 77.61 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.101 0.96 . . . . 73.22 112.273 178.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.06 -34.16 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.14 0.576 . . . . 73.23 109.498 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 39.5 t -65.19 -38.81 91.66 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-N 115.381 -0.827 . . . . 71.14 111.727 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.436 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.5 mtt-85 -72.21 -23.81 61.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.19 -0.914 . . . . 53.34 111.18 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.43 6.42 83.29 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 119.865 -0.408 . . . . 54.14 113.146 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.439 HG23 ' HB3' ' D' ' 17' ' ' TYR . 38.0 p 60.75 35.64 19.56 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.014 1.726 . . . . 54.41 112.18 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -115.06 148.12 39.88 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.534 0.734 . . . . 75.34 110.89 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -45.89 109.03 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.295 3.33 . . . . 42.44 112.822 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.06 131.55 51.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.304 -1.316 . . . . 70.53 111.967 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.3 tp -108.58 102.16 11.25 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.401 0.68 . . . . 74.24 109.443 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -90.97 111.89 23.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.952 -1.129 . . . . 64.13 107.952 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.557 HD23 ' HE1' ' C' ' 107' ' ' PHE . 16.9 tp -73.43 149.05 42.69 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.113 0.782 . . . . 71.14 113.113 -164.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.552 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -65.9 157.92 77.85 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.611 1.565 . . . . 74.31 112.784 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.57 ' HG2' HG21 ' A' ' 13' ' ' ILE . 8.2 Cg_exo -73.73 129.49 13.6 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.059 2.506 . . . . 74.41 112.56 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.53 107.66 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.751 -1.574 . . . . 53.05 106.751 168.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -102.78 103.64 13.87 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.234 -1.025 . . . . 73.33 108.234 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -62.25 -35.83 80.15 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.781 -0.645 . . . . 63.22 110.523 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 . . . . . 0 N--CA 1.476 0.832 0 C-N-CA 123.578 0.751 . . . . 73.54 112.092 176.371 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 57.5 m . . . . . 0 C--O 1.24 0.555 0 N-CA-C 108.031 -1.1 . . . . 72.43 108.031 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -157.59 93.32 1.28 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.728 -1.212 . . . . 74.0 107.728 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -117.56 115.88 26.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.87 -0.789 . . . . 63.25 108.87 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.402 HG12 ' HD2' ' D' ' 84' ' ' PHE . 22.0 mt -68.41 127.67 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.135 -1.061 . . . . 55.42 108.135 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.95 -42.47 14.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.65 -0.87 . . . . 72.11 108.65 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 178.92 150.6 0.28 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.312 1.045 . . . . 73.4 109.759 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.545 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -116.1 144.07 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.466 -1.309 . . . . 63.13 107.466 169.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.511 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 13.6 p90 -165.53 150.46 8.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.669 0.747 . . . . 74.2 111.108 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -78.02 109.76 12.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.623 -1.171 . . . . 62.33 109.228 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.579 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 46.6 mtpt -75.83 -32.86 59.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.819 -0.628 . . . . 73.34 109.435 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.4 t70 -149.23 137.42 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.697 -1.138 . . . . 64.43 109.452 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.618 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.0 mt -135.73 146.82 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.321 1.048 . . . . 71.41 108.674 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 m -147.66 138.3 23.25 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.161 0.984 . . . . 73.45 110.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.488 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.6 t80 -142.62 111.67 6.48 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 105.516 -2.031 . . . . 75.42 105.516 166.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.1 mt-10 -123.08 110.89 15.89 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.897 -0.779 . . . . 74.13 108.897 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.821 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -113.64 83.25 6.99 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.477 0.711 . . . . 71.35 109.336 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.27 -36.9 6.45 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.505 2.137 . . . . 71.24 111.807 -175.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 30.8 m-20 -112.41 22.77 14.32 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.041 0.936 . . . . 75.52 109.891 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.821 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.82 -60.48 4.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 114.394 1.257 . . . . 41.33 114.394 -168.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HE3' ' C' ' 19' ' ' LYS . 82.7 Cg_endo -75.12 -8.76 20.21 Favored 'Trans proline' 0 C--N 1.387 2.585 0 CA-C-N 121.751 1.661 . . . . 73.13 112.845 -175.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.428 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.3 t-160 -83.5 -37.17 23.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.43 1.492 . . . . 64.31 109.427 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' D' ' 73' ' ' ALA . 96.3 t -72.42 -32.49 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.777 . . . . 71.13 110.357 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -69.07 -3.1 11.87 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.528 0.936 . . . . 73.51 113.528 -176.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.94 -9.92 58.34 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.57 0.748 . . . . 72.23 111.306 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -110.4 114.29 27.61 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.672 1.189 . . . . 74.15 109.677 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.11 93.9 5.96 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.826 0.85 . . . . 73.21 112.106 -177.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' D' ' 68' ' ' LEU . 0.0 OUTLIER -168.78 -164.48 0.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.684 0.794 . . . . 73.33 111.262 -177.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -89.12 122.08 69.05 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 124.193 0.997 . . . . 74.4 111.544 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.743 ' HB3' HD11 ' D' ' 68' ' ' LEU . 74.2 Cg_exo -56.43 134.52 64.79 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.51 2.807 . . . . 73.51 114.531 165.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.11 114.0 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.553 -1.647 . . . . 74.4 106.553 166.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.18 138.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.554 0.742 . . . . 55.22 109.852 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -130.92 153.18 49.43 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.424 1.09 . . . . 71.0 111.134 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.6 120.0 37.18 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.847 -1.168 . . . . 62.3 107.847 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.582 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -105.66 145.38 31.13 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.105 -1.072 . . . . 74.12 108.105 171.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.68 147.34 44.79 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.489 0.661 . . . . 63.51 111.93 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.67 146.85 27.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.328 1.451 . . . . 62.41 107.705 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -123.62 155.76 37.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.411 0.684 . . . . 73.22 110.757 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -159.25 158.37 32.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.506 0.722 . . . . 70.13 110.312 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 60.7 p -160.25 153.22 21.52 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.395 0.678 . . . . 74.11 109.434 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 26.7 p -157.56 123.31 4.66 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.521 0.728 . . . . 71.21 109.582 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -70.36 120.46 16.05 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.434 -0.58 . . . . 72.12 109.434 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -89.88 -38.35 13.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 71.33 110.138 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.0 -175.95 5.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 75.12 110.262 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -67.19 128.26 35.71 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.671 -0.695 . . . . 71.32 109.291 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 45.5 m-20 63.13 13.99 7.3 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.349 1.06 . . . . 75.22 112.135 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.28 119.9 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.238 1.015 . . . . 71.44 108.483 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -132.86 128.61 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.185 -1.043 . . . . 53.13 108.185 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -94.71 130.97 41.01 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.367 -0.605 . . . . 65.21 109.367 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.87 119.08 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.839 -1.171 . . . . 73.44 107.839 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.9 t -106.28 129.42 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.85 -0.796 . . . . 75.44 108.85 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.29 113.1 20.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.115 -1.069 . . . . 60.22 108.115 176.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -86.87 98.26 11.11 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.884 -0.784 . . . . 71.13 108.884 172.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -91.48 127.32 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.008 -1.108 . . . . 74.55 108.008 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 16.9 m -126.62 148.33 49.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.988 -0.745 . . . . 51.02 108.988 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.1 t -136.42 109.49 8.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 125.317 1.447 . . . . 72.43 108.192 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 122.27 44.78 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.994 0.518 . . . . 72.43 109.633 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' D' ' 73' ' ' ALA . . . -107.63 135.14 49.57 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.78 -0.822 . . . . 71.51 108.78 172.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -135.39 116.22 14.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.031 -1.47 . . . . 62.54 107.031 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' D' ' 38' ' ' PRO . 9.9 mp -122.42 115.45 22.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.555 -0.748 . . . . 64.41 110.662 -167.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.79 -111.32 3.27 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.799 -0.92 . . . . 53.35 110.799 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.59 6.61 8.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.067 0.947 . . . . 72.21 109.172 174.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.5 174.92 7.48 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.846 0.858 . . . . 72.21 110.035 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -84.18 135.29 34.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.249 0.619 . . . . 63.14 110.793 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' D' ' 68' ' ' LEU . . . -81.19 -73.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.725 . . . . 73.3 109.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -153.6 155.55 36.31 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.272 -1.331 . . . . 74.44 109.947 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.2 mt -123.08 110.93 15.94 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 107.928 -1.138 . . . . 53.24 107.928 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.4 t -115.78 133.74 55.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.966 -0.753 . . . . 62.15 108.966 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -153.86 132.87 12.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.637 0.375 . . . . 72.12 110.252 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.58 115.69 15.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.901 0.881 . . . . 74.13 109.327 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -88.7 86.82 7.06 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.723 -0.843 . . . . 71.31 108.723 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.21 95.13 6.19 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.704 -1.135 . . . . 73.43 109.468 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -91.96 143.35 16.5 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.208 -0.757 . . . . 61.43 111.208 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.57 130.03 3.92 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 110.274 -1.13 . . . . 74.34 110.274 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -89.8 127.1 42.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.816 . . . . 74.23 108.795 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.402 ' HD2' HG12 ' D' ' 13' ' ' ILE . 36.6 m-85 -130.21 125.41 34.85 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.602 -0.518 . . . . 75.51 109.602 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.3 m -79.33 95.24 5.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.471 0.709 . . . . 73.12 109.304 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 mt -108.4 123.32 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.721 0.808 . . . . 52.31 109.625 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -152.64 169.84 21.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.278 1.031 . . . . 62.33 109.711 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.63 2.01 73.79 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.9 0.72 . . . . 62.24 114.9 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 pt -135.93 148.5 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.005 0.922 . . . . 73.21 109.517 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.86 159.71 41.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.566 0.746 . . . . 63.21 110.813 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.82 -115.53 7.38 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 124.279 0.987 . . . . 63.43 115.372 167.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.4 m -68.68 -33.04 73.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.063 0.945 . . . . 64.44 111.891 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.08 -44.74 62.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.762 0.425 . . . . 72.35 111.025 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.82 67.68 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.979 -0.378 . . . . 51.42 109.979 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.24 -39.19 82.35 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.547 0.739 . . . . 54.21 110.649 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -63.61 -42.27 98.24 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.849 0.46 . . . . 73.44 110.034 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.4 -47.77 80.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.848 0.459 . . . . 74.41 110.955 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -34.36 46.92 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.452 0.701 . . . . 63.14 110.576 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.82 -15.57 72.57 Favored Glycine 0 N--CA 1.466 0.677 0 CA-C-N 116.271 -0.422 . . . . 61.1 113.47 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.17 -63.89 0.83 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.618 0.599 . . . . 73.22 112.618 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -72.46 -48.02 44.21 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 112.634 0.605 . . . . 65.1 112.634 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.35 -46.23 90.13 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.556 0.742 . . . . 70.54 112.855 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.16 -31.19 54.7 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.043 1.828 . . . . 72.24 112.182 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -72.09 -17.99 61.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.703 0.801 . . . . 72.25 111.024 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.0 mm -80.2 -43.81 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.478 0.711 . . . . 50.12 110.051 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.81 -32.62 57.75 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.545 0.738 . . . . 71.11 112.571 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.06 -44.79 95.47 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 124.154 0.981 . . . . 54.01 113.095 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.85 -37.24 98.6 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.536 2.157 . . . . 74.25 114.075 172.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -79.91 -25.96 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.087 0.555 . . . . 62.13 111.838 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.22 -50.07 62.14 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.105 -0.702 . . . . 41.04 109.105 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.5 -35.59 76.29 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.564 1.165 . . . . 52.42 111.301 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . 0.436 ' HG2' HH12 ' C' ' 120' ' ' ARG . 26.8 tt0 -56.35 -52.13 65.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.151 0.98 . . . . 71.03 110.865 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.915 -1.039 . . . . 73.3 111.132 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.444 HG12 ' SG ' ' D' ' 76' ' ' CYS . 87.7 mt -58.74 -63.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.185 0.994 . . . . 64.51 110.508 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 34.9 m -52.03 -38.17 56.0 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.467 1.107 . . . . 75.21 112.206 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 25.9 t -66.41 -45.21 80.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.52 0.728 . . . . 73.34 111.04 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.95 -36.71 80.57 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.886 0.475 . . . . 70.33 111.554 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.9 t -64.4 -40.27 88.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 115.306 -0.861 . . . . 64.35 110.224 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -31.33 65.99 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.601 0.36 . . . . 73.35 111.202 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 93.8 mtt-85 -73.16 -23.52 60.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.286 0.634 . . . . 62.03 110.994 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.31 12.41 69.01 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.743 0.652 . . . . 60.51 112.861 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.493 HG23 ' HB3' ' C' ' 17' ' ' TYR . 54.3 p 59.78 22.21 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.277 1.831 . . . . 71.11 113.619 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.23 161.64 30.45 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.423 1.089 . . . . 70.52 109.387 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -74.9 144.34 30.5 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.256 1.971 . . . . 62.33 111.172 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.78 HE21 HG21 ' A' ' 122' ' ' THR . 5.0 pt20 -44.84 121.78 2.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.666 1.186 . . . . 73.34 111.934 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.78 95.42 5.72 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.616 -1.253 . . . . 74.15 107.616 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -103.77 109.26 20.91 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.303 -0.862 . . . . 72.3 109.134 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.83 118.97 11.77 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.614 -0.721 . . . . 35.44 109.057 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.2 138.66 97.49 Favored Pre-proline 0 CA--C 1.55 0.953 0 O-C-N 123.963 0.789 . . . . 53.25 111.15 -178.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.45 132.12 10.97 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.429 2.086 . . . . 73.54 112.882 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.71 121.96 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.366 -0.976 . . . . 73.41 108.366 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -77.27 97.54 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.084 -0.71 . . . . 70.32 109.084 175.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 . . . . . 0 CA--C 1.542 0.659 0 CA-C-N 115.48 -0.782 . . . . 62.01 111.156 -179.404 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.9 m . . . . . 0 N--CA 1.469 0.499 0 N-CA-C 109.665 -0.495 . . . . 63.31 109.665 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.557 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.7 t80 -135.89 122.33 20.67 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.908 -1.145 . . . . 73.55 107.908 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 61.2 tp60 -144.78 102.71 3.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.099 -0.334 . . . . 72.52 110.099 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.706 HG21 ' HG2' ' C' ' 130' ' ' PRO . 58.2 mt -71.93 128.34 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.101 -0.703 . . . . 71.34 109.101 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -103.68 -37.55 7.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.917 0.487 . . . . 42.23 110.011 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -165.53 138.73 4.42 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 110.209 -0.293 . . . . 74.22 110.209 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -128.4 134.01 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.57 -0.9 . . . . 74.21 108.57 172.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' B' ' 122' ' ' THR . 22.9 p90 -165.07 147.02 7.87 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 65.43 110.961 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.44 110.48 11.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.79 -0.819 . . . . 75.3 108.79 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -76.05 -22.52 55.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.025 -0.534 . . . . 74.23 110.511 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.87 142.16 17.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.797 -1.092 . . . . 71.43 109.441 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.7 140.2 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 106.732 -1.581 . . . . 73.03 106.732 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 31.1 t -150.85 141.75 22.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.8 -0.815 . . . . 73.02 108.8 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.8 t80 -151.78 110.78 3.87 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 105.955 -1.869 . . . . 62.25 105.955 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -122.35 118.15 27.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.356 -0.609 . . . . 74.23 109.356 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.89 83.73 1.11 Allowed Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 107.802 -1.185 . . . . 55.53 107.802 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.88 -42.64 36.19 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.859 2.372 . . . . 71.4 112.929 -166.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.435 HD22 ' HG2' ' A' ' 71' ' ' GLU . 14.3 m-20 -109.64 29.89 7.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 118.415 -0.803 . . . . 64.32 109.815 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.89 -57.06 5.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 117.583 -1.199 . . . . 70.32 113.669 -173.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.7 Cg_exo -64.42 -29.33 62.52 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.618 1.614 . . . . 62.31 112.348 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -79.8 -35.75 38.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.853 -1.067 . . . . 72.22 110.883 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.1 p -80.88 -13.49 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 115.749 -0.66 . . . . 73.05 111.879 -168.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -76.57 -11.72 59.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.174 0.59 . . . . 72.34 110.781 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -91.25 -12.5 35.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.495 1.118 . . . . 64.13 110.913 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 27.9 mmmt -81.62 166.2 20.4 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.671 0.788 . . . . 74.21 112.103 -173.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.14 139.18 39.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.254 -1.339 . . . . 75.3 108.576 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -81.31 69.35 7.92 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.579 0.704 . . . . 74.43 111.16 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -134.35 71.48 72.01 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.871 0.868 . . . . 54.12 108.93 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 67' ' ' SER . 92.4 Cg_endo -81.91 143.18 12.92 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.28 1.987 . . . . 62.34 111.704 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -104.65 102.37 11.97 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.79 -1.189 . . . . 65.35 107.79 164.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 65' ' ' THR . 42.4 t -74.43 94.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 60.1 tttm -80.85 113.84 19.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.129 0.972 . . . . 75.53 109.519 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.13 125.67 44.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.121 -1.066 . . . . 53.2 108.121 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -120.01 129.65 54.36 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.334 -0.987 . . . . 75.11 108.334 176.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.43 117.56 34.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.15 -0.685 . . . . 72.41 109.15 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.079 -1.082 . . . . 75.45 108.079 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -152.14 163.46 39.32 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 122.834 0.454 . . . . 75.05 111.15 -174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -160.91 153.23 20.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.099 0.96 . . . . 44.34 109.974 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -131.23 151.45 51.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.814 -0.81 . . . . 54.2 108.814 167.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -158.21 145.5 18.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.859 0.464 . . . . 73.24 110.675 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -88.19 113.62 23.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.504 0.722 . . . . 51.41 109.585 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.46 -35.81 24.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.836 0.455 . . . . 73.23 110.269 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.74 -174.61 4.7 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.364 1.066 . . . . 70.14 109.839 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.64 130.09 40.31 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.225 -0.658 . . . . 74.42 109.225 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 69.37 -9.89 0.6 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.819 1.648 . . . . 63.02 112.813 -170.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.57 109.41 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.649 0.78 . . . . 74.22 109.188 -170.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -126.81 157.2 39.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.039 -1.097 . . . . 73.34 108.039 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -132.51 146.08 51.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.027 0.931 . . . . 64.25 109.355 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.92 132.87 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.853 -1.166 . . . . 53.53 107.853 167.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.22 133.63 58.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.774 -0.824 . . . . 72.54 108.774 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 103' ' ' PRO . 75.5 mt -116.69 100.55 7.89 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.969 -1.122 . . . . 73.5 107.969 173.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -85.32 102.31 13.28 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.647 -0.871 . . . . 71.22 108.647 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.531 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.9 t -92.13 119.78 40.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.133 -1.062 . . . . 73.11 108.133 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -103.7 135.08 45.93 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.391 0.615 . . . . 71.54 110.207 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -131.12 114.17 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.589 -1.187 . . . . 74.13 108.738 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 1.1 m -115.35 138.72 50.68 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 108.627 -0.879 . . . . 53.43 108.627 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.27 129.08 42.82 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.105 -0.702 . . . . 73.54 109.105 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 64.1 m -134.18 124.34 25.86 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.589 -0.523 . . . . 72.32 109.589 173.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 73' ' ' ALA . 9.5 mp -88.4 85.14 6.82 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.398 -0.964 . . . . 75.22 108.398 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 -82.59 1.64 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.011 -0.995 . . . . 70.14 110.711 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -27.15 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.122 0.969 . . . . 72.21 111.612 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG2' HD22 ' A' ' 27' ' ' ASN . 36.9 tt0 -99.32 127.18 45.3 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.086 0.555 . . . . 72.14 110.239 -172.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 65.8 m -74.05 138.36 43.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.471 0.709 . . . . 63.12 111.909 -175.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -87.3 -64.06 1.21 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.63 1.172 . . . . 72.13 110.56 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -153.76 172.56 17.12 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.264 -0.88 . . . . 64.02 111.781 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.0 tp -141.53 137.95 32.38 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.813 -1.539 . . . . 35.12 107.799 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.9 m -121.86 139.62 53.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.702 0.801 . . . . 52.15 109.864 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 22.3 mp0 -137.25 122.78 19.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.614 1.166 . . . . 65.14 108.068 169.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.95 108.03 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 108.184 -1.043 . . . . 63.52 108.184 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.01 81.76 8.37 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 124.296 0.998 . . . . 74.11 108.314 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.06 93.84 3.36 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.309 -0.997 . . . . 72.44 108.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.93 153.58 27.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.407 -0.815 . . . . 65.44 111.376 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.55 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.29 122.17 1.19 Allowed Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.083 -0.807 . . . . 43.43 111.083 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mt -82.78 116.3 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.397 0.679 . . . . 63.42 109.431 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HD2' HG12 ' A' ' 13' ' ' ILE . 31.6 m-85 -120.63 118.7 30.81 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 73.01 108.267 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 t -91.33 99.71 12.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.583 -0.895 . . . . 53.41 108.583 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.529 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -121.14 152.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.255 0.622 . . . . 40.4 111.191 -173.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 162.89 33.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.117 0.967 . . . . 72.14 109.843 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.61 -14.38 47.25 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.793 -0.448 . . . . 71.41 114.013 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.76 136.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.618 0.709 . . . . 74.12 109.676 177.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -145.56 175.28 10.46 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.99 1.316 . . . . 72.14 108.467 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.52 -121.45 26.63 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 123.439 0.462 . . . . 52.11 113.798 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -73.07 -25.7 61.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.285 0.634 . . . . 73.32 111.416 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -67.67 -47.11 70.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.446 0.698 . . . . 73.55 110.057 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.458 ' HA ' ' HB3' ' A' ' 97' ' ' CYS . 21.7 ttt -81.93 -19.47 40.68 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.571 -0.741 . . . . 75.45 110.518 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.22 73.67 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.599 0.36 . . . . 62.12 110.395 171.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -79.46 -37.56 36.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.357 0.663 . . . . 74.13 110.503 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.6 t -63.91 -44.76 92.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.228 0.611 . . . . 42.31 110.752 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 15.9 mt -92.39 -9.42 41.77 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.53 0.332 . . . . 54.2 111.049 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.65 -29.04 17.27 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.28 0.472 . . . . 64.42 114.28 -177.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.42 -46.14 0.14 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.485 0.55 . . . . 75.2 112.485 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.0 t80 -60.88 -65.63 0.66 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.053 0.941 . . . . 73.42 112.699 -171.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.4 m -70.75 -34.04 3.42 Favored Pre-proline 0 CA--C 1.565 1.52 0 C-N-CA 123.72 0.808 . . . . 71.44 112.647 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.524 ' HA ' HD11 ' A' ' 60' ' ' LEU . 98.0 Cg_exo -49.5 -39.85 45.31 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.263 1.975 . . . . 71.35 113.874 162.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.28 -12.79 61.64 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.364 0.665 . . . . 70.32 111.802 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -78.11 -48.38 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.285 -0.635 . . . . 75.41 109.285 171.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.55 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.0 mt -82.31 -28.43 31.69 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.917 0.887 . . . . 72.42 113.103 -170.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.23 -41.5 69.35 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.169 -0.92 . . . . 75.0 113.425 -172.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.33 -36.51 87.18 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.93 1.753 . . . . 74.15 113.138 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -69.89 -42.38 73.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.062 0.545 . . . . 75.0 111.452 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.0 94.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.176 0.591 . . . . 42.41 109.846 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -54.02 -51.86 62.64 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.676 1.235 . . . . 71.14 110.425 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.12 -47.04 86.36 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.395 1.06 . . . . 72.54 110.979 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.406 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 36.4 t -57.61 -43.56 84.8 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.082 0.864 . . . . 72.43 110.763 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 ' HB ' ' A' ' 62' ' ' VAL . 81.2 mt -65.81 -51.19 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 124.074 0.859 . . . . 64.43 110.303 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.453 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.4 m -53.96 -41.88 68.31 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.094 0.871 . . . . 73.51 111.096 -176.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.9 t -68.93 -45.82 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.63 -1.168 . . . . 71.13 110.471 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 17.2 mtp -56.76 -41.86 78.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.648 0.779 . . . . 52.03 111.428 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.498 HG21 HD23 ' A' ' 126' ' ' LEU . 73.5 t -66.1 -45.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.655 1.182 . . . . 64.21 110.544 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.4 p -73.52 -26.72 61.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.331 -0.395 . . . . 44.11 111.181 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.7 mtt-85 -73.81 -33.12 64.05 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.668 0.787 . . . . 52.31 109.399 172.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' B' ' 18' ' ' THR . . . -74.95 -1.38 62.57 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 115.437 -0.801 . . . . 73.41 112.686 170.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.34 31.98 17.14 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.744 2.018 . . . . 74.32 112.433 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -94.01 154.91 40.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.758 -1.201 . . . . 53.51 107.758 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_exo -51.78 142.19 42.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.776 2.318 . . . . 72.12 112.161 177.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.24 127.26 28.5 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.878 0.736 . . . . 73.12 111.516 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 118' ' ' VAL . 32.9 tp -111.05 95.18 5.38 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.608 -1.178 . . . . 64.4 109.294 -176.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -103.04 107.53 18.37 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.843 -1.169 . . . . 51.41 107.843 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.2 tp -72.39 134.15 45.28 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.381 -0.6 . . . . 65.32 109.381 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -63.63 141.24 97.9 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.578 0.751 . . . . 73.32 111.861 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 21.0 Cg_endo -87.21 110.91 0.81 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.562 2.174 . . . . 71.52 111.838 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.7 125.05 54.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.422 -0.955 . . . . 72.13 108.422 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.73 79.93 7.28 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -61.85 -34.21 75.57 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.6 -0.727 . . . . 73.23 110.041 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 . . . . . 0 C--N 1.351 0.655 0 CA-C-N 114.549 -1.205 . . . . 75.24 111.094 179.614 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.687 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 19.9 m . . . . . 0 C--O 1.24 0.554 0 N-CA-C 107.948 -1.13 . . . . 71.43 107.948 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -146.67 113.71 6.17 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.175 -0.676 . . . . 72.25 109.175 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.66 140.12 27.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.885 -0.783 . . . . 74.11 108.885 165.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.683 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -90.66 126.81 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.275 -0.875 . . . . 70.54 108.816 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.69 -52.6 5.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.52 0.676 . . . . 73.0 109.988 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -151.07 132.9 15.02 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.944 -0.472 . . . . 73.12 110.878 -169.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.683 HG13 HD11 ' B' ' 13' ' ' ILE . 96.5 mt -114.36 140.73 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.214 -1.773 . . . . 63.04 106.214 166.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.427 ' HE1' HG13 ' B' ' 83' ' ' ILE . 34.9 p90 -164.09 150.73 11.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.416 0.627 . . . . 75.12 111.333 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.424 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 96.3 m -74.18 126.83 31.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.589 -1.187 . . . . 71.1 108.246 167.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -91.91 -48.04 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.769 -1.197 . . . . 71.41 107.769 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 21.5 m-20 -138.88 143.0 38.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 115.091 -0.959 . . . . 75.22 110.471 -165.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.5 mm -136.23 144.44 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.939 1.296 . . . . 72.53 109.164 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 60.3 m -142.83 135.29 27.62 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.201 1.4 . . . . 73.14 108.166 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.36 107.95 3.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.364 -1.717 . . . . 74.44 106.364 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.73 124.02 47.45 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.993 -0.743 . . . . 75.12 108.993 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -125.02 82.11 61.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 106.917 -1.512 . . . . 61.24 106.917 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.33 -22.11 34.5 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.317 2.678 . . . . 75.22 112.164 -172.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -122.64 29.77 6.75 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.751 1.22 . . . . 52.24 109.392 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.3 -45.42 42.8 Favored Pre-proline 0 CA--C 1.576 1.944 0 N-CA-C 115.819 1.785 . . . . 72.42 115.819 -173.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 59.8 Cg_endo -75.51 -30.12 6.79 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.543 1.496 . . . . 42.35 113.137 172.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 71.0 m80 -90.92 -15.2 30.22 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.322 0.86 . . . . 72.32 113.322 -170.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -19.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.927 0.891 . . . . 70.24 111.819 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.26 -19.11 64.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.977 1.311 . . . . 71.14 112.295 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 23.8 pt20 -64.36 -36.92 85.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.811 0.444 . . . . 62.32 110.442 175.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' B' ' 68' ' ' LEU . 90.5 mttt -106.34 65.48 0.68 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.671 -0.863 . . . . 72.03 108.671 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.28 100.43 5.1 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.322 -0.399 . . . . 73.32 110.045 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.475 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 163.41 -177.36 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 127.643 2.377 . . . . 75.32 109.731 156.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.15 121.15 28.91 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.984 1.314 . . . . 61.51 114.175 -170.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.06 174.55 10.0 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.413 2.075 . . . . 75.34 110.816 163.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.57 103.23 6.45 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.481 -1.303 . . . . 73.53 107.481 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.72 141.13 14.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.864 -0.791 . . . . 72.31 108.864 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -132.65 130.85 40.7 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.355 -0.609 . . . . 72.12 109.355 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.409 HD22 HD11 ' B' ' 128' ' ' LEU . 4.4 pp -86.22 140.6 29.99 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.02 -1.104 . . . . 73.22 108.02 165.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.38 151.52 46.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.671 -1.233 . . . . 65.02 107.671 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.84 134.1 40.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.147 0.431 . . . . 73.35 110.171 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' B' ' 61' ' ' ARG . 7.8 m-20 -123.4 138.2 54.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.973 0.909 . . . . 63.31 109.06 173.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.2 p -109.62 146.75 34.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.207 0.603 . . . . 61.0 110.315 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.76 143.51 15.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.958 0.903 . . . . 70.35 108.933 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.2 p -141.75 160.93 39.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.895 0.316 . . . . 65.54 110.626 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.19 141.83 21.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.53 0.732 . . . . 64.43 110.446 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.44 121.83 30.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.438 0.695 . . . . 71.42 109.927 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 mt -94.17 -40.12 10.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 34.32 110.435 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.69 -168.33 1.78 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.728 -1.124 . . . . 71.24 109.716 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.66 112.77 14.82 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.164 -0.925 . . . . 60.02 109.387 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 65.26 3.95 2.45 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.184 1.394 . . . . 73.43 112.745 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 92.8 t -104.73 113.64 42.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.902 -1.148 . . . . 53.14 107.902 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.14 169.81 13.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.441 -0.8 . . . . 65.01 109.101 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -138.5 107.77 6.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.783 -0.821 . . . . 73.04 108.783 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.09 127.75 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.343 1.457 . . . . 62.21 109.577 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.69 132.29 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.888 0.875 . . . . 75.21 109.631 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' B' ' 103' ' ' PRO . 50.0 tp -124.5 118.3 26.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.942 -0.762 . . . . 75.54 108.942 171.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.455 ' HD2' ' HB2' ' B' ' 45' ' ' ASP . 28.9 ttm180 -84.17 133.22 34.61 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.127 -1.064 . . . . 74.11 108.127 169.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.97 116.58 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.193 -1.04 . . . . 74.34 108.193 169.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -104.98 146.43 29.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.808 1.243 . . . . 74.31 109.017 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.75 97.8 3.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 107.907 -1.146 . . . . 74.23 107.907 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.0 m -93.89 135.32 35.34 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.21 -0.663 . . . . 71.22 109.21 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.1 136.64 25.29 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.751 0.821 . . . . 51.13 108.887 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -147.66 130.3 15.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.154 0.582 . . . . 53.31 111.067 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 57.8 mt -98.99 104.85 16.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.374 1.069 . . . . 53.33 109.651 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.44 -110.23 3.2 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.908 -0.587 . . . . 71.32 111.643 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.94 4.71 14.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.73 0.812 . . . . 72.12 111.121 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.17 176.17 5.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.462 -0.569 . . . . 71.52 109.462 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 7.4 m -75.72 157.25 33.82 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.702 0.801 . . . . 65.52 110.34 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -110.18 -61.73 1.62 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.034 -0.728 . . . . 65.14 109.034 166.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -166.04 141.09 4.67 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.738 -1.119 . . . . 74.43 108.644 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.26 132.55 54.87 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.381 -0.97 . . . . 74.21 108.381 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.429 ' SG ' HG23 ' B' ' 114' ' ' ILE . 48.4 t -140.74 153.59 45.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.591 -0.892 . . . . 50.44 108.591 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.3 tt0 -166.18 141.59 4.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.134 -0.691 . . . . 75.54 109.134 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' B' ' 113' ' ' CYS . 86.2 t -129.45 146.29 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.257 -1.016 . . . . 75.4 108.257 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 49.2 mt-30 -122.54 96.93 5.23 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.96 -1.126 . . . . 72.03 107.96 171.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -92.85 106.85 18.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.877 -1.056 . . . . 72.04 108.811 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.34 171.58 35.34 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.632 -0.587 . . . . 73.02 111.632 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.83 126.99 1.54 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 112.056 -0.418 . . . . 70.02 112.056 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.8 mt -84.68 116.69 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.877 0.871 . . . . 73.2 109.038 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -124.0 146.83 48.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.467 1.107 . . . . 63.3 108.609 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 61.3 m -106.86 104.61 14.34 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.153 -0.684 . . . . 50.32 109.153 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -114.03 134.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.828 0.851 . . . . 73.14 109.693 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.5 167.9 29.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.522 1.129 . . . . 73.14 109.317 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.66 -50.21 4.32 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.323 0.389 . . . . 65.54 112.9 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -62.68 146.39 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.403 0.681 . . . . 72.12 111.504 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.3 178.46 6.21 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.731 0.813 . . . . 72.21 110.627 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -122.05 27.41 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 123.845 0.715 . . . . 63.05 113.536 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.7 m -78.3 -37.38 44.94 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.023 0.929 . . . . 72.12 110.569 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -76.03 -26.97 57.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.561 -0.745 . . . . 65.32 111.987 -166.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -66.11 -30.85 71.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.479 0.181 . . . . 74.14 110.693 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.52 75.72 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.868 0.73 . . . . 72.53 110.515 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 62.9 t-80 -76.01 -32.4 59.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.451 0.3 . . . . 73.0 110.896 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.47 -55.65 9.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.946 0.498 . . . . 72.44 110.629 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.75 -38.43 38.77 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.806 0.842 . . . . 72.52 110.0 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.68 -1.62 85.24 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.084 0.794 . . . . 55.25 115.084 -171.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -142.02 -56.88 0.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.909 0.855 . . . . 52.5 111.524 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.87 -46.03 47.27 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.451 0.537 . . . . 71.04 112.451 -170.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -62.04 -46.34 91.68 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.503 -0.761 . . . . 50.11 112.988 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.472 ' HB2' HD22 ' B' ' 60' ' ' LEU . 59.4 Cg_endo -68.9 -22.2 36.54 Favored 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 121.889 1.726 . . . . 74.23 112.849 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -71.76 -30.49 65.63 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.407 0.683 . . . . 71.41 111.13 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.52 -48.16 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 65.23 110.986 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.63 -10.78 57.03 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.866 -0.606 . . . . 72.22 111.941 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -56.5 -47.6 98.64 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-O 117.895 -1.05 . . . . 73.31 113.656 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.03 -31.3 53.03 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.531 2.154 . . . . 70.14 114.323 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -74.06 -43.64 57.08 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.12 0.568 . . . . 53.14 110.515 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.92 91.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.105 0.562 . . . . 62.04 110.4 174.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . 0.701 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 52.7 ttt-85 -51.35 -53.72 33.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.081 1.752 . . . . 74.43 112.215 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -70.59 -34.01 71.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.308 0.643 . . . . 75.31 110.703 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.6 t -71.13 -30.41 66.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.04 0.536 . . . . 62.45 111.446 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.429 HG23 ' SG ' ' B' ' 76' ' ' CYS . 63.7 mt -65.28 -52.18 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 109.525 -0.546 . . . . 75.0 109.525 173.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -60.06 -34.08 72.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.926 0.89 . . . . 75.24 111.854 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -57.98 -49.8 75.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.549 0.74 . . . . 75.32 110.493 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.0 mmt -72.22 -34.32 68.25 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.665 0.786 . . . . 74.24 111.563 -173.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.88 -37.19 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.776 0.83 . . . . 73.1 110.798 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . 0.422 ' HB2' ' OE1' ' C' ' 125' ' ' GLN . 3.6 t -74.18 -30.85 62.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.628 0.771 . . . . 52.21 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' B' ' 116' ' ' SER . 87.6 mtt-85 -67.02 -30.09 70.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.326 0.65 . . . . 74.22 110.295 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.41 12.99 59.32 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-O 119.468 -0.629 . . . . 55.11 113.554 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 17' ' ' TYR . 60.3 p 58.23 27.08 14.65 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.843 1.657 . . . . 75.25 113.364 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -91.8 165.26 21.0 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.07 0.948 . . . . 71.3 110.736 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -59.55 177.48 0.44 Allowed 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.436 2.757 . . . . 70.15 115.696 177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.757 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 67.3 tp60 -64.44 143.57 57.81 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.565 -1.198 . . . . 71.41 111.806 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 30.7 tp -134.77 93.02 2.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.998 -0.742 . . . . 74.41 108.998 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.425 HD21 ' HA ' ' C' ' 122' ' ' THR . 17.1 m120 -92.86 98.89 11.67 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.46 -0.941 . . . . 74.22 108.46 173.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.701 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 42.8 tp -71.93 131.17 42.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.216 0.606 . . . . 60.51 109.764 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.25 151.5 56.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.835 0.854 . . . . 52.42 112.199 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -54.93 124.58 16.64 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.505 2.803 . . . . 75.12 113.297 171.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.61 112.64 40.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.633 -1.247 . . . . 65.21 107.633 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -79.94 83.44 5.85 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.657 -0.868 . . . . 70.23 108.657 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 . . . . . 0 N--CA 1.48 1.065 0 C-N-CA 123.979 0.911 . . . . 63.43 111.125 -177.87 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.408 ' HA ' HG13 ' C' ' 89' ' ' ILE . 56.8 ttp . . . . . 0 CA--C 1.551 1.015 0 CA-C-O 121.235 0.541 . . . . 73.33 111.508 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 28.6 m -87.6 97.65 10.98 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.253 -1.017 . . . . 45.0 108.253 172.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -124.51 140.58 52.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.623 -0.717 . . . . 65.14 109.971 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' C' ' 85' ' ' SER . 0.1 OUTLIER -161.05 140.63 10.61 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 125.174 1.39 . . . . 75.34 107.491 172.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.423 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.8 pp -74.59 130.25 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.249 -0.649 . . . . 64.43 109.249 176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -95.24 -46.52 6.72 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.314 -0.624 . . . . 64.52 109.314 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 28.4 ttt85 -169.78 151.47 4.23 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.666 0.604 . . . . 64.1 110.741 -177.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.74 133.91 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.949 1.3 . . . . 70.24 107.546 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -171.0 157.05 5.1 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.433 0.635 . . . . 75.02 111.693 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.0 p -85.8 108.37 18.07 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.469 -0.787 . . . . 65.51 109.433 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . 0.423 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 13.0 mtmt -76.58 -35.95 57.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.441 0.639 . . . . 70.41 109.709 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.9 t70 -142.14 122.63 14.1 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.777 -1.102 . . . . 72.52 109.048 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -116.57 140.91 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.775 -1.565 . . . . 72.44 106.775 166.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -150.9 146.26 26.18 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.224 0.535 . . . . 72.21 110.203 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -152.43 109.8 3.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.491 -1.299 . . . . 74.43 107.491 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.7 116.27 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 74.52 108.551 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.01 89.78 10.16 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 106.914 -1.513 . . . . 73.24 106.914 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -49.99 0.92 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.595 2.196 . . . . 63.23 111.605 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.96 22.7 3.07 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 118.619 -0.705 . . . . 75.11 110.339 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.52 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -38.94 -53.3 3.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 115.524 1.676 . . . . 71.25 115.524 -171.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.7 Cg_exo -75.49 -39.41 1.06 Allowed 'Trans proline' 0 C--N 1.393 2.91 0 CA-C-N 121.472 1.561 . . . . 72.02 112.23 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.402 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.9 t60 -70.08 -26.23 63.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.643 1.177 . . . . 74.51 112.884 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -80.72 -22.71 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.754 0.422 . . . . 71.35 110.82 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . 0.494 ' HA ' ' CH2' ' C' ' 36' ' ' TRP . 19.0 m-30 -62.87 -32.87 74.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.759 0.424 . . . . 71.41 111.38 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 12.2 pt20 -86.24 6.28 30.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.052 0.541 . . . . 73.3 111.415 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -100.4 144.08 29.82 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.39 0.676 . . . . 65.31 110.505 -179.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.62 122.59 15.08 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.921 0.888 . . . . 62.41 110.011 171.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . 0.494 ' CH2' ' HA ' ' C' ' 32' ' ' PHE . 47.9 m95 -67.96 96.32 0.59 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.947 0.899 . . . . 71.23 112.147 -172.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -145.69 73.43 13.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.996 -0.547 . . . . 75.12 109.811 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -83.24 133.7 6.54 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.986 2.457 . . . . 72.54 112.41 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.7 91.66 8.36 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.253 -1.388 . . . . 73.44 107.253 167.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' C' ' 65' ' ' THR . 58.3 t -76.3 111.84 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.331 -0.849 . . . . 74.55 109.303 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 59.2 mttm -99.98 117.54 34.48 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.562 -0.903 . . . . 72.44 108.562 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.502 HD11 HD11 ' C' ' 128' ' ' LEU . 3.7 tt -86.6 122.34 30.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.333 -1.358 . . . . 73.43 107.333 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.514 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 18.9 m-20 -127.02 132.28 50.78 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.524 1.13 . . . . 64.12 109.13 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 33.5 mt -128.45 124.47 36.28 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.943 0.897 . . . . 73.05 109.37 174.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 16.6 t70 -116.31 150.86 36.97 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.647 1.179 . . . . 70.43 108.902 172.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 41.7 p -130.78 118.38 20.74 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.834 0.854 . . . . 62.01 109.649 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -125.69 149.1 48.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.834 0.854 . . . . 72.34 110.206 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -154.38 153.46 31.64 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.237 0.615 . . . . 61.44 110.802 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 71.6 p -157.37 152.31 25.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.252 0.621 . . . . 62.03 110.573 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -89.36 119.53 29.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.647 0.779 . . . . 71.0 109.265 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.1 mt -95.87 -31.61 13.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.114 0.566 . . . . 71.52 110.342 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.49 -172.87 3.32 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.083 0.953 . . . . 53.43 109.687 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -77.23 119.33 20.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.594 0.757 . . . . 63.23 109.265 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 69.89 -3.17 1.79 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.714 1.605 . . . . 73.13 112.556 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 81.5 t -104.34 115.2 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.631 0.772 . . . . 61.41 109.536 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.8 125.53 33.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.805 0.842 . . . . 71.21 108.878 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.2 tt0 -81.77 123.84 29.12 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.392 -0.596 . . . . 74.02 109.392 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -102.65 115.74 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.881 -1.155 . . . . 62.13 107.881 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.2 t -104.8 132.19 52.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.845 -0.798 . . . . 60.34 108.845 172.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.7 102.34 10.16 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.936 -1.505 . . . . 74.14 106.936 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 30.0 ttm180 -83.34 125.7 31.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.788 -0.819 . . . . 74.42 108.788 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.4 t -115.52 131.41 67.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.442 -1.318 . . . . 73.41 107.442 172.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 24.1 m -127.85 125.45 39.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.292 -1.003 . . . . 72.45 108.292 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.427 HG21 HG21 ' C' ' 114' ' ' ILE . 50.3 t -120.37 115.1 46.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.026 -0.731 . . . . 72.3 109.026 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.1 m -99.29 148.39 24.2 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 109.425 -0.583 . . . . 72.24 109.425 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.09 106.81 4.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.071 -1.085 . . . . 64.23 108.071 171.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.8 m -135.9 127.49 28.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.081 -0.34 . . . . 72.15 110.081 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.429 HD12 ' N ' ' C' ' 68' ' ' LEU . 4.2 mp -86.78 56.43 4.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.365 1.466 . . . . 43.41 108.238 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.34 -108.19 3.45 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 109.728 -1.349 . . . . 74.41 109.728 -173.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -25.61 17.37 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.193 0.997 . . . . 71.43 109.318 168.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -68.03 83.85 0.22 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.416 1.486 . . . . 60.2 110.884 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.1 m -73.55 120.35 19.03 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 121.083 0.468 . . . . 73.01 111.136 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.79 -55.72 7.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.536 -1.211 . . . . 74.2 108.847 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -167.16 169.36 12.75 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.789 -1.096 . . . . 71.02 111.477 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.85 138.51 49.88 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 105.232 -2.136 . . . . 51.15 105.232 165.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.6 t -139.88 111.99 7.58 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.888 -0.782 . . . . 70.22 108.888 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.45 128.12 52.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.019 0.527 . . . . 72.03 109.907 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.84 114.5 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.836 0.854 . . . . 73.13 108.75 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -88.73 91.05 8.66 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.911 -1.144 . . . . 70.52 107.911 170.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -78.95 97.72 6.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.806 -1.088 . . . . 75.14 109.146 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.423 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -84.49 151.47 26.73 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.731 -0.668 . . . . 71.1 111.832 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.81 120.89 1.1 Allowed Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.823 -0.911 . . . . 53.52 110.823 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.452 HD12 HD11 ' C' ' 51' ' ' LEU . 17.7 mm -81.72 128.56 38.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.423 ' HE2' HG22 ' C' ' 13' ' ' ILE . 58.7 m-85 -137.62 151.62 48.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.38 -0.97 . . . . 44.41 108.38 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.544 ' HB2' ' NE2' ' C' ' 12' ' ' GLN . 34.9 m -111.31 121.49 45.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.824 -0.806 . . . . 53.53 108.824 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.555 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.9 mp -113.5 120.88 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.224 -1.399 . . . . 72.5 107.224 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.21 171.07 17.07 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.707 0.803 . . . . 61.44 110.326 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.51 -57.4 3.07 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.807 -0.633 . . . . 72.13 112.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' C' ' 9' ' ' MET . 2.6 pp -113.94 179.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.054 0.941 . . . . 71.3 111.013 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.44 -169.42 3.22 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.825 0.85 . . . . 75.24 109.706 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.73 -135.17 20.09 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.964 -0.353 . . . . 72.13 113.539 171.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -66.83 -28.6 68.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.767 0.827 . . . . 40.42 111.489 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -64.49 -43.13 95.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.202 0.601 . . . . 75.34 110.44 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.555 ' HG2' HG21 ' C' ' 86' ' ' ILE . 0.3 OUTLIER -72.73 -43.8 62.48 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.961 -0.563 . . . . 71.52 110.317 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.03 -30.94 71.97 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.433 0.693 . . . . 74.41 111.671 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -71.5 -41.81 68.81 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.657 0.783 . . . . 75.12 110.275 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.84 -40.63 91.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.83 0.452 . . . . 34.33 111.024 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.5 tp -73.67 -37.66 65.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.302 1.041 . . . . 60.34 110.875 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 -3.85 56.91 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 115.117 0.807 . . . . 70.44 115.117 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.3 -54.36 0.63 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.903 0.851 . . . . 52.21 112.052 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.84 -49.21 40.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.635 0.374 . . . . 72.13 111.978 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.1 m -68.8 -44.06 29.81 Favored Pre-proline 0 CA--C 1.569 1.674 0 CA-C-O 118.726 -0.654 . . . . 74.14 112.041 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -56.85 -37.65 97.65 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 122.703 2.269 . . . . 65.02 113.865 170.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -56.84 -38.69 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.892 0.877 . . . . 74.44 110.927 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -73.16 -47.16 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.177 -0.919 . . . . 74.33 111.2 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' C' ' 82' ' ' GLY . 98.0 mt -79.11 -24.33 43.47 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.923 0.712 . . . . 74.21 112.923 -170.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.68 -53.13 66.03 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.244 1.018 . . . . 71.24 113.568 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.7 -31.15 49.83 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.788 1.659 . . . . 62.34 112.809 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 115' ' ' THR . 79.8 m-85 -68.5 -38.52 81.04 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.241 0.616 . . . . 50.15 111.317 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.77 91.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.231 -0.441 . . . . 63.41 110.154 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -53.34 -59.89 3.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.084 0.954 . . . . 75.22 111.906 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . 0.44 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -65.27 -31.33 72.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 73.13 110.837 -172.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.482 ' SG ' HG12 ' C' ' 21' ' ' ILE . 47.5 t -69.09 -36.83 78.02 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.1 0.56 . . . . 71.32 111.457 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.532 HD11 ' HB ' ' C' ' 62' ' ' VAL . 96.7 mt -70.7 -50.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.638 0.775 . . . . 62.52 110.174 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.1 m -64.4 -29.14 70.21 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.574 0.749 . . . . 71.03 111.052 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 24.1 t -63.53 -49.94 71.53 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.596 0.758 . . . . 64.24 109.316 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.39 -40.34 82.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.569 1.148 . . . . 71.53 112.315 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.1 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.697 0.799 . . . . 72.52 109.852 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.455 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 41.4 t -65.92 -31.75 72.85 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.992 0.917 . . . . 62.3 112.188 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -73.98 -37.43 64.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.599 0.76 . . . . 73.53 110.817 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.18 6.08 64.77 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.469 0.481 . . . . 74.11 112.591 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.425 ' HA ' HD21 ' B' ' 127' ' ' ASN . 46.2 p 63.98 20.11 12.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.865 2.066 . . . . 73.23 113.145 174.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -84.82 141.2 38.01 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.292 1.037 . . . . 54.22 108.987 173.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.757 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 84.3 Cg_exo -53.07 140.16 60.56 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.811 3.008 . . . . 70.41 116.854 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.455 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 9.1 mm-40 -56.45 117.06 3.47 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.601 1.56 . . . . 72.41 113.175 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 66.6 tp -119.57 125.41 48.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.996 0.918 . . . . 52.1 108.91 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -121.55 132.58 54.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 71.35 109.388 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.502 HD11 HD11 ' C' ' 42' ' ' LEU . 0.1 OUTLIER -71.5 138.43 48.93 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.581 0.753 . . . . 74.11 109.808 179.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.54 161.02 79.41 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.25 1.02 . . . . 62.45 110.833 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.706 ' HG2' HG21 ' A' ' 13' ' ' ILE . 35.0 Cg_exo -59.58 108.64 0.48 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.275 1.983 . . . . 72.11 112.563 177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.48 108.52 21.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.526 -1.287 . . . . 74.12 107.526 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -91.34 99.37 12.35 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.004 -1.11 . . . . 74.3 108.004 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -64.36 -38.54 91.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.546 -0.752 . . . . 75.24 110.393 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 . . . . . 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 70.35 112.0 176.904 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 21.4 m . . . . . 0 C--O 1.238 0.473 0 N-CA-C 109.192 -0.67 . . . . 72.22 109.192 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.75 94.38 0.95 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.447 -1.316 . . . . 72.43 107.447 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.56 123.24 37.26 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.854 -0.795 . . . . 64.53 108.854 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.582 HD13 HG21 ' D' ' 105' ' ' ILE . 5.8 mt -82.16 119.32 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.206 -0.665 . . . . 60.45 109.206 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -86.3 -34.21 20.4 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.374 -0.376 . . . . 75.32 111.104 -173.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -179.74 133.61 0.11 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.672 0.607 . . . . 61.34 110.094 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.475 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.2 mp -114.21 119.39 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.205 -1.776 . . . . 73.52 106.205 174.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.52 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 27.2 p90 -144.3 153.45 42.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 122.073 0.939 . . . . 74.22 110.16 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -85.27 113.69 21.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.235 -1.348 . . . . 71.35 108.766 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -78.79 -30.95 45.82 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.156 0.503 . . . . 74.55 109.769 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.0 142.3 24.21 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.482 -1.236 . . . . 54.53 109.89 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.3 mt -137.73 138.31 44.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.072 1.349 . . . . 74.01 107.96 173.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -139.4 136.82 35.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.301 1.04 . . . . 73.54 108.297 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -140.67 117.83 11.27 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.38 -1.711 . . . . 75.23 106.38 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.7 mt-10 -122.36 139.42 53.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.485 0.714 . . . . 65.51 109.158 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -127.29 79.91 72.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 106.906 -1.516 . . . . 73.21 106.906 173.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.25 -38.87 8.28 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.947 2.431 . . . . 41.21 113.036 -169.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -110.67 35.09 3.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.336 -0.987 . . . . 70.12 108.336 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.71 -66.53 0.6 Allowed Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 113.845 1.054 . . . . 24.13 113.845 -166.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' D' ' 28' ' ' ALA . 84.0 Cg_endo -74.69 -16.47 21.02 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 121.852 1.697 . . . . 71.21 112.653 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.419 ' HA ' HE21 ' D' ' 33' ' ' GLN . 13.6 t-160 -66.46 -42.3 87.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.925 1.29 . . . . 64.13 110.26 172.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.06 -41.48 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.492 0.717 . . . . 73.21 110.594 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -67.25 -15.38 63.66 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 124.02 0.825 . . . . 65.24 112.571 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.419 HE21 ' HA ' ' D' ' 30' ' ' HIS . 48.2 mt-30 -86.09 -7.57 58.51 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.506 1.122 . . . . 75.13 112.703 177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -127.31 114.62 17.82 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.678 1.191 . . . . 75.03 108.605 -172.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -98.42 95.26 7.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.428 1.013 . . . . 73.23 112.68 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.442 ' CH2' HD13 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -157.65 -179.54 8.26 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.859 0.864 . . . . 73.35 112.935 178.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -91.51 141.98 26.44 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 124.693 1.197 . . . . 54.5 112.185 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -91.74 124.5 0.8 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.578 2.852 . . . . 75.43 113.389 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.61 113.08 11.46 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.316 -0.994 . . . . 73.53 108.316 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -101.06 125.17 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.517 0.727 . . . . 74.1 110.498 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -109.56 144.33 38.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.1 0.96 . . . . 72.41 108.851 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 3.7 tt -119.59 124.45 46.38 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.49 -0.93 . . . . 64.24 108.49 178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -108.82 133.43 52.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.516 1.126 . . . . 75.03 108.805 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.62 130.95 55.59 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.973 -0.751 . . . . 52.31 108.973 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.69 146.44 43.78 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.815 0.846 . . . . 62.04 108.943 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -125.45 147.3 49.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.364 0.665 . . . . 70.22 110.651 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.42 164.02 36.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.745 1.218 . . . . 63.24 108.872 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -175.6 154.33 1.59 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.745 0.818 . . . . 63.23 110.708 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -165.76 138.79 4.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.368 0.667 . . . . 63.24 110.462 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.95 123.82 24.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.896 0.479 . . . . 72.53 109.926 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.32 -41.61 10.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.158 0.583 . . . . 64.35 110.593 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -152.22 -174.92 5.05 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.276 0.63 . . . . 65.01 110.541 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.59 111.4 3.6 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.209 -0.905 . . . . 71.45 109.87 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 67.37 21.61 9.7 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.415 1.086 . . . . 63.23 110.956 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 81.8 t -126.52 117.51 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.398 1.079 . . . . 70.24 108.614 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.61 ' HB2' HD12 ' D' ' 86' ' ' ILE . 54.1 m-85 -131.0 137.25 49.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.206 1.002 . . . . 74.02 108.503 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.47 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -92.24 136.24 33.35 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.832 0.853 . . . . 71.24 109.362 173.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -118.65 118.66 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.373 -1.343 . . . . 75.45 107.373 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 40.1 t -103.13 130.81 52.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.613 -0.884 . . . . 72.21 108.613 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -124.15 108.28 12.14 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.846 -1.168 . . . . 62.2 107.846 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.9 ttm180 -86.26 117.88 25.35 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.977 -0.556 . . . . 73.02 109.79 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.1 t -104.62 121.55 56.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.887 -1.153 . . . . 71.2 107.887 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -120.32 139.44 52.75 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.566 -0.531 . . . . 64.15 109.566 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 83.8 t -128.33 102.26 8.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 65.3 108.451 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.4 p -98.49 93.71 6.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.231 -1.026 . . . . 71.13 108.231 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.57 142.07 32.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.513 -1.221 . . . . 71.54 109.684 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 52.1 p -155.52 130.43 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 122.931 0.492 . . . . 54.51 110.717 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.672 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.2 OUTLIER -121.79 137.83 54.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.655 1.182 . . . . 54.1 109.461 177.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -113.43 4.0 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.392 0.433 . . . . 73.44 112.855 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.84 3.84 10.55 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.606 0.763 . . . . 74.45 110.288 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -130.69 173.5 10.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.144 0.578 . . . . 75.22 111.917 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 68.6 m -74.31 139.42 44.18 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.069 -0.969 . . . . 74.04 109.958 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.672 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -81.85 -70.66 0.53 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.802 -0.814 . . . . 44.32 108.802 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.54 139.78 18.48 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.155 -0.93 . . . . 72.23 109.552 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 96.3 mt -105.82 109.0 20.81 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.065 -1.087 . . . . 74.32 108.065 174.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.9 t -125.36 114.4 18.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.311 -0.626 . . . . 60.41 109.311 -174.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.17 122.24 17.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.14 -0.689 . . . . 53.34 109.14 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.86 117.61 48.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.836 0.854 . . . . 63.22 109.215 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.29 86.72 6.9 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.239 -1.023 . . . . 72.11 108.239 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.97 94.88 6.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.667 -1.151 . . . . 70.42 109.32 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.77 146.43 19.93 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.431 -0.668 . . . . 62.45 111.431 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.43 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -145.47 131.82 4.36 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.912 -0.875 . . . . 52.55 110.912 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 42.5 mt -90.24 131.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.897 -0.779 . . . . 62.33 108.897 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -132.51 139.93 48.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.24 0.616 . . . . 75.14 110.162 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -80.14 102.1 9.19 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 107.912 -1.144 . . . . 71.05 107.912 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' D' ' 56' ' ' TYR . 58.2 mt -106.6 110.31 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.378 -0.601 . . . . 63.33 109.378 -175.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -152.73 165.1 36.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.285 1.034 . . . . 72.13 110.18 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.33 44.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.733 0.653 . . . . 71.11 114.733 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.477 HD11 HG23 ' D' ' 86' ' ' ILE . 28.8 pt -124.94 147.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.907 1.283 . . . . 61.21 108.503 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.37 177.55 11.32 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 71.32 110.95 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.95 -137.44 46.12 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 123.596 0.56 . . . . 63.42 113.782 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -80.21 -15.77 56.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.515 0.726 . . . . 52.44 111.655 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.85 -51.13 66.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.303 0.641 . . . . 72.44 109.802 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -73.32 -28.79 62.27 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.612 -0.722 . . . . 63.15 110.303 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.66 72.53 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.831 0.453 . . . . 74.34 111.017 175.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -72.97 -40.68 65.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.807 0.843 . . . . 73.22 110.552 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -65.63 -44.66 85.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.267 0.627 . . . . 61.02 110.606 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.463 HD21 HD13 ' D' ' 86' ' ' ILE . 3.8 mm? -77.73 -20.18 53.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.078 0.951 . . . . 75.34 111.403 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 13.93 57.74 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.73 -0.483 . . . . 65.13 113.456 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.59 -64.04 0.09 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.031 0.416 . . . . 63.11 111.978 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -72.53 -48.96 36.12 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.418 0.687 . . . . 72.14 112.654 -167.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 59.9 m -63.58 -45.57 83.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.578 0.751 . . . . 43.24 112.506 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 43.7 Cg_exo -61.88 -30.97 84.74 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.261 1.974 . . . . 73.02 113.439 171.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -66.54 -28.24 68.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.768 0.827 . . . . 74.05 110.755 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.582 HG21 HD13 ' D' ' 13' ' ' ILE . 40.9 mm -67.82 -46.4 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.222 0.609 . . . . 75.23 110.478 174.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.43 HD21 ' HA3' ' D' ' 82' ' ' GLY . 64.9 mt -76.99 -23.37 52.27 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.231 -0.895 . . . . 74.03 111.734 -170.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -66.08 -44.22 59.42 Favored Pre-proline 0 CA--C 1.569 1.7 0 N-CA-C 113.572 0.953 . . . . 73.13 113.572 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.85 -32.46 95.37 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.42 2.08 . . . . 72.03 113.725 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.09 -31.68 50.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.206 0.602 . . . . 74.25 111.232 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.64 -51.6 58.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.333 -0.618 . . . . 50.44 109.333 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.15 -49.42 69.29 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.752 1.282 . . . . 64.11 111.069 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.53 -45.86 91.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.196 0.935 . . . . 75.32 110.783 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.1 -45.13 87.75 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.801 0.688 . . . . 73.3 110.997 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' D' ' 76' ' ' CYS . 73.5 mt -64.57 -53.41 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.021 0.928 . . . . 72.12 110.786 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -53.91 -42.97 69.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.347 1.059 . . . . 64.24 111.564 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.8 t -67.77 -32.07 72.4 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.275 -0.875 . . . . 64.32 111.666 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -80.04 -36.05 36.28 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.668 0.387 . . . . 65.32 111.999 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' D' ' 114' ' ' ILE . 47.4 t -67.14 -34.99 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 122.979 0.511 . . . . 61.05 110.025 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -69.42 -33.89 73.66 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.363 0.665 . . . . 72.14 111.27 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.8 mtt-85 -68.96 -34.14 74.86 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.282 0.633 . . . . 75.22 110.994 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.01 8.76 65.48 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.209 -0.45 . . . . 74.14 113.196 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p 61.93 20.86 11.86 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.616 1.966 . . . . 74.23 113.567 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 47.9 m-85 -87.83 167.16 21.17 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.653 1.181 . . . . 71.5 107.862 165.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 72.9 Cg_endo -67.82 -166.5 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.614 2.209 . . . . 70.15 113.875 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -75.24 156.6 35.57 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.679 -0.691 . . . . 70.21 110.851 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.6 tp -127.61 95.23 4.18 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.456 -1.313 . . . . 70.43 107.456 164.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.667 ' HB3' HD12 ' B' ' 13' ' ' ILE . 78.6 m-20 -99.2 89.55 4.27 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.187 -1.042 . . . . 74.23 108.187 -175.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 123.06 17.32 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.172 -0.922 . . . . 73.5 110.687 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.67 124.04 86.31 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.641 0.776 . . . . 71.22 110.405 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.31 127.36 11.84 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.284 1.99 . . . . 34.11 111.692 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.49 133.85 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.801 0.84 . . . . 72.12 109.165 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -76.64 85.18 3.3 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.966 -0.753 . . . . 53.41 108.966 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 . . . . . 0 N--CA 1.474 0.738 0 CA-C-N 115.744 -0.662 . . . . 63.34 110.791 178.296 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 96.8 m . . . . . 0 C--O 1.24 0.596 0 N-CA-C 108.483 -0.932 . . . . 62.23 108.483 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.663 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.1 t80 -139.63 135.56 33.43 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.717 0.636 . . . . 63.52 110.511 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -154.44 126.16 7.58 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.9 mt -81.32 113.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.604 -0.887 . . . . 74.2 108.604 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -79.13 -31.05 43.98 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.16 0.913 . . . . 64.43 109.771 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -173.25 143.64 1.12 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.361 0.664 . . . . 72.1 110.293 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.63 140.2 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.788 0.835 . . . . 74.3 109.161 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -173.63 175.68 2.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.955 0.902 . . . . 70.33 110.495 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.1 p -100.15 119.54 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.725 0.81 . . . . 44.11 109.009 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -84.48 -32.75 23.82 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.5 0.32 . . . . 64.25 110.405 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -148.93 139.44 22.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.695 -0.684 . . . . 73.41 109.641 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 89.2 mt -138.42 139.5 41.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.398 -1.704 . . . . 71.53 106.398 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 t -154.85 110.21 3.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.711 0.632 . . . . 71.44 109.636 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.666 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 74.1 t80 -110.54 113.65 26.45 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.268 -1.382 . . . . 73.32 107.268 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.44 118.27 31.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.21 0.604 . . . . 64.11 109.748 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.61 78.77 0.93 Allowed Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 107.271 -1.381 . . . . 74.34 107.271 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 -39.03 34.24 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.814 2.343 . . . . 70.11 112.464 -166.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 7.2 m-20 -106.85 48.32 0.84 Allowed 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.998 -1.482 . . . . 74.54 106.998 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -54.39 -62.13 4.47 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.503 -1.237 . . . . 61.43 111.499 -176.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.7 Cg_exo -64.59 -21.95 65.2 Favored 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 121.578 1.599 . . . . 52.41 113.23 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 1.9 t60 -81.44 -55.78 4.47 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.489 0.715 . . . . 73.42 110.118 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 73' ' ' ALA . 5.0 p -67.99 -18.22 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.85 0.86 . . . . 71.14 111.626 -165.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 20.1 m-30 -62.87 -27.03 69.07 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.281 1.032 . . . . 74.23 112.718 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -96.83 -12.93 22.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.085 0.402 . . . . 74.11 112.085 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.4 tmtp? -74.59 141.62 44.72 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.213 0.605 . . . . 70.14 109.838 -173.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.512 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 25.1 t70 -51.03 128.16 20.79 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.408 1.483 . . . . 60.3 112.348 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.406 ' HH2' ' HA ' ' A' ' 32' ' ' PHE . 51.8 m95 -78.11 90.4 4.24 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.019 0.825 . . . . 74.22 111.262 -171.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -139.94 78.22 25.04 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 114.651 -1.159 . . . . 64.45 108.446 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.52 121.36 3.36 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.828 2.352 . . . . 63.35 112.662 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -96.39 95.39 8.02 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.006 -1.479 . . . . 72.3 107.006 171.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' THR . 20.0 t -84.27 97.94 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.318 -0.855 . . . . 74.42 110.075 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 55.8 tttm -82.53 125.83 31.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.626 0.77 . . . . 73.34 110.418 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -111.43 115.59 29.51 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.596 -0.89 . . . . 72.25 108.596 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.694 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -106.75 129.67 54.59 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 74.4 109.165 173.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -113.96 116.31 29.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.967 -0.753 . . . . 64.55 108.967 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -132.99 153.93 51.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.81 0.844 . . . . 75.44 109.292 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -151.43 163.47 38.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.322 0.649 . . . . 55.03 110.883 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -164.26 154.42 14.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.154 0.982 . . . . 42.13 109.838 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.5 p -131.16 159.85 36.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.97 0.35 . . . . 73.53 111.21 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -150.53 128.51 11.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.736 0.815 . . . . 44.34 109.46 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.54 110.74 12.58 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.05 -0.722 . . . . 72.23 109.05 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.529 HD12 HG23 ' A' ' 83' ' ' ILE . 74.1 mt -94.54 -38.67 10.78 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.78 -0.646 . . . . 64.11 109.571 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.62 -179.51 7.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.733 0.813 . . . . 53.01 110.042 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -73.3 126.52 30.31 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.846 -0.798 . . . . 45.23 108.846 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 68.78 1.78 3.22 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.318 1.447 . . . . 44.54 112.258 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 94.5 t -115.68 107.33 22.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.883 -0.784 . . . . 72.14 108.883 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.65 ' HB2' HD13 ' A' ' 86' ' ' ILE . 76.0 m-85 -126.85 126.87 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.184 -1.414 . . . . 74.53 107.184 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -84.47 133.1 34.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.191 -1.04 . . . . 75.34 108.191 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -113.06 127.06 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.343 -1.354 . . . . 73.43 107.343 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.2 t -100.65 138.02 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 172.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.63 109.35 12.0 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -95.31 124.02 39.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 73.1 110.326 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.74 132.14 57.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.409 -1.33 . . . . 74.24 107.409 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.9 m -120.29 121.46 38.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.037 -0.727 . . . . 64.04 109.037 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 114' ' ' ILE . 50.1 t -114.72 106.65 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.532 1.133 . . . . 72.31 108.679 -174.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 11.6 m -105.94 145.52 31.2 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 108.04 -1.096 . . . . 63.02 108.04 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.87 103.88 7.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.252 -1.388 . . . . 74.2 107.252 168.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 36.0 m -108.09 124.16 49.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.98 0.419 . . . . 71.0 109.992 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.52 80.54 2.23 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.658 -1.608 . . . . 74.43 106.658 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -117.81 5.46 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.212 -1.155 . . . . 55.41 110.212 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.09 -26.31 22.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.397 0.679 . . . . 73.33 109.972 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.1 100.35 11.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.24 0.616 . . . . 62.44 111.061 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.3 m -72.53 133.85 44.96 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 120.923 0.392 . . . . 73.25 110.298 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.5 -63.48 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.645 1.178 . . . . 73.02 110.183 177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -149.2 162.96 38.97 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.591 -1.186 . . . . 64.53 110.689 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 14.0 tp -141.29 140.6 33.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.613 -1.625 . . . . 63.41 106.613 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.666 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 16.3 m -145.51 99.08 3.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.186 -0.672 . . . . 64.3 109.186 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.01 116.68 29.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.661 -0.866 . . . . 74.12 108.661 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.49 110.39 20.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.715 0.806 . . . . 71.34 109.392 -174.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -84.85 89.21 7.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.302 -0.999 . . . . 73.11 108.302 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -76.71 97.21 4.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.118 -0.697 . . . . 75.52 109.118 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.3 143.25 16.81 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.552 -0.619 . . . . 73.21 111.552 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.47 122.91 2.15 Favored Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.44 -1.064 . . . . 73.21 110.44 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.529 HG23 HD12 ' A' ' 51' ' ' LEU . 43.5 mt -80.12 116.33 24.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.656 -1.238 . . . . 71.24 107.656 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.663 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -122.38 158.57 29.36 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.281 0.632 . . . . 63.11 109.416 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 42.8 m -104.57 98.76 8.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.226 -1.028 . . . . 65.24 108.226 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.65 HD13 ' HB2' ' A' ' 56' ' ' TYR . 3.9 mp -97.46 124.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.739 -1.208 . . . . 71.23 107.739 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -162.04 151.93 16.55 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.772 0.67 . . . . 42.43 110.714 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.55 -33.24 6.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.334 -0.848 . . . . 53.44 113.081 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.558 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -116.67 147.5 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.339 0.656 . . . . 53.11 111.467 -168.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.52 173.88 10.85 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.226 -0.897 . . . . 41.15 110.708 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -114.46 5.79 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.639 1.212 . . . . 52.43 115.011 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -65.42 -42.54 92.38 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.019 0.928 . . . . 61.0 111.551 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -70.39 -36.91 74.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.226 0.611 . . . . 53.52 111.042 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -65.19 -44.03 89.7 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.368 0.667 . . . . 62.12 109.799 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.83 88.74 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.044 0.938 . . . . 51.4 111.243 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -74.07 -31.09 62.7 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 65.14 110.79 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.76 -44.36 70.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.336 0.589 . . . . 74.51 110.055 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.34 -44.28 37.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.876 -1.056 . . . . 63.15 111.403 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.36 62.42 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.434 0.933 . . . . 72.12 115.434 -167.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.63 -61.23 0.21 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.708 0.754 . . . . 75.41 112.055 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.1 t80 -61.75 -59.33 5.32 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 74.21 112.625 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.41 -36.5 4.75 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 118.557 -0.735 . . . . 42.34 112.951 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.48 -40.96 45.1 Favored 'Trans proline' 0 C--N 1.387 2.59 0 C-N-CA 123.089 2.526 . . . . 74.42 114.287 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -60.04 -35.33 74.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.942 0.897 . . . . 74.44 111.108 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.8 mm -68.15 -42.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.638 0.775 . . . . 65.14 110.145 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.61 -33.09 60.51 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.582 -1.19 . . . . 52.02 112.547 -172.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.65 -43.76 96.14 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.032 1.123 . . . . 70.12 114.032 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.06 -38.23 96.34 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.483 2.122 . . . . 72.1 113.73 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.494 0.718 . . . . 73.32 111.845 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.52 87.28 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.728 0.411 . . . . 75.03 110.16 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -54.07 -52.43 60.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.637 1.175 . . . . 73.13 110.477 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -62.98 -46.13 89.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.809 0.844 . . . . 71.34 111.141 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 40.5 t -55.16 -47.12 75.59 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.855 0.722 . . . . 63.14 110.469 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -60.69 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.918 -1.037 . . . . 63.24 110.371 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 125' ' ' GLN . 99.3 m -52.41 -46.66 66.41 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 124.248 1.019 . . . . 62.13 112.18 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.04 -44.04 85.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.061 -0.972 . . . . 74.41 109.848 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 mtp -58.87 -42.08 88.61 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.785 0.834 . . . . 62.32 111.206 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.4 t -59.96 -49.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.788 0.835 . . . . 75.33 110.307 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.0 p -69.25 -28.97 66.79 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.866 0.467 . . . . 64.12 112.135 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -66.49 -28.34 68.49 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.813 0.845 . . . . 74.12 111.235 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.04 11.85 61.56 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.478 -0.623 . . . . 62.04 114.053 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.408 ' HB ' HH21 ' B' ' 15' ' ' ARG . 3.8 m 65.62 16.11 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.0 1.32 . . . . 45.1 111.192 -175.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -88.21 141.23 30.81 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.736 -0.838 . . . . 74.44 108.736 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 144.4 84.71 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.14 2.56 . . . . 50.21 112.71 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.8 tt0 -53.71 138.85 34.21 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.352 1.033 . . . . 64.44 111.958 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.46 114.92 18.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.632 -0.713 . . . . 74.4 109.398 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -112.0 118.89 36.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.462 -1.31 . . . . 74.3 107.462 172.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.36 122.64 20.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.274 -0.639 . . . . 65.54 109.274 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.18 134.91 94.75 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 123.399 0.437 . . . . 72.41 110.913 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.0 106.62 0.8 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.783 2.322 . . . . 64.24 111.975 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.15 117.77 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.716 -1.216 . . . . 63.23 107.716 175.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -80.98 73.22 8.03 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.668 0.747 . . . . 72.22 110.628 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -67.2 -33.75 76.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.78 -1.1 . . . . 74.52 108.997 169.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.652 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.4 p-10 . . . . . 0 C--O 1.24 0.577 0 CA-C-N 114.328 -1.306 . . . . 60.1 111.654 176.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.6 m . . . . . 0 N--CA 1.468 0.469 0 N-CA-C 107.185 -1.413 . . . . 52.35 107.185 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -121.69 143.46 49.33 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.298 -0.63 . . . . 74.15 109.298 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.15 132.18 9.88 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.6 -0.889 . . . . 72.03 108.6 175.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.475 HG22 ' HE2' ' B' ' 84' ' ' PHE . 1.8 pp -76.4 104.33 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 122.112 0.958 . . . . 73.01 108.842 173.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . 0.418 ' HG3' ' OG ' ' B' ' 85' ' ' SER . 1.4 tm0? -76.71 -36.37 57.24 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.963 -0.754 . . . . 55.41 108.963 -170.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.408 HH21 ' HB ' ' A' ' 122' ' ' THR . 21.8 ttt180 -168.06 140.08 2.97 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 124.036 0.835 . . . . 74.43 109.199 173.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.0 mt -124.82 134.38 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.597 -1.26 . . . . 32.31 107.597 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.27 157.39 13.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.576 0.547 . . . . 70.24 111.813 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -83.0 127.9 33.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.407 -0.815 . . . . 54.52 109.039 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.564 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 25.4 mtpp -93.51 -41.05 9.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.549 -0.75 . . . . 75.33 110.095 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.5 t70 -152.4 145.63 24.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.827 -0.624 . . . . 74.34 111.4 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.8 mm -140.02 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 C-N-CA 125.291 1.437 . . . . 73.23 108.411 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -146.22 134.9 22.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.454 1.101 . . . . 73.4 108.325 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.447 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -148.2 120.14 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.061 -1.459 . . . . 73.23 107.061 170.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -119.08 142.91 47.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.153 -1.055 . . . . 71.33 108.153 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.976 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -139.25 77.59 29.82 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.635 -1.246 . . . . 72.42 107.635 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.62 -40.4 10.22 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.902 2.401 . . . . 64.33 112.509 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -109.03 21.06 17.69 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.255 -0.884 . . . . 71.22 110.072 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.976 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.44 -48.88 35.24 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 115.524 1.676 . . . . 72.01 115.524 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -38.44 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.539 2.16 . . . . 74.1 112.256 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 37.8 m80 -90.09 -4.98 57.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.147 0.795 . . . . 65.31 113.147 -171.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.466 HG23 HD11 ' B' ' 68' ' ' LEU . 7.6 p -69.99 -18.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.115 0.566 . . . . 64.43 111.082 -175.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . 0.4 ' HA ' ' HB3' ' B' ' 35' ' ' ASP . 55.2 t80 -66.47 -14.95 62.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.645 0.778 . . . . 73.31 111.865 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -69.15 -37.3 78.18 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.602 -0.518 . . . . 75.41 109.602 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.6 mttt -110.75 62.46 0.61 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.615 -0.883 . . . . 52.2 108.615 172.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.4 ' HB3' ' HA ' ' B' ' 32' ' ' PHE . 11.1 p-10 -88.17 98.44 11.56 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.03 -0.419 . . . . 73.24 110.662 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 172.36 -174.96 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.244 1.417 . . . . 63.04 111.429 163.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -49.03 110.1 1.41 Allowed Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.464 1.506 . . . . 65.35 113.494 -169.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.51 165.84 16.0 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.688 2.259 . . . . 71.54 110.836 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.86 104.46 4.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.205 -1.406 . . . . 75.22 107.205 169.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.65 143.53 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -138.96 116.75 11.5 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.231 0.612 . . . . 54.02 109.909 -170.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -86.78 125.72 34.13 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 74.44 108.55 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -133.83 107.41 7.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.814 -1.18 . . . . 64.35 107.814 177.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.39 127.37 53.52 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.72 -0.844 . . . . 63.21 108.72 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.1 t70 -123.14 136.91 54.98 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.801 -1.185 . . . . 73.11 107.801 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -109.19 115.05 29.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.325 0.65 . . . . 74.22 110.998 -168.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -119.63 144.57 47.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.909 0.884 . . . . 63.33 109.161 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.8 p -145.14 163.21 35.04 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.375 0.67 . . . . 75.51 109.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -151.26 167.28 28.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.525 0.73 . . . . 74.53 109.804 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -113.42 112.61 23.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.885 -0.783 . . . . 73.12 108.885 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.49 -40.21 23.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.894 0.477 . . . . 71.21 110.035 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.78 -173.32 4.32 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.28 -0.873 . . . . 74.32 110.706 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.2 106.62 0.45 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.645 -1.162 . . . . 75.35 109.73 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 73.49 5.22 4.94 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.197 1.399 . . . . 71.12 112.209 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.81 113.07 39.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 107.958 -1.127 . . . . 73.45 107.958 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -122.5 140.76 52.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.22 0.608 . . . . 71.15 110.119 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.629 ' HG2' HG12 ' B' ' 83' ' ' ILE . 3.9 tm-20 -108.15 98.31 7.88 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.58 -1.267 . . . . 71.42 107.58 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -93.96 119.87 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.703 1.201 . . . . 62.41 110.236 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 21.8 t -107.13 139.21 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.204 1.002 . . . . 53.13 109.981 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.815 HD11 ' HA ' ' B' ' 103' ' ' PRO . 84.9 mt -121.56 112.85 18.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.373 0.669 . . . . 74.24 109.376 174.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.2 ttm-85 -86.89 107.6 18.41 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.185 -1.043 . . . . 72.34 108.185 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.83 101.88 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.075 -1.454 . . . . 74.25 107.075 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 32.3 m -97.31 139.12 33.74 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.931 -1.486 . . . . 54.41 108.443 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.61 114.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.203 -1.036 . . . . 71.23 108.203 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -101.38 140.58 35.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.371 -0.974 . . . . 71.11 108.371 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.95 126.38 23.34 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.314 -0.995 . . . . 41.11 108.314 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.4 p -146.27 140.03 26.2 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.357 0.663 . . . . 74.21 110.514 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -133.36 140.87 47.63 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.992 0.917 . . . . 74.4 109.655 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.84 -111.75 3.66 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.434 -0.803 . . . . 30.12 111.429 -172.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -121.6 2.5 10.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 74.1 109.885 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -135.63 171.95 13.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.949 0.5 . . . . 70.2 110.877 -169.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -75.03 140.37 43.5 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.493 -0.776 . . . . 73.23 111.352 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.628 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.04 -62.2 1.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.247 -1.02 . . . . 71.51 108.247 172.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -163.07 167.08 22.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.475 -1.693 . . . . 74.25 107.917 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.63 143.31 49.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 71.33 108.013 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.7 t -143.33 144.34 32.05 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.372 -0.973 . . . . 62.13 108.372 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -160.12 139.01 10.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.97 -0.752 . . . . 60.43 108.97 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' B' ' 113' ' ' CYS . 69.7 t -135.43 145.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.547 -1.279 . . . . 72.22 107.547 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.0 mt-30 -124.88 92.78 3.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.939 -1.134 . . . . 64.02 107.939 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -89.38 104.42 16.97 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.956 -1.02 . . . . 61.41 108.848 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.21 156.65 25.3 Favored Glycine 0 C--O 1.244 0.767 0 N-CA-C 111.131 -0.788 . . . . 74.14 111.131 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.18 1.33 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.072 -0.811 . . . . 73.11 111.072 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.629 HG12 ' HG2' ' B' ' 57' ' ' GLU . 26.0 mt -85.99 134.55 27.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 108.076 -1.083 . . . . 60.32 108.076 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . 0.475 ' HE2' HG22 ' B' ' 13' ' ' ILE . 65.4 m-85 -133.64 135.08 43.94 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 71.34 108.343 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.418 ' OG ' ' HG3' ' B' ' 14' ' ' GLN . 65.5 m -107.61 91.85 3.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 172.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.555 ' HB ' HD11 ' B' ' 89' ' ' ILE . 35.2 pt -98.11 138.21 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.386 -0.825 . . . . 65.33 110.974 -169.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -145.01 167.77 21.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.28 1.032 . . . . 65.35 109.945 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.79 -63.72 4.42 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.696 -0.684 . . . . 75.42 112.006 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.555 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.3 pp -61.35 138.1 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.618 0.767 . . . . 73.13 112.123 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.12 149.66 16.08 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.477 -0.783 . . . . 73.41 109.197 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.08 -124.9 14.69 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.68 0.613 . . . . 42.33 112.793 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.0 m -67.19 -33.37 75.25 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.402 0.681 . . . . 62.11 110.964 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.88 -33.24 71.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.763 -0.653 . . . . 71.21 110.468 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -65.57 -45.57 82.8 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.024 0.53 . . . . 62.33 110.138 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.14 -31.87 70.5 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.812 0.845 . . . . 62.34 112.09 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -77.71 -43.92 29.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.168 0.587 . . . . 74.55 111.2 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.46 -47.26 56.82 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.37 0.605 . . . . 54.33 111.909 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.564 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.1 tm? -89.38 -37.61 14.73 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.112 0.965 . . . . 73.43 110.202 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.28 -26.32 57.68 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.34 0.4 . . . . 54.04 114.015 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -120.91 -48.99 2.23 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.985 0.514 . . . . 70.43 112.203 -173.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.512 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 67.2 t80 -77.84 -45.71 23.57 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.51 0.559 . . . . 73.51 112.51 -172.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 78.5 m -59.48 -42.55 92.82 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 112.981 0.734 . . . . 62.04 112.981 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.815 ' HA ' HD11 ' B' ' 60' ' ' LEU . 83.6 Cg_exo -52.08 -39.61 70.0 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.529 2.153 . . . . 73.31 114.818 168.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.54 -24.05 65.5 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.114 0.566 . . . . 61.42 112.062 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.534 HG23 ' NH2' ' D' ' 111' ' ' ARG . 92.8 mt -73.15 -47.39 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.778 0.831 . . . . 71.33 111.348 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.513 ' HB2' HD12 ' B' ' 60' ' ' LEU . 75.1 mt -79.72 -18.79 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.871 -0.604 . . . . 63.45 110.987 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.76 -50.55 86.42 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-O 117.699 -1.143 . . . . 73.53 113.733 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.1 -35.86 97.18 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.552 2.168 . . . . 71.2 113.959 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -69.44 -46.73 66.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.481 0.712 . . . . 73.53 110.575 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.3 -41.28 88.63 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.398 -0.819 . . . . 75.33 110.616 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -63.14 -50.43 70.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.557 1.543 . . . . 74.32 111.268 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.85 -37.99 89.47 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.95 0.781 . . . . 64.51 109.998 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.545 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -68.62 -39.21 80.91 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.508 0.505 . . . . 64.4 111.169 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.2 -49.69 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.062 0.545 . . . . 43.45 110.014 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -56.53 -39.37 73.25 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.301 -0.863 . . . . 71.14 111.168 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -68.05 -46.53 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.123 -0.944 . . . . 65.4 110.394 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -66.74 -39.48 87.95 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.006 0.523 . . . . 73.21 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.28 -39.47 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.867 0.467 . . . . 75.13 110.251 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -68.5 -28.57 67.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.071 0.948 . . . . 61.13 111.761 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.0 mtt-85 -73.58 -35.79 65.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.744 0.818 . . . . 73.14 110.101 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 3.4 55.0 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 123.757 0.661 . . . . 73.44 112.673 170.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 58.81 28.87 18.01 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.516 1.926 . . . . 61.21 112.304 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -98.77 153.03 38.07 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 114.849 -1.069 . . . . 75.45 109.645 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -51.2 102.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.13 2.553 . . . . 74.23 111.523 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.408 ' NE2' ' HB3' ' C' ' 119' ' ' SER . 4.6 pt20 -62.38 155.41 25.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.604 -1.18 . . . . 75.35 111.527 -171.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.6 tp -109.29 100.82 9.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.459 -0.791 . . . . 73.22 109.612 -168.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.471 HD21 ' HB2' ' C' ' 119' ' ' SER . 10.0 m120 -89.37 92.85 9.31 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 106.44 -1.689 . . . . 73.14 106.44 176.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.25 150.1 46.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.959 -1.473 . . . . 63.51 111.19 -168.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.26 74.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 122.97 0.508 . . . . 71.1 110.779 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.08 111.8 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.942 2.428 . . . . 75.11 112.233 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.64 113.85 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.479 -0.934 . . . . 61.12 108.479 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.38 80.11 7.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.279 0.632 . . . . 74.11 109.375 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 N--CA 1.486 1.372 0 C-N-CA 123.653 0.781 . . . . 72.41 111.303 -179.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.531 ' HB2' HG21 ' C' ' 89' ' ' ILE . 46.9 ttp . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 121.435 0.636 . . . . 74.03 111.088 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.2 m -85.77 88.38 7.54 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.975 -1.12 . . . . 72.42 107.975 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 52.1 t80 -96.62 122.31 39.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.784 -0.821 . . . . 54.52 108.784 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -138.57 139.11 38.51 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.465 0.706 . . . . 73.35 110.472 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.58 96.79 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.764 -0.828 . . . . 73.41 108.764 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.452 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.5 mm100 -75.98 -43.47 44.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.69 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.4 ttt85 -169.84 122.99 0.73 Allowed 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.894 0.746 . . . . 72.52 109.892 178.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.84 133.54 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.347 -0.983 . . . . 44.12 108.347 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.463 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.0 p90 -169.67 158.72 7.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.697 0.761 . . . . 72.31 112.267 -173.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -81.56 110.37 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.518 -1.219 . . . . 70.41 108.864 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -79.47 -23.92 42.71 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 122.277 -0.264 . . . . 71.33 110.605 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -150.06 142.08 23.94 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.954 0.783 . . . . 74.34 109.467 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -137.26 144.26 32.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 106.916 -1.513 . . . . 74.21 106.916 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . 0.551 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 40.3 t -151.82 147.71 26.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.482 0.713 . . . . 73.21 110.125 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -154.87 119.93 4.93 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.342 -1.355 . . . . 74.5 107.342 168.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.48 130.14 54.16 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.489 0.716 . . . . 75.54 109.236 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.31 77.36 76.3 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.652 -1.24 . . . . 72.33 107.652 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -68.02 -27.72 35.91 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.037 2.491 . . . . 62.44 112.051 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -109.91 41.96 1.61 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.496 1.118 . . . . 35.21 109.457 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.617 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.64 -54.94 49.83 Favored Pre-proline 0 CA--C 1.571 1.753 0 N-CA-C 114.47 1.285 . . . . 54.42 114.47 -175.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 12.5 Cg_exo -72.66 -28.42 14.11 Favored 'Trans proline' 0 C--N 1.386 2.533 0 CA-C-N 121.891 1.711 . . . . 73.41 111.775 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -68.7 -22.08 64.38 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.04 1.336 . . . . 74.0 111.953 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -72.2 -18.84 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.539 0.736 . . . . 72.23 111.497 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -68.79 -23.48 64.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.623 0.369 . . . . 65.05 111.201 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -109.52 24.04 13.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.51 0.724 . . . . 71.35 110.722 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.681 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -81.08 148.05 29.83 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.35 0.66 . . . . 73.43 110.046 -176.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' C' ' 68' ' ' LEU . 12.7 t70 -69.37 125.01 25.37 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.315 -0.994 . . . . 75.04 108.315 169.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -86.76 63.12 7.79 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.882 0.738 . . . . 74.24 110.372 -168.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -164.95 77.4 1.39 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.227 1.011 . . . . 61.25 108.403 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.97 156.11 26.62 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.77 2.313 . . . . 71.13 111.371 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.37 86.85 7.35 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.132 -1.433 . . . . 73.51 107.132 170.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -69.42 112.43 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.427 -1.26 . . . . 62.21 109.835 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -134.29 127.12 31.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.749 0.82 . . . . 74.31 109.852 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . 0.409 HD23 ' N ' ' C' ' 43' ' ' ASP . 6.1 tt -86.41 139.14 31.21 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 107.648 -1.241 . . . . 70.45 107.648 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.4 t70 -119.61 107.5 13.33 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.577 -1.268 . . . . 61.15 107.577 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.17 116.16 28.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.268 1.027 . . . . 74.42 109.059 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.9 t70 -115.08 143.94 44.41 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.606 -0.887 . . . . 64.42 108.606 172.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -131.19 134.96 47.0 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.614 0.766 . . . . 64.11 109.789 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -148.21 157.34 43.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.138 0.575 . . . . 54.35 110.628 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -161.28 145.75 13.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.87 0.868 . . . . 52.51 110.413 178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -156.06 140.85 17.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 73.03 109.898 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -72.55 127.87 33.87 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' C' ' 57' ' ' GLU . 34.9 mt -96.06 -39.67 9.62 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 64.45 109.581 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.32 176.59 12.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.919 -1.491 . . . . 45.21 108.964 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -68.31 121.98 17.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.673 -0.694 . . . . 71.11 109.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 76.51 -8.37 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 126.401 1.881 . . . . 72.15 112.632 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.81 96.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 70.22 108.879 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.8 161.97 13.72 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.493 0.717 . . . . 74.34 109.378 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.667 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.0 tt0 -124.73 133.61 53.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.14 0.576 . . . . 73.52 109.768 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.426 HG22 HD12 ' C' ' 98' ' ' LEU . 77.2 t -110.69 129.22 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.402 -1.333 . . . . 52.04 107.402 169.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 96.7 t -114.18 136.76 49.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.257 -1.016 . . . . 74.53 108.257 173.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.13 101.76 5.95 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.324 -1.361 . . . . 74.25 107.324 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 8.1 ttm180 -87.29 135.13 33.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.262 0.625 . . . . 73.41 109.687 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.5 t -125.81 121.89 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.137 -1.431 . . . . 55.45 107.137 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 30.7 m -124.7 119.56 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.423 -0.584 . . . . 64.2 109.423 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 114' ' ' ILE . 59.1 t -100.35 116.43 43.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.635 -0.876 . . . . 74.33 108.635 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.5 m -106.21 137.71 43.68 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.688 0.618 . . . . 62.23 109.511 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.64 94.49 3.2 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.516 -1.291 . . . . 74.24 107.516 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -143.57 139.15 29.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.392 -0.966 . . . . 64.24 108.392 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.681 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 23.65 8.74 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.506 0.722 . . . . 74.02 110.329 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.94 -120.57 1.4 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.827 -1.309 . . . . 72.44 109.827 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.79 -28.47 21.66 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.56 -0.904 . . . . 75.31 108.56 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.0 99.2 0.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.466 1.106 . . . . 64.54 109.608 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.1 m -87.75 130.24 34.9 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.058 0.543 . . . . 64.0 110.644 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.66 5.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.495 -0.775 . . . . 72.24 109.256 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -167.21 169.75 12.33 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.827 0.851 . . . . 70.32 110.768 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.411 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -142.87 144.67 32.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.939 -1.134 . . . . 62.4 107.939 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.411 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.6 t -146.68 146.28 30.3 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.353 -0.98 . . . . 61.44 108.353 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 38.4 tt0 -153.76 137.49 16.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.25 0.62 . . . . 71.44 110.218 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.4 t -141.9 115.02 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.305 1.042 . . . . 74.33 108.615 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 73.2 mt-30 -95.03 97.69 10.14 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.889 -0.782 . . . . 64.12 108.889 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.1 102.32 14.32 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 44.25 110.009 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.16 151.82 21.8 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.918 -0.473 . . . . 73.43 111.918 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.97 128.59 2.82 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.645 -0.582 . . . . 32.03 111.645 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' D' ' 29' ' ' PRO . 8.3 mm -90.14 130.38 39.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 108.491 -0.929 . . . . 73.33 108.491 178.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.98 119.91 17.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.316 -0.624 . . . . 71.54 109.316 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.0 p -85.93 99.9 11.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.212 -1.033 . . . . 22.42 108.212 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.63 124.7 68.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.472 0.709 . . . . 62.13 109.645 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 169.06 25.23 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.029 -0.987 . . . . 72.22 110.228 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.69 -28.58 11.9 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.033 -0.985 . . . . 63.02 111.045 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.2 OUTLIER -119.14 167.51 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.943 0.897 . . . . 64.41 110.903 -173.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -160.1 -171.76 3.34 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.799 -1.092 . . . . 75.55 108.954 173.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.52 -124.44 33.43 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.824 0.703 . . . . 63.43 114.109 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.6 t -63.62 -32.19 73.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.103 0.961 . . . . 75.01 112.789 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -68.28 -57.52 5.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.249 0.62 . . . . 73.24 111.218 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.553 ' HB3' HG12 ' C' ' 89' ' ' ILE . 3.3 ppp? -73.92 -21.19 60.14 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.698 -0.683 . . . . 61.52 110.739 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.4 96.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.946 0.498 . . . . 73.45 110.414 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.29 -39.18 75.22 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.007 -0.542 . . . . 72.12 110.844 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 94.2 m -67.49 -52.98 32.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.028 -0.533 . . . . 63.43 110.232 175.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.426 HD12 HG22 ' C' ' 58' ' ' VAL . 52.2 tp -60.38 -53.98 51.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.072 0.949 . . . . 70.43 111.546 -168.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.53 11.29 59.64 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.433 -0.648 . . . . 75.23 114.687 -170.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.23 -63.79 0.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.837 0.818 . . . . 74.31 112.477 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 38.5 t80 -72.76 -53.25 12.12 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.823 0.449 . . . . 62.54 111.919 -168.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.546 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 44.1 m -59.11 -47.39 98.58 Favored Pre-proline 0 CA--C 1.569 1.675 0 C-N-CA 123.969 0.908 . . . . 72.5 112.352 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 86.5 Cg_exo -54.55 -37.28 90.4 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.96 2.44 . . . . 64.35 113.711 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -66.58 -38.49 87.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.886 0.741 . . . . 61.33 110.286 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.1 mm -61.53 -44.6 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.05 0.54 . . . . 74.13 110.324 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.573 HD21 ' HA3' ' C' ' 82' ' ' GLY . 97.0 mt -75.31 -30.85 60.46 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.291 -0.868 . . . . 74.23 112.302 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . 0.407 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 61.5 t80 -53.94 -49.77 87.73 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.298 1.221 . . . . 73.34 114.298 -171.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.09 -31.85 94.12 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.299 1.999 . . . . 72.35 113.841 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.468 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.5 m-85 -71.98 -43.15 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.238 0.615 . . . . 64.25 110.64 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -65.3 -38.33 89.89 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 116.038 -0.528 . . . . 60.4 110.484 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.516 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 39.2 ttt-85 -56.66 -53.48 57.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.556 1.542 . . . . 64.41 111.797 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.35 -32.91 74.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.825 0.45 . . . . 71.21 110.307 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.13 -32.38 71.72 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.065 0.546 . . . . 73.14 111.269 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' C' ' 62' ' ' VAL . 59.3 mt -70.29 -56.06 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.408 0.683 . . . . 72.4 109.739 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -63.33 -27.14 69.12 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.563 0.745 . . . . 72.3 111.276 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.36 -48.83 68.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.422 0.689 . . . . 50.35 109.544 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -32.79 74.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.482 0.713 . . . . 72.34 112.16 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.65 -46.97 95.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.473 0.709 . . . . 65.33 109.549 174.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.471 ' HB2' HD21 ' B' ' 127' ' ' ASN . 58.9 p -73.73 -23.78 59.81 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.275 0.63 . . . . 72.14 112.185 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -72.76 -37.8 67.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.575 0.75 . . . . 74.34 110.192 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.16 1.86 73.26 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.524 0.515 . . . . 45.41 112.43 169.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 62.42 36.97 13.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.93 2.092 . . . . 70.34 112.665 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -94.94 154.15 39.77 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.781 -1.1 . . . . 73.42 109.44 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 -177.78 1.49 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.032 2.488 . . . . 43.25 113.591 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.71 133.9 56.33 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.133 1.16 . . . . 62.34 114.133 -169.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.3 tt -138.7 85.31 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.079 -1.822 . . . . 73.13 106.079 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.7 129.88 44.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.787 0.835 . . . . 55.03 109.493 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.516 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.6 mm? -80.47 143.89 33.0 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.642 0.589 . . . . 73.54 110.472 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.72 150.23 50.24 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.951 0.9 . . . . 72.22 111.376 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.06 130.08 7.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.174 2.583 . . . . 61.22 112.297 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 9.4 t -135.08 112.97 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 109.067 -0.716 . . . . 74.32 109.067 173.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.34 90.75 5.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.438 0.695 . . . . 73.11 110.128 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.63 -39.07 77.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.778 0.799 . . . . 73.15 109.705 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 . . . . . 0 N--CA 1.473 0.7 0 CA-C-N 113.984 -1.462 . . . . 75.23 112.193 -176.717 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 C--O 1.24 0.559 0 N-CA-C 108.897 -0.779 . . . . 65.33 108.897 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -171.87 104.46 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.164 -1.791 . . . . 71.41 106.164 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -156.07 138.39 14.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.826 0.851 . . . . 63.42 108.844 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.426 HG21 HD13 ' D' ' 16' ' ' ILE . 10.1 mt -76.4 137.28 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.536 0.522 . . . . 73.52 110.368 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -99.93 -40.56 7.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.64 0.776 . . . . 71.3 110.257 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -167.15 125.9 1.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.474 -0.33 . . . . 61.23 111.207 -170.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.426 HD13 HG21 ' D' ' 13' ' ' ILE . 1.3 mp -103.91 132.56 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.13 -1.433 . . . . 55.25 107.13 165.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.617 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 26.0 p90 -166.09 154.95 11.27 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.954 0.784 . . . . 74.53 110.475 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -80.22 121.31 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.218 -0.901 . . . . 70.32 109.05 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 42.4 mtpt -87.28 -30.51 20.84 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.767 -0.457 . . . . 71.32 109.767 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.17 135.33 17.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.891 -1.049 . . . . 62.45 109.018 -177.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.676 HG23 HG22 ' D' ' 78' ' ' VAL . 48.7 mt -134.84 144.26 35.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 107.991 -1.114 . . . . 74.43 107.991 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -151.82 137.78 18.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.359 0.664 . . . . 73.41 110.313 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 55.2 t80 -143.88 115.66 8.24 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 106.767 -1.568 . . . . 71.12 106.767 171.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.56 126.19 48.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.13 0.572 . . . . 75.42 109.601 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.56 80.35 22.8 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.578 -1.267 . . . . 64.23 107.578 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.24 -31.91 17.54 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.017 2.478 . . . . 65.15 112.672 -170.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -114.95 36.49 3.84 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.45 -0.944 . . . . 73.3 108.45 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.443 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -56.38 -62.48 4.8 Favored Pre-proline 0 CA--C 1.559 1.321 0 N-CA-C 113.919 1.081 . . . . 74.44 113.919 -167.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.509 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -78.07 -2.21 12.33 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 122.796 2.034 . . . . 64.1 113.318 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -84.35 -42.17 16.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.758 1.223 . . . . 71.15 109.75 174.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.0 p -76.6 -27.26 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.102 0.561 . . . . 72.14 111.049 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -68.2 -7.95 34.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.247 0.832 . . . . 72.21 113.247 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -82.72 -18.79 39.57 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.799 0.84 . . . . 74.31 111.19 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.99 99.46 8.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.101 0.96 . . . . 64.21 110.954 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -75.52 94.63 3.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.861 0.865 . . . . 74.21 111.743 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.481 ' CE3' HD23 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -155.84 175.02 14.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.71 0.804 . . . . 75.13 111.961 174.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -94.92 109.56 44.81 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 124.299 1.04 . . . . 70.41 110.942 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.407 ' HA ' HD22 ' D' ' 68' ' ' LEU . 19.0 Cg_exo -65.3 146.13 85.26 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.231 2.62 . . . . 33.04 111.85 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.27 156.17 38.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.903 -0.777 . . . . 65.14 108.903 164.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.526 HG23 HG13 ' D' ' 64' ' ' VAL . 1.3 p -136.3 118.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.775 -1.194 . . . . 75.34 107.775 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -106.1 125.69 51.3 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.104 0.962 . . . . 61.11 108.514 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.5 tt -95.89 126.54 41.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.277 -1.008 . . . . 75.2 108.277 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.9 t70 -114.95 125.87 54.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.879 -1.156 . . . . 64.45 107.879 169.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.06 130.85 46.26 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.1 -0.704 . . . . 63.23 109.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -134.01 143.29 48.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.723 -0.843 . . . . 73.21 108.723 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -121.47 147.74 45.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.139 0.976 . . . . 65.25 110.019 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.07 142.74 18.71 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.785 0.834 . . . . 63.44 109.261 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -160.64 153.4 21.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.889 0.476 . . . . 61.22 109.98 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -164.08 147.17 9.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.33 0.652 . . . . 63.04 109.948 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.8 122.13 25.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.162 -0.681 . . . . 72.55 109.162 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' C' ' 29' ' ' PRO . 71.6 mt -89.95 -34.61 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.549 0.74 . . . . 75.12 110.524 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 -177.8 6.43 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.349 -0.841 . . . . 71.55 109.667 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.43 116.25 5.92 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.75 -0.659 . . . . 72.32 110.495 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 62.4 24.59 14.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.435 1.094 . . . . 71.25 111.899 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.08 116.82 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.396 -0.964 . . . . 75.45 108.396 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.485 ' HB2' HD12 ' D' ' 86' ' ' ILE . 82.3 m-85 -131.91 129.05 39.8 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.745 1.218 . . . . 61.41 108.036 -173.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' D' ' 51' ' ' LEU . 34.6 tt0 -102.52 139.7 37.77 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.599 0.76 . . . . 73.02 109.803 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.476 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 96.6 t -118.72 122.82 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.617 -1.253 . . . . 72.35 107.617 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 39.1 t -108.55 131.99 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.329 -0.989 . . . . 64.15 108.329 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tt -116.43 116.96 28.64 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.373 -1.343 . . . . 64.14 107.373 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -97.63 108.69 21.47 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.116 -0.698 . . . . 73.22 109.116 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.92 129.09 43.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 107.645 -1.243 . . . . 72.13 107.645 166.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.0 m -120.41 134.06 55.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.243 0.544 . . . . 73.21 109.701 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 78.5 t -125.62 106.81 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.128 1.371 . . . . 71.42 108.199 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -113.21 106.75 15.01 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.465 -0.568 . . . . 75.51 109.465 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.87 123.93 48.75 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.209 0.604 . . . . 51.55 109.679 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.7 m -147.31 121.54 9.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.304 -0.998 . . . . 50.12 108.304 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.481 HD23 ' CE3' ' D' ' 36' ' ' TRP . 17.3 tp -137.55 136.85 38.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.808 0.443 . . . . 51.31 110.013 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . 0.417 ' H ' HD12 ' D' ' 68' ' ' LEU . . . 91.75 -136.11 13.11 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.336 -1.106 . . . . 74.54 110.336 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 16.4 23.65 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.316 0.558 . . . . 73.31 110.881 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -136.21 164.66 27.55 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.071 0.548 . . . . 65.11 111.562 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -79.85 129.74 34.73 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.874 -1.057 . . . . 64.44 109.764 170.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.526 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.91 -66.15 0.88 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.178 -0.675 . . . . 74.44 109.178 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.35 165.88 32.36 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.061 -0.972 . . . . 72.5 111.191 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -129.07 146.54 51.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.888 1.275 . . . . 74.12 108.481 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.647 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 5.4 m -148.66 138.23 21.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.015 0.926 . . . . 62.15 109.661 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.57 122.31 5.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.332 -0.988 . . . . 70.53 108.332 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.676 HG22 HG23 ' D' ' 21' ' ' ILE . 91.6 t -130.54 118.49 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.448 -0.575 . . . . 54.53 109.448 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 76.6 mt-30 -90.02 90.81 8.3 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.132 -0.94 . . . . 74.42 108.651 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.28 103.66 10.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.427 -0.806 . . . . 75.12 109.401 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 143.37 16.51 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.519 -0.633 . . . . 34.33 111.519 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.43 128.47 4.16 Favored Glycine 0 CA--C 1.506 -0.515 0 N-CA-C 109.942 -1.263 . . . . 52.13 109.942 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.27 131.68 36.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.12 -1.067 . . . . 71.2 108.12 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.476 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 18.7 m-85 -130.65 139.72 50.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.428 -0.582 . . . . 73.43 109.428 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.7 m -82.65 100.9 10.47 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 108.084 -1.08 . . . . 34.04 108.084 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' D' ' 56' ' ' TYR . 36.3 mt -117.28 138.65 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.294 0.638 . . . . 72.31 110.218 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 167.52 15.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.804 0.841 . . . . 65.54 110.456 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 82.8 -19.78 10.95 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 114.914 0.726 . . . . 53.41 114.914 169.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 13.1 pt -121.67 138.31 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.969 -1.122 . . . . 74.34 107.969 177.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -141.87 167.67 21.57 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.681 0.792 . . . . 64.3 110.809 -176.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.87 -135.19 40.76 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.849 0.718 . . . . 44.32 113.054 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -66.08 -29.86 70.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.265 0.626 . . . . 64.04 111.324 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.522 HE21 ' HA ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -63.77 -40.96 97.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.371 0.669 . . . . 74.32 110.728 -178.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -81.34 -34.6 31.69 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.301 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.21 -23.92 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.64 0.776 . . . . 73.15 112.545 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . 0.565 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.6 t-80 -69.91 -38.55 76.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.695 0.398 . . . . 73.02 110.506 171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.18 -33.67 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 110.338 -0.245 . . . . 44.3 110.338 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.52 -54.16 11.47 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.475 1.11 . . . . 74.34 109.877 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.92 14.31 64.86 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.562 -0.745 . . . . 61.43 114.405 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -145.23 -56.42 0.32 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 117.405 0.603 . . . . 54.41 112.333 -175.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -75.63 -51.6 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.532 0.567 . . . . 72.42 112.532 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.9 m -59.14 -48.61 96.11 Favored Pre-proline 0 CA--C 1.568 1.653 0 C-N-CA 124.206 1.002 . . . . 72.1 112.93 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.81 -30.79 78.09 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 122.265 1.976 . . . . 70.03 112.852 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.94 -32.2 73.45 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.298 0.639 . . . . 74.44 111.126 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 13' ' ' ILE . 49.5 mm -74.21 -42.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.584 0.754 . . . . 64.21 110.678 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.16 -30.25 49.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.325 -0.852 . . . . 73.31 111.997 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.51 -44.4 97.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.187 1.18 . . . . 62.44 114.187 -170.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.42 -41.59 51.22 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.452 2.101 . . . . 63.12 114.159 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -75.92 -38.62 57.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.811 . . . . 75.3 111.756 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.67 99.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.476 0.71 . . . . 51.05 110.753 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.536 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.7 ttp180 -62.56 -49.91 73.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.542 -1.208 . . . . 72.22 110.59 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -58.4 -48.47 80.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.379 1.072 . . . . 71.35 111.531 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.69 -40.12 75.03 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.811 0.694 . . . . 73.35 111.224 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.492 HG21 HG21 ' D' ' 64' ' ' VAL . 93.7 mt -65.98 -50.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.132 -0.94 . . . . 74.43 110.582 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.6 m -53.9 -38.88 65.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.507 1.123 . . . . 75.42 111.759 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -70.54 -50.24 39.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.01 110.316 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -56.62 -43.16 79.95 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.453 0.701 . . . . 73.33 111.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.553 HG11 HD23 ' D' ' 126' ' ' LEU . 82.3 t -63.73 -42.28 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 114.441 -1.254 . . . . 64.22 110.814 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 59.6 p -68.8 -30.79 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 120.817 0.341 . . . . 61.11 110.965 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -69.63 -29.45 66.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.072 0.949 . . . . 73.44 110.525 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.45 11.42 69.97 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-N 115.579 -0.737 . . . . 71.12 112.905 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.463 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.7 p 61.31 16.04 7.02 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 126.771 2.028 . . . . 70.44 113.721 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -90.41 164.66 26.21 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.237 1.015 . . . . 75.23 108.359 170.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -86.65 150.77 8.77 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.655 2.237 . . . . 74.42 112.466 -172.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.17 133.21 28.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.949 0.9 . . . . 62.43 112.749 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.553 HD23 HG11 ' D' ' 118' ' ' VAL . 3.8 mm? -105.82 95.0 5.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.533 -0.914 . . . . 75.13 108.533 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -98.87 98.79 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.9 mm? -76.08 135.15 39.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.3 -0.864 . . . . 61.32 109.625 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.88 128.69 92.74 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-O 119.56 -0.257 . . . . 75.32 110.989 -176.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.536 ' HB3' HH12 ' D' ' 111' ' ' ARG . 65.6 Cg_endo -74.65 117.48 4.96 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.508 2.139 . . . . 61.41 111.299 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.76 110.3 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.534 -0.913 . . . . 71.4 108.534 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 32.9 t30 -78.4 98.8 6.13 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.859 -0.793 . . . . 73.3 108.859 174.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 62.8 m-85 . . . . . 0 N--CA 1.473 0.678 0 CA-C-N 115.102 -0.953 . . . . 74.04 111.267 -177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m . . . . . 0 N--CA 1.472 0.63 0 N-CA-C 110.181 -0.303 . . . . 72.12 110.181 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 28.1 t80 -138.83 127.59 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.005 -0.739 . . . . 71.44 109.005 171.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -159.17 110.91 2.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.466 0.479 . . . . 71.52 110.143 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.688 HG12 ' HD2' ' A' ' 84' ' ' PHE . 56.6 mt -69.5 116.02 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.057 0.543 . . . . 60.22 110.329 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 22.7 tm0? -81.43 -36.04 29.91 Favored 'General case' 0 C--O 1.248 0.996 0 O-C-N 124.159 0.912 . . . . 65.41 110.007 178.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -176.28 123.01 0.17 Allowed 'General case' 0 C--N 1.363 1.195 0 O-C-N 123.557 0.536 . . . . 64.53 111.025 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.06 142.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 123.614 0.766 . . . . 74.43 109.024 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -168.44 155.83 7.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.674 0.75 . . . . 75.11 111.71 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -86.6 114.99 23.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.953 -1.021 . . . . 32.45 109.193 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -79.3 -22.07 45.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.147 -0.479 . . . . 74.1 111.009 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -159.84 144.27 14.82 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.88 0.872 . . . . 62.11 109.357 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 84.3 mt -141.93 143.88 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.361 1.464 . . . . 75.22 107.806 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -145.73 128.29 16.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.525 0.73 . . . . 60.21 109.537 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 89.7 t80 -126.12 117.25 22.76 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 106.082 -1.821 . . . . 71.4 106.082 162.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 47.1 mt-10 -118.99 140.56 49.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.965 -0.754 . . . . 73.51 108.965 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.53 72.96 69.16 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 105.804 -1.925 . . . . 53.21 105.804 168.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.58 -20.27 41.24 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.798 2.332 . . . . 73.2 112.042 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 37.9 m-20 -119.42 23.43 11.24 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.242 1.017 . . . . 64.3 109.434 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -47.95 -57.45 10.2 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.625 -1.179 . . . . 24.34 113.485 -170.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 14.1 Cg_exo -65.9 -19.4 58.42 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 121.873 1.715 . . . . 61.11 112.572 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.61 -44.62 14.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.803 0.841 . . . . 64.41 109.889 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -78.99 -19.6 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.824 -1.08 . . . . 70.51 111.943 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.61 -6.25 42.88 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.497 0.719 . . . . 71.15 111.301 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -102.2 -12.55 17.94 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.661 1.185 . . . . 74.15 111.978 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -71.42 168.66 17.0 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.719 0.808 . . . . 75.24 113.016 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 68' ' ' LEU . 23.3 m-20 -69.97 135.19 49.14 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.182 -0.917 . . . . 64.31 109.368 169.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -82.77 67.18 8.73 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.491 1.116 . . . . 73.33 110.617 -169.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -141.75 71.0 25.01 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.137 0.975 . . . . 55.41 109.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -91.26 129.47 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.61 2.873 . . . . 75.4 112.217 176.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -96.63 110.5 22.91 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.034 -1.098 . . . . 73.24 108.034 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 t -79.22 136.64 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.672 0.789 . . . . 62.25 109.108 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -117.04 118.58 32.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.486 1.114 . . . . 75.01 108.136 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -102.37 107.72 18.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.109 -1.071 . . . . 61.33 108.109 -177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.701 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 14.8 m-20 -108.01 151.16 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.935 0.894 . . . . 73.54 108.982 172.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -139.0 134.58 33.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.202 1.001 . . . . 64.41 108.42 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 35.0 t70 -135.96 137.27 41.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.076 0.951 . . . . 73.14 109.354 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 p -124.86 134.9 52.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.339 1.056 . . . . 64.24 110.157 -172.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.95 143.09 25.0 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 61.24 109.77 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -132.18 161.1 34.2 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.28 0.632 . . . . 74.54 109.338 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -163.49 127.8 2.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.499 0.72 . . . . 74.15 109.74 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -74.23 114.06 12.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.845 -0.798 . . . . 54.4 108.845 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 57' ' ' GLU . 39.9 mt -79.42 -43.96 22.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.146 0.578 . . . . 63.11 109.629 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.64 -172.69 2.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.939 -1.028 . . . . 75.52 109.815 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.34 120.99 14.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.371 0.668 . . . . 64.35 109.387 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.37 16.55 9.6 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.668 1.187 . . . . 71.45 112.528 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.49 HG12 HD12 ' A' ' 51' ' ' LEU . 28.7 t -127.48 106.32 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.301 -1.0 . . . . 71.51 108.301 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -133.78 127.9 33.68 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.089 0.956 . . . . 74.12 108.479 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.7 tt0 -104.65 134.41 47.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.36 0.664 . . . . 70.32 109.762 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.61 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 97.2 t -122.82 123.79 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.967 -1.123 . . . . 71.43 107.967 169.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.551 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -99.68 135.48 34.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.357 1.063 . . . . 73.13 109.374 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.14 99.52 6.4 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.158 -1.423 . . . . 73.04 107.158 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.7 ttp180 -87.46 113.29 23.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.045 0.538 . . . . 73.31 109.806 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -93.76 143.33 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.498 -1.297 . . . . 74.11 107.498 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.701 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.5 m -131.56 133.86 45.47 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.42 -0.585 . . . . 62.53 109.42 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.8 t -131.19 111.02 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.1 1.36 . . . . 72.24 108.709 -173.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 m -120.69 121.64 38.71 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.326 0.512 . . . . 74.41 110.212 173.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.33 22.53 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.339 -1.356 . . . . 72.0 107.339 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 66.2 m -118.25 126.56 52.42 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.306 0.503 . . . . 73.42 110.485 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 35' ' ' ASP . 5.3 mp -90.22 85.72 6.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.879 -1.156 . . . . 74.14 107.879 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.15 -85.11 1.53 Allowed Glycine 0 C--N 1.343 0.94 0 CA-C-N 114.434 -1.257 . . . . 45.53 110.643 -173.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.13 -28.74 3.11 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.482 0.713 . . . . 64.3 110.872 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 30.4 tt0 -95.73 125.65 40.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.835 0.35 . . . . 65.15 110.307 -174.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 29.5 m -77.77 142.23 38.78 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.783 1.233 . . . . 71.11 112.805 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.686 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.04 -65.98 0.94 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.522 1.129 . . . . 53.32 109.199 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.414 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 50.6 p90 -146.1 148.94 33.15 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.513 -1.221 . . . . 74.35 111.865 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -109.29 143.08 39.25 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.22 -1.355 . . . . 71.32 107.904 167.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.3 m -143.06 109.7 5.45 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.6 119.54 17.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.755 -0.461 . . . . 70.45 109.755 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.09 114.37 32.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.382 1.073 . . . . 75.22 109.404 -171.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.86 84.22 7.65 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.38 -0.97 . . . . 72.44 108.38 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.57 91.7 5.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.811 -0.811 . . . . 60.42 108.811 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.09 167.27 37.69 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.39 -0.823 . . . . 52.43 111.715 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 124.95 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.186 -0.366 . . . . 75.34 112.186 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -81.98 115.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.964 -0.754 . . . . 41.32 108.964 171.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.7 m-85 -116.98 120.08 37.31 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.17 1.388 . . . . 75.55 107.81 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 t -75.57 94.17 3.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.797 -0.816 . . . . 71.41 108.797 171.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.681 HD13 HD21 ' A' ' 98' ' ' LEU . 50.8 pt -112.72 155.57 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.165 0.586 . . . . 53.5 110.708 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.76 167.69 11.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.456 -1.247 . . . . 71.45 109.111 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -11.65 57.6 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 114.511 0.564 . . . . 71.24 114.511 173.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.47 144.21 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.755 0.822 . . . . 45.14 110.3 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -162.06 173.31 14.55 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.785 -1.561 . . . . 65.31 106.785 179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.25 -129.82 48.11 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 117.888 0.313 . . . . 61.04 113.543 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 71.3 p -75.09 -20.98 59.23 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.805 0.842 . . . . 74.43 111.826 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -69.82 -44.59 69.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.135 0.574 . . . . 74.14 109.619 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 50.4 ttm -68.95 -34.27 75.08 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.01 -0.541 . . . . 72.24 110.066 174.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.418 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -60.98 -28.34 68.94 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.188 0.595 . . . . 62.44 111.777 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.8 t-80 -88.47 -31.13 18.92 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.297 0.639 . . . . 71.43 111.065 171.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.11 -64.69 0.84 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.582 0.353 . . . . 72.33 111.149 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 86' ' ' ILE . 47.2 mt -90.09 -12.74 37.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.168 0.433 . . . . 72.52 112.168 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.78 -2.45 55.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.768 -0.462 . . . . 61.4 113.347 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.19 -53.17 0.17 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.365 0.582 . . . . 73.33 112.186 -174.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -77.3 -56.94 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 64.34 112.085 -168.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 80.5 m -74.97 -34.48 1.72 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.563 0.949 . . . . 73.32 113.563 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.6 Cg_endo -67.06 -23.01 46.8 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 121.958 1.772 . . . . 61.1 112.936 168.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -70.19 -33.76 72.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.3 0.64 . . . . 62.31 109.487 174.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 13' ' ' ILE . 45.3 mm -63.04 -42.17 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.799 0.84 . . . . 50.23 110.14 173.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.66 -32.62 69.97 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.982 -1.008 . . . . 64.34 111.981 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.27 -39.99 55.75 Favored Pre-proline 0 CA--C 1.575 1.927 0 N-CA-C 114.597 1.332 . . . . 74.41 114.597 -169.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.05 -41.75 73.69 Favored 'Trans proline' 0 C--N 1.392 2.835 0 C-N-CA 122.592 2.195 . . . . 73.32 113.489 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -71.97 -37.3 69.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.985 0.514 . . . . 64.25 111.376 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.46 88.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.785 0.434 . . . . 74.24 109.86 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.97 -53.38 56.44 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 124.726 1.266 . . . . 75.23 110.126 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.52 -42.75 95.59 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.044 0.84 . . . . 73.41 111.231 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.522 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.4 t -60.64 -34.52 74.39 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.504 0.722 . . . . 72.45 111.257 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.459 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 95.5 mt -73.44 -55.51 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.593 0.757 . . . . 71.21 109.867 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 125' ' ' GLN . 90.0 m -53.08 -40.33 63.98 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 125.199 1.4 . . . . 54.05 111.952 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -61.49 -50.78 71.33 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 60.03 110.303 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -61.17 -44.22 97.65 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.461 0.704 . . . . 71.44 111.527 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.4 t -55.83 -46.81 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 O-C-N 124.25 0.969 . . . . 63.02 110.299 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.6 t -69.87 -29.58 66.83 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.199 -0.91 . . . . 74.43 111.504 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -70.95 -27.67 63.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.363 0.665 . . . . 73.34 111.259 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.78 11.77 58.71 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.93 -0.372 . . . . 62.24 113.339 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.524 ' HB ' HH21 ' B' ' 15' ' ' ARG . 2.4 m 61.03 25.62 15.63 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 125.141 1.376 . . . . 71.4 111.022 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -94.01 146.23 31.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.825 -0.806 . . . . 74.24 108.825 171.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.73 149.55 90.55 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.66 2.24 . . . . 63.51 112.088 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.502 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.6 tt0 -58.37 133.16 55.49 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.295 0.997 . . . . 60.24 112.003 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.01 103.73 9.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.256 1.022 . . . . 55.5 108.783 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -105.97 110.89 23.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.127 -1.064 . . . . 73.23 108.127 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.55 135.5 54.27 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 123.404 0.44 . . . . 73.03 110.402 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.403 ' HA ' HD13 ' C' ' 13' ' ' ILE . . . -69.38 155.93 92.59 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.39 0.676 . . . . 63.3 110.312 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.24 125.33 14.94 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.524 2.149 . . . . 73.1 112.181 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -99.8 113.1 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.717 -1.586 . . . . 63.52 106.717 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -72.79 81.33 1.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 74.11 110.488 -177.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.09 -44.26 97.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.449 0.7 . . . . 63.32 110.951 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.519 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.2 p-10 . . . . . 0 CA--C 1.532 0.277 0 CA-C-N 114.286 -1.325 . . . . 65.13 111.707 -176.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.468 0.426 0 N-CA-C 109.381 -0.6 . . . . 70.52 109.381 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.593 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 31.9 t80 -139.58 131.33 27.46 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.224 -0.658 . . . . 65.24 109.224 176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' B' ' 85' ' ' SER . 3.9 pp0? -152.29 140.9 20.81 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.055 0.542 . . . . 72.31 109.54 168.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.594 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -69.28 113.8 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.247 -0.888 . . . . 72.12 109.344 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -88.24 -35.31 17.38 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.008 -0.738 . . . . 62.32 109.008 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.524 HH21 ' HB ' ' A' ' 122' ' ' THR . 24.3 ttt180 -168.47 142.0 3.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.999 0.92 . . . . 72.32 109.726 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.11 137.66 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.007 -1.479 . . . . 72.04 107.007 172.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 36.2 p90 -166.28 159.24 14.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.687 0.756 . . . . 75.24 110.96 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.9 m -84.63 119.42 25.21 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.283 -1.006 . . . . 75.51 108.283 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.404 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 41.8 mtpt -87.03 -34.44 19.2 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.289 0.635 . . . . 75.51 111.142 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -158.84 146.26 17.64 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.322 -0.399 . . . . 73.52 110.746 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.7 mm -142.49 138.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 125.965 1.706 . . . . 73.22 107.619 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -140.1 118.9 12.44 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.522 -1.288 . . . . 63.31 107.522 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.5 t80 -131.59 136.42 47.77 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.08 -1.081 . . . . 73.33 108.08 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.76 145.28 38.05 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.131 0.972 . . . . 65.03 108.696 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -148.34 72.3 10.93 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 105.9 -1.889 . . . . 74.34 105.9 171.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.55 -14.71 30.65 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.79 2.327 . . . . 71.45 112.177 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -127.04 28.53 5.76 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.032 0.933 . . . . 60.14 109.502 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -46.69 -59.35 5.25 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.477 1.111 . . . . 63.2 113.305 -173.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.29 -18.97 34.16 Favored 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 121.926 1.751 . . . . 53.33 113.029 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -94.73 -21.81 18.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.439 0.696 . . . . 74.1 112.382 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -81.94 -28.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 110.051 -0.351 . . . . 71.44 110.051 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -62.47 -27.03 68.85 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.278 1.031 . . . . 72.04 113.216 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -72.77 -16.18 61.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.235 0.614 . . . . 71.11 112.204 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -107.55 113.34 26.59 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.149 0.98 . . . . 73.32 109.227 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -110.38 104.57 13.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 118.707 0.685 . . . . 62.15 112.605 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.473 ' HE3' ' N ' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 179.21 -177.38 0.3 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.384 1.474 . . . . 73.35 110.898 176.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.54 133.73 70.45 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.293 1.037 . . . . 74.41 111.956 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . 0.611 ' HB3' HD21 ' B' ' 68' ' ' LEU . 93.1 Cg_endo -93.43 170.6 2.08 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.329 2.686 . . . . 73.34 114.564 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -80.98 101.69 9.67 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.879 -1.526 . . . . 54.31 106.879 164.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 t -99.7 134.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.343 -0.984 . . . . 63.41 108.343 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.3 tttp -125.35 117.17 23.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.251 0.62 . . . . 74.33 110.195 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.88 136.57 33.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.968 -1.123 . . . . 71.53 107.968 169.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 15.4 t70 -145.93 154.72 42.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.19 0.596 . . . . 61.33 109.584 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.5 tp -135.42 128.32 31.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.228 1.011 . . . . 74.43 109.71 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.6 t70 -124.01 130.99 53.49 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.232 -1.025 . . . . 64.31 108.232 170.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -118.31 104.54 10.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.36 0.664 . . . . 74.43 109.947 -176.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.27 118.77 33.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.575 -0.898 . . . . 73.2 108.575 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 41.1 p -129.31 160.58 32.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.22 0.608 . . . . 52.41 110.53 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.1 p -165.69 138.37 4.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.972 0.909 . . . . 62.34 110.016 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 50.3 tt0 -81.16 115.46 20.59 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.477 0.711 . . . . 62.12 109.405 175.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' B' ' 57' ' ' GLU . 32.7 mt -75.5 -43.38 49.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.67 0.788 . . . . 70.23 110.538 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.65 -171.21 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.84 0.856 . . . . 53.51 110.481 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.62 116.49 4.05 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.36 0.664 . . . . 64.31 110.243 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 67.12 -3.36 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.568 1.547 . . . . 70.23 113.383 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -102.92 110.56 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.822 -1.177 . . . . 74.44 107.822 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 45.6 m-85 -111.68 172.04 7.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.379 -0.828 . . . . 71.32 108.996 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' B' ' 51' ' ' LEU . 20.3 tt0 -142.43 129.0 20.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.485 -0.931 . . . . 61.43 108.485 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -112.51 119.0 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.504 -1.295 . . . . 71.33 107.504 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -103.09 111.91 34.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 108.965 -0.754 . . . . 72.35 108.965 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.49 101.47 13.67 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.993 -1.003 . . . . 64.25 108.772 -176.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.7 ttm-85 -94.93 121.0 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.366 -0.605 . . . . 63.0 109.366 174.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . 0.43 HG11 HD21 ' B' ' 128' ' ' LEU . 41.3 t -115.75 125.48 72.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.222 -1.029 . . . . 61.0 108.222 172.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.6 m -111.96 140.34 46.71 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.616 0.722 . . . . 71.22 110.129 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.554 HG21 HG21 ' B' ' 114' ' ' ILE . 54.5 t -124.72 130.81 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 113.818 -1.537 . . . . 61.1 108.161 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.1 m -122.23 143.61 49.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.127 0.571 . . . . 70.33 109.466 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.05 125.77 13.42 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.524 -1.287 . . . . 70.55 107.524 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.8 p -140.82 140.08 34.61 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.303 0.641 . . . . 62.41 109.566 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' B' ' 73' ' ' ALA . 3.2 mm? -124.68 123.0 39.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.59 1.156 . . . . 55.21 109.974 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.89 -113.03 4.75 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.595 0.56 . . . . 63.35 112.057 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -113.02 4.16 16.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.856 0.863 . . . . 73.54 110.326 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 10.6 pt-20 -123.6 146.51 48.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.063 0.545 . . . . 75.53 110.282 -169.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -83.03 124.89 30.85 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.469 0.308 . . . . 74.22 110.341 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.63 ' HB2' HD23 ' B' ' 68' ' ' LEU . . . -71.45 -63.98 1.01 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.257 0.973 . . . . 63.44 109.262 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -157.03 149.44 23.17 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 121.657 0.741 . . . . 73.05 112.511 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.89 118.96 35.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.946 -1.501 . . . . 74.52 106.946 166.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 34.5 t -125.42 124.8 42.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.797 -0.816 . . . . 34.45 108.797 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -148.55 130.81 15.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.5 -0.926 . . . . 65.21 108.5 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -124.45 146.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 123.953 0.901 . . . . 74.11 109.512 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -121.66 96.49 5.09 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.193 -1.04 . . . . 63.25 108.193 170.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.529 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -90.99 99.33 12.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.292 -1.003 . . . . 70.43 108.292 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.13 142.66 16.07 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 110.788 -0.925 . . . . 55.33 110.788 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.27 124.93 3.35 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.43 -1.068 . . . . 42.21 110.43 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -85.69 127.7 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.305 -1.369 . . . . 73.24 107.305 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.73 133.66 43.77 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.402 -0.962 . . . . 75.32 108.402 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.592 ' HB2' ' NE2' ' B' ' 12' ' ' GLN . 48.4 m -94.04 103.58 15.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.628 -1.249 . . . . 70.44 107.628 171.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.86 146.16 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.405 1.082 . . . . 73.52 110.265 -171.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.05 172.22 16.08 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.798 1.239 . . . . 40.44 109.198 172.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.0 -30.39 6.7 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.173 0.416 . . . . 71.51 114.003 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.36 162.79 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.343 0.657 . . . . 61.21 112.135 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -172.09 145.38 1.79 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.925 1.29 . . . . 62.2 109.04 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -111.3 3.3 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 114.74 0.656 . . . . 75.25 114.74 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -65.49 -44.02 88.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.833 0.853 . . . . 52.34 110.122 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -69.07 -29.77 67.95 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.693 -1.594 . . . . 75.31 110.545 -171.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.468 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 19.9 ptm -81.84 -34.09 30.35 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 116.496 -0.32 . . . . 71.21 111.016 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -34.75 74.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.515 0.726 . . . . 14.44 111.912 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -77.83 -34.02 52.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.238 0.615 . . . . 74.13 111.05 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.92 -65.84 0.63 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.698 0.399 . . . . 71.35 111.013 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.551 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.4 pp -70.95 -24.1 62.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.735 0.414 . . . . 72.21 111.961 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.453 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -84.4 -32.89 21.34 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.661 0.601 . . . . 54.14 113.729 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.7 -50.35 1.49 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.007 0.523 . . . . 70.43 111.564 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . 0.42 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 70.3 t80 -71.22 -40.8 70.9 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.361 0.664 . . . . 71.02 111.945 -172.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.593 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 55.6 m -72.21 -46.99 10.93 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.803 -0.618 . . . . 74.12 111.121 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.1 Cg_exo -57.62 -33.24 96.32 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.462 2.108 . . . . 53.41 113.708 168.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.78 -37.57 68.75 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.886 0.874 . . . . 54.41 110.919 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.19 -48.87 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.865 -1.062 . . . . 72.22 111.159 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.447 ' HB2' HD12 ' B' ' 60' ' ' LEU . 62.3 mt -77.72 -19.33 55.42 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.538 0.735 . . . . 74.33 112.405 -170.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.26 -45.56 85.12 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 114.164 1.172 . . . . 74.32 114.164 -170.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -57.02 -38.94 94.75 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 122.511 2.141 . . . . 55.33 113.351 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.529 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.1 m-85 -69.14 -40.11 78.45 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.153 -0.93 . . . . 71.24 109.858 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.99 93.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.523 0.729 . . . . 63.12 110.308 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -54.86 -57.59 11.0 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.623 1.169 . . . . 64.43 111.373 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.43 80.53 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.989 0.805 . . . . 74.2 110.244 -175.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.1 t -72.37 -32.58 66.56 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.868 0.467 . . . . 64.13 111.643 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.554 HG21 HG21 ' B' ' 64' ' ' VAL . 50.9 mt -65.3 -51.81 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.357 -0.979 . . . . 71.23 108.357 171.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . 0.437 HG21 ' OG ' ' C' ' 119' ' ' SER . 24.8 m -61.28 -30.17 70.31 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.667 -1.152 . . . . 60.41 111.698 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.2 t -64.86 -46.7 80.74 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.789 0.836 . . . . 74.21 109.443 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.512 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 13.3 mmt -72.54 -30.54 64.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.217 0.607 . . . . 74.53 110.944 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.497 HG21 HD23 ' B' ' 126' ' ' LEU . 83.3 t -64.46 -41.16 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.911 0.884 . . . . 75.02 110.311 172.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -65.65 -35.11 79.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.058 0.943 . . . . 72.03 111.452 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.522 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.4 mtt-85 -73.03 -37.21 66.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.614 -0.721 . . . . 75.1 110.317 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.39 1.94 74.14 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.737 0.648 . . . . 71.21 112.59 173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p 63.93 18.32 11.11 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.581 1.952 . . . . 73.42 113.544 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.57 152.79 81.08 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.47 0.708 . . . . 73.5 109.433 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.54 -178.81 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 123.106 2.538 . . . . 73.43 114.236 -176.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 26.5 tp60 -65.37 113.48 4.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.753 -0.658 . . . . 63.12 112.445 -170.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.497 HD23 HG21 ' B' ' 118' ' ' VAL . 55.9 tp -114.35 93.78 4.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.05 -0.977 . . . . 72.23 108.855 171.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.08 128.5 36.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.591 -1.262 . . . . 74.41 107.591 166.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.43 HD21 HG11 ' B' ' 62' ' ' VAL . 30.2 tp -75.77 145.6 40.64 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.377 0.671 . . . . 73.31 110.51 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 127.49 85.02 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.817 0.847 . . . . 51.12 111.316 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.47 122.84 10.62 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.891 2.394 . . . . 54.35 111.594 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 29.1 t -111.91 116.85 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.409 0.684 . . . . 73.02 109.978 -175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -86.23 86.47 7.35 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.546 -0.909 . . . . 52.34 108.546 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 11.3 t80 . . . . . 0 N--CA 1.474 0.736 0 CA-C-N 115.742 -0.663 . . . . 72.12 109.668 178.567 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 73.5 mtp . . . . . 0 N--CA 1.483 1.198 0 N-CA-C 112.365 0.506 . . . . 53.01 112.365 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 89.3 m -86.26 99.5 11.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.677 -0.86 . . . . 54.03 108.677 169.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -124.33 126.76 46.55 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.789 -1.189 . . . . 71.03 107.789 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -151.85 144.09 23.99 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.918 0.487 . . . . 71.02 110.257 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.467 HG13 ' HE2' ' C' ' 84' ' ' PHE . 3.1 mp -82.63 115.73 25.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.219 -1.03 . . . . 62.44 108.219 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -80.93 -44.08 18.79 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.951 -0.388 . . . . 72.31 109.951 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -169.11 141.78 2.67 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.304 0.378 . . . . 75.11 110.098 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -125.45 135.52 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.053 -1.091 . . . . 70.2 108.053 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.595 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 32.6 p90 -173.77 155.9 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.914 0.387 . . . . 71.41 111.129 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -77.36 115.59 17.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.392 -0.822 . . . . 51.15 109.871 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -65.1 -41.02 95.34 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.995 -0.743 . . . . 74.22 108.995 171.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -149.34 150.11 31.96 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.316 -1.311 . . . . 74.14 110.353 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -142.14 145.28 24.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.501 1.92 . . . . 65.34 106.507 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -161.87 150.87 15.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.822 0.449 . . . . 64.25 110.053 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.86 106.67 2.68 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.436 -1.32 . . . . 62.33 107.436 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.39 120.22 36.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.747 0.819 . . . . 70.33 109.41 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.95 83.34 61.42 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.343 1.057 . . . . 70.31 108.496 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.92 -39.21 34.01 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.628 2.219 . . . . 73.13 112.081 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -97.13 20.9 10.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.957 0.903 . . . . 64.11 110.952 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.15 76.08 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.419 1.266 . . . . 70.25 114.419 -171.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.75 -26.35 8.32 Favored 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 121.235 1.477 . . . . 73.32 112.655 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.66 -30.37 65.65 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.336 1.054 . . . . 63.2 112.511 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' C' ' 73' ' ' ALA . 99.4 t -80.02 -20.17 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.32 0.648 . . . . 64.21 110.639 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -60.47 -28.97 68.75 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.072 0.549 . . . . 74.24 111.348 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.42 26.26 6.82 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.558 0.743 . . . . 74.34 110.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.25 152.36 37.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.605 0.762 . . . . 74.23 111.084 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.62 130.71 43.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.816 0.847 . . . . 71.5 110.449 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -76.34 98.14 4.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.838 0.855 . . . . 73.3 110.889 -172.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -156.59 75.82 4.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.397 -0.964 . . . . 74.41 108.397 173.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -86.63 130.09 3.17 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.391 2.06 . . . . 73.11 112.126 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.53 80.25 9.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.582 -1.636 . . . . 74.42 106.582 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.442 HG11 HD21 ' C' ' 126' ' ' LEU . 90.2 t -74.45 118.26 19.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.226 -1.352 . . . . 75.45 108.617 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -128.71 141.34 51.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.276 -1.379 . . . . 72.4 107.276 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.16 166.39 14.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.554 -0.906 . . . . 61.33 108.554 167.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.1 t70 -140.0 127.91 22.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.611 -1.255 . . . . 54.44 107.611 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 tp -104.85 140.62 37.86 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.691 0.796 . . . . 63.14 109.991 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 29.3 t70 -144.84 149.93 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.17 0.988 . . . . 73.4 108.676 172.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 66.3 p -126.77 141.09 51.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 62.05 109.928 -172.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -150.25 139.98 21.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.055 0.542 . . . . 63.32 110.104 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p -148.01 156.07 42.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.533 0.733 . . . . 64.51 109.529 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -152.68 165.55 34.93 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.282 0.633 . . . . 74.01 109.937 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -105.16 118.08 35.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.824 -0.806 . . . . 63.41 108.824 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.576 HD11 HD12 ' C' ' 83' ' ' ILE . 76.4 mt -89.04 -35.61 16.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.181 0.592 . . . . 73.2 110.366 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -171.3 2.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.036 0.934 . . . . 44.21 110.219 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.43 116.41 8.96 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.278 -0.874 . . . . 75.22 109.423 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 69.57 -0.46 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.371 1.468 . . . . 75.43 112.601 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.32 112.29 38.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 108.146 -1.057 . . . . 63.02 108.146 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' C' ' 86' ' ' ILE . 94.0 m-85 -129.56 144.13 51.13 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.889 0.876 . . . . 72.24 108.856 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -99.73 136.42 39.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.529 1.132 . . . . 74.52 110.021 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . 0.431 HG22 HD22 ' C' ' 98' ' ' LEU . 40.8 t -114.95 120.04 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.816 -1.179 . . . . 74.42 107.816 173.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 88.7 t -118.59 129.92 74.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.764 -0.828 . . . . 71.02 108.764 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -125.01 107.0 10.38 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.948 -1.501 . . . . 73.43 106.948 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 25.5 ttm180 -84.06 127.02 33.62 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.906 -0.588 . . . . 71.3 109.774 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.15 121.28 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.52 -1.218 . . . . 73.2 107.881 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 68.5 m -120.59 142.54 49.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.566 -0.902 . . . . 72.15 108.566 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.468 HG23 HD13 ' C' ' 114' ' ' ILE . 72.8 t -122.39 115.31 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.889 0.876 . . . . 74.31 109.421 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 28.2 m -99.31 135.79 40.21 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.879 -0.786 . . . . 43.35 108.879 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.29 107.29 7.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.082 -1.451 . . . . 60.52 107.082 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.3 m -143.44 128.36 18.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.286 0.634 . . . . 73.3 109.468 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' C' ' 73' ' ' ALA . 5.3 mp -85.8 56.71 4.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.469 1.507 . . . . 74.41 109.313 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.0 -82.33 0.44 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 109.893 -1.283 . . . . 71.54 109.893 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.12 -30.6 4.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.604 1.161 . . . . 71.02 109.104 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.19 91.79 0.08 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.191 1.397 . . . . 62.11 110.796 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 38.6 m -71.98 121.36 19.0 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.749 0.309 . . . . 63.05 111.389 -173.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.617 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -68.72 -62.67 1.29 Allowed 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.722 1.263 . . . . 60.13 109.646 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -163.48 175.66 10.52 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.442 -1.254 . . . . 73.11 109.794 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.431 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -140.41 145.71 37.4 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.251 -1.759 . . . . 73.11 106.251 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.431 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.0 t -144.92 149.61 35.56 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.325 -0.991 . . . . 64.11 108.325 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.88 121.03 3.93 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.61 -0.515 . . . . 62.42 109.61 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -119.64 114.41 44.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.869 -0.789 . . . . 73.42 108.869 170.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.1 96.79 10.84 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.628 -1.249 . . . . 74.51 107.628 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.564 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.1 tp-100 -82.75 129.22 34.94 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.941 0.496 . . . . 53.44 109.678 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.16 154.84 16.72 Favored Glycine 0 N--CA 1.461 0.328 0 O-C-N 123.51 0.506 . . . . 61.43 112.051 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.462 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.47 122.25 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.147 -0.781 . . . . 73.43 111.147 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -89.25 127.08 42.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.468 -0.938 . . . . 71.32 108.468 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.467 ' HE2' HG13 ' C' ' 13' ' ' ILE . 83.8 m-85 -136.59 131.68 34.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 71.43 109.871 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -81.05 104.09 11.31 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.405 -0.961 . . . . 71.44 108.405 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.586 HD12 ' SD ' ' C' ' 94' ' ' MET . 10.5 pt -119.45 120.55 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.705 0.802 . . . . 65.44 109.867 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.35 168.05 25.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.715 0.806 . . . . 75.53 110.72 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.28 -61.17 3.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.048 -0.978 . . . . 71.55 111.411 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.17 142.52 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.789 0.328 . . . . 74.44 110.331 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 12.2 pt-20 -147.91 179.03 8.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.797 0.839 . . . . 63.23 109.397 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -122.43 29.81 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 123.687 0.617 . . . . 71.03 113.652 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -78.79 -22.99 45.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.93 0.892 . . . . 73.31 111.595 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -72.86 -31.7 64.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.882 0.473 . . . . 74.41 109.913 173.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.586 ' SD ' HD12 ' C' ' 86' ' ' ILE . 51.6 tpp -66.66 -40.52 88.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.659 -0.7 . . . . 71.34 110.114 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.11 70.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.934 0.894 . . . . 73.34 112.767 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 43.7 t-80 -69.27 -39.06 78.61 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.737 0.415 . . . . 65.43 111.426 177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -76.16 -41.47 49.71 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.168 0.509 . . . . 73.3 110.732 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.431 HD22 HG22 ' C' ' 58' ' ' VAL . 3.4 tm? -82.62 -53.38 5.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.995 1.318 . . . . 71.05 110.75 -168.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.7 -0.19 69.58 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.708 -0.678 . . . . 63.4 114.176 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -128.97 -66.81 0.81 Allowed 'General case' 0 C--N 1.35 0.598 0 CA-C-N 117.211 0.506 . . . . 45.2 111.503 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.15 -49.01 63.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.678 0.622 . . . . 73.4 112.678 -169.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.12 -42.67 77.87 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 118.237 -0.887 . . . . 70.34 112.477 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.57 -41.36 44.99 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.129 2.553 . . . . 61.11 113.691 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 89.0 m-20 -67.62 -31.22 71.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.766 0.827 . . . . 75.41 111.467 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 39.6 mm -70.39 -44.23 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.16 0.584 . . . . 75.14 109.735 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.462 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.4 mt -79.24 -21.56 46.01 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.452 -0.794 . . . . 73.54 111.773 -173.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.42 -54.88 46.1 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.788 1.235 . . . . 74.44 113.199 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.67 -30.26 78.46 Favored 'Trans proline' 0 C--N 1.392 2.867 0 C-N-CA 122.024 1.816 . . . . 74.04 112.662 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.26 -48.75 64.23 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.574 0.75 . . . . 73.33 110.809 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.564 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.75 -37.22 86.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.426 0.69 . . . . 75.44 110.802 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -42.01 72.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.534 1.134 . . . . 74.22 110.568 -174.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.66 -36.45 73.36 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.616 0.766 . . . . 53.31 109.581 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.8 t -67.04 -35.18 79.3 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.69 0.796 . . . . 74.3 111.256 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.468 HD13 HG23 ' C' ' 64' ' ' VAL . 51.7 mt -68.61 -49.0 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.135 0.574 . . . . 62.01 110.083 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 30.4 m -61.01 -33.25 72.96 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.55 0.74 . . . . 74.41 111.249 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -61.26 -51.81 67.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.917 0.887 . . . . 71.53 109.359 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.521 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.68 -42.02 78.33 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.716 1.207 . . . . 64.13 112.622 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' C' ' 126' ' ' LEU . 61.2 t -65.62 -41.7 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.156 0.582 . . . . 60.44 110.595 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.437 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.1 t -68.16 -33.79 75.11 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.623 0.769 . . . . 73.24 111.218 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -64.92 -38.68 91.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.417 0.687 . . . . 73.34 110.282 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 7.86 55.58 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 123.8 0.688 . . . . 72.2 113.059 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 41.2 p 60.6 34.15 20.25 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.016 1.726 . . . . 62.12 112.195 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -108.41 152.82 42.2 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.808 1.243 . . . . 73.41 109.094 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.585 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 34.0 Cg_exo -60.99 158.82 32.23 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.684 2.923 . . . . 55.11 114.776 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -51.9 111.0 0.53 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.916 1.286 . . . . 63.22 112.477 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . 0.442 HD21 HG11 ' C' ' 40' ' ' VAL . 2.8 tm? -112.2 99.16 7.82 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.594 -1.261 . . . . 74.5 107.594 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.51 127.61 49.76 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.168 0.987 . . . . 71.41 108.709 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.413 HD23 ' N ' ' C' ' 129' ' ' ALA . 2.2 tt -71.74 143.03 49.75 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.763 0.825 . . . . 74.01 109.677 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.413 ' N ' HD23 ' C' ' 128' ' ' LEU . . . -72.2 146.9 90.16 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.278 1.031 . . . . 64.54 111.855 -177.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.0 124.61 16.35 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.24 2.627 . . . . 64.21 112.045 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 5.8 p -133.64 126.86 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.631 0.773 . . . . 75.22 109.746 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.98 90.83 7.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.452 0.701 . . . . 43.24 110.535 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -65.42 -30.41 71.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.536 -0.542 . . . . 71.2 109.536 169.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.676 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.9 t70 . . . . . 0 C--N 1.351 0.668 0 CA-C-N 114.755 -1.111 . . . . 71.52 111.28 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 23.5 m . . . . . 0 C--O 1.24 0.559 0 N-CA-C 110.17 -0.307 . . . . 64.25 110.17 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' D' ' 85' ' ' SER . 30.1 t80 -158.57 114.02 2.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.213 1.005 . . . . 71.15 108.474 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -135.07 131.14 36.62 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.905 -0.776 . . . . 73.53 108.905 175.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.48 132.95 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.652 . . . . 72.21 109.238 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 40.9 mt-30 -95.48 -35.04 11.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 122.562 0.345 . . . . 54.34 110.446 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 178.79 160.92 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.187 0.995 . . . . 75.11 110.766 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.24 118.61 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.542 -1.651 . . . . 54.22 106.542 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.438 ' HE1' HG13 ' D' ' 83' ' ' ILE . 9.9 p90 -140.7 141.88 34.91 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.298 0.639 . . . . 54.04 110.503 -173.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 41.1 p -76.85 119.68 20.94 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.658 -0.497 . . . . 72.33 109.658 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -93.84 -21.82 19.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.094 0.558 . . . . 62.11 109.928 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.72 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.4 t70 -153.91 137.06 15.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.378 1.071 . . . . 72.44 109.343 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.521 HD13 ' HE3' ' C' ' 117' ' ' MET . 30.1 mt -139.36 146.76 25.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 124.857 1.263 . . . . 74.54 107.682 174.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -154.13 137.9 16.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.328 0.651 . . . . 73.12 109.849 168.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 78.9 t80 -133.93 121.49 21.75 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 105.798 -1.927 . . . . 71.52 105.798 165.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -122.4 131.24 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.188 -0.671 . . . . 73.05 109.188 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.8 83.52 9.32 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 106.34 -1.726 . . . . 72.53 106.34 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.5 -37.54 69.93 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.732 2.288 . . . . 51.25 112.614 -167.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 25.48 10.35 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.893 0.877 . . . . 74.21 109.247 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.595 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.42 -68.58 0.05 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 N-CA-C 117.413 2.375 . . . . 73.42 117.413 -167.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.74 -24.84 15.26 Favored 'Trans proline' 0 C--N 1.395 2.979 0 CA-C-N 122.777 2.028 . . . . 54.33 112.976 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 16.9 t-160 -66.25 -35.11 79.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.894 1.277 . . . . 64.51 109.725 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' D' ' 73' ' ' ALA . 94.1 t -70.98 -39.9 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.707 -0.679 . . . . 73.24 111.604 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -65.71 -15.0 62.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.706 1.002 . . . . 64.35 113.706 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.73 -33.08 74.84 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.131 0.572 . . . . 74.41 110.581 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.459 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 44.9 mtpt -87.42 111.18 20.87 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.933 0.893 . . . . 65.21 108.594 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -99.7 99.32 10.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.256 1.023 . . . . 73.21 111.374 -173.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.595 ' CD2' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -156.7 -176.65 6.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.758 1.021 . . . . 74.35 113.758 -170.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -97.43 102.94 14.07 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 124.761 1.224 . . . . 75.31 112.975 175.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.536 ' HA ' HD21 ' D' ' 68' ' ' LEU . 75.2 Cg_exo -53.2 131.84 45.06 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 124.059 3.173 . . . . 73.24 115.32 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -98.15 115.44 28.29 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.048 -1.433 . . . . 62.54 107.177 170.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' D' ' 66' ' ' ALA . 31.9 m -98.64 143.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.605 0.762 . . . . 73.41 110.073 -176.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 83.1 tttt -107.22 130.54 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.168 0.987 . . . . 73.54 109.243 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -96.61 128.77 43.87 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.316 -1.364 . . . . 71.44 107.316 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.4 t70 -132.59 126.6 33.15 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.571 -1.27 . . . . 61.15 107.571 172.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.36 139.91 41.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.558 0.743 . . . . 64.03 110.764 -172.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.4 t70 -138.88 139.63 38.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.588 0.755 . . . . 63.43 109.003 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 46.6 p -108.11 144.07 35.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.691 0.796 . . . . 74.13 110.76 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.8 161.99 41.85 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.688 0.795 . . . . 61.43 109.653 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -170.9 156.41 4.97 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.113 0.965 . . . . 62.12 109.499 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 64.7 p -149.53 120.35 7.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.532 0.733 . . . . 44.55 109.154 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -69.99 118.35 12.72 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.389 -0.597 . . . . 75.23 109.389 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 -30.02 17.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.941 -0.572 . . . . 75.31 110.211 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.13 -179.89 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.6 -0.727 . . . . 53.42 110.601 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.35 130.44 40.74 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.926 -1.033 . . . . 63.45 108.538 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 69.21 2.24 3.57 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.395 1.478 . . . . 74.03 112.23 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.26 117.65 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.284 -0.636 . . . . 74.22 109.284 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.672 ' HB2' HD13 ' D' ' 86' ' ' ILE . 97.6 m-85 -128.37 130.13 47.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.036 -1.098 . . . . 74.11 108.036 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -90.91 135.85 33.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.68 -1.6 . . . . 41.44 106.68 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.95 131.67 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.042 0.937 . . . . 75.44 108.637 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 17.5 t -115.16 135.85 53.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.068 -0.716 . . . . 71.41 109.068 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.21 114.84 20.16 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.873 -1.158 . . . . 72.21 107.873 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.8 ttm180 -96.57 114.9 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.136 0.574 . . . . 73.31 110.01 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.49 122.26 55.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.638 -0.875 . . . . 73.44 108.638 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.8 m -115.32 128.65 56.24 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.276 0.631 . . . . 65.22 109.434 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.4 t -115.8 117.64 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.069 1.348 . . . . 73.21 109.342 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.5 m -119.03 95.21 4.72 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.741 -0.837 . . . . 74.4 108.741 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.572 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -98.05 135.0 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.998 -0.741 . . . . 75.45 108.998 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 39.9 p -163.82 135.73 4.88 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.869 0.731 . . . . 64.1 109.704 -173.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' D' ' 36' ' ' TRP . 4.7 mp -134.74 136.44 42.65 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.54 0.736 . . . . 72.03 110.701 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.66 -111.6 3.35 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.238 -0.745 . . . . 42.31 111.238 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.55 11.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.231 1.012 . . . . 75.5 109.588 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -139.82 144.11 37.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.04 0.536 . . . . 71.24 111.409 -163.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.1 m -67.53 140.54 57.0 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 124.298 1.039 . . . . 63.14 110.633 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.478 ' HA ' HG11 ' D' ' 31' ' ' VAL . . . -84.96 -69.48 0.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.748 -0.834 . . . . 72.35 108.748 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -154.91 148.45 25.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.623 -1.171 . . . . 73.51 109.074 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.2 mt -108.24 152.94 23.92 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.853 1.261 . . . . 55.13 108.979 172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.3 t -158.87 144.02 16.14 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.659 0.784 . . . . 52.33 109.002 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.857 -0.794 . . . . 44.22 108.857 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . 0.462 HG22 HG23 ' D' ' 21' ' ' ILE . 51.1 t -125.94 119.71 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.819 0.448 . . . . 74.3 110.054 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.72 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 16.0 mt-30 -89.5 91.79 8.85 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 109.02 -0.733 . . . . 75.21 109.02 166.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -81.1 101.64 9.74 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.889 -1.051 . . . . 63.41 108.391 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 171.39 44.16 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 111.442 -0.663 . . . . 41.03 111.442 175.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.56 131.59 1.96 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.433 -0.667 . . . . 71.11 111.433 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' D' ' 17' ' ' TYR . 32.7 mt -89.43 134.19 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 109.151 -0.685 . . . . 74.41 109.151 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.492 ' HB2' HD11 ' D' ' 86' ' ' ILE . 32.8 m-85 -133.63 162.29 32.33 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.3 0.64 . . . . 74.32 109.687 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 36.2 m -109.61 103.23 12.06 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.409 -0.96 . . . . 54.53 108.409 171.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.672 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.1 mp -107.15 117.57 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.999 0.92 . . . . 65.15 108.837 -176.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -149.8 164.55 35.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.738 0.815 . . . . 72.25 110.336 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.51 -0.98 59.11 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 116.103 1.201 . . . . 42.14 116.103 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.67 133.47 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.58 0.752 . . . . 73.11 109.737 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -133.61 154.23 51.05 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.866 0.866 . . . . 74.41 110.299 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.02 -110.59 2.75 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.23 0.956 . . . . 50.22 114.489 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 m -65.82 -41.04 92.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.359 1.064 . . . . 63.04 112.298 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -72.78 -36.73 67.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.781 0.432 . . . . 65.4 111.106 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -79.92 -23.93 41.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.531 0.205 . . . . 53.52 110.602 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -32.38 68.78 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.79 -0.448 . . . . 63.33 109.79 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -74.04 -45.45 49.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.546 0.738 . . . . 74.32 110.6 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -66.58 -51.6 54.67 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 122.743 0.417 . . . . 63.14 110.285 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.447 HD13 ' SG ' ' D' ' 102' ' ' CYS . 3.8 mm? -78.98 -19.11 52.44 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.959 0.503 . . . . 63.45 110.87 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.11 -1.98 64.59 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-O 119.775 -0.459 . . . . 74.22 114.154 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 -61.31 0.23 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.345 0.573 . . . . 73.51 111.135 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.41 -50.59 51.76 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.195 0.998 . . . . 74.24 113.278 -166.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . 0.447 ' SG ' HD13 ' D' ' 98' ' ' LEU . 22.1 m -68.1 -45.78 40.69 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.797 0.839 . . . . 63.11 112.202 -175.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.02 -24.28 45.51 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 121.54 1.494 . . . . 73.23 112.847 172.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -66.36 -32.62 74.12 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.457 0.703 . . . . 64.3 110.285 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.16 -46.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 54.04 110.193 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -75.9 -32.72 59.78 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.271 -0.877 . . . . 72.45 111.987 -172.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.629 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 75.7 t80 -59.76 -46.01 98.43 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.81 1.411 . . . . 65.31 114.81 -167.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.18 -33.11 91.15 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 121.919 1.746 . . . . 72.41 112.618 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -75.67 -34.91 60.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.645 0.778 . . . . 73.12 110.993 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.9 84.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.479 0.711 . . . . 61.51 110.06 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -60.66 -46.64 89.57 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.585 -1.189 . . . . 74.2 110.956 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.67 -38.33 83.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 62.24 111.117 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.49 -41.86 95.14 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.715 0.635 . . . . 62.4 110.14 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.59 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.5 mt -63.05 -56.19 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.21 0.944 . . . . 64.33 110.061 173.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.467 HG21 ' HE2' ' B' ' 109' ' ' TYR . 88.9 m -51.76 -45.13 63.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.971 1.308 . . . . 74.33 112.003 -172.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -66.4 -43.14 86.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.832 -1.076 . . . . 72.4 110.724 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 62.7 mtm -66.12 -34.61 78.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.945 0.498 . . . . 72.42 111.812 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -66.11 -42.75 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.155 -0.93 . . . . 71.43 109.913 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.9 p -72.49 -30.76 64.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.834 0.454 . . . . 74.45 111.392 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -69.83 -30.89 68.51 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.345 0.658 . . . . 63.54 110.167 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.06 11.16 65.79 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.492 -0.777 . . . . 64.14 112.613 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.409 HG23 ' HB3' ' C' ' 17' ' ' TYR . 75.7 p 59.27 13.98 3.38 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.865 2.066 . . . . 63.51 114.424 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -82.15 162.67 56.06 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 107.417 -1.327 . . . . 72.31 107.417 164.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -82.34 152.74 15.91 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.017 1.811 . . . . 74.12 112.444 -171.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -54.02 120.46 6.43 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.372 0.669 . . . . 51.52 110.906 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 48.7 tp -104.58 108.59 20.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.281 -1.007 . . . . 73.23 108.281 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.465 ' HB3' HG13 ' B' ' 13' ' ' ILE . 57.9 m-20 -100.28 93.09 5.5 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.463 -0.94 . . . . 74.41 108.463 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.629 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.3 OUTLIER -61.61 137.48 58.25 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.079 1.352 . . . . 75.23 109.785 -178.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.28 129.3 83.23 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 123.902 0.881 . . . . 64.11 112.295 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.457 ' HD3' HD12 ' B' ' 13' ' ' ILE . 59.3 Cg_endo -76.13 117.63 4.72 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.717 1.612 . . . . 71.32 109.841 168.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 95.4 t -106.1 110.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.679 -0.86 . . . . 74.14 108.679 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -70.33 99.43 1.55 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.336 -0.847 . . . . 74.14 109.665 178.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 . . . . . 0 CA--C 1.538 0.514 0 CA-C-N 115.484 -0.78 . . . . 72.13 111.249 179.16 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.4 m . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 109.458 -0.571 . . . . 64.42 109.458 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 29.1 t80 -140.16 129.4 23.8 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.214 -1.032 . . . . 74.21 108.214 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -148.77 109.44 4.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.706 0.289 . . . . 75.54 110.744 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.669 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.2 mt -73.0 111.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.237 -0.653 . . . . 63.52 109.237 172.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -91.7 -27.46 18.07 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.82 0.7 . . . . 64.4 110.209 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -164.27 144.29 7.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 121.382 -0.127 . . . . 74.43 110.924 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -143.51 118.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.074 1.349 . . . . 71.14 108.72 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.8 p90 -166.63 176.66 7.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.864 0.84 . . . . 75.52 111.821 -163.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -103.55 112.36 25.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.712 -1.131 . . . . 62.22 108.582 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -76.83 -19.63 57.3 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 110.103 -0.332 . . . . 54.55 110.103 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.14 144.88 17.68 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.716 0.806 . . . . 65.45 109.646 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -135.22 145.47 31.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 124.993 1.317 . . . . 72.45 107.742 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.9 p -147.9 138.95 23.37 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.039 -0.726 . . . . 51.14 109.039 166.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 93.6 t80 -136.06 111.17 8.94 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.831 -1.914 . . . . 73.54 105.831 170.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.25 107.24 13.17 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.292 -0.633 . . . . 75.42 109.292 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.29 78.41 10.55 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 107.477 -1.305 . . . . 71.52 107.477 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.47 -34.74 5.48 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.155 1.903 . . . . 71.24 111.737 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -89.41 10.67 21.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.69 -0.686 . . . . 71.23 110.879 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.98 -57.59 9.9 Favored Pre-proline 0 CA--C 1.566 1.573 0 CA-C-O 117.455 -1.259 . . . . 73.32 113.426 -166.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -47.8 -41.88 31.24 Favored 'Trans proline' 0 C--N 1.403 3.411 0 C-N-CA 123.381 2.721 . . . . 63.33 113.885 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -100.95 -14.04 18.05 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.145 0.794 . . . . 74.22 113.145 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.529 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.6 -18.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.29 0.495 . . . . 73.52 110.582 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.25 -5.37 41.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.767 0.827 . . . . 72.44 111.689 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -99.95 -18.79 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.203 1.001 . . . . 71.41 111.18 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -67.57 150.19 49.13 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 75.21 111.912 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.39 134.83 55.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.581 0.753 . . . . 75.31 110.139 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -78.82 75.91 5.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.273 0.629 . . . . 75.01 112.101 -169.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -132.91 74.86 73.44 Favored Pre-proline 0 N--CA 1.48 1.033 0 N-CA-C 108.324 -0.991 . . . . 72.12 108.324 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.75 128.09 2.8 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.102 2.535 . . . . 74.43 112.113 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.72 98.47 11.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.312 -2.107 . . . . 72.1 105.312 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.8 t -91.78 102.04 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.312 -1.313 . . . . 75.52 108.997 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -78.91 148.08 32.84 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.572 0.749 . . . . 74.32 111.048 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.51 111.53 18.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.617 -1.253 . . . . 75.44 107.617 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.778 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -107.3 144.06 34.67 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.277 -1.008 . . . . 73.11 108.277 170.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.68 129.45 24.65 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.903 0.481 . . . . 54.54 109.918 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.65 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.1 m-20 -127.22 127.4 44.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.194 0.998 . . . . 74.45 109.317 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.9 p -118.17 122.83 44.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.56 1.144 . . . . 75.4 109.522 -175.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.97 147.28 31.52 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.082 0.553 . . . . 51.11 110.938 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 p -119.42 167.12 12.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.76 0.824 . . . . 74.35 110.014 170.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -156.07 153.16 28.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.617 1.167 . . . . 73.4 108.355 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -113.44 127.04 55.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.488 0.315 . . . . 64.03 110.349 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 57' ' ' GLU . 41.6 mt -93.65 -44.33 8.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.604 0.762 . . . . 64.34 110.495 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -150.1 -179.01 6.82 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.482 -1.235 . . . . 75.44 108.914 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.39 118.87 8.68 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 109.483 -0.562 . . . . 71.42 109.483 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 71.96 -4.61 1.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.707 1.603 . . . . 72.03 113.312 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 42.1 t -104.86 118.62 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.915 -0.772 . . . . 71.21 108.915 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -122.3 160.43 25.34 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.488 0.715 . . . . 73.14 110.676 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' HB2' HD11 ' A' ' 51' ' ' LEU . 8.1 tm-20 -132.71 136.87 46.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.318 -1.364 . . . . 73.51 107.318 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.418 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 86.3 t -126.49 125.88 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.449 -0.945 . . . . 73.3 108.449 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.4 t -101.71 136.94 31.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.159 0.584 . . . . 61.44 110.025 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -122.3 97.68 5.58 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.67 -1.604 . . . . 54.04 106.67 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.65 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 47.2 ttp180 -86.53 109.81 19.36 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 109.319 -0.622 . . . . 74.1 109.319 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.8 139.49 18.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.295 -1.372 . . . . 61.41 107.295 169.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.778 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 40.3 m -132.27 136.03 46.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.611 -0.885 . . . . 51.23 108.611 173.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.705 HG11 HD21 ' A' ' 126' ' ' LEU . 92.5 t -134.85 109.07 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.464 1.106 . . . . 72.44 108.421 -173.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.3 m -106.05 137.22 44.35 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 108.684 -0.858 . . . . 75.55 108.684 174.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.39 123.57 38.24 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.021 -0.733 . . . . 63.11 109.021 176.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 63.8 m -132.14 125.45 31.29 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.768 0.427 . . . . 72.13 110.143 175.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -89.39 84.41 6.44 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.239 -1.393 . . . . 75.01 107.239 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.98 -98.86 1.23 Allowed Glycine 0 C--N 1.344 1.011 0 CA-C-N 114.245 -1.343 . . . . 35.22 110.93 -170.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -104.88 -25.87 12.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.299 1.04 . . . . 64.51 110.253 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.88 106.13 17.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 75.14 110.277 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.77 130.31 42.46 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.506 0.669 . . . . 70.31 111.248 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.53 -60.76 2.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.898 -1.046 . . . . 73.13 109.724 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -155.82 162.98 40.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.956 -1.02 . . . . 72.4 111.478 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -135.9 111.32 9.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.55 1.14 . . . . 74.03 108.465 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.43 124.05 48.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.25 1.02 . . . . 64.11 109.865 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -135.54 119.01 16.87 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.211 -0.663 . . . . 65.44 109.211 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.96 110.36 21.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.912 0.885 . . . . 64.3 109.132 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -83.91 82.8 8.18 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.396 -1.335 . . . . 75.51 107.396 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 7.8 tp-100 -76.91 94.51 3.94 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.624 -0.88 . . . . 53.25 108.624 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.15 149.79 19.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.3 -0.864 . . . . 73.01 111.754 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 134.76 5.12 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.802 -0.519 . . . . 63.22 111.802 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' B' ' 29' ' ' PRO . 63.8 mt -81.72 123.86 38.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.941 -0.763 . . . . 63.52 108.941 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.669 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.3 m-85 -132.78 117.14 17.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.792 -1.188 . . . . 75.52 107.792 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 t -77.93 93.84 4.48 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.565 -0.902 . . . . 71.45 108.565 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.5 mt -104.34 131.61 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.862 -0.792 . . . . 75.11 108.862 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -153.34 162.65 41.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.721 0.808 . . . . 63.25 110.133 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.2 -28.92 8.12 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.938 -0.573 . . . . 73.12 114.521 168.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.79 140.9 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.448 0.699 . . . . 70.21 111.636 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -147.19 176.03 10.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.15 0.98 . . . . 63.24 108.6 177.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.59 -135.82 23.93 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.561 -0.577 . . . . 33.54 112.055 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 48.1 p -71.85 -14.99 62.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 72.21 111.729 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -74.25 -57.43 3.95 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.173 0.989 . . . . 75.52 110.253 -176.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.7 ttt -80.27 -15.32 57.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.821 -0.172 . . . . 71.42 110.648 175.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -62.57 -39.66 94.4 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.884 0.373 . . . . 71.15 110.108 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.559 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.7 t-80 -77.3 -19.54 56.29 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.878 -0.601 . . . . 63.54 110.988 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.6 -61.05 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.813 -0.554 . . . . 74.14 110.278 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.46 -45.5 72.29 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.873 0.869 . . . . 70.4 111.702 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.69 6.38 79.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.116 -0.825 . . . . 34.33 114.559 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.683 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.37 -61.71 0.22 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.117 0.958 . . . . 62.13 112.714 -175.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 87.5 t80 -78.32 -55.46 5.22 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.036 1.124 . . . . 71.54 114.036 -164.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.5 m -70.21 -33.06 3.1 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 114.048 1.129 . . . . 74.32 114.048 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.4 Cg_endo -63.8 -16.8 56.91 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.039 1.826 . . . . 62.43 113.149 167.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -71.98 -14.95 62.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.59 . . . . 53.21 110.825 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.66 HD11 HD21 ' C' ' 132' ' ' ASN . 36.0 mm -84.11 -41.8 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.848 0.832 . . . . 72.33 109.855 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 76.0 mt -76.35 -44.38 36.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.251 -1.341 . . . . 74.01 111.598 -171.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -59.82 -41.35 85.13 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 113.706 1.002 . . . . 74.03 113.706 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.96 -44.73 33.01 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.12 1.88 . . . . 72.44 113.375 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' C' ' 108' ' ' PRO . 26.7 m-85 -73.7 -24.06 59.88 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.989 0.516 . . . . 72.45 111.997 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -51.69 23.28 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.832 -0.803 . . . . 61.24 108.832 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -50.91 -46.78 60.8 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.944 1.402 . . . . 73.01 110.488 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -65.36 -42.02 93.22 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 124.765 1.291 . . . . 74.04 111.073 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.5 t -62.26 -45.43 93.35 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.739 0.649 . . . . 73.15 110.188 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.56 -43.0 98.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 O-C-N 124.267 0.98 . . . . 74.55 110.105 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.5 m -57.14 -44.06 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.824 0.85 . . . . 65.25 110.552 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 14.6 t -67.77 -47.7 68.47 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.071 -0.968 . . . . 65.33 110.589 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.7 mtp -57.11 -48.58 78.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 71.44 111.502 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.81 -43.44 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.069 1.348 . . . . 54.15 110.859 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -67.51 -33.61 75.43 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.795 0.838 . . . . 75.32 111.59 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 116' ' ' SER . 37.0 mtt180 -72.13 -29.63 64.25 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.428 0.691 . . . . 74.33 110.659 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.87 14.25 38.6 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.498 -0.612 . . . . 75.5 113.555 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 57.51 22.48 8.13 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.105 1.762 . . . . 41.33 113.329 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -89.22 156.51 48.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 73.43 108.759 171.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -66.71 151.98 81.52 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.813 2.342 . . . . 53.45 111.755 -179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.592 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.9 tt0 -53.99 127.74 27.64 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.976 0.797 . . . . 53.43 111.569 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 64' ' ' VAL . 16.5 tp -110.71 101.15 9.81 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.21 -0.904 . . . . 73.43 109.825 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -107.48 100.07 9.53 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.377 -1.342 . . . . 74.12 107.377 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.77 121.38 14.43 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.492 -0.558 . . . . 64.12 109.492 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -50.63 129.82 27.0 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.119 0.968 . . . . 62.01 112.219 -170.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 46.5 Cg_endo -84.1 115.86 2.05 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.678 2.252 . . . . 61.34 113.07 -175.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.65 141.43 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.573 -0.899 . . . . 73.14 108.573 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.34 72.43 4.86 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.37 -0.974 . . . . 71.55 108.37 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.46 -35.74 75.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.818 1.247 . . . . 72.02 110.586 -172.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.683 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.0 p-10 . . . . . 0 CA--C 1.546 0.824 0 CA-C-N 114.655 -1.157 . . . . 72.43 111.511 174.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m . . . . . 0 C--O 1.241 0.639 0 N-CA-C 107.377 -1.342 . . . . 51.31 107.377 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.86 156.69 44.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.807 0.813 . . . . 74.02 110.957 161.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 17.1 pm0 -126.43 132.67 51.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 113.644 -1.616 . . . . 65.33 107.722 176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.414 ' O ' HG13 ' B' ' 13' ' ' ILE . 35.5 pt -76.89 108.68 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.497 -0.774 . . . . 72.13 109.136 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -74.93 -46.68 34.04 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.611 -0.515 . . . . 73.31 109.611 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 18.2 ttt85 -162.04 135.62 6.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 110.28 -0.267 . . . . 70.45 110.28 -174.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.9 mt -116.74 131.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 106.147 -1.797 . . . . 73.35 106.147 170.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -164.01 141.58 7.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.644 0.378 . . . . 65.32 110.975 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 45.2 m -72.34 116.89 13.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.726 -0.842 . . . . 74.13 108.726 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -84.99 -40.28 17.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.944 -0.571 . . . . 71.12 110.458 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 11.6 t70 -145.62 144.2 30.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.108 -0.496 . . . . 63.21 111.081 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.533 HD11 ' SG ' ' B' ' 113' ' ' CYS . 32.2 mm -137.15 145.85 29.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.277 1.431 . . . . 65.52 108.487 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.552 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 26.7 t -146.25 138.86 25.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.284 -1.326 . . . . 22.52 107.434 176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -155.92 143.12 19.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.024 -1.102 . . . . 73.53 108.024 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.3 mt-10 -143.6 155.59 44.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.733 1.213 . . . . 70.43 108.716 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -151.27 86.09 4.85 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 107.878 -1.156 . . . . 60.01 107.878 172.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.5 -43.22 4.31 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.779 2.319 . . . . 71.13 113.006 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 38.0 m-80 -105.0 29.02 6.66 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.018 0.527 . . . . 70.34 109.893 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.54 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.55 -54.06 25.42 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.866 1.266 . . . . 42.44 113.233 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HA ' HD11 ' A' ' 83' ' ' ILE . 2.5 Cg_endo -80.35 -20.44 8.36 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 121.527 1.485 . . . . 60.22 112.77 -176.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.52 ' HB3' ' NE2' ' B' ' 33' ' ' GLN . 51.5 m-70 -97.41 2.66 50.68 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.405 1.082 . . . . 60.32 112.686 -175.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.25 -15.12 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.62 0.768 . . . . 75.2 112.08 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -84.94 -27.11 26.78 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.606 0.762 . . . . 73.12 112.836 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.52 ' NE2' ' HB3' ' B' ' 30' ' ' HIS . 23.0 pt20 -75.69 -29.43 59.01 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.591 0.356 . . . . 72.45 111.626 -172.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.433 ' HB2' ' CZ2' ' B' ' 36' ' ' TRP . 38.1 mtpt -108.85 117.44 34.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.726 1.21 . . . . 52.33 108.707 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -89.71 117.41 28.55 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.458 0.572 . . . . 75.23 110.857 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.472 ' CZ2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -171.39 162.5 6.72 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 123.982 0.913 . . . . 71.53 112.916 -178.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -93.24 132.72 29.89 Favored Pre-proline 0 N--CA 1.485 1.322 0 C-N-CA 124.328 1.051 . . . . 64.2 109.997 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.44 147.39 36.48 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.25 1.966 . . . . 73.21 112.83 171.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.23 109.65 16.7 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.845 -1.169 . . . . 62.4 107.845 163.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 60.8 t -100.24 123.21 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.731 -0.668 . . . . 61.21 109.422 -179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.3 142.24 35.41 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.776 0.83 . . . . 71.31 109.555 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.601 HD11 HD21 ' B' ' 128' ' ' LEU . 3.7 tt -106.52 134.98 48.83 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.962 -1.496 . . . . 61.1 106.962 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 4.7 m-20 -128.42 114.55 16.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.215 -1.032 . . . . 60.21 108.215 -177.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.17 127.2 46.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.239 -1.393 . . . . 73.53 107.239 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -137.66 147.12 44.62 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.453 0.701 . . . . 73.23 109.199 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.1 p -121.82 128.85 52.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.412 0.685 . . . . 63.41 110.217 -173.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . 0.41 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -131.57 137.3 48.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.044 -1.095 . . . . 63.44 108.044 174.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.7 p -144.6 163.17 34.72 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.132 0.491 . . . . 55.32 110.559 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.88 173.09 15.79 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.065 -0.97 . . . . 75.53 108.845 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -120.51 125.14 47.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.801 0.44 . . . . 73.51 110.25 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.1 mt -87.45 -46.56 9.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.397 0.679 . . . . 72.43 109.459 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.25 -174.33 4.93 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.209 -0.905 . . . . 54.24 111.059 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.79 120.72 13.01 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.5 -0.773 . . . . 72.22 110.197 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 70.02 -5.48 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.522 1.529 . . . . 75.21 112.542 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -102.43 111.62 32.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.728 -0.842 . . . . 73.31 108.728 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -119.79 139.93 51.56 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.597 -0.729 . . . . 64.32 109.861 178.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.581 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.9 tm-20 -104.05 97.13 7.15 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.694 -1.595 . . . . 70.22 106.694 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -92.62 118.72 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.864 0.866 . . . . 74.02 109.533 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.61 119.23 51.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 123.632 0.773 . . . . 64.31 110.033 176.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.23 109.14 20.97 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.096 -1.076 . . . . 64.34 108.096 172.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.7 122.95 33.91 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.351 -0.611 . . . . 74.42 109.351 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.43 124.99 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 107.985 -1.117 . . . . 71.43 107.985 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 12.4 m -119.7 138.53 53.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.579 0.752 . . . . 71.45 109.227 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.533 HG23 HD13 ' B' ' 114' ' ' ILE . 51.6 t -122.0 128.78 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 123.932 0.893 . . . . 62.13 109.164 175.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -118.84 144.28 46.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.576 -0.898 . . . . 75.02 108.576 171.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.81 133.79 30.86 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.66 -0.867 . . . . 71.23 108.66 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.4 p -149.88 140.11 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.883 0.473 . . . . 74.15 110.321 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -137.41 144.3 42.33 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.597 1.159 . . . . 71.33 109.228 -171.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.86 -108.06 1.95 Allowed Glycine 0 C--N 1.347 1.143 0 O-C-N 123.341 0.401 . . . . 74.14 113.81 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -116.05 1.17 13.2 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.226 1.01 . . . . 74.34 110.11 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 0.9 OUTLIER -139.88 177.98 7.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.002 0.742 . . . . 72.24 113.002 -169.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 140.34 29.68 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.419 1.088 . . . . 55.12 109.808 171.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -80.44 -67.58 0.76 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.106 0.962 . . . . 71.22 109.477 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -159.3 157.79 31.19 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.146 -1.388 . . . . 62.53 109.472 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.98 150.51 47.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.608 1.163 . . . . 75.54 108.22 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.5 t -157.96 152.02 24.24 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.44 -0.578 . . . . 71.14 109.44 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -164.85 131.51 2.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.147 -0.686 . . . . 62.41 109.147 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -124.23 146.39 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.771 -0.826 . . . . 72.34 108.771 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -125.09 98.26 5.59 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.939 . . . . 75.32 108.463 171.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -86.52 102.08 13.78 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.445 -0.798 . . . . 44.12 109.186 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.62 148.66 20.61 Favored Glycine 0 C--O 1.24 0.516 0 N-CA-C 111.189 -0.765 . . . . 62.02 111.189 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -152.38 125.46 1.82 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.889 -0.885 . . . . 71.2 110.889 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.581 HG12 ' HG2' ' B' ' 57' ' ' GLU . 38.0 mt -88.94 117.22 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.113 -0.699 . . . . 70.41 109.113 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -122.27 131.37 53.88 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.195 -1.409 . . . . 72.22 107.195 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.7 m -97.62 88.87 4.47 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.216 -1.031 . . . . 73.43 108.216 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' B' ' 89' ' ' ILE . 4.4 pt -95.67 121.98 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.24 -1.346 . . . . 75.42 110.028 -169.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.46 159.68 40.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.924 0.889 . . . . 45.42 109.89 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.19 -56.55 3.6 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.989 -0.55 . . . . 62.42 111.957 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.3 pp -58.5 153.04 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.152 0.981 . . . . 75.25 113.308 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -169.28 146.5 3.54 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.842 -1.072 . . . . 70.52 108.43 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -130.45 13.13 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 120.028 -0.318 . . . . 62.12 113.465 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -65.8 -33.22 75.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.479 1.111 . . . . 35.05 110.883 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.83 -40.54 97.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.202 -0.908 . . . . 74.3 110.561 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 23.0 ttt -76.93 -31.73 56.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.808 -0.633 . . . . 70.11 110.438 179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.05 -21.3 66.37 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.877 -0.602 . . . . 65.32 111.517 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 33.7 t-80 -84.71 -37.0 21.47 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.22 0.608 . . . . 73.1 110.552 169.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.47 -67.2 0.45 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.482 0.313 . . . . 61.15 111.38 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -12.79 42.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.383 0.512 . . . . 72.51 112.383 -176.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.03 -4.97 53.9 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-O 119.715 -0.492 . . . . 53.43 113.82 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -141.43 -58.41 0.49 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.185 0.493 . . . . 74.31 111.753 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -75.28 -44.61 44.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.2 0.6 . . . . 72.1 111.922 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.9 m -67.21 -44.68 49.23 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 118.572 -0.728 . . . . 71.03 111.721 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -57.16 -36.27 99.1 Favored 'Trans proline' 0 C--N 1.397 3.088 0 C-N-CA 122.435 2.09 . . . . 64.14 113.143 168.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -61.87 -35.91 79.72 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.389 0.676 . . . . 60.44 110.429 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -48.02 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.328 0.651 . . . . 74.1 110.752 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.422 HD21 ' HA3' ' B' ' 82' ' ' GLY . 96.5 mt -74.26 -21.12 59.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.188 0.595 . . . . 65.02 112.24 -173.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.573 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 50.0 t80 -60.64 -52.32 73.48 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-O 117.143 -1.408 . . . . 65.22 113.578 -171.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.88 -35.58 80.34 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.204 1.936 . . . . 55.21 113.267 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -68.81 -49.87 54.9 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.683 0.793 . . . . 74.42 110.548 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.54 92.0 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.574 0.749 . . . . 50.41 111.087 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -57.23 -62.09 2.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.236 1.814 . . . . 73.34 111.7 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . 0.466 ' HG2' ' NH2' ' C' ' 120' ' ' ARG . 13.7 tp10 -70.34 -23.89 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.498 0.719 . . . . 72.41 110.709 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.533 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.1 t -69.97 -35.84 74.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.683 -0.199 . . . . 61.43 110.632 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.533 HD13 HG23 ' B' ' 64' ' ' VAL . 61.7 mt -63.82 -54.86 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.048 -0.723 . . . . 72.44 109.048 171.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.6 m -56.62 -34.69 67.5 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.382 1.073 . . . . 61.32 112.072 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -66.64 -45.01 80.41 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.644 -0.707 . . . . 71.04 110.43 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 13.7 mmt -71.2 -33.93 70.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.498 0.499 . . . . 52.03 111.165 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.61 -44.0 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.833 0.853 . . . . 63.22 109.746 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -72.0 -25.48 61.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.35 -0.841 . . . . 65.34 111.399 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -72.94 -27.51 61.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.877 0.471 . . . . 74.33 109.883 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.71 38.6 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.837 0.711 . . . . 52.11 112.756 169.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.9 p 54.86 46.6 24.13 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 125.888 1.675 . . . . 74.53 112.253 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -108.8 158.5 33.95 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.523 1.129 . . . . 63.1 109.099 174.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -72.93 -163.21 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.073 2.515 . . . . 71.21 113.696 -174.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 21.6 tp60 -64.08 130.38 43.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.724 0.81 . . . . 65.03 112.098 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 29.9 tp -130.5 85.09 2.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.141 0.576 . . . . 74.52 109.615 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -91.01 115.55 28.1 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.623 -0.88 . . . . 74.34 108.623 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.601 HD21 HD11 ' B' ' 42' ' ' LEU . 1.6 tt -77.12 140.22 40.18 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.841 -1.17 . . . . 71.44 107.841 173.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.77 148.31 79.13 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.143 0.577 . . . . 71.45 111.057 -179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.87 109.67 0.48 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.576 2.184 . . . . 65.4 112.354 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.84 110.37 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.747 -0.834 . . . . 42.12 108.747 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -90.31 85.44 6.21 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.724 -0.843 . . . . 64.13 108.724 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 . . . . . 0 N--CA 1.483 1.202 0 C-N-CA 123.921 0.889 . . . . 74.44 111.525 179.243 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 89.3 mtp . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.52 0.676 . . . . 72.21 112.379 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -122.45 97.12 5.32 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -105.59 129.3 53.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.446 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . 0.622 ' HG2' ' HB2' ' C' ' 85' ' ' SER . 0.7 OUTLIER -137.71 108.87 6.8 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.401 0.681 . . . . 63.14 109.254 173.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.7 120.07 13.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.222 -0.899 . . . . 63.32 108.626 171.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -86.15 -49.91 7.39 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.685 -0.689 . . . . 70.22 109.9 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -171.69 129.41 0.66 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.174 -0.467 . . . . 65.42 109.893 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.21 143.88 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.197 -1.409 . . . . 72.33 107.197 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.488 ' HE1' HG12 ' C' ' 83' ' ' ILE . 15.7 p90 -175.73 151.4 1.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.315 0.579 . . . . 71.55 110.444 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -76.6 107.12 8.67 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.622 -0.881 . . . . 72.12 108.622 171.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -70.48 -29.73 66.35 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.008 -0.738 . . . . 72.53 109.008 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.756 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -145.84 140.51 27.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.26 -0.882 . . . . 53.42 110.687 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.4 mt -134.66 144.98 33.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.275 -1.75 . . . . 62.32 106.275 170.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.0 t -159.68 151.77 20.71 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.484 0.659 . . . . 54.34 110.674 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 80.7 t80 -149.36 109.7 4.18 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.335 -1.357 . . . . 75.14 107.335 171.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.3 119.17 35.41 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.98 -0.748 . . . . 64.12 108.98 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.07 79.62 12.98 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.626 -0.879 . . . . 65.53 108.626 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.17 -12.53 25.62 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.815 2.343 . . . . 72.11 111.409 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -103.97 13.25 33.05 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.453 1.101 . . . . 51.41 109.357 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.02 96.0 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.613 1.338 . . . . 65.12 114.613 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.402 ' HA ' HH21 ' D' ' 15' ' ' ARG . 24.0 Cg_exo -65.24 -39.72 22.09 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.624 1.549 . . . . 62.43 112.181 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -68.76 -41.59 78.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.977 -1.011 . . . . 71.25 112.359 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.435 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 13.5 p -70.94 -25.83 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.065 0.394 . . . . 71.43 112.065 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -69.63 -12.16 61.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.668 0.787 . . . . 75.11 112.173 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -128.47 22.84 5.95 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.584 0.753 . . . . 71.45 110.635 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.6 ' HE3' HD21 ' C' ' 68' ' ' LEU . 31.9 ttpt -109.1 168.1 9.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.934 0.894 . . . . 75.35 110.626 -174.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.67 125.23 19.03 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.942 1.297 . . . . 65.02 112.243 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -85.53 68.21 10.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.955 0.902 . . . . 72.34 111.39 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -149.3 71.65 10.02 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 109.379 -0.6 . . . . 75.24 109.379 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.03 143.19 4.0 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.673 2.249 . . . . 63.02 112.023 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -88.06 91.6 8.83 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.61 -1.256 . . . . 75.53 107.61 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.41 129.02 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.662 -0.866 . . . . 55.3 108.662 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.77 118.24 22.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.394 0.678 . . . . 71.1 109.222 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -87.17 119.76 27.74 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.423 -1.325 . . . . 65.41 107.423 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.73 114.35 19.81 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.959 -0.756 . . . . 74.42 108.959 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.83 150.11 24.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.38 0.672 . . . . 73.32 109.284 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.729 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 6.5 t70 -148.02 150.93 34.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.345 1.058 . . . . 74.42 109.158 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -119.34 131.12 55.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.886 0.874 . . . . 54.42 110.272 -174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -134.57 145.77 49.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 64.13 109.509 174.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -151.89 146.05 25.36 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.734 . . . . 74.14 110.262 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.8 p -148.09 137.09 21.96 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.556 0.742 . . . . 75.43 109.93 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -83.58 116.62 22.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.096 -0.705 . . . . 70.32 109.096 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' C' ' 57' ' ' GLU . 43.7 mt -93.91 -34.02 13.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.453 0.701 . . . . 54.1 109.933 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.71 -173.99 4.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.896 . . . . 73.54 110.101 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.95 116.39 5.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.32 -0.854 . . . . 75.15 110.188 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 70.28 -5.85 1.26 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.559 1.543 . . . . 44.3 113.129 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -94.76 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.724 -0.843 . . . . 75.33 108.724 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -124.62 126.18 45.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.518 1.127 . . . . 75.53 108.748 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.593 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.1 tt0 -82.21 116.17 21.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.051 -0.977 . . . . 71.55 108.783 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -97.23 122.82 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.597 -1.26 . . . . 63.21 107.597 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 92.5 t -115.85 132.81 64.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.536 -0.912 . . . . 73.45 108.536 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.94 102.59 9.49 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.343 -1.354 . . . . 60.2 107.343 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.729 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.2 tmt_? -82.59 110.03 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.226 1.01 . . . . 74.13 108.481 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.5 t -102.57 136.88 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.92 -1.141 . . . . 64.35 107.92 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -140.03 116.54 10.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.217 -0.66 . . . . 72.12 109.217 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 78.4 t -102.35 109.09 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.793 -1.094 . . . . 71.22 108.1 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.0 m -98.67 150.68 21.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.623 -1.171 . . . . 71.34 109.301 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.94 111.24 7.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 74.24 107.141 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -144.39 127.08 16.16 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.621 -0.511 . . . . 33.32 109.621 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.645 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -90.29 60.5 4.76 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.283 1.039 . . . . 71.22 108.798 176.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 -122.7 6.41 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 114.063 -1.426 . . . . 43.15 110.517 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.86 -23.93 19.5 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.449 -0.945 . . . . 73.12 108.449 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.11 115.89 5.94 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.424 1.09 . . . . 72.21 109.722 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -85.73 140.19 30.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.427 . . . . 63.34 111.085 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.37 -61.54 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.962 0.905 . . . . 41.4 109.058 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -164.47 176.42 9.03 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.454 0.702 . . . . 71.12 110.653 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -141.57 143.9 33.96 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.934 -1.135 . . . . 54.14 107.934 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.501 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.7 t -147.17 129.83 16.02 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.558 0.743 . . . . 65.04 109.113 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -132.15 139.6 48.47 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.344 0.658 . . . . 71.13 110.407 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.97 114.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.526 1.13 . . . . 65.44 108.365 172.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.756 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -92.31 93.62 8.73 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 75.43 108.849 171.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.5 tp-100 -80.04 105.39 11.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.407 -0.815 . . . . 75.53 110.073 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.06 155.0 27.06 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.917 -0.583 . . . . 73.24 112.08 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . 0.487 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.57 116.22 0.71 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.703 -0.959 . . . . 73.22 110.703 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.511 HD12 HD11 ' C' ' 51' ' ' LEU . 15.3 mm -81.41 122.73 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.192 -1.04 . . . . 75.03 108.192 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -132.68 142.07 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . 0.622 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 38.3 m -109.8 121.47 45.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.633 -1.247 . . . . 72.2 107.633 169.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.505 ' HB ' HD11 ' C' ' 89' ' ' ILE . 1.9 pp -121.49 141.41 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.873 0.869 . . . . 75.44 110.852 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.76 164.22 36.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.003 0.921 . . . . 74.1 109.645 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.64 -19.11 34.56 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 114.092 0.397 . . . . 71.51 114.092 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' C' ' 86' ' ' ILE . 0.8 OUTLIER -101.91 141.88 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.76 1.224 . . . . 64.24 110.581 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -156.15 148.24 23.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.591 0.757 . . . . 74.02 110.068 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.18 -146.06 35.69 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.27 -0.423 . . . . 73.32 112.874 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -67.83 -21.54 65.2 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.481 0.712 . . . . 72.45 111.357 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.6 -36.74 84.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.588 0.755 . . . . 71.35 110.926 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.505 ' HG3' HD13 ' C' ' 89' ' ' ILE . 28.1 ttt -70.42 -29.92 66.65 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 116.288 -0.415 . . . . 62.2 110.883 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.82 69.02 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.313 0.645 . . . . 54.44 111.679 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 50.1 t-80 -74.14 -26.93 60.61 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.154 0.582 . . . . 72.52 110.816 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -81.18 -60.68 2.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.511 0.324 . . . . 33.42 110.712 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.487 HD23 ' HG2' ' C' ' 94' ' ' MET . 4.6 pp -73.23 -36.96 66.52 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.257 0.623 . . . . 63.12 111.695 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . 0.436 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -90.95 -14.65 57.54 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 114.3 0.48 . . . . 72.15 114.3 -170.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -127.09 -58.16 1.29 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.725 0.41 . . . . 64.12 111.579 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.8 -45.24 75.36 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.602 0.361 . . . . 44.41 111.935 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -63.94 -45.52 80.65 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.641 -0.695 . . . . 73.21 112.124 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.63 -39.73 81.97 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.559 2.173 . . . . 72.43 113.87 165.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.9 -18.75 65.55 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.826 0.451 . . . . 61.32 112.202 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mm -86.66 -45.94 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.254 0.622 . . . . 73.41 110.537 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.487 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.7 mt -79.85 -43.53 22.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.936 0.717 . . . . 60.31 112.936 -168.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.4 -42.08 89.87 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.239 1.016 . . . . 73.13 113.041 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . 0.586 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 69.9 Cg_exo -44.36 -46.97 11.34 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.628 2.219 . . . . 54.23 115.091 169.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . 0.417 ' HE2' HG21 ' A' ' 115' ' ' THR . 53.0 m-85 -69.64 -42.21 74.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.155 0.582 . . . . 72.31 111.252 -177.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.82 -29.8 69.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.705 -0.679 . . . . 60.12 111.354 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.619 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 34.7 ttp180 -56.08 -58.27 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 123.93 0.769 . . . . 74.22 111.179 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -73.5 -32.69 64.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.258 0.623 . . . . 75.2 110.338 -176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . 0.495 ' SG ' HG12 ' C' ' 21' ' ' ILE . 36.2 t -62.54 -34.68 77.42 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.396 0.678 . . . . 61.44 111.865 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' C' ' 62' ' ' VAL . 96.7 mt -71.36 -47.16 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.608 0.763 . . . . 75.02 110.206 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -64.7 -28.32 69.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.327 0.651 . . . . 63.52 111.852 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -68.28 -39.97 81.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.581 0.753 . . . . 72.13 110.011 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.636 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.06 -41.11 95.41 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.729 0.811 . . . . 73.34 111.105 175.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.24 -34.14 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.831 0.852 . . . . 72.32 110.246 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . 0.461 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 42.0 t -65.59 -43.04 90.91 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.57 -0.741 . . . . 52.25 110.98 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.466 ' NH2' ' HG2' ' B' ' 112' ' ' GLU . 91.3 mtt-85 -72.28 -21.28 61.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.22 -0.9 . . . . 74.02 111.439 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.65 -1.04 87.7 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.79 -0.45 . . . . 24.51 113.365 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.444 HG23 ' HB3' ' D' ' 17' ' ' TYR . 30.2 p 59.66 43.09 16.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.507 1.523 . . . . 64.23 111.489 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -119.69 141.11 30.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.733 0.813 . . . . 71.41 110.033 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 13.1 Cg_endo -53.09 107.16 0.18 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.729 2.953 . . . . 71.21 112.898 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -55.74 143.21 31.63 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.058 1.343 . . . . 73.53 113.52 -170.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tt -134.61 114.65 12.99 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.787 -1.19 . . . . 71.21 107.787 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -92.12 126.24 37.13 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.395 -0.965 . . . . 75.52 108.395 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.619 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.0 mm? -66.67 148.33 52.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.667 0.787 . . . . 72.21 111.447 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.92 153.4 60.33 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 123.356 0.663 . . . . 74.42 110.86 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.529 ' HG2' HG21 ' A' ' 13' ' ' ILE . 6.3 Cg_exo -76.9 125.53 8.12 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.301 2.668 . . . . 75.24 112.295 -172.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.37 110.6 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.13 0.572 . . . . 65.23 109.493 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . 0.66 HD21 HD11 ' A' ' 105' ' ' ILE . 3.4 m-20 -91.3 93.89 9.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 62.32 109.451 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -76.57 -33.11 58.5 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.36 0.6 . . . . 75.31 109.592 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 . . . . . 0 N--CA 1.471 0.619 0 CA-C-N 114.885 -1.052 . . . . 51.42 111.503 -178.424 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 57.5 m . . . . . 0 C--O 1.237 0.427 0 N-CA-C 109.45 -0.574 . . . . 75.32 109.45 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -157.47 105.77 2.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.492 -1.299 . . . . 53.23 107.492 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -125.26 119.19 27.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 74.12 109.257 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mt -73.4 114.93 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 107.837 -1.171 . . . . 65.53 107.837 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.91 -45.54 16.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.27 -0.641 . . . . 74.05 109.27 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' C' ' 29' ' ' PRO . 16.6 ptt180 -174.04 159.73 3.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.025 0.93 . . . . 71.12 109.897 172.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.489 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -130.03 143.2 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.375 1.07 . . . . 65.2 108.128 174.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' C' ' 122' ' ' THR . 31.0 p90 -170.26 172.27 6.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.933 0.873 . . . . 75.14 110.988 -169.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.414 HG21 HD11 ' D' ' 21' ' ' ILE . 81.4 p -98.74 115.77 29.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.507 -1.224 . . . . 73.0 109.56 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -87.69 -23.42 24.19 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.356 -0.609 . . . . 74.15 109.356 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.1 t70 -151.23 134.56 16.11 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.553 -1.203 . . . . 63.11 109.338 175.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.636 HD13 ' HE3' ' C' ' 117' ' ' MET . 72.0 mt -129.45 138.39 54.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.562 -1.273 . . . . 64.22 107.562 171.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -143.08 128.47 18.91 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.107 -1.071 . . . . 72.23 108.107 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 56.6 t80 -138.0 113.63 9.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.653 -1.98 . . . . 72.3 105.653 167.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.36 138.54 54.21 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.373 -0.603 . . . . 74.31 109.373 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -143.53 77.06 15.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.436 -1.32 . . . . 55.14 107.436 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.46 -45.44 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.664 2.243 . . . . 51.02 111.901 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -93.48 30.09 1.82 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.442 1.097 . . . . 73.0 108.78 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -59.47 -57.45 26.81 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 124.112 0.965 . . . . 65.51 112.702 -172.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -76.88 -12.19 17.97 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.468 1.56 . . . . 71.43 112.163 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -78.19 -41.65 33.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.02 1.328 . . . . 72.31 109.982 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -79.32 -32.48 14.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-O 118.812 -0.613 . . . . 73.03 110.097 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -50.95 -28.67 10.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.094 0.872 . . . . 73.43 113.197 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.43 -38.01 89.48 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.442 0.697 . . . . 71.34 111.141 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.48 ' HD2' ' O ' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -132.5 64.07 1.61 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.639 0.776 . . . . 72.15 110.202 168.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -112.16 95.98 5.77 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.795 0.807 . . . . 74.22 110.152 -177.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -123.01 -157.45 0.75 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.044 1.738 . . . . 63.14 106.804 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 15.9 pm0 -50.87 106.28 0.63 Allowed Pre-proline 0 CA--C 1.567 1.618 0 C-N-CA 123.386 0.674 . . . . 75.42 111.915 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 4.7 Cg_exo -78.06 147.32 23.66 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.737 2.291 . . . . 51.31 112.295 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.4 110.98 5.63 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 107.243 -1.392 . . . . 74.53 107.243 168.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.74 114.81 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.539 -0.755 . . . . 63.3 110.18 -169.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.56 138.49 32.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.109 0.964 . . . . 55.22 109.767 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . 0.47 HD12 HD21 ' D' ' 128' ' ' LEU . 6.2 tt -98.8 131.91 44.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.331 -1.359 . . . . 74.14 107.331 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -132.33 147.14 52.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.865 -0.791 . . . . 75.04 108.865 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.16 139.39 49.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.251 0.62 . . . . 73.45 110.394 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 12.1 t70 -137.43 135.27 36.74 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.109 -1.071 . . . . 75.51 108.109 170.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -113.42 144.4 42.87 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 65.13 109.584 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.16 155.1 39.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.355 0.662 . . . . 63.32 110.197 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 73.6 p -164.72 153.14 12.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.191 0.596 . . . . 74.25 110.649 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -154.31 137.06 15.26 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.356 0.663 . . . . 51.21 109.449 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.19 116.99 15.48 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.912 -0.773 . . . . 61.4 108.912 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.89 -32.12 15.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.674 0.39 . . . . 65.4 110.358 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.83 -175.25 5.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.785 -0.643 . . . . 75.21 111.361 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.67 118.08 7.16 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.598 -1.183 . . . . 74.21 109.749 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 13.0 m-20 65.09 11.05 6.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.508 1.123 . . . . 74.5 112.314 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.83 120.21 64.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 123.779 0.831 . . . . 75.12 109.239 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.614 ' HB2' HD13 ' D' ' 86' ' ' ILE . 73.8 m-85 -129.67 128.88 43.48 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.502 -1.295 . . . . 64.52 107.502 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -92.27 128.37 38.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.116 -0.698 . . . . 75.34 109.116 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.92 118.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.849 -1.167 . . . . 70.4 107.849 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 49.0 t -99.97 133.41 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.365 -0.976 . . . . 73.12 108.365 172.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.29 109.74 13.17 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.384 -0.969 . . . . 64.33 108.384 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -88.53 112.65 23.26 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.475 0.71 . . . . 74.41 110.051 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.7 t -101.27 126.31 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 74.5 108.564 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.0 m -129.42 134.3 47.77 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.97 0.508 . . . . 73.44 110.2 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.659 HG11 HD13 ' D' ' 126' ' ' LEU . 47.6 t -130.72 113.44 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.425 1.09 . . . . 60.41 108.892 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -103.87 101.12 10.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.465 0.706 . . . . 63.52 109.415 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.47 124.79 43.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.827 -0.435 . . . . 72.21 109.827 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.7 m -139.2 124.61 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.694 0.798 . . . . 73.05 108.894 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.6 103.36 15.96 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.771 -1.196 . . . . 75.44 107.771 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.19 -115.94 4.61 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.885 0.741 . . . . 75.24 112.465 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.47 5.0 51.75 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.741 0.816 . . . . 64.11 110.742 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -135.86 145.83 46.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.763 0.825 . . . . 63.34 110.473 -165.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -73.08 130.57 40.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.298 0.639 . . . . 61.13 111.334 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.477 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.36 -61.38 1.78 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.991 . . . . 30.21 108.679 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . 0.571 ' HE2' HD11 ' D' ' 126' ' ' LEU . 42.9 p90 -159.05 151.69 21.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.175 -1.375 . . . . 63.32 110.311 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 84.1 mt -113.65 151.49 31.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.489 1.116 . . . . 73.24 109.127 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.599 ' SG ' HG23 ' D' ' 114' ' ' ILE . 34.7 t -154.64 134.68 13.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.722 -0.473 . . . . 65.44 109.722 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.485 0.714 . . . . 73.31 109.832 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.44 121.09 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.61 0.764 . . . . 42.15 109.473 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.5 mt-30 -89.87 89.84 7.92 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.722 -0.844 . . . . 75.1 108.722 171.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.22 93.39 5.86 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.821 -1.081 . . . . 70.13 109.107 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.6 140.38 17.25 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.36 -0.696 . . . . 70.12 111.36 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.19 128.09 3.58 Favored Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 110.189 -1.164 . . . . 34.24 110.189 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.2 mt -90.85 129.23 41.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.834 -0.802 . . . . 71.12 108.834 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.516 ' HB2' HD11 ' D' ' 86' ' ' ILE . 22.1 m-85 -132.48 158.26 42.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.353 0.408 . . . . 63.0 110.368 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 25.4 m -107.14 102.29 11.63 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.504 -0.924 . . . . 75.32 108.504 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.0 mp -107.51 113.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.818 -1.179 . . . . 74.0 107.818 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -142.57 124.79 15.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.177 0.591 . . . . 71.13 110.492 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.19 5.65 57.09 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.421 -0.655 . . . . 52.13 114.577 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.408 HD13 HG23 ' D' ' 86' ' ' ILE . 2.4 mp -114.96 126.39 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.69 -0.856 . . . . 74.41 108.69 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 -177.83 4.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.776 0.83 . . . . 74.12 110.56 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.59 -141.06 39.83 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.501 -0.772 . . . . 75.1 113.799 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.2 p -84.31 -13.5 52.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.635 0.774 . . . . 73.14 111.656 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.89 0.476 . . . . 74.33 110.403 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.471 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -69.95 -31.84 69.79 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 110.421 -0.214 . . . . 74.24 110.421 175.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.62 68.6 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.866 0.729 . . . . 75.02 111.218 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -72.62 -35.67 67.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.224 0.61 . . . . 61.11 110.204 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.25 -51.45 52.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.859 0.464 . . . . 74.22 110.908 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' D' ' 94' ' ' MET . 2.9 pp -75.84 -19.74 58.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.755 0.422 . . . . 70.34 112.065 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -7.79 60.32 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.73 -0.483 . . . . 71.21 113.364 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.56 -62.6 0.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.342 0.571 . . . . 52.12 111.952 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -68.13 -52.33 36.02 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.424 0.527 . . . . 75.22 112.424 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 60.7 m -61.55 -43.81 89.9 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 123.673 0.789 . . . . 63.34 111.944 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.13 -46.52 32.08 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.13 1.887 . . . . 71.03 112.898 165.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -66.9 -15.79 63.89 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.442 0.697 . . . . 63.5 112.584 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -80.11 -49.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.464 -0.569 . . . . 72.42 109.464 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.3 mt -79.22 -28.91 42.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.73 0.812 . . . . 71.34 112.247 -169.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.93 -40.43 16.39 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.035 -0.983 . . . . 72.44 113.07 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -50.91 -43.52 46.83 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.282 1.988 . . . . 73.22 113.229 169.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -74.84 -37.08 62.35 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.477 0.711 . . . . 54.05 111.6 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.3 67.59 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.084 0.553 . . . . 74.22 110.281 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -43.6 79.72 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.905 1.378 . . . . 64.14 111.13 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -73.2 -36.48 66.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.779 0.832 . . . . 75.51 111.236 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -62.92 -44.92 94.77 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.893 0.477 . . . . 45.02 110.163 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.599 HG23 ' SG ' ' D' ' 76' ' ' CYS . 73.0 mt -61.83 -50.3 80.74 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.225 1.01 . . . . 71.52 110.213 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.568 HG23 ' HB3' ' D' ' 125' ' ' GLN . 30.4 m -50.84 -46.9 60.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.494 1.117 . . . . 73.33 111.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.8 t -73.53 -22.63 60.05 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.065 0.946 . . . . 35.2 112.635 -172.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.45 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.8 mtm -87.31 -43.46 12.14 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.062 0.458 . . . . 64.22 111.243 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.5 -34.45 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 114.691 -1.14 . . . . 72.02 110.382 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -66.55 -36.81 83.59 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.387 0.675 . . . . 74.23 111.405 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.5 mtt-85 -69.65 -26.74 64.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.143 0.577 . . . . 70.41 111.164 177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 11.04 60.71 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-O 119.689 -0.506 . . . . 74.43 113.316 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.479 HG23 ' HB3' ' C' ' 17' ' ' TYR . 25.6 p 65.42 16.36 10.48 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.581 1.952 . . . . 71.13 112.921 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -96.31 165.66 15.79 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.707 1.203 . . . . 72.44 108.406 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.64 150.58 24.59 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.258 1.972 . . . . 74.1 112.628 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . 0.568 ' HB3' HG23 ' D' ' 115' ' ' THR . 21.4 mt-30 -57.54 135.25 56.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.144 0.578 . . . . 74.55 111.092 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.659 HD13 HG11 ' D' ' 64' ' ' VAL . 88.4 mt -106.33 93.32 4.54 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.367 -0.605 . . . . 62.02 109.367 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -100.43 100.36 11.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.474 -0.936 . . . . 71.22 108.474 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.47 HD21 HD12 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.39 132.79 48.36 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.961 0.904 . . . . 70.44 109.136 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.21 146.95 87.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.815 0.846 . . . . 62.13 111.615 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.05 111.54 2.02 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 121.939 1.759 . . . . 65.41 111.393 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 77.1 t -106.65 124.99 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.375 -0.972 . . . . 75.31 108.375 -178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.02 92.41 5.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.242 0.617 . . . . 73.41 110.036 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 . . . . . 0 N--CA 1.476 0.873 0 C-N-CA 124.023 0.929 . . . . 74.22 111.202 178.066 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.2 m . . . . . 0 N--CA 1.466 0.342 0 N-CA-C 109.088 -0.708 . . . . 74.35 109.088 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.481 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 20.4 t80 -136.76 120.83 17.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.824 -1.176 . . . . 74.4 107.824 171.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 45.9 tp60 -142.83 108.25 5.04 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.087 -0.708 . . . . 71.11 109.087 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.521 HG12 ' HD2' ' A' ' 84' ' ' PHE . 20.0 mt -71.03 125.2 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.2 -0.455 . . . . 63.13 109.91 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -101.23 -31.89 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.975 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -179.27 132.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 119.369 -0.348 . . . . 72.35 110.996 -167.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.418 HD13 ' HG3' ' C' ' 130' ' ' PRO . 3.6 mp -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 107.417 -1.327 . . . . 61.31 107.417 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 23.5 p90 -164.06 167.53 20.22 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 122.218 1.009 . . . . 62.33 111.299 -174.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.5 109.09 21.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.038 -1.437 . . . . 65.22 108.674 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.9 mtpt -78.26 -29.97 48.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.105 0.479 . . . . 62.13 109.791 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.33 141.4 27.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.902 -1.045 . . . . 75.35 109.616 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 61.8 mt -137.54 136.68 46.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.077 -1.823 . . . . 73.22 106.077 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -148.08 125.59 11.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.66 -0.867 . . . . 75.02 108.66 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.0 t80 -127.18 140.15 52.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.18 -1.415 . . . . 71.31 107.18 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -134.74 151.58 51.09 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.752 -0.832 . . . . 65.11 108.752 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.24 73.96 11.87 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 105.682 -1.97 . . . . 73.31 105.682 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.66 -43.02 10.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.893 2.396 . . . . 75.32 113.197 -165.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.34 30.19 5.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.971 -0.751 . . . . 61.13 108.971 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.38 -57.92 7.62 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.595 -1.193 . . . . 75.14 113.052 -174.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 45.0 Cg_exo -55.74 -20.31 27.8 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.979 2.453 . . . . 75.12 113.722 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -98.96 -38.14 9.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.018 0.927 . . . . 73.13 110.798 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.85 -15.4 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.074 0.549 . . . . 72.45 111.444 -164.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.73 -30.95 71.97 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.081 0.553 . . . . 53.52 111.193 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -90.93 -7.12 52.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 112.363 0.505 . . . . 73.05 112.363 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -64.01 173.05 2.02 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.016 1.117 . . . . 72.11 114.016 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.45 159.12 30.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.928 1.291 . . . . 74.31 111.691 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -94.14 64.46 3.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.063 0.459 . . . . 74.32 110.166 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -142.81 82.84 11.95 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.918 0.887 . . . . 61.12 109.241 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.57 138.44 13.64 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 121.735 1.623 . . . . 64.42 110.891 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -92.57 82.58 4.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.978 -1.86 . . . . 71.25 105.978 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 65' ' ' THR . 10.2 m -82.53 114.65 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.993 -1.458 . . . . 42.32 109.382 -176.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -121.48 143.95 48.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.753 0.821 . . . . 74.21 109.96 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -112.97 118.91 36.15 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.865 0.866 . . . . 73.21 109.786 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -107.41 143.13 36.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.594 -1.261 . . . . 64.25 107.594 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.59 129.24 32.61 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.728 -0.842 . . . . 54.33 108.728 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.3 m-20 -117.74 120.81 39.09 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.738 -1.208 . . . . 74.52 107.738 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -107.29 121.81 45.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 75.33 108.627 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.0 140.33 28.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.991 0.517 . . . . 62.44 110.377 -173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 p -130.35 158.79 38.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.415 0.686 . . . . 74.22 110.616 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 154.98 39.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.336 1.054 . . . . 73.14 109.534 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -103.76 105.61 15.87 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.693 -0.855 . . . . 75.41 108.693 172.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.0 mt -79.22 -38.2 36.29 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.221 0.609 . . . . 74.23 110.55 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.62 -178.19 6.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.333 1.053 . . . . 63.23 109.246 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.47 123.15 18.89 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 71.18 -9.81 0.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.019 1.728 . . . . 75.53 112.771 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.67 110.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 N-CA-C 108.385 -0.969 . . . . 71.24 108.385 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -125.3 164.13 21.02 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.703 0.801 . . . . 70.14 109.536 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.0 tt0 -131.69 142.73 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.693 0.797 . . . . 65.15 109.449 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.36 132.52 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.601 -1.259 . . . . 74.24 107.601 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.2 t -125.08 131.36 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 123.625 0.77 . . . . 74.4 108.934 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 106' ' ' LEU . 3.9 mm? -117.99 106.0 12.47 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.106 -1.072 . . . . 73.12 108.106 177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.594 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 23.9 ttp180 -83.82 102.63 12.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.151 -1.055 . . . . 54.44 108.151 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.31 119.75 39.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.995 -1.483 . . . . 70.41 106.995 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 44.0 m -118.97 122.64 42.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.344 -0.613 . . . . 72.11 109.344 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.85 HG11 HD21 ' A' ' 126' ' ' LEU . 28.9 t -118.52 108.99 25.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.652 -0.87 . . . . 62.53 108.652 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.0 m -107.63 137.4 45.73 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.537 -0.542 . . . . 71.02 109.537 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.95 105.25 8.78 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.362 -0.977 . . . . 63.41 108.362 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -114.2 127.56 55.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.996 0.519 . . . . 72.24 110.796 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.12 85.19 2.09 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.91 -1.145 . . . . 65.43 107.91 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -111.29 3.23 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.562 -1.015 . . . . 73.15 110.562 -171.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -100.8 -8.49 22.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.058 0.543 . . . . 74.44 110.512 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -102.26 97.71 7.95 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.753 0.821 . . . . 60.43 110.383 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -66.86 124.29 22.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 122.911 0.484 . . . . 73.42 110.823 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -67.64 -57.3 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.203 1.001 . . . . 54.13 109.974 175.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -157.48 158.85 36.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.528 -1.215 . . . . 62.44 112.204 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.6 tp -126.89 135.17 50.57 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.95 1.3 . . . . 64.14 108.035 171.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 118' ' ' VAL . 51.2 m -130.64 97.75 4.45 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.404 -0.591 . . . . 71.33 109.404 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -116.9 116.28 27.12 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.021 0.929 . . . . 74.43 109.392 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -133.94 110.94 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.784 0.834 . . . . 70.42 109.215 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -84.93 89.31 7.55 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.684 -0.858 . . . . 74.45 108.684 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.86 96.69 7.09 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.506 -0.77 . . . . 70.32 109.048 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.99 151.52 22.21 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.48 -0.782 . . . . 72.45 111.92 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -153.19 124.55 1.61 Allowed Glycine 0 CA--C 1.509 -0.309 0 N-CA-C 111.302 -0.719 . . . . 44.45 111.302 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -85.14 124.59 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.208 0.603 . . . . 70.31 109.763 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HD2' HG12 ' A' ' 13' ' ' ILE . 37.9 m-85 -132.94 119.87 20.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.764 -1.198 . . . . 63.0 107.764 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 25.8 t -82.19 98.61 8.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 109.493 -0.558 . . . . 65.52 109.493 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.55 HD13 HD21 ' A' ' 98' ' ' LEU . 45.3 pt -103.49 147.46 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.999 0.919 . . . . 74.35 110.411 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -169.68 161.08 9.19 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.228 0.611 . . . . 41.11 111.863 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.31 -33.96 3.54 Favored Glycine 0 C--N 1.356 1.655 0 CA-C-N 115.605 -0.725 . . . . 75.24 113.964 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.422 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.1 pp -117.04 135.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.877 0.871 . . . . 64.34 109.432 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -139.56 175.86 9.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.376 0.67 . . . . 71.43 110.326 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.59 -115.32 7.85 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.77 0.669 . . . . 65.3 112.831 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.1 t -74.58 -30.46 61.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.54 0.736 . . . . 74.33 111.567 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -67.32 -37.5 83.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.536 -0.757 . . . . 73.14 109.562 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.431 ' HG2' ' HG ' ' A' ' 98' ' ' LEU . 3.4 ttp -82.3 -24.45 34.65 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.311 -0.859 . . . . 74.45 110.833 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.48 -34.74 78.6 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.086 0.402 . . . . 75.44 112.086 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -77.28 -30.77 54.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.559 -0.292 . . . . 74.24 110.34 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.39 -65.05 0.76 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.582 0.353 . . . . 70.2 110.951 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.55 HD21 HD13 ' A' ' 86' ' ' ILE . 14.7 mt -75.66 -23.81 56.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.742 0.417 . . . . 65.41 111.739 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.94 -5.97 59.44 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.313 -0.715 . . . . 34.51 114.751 -172.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.41 -57.78 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.992 0.896 . . . . 72.13 112.319 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 89.8 t80 -68.4 -54.89 14.15 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.245 0.618 . . . . 73.42 112.066 -171.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.0 m -71.01 -33.16 2.71 Favored Pre-proline 0 CA--C 1.569 1.674 0 C-N-CA 123.673 0.789 . . . . 64.25 112.876 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.96 -41.96 60.87 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.493 2.128 . . . . 64.13 113.154 160.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -70.87 -14.03 62.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.384 0.674 . . . . 64.11 111.766 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -78.86 -41.39 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.98 -0.748 . . . . 75.32 108.98 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.9 mt -84.33 -30.21 25.69 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.059 0.944 . . . . 72.44 113.189 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -64.94 -38.63 30.97 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.037 -0.983 . . . . 75.43 113.537 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.54 -38.45 93.8 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.923 1.749 . . . . 74.24 113.25 171.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -73.84 -37.45 64.81 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.985 0.514 . . . . 75.45 111.141 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -44.6 91.55 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.777 -0.453 . . . . 45.12 109.777 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -52.51 -53.58 44.09 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.777 1.298 . . . . 74.11 110.72 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -68.19 -38.92 82.52 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.242 0.964 . . . . 73.4 111.374 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.5 t -61.79 -32.25 72.53 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.978 0.511 . . . . 74.1 110.648 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 118' ' ' VAL . 84.9 mt -74.34 -52.94 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.287 -0.869 . . . . 74.22 110.323 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.7 m -55.28 -41.56 72.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.223 1.009 . . . . 72.22 111.297 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -64.96 -44.86 88.0 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.72 -1.127 . . . . 72.34 110.776 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.4 mtm -64.52 -38.59 91.56 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.689 0.395 . . . . 75.15 111.492 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.2 t -64.36 -42.01 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.664 0.785 . . . . 74.52 110.704 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.3 p -72.4 -30.73 64.92 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.09 -0.505 . . . . 73.35 110.907 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -68.3 -25.32 65.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.594 0.758 . . . . 70.33 110.882 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 7.51 65.36 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.595 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 m 61.86 35.49 16.45 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.255 1.422 . . . . 73.01 110.945 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -107.31 160.89 24.87 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.064 0.946 . . . . 65.2 109.723 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.25 146.22 61.91 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.242 1.961 . . . . 73.13 111.522 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.11 148.19 48.63 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.775 0.322 . . . . 74.32 110.3 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.85 HD21 HG11 ' A' ' 64' ' ' VAL . 48.7 tp -113.72 113.48 25.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.004 0.522 . . . . 65.43 110.127 -177.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -114.17 114.19 25.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.653 -1.24 . . . . 71.23 107.653 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 128' ' ' LEU . 3.9 mm? -74.4 135.14 42.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.92 0.391 . . . . 70.34 110.152 174.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -71.87 132.23 85.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.935 -0.575 . . . . 51.24 110.368 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -77.54 116.95 4.17 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.505 2.136 . . . . 74.02 111.515 -177.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.3 t -101.76 135.36 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.189 0.596 . . . . 72.54 109.953 -178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -76.78 69.94 3.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.334 1.054 . . . . 74.54 110.605 172.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -56.08 -38.74 71.09 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.247 1.019 . . . . 75.1 111.749 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 CA--C 1.536 0.433 0 CA-C-N 114.487 -1.233 . . . . 53.53 111.917 179.922 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.9 m . . . . . 0 N--CA 1.47 0.531 0 N-CA-C 108.536 -0.913 . . . . 72.53 108.536 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . 0.41 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 49.4 t80 -135.32 132.8 38.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.828 0.851 . . . . 74.35 109.492 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.423 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 9.3 pt20 -156.41 140.17 16.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.942 0.897 . . . . 71.44 109.022 173.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.71 135.42 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.834 -1.173 . . . . 61.15 107.834 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -93.19 -53.84 3.95 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.858 -0.423 . . . . 61.23 109.858 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.9 ttt180 -155.49 131.52 10.06 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.914 -0.402 . . . . 73.12 109.914 -172.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.51 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 83.7 mt -114.97 136.96 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.287 -1.746 . . . . 63.45 106.287 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -165.45 140.44 4.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.881 0.472 . . . . 74.25 111.142 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.0 m -73.47 117.85 15.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.873 0.869 . . . . 54.42 109.24 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -94.59 -22.41 18.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.471 0.708 . . . . 72.13 111.58 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.1 t70 -163.1 142.48 8.69 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.337 0.398 . . . . 65.05 110.473 -172.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.448 HD11 ' SG ' ' B' ' 113' ' ' CYS . 33.1 mm -137.27 141.59 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.975 1.31 . . . . 40.24 108.467 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.5 t -142.8 124.09 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.785 -1.191 . . . . 74.13 107.785 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -146.56 115.73 7.0 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 107.274 -1.38 . . . . 72.52 107.274 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -119.91 158.81 25.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.448 0.699 . . . . 64.55 109.513 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -149.99 78.19 8.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.664 -1.235 . . . . 70.33 107.664 175.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.88 -22.65 42.19 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.936 2.424 . . . . 53.31 112.675 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -122.97 24.55 8.92 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.959 . . . . 73.1 109.663 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.42 -50.16 59.26 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.744 1.387 . . . . 71.3 114.744 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -28.7 2.77 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 121.849 1.7 . . . . 54.54 112.789 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 51.5 m80 -96.18 4.67 52.27 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.354 1.061 . . . . 71.14 112.09 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.31 -26.25 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.632 0.773 . . . . 75.42 110.788 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' B' ' 35' ' ' ASP . 30.2 t80 -69.0 -16.09 63.64 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.104 0.779 . . . . 72.31 113.104 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.2 pt20 -73.16 -47.08 46.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.065 0.393 . . . . 75.53 110.73 176.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.52 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 45.4 pttt -112.62 66.79 0.65 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.548 -1.279 . . . . 75.21 107.548 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.57 ' HB2' ' HA ' ' B' ' 32' ' ' PHE . 39.1 t70 -96.86 108.47 21.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.275 -0.875 . . . . 73.51 111.563 -164.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.514 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.8 OUTLIER 177.74 -170.86 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.597 1.186 . . . . 73.03 109.437 163.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.89 116.77 7.59 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.096 0.958 . . . . 73.3 111.995 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.65 156.73 18.68 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.651 2.234 . . . . 72.43 111.464 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.03 102.19 0.47 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.123 -1.066 . . . . 73.13 108.123 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.4 151.16 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.066 -0.97 . . . . 61.22 109.632 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -139.12 137.42 36.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.34 0.656 . . . . 74.2 109.621 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . 0.511 HD12 HD11 ' B' ' 128' ' ' LEU . 2.4 tt -93.18 126.11 38.12 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.148 -1.427 . . . . 62.43 107.148 167.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.4 t0 -131.34 145.21 51.75 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 106.547 -1.649 . . . . 73.3 106.547 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.62 133.27 28.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.667 -0.864 . . . . 73.31 108.667 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.7 t70 -124.3 134.38 53.22 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.694 1.198 . . . . 74.44 108.701 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -107.9 108.25 19.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.455 0.702 . . . . 64.42 109.759 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.91 119.3 32.22 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.538 -0.912 . . . . 72.21 108.538 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.2 p -139.15 166.08 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.141 0.577 . . . . 73.13 110.688 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.2 p -151.16 165.99 32.22 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.136 0.974 . . . . 72.35 109.146 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -115.07 107.74 15.74 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.454 -0.943 . . . . 72.21 108.454 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.11 -42.52 84.39 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.585 0.754 . . . . 75.11 110.892 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.77 -170.98 3.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.667 0.787 . . . . 43.43 110.363 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.41 114.39 5.4 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.226 -0.897 . . . . 75.21 109.517 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 73.22 -6.69 1.67 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 126.332 1.853 . . . . 70.41 113.202 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.74 120.59 52.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 109.151 -0.685 . . . . 73.31 109.151 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -114.11 173.11 6.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.605 -0.725 . . . . 73.21 110.945 177.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -142.17 95.19 2.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 105.541 -2.022 . . . . 74.52 105.541 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.35 122.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.03 0.932 . . . . 62.12 109.09 -175.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -111.7 143.47 21.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.57 0.748 . . . . 75.31 109.454 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' B' ' 103' ' ' PRO . 93.6 mt -120.1 112.43 19.11 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.753 -0.462 . . . . 43.21 109.753 174.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.7 ttm-85 -86.6 107.24 18.07 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.155 -1.054 . . . . 73.43 108.155 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 105.54 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.27 -1.382 . . . . 75.01 107.27 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 28.6 m -96.48 137.79 35.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.447 -0.797 . . . . 74.43 108.994 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -134.62 101.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.887 -1.153 . . . . 64.23 107.887 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.5 m -98.08 141.58 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 72.1 109.516 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.73 148.44 52.58 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.02 -0.733 . . . . 75.31 109.02 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -157.39 128.61 6.76 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.368 0.417 . . . . 52.34 111.238 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.671 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -127.84 143.19 51.12 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.552 0.741 . . . . 63.31 109.917 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.25 -112.24 3.51 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.929 -0.869 . . . . 53.12 110.929 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -123.86 6.1 8.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.966 0.906 . . . . 73.34 109.922 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . 0.52 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 8.8 pt-20 -149.28 -178.98 6.71 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.625 0.37 . . . . 74.41 111.209 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -64.6 147.69 52.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.685 1.194 . . . . 72.33 111.674 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.671 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -96.34 -63.49 1.14 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.111 -1.07 . . . . 75.43 108.111 171.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -152.78 163.66 39.28 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.622 -1.626 . . . . 73.41 108.041 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -125.84 144.69 50.55 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.736 1.215 . . . . 75.4 108.543 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . 0.492 ' SG ' HG23 ' B' ' 114' ' ' ILE . 33.8 t -147.44 144.08 28.37 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.53 -0.915 . . . . 61.31 108.53 173.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.1 tt0 -164.95 138.98 4.95 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.171 -0.677 . . . . 71.43 109.171 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' B' ' 113' ' ' CYS . 97.4 t -132.07 148.07 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.675 0.79 . . . . 73.5 109.257 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 41.5 mt-30 -122.6 103.17 8.51 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.407 -0.96 . . . . 70.11 108.407 168.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.05 105.29 17.3 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.14 -1.059 . . . . 51.41 108.14 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 155.0 24.18 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.205 -0.758 . . . . 61.55 111.205 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 125.29 1.72 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.566 -0.614 . . . . 65.13 111.566 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.28 126.36 40.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.055 -1.091 . . . . 73.42 108.055 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.74 162.57 28.12 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 74.53 108.988 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 48.7 m -132.5 113.26 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.083 -0.71 . . . . 71.1 109.083 168.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.462 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.9 pt -119.17 137.85 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.919 0.888 . . . . 63.33 110.084 -177.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.23 164.0 39.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 71.44 109.743 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.63 -47.46 3.6 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.242 -0.435 . . . . 73.31 112.493 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' B' ' 94' ' ' MET . 19.9 pt -64.04 148.89 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.523 1.129 . . . . 74.42 113.211 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 15.4 pt-20 -157.36 162.7 39.07 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.306 1.042 . . . . 72.4 109.704 172.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.57 -115.07 6.61 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.398 0.436 . . . . 54.24 113.614 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.9 m -77.77 -28.88 50.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.413 0.685 . . . . 55.5 110.79 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 97.0 mt-30 -58.56 -42.15 87.26 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.053 0.541 . . . . 71.52 110.588 177.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.558 ' HA ' HD12 ' B' ' 89' ' ' ILE . 23.9 ttt -71.87 -41.54 67.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 74.43 110.767 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.55 82.54 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.783 0.677 . . . . 74.23 111.29 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 57.9 t-80 -79.54 -20.15 47.82 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.963 -1.017 . . . . 71.32 110.916 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -83.29 -67.05 0.82 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.293 0.237 . . . . 41.32 111.009 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.451 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.5 pp -83.92 -15.0 49.58 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.64 0.608 . . . . 75.12 112.64 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.64 -27.75 11.15 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.986 -0.341 . . . . 55.14 112.929 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -114.93 -60.24 1.91 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.252 0.621 . . . . 65.05 111.391 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.87 -46.0 66.46 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.195 0.598 . . . . 73.11 112.133 -170.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 62.6 m -68.38 -40.86 21.72 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.851 -0.595 . . . . 74.55 112.299 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.561 ' HA ' HD11 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -52.91 -39.9 77.16 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 122.273 1.982 . . . . 64.33 113.961 165.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -16.43 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 111.715 0.265 . . . . 63.54 111.715 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.67 -55.76 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.368 0.667 . . . . 65.04 110.526 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . 0.435 ' HB2' HD12 ' B' ' 60' ' ' LEU . 91.0 mt -76.83 -25.32 53.09 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.265 0.626 . . . . 73.55 112.681 -169.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.7 -48.98 88.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 CA-C-O 117.72 -1.134 . . . . 70.41 113.628 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.92 -38.47 86.18 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.052 1.835 . . . . 51.44 113.374 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.469 ' HE2' HG21 ' D' ' 115' ' ' THR . 29.3 m-85 -65.3 -45.33 84.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.596 0.759 . . . . 74.02 110.296 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.19 79.82 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.791 -0.641 . . . . 65.21 111.044 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ttt-85 -61.2 -56.23 23.1 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.331 1.052 . . . . 55.15 111.106 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -36.86 85.03 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.517 0.511 . . . . 63.45 110.087 -176.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.0 t -69.44 -26.9 64.83 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 123.684 0.615 . . . . 74.42 111.503 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.492 HG23 ' SG ' ' B' ' 76' ' ' CYS . 81.7 mt -74.56 -52.35 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 122.889 0.475 . . . . 73.33 109.846 170.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 28.9 m -60.26 -27.74 67.49 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.053 0.941 . . . . 71.44 111.665 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.16 -48.73 64.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.632 0.773 . . . . 65.12 109.769 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -71.72 -32.2 67.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.921 0.488 . . . . 75.12 111.484 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.33 -38.94 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.228 0.611 . . . . 64.31 110.139 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.5 t -65.66 -38.99 90.87 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 71.33 111.166 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.435 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -67.66 -33.76 75.59 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.608 0.763 . . . . 62.33 110.356 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.82 11.66 61.59 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.875 -0.602 . . . . 73.13 112.963 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.2 p 56.97 29.69 16.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.735 1.614 . . . . 52.43 113.847 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -109.72 145.47 32.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.106 0.962 . . . . 74.12 109.045 172.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.571 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 61.6 Cg_exo -57.21 140.34 92.56 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.838 2.358 . . . . 65.12 113.843 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.495 ' NE2' HD21 ' B' ' 127' ' ' ASN . 20.3 pt20 -65.43 160.01 22.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 113.476 -1.693 . . . . 74.21 112.695 -174.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.4 116.38 15.11 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.574 -1.269 . . . . 62.34 107.574 168.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . 0.495 HD21 ' NE2' ' B' ' 125' ' ' GLN . 54.8 m-80 -89.97 104.08 16.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 106.924 -1.51 . . . . 71.04 106.924 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . 0.511 HD11 HD12 ' B' ' 42' ' ' LEU . 16.0 tp -66.46 134.85 53.3 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.846 -0.616 . . . . 75.11 110.874 -172.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.14 137.97 94.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.228 1.011 . . . . 73.51 111.745 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.46 111.72 0.5 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.143 2.562 . . . . 72.34 112.013 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.15 108.13 18.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.14 -1.059 . . . . 61.24 108.14 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.47 77.24 2.6 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.436 -0.95 . . . . 61.42 108.436 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 t80 . . . . . 0 CA--C 1.55 0.951 0 CA-C-N 114.862 -1.063 . . . . 74.31 109.917 178.352 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.423 ' HB2' HG23 ' C' ' 89' ' ' ILE . 23.7 ttt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.34 0.59 . . . . 70.15 111.651 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 91.0 m -98.58 96.36 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.836 -0.801 . . . . 61.45 108.836 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . 0.596 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 57.1 t80 -99.38 128.38 45.49 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.652 -0.87 . . . . 74.35 108.652 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -152.79 136.74 16.31 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.262 -0.644 . . . . 60.35 109.262 175.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 66.7 mt -90.07 104.39 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.069 0.947 . . . . 74.14 109.745 -176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -73.56 -50.51 20.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.309 -0.256 . . . . 71.33 110.309 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -169.48 123.83 0.8 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.734 -0.469 . . . . 74.33 109.734 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -107.98 137.3 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.388 -0.967 . . . . 74.32 108.388 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.491 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 33.6 p90 -168.56 159.54 10.24 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.815 0.817 . . . . 72.35 111.09 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -77.5 114.32 16.21 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.138 -1.392 . . . . 72.33 108.763 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -68.89 -41.59 78.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.864 0.84 . . . . 61.24 109.469 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -145.23 140.85 28.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.033 -1.439 . . . . 75.53 109.058 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 65.6 mt -134.63 141.51 43.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.333 -1.358 . . . . 74.14 107.333 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -161.74 150.7 15.79 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.397 0.618 . . . . 72.41 111.276 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 88.4 t80 -141.86 131.0 23.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.584 -1.265 . . . . 53.41 107.584 173.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.2 mt-10 -123.73 123.73 41.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.351 0.66 . . . . 73.31 109.266 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.8 83.21 62.19 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 107.432 -1.321 . . . . 33.31 107.432 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.28 -35.45 62.69 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.708 2.272 . . . . 72.51 111.875 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -110.66 33.39 4.57 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.811 -1.086 . . . . 75.02 109.223 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.23 -50.19 48.8 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 114.299 1.222 . . . . 71.34 114.299 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 15.2 Cg_exo -66.47 -39.51 16.48 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 121.788 1.659 . . . . 75.33 112.971 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -67.2 -57.58 6.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.313 1.045 . . . . 62.2 112.333 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' C' ' 73' ' ' ALA . 46.0 t -54.91 -24.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 125.176 1.39 . . . . 73.12 112.877 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -51.95 -35.11 44.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.113 0.565 . . . . 62.32 112.05 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.48 45.9 0.95 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.666 0.787 . . . . 70.25 110.749 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -124.53 151.86 44.16 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.011 0.924 . . . . 71.13 110.82 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.37 131.84 33.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.384 1.074 . . . . 72.34 112.636 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -86.39 69.31 10.41 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.082 0.953 . . . . 74.22 111.253 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -158.13 77.87 3.44 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.313 0.645 . . . . 71.32 109.679 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.501 ' HA ' ' HB3' ' C' ' 68' ' ' LEU . 95.7 Cg_endo -90.83 154.13 4.06 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.814 2.342 . . . . 71.13 113.122 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.05 95.2 9.86 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.455 -1.313 . . . . 73.45 107.455 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.4 114.3 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.938 -1.028 . . . . 72.2 109.461 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.474 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 89.6 mttt -102.24 146.51 27.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.757 0.823 . . . . 61.13 109.752 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.34 123.42 39.36 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 106.836 -1.542 . . . . 72.34 106.836 171.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.53 104.19 7.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.832 -1.173 . . . . 74.25 107.832 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.42 154.5 17.17 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.036 0.534 . . . . 64.03 110.224 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 10.6 t70 -146.79 151.91 37.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.774 0.83 . . . . 75.25 109.036 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -121.52 122.01 38.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.296 0.638 . . . . 73.05 110.093 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.76 138.7 48.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.503 -0.925 . . . . 75.3 108.503 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . 0.58 ' HB3' ' HE1' ' C' ' 56' ' ' TYR . 71.2 m -155.06 151.54 28.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.038 0.535 . . . . 72.43 110.692 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -152.91 138.07 17.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.077 0.551 . . . . 72.34 110.498 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.53 122.92 27.07 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.671 -0.492 . . . . 75.2 109.671 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' C' ' 57' ' ' GLU . 41.1 mt -95.44 -43.32 8.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.767 0.827 . . . . 73.12 111.103 -172.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -158.83 -168.1 2.3 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.676 0.79 . . . . 75.41 110.066 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.91 103.63 0.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.093 -0.958 . . . . 74.22 110.066 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 72.77 -6.35 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 126.126 1.77 . . . . 64.31 113.024 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 60.2 t -91.85 107.49 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.792 -1.188 . . . . 65.24 107.792 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . 0.58 ' HE1' ' HB3' ' C' ' 48' ' ' SER . 2.1 t80 -128.59 141.0 51.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.11 -1.07 . . . . 62.31 108.11 -173.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.2 tt0 -98.05 129.33 44.9 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.348 0.659 . . . . 70.14 110.829 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -110.35 114.69 47.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.08 -1.081 . . . . 74.44 108.08 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.21 135.84 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.831 -0.803 . . . . 55.43 108.831 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.16 109.38 12.81 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.945 -1.502 . . . . 74.52 106.945 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.2 ttm-85 -80.55 125.0 29.44 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.102 -0.703 . . . . 63.1 109.102 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' C' ' 114' ' ' ILE . 43.9 t -116.11 105.75 19.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.468 -1.308 . . . . 73.1 107.468 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.8 m -108.57 119.17 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.741 -0.837 . . . . 62.2 108.741 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.52 130.44 74.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.742 -0.836 . . . . 61.55 108.742 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 9.7 m -121.22 152.11 39.21 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.245 1.018 . . . . 61.51 109.309 -171.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.67 112.83 10.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.476 -1.305 . . . . 73.31 107.476 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -145.02 135.06 23.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.329 -0.619 . . . . 74.25 109.329 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.5 OUTLIER -120.23 57.01 0.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 122.216 1.008 . . . . 53.44 110.49 -173.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.29 -119.94 4.47 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.692 -1.594 . . . . 54.24 110.285 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.92 -30.59 18.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.855 -0.794 . . . . 65.25 108.855 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.436 ' HB3' HD12 ' C' ' 68' ' ' LEU . 11.7 tp10 -72.72 109.72 6.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.743 -1.117 . . . . 64.04 109.984 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -83.41 122.76 28.93 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.975 -0.75 . . . . 65.54 108.975 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.419 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -72.64 -54.77 8.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.407 1.067 . . . . 65.11 109.264 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -165.82 171.65 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.476 -0.784 . . . . 71.42 111.45 171.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -137.86 145.97 42.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.185 1.394 . . . . 74.53 107.242 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -152.85 121.39 6.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.044 0.537 . . . . 73.22 109.671 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.45 127.98 47.35 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.963 0.505 . . . . 73.3 110.285 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.91 124.46 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.895 -0.78 . . . . 74.2 108.895 169.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.551 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 23.3 mt-30 -96.62 105.52 17.63 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.988 -1.116 . . . . 71.33 107.988 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -92.24 112.05 23.84 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.724 0.41 . . . . 72.31 110.656 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 155.5 23.75 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.93 -0.577 . . . . 60.32 111.92 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.95 116.62 0.74 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.825 -1.31 . . . . 41.44 109.825 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.516 HD12 HD11 ' C' ' 51' ' ' LEU . 19.4 mm -81.71 119.51 31.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.322 -0.992 . . . . 70.55 108.322 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -126.93 119.18 26.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.661 -1.237 . . . . 74.24 107.661 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -84.65 98.61 10.29 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.505 -1.294 . . . . 74.14 107.505 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' C' ' 10' ' ' THR . 0.2 OUTLIER -121.34 142.29 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.169 0.509 . . . . 74.43 111.242 -175.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.58 168.38 27.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.547 1.139 . . . . 62.1 109.416 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.77 -45.67 2.71 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.939 -0.464 . . . . 61.12 111.939 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' C' ' 93' ' ' GLN . 1.6 pp -80.93 145.66 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.482 0.713 . . . . 75.21 111.021 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -162.04 148.32 13.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.791 0.837 . . . . 71.0 109.081 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 -117.22 10.79 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.603 0.564 . . . . 52.12 113.328 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 56.6 p -65.12 -35.66 81.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.875 . . . . 74.3 111.532 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . 0.6 ' HB3' HG22 ' C' ' 89' ' ' ILE . 26.4 mt-30 -67.64 -43.3 80.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.92 -0.582 . . . . 61.24 110.623 178.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.491 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.5 ttt -75.78 -23.51 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.32 110.801 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.49 96.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.038 0.535 . . . . 74.53 110.674 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.25 -34.19 74.41 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.433 -0.803 . . . . 71.44 110.745 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -65.74 -61.26 2.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.797 -0.638 . . . . 71.43 111.317 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -87.08 -12.97 45.62 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.502 0.556 . . . . 72.35 112.502 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.15 8.02 60.62 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-O 119.584 -0.564 . . . . 60.32 113.36 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -154.79 -59.95 0.11 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.93 0.492 . . . . 64.22 111.273 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.53 -49.59 21.4 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.556 0.742 . . . . 75.13 112.094 -168.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . 0.596 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -69.86 -44.52 22.68 Favored Pre-proline 0 CA--C 1.561 1.401 0 CA-C-O 118.156 -0.926 . . . . 73.11 113.223 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' C' ' 102' ' ' CYS . 28.7 Cg_endo -61.59 -38.42 62.26 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 121.722 1.615 . . . . 74.05 111.259 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -62.95 -22.74 67.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.591 0.756 . . . . 75.04 112.392 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -73.32 -54.46 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 110.224 -0.287 . . . . 74.13 110.224 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 pp -87.16 -8.51 56.86 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.955 -0.566 . . . . 62.12 112.517 -170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -58.44 -50.67 86.77 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.421 1.088 . . . . 64.24 113.303 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.51 -29.94 89.67 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 121.654 1.57 . . . . 63.15 113.189 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.68 -45.78 67.55 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.223 0.609 . . . . 74.32 110.462 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.63 91.95 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.547 0.739 . . . . 73.13 110.631 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . 0.533 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 36.1 ttt180 -61.78 -53.74 51.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.431 -1.713 . . . . 75.32 111.927 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.322 0.649 . . . . 71.1 110.315 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -67.91 -31.35 71.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.2 0.6 . . . . 73.43 111.449 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.431 HG23 ' SG ' ' C' ' 76' ' ' CYS . 83.2 mt -75.4 -49.97 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.617 0.767 . . . . 72.11 110.526 174.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -62.2 -29.37 70.33 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.515 0.726 . . . . 74.33 111.457 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -67.26 -49.69 63.41 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.56 -0.745 . . . . 74.14 109.622 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.672 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.04 -36.59 75.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.055 0.942 . . . . 63.43 112.615 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.4 t -64.88 -41.74 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.588 0.755 . . . . 75.01 110.346 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.1 p -74.91 -27.01 60.05 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.031 -0.532 . . . . 72.31 111.349 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -70.3 -39.44 74.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.835 0.854 . . . . 74.21 110.742 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . 0.491 ' HA2' ' H ' ' D' ' 18' ' ' THR . . . -83.89 10.06 61.23 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.045 -0.525 . . . . 61.43 113.461 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p 55.12 62.28 2.57 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 125.482 1.513 . . . . 73.35 111.718 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -126.59 154.39 75.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.867 1.267 . . . . 74.35 109.139 170.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -64.32 167.8 13.99 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.276 2.651 . . . . 72.01 113.759 -179.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 17.3 mm-40 -56.26 123.64 15.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.571 1.148 . . . . 74.14 113.912 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.97 84.18 1.91 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.117 -1.438 . . . . 70.12 107.117 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . 0.4 ' OD1' ' HB3' ' C' ' 125' ' ' GLN . 13.7 m120 -91.77 102.11 14.71 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.248 -1.019 . . . . 63.05 108.248 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . 0.533 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 14.8 tp -68.08 137.15 54.76 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 64.53 110.382 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . 0.417 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -81.08 152.19 70.99 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.035 0.934 . . . . 64.03 111.146 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.418 ' HG3' HD13 ' A' ' 16' ' ' ILE . 41.3 Cg_exo -50.11 142.19 28.43 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.16 2.573 . . . . 74.21 113.111 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 22.0 t -123.11 110.29 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.779 -0.823 . . . . 72.14 108.779 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -97.98 85.65 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.389 0.676 . . . . 71.43 109.922 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 91.0 m-85 -69.59 -46.65 65.84 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.264 -0.426 . . . . 75.23 110.866 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.419 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 29.8 t70 . . . . . 0 N--CA 1.475 0.804 0 CA-C-N 115.72 -0.673 . . . . 72.45 110.801 -176.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m . . . . . 0 C--O 1.242 0.707 0 N-CA-C 108.924 -0.769 . . . . 73.53 108.924 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -157.15 100.66 1.87 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.945 -1.131 . . . . 61.52 107.945 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.3 143.53 51.03 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.842 0.857 . . . . 71.33 109.221 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' D' ' 84' ' ' PHE . 47.7 mt -96.11 136.22 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.016 0.526 . . . . 51.15 109.754 175.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . 0.426 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.6 mt-30 -89.13 -42.1 11.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.978 -0.379 . . . . 62.15 109.978 172.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -176.03 153.64 1.34 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 65.31 110.919 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.842 -1.54 . . . . 73.32 106.842 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -149.43 170.81 17.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.173 0.987 . . . . 64.43 111.613 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . 0.491 ' H ' ' HA2' ' C' ' 121' ' ' GLY . 68.4 p -105.09 117.65 34.54 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.312 -1.313 . . . . 71.11 109.726 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -85.6 -29.29 24.21 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.889 -0.596 . . . . 72.54 109.458 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 24.5 t70 -151.03 139.1 20.08 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.338 -1.301 . . . . 72.55 108.924 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.672 HD13 ' HE3' ' C' ' 117' ' ' MET . 92.1 mt -132.49 146.84 32.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.729 -1.211 . . . . 74.44 107.729 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.8 t -148.75 140.0 23.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.65 0.78 . . . . 53.11 109.715 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -149.35 117.67 6.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.372 -2.084 . . . . 74.23 105.372 167.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -121.88 135.64 54.9 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.966 -0.753 . . . . 70.21 108.966 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.04 83.45 55.66 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.371 -1.344 . . . . 72.11 107.371 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.38 -29.82 10.84 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.89 2.393 . . . . 63.01 113.558 -169.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -114.71 33.22 5.49 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.03 -0.73 . . . . 64.5 109.03 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.491 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -43.15 -62.33 1.39 Allowed Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.433 1.642 . . . . 61.33 115.433 -163.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.21 -15.61 7.69 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 121.794 1.676 . . . . 61.15 112.888 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.478 ' HA ' HE21 ' D' ' 33' ' ' GLN . 18.6 t-160 -68.18 -34.29 76.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.815 1.246 . . . . 63.42 109.079 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.565 HG13 ' HH2' ' D' ' 36' ' ' TRP . 55.8 t -68.44 -38.97 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.81 0.844 . . . . 71.24 110.398 175.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -74.04 4.69 5.12 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.831 0.678 . . . . 72.42 112.831 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' D' ' 30' ' ' HIS . 38.1 mt-30 -87.04 -17.75 32.21 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.058 0.543 . . . . 73.03 111.181 167.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.648 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 29.5 mtpt -126.34 107.3 10.18 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.336 1.054 . . . . 73.54 110.656 -167.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.47 97.6 9.56 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 118.905 0.775 . . . . 65.33 111.295 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.648 ' HE1' ' HE2' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -136.4 176.67 8.48 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 71.02 110.4 175.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.43 111.82 39.63 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.046 0.938 . . . . 74.05 110.336 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.616 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.1 Cg_exo -64.35 140.07 68.47 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.049 2.499 . . . . 52.4 113.871 173.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . 0.45 ' H ' HD11 ' D' ' 68' ' ' LEU . 14.4 pt-20 -82.77 130.15 35.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.042 -1.095 . . . . 75.1 108.042 162.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.503 HG13 HG13 ' D' ' 64' ' ' VAL . 77.2 t -105.57 104.74 17.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 107.694 -1.224 . . . . 42.34 107.694 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.16 127.86 36.75 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.17 -0.307 . . . . 74.02 110.17 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -95.89 124.43 39.9 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.621 -1.251 . . . . 61.33 107.621 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -137.59 138.26 39.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.36 -0.978 . . . . 74.12 108.36 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.88 147.36 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.417 0.627 . . . . 75.2 110.945 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -133.07 137.52 46.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.823 -1.177 . . . . 72.52 107.823 170.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.1 p -105.16 144.16 32.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 51.23 110.205 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.33 145.08 23.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.462 0.705 . . . . 62.34 109.32 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -151.22 157.46 42.65 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.873 0.469 . . . . 74.24 109.973 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 6.4 m -147.82 149.62 32.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.98 -1.118 . . . . 71.22 107.98 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -101.1 118.03 36.18 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.56 -1.274 . . . . 55.11 107.56 161.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 mt -89.68 -34.02 16.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.805 -0.442 . . . . 62.41 109.805 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.68 -177.8 6.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.599 -0.728 . . . . 73.15 110.679 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.34 130.94 45.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.252 -0.885 . . . . 71.43 109.126 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 66.33 5.64 3.82 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.63 1.172 . . . . 72.52 112.4 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.86 123.32 71.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 C-N-CA 123.381 0.672 . . . . 63.44 109.937 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -128.11 127.34 42.86 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.316 -0.994 . . . . 61.21 108.316 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -88.15 143.0 27.31 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.776 0.831 . . . . 64.43 109.114 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 48.6 t -125.32 123.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.268 -1.012 . . . . 74.41 108.268 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 43.4 t -109.83 131.33 61.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.167 -1.049 . . . . 61.21 108.167 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -126.38 117.66 23.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.588 -0.893 . . . . 75.24 108.588 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.1 ttm-85 -95.64 106.93 19.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.78 0.832 . . . . 71.11 109.938 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -94.46 112.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.778 -0.823 . . . . 73.31 108.778 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -112.15 128.59 56.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.485 0.66 . . . . 70.44 109.868 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . 0.503 HG13 HG13 ' D' ' 40' ' ' VAL . 42.2 t -124.8 107.42 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.458 1.503 . . . . 72.14 108.649 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.9 m -106.02 117.46 34.09 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.904 0.881 . . . . 74.44 110.375 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.48 126.55 53.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.307 -0.627 . . . . 72.23 109.307 172.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.2 m -153.76 122.83 6.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.304 0.641 . . . . 52.11 109.344 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' D' ' 38' ' ' PRO . 2.5 mm? -130.49 135.46 47.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.795 0.838 . . . . 63.13 109.448 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 -116.39 4.93 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.972 -0.851 . . . . 45.12 110.972 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.03 8.3 8.64 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.998 -0.742 . . . . 63.01 108.998 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.46 155.87 33.98 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.651 0.78 . . . . 61.02 110.793 -173.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -82.64 129.14 34.9 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 72.23 110.529 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -69.33 -68.61 0.39 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.093 -1.077 . . . . 55.45 108.093 173.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.88 152.61 28.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.388 -0.824 . . . . 73.43 109.596 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 77.1 mt -110.64 150.27 29.23 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.426 1.09 . . . . 71.34 108.243 167.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.484 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.1 t -150.9 136.23 17.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.432 -0.951 . . . . 71.22 108.432 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -155.53 129.56 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.644 0.378 . . . . 74.13 110.313 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -134.43 120.1 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.049 0.539 . . . . 74.54 110.07 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 7.1 mt-30 -87.7 91.25 8.68 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.607 -0.886 . . . . 62.52 108.607 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.72 95.54 6.65 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.383 -0.969 . . . . 63.34 108.383 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 144.18 16.95 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.83 -0.623 . . . . 61.14 111.562 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.39 136.22 6.61 Favored Glycine 0 CA--C 1.507 -0.43 0 N-CA-C 110.515 -1.034 . . . . 50.12 110.515 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.8 mt -88.42 126.54 41.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.6 -0.889 . . . . 65.01 108.6 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . 0.404 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 52.6 m-85 -123.92 148.65 46.69 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.565 -0.532 . . . . 72.55 109.565 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 27.0 m -103.57 94.22 5.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.671 -1.233 . . . . 63.33 107.671 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.8 mt -110.17 116.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.999 0.919 . . . . 74.33 108.72 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.45 153.5 15.47 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.145 0.578 . . . . 75.11 110.33 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.05 59.97 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.127 -0.488 . . . . 71.45 112.738 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.65 129.1 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.736 -0.839 . . . . 53.35 108.736 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -134.5 168.07 19.62 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.883 0.873 . . . . 73.14 110.362 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.42 -135.61 23.95 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.855 -0.611 . . . . 70.24 114.177 174.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -70.61 -34.63 72.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.166 0.987 . . . . 55.11 112.056 -173.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.98 -38.76 83.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.971 0.508 . . . . 62.01 110.726 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -44.11 76.66 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.5 -0.555 . . . . 73.0 109.5 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.54 71.66 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.204 0.94 . . . . 71.33 111.508 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -72.01 -45.0 62.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.572 0.749 . . . . 64.45 110.646 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.44 -37.9 88.27 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.807 0.443 . . . . 61.22 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 41.3 tp -79.32 -37.77 36.81 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.262 1.025 . . . . 53.22 111.301 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -7.79 76.09 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.657 -0.524 . . . . 74.24 113.769 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 -54.98 0.73 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.763 0.782 . . . . 73.31 112.211 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -72.37 -49.02 37.16 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.064 0.393 . . . . 75.22 111.573 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.0 m -60.78 -48.47 92.89 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.252 -0.88 . . . . 75.34 112.531 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.24 -27.75 48.22 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 121.636 1.557 . . . . 74.31 112.604 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -71.99 -24.09 61.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.066 0.546 . . . . 74.11 111.099 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -80.64 -41.68 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.607 0.763 . . . . 62.54 110.455 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.77 -30.57 62.84 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.202 0.601 . . . . 64.04 111.547 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -63.87 -42.36 70.09 Favored Pre-proline 0 CA--C 1.564 1.508 0 N-CA-C 114.187 1.18 . . . . 75.31 114.187 -170.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.57 -45.09 32.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.413 2.076 . . . . 75.42 113.821 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -79.63 -30.98 41.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.357 0.663 . . . . 74.13 111.798 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.91 74.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.912 0.485 . . . . 73.42 109.863 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.85 -51.27 70.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.293 -1.321 . . . . 55.23 110.352 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.54 -42.17 91.72 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.218 0.949 . . . . 73.11 111.385 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -44.56 94.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.754 0.659 . . . . 65.21 110.793 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.484 HG23 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -62.46 -52.38 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.073 0.949 . . . . 73.11 110.697 175.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.469 HG21 ' HE2' ' B' ' 109' ' ' TYR . 32.0 m -56.36 -41.25 75.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.824 1.249 . . . . 63.25 111.135 -171.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -67.93 -43.58 78.84 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.549 -1.205 . . . . 74.12 110.507 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.9 mtm -66.64 -31.55 72.31 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.371 0.508 . . . . 62.05 112.371 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.5 t -68.34 -44.83 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.27 0.628 . . . . 73.12 109.712 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.0 p -70.37 -28.96 65.52 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.994 0.518 . . . . 74.02 111.45 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -73.38 -31.71 64.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.337 0.655 . . . . 74.52 110.186 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 3.0 86.12 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.959 -0.564 . . . . 73.32 112.851 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . 0.406 HG23 ' HB3' ' C' ' 17' ' ' TYR . 69.3 p 63.29 14.43 7.81 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.794 2.038 . . . . 73.34 113.672 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.447 ' HE1' HG11 ' D' ' 31' ' ' VAL . 87.8 m-85 -80.29 158.83 71.34 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 165.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -70.88 134.29 25.32 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 121.61 1.54 . . . . 73.32 110.878 -168.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -48.72 116.94 1.81 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.333 1.021 . . . . 54.2 110.349 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -105.5 104.79 14.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.039 -0.726 . . . . 64.43 109.039 -164.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . 0.51 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 78.6 m-20 -99.0 94.24 6.44 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.513 -1.221 . . . . 74.23 107.998 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 127.48 32.43 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.121 0.969 . . . . 71.01 109.368 -175.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -59.88 128.63 87.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.58 0.752 . . . . 72.42 111.235 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HG2' ' HE2' ' B' ' 11' ' ' PHE . 1.2 Cg_endo -79.73 122.61 5.0 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.852 2.368 . . . . 73.03 111.391 -177.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.36 115.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.273 0.629 . . . . 74.53 109.448 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -76.55 105.28 7.52 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.143 -0.688 . . . . 65.44 109.143 174.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 . . . . . 0 N--CA 1.476 0.83 0 C-N-CA 123.798 0.839 . . . . 70.35 110.571 -177.202 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.8 m . . . . . 0 C--O 1.24 0.562 0 N-CA-C 108.382 -0.97 . . . . 52.22 108.382 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 47.5 t80 -137.08 129.07 29.27 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.818 -1.178 . . . . 74.15 107.818 172.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -153.02 119.29 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.074 -0.713 . . . . 71.35 109.074 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.623 HG21 ' HG2' ' C' ' 130' ' ' PRO . 52.8 mt -65.69 133.24 31.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 114.922 -1.036 . . . . 73.44 110.026 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -115.66 -22.32 9.24 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.568 0.747 . . . . 74.23 112.447 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 24.6 ttt85 -176.12 122.81 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.192 0.451 . . . . 74.31 111.628 -175.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.524 HD13 ' HG2' ' C' ' 130' ' ' PRO . 1.4 mp -110.11 127.45 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.209 -1.034 . . . . 55.42 108.209 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 27.2 p90 -158.44 150.69 21.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.014 0.926 . . . . 74.21 110.284 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.422 HG21 ' SG ' ' A' ' 113' ' ' CYS . 82.2 p -76.81 119.02 20.01 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.834 -0.802 . . . . 73.55 108.834 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -81.68 -42.36 20.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 53.33 109.568 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.69 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 15.3 m-20 -136.26 137.31 40.64 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.724 -1.125 . . . . 64.43 109.053 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.3 mt -133.74 142.53 41.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.458 -1.312 . . . . 75.45 107.458 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -150.49 133.93 16.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.849 -0.797 . . . . 70.51 108.849 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.9 t80 -136.22 132.65 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.564 -1.643 . . . . 62.41 106.564 172.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.42 138.09 42.91 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.622 -0.881 . . . . 74.21 108.622 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.82 79.83 63.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.356 -1.72 . . . . 51.2 106.356 171.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.68 -40.81 76.69 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.297 2.664 . . . . 70.23 113.049 -164.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.37 38.5 3.97 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.748 -0.834 . . . . 54.51 108.748 -177.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.06 -57.63 7.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 117.935 -1.031 . . . . 50.31 113.262 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.5 Cg_exo -62.79 -20.25 70.67 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 122.073 1.849 . . . . 34.2 113.383 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -94.24 -31.87 13.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.178 0.991 . . . . 63.42 111.049 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.1 p -78.33 -19.45 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.716 0.807 . . . . 54.54 111.025 -169.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -73.78 -7.52 52.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.744 0.818 . . . . 73.44 111.397 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -98.33 -19.8 17.56 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 60.44 111.003 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -82.03 166.61 19.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.659 0.783 . . . . 72.44 111.546 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.94 149.18 49.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.996 0.918 . . . . 70.1 110.02 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -86.77 62.35 7.35 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.266 0.555 . . . . 74.3 111.948 -168.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -134.34 66.71 71.4 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.007 0.523 . . . . 75.02 111.298 173.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.18 126.65 2.81 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.008 1.805 . . . . 61.22 110.615 167.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -95.54 105.31 17.27 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.459 -0.941 . . . . 72.23 108.459 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.614 HG23 HG13 ' A' ' 64' ' ' VAL . 2.1 p -75.52 129.64 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.278 -1.328 . . . . 74.31 110.218 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -99.92 141.17 33.09 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 74.21 110.089 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' A' ' 128' ' ' LEU . 0.8 OUTLIER -100.65 118.67 37.26 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.954 -1.128 . . . . 64.5 107.954 173.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.54 145.05 33.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.012 0.525 . . . . 64.13 110.068 170.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.87 141.49 51.27 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.355 -0.979 . . . . 65.12 108.355 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.9 t70 -119.37 138.0 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.583 -1.266 . . . . 63.24 107.583 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.4 p -106.66 138.21 43.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.374 0.669 . . . . 75.41 110.629 -167.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.16 110.45 0.91 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.17 0.588 . . . . 54.34 110.492 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -112.76 159.76 18.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.019 -0.734 . . . . 73.33 109.019 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -154.14 150.42 28.12 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.536 0.734 . . . . 53.12 109.716 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.46 143.45 30.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.403 -0.962 . . . . 65.31 108.403 171.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 57' ' ' GLU . 28.6 mt -115.94 -43.88 2.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.396 0.679 . . . . 75.14 109.719 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.86 -167.94 2.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.108 -0.951 . . . . 74.31 110.073 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.76 106.41 0.8 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.553 0.741 . . . . 73.51 110.132 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 23.9 m-20 67.34 13.87 9.5 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.727 1.211 . . . . 73.45 113.095 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.25 117.14 45.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.379 -0.971 . . . . 63.21 108.379 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 64.0 m-85 -125.06 123.39 39.68 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.512 -0.921 . . . . 64.54 108.512 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.589 ' HB2' HD11 ' A' ' 51' ' ' LEU . 27.4 tt0 -88.88 143.11 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.094 -0.957 . . . . 75.2 108.761 173.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.441 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.7 t -119.08 136.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.815 -1.18 . . . . 63.2 107.815 172.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.8 t -127.13 132.38 69.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.065 0.946 . . . . 74.4 108.762 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 106' ' ' LEU . 4.5 mm? -119.67 110.09 16.42 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.336 1.055 . . . . 73.25 108.344 175.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.727 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 26.3 ttp180 -83.81 99.55 10.37 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.012 -0.736 . . . . 62.44 109.012 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 117.35 34.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.313 -1.365 . . . . 72.43 107.313 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 m -116.03 122.24 44.6 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.911 0.862 . . . . 74.45 109.544 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.614 HG13 HG23 ' A' ' 40' ' ' VAL . 49.1 t -112.98 120.93 64.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.492 -1.685 . . . . 72.13 108.181 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -121.45 125.95 48.12 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.934 -0.765 . . . . 73.43 108.934 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.94 121.63 38.44 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.97 -1.122 . . . . 75.03 107.97 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -136.93 132.86 35.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.095 0.558 . . . . 70.15 110.344 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.24 85.18 3.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.003 0.921 . . . . 72.43 109.166 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -90.98 1.54 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-N 114.45 -1.25 . . . . 71.32 110.889 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -122.36 -30.2 4.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.637 0.775 . . . . 73.21 110.423 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.01 131.35 35.78 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.333 -0.617 . . . . 61.11 109.333 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 m -87.01 136.23 32.99 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.232 0.539 . . . . 53.03 111.156 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.776 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.61 -65.22 0.93 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.893 -1.049 . . . . 70.32 109.323 172.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.69 159.28 44.62 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.511 -1.222 . . . . 74.21 111.319 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.9 tp -132.14 115.4 15.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.173 1.389 . . . . 74.23 107.964 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 67.7 m -105.76 138.28 42.21 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.26 -1.015 . . . . 60.33 108.26 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -146.81 115.39 6.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.28 -1.007 . . . . 65.24 108.28 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.39 110.14 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.448 0.699 . . . . 45.32 109.501 -175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.727 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 39.5 mt-30 -84.64 83.19 8.1 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.894 -1.15 . . . . 52.34 107.894 169.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.22 102.22 5.73 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.443 -1.253 . . . . 41.33 107.884 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 156.31 24.77 Favored Glycine 0 C--O 1.243 0.685 0 CA-C-N 115.939 -0.573 . . . . 64.14 111.882 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.3 120.61 1.09 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.503 -1.039 . . . . 71.21 110.503 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.75 125.99 39.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 N-CA-C 108.267 -1.012 . . . . 34.42 108.267 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.553 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.7 m-85 -135.65 144.75 46.22 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.642 -1.244 . . . . 74.13 107.642 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -84.47 93.53 8.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.907 -1.145 . . . . 53.23 107.907 169.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 55.3 mt -100.08 117.92 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 108.56 -0.904 . . . . 62.2 108.56 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -151.03 158.33 43.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.679 0.791 . . . . 64.04 110.38 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.75 10.13 86.11 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.339 0.399 . . . . 65.13 113.788 171.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.2 pp -113.26 163.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.967 1.307 . . . . 73.44 110.299 -173.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.56 170.64 6.75 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.296 -1.001 . . . . 72.1 108.296 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.05 -126.53 26.88 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 124.07 0.843 . . . . 74.4 114.947 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -72.97 -22.47 60.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.086 0.955 . . . . 71.53 111.639 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.6 -43.96 65.31 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.926 0.491 . . . . 75.11 110.3 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.4 ttt -71.42 -38.52 71.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.759 -0.655 . . . . 64.14 109.358 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.93 72.93 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.49 -0.777 . . . . 65.35 111.233 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -78.98 -27.03 43.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.861 0.464 . . . . 74.0 110.695 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.1 t -73.95 -66.03 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.161 0.184 . . . . 54.33 110.519 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.65 -17.26 36.58 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.445 0.535 . . . . 73.32 112.445 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.85 1.33 44.97 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.43 -0.65 . . . . 50.42 114.265 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.96 -56.8 0.2 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.885 0.842 . . . . 44.24 113.25 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.482 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.6 t80 -76.04 -59.05 2.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.477 0.711 . . . . 75.13 111.221 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.82 -31.99 4.57 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.913 0.885 . . . . 62.42 113.105 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.54 -49.06 14.01 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.647 2.231 . . . . 74.13 113.192 160.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -68.67 -26.53 65.36 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.574 0.75 . . . . 74.23 110.437 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -69.62 -42.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.194 0.597 . . . . 73.25 110.196 172.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.53 HD12 HD23 ' A' ' 60' ' ' LEU . 96.7 mt -80.75 -17.42 51.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.733 0.813 . . . . 75.41 111.568 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.85 -45.8 65.17 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 118.075 -0.964 . . . . 72.44 113.277 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.25 -30.91 64.21 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.986 1.791 . . . . 65.41 112.616 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -78.89 -36.46 42.07 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.423 0.689 . . . . 73.1 111.356 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.53 74.67 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.853 -0.795 . . . . 72.22 108.853 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -51.25 -50.31 59.46 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 125.098 1.499 . . . . 70.23 110.757 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -72.81 -37.63 67.44 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.197 0.936 . . . . 63.4 111.106 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 18' ' ' THR . 41.8 t -62.9 -35.89 81.52 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.08 0.467 . . . . 71.55 110.651 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.467 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 97.0 mt -68.13 -52.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.333 -0.849 . . . . 71.33 109.527 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.481 HG23 ' HG3' ' A' ' 125' ' ' GLN . 92.6 m -52.25 -44.8 65.08 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.775 1.23 . . . . 71.0 111.422 -174.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -66.42 -45.8 78.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.412 -1.267 . . . . 71.24 110.546 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.3 mtm -61.91 -41.16 97.59 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.789 0.436 . . . . 72.53 111.147 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 114' ' ' ILE . 72.4 t -58.5 -49.46 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.227 1.011 . . . . 44.34 110.334 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -69.14 -27.45 65.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.847 0.459 . . . . 55.34 111.383 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.1 mtt-85 -73.61 -20.75 60.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.717 0.807 . . . . 74.44 110.837 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.95 10.83 64.18 Favored Glycine 0 C--N 1.354 1.568 0 CA-C-O 119.676 -0.513 . . . . 61.41 113.539 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m 56.94 32.74 22.08 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.171 1.389 . . . . 73.11 110.646 -173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -99.09 153.85 37.59 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-N 114.897 -1.047 . . . . 75.13 109.097 173.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -62.47 144.97 95.54 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.365 2.043 . . . . 72.31 110.944 177.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.1 tt0 -55.05 130.13 40.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.864 0.728 . . . . 73.14 111.298 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.4 tp -111.51 102.71 11.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.03 0.932 . . . . 63.4 109.516 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.36 102.63 14.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.753 -1.203 . . . . 64.31 107.753 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.65 116.97 6.17 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 107.765 -1.198 . . . . 62.5 107.765 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.61 135.92 94.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.428 0.691 . . . . 70.2 112.241 -172.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.24 137.81 49.01 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.763 2.308 . . . . 64.41 112.983 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.94 134.7 65.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.033 0.933 . . . . 71.4 109.258 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -84.01 77.61 9.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.201 1.0 . . . . 71.3 110.908 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -66.59 -40.79 89.06 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.45 0.643 . . . . 72.43 109.932 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.646 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.3 p-10 . . . . . 0 N--CA 1.472 0.659 0 C-N-CA 125.036 1.334 . . . . 71.54 111.69 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 107.394 -1.336 . . . . 53.35 107.394 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -140.62 135.72 32.01 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.314 0.646 . . . . 70.11 109.314 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -152.99 140.59 19.86 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.146 0.903 . . . . 72.24 109.708 167.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.4 pp -80.51 140.21 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.333 -1.358 . . . . 75.24 107.333 169.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -98.02 -44.32 6.7 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.071 -0.714 . . . . 62.01 109.071 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -164.41 138.67 5.42 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.331 -0.85 . . . . 71.23 109.28 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.77 137.22 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 106.344 -1.724 . . . . 75.12 106.344 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -166.08 161.64 17.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.414 0.626 . . . . 74.44 111.88 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.9 m -90.24 117.66 29.16 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.017 -0.992 . . . . 71.31 108.818 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -87.67 -27.91 22.15 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.453 -0.794 . . . . 74.42 111.056 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -159.81 143.69 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.411 0.444 . . . . 70.42 111.928 -174.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . 0.474 HD11 ' SG ' ' B' ' 113' ' ' CYS . 44.9 mm -134.63 143.46 37.68 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 125.286 1.435 . . . . 74.13 109.055 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -144.37 130.53 19.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.757 -1.201 . . . . 53.43 107.757 173.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -145.59 114.45 6.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.352 -1.351 . . . . 71.03 107.352 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.1 mt-10 -118.78 137.51 53.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.131 0.572 . . . . 72.41 109.673 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.931 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -129.34 78.69 75.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.814 -1.18 . . . . 73.42 107.814 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.4 -18.24 38.78 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.471 2.781 . . . . 65.44 113.448 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -126.81 12.88 7.36 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.315 1.446 . . . . 71.0 110.739 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.931 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -44.71 -57.18 7.19 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 115.817 1.784 . . . . 71.22 115.817 -165.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.0 Cg_exo -66.01 -26.8 50.63 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.528 2.152 . . . . 62.21 112.336 -173.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.459 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.9 m80 -91.46 -43.79 9.5 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.129 -0.941 . . . . 71.32 111.465 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.7 -26.37 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.244 0.618 . . . . 73.03 112.389 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -58.8 -24.01 61.23 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.026 0.93 . . . . 71.32 113.029 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.459 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 24.2 pt20 -76.47 -6.52 52.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.224 0.61 . . . . 71.2 112.424 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -103.93 109.49 21.26 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.162 -0.681 . . . . 74.44 109.162 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -95.46 96.93 9.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.266 0.469 . . . . 74.55 112.266 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.18 177.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.18 1.392 . . . . 74.23 110.511 162.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -78.7 138.03 58.36 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.121 0.968 . . . . 75.14 112.082 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -84.41 158.3 12.72 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.796 2.33 . . . . 73.01 112.881 167.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.49 128.2 35.23 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.813 -1.18 . . . . 74.22 107.813 162.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.9 t -108.48 131.72 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.302 0.641 . . . . 74.25 109.891 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.74 135.6 46.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.603 1.161 . . . . 72.51 109.194 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -109.16 125.62 52.38 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.222 1.009 . . . . 72.54 108.331 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -141.01 118.55 11.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.217 0.607 . . . . 61.12 109.368 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 pp -99.75 165.31 11.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.789 -0.449 . . . . 60.14 109.789 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -146.82 136.52 23.1 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.805 1.242 . . . . 71.13 108.095 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -120.93 105.54 10.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.609 0.764 . . . . 62.45 111.189 -167.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.19 155.27 31.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.861 0.864 . . . . 72.21 109.984 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.2 p -146.85 169.04 19.95 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.272 1.029 . . . . 53.45 109.885 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -153.46 137.63 16.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.308 0.643 . . . . 62.0 109.523 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -83.54 111.69 19.31 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.716 -0.476 . . . . 71.45 109.716 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.24 -45.78 13.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.689 0.618 . . . . 74.23 110.257 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 -168.01 2.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.218 -0.901 . . . . 60.32 110.701 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.01 108.32 3.03 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.997 -1.001 . . . . 72.43 109.883 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.8 11.11 7.37 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.945 1.298 . . . . 72.14 112.641 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.42 113.63 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.646 -0.872 . . . . 51.52 108.646 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.92 139.87 53.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.438 0.695 . . . . 74.02 109.522 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -101.78 106.39 17.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.528 -1.286 . . . . 54.3 107.528 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.19 123.6 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.256 1.022 . . . . 64.25 110.213 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -103.39 113.47 40.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.003 0.921 . . . . 74.21 109.496 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.61 100.02 10.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.614 -1.254 . . . . 75.52 107.614 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.7 ttm180 -85.3 128.18 34.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.116 -0.698 . . . . 71.35 109.116 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.26 106.13 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.1 -1.074 . . . . 71.4 108.1 172.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -98.55 126.72 44.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.522 0.729 . . . . 75.52 109.375 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.621 HG21 HG21 ' B' ' 114' ' ' ILE . 93.7 t -118.33 116.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.889 -1.05 . . . . 64.15 108.575 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.7 m -116.32 140.48 49.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.653 -0.869 . . . . 75.23 108.653 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.92 142.73 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.81 -1.181 . . . . 52.0 107.81 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 38.9 p -150.31 141.96 23.59 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.074 0.55 . . . . 74.15 110.64 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -138.1 136.53 36.84 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.223 1.009 . . . . 62.23 110.534 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.4 -124.1 26.68 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.766 -0.652 . . . . 31.21 112.455 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -96.98 2.91 52.11 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.328 1.051 . . . . 73.42 111.066 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.65 -179.87 7.45 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.469 0.544 . . . . 63.33 112.469 -167.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -73.29 154.67 40.06 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.518 1.127 . . . . 53.2 111.235 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.533 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.77 -57.8 2.15 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.052 -1.092 . . . . 51.42 108.052 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -160.28 161.41 33.36 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.492 -1.231 . . . . 71.33 109.674 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 50.7 mt -116.95 131.34 56.98 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.273 -1.38 . . . . 72.31 107.273 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.09 150.46 39.54 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.09 -0.707 . . . . 75.35 109.09 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 45.0 tt0 -164.55 133.71 3.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.66 0.784 . . . . 63.32 108.975 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.3 t -130.61 145.7 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.276 1.03 . . . . 71.34 108.289 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -121.87 95.68 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.668 -1.234 . . . . 74.23 107.668 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.6 tp-100 -90.4 99.69 12.67 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.28 -1.007 . . . . 74.25 108.28 177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 165.49 32.14 Favored Glycine 0 C--O 1.242 0.631 0 N-CA-C 111.165 -0.774 . . . . 72.42 111.165 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.51 127.18 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.025 -0.83 . . . . 10.43 111.025 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.58 129.09 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.961 -1.125 . . . . 63.41 107.961 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -133.02 134.79 44.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.074 0.95 . . . . 75.03 109.084 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.8 m -99.36 105.15 17.09 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 61.3 107.75 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.463 HD12 HD11 ' B' ' 89' ' ' ILE . 29.9 pt -119.75 142.88 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.631 0.772 . . . . 71.54 110.065 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.58 161.12 41.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.757 0.823 . . . . 44.21 109.984 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.49 -54.43 3.83 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 123.647 0.592 . . . . 71.23 112.13 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.463 HD11 HD12 ' B' ' 86' ' ' ILE . 28.6 pt -54.44 145.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.531 1.132 . . . . 53.43 112.026 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -165.99 152.5 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.553 0.533 . . . . 70.3 110.485 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.95 -128.29 34.19 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.869 0.73 . . . . 44.35 114.058 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.6 m -69.25 -29.94 67.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.726 0.811 . . . . 74.32 110.77 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.65 -26.81 58.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.919 0.888 . . . . 63.21 110.392 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 35.3 ttm -62.71 -32.96 74.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.826 0.85 . . . . 71.54 110.422 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.77 -29.01 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.96 0.904 . . . . 33.21 112.608 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . 0.476 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 51.4 t-80 -69.07 -26.55 65.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.522 0.329 . . . . 74.34 110.773 175.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -80.94 -63.17 1.46 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.179 -0.304 . . . . 64.33 110.179 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.481 HD12 ' N ' ' B' ' 99' ' ' GLY . 3.5 pp -67.12 -31.66 72.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.656 0.613 . . . . 74.3 112.656 -172.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . 0.481 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -108.32 3.08 32.94 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 119.718 -0.49 . . . . 61.42 114.284 -171.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -144.16 -57.64 0.38 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.377 0.588 . . . . 52.32 111.7 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.38 -53.75 11.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.312 0.645 . . . . 73.43 111.459 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 68.0 m -64.28 -45.05 78.27 Favored Pre-proline 0 CA--C 1.565 1.522 0 C-N-CA 123.956 0.903 . . . . 64.33 111.601 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.7 Cg_exo -55.6 -39.96 88.09 Favored 'Trans proline' 0 C--N 1.402 3.348 0 C-N-CA 122.649 2.233 . . . . 64.02 113.236 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -58.4 -29.17 65.86 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 123.579 0.752 . . . . 61.44 111.29 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . 0.403 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 73.1 mt -80.54 -53.42 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.786 0.834 . . . . 73.31 110.886 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.48 -24.54 56.95 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.367 0.667 . . . . 72.31 112.545 -170.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -63.53 -48.15 81.71 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.913 -1.041 . . . . 65.13 112.893 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 84.7 Cg_exo -51.9 -43.09 54.3 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.455 2.103 . . . . 53.42 113.966 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE2' HG21 ' D' ' 115' ' ' THR . 86.7 m-85 -67.1 -47.43 71.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.348 0.659 . . . . 75.25 110.888 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . 0.536 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.09 -48.27 80.67 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.813 0.696 . . . . 72.11 110.127 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -51.85 -52.27 50.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.806 1.642 . . . . 73.44 111.628 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.39 -35.0 78.43 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 123.657 0.598 . . . . 63.03 109.727 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.474 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.8 t -68.08 -31.0 70.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 122.93 0.492 . . . . 53.52 111.527 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.621 HG21 HG21 ' B' ' 64' ' ' VAL . 53.7 mt -70.14 -55.25 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.562 -0.903 . . . . 73.31 108.562 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -54.93 -33.91 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.88 1.363 . . . . 64.42 111.628 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -63.35 -51.56 65.4 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.398 -0.819 . . . . 62.13 109.552 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.76 -34.17 69.26 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.786 0.679 . . . . 75.2 111.318 -174.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . 0.422 HG21 HD23 ' B' ' 126' ' ' LEU . 85.0 t -62.64 -44.73 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.879 0.872 . . . . 72.5 110.011 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.8 t -68.6 -35.28 77.13 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.179 -0.919 . . . . 71.21 110.634 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.59 -29.42 69.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.026 0.53 . . . . 65.24 110.326 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.7 18.28 35.38 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.967 0.792 . . . . 54.35 112.629 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 35.5 p 54.51 44.98 27.94 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.876 1.67 . . . . 65.23 112.881 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' B' ' 124' ' ' PRO . 41.4 m-85 -112.78 147.32 36.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.403 0.681 . . . . 71.43 109.709 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 123' ' ' PHE . 10.6 Cg_exo -70.01 -165.63 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.41 2.74 . . . . 43.24 113.954 -175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.421 HE21 ' N ' ' B' ' 126' ' ' LEU . 22.9 tp60 -61.27 129.56 41.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.967 1.099 . . . . 71.11 113.967 -163.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . 0.422 HD23 HG21 ' B' ' 118' ' ' VAL . 27.5 tp -136.3 118.35 15.37 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.609 1.163 . . . . 62.11 108.951 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -134.5 134.48 41.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.157 -1.053 . . . . 72.44 108.157 166.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.58 148.17 24.98 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.928 0.394 . . . . 74.34 111.342 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.07 147.94 55.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.204 1.002 . . . . 52.24 112.352 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . 0.454 ' HG3' ' CD1' ' D' ' 16' ' ' ILE . 85.0 Cg_endo -75.82 79.78 2.77 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.53 2.82 . . . . 75.13 111.306 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 58.4 t -88.99 111.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.781 -1.192 . . . . 74.21 107.781 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -71.54 94.52 1.31 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 124.162 0.914 . . . . 75.05 109.341 -171.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 . . . . . 0 N--CA 1.483 1.179 0 C-N-CA 124.091 0.956 . . . . 74.03 111.391 -177.596 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.445 ' HG3' HD13 ' C' ' 89' ' ' ILE . 41.0 ttm . . . . . 0 CA--C 1.549 0.92 0 CA-C-O 121.384 0.611 . . . . 72.12 111.703 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.2 m -89.82 79.57 6.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.486 -0.931 . . . . 71.15 108.486 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -90.78 120.88 32.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -146.14 125.7 13.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.292 0.637 . . . . 74.22 109.594 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.29 138.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.433 -0.803 . . . . 72.3 110.395 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.86 -51.65 3.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.02 -0.363 . . . . 73.54 110.02 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -172.22 129.81 0.59 Allowed 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.276 0.36 . . . . 74.52 110.466 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.347 -0.982 . . . . 63.32 108.347 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG12 ' C' ' 83' ' ' ILE . 39.9 p90 -173.32 172.5 3.76 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.428 0.632 . . . . 74.34 111.417 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -92.16 114.95 27.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.647 -0.706 . . . . 61.24 110.103 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -64.48 -38.41 90.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.033 -0.728 . . . . 74.41 109.033 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.7 t70 -153.73 148.14 26.04 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.571 -1.195 . . . . 74.23 110.043 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -136.15 143.26 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 105.606 -1.998 . . . . 73.25 105.606 171.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -156.18 150.1 25.16 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.391 0.615 . . . . 62.32 109.868 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -152.59 118.19 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.481 -1.303 . . . . 71.45 107.481 173.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -115.44 139.43 50.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.655 -1.239 . . . . 75.42 107.655 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 84.25 53.48 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.66 -1.237 . . . . 75.1 107.66 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.32 -45.09 28.77 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.101 2.534 . . . . 72.23 112.226 -176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.27 50.73 0.79 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.591 -0.892 . . . . 72.21 108.591 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.59 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -55.73 -48.15 97.17 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 115.518 -0.764 . . . . 73.23 112.832 -175.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 1.9 Cg_endo -85.91 -33.7 0.2 Allowed 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.929 1.752 . . . . 74.02 112.836 169.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 55.8 t60 -70.23 -33.52 71.75 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.657 0.984 . . . . 72.05 113.657 -167.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -79.44 -14.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 122.815 0.446 . . . . 75.02 111.224 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -71.31 -14.91 62.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.624 0.77 . . . . 74.04 111.601 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.1 pt20 -105.14 12.51 31.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.525 0.73 . . . . 62.23 110.824 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.443 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 1.1 mptm? -97.45 176.71 5.77 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.021 0.915 . . . . 63.51 112.994 -170.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -87.91 128.5 35.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.384 -1.735 . . . . 72.03 108.938 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.648 0.592 . . . . 73.44 111.206 -168.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -148.24 58.89 4.06 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.247 0.619 . . . . 52.31 110.319 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.37 123.31 10.1 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.767 2.311 . . . . 64.54 112.387 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.98 77.57 8.42 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.551 -1.648 . . . . 64.43 106.551 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -73.83 97.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.838 -1.074 . . . . 65.32 108.4 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -93.49 122.08 35.55 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.95 -1.023 . . . . 74.31 109.01 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.31 121.51 28.98 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.308 -1.368 . . . . 64.03 107.308 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.0 t70 -121.85 135.43 54.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.691 -1.225 . . . . 74.03 107.691 176.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tt -137.21 120.12 16.43 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.335 -0.987 . . . . 71.23 108.335 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.547 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 5.6 t70 -113.46 148.11 36.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.056 0.942 . . . . 62.44 108.71 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 62.0 p -117.19 118.85 33.46 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.212 -0.904 . . . . 75.45 109.753 -173.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -124.37 146.6 48.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.0 0.92 . . . . 34.42 109.5 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.6 p -151.48 157.4 42.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.687 0.395 . . . . 75.21 110.584 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 20.0 m -143.81 147.53 34.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.133 0.973 . . . . 71.14 108.635 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -101.93 115.76 31.23 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.953 -1.129 . . . . 74.34 107.953 168.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' C' ' 57' ' ' GLU . 28.5 mt -98.18 -27.6 14.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.324 0.65 . . . . 63.12 110.034 -175.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.72 -171.38 1.83 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.242 1.017 . . . . 70.32 110.334 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.51 124.76 25.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.254 -0.884 . . . . 71.14 109.237 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 69.85 -8.88 0.75 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.878 1.671 . . . . 74.41 112.728 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.91 112.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.407 -0.59 . . . . 64.31 109.407 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -127.54 126.08 41.52 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.476 1.11 . . . . 63.44 108.685 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.603 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.4 tt0 -82.52 118.53 23.33 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.809 0.843 . . . . 75.33 108.745 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.15 114.75 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.952 -1.129 . . . . 53.43 107.952 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 43.6 t -110.64 131.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.071 -0.714 . . . . 63.04 109.071 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.436 HD13 ' HB3' ' C' ' 103' ' ' PRO . 36.2 tp -111.97 103.14 11.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.971 -1.122 . . . . 64.12 107.971 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.547 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 55.1 ttm-85 -81.32 115.36 20.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.883 -1.154 . . . . 64.4 107.883 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -116.73 108.74 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.905 -1.146 . . . . 75.43 107.905 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.1 m -116.02 124.37 50.29 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.834 0.854 . . . . 71.11 108.755 -174.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 56.2 t -117.8 113.71 43.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.846 -0.798 . . . . 73.31 108.846 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -100.88 146.84 26.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.595 -0.73 . . . . 72.13 109.343 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.66 13.06 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.132 -0.692 . . . . 74.24 109.132 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -131.63 126.28 34.32 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.841 -0.799 . . . . 70.14 108.841 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' C' ' 73' ' ' ALA . 9.2 mp -84.56 57.32 4.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.894 0.878 . . . . 63.25 109.399 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.1 -114.03 4.2 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.072 -1.211 . . . . 73.52 110.072 -174.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -90.8 -22.83 20.83 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.87 0.868 . . . . 62.15 110.322 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 7.3 tp10 -87.87 117.83 26.98 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.433 0.693 . . . . 70.12 110.844 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -76.23 128.05 34.13 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.006 0.431 . . . . 73.33 110.647 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' C' ' 68' ' ' LEU . . . -77.32 -60.45 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.792 -1.094 . . . . 60.42 109.422 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.11 176.47 12.21 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.88 -1.055 . . . . 72.32 110.58 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -140.98 120.86 13.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 106.357 -1.72 . . . . 71.13 106.357 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -117.01 119.89 36.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.439 -0.949 . . . . 72.02 108.439 177.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.69 141.71 51.53 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.72 -0.844 . . . . 70.31 108.72 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -147.41 115.14 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.444 1.098 . . . . 73.41 108.823 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.1 mt-30 -89.41 97.84 11.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.988 -1.115 . . . . 71.15 107.988 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -88.97 100.86 13.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.719 -0.673 . . . . 52.33 109.328 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.21 147.24 18.5 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.146 -0.479 . . . . 64.21 112.366 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.38 125.57 2.37 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 111.008 -0.837 . . . . 75.21 111.008 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' D' ' 29' ' ' PRO . 13.4 mm -81.76 122.66 37.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.765 -0.828 . . . . 61.1 108.765 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.54 138.17 45.93 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.3 p -109.34 106.17 15.86 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.933 -0.765 . . . . 71.21 108.933 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.46 142.24 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.856 0.863 . . . . 72.42 110.709 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.8 163.18 35.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.942 0.897 . . . . 43.01 110.406 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.82 -21.13 34.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.833 -0.621 . . . . 64.51 113.406 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . 0.445 HD13 ' HG3' ' C' ' 9' ' ' MET . 36.4 pt -114.18 148.16 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.063 0.945 . . . . 54.35 109.914 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -160.22 148.19 16.61 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.494 0.497 . . . . 61.03 110.099 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.51 -112.66 4.49 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 124.293 0.996 . . . . 72.22 113.543 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -64.69 -37.22 86.85 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.062 0.945 . . . . 65.12 111.775 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.88 -46.73 77.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.135 0.574 . . . . 72.25 110.937 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . 0.437 ' HA ' HD12 ' C' ' 89' ' ' ILE . 3.1 ppp? -74.53 -20.97 59.76 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.509 -0.769 . . . . 63.55 110.146 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.66 72.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.408 0.683 . . . . 64.12 111.074 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 53.1 t-80 -68.18 -46.86 69.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.247 -0.433 . . . . 74.32 110.596 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.98 -56.56 9.62 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.141 -0.481 . . . . 64.02 110.376 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.02 -40.43 96.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.449 1.1 . . . . 63.14 111.894 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.93 70.42 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.481 -0.622 . . . . 70.04 114.415 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -149.87 -59.76 0.2 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.808 0.804 . . . . 73.12 111.988 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -75.0 -50.93 14.91 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.244 -0.435 . . . . 72.15 112.008 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.66 -45.76 97.09 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.577 0.751 . . . . 63.45 112.95 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . 0.436 ' HB3' HD13 ' C' ' 60' ' ' LEU . 44.2 Cg_endo -67.65 -24.72 41.11 Favored 'Trans proline' 0 C--N 1.393 2.875 0 C-N-CA 121.983 1.788 . . . . 74.32 112.882 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.47 -40.49 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.257 0.623 . . . . 71.24 109.392 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.08 -46.76 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.634 -0.712 . . . . 71.41 110.195 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.07 -20.84 44.23 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.27 -0.877 . . . . 70.41 112.226 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.9 -54.74 48.78 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.109 -0.948 . . . . 73.55 113.538 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.49 -31.52 71.53 Favored 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.994 1.796 . . . . 53.44 112.972 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -66.1 -45.38 81.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.524 0.73 . . . . 63.21 110.756 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.13 -37.78 86.54 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.852 -0.613 . . . . 74.04 110.439 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -60.56 -54.11 49.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.298 1.439 . . . . 70.32 111.425 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -35.39 80.28 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.608 0.568 . . . . 74.12 110.172 -177.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.09 -38.87 86.46 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.079 0.552 . . . . 71.44 111.822 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -67.76 -50.94 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.436 0.694 . . . . 61.53 110.169 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.4 m -63.14 -28.79 70.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.368 0.667 . . . . 61.11 111.311 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.6 t -67.58 -47.85 68.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.18 -0.674 . . . . 61.53 109.18 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.555 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.45 -37.67 86.82 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.961 0.904 . . . . 75.41 112.325 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.52 -40.58 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.049 0.539 . . . . 61.32 109.918 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.33 -33.96 76.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.651 0.78 . . . . 75.24 111.229 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.474 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 71.4 mtt-85 -70.48 -27.11 63.96 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.9 0.88 . . . . 73.12 110.901 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.24 15.01 62.13 Favored Glycine 0 C--N 1.352 1.45 0 O-C-N 123.63 0.581 . . . . 44.24 112.817 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.534 HG23 ' HB3' ' D' ' 17' ' ' TYR . 49.6 p 55.0 26.39 7.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.901 1.681 . . . . 65.21 112.638 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -103.46 141.86 23.38 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 124.425 1.09 . . . . 72.21 108.887 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -40.6 111.77 0.16 Allowed 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 124.148 3.232 . . . . 75.15 113.893 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -57.23 123.67 16.13 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.148 0.905 . . . . 74.13 111.268 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -112.36 110.75 21.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.128 -1.064 . . . . 73.54 108.128 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -94.97 117.38 30.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.635 -0.876 . . . . 71.33 108.635 175.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.55 142.25 53.66 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.516 0.51 . . . . 61.32 110.268 175.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.2 160.84 81.73 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 115.099 -0.955 . . . . 63.32 111.065 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.623 ' HG2' HG21 ' A' ' 13' ' ' ILE . 26.0 Cg_exo -59.76 100.73 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.65 2.233 . . . . 63.42 112.455 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.2 t -98.85 107.12 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.399 -0.963 . . . . 74.01 108.399 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -114.34 106.25 14.09 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.232 1.013 . . . . 64.31 108.559 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 51.1 m-85 -63.91 -30.64 71.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.731 0.812 . . . . 72.43 111.429 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 N--CA 1.482 1.126 0 C-N-CA 123.849 0.86 . . . . 63.22 110.515 173.844 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.5 m . . . . . 0 C--O 1.236 0.365 0 N-CA-C 107.735 -1.209 . . . . 54.42 107.735 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -156.8 92.93 1.32 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.05 -1.463 . . . . 55.25 107.05 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -122.02 156.44 33.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.674 0.79 . . . . 63.13 109.363 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.507 HD13 HG21 ' D' ' 105' ' ' ILE . 11.3 mt -102.0 122.48 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.983 -0.747 . . . . 42.15 108.983 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.25 -49.57 10.6 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.433 -0.58 . . . . 74.11 109.433 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . 0.513 ' HE ' HD12 ' D' ' 83' ' ' ILE . 19.4 ptt180 -173.65 152.67 2.11 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 112.171 0.434 . . . . 72.14 112.171 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.454 ' CD1' ' HG3' ' B' ' 130' ' ' PRO . 4.0 mp -114.36 139.35 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.621 -1.622 . . . . 72.42 106.621 167.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.59 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 41.2 p90 -162.56 157.67 22.43 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.833 0.853 . . . . 64.22 109.691 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -81.42 113.55 19.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.459 -1.246 . . . . 72.45 109.175 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.9 mtpt -83.33 -33.2 25.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.098 0.475 . . . . 63.14 109.812 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.6 t70 -144.93 135.54 24.45 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.537 -1.21 . . . . 71.34 109.038 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.555 HG21 ' HE2' ' C' ' 117' ' ' MET . 53.4 mt -133.43 140.89 45.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.351 -1.351 . . . . 64.05 107.351 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -154.44 102.32 2.41 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.675 0.79 . . . . 62.55 109.466 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.0 t80 -108.39 115.49 30.2 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 105.783 -1.932 . . . . 73.32 105.783 167.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -121.01 131.78 54.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.149 -0.686 . . . . 74.23 109.149 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.45 78.26 45.77 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.284 -1.376 . . . . 75.13 107.284 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.9 -35.15 36.49 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.675 2.25 . . . . 62.42 111.522 -172.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 6.5 m-80 -109.91 22.29 15.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.775 0.83 . . . . 72.01 109.99 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.43 -64.82 0.31 Allowed Pre-proline 0 CA--C 1.571 1.773 0 N-CA-C 116.13 1.9 . . . . 74.13 116.13 -171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.508 ' HB3' HD11 ' C' ' 83' ' ' ILE . 40.0 Cg_endo -81.03 -14.5 10.91 Favored 'Trans proline' 0 C--N 1.39 2.744 0 CA-C-N 122.023 1.758 . . . . 74.41 113.339 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.0 t-160 -71.35 -37.43 71.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.901 1.28 . . . . 71.44 109.06 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.633 HG13 HD11 ' D' ' 68' ' ' LEU . 76.1 t -74.12 -30.98 28.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 115.131 -0.94 . . . . 74.32 109.95 175.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -70.84 6.76 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.644 0.979 . . . . 73.21 113.644 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -84.48 -37.84 20.84 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.367 -0.605 . . . . 75.24 109.367 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . 0.426 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 30.4 pttt -132.45 95.87 3.72 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 124.23 1.012 . . . . 74.12 112.319 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -108.72 92.74 4.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 72.42 109.522 170.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . 0.426 ' HZ3' ' HA ' ' D' ' 34' ' ' LYS . 12.3 m-90 -125.86 -179.99 4.93 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.364 -1.347 . . . . 75.13 107.364 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.05 104.65 0.44 Allowed Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.476 0.71 . . . . 73.03 112.055 -163.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.69 109.72 2.91 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.958 2.438 . . . . 70.41 109.464 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.62 113.9 4.04 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.589 -0.893 . . . . 74.54 108.589 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . 0.418 HG11 HD11 ' D' ' 126' ' ' LEU . 1.2 m -104.78 114.2 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 114.436 -1.256 . . . . 45.44 110.64 -166.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 81.1 tttt -87.54 128.65 35.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.198 1.399 . . . . 73.4 108.945 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -101.77 114.17 27.99 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.382 0.673 . . . . 75.55 109.828 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.646 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -106.84 109.43 21.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.256 -1.387 . . . . 73.41 107.256 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -97.5 130.88 44.54 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.245 -1.02 . . . . 74.44 108.245 177.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -133.49 130.39 38.48 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.149 -1.056 . . . . 72.23 108.149 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -103.88 142.4 34.47 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.6 0.76 . . . . 63.14 109.781 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.24 150.65 27.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.549 0.74 . . . . 71.22 109.251 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.5 p -164.63 153.32 12.72 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.393 0.677 . . . . 41.53 109.332 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -158.65 142.55 15.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.063 0.545 . . . . 63.35 110.054 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -73.05 128.47 35.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.356 0.662 . . . . 71.22 109.393 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -100.88 -26.32 13.79 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.884 0.474 . . . . 73.32 110.552 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.52 -179.09 4.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.753 0.821 . . . . 61.21 110.82 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.04 119.82 12.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.852 -1.067 . . . . 62.51 108.858 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 40.5 m-20 66.39 16.79 10.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.044 1.338 . . . . 75.03 111.891 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.81 114.81 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.934 0.894 . . . . 72.23 108.969 175.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . 0.448 ' HB2' HD12 ' D' ' 86' ' ' ILE . 90.4 m-85 -132.81 129.45 38.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.352 1.061 . . . . 73.22 108.489 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -100.27 139.73 35.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.384 1.074 . . . . 50.5 109.789 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.58 118.8 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 73.45 108.305 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.5 t -104.99 131.4 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.442 -0.947 . . . . 72.51 108.442 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.93 109.76 12.84 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.991 -1.115 . . . . 70.24 107.991 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.2 ttm-85 -87.05 109.36 19.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.537 0.735 . . . . 74.12 109.838 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.56 104.25 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.591 -1.263 . . . . 50.22 107.591 166.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.8 m -100.0 136.51 39.8 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.433 -0.58 . . . . 65.31 109.433 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.06 110.12 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.46 1.104 . . . . 63.24 108.255 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 39.6 m -102.97 103.08 13.17 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.597 0.759 . . . . 63.5 109.244 175.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.59 135.99 36.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 29.5 p -148.36 124.28 10.64 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.641 0.588 . . . . 63.33 110.433 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.634 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.5 OUTLIER -113.04 126.7 55.78 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.422 -0.955 . . . . 54.01 108.422 172.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -134.03 28.11 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.474 -0.65 . . . . 65.32 111.474 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.26 4.2 54.38 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.979 0.512 . . . . 73.33 110.874 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -119.07 144.18 46.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 75.41 111.337 -168.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.8 m -74.72 120.1 19.81 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 123.469 0.708 . . . . 75.13 109.895 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.634 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -67.94 -61.53 1.82 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.252 0.97 . . . . 72.42 110.191 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.37 168.56 26.24 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.247 -1.342 . . . . 63.54 110.454 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.7 mt -127.45 139.57 52.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.65 -1.611 . . . . 72.31 106.65 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' HG23 ' D' ' 114' ' ' ILE . 36.2 t -153.38 110.21 3.42 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.415 -0.587 . . . . 70.32 109.415 -175.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -136.45 132.18 35.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.45 1.1 . . . . 71.43 108.998 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.39 121.79 20.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.117 0.567 . . . . 65.31 109.614 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -88.74 88.83 7.74 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.321 -0.992 . . . . 61.42 108.321 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -81.11 96.63 7.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.565 -1.198 . . . . 65.15 108.958 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.09 144.24 17.01 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.579 -0.608 . . . . 64.45 111.579 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.74 130.0 4.03 Favored Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 110.834 -0.906 . . . . 74.33 110.834 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . 0.513 HD12 ' HE ' ' D' ' 15' ' ' ARG . 48.0 mt -89.82 127.04 42.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.527 -0.916 . . . . 64.4 108.527 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -129.12 133.51 47.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.724 0.809 . . . . 74.24 109.759 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.1 m -80.92 94.98 6.61 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 108.901 -0.777 . . . . 55.11 108.901 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' D' ' 56' ' ' TYR . 40.1 mt -111.34 123.63 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.444 0.698 . . . . 62.13 110.202 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -149.67 165.01 33.63 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.767 0.827 . . . . 52.53 110.671 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.71 -19.44 24.73 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.411 0.925 . . . . 52.12 115.411 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 19.7 pt -129.2 134.73 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 117.835 0.817 . . . . 40.31 111.879 -170.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.33 -171.26 3.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.617 0.767 . . . . 63.04 110.061 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 -140.41 34.5 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.622 0.576 . . . . 61.04 112.18 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -78.19 -20.87 51.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.381 0.672 . . . . 70.31 111.57 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . 0.446 HE21 ' HA ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -60.44 -52.96 63.01 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.759 0.823 . . . . 75.21 110.17 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.27 -41.56 69.87 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 114.86 -1.063 . . . . 55.45 109.923 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.38 -26.92 68.68 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.476 0.71 . . . . 75.11 112.36 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.88 -42.04 25.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.347 0.659 . . . . 73.44 109.694 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.39 -31.03 71.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.068 0.547 . . . . 63.42 110.836 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -46.59 18.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 71.3 108.611 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.14 -20.05 79.41 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.97 -1.013 . . . . 75.2 114.377 -173.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.98 -61.71 1.22 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 117.17 0.485 . . . . 72.35 111.805 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -67.11 -40.89 86.95 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 112.677 0.621 . . . . 75.44 112.677 -170.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.5 m -63.76 -47.48 81.52 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-O 118.72 -0.657 . . . . 65.33 111.742 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.3 -40.2 35.43 Favored 'Trans proline' 0 C--N 1.4 3.269 0 C-N-CA 123.045 2.497 . . . . 63.11 114.196 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -59.78 -27.0 66.17 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 112.764 0.653 . . . . 64.11 112.764 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.507 HG21 HD13 ' D' ' 13' ' ' ILE . 41.6 mm -82.42 -44.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-O 121.157 0.503 . . . . 53.02 110.572 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.1 mt -76.29 -32.2 58.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.97 -1.014 . . . . 72.25 111.722 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . 0.408 ' HZ ' ' HG ' ' D' ' 128' ' ' LEU . 62.8 t80 -63.48 -42.86 76.36 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.566 1.146 . . . . 75.44 113.872 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.08 -42.65 45.37 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 122.386 2.058 . . . . 61.04 113.19 171.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -81.26 -27.67 35.07 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.58 0.752 . . . . 75.21 111.858 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.61 -53.54 49.97 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 173.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 39.1 ttp180 -58.74 -42.08 87.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.837 -1.529 . . . . 61.11 110.99 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.74 -49.92 74.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.771 0.828 . . . . 72.0 110.708 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -60.19 -44.2 95.28 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.843 0.714 . . . . 52.51 111.176 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.578 HG23 ' SG ' ' D' ' 76' ' ' CYS . 49.8 mt -58.57 -55.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 72.42 111.07 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . 0.505 HG21 ' HE2' ' B' ' 109' ' ' TYR . 63.2 m -53.24 -47.46 69.01 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.239 1.016 . . . . 72.43 111.758 -174.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 46.7 t -62.14 -37.8 86.54 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.655 -1.157 . . . . 63.12 111.204 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 72.6 mtm -75.17 -32.14 61.19 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.871 0.469 . . . . 74.22 111.998 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.516 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -68.07 -36.93 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 116.066 -0.515 . . . . 54.41 109.733 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.2 p -72.54 -28.44 62.84 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.874 0.47 . . . . 65.24 111.085 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.4 mtt-85 -73.06 -27.23 61.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.673 0.789 . . . . 71.24 110.635 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.95 8.42 76.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.015 -0.538 . . . . 74.43 112.395 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p 66.54 13.67 9.39 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.084 2.154 . . . . 51.32 114.02 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . 0.489 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 76.5 m-85 -90.99 169.19 12.12 Favored Pre-proline 0 CA--C 1.568 1.647 0 C-N-CA 124.536 1.135 . . . . 70.02 107.964 169.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 93.0 Cg_endo -74.47 166.94 28.29 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.532 2.155 . . . . 61.45 112.92 -172.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -60.9 121.69 13.02 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.114 -0.494 . . . . 70.45 109.757 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . 0.418 HD11 HG11 ' D' ' 40' ' ' VAL . 7.5 tt -104.24 93.53 4.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.16 -1.422 . . . . 65.21 107.16 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -103.25 89.82 3.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.011 -1.45 . . . . 73.22 108.596 -171.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 23.1 tp -71.96 122.78 21.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.854 -0.612 . . . . 71.21 110.514 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.91 140.31 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.492 1.117 . . . . 44.15 112.223 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.67 114.42 3.67 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.661 2.241 . . . . 73.35 110.371 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.56 143.56 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.555 0.742 . . . . 34.44 109.682 -172.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -69.67 101.72 1.72 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.189 0.996 . . . . 73.34 110.302 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 . . . . . 0 N--CA 1.476 0.852 0 C-N-CA 123.262 0.625 . . . . 73.22 111.175 179.006 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 108.7 -0.852 . . . . 75.05 108.7 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.627 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.8 t80 -126.34 123.47 38.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.079 0.952 . . . . 65.43 108.646 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -143.3 103.5 4.13 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.423 0.452 . . . . 73.12 109.878 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.642 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.4 mt -64.9 121.57 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.041 -0.725 . . . . 72.04 109.041 174.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -87.61 -41.39 13.46 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.677 0.611 . . . . 75.43 109.656 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 59.0 ttt180 -168.28 144.01 3.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.996 -0.281 . . . . 74.42 111.428 -162.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -129.67 137.29 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.09 -1.078 . . . . 60.31 108.09 172.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.47 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 21.4 p90 -160.96 165.97 29.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.453 0.701 . . . . 71.21 110.996 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -100.24 117.57 34.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.651 -0.87 . . . . 43.45 108.651 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -77.83 -26.69 49.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.382 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.35 142.39 16.93 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 123.912 0.757 . . . . 70.31 109.223 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 95.9 mt -134.75 142.38 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 106.612 -1.625 . . . . 74.23 106.612 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -155.14 114.0 3.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.413 0.446 . . . . 34.52 110.045 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -109.08 117.89 35.36 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 106.766 -1.568 . . . . 73.34 106.766 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.81 137.1 52.44 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.273 -0.64 . . . . 65.03 109.273 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.45 72.2 12.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.818 -1.549 . . . . 73.22 106.818 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.16 -30.98 37.27 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.772 2.315 . . . . 64.24 111.577 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.04 28.31 8.62 Favored 'General case' 0 C--O 1.213 -0.842 0 C-N-CA 124.207 1.003 . . . . 53.35 108.381 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.29 -53.5 43.9 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.272 -0.871 . . . . 53.1 112.486 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 16.0 Cg_exo -66.63 -17.53 52.86 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 121.882 1.721 . . . . 73.44 112.696 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -95.9 -29.16 14.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 72.32 111.285 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -82.94 -25.39 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.791 0.436 . . . . 72.35 111.652 -172.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -72.49 -9.6 58.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.516 0.726 . . . . 71.15 112.277 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -102.71 -10.78 18.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.651 0.78 . . . . 54.31 111.472 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -77.73 165.44 24.2 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.152 0.581 . . . . 62.34 111.965 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.74 145.15 55.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.376 1.07 . . . . 72.52 110.922 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -81.13 90.3 6.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.516 0.726 . . . . 75.35 110.183 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.411 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tp60 -141.8 50.04 1.62 Allowed Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 114.729 -1.123 . . . . 71.11 109.261 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 37' ' ' GLN . 6.9 Cg_exo -74.99 96.43 1.02 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 122.539 2.159 . . . . 63.32 111.624 -172.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.14 98.0 10.67 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.279 -1.008 . . . . 64.34 108.279 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 65' ' ' THR . 2.6 p -93.33 104.94 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 114.055 -1.429 . . . . 72.21 110.616 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -83.17 137.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.007 1.323 . . . . 74.24 110.15 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 tt -105.72 127.56 53.15 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.122 -1.066 . . . . 74.34 108.122 174.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.8 m-20 -120.34 144.21 47.98 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.095 -1.076 . . . . 72.33 108.095 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.566 HD11 HD12 ' A' ' 60' ' ' LEU . 27.1 tp -139.31 124.61 19.1 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.73 -0.47 . . . . 62.54 109.73 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.3 m-20 -119.3 127.09 52.88 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.763 0.825 . . . . 74.12 109.042 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -106.33 121.42 44.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.053 0.941 . . . . 55.13 109.485 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.88 147.08 38.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.975 0.91 . . . . 72.31 109.544 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -133.08 168.57 18.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.693 0.797 . . . . 55.25 110.271 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -161.71 154.44 20.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.385 1.074 . . . . 74.42 109.506 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -111.25 121.87 46.38 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.152 -1.055 . . . . 54.21 108.152 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 57' ' ' GLU . 26.9 mt -97.43 -33.88 11.23 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.338 0.655 . . . . 74.22 110.599 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.14 -173.13 3.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.266 0.626 . . . . 72.23 110.729 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.04 112.35 3.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.229 1.012 . . . . 64.41 110.093 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' SER . 62.0 m-20 70.45 1.69 3.74 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.579 1.552 . . . . 75.53 113.323 -175.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -100.86 115.82 43.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.508 0.723 . . . . 64.32 109.382 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -131.64 124.76 30.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.535 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.4 tt0 -95.59 116.54 28.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.261 1.025 . . . . 64.04 109.408 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.1 124.11 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.418 -1.327 . . . . 73.04 107.418 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 t -112.7 129.84 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.595 0.758 . . . . 71.45 109.195 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.566 HD12 HD11 ' A' ' 44' ' ' LEU . 3.9 mm? -120.86 104.27 9.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.708 1.203 . . . . 73.22 108.443 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.604 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 30.4 ttp180 -84.49 104.55 14.59 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.743 -0.836 . . . . 74.2 108.743 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.9 120.48 43.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.393 -1.336 . . . . 74.0 107.393 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 36.9 m -122.07 130.6 53.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.225 -0.657 . . . . 71.52 109.225 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.689 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -123.47 116.46 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 124.932 1.293 . . . . 72.15 108.777 -174.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.9 m -118.61 130.15 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.249 0.477 . . . . 73.42 110.12 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.36 130.28 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.556 -0.905 . . . . 44.2 108.556 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.9 m -127.35 126.82 43.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.125 0.57 . . . . 61.35 109.704 176.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.685 HD13 ' HB2' ' A' ' 73' ' ' ALA . 11.0 mp -88.65 85.89 6.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.97 -1.122 . . . . 72.22 107.97 174.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.94 -88.29 1.17 Allowed Glycine 0 C--N 1.346 1.091 0 CA-C-N 114.924 -1.034 . . . . 50.14 111.488 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.21 -27.78 7.16 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.472 0.709 . . . . 71.14 111.357 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -102.75 132.93 48.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.188 0.595 . . . . 64.03 110.629 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 47.2 m -69.03 130.61 43.24 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.077 0.951 . . . . 74.32 111.315 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -74.63 -61.51 1.85 Allowed 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.998 0.919 . . . . 74.51 109.504 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.459 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 40.3 p90 -152.9 163.26 40.12 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.564 -1.198 . . . . 73.25 111.38 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 tp -130.67 137.5 49.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.149 -1.387 . . . . 75.11 107.274 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.689 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.2 m -137.03 98.99 3.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.557 0.743 . . . . 75.43 109.306 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -119.13 117.83 29.75 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.23 -1.026 . . . . 72.34 108.23 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.54 109.22 15.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.985 0.914 . . . . 72.41 109.148 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -84.59 81.24 8.94 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.593 -1.262 . . . . 70.33 107.593 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.63 93.56 3.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.718 -0.845 . . . . 74.14 108.718 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.16 147.26 21.56 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.073 -0.811 . . . . 71.32 111.073 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.635 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.68 122.97 1.41 Allowed Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 111.783 -0.527 . . . . 43.53 111.783 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.79 125.62 39.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.233 -0.654 . . . . 71.42 109.233 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.642 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.0 m-85 -132.17 148.76 52.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.767 -1.197 . . . . 71.21 107.767 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 41.9 t -102.51 110.84 22.9 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.425 -0.954 . . . . 63.25 108.425 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.55 HG21 ' HG2' ' A' ' 94' ' ' MET . 4.2 mp -112.95 125.27 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.97 44.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.559 0.744 . . . . 52.41 109.644 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 101.26 -32.55 7.34 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 123.72 0.637 . . . . 73.34 113.667 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.82 147.75 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.435 0.694 . . . . 73.25 110.287 -175.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -138.82 -179.08 5.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.706 0.802 . . . . 74.34 109.38 176.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.61 -132.88 32.35 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 119.623 -0.543 . . . . 62.24 112.897 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 18.6 p -74.96 -17.54 60.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.64 0.776 . . . . 55.55 111.977 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -72.01 -42.67 66.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.999 0.52 . . . . 71.51 109.668 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' MET . . . . . 0.55 ' HG2' HG21 ' A' ' 86' ' ' ILE . 1.1 tmt? -81.7 -24.84 35.94 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.637 0.775 . . . . 73.24 110.043 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.65 -37.18 79.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.368 0.667 . . . . 64.23 110.135 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.71 -34.47 77.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.357 0.663 . . . . 74.13 110.11 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.5 t -67.89 -42.42 81.24 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.016 -0.538 . . . . 64.24 110.999 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.0 mt -86.15 -29.19 23.46 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.912 0.708 . . . . 72.41 112.912 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.78 3.89 34.2 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.597 0.599 . . . . 50.14 114.597 -170.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -51.22 0.16 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.42 0.61 . . . . 71.02 111.745 -174.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 60.0 t80 -79.46 -66.84 0.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.445 1.098 . . . . 74.2 112.23 -169.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' CYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 67.2 m -70.72 -32.17 2.42 Favored Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 114.78 1.4 . . . . 70.44 114.78 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 36.3 Cg_endo -63.99 -20.66 68.13 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 122.055 1.77 . . . . 65.43 112.775 171.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -76.14 -17.75 59.43 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.227 0.611 . . . . 74.04 109.981 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.532 HG21 HD13 ' A' ' 13' ' ' ILE . 42.2 mm -75.41 -39.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.961 -0.755 . . . . 72.52 108.961 170.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.635 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.5 mt -78.47 -33.02 48.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.953 0.901 . . . . 74.32 112.959 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -62.16 -43.75 86.88 Favored Pre-proline 0 CA--C 1.572 1.789 0 N-CA-C 113.758 1.022 . . . . 75.24 113.758 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.53 -28.08 22.01 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.113 1.875 . . . . 75.02 113.157 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -76.02 -34.56 59.68 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.084 0.553 . . . . 75.51 111.156 175.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.27 78.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.111 -0.699 . . . . 42.41 109.111 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.436 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.7 ttm180 -55.18 -49.86 70.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.594 1.184 . . . . 75.1 109.845 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.266 0.979 . . . . 71.34 110.738 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 28.3 t -59.51 -44.25 93.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.386 0.674 . . . . 44.32 110.558 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.4 mt -64.41 -54.13 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.818 0.847 . . . . 65.44 109.965 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 58.2 m -55.22 -39.77 70.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.126 0.97 . . . . 75.15 111.212 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -64.22 -51.35 64.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.824 -1.08 . . . . 60.14 109.793 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 21' ' ' ILE . 16.0 mtp -56.83 -44.49 82.12 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.376 1.07 . . . . 73.1 111.646 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.9 t -62.5 -45.82 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.324 1.05 . . . . 74.24 110.436 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.4 t -68.77 -31.68 70.88 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.402 -0.817 . . . . 62.4 110.881 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -70.63 -31.98 69.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.807 0.843 . . . . 74.51 110.11 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.68 2.68 78.11 Favored Glycine 0 C--N 1.355 1.629 0 O-C-N 123.858 0.724 . . . . 60.33 113.181 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m 65.69 32.86 8.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.824 1.25 . . . . 73.54 111.159 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -101.09 140.63 21.45 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 106.723 -1.584 . . . . 64.13 106.723 168.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -56.94 149.79 59.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.562 2.174 . . . . 41.22 111.672 -178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.5 tt0 -51.53 136.47 26.18 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.349 1.03 . . . . 73.11 113.202 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.517 HD21 HG11 ' A' ' 64' ' ' VAL . 10.3 tp -125.69 120.65 31.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.306 -1.315 . . . . 73.1 108.064 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.01 120.18 32.58 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.44 -0.948 . . . . 71.23 108.44 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.06 118.32 15.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.935 -0.765 . . . . 74.03 108.935 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.66 139.67 59.76 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 124.209 1.004 . . . . 74.14 111.98 -174.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 4.6 Cg_exo -72.25 110.17 2.89 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.835 1.69 . . . . 61.25 110.208 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.84 123.75 52.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -65.54 97.3 0.3 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.409 1.084 . . . . 63.33 110.835 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.2 -50.27 6.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.256 0.623 . . . . 74.31 109.556 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.0 p-10 . . . . . 0 N--CA 1.475 0.795 0 C-N-CA 124.704 1.201 . . . . 74.53 111.312 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.2 m . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 109.694 -0.484 . . . . 73.45 109.694 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -134.7 139.89 45.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.724 -1.213 . . . . 74.45 107.724 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 2.7 pp0? -163.39 139.61 6.93 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.057 -0.72 . . . . 71.4 109.057 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ILE . . . . . 0.624 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -91.79 134.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.378 -0.971 . . . . 64.15 108.378 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -97.97 -52.67 3.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.164 0.586 . . . . 65.14 110.566 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -151.3 134.52 16.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.609 -0.269 . . . . 75.13 110.45 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' ILE . . . . . 0.624 HG13 HD11 ' B' ' 13' ' ' ILE . 98.5 mt -114.4 136.12 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.072 -1.455 . . . . 71.02 107.072 167.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.2 p90 -166.21 144.98 5.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.943 0.497 . . . . 73.4 110.882 -172.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.5 m -76.67 120.52 21.97 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.484 -0.78 . . . . 72.33 109.295 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' LYS . . . . . 0.441 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 44.5 mtpt -92.1 -30.82 15.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.451 0.7 . . . . 63.14 111.34 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.6 142.18 17.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.59 0.233 . . . . 75.02 110.636 -173.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mm -141.1 139.35 33.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.633 1.573 . . . . 65.12 108.02 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -143.0 130.61 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.486 -1.302 . . . . 71.24 107.486 172.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 79.2 t80 -137.45 119.23 15.13 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.708 -1.589 . . . . 72.2 106.708 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -117.38 122.49 43.98 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.402 -0.962 . . . . 75.14 108.402 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -119.49 79.84 21.74 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 107.302 -1.369 . . . . 73.14 107.302 165.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.26 -18.25 34.76 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.207 1.938 . . . . 61.42 110.419 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -111.59 15.67 21.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.984 1.314 . . . . 73.31 110.821 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.1 -54.5 7.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 N-CA-C 114.396 1.258 . . . . 64.52 114.396 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' PRO . . . . . 0.465 ' HG2' ' ND1' ' B' ' 30' ' ' HIS . 95.0 Cg_endo -78.76 -31.75 2.32 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 121.765 1.643 . . . . 74.32 113.274 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' HIS . . . . . 0.465 ' ND1' ' HG2' ' B' ' 29' ' ' PRO . 77.0 m80 -92.35 4.11 54.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.096 0.959 . . . . 74.13 113.303 -169.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 7.7 p -79.06 -6.96 10.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 C-N-CA 123.516 0.726 . . . . 72.44 110.061 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.14 -33.04 74.57 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.797 0.439 . . . . 71.43 111.141 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -76.03 -41.85 49.66 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.358 0.663 . . . . 72.22 109.931 175.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' LYS . . . . . 0.618 ' HB3' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -108.42 64.34 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.584 1.154 . . . . 75.32 109.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 31' ' ' VAL . 13.6 t70 -118.82 118.55 31.88 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.565 -0.531 . . . . 73.34 109.565 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -179.81 179.43 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.029 1.732 . . . . 73.34 107.883 155.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -47.35 106.43 0.59 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.011 0.925 . . . . 74.2 110.92 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.23 169.1 7.42 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.723 2.282 . . . . 73.5 110.667 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.26 100.69 3.19 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 106.907 -1.516 . . . . 72.32 106.907 170.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.25 126.66 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.68 -1.145 . . . . 72.23 109.401 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -128.05 135.09 49.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.738 0.815 . . . . 74.23 109.477 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 22.5 mt -97.41 151.79 19.6 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.337 -0.986 . . . . 73.11 108.337 172.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -148.2 109.9 4.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.419 -1.326 . . . . 75.01 107.419 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mp -103.72 129.63 51.11 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.136 0.574 . . . . 72.0 109.478 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ASP . . . . . 0.526 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.2 t70 -122.62 149.92 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.335 1.054 . . . . 74.02 110.192 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -118.07 128.57 54.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.631 -1.168 . . . . 74.22 109.438 -170.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.13 126.74 15.14 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.038 0.535 . . . . 72.04 110.175 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 56.5 p -136.49 160.78 37.75 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.348 . . . . 72.43 110.795 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -157.64 137.66 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.723 -0.671 . . . . 63.54 110.045 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.93 114.69 20.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.197 0.599 . . . . 74.42 110.263 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' B' ' 57' ' ' GLU . 23.5 mt -88.41 -34.55 17.5 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.603 0.761 . . . . 63.01 110.461 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.83 -167.93 1.5 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.654 0.782 . . . . 73.4 110.573 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.86 106.24 0.98 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.576 -1.193 . . . . 61.04 110.166 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.29 9.16 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.954 1.301 . . . . 72.3 113.044 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -103.89 108.46 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.262 -1.014 . . . . 71.32 108.262 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.14 140.13 51.55 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.168 0.987 . . . . 71.44 109.239 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' B' ' 51' ' ' LEU . 5.8 tm-20 -103.6 99.96 9.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.234 -1.024 . . . . 74.12 108.234 -174.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 77.0 t -88.68 125.93 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.354 1.462 . . . . 62.3 109.925 -175.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.3 t -118.7 131.26 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.874 0.869 . . . . 74.14 109.543 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.33 108.12 18.09 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.762 -1.199 . . . . 71.02 107.762 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.5 ttm180 -88.21 113.79 24.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.622 -0.881 . . . . 64.54 108.622 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.7 104.17 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.891 -1.151 . . . . 71.23 107.891 169.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -98.7 132.99 43.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.589 -0.522 . . . . 44.04 109.589 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' VAL . . . . . 0.403 HG21 HG21 ' B' ' 114' ' ' ILE . 95.8 t -122.09 120.22 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.347 1.059 . . . . 72.43 108.933 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -115.11 143.03 45.84 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.354 0.661 . . . . 70.42 109.305 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.3 136.58 38.14 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.75 -0.833 . . . . 74.34 108.75 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 52.1 p -147.1 139.01 24.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.879 0.472 . . . . 75.41 110.672 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' LEU . . . . . 0.618 HD13 ' HB3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -136.45 139.67 42.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.905 1.282 . . . . 73.51 108.615 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.09 -115.95 6.84 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.016 -0.834 . . . . 72.44 111.016 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -122.94 3.01 9.41 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.061 0.944 . . . . 72.13 108.853 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.1 168.96 9.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.338 0.59 . . . . 74.32 111.342 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 14.8 m -71.04 143.77 50.61 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.651 -1.158 . . . . 63.22 111.028 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -95.32 -60.02 1.76 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.27 -1.011 . . . . 64.05 108.27 169.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -164.68 155.52 14.76 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.339 -1.3 . . . . 74.14 108.401 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 62.9 mt -128.23 136.52 51.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -148.69 152.71 37.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.235 0.614 . . . . 71.12 109.357 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -160.39 129.19 4.84 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.952 -1.129 . . . . 63.33 107.952 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.9 t -124.04 142.37 41.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.676 -0.861 . . . . 52.42 108.676 176.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -125.32 93.23 3.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.138 -1.06 . . . . 71.23 108.138 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 80' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -83.52 102.8 12.37 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.23 -1.026 . . . . 41.2 108.23 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.29 166.85 35.25 Favored Glycine 0 C--O 1.244 0.724 0 N-CA-C 111.02 -0.832 . . . . 23.35 111.02 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.33 126.91 1.57 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.15 -0.78 . . . . 71.23 111.15 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' B' ' 17' ' ' TYR . 69.1 mt -83.68 118.51 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.67 -1.233 . . . . 64.35 107.67 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -124.34 166.84 15.23 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.358 1.063 . . . . 72.42 108.68 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 40.9 m -130.53 112.69 13.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.466 -0.939 . . . . 64.14 108.466 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 86' ' ' ILE . . . . . 0.712 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -117.36 133.77 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.985 0.914 . . . . 51.44 109.743 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 87' ' ' ALA . . . . . 0.658 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.37 158.35 38.54 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.107 0.963 . . . . 52.5 109.399 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.71 3.11 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.302 -0.408 . . . . 73.44 112.526 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 89' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' B' ' 86' ' ' ILE . 20.5 pt -68.5 150.12 10.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 123.041 0.536 . . . . 63.42 110.297 169.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 90' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 39.8 tt0 -164.31 146.32 8.74 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.537 -0.756 . . . . 61.03 109.818 -174.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.76 -103.75 1.5 Allowed Glycine 0 C--N 1.349 1.298 0 O-C-N 123.332 0.395 . . . . 45.21 113.109 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.4 m -88.3 -29.28 20.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.486 0.714 . . . . 50.43 110.947 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 47.9 mt-30 -58.66 -45.21 89.85 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.787 0.835 . . . . 73.13 110.986 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 94' ' ' MET . . . . . 0.637 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.8 ptt? -65.1 -39.56 93.33 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.214 -0.903 . . . . 63.24 110.864 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.33 82.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.738 0.815 . . . . 75.33 110.884 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -76.57 -33.56 58.48 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.591 0.757 . . . . 64.43 110.837 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -62.46 -63.11 1.33 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.89 0.476 . . . . 75.02 110.531 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.86 -3.43 54.08 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.102 0.408 . . . . 71.25 112.102 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.21 -1.78 56.9 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 119.648 -0.529 . . . . 63.04 113.49 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.26 0.18 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.477 0.639 . . . . 44.52 111.585 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -72.02 -55.54 7.22 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.377 0.671 . . . . 71.51 111.547 -170.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -65.43 -37.65 21.09 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 123.875 0.87 . . . . 72.21 112.583 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -49.6 -48.79 17.72 Favored 'Trans proline' 0 C--N 1.397 3.117 0 C-N-CA 122.885 2.39 . . . . 72.53 113.052 164.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -64.89 -15.89 62.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 112.52 0.563 . . . . 74.24 112.52 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -80.02 -49.86 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.92 0.488 . . . . 73.2 110.264 171.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.15 -19.52 39.8 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.396 0.678 . . . . 53.1 112.784 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' PHE . . . . . 0.41 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 84.3 t80 -66.49 -45.53 58.34 Favored Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.54 1.136 . . . . 72.33 113.423 -172.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.6 Cg_endo -57.58 -35.7 98.77 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 122.105 1.87 . . . . 64.32 113.256 176.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' TYR . . . . . 0.403 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.9 m-85 -68.05 -45.13 74.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.292 0.637 . . . . 73.05 110.418 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.57 84.47 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.925 -0.58 . . . . 71.43 110.813 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -59.84 -57.55 12.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.482 1.113 . . . . 64.35 110.254 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -31.69 71.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.697 0.799 . . . . 62.31 110.831 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.2 t -72.04 -43.56 64.77 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.931 0.492 . . . . 75.1 111.269 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 114' ' ' ILE . . . . . 0.403 HG21 HG21 ' B' ' 64' ' ' VAL . 87.4 mt -62.99 -44.74 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.347 0.659 . . . . 50.01 109.671 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -61.56 -30.83 70.91 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.995 -1.002 . . . . 75.52 111.344 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -73.58 -52.95 11.7 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.317 0.647 . . . . 73.32 110.07 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 36.4 mmt -59.31 -46.94 87.22 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.903 0.881 . . . . 75.34 111.641 -173.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.65 -34.9 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.25 110.879 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t -67.99 -30.76 70.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.357 -0.383 . . . . 74.32 110.74 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -68.76 -18.93 64.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.435 0.694 . . . . 73.13 110.823 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.1 15.71 42.42 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-O 119.533 -0.593 . . . . 74.41 112.488 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 17' ' ' TYR . 57.6 p 62.14 28.8 17.32 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.856 2.063 . . . . 70.25 112.809 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -97.16 150.93 37.36 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.817 0.447 . . . . 73.34 110.938 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.86 -165.06 0.11 Allowed 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 123.751 2.967 . . . . 72.1 113.579 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.3 tp60 -63.78 115.79 5.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.753 -0.658 . . . . 72.2 112.565 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -119.43 100.92 7.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.899 -1.148 . . . . 74.53 107.899 168.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.49 135.19 54.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 65.01 109.766 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.09 139.26 33.32 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 124.255 0.972 . . . . 72.24 110.39 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.37 147.26 52.68 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.101 0.961 . . . . 73.22 110.35 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.13 109.37 1.31 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.939 2.426 . . . . 74.4 111.489 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 56.0 t -95.24 131.5 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.896 0.879 . . . . 72.04 109.897 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -82.12 90.3 6.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.33 0.586 . . . . 60.04 109.771 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 . . . . . 0 N--CA 1.48 1.073 0 CA-C-N 114.993 -1.003 . . . . 64.32 111.363 177.106 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' C' C ' 9' ' ' MET . . . . . 0.423 ' SD ' HG23 ' C' ' 86' ' ' ILE . 48.6 ttp . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 113.039 0.755 . . . . 74.21 113.039 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 3.8 m -84.77 85.12 7.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.333 -1.358 . . . . 71.3 107.333 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -93.77 120.17 33.69 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.635 -0.712 . . . . 72.23 109.875 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -138.79 142.64 38.75 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.464 0.706 . . . . 64.32 110.144 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 13' ' ' ILE . . . . . 0.406 HG22 ' CE2' ' C' ' 84' ' ' PHE . 2.7 pp -77.96 137.79 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.945 0.778 . . . . 52.12 109.279 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 14' ' ' GLN . . . . . 0.403 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 15.3 mm100 -101.78 -51.17 3.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.802 -0.444 . . . . 63.04 109.802 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -167.86 124.77 1.12 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.092 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.73 147.14 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -175.15 160.77 2.76 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.142 0.496 . . . . 73.23 110.807 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 18' ' ' THR . . . . . 0.411 HG22 HE22 ' C' ' 80' ' ' GLN . 60.8 p -78.87 115.03 18.3 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.005 -0.998 . . . . 75.14 108.534 173.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -66.6 -43.68 84.17 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.904 0.859 . . . . 71.14 109.415 172.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.1 t70 -150.52 145.94 26.28 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.959 -1.473 . . . . 75.42 109.211 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 21' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.2 mt -140.25 141.27 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.6 -1.629 . . . . 61.24 106.6 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.3 t -153.16 150.62 29.24 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.111 0.481 . . . . 54.41 110.116 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -151.14 115.42 5.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.579 -1.267 . . . . 72.13 107.579 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -116.22 116.1 27.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.966 -1.124 . . . . 63.21 107.966 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.19 85.53 5.5 Favored Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.285 -1.376 . . . . 73.01 107.285 170.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.31 -26.11 30.0 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.635 2.223 . . . . 64.31 112.025 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.31 36.83 4.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 124.142 0.977 . . . . 54.12 109.081 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -45.31 -52.77 20.25 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 124.613 1.165 . . . . 73.53 114.012 -177.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.22 -32.81 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 121.563 1.509 . . . . 72.54 113.345 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -70.06 -27.1 64.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.887 0.875 . . . . 63.31 113.071 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.22 -15.15 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.542 0.737 . . . . 65.23 110.271 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.06 -34.9 79.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.102 0.561 . . . . 74.55 111.3 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -89.75 7.49 36.62 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.964 0.906 . . . . 62.2 111.889 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 34' ' ' LYS . . . . . 0.442 ' HD2' HD11 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -98.73 147.25 25.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 63.21 111.202 -171.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.74 131.09 44.9 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.414 1.085 . . . . 52.51 109.832 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -80.06 71.33 6.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.737 0.815 . . . . 75.24 110.786 -174.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -143.98 72.53 16.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 108.179 -1.045 . . . . 71.4 108.179 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 38' ' ' PRO . . . . . 0.613 ' HG2' HG13 ' C' ' 40' ' ' VAL . 69.4 Cg_endo -90.97 155.84 3.94 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.795 2.33 . . . . 75.22 111.18 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -87.1 81.39 8.05 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 106.893 -1.521 . . . . 71.32 106.893 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 40' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' C' ' 38' ' ' PRO . 12.6 m -68.35 123.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 CA-C-N 114.517 -1.219 . . . . 71.13 109.383 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 41' ' ' LYS . . . . . 0.422 ' HZ2' ' HB3' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -136.86 126.73 25.74 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.528 -0.916 . . . . 74.21 108.528 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.56 138.41 31.73 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.121 0.968 . . . . 74.33 108.637 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 43' ' ' ASP . . . . . 0.828 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.2 m-20 -119.01 119.1 33.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.114 0.965 . . . . 41.21 109.177 -175.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.02 125.54 52.6 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.125 -1.065 . . . . 70.52 108.125 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 45' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 7.3 t70 -137.12 142.67 42.29 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.698 0.799 . . . . 62.24 109.583 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -115.4 116.73 28.74 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.962 0.905 . . . . 62.31 110.836 -171.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.03 153.01 47.25 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.371 1.068 . . . . 72.34 110.072 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.3 p -166.13 159.05 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.985 0.514 . . . . 74.0 111.732 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -149.88 153.88 37.43 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.556 0.742 . . . . 63.42 111.08 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.2 122.75 33.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 108.991 -0.744 . . . . 73.1 108.991 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 51' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -96.58 -44.17 7.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.717 0.807 . . . . 54.1 110.205 -176.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.94 -165.31 1.71 Allowed 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.139 -0.937 . . . . 75.21 109.952 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -70.4 102.78 2.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.725 0.81 . . . . 74.03 109.601 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 71.62 -3.24 2.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.726 1.61 . . . . 42.03 113.444 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.5 t -92.09 113.48 27.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.242 -1.392 . . . . 35.11 107.242 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.34 149.17 49.36 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.074 0.95 . . . . 72.44 108.945 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 57' ' ' GLU . . . . . 0.637 ' HB2' HD11 ' C' ' 51' ' ' LEU . 45.9 tt0 -104.41 136.23 44.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.112 -0.699 . . . . 62.55 109.112 172.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.43 120.84 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.442 -1.688 . . . . 63.51 106.442 171.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.53 135.56 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.078 0.951 . . . . 33.31 109.048 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 60' ' ' LEU . . . . . 0.43 HD23 HD12 ' C' ' 106' ' ' LEU . 3.8 mm? -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.698 0.799 . . . . 73.45 109.072 172.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 61' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 17.2 ttm-85 -81.84 106.15 13.53 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.443 -0.947 . . . . 64.45 108.443 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.85 120.4 59.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.92 -1.141 . . . . 62.43 107.92 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 63' ' ' THR . . . . . 0.828 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 48.0 m -133.26 145.77 50.8 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.242 1.017 . . . . 74.2 108.405 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 64' ' ' VAL . . . . . 0.403 HG23 HD13 ' C' ' 114' ' ' ILE . 98.9 t -127.08 121.23 57.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.9 -0.778 . . . . 72.33 108.9 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -104.58 142.5 34.54 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.007 0.817 . . . . 74.43 109.514 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 100.42 4.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.137 -1.06 . . . . 63.2 108.137 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -139.23 126.59 21.51 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.888 -0.412 . . . . 71.14 109.888 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 68' ' ' LEU . . . . . 0.462 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.3 OUTLIER -100.82 60.04 0.95 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 122.172 0.987 . . . . 74.15 109.416 176.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -122.05 7.18 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 113.979 -1.464 . . . . 73.31 110.4 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -89.65 -16.96 29.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.498 0.719 . . . . 65.15 109.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -75.92 92.49 3.12 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.249 1.019 . . . . 73.11 109.091 170.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 84.9 m -83.35 121.7 27.49 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 109.036 -0.727 . . . . 73.31 109.036 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.7 -51.48 10.51 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.45 -1.25 . . . . 71.53 109.478 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -161.08 175.64 12.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.663 0.745 . . . . 62.23 110.976 168.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -145.12 144.36 30.87 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.403 -1.702 . . . . 62.13 106.403 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.3 t -146.21 112.03 5.64 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.158 -0.682 . . . . 75.05 109.158 175.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -118.38 117.39 28.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.06 0.544 . . . . 72.2 110.459 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.44 122.01 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.129 0.572 . . . . 73.25 109.554 172.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -99.68 105.04 16.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.956 -1.127 . . . . 75.23 107.956 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 80' ' ' GLN . . . . . 0.411 HE22 HG22 ' C' ' 18' ' ' THR . 8.9 tp-100 -93.2 112.96 25.05 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.516 0.727 . . . . 72.34 110.234 -176.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.58 161.57 25.06 Favored Glycine 0 C--N 1.337 0.627 0 O-C-N 123.473 0.483 . . . . 62.21 112.782 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.81 120.58 0.98 Allowed Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.253 -0.739 . . . . 73.45 111.253 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 83' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 12.6 mm -84.31 122.76 38.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.207 -1.034 . . . . 65.52 108.207 176.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 84' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' C' ' 13' ' ' ILE . 70.6 m-85 -133.49 130.59 38.75 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 72.35 109.062 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -85.96 106.58 17.24 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.892 -0.781 . . . . 70.23 108.892 171.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 86' ' ' ILE . . . . . 0.423 HG23 ' SD ' ' C' ' 9' ' ' MET . 66.7 mt -116.32 107.93 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.954 0.902 . . . . 75.03 108.987 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.15 138.32 20.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.786 0.835 . . . . 73.31 109.458 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.33 -47.74 1.0 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.641 0.588 . . . . 75.1 112.366 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.89 172.68 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.147 0.579 . . . . 64.53 111.526 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.28 151.31 17.26 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.594 0.758 . . . . 75.42 110.585 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.11 -112.62 4.47 Favored Glycine 0 C--N 1.356 1.669 0 O-C-N 123.731 0.644 . . . . 52.21 114.191 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.3 p -64.3 -35.03 79.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.982 0.913 . . . . 71.24 111.842 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -77.86 -35.69 50.69 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.914 -0.585 . . . . 74.0 111.41 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 12.6 ptt? -70.66 -23.66 62.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 110.333 -0.247 . . . . 63.54 110.333 175.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.75 92.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.762 0.425 . . . . 51.1 110.878 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 96' ' ' HIS . . . . . 0.485 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.3 t-80 -73.7 -32.45 63.93 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 116.203 -0.453 . . . . 51.21 111.305 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -81.81 -62.55 1.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.157 0.503 . . . . 65.41 110.628 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.42 -43.83 96.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.484 1.113 . . . . 70.52 111.817 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.57 5.27 82.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.295 -0.725 . . . . 72.12 114.876 -172.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 100' ' ' ALA . . . . . 0.589 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -149.39 -56.35 0.19 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.306 1.053 . . . . 64.13 112.908 -173.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 101' ' ' TYR . . . . . 0.417 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 89.3 t80 -71.13 -49.43 44.14 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.349 1.06 . . . . 75.44 111.543 -173.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.53 -44.42 65.83 Favored Pre-proline 0 CA--C 1.571 1.788 0 C-N-CA 124.144 0.977 . . . . 65.23 112.249 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.06 -40.64 67.73 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.948 2.432 . . . . 51.02 114.196 169.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -64.14 -31.64 72.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.787 0.679 . . . . 63.22 110.825 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 105' ' ' ILE . . . . . 0.436 HG23 ' NH1' ' A' ' 111' ' ' ARG . 39.9 mm -68.2 -41.55 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.82 0.448 . . . . 72.51 110.856 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 106' ' ' LEU . . . . . 0.43 HD12 HD23 ' C' ' 60' ' ' LEU . 86.4 mt -88.88 -22.22 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.701 0.8 . . . . 54.41 113.014 -172.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -56.36 -48.54 96.79 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 113.947 1.092 . . . . 52.44 113.947 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.8 -33.27 76.6 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 121.912 1.741 . . . . 60.13 113.64 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -48.04 69.4 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.432 0.693 . . . . 73.34 110.359 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.36 81.25 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.948 -1.023 . . . . 71.05 110.597 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.48 -52.47 64.6 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.938 -1.483 . . . . 75.45 112.003 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -33.27 73.91 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.607 0.363 . . . . 71.44 110.568 -173.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.46 -29.44 66.0 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 122.999 0.519 . . . . 75.43 110.839 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 114' ' ' ILE . . . . . 0.403 HD13 HG23 ' C' ' 64' ' ' VAL . 73.3 mt -72.04 -44.16 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.599 0.76 . . . . 74.24 109.768 170.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -64.34 -30.13 71.18 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.47 0.708 . . . . 72.21 111.174 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.9 t -71.76 -49.57 37.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.824 0.85 . . . . 74.1 109.002 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 117' ' ' MET . . . . . 0.528 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.0 -39.88 94.12 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.097 0.959 . . . . 74.05 113.041 -175.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.7 -34.78 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 109.944 -0.391 . . . . 60.41 109.944 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -72.71 -32.07 65.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.559 0.744 . . . . 60.54 111.587 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -68.16 -26.76 65.92 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.21 0.604 . . . . 60.12 110.42 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 11.52 68.35 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 119.246 -0.752 . . . . 74.03 113.271 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 122' ' ' THR . . . . . 0.495 HG23 ' HB3' ' D' ' 17' ' ' TYR . 52.7 p 58.76 26.86 15.21 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.91 1.684 . . . . 71.51 112.82 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -102.05 151.64 38.07 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.706 0.802 . . . . 75.31 109.922 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 124' ' ' PRO . . . . . 0.413 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 35.3 Cg_exo -59.87 121.55 10.01 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.016 2.477 . . . . 71.53 113.108 -171.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -60.33 146.37 44.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.111 0.882 . . . . 73.43 112.496 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -141.66 127.58 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 108.316 -0.994 . . . . 65.34 108.316 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.13 114.88 25.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.587 -1.264 . . . . 70.24 107.587 172.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 29.9 tp -64.86 129.01 38.14 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.86 0.725 . . . . 60.21 110.532 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -68.2 151.09 97.46 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.98 1.312 . . . . 74.11 112.039 -171.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 130' ' ' PRO . . . . . 0.474 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.1 Cg_exo -64.02 109.88 1.21 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.979 2.453 . . . . 60.05 112.28 -177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 61.3 t -97.16 108.67 21.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.619 -1.252 . . . . 42.24 107.619 175.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -82.23 101.39 10.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.557 -0.747 . . . . 75.14 110.239 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -80.02 -38.46 31.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.332 -0.988 . . . . 73.42 108.332 168.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' C' C ' 134' ' ' ASP . . . . . 0.589 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.1 p-10 . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 126.118 1.767 . . . . 52.15 112.856 -178.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.7 m . . . . . 0 C--O 1.245 0.863 0 CA-C-O 121.301 0.572 . . . . 72.1 109.611 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -143.87 112.11 6.34 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.233 -1.025 . . . . 54.41 108.233 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 12' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 71.3 mt-30 -131.59 154.54 48.76 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.467 -0.938 . . . . 75.32 108.467 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 13' ' ' ILE . . . . . 0.44 HD11 HG21 ' D' ' 105' ' ' ILE . 35.6 mt -104.02 132.94 49.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.913 -1.143 . . . . 53.13 107.913 168.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.36 -48.14 8.23 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.627 -0.509 . . . . 71.03 109.627 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -155.64 148.29 24.08 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.32 0.648 . . . . 70.15 109.873 -176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 16' ' ' ILE . . . . . 0.463 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -124.05 111.21 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.345 -1.354 . . . . 71.21 107.345 168.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HB3' HG23 ' C' ' 122' ' ' THR . 31.8 p90 -140.56 170.2 16.23 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.82 0.819 . . . . 73.51 111.764 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.4 p -101.2 121.31 41.61 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.556 -1.202 . . . . 65.03 108.883 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 19' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -88.23 -30.62 19.56 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.984 0.513 . . . . 73.43 110.346 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.6 t70 -152.86 127.02 9.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.142 -0.935 . . . . 73.22 108.573 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 21' ' ' ILE . . . . . 0.528 HG21 ' HE2' ' C' ' 117' ' ' MET . 82.7 mt -123.93 144.07 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.335 -1.357 . . . . 72.03 107.335 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -152.49 110.67 3.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 124.188 0.93 . . . . 62.21 109.494 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 23' ' ' PHE . . . . . 0.436 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 75.1 t80 -108.39 128.75 55.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.109 -1.812 . . . . 63.32 106.109 162.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -123.86 151.01 43.91 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.851 -0.796 . . . . 75.03 108.851 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 25' ' ' ALA . . . . . 0.778 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -132.82 76.59 70.55 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 106.616 -1.624 . . . . 74.21 106.616 170.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.5 -45.23 31.47 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.561 2.841 . . . . 71.43 113.113 -166.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 27' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' D' ' 31' ' ' VAL . 20.3 m-80 -114.59 25.99 10.57 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.232 -0.895 . . . . 63.42 110.101 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 28' ' ' ALA . . . . . 0.778 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -39.01 -60.02 1.27 Allowed Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 115.798 1.777 . . . . 63.11 115.798 -163.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 29' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 31.3 Cg_endo -81.94 -14.47 9.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 CA-C-N 122.282 1.851 . . . . 74.44 113.542 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.02 -38.77 69.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.36 1.064 . . . . 74.33 109.301 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 31' ' ' VAL . . . . . 0.607 HG13 HD11 ' D' ' 68' ' ' LEU . 52.8 t -63.35 -39.04 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.914 0.886 . . . . 61.42 109.991 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 32' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.9 m-30 -60.12 -9.22 2.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.378 1.251 . . . . 74.05 114.378 -173.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -77.77 -37.67 48.44 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.974 0.51 . . . . 75.34 111.108 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -132.8 62.83 1.65 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.847 0.859 . . . . 75.3 109.979 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 35' ' ' ASP . . . . . 0.401 ' HB2' ' HA ' ' D' ' 32' ' ' PHE . 42.5 t0 -107.79 83.28 1.77 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.847 0.832 . . . . 65.31 110.706 -169.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -126.5 -178.53 4.39 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.713 -1.131 . . . . 71.44 108.062 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pm0 -48.56 100.59 0.24 Allowed Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 123.571 0.749 . . . . 60.23 112.728 -162.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 38' ' ' PRO . . . . . 0.475 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 59.9 Cg_endo -71.62 149.09 54.65 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.601 2.201 . . . . 62.13 111.107 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.63 111.45 4.79 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.873 -1.158 . . . . 73.42 107.873 173.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 2.8 m -103.54 106.27 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.919 0.888 . . . . 74.22 109.164 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -100.95 129.98 46.88 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.069 0.948 . . . . 63.23 109.952 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 tp -97.09 119.53 35.76 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.05 -0.722 . . . . 55.45 109.05 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 43' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.2 m-20 -120.32 130.82 54.61 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.782 0.833 . . . . 75.0 109.15 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.02 137.42 47.81 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.831 0.853 . . . . 54.13 109.155 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 45' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 6.3 t70 -135.83 132.27 36.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 44.4 p -104.94 143.61 32.93 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.717 0.807 . . . . 62.32 109.773 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 47' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.18 155.47 36.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.892 0.877 . . . . 71.03 110.025 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 28.6 p -158.99 162.8 36.82 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.219 0.533 . . . . 65.0 111.228 178.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -150.01 150.02 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.649 -1.16 . . . . 74.4 109.462 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -100.71 122.52 43.49 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.335 -1.358 . . . . 74.42 107.335 159.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 51' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.0 mt -96.3 -26.36 15.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.453 0.701 . . . . 52.11 109.38 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.33 173.46 5.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.758 1.223 . . . . 52.23 109.532 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.93 131.47 46.33 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.623 -0.88 . . . . 71.53 108.623 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 70.15 -2.05 2.23 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.112 1.365 . . . . 61.11 113.086 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.65 116.34 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.35 0.66 . . . . 72.04 109.29 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.01 162.13 31.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.979 -0.749 . . . . 72.51 108.979 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 57' ' ' GLU . . . . . 0.494 ' HB2' HD11 ' D' ' 51' ' ' LEU . 28.4 tt0 -130.42 118.31 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.084 0.954 . . . . 74.11 108.604 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 77.3 t -100.48 113.31 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.387 -1.338 . . . . 64.31 107.387 175.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.9 t -107.01 127.72 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.997 -1.112 . . . . 73.25 107.997 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HB3' HD22 ' D' ' 106' ' ' LEU . 0.9 OUTLIER -128.94 112.65 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.762 -1.199 . . . . 63.0 107.762 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 61' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.3 ttm180 -85.18 118.4 24.71 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.733 0.813 . . . . 75.41 109.459 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.59 122.0 62.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.943 -1.132 . . . . 74.1 107.943 170.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 63' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.4 m -119.36 137.27 53.83 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.561 0.745 . . . . 65.11 109.92 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 71.5 t -128.24 103.73 10.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 C-N-CA 125.146 1.378 . . . . 70.53 107.729 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.2 m -101.91 105.24 16.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.515 0.726 . . . . 61.25 109.454 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 66' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -99.28 128.5 45.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.276 0.63 . . . . 74.05 110.633 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -144.81 126.06 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.174 0.589 . . . . 65.41 110.443 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 68' ' ' LEU . . . . . 0.607 HD11 HG13 ' D' ' 31' ' ' VAL . 3.4 pp -124.96 139.81 53.49 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.723 0.809 . . . . 63.42 111.187 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.57 -111.47 3.34 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 110.479 -1.049 . . . . 32.21 110.479 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 3.35 8.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 75.02 110.446 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.78 167.76 14.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.109 0.564 . . . . 53.55 110.082 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.0 m -84.65 126.47 33.39 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.492 -0.777 . . . . 54.53 110.593 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 73' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -69.7 -64.95 0.78 Allowed 'General case' 0 C--O 1.242 0.668 0 O-C-N 124.259 0.974 . . . . 55.11 109.299 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.1 162.2 39.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.559 -1.201 . . . . 74.31 110.432 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -124.12 141.42 52.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.898 1.279 . . . . 72.03 108.012 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 76' ' ' CYS . . . . . 0.605 ' SG ' HG23 ' D' ' 114' ' ' ILE . 21.8 t -152.27 109.5 3.55 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.652 -0.499 . . . . 72.14 109.652 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 77' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' D' ' 63' ' ' THR . 38.7 tt0 -140.41 130.65 25.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.404 1.082 . . . . 74.53 108.848 -171.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.68 116.36 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.428 0.691 . . . . 73.53 109.788 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -88.04 83.93 6.99 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.851 -1.166 . . . . 74.15 107.851 166.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 80' ' ' GLN . . . . . 0.483 ' HB3' HD21 ' D' ' 106' ' ' LEU . 4.4 tp-100 -79.84 114.82 19.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.44 -1.318 . . . . 71.15 107.44 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -109.16 142.03 16.11 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.194 -0.762 . . . . 61.23 111.194 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.9 5.92 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.058 -0.817 . . . . 65.33 111.058 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.31 126.06 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.062 -1.088 . . . . 72.32 108.062 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -123.65 127.96 48.97 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.593 1.157 . . . . 75.11 109.229 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 85' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 43.8 m -78.63 101.16 7.32 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.301 -1.0 . . . . 72.04 108.301 169.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 86' ' ' ILE . . . . . 0.442 HG23 HD11 ' D' ' 89' ' ' ILE . 61.4 mt -108.59 128.99 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.914 0.886 . . . . 63.13 109.725 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.24 159.15 25.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.973 0.909 . . . . 72.22 110.328 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.79 14.96 78.79 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 115.011 0.765 . . . . 71.35 115.011 169.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 89' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' D' ' 94' ' ' MET . 18.3 pt -136.67 134.93 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.355 -0.979 . . . . 52.12 108.355 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.98 157.66 45.93 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.949 -0.47 . . . . 73.51 111.202 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -118.51 14.5 Favored Glycine 0 C--N 1.355 1.605 0 O-C-N 124.658 1.224 . . . . 74.43 113.565 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 17.4 m -69.6 -31.36 69.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.738 0.815 . . . . 75.23 111.985 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -72.99 -42.33 63.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.828 0.451 . . . . 65.43 110.871 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 94' ' ' MET . . . . . 0.469 ' HA ' HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -72.04 -34.37 68.73 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.234 -0.284 . . . . 62.45 110.234 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.84 92.54 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.782 0.833 . . . . 54.22 110.893 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -67.7 -36.42 80.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 72.53 110.953 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.8 -51.41 34.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.582 0.353 . . . . 70.43 110.85 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.19 -20.48 44.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.649 0.379 . . . . 71.04 111.652 -177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.39 -2.98 55.59 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.608 -0.551 . . . . 63.21 114.007 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.82 -64.48 0.41 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.69 0.745 . . . . 65.41 111.251 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -64.23 -56.11 16.92 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.812 0.671 . . . . 72.52 112.812 -170.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.3 m -60.2 -45.41 97.76 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.31 1.044 . . . . 73.45 112.417 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.76 -40.2 80.91 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 122.65 2.234 . . . . 71.34 113.254 168.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.33 -22.81 57.35 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.465 0.706 . . . . 71.1 112.406 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 105' ' ' ILE . . . . . 0.44 HG21 HD11 ' D' ' 13' ' ' ILE . 29.0 mm -71.74 -42.77 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 122.302 1.048 . . . . 74.35 109.166 169.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 106' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' D' ' 80' ' ' GLN . 8.6 tt -76.55 -27.82 56.06 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 113.562 -1.653 . . . . 72.42 111.171 -173.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.91 -40.83 72.52 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 125.254 1.422 . . . . 61.41 113.905 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.38 -34.42 88.87 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.477 2.118 . . . . 41.05 114.272 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -79.55 -30.9 41.88 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.185 0.594 . . . . 72.52 111.055 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.35 79.14 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.363 -0.606 . . . . 74.13 109.363 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 111' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 25.2 ttp180 -54.52 -55.41 29.42 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.098 -1.41 . . . . 71.44 111.158 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -60.16 -43.93 95.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.027 0.829 . . . . 71.04 111.177 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -63.26 -45.44 91.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.804 0.442 . . . . 74.21 111.318 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 114' ' ' ILE . . . . . 0.605 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.2 mt -58.06 -59.39 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.877 0.871 . . . . 55.1 110.555 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 94.9 m -51.64 -43.57 62.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.569 1.548 . . . . 64.31 112.426 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.2 t -68.9 -39.33 79.79 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.204 -0.907 . . . . 74.33 110.741 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 117' ' ' MET . . . . . 0.422 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.8 mtm -71.33 -32.33 68.44 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.0 0.52 . . . . 60.41 111.721 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -63.65 -44.98 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 O-C-N 123.683 0.614 . . . . 74.12 109.432 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -73.02 -27.84 62.0 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.171 0.588 . . . . 44.42 111.808 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -73.4 -31.4 63.85 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.6 0.76 . . . . 74.21 110.499 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.94 5.44 75.85 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.599 0.562 . . . . 61.33 111.933 171.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p 61.5 14.67 6.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.128 2.171 . . . . 75.21 113.333 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -80.01 158.81 72.04 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.483 1.113 . . . . 72.43 108.585 169.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -67.42 124.5 12.13 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.746 2.297 . . . . 75.2 111.419 -168.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -53.3 116.8 2.61 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.298 0.999 . . . . 63.02 110.282 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -109.13 131.45 55.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.831 -1.174 . . . . 74.11 107.831 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -107.34 98.2 7.86 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.37 -0.974 . . . . 71.12 108.37 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 128' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 65.3 tp -56.73 115.7 2.71 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.874 1.27 . . . . 73.14 111.053 -176.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.13 95.85 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.933 0.893 . . . . 44.43 110.895 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.26 139.05 25.87 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.104 1.869 . . . . 62.24 111.719 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.48 111.27 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.727 -0.842 . . . . 74.31 108.727 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.41 81.39 4.76 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.402 -0.962 . . . . 72.33 108.402 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 31.2 t80 . . . . . 0 C--O 1.241 0.63 0 CA-C-N 114.862 -1.063 . . . . 75.41 111.44 -173.022 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.475 0.793 0 N-CA-C 109.774 -0.454 . . . . 74.32 109.774 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.1 t -162.73 50.05 0.17 Allowed 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.965 -0.754 . . . . 74.42 108.965 -177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -57.88 -38.87 76.53 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.084 0.954 . . . . 71.34 111.23 -173.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 6' ' ' ASN . 0.1 OUTLIER 55.5 63.07 2.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.546 1.138 . . . . 54.51 110.481 165.283 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -80.13 80.23 6.58 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.545 0.688 . . . . 73.24 109.894 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.41 ' HB2' ' OE1' ' A' ' 4' ' ' GLN . 34.5 t-20 -97.53 162.04 13.49 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 114.842 -1.072 . . . . 73.53 108.282 173.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 37.2 p -72.93 8.31 1.61 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 123.976 0.91 . . . . 74.45 112.277 174.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -66.69 -175.21 0.37 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 124.14 0.976 . . . . 71.13 110.29 163.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 62.9 mtm 72.95 145.3 0.07 Allowed 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 124.531 1.132 . . . . 70.12 111.56 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 56.3 m -142.47 142.33 32.29 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.675 0.79 . . . . 73.32 109.098 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.523 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 20.6 t80 -138.47 132.28 31.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.199 1.0 . . . . 72.51 109.76 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tp60 -153.56 109.11 3.23 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.153 0.581 . . . . 71.41 109.764 176.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.598 HG12 ' HD2' ' A' ' 84' ' ' PHE . 45.5 mt -75.06 122.92 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 N-CA-C 109.294 -0.632 . . . . 73.13 109.294 177.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -93.57 -35.34 12.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 123.598 0.561 . . . . 70.4 110.677 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.6 ttt180 -169.23 140.29 2.35 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 116.658 -0.246 . . . . 63.25 110.356 -170.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.63 HD12 ' HG3' ' C' ' 130' ' ' PRO . 0.2 OUTLIER -125.95 141.54 45.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 N-CA-C 108.175 -1.046 . . . . 75.22 108.175 173.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 28.6 p90 -174.16 155.7 2.49 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.926 0.49 . . . . 73.13 111.365 -173.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -78.36 121.29 24.29 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.808 -0.633 . . . . 72.51 109.569 171.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.417 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.5 mtpt -87.02 -25.2 24.35 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 122.625 0.37 . . . . 73.23 110.187 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 30.2 t70 -151.27 139.31 20.07 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.462 -0.79 . . . . 75.21 109.623 176.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.437 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 83.3 mt -131.38 139.47 50.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 106.77 -1.567 . . . . 75.41 106.77 176.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -147.59 127.4 13.48 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 108.235 -1.024 . . . . 65.5 108.235 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.558 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.2 t80 -135.63 113.12 10.73 Favored 'General case' 0 C--O 1.218 -0.586 0 N-CA-C 107.227 -1.397 . . . . 64.0 107.227 174.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -118.82 130.03 55.55 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 108.797 -0.816 . . . . 63.03 108.797 177.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -121.1 78.52 33.38 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 107.222 -1.399 . . . . 62.23 107.222 174.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.05 -46.77 23.56 Favored 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 123.641 2.894 . . . . 62.31 113.272 -164.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -120.16 41.68 3.14 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.759 -0.83 . . . . 74.03 108.759 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.495 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -45.65 -53.5 19.41 Favored Pre-proline 0 CA--C 1.561 1.379 0 O-C-N 124.199 0.937 . . . . 61.44 112.322 175.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -63.96 -23.84 67.71 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 121.951 1.767 . . . . 72.41 113.173 -177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 24.8 m-70 -95.35 -21.95 18.06 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.728 0.811 . . . . 65.41 111.342 -174.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.624 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.2 t -80.79 -32.55 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.002 0.921 . . . . 63.54 112.424 -173.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -74.08 -1.47 20.27 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.453 0.701 . . . . 74.51 112.863 -177.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -105.71 -11.3 16.35 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.003 0.921 . . . . 64.12 112.236 170.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -80.17 170.96 15.71 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 113.567 0.951 . . . . 73.44 113.567 -171.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.427 ' O ' HD23 ' A' ' 68' ' ' LEU . 1.9 m-20 -61.01 134.36 57.02 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.766 1.226 . . . . 65.23 110.013 174.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 36.1 m95 -85.44 62.29 7.39 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.667 0.787 . . . . 73.34 111.604 -169.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -146.59 76.73 11.73 Favored Pre-proline 0 CA--C 1.557 1.215 0 C-N-CA 124.153 0.981 . . . . 73.11 109.906 175.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.501 ' HD2' ' HB1' ' E' ' 295' ' ' ALA . 59.4 Cg_endo -75.88 149.14 32.85 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.525 2.15 . . . . 73.03 112.428 163.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -97.49 102.12 13.81 Favored 'General case' 0 C--O 1.24 0.565 0 N-CA-C 107.707 -1.219 . . . . 75.42 107.707 172.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 t -84.92 95.44 4.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 N-CA-C 109.746 -0.464 . . . . 72.41 109.746 -175.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.3 tttm -85.32 119.74 26.03 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.087 -0.961 . . . . 70.41 109.605 175.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.483 HD22 ' HB2' ' E' ' 290' ' ' TRP . 2.1 pt? -97.58 146.18 25.54 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-O 121.382 0.61 . . . . 72.41 109.423 177.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.676 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 6.9 m-20 -136.84 146.8 46.05 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.41 1.084 . . . . 73.51 108.531 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 tt -141.32 125.34 17.22 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 107.715 -1.217 . . . . 70.21 107.715 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.632 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.9 m-20 -116.32 131.95 56.8 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.102 -1.073 . . . . 71.42 108.102 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.6 p -106.06 125.02 50.49 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.812 -1.085 . . . . 61.13 109.085 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.05 126.05 9.82 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.257 0.623 . . . . 74.34 109.352 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 8.7 p -110.57 162.67 14.48 Favored 'General case' 0 C--O 1.242 0.667 0 C-N-CA 123.638 0.775 . . . . 73.34 109.21 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 44.4 t -148.44 153.61 38.75 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.502 0.721 . . . . 44.02 109.665 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.532 ' HB2' ' HE3' ' E' ' 275' ' ' LYS . 45.4 tt0 -104.96 116.44 31.96 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 108.151 -1.055 . . . . 72.14 108.151 172.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 71.5 mt -96.36 -35.78 11.09 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-O 121.07 0.462 . . . . 65.34 109.96 175.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -153.87 -179.03 7.47 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 115.164 -0.925 . . . . 73.0 109.653 177.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.29 121.94 16.37 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 108.585 -0.895 . . . . 71.42 108.585 172.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 67.3 8.22 6.08 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.57 1.148 . . . . 53.1 112.515 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 67.8 t -113.51 106.2 20.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.804 0 N-CA-C 107.929 -1.137 . . . . 72.05 107.929 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 54.7 m-85 -117.98 125.27 50.08 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.772 -1.104 . . . . 71.12 108.593 -176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 34.9 tt0 -91.98 148.95 21.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.346 -0.843 . . . . 52.22 109.315 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.587 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 41.2 t -127.13 130.11 71.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.58 -1.267 . . . . 74.13 107.58 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.6 t -125.55 131.1 72.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.661 0 N-CA-C 108.432 -0.951 . . . . 75.1 108.432 178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.494 HD21 ' HA ' ' A' ' 103' ' ' PRO . 2.7 mm? -119.52 114.9 22.97 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.842 -1.17 . . . . 73.4 107.842 176.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.632 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 21.5 ttp180 -85.18 100.35 11.69 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.665 -1.235 . . . . 75.11 107.665 172.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 t -93.99 110.1 23.01 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 N-CA-C 107.522 -1.288 . . . . 44.41 107.522 174.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.676 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.1 m -109.12 126.91 53.7 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.962 -0.755 . . . . 72.54 108.962 -178.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.469 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 80.6 t -116.03 124.17 72.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 106.906 -1.516 . . . . 63.01 106.906 179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 2.6 m -127.16 129.65 48.29 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.351 -0.611 . . . . 42.44 109.351 -178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.65 124.16 37.29 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 108.814 -0.81 . . . . 72.22 108.814 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 57.9 m -134.03 127.42 32.23 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.298 0.639 . . . . 54.22 109.938 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD23 ' O ' ' A' ' 35' ' ' ASP . 5.2 mp -87.4 80.66 8.08 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.559 -1.275 . . . . 70.04 107.559 -178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.44 -83.49 1.32 Allowed Glycine 0 C--N 1.349 1.272 0 CA-C-N 114.232 -1.349 . . . . 35.22 111.286 -175.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -114.34 -21.73 10.26 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.211 1.004 . . . . 72.43 111.586 -175.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -110.73 119.32 38.75 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.53 0.332 . . . . 73.23 111.207 -168.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.465 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 25.0 m -70.47 133.24 46.64 Favored 'General case' 0 CA--C 1.548 0.882 0 N-CA-C 112.75 0.648 . . . . 63.43 112.75 -178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.624 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.12 -63.62 1.36 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 124.885 1.274 . . . . 54.31 109.99 174.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -153.35 168.82 24.78 Favored 'General case' 0 C--O 1.246 0.871 0 CA-C-N 114.694 -1.139 . . . . 73.31 110.931 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 64.2 tp -143.89 107.29 4.58 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 113.599 -1.637 . . . . 62.42 107.352 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.469 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.9 m -105.8 97.91 7.67 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.102 0.561 . . . . 64.03 110.525 177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -111.99 115.48 29.0 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 123.859 0.863 . . . . 73.41 108.796 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 58.5 t -130.83 109.89 17.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.656 0.783 . . . . 71.12 109.317 -173.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.429 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 44.0 mt-30 -85.38 86.44 7.37 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.753 -0.832 . . . . 74.02 108.753 173.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -78.49 104.6 9.19 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.806 -1.088 . . . . 72.44 108.876 178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.73 160.11 28.6 Favored Glycine 0 C--N 1.339 0.742 0 CA-C-N 115.797 -0.638 . . . . 62.22 112.106 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.02 123.33 1.23 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 111.115 -0.794 . . . . 45.43 111.115 178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.7 mt -82.33 123.54 38.37 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 C-N-CA 123.364 0.666 . . . . 70.23 109.463 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.598 ' HD2' HG12 ' A' ' 13' ' ' ILE . 33.7 m-85 -134.44 118.89 17.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.445 -0.946 . . . . 61.22 108.445 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.9 t -83.48 100.69 10.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.77 -0.826 . . . . 72.41 108.77 174.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 37.7 pt -117.39 140.53 39.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 C-N-CA 123.328 0.651 . . . . 51.01 110.697 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -149.16 165.87 30.51 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.461 1.104 . . . . 63.22 109.534 175.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 77.96 9.89 86.61 Favored Glycine 0 C--N 1.35 1.32 0 N-CA-C 114.086 0.395 . . . . 64.44 114.086 176.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.567 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -110.1 134.08 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 123.236 0.615 . . . . 51.42 109.522 -172.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -146.56 171.68 14.72 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 124.581 1.152 . . . . 74.34 108.6 176.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.44 -129.02 24.53 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 115.404 0.922 . . . . 43.34 115.404 174.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.585 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.44 -15.18 59.98 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.454 0.702 . . . . 72.24 111.922 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -67.64 -45.21 76.02 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 109.618 -0.512 . . . . 71.43 109.618 177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -27.96 49.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.683 0.393 . . . . 45.11 110.625 176.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.585 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.65 -32.01 71.55 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.293 0.637 . . . . 63.22 111.718 177.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -87.31 -33.91 19.05 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.206 0.603 . . . . 61.43 110.209 176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -61.65 -45.91 92.01 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 122.95 0.5 . . . . 70.44 110.355 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.0 mt -89.02 -30.21 18.9 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 115.487 -0.779 . . . . 53.42 111.176 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.65 -3.27 81.0 Favored Glycine 0 N--CA 1.481 1.677 0 N-CA-C 114.846 0.698 . . . . 64.02 114.846 -174.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.96 -60.38 0.23 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.937 0.868 . . . . 71.34 112.208 -175.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.484 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 71.0 t80 -68.89 -70.68 0.26 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 113.101 0.778 . . . . 74.13 113.101 -168.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.457 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 79.3 m -63.71 -33.11 9.17 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 114.889 1.44 . . . . 64.33 114.889 -174.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.494 ' HA ' HD21 ' A' ' 60' ' ' LEU . 30.0 Cg_endo -62.64 -33.46 77.39 Favored 'Trans proline' 0 C--N 1.383 2.363 0 C-N-CA 121.768 1.645 . . . . 50.25 112.98 168.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -74.54 -15.92 60.84 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.185 0.594 . . . . 73.43 111.097 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 37.2 mm -67.72 -40.97 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 CA-C-O 121.46 0.648 . . . . 54.14 109.527 170.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 96.0 mt -89.97 -17.89 27.07 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.15 -0.932 . . . . 73.5 112.346 -174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -59.32 -45.37 99.09 Favored Pre-proline 0 CA--C 1.564 1.506 0 CA-C-O 118.243 -0.884 . . . . 72.43 113.156 -178.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -62.99 -31.25 76.94 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 122.202 1.934 . . . . 73.32 113.509 174.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -76.64 -36.48 57.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.365 0.666 . . . . 72.23 111.911 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.55 -42.77 77.91 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 109.133 -0.692 . . . . 63.15 109.133 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.548 HH12 HD12 ' C' ' 105' ' ' ILE . 31.6 ttm180 -52.62 -52.01 57.43 Favored 'General case' 0 N--CA 1.478 0.955 0 O-C-N 124.742 1.276 . . . . 72.15 109.932 175.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.81 -48.68 78.05 Favored 'General case' 0 N--CA 1.475 0.812 0 O-C-N 124.394 1.059 . . . . 75.15 110.601 -177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.436 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 49.2 t -57.59 -43.22 84.46 Favored 'General case' 0 N--CA 1.482 1.137 0 O-C-N 123.77 0.669 . . . . 70.43 111.252 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' VAL . 76.9 mt -62.78 -56.9 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 CA-C-N 115.164 -0.925 . . . . 74.5 109.785 176.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.427 HG21 ' HE2' ' C' ' 109' ' ' TYR . 89.7 m -50.55 -43.72 56.29 Favored 'General case' 0 C--O 1.244 0.77 0 O-C-N 124.595 1.184 . . . . 64.11 111.667 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.7 t -62.72 -48.4 79.38 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.539 -1.209 . . . . 65.03 109.945 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.433 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 36.6 mtm -64.4 -40.41 95.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 123.163 0.585 . . . . 62.11 111.296 -178.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 114' ' ' ILE . 91.5 t -56.46 -48.18 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 O-C-N 123.906 0.754 . . . . 64.2 109.807 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 44.3 t -73.38 -26.87 61.18 Favored 'General case' 0 CA--C 1.556 1.211 0 CA-C-N 114.955 -1.02 . . . . 73.13 111.438 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -73.06 -27.93 62.02 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.619 0.768 . . . . 73.12 110.59 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.86 3.6 74.62 Favored Glycine 0 C--N 1.354 1.576 0 O-C-N 123.779 0.674 . . . . 44.44 112.896 174.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 4.3 m 62.1 44.16 8.18 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 125.077 1.351 . . . . 70.11 110.272 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.7 t80 -116.97 145.42 35.56 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.201 -1.363 . . . . 75.02 108.068 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -36.54 131.82 0.39 Allowed 'Trans proline' 0 C--N 1.389 2.705 0 C-N-CA 124.196 3.264 . . . . 61.21 114.263 171.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -58.95 133.6 56.21 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 124.033 0.833 . . . . 71.13 110.969 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.511 HD11 ' HH2' ' E' ' 290' ' ' TRP . 50.9 tp -110.06 110.67 21.65 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 109.254 -0.647 . . . . 74.35 109.254 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -99.57 108.69 21.16 Favored 'General case' 0 C--O 1.239 0.545 0 N-CA-C 107.284 -1.376 . . . . 75.54 107.284 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -65.31 117.43 7.85 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 108.647 -0.871 . . . . 72.53 108.647 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -67.85 145.95 98.14 Favored Pre-proline 0 CA--C 1.549 0.934 0 C-N-CA 123.314 0.646 . . . . 71.35 111.08 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.425 ' HB3' ' OH ' ' C' ' 101' ' ' TYR . 76.4 Cg_exo -54.78 109.42 0.4 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.119 2.546 . . . . 63.23 113.484 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.44 HG11 HG13 ' E' ' 288' ' ' VAL . 57.4 t -101.95 112.8 36.35 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 107.035 -1.469 . . . . 74.12 107.035 168.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 43.3 t30 -81.39 95.03 6.91 Favored 'General case' 0 C--O 1.241 0.606 0 N-CA-C 108.768 -0.827 . . . . 72.33 108.768 178.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -57.8 -32.48 67.6 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 114.735 -1.121 . . . . 62.31 111.45 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -57.69 -52.6 64.76 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 124.309 1.005 . . . . 65.25 110.741 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -62.1 -54.64 38.42 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 124.118 0.886 . . . . 74.23 111.339 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.5 mp -61.56 -32.65 72.73 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.645 0.378 . . . . 75.35 111.357 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -71.32 -36.44 71.6 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.277 0.631 . . . . 64.51 109.828 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -65.38 -38.56 90.4 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.389 0.676 . . . . 72.11 110.887 176.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -55.82 -30.41 61.36 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.105 0.562 . . . . 72.22 110.43 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -85.27 -52.48 5.87 Favored 'General case' 0 CA--C 1.55 0.952 0 CA-C-N 115.03 -0.987 . . . . 75.12 110.923 174.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 39.9 tp -68.53 -51.02 47.61 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.521 0.934 . . . . 74.22 113.521 -162.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -151.81 -4.16 0.27 Allowed 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 112.095 0.405 . . . . 72.12 112.095 -169.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 69.63 123.3 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 124.556 1.143 . . . . 72.21 111.357 176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 7.4 tp60 -137.98 104.75 5.34 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.173 0.589 . . . . 72.24 110.452 -172.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.641 ' HB1' ' HB2' ' C' ' 5' ' ' ASN . . . -177.35 144.89 0.42 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.908 1.283 . . . . 75.12 109.416 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 141.6 131.75 2.69 Favored Glycine 0 C--N 1.352 1.429 0 CA-C-O 119.785 -0.453 . . . . 71.53 112.808 170.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -147.34 146.28 29.62 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.201 1.0 . . . . 54.03 110.497 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -95.25 57.38 1.72 Allowed Glycine 0 C--N 1.352 1.464 0 O-C-N 123.534 0.521 . . . . 52.03 112.939 -177.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 42.9 p -95.53 109.54 21.75 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 123.305 0.642 . . . . 65.54 109.891 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -153.91 -49.52 0.09 Allowed 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 111.768 0.285 . . . . 71.55 111.768 -174.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -80.74 145.15 31.67 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.904 0.881 . . . . 63.35 110.905 -175.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 24.3 m-70 -128.18 155.88 43.79 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.324 1.049 . . . . 55.51 108.93 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.85 105.36 0.45 Allowed 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.56 0.744 . . . . 71.44 109.505 173.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -108.02 154.88 21.02 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.837 0.855 . . . . 70.41 109.753 175.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 C-N-CA 123.678 0.791 . . . . 72.05 108.955 -179.948 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 79.6 mtp . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.472 -0.566 . . . . 75.4 109.472 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 74.5 m 62.65 43.61 7.35 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.247 1.019 . . . . 65.53 111.37 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 26.5 mm-40 -62.79 95.21 0.07 Allowed 'General case' 0 C--N 1.357 0.894 0 N-CA-C 109.612 -0.514 . . . . 45.32 109.612 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -71.59 91.29 1.07 Allowed 'General case' 0 C--N 1.348 0.534 0 CA-C-N 115.267 -0.879 . . . . 73.01 109.666 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -83.55 152.89 24.65 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 114.897 -1.047 . . . . 73.34 109.588 175.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -63.57 -37.15 86.23 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.438 0.695 . . . . 43.11 110.165 176.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 16.3 m -93.34 102.47 14.73 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.033 -0.985 . . . . 73.12 108.868 174.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.46 100.33 2.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 107.262 -1.384 . . . . 71.43 107.262 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 19.5 ptm 51.77 169.7 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 126.984 2.114 . . . . 64.25 114.378 -173.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 61.8 m -154.5 140.31 18.13 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.047 -1.464 . . . . 74.14 107.047 176.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.568 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 77.2 t80 -140.88 132.34 26.88 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.01 -0.737 . . . . 71.22 109.01 176.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.468 HE21 ' HB2' ' B' ' 85' ' ' SER . 8.6 tt0 -144.07 131.61 21.09 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.306 -0.998 . . . . 72.13 108.306 171.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 13.3 tt -82.02 126.73 39.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 N-CA-C 109.044 -0.724 . . . . 74.3 109.044 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -108.12 -42.44 4.65 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.25 0.62 . . . . 71.2 110.521 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 51.3 ttt85 -165.01 151.02 10.0 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 120.466 0.174 . . . . 75.31 110.764 -176.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 85.6 mt -134.71 135.16 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.244 -1.762 . . . . 63.35 106.244 169.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.446 ' HE1' HG13 ' B' ' 83' ' ' ILE . 7.3 p90 -168.24 146.29 4.29 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.166 0.586 . . . . 75.23 109.962 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 95.5 m -76.97 122.55 25.05 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 115.511 -0.768 . . . . 53.24 108.982 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -98.08 -27.22 14.31 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.223 0.609 . . . . 72.23 111.379 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.7 t70 -158.35 139.69 13.39 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.527 0.517 . . . . 72.41 111.261 -172.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 48.2 mm -140.88 141.86 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 C-N-CA 125.423 1.489 . . . . 74.04 108.001 177.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 21.3 t -145.78 131.58 19.04 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.211 -1.403 . . . . 54.42 107.211 172.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.437 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 80.5 t80 -145.76 110.28 5.06 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 107.73 -1.211 . . . . 63.23 107.73 174.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -117.42 134.3 54.99 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 108.803 -0.814 . . . . 74.33 108.803 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -124.6 81.22 60.5 Favored Pre-proline 0 C--N 1.314 -0.956 0 N-CA-C 106.419 -1.696 . . . . 62.23 106.419 171.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.69 -32.62 37.5 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.371 2.714 . . . . 74.15 112.469 -171.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -116.45 31.56 6.66 Favored 'General case' 0 C--O 1.212 -0.896 0 C-N-CA 124.605 1.162 . . . . 72.21 109.855 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.442 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -43.07 -48.4 14.93 Favored Pre-proline 0 CA--C 1.566 1.585 0 N-CA-C 115.818 1.784 . . . . 71.54 115.818 -176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -80.74 -25.02 4.6 Favored 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 121.843 1.696 . . . . 35.4 112.789 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.42 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 72.0 m80 -94.74 -16.19 23.25 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 113.024 0.75 . . . . 72.11 113.024 -171.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' B' ' 73' ' ' ALA . 12.0 p -64.23 -12.75 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.803 0.841 . . . . 75.15 111.96 175.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 43.0 t80 -56.37 -25.74 50.55 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 124.013 0.925 . . . . 73.15 112.637 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.423 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 24.8 pt20 -71.44 -29.13 64.52 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.23 0.612 . . . . 72.42 111.108 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' B' ' 68' ' ' LEU . 32.2 mmtp -107.52 80.3 1.39 Allowed 'General case' 0 C--O 1.246 0.909 0 C-N-CA 124.342 1.057 . . . . 74.33 108.691 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -112.71 109.19 18.54 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.408 -0.815 . . . . 62.42 110.283 -174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.436 ' O ' HD21 ' B' ' 68' ' ' LEU . 0.0 OUTLIER 161.69 -158.91 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.965 2.506 . . . . 74.33 109.262 157.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.424 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 15.0 mp0 -49.44 106.99 0.69 Allowed Pre-proline 0 N--CA 1.486 1.335 0 C-N-CA 124.679 1.192 . . . . 72.42 111.621 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.22 153.07 14.12 Favored 'Trans proline' 0 C--N 1.38 2.21 0 C-N-CA 122.479 2.119 . . . . 62.42 110.944 178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -71.1 102.33 2.45 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.269 -1.011 . . . . 62.45 108.269 172.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -88.9 140.61 15.52 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 N-CA-C 108.481 -0.933 . . . . 74.43 108.481 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -134.56 125.61 27.62 Favored 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 124.35 1.06 . . . . 75.31 109.211 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 53.8 mt -97.2 148.0 23.52 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 124.131 0.972 . . . . 64.34 109.17 175.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 20.2 t0 -158.69 112.5 2.41 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.903 -0.777 . . . . 72.34 108.903 171.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.5 mp -100.18 134.04 43.68 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 109.127 -0.694 . . . . 70.14 109.127 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -124.06 142.06 51.52 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.13 0.972 . . . . 52.13 108.882 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 53.1 p -109.19 117.5 34.28 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.538 0.735 . . . . 61.11 110.427 -175.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.474 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -124.68 140.25 53.1 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.248 1.019 . . . . 75.21 109.036 175.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.5 p -145.12 162.89 35.93 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 122.848 0.459 . . . . 53.33 111.102 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.7 p -158.89 145.81 17.27 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.301 1.04 . . . . 64.54 109.238 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -96.49 112.05 23.94 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 108.527 -0.916 . . . . 74.14 108.527 174.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.24 -45.12 50.02 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.424 0.69 . . . . 74.2 110.681 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -152.4 -174.1 4.78 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 114.669 -1.151 . . . . 40.13 109.584 -176.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -70.59 116.92 11.47 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.353 -0.84 . . . . 73.43 109.065 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 70.6 -2.29 2.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.541 1.536 . . . . 71.14 112.978 -175.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.9 t -104.52 113.52 41.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 N-CA-C 108.62 -0.881 . . . . 74.51 108.62 176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -117.63 169.16 9.78 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 115.56 -0.745 . . . . 73.23 109.31 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.427 ' HG2' HG12 ' B' ' 83' ' ' ILE . 4.7 tm-20 -142.47 105.92 4.64 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.721 -1.214 . . . . 74.43 107.721 -174.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 94.8 t -103.08 121.15 53.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.515 1.126 . . . . 54.0 109.434 -176.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 23.3 t -106.02 121.74 58.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 C-N-CA 124.24 1.016 . . . . 64.25 108.694 176.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -108.51 114.36 28.13 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.795 -1.187 . . . . 73.41 107.795 175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -93.38 129.92 39.34 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.306 -0.861 . . . . 74.43 109.442 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -120.21 104.27 15.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 107.707 -1.22 . . . . 73.42 107.707 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 10.0 m -98.99 131.09 45.3 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 109.578 -0.527 . . . . 74.03 109.578 177.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.411 HG23 HD13 ' B' ' 114' ' ' ILE . 91.4 t -122.53 122.12 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 C-N-CA 124.41 1.084 . . . . 73.24 108.922 178.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 89.5 m -115.05 143.71 44.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.625 -0.88 . . . . 72.14 108.625 172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.81 142.87 38.7 Favored 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.766 -0.827 . . . . 63.14 108.766 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.5 p -161.37 148.02 14.55 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 123.826 0.704 . . . . 62.42 111.041 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.659 ' HB2' ' HB3' ' B' ' 34' ' ' LYS . 2.7 mp -123.73 130.78 53.16 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 108.636 -0.875 . . . . 74.43 108.636 173.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.17 -119.02 7.11 Favored Glycine 0 C--N 1.338 0.69 0 N-CA-C 110.723 -0.951 . . . . 71.01 110.723 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -115.41 4.93 14.43 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.046 0.538 . . . . 64.51 110.967 176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -117.23 161.95 18.65 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.572 0.349 . . . . 71.34 110.259 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 21.8 m -78.53 152.35 32.01 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.112 0.965 . . . . 71.2 111.538 -171.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.62 ' HA ' HG21 ' B' ' 31' ' ' VAL . . . -97.49 -62.21 1.28 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.859 -1.164 . . . . 65.42 107.859 167.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -159.97 153.29 22.15 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 114.439 -1.255 . . . . 61.43 109.657 174.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 72.1 mt -118.97 138.38 52.85 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.608 -1.256 . . . . 55.34 107.608 178.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.9 t -150.45 152.2 33.91 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 122.993 0.517 . . . . 70.13 109.811 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -163.39 132.14 3.89 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.384 -0.969 . . . . 44.01 108.384 177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 88.5 t -124.94 146.63 30.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.558 -0.904 . . . . 73.33 108.558 175.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.9 mt-30 -124.08 95.39 4.54 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.545 -1.28 . . . . 74.43 107.545 170.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.9 tp-100 -86.61 102.57 14.29 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.827 -1.175 . . . . 74.4 107.827 176.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.488 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.57 159.48 29.5 Favored Glycine 0 C--O 1.242 0.64 0 N-CA-C 110.958 -0.857 . . . . 50.41 110.958 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.89 125.69 1.55 Allowed Glycine 0 N--CA 1.441 -1.008 0 N-CA-C 111.025 -0.83 . . . . 73.3 111.025 -177.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.446 HG13 ' HE1' ' B' ' 17' ' ' TYR . 52.3 mt -85.71 131.36 34.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 107.89 -1.152 . . . . 74.22 107.89 175.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -139.05 132.84 30.78 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.43 -0.952 . . . . 74.54 108.43 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.468 ' HB2' HE21 ' B' ' 12' ' ' GLN . 66.1 m -89.8 101.91 14.61 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.757 -0.831 . . . . 74.23 108.757 172.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.412 HG22 ' HA ' ' B' ' 11' ' ' PHE . 15.1 pt -125.69 138.45 54.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 124.014 0.926 . . . . 72.21 109.605 -176.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.65 166.54 33.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.566 1.146 . . . . 44.2 108.941 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 80.17 -28.16 2.64 Favored Glycine 0 N--CA 1.48 1.614 0 CA-C-N 117.569 0.168 . . . . 62.1 113.438 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.609 ' HB ' ' HA ' ' B' ' 94' ' ' MET . 40.6 pt -54.35 135.31 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 C-N-CA 125.322 1.449 . . . . 61.13 111.249 177.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -151.7 140.65 21.07 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.94 -0.573 . . . . 75.2 110.41 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.96 -110.78 2.11 Favored Glycine 0 C--N 1.355 1.611 0 O-C-N 124.738 1.274 . . . . 71.44 113.402 170.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.456 HG23 HD13 ' B' ' 141' ' ' LEU . 63.4 m -66.48 -42.93 86.73 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.113 0.965 . . . . 62.14 111.196 177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -68.88 -31.93 71.22 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.62 0.768 . . . . 71.14 111.137 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.609 ' HA ' ' HB ' ' B' ' 89' ' ' ILE . 24.6 ttt -67.28 -57.32 6.89 Favored 'General case' 0 N--CA 1.472 0.659 0 O-C-N 123.512 0.507 . . . . 73.2 110.026 173.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.425 ' HB2' ' HB3' ' H' ' 280' ' ' LEU . . . -57.96 -36.58 72.77 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 124.438 1.086 . . . . 74.52 111.95 -176.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -75.85 -31.73 59.46 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.421 0.688 . . . . 65.45 111.188 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 49.4 t -69.97 -67.53 0.48 Allowed 'General case' 0 N--CA 1.477 0.88 0 CA-C-O 120.654 0.264 . . . . 42.25 110.593 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.468 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.4 OUTLIER -83.62 -13.14 54.98 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.831 0.678 . . . . 74.44 112.831 -174.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -105.16 0.09 41.04 Favored Glycine 0 N--CA 1.479 1.51 0 N-CA-C 114.178 0.431 . . . . 74.51 114.178 -176.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.606 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -144.24 -54.04 0.34 Allowed 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 117.244 0.522 . . . . 74.02 110.954 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -71.33 -52.43 18.79 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.688 0.795 . . . . 75.43 111.181 -173.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.568 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 33.4 m -67.03 -45.93 52.89 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 123.872 0.869 . . . . 55.41 112.538 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.401 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 84.9 Cg_exo -55.45 -38.25 94.13 Favored 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 122.544 2.163 . . . . 62.21 113.649 173.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -69.67 -22.41 63.44 Favored 'General case' 0 N--CA 1.484 1.228 0 O-C-N 123.874 0.734 . . . . 51.13 111.276 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 78.4 mt -74.14 -46.15 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.172 0.589 . . . . 64.54 109.864 172.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 86.0 mt -73.83 -26.64 60.7 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 115.484 -0.78 . . . . 73.54 111.586 -174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -57.4 -50.32 88.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.223 1.194 . . . . 71.02 114.223 -172.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.43 -38.48 74.14 Favored 'Trans proline' 0 C--N 1.384 2.396 0 C-N-CA 122.6 2.2 . . . . 75.53 114.138 178.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.486 ' HE2' HG21 ' D' ' 115' ' ' THR . 52.5 m-85 -70.79 -45.08 65.32 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.812 0.845 . . . . 73.04 110.562 -179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.31 -37.38 85.34 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 115.39 -0.823 . . . . 64.55 110.901 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.5 ttt180 -63.62 -51.42 65.29 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.269 1.428 . . . . 71.3 110.207 -179.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -68.24 -29.82 68.72 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.75 0.656 . . . . 72.14 110.301 -178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.5 ' O ' ' HG2' ' B' ' 117' ' ' MET . 3.2 t -67.82 -42.12 82.01 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 122.533 0.333 . . . . 60.43 110.427 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.411 HD13 HG23 ' B' ' 64' ' ' VAL . 76.5 mt -62.21 -48.18 89.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 123.42 0.688 . . . . 65.01 109.623 173.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.416 HG23 ' OE1' ' B' ' 125' ' ' GLN . 89.3 m -56.67 -34.71 67.64 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 124.369 1.068 . . . . 62.42 111.599 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 27.9 t -69.42 -48.19 61.74 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.289 0.636 . . . . 70.2 110.066 178.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -70.47 -33.51 71.35 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.031 0.532 . . . . 54.21 111.545 -173.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.46 -39.06 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 C-N-CA 123.446 0.698 . . . . 74.22 109.855 174.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.485 ' OG ' HG21 ' C' ' 115' ' ' THR . 11.9 t -69.93 -27.2 64.57 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.456 -0.793 . . . . 63.34 111.824 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.457 ' HG3' ' O ' ' B' ' 116' ' ' SER . 85.5 mtt-85 -76.61 -32.1 57.84 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.304 0.642 . . . . 72.54 109.84 176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.73 0.2 82.71 Favored Glycine 0 C--N 1.352 1.456 0 O-C-N 123.547 0.529 . . . . 73.0 112.259 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.456 HG22 ' OD1' ' C' ' 127' ' ' ASN . 61.4 p 61.38 33.88 18.58 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 126.675 1.99 . . . . 52.35 112.518 171.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -94.68 155.85 38.96 Favored Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.237 -0.892 . . . . 71.23 109.801 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -55.62 167.02 2.31 Favored 'Trans proline' 0 C--N 1.386 2.541 0 C-N-CA 123.54 2.827 . . . . 72.12 114.422 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.485 ' HG3' HD22 ' B' ' 127' ' ' ASN . 5.7 tp60 -59.56 134.03 56.64 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-N 114.835 -1.075 . . . . 74.21 113.413 -172.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 54.6 tp -122.77 96.13 4.9 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.42 -1.263 . . . . 65.23 107.867 177.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.485 HD22 ' HG3' ' B' ' 125' ' ' GLN . 4.0 p30 -108.28 112.79 25.43 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 108.574 -0.899 . . . . 75.03 108.574 172.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.406 HD12 ' H ' ' B' ' 129' ' ' ALA . 20.5 tp -75.18 139.76 42.87 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-N 116.001 -0.545 . . . . 74.21 109.828 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.406 ' H ' HD12 ' B' ' 128' ' ' LEU . . . -63.05 148.05 93.33 Favored Pre-proline 0 CA--C 1.549 0.909 0 C-N-CA 124.48 1.112 . . . . 71.12 111.619 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.602 ' HG3' HD12 ' D' ' 16' ' ' ILE . 5.5 Cg_exo -71.09 110.41 2.81 Favored 'Trans proline' 0 C--N 1.377 2.035 0 C-N-CA 122.24 1.96 . . . . 74.32 110.21 175.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 62.4 t -99.39 121.43 50.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 107.55 -1.278 . . . . 63.11 107.55 171.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 61.7 t-20 -74.21 88.69 1.99 Allowed 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.357 -0.979 . . . . 72.03 108.357 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -62.38 -32.36 73.16 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.479 0.712 . . . . 72.51 111.137 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.606 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 24.7 t70 -60.0 -59.05 6.05 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.522 1.129 . . . . 73.33 111.142 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.72 77.11 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.691 0.796 . . . . 41.55 111.203 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 55.1 tp -59.28 -39.36 82.67 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.948 0.899 . . . . 73.32 110.791 178.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -77.71 -30.23 51.7 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-N 115.686 -0.688 . . . . 64.42 110.838 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.2 mtt -62.94 -35.86 81.53 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 109.819 -0.437 . . . . 74.02 109.819 171.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.58 -31.94 62.22 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.158 0.983 . . . . 74.11 110.456 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -62.06 -36.39 81.49 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.802 0.841 . . . . 71.13 110.146 173.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.456 HD13 HG23 ' B' ' 92' ' ' THR . 58.1 mt -99.77 22.09 11.53 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.216 1.007 . . . . 61.31 110.914 178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 67.84 -79.14 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.859 1.263 . . . . 71.11 109.554 -177.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 7.7 mm-40 -153.13 150.41 29.06 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.646 1.179 . . . . 63.1 109.0 170.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.61 178.99 8.34 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.529 0.731 . . . . 64.32 110.76 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.11 139.22 30.84 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.809 0.843 . . . . 63.33 111.342 -178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.38 43.63 1.0 Allowed Glycine 0 N--CA 1.47 0.924 0 N-CA-C 110.8 -0.92 . . . . 62.42 110.8 175.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -151.35 137.6 18.43 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.21 1.004 . . . . 74.23 108.447 -175.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.56 169.05 38.45 Favored Glycine 0 C--N 1.347 1.162 0 O-C-N 123.645 0.591 . . . . 35.33 112.522 -177.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 35.2 m -93.75 134.54 35.97 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.653 0.781 . . . . 74.12 109.374 177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -72.36 142.83 48.76 Favored 'General case' 0 C--O 1.24 0.604 0 O-C-N 123.845 0.716 . . . . 74.11 110.944 -179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -144.37 94.97 2.64 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 107.836 -1.172 . . . . 62.44 107.836 170.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -142.41 127.94 19.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.612 0.765 . . . . 60.23 110.715 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.35 154.51 14.5 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.386 -1.339 . . . . 73.35 107.386 -178.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -52.68 124.78 14.69 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.9 0.88 . . . . 73.34 110.955 173.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.878 0 C-N-CA 123.899 0.88 . . . . 73.35 108.707 177.827 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.341 -0.615 . . . . 64.31 109.341 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 17.4 t -176.5 88.92 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.626 1.17 . . . . 54.41 108.58 178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -161.96 128.14 3.66 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.522 0.729 . . . . 61.41 109.899 -177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -87.19 99.89 12.27 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.061 0.545 . . . . 73.11 110.688 -175.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.641 ' HB2' ' HB1' ' A' ' 145' ' ' ALA . 65.7 t30 -87.18 127.93 35.14 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 108.674 -0.862 . . . . 74.1 108.674 173.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -154.98 118.78 4.58 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 109.513 -0.551 . . . . 74.02 109.513 -168.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 75.3 m 66.25 80.91 0.21 Allowed 'General case' 0 CA--C 1.554 1.11 0 CA-C-O 122.267 1.032 . . . . 72.4 109.338 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.437 ' HG3' HD21 ' C' ' 5' ' ' ASN . 0.2 OUTLIER -139.36 24.2 2.5 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 114.786 -1.097 . . . . 71.21 110.145 -168.997 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.404 ' SD ' ' HB2' ' C' ' 97' ' ' CYS . 54.3 ttp 65.83 114.54 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.947 1.299 . . . . 73.3 111.081 -166.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 20.7 m -109.0 99.69 8.98 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 107.593 -1.262 . . . . 74.32 107.593 173.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -105.76 130.27 53.79 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.027 -0.988 . . . . 72.31 109.533 -172.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -151.14 139.17 20.04 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.902 0.881 . . . . 75.4 109.575 174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.422 ' O ' HG11 ' G' ' 306' ' ' VAL . 2.8 pp -86.94 142.5 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 C-N-CA 123.661 0.784 . . . . 55.31 110.004 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.414 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 75.9 mt-30 -101.56 -49.89 3.89 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.596 0.358 . . . . 62.01 110.584 175.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.513 HH12 HD13 ' G' ' 301' ' ' ILE . 57.3 ttt180 -167.79 127.04 1.3 Allowed 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.466 0.306 . . . . 65.34 110.824 -173.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 78.1 mt -107.89 143.63 18.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 108.108 -1.071 . . . . 72.13 108.108 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.406 ' CE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -172.03 164.07 6.14 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-O 121.535 0.683 . . . . 72.41 111.139 -177.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.4 p -85.33 109.69 18.56 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.382 -0.969 . . . . 55.13 108.382 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 10.8 mmmt -66.81 -33.12 74.9 Favored 'General case' 0 N--CA 1.48 1.07 0 CA-C-O 121.177 0.513 . . . . 75.23 109.875 173.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.566 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.3 t70 -155.41 150.29 26.54 Favored 'General case' 0 C--O 1.239 0.548 0 CA-C-N 114.577 -1.192 . . . . 72.3 109.572 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.424 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 60.2 mt -138.63 149.09 23.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 N-CA-C 106.506 -1.665 . . . . 63.42 106.506 175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 21.2 t -160.67 152.08 19.33 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 121.332 0.587 . . . . 65.22 110.789 175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -147.02 141.86 26.85 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 107.691 -1.226 . . . . 73.54 107.691 172.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.581 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 50.2 mt-10 -132.92 150.89 52.12 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.707 0.803 . . . . 75.42 109.189 170.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -149.73 80.7 7.38 Favored Pre-proline 0 CA--C 1.541 0.621 0 N-CA-C 106.957 -1.497 . . . . 72.32 106.957 170.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -68.07 -35.04 20.99 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.488 2.125 . . . . 75.44 111.741 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -102.39 32.03 3.75 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.266 1.027 . . . . 74.01 109.489 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.472 ' HB1' ' CE2' ' D' ' 17' ' ' TYR . . . -59.67 -51.2 82.68 Favored Pre-proline 0 CA--C 1.56 1.347 0 N-CA-C 114.512 1.301 . . . . 21.55 114.512 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 15.4 Cg_exo -71.46 -35.55 7.99 Favored 'Trans proline' 0 C--N 1.384 2.421 0 CA-C-N 121.627 1.617 . . . . 71.33 111.073 174.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -62.68 -23.41 67.11 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 126.131 1.772 . . . . 73.21 112.85 -178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.502 ' HA ' ' HZ2' ' C' ' 34' ' ' LYS . 4.0 p -61.28 -20.33 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 N-CA-C 113.03 0.752 . . . . 72.31 113.03 -177.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -62.52 -40.3 96.3 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.436 0.695 . . . . 74.11 110.826 178.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -97.48 23.19 7.92 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.864 0.866 . . . . 74.41 110.461 -178.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.641 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 4.2 ttmp? -109.06 150.28 28.04 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.379 1.071 . . . . 73.03 109.913 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.75 125.96 30.07 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 108.889 -0.782 . . . . 51.51 108.889 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.6 m95 -84.74 75.59 10.31 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.331 0.586 . . . . 74.51 109.958 -176.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 60.0 tt0 -162.8 80.05 1.73 Allowed Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 107.895 -1.15 . . . . 73.01 107.895 175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -87.65 154.2 7.57 Favored 'Trans proline' 0 C--N 1.369 1.642 0 C-N-CA 122.901 2.4 . . . . 63.45 112.477 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -85.87 89.31 7.74 Favored 'General case' 0 C--O 1.242 0.675 0 N-CA-C 106.3 -1.741 . . . . 62.33 106.3 168.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 43.9 t -75.97 120.67 26.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 114.999 -1.001 . . . . 75.03 109.062 -178.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -109.98 130.8 55.48 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.77 1.228 . . . . 53.32 109.592 177.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.472 HD21 HD21 ' C' ' 128' ' ' LEU . 16.9 mt -87.32 122.89 31.68 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 109.025 -0.731 . . . . 55.45 109.025 168.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -122.39 103.19 8.57 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.467 1.107 . . . . 64.42 108.167 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -111.71 146.51 37.4 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.483 0.713 . . . . 51.01 109.518 -176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.524 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 21.4 t70 -138.8 135.32 34.5 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 107.283 -1.377 . . . . 50.52 107.283 174.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 22.0 p -127.13 126.94 43.79 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 122.456 0.302 . . . . 43.32 111.05 -173.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -126.47 164.67 20.63 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.915 0.886 . . . . 50.14 110.058 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 49.4 m -144.46 148.36 34.48 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.984 0.914 . . . . 51.12 108.974 176.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 16.0 p -147.64 129.02 14.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.12 0.568 . . . . 60.04 109.964 178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -75.4 125.38 28.87 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 109.295 -0.632 . . . . 72.13 109.295 176.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.459 HD11 HD12 ' C' ' 83' ' ' ILE . 73.5 mt -99.65 -31.4 11.6 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.696 0.798 . . . . 71.41 110.547 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -161.37 -177.79 6.22 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.269 1.028 . . . . 73.32 109.644 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.84 121.85 13.93 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.603 -0.726 . . . . 64.33 109.506 177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 69.0 -3.0 1.59 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.85 1.26 . . . . 54.33 112.791 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 80.0 t -100.38 112.66 33.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 N-CA-C 108.844 -0.799 . . . . 63.43 108.844 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -126.89 124.47 39.64 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.201 -1.037 . . . . 72.23 108.201 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -81.63 119.48 23.87 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.969 -1.014 . . . . 75.13 108.434 172.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.8 t -96.16 124.55 48.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 108.119 -1.067 . . . . 41.24 108.119 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 67.6 t -107.35 129.78 60.63 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 N-CA-C 108.057 -1.09 . . . . 75.3 108.057 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 48.9 tp -122.68 95.67 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.931 -1.137 . . . . 75.45 107.931 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.524 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.7 tmt_? -86.05 114.12 22.67 Favored 'General case' 0 C--N 1.332 -0.158 0 N-CA-C 107.822 -1.177 . . . . 72.1 107.822 175.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.482 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.9 t -113.28 132.81 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 108.107 -1.071 . . . . 63.35 108.107 175.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 19.5 m -128.81 124.2 34.8 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 108.493 -0.928 . . . . 53.23 108.493 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.5 HG11 HD13 ' C' ' 126' ' ' LEU . 39.0 t -106.55 110.48 31.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 107.928 -1.138 . . . . 55.31 107.928 175.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.452 HG23 HD23 ' C' ' 75' ' ' LEU . 8.0 m -106.71 127.03 53.04 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 109.113 -0.699 . . . . 71.02 109.113 175.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -113.85 110.9 20.86 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.065 -1.087 . . . . 63.33 108.065 175.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.7 m -148.15 126.7 12.44 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.966 0.506 . . . . 74.42 109.782 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.503 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.2 OUTLIER -87.44 58.6 5.05 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.727 0.811 . . . . 73.32 109.473 177.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.72 -119.18 5.86 Favored Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.877 -1.289 . . . . 64.43 109.877 -171.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -89.71 -24.02 21.67 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.616 0.766 . . . . 74.33 109.512 173.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.624 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 14.7 tp10 -68.2 96.1 0.62 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.192 0.997 . . . . 71.24 110.553 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 36.2 m -83.12 126.52 32.68 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.738 0.78 . . . . 61.41 111.259 -174.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.641 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -82.78 -53.67 5.71 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 125.174 1.39 . . . . 51.0 110.19 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -163.88 170.46 16.75 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.022 0.826 . . . . 74.0 110.379 173.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.581 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.8 tm? -136.99 137.9 39.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 106.507 -1.664 . . . . 71.32 106.507 177.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.444 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 42.1 t -146.8 143.04 28.34 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.284 -1.006 . . . . 74.05 108.284 177.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -155.32 135.53 13.09 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.061 0.544 . . . . 72.0 109.887 -175.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 85.0 t -138.3 135.23 44.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.235 1.014 . . . . 63.33 108.355 177.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -105.92 89.15 2.99 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.944 -1.132 . . . . 75.12 107.944 171.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -81.21 107.73 14.25 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.045 -0.979 . . . . 74.24 109.749 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.62 145.67 16.23 Favored Glycine 0 C--N 1.337 0.627 0 N-CA-C 111.98 -0.448 . . . . 74.31 111.98 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.52 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -142.05 127.71 3.34 Favored Glycine 0 CA--C 1.5 -0.897 0 N-CA-C 110.416 -1.074 . . . . 61.32 110.416 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.459 HD12 HD11 ' C' ' 51' ' ' LEU . 10.2 mm -81.28 114.64 22.55 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 107.842 -1.17 . . . . 72.34 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -121.55 137.11 54.87 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.037 -0.727 . . . . 74.3 109.037 -175.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 10.2 m -109.96 105.59 14.81 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.425 -0.954 . . . . 71.13 108.425 177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.422 HG21 ' HG3' ' C' ' 94' ' ' MET . 2.2 mp -114.7 111.88 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 N-CA-C 106.648 -1.612 . . . . 73.53 106.648 179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.64 157.94 31.11 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.994 0.518 . . . . 62.23 111.726 -170.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.07 -60.51 0.97 Allowed Glycine 0 C--N 1.339 0.717 0 CA-C-N 115.016 -0.993 . . . . 53.32 112.384 173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.4 pp -107.68 178.03 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 C-N-CA 122.833 0.453 . . . . 72.33 111.726 -174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.462 ' HB2' ' H ' ' F' ' 277' ' ' LEU . 9.9 pt-20 -154.32 -171.07 3.74 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.631 -0.713 . . . . 72.43 110.419 -176.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.45 -128.8 44.34 Favored Glycine 0 C--N 1.355 1.634 0 O-C-N 123.856 0.723 . . . . 60.01 114.166 170.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 47.1 p -68.18 -31.92 71.8 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.065 0.946 . . . . 63.14 111.743 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -64.88 -46.32 82.28 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.658 0.783 . . . . 74.14 110.117 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.736 ' HG2' HD23 ' C' ' 98' ' ' LEU . 27.9 ttt -78.32 -25.69 46.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.342 -0.845 . . . . 74.14 110.987 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -32.73 74.14 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 122.999 0.52 . . . . 72.14 111.003 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.503 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 38.9 t-80 -65.49 -36.75 84.79 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 115.644 -0.707 . . . . 65.33 111.073 172.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.404 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 53.9 t -76.17 -61.35 1.97 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 122.627 0.371 . . . . 64.52 111.143 -176.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.736 HD23 ' HG2' ' C' ' 94' ' ' MET . 3.4 pp -70.71 -34.04 71.51 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.186 0.594 . . . . 74.24 110.989 -175.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -89.65 -2.47 75.84 Favored Glycine 0 C--N 1.352 1.451 0 N-CA-C 114.65 0.62 . . . . 71.25 114.65 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -137.24 -57.86 0.7 Allowed 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 117.349 0.575 . . . . 74.42 111.193 -176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.425 ' OH ' ' HB3' ' A' ' 130' ' ' PRO . 68.0 t80 -72.59 -48.95 35.6 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 122.897 0.479 . . . . 74.13 111.586 -174.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.589 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 81.2 m -58.21 -45.03 99.76 Favored Pre-proline 0 CA--C 1.569 1.687 0 N-CA-C 113.383 0.883 . . . . 72.44 113.383 -177.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.438 ' HD3' ' O ' ' C' ' 98' ' ' LEU . 50.3 Cg_exo -56.92 -36.5 99.1 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 122.548 2.165 . . . . 75.3 113.209 172.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.459 HD21 ' HD2' ' C' ' 133' ' ' PHE . 0.9 OUTLIER -68.7 -22.53 64.35 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.714 0.805 . . . . 55.14 111.734 -178.949 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.548 HD12 HH12 ' A' ' 111' ' ' ARG . 35.3 mm -83.33 -36.45 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 C-N-CA 122.803 0.441 . . . . 50.41 110.052 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.52 HD21 ' HA3' ' C' ' 82' ' ' GLY . 96.4 mt -82.34 -24.89 34.32 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.75 0.82 . . . . 71.25 112.131 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -58.77 -48.84 96.08 Favored Pre-proline 0 CA--C 1.559 1.308 0 N-CA-C 113.571 0.952 . . . . 53.51 113.571 -174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_exo -58.96 -40.03 75.26 Favored 'Trans proline' 0 C--N 1.383 2.362 0 C-N-CA 122.066 1.844 . . . . 74.21 113.184 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.427 ' HE2' HG21 ' A' ' 115' ' ' THR . 97.0 m-85 -70.51 -42.91 70.69 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 115.405 -0.816 . . . . 74.44 111.519 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.88 -46.47 87.75 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.357 0.663 . . . . 73.41 109.215 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.0 ttt-85 -55.93 -51.64 66.92 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.483 1.513 . . . . 64.5 111.827 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.68 -33.2 70.65 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 122.503 0.321 . . . . 75.43 110.163 -175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.2 t -70.59 -31.02 67.86 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.637 0.375 . . . . 64.04 111.013 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.482 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -72.05 -51.17 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 123.676 0.79 . . . . 74.54 109.76 173.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.485 HG21 ' OG ' ' B' ' 119' ' ' SER . 88.4 m -59.23 -41.27 88.32 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.626 0.77 . . . . 75.42 111.071 -176.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 26.2 t -60.3 -44.38 95.45 Favored 'General case' 0 C--O 1.21 -0.984 0 O-C-N 124.064 0.853 . . . . 61.35 109.653 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.537 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.92 -39.95 91.0 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.312 0.645 . . . . 74.4 111.824 179.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 72.6 t -62.16 -40.66 88.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 123.022 0.529 . . . . 63.55 110.116 175.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.427 ' HB2' ' NE2' ' B' ' 125' ' ' GLN . 84.1 p -76.17 -26.41 56.21 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 115.568 -0.742 . . . . 71.45 111.742 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' C' ' 116' ' ' SER . 71.9 mtt-85 -71.52 -34.58 70.21 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.758 0.823 . . . . 75.24 110.168 174.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.62 6.06 59.25 Favored Glycine 0 C--N 1.355 1.593 0 O-C-N 123.576 0.548 . . . . 50.15 112.384 170.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 58.2 p 61.67 19.49 10.52 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.168 2.187 . . . . 75.2 113.314 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.424 ' HE1' HG11 ' C' ' 31' ' ' VAL . 52.2 m-85 -85.88 156.27 58.18 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.136 0.974 . . . . 73.32 109.688 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.45 ' HG3' ' HB2' ' F' ' 300' ' ' ASN . 68.3 Cg_exo -51.68 120.58 7.24 Favored 'Trans proline' 0 C--N 1.383 2.393 0 C-N-CA 123.033 2.489 . . . . 72.54 111.958 173.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' B' ' 125' ' ' GLN . 96.2 mt-30 -57.08 143.99 36.31 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 124.309 1.006 . . . . 73.11 112.477 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.754 HD21 ' HH2' ' F' ' 290' ' ' TRP . 5.9 tt -119.28 109.18 15.51 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.178 -1.045 . . . . 75.0 108.178 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.456 ' OD1' HG22 ' B' ' 122' ' ' THR . 1.0 OUTLIER -91.95 119.0 31.29 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.43 -0.952 . . . . 71.43 108.43 170.206 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.472 HD21 HD21 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -73.13 136.75 44.87 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.083 -0.71 . . . . 75.41 109.083 -179.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.9 151.75 94.56 Favored Pre-proline 0 CA--C 1.55 0.944 0 C-N-CA 124.288 1.035 . . . . 62.13 111.574 -178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.63 ' HG3' HD12 ' A' ' 16' ' ' ILE . 15.0 Cg_exo -66.39 98.54 0.4 Allowed 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.486 2.124 . . . . 35.51 111.325 177.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 58.3 t -97.92 108.8 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 N-CA-C 107.908 -1.145 . . . . 54.31 107.908 177.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -95.04 99.05 11.12 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 108.762 -0.829 . . . . 73.41 108.762 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.459 ' HD2' HD21 ' C' ' 104' ' ' ASN . 78.1 m-85 -68.71 -37.0 79.16 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 115.402 -0.817 . . . . 71.12 109.949 176.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -63.9 -27.99 69.53 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.474 1.11 . . . . 75.44 112.265 -175.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.78 -41.46 91.16 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.789 0.836 . . . . 44.32 111.552 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 59.9 tp -62.98 -46.38 87.95 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.176 0.59 . . . . 75.35 110.534 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.461 ' HB3' ' HD2' ' C' ' 96' ' ' HIS . 55.0 m-85 -64.79 -31.58 72.88 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 115.321 -0.854 . . . . 74.42 111.146 177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 48.1 ttm -66.97 -38.48 86.16 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.93 0.892 . . . . 53.3 110.822 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -68.57 -38.98 81.15 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 116.154 -0.476 . . . . 72.21 110.962 175.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -71.01 -88.27 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.235 0 O-C-N 123.568 0.542 . . . . 73.13 110.826 178.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.431 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 15.1 tp -177.63 176.2 1.28 Allowed 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.971 0.908 . . . . 74.23 108.691 -171.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.431 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 25.1 mm-40 75.04 8.76 4.04 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.396 1.478 . . . . 71.12 111.277 179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.77 -15.85 61.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.465 1.106 . . . . 61.24 111.211 175.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 90.9 mt-30 -65.27 115.63 5.78 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.499 1.12 . . . . 73.15 111.199 -177.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -148.9 -178.22 6.24 Favored 'General case' 0 C--O 1.245 0.836 0 C-N-CA 123.892 0.877 . . . . 71.53 110.202 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 145.69 109.46 0.61 Allowed Glycine 0 C--N 1.339 0.71 0 N-CA-C 108.437 -1.865 . . . . 62.0 108.437 -173.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -67.86 148.74 50.75 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.639 0.775 . . . . 70.54 112.295 -165.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.63 -114.38 0.42 Allowed Glycine 0 C--N 1.349 1.263 0 CA-C-N 115.157 -0.929 . . . . 62.34 111.508 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 50.4 p -140.14 131.17 26.24 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.905 0.882 . . . . 71.32 111.278 -174.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.52 166.98 12.56 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.239 0.616 . . . . 73.32 110.324 172.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -106.83 -70.85 0.77 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 123.005 0.522 . . . . 62.41 111.544 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 m170 61.54 72.63 0.5 Allowed 'General case' 0 C--N 1.356 0.887 0 O-C-N 124.157 0.911 . . . . 74.52 110.363 -166.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -143.75 10.31 1.59 Allowed 'General case' 0 CA--C 1.554 1.114 0 CA-C-N 115.186 -0.915 . . . . 72.45 109.248 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -133.05 102.28 5.54 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.849 0.859 . . . . 70.44 108.803 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.358 0 C-N-CA 124.107 0.963 . . . . 54.41 111.636 -173.652 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.479 1.005 0 N-CA-C 108.805 -0.813 . . . . 64.15 108.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . 0.505 ' H ' ' HA ' ' D' ' 150' ' ' GLU . 20.2 m -145.34 161.82 38.72 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.154 0.582 . . . . 72.11 111.001 -174.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.84 121.31 3.6 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.059 0.944 . . . . 51.52 109.805 176.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 82.4 mt-30 -128.13 105.08 8.13 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.907 0.883 . . . . 62.43 110.025 177.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -156.17 162.74 40.17 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 107.987 -1.116 . . . . 53.33 107.987 174.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -146.46 109.46 4.65 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.694 0.398 . . . . 72.13 110.186 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.756 ' HB ' ' HA2' ' D' ' 88' ' ' GLY . 32.1 m -80.88 166.91 20.47 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 108.352 -0.981 . . . . 51.01 108.352 169.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -60.09 94.12 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.338 0.655 . . . . 71.3 111.209 178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.46 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 7.6 ttp -35.34 128.55 0.56 Allowed 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 125.232 1.413 . . . . 72.42 113.416 173.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.459 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 30.1 m -139.72 140.31 36.76 Favored 'General case' 0 C--O 1.243 0.759 0 N-CA-C 108.094 -1.076 . . . . 62.53 108.094 171.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -161.63 99.39 1.14 Allowed 'General case' 0 C--O 1.237 0.445 0 N-CA-C 108.39 -0.967 . . . . 73.22 108.39 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -136.42 131.26 33.88 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.544 -0.91 . . . . 53.14 108.544 178.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.444 HD11 HG21 ' D' ' 105' ' ' ILE . 22.8 mt -82.34 122.12 36.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 109.206 -0.665 . . . . 63.33 109.206 178.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -87.63 -31.78 19.62 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 122.819 0.448 . . . . 73.43 110.826 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.8 ttt180 -167.3 144.66 4.59 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 110.48 -0.193 . . . . 75.13 110.48 -173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.602 HD12 ' HG3' ' B' ' 130' ' ' PRO . 0.1 OUTLIER -133.56 133.15 57.44 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 106.357 -1.72 . . . . 74.52 106.357 173.038 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.472 ' CE2' ' HB1' ' C' ' 28' ' ' ALA . 21.6 p90 -168.31 166.79 12.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.793 0.806 . . . . 71.4 111.12 -173.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.6 p -93.09 121.63 34.63 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.371 -1.286 . . . . 74.13 108.769 175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.436 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -88.77 -31.26 18.48 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.884 0.474 . . . . 75.23 110.069 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -153.01 139.44 18.61 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 114.946 -1.024 . . . . 51.12 109.012 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.537 HG21 ' HE2' ' C' ' 117' ' ' MET . 63.2 mt -139.59 151.3 22.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.771 -1.196 . . . . 63.3 107.771 178.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.7 t -158.68 121.67 3.75 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.663 0.785 . . . . 74.12 110.264 170.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB2' ' SD ' ' D' ' 117' ' ' MET . 66.9 t80 -113.65 121.22 43.5 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 106.657 -1.609 . . . . 72.22 106.657 165.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 41.4 mt-10 -121.88 117.63 26.95 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.708 -0.478 . . . . 72.53 109.708 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.68 87.66 2.39 Favored Pre-proline 0 CA--C 1.545 0.765 0 N-CA-C 107.806 -1.183 . . . . 42.25 107.806 171.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -72.13 -36.77 5.35 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 122.739 2.293 . . . . 70.32 112.727 -170.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -113.0 40.1 2.39 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.27 1.028 . . . . 64.25 108.623 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.406 ' HB1' ' CE2' ' C' ' 17' ' ' TYR . . . -51.98 -65.09 1.1 Allowed Pre-proline 0 CA--C 1.563 1.468 0 CA-C-O 117.916 -1.04 . . . . 61.44 113.799 -166.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.92 -9.81 11.8 Favored 'Trans proline' 0 C--N 1.382 2.337 0 CA-C-N 122.6 1.964 . . . . 72.51 112.91 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -74.07 -42.44 60.18 Favored 'General case' 0 C--O 1.245 0.821 0 C-N-CA 124.688 1.195 . . . . 75.35 110.377 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 7.9 p -80.28 -33.69 14.29 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.633 0 CA-C-N 115.951 -0.568 . . . . 61.15 109.909 -173.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -56.16 -22.55 29.47 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 124.237 1.015 . . . . 74.04 113.699 -175.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -70.6 -36.16 73.37 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.015 0.526 . . . . 51.03 110.436 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.34 63.32 1.63 Allowed 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.778 0.831 . . . . 64.41 111.381 171.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.509 ' HB3' HD12 ' G' ' 301' ' ' ILE . 9.6 t70 -107.47 97.93 7.61 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.529 0.732 . . . . 50.2 109.714 -175.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.453 ' O ' HD22 ' D' ' 68' ' ' LEU . 13.2 m95 -121.87 -155.12 0.62 Allowed 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 108.037 -1.097 . . . . 62.32 108.037 -169.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.584 HE21 ' HA ' ' G' ' 295' ' ' ALA . 63.1 tt0 -54.45 109.04 1.32 Allowed Pre-proline 0 CA--C 1.558 1.279 0 N-CA-C 113.082 0.771 . . . . 72.11 113.082 -175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.709 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 9.8 Cg_exo -72.03 139.45 32.87 Favored 'Trans proline' 0 C--N 1.386 2.525 0 C-N-CA 123.102 2.535 . . . . 64.25 112.968 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -96.0 116.48 29.0 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.561 -1.274 . . . . 74.04 107.561 166.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 m -103.32 149.85 7.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 123.923 0.889 . . . . 74.45 112.21 -170.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 17.1 tptm -127.83 139.35 52.69 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.72 1.608 . . . . 73.14 108.473 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.509 HD13 HG11 ' G' ' 288' ' ' VAL . 1.2 tt -120.84 114.7 21.98 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.944 -0.762 . . . . 62.34 108.944 -179.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -109.08 141.98 40.47 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.209 1.004 . . . . 74.34 108.501 172.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.546 HD22 ' SD ' ' G' ' 286' ' ' MET . 4.9 mp -122.04 145.03 48.54 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 109.335 -0.617 . . . . 61.21 109.335 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -149.04 159.55 44.12 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.177 0.991 . . . . 70.34 108.47 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 12.5 t -136.6 168.78 18.84 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.13 0.572 . . . . 74.1 110.501 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.512 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.32 154.31 36.48 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 124.603 1.161 . . . . 72.34 108.347 174.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.485 ' HB2' ' HG ' ' G' ' 278' ' ' LEU . 58.6 p -149.44 150.67 32.75 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 122.31 0.244 . . . . 73.42 111.117 -174.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 75.1 p -174.18 127.73 0.36 Allowed 'General case' 0 C--O 1.243 0.722 0 C-N-CA 124.34 1.056 . . . . 73.13 108.93 175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -68.89 127.31 32.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 108.898 -0.779 . . . . 74.34 108.898 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.472 HD11 ' HB2' ' D' ' 57' ' ' GLU . 57.6 mt -92.55 -36.01 13.27 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.886 0.474 . . . . 65.5 111.147 -177.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.61 -171.1 1.99 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.433 0.693 . . . . 65.04 111.115 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -58.13 114.31 2.32 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-N 114.869 -1.06 . . . . 65.44 110.785 175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 62.29 13.01 5.61 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.591 1.156 . . . . 62.15 112.501 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 80.6 t -115.52 118.48 58.92 Favored 'Isoleucine or valine' 0 C--O 1.239 0.513 0 N-CA-C 108.512 -0.921 . . . . 70.44 108.512 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.626 ' HB3' HD22 ' G' ' 278' ' ' LEU . 96.1 m-85 -131.25 132.54 44.68 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 124.657 1.183 . . . . 74.35 108.144 -174.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.472 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.5 tt0 -99.77 126.0 45.77 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.375 0.422 . . . . 72.12 110.596 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 44.6 t -107.36 117.75 53.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 107.248 -1.389 . . . . 73.5 107.248 170.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 38.0 t -100.27 132.25 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 107.649 -1.241 . . . . 72.3 107.649 172.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -124.26 110.81 15.09 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.555 -0.906 . . . . 73.45 108.555 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.07 118.4 29.58 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.272 1.029 . . . . 74.11 109.694 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . 0.455 HG13 HD21 ' D' ' 42' ' ' LEU . 65.3 t -102.42 130.56 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 107.867 -1.161 . . . . 72.23 107.867 166.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 23.3 m -121.4 131.2 54.04 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.449 0.642 . . . . 74.35 109.887 177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.437 HG21 HG21 ' D' ' 114' ' ' ILE . 88.5 t -122.42 105.89 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.473 1.509 . . . . 63.21 108.938 -175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -107.45 108.84 20.36 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.847 0.859 . . . . 73.22 109.258 179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.59 137.0 37.18 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.451 -0.574 . . . . 74.14 109.451 176.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 35.8 p -139.21 123.08 17.69 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.309 -0.996 . . . . 53.43 108.309 172.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.709 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.4 pp -129.1 137.55 51.3 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.711 -0.478 . . . . 74.03 109.711 174.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.38 -113.09 3.57 Favored Glycine 0 C--N 1.339 0.706 0 CA-C-N 115.683 -0.689 . . . . 71.04 112.119 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -116.37 3.14 13.29 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.723 0.809 . . . . 72.23 111.21 -173.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -155.78 176.05 13.12 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.071 0.462 . . . . 74.51 111.497 -168.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 78.1 m -66.78 138.13 57.13 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.918 -1.037 . . . . 55.21 111.015 174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . . . . . . . . . . . -82.4 -65.79 0.97 Allowed 'General case' 0 C--O 1.24 0.582 0 N-CA-C 108.06 -1.089 . . . . 65.25 108.06 171.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -156.52 164.72 37.89 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 113.787 -1.551 . . . . 74.24 109.231 178.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.482 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 89.6 mt -126.26 144.31 50.84 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.665 1.186 . . . . 71.22 107.842 177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.406 ' SG ' ' HD1' ' D' ' 23' ' ' PHE . 0.7 OUTLIER -145.7 139.24 26.39 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 124.204 1.002 . . . . 54.12 108.348 -178.328 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -157.79 130.1 7.18 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.52 -0.548 . . . . 74.12 109.52 177.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 55.3 t -137.6 119.52 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.4 0.68 . . . . 74.35 109.682 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -89.29 91.24 8.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.539 0.735 . . . . 62.44 109.083 169.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -80.59 94.66 6.33 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.259 0.624 . . . . 72.01 109.491 177.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.7 141.73 18.11 Favored Glycine 0 C--N 1.34 0.803 0 N-CA-C 111.524 -0.63 . . . . 52.23 111.524 177.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.447 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.23 129.83 5.05 Favored Glycine 0 CA--C 1.506 -0.523 0 N-CA-C 110.953 -0.859 . . . . 63.43 110.953 -177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.417 HG23 HD12 ' D' ' 51' ' ' LEU . 45.8 mt -89.41 119.42 36.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.793 -1.188 . . . . 65.34 107.793 175.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -121.47 147.52 45.66 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.04 0.936 . . . . 73.11 109.199 -176.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.5 m -99.57 93.3 5.79 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.173 -1.418 . . . . 74.2 107.173 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 71.9 mt -106.78 118.35 54.35 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 N-CA-C 109.107 -0.701 . . . . 64.01 109.107 -172.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.459 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -151.94 160.74 43.41 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.114 0.966 . . . . 71.35 109.447 177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.756 ' HA2' ' HB ' ' D' ' 7' ' ' THR . . . 81.44 -23.16 4.91 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 115.696 1.038 . . . . 53.14 115.696 170.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.419 HG13 ' HG2' ' D' ' 94' ' ' MET . 26.2 pt -96.11 135.7 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 108.597 -0.89 . . . . 73.23 108.597 176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -161.05 172.93 15.98 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.518 -0.765 . . . . 74.43 110.153 -169.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.528 ' H ' ' HG3' ' G' ' 276' ' ' PRO . . . 62.69 -137.28 44.39 Favored Glycine 0 C--N 1.35 1.309 0 O-C-N 123.492 0.495 . . . . 70.05 112.595 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 31.9 p -77.58 -20.41 54.08 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.861 0.864 . . . . 75.42 111.511 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -62.38 -47.38 84.4 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.77 0.828 . . . . 71.34 110.318 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.572 ' HG3' HD23 ' G' ' 277' ' ' LEU . 0.0 OUTLIER -64.69 -46.96 80.15 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.246 -0.888 . . . . 74.33 109.681 178.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -53.61 -42.17 67.41 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.341 1.026 . . . . 71.3 112.182 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -67.25 -50.55 60.11 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.247 -0.888 . . . . 65.43 111.159 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.6 t -61.84 -35.54 78.55 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.058 0.543 . . . . 75.14 111.462 -177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.539 HD12 ' SD ' ' D' ' 94' ' ' MET . 4.1 tt -70.27 -45.64 65.98 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.94 1.296 . . . . 63.21 109.226 -178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.74 -22.39 72.31 Favored Glycine 0 C--N 1.344 1.011 0 CA-C-N 115.35 -0.841 . . . . 72.55 113.831 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.33 -66.82 1.04 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 112.405 0.52 . . . . 74.34 112.405 -170.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.6 t80 -72.92 -48.19 39.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.551 0.741 . . . . 74.51 112.51 -166.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 56.6 m -60.1 -48.71 93.77 Favored Pre-proline 0 CA--C 1.571 1.781 0 C-N-CA 123.89 0.876 . . . . 71.21 112.784 -176.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -73.64 -21.72 18.86 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.964 1.776 . . . . 53.15 112.906 176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -67.09 -31.58 72.15 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 123.226 0.61 . . . . 64.5 110.577 177.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.444 HG21 HD11 ' D' ' 13' ' ' ILE . 47.8 mm -68.0 -42.82 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.674 0.79 . . . . 74.01 110.332 175.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.447 HD21 ' HA3' ' D' ' 82' ' ' GLY . 89.1 mt -73.73 -29.9 62.52 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 115.235 -0.893 . . . . 74.0 111.716 -174.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -59.98 -44.11 96.0 Favored Pre-proline 0 CA--C 1.566 1.587 0 N-CA-C 114.338 1.236 . . . . 74.33 114.338 -171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -54.48 -41.09 80.15 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.445 2.097 . . . . 74.11 114.03 173.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 78.7 m-85 -74.29 -37.36 63.7 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.258 0.623 . . . . 74.11 111.371 -179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . 0.4 ' O ' HG13 ' D' ' 114' ' ' ILE . . . -63.71 -47.45 81.07 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.086 0.554 . . . . 71.54 109.975 175.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -53.9 -53.51 51.64 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.772 1.295 . . . . 60.41 110.562 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -58.56 -46.98 85.74 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 124.523 1.139 . . . . 74.44 110.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 45.3 t -59.44 -32.88 70.62 Favored 'General case' 0 N--CA 1.479 0.98 0 O-C-N 123.579 0.549 . . . . 75.45 111.708 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.456 ' O ' HG23 ' D' ' 118' ' ' VAL . 73.3 mt -73.24 -49.51 37.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 123.157 0.583 . . . . 71.44 109.916 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.486 HG21 ' HE2' ' B' ' 109' ' ' TYR . 21.8 m -55.07 -40.99 70.95 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 124.719 1.208 . . . . 72.13 111.577 -175.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.7 t -71.65 -37.51 70.81 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 115.335 -0.848 . . . . 72.11 110.955 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.543 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 71.3 mtm -63.37 -45.34 91.56 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 122.742 0.417 . . . . 75.03 111.287 178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.456 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.6 t -63.05 -41.87 94.49 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 CA-C-N 115.142 -0.936 . . . . 65.21 110.451 -176.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.2 p -68.16 -31.86 71.72 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 123.207 0.603 . . . . 63.33 111.754 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 80.2 mtt-85 -71.93 -30.1 64.98 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.74 0.816 . . . . 63.13 110.931 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.62 8.63 64.7 Favored Glycine 0 C--N 1.354 1.543 0 CA-C-N 115.965 -0.561 . . . . 71.11 112.569 173.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 34.6 p 60.73 24.97 14.8 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.018 2.127 . . . . 72.4 113.036 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -97.23 161.17 27.02 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 124.836 1.255 . . . . 72.43 109.499 172.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -65.74 120.04 7.16 Favored 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.475 2.117 . . . . 73.44 111.102 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -56.87 139.68 50.66 Favored 'General case' 0 CA--C 1.551 1.002 0 O-C-N 123.689 0.618 . . . . 74.5 110.093 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 1.5 tt -109.19 117.75 34.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 109.401 -0.592 . . . . 74.32 109.401 -170.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -99.98 95.39 6.83 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.969 -1.014 . . . . 72.54 108.362 -177.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.12 121.19 12.46 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.433 0.693 . . . . 74.02 110.08 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -66.95 140.7 96.25 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.38 0.672 . . . . 51.21 110.577 178.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 4.2 Cg_exo -75.0 108.65 2.77 Favored 'Trans proline' 0 C--N 1.374 1.878 0 C-N-CA 122.549 2.166 . . . . 73.34 110.777 -178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -108.94 138.88 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 123.443 0.697 . . . . 74.31 109.199 -177.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -74.17 112.37 10.26 Favored 'General case' 0 CA--C 1.544 0.72 0 O-C-N 123.97 0.794 . . . . 74.25 110.428 -178.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -74.83 -32.2 61.89 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.56 0.744 . . . . 72.53 110.988 177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -49.77 -55.02 15.63 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.17 0.988 . . . . 73.55 111.445 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.41 -41.59 85.29 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.215 1.006 . . . . 51.13 112.63 -176.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.4 HD22 ' HG2' ' G' ' 287' ' ' PRO . 73.5 mt -63.14 -40.15 96.74 Favored 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 115.18 -0.918 . . . . 74.0 111.055 179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -78.76 -26.46 44.57 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.353 1.061 . . . . 72.41 112.991 -176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.1 mmt -46.74 -47.47 20.66 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 123.202 0.601 . . . . 73.45 110.99 178.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.98 -48.96 78.02 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.947 -1.024 . . . . 61.14 110.953 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.69 -35.98 75.57 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.114 0.966 . . . . 71.04 112.028 -175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mp -72.6 -28.67 62.92 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.873 0.869 . . . . 73.02 110.939 178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 66.0 mt-30 -87.04 3.7 44.98 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.125 0.97 . . . . 73.31 111.059 174.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -130.84 51.1 2.16 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.244 1.018 . . . . 74.4 110.276 -178.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -144.45 155.0 43.53 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.193 0.597 . . . . 73.31 109.786 176.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.31 89.81 1.07 Allowed 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 108.548 -0.908 . . . . 62.25 108.548 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 160.7 65.24 0.02 OUTLIER Glycine 0 C--N 1.343 0.972 0 N-CA-C 110.44 -1.064 . . . . 42.5 110.44 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -81.57 169.67 16.79 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.821 0.848 . . . . 71.35 110.041 -178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -67.47 -24.73 73.81 Favored Glycine 0 C--N 1.347 1.141 0 O-C-N 123.784 0.677 . . . . 40.0 114.517 -172.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 12.3 t -161.5 177.74 9.77 Favored 'General case' 0 C--O 1.245 0.837 0 C-N-CA 123.374 0.67 . . . . 71.23 110.068 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . 0.505 ' HA ' ' H ' ' D' ' 2' ' ' SER . 34.3 tt0 -132.76 104.71 6.75 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.822 -0.807 . . . . 61.11 108.822 170.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -151.35 93.24 1.87 Allowed 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.128 -1.064 . . . . 71.22 108.128 177.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 80.7 t60 -67.2 93.76 0.32 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 114.763 -1.108 . . . . 74.45 110.66 -177.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -94.43 152.73 18.38 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 108.617 -0.883 . . . . 73.53 108.617 165.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -159.88 161.61 34.43 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.319 0.648 . . . . 72.11 109.705 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.956 0 C-N-CA 123.45 0.7 . . . . 54.42 110.374 177.931 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.021 0 N-CA-C 110.213 -0.292 . . . . 62.15 110.213 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -154.26 126.51 7.89 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 108.887 -0.783 . . . . 53.34 108.887 175.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -82.26 97.42 8.27 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.586 0.754 . . . . 72.35 109.436 178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -78.56 104.9 9.47 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.751 -0.833 . . . . 74.32 108.751 172.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . 0.532 ' HE3' ' HB2' ' A' ' 50' ' ' GLN . 21.6 pttm -82.27 118.76 73.09 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.173 0.589 . . . . 73.31 110.37 -178.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.39 -1.8 11.51 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.822 2.348 . . . . 74.35 113.559 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 78.9 mt -78.72 -35.78 44.34 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.655 0.782 . . . . 74.33 111.776 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -100.81 104.27 15.5 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 107.334 -1.358 . . . . 61.23 107.334 -178.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -154.39 31.26 0.7 Allowed Glycine 0 C--N 1.343 0.955 0 O-C-N 123.631 0.582 . . . . 65.33 112.15 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 95' ' ' ALA . 4.5 tt -164.46 167.02 20.0 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 107.998 -1.112 . . . . 55.21 107.998 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . 0.405 ' CZ ' HG13 ' A' ' 58' ' ' VAL . 72.6 t80 73.94 30.15 1.33 Allowed 'General case' 0 CA--C 1.561 1.388 0 CA-C-O 122.862 1.315 . . . . 73.42 110.3 172.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -109.18 13.05 24.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 114.69 -1.141 . . . . 72.01 109.063 166.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -148.93 147.22 28.38 Favored 'General case' 0 C--O 1.246 0.88 0 C-N-CA 124.657 1.183 . . . . 65.14 109.398 -166.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.71 100.03 0.35 Allowed Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.558 -0.617 . . . . 54.42 111.558 176.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . 0.442 ' HB2' ' SD ' ' E' ' 286' ' ' MET . 18.8 m120 -57.99 -51.08 71.12 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.157 0.983 . . . . 71.44 112.276 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . 0.442 ' SD ' ' HB2' ' E' ' 285' ' ' ASN . 0.0 OUTLIER -145.28 146.09 29.03 Favored Pre-proline 0 N--CA 1.48 1.045 0 C-N-CA 123.595 0.758 . . . . 73.3 110.202 -179.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.46 128.35 20.06 Favored 'Trans proline' 0 C--N 1.381 2.251 0 C-N-CA 122.998 2.466 . . . . 74.52 112.258 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . 0.44 HG13 HG11 ' A' ' 131' ' ' VAL . 99.8 t -95.73 122.63 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 N-CA-C 108.556 -0.905 . . . . 70.01 108.556 177.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -78.12 149.62 33.81 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.891 -0.781 . . . . 71.13 108.891 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . 0.511 ' HH2' HD11 ' A' ' 126' ' ' LEU . 5.0 t-105 -91.62 124.95 36.16 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.639 -0.504 . . . . 74.42 109.639 174.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.5 15.78 28.12 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.108 0.963 . . . . 73.1 110.846 -171.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -128.07 64.98 0.58 Allowed Glycine 0 C--N 1.351 1.407 0 CA-C-O 119.404 -0.664 . . . . 52.22 112.475 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.52 177.29 9.01 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 122.385 2.057 . . . . 63.12 111.653 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt 67.77 12.77 9.0 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.308 1.043 . . . . 71.02 111.388 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . 0.501 ' HB1' ' HD2' ' A' ' 38' ' ' PRO . . . 68.52 153.97 0.1 Allowed 'General case' 0 C--N 1.361 1.074 0 C-N-CA 125.342 1.457 . . . . 71.34 113.192 -177.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 6.0 t -85.09 70.35 10.89 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-O 122.426 1.108 . . . . 42.22 110.421 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -151.94 -67.98 0.17 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 114.673 -1.148 . . . . 75.03 109.309 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 64.9 14.29 9.15 Favored 'General case' 0 CA--C 1.567 1.598 0 C-N-CA 124.888 1.275 . . . . 73.45 110.826 -173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 159.51 -166.24 34.75 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-N 116.243 -0.435 . . . . 50.02 112.496 -177.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -79.52 175.98 10.11 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.056 0.942 . . . . 75.05 110.103 -177.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 20.7 pt -136.52 -153.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 123.59 0.756 . . . . 73.23 110.11 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.54 -172.78 0.08 Allowed 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.161 0.984 . . . . 70.13 111.369 162.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -146.8 164.45 23.68 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 122.689 0.396 . . . . 54.24 110.872 -172.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -75.49 55.13 4.1 Favored 'Trans proline' 0 C--N 1.377 2.034 0 C-N-CA 122.835 2.357 . . . . 64.34 112.532 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -167.07 115.84 0.84 Allowed 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.975 1.31 . . . . 73.42 108.152 178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 95.3 t -73.89 -79.97 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 122.786 0.434 . . . . 55.22 110.338 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . 0.41 HG22 ' HB3' ' G' ' 295' ' ' ALA . 20.2 p -141.15 -84.63 0.2 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.835 0.454 . . . . 64.41 110.703 -173.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . 0.518 ' SG ' ' HD2' ' E' ' 310' ' ' PRO . 48.9 t -178.73 -176.96 0.49 Allowed 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.442 1.097 . . . . 74.11 109.226 -174.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . 0.433 ' HA ' HD23 ' G' ' 291' ' ' LEU . 4.4 p -135.34 -45.52 0.02 OUTLIER Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 117.952 -1.023 . . . . 52.44 112.581 170.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . 0.518 ' HD2' ' SG ' ' E' ' 308' ' ' CYS . 51.3 Cg_exo . . . . . 0 C--N 1.398 3.157 0 C-N-CA 122.382 2.054 . . . . 75.15 112.5 168.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.771 0 N-CA-C 109.939 -0.393 . . . . 53.13 109.939 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -150.96 -77.97 0.13 Allowed 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 108.821 -0.807 . . . . 74.5 108.821 177.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -146.13 -79.27 0.17 Allowed 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 123.598 0.759 . . . . 65.13 109.87 176.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 98.2 mt-30 -109.51 125.08 52.12 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.704 0.802 . . . . 74.21 110.582 -170.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -113.93 96.66 42.32 Favored Pre-proline 0 CA--C 1.548 0.869 0 N-CA-C 108.172 -1.048 . . . . 74.24 108.172 172.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -61.05 146.46 97.68 Favored 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.899 2.4 . . . . 62.43 112.694 -176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . 0.515 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 96.0 mt 61.22 27.97 17.63 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 124.982 1.313 . . . . 71.01 112.594 -178.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.591 HD12 HD22 ' C' ' 98' ' ' LEU . 8.9 tp -167.12 178.32 5.74 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.772 0.829 . . . . 72.31 109.027 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 155.61 37.1 0.02 OUTLIER Glycine 0 C--N 1.353 1.497 0 CA-C-O 119.793 -0.449 . . . . 63.14 113.677 173.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . 0.708 HD13 ' H ' ' F' ' 281' ' ' PHE . 0.2 OUTLIER -168.5 168.46 11.06 Favored 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 107.607 -1.257 . . . . 75.21 107.607 178.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . 0.708 ' H ' HD13 ' F' ' 280' ' ' LEU . 22.2 m-30 80.64 -62.16 0.23 Allowed 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 126.265 1.826 . . . . 74.34 110.906 178.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -68.18 -8.43 38.69 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 123.949 0.9 . . . . 73.31 111.59 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -68.77 -35.25 76.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.754 0.822 . . . . 63.12 110.803 176.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 165.13 4.68 0.04 OUTLIER Glycine 0 C--N 1.355 1.588 0 CA-C-O 118.729 -1.039 . . . . 70.14 114.444 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 67.8 117.93 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 124.969 1.308 . . . . 75.13 110.752 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 28.4 ttt -69.84 115.46 33.73 Favored Pre-proline 0 CA--C 1.552 1.026 0 C-N-CA 122.932 0.493 . . . . 53.44 110.506 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -75.45 142.71 26.84 Favored 'Trans proline' 0 C--N 1.383 2.382 0 C-N-CA 122.467 2.112 . . . . 74.23 112.412 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 57.3 t -114.16 130.83 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.447 0.699 . . . . 72.1 109.145 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -105.83 145.97 30.52 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.923 0.889 . . . . 61.42 109.146 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . 0.754 ' HH2' HD21 ' C' ' 126' ' ' LEU . 47.8 m95 -76.84 162.11 27.9 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.842 0.83 . . . . 72.23 112.309 177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 4.8 mp -93.25 -45.73 7.71 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 113.946 -1.479 . . . . 71.32 108.074 174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.74 122.51 0.66 Allowed Glycine 0 CA--C 1.532 1.15 0 CA-C-N 114.996 -1.002 . . . . 53.4 111.387 179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.26 -2.93 13.2 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.09 2.527 . . . . 71.21 112.798 176.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -61.67 -33.2 73.57 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 124.653 1.181 . . . . 65.02 112.029 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.51 -16.98 63.55 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.14 0.976 . . . . 63.24 112.552 -176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 27.1 m -125.22 151.92 45.26 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.675 0.79 . . . . 55.44 110.376 -176.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.424 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 6.4 t80 70.31 51.87 0.37 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.387 1.075 . . . . 74.5 111.375 165.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -92.75 5.64 50.41 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.758 0.79 . . . . 62.43 109.876 170.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 115.68 139.65 6.8 Favored Glycine 0 C--N 1.345 1.057 0 CA-C-N 115.676 -0.693 . . . . 61.11 111.987 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . 0.45 ' HB2' ' HG3' ' C' ' 124' ' ' PRO . 15.6 t-20 -132.01 -22.01 2.35 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.027 -0.731 . . . . 72.51 109.027 168.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.583 HG23 ' HB2' ' F' ' 305' ' ' ALA . 2.6 mp -115.88 78.49 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.931 0 C-N-CA 124.147 0.979 . . . . 71.41 109.645 -175.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -97.21 164.88 12.3 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.136 -1.061 . . . . 64.44 108.136 166.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 65.62 -164.8 0.01 OUTLIER Pre-proline 0 CA--C 1.576 1.968 0 CA-C-O 118.395 -0.812 . . . . 75.22 109.566 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -72.41 20.13 0.31 Allowed 'Trans proline' 0 C--N 1.389 2.705 0 CA-C-N 122.506 1.931 . . . . 73.13 113.977 165.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . 0.583 ' HB2' HG23 ' F' ' 301' ' ' ILE . . . 67.36 -75.75 0.06 Allowed 'General case' 0 C--N 1.366 1.296 0 C-N-CA 125.658 1.583 . . . . 64.33 111.574 -177.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 57.1 t -110.18 113.12 43.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 N-CA-C 105.752 -1.944 . . . . 72.02 105.752 171.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 18.8 m -83.91 -24.35 30.8 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 122.801 0.44 . . . . 73.54 111.145 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 67.8 m -144.47 139.67 28.45 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.846 0.459 . . . . 74.22 111.075 -176.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . 0.442 HG23 ' O ' ' B' ' 130' ' ' PRO . 38.1 m -124.52 113.03 27.5 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.788 0.835 . . . . 63.43 109.984 -178.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo . . . . . 0 C--N 1.379 2.184 0 C-N-CA 123.49 2.793 . . . . 73.14 111.501 175.404 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 109.484 -0.562 . . . . 52.12 109.484 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -163.12 109.8 1.18 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 107.458 -1.312 . . . . 61.25 107.458 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -142.43 166.16 25.42 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.349 -0.982 . . . . 74.3 108.349 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . 0.481 ' HA ' HD12 ' G' ' 277' ' ' LEU . 15.8 mt-30 69.5 38.73 1.71 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.4 1.08 . . . . 75.4 110.598 177.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . 0.51 ' HB2' ' HD3' ' G' ' 276' ' ' PRO . 18.9 mtmt -69.66 -52.43 14.05 Favored Pre-proline 0 CA--C 1.566 1.573 0 CA-C-N 115.137 -0.938 . . . . 72.41 111.442 -173.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . 0.528 ' HG3' ' H ' ' D' ' 91' ' ' GLY . 43.1 Cg_endo -90.37 -5.13 4.83 Favored 'Trans proline' 0 C--N 1.395 3.006 0 C-N-CA 121.69 1.593 . . . . 75.13 112.572 173.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.572 HD23 ' HG3' ' D' ' 94' ' ' MET . 94.3 mt -74.96 93.66 2.72 Favored 'General case' 0 C--N 1.358 0.954 0 C-N-CA 123.007 0.523 . . . . 70.11 109.884 -176.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . 0.626 HD22 ' HB3' ' D' ' 56' ' ' TYR . 22.6 tp 74.34 80.57 0.12 Allowed 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 113.879 -1.509 . . . . 73.15 111.71 173.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . 0.437 ' H ' HD11 ' D' ' 98' ' ' LEU . . . 165.46 53.28 0.02 OUTLIER Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.591 -0.731 . . . . 72.15 112.09 174.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.475 ' HB2' HD13 ' D' ' 98' ' ' LEU . 2.9 tm? -92.78 -68.11 0.82 Allowed 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 109.609 -0.515 . . . . 63.32 109.609 179.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -110.07 142.99 40.75 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 122.922 0.489 . . . . 65.31 109.708 178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -148.44 -31.68 0.26 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.707 0.803 . . . . 74.5 110.92 -177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -59.8 -49.61 77.04 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.413 1.085 . . . . 64.21 111.742 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.05 -166.17 29.65 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.849 -0.614 . . . . 61.41 113.166 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 19.6 m120 52.43 85.67 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.315 1.446 . . . . 74.25 111.743 -173.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . 0.546 ' SD ' HD22 ' D' ' 44' ' ' LEU . 64.0 mtt -76.07 161.19 76.32 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-N 115.398 -0.819 . . . . 74.41 109.528 173.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . 0.4 ' HG2' HD22 ' D' ' 136' ' ' LEU . 93.0 Cg_endo -75.48 38.04 0.54 Allowed 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.941 2.427 . . . . 73.41 113.764 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . 0.509 HG11 HD13 ' D' ' 42' ' ' LEU . 48.1 t -80.51 94.69 2.28 Favored 'Isoleucine or valine' 0 C--N 1.353 0.743 0 N-CA-C 108.568 -0.901 . . . . 75.1 108.568 175.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 14.1 tpt180 -92.21 27.03 2.32 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 124.32 1.048 . . . . 74.31 109.327 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 66.6 m95 63.6 172.39 0.17 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 124.93 1.292 . . . . 74.01 112.891 -171.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' E' ' 309' ' ' THR . 3.5 mp -104.99 -15.02 15.23 Favored 'General case' 0 CA--C 1.548 0.871 0 CA-C-N 114.026 -1.443 . . . . 70.51 108.638 173.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -161.87 94.67 0.13 Allowed Glycine 0 C--N 1.349 1.279 0 N-CA-C 109.2 -1.56 . . . . 75.33 109.2 174.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.06 -23.21 59.59 Favored 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 123.523 2.815 . . . . 72.33 114.629 -173.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -144.44 88.5 1.94 Allowed 'General case' 0 C--O 1.242 0.695 0 N-CA-C 109.16 -0.682 . . . . 75.22 109.16 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . 0.584 ' HA ' HE21 ' D' ' 37' ' ' GLN . . . -169.03 99.51 0.37 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.083 -0.962 . . . . 74.22 109.138 178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . 0.488 ' HB ' ' HD2' ' D' ' 38' ' ' PRO . 5.6 m -146.48 -62.31 0.3 Allowed 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 123.015 0.526 . . . . 63.22 110.34 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.402 ' O ' ' HA ' ' D' ' 37' ' ' GLN . 0.0 OUTLIER -157.97 163.88 37.37 Favored 'General case' 0 N--CA 1.501 2.12 0 C-N-CA 123.107 0.563 . . . . 75.42 110.906 -177.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -161.36 134.46 6.33 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.637 -0.875 . . . . 63.24 108.637 170.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -161.49 -146.01 4.5 Favored Glycine 0 C--N 1.344 1.021 0 CA-C-O 119.848 -0.418 . . . . 74.4 113.007 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -147.73 97.86 2.88 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.335 0.654 . . . . 65.53 109.369 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.513 HD13 HH12 ' C' ' 15' ' ' ARG . 80.6 mt -72.16 125.48 30.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 CA-C-N 115.104 -0.953 . . . . 73.21 111.432 -176.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -171.36 149.33 2.72 Favored 'General case' 0 C--O 1.238 0.48 0 O-C-N 124.509 1.131 . . . . 73.13 108.619 163.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . 0.518 ' HD3' ' HB ' ' G' ' 306' ' ' VAL . 1.0 OUTLIER -60.61 141.97 91.75 Favored Pre-proline 0 CA--C 1.561 1.393 0 C-N-CA 123.894 0.878 . . . . 54.3 110.467 174.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -71.83 81.32 1.37 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.584 2.189 . . . . 64.41 112.545 -179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . 70.53 -68.07 0.22 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.954 1.701 . . . . 55.41 111.795 -178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.518 ' HB ' ' HD3' ' G' ' 303' ' ' LYS . 33.4 t 35.9 70.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 C-N-CA 126.405 1.882 . . . . 54.14 112.698 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 40.9 p -90.63 -60.07 2.01 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 115.306 -0.861 . . . . 63.4 109.91 -177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 83.8 m -149.36 148.64 29.74 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 123.701 0.8 . . . . 61.22 110.139 -178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . 0.504 ' N ' ' HD2' ' G' ' 310' ' ' PRO . 15.8 p -78.54 -32.82 0.86 Allowed Pre-proline 0 CA--C 1.572 1.824 0 CA-C-O 117.627 -1.178 . . . . 65.21 114.001 175.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' G' ' 309' ' ' THR . 11.2 Cg_endo . . . . . 0 C--N 1.408 3.705 0 C-N-CA 122.492 2.128 . . . . 51.34 112.976 170.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 109.841 -0.429 . . . . 61.14 109.841 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -72.33 -9.7 58.84 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.571 0.748 . . . . 74.34 111.27 176.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 -63.36 93.84 0.07 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.276 1.03 . . . . 73.41 110.024 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -114.5 162.21 17.0 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.365 1.066 . . . . 74.53 109.463 178.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 22.5 pttm -147.33 103.19 3.76 Favored Pre-proline 0 CA--C 1.548 0.879 0 C-N-CA 122.905 0.482 . . . . 74.14 110.362 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -70.44 133.62 24.72 Favored 'Trans proline' 0 C--N 1.368 1.6 0 C-N-CA 121.869 1.713 . . . . 74.41 109.993 165.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 9.7 tt -60.33 -36.53 78.18 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.071 0.548 . . . . 70.31 109.845 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -71.51 90.68 1.01 Allowed 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 109.196 -0.668 . . . . 72.4 109.196 173.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . 0.448 ' H ' ' HE1' ' B' ' 94' ' ' MET . . . -116.52 -64.46 0.35 Allowed Glycine 0 C--N 1.345 1.06 0 N-CA-C 110.446 -1.061 . . . . 62.25 110.446 173.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' B' ' 95' ' ' ALA . 4.4 mm? -71.21 74.06 0.68 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 124.527 1.131 . . . . 70.44 111.625 -178.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -176.49 -88.13 0.0 OUTLIER 'General case' 0 C--N 1.361 1.1 0 C-N-CA 123.619 0.768 . . . . 72.34 110.939 177.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -85.69 80.64 8.92 Favored 'General case' 0 C--N 1.357 0.917 0 CA-C-O 121.438 0.637 . . . . 65.53 109.903 -170.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -126.1 -36.26 2.36 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.691 -1.14 . . . . 71.14 108.951 177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -155.85 148.95 19.76 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.032 -0.986 . . . . 62.45 111.053 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -73.12 165.63 24.67 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 123.274 0.63 . . . . 71.44 111.072 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 52.2 ttp -126.01 89.95 51.28 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 123.307 0.643 . . . . 43.33 109.554 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.65 111.96 2.93 Favored 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.8 2.334 . . . . 44.25 110.919 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 87.6 t -74.03 127.2 35.72 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 123.003 0.521 . . . . 52.41 109.658 177.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -64.91 112.64 3.38 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 108.761 -0.829 . . . . 63.42 108.761 173.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -61.05 124.05 19.39 Favored 'General case' 0 CA--C 1.543 0.691 0 O-C-N 124.118 0.886 . . . . 72.54 111.16 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.32 139.74 45.89 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 124.166 0.987 . . . . 64.44 108.598 175.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 178.83 85.31 0.06 OUTLIER Glycine 0 C--N 1.336 0.556 0 N-CA-C 110.333 -1.107 . . . . 34.4 110.333 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.36 -33.57 94.22 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 123.143 2.562 . . . . 74.53 113.167 -176.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -81.06 -20.11 42.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.036 0.534 . . . . 61.2 111.308 179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 65.24 -176.85 0.18 Allowed 'General case' 0 CA--C 1.557 1.227 0 C-N-CA 124.729 1.212 . . . . 75.51 112.678 -178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 43.9 m -94.05 -63.22 1.22 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.923 0.889 . . . . 61.22 110.262 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.68 148.14 28.09 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 115.076 -0.965 . . . . 73.11 109.531 -175.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 63.9 m80 -136.96 -72.01 0.44 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 109.006 -0.739 . . . . 75.23 109.006 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.93 62.31 0.14 Allowed Glycine 0 C--N 1.352 1.454 0 C-N-CA 121.24 -0.505 . . . . 55.42 113.416 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -136.83 109.69 7.61 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 124.624 1.169 . . . . 71.32 108.334 178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . 0.567 HG12 ' H ' ' H' ' 302' ' ' ASP . 10.7 tt -163.05 179.58 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.255 0 O-C-N 123.405 0.44 . . . . 62.45 110.653 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . 0.567 ' H ' HG12 ' H' ' 301' ' ' ILE . 5.4 m-20 -55.68 106.85 0.28 Allowed 'General case' 0 C--N 1.363 1.185 0 C-N-CA 124.943 1.297 . . . . 74.34 110.48 176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . 0.617 ' HB3' ' HD3' ' H' ' 304' ' ' PRO . 37.6 ttpt -162.17 -54.57 0.01 OUTLIER Pre-proline 0 CA--C 1.548 0.902 0 N-CA-C 108.219 -1.03 . . . . 75.42 108.219 171.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' H' ' 303' ' ' LYS . 10.4 Cg_endo -95.95 47.7 0.16 Allowed 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 122.689 2.259 . . . . 70.25 109.973 163.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.14 -171.34 1.68 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.364 1.065 . . . . 75.43 111.874 -174.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 19.5 t -79.97 76.48 0.84 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 CA-C-O 122.144 0.973 . . . . 65.25 109.848 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 31.4 m -121.42 -38.22 2.81 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.133 0.973 . . . . 73.2 108.604 175.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 85.7 m -85.7 77.17 9.85 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 115.56 -0.746 . . . . 44.41 110.82 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 16.5 p -135.47 78.01 51.77 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 124.229 1.011 . . . . 71.34 108.554 172.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo . . . . . 0 C--N 1.377 2.073 0 C-N-CA 122.964 2.443 . . . . 71.33 111.636 178.758 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ttt . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 109.652 -0.499 . . . . 62.31 109.652 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.5 t -160.07 -64.88 0.07 Allowed 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.386 0.674 . . . . 41.43 109.548 176.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -138.29 -58.5 0.64 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 124.229 1.012 . . . . 62.14 110.079 176.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -78.08 -15.15 59.15 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.47 0.708 . . . . 71.2 112.807 -174.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.8 t30 73.76 138.32 0.06 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.542 1.537 . . . . 72.32 111.451 -174.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.9 m120 -105.33 -7.23 18.99 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.642 0.777 . . . . 62.44 111.961 -175.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.4 p -92.78 25.45 3.13 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.899 0.48 . . . . 72.04 111.028 177.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.419 ' O ' ' HA3' ' A' ' 88' ' ' GLY . 40.7 tt0 -124.72 122.51 37.68 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.625 0.77 . . . . 72.41 109.633 176.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.517 ' HG3' HG23 ' A' ' 89' ' ' ILE . 1.9 mpp? -75.6 146.88 40.02 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.675 0.79 . . . . 71.4 110.0 -179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.2 m -142.73 135.77 28.27 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.415 0.686 . . . . 63.13 109.932 176.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.451 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 21.7 t80 -137.08 131.69 33.07 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.784 0.834 . . . . 71.12 109.442 174.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.0 tp60 -154.96 108.09 2.81 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 123.688 0.618 . . . . 64.51 109.904 177.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.684 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.4 mt -70.84 119.56 17.27 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 N-CA-C 110.015 -0.365 . . . . 74.14 110.015 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.658 ' HA ' ' HA ' ' H' ' 307' ' ' THR . 1.5 tm0? -82.68 -33.01 27.8 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.646 0.778 . . . . 73.13 110.674 -177.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -173.37 136.77 0.62 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.011 0.524 . . . . 64.25 110.182 -175.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.43 ' O ' HD12 ' A' ' 16' ' ' ILE . 2.5 pp -122.59 139.39 49.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 109.058 -0.719 . . . . 74.32 109.058 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 12.4 p90 -173.91 172.28 3.48 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-O 121.422 0.63 . . . . 73.41 111.189 -170.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.4 p -94.93 123.45 38.41 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 115.386 -0.825 . . . . 61.53 108.849 171.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.425 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 39.8 mtpt -83.24 -34.89 25.74 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 110.003 -0.369 . . . . 74.12 110.003 176.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.404 ' HA ' ' O ' ' B' ' 23' ' ' PHE . 10.2 t70 -152.99 140.66 19.94 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 115.524 -0.762 . . . . 72.32 109.127 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 77.5 mt -129.96 143.67 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 C-N-CA 124.268 1.027 . . . . 62.32 108.5 -178.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.1 t -146.64 122.53 10.65 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.313 0.383 . . . . 74.22 110.41 174.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.47 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 91.6 t80 -123.58 140.72 52.72 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 107.721 -1.214 . . . . 72.34 107.721 166.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -139.36 133.93 31.79 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.828 0.451 . . . . 75.41 110.438 175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.655 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -150.34 72.61 9.19 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 125.606 1.562 . . . . 75.24 107.414 167.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.4 Cg_exo -69.42 -42.57 3.63 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 122.791 2.327 . . . . 73.31 111.465 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -94.94 27.7 3.04 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 114.631 -1.168 . . . . 63.45 110.803 176.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.655 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -49.24 -53.2 41.76 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 118.216 -0.897 . . . . 74.33 112.211 176.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -61.93 -30.41 83.61 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 121.945 1.763 . . . . 74.01 113.036 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -74.42 -50.03 20.13 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-O 121.58 0.705 . . . . 61.33 110.139 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.4 p -70.42 -22.6 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.055 0 CA-C-N 114.49 -1.232 . . . . 73.21 112.168 -170.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 19.0 m-85 -64.74 -27.94 69.25 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 112.105 0.409 . . . . 63.41 112.105 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -100.94 -10.81 20.26 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 112.653 0.612 . . . . 74.12 112.653 -179.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.641 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 32.0 mmtp -72.0 172.67 9.61 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.744 0.646 . . . . 73.23 112.744 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -50.79 117.56 2.57 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.599 1.16 . . . . 73.32 110.997 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -69.61 65.0 0.19 Allowed 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 126.063 1.745 . . . . 73.21 110.691 -172.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -148.63 68.96 10.13 Favored Pre-proline 0 N--CA 1.485 1.314 0 C-N-CA 124.603 1.161 . . . . 71.45 109.491 -171.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.59 ' HG2' ' HB ' ' E' ' 296' ' ' THR . 56.6 Cg_endo -85.94 120.3 1.95 Allowed 'Trans proline' 0 C--N 1.373 1.822 0 C-N-CA 122.791 2.327 . . . . 72.2 112.706 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -93.93 105.16 17.19 Favored 'General case' 0 C--O 1.245 0.825 0 N-CA-C 107.651 -1.24 . . . . 53.53 107.651 176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.1 p -85.09 124.98 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.487 -0.779 . . . . 72.01 109.932 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.0 tttm -102.82 117.77 35.35 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 124.552 1.141 . . . . 61.15 108.737 -178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.433 ' HB2' ' NE1' ' E' ' 290' ' ' TRP . 1.1 tt -96.82 129.02 44.32 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.045 -1.094 . . . . 61.44 108.045 -179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.734 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.0 m-20 -134.51 140.01 45.87 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.669 0.788 . . . . 74.42 109.951 175.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.48 119.06 31.89 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.219 -1.03 . . . . 74.14 108.219 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 32.3 t70 -121.42 141.56 50.87 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 107.18 -1.415 . . . . 73.1 107.18 172.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.0 t -149.07 159.18 44.47 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 117.881 0.309 . . . . 74.0 111.518 -168.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.44 116.12 1.08 Allowed 'General case' 0 N--CA 1.473 0.681 0 O-C-N 123.697 0.623 . . . . 72.34 110.917 -175.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.2 p -89.91 153.45 20.61 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.809 -0.811 . . . . 64.52 108.809 168.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -159.02 159.65 35.0 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 108.327 -0.99 . . . . 64.34 108.327 -174.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -112.29 129.78 56.17 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 109.432 -0.581 . . . . 74.02 109.432 177.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 57' ' ' GLU . 77.4 mt -99.1 -39.43 8.5 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.947 0.899 . . . . 62.34 110.965 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -148.7 178.43 8.65 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.627 0.771 . . . . 72.24 109.556 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -62.07 117.64 6.26 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.952 -0.758 . . . . 70.42 108.952 175.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 71.51 0.72 3.58 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.275 1.43 . . . . 64.34 112.835 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.45 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 61.7 t -108.51 119.02 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 N-CA-C 108.567 -0.901 . . . . 74.44 108.567 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -130.14 141.1 50.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 122.952 0.501 . . . . 75.52 110.108 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.649 ' HB2' HD11 ' A' ' 51' ' ' LEU . 39.9 tt0 -104.03 142.49 34.36 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.419 0.688 . . . . 72.32 109.899 175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 97.9 t -123.83 128.28 74.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 N-CA-C 108.423 -0.954 . . . . 64.04 108.423 169.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.7 t -107.88 131.13 59.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 N-CA-C 109.137 -0.69 . . . . 70.44 109.137 174.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.523 HD23 HD12 ' A' ' 106' ' ' LEU . 4.1 mm? -110.94 100.8 9.44 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 107.767 -1.197 . . . . 62.3 107.767 173.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.448 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 37.6 ttp85 -84.01 100.52 11.12 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.423 -0.954 . . . . 71.43 108.423 172.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.479 ' HB ' HD11 ' A' ' 114' ' ' ILE . 35.7 t -95.08 121.62 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 108.414 -0.958 . . . . 71.34 108.414 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.734 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 23.4 m -108.52 131.38 54.89 Favored 'General case' 0 C--O 1.238 0.498 0 N-CA-C 109.66 -0.496 . . . . 72.11 109.66 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.41 HG21 HG21 ' A' ' 114' ' ' ILE . 67.0 t -128.86 109.27 18.62 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.134 0 C-N-CA 124.824 1.249 . . . . 64.34 107.805 178.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 9.8 m -108.1 151.49 25.81 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.062 -1.088 . . . . 73.41 108.062 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.28 128.14 23.49 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.149 -1.056 . . . . 64.13 108.149 171.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 42.7 m -137.54 127.61 25.94 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 118.202 0.456 . . . . 51.54 111.594 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.1 mp -89.75 80.45 6.55 Favored 'General case' 0 C--O 1.246 0.873 0 C-N-CA 124.837 1.255 . . . . 43.12 108.354 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.53 -84.04 0.88 Allowed Glycine 0 C--N 1.348 1.231 0 N-CA-C 110.22 -1.152 . . . . 63.45 110.22 -172.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -126.95 -12.94 5.84 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.132 0.973 . . . . 65.21 111.387 177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.641 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 4.5 tp10 -90.17 99.77 12.73 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.286 0.634 . . . . 72.34 110.553 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 87.4 m -67.58 129.58 40.34 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.206 0.526 . . . . 64.51 111.985 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.494 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -76.12 -64.07 1.18 Allowed 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.394 0.678 . . . . 54.03 110.077 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.11 158.92 41.16 Favored 'General case' 0 C--O 1.242 0.679 0 CA-C-N 115.179 -0.919 . . . . 72.33 111.854 -176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 52.6 tp -130.29 107.54 9.35 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 114.622 -1.172 . . . . 54.25 107.882 172.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.47 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 62.0 m -108.98 110.53 21.84 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.327 1.051 . . . . 72.14 109.191 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -130.29 117.37 19.71 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.603 -0.888 . . . . 62.32 108.603 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 66.1 t -123.63 120.55 60.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 123.745 0.818 . . . . 72.33 110.241 -173.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -90.68 82.49 5.76 Favored 'General case' 0 C--O 1.245 0.865 0 C-N-CA 124.217 1.007 . . . . 73.42 108.358 176.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.36 100.32 8.37 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.909 -1.041 . . . . 73.15 109.571 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.96 145.32 17.54 Favored Glycine 0 C--N 1.34 0.774 0 N-CA-C 111.796 -0.521 . . . . 74.11 111.796 178.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.02 120.31 1.88 Allowed Glycine 0 CA--C 1.504 -0.624 0 N-CA-C 110.388 -1.085 . . . . 64.3 110.388 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.455 HG23 HD12 ' A' ' 51' ' ' LEU . 55.7 mt -87.45 127.72 40.56 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.555 -0.905 . . . . 74.31 108.555 174.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.684 ' HD2' HG12 ' A' ' 13' ' ' ILE . 1.4 m-85 -133.54 162.78 30.98 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 108.959 -0.756 . . . . 74.13 108.959 178.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.4 t -119.73 113.47 20.7 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.156 0.982 . . . . 63.22 108.494 174.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.473 HD12 ' SG ' ' A' ' 97' ' ' CYS . 11.5 tt -126.71 148.71 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 C-N-CA 122.964 0.506 . . . . 74.43 110.529 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.65 165.83 22.93 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 124.02 0.928 . . . . 74.11 109.308 174.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 8' ' ' GLU . . . 88.49 11.78 65.84 Favored Glycine 0 C--N 1.345 1.077 0 CA-C-O 118.883 -0.954 . . . . 71.31 114.693 171.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.517 HG23 ' HG3' ' A' ' 9' ' ' MET . 1.6 pp -141.61 161.77 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 CA-C-N 117.92 0.86 . . . . 63.53 112.24 -179.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.52 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.8 tt0 -160.59 -175.59 5.08 Favored 'General case' 0 CA--C 1.563 1.453 0 C-N-CA 124.951 1.3 . . . . 74.41 107.689 167.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.52 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 70.43 -140.04 31.5 Favored Glycine 0 C--N 1.351 1.405 0 CA-C-N 118.04 0.382 . . . . 72.02 113.348 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 64.1 p -72.6 -29.94 63.93 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.386 0.674 . . . . 74.31 111.116 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -61.64 -45.69 92.97 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.604 0.762 . . . . 50.54 111.027 177.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.516 ' SD ' HD21 ' A' ' 98' ' ' LEU . 9.0 tmm? -66.64 -51.22 58.63 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 115.452 -0.795 . . . . 64.04 110.116 174.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.43 ' HB1' HD23 ' E' ' 280' ' ' LEU . . . -60.7 -22.74 64.26 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 124.021 0.928 . . . . 71.04 112.528 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -77.23 -32.16 55.62 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.548 0.739 . . . . 72.11 110.846 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.473 ' SG ' HD12 ' A' ' 86' ' ' ILE . 49.4 t -69.65 -64.52 0.86 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 122.375 0.27 . . . . 72.34 110.886 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.54 HD23 ' H ' ' A' ' 98' ' ' LEU . 1.2 pt? -67.97 -27.14 66.34 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 119.09 -0.481 . . . . 72.22 110.671 177.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -88.16 -8.99 71.02 Favored Glycine 0 C--N 1.351 1.372 0 N-CA-C 114.913 0.725 . . . . 60.22 114.913 -173.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.62 0.18 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 118.399 1.099 . . . . 74.02 111.821 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.451 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 76.0 t80 -63.33 -62.51 1.64 Allowed 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.202 1.001 . . . . 75.12 112.442 -170.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 92.9 m -65.53 -33.29 7.32 Favored Pre-proline 0 CA--C 1.564 1.519 0 N-CA-C 114.114 1.153 . . . . 55.02 114.114 -179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -50.17 -50.79 12.42 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.451 2.1 . . . . 73.11 112.405 161.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -64.92 -22.63 67.03 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.606 0.762 . . . . 64.21 112.069 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.432 HG21 HD11 ' A' ' 13' ' ' ILE . 49.7 mm -71.16 -50.34 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 109.385 -0.598 . . . . 54.3 109.385 172.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.523 HD12 HD23 ' A' ' 60' ' ' LEU . 77.7 mt -82.87 -19.54 37.25 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.736 -0.666 . . . . 60.15 112.749 -171.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -62.3 -42.97 83.79 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 124.09 0.956 . . . . 72.13 112.785 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.0 -37.73 91.75 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.106 1.871 . . . . 73.12 113.713 170.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -71.21 -39.72 71.57 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.218 0.607 . . . . 72.32 111.487 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.76 -47.83 73.91 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 109.459 -0.571 . . . . 72.14 109.459 175.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 37.4 ttm105 -51.61 -48.56 63.21 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 124.728 1.267 . . . . 71.31 110.891 177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.95 -48.91 72.37 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.609 0.764 . . . . 64.41 110.906 -177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.8 t -62.16 -30.06 70.79 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 122.953 0.501 . . . . 64.31 111.958 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.479 HD11 ' HB ' ' A' ' 62' ' ' VAL . 96.4 mt -72.17 -59.16 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 N-CA-C 109.375 -0.602 . . . . 72.33 109.375 172.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 86.7 m -51.48 -40.32 59.28 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.882 1.273 . . . . 72.1 112.676 -174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -66.4 -41.83 88.75 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.473 -0.785 . . . . 75.33 110.368 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.457 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 30.5 mtm -69.21 -35.62 76.4 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 122.468 0.307 . . . . 65.53 110.832 177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 114' ' ' ILE . 86.7 t -59.67 -44.27 93.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 O-C-N 123.848 0.717 . . . . 72.34 109.948 177.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.5 p -75.29 -32.25 60.94 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 116.059 -0.519 . . . . 72.11 111.411 -179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.2 mtt-85 -68.84 -31.75 70.95 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 123.434 0.694 . . . . 72.13 110.528 175.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.3 7.15 68.91 Favored Glycine 0 C--N 1.354 1.552 0 O-C-N 123.531 0.519 . . . . 74.25 112.613 173.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.5 p 56.17 49.71 14.91 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 126.493 1.917 . . . . 64.42 112.483 175.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -110.42 161.61 23.89 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-N 113.028 -1.896 . . . . 73.34 108.329 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.8 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 33.5 Cg_endo -59.98 162.11 17.2 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.157 2.571 . . . . 73.01 111.982 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -72.55 137.7 46.42 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.535 0.684 . . . . 72.31 110.71 -177.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 56.7 tp -120.36 137.38 54.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 114.699 -1.137 . . . . 73.02 108.611 176.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 64.9 m-80 -135.12 127.14 29.68 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 108.763 -0.828 . . . . 73.0 108.763 175.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -68.44 125.77 27.52 Favored 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 109.229 -0.656 . . . . 74.1 109.229 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.541 ' HB3' HD11 ' E' ' 291' ' ' LEU . . . -71.78 150.51 93.14 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 122.844 0.458 . . . . 72.14 111.382 -177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.496 ' HG2' ' HD2' ' C' ' 11' ' ' PHE . 32.2 Cg_exo -60.29 105.12 0.27 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.764 2.309 . . . . 60.52 111.931 176.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.36 116.16 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 107.132 -1.432 . . . . 70.21 107.132 174.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -77.86 83.05 4.21 Favored 'General case' 0 CA--C 1.549 0.92 0 O-C-N 123.691 0.62 . . . . 52.03 109.506 -176.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -62.55 -33.39 74.84 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 115.088 -0.96 . . . . 70.32 110.555 177.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -56.74 -49.2 75.95 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.405 1.066 . . . . 73.13 110.41 177.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.13 -38.73 80.32 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 124.151 0.907 . . . . 73.21 111.99 -173.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 6.2 tt -53.64 -46.03 70.4 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.324 0.65 . . . . 73.2 110.259 -176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -82.82 -35.61 26.24 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.553 0.741 . . . . 75.35 111.108 178.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.2 tpt -73.22 -32.09 64.56 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.202 0.601 . . . . 74.13 112.321 -169.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 88.8 m-20 -64.4 -31.27 72.42 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.801 0.84 . . . . 73.13 111.238 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -82.48 -32.57 28.78 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.059 -0.973 . . . . 75.22 110.375 176.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 12.2 tp -67.05 -49.33 65.52 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.294 0.638 . . . . 74.35 110.765 -177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -169.74 -4.24 0.02 OUTLIER 'General case' 0 CA--C 1.563 1.471 0 CA-C-N 115.435 -0.802 . . . . 63.31 111.69 -174.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.749 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 29.1 tt0 69.33 147.93 0.07 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.523 1.529 . . . . 74.23 111.997 -169.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 -72.24 133.45 45.07 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.049 0.54 . . . . 64.51 110.748 177.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -112.79 124.34 52.37 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.516 0.727 . . . . 72.42 109.354 176.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -147.51 66.12 0.41 Allowed Glycine 0 C--N 1.345 1.04 0 N-CA-C 111.672 -0.571 . . . . 74.0 111.672 -179.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -101.82 145.72 28.79 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.473 0.709 . . . . 72.23 110.226 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 155.34 71.79 0.01 OUTLIER Glycine 0 C--N 1.346 1.136 0 N-CA-C 110.33 -1.108 . . . . 55.31 110.33 -176.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.1 p -94.53 126.8 40.04 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.085 0.954 . . . . 51.43 111.749 -171.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.756 ' H ' ' HG2' ' C' ' 90' ' ' GLU . 44.0 mt-10 -133.16 179.64 6.06 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.707 1.603 . . . . 73.04 107.597 170.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -105.92 133.27 50.91 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 107.72 -1.215 . . . . 65.31 107.72 172.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.48 ' HA ' ' O ' ' F' ' 275' ' ' LYS . 31.8 p-80 -121.4 145.82 47.52 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.678 0.275 . . . . 61.14 111.695 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.516 ' HB3' ' HG3' ' F' ' 274' ' ' GLN . 8.5 pt20 -91.11 -178.4 5.16 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.526 0.73 . . . . 74.21 110.953 172.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -82.12 160.16 23.2 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.914 -1.039 . . . . 75.31 110.305 170.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.229 -0.891 . . . . 73.24 109.77 -178.117 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 96.1 mmm . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.041 0.448 . . . . 73.22 109.805 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.7 t -166.57 132.68 2.37 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.948 -1.13 . . . . 53.23 107.948 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -79.11 75.23 5.64 Favored 'General case' 0 CA--C 1.552 1.047 0 CA-C-O 122.37 1.081 . . . . 74.51 110.094 178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -82.04 89.12 6.4 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.698 -1.137 . . . . 55.41 109.042 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -102.47 150.04 23.78 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.478 0.711 . . . . 72.51 109.657 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -140.0 105.16 5.02 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 108.654 -0.869 . . . . 75.0 108.654 178.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 75.7 p -114.15 169.37 9.07 Favored 'General case' 0 C--O 1.247 0.947 0 C-N-CA 124.814 1.246 . . . . 64.21 109.706 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -69.77 -20.56 63.48 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.764 0.826 . . . . 70.33 111.089 178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.589 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 18.1 ptm 58.45 174.65 0.06 Allowed 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 127.14 2.176 . . . . 62.11 113.905 176.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 52.1 m -149.88 121.9 8.25 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.187 0.995 . . . . 54.23 108.348 176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -137.91 128.9 27.25 Favored 'General case' 0 C--O 1.24 0.564 0 C-N-CA 123.514 0.725 . . . . 74.52 109.824 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.507 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 3.1 pm0 -147.25 129.35 15.52 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.657 0.783 . . . . 63.31 109.568 175.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.32 143.19 12.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 115.446 -0.797 . . . . 75.01 108.987 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -105.48 -50.78 3.14 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.505 0.322 . . . . 63.23 110.136 173.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 33.1 ttt85 -159.39 135.6 8.96 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.802 -167.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -122.14 129.51 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 123.434 0.694 . . . . 75.01 109.162 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.43 ' HE1' HG13 ' B' ' 83' ' ' ILE . 17.5 p90 -157.81 151.26 23.57 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.525 0.679 . . . . 73.44 111.366 -173.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.6 m -76.26 122.13 23.94 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.672 -1.149 . . . . 65.1 109.099 173.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 mtpt -97.93 -17.64 19.11 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.961 0.504 . . . . 70.32 112.082 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -167.97 139.16 2.85 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.104 0.252 . . . . 73.02 111.031 -175.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.467 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.1 mm -134.35 141.12 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.713 1.205 . . . . 65.43 109.414 175.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.498 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 44.6 t -139.15 137.14 35.83 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 124.779 1.232 . . . . 74.51 107.811 172.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.466 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 92.0 t80 -143.76 119.61 10.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 106.904 -1.517 . . . . 73.43 106.904 169.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 31.6 mt-10 -120.61 117.87 28.68 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 109.12 -0.696 . . . . 72.3 109.12 -178.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -121.92 83.45 43.7 Favored Pre-proline 0 CA--C 1.537 0.456 0 N-CA-C 109.012 -0.736 . . . . 44.44 109.012 170.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.11 -24.77 32.27 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.879 2.386 . . . . 75.34 111.215 177.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -114.91 24.5 11.69 Favored 'General case' 0 C--O 1.216 -0.662 0 C-N-CA 124.502 1.121 . . . . 74.32 109.785 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.612 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -44.08 -55.48 9.38 Favored Pre-proline 0 CA--C 1.561 1.372 0 C-N-CA 125.014 1.325 . . . . 74.02 114.047 177.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -77.61 -33.74 2.22 Favored 'Trans proline' 0 C--N 1.388 2.608 0 C-N-CA 122.235 1.957 . . . . 62.2 111.89 -179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.515 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 70.5 m80 -96.0 4.3 52.76 Favored 'General case' 0 C--O 1.211 -0.963 0 C-N-CA 124.245 1.018 . . . . 73.04 112.83 -169.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.14 -25.78 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 C-N-CA 123.886 0.875 . . . . 71.15 111.889 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -66.29 -26.5 67.35 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.594 1.158 . . . . 65.24 112.281 -174.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 24.4 pt20 -67.83 -33.58 75.05 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 110.047 -0.353 . . . . 55.35 110.047 178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.548 ' HB2' HD13 ' B' ' 68' ' ' LEU . 80.1 mttt -108.27 65.48 0.63 Allowed 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.584 -0.895 . . . . 72.22 108.584 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -81.39 108.32 14.9 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 109.698 -0.482 . . . . 64.43 109.698 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.505 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 161.5 -171.24 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 127.842 2.457 . . . . 71.34 109.605 157.133 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -58.56 128.36 83.16 Favored Pre-proline 0 CA--C 1.561 1.395 0 C-N-CA 122.635 0.374 . . . . 61.52 111.758 -170.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -88.19 161.55 7.08 Favored 'Trans proline' 0 C--N 1.372 1.776 0 C-N-CA 123.069 2.513 . . . . 75.23 112.099 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -75.49 107.53 7.68 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.92 -0.77 . . . . 72.04 108.92 173.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.6 m -89.16 142.55 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.198 -0.91 . . . . 62.04 110.693 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.419 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 56.7 tttm -139.39 144.1 38.0 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.519 1.128 . . . . 74.01 109.528 -178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 84.7 mt -105.24 156.09 18.45 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.215 0.606 . . . . 71.4 110.702 173.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.469 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 23.8 t70 -152.04 109.97 3.67 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.967 -1.015 . . . . 64.24 108.409 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 mp -109.36 128.89 55.46 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 108.607 -0.886 . . . . 74.02 108.607 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -131.45 145.19 51.67 Favored 'General case' 0 C--O 1.24 0.578 0 C-N-CA 123.78 0.832 . . . . 74.44 109.331 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 75.3 p -116.0 119.45 35.93 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.308 0.643 . . . . 70.21 110.308 -176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -118.93 139.79 51.06 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 108.765 -0.828 . . . . 51.13 108.765 173.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 68.4 p -143.32 162.85 34.61 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 111.763 0.283 . . . . 71.14 111.763 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 63.7 p -165.55 153.6 11.15 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.018 0.824 . . . . 72.43 110.024 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.0 126.51 31.48 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.098 -0.704 . . . . 74.41 109.098 171.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' B' ' 57' ' ' GLU . 34.5 mt -93.66 -49.37 5.9 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.37 0.668 . . . . 73.44 109.495 174.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.57 -166.21 2.35 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 115.536 -0.756 . . . . 62.33 110.845 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -61.84 108.95 1.11 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.669 1.188 . . . . 73.0 111.062 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 66.35 6.75 4.48 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.273 1.429 . . . . 54.2 112.107 -178.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.3 t -104.98 115.05 46.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.653 0 N-CA-C 108.752 -0.832 . . . . 72.3 108.752 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -124.83 144.82 50.09 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.563 -0.903 . . . . 64.02 108.563 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.573 ' HB2' HD11 ' B' ' 51' ' ' LEU . 38.4 tt0 -99.53 127.61 45.61 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.489 0.715 . . . . 63.42 109.539 -179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 77.7 t -105.0 116.95 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.359 -0.978 . . . . 74.14 108.359 173.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 48.4 t -103.64 128.82 56.51 Favored 'Isoleucine or valine' 0 C--O 1.242 0.696 0 N-CA-C 107.379 -1.341 . . . . 75.44 107.379 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.01 100.15 7.36 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 107.063 -1.458 . . . . 73.41 107.063 -176.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 36.0 ttt180 -85.7 108.28 17.96 Favored 'General case' 0 CA--C 1.528 0.098 0 CA-C-N 115.0 -1.0 . . . . 70.54 109.159 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 22.0 t -105.49 102.88 14.49 Favored 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 107.567 -1.272 . . . . 73.23 107.567 174.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.469 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 9.1 m -101.68 130.35 48.03 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-N 115.341 -0.845 . . . . 61.23 108.757 177.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.451 HG23 HD13 ' B' ' 114' ' ' ILE . 71.7 t -118.14 133.47 64.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 124.166 0.986 . . . . 70.45 108.594 178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.419 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 99.5 m -118.88 144.45 46.39 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.927 0.891 . . . . 74.11 109.037 177.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.52 128.96 21.27 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.606 -1.257 . . . . 71.34 107.606 173.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 25.0 p -139.89 128.43 22.93 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.949 0.5 . . . . 70.45 111.825 -174.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.548 HD13 ' HB2' ' B' ' 34' ' ' LYS . 28.6 mt -95.48 100.96 12.64 Favored 'General case' 0 C--O 1.245 0.852 0 C-N-CA 124.563 1.145 . . . . 64.25 109.017 176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.77 -125.44 10.02 Favored Glycine 0 C--N 1.347 1.147 0 N-CA-C 112.007 -0.437 . . . . 65.33 112.007 -177.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -99.06 18.69 16.74 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.763 0.825 . . . . 73.21 110.283 176.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -126.45 147.23 49.84 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.94 0.896 . . . . 71.01 109.888 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 45.9 m -70.12 133.13 46.83 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.568 0.747 . . . . 75.43 110.717 176.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.524 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.66 -62.19 1.56 Allowed 'General case' 0 C--O 1.241 0.609 0 N-CA-C 109.054 -0.721 . . . . 72.31 109.054 173.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -162.95 154.93 18.16 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.45 -1.25 . . . . 72.42 108.737 176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 87.6 mt -130.92 144.91 51.82 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.45 1.1 . . . . 63.54 108.386 -176.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.1 t -147.55 152.56 38.19 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.746 -0.835 . . . . 73.24 108.746 174.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.498 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 42.4 tt0 -159.53 132.16 6.71 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.606 -0.887 . . . . 64.12 108.606 -177.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' B' ' 113' ' ' CYS . 75.5 t -128.59 144.41 38.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.427 -0.953 . . . . 75.05 108.427 176.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.4 mt-30 -122.64 91.87 3.59 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.938 -1.134 . . . . 72.23 107.938 172.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -83.95 101.85 12.0 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.738 -0.838 . . . . 74.41 108.738 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.77 142.83 16.8 Favored Glycine 0 C--N 1.34 0.783 0 N-CA-C 111.124 -0.79 . . . . 64.31 111.124 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -139.92 126.31 3.21 Favored Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.741 -0.944 . . . . 41.23 110.741 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.432 HG23 HD12 ' B' ' 51' ' ' LEU . 65.2 mt -84.25 123.2 38.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.9 0 N-CA-C 108.431 -0.951 . . . . 65.04 108.431 174.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -132.75 134.74 45.13 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.321 1.048 . . . . 71.31 108.309 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.507 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 16.4 m -103.85 99.81 9.59 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.564 -1.273 . . . . 53.55 107.564 172.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.537 ' HB ' HD11 ' B' ' 89' ' ' ILE . 34.2 pt -107.03 139.43 28.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 123.368 0.667 . . . . 45.44 110.521 -173.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.52 161.49 40.0 Favored 'General case' 0 C--O 1.243 0.754 0 C-N-CA 124.11 0.964 . . . . 72.34 109.55 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.78 -59.17 4.94 Favored Glycine 0 C--N 1.345 1.045 0 CA-C-N 116.259 -0.428 . . . . 74.42 113.298 176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.537 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.7 pp -58.19 125.87 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-O 121.355 0.598 . . . . 71.33 110.691 177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.73 167.86 29.19 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.672 -0.695 . . . . 73.42 110.877 -173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.21 -118.04 12.97 Favored Glycine 0 C--N 1.344 0.986 0 CA-C-N 115.18 -0.918 . . . . 73.23 113.191 -175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.2 m -71.72 -35.01 70.06 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.343 0.657 . . . . 64.13 110.945 175.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -66.58 -36.89 83.73 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.184 -0.916 . . . . 72.2 111.093 -169.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.544 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 16.9 ptp -60.28 -43.32 96.32 Favored 'General case' 0 C--N 1.356 0.882 0 O-C-N 123.576 0.547 . . . . 64.33 110.008 177.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.01 -28.4 69.48 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.492 0.717 . . . . 71.44 111.383 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -75.4 -40.66 57.57 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.888 0.475 . . . . 74.4 110.65 173.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -68.32 -67.48 0.46 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.011 0.524 . . . . 61.41 110.945 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.544 ' HG ' ' O ' ' B' ' 94' ' ' MET . 4.0 pp -75.81 -12.62 60.21 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 122.917 0.487 . . . . 73.33 112.185 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.57 -23.01 24.93 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-O 119.945 -0.364 . . . . 35.44 113.986 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -128.69 -58.7 1.16 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 117.2 0.5 . . . . 72.0 110.717 -177.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -60.14 -50.78 72.32 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.489 1.115 . . . . 72.31 112.181 -171.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 57.4 m -69.03 -47.27 30.12 Favored Pre-proline 0 CA--C 1.569 1.691 0 C-N-CA 123.481 0.712 . . . . 41.25 112.048 -177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 82.8 Cg_exo -53.71 -35.23 77.49 Favored 'Trans proline' 0 C--N 1.397 3.121 0 C-N-CA 122.721 2.28 . . . . 73.34 114.098 170.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . 0.59 HD21 ' HD1' ' B' ' 133' ' ' PHE . 0.9 OUTLIER -67.68 -24.57 65.43 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 123.399 0.68 . . . . 72.11 111.856 179.509 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.2 mt -74.41 -45.24 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 122.997 0.519 . . . . 52.43 110.213 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 95.4 mt -78.08 -21.92 49.8 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.732 -0.667 . . . . 71.35 112.066 -176.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.457 ' HB3' ' HD3' ' B' ' 108' ' ' PRO . 75.5 t80 -56.67 -51.74 78.97 Favored Pre-proline 0 CA--C 1.565 1.554 0 CA-C-O 117.997 -1.001 . . . . 73.5 113.098 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 51.8 Cg_exo -58.25 -38.92 88.86 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.437 2.091 . . . . 74.51 113.584 178.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -67.5 -41.73 83.99 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.411 0.684 . . . . 74.4 111.191 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.24 88.01 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.018 0.527 . . . . 73.13 110.573 175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.416 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 44.5 ttt180 -59.56 -60.27 4.11 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.69 1.596 . . . . 74.1 111.062 -175.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.77 -31.12 70.49 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.38 1.072 . . . . 74.22 111.135 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.467 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.7 t -70.96 -36.65 72.66 Favored 'General case' 0 CA--C 1.55 0.972 0 O-C-N 122.483 -0.136 . . . . 60.11 111.022 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.451 HD13 HG23 ' B' ' 64' ' ' VAL . 70.3 mt -68.18 -45.92 82.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 123.167 0.587 . . . . 73.2 109.448 173.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.3 m -56.92 -38.68 73.21 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 114.749 -1.114 . . . . 72.23 111.164 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 29.9 t -63.97 -47.79 79.01 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.582 0.753 . . . . 71.41 110.667 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.1 mmt -72.14 -34.73 68.75 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 122.972 0.509 . . . . 74.02 111.573 -172.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.7 t -67.64 -38.46 80.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.186 0.594 . . . . 72.11 110.15 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.8 t -67.97 -30.92 70.31 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.913 0.885 . . . . 72.42 111.013 176.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.5 mtt-85 -72.62 -34.18 67.16 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.624 0.77 . . . . 75.51 110.504 176.017 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.32 3.39 53.54 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.626 0.579 . . . . 74.05 112.3 170.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.8 p 58.21 54.56 5.7 Favored 'General case' 0 C--N 1.356 0.86 0 C-N-CA 126.445 1.898 . . . . 73.21 111.357 175.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -119.44 154.1 54.08 Favored Pre-proline 0 C--O 1.241 0.655 0 CA-C-N 114.139 -1.391 . . . . 53.52 110.265 175.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -60.22 -167.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.319 2.679 . . . . 63.21 114.776 175.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.733 ' H ' HD21 ' F' ' 300' ' ' ASN . 15.6 tp60 -64.98 129.89 41.37 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.167 -0.924 . . . . 62.34 112.814 -159.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -129.9 84.78 2.24 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 106.439 -1.689 . . . . 74.25 106.439 170.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -115.73 127.55 55.21 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 108.352 -0.981 . . . . 64.1 108.352 174.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.416 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 4.3 mm? -72.07 147.86 46.35 Favored 'General case' 0 C--O 1.237 0.427 0 O-C-N 123.871 0.732 . . . . 71.1 110.311 173.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.401 ' HB3' HD22 ' H' ' 291' ' ' LEU . . . -79.67 150.79 73.42 Favored Pre-proline 0 CA--C 1.545 0.76 0 CA-C-N 115.464 -0.789 . . . . 63.04 109.205 175.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -64.03 102.13 0.36 Allowed 'Trans proline' 0 C--N 1.369 1.632 0 C-N-CA 122.63 2.22 . . . . 64.23 110.938 177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.23 110.23 21.73 Favored 'Isoleucine or valine' 0 C--O 1.242 0.674 0 N-CA-C 109.284 -0.635 . . . . 71.13 109.284 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 44.6 t30 -85.75 88.32 7.53 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 108.8 -0.815 . . . . 71.34 108.8 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.59 ' HD1' HD21 ' B' ' 104' ' ' ASN . 98.7 m-85 -62.84 -26.03 68.56 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 115.438 -0.801 . . . . 64.43 111.378 179.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -61.28 -38.88 88.37 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 124.303 1.002 . . . . 74.1 110.641 175.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -58.92 -47.37 85.26 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.996 0.518 . . . . 75.32 110.689 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.87 -41.69 99.48 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-N 115.368 -0.833 . . . . 73.32 110.084 177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -71.56 -28.39 63.81 Favored 'General case' 0 CA--C 1.548 0.884 0 CA-C-N 114.922 -1.036 . . . . 72.01 111.296 -173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 19.2 mmt -69.22 -38.68 78.66 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.425 0.69 . . . . 61.35 110.012 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 45.9 m-80 -79.49 -25.38 41.83 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.276 0.63 . . . . 62.02 111.111 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -63.62 -48.27 77.96 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.261 0.625 . . . . 74.04 111.144 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 2.2 pp -119.8 31.5 6.51 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 115.582 -0.735 . . . . 75.12 110.93 -174.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -62.34 100.0 0.16 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.815 0.846 . . . . 63.44 110.777 -175.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -155.14 109.94 2.99 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 108.336 -0.987 . . . . 65.53 108.336 176.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -104.86 147.18 28.02 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 108.684 -0.858 . . . . 73.51 108.684 174.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -134.95 137.63 43.28 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.68 0.792 . . . . 72.02 109.634 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -146.39 152.52 24.64 Favored Glycine 0 C--N 1.342 0.863 0 N-CA-C 111.681 -0.568 . . . . 63.55 111.681 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -148.95 146.3 27.77 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.982 0.913 . . . . 72.21 109.239 179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.37 86.53 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.399 0 N-CA-C 110.27 -1.132 . . . . 71.23 110.27 -177.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 9.8 t -135.78 140.32 44.19 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.488 0.715 . . . . 41.31 109.074 176.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -158.6 156.04 29.35 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 123.528 0.731 . . . . 64.31 110.495 -176.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -166.04 135.41 3.23 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.285 1.034 . . . . 75.14 108.787 174.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 44.0 t-80 -156.34 83.4 0.98 Allowed 'General case' 0 C--O 1.242 0.661 0 N-CA-C 108.675 -0.861 . . . . 74.02 108.675 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -125.97 107.42 10.43 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 124.047 0.939 . . . . 74.1 108.899 175.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -138.04 110.27 7.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.898 0.879 . . . . 75.22 109.311 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 C-N-CA 123.411 0.685 . . . . 63.12 109.986 -179.683 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ttt . . . . . 0 N--CA 1.482 1.155 0 N-CA-C 109.239 -0.652 . . . . 74.33 109.239 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 31.3 p -96.2 13.66 26.67 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.63 0.772 . . . . 73.42 112.016 -176.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 65.9 109.12 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.818 1.247 . . . . 75.13 111.466 -178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -74.74 79.1 2.06 Favored 'General case' 0 CA--C 1.556 1.174 0 CA-C-O 122.108 0.956 . . . . 75.41 110.575 178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -66.72 93.83 0.27 Allowed 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.089 -0.96 . . . . 74.34 109.279 176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -141.84 118.46 11.0 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.696 -0.684 . . . . 60.21 109.616 179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 14.5 t -148.13 5.11 0.74 Allowed 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.007 0.923 . . . . 72.3 109.079 166.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -68.93 126.61 30.33 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.217 1.007 . . . . 70.01 108.368 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.563 ' HG2' ' HB2' ' C' ' 11' ' ' PHE . 50.2 ttp 66.23 119.2 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 O-C-N 124.801 1.313 . . . . 74.21 111.878 -175.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 21.1 m -86.02 78.01 9.53 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 108.286 -1.005 . . . . 61.13 108.286 172.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.563 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 35.0 t80 -112.42 133.96 54.22 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.035 -0.984 . . . . 73.25 109.096 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -154.76 142.15 19.61 Favored 'General case' 0 C--O 1.245 0.849 0 C-N-CA 123.201 0.6 . . . . 65.04 109.646 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -77.21 97.27 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-N 115.317 -0.856 . . . . 53.05 109.308 175.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.44 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 14.7 mm-40 -75.06 -42.11 57.66 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 109.603 -0.517 . . . . 74.44 109.603 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.499 ' NH2' ' HB3' ' G' ' 302' ' ' ASP . 49.7 ttt180 -174.25 147.42 1.2 Allowed 'General case' 0 C--N 1.351 0.665 0 O-C-N 124.274 0.984 . . . . 73.24 109.561 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.1 mt -129.1 142.03 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 N-CA-C 107.62 -1.252 . . . . 72.35 107.62 175.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 24.3 p90 -172.64 158.29 4.06 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.468 0.651 . . . . 74.4 111.418 -176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.507 HG22 HE22 ' C' ' 80' ' ' GLN . 66.7 p -83.22 106.35 14.94 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.804 -1.089 . . . . 64.41 108.387 173.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 6.6 mmmt -65.93 -47.47 74.61 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 121.554 0.692 . . . . 62.42 109.268 175.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -135.51 140.42 44.76 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.611 -1.177 . . . . 50.5 109.204 -177.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.441 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 69.9 mt -134.22 138.32 50.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.325 -1.361 . . . . 64.14 107.325 172.398 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -154.79 150.53 27.63 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 120.964 0.411 . . . . 72.03 110.034 176.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -151.14 108.59 3.62 Favored 'General case' 0 C--O 1.225 -0.216 0 N-CA-C 107.912 -1.144 . . . . 63.4 107.912 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -115.77 108.82 16.83 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.148 0.579 . . . . 73.24 109.546 -176.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.14 85.45 18.7 Favored Pre-proline 0 CA--C 1.547 0.835 0 N-CA-C 108.398 -0.964 . . . . 53.11 108.398 172.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -65.93 -36.22 31.69 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.009 2.473 . . . . 71.41 112.368 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -107.6 34.29 3.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.516 0.726 . . . . 73.22 109.413 -178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.48 -50.76 63.72 Favored Pre-proline 0 CA--C 1.568 1.635 0 N-CA-C 114.223 1.194 . . . . 65.32 114.223 -174.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -72.97 -32.96 8.2 Favored 'Trans proline' 0 C--N 1.388 2.625 0 CA-C-N 121.036 1.406 . . . . 71.43 112.78 175.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 78.4 t60 -70.18 -37.13 75.08 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.836 0.854 . . . . 73.32 112.642 -173.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.36 -21.09 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 C-N-CA 123.165 0.586 . . . . 75.3 110.608 178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.474 ' HE2' ' HB ' ' F' ' 301' ' ' ILE . 2.3 t80 -75.47 -2.26 27.96 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 123.268 0.627 . . . . 74.11 111.095 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -124.12 26.28 7.54 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.417 1.087 . . . . 73.42 109.837 170.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.98 147.44 35.93 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.248 1.019 . . . . 70.44 109.947 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -61.44 131.13 49.22 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 73.42 111.114 177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.425 ' HB3' ' HD2' ' F' ' 297' ' ' TYR . 20.4 m95 -71.61 93.57 1.24 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.148 0.979 . . . . 73.41 112.011 -171.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -154.91 74.49 5.64 Favored Pre-proline 0 CA--C 1.549 0.928 0 C-N-CA 123.738 0.815 . . . . 70.34 108.991 177.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.787 ' HD2' ' HG2' ' F' ' 294' ' ' LYS . 55.7 Cg_endo -84.44 127.95 3.97 Favored 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 122.563 2.175 . . . . 74.21 112.357 178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -86.56 97.22 10.4 Favored 'General case' 0 C--O 1.247 0.934 0 N-CA-C 106.502 -1.666 . . . . 74.13 106.502 166.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 16.4 t -91.96 117.05 34.45 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 114.57 -1.196 . . . . 73.01 109.8 -169.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -97.36 109.0 21.85 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.053 -1.091 . . . . 64.44 108.053 175.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 tt -86.81 123.8 32.35 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 106.264 -1.754 . . . . 75.52 106.264 170.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.593 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 38.9 t70 -120.02 147.91 44.21 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.642 0.777 . . . . 75.21 109.462 179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.1 tp -134.54 131.85 38.44 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.396 1.078 . . . . 64.31 108.129 -176.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.742 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 18.3 t70 -133.52 135.26 44.3 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 109.511 -0.551 . . . . 75.52 109.511 178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 30.8 p -113.41 111.2 21.56 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.754 0.822 . . . . 64.33 109.559 -175.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -124.79 157.62 35.34 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.204 1.002 . . . . 52.2 109.851 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 67.5 p -155.15 167.25 30.99 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 122.817 0.447 . . . . 63.52 110.95 -179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -164.86 127.34 2.24 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 123.661 0.785 . . . . 73.15 109.839 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -86.31 135.96 33.33 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 118.264 0.483 . . . . 75.42 109.784 175.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.653 HD11 HD12 ' C' ' 83' ' ' ILE . 41.2 mt -106.11 -47.01 3.94 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.03 0.932 . . . . 74.45 109.993 -176.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.7 -178.01 5.45 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.138 0.975 . . . . 70.31 108.973 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -59.64 110.91 1.24 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.6 0.76 . . . . 71.31 111.019 -177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.422 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 19.1 m-20 62.85 30.75 16.6 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.493 1.117 . . . . 71.43 111.768 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.4 t -118.98 111.59 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.619 -1.252 . . . . 75.42 107.619 168.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.421 ' HB2' HD12 ' C' ' 86' ' ' ILE . 95.4 m-85 -123.51 125.85 45.65 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 123.772 0.829 . . . . 52.24 109.81 -177.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -80.78 120.3 24.48 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.063 -0.971 . . . . 65.21 108.917 168.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -96.78 117.33 41.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.585 -1.265 . . . . 75.25 107.585 169.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 60.0 t -104.08 131.61 52.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 108.006 -1.109 . . . . 71.22 108.006 173.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -126.62 105.85 9.0 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.191 -1.04 . . . . 75.21 108.191 -175.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.742 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 59.3 mtt180 -83.3 134.61 34.92 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.646 -0.502 . . . . 63.24 109.646 175.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' C' ' 114' ' ' ILE . 15.7 t -122.0 123.77 69.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.612 0 N-CA-C 106.798 -1.556 . . . . 73.04 106.798 162.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 5.8 m -121.17 112.33 18.53 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.446 0.641 . . . . 72.54 109.321 -175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.455 HG21 HG21 ' C' ' 114' ' ' ILE . 51.5 t -101.13 117.67 46.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.105 -0.952 . . . . 54.23 108.586 -177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 4.4 m -115.13 141.89 47.4 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 108.667 -0.864 . . . . 65.01 108.667 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.07 123.0 22.54 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.941 -1.133 . . . . 70.52 107.941 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 69.2 m -143.47 127.07 16.97 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 122.852 0.461 . . . . 73.13 110.548 179.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.51 ' H ' HD12 ' C' ' 68' ' ' LEU . 1.5 mp -90.63 49.25 1.64 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.045 1.338 . . . . 53.54 109.121 -176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.01 -106.58 2.81 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.212 -0.903 . . . . 73.05 110.901 -174.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -90.35 -30.88 17.15 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.962 0.905 . . . . 70.03 110.162 175.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -66.32 115.47 6.31 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.308 1.043 . . . . 65.42 109.891 174.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 91.2 m -89.82 125.6 35.38 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 118.714 0.688 . . . . 64.22 109.653 168.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.482 ' HB2' HD11 ' C' ' 68' ' ' LEU . . . -72.23 -64.02 1.03 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.79 -1.095 . . . . 65.1 109.502 177.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.59 170.16 23.02 Favored 'General case' 0 C--O 1.243 0.744 0 CA-C-N 114.564 -1.198 . . . . 73.32 110.814 177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.426 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -133.69 146.61 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.562 -2.014 . . . . 72.24 105.562 172.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.426 ' N ' HD13 ' C' ' 75' ' ' LEU . 42.3 t -151.47 145.26 25.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.394 -0.965 . . . . 54.23 108.394 178.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . 0.457 ' HB2' HG23 ' C' ' 63' ' ' THR . 34.3 tt0 -157.56 136.37 11.5 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 109.294 -0.632 . . . . 73.42 109.294 178.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.58 123.7 49.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 115.114 -0.948 . . . . 74.32 108.927 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.732 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 29.1 mt-30 -92.33 87.56 6.09 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 107.656 -1.239 . . . . 75.41 107.656 174.139 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.507 HE22 HG22 ' C' ' 18' ' ' THR . 9.5 tp-100 -79.08 96.88 5.93 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.317 -0.624 . . . . 73.12 109.317 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -84.07 149.05 24.88 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 115.26 -0.882 . . . . 42.33 111.577 177.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -151.92 117.23 0.81 Allowed Glycine 0 CA--C 1.503 -0.701 0 N-CA-C 110.825 -0.91 . . . . 73.13 110.825 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.653 HD12 HD11 ' C' ' 51' ' ' LEU . 14.5 mm -80.98 121.2 34.11 Favored 'Isoleucine or valine' 0 C--O 1.243 0.744 0 N-CA-C 108.398 -0.964 . . . . 75.33 108.398 177.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -134.97 126.73 29.16 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.596 -0.89 . . . . 53.15 108.596 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.8 m -69.61 119.26 13.58 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 108.344 -0.984 . . . . 44.33 108.344 166.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.611 HG23 HD11 ' C' ' 89' ' ' ILE . 59.1 mt -116.3 100.8 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 109.066 -0.716 . . . . 71.01 109.066 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.422 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -148.71 164.47 34.26 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.648 1.179 . . . . 73.31 109.031 178.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.43 -19.34 32.5 Favored Glycine 0 N--CA 1.473 1.14 0 O-C-N 123.13 0.269 . . . . 70.55 112.988 178.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.611 HD11 HG23 ' C' ' 86' ' ' ILE . 11.9 pt -114.45 156.18 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.598 1.159 . . . . 73.25 110.37 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.756 ' HG2' ' H ' ' A' ' 150' ' ' GLU . 9.1 tp10 -164.96 156.21 14.79 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.945 -1.025 . . . . 71.21 109.264 -176.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.464 ' O ' ' HG2' ' C' ' 94' ' ' MET . . . 63.08 -110.37 3.32 Favored Glycine 0 C--N 1.352 1.46 0 O-C-N 123.423 0.452 . . . . 73.45 114.006 171.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 7.9 t -83.1 -27.19 30.38 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 122.664 0.386 . . . . 72.13 111.797 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.5 -42.07 75.25 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.925 -0.398 . . . . 75.33 109.925 178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.476 ' HA ' HD12 ' C' ' 89' ' ' ILE . 19.2 ptt? -63.57 -35.78 81.62 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.67 -0.696 . . . . 73.33 110.004 178.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.23 -39.64 93.49 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.708 0.803 . . . . 45.11 112.024 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 47.7 t-80 -78.76 -20.92 48.77 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 116.304 -0.407 . . . . 73.41 111.265 177.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 43.5 t -82.56 -63.25 1.41 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.154 -0.342 . . . . 64.55 111.27 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.566 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 4.6 pp -77.51 -32.16 53.95 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 122.847 0.459 . . . . 45.32 111.387 -174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -97.34 8.77 64.7 Favored Glycine 0 C--N 1.351 1.414 0 CA-C-O 119.727 -0.485 . . . . 73.44 113.702 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -148.64 -56.5 0.21 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 117.246 0.523 . . . . 63.34 111.838 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -74.49 -40.27 61.94 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.193 0.442 . . . . 72.2 112.193 -175.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.566 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 85.4 m -64.84 -47.24 75.14 Favored Pre-proline 0 CA--C 1.559 1.296 0 CA-C-O 118.723 -0.656 . . . . 63.31 111.176 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.463 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 55.3 Cg_exo -57.34 -37.24 98.21 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 122.123 1.882 . . . . 72.24 113.023 168.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.09 -37.97 81.54 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 123.787 0.835 . . . . 74.33 111.348 178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -73.23 -46.78 49.29 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 123.242 0.617 . . . . 63.02 110.92 178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 95.8 mt -78.92 -20.56 49.04 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 115.552 -0.749 . . . . 73.34 112.298 -172.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.404 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 61.4 t80 -58.56 -51.86 78.77 Favored Pre-proline 0 CA--C 1.56 1.333 0 CA-C-O 117.747 -1.121 . . . . 72.45 113.192 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.404 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 52.3 Cg_exo -56.71 -38.57 95.37 Favored 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.036 1.824 . . . . 74.21 113.518 177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 -69.16 -42.64 75.63 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.322 0.649 . . . . 73.22 111.517 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.72 99.52 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.255 0.622 . . . . 74.33 109.637 175.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.461 ' NH2' ' HB3' ' C' ' 127' ' ' ASN . 41.1 ttt180 -58.43 -53.88 53.34 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.924 1.69 . . . . 75.24 111.469 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.57 -34.77 78.64 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.579 0.549 . . . . 70.33 110.321 -176.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.407 ' SG ' HG21 ' C' ' 18' ' ' THR . 6.4 t -68.56 -32.91 73.16 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.034 0.534 . . . . 70.33 111.128 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.607 HD11 ' HB ' ' C' ' 62' ' ' VAL . 78.6 mt -71.52 -53.64 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-N 115.777 -0.647 . . . . 71.32 109.869 174.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 9.2 m -63.05 -28.87 70.38 Favored 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 123.258 0.623 . . . . 64.32 111.693 -172.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -64.42 -51.51 62.8 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.498 0.719 . . . . 55.21 109.424 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.605 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.21 -38.9 81.05 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.325 1.05 . . . . 65.32 112.213 178.33 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.414 HG23 ' O ' ' C' ' 114' ' ' ILE . 86.9 t -60.7 -44.35 96.96 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 C-N-CA 123.561 0.744 . . . . 71.33 109.749 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 41.1 t -67.08 -35.36 79.64 Favored 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 123.671 0.789 . . . . 73.31 112.083 177.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.0 mtt-85 -69.3 -31.84 70.6 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.432 0.693 . . . . 75.34 110.551 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.61 12.18 70.08 Favored Glycine 0 C--N 1.353 1.497 0 O-C-N 123.559 0.537 . . . . 71.41 113.073 174.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.422 HG22 ' NH2' ' D' ' 15' ' ' ARG . 6.9 p 64.84 20.88 12.24 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 126.652 1.981 . . . . 74.31 113.423 173.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -89.1 151.1 46.38 Favored Pre-proline 0 CA--C 1.549 0.934 0 N-CA-C 109.267 -0.642 . . . . 62.53 109.267 172.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.693 ' HG2' ' HB3' ' F' ' 297' ' ' TYR . 31.9 Cg_exo -61.78 144.28 96.87 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 123.205 2.603 . . . . 75.42 113.282 -176.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.473 ' HA ' HE21 ' C' ' 125' ' ' GLN . 0.0 OUTLIER -51.08 111.07 0.5 Allowed 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.74 1.275 . . . . 71.51 111.415 -177.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 45.9 tp -108.11 85.71 2.16 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.332 -0.988 . . . . 74.14 108.332 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.461 ' HB3' ' NH2' ' C' ' 111' ' ' ARG . 17.5 m120 -91.6 109.32 20.63 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 114.47 -1.241 . . . . 73.45 108.427 178.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -58.65 135.08 57.29 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 124.263 0.977 . . . . 52.43 111.929 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.24 157.85 88.93 Favored Pre-proline 0 CA--C 1.557 1.239 0 C-N-CA 124.281 1.032 . . . . 42.41 110.345 179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.54 105.49 0.76 Allowed 'Trans proline' 0 C--N 1.384 2.418 0 C-N-CA 122.389 2.059 . . . . 72.25 112.171 -173.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.445 HG22 HD11 ' F' ' 291' ' ' LEU . 46.4 t -99.59 107.85 21.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 N-CA-C 107.488 -1.301 . . . . 74.31 107.488 171.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -105.72 93.91 4.91 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.432 -0.803 . . . . 73.21 110.004 -177.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -63.7 -41.84 98.07 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 109.117 -0.697 . . . . 73.22 109.117 174.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.449 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.9 p-10 -53.32 -46.96 69.64 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.959 1.304 . . . . 63.23 111.822 177.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.43 -38.28 74.53 Favored 'General case' 0 C--O 1.219 -0.552 0 C-N-CA 123.9 0.88 . . . . 43.42 111.416 -177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.6 mp -64.1 -37.04 86.02 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.454 0.702 . . . . 75.02 111.946 175.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.69 -42.81 73.59 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 122.86 0.464 . . . . 75.42 111.087 176.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 75.3 mtm -72.05 -28.59 63.45 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.272 0.629 . . . . 64.02 111.129 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -60.46 -37.02 79.64 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.966 1.306 . . . . 74.52 110.717 176.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -59.73 -82.87 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 O-C-N 124.019 0.825 . . . . 74.31 109.883 176.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.514 ' HG ' ' H ' ' C' ' 142' ' ' GLN . 17.5 tp 65.85 -176.35 0.18 Allowed 'General case' 0 CA--C 1.564 1.486 0 C-N-CA 124.159 0.984 . . . . 72.13 110.565 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . 0.514 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 63.2 tt0 -150.78 -43.79 0.12 Allowed 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.844 -0.535 . . . . 73.32 109.995 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 -131.02 155.42 46.89 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.13 0.572 . . . . 73.43 109.69 177.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -86.36 170.78 11.71 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 122.883 0.473 . . . . 53.44 111.048 -178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.15 166.16 13.11 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.749 -0.66 . . . . 75.11 110.877 174.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.92 -166.0 35.74 Favored Glycine 0 C--N 1.342 0.873 0 CA-C-N 115.724 -0.671 . . . . 75.34 111.907 174.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -164.19 135.86 4.63 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.872 0.869 . . . . 60.12 108.905 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -162.55 156.61 28.34 Favored Glycine 0 C--N 1.345 1.06 0 C-N-CA 121.669 -0.3 . . . . 64.14 113.215 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 28.7 m -104.47 93.0 4.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.883 0.873 . . . . 74.23 108.865 175.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -82.98 101.27 10.97 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 116.122 -0.49 . . . . 73.41 110.72 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -81.32 122.34 27.33 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.819 0.848 . . . . 71.41 110.111 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 74.1 m-70 -114.08 86.28 2.39 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.937 -1.134 . . . . 75.01 107.937 173.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -81.94 127.31 32.91 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.067 -0.97 . . . . 63.52 109.418 -178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -73.56 155.57 39.0 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.261 0.624 . . . . 74.2 111.162 -176.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.973 0 CA-C-N 115.363 -0.835 . . . . 60.21 110.469 -176.253 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 21.9 ptt? . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 111.583 0.216 . . . . 70.52 111.583 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 49.8 m -153.73 59.91 0.74 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.04 0.936 . . . . 65.22 109.401 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -81.72 81.39 7.78 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.229 -0.896 . . . . 72.34 109.286 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -78.13 110.92 13.52 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.541 -0.754 . . . . 70.14 109.522 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -141.46 90.08 2.27 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.658 -0.868 . . . . 64.54 108.658 -177.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 29.7 p-10 -135.78 16.33 3.33 Favored 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 123.518 0.727 . . . . 60.44 110.568 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 10.2 t -155.66 162.55 40.57 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.332 0.653 . . . . 64.15 110.324 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 66.46 -178.31 0.2 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 125.254 1.422 . . . . 75.02 111.814 -173.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.6 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 2.1 ptm -32.93 140.43 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 124.819 1.248 . . . . 64.0 113.88 170.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 95.1 m -112.6 119.89 39.69 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.185 0.594 . . . . 75.0 110.381 -177.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.499 ' HA ' ' O ' ' D' ' 85' ' ' SER . 68.8 t80 -138.98 122.56 17.38 Favored 'General case' 0 CA--C 1.52 -0.192 0 N-CA-C 107.053 -1.462 . . . . 72.05 107.053 172.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -138.5 130.52 28.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.446 -0.576 . . . . 64.22 109.446 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 54.1 mt -80.88 125.79 39.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 107.67 -1.233 . . . . 74.43 107.67 168.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -99.06 -43.6 6.61 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.766 0.426 . . . . 71.2 110.259 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.659 HH11 HG11 ' F' ' 306' ' ' VAL . 7.8 tpt180 -179.69 141.0 0.15 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.827 0.851 . . . . 72.35 110.627 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 3.9 mp -107.95 141.75 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 N-CA-C 108.15 -1.055 . . . . 70.51 108.15 171.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HE1' HG13 ' D' ' 83' ' ' ILE . 27.1 p90 -156.55 173.39 16.99 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.847 0.832 . . . . 74.31 111.2 -175.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -104.81 119.62 39.45 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-N 114.437 -1.256 . . . . 74.01 109.111 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.437 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 34.6 mtpt -90.52 -26.87 19.54 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 116.279 -0.419 . . . . 62.42 110.42 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -159.71 110.72 1.97 Allowed 'General case' 0 C--N 1.343 0.309 0 O-C-N 123.792 0.682 . . . . 72.24 109.278 -174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.605 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.0 mt -111.27 149.44 14.01 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.708 -0.849 . . . . 65.11 108.708 177.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.4 t -148.82 142.29 25.3 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 123.955 0.902 . . . . 51.54 109.82 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.441 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.0 t80 -152.55 120.08 6.01 Favored 'General case' 0 C--O 1.22 -0.457 0 N-CA-C 106.406 -1.702 . . . . 44.15 106.406 171.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' D' ' 74' ' ' PHE . 45.0 mt-10 -128.32 120.28 26.75 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.499 0.72 . . . . 71.14 109.269 -178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -110.97 85.01 4.75 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 108.01 -1.107 . . . . 74.13 108.01 171.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -75.29 -28.68 8.49 Favored 'Trans proline' 0 C--N 1.375 1.964 0 C-N-CA 123.114 2.543 . . . . 75.53 113.502 -167.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.411 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 14.5 m-80 -115.05 28.61 8.59 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 109.206 -0.664 . . . . 64.45 109.206 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -42.85 -66.1 0.47 Allowed Pre-proline 0 CA--C 1.566 1.569 0 N-CA-C 114.992 1.478 . . . . 44.42 114.992 -165.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.456 ' HB3' HD11 ' C' ' 83' ' ' ILE . 78.7 Cg_endo -77.22 -15.22 16.22 Favored 'Trans proline' 0 C--N 1.382 2.296 0 CA-C-N 122.566 1.952 . . . . 75.42 113.199 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.537 ' HA ' HE21 ' D' ' 33' ' ' GLN . 19.5 t-160 -70.23 -38.87 75.3 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.238 1.015 . . . . 74.12 109.609 174.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 50.2 t -60.61 -39.82 82.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 124.266 1.026 . . . . 64.44 110.66 176.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 16.4 m-30 -75.85 -3.77 37.01 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.754 -1.112 . . . . 73.12 113.764 -168.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' D' ' 30' ' ' HIS . 43.4 mt-30 -85.33 -6.88 59.21 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.774 0.83 . . . . 75.42 111.305 172.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -121.92 115.21 22.16 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.386 1.474 . . . . 73.23 108.093 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.567 ' HA ' ' HB ' ' G' ' 301' ' ' ILE . 3.8 p-10 -92.83 93.94 8.69 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.556 0.743 . . . . 71.14 112.381 -179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.415 ' HE3' ' H ' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -165.22 -179.19 5.47 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.951 0.9 . . . . 73.31 111.848 177.765 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -90.86 140.58 26.27 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 123.603 0.761 . . . . 73.31 111.935 -176.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 58.6 Cg_endo -75.03 156.13 42.83 Favored 'Trans proline' 0 C--N 1.379 2.134 0 C-N-CA 123.019 2.479 . . . . 73.33 114.152 168.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -89.17 140.68 29.22 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.354 -1.294 . . . . 61.21 108.058 164.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.66 HG23 ' HE1' ' G' ' 290' ' ' TRP . 4.6 m -119.78 119.69 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 123.337 0.655 . . . . 63.43 110.778 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.458 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 61.7 tttt -98.74 137.15 37.77 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.93 0.892 . . . . 71.0 109.339 175.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 50.8 tp -100.61 123.51 44.92 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.589 0.756 . . . . 60.03 109.789 177.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 10.2 m-20 -118.84 127.49 53.56 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.15 0.98 . . . . 75.04 108.541 174.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' G' ' 286' ' ' MET . 3.8 mp -109.06 138.17 45.83 Favored 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 109.251 -0.648 . . . . 65.12 109.251 -179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.512 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.1 t70 -150.49 152.94 34.98 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.536 0.735 . . . . 60.32 109.082 172.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 20.6 p -140.94 160.88 39.11 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.008 0.923 . . . . 73.14 110.393 -176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.483 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -154.95 167.82 29.04 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.006 0.922 . . . . 73.33 109.593 174.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 42.2 p -159.07 153.01 23.32 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.176 0.59 . . . . 75.14 109.799 174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 92.6 p -151.9 149.08 28.54 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 109.281 -0.637 . . . . 74.42 109.281 176.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -89.01 118.35 28.68 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 109.35 -0.611 . . . . 64.1 109.35 175.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' D' ' 57' ' ' GLU . 32.6 mt -92.02 -36.7 13.24 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.021 0.529 . . . . 73.32 110.152 -178.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.52 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -154.33 -179.75 8.22 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.294 -0.867 . . . . 55.34 109.955 -176.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.41 125.85 28.83 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 108.987 -0.746 . . . . 63.54 108.987 177.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 65.82 14.84 9.78 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.374 1.07 . . . . 74.34 111.773 -177.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 41.9 t -129.57 124.74 60.13 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 124.125 0.97 . . . . 63.12 109.145 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.621 ' HB2' HD13 ' D' ' 86' ' ' ILE . 62.7 m-85 -136.1 141.18 44.16 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 121.342 0.591 . . . . 73.55 109.805 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.56 ' HB2' HD11 ' D' ' 51' ' ' LEU . 22.6 tt0 -91.83 132.66 36.29 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.471 -1.24 . . . . 74.32 109.792 173.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.8 t -110.57 125.85 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 N-CA-C 107.541 -1.281 . . . . 63.44 107.541 170.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.531 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 34.1 t -110.15 129.58 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.039 -0.726 . . . . 72.2 109.039 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.504 HD23 HD12 ' D' ' 106' ' ' LEU . 1.8 mm? -118.65 106.21 12.37 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.529 0.731 . . . . 70.44 109.599 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.512 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.7 ttm180 -88.39 102.03 14.47 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-N 115.622 -0.717 . . . . 61.43 109.443 177.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.3 t -91.74 121.18 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 N-CA-C 107.786 -1.19 . . . . 74.23 107.786 170.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 22.4 m -127.0 146.07 50.48 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.602 0.761 . . . . 52.4 109.298 -175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.505 HG11 HD21 ' D' ' 126' ' ' LEU . 54.0 t -139.5 111.74 5.43 Favored 'Isoleucine or valine' 0 C--O 1.243 0.729 0 C-N-CA 124.997 1.319 . . . . 65.02 109.038 -172.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 53.2 m -96.75 95.63 8.04 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 108.768 -0.827 . . . . 51.11 108.768 173.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.36 129.82 44.58 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.35 -0.611 . . . . 73.4 109.35 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.503 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 47.0 m -142.33 141.1 32.32 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.361 0.665 . . . . 74.15 110.778 176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.718 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -132.17 135.64 46.5 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.912 1.285 . . . . 63.32 110.17 -179.086 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.05 -114.51 5.57 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.902 -0.879 . . . . 53.42 110.902 -174.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -117.61 4.69 12.36 Favored 'General case' 0 CA--C 1.553 1.071 0 C-N-CA 123.039 0.535 . . . . 65.54 110.418 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -127.36 161.84 27.7 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.074 0.55 . . . . 73.02 110.946 -172.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 53.2 m -80.75 131.55 35.44 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 122.964 0.505 . . . . 65.01 111.469 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.718 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -72.68 -71.62 0.28 Allowed 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.754 1.222 . . . . 74.14 108.379 173.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' D' ' 24' ' ' GLU . 51.4 p90 -153.93 140.32 18.68 Favored 'General case' 0 C--N 1.347 0.477 0 CA-C-N 115.746 -0.661 . . . . 73.04 111.033 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.7 mt -101.37 110.2 22.17 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 107.272 -1.381 . . . . 44.5 107.272 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.584 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.2 t -119.0 132.89 56.09 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 109.478 -0.564 . . . . 74.51 109.478 -176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.412 ' HB2' HG23 ' D' ' 63' ' ' THR . 32.3 tt0 -152.08 132.13 13.46 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.14 0.576 . . . . 60.42 110.249 -174.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 54.3 t -136.71 117.35 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 C-N-CA 123.356 0.663 . . . . 61.43 109.669 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -87.28 87.33 7.4 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 107.852 -1.166 . . . . 73.51 107.852 170.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -80.33 91.17 5.62 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 115.289 -0.869 . . . . 63.35 108.796 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.94 143.61 17.61 Favored Glycine 0 C--N 1.343 0.96 0 N-CA-C 111.071 -0.811 . . . . 53.14 111.071 179.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.92 132.13 5.08 Favored Glycine 0 CA--C 1.507 -0.464 0 N-CA-C 111.209 -0.756 . . . . 62.45 111.209 -174.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.495 HG13 ' HE1' ' D' ' 17' ' ' TYR . 49.1 mt -88.19 124.37 41.23 Favored 'Isoleucine or valine' 0 C--O 1.245 0.861 0 N-CA-C 108.407 -0.96 . . . . 65.11 108.407 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -129.48 160.77 32.13 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.26 0.552 . . . . 74.1 110.112 176.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 35.5 m -104.9 117.19 33.42 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 107.992 -1.114 . . . . 74.51 107.992 172.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.621 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.4 mp -118.15 108.76 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 N-CA-C 109.197 -0.668 . . . . 72.12 109.197 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.32 160.82 41.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.037 0.935 . . . . 74.01 110.014 179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.6 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 79.01 -4.13 62.9 Favored Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.728 -0.669 . . . . 72.53 113.904 176.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.447 HD11 HG23 ' D' ' 86' ' ' ILE . 15.0 pt -126.65 142.11 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 C-N-CA 124.123 0.969 . . . . 73.14 109.696 -177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.8 167.21 22.68 Favored 'General case' 0 C--O 1.247 0.944 0 C-N-CA 123.43 0.692 . . . . 74.34 110.114 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.17 -122.7 27.1 Favored Glycine 0 C--N 1.349 1.285 0 O-C-N 124.605 1.191 . . . . 72.05 114.606 173.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 36.4 m -66.27 -44.38 83.74 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.162 0.985 . . . . 61.0 112.128 -175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -65.69 -38.33 88.93 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.027 0.531 . . . . 70.43 110.873 -176.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -64.76 -48.61 73.92 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.67 -0.695 . . . . 72.44 110.199 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -28.7 67.95 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.748 0.819 . . . . 71.32 111.767 -178.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 53.0 t-80 -78.69 -30.64 46.23 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.561 0.745 . . . . 74.12 110.513 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.9 t -76.61 -50.86 12.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 121.295 0.569 . . . . 54.12 110.071 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.601 HD12 HG12 ' D' ' 86' ' ' ILE . 6.3 tt -81.96 -23.28 36.2 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.654 -0.703 . . . . 62.43 111.124 -171.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.94 3.18 57.09 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 119.447 -0.641 . . . . 44.5 114.145 -178.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -141.01 -53.96 0.48 Allowed 'General case' 0 N--CA 1.484 1.264 0 CA-C-N 117.868 0.834 . . . . 73.55 111.782 -177.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -73.89 -54.32 8.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.243 0.617 . . . . 71.12 110.978 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.573 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 61.2 m -59.25 -44.95 99.14 Favored Pre-proline 0 CA--C 1.565 1.523 0 N-CA-C 113.895 1.072 . . . . 74.22 113.895 -174.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -59.72 -35.49 94.51 Favored 'Trans proline' 0 C--N 1.394 2.97 0 C-N-CA 121.915 1.743 . . . . 71.12 112.794 174.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -80.78 -7.57 59.43 Favored 'General case' 0 CA--C 1.557 1.243 0 C-N-CA 123.518 0.727 . . . . 70.23 111.415 -177.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 46.1 mm -78.71 -37.38 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.491 0.662 . . . . 74.1 109.747 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.504 HD12 HD23 ' D' ' 60' ' ' LEU . 50.9 mt -81.79 -32.02 31.55 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.129 -0.941 . . . . 53.11 111.409 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -58.54 -44.21 98.84 Favored Pre-proline 0 CA--C 1.572 1.805 0 N-CA-C 114.195 1.183 . . . . 63.41 114.195 -174.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -58.56 -39.99 78.09 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.317 2.011 . . . . 72.11 113.421 175.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -74.9 -33.61 62.05 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.295 0.638 . . . . 65.13 110.97 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.0 -43.35 88.02 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.217 0.607 . . . . 72.35 109.994 176.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.495 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 33.4 ttp180 -59.42 -52.19 66.68 Favored 'General case' 0 C--N 1.347 0.479 0 CA-C-N 114.412 -1.267 . . . . 73.33 110.754 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -61.72 -45.34 94.39 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 124.176 0.923 . . . . 74.23 110.925 -175.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -58.3 -41.47 84.51 Favored 'General case' 0 N--CA 1.478 0.968 0 O-C-N 123.761 0.663 . . . . 75.43 110.953 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.584 HG23 ' SG ' ' D' ' 76' ' ' CYS . 47.6 mt -63.29 -55.66 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 CA-C-N 115.612 -0.722 . . . . 74.52 110.39 174.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 21.8 m -53.49 -39.68 64.76 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.337 1.055 . . . . 64.43 111.47 -173.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 20.6 t -65.95 -45.91 80.07 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 114.987 -1.006 . . . . 74.22 110.501 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 74.9 mtm -67.39 -35.89 80.22 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 122.967 0.507 . . . . 73.02 111.776 -178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' D' ' 114' ' ' ILE . 57.7 t -64.04 -43.59 97.59 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.85 0 O-C-N 123.838 0.711 . . . . 71.33 109.399 177.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.0 p -71.62 -29.32 64.53 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.007 0.523 . . . . 73.51 111.87 178.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' D' ' 116' ' ' SER . 86.3 mtt-85 -72.86 -34.28 66.64 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 123.574 0.75 . . . . 74.21 110.473 177.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 9.01 63.96 Favored Glycine 0 C--N 1.351 1.387 0 O-C-N 123.759 0.662 . . . . 24.04 112.202 173.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 59.4 p 62.14 18.7 10.29 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 126.935 2.094 . . . . 64.35 113.544 175.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -83.34 165.46 40.42 Favored Pre-proline 0 CA--C 1.569 1.676 0 N-CA-C 107.557 -1.275 . . . . 75.05 107.557 162.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -84.05 -157.9 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.946 0 C-N-CA 122.284 1.989 . . . . 63.45 113.549 -165.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -74.44 120.57 20.18 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 122.442 0.297 . . . . 74.1 110.891 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.505 HD21 HG11 ' D' ' 64' ' ' VAL . 63.1 tp -116.51 95.0 4.85 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 108.184 -1.043 . . . . 42.24 108.184 170.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -108.27 104.26 13.61 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 108.508 -0.923 . . . . 62.21 108.508 -175.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.495 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.5 mm? -62.99 113.87 3.35 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.607 0.763 . . . . 75.12 109.372 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -64.16 137.12 97.02 Favored Pre-proline 0 CA--C 1.55 0.964 0 C-N-CA 122.946 0.499 . . . . 64.13 110.477 -176.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 15.8 Cg_exo -65.3 131.63 28.92 Favored 'Trans proline' 0 C--N 1.379 2.167 0 C-N-CA 122.939 2.426 . . . . 72.45 112.273 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.621 HG22 HD21 ' G' ' 291' ' ' LEU . 65.1 t -109.28 130.92 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.23 0.612 . . . . 73.34 109.788 -176.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -86.6 85.51 7.3 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.428 -0.953 . . . . 43.14 108.428 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -63.46 -22.49 66.92 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 115.377 -0.829 . . . . 72.43 111.185 177.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -59.88 -53.85 53.02 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.924 1.29 . . . . 73.14 111.566 -176.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.421 ' HA ' ' CE ' ' D' ' 138' ' ' MET . . . -64.32 -43.25 95.27 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.344 -0.844 . . . . 63.2 111.468 -178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 65.4 mt -62.53 -37.88 87.79 Favored 'General case' 0 N--CA 1.479 0.992 0 O-C-N 124.208 0.942 . . . . 71.24 111.261 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -67.55 -47.26 70.38 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.44 -0.8 . . . . 70.33 110.517 177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.47 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 71.4 mtm -62.89 -41.99 99.61 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.121 0.568 . . . . 64.1 110.894 -178.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -59.7 -27.32 66.33 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 123.769 0.828 . . . . 72.53 112.425 -177.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 92.0 t80 -65.37 -48.98 71.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 122.91 0.484 . . . . 74.35 110.561 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.9 mp -64.03 -27.05 68.85 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.667 0.787 . . . . 75.01 111.352 -178.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.47 ' HG3' ' O ' ' D' ' 138' ' ' MET . 19.6 mt-30 -74.72 1.98 11.08 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 123.979 0.912 . . . . 75.11 112.795 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.92 44.44 1.47 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.141 0.496 . . . . 75.21 111.433 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.75 167.64 18.73 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.894 0.877 . . . . 73.4 109.92 173.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -102.47 25.28 9.22 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.741 0.816 . . . . 75.03 112.139 -171.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 82.9 -69.49 3.36 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-N 116.211 -0.449 . . . . 55.13 112.543 179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -71.59 122.96 21.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.166 0.986 . . . . 65.23 110.581 -179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.22 -145.03 4.9 Favored Glycine 0 C--N 1.346 1.087 0 C-N-CA 121.169 -0.539 . . . . 73.32 113.281 -176.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 44.8 m -63.98 106.33 1.02 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.406 0.683 . . . . 75.3 110.48 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . 0.589 ' HB2' HE21 ' G' ' 274' ' ' GLN . 17.0 pt-20 -147.28 137.91 23.49 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.434 -0.803 . . . . 73.33 109.139 -176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -86.58 141.1 29.26 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 115.339 -0.846 . . . . 74.21 110.576 -171.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 32.5 p80 -70.45 108.35 4.24 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.594 -0.891 . . . . 55.45 108.594 173.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . 0.451 ' HG3' ' HA2' ' G' ' 279' ' ' GLY . 0.1 OUTLIER -84.9 116.36 23.29 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.244 -1.391 . . . . 65.34 107.244 176.621 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -76.1 87.72 3.0 Favored 'General case' 0 CA--C 1.536 0.436 0 O-C-N 123.944 0.778 . . . . 61.14 110.075 -175.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 N-CA-C 107.621 -1.252 . . . . 63.5 107.621 178.054 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 120.934 0.397 . . . . 62.04 111.17 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -70.7 91.03 0.79 Allowed 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.904 0.859 . . . . 54.51 110.278 175.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -97.08 -138.01 0.27 Allowed 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.37 1.068 . . . . 73.44 109.522 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -74.73 81.16 2.06 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 122.028 0.918 . . . . 75.51 110.239 -177.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -82.69 147.87 56.53 Favored Pre-proline 0 CA--C 1.548 0.892 0 CA-C-N 113.905 -1.498 . . . . 71.04 108.515 175.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -40.94 98.07 0.03 OUTLIER 'Trans proline' 0 C--N 1.389 2.699 0 C-N-CA 123.148 2.566 . . . . 54.42 112.91 170.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 6.9 tt -88.56 -48.49 7.54 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 113.59 -1.641 . . . . 70.24 109.964 -168.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . 0.413 HD22 HD13 ' A' ' 98' ' ' LEU . 89.1 mt -72.36 126.35 29.6 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.78 0.832 . . . . 51.33 111.802 -171.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -160.47 143.47 9.04 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-O 118.82 -0.989 . . . . 64.43 110.861 177.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.43 HD23 ' HB1' ' A' ' 95' ' ' ALA . 59.0 tp 66.1 107.84 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.754 1.221 . . . . 75.32 110.844 -175.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -171.7 -57.87 0.02 OUTLIER 'General case' 0 C--N 1.355 0.829 0 CA-C-O 121.154 0.502 . . . . 74.41 111.802 -179.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -82.9 27.4 0.54 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.254 1.022 . . . . 61.24 112.092 -173.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -99.83 142.1 31.76 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.142 0.977 . . . . 73.24 108.994 -179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.55 70.86 1.9 Allowed Glycine 0 C--N 1.345 1.069 0 N-CA-C 111.286 -0.726 . . . . 74.41 111.286 172.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -102.79 -22.46 13.89 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.896 1.278 . . . . 44.04 109.375 177.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . 0.612 ' HB3' HG23 ' E' ' 288' ' ' VAL . 64.9 mtt -100.54 114.59 65.78 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 124.235 1.014 . . . . 72.4 110.351 -178.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -92.63 38.5 0.24 Allowed 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 123.458 2.772 . . . . 71.14 112.249 173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . 0.612 HG23 ' HB3' ' E' ' 286' ' ' MET . 66.4 t -66.05 128.72 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 123.799 0.839 . . . . 54.34 111.353 -171.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -149.92 -166.1 2.45 Favored 'General case' 0 C--O 1.245 0.86 0 C-N-CA 124.525 1.13 . . . . 74.21 108.555 -176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . 0.433 ' NE1' ' HB2' ' A' ' 42' ' ' LEU . 98.6 m95 -77.32 118.39 19.76 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 109.339 -0.615 . . . . 74.3 109.339 172.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.682 ' H ' HD13 ' E' ' 291' ' ' LEU . 0.0 OUTLIER -82.86 -11.43 58.23 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.446 1.098 . . . . 64.32 110.602 178.899 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . 0.463 ' HA2' ' SG ' ' G' ' 308' ' ' CYS . . . -126.99 177.48 17.33 Favored Glycine 0 C--N 1.353 1.478 0 CA-C-N 115.328 -0.851 . . . . 73.34 112.472 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -69.15 147.22 66.28 Favored 'Trans proline' 0 C--N 1.376 2.019 0 C-N-CA 123.202 2.601 . . . . 63.42 112.67 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 11.4 mptt -80.94 82.96 6.77 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.524 0.73 . . . . 54.32 109.434 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' G' ' 305' ' ' ALA . . . -71.33 -77.83 0.09 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 109.265 -0.643 . . . . 64.33 109.265 175.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . 0.59 ' HB ' ' HG2' ' A' ' 38' ' ' PRO . 1.9 m 58.59 12.1 2.0 Favored 'General case' 0 CA--C 1.562 1.416 0 C-N-CA 125.005 1.322 . . . . 74.52 112.7 174.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.8 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 0.6 OUTLIER -151.31 -171.67 4.0 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.761 1.624 . . . . 61.21 108.664 176.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 54.9 m80 74.85 28.95 1.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 125.383 1.473 . . . . 74.02 111.433 -175.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 124' ' ' PRO . . . -148.76 11.5 1.1 Allowed Glycine 0 C--N 1.357 1.727 0 N-CA-C 115.956 1.143 . . . . 71.4 115.956 -177.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -169.58 -165.4 0.5 Allowed 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.263 -1.014 . . . . 74.31 108.263 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 68.3 mt 66.94 96.97 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.291 1.436 . . . . 71.05 109.269 -176.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -93.52 -68.67 0.79 Allowed 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.322 -0.853 . . . . 55.32 111.279 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' E' ' 304' ' ' PRO . 65.6 tttp -175.34 127.78 0.39 Allowed Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.395 0.678 . . . . 72.14 109.54 -174.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' E' ' 303' ' ' LYS . 2.9 Cg_endo -83.35 50.06 3.16 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 123.481 2.787 . . . . 65.43 111.944 174.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -171.03 127.52 0.71 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.001 0.92 . . . . 70.51 109.305 176.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 83.0 t -127.62 142.37 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 C-N-CA 123.611 0.764 . . . . 75.33 109.232 177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' G' ' 293' ' ' PRO . 18.9 m -70.4 128.38 35.97 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.35 0.66 . . . . 65.12 110.024 177.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 29.7 p -76.43 172.47 12.88 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.324 0.65 . . . . 62.14 111.162 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 34.3 p -65.27 113.3 10.84 Favored Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 123.489 0.716 . . . . 55.44 110.16 173.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo . . . . . 0 C--N 1.381 2.286 0 C-N-CA 123.322 2.682 . . . . 71.14 111.434 177.892 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.786 0 N-CA-C 110.161 -0.311 . . . . 63.2 110.161 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -153.22 170.18 21.2 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.201 1.0 . . . . 74.24 108.472 -178.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -73.24 79.94 1.31 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.669 0.747 . . . . 63.01 109.532 175.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . 0.516 ' HG3' ' HB3' ' A' ' 153' ' ' GLN . 6.5 tp-100 -133.17 -11.58 2.88 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.673 1.189 . . . . 64.55 108.821 176.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 152' ' ' HIS . 25.5 tptp 68.22 99.81 0.04 OUTLIER Pre-proline 0 CA--C 1.553 1.086 0 C-N-CA 124.257 1.023 . . . . 73.42 111.507 166.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.91 156.89 8.67 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.319 2.012 . . . . 73.3 111.287 167.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 87.3 mt -64.6 -40.2 95.09 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 121.419 0.628 . . . . 74.33 110.16 173.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' F' ' 281' ' ' PHE . 3.0 mm? -98.34 66.04 1.72 Allowed 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.372 0.669 . . . . 71.43 109.267 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -99.29 -60.41 0.86 Allowed Glycine 0 C--N 1.356 1.649 0 CA-C-N 115.695 -0.684 . . . . 52.32 112.029 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -68.04 -19.14 64.87 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.6 0.76 . . . . 64.13 111.217 177.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . 0.41 ' CD2' HD12 ' F' ' 278' ' ' LEU . 24.2 t80 -74.73 -11.22 60.11 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.538 1.135 . . . . 74.3 111.668 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.36 68.56 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.51 0.724 . . . . 53.03 110.554 172.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -137.7 96.33 3.22 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.9 0.88 . . . . 74.21 109.473 176.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -94.61 61.68 1.71 Allowed Glycine 0 C--N 1.341 0.846 0 N-CA-C 111.017 -0.833 . . . . 70.43 111.017 172.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -72.4 87.36 1.16 Allowed 'General case' 0 C--N 1.358 0.958 0 C-N-CA 123.079 0.552 . . . . 73.32 109.852 -179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 51.4 tpp -97.04 123.69 52.36 Favored Pre-proline 0 C--O 1.239 0.541 0 N-CA-C 107.427 -1.323 . . . . 71.43 107.427 171.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -71.88 74.86 2.26 Favored 'Trans proline' 0 C--N 1.375 1.97 0 C-N-CA 122.61 2.207 . . . . 74.45 112.286 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 45.3 t -80.84 96.62 2.98 Favored 'Isoleucine or valine' 0 C--N 1.348 0.526 0 N-CA-C 108.138 -1.06 . . . . 71.32 108.138 176.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -95.52 34.07 1.52 Allowed 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.165 0.986 . . . . 74.51 110.543 -177.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . 0.524 ' HE3' ' H ' ' F' ' 291' ' ' LEU . 7.0 m95 61.37 162.99 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 125.529 1.531 . . . . 74.13 113.05 -173.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.524 ' H ' ' HE3' ' F' ' 290' ' ' TRP . 51.7 mt -118.47 -21.54 7.97 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 113.807 -1.542 . . . . 73.31 109.282 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . 0.419 ' H ' ' HE3' ' F' ' 290' ' ' TRP . . . -149.16 96.62 0.17 Allowed Glycine 0 C--N 1.358 1.766 0 C-N-CA 124.252 0.93 . . . . 51.42 111.163 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -64.66 -65.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 123.066 2.511 . . . . 72.22 114.114 -170.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . 0.787 ' HG2' ' HD2' ' C' ' 38' ' ' PRO . 0.0 OUTLIER -96.99 14.83 24.18 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 121.692 0.758 . . . . 62.51 110.081 -174.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.04 -14.96 63.33 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.863 0.865 . . . . 74.23 112.625 -177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 32.5 m -59.73 -55.78 30.05 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.458 0.703 . . . . 73.15 110.854 177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.693 ' HB3' ' HG2' ' C' ' 124' ' ' PRO . 16.4 p90 -146.82 106.31 3.92 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.476 0.655 . . . . 75.3 111.448 169.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . 0.405 ' HB3' ' HA ' ' H' ' 300' ' ' ASN . 62.1 t60 -80.92 -41.14 23.43 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.673 -1.148 . . . . 72.42 108.808 167.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 165.25 50.94 0.02 OUTLIER Glycine 0 C--N 1.35 1.339 0 CA-C-N 115.548 -0.751 . . . . 45.13 112.506 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . 0.733 HD21 ' H ' ' B' ' 125' ' ' GLN . 61.0 t30 -84.26 -51.71 6.8 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.323 0.583 . . . . 71.14 110.064 176.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.474 ' HB ' ' HE2' ' C' ' 32' ' ' PHE . 47.6 pt -87.14 37.41 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 CA-C-N 115.18 -0.918 . . . . 62.42 109.982 178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -62.33 -25.79 68.08 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.067 1.347 . . . . 74.12 111.649 -172.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -99.86 129.38 28.71 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 123.58 0.752 . . . . 71.33 109.569 177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -84.4 23.25 0.85 Allowed 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.669 2.913 . . . . 72.34 113.957 -172.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -158.5 141.38 14.64 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.676 0.79 . . . . 73.25 109.346 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . 0.659 HG11 HH11 ' D' ' 15' ' ' ARG . 17.4 m -88.81 -51.57 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 O-C-N 123.107 0.255 . . . . 72.01 110.338 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . 0.642 HG21 ' HB3' ' H' ' 291' ' ' LEU . 64.1 m -161.65 125.81 3.32 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 107.676 -1.231 . . . . 74.33 107.676 176.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 60.7 m -85.31 82.8 8.19 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.863 -0.791 . . . . 74.12 108.863 172.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . 0.428 ' HA ' ' HD3' ' F' ' 310' ' ' PRO . 8.0 t -115.36 134.52 22.58 Favored Pre-proline 0 N--CA 1.481 1.109 0 C-N-CA 123.104 0.562 . . . . 43.23 110.753 -174.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' F' ' 309' ' ' THR . 6.9 Cg_endo . . . . . 0 C--N 1.375 1.974 0 C-N-CA 122.861 2.374 . . . . 75.53 111.124 173.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.992 -0.373 . . . . 75.51 109.992 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -99.81 159.71 14.86 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.546 0.738 . . . . 71.03 109.931 175.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -114.09 26.85 9.96 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 122.143 0.973 . . . . 70.25 109.57 178.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . 0.589 HE21 ' HB2' ' D' ' 150' ' ' GLU . 62.6 mt-30 -89.6 -163.94 1.08 Allowed 'General case' 0 C--O 1.242 0.707 0 CA-C-N 115.152 -0.931 . . . . 61.0 109.933 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 13.7 tppt? -63.06 134.45 95.81 Favored Pre-proline 0 CA--C 1.555 1.171 0 CA-C-O 118.518 -0.753 . . . . 74.43 109.047 171.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -49.81 -43.24 41.55 Favored 'Trans proline' 0 C--N 1.383 2.351 0 C-N-CA 122.946 2.431 . . . . 74.22 113.033 177.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.455 HD21 HG22 ' D' ' 86' ' ' ILE . 3.2 tm? -106.88 111.63 24.22 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 108.127 -1.064 . . . . 72.04 108.127 178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 3.7 mm? 70.06 166.8 0.29 Allowed 'General case' 0 N--CA 1.484 1.271 0 O-C-N 124.593 1.183 . . . . 71.42 112.992 178.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . 0.451 ' HA2' ' HG3' ' D' ' 153' ' ' GLN . . . 158.29 -73.11 0.23 Allowed Glycine 0 C--N 1.337 0.636 0 CA-C-N 114.791 -1.095 . . . . 43.32 111.235 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.22 137.43 33.49 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.069 0.548 . . . . 74.34 111.073 -178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 22.1 t80 176.88 174.78 0.39 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.641 1.577 . . . . 74.43 108.459 172.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . 77.27 89.18 0.07 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.598 1.559 . . . . 53.14 111.845 171.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -150.87 145.03 25.39 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.99 1.316 . . . . 72.15 108.606 172.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -120.96 0.76 11.84 Favored Glycine 0 C--N 1.344 0.973 0 CA-C-O 119.842 -0.421 . . . . 51.52 113.074 -176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -94.88 58.79 2.28 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 117.377 0.589 . . . . 51.4 109.865 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . 0.546 ' HB2' HD22 ' D' ' 44' ' ' LEU . 94.8 mmm -102.64 98.71 11.57 Favored Pre-proline 0 CA--C 1.548 0.866 0 N-CA-C 109.064 -0.717 . . . . 62.45 109.064 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.3 97.6 1.14 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 122.841 2.361 . . . . 73.23 111.087 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 10.4 p -99.79 5.14 10.05 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.16 0 C-N-CA 123.585 0.754 . . . . 72.35 110.187 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 2.6 tmt_? 71.54 4.32 5.0 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.911 1.284 . . . . 73.42 111.352 176.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.66 ' HE1' HG23 ' D' ' 40' ' ' VAL . 0.1 OUTLIER 62.15 27.4 16.49 Favored 'General case' 0 CA--C 1.56 1.352 0 C-N-CA 124.595 1.158 . . . . 75.25 110.349 -173.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.621 HD21 HG22 ' D' ' 131' ' ' VAL . 4.8 mp 53.54 -84.76 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.727 1.611 . . . . 64.43 112.889 173.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -163.52 139.89 6.15 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.509 -1.036 . . . . 63.01 110.509 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' E' ' 307' ' ' THR . 72.9 Cg_endo -76.68 117.54 4.56 Favored 'Trans proline' 0 C--N 1.369 1.612 0 C-N-CA 122.693 2.262 . . . . 72.22 112.707 -173.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 51.5 tttm -76.64 140.86 41.12 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 108.417 -0.957 . . . . 74.15 108.417 165.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -68.49 139.02 55.66 Favored 'General case' 0 C--O 1.24 0.585 0 O-C-N 123.519 0.512 . . . . 61.33 109.75 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 8.3 p -98.79 -65.35 0.97 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.598 0.759 . . . . 70.24 109.819 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 64.7 m-85 -118.72 140.91 49.18 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 109.353 -0.61 . . . . 74.32 109.353 172.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -72.74 -42.71 63.78 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.046 0.538 . . . . 73.21 109.941 174.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 175.53 54.47 0.06 OUTLIER Glycine 0 C--N 1.338 0.664 0 N-CA-C 111.134 -0.786 . . . . 75.04 111.134 178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . 0.515 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 9.8 p30 -157.19 -174.21 4.8 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.323 0.649 . . . . 54.32 109.837 -176.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.567 ' HB ' ' HA ' ' D' ' 35' ' ' ASP . 10.2 tp -155.44 9.63 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.321 0 C-N-CA 122.749 0.42 . . . . 74.41 111.051 -177.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . 0.499 ' HB3' ' NH2' ' C' ' 15' ' ' ARG . 31.0 t70 70.16 98.88 0.06 Allowed 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.556 1.543 . . . . 73.15 110.765 -167.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -134.29 85.72 37.86 Favored Pre-proline 0 C--O 1.244 0.765 0 N-CA-C 107.58 -1.267 . . . . 74.25 107.58 173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.91 120.37 7.6 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.238 1.959 . . . . 72.44 110.092 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . 0.443 ' HB3' ' HB2' ' E' ' 295' ' ' ALA . . . -66.59 83.76 0.1 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.315 0.646 . . . . 75.14 110.534 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 61.5 t -116.5 89.98 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 106.187 -1.783 . . . . 71.44 106.187 174.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 25.9 p -117.76 12.0 13.77 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 123.935 0.894 . . . . 75.23 111.143 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . 0.463 ' SG ' ' HA2' ' E' ' 292' ' ' GLY . 21.2 p -166.69 126.49 1.54 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.609 0.764 . . . . 72.42 110.287 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 39.0 m -142.99 69.55 18.45 Favored Pre-proline 0 CA--C 1.559 1.322 0 C-N-CA 124.455 1.102 . . . . 74.22 108.218 171.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo . . . . . 0 C--N 1.381 2.285 0 C-N-CA 123.365 2.71 . . . . 72.44 110.905 -179.378 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 120.512 0.196 . . . . 71.23 110.707 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -122.24 119.26 30.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.638 0.775 . . . . 63.24 108.989 177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -76.68 178.58 6.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.731 0.812 . . . . 43.45 109.645 175.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . 0.418 ' NE2' ' HB1' ' B' ' 87' ' ' ALA . 79.2 mt-30 -58.21 -49.23 77.8 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 122.94 0.496 . . . . 71.2 110.377 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 12.4 mtmt -168.83 163.39 7.88 Favored Pre-proline 0 N--CA 1.487 1.383 0 C-N-CA 125.406 1.482 . . . . 75.24 109.053 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -64.96 -31.34 56.26 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.603 2.202 . . . . 75.23 112.793 179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . 0.463 ' HG ' ' HE2' ' B' ' 94' ' ' MET . 9.2 mp 62.24 -165.56 0.23 Allowed 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 124.299 1.04 . . . . 73.0 111.27 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 8.0 mp 68.99 -159.22 0.18 Allowed 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.983 0.913 . . . . 63.31 111.36 173.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 117.6 -45.72 1.24 Allowed Glycine 0 C--N 1.352 1.426 0 N-CA-C 112.087 -0.405 . . . . 72.41 112.087 178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 30.9 tp -68.3 -23.89 64.79 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.335 0.654 . . . . 74.05 110.507 175.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -72.95 173.53 9.12 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 115.585 -0.734 . . . . 75.32 111.424 171.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . 59.0 28.18 17.35 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 124.039 0.837 . . . . 75.4 109.874 -170.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -165.34 -89.51 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 114.154 -1.385 . . . . 64.24 107.602 -173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 56.37 30.38 58.34 Favored Glycine 0 C--N 1.353 1.474 0 C-N-CA 123.05 0.357 . . . . 74.42 112.783 -177.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -77.71 80.37 4.17 Favored 'General case' 0 C--N 1.349 0.581 0 C-N-CA 123.811 0.844 . . . . 71.24 109.949 -174.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . 0.437 ' HA ' ' HD3' ' H' ' 287' ' ' PRO . 73.8 mtm -115.66 132.22 23.26 Favored Pre-proline 0 C--O 1.238 0.493 0 N-CA-C 107.268 -1.382 . . . . 63.01 107.268 171.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' H' ' 286' ' ' MET . 12.8 Cg_exo -67.98 90.15 0.37 Allowed 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 122.438 2.092 . . . . 73.31 111.667 -175.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 82.0 t -75.35 -55.11 12.51 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 N-CA-C 108.29 -1.004 . . . . 72.33 108.29 173.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 59.58 -82.67 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 O-C-N 124.796 1.31 . . . . 73.14 110.066 -177.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -172.02 157.13 4.27 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 126.364 1.866 . . . . 65.13 106.31 176.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.642 ' HB3' HG21 ' F' ' 307' ' ' THR . 6.8 mp -92.42 41.4 1.07 Allowed 'General case' 0 CA--C 1.546 0.794 0 N-CA-C 108.384 -0.969 . . . . 62.12 108.384 176.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 102.55 143.43 13.23 Favored Glycine 0 C--N 1.358 1.759 0 CA-C-N 114.656 -1.156 . . . . 62.34 111.426 -170.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.08 116.98 4.03 Favored 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 122.981 2.454 . . . . 64.15 111.227 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -92.64 146.37 23.71 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 110.088 -0.338 . . . . 75.24 110.088 -177.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . 0.404 ' HB1' ' HD2' ' H' ' 298' ' ' HIS . . . -84.26 67.06 9.65 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 123.488 0.715 . . . . 71.54 110.181 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 89.8 m -71.21 145.69 49.51 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.236 1.015 . . . . 74.53 109.093 174.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 43.1 t80 74.37 -64.34 0.39 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.713 1.205 . . . . 74.41 108.91 -176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . 0.404 ' HD2' ' HB1' ' H' ' 295' ' ' ALA . 61.7 t-80 62.55 -82.4 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 125.461 1.504 . . . . 44.14 111.747 167.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 164.76 69.62 0.02 OUTLIER Glycine 0 C--N 1.339 0.715 0 N-CA-C 110.36 -1.096 . . . . 63.01 110.36 -174.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . 0.563 ' HB2' ' HB2' ' F' ' 300' ' ' ASN . 7.0 t30 -113.16 0.61 14.98 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.201 0.6 . . . . 74.1 110.496 175.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 48.6 mt -68.23 85.37 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.77 0 N-CA-C 107.412 -1.329 . . . . 74.24 107.412 171.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -62.94 -64.31 0.95 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.899 0.88 . . . . 71.22 111.042 -170.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -139.67 158.73 67.5 Favored Pre-proline 0 N--CA 1.477 0.911 0 C-N-CA 123.781 0.832 . . . . 73.45 109.392 -178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -64.48 73.08 0.2 Allowed 'Trans proline' 0 C--N 1.383 2.355 0 C-N-CA 123.131 2.554 . . . . 72.34 111.461 169.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -88.07 -57.9 2.76 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.785 -1.098 . . . . 61.43 112.367 -166.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 5.2 p -65.39 -34.81 72.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 115.203 -0.908 . . . . 64.05 111.484 -176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . 0.658 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 12.0 t -69.99 -21.64 63.2 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.319 0.647 . . . . 72.13 111.999 -179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . 0.536 ' SG ' HG23 ' H' ' 307' ' ' THR . 57.4 m -131.84 76.9 1.73 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.335 0.654 . . . . 71.33 109.323 -177.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 23.3 p -69.91 110.13 6.03 Favored Pre-proline 0 CA--C 1.558 1.284 0 O-C-N 123.464 0.477 . . . . 70.13 109.746 178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo . . . . . 0 C--N 1.379 2.18 0 C-N-CA 123.044 2.496 . . . . 61.52 111.628 -177.535 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.6 tpt . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.396 -0.594 . . . . 64.25 109.396 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.0 t -72.31 95.58 1.74 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.515 0.726 . . . . 64.01 109.179 173.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -115.65 140.96 48.7 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.97 0.908 . . . . 73.2 110.226 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -91.47 174.36 7.41 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.483 0.713 . . . . 73.24 110.663 179.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -165.86 139.36 4.34 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.292 1.037 . . . . 75.44 109.14 176.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -166.45 150.9 7.65 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.417 0.687 . . . . 74.12 109.542 179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.8 p -66.86 92.83 0.24 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.651 0.78 . . . . 64.01 111.299 -177.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.78 5.47 15.78 Favored 'General case' 0 CA--C 1.556 1.197 0 C-N-CA 124.769 1.228 . . . . 72.31 111.544 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 59.8 mtt -61.75 133.4 55.49 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.822 0.849 . . . . 63.32 110.629 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 87.8 m -153.37 137.06 16.05 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.958 0.903 . . . . 60.44 109.442 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.453 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 27.2 t80 -137.81 126.13 23.22 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.214 1.005 . . . . 71.15 108.712 172.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.4 tp60 -151.06 128.51 11.38 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.307 0.643 . . . . 72.03 109.502 174.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.532 ' CD1' HG21 ' A' ' 105' ' ' ILE . 56.4 mt -85.12 129.03 38.47 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 CA-C-O 120.921 0.391 . . . . 73.15 109.955 176.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -88.6 -42.71 11.86 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.108 -0.951 . . . . 73.43 110.255 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' HB3' HD12 ' A' ' 83' ' ' ILE . 60.1 ttt180 -169.83 140.75 2.14 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 116.314 -0.403 . . . . 74.2 110.714 -170.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.482 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -122.81 137.95 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.221 -1.029 . . . . 74.34 108.221 172.014 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -168.23 143.58 3.64 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.388 0.675 . . . . 73.44 110.463 -171.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 77.9 p -76.59 111.01 11.62 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 108.735 -0.839 . . . . 70.43 108.735 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 40.4 mtpt -77.27 -25.28 51.29 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.969 0.508 . . . . 74.03 110.565 178.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -153.24 146.71 24.94 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.941 -1.027 . . . . 72.25 109.895 176.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 47.4 mt -140.24 145.2 26.45 Favored 'Isoleucine or valine' 0 C--O 1.242 0.66 0 C-N-CA 125.06 1.344 . . . . 54.42 107.498 177.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.507 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 36.5 t -154.7 138.39 16.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.634 0.774 . . . . 61.2 109.103 175.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.546 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -143.58 131.63 21.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 106.565 -1.643 . . . . 74.52 106.565 173.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -134.51 128.81 34.09 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 109.006 -0.739 . . . . 74.14 109.006 -176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.02 78.65 72.94 Favored Pre-proline 0 C--O 1.241 0.618 0 N-CA-C 107.33 -1.359 . . . . 73.44 107.33 171.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.73 -26.07 19.75 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.68 2.253 . . . . 70.24 112.055 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -109.39 24.22 13.38 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.773 0.829 . . . . 62.35 109.019 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.615 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.21 -61.17 2.48 Favored Pre-proline 0 CA--C 1.571 1.758 0 CA-C-O 117.879 -1.057 . . . . 70.22 112.595 -174.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 18.7 Cg_exo -63.21 -24.3 72.5 Favored 'Trans proline' 0 C--N 1.395 2.98 0 C-N-CA 122.28 1.987 . . . . 73.15 113.008 -178.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.407 ' O ' ' HG3' ' A' ' 34' ' ' LYS . 16.2 m-70 -77.95 -47.37 18.75 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.673 0.789 . . . . 45.34 110.442 -177.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 73' ' ' ALA . 0.8 OUTLIER -73.9 -20.02 17.71 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 CA-C-N 115.16 -0.927 . . . . 75.12 110.949 -163.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.9 -19.22 62.62 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 124.354 1.062 . . . . 75.41 112.765 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -102.53 -10.28 19.47 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 122.696 0.398 . . . . 55.32 111.979 174.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 30' ' ' HIS . 36.6 mtpt -82.12 167.63 18.56 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 122.875 0.47 . . . . 74.44 112.248 -175.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -61.53 141.33 57.8 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.457 1.103 . . . . 71.34 111.933 -176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.48 ' HB3' ' HB3' ' E' ' 297' ' ' TYR . 48.4 m95 -91.87 64.08 4.66 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.07 0.548 . . . . 74.12 110.68 -172.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 68' ' ' LEU . 0.8 OUTLIER -127.07 73.68 76.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 123.393 0.677 . . . . 75.54 110.054 175.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -89.72 118.44 0.78 Allowed 'Trans proline' 0 C--N 1.375 1.952 0 C-N-CA 122.619 2.213 . . . . 74.45 112.187 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -95.73 101.1 12.75 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.901 -1.518 . . . . 72.14 106.901 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.3 t -76.46 114.89 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 CA-C-N 115.355 -0.839 . . . . 54.04 110.133 -179.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -81.35 134.41 35.57 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 123.355 0.662 . . . . 53.53 109.565 170.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 78.2 mt -103.28 108.61 19.9 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 108.527 -0.916 . . . . 71.01 108.527 173.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 21.3 t70 -104.26 113.9 27.77 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.004 0.922 . . . . 64.35 108.735 175.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -98.48 135.87 39.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.312 0.645 . . . . 64.42 109.586 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -140.57 134.44 30.56 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 108.397 -0.964 . . . . 75.03 108.397 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.454 HG23 HD22 ' A' ' 60' ' ' LEU . 11.5 m -148.63 140.57 23.84 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.64 0.376 . . . . 63.12 110.092 -175.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.06 135.07 13.87 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.369 0.668 . . . . 74.31 110.644 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.416 ' OG ' HD11 ' E' ' 278' ' ' LEU . 45.7 p -96.45 164.09 12.77 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.859 0.864 . . . . 63.33 111.013 176.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -162.09 119.99 2.2 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.45 1.1 . . . . 73.32 108.752 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -75.39 118.69 18.55 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 109.958 -0.386 . . . . 74.33 109.958 177.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 92.9 mt -89.25 -33.1 17.1 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.487 0.715 . . . . 75.13 111.137 178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.53 -174.07 4.29 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.414 0.686 . . . . 72.35 110.765 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -63.24 116.66 5.65 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.425 0.69 . . . . 72.12 110.531 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 66.16 -0.14 1.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 125.403 1.481 . . . . 70.05 113.091 -174.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.9 t -98.91 106.57 19.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 108.334 -0.987 . . . . 74.35 108.334 -178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -119.57 124.04 45.4 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.801 -1.185 . . . . 74.2 107.801 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -88.77 136.16 33.15 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.563 1.145 . . . . 71.42 108.532 172.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 99.0 t -122.76 125.57 72.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 107.644 -1.243 . . . . 74.02 107.644 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.516 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 48.6 t -104.97 128.02 59.06 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 123.023 0.529 . . . . 62.34 109.875 178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.75 HD23 HD12 ' A' ' 106' ' ' LEU . 3.9 mm? -106.28 98.17 7.88 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.443 1.097 . . . . 73.42 108.906 178.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 17.2 ttp180 -87.18 100.88 12.99 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 108.651 -0.87 . . . . 73.14 108.651 171.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.5 t -93.64 122.66 45.31 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 106.999 -1.482 . . . . 65.32 106.999 174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' A' ' 43' ' ' ASP . 8.3 m -116.35 121.38 41.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.531 0.681 . . . . 71.44 109.281 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.657 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 41.3 t -111.18 109.84 30.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 C-N-CA 124.95 1.3 . . . . 72.32 108.672 -176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 16.7 m -103.56 140.07 38.02 Favored 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 108.31 -0.996 . . . . 73.11 108.31 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.16 121.22 37.33 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.182 -0.673 . . . . 71.14 109.182 173.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.4 m -122.73 124.82 44.24 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.245 0.545 . . . . 60.51 110.768 178.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 37' ' ' GLN . 5.1 mp -88.81 77.08 7.87 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.351 1.46 . . . . 71.43 107.578 173.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.01 -86.78 0.88 Allowed Glycine 0 C--N 1.343 0.938 0 CA-C-N 114.865 -1.061 . . . . 62.44 111.15 -172.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -113.9 -27.89 7.58 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.882 0.873 . . . . 52.52 110.65 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -86.07 133.71 33.87 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.351 0.66 . . . . 71.13 111.042 -172.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.4 m -78.26 147.24 34.43 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 118.127 0.421 . . . . 74.32 110.526 176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.734 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -96.8 -63.25 1.15 Allowed 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.971 0.908 . . . . 71.44 108.964 171.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -151.6 163.86 38.15 Favored 'General case' 0 C--O 1.243 0.712 0 CA-C-N 114.154 -1.384 . . . . 74.4 110.548 -179.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 56.7 tp -132.89 121.26 22.63 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.498 1.119 . . . . 72.22 108.461 175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.657 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 85.2 m -105.79 141.03 37.92 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 124.603 1.161 . . . . 43.51 108.719 174.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 39.4 tt0 -146.66 115.35 6.81 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.091 -1.077 . . . . 54.31 108.091 174.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.483 HG11 ' HB3' ' A' ' 113' ' ' CYS . 46.4 t -131.32 109.96 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.102 -0.703 . . . . 75.31 109.102 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.443 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 64.5 mt-30 -87.7 81.79 7.56 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.3 -0.864 . . . . 55.24 109.086 175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -75.87 93.11 3.15 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.108 -0.951 . . . . 74.13 108.633 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.55 145.4 21.92 Favored Glycine 0 C--N 1.337 0.612 0 N-CA-C 111.317 -0.713 . . . . 65.31 111.317 179.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.485 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -142.07 142.82 12.15 Favored Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 110.539 -1.024 . . . . 64.15 110.539 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 15' ' ' ARG . 54.8 mt -106.9 126.41 62.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 N-CA-C 108.578 -0.897 . . . . 73.25 108.578 -178.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.48 ' HE1' ' HB ' ' A' ' 58' ' ' VAL . 14.5 m-85 -131.45 117.43 18.81 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.393 0.677 . . . . 71.43 109.199 -174.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 40.5 t -78.55 90.63 4.52 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.889 0.876 . . . . 51.35 108.661 168.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.43 ' HB ' HD11 ' A' ' 89' ' ' ILE . 48.5 pt -106.44 143.94 16.47 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.654 0.782 . . . . 61.02 110.286 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.22 154.88 28.0 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.809 0.844 . . . . 61.31 109.544 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 78.66 5.37 88.27 Favored Glycine 0 C--N 1.345 1.082 0 N-CA-C 115.155 0.822 . . . . 61.21 115.155 172.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -113.6 134.51 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 108.392 -0.966 . . . . 74.35 108.392 174.079 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -142.47 171.93 13.38 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.227 1.011 . . . . 70.23 108.946 -175.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.06 -120.18 14.27 Favored Glycine 0 CA--C 1.536 1.398 0 N-CA-C 114.459 0.543 . . . . 61.3 114.459 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 73.3 p -80.21 -24.17 40.44 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.01 0.924 . . . . 72.22 111.593 -178.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -70.13 -36.91 75.12 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.348 0.659 . . . . 64.43 109.949 174.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.57 ' SD ' HD23 ' E' ' 277' ' ' LEU . 52.1 ttp -65.98 -43.06 88.94 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.915 0.886 . . . . 51.44 110.193 171.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.93 82.39 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 115.347 -0.842 . . . . 73.15 111.426 177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -74.74 -35.63 62.63 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.731 0.813 . . . . 72.33 110.763 177.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -65.46 -49.56 68.67 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.01 0.524 . . . . 53.24 110.836 -177.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 mt -85.03 -32.2 23.04 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 116.037 -0.529 . . . . 64.02 111.512 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.58 -1.88 63.69 Favored Glycine 0 N--CA 1.474 1.217 0 N-CA-C 114.823 0.689 . . . . 74.25 114.823 -171.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.75 -54.65 0.19 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.998 0.899 . . . . 62.25 112.445 -176.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -71.31 -64.4 0.92 Allowed 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.318 1.047 . . . . 71.31 112.629 -167.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.467 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.9 m -70.37 -34.25 3.84 Favored Pre-proline 0 CA--C 1.574 1.87 0 N-CA-C 113.933 1.086 . . . . 55.43 113.933 -177.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.61 ' HB3' HD21 ' A' ' 60' ' ' LEU . 26.2 Cg_endo -64.03 -31.53 65.8 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 122.249 1.966 . . . . 55.35 113.319 169.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -62.05 -34.93 77.18 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.246 0.618 . . . . 72.23 109.666 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.532 HG21 ' CD1' ' A' ' 13' ' ' ILE . 45.6 mm -60.03 -47.3 92.34 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 C-N-CA 123.855 0.862 . . . . 73.44 110.603 175.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.75 HD12 HD23 ' A' ' 60' ' ' LEU . 98.4 mt -76.27 -25.62 55.1 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.454 -0.793 . . . . 60.25 112.091 -171.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -59.16 -44.58 98.74 Favored Pre-proline 0 CA--C 1.57 1.741 0 N-CA-C 114.003 1.112 . . . . 62.33 114.003 -170.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -59.92 -33.98 95.48 Favored 'Trans proline' 0 C--N 1.392 2.818 0 C-N-CA 122.117 1.878 . . . . 53.21 113.7 173.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -77.16 -35.27 56.12 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.255 0.622 . . . . 75.23 110.98 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.7 -44.27 82.12 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 109.504 -0.554 . . . . 30.02 109.504 172.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.484 ' NH1' HG23 ' C' ' 105' ' ' ILE . 38.1 ttm180 -54.28 -53.91 47.35 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 124.663 1.227 . . . . 74.54 110.116 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.48 -43.4 98.92 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 124.542 1.151 . . . . 75.42 110.98 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.488 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 48.0 t -60.15 -40.51 90.11 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.581 0.551 . . . . 44.13 111.002 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.554 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 94.7 mt -65.49 -54.76 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 O-C-N 123.901 0.751 . . . . 72.23 109.669 174.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.584 HG21 ' HE2' ' C' ' 109' ' ' TYR . 93.5 m -53.17 -39.06 63.31 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.936 1.397 . . . . 71.12 111.343 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 10.8 t -65.94 -47.63 74.05 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.546 -1.206 . . . . 64.42 109.257 -177.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.554 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 44.4 mtm -61.85 -42.94 99.65 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 123.194 0.598 . . . . 73.31 111.066 177.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 114' ' ' ILE . 97.9 t -56.21 -50.48 70.81 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 124.388 1.055 . . . . 55.2 109.957 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 32.7 t -72.0 -32.29 67.06 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.222 -0.899 . . . . 61.21 111.588 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.511 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 61.6 mtt-85 -72.16 -27.43 62.59 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.5 0.72 . . . . 75.03 110.036 176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.67 12.36 56.67 Favored Glycine 0 C--N 1.352 1.471 0 CA-C-N 115.749 -0.659 . . . . 73.52 113.182 174.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 62.5 p 57.99 17.77 4.63 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 126.808 2.043 . . . . 53.52 113.393 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.28 145.75 49.41 Favored Pre-proline 0 CA--C 1.542 0.66 0 N-CA-C 107.245 -1.391 . . . . 73.43 107.245 167.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.63 141.74 80.89 Favored 'Trans proline' 0 C--N 1.362 1.249 0 C-N-CA 122.494 2.129 . . . . 74.45 111.149 -176.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -48.03 123.16 5.85 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 124.619 1.199 . . . . 72.32 111.336 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 43.7 tp -108.47 118.94 38.09 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 123.256 0.622 . . . . 54.25 109.387 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -115.48 114.85 25.57 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 109.153 -0.684 . . . . 71.31 109.153 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -68.63 122.09 17.8 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.644 0.778 . . . . 70.22 109.939 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.545 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -64.12 132.28 95.25 Favored Pre-proline 0 CA--C 1.546 0.803 0 N-CA-C 109.276 -0.639 . . . . 63.0 109.276 173.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.432 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 4.3 Cg_endo -76.72 113.49 3.66 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.119 1.879 . . . . 74.33 110.569 -173.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -98.99 123.1 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 N-CA-C 107.713 -1.217 . . . . 51.33 107.713 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -76.72 89.98 3.41 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.425 -0.954 . . . . 75.31 108.425 -178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -62.66 -31.91 72.87 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.881 0.873 . . . . 73.21 110.902 178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.406 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.6 m-20 -59.93 -48.93 79.69 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.672 0.789 . . . . 64.03 110.566 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.11 -46.72 89.45 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 124.23 0.956 . . . . 62.53 111.027 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -62.66 -50.94 69.2 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 124.038 0.836 . . . . 73.14 110.145 -176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -64.95 -38.86 92.35 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.44 0.696 . . . . 74.31 110.466 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.623 ' O ' ' HG2' ' A' ' 142' ' ' GLN . 12.5 tpt -66.68 -44.79 80.83 Favored 'General case' 0 C--O 1.212 -0.874 0 CA-C-N 115.413 -0.812 . . . . 71.15 110.146 -175.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.52 -36.89 64.72 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 123.464 0.706 . . . . 75.25 112.006 -178.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -70.31 -40.62 74.09 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.094 0.558 . . . . 74.4 110.555 175.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.458 HD23 ' SD ' ' A' ' 138' ' ' MET . 35.2 tp -65.97 -16.57 64.0 Favored 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 124.88 1.272 . . . . 73.3 112.289 -176.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.707 ' HB2' ' HA ' ' C' ' 2' ' ' SER . 11.2 pt20 -144.74 29.36 1.24 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.925 0.89 . . . . 71.52 110.293 -173.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 18.8 tt0 -59.74 98.18 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.564 1.146 . . . . 65.03 113.775 -171.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 174.1 158.04 0.15 Allowed 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 125.775 1.63 . . . . 70.5 109.055 164.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -53.47 102.98 0.06 Allowed 'General case' 0 N--CA 1.476 0.858 0 O-C-N 124.333 1.021 . . . . 72.43 110.929 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' C' ' 3' ' ' GLU . . . -86.89 133.62 11.93 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-N 115.617 -0.72 . . . . 34.32 112.209 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.68 122.88 12.95 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 108.196 -1.039 . . . . 74.54 108.196 176.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 154.74 126.19 1.02 Allowed Glycine 0 C--N 1.343 0.958 0 O-C-N 123.556 0.535 . . . . 63.54 111.834 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.2 t -145.91 120.55 9.81 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.503 0.721 . . . . 71.05 109.604 173.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -91.29 84.85 5.68 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.877 -0.786 . . . . 70.24 108.877 175.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -99.49 107.56 19.79 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.274 -0.876 . . . . 72.32 108.769 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -125.22 109.22 12.58 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.924 0.889 . . . . 70.43 108.947 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.76 87.02 2.21 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 108.655 -0.868 . . . . 74.41 108.655 175.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -85.59 118.43 25.1 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 108.972 -0.751 . . . . 63.42 108.972 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.98 0 N-CA-C 109.141 -0.688 . . . . 73.14 109.141 -177.058 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 109.363 -0.606 . . . . 73.2 109.363 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 39.9 m -66.77 98.71 0.55 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.757 -0.831 . . . . 73.22 108.757 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.547 ' HA ' ' O ' ' B' ' 151' ' ' GLU . 23.7 tt0 -124.77 127.58 47.43 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 115.724 -0.671 . . . . 42.42 111.981 -169.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.4 ' HG2' ' HG3' ' B' ' 151' ' ' GLU . 9.9 pt20 -159.18 161.8 36.24 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.195 1.398 . . . . 64.23 108.821 176.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -144.97 136.08 24.91 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.033 0.533 . . . . 75.31 109.972 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.427 ' ND2' ' HB3' ' B' ' 147' ' ' GLU . 6.5 t30 -164.9 106.25 0.82 Allowed 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.173 0.989 . . . . 74.12 109.216 175.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.599 HG21 ' HB2' ' E' ' 310' ' ' PRO . 41.1 p -118.26 100.77 7.72 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.395 0.678 . . . . 54.55 109.601 175.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -80.86 163.3 23.5 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 116.126 -0.488 . . . . 74.25 110.626 173.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.567 ' HB3' HG23 ' B' ' 89' ' ' ILE . 24.2 ptm 49.43 -174.13 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 126.261 1.824 . . . . 74.33 113.874 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 91.8 m -135.95 123.47 22.16 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.295 -1.002 . . . . 70.54 108.295 171.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.463 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 56.6 t80 -127.68 112.61 15.02 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 107.736 -1.209 . . . . 74.33 107.736 174.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.557 ' HG2' HG23 ' E' ' 309' ' ' THR . 0.0 OUTLIER -131.83 135.29 46.61 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 108.008 -1.108 . . . . 73.03 108.008 -178.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.476 ' O ' HD12 ' B' ' 13' ' ' ILE . 2.4 pp -94.99 130.52 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 123.397 0.679 . . . . 71.02 110.277 176.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -99.12 -50.83 4.02 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 121.807 -0.558 . . . . 63.34 110.06 175.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.459 ' HA ' ' ND2' ' D' ' 127' ' ' ASN . 41.8 ttt180 -162.59 134.23 5.22 Favored 'General case' 0 C--O 1.219 -0.531 0 CA-C-N 115.998 -0.546 . . . . 74.3 110.452 -172.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.3 mt -113.91 142.55 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 106.71 -1.589 . . . . 53.31 106.71 172.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -168.9 149.35 4.38 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.615 0.643 . . . . 73.04 112.733 -174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.661 HG21 HD11 ' B' ' 21' ' ' ILE . 37.9 m -79.71 120.1 23.55 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 115.345 -0.843 . . . . 72.53 109.529 172.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.579 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 9.3 mtpt -89.14 -28.88 19.74 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 123.4 0.68 . . . . 74.45 110.835 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -154.7 136.92 14.82 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.846 -0.616 . . . . 72.24 110.406 -169.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.661 HD11 HG21 ' B' ' 18' ' ' THR . 31.2 mm -124.99 148.88 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 124.398 1.079 . . . . 75.25 108.155 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 22.7 t -154.15 141.37 19.51 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-N 115.789 -0.641 . . . . 71.51 109.576 170.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -152.71 109.0 3.39 Favored 'General case' 0 C--O 1.216 -0.662 0 N-CA-C 107.26 -1.385 . . . . 65.35 107.26 171.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -118.08 111.53 19.02 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.456 -1.313 . . . . 74.53 107.456 -178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.521 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -109.79 88.23 6.42 Favored Pre-proline 0 CA--C 1.543 0.68 0 N-CA-C 108.313 -0.995 . . . . 43.12 108.313 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.74 -24.33 41.0 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 123.095 2.53 . . . . 61.34 111.938 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -121.6 24.14 9.93 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 123.936 0.895 . . . . 73.25 110.391 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.521 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -41.69 -54.41 6.74 Favored Pre-proline 0 CA--C 1.578 2.03 0 C-N-CA 124.788 1.235 . . . . 72.31 114.16 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 29.9 Cg_endo -66.17 -32.93 41.74 Favored 'Trans proline' 0 C--N 1.395 2.984 0 C-N-CA 122.317 2.011 . . . . 74.3 113.157 178.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 57.4 m-70 -94.42 -15.5 24.24 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 112.877 0.695 . . . . 65.22 112.877 -169.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 10.7 p -52.64 -23.25 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 124.743 1.217 . . . . 71.42 113.682 -169.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -66.57 -21.72 66.14 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.122 0.969 . . . . 54.21 112.149 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.421 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.6 pt20 -61.98 -29.06 70.0 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 122.879 0.472 . . . . 51.03 110.619 175.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.421 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 32.8 mmtp -105.1 67.65 0.79 Allowed 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 107.536 -1.283 . . . . 74.04 107.536 173.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -80.02 79.5 6.55 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.546 0.738 . . . . 73.0 111.93 -171.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 164.79 -174.06 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 126.899 2.079 . . . . 71.33 110.647 160.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -56.2 126.25 67.2 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 124.553 1.141 . . . . 72.21 112.335 -170.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -80.71 176.15 9.33 Favored 'Trans proline' 0 C--N 1.369 1.64 0 C-N-CA 122.752 2.301 . . . . 62.23 111.597 175.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -77.04 104.22 7.4 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 107.11 -1.441 . . . . 74.24 107.11 168.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 23.9 t -94.46 154.91 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 123.503 0.721 . . . . 70.02 109.197 -178.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -147.18 138.7 24.07 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.813 0.845 . . . . 71.13 109.801 -178.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.658 HD21 HD11 ' B' ' 128' ' ' LEU . 5.5 mp -85.4 141.11 30.21 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 108.052 -1.092 . . . . 75.14 108.052 165.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.8 t70 -141.18 109.99 6.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.35 -1.352 . . . . 72.13 107.35 173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 mp -102.33 131.6 48.83 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.846 0.458 . . . . 75.33 109.886 -173.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -122.3 135.41 54.73 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.968 1.307 . . . . 72.54 107.895 177.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.8 p -109.97 145.87 36.22 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.385 0.674 . . . . 72.53 110.195 -175.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -154.83 148.3 25.17 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.805 0.842 . . . . 54.32 109.282 175.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.2 m -144.69 167.89 21.49 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.365 0.666 . . . . 73.55 110.784 176.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.5 p -157.63 154.17 27.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.161 0.985 . . . . 71.05 109.599 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -102.85 130.5 49.89 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 108.974 -0.75 . . . . 74.43 108.974 171.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 67.2 mt -97.74 -38.05 9.64 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.194 0.597 . . . . 64.42 110.459 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.7 -171.95 2.48 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.437 0.695 . . . . 73.52 110.808 179.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.7 114.48 4.47 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.631 -1.168 . . . . 71.42 110.123 176.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 25.2 m-20 72.08 -3.81 2.15 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 125.691 1.597 . . . . 60.21 112.589 -178.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 62.9 t -104.08 110.74 31.22 Favored 'Isoleucine or valine' 0 C--N 1.35 0.6 0 N-CA-C 107.859 -1.163 . . . . 71.12 107.859 177.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -122.11 173.24 7.69 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 109.038 -0.727 . . . . 74.25 109.038 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -142.87 109.98 5.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 108.022 -1.103 . . . . 71.43 108.022 -175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 69.7 t -101.65 134.54 41.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.331 1.052 . . . . 70.31 109.965 -177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 22.9 t -121.28 132.45 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.532 1.133 . . . . 73.31 109.059 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 57.8 tp -123.44 112.32 17.39 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 108.931 -0.766 . . . . 53.33 108.931 170.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.76 ' HB2' ' HG2' ' B' ' 79' ' ' GLN . 28.0 ttm180 -89.92 124.93 35.14 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 123.607 0.763 . . . . 72.53 109.62 171.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 24.4 t -111.61 126.56 69.02 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 107.76 -1.2 . . . . 44.13 107.76 174.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 24.4 m -121.11 122.1 39.31 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.775 0.798 . . . . 62.13 109.903 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.662 HG11 HD21 ' B' ' 126' ' ' LEU . 87.8 t -102.05 95.99 4.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 C-N-CA 125.29 1.436 . . . . 63.3 108.331 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 24.7 m -85.48 137.06 33.16 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 108.749 -0.834 . . . . 75.53 108.749 174.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.99 127.3 13.04 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 109.652 -0.499 . . . . 55.41 109.652 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.431 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 64.3 p -145.89 144.72 30.37 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.203 0.601 . . . . 63.24 110.809 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.569 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -133.54 102.31 5.46 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.532 1.133 . . . . 50.11 109.406 -176.425 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.73 -132.97 11.43 Favored Glycine 0 C--N 1.342 0.909 0 CA-C-N 115.949 -0.569 . . . . 20.12 112.594 178.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -87.81 8.77 24.35 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.172 0.589 . . . . 63.14 110.744 -178.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -138.19 154.68 49.13 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.522 0.729 . . . . 71.35 110.675 -172.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . 0.434 HG21 ' HG ' ' B' ' 75' ' ' LEU . 66.4 m -83.79 138.67 33.13 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.301 0.64 . . . . 62.23 110.273 174.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -76.61 -60.24 2.43 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.894 0.878 . . . . 64.32 108.974 177.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -165.69 153.01 10.36 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 113.656 -1.611 . . . . 71.03 109.054 177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.434 ' HG ' HG21 ' B' ' 72' ' ' THR . 94.8 mt -124.1 112.78 17.52 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 107.562 -1.273 . . . . 70.21 107.562 175.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' B' ' 114' ' ' ILE . 35.8 t -115.98 143.43 45.46 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 107.776 -1.194 . . . . 61.21 107.776 178.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.484 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 41.4 tt0 -157.26 124.2 5.1 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.809 -0.811 . . . . 73.12 108.809 -173.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 95.4 t -129.78 142.02 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 123.215 0.606 . . . . 74.44 109.574 177.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.76 ' HG2' ' HB2' ' B' ' 61' ' ' ARG . 42.1 mt-30 -108.1 114.58 28.58 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.739 -1.208 . . . . 74.43 107.739 166.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HB2' ' HB2' ' B' ' 110' ' ' ALA . 8.4 tp-100 -103.11 110.86 22.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.297 -1.001 . . . . 70.14 108.297 172.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -100.96 166.9 19.32 Favored Glycine 0 C--O 1.241 0.59 0 O-C-N 123.682 0.613 . . . . 65.22 111.719 176.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.84 127.56 1.72 Allowed Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.446 -0.661 . . . . 63.31 111.446 -176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.17 125.05 40.41 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 C-N-CA 123.605 0.762 . . . . 71.1 109.066 173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -132.69 132.56 42.5 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.227 1.011 . . . . 74.33 108.959 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HB3' ' B' ' 12' ' ' GLN . 49.6 m -96.59 97.98 9.83 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.732 0.813 . . . . 62.31 108.908 172.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 30.1 pt -116.06 132.9 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 123.398 0.679 . . . . 52.34 110.09 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.24 172.86 16.33 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.004 0.922 . . . . 63.12 110.605 -172.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.1 -62.46 1.04 Allowed Glycine 0 C--N 1.346 1.109 0 CA-C-N 116.045 -0.525 . . . . 52.23 112.346 175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.567 HG23 ' HB3' ' B' ' 9' ' ' MET . 0.2 OUTLIER -90.48 170.62 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 C-N-CA 123.915 0.886 . . . . 74.34 111.126 -179.11 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -150.58 171.91 16.36 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.19 0.596 . . . . 72.54 111.089 -178.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.27 -129.28 42.91 Favored Glycine 0 C--N 1.35 1.329 0 CA-C-N 115.121 -0.945 . . . . 43.42 113.286 177.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 28.4 m -70.73 -28.06 64.43 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.139 0.976 . . . . 71.42 111.689 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.82 -37.93 89.21 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.221 0.608 . . . . 54.33 109.822 176.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.504 ' HG2' HD23 ' B' ' 98' ' ' LEU . 22.9 ttt -80.32 -33.99 37.09 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.235 -0.893 . . . . 73.43 110.133 178.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.17 -28.07 69.51 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.922 0.889 . . . . 62.53 111.814 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -62.0 -43.31 99.1 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.602 0.761 . . . . 65.22 110.247 170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -70.72 -64.04 0.98 Allowed 'General case' 0 CA--C 1.544 0.733 0 CA-C-N 115.577 -0.738 . . . . 72.03 110.81 -177.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.504 HD23 ' HG2' ' B' ' 94' ' ' MET . 4.5 pp -71.04 -30.84 67.12 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 123.569 0.747 . . . . 72.43 112.496 -173.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.63 -33.67 11.13 Favored Glycine 0 C--N 1.343 0.93 0 O-C-N 123.575 0.547 . . . . 74.41 113.264 -173.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -112.88 -67.17 1.02 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 122.887 0.475 . . . . 61.43 111.33 -173.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -60.18 -46.76 88.61 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.586 0.754 . . . . 71.42 112.898 -172.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.504 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 72.7 m -63.86 -51.41 64.63 Favored Pre-proline 0 CA--C 1.569 1.678 0 C-N-CA 123.932 0.893 . . . . 75.15 112.292 -176.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.504 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 50.3 Cg_exo -58.94 -30.12 92.33 Favored 'Trans proline' 0 C--N 1.396 3.063 0 C-N-CA 122.659 2.239 . . . . 53.12 113.733 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -27.98 62.78 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 123.301 0.64 . . . . 62.03 111.437 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 72.7 mt -67.48 -40.47 84.52 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.543 0.737 . . . . 73.1 109.902 170.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' B' ' 80' ' ' GLN . 86.4 mt -75.39 -29.34 59.81 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.943 -1.026 . . . . 73.22 111.709 -173.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -55.52 -47.55 98.39 Favored Pre-proline 0 CA--C 1.573 1.865 0 CA-C-O 117.66 -1.162 . . . . 71.23 113.782 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -48.58 -43.36 33.74 Favored 'Trans proline' 0 C--N 1.391 2.798 0 C-N-CA 123.131 2.554 . . . . 74.44 114.622 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE2' HG21 ' D' ' 115' ' ' THR . 81.4 m-85 -70.6 -42.58 70.79 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.382 0.673 . . . . 72.2 110.325 -177.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.468 ' HB2' ' HB2' ' B' ' 80' ' ' GLN . . . -65.54 -32.17 73.62 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.702 -0.681 . . . . 53.01 110.888 176.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -59.76 -58.09 10.09 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.292 1.037 . . . . 71.12 110.482 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.483 1.219 0 O-C-N 123.533 0.52 . . . . 75.21 109.878 -177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.608 ' SG ' HD11 ' B' ' 21' ' ' ILE . 0.0 OUTLIER -67.4 -40.13 85.58 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.232 0.613 . . . . 74.52 110.776 177.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.457 HG21 HG21 ' B' ' 64' ' ' VAL . 78.5 mt -67.37 -54.3 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 123.969 0.908 . . . . 75.24 109.868 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 26.7 m -60.15 -33.0 71.56 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.222 1.009 . . . . 62.32 111.55 -173.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.469 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.3 t -60.69 -49.79 76.11 Favored 'General case' 0 C--N 1.353 0.728 0 C-N-CA 123.47 0.708 . . . . 64.12 110.124 176.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.5 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 15.7 mmt -71.26 -34.89 71.12 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.57 0.748 . . . . 75.25 111.584 -172.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.503 HG21 HD23 ' B' ' 126' ' ' LEU . 97.0 t -66.33 -40.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.667 0.787 . . . . 75.33 110.153 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.6 t -68.67 -28.13 66.6 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.288 -0.869 . . . . 74.31 111.024 176.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.488 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 88.9 mtt-85 -72.64 -25.11 61.17 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.187 0.595 . . . . 65.33 110.753 176.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.23 13.8 43.2 Favored Glycine 0 C--N 1.353 1.514 0 O-C-N 123.346 0.404 . . . . 50.34 112.557 168.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 61.45 31.48 19.05 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 126.903 2.081 . . . . 74.22 112.227 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -95.79 148.36 34.44 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 115.575 -0.739 . . . . 75.23 110.175 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.459 ' HG2' ' H ' ' H' ' 297' ' ' TYR . 36.4 Cg_endo -63.76 -171.23 0.13 Allowed 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 123.597 2.865 . . . . 64.33 114.252 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.501 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 17.7 tp60 -59.13 113.44 2.12 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.385 -1.279 . . . . 72.23 112.011 -174.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.662 HD21 HG11 ' B' ' 64' ' ' VAL . 66.5 tp -111.09 100.58 9.23 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 108.614 -0.884 . . . . 63.2 108.614 171.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -121.21 123.26 41.82 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.95 0.9 . . . . 62.34 109.875 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.658 HD11 HD21 ' B' ' 42' ' ' LEU . 0.6 OUTLIER -87.28 144.33 26.85 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.789 0.836 . . . . 73.43 109.011 178.566 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.428 ' N ' HD13 ' B' ' 128' ' ' LEU . . . -64.61 143.36 98.63 Favored Pre-proline 0 CA--C 1.561 1.375 0 C-N-CA 124.34 1.056 . . . . 43.04 111.568 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 129' ' ' ALA . 5.8 Cg_exo -75.05 90.53 1.08 Allowed 'Trans proline' 0 C--N 1.38 2.216 0 C-N-CA 122.797 2.331 . . . . 70.11 111.311 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.512 HG11 HG11 ' H' ' 288' ' ' VAL . 37.7 t -91.33 111.33 23.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 108.983 -0.747 . . . . 42.11 108.983 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -93.01 91.97 7.62 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 108.568 -0.901 . . . . 73.12 108.568 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -63.65 -29.51 70.74 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.764 0.826 . . . . 74.13 111.319 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -67.0 -36.83 83.03 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.76 0.824 . . . . 71.01 110.994 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.2 -35.58 81.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 123.905 0.882 . . . . 61.14 111.256 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.2 mp -76.47 -25.76 54.67 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-N 116.022 -0.535 . . . . 65.22 110.585 178.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -74.97 -17.45 60.54 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 122.944 0.498 . . . . 52.25 111.356 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 60.0 mtm -58.18 -29.51 65.68 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 122.959 0.504 . . . . 74.11 111.171 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -78.26 -6.56 55.34 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.27 1.028 . . . . 54.35 112.155 -178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -88.93 -31.59 18.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.656 -0.498 . . . . 72.24 109.656 166.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 68.4 mt -88.73 6.2 39.76 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.662 0.785 . . . . 71.34 111.968 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -65.27 103.49 0.8 Allowed 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.214 1.006 . . . . 73.22 111.23 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . 0.708 ' HA ' HE21 ' B' ' 143' ' ' GLN . 0.0 OUTLIER -142.07 -96.66 0.13 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.067 -1.457 . . . . 74.14 107.067 169.565 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 -157.51 157.27 33.51 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.058 1.743 . . . . 75.12 106.726 171.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.39 177.49 10.93 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.822 0.449 . . . . 62.54 110.377 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -175.29 55.49 0.12 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 112.192 -0.363 . . . . 73.41 112.192 179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . 0.427 ' HB3' ' ND2' ' B' ' 6' ' ' ASN . 39.1 mt-10 -78.71 145.91 34.25 Favored 'General case' 0 C--O 1.244 0.788 0 C-N-CA 122.612 0.365 . . . . 75.21 110.435 176.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -65.83 134.38 34.92 Favored Glycine 0 C--N 1.347 1.171 0 O-C-N 124.166 0.916 . . . . 75.04 112.432 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 36.7 m -76.55 155.04 33.98 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.683 0.793 . . . . 72.32 109.85 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . 0.662 ' H ' HD13 ' D' ' 136' ' ' LEU . 23.5 mm-40 -82.2 43.0 0.77 Allowed 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.75 0.82 . . . . 61.12 111.535 177.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' B' ' 3' ' ' GLU . 7.6 pt-20 -90.06 83.33 6.07 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 108.185 -1.043 . . . . 73.14 108.185 170.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 28.3 p80 -154.4 139.98 17.89 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.342 0.657 . . . . 62.33 109.32 178.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 17.3 tm0? -67.11 134.93 52.78 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 108.018 -1.104 . . . . 71.35 108.018 172.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . 0.432 ' O ' ' HD2' ' G' ' 289' ' ' ARG . 38.6 t70 -153.44 119.17 5.31 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 107.807 -1.182 . . . . 73.1 107.807 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 107.946 -1.131 . . . . 71.43 107.946 177.568 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.1 pmm? . . . . . 0 N--CA 1.477 0.9 0 N-CA-C 110.401 -0.222 . . . . 72.3 110.401 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . 0.707 ' HA ' ' HB2' ' A' ' 142' ' ' GLN . 55.9 p -164.83 157.01 15.93 Favored 'General case' 0 C--N 1.354 0.773 0 C-N-CA 123.647 0.779 . . . . 75.51 111.357 178.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . 0.589 ' HA ' ' HA3' ' A' ' 146' ' ' GLY . 28.9 tt0 -168.95 149.82 4.44 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.98 0.912 . . . . 73.31 109.628 -174.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -167.12 104.79 0.55 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 109.13 -0.692 . . . . 62.41 109.13 176.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -83.92 132.83 34.74 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 108.81 -0.811 . . . . 60.42 108.81 176.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 -67.62 -60.88 2.19 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.46 0.704 . . . . 62.4 111.746 -173.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 6.9 p -153.67 97.91 2.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.742 1.217 . . . . 75.03 108.247 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -128.24 144.19 51.1 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.901 0.881 . . . . 73.0 109.792 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 52.3 ttm 64.5 114.49 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 125.336 1.455 . . . . 72.43 112.492 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 63.6 m -103.76 92.8 4.58 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 107.826 -1.175 . . . . 74.21 107.826 166.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.478 ' CE1' ' SG ' ' C' ' 102' ' ' CYS . 87.8 t80 -112.43 132.66 54.92 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.248 -1.019 . . . . 74.21 108.248 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.53 ' HG2' ' HA ' ' G' ' 307' ' ' THR . 50.1 tp60 -147.35 144.59 28.85 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.034 0.445 . . . . 75.02 111.209 177.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.472 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.3 pp -93.7 139.76 17.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.678 0 CA-C-N 115.09 -0.959 . . . . 70.15 108.451 173.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -110.55 -51.09 2.9 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 109.863 -0.421 . . . . 63.03 109.863 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -166.79 128.86 1.75 Allowed 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 115.777 -0.647 . . . . 71.12 110.312 -170.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.1 mt -108.55 143.05 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 N-CA-C 106.838 -1.541 . . . . 73.25 106.838 173.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.493 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 15.2 p90 -174.34 158.67 2.95 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.575 0.625 . . . . 72.44 111.291 -177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.6 p -81.29 119.26 23.43 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 109.09 -0.708 . . . . 71.32 109.09 173.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.589 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 11.7 mmmm -73.39 -42.0 62.66 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 169.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 32.3 t70 -143.95 142.33 30.68 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 114.777 -1.101 . . . . 61.13 110.526 -172.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.543 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 70.4 mt -139.74 143.65 30.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 125.521 1.528 . . . . 74.02 107.2 175.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 30.8 t -158.76 151.38 21.9 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.275 0.559 . . . . 72.11 110.283 175.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -150.41 125.66 10.05 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 107.767 -1.198 . . . . 72.43 107.767 173.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -118.26 140.53 49.67 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.291 0.636 . . . . 52.01 110.215 178.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -140.59 77.65 22.61 Favored Pre-proline 0 CA--C 1.546 0.792 0 N-CA-C 106.787 -1.56 . . . . 75.33 106.787 171.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -63.94 -32.78 65.3 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 123.064 2.51 . . . . 65.44 112.467 -174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.714 ' HB2' ' HB3' ' C' ' 30' ' ' HIS . 9.2 p30 -112.22 45.49 1.27 Allowed 'General case' 0 C--O 1.215 -0.727 0 C-N-CA 123.815 0.846 . . . . 44.44 109.677 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.574 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -53.31 -41.34 85.94 Favored Pre-proline 0 CA--C 1.577 1.995 0 N-CA-C 114.697 1.369 . . . . 65.34 114.697 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -76.7 -37.9 1.1 Allowed 'Trans proline' 0 C--N 1.387 2.597 0 C-N-CA 121.744 1.63 . . . . 64.24 112.97 169.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.714 ' HB3' ' HB2' ' C' ' 27' ' ' ASN . 75.5 t60 -69.19 -21.9 63.94 Favored 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.317 1.047 . . . . 65.12 112.338 -178.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.0 p -64.69 -13.84 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 123.667 0.787 . . . . 74.43 112.566 -175.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -74.55 -15.45 60.85 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.563 -0.71 . . . . 71.15 112.301 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -109.1 21.67 16.88 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.578 0.751 . . . . 71.33 110.355 172.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.548 ' HZ3' ' HB2' ' C' ' 34' ' ' LYS . 0.2 OUTLIER -82.69 136.96 34.6 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.223 1.009 . . . . 71.32 109.028 175.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -64.17 123.56 19.41 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.058 -0.719 . . . . 60.21 109.058 175.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.479 ' HZ2' ' HB3' ' F' ' 302' ' ' ASP . 22.7 m95 -85.16 58.94 5.32 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.55 0.34 . . . . 71.23 111.04 -173.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -156.51 53.91 0.81 Allowed Pre-proline 0 N--CA 1.491 1.603 0 C-N-CA 124.367 1.067 . . . . 71.13 109.448 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -76.08 153.3 36.68 Favored 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 121.927 1.751 . . . . 70.24 112.208 -176.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -84.29 115.59 22.56 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.362 -1.347 . . . . 75.53 107.362 173.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 41.8 t -86.24 133.82 28.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.505 -0.554 . . . . 64.01 109.505 178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -123.57 112.13 17.08 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.205 1.002 . . . . 74.01 108.416 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.432 HD21 HD22 ' C' ' 128' ' ' LEU . 8.4 mp -86.06 133.93 33.87 Favored 'General case' 0 C--O 1.244 0.768 0 N-CA-C 107.241 -1.392 . . . . 75.44 107.241 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.447 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 34.5 t70 -117.36 103.11 9.81 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 107.176 -1.416 . . . . 62.1 107.176 172.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.5 tp -93.34 112.63 24.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 106.876 -1.528 . . . . 73.13 106.876 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.615 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 20.3 t70 -127.8 135.1 49.63 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.157 -0.683 . . . . 51.44 109.157 -178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 52.9 p -114.94 123.62 49.59 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.84 0.856 . . . . 74.42 109.952 -175.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -142.56 146.11 34.28 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.32 0.648 . . . . 71.25 110.168 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 20.9 p -163.38 152.4 14.45 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 123.185 0.594 . . . . 53.11 110.438 -177.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 67.2 p -151.25 159.35 44.41 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.81 0.844 . . . . 74.52 109.406 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -75.21 120.61 20.94 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.612 -0.722 . . . . 74.31 110.479 178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.522 HD11 ' HB2' ' C' ' 57' ' ' GLU . 83.3 mt -84.95 -46.32 11.36 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.87 -0.789 . . . . 62.22 108.87 169.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.33 178.27 9.43 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.532 -1.213 . . . . 72.33 108.88 178.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 54.0 m-20 -66.05 122.37 17.26 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 116.34 -0.391 . . . . 73.3 110.052 -176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 74.55 -5.6 2.08 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 125.813 1.645 . . . . 64.34 112.599 -176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -104.9 116.62 49.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 C-N-CA 124.035 0.934 . . . . 64.41 109.475 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -124.76 135.58 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 108.411 -0.959 . . . . 73.22 108.411 178.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.522 ' HB2' HD11 ' C' ' 51' ' ' LEU . 43.2 tt0 -87.52 120.24 28.62 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 108.799 -0.815 . . . . 53.41 108.799 173.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 75.1 t -96.31 111.49 26.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 108.399 -0.963 . . . . 74.11 108.399 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 87.8 t -106.57 127.26 62.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 107.838 -1.171 . . . . 70.14 107.838 178.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -130.4 105.48 7.9 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.758 -1.201 . . . . 72.23 107.758 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.615 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 24.0 ttm180 -82.65 125.12 30.84 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.855 -0.611 . . . . 71.45 109.614 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 47.3 t -116.71 106.97 21.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 106.791 -1.559 . . . . 71.11 106.791 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.447 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 24.4 m -116.29 114.05 23.83 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.521 0.677 . . . . 64.23 109.618 175.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 71.1 t -106.93 111.36 35.29 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-N 114.619 -1.173 . . . . 65.12 108.486 -176.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 13.8 m -111.33 125.86 54.29 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.471 0.708 . . . . 71.02 110.238 -176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.86 116.83 31.92 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.338 -1.356 . . . . 60.43 107.338 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 32.5 m -148.39 152.65 37.36 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 122.827 0.451 . . . . 64.41 110.78 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.497 HD23 ' HD2' ' C' ' 34' ' ' LYS . 4.1 mm? -95.37 26.98 3.53 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.63 1.172 . . . . 73.02 110.203 172.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.85 -104.95 0.95 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 110.641 -0.984 . . . . 75.44 110.641 -175.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -89.36 -25.47 21.58 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.359 0.664 . . . . 72.51 110.261 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -84.54 113.62 21.37 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.056 0.942 . . . . 65.13 109.679 178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 92.3 m -88.88 129.65 35.56 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 122.944 0.497 . . . . 51.24 111.525 -178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.22 -57.83 4.12 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.104 0.961 . . . . 44.14 109.728 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 52.3 p90 -157.73 155.04 29.21 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.503 -0.771 . . . . 72.02 109.941 171.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.455 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -117.02 145.28 43.78 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.367 -1.345 . . . . 73.43 107.367 171.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.455 ' N ' HD13 ' C' ' 75' ' ' LEU . 48.9 t -150.07 131.86 15.05 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.71 -0.848 . . . . 51.43 108.71 173.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -139.79 132.88 29.6 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 123.526 0.73 . . . . 74.12 110.24 -177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 66.8 t -132.62 138.69 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 C-N-CA 123.867 0.867 . . . . 71.42 109.07 172.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -113.21 96.65 6.03 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.983 -1.488 . . . . 72.14 106.983 171.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.7 tp-100 -83.52 107.36 15.94 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.044 -0.526 . . . . 71.0 109.631 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 145.94 18.27 Favored Glycine 0 C--N 1.34 0.776 0 CA-C-N 115.788 -0.642 . . . . 71.13 111.68 176.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.76 117.44 0.91 Allowed Glycine 0 CA--C 1.509 -0.281 0 N-CA-C 110.518 -1.033 . . . . 23.2 110.518 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.403 HD12 HD11 ' C' ' 51' ' ' LEU . 15.9 mm -81.56 119.73 31.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 108.627 -0.879 . . . . 71.11 108.627 177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.472 ' HE2' HG22 ' C' ' 13' ' ' ILE . 97.3 m-85 -132.52 145.29 51.04 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.837 0.855 . . . . 63.11 109.552 -177.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 65.9 m -110.69 112.43 24.31 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 123.781 0.833 . . . . 41.15 109.287 173.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.513 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.5 mp -116.11 123.26 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.895 -1.15 . . . . 72.12 107.895 177.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -143.41 162.75 34.95 Favored 'General case' 0 C--O 1.243 0.734 0 C-N-CA 124.357 1.063 . . . . 65.51 109.843 -176.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.08 -58.51 4.25 Favored Glycine 0 C--N 1.344 1.004 0 CA-C-N 115.944 -0.571 . . . . 53.43 112.258 176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 40.3 pt -83.51 168.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 123.622 0.769 . . . . 54.41 111.536 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -161.28 -177.22 5.88 Favored 'General case' 0 C--O 1.246 0.879 0 C-N-CA 124.867 1.267 . . . . 64.42 109.012 177.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 57.79 -124.45 36.16 Favored Glycine 0 C--N 1.349 1.255 0 O-C-N 123.772 0.67 . . . . 73.33 113.683 175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 49.0 p -70.22 -36.57 74.63 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.491 1.116 . . . . 73.41 111.953 -176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -66.16 -36.23 82.55 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.097 0.559 . . . . 72.13 110.858 -179.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.513 ' HG2' HG21 ' C' ' 86' ' ' ILE . 0.1 OUTLIER -83.14 -33.83 26.18 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.426 0.69 . . . . 75.43 109.971 178.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' F' ' 280' ' ' LEU . . . -60.41 -44.46 95.69 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 124.075 0.95 . . . . 72.1 111.263 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -76.8 -26.44 54.42 Favored 'General case' 0 CA--C 1.549 0.91 0 CA-C-N 115.642 -0.708 . . . . 71.22 111.079 178.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.419 ' O ' ' HB3' ' C' ' 101' ' ' TYR . 47.2 t -73.86 -61.84 1.7 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.739 0.416 . . . . 71.1 110.491 -177.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.66 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 8.4 tt -79.89 -25.5 40.6 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 122.404 0.282 . . . . 55.22 110.791 -178.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.547 ' HA3' HD22 ' F' ' 280' ' ' LEU . . . -86.75 -7.16 78.86 Favored Glycine 0 C--N 1.342 0.911 0 N-CA-C 115.083 0.793 . . . . 51.32 115.083 -174.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.98 -55.53 0.19 Allowed 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 117.491 0.646 . . . . 75.12 111.369 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.468 ' O ' HG12 ' C' ' 105' ' ' ILE . 82.8 t80 -65.89 -39.11 90.35 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 123.998 0.919 . . . . 72.32 111.734 -175.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.66 ' SG ' ' HA ' ' C' ' 98' ' ' LEU . 38.3 m -76.37 -47.19 3.39 Favored Pre-proline 0 CA--C 1.566 1.564 0 CA-C-O 118.474 -0.774 . . . . 61.44 112.288 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 74.7 Cg_exo -53.14 -40.36 77.27 Favored 'Trans proline' 0 C--N 1.399 3.206 0 C-N-CA 122.761 2.307 . . . . 54.21 112.891 172.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -59.27 -29.34 67.5 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.692 0.797 . . . . 71.23 112.52 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.484 HG23 ' NH1' ' A' ' 111' ' ' ARG . 29.4 mm -75.6 -43.66 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 123.096 0.558 . . . . 75.25 110.943 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.8 pp -93.29 -11.07 33.35 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 112.738 0.644 . . . . 73.42 112.738 -175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -57.44 -49.47 93.66 Favored Pre-proline 0 N--CA 1.491 1.604 0 CA-C-O 117.968 -1.015 . . . . 75.41 112.776 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -56.99 -31.29 89.5 Favored 'Trans proline' 0 C--N 1.395 2.981 0 C-N-CA 121.94 1.76 . . . . 71.11 112.755 179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.584 ' HE2' HG21 ' A' ' 115' ' ' THR . 92.8 m-85 -68.37 -48.5 64.59 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.951 0.9 . . . . 64.34 111.147 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.466 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -58.72 -41.22 85.86 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.556 0.742 . . . . 61.41 110.539 176.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 39.5 ttp180 -69.57 -47.73 62.63 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 113.954 -1.476 . . . . 74.33 111.252 -174.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -67.06 -31.92 72.76 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 123.161 0.584 . . . . 64.43 109.95 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.417 ' O ' ' SD ' ' C' ' 117' ' ' MET . 43.0 t -63.99 -40.96 97.54 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 123.551 0.532 . . . . 73.34 110.589 175.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.419 ' O ' HG23 ' C' ' 118' ' ' VAL . 86.6 mt -68.02 -41.81 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 C-N-CA 123.329 0.651 . . . . 75.44 110.823 175.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.469 HG23 ' HB3' ' C' ' 125' ' ' GLN . 30.8 m -62.98 -30.16 71.37 Favored 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 123.432 0.693 . . . . 54.33 110.684 177.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.6 t -74.16 -46.23 43.59 Favored 'General case' 0 C--N 1.351 0.637 0 C-N-CA 123.922 0.889 . . . . 73.1 109.973 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.469 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -57.69 -42.71 84.21 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 123.923 0.889 . . . . 60.33 111.642 177.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.419 HG23 ' O ' ' C' ' 114' ' ' ILE . 97.9 t -70.91 -33.99 54.14 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 C-N-CA 123.86 0.864 . . . . 74.35 110.185 177.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.501 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 38.5 t -65.59 -33.02 74.94 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.389 0.676 . . . . 53.21 111.464 175.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.539 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 73.4 mtt-85 -81.66 -31.89 32.09 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.07 0.948 . . . . 73.55 110.618 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.45 -1.56 86.45 Favored Glycine 0 C--N 1.348 1.247 0 CA-C-N 115.791 -0.641 . . . . 73.2 112.29 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 49.6 p 61.88 31.72 18.16 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 126.075 1.75 . . . . 64.55 112.262 169.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -104.0 150.06 37.88 Favored Pre-proline 0 CA--C 1.553 1.069 0 CA-C-N 114.495 -1.23 . . . . 71.14 109.385 175.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.533 ' HG2' ' HA ' ' F' ' 297' ' ' TYR . 23.9 Cg_exo -40.3 109.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 124.365 3.377 . . . . 71.35 113.908 170.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.469 ' HB3' HG23 ' C' ' 115' ' ' THR . 50.6 mt-30 -60.54 142.54 55.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.755 1.222 . . . . 63.43 111.99 -175.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 53.2 tp -121.2 106.5 11.57 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.306 0.642 . . . . 60.14 109.553 -177.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -100.34 108.44 20.48 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 107.458 -1.312 . . . . 71.22 107.458 173.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.432 HD22 HD21 ' C' ' 42' ' ' LEU . 85.2 mt -63.24 144.69 56.71 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 123.687 0.795 . . . . 73.25 111.868 -176.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.407 ' HB3' HD22 ' F' ' 291' ' ' LEU . . . -67.54 159.57 77.4 Favored Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 124.838 1.255 . . . . 74.31 111.475 -178.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.418 ' HG2' HG21 ' A' ' 13' ' ' ILE . 22.4 Cg_exo -63.8 104.22 0.45 Allowed 'Trans proline' 0 C--N 1.386 2.548 0 C-N-CA 122.528 2.152 . . . . 74.23 111.76 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 4.5 p -97.97 109.35 23.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 108.445 -0.946 . . . . 72.15 108.445 174.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -104.04 88.62 3.06 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 114.818 -1.083 . . . . 75.21 109.576 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -60.62 -37.98 83.25 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.099 -0.955 . . . . 72.53 108.763 174.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -67.05 -50.33 62.24 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.895 -1.048 . . . . 65.25 111.83 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.45 ' HA ' ' HB2' ' C' ' 138' ' ' MET . . . -66.0 -33.56 76.09 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.113 0.965 . . . . 63.53 112.172 -169.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 94.1 mt -52.27 -47.66 65.7 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 124.436 1.085 . . . . 71.11 110.8 174.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -76.3 -38.7 55.71 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.477 -0.783 . . . . 73.24 111.14 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.45 ' HB2' ' HA ' ' C' ' 135' ' ' ALA . 88.1 mtp -56.11 -26.66 50.78 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 124.332 1.053 . . . . 73.51 113.434 -175.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 66.2 m-80 -47.31 -30.88 3.43 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 124.246 1.019 . . . . 71.11 113.288 173.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.54 -152.72 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 123.714 0.806 . . . . 75.24 111.8 176.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 42.4 tp 74.1 119.8 0.05 OUTLIER 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.801 1.241 . . . . 71.11 111.845 167.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -107.19 125.15 50.74 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 123.653 0.781 . . . . 73.24 108.925 176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -61.8 127.41 31.3 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 109.06 -0.719 . . . . 64.33 109.06 172.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -88.36 -169.99 2.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.562 0.745 . . . . 75.2 111.24 -173.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -104.86 166.85 10.1 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.968 0.907 . . . . 71.04 109.985 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -154.35 142.19 8.86 Favored Glycine 0 C--N 1.345 1.035 0 CA-C-N 116.431 -0.349 . . . . 62.13 112.75 -176.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -176.35 105.94 0.07 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.487 1.115 . . . . 74.34 108.432 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -163.45 82.75 0.11 Allowed Glycine 0 C--N 1.341 0.808 0 N-CA-C 111.95 -0.46 . . . . 32.03 111.95 -177.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 18.6 p -135.68 96.82 3.51 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.824 0.85 . . . . 74.53 110.731 177.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -122.29 111.47 16.95 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.784 -1.191 . . . . 75.35 107.784 167.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -151.47 132.47 14.28 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 123.234 0.614 . . . . 72.03 109.595 -177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -154.98 85.69 1.1 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.701 0.8 . . . . 63.34 109.474 -177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -101.39 88.52 3.48 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 108.79 -0.819 . . . . 73.43 108.79 170.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -121.38 103.66 9.12 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.48 0.712 . . . . 72.31 109.391 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.07 0 C-N-CA 123.796 0.838 . . . . 62.11 109.113 -177.267 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 109.406 -0.59 . . . . 74.52 109.406 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 31.3 m 58.69 56.03 4.41 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.663 0.785 . . . . 63.22 110.486 -176.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 23.4 mm-40 -75.12 169.85 17.2 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.123 -0.944 . . . . 74.34 111.861 -172.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 71.5 mt-30 -99.96 105.36 17.04 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.718 0.807 . . . . 75.51 110.509 -176.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -173.34 115.07 0.25 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.073 0.949 . . . . 64.13 109.236 178.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -103.41 87.16 2.79 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.034 0.534 . . . . 74.25 110.022 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 26.5 m -67.12 153.04 44.64 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.131 0.573 . . . . 54.02 110.829 178.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.46 161.24 17.57 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.243 0.617 . . . . 74.52 109.946 170.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -28.47 122.17 0.12 Allowed 'General case' 0 N--CA 1.502 2.141 0 C-N-CA 125.922 1.689 . . . . 61.32 114.685 -166.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 38.3 m -146.49 143.76 29.18 Favored 'General case' 0 C--O 1.243 0.736 0 C-N-CA 124.141 0.976 . . . . 50.22 108.83 -178.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -174.07 97.1 0.1 Allowed 'General case' 0 C--O 1.239 0.535 0 N-CA-C 106.848 -1.538 . . . . 73.44 106.848 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -133.13 119.81 20.43 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 115.198 -0.91 . . . . 64.25 108.658 178.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 41.7 mt -70.55 107.28 1.96 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 114.711 -1.132 . . . . 71.0 109.482 177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -74.87 -37.64 62.12 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 110.203 -0.295 . . . . 75.22 110.203 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.42 HH22 ' HB ' ' F' ' 301' ' ' ILE . 7.7 ttt85 -170.5 143.89 2.33 Favored 'General case' 0 CA--C 1.546 0.819 0 O-C-N 123.963 0.79 . . . . 73.54 109.95 -177.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.622 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.1 OUTLIER -120.29 108.36 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.468 1.107 . . . . 72.4 108.205 175.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -138.25 158.69 43.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.447 1.118 . . . . 63.14 111.195 -170.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.5 p -92.56 110.31 21.73 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 113.768 -1.56 . . . . 74.51 108.873 175.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.574 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 41.3 mtpt -74.05 -31.69 62.99 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 121.149 0.5 . . . . 73.14 110.124 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -150.61 141.66 23.03 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 114.781 -1.1 . . . . 63.53 109.367 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.469 HD13 ' HE3' ' C' ' 117' ' ' MET . 28.8 mt -136.55 141.75 40.16 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.825 1.25 . . . . 74.32 107.802 178.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.2 t -146.55 137.5 24.18 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.988 0.915 . . . . 72.12 109.656 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.543 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 90.0 t80 -149.32 121.06 8.09 Favored 'General case' 0 C--O 1.222 -0.359 0 N-CA-C 106.127 -1.805 . . . . 64.43 106.127 167.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -131.1 124.78 31.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 -175.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -127.48 82.45 68.23 Favored Pre-proline 0 CA--C 1.542 0.652 0 N-CA-C 108.106 -1.072 . . . . 73.13 108.106 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.58 -34.34 5.76 Favored 'Trans proline' 0 C--N 1.382 2.339 0 C-N-CA 122.866 2.377 . . . . 73.55 112.327 -175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' D' ' 71' ' ' GLU . 64.7 m-20 -106.98 23.55 14.21 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.403 1.081 . . . . 75.14 109.573 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.589 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -45.57 -59.77 4.14 Favored Pre-proline 0 CA--C 1.571 1.751 0 C-N-CA 125.194 1.398 . . . . 73.43 114.492 -168.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.19 -16.73 15.45 Favored 'Trans proline' 0 C--N 1.392 2.86 0 CA-C-N 121.886 1.709 . . . . 63.44 113.133 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.478 ' HA ' HE21 ' D' ' 33' ' ' GLN . 12.4 t-160 -68.52 -43.55 76.54 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.082 0.953 . . . . 73.11 109.972 174.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.712 HG21 ' HA ' ' D' ' 73' ' ' ALA . 99.0 t -65.62 -34.82 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 123.857 0.863 . . . . 73.22 110.533 -177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.28 -7.98 46.67 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 113.871 1.063 . . . . 70.31 113.871 -175.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' D' ' 30' ' ' HIS . 38.6 mt-30 -84.81 -29.33 25.46 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.102 0.561 . . . . 73.14 111.274 178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 mtpt -109.9 114.26 27.67 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.76 1.224 . . . . 62.24 108.7 -170.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' G' ' 300' ' ' ASN . 7.2 p-10 -91.11 95.09 9.9 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.312 0.577 . . . . 73.41 112.081 -177.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.406 ' HE3' ' H ' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -146.86 171.29 15.43 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 123.639 0.776 . . . . 72.52 112.333 175.07 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' G' ' 297' ' ' TYR . 21.8 mp0 -84.22 134.34 43.46 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.094 1.358 . . . . 64.43 111.388 -169.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.593 ' HD3' ' HB2' ' G' ' 297' ' ' TYR . 16.6 Cg_exo -68.23 117.55 5.02 Favored 'Trans proline' 0 C--N 1.378 2.084 0 C-N-CA 122.809 2.339 . . . . 65.13 114.301 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -72.91 114.37 10.98 Favored 'General case' 0 C--N 1.352 0.686 0 N-CA-C 107.19 -1.411 . . . . 52.44 107.19 163.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 4.2 p -112.85 123.24 68.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 CA-C-O 121.65 0.738 . . . . 50.5 110.216 -170.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.625 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 51.7 tttp -93.44 125.59 38.13 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 124.841 1.256 . . . . 70.12 109.132 176.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.451 ' HB2' ' NE1' ' G' ' 290' ' ' TRP . 4.8 tt -97.66 114.62 26.62 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 106.662 -1.607 . . . . 72.45 106.662 173.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 15.8 t70 -127.89 129.85 47.55 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 108.665 -0.865 . . . . 65.31 108.665 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 64.0 tp -122.71 135.61 54.63 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.558 0.743 . . . . 72.04 110.118 -174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.481 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 23.3 t70 -134.51 148.88 50.61 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.682 1.193 . . . . 75.54 108.165 171.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -124.08 149.07 46.58 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.295 0.638 . . . . 55.44 110.674 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.651 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.39 152.09 35.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.971 0.908 . . . . 64.24 109.266 178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.702 ' HB2' HD21 ' G' ' 278' ' ' LEU . 16.6 p -174.8 154.17 1.87 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.319 0.648 . . . . 72.14 111.373 -176.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 55.2 p -171.46 158.57 5.26 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.369 1.068 . . . . 41.32 109.81 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -87.5 125.61 34.42 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.397 -0.594 . . . . 64.3 109.397 173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.607 HD11 ' HB2' ' D' ' 57' ' ' GLU . 50.4 mt -91.36 -42.23 10.46 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.363 0.665 . . . . 44.23 110.456 -177.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.15 -172.36 4.19 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.431 -0.804 . . . . 64.11 110.31 -174.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.73 118.2 9.26 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.022 -0.99 . . . . 72.11 109.895 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 66.65 0.81 1.96 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 125.772 1.629 . . . . 73.23 112.661 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 72.1 t -108.49 124.82 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 123.048 0.539 . . . . 75.21 109.988 -172.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -127.15 159.88 32.93 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 124.317 1.047 . . . . 75.24 109.403 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.607 ' HB2' HD11 ' D' ' 51' ' ' LEU . 39.6 tt0 -118.27 137.29 53.15 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.889 0.876 . . . . 72.43 108.715 174.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.471 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 69.3 t -121.11 121.43 64.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 107.509 -1.293 . . . . 71.24 107.509 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.651 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 31.2 t -117.89 129.77 73.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.965 -0.754 . . . . 74.1 108.965 177.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -115.33 110.93 20.11 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 108.636 -0.875 . . . . 72.24 108.636 170.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 13.7 ttm180 -84.16 99.71 10.69 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.717 -0.846 . . . . 74.24 108.717 173.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.3 t -94.27 122.38 45.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.508 0 CA-C-N 115.116 -0.947 . . . . 73.31 108.487 175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 23.1 m -129.28 130.29 46.01 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.367 -0.833 . . . . 75.14 109.908 -171.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 82.2 t -124.01 126.43 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 125.665 1.586 . . . . 72.42 108.146 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.625 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 89.2 m -126.42 110.63 13.54 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 109.76 -0.459 . . . . 61.31 109.76 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -106.84 124.19 49.26 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.068 0.547 . . . . 64.35 109.948 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' D' ' 72' ' ' THR . 58.8 m -135.91 119.61 17.19 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 107.571 -1.27 . . . . 53.52 107.571 178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.737 HD13 ' HB2' ' D' ' 73' ' ' ALA . 6.8 mp -123.35 133.78 54.08 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.838 0.855 . . . . 74.21 109.734 -170.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.6 -116.87 5.9 Favored Glycine 0 C--N 1.347 1.169 0 N-CA-C 112.076 -0.41 . . . . 74.01 112.076 178.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -112.26 3.76 17.32 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.201 0.6 . . . . 64.3 110.52 176.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . 0.502 ' HB2' ' ND2' ' D' ' 27' ' ' ASN . 9.7 pm0 -127.54 164.57 21.66 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 123.681 0.792 . . . . 62.53 110.814 -174.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.478 ' HA ' ' HA ' ' D' ' 67' ' ' SER . 53.4 m -86.46 129.98 34.67 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.147 0.579 . . . . 73.31 110.278 169.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.737 ' HB2' HD13 ' D' ' 68' ' ' LEU . . . -72.39 -68.61 0.46 Allowed 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.325 0.65 . . . . 64.54 109.47 174.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.8 152.03 31.14 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 114.906 -1.043 . . . . 72.1 111.947 -178.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -119.63 116.64 26.43 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.572 1.549 . . . . 71.54 107.574 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.601 ' SG ' HG23 ' D' ' 114' ' ' ILE . 17.1 t -127.83 134.94 49.45 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 109.784 -0.451 . . . . 72.21 109.784 -176.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -153.7 133.71 13.22 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 123.189 0.596 . . . . 75.4 109.941 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 94.5 t -136.63 119.78 22.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 123.656 0.782 . . . . 74.05 109.324 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.506 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 64.6 mt-30 -90.53 88.52 7.18 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 108.29 -1.004 . . . . 74.32 108.29 174.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -79.33 97.95 6.51 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-N 115.451 -0.795 . . . . 75.13 109.118 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.84 143.88 16.85 Favored Glycine 0 C--N 1.339 0.75 0 N-CA-C 111.183 -0.767 . . . . 53.45 111.183 177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.79 130.96 3.8 Favored Glycine 0 CA--C 1.507 -0.459 0 N-CA-C 110.224 -1.15 . . . . 70.31 110.224 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 46.3 mt -90.02 131.82 36.27 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 N-CA-C 108.94 -0.763 . . . . 74.05 108.94 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.471 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 30.0 m-85 -134.02 125.31 27.85 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.889 -0.782 . . . . 74.41 108.889 177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 19.8 m -76.14 103.42 6.17 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 107.878 -1.156 . . . . 62.54 107.878 168.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.533 HG23 HD11 ' D' ' 89' ' ' ILE . 75.0 mt -107.8 132.18 56.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.358 1.063 . . . . 64.44 109.475 -175.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -165.66 164.86 19.03 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.431 0.692 . . . . 62.45 110.948 178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 74.83 -2.81 47.75 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 115.262 0.865 . . . . 73.14 115.262 172.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.533 HD11 HG23 ' D' ' 86' ' ' ILE . 15.9 pt -123.97 128.43 74.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.628 1.171 . . . . 73.42 108.036 -177.298 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -137.29 159.7 41.17 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 123.115 0.566 . . . . 73.1 111.352 -174.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.88 -123.42 31.51 Favored Glycine 0 C--N 1.352 1.422 0 CA-C-N 115.46 -0.791 . . . . 73.05 113.201 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 13.5 t -69.19 -25.74 64.49 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.007 0.923 . . . . 74.21 111.685 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -72.9 -39.74 66.1 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 123.385 0.674 . . . . 75.2 110.133 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.1 -31.83 56.18 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 109.528 -0.545 . . . . 73.43 109.528 173.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.59 -41.44 90.29 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.901 0.88 . . . . 71.5 111.89 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.47 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 17.6 t-80 -61.53 -48.13 82.42 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.582 -0.736 . . . . 74.02 110.34 172.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -73.17 -29.36 62.79 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 115.927 -0.579 . . . . 72.31 112.128 -171.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 29.7 tp -95.52 -51.21 4.65 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.217 1.007 . . . . 71.34 110.834 -171.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.77 5.18 66.53 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 115.702 -0.681 . . . . 44.53 114.057 -173.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.537 ' HB1' ' HA ' ' D' ' 134' ' ' ASP . . . -136.86 -55.96 0.73 Allowed 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 117.064 0.432 . . . . 74.22 110.696 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.1 t80 -75.61 -41.24 54.95 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 112.809 0.67 . . . . 73.3 112.809 -173.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 90.7 m -62.24 -46.98 90.85 Favored Pre-proline 0 CA--C 1.564 1.516 0 CA-C-O 118.834 -0.603 . . . . 51.14 111.026 176.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.63 -40.0 87.85 Favored 'Trans proline' 0 C--N 1.395 3.02 0 C-N-CA 122.299 1.999 . . . . 72.44 113.061 165.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -60.98 -28.08 68.75 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 123.406 0.682 . . . . 74.11 111.4 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 38.7 mm -79.42 -50.54 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.996 0 C-N-CA 123.842 0.857 . . . . 74.25 110.921 175.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 96.5 mt -82.11 -28.63 32.16 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 113.057 0.762 . . . . 71.33 113.057 -167.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 61.3 t80 -65.83 -42.57 54.48 Favored Pre-proline 0 CA--C 1.561 1.384 0 C-N-CA 124.21 1.004 . . . . 61.32 112.873 -172.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -55.19 -37.41 94.26 Favored 'Trans proline' 0 C--N 1.39 2.711 0 C-N-CA 121.922 1.748 . . . . 73.12 113.087 171.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -77.2 -31.04 55.03 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.426 0.691 . . . . 64.34 111.887 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.55 -51.91 63.39 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.299 0.64 . . . . 71.44 109.67 174.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.502 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.3 ttp180 -55.83 -54.32 45.96 Favored 'General case' 0 C--O 1.214 -0.785 0 CA-C-N 114.074 -1.421 . . . . 74.25 110.396 178.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -59.8 -39.22 84.26 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.073 0.949 . . . . 75.31 111.58 -174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.539 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -62.21 -47.54 83.99 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.029 0.532 . . . . 64.22 111.02 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.601 HG23 ' SG ' ' D' ' 76' ' ' CYS . 85.5 mt -60.11 -51.73 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 C-N-CA 124.099 0.96 . . . . 73.24 110.225 175.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.505 HG21 ' HE2' ' B' ' 109' ' ' TYR . 87.0 m -54.71 -43.66 72.78 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.881 1.672 . . . . 64.42 112.452 -174.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 39.1 t -66.65 -38.49 86.99 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 123.486 0.714 . . . . 71.54 110.718 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.1 mtm -72.1 -29.78 64.44 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.771 0.428 . . . . 64.02 111.842 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 98.5 t -64.49 -44.32 96.94 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.929 0 C-N-CA 123.376 0.67 . . . . 71.33 109.73 175.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.1 p -72.27 -29.95 64.37 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.07 0.548 . . . . 74.32 111.417 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 87.9 mtt-85 -69.69 -32.39 70.96 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 123.583 0.753 . . . . 64.24 110.574 174.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.48 6.76 81.44 Favored Glycine 0 C--N 1.353 1.512 0 CA-C-N 115.908 -0.587 . . . . 43.43 112.818 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.6 p 60.09 21.38 10.59 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 126.819 2.048 . . . . 65.42 113.311 177.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -86.74 163.06 42.73 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 124.957 1.303 . . . . 75.11 109.627 172.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.71 133.69 20.73 Favored 'Trans proline' 0 C--N 1.382 2.335 0 C-N-CA 122.114 1.876 . . . . 75.04 110.68 -173.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -57.8 135.51 56.82 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 123.752 0.658 . . . . 72.11 111.455 -172.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -104.65 107.75 18.86 Favored 'General case' 0 CA--C 1.532 0.28 0 N-CA-C 107.134 -1.432 . . . . 55.23 107.134 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.459 ' ND2' ' HA ' ' B' ' 15' ' ' ARG . 75.8 m-20 -97.81 93.27 6.27 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 107.069 -1.456 . . . . 74.23 107.069 178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 30.7 tp -74.18 120.08 19.26 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 115.24 -0.891 . . . . 62.4 109.507 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -62.65 123.22 78.45 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.618 0.767 . . . . 73.53 111.781 -173.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.502 ' HB3' HH12 ' D' ' 111' ' ' ARG . 18.7 Cg_endo -86.86 115.31 1.21 Allowed 'Trans proline' 0 C--N 1.378 2.088 0 C-N-CA 123.082 2.521 . . . . 64.25 111.58 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 26.7 t -107.8 110.13 30.75 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.668 -1.234 . . . . 73.52 107.668 175.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 57.5 t30 -79.03 87.99 4.8 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.021 0.528 . . . . 74.05 110.208 -176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -72.39 -19.13 61.66 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 115.658 -0.701 . . . . 73.22 111.06 174.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.537 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 20.7 t70 -61.75 -35.55 78.44 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.629 0.772 . . . . 64.2 111.28 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.511 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -59.35 -37.25 77.39 Favored 'General case' 0 N--CA 1.482 1.157 0 O-C-N 124.338 1.024 . . . . 72.12 113.023 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.662 HD13 ' H ' ' B' ' 150' ' ' GLU . 24.5 mt -59.66 -47.71 84.54 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.93 0.892 . . . . 64.1 111.173 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 92.9 m-85 -77.45 -31.03 53.61 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 115.018 -0.992 . . . . 74.32 110.897 178.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 33.4 ttm -59.76 -39.41 84.74 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 125.423 1.489 . . . . 72.44 110.606 -178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -58.54 -21.84 53.78 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 124.682 1.239 . . . . 73.12 112.827 178.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -84.63 -35.95 22.33 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.647 0.779 . . . . 72.1 110.932 174.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.4 mp -78.66 -30.25 46.14 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 112.014 0.376 . . . . 51.24 112.014 -176.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -88.96 44.5 1.22 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 122.967 0.507 . . . . 73.24 111.484 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -120.44 46.03 2.08 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.764 0.826 . . . . 41.51 109.829 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -162.31 -81.84 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 122.412 0.285 . . . . 75.44 111.115 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.97 162.29 31.84 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.503 0.721 . . . . 61.11 111.835 -169.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 178.25 138.19 3.04 Favored Glycine 0 C--N 1.349 1.304 0 N-CA-C 111.796 -0.522 . . . . 53.12 111.796 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -113.63 137.59 51.38 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 117.694 0.747 . . . . 74.31 110.215 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 121.82 160.77 11.1 Favored Glycine 0 C--N 1.344 0.996 0 N-CA-C 111.554 -0.618 . . . . 63.32 111.554 -178.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 76.4 m -143.88 -90.25 0.12 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.447 0.699 . . . . 74.42 109.252 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -165.51 152.19 10.07 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 107.655 -1.239 . . . . 63.32 107.655 -178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -98.08 118.88 35.68 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.587 -0.894 . . . . 72.43 108.587 173.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -79.55 82.59 5.65 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.807 -1.183 . . . . 72.23 107.807 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . 0.565 ' HA ' HE21 ' D' ' 153' ' ' GLN . 0.0 OUTLIER -66.06 90.85 0.14 Allowed 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.515 -1.22 . . . . 74.24 110.619 -179.269 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -142.96 115.3 8.47 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.411 -1.268 . . . . 71.4 108.583 -178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.885 0 C-N-CA 123.771 0.828 . . . . 70.13 109.792 179.881 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 110.377 -0.231 . . . . 61.33 110.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -80.52 130.83 35.38 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 108.941 -0.763 . . . . 62.04 108.941 174.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -96.04 166.75 11.61 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.33 0.652 . . . . 73.41 110.561 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -167.11 164.23 15.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.04 0.936 . . . . 74.4 110.048 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -159.15 102.32 1.56 Allowed Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 123.25 0.62 . . . . 71.34 110.067 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -71.91 125.71 11.24 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.672 2.248 . . . . 75.01 112.861 174.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . 0.57 HD23 ' SD ' ' A' ' 94' ' ' MET . 0.6 OUTLIER -96.79 31.37 2.36 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.553 -0.906 . . . . 72.25 108.553 170.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . 0.416 HD11 ' OG ' ' A' ' 48' ' ' SER . 15.5 tp -164.38 37.99 0.08 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.208 1.003 . . . . 73.11 108.386 176.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -66.85 -26.93 73.15 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 114.726 -1.125 . . . . 51.34 114.571 -173.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -146.86 142.72 27.95 Favored 'General case' 0 C--O 1.244 0.814 0 C-N-CA 122.749 0.419 . . . . 75.12 111.002 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -176.92 -21.72 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.866 0 O-C-N 124.61 1.194 . . . . 74.32 110.424 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -69.04 -7.0 31.59 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.657 0.783 . . . . 74.23 112.735 -178.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.82 89.79 0.58 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.992 0.917 . . . . 61.22 110.488 178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -99.42 -131.04 7.17 Favored Glycine 0 C--N 1.344 0.982 0 N-CA-C 111.335 -0.706 . . . . 52.41 111.335 176.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 63.1 t30 57.28 74.69 0.4 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.711 1.204 . . . . 71.53 111.751 173.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 65.4 mtt -118.43 142.74 31.91 Favored Pre-proline 0 N--CA 1.476 0.867 0 C-N-CA 123.739 0.816 . . . . 54.25 109.344 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -82.78 33.94 0.54 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.218 2.612 . . . . 54.14 113.444 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 61.8 t -74.61 88.0 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 108.71 -0.848 . . . . 72.11 108.71 178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 20.8 mtm180 -128.34 44.35 2.97 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.42 1.088 . . . . 74.23 108.88 -175.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 96.9 m95 73.83 158.36 0.2 Allowed 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.794 1.637 . . . . 75.25 112.979 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.545 HD13 ' HB3' ' A' ' 129' ' ' ALA . 3.9 mp -109.42 66.13 0.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.119 -1.4 . . . . 75.03 108.777 -171.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 106.47 -152.3 16.99 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-N 115.224 -0.898 . . . . 71.02 112.626 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -75.09 120.79 6.19 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.25 2.633 . . . . 64.42 112.748 -174.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . 0.555 ' HD3' ' H ' ' E' ' 294' ' ' LYS . 0.0 OUTLIER -114.64 88.21 2.81 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.784 0.802 . . . . 74.44 110.24 -178.49 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.96 83.69 4.78 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.486 -0.931 . . . . 73.24 108.486 172.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 47.2 m -59.54 -58.09 10.11 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 115.277 -0.874 . . . . 74.43 108.879 175.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.48 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 21.5 m-30 -67.75 89.95 0.27 Allowed 'General case' 0 C--N 1.35 0.624 0 N-CA-C 108.464 -0.939 . . . . 75.12 108.464 168.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -78.67 -2.5 39.47 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 114.243 -1.344 . . . . 63.32 112.712 -173.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 172.03 -168.66 41.76 Favored Glycine 0 C--O 1.247 0.922 0 N-CA-C 110.748 -0.941 . . . . 42.01 110.748 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -70.94 108.38 4.51 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.077 0.551 . . . . 74.42 109.876 177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.442 HG21 HH22 ' B' ' 15' ' ' ARG . 13.8 mt -75.78 -64.14 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 N-CA-C 107.71 -1.218 . . . . 64.2 107.71 171.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 32.3 t70 58.26 -80.38 0.02 OUTLIER 'General case' 0 C--N 1.359 0.979 0 C-N-CA 125.67 1.588 . . . . 52.23 111.304 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 17.1 pttp 169.0 156.94 0.17 Allowed Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 126.966 2.106 . . . . 52.03 107.841 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -57.0 120.83 9.02 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.1 1.867 . . . . 71.32 110.928 169.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . 0.815 ' HB3' ' HB3' ' G' ' 295' ' ' ALA . . . -70.41 86.54 0.61 Allowed 'General case' 0 C--N 1.352 0.699 0 CA-C-O 121.786 0.803 . . . . 70.42 110.236 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . 0.694 ' HA ' ' HD2' ' G' ' 293' ' ' PRO . 6.6 m -131.51 135.38 59.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.712 1.605 . . . . 61.23 106.804 170.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 15.4 t -163.22 20.85 0.08 Allowed 'General case' 0 N--CA 1.482 1.145 0 CA-C-O 120.753 0.311 . . . . 73.4 111.062 -174.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 49.2 t -134.52 128.38 33.23 Favored 'General case' 0 N--CA 1.478 0.966 0 O-C-N 122.111 -0.368 . . . . 62.04 110.434 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . 0.559 HG22 HD23 ' G' ' 291' ' ' LEU . 23.1 p -130.49 158.46 74.47 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 124.698 1.199 . . . . 63.32 109.304 177.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . 0.599 ' HB2' HG21 ' B' ' 7' ' ' THR . 19.2 Cg_endo . . . . . 0 C--N 1.377 2.039 0 C-N-CA 122.595 2.197 . . . . 70.22 111.412 171.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 109.533 -0.543 . . . . 62.53 109.533 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . 0.429 HD22 ' HG3' ' F' ' 274' ' ' GLN . 4.2 p-10 -98.24 119.41 36.86 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.654 0.781 . . . . 75.55 109.169 178.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -82.0 77.27 8.84 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.354 0.662 . . . . 75.01 111.177 -172.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . 0.429 ' HG3' HD22 ' F' ' 272' ' ' ASN . 51.5 mt-30 -71.68 -33.28 68.69 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.73 0.812 . . . . 73.42 109.982 167.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -64.1 129.16 93.82 Favored Pre-proline 0 CA--C 1.541 0.631 0 CA-C-N 115.09 -0.959 . . . . 65.31 109.245 175.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -61.27 107.31 0.47 Allowed 'Trans proline' 0 C--N 1.376 1.984 0 C-N-CA 121.978 1.786 . . . . 72.31 109.998 175.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . 0.412 ' HG ' ' HG3' ' C' ' 94' ' ' MET . 17.0 tp -69.72 2.59 3.15 Favored 'General case' 0 CA--C 1.565 1.541 0 C-N-CA 125.06 1.344 . . . . 73.23 112.809 -171.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.517 HD22 HD22 ' C' ' 98' ' ' LEU . 19.6 mt -71.3 161.79 30.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.979 1.312 . . . . 71.34 111.602 -177.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -154.87 25.33 0.63 Allowed Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.8 -0.636 . . . . 65.34 112.023 173.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . 0.592 ' HB2' ' HB1' ' C' ' 95' ' ' ALA . 8.7 tt -165.6 -62.61 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.339 0.656 . . . . 74.14 109.282 -173.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . 0.45 ' HB2' ' HA2' ' C' ' 99' ' ' GLY . 38.6 t80 -65.05 133.76 52.35 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.185 -0.916 . . . . 62.35 110.132 -173.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 71.95 147.2 0.08 Allowed 'General case' 0 N--CA 1.477 0.899 0 O-C-N 124.894 1.371 . . . . 61.22 111.288 -177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 68.45 -72.3 0.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.002 1.321 . . . . 63.45 111.218 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -86.01 60.08 4.65 Favored Glycine 0 C--N 1.347 1.17 0 N-CA-C 112.182 -0.367 . . . . 73.24 112.182 176.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -82.52 144.08 30.65 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.028 0.531 . . . . 73.33 110.395 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 63.9 ttp -102.38 103.6 32.24 Favored Pre-proline 0 CA--C 1.548 0.887 0 N-CA-C 108.253 -1.018 . . . . 74.24 108.253 173.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -72.11 108.58 2.5 Favored 'Trans proline' 0 C--N 1.378 2.086 0 C-N-CA 122.479 2.12 . . . . 62.3 111.981 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 58.9 t -74.33 90.38 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 108.818 -0.808 . . . . 72.45 108.818 174.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 36.8 ttp-105 -84.14 80.19 9.27 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.719 -1.128 . . . . 75.22 108.541 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 13.2 m95 65.96 168.07 0.21 Allowed 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 114.098 -1.41 . . . . 74.3 113.821 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.407 HD22 ' HB3' ' C' ' 129' ' ' ALA . 4.8 mp -119.85 -33.09 4.07 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.229 -1.35 . . . . 65.32 109.905 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -159.21 -100.94 0.17 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-O 118.961 -0.911 . . . . 63.12 112.198 -177.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.75 154.25 63.92 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.019 2.479 . . . . 65.02 112.24 -179.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -133.5 14.92 4.08 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.519 0.727 . . . . 74.54 112.454 -176.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -102.19 155.53 18.15 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 122.963 0.505 . . . . 71.32 110.923 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 72.7 m -134.96 163.69 29.28 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.69 1.196 . . . . 55.22 108.168 173.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.533 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 48.9 m-85 69.36 -89.08 0.03 OUTLIER 'General case' 0 C--N 1.353 0.72 0 C-N-CA 125.219 1.408 . . . . 74.52 109.532 -177.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 51.77 32.96 10.3 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 124.81 1.244 . . . . 72.04 111.248 -174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -164.58 144.25 9.22 Favored Glycine 0 C--N 1.341 0.826 0 CA-C-N 114.826 -1.079 . . . . 71.53 111.424 -175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -73.72 77.82 1.55 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.237 1.015 . . . . 71.15 110.739 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.42 ' HB ' HH22 ' D' ' 15' ' ' ARG . 32.0 pt -78.44 -13.16 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 116.304 -0.407 . . . . 74.42 110.813 177.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . 0.479 ' HB3' ' HZ2' ' C' ' 36' ' ' TRP . 3.9 p30 -57.24 -26.58 60.97 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.308 1.043 . . . . 72.43 112.288 179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -66.75 115.03 20.61 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 123.958 0.786 . . . . 74.34 109.821 175.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.5 97.34 1.14 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.201 1.934 . . . . 71.32 111.889 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -87.28 17.64 4.25 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.814 0.846 . . . . 51.1 111.031 174.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 93.1 t -102.22 -68.34 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.709 0 C-N-CA 124.596 1.158 . . . . 63.01 109.031 177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 77.5 p 43.59 -88.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 125.795 1.638 . . . . 74.03 113.184 -178.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 18.0 p -161.75 168.71 22.75 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 107.703 -1.221 . . . . 73.23 107.703 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 9.6 m -128.43 68.54 77.66 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-N 117.934 0.334 . . . . 74.44 110.598 -178.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo . . . . . 0 C--N 1.389 2.672 0 C-N-CA 123.954 3.103 . . . . 52.33 111.631 175.371 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 109.681 -0.488 . . . . 55.54 109.681 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -64.5 91.67 0.08 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 122.88 0.472 . . . . 73.34 110.061 176.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -82.09 94.63 7.25 Favored 'General case' 0 C--N 1.346 0.421 0 N-CA-C 108.09 -1.078 . . . . 71.23 108.09 170.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -162.64 170.72 18.03 Favored 'General case' 0 C--O 1.247 0.958 0 CA-C-N 114.24 -1.345 . . . . 74.22 108.514 -177.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 12.8 mptt 68.91 145.57 0.11 Allowed Pre-proline 0 N--CA 1.482 1.166 0 C-N-CA 124.69 1.196 . . . . 73.11 110.644 -173.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.87 177.0 1.53 Allowed 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 122.036 1.824 . . . . 73.22 111.659 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 36.9 mt -85.01 38.0 0.69 Allowed 'General case' 0 N--CA 1.486 1.353 0 CA-C-O 121.565 0.698 . . . . 62.01 110.447 -178.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . 0.702 HD21 ' HB2' ' D' ' 48' ' ' SER . 0.4 OUTLIER -156.35 136.82 13.11 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 107.231 -1.396 . . . . 74.33 107.231 -175.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 165.22 -49.38 0.28 Allowed Glycine 0 C--N 1.349 1.276 0 C-N-CA 121.88 -0.2 . . . . 71.43 113.269 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -76.37 77.58 3.12 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 123.519 0.728 . . . . 73.25 111.645 -169.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 75.9 m-85 -143.38 2.52 1.27 Allowed 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.859 1.264 . . . . 72.14 110.379 178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -102.8 153.78 19.84 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.536 0.734 . . . . 52.34 110.396 -178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -71.0 95.76 1.22 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.349 0.66 . . . . 71.03 109.854 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -63.57 -75.1 0.37 Allowed Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.825 -0.51 . . . . 74.33 111.825 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -157.52 23.31 0.29 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 107.945 -1.131 . . . . 71.41 107.945 169.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 72.9 mmm -90.02 117.33 67.99 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.337 1.055 . . . . 75.14 110.262 -170.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -93.02 154.72 2.66 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.888 2.392 . . . . 75.24 112.426 173.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 57.9 t -130.93 -61.82 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 107.855 -1.165 . . . . 75.33 107.855 174.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' B' ' 154' ' ' ASP . 71.2 mtp180 60.5 -86.54 0.02 OUTLIER 'General case' 0 C--N 1.362 1.128 0 C-N-CA 125.454 1.502 . . . . 62.44 110.725 -179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.631 ' HE3' ' H ' ' G' ' 291' ' ' LEU . 0.8 OUTLIER -179.68 159.57 0.88 Allowed 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.397 1.479 . . . . 74.11 108.905 -176.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.631 ' H ' ' HE3' ' G' ' 290' ' ' TRP . 4.7 mp -125.21 143.67 50.83 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.226 1.01 . . . . 63.3 108.929 179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 82.9 167.65 41.47 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 116.304 -0.407 . . . . 61.44 113.582 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . 0.694 ' HD2' ' HA ' ' E' ' 306' ' ' VAL . 61.2 Cg_endo -69.9 -20.26 34.39 Favored 'Trans proline' 0 C--N 1.376 1.999 0 C-N-CA 122.877 2.385 . . . . 64.42 112.57 177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . 0.472 ' HD3' ' CG ' ' G' ' 290' ' ' TRP . 7.1 mtmp? 68.39 89.85 0.1 Allowed 'General case' 0 C--N 1.362 1.109 0 C-N-CA 125.097 1.359 . . . . 71.11 111.333 174.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . 0.815 ' HB3' ' HB3' ' E' ' 305' ' ' ALA . . . -141.13 78.42 1.64 Allowed 'General case' 0 C--O 1.238 0.459 0 N-CA-C 107.998 -1.112 . . . . 31.04 107.998 173.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m -62.26 -37.73 86.56 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.729 -1.123 . . . . 71.32 111.497 -171.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.593 ' HB2' ' HD3' ' D' ' 38' ' ' PRO . 0.1 OUTLIER -91.11 115.32 27.93 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 107.607 -1.257 . . . . 73.11 107.607 171.513 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 21.2 t-80 -97.08 10.58 38.93 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-O 120.582 0.23 . . . . 61.13 110.632 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -167.51 -155.84 9.52 Favored Glycine 0 C--N 1.352 1.455 0 CA-C-N 116.587 -0.279 . . . . 44.43 113.627 -178.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . 0.427 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 23.8 t-20 -68.58 151.1 47.21 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 124.061 0.945 . . . . 73.43 111.242 -175.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . . . . . . . . . 16.9 tt -98.08 -38.06 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.47 0.708 . . . . 72.15 112.315 -173.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.68 157.09 32.05 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.33 0.652 . . . . 51.33 110.02 -173.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -113.21 102.79 55.26 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 123.536 0.734 . . . . 75.21 109.882 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.59 80.02 0.86 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.841 2.36 . . . . 74.14 111.114 170.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -83.71 177.38 8.39 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 115.183 -0.917 . . . . 63.01 110.406 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.445 HG23 ' NE2' ' C' ' 12' ' ' GLN . 9.3 m -59.18 149.98 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 123.276 0.631 . . . . 72.54 110.943 174.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . 0.53 ' HA ' ' HG2' ' C' ' 12' ' ' GLN . 11.5 t -151.09 18.69 0.77 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.75 0.42 . . . . 74.43 111.358 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 31.4 m -126.28 80.3 1.91 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.744 0.418 . . . . 72.34 110.915 -174.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . 0.4 ' OG1' ' HD3' ' G' ' 310' ' ' PRO . 0.8 OUTLIER -91.37 -51.03 0.31 Allowed Pre-proline 0 CA--C 1.567 1.618 0 CA-C-O 118.258 -0.877 . . . . 75.53 111.892 172.172 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . 0.4 ' HD3' ' OG1' ' G' ' 309' ' ' THR . 1.0 OUTLIER . . . . . 0 C--N 1.396 3.068 0 C-N-CA 122.454 2.103 . . . . 61.53 111.705 179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.874 0.368 . . . . 65.11 110.419 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -121.16 109.43 14.98 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 108.04 -1.096 . . . . 74.34 108.04 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -173.16 124.14 0.41 Allowed 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.724 0.81 . . . . 74.15 109.08 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -147.57 131.19 16.84 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.312 0.645 . . . . 73.25 109.534 178.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.23 133.54 21.98 Favored Pre-proline 0 N--CA 1.48 1.039 0 C-N-CA 123.765 0.826 . . . . 61.52 109.711 -179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -82.95 155.14 15.05 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.752 2.301 . . . . 75.44 111.377 176.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 7.1 mp -76.89 -10.36 59.31 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.415 0.686 . . . . 73.13 112.239 -173.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . 0.438 HD22 HD22 ' B' ' 98' ' ' LEU . 71.9 mt -58.86 -45.02 91.11 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.469 0.708 . . . . 74.14 111.226 -177.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 75.89 -76.39 1.4 Allowed Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.253 -0.885 . . . . 54.34 112.088 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . 0.411 HD13 ' H ' ' H' ' 283' ' ' ASP . 3.3 pp -153.46 157.55 40.04 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.464 1.106 . . . . 71.53 109.311 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -100.77 91.94 4.85 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 108.938 -0.764 . . . . 74.35 108.938 175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . 48.35 69.23 0.57 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.858 1.263 . . . . 43.4 112.591 172.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . 0.411 ' H ' HD13 ' H' ' 280' ' ' LEU . 36.2 t70 -94.16 143.17 26.61 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.317 -0.401 . . . . 75.33 111.124 -173.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 138.17 -164.69 25.56 Favored Glycine 0 C--N 1.347 1.151 0 CA-C-N 115.607 -0.724 . . . . 32.34 112.379 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -133.54 139.54 46.66 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.187 0.995 . . . . 74.41 109.407 175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 54.8 ttp -165.31 102.43 0.77 Allowed Pre-proline 0 CA--C 1.552 1.025 0 C-N-CA 124.049 0.939 . . . . 75.32 108.738 178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.57 98.03 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.346 2.698 . . . . 64.53 113.48 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . 0.512 HG11 HG11 ' B' ' 131' ' ' VAL . 56.1 t -126.69 95.61 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.643 1.177 . . . . 65.22 108.566 176.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -125.49 -156.46 0.73 Allowed 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.176 0.99 . . . . 74.13 108.596 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 25.4 m95 -64.89 122.05 16.07 Favored 'General case' 0 C--N 1.356 0.853 0 CA-C-N 118.098 0.408 . . . . 72.1 110.993 176.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.28 -25.64 63.44 Favored 'General case' 0 N--CA 1.474 0.728 0 O-C-N 124.107 0.88 . . . . 55.51 111.16 168.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -178.62 96.64 0.1 Allowed Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.018 -0.833 . . . . 52.14 111.018 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -81.31 34.72 0.56 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.696 2.931 . . . . 70.2 112.972 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -101.15 3.71 41.37 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.163 0.985 . . . . 62.25 110.53 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.21 159.28 28.63 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 123.668 0.787 . . . . 71.32 110.494 176.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 9.0 m 72.4 155.32 0.15 Allowed 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.657 1.183 . . . . 61.2 111.507 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.459 ' H ' ' HG2' ' B' ' 124' ' ' PRO . 15.3 m-85 67.99 7.76 6.03 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.161 1.384 . . . . 63.22 112.081 -174.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -95.84 76.29 3.17 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 107.997 -1.112 . . . . 70.43 107.997 175.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 119.7 170.55 14.49 Favored Glycine 0 C--O 1.247 0.923 0 CA-C-N 114.215 -1.357 . . . . 74.23 111.085 -173.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 23.3 m120 65.77 -176.93 0.18 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.688 1.195 . . . . 71.34 111.027 -173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 25.8 pt 46.94 25.16 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 126.038 1.735 . . . . 55.13 112.923 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -67.21 -37.86 84.33 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 124.697 1.199 . . . . 62.41 110.717 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' H' ' 303' ' ' LYS . 0.1 OUTLIER -136.08 92.26 16.32 Favored Pre-proline 0 CA--C 1.543 0.682 0 CA-C-N 115.01 -0.995 . . . . 62.41 108.997 -179.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -71.85 157.13 55.72 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 122.525 2.15 . . . . 73.43 110.826 169.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 70.69 122.59 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 124.768 1.227 . . . . 62.24 111.172 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 52.6 t -61.66 -41.38 90.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 C-N-CA 123.36 0.664 . . . . 71.41 110.163 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 5.7 m 54.89 80.39 0.13 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.318 1.447 . . . . 72.2 111.917 173.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 57.7 m 69.51 139.44 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 125.166 1.386 . . . . 73.4 112.34 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 24.6 p -112.99 94.55 30.36 Favored Pre-proline 0 N--CA 1.476 0.837 0 N-CA-C 108.619 -0.882 . . . . 72.14 108.619 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo . . . . . 0 C--N 1.379 2.171 0 C-N-CA 123.095 2.53 . . . . 75.05 112.144 -178.564 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.77 ' HA ' ' HA ' ' C' ' 149' ' ' THR . 61.9 mtt . . . . . 0 N--CA 1.474 0.752 0 N-CA-C 109.614 -0.513 . . . . 75.11 109.614 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.6 m 66.9 37.54 3.96 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 124.199 1.0 . . . . 62.53 113.569 172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 28.4 mp0 -87.71 173.83 8.77 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 108.933 -0.766 . . . . 74.53 108.933 166.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -82.55 91.86 7.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 106.62 -1.622 . . . . 63.04 106.62 167.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -109.54 117.27 33.52 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.359 0.664 . . . . 73.21 109.884 -174.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -143.98 121.52 11.76 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.208 -1.034 . . . . 72.22 108.208 176.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.497 ' HA ' ' HA ' ' C' ' 144' ' ' GLN . 31.5 p -116.93 162.04 18.39 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.62 0.768 . . . . 64.04 110.922 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -65.22 125.45 25.07 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.96 0.904 . . . . 71.3 110.05 178.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 82.1 mtp -116.09 161.63 18.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.524 0.73 . . . . 62.43 109.622 174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 87.3 m -141.23 126.69 18.79 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 107.731 -1.211 . . . . 75.04 107.731 172.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.738 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 2.4 t80 -135.63 132.82 37.54 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 122.725 0.41 . . . . 73.33 110.028 -178.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.453 ' NE2' ' HA ' ' H' ' 307' ' ' THR . 53.6 tp60 -152.9 114.31 4.23 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.759 0.824 . . . . 73.52 108.794 172.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.639 HG12 ' HD2' ' A' ' 84' ' ' PHE . 43.0 mt -83.13 119.79 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 109.797 -0.446 . . . . 74.32 109.797 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tm0? -87.19 -31.05 20.55 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.463 0.705 . . . . 74.0 109.651 178.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.3 ttt180 -163.43 142.17 8.11 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 116.757 -0.201 . . . . 53.33 110.999 -172.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.1 OUTLIER -130.94 140.27 49.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 124.553 1.141 . . . . 53.21 108.166 170.083 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 40.3 p90 -172.76 167.95 5.18 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.662 0.744 . . . . 72.14 111.023 -172.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -95.88 119.04 33.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.961 -1.018 . . . . 75.45 108.729 175.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HE3' ' HB3' ' B' ' 28' ' ' ALA . 29.7 mtpt -81.87 -23.46 36.33 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.111 0.481 . . . . 63.12 110.464 176.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 15.2 t70 -154.58 144.15 21.46 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 114.97 -1.014 . . . . 72.45 110.026 177.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.514 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 76.7 mt -137.26 144.36 32.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 125.887 1.675 . . . . 72.25 106.987 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 33.3 t -153.71 125.99 7.99 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 121.258 0.551 . . . . 63.11 110.033 174.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 90.1 t80 -124.1 120.85 33.56 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 105.939 -1.874 . . . . 74.2 105.939 168.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 35.4 mt-10 -126.95 108.41 10.94 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.715 0.689 . . . . 74.41 110.702 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -112.18 79.02 2.64 Favored Pre-proline 0 C--O 1.245 0.819 0 N-CA-C 106.424 -1.695 . . . . 55.03 106.424 168.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -67.4 -46.12 3.1 Favored 'Trans proline' 0 C--N 1.384 2.426 0 C-N-CA 122.388 2.058 . . . . 72.13 111.192 -170.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.419 ' HB3' ' HB2' ' A' ' 30' ' ' HIS . 3.8 m-20 -100.81 28.38 5.24 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.914 -1.039 . . . . 74.02 108.874 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.511 ' HB3' ' HE3' ' B' ' 19' ' ' LYS . . . -41.47 -56.77 4.28 Favored Pre-proline 0 CA--C 1.574 1.873 0 CA-C-O 118.038 -0.982 . . . . 63.42 113.093 -172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HG2' ' HD2' ' A' ' 30' ' ' HIS . 36.3 Cg_endo -63.19 -30.32 74.49 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 121.794 1.663 . . . . 62.21 112.878 178.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.527 ' HD2' ' HG2' ' A' ' 29' ' ' PRO . 9.3 m-70 -79.53 -30.2 41.74 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.748 0.819 . . . . 74.11 111.279 -178.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -82.25 -18.39 11.05 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.94 0 C-N-CA 122.55 0.34 . . . . 54.2 110.939 -174.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -75.96 -31.07 58.87 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.203 0.601 . . . . 73.11 110.498 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -82.19 -18.96 40.88 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.768 0.427 . . . . 75.2 110.595 176.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -68.82 142.09 54.96 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.873 0.469 . . . . 71.41 110.166 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -65.47 139.46 58.51 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.156 0.582 . . . . 64.33 109.847 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.419 ' CZ2' ' HA ' ' E' ' 300' ' ' ASN . 8.1 m95 -66.66 90.81 0.17 Allowed 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.078 0.861 . . . . 71.41 109.889 -171.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' H ' ' HG ' ' A' ' 68' ' ' LEU . 94.1 mt-30 -133.81 63.11 61.88 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 124.365 1.066 . . . . 74.51 108.389 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.452 ' HG3' ' HB3' ' E' ' 297' ' ' TYR . 91.4 Cg_endo -81.47 133.29 8.35 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.212 1.941 . . . . 43.31 112.063 -172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -96.47 91.96 6.05 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 107.523 -1.288 . . . . 75.12 107.523 170.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.5 t -78.38 107.56 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 N-CA-C 108.162 -1.051 . . . . 75.34 108.162 -177.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -94.27 156.78 16.36 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.317 1.047 . . . . 72.33 109.69 -173.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 128' ' ' LEU . 3.5 tt -137.82 109.01 6.81 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.363 -0.977 . . . . 74.54 108.363 -178.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 10.4 m-20 -125.46 141.88 51.81 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.178 0.991 . . . . 73.22 109.252 177.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 97.3 mt -130.24 126.67 37.89 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.752 0.821 . . . . 63.34 109.245 178.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 13.1 t70 -118.82 129.08 55.03 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.675 1.19 . . . . 75.05 108.622 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.8 p -110.38 144.9 38.45 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.859 0.864 . . . . 70.35 110.339 -175.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -153.22 131.78 12.21 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.166 0.586 . . . . 74.12 110.55 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.2 p -133.81 151.92 51.71 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.235 0.614 . . . . 70.41 109.994 170.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.3 t -154.71 162.19 41.23 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.652 0.781 . . . . 72.11 109.672 -177.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.7 tt0 -109.22 113.17 25.78 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.762 0.825 . . . . 72.01 108.784 174.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.405 ' HB2' HG12 ' A' ' 55' ' ' VAL . 65.5 mt -82.79 -33.63 27.25 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.259 0.624 . . . . 64.24 110.301 178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.42 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -170.91 -174.42 1.54 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.337 1.055 . . . . 73.04 109.989 -177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.98 123.2 19.18 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.084 0.554 . . . . 65.45 109.738 173.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 67.52 -4.43 0.92 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 125.455 1.502 . . . . 74.22 112.943 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 59.3 t -112.1 111.31 35.62 Favored 'Isoleucine or valine' 0 C--N 1.349 0.582 0 N-CA-C 108.241 -1.022 . . . . 63.53 108.241 -176.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -126.82 167.14 16.2 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 124.103 0.961 . . . . 64.2 108.611 -176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -129.58 138.8 51.49 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 123.427 0.691 . . . . 74.51 109.326 175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -126.66 129.07 71.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.415 -1.328 . . . . 73.34 107.415 171.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 39.8 t -123.65 131.6 72.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 124.118 0.967 . . . . 75.31 109.068 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -118.6 103.45 9.71 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 107.987 -1.116 . . . . 70.34 107.987 176.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.645 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 9.8 ttp180 -84.74 110.51 18.84 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 109.453 -0.573 . . . . 72.51 109.453 174.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.428 ' HB ' HD11 ' A' ' 114' ' ' ILE . 12.4 t -92.92 128.93 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 N-CA-C 107.394 -1.336 . . . . 72.23 107.394 173.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 16.8 m -123.9 126.83 47.07 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 109.471 -0.566 . . . . 61.35 109.471 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.762 HG11 HD21 ' A' ' 126' ' ' LEU . 47.2 t -125.0 131.72 72.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 C-N-CA 124.767 1.227 . . . . 73.22 107.823 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.6 m -116.38 151.64 35.55 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 108.702 -0.851 . . . . 63.34 108.702 173.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.54 115.69 11.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.926 -1.509 . . . . 64.14 106.926 167.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 8.8 t -130.02 128.21 41.52 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 120.99 0.424 . . . . 55.2 110.228 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD21 ' HE2' ' E' ' 297' ' ' TYR . 8.2 mp -90.3 85.74 6.3 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.687 1.195 . . . . 64.43 107.984 176.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.43 -98.28 2.08 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 114.822 -1.081 . . . . 65.45 110.534 -172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -124.68 -5.03 7.6 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.4 0.68 . . . . 74.41 110.01 171.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -85.83 100.8 12.3 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.005 -1.109 . . . . 73.31 108.005 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 59.8 m -71.21 129.66 39.46 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.269 0.556 . . . . 72.23 111.671 -175.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.568 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.24 -59.74 2.65 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 114.06 -1.427 . . . . 74.22 109.897 176.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.594 ' HE2' HD22 ' A' ' 126' ' ' LEU . 43.1 p90 -159.57 136.9 9.72 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 115.322 -0.854 . . . . 72.11 111.4 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 45.5 tp -112.54 107.85 16.73 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.054 1.342 . . . . 74.52 107.495 172.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.614 ' HB3' HG23 ' A' ' 114' ' ' ILE . 72.6 m -107.93 106.05 16.12 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.809 0.844 . . . . 61.45 111.156 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.443 ' HB2' HG23 ' A' ' 63' ' ' THR . 40.8 tt0 -127.64 125.04 39.43 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.928 1.291 . . . . 71.31 109.186 -173.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.0 t -137.43 115.32 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 123.872 0.869 . . . . 52.12 109.752 -172.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.645 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 73.4 mt-30 -83.36 89.33 7.01 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.378 -0.971 . . . . 63.52 108.378 168.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -83.12 106.4 14.89 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 108.444 -0.947 . . . . 73.4 108.444 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -114.2 -177.38 19.13 Favored Glycine 0 N--CA 1.465 0.614 0 O-C-N 123.528 0.518 . . . . 41.35 112.422 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 179.3 155.71 15.65 Favored Glycine 0 C--N 1.334 0.442 0 N-CA-C 112.443 -0.263 . . . . 51.23 112.443 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 56.2 mt -90.34 115.84 30.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.569 0 N-CA-C 108.873 -0.788 . . . . 65.02 108.873 175.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.738 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 33.0 m-85 -121.1 119.67 33.08 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.946 0.899 . . . . 75.42 109.564 -176.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.2 t -83.33 97.94 9.19 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.685 -0.858 . . . . 64.45 108.685 172.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 25.6 pt -112.53 142.9 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.603 0.761 . . . . 71.05 110.386 -177.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -154.81 164.33 38.97 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.098 0.959 . . . . 55.44 110.184 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.36 -5.89 83.33 Favored Glycine 0 C--N 1.349 1.257 0 CA-C-N 115.86 -0.609 . . . . 71.22 113.925 176.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.468 HD12 ' HG3' ' A' ' 94' ' ' MET . 18.8 pt -114.57 144.79 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.008 0.923 . . . . 75.13 111.118 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -163.18 172.18 15.19 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.754 0.822 . . . . 72.33 108.783 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 48.47 -124.6 11.9 Favored Glycine 0 CA--C 1.54 1.633 0 N-CA-C 114.692 0.637 . . . . 73.22 114.692 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -74.8 -23.62 58.52 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.867 0.867 . . . . 72.45 111.399 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -68.04 -36.98 80.81 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.691 0.796 . . . . 63.15 109.411 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.468 ' HG3' HD12 ' A' ' 89' ' ' ILE . 24.8 ttt -81.55 -24.68 36.41 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.715 -0.675 . . . . 72.53 110.822 176.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.32 -38.05 85.48 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 122.852 0.461 . . . . 72.32 111.115 175.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -68.25 -37.17 80.49 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.404 -0.816 . . . . 65.22 110.781 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.486 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.3 t -73.82 -42.33 61.06 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.828 0.451 . . . . 53.4 111.647 -176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 86.5 mt -77.38 -47.3 20.21 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.365 0.666 . . . . 62.14 110.264 -179.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.4 -2.69 88.99 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 115.077 0.791 . . . . 55.04 115.077 -170.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.11 -56.75 0.23 Allowed 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 117.91 0.855 . . . . 74.3 112.279 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.486 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.8 t80 -64.78 -47.76 76.94 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.731 1.213 . . . . 72.14 113.065 -168.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.32 -35.5 1.17 Allowed Pre-proline 0 CA--C 1.57 1.727 0 CA-C-O 118.851 -0.595 . . . . 62.43 112.502 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -49.85 -39.68 48.64 Favored 'Trans proline' 0 C--N 1.385 2.479 0 C-N-CA 122.77 2.314 . . . . 60.41 113.295 161.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -61.1 -25.93 67.31 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.42 0.688 . . . . 64.14 111.419 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.451 HG21 ' CD1' ' A' ' 13' ' ' ILE . 36.1 mm -78.95 -55.42 9.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.695 0.798 . . . . 72.05 110.227 176.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 87.2 mt -82.95 -24.46 33.01 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.75 1.018 . . . . 72.45 113.75 -165.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -64.13 -41.57 62.49 Favored Pre-proline 0 CA--C 1.563 1.472 0 CA-C-O 118.382 -0.818 . . . . 71.31 112.68 -173.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -54.34 -43.17 61.15 Favored 'Trans proline' 0 C--N 1.389 2.681 0 C-N-CA 122.095 1.863 . . . . 73.52 113.225 167.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -67.95 -38.62 83.03 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.441 0.696 . . . . 74.0 112.092 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.91 -45.96 76.3 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 109.684 -0.487 . . . . 61.1 109.684 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 41.7 ttm105 -53.71 -46.49 70.79 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 124.576 1.173 . . . . 75.34 110.755 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.23 -49.37 72.2 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 124.43 1.081 . . . . 73.42 111.148 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 39.7 t -58.22 -41.47 84.13 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 123.834 0.709 . . . . 70.25 110.735 -177.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.614 HG23 ' HB3' ' A' ' 76' ' ' CYS . 78.7 mt -64.94 -48.49 83.95 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 O-C-N 124.097 0.873 . . . . 52.51 109.958 176.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.648 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.0 m -51.76 -49.98 61.54 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.133 0.973 . . . . 74.21 111.768 -178.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 29.8 t -64.02 -42.94 96.94 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.088 0.867 . . . . 64.32 110.409 -175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.432 ' SD ' HG23 ' A' ' 21' ' ' ILE . 5.7 mtp -56.38 -46.76 79.95 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.835 0.854 . . . . 72.02 111.442 175.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.455 HG21 ' HB3' ' A' ' 126' ' ' LEU . 77.5 t -65.69 -44.2 93.46 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.195 0.998 . . . . 71.24 111.68 -176.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 79.7 p -67.66 -31.35 71.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 122.981 0.513 . . . . 72.21 111.346 -176.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 88.3 mtt-85 -68.02 -29.6 68.64 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.602 0.761 . . . . 54.21 110.858 176.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.47 3.04 80.2 Favored Glycine 0 C--N 1.352 1.417 0 CA-C-N 116.177 -0.465 . . . . 54.2 113.547 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.423 ' HB ' HH21 ' B' ' 15' ' ' ARG . 6.8 m 63.74 35.75 11.09 Favored 'General case' 0 CA--C 1.554 1.125 0 C-N-CA 124.808 1.243 . . . . 75.34 110.045 -178.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.419 ' HD1' ' HE1' ' E' ' 297' ' ' TYR . 93.6 m-85 -105.58 151.66 39.86 Favored Pre-proline 0 CA--C 1.55 0.95 0 CA-C-N 114.547 -1.206 . . . . 72.12 108.386 170.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.05 147.87 91.38 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.431 2.087 . . . . 70.35 111.94 176.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.648 ' HG3' HG23 ' A' ' 115' ' ' THR . 24.2 tt0 -52.9 128.67 27.83 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.772 0.829 . . . . 63.35 112.472 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.762 HD21 HG11 ' A' ' 64' ' ' VAL . 38.4 tp -108.48 118.44 36.78 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.256 0.623 . . . . 74.54 109.419 -179.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -140.05 109.05 6.03 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.162 0.985 . . . . 62.35 108.939 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.448 HD11 HD11 ' A' ' 42' ' ' LEU . 17.9 tp -67.48 135.74 53.54 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.198 0.599 . . . . 63.42 110.544 -178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -53.52 133.29 54.2 Favored Pre-proline 0 CA--C 1.553 1.093 0 C-N-CA 124.647 1.179 . . . . 63.41 112.293 -177.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.418 ' HD3' HD12 ' C' ' 13' ' ' ILE . 6.0 Cg_exo -78.3 92.88 1.11 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 123.039 2.493 . . . . 75.01 110.864 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 66.9 t -100.54 126.85 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 108.222 -1.029 . . . . 65.33 108.222 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 134' ' ' ASP . 40.9 t-20 -73.28 98.69 2.72 Favored 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 123.357 0.663 . . . . 71.4 110.143 -173.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -72.08 -27.15 62.48 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.928 0.891 . . . . 75.31 110.756 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.456 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 7.1 t70 -63.55 -42.04 98.39 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.904 0.881 . . . . 74.31 110.587 175.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -57.31 -35.11 69.43 Favored 'General case' 0 N--CA 1.474 0.726 0 O-C-N 124.01 0.819 . . . . 64.31 111.639 -178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.05 -51.46 66.61 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.114 0.565 . . . . 71.52 109.521 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -66.98 -29.2 68.98 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.751 0.82 . . . . 43.31 112.472 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 82.0 mmm -78.87 -39.22 35.81 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 119.606 -0.235 . . . . 75.45 110.737 179.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 95.0 m-20 -60.17 -42.63 95.37 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.066 0.546 . . . . 74.42 109.834 174.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 13.0 t80 -56.71 -41.64 77.79 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.717 1.207 . . . . 72.35 111.449 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 21.1 tp -69.58 -54.22 15.1 Favored 'General case' 0 CA--C 1.55 0.96 0 O-C-N 123.128 0.268 . . . . 64.24 111.62 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.87 28.84 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 124.202 1.001 . . . . 71.22 108.863 -176.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.658 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.9 OUTLIER 63.02 -91.35 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 108.011 -1.107 . . . . 73.41 108.011 -172.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -156.49 133.44 10.41 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.255 1.422 . . . . 72.15 107.613 174.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -75.46 148.93 38.66 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 109.455 -0.572 . . . . 34.41 109.455 173.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.57 65.41 3.14 Favored Glycine 0 C--N 1.35 1.311 0 O-C-N 123.3 0.375 . . . . 52.34 113.119 -177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -97.36 124.4 41.5 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.067 0.947 . . . . 74.41 108.58 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -124.39 75.53 0.39 Allowed Glycine 0 C--N 1.342 0.866 0 N-CA-C 111.212 -0.755 . . . . 72.11 111.212 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 45.0 p -87.81 124.1 33.28 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.896 0.478 . . . . 72.43 110.801 -177.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.5 tt0 -132.39 152.46 51.45 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.394 1.077 . . . . 75.25 109.313 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -149.41 173.22 13.78 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 123.736 0.814 . . . . 72.31 110.265 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 45.3 m80 -146.39 125.78 13.15 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.16 0.984 . . . . 64.42 109.161 -177.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -68.02 109.22 3.38 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-O 121.309 0.576 . . . . 61.44 110.061 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -72.36 -22.0 61.22 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.628 0.771 . . . . 64.1 110.574 177.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.471 1.109 . . . . 74.34 108.668 176.419 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttm . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 109.953 -0.388 . . . . 61.24 109.953 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 32.8 t -120.34 109.66 15.62 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.67 -0.863 . . . . 73.44 108.67 172.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -68.52 -37.74 80.27 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.697 0.799 . . . . 73.22 110.19 176.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.509 HE22 ' HA3' ' B' ' 91' ' ' GLY . 48.7 tt0 -75.79 102.87 5.63 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-N 115.456 -0.793 . . . . 61.1 108.984 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -127.22 153.97 45.43 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.279 1.032 . . . . 63.51 110.047 -170.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.492 HD21 ' HG2' ' B' ' 93' ' ' GLN . 4.9 m-80 -100.24 -179.18 4.05 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.55 -0.907 . . . . 75.23 108.55 175.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 48.1 m -138.93 -85.8 0.25 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.906 -0.496 . . . . 62.23 110.772 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -102.38 -37.8 7.88 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.154 0.582 . . . . 75.22 110.591 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.565 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 27.8 ttt 65.68 168.4 0.2 Allowed 'General case' 0 CA--C 1.563 1.449 0 O-C-N 124.845 1.341 . . . . 62.14 111.18 -171.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.445 ' O ' ' HA ' ' B' ' 86' ' ' ILE . 94.0 m -150.6 101.62 2.96 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.334 -1.358 . . . . 73.51 107.334 175.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -116.59 114.71 24.5 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 108.0 -1.111 . . . . 72.52 108.0 170.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -134.75 141.0 46.35 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.235 0.614 . . . . 74.23 110.344 176.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -86.2 102.18 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.903 0 CA-C-N 114.884 -1.053 . . . . 74.2 110.656 -177.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -77.38 -32.02 54.66 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 122.019 -0.425 . . . . 62.14 110.055 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.423 HH21 ' HB ' ' A' ' 122' ' ' THR . 37.6 ttt180 -173.75 134.13 0.47 Allowed 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.19 -0.67 . . . . 63.45 109.19 174.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.7 mt -113.8 134.62 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 N-CA-C 106.915 -1.513 . . . . 74.14 106.915 171.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -166.17 151.24 8.29 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-O 121.679 0.752 . . . . 73.52 112.163 -177.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.7 m -77.45 122.12 24.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.905 -1.043 . . . . 63.31 109.027 170.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.511 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 43.7 mtpt -89.71 -39.33 13.24 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.141 0.576 . . . . 60.41 111.105 177.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.421 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 16.3 t70 -150.09 136.04 18.58 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.57 -0.286 . . . . 74.21 110.632 -169.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.471 HD11 ' SG ' ' B' ' 113' ' ' CYS . 47.9 mm -128.59 139.13 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 124.477 1.111 . . . . 43.24 108.687 173.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 28.8 t -141.56 121.55 13.68 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.719 -1.215 . . . . 50.21 107.719 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.2 t80 -136.19 137.33 40.77 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.664 -0.865 . . . . 75.14 108.664 172.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.42 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 38.4 mt-10 -136.42 153.35 51.1 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.862 1.265 . . . . 74.03 108.833 177.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -148.93 82.49 7.15 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.833 -1.543 . . . . 74.55 106.833 172.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -64.62 -46.44 7.01 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.882 2.388 . . . . 73.1 111.712 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 53.8 m-20 -96.89 28.21 3.61 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 123.928 0.891 . . . . 75.23 109.641 -178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.582 ' HB3' ' HE3' ' A' ' 19' ' ' LYS . . . -46.86 -51.71 37.26 Favored Pre-proline 0 CA--C 1.568 1.655 0 N-CA-C 114.22 1.193 . . . . 53.21 114.22 -176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 9.3 Cg_endo -79.56 -24.21 6.49 Favored 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 121.715 1.61 . . . . 73.31 112.538 176.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.463 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 79.4 m80 -97.09 2.18 50.94 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.225 1.01 . . . . 74.5 112.81 -172.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.539 HG23 HD11 ' B' ' 68' ' ' LEU . 11.1 p -71.51 -19.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.053 0.941 . . . . 75.21 111.334 -179.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -67.08 -23.12 65.82 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.516 1.127 . . . . 73.03 111.938 -172.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.614 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 28.4 pt20 -69.91 -34.04 72.99 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.373 0.669 . . . . 71.13 110.44 175.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.635 ' HB2' HD13 ' B' ' 68' ' ' LEU . 31.9 mmtp -107.67 63.71 0.62 Allowed 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.329 -0.989 . . . . 63.51 108.329 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.05 105.21 14.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.147 -0.686 . . . . 74.13 109.147 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.445 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 162.65 -165.94 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 C-N-CA 127.39 2.276 . . . . 74.24 109.216 159.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.414 ' H ' ' HB3' ' B' ' 36' ' ' TRP . 28.7 pt20 -61.08 127.35 87.74 Favored Pre-proline 0 C--N 1.363 1.159 0 O-C-N 123.248 0.342 . . . . 75.1 111.18 -171.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -83.11 160.86 15.55 Favored 'Trans proline' 0 C--N 1.362 1.28 0 C-N-CA 122.542 2.161 . . . . 71.1 112.112 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -70.19 106.25 3.23 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 107.999 -1.112 . . . . 71.25 107.999 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 16.0 m -95.95 158.33 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 123.346 0.659 . . . . 73.23 111.705 -175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.602 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.0 tttm -143.64 108.84 5.01 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.377 1.071 . . . . 72.05 109.058 -177.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 tt -86.59 135.47 33.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 106.772 -1.566 . . . . 73.3 106.772 171.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.606 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 16.9 t70 -144.51 147.45 33.26 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.944 -0.761 . . . . 74.23 108.944 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -125.4 140.01 53.16 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 109.294 -0.632 . . . . 51.23 109.294 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 8.7 t70 -123.49 140.95 52.48 Favored 'General case' 0 C--O 1.244 0.781 0 C-N-CA 124.403 1.081 . . . . 73.22 108.615 174.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.0 p -108.81 115.53 30.26 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.281 -0.872 . . . . 61.33 109.977 -173.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.419 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -136.22 133.68 37.33 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.743 0.817 . . . . 72.3 108.892 176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 15.5 p -144.7 167.68 21.99 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.326 0.65 . . . . 53.22 110.032 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -150.56 137.38 19.09 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 123.19 0.596 . . . . 75.11 110.089 -179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -90.81 94.73 9.8 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.455 0.702 . . . . 61.14 109.401 177.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.502 HD11 ' HB2' ' B' ' 57' ' ' GLU . 38.5 mt -69.87 -39.41 76.35 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 121.38 0.609 . . . . 71.05 110.102 178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -157.44 -179.59 8.32 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.648 -1.16 . . . . 71.41 109.413 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -67.08 120.43 13.67 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 109.357 -0.609 . . . . 60.22 109.357 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 73.9 -4.79 2.18 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 125.375 1.47 . . . . 64.22 112.394 -178.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.423 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 87.9 t -104.51 111.22 33.21 Favored 'Isoleucine or valine' 0 C--N 1.351 0.655 0 N-CA-C 108.05 -1.093 . . . . 72.03 108.05 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -126.51 137.6 53.39 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.877 -0.602 . . . . 75.33 109.706 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.502 ' HB2' HD11 ' B' ' 51' ' ' LEU . 6.1 tm-20 -101.64 102.01 12.63 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.738 -1.579 . . . . 75.21 106.738 173.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 75.7 t -95.54 121.92 46.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 124.67 1.188 . . . . 74.11 110.219 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.478 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.1 t -104.95 120.79 56.03 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 C-N-CA 124.731 1.213 . . . . 23.01 109.633 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' B' ' 103' ' ' PRO . 61.7 tp -104.39 104.66 14.57 Favored 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.811 -0.811 . . . . 70.24 108.811 172.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 38.5 ttm180 -88.67 114.09 24.92 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 109.356 -0.609 . . . . 73.22 109.356 173.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.4 t -106.43 112.03 37.86 Favored 'Isoleucine or valine' 0 C--O 1.239 0.539 0 N-CA-C 108.084 -1.08 . . . . 62.43 108.084 173.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 26.9 m -98.2 138.36 35.59 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 123.992 0.917 . . . . 62.42 110.038 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.679 HG21 HG21 ' B' ' 114' ' ' ILE . 55.5 t -127.34 124.3 63.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 C-N-CA 124.822 1.249 . . . . 55.44 108.355 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.602 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 85.0 m -119.18 145.61 45.87 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 108.008 -1.108 . . . . 74.33 108.008 173.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.1 131.72 17.82 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.673 -0.862 . . . . 73.54 108.673 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 39.6 p -152.98 126.91 8.96 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.088 0.555 . . . . 64.03 110.433 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.713 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.1 OUTLIER -104.65 123.75 48.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.816 0.847 . . . . 73.25 109.188 -176.095 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.51 -111.49 3.26 Favored Glycine 0 C--N 1.343 0.937 0 N-CA-C 110.14 -1.184 . . . . 60.05 110.14 -169.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -126.46 6.25 6.93 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.617 0.767 . . . . 72.25 109.798 173.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.525 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 10.8 pt-20 -113.52 143.4 44.6 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.029 0.531 . . . . 72.31 109.745 -176.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 54.4 m -70.0 133.71 47.54 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.104 0.562 . . . . 71.21 111.932 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.713 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -88.55 -59.46 2.23 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.303 1.041 . . . . 72.12 109.426 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -165.02 150.4 9.58 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 113.896 -1.502 . . . . 75.21 109.242 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.42 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.32 123.66 39.89 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 124.819 1.248 . . . . 70.42 107.695 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.499 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 47.7 t -129.85 149.91 51.38 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 109.257 -0.645 . . . . 73.42 109.257 176.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -162.78 132.53 4.39 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 109.026 -0.731 . . . . 60.12 109.026 -177.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.408 HG21 ' HB3' ' B' ' 113' ' ' CYS . 85.3 t -126.83 145.62 34.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 C-N-CA 123.612 0.765 . . . . 35.32 109.505 178.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -118.01 103.24 9.71 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.288 -1.375 . . . . 72.51 107.288 167.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.493 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 5.8 tp-100 -93.21 99.48 12.03 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 107.378 -1.341 . . . . 61.43 107.378 173.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.478 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.25 171.62 38.79 Favored Glycine 0 C--O 1.248 1.024 0 N-CA-C 110.724 -0.95 . . . . 72.33 110.724 176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -176.18 126.66 1.16 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.915 -0.659 . . . . 52.41 112.022 -175.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 28.4 mt -84.73 129.0 38.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 N-CA-C 108.042 -1.096 . . . . 70.43 108.042 174.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -133.74 150.59 51.48 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.602 1.161 . . . . 74.01 108.222 -177.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 58.6 m -114.46 114.8 26.3 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.074 -1.084 . . . . 74.33 108.074 169.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' B' ' 10' ' ' THR . 46.3 pt -121.02 130.69 74.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 C-N-CA 123.348 0.659 . . . . 75.03 110.712 -174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -153.66 171.11 19.33 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.311 1.045 . . . . 71.25 109.79 177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.7 -47.08 3.79 Favored Glycine 0 C--N 1.35 1.341 0 C-N-CA 123.091 0.377 . . . . 64.52 112.391 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.425 ' HA ' ' OD1' ' B' ' 6' ' ' ASN . 1.8 pp -70.18 152.29 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 C-N-CA 123.691 0.797 . . . . 73.33 111.154 169.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -150.41 143.28 24.71 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 111.726 0.269 . . . . 63.4 111.726 -173.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.509 ' HA3' HE22 ' B' ' 4' ' ' GLN . . . 58.55 -111.1 2.95 Favored Glycine 0 C--N 1.356 1.693 0 C-N-CA 123.99 0.805 . . . . 63.02 113.934 173.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.448 HG22 HD23 ' B' ' 141' ' ' LEU . 2.8 m -72.61 -34.25 67.24 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.97 0.908 . . . . 71.25 110.144 -178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.492 ' HG2' HD21 ' B' ' 6' ' ' ASN . 25.3 mp0 -76.02 -25.82 56.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.049 0.939 . . . . 73.12 110.327 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 43.7 ttp -73.32 -34.8 65.89 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.913 0.885 . . . . 73.44 110.307 170.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -28.38 68.75 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.604 -0.726 . . . . 71.32 110.814 173.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.463 ' HB2' HD21 ' B' ' 141' ' ' LEU . 57.1 t-80 -73.56 -24.12 60.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.419 0.687 . . . . 74.43 111.198 173.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -73.59 -63.54 1.18 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 122.672 0.389 . . . . 64.01 111.024 -178.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.716 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -87.02 -19.23 28.96 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 112.577 0.584 . . . . 73.12 112.577 -175.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.71 2.8 52.81 Favored Glycine 0 C--N 1.347 1.158 0 CA-C-O 119.83 -0.428 . . . . 63.11 113.972 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.493 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -146.39 -46.8 0.19 Allowed 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 117.034 0.417 . . . . 64.32 111.43 -177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -83.23 -38.39 22.31 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 111.577 0.214 . . . . 72.24 111.577 -177.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.716 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 81.7 m -62.1 -46.54 91.43 Favored Pre-proline 0 CA--C 1.562 1.406 0 CA-C-O 118.47 -0.776 . . . . 74.33 111.077 175.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.652 ' HA ' HD22 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -49.26 -42.2 40.7 Favored 'Trans proline' 0 C--N 1.396 3.057 0 C-N-CA 122.547 2.165 . . . . 62.22 113.878 166.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -58.01 -36.86 73.29 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 123.547 0.739 . . . . 72.14 111.68 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.402 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 47.3 mt -80.49 -48.3 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 123.591 0.756 . . . . 73.35 111.484 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 93.0 mt -77.38 -21.13 53.67 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.258 0.623 . . . . 74.22 112.167 -169.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -65.5 -47.73 67.77 Favored Pre-proline 0 CA--C 1.562 1.429 0 CA-C-O 117.665 -1.159 . . . . 71.3 113.064 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.402 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 97.2 Cg_exo -49.98 -45.89 30.57 Favored 'Trans proline' 0 C--N 1.389 2.677 0 C-N-CA 122.741 2.294 . . . . 73.01 113.917 172.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.493 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 95.8 m-85 -65.61 -43.45 89.58 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.3 0.64 . . . . 71.25 110.893 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.413 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -66.4 -34.41 77.9 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 115.877 -0.602 . . . . 55.52 110.623 178.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 46.3 ttt180 -59.42 -57.27 13.72 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.152 0.981 . . . . 73.43 110.466 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -63.18 -33.05 74.64 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 123.807 0.692 . . . . 71.01 110.307 -177.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.522 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.6 t -74.03 -36.44 64.43 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.193 -0.458 . . . . 74.42 111.427 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.679 HG21 HG21 ' B' ' 64' ' ' VAL . 81.6 mt -67.83 -51.77 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 109.05 -0.722 . . . . 74.01 109.05 174.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.674 HG23 ' HB2' ' B' ' 125' ' ' GLN . 66.6 m -62.19 -28.33 69.59 Favored 'General case' 0 CA--C 1.558 1.264 0 CA-C-N 114.359 -1.292 . . . . 64.23 111.194 -176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.414 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.8 t -65.3 -46.34 80.77 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 123.344 0.658 . . . . 63.52 109.7 174.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.522 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -71.79 -33.02 68.24 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 122.999 0.52 . . . . 55.12 111.249 -175.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 89.5 t -63.41 -41.61 93.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.246 0 C-N-CA 123.407 0.683 . . . . 73.44 109.909 172.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 30.1 t -68.68 -31.07 69.92 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 115.321 -0.854 . . . . 61.12 111.515 177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.2 mtt-85 -74.53 -32.27 62.41 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.319 0.648 . . . . 43.2 110.227 178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.73 -3.32 83.49 Favored Glycine 0 C--N 1.351 1.381 0 O-C-N 123.443 0.464 . . . . 72.24 112.432 170.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 59.45 51.17 6.8 Favored 'General case' 0 C--N 1.349 0.571 0 C-N-CA 126.424 1.89 . . . . 75.45 111.819 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.85 145.76 40.28 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-N 114.013 -1.449 . . . . 75.05 109.01 170.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -50.16 130.05 27.11 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.31 2.673 . . . . 72.42 112.432 172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.674 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.7 pt20 -65.43 156.94 30.79 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 114.849 -1.069 . . . . 72.13 113.148 -171.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.46 114.05 25.29 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 107.503 -1.295 . . . . 41.35 107.503 170.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 -91.47 108.65 20.04 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 107.959 -1.126 . . . . 45.43 107.959 173.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -63.87 150.2 45.4 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 123.821 0.849 . . . . 70.31 112.326 -175.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -75.22 138.46 71.96 Favored Pre-proline 0 CA--C 1.548 0.875 0 CA-C-N 114.849 -1.069 . . . . 65.3 109.789 174.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.599 ' HG3' HD11 ' D' ' 16' ' ' ILE . 60.5 Cg_endo -71.48 97.22 0.77 Allowed 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 122.499 2.133 . . . . 73.44 110.811 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 61.0 t -89.73 109.34 20.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.261 -1.014 . . . . 65.3 108.261 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.461 ' HB3' ' HB3' ' B' ' 135' ' ' ALA . 9.5 m120 -76.29 87.34 3.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.705 0.802 . . . . 75.34 109.871 177.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -64.51 -37.77 88.69 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.467 -0.568 . . . . 54.43 109.467 171.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.493 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 5.7 p-10 -57.43 -61.49 2.45 Favored 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 124.501 1.12 . . . . 73.23 111.411 176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.461 ' HB3' ' HB3' ' B' ' 132' ' ' ASN . . . -66.51 -34.87 78.89 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.666 0.786 . . . . 75.44 111.83 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 64.2 tp -64.55 -49.55 70.8 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.676 0.791 . . . . 62.21 110.953 177.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -73.72 -15.24 61.22 Favored 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 115.373 -0.831 . . . . 74.02 111.348 -174.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 88.5 mtp -62.25 -35.98 80.61 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 122.983 0.513 . . . . 71.01 110.851 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -75.02 -20.72 59.49 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.371 0.668 . . . . 71.14 111.275 -177.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 83.5 t80 -68.63 -42.56 77.9 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.766 0.826 . . . . 74.13 110.626 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' B' ' 96' ' ' HIS . 1.4 pp -118.89 36.71 4.34 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.741 1.216 . . . . 74.33 110.147 -174.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -58.46 99.72 0.05 Allowed 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.748 0.819 . . . . 54.23 111.541 -173.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.82 116.87 29.26 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.268 1.027 . . . . 74.32 109.321 179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -74.22 120.35 19.67 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.912 0.885 . . . . 74.21 109.962 -179.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -100.29 176.42 5.38 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.777 0.831 . . . . 74.54 110.548 -179.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.32 134.83 13.18 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.981 -0.554 . . . . 62.45 112.149 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -82.03 -61.09 2.01 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.551 0.74 . . . . 71.22 110.117 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.84 -155.29 26.39 Favored Glycine 0 C--N 1.336 0.557 0 CA-C-N 115.583 -0.735 . . . . 64.42 111.336 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 15.0 t -135.27 147.75 49.34 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.353 0.661 . . . . 64.21 109.688 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -128.7 142.26 51.07 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.953 0.901 . . . . 72.22 109.772 -175.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -104.21 97.96 7.84 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 123.907 0.883 . . . . 75.15 109.72 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 61.7 m80 -100.18 101.8 12.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 108.999 -0.741 . . . . 71.41 108.999 176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -66.67 99.91 0.64 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 124.088 0.955 . . . . 60.44 110.68 -178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.77 139.44 58.33 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.259 1.023 . . . . 73.53 111.861 -175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.879 0 C-N-CA 123.875 0.87 . . . . 74.1 109.184 179.394 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 61.6 ttp . . . . . 0 N--CA 1.477 0.916 0 N-CA-C 109.948 -0.39 . . . . 63.32 109.948 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -109.02 71.72 0.78 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.165 0.586 . . . . 42.04 109.952 -175.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -83.07 126.43 32.56 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.447 -0.797 . . . . 62.52 109.606 177.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -58.3 -45.43 88.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.94 0.896 . . . . 73.54 110.301 174.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -153.96 155.24 35.25 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.52 -1.218 . . . . 64.2 109.22 179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -161.27 132.11 5.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 108.733 -0.84 . . . . 75.45 108.733 173.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 20.9 p -108.88 115.54 30.27 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 108.372 -0.973 . . . . 63.51 108.372 171.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -75.78 -21.16 57.67 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.388 0.675 . . . . 71.31 110.978 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.514 ' HG3' HD12 ' C' ' 89' ' ' ILE . 26.9 ttt 64.48 113.99 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.104 1.361 . . . . 70.4 111.512 -177.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 28.1 m -92.35 88.74 6.53 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.573 0.749 . . . . 63.15 109.116 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -119.61 126.55 51.45 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.711 -0.848 . . . . 53.53 108.711 173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -150.75 131.04 13.64 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.872 0.869 . . . . 72.4 108.995 -176.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.418 HD12 ' HD3' ' A' ' 130' ' ' PRO . 0.2 OUTLIER -78.52 132.02 33.22 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 N-CA-C 108.768 -0.827 . . . . 74.34 108.768 174.267 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.434 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 85.6 mm-40 -93.57 -46.04 7.47 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 123.077 0.551 . . . . 63.33 109.553 177.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 27.8 ttt180 -176.31 126.0 0.19 Allowed 'General case' 0 C--N 1.356 0.891 0 O-C-N 124.168 0.917 . . . . 75.23 110.192 -175.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 83.2 mt -108.01 142.99 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 107.636 -1.246 . . . . 75.2 107.636 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.443 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 30.6 p90 -176.79 156.01 1.34 Allowed 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 118.617 0.644 . . . . 74.54 111.806 -177.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.1 p -75.94 121.79 23.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.786 0.834 . . . . 74.32 109.061 174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.531 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 12.6 mmmm -76.15 -47.99 22.23 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 122.305 1.05 . . . . 73.32 108.875 175.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 16.0 t70 -140.59 146.0 37.45 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 113.772 -1.558 . . . . 62.1 109.198 -173.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.596 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 98.7 mt -140.91 144.84 26.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 125.096 1.358 . . . . 63.44 107.482 176.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.2 t -156.22 151.14 26.2 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-O 121.573 0.702 . . . . 73.44 110.433 177.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -148.89 127.58 12.47 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.531 -1.285 . . . . 75.42 107.531 171.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.51 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 42.1 mt-10 -120.84 133.89 55.3 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.789 0.835 . . . . 75.43 109.411 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.53 79.36 24.76 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 108.335 -0.987 . . . . 74.23 108.335 172.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.87 -25.13 12.45 Favored 'Trans proline' 0 C--N 1.382 2.316 0 C-N-CA 122.679 2.253 . . . . 71.14 112.112 179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.441 ' HB3' ' HB3' ' C' ' 30' ' ' HIS . 96.9 m-20 -106.87 34.96 3.18 Favored 'General case' 0 C--O 1.244 0.807 0 C-N-CA 124.444 1.098 . . . . 73.02 109.504 175.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.577 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.38 -55.6 43.58 Favored Pre-proline 0 CA--C 1.561 1.39 0 CA-C-O 118.388 -0.815 . . . . 51.54 112.997 -179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 26.0 Cg_exo -65.53 -30.09 52.3 Favored 'Trans proline' 0 C--N 1.394 2.932 0 CA-C-N 121.421 1.543 . . . . 72.45 112.204 172.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.441 ' HB3' ' HB3' ' C' ' 27' ' ' ASN . 7.1 t60 -62.76 -23.51 67.24 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.784 1.234 . . . . 71.45 112.001 -178.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' C' ' 34' ' ' LYS . 8.8 p -52.67 -25.34 8.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.295 0 N-CA-C 112.828 0.677 . . . . 75.33 112.828 -175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -79.7 -24.56 41.62 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 121.583 -0.698 . . . . 74.2 112.305 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -102.24 17.63 22.92 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 121.274 0.559 . . . . 53.31 110.503 170.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.73 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.0 OUTLIER -84.07 138.26 33.15 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.085 0.954 . . . . 62.25 110.333 176.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -77.04 129.17 35.71 Favored 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.927 -0.768 . . . . 72.51 108.927 170.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.44 ' CD1' ' HA ' ' F' ' 300' ' ' ASN . 29.7 m95 -80.2 77.55 6.92 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.334 0.588 . . . . 75.14 110.667 -174.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.442 ' O ' ' HB3' ' C' ' 68' ' ' LEU . 36.6 tt0 -160.45 63.64 1.98 Allowed Pre-proline 0 CA--C 1.555 1.163 0 CA-C-N 115.048 -0.978 . . . . 64.54 109.293 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -80.72 126.67 6.01 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.216 1.944 . . . . 74.34 111.416 178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -85.88 99.11 11.17 Favored 'General case' 0 C--O 1.241 0.638 0 N-CA-C 106.609 -1.626 . . . . 75.22 106.609 169.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.437 HG11 HD13 ' C' ' 126' ' ' LEU . 43.2 t -73.19 122.93 27.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-N 114.794 -1.094 . . . . 70.12 109.038 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -124.62 112.34 16.69 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.345 1.058 . . . . 63.2 109.254 -171.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 10.4 tt -87.15 145.66 26.34 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.839 0.856 . . . . 62.45 109.156 -179.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 19.5 t70 -132.95 143.63 49.59 Favored 'General case' 0 N--CA 1.468 0.425 0 N-CA-C 107.909 -1.145 . . . . 63.33 107.909 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 51.5 tp -135.08 115.01 12.98 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 109.247 -0.649 . . . . 72.4 109.247 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.535 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 15.0 t70 -111.44 143.39 42.34 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 108.104 -1.072 . . . . 73.1 108.104 175.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 19.8 p -115.05 117.39 30.43 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.728 0.811 . . . . 75.55 110.224 -172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.569 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -112.74 141.98 45.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.872 0.869 . . . . 71.21 108.824 176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 56.4 p -151.32 158.1 43.36 Favored 'General case' 0 C--O 1.243 0.758 0 C-N-CA 123.134 0.574 . . . . 73.32 110.518 -176.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 48.0 t -167.62 131.88 1.81 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 123.858 0.863 . . . . 52.45 109.434 -177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -85.63 117.91 24.81 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.82 -0.807 . . . . 73.44 108.82 171.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.515 HD11 HD12 ' C' ' 83' ' ' ILE . 56.6 mt -86.33 -38.97 16.93 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.022 0.929 . . . . 74.04 111.354 -178.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.34 -171.19 3.08 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.669 -0.696 . . . . 73.53 110.572 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -57.5 110.39 0.86 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 114.983 -1.008 . . . . 75.31 110.104 175.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 70.26 -2.19 2.21 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.927 1.291 . . . . 63.11 112.781 177.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.1 t -94.28 103.77 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.73 0.812 . . . . 71.34 108.859 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -115.48 126.15 53.95 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.084 0.954 . . . . 60.51 109.534 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -84.43 119.26 24.92 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 109.44 -0.578 . . . . 63.15 109.44 171.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.407 HG13 ' CZ ' ' F' ' 281' ' ' PHE . 87.0 t -98.23 128.43 49.7 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 C-N-CA 124.495 1.118 . . . . 74.35 108.244 172.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.569 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 70.2 t -131.7 137.38 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.441 0.696 . . . . 65.24 109.413 176.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.464 HD11 ' HA ' ' C' ' 103' ' ' PRO . 92.9 mt -125.51 112.42 16.2 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.741 0.816 . . . . 75.13 109.917 175.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.535 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 27.4 ttm180 -82.61 105.79 13.93 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 109.024 -0.732 . . . . 75.12 109.024 168.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.658 ' HB ' HD11 ' C' ' 114' ' ' ILE . 9.3 t -101.19 125.36 55.18 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 107.968 -1.123 . . . . 62.12 107.968 171.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 15.5 m -124.41 113.29 17.97 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.795 -0.817 . . . . 73.02 108.795 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.502 HG21 HG21 ' C' ' 114' ' ' ILE . 60.2 t -102.19 114.22 40.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.681 0.792 . . . . 73.03 109.065 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.6 m -102.41 150.71 23.08 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.535 -0.913 . . . . 71.23 108.535 175.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.5 106.09 6.15 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 106.48 -1.674 . . . . 73.31 106.48 169.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -148.39 146.22 28.38 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 122.913 0.485 . . . . 62.45 110.544 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.73 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.3 OUTLIER -110.78 55.79 0.64 Allowed 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.095 0.958 . . . . 71.53 108.544 174.04 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.95 -113.72 4.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 114.48 -1.237 . . . . 40.32 111.131 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -88.36 -17.78 29.83 Favored 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 123.457 0.703 . . . . 74.13 110.301 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -88.96 99.35 12.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 124.072 0.949 . . . . 74.54 109.529 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 52.8 m -85.57 132.78 34.12 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.94 0.496 . . . . 60.45 111.096 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -77.47 -64.25 1.19 Allowed 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.146 0.979 . . . . 63.41 109.591 174.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -163.58 175.67 10.43 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 115.416 -0.811 . . . . 73.43 110.324 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.1 tm? -139.27 144.21 38.29 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 107.901 -1.148 . . . . 74.51 107.901 -178.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.435 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.5 t -143.87 149.13 36.46 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 108.27 -1.011 . . . . 70.11 108.27 176.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -157.25 136.46 11.9 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.922 0.489 . . . . 53.12 110.056 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 93.7 t -138.08 134.79 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 124.237 1.015 . . . . 71.4 108.456 174.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 63.3 mt-30 -110.57 91.22 3.57 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.951 -1.129 . . . . 64.14 107.951 173.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.05 117.43 20.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.626 -0.715 . . . . 71.53 110.55 -176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -98.37 162.52 20.75 Favored Glycine 0 C--N 1.336 0.555 0 O-C-N 123.517 0.51 . . . . 61.24 112.556 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.524 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -166.94 118.19 0.78 Allowed Glycine 0 C--N 1.334 0.468 0 N-CA-C 111.306 -0.718 . . . . 62.44 111.306 178.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.515 HD12 HD11 ' C' ' 51' ' ' LEU . 13.6 mm -83.21 122.73 37.9 Favored 'Isoleucine or valine' 0 C--O 1.241 0.605 0 N-CA-C 108.764 -0.828 . . . . 71.22 108.764 178.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -132.78 132.25 42.03 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.65 0.78 . . . . 73.21 109.417 -178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 47.8 m -94.18 114.36 26.46 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 108.594 -0.891 . . . . 72.04 108.594 169.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 50.8 mt -115.08 119.26 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.554 1.142 . . . . 74.52 107.994 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 171.55 19.83 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.246 1.019 . . . . 63.55 109.923 -175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.78 -34.3 4.59 Favored Glycine 0 C--N 1.343 0.948 0 CA-C-N 116.271 -0.422 . . . . 52.05 112.772 176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.525 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -121.9 165.91 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.986 0.914 . . . . 71.32 110.176 178.603 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -156.46 -179.9 8.61 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.41 0.684 . . . . 61.03 110.42 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' C' ' 94' ' ' MET . . . 68.81 -130.35 25.16 Favored Glycine 0 C--N 1.348 1.198 0 CA-C-N 116.384 -0.371 . . . . 73.01 113.052 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 32.2 p -78.95 -20.72 48.53 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.254 0.622 . . . . 72.43 111.272 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -63.21 -44.52 95.1 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.392 0.677 . . . . 75.15 110.184 175.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.58 ' HG2' HD22 ' F' ' 277' ' ' LEU . 0.0 OUTLIER -76.58 -26.32 54.93 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 116.029 -0.532 . . . . 70.43 110.785 178.6 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.66 -32.13 70.59 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 122.892 0.477 . . . . 75.41 111.087 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.432 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 60.1 t-80 -73.73 -24.3 59.88 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.288 0.635 . . . . 54.45 110.73 175.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -81.67 -58.57 2.95 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.205 0.602 . . . . 54.35 110.324 178.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.33 -48.37 42.52 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.19 1.396 . . . . 72.23 110.826 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.83 11.46 72.05 Favored Glycine 0 C--N 1.342 0.888 0 CA-C-O 119.547 -0.585 . . . . 61.42 114.111 -171.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.432 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -148.61 -59.3 0.23 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 117.554 0.677 . . . . 71.04 112.217 -175.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 81.7 t80 -74.85 -38.88 61.86 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 122.981 0.512 . . . . 75.33 112.243 -173.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 77.2 m -64.9 -45.46 74.41 Favored Pre-proline 0 CA--C 1.557 1.249 0 CA-C-O 118.833 -0.603 . . . . 55.21 111.277 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.464 ' HA ' HD11 ' C' ' 60' ' ' LEU . 69.9 Cg_exo -48.8 -42.8 36.45 Favored 'Trans proline' 0 C--N 1.392 2.861 0 C-N-CA 122.647 2.232 . . . . 73.2 114.457 164.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -60.7 -40.21 91.39 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.784 0.833 . . . . 74.44 110.798 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 47.2 mm -62.11 -48.21 89.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 122.919 0.488 . . . . 75.02 110.72 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.524 HD21 ' HA3' ' C' ' 82' ' ' GLY . 80.3 mt -80.11 -19.57 47.05 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.76 -0.655 . . . . 74.14 112.53 -172.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -58.64 -48.42 96.92 Favored Pre-proline 0 CA--C 1.566 1.593 0 CA-C-O 118.061 -0.971 . . . . 71.04 113.29 -173.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -58.94 -36.64 96.52 Favored 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 122.358 2.039 . . . . 73.45 113.463 175.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -66.69 -45.18 79.68 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.425 0.69 . . . . 75.42 111.146 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -46.77 88.96 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.282 0.633 . . . . 74.12 109.64 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 75.2 ttt-85 -53.7 -49.23 68.49 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.639 1.576 . . . . 72.02 112.091 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.94 -39.01 72.88 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.81 0.694 . . . . 65.53 110.163 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 5.2 t -68.49 -33.6 74.44 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 122.994 0.517 . . . . 65.45 111.274 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.658 HD11 ' HB ' ' C' ' 62' ' ' VAL . 81.3 mt -66.27 -52.29 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.597 0.759 . . . . 72.13 109.53 174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 29.1 m -65.28 -29.08 69.82 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.049 -0.978 . . . . 61.44 110.75 -175.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.4 t -66.84 -43.75 82.85 Favored 'General case' 0 C--N 1.352 0.704 0 C-N-CA 123.694 0.798 . . . . 50.34 109.925 176.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.562 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -66.44 -37.64 85.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.524 0.73 . . . . 74.03 111.646 178.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -65.03 -37.78 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 C-N-CA 123.253 0.621 . . . . 63.13 109.811 173.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.0 t -66.24 -35.9 81.61 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.229 1.012 . . . . 74.12 111.829 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.422 ' NH1' ' HA ' ' D' ' 113' ' ' CYS . 68.4 mtt-85 -74.35 -35.76 63.6 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.614 0.766 . . . . 74.22 110.332 -179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.17 1.14 76.85 Favored Glycine 0 C--N 1.348 1.236 0 O-C-N 123.622 0.576 . . . . 74.13 112.592 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.3 p 61.36 24.05 14.21 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 126.035 1.734 . . . . 61.01 112.656 172.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -90.42 155.24 46.46 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 124.127 0.971 . . . . 73.03 110.03 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_exo -57.08 122.43 11.8 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.058 2.505 . . . . 71.52 112.38 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.13 153.59 25.38 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.311 1.045 . . . . 62.45 112.881 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' F' ' 294' ' ' LYS . 5.1 tt -141.52 114.01 8.27 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 106.68 -1.6 . . . . 75.11 106.68 171.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -90.9 131.73 36.35 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.799 0.84 . . . . 65.43 109.749 -178.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -67.43 141.69 56.92 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.444 0.698 . . . . 70.24 110.964 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.512 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -83.76 148.89 55.65 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 124.025 0.93 . . . . 72.1 110.907 -176.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.542 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.9 Cg_exo -64.52 94.69 0.21 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 123.144 2.563 . . . . 71.23 112.465 -177.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 45.1 t -99.38 106.71 19.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 N-CA-C 107.938 -1.134 . . . . 71.23 107.938 172.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -104.89 102.42 11.96 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.609 -1.256 . . . . 63.35 107.609 173.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -63.06 -42.3 99.65 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.454 0.645 . . . . 61.24 109.308 179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -62.67 -49.01 76.83 Favored 'General case' 0 N--CA 1.474 0.725 0 C-N-CA 125.195 1.398 . . . . 73.2 112.382 179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -73.26 -23.15 60.29 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.328 0.651 . . . . 52.14 111.133 -177.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.8 tt -69.61 -40.02 76.89 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.552 0.741 . . . . 74.31 109.374 175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 19.9 m-30 -64.27 -34.78 78.91 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.928 0.491 . . . . 65.51 110.973 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 91.0 mtp -77.51 -30.82 53.13 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.686 0.795 . . . . 71.42 111.204 176.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -65.69 -36.17 82.85 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 124.811 1.244 . . . . 53.33 111.555 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -42.36 -84.72 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.394 0 C-N-CA 125.304 1.442 . . . . 71.14 112.956 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 5.1 tt -81.94 115.24 21.03 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 109.161 -0.681 . . . . 73.22 109.161 -175.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -147.28 90.76 1.91 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.594 1.158 . . . . 51.04 109.016 175.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -73.03 160.63 31.77 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.04 0.536 . . . . 63.21 109.588 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.497 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 0.6 OUTLIER -115.15 93.28 4.23 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 108.859 -0.793 . . . . 74.03 108.859 178.09 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -174.9 104.63 0.09 Allowed 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.821 1.249 . . . . 61.01 109.218 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 158.96 161.3 11.0 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 116.562 -0.29 . . . . 34.42 112.44 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -113.4 -52.37 2.76 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.167 0.987 . . . . 74.1 109.186 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 124.36 175.55 14.38 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 115.27 -0.877 . . . . 73.04 111.824 179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 95.2 m -68.96 -51.83 35.45 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.095 -0.705 . . . . 65.41 109.095 169.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 58.7 103.0 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.113 1.365 . . . . 70.31 112.519 176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.49 140.49 4.98 Favored 'General case' 0 C--O 1.241 0.628 0 N-CA-C 107.223 -1.399 . . . . 74.23 107.223 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 15.8 p80 -63.31 128.69 36.98 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 122.921 0.488 . . . . 54.44 110.526 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -79.81 97.67 6.74 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-O 121.983 0.897 . . . . 62.4 109.752 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -131.07 31.72 4.4 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.293 1.037 . . . . 61.55 109.557 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.2 0 C-N-CA 123.671 0.788 . . . . 71.42 110.14 179.89 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.488 1.453 0 CA-C-O 120.734 0.302 . . . . 75.11 110.761 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 82.1 p -162.1 171.17 17.91 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.055 0.942 . . . . 53.12 109.665 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -92.04 64.69 4.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.58 0.705 . . . . 45.0 109.528 177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -89.14 97.95 11.49 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.49 -1.3 . . . . 74.34 107.49 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -141.31 94.44 2.7 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 108.473 -0.936 . . . . 73.34 108.473 -178.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -148.92 -174.69 4.7 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 124.174 0.99 . . . . 64.11 108.367 -178.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -51.43 100.82 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 CA-C-O 121.766 0.793 . . . . 74.44 111.136 170.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -83.08 -174.76 5.48 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.04 -0.982 . . . . 74.52 111.422 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 1.4 ptm -30.13 145.32 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 125.422 1.489 . . . . 72.02 113.407 165.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.5 m -105.09 143.88 32.66 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.14 0.495 . . . . 64.4 110.299 -176.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 31.3 t80 -159.88 90.62 0.92 Allowed 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.629 -1.619 . . . . 62.31 106.629 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -111.85 114.97 28.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.066 -1.087 . . . . 70.24 108.066 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.505 ' O ' ' HB ' ' F' ' 306' ' ' VAL . 14.5 mt -77.13 104.5 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 108.203 -1.036 . . . . 72.21 108.203 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -71.96 -45.48 60.9 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 109.769 -0.456 . . . . 75.43 109.769 -170.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.489 ' HA ' ' HE ' ' D' ' 15' ' ' ARG . 3.4 mmp_? -157.66 147.75 20.54 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.374 1.07 . . . . 73.21 110.138 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.599 HD11 ' HG3' ' B' ' 130' ' ' PRO . 2.7 mp -120.04 113.38 40.41 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 106.496 -1.668 . . . . 74.54 106.496 175.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.577 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 42.0 p90 -145.93 150.73 36.62 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.759 0.79 . . . . 63.34 111.282 -174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -81.38 115.28 20.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.897 -1.047 . . . . 43.45 109.549 177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -82.53 -33.14 28.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.424 0.631 . . . . 74.22 109.885 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.592 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 6.5 t70 -144.26 137.2 27.11 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 114.483 -1.235 . . . . 51.24 109.524 177.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.562 HD13 ' HE3' ' C' ' 117' ' ' MET . 93.3 mt -132.05 140.52 47.72 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 124.68 1.192 . . . . 73.21 107.885 173.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.407 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 38.6 t -142.34 133.74 26.44 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.562 1.145 . . . . 73.32 108.053 176.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.596 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 85.1 t80 -147.91 124.7 11.2 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.754 -1.573 . . . . 73.21 106.754 169.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -129.19 137.09 50.94 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 124.488 1.115 . . . . 74.01 108.898 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.11 85.36 59.81 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.703 -1.591 . . . . 53.22 106.703 172.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.39 -61.59 0.11 Allowed 'Trans proline' 0 C--N 1.381 2.247 0 C-N-CA 122.901 2.401 . . . . 74.02 112.547 -172.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -94.76 41.83 1.09 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.0 -1.111 . . . . 72.32 108.0 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.531 ' HB3' ' HE3' ' C' ' 19' ' ' LYS . . . -49.07 -59.72 5.93 Favored Pre-proline 0 CA--C 1.566 1.589 0 N-CA-C 114.389 1.255 . . . . 53.4 114.389 -167.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -78.54 -12.86 15.13 Favored 'Trans proline' 0 C--N 1.385 2.462 0 CA-C-N 121.727 1.652 . . . . 54.01 112.772 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.409 ' HA ' HE21 ' D' ' 33' ' ' GLN . 8.1 t-160 -75.2 -41.4 57.88 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.122 1.369 . . . . 62.32 109.597 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 41.8 t -62.06 -40.69 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 114.746 -1.116 . . . . 64.44 110.471 178.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.588 ' HA ' HG21 ' G' ' 301' ' ' ILE . 20.9 m-85 -67.68 -18.37 64.91 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.146 -0.933 . . . . 71.22 113.064 -174.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' D' ' 30' ' ' HIS . 45.0 mt-30 -78.79 -14.65 59.15 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 123.386 0.674 . . . . 71.35 112.222 178.171 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -109.04 114.51 28.31 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.06 0.944 . . . . 61.11 108.593 179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -88.14 96.17 10.43 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 112.627 0.603 . . . . 64.4 112.627 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.475 ' CZ3' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -169.42 -174.26 1.89 Allowed 'General case' 0 N--CA 1.504 2.249 0 N-CA-C 113.097 0.777 . . . . 73.04 113.097 171.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.41 ' HG2' ' H ' ' G' ' 298' ' ' HIS . 12.0 mt-30 -92.1 126.5 52.9 Favored Pre-proline 0 N--CA 1.485 1.277 0 C-N-CA 125.05 1.34 . . . . 72.03 111.509 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.588 ' HB3' HD23 ' D' ' 68' ' ' LEU . 56.0 Cg_endo -75.31 150.59 37.09 Favored 'Trans proline' 0 C--N 1.378 2.098 0 C-N-CA 122.928 2.419 . . . . 74.2 113.783 172.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -83.21 135.59 34.72 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.504 1.122 . . . . 65.22 108.392 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 67.8 t -118.82 138.82 48.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 123.381 0.672 . . . . 54.33 109.262 -177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 47.9 tttm -125.81 121.26 32.78 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 124.186 0.994 . . . . 73.43 108.653 -172.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.47 HD11 HD11 ' D' ' 128' ' ' LEU . 0.4 OUTLIER -97.62 112.68 24.45 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.586 0.754 . . . . 41.45 109.062 -172.524 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.609 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.9 m-20 -111.75 127.8 55.9 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.277 1.031 . . . . 74.23 108.848 177.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.9 mp -115.17 140.02 49.43 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.376 0.67 . . . . 75.32 109.431 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 26.6 t70 -142.0 136.47 30.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.107 0.963 . . . . 74.31 108.723 175.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 48.1 p -105.47 143.9 32.99 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 123.461 0.704 . . . . 70.42 110.193 -176.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.55 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.69 159.02 44.16 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.694 0.798 . . . . 23.23 109.772 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 53.2 p -168.27 166.68 12.53 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.119 0.568 . . . . 64.04 111.166 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 89.1 p -158.84 145.56 17.17 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.368 1.067 . . . . 62.35 109.107 176.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.0 tt0 -87.0 117.71 25.9 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 108.942 -0.762 . . . . 71.23 108.942 171.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.457 HD11 ' HB2' ' D' ' 57' ' ' GLU . 31.5 mt -92.85 -24.78 18.37 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.598 0.359 . . . . 53.34 110.281 178.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.87 -178.84 3.05 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.125 0.97 . . . . 74.35 110.608 177.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -64.56 118.92 9.54 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 114.914 -1.039 . . . . 74.24 108.937 172.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 70.07 5.17 5.16 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.696 1.198 . . . . 64.45 112.088 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 50.1 t -119.26 114.91 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 N-CA-C 108.767 -0.827 . . . . 70.41 108.767 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 15.2 m-85 -132.59 129.8 39.45 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 124.356 1.062 . . . . 63.11 108.883 -174.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.457 ' HB2' HD11 ' D' ' 51' ' ' LEU . 23.4 tt0 -88.42 124.79 34.31 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.428 -0.953 . . . . 74.03 108.428 170.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.495 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 47.4 t -108.77 122.99 64.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 107.039 -1.467 . . . . 62.13 107.039 173.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 23.3 t -106.28 128.45 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.724 -0.843 . . . . 65.42 108.724 177.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.64 HD23 HD12 ' D' ' 106' ' ' LEU . 4.1 mm? -112.06 114.21 26.94 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 109.677 -0.49 . . . . 74.3 109.677 173.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.6 ttm180 -86.93 106.08 17.54 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.633 -0.712 . . . . 73.11 109.152 172.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 70.8 t -96.95 127.73 48.85 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.895 -1.15 . . . . 70.51 107.895 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.609 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 39.6 m -125.66 130.13 50.96 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.382 -0.826 . . . . 61.51 108.793 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 94.2 t -120.42 121.27 65.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 124.785 1.234 . . . . 61.35 108.474 -178.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 87.6 m -120.63 100.43 7.12 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.054 0.942 . . . . 74.34 109.099 -170.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.15 137.47 37.63 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.187 -0.46 . . . . 65.22 110.098 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 53.4 p -150.47 140.12 21.65 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.603 0.761 . . . . 71.14 109.598 174.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.652 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -136.22 136.4 39.88 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.501 1.12 . . . . 75.12 110.135 -174.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 71.42 -111.67 3.78 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 111.337 -0.705 . . . . 73.54 111.337 -176.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.52 4.2 8.99 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.703 0.801 . . . . 74.12 110.346 175.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -120.63 166.85 13.1 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.15 0.58 . . . . 72.13 110.821 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 87.1 m -80.97 139.14 35.99 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 115.821 -0.627 . . . . 63.33 110.483 177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.652 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -80.56 -72.02 0.43 Allowed 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.027 -1.101 . . . . 75.44 108.027 172.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -152.45 146.46 25.31 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.17 -0.923 . . . . 63.21 108.928 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 86.1 mt -110.34 130.06 55.63 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 107.57 -1.271 . . . . 74.11 107.57 171.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.554 ' SG ' HG12 ' D' ' 114' ' ' ILE . 34.4 t -138.29 135.58 35.6 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.871 -0.789 . . . . 72.31 108.871 -175.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.407 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 41.9 tt0 -154.59 121.8 5.64 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.085 0.554 . . . . 63.33 110.065 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.7 t -130.21 118.11 42.51 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.068 -0.715 . . . . 75.14 109.068 -178.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.592 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 48.6 mt-30 -87.8 86.78 7.21 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.612 -1.255 . . . . 63.44 107.612 169.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -78.98 97.38 6.04 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 114.184 -1.371 . . . . 64.32 108.565 -178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.52 144.0 18.82 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.453 -0.659 . . . . 53.14 111.453 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -140.13 130.28 4.58 Favored Glycine 0 CA--C 1.504 -0.622 0 N-CA-C 109.826 -1.31 . . . . 71.44 109.826 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 63.7 mt -88.75 130.23 38.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 107.834 -1.173 . . . . 63.3 107.834 176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.495 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 42.3 m-85 -129.0 136.16 49.94 Favored 'General case' 0 CA--C 1.537 0.452 0 O-C-N 123.483 0.49 . . . . 64.02 109.98 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.9 m -86.52 93.32 9.13 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.924 -1.139 . . . . 74.02 107.924 167.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 14.9 mt -106.58 114.05 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 109.437 -0.579 . . . . 73.43 109.437 -172.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -144.4 163.0 35.06 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 123.915 0.886 . . . . 63.32 109.679 -176.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 88.63 -6.3 83.76 Favored Glycine 0 C--N 1.342 0.865 0 CA-C-O 119.508 -0.607 . . . . 51.2 114.568 174.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 21.9 pt -129.11 147.97 33.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 117.639 0.719 . . . . 73.42 111.716 -175.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.92 173.57 13.18 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.823 1.249 . . . . 53.12 109.426 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.24 -127.28 43.08 Favored Glycine 0 N--CA 1.474 1.189 0 N-CA-C 115.258 0.863 . . . . 74.42 115.258 173.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 90.1 m -66.23 -38.46 87.95 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.68 1.192 . . . . 74.14 111.642 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.6 tp60 -69.2 -36.77 77.63 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.881 0.873 . . . . 75.13 110.75 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.683 ' SD ' HD23 ' D' ' 98' ' ' LEU . 0.0 OUTLIER -72.12 -42.52 65.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 109.508 -0.553 . . . . 72.11 109.508 176.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -58.34 -43.82 88.46 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.588 0.755 . . . . 64.22 110.805 178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 15.0 t-80 -64.91 -36.55 84.75 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.158 -0.928 . . . . 71.42 110.669 178.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 54.0 t -68.03 -50.53 54.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 122.513 0.325 . . . . 74.44 111.236 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.683 HD23 ' SD ' ' D' ' 94' ' ' MET . 4.6 pp -71.18 -30.3 66.25 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 122.9 0.48 . . . . 74.31 111.305 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.24 7.5 56.66 Favored Glycine 0 C--N 1.348 1.199 0 CA-C-O 119.61 -0.55 . . . . 75.0 114.06 -173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -148.05 -57.82 0.24 Allowed 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 117.465 0.633 . . . . 54.25 111.762 -179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -70.62 -52.94 18.02 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.211 0.604 . . . . 75.21 111.238 -171.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.436 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 34.0 m -60.58 -45.7 97.2 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.873 0.869 . . . . 34.45 112.127 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.436 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 75.0 Cg_exo -53.93 -45.59 39.9 Favored 'Trans proline' 0 C--N 1.396 3.033 0 C-N-CA 122.747 2.298 . . . . 72.2 113.156 168.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -63.03 -26.31 68.79 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.559 0.743 . . . . 71.12 111.725 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.0 mm -73.51 -49.49 36.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 123.373 0.669 . . . . 61.24 110.962 176.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.64 HD12 HD23 ' D' ' 60' ' ' LEU . 83.2 mt -87.13 -13.95 42.66 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.13 0.572 . . . . 73.41 112.46 -170.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 45.8 t80 -67.51 -45.69 47.29 Favored Pre-proline 0 CA--C 1.559 1.326 0 CA-C-O 118.188 -0.91 . . . . 72.31 112.328 -176.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -57.79 -33.43 96.87 Favored 'Trans proline' 0 C--N 1.39 2.712 0 C-N-CA 122.21 1.94 . . . . 72.35 113.408 173.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -78.96 -34.96 43.87 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.533 0.733 . . . . 73.33 112.227 -179.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.56 -50.05 68.81 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 108.933 -0.766 . . . . 74.12 108.933 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.2 ttp180 -54.18 -48.01 71.4 Favored 'General case' 0 C--O 1.213 -0.829 0 O-C-N 124.991 1.432 . . . . 71.43 110.574 178.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -61.34 -50.1 74.29 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 124.169 0.918 . . . . 74.13 110.911 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.422 ' HA ' ' NH1' ' C' ' 120' ' ' ARG . 44.6 t -55.32 -43.29 74.76 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 123.973 0.795 . . . . 73.51 110.913 -179.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.554 HG12 ' SG ' ' D' ' 76' ' ' CYS . 86.1 mt -65.8 -51.91 56.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 O-C-N 124.355 1.034 . . . . 50.0 110.624 177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.458 HG23 ' HB2' ' D' ' 125' ' ' GLN . 68.9 m -51.03 -44.45 61.04 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.986 1.315 . . . . 72.54 111.658 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -69.41 -45.61 68.8 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 114.849 -1.069 . . . . 72.44 110.812 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.98 -36.96 85.26 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 122.741 0.416 . . . . 65.03 111.981 -179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.473 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.2 t -66.79 -44.33 89.29 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.012 0 CA-C-N 115.097 -0.956 . . . . 70.31 109.998 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 85.0 p -69.73 -27.31 64.86 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 122.817 0.447 . . . . 73.15 111.414 177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 75.2 mtt-85 -73.21 -29.72 63.0 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.588 0.755 . . . . 73.42 110.205 175.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.89 11.48 66.69 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-N 115.69 -0.686 . . . . 43.11 112.438 175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.428 HG23 ' HB3' ' C' ' 17' ' ' TYR . 59.9 p 57.87 14.11 2.41 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.725 2.01 . . . . 74.23 113.518 -177.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -82.02 162.91 55.55 Favored Pre-proline 0 CA--C 1.56 1.342 0 C-N-CA 124.482 1.113 . . . . 43.35 108.342 169.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.6 ' HG2' HG22 ' G' ' 296' ' ' THR . 90.1 Cg_endo -75.32 127.02 10.15 Favored 'Trans proline' 0 C--N 1.371 1.725 0 C-N-CA 122.212 1.941 . . . . 74.43 111.41 -174.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.458 ' HB2' HG23 ' D' ' 115' ' ' THR . 0.0 OUTLIER -54.12 142.8 24.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.319 0.648 . . . . 64.11 111.291 -176.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -104.89 103.79 13.44 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.021 -0.733 . . . . 55.13 109.021 -161.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -97.05 91.92 5.81 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 107.98 -1.118 . . . . 74.41 107.98 178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.47 HD11 HD11 ' D' ' 42' ' ' LEU . 0.1 OUTLIER -73.82 126.81 31.23 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 108.453 -0.943 . . . . 64.13 108.453 178.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.17 141.52 95.95 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 123.6 0.76 . . . . 64.45 111.374 176.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -61.31 122.8 11.65 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.408 2.072 . . . . 60.22 111.261 176.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -107.17 117.9 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 108.217 -1.031 . . . . 71.42 108.217 -178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -72.09 84.29 1.0 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.448 0.699 . . . . 72.5 109.686 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -62.6 -29.76 70.84 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.654 0.782 . . . . 74.52 110.903 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -60.44 -59.62 5.11 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 123.841 0.857 . . . . 72.43 111.233 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.99 -37.91 84.17 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.559 0.744 . . . . 73.43 111.969 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 86.2 mt -69.97 -41.76 74.06 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 115.342 -0.844 . . . . 65.22 111.75 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.414 ' O ' ' HB3' ' D' ' 140' ' ' TYR . 64.6 t80 -75.04 -40.58 60.32 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.884 0.474 . . . . 74.31 111.199 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 51.1 mtm -63.08 -38.97 93.3 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 122.832 0.453 . . . . 73.55 110.395 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 18.8 t-20 -69.58 -27.63 65.28 Favored 'General case' 0 CA--C 1.549 0.933 0 CA-C-N 115.618 -0.719 . . . . 74.35 110.745 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.414 ' HB3' ' O ' ' D' ' 137' ' ' PHE . 45.1 t80 -60.26 -33.71 72.7 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 123.438 0.695 . . . . 72.4 111.708 176.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.6 mp -62.32 -34.66 77.06 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.294 0.638 . . . . 62.21 111.754 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -91.96 21.85 4.68 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 122.707 0.403 . . . . 75.11 112.07 177.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 89.0 mt-30 -120.39 88.5 2.95 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.48 0.712 . . . . 73.0 109.524 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -172.3 66.53 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.945 0.898 . . . . 63.31 109.149 -178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.76 -40.16 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.768 -0.651 . . . . 72.54 111.347 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -74.59 -79.66 0.55 Allowed Glycine 0 C--N 1.342 0.907 0 N-CA-C 112.213 -0.355 . . . . 41.12 112.213 -177.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.3 -177.43 6.44 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.849 0.86 . . . . 72.15 110.558 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 140.44 137.23 3.43 Favored Glycine 0 C--N 1.344 1.001 0 N-CA-C 111.62 -0.592 . . . . 72.42 111.62 177.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.9 t -131.86 142.1 49.59 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 121.737 0.78 . . . . 61.45 111.307 -177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -129.18 74.61 1.59 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.861 1.265 . . . . 71.34 107.714 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.84 -87.14 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 115.092 -0.958 . . . . 74.45 110.848 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 m170 65.08 120.54 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 124.708 1.203 . . . . 71.02 112.899 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -121.26 159.6 25.63 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.035 0.934 . . . . 73.43 110.669 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -74.07 137.51 43.39 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.663 -0.699 . . . . 62.22 110.124 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.967 0 N-CA-C 108.81 -0.811 . . . . 73.21 108.81 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 110.348 -0.241 . . . . 41.51 110.348 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -94.35 103.62 15.62 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 108.714 -0.846 . . . . 73.13 108.714 173.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -75.58 162.81 27.96 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.115 0.484 . . . . 64.52 110.107 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -95.98 14.01 25.07 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.939 0.896 . . . . 74.44 111.079 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 11.4 mptt 57.22 80.91 0.27 Allowed Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 125.385 1.474 . . . . 73.55 112.502 175.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -86.8 27.54 0.57 Allowed 'Trans proline' 0 C--N 1.373 1.828 0 C-N-CA 123.082 2.522 . . . . 73.51 111.896 169.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 5.7 mp -79.59 76.13 6.22 Favored 'General case' 0 C--O 1.242 0.664 0 N-CA-C 108.394 -0.965 . . . . 61.54 108.394 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 176.2 143.54 0.07 Allowed 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 107.137 -1.431 . . . . 71.11 107.137 179.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . 177.31 -120.01 0.71 Allowed Glycine 0 C--N 1.343 0.949 0 C-N-CA 121.546 -0.359 . . . . 51.31 112.947 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.649 ' H ' HD23 ' E' ' 280' ' ' LEU . 1.5 pt? -64.87 86.26 0.05 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.667 1.187 . . . . 72.13 111.981 -176.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 67.5 t80 179.03 -26.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.094 1.358 . . . . 71.45 109.608 -178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -71.74 -1.48 14.1 Favored 'General case' 0 CA--C 1.558 1.26 0 CA-C-O 121.486 0.66 . . . . 74.11 110.711 168.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -137.56 -168.66 2.36 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.536 1.934 . . . . 73.12 108.069 174.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 85.84 72.77 1.29 Allowed Glycine 0 C--N 1.343 0.946 0 CA-C-O 120.964 0.202 . . . . 74.33 113.053 172.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -69.82 99.76 1.43 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.811 0.845 . . . . 70.31 109.419 173.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 85.6 mtp -70.41 117.1 51.73 Favored Pre-proline 0 CA--C 1.551 0.983 0 C-N-CA 123.485 0.714 . . . . 74.45 110.305 -178.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -73.83 90.58 0.94 Allowed 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 122.985 2.457 . . . . 62.34 110.815 178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 40.9 t -114.4 107.07 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 107.947 -1.131 . . . . 71.2 107.947 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.01 160.46 14.3 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.015 0.926 . . . . 73.03 110.631 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . 0.434 ' CD1' ' HB2' ' A' ' 42' ' ' LEU . 93.8 m95 -72.46 144.37 48.11 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 115.691 -0.686 . . . . 74.54 109.621 168.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.476 HD22 ' H ' ' E' ' 291' ' ' LEU . 0.0 OUTLIER -109.14 -11.22 14.95 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 124.7 1.2 . . . . 73.33 110.672 -177.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -149.47 72.34 0.3 Allowed Glycine 0 C--N 1.349 1.251 0 N-CA-C 111.277 -0.729 . . . . 74.44 111.277 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -74.62 175.48 11.04 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 123.291 2.661 . . . . 44.11 112.848 178.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 4.0 tmtp? 77.8 -29.45 0.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.424 1.489 . . . . 75.34 111.191 178.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -66.2 170.86 5.27 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.91 0.884 . . . . 72.23 111.599 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 5.1 m 70.75 21.35 5.26 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.208 1.003 . . . . 74.34 110.751 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.487 ' HE2' HD21 ' A' ' 68' ' ' LEU . 11.0 t80 -168.69 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.125 0.488 . . . . 72.3 110.959 -175.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -92.36 -2.57 56.28 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 122.87 0.468 . . . . 72.52 110.796 177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.14 130.51 9.87 Favored Glycine 0 C--N 1.345 1.073 0 CA-C-O 119.817 -0.435 . . . . 72.43 112.743 -178.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . 0.419 ' HA ' ' CZ2' ' A' ' 36' ' ' TRP . 4.4 m-20 -72.78 85.14 1.22 Allowed 'General case' 0 C--N 1.355 0.83 0 C-N-CA 123.062 0.545 . . . . 75.14 110.225 174.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 14.0 pt -78.56 79.48 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 CA-C-O 122.291 1.043 . . . . 60.14 109.041 175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' G' ' 298' ' ' HIS . 12.6 t70 -118.73 -155.65 0.61 Allowed 'General case' 0 CA--C 1.556 1.205 0 CA-C-N 114.211 -1.359 . . . . 61.24 108.635 -169.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . 0.485 ' HE3' ' N ' ' E' ' 303' ' ' LYS . 0.6 OUTLIER -73.11 142.4 82.39 Favored Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 123.332 0.653 . . . . 62.22 110.459 -178.473 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -84.89 -165.21 0.28 Allowed 'Trans proline' 0 C--N 1.371 1.726 0 C-N-CA 123.292 2.662 . . . . 70.22 111.685 174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -89.9 25.81 1.99 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.606 0.763 . . . . 73.53 112.309 -176.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 21.8 m -69.68 147.11 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.975 0 C-N-CA 123.13 0.572 . . . . 61.14 109.694 170.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 5.0 t -154.58 -48.71 0.09 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 122.667 0.387 . . . . 63.33 110.974 -173.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 79.2 m -155.09 119.26 4.66 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.879 0.872 . . . . 75.41 108.989 -178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 29.6 m -145.03 116.07 5.15 Favored Pre-proline 0 CA--C 1.547 0.856 0 N-CA-C 108.377 -0.971 . . . . 64.35 108.377 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo . . . . . 0 C--N 1.38 2.2 0 C-N-CA 123.307 2.671 . . . . 74.51 112.367 179.876 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 108.578 -0.897 . . . . 64.31 108.578 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -137.38 -66.68 0.5 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.783 0.833 . . . . 74.44 109.644 -172.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 82.1 mm-40 53.01 -107.95 0.38 Allowed 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 123.994 0.918 . . . . 55.14 109.522 -166.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -171.27 110.08 0.31 Allowed 'General case' 0 C--N 1.351 0.659 0 N-CA-C 107.557 -1.275 . . . . 63.23 107.557 168.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -139.83 115.74 8.08 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 107.763 -1.199 . . . . 64.34 107.763 172.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.83 94.75 0.09 OUTLIER 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.756 2.304 . . . . 63.33 111.833 178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . 0.58 HD22 ' HG2' ' C' ' 94' ' ' MET . 51.4 mt -78.41 75.75 4.92 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.933 0.873 . . . . 54.13 108.756 177.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -154.66 89.93 1.28 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 106.467 -1.679 . . . . 74.21 106.467 -175.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -128.14 -59.79 0.12 Allowed Glycine 0 N--CA 1.471 0.998 0 N-CA-C 111.152 -0.779 . . . . 65.2 111.152 -176.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -107.4 116.32 31.72 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 107.473 -1.306 . . . . 73.15 107.473 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . 0.407 ' CZ ' HG13 ' C' ' 58' ' ' VAL . 61.9 t80 -164.46 -54.57 0.03 OUTLIER 'General case' 0 C--O 1.239 0.548 0 O-C-N 123.669 0.606 . . . . 71.14 110.495 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.75 -74.01 0.06 Allowed 'General case' 0 CA--C 1.541 0.63 0 O-C-N 124.486 1.117 . . . . 73.1 111.999 -170.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -171.39 170.42 5.9 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.343 0.657 . . . . 74.13 110.714 -177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 176.13 -63.25 0.1 OUTLIER Glycine 0 C--N 1.337 0.607 0 N-CA-C 109.603 -1.399 . . . . 55.43 109.603 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -175.25 108.19 0.1 Allowed 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.514 1.126 . . . . 72.33 108.882 177.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 14.9 tpt -148.24 113.74 3.85 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 123.141 0.577 . . . . 64.34 109.468 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -76.83 83.76 2.04 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 122.812 2.342 . . . . 62.14 112.78 -179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 66.4 t -141.14 99.72 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 N-CA-C 108.605 -0.887 . . . . 70.5 108.605 174.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 5.2 mpt_? -117.75 -71.08 0.75 Allowed 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 108.006 -1.109 . . . . 73.42 108.006 172.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 27.6 m95 -147.3 130.0 16.04 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.691 0.796 . . . . 63.54 110.305 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.512 HD13 ' HB3' ' C' ' 129' ' ' ALA . 4.7 mp -79.75 79.91 6.2 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.314 1.009 . . . . 64.22 108.857 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 90.09 132.66 4.98 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 119.116 -0.824 . . . . 62.32 111.562 -172.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -63.16 122.9 11.28 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.581 2.187 . . . . 73.42 111.201 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' C' ' 126' ' ' LEU . 0.1 OUTLIER -141.16 161.9 36.76 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.553 0.741 . . . . 71.13 110.957 -174.227 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -132.03 144.9 51.09 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.097 -0.956 . . . . 55.4 109.724 -176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 35.4 p -70.73 -52.84 18.23 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 123.534 0.521 . . . . 64.54 110.002 176.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -73.42 89.86 1.66 Allowed 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 109.024 -0.732 . . . . 75.21 109.024 177.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 65.6 t-80 -83.55 66.08 8.76 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.287 1.035 . . . . 64.42 109.103 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 101.09 -162.35 18.25 Favored Glycine 0 C--N 1.347 1.157 0 CA-C-N 115.61 -0.723 . . . . 35.23 112.413 -175.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . 0.44 ' HA ' ' CD1' ' C' ' 36' ' ' TRP . 2.2 m-20 -80.07 98.35 7.22 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.652 0.781 . . . . 75.14 110.135 -176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 12.4 pt -81.68 -5.55 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 112.634 0.605 . . . . 64.21 112.634 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -40.96 115.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.097 1.759 . . . . 74.33 113.855 -165.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -158.09 116.14 1.82 Allowed Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 123.629 0.771 . . . . 41.2 109.913 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.91 -12.44 17.87 Favored 'Trans proline' 0 C--N 1.367 1.509 0 C-N-CA 122.591 2.194 . . . . 55.15 110.673 161.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 65.52 -87.8 0.03 OUTLIER 'General case' 0 C--N 1.359 1.017 0 C-N-CA 125.691 1.597 . . . . 62.25 112.279 173.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . 0.532 HG21 ' HD2' ' B' ' 130' ' ' PRO . 16.4 t -96.49 60.59 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 123.064 1.412 . . . . 71.11 109.645 -172.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 12.7 t -117.29 -10.82 10.7 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 113.384 -1.735 . . . . 75.22 108.446 165.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 25.4 t -135.57 87.4 2.32 Favored 'General case' 0 C--N 1.348 0.529 0 C-N-CA 124.984 1.313 . . . . 74.4 107.627 -178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . 0.459 ' HB ' ' HD3' ' F' ' 310' ' ' PRO . 97.5 m -155.64 -52.63 0.02 OUTLIER Pre-proline 0 CA--C 1.562 1.439 0 C-N-CA 124.655 1.182 . . . . 71.35 110.24 -175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . 0.459 ' HD3' ' HB ' ' F' ' 309' ' ' THR . 6.4 Cg_exo . . . . . 0 C--N 1.403 3.4 0 C-N-CA 122.116 1.877 . . . . 54.44 111.535 178.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.903 -0.406 . . . . 43.42 109.903 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -74.38 83.57 1.94 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.585 0.754 . . . . 62.23 110.084 176.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -108.54 76.87 1.05 Allowed 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.672 -1.232 . . . . 44.33 107.672 177.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -105.1 23.63 13.31 Favored 'General case' 0 CA--C 1.549 0.905 0 CA-C-N 114.944 -1.025 . . . . 74.24 110.457 -172.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -60.83 126.69 86.06 Favored Pre-proline 0 N--CA 1.482 1.139 0 N-CA-C 108.058 -1.09 . . . . 65.01 108.058 174.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.06 -49.6 14.91 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.782 2.322 . . . . 71.24 111.967 -172.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.416 HD23 ' N ' ' G' ' 278' ' ' LEU . 8.2 tt -178.05 153.83 0.83 Allowed 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.044 -1.465 . . . . 65.21 107.044 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . 0.56 HD22 HD22 ' D' ' 98' ' ' LEU . 0.2 OUTLIER 74.85 125.12 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 124.758 1.223 . . . . 73.44 109.812 179.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.88 -99.44 0.21 Allowed Glycine 0 C--N 1.346 1.108 0 N-CA-C 111.435 -0.666 . . . . 75.1 111.435 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -71.84 96.6 1.68 Allowed 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.845 -1.169 . . . . 74.25 107.845 177.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -137.53 90.84 2.54 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.512 0.672 . . . . 74.01 109.292 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -161.12 -172.13 3.32 Favored 'General case' 0 C--O 1.244 0.805 0 CA-C-N 114.305 -1.316 . . . . 54.24 108.615 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -71.71 94.58 1.38 Allowed 'General case' 0 CA--C 1.548 0.866 0 CA-C-O 121.497 0.665 . . . . 72.42 109.342 173.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -74.05 -110.35 0.08 OUTLIER Glycine 0 C--N 1.352 1.469 0 CA-C-N 115.515 -0.766 . . . . 63.41 111.412 177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -93.88 98.28 10.95 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 107.936 -1.135 . . . . 64.4 107.936 168.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 18.8 mmt -114.86 86.84 13.86 Favored Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 123.754 0.822 . . . . 74.31 109.264 178.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -91.46 27.99 0.4 Allowed 'Trans proline' 0 C--N 1.375 1.971 0 C-N-CA 123.046 2.497 . . . . 54.15 111.335 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 29.2 t -76.65 82.54 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 N-CA-C 108.886 -0.783 . . . . 63.34 108.886 -178.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 26.6 mmt180 -98.51 19.2 14.96 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 114.961 -1.018 . . . . 72.54 110.761 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 43.6 m95 70.64 153.89 0.12 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.266 1.426 . . . . 73.41 112.446 -170.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.2 9.36 21.81 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 114.574 -1.193 . . . . 71.43 110.013 -178.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 120.95 88.37 1.01 Allowed Glycine 0 C--N 1.353 1.491 0 N-CA-C 111.374 -0.69 . . . . 62.43 111.374 -178.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -98.91 11.87 0.72 Allowed 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.627 2.885 . . . . 71.14 113.531 172.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -89.52 49.16 1.7 Allowed 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.982 0.513 . . . . 73.52 112.154 -174.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -168.62 35.69 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.284 1.034 . . . . 71.01 109.179 172.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . 0.6 HG22 ' HG2' ' D' ' 124' ' ' PRO . 11.5 m -61.85 -56.6 17.66 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 115.379 -0.828 . . . . 74.31 110.846 -176.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -80.79 -46.2 15.76 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.332 -0.618 . . . . 64.43 109.332 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . 0.436 ' CE1' ' HB3' ' E' ' 302' ' ' ASP . 62.6 t-80 68.43 -75.99 0.06 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.278 1.431 . . . . 75.44 111.331 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -85.58 70.31 3.09 Favored Glycine 0 C--N 1.34 0.796 0 CA-C-N 116.248 -0.433 . . . . 65.25 113.693 -174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 59.21 -162.28 0.25 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.796 0.838 . . . . 75.12 111.878 173.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.588 HG21 ' HA ' ' D' ' 32' ' ' PHE . 11.2 mt -128.42 92.19 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.423 -1.325 . . . . 71.14 107.423 165.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -87.94 153.69 21.1 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.99 -0.55 . . . . 74.15 110.611 -177.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -136.06 150.46 71.32 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 124.82 1.248 . . . . 74.41 109.088 -175.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -60.28 -60.68 0.25 Allowed 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.136 1.891 . . . . 71.11 111.441 171.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . 51.85 85.65 0.04 OUTLIER 'General case' 0 C--N 1.364 1.23 0 C-N-CA 124.704 1.202 . . . . 73.0 112.299 176.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 46.8 t -85.68 62.12 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 CA-C-O 122.447 1.118 . . . . 53.12 110.339 -173.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 11.0 m -89.93 58.92 4.37 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.304 1.049 . . . . 71.55 109.799 -177.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 34.3 m -129.55 -10.08 4.55 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 114.767 -1.106 . . . . 65.54 110.743 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 70.0 p -67.36 165.4 29.16 Favored Pre-proline 0 CA--C 1.563 1.473 0 C-N-CA 123.826 0.85 . . . . 75.43 110.193 176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo . . . . . 0 C--N 1.39 2.717 0 C-N-CA 123.641 2.894 . . . . 64.34 114.217 178.21 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 110.393 -0.225 . . . . 72.34 110.393 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -85.81 132.99 34.01 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.357 0.663 . . . . 75.21 109.955 175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -89.11 -32.57 17.45 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 123.976 0.91 . . . . 73.43 110.452 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.26 86.36 1.44 Allowed 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.749 0.82 . . . . 62.41 110.665 -175.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -138.97 168.0 17.18 Favored Pre-proline 0 CA--C 1.553 1.073 0 C-N-CA 124.252 1.021 . . . . 75.32 109.97 -176.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -59.13 173.41 1.32 Allowed 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.596 2.197 . . . . 62.2 113.232 168.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 19.7 tp -84.08 41.7 0.83 Allowed 'General case' 0 CA--C 1.566 1.59 0 CA-C-O 122.019 0.914 . . . . 73.15 111.086 -177.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.1 -60.79 1.82 Allowed 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 107.53 -1.285 . . . . 73.31 107.53 168.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 82.98 -55.54 5.04 Favored Glycine 0 C--N 1.352 1.441 0 CA-C-N 115.304 -0.862 . . . . 71.43 112.827 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . 0.622 ' HG ' ' H ' ' H' ' 281' ' ' PHE . 15.6 tp -128.61 -167.37 1.76 Allowed 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 124.257 1.023 . . . . 42.2 108.658 -178.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . 0.622 ' H ' ' HG ' ' H' ' 280' ' ' LEU . 23.8 t80 81.63 0.84 1.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 125.407 1.483 . . . . 73.33 111.952 170.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -100.25 86.25 3.17 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.032 -1.47 . . . . 72.13 107.032 168.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 21.6 t70 74.21 134.76 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 125.011 1.325 . . . . 73.54 110.664 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -168.83 144.35 8.69 Favored Glycine 0 C--N 1.343 0.972 0 N-CA-C 111.677 -0.569 . . . . 71.42 111.677 -177.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -122.83 127.71 49.42 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.276 0.63 . . . . 75.3 110.435 -176.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -135.22 152.49 76.97 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.634 1.174 . . . . 74.23 108.252 173.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -70.79 70.48 2.12 Favored 'Trans proline' 0 C--N 1.379 2.154 0 C-N-CA 122.847 2.365 . . . . 73.31 112.064 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 15.3 t -130.5 24.77 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 124.025 0.93 . . . . 74.0 109.014 -178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 20.3 ttp180 -55.99 -60.14 3.9 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 108.809 -0.811 . . . . 72.33 108.809 169.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 24.5 m95 -166.26 -179.9 5.31 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.508 1.523 . . . . 73.32 108.637 171.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.5 -169.01 1.63 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.365 1.066 . . . . 72.15 108.835 172.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -56.62 114.54 5.31 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-O 118.553 -1.137 . . . . 61.21 111.206 172.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -70.99 117.54 5.21 Favored 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.756 2.304 . . . . 74.32 113.535 -169.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -90.26 139.2 30.88 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.877 -1.157 . . . . 71.43 107.877 169.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -56.26 109.86 0.67 Allowed 'General case' 0 CA--C 1.543 0.675 0 O-C-N 124.088 0.867 . . . . 65.1 110.801 -176.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 94.0 m -78.01 -51.38 10.44 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.908 0.883 . . . . 64.23 111.506 -176.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -67.38 -75.98 0.09 Allowed 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.481 -0.781 . . . . 72.41 111.614 -165.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 70.7 m-70 70.57 -56.23 0.61 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 124.868 1.267 . . . . 64.24 111.451 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 154.55 171.39 21.35 Favored Glycine 0 C--N 1.342 0.873 0 N-CA-C 112.262 -0.335 . . . . 72.22 112.262 171.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -171.14 -46.47 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 106.378 -1.712 . . . . 74.03 106.378 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 29.5 pt -61.62 150.65 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 CA-C-N 113.449 -1.705 . . . . 71.12 110.124 165.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -165.09 171.87 13.31 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 109.191 -0.67 . . . . 61.52 109.191 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . 0.423 ' HB2' ' HD3' ' H' ' 304' ' ' PRO . 52.2 mtpt -76.18 -54.66 1.95 Allowed Pre-proline 0 CA--C 1.562 1.432 0 CA-C-O 118.672 -0.68 . . . . 71.11 111.548 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . 0.423 ' HD3' ' HB2' ' H' ' 303' ' ' LYS . 42.0 Cg_endo -84.12 44.06 1.48 Allowed 'Trans proline' 0 C--N 1.393 2.881 0 C-N-CA 122.14 1.893 . . . . 71.41 111.747 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -55.75 -71.82 0.08 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.236 1.014 . . . . 72.12 111.619 -171.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . 0.414 HG11 ' HB2' ' C' ' 129' ' ' ALA . 15.6 m -144.4 123.96 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.197 0.599 . . . . 74.43 110.202 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . 0.453 ' HA ' ' NE2' ' A' ' 12' ' ' GLN . 2.0 p -151.52 117.38 5.48 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.907 1.283 . . . . 54.44 108.908 172.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 57.9 m 62.43 173.31 0.14 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 124.612 1.165 . . . . 75.32 112.389 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 64.5 p -113.56 94.06 30.55 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.062 0.545 . . . . 74.33 109.982 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo . . . . . 0 C--N 1.377 2.045 0 C-N-CA 122.671 2.247 . . . . 53.53 109.897 167.133 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.8 ttt . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.954 0.407 . . . . 71.4 110.017 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.6 m -91.26 -69.19 0.75 Allowed 'General case' 0 C--N 1.345 0.397 0 C-N-CA 123.652 0.781 . . . . 73.15 109.51 -176.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 58.39 26.14 13.74 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.34 1.056 . . . . 71.43 112.93 174.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -86.42 165.32 16.42 Favored 'General case' 0 C--O 1.24 0.599 0 C-N-CA 123.235 0.614 . . . . 65.52 109.56 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -170.62 133.43 1.0 Allowed 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.989 0.916 . . . . 64.34 108.884 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.439 ' HB3' ' HB2' ' A' ' 9' ' ' MET . 44.3 t-20 -87.81 108.83 19.34 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.939 -1.134 . . . . 74.42 107.939 176.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 38.3 p -66.21 -28.18 68.55 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.361 0.664 . . . . 65.15 111.743 -177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -80.28 -17.55 51.83 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.565 0.746 . . . . 52.42 111.622 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.458 ' HG3' HD12 ' A' ' 89' ' ' ILE . 57.3 ttp -60.8 134.23 56.88 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.304 0.573 . . . . 75.54 110.3 178.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.7 m -143.04 117.48 9.68 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 114.611 -1.177 . . . . 72.43 108.384 -176.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.72 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.2 t80 -123.83 117.69 25.44 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.527 -0.916 . . . . 73.01 108.527 172.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.3 tp60 -141.62 112.67 7.37 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 108.832 -0.803 . . . . 74.5 108.832 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.662 HG21 ' HG2' ' C' ' 130' ' ' PRO . 66.5 mt -69.91 130.64 34.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 C-N-CA 122.844 0.458 . . . . 73.05 109.986 176.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.519 ' O ' ' HB1' ' H' ' 305' ' ' ALA . 63.9 tt0 -96.47 -38.29 10.08 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 118.954 -0.546 . . . . 74.5 110.567 177.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -173.01 123.13 0.41 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.196 0.907 . . . . 73.34 112.686 -170.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -106.83 133.18 52.16 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 108.582 -0.896 . . . . 70.55 108.582 170.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -167.88 158.5 10.76 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.243 1.017 . . . . 62.34 110.653 -172.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -91.73 115.24 27.89 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.347 -0.842 . . . . 72.05 109.425 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.6 mtpt -85.56 -18.87 32.12 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 116.381 -0.372 . . . . 75.25 110.405 177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.5 t70 -155.9 140.84 17.25 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.906 0.882 . . . . 75.14 109.735 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 56.9 mt -140.73 135.29 34.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.537 0 C-N-CA 125.447 1.499 . . . . 64.14 107.301 176.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 39.6 t -141.45 125.77 17.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.423 -0.955 . . . . 45.3 108.423 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.481 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 87.4 t80 -136.42 110.13 8.08 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 107.639 -1.245 . . . . 74.42 107.639 171.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -120.13 120.14 35.35 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.813 0.445 . . . . 55.02 109.945 -176.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.78 80.79 14.45 Favored Pre-proline 0 CA--C 1.547 0.859 0 N-CA-C 107.633 -1.247 . . . . 34.34 107.633 172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -69.75 -24.74 29.36 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.825 2.35 . . . . 73.53 113.061 -170.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -107.02 12.98 28.04 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.395 0.678 . . . . 54.23 111.269 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -39.39 -53.08 4.24 Favored Pre-proline 0 CA--C 1.565 1.53 0 N-CA-C 114.964 1.468 . . . . 72.42 114.964 -165.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.4 ' HB3' HD22 ' B' ' 51' ' ' LEU . 26.1 Cg_exo -56.74 -46.51 29.1 Favored 'Trans proline' 0 C--N 1.396 3.037 0 CA-C-N 122.107 1.788 . . . . 64.11 113.045 -178.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -98.7 -6.99 28.54 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.94 0.896 . . . . 72.11 112.911 -171.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.599 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.5 p -79.88 -20.18 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 O-C-N 121.615 -0.678 . . . . 52.22 111.731 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -86.52 -3.86 59.08 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 123.446 0.698 . . . . 74.14 112.016 -176.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -100.64 -7.73 23.64 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.653 0.781 . . . . 73.33 111.0 175.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -70.29 163.92 25.52 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.738 0.815 . . . . 71.32 112.469 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -70.39 144.22 51.64 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 124.216 1.006 . . . . 64.24 110.049 174.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 47.6 m95 -87.24 73.98 9.61 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-O 121.703 0.764 . . . . 74.23 111.404 -169.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -143.41 84.1 10.39 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-N 114.614 -1.175 . . . . 74.4 108.066 174.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -80.26 136.28 11.29 Favored 'Trans proline' 0 C--N 1.369 1.618 0 C-N-CA 122.335 2.023 . . . . 43.42 112.131 178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -95.13 93.88 7.6 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 106.765 -1.569 . . . . 62.22 106.765 170.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 65' ' ' THR . 34.0 t -92.46 96.51 6.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 114.983 -1.008 . . . . 52.52 111.061 -170.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 66.9 tttm -80.47 111.53 16.97 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 115.1 -0.955 . . . . 73.52 108.938 176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.408 HD13 ' O ' ' E' ' 289' ' ' ARG . 10.5 tt -98.74 121.9 41.28 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.343 -0.984 . . . . 64.22 108.343 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.55 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 24.0 m-20 -116.72 150.32 38.4 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.356 1.062 . . . . 61.43 108.849 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.3 tp -130.52 133.47 46.27 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.946 -0.761 . . . . 64.24 108.946 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -132.97 144.14 49.92 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.076 0.95 . . . . 73.51 108.769 176.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.501 ' HB ' ' CZ ' ' E' ' 281' ' ' PHE . 41.6 p -136.36 136.38 39.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.778 0.831 . . . . 63.11 109.466 -173.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -144.6 111.03 5.59 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.977 0.511 . . . . 43.41 110.079 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 p -92.05 152.07 20.14 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 109.501 -0.555 . . . . 74.1 109.501 172.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 45.9 t -151.96 154.98 37.12 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.435 -1.32 . . . . 73.41 107.435 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -117.46 130.97 56.8 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.962 -0.755 . . . . 73.33 108.962 167.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 68.5 mt -93.45 -40.48 10.33 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.513 0.725 . . . . 73.45 110.539 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -154.26 -177.23 6.3 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.904 0.882 . . . . 54.22 110.077 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -66.25 123.61 20.41 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 109.386 -0.598 . . . . 63.52 109.386 176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 69.0 -8.1 0.71 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 125.809 1.643 . . . . 73.11 112.963 -173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.8 t -100.36 109.77 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 N-CA-C 109.032 -0.729 . . . . 73.32 109.032 -178.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -116.73 153.53 32.22 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.947 0.899 . . . . 64.53 108.67 -178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -129.73 118.95 22.66 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 124.337 1.055 . . . . 73.54 108.852 176.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 42.2 t -107.77 118.92 56.44 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 108.205 -1.035 . . . . 70.01 108.205 174.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 95.3 t -98.28 128.22 49.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.547 0 N-CA-C 108.848 -0.797 . . . . 61.44 108.848 173.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -115.24 97.92 6.47 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 106.401 -1.703 . . . . 73.44 106.401 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.415 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 16.8 ttp180 -88.41 109.13 19.76 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 109.375 -0.602 . . . . 73.55 109.375 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 11.1 t -93.87 130.12 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 N-CA-C 107.266 -1.383 . . . . 71.12 107.266 171.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 20.6 m -120.87 128.57 52.94 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 108.73 -0.841 . . . . 75.44 108.73 176.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.831 HG11 HD21 ' A' ' 126' ' ' LEU . 52.9 t -130.73 107.72 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 123.349 0.66 . . . . 75.3 109.874 -177.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.428 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 13.5 m -102.81 141.23 35.97 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 108.465 -0.939 . . . . 61.44 108.465 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.55 141.53 46.71 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.004 -1.109 . . . . 73.3 108.004 173.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 48.7 m -142.76 127.46 18.1 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 122.858 0.463 . . . . 74.2 110.862 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 73' ' ' ALA . 9.2 mp -95.17 84.93 4.17 Favored 'General case' 0 C--O 1.245 0.86 0 N-CA-C 107.471 -1.307 . . . . 64.31 107.471 172.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.22 -127.13 8.29 Favored Glycine 0 C--N 1.344 1.023 0 CA-C-N 114.268 -1.333 . . . . 54.34 111.281 -171.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -88.28 -25.09 22.99 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.526 0.73 . . . . 75.24 110.028 176.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -79.21 117.53 20.32 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.277 1.031 . . . . 72.41 110.296 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.4 m -66.79 128.4 36.16 Favored 'General case' 0 CA--C 1.541 0.632 0 O-C-N 124.122 0.889 . . . . 74.43 110.749 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.642 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -70.89 -62.91 1.22 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.393 -0.966 . . . . 72.13 108.393 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -158.22 166.07 33.29 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 114.713 -1.13 . . . . 73.03 110.183 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 18.1 tp -132.41 135.8 46.34 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 107.163 -1.421 . . . . 71.12 107.163 172.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 84.1 m -134.96 101.05 4.76 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.562 0.745 . . . . 73.12 109.829 -174.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 34.7 tt0 -125.81 116.01 20.91 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.207 -0.664 . . . . 62.0 109.207 -176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 46.1 t -128.88 111.63 23.72 Favored 'Isoleucine or valine' 0 C--O 1.24 0.588 0 C-N-CA 124.088 0.955 . . . . 52.51 108.94 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.442 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 70.6 mt-30 -84.39 84.28 7.7 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 108.316 -0.994 . . . . 71.13 108.316 172.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.78 93.33 3.68 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 114.784 -1.098 . . . . 71.4 108.391 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.49 145.29 21.06 Favored Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.379 -0.828 . . . . 74.13 111.241 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.509 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -146.74 121.46 1.43 Allowed Glycine 0 CA--C 1.503 -0.667 0 N-CA-C 111.188 -0.765 . . . . 63.41 111.188 -178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 40.2 mt -82.09 116.15 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 108.624 -0.88 . . . . 61.32 108.624 175.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.72 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 39.3 m-85 -121.83 121.55 37.44 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.335 1.054 . . . . 63.0 108.32 178.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.2 t -79.72 99.84 7.62 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 108.603 -0.888 . . . . 72.13 108.603 174.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.1 mt -109.94 121.04 62.17 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 C-N-CA 124.061 0.944 . . . . 65.45 109.375 -174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.27 161.53 42.55 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.387 0.675 . . . . 55.12 110.063 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.416 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 94.33 -29.81 8.47 Favored Glycine 0 C--N 1.344 0.978 0 N-CA-C 114.69 0.636 . . . . 53.12 114.69 171.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.586 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.67 170.19 4.23 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 123.423 0.689 . . . . 71.14 109.976 178.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -152.74 172.29 16.92 Favored 'General case' 0 CA--C 1.554 1.128 0 O-C-N 123.553 0.533 . . . . 73.1 110.225 -173.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.41 -116.31 3.49 Favored Glycine 0 N--CA 1.473 1.116 0 C-N-CA 125.422 1.487 . . . . 55.55 115.544 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.7 t -57.07 -31.74 65.54 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 125.31 1.444 . . . . 51.2 112.445 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -75.42 -39.15 59.28 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.482 0.713 . . . . 70.01 110.437 -178.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 83.4 mtp -77.4 -21.18 53.54 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 123.266 0.354 . . . . 75.53 110.617 174.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.484 ' HB1' HD12 ' E' ' 280' ' ' LEU . . . -72.28 -33.45 67.46 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.124 0.57 . . . . 73.22 109.708 172.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.437 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 44.1 t-80 -76.16 -35.15 59.31 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.199 -0.91 . . . . 65.33 110.204 173.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.7 t -70.25 -47.52 60.95 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 122.234 -0.291 . . . . 74.53 110.226 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.3 mt -74.16 -40.48 62.54 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.878 -0.601 . . . . 75.44 110.942 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.69 4.25 59.49 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-O 119.239 -0.756 . . . . 43.31 114.781 -168.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.639 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.41 -68.51 0.27 Allowed 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 118.178 0.989 . . . . 61.04 112.434 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.485 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 92.1 t80 -68.84 -51.37 41.27 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.87 0.868 . . . . 75.12 113.065 -167.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.8 m -73.57 -31.74 1.44 Allowed Pre-proline 0 CA--C 1.563 1.48 0 CA-C-O 118.402 -0.808 . . . . 63.23 113.081 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -48.4 -42.64 34.24 Favored 'Trans proline' 0 C--N 1.395 3.01 0 C-N-CA 122.594 2.196 . . . . 72.11 112.799 159.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.559 ' ND2' ' HB2' ' A' ' 134' ' ' ASP . 91.9 m-20 -64.63 -19.51 65.74 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.646 0.778 . . . . 71.23 112.093 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.414 HD12 ' ND2' ' C' ' 132' ' ' ASN . 39.1 mm -81.6 -46.43 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 109.307 -0.627 . . . . 63.11 109.307 173.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.509 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.3 mt -78.67 -30.56 46.28 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.049 0.94 . . . . 61.11 113.073 -171.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -69.78 -38.36 9.47 Favored Pre-proline 0 CA--C 1.561 1.384 0 CA-C-O 118.005 -0.997 . . . . 72.11 112.6 -169.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.41 -41.93 71.07 Favored 'Trans proline' 0 C--N 1.392 2.827 0 C-N-CA 122.277 1.984 . . . . 64.32 113.543 167.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -76.53 -32.37 58.2 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.146 0.578 . . . . 72.52 111.848 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.78 -45.23 68.44 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.296 -0.631 . . . . 71.1 109.296 174.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm105 -54.86 -47.19 74.54 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 124.651 1.18 . . . . 74.14 110.623 177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -66.38 -47.14 74.33 Favored 'General case' 0 N--CA 1.475 0.804 0 O-C-N 124.161 0.913 . . . . 63.52 110.809 -178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.0 t -57.6 -43.79 84.95 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 123.382 0.673 . . . . 75.41 110.402 -179.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.431 HG23 ' HB3' ' A' ' 76' ' ' CYS . 87.0 mt -64.69 -46.92 90.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 O-C-N 124.255 0.972 . . . . 74.32 110.142 176.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 125' ' ' GLN . 95.7 m -52.89 -45.75 67.66 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.651 0.78 . . . . 61.4 111.28 -179.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 30.1 t -69.37 -44.92 70.54 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 114.887 -1.051 . . . . 75.42 110.511 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.9 mtp -55.86 -44.59 78.19 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 123.654 0.781 . . . . 73.0 111.362 175.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.427 HG13 ' HB2' ' A' ' 123' ' ' PHE . 41.0 t -61.9 -48.25 89.47 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 C-N-CA 124.971 1.308 . . . . 74.21 110.59 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 77.9 p -68.02 -32.26 72.52 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.001 0.52 . . . . 63.45 111.628 -179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 87.8 mtt-85 -68.29 -33.82 75.04 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.688 0.795 . . . . 74.04 110.366 176.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.22 9.53 66.54 Favored Glycine 0 C--N 1.348 1.196 0 CA-C-N 115.462 -0.79 . . . . 61.32 113.308 176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.825 HG21 ' HD2' ' B' ' 15' ' ' ARG . 17.9 m 73.2 9.13 5.28 Favored 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 124.388 1.075 . . . . 64.25 112.782 173.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.427 ' HB2' HG13 ' A' ' 118' ' ' VAL . 96.1 m-85 -85.47 138.5 36.08 Favored Pre-proline 0 CA--C 1.547 0.858 0 N-CA-C 107.762 -1.199 . . . . 74.32 107.762 168.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.45 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 24.5 Cg_endo -62.24 160.2 31.87 Favored 'Trans proline' 0 C--N 1.369 1.621 0 C-N-CA 122.702 2.268 . . . . 75.51 112.622 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.578 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.1 tt0 -45.44 121.95 3.27 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 124.795 1.31 . . . . 71.43 112.507 -172.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.831 HD21 HG11 ' A' ' 64' ' ' VAL . 48.8 tp -108.4 115.49 30.2 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 114.885 -1.052 . . . . 75.13 108.374 174.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.7 p30 -129.28 124.15 33.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.641 -1.163 . . . . 62.21 107.977 -177.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -72.77 138.86 46.72 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 109.318 -0.623 . . . . 74.41 109.318 177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.735 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -63.22 145.61 96.76 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 122.774 0.429 . . . . 61.32 110.359 -178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.61 ' HD3' HG22 ' C' ' 13' ' ' ILE . 23.8 Cg_exo -64.6 104.74 0.56 Allowed 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.967 2.445 . . . . 75.14 112.455 -173.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.658 HG22 HD21 ' E' ' 291' ' ' LEU . 14.5 t -100.12 112.46 32.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 107.881 -1.155 . . . . 72.21 107.881 176.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 39.7 t-20 -85.82 86.23 7.37 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.207 -1.405 . . . . 75.15 107.207 173.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.4 ' HB3' ' HA ' ' A' ' 100' ' ' ALA . 98.6 m-85 -60.71 -29.18 69.19 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.523 -0.762 . . . . 74.1 110.659 -179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.639 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.8 t70 -65.54 -50.73 64.13 Favored 'General case' 0 C--N 1.356 0.87 0 C-N-CA 123.762 0.825 . . . . 41.14 109.377 -178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.54 -38.73 88.5 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 124.773 1.295 . . . . 74.44 111.252 178.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 58.9 tp -58.73 -47.41 84.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.734 0.814 . . . . 70.24 111.022 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 16.3 t80 -79.22 -24.21 43.26 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.133 0.573 . . . . 72.44 110.593 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.449 ' SD ' HD23 ' A' ' 141' ' ' LEU . 51.9 tpp -68.82 -30.72 69.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.494 0.718 . . . . 74.01 110.354 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 64.4 m-80 -69.63 -25.52 63.97 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 116.169 -0.469 . . . . 61.35 111.665 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -80.8 -36.84 31.19 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 122.993 0.517 . . . . 72.55 109.98 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.449 HD23 ' SD ' ' A' ' 138' ' ' MET . 29.8 tp -67.36 -48.36 67.68 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.254 1.022 . . . . 44.33 111.884 -174.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.29 11.82 0.11 Allowed 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.085 0.554 . . . . 74.13 112.387 -172.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.59 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 20.6 tt0 64.84 -110.24 0.22 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 124.604 1.162 . . . . 63.33 110.081 -171.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.5 ' HA ' HE21 ' A' ' 144' ' ' GLN . 0.0 OUTLIER -176.78 125.43 0.16 Allowed 'General case' 0 N--CA 1.482 1.154 0 CA-C-N 118.678 0.672 . . . . 65.32 109.79 -177.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.53 86.17 5.96 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.123 0.569 . . . . 65.03 109.914 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.62 138.78 16.65 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 115.76 -0.655 . . . . 71.33 112.626 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -162.42 144.22 10.68 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 123.195 0.598 . . . . 74.41 110.004 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.93 171.74 44.66 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.712 -0.676 . . . . 60.12 111.948 176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 t -158.88 -175.16 5.13 Favored 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 123.4 0.68 . . . . 62.42 109.937 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -133.43 176.54 8.44 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.134 0.974 . . . . 74.43 109.503 175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -151.68 125.01 8.8 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.854 -0.425 . . . . 63.5 109.854 173.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -89.07 157.01 18.48 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 122.95 0.5 . . . . 74.44 111.076 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -139.33 140.24 37.48 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.94 0.896 . . . . 74.44 109.119 174.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -123.42 174.98 7.01 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.442 0.697 . . . . 74.23 110.24 178.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.212 0 C-N-CA 123.845 0.858 . . . . 61.2 109.41 179.249 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptm . . . . . 0 N--CA 1.47 0.542 0 N-CA-C 109.576 -0.527 . . . . 75.12 109.576 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 46.1 m -131.98 7.17 4.33 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.166 0.987 . . . . 71.32 110.224 173.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 56.19 22.9 6.5 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 124.954 1.301 . . . . 70.51 112.061 176.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.413 HE21 ' HB3' ' D' ' 151' ' ' GLU . 20.1 mt-30 -141.03 127.71 20.23 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.223 1.409 . . . . 74.42 107.489 -177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' D' ' 148' ' ' GLY . 27.7 m120 -99.47 114.37 27.29 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 112.166 0.432 . . . . 64.32 112.166 -168.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -166.02 -72.47 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.921 0.888 . . . . 44.31 109.885 171.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 26.8 m 70.08 122.42 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 125.55 1.54 . . . . 74.55 112.29 -177.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -124.7 -55.85 1.6 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.515 1.126 . . . . 64.43 109.274 175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 13.8 ptm 52.52 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 128.084 2.553 . . . . 74.32 113.522 -164.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.423 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 25.3 m -159.02 123.82 4.11 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 106.935 -1.505 . . . . 74.04 106.935 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -139.74 130.69 26.22 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 109.25 -0.648 . . . . 75.12 109.25 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.532 ' HG2' ' HB2' ' B' ' 85' ' ' SER . 2.6 pm0 -148.47 129.82 14.73 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 109.573 -0.528 . . . . 75.32 109.573 172.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -74.17 144.33 12.56 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 CA-C-N 115.565 -0.743 . . . . 51.21 109.16 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -108.49 -47.49 3.49 Favored 'General case' 0 C--O 1.241 0.626 0 N-CA-C 109.456 -0.572 . . . . 74.43 109.456 169.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.825 ' HD2' HG21 ' A' ' 122' ' ' THR . 34.8 ttp180 -165.79 152.95 10.14 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.784 -0.644 . . . . 64.2 110.98 -170.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.7 mt -131.73 139.25 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 107.343 -1.355 . . . . 64.41 107.343 170.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.59 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 33.6 p90 -161.46 168.69 23.27 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.785 0.803 . . . . 73.02 112.256 179.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 89.2 m -93.25 121.21 34.38 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.473 -1.239 . . . . 73.5 108.763 173.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.613 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 24.6 mtpp -87.66 -30.46 20.39 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.428 0.691 . . . . 75.25 110.614 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -157.86 145.6 18.58 Favored 'General case' 0 C--N 1.352 0.69 0 N-CA-C 112.016 0.376 . . . . 74.43 112.016 -174.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.481 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 28.3 mm -138.81 141.94 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 126.031 1.732 . . . . 70.04 109.104 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 34.5 t -150.45 117.4 5.91 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.181 -1.044 . . . . 71.31 108.181 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -131.81 116.18 16.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 107.259 -1.385 . . . . 74.11 107.259 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -118.86 157.56 27.38 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.405 0.682 . . . . 74.1 109.694 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.536 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -148.88 79.2 8.62 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 107.333 -1.358 . . . . 75.45 107.333 175.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.58 -9.81 20.09 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.006 2.471 . . . . 61.41 112.602 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.429 ' OD1' ' HB ' ' B' ' 72' ' ' THR . 3.0 m120 -116.63 11.25 14.64 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.214 1.006 . . . . 74.4 109.043 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.536 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.66 -54.51 26.36 Favored Pre-proline 0 CA--C 1.558 1.268 0 C-N-CA 124.779 1.232 . . . . 61.24 114.216 -170.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -74.71 -23.27 14.63 Favored 'Trans proline' 0 C--N 1.39 2.722 0 C-N-CA 121.696 1.597 . . . . 73.21 112.436 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.476 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 3.4 m-70 -90.33 -0.36 57.6 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.833 0.853 . . . . 62.54 112.044 -173.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.95 -28.39 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 123.66 0.784 . . . . 72.31 111.857 -179.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.0 -23.15 64.98 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.083 0.953 . . . . 65.31 112.146 -170.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.623 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -70.0 -40.01 75.53 Favored 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 109.746 -0.465 . . . . 71.33 109.746 176.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.623 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 78.5 mttt -109.73 64.52 0.61 Allowed 'General case' 0 C--N 1.359 1.02 0 N-CA-C 108.434 -0.95 . . . . 73.14 108.434 176.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 9.4 p-10 -78.61 94.06 4.96 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 115.921 -0.581 . . . . 64.32 110.388 -173.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' B' ' 35' ' ' ASP . 0.4 OUTLIER 173.93 -173.88 0.06 Allowed 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 124.945 1.298 . . . . 75.13 111.024 159.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -55.08 117.99 16.22 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 125.037 1.335 . . . . 55.04 112.503 -178.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.49 169.31 22.12 Favored 'Trans proline' 0 C--N 1.371 1.737 0 C-N-CA 122.742 2.295 . . . . 74.31 111.166 171.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -73.55 102.01 3.73 Favored 'General case' 0 C--N 1.346 0.447 0 N-CA-C 106.882 -1.525 . . . . 74.53 106.882 167.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' H' ' 295' ' ' ALA . 13.7 m -89.95 140.06 16.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 114.807 -1.088 . . . . 71.44 108.976 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -119.1 130.57 55.66 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.239 -0.652 . . . . 73.54 109.239 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.65 HD21 HD11 ' B' ' 128' ' ' LEU . 0.3 OUTLIER -86.04 136.91 33.05 Favored 'General case' 0 CA--C 1.546 0.827 0 N-CA-C 107.032 -1.47 . . . . 63.45 107.032 168.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.436 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 18.4 t0 -142.88 128.36 19.0 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 107.77 -1.196 . . . . 75.43 107.77 177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.471 HD22 ' HE1' ' B' ' 133' ' ' PHE . 1.4 mp -131.38 126.49 35.34 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.093 -1.077 . . . . 73.13 108.093 -177.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.3 t70 -123.3 142.61 50.76 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 124.49 1.116 . . . . 75.23 108.371 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 61.2 p -117.39 119.26 34.55 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.088 0.555 . . . . 72.53 110.411 -172.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -139.32 135.29 33.63 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.9 0.88 . . . . 64.34 108.912 178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 36.1 p -134.62 169.91 16.59 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.318 0.647 . . . . 74.04 110.054 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.7 p -151.97 163.86 38.39 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.561 0.744 . . . . 70.33 110.232 -176.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -108.58 120.08 41.39 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.812 -0.811 . . . . 71.32 108.812 170.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.597 HD11 ' HB2' ' B' ' 57' ' ' GLU . 17.6 mt -92.06 -46.03 8.0 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.847 0.859 . . . . 73.33 109.336 -176.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.93 -178.86 6.34 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 114.3 -1.318 . . . . 74.03 108.803 174.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -69.52 122.39 18.94 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.956 -1.02 . . . . 73.22 108.825 179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 71.59 -4.3 1.92 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 125.644 1.577 . . . . 73.11 112.699 -173.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 65.6 t -106.16 107.87 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 108.925 -0.769 . . . . 74.44 108.925 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' H' ' 278' ' ' LEU . 92.5 m-85 -120.43 140.71 50.97 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 124.182 0.993 . . . . 61.44 109.586 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.597 ' HB2' HD11 ' B' ' 51' ' ' LEU . 40.2 tt0 -102.72 138.48 39.57 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 123.916 0.886 . . . . 55.11 109.369 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 90.5 t -115.08 122.94 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 C-N-CA 124.309 1.044 . . . . 75.01 108.301 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 44.9 t -121.94 116.21 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 123.539 0.736 . . . . 62.3 109.479 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 55.1 tp -106.59 108.44 19.96 Favored 'General case' 0 C--O 1.243 0.726 0 N-CA-C 108.907 -0.775 . . . . 74.23 108.907 175.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.534 ' HG3' ' HG2' ' B' ' 79' ' ' GLN . 55.0 ttt180 -86.89 106.19 17.59 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.828 0.851 . . . . 72.14 108.834 177.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.02 115.72 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.948 -0.76 . . . . 62.04 108.948 178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 16.8 m -116.12 136.12 53.31 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 124.211 1.004 . . . . 73.1 109.302 -175.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.404 HG11 HD13 ' B' ' 126' ' ' LEU . 54.1 t -120.0 125.03 73.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.811 1.245 . . . . 63.45 109.086 175.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.0 m -124.89 125.9 44.68 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.689 -0.486 . . . . 61.01 109.689 172.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -123.88 146.48 48.39 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.309 1.044 . . . . 44.41 109.335 -174.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 78.2 p -149.16 128.93 13.28 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 112.443 0.535 . . . . 72.02 112.443 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.482 HD13 ' HB2' ' B' ' 34' ' ' LYS . 82.7 mt -97.32 108.4 21.12 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.396 1.079 . . . . 74.12 109.299 176.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.57 -124.2 7.96 Favored Glycine 0 C--N 1.341 0.859 0 CA-C-N 116.002 -0.545 . . . . 72.43 111.784 -177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -98.9 1.96 46.15 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.378 0.671 . . . . 60.24 110.857 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -127.71 177.18 6.98 Favored 'General case' 0 N--CA 1.481 1.094 0 O-C-N 121.942 -0.474 . . . . 72.11 110.651 -178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . 0.429 ' HB ' ' OD1' ' B' ' 27' ' ' ASN . 11.9 m -68.49 157.46 35.89 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.534 1.133 . . . . 65.45 110.709 -174.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.472 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -111.59 -58.68 2.09 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 109.018 -0.734 . . . . 65.54 109.018 168.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -162.73 158.45 22.98 Favored 'General case' 0 C--O 1.245 0.827 0 CA-C-N 114.237 -1.347 . . . . 61.2 108.266 176.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 76.8 mt -124.08 138.71 54.4 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.724 1.209 . . . . 74.31 108.589 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.7 t -146.88 149.47 33.33 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.274 -0.639 . . . . 71.22 109.274 177.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -165.34 133.76 3.22 Favored 'General case' 0 C--O 1.239 0.537 0 C-N-CA 123.535 0.734 . . . . 73.21 109.036 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 113' ' ' CYS . 96.6 t -127.02 145.94 33.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 C-N-CA 124.526 1.13 . . . . 64.54 108.704 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.534 ' HG2' ' HG3' ' B' ' 61' ' ' ARG . 21.1 mt-30 -126.03 96.89 4.89 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.258 -1.015 . . . . 70.22 108.258 173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -94.42 107.17 19.15 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.634 -0.712 . . . . 71.24 109.127 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.613 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -109.35 141.59 16.06 Favored Glycine 0 C--N 1.34 0.799 0 N-CA-C 111.237 -0.745 . . . . 55.43 111.237 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -137.71 132.4 5.89 Favored Glycine 0 CA--C 1.503 -0.682 0 N-CA-C 110.35 -1.1 . . . . 73.45 110.35 -175.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.469 HG23 HD12 ' B' ' 51' ' ' LEU . 80.5 mt -85.73 125.95 40.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 C-N-CA 123.509 0.724 . . . . 75.44 109.164 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -133.06 160.93 35.75 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.421 1.088 . . . . 74.34 108.629 -177.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.532 ' HB2' ' HG2' ' B' ' 12' ' ' GLN . 50.9 m -129.41 112.96 14.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.29 -1.004 . . . . 51.25 108.29 173.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.725 ' HB ' HD11 ' B' ' 89' ' ' ILE . 40.1 pt -119.31 144.45 27.7 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 124.228 1.011 . . . . 74.04 110.314 -173.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.423 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.57 156.65 33.96 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.15 0.98 . . . . 72.25 109.092 176.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.72 -61.11 3.5 Favored Glycine 0 C--N 1.343 0.971 0 O-C-N 123.304 0.377 . . . . 72.34 112.542 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.725 HD11 ' HB ' ' B' ' 86' ' ' ILE . 0.2 OUTLIER -57.93 133.59 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.524 0.73 . . . . 74.21 111.676 -176.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -152.02 147.51 26.6 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.073 0.549 . . . . 74.14 110.433 -175.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.42 -104.41 0.98 Allowed Glycine 0 C--N 1.348 1.218 0 CA-C-N 115.468 -0.787 . . . . 53.35 112.506 176.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -78.58 -35.04 46.42 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.685 0.794 . . . . 74.11 110.465 -177.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 23.8 mp0 -64.99 -41.71 95.17 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.329 0.652 . . . . 63.42 110.021 175.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 58.4 ttp -70.13 -37.43 75.3 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 115.813 -0.631 . . . . 73.4 110.66 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.52 -34.19 75.44 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.066 0.547 . . . . 72.44 111.258 179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -74.82 -41.8 59.23 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.504 0.722 . . . . 73.41 110.628 178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.9 t -70.83 -65.53 0.73 Allowed 'General case' 0 CA--C 1.545 0.773 0 CA-C-N 115.85 -0.614 . . . . 53.35 110.235 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -64.67 -34.42 78.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.277 1.031 . . . . 65.43 111.305 -175.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.88 -21.79 54.73 Favored Glycine 0 C--N 1.35 1.34 0 CA-C-O 119.568 -0.573 . . . . 51.22 114.509 -173.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -133.41 -57.84 0.89 Allowed 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 117.824 0.812 . . . . 65.43 112.012 -173.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -61.88 -56.83 15.26 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.991 0.916 . . . . 72.05 112.036 -172.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.422 ' HA ' HD12 ' B' ' 105' ' ' ILE . 61.9 m -62.39 -43.24 84.28 Favored Pre-proline 0 CA--C 1.566 1.573 0 C-N-CA 124.124 0.969 . . . . 72.53 112.808 -177.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -54.38 -46.38 33.88 Favored 'Trans proline' 0 C--N 1.4 3.254 0 C-N-CA 122.536 2.157 . . . . 74.43 112.757 167.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.78 -20.44 63.58 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 123.719 0.808 . . . . 54.11 112.743 -177.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.422 HD12 ' HA ' ' B' ' 102' ' ' CYS . 73.3 mt -71.58 -52.09 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 C-N-CA 123.022 0.529 . . . . 64.31 110.311 175.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.3 pp -91.41 -6.18 53.25 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.554 -0.748 . . . . 63.04 112.166 -174.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -62.22 -44.36 88.46 Favored Pre-proline 0 CA--C 1.561 1.398 0 C-N-CA 124.58 1.152 . . . . 75.35 112.684 -179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -53.21 -34.82 71.11 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.674 2.25 . . . . 70.04 113.802 173.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' D' ' 115' ' ' THR . 76.6 m-85 -73.46 -42.57 61.77 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.16 0.584 . . . . 74.15 110.515 -178.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -42.31 98.07 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.132 0.573 . . . . 52.41 110.558 174.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.427 ' HG3' ' H ' ' B' ' 128' ' ' LEU . 47.8 ttt-85 -57.27 -57.66 11.66 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.903 1.281 . . . . 72.32 111.089 176.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -66.03 -28.07 68.59 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.225 1.01 . . . . 75.45 110.876 -172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.504 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.1 t -74.0 -41.51 61.77 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 122.623 0.369 . . . . 73.41 110.941 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.428 HG21 HD22 ' B' ' 126' ' ' LEU . 63.1 mt -62.09 -41.68 92.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.375 -0.602 . . . . 61.34 109.375 172.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.592 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.5 m -62.28 -35.99 80.7 Favored 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 124.714 1.206 . . . . 64.52 111.449 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 24.7 t -70.01 -52.77 21.42 Favored 'General case' 0 C--N 1.352 0.676 0 C-N-CA 123.12 0.568 . . . . 73.21 109.875 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.504 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -65.43 -36.97 85.53 Favored 'General case' 0 N--CA 1.48 1.041 0 O-C-N 123.713 0.633 . . . . 74.14 112.028 -170.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.431 HG22 ' HB2' ' B' ' 123' ' ' PHE . 10.7 p -69.63 -34.12 59.85 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.049 0 C-N-CA 122.481 0.312 . . . . 73.51 110.651 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.6 t -77.05 -21.73 54.04 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.341 0.656 . . . . 70.23 111.066 176.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 92.7 mtt-85 -73.54 -34.65 65.3 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.13 0.572 . . . . 75.23 109.822 173.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.71 5.65 45.14 Favored Glycine 0 C--N 1.355 1.632 0 O-C-N 123.706 0.629 . . . . 62.24 112.549 169.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.4 p 59.43 46.83 11.87 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.614 1.965 . . . . 73.54 111.679 176.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.431 ' HB2' HG22 ' B' ' 118' ' ' VAL . 33.4 m-85 -119.48 157.05 52.64 Favored Pre-proline 0 C--O 1.242 0.696 0 CA-C-N 113.898 -1.501 . . . . 75.01 109.781 174.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.46 ' HG3' ' O ' ' H' ' 300' ' ' ASN . 50.3 Cg_exo -55.57 143.89 76.73 Favored 'Trans proline' 0 C--N 1.38 2.197 0 C-N-CA 122.902 2.401 . . . . 74.24 112.178 173.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.592 ' HB2' HG23 ' B' ' 115' ' ' THR . 3.4 pt20 -63.44 156.68 25.39 Favored 'General case' 0 C--O 1.24 0.555 0 O-C-N 124.064 0.852 . . . . 64.54 111.993 -174.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.428 HD22 HG21 ' B' ' 114' ' ' ILE . 9.7 tt -125.23 105.01 8.81 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.353 -1.351 . . . . 75.32 107.353 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -91.44 115.72 28.27 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 108.997 -0.742 . . . . 70.44 108.997 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.65 HD11 HD21 ' B' ' 42' ' ' LEU . 1.1 mm? -67.16 107.56 2.37 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 108.197 -1.038 . . . . 72.31 108.197 166.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.76 158.05 54.68 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.127 0.971 . . . . 73.4 111.154 -178.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -61.43 85.92 0.09 OUTLIER 'Trans proline' 0 C--N 1.385 2.5 0 C-N-CA 122.261 1.974 . . . . 74.12 112.153 177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.07 110.79 22.81 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 109.269 -0.641 . . . . 75.45 109.269 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 22.8 t30 -82.3 104.22 12.46 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 108.256 -1.016 . . . . 73.15 108.256 173.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . 0.471 ' HE1' HD22 ' B' ' 44' ' ' LEU . 87.1 m-85 -58.94 -37.05 75.83 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.429 0.692 . . . . 74.41 111.306 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -64.74 -27.98 69.27 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.758 0.823 . . . . 73.22 111.68 -178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.436 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -64.74 -35.65 81.76 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 122.689 0.396 . . . . 71.42 110.902 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 7.9 mp -67.69 -45.49 75.02 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.302 0.641 . . . . 74.23 109.743 176.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -65.67 -35.63 81.34 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 116.018 -0.537 . . . . 71.42 111.391 177.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -70.8 -40.51 72.48 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.314 0.645 . . . . 75.01 110.39 -176.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -75.48 -8.09 55.81 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 122.399 0.279 . . . . 72.53 111.6 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -79.05 -49.95 11.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 122.748 0.419 . . . . 75.24 110.946 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.8 -4.64 16.74 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 112.362 0.505 . . . . 71.32 112.362 -175.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 44.1 tp60 -136.82 139.56 41.83 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 121.327 0.584 . . . . 54.32 110.316 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -87.22 -178.26 6.18 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.279 1.032 . . . . 75.42 110.71 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -65.18 132.47 49.19 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-N 115.898 -0.592 . . . . 75.41 109.544 169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.82 126.97 13.78 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.832 -0.803 . . . . 71.21 108.832 174.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.613 ' HA3' ' HG2' ' D' ' 8' ' ' GLU . . . -88.24 54.75 4.24 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.584 0.553 . . . . 32.11 112.539 -178.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -95.36 170.94 9.02 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.922 0.889 . . . . 72.34 110.603 -179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 175.02 172.04 39.61 Favored Glycine 0 C--O 1.24 0.511 0 N-CA-C 110.912 -0.875 . . . . 52.24 110.912 -177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.2 m -142.55 142.77 32.25 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.201 -0.666 . . . . 61.44 109.201 178.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -95.15 107.63 19.72 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.861 0.864 . . . . 72.01 109.438 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -81.11 110.31 16.5 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.016 0.526 . . . . 72.42 110.116 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -85.42 141.69 29.8 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 115.196 -0.911 . . . . 65.21 109.983 179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -149.43 131.71 15.54 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.988 0.915 . . . . 62.13 109.397 -175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -115.64 93.4 4.25 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.217 -1.031 . . . . 75.42 108.217 173.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.116 0 C-N-CA 124.113 0.965 . . . . 72.0 110.547 -176.552 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.478 0.939 0 N-CA-C 109.689 -0.486 . . . . 75.45 109.689 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 53.6 p -170.04 177.24 4.36 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.702 0.801 . . . . 70.02 110.707 -178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 64.36 -176.5 0.17 Allowed 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 124.656 1.182 . . . . 74.3 112.196 177.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -136.95 136.24 38.41 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 109.858 -0.423 . . . . 74.41 109.858 -177.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -83.18 110.29 17.92 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.238 1.015 . . . . 73.4 110.33 -177.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.436 ' OD1' ' HG2' ' C' ' 8' ' ' GLU . 23.2 t-20 -66.59 135.83 54.72 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.46 0.704 . . . . 73.51 109.457 170.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 11.6 p -118.55 78.0 1.22 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.567 0.747 . . . . 41.32 110.781 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.436 ' HG2' ' OD1' ' C' ' 6' ' ' ASN . 62.1 mm-40 -71.78 144.09 49.31 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.702 -0.681 . . . . 73.41 109.853 168.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.638 ' HA ' HD12 ' C' ' 89' ' ' ILE . 58.0 ttp 65.47 115.76 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 124.912 1.285 . . . . 74.03 113.133 177.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 6.6 m -93.77 80.52 4.21 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 108.588 -0.893 . . . . 62.54 108.588 173.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -104.45 126.91 51.97 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.597 -0.729 . . . . 70.12 109.669 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.676 ' HG2' ' HB3' ' C' ' 85' ' ' SER . 1.6 pm0 -143.23 132.85 23.7 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.855 0.862 . . . . 63.23 109.808 174.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.61 HG22 ' HD3' ' A' ' 130' ' ' PRO . 0.0 OUTLIER -79.56 130.28 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 C-N-CA 123.516 0.726 . . . . 61.52 109.213 178.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.429 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.6 mm100 -92.58 -54.2 3.88 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 116.398 -0.364 . . . . 72.5 110.104 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -169.02 126.84 0.99 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 122.825 0.45 . . . . 72.15 109.961 -173.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.602 HG13 HD11 ' C' ' 13' ' ' ILE . 80.0 mt -106.13 145.0 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 107.428 -1.323 . . . . 54.14 107.428 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.502 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 36.8 p90 -174.38 143.74 0.87 Allowed 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.045 -0.724 . . . . 74.01 109.045 -177.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 59.2 p -69.84 111.35 5.52 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.644 -0.873 . . . . 65.51 108.644 174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -65.36 -42.18 93.04 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.594 0.711 . . . . 71.34 109.506 176.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.618 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 11.7 t70 -149.06 141.87 24.63 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 114.433 -1.258 . . . . 73.24 108.951 -176.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.1 mt -130.46 143.43 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 N-CA-C 107.092 -1.447 . . . . 73.22 107.092 176.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.5 t -152.87 151.29 30.22 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-O 121.41 0.624 . . . . 70.52 110.897 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 73.1 t80 -152.41 121.19 6.51 Favored 'General case' 0 C--O 1.223 -0.319 0 N-CA-C 107.101 -1.444 . . . . 73.15 107.101 175.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 46.3 mt-10 -122.85 112.08 17.44 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.218 -0.66 . . . . 73.13 109.218 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.23 80.96 67.18 Favored Pre-proline 0 C--O 1.241 0.608 0 N-CA-C 108.032 -1.099 . . . . 64.12 108.032 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.2 -36.65 16.08 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.169 1.912 . . . . 75.44 111.135 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.461 ' O ' HG23 ' C' ' 31' ' ' VAL . 1.7 m-20 -85.07 14.25 5.24 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.465 1.106 . . . . 73.34 111.174 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.43 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -42.3 -56.99 4.88 Favored Pre-proline 0 N--CA 1.497 1.88 0 C-N-CA 125.773 1.629 . . . . 75.23 114.599 -171.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.4 -29.43 13.74 Favored 'Trans proline' 0 C--N 1.388 2.644 0 C-N-CA 121.754 1.636 . . . . 74.11 111.997 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 68.1 t60 -69.76 -24.92 63.59 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 124.211 1.004 . . . . 74.53 112.129 179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.567 ' HA ' ' HZ3' ' C' ' 34' ' ' LYS . 58.4 t -64.4 -26.87 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 122.246 0.218 . . . . 61.2 111.226 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -73.02 0.0 12.61 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 112.875 0.695 . . . . 75.34 112.875 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -127.97 9.17 6.28 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.393 0.677 . . . . 72.24 110.959 170.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.698 ' HE3' ' HG3' ' C' ' 71' ' ' GLU . 3.4 ttmp? -87.9 151.92 22.47 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.335 1.054 . . . . 71.24 111.229 -176.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -66.36 125.82 26.84 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.805 1.242 . . . . 73.15 109.617 174.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 34.7 m95 -82.78 70.84 9.85 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.277 0.631 . . . . 73.43 110.181 -176.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -163.08 71.38 1.97 Allowed Pre-proline 0 CA--C 1.556 1.209 0 C-N-CA 123.154 0.581 . . . . 73.02 109.924 175.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -87.04 154.14 8.37 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.86 2.374 . . . . 41.15 110.629 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -87.14 88.08 7.61 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 107.522 -1.288 . . . . 73.43 107.522 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.525 HG23 ' NE1' ' F' ' 290' ' ' TRP . 3.5 m -59.04 137.34 21.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 114.4 -1.273 . . . . 73.43 109.948 175.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' C' ' 64' ' ' VAL . 8.8 tmtt? -135.99 115.77 13.04 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.026 0.531 . . . . 70.43 109.771 -166.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 81.7 mt -87.58 130.37 34.77 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.024 0.929 . . . . 75.21 108.591 173.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.448 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.2 t70 -142.78 106.34 4.63 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.827 0.451 . . . . 62.4 109.933 -175.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.5 mp -111.42 123.02 49.35 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.463 0.705 . . . . 74.31 110.315 -173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.669 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 2.5 m-20 -111.71 154.29 25.2 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.426 -0.953 . . . . 75.1 108.426 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 40.5 p -113.35 111.69 22.41 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.672 0.789 . . . . 74.13 109.379 -175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -125.21 136.49 53.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.159 0.984 . . . . 62.43 108.914 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 61.5 p -134.85 156.68 48.48 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 122.999 0.52 . . . . 73.33 110.283 -176.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.28 126.82 15.08 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.257 1.023 . . . . 61.14 108.376 177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -88.25 117.25 27.02 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.105 -1.072 . . . . 73.0 108.105 172.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.685 HD11 HD12 ' C' ' 83' ' ' ILE . 58.3 mt -87.71 -40.47 14.09 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.502 -0.772 . . . . 72.24 109.521 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.75 -173.01 3.07 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.718 -1.128 . . . . 73.54 110.101 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -64.56 120.56 12.57 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.719 -1.128 . . . . 61.23 109.049 171.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' C' ' 85' ' ' SER . 7.1 m-20 69.64 1.13 3.25 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.978 1.311 . . . . 63.02 112.831 177.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 69.3 t -112.01 95.88 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 107.757 -1.201 . . . . 61.31 107.757 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -119.64 125.59 49.1 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.759 0.824 . . . . 74.13 109.615 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -83.2 119.43 24.54 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.022 -0.99 . . . . 62.45 109.531 173.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.401 HG13 ' CZ ' ' F' ' 281' ' ' PHE . 98.0 t -100.11 123.02 52.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 N-CA-C 107.854 -1.165 . . . . 73.21 107.854 172.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 85.5 t -119.84 132.76 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 123.875 0.87 . . . . 63.3 108.699 175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.78 112.23 23.77 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.38 -0.97 . . . . 73.24 108.38 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.672 ' HG2' ' HG2' ' C' ' 79' ' ' GLN . 1.6 tmm_? -82.53 104.18 12.61 Favored 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 106.847 -1.538 . . . . 72.44 106.847 176.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.2 t -100.22 133.22 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 N-CA-C 108.264 -1.013 . . . . 54.42 108.264 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 94.3 m -128.77 133.88 48.22 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 108.159 -1.052 . . . . 71.02 108.159 175.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' C' ' 41' ' ' LYS . 39.1 t -121.43 112.2 34.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.751 -0.833 . . . . 71.04 108.751 170.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.532 HG23 HD23 ' C' ' 75' ' ' LEU . 2.2 m -99.74 148.72 24.08 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.704 -0.85 . . . . 72.52 108.704 174.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.96 108.43 6.91 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.342 -1.355 . . . . 63.53 107.342 172.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 34.0 m -146.67 139.85 25.53 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 109.06 -0.718 . . . . 73.33 109.06 178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -104.92 45.99 0.94 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.131 0.972 . . . . 64.34 109.228 176.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.88 -116.61 4.05 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 114.795 -1.093 . . . . 73.31 111.043 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -88.36 -19.85 26.1 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.318 0.647 . . . . 73.31 110.024 176.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.698 ' HG3' ' HE3' ' C' ' 34' ' ' LYS . 12.4 tp10 -81.31 99.84 8.87 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 124.178 0.991 . . . . 60.34 109.252 176.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 77.8 m -87.96 131.25 34.68 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 120.984 0.421 . . . . 75.1 110.602 -179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.653 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -79.0 -64.0 1.29 Allowed 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.616 1.166 . . . . 71.5 110.385 176.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -163.34 176.57 9.74 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 121.586 0.708 . . . . 62.41 110.149 177.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.532 HD23 HG23 ' C' ' 65' ' ' THR . 2.9 tm? -141.56 139.13 33.1 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 106.603 -1.628 . . . . 73.22 106.603 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.595 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 50.0 t -143.87 116.25 8.54 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.029 -0.73 . . . . 73.25 109.029 173.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -124.77 131.96 53.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.515 0.726 . . . . 72.0 109.414 -175.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.4 t -132.99 115.73 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 124.233 1.013 . . . . 62.12 109.386 178.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.672 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 40.4 mt-30 -89.45 91.25 8.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.319 1.048 . . . . 64.22 108.209 172.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -88.79 119.04 28.92 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.321 -0.854 . . . . 75.2 110.122 -175.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.39 159.3 15.04 Favored Glycine 0 C--N 1.339 0.735 0 O-C-N 123.588 0.555 . . . . 64.2 112.26 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.04 119.13 0.88 Allowed Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.567 -1.013 . . . . 74.12 110.567 177.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.685 HD12 HD11 ' C' ' 51' ' ' LEU . 18.2 mm -79.78 122.08 34.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 107.607 -1.257 . . . . 72.52 107.607 174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -128.72 124.79 36.48 Favored 'General case' 0 C--O 1.24 0.597 0 C-N-CA 123.548 0.739 . . . . 73.25 109.233 -177.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.676 ' HB3' ' HG2' ' C' ' 12' ' ' GLN . 10.5 t -87.46 109.84 19.88 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 108.091 -1.077 . . . . 60.24 108.091 173.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.417 HD12 ' SD ' ' C' ' 94' ' ' MET . 22.6 pt -115.32 123.24 70.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.801 1.24 . . . . 73.14 109.205 -175.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -150.75 170.42 19.26 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.816 0.446 . . . . 72.34 111.726 -171.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.34 -48.34 1.92 Allowed Glycine 0 C--N 1.345 1.049 0 CA-C-N 115.372 -0.831 . . . . 33.12 113.149 170.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.638 HD12 ' HA ' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.74 176.32 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.401 0.681 . . . . 62.15 110.929 -174.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -146.48 -171.23 3.69 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.028 0.931 . . . . 72.32 109.196 174.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.621 ' HA2' ' HB2' ' F' ' 275' ' ' LYS . . . 69.08 -147.98 47.02 Favored Glycine 0 C--N 1.347 1.14 0 O-C-N 123.527 0.517 . . . . 73.3 113.193 177.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 73.7 p -67.9 -18.69 64.86 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.007 0.923 . . . . 73.35 111.733 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.57 ' HG3' ' HB3' ' F' ' 272' ' ' ASN . 17.6 mt-30 -66.25 -43.95 85.1 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.684 0.794 . . . . 71.1 110.278 178.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.417 ' SD ' HD12 ' C' ' 86' ' ' ILE . 3.5 tmm? -81.32 -44.56 17.47 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.518 -0.765 . . . . 73.51 109.189 179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' F' ' 280' ' ' LEU . . . -61.8 -25.67 67.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.237 1.015 . . . . 64.04 112.117 -177.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.457 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 28.0 t-80 -58.56 -47.16 85.17 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 123.701 0.8 . . . . 71.14 110.334 171.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.9 t -72.86 -55.07 7.18 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.352 -0.386 . . . . 70.24 111.292 -178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 10.2 tt -62.09 -35.83 79.87 Favored 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 123.014 0.525 . . . . 71.22 111.462 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.0 -4.86 62.91 Favored Glycine 0 C--N 1.347 1.184 0 CA-C-O 119.045 -0.864 . . . . 61.22 114.437 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -140.35 -53.07 0.5 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 118.558 1.179 . . . . 62.15 112.681 -176.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -69.76 -48.18 60.26 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 122.973 0.509 . . . . 74.35 112.121 -177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.4 m -60.28 -43.76 94.29 Favored Pre-proline 0 CA--C 1.565 1.528 0 C-N-CA 123.449 0.7 . . . . 72.22 111.988 179.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.94 -47.37 21.69 Favored 'Trans proline' 0 C--N 1.396 3.062 0 C-N-CA 122.78 2.32 . . . . 65.43 113.909 163.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -62.37 -29.12 70.25 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 123.392 0.677 . . . . 34.24 112.178 179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.2 mm -75.1 -50.84 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 122.926 0.491 . . . . 62.11 110.252 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 81.1 mt -79.14 -18.41 53.23 Favored 'General case' 0 CA--C 1.543 0.691 0 CA-C-N 115.909 -0.587 . . . . 73.44 112.225 -170.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -60.52 -54.6 53.27 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 117.677 -1.154 . . . . 71.31 112.702 -176.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.79 -32.2 92.63 Favored 'Trans proline' 0 C--N 1.391 2.78 0 C-N-CA 121.939 1.759 . . . . 75.1 112.843 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.402 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.0 m-85 -66.45 -47.32 73.54 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.541 0.737 . . . . 73.14 110.962 177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.14 -37.91 84.62 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.122 0.569 . . . . 72.15 110.524 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.595 ' HG3' HD23 ' C' ' 128' ' ' LEU . 56.2 ttt180 -61.1 -49.17 78.4 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.907 1.283 . . . . 74.2 110.943 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.34 -29.99 69.69 Favored 'General case' 0 N--CA 1.482 1.174 0 O-C-N 123.619 0.574 . . . . 73.14 110.082 -176.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.477 ' SG ' HG12 ' C' ' 21' ' ' ILE . 42.0 t -73.91 -36.56 64.73 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 123.182 0.593 . . . . 74.01 111.42 177.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.595 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 91.7 mt -68.63 -47.85 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 C-N-CA 123.486 0.714 . . . . 74.04 109.754 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 98.7 m -60.45 -35.78 76.67 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 125.077 1.351 . . . . 71.34 111.306 177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 22.8 t -68.28 -41.68 80.67 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 123.51 0.724 . . . . 74.21 109.844 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.613 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -67.37 -35.09 78.64 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.334 0.654 . . . . 75.23 111.796 179.078 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' C' ' 114' ' ' ILE . 96.7 t -62.56 -44.11 99.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 C-N-CA 123.407 0.683 . . . . 73.31 109.896 173.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 84.7 p -75.03 -25.78 58.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.549 -0.75 . . . . 51.13 112.223 -174.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.526 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.2 mtt-85 -74.58 -40.17 61.78 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.69 0.796 . . . . 74.1 110.391 175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.94 3.1 66.13 Favored Glycine 0 C--N 1.354 1.571 0 O-C-N 123.736 0.647 . . . . 64.22 112.56 172.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.0 p 61.31 24.32 14.44 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 126.154 1.781 . . . . 54.23 112.533 170.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -83.88 154.65 64.6 Favored Pre-proline 0 C--O 1.242 0.659 0 CA-C-N 114.739 -1.119 . . . . 74.12 110.118 178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.771 ' HD3' HD13 ' F' ' 301' ' ' ILE . 92.9 Cg_exo -47.71 137.16 21.27 Favored 'Trans proline' 0 C--N 1.378 2.103 0 C-N-CA 123.483 2.789 . . . . 75.12 113.154 175.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' B' ' 125' ' ' GLN . 23.7 mm-40 -60.95 147.26 43.91 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 114.205 1.187 . . . . 63.21 114.205 -171.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 68.3 tp -125.14 96.1 4.73 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.483 -1.235 . . . . 74.44 108.693 177.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -100.8 105.1 16.37 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.489 -0.93 . . . . 74.42 108.489 177.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.595 HD23 ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -71.15 151.26 44.59 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.699 0.8 . . . . 74.42 111.935 -178.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.09 155.61 72.35 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 115.151 -0.931 . . . . 51.13 109.946 172.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.662 ' HG2' HG21 ' A' ' 13' ' ' ILE . 34.4 Cg_exo -60.54 102.63 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.375 2.05 . . . . 45.12 111.95 171.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 48.5 t -96.18 106.25 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 106.7 -1.592 . . . . 74.42 106.7 173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.414 ' ND2' HD12 ' A' ' 105' ' ' ILE . 78.7 m-20 -113.03 91.63 3.72 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 115.109 -0.951 . . . . 72.52 109.767 -169.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.521 ' HD1' ' SD ' ' F' ' 286' ' ' MET . 89.9 m-85 -64.35 -43.91 93.1 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.032 -0.985 . . . . 72.32 110.878 -177.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -71.75 -38.77 70.34 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.245 -0.889 . . . . 74.24 111.419 -176.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -67.59 -28.84 68.1 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 115.413 -0.812 . . . . 70.51 111.63 -177.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 61.9 tp -54.45 -45.57 73.11 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.693 0.797 . . . . 73.54 110.668 173.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -64.58 -43.07 95.03 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 115.772 -0.649 . . . . 74.13 111.008 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 59.5 mtt -60.35 -42.96 96.81 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.076 0.95 . . . . 72.51 112.714 -175.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -60.31 -36.56 78.18 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 123.601 0.76 . . . . 72.04 112.57 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -61.85 -83.35 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.188 0.995 . . . . 73.23 112.238 -171.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 46.8 tp -73.87 105.58 5.2 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.28 0.632 . . . . 62.51 110.878 -173.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -90.39 130.4 36.48 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 107.552 -1.277 . . . . 60.12 107.552 175.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -78.71 -73.63 0.32 Allowed 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.153 0.581 . . . . 72.35 110.09 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -172.76 -179.7 2.17 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.861 0.865 . . . . 64.33 110.059 -173.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -109.53 140.73 42.95 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.136 0.974 . . . . 55.25 108.774 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -116.97 -134.86 5.38 Favored Glycine 0 C--N 1.346 1.104 0 N-CA-C 111.121 -0.792 . . . . 75.23 111.121 -179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 31.8 mm-40 -111.46 175.47 5.41 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.294 0.638 . . . . 75.33 110.569 176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -176.13 -154.43 11.6 Favored Glycine 0 C--N 1.336 0.568 0 CA-C-N 115.012 -0.995 . . . . 71.1 110.964 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.2 m 51.51 53.8 12.16 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 124.795 1.238 . . . . 64.24 111.943 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -123.36 94.13 4.16 Favored 'General case' 0 C--N 1.348 0.534 0 N-CA-C 108.674 -0.862 . . . . 71.41 108.674 176.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.57 106.93 15.69 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.994 -1.003 . . . . 74.13 110.358 -177.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 30.1 p-80 -109.57 136.67 48.57 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 108.72 -0.844 . . . . 73.5 108.72 169.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -145.92 137.77 25.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.686 0.794 . . . . 73.52 109.507 178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -153.68 155.98 37.01 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.133 0.973 . . . . 65.35 109.308 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.154 0 N-CA-C 108.985 -0.746 . . . . 55.12 108.985 -178.101 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.918 -0.401 . . . . 63.32 109.918 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.4 t -132.13 81.66 1.98 Allowed 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 107.448 -1.316 . . . . 72.22 107.448 174.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 -79.02 -52.98 7.49 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.153 -0.93 . . . . 73.1 111.689 -169.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 69.05 -66.84 0.24 Allowed 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 125.416 1.486 . . . . 74.51 110.813 -171.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 61.7 t30 63.76 39.25 8.63 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.113 1.365 . . . . 62.01 110.843 179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -119.76 -64.64 1.24 Allowed 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 124.078 0.951 . . . . 53.32 108.908 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 7.6 p -153.2 83.22 1.2 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 124.121 0.968 . . . . 71.35 109.547 -178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.613 ' HG2' ' HA3' ' B' ' 146' ' ' GLY . 4.6 mp0 -90.2 -165.32 1.32 Allowed 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.365 0.666 . . . . 70.13 109.796 -179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 9.1 ttp -33.28 125.61 0.38 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.249 1.02 . . . . 74.12 111.961 167.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 41.8 m -129.96 137.53 50.38 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.11 -0.7 . . . . 72.25 109.11 175.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -157.79 98.62 1.65 Allowed 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.057 -1.46 . . . . 73.0 107.057 179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -130.18 128.1 41.03 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 107.652 -1.24 . . . . 74.43 107.652 175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.421 HD13 HG21 ' D' ' 105' ' ' ILE . 17.5 mt -70.87 136.28 26.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 O-C-N 123.685 0.616 . . . . 63.42 110.329 -174.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.612 ' HA ' ' HB3' ' F' ' 304' ' ' PRO . 73.7 mt-30 -94.71 -47.54 6.45 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 115.682 -0.69 . . . . 74.44 110.29 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -155.04 145.88 22.48 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.3 0.64 . . . . 71.32 110.558 -166.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 1.1 mp -133.23 137.02 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 N-CA-C 105.033 -2.21 . . . . 75.24 105.033 169.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 28.8 p90 -169.22 153.3 5.35 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 121.634 0.73 . . . . 74.41 110.691 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 77.0 p -84.4 118.43 24.25 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.688 -0.856 . . . . 74.2 108.688 171.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.43 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 39.4 mtpt -80.2 -37.61 32.88 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.236 0.541 . . . . 54.52 110.228 176.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.416 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 22.3 t70 -151.1 140.87 21.82 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 114.914 -1.039 . . . . 72.43 109.129 -176.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.613 HG21 ' HE2' ' C' ' 117' ' ' MET . 67.1 mt -135.98 145.65 30.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 C-N-CA 124.252 1.021 . . . . 73.44 108.25 178.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . 0.463 ' HB3' ' HB3' ' D' ' 77' ' ' GLU . 45.2 t -147.88 133.52 18.84 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.734 1.214 . . . . 54.34 108.244 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.574 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 73.4 t80 -144.68 117.58 8.79 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 105.849 -1.908 . . . . 71.11 105.849 170.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -122.14 129.0 51.93 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.294 -0.632 . . . . 71.31 109.294 -178.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -120.21 79.67 27.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 N-CA-C 108.205 -1.035 . . . . 73.04 108.205 174.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -70.86 -28.28 20.15 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.66 2.24 . . . . 62.12 112.743 -174.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 40.6 m-20 -113.71 40.69 2.36 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 108.501 -0.925 . . . . 72.43 108.501 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.502 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -58.97 -65.08 2.22 Favored Pre-proline 0 CA--C 1.568 1.666 0 N-CA-C 114.139 1.163 . . . . 61.12 114.139 -167.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -81.82 -11.0 11.53 Favored 'Trans proline' 0 C--N 1.393 2.901 0 CA-C-N 122.624 1.973 . . . . 74.3 112.067 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -71.4 -42.9 67.78 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.931 1.292 . . . . 75.14 110.107 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 p -74.23 -35.37 40.2 Favored 'Isoleucine or valine' 0 C--N 1.347 0.464 0 N-CA-C 109.504 -0.554 . . . . 74.1 109.504 -176.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.7 m-30 -58.05 -12.13 3.12 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 124.395 1.078 . . . . 74.11 113.55 -176.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -77.64 -36.55 51.42 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.181 0.593 . . . . 75.45 110.685 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.7 60.97 1.67 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.861 0.464 . . . . 75.21 111.399 167.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -98.6 101.23 12.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.62 -0.675 . . . . 72.03 111.044 -169.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 55.5 m95 -122.59 -158.98 0.81 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.195 0.998 . . . . 64.14 108.671 -173.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -58.24 106.52 0.71 Allowed Pre-proline 0 N--CA 1.483 1.223 0 C-N-CA 123.539 0.736 . . . . 74.3 110.589 -173.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.35 122.21 5.06 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.819 2.346 . . . . 71.52 110.515 -177.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -70.96 111.28 6.22 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.902 -1.148 . . . . 61.44 107.902 173.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.611 HG23 ' HE1' ' G' ' 290' ' ' TRP . 29.3 m -100.9 144.86 12.21 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 C-N-CA 123.318 0.647 . . . . 63.42 110.081 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -120.05 129.22 54.13 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.09 0.956 . . . . 63.24 108.468 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -99.01 112.11 24.33 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 109.506 -0.553 . . . . 75.23 109.506 -176.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.785 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 12.9 m-20 -108.07 132.05 53.96 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.994 0.918 . . . . 75.21 109.912 -177.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.613 HD11 HG12 ' G' ' 288' ' ' VAL . 5.0 mp -110.8 131.41 55.08 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.262 0.625 . . . . 73.12 109.434 -178.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.532 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.8 t70 -133.55 131.46 39.77 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.487 -1.301 . . . . 52.41 107.487 172.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 60.2 p -105.52 141.81 36.35 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.98 0.512 . . . . 42.34 109.883 -177.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -150.64 164.04 37.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.787 0.835 . . . . 54.12 109.071 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.55 ' HB2' HD11 ' G' ' 278' ' ' LEU . 51.1 p -174.92 161.04 2.94 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.376 0.67 . . . . 74.32 110.896 -178.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 86.6 p -152.17 145.71 24.91 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.76 0.824 . . . . 73.43 109.474 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -81.92 130.93 35.22 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.284 -0.636 . . . . 64.31 109.284 173.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' D' ' 57' ' ' GLU . 54.6 mt -104.38 -34.93 8.11 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.134 0.573 . . . . 65.3 109.511 176.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.462 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -162.51 -174.88 4.2 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.159 0.584 . . . . 71.24 111.082 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -67.34 116.14 7.77 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.535 -1.211 . . . . 71.32 109.189 176.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 68.05 7.25 5.7 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 124.465 1.106 . . . . 64.14 112.126 -179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.462 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 88.1 t -113.51 119.06 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.322 1.049 . . . . 64.55 108.533 175.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -139.49 134.2 31.96 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 122.705 0.402 . . . . 75.12 110.055 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' D' ' 51' ' ' LEU . 11.0 tt0 -88.22 114.5 24.9 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.857 -1.164 . . . . 72.25 107.857 170.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.09 120.11 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 N-CA-C 107.617 -1.253 . . . . 44.54 107.617 173.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.42 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 41.9 t -105.61 131.93 53.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 123.668 0.787 . . . . 53.33 109.064 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -120.24 108.15 13.84 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 107.497 -1.297 . . . . 74.25 107.497 173.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.532 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.3 ttm-85 -84.11 106.24 15.59 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.991 -0.744 . . . . 72.15 108.991 175.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 88.4 t -91.26 130.49 40.35 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 108.267 -1.012 . . . . 73.22 108.267 169.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.785 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 54.2 m -124.73 147.47 48.62 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.429 0.691 . . . . 72.5 109.15 178.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 97.0 t -135.95 115.74 17.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.666 1.186 . . . . 74.24 109.07 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 32.5 m -106.29 103.63 13.15 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 123.919 0.888 . . . . 74.11 109.446 178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.431 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -97.18 125.06 41.45 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.456 0.302 . . . . 62.42 110.386 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 52.2 p -125.55 125.47 43.27 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 124.001 0.92 . . . . 63.52 109.359 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.543 ' HB2' ' HB2' ' D' ' 73' ' ' ALA . 3.2 tm? -104.47 114.05 28.02 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 108.455 -0.943 . . . . 75.13 108.455 176.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -111.22 3.84 Favored Glycine 0 C--N 1.348 1.212 0 O-C-N 123.621 0.575 . . . . 34.52 111.998 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -112.33 8.38 19.59 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.12 0.968 . . . . 74.42 110.97 -177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -137.0 175.26 9.77 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.492 0.717 . . . . 64.44 110.119 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 94.3 m -80.28 137.06 36.56 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.495 0.718 . . . . 51.1 111.07 177.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' D' ' 68' ' ' LEU . . . -84.89 -63.97 1.24 Allowed 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 108.718 -0.845 . . . . 71.03 108.718 170.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.1 p90 -152.46 168.67 24.75 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 114.423 -1.262 . . . . 73.21 109.994 176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 97.7 mt -132.7 151.62 51.93 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 107.89 -1.152 . . . . 73.54 107.89 177.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.633 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.6 t -154.9 141.29 18.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.155 0.582 . . . . 71.21 109.939 -177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.463 ' HB3' ' HB3' ' D' ' 22' ' ' SER . 33.3 tt0 -158.14 134.68 9.59 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 123.782 0.833 . . . . 71.13 109.995 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -138.94 126.23 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 123.746 0.818 . . . . 74.42 109.302 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -97.22 87.22 4.12 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 107.678 -1.23 . . . . 72.01 107.678 174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -80.89 98.76 8.01 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.847 -0.615 . . . . 70.12 109.562 -177.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -91.49 144.36 17.13 Favored Glycine 0 C--N 1.344 0.987 0 CA-C-N 115.596 -0.729 . . . . 45.55 111.698 178.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.49 131.05 3.74 Favored Glycine 0 C--N 1.334 0.447 0 N-CA-C 111.314 -0.715 . . . . 71.05 111.314 -179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 49.0 mt -90.33 126.98 43.12 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 N-CA-C 108.376 -0.972 . . . . 61.24 108.376 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -126.96 144.39 51.02 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.01 0.924 . . . . 64.2 110.075 -176.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 4.4 m -96.81 94.51 7.3 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.51 -0.922 . . . . 74.25 108.51 174.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 15.1 mt -108.78 101.06 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 N-CA-C 109.361 -0.607 . . . . 71.35 109.361 -175.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.31 168.19 17.3 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.42 1.088 . . . . 61.34 109.838 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.81 -11.33 59.97 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 114.343 0.497 . . . . 44.53 114.343 174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -139.21 154.46 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.021 0.928 . . . . 70.21 110.781 -173.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.57 -174.52 4.79 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.283 1.033 . . . . 75.33 110.043 172.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.54 -140.51 39.01 Favored Glycine 0 CA--C 1.535 1.296 0 N-CA-C 114.282 0.473 . . . . 65.01 114.282 174.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 60.9 p -70.84 -32.6 69.69 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 124.315 1.046 . . . . 75.12 112.037 -174.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -68.19 -43.45 78.06 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.715 0.806 . . . . 70.22 110.649 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -74.06 -32.81 63.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.811 -0.631 . . . . 61.51 110.506 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.426 ' HB1' ' HB2' ' G' ' 280' ' ' LEU . . . -60.38 -43.37 96.65 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.943 0.497 . . . . 53.3 110.461 174.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -60.09 -36.05 76.56 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.715 0.806 . . . . 74.4 110.884 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.54 -50.43 67.36 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 122.864 0.465 . . . . 75.43 111.498 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.485 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 2.9 pp -75.63 -23.35 56.35 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 111.974 0.361 . . . . 60.44 111.974 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . 0.463 ' HA3' HD23 ' G' ' 280' ' ' LEU . . . -99.33 -0.98 56.84 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.53 -0.595 . . . . 72.4 114.361 -172.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.6 -60.69 0.51 Allowed 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 117.241 0.52 . . . . 51.42 111.068 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -68.18 -45.71 72.71 Favored 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.577 0.751 . . . . 64.25 111.51 -173.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.485 ' SG ' ' HA ' ' D' ' 98' ' ' LEU . 63.5 m -65.66 -45.76 67.06 Favored Pre-proline 0 CA--C 1.565 1.545 0 CA-C-O 118.695 -0.669 . . . . 72.13 112.018 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.408 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 84.0 Cg_exo -54.25 -34.93 81.62 Favored 'Trans proline' 0 C--N 1.397 3.101 0 C-N-CA 122.665 2.243 . . . . 70.32 113.908 168.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -66.85 -26.43 66.9 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 122.85 0.46 . . . . 63.14 111.775 177.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.421 HG21 HD13 ' D' ' 13' ' ' ILE . 32.6 mm -75.71 -47.92 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 C-N-CA 123.165 0.586 . . . . 74.55 109.775 174.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.6 mt -76.02 -32.23 59.27 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.154 -0.93 . . . . 53.01 112.609 -169.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 57.6 t80 -62.71 -44.57 86.75 Favored Pre-proline 0 CA--C 1.563 1.445 0 CA-C-O 118.177 -0.916 . . . . 65.22 113.042 -171.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.98 -39.02 80.48 Favored 'Trans proline' 0 C--N 1.388 2.628 0 C-N-CA 122.552 2.168 . . . . 53.24 113.996 171.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -79.87 -28.31 39.97 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.156 0.582 . . . . 75.53 111.906 -178.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.22 -50.21 66.72 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 108.798 -0.815 . . . . 65.43 108.798 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -60.84 -35.08 75.63 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 125.003 1.321 . . . . 71.1 111.396 -179.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.526 ' HG2' HH12 ' C' ' 120' ' ' ARG . 20.0 tt0 -56.05 -53.54 55.74 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.021 0.928 . . . . 75.23 110.424 174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.431 ' SG ' HD13 ' D' ' 21' ' ' ILE . 49.8 t -67.25 -42.3 84.14 Favored 'General case' 0 C--N 1.35 0.597 0 CA-C-N 114.806 -1.088 . . . . 62.1 111.306 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.633 HG23 ' SG ' ' D' ' 76' ' ' CYS . 80.7 mt -58.57 -60.05 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 C-N-CA 123.822 0.849 . . . . 50.14 110.486 178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.469 HG23 ' HB3' ' D' ' 125' ' ' GLN . 97.6 m -52.51 -43.56 65.17 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 124.512 1.125 . . . . 72.31 112.1 -176.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 28.9 t -68.15 -36.96 80.49 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.501 -0.772 . . . . 73.02 111.014 -177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 77.7 mtm -67.87 -37.77 82.22 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 122.662 0.385 . . . . 45.13 111.315 176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.464 HG23 ' O ' ' D' ' 114' ' ' ILE . 95.9 t -65.41 -41.6 91.53 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.909 0 CA-C-N 115.324 -0.853 . . . . 73.33 110.337 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 78.3 p -72.28 -30.47 64.85 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.162 0.585 . . . . 62.41 111.388 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -71.51 -29.95 65.38 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.927 0.491 . . . . 74.12 110.56 173.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.91 6.67 73.66 Favored Glycine 0 C--N 1.355 1.621 0 O-C-N 123.591 0.557 . . . . 45.24 112.456 174.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 32.8 p 60.5 25.45 15.08 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 126.591 1.956 . . . . 74.33 113.342 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -96.18 159.68 31.57 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.575 1.15 . . . . 72.24 108.441 168.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.453 ' HD3' ' CZ ' ' G' ' 297' ' ' TYR . 61.5 Cg_endo -69.76 135.01 29.36 Favored 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 122.473 2.116 . . . . 73.2 111.021 -176.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.469 ' HB3' HG23 ' D' ' 115' ' ' THR . 26.7 mt-30 -49.19 120.03 3.71 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.381 1.051 . . . . 74.15 110.842 -177.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 51.5 tp -105.02 94.05 5.03 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.501 -0.925 . . . . 73.02 108.501 -174.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 3.7 p30 -100.65 104.23 15.54 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 114.207 -1.361 . . . . 73.32 107.946 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -74.37 143.76 44.7 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.863 -0.608 . . . . 62.34 111.459 -175.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.59 ' HB2' HG21 ' E' ' 306' ' ' VAL . . . -63.46 133.3 95.44 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 114.968 -1.014 . . . . 63.45 110.757 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 9.7 Cg_endo -80.39 124.61 5.37 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.643 2.229 . . . . 62.12 111.119 -176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.524 HG22 HD21 ' G' ' 291' ' ' LEU . 60.3 t -107.72 109.36 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 108.628 -0.879 . . . . 50.14 108.628 -179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -72.63 96.37 1.98 Allowed 'General case' 0 C--O 1.24 0.569 0 N-CA-C 108.043 -1.095 . . . . 71.24 108.043 174.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -62.19 -31.1 71.57 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.302 0.641 . . . . 72.34 112.023 -174.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -54.84 -37.3 66.01 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.844 0.857 . . . . 75.53 111.346 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.12 -40.36 97.39 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.536 0.735 . . . . 63.53 110.707 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 71.3 mt -65.03 -42.28 94.47 Favored 'General case' 0 N--CA 1.479 0.989 0 O-C-N 123.919 0.762 . . . . 54.32 110.631 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -64.83 -41.86 95.41 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 115.812 -0.631 . . . . 63.42 111.211 176.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 75.5 mtm -72.83 -30.42 64.02 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 122.994 0.518 . . . . 63.21 111.52 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.472 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 79.6 m-20 -60.19 -37.72 81.08 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 123.542 0.737 . . . . 72.02 110.426 176.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -56.86 -31.7 65.08 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.121 0.969 . . . . 75.11 111.055 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -84.9 -48.84 8.91 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.015 0.526 . . . . 74.3 111.583 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.472 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 13.8 pt20 -89.02 33.33 0.79 Allowed 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 113.293 0.849 . . . . 75.11 113.293 -164.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -116.62 48.63 1.25 Allowed 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.733 -1.21 . . . . 72.22 107.733 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 21.8 mm-40 -143.52 -55.11 0.38 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 113.208 -1.815 . . . . 65.05 107.188 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.45 111.43 10.72 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.678 -0.86 . . . . 62.31 108.678 175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.14 120.47 5.62 Favored Glycine 0 C--N 1.345 1.075 0 O-C-N 123.817 0.698 . . . . 61.34 111.789 178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -130.67 110.43 11.37 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 107.911 -1.144 . . . . 52.34 107.911 178.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' B' ' 5' ' ' ASN . . . -158.83 143.58 9.42 Favored Glycine 0 C--N 1.34 0.75 0 N-CA-C 110.781 -0.928 . . . . 51.34 110.781 178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 72.1 p -86.2 -13.17 47.71 Favored 'General case' 0 N--CA 1.483 1.183 0 CA-C-N 117.585 0.693 . . . . 64.44 112.04 -173.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -78.92 151.83 31.48 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.184 0.994 . . . . 72.11 109.44 176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . 0.413 ' HB3' HE21 ' B' ' 4' ' ' GLN . 11.0 pt-20 -89.01 -164.51 1.15 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 124.074 0.949 . . . . 75.03 113.15 -168.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . 0.615 ' HE1' ' HB3' ' D' ' 155' ' ' ALA . 52.9 t-80 -126.75 147.45 49.98 Favored 'General case' 0 C--N 1.358 0.953 0 C-N-CA 124.58 1.152 . . . . 75.41 109.033 174.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -73.65 -179.47 3.6 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.684 0.794 . . . . 50.25 111.911 175.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.25 93.69 1.12 Allowed 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 122.834 0.454 . . . . 65.1 110.768 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . 0.615 ' HB3' ' HE1' ' D' ' 152' ' ' HIS . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 124.568 1.147 . . . . 74.2 108.106 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.924 0 N-CA-C 109.074 -0.713 . . . . 52.32 109.074 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . 0.439 ' HA ' HE22 ' E' ' 274' ' ' GLN . 88.2 m-20 -117.03 75.88 1.0 Allowed 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.508 0.723 . . . . 71.5 110.46 -176.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 80.9 mm-40 -120.11 22.09 11.55 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 115.126 -0.943 . . . . 74.54 109.301 172.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . 0.439 HE22 ' HA ' ' E' ' 272' ' ' ASN . 1.6 mp0 -74.26 118.18 16.92 Favored 'General case' 0 C--N 1.347 0.459 0 C-N-CA 124.198 0.999 . . . . 71.42 109.759 -177.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -107.65 98.38 24.17 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.139 0.976 . . . . 72.23 108.381 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -60.7 88.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.381 2.266 0 C-N-CA 122.906 2.404 . . . . 74.1 112.368 -176.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 41.4 tp -73.45 -24.28 60.21 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.706 -1.134 . . . . 71.12 109.75 174.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 2.8 pp -76.56 169.43 18.28 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-N 115.093 -0.958 . . . . 73.32 110.896 172.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -158.63 -68.29 0.01 OUTLIER Glycine 0 C--N 1.34 0.802 0 N-CA-C 111.294 -0.722 . . . . 24.44 111.294 179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.484 HD12 ' HB1' ' A' ' 95' ' ' ALA . 3.2 tm? -74.12 123.21 24.0 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 122.802 0.441 . . . . 62.31 110.535 -178.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . 0.501 ' CZ ' ' HB ' ' A' ' 46' ' ' THR . 1.6 t80 -167.9 13.91 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.601 1.188 . . . . 72.24 109.406 170.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -79.44 -16.44 56.13 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 123.704 0.801 . . . . 41.34 112.037 -173.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -66.25 -72.89 0.14 Allowed 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 108.608 -0.886 . . . . 72.53 108.608 174.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 67.16 -80.59 0.14 Allowed Glycine 0 C--N 1.352 1.435 0 O-C-N 123.882 0.739 . . . . 72.05 114.789 172.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -78.22 105.79 9.69 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.878 0.871 . . . . 73.33 109.762 -179.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -78.53 143.85 64.43 Favored Pre-proline 0 CA--C 1.551 1.005 0 N-CA-C 108.767 -0.827 . . . . 65.21 108.767 168.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.55 40.92 1.04 Allowed 'Trans proline' 0 C--N 1.383 2.357 0 C-N-CA 123.493 2.796 . . . . 72.04 113.278 -177.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 98.4 t -71.25 -52.87 23.74 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 123.896 0.879 . . . . 53.13 110.3 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . 0.408 ' O ' HD13 ' A' ' 42' ' ' LEU . 32.4 mmt180 62.16 -77.52 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.153 1.381 . . . . 61.32 109.984 -170.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -134.18 144.55 48.55 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.571 0.748 . . . . 74.51 109.754 173.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.735 HD13 ' HB3' ' A' ' 129' ' ' ALA . 5.2 mp -83.24 -46.01 13.17 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.996 0.918 . . . . 71.11 109.879 -175.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -157.14 144.8 11.06 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-O 119.041 -0.866 . . . . 41.3 111.152 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -67.62 133.29 29.36 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.74 2.293 . . . . 71.43 111.198 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . 0.572 ' HB3' ' HA ' ' G' ' 306' ' ' VAL . 0.0 OUTLIER -155.91 15.68 0.35 Allowed 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.86 0.864 . . . . 73.0 111.359 -176.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 66.3 157.05 0.11 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.173 1.389 . . . . 71.22 112.483 -175.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 27.9 m -99.62 -43.87 6.34 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 108.525 -0.917 . . . . 53.34 108.525 171.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.45 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 51.0 m-85 -78.79 110.59 14.09 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 114.965 -1.016 . . . . 74.43 110.58 176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -116.65 8.14 13.74 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.638 1.175 . . . . 65.01 111.393 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . 0.492 ' HA3' ' HB ' ' G' ' 301' ' ' ILE . . . 108.86 101.01 2.67 Favored Glycine 0 C--N 1.361 1.944 0 N-CA-C 115.05 0.78 . . . . 74.24 115.05 174.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -162.05 -110.88 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.191 -1.411 . . . . 53.13 107.191 168.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 48.1 mm 68.02 -14.73 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.574 1.883 0 C-N-CA 125.956 1.702 . . . . 63.32 114.713 173.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 48.93 95.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 125.563 1.545 . . . . 64.43 112.389 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -71.77 129.65 88.03 Favored Pre-proline 0 CA--C 1.547 0.84 0 CA-C-O 119.123 -0.465 . . . . 74.41 109.958 175.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_exo -41.68 110.89 0.15 Allowed 'Trans proline' 0 C--N 1.383 2.394 0 C-N-CA 123.911 3.074 . . . . 32.44 113.991 170.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -109.9 -176.53 3.03 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.27 1.028 . . . . 61.15 109.616 175.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . 0.59 HG21 ' HB2' ' D' ' 129' ' ' ALA . 59.2 t 68.69 126.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 C-N-CA 124.672 1.189 . . . . 70.33 111.844 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . 0.526 ' H ' ' HA3' ' G' ' 292' ' ' GLY . 62.3 m -74.58 -66.71 0.71 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 109.21 -0.663 . . . . 72.54 109.21 175.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 91.0 m -159.35 160.47 35.05 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.603 0.761 . . . . 60.14 110.941 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 7.0 m -128.33 84.21 63.87 Favored Pre-proline 0 CA--C 1.551 0.991 0 N-CA-C 107.647 -1.242 . . . . 63.0 107.647 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo . . . . . 0 C--N 1.377 2.048 0 C-N-CA 123.289 2.659 . . . . 75.31 111.035 174.369 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.01 -0.367 . . . . 53.44 110.01 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . 0.57 ' HB3' ' HG3' ' C' ' 93' ' ' GLN . 85.1 m-20 74.25 -67.47 0.26 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 126.169 1.788 . . . . 74.12 112.914 172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -73.09 -158.35 0.05 Allowed 'General case' 0 CA--C 1.559 1.324 0 C-N-CA 124.556 1.142 . . . . 73.04 112.289 -178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 76.06 11.26 3.01 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.255 1.422 . . . . 71.42 109.89 -172.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . 0.621 ' HB2' ' HA2' ' C' ' 91' ' ' GLY . 97.1 mttt -132.29 134.22 24.7 Favored Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 124.502 1.121 . . . . 74.14 108.564 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -57.73 160.64 14.22 Favored 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.745 2.297 . . . . 72.02 112.446 172.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.8 mp -57.39 -60.1 4.15 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.61 0.764 . . . . 72.22 110.817 -176.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 37.9 tp -67.49 93.2 0.34 Allowed 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.039 0.535 . . . . 60.51 110.088 -177.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -166.02 158.11 30.87 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.751 -0.94 . . . . 64.14 110.751 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . 0.44 ' HB3' ' HB1' ' C' ' 95' ' ' ALA . 5.2 tt 60.85 75.99 0.39 Allowed 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.366 1.066 . . . . 73.21 108.795 -176.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . 0.401 ' CZ ' HG13 ' C' ' 58' ' ' VAL . 12.4 t80 -170.96 45.11 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.108 0 CA-C-O 121.773 0.797 . . . . 74.32 109.621 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -151.95 97.2 2.31 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.689 0.796 . . . . 73.44 109.485 -178.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 49.5 m-20 57.49 77.31 0.28 Allowed 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.757 1.223 . . . . 74.01 111.511 -177.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -148.59 30.95 1.26 Allowed Glycine 0 C--N 1.34 0.767 0 CA-C-N 115.297 -0.865 . . . . 64.34 112.207 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -74.22 137.63 43.17 Favored 'General case' 0 C--O 1.242 0.69 0 N-CA-C 108.921 -0.77 . . . . 73.13 108.921 174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . 0.521 ' SD ' ' HD1' ' C' ' 133' ' ' PHE . 1.0 OUTLIER -64.43 158.27 67.26 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.365 1.066 . . . . 63.43 109.953 178.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.21 77.88 0.12 Allowed 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.641 2.227 . . . . 54.44 112.517 176.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 64.0 t -104.17 84.87 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 124.522 1.129 . . . . 75.11 108.775 -177.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -82.83 -76.34 0.28 Allowed 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 106.198 -1.778 . . . . 71.42 106.198 168.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . 0.525 ' NE1' HG23 ' C' ' 40' ' ' VAL . 54.2 m95 -152.66 -177.62 6.36 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.346 1.058 . . . . 74.03 109.872 170.054 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -137.84 86.34 2.17 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 106.709 -1.589 . . . . 74.54 106.709 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 108.21 136.49 7.9 Favored Glycine 0 CA--C 1.533 1.164 0 CA-C-N 114.922 -1.035 . . . . 73.53 110.601 -167.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.38 122.27 11.25 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 123.158 2.572 . . . . 71.13 112.563 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . 0.492 ' HB2' ' NZ ' ' F' ' 294' ' ' LYS . 7.9 mtmp? 68.38 176.01 0.27 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.338 1.455 . . . . 74.21 112.656 179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -169.69 135.66 1.52 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 113.823 -1.535 . . . . 61.32 107.378 170.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . 0.608 HG22 ' HD1' ' F' ' 297' ' ' TYR . 56.0 m 73.01 159.91 0.23 Allowed 'General case' 0 CA--C 1.568 1.648 0 O-C-N 123.73 0.644 . . . . 74.1 112.696 169.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.608 ' HD1' HG22 ' F' ' 296' ' ' THR . 5.1 m-85 65.83 78.16 0.28 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.936 1.294 . . . . 75.3 112.072 178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -153.36 157.44 40.03 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.086 0.955 . . . . 74.42 109.043 168.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . 0.436 ' HA3' ' HA3' ' H' ' 299' ' ' GLY . . . 86.43 -131.75 10.72 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 115.906 -0.588 . . . . 54.23 112.16 -174.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -152.57 129.81 11.24 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.135 0.574 . . . . 73.13 110.121 -173.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.771 HD13 ' HD3' ' C' ' 124' ' ' PRO . 38.7 pt -117.45 14.99 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 C-N-CA 124.284 1.033 . . . . 62.32 110.347 173.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -93.9 -174.24 3.37 Favored 'General case' 0 CA--C 1.558 1.268 0 C-N-CA 124.488 1.115 . . . . 71.5 109.455 -175.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 4.5 mmpt? 74.23 108.24 0.03 OUTLIER Pre-proline 0 N--CA 1.481 1.083 0 C-N-CA 125.412 1.485 . . . . 72.24 111.833 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . 0.612 ' HB3' ' HA ' ' D' ' 14' ' ' GLN . 35.5 Cg_exo -60.5 104.73 0.27 Allowed 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 123.02 2.48 . . . . 74.34 111.739 173.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -92.84 -5.71 50.39 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.898 0.479 . . . . 74.44 111.141 173.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' H' ' 291' ' ' LEU . 19.3 t -76.93 -13.34 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.427 0 C-N-CA 123.715 0.806 . . . . 74.24 111.017 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 8.3 t -70.23 78.12 0.53 Allowed 'General case' 0 CA--C 1.563 1.475 0 CA-C-O 122.08 0.943 . . . . 73.4 111.11 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 52.3 t -172.44 -36.0 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.427 1.091 . . . . 54.23 109.509 -176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 3.3 t -104.65 106.32 54.14 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 124.027 0.931 . . . . 51.23 109.933 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo . . . . . 0 CA--C 1.565 2.067 0 C-N-CA 122.698 2.265 . . . . 61.04 110.846 169.682 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.451 -0.203 . . . . 42.44 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -159.34 -30.15 0.07 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.236 0.615 . . . . 73.0 111.265 -178.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -62.95 -33.01 74.46 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.74 0.816 . . . . 72.1 111.744 -177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -69.8 155.63 40.25 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.498 -0.556 . . . . 74.5 109.498 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . 0.642 ' H ' ' HD3' ' G' ' 275' ' ' LYS . 0.0 OUTLIER -104.21 141.19 22.01 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 122.888 0.475 . . . . 74.14 110.017 -178.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -65.55 142.55 71.83 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.786 2.324 . . . . 73.04 111.609 176.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 69.7 mt 67.62 22.05 9.21 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.884 1.274 . . . . 51.21 112.227 176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . 0.55 HD11 ' HB2' ' D' ' 48' ' ' SER . 14.6 tp -159.45 98.25 1.39 Allowed 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 108.896 -0.779 . . . . 55.2 108.896 174.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -174.42 -140.29 3.23 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-N 115.799 -0.637 . . . . 63.14 112.232 -177.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.463 HD23 ' HA3' ' D' ' 99' ' ' GLY . 43.4 tp 67.59 -58.55 0.43 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 126.879 2.071 . . . . 74.21 112.61 -175.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -44.19 -58.53 2.82 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.731 1.213 . . . . 64.03 111.379 177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . 57.04 -86.95 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.621 1.169 . . . . 61.41 111.022 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -96.3 -40.1 9.31 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.51 0.724 . . . . 75.25 109.387 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.36 173.63 34.94 Favored Glycine 0 C--N 1.343 0.941 0 CA-C-N 115.461 -0.791 . . . . 72.35 111.674 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 27.0 p-10 -93.5 -179.88 5.17 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.33 0.652 . . . . 72.03 110.248 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.98 125.76 89.81 Favored Pre-proline 0 CA--C 1.556 1.198 0 CA-C-N 115.801 -0.636 . . . . 63.22 110.628 175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -62.66 133.71 43.73 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 122.633 2.222 . . . . 72.53 111.525 175.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . 0.613 HG12 HD11 ' D' ' 44' ' ' LEU . 11.6 p -64.9 -27.98 43.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.355 0.662 . . . . 70.14 111.396 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 25.6 tpt180 66.37 -83.69 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.898 1.279 . . . . 64.04 109.196 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.672 ' HE3' ' H ' ' G' ' 291' ' ' LEU . 0.1 OUTLIER -176.31 176.96 1.58 Allowed 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.456 1.502 . . . . 72.04 107.869 173.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.672 ' H ' ' HE3' ' G' ' 290' ' ' TRP . 3.7 mp -126.02 6.69 7.25 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.042 0.937 . . . . 61.13 110.683 -174.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . 0.526 ' HA3' ' H ' ' E' ' 307' ' ' THR . . . 153.64 -152.88 24.44 Favored Glycine 0 C--N 1.354 1.562 0 CA-C-O 119.234 -0.759 . . . . 74.25 112.649 179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -59.97 151.77 69.51 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.699 2.933 . . . . 71.42 113.392 -178.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' G' ' 294' ' ' LYS . 8.6 mptt -105.57 12.83 30.8 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.735 1.214 . . . . 75.15 110.023 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -69.96 84.78 0.51 Allowed 'General case' 0 C--N 1.356 0.87 0 C-N-CA 124.077 0.951 . . . . 74.3 110.518 -178.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 4.4 m -91.94 -32.25 15.33 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.191 -0.913 . . . . 65.02 110.226 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.453 ' CZ ' ' HD3' ' D' ' 124' ' ' PRO . 1.5 m-85 -78.06 141.0 39.13 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 109.769 -0.456 . . . . 72.24 109.769 169.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -98.46 7.46 46.14 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.469 0.708 . . . . 74.31 110.035 174.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 85.72 -156.13 29.89 Favored Glycine 0 C--N 1.346 1.137 0 N-CA-C 110.051 -1.22 . . . . 74.03 110.051 -163.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 52.46 64.23 1.93 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 124.647 1.179 . . . . 52.35 111.252 177.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.492 ' HB ' ' HA3' ' E' ' 299' ' ' GLY . 0.0 OUTLIER -155.6 132.53 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 113.858 -1.519 . . . . 65.54 108.299 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -164.36 -174.57 3.55 Favored 'General case' 0 C--O 1.246 0.893 0 N-CA-C 108.537 -0.912 . . . . 73.23 108.537 -176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -67.35 122.58 83.65 Favored Pre-proline 0 CA--C 1.548 0.897 0 N-CA-C 108.107 -1.072 . . . . 71.54 108.107 169.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -62.22 104.23 0.34 Allowed 'Trans proline' 0 C--N 1.374 1.871 0 C-N-CA 122.394 2.062 . . . . 44.5 110.469 172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -77.03 79.74 3.56 Favored 'General case' 0 C--O 1.24 0.576 0 C-N-CA 123.823 0.849 . . . . 41.11 110.477 -174.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.572 ' HA ' ' HB3' ' E' ' 294' ' ' LYS . 5.3 t -74.56 107.28 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 N-CA-C 108.503 -0.925 . . . . 71.24 108.503 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 25.8 m -61.67 -67.98 0.36 Allowed 'General case' 0 CA--C 1.545 0.783 0 O-C-N 124.061 0.851 . . . . 72.41 110.65 -174.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 84.7 m -160.57 134.79 7.23 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.669 0.788 . . . . 75.53 109.683 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . 0.501 ' HB ' ' HD3' ' G' ' 310' ' ' PRO . 94.1 m -71.89 -50.59 9.45 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 118.732 -0.651 . . . . 74.32 109.896 166.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . 0.501 ' HD3' ' HB ' ' G' ' 309' ' ' THR . 3.7 Cg_endo . . . . . 0 C--N 1.406 3.569 0 C-N-CA 122.738 2.292 . . . . 63.13 111.679 171.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 110.513 -0.18 . . . . 52.02 110.513 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -85.22 85.56 7.45 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 108.266 -1.013 . . . . 74.42 108.266 173.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -126.83 120.3 28.94 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.888 0.875 . . . . 74.01 109.564 178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -82.89 23.35 0.84 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.933 0.893 . . . . 74.43 111.568 178.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 58.4 tttm -134.34 82.77 45.89 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 124.595 1.158 . . . . 55.25 109.14 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -99.79 -166.25 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 2.006 0 C-N-CA 123.625 2.883 . . . . 64.32 112.261 173.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 90.4 mt -103.48 43.06 1.11 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.024 0.93 . . . . 73.42 109.369 171.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . 0.423 ' HB2' ' CE2' ' B' ' 56' ' ' TYR . 17.9 tp -149.55 153.25 36.86 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 115.204 -0.907 . . . . 71.34 109.375 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 146.01 164.66 11.0 Favored Glycine 0 N--CA 1.472 1.085 0 CA-C-O 119.405 -0.664 . . . . 54.22 111.536 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 61.4 tp 77.52 -51.28 0.53 Allowed 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 125.709 1.604 . . . . 75.1 112.353 176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 15.4 t80 -85.8 47.93 1.52 Allowed 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 125.104 1.362 . . . . 73.12 110.392 -173.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -121.92 -6.11 9.03 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.053 0.941 . . . . 64.2 110.599 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -147.65 -77.42 0.17 Allowed 'General case' 0 C--O 1.241 0.639 0 N-CA-C 108.432 -0.951 . . . . 74.13 108.432 -178.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 56.78 -89.29 0.01 OUTLIER Glycine 0 C--N 1.357 1.742 0 O-C-N 123.971 0.794 . . . . 62.31 113.646 176.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' B' ' 44' ' ' LEU . 3.5 t-20 59.64 87.66 0.08 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.576 1.551 . . . . 72.15 111.541 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . 0.432 ' HB3' HG23 ' H' ' 288' ' ' VAL . 1.2 mpt? -68.37 119.36 67.54 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 115.445 -0.798 . . . . 75.31 109.959 178.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.21 37.91 0.71 Allowed 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.927 3.084 . . . . 71.31 112.709 -178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . 0.432 HG23 ' HB3' ' H' ' 286' ' ' MET . 53.2 t -68.12 115.6 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.519 0.727 . . . . 73.54 109.177 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -65.03 -68.61 0.35 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.701 -0.851 . . . . 72.12 108.701 177.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 15.9 m95 -175.11 169.58 3.29 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.921 1.688 . . . . 64.33 109.588 173.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' F' ' 306' ' ' VAL . 5.9 mp -100.84 78.07 1.92 Allowed 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 106.98 -1.489 . . . . 70.41 106.98 167.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 74.72 172.0 28.37 Favored Glycine 0 CA--C 1.537 1.451 0 CA-C-N 114.64 -1.163 . . . . 71.44 112.96 -173.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -82.32 32.35 0.52 Allowed 'Trans proline' 0 CA--C 1.557 1.631 0 C-N-CA 122.951 2.434 . . . . 75.31 112.151 171.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -93.72 31.39 1.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.454 1.101 . . . . 75.12 110.533 -177.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . 0.62 ' HB3' HG21 ' B' ' 40' ' ' VAL . . . -92.47 -80.64 0.36 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.069 0.548 . . . . 64.34 110.159 -179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . 0.412 ' OG1' HD12 ' B' ' 126' ' ' LEU . 21.2 m -104.99 149.14 26.0 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.634 0.774 . . . . 62.22 110.551 -178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.558 ' HE1' HD12 ' H' ' 301' ' ' ILE . 74.1 m-85 57.66 83.82 0.11 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 124.797 1.239 . . . . 65.02 111.69 -176.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -88.1 26.41 1.39 Allowed 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 115.414 -0.812 . . . . 64.25 109.925 171.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . 0.436 ' HA3' ' HA3' ' F' ' 299' ' ' GLY . . . 87.85 -26.3 7.67 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-O 120.174 -0.237 . . . . 63.04 112.97 -175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . 0.46 ' O ' ' HG3' ' B' ' 124' ' ' PRO . 8.6 t30 -67.72 93.49 0.39 Allowed 'General case' 0 C--N 1.352 0.713 0 C-N-CA 123.693 0.797 . . . . 64.2 110.898 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . 0.558 HD12 ' HE1' ' H' ' 297' ' ' TYR . 13.2 tt -138.97 12.59 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.092 0 N-CA-C 107.458 -1.312 . . . . 75.03 107.458 169.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -74.44 83.37 1.97 Allowed 'General case' 0 C--N 1.362 1.124 0 CA-C-N 114.828 -1.078 . . . . 73.51 110.463 -169.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . 0.533 ' HA ' ' HE2' ' H' ' 303' ' ' LYS . 0.7 OUTLIER 169.68 93.38 0.04 OUTLIER Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 127.117 2.167 . . . . 70.1 105.284 179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.74 77.4 1.07 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.611 2.207 . . . . 71.3 111.58 -177.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . 0.519 ' HB1' ' O ' ' A' ' 14' ' ' GLN . . . 60.04 -151.56 0.41 Allowed 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 124.346 1.058 . . . . 71.5 110.482 -174.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.81 -24.76 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.174 0 C-N-CA 123.161 0.584 . . . . 74.1 110.171 168.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 49.1 m 65.98 -79.03 0.03 OUTLIER 'General case' 0 C--N 1.355 0.847 0 C-N-CA 124.967 1.307 . . . . 75.32 110.274 -172.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 42.7 t -165.35 137.29 4.16 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.214 -1.032 . . . . 64.41 108.214 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 6.7 m -102.5 104.98 41.39 Favored Pre-proline 0 CA--C 1.552 1.02 0 N-CA-C 108.723 -0.843 . . . . 74.42 108.723 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo . . . . . 0 C--N 1.381 2.259 0 C-N-CA 122.899 2.399 . . . . 62.15 112.367 -177.047 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.0 mtm . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 109.613 -0.514 . . . . 72.23 109.613 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.0 m 68.65 148.47 0.06 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.788 1.635 . . . . 41.44 113.562 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -101.51 108.33 19.88 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.131 0.972 . . . . 73.11 109.773 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -141.29 55.75 1.54 Allowed 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.195 0.998 . . . . 74.01 110.325 -178.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.504 ' HB3' ' NE2' ' A' ' 93' ' ' GLN . 12.9 m120 -117.24 33.02 5.83 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 114.951 -1.022 . . . . 64.13 109.373 172.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -78.15 79.91 4.58 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 108.289 -1.004 . . . . 75.32 108.289 175.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 50.1 p -99.98 154.95 17.97 Favored 'General case' 0 C--O 1.243 0.745 0 C-N-CA 123.688 0.795 . . . . 64.04 110.34 -175.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.24 -33.29 73.04 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 123.822 0.701 . . . . 64.2 110.699 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.443 ' SD ' ' HB3' ' A' ' 147' ' ' GLU . 46.9 mtt 63.53 172.3 0.16 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.779 1.632 . . . . 55.25 112.593 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 m -140.99 134.52 29.99 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 108.702 -0.851 . . . . 72.44 108.702 174.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.59 ' HB3' HG22 ' A' ' 149' ' ' THR . 3.1 t80 -137.7 134.42 35.36 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.305 0.574 . . . . 73.2 110.139 163.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 55.7 tp60 -154.54 136.0 14.2 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 114.101 -1.409 . . . . 74.3 107.396 168.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.58 HD12 HD21 ' C' ' 132' ' ' ASN . 32.0 mt -92.44 130.84 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.229 0 N-CA-C 109.322 -0.622 . . . . 65.14 109.322 173.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.47 ' O ' ' HA ' ' H' ' 307' ' ' THR . 24.6 tt0 -98.1 -41.33 7.98 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 118.779 -0.629 . . . . 71.31 110.537 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.573 ' HA ' HG12 ' H' ' 306' ' ' VAL . 18.2 ttt180 -177.89 123.5 0.12 Allowed 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 112.926 0.713 . . . . 64.32 112.926 -170.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.592 HD13 ' HG3' ' C' ' 130' ' ' PRO . 4.0 mp -104.61 134.74 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 N-CA-C 107.836 -1.172 . . . . 71.03 107.836 168.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -166.16 152.42 9.11 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.484 1.113 . . . . 71.31 109.416 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.7 p -75.51 118.28 18.2 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.871 -0.788 . . . . 64.23 108.871 172.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -80.56 -24.33 39.31 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.65 -0.5 . . . . 72.43 109.65 172.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 20.0 t70 -158.91 143.3 15.62 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.1 -0.954 . . . . 74.02 109.8 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.421 HD13 ' SD ' ' B' ' 117' ' ' MET . 86.0 mt -132.33 146.86 32.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 124.914 1.286 . . . . 63.31 107.972 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.9 t -151.89 135.13 15.91 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.491 0.717 . . . . 73.21 109.516 175.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 88.9 t80 -138.06 131.21 30.26 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 106.686 -1.598 . . . . 73.32 106.686 171.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -133.6 114.21 13.28 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 123.276 0.63 . . . . 64.1 109.556 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -107.39 83.03 1.37 Allowed Pre-proline 0 CA--C 1.545 0.773 0 N-CA-C 106.496 -1.668 . . . . 21.02 106.496 162.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.58 -31.94 16.04 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 122.605 2.203 . . . . 62.3 112.155 -169.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 17.6 m-20 -113.88 22.9 13.52 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.278 1.031 . . . . 62.41 109.053 -175.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -43.54 -63.11 1.11 Allowed Pre-proline 0 CA--C 1.561 1.381 0 CA-C-O 117.997 -1.002 . . . . 74.13 113.384 -168.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -63.51 -17.42 59.92 Favored 'Trans proline' 0 C--N 1.399 3.224 0 C-N-CA 122.024 1.816 . . . . 73.24 113.354 -174.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -85.9 -52.4 5.76 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.929 0.871 . . . . 64.23 109.995 -178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.623 HG11 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -70.52 -21.7 23.19 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 CA-C-N 114.034 -1.439 . . . . 52.33 111.941 -160.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -64.42 -30.1 71.15 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.534 0.734 . . . . 74.44 112.22 -176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -99.83 -11.58 20.64 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.217 0.607 . . . . 75.21 112.423 -176.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -78.64 171.74 14.71 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.01 0.524 . . . . 71.21 111.086 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -61.37 118.22 6.66 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 124.052 0.941 . . . . 62.23 110.741 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.478 ' CE2' HD11 ' E' ' 301' ' ' ILE . 20.9 m0 -79.84 82.37 5.94 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.573 0.702 . . . . 74.2 110.097 -177.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -126.12 70.28 68.08 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 124.419 1.087 . . . . 74.03 108.948 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.717 ' HG3' ' HB3' ' E' ' 297' ' ' TYR . 94.8 Cg_endo -78.74 127.67 8.07 Favored 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 122.609 2.206 . . . . 54.44 112.045 -172.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -97.97 93.95 6.6 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 106.854 -1.536 . . . . 42.44 106.854 168.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 65' ' ' THR . 5.5 m -76.73 106.11 6.32 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 114.617 -1.174 . . . . 75.02 110.578 -177.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 16.7 mtpp -81.73 134.96 35.5 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.959 -1.019 . . . . 74.34 110.402 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.2 tt -110.74 106.45 15.66 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 106.154 -1.795 . . . . 63.13 106.154 170.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.3 m-20 -114.16 142.33 46.37 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.228 -1.397 . . . . 64.42 107.228 174.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.76 ' HB3' ' HA ' ' E' ' 287' ' ' PRO . 5.7 tt -141.46 128.64 20.93 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.948 -1.13 . . . . 74.12 107.948 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.588 ' HA ' HD21 ' E' ' 285' ' ' ASN . 13.1 t70 -117.15 134.28 54.97 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.581 1.153 . . . . 74.44 108.678 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 50.4 p -110.57 123.1 49.32 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 114.906 -1.043 . . . . 74.12 110.589 -167.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -134.93 131.69 37.55 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.683 0.793 . . . . 71.23 110.477 -177.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 54.4 p -133.55 152.56 51.92 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 121.035 0.445 . . . . 64.22 110.325 171.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -152.24 163.64 39.01 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.952 1.301 . . . . 71.1 108.233 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.575 HE22 ' HB3' ' C' ' 152' ' ' HIS . 48.7 tt0 -112.54 146.56 38.29 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.206 0.602 . . . . 72.4 109.515 174.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 57.8 mt -117.62 -43.75 2.78 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 123.878 0.871 . . . . 63.43 110.361 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -151.58 -168.52 3.11 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 123.204 0.601 . . . . 73.32 110.819 -172.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.507 ' HA ' ' HG2' ' C' ' 150' ' ' GLU . 4.6 m-20 -64.43 112.33 3.06 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.781 0.832 . . . . 71.55 110.346 178.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 67.4 0.39 2.12 Favored 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.516 1.527 . . . . 63.23 112.364 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -96.81 107.09 19.33 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 107.475 -1.306 . . . . 75.12 107.475 -174.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -123.62 125.34 44.65 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 108.471 -0.937 . . . . 71.14 108.471 -173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -92.07 112.83 24.92 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.938 0.895 . . . . 70.01 109.396 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.2 t -102.14 111.32 31.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 107.619 -1.252 . . . . 65.33 107.619 179.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 32.1 t -106.7 129.54 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 123.621 0.768 . . . . 74.04 110.001 177.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.724 HD12 HD21 ' A' ' 44' ' ' LEU . 4.2 mm? -117.89 110.04 17.26 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 108.643 -0.873 . . . . 62.21 108.643 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.527 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 11.0 ttp180 -84.82 107.44 16.99 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.58 -0.896 . . . . 74.24 108.58 175.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 77' ' ' GLU . 16.4 t -92.45 125.34 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 N-CA-C 107.807 -1.183 . . . . 75.21 107.807 175.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 28.9 m -118.79 136.89 53.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 109.019 -0.734 . . . . 44.54 109.019 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.783 HG11 HD21 ' A' ' 126' ' ' LEU . 45.4 t -136.78 115.88 15.54 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.152 0 C-N-CA 124.44 1.096 . . . . 73.21 108.068 -177.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 7.1 m -105.25 148.02 27.43 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.912 -0.773 . . . . 74.42 108.912 173.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.23 106.65 7.69 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 107.086 -1.45 . . . . 73.21 107.086 168.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.602 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 17.9 t -116.8 126.97 53.86 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 109.682 -0.488 . . . . 73.22 109.682 178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.551 HD22 HG22 ' A' ' 31' ' ' VAL . 7.7 mp -87.56 82.49 7.44 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 107.914 -1.143 . . . . 74.01 107.914 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.28 -84.72 0.83 Allowed Glycine 0 C--N 1.345 1.036 0 CA-C-N 114.976 -1.011 . . . . 54.43 111.881 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -111.92 -27.88 8.26 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 124.294 1.037 . . . . 71.13 111.686 -175.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -112.7 125.15 54.0 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 122.564 0.346 . . . . 70.04 111.005 -169.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.602 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 63.7 m -73.7 129.3 37.66 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.573 0.749 . . . . 71.3 112.441 -174.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.623 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -69.75 -65.64 0.69 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.868 -1.06 . . . . 54.33 109.911 169.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -152.13 167.77 27.46 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 115.289 -0.869 . . . . 65.1 111.607 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.8 tp -141.36 116.09 9.7 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.354 1.461 . . . . 65.35 107.728 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 71.6 m -105.66 131.79 52.6 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 123.332 0.653 . . . . 64.2 109.559 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 62' ' ' VAL . 32.6 tt0 -146.59 115.38 6.85 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 109.58 -0.526 . . . . 64.34 109.58 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -130.74 114.27 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.97 0.908 . . . . 63.31 109.231 -172.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.527 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 48.5 mt-30 -83.88 84.39 7.59 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 108.265 -1.013 . . . . 75.1 108.265 171.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -78.86 98.26 6.28 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.322 -0.992 . . . . 63.0 108.322 177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.89 145.88 21.04 Favored Glycine 0 C--N 1.339 0.742 0 N-CA-C 111.202 -0.759 . . . . 72.03 111.202 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.728 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -150.14 121.79 1.31 Allowed Glycine 0 CA--C 1.496 -1.125 0 N-CA-C 111.047 -0.821 . . . . 64.54 111.047 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.6 mt -87.78 123.59 40.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 C-N-CA 123.87 0.868 . . . . 54.34 108.736 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.535 ' HD2' HG12 ' A' ' 13' ' ' ILE . 46.9 m-85 -131.71 120.26 22.48 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.856 -0.794 . . . . 74.21 108.856 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 25.2 m -77.78 90.91 4.06 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.551 0.74 . . . . 54.2 109.333 172.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.496 HG21 ' SG ' ' A' ' 97' ' ' CYS . 1.6 pp -118.69 133.26 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.806 0.842 . . . . 75.12 110.509 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.4 177.15 11.48 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.695 0.798 . . . . 61.4 111.125 -174.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.97 9.52 86.68 Favored Glycine 0 C--N 1.354 1.55 0 O-C-N 123.758 0.662 . . . . 71.54 112.298 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.2 pt -133.76 136.12 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 C-N-CA 124.497 1.119 . . . . 73.02 109.936 -171.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.5 mp0 -131.41 172.07 12.62 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 124.136 0.974 . . . . 74.51 108.863 174.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 49.71 -117.42 4.59 Favored Glycine 0 N--CA 1.479 1.558 0 N-CA-C 115.001 0.761 . . . . 65.4 115.001 172.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.472 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 8.9 t -76.2 -18.74 58.92 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.953 0.901 . . . . 22.43 112.041 -176.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.504 ' NE2' ' HB3' ' A' ' 5' ' ' ASN . 98.4 mt-30 -67.87 -48.88 64.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.176 0.591 . . . . 71.11 110.236 175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.723 ' SD ' ' HB3' ' E' ' 277' ' ' LEU . 50.2 ttm -80.63 -18.56 47.77 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 116.592 -0.276 . . . . 64.51 110.454 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -66.38 -33.87 76.69 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.037 0.446 . . . . 73.12 110.428 169.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 37.3 t-80 -68.66 -41.74 78.92 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.874 -0.603 . . . . 75.14 110.26 171.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.496 ' SG ' HG21 ' A' ' 86' ' ' ILE . 47.3 t -64.26 -54.21 36.92 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 122.984 0.514 . . . . 72.41 111.959 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 37.2 mt -76.26 -35.94 58.69 Favored 'General case' 0 N--CA 1.474 0.741 0 O-C-N 123.409 0.443 . . . . 65.12 111.719 -172.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -106.09 4.59 38.58 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 114.858 0.703 . . . . 70.4 114.858 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.508 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -146.6 -52.23 0.23 Allowed 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 117.85 0.825 . . . . 43.23 112.436 -175.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.564 ' HA ' ' HB3' ' A' ' 134' ' ' ASP . 66.4 t80 -79.81 -68.92 0.62 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.52 0.728 . . . . 63.55 111.939 -168.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.496 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 72.3 m -68.86 -32.36 3.45 Favored Pre-proline 0 CA--C 1.572 1.826 0 N-CA-C 114.844 1.424 . . . . 54.33 114.844 -175.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 28.8 Cg_endo -61.45 -21.87 73.03 Favored 'Trans proline' 0 C--N 1.398 3.156 0 C-N-CA 122.556 2.17 . . . . 65.13 113.458 172.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -68.12 -26.12 65.64 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.203 0.601 . . . . 75.23 110.034 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.453 HG21 HD13 ' A' ' 13' ' ' ILE . 39.5 mm -71.2 -36.01 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 123.477 0.711 . . . . 74.53 109.858 174.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.728 HD21 ' HA3' ' A' ' 82' ' ' GLY . 97.0 mt -83.48 -30.68 26.99 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.936 0.894 . . . . 73.54 112.883 -173.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.8 t80 -62.9 -39.79 56.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 113.818 1.044 . . . . 55.21 113.818 -170.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -63.01 -37.67 51.58 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.387 2.058 . . . . 63.12 113.281 172.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 80.9 m-85 -71.76 -38.62 70.34 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.14 0.576 . . . . 73.35 111.625 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.78 -45.18 83.42 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.572 -0.529 . . . . 74.33 109.572 174.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.431 HH22 ' HB3' ' A' ' 130' ' ' PRO . 40.1 ttm180 -53.75 -50.45 65.97 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 124.646 1.216 . . . . 70.05 110.905 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -69.65 -41.6 75.36 Favored 'General case' 0 N--CA 1.474 0.756 0 O-C-N 124.204 0.94 . . . . 75.24 111.303 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 44.0 t -56.17 -42.21 76.69 Favored 'General case' 0 N--CA 1.48 1.038 0 O-C-N 123.576 0.547 . . . . 74.23 110.169 176.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.445 ' O ' HG23 ' A' ' 118' ' ' VAL . 92.8 mt -66.13 -50.33 69.66 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-N 114.593 -1.185 . . . . 75.13 110.296 175.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.445 HG23 ' HG3' ' A' ' 125' ' ' GLN . 63.0 m -52.8 -41.93 64.59 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.301 1.041 . . . . 44.51 111.375 -176.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.3 t -69.17 -51.22 40.26 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 114.647 -1.161 . . . . 73.4 110.616 -178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 6.1 mtp -51.05 -42.91 60.82 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 124.026 0.931 . . . . 74.14 111.725 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 114' ' ' ILE . 70.2 t -64.82 -50.96 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 CA-C-N 114.376 -1.284 . . . . 72.34 110.718 179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' D' ' 119' ' ' SER . 93.2 p -70.38 -22.71 62.73 Favored 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 123.029 0.532 . . . . 54.12 111.947 -176.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.61 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.9 mtt-85 -75.19 -31.19 60.88 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.796 0.838 . . . . 73.2 110.048 175.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.47 -3.26 86.13 Favored Glycine 0 C--N 1.355 1.61 0 CA-C-N 116.124 -0.489 . . . . 74.34 112.604 171.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.585 ' HB ' HH21 ' B' ' 15' ' ' ARG . 23.3 m 60.05 43.73 14.06 Favored 'General case' 0 CA--C 1.552 1.022 0 CA-C-O 123.318 1.532 . . . . 65.3 110.133 -175.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.51 ' HA ' HG22 ' E' ' 301' ' ' ILE . 69.1 m-85 -99.53 163.9 17.65 Favored Pre-proline 0 CA--C 1.555 1.16 0 CA-C-N 113.029 -1.896 . . . . 64.04 108.888 169.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.511 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 17.4 Cg_exo -68.12 136.46 37.76 Favored 'Trans proline' 0 C--N 1.378 2.111 0 C-N-CA 122.766 2.311 . . . . 64.53 111.795 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.0 tt0 -48.31 124.37 7.82 Favored 'General case' 0 N--CA 1.477 0.916 0 O-C-N 124.584 1.177 . . . . 60.02 111.521 -176.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.783 HD21 HG11 ' A' ' 64' ' ' VAL . 12.4 tp -108.13 100.54 9.85 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 123.695 0.798 . . . . 65.32 110.484 -170.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -109.84 97.75 7.22 Favored 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 107.891 -1.152 . . . . 73.14 107.891 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 22.3 tp -72.67 120.89 18.92 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 116.239 -0.437 . . . . 75.13 110.314 -177.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.63 133.04 88.87 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.118 0.967 . . . . 72.34 111.934 -173.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.431 ' HB3' HH22 ' A' ' 111' ' ' ARG . 18.0 Cg_endo -87.22 166.49 8.08 Favored 'Trans proline' 0 C--N 1.379 2.14 0 C-N-CA 122.646 2.231 . . . . 74.43 113.351 -177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.9 t -137.58 142.51 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 106.779 -1.563 . . . . 71.12 106.779 168.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.45 75.46 6.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.907 -1.146 . . . . 72.54 107.907 174.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -58.5 -43.73 89.17 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 124.475 1.11 . . . . 74.21 111.843 -171.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.564 ' HB3' ' HA ' ' A' ' 101' ' ' TYR . 5.3 p-10 -61.12 -45.26 95.43 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.994 0.917 . . . . 74.42 111.806 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.53 -38.75 87.86 Favored 'General case' 0 N--CA 1.472 0.651 0 O-C-N 123.76 0.662 . . . . 62.11 110.982 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 52.3 tp -68.45 -39.41 81.48 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.823 0.702 . . . . 51.42 111.124 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -70.35 -36.9 74.48 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 109.44 -0.578 . . . . 74.43 109.44 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.0 mmt -64.46 -56.92 11.02 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 123.408 0.443 . . . . 55.02 110.59 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 24.2 p30 -62.75 -27.72 69.48 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.017 0.527 . . . . 75.14 111.835 -175.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.5 t80 -73.33 -42.24 62.55 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.694 0.798 . . . . 61.01 111.156 173.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.8 tp -69.19 -56.71 6.8 Favored 'General case' 0 CA--C 1.554 1.099 0 CA-C-O 119.211 -0.423 . . . . 54.12 111.144 -174.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.447 ' H ' ' H ' ' A' ' 143' ' ' GLN . 51.8 mt-30 -168.42 -12.92 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.571 0 C-N-CA 125.348 1.459 . . . . 72.4 111.154 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.447 ' H ' ' H ' ' A' ' 142' ' ' GLN . 0.1 OUTLIER 69.44 72.42 0.25 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 125.588 1.555 . . . . 51.14 108.867 -177.029 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -157.79 116.01 3.11 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.58 0.752 . . . . 54.15 109.899 -177.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -137.24 156.47 48.26 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 124.289 1.036 . . . . 62.13 109.73 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 162.46 40.39 0.02 OUTLIER Glycine 0 N--CA 1.47 0.914 0 N-CA-C 111.818 -0.513 . . . . 54.44 111.818 -177.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.443 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 1.7 pm0 -68.96 125.68 27.42 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 123.849 0.86 . . . . 72.23 111.167 -177.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -74.66 140.91 27.75 Favored Glycine 0 C--N 1.347 1.194 0 CA-C-N 115.75 -0.659 . . . . 64.02 112.363 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.59 HG22 ' HB3' ' A' ' 11' ' ' PHE . 25.5 p -113.84 125.71 54.37 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 123.857 0.863 . . . . 74.13 110.285 -178.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -159.74 138.18 10.49 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.6 0.76 . . . . 71.24 109.666 175.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.01 156.1 23.59 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.428 0.691 . . . . 74.21 112.81 -175.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -173.49 140.94 0.84 Allowed 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 125.073 1.349 . . . . 51.32 107.747 164.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.616 HE22 ' HB2' ' A' ' 155' ' ' ALA . 11.2 tm0? -140.29 107.8 5.58 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 107.897 -1.149 . . . . 63.02 107.897 -178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.7 p-10 -105.61 -35.56 7.38 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.777 0.831 . . . . 75.12 111.182 -176.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.616 ' HB2' HE22 ' A' ' 153' ' ' GLN . . . . . . . . 0 N--CA 1.486 1.353 0 C-N-CA 124.806 1.243 . . . . 71.22 112.229 176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 22.8 ttt . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 110.497 -0.186 . . . . 73.32 110.497 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 43.5 p -72.77 101.41 3.1 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 123.928 0.767 . . . . 72.01 109.308 172.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -88.59 154.86 19.99 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 108.734 -0.839 . . . . 71.43 108.734 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -60.71 100.64 0.11 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.805 0.842 . . . . 74.42 110.419 173.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 59.4 t30 55.54 98.75 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.326 1.45 . . . . 70.2 111.818 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -58.73 -61.4 2.64 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.645 0.778 . . . . 74.32 111.196 -176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 8.3 m 51.36 45.3 28.16 Favored 'General case' 0 N--CA 1.482 1.154 0 CA-C-O 122.369 1.08 . . . . 72.43 110.154 -173.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -75.65 174.38 9.84 Favored 'General case' 0 C--O 1.241 0.643 0 CA-C-N 114.616 -1.175 . . . . 64.42 110.331 176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.431 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 9.5 ptt? 54.49 -166.62 0.09 Allowed 'General case' 0 CA--C 1.56 1.348 0 C-N-CA 126.079 1.751 . . . . 63.4 112.966 176.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.438 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 63.1 m -148.7 125.65 11.29 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 107.765 -1.198 . . . . 52.2 107.765 176.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.64 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 19.4 t80 -141.86 118.59 11.07 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.556 0.742 . . . . 72.02 109.312 174.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.476 ' HB3' ' HB ' ' E' ' 309' ' ' THR . 7.3 pt20 -154.88 130.38 9.83 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.743 0.817 . . . . 72.02 109.155 177.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 31.8 mt -81.31 132.53 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 123.142 0.577 . . . . 62.41 109.825 -174.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -89.24 -48.54 7.31 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 109.884 -0.413 . . . . 74.24 109.884 168.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.585 HH21 ' HB ' ' A' ' 122' ' ' THR . 58.9 ttt180 -162.95 154.85 18.07 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 111.395 0.146 . . . . 74.22 111.395 -173.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.408 ' HB ' HD21 ' D' ' 127' ' ' ASN . 87.3 mt -137.39 111.37 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.403 1.081 . . . . 75.22 108.083 171.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.406 ' HE1' HG13 ' B' ' 83' ' ' ILE . 24.9 p90 -137.2 147.92 46.18 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.853 0.461 . . . . 75.13 110.379 -171.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -75.3 119.05 18.88 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 115.742 -0.663 . . . . 61.03 109.744 174.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -89.92 -23.15 21.67 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.68 0.792 . . . . 73.32 111.121 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -166.37 141.64 4.54 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 123.217 0.323 . . . . 73.5 111.789 -173.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.411 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 45.5 mm -133.12 146.41 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 125.195 1.398 . . . . 73.02 109.084 173.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.0 t -149.08 151.94 35.32 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.881 0.872 . . . . 72.15 109.009 172.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.419 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 91.2 t80 -156.01 122.7 5.22 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 106.523 -1.658 . . . . 75.23 106.523 174.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.2 mt-10 -125.12 113.05 17.2 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.031 -0.729 . . . . 71.13 109.031 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.686 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -114.42 84.03 9.2 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 107.874 -1.158 . . . . 74.24 107.874 170.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.7 -22.96 17.31 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.661 2.241 . . . . 73.45 111.638 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -113.37 15.31 19.22 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 124.538 1.135 . . . . 73.1 110.576 -175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.686 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.68 -58.1 9.29 Favored Pre-proline 0 CA--C 1.573 1.833 0 C-N-CA 125.335 1.454 . . . . 62.52 114.607 -176.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -67.76 -25.63 39.52 Favored 'Trans proline' 0 C--N 1.398 3.154 0 C-N-CA 121.903 1.735 . . . . 70.34 112.712 -176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.492 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 75.2 m80 -97.99 1.21 47.62 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.485 0.714 . . . . 73.3 112.876 -174.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.8 p -59.91 -22.66 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 123.227 0.611 . . . . 73.35 112.521 -176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 60.7 t80 -64.95 -30.77 71.78 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.941 0.897 . . . . 74.33 112.175 -175.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.7 pt20 -65.49 -36.08 82.81 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 110.101 -0.333 . . . . 63.51 110.101 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.658 ' HB2' HD13 ' B' ' 68' ' ' LEU . 83.3 mttt -108.89 65.63 0.62 Allowed 'General case' 0 C--N 1.35 0.612 0 CA-C-O 121.616 0.722 . . . . 74.25 109.169 173.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -75.28 108.29 7.95 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-N 115.116 -0.947 . . . . 64.12 109.643 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.443 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 162.13 -171.69 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.221 0 C-N-CA 127.61 2.364 . . . . 74.13 108.985 159.517 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.611 ' HB3' ' H ' ' H' ' 297' ' ' TYR . 1.8 pt20 -72.3 128.8 88.38 Favored Pre-proline 0 CA--C 1.545 0.781 0 O-C-N 122.963 0.164 . . . . 72.42 110.838 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -76.52 -176.22 3.0 Favored 'Trans proline' 0 C--N 1.366 1.459 0 C-N-CA 122.673 2.249 . . . . 75.43 111.05 168.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -76.04 106.78 7.83 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.796 -1.187 . . . . 72.0 107.796 166.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 10.9 p -85.13 136.52 22.61 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 108.079 -1.082 . . . . 74.35 108.079 176.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -150.98 142.41 23.43 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.279 0.631 . . . . 72.33 109.653 -175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 10.3 mp -85.97 159.72 19.55 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.976 0.893 . . . . 71.1 110.505 171.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.553 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 33.7 t70 -140.09 110.46 6.64 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 105.448 -2.056 . . . . 64.42 105.448 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.0 tt -104.87 134.63 47.66 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 108.885 -0.783 . . . . 71.43 108.885 -167.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 24.8 t70 -131.36 139.97 49.61 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.844 -0.799 . . . . 73.52 108.844 172.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 20.9 p -109.71 124.94 52.09 Favored 'General case' 0 C--O 1.239 0.522 0 C-N-CA 124.124 0.969 . . . . 72.4 109.605 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -135.63 138.61 43.06 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.699 0.8 . . . . 75.31 108.893 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 45.5 p -143.19 161.33 38.52 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 122.674 0.389 . . . . 73.14 110.198 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 84.9 p -153.06 150.76 29.48 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.786 0.834 . . . . 64.22 109.514 176.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -100.99 114.91 29.26 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.862 -0.792 . . . . 65.43 108.862 172.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.403 ' HG ' ' HB2' ' B' ' 57' ' ' GLU . 77.5 mt -77.75 -42.83 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 122.807 0.443 . . . . 64.23 110.343 177.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.11 -171.07 2.3 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.63 -0.714 . . . . 64.53 111.118 -176.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.33 118.53 9.47 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.438 -1.256 . . . . 53.22 110.091 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 68.75 -3.94 1.3 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.296 1.438 . . . . 75.41 112.488 -175.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.7 t -104.96 107.11 21.8 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.462 -0.94 . . . . 65.23 108.462 -176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.22 156.63 30.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.401 -0.818 . . . . 64.23 109.136 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.403 ' HB2' ' HG ' ' B' ' 51' ' ' LEU . 7.4 tm-20 -133.12 97.26 3.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.214 -1.402 . . . . 75.1 107.214 -167.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -94.4 128.83 45.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.341 1.056 . . . . 71.11 109.238 -174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 20.1 t -122.33 143.65 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.917 0.887 . . . . 72.03 109.401 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' B' ' 103' ' ' PRO . 58.6 mt -129.32 122.8 30.3 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.419 0.687 . . . . 74.12 109.406 170.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.639 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.8 ttm180 -92.19 108.57 20.04 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.469 -0.937 . . . . 71.31 108.469 172.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.12 103.14 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 N-CA-C 107.197 -1.408 . . . . 73.4 107.197 175.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 10.8 m -104.53 124.43 49.28 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.228 -0.656 . . . . 74.25 109.228 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.565 HG21 HG21 ' B' ' 114' ' ' ILE . 90.8 t -103.09 104.72 17.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 C-N-CA 123.626 0.77 . . . . 63.52 109.124 -178.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 61.4 m -94.96 136.89 34.73 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 115.341 -0.845 . . . . 73.2 109.415 174.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.62 136.05 24.1 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.586 -0.894 . . . . 73.43 108.586 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 71.9 p -142.05 130.59 22.58 Favored 'General case' 0 C--O 1.239 0.54 0 O-C-N 123.531 0.519 . . . . 55.04 111.532 -171.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.658 HD13 ' HB2' ' B' ' 34' ' ' LYS . 46.5 mt -92.29 99.34 12.13 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 108.208 -1.034 . . . . 72.43 108.208 178.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.14 -109.82 2.96 Favored Glycine 0 C--N 1.345 1.065 0 CA-C-N 115.473 -0.785 . . . . 52.25 111.742 -177.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -111.8 4.3 18.3 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.453 1.101 . . . . 65.11 111.564 -176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.66 170.88 9.28 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.609 0.764 . . . . 61.1 109.726 176.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.7 m -76.49 152.53 36.07 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 122.876 0.47 . . . . 63.04 110.903 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.575 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -104.98 -63.28 1.24 Allowed 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 108.271 -1.011 . . . . 45.33 108.271 172.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -161.94 156.67 22.69 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 114.13 -1.396 . . . . 64.44 108.253 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.459 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 80.0 mt -132.77 148.82 52.32 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.532 1.133 . . . . 70.4 108.3 179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.6 t -148.92 159.63 44.02 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 108.333 -0.988 . . . . 64.33 108.333 175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.623 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 44.4 tt0 -163.34 137.78 6.14 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 122.671 0.388 . . . . 75.23 110.004 -177.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.406 HG22 HD12 ' B' ' 21' ' ' ILE . 78.5 t -135.97 144.63 32.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.154 0.981 . . . . 64.45 109.202 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 14.5 mt-30 -122.56 105.43 10.11 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.5 -1.296 . . . . 72.41 107.5 169.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.522 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.2 tp-100 -99.59 108.75 21.23 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.904 -0.776 . . . . 74.31 108.904 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.28 149.94 20.55 Favored Glycine 0 C--O 1.242 0.605 0 N-CA-C 110.914 -0.874 . . . . 61.14 110.914 175.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.44 123.66 2.03 Favored Glycine 0 C--N 1.332 0.342 0 N-CA-C 111.015 -0.834 . . . . 63.42 111.015 179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.406 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.3 mt -88.11 126.78 41.5 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 N-CA-C 108.691 -0.855 . . . . 62.1 108.691 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -135.36 134.38 39.72 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.483 1.113 . . . . 75.21 108.819 -176.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.466 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 32.7 m -93.92 96.65 9.85 Favored 'General case' 0 C--O 1.241 0.644 0 N-CA-C 108.75 -0.833 . . . . 72.13 108.75 172.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 26.0 pt -110.7 135.4 49.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 124.018 0.927 . . . . 61.43 110.668 -177.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.438 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -152.16 164.47 37.25 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.369 1.068 . . . . 74.15 109.296 179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.431 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 83.67 -39.02 2.8 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 123.003 0.335 . . . . 70.42 113.776 175.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.605 HG13 HD11 ' H' ' 277' ' ' LEU . 28.9 pt -60.85 145.52 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.326 1.05 . . . . 73.31 111.587 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -166.28 163.1 17.67 Favored 'General case' 0 C--O 1.245 0.85 0 C-N-CA 123.663 0.785 . . . . 75.22 109.891 175.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.8 -123.19 32.65 Favored Glycine 0 C--N 1.346 1.099 0 O-C-N 123.87 0.732 . . . . 44.34 113.391 -176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 8.9 m -67.98 -36.21 79.66 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.407 1.083 . . . . 54.21 110.936 178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -69.64 -29.97 67.57 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.794 -1.094 . . . . 74.31 110.674 -172.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -67.98 -49.66 60.33 Favored 'General case' 0 C--N 1.35 0.589 0 CA-C-N 115.358 -0.837 . . . . 75.43 109.632 175.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.3 73.94 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.123 0.969 . . . . 72.43 111.85 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 52.6 t-80 -69.7 -34.22 73.61 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.89 0.876 . . . . 65.12 110.709 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -70.35 -66.88 0.54 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 116.043 -0.526 . . . . 73.41 111.112 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.548 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 0.0 OUTLIER -87.9 -14.47 39.27 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 112.339 0.496 . . . . 62.32 112.339 -169.151 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.401 ' N ' HD13 ' B' ' 98' ' ' LEU . . . -101.23 -4.22 53.66 Favored Glycine 0 C--N 1.351 1.38 0 CA-C-O 119.896 -0.391 . . . . 63.01 113.379 -177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -140.82 -58.79 0.51 Allowed 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 117.149 0.475 . . . . 63.34 111.66 -176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -73.41 -44.93 57.36 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 123.815 0.846 . . . . 73.04 111.999 -172.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.64 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 35.2 m -68.01 -43.8 37.46 Favored Pre-proline 0 N--CA 1.485 1.291 0 CA-C-O 118.752 -0.642 . . . . 64.25 111.64 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.42 ' HB3' HD11 ' B' ' 60' ' ' LEU . 29.1 Cg_exo -44.94 -53.03 5.61 Favored 'Trans proline' 0 C--N 1.4 3.241 0 C-N-CA 123.038 2.492 . . . . 63.51 113.354 167.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -56.62 -23.65 42.52 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 124.219 1.008 . . . . 73.03 113.467 -177.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.408 HG23 ' NH2' ' D' ' 111' ' ' ARG . 74.7 mt -78.81 -52.57 15.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 123.06 0.544 . . . . 72.44 110.929 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.5 pp -87.38 -7.99 57.1 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -173.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 77.3 t80 -65.28 -45.02 70.61 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.669 1.188 . . . . 45.54 113.186 -178.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -51.87 -37.66 66.79 Favored 'Trans proline' 0 C--N 1.393 2.878 0 C-N-CA 122.627 2.218 . . . . 63.33 113.531 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.522 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 44.0 m-85 -68.96 -39.84 79.25 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.243 -0.89 . . . . 74.43 110.393 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.37 -45.49 79.93 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 122.669 0.388 . . . . 50.3 110.669 176.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 38.2 ttt-85 -54.66 -56.13 22.37 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.329 1.452 . . . . 74.32 111.699 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 2.6 tm-20 -67.31 -37.65 83.69 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.856 0.863 . . . . 75.14 110.791 -173.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.61 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 6.0 t -66.86 -31.75 72.56 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 116.0 -0.545 . . . . 70.15 111.385 -178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.565 HG21 HG21 ' B' ' 64' ' ' VAL . 70.8 mt -67.53 -50.31 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 123.561 0.744 . . . . 73.04 110.314 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.5 m -61.84 -27.68 68.95 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 123.945 0.778 . . . . 73.35 111.245 -175.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.428 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 48.2 t -64.14 -50.31 68.71 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 123.746 0.818 . . . . 64.34 110.295 173.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.48 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 13.4 mmt -72.49 -34.36 67.61 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.188 0.595 . . . . 62.01 111.653 -171.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 87.7 t -62.73 -38.55 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 C-N-CA 123.469 0.708 . . . . 65.11 110.029 173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 6.9 t -72.94 -26.19 61.3 Favored 'General case' 0 CA--C 1.545 0.75 0 CA-C-N 115.064 -0.971 . . . . 61.32 111.344 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.4 mtt-85 -73.81 -25.07 59.92 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.143 0.577 . . . . 52.41 110.5 175.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.24 14.71 32.33 Favored Glycine 0 C--N 1.357 1.697 0 O-C-N 123.541 0.525 . . . . 74.4 112.342 168.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 51.7 p 56.43 47.67 18.41 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.756 2.022 . . . . 63.24 112.612 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -115.08 151.96 46.17 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-N 114.205 -1.361 . . . . 74.12 109.658 173.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -71.26 -160.26 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.332 0 C-N-CA 122.957 2.438 . . . . 54.44 113.33 178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.648 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.43 125.69 25.44 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.347 1.059 . . . . 62.43 113.115 -170.548 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 59.5 tp -136.93 95.38 3.11 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.438 -0.949 . . . . 44.45 108.438 171.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -103.74 135.97 44.3 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.032 0.933 . . . . 73.41 110.547 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.3 tp -83.35 137.33 34.0 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 123.681 0.792 . . . . 71.5 109.709 176.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.459 ' HB3' HD13 ' H' ' 291' ' ' LEU . . . -70.51 152.82 95.34 Favored Pre-proline 0 CA--C 1.557 1.245 0 C-N-CA 124.278 1.031 . . . . 72.21 112.054 -173.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.4 111.28 1.42 Allowed 'Trans proline' 0 C--N 1.383 2.381 0 C-N-CA 123.492 2.795 . . . . 61.41 112.863 176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.502 HG22 HD11 ' H' ' 291' ' ' LEU . 35.4 t -106.6 110.28 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 123.317 0.647 . . . . 61.41 109.341 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.43 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 52.8 t30 -97.25 100.25 11.71 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 108.355 -0.98 . . . . 72.5 108.355 176.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -68.4 -31.31 70.57 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.464 0.706 . . . . 73.14 110.701 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -62.23 -33.91 75.48 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.528 -0.76 . . . . 75.33 111.475 177.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.43 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -55.94 -55.6 30.78 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 123.919 0.762 . . . . 62.3 111.353 -175.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.63 -38.99 84.68 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 122.996 0.518 . . . . 64.43 110.598 -178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -65.58 -36.34 83.47 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.803 0.841 . . . . 72.23 111.088 -177.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 95.1 mmm -85.31 -36.32 20.9 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.211 0.604 . . . . 75.42 110.868 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.435 HD21 ' HA3' ' B' ' 146' ' ' GLY . 12.8 m120 -73.23 -13.18 61.1 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 117.672 0.215 . . . . 64.23 111.394 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 74.7 t80 -62.18 -48.66 79.05 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 123.774 0.671 . . . . 65.34 110.607 171.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 1.6 pp -115.71 -4.5 12.17 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.845 0.858 . . . . 74.22 112.336 -168.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -147.26 95.6 2.58 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.671 0.788 . . . . 74.52 109.023 -178.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -86.39 -8.36 57.72 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 114.987 -1.006 . . . . 65.32 111.624 -176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -70.14 -30.05 67.13 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 124.02 0.928 . . . . 64.31 111.687 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -120.31 87.98 2.85 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.369 0.668 . . . . 73.34 110.038 -178.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.435 ' HA3' HD21 ' B' ' 139' ' ' ASN . . . 156.76 -160.36 30.25 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.833 -0.621 . . . . 61.24 111.872 177.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -142.44 160.93 39.31 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.798 0.839 . . . . 73.14 110.016 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.48 61.34 4.21 Favored Glycine 0 C--N 1.346 1.126 0 CA-C-N 115.122 -0.945 . . . . 74.42 111.113 -173.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 58.6 p -67.21 143.79 56.34 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 123.355 0.662 . . . . 74.23 111.265 -175.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 69.63 138.05 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 125.736 1.614 . . . . 62.4 111.371 -174.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -60.36 110.17 1.18 Allowed 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 107.774 -1.195 . . . . 63.34 107.774 170.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 32.8 t60 -60.91 108.14 0.82 Allowed 'General case' 0 C--N 1.351 0.645 0 O-C-N 124.09 0.869 . . . . 65.04 110.593 -170.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -68.72 95.75 0.69 Allowed 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.258 0.974 . . . . 72.11 110.393 -179.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -102.74 -26.09 13.29 Favored 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 115.017 -0.992 . . . . 74.3 110.004 177.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 C-N-CA 125.49 1.516 . . . . 53.51 112.109 170.407 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.48 1.071 0 N-CA-C 109.153 -0.684 . . . . 73.45 109.153 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 143' ' ' GLN . 49.6 m -144.18 131.53 20.85 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.25 0.62 . . . . 44.24 109.563 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -127.2 122.12 33.18 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.471 0.709 . . . . 72.32 109.118 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -152.15 133.59 14.55 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.867 0.867 . . . . 63.25 110.325 177.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -125.29 81.37 1.96 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 107.475 -1.305 . . . . 62.34 107.475 172.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -89.53 -61.19 1.75 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.397 -0.819 . . . . 71.54 108.844 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 76.5 p -104.09 127.56 51.68 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.053 0.941 . . . . 52.42 110.03 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.42 ' HG3' ' H ' ' C' ' 9' ' ' MET . 4.4 pt-20 -97.15 -51.13 4.32 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 122.5 0.32 . . . . 52.25 110.279 172.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.5 ' HA ' HG13 ' C' ' 89' ' ' ILE . 59.6 ttp 63.38 128.49 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.601 1.56 . . . . 71.52 113.573 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 26.6 m -120.5 94.19 4.29 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 107.689 -1.226 . . . . 32.2 107.689 167.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -97.13 157.25 16.02 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.133 -0.939 . . . . 74.41 108.902 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.531 ' HB2' HG23 ' G' ' 306' ' ' VAL . 10.9 pt20 -170.92 129.28 0.77 Allowed 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 123.533 0.733 . . . . 75.52 110.155 175.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.667 HD13 ' H ' ' C' ' 13' ' ' ILE . 0.2 OUTLIER -90.88 107.88 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.15 0 C-N-CA 123.7 0.8 . . . . 73.42 109.594 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.41 HE21 ' HG3' ' C' ' 12' ' ' GLN . 79.7 mm-40 -76.52 -52.83 9.02 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 122.079 -0.388 . . . . 51.32 110.609 -177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.738 HH12 HD13 ' G' ' 301' ' ' ILE . 63.3 ttt180 -166.21 128.58 1.92 Allowed 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 109.987 -0.375 . . . . 72.4 109.987 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.8 mt -108.07 146.36 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 N-CA-C 107.849 -1.167 . . . . 70.42 107.849 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.507 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 29.9 p90 -176.93 163.39 2.2 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 121.565 0.698 . . . . 73.34 110.912 -175.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 53.6 p -85.08 117.44 24.04 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 115.108 -0.951 . . . . 75.24 108.892 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.3 mmmt -68.82 -42.93 76.57 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 121.844 0.831 . . . . 63.11 108.772 171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -146.27 141.18 27.09 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 114.092 -1.413 . . . . 71.41 109.155 -176.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 84.9 mt -129.21 140.7 48.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 106.769 -1.567 . . . . 63.41 106.769 169.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 32.7 t -157.61 145.84 19.1 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.259 0.552 . . . . 51.2 110.611 178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.452 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -146.45 105.65 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 N-CA-C 106.236 -1.764 . . . . 74.41 106.236 170.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -114.73 110.19 19.35 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.069 -1.086 . . . . 74.21 108.069 -174.079 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.424 ' HB1' ' HB2' ' C' ' 28' ' ' ALA . . . -124.55 80.06 61.38 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 124.342 1.057 . . . . 74.33 108.827 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -79.92 -4.18 13.19 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.491 2.127 . . . . 74.32 111.731 178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -117.7 18.65 14.1 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.449 1.1 . . . . 72.25 109.617 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.424 ' HB2' ' HB1' ' C' ' 25' ' ' ALA . . . -58.07 -52.3 75.5 Favored Pre-proline 0 CA--C 1.571 1.763 0 N-CA-C 114.177 1.177 . . . . 63.05 114.177 -170.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.514 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 73.8 Cg_endo -75.92 -31.61 4.97 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.47 1.561 . . . . 71.44 112.009 174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -70.61 -23.69 62.6 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.968 1.307 . . . . 64.34 112.734 -176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.541 HG22 ' HA2' ' F' ' 299' ' ' GLY . 9.5 p -79.51 -16.85 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 O-C-N 121.837 -0.54 . . . . 61.04 111.576 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.434 ' HD2' ' HA ' ' C' ' 29' ' ' PRO . 57.1 m-85 -67.39 -8.37 32.37 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.054 0.542 . . . . 64.33 112.251 176.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -116.09 25.18 10.87 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.784 0.834 . . . . 73.32 111.105 177.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.531 ' HG2' HD13 ' C' ' 68' ' ' LEU . 3.9 tppt? -91.83 172.69 8.3 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.002 0.521 . . . . 72.11 111.252 -173.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -88.64 130.31 35.32 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 108.729 -0.841 . . . . 72.14 108.729 168.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 3.0 t-105 -70.18 85.15 0.55 Allowed 'General case' 0 CA--C 1.555 1.161 0 C-N-CA 124.642 1.177 . . . . 74.3 110.334 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -157.44 66.37 3.7 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.91 0.884 . . . . 61.44 108.967 173.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -74.34 109.16 2.84 Favored 'Trans proline' 0 C--N 1.375 1.937 0 C-N-CA 122.667 2.244 . . . . 74.01 112.33 -177.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -85.86 88.76 7.61 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 106.753 -1.573 . . . . 74.51 106.753 171.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.5 p -81.81 134.39 27.17 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 CA-C-N 114.842 -1.072 . . . . 75.41 109.269 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.614 ' HE3' ' HB2' ' C' ' 43' ' ' ASP . 29.2 ttpt -114.97 129.18 56.66 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.141 -1.059 . . . . 74.21 108.141 169.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.47 HD22 HD11 ' C' ' 128' ' ' LEU . 49.4 tp -88.03 141.49 28.53 Favored 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 107.463 -1.31 . . . . 62.43 107.463 166.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.614 ' HB2' ' HE3' ' C' ' 41' ' ' LYS . 20.8 t70 -140.54 109.7 6.16 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.008 0.523 . . . . 61.34 109.692 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.7 mp -105.64 145.73 30.63 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 109.245 -0.65 . . . . 71.14 109.245 177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.605 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 12.7 t70 -143.29 149.76 38.28 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.519 1.127 . . . . 71.51 108.993 178.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.476 ' OG1' ' HA ' ' F' ' 282' ' ' ALA . 34.1 p -115.23 140.78 48.8 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.895 0.878 . . . . 72.11 110.257 -178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.454 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -143.11 151.31 40.59 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.851 0.86 . . . . 73.24 109.527 177.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 24.3 m -141.29 155.96 45.92 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 122.937 0.495 . . . . 73.14 111.289 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 37.7 t -149.08 126.6 11.62 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.332 -0.988 . . . . 52.03 108.332 168.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -81.63 117.48 22.03 Favored 'General case' 0 C--N 1.349 0.565 0 N-CA-C 107.828 -1.175 . . . . 54.33 107.828 173.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.9 mt -97.07 -25.76 15.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 122.892 0.477 . . . . 73.12 110.549 -177.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.44 -179.72 6.19 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.773 0.829 . . . . 73.11 110.119 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -62.67 122.35 15.64 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 108.937 -0.764 . . . . 75.51 108.937 170.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 62.8 21.19 12.64 Favored 'General case' 0 CA--C 1.559 1.312 0 O-C-N 124.447 1.092 . . . . 64.14 111.44 178.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 67.8 t -125.69 117.34 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 C-N-CA 124.01 0.924 . . . . 62.04 108.63 175.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -130.66 130.42 43.89 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.931 0.892 . . . . 75.04 110.19 -178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' C' ' 51' ' ' LEU . 34.8 tt0 -82.02 109.28 16.2 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 107.527 -1.286 . . . . 64.44 107.527 168.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 98.9 t -96.39 114.12 32.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 107.031 -1.47 . . . . 52.43 107.031 177.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.454 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 48.9 t -111.88 131.28 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.455 0.702 . . . . 71.34 109.321 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.54 HD23 HD12 ' C' ' 106' ' ' LEU . 3.6 mm? -117.22 111.31 19.26 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 124.334 1.054 . . . . 74.14 108.312 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.605 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 7.4 ttm180 -81.99 114.76 20.79 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.912 -0.773 . . . . 74.12 108.912 174.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 33.9 t -105.28 117.03 50.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.854 -1.165 . . . . 73.14 107.854 173.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 89.0 m -123.74 139.83 53.59 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 124.417 1.087 . . . . 34.42 108.075 -174.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 49.8 t -123.7 113.74 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 C-N-CA 124.136 0.974 . . . . 74.11 108.971 177.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 45.8 m -98.24 137.09 37.5 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.278 -0.874 . . . . 74.14 108.658 173.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.29 112.9 10.09 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.878 -1.527 . . . . 42.25 106.878 -179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.439 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 48.7 m -145.35 127.6 15.77 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 109.052 -0.721 . . . . 64.44 109.052 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.531 HD13 ' HG2' ' C' ' 34' ' ' LYS . 3.8 mp -90.47 48.78 1.59 Allowed 'General case' 0 N--CA 1.481 1.09 0 CA-C-O 121.301 0.572 . . . . 62.33 110.543 -175.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.3 -117.82 3.21 Favored Glycine 0 C--N 1.344 1.0 0 N-CA-C 110.179 -1.168 . . . . 35.31 110.179 -173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.72 -33.19 16.68 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.134 0.974 . . . . 63.22 109.267 173.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -79.71 121.3 25.16 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.592 1.157 . . . . 60.53 110.851 -178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 91.7 m -78.77 137.84 37.93 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.081 0.952 . . . . 55.2 111.584 -178.026 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.63 -66.11 0.74 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.106 0.963 . . . . 74.43 109.241 165.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -159.32 175.87 12.84 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-O 121.702 0.763 . . . . 60.54 110.858 173.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -126.4 143.36 51.2 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 106.982 -1.488 . . . . 73.25 106.982 171.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 53.2 t -137.44 140.21 41.13 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 107.659 -1.237 . . . . 74.3 107.659 176.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -151.46 119.74 6.36 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 118.373 0.533 . . . . 62.15 110.875 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 77.6 t -117.24 114.14 44.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 N-CA-C 108.512 -0.922 . . . . 72.21 108.512 170.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.509 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 25.9 mt-30 -90.25 97.53 11.24 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.615 -1.254 . . . . 74.35 107.615 172.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -87.14 119.67 27.6 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.754 0.822 . . . . 64.12 109.806 -177.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.23 148.95 18.28 Favored Glycine 0 C--N 1.34 0.767 0 O-C-N 123.188 0.305 . . . . 72.35 112.593 -178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.82 126.7 2.82 Favored Glycine 0 C--O 1.237 0.313 0 N-CA-C 110.902 -0.879 . . . . 62.2 110.902 177.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.508 HD12 HD11 ' C' ' 51' ' ' LEU . 16.2 mm -81.26 119.85 31.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.566 0 N-CA-C 107.952 -1.129 . . . . 74.52 107.952 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -129.41 142.89 50.69 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.418 -0.956 . . . . 72.03 108.418 -179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 15.1 m -105.98 123.31 47.78 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.124 -1.065 . . . . 73.24 108.124 171.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 71.9 mt -112.87 100.66 11.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 123.914 0.886 . . . . 71.05 108.757 -173.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -128.14 169.34 14.22 Favored 'General case' 0 C--O 1.239 0.509 0 C-N-CA 124.871 1.269 . . . . 75.23 108.818 177.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.18 -40.94 3.03 Favored Glycine 0 N--CA 1.466 0.7 0 CA-C-N 116.567 -0.288 . . . . 50.22 112.966 174.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.5 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.9 pp -124.86 165.84 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.041 0.937 . . . . 63.43 110.489 175.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.414 ' HG2' ' N ' ' C' ' 91' ' ' GLY . 28.4 tt0 -152.97 166.0 33.78 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.417 0.687 . . . . 74.12 109.985 -175.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' C' ' 90' ' ' GLU . . . 70.59 -118.44 7.74 Favored Glycine 0 C--N 1.348 1.225 0 CA-C-N 116.565 -0.289 . . . . 75.2 113.71 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -77.96 -24.48 48.13 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 123.503 0.721 . . . . 55.13 111.194 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -71.67 -41.01 69.23 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 109.567 -0.531 . . . . 70.14 109.567 178.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' F' ' 277' ' ' LEU . 20.0 ptm -76.98 -28.34 55.08 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 116.12 -0.491 . . . . 64.21 110.755 176.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' F' ' 280' ' ' LEU . . . -66.46 -29.2 69.28 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.149 0.58 . . . . 71.13 110.836 176.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 47.6 t-80 -70.92 -36.07 72.51 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.656 0.782 . . . . 74.35 110.496 171.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.7 t -67.8 -62.13 1.56 Allowed 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.966 0.506 . . . . 51.34 110.568 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -76.57 -12.42 60.02 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.628 0.603 . . . . 75.11 112.628 -177.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.48 -4.41 57.22 Favored Glycine 0 C--N 1.351 1.406 0 CA-C-O 119.58 -0.567 . . . . 72.33 113.917 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -144.49 -50.87 0.29 Allowed 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 117.761 0.781 . . . . 71.14 111.726 -178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -75.98 -54.2 7.23 Favored 'General case' 0 CA--C 1.552 1.039 0 C-N-CA 123.293 0.637 . . . . 73.4 111.677 -173.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 60.4 m -63.61 -42.32 71.78 Favored Pre-proline 0 CA--C 1.564 1.484 0 C-N-CA 123.766 0.827 . . . . 75.33 113.167 -177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -62.59 -30.84 79.66 Favored 'Trans proline' 0 C--N 1.397 3.127 0 C-N-CA 122.209 1.94 . . . . 72.44 112.68 171.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -69.14 -33.77 73.97 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.232 0.613 . . . . 75.03 110.743 176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 35.0 mm -65.87 -50.49 69.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.055 0.542 . . . . 73.31 110.091 174.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.54 HD12 HD23 ' C' ' 60' ' ' LEU . 82.3 mt -79.52 -15.55 57.54 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.831 -0.622 . . . . 53.51 112.409 -172.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.438 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 87.8 t80 -56.41 -55.6 40.69 Favored Pre-proline 0 CA--C 1.561 1.394 0 C-N-CA 124.284 1.034 . . . . 72.5 113.131 -175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.438 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 21.0 Cg_exo -66.24 -29.87 46.43 Favored 'Trans proline' 0 C--N 1.39 2.744 0 C-N-CA 121.914 1.743 . . . . 42.44 112.828 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.422 ' HE2' HG21 ' A' ' 115' ' ' THR . 86.1 m-85 -65.64 -45.78 81.71 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.364 0.666 . . . . 73.33 110.881 178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.09 -38.63 91.35 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.437 0.695 . . . . 75.23 110.651 174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -60.92 -57.1 14.07 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.749 1.22 . . . . 72.04 111.484 -173.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -33.38 75.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 123.415 0.447 . . . . 75.33 110.008 -177.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.479 ' SG ' HG12 ' C' ' 21' ' ' ILE . 26.1 t -61.2 -43.87 98.19 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 122.978 0.511 . . . . 53.13 110.565 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . . . . . . . . . 66.4 mt -65.15 -43.98 95.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 C-N-CA 123.177 0.591 . . . . 72.24 110.542 173.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 53.0 m -63.19 -33.15 74.86 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.441 0.697 . . . . 54.31 111.471 -176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 42.2 p -76.78 -41.61 43.95 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.84 -0.8 . . . . 70.24 108.84 178.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.724 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.2 OUTLIER -54.95 -46.4 75.0 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 123.89 0.876 . . . . 62.53 112.111 178.043 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 11.9 p -74.81 -26.89 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 122.736 0.414 . . . . 72.12 111.126 178.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 33.5 t -70.88 -29.89 66.11 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.537 0.735 . . . . 72.55 111.416 175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.405 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 50.6 mtt-85 -78.68 -33.17 47.21 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.744 0.818 . . . . 54.1 109.39 177.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.69 1.53 61.82 Favored Glycine 0 C--N 1.361 1.937 0 CA-C-N 115.553 -0.748 . . . . 72.54 112.881 170.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.6 p 61.74 25.2 15.14 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 126.381 1.873 . . . . 40.25 113.069 170.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -103.4 156.44 35.46 Favored Pre-proline 0 N--CA 1.475 0.795 0 C-N-CA 124.35 1.06 . . . . 71.53 110.421 174.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 32.3 Cg_exo -40.66 118.9 0.67 Allowed 'Trans proline' 0 C--N 1.393 2.919 0 C-N-CA 124.238 3.292 . . . . 72.51 113.779 175.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -60.16 139.55 57.47 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.54 -0.754 . . . . 71.4 111.743 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.7 tt -106.18 105.7 15.86 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.029 -1.1 . . . . 64.01 108.029 -178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.18 112.66 22.98 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 107.211 -1.403 . . . . 72.44 107.211 172.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.47 HD11 HD22 ' C' ' 42' ' ' LEU . 20.4 tp -84.6 141.86 30.37 Favored 'General case' 0 CA--C 1.538 0.494 0 O-C-N 123.597 0.561 . . . . 74.23 110.039 -178.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.426 ' HB1' HG21 ' H' ' 309' ' ' THR . . . -79.35 145.29 63.74 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 115.686 -0.688 . . . . 71.24 112.095 -170.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.592 ' HG3' HD13 ' A' ' 16' ' ' ILE . 5.3 Cg_endo -46.8 102.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.378 2.092 0 C-N-CA 123.977 3.118 . . . . 73.2 112.762 169.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 49.9 t -96.25 106.71 18.71 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 107.042 -1.466 . . . . 65.51 107.042 174.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.58 HD21 HD12 ' A' ' 13' ' ' ILE . 77.6 m-20 -98.77 85.68 3.36 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.541 -1.281 . . . . 72.01 107.541 -178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -51.22 -38.3 51.68 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.342 1.057 . . . . 71.34 111.9 -174.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.48 -38.47 62.9 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.211 1.004 . . . . 71.55 111.811 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -68.93 -28.86 67.03 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.935 0.494 . . . . 60.23 111.078 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 mp -56.13 -41.02 74.68 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.821 0.701 . . . . 65.21 110.888 171.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -66.48 -29.92 70.14 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.088 0.555 . . . . 75.22 111.883 177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 65.1 mtt -74.07 -31.59 62.91 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.186 0.594 . . . . 64.33 110.843 175.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . 0.486 HD21 ' HB2' ' H' ' 310' ' ' PRO . 83.7 m-20 -69.64 -38.09 77.02 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.529 0.732 . . . . 60.21 109.897 174.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -66.56 -82.52 0.03 OUTLIER 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.57 0.748 . . . . 74.3 110.068 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 41.7 tp -115.17 93.06 4.14 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.001 0.52 . . . . 73.32 110.586 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.17 -98.97 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 107.421 -1.326 . . . . 75.3 107.421 168.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -156.62 112.82 3.01 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.656 1.182 . . . . 63.53 108.411 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -90.83 93.93 9.44 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 107.652 -1.24 . . . . 44.43 107.652 169.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -157.74 141.62 15.81 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.623 0.769 . . . . 50.4 110.352 -170.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -174.76 144.94 7.68 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 115.806 -0.634 . . . . 61.31 112.088 175.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -167.4 148.76 5.63 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 122.713 0.405 . . . . 54.14 110.735 176.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -167.17 -89.7 0.08 OUTLIER Glycine 0 C--N 1.345 1.028 0 N-CA-C 110.773 -0.931 . . . . 73.55 110.773 174.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' A' ' 53' ' ' ASP . 33.6 p 61.6 128.43 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 127.079 2.152 . . . . 73.22 111.71 -175.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.507 ' HG2' ' HA ' ' A' ' 53' ' ' ASP . 16.0 pt-20 -135.85 -175.06 3.84 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.524 0.73 . . . . 74.44 110.787 -171.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -134.26 111.54 10.32 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.027 -1.842 . . . . 63.1 106.027 172.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.575 ' HB3' HE22 ' A' ' 50' ' ' GLN . 33.9 t-80 -167.89 112.4 0.66 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.431 -0.952 . . . . 71.1 108.431 -174.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -83.26 120.9 26.4 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.409 0.684 . . . . 70.3 109.927 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -119.19 147.08 44.62 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.176 0.59 . . . . 74.31 111.078 -177.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.306 0 C-N-CA 123.992 0.917 . . . . 74.55 110.66 -178.886 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 24.4 mmt . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 109.844 -0.428 . . . . 72.33 109.844 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m -84.14 76.07 10.12 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.261 0.625 . . . . 55.13 109.836 173.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -86.0 93.68 9.03 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 115.775 -0.648 . . . . 64.42 110.188 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -76.46 176.58 8.12 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.614 -0.721 . . . . 72.54 110.588 176.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -156.04 -60.8 0.1 Allowed 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.301 0.64 . . . . 74.12 109.454 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 24.6 m120 -143.31 124.46 14.51 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 123.808 0.843 . . . . 70.54 109.196 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.1 t -123.21 -12.72 7.83 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.597 0.759 . . . . 54.1 110.274 176.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.29 -0.48 56.7 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.156 0.982 . . . . 75.01 111.013 178.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 8.1 ttp -30.88 127.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 125.457 1.503 . . . . 71.3 113.583 174.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 25.7 m -118.83 139.34 51.77 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 123.437 0.695 . . . . 61.42 109.726 176.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -157.68 116.4 3.19 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 107.537 -1.283 . . . . 70.12 107.537 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -135.59 140.52 44.68 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.876 -1.157 . . . . 51.4 107.876 178.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.507 HG21 HD11 ' D' ' 16' ' ' ILE . 8.7 mt -97.46 124.77 50.56 Favored 'Isoleucine or valine' 0 C--O 1.24 0.56 0 N-CA-C 109.017 -0.735 . . . . 60.24 109.017 172.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -92.82 -37.54 12.25 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.485 0.714 . . . . 64.24 110.344 176.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -161.12 148.34 15.17 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.807 0.843 . . . . 75.14 110.675 -173.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.507 HD11 HG21 ' D' ' 13' ' ' ILE . 1.8 mp -135.34 114.66 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 105.302 -2.11 . . . . 74.31 105.302 166.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -151.72 151.53 31.55 Favored 'General case' 0 C--O 1.24 0.573 0 CA-C-O 121.576 0.703 . . . . 65.44 111.081 -172.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 76.4 p -77.32 109.89 11.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.761 -1.108 . . . . 64.2 109.134 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.514 ' HE3' ' HD3' ' C' ' 29' ' ' PRO . 34.9 mtpt -79.28 -33.16 43.61 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 116.187 -0.46 . . . . 71.23 110.041 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -141.33 142.2 33.82 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.371 -0.974 . . . . 72.42 108.371 173.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.724 HD13 ' HE3' ' C' ' 117' ' ' MET . 98.0 mt -133.06 140.91 46.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.465 0 N-CA-C 106.574 -1.639 . . . . 75.31 106.574 173.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 33.8 t -146.7 136.47 23.19 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.605 0.762 . . . . 51.13 109.116 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.61 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 57.2 t80 -148.72 123.68 10.02 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 105.764 -1.939 . . . . 65.23 105.764 169.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -125.12 142.12 51.69 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.431 0.692 . . . . 75.21 109.298 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -125.66 80.36 66.55 Favored Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 107.913 -1.143 . . . . 64.45 107.913 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -68.79 -29.97 27.96 Favored 'Trans proline' 0 C--N 1.385 2.486 0 C-N-CA 122.733 2.289 . . . . 62.22 111.784 -176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -114.47 40.74 2.47 Favored 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.959 1.304 . . . . 73.33 108.775 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.507 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -55.11 -66.41 1.0 Allowed Pre-proline 0 CA--C 1.563 1.453 0 N-CA-C 114.315 1.228 . . . . 74.44 114.315 -166.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -86.21 -3.92 8.66 Favored 'Trans proline' 0 C--N 1.387 2.578 0 CA-C-N 123.074 2.134 . . . . 63.3 112.123 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.25 -39.86 68.13 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.933 1.293 . . . . 74.33 109.901 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.531 HG21 ' HA ' ' D' ' 73' ' ' ALA . 9.3 p -82.29 -28.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 116.337 -0.392 . . . . 75.25 110.1 -177.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 15.2 m-30 -65.98 -2.33 3.89 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.235 1.198 . . . . 64.04 114.235 -174.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -76.83 -38.18 54.29 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 123.145 0.578 . . . . 62.02 109.672 168.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.491 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 0.0 OUTLIER -136.3 96.69 3.42 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.373 0.669 . . . . 73.23 112.303 173.011 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -107.13 98.03 7.72 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.542 -0.91 . . . . 74.52 108.542 164.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.636 ' H ' HD11 ' D' ' 68' ' ' LEU . 5.6 m-90 -122.31 -162.85 1.03 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 106.231 -1.766 . . . . 70.34 106.231 169.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.608 ' HB3' ' HB3' ' G' ' 295' ' ' ALA . 26.6 mt-30 -52.52 104.23 0.42 Allowed Pre-proline 0 N--CA 1.486 1.367 0 CA-C-N 118.66 0.664 . . . . 75.02 112.521 -168.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.412 ' O ' HG13 ' D' ' 40' ' ' VAL . 5.9 Cg_exo -75.7 105.07 2.01 Favored 'Trans proline' 0 C--N 1.391 2.808 0 C-N-CA 122.662 2.241 . . . . 52.12 109.892 -178.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -61.23 111.0 1.56 Allowed 'General case' 0 CA--C 1.545 0.757 0 N-CA-C 107.701 -1.222 . . . . 74.44 107.701 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.544 HG11 HD11 ' D' ' 126' ' ' LEU . 2.2 m -104.61 149.42 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 114.797 -1.092 . . . . 71.14 110.876 -165.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.567 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 74.7 mmtt -109.17 133.05 53.52 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.069 0.947 . . . . 73.21 108.511 178.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 52.6 tp -96.9 111.97 23.93 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.568 -1.271 . . . . 74.55 107.568 174.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.653 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 15.8 m-20 -124.29 141.47 52.04 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.873 0.869 . . . . 72.22 108.79 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.2 pp -138.74 167.14 22.63 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 121.22 0.533 . . . . 52.4 110.762 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.499 ' HB3' ' HD2' ' D' ' 61' ' ' ARG . 4.3 t70 -156.31 145.83 20.82 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.825 -1.176 . . . . 73.43 107.825 175.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.5 p -106.59 141.79 37.3 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 109.019 -0.734 . . . . 70.43 109.019 177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.447 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.5 159.39 42.25 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 108.528 -0.915 . . . . 62.3 108.528 177.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 20.4 p -170.89 162.08 7.3 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.576 0.35 . . . . 63.43 110.931 -175.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 90.0 p -152.0 152.24 32.2 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.212 0.605 . . . . 60.2 110.166 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -90.75 117.56 29.48 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 108.604 -0.887 . . . . 74.04 108.604 171.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 55.6 mt -93.21 -27.98 16.54 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 123.393 0.677 . . . . 72.41 109.434 176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.403 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -166.94 177.11 6.54 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.319 1.048 . . . . 63.32 110.218 176.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -70.28 127.06 31.48 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 107.998 -1.112 . . . . 72.04 107.998 172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 70.85 5.92 5.64 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.445 1.098 . . . . 74.22 111.856 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 86.3 t -125.51 115.22 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 124.252 1.021 . . . . 74.21 108.277 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -135.92 130.84 34.37 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 123.12 0.568 . . . . 72.23 109.553 -175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -90.26 136.12 33.25 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.314 -0.857 . . . . 73.0 109.881 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 61.3 t -113.12 114.55 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 124.654 1.182 . . . . 74.12 108.26 175.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 21.9 t -101.85 108.89 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 123.553 0.741 . . . . 64.35 109.339 175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.86 111.25 23.57 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.25 -1.019 . . . . 73.22 108.25 175.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.499 ' HD2' ' HB3' ' D' ' 45' ' ' ASP . 14.7 ttm180 -83.91 114.34 21.6 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 123.324 0.65 . . . . 72.41 109.489 176.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.4 t -104.4 123.69 58.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 N-CA-C 108.202 -1.036 . . . . 75.21 108.202 173.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.653 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 25.5 m -129.65 135.32 48.38 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.324 0.65 . . . . 71.33 109.817 -174.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 40.5 t -130.9 109.27 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 C-N-CA 123.974 0.91 . . . . 72.44 109.574 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.567 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 31.3 m -102.46 102.37 12.66 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 109.08 -0.711 . . . . 73.3 109.08 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.77 129.35 43.02 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 110.059 -0.348 . . . . 73.25 110.059 -175.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -124.27 124.11 41.7 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.921 0.889 . . . . 64.14 109.152 -177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.636 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.1 OUTLIER -90.9 96.57 10.7 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.512 -1.292 . . . . 74.23 107.512 177.429 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.14 -112.99 4.68 Favored Glycine 0 C--N 1.339 0.739 0 O-C-N 123.477 0.485 . . . . 64.14 112.548 179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.95 6.43 48.64 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.306 1.042 . . . . 63.51 111.908 -175.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -146.75 157.2 43.63 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.667 0.787 . . . . 62.32 109.336 -171.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 24.5 m -66.66 132.47 48.2 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.973 0.909 . . . . 70.02 111.909 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.531 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -81.08 -64.51 1.17 Allowed 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.925 -0.769 . . . . 74.34 108.925 169.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -156.58 159.26 38.35 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.432 -1.258 . . . . 74.11 110.004 178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 60.6 mt -109.79 146.59 34.75 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.326 1.05 . . . . 73.12 108.6 173.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.638 ' SG ' HG23 ' D' ' 114' ' ' ILE . 51.8 t -152.29 140.84 20.75 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 122.999 0.52 . . . . 72.32 110.171 179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -157.95 145.79 18.59 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.712 0.805 . . . . 64.51 109.872 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 90.9 t -142.8 116.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 124.322 1.049 . . . . 62.14 109.018 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.75 90.58 8.47 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 108.847 -0.797 . . . . 75.13 108.847 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -82.4 98.23 8.76 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 115.353 -0.84 . . . . 73.13 109.819 -177.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.559 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.63 144.68 17.52 Favored Glycine 0 C--N 1.342 0.917 0 N-CA-C 111.602 -0.599 . . . . 53.51 111.602 176.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.31 130.92 4.15 Favored Glycine 0 CA--C 1.505 -0.552 0 N-CA-C 111.142 -0.783 . . . . 71.31 111.142 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.7 123.23 41.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.568 0 N-CA-C 108.525 -0.917 . . . . 72.21 108.525 -177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -130.68 126.66 37.1 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.814 0.846 . . . . 72.02 110.024 -175.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 16.3 m -76.26 98.01 4.34 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 108.82 -0.807 . . . . 74.25 108.82 169.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 63.6 mt -107.81 109.94 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 108.376 -0.972 . . . . 63.3 108.376 -176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -151.16 168.33 25.03 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.108 0.963 . . . . 54.22 110.133 -172.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.52 -20.2 19.63 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.04 -0.527 . . . . 44.01 114.008 173.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 8.0 pt -124.22 162.01 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 123.938 0.895 . . . . 73.41 111.178 -170.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.55 173.67 13.83 Favored 'General case' 0 C--O 1.242 0.659 0 CA-C-N 115.368 -0.833 . . . . 64.34 111.054 178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.83 -118.62 12.39 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 124.156 0.91 . . . . 61.13 114.042 173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 27.7 m -74.54 -31.05 61.99 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.778 0.831 . . . . 74.25 111.684 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -65.52 -43.76 89.06 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 122.994 0.518 . . . . 75.51 110.987 -178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.471 ' HG2' ' O ' ' G' ' 276' ' ' PRO . 0.0 OUTLIER -75.55 -34.91 60.76 Favored 'General case' 0 C--O 1.215 -0.74 0 CA-C-N 116.012 -0.54 . . . . 61.02 110.363 177.263 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.36 -29.35 68.86 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.136 0.574 . . . . 74.11 111.504 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.446 ' HD1' ' HD2' ' D' ' 137' ' ' PHE . 18.4 t60 -71.49 -49.74 38.3 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.614 0.766 . . . . 70.43 109.492 175.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -64.73 -39.06 93.0 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.753 -0.658 . . . . 71.1 111.155 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.463 HD21 HD13 ' G' ' 278' ' ' LEU . 58.5 tp -78.78 -37.08 41.87 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.499 1.12 . . . . 74.55 111.013 -173.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -93.33 -23.28 24.79 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-N 116.089 -0.505 . . . . 55.0 113.901 -173.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.86 -58.43 2.07 Favored 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 117.395 0.598 . . . . 54.3 111.635 -174.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -73.63 -46.29 47.69 Favored 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 112.251 0.463 . . . . 71.31 112.251 -168.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 76.1 m -64.91 -47.27 74.65 Favored Pre-proline 0 CA--C 1.561 1.373 0 CA-C-O 118.297 -0.858 . . . . 61.22 112.279 -176.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -57.2 -34.27 97.49 Favored 'Trans proline' 0 C--N 1.399 3.217 0 C-N-CA 122.444 2.096 . . . . 71.55 112.998 171.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -67.2 -30.11 69.96 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.093 0.957 . . . . 71.54 111.24 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -72.41 -43.58 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 C-N-CA 123.267 0.627 . . . . 73.31 110.266 175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 74.0 mt -74.93 -34.57 62.12 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 115.301 -0.863 . . . . 74.41 112.214 -170.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 40.1 t80 -59.71 -42.6 92.24 Favored Pre-proline 0 CA--C 1.567 1.609 0 N-CA-C 114.372 1.249 . . . . 70.1 114.372 -168.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -51.65 -42.84 54.44 Favored 'Trans proline' 0 C--N 1.389 2.689 0 C-N-CA 122.464 2.109 . . . . 74.4 113.858 172.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -76.5 -27.99 56.26 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.458 0.703 . . . . 75.33 111.493 -177.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.01 -54.29 36.58 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.983 0.42 . . . . 70.02 109.955 173.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.408 ' NH2' HG23 ' B' ' 105' ' ' ILE . 40.9 ttp180 -62.51 -34.22 76.44 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 114.622 -1.172 . . . . 73.12 111.285 -178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -53.64 -52.87 58.52 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 124.357 1.063 . . . . 53.4 110.84 174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.405 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 50.9 t -65.44 -43.68 89.7 Favored 'General case' 0 C--N 1.35 0.613 0 CA-C-N 114.841 -1.072 . . . . 73.42 111.377 -176.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.638 HG23 ' SG ' ' D' ' 76' ' ' CYS . 68.3 mt -60.58 -56.7 15.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.752 0.821 . . . . 73.31 110.86 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.449 HG23 ' HB2' ' D' ' 125' ' ' GLN . 97.7 m -51.83 -42.71 62.75 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.32 1.048 . . . . 61.43 111.825 -179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 35.6 t -71.05 -28.4 64.35 Favored 'General case' 0 CA--C 1.548 0.879 0 CA-C-N 115.399 -0.819 . . . . 54.24 111.645 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 77.0 mtm -77.99 -36.65 48.67 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.832 0.453 . . . . 75.3 111.391 177.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.499 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.7 t -64.5 -36.6 77.76 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 C-N-CA 123.614 0.766 . . . . 73.45 110.752 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 119' ' ' SER . 84.9 p -69.71 -31.07 68.88 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.437 0.695 . . . . 62.21 111.322 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' D' ' 116' ' ' SER . 68.8 mtt-85 -74.79 -26.06 59.48 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.559 0.743 . . . . 54.41 110.821 177.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.32 10.07 62.37 Favored Glycine 0 C--N 1.356 1.673 0 O-C-N 123.572 0.545 . . . . 65.21 112.538 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.8 p 63.7 23.14 13.39 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 126.386 1.874 . . . . 74.0 113.287 176.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -97.44 163.83 18.94 Favored Pre-proline 0 CA--C 1.556 1.195 0 C-N-CA 124.487 1.115 . . . . 71.42 109.438 173.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.64 155.48 44.68 Favored 'Trans proline' 0 C--N 1.384 2.404 0 C-N-CA 122.221 1.947 . . . . 55.22 110.555 175.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.449 ' HB2' HG23 ' D' ' 115' ' ' THR . 16.7 pt20 -55.57 147.27 18.36 Favored 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 123.513 0.725 . . . . 72.13 111.694 -174.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.544 HD11 HG11 ' D' ' 40' ' ' VAL . 3.0 tt -126.39 106.19 9.32 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 109.059 -0.719 . . . . 74.35 109.059 -175.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.408 HD21 ' HB ' ' B' ' 16' ' ' ILE . 7.6 m-20 -112.52 110.38 20.51 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.233 1.013 . . . . 70.43 110.577 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -75.76 125.39 28.98 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 123.639 0.776 . . . . 73.53 108.993 171.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.427 ' HB3' HD13 ' G' ' 291' ' ' LEU . . . -66.02 145.54 99.01 Favored Pre-proline 0 N--CA 1.48 1.072 0 C-N-CA 122.395 0.278 . . . . 50.11 110.719 178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.75 134.41 25.83 Favored 'Trans proline' 0 C--N 1.376 2.011 0 C-N-CA 122.317 2.011 . . . . 71.42 111.378 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.402 HG22 HD21 ' G' ' 291' ' ' LEU . 41.5 t -108.89 120.23 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.152 -0.684 . . . . 41.12 109.152 -179.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -86.41 82.42 7.97 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 123.395 0.678 . . . . 53.42 109.656 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -62.38 -28.57 69.86 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.174 0.99 . . . . 73.12 111.14 177.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.45 -49.32 77.73 Favored 'General case' 0 C--N 1.349 0.558 0 C-N-CA 125.068 1.347 . . . . 73.25 110.439 -176.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.83 94.44 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.944 0.898 . . . . 64.45 111.783 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.8 mt -66.63 -34.42 77.84 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 115.197 -0.91 . . . . 75.41 111.683 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.446 ' HD2' ' HD1' ' D' ' 96' ' ' HIS . 71.5 t80 -80.3 -44.24 19.9 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.31 0.644 . . . . 64.42 110.738 -178.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 21.7 ptp -64.38 -26.38 68.44 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.876 0.47 . . . . 71.55 111.736 -175.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -54.66 -49.35 70.81 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.432 1.093 . . . . 73.31 111.199 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -59.06 -36.42 75.02 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.937 0.895 . . . . 74.24 111.77 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.58 -31.73 62.16 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.435 0.694 . . . . 44.4 112.254 -176.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -90.76 12.53 18.9 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.16 0.43 . . . . 62.23 112.16 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -116.68 75.52 0.97 Allowed 'General case' 0 N--CA 1.474 0.77 0 CA-C-O 121.641 0.734 . . . . 73.52 109.153 -178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.06 -25.36 0.08 Allowed 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 114.523 -1.217 . . . . 74.31 110.652 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -143.24 132.48 23.22 Favored 'General case' 0 C--O 1.241 0.637 0 N-CA-C 107.671 -1.233 . . . . 60.22 107.671 175.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.22 73.49 2.47 Favored Glycine 0 C--N 1.346 1.121 0 O-C-N 123.734 0.646 . . . . 70.13 112.454 -174.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -79.41 118.67 21.51 Favored 'General case' 0 C--O 1.241 0.636 0 C-N-CA 123.263 0.625 . . . . 73.54 109.347 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.05 57.51 0.12 Allowed Glycine 0 C--N 1.343 0.963 0 O-C-N 123.489 0.493 . . . . 63.55 112.963 -178.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 82.0 m -64.54 89.93 0.07 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 123.803 0.841 . . . . 73.34 110.038 175.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -179.17 166.23 1.52 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 125.365 1.466 . . . . 65.11 109.655 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -152.99 -59.24 0.14 Allowed 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.103 0.961 . . . . 74.13 108.421 176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 84.5 t60 42.5 75.38 0.09 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 125.83 1.652 . . . . 71.1 112.115 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -65.32 108.3 1.89 Allowed 'General case' 0 CA--C 1.55 0.953 0 CA-C-N 115.936 -0.575 . . . . 72.42 109.857 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -156.33 28.71 0.34 Allowed 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.751 -0.658 . . . . 70.24 109.352 -170.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.088 0 C-N-CA 124.033 0.933 . . . . 62.34 111.165 -174.68 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.847 0 N-CA-C 109.873 -0.417 . . . . 53.42 109.873 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 28.1 p-10 -169.12 154.09 5.83 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.216 1.006 . . . . 72.34 109.724 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -168.35 -85.22 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.811 0.845 . . . . 64.24 108.833 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -144.54 102.05 3.76 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.109 -1.071 . . . . 74.15 108.109 -177.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -78.45 150.0 76.03 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 123.144 0.578 . . . . 63.14 111.11 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -50.84 132.08 36.04 Favored 'Trans proline' 0 C--N 1.391 2.81 0 C-N-CA 123.953 3.102 . . . . 64.03 113.608 -173.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . 0.723 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 40.5 mt -73.73 -60.82 2.07 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 114.817 -1.083 . . . . 63.31 110.095 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 6.6 mp -94.33 51.03 1.42 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.004 0.921 . . . . 64.33 109.568 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -102.8 16.81 54.16 Favored Glycine 0 C--N 1.345 1.05 0 CA-C-N 116.099 -0.5 . . . . 73.12 112.643 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.451 HD22 ' HA ' ' A' ' 95' ' ' ALA . 64.3 tp -92.66 -65.37 1.01 Allowed 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.122 0.569 . . . . 64.15 111.43 -173.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -67.48 -36.48 81.22 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.639 0.776 . . . . 75.45 110.805 -176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -62.05 -29.01 70.0 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 114.6 -1.182 . . . . 73.24 111.225 176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -83.34 -54.87 4.67 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.859 0.864 . . . . 63.33 110.767 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -141.59 120.82 1.73 Allowed Glycine 0 C--N 1.345 1.055 0 CA-C-N 115.598 -0.728 . . . . 72.32 112.128 -171.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . 0.588 HD21 ' HA ' ' A' ' 45' ' ' ASP . 26.1 t-20 -80.07 120.77 24.67 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.423 1.089 . . . . 72.0 108.894 174.1 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 28.3 ttt -112.45 104.58 56.03 Favored Pre-proline 0 N--CA 1.478 0.964 0 C-N-CA 123.116 0.567 . . . . 72.21 111.118 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . 0.76 ' HA ' ' HB3' ' A' ' 44' ' ' LEU . 65.7 Cg_endo -85.04 176.04 6.21 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.724 2.283 . . . . 74.41 112.532 168.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.19 151.34 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 C-N-CA 124.097 0.959 . . . . 74.04 109.105 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -103.57 156.24 17.93 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.568 0.747 . . . . 73.14 109.438 175.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -63.51 143.26 57.97 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.258 0.623 . . . . 72.25 110.844 175.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 6.9 mp -89.15 81.61 6.73 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.47 0.708 . . . . 61.52 109.992 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 69.25 -113.28 5.05 Favored Glycine 0 C--N 1.351 1.368 0 CA-C-O 118.619 -1.101 . . . . 71.11 113.691 175.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.39 107.59 0.6 Allowed 'Trans proline' 0 C--N 1.384 2.438 0 C-N-CA 123.1 2.533 . . . . 73.33 111.688 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -115.37 19.68 15.34 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 124.667 1.187 . . . . 63.54 110.753 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -79.09 72.85 5.65 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 121.94 0.876 . . . . 31.13 110.337 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 43.9 m -86.8 -34.31 19.59 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.469 -1.241 . . . . 60.34 110.622 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.717 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 45.7 t80 -85.13 91.08 8.03 Favored 'General case' 0 CA--C 1.551 0.99 0 CA-C-N 115.231 -0.895 . . . . 63.15 110.382 -172.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 73.6 m-70 -93.72 -166.63 1.54 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.421 1.088 . . . . 60.31 109.977 174.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.25 67.72 0.22 Allowed Glycine 0 C--N 1.344 1.008 0 C-N-CA 122.796 0.236 . . . . 72.43 113.682 -177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 28.4 p-10 -107.09 7.54 29.72 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 109.035 -0.728 . . . . 62.44 109.035 164.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.51 HG22 ' HA ' ' A' ' 123' ' ' PHE . 25.2 pt -81.69 48.73 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 125.217 1.407 . . . . 71.55 110.397 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -108.24 -179.69 3.96 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-N 115.434 -0.803 . . . . 72.34 109.988 -170.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -100.61 136.28 19.94 Favored Pre-proline 0 C--O 1.241 0.644 0 CA-C-N 114.92 -1.037 . . . . 63.03 108.782 176.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . 0.442 ' HG3' ' HG3' ' D' ' 125' ' ' GLN . 74.1 Cg_exo -49.22 -41.41 41.97 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 122.476 2.117 . . . . 52.02 110.91 160.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . 0.534 ' HB3' ' HG2' ' G' ' 294' ' ' LYS . . . 50.14 47.73 23.12 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 125.468 1.73 . . . . 43.22 110.956 176.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 3.7 p -68.56 81.35 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.152 0 CA-C-O 123.233 1.492 . . . . 65.52 108.566 177.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 11.6 t -101.4 175.4 5.59 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 112.908 -1.951 . . . . 70.11 109.205 -173.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 53.9 m 63.46 20.84 12.47 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.079 0.952 . . . . 74.21 111.703 -177.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' B' ' 12' ' ' GLN . 36.7 m -70.54 142.54 89.1 Favored Pre-proline 0 CA--C 1.556 1.181 0 C-N-CA 124.249 1.019 . . . . 65.44 108.548 171.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo . . . . . 0 C--N 1.379 2.159 0 C-N-CA 122.819 2.346 . . . . 70.21 112.315 172.063 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.801 0 N-CA-C 110.198 -0.297 . . . . 34.45 110.198 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -93.8 -176.29 4.0 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.709 0.804 . . . . 71.33 109.398 172.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -84.93 -171.3 3.56 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.17 0.588 . . . . 65.11 109.651 176.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -60.76 99.07 0.08 Allowed 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.832 0.853 . . . . 72.51 108.859 175.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -45.55 -40.54 14.1 Favored Pre-proline 0 N--CA 1.498 1.935 0 N-CA-C 115.073 1.509 . . . . 64.41 115.073 -168.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.43 61.23 6.7 Favored 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 121.364 1.376 . . . . 71.14 111.873 163.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . 0.503 ' HB3' ' SD ' ' C' ' 94' ' ' MET . 5.5 mp -61.5 101.86 0.21 Allowed 'General case' 0 C--N 1.363 1.195 0 C-N-CA 122.916 0.486 . . . . 73.33 110.16 175.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 15.6 tp -168.66 168.17 10.93 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.226 0.61 . . . . 61.22 109.785 178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -171.15 -126.84 0.9 Allowed Glycine 0 C--N 1.349 1.254 0 N-CA-C 111.358 -0.697 . . . . 44.22 111.358 177.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . 0.422 ' HB3' ' HB1' ' C' ' 95' ' ' ALA . 8.0 tt -63.97 108.5 1.52 Allowed 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 124.276 1.03 . . . . 73.21 109.562 177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -162.5 -69.72 0.05 Allowed 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.256 0.622 . . . . 75.41 110.787 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . 0.476 ' HA ' ' OG1' ' C' ' 46' ' ' THR . . . -68.24 -46.55 70.18 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.358 0.663 . . . . 64.24 111.314 -176.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -86.57 -0.0 55.27 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.507 -0.77 . . . . 71.0 110.712 172.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -91.15 15.65 60.56 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-N 115.908 -0.587 . . . . 42.02 113.508 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -71.43 95.3 1.34 Allowed 'General case' 0 C--N 1.351 0.64 0 N-CA-C 108.333 -0.988 . . . . 74.23 108.333 174.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 69.7 mtm -67.24 133.11 93.35 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 115.25 -0.886 . . . . 74.12 109.617 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.74 84.29 0.23 Allowed 'Trans proline' 0 C--N 1.379 2.146 0 C-N-CA 122.74 2.294 . . . . 75.42 112.233 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 84.6 t -90.28 -51.84 11.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-N 114.72 -1.127 . . . . 63.02 108.251 173.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 67.24 -75.27 0.06 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 125.322 1.449 . . . . 64.22 109.992 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -137.89 124.25 20.63 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 108.321 -0.992 . . . . 74.33 108.321 169.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.692 HD13 ' H ' ' F' ' 291' ' ' LEU . 0.0 OUTLIER -74.93 -14.97 60.7 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.252 0.621 . . . . 74.25 110.563 174.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -173.77 97.81 0.12 Allowed Glycine 0 C--N 1.35 1.323 0 CA-C-O 118.884 -0.953 . . . . 73.41 111.035 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -70.47 -174.7 1.1 Allowed 'Trans proline' 0 C--N 1.38 2.218 0 C-N-CA 122.807 2.338 . . . . 50.43 111.439 174.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . 0.413 ' HE2' ' HA ' ' F' ' 294' ' ' LYS . 0.6 OUTLIER 62.0 29.47 17.72 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.113 0.958 . . . . 75.43 109.944 -176.301 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . 0.699 ' HA ' ' HB3' ' H' ' 303' ' ' LYS . . . -117.77 117.98 30.81 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.209 1.004 . . . . 75.12 110.877 -172.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 41.4 m 63.58 98.88 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.14 1.376 . . . . 62.13 111.867 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -77.16 156.43 31.59 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 122.637 0.375 . . . . 74.54 110.37 178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -149.67 102.27 3.14 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.824 1.25 . . . . 74.13 108.49 174.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . 0.541 ' HA2' HG22 ' C' ' 31' ' ' VAL . . . -167.14 -139.28 2.63 Favored Glycine 0 C--N 1.346 1.099 0 CA-C-O 119.8 -0.444 . . . . 74.45 112.341 -178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -71.44 141.22 50.27 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.114 -0.699 . . . . 64.25 109.114 173.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 30.5 mm -116.33 147.75 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.772 0.429 . . . . 74.44 110.117 -170.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -64.88 91.35 0.09 Allowed 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.687 -0.486 . . . . 74.41 109.687 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 42.4 tptt 49.45 82.77 0.23 Allowed Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 126.229 1.812 . . . . 73.33 112.54 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -79.23 9.03 3.54 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.833 2.355 . . . . 63.3 114.425 -175.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -83.23 145.43 29.14 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.069 0.548 . . . . 64.21 110.927 178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 39.6 t -81.68 151.49 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 N-CA-C 109.016 -0.735 . . . . 71.14 109.016 172.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 5.0 m -80.59 62.6 4.73 Favored 'General case' 0 CA--C 1.565 1.531 0 C-N-CA 123.756 0.822 . . . . 45.1 110.807 -179.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 82.9 m 51.75 97.24 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 125.813 1.645 . . . . 72.54 113.518 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 20.5 p -73.21 146.63 87.13 Favored Pre-proline 0 N--CA 1.476 0.87 0 CA-C-O 119.036 -0.507 . . . . 73.13 110.664 173.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 C--N 1.38 2.189 0 C-N-CA 122.957 2.438 . . . . 61.31 111.904 -179.537 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.141 0 CA-C-O 120.674 0.273 . . . . 71.43 110.661 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 -145.39 174.54 11.04 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 108.841 -0.8 . . . . 74.12 108.841 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 75.0 mm-40 73.61 128.64 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 125.165 1.386 . . . . 63.12 110.717 176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.89 139.92 58.77 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.027 0.931 . . . . 71.03 111.882 -174.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -95.34 101.28 7.25 Favored Pre-proline 0 N--CA 1.476 0.872 0 N-CA-C 107.549 -1.278 . . . . 71.1 107.549 172.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' D' ' 94' ' ' MET . 71.3 Cg_exo -53.12 -44.48 48.52 Favored 'Trans proline' 0 C--N 1.385 2.457 0 C-N-CA 123.475 2.783 . . . . 44.52 113.135 -173.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 81.4 mt -129.58 144.52 51.31 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.954 0.902 . . . . 75.12 108.888 176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . 0.463 HD13 HD21 ' D' ' 98' ' ' LEU . 3.8 mm? 64.78 41.81 4.88 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 124.064 0.946 . . . . 74.43 111.354 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -102.56 -1.37 50.0 Favored Glycine 0 N--CA 1.472 1.087 0 CA-C-N 115.427 -0.806 . . . . 62.42 113.398 175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 4.6 tt -163.96 114.81 1.32 Allowed 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 108.088 -1.078 . . . . 70.4 108.088 -178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -163.82 -70.8 0.04 OUTLIER 'General case' 0 C--N 1.358 0.959 0 C-N-CA 123.565 0.746 . . . . 74.11 110.77 178.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.54 68.78 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.408 0.683 . . . . 74.14 111.692 -176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -78.28 -4.96 50.5 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.393 1.077 . . . . 65.45 111.669 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.78 80.73 0.33 Allowed Glycine 0 C--N 1.352 1.448 0 O-C-N 123.886 0.741 . . . . 75.31 112.371 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -76.69 91.07 3.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.414 1.085 . . . . 72.01 110.144 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 88.9 mtp -118.56 90.57 39.75 Favored Pre-proline 0 CA--C 1.544 0.747 0 N-CA-C 107.568 -1.271 . . . . 72.33 107.568 170.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -60.92 101.98 0.19 Allowed 'Trans proline' 0 C--N 1.385 2.453 0 C-N-CA 123.137 2.558 . . . . 74.13 112.742 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 51.8 t -84.69 108.64 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 C-N-CA 123.565 0.746 . . . . 72.23 109.401 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -69.22 159.14 33.58 Favored 'General case' 0 C--O 1.245 0.826 0 C-N-CA 123.637 0.775 . . . . 71.5 110.783 175.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -76.05 103.76 6.25 Favored 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 107.139 -1.43 . . . . 70.32 107.139 171.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.476 HD22 HG23 ' E' ' 309' ' ' THR . 0.3 OUTLIER -82.49 25.11 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.273 1.029 . . . . 75.42 112.246 -178.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -150.84 91.98 0.14 Allowed Glycine 0 C--N 1.342 0.905 0 N-CA-C 110.627 -0.989 . . . . 41.34 110.627 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.03 -15.36 29.18 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.166 2.577 . . . . 75.13 112.407 177.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . 0.534 ' HG2' ' HB3' ' E' ' 305' ' ' ALA . 17.4 tppt? -78.81 123.94 27.71 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.395 0.678 . . . . 75.34 109.665 174.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' D' ' 37' ' ' GLN . . . -89.65 131.49 35.61 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 108.263 -1.014 . . . . 72.54 108.263 172.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 5.5 t -62.7 96.08 0.08 Allowed 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 123.81 0.844 . . . . 62.35 113.232 -168.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' D' ' 37' ' ' GLN . 0.2 OUTLIER 179.12 163.17 0.83 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.775 1.63 . . . . 71.11 108.21 171.058 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -159.29 -37.52 0.06 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.303 1.041 . . . . 74.11 109.381 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -88.74 -125.14 2.43 Favored Glycine 0 C--N 1.34 0.756 0 CA-C-N 115.815 -0.63 . . . . 52.3 112.271 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 37.1 p30 -168.23 151.82 5.85 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.351 0.66 . . . . 63.24 111.489 -175.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.738 HD13 HH12 ' C' ' 15' ' ' ARG . 2.8 pp -125.64 146.47 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 107.95 -1.13 . . . . 55.25 107.95 158.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -132.53 169.48 16.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.522 -0.918 . . . . 75.25 108.522 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -55.42 110.66 2.38 Favored Pre-proline 0 CA--C 1.558 1.261 0 C-N-CA 124.716 1.206 . . . . 60.14 110.859 178.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -77.61 144.6 22.52 Favored 'Trans proline' 0 C--N 1.371 1.72 0 C-N-CA 122.134 1.89 . . . . 61.34 110.625 176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -138.27 86.16 2.14 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 122.853 0.461 . . . . 64.33 109.888 -178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' C' ' 12' ' ' GLN . 26.6 m -91.69 153.17 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 N-CA-C 108.118 -1.067 . . . . 74.4 108.118 169.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 30.1 m -149.05 149.42 31.08 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 122.947 0.499 . . . . 75.13 109.814 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 53.8 t 67.13 87.17 0.12 Allowed 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.995 1.318 . . . . 64.41 112.16 176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 96.8 m -122.86 103.87 36.59 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 108.126 -1.064 . . . . 55.11 108.126 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo . . . . . 0 C--N 1.378 2.084 0 C-N-CA 123.573 2.849 . . . . 73.14 111.796 176.351 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 110.544 -0.169 . . . . 65.42 110.544 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -157.23 -81.9 0.06 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.604 0.762 . . . . 54.44 109.189 176.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 63.69 127.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 125.043 1.337 . . . . 53.32 111.908 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.29 136.48 47.93 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 122.649 0.379 . . . . 72.21 110.735 176.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 4.8 ttmp? -107.51 102.37 44.1 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.519 0.727 . . . . 62.1 109.204 177.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.82 -65.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.376 2.026 0 C-N-CA 122.575 2.183 . . . . 74.42 110.467 175.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . 0.605 HD11 HG13 ' B' ' 89' ' ' ILE . 35.6 tp -160.82 46.45 0.21 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 106.849 -1.537 . . . . 64.22 106.849 172.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 26.3 tp -167.51 136.11 2.56 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.253 -1.34 . . . . 63.14 108.399 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 173.1 -43.69 0.16 Allowed Glycine 0 C--N 1.345 1.071 0 O-C-N 123.178 0.299 . . . . 62.21 112.794 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 97.4 mt -96.04 109.45 21.85 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.417 0.687 . . . . 72.24 110.068 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -163.12 -66.46 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.151 0.581 . . . . 75.45 109.973 -179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -84.43 12.76 6.3 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.248 1.019 . . . . 75.12 112.261 -178.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -85.31 -46.56 10.88 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.079 0.952 . . . . 74.23 110.26 -178.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -85.6 74.05 2.49 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-N 115.927 -0.579 . . . . 72.54 111.756 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -78.61 78.74 5.06 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.321 0.648 . . . . 54.44 109.593 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 72.8 mtm -77.31 119.82 79.02 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 107.738 -1.208 . . . . 62.25 107.738 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -67.99 81.8 0.48 Allowed 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 122.763 2.309 . . . . 65.12 112.002 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 47.0 t -81.52 81.62 1.38 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.601 0 N-CA-C 108.497 -0.927 . . . . 73.11 108.497 177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -78.92 -67.82 0.71 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.747 -1.115 . . . . 60.3 109.272 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 17.6 m95 -159.85 155.46 25.75 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 124.626 1.17 . . . . 71.32 110.16 177.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.502 HD11 HG22 ' B' ' 131' ' ' VAL . 4.9 mp -97.33 76.61 2.6 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.095 -0.957 . . . . 73.22 108.546 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 82.4 177.35 51.85 Favored Glycine 0 C--N 1.346 1.098 0 CA-C-N 115.106 -0.952 . . . . 73.11 113.798 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -52.45 126.41 20.66 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.844 3.03 . . . . 60.23 111.405 175.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.0 114.3 14.42 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 120.67 0.271 . . . . 71.52 110.821 -172.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . 0.539 ' HB1' ' HB2' ' H' ' 298' ' ' HIS . . . -77.25 102.49 6.7 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.758 0.823 . . . . 72.12 110.276 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 11.3 m -64.45 -49.55 70.99 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 121.818 0.818 . . . . 63.34 109.977 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.611 ' H ' ' HB3' ' B' ' 37' ' ' GLN . 28.0 m-85 -128.32 -20.31 3.72 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.191 -1.368 . . . . 73.54 110.1 178.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . 0.539 ' HB2' ' HB1' ' H' ' 295' ' ' ALA . 55.3 t-80 60.29 -83.21 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.921 1.288 . . . . 73.01 110.074 -171.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -174.88 28.65 0.08 OUTLIER Glycine 0 C--N 1.333 0.384 0 N-CA-C 109.642 -1.383 . . . . 65.45 109.642 177.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -132.01 53.76 1.98 Allowed 'General case' 0 C--N 1.353 0.743 0 C-N-CA 124.284 1.034 . . . . 74.33 109.804 -171.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 21.5 pt -78.1 69.38 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 N-CA-C 107.022 -1.473 . . . . 70.13 107.022 163.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -46.32 -56.08 6.34 Favored 'General case' 0 C--N 1.365 1.259 0 CA-C-N 113.544 -1.662 . . . . 72.31 112.195 -163.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . 0.699 ' HB3' ' HA ' ' F' ' 295' ' ' ALA . 39.6 ttmt -175.23 111.65 0.27 Allowed Pre-proline 0 C--O 1.243 0.721 0 O-C-N 124.825 1.328 . . . . 72.14 108.035 166.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -67.99 94.8 0.41 Allowed 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 122.07 1.847 . . . . 74.33 108.809 165.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . 0.414 ' HB2' ' HB1' ' F' ' 295' ' ' ALA . . . -65.56 84.78 0.07 Allowed 'General case' 0 C--N 1.35 0.599 0 O-C-N 123.831 0.707 . . . . 73.43 109.91 -178.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 15' ' ' ARG . 70.7 t -154.85 -34.55 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 C-N-CA 127.276 2.23 . . . . 74.32 106.468 177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 14' ' ' GLN . 37.7 p -59.58 110.91 1.23 Allowed 'General case' 0 CA--C 1.554 1.104 0 CA-C-N 114.318 -1.31 . . . . 62.25 112.36 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 85.9 m 69.43 95.04 0.07 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.485 1.514 . . . . 73.13 112.105 175.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . 0.426 HG21 ' HB1' ' C' ' 129' ' ' ALA . 36.4 p -132.19 135.48 26.52 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.43 1.092 . . . . 72.53 109.684 177.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . 0.486 ' HB2' HD21 ' C' ' 139' ' ' ASN . 60.6 Cg_endo . . . . . 0 CA--C 1.568 2.188 0 C-N-CA 123.073 2.515 . . . . 43.43 111.756 175.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.484 1.272 0 CA-C-O 120.142 0.02 . . . . 60.32 110.98 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.0 m -82.8 102.3 11.5 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.316 0.646 . . . . 73.32 110.618 -178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -138.31 30.98 2.39 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 124.385 1.074 . . . . 63.41 109.648 178.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -79.12 106.9 11.49 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 122.904 0.482 . . . . 72.12 110.082 -177.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -76.25 165.11 25.35 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 124.16 0.984 . . . . 70.41 109.223 175.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 57.2 t30 67.49 42.11 2.22 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 122.573 1.178 . . . . 72.5 108.799 -173.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 t -74.47 92.85 2.39 Favored 'General case' 0 CA--C 1.549 0.937 0 CA-C-N 114.547 -1.206 . . . . 63.33 109.261 176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.514 ' HA ' ' HB3' ' C' ' 144' ' ' GLN . 39.6 tt0 -62.17 -57.79 10.2 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.041 -0.981 . . . . 72.1 112.123 -174.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.62 ' H ' ' HA3' ' A' ' 88' ' ' GLY . 44.7 ttp 63.08 133.69 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.073 0 CA-C-N 113.646 -1.615 . . . . 63.53 111.815 -170.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 83.8 m -151.59 143.08 23.53 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 107.675 -1.231 . . . . 63.12 107.675 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.564 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 9.7 t80 -137.59 124.6 21.45 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 122.982 0.513 . . . . 73.02 109.984 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -153.38 112.02 3.69 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 108.731 -0.84 . . . . 73.13 108.731 173.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.585 HG12 ' HD2' ' A' ' 84' ' ' PHE . 67.8 mt -73.96 130.31 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 122.986 0.514 . . . . 72.13 110.418 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -91.55 -32.13 15.66 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.478 1.111 . . . . 63.24 111.068 -176.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -164.69 140.71 5.86 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 122.752 0.421 . . . . 74.23 110.764 -172.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.78 123.73 55.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 106.935 -1.506 . . . . 70.3 106.935 176.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.657 ' HB3' HG23 ' B' ' 122' ' ' THR . 3.2 p90 -163.52 149.22 11.38 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 121.534 0.683 . . . . 71.54 112.703 -173.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.419 HG21 ' SG ' ' A' ' 113' ' ' CYS . 76.7 p -77.61 112.68 14.67 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 115.116 -0.947 . . . . 51.02 109.075 172.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -77.94 -25.97 48.62 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 116.362 -0.381 . . . . 63.41 110.522 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.666 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 17.4 t70 -152.42 144.12 23.55 Favored 'General case' 0 CA--C 1.537 0.468 0 O-C-N 124.245 0.966 . . . . 75.24 110.301 176.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.1 mt -138.08 141.85 37.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.812 0 C-N-CA 125.635 1.574 . . . . 73.25 107.055 176.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -154.32 119.01 4.9 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.594 0.559 . . . . 74.42 109.807 172.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.525 ' HD1' ' SG ' ' A' ' 76' ' ' CYS . 81.2 t80 -111.31 127.18 55.56 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 106.381 -1.711 . . . . 73.35 106.381 167.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -131.61 108.9 9.84 Favored 'General case' 0 N--CA 1.468 0.472 0 N-CA-C 109.533 -0.544 . . . . 73.33 109.533 -178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.92 82.99 1.97 Allowed Pre-proline 0 CA--C 1.545 0.754 0 N-CA-C 107.841 -1.17 . . . . 65.42 107.841 172.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -66.77 -35.84 26.37 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 123.006 2.471 . . . . 71.22 112.347 -169.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -116.4 33.8 5.36 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 115.142 -0.935 . . . . 53.33 108.867 -175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -49.66 -61.04 3.95 Favored Pre-proline 0 CA--C 1.571 1.778 0 CA-C-O 118.279 -0.867 . . . . 71.11 113.021 -170.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.07 -0.2 8.18 Favored 'Trans proline' 0 C--N 1.386 2.522 0 CA-C-N 121.765 1.666 . . . . 50.55 113.812 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -99.59 -42.61 6.83 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.139 0.976 . . . . 75.32 110.916 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 73' ' ' ALA . 9.4 p -77.1 -21.5 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 115.309 -0.859 . . . . 72.1 111.876 -163.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -76.8 0.57 20.17 Favored 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 123.126 0.57 . . . . 74.2 111.259 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -100.95 -22.57 14.75 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.631 1.173 . . . . 72.5 111.513 175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 32.0 mmtp -78.69 172.73 13.3 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 123.971 0.908 . . . . 75.22 113.24 -168.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -55.96 136.9 51.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 124.11 0.964 . . . . 71.14 111.249 177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.401 ' HB3' ' O ' ' E' ' 298' ' ' HIS . 19.2 m95 -82.17 75.71 9.09 Favored 'General case' 0 C--O 1.241 0.615 0 C-N-CA 123.718 0.807 . . . . 75.52 110.478 -173.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.3 pt20 -148.96 69.37 9.91 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 114.961 -1.018 . . . . 73.24 110.043 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.622 ' HG3' ' HB3' ' E' ' 297' ' ' TYR . 60.0 Cg_endo -73.06 118.12 5.41 Favored 'Trans proline' 0 C--N 1.38 2.205 0 C-N-CA 122.029 1.819 . . . . 65.54 111.107 175.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -93.72 118.66 31.7 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.601 -1.629 . . . . 74.51 106.601 173.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.681 ' HB ' ' HE1' ' E' ' 290' ' ' TRP . 43.9 t -104.9 116.45 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 122.855 0.462 . . . . 52.02 110.115 -171.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.406 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 27.8 ttpp -100.19 123.52 44.52 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.217 1.007 . . . . 72.5 109.694 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.4 mp -96.95 121.52 38.92 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.463 1.105 . . . . 75.3 108.204 176.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.703 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.7 m-20 -111.65 115.39 29.04 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.466 -0.939 . . . . 62.34 108.466 175.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 tt -97.9 117.95 33.37 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 107.176 -1.416 . . . . 64.14 107.176 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -142.63 136.24 28.93 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.624 0.77 . . . . 75.1 109.197 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.1 m -149.3 150.91 33.28 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 122.793 0.437 . . . . 74.33 110.5 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.57 154.7 41.82 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.92 0.888 . . . . 60.35 110.142 -178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 66.8 p -120.48 161.59 21.01 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.848 0.459 . . . . 62.21 110.702 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.1 t -156.58 119.17 4.04 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 108.249 -1.019 . . . . 63.12 108.249 174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -80.95 104.79 11.69 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 108.672 -0.862 . . . . 72.11 108.672 -178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.651 HD11 ' HB2' ' A' ' 57' ' ' GLU . 60.1 mt -79.33 -41.95 26.79 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.682 0.793 . . . . 63.13 111.127 -170.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -147.17 -172.65 4.06 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.777 0.831 . . . . 74.32 109.978 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.507 ' HB2' ' HA ' ' C' ' 150' ' ' GLU . 7.8 p-10 -73.62 125.06 27.17 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 109.021 -0.733 . . . . 62.21 109.021 174.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 66.56 5.56 3.91 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 124.731 1.212 . . . . 61.23 113.15 -173.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 84.2 t -121.94 120.59 61.89 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 123.678 0.791 . . . . 74.22 108.904 -176.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.457 ' CE2' HG12 ' A' ' 86' ' ' ILE . 2.0 p90 -133.91 171.04 14.72 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.499 0.666 . . . . 72.41 110.061 172.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HB2' HD11 ' A' ' 51' ' ' LEU . 34.4 tt0 -121.44 140.42 52.17 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 113.821 -1.536 . . . . 71.42 108.653 176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -123.26 126.7 73.79 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 107.154 -1.424 . . . . 74.12 107.154 165.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 46.9 t -106.65 115.45 48.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 N-CA-C 109.24 -0.652 . . . . 62.14 109.24 176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.48 100.48 12.06 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 107.457 -1.312 . . . . 53.55 107.457 178.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.479 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 12.4 ttp180 -85.82 106.38 17.01 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.878 -0.786 . . . . 72.14 108.878 173.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 16.5 t -93.61 131.46 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 107.142 -1.429 . . . . 53.15 107.142 169.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.703 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 12.5 m -127.81 125.58 40.09 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.575 -0.898 . . . . 54.32 108.575 173.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.818 HG11 HD21 ' A' ' 126' ' ' LEU . 44.7 t -119.35 115.22 47.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.055 -0.975 . . . . 70.45 108.81 -176.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 4.8 m -102.14 146.21 28.27 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.64 -0.874 . . . . 75.11 108.64 172.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.08 132.08 26.15 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.868 -1.16 . . . . 74.45 107.868 172.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.3 m -142.78 128.01 18.71 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 123.52 0.513 . . . . 72.33 110.619 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.435 HD13 ' HB2' ' A' ' 73' ' ' ALA . 10.3 mp -87.05 84.29 7.33 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 107.561 -1.274 . . . . 62.33 107.561 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.6 -116.4 4.88 Favored Glycine 0 C--N 1.352 1.427 0 CA-C-N 114.708 -1.133 . . . . 64.1 111.757 -174.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.26 -16.05 34.21 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 124.053 0.941 . . . . 71.11 110.823 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -95.27 116.29 28.57 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.279 1.032 . . . . 73.41 109.963 -175.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 67.2 m -70.31 132.13 45.21 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.617 0.644 . . . . 74.24 111.05 176.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.49 -60.94 2.13 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.237 1.015 . . . . 73.33 109.416 175.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -160.08 170.17 21.82 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 115.19 -0.914 . . . . 63.35 111.22 178.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.2 tp -141.99 112.42 7.1 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 114.196 -1.366 . . . . 63.23 107.368 175.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.525 ' SG ' ' HD1' ' A' ' 23' ' ' PHE . 70.7 m -111.93 104.4 12.68 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 123.469 0.708 . . . . 61.21 111.016 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.418 ' HB2' HG23 ' A' ' 63' ' ' THR . 34.7 tt0 -113.4 115.74 28.56 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.406 1.082 . . . . 72.34 109.636 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 77.3 t -126.04 115.24 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.952 0.901 . . . . 73.44 109.399 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.666 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 49.2 mt-30 -84.86 85.62 7.45 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 108.966 -0.753 . . . . 73.35 108.966 169.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -77.39 96.2 4.6 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.515 0.726 . . . . 72.33 109.814 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -85.66 147.45 22.09 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 111.852 -0.499 . . . . 52.01 111.852 177.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.455 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -143.19 143.16 12.1 Favored Glycine 0 CA--C 1.501 -0.832 0 N-CA-C 110.661 -0.975 . . . . 61.24 110.661 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -109.24 127.65 65.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 108.044 -1.095 . . . . 74.32 108.044 177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.585 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.8 m-85 -128.72 120.17 25.96 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.14 -1.059 . . . . 63.44 108.14 -171.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.4 t -88.88 110.19 20.86 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.493 -0.929 . . . . 65.31 108.493 174.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.61 HD13 HD11 ' A' ' 89' ' ' ILE . 2.5 pp -124.76 162.47 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 C-N-CA 125.089 1.356 . . . . 74.52 109.915 -175.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.78 135.89 1.91 Allowed 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.326 0.65 . . . . 64.14 109.659 175.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.62 ' HA3' ' H ' ' A' ' 9' ' ' MET . . . 108.97 8.77 27.28 Favored Glycine 0 C--N 1.344 1.015 0 CA-C-O 119.218 -0.768 . . . . 65.12 114.076 175.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.61 HD11 HD13 ' A' ' 86' ' ' ILE . 2.2 pp -120.91 154.09 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 117.931 0.865 . . . . 64.14 112.044 -173.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.57 170.96 18.87 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.094 -0.957 . . . . 65.21 108.62 178.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 53.31 -119.02 9.29 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 115.962 1.145 . . . . 72.1 115.962 173.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.6 p -76.19 -20.29 57.63 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 123.424 0.689 . . . . 60.12 111.818 -177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 42.3 mt-30 -72.99 -50.35 23.69 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.098 0.559 . . . . 63.34 110.253 179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -64.26 -35.69 81.67 Favored 'General case' 0 N--CA 1.482 1.13 0 O-C-N 123.504 0.502 . . . . 72.51 109.83 176.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.437 ' HB2' HD11 ' E' ' 280' ' ' LEU . . . -61.02 -46.37 91.02 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.648 0.779 . . . . 50.25 111.004 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.41 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 53.5 t-80 -70.75 -28.93 65.06 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.3 -0.864 . . . . 70.25 110.75 -178.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.464 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 32.6 t -73.43 -37.17 65.97 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.2 0.524 . . . . 61.34 110.292 177.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.536 HD11 HD22 ' E' ' 278' ' ' LEU . 82.2 mt -78.59 -36.01 44.96 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.13 0.972 . . . . 74.43 112.016 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.82 3.96 34.14 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.637 -0.535 . . . . 62.34 114.294 -169.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.43 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.14 -63.88 0.25 Allowed 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 117.623 0.711 . . . . 65.42 112.818 -177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.464 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 57.4 t80 -62.84 -61.28 2.51 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.435 1.094 . . . . 61.12 112.831 -169.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 80.9 m -70.78 -34.89 3.94 Favored Pre-proline 0 CA--C 1.565 1.522 0 N-CA-C 113.495 0.924 . . . . 71.31 113.495 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -46.12 -48.37 13.05 Favored 'Trans proline' 0 C--N 1.384 2.402 0 C-N-CA 122.701 2.267 . . . . 75.34 113.881 162.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -65.65 -27.89 68.71 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.312 1.045 . . . . 73.42 111.013 -178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 13' ' ' ILE . 43.5 mm -70.07 -47.69 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.591 0.756 . . . . 73.11 110.593 174.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.455 HD21 ' HA3' ' A' ' 82' ' ' GLY . 89.4 mt -73.61 -31.25 63.46 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.335 -0.848 . . . . 50.45 112.177 -171.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.531 ' HZ ' HD12 ' A' ' 128' ' ' LEU . 45.2 t80 -59.13 -44.18 98.22 Favored Pre-proline 0 CA--C 1.568 1.668 0 N-CA-C 113.866 1.062 . . . . 54.42 113.866 -170.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -55.81 -38.64 94.2 Favored 'Trans proline' 0 C--N 1.383 2.389 0 C-N-CA 122.567 2.178 . . . . 74.21 114.359 171.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 86.2 m-85 -71.41 -40.13 70.68 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.27 0.628 . . . . 74.45 111.64 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.23 -42.15 93.68 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.938 0.495 . . . . 75.22 109.951 174.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -53.39 -55.02 28.41 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 124.583 1.177 . . . . 73.52 110.41 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -65.55 -41.26 93.22 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 124.151 0.907 . . . . 75.54 110.662 -177.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.419 ' SG ' HG21 ' A' ' 18' ' ' THR . 47.5 t -58.5 -36.29 73.55 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.104 0.478 . . . . 75.31 111.302 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.441 ' O ' HG23 ' A' ' 118' ' ' VAL . 24.2 mt -72.23 -51.67 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 123.963 0.905 . . . . 70.45 109.982 173.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.536 HG21 ' HE2' ' C' ' 109' ' ' TYR . 97.7 m -53.81 -40.69 66.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.765 1.226 . . . . 64.43 111.346 -173.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -62.29 -48.96 77.57 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.318 -1.31 . . . . 63.01 109.514 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 44.0 mtm -64.05 -40.66 96.79 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.563 0.745 . . . . 75.55 111.24 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.2 t -58.33 -48.63 84.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 C-N-CA 124.058 0.943 . . . . 64.51 110.364 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 34.4 t -71.45 -28.99 64.34 Favored 'General case' 0 CA--C 1.551 1.013 0 CA-C-N 115.331 -0.85 . . . . 73.32 111.253 -177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -71.11 -29.1 64.84 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.502 0.721 . . . . 65.22 110.195 175.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.58 2.79 66.01 Favored Glycine 0 C--N 1.356 1.683 0 O-C-N 123.65 0.594 . . . . 63.25 112.936 172.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.402 ' HB ' ' NH2' ' B' ' 15' ' ' ARG . 4.2 m 65.86 24.17 11.3 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 125.211 1.404 . . . . 73.5 110.521 177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -94.45 140.54 22.75 Favored Pre-proline 0 CA--C 1.552 1.034 0 N-CA-C 107.538 -1.282 . . . . 74.41 107.538 173.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.411 ' HG2' ' CD1' ' E' ' 297' ' ' TYR . 64.2 Cg_exo -44.5 134.46 9.55 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.079 2.519 . . . . 60.45 113.898 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.494 ' HG3' HG23 ' A' ' 115' ' ' THR . 28.6 tt0 -46.5 130.79 11.14 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.411 1.084 . . . . 73.15 112.864 -177.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.818 HD21 HG11 ' A' ' 64' ' ' VAL . 23.1 tp -108.11 100.99 10.26 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.541 1.137 . . . . 72.22 109.48 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -101.94 103.2 13.83 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 107.926 -1.139 . . . . 64.21 107.926 171.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.531 HD12 ' HZ ' ' A' ' 107' ' ' PHE . 0.3 OUTLIER -68.18 124.55 23.75 Favored 'General case' 0 CA--C 1.552 1.036 0 N-CA-C 108.635 -0.876 . . . . 60.33 108.635 -179.514 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.487 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -60.09 130.7 89.26 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 123.384 0.674 . . . . 74.03 111.854 -173.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' G' ' 309' ' ' THR . 3.1 Cg_exo -76.56 146.17 27.01 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.988 2.459 . . . . 61.22 112.351 -175.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 83.5 t -130.56 131.4 65.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.833 0.853 . . . . 70.42 109.408 -177.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 40.2 t-20 -74.09 96.03 2.65 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 108.977 -0.749 . . . . 71.13 108.977 174.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -72.47 -26.55 61.86 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 115.76 -0.654 . . . . 72.35 111.451 177.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.43 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 7.1 m-20 -62.0 -35.37 78.32 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.106 0.562 . . . . 62.34 110.225 176.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.5 -55.88 7.89 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.22 -0.9 . . . . 72.4 110.61 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 27.4 mt -65.3 -28.14 69.11 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 113.115 0.783 . . . . 71.34 113.115 -173.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.2 t80 -60.05 -45.87 91.43 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.395 0.678 . . . . 73.31 109.567 178.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 10.6 mmt -69.71 -36.33 75.82 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.473 -0.785 . . . . 54.41 110.87 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -68.94 -26.94 65.32 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 115.237 -0.892 . . . . 71.21 111.838 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -95.3 -44.1 7.74 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 122.535 0.334 . . . . 70.41 111.233 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 68.0 tp -60.46 -45.2 94.56 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.532 0.733 . . . . 63.34 112.149 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -147.55 5.52 0.81 Allowed 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 122.902 0.481 . . . . 71.23 111.986 -174.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 63.56 22.16 13.05 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.583 1.153 . . . . 72.03 112.642 178.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 22.1 tt0 -161.81 159.01 26.47 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.89 0.876 . . . . 72.55 109.132 -177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -83.25 -179.88 7.52 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 122.775 0.43 . . . . 14.25 110.625 170.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -143.59 -144.29 4.22 Favored Glycine 0 N--CA 1.472 1.083 0 CA-C-O 119.312 -0.715 . . . . 11.14 111.907 -178.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 63.79 92.08 0.07 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 124.745 1.218 . . . . 64.03 110.815 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -174.83 128.47 1.43 Allowed Glycine 0 C--N 1.343 0.935 0 N-CA-C 111.7 -0.56 . . . . 71.55 111.7 -179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.8 p -119.19 123.76 45.12 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.754 0.822 . . . . 72.53 109.982 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -86.13 91.24 8.37 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.505 0.722 . . . . 73.35 110.286 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -86.33 141.24 29.36 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 109.553 -0.536 . . . . 72.54 109.553 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -118.01 118.82 32.98 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.483 0.713 . . . . 75.15 109.651 -176.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -83.79 110.44 18.34 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 123.398 0.679 . . . . 75.12 109.734 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -105.77 159.11 16.25 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.155 0.982 . . . . 71.32 110.327 176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.816 0.847 . . . . 73.31 109.218 -177.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.026 -0.361 . . . . 71.32 110.026 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.455 ' O ' ' HA3' ' B' ' 91' ' ' GLY . 61.7 m -127.41 -83.17 0.61 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 122.868 0.467 . . . . 74.52 110.1 175.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 59.65 175.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.72 0.808 . . . . 63.41 112.427 -174.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -162.26 142.34 9.9 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 123.018 0.527 . . . . 53.43 110.528 -177.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -169.73 93.4 0.25 Allowed 'General case' 0 C--O 1.239 0.549 0 N-CA-C 107.291 -1.374 . . . . 72.3 107.291 177.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -56.57 112.44 1.28 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.834 0.854 . . . . 73.44 111.064 -176.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.623 HG22 ' H ' ' B' ' 9' ' ' MET . 32.0 m -137.55 148.82 46.24 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 108.477 -0.935 . . . . 61.5 108.477 177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -66.54 -12.29 56.97 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 124.231 1.012 . . . . 73.35 112.293 176.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.623 ' H ' HG22 ' B' ' 7' ' ' THR . 19.6 ptm 55.91 -173.75 0.06 Allowed 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.766 2.026 . . . . 54.41 113.245 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 90.6 m -138.77 118.74 13.33 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.416 -1.327 . . . . 55.52 107.416 175.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -134.98 113.25 11.31 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 109.703 -0.481 . . . . 74.12 109.703 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.26 139.31 33.7 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.926 0.891 . . . . 65.53 108.678 172.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.428 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -87.46 134.94 26.48 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 109.026 -0.731 . . . . 74.32 109.026 177.482 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 64.0 mt-30 -93.24 -52.64 4.45 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.255 -0.646 . . . . 74.42 109.255 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.402 ' NH2' ' HB ' ' A' ' 122' ' ' THR . 31.0 ttt180 -155.65 132.78 10.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.955 -0.566 . . . . 75.14 109.86 -172.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.7 mt -114.31 136.57 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 N-CA-C 106.349 -1.723 . . . . 53.14 106.349 169.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.424 ' HE1' HG13 ' B' ' 83' ' ' ILE . 18.6 p90 -166.99 148.55 5.95 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.907 0.384 . . . . 62.24 110.961 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.456 HG21 HD11 ' B' ' 21' ' ' ILE . 94.8 m -77.28 129.21 35.58 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 108.964 -0.754 . . . . 71.14 108.964 171.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.413 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 40.7 mtpt -98.87 -31.13 12.0 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.641 0.776 . . . . 65.14 110.865 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -154.43 145.73 22.95 Favored 'General case' 0 N--CA 1.477 0.909 0 O-C-N 123.392 0.433 . . . . 75.43 111.662 -175.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.456 HD11 HG21 ' B' ' 18' ' ' THR . 39.1 mm -137.18 148.18 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 125.199 1.399 . . . . 73.41 109.03 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.412 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 72.5 m -146.97 140.41 25.56 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.746 -1.116 . . . . 75.44 109.445 168.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.437 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 90.6 t80 -147.5 110.34 4.74 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 105.825 -1.917 . . . . 72.32 105.825 162.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -125.26 111.88 15.73 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.103 -1.073 . . . . 72.53 108.103 -171.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -116.47 87.03 19.3 Favored Pre-proline 0 CA--C 1.542 0.651 0 N-CA-C 108.543 -0.91 . . . . 71.2 108.543 177.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.16 -25.17 19.34 Favored 'Trans proline' 0 C--N 1.38 2.185 0 C-N-CA 122.443 2.095 . . . . 71.22 111.475 176.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -103.34 7.8 38.2 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.483 1.113 . . . . 64.42 110.457 -179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.642 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -40.86 -54.48 5.33 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 115.907 1.817 . . . . 52.41 115.907 -177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.515 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 6.3 Cg_exo -72.75 -50.25 0.22 Allowed 'Trans proline' 0 C--N 1.387 2.583 0 C-N-CA 122.54 2.16 . . . . 50.02 111.955 -175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.542 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.3 m80 -85.37 5.51 30.48 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 114.724 -1.126 . . . . 74.3 112.133 -173.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 p -62.76 -16.72 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 123.197 0.599 . . . . 74.25 111.904 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -51.34 -32.72 26.53 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.787 0.835 . . . . 72.44 112.206 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.571 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 29.3 pt20 -73.21 -48.93 30.92 Favored 'General case' 0 CA--C 1.555 1.137 0 CA-C-N 116.269 -0.423 . . . . 71.54 110.858 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.571 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 83.7 mttt -110.82 62.41 0.61 Allowed 'General case' 0 C--N 1.362 1.124 0 CA-C-O 121.937 0.875 . . . . 52.01 109.513 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -117.11 118.69 33.05 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 106.032 -1.84 . . . . 64.41 106.032 171.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER 169.01 -168.36 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 126.64 1.976 . . . . 61.53 106.217 176.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.58 109.8 1.62 Allowed Pre-proline 0 CA--C 1.562 1.437 0 C-N-CA 122.977 0.511 . . . . 72.23 112.193 -177.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.465 ' HG2' HG13 ' B' ' 40' ' ' VAL . 91.6 Cg_endo -94.69 162.79 1.82 Allowed 'Trans proline' 0 C--N 1.382 2.308 0 C-N-CA 122.99 2.46 . . . . 51.31 112.099 176.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -80.52 103.53 10.44 Favored 'General case' 0 C--O 1.242 0.679 0 N-CA-C 107.293 -1.373 . . . . 54.44 107.293 166.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.465 HG13 ' HG2' ' B' ' 38' ' ' PRO . 5.4 m -99.3 143.2 13.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 CA-C-N 115.149 -0.932 . . . . 35.33 109.576 178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -137.99 132.67 32.61 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.609 -0.886 . . . . 53.45 108.609 -171.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.459 ' HB2' ' HB ' ' H' ' 288' ' ' VAL . 51.4 mt -99.92 123.9 44.66 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 108.899 -0.778 . . . . 73.45 108.899 173.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.505 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 32.4 t70 -126.12 111.73 14.99 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.902 -0.777 . . . . 73.54 108.902 -178.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 9.9 mp -100.33 131.65 46.14 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.69 -0.687 . . . . 71.11 109.302 -175.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 21.6 t70 -120.7 125.97 49.01 Favored 'General case' 0 C--O 1.243 0.751 0 N-CA-C 107.464 -1.31 . . . . 71.13 107.464 178.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.5 p -109.2 103.69 12.71 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.305 -0.861 . . . . 72.53 109.506 -168.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 130.84 44.13 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.747 0.819 . . . . 65.42 109.159 -177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 74.9 p -142.45 162.8 34.54 Favored 'General case' 0 C--O 1.241 0.64 0 C-N-CA 122.962 0.505 . . . . 74.51 110.389 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.1 p -152.87 137.46 16.86 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.916 0.886 . . . . 74.03 109.346 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -81.95 122.99 28.48 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.013 0.525 . . . . 71.13 109.764 177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 57.6 mt -83.09 -43.2 16.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.058 0.543 . . . . 62.43 110.459 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.86 -169.03 2.25 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.373 0.669 . . . . 72.3 111.082 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -60.89 112.32 2.01 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.488 1.115 . . . . 61.04 110.681 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 67.06 1.64 2.43 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 125.278 1.431 . . . . 71.51 112.805 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 76.1 t -105.26 110.89 32.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 N-CA-C 108.563 -0.903 . . . . 64.43 108.563 -178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -115.16 160.23 19.95 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 123.779 0.832 . . . . 72.03 108.993 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -132.75 106.25 7.64 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 106.782 -1.562 . . . . 63.51 106.782 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 81.5 t -105.51 122.6 59.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 124.372 1.069 . . . . 73.44 109.817 -171.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 21.2 t -107.69 128.78 62.62 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.125 0.97 . . . . 71.53 108.846 177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -118.7 111.77 18.92 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 107.464 -1.31 . . . . 70.31 107.464 174.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.451 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 38.6 ttm180 -87.16 132.51 33.84 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.669 0.788 . . . . 62.34 109.587 176.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 48.5 t -120.4 107.16 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 107.768 -1.197 . . . . 71.14 107.768 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.505 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 38.8 m -97.19 137.94 35.44 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 108.642 -0.873 . . . . 71.52 108.642 176.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.511 HG21 HG21 ' B' ' 114' ' ' ILE . 61.2 t -121.86 97.35 4.83 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 N-CA-C 108.428 -0.953 . . . . 75.11 108.428 176.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 53.5 m -90.27 137.8 32.05 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.579 -0.737 . . . . 62.14 109.155 175.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.452 ' HB2' HG12 ' B' ' 40' ' ' VAL . . . -143.26 145.94 33.18 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 123.362 0.665 . . . . 71.25 109.753 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 70.6 p -159.31 135.97 9.32 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 123.816 0.698 . . . . 60.3 110.51 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.469 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.5 mp -113.45 137.96 50.78 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.558 -0.905 . . . . 75.33 108.558 168.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.1 -127.74 13.21 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.919 -0.473 . . . . 53.2 111.919 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.8 mm-40 -109.87 6.01 22.99 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.264 1.025 . . . . 75.43 110.412 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -121.01 167.12 12.93 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.559 0.743 . . . . 72.12 111.088 -174.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 8.2 m -68.91 155.14 40.8 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 124.185 0.994 . . . . 75.24 110.542 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.469 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -109.88 -60.54 1.77 Allowed 'General case' 0 C--O 1.243 0.746 0 N-CA-C 108.581 -0.896 . . . . 61.41 108.581 170.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -164.27 156.17 16.41 Favored 'General case' 0 C--O 1.246 0.909 0 CA-C-N 114.767 -1.106 . . . . 70.32 108.336 174.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 56.0 mt -132.24 108.96 9.58 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.383 -1.339 . . . . 61.31 107.383 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.7 t -116.75 157.04 26.15 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.197 -1.038 . . . . 74.55 108.197 -178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.4 tt0 -164.9 142.49 6.23 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 123.153 0.581 . . . . 71.42 109.856 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' B' ' 113' ' ' CYS . 69.9 t -132.57 144.51 36.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 107.79 -1.189 . . . . 75.12 107.79 170.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -123.83 90.83 3.34 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 107.914 -1.143 . . . . 70.05 107.914 174.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -84.74 102.02 12.68 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 108.905 -0.776 . . . . 74.32 108.905 -178.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.39 167.83 34.4 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.368 -0.833 . . . . 71.12 111.608 177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.26 126.37 1.43 Allowed Glycine 0 C--N 1.336 0.559 0 C-N-CA 121.558 -0.353 . . . . 72.22 112.415 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.424 HG13 ' HE1' ' B' ' 17' ' ' TYR . 53.4 mt -85.37 128.09 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 N-CA-C 108.56 -0.904 . . . . 75.25 108.56 171.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -135.8 135.11 39.61 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.626 1.171 . . . . 74.1 109.233 -174.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.2 m -91.32 99.96 12.84 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.663 0.785 . . . . 74.13 108.99 169.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.414 ' HB ' HD11 ' B' ' 89' ' ' ILE . 29.5 pt -121.8 138.69 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 123.582 0.753 . . . . 74.32 110.439 -176.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -156.28 169.36 24.74 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.374 1.07 . . . . 70.24 109.89 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.84 -47.63 3.74 Favored Glycine 0 N--CA 1.478 1.45 0 C-N-CA 123.356 0.503 . . . . 51.12 112.668 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.428 ' O ' HD11 ' H' ' 277' ' ' LEU . 16.9 pt -64.15 148.37 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 124.285 1.034 . . . . 74.22 111.73 173.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.588 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 42.6 tt0 -157.73 144.44 17.94 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.143 0.977 . . . . 72.11 109.909 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' B' ' 2' ' ' SER . . . 59.51 -108.88 1.85 Allowed Glycine 0 C--N 1.351 1.379 0 CA-C-O 119.381 -0.677 . . . . 72.5 113.602 174.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 36.5 m -67.7 -36.67 81.07 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.386 0.675 . . . . 72.12 110.948 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.588 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 44.8 mt-30 -62.97 -45.22 93.49 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.598 0.759 . . . . 73.2 109.513 -178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.602 ' SD ' ' HG ' ' H' ' 277' ' ' LEU . 25.9 ttt -73.71 -38.77 64.72 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 115.037 -0.983 . . . . 74.2 110.511 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.99 -28.58 69.61 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.346 0.658 . . . . 70.3 111.161 177.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -79.2 -35.8 41.18 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.03 0.932 . . . . 63.51 110.124 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.9 t -67.15 -68.4 0.38 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 116.356 -0.384 . . . . 72.31 110.104 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.442 HD11 ' HB3' ' H' ' 280' ' ' LEU . 1.6 pp -75.8 -8.27 56.45 Favored 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 112.462 0.541 . . . . 75.44 112.462 -178.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.99 -9.19 46.12 Favored Glycine 0 C--N 1.354 1.549 0 N-CA-C 114.303 0.481 . . . . 50.43 114.303 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -143.17 -54.72 0.4 Allowed 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 117.49 0.645 . . . . 73.44 110.962 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.7 t80 -68.0 -55.75 11.48 Favored 'General case' 0 CA--C 1.559 1.294 0 C-N-CA 123.879 0.872 . . . . 63.02 111.506 -172.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.7 m -63.59 -44.06 79.82 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.374 1.069 . . . . 55.04 112.286 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -48.75 -53.52 6.79 Favored 'Trans proline' 0 C--N 1.399 3.222 0 C-N-CA 122.837 2.358 . . . . 72.31 112.601 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.14 -18.89 50.87 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 112.966 0.728 . . . . 64.35 112.966 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.404 ' HA ' HH21 ' D' ' 111' ' ' ARG . 71.7 mt -77.26 -57.09 6.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 123.189 0.596 . . . . 72.33 110.623 172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.0 pp -85.33 -4.83 59.29 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.093 0.557 . . . . 74.41 112.234 -172.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -67.53 -46.74 47.61 Favored Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 124.48 1.112 . . . . 65.0 112.454 -176.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -56.3 -34.78 94.77 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 121.875 1.717 . . . . 65.51 112.978 173.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.612 ' HE2' HG21 ' D' ' 115' ' ' THR . 57.2 m-85 -65.25 -52.57 53.63 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.122 0.969 . . . . 75.32 110.752 178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.424 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -59.09 -43.19 91.83 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.501 0.72 . . . . 64.11 110.341 177.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttt180 -56.23 -56.33 22.27 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.926 1.291 . . . . 72.32 111.259 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.74 -38.88 92.49 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 123.611 0.569 . . . . 74.33 109.602 -177.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.488 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.5 t -64.97 -38.94 92.62 Favored 'General case' 0 CA--C 1.55 0.948 0 O-C-N 123.522 0.514 . . . . 73.4 111.719 -175.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.511 HG21 HG21 ' B' ' 64' ' ' VAL . 57.6 mt -65.35 -52.66 49.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 123.242 0.617 . . . . 72.15 109.542 175.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.518 HG22 HE21 ' C' ' 125' ' ' GLN . 23.3 m -61.45 -29.02 69.69 Favored 'General case' 0 CA--C 1.556 1.181 0 CA-C-N 115.089 -0.959 . . . . 72.11 111.475 -175.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.9 t -63.14 -49.48 74.2 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 123.72 0.808 . . . . 65.21 109.326 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.488 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -69.96 -34.41 73.35 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.733 0.813 . . . . 74.44 111.16 -175.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.598 HG21 HD13 ' B' ' 126' ' ' LEU . 80.6 t -64.52 -39.77 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 C-N-CA 123.669 0.788 . . . . 64.34 110.239 175.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 16.4 t -71.29 -31.28 67.27 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.222 0.609 . . . . 63.14 110.83 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.453 ' HG3' ' O ' ' B' ' 116' ' ' SER . 92.8 mtt-85 -67.87 -22.89 65.09 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.244 0.618 . . . . 72.31 110.279 174.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.71 17.98 56.48 Favored Glycine 0 C--N 1.355 1.591 0 O-C-N 123.504 0.502 . . . . 31.42 113.221 174.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.657 HG23 ' HB3' ' A' ' 17' ' ' TYR . 75.0 p 62.96 14.87 7.88 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 126.559 1.944 . . . . 73.15 113.7 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -92.47 148.7 36.88 Favored Pre-proline 0 N--CA 1.474 0.773 0 C-N-CA 122.921 0.488 . . . . 71.54 109.887 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.536 ' HA ' ' HB2' ' C' ' 125' ' ' GLN . 96.6 Cg_endo -74.21 -159.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.062 2.508 . . . . 34.43 113.059 -175.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.623 HE21 ' HA ' ' B' ' 125' ' ' GLN . 0.0 OUTLIER -64.4 122.74 17.43 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.368 -0.833 . . . . 71.42 113.153 -167.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.598 HD13 HG21 ' B' ' 118' ' ' VAL . 9.4 tt -109.89 127.42 54.72 Favored 'General case' 0 C--O 1.223 -0.317 0 N-CA-C 106.018 -1.845 . . . . 72.11 106.018 166.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -128.29 106.67 9.18 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 109.313 -0.625 . . . . 64.1 109.313 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.65 107.88 0.89 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 108.005 -1.109 . . . . 75.3 108.005 169.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -69.39 135.07 88.76 Favored Pre-proline 0 CA--C 1.548 0.896 0 O-C-N 124.075 0.859 . . . . 73.31 110.256 -175.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -55.28 109.25 0.39 Allowed 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 123.278 2.652 . . . . 64.11 112.206 -179.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 16.3 t -90.17 113.41 26.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.511 -0.922 . . . . 53.1 108.511 -177.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -80.15 76.93 6.89 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.695 -0.854 . . . . 75.54 108.695 176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -54.47 -36.27 63.95 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.215 1.006 . . . . 62.43 111.017 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -61.67 -52.0 66.11 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 114.152 -1.386 . . . . 64.32 111.127 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.39 -36.16 83.24 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.659 0.784 . . . . 72.32 111.762 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.48 -31.84 73.22 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.52 0.728 . . . . 74.13 111.098 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -88.37 -26.49 22.16 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.299 0.64 . . . . 51.42 109.989 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 39.5 ttm -70.29 -37.05 74.72 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.98 0.912 . . . . 62.02 111.295 -174.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -74.08 -26.15 60.22 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.079 0.551 . . . . 62.12 110.781 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -68.13 -32.89 73.49 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.106 0.479 . . . . 74.4 110.377 173.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.2 mt -103.82 14.59 30.57 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.227 1.011 . . . . 64.24 111.649 -174.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -76.6 147.66 37.48 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.12 0.568 . . . . 75.34 111.615 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -91.51 176.64 6.48 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 124.241 1.017 . . . . 53.23 110.815 175.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -74.47 -74.6 0.19 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.028 0.531 . . . . 75.24 110.527 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -169.47 -174.1 1.84 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 123.274 0.63 . . . . 53.02 111.383 -177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -152.15 -168.71 16.72 Favored Glycine 0 C--N 1.346 1.107 0 N-CA-C 110.826 -0.91 . . . . 72.34 110.826 174.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -160.38 142.55 12.88 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.992 0.517 . . . . 70.35 110.752 178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -99.77 131.95 10.75 Favored Glycine 0 C--N 1.346 1.112 0 N-CA-C 111.529 -0.628 . . . . 61.12 111.529 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 17.7 p -97.93 143.03 28.94 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.275 0.63 . . . . 70.23 110.466 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -146.62 98.22 3.03 Favored 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 108.744 -0.836 . . . . 64.23 108.744 -177.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.67 149.92 27.08 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.372 1.069 . . . . 75.45 110.864 -172.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -126.58 159.11 34.46 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.028 0.931 . . . . 71.15 110.013 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -147.35 98.29 2.98 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.56 1.144 . . . . 70.15 108.617 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -86.9 147.36 25.81 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.77 -0.456 . . . . 70.31 109.77 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.593 -0.718 . . . . 74.53 110.463 -179.722 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 62.5 mtt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 120.656 0.265 . . . . 74.31 111.394 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 15.1 m -148.68 18.56 1.02 Allowed 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 123.674 0.79 . . . . 70.21 110.612 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -101.96 128.24 48.46 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.222 0.609 . . . . 74.21 110.803 -168.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -126.03 138.78 53.75 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 107.433 -1.321 . . . . 74.03 107.433 168.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -68.15 109.45 3.55 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.014 -0.736 . . . . 74.22 109.014 177.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 43.6 t30 -66.04 127.06 30.6 Favored 'General case' 0 C--N 1.349 0.546 0 N-CA-C 109.429 -0.582 . . . . 75.42 109.429 177.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -87.61 35.94 0.74 Allowed 'General case' 0 CA--C 1.556 1.189 0 CA-C-O 121.999 0.905 . . . . 63.22 110.031 -176.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -143.44 118.03 9.78 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 124.073 0.949 . . . . 74.53 108.595 177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.47 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 51.4 ttp 63.58 112.02 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.984 1.714 . . . . 74.32 112.773 175.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 98.1 m -91.38 92.87 8.77 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 107.076 -1.453 . . . . 75.23 107.076 166.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.466 ' HB2' ' HG2' ' C' ' 9' ' ' MET . 72.6 t80 -108.57 154.35 22.08 Favored 'General case' 0 C--O 1.238 0.497 0 CA-C-N 114.884 -1.053 . . . . 72.35 109.67 -175.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -163.54 139.59 6.75 Favored 'General case' 0 C--O 1.246 0.905 0 C-N-CA 124.308 1.043 . . . . 74.41 109.017 173.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.9 pp -80.89 141.32 15.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 123.447 0.699 . . . . 74.34 109.369 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -109.83 -51.25 2.89 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.777 0.431 . . . . 74.43 110.009 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.546 ' NH1' HD12 ' G' ' 301' ' ' ILE . 72.0 ttt180 -172.43 123.82 0.47 Allowed 'General case' 0 N--CA 1.481 1.102 0 O-C-N 123.471 0.482 . . . . 74.32 109.846 -178.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 64.9 mt -109.01 136.02 46.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 108.012 -1.107 . . . . 64.51 108.012 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.509 ' HE1' HG12 ' C' ' 83' ' ' ILE . 19.5 p90 -168.68 162.92 11.99 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.861 0.839 . . . . 72.43 112.432 -173.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 63.6 p -86.38 103.75 15.23 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.375 -1.284 . . . . 73.12 108.662 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -67.8 -35.21 78.23 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.64 0.733 . . . . 74.41 109.981 176.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.72 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.9 t70 -148.21 139.48 23.43 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.473 -1.24 . . . . 70.4 109.095 -176.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.444 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 59.2 mt -133.55 141.62 43.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 107.077 -1.453 . . . . 45.13 107.077 174.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 48.3 t -152.87 146.34 24.94 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.411 -0.588 . . . . 72.13 109.411 175.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -148.95 113.63 5.36 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 107.131 -1.433 . . . . 72.33 107.131 173.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -115.48 111.26 20.49 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.297 -1.001 . . . . 64.33 108.297 -178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -123.75 80.21 55.91 Favored Pre-proline 0 CA--C 1.546 0.795 0 C-N-CA 124.356 1.063 . . . . 63.4 108.262 171.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -73.39 -16.78 24.44 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.172 1.915 . . . . 75.44 109.898 169.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -92.96 11.86 25.91 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.231 1.412 . . . . 52.01 110.041 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -53.16 -46.55 97.72 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.028 1.122 . . . . 71.34 114.028 -171.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -81.28 -36.15 0.39 Allowed 'Trans proline' 0 C--N 1.382 2.324 0 C-N-CA 121.404 1.402 . . . . 62.51 113.032 169.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 61.9 t60 -67.67 -25.68 65.82 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.884 1.274 . . . . 72.03 112.869 -171.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.461 HG11 ' HE1' ' C' ' 123' ' ' PHE . 14.4 p -62.31 -27.13 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 124.455 1.102 . . . . 73.14 111.853 -174.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.507 ' HZ ' ' HA ' ' F' ' 303' ' ' LYS . 30.0 t80 -65.9 -26.76 67.76 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 115.588 -0.733 . . . . 72.43 111.96 -172.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -99.0 6.12 46.84 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.455 0.539 . . . . 71.02 112.455 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' C' ' 31' ' ' VAL . 0.1 OUTLIER -99.7 173.11 6.86 Favored 'General case' 0 N--CA 1.485 1.287 0 CA-C-N 118.467 0.576 . . . . 75.23 110.054 175.543 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.26 123.38 25.2 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 108.455 -0.943 . . . . 70.05 108.455 173.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.502 ' HZ2' ' HA ' ' C' ' 32' ' ' PHE . 59.4 m95 -85.37 69.76 10.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.186 0.595 . . . . 72.21 110.683 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -163.17 60.1 0.91 Allowed Pre-proline 0 CA--C 1.56 1.344 0 CA-C-N 115.087 -0.96 . . . . 75.35 109.003 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.12 158.98 37.62 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 123.034 2.489 . . . . 63.33 111.61 -174.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -82.43 88.84 6.58 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 106.664 -1.606 . . . . 75.55 106.664 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 7.3 m -65.93 102.7 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 CA-C-N 113.61 -1.632 . . . . 74.33 109.749 176.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -93.1 110.82 22.31 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 114.553 -1.203 . . . . 74.22 108.537 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.15 130.57 34.58 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.366 -1.346 . . . . 60.13 107.366 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.427 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 27.9 t70 -119.36 103.81 9.81 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.882 1.273 . . . . 65.44 107.78 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 23.5 tp -100.16 112.53 24.84 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.348 -0.982 . . . . 63.53 108.348 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.426 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.1 t70 -114.67 139.62 49.51 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.763 1.225 . . . . 51.41 108.921 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -114.53 145.62 41.71 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.436 0.694 . . . . 55.21 110.361 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -152.21 150.5 29.89 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 123.607 0.763 . . . . 73.21 109.739 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 66.8 m -155.78 155.24 32.68 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.249 0.62 . . . . 74.01 110.425 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.3 p -148.85 140.42 23.46 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.53 0.732 . . . . 73.45 109.918 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -83.47 115.41 22.06 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.211 -1.033 . . . . 72.25 108.211 170.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.534 HD11 HD12 ' C' ' 83' ' ' ILE . 74.6 mt -88.88 -39.01 14.12 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.516 0.726 . . . . 63.22 110.343 -177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.08 -168.79 2.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-N 115.017 -0.992 . . . . 64.44 110.348 -175.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.98 100.55 0.16 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.356 1.063 . . . . 52.02 110.654 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 66.94 10.69 7.85 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.497 1.519 . . . . 75.42 113.234 -178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 92.5 t -94.27 114.13 30.26 Favored 'Isoleucine or valine' 0 C--O 1.239 0.536 0 N-CA-C 107.866 -1.161 . . . . 63.52 107.866 173.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.403 ' HB2' HD13 ' C' ' 86' ' ' ILE . 75.6 m-85 -123.23 124.23 42.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.108 0.963 . . . . 74.11 109.057 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.489 ' HB2' HD11 ' C' ' 51' ' ' LEU . 40.6 tt0 -83.67 120.52 26.09 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.326 -0.852 . . . . 75.43 109.34 174.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 84.9 t -97.65 114.12 34.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.135 -1.061 . . . . 62.45 108.135 173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.5 t -111.6 134.55 53.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.28 -1.007 . . . . 73.33 108.28 176.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 25.8 tp -128.9 102.81 6.7 Favored 'General case' 0 C--O 1.24 0.591 0 N-CA-C 107.905 -1.146 . . . . 52.31 107.905 175.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.519 ' HB2' ' HG2' ' C' ' 79' ' ' GLN . 23.8 ttt180 -82.69 108.21 15.89 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.525 -0.761 . . . . 74.24 109.279 176.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.417 ' HB ' HD11 ' C' ' 114' ' ' ILE . 12.4 t -100.08 121.77 51.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 107.477 -1.305 . . . . 74.25 107.477 172.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.427 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 28.4 m -127.31 117.47 22.32 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 108.648 -0.871 . . . . 72.4 108.648 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 94.1 t -105.1 110.28 30.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.62 0 N-CA-C 108.699 -0.852 . . . . 70.32 108.699 -176.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.4 m -99.83 144.04 29.35 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 108.666 -0.865 . . . . 52.05 108.666 173.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.56 130.46 44.11 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.752 -1.203 . . . . 63.23 107.752 172.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 71.1 m -147.88 130.44 15.87 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.03 0.443 . . . . 74.23 110.965 176.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.07 58.1 4.86 Favored 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.016 1.326 . . . . 74.14 107.476 173.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 103.23 -118.0 5.93 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-N 114.732 -1.122 . . . . 51.02 110.567 -171.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.06 -28.67 18.87 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.449 0.7 . . . . 54.31 109.308 169.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -65.68 102.63 0.76 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.939 0.896 . . . . 65.51 109.666 178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 28.1 m -72.92 144.43 47.34 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.239 0.616 . . . . 74.22 111.021 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.409 ' HB1' ' CE2' ' F' ' 297' ' ' TYR . . . -97.65 -56.27 2.56 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.507 1.123 . . . . 63.22 109.455 178.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -158.03 172.01 19.21 Favored 'General case' 0 N--CA 1.481 1.088 0 CA-C-N 115.99 -0.55 . . . . 74.54 110.923 172.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.442 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -136.37 146.16 46.2 Favored 'General case' 0 CA--C 1.545 0.782 0 N-CA-C 106.9 -1.518 . . . . 74.51 106.9 173.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.442 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.5 t -151.76 113.58 4.43 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.13 0.572 . . . . 73.34 109.789 176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -117.34 117.51 29.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.653 0.781 . . . . 74.24 110.04 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 98.9 t -121.84 122.24 66.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 109.504 -0.554 . . . . 71.4 109.504 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.72 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 48.8 mt-30 -99.04 91.34 4.97 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.043 -1.095 . . . . 73.44 108.043 175.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -83.14 104.86 13.65 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 115.235 -0.893 . . . . 63.33 110.062 -176.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.8 146.6 18.3 Favored Glycine 0 C--N 1.337 0.599 0 CA-C-N 116.108 -0.497 . . . . 74.14 112.015 177.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.05 116.85 1.11 Allowed Glycine 0 CA--C 1.506 -0.498 0 N-CA-C 110.07 -1.212 . . . . 32.14 110.07 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.534 HD12 HD11 ' C' ' 51' ' ' LEU . 15.5 mm -81.46 122.33 36.3 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.449 -0.945 . . . . 74.43 108.449 177.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -138.51 148.68 44.57 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 108.35 -0.981 . . . . 71.43 108.35 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 16.1 p -110.17 119.02 37.93 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.458 -0.941 . . . . 51.13 108.458 171.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' C' ' 56' ' ' TYR . 4.1 mp -114.88 120.68 65.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 108.267 -1.012 . . . . 73.1 108.267 -175.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.47 165.02 30.65 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.132 0.973 . . . . 73.1 109.565 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 111.08 -46.68 1.14 Allowed Glycine 0 C--N 1.34 0.76 0 CA-C-N 115.965 -0.561 . . . . 63.43 112.242 174.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.502 HD13 ' H ' ' C' ' 89' ' ' ILE . 0.2 OUTLIER -121.81 171.86 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 123.24 0.616 . . . . 72.1 111.253 -177.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -146.74 -173.03 4.11 Favored 'General case' 0 C--O 1.242 0.701 0 CA-C-N 115.019 -0.991 . . . . 74.45 109.425 174.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.78 -139.72 39.3 Favored Glycine 0 C--N 1.344 1.011 0 O-C-N 123.529 0.518 . . . . 64.32 114.159 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.8 t -70.56 -21.72 62.66 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.117 0.967 . . . . 73.02 112.038 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 13.1 mt-30 -71.48 -38.01 71.25 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.537 0.735 . . . . 75.32 110.388 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.408 ' SD ' HD12 ' C' ' 98' ' ' LEU . 9.8 tmm? -71.99 -41.08 68.05 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 109.018 -0.734 . . . . 70.25 109.018 174.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.65 69.4 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.569 0.747 . . . . 51.52 111.262 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.9 t-80 -70.64 -34.18 71.8 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.504 0.722 . . . . 74.21 110.491 173.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.47 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 40.6 t -68.21 -64.66 0.82 Allowed 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.444 0.465 . . . . 53.2 110.398 -178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.408 HD12 ' SD ' ' C' ' 94' ' ' MET . 0.0 OUTLIER -84.04 -12.69 54.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 122.047 -0.408 . . . . 73.31 112.093 -172.411 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.97 -7.84 46.32 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 114.706 0.642 . . . . 73.5 114.706 -176.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.33 -55.93 0.48 Allowed 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 117.395 0.598 . . . . 75.22 110.847 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.438 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 81.0 t80 -69.12 -56.54 7.36 Favored 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 123.907 0.883 . . . . 71.15 111.822 -172.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.5 m -64.76 -44.97 74.99 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 124.59 1.156 . . . . 72.42 112.951 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.94 -34.37 81.48 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 121.758 1.639 . . . . 75.21 111.995 174.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -28.5 67.28 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 123.317 0.647 . . . . 64.15 111.695 176.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 33.3 mm -66.24 -53.52 35.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 109.978 -0.378 . . . . 74.11 109.978 174.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 3.7 pp -87.21 -8.35 56.95 Favored 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 112.412 0.523 . . . . 71.22 112.412 -172.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.3 t80 -58.13 -50.09 89.99 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 124.21 1.004 . . . . 75.02 113.416 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -62.87 -25.74 74.47 Favored 'Trans proline' 0 C--N 1.382 2.306 0 C-N-CA 121.489 1.459 . . . . 70.52 113.121 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.536 ' HE2' HG21 ' A' ' 115' ' ' THR . 70.1 m-85 -69.51 -46.07 67.4 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.285 0.634 . . . . 42.32 110.232 175.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.46 -44.4 89.24 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.603 0.761 . . . . 73.4 110.396 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.521 ' HG3' HD23 ' C' ' 128' ' ' LEU . 39.5 ttt180 -58.38 -55.68 31.87 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 113.945 -1.48 . . . . 73.13 111.157 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.451 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 1.1 tm-20 -67.81 -27.46 66.75 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 122.979 0.512 . . . . 54.13 110.328 -174.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 32.0 t -71.5 -36.57 71.15 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.744 0.418 . . . . 51.43 111.407 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.417 HD11 ' HB ' ' C' ' 62' ' ' VAL . 88.5 mt -72.67 -48.21 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.454 0.701 . . . . 74.35 110.025 174.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 49.1 m -60.92 -33.71 73.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 124.09 0.956 . . . . 74.53 111.36 -176.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 33.5 t -62.2 -47.73 83.14 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.791 -0.64 . . . . 73.24 109.444 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.493 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.28 -37.5 87.71 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 124.709 1.203 . . . . 62.11 112.226 -179.388 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.3 t -63.33 -42.21 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.181 0.592 . . . . 74.1 109.407 174.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 26.3 t -69.05 -28.99 67.04 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.641 0.777 . . . . 74.25 111.711 178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -76.03 -28.8 57.84 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.694 0.797 . . . . 71.52 110.468 178.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.52 4.63 81.18 Favored Glycine 0 C--N 1.351 1.385 0 O-C-N 123.525 0.516 . . . . 74.31 112.433 172.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 20.8 p 62.38 33.04 16.62 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 126.044 1.738 . . . . 72.24 111.961 177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.461 ' HE1' HG11 ' C' ' 31' ' ' VAL . 24.8 m-85 -102.17 154.05 37.64 Favored Pre-proline 0 CA--C 1.548 0.887 0 CA-C-N 115.004 -0.998 . . . . 64.35 110.608 -178.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.484 ' HD3' HD11 ' F' ' 301' ' ' ILE . 75.4 Cg_exo -53.7 132.18 47.88 Favored 'Trans proline' 0 C--N 1.383 2.392 0 C-N-CA 123.263 2.642 . . . . 71.12 112.949 177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.536 ' HB2' ' HA ' ' B' ' 124' ' ' PRO . 14.6 mm-40 -59.63 142.74 52.26 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.026 0.829 . . . . 70.34 112.461 -176.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.616 HD11 ' HH2' ' F' ' 290' ' ' TRP . 3.0 tm? -126.82 126.32 43.17 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.744 0.818 . . . . 74.44 108.863 -178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -101.43 127.28 48.16 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.206 1.003 . . . . 61.35 109.128 176.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.521 HD23 ' HG3' ' C' ' 111' ' ' ARG . 4.0 mm? -80.48 141.36 35.28 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 123.697 0.623 . . . . 74.12 110.159 176.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.594 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -85.34 158.96 57.15 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 124.856 1.262 . . . . 63.14 111.183 -177.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -76.34 107.45 2.46 Favored 'Trans proline' 0 C--N 1.383 2.371 0 C-N-CA 123.102 2.535 . . . . 71.11 111.532 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.499 HG22 HD11 ' F' ' 291' ' ' LEU . 44.9 t -98.44 107.48 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.54 -0.911 . . . . 72.02 108.54 178.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -113.73 99.24 7.56 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.588 1.155 . . . . 75.02 108.83 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -62.51 -42.99 99.88 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.794 0.838 . . . . 74.25 111.337 -177.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -66.85 -37.69 84.94 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.865 -1.061 . . . . 74.14 111.714 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.35 -33.83 75.48 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 123.831 0.707 . . . . 72.21 111.246 177.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 91.2 mt -63.0 -36.14 82.57 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.294 0.638 . . . . 61.22 110.99 176.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -71.5 -33.39 69.21 Favored 'General case' 0 N--CA 1.488 1.475 0 C-N-CA 123.269 0.627 . . . . 74.24 110.989 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 29.9 mmt -72.42 -34.54 67.91 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.342 0.657 . . . . 64.44 110.98 177.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -72.27 -35.68 68.82 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.199 0.999 . . . . 64.45 110.432 175.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -54.13 -80.74 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 124.316 1.047 . . . . 70.55 111.037 177.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 34.3 tp -73.28 85.15 1.42 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-O 121.3 0.571 . . . . 64.13 110.866 -174.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -142.65 168.36 19.91 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.786 1.234 . . . . 61.42 108.869 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -156.32 87.84 1.06 Allowed 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 105.964 -1.865 . . . . 75.51 105.964 172.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 8' ' ' GLU . 85.4 mm-40 -145.66 156.87 43.93 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.788 0.835 . . . . 65.31 111.338 -173.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -160.46 65.64 0.33 Allowed 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.894 0.878 . . . . 64.43 109.615 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.421 ' H ' ' HB2' ' A' ' 8' ' ' GLU . . . -89.55 -146.63 14.56 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 115.548 -0.751 . . . . 73.21 112.892 -176.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -136.91 145.33 44.17 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.152 0.501 . . . . 73.53 111.839 -174.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.91 131.36 10.34 Favored Glycine 0 C--N 1.342 0.878 0 CA-C-N 114.668 -1.151 . . . . 62.22 110.372 167.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 58.3 m -101.56 138.28 38.77 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.02 0.928 . . . . 74.23 111.178 -171.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.507 ' HA ' ' HB2' ' A' ' 53' ' ' ASP . 12.2 pt-20 -70.83 140.81 51.27 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.368 -0.604 . . . . 72.41 109.368 172.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.492 ' HG3' ' HB3' ' E' ' 277' ' ' LEU . 3.1 mm-40 -161.9 161.62 28.88 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.342 -0.39 . . . . 51.01 111.224 -173.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 13.0 p80 -176.54 141.75 0.41 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.984 1.314 . . . . 74.21 109.213 -177.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -156.8 117.64 3.67 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.431 -1.322 . . . . 75.52 107.431 174.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -66.77 152.7 45.01 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.548 0.739 . . . . 63.44 111.75 -174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.553 -0.737 . . . . 52.0 109.344 -179.155 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.456 -0.572 . . . . 64.2 109.456 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 42.3 t -156.36 143.14 18.69 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.196 0.998 . . . . 74.12 108.784 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -71.14 -64.43 0.91 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 108.302 -0.999 . . . . 73.33 108.302 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -176.82 -68.47 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 106.662 -1.607 . . . . 73.25 106.662 174.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -165.71 143.86 5.89 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.295 1.038 . . . . 64.33 109.092 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -168.43 154.44 6.99 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.616 1.167 . . . . 74.45 108.494 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 37.5 p -69.65 83.41 0.44 Allowed 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 123.893 0.877 . . . . 73.12 110.919 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.91 131.47 35.81 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 107.331 -1.359 . . . . 74.25 107.331 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.411 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 4.9 ttp 16.37 119.65 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 127.448 2.299 . . . . 63.32 115.718 -169.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 21.0 m -129.27 143.37 50.83 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.898 -0.779 . . . . 75.42 108.898 179.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -163.03 104.48 1.01 Allowed 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.387 -1.338 . . . . 71.41 107.387 178.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -127.48 140.95 51.81 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.394 -0.965 . . . . 71.43 108.394 176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 14.3 mt -87.25 133.21 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 108.147 -1.057 . . . . 75.22 108.147 171.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -89.21 -39.6 13.43 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 123.345 0.403 . . . . 74.53 110.384 173.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 176.07 150.27 0.13 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 124.336 1.054 . . . . 72.25 110.6 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.6 mp -109.26 134.45 51.25 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 N-CA-C 107.624 -1.25 . . . . 75.43 107.624 168.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.444 ' HE1' HG13 ' D' ' 83' ' ' ILE . 25.0 p90 -147.73 162.53 39.0 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.267 1.027 . . . . 73.2 110.347 -176.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.43 HG21 HD11 ' D' ' 21' ' ' ILE . 75.6 p -95.44 119.68 34.37 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.764 -1.107 . . . . 71.42 109.52 178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -90.56 -27.44 19.14 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.781 0.432 . . . . 72.31 110.585 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -154.76 140.27 17.85 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.087 -0.961 . . . . 74.11 108.696 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.493 HG21 ' HE2' ' C' ' 117' ' ' MET . 71.9 mt -137.95 143.05 34.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 108.081 -1.081 . . . . 74.31 108.081 175.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.7 t -148.07 123.36 10.25 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.142 0.977 . . . . 73.53 109.293 177.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.444 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 86.5 t80 -131.3 120.72 23.57 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 106.103 -1.814 . . . . 70.23 106.103 170.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.433 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 35.9 mt-10 -123.06 144.55 49.21 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 109.67 -0.492 . . . . 60.33 109.67 -177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.62 76.54 47.91 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 106.27 -1.752 . . . . 74.25 106.27 170.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.63 -25.26 24.78 Favored 'Trans proline' 0 C--N 1.378 2.082 0 C-N-CA 122.695 2.263 . . . . 65.22 112.541 -171.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 -112.73 25.77 11.14 Favored 'General case' 0 C--O 1.213 -0.839 0 C-N-CA 124.157 0.983 . . . . 65.43 109.169 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.501 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -49.02 -62.18 2.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 N-CA-C 114.453 1.279 . . . . 72.44 114.453 -166.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.497 ' HB3' HD11 ' C' ' 83' ' ' ILE . 37.7 Cg_endo -83.14 -8.91 10.74 Favored 'Trans proline' 0 C--N 1.373 1.841 0 CA-C-N 122.358 1.878 . . . . 73.14 113.245 -178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.2 t-160 -78.73 -36.78 42.74 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.67 1.188 . . . . 73.42 109.67 174.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.604 HG21 ' HA ' ' D' ' 73' ' ' ALA . 6.0 p -80.31 -21.66 11.61 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.816 0 CA-C-N 116.057 -0.52 . . . . 42.45 109.729 -173.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 21.8 m-30 -66.07 -6.51 13.27 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.427 0.899 . . . . 73.11 113.427 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -78.49 -36.22 45.4 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.372 0.669 . . . . 74.33 109.541 172.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.0 ptpt -131.38 61.36 1.64 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.122 0.969 . . . . 63.54 110.438 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.708 ' HB3' HD13 ' G' ' 301' ' ' ILE . 20.6 t0 -108.44 82.77 1.67 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.376 -0.828 . . . . 75.43 110.065 -172.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.605 ' H ' HD22 ' D' ' 68' ' ' LEU . 8.2 m95 -124.14 -159.71 0.88 Allowed 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 107.987 -1.116 . . . . 73.31 107.987 -173.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.457 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 45.8 tt0 -59.91 109.62 2.13 Favored Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 123.512 0.725 . . . . 74.25 111.763 -171.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' G' ' 297' ' ' TYR . 3.4 Cg_endo -84.76 150.87 11.33 Favored 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 123.093 2.528 . . . . 73.32 113.522 -175.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -73.73 120.46 19.36 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 115.093 -0.958 . . . . 71.24 109.253 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.677 HG23 ' HE1' ' G' ' 290' ' ' TRP . 16.4 m -99.36 129.05 50.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.962 0 C-N-CA 124.104 0.962 . . . . 72.45 110.896 -172.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -130.62 117.75 19.98 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.238 1.015 . . . . 73.12 110.113 -176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.732 HD12 HD12 ' D' ' 128' ' ' LEU . 8.8 tt -98.15 137.97 36.12 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 109.103 -0.703 . . . . 73.13 109.103 175.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.64 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 8.0 m-20 -127.68 147.34 50.38 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.189 0.996 . . . . 75.21 108.845 172.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.83 150.76 39.91 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.346 0.659 . . . . 73.32 109.614 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.563 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 14.5 t70 -149.56 125.25 10.41 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.487 1.115 . . . . 74.52 108.108 175.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.9 p -104.21 144.27 31.82 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.431 0.692 . . . . 75.2 110.638 -174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.35 156.94 31.44 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.936 0.894 . . . . 33.23 109.332 179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 77.7 p -168.61 154.31 6.64 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.328 0.651 . . . . 72.13 110.292 176.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -155.63 136.24 13.37 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.635 0.774 . . . . 54.43 109.357 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -74.32 122.94 23.69 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 109.529 -0.545 . . . . 65.32 109.529 176.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' D' ' 57' ' ' GLU . 55.2 mt -90.58 -37.94 13.49 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.033 0.533 . . . . 73.13 110.58 -179.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.17 -176.35 5.92 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.381 0.673 . . . . 70.44 111.023 -176.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -60.11 119.21 7.4 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.932 -1.031 . . . . 50.43 110.365 177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 61.87 19.18 10.44 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.343 1.057 . . . . 73.34 112.058 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 67.6 t -121.17 126.62 75.32 Favored 'Isoleucine or valine' 0 C--O 1.24 0.562 0 C-N-CA 124.086 0.954 . . . . 72.45 109.076 177.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -132.85 129.93 39.11 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.008 -1.108 . . . . 72.11 108.008 177.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' D' ' 51' ' ' LEU . 15.1 tt0 -91.12 119.42 31.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.567 -0.901 . . . . 54.5 108.567 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -100.96 129.35 52.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 107.935 -1.135 . . . . 75.32 107.935 174.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.482 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 37.4 t -116.84 128.34 74.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 N-CA-C 108.157 -1.053 . . . . 74.14 108.157 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -126.54 105.91 9.07 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.307 -1.368 . . . . 72.13 107.307 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.563 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.4 ttm180 -84.17 123.25 29.89 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 115.573 -0.74 . . . . 74.53 109.4 176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 85.4 t -112.07 137.12 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 108.45 -0.944 . . . . 63.02 108.45 170.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.64 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.9 m -126.55 138.89 53.53 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.373 0.669 . . . . 72.01 109.515 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.561 HG11 ' HG ' ' D' ' 126' ' ' LEU . 75.5 t -127.72 108.21 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 124.244 1.018 . . . . 51.25 109.445 174.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 36.5 m -99.92 124.53 45.35 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 123.709 0.804 . . . . 74.32 109.013 173.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.67 126.69 54.45 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.485 0.714 . . . . 70.4 110.127 176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 33.9 p -140.79 121.11 13.95 Favored 'General case' 0 C--O 1.22 -0.462 0 N-CA-C 109.313 -0.625 . . . . 55.22 109.313 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.605 HD22 ' H ' ' D' ' 36' ' ' TRP . 1.0 OUTLIER -98.95 135.25 40.63 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.706 0.803 . . . . 63.3 110.104 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 64.35 -111.44 4.16 Favored Glycine 0 C--N 1.34 0.77 0 N-CA-C 111.43 -0.668 . . . . 71.13 111.43 -174.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.14 18.26 9.16 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.336 1.054 . . . . 61.21 109.961 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -124.15 143.75 50.31 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.839 1.256 . . . . 72.13 109.973 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.7 m -76.89 121.98 24.18 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 122.951 0.5 . . . . 63.35 110.979 177.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.604 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.39 -65.49 0.95 Allowed 'General case' 0 C--O 1.24 0.604 0 C-N-CA 123.395 0.678 . . . . 74.53 109.608 175.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.6 p90 -153.53 164.25 38.55 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 114.391 -1.277 . . . . 70.04 110.549 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 67.2 mt -126.47 142.54 51.5 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 107.245 -1.391 . . . . 73.02 107.245 -178.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.572 ' SG ' HG23 ' D' ' 114' ' ' ILE . 42.2 t -147.87 139.06 23.48 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.33 -0.618 . . . . 71.53 109.33 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -157.74 139.86 14.31 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.896 0.878 . . . . 70.23 109.22 177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.0 t -141.47 118.89 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.742 0.817 . . . . 71.31 109.334 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -89.97 82.74 6.12 Favored 'General case' 0 C--O 1.244 0.778 0 N-CA-C 108.174 -1.047 . . . . 65.3 108.174 173.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -83.46 102.48 12.11 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.463 -0.79 . . . . 71.22 109.9 -171.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 170.26 29.94 Favored Glycine 0 C--N 1.344 1.0 0 CA-C-N 116.324 -0.398 . . . . 63.55 112.385 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.56 137.68 4.47 Favored Glycine 0 C--N 1.336 0.535 0 N-CA-C 111.534 -0.627 . . . . 71.13 111.534 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.444 HG13 ' HE1' ' D' ' 17' ' ' TYR . 64.6 mt -90.28 135.51 26.25 Favored 'Isoleucine or valine' 0 C--O 1.244 0.808 0 N-CA-C 109.175 -0.676 . . . . 74.02 109.175 177.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -134.01 126.08 29.47 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.443 0.697 . . . . 65.23 109.875 176.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 18.4 m -78.88 94.98 5.29 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 123.633 0.773 . . . . 63.42 109.092 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.593 HG22 HD11 ' D' ' 89' ' ' ILE . 21.8 mt -113.13 131.76 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.625 0.77 . . . . 75.22 110.142 -173.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.45 169.25 23.43 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.075 0.95 . . . . 53.44 110.35 -178.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 72.42 21.39 79.45 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.078 -0.51 . . . . 73.23 113.617 173.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.593 HD11 HG22 ' D' ' 86' ' ' ILE . 1.5 pp -135.46 160.55 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 124.565 1.146 . . . . 75.42 109.604 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -168.4 166.53 12.3 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.522 0.729 . . . . 74.13 110.515 -177.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.69 -135.47 47.04 Favored Glycine 0 C--N 1.351 1.405 0 O-C-N 123.998 0.811 . . . . 54.13 114.149 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 4.8 m -77.0 -22.86 52.48 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.842 0.857 . . . . 73.42 111.066 -177.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 55.0 tp60 -62.31 -46.12 90.17 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.784 0.834 . . . . 72.45 110.444 177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 20.3 ptm -77.75 -24.09 49.11 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.657 -0.701 . . . . 73.44 110.905 178.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.15 -32.97 74.75 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 122.812 0.445 . . . . 73.23 111.148 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -77.59 -39.04 46.92 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.182 0.593 . . . . 73.22 111.276 175.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 48.2 t -63.66 -44.18 94.56 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-O 121.25 0.548 . . . . 71.21 110.963 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.578 ' HB3' ' HE2' ' G' ' 281' ' ' PHE . 4.6 mm? -84.04 -41.38 17.27 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.473 1.109 . . . . 72.23 111.11 -176.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -86.62 -10.39 73.28 Favored Glycine 0 N--CA 1.477 1.391 0 N-CA-C 114.702 0.641 . . . . 60.54 114.702 -172.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -132.29 -61.42 0.87 Allowed 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 117.234 0.517 . . . . 75.12 111.232 -176.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -65.25 -44.14 89.1 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 112.698 0.629 . . . . 73.3 112.698 -173.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 79.8 m -64.38 -44.68 76.45 Favored Pre-proline 0 CA--C 1.567 1.608 0 CA-C-O 118.824 -0.608 . . . . 70.34 112.498 -179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -48.19 -42.26 33.4 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 122.51 2.14 . . . . 72.43 114.093 165.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 59.4 m-80 -64.75 -20.51 66.39 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 112.758 0.651 . . . . 73.45 112.758 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.3 mm -82.21 -46.8 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 121.398 0.618 . . . . 74.4 110.382 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 89.3 mt -79.72 -28.85 40.53 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 115.169 -0.923 . . . . 54.35 111.826 -171.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -62.55 -42.56 80.13 Favored Pre-proline 0 N--CA 1.487 1.38 0 C-N-CA 124.205 1.002 . . . . 74.24 113.474 -174.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -52.64 -39.98 74.47 Favored 'Trans proline' 0 C--N 1.381 2.244 0 C-N-CA 122.48 2.12 . . . . 74.33 114.352 170.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -77.69 -32.69 53.18 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.522 0.729 . . . . 73.52 111.6 -178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.11 -46.96 81.87 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 109.072 -0.714 . . . . 54.35 109.072 171.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.599 ' HA ' HD23 ' D' ' 128' ' ' LEU . 24.9 ttp180 -54.01 -55.37 27.89 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.899 1.374 . . . . 72.23 110.886 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -66.27 -39.71 89.63 Favored 'General case' 0 N--CA 1.473 0.684 0 O-C-N 124.142 0.901 . . . . 73.32 111.149 -173.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 41.8 t -60.9 -44.1 97.61 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 123.31 0.381 . . . . 72.25 110.429 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.572 HG23 ' SG ' ' D' ' 76' ' ' CYS . 93.5 mt -59.03 -54.98 26.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.176 0.99 . . . . 72.04 110.238 172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.612 HG21 ' HE2' ' B' ' 109' ' ' TYR . 71.7 m -52.08 -48.3 64.76 Favored 'General case' 0 C--O 1.245 0.844 0 C-N-CA 125.078 1.351 . . . . 63.33 111.595 -174.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 33.2 t -67.81 -41.56 82.9 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.626 -1.17 . . . . 72.03 110.797 -175.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.422 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -65.61 -36.68 84.44 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 122.709 0.404 . . . . 75.21 111.663 -179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.47 HG23 ' O ' ' D' ' 114' ' ' ILE . 86.1 t -64.63 -44.74 96.7 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.605 -0.725 . . . . 62.45 109.969 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . 0.537 ' HB3' ' HB3' ' D' ' 125' ' ' GLN . 88.1 p -69.62 -31.48 69.62 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.849 0.459 . . . . 71.2 111.614 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 92.6 mtt-85 -69.79 -30.52 68.08 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 123.8 0.84 . . . . 75.22 110.488 175.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.01 11.55 59.97 Favored Glycine 0 C--N 1.353 1.48 0 CA-C-N 115.375 -0.829 . . . . 15.0 112.281 174.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 67.3 p 60.67 14.57 5.1 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 127.092 2.157 . . . . 70.31 113.782 179.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -91.41 160.69 36.42 Favored Pre-proline 0 CA--C 1.549 0.906 0 C-N-CA 124.493 1.117 . . . . 72.14 108.495 173.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.424 ' HG2' ' HB ' ' G' ' 296' ' ' THR . 86.5 Cg_endo -73.54 115.66 4.41 Favored 'Trans proline' 0 C--N 1.365 1.439 0 C-N-CA 122.429 2.086 . . . . 55.05 110.805 -175.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.537 ' HB3' ' HB3' ' D' ' 119' ' ' SER . 12.6 pt20 -51.21 139.17 19.13 Favored 'General case' 0 CA--C 1.55 0.966 0 O-C-N 124.425 1.078 . . . . 73.24 112.407 -172.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.561 ' HG ' HG11 ' D' ' 64' ' ' VAL . 0.7 OUTLIER -107.15 110.48 22.57 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 109.469 -0.567 . . . . 54.35 109.469 -165.701 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -98.59 102.57 14.35 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.468 0.707 . . . . 73.53 109.362 -177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.732 HD12 HD12 ' D' ' 42' ' ' LEU . 3.2 mm? -70.11 115.7 9.61 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.252 1.021 . . . . 63.21 109.912 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.715 ' HB3' HD11 ' G' ' 291' ' ' LEU . . . -66.1 137.55 95.81 Favored Pre-proline 0 N--CA 1.475 0.793 0 CA-C-O 119.581 -0.247 . . . . 54.52 110.376 177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -70.23 133.06 23.84 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.131 1.888 . . . . 71.05 110.995 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 88.5 t -108.06 136.38 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.291 -1.003 . . . . 71.01 108.291 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -78.36 86.78 4.41 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 109.366 -0.605 . . . . 72.43 109.366 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -64.76 -31.63 72.95 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.447 -0.797 . . . . 65.24 110.713 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' D' ' 138' ' ' MET . 6.1 m-20 -63.52 -58.43 7.03 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.221 1.008 . . . . 73.51 111.245 -177.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.9 91.17 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 123.503 0.721 . . . . 74.02 112.339 -174.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 90.2 mt -63.48 -37.56 87.75 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.076 -0.966 . . . . 75.01 110.965 177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -77.39 -30.76 53.81 Favored 'General case' 0 CA--C 1.549 0.925 0 CA-C-N 115.642 -0.708 . . . . 72.13 111.512 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 57.4 mtt -59.81 -28.38 67.41 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.572 0.749 . . . . 54.45 111.603 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.402 ' O ' ' HG3' ' D' ' 143' ' ' GLN . 18.3 m120 -60.14 -35.86 76.23 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.186 0.595 . . . . 74.45 111.359 177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 51.3 t80 -64.93 -41.76 95.26 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.928 0.891 . . . . 75.0 110.863 175.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 8.8 mp -61.74 -35.16 77.28 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 123.035 0.534 . . . . 74.44 110.579 -179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -80.42 9.2 6.2 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.968 0.907 . . . . 61.05 111.63 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.402 ' HG3' ' O ' ' D' ' 139' ' ' ASN . 69.8 mt-30 -121.99 46.98 1.98 Allowed 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.739 1.216 . . . . 64.33 108.541 176.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -161.97 111.29 1.51 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 115.588 -0.733 . . . . 74.13 109.593 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.48 146.98 31.1 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.029 0.532 . . . . 60.51 110.384 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -85.66 54.31 4.79 Favored Glycine 0 C--N 1.345 1.057 0 O-C-N 123.326 0.391 . . . . 34.14 112.631 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -105.24 27.71 7.99 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.218 1.007 . . . . 75.35 109.196 178.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -80.37 64.96 3.92 Favored Glycine 0 C--N 1.35 1.313 0 CA-C-N 115.713 -0.676 . . . . 53.35 112.526 -179.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 35.3 p -76.14 85.54 2.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.074 0.95 . . . . 64.12 108.613 177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -50.0 85.58 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 125.613 1.565 . . . . 72.11 113.253 -171.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -83.85 87.83 7.1 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 107.087 -1.449 . . . . 71.32 107.087 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -140.48 150.19 43.46 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.774 0.83 . . . . 73.01 109.849 -176.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 28.4 pt20 -67.05 149.64 50.31 Favored 'General case' 0 C--O 1.244 0.773 0 O-C-N 124.035 0.834 . . . . 74.23 110.718 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -62.05 141.17 58.25 Favored 'General case' 0 CA--C 1.543 0.7 0 O-C-N 123.787 0.679 . . . . 70.32 110.787 -177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.008 0 N-CA-C 107.929 -1.138 . . . . 72.15 107.929 -178.94 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.66 0.267 . . . . 75.14 110.348 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -62.7 138.24 58.46 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.327 0.651 . . . . 75.02 109.396 172.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -71.05 -37.96 72.52 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 109.416 -0.587 . . . . 75.22 109.416 178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 58.35 76.17 0.35 Allowed 'General case' 0 C--N 1.357 0.929 0 C-N-CA 124.896 1.278 . . . . 72.23 109.103 -177.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . 0.406 ' HZ2' ' HB3' ' E' ' 278' ' ' LEU . 9.4 ptmm? -115.62 137.61 23.3 Favored Pre-proline 0 CA--C 1.548 0.897 0 CA-C-N 114.371 -1.286 . . . . 74.33 109.538 -171.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.21 9.11 4.24 Favored 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 123.431 2.754 . . . . 74.3 114.307 -172.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . 0.492 ' HB3' ' HG3' ' C' ' 151' ' ' GLU . 3.8 tt -166.36 144.58 5.48 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 106.545 -1.65 . . . . 60.1 106.545 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . 0.536 HD22 HD11 ' A' ' 98' ' ' LEU . 0.2 OUTLIER 66.82 42.89 2.45 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 124.463 1.105 . . . . 73.13 109.939 176.088 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -71.63 -25.05 75.94 Favored Glycine 0 CA--C 1.53 1.022 0 CA-C-N 115.615 -0.72 . . . . 53.25 113.754 176.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 95' ' ' ALA . 3.6 pp -149.74 -174.45 4.7 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.997 0.919 . . . . 52.41 110.016 -177.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . 0.424 ' CD2' ' HB3' ' A' ' 98' ' ' LEU . 76.8 t80 -140.39 123.61 16.77 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.83 0.852 . . . . 75.01 109.642 174.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 61.96 -172.7 0.15 Allowed 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 124.415 1.086 . . . . 65.34 112.614 176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 17.9 p-10 -106.63 -33.85 7.51 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.741 0.817 . . . . 73.21 110.533 174.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -175.68 -157.48 17.05 Favored Glycine 0 C--N 1.341 0.829 0 N-CA-C 111.681 -0.568 . . . . 73.13 111.681 176.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -116.54 148.09 41.18 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.584 0.754 . . . . 62.44 109.965 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -119.68 92.23 46.0 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 123.704 0.802 . . . . 65.41 109.944 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -63.5 107.4 0.7 Allowed 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.69 2.26 . . . . 74.44 110.791 166.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.69 134.66 61.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 C-N-CA 124.41 1.084 . . . . 65.4 109.135 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -83.31 -63.94 1.26 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.273 0.629 . . . . 64.24 109.579 173.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . 0.681 ' HE1' ' HB ' ' A' ' 40' ' ' VAL . 28.4 m95 -153.7 -173.17 4.48 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.268 1.027 . . . . 75.15 110.508 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.487 HD13 ' HB3' ' A' ' 129' ' ' ALA . 5.1 mp -106.34 31.4 5.19 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 124.94 1.296 . . . . 74.25 109.023 177.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 132.45 162.82 10.45 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 111.074 -0.811 . . . . 54.31 111.074 -175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -69.22 90.34 0.46 Allowed 'Trans proline' 0 C--N 1.37 1.699 0 C-N-CA 122.837 2.358 . . . . 51.11 111.275 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' G' ' 304' ' ' PRO . 5.1 ptmm? -146.24 128.2 15.48 Favored 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 115.99 -0.55 . . . . 74.41 110.871 -177.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -86.65 -166.38 1.54 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.52 0.728 . . . . 61.2 109.542 169.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 25.2 m -120.05 -14.02 8.92 Favored 'General case' 0 CA--C 1.555 1.139 0 CA-C-O 121.327 0.584 . . . . 35.51 110.147 174.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.622 ' HB3' ' HG3' ' A' ' 38' ' ' PRO . 51.2 t80 -147.82 154.35 40.35 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.898 0.879 . . . . 72.14 110.091 -172.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . 0.401 ' O ' ' HB3' ' A' ' 36' ' ' TRP . 9.1 t60 -162.06 -76.04 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 106.434 -1.691 . . . . 74.14 106.434 167.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -95.55 120.49 6.55 Favored Glycine 0 C--N 1.341 0.842 0 CA-C-O 119.212 -0.771 . . . . 61.03 111.364 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . 0.503 ' HB3' ' HE1' ' E' ' 297' ' ' TYR . 10.8 t-20 173.72 -174.4 0.06 Allowed 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 125.736 1.614 . . . . 55.23 107.507 174.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 72.6 mt 73.41 100.34 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.173 0 C-N-CA 125.03 1.332 . . . . 74.22 110.067 178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -74.49 156.17 37.2 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.153 -0.684 . . . . 72.13 109.153 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -88.02 105.26 8.64 Favored Pre-proline 0 C--O 1.242 0.71 0 C-N-CA 123.964 0.905 . . . . 71.54 109.569 -177.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -83.65 91.04 0.89 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.291 1.994 . . . . 42.23 111.229 -178.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -82.09 -56.62 3.83 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 108.539 -0.912 . . . . 70.44 108.539 172.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 10.9 t 48.26 64.32 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 125.359 1.463 . . . . 64.21 110.51 177.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 33.4 p -105.93 116.99 32.88 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 115.229 -0.896 . . . . 73.25 109.67 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 48.4 t 65.17 102.36 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 125.261 1.424 . . . . 52.3 112.062 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 97.7 m -68.66 -46.59 34.66 Favored Pre-proline 0 CA--C 1.562 1.41 0 C-N-CA 124.132 0.973 . . . . 71.11 112.297 173.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo . . . . . 0 C--N 1.394 2.959 0 C-N-CA 122.069 1.846 . . . . 72.14 112.558 178.813 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.787 0 N-CA-C 109.774 -0.454 . . . . 51.52 109.774 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 61.6 t30 -164.18 35.24 0.08 Allowed 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.782 -1.192 . . . . 74.21 107.782 178.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -80.77 114.03 19.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.726 -1.125 . . . . 73.14 110.038 -174.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -165.22 144.88 6.8 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.985 0.914 . . . . 60.52 109.312 179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.56 157.88 34.01 Favored Pre-proline 0 N--CA 1.477 0.904 0 C-N-CA 124.098 0.959 . . . . 72.23 109.33 176.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -63.29 -155.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.297 0 C-N-CA 123.29 2.66 . . . . 44.13 113.176 172.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 66.3 tp -58.3 -40.13 81.2 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 109.741 -0.466 . . . . 62.52 109.741 172.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 45.1 tp -71.03 138.83 50.17 Favored 'General case' 0 CA--C 1.546 0.789 0 CA-C-N 115.167 -0.924 . . . . 65.33 110.655 177.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -156.69 -86.92 0.06 OUTLIER Glycine 0 C--N 1.345 1.046 0 N-CA-C 111.494 -0.642 . . . . 65.42 111.494 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 4.2 tt -83.57 121.92 27.88 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 108.737 -0.838 . . . . 73.22 108.737 -175.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -92.41 -86.62 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 107.294 -1.373 . . . . 72.31 107.294 172.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -160.02 -166.75 1.78 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.727 0.811 . . . . 64.51 109.378 -174.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 26.0 t70 71.23 174.74 0.3 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.528 1.131 . . . . 71.54 110.891 176.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 106.78 -74.21 0.22 Allowed Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.668 -0.973 . . . . 74.21 110.668 176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -73.29 -24.71 60.45 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.999 0.519 . . . . 72.15 109.879 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -119.23 95.81 49.56 Favored Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 123.995 0.918 . . . . 71.41 110.391 -177.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.39 89.66 1.25 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 122.148 1.899 . . . . 74.3 109.628 166.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.82 91.39 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 115.645 -0.707 . . . . 65.12 110.396 -174.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.35 -41.54 10.3 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 115.153 -0.93 . . . . 70.44 109.493 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . 0.616 ' HH2' HD11 ' C' ' 126' ' ' LEU . 13.6 m95 179.68 175.6 0.74 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 126.85 2.06 . . . . 73.55 109.081 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.594 HD13 ' HB3' ' C' ' 129' ' ' ALA . 5.2 mp -118.93 -1.46 10.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.752 0.821 . . . . 74.41 110.722 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -148.6 -175.38 21.1 Favored Glycine 0 C--N 1.345 1.038 0 CA-C-O 119.335 -0.703 . . . . 34.41 112.608 -178.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.81 -68.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.374 1.911 0 C-N-CA 122.901 2.401 . . . . 54.23 112.496 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -175.83 153.5 1.39 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.125 0.97 . . . . 71.13 109.237 -177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -150.95 -36.5 0.14 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.014 0.526 . . . . 63.2 111.773 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 4.3 m -62.93 136.17 57.7 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.46 0.704 . . . . 64.21 111.435 -175.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.409 ' CE2' ' HB1' ' C' ' 73' ' ' ALA . 5.1 m-30 74.55 -19.56 0.37 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 125.098 1.359 . . . . 54.12 113.633 177.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -65.87 96.92 0.32 Allowed 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.419 0.687 . . . . 64.43 109.232 -175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 161.05 -20.27 0.21 Allowed Glycine 0 C--N 1.339 0.743 0 CA-C-N 114.423 -1.262 . . . . 63.3 111.026 -170.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . 0.444 ' HA ' ' HB2' ' C' ' 36' ' ' TRP . 26.5 t-20 81.22 -43.14 0.18 Allowed 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 125.441 1.497 . . . . 41.02 113.388 169.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.484 HD11 ' HD3' ' C' ' 124' ' ' PRO . 53.7 mt 66.27 108.99 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 C-N-CA 124.524 1.13 . . . . 75.11 109.344 -168.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.22 -73.8 0.08 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.619 0.768 . . . . 72.35 110.609 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . 0.507 ' HA ' ' HZ ' ' C' ' 32' ' ' PHE . 98.2 mttt -147.86 161.01 36.54 Favored Pre-proline 0 N--CA 1.48 1.032 0 C-N-CA 124.287 1.035 . . . . 73.35 109.611 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -56.64 102.02 0.1 Allowed 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.478 2.119 . . . . 62.24 110.28 168.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . 0.452 ' HB2' ' HG3' ' H' ' 294' ' ' LYS . . . -56.59 -31.56 64.36 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.89 1.276 . . . . 32.45 112.85 -173.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 19.6 t -70.7 101.25 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 N-CA-C 108.892 -0.781 . . . . 74.44 108.892 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . 0.402 ' H ' ' H ' ' F' ' 308' ' ' CYS . 15.1 t -160.97 -2.32 0.06 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.587 0.755 . . . . 73.04 110.338 173.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . 0.402 ' H ' ' H ' ' F' ' 307' ' ' THR . 60.8 m -97.19 24.3 6.53 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 123.471 0.708 . . . . 72.24 110.769 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 3.4 t -154.12 79.17 5.15 Favored Pre-proline 0 CA--C 1.552 1.057 0 C-N-CA 123.574 0.749 . . . . 73.53 110.072 -176.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo . . . . . 0 C--N 1.374 1.894 0 C-N-CA 122.544 2.163 . . . . 64.43 111.276 172.178 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 121.379 0.609 . . . . 55.32 111.054 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -125.34 83.56 2.18 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.164 1.386 . . . . 65.34 107.575 172.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -71.85 90.73 1.13 Allowed 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 115.291 -0.868 . . . . 72.15 111.013 -176.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -156.26 95.62 1.61 Allowed 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.361 1.064 . . . . 74.24 109.373 177.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -118.37 97.82 50.97 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 123.17 0.588 . . . . 64.32 109.446 177.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.15 90.93 0.65 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.618 2.212 . . . . 65.13 110.095 171.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 73.2 mt -71.52 144.65 49.53 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.33 0.652 . . . . 72.32 110.161 -179.052 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 34.4 tp 69.82 71.46 0.23 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.526 1.13 . . . . 44.13 109.988 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -100.72 41.75 2.08 Favored Glycine 0 C--N 1.348 1.207 0 CA-C-N 114.848 -1.069 . . . . 75.33 111.822 177.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -153.76 -176.78 5.99 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.943 0.897 . . . . 70.54 109.917 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . 0.578 ' HE2' ' HB3' ' D' ' 98' ' ' LEU . 72.6 m-85 71.69 82.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 125.033 1.333 . . . . 63.1 110.33 -171.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -166.69 -35.65 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.765 1.226 . . . . 75.13 108.689 178.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.33 131.83 34.84 Favored 'General case' 0 C--O 1.242 0.66 0 C-N-CA 124.365 1.066 . . . . 71.22 108.763 175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -127.89 61.27 0.65 Allowed Glycine 0 C--N 1.342 0.906 0 O-C-N 123.725 0.641 . . . . 75.23 112.422 -177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -73.82 81.19 1.61 Allowed 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.407 0.622 . . . . 70.45 110.053 171.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 49.7 tpp -103.99 120.02 52.49 Favored Pre-proline 0 CA--C 1.544 0.723 0 C-N-CA 124.242 1.017 . . . . 73.5 108.364 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_exo -70.38 80.79 1.03 Allowed 'Trans proline' 0 C--N 1.375 1.933 0 C-N-CA 122.907 2.405 . . . . 75.22 111.831 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . 0.606 HG11 HD22 ' D' ' 42' ' ' LEU . 67.0 t -85.45 96.59 5.07 Favored 'Isoleucine or valine' 0 C--N 1.349 0.585 0 N-CA-C 107.562 -1.273 . . . . 52.34 107.562 174.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -69.4 -31.85 70.48 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.01 -0.995 . . . . 71.14 110.716 -179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.677 ' HE1' HG23 ' D' ' 40' ' ' VAL . 57.9 t-105 69.09 161.25 0.2 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 124.903 1.281 . . . . 61.35 112.083 175.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.715 HD11 ' HB3' ' D' ' 129' ' ' ALA . 5.7 mp -74.91 112.56 11.27 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.336 -0.847 . . . . 74.45 109.712 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -61.53 -57.87 15.91 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 123.813 0.695 . . . . 72.34 111.724 165.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -62.68 123.79 12.97 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.462 2.108 . . . . 54.25 112.984 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -99.87 142.27 31.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.192 0.997 . . . . 74.43 109.938 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -144.7 88.88 1.94 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 109.031 -0.729 . . . . 74.33 109.031 178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . 0.424 ' HB ' ' HG2' ' D' ' 124' ' ' PRO . 4.4 p -150.2 -88.13 0.07 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 123.653 0.781 . . . . 63.3 110.796 -173.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.483 ' HB2' ' HD3' ' D' ' 38' ' ' PRO . 0.1 OUTLIER -102.3 179.8 4.2 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.995 0.918 . . . . 75.24 109.166 178.15 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -166.14 -38.77 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.168 -0.679 . . . . 72.15 109.168 171.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 176.02 163.41 28.61 Favored Glycine 0 C--N 1.344 0.982 0 CA-C-N 115.881 -0.6 . . . . 42.42 113.195 175.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 62.35 109.61 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 125.385 1.474 . . . . 72.15 112.524 176.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.708 HD13 ' HB3' ' D' ' 35' ' ' ASP . 10.5 pt -122.46 11.43 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 124.303 1.041 . . . . 63.11 109.797 -178.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -93.95 136.59 34.08 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.068 -0.969 . . . . 70.3 111.171 -163.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . 0.46 ' HZ1' ' HB3' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -104.47 131.1 22.19 Favored Pre-proline 0 CA--C 1.538 0.518 0 N-CA-C 107.86 -1.163 . . . . 74.42 107.86 173.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . 0.419 ' HB2' ' HB2' ' E' ' 294' ' ' LYS . 85.3 Cg_exo -49.67 128.93 22.39 Favored 'Trans proline' 0 C--N 1.374 1.888 0 C-N-CA 123.1 2.534 . . . . 74.03 113.127 176.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -69.91 148.3 49.17 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.691 0.796 . . . . 65.12 111.898 -174.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 15.4 t -87.54 146.95 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.391 -0.966 . . . . 52.43 108.391 175.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 73.9 p -68.08 -65.95 0.63 Allowed 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.03 0.532 . . . . 72.41 109.75 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 66.9 m -154.67 109.76 3.08 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.326 -1.361 . . . . 71.13 107.326 177.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . 0.469 HG21 ' HD2' ' A' ' 130' ' ' PRO . 67.7 p -74.69 120.63 82.46 Favored Pre-proline 0 C--N 1.351 0.662 0 N-CA-C 108.154 -1.054 . . . . 75.21 108.154 171.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo . . . . . 0 C--N 1.374 1.88 0 C-N-CA 122.129 1.886 . . . . 72.3 110.613 174.06 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.172 0 N-CA-C 110.214 -0.291 . . . . 63.22 110.214 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 73.4 -72.72 0.11 Allowed 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.384 1.474 . . . . 71.23 111.958 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -63.1 104.99 0.63 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.391 0.676 . . . . 73.11 110.603 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -100.37 -44.45 5.91 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.586 0.754 . . . . 74.24 109.999 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -151.5 135.73 9.81 Favored Pre-proline 0 CA--C 1.541 0.604 0 C-N-CA 124.617 1.167 . . . . 71.02 108.889 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.98 -172.41 0.6 Allowed 'Trans proline' 0 C--N 1.371 1.715 0 C-N-CA 122.744 2.296 . . . . 73.51 111.773 169.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . 0.602 ' HG ' ' SD ' ' B' ' 94' ' ' MET . 23.3 tp -58.55 -42.61 88.25 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 123.394 0.678 . . . . 53.43 110.204 175.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 38.5 tp -69.93 89.99 0.61 Allowed 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 114.367 -1.288 . . . . 74.22 110.094 178.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -94.94 -24.53 17.03 Favored Glycine 0 C--N 1.347 1.189 0 CA-C-N 115.011 -0.995 . . . . 64.54 113.213 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . 0.442 ' HB3' HD11 ' B' ' 98' ' ' LEU . 13.4 tp -117.86 170.21 8.99 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 123.173 0.589 . . . . 64.34 109.43 -177.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 67.42 45.03 1.66 Allowed 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 124.526 1.13 . . . . 73.43 111.875 178.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -114.48 -2.34 13.22 Favored 'General case' 0 CA--C 1.55 0.948 0 CA-C-N 114.791 -1.095 . . . . 73.51 111.189 175.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -153.78 -93.94 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 122.773 0.429 . . . . 74.12 111.035 -176.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 142.87 99.95 0.34 Allowed Glycine 0 C--N 1.356 1.669 0 CA-C-N 118.21 0.459 . . . . 65.33 112.348 -177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -118.68 67.25 0.77 Allowed 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 124.049 0.94 . . . . 72.32 109.548 177.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 48.1 ttm -163.34 84.3 1.39 Allowed Pre-proline 0 CA--C 1.556 1.201 0 CA-C-N 116.401 -0.363 . . . . 73.13 110.973 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.4 89.31 1.27 Allowed 'Trans proline' 0 C--N 1.377 2.047 0 C-N-CA 123.331 2.687 . . . . 73.31 109.516 166.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' B' ' 42' ' ' LEU . 60.0 t -69.76 112.72 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 C-N-CA 123.554 0.742 . . . . 72.21 111.261 -172.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 29.7 ttp180 -78.64 138.81 38.5 Favored 'General case' 0 C--O 1.242 0.659 0 N-CA-C 107.059 -1.46 . . . . 74.25 107.059 164.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 45.8 m95 -57.37 151.75 15.63 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.697 0.76 . . . . 73.41 112.726 -174.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 21.8 mt -90.57 7.57 38.46 Favored 'General case' 0 CA--C 1.551 1.006 0 CA-C-N 114.401 -1.272 . . . . 72.22 110.299 176.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . 0.438 ' HA3' ' HB1' ' F' ' 305' ' ' ALA . . . 148.67 84.15 0.05 OUTLIER Glycine 0 C--N 1.348 1.229 0 N-CA-C 109.831 -1.308 . . . . 50.1 109.831 -176.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -63.3 -51.41 2.69 Favored 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.557 2.171 . . . . 54.23 113.075 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' H' ' 294' ' ' LYS . 8.3 mmpt? 55.02 31.08 15.38 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.682 1.193 . . . . 72.1 113.448 177.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 65.55 101.39 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.395 1.078 . . . . 74.03 112.183 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 80.5 m -63.56 -27.77 69.48 Favored 'General case' 0 CA--C 1.551 0.991 0 CA-C-N 115.619 -0.718 . . . . 74.52 111.171 172.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.415 ' OH ' ' HB1' ' B' ' 73' ' ' ALA . 3.9 m-30 -86.25 176.45 7.93 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.229 1.011 . . . . 74.25 111.947 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 66.6 m80 -68.28 117.89 10.67 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 114.861 -1.063 . . . . 72.23 110.113 -172.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -66.24 -23.63 71.66 Favored Glycine 0 C--N 1.344 0.998 0 O-C-N 123.854 0.721 . . . . 63.12 112.033 168.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 20.9 m120 -143.7 129.15 19.02 Favored 'General case' 0 C--N 1.355 0.821 0 C-N-CA 124.439 1.096 . . . . 71.24 110.33 176.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 98.8 mt -121.62 125.36 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 107.623 -1.251 . . . . 64.33 107.623 167.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -132.48 -73.26 0.51 Allowed 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.846 -0.798 . . . . 74.52 108.846 177.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -138.59 151.2 68.44 Favored Pre-proline 0 N--CA 1.48 1.043 0 C-N-CA 123.87 0.868 . . . . 73.34 109.739 177.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.06 166.38 23.2 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.64 2.226 . . . . 74.03 112.624 175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.03 8.47 8.45 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 123.462 0.705 . . . . 71.23 111.482 176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 7.1 p -141.51 136.95 32.34 Favored 'Isoleucine or valine' 0 C--O 1.241 0.633 0 C-N-CA 124.38 1.072 . . . . 62.01 109.482 177.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 9.9 t -168.7 -34.13 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.132 0.973 . . . . 71.52 110.69 -178.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 64.4 m -144.11 110.74 5.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.933 0.893 . . . . 74.24 108.992 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . 0.572 HG22 HD23 ' F' ' 291' ' ' LEU . 32.1 p -64.45 142.8 98.46 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 123.024 0.529 . . . . 74.32 110.323 175.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . 0.51 ' HD3' ' HG ' ' F' ' 291' ' ' LEU . 55.0 Cg_endo . . . . . 0 C--N 1.379 2.154 0 C-N-CA 123.104 2.536 . . . . 64.53 112.43 -179.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 73.1 mtm . . . . . 0 N--CA 1.481 1.115 0 N-CA-C 109.732 -0.47 . . . . 54.43 109.732 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.4 p -78.48 82.68 4.73 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-O 121.791 0.805 . . . . 72.21 109.64 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -125.95 -53.36 1.53 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.376 1.071 . . . . 74.5 108.826 -174.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -88.91 126.52 35.42 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.179 -1.045 . . . . 74.25 108.179 169.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 71.5 m-20 -70.12 111.14 5.55 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.474 -0.936 . . . . 72.42 108.474 175.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.453 ' HB3' HG22 ' A' ' 89' ' ' ILE . 11.5 m120 -84.22 58.38 4.75 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.467 0.707 . . . . 63.22 111.214 -172.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.6 m 62.03 -74.89 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 125.533 1.533 . . . . 62.24 110.6 -176.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -151.98 -53.58 0.12 Allowed 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.172 1.389 . . . . 72.01 107.645 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER 71.39 137.03 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 125.902 1.681 . . . . 74.31 111.163 -176.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 52.5 m -142.41 138.32 31.02 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.571 0.748 . . . . 75.13 109.854 -177.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.428 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 18.7 t80 -133.05 124.79 28.28 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.737 0.815 . . . . 62.13 108.887 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.3 tp60 -146.56 110.02 4.82 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 108.96 -0.756 . . . . 73.24 108.96 174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.676 HG12 ' HD2' ' A' ' 84' ' ' PHE . 37.6 mt -69.65 128.69 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 108.639 -0.874 . . . . 71.14 108.639 173.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.631 ' HA ' HE21 ' A' ' 14' ' ' GLN . 0.0 OUTLIER -97.73 -36.98 10.06 Favored 'General case' 0 C--O 1.223 -0.318 0 C-N-CA 122.936 0.494 . . . . 74.14 110.461 177.344 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.563 HH11 ' HB2' ' H' ' 305' ' ' ALA . 40.8 ttt85 -166.86 142.99 4.46 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 109.885 -0.413 . . . . 75.33 109.885 -174.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.1 pp -126.69 138.81 53.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 C-N-CA 123.549 0.74 . . . . 72.14 109.027 170.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.492 ' HE1' HG13 ' A' ' 83' ' ' ILE . 21.2 p90 -169.02 149.8 4.37 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.919 0.888 . . . . 63.24 110.299 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 75.7 p -79.33 119.81 22.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.899 -1.046 . . . . 74.52 108.83 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.416 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 36.2 mtpt -88.22 -17.93 29.76 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 120.847 0.356 . . . . 72.24 110.284 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.568 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 8.1 t70 -156.53 141.76 17.38 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 124.305 1.042 . . . . 72.45 109.141 178.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.482 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 64.4 mt -138.14 144.91 29.5 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 N-CA-C 107.238 -1.393 . . . . 60.14 107.238 175.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.616 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 28.3 t -150.8 130.51 13.16 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.852 0.861 . . . . 61.11 108.935 175.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.3 t80 -132.64 136.44 46.49 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 106.406 -1.701 . . . . 70.52 106.406 167.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -133.91 140.13 46.61 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.414 -0.587 . . . . 74.42 109.414 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.91 69.23 10.92 Favored Pre-proline 0 CA--C 1.538 0.499 0 N-CA-C 106.065 -1.828 . . . . 74.25 106.065 168.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.46 -19.41 21.93 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.324 2.016 . . . . 73.24 112.453 -171.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 20.2 m-20 -110.52 20.53 17.61 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.867 0.867 . . . . 64.11 109.798 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.74 -61.28 3.13 Favored Pre-proline 0 CA--C 1.571 1.787 0 CA-C-O 118.05 -0.976 . . . . 71.11 113.38 -167.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.4 -20.66 49.52 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.404 2.069 . . . . 71.52 113.912 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -83.85 -53.19 5.77 Favored 'General case' 0 N--CA 1.485 1.312 0 CA-C-O 122.104 0.954 . . . . 73.34 109.906 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.611 HG11 ' HA ' ' A' ' 73' ' ' ALA . 3.8 p -77.43 -12.74 14.05 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.201 0 CA-C-N 114.61 -1.177 . . . . 71.2 111.8 -162.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -74.18 -18.03 60.82 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.641 0.776 . . . . 64.43 112.606 176.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.07 -8.92 21.02 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 112.787 0.662 . . . . 73.41 112.787 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -79.9 168.95 18.58 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 122.957 0.503 . . . . 75.32 112.296 -174.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -64.93 138.62 58.48 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.67 1.188 . . . . 73.34 111.153 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -86.84 80.43 8.49 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.483 0.659 . . . . 73.34 110.146 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -137.31 77.53 41.26 Favored Pre-proline 0 CA--C 1.545 0.767 0 CA-C-N 114.938 -1.028 . . . . 70.1 109.006 171.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -81.4 138.82 11.18 Favored 'Trans proline' 0 C--N 1.372 1.805 0 C-N-CA 122.38 2.054 . . . . 62.35 111.762 176.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.56 84.32 3.39 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 106.006 -1.85 . . . . 64.42 106.006 164.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 65' ' ' THR . 12.0 p -81.91 123.39 38.01 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 CA-C-N 114.748 -1.114 . . . . 60.2 109.153 -175.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.512 ' HG2' ' HB ' ' A' ' 65' ' ' THR . 18.0 pttp -123.6 127.62 48.54 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.143 0.577 . . . . 74.24 110.591 -174.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 tt -98.55 109.49 22.23 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 106.629 -1.619 . . . . 70.33 106.629 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.655 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -106.34 147.89 28.69 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.792 0.837 . . . . 75.15 108.815 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 94.7 mt -126.19 125.57 42.66 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.74 0.816 . . . . 61.44 109.342 176.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 26.5 t70 -119.08 122.13 41.41 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.093 0.957 . . . . 74.53 108.455 176.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -108.17 129.46 55.18 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.879 0.872 . . . . 72.21 111.597 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.16 130.72 17.83 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.705 0.802 . . . . 64.54 109.987 177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 60.5 p -125.05 151.58 45.43 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 108.896 -0.779 . . . . 71.33 108.896 172.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 34.5 t -158.33 133.66 8.71 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.486 0.714 . . . . 72.24 109.857 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.8 tt0 -78.32 125.53 29.49 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.227 0.611 . . . . 75.34 110.018 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.5 mt -93.12 -34.28 13.71 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.453 0.701 . . . . 73.11 110.64 177.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.24 -178.58 6.05 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.057 0.943 . . . . 34.22 109.707 -178.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -69.26 125.34 26.39 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 109.902 -0.407 . . . . 71.35 109.902 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 68.58 -8.22 0.64 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.968 1.707 . . . . 64.44 112.805 -171.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.0 t -101.33 109.52 25.91 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.997 -0.742 . . . . 71.3 108.997 -176.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.524 ' HB2' HD13 ' A' ' 86' ' ' ILE . 93.2 m-85 -123.64 127.19 47.87 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.965 0.906 . . . . 70.22 108.607 -177.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -93.31 132.04 37.88 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.681 -1.145 . . . . 73.4 108.992 175.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.583 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 58.9 t -116.86 121.43 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 N-CA-C 107.694 -1.224 . . . . 73.45 107.694 169.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 58.8 t -99.41 129.76 49.42 Favored 'Isoleucine or valine' 0 C--O 1.241 0.655 0 C-N-CA 123.839 0.855 . . . . 73.21 108.711 171.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -120.57 100.5 7.17 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 106.547 -1.649 . . . . 74.55 106.547 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 6.6 ttm180 -87.35 131.22 34.34 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 108.843 -0.799 . . . . 74.35 108.843 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.446 ' HB ' HD11 ' A' ' 114' ' ' ILE . 47.9 t -117.84 130.61 72.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.328 -0.989 . . . . 72.43 108.328 173.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.655 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 69.2 m -113.72 140.97 47.82 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 123.635 0.584 . . . . 65.32 109.693 173.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.482 HG21 HD21 ' A' ' 126' ' ' LEU . 92.7 t -130.43 113.29 25.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 C-N-CA 123.961 0.904 . . . . 50.13 108.747 174.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 3.5 m -112.73 131.49 55.65 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 109.114 -0.698 . . . . 71.11 109.114 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.27 105.74 8.75 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 108.316 -0.994 . . . . 72.12 108.316 177.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 51.6 m -110.58 122.92 48.94 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 118.29 0.495 . . . . 62.11 110.816 178.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 73' ' ' ALA . 10.4 mp -89.57 86.96 6.87 Favored 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.111 0.964 . . . . 74.11 109.012 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 89.1 -84.41 1.43 Allowed Glycine 0 C--N 1.345 1.073 0 CA-C-N 114.757 -1.111 . . . . 61.43 110.5 -178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.65 -25.37 3.41 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.627 0.771 . . . . 60.31 110.446 176.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -98.4 129.87 45.04 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.312 1.045 . . . . 63.13 110.225 -171.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 26.6 m -79.85 135.49 36.47 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.196 0.522 . . . . 73.53 112.19 -175.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.611 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.64 -63.81 1.29 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.2 1.4 . . . . 72.03 109.766 173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -147.09 159.75 43.23 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-N 115.104 -0.953 . . . . 75.12 111.645 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.2 tp -139.65 117.26 11.49 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 114.399 -1.273 . . . . 72.32 108.335 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 63' ' ' THR . 83.9 m -110.61 136.72 49.28 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 123.392 0.677 . . . . 60.14 110.709 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.616 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 43.2 mp0 -135.9 131.27 35.02 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 107.618 -1.253 . . . . 71.21 107.618 169.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 72.5 t -138.27 115.2 11.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 108.6 -0.889 . . . . 53.14 108.6 174.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.568 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 42.3 mt-30 -90.23 86.98 6.66 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 108.273 -1.01 . . . . 75.52 108.273 172.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -78.71 93.11 4.86 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 114.727 -1.124 . . . . 73.3 108.62 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.01 148.24 22.3 Favored Glycine 0 C--N 1.342 0.866 0 CA-C-N 115.264 -0.88 . . . . 71.12 111.082 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.74 123.27 2.01 Favored Glycine 0 CA--C 1.504 -0.595 0 N-CA-C 111.349 -0.7 . . . . 50.15 111.349 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.492 HG13 ' HE1' ' A' ' 17' ' ' TYR . 56.3 mt -80.97 123.67 37.86 Favored 'Isoleucine or valine' 0 C--O 1.243 0.731 0 N-CA-C 107.896 -1.149 . . . . 71.4 107.896 170.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.676 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.3 m-85 -133.83 162.9 30.74 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 108.263 -1.014 . . . . 63.23 108.263 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 36.4 t -118.43 102.47 8.95 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.489 -0.93 . . . . 74.55 108.489 175.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 56' ' ' TYR . 3.3 mp -112.82 137.13 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 123.568 0.747 . . . . 71.31 109.032 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -152.8 174.87 13.51 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.981 0.912 . . . . 60.42 109.876 177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.88 -21.21 16.14 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 114.742 0.657 . . . . 53.12 114.742 172.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.489 HD12 ' HA ' ' A' ' 94' ' ' MET . 11.2 pt -121.29 157.07 24.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 123.918 0.887 . . . . 73.3 110.776 -173.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.443 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 2.8 tt0 -140.31 174.63 10.33 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.96 0.904 . . . . 61.15 109.32 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.443 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 41.91 -116.11 0.98 Allowed Glycine 0 N--CA 1.481 1.661 0 N-CA-C 115.927 1.131 . . . . 72.34 115.927 174.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.6 p -73.05 -28.58 62.4 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.7 1.2 . . . . 72.34 111.978 -177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 30.2 mt-30 -62.08 -46.74 87.77 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.383 0.673 . . . . 74.34 109.206 177.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.514 ' HE1' HD23 ' E' ' 278' ' ' LEU . 1.4 ppp? -83.59 -21.7 32.51 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 115.49 -0.777 . . . . 61.04 111.336 -178.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.63 -27.42 66.87 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.156 0.583 . . . . 70.02 110.692 175.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 43.9 t-80 -64.52 -35.14 80.0 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.773 0.829 . . . . 75.24 110.597 171.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 45.1 t -72.33 -41.11 66.88 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.878 -0.601 . . . . 42.54 110.91 178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 79.2 mt -72.57 -51.1 21.22 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.3 0.24 . . . . 73.4 111.605 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.9 3.79 77.83 Favored Glycine 0 N--CA 1.472 1.08 0 N-CA-C 114.871 0.708 . . . . 54.45 114.871 -165.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.695 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.64 -58.26 0.2 Allowed 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 118.013 0.907 . . . . 75.22 113.271 -173.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.482 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 64.3 t80 -70.55 -59.21 2.97 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 114.692 -1.14 . . . . 61.11 112.086 -167.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 90.9 m -70.02 -32.48 2.91 Favored Pre-proline 0 CA--C 1.566 1.59 0 N-CA-C 113.546 0.943 . . . . 52.11 113.546 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -48.16 -45.58 25.25 Favored 'Trans proline' 0 C--N 1.395 3.001 0 C-N-CA 122.732 2.288 . . . . 75.52 113.011 162.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -64.18 -27.76 69.29 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.747 0.819 . . . . 74.25 111.439 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.437 HG21 HD11 ' A' ' 13' ' ' ILE . 47.9 mm -74.74 -47.59 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 123.634 0.774 . . . . 74.32 110.257 175.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 88.6 mt -78.54 -29.68 46.54 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.623 0.769 . . . . 74.55 112.798 -170.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -65.15 -38.65 29.79 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 113.599 0.962 . . . . 73.45 113.599 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_exo -53.81 -40.68 79.34 Favored 'Trans proline' 0 C--N 1.387 2.588 0 C-N-CA 122.14 1.893 . . . . 71.32 113.608 168.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -73.44 -40.56 64.11 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 75.2 111.636 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.93 -45.87 84.0 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 122.814 0.446 . . . . 63.42 109.939 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -49.61 -53.75 22.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.096 1.498 . . . . 70.54 110.522 175.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -65.6 -41.11 93.16 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.178 0.924 . . . . 70.5 111.658 -175.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 48.0 t -64.8 -31.59 72.89 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.034 0.533 . . . . 55.33 111.249 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.446 HD11 ' HB ' ' A' ' 62' ' ' VAL . 89.7 mt -71.84 -51.78 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.555 0.742 . . . . 75.32 109.206 172.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.407 HG23 ' HG3' ' A' ' 125' ' ' GLN . 33.0 m -53.57 -40.04 65.27 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.705 1.202 . . . . 55.14 111.609 -174.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.0 t -59.72 -55.2 37.26 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.719 -1.128 . . . . 22.0 110.386 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.4 mtm -60.75 -43.33 98.1 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 123.53 0.732 . . . . 71.24 111.515 -177.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 114' ' ' ILE . 78.5 t -57.38 -46.38 85.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 124.411 1.084 . . . . 50.21 110.691 179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 35.5 t -70.67 -29.25 65.53 Favored 'General case' 0 CA--C 1.552 1.035 0 CA-C-N 115.15 -0.932 . . . . 74.0 111.369 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.412 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.2 mtt-85 -71.55 -30.74 66.22 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.788 0.835 . . . . 52.13 110.653 177.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.08 6.25 76.21 Favored Glycine 0 C--N 1.353 1.493 0 CA-C-O 119.774 -0.459 . . . . 74.21 112.992 175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.622 ' HB ' HH21 ' B' ' 15' ' ' ARG . 1.6 m 67.9 18.71 9.58 Favored 'General case' 0 CA--C 1.56 1.36 0 C-N-CA 125.258 1.423 . . . . 75.32 111.681 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.92 151.57 64.2 Favored Pre-proline 0 N--CA 1.478 0.933 0 N-CA-C 109.284 -0.635 . . . . 72.44 109.284 173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -58.97 146.01 95.43 Favored 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 122.795 2.33 . . . . 35.21 111.53 178.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.407 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.5 tt0 -55.23 129.58 38.86 Favored 'General case' 0 C--N 1.357 0.912 0 O-C-N 123.747 0.654 . . . . 75.25 111.393 -175.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.482 HD21 HG21 ' A' ' 64' ' ' VAL . 48.0 tp -112.3 96.14 5.85 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 114.765 -1.107 . . . . 55.24 110.004 -177.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -102.57 105.46 15.98 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 107.562 -1.273 . . . . 75.42 107.562 170.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.15 143.53 57.71 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 122.871 0.468 . . . . 72.35 110.045 177.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.625 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -63.17 130.51 94.24 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 122.95 0.5 . . . . 62.23 111.141 -177.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 56.2 Cg_endo -72.37 104.9 1.77 Allowed 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.241 1.961 . . . . 65.04 111.246 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.487 HG22 HD21 ' E' ' 291' ' ' LEU . 32.7 t -101.02 122.78 53.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 N-CA-C 108.27 -1.011 . . . . 73.3 108.27 -178.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 135' ' ' ALA . 51.3 t30 -68.29 86.62 0.28 Allowed 'General case' 0 C--O 1.243 0.716 0 N-CA-C 108.65 -0.87 . . . . 62.15 108.65 170.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -60.83 -32.49 71.88 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.467 -1.242 . . . . 73.32 109.922 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.695 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 5.2 t70 -66.27 -36.31 82.64 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-N 114.239 -1.346 . . . . 62.13 111.498 -174.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.469 ' HB2' ' ND2' ' A' ' 132' ' ' ASN . . . -66.91 -53.4 32.4 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-O 120.568 0.223 . . . . 73.33 110.606 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 64.4 mt -65.64 -28.07 68.84 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 122.894 0.478 . . . . 71.04 112.277 -173.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -81.98 -50.44 9.13 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 115.929 -0.578 . . . . 64.51 110.167 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.435 ' HB2' ' O ' ' A' ' 134' ' ' ASP . 0.0 OUTLIER -72.03 -39.98 68.74 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.481 0.712 . . . . 61.11 110.979 -169.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.637 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 87.1 m-20 -53.94 -41.06 67.34 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.226 0.611 . . . . 72.32 110.675 174.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -78.28 -31.94 49.23 Favored 'General case' 0 CA--C 1.55 0.958 0 CA-C-N 115.901 -0.59 . . . . 74.41 111.459 177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.7 tp -67.54 -51.18 53.93 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.322 0.649 . . . . 41.42 111.465 -175.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -166.59 18.21 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.517 0.727 . . . . 75.1 110.015 -172.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.637 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 64.0 tt0 67.49 135.7 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 125.101 1.361 . . . . 74.13 111.052 -171.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -83.36 43.28 0.87 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.948 0.88 . . . . 62.5 110.311 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -78.49 104.62 9.21 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 124.196 0.998 . . . . 74.14 109.694 -179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -145.19 121.97 1.63 Allowed Glycine 0 C--N 1.339 0.716 0 CA-C-N 115.648 -0.706 . . . . 73.41 111.517 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -161.19 103.29 1.27 Allowed 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.713 0.805 . . . . 72.4 108.925 -177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -108.15 77.23 0.23 Allowed Glycine 0 C--N 1.345 1.082 0 N-CA-C 111.33 -0.708 . . . . 71.11 111.33 177.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.6 p -73.16 86.09 1.38 Allowed 'General case' 0 CA--C 1.553 1.079 0 CA-C-O 121.613 0.72 . . . . 62.01 109.421 175.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -85.15 141.48 30.16 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 124.433 1.093 . . . . 75.3 111.615 -170.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.01 151.08 20.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.545 0.738 . . . . 73.31 109.724 178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -145.69 89.37 1.9 Allowed 'General case' 0 CA--C 1.555 1.135 0 C-N-CA 124.232 1.013 . . . . 74.01 110.003 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 14.5 tm0? -162.66 102.41 1.04 Allowed 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 107.208 -1.404 . . . . 71.4 107.208 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -86.23 -45.43 11.31 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.571 0.748 . . . . 55.0 111.937 -171.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.798 0 C-N-CA 123.593 0.757 . . . . 73.44 109.097 -172.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 110.362 -0.236 . . . . 73.4 110.362 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 61.3 p -163.82 57.15 0.17 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.909 1.284 . . . . 65.11 108.458 177.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -105.9 171.82 7.13 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 114.763 -1.108 . . . . 73.33 111.374 -167.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 70.36 107.77 0.06 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.273 1.429 . . . . 64.13 111.965 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -65.21 133.09 50.75 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.435 0.694 . . . . 74.32 110.376 174.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -139.92 145.11 37.55 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.166 0.986 . . . . 71.3 108.762 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 56.3 m 74.42 129.62 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 125.197 1.399 . . . . 73.43 112.011 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -83.54 -157.59 0.25 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.122 0.969 . . . . 71.25 109.565 174.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.449 ' HB2' HG23 ' B' ' 89' ' ' ILE . 17.1 ptm 59.46 -177.8 0.09 Allowed 'General case' 0 N--CA 1.499 1.986 0 C-N-CA 126.137 1.775 . . . . 75.53 113.368 176.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 98.9 m -148.09 113.31 5.55 Favored 'General case' 0 C--O 1.24 0.561 0 C-N-CA 123.28 0.632 . . . . 62.33 109.85 177.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.471 ' HE1' ' SG ' ' B' ' 102' ' ' CYS . 74.4 t80 -110.45 117.38 33.42 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.072 -1.084 . . . . 60.3 108.072 175.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -126.31 106.28 9.4 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.427 -0.583 . . . . 74.24 109.427 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.721 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -79.77 118.03 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 106.887 -1.523 . . . . 64.11 106.887 167.053 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -87.07 -53.61 4.77 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 116.472 -0.331 . . . . 73.5 110.188 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.622 HH21 ' HB ' ' A' ' 122' ' ' THR . 52.6 ttt180 -156.35 139.93 15.94 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 110.093 -0.336 . . . . 73.33 110.093 -172.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.721 HG13 HD11 ' B' ' 13' ' ' ILE . 92.5 mt -116.8 140.13 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 106.722 -1.584 . . . . 60.43 106.722 169.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -168.51 159.64 10.41 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 123.569 0.543 . . . . 71.54 110.552 -179.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 87.6 m -85.93 120.26 27.13 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 109.403 -0.591 . . . . 74.05 109.403 174.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -87.81 -30.63 20.08 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.089 0.556 . . . . 71.25 110.689 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -158.86 146.81 17.96 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 120.715 0.293 . . . . 54.13 111.552 -174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 42.0 mm -132.46 141.61 44.76 Favored 'Isoleucine or valine' 0 C--N 1.349 0.568 0 C-N-CA 125.281 1.432 . . . . 61.44 108.911 175.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.545 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 42.2 t -139.44 130.84 26.93 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 124.921 1.288 . . . . 71.13 107.655 177.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.482 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -148.13 125.17 11.37 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.462 -1.311 . . . . 50.0 107.462 168.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 45.9 mt-10 -122.92 144.99 48.86 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.623 -0.881 . . . . 53.12 108.623 175.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.856 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -142.22 74.88 20.54 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.6 -1.259 . . . . 75.31 107.6 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -70.31 -38.28 6.79 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 122.663 2.242 . . . . 53.02 112.566 -171.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 71.9 m-20 -105.41 10.96 33.18 Favored 'General case' 0 C--O 1.208 -1.102 0 C-N-CA 123.28 0.632 . . . . 74.22 111.01 -177.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.856 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -44.59 -50.71 23.12 Favored Pre-proline 0 CA--C 1.571 1.785 0 N-CA-C 115.016 1.487 . . . . 71.45 115.016 -171.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -70.72 -30.35 17.94 Favored 'Trans proline' 0 C--N 1.383 2.384 0 CA-C-N 121.141 1.443 . . . . 42.35 112.829 176.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.426 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.0 m80 -97.61 -2.36 41.78 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 123.873 0.869 . . . . 64.41 112.956 -175.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 4.4 p -78.53 -12.73 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 C-N-CA 122.928 0.491 . . . . 72.24 110.492 -176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.585 ' HZ ' ' HG2' ' H' ' 303' ' ' LYS . 71.8 t80 -61.36 -29.52 69.96 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.289 1.036 . . . . 71.42 111.735 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.6 pt20 -62.06 -31.98 72.45 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.193 0.597 . . . . 72.41 110.58 174.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.602 ' HB3' ' HB3' ' B' ' 68' ' ' LEU . 35.3 mmtp -97.05 64.98 2.01 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 108.311 -0.996 . . . . 74.25 108.311 175.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -85.91 99.72 11.6 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.802 -0.635 . . . . 75.13 110.324 -175.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.52 ' HZ3' HG21 ' H' ' 301' ' ' ILE . 0.0 OUTLIER 163.89 -165.16 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.451 0 C-N-CA 126.953 2.101 . . . . 73.43 110.231 160.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' H' ' 297' ' ' TYR . 26.6 pt20 -59.35 125.11 78.1 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 124.112 0.965 . . . . 63.13 112.589 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.42 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 87.9 Cg_endo -84.98 150.61 10.97 Favored 'Trans proline' 0 C--N 1.379 2.145 0 C-N-CA 123.115 2.544 . . . . 74.32 112.56 176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -71.44 106.45 3.94 Favored 'General case' 0 C--O 1.243 0.725 0 N-CA-C 108.015 -1.106 . . . . 74.25 108.015 170.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 65' ' ' THR . 91.9 t -93.13 128.69 44.45 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 123.62 0.768 . . . . 75.53 110.862 -175.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.597 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.8 tttp -109.98 124.39 51.35 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.165 0.986 . . . . 61.35 109.478 175.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 69.1 mt -104.21 152.51 22.08 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.43 0.692 . . . . 71.32 109.94 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -163.09 111.7 1.29 Allowed 'General case' 0 N--CA 1.47 0.56 0 O-C-N 123.715 0.635 . . . . 54.14 109.525 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.402 ' HG ' HG22 ' B' ' 62' ' ' VAL . 10.1 mp -99.1 139.21 35.09 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 107.949 -1.13 . . . . 61.21 107.949 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.617 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 25.8 t70 -121.75 126.24 48.42 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.89 0.876 . . . . 75.3 108.841 -174.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 19.4 p -106.96 103.93 13.48 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.17 0.988 . . . . 74.22 108.418 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -130.84 140.73 50.28 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.482 -0.781 . . . . 73.23 109.014 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 38.9 p -144.52 163.88 32.55 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 122.619 0.368 . . . . 62.34 111.28 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 80.7 p -153.06 140.38 19.57 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.04 0.936 . . . . 72.02 109.536 176.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -80.03 133.6 36.16 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.574 0.35 . . . . 75.53 110.527 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 74.2 mt -94.84 -44.31 7.81 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.325 0.65 . . . . 70.44 110.592 176.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.62 -167.55 1.59 Allowed 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.656 0.782 . . . . 63.15 110.965 -171.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -63.9 106.08 0.96 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 114.884 -1.053 . . . . 60.35 110.784 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . 0.423 ' O ' ' HA ' ' B' ' 85' ' ' SER . 33.8 m-20 73.18 -1.72 2.96 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 126.303 1.841 . . . . 64.43 112.057 -178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 42.7 t -103.93 124.13 58.09 Favored 'Isoleucine or valine' 0 C--N 1.348 0.524 0 C-N-CA 124.182 0.993 . . . . 54.0 108.782 -176.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -134.39 -178.62 5.13 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 123.512 0.725 . . . . 70.31 109.235 173.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.459 ' HG2' HG12 ' B' ' 83' ' ' ILE . 5.0 tm-20 -138.17 116.64 12.03 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 106.805 -1.554 . . . . 75.15 106.805 -174.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 97.1 t -106.83 127.17 62.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 C-N-CA 123.835 0.854 . . . . 73.53 110.309 -177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.402 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 20.6 t -102.48 112.89 37.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.758 0 C-N-CA 124.297 1.039 . . . . 74.33 108.829 174.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -99.4 97.81 8.8 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 107.367 -1.346 . . . . 75.32 107.367 173.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 27.8 ttm180 -84.81 133.31 34.34 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.873 -0.788 . . . . 62.33 108.873 175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.402 HG22 ' HG ' ' B' ' 44' ' ' LEU . 57.6 t -117.77 109.23 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 N-CA-C 107.577 -1.268 . . . . 51.33 107.577 169.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 54.4 m -96.23 136.64 36.43 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 108.627 -0.879 . . . . 64.1 108.627 177.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 93.8 t -133.03 132.27 58.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 124.417 1.087 . . . . 61.41 108.455 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.597 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 59.7 m -123.19 144.08 49.6 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.686 -1.227 . . . . 72.04 107.686 175.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.04 135.14 39.18 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.953 -1.499 . . . . 70.11 106.953 172.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 14.8 p -145.77 139.03 26.16 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 122.982 0.513 . . . . 52.53 110.683 -173.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.602 ' HB3' ' HB3' ' B' ' 34' ' ' LYS . 23.7 mt -129.46 104.67 7.61 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.853 1.261 . . . . 73.35 109.694 -171.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.9 -135.92 19.79 Favored Glycine 0 C--N 1.346 1.107 0 CA-C-O 119.542 -0.588 . . . . 65.04 111.953 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.7 11.08 18.56 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.546 0.673 . . . . 75.24 111.532 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.457 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 13.4 pt-20 -130.13 167.59 18.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.341 0.657 . . . . 62.12 110.936 -175.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 62.3 m -79.56 145.87 32.91 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.495 -0.775 . . . . 75.53 109.807 174.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -92.46 -67.11 0.88 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 122.947 0.499 . . . . 53.41 109.668 172.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -160.63 152.08 19.4 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 114.975 -1.011 . . . . 73.51 108.792 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.43 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 65.9 mt -128.07 137.1 52.02 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.56 1.144 . . . . 51.33 108.309 -174.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -146.49 147.03 30.76 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 109.522 -0.548 . . . . 74.24 109.522 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.545 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 32.3 tt0 -160.88 138.61 9.42 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.453 -0.943 . . . . 72.11 108.453 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' B' ' 113' ' ' CYS . 74.5 t -130.15 146.26 34.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.677 -1.231 . . . . 62.12 107.677 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -121.9 91.79 3.59 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.777 -1.194 . . . . 54.4 107.777 173.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.8 tp-100 -88.04 100.07 12.65 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.343 -0.984 . . . . 71.25 108.343 -178.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.402 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.34 162.11 30.52 Favored Glycine 0 C--O 1.241 0.574 0 N-CA-C 111.047 -0.821 . . . . 64.23 111.047 178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.64 126.8 1.6 Allowed Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 110.938 -0.865 . . . . 34.05 110.938 -175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.459 HG12 ' HG2' ' B' ' 57' ' ' GLU . 59.0 mt -84.39 129.62 37.34 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.467 -0.938 . . . . 74.31 108.467 177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -131.81 148.75 52.58 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 109.38 -0.6 . . . . 75.14 109.38 176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' B' ' 54' ' ' ASP . 22.6 m -131.23 106.64 8.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.43 1.092 . . . . 73.22 109.161 177.468 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.459 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.8 pp -117.69 145.02 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 122.946 0.498 . . . . 73.01 110.634 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.13 161.73 39.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.865 0.866 . . . . 32.01 109.986 174.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.47 -41.2 2.51 Favored Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.895 -0.593 . . . . 74.34 111.775 -178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.609 HD12 ' HA ' ' B' ' 94' ' ' MET . 11.0 pt -71.66 143.38 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 123.727 0.811 . . . . 72.21 110.574 173.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.18 145.0 24.36 Favored 'General case' 0 C--O 1.243 0.714 0 N-CA-C 108.857 -0.794 . . . . 60.24 108.857 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.73 -109.4 2.83 Favored Glycine 0 C--N 1.348 1.2 0 O-C-N 123.831 0.707 . . . . 74.41 113.68 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 4.0 m -65.09 -53.44 45.41 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.233 1.013 . . . . 73.33 111.487 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -66.55 -34.3 77.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 114.248 -1.342 . . . . 70.02 110.417 -172.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.609 ' HA ' HD12 ' B' ' 89' ' ' ILE . 52.2 ttp -65.86 -50.94 62.74 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.679 1.192 . . . . 75.3 110.606 178.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.85 -36.9 77.82 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.14 0.976 . . . . 72.22 111.919 -177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -78.2 -36.02 47.85 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 123.215 0.606 . . . . 73.33 111.227 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.2 t -65.11 -52.18 56.94 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.07 0.548 . . . . 70.11 111.673 -175.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.61 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 4.1 pp -86.75 -31.95 20.67 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 116.591 -0.277 . . . . 64.0 111.532 -178.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.48 -21.08 73.4 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 114.09 0.396 . . . . 35.13 114.09 -174.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -121.75 -51.6 2.03 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.808 0.443 . . . . 74.15 111.801 -174.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 49.7 t80 -75.54 -40.75 56.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.806 0.442 . . . . 71.33 111.99 -170.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.61 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 84.4 m -66.49 -43.89 53.88 Favored Pre-proline 0 CA--C 1.569 1.701 0 N-CA-C 113.466 0.913 . . . . 61.32 113.466 -177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.86 -37.09 97.61 Favored 'Trans proline' 0 C--N 1.396 3.077 0 C-N-CA 122.359 2.039 . . . . 51.53 113.218 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -65.23 -19.7 66.09 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.497 0.719 . . . . 53.24 112.491 178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.412 HG23 ' NH2' ' D' ' 111' ' ' ARG . 86.3 mt -81.68 -48.31 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 C-N-CA 123.344 0.658 . . . . 72.24 110.75 177.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 96.1 mt -75.24 -25.82 58.4 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 115.915 -0.584 . . . . 72.33 111.591 -174.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -57.68 -52.54 73.61 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 114.066 1.136 . . . . 74.24 114.066 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -51.71 -41.42 61.96 Favored 'Trans proline' 0 C--N 1.394 2.936 0 C-N-CA 122.439 2.093 . . . . 72.24 113.731 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.432 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 91.7 m-85 -65.15 -48.13 74.64 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.8 0.84 . . . . 75.45 111.396 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.73 -38.54 82.0 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 115.486 -0.779 . . . . 62.52 110.988 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 ttp-105 -65.71 -49.73 67.43 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.047 -1.433 . . . . 74.04 111.386 -174.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.92 -35.37 79.83 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 122.995 0.518 . . . . 74.31 110.232 -179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.484 ' O ' ' HG2' ' B' ' 117' ' ' MET . 7.6 t -67.21 -32.0 72.76 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 122.623 0.369 . . . . 71.23 111.405 -177.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 70.7 mt -68.63 -45.63 81.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.499 0.72 . . . . 52.54 109.651 170.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.728 HG23 ' HB2' ' B' ' 125' ' ' GLN . 87.8 m -60.51 -25.01 65.77 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 124.382 1.073 . . . . 74.22 111.521 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 34.3 t -75.24 -51.4 13.39 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.652 0.781 . . . . 72.45 110.136 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.484 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.5 mmt -70.31 -34.99 73.37 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 122.914 0.486 . . . . 72.03 111.933 -171.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.1 t -62.55 -39.47 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.195 0 C-N-CA 123.463 0.705 . . . . 44.02 110.039 174.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 9.3 t -72.92 -27.51 61.91 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.702 0.801 . . . . 62.5 111.605 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.408 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 93.4 mtt-85 -73.34 -33.34 65.06 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.413 0.685 . . . . 71.13 110.086 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -78.34 1.75 69.49 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 123.855 0.722 . . . . 52.42 112.305 168.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 30.7 p 63.33 38.61 10.1 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 126.85 2.06 . . . . 52.35 112.606 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 60.3 m-85 -111.11 156.76 40.44 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 124.484 1.114 . . . . 64.32 109.869 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.522 ' HG3' ' HB2' ' H' ' 300' ' ' ASN . 11.8 Cg_exo -66.58 143.42 68.53 Favored 'Trans proline' 0 C--N 1.383 2.386 0 C-N-CA 122.428 2.085 . . . . 65.44 111.54 177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.728 ' HB2' HG23 ' B' ' 115' ' ' THR . 16.7 pt20 -65.14 161.65 18.64 Favored 'General case' 0 C--O 1.245 0.817 0 C-N-CA 125.28 1.432 . . . . 74.51 114.566 -167.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.633 HD11 ' HH2' ' H' ' 290' ' ' TRP . 26.5 tp -135.29 104.38 5.86 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 114.345 -1.298 . . . . 73.05 109.876 168.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.516 HD21 ' NE2' ' B' ' 125' ' ' GLN . 6.1 m-80 -92.2 107.43 19.21 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 106.48 -1.674 . . . . 70.02 106.48 167.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 21.1 tp -62.88 134.98 57.05 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 123.302 0.376 . . . . 65.02 110.153 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' H' ' 292' ' ' GLY . . . -61.25 156.46 50.42 Favored Pre-proline 0 CA--C 1.548 0.868 0 C-N-CA 124.775 1.23 . . . . 54.43 111.867 -177.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -53.9 108.43 0.28 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.754 2.302 . . . . 72.01 111.992 177.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.466 HG22 HD11 ' H' ' 291' ' ' LEU . 38.2 t -88.14 108.57 18.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 106.775 -1.565 . . . . 54.21 106.775 176.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.424 ' OD1' ' HB3' ' B' ' 134' ' ' ASP . 64.9 t30 -90.23 88.99 7.45 Favored 'General case' 0 C--O 1.242 0.674 0 N-CA-C 108.854 -0.795 . . . . 75.03 108.854 -177.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -63.33 -28.62 70.13 Favored 'General case' 0 N--CA 1.477 0.918 0 CA-C-N 115.199 -0.909 . . . . 74.54 110.466 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.424 ' HB3' ' OD1' ' B' ' 132' ' ' ASN . 7.6 t70 -51.5 -51.07 58.23 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.49 1.116 . . . . 71.32 111.398 173.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.409 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -65.44 -32.43 74.05 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 123.877 0.736 . . . . 74.55 112.221 -175.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 58.3 tp -61.74 -45.61 93.18 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.873 0.869 . . . . 75.54 110.686 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.423 ' O ' ' HG ' ' B' ' 141' ' ' LEU . 71.4 m-85 -78.53 -34.91 46.87 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 115.8 -0.636 . . . . 71.4 110.853 178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.92 -36.96 85.67 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.657 0.783 . . . . 52.23 110.528 -177.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -77.53 -7.66 56.62 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 115.368 -0.833 . . . . 71.15 111.35 -176.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -89.0 -29.23 19.65 Favored 'General case' 0 CA--C 1.547 0.827 0 N-CA-C 109.356 -0.609 . . . . 74.04 109.356 168.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.423 ' HG ' ' O ' ' B' ' 137' ' ' PHE . 62.9 mt -86.81 26.3 1.15 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.983 0.913 . . . . 73.32 111.792 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -71.21 95.67 1.3 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 109.373 -0.602 . . . . 62.52 109.373 174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -78.23 162.82 26.29 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.669 0.787 . . . . 70.52 111.68 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -87.56 173.29 9.16 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.171 0.988 . . . . 63.44 111.433 -176.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.28 134.84 20.93 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.919 0.888 . . . . 72.52 109.339 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.58 148.8 18.68 Favored Glycine 0 N--CA 1.471 0.97 0 N-CA-C 111.759 -0.537 . . . . 53.52 111.759 177.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -165.75 112.42 0.91 Allowed 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.534 0.734 . . . . 73.24 110.116 -177.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -94.81 -149.18 25.3 Favored Glycine 0 C--N 1.349 1.258 0 N-CA-C 112.159 -0.377 . . . . 71.44 112.159 176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 88.3 m -146.95 126.47 13.25 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.288 0.635 . . . . 63.04 110.478 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -75.59 103.77 5.85 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 108.743 -0.836 . . . . 73.11 108.743 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -80.38 166.16 21.55 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.79 0.805 . . . . 74.04 112.741 -177.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -118.81 106.99 13.08 Favored 'General case' 0 CA--C 1.547 0.854 0 CA-C-N 113.854 -1.521 . . . . 71.33 109.39 -174.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -87.56 89.28 7.93 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.2 0.524 . . . . 64.24 110.056 179.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -107.8 155.59 20.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.167 0.987 . . . . 72.13 110.581 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.108 0 C-N-CA 123.721 0.808 . . . . 75.41 109.721 -177.146 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 25.3 ttt . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.789 -0.449 . . . . 70.14 109.789 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 69.7 m -154.36 169.09 24.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.872 0.869 . . . . 71.42 110.26 172.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -138.9 88.49 2.29 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 107.332 -1.358 . . . . 52.54 107.332 177.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.19 142.3 45.43 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.547 0.739 . . . . 72.43 109.592 -179.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -60.63 -41.41 94.85 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.189 0.596 . . . . 73.33 111.669 -175.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -70.41 128.19 35.34 Favored 'General case' 0 N--CA 1.477 0.899 0 O-C-N 123.22 0.325 . . . . 62.14 110.216 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 35.4 p -132.36 94.8 3.51 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.485 1.114 . . . . 71.04 108.581 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -110.57 139.84 45.44 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.97 0.908 . . . . 72.04 110.365 -176.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.716 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.3 tmm? 65.7 115.23 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 125.391 1.476 . . . . 75.34 112.222 177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.577 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 31.1 m -100.14 92.07 5.06 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.816 0.846 . . . . 73.32 109.36 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.716 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 49.0 t80 -92.01 145.78 24.26 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 108.799 -0.815 . . . . 60.13 108.799 173.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.01 132.2 4.8 Favored 'General case' 0 C--O 1.245 0.848 0 N-CA-C 108.844 -0.798 . . . . 72.12 108.844 167.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.8 pp -70.88 134.62 29.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 N-CA-C 109.17 -0.678 . . . . 70.04 109.17 175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -103.19 -45.13 5.0 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 109.488 -0.56 . . . . 73.25 109.488 176.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.536 HH12 HG23 ' G' ' 301' ' ' ILE . 29.8 ttt85 -169.09 147.0 3.75 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.999 -0.546 . . . . 74.43 109.73 -178.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -130.02 136.22 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 107.328 -1.36 . . . . 75.31 107.328 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.558 ' HB3' HG23 ' D' ' 122' ' ' THR . 19.2 p90 -171.22 154.1 3.88 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.418 0.627 . . . . 71.41 111.258 -175.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 58.3 p -77.95 109.26 11.84 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.237 -1.023 . . . . 72.34 108.237 172.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 mmmt -70.28 -45.55 66.12 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.74 0.781 . . . . 72.42 108.945 177.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.612 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 18.9 t70 -138.09 141.53 40.24 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 114.362 -1.29 . . . . 71.23 109.318 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 99.9 mt -136.16 142.71 37.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 125.718 1.607 . . . . 72.2 106.686 177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 33.0 t -155.92 150.91 26.4 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.298 0.57 . . . . 62.13 110.987 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.466 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 90.1 t80 -152.45 121.61 6.68 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 114.595 -1.184 . . . . 75.52 107.842 174.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -117.96 131.86 56.46 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.522 0.729 . . . . 72.41 109.157 177.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.412 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -137.1 86.18 20.83 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 108.453 -0.943 . . . . 51.13 108.453 174.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.27 -39.08 10.72 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.386 2.057 . . . . 75.44 111.316 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -99.26 33.77 2.34 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.188 0.995 . . . . 75.31 110.035 -178.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.483 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -59.78 -51.9 77.63 Favored Pre-proline 0 CA--C 1.569 1.689 0 C-N-CA 124.615 1.166 . . . . 62.22 114.128 -178.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.45 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 4.4 Cg_exo -74.85 -26.95 10.74 Favored 'Trans proline' 0 C--N 1.396 3.066 0 C-N-CA 121.718 1.612 . . . . 71.42 111.37 174.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 86.8 t60 -66.03 -18.34 65.28 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.138 1.375 . . . . 71.55 112.166 179.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -54.71 -26.69 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.342 0 N-CA-C 113.324 0.861 . . . . 55.0 113.324 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -68.25 -26.4 65.66 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 120.974 0.416 . . . . 74.14 111.886 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -112.44 30.95 6.67 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.508 1.123 . . . . 70.11 109.683 173.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.631 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 0.0 OUTLIER -95.32 137.07 34.88 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 124.175 0.99 . . . . 73.0 108.7 171.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -69.73 130.37 42.14 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.576 -0.898 . . . . 73.23 108.576 170.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 51.3 m95 -83.79 66.59 9.15 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.109 0.564 . . . . 74.54 111.238 -170.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -165.7 78.34 1.22 Allowed Pre-proline 0 CA--C 1.558 1.255 0 C-N-CA 123.543 0.737 . . . . 53.5 109.824 172.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.452 ' HD2' ' HB1' ' F' ' 295' ' ' ALA . 12.3 Cg_exo -73.29 163.4 38.0 Favored 'Trans proline' 0 C--N 1.375 1.966 0 C-N-CA 122.716 2.277 . . . . 74.2 112.941 172.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -86.85 76.61 9.41 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 107.269 -1.382 . . . . 74.51 107.269 165.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.651 HG21 ' H ' ' F' ' 296' ' ' THR . 64.1 t -73.7 97.96 1.0 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 114.234 -1.348 . . . . 71.34 108.468 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.501 ' HA ' ' HB2' ' F' ' 290' ' ' TRP . 98.8 mttt -133.22 128.21 35.42 Favored 'General case' 0 C--O 1.243 0.72 0 C-N-CA 124.105 0.962 . . . . 73.24 108.757 -175.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.616 ' HG ' HD21 ' C' ' 128' ' ' LEU . 0.0 OUTLIER -89.41 161.86 16.07 Favored 'General case' 0 CA--C 1.542 0.646 0 O-C-N 123.701 0.626 . . . . 75.53 109.999 175.494 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.414 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 32.5 t70 -139.12 141.58 38.08 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.307 1.043 . . . . 72.04 108.703 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.4 tp -112.36 113.02 25.01 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.241 0.616 . . . . 75.02 109.455 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.644 ' HA ' HD22 ' F' ' 285' ' ' ASN . 20.4 t70 -114.89 142.01 47.16 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 108.484 -0.932 . . . . 71.34 108.484 172.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 69.4 p -128.39 136.94 51.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 122.915 0.486 . . . . 75.53 110.335 -172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -147.6 167.29 24.93 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.258 1.023 . . . . 62.41 109.347 177.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 52.8 m -159.18 164.37 35.19 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.341 0.656 . . . . 65.03 111.365 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 92.3 p -145.91 155.23 42.73 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.008 0.923 . . . . 75.51 109.791 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -101.72 114.76 29.1 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.892 -0.781 . . . . 63.13 108.892 174.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.613 HD11 HD12 ' C' ' 83' ' ' ILE . 39.5 mt -94.06 -32.52 13.76 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.635 0.774 . . . . 74.11 110.456 -178.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.92 -170.2 1.3 Allowed 'General case' 0 C--O 1.247 0.924 0 C-N-CA 124.001 0.92 . . . . 71.14 110.219 -177.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.7 111.92 2.29 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.791 0.836 . . . . 73.31 109.417 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 69.3 -5.56 1.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 125.37 1.468 . . . . 73.54 112.88 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.19 94.87 5.11 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 106.935 -1.505 . . . . 75.33 106.935 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -114.0 124.36 51.94 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.72 -1.127 . . . . 74.33 108.442 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' C' ' 51' ' ' LEU . 36.2 tt0 -82.62 125.15 30.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.871 -0.788 . . . . 64.21 108.871 176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 97.0 t -97.99 118.52 44.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.669 -0.863 . . . . 73.34 108.669 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 72.5 t -102.9 127.76 56.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.715 0 N-CA-C 107.696 -1.224 . . . . 74.41 107.696 175.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -129.44 94.5 3.79 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 106.993 -1.484 . . . . 70.03 106.993 -173.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.47 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 13.9 ttm180 -82.67 121.69 27.17 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 115.717 -0.674 . . . . 70.31 109.211 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.437 ' HB ' HD11 ' C' ' 114' ' ' ILE . 18.3 t -115.72 117.63 56.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 107.735 -1.209 . . . . 42.14 107.735 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 41.1 m -110.35 137.76 47.63 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.259 -1.015 . . . . 73.43 108.259 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.493 HG21 HG21 ' C' ' 114' ' ' ILE . 97.8 t -120.64 109.93 26.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.332 -0.988 . . . . 71.41 108.332 170.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 32.2 m -99.55 140.64 33.43 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.863 -0.792 . . . . 73.23 108.863 171.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.64 97.28 3.23 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 106.975 -1.491 . . . . 72.55 106.975 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 48.9 m -141.64 146.25 35.96 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.169 0.588 . . . . 62.12 109.765 -176.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 5.7 mp -98.47 36.07 1.69 Allowed 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.664 1.186 . . . . 70.1 108.819 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.48 -111.75 3.25 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 110.059 -1.216 . . . . 60.24 110.059 -168.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -90.77 -19.6 23.31 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.773 0.829 . . . . 71.12 110.415 172.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -78.0 84.43 4.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.298 1.039 . . . . 71.23 109.712 178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 17.8 m -73.09 126.97 31.23 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 116.159 -0.473 . . . . 62.43 110.853 -174.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.631 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -74.48 -52.14 12.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.748 0.819 . . . . 53.22 109.039 173.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.426 ' HZ ' HG21 ' F' ' 296' ' ' THR . 55.8 p90 -170.56 175.68 4.6 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 114.128 -1.396 . . . . 72.32 109.237 173.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.463 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -143.96 144.62 31.77 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 106.991 -1.485 . . . . 75.24 106.991 178.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.463 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.2 t -148.47 150.01 32.69 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 108.814 -0.81 . . . . 62.3 108.814 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -158.28 133.53 8.67 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 122.953 0.501 . . . . 71.34 109.829 175.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 53.1 t -128.07 115.45 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 123.939 0.896 . . . . 65.3 109.044 172.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.612 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.4 mt-30 -90.39 90.49 8.06 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.426 -0.953 . . . . 65.33 108.426 173.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -80.12 116.61 20.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 114.541 -1.209 . . . . 62.4 110.364 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -100.98 149.56 18.48 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 112.065 -0.414 . . . . 50.43 112.065 177.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.503 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -147.22 117.64 0.94 Allowed Glycine 0 CA--C 1.504 -0.656 0 N-CA-C 110.53 -1.028 . . . . 75.43 110.53 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.613 HD12 HD11 ' C' ' 51' ' ' LEU . 15.7 mm -80.89 114.66 22.19 Favored 'Isoleucine or valine' 0 C--O 1.24 0.573 0 N-CA-C 107.963 -1.125 . . . . 72.14 107.963 177.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -126.66 147.54 49.92 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.87 0.468 . . . . 42.23 109.935 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.9 m -106.99 113.37 26.81 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 108.257 -1.016 . . . . 74.34 108.257 172.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 4.1 mp -114.24 106.18 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 107.969 -1.123 . . . . 74.42 107.969 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.577 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -123.35 170.27 10.49 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.977 0.911 . . . . 74.13 110.659 -176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.12 -60.16 1.97 Allowed Glycine 0 C--N 1.346 1.089 0 CA-C-N 116.103 -0.499 . . . . 74.24 113.031 173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.594 HD13 ' HA ' ' C' ' 94' ' ' MET . 1.3 pp -99.39 171.27 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.158 0.583 . . . . 63.43 111.966 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -148.93 -177.52 5.85 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.403 1.081 . . . . 73.15 109.026 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.46 -130.11 49.43 Favored Glycine 0 C--N 1.349 1.297 0 C-N-CA 123.758 0.694 . . . . 74.42 114.747 175.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 9.8 t -70.13 -25.99 63.73 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.215 1.006 . . . . 53.31 111.543 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.43 ' HG2' ' NE2' ' C' ' 143' ' ' GLN . 23.7 mt-30 -76.48 -31.36 57.71 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.325 0.65 . . . . 71.3 110.251 178.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.594 ' HA ' HD13 ' C' ' 89' ' ' ILE . 0.7 OUTLIER -74.06 -42.29 60.44 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 109.326 -0.62 . . . . 65.14 109.326 172.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' F' ' 280' ' ' LEU . . . -64.04 -24.94 67.9 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.181 0.926 . . . . 51.51 112.057 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 -69.88 -51.12 35.91 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 122.661 0.384 . . . . 75.52 110.412 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -71.28 -32.43 68.67 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.266 0.626 . . . . 44.15 111.438 -178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 52.3 tp -73.13 -53.83 10.03 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.087 0.955 . . . . 65.4 109.36 179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 -29.0 64.48 Favored Glycine 0 C--N 1.341 0.848 0 CA-C-N 114.506 -1.225 . . . . 41.14 114.118 -169.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -114.0 -45.65 3.06 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 117.461 0.63 . . . . 72.31 111.569 -168.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.422 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 22.0 t80 -76.36 -43.55 40.38 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 111.567 0.21 . . . . 61.21 111.567 -174.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -66.23 -45.69 61.13 Favored Pre-proline 0 CA--C 1.57 1.716 0 CA-C-O 118.446 -0.788 . . . . 74.11 112.913 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.38 -35.11 99.06 Favored 'Trans proline' 0 C--N 1.401 3.292 0 C-N-CA 122.316 2.011 . . . . 74.25 113.417 171.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -59.86 -36.17 76.32 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 124.005 0.922 . . . . 72.4 110.725 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.7 mm -74.76 -46.22 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 C-N-CA 123.506 0.722 . . . . 74.5 111.091 177.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.503 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.3 mt -78.7 -20.26 50.51 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.733 0.642 . . . . 72.34 112.733 -170.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.406 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 89.8 t80 -58.26 -52.68 72.82 Favored Pre-proline 0 CA--C 1.565 1.53 0 C-N-CA 124.5 1.12 . . . . 74.2 113.242 -175.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 33.0 Cg_exo -61.32 -37.09 75.47 Favored 'Trans proline' 0 C--N 1.392 2.856 0 C-N-CA 121.976 1.784 . . . . 73.14 112.964 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -68.58 -39.55 80.9 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.578 0.751 . . . . 73.44 111.682 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.08 -37.78 81.63 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.306 -0.406 . . . . 52.2 110.347 174.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 44.4 ttt180 -58.09 -63.26 1.32 Allowed 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 62.34 111.469 -175.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.27 -30.99 72.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 123.334 0.397 . . . . 43.44 110.524 -173.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.435 ' O ' ' SD ' ' C' ' 117' ' ' MET . 34.3 t -66.52 -41.26 89.07 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 123.334 0.654 . . . . 74.13 111.362 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.493 HG21 HG21 ' C' ' 64' ' ' VAL . 67.1 mt -65.49 -48.1 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 123.231 0.613 . . . . 70.41 110.041 173.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 26.2 m -60.77 -29.36 69.36 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.87 -1.059 . . . . 72.02 110.848 -176.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 35.0 t -68.81 -47.05 67.06 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 124.143 0.977 . . . . 74.01 110.356 174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.522 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.59 -45.19 89.61 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 123.327 0.651 . . . . 75.31 111.905 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.7 t -64.51 -39.05 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.493 0.717 . . . . 60.53 110.534 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.553 ' HB3' HE21 ' C' ' 125' ' ' GLN . 80.6 p -74.01 -29.24 61.84 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.749 -0.66 . . . . 74.14 112.144 -176.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.44 ' HD3' ' SG ' ' D' ' 113' ' ' CYS . 74.1 mtt-85 -75.44 -31.37 60.3 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.941 0.897 . . . . 72.12 110.75 178.004 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -74.09 -2.47 62.26 Favored Glycine 0 C--N 1.356 1.656 0 O-C-N 123.485 0.491 . . . . 65.32 112.427 169.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 27.9 p 63.74 27.93 14.78 Favored 'General case' 0 C--N 1.36 1.058 0 C-N-CA 126.692 1.997 . . . . 74.2 111.674 176.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -99.22 142.86 25.36 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 114.506 -1.225 . . . . 75.22 108.915 175.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.66 124.13 13.76 Favored 'Trans proline' 0 C--N 1.384 2.423 0 C-N-CA 123.248 2.632 . . . . 63.42 112.768 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.553 HE21 ' HB3' ' C' ' 119' ' ' SER . 97.7 mt-30 -59.84 154.6 18.11 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.27 1.211 . . . . 61.2 114.27 -172.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.5 tp -127.89 119.98 26.75 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 114.531 -1.213 . . . . 74.11 108.635 171.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -98.97 130.12 45.31 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.111 -1.07 . . . . 65.04 108.111 170.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.616 HD21 ' HG ' ' C' ' 42' ' ' LEU . 0.2 OUTLIER -74.85 128.21 35.02 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 109.446 -0.576 . . . . 61.32 109.446 -177.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.499 ' HB1' HG22 ' H' ' 306' ' ' VAL . . . -66.56 137.52 95.22 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.869 0.868 . . . . 44.2 110.708 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.498 ' HG2' HG21 ' H' ' 306' ' ' VAL . 10.0 Cg_endo -51.64 103.71 0.08 OUTLIER 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 123.38 2.72 . . . . 60.23 111.757 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 3.6 p -97.24 110.34 24.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 108.118 -1.067 . . . . 74.13 108.118 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.621 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 11.2 m120 -77.6 83.73 3.98 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 114.912 -1.04 . . . . 64.23 111.18 -176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.504 ' CZ ' ' HG3' ' F' ' 286' ' ' MET . 0.3 OUTLIER -69.9 -43.55 71.52 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.303 -1.317 . . . . 70.15 107.803 171.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.636 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 5.4 p-10 -54.39 -50.33 67.82 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 113.12 -1.855 . . . . 74.41 112.118 175.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.621 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -67.63 -35.26 78.58 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.384 0.673 . . . . 74.52 112.002 -171.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 56.3 tp -55.36 -43.93 75.52 Favored 'General case' 0 N--CA 1.48 1.062 0 O-C-N 124.112 0.883 . . . . 74.44 110.395 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -80.65 -18.6 47.56 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 115.098 -0.956 . . . . 72.3 112.329 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.402 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 67.1 mtt -75.24 -50.34 16.44 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 122.751 0.42 . . . . 73.52 110.692 178.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -70.76 -36.89 73.32 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 123.344 0.402 . . . . 73.02 111.048 -177.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -66.44 -84.36 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 123.632 0.773 . . . . 72.01 111.019 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.21 96.17 6.46 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 108.573 -0.899 . . . . 74.04 108.573 -177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -76.62 122.62 24.9 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.873 0.869 . . . . 45.35 110.079 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.43 ' NE2' ' HG2' ' C' ' 93' ' ' GLN . 96.9 mt-30 -126.13 174.55 8.41 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.371 1.069 . . . . 75.21 109.615 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 25.8 mp0 -69.19 122.17 18.27 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.543 -0.91 . . . . 74.0 108.543 175.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.37 90.83 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.136 0.974 . . . . 73.04 112.725 -169.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 126.03 117.84 2.19 Favored Glycine 0 C--N 1.348 1.205 0 CA-C-O 120.293 -0.171 . . . . 71.53 112.9 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -114.22 153.52 29.5 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.166 0.986 . . . . 74.21 109.17 173.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 169.54 37.37 0.03 OUTLIER Glycine 0 C--N 1.344 0.989 0 CA-C-O 120.109 -0.273 . . . . 65.42 112.621 175.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 89.0 m -75.32 95.79 3.26 Favored 'General case' 0 C--N 1.353 0.728 0 CA-C-O 121.507 0.67 . . . . 63.31 109.89 177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.37 148.55 51.84 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 124.422 1.089 . . . . 64.35 109.971 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -149.74 112.53 4.8 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 123.389 0.676 . . . . 71.24 109.576 174.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -132.77 118.84 19.54 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.523 -1.288 . . . . 74.33 107.523 168.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 22.6 tm0? -120.45 130.17 54.2 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 108.138 -1.06 . . . . 74.52 108.138 -177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -117.08 112.38 20.82 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 108.454 -0.943 . . . . 63.42 108.454 176.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 N-CA-C 108.306 -0.998 . . . . 65.1 108.306 174.04 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 64.4 mtt . . . . . 0 N--CA 1.48 1.04 0 N-CA-C 110.024 -0.362 . . . . 65.23 110.024 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 57.6 m -86.09 54.0 2.99 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.572 0.749 . . . . 73.14 110.916 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 50.6 mt-10 -138.11 176.96 8.25 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.242 1.017 . . . . 74.35 108.419 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -160.74 142.38 12.22 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 107.652 -1.24 . . . . 73.45 107.652 175.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -132.96 168.69 18.0 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 122.868 0.467 . . . . 54.31 111.476 -172.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -168.53 142.64 3.22 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.484 1.114 . . . . 63.33 108.607 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 15.1 p -86.04 -59.56 2.26 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.327 0.651 . . . . 64.35 110.018 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.78 -31.63 1.03 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.833 0.853 . . . . 74.21 109.9 172.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 7.9 ttp -33.87 134.29 0.17 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 125.126 1.37 . . . . 72.12 112.342 167.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 27.3 m -139.39 137.95 36.13 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.888 -0.782 . . . . 62.34 108.888 176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -164.57 91.7 0.59 Allowed 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.144 -1.428 . . . . 74.01 107.144 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -119.73 115.39 23.8 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.869 -0.789 . . . . 74.22 108.869 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.435 HG21 HD11 ' D' ' 16' ' ' ILE . 13.5 mt -74.94 122.95 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.473 -0.936 . . . . 73.25 108.473 177.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.455 ' HA ' HG11 ' F' ' 306' ' ' VAL . 74.8 mt-30 -88.51 -49.02 7.17 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 117.935 0.334 . . . . 74.11 110.559 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -156.43 147.33 21.98 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.629 0.772 . . . . 74.33 109.837 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.435 HD11 HG21 ' D' ' 13' ' ' ILE . 2.9 mp -117.81 122.82 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 105.582 -2.007 . . . . 72.32 105.582 161.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.483 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 32.8 p90 -152.23 162.08 41.66 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.926 0.869 . . . . 74.5 110.361 -171.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.9 p -90.02 114.64 26.54 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 114.184 -1.371 . . . . 63.51 109.424 178.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -82.69 -23.8 33.96 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.793 -0.64 . . . . 71.1 109.406 174.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.709 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 4.5 t70 -152.29 142.17 22.06 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 124.794 1.238 . . . . 65.11 109.11 178.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.522 HD13 ' HE3' ' C' ' 117' ' ' MET . 50.4 mt -138.69 142.13 35.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 125.187 1.395 . . . . 64.1 107.398 174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -157.74 103.8 1.92 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.225 0.61 . . . . 73.53 110.476 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.59 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -109.68 120.37 42.27 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 107.114 -1.439 . . . . 75.04 107.114 166.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -124.72 120.02 30.62 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.457 0.703 . . . . 75.32 109.454 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.81 82.39 5.06 Favored Pre-proline 0 CA--C 1.546 0.806 0 N-CA-C 108.0 -1.111 . . . . 64.42 108.0 173.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.65 -28.31 11.88 Favored 'Trans proline' 0 C--N 1.383 2.359 0 C-N-CA 122.536 2.157 . . . . 65.42 112.77 -171.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.532 ' ND2' ' HB ' ' D' ' 72' ' ' THR . 43.1 m-20 -116.52 40.85 2.8 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.21 1.004 . . . . 74.44 108.91 179.65 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.46 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -59.76 -68.99 0.6 Allowed Pre-proline 0 CA--C 1.565 1.547 0 CA-C-O 117.628 -1.177 . . . . 62.14 113.791 -170.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -74.26 -14.32 23.05 Favored 'Trans proline' 0 C--N 1.39 2.761 0 CA-C-N 123.144 2.159 . . . . 73.42 112.022 -179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -68.6 -43.48 76.34 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.004 1.322 . . . . 75.21 110.313 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.46 HG12 ' O ' ' D' ' 28' ' ' ALA . 6.6 p -72.73 -33.08 43.17 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.794 0 CA-C-O 119.136 -0.459 . . . . 61.32 110.245 -173.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -61.83 -4.52 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.4 0.889 . . . . 71.31 113.4 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -84.28 -38.63 20.21 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 123.636 0.774 . . . . 73.44 110.578 171.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 1.7 ptpt -128.58 61.0 1.49 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 124.374 1.07 . . . . 61.34 109.287 176.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' D' ' 31' ' ' VAL . 32.0 t0 -113.62 93.74 4.53 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.482 0.658 . . . . 60.31 110.858 -171.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.521 ' H ' HD11 ' D' ' 68' ' ' LEU . 40.3 m95 -126.09 -158.04 0.83 Allowed 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 106.636 -1.616 . . . . 71.31 106.636 -175.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' G' ' 297' ' ' TYR . 0.0 OUTLIER -57.05 112.95 5.23 Favored Pre-proline 0 CA--C 1.554 1.114 0 CA-C-N 119.34 0.973 . . . . 72.13 110.934 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.458 ' HD2' ' HB ' ' G' ' 296' ' ' THR . 54.2 Cg_endo -74.25 135.14 20.18 Favored 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 121.715 1.61 . . . . 71.25 111.338 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -64.98 113.31 3.78 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 107.089 -1.448 . . . . 62.13 107.089 165.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -104.9 142.64 17.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 C-N-CA 123.691 0.796 . . . . 55.44 110.42 -173.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -129.51 127.52 40.96 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.059 1.343 . . . . 61.12 108.006 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -97.43 111.87 23.95 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 106.721 -1.585 . . . . 55.42 106.721 -178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.79 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.3 m-20 -106.4 128.18 53.84 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 108.163 -1.051 . . . . 63.51 108.163 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -113.19 140.25 48.09 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.282 -0.636 . . . . 74.13 109.282 177.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.514 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 21.7 t70 -140.98 130.76 24.27 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.093 -1.077 . . . . 53.15 108.093 176.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 26.6 p -104.63 143.7 32.71 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.623 0.769 . . . . 65.52 110.808 -172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.678 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.77 151.87 30.98 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.632 0.773 . . . . 63.21 109.808 176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.7 p -157.08 157.72 35.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 122.976 0.51 . . . . 43.1 109.745 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 82.2 p -153.06 154.29 34.58 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 123.665 0.786 . . . . 44.34 109.336 174.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -97.1 121.12 38.63 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.078 -1.453 . . . . 74.53 107.078 164.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 82.0 mt -91.0 -30.05 17.02 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 122.77 0.428 . . . . 74.32 110.383 -178.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.73 -173.99 1.49 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.59 0.756 . . . . 73.44 111.008 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -65.0 123.93 20.75 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.929 -1.032 . . . . 72.32 108.995 173.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 66.86 10.89 7.95 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.575 1.15 . . . . 73.21 112.09 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.9 t -123.5 123.15 66.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 N-CA-C 109.151 -0.685 . . . . 61.31 109.151 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -133.68 149.61 51.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 123.801 0.84 . . . . 74.44 109.077 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -119.49 133.56 55.63 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 123.788 0.835 . . . . 75.34 109.733 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 66.8 t -110.49 112.63 41.37 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 N-CA-C 107.689 -1.226 . . . . 64.44 107.689 174.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.0 t -101.76 127.37 55.25 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 107.774 -1.195 . . . . 72.23 107.774 172.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 59.3 tp -124.15 111.63 16.13 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 108.85 -0.796 . . . . 74.54 108.85 175.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.72 ' HB2' ' HG2' ' D' ' 79' ' ' GLN . 16.3 ttp180 -84.74 108.25 17.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.054 -0.976 . . . . 75.32 109.481 174.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 45.2 t -98.42 129.44 48.69 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 N-CA-C 107.704 -1.221 . . . . 62.13 107.704 169.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.79 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 26.1 m -126.76 136.85 52.97 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.565 -0.902 . . . . 62.21 108.565 -179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.408 HG11 HD13 ' D' ' 126' ' ' LEU . 84.6 t -121.17 109.8 26.15 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 C-N-CA 123.926 0.891 . . . . 52.35 108.706 176.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.7 m -93.03 118.99 31.8 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 108.161 -1.051 . . . . 71.11 108.161 174.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -114.29 129.49 56.64 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.658 -0.497 . . . . 75.45 109.658 176.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 68.1 m -134.75 128.12 32.26 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.842 0.857 . . . . 61.15 109.677 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.521 HD11 ' H ' ' D' ' 36' ' ' TRP . 0.3 OUTLIER -92.04 92.38 8.25 Favored 'General case' 0 C--O 1.244 0.81 0 C-N-CA 123.019 0.528 . . . . 61.3 109.925 177.368 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.27 -125.48 10.74 Favored Glycine 0 C--N 1.341 0.846 0 CA-C-N 115.332 -0.849 . . . . 73.14 111.351 -178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -86.05 9.08 18.24 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.578 0.751 . . . . 74.15 111.334 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -115.82 155.18 28.34 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.931 0.892 . . . . 72.14 109.918 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . 0.532 ' HB ' ' ND2' ' D' ' 27' ' ' ASN . 94.1 m -82.32 136.21 35.06 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 109.556 -0.535 . . . . 74.4 109.556 168.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.433 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -87.59 -68.07 0.78 Allowed 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 108.821 -0.807 . . . . 74.51 108.821 172.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -155.43 167.65 29.69 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 114.401 -1.272 . . . . 64.22 109.974 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.0 mt -133.05 142.99 49.08 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.946 1.299 . . . . 64.43 107.65 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.54 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.0 t -145.66 136.24 24.23 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.37 -0.604 . . . . 65.43 109.37 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.18 134.9 11.76 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.147 0.579 . . . . 74.23 110.514 -176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.2 t -142.69 122.99 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 123.658 0.783 . . . . 63.32 109.759 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.72 ' HG2' ' HB2' ' D' ' 61' ' ' ARG . 50.1 mt-30 -89.04 89.45 7.98 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.763 -0.829 . . . . 71.51 108.763 168.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -82.62 96.63 8.16 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.965 -1.016 . . . . 72.53 109.158 -178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -88.65 142.46 17.15 Favored Glycine 0 C--N 1.341 0.838 0 N-CA-C 111.358 -0.697 . . . . 25.32 111.358 176.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.33 128.65 4.59 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 110.342 -1.103 . . . . 53.53 110.342 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 60.8 mt -90.73 128.23 42.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 N-CA-C 108.846 -0.798 . . . . 74.34 108.846 178.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.406 ' HD2' HG12 ' D' ' 13' ' ' ILE . 27.4 m-85 -133.96 124.82 26.98 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.304 0.642 . . . . 70.33 109.606 178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 15.2 m -77.4 93.94 4.16 Favored 'General case' 0 CA--C 1.551 1.008 0 N-CA-C 108.855 -0.794 . . . . 73.34 108.855 171.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.2 mt -109.11 125.94 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 C-N-CA 123.555 0.742 . . . . 72.32 110.359 -173.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.88 158.1 34.45 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.049 0.939 . . . . 71.44 109.924 177.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.97 -20.64 41.38 Favored Glycine 0 N--CA 1.472 1.082 0 CA-C-O 119.911 -0.383 . . . . 74.04 113.684 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 2.5 mp -104.08 142.24 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 108.561 -0.903 . . . . 52.41 108.561 178.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -136.69 156.59 48.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.285 0.634 . . . . 72.32 111.883 -174.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.61 -125.75 35.98 Favored Glycine 0 C--N 1.355 1.59 0 O-C-N 124.58 1.175 . . . . 75.33 115.055 166.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.3 p -67.33 -32.61 73.68 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.392 1.077 . . . . 71.52 112.127 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -79.68 -28.57 40.72 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.032 0.533 . . . . 75.22 110.499 -178.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.616 ' HG3' ' HB3' ' G' ' 277' ' ' LEU . 0.1 OUTLIER -77.55 -33.28 54.18 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.069 -0.715 . . . . 74.2 109.069 173.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.548 ' HB1' ' HB3' ' G' ' 280' ' ' LEU . . . -65.94 -30.91 71.57 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.828 0.851 . . . . 72.3 110.695 173.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 10.5 t60 -66.09 -52.24 50.57 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.621 0.768 . . . . 73.34 109.093 169.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.3 t -62.09 -35.27 78.19 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.849 0.46 . . . . 73.44 112.003 -176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' G' ' 281' ' ' PHE . 1.1 tm? -85.04 -40.33 16.96 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.046 0.938 . . . . 72.42 110.223 -173.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.13 11.72 58.69 Favored Glycine 0 C--N 1.346 1.11 0 CA-C-N 116.165 -0.47 . . . . 64.24 113.9 -173.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.5 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -144.44 -57.6 0.36 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.463 0.632 . . . . 70.14 112.073 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -73.66 -61.01 1.99 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 122.62 0.368 . . . . 75.15 111.287 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 62.2 m -56.04 -44.08 99.53 Favored Pre-proline 0 CA--C 1.566 1.566 0 C-N-CA 124.404 1.082 . . . . 64.53 113.758 -175.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.3 -40.47 68.08 Favored 'Trans proline' 0 C--N 1.4 3.242 0 C-N-CA 122.338 2.025 . . . . 74.35 112.691 173.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -68.4 -26.57 65.61 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.576 0.75 . . . . 71.33 111.494 -178.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.5 mm -69.52 -50.87 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.125 0 C-N-CA 122.948 0.499 . . . . 72.3 110.624 177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 4.0 pp -84.73 -12.89 52.84 Favored 'General case' 0 CA--C 1.548 0.868 0 CA-C-N 115.759 -0.655 . . . . 44.41 112.243 -173.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -62.24 -43.79 86.63 Favored Pre-proline 0 N--CA 1.486 1.355 0 C-N-CA 124.174 0.99 . . . . 63.31 113.635 -177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -53.67 -33.19 68.43 Favored 'Trans proline' 0 C--N 1.389 2.7 0 C-N-CA 122.197 1.932 . . . . 61.54 113.912 172.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -79.14 -35.58 41.87 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 123.432 0.693 . . . . 74.32 110.708 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.15 -47.97 82.18 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.439 0.696 . . . . 62.23 110.448 174.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.683 HH12 ' HB3' ' D' ' 130' ' ' PRO . 31.6 ttp180 -56.27 -50.37 71.56 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.322 -1.308 . . . . 53.22 110.627 175.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -65.17 -32.33 73.97 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 124.119 0.968 . . . . 74.21 111.501 -171.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.44 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 49.0 t -70.35 -44.98 67.04 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 122.962 0.505 . . . . 63.13 111.021 176.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.54 HG23 ' SG ' ' D' ' 76' ' ' CYS . 61.8 mt -56.9 -54.79 25.29 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 124.408 1.083 . . . . 72.21 110.826 174.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 33.0 m -53.77 -45.72 70.75 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.083 1.353 . . . . 74.12 111.677 -173.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 34.5 t -63.52 -43.39 97.31 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 114.429 -1.259 . . . . 64.13 110.842 -176.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.413 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 74.2 mtm -68.93 -36.04 77.51 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 122.879 0.472 . . . . 71.25 111.817 -178.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.448 HG23 ' O ' ' D' ' 114' ' ' ILE . 91.7 t -61.21 -45.14 99.18 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 CA-C-N 115.76 -0.654 . . . . 72.43 109.897 175.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -71.25 -28.2 64.0 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 123.116 0.566 . . . . 75.13 111.498 -179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' D' ' 116' ' ' SER . 88.0 mtt-85 -72.42 -28.69 63.12 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 123.709 0.804 . . . . 53.51 111.208 176.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.7 11.45 59.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-O 119.678 -0.512 . . . . 74.31 112.916 174.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.558 HG23 ' HB3' ' C' ' 17' ' ' TYR . 32.6 p 65.44 17.74 11.06 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 126.689 1.996 . . . . 62.03 113.215 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -93.52 159.39 35.1 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.197 0.999 . . . . 74.53 108.524 173.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.902 ' HG3' ' HA ' ' G' ' 297' ' ' TYR . 71.8 Cg_endo -67.86 127.6 16.42 Favored 'Trans proline' 0 C--N 1.369 1.622 0 C-N-CA 122.648 2.232 . . . . 75.43 111.342 -175.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -53.38 120.81 6.52 Favored 'General case' 0 CA--C 1.55 0.976 0 O-C-N 123.761 0.663 . . . . 52.55 110.483 177.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.408 HD13 HG11 ' D' ' 64' ' ' VAL . 5.1 tt -104.04 102.52 12.28 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 107.427 -1.323 . . . . 62.24 107.427 -170.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -94.84 85.09 4.32 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.195 -1.039 . . . . 72.24 108.195 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.538 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 33.0 tp -61.25 123.19 17.02 Favored 'General case' 0 C--N 1.351 0.648 0 CA-C-N 113.377 -1.738 . . . . 71.55 111.347 -175.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -59.85 133.13 89.46 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 123.919 0.888 . . . . 64.13 111.645 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.683 ' HB3' HH12 ' D' ' 111' ' ' ARG . 90.3 Cg_endo -82.86 134.23 7.14 Favored 'Trans proline' 0 C--N 1.38 2.189 0 C-N-CA 122.292 1.995 . . . . 74.25 112.478 -169.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.428 HG22 HD11 ' G' ' 291' ' ' LEU . 44.3 t -108.04 110.06 30.53 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 108.466 -0.939 . . . . 74.41 108.466 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 50.8 t30 -89.6 93.49 9.5 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 109.113 -0.699 . . . . 62.0 109.113 177.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.5 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 76.4 m-85 -65.86 -30.5 71.12 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 115.242 -0.89 . . . . 72.44 110.479 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.439 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 7.4 t70 -58.6 -42.22 87.62 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.103 0.961 . . . . 71.01 110.284 -178.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.495 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -60.55 -46.57 89.71 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.717 -1.128 . . . . 41.05 111.25 175.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 72.7 mt -56.62 -47.59 79.33 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 123.819 0.699 . . . . 75.32 111.593 -177.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -69.29 -39.58 78.24 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 122.904 0.482 . . . . 71.24 112.085 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 18.5 ptp -73.74 -29.74 62.41 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 117.839 0.29 . . . . 75.02 111.283 -177.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -75.33 -9.59 58.69 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.083 0.953 . . . . 65.24 111.781 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -65.07 -38.78 91.91 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 109.474 -0.565 . . . . 70.02 109.474 164.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 6.3 mp -83.39 -55.64 4.2 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.934 0.894 . . . . 73.41 112.297 -177.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -91.93 35.98 0.97 Allowed 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 114.266 1.21 . . . . 74.13 114.266 -162.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.1 mm-40 -117.64 75.49 0.99 Allowed 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 122.0 0.905 . . . . 63.44 109.345 177.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -160.46 19.34 0.14 Allowed 'General case' 0 CA--C 1.559 1.292 0 CA-C-N 113.921 -1.49 . . . . 65.21 109.263 -177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -136.3 108.29 7.16 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.775 0.83 . . . . 53.41 110.43 -178.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.0 106.77 1.48 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 109.932 -1.267 . . . . 23.32 109.932 173.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -118.87 -84.08 0.65 Allowed 'General case' 0 N--CA 1.48 1.07 0 CA-C-N 117.201 0.501 . . . . 74.13 111.773 -170.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -107.71 89.28 0.57 Allowed Glycine 0 C--N 1.35 1.334 0 CA-C-N 116.346 -0.388 . . . . 73.14 112.841 -166.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.9 t -155.8 93.77 1.49 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-O 121.867 0.841 . . . . 60.44 110.017 176.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -165.45 -31.27 0.03 OUTLIER 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.299 -0.864 . . . . 65.1 111.065 -178.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -97.84 48.52 1.01 Allowed 'General case' 0 N--CA 1.478 0.938 0 CA-C-O 121.386 0.612 . . . . 72.25 109.933 -179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -73.42 100.52 3.24 Favored 'General case' 0 C--N 1.347 0.486 0 CA-C-N 115.196 -0.911 . . . . 61.22 108.733 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 21.4 mm-40 -59.3 136.87 58.1 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.043 0.937 . . . . 63.34 110.759 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -62.48 -43.26 99.25 Favored 'General case' 0 N--CA 1.479 0.984 0 O-C-N 123.961 0.788 . . . . 71.21 109.998 176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.23 0 CA-C-N 114.602 -1.181 . . . . 54.14 107.909 176.312 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 109.947 -0.39 . . . . 73.4 109.947 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 49.5 t30 65.48 -76.05 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 125.417 1.487 . . . . 61.02 111.507 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 60.76 75.43 0.41 Allowed 'General case' 0 C--N 1.356 0.867 0 C-N-CA 124.945 1.298 . . . . 74.13 110.845 -176.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -103.2 128.44 50.17 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.827 -1.175 . . . . 64.42 107.827 170.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 47.9 mttp -80.03 167.09 36.12 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.787 0.835 . . . . 73.11 109.949 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.57 143.83 97.86 Favored 'Trans proline' 0 C--N 1.378 2.114 0 C-N-CA 121.776 1.651 . . . . 71.43 109.885 164.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 7.9 mp -71.51 -177.44 1.84 Allowed 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.778 0.431 . . . . 41.15 110.681 -178.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . 0.514 HD23 ' HE1' ' A' ' 94' ' ' MET . 40.1 mt 75.88 -172.07 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 125.675 1.59 . . . . 73.53 110.022 -174.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . 125.65 -49.67 0.9 Allowed Glycine 0 C--N 1.346 1.093 0 N-CA-C 111.558 -0.617 . . . . 64.33 111.558 176.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.496 ' H ' HD23 ' E' ' 280' ' ' LEU . 2.2 pt? -121.08 125.14 46.52 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.584 0.753 . . . . 61.33 109.369 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -172.7 48.33 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.48 1.112 . . . . 73.4 108.531 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -132.77 172.19 12.89 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-N 115.015 -0.993 . . . . 73.44 110.325 -178.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 28.1 t70 67.27 131.1 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 125.47 1.508 . . . . 74.54 111.25 -179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -59.73 107.16 1.17 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 111.358 -0.697 . . . . 70.34 111.358 175.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . 0.463 ' HB2' ' SD ' ' E' ' 286' ' ' MET . 14.3 m120 -62.81 -35.54 80.24 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.046 0.938 . . . . 74.32 111.306 -176.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' E' ' 285' ' ' ASN . 0.0 OUTLIER -143.73 134.89 12.55 Favored Pre-proline 0 CA--C 1.546 0.821 0 C-N-CA 124.457 1.103 . . . . 75.51 108.861 174.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -71.53 92.95 0.67 Allowed 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.474 2.116 . . . . 73.3 110.394 174.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 96.8 t -63.17 -55.81 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 115.113 -0.949 . . . . 61.52 110.614 -177.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 56.92 -83.68 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.915 1.286 . . . . 73.32 110.292 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -168.83 155.28 6.88 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.333 1.853 . . . . 74.43 107.846 178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.625 HD13 ' HB3' ' A' ' 129' ' ' ALA . 5.5 mp -106.22 119.9 40.45 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 122.794 0.438 . . . . 73.14 110.007 -175.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.48 162.45 33.19 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-N 115.517 -0.765 . . . . 64.34 111.475 -169.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.29 83.91 1.2 Allowed 'Trans proline' 0 C--N 1.368 1.554 0 C-N-CA 122.355 2.037 . . . . 65.41 111.153 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt 62.09 107.59 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.31 1.444 . . . . 63.45 110.448 -174.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -100.29 -1.01 37.37 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.179 0.807 . . . . 55.52 113.179 -173.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 40.8 m -147.46 142.79 27.35 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.643 0.377 . . . . 64.32 110.887 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 1.1 t80 71.29 95.38 0.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.022 1.329 . . . . 74.52 110.296 168.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -131.7 -43.09 1.01 Allowed 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 123.103 0.561 . . . . 75.33 111.236 -176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -154.65 62.53 0.36 Allowed Glycine 0 C--N 1.339 0.702 0 N-CA-C 110.631 -0.988 . . . . 71.22 110.631 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . 0.405 HD21 ' HB2' ' G' ' 302' ' ' ASP . 17.1 m120 -125.68 166.03 17.51 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.548 0.739 . . . . 74.14 111.085 -170.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 68.4 mt 70.97 138.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 C-N-CA 125.638 1.575 . . . . 75.31 111.301 178.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . 0.571 ' HB3' ' HB3' ' G' ' 298' ' ' HIS . 38.6 t70 -153.2 169.55 22.73 Favored 'General case' 0 C--O 1.244 0.805 0 C-N-CA 122.748 0.419 . . . . 65.43 110.094 178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . 0.566 ' HD2' ' H ' ' E' ' 303' ' ' LYS . 10.3 mptt -60.08 141.14 90.45 Favored Pre-proline 0 N--CA 1.477 0.914 0 C-N-CA 125.361 1.464 . . . . 73.12 110.665 -176.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -67.48 -51.59 0.7 Allowed 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.347 2.032 . . . . 71.34 112.611 -177.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . 46.84 67.95 0.7 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.123 1.369 . . . . 62.15 112.057 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 21.3 t -112.3 28.62 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 CA-C-O 122.778 1.275 . . . . 72.54 108.484 177.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 31.3 p -73.66 87.01 1.66 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.541 -1.209 . . . . 74.13 109.293 170.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 26.7 p -157.72 -22.1 0.09 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 115.145 -0.934 . . . . 65.25 110.79 -171.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . 0.542 HG22 HD13 ' G' ' 291' ' ' LEU . 17.0 p -66.8 151.31 96.92 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.034 1.334 . . . . 64.42 111.797 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo . . . . . 0 C--N 1.378 2.122 0 C-N-CA 123.507 2.805 . . . . 74.43 112.874 176.129 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.896 0 N-CA-C 110.035 -0.358 . . . . 71.02 110.035 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -66.52 132.5 48.37 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.738 0.815 . . . . 64.33 110.946 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -108.3 157.66 18.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.868 0.867 . . . . 64.34 109.385 173.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 51.3 mt-30 -119.42 -55.57 2.12 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.469 0.707 . . . . 63.42 110.635 177.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -159.35 87.05 2.13 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 123.496 0.718 . . . . 74.5 109.432 -170.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -89.28 141.67 4.17 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 122.469 2.113 . . . . 74.12 112.324 173.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . 0.519 ' HB3' ' HG3' ' C' ' 94' ' ' MET . 6.2 mp -70.19 -24.42 63.12 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 123.66 0.784 . . . . 74.13 109.097 170.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 50.0 tp -62.37 123.07 17.28 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.346 1.458 . . . . 74.53 110.813 173.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -177.89 90.74 0.08 OUTLIER Glycine 0 C--N 1.351 1.411 0 O-C-N 123.35 0.406 . . . . 63.31 113.169 177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . 0.48 HD12 ' HB1' ' C' ' 95' ' ' ALA . 6.8 tt -171.49 -58.31 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.395 -0.965 . . . . 62.11 108.395 172.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -71.35 86.36 0.82 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.294 -0.867 . . . . 73.44 111.729 -174.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -169.34 -61.22 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.493 -1.299 . . . . 75.54 107.493 177.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -95.76 -34.66 11.83 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 115.051 -0.977 . . . . 54.42 110.262 174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -81.05 71.0 2.97 Favored Glycine 0 C--N 1.352 1.44 0 O-C-N 123.641 0.588 . . . . 55.35 112.945 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . 0.644 HD22 ' HA ' ' C' ' 45' ' ' ASP . 10.8 m120 -68.64 -41.85 78.82 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.447 1.099 . . . . 73.43 111.489 179.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . 0.504 ' HG3' ' CZ ' ' C' ' 133' ' ' PHE . 20.3 mmt 60.39 89.23 0.11 Allowed Pre-proline 0 N--CA 1.481 1.097 0 C-N-CA 124.705 1.202 . . . . 73.31 109.124 -167.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.02 84.31 0.25 Allowed 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 122.966 2.444 . . . . 75.32 112.516 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 59.6 t -86.05 120.88 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 N-CA-C 107.878 -1.156 . . . . 62.35 107.878 175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -123.56 175.94 6.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.109 0.964 . . . . 75.23 108.739 -175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . 0.501 ' HB2' ' HA ' ' C' ' 41' ' ' LYS . 2.0 t-105 -55.84 130.64 44.37 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.128 0.971 . . . . 74.33 111.556 -178.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 86.1 mt -78.07 -0.28 27.42 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 113.424 0.898 . . . . 71.11 113.424 -165.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 169.01 -134.61 3.27 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.395 -0.67 . . . . 42.52 112.446 178.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -87.64 -161.9 0.13 Allowed 'Trans proline' 0 C--N 1.375 1.961 0 C-N-CA 123.443 2.762 . . . . 74.31 112.406 178.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 11.3 mptt 76.2 164.37 0.25 Allowed 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.035 1.334 . . . . 63.33 112.419 176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . 0.452 ' HB1' ' HD2' ' C' ' 38' ' ' PRO . . . -158.42 173.1 17.16 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 114.997 -1.001 . . . . 64.23 110.132 -175.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . 0.651 ' H ' HG21 ' C' ' 40' ' ' VAL . 40.5 p -66.04 -52.99 44.05 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.753 0.821 . . . . 61.23 110.748 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 5.8 m-30 -77.01 82.62 3.53 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 107.905 -1.146 . . . . 62.55 107.905 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 18.0 t60 -75.07 -46.14 36.74 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.184 0.594 . . . . 72.53 110.831 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 178.63 -52.64 0.09 OUTLIER Glycine 0 C--N 1.344 0.995 0 CA-C-N 115.969 -0.559 . . . . 63.11 112.572 -179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -81.61 82.14 7.46 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.482 0.658 . . . . 72.22 111.13 -175.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 6.1 tt -167.52 118.22 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.596 0 C-N-CA 125.493 1.517 . . . . 73.1 107.042 169.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -134.57 -79.13 0.45 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.418 0.687 . . . . 64.05 109.441 -176.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -116.98 152.67 48.99 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.994 0.918 . . . . 65.4 109.528 176.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -73.5 109.27 2.81 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.171 1.914 . . . . 54.02 111.853 176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . 0.548 ' HB3' ' HA ' ' H' ' 293' ' ' PRO . . . -75.33 93.52 2.9 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.177 -1.046 . . . . 73.55 108.177 169.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . 0.455 HG11 ' HA ' ' D' ' 14' ' ' GLN . 3.4 p -134.52 -29.15 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 124.436 1.094 . . . . 64.35 109.567 -173.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 40.1 p -88.9 28.02 1.24 Allowed 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 124.36 1.064 . . . . 73.24 111.336 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 76.0 m -89.28 13.48 13.33 Favored 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 124.099 0.96 . . . . 55.55 110.401 170.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 16.7 p -64.49 147.62 97.26 Favored Pre-proline 0 CA--C 1.559 1.319 0 C-N-CA 125.108 1.363 . . . . 73.15 112.56 -179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.39 2.747 0 C-N-CA 124.547 3.498 . . . . 74.12 114.409 -178.851 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.095 0 N-CA-C 110.544 -0.169 . . . . 44.15 110.544 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -85.76 120.86 27.65 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 109.223 -0.658 . . . . 73.3 109.223 178.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -158.81 90.94 1.02 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.546 0.738 . . . . 75.51 109.963 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -85.26 64.06 8.45 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.388 0.613 . . . . 62.14 110.122 -178.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt -91.14 146.4 33.49 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 123.542 0.737 . . . . 63.42 110.01 -178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -68.66 87.99 0.43 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 122.764 2.31 . . . . 71.22 110.067 173.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.616 ' HB3' ' HG3' ' D' ' 94' ' ' MET . 71.6 mt -59.93 -48.17 82.8 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.486 0.714 . . . . 74.23 111.164 -174.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 1.8 pp -86.59 173.47 9.53 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.586 -0.734 . . . . 71.11 110.917 174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 171.39 -57.13 0.18 Allowed Glycine 0 C--N 1.344 1.007 0 N-CA-C 110.845 -0.902 . . . . 74.31 110.845 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.548 ' HB3' ' HB1' ' D' ' 95' ' ' ALA . 7.2 tt -76.38 113.05 13.53 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 108.672 -0.862 . . . . 71.35 108.672 175.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . 0.462 ' HB2' HD12 ' D' ' 98' ' ' LEU . 39.2 t80 -170.92 -60.18 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.319 1.048 . . . . 64.24 108.328 175.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -97.66 25.55 5.73 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 114.888 -1.051 . . . . 50.0 109.306 172.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -123.29 138.23 54.67 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.997 0.919 . . . . 62.12 109.417 -171.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 73.87 -110.87 3.24 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 111.269 -0.732 . . . . 75.45 111.269 -174.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -165.69 134.55 3.22 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.996 0.918 . . . . 55.4 109.739 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 96.5 mmm -123.51 80.64 54.14 Favored Pre-proline 0 N--CA 1.482 1.13 0 C-N-CA 124.463 1.105 . . . . 62.33 108.461 173.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -88.27 125.78 1.88 Allowed 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.022 2.481 . . . . 72.44 113.627 -173.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.82 -26.43 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 124.111 0.964 . . . . 70.41 109.959 175.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 60.17 -88.8 0.02 OUTLIER 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 125.461 1.504 . . . . 75.23 109.986 -171.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -177.6 124.11 0.13 Allowed 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 105.456 -2.053 . . . . 72.02 105.456 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.542 HD13 HG22 ' E' ' 309' ' ' THR . 89.7 mt -66.59 -50.37 63.28 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 122.564 0.346 . . . . 64.24 110.61 -178.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -156.58 99.28 0.18 Allowed Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.369 -0.684 . . . . 72.52 112.208 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -83.94 -177.73 3.21 Favored 'Trans proline' 0 C--N 1.374 1.891 0 C-N-CA 122.75 2.3 . . . . 74.45 111.367 172.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 95.9 mttt 69.04 168.34 0.29 Allowed 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.842 1.257 . . . . 65.22 112.242 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . 58.88 9.65 1.27 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.375 1.47 . . . . 61.0 112.715 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . 0.458 ' HB ' ' HD2' ' D' ' 38' ' ' PRO . 26.5 m -62.57 -24.52 67.59 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.383 1.073 . . . . 74.04 113.327 -163.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.902 ' HA ' ' HG3' ' D' ' 124' ' ' PRO . 2.5 t80 -74.6 -75.53 0.16 Allowed 'General case' 0 C--N 1.359 0.993 0 CA-C-N 117.921 0.328 . . . . 75.23 110.789 -175.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . 0.571 ' HB3' ' HB3' ' E' ' 302' ' ' ASP . 78.7 m-70 73.46 -53.96 0.69 Allowed 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 124.794 1.238 . . . . 54.05 113.089 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -64.63 -33.68 87.89 Favored Glycine 0 C--N 1.355 1.594 0 N-CA-C 116.006 1.162 . . . . 75.04 116.006 -168.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . 0.468 ' H ' ' HD1' ' G' ' 297' ' ' TYR . 49.6 t30 66.32 149.07 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 124.823 1.249 . . . . 63.02 112.769 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.536 HG23 HH12 ' C' ' 15' ' ' ARG . 2.8 mp -77.12 125.39 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 123.919 0.887 . . . . 74.21 109.37 177.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . 0.405 ' HB2' HD21 ' E' ' 300' ' ' ASN . 12.2 t70 -96.98 145.5 25.87 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.275 -0.639 . . . . 74.24 109.275 170.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . 0.422 ' HD2' ' N ' ' G' ' 303' ' ' LYS . 0.1 OUTLIER -103.44 122.16 45.98 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 123.837 0.855 . . . . 61.2 108.871 -175.413 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.64 113.58 3.22 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.641 2.227 . . . . 62.02 111.26 176.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -81.82 22.72 0.73 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.778 0.831 . . . . 74.11 111.695 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 22.6 m -67.07 84.66 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.556 1.208 0 C-N-CA 124.728 1.211 . . . . 73.23 110.987 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 28.8 m -82.72 100.42 10.24 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.369 -0.832 . . . . 75.4 110.253 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 59.6 m 63.67 87.73 0.11 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.871 1.268 . . . . 70.32 111.698 176.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 8.4 t -134.21 101.21 12.47 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 123.629 0.772 . . . . 60.32 109.51 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo . . . . . 0 C--N 1.383 2.367 0 C-N-CA 123.481 2.787 . . . . 71.2 112.69 -175.764 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.893 -0.41 . . . . 73.44 109.893 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -168.88 126.84 1.02 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.838 0.855 . . . . 71.53 109.896 -178.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -84.08 171.89 12.48 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 123.852 0.861 . . . . 61.44 109.594 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -59.09 -78.29 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.092 0.557 . . . . 70.33 109.953 -175.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 47.8 tttt 178.03 149.28 0.38 Allowed Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.163 0.985 . . . . 73.43 108.633 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -49.48 170.27 0.1 OUTLIER 'Trans proline' 0 C--N 1.388 2.632 0 C-N-CA 123.853 3.035 . . . . 62.25 115.245 170.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 8.4 tt -57.68 -53.09 62.08 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.787 1.235 . . . . 74.54 109.621 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 22.6 tp -89.51 52.1 2.26 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 108.405 -0.961 . . . . 71.21 108.405 176.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -83.49 56.02 5.04 Favored Glycine 0 C--N 1.352 1.428 0 CA-C-N 115.182 -0.917 . . . . 71.34 111.784 178.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 34.0 tp 165.55 161.97 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.867 2.067 . . . . 65.41 105.915 -169.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 1.6 t80 79.95 -49.83 0.36 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 124.692 1.197 . . . . 71.21 111.76 168.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.74 -25.24 67.85 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 109.202 -0.666 . . . . 73.34 109.202 159.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -135.99 120.44 18.1 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 107.696 -1.224 . . . . 62.01 107.696 167.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 169.97 78.44 0.04 OUTLIER Glycine 0 C--O 1.243 0.677 0 O-C-N 121.873 -0.517 . . . . 72.1 111.847 -174.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.22 130.1 42.07 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.881 0.872 . . . . 60.2 110.09 177.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 14.9 ptp -139.38 125.38 12.16 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 123.441 0.696 . . . . 72.51 110.423 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -79.08 123.54 5.7 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.636 2.224 . . . . 34.44 111.524 176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 61.0 t -76.62 -53.51 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 CA-C-N 115.928 -0.578 . . . . 74.43 109.619 178.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 16.2 tpt180 69.48 153.96 0.11 Allowed 'General case' 0 N--CA 1.481 1.095 0 O-C-N 124.689 1.243 . . . . 73.33 110.265 -172.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . 0.633 ' HH2' HD11 ' B' ' 126' ' ' LEU . 0.0 OUTLIER -74.97 76.17 2.19 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 108.252 -1.018 . . . . 74.42 108.252 177.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.466 HD11 HG22 ' B' ' 131' ' ' VAL . 2.3 pp -91.73 -11.06 37.85 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.289 -0.869 . . . . 71.05 112.47 -172.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' B' ' 129' ' ' ALA . . . -97.51 -166.29 32.24 Favored Glycine 0 C--N 1.343 0.955 0 O-C-N 123.525 0.516 . . . . 32.42 114.295 -174.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . 0.548 ' HA ' ' HB3' ' F' ' 305' ' ' ALA . 46.1 Cg_endo -68.12 100.84 0.66 Allowed 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.03 2.487 . . . . 74.4 111.872 -178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 50.7 mtmt -77.54 57.68 1.62 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.352 1.061 . . . . 72.22 110.015 177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -160.04 35.55 0.18 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.878 1.271 . . . . 73.42 108.766 -171.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . 0.517 HG23 ' HB2' ' B' ' 126' ' ' LEU . 36.8 m -45.87 -50.77 14.0 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.67 1.588 . . . . 51.31 111.786 -177.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.582 ' HE1' ' HB ' ' H' ' 301' ' ' ILE . 0.3 OUTLIER -81.06 91.53 6.11 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.032 -0.985 . . . . 74.24 108.597 177.118 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -79.62 14.72 1.55 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.047 0.939 . . . . 71.44 112.327 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 93.82 -4.83 72.45 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-O 119.625 -0.542 . . . . 62.13 113.088 178.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' B' ' 124' ' ' PRO . 1.8 m-20 -73.99 92.46 2.13 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-O 121.443 0.64 . . . . 73.15 109.291 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . 0.582 ' HB ' ' HE1' ' H' ' 297' ' ' TYR . 13.1 tt -149.58 132.46 6.88 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 C-N-CA 124.492 1.117 . . . . 74.23 108.593 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . 0.524 ' HB2' HH12 ' A' ' 15' ' ' ARG . 3.0 m-20 -119.81 129.3 54.38 Favored 'General case' 0 C--O 1.241 0.647 0 N-CA-C 109.104 -0.702 . . . . 73.01 109.104 -171.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . 0.585 ' HG2' ' HZ ' ' B' ' 32' ' ' PHE . 40.1 mtmt -78.68 -51.39 1.44 Allowed Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 123.208 0.603 . . . . 63.13 110.712 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' H' ' 303' ' ' LYS . 33.3 Cg_endo -93.4 -21.08 0.38 Allowed 'Trans proline' 0 C--N 1.391 2.77 0 C-N-CA 121.916 1.744 . . . . 60.22 113.181 170.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . 0.563 ' HB2' HH11 ' A' ' 15' ' ' ARG . . . 52.49 -80.36 0.01 OUTLIER 'General case' 0 C--N 1.363 1.155 0 C-N-CA 125.608 1.563 . . . . 51.31 111.771 -166.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . 0.499 HG22 ' HB1' ' C' ' 129' ' ' ALA . 18.6 t -88.16 98.27 7.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 108.177 -1.046 . . . . 74.32 108.177 176.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 68.8 m -55.56 -58.61 7.07 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.164 0.985 . . . . 60.54 110.586 176.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 30.6 t -172.24 165.92 5.96 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.474 1.11 . . . . 74.54 109.277 175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 68.7 p -126.99 152.95 76.35 Favored Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 124.002 0.921 . . . . 74.24 109.871 178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo . . . . . 0 C--N 1.379 2.141 0 C-N-CA 122.762 2.308 . . . . 74.3 111.85 173.102 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 109.174 -0.676 . . . . 74.21 109.174 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.8 m -116.8 9.48 13.93 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.852 0.861 . . . . 64.21 113.01 -170.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.35 -55.29 8.28 Favored 'General case' 0 N--CA 1.483 1.2 0 CA-C-O 119.296 -0.383 . . . . 73.33 110.802 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 59.35 116.63 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 125.148 1.379 . . . . 71.1 112.987 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -109.67 -62.81 1.44 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.176 0.59 . . . . 72.34 109.751 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 14.0 t30 -173.03 155.64 3.08 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.857 0.863 . . . . 64.31 109.319 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.7 m -138.63 159.99 40.71 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.301 0.64 . . . . 72.04 109.642 177.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -62.02 -39.05 90.96 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.138 0.975 . . . . 62.32 111.076 -178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 58.1 mtm 71.18 144.73 0.06 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.619 1.568 . . . . 74.31 111.639 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 78.8 m -140.95 135.4 31.18 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.823 0.849 . . . . 73.12 109.762 -177.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.596 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.9 t80 -138.35 133.27 32.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.617 0.767 . . . . 74.23 109.954 170.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 45.9 tp60 -160.58 116.32 2.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.813 0.845 . . . . 74.34 109.975 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.576 HG12 ' HD2' ' A' ' 84' ' ' PHE . 36.0 mt -76.17 125.68 36.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 109.536 -0.542 . . . . 70.51 109.536 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -97.3 -33.69 11.35 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.078 0.551 . . . . 74.12 111.13 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -172.24 128.41 0.57 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 110.079 -0.341 . . . . 74.33 110.079 -171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.2 pp -121.79 126.9 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 123.664 0.785 . . . . 74.34 109.852 177.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' CE2' ' HB1' ' B' ' 28' ' ' ALA . 48.4 p90 -164.19 153.71 14.06 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.311 0.645 . . . . 72.22 111.202 -169.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.55 111.02 12.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.966 -1.015 . . . . 72.24 109.533 176.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.409 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 37.1 mtpt -76.43 -28.38 56.59 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 116.189 -0.459 . . . . 52.44 110.912 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 23.3 t70 -151.99 142.38 22.52 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.006 -0.997 . . . . 74.3 109.528 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.8 mt -135.24 141.47 42.59 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 125.276 1.43 . . . . 45.12 107.293 174.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -149.78 130.4 14.01 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 108.966 -0.753 . . . . 72.44 108.966 175.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -133.5 120.48 20.88 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 106.482 -1.673 . . . . 62.32 106.482 173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.1 114.29 20.7 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 122.773 0.429 . . . . 75.11 110.592 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -129.19 70.3 81.6 Favored Pre-proline 0 C--O 1.243 0.738 0 N-CA-C 107.09 -1.448 . . . . 62.53 107.09 165.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -78.37 -3.56 13.48 Favored 'Trans proline' 0 C--N 1.379 2.182 0 C-N-CA 122.246 1.964 . . . . 71.42 111.573 -175.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -119.86 17.06 12.65 Favored 'General case' 0 C--N 1.348 0.516 0 C-N-CA 124.417 1.087 . . . . 62.41 109.317 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -43.98 -58.84 4.24 Favored Pre-proline 0 CA--C 1.573 1.839 0 CA-C-O 117.801 -1.095 . . . . 44.23 113.818 -167.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -63.31 -25.71 71.6 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.376 2.051 . . . . 74.13 112.432 -178.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -77.94 -48.1 17.08 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.5 -0.773 . . . . 72.1 109.914 -178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.421 ' HA ' ' HG2' ' A' ' 34' ' ' LYS . 6.2 p -77.29 -10.57 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-N 115.731 -0.668 . . . . 75.35 112.151 -163.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.462 ' HA ' HD11 ' E' ' 301' ' ' ILE . 22.5 m-85 -72.62 -18.23 61.61 Favored 'General case' 0 CA--C 1.555 1.138 0 C-N-CA 123.159 0.583 . . . . 74.11 112.392 176.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -102.27 -8.54 21.17 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.339 0.866 . . . . 74.44 113.339 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HD2' ' HB3' ' A' ' 71' ' ' GLU . 8.7 mmpt? -55.11 164.07 0.95 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.13 1.159 . . . . 72.11 114.13 -175.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -63.4 133.69 54.44 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 114.699 -1.137 . . . . 61.13 109.498 175.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -77.57 73.99 4.13 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.631 0.772 . . . . 74.53 111.791 -169.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 22.4 pt20 -139.66 79.05 24.9 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 124.299 1.039 . . . . 73.42 108.993 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.02 114.89 4.16 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.042 1.828 . . . . 70.21 111.867 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -93.22 83.96 4.72 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 106.333 -1.729 . . . . 75.1 106.333 173.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 65' ' ' THR . 39.8 t -98.08 102.69 13.76 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 113.983 -1.462 . . . . 60.35 108.441 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.12 144.19 32.26 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.85 0.86 . . . . 74.41 110.41 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 tt -97.51 111.65 23.83 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 107.167 -1.42 . . . . 62.24 107.167 171.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.674 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.2 m-20 -102.9 112.49 25.33 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.86 -1.163 . . . . 71.44 107.86 175.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.8 tt -110.05 129.09 55.74 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 122.588 0.355 . . . . 75.25 110.339 -175.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -139.51 145.35 38.62 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.659 1.183 . . . . 71.25 108.583 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.1 p -136.64 153.22 50.98 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.265 0.626 . . . . 72.02 110.828 -178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.54 ' HA ' ' HB2' ' E' ' 282' ' ' ALA . . . -141.84 153.26 44.36 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.512 1.125 . . . . 71.51 110.423 -178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 17.3 p -119.47 172.46 7.62 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.709 0.804 . . . . 70.0 109.231 168.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.549 ' HB3' ' HB3' ' A' ' 57' ' ' GLU . 42.4 t -160.86 144.78 13.54 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.862 0.865 . . . . 74.33 109.467 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -114.82 109.79 18.71 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.292 -0.633 . . . . 74.4 109.292 171.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 23.1 mt -82.4 -40.32 21.45 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.529 0.732 . . . . 71.24 109.722 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.01 -178.12 7.13 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.682 1.193 . . . . 64.25 109.073 174.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -70.14 121.55 17.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 109.267 -0.642 . . . . 75.03 109.267 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 72.02 -8.5 1.12 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 125.904 1.682 . . . . 73.21 112.879 -171.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 52.0 t -101.05 103.42 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 N-CA-C 108.135 -1.061 . . . . 42.42 108.135 175.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -121.08 163.56 18.17 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.232 -0.894 . . . . 72.01 108.615 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HB3' ' HB3' ' A' ' 49' ' ' SER . 29.2 tt0 -133.7 145.11 49.59 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 124.527 1.131 . . . . 64.42 108.737 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.9 t -120.83 133.86 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 N-CA-C 107.876 -1.157 . . . . 53.32 107.876 168.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 59.5 t -111.39 139.04 37.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 124.585 1.154 . . . . 75.1 108.437 174.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.04 106.11 10.53 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.896 -1.15 . . . . 75.14 107.896 173.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 21.7 ttm-85 -84.41 102.35 12.7 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.827 -0.805 . . . . 72.52 108.827 175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.1 t -95.34 115.91 35.51 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.05 -1.092 . . . . 75.44 108.05 172.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.674 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 48.5 m -117.92 138.55 52.07 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.48 -0.933 . . . . 72.11 108.48 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.564 HG11 HD21 ' A' ' 126' ' ' LEU . 99.1 t -129.94 117.83 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 C-N-CA 124.6 1.16 . . . . 64.2 108.209 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 20.8 m -101.88 136.61 41.42 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.332 -0.988 . . . . 71.5 108.332 171.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.34 125.34 21.31 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.741 -1.207 . . . . 54.12 107.741 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.0 m -146.02 127.76 15.28 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.582 0.551 . . . . 60.33 110.464 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.87 86.23 6.58 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 108.01 -1.108 . . . . 74.14 108.01 174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.46 -123.22 6.05 Favored Glycine 0 C--N 1.342 0.905 0 CA-C-N 114.569 -1.196 . . . . 74.34 110.613 -170.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -88.1 -28.01 21.56 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.285 0.634 . . . . 64.13 111.094 -178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.465 ' HB3' ' HD2' ' A' ' 34' ' ' LYS . 27.6 tt0 -90.03 126.14 35.65 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 122.977 0.511 . . . . 71.04 110.475 -173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 63.5 m -72.65 129.29 37.92 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.97 0.908 . . . . 75.05 111.744 -174.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.5 -65.5 0.75 Allowed 'General case' 0 C--N 1.346 0.428 0 O-C-N 124.162 0.913 . . . . 74.0 108.762 170.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.548 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 50.3 p90 -155.92 144.42 20.16 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 115.785 -0.643 . . . . 74.31 110.748 179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.1 tp -121.13 110.15 15.86 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 108.154 -1.054 . . . . 51.14 108.154 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.548 ' HG ' ' HD2' ' A' ' 74' ' ' PHE . 84.0 m -111.15 114.84 28.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.182 0.993 . . . . 74.41 110.892 -176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -127.5 124.98 39.61 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.5 -0.926 . . . . 60.23 108.5 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 52.3 t -132.81 108.52 13.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 107.844 -1.169 . . . . 71.41 107.844 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 20' ' ' ASP . 76.2 mt-30 -85.28 80.19 9.26 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 107.299 -1.371 . . . . 62.31 107.299 173.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -76.46 96.54 4.09 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.176 -1.375 . . . . 70.12 108.651 -176.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -94.1 166.18 27.05 Favored Glycine 0 C--N 1.339 0.705 0 CA-C-N 115.955 -0.566 . . . . 63.43 112.124 -178.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -167.21 128.41 1.73 Allowed Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 110.933 -0.867 . . . . 63.44 110.933 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 53.7 mt -80.57 120.28 31.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 N-CA-C 108.635 -0.876 . . . . 64.51 108.635 176.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.596 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 47.8 m-85 -125.7 117.3 23.18 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 107.739 -1.208 . . . . 75.41 107.739 -178.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.4 t -79.67 86.77 5.25 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.92 -0.77 . . . . 71.21 108.92 177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 26.9 pt -113.49 143.93 22.17 Favored 'Isoleucine or valine' 0 C--O 1.241 0.632 0 C-N-CA 123.833 0.853 . . . . 73.31 110.496 -174.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.09 161.37 12.53 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 114.706 -1.134 . . . . 72.33 109.806 177.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 97.42 2.75 58.81 Favored Glycine 0 C--N 1.339 0.743 0 CA-C-N 115.59 -0.732 . . . . 64.51 114.15 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.452 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.56 137.35 57.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 C-N-CA 123.192 0.597 . . . . 74.44 110.441 -178.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -142.72 -177.59 5.38 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.724 1.21 . . . . 64.22 109.653 173.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.89 -125.15 29.93 Favored Glycine 0 C--N 1.352 1.449 0 O-C-N 123.459 0.475 . . . . 71.31 112.537 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 11.5 t -82.56 -19.42 38.56 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.053 0.541 . . . . 74.31 111.012 177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -71.34 -39.2 71.49 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.063 0.545 . . . . 74.14 110.992 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.441 ' SD ' ' N ' ' A' ' 95' ' ' ALA . 3.8 ppp? -70.95 -32.09 68.86 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.055 0.222 . . . . 72.3 110.478 175.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.486 ' HB2' HD11 ' E' ' 280' ' ' LEU . . . -75.97 -23.91 55.37 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.314 0.646 . . . . 65.32 111.215 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 61.5 t-80 -83.98 -32.52 24.94 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.335 0.654 . . . . 73.15 109.56 173.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.1 t -67.35 -43.56 81.18 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.182 0.593 . . . . 72.23 110.3 177.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 59.8 mt -88.42 -31.44 18.82 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.289 -0.869 . . . . 75.54 111.84 -177.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.09 3.77 58.55 Favored Glycine 0 N--CA 1.475 1.283 0 CA-C-O 119.62 -0.545 . . . . 65.14 114.241 -173.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.478 ' HB1' ' HB3' ' A' ' 134' ' ' ASP . . . -149.25 -65.58 0.22 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 117.504 0.652 . . . . 70.4 111.699 -177.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.411 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 74.3 t80 -64.36 -68.95 0.31 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.11 0.964 . . . . 61.41 112.974 -168.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 76.6 m -66.34 -33.52 6.81 Favored Pre-proline 0 CA--C 1.571 1.754 0 N-CA-C 114.26 1.207 . . . . 63.44 114.26 -175.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 56.2 Cg_endo -69.49 -22.41 33.38 Favored 'Trans proline' 0 C--N 1.389 2.679 0 C-N-CA 121.813 1.675 . . . . 73.41 113.083 169.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.403 HD21 ' HD2' ' A' ' 133' ' ' PHE . 1.3 m-80 -72.13 -19.48 61.77 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 118.229 0.468 . . . . 70.2 110.804 173.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 40.7 mm -68.73 -41.28 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 108.639 -0.875 . . . . 64.21 108.639 169.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 63.0 mt -78.66 -29.78 45.9 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.249 1.02 . . . . 74.44 112.547 -174.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -60.39 -45.12 97.44 Favored Pre-proline 0 CA--C 1.573 1.862 0 N-CA-C 114.064 1.135 . . . . 74.32 114.064 -169.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.28 -31.71 34.81 Favored 'Trans proline' 0 C--N 1.39 2.73 0 C-N-CA 121.894 1.73 . . . . 70.11 113.204 175.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -72.0 -37.67 69.77 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 122.912 0.485 . . . . 64.14 110.907 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.41 -45.56 79.51 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.228 0.611 . . . . 61.32 109.628 176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.495 ' NH1' HD12 ' C' ' 105' ' ' ILE . 34.8 ttm180 -52.23 -51.39 58.58 Favored 'General case' 0 C--N 1.354 0.77 0 O-C-N 124.803 1.314 . . . . 73.42 110.382 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -64.77 -45.36 86.68 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.036 0.934 . . . . 74.03 111.537 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.404 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 41.9 t -57.58 -41.89 82.02 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 123.816 0.698 . . . . 64.11 110.451 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.4 ' O ' HG23 ' A' ' 118' ' ' VAL . 85.1 mt -69.11 -45.7 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 CA-C-N 115.177 -0.919 . . . . 74.44 110.072 176.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 24.5 m -54.95 -40.73 70.27 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.438 0.695 . . . . 34.31 110.802 -179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 25.4 t -68.87 -53.46 21.14 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.923 -1.035 . . . . 71.14 110.306 -179.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.7 mtp -51.94 -47.09 64.88 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 124.282 1.033 . . . . 71.22 111.734 178.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.406 HG22 ' SG ' ' A' ' 76' ' ' CYS . 75.4 t -63.84 -45.68 96.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 CA-C-N 114.544 -1.207 . . . . 73.4 110.813 -178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.8 t -66.72 -28.6 68.56 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.275 0.63 . . . . 73.33 111.396 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 91.0 mtt-85 -72.07 -31.16 65.84 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.433 0.693 . . . . 55.24 110.296 177.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.81 1.79 82.35 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 116.205 -0.452 . . . . 54.42 113.133 174.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.1 m 64.99 24.84 12.66 Favored 'General case' 0 CA--C 1.562 1.421 0 C-N-CA 125.361 1.464 . . . . 73.31 110.711 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -93.42 160.13 33.73 Favored Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 114.559 -1.2 . . . . 74.24 110.263 176.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.815 ' HB3' ' H ' ' E' ' 298' ' ' HIS . 12.1 Cg_endo -52.54 137.52 57.92 Favored 'Trans proline' 0 N--CA 1.507 2.274 0 C-N-CA 124.398 3.399 . . . . 74.44 115.38 -177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -50.34 122.98 7.69 Favored 'General case' 0 N--CA 1.481 1.09 0 O-C-N 123.651 0.594 . . . . 61.5 110.549 174.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.564 HD21 HG11 ' A' ' 64' ' ' VAL . 21.4 tp -118.99 105.27 11.28 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.491 -1.232 . . . . 72.02 109.63 -175.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -135.7 107.99 7.29 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.44 -1.254 . . . . 70.35 107.877 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.9 146.76 54.49 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.761 0.824 . . . . 73.42 111.893 -172.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.25 148.18 96.09 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.734 0.813 . . . . 73.22 111.175 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -57.76 105.28 0.19 Allowed 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.775 2.317 . . . . 71.51 112.834 173.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -102.35 116.91 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 108.998 -0.742 . . . . 52.33 108.998 177.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -93.14 77.97 4.58 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.369 1.068 . . . . 74.01 108.422 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.403 ' HD2' HD21 ' A' ' 104' ' ' ASN . 91.2 m-85 -55.79 -34.89 65.72 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 124.7 1.2 . . . . 73.21 112.725 -173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.478 ' HB3' ' HB1' ' A' ' 100' ' ' ALA . 6.0 p-10 -66.62 -32.51 73.88 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.849 0.86 . . . . 54.3 112.097 -176.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.75 -52.63 55.98 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 122.576 0.35 . . . . 54.22 110.314 177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.4 tt -57.3 -42.03 80.99 Favored 'General case' 0 N--CA 1.481 1.123 0 O-C-N 123.97 0.794 . . . . 74.54 110.002 177.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -62.04 -42.62 99.37 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.759 0.823 . . . . 70.35 111.491 -178.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.4 mmt -68.81 -44.38 73.63 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 122.597 0.359 . . . . 75.45 110.344 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 -64.54 -34.41 78.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.841 0.856 . . . . 75.01 111.105 -179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -74.0 -39.44 63.64 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-N 115.165 -0.925 . . . . 71.53 110.546 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 53.7 tp -61.81 -55.72 26.96 Favored 'General case' 0 N--CA 1.474 0.748 0 O-C-N 123.522 0.514 . . . . 74.32 110.725 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.475 ' HB3' ' HG2' ' A' ' 144' ' ' GLN . 11.6 mm-40 -166.47 -17.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.859 0.864 . . . . 70.33 111.258 -177.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 55.23 26.29 8.3 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 125.048 1.339 . . . . 43.32 111.605 -175.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.475 ' HG2' ' HB3' ' A' ' 142' ' ' GLN . 9.2 pt20 -134.96 170.11 16.38 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.046 0.539 . . . . 55.33 111.047 -175.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.92 135.9 8.63 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.397 1.079 . . . . 54.3 109.139 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -150.31 163.15 29.46 Favored Glycine 0 C--N 1.339 0.7 0 O-C-N 123.388 0.43 . . . . 71.32 112.164 -178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.99 149.68 44.76 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 122.981 0.512 . . . . 75.05 109.877 175.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.32 69.77 0.05 OUTLIER Glycine 0 C--N 1.337 0.632 0 N-CA-C 111.291 -0.724 . . . . 72.4 111.291 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 10.9 t -162.94 159.1 23.21 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 123.178 0.591 . . . . 62.44 110.659 -176.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -163.48 134.39 4.62 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.641 1.176 . . . . 64.31 108.855 178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -95.01 88.47 5.26 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 107.338 -1.356 . . . . 61.14 107.338 168.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -133.46 145.23 50.03 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.643 1.177 . . . . 75.12 108.113 -174.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -76.24 74.39 3.05 Favored 'General case' 0 CA--C 1.544 0.733 0 CA-C-O 121.438 0.637 . . . . 73.12 110.307 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -93.91 79.58 4.15 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.159 -1.052 . . . . 51.04 108.159 178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.871 0 CA-C-O 118.535 -0.745 . . . . 62.32 109.185 -179.394 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 52.5 ttm . . . . . 0 N--CA 1.476 0.83 0 N-CA-C 109.03 -0.73 . . . . 73.43 109.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.6 m -145.77 125.41 13.32 Favored 'General case' 0 C--O 1.241 0.623 0 N-CA-C 108.847 -0.797 . . . . 73.41 108.847 176.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -73.67 83.82 1.59 Allowed 'General case' 0 C--N 1.346 0.454 0 N-CA-C 108.532 -0.914 . . . . 75.33 108.532 175.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.89 70.33 9.87 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.696 -0.853 . . . . 71.14 108.696 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -148.41 125.97 11.72 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.804 -1.089 . . . . 73.52 108.167 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . 0.719 ' HB2' HE22 ' B' ' 93' ' ' GLN . 3.2 p-10 -89.91 12.07 18.5 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.608 1.163 . . . . 74.55 112.448 -170.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 40.6 p -117.58 -60.07 1.86 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.222 0.609 . . . . 70.33 110.969 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -71.68 -41.87 68.16 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.311 0.645 . . . . 62.4 111.547 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 22.6 ptm 47.28 -163.04 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.149 0 C-N-CA 125.692 1.597 . . . . 74.24 112.765 -173.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 61.2 m -143.14 122.68 13.21 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 108.175 -1.046 . . . . 61.41 108.175 174.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -146.72 124.24 11.72 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.388 0.675 . . . . 71.34 109.274 -175.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -144.5 132.94 21.98 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 122.885 0.474 . . . . 62.22 110.102 176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.643 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -77.39 120.73 28.46 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 CA-C-N 115.186 -0.915 . . . . 74.42 108.83 178.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -86.24 -50.26 7.1 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 116.329 -0.396 . . . . 74.42 111.055 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -164.52 140.02 5.8 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 122.467 0.307 . . . . 73.23 110.424 -176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.643 HG13 HD11 ' B' ' 13' ' ' ILE . 90.6 mt -115.53 139.48 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 124.107 0.963 . . . . 72.34 108.879 174.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -164.89 164.76 20.78 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-O 121.731 0.777 . . . . 74.12 112.219 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.449 HG21 HD11 ' B' ' 21' ' ' ILE . 97.3 m -93.74 124.69 37.9 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-N 114.99 -1.004 . . . . 70.51 108.474 171.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -88.9 -33.49 17.29 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.124 0.57 . . . . 61.1 110.677 176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -155.31 142.29 19.14 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 112.164 0.431 . . . . 74.2 112.164 -172.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.449 HD11 HG21 ' B' ' 18' ' ' THR . 47.5 mm -133.13 142.16 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 124.492 1.117 . . . . 72.52 109.301 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 58.6 m -143.13 131.67 22.38 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.597 -1.183 . . . . 51.52 108.341 173.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -144.12 107.6 4.61 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.808 -1.552 . . . . 72.0 106.808 167.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -119.23 115.46 24.25 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.844 -0.799 . . . . 75.14 108.844 -173.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.864 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -107.17 88.28 3.72 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.583 1.153 . . . . 75.31 109.185 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.45 -44.1 1.77 Allowed 'Trans proline' 0 C--N 1.38 2.203 0 C-N-CA 122.722 2.281 . . . . 63.14 112.681 -173.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.442 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 77.1 m-20 -102.61 23.0 12.64 Favored 'General case' 0 C--O 1.215 -0.743 0 C-N-CA 123.964 0.906 . . . . 71.32 109.705 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.864 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.5 -46.67 59.49 Favored Pre-proline 0 CA--C 1.565 1.545 0 N-CA-C 115.774 1.768 . . . . 72.41 115.774 -174.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 7.0 Cg_exo -75.79 -29.65 6.83 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 122.286 1.99 . . . . 53.42 112.325 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 52.7 m80 -94.36 1.0 55.89 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.39 1.076 . . . . 71.34 111.557 -172.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.427 HG12 ' O ' ' B' ' 28' ' ' ALA . 4.5 p -83.57 -17.19 10.81 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.608 0 C-N-CA 123.38 0.672 . . . . 71.31 110.419 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 70.8 t80 -57.59 -28.66 63.82 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 118.481 0.582 . . . . 73.51 112.093 -174.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -73.65 -45.77 50.64 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.446 0.698 . . . . 70.52 111.07 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.522 ' HB3' HD13 ' B' ' 68' ' ' LEU . 10.9 mmmm -107.37 62.62 0.62 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.288 1.035 . . . . 64.35 108.97 -177.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.53 ' HB3' HD11 ' H' ' 301' ' ' ILE . 6.9 t70 -119.07 80.73 1.59 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.691 -0.855 . . . . 72.13 108.691 -171.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.5 m-90 -152.64 -177.27 6.14 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.087 0.955 . . . . 74.0 109.511 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -59.53 109.19 1.75 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 123.509 0.724 . . . . 52.11 110.835 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -86.34 173.87 6.35 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.587 2.191 . . . . 72.04 112.902 -175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -73.28 103.77 4.09 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 107.385 -1.339 . . . . 65.13 107.385 164.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.457 HG21 ' HB ' ' H' ' 296' ' ' THR . 44.4 t -101.41 151.9 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.699 -1.137 . . . . 50.44 110.492 -173.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.413 ' HB2' ' HB ' ' B' ' 65' ' ' THR . 55.5 mtpt -138.11 138.81 39.07 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 124.116 0.966 . . . . 72.41 109.393 175.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 4.4 tt -99.76 126.25 45.79 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 105.992 -1.855 . . . . 70.45 105.992 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 21.1 t70 -124.7 139.95 53.39 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 108.423 -0.955 . . . . 72.34 108.423 177.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.446 ' H ' HD23 ' B' ' 44' ' ' LEU . 2.6 pt? -125.55 141.19 52.17 Favored 'General case' 0 C--O 1.242 0.668 0 N-CA-C 109.021 -0.733 . . . . 73.4 109.021 175.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.638 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 13.2 t70 -130.45 137.36 49.77 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.139 0.976 . . . . 60.24 108.575 175.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 35.6 p -108.69 103.11 12.14 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.841 0.857 . . . . 64.31 110.393 -172.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.24 141.07 50.29 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.218 1.007 . . . . 64.14 109.416 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 63.8 p -145.58 168.45 20.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.166 0.586 . . . . 53.13 110.903 175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 87.2 p -152.72 138.64 18.08 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.11 0.564 . . . . 60.32 110.482 174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -82.45 101.27 10.56 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 109.079 -0.711 . . . . 54.02 109.079 173.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 63.0 mt -74.54 -35.99 63.13 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.305 0.642 . . . . 74.54 109.996 178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.23 -174.2 3.43 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 114.295 -1.32 . . . . 75.43 109.232 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.61 128.06 35.27 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 115.133 -0.94 . . . . 73.22 109.821 177.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 67.62 -5.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 125.437 1.495 . . . . 74.22 112.955 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 61.9 t -106.91 115.14 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 C-N-CA 123.719 0.808 . . . . 72.43 109.146 -176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -129.91 143.38 50.77 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.369 0.668 . . . . 60.14 110.416 -179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -99.8 116.16 31.23 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.144 -1.058 . . . . 70.24 108.144 172.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 68.4 t -91.42 118.02 35.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 C-N-CA 124.038 0.935 . . . . 64.44 109.001 172.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.412 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 40.1 t -114.42 112.64 40.99 Favored 'Isoleucine or valine' 0 C--O 1.242 0.658 0 C-N-CA 124.053 0.941 . . . . 71.02 108.561 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.93 108.68 20.31 Favored 'General case' 0 C--O 1.243 0.729 0 N-CA-C 107.872 -1.158 . . . . 74.34 107.872 176.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.638 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 18.9 ttm-85 -85.58 112.41 20.93 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 108.78 -0.822 . . . . 73.22 108.78 176.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 39.5 t -105.35 103.02 14.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 N-CA-C 107.872 -1.159 . . . . 61.32 107.872 176.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.433 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 14.0 m -100.96 130.95 47.04 Favored 'General case' 0 C--N 1.334 -0.105 0 N-CA-C 109.055 -0.72 . . . . 70.13 109.055 177.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.462 HG11 HD21 ' B' ' 126' ' ' LEU . 68.9 t -117.53 115.86 49.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 109.261 -0.644 . . . . 74.21 109.261 176.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' B' ' 41' ' ' LYS . 85.8 m -92.57 141.67 28.24 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.147 0.979 . . . . 41.44 108.612 177.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.77 121.5 12.63 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.723 -0.843 . . . . 64.05 108.723 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 40.4 p -147.2 127.8 14.19 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.637 0.775 . . . . 43.44 109.456 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.721 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.3 OUTLIER -118.31 134.6 54.9 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.446 0.698 . . . . 54.52 109.305 -176.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.78 -118.28 6.43 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 111.206 -0.758 . . . . 74.14 111.206 -174.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -119.17 11.35 12.33 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.874 0.87 . . . . 64.33 110.315 178.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.442 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 3.7 pm0 -127.67 158.96 36.16 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.677 0.791 . . . . 74.12 110.682 -176.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 23.2 m -78.81 135.99 37.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.942 -0.572 . . . . 74.21 110.328 177.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.721 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -83.72 -64.75 1.11 Allowed 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.901 0.858 . . . . 75.43 108.993 177.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -162.83 152.95 16.18 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 113.563 -1.653 . . . . 44.21 108.094 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.3 mt -123.74 137.02 54.77 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 108.324 -0.991 . . . . 63.33 108.324 177.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 43.0 t -134.18 148.18 50.87 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 108.809 -0.812 . . . . 54.11 108.809 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.418 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.7 tt0 -156.16 138.8 15.06 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.925 -0.768 . . . . 61.41 108.925 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 72.2 t -132.14 145.27 35.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 124.403 1.081 . . . . 74.5 108.632 174.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -118.82 97.1 5.54 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.285 -1.376 . . . . 60.23 107.285 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -87.74 100.11 12.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 108.043 -1.095 . . . . 74.02 108.043 177.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -90.37 157.65 25.92 Favored Glycine 0 C--N 1.339 0.741 0 N-CA-C 110.392 -1.083 . . . . 63.41 110.392 176.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.93 125.65 1.37 Allowed Glycine 0 N--CA 1.444 -0.779 0 N-CA-C 111.177 -0.769 . . . . 42.23 111.177 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 44.0 mt -84.7 130.91 35.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 N-CA-C 108.825 -0.805 . . . . 53.22 108.825 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -130.72 165.63 22.48 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 124.109 0.963 . . . . 64.15 108.633 172.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 66.5 m -129.35 120.91 26.39 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 108.921 -0.77 . . . . 73.13 108.921 172.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 36.7 pt -119.13 145.81 24.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 C-N-CA 124.584 1.153 . . . . 72.21 110.742 -171.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.552 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.21 157.67 36.26 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.608 1.163 . . . . 73.25 108.682 172.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.52 -42.39 2.57 Favored Glycine 0 N--CA 1.469 0.866 0 CA-C-N 116.856 -0.156 . . . . 55.21 112.889 177.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 35.5 pt -79.31 149.97 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 123.086 0.555 . . . . 72.22 110.655 175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -170.64 160.08 6.97 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.019 0.928 . . . . 70.3 109.376 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.77 -119.42 12.22 Favored Glycine 0 C--N 1.349 1.295 0 O-C-N 123.398 0.436 . . . . 73.21 112.452 177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 9.0 m -73.69 -28.55 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.929 0.892 . . . . 74.23 111.292 -178.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.719 HE22 ' HB2' ' B' ' 6' ' ' ASN . 18.2 tt0 -70.97 -24.39 62.4 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.651 -0.704 . . . . 72.33 112.317 -167.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 20.5 ptp -67.25 -32.02 72.75 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 115.938 -0.574 . . . . 61.12 110.592 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.595 ' HA ' HD22 ' H' ' 280' ' ' LEU . . . -62.97 -22.14 66.6 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.603 0.761 . . . . 73.54 112.027 -178.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 59.7 t-80 -83.83 -45.9 12.77 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 122.934 0.494 . . . . 74.12 109.907 173.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -74.95 -67.8 0.61 Allowed 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 116.181 -0.463 . . . . 74.33 111.457 -172.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.605 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.0 pp -80.73 -20.75 42.09 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 119.488 -0.291 . . . . 73.3 111.683 -178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.9 -32.57 26.29 Favored Glycine 0 C--N 1.347 1.156 0 N-CA-C 113.887 0.315 . . . . 62.44 113.887 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -116.18 -59.23 2.01 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.01 0.524 . . . . 71.51 110.899 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -67.17 -45.62 76.45 Favored 'General case' 0 CA--C 1.555 1.152 0 C-N-CA 123.462 0.705 . . . . 74.44 112.779 -169.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 60.4 m -65.99 -45.07 63.28 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 118.606 -0.712 . . . . 63.42 112.761 -177.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -57.78 -34.48 98.29 Favored 'Trans proline' 0 C--N 1.394 2.931 0 C-N-CA 122.303 2.002 . . . . 71.22 112.901 169.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -66.61 -27.63 67.86 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 123.117 0.567 . . . . 64.11 111.905 177.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.93 -45.41 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.221 0.608 . . . . 34.4 110.049 173.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 83.5 mt -81.13 -17.42 49.94 Favored 'General case' 0 CA--C 1.55 0.95 0 CA-C-N 115.478 -0.783 . . . . 74.14 111.692 -174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -61.17 -47.22 95.3 Favored Pre-proline 0 CA--C 1.564 1.491 0 C-N-CA 124.602 1.161 . . . . 72.33 113.944 -173.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -61.41 -35.44 83.23 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.027 1.818 . . . . 51.34 112.978 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -68.9 -44.67 72.71 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.356 0.662 . . . . 74.41 110.618 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.17 -41.09 99.17 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.36 0.664 . . . . 71.55 110.475 176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.575 HH12 HD11 ' D' ' 16' ' ' ILE . 33.6 mtp180 -54.87 -60.46 3.33 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 124.191 0.996 . . . . 71.42 111.262 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -60.57 -31.71 70.83 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 124.244 0.965 . . . . 72.24 110.519 -173.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.538 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 4.9 t -73.76 -37.74 64.94 Favored 'General case' 0 CA--C 1.551 0.992 0 CA-C-N 115.967 -0.56 . . . . 44.24 111.344 -179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.441 HD13 HG23 ' B' ' 64' ' ' VAL . 69.0 mt -67.09 -45.63 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 C-N-CA 123.134 0.574 . . . . 74.33 109.836 174.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.515 HG21 ' OG ' ' C' ' 119' ' ' SER . 10.2 m -62.13 -39.67 93.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.072 0.949 . . . . 73.51 111.385 -178.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 40.5 t -61.68 -42.35 98.8 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.787 0.835 . . . . 71.22 110.516 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.516 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 10.0 mmt -72.48 -31.58 65.51 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 122.726 0.41 . . . . 55.24 111.186 -177.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.624 HG21 HD23 ' B' ' 126' ' ' LEU . 92.8 t -65.83 -41.23 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.803 0.841 . . . . 75.44 110.221 172.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 53.0 m -64.31 -36.85 85.46 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.18 0.992 . . . . 55.02 111.05 174.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.516 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 84.0 mtt-85 -71.05 -27.58 63.75 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 115.815 -0.629 . . . . 71.03 110.714 178.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -90.04 14.51 61.86 Favored Glycine 0 C--N 1.351 1.37 0 CA-C-O 119.513 -0.604 . . . . 74.32 113.082 176.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 55.05 45.69 25.73 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.397 1.479 . . . . 74.4 113.12 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -119.87 149.25 48.28 Favored Pre-proline 0 CA--C 1.557 1.228 0 C-N-CA 123.657 0.783 . . . . 74.21 110.253 174.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -63.59 -165.56 0.06 OUTLIER 'Trans proline' 0 C--N 1.39 2.732 0 C-N-CA 124.352 3.368 . . . . 74.13 114.945 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.465 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.7 tp60 -60.13 128.51 37.16 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.564 1.146 . . . . 72.34 113.587 -168.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.624 HD23 HG21 ' B' ' 118' ' ' VAL . 12.3 tp -136.05 108.86 7.55 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.301 1.04 . . . . 71.22 108.59 165.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -128.46 135.75 49.89 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 108.382 -0.969 . . . . 74.4 108.382 167.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -82.25 139.27 34.31 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.924 -0.769 . . . . 73.52 108.924 177.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.433 ' HB1' HG13 ' F' ' 306' ' ' VAL . . . -67.94 148.18 98.43 Favored Pre-proline 0 CA--C 1.552 1.028 0 C-N-CA 123.698 0.799 . . . . 71.12 111.504 -175.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.36 92.68 0.07 OUTLIER 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 123.159 2.573 . . . . 72.13 111.504 173.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 90.3 t -89.86 108.34 19.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.71 0 N-CA-C 108.804 -0.813 . . . . 73.42 108.804 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -83.16 109.18 16.96 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.34 -1.356 . . . . 71.22 107.34 172.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -63.89 -31.51 72.72 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 122.53 0.332 . . . . 75.12 111.145 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -61.41 -34.38 75.27 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 123.729 0.643 . . . . 75.5 111.385 175.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.06 -45.48 85.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.029 0.531 . . . . 65.41 109.926 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.57 -34.42 75.57 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.513 0.725 . . . . 61.34 111.233 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -64.86 -53.17 50.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 122.903 0.481 . . . . 65.34 110.445 173.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.461 ' O ' ' HG2' ' B' ' 142' ' ' GLN . 70.5 mtm -68.39 -40.28 81.43 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 112.368 0.507 . . . . 75.41 112.368 -171.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -76.15 -12.11 60.05 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 122.768 0.427 . . . . 74.13 111.289 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -87.46 -43.77 11.81 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 109.136 -0.691 . . . . 62.02 109.136 171.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 80.6 mt -87.11 -5.76 58.91 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.623 -0.717 . . . . 73.14 112.615 -172.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' B' ' 138' ' ' MET . 8.7 pt20 -163.13 152.31 14.86 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.399 0.68 . . . . 73.05 110.07 175.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -98.93 5.82 47.07 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.748 0.819 . . . . 71.33 111.021 176.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -81.87 85.21 6.7 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 123.22 0.608 . . . . 73.34 109.506 178.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.8 -46.19 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 125.066 1.346 . . . . 74.01 108.792 177.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 81.64 85.89 0.71 Allowed Glycine 0 C--N 1.346 1.116 0 N-CA-C 109.834 -1.306 . . . . 64.32 109.834 -171.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.93 119.21 5.07 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.445 0.698 . . . . 73.01 110.305 -178.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -82.58 29.0 3.35 Favored Glycine 0 C--N 1.346 1.13 0 CA-C-N 116.242 -0.436 . . . . 73.3 113.855 -171.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . 0.417 ' HA ' ' SG ' ' F' ' 308' ' ' CYS . 42.6 p -79.12 82.92 5.24 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.083 0.953 . . . . 74.12 110.887 -178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -92.82 93.88 8.66 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 115.375 -0.829 . . . . 73.23 108.919 176.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -161.81 176.67 10.63 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.988 0.915 . . . . 62.2 110.774 178.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -164.85 67.09 0.14 Allowed 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 106.679 -1.6 . . . . 73.35 106.679 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -63.45 96.47 0.11 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 114.975 -1.011 . . . . 64.12 111.494 -173.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -88.54 149.28 23.69 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.681 0.792 . . . . 71.33 110.534 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 C-N-CA 124.143 0.977 . . . . 70.24 108.699 -178.113 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 109.701 -0.481 . . . . 72.41 109.701 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 24.1 p -120.48 86.67 2.61 Favored 'General case' 0 C--O 1.24 0.574 0 N-CA-C 108.837 -0.801 . . . . 74.05 108.837 -178.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -81.46 73.27 8.51 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.933 -1.03 . . . . 71.32 109.072 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -109.91 46.65 1.0 Allowed 'General case' 0 C--O 1.241 0.627 0 CA-C-N 114.741 -1.118 . . . . 72.32 108.694 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.09 133.39 50.64 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.413 -0.812 . . . . 73.02 110.618 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -117.31 142.17 47.41 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.376 1.07 . . . . 64.11 108.366 177.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 4.0 m -139.72 45.87 1.9 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-O 121.898 0.856 . . . . 53.01 109.422 177.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.66 153.31 38.98 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.604 -0.726 . . . . 63.31 109.825 172.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.419 ' HA ' ' O ' ' C' ' 87' ' ' ALA . 56.9 ttp 65.44 115.26 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.163 1.385 . . . . 74.23 112.364 -174.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.6 m -98.54 101.85 13.41 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.181 -1.044 . . . . 60.34 108.181 170.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -120.14 134.97 55.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.354 0.662 . . . . 74.05 110.03 -179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.404 ' HG2' ' HB2' ' C' ' 85' ' ' SER . 29.3 pt20 -154.92 144.48 21.38 Favored 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.998 0.919 . . . . 75.34 108.769 174.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 27.0 pt -88.84 112.55 24.22 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.186 0 N-CA-C 109.641 -0.503 . . . . 73.15 109.641 -178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -79.35 -50.53 10.71 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 122.078 -0.389 . . . . 75.1 111.02 -174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 61.5 ttt180 -166.91 125.9 1.41 Allowed 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.335 -0.617 . . . . 53.12 109.335 -175.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 62.5 mt -108.19 141.68 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 N-CA-C 107.865 -1.161 . . . . 61.5 107.865 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.518 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 23.2 p90 -173.23 159.88 3.92 Favored 'General case' 0 N--CA 1.484 1.23 0 CA-C-O 121.644 0.735 . . . . 73.32 112.187 -176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.4 p -85.2 114.63 22.45 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 108.747 -0.834 . . . . 73.33 108.747 174.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 14.7 mtmt -80.7 -33.87 35.04 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.128 0.49 . . . . 72.43 110.112 176.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 33.5 t70 -147.33 139.51 24.47 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.429 -0.805 . . . . 51.44 109.395 -176.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.404 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 73.8 mt -140.04 139.69 36.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 107.632 -1.247 . . . . 50.44 107.632 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 61.8 m -148.46 146.76 28.54 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 123.197 0.599 . . . . 55.42 110.54 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -145.08 107.62 4.42 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.472 -1.677 . . . . 71.5 106.472 165.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -118.82 109.63 16.26 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 109.165 -0.68 . . . . 75.44 109.165 -174.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.28 80.7 12.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 N-CA-C 108.137 -1.06 . . . . 74.34 108.137 176.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.98 -18.57 35.89 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.073 2.515 . . . . 64.41 112.041 -175.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -122.94 32.69 5.63 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.052 0.941 . . . . 71.35 110.041 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.49 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -51.64 -51.31 71.09 Favored Pre-proline 0 CA--C 1.573 1.855 0 N-CA-C 113.813 1.042 . . . . 73.4 113.813 -175.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 11.5 Cg_exo -72.89 -30.76 10.86 Favored 'Trans proline' 0 C--N 1.392 2.84 0 C-N-CA 122.175 1.916 . . . . 51.24 113.786 174.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 35.3 t60 -70.3 -40.1 74.45 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.14 0.576 . . . . 74.43 111.719 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.43 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 7.3 p -78.68 -20.56 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 C-N-CA 123.665 0.786 . . . . 61.35 110.72 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -62.26 -20.79 64.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.948 1.299 . . . . 74.35 111.451 179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -122.5 23.58 9.58 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.748 0.819 . . . . 72.5 111.415 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.43 ' HB2' ' HA ' ' C' ' 31' ' ' VAL . 2.1 tppp? -98.0 146.79 25.15 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.2 0.6 . . . . 71.41 109.772 -178.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -63.71 122.71 17.03 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.928 0.891 . . . . 74.3 110.276 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 22.2 m95 -72.07 90.32 1.18 Allowed 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 123.842 0.857 . . . . 71.52 111.571 -166.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -127.67 64.11 62.57 Favored Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 124.078 0.951 . . . . 74.34 108.924 170.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -85.95 109.21 1.01 Allowed 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.469 2.779 . . . . 71.52 113.302 -165.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -84.55 106.37 16.08 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 108.504 -0.925 . . . . 72.35 108.504 170.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 10.4 m -84.38 139.72 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.892 -1.049 . . . . 75.34 109.369 173.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.431 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 23.6 mtpp -131.87 103.18 6.18 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.635 0.774 . . . . 71.1 109.038 -172.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -91.72 120.31 32.35 Favored 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 107.255 -1.387 . . . . 74.1 107.255 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.726 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 2.1 m-20 -119.94 104.3 10.05 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 124.254 1.022 . . . . 53.43 108.421 179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -96.28 110.97 23.19 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 107.506 -1.294 . . . . 61.32 107.506 176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 14.7 t70 -116.35 149.25 39.63 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.36 1.464 . . . . 71.44 108.53 179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 34.8 p -120.5 143.13 48.71 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.086 0.554 . . . . 73.45 109.756 -175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -143.22 145.92 33.19 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.178 0.991 . . . . 64.11 108.654 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.0 t -160.6 146.85 15.19 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 117.963 0.347 . . . . 64.22 111.213 -176.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 61.1 p -154.35 144.01 21.59 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.836 0.854 . . . . 43.2 109.752 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -80.73 122.99 27.83 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 122.845 0.458 . . . . 73.13 109.813 179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.616 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.3 mt -95.85 -36.4 11.13 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.485 0.714 . . . . 65.3 110.661 -179.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.401 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -156.22 -177.51 6.64 Favored 'General case' 0 C--O 1.242 0.692 0 CA-C-N 115.172 -0.922 . . . . 54.12 109.976 -176.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -65.22 116.65 6.79 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 115.013 -0.994 . . . . 75.52 109.592 178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . 0.477 ' HB3' ' HB2' ' C' ' 87' ' ' ALA . 23.6 m-20 67.05 12.12 8.79 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.953 1.301 . . . . 73.15 112.048 179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 69.2 t -119.05 107.38 21.37 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 C-N-CA 124.244 1.018 . . . . 72.53 109.096 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.636 ' HB2' HD13 ' C' ' 86' ' ' ILE . 89.7 m-85 -116.74 134.45 54.79 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 124.23 1.012 . . . . 74.24 108.62 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.616 ' HB2' HD11 ' C' ' 51' ' ' LEU . 41.7 tt0 -83.58 119.58 24.9 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 115.752 -0.658 . . . . 72.54 109.294 173.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.55 118.97 49.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 107.792 -1.188 . . . . 71.25 107.792 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 32.7 t -119.82 133.76 65.56 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 123.564 0.746 . . . . 74.43 109.168 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.573 HD23 HD12 ' C' ' 106' ' ' LEU . 4.1 mm? -118.96 106.38 12.4 Favored 'General case' 0 C--O 1.24 0.571 0 C-N-CA 124.324 1.05 . . . . 75.24 108.699 176.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.428 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 6.6 ttm-85 -81.07 106.51 13.13 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 107.855 -1.165 . . . . 73.13 107.855 172.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.72 119.51 50.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 107.766 -1.198 . . . . 71.15 107.766 172.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.726 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 55.9 m -116.39 141.08 48.63 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.951 -1.129 . . . . 62.21 107.951 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 88.1 t -135.34 128.0 47.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 107.671 -1.233 . . . . 71.34 107.671 173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.431 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.0 m -122.57 125.84 46.53 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.705 -0.85 . . . . 72.11 108.705 -178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -107.49 123.64 48.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.535 -1.283 . . . . 63.23 107.535 177.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 66.8 m -143.44 123.9 13.95 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.877 0.471 . . . . 52.51 110.746 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -90.08 57.65 3.85 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.649 1.18 . . . . 75.35 109.798 178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.45 -111.53 4.05 Favored Glycine 0 C--N 1.349 1.283 0 N-CA-C 110.558 -1.017 . . . . 54.23 110.558 -177.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -89.53 -28.09 19.85 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.732 0.813 . . . . 72.21 109.429 173.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -64.91 117.65 7.89 Favored 'General case' 0 C--O 1.221 -0.418 0 CA-C-N 115.043 -0.98 . . . . 74.21 110.175 173.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 87.8 m -87.6 125.64 34.48 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.706 -0.849 . . . . 60.21 108.706 167.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -75.07 -63.02 1.36 Allowed 'General case' 0 C--O 1.239 0.51 0 CA-C-N 114.572 -1.195 . . . . 71.54 109.806 177.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 41.1 p90 -156.34 177.11 11.83 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 114.85 -1.068 . . . . 62.13 111.217 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.416 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.1 tm? -135.98 147.51 48.04 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 105.83 -1.915 . . . . 54.34 105.83 176.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' C' ' 114' ' ' ILE . 49.3 t -150.48 113.08 4.71 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.148 -1.056 . . . . 54.31 108.148 176.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -133.4 126.78 31.99 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 109.207 -0.664 . . . . 72.33 109.207 -175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.512 HG21 ' HB3' ' C' ' 113' ' ' CYS . 80.2 t -130.21 113.74 26.99 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 C-N-CA 123.917 0.887 . . . . 62.11 108.842 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.616 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 52.2 mt-30 -89.83 90.52 8.23 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.849 -1.167 . . . . 64.35 107.849 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -81.25 104.04 11.44 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 114.473 -1.239 . . . . 71.33 109.46 -177.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.85 150.73 19.73 Favored Glycine 0 C--N 1.337 0.589 0 N-CA-C 112.08 -0.408 . . . . 62.41 112.08 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.34 125.0 1.98 Allowed Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 110.226 -1.15 . . . . 43.5 110.226 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.514 HD12 HD11 ' C' ' 51' ' ' LEU . 9.8 mm -81.93 126.52 39.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.759 -1.2 . . . . 71.23 107.759 173.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -136.51 154.72 50.65 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.419 0.688 . . . . 74.24 109.144 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.404 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 31.2 m -96.45 116.12 28.55 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 108.459 -0.941 . . . . 74.43 108.459 169.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.636 HD13 ' HB2' ' C' ' 56' ' ' TYR . 3.8 mp -116.73 118.16 57.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 108.503 -0.925 . . . . 75.51 108.503 175.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.477 ' HB2' ' HB3' ' C' ' 54' ' ' ASP . . . -153.21 170.51 20.39 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.134 0.974 . . . . 74.03 110.054 -177.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 106.4 -59.39 0.4 Allowed Glycine 0 C--N 1.345 1.056 0 CA-C-N 116.54 -0.3 . . . . 65.22 113.434 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.23 -179.25 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.383 0.673 . . . . 63.43 112.176 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -145.93 -173.31 4.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 124.078 0.951 . . . . 63.11 109.822 -178.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.21 -140.76 38.13 Favored Glycine 0 C--N 1.35 1.326 0 O-C-N 123.533 0.521 . . . . 71.32 113.305 177.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 41.7 p -75.2 -17.64 60.32 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 123.856 0.863 . . . . 71.24 112.182 -177.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -73.47 -36.58 65.87 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.025 0.53 . . . . 70.13 110.595 174.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.546 ' HE3' HD12 ' F' ' 278' ' ' LEU . 1.2 tmt? -72.15 -41.63 66.9 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 109.373 -0.603 . . . . 74.22 109.373 174.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.86 -23.89 66.07 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.854 -1.066 . . . . 64.52 111.568 176.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.575 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 39.9 t-80 -66.84 -41.66 87.05 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.427 0.691 . . . . 74.32 111.254 176.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.6 t -77.74 -57.43 3.81 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.856 -0.424 . . . . 63.01 109.856 178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 61.2 tp -62.44 -39.65 94.03 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 124.366 1.066 . . . . 53.35 112.542 -173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.81 11.21 57.6 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.543 -0.587 . . . . 71.23 114.155 -174.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -144.63 -63.41 0.36 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.59 0.695 . . . . 71.22 111.51 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -69.34 -55.12 11.36 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 122.723 0.409 . . . . 74.4 111.887 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 23.9 m -55.88 -44.77 99.84 Favored Pre-proline 0 CA--C 1.573 1.85 0 C-N-CA 123.581 0.752 . . . . 71.53 112.567 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -51.18 -43.46 48.5 Favored 'Trans proline' 0 C--N 1.399 3.186 0 C-N-CA 123.062 2.508 . . . . 75.31 114.344 168.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.421 HD22 ' N ' ' C' ' 104' ' ' ASN . 0.9 OUTLIER -74.24 -20.19 60.25 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.463 0.705 . . . . 63.11 111.715 -174.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.495 HD12 ' NH1' ' A' ' 111' ' ' ARG . 32.3 mm -76.88 -44.86 32.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 122.984 0.514 . . . . 73.42 110.061 173.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.573 HD12 HD23 ' C' ' 60' ' ' LEU . 73.1 mt -81.61 -18.72 43.74 Favored 'General case' 0 CA--C 1.547 0.864 0 CA-C-N 116.044 -0.526 . . . . 74.03 112.004 -174.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -57.11 -54.25 56.63 Favored Pre-proline 0 CA--C 1.564 1.498 0 CA-C-O 117.72 -1.133 . . . . 72.5 113.08 -177.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -60.79 -27.45 84.84 Favored 'Trans proline' 0 C--N 1.391 2.766 0 C-N-CA 122.026 1.818 . . . . 71.12 113.221 -176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -71.08 -45.98 62.71 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.208 0.603 . . . . 73.21 110.79 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.44 -36.59 84.65 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.795 -0.638 . . . . 71.51 110.315 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.719 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 33.6 ttt180 -60.13 -47.88 84.07 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 125.489 1.516 . . . . 75.22 111.47 -177.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.1 -38.71 86.15 Favored 'General case' 0 N--CA 1.48 1.051 0 O-C-N 123.907 0.755 . . . . 75.51 109.765 -177.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.512 ' HB3' HG21 ' C' ' 78' ' ' VAL . 12.2 m -58.5 -46.67 86.23 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.38 0.672 . . . . 51.02 112.357 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.53 ' HA ' ' SG ' ' C' ' 76' ' ' CYS . 86.9 mt -66.16 -48.43 81.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 C-N-CA 122.916 0.486 . . . . 63.02 110.762 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 35.6 m -65.81 -32.71 74.39 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 123.088 0.555 . . . . 50.04 111.272 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.5 t -69.41 -37.99 77.73 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.325 0.65 . . . . 74.53 109.98 176.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.471 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -70.9 -35.97 72.52 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.661 0.784 . . . . 74.11 111.514 -178.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' C' ' 114' ' ' ILE . 58.8 t -63.76 -37.31 79.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 N-CA-C 109.543 -0.54 . . . . 61.13 109.543 172.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.515 ' OG ' HG21 ' B' ' 115' ' ' THR . 42.1 t -67.77 -35.34 78.52 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.85 0.86 . . . . 70.14 112.194 175.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -72.68 -32.46 65.81 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.2 0.6 . . . . 74.33 110.022 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.2 1.6 86.66 Favored Glycine 0 C--N 1.352 1.441 0 O-C-N 123.465 0.478 . . . . 71.41 112.612 171.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 40.2 p 62.42 19.59 11.25 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.836 2.054 . . . . 70.45 113.17 174.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -88.64 150.04 45.31 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 124.09 0.956 . . . . 74.31 109.43 177.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.523 ' HD3' HG21 ' F' ' 301' ' ' ILE . 35.7 Cg_endo -62.54 113.25 1.87 Allowed 'Trans proline' 0 C--N 1.383 2.379 0 C-N-CA 122.722 2.281 . . . . 74.14 111.442 -174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -55.47 141.79 35.34 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-N 114.254 -1.339 . . . . 63.03 113.168 -168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.36 121.24 36.23 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.822 -1.548 . . . . 75.3 106.822 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -95.86 126.55 41.19 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.941 0.896 . . . . 72.42 108.653 -175.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.719 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.5 mm? -63.92 145.02 56.59 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.218 0.607 . . . . 73.52 110.403 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.512 ' HB2' ' HE2' ' F' ' 294' ' ' LYS . . . -83.49 164.33 45.73 Favored Pre-proline 0 N--CA 1.481 1.119 0 C-N-CA 124.095 0.958 . . . . 53.12 111.232 -177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -66.52 117.26 4.59 Favored 'Trans proline' 0 C--N 1.387 2.605 0 C-N-CA 122.064 1.842 . . . . 70.23 111.729 176.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.36 109.34 28.18 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-O 121.944 0.878 . . . . 73.44 108.964 171.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.552 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 9.1 m120 -107.9 94.4 5.06 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-N 115.044 -0.98 . . . . 75.14 109.708 178.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -75.9 -40.59 54.1 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 109.139 -0.689 . . . . 74.1 109.139 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' C' ' 138' ' ' MET . 11.3 p-10 -60.64 -41.54 95.13 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.824 0.85 . . . . 74.13 110.91 -176.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.552 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -71.82 -24.97 61.8 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.039 0.935 . . . . 63.33 111.691 -176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' C' ' 132' ' ' ASN . 98.8 mt -74.43 -40.13 62.15 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.187 0.595 . . . . 64.03 109.801 172.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . 0.492 ' HB3' ' HD2' ' C' ' 96' ' ' HIS . 52.7 m-85 -80.74 -11.45 59.61 Favored 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 123.912 0.885 . . . . 63.44 112.736 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.429 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 66.3 mtt -62.11 -32.92 73.54 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 123.092 0.557 . . . . 74.34 110.704 170.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -64.16 -33.73 76.46 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.295 1.038 . . . . 74.04 111.342 178.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -58.75 -83.74 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.446 0 C-N-CA 124.048 0.939 . . . . 64.2 111.519 176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 tt -143.48 125.54 15.37 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 108.35 -0.982 . . . . 64.44 108.35 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -124.5 121.59 35.26 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.056 0.943 . . . . 74.34 109.177 177.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -97.58 169.53 9.65 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.65 0.78 . . . . 71.04 110.202 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -87.65 89.72 8.1 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.684 -0.858 . . . . 73.24 108.684 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -66.21 146.52 54.53 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 123.98 0.912 . . . . 75.04 112.454 -173.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.54 132.44 11.08 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-N 115.682 -0.69 . . . . 63.13 111.63 178.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -147.48 142.52 27.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.445 0.698 . . . . 73.11 109.85 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -172.25 -169.59 35.14 Favored Glycine 0 C--N 1.339 0.732 0 N-CA-C 111.178 -0.769 . . . . 64.4 111.178 176.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 51.8 m -147.99 81.0 1.49 Allowed 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 109.328 -0.619 . . . . 61.51 109.328 177.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.429 ' HB3' ' HB2' ' G' ' 310' ' ' PRO . 3.0 tm-20 -74.48 102.76 4.58 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 107.289 -1.374 . . . . 71.0 107.289 170.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -68.62 108.94 3.54 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 109.119 -0.697 . . . . 75.21 109.119 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -125.12 137.71 54.17 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.043 0.937 . . . . 74.42 109.957 178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -142.69 133.18 25.01 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.351 1.06 . . . . 74.55 109.099 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -137.41 131.31 31.83 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 107.968 -1.123 . . . . 75.51 107.968 169.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.817 0 N-CA-C 108.862 -0.792 . . . . 37.97 108.862 -177.132 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 28.3 ttt . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 109.148 -0.686 . . . . 63.05 109.148 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 62.2 m -154.3 96.78 1.96 Allowed 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 107.793 -1.188 . . . . 65.52 107.793 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.7 151.17 40.78 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.482 0.713 . . . . 64.35 110.149 -172.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -129.2 102.5 6.49 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.632 0.773 . . . . 73.2 109.909 -176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . 0.416 ' ND2' HG22 ' D' ' 89' ' ' ILE . 4.5 p-10 -92.53 139.12 30.9 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.896 0.878 . . . . 64.33 110.852 -177.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -150.18 112.38 4.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.785 0.834 . . . . 50.25 109.257 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.8 t -179.62 -40.31 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.966 1.307 . . . . 72.11 109.51 171.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -98.83 -29.23 13.09 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.239 1.016 . . . . 64.02 110.095 178.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.451 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 10.4 ptm -34.21 142.53 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 115.284 1.587 . . . . 74.14 115.284 175.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 32.5 m -143.89 142.93 31.05 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 107.989 -1.115 . . . . 72.52 107.989 169.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -154.66 98.36 2.07 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.01 -1.107 . . . . 65.33 108.01 176.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -131.26 125.9 34.04 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.604 -1.258 . . . . 54.42 107.604 172.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 33.2 mt -69.59 124.42 25.46 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 108.504 -0.924 . . . . 62.43 108.504 175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.483 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 19.7 mm-40 -74.31 -48.98 24.9 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 109.707 -0.479 . . . . 74.43 109.707 177.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -161.85 156.63 22.86 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.824 1.25 . . . . 75.02 109.845 176.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.575 HD11 HH12 ' B' ' 111' ' ' ARG . 0.2 OUTLIER -126.87 125.41 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 105.631 -1.988 . . . . 70.51 105.631 165.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.479 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 32.4 p90 -155.36 153.74 30.92 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 121.889 0.852 . . . . 74.05 110.707 -172.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 69.7 p -77.77 110.75 12.9 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 114.172 -1.376 . . . . 52.03 108.438 174.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.479 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.7 mtpt -77.57 -36.54 51.96 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.061 -0.718 . . . . 74.12 109.061 175.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.627 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 23.5 t70 -140.49 137.86 34.16 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-N 114.537 -1.21 . . . . 74.15 109.324 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.471 HG21 ' HE2' ' C' ' 117' ' ' MET . 90.2 mt -132.81 142.95 41.02 Favored 'Isoleucine or valine' 0 C--O 1.241 0.63 0 C-N-CA 124.821 1.249 . . . . 73.22 107.963 174.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.1 t -147.16 136.54 22.68 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.569 1.148 . . . . 74.31 108.653 174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.404 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.1 t80 -143.36 123.58 13.76 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 106.592 -1.633 . . . . 75.52 106.592 167.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 34.3 mt-10 -127.37 127.03 43.54 Favored 'General case' 0 C--O 1.221 -0.402 0 C-N-CA 123.397 0.679 . . . . 71.32 109.269 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -113.72 84.18 8.04 Favored Pre-proline 0 CA--C 1.542 0.644 0 N-CA-C 106.549 -1.649 . . . . 72.1 106.549 169.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -72.46 -30.22 12.65 Favored 'Trans proline' 0 C--N 1.381 2.25 0 C-N-CA 122.823 2.349 . . . . 71.23 112.633 -167.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 69.2 m-20 -115.26 36.36 3.95 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 124.266 1.026 . . . . 53.33 108.89 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.518 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -48.48 -61.54 3.1 Favored Pre-proline 0 CA--C 1.569 1.703 0 N-CA-C 115.076 1.51 . . . . 70.34 115.076 -165.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.487 ' HB3' HD11 ' C' ' 83' ' ' ILE . 33.0 Cg_endo -85.65 -4.03 9.13 Favored 'Trans proline' 0 C--N 1.383 2.379 0 CA-C-N 122.671 1.99 . . . . 51.44 113.075 179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -80.92 -42.0 22.07 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.544 1.138 . . . . 74.0 109.414 176.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.744 HG21 ' HA ' ' D' ' 73' ' ' ALA . 14.0 p -76.27 -34.02 24.9 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.297 0 CA-C-N 115.248 -0.887 . . . . 63.53 110.295 -173.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -57.23 -16.78 9.09 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.12 0.968 . . . . 72.43 113.403 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -75.59 -37.21 60.02 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 122.887 0.475 . . . . 75.33 110.535 178.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 18.6 pttp -130.85 57.93 1.72 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 122.461 0.304 . . . . 73.52 110.899 168.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' G' ' 301' ' ' ILE . 12.0 t70 -100.7 94.96 6.35 Favored 'General case' 0 N--CA 1.485 1.28 0 O-C-N 121.354 -0.841 . . . . 55.23 109.556 -178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.403 ' H ' HD22 ' D' ' 68' ' ' LEU . 16.4 m95 -124.08 -164.85 1.28 Allowed 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 106.576 -1.638 . . . . 74.01 106.576 -175.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.484 ' HA ' ' HB3' ' G' ' 297' ' ' TYR . 0.0 OUTLIER -51.41 106.65 0.68 Allowed Pre-proline 0 N--CA 1.498 1.942 0 CA-C-N 119.167 0.894 . . . . 74.34 112.172 -176.413 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.451 ' HA ' ' HB3' ' D' ' 68' ' ' LEU . 4.7 Cg_exo -78.35 144.82 20.77 Favored 'Trans proline' 0 C--N 1.381 2.283 0 C-N-CA 122.589 2.193 . . . . 73.41 111.291 -174.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -79.09 112.89 16.75 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 107.276 -1.379 . . . . 61.55 107.276 168.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.9 142.58 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 123.496 0.718 . . . . 72.34 110.099 -168.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -118.89 147.46 43.96 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.534 1.134 . . . . 71.33 109.421 173.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.44 HD21 HD21 ' D' ' 128' ' ' LEU . 95.1 mt -106.83 118.38 36.54 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 108.04 -1.096 . . . . 73.0 108.04 170.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.622 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 19.3 t70 -106.46 129.93 54.35 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 107.908 -1.145 . . . . 75.33 107.908 175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.3 pp -106.82 156.52 18.58 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 123.698 0.799 . . . . 75.32 111.106 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.539 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 30.3 t70 -168.16 129.29 1.37 Allowed 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.274 -0.876 . . . . 70.01 109.265 172.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 40.7 p -106.09 148.49 27.74 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.647 0.779 . . . . 64.0 110.072 177.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.608 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -149.85 155.53 40.22 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.93 0.892 . . . . 50.25 108.789 177.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 51.0 p -163.17 153.91 16.53 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 123.275 0.63 . . . . 71.45 110.441 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 68.3 p -163.7 143.52 8.36 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 123.539 0.736 . . . . 61.45 110.079 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -78.4 122.59 25.99 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.463 -0.569 . . . . 71.22 109.463 173.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 35.7 mt -93.05 -39.43 11.09 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 109.454 -0.573 . . . . 70.3 109.454 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.404 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -153.5 -176.67 5.92 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.575 0.75 . . . . 75.04 110.49 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -68.34 119.85 13.52 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.201 -0.909 . . . . 50.33 109.594 -178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 64.03 7.02 3.12 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 124.811 1.245 . . . . 71.31 112.686 -175.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 56.1 t -114.89 108.9 26.6 Favored 'Isoleucine or valine' 0 C--O 1.242 0.688 0 N-CA-C 108.365 -0.976 . . . . 71.31 108.365 178.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -128.39 129.71 46.59 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.649 -1.16 . . . . 62.15 108.776 -169.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -96.69 129.26 44.13 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 124.267 1.027 . . . . 71.14 109.919 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 57.4 t -110.9 116.98 53.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 107.81 -1.182 . . . . 51.51 107.81 170.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.608 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 30.4 t -99.66 131.88 46.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 N-CA-C 108.521 -0.918 . . . . 50.35 108.521 175.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.85 108.92 12.99 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 108.064 -1.087 . . . . 64.24 108.064 -177.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.539 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 12.4 ttm180 -85.54 113.08 21.51 Favored 'General case' 0 C--O 1.241 0.616 0 C-N-CA 123.481 0.713 . . . . 73.22 109.796 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.49 103.43 15.25 Favored 'Isoleucine or valine' 0 C--O 1.24 0.575 0 N-CA-C 108.26 -1.015 . . . . 74.42 108.26 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.622 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 19.4 m -102.37 138.87 38.73 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.097 -0.705 . . . . 65.25 109.097 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 75.4 t -132.63 122.61 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.203 1.001 . . . . 74.12 109.91 -176.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 39.8 m -120.49 100.37 7.11 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.987 0.915 . . . . 51.32 109.59 -177.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.1 133.7 42.18 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.333 0.653 . . . . 74.23 109.879 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 20.7 m -148.03 126.7 12.54 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.064 0.946 . . . . 75.52 109.636 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.451 ' HB3' ' HA ' ' D' ' 38' ' ' PRO . 4.0 pp -126.53 140.26 52.59 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.267 0.627 . . . . 72.53 111.404 -179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.66 -111.84 3.72 Favored Glycine 0 C--N 1.343 0.954 0 N-CA-C 110.196 -1.161 . . . . 55.23 110.196 -176.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -123.45 4.47 9.03 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.769 0.828 . . . . 63.1 110.797 176.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -121.99 173.7 7.37 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.981 0.512 . . . . 54.21 110.542 -175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 23.9 m -82.09 139.15 34.59 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.776 -0.647 . . . . 52.13 109.638 173.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.744 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -84.7 -67.36 0.8 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 108.567 -0.901 . . . . 24.35 108.567 172.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -155.2 164.89 38.19 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.443 -1.253 . . . . 64.3 110.061 178.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.561 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 94.6 mt -134.38 151.68 51.35 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 125.229 1.412 . . . . 74.11 108.529 -176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.577 ' SG ' HG12 ' D' ' 114' ' ' ILE . 49.6 t -158.22 148.11 19.92 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.229 0.612 . . . . 52.14 110.097 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -156.59 126.05 6.18 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.476 0.71 . . . . 74.11 109.593 171.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.6 t -131.23 114.79 27.22 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.899 0.48 . . . . 71.43 109.772 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.627 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 52.8 mt-30 -90.56 88.78 7.27 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.949 -0.76 . . . . 74.5 108.949 173.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -80.34 96.39 6.65 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 114.657 -1.156 . . . . 72.32 109.328 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.01 141.64 17.81 Favored Glycine 0 C--N 1.341 0.85 0 N-CA-C 111.046 -0.822 . . . . 63.13 111.046 176.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -136.41 128.59 4.56 Favored Glycine 0 CA--C 1.505 -0.578 0 N-CA-C 110.537 -1.025 . . . . 61.15 110.537 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.483 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 29.5 mt -93.39 127.04 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 107.987 -1.116 . . . . 71.11 107.987 179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -128.78 126.66 40.41 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.658 0.783 . . . . 63.21 110.18 -175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.1 m -82.99 93.4 7.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 108.602 -0.888 . . . . 63.23 108.602 169.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 49.9 mt -108.45 109.73 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 108.772 -0.825 . . . . 72.41 108.772 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.48 167.15 21.91 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.16 0.984 . . . . 62.31 110.428 -176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 73.94 0.78 57.32 Favored Glycine 0 C--N 1.347 1.165 0 N-CA-C 114.787 0.675 . . . . 64.41 114.787 170.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.498 HG21 HE21 ' D' ' 93' ' ' GLN . 29.0 pt -137.92 162.21 31.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 C-N-CA 124.513 1.125 . . . . 74.44 109.73 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.14 -171.29 3.44 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.326 1.051 . . . . 73.34 109.501 176.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 56.41 -122.79 29.31 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 115.514 0.966 . . . . 75.32 115.514 167.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -60.31 -54.13 49.34 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.911 1.284 . . . . 54.22 112.137 -173.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.498 HE21 HG21 ' D' ' 89' ' ' ILE . 29.3 tt0 -70.94 -39.72 72.45 Favored 'General case' 0 N--CA 1.476 0.873 0 O-C-N 123.383 0.427 . . . . 71.45 111.752 -172.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.16 -42.89 59.23 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 122.908 0.483 . . . . 74.43 111.269 -174.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.6 -36.92 83.79 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 122.94 0.496 . . . . 72.34 110.817 178.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -74.7 -27.18 60.28 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.681 -0.69 . . . . 75.34 110.771 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -65.51 -50.76 64.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.036 0.534 . . . . 71.01 110.381 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.609 HD21 ' HA ' ' G' ' 278' ' ' LEU . 4.3 pp -79.66 -17.51 53.54 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.404 0.282 . . . . 74.54 111.391 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -85.36 -5.7 84.81 Favored Glycine 0 C--N 1.344 1.008 0 O-C-N 123.327 0.392 . . . . 71.34 114.069 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -146.12 -59.03 0.31 Allowed 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.908 0.354 . . . . 64.32 111.534 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -74.38 -53.71 9.07 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.413 0.685 . . . . 62.21 112.118 -170.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 63.4 m -61.45 -43.27 88.55 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 114.053 1.131 . . . . 74.33 114.053 -174.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -65.79 -29.15 50.87 Favored 'Trans proline' 0 C--N 1.396 3.069 0 C-N-CA 121.823 1.682 . . . . 64.54 111.874 174.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -73.9 -22.32 59.74 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.191 0.996 . . . . 73.12 110.664 177.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 36.1 mm -76.95 -45.01 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 C-N-CA 123.387 0.675 . . . . 74.03 109.95 172.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' D' ' 82' ' ' GLY . 95.7 mt -72.47 -30.98 65.04 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.576 -0.738 . . . . 71.5 111.807 -174.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 49.5 t80 -64.78 -41.96 60.14 Favored Pre-proline 0 CA--C 1.568 1.662 0 N-CA-C 114.405 1.261 . . . . 62.24 114.405 -169.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -52.48 -39.56 74.02 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.381 2.054 . . . . 61.11 113.578 172.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -75.72 -35.5 60.23 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.612 0.765 . . . . 74.3 110.913 -178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.96 -47.8 79.01 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.234 0.614 . . . . 72.4 110.279 174.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 39.8 ttp180 -59.6 -46.17 89.75 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.626 1.17 . . . . 71.13 110.78 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.73 -44.78 96.24 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 124.141 0.901 . . . . 74.3 111.014 -177.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -59.82 -45.14 93.3 Favored 'General case' 0 N--CA 1.475 0.807 0 O-C-N 123.864 0.728 . . . . 74.3 110.691 -179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.577 HG12 ' SG ' ' D' ' 76' ' ' CYS . 57.6 mt -59.53 -54.77 29.81 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.017 0.927 . . . . 74.24 110.686 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 27.8 m -52.46 -47.62 66.34 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.481 1.112 . . . . 62.42 111.302 -176.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 35.5 t -65.06 -42.8 93.87 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.425 -1.261 . . . . 51.53 110.809 -173.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.416 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.9 mtm -70.68 -37.34 73.63 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 122.777 0.431 . . . . 53.22 111.812 -178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.442 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -65.15 -41.51 91.92 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 CA-C-N 115.684 -0.689 . . . . 74.53 109.774 177.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 94.1 p -72.21 -29.04 63.58 Favored 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 122.985 0.514 . . . . 55.03 111.241 177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 63.5 mtt-85 -70.82 -29.07 65.13 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.397 0.679 . . . . 70.11 110.418 174.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.51 10.1 60.11 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.954 -0.566 . . . . 42.03 112.576 173.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 42.9 p 59.87 23.43 12.44 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.853 2.061 . . . . 74.13 112.985 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 51.5 m-85 -88.84 174.61 4.83 Favored Pre-proline 0 CA--C 1.564 1.487 0 C-N-CA 125.193 1.397 . . . . 65.33 108.831 170.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.552 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 33.9 Cg_endo -59.21 167.36 6.04 Favored 'Trans proline' 0 C--N 1.386 2.542 0 C-N-CA 122.913 2.408 . . . . 75.31 113.929 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.496 ' NE2' HD21 ' D' ' 127' ' ' ASN . 3.5 pt20 -73.82 131.28 41.37 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.937 -1.135 . . . . 74.45 107.937 164.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 5.2 tt -107.46 93.59 4.63 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.706 -1.22 . . . . 64.51 107.706 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.496 HD21 ' NE2' ' D' ' 125' ' ' GLN . 50.3 m-20 -98.23 99.01 10.2 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 107.539 -1.282 . . . . 71.21 107.539 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.44 HD21 HD21 ' D' ' 42' ' ' LEU . 0.3 OUTLIER -71.08 136.03 48.04 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.768 -0.651 . . . . 73.24 109.664 -176.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -58.81 137.31 87.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 C-N-CA 124.417 1.087 . . . . 73.21 111.42 -178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.478 ' HD3' HG22 ' B' ' 13' ' ' ILE . 16.9 Cg_exo -68.91 106.26 1.48 Allowed 'Trans proline' 0 C--N 1.372 1.766 0 C-N-CA 122.935 2.423 . . . . 44.23 111.921 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 75.8 t -108.81 109.16 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 123.554 0.741 . . . . 45.11 109.152 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -85.73 106.88 17.31 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.338 0.655 . . . . 44.41 109.795 -179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -64.42 -31.84 73.22 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 124.148 0.979 . . . . 72.31 111.429 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -62.72 -46.78 86.52 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.106 -0.952 . . . . 74.21 110.772 -176.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.2 -39.5 92.95 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 124.288 0.993 . . . . 72.44 111.815 -178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 84.1 mt -67.16 -48.58 67.58 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.423 0.689 . . . . 73.43 111.513 -175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -71.86 -32.12 67.17 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.097 0.559 . . . . 74.45 111.059 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 43.7 ttm -58.68 -37.57 76.34 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.558 1.143 . . . . 63.05 111.379 -178.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -62.21 -35.46 78.95 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.022 -0.99 . . . . 61.41 111.695 -177.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 65.1 t80 -57.84 -43.74 86.03 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.351 0.661 . . . . 74.24 110.921 176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.594 ' HA ' HE21 ' D' ' 144' ' ' GLN . 8.2 mp -67.14 -43.15 83.08 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 115.771 -0.65 . . . . 71.21 111.336 -177.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.421 ' OE1' ' HG3' ' D' ' 143' ' ' GLN . 0.0 OUTLIER -90.34 4.24 51.37 Favored 'General case' 0 N--CA 1.483 1.176 0 N-CA-C 112.92 0.711 . . . . 71.12 112.92 -174.454 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.421 ' HG3' ' OE1' ' D' ' 142' ' ' GLN . 75.6 mt-30 -119.62 46.95 1.81 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.345 0.593 . . . . 73.34 109.889 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . 0.594 HE21 ' HA ' ' D' ' 141' ' ' LEU . 28.2 pt20 -159.05 19.76 0.19 Allowed 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 115.527 -0.761 . . . . 64.15 110.919 173.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -124.62 6.72 8.21 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.503 0.721 . . . . 73.02 111.224 -177.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 71.78 -84.24 0.47 Allowed Glycine 0 C--N 1.35 1.325 0 N-CA-C 111.02 -0.832 . . . . 75.01 111.02 -174.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -130.17 -59.0 1.06 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 108.017 -1.105 . . . . 72.11 108.017 173.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 77.27 -77.06 1.58 Allowed Glycine 0 C--N 1.346 1.111 0 CA-C-N 114.83 -1.077 . . . . 72.21 111.696 -177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.7 t -151.29 157.88 43.12 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.977 0.911 . . . . 73.52 109.293 178.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.71 -175.96 5.0 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 123.495 0.718 . . . . 73.31 109.974 -178.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -131.63 -64.4 0.79 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.223 0.609 . . . . 73.11 109.389 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -84.33 84.75 7.52 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 108.737 -0.838 . . . . 72.11 108.737 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -64.35 108.83 1.72 Allowed 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.468 0.707 . . . . 72.31 111.688 -170.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -160.74 86.08 0.71 Allowed 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.482 -0.932 . . . . 75.34 108.482 177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 C-N-CA 123.879 0.872 . . . . 73.41 109.188 178.715 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 119.267 -0.397 . . . . 72.44 110.186 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 66.1 t30 79.86 -12.21 1.08 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 125.683 1.593 . . . . 72.12 111.818 -178.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 67.18 -73.11 0.08 Allowed 'General case' 0 C--N 1.36 1.031 0 C-N-CA 126.168 1.787 . . . . 74.34 111.878 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -60.95 -74.58 0.08 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.664 1.186 . . . . 54.4 111.459 -173.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -125.08 88.9 53.49 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 122.809 0.443 . . . . 60.2 110.504 -172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -74.14 -32.11 7.13 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 123.408 2.739 . . . . 74.03 114.406 -172.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 1.1 tt -67.13 -30.4 70.39 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.702 0.401 . . . . 72.25 110.427 -173.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 67.0 mt -101.31 55.88 0.84 Allowed 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.078 0.551 . . . . 72.34 110.182 175.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -75.86 -38.21 36.82 Favored Glycine 0 C--N 1.346 1.138 0 CA-C-N 115.97 -0.559 . . . . 62.53 112.226 174.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.486 HD11 ' HB2' ' A' ' 95' ' ' ALA . 1.0 OUTLIER -133.17 -168.62 2.12 Favored 'General case' 0 C--O 1.244 0.787 0 C-N-CA 124.016 0.926 . . . . 73.12 109.634 -179.879 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 85.3 t80 73.41 132.95 0.04 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.839 1.656 . . . . 65.52 110.096 -171.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 47' ' ' ALA . . . 72.87 5.38 5.19 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 125.215 1.406 . . . . 64.45 111.457 -169.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.1 -9.11 49.62 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.612 0.765 . . . . 73.5 110.611 179.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -157.97 -58.61 0.01 OUTLIER Glycine 0 C--N 1.35 1.345 0 N-CA-C 111.963 -0.455 . . . . 65.54 111.963 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 70.08 172.58 0.31 Allowed 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 125.474 1.51 . . . . 75.31 111.904 -179.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . 0.411 ' HA ' ' HD3' ' E' ' 287' ' ' PRO . 0.0 OUTLIER -131.45 122.84 19.13 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.399 0.679 . . . . 75.54 110.171 -179.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' E' ' 286' ' ' MET . 2.0 Cg_endo -82.15 115.32 2.62 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.702 2.268 . . . . 74.55 111.169 174.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 84.1 t -86.09 125.36 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 N-CA-C 108.569 -0.9 . . . . 70.23 108.569 174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 8.6 mpt_? -89.23 172.74 8.84 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.554 0.741 . . . . 45.24 109.747 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 69.1 m95 -72.27 150.01 43.99 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-O 121.314 0.578 . . . . 62.12 111.556 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 4.2 mp -88.23 11.12 17.33 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-N 114.603 -1.181 . . . . 72.54 110.932 -178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -159.49 -176.74 31.89 Favored Glycine 0 C--N 1.351 1.382 0 CA-C-N 115.978 -0.556 . . . . 65.15 112.42 -178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -87.89 -155.44 0.05 OUTLIER 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 123.893 3.062 . . . . 74.31 113.842 -171.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 pttt -56.75 87.31 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.565 1.146 . . . . 51.34 110.597 169.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . 0.41 ' HB1' ' O ' ' G' ' 304' ' ' PRO . . . -142.15 -168.64 2.76 Favored 'General case' 0 C--O 1.241 0.648 0 CA-C-N 115.472 -0.786 . . . . 60.53 109.815 -172.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 46.6 m 79.22 -28.47 0.15 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.93 1.692 . . . . 75.33 112.114 178.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.728 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 21.7 t80 -77.0 86.3 3.52 Favored 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.784 0.834 . . . . 70.41 111.691 -170.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . 0.815 ' H ' ' HB3' ' A' ' 124' ' ' PRO . 1.2 p-80 -145.76 54.69 1.17 Allowed 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 125.067 1.347 . . . . 73.53 111.279 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.06 166.5 19.04 Favored Glycine 0 N--CA 1.482 1.708 0 CA-C-O 119.062 -0.854 . . . . 53.13 112.016 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . 0.534 ' HA ' ' ND2' ' G' ' 300' ' ' ASN . 9.4 t30 -64.42 96.48 0.16 Allowed 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 122.97 0.508 . . . . 74.12 110.224 -176.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.462 HD11 ' HA ' ' A' ' 32' ' ' PHE . 15.4 tt -133.54 4.76 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.972 0 C-N-CA 123.859 0.864 . . . . 70.33 110.446 -172.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -52.79 -63.99 0.96 Allowed 'General case' 0 C--N 1.363 1.163 0 C-N-CA 124.5 1.12 . . . . 61.34 111.495 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 19.1 mmmt 53.73 70.02 1.95 Allowed Pre-proline 0 CA--C 1.558 1.286 0 O-C-N 124.785 1.303 . . . . 74.41 110.432 -171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -71.35 -63.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.384 2.414 0 C-N-CA 122.265 1.977 . . . . 73.11 112.468 -175.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -171.82 124.56 0.55 Allowed 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.923 0.889 . . . . 63.22 109.352 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 86.4 t -100.46 122.13 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 108.822 -0.807 . . . . 74.42 108.822 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 27.0 m -77.02 132.53 39.0 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 123.171 0.588 . . . . 74.22 110.34 177.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 53.9 m -66.76 159.63 27.54 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.054 0.941 . . . . 51.01 111.133 178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 6.1 p -68.67 -40.77 19.24 Favored Pre-proline 0 CA--C 1.564 1.487 0 CA-C-O 117.887 -1.054 . . . . 73.33 113.364 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 C--N 1.399 3.234 0 CA-C-N 121.733 1.655 . . . . 73.45 111.573 170.05 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 110.219 -0.289 . . . . 53.31 110.219 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -80.68 142.82 33.54 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.789 0.836 . . . . 73.54 111.859 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -113.85 -50.81 2.82 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.904 0.882 . . . . 72.31 109.504 177.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -155.91 129.14 8.16 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.66 0.784 . . . . 74.35 109.65 -175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -63.78 -50.3 71.81 Favored Pre-proline 0 N--CA 1.49 1.542 0 CA-C-O 118.422 -0.799 . . . . 70.31 112.927 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -70.63 -174.0 0.97 Allowed 'Trans proline' 0 C--N 1.385 2.495 0 C-N-CA 121.623 1.549 . . . . 72.31 112.423 173.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.1 mp -64.27 168.63 5.37 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 115.435 -0.802 . . . . 70.22 110.304 175.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.546 HD12 ' HE3' ' C' ' 94' ' ' MET . 5.4 mp 79.15 95.18 0.06 Allowed 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 125.211 1.404 . . . . 74.55 109.874 -170.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -139.54 43.78 1.13 Allowed Glycine 0 C--N 1.354 1.581 0 CA-C-N 116.058 -0.519 . . . . 74.33 113.104 -178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 10.5 tt -178.98 -53.32 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.938 -1.134 . . . . 72.42 107.938 -176.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -80.9 172.0 14.29 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 114.133 -1.394 . . . . 73.11 110.549 -174.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 72.04 20.55 4.3 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 125.001 1.32 . . . . 61.12 109.664 -171.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -140.82 134.49 30.23 Favored 'General case' 0 C--O 1.241 0.621 0 C-N-CA 125.973 1.709 . . . . 61.5 108.001 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -80.07 64.63 3.91 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 112.007 -0.437 . . . . 42.01 112.007 178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -67.91 -49.89 59.28 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.709 0.804 . . . . 73.31 110.724 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 65.6 mtt -103.36 106.32 51.0 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.884 0.874 . . . . 73.31 109.284 -178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -65.97 -38.16 23.71 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 123.32 2.68 . . . . 74.51 112.817 178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 17.6 t 56.42 55.69 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.986 1.314 . . . . 72.4 110.548 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 19.2 mmt85 -79.62 71.01 6.21 Favored 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.511 -0.768 . . . . 55.55 110.724 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 98.6 m95 61.17 91.85 0.06 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 125.962 1.705 . . . . 75.24 114.144 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.24 91.66 0.17 Allowed 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 114.75 -1.114 . . . . 75.44 108.808 163.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 87.89 108.68 0.98 Allowed Glycine 0 C--N 1.349 1.267 0 CA-C-O 118.493 -1.17 . . . . 71.12 110.517 -169.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -58.16 113.51 1.56 Allowed 'Trans proline' 0 C--N 1.379 2.165 0 C-N-CA 123.528 2.819 . . . . 71.11 112.539 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . 0.512 ' HE2' ' HB2' ' C' ' 129' ' ' ALA . 60.7 mttp -126.87 86.31 2.49 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.849 0.859 . . . . 72.44 109.165 -177.372 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -77.32 142.32 39.46 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 115.303 -0.862 . . . . 62.43 111.778 -176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . 0.483 HG22 ' H ' ' F' ' 297' ' ' TYR . 4.6 m -80.17 178.45 8.25 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 108.132 -1.062 . . . . 75.04 108.132 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.483 ' H ' HG22 ' F' ' 296' ' ' THR . 94.1 m-85 64.4 19.67 11.88 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.882 0.873 . . . . 71.41 112.596 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -68.15 116.64 8.99 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 108.439 -0.948 . . . . 64.4 108.439 170.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 90.0 123.89 2.59 Favored Glycine 0 CA--C 1.528 0.896 0 N-CA-C 110.629 -0.989 . . . . 44.24 110.629 -169.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -60.78 116.53 4.49 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.195 0.998 . . . . 64.12 110.734 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.523 HG21 ' HD3' ' C' ' 124' ' ' PRO . 2.7 pp -114.92 14.83 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.273 0 C-N-CA 123.49 0.716 . . . . 42.14 111.796 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -55.36 -27.84 49.94 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 124.318 1.047 . . . . 73.02 111.306 173.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' F' ' 303' ' ' LYS . 0.3 OUTLIER -78.28 123.11 85.92 Favored Pre-proline 0 CA--C 1.547 0.834 0 CA-C-N 114.779 -1.101 . . . . 71.32 108.762 175.033 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -52.59 -31.29 48.86 Favored 'Trans proline' 0 C--N 1.373 1.84 0 C-N-CA 124.081 3.188 . . . . 71.4 114.072 -179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 76.21 -47.13 0.55 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.579 1.552 . . . . 63.41 112.017 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . 0.433 HG13 ' HB1' ' B' ' 129' ' ' ALA . 57.5 t -71.85 101.83 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 109.058 -0.719 . . . . 63.42 109.058 172.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 15.0 t -162.17 -175.59 4.67 Favored 'General case' 0 C--O 1.247 0.933 0 C-N-CA 125.164 1.386 . . . . 73.45 107.399 176.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . 0.417 ' SG ' ' HA ' ' B' ' 149' ' ' THR . 52.0 t 64.69 30.45 12.51 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-O 121.768 0.794 . . . . 52.1 110.455 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 40.4 p -88.48 119.96 70.25 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 124.028 0.931 . . . . 71.13 109.773 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo . . . . . 0 C--N 1.38 2.186 0 C-N-CA 122.764 2.31 . . . . 72.2 111.311 174.542 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 110.308 -0.256 . . . . 73.23 110.308 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -79.33 86.38 5.07 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.342 -0.614 . . . . 71.52 109.342 172.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -121.48 154.46 36.58 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.22 0.608 . . . . 62.43 109.781 176.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -123.7 149.53 45.4 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.218 1.007 . . . . 65.21 109.209 176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 57.9 mttp 55.27 65.54 4.64 Favored Pre-proline 0 CA--C 1.562 1.429 0 C-N-CA 124.486 1.114 . . . . 65.52 110.306 -171.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -77.12 80.08 2.97 Favored 'Trans proline' 0 C--N 1.384 2.419 0 C-N-CA 122.51 2.14 . . . . 64.23 110.706 -176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 50.7 mt 66.29 170.57 0.23 Allowed 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 124.838 1.255 . . . . 73.32 111.241 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . 0.609 ' HA ' HD21 ' D' ' 98' ' ' LEU . 3.8 mm? 67.06 -80.09 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.246 1.418 . . . . 62.32 112.3 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 67.84 -97.46 0.42 Allowed Glycine 0 CA--C 1.535 1.293 0 N-CA-C 111.903 -0.479 . . . . 75.43 111.903 -173.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.5 HD13 ' H ' ' G' ' 283' ' ' ASP . 2.8 pp -165.18 168.88 16.69 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 124.272 1.029 . . . . 65.23 110.204 177.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -76.76 -70.32 0.46 Allowed 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.392 0.433 . . . . 72.54 110.023 174.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -158.26 43.5 0.29 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 109.32 -0.622 . . . . 63.42 109.32 -177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . 0.5 ' H ' HD13 ' G' ' 280' ' ' LEU . 6.3 m-20 58.25 78.06 0.26 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.728 1.211 . . . . 55.34 110.126 -176.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.64 -159.77 25.05 Favored Glycine 0 CA--C 1.527 0.819 0 CA-C-N 115.428 -0.806 . . . . 72.22 111.549 -170.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -95.82 145.53 25.27 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.663 0.785 . . . . 73.24 110.111 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 54.7 tpp -65.82 128.16 93.62 Favored Pre-proline 0 CA--C 1.548 0.897 0 C-N-CA 123.671 0.789 . . . . 70.05 110.05 177.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -65.97 86.47 0.24 Allowed 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 122.43 2.086 . . . . 71.34 112.018 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 89.7 t -79.23 114.22 19.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.596 0.758 . . . . 63.21 109.409 178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -121.07 147.51 45.43 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.902 0.881 . . . . 73.33 109.697 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.428 ' NE1' ' HG ' ' D' ' 42' ' ' LEU . 15.5 m95 -70.84 115.1 9.59 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.046 0.539 . . . . 72.12 110.407 173.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.79 -48.92 77.04 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.404 0.682 . . . . 73.41 109.248 173.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -127.5 99.78 0.53 Allowed Glycine 0 C--N 1.345 1.047 0 CA-C-O 118.763 -1.02 . . . . 62.25 110.672 177.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -61.94 -11.88 23.38 Favored 'Trans proline' 0 C--N 1.378 2.101 0 C-N-CA 123.545 2.83 . . . . 63.24 114.085 -175.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -138.78 25.78 2.54 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.043 0.937 . . . . 73.31 110.571 -178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -73.32 -1.61 18.7 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.67 0.788 . . . . 75.04 112.554 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 77.4 m -124.02 130.93 53.39 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.12 1.368 . . . . 73.24 109.462 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.484 ' HB3' ' HA ' ' D' ' 37' ' ' GLN . 0.6 OUTLIER 75.43 160.37 0.23 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.035 1.334 . . . . 73.54 112.165 172.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -151.38 -42.61 0.12 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.247 1.419 . . . . 71.52 107.776 170.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 152.58 112.23 0.5 Allowed Glycine 0 C--N 1.344 1.024 0 N-CA-C 111.555 -0.618 . . . . 45.21 111.555 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . 0.534 ' ND2' ' HA ' ' E' ' 300' ' ' ASN . 38.2 m-80 -115.67 -2.71 12.4 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-N 117.166 0.483 . . . . 71.12 111.187 177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.418 ' CD1' ' HB3' ' D' ' 35' ' ' ASP . 63.0 mt -72.86 89.16 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.954 0 CA-C-O 121.976 0.893 . . . . 74.04 109.498 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -161.36 175.52 12.14 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.941 1.696 . . . . 70.23 106.852 -177.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm 67.14 127.04 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.895 0 C-N-CA 124.144 0.978 . . . . 64.21 111.913 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . 0.41 ' O ' ' HB1' ' E' ' 295' ' ' ALA . 34.4 Cg_exo -61.52 156.37 47.4 Favored 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.702 2.268 . . . . 64.1 112.687 175.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -154.04 125.32 7.42 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 108.955 -0.757 . . . . 61.34 108.955 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 99.9 t 67.17 136.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 C-N-CA 124.887 1.275 . . . . 62.21 111.885 -177.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 38.8 m -140.58 143.87 35.53 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.453 -0.943 . . . . 72.32 108.453 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 11.3 p -58.55 140.27 54.47 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.811 0.844 . . . . 40.25 110.575 175.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 24.8 p -55.2 103.69 0.38 Allowed Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.929 1.291 . . . . 62.15 112.192 -172.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . 0.429 ' HB2' ' HB3' ' C' ' 150' ' ' GLU . 60.1 Cg_endo . . . . . 0 C--N 1.38 2.207 0 C-N-CA 123.204 2.603 . . . . 64.52 111.551 -176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.588 -0.523 . . . . 74.33 109.588 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 14.4 m120 60.31 36.49 20.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.397 1.079 . . . . 60.24 112.021 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -61.83 -24.25 66.76 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 123.216 0.607 . . . . 74.32 111.314 178.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 16.3 mp0 -92.54 134.22 35.19 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 107.494 -1.298 . . . . 74.12 107.494 172.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -109.19 93.16 12.49 Favored Pre-proline 0 N--CA 1.475 0.779 0 N-CA-C 108.953 -0.758 . . . . 71.53 108.953 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -85.03 112.78 1.47 Allowed 'Trans proline' 0 C--N 1.374 1.887 0 C-N-CA 122.543 2.162 . . . . 75.23 111.401 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 mp -59.17 -44.52 92.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.326 0.65 . . . . 74.34 110.23 174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . 0.573 HD11 ' HB2' ' H' ' 281' ' ' PHE . 1.9 tm? -58.48 118.07 5.2 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.156 0.982 . . . . 73.33 111.257 -172.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -144.74 50.66 0.64 Allowed Glycine 0 C--N 1.345 1.06 0 O-C-N 123.842 0.714 . . . . 74.44 111.694 175.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' B' ' 95' ' ' ALA . 47.8 tp -146.11 -59.64 0.31 Allowed 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 122.828 0.451 . . . . 63.14 110.85 179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . 0.573 ' HB2' HD11 ' H' ' 278' ' ' LEU . 38.4 m-85 -61.89 103.42 0.35 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.064 0.546 . . . . 75.45 110.926 -179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -163.81 -73.29 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.836 0.854 . . . . 35.42 108.714 175.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -133.89 -34.05 1.02 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.034 0.934 . . . . 70.34 110.297 177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -69.63 93.24 0.37 Allowed Glycine 0 C--N 1.348 1.245 0 O-C-N 123.568 0.543 . . . . 74.03 112.739 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -124.27 154.18 40.61 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.83 0.852 . . . . 65.15 109.043 176.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -72.54 121.11 84.02 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 123.213 0.605 . . . . 70.33 109.502 176.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -66.45 99.87 0.45 Allowed 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 122.28 1.987 . . . . 62.53 111.267 178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 74.1 t -62.02 -33.23 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 124.335 1.054 . . . . 75.12 111.043 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 76.93 -20.03 0.4 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 125.086 1.354 . . . . 74.02 112.535 173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 14.6 t-105 66.98 124.31 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 125.187 1.395 . . . . 74.01 109.845 -167.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 6.1 mp -63.56 155.24 30.09 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.239 1.016 . . . . 62.23 112.105 -168.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -52.84 -59.59 9.1 Favored Glycine 0 C--N 1.352 1.454 0 O-C-N 124.653 1.221 . . . . 51.13 113.881 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -74.97 127.28 10.58 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.565 2.177 . . . . 73.51 111.474 170.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -94.12 112.66 24.5 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 108.612 -0.884 . . . . 72.3 108.612 176.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -78.14 -9.89 59.38 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.708 0.803 . . . . 71.44 112.169 178.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . 0.457 ' HB ' HG21 ' B' ' 40' ' ' VAL . 4.7 m -70.92 130.24 41.12 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.396 1.078 . . . . 73.22 111.556 -177.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 1.7 t80 59.62 98.94 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 125.398 1.479 . . . . 73.42 111.305 176.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 51.3 m80 -131.52 131.63 43.56 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.449 0.7 . . . . 73.21 109.384 171.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 109.39 170.41 20.49 Favored Glycine 0 C--N 1.335 0.523 0 N-CA-C 110.476 -1.05 . . . . 62.44 110.476 -167.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -132.75 161.96 32.69 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.983 0.913 . . . . 75.11 108.981 176.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . 0.53 HD11 ' HB3' ' B' ' 35' ' ' ASP . 67.9 mt -63.58 -58.91 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.628 -0.878 . . . . 72.33 108.628 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 37.3 t70 61.94 -76.93 0.03 OUTLIER 'General case' 0 C--N 1.356 0.89 0 C-N-CA 126.005 1.722 . . . . 62.43 112.021 176.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -106.06 119.79 51.04 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 123.895 0.878 . . . . 60.1 109.202 177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.33 85.97 0.16 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.73 2.287 . . . . 63.22 111.021 169.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.41 -9.96 59.04 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.962 0.905 . . . . 72.44 112.574 -175.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 22.1 t -81.72 78.82 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 N-CA-C 108.505 -0.924 . . . . 74.12 108.505 173.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 21.5 p -110.31 -178.14 3.43 Favored 'General case' 0 C--O 1.246 0.897 0 CA-C-N 114.289 -1.323 . . . . 74.13 109.957 -178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 74.6 m -58.43 120.17 8.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.182 0.593 . . . . 74.22 109.979 174.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 41.2 p -55.54 113.79 6.2 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.771 1.229 . . . . 74.43 111.429 -175.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo . . . . . 0 C--N 1.38 2.233 0 C-N-CA 122.88 2.386 . . . . 41.52 112.509 -175.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.7 ttm . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.111 -0.7 . . . . 63.21 109.111 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.4 m -64.9 119.58 10.96 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.069 0.948 . . . . 74.4 111.118 -179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -81.43 -87.9 0.08 Allowed 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 106.908 -1.516 . . . . 60.24 106.908 170.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 61.04 11.67 3.53 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 114.758 1.392 . . . . 54.44 114.758 167.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -74.81 -28.68 60.81 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 122.873 0.469 . . . . 63.12 110.693 177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.521 ' HB3' ' SD ' ' A' ' 9' ' ' MET . 87.2 m-20 59.75 47.92 9.82 Favored 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.085 0.866 . . . . 73.44 111.608 172.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 54.0 p -78.13 -67.26 0.75 Allowed 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.714 0.805 . . . . 64.13 111.798 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -90.67 3.18 54.91 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.339 0.656 . . . . 72.25 112.187 -171.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.521 ' SD ' ' HB3' ' A' ' 6' ' ' ASN . 17.7 ptm -58.28 133.78 55.98 Favored 'General case' 0 C--N 1.359 0.989 0 CA-C-O 121.526 0.679 . . . . 74.42 111.883 -172.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 61.9 m -151.06 140.17 21.15 Favored 'General case' 0 C--O 1.241 0.633 0 CA-C-N 114.7 -1.136 . . . . 41.51 108.391 -178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 1.6 t80 -134.25 134.87 42.45 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 109.168 -0.678 . . . . 73.4 109.168 174.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -152.39 117.71 5.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.89 -1.152 . . . . 75.45 107.89 174.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.402 HG12 ' HD2' ' A' ' 84' ' ' PHE . 51.5 mt -75.07 126.78 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 109.123 -0.695 . . . . 63.24 109.123 176.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.3 mm-40 -92.04 -37.93 12.52 Favored 'General case' 0 C--O 1.243 0.758 0 O-C-N 123.829 0.705 . . . . 74.14 110.793 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 36.3 ttt85 -176.92 127.92 0.17 Allowed 'General case' 0 N--CA 1.486 1.333 0 O-C-N 123.78 0.675 . . . . 72.4 111.629 -173.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.4 mp -110.52 136.62 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 N-CA-C 108.328 -0.99 . . . . 61.43 108.328 169.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.475 ' HE2' ' HB1' ' B' ' 28' ' ' ALA . 26.1 p90 -170.02 156.45 6.05 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.793 0.837 . . . . 64.15 111.226 -176.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 82.4 p -82.27 113.55 20.16 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.801 -0.814 . . . . 71.53 108.801 172.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.7 mtpt -75.04 -31.23 61.26 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.66 -0.496 . . . . 74.52 109.66 174.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 27.1 t70 -150.88 141.13 22.29 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 115.008 -0.996 . . . . 61.52 109.889 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.462 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 80.9 mt -134.67 143.86 36.49 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 C-N-CA 125.503 1.521 . . . . 64.14 107.167 176.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 35.9 t -153.02 132.83 13.19 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 123.841 0.856 . . . . 64.13 108.738 174.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 82.4 t80 -139.87 119.21 12.91 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 106.78 -1.563 . . . . 72.42 106.78 174.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -120.19 131.09 54.85 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 123.147 0.579 . . . . 65.21 109.869 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.62 77.67 63.8 Favored Pre-proline 0 C--O 1.243 0.761 0 N-CA-C 106.709 -1.589 . . . . 63.35 106.709 169.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -64.75 -39.89 24.46 Favored 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.519 2.146 . . . . 74.02 111.764 -173.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -97.13 25.38 5.51 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.353 -0.84 . . . . 44.22 110.154 -176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -57.09 9.22 Favored Pre-proline 0 CA--C 1.565 1.557 0 CA-C-O 117.565 -1.207 . . . . 65.11 113.458 -169.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -64.0 -21.78 68.33 Favored 'Trans proline' 0 C--N 1.398 3.135 0 CA-C-N 122.132 1.797 . . . . 44.13 112.804 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.5 m-70 -85.07 -40.31 16.96 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.15 0.98 . . . . 74.4 110.643 -177.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.838 HG21 ' HA ' ' A' ' 73' ' ' ALA . 5.9 p -76.92 -20.35 14.56 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.545 -0.752 . . . . 74.5 112.079 -159.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.5 ' HA ' HD11 ' E' ' 301' ' ' ILE . 38.5 m-85 -64.57 -23.17 67.18 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.002 0.521 . . . . 74.1 112.231 176.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -103.9 -11.13 17.67 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.43 0.692 . . . . 71.42 112.755 174.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.468 ' HE3' ' HG2' ' A' ' 71' ' ' GLU . 20.9 mmtt -65.4 171.1 4.18 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 124.136 0.974 . . . . 73.13 113.598 -170.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -49.12 122.05 5.51 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 125.181 1.393 . . . . 71.44 111.948 -177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 50.6 m95 -86.95 63.26 7.86 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.085 0.554 . . . . 72.43 110.241 -176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -147.38 82.31 8.27 Favored Pre-proline 0 N--CA 1.476 0.828 0 C-N-CA 123.871 0.868 . . . . 50.44 109.082 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' E' ' 294' ' ' LYS . 5.2 Cg_endo -84.47 165.52 12.39 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.98 2.454 . . . . 75.52 112.772 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -131.36 106.05 8.02 Favored 'General case' 0 C--O 1.237 0.401 0 N-CA-C 107.288 -1.375 . . . . 73.0 107.288 161.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' E' ' 294' ' ' LYS . 10.3 p -79.0 91.54 1.44 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.243 0 CA-C-O 123.066 1.412 . . . . 74.24 108.467 176.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 40.6 tttm -83.7 118.15 23.69 Favored 'General case' 0 C--O 1.239 0.528 0 CA-C-N 113.924 -1.489 . . . . 52.23 109.89 -176.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -97.22 111.35 23.63 Favored 'General case' 0 C--O 1.237 0.415 0 N-CA-C 107.388 -1.338 . . . . 70.42 107.388 -175.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.67 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 19.6 m-20 -108.4 108.35 19.27 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.262 -1.014 . . . . 71.22 108.262 175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -98.38 118.09 34.26 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 107.487 -1.301 . . . . 72.4 107.487 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -121.64 153.99 37.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.984 0.914 . . . . 64.43 109.074 177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.7 p -135.16 156.61 48.71 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.07 0.948 . . . . 71.2 110.415 -172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.5 ' HB3' ' HB ' ' A' ' 59' ' ' VAL . . . -163.97 142.5 7.51 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.848 0.859 . . . . 41.13 109.493 177.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.535 ' HB2' HD13 ' E' ' 278' ' ' LEU . 37.4 p -128.81 158.46 38.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.229 0.611 . . . . 60.43 109.532 173.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.1 t -154.85 136.77 14.56 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.933 0.893 . . . . 53.34 108.599 -175.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -103.72 103.39 13.28 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 108.515 -0.92 . . . . 72.21 108.515 175.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -80.49 -31.21 37.31 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.339 0.655 . . . . 71.03 110.807 -176.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.449 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -162.83 176.77 9.9 Favored 'General case' 0 C--O 1.244 0.784 0 C-N-CA 124.618 1.167 . . . . 72.12 109.243 177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -66.69 135.91 54.75 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 109.091 -0.707 . . . . 74.3 109.091 170.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.6 t70 69.36 -7.79 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 124.929 1.291 . . . . 65.43 111.975 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 90.9 t -119.88 98.24 6.03 Favored 'Isoleucine or valine' 0 C--O 1.243 0.761 0 C-N-CA 123.667 0.787 . . . . 74.2 109.046 -172.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 61.9 m-85 -120.57 125.28 47.4 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 114.734 -1.121 . . . . 74.11 108.386 -171.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -93.78 131.48 39.1 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 123.921 0.888 . . . . 75.2 110.126 178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 77.4 t -108.58 126.67 65.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 107.584 -1.265 . . . . 72.25 107.584 168.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.5 ' HB ' ' HB3' ' A' ' 47' ' ' ALA . 57.3 t -109.39 133.72 53.71 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 N-CA-C 108.612 -0.884 . . . . 75.13 108.612 170.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -125.41 106.09 9.56 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 107.171 -1.418 . . . . 70.11 107.171 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.578 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 31.6 ttp180 -92.28 109.31 20.68 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 122.911 0.485 . . . . 61.32 109.745 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.1 t -93.69 126.84 46.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 N-CA-C 106.934 -1.506 . . . . 53.11 106.934 171.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.67 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 98.0 m -123.82 123.26 40.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.498 -0.927 . . . . 54.53 108.498 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.509 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 69.8 t -116.51 108.25 24.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 C-N-CA 124.184 0.994 . . . . 44.23 109.19 -170.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.628 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 9.8 m -105.05 146.37 29.19 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.153 -0.684 . . . . 54.31 109.153 176.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 121.81 20.15 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 107.985 -1.117 . . . . 74.2 107.985 169.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 65.2 m -124.59 127.38 47.28 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.259 0.552 . . . . 73.32 110.86 176.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 57.3 mt -87.67 85.26 7.05 Favored 'General case' 0 C--O 1.248 0.979 0 C-N-CA 126.134 1.773 . . . . 72.03 110.259 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.95 -80.88 1.55 Allowed Glycine 0 C--N 1.339 0.742 0 N-CA-C 110.897 -0.881 . . . . 72.1 110.897 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -130.75 -25.94 2.27 Favored 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 123.78 0.832 . . . . 65.03 110.83 174.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.468 ' HG2' ' HE3' ' A' ' 34' ' ' LYS . 7.8 tp10 -82.96 134.91 35.04 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.648 0.779 . . . . 75.51 110.795 177.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 90.8 m -79.54 139.29 37.59 Favored 'General case' 0 CA--C 1.556 1.194 0 CA-C-N 118.738 0.699 . . . . 63.25 111.893 179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.838 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -81.79 -68.49 0.69 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.169 0.988 . . . . 71.51 110.512 170.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -152.82 167.28 29.58 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.492 -0.777 . . . . 72.25 111.126 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 18.8 tp -141.39 142.95 33.72 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.639 1.175 . . . . 65.2 108.65 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 35.2 m -142.37 104.53 4.43 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 122.633 0.373 . . . . 71.5 111.154 -177.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 7.0 mp0 -103.5 132.86 49.39 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 109.259 -0.645 . . . . 71.31 109.259 174.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.5 t -140.4 110.38 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 109.16 -0.681 . . . . 62.44 109.16 173.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.578 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 51.7 mt-30 -85.27 85.39 7.46 Favored 'General case' 0 C--O 1.243 0.745 0 N-CA-C 108.139 -1.06 . . . . 74.24 108.139 171.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -77.23 97.03 4.69 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.102 -0.954 . . . . 74.34 108.887 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.71 146.16 20.52 Favored Glycine 0 C--N 1.334 0.466 0 CA-C-N 115.434 -0.803 . . . . 73.13 111.5 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.597 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -148.39 120.82 1.25 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 110.397 -1.081 . . . . 73.44 110.397 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 34.0 mt -83.03 122.94 38.14 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.646 -0.872 . . . . 64.23 108.646 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.49 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 49.9 m-85 -126.37 120.49 29.97 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 109.133 -0.692 . . . . 73.31 109.133 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 6.7 t -81.67 104.48 12.1 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.001 -1.111 . . . . 72.32 108.001 174.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 21.6 pt -137.9 149.41 25.01 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.871 0.869 . . . . 73.3 110.598 -171.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 9' ' ' MET . . . -173.75 177.99 2.34 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.988 1.315 . . . . 65.31 109.512 173.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.18 10.27 71.75 Favored Glycine 0 C--N 1.347 1.161 0 O-C-N 123.553 0.533 . . . . 74.2 114.061 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 1.6 pp -131.19 138.08 54.16 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 123.89 0.876 . . . . 63.24 109.749 -176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 41.5 mm-40 -130.39 170.15 14.55 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.234 0.614 . . . . 62.22 110.841 -173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 45.42 -117.04 2.2 Favored Glycine 0 C--N 1.351 1.365 0 O-C-N 124.176 0.923 . . . . 75.33 115.22 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.0 t -64.25 -26.9 68.71 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.133 0.973 . . . . 73.23 112.261 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -74.06 -44.01 55.73 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.607 0.763 . . . . 71.44 110.828 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.431 ' SD ' ' C ' ' A' ' 94' ' ' MET . 0.0 OUTLIER -71.17 -34.16 70.69 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 109.706 -0.479 . . . . 64.43 109.706 179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.415 ' HB1' HD22 ' E' ' 280' ' ' LEU . . . -67.28 -40.28 86.12 Favored 'General case' 0 C--N 1.349 0.574 0 CA-C-N 115.418 -0.81 . . . . 73.43 110.174 177.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 54.9 t-80 -67.85 -29.6 68.77 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.154 -0.93 . . . . 75.21 110.444 175.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.544 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 29.6 t -66.79 -38.56 86.77 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 122.859 0.464 . . . . 74.33 110.957 -178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.675 HD21 HD22 ' E' ' 278' ' ' LEU . 74.6 mt -81.71 -43.57 18.28 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 122.493 0.317 . . . . 72.45 110.804 175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.96 -20.69 77.5 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 114.709 0.644 . . . . 72.24 114.709 -171.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 104' ' ' ASN . . . -141.58 -63.39 0.45 Allowed 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 117.407 0.604 . . . . 44.31 112.56 -168.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.544 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 53.8 t80 -56.71 -64.45 0.87 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 125.529 1.532 . . . . 73.23 113.024 -167.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 90.9 m -77.42 -35.57 1.34 Allowed Pre-proline 0 CA--C 1.576 1.95 0 N-CA-C 114.426 1.269 . . . . 50.11 114.426 -173.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 55.6 Cg_endo -67.81 -20.08 46.22 Favored 'Trans proline' 0 C--N 1.394 2.972 0 C-N-CA 122.022 1.815 . . . . 32.43 112.999 174.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' ALA . 3.3 t30 -74.66 -18.09 60.59 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.217 0.607 . . . . 73.33 110.091 177.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 41.7 mm -74.85 -39.28 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.74 0.816 . . . . 70.31 109.281 170.891 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.597 HD21 ' HA3' ' A' ' 82' ' ' GLY . 87.1 mt -75.29 -37.87 60.65 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.294 1.038 . . . . 64.43 112.495 -173.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.411 ' HZ ' ' HG ' ' A' ' 128' ' ' LEU . 52.4 t80 -57.26 -43.13 99.01 Favored Pre-proline 0 CA--C 1.57 1.742 0 N-CA-C 114.04 1.126 . . . . 72.05 114.04 -169.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -53.99 -39.06 86.59 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 122.188 1.925 . . . . 72.35 113.726 171.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -76.77 -38.63 53.73 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.41 0.684 . . . . 73.21 111.904 -177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.78 -42.67 94.9 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.847 -0.427 . . . . 71.53 109.847 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -57.71 -49.93 74.89 Favored 'General case' 0 N--CA 1.473 0.725 0 O-C-N 124.618 1.199 . . . . 73.42 110.278 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -62.74 -44.43 96.24 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 124.577 1.173 . . . . 75.01 110.905 -176.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.454 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 50.6 t -56.72 -48.54 77.52 Favored 'General case' 0 N--CA 1.476 0.844 0 O-C-N 124.099 0.874 . . . . 71.2 110.23 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.478 ' O ' HG23 ' A' ' 118' ' ' VAL . 60.2 mt -64.69 -42.26 94.53 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 O-C-N 124.263 0.977 . . . . 75.11 110.814 177.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.528 HG21 ' HE2' ' C' ' 109' ' ' TYR . 95.9 m -54.63 -48.04 72.75 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.562 0.745 . . . . 55.32 110.422 -177.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.1 t -63.8 -46.05 86.9 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.306 -1.316 . . . . 74.35 109.838 -179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 20.1 mtp -57.64 -46.44 84.17 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 124.118 0.967 . . . . 54.44 112.115 178.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.0 t -63.27 -45.02 99.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.232 1.013 . . . . 71.01 110.283 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 43.2 t -66.19 -30.43 70.89 Favored 'General case' 0 CA--C 1.554 1.1 0 CA-C-N 114.813 -1.085 . . . . 72.0 110.788 -176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 76.7 mtt-85 -75.13 -28.6 60.24 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.702 0.801 . . . . 63.22 110.435 175.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.81 10.27 52.64 Favored Glycine 0 C--N 1.356 1.647 0 CA-C-N 116.146 -0.479 . . . . 43.32 113.345 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.3 m 71.33 13.34 6.63 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.428 1.491 . . . . 71.11 112.122 174.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -96.16 145.8 30.19 Favored Pre-proline 0 C--O 1.242 0.708 0 N-CA-C 107.732 -1.21 . . . . 73.14 107.732 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.446 ' HB2' ' HD2' ' G' ' 303' ' ' LYS . 36.7 Cg_endo -59.05 157.59 28.83 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.722 2.281 . . . . 74.44 112.213 -176.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HG3' HG23 ' A' ' 115' ' ' THR . 2.4 tt0 -50.71 125.39 13.09 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 124.195 0.934 . . . . 63.22 111.28 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 64' ' ' VAL . 17.9 tp -109.2 119.48 39.65 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.146 -0.934 . . . . 64.43 109.222 177.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -134.85 94.94 3.24 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.394 1.078 . . . . 65.22 108.18 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.411 ' HG ' ' HZ ' ' A' ' 107' ' ' PHE . 18.8 tp -62.12 131.78 50.64 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.027 -0.988 . . . . 74.42 109.723 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -52.91 129.27 47.57 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 124.266 1.027 . . . . 52.22 111.641 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.16 104.19 0.84 Allowed 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 122.397 2.064 . . . . 72.32 111.034 175.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.57 HG21 HG13 ' E' ' 288' ' ' VAL . 85.3 t -98.71 117.6 43.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.026 -1.102 . . . . 73.54 108.026 -179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.421 HD22 ' HB2' ' A' ' 135' ' ' ALA . 33.5 t30 -63.48 99.65 0.22 Allowed 'General case' 0 CA--C 1.542 0.665 0 O-C-N 124.409 1.068 . . . . 63.25 109.475 178.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -67.1 -24.21 65.91 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 116.176 -0.466 . . . . 72.44 111.247 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.408 ' HB3' ' OD1' ' A' ' 132' ' ' ASN . 10.2 t70 -56.09 -47.79 77.35 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.896 0.878 . . . . 74.43 110.654 173.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.537 ' HB1' HG21 ' C' ' 7' ' ' THR . . . -57.82 -37.66 74.2 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.503 1.127 . . . . 50.0 112.679 -172.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.46 -37.9 85.3 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 120.925 0.393 . . . . 74.15 111.324 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -86.22 -29.9 22.8 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.548 0.739 . . . . 60.42 111.425 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 59.6 tpp -74.01 -39.89 63.31 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.826 0.851 . . . . 75.14 111.231 -171.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -56.13 -39.95 73.03 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 123.98 0.8 . . . . 72.15 110.458 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -76.27 -38.92 55.53 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.295 -0.866 . . . . 74.54 111.004 176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 57.7 tp -62.68 -50.95 69.14 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 122.87 0.468 . . . . 75.34 111.427 -170.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -178.31 12.84 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 124.237 0.961 . . . . 65.04 112.085 -178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 65.74 144.38 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 124.967 1.307 . . . . 75.35 112.562 -173.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.04 143.66 32.32 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.73 0.812 . . . . 72.33 112.059 -177.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -168.86 177.88 4.82 Favored 'General case' 0 C--O 1.246 0.869 0 C-N-CA 125.34 1.456 . . . . 53.23 108.647 176.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -136.53 174.92 21.31 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 116.125 -0.489 . . . . 25.54 112.421 179.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -137.76 -173.44 3.5 Favored 'General case' 0 C--O 1.243 0.716 0 C-N-CA 124.13 0.972 . . . . 74.45 109.03 175.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.46 67.58 0.55 Allowed Glycine 0 C--N 1.34 0.801 0 N-CA-C 110.654 -0.978 . . . . 54.0 110.654 175.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.3 t -76.31 151.58 36.68 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 123.052 0.541 . . . . 74.12 110.17 176.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -70.75 125.42 26.78 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.279 0.632 . . . . 71.1 110.456 -176.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -81.83 68.05 8.05 Favored 'General case' 0 CA--C 1.552 1.049 0 CA-C-O 122.18 0.99 . . . . 63.42 110.859 -177.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 42.2 m170 -132.23 106.17 7.78 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.608 0.763 . . . . 65.41 109.56 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 -158.88 52.14 0.4 Allowed 'General case' 0 CA--C 1.548 0.901 0 N-CA-C 107.901 -1.148 . . . . 74.53 107.901 176.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -160.45 133.64 6.69 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 115.48 -0.782 . . . . 63.2 110.878 -176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 0.988 0 C-N-CA 123.488 0.715 . . . . 44.34 109.095 170.721 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 61.9 ttp . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 109.643 -0.502 . . . . 75.31 109.643 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.1 m -150.28 123.99 9.18 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 123.935 0.894 . . . . 55.4 109.593 -174.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -95.0 -60.26 1.72 Allowed 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.198 0.599 . . . . 73.1 109.977 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -74.68 81.14 2.04 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 123.613 0.765 . . . . 71.33 109.778 176.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -155.15 144.02 20.75 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.042 0.937 . . . . 73.42 108.903 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -78.63 76.4 5.13 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.417 0.687 . . . . 52.43 110.122 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 30.9 m -106.8 -34.04 7.38 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 124.183 0.993 . . . . 54.42 110.832 -175.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -72.3 -25.73 61.69 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.316 0.647 . . . . 71.02 110.615 175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.596 ' HB3' HG23 ' B' ' 89' ' ' ILE . 0.9 OUTLIER 56.25 -165.85 0.13 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 126.005 1.722 . . . . 61.11 113.106 177.275 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.727 HG22 HE22 ' B' ' 12' ' ' GLN . 41.4 m -149.28 120.83 7.98 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.111 0.964 . . . . 74.44 108.923 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -115.96 138.61 51.03 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.525 0.73 . . . . 64.45 109.734 -178.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.727 HE22 HG22 ' B' ' 10' ' ' THR . 0.0 OUTLIER -152.53 135.47 15.56 Favored 'General case' 0 C--N 1.35 0.609 0 C-N-CA 123.346 0.658 . . . . 63.4 110.116 168.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.46 118.38 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 124.331 1.053 . . . . 72.23 108.549 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.578 ' HB3' ' HB3' ' E' ' 304' ' ' PRO . 76.4 mm-40 -82.5 -39.12 22.87 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 122.659 0.384 . . . . 73.41 111.655 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.528 ' HG2' ' HD1' ' B' ' 17' ' ' TYR . 28.4 ttm180 -166.28 145.86 5.99 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 123.51 0.724 . . . . 73.33 110.258 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.444 ' HB ' ' ND2' ' D' ' 127' ' ' ASN . 86.6 mt -119.54 145.88 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 N-CA-C 106.44 -1.689 . . . . 72.23 106.44 166.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.528 ' HD1' ' HG2' ' B' ' 15' ' ' ARG . 35.1 p90 -170.03 163.85 9.37 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.935 0.874 . . . . 75.32 111.977 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 71.5 m -92.01 122.79 34.86 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 114.612 -1.176 . . . . 75.4 109.072 173.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -89.12 -37.93 14.7 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.87 0.868 . . . . 74.21 110.043 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -155.82 143.77 19.78 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 116.102 -0.499 . . . . 73.44 110.766 -170.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.452 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.4 mm -134.76 139.18 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 124.914 1.286 . . . . 74.15 108.201 176.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.573 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 34.7 t -140.72 132.08 26.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.018 -1.105 . . . . 72.01 108.018 176.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.462 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 88.3 t80 -147.03 114.81 6.45 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 107.608 -1.256 . . . . 70.44 107.608 171.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -118.58 130.72 56.05 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.851 0.86 . . . . 74.41 108.989 178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.8 83.43 65.44 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 106.847 -1.538 . . . . 54.41 106.847 172.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -68.7 -32.81 22.92 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 122.923 2.415 . . . . 63.21 111.971 -176.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 20.4 p-10 -106.6 25.8 10.74 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.88 1.272 . . . . 72.15 110.206 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.475 ' HB1' ' HE2' ' A' ' 17' ' ' TYR . . . -46.68 -50.01 44.36 Favored Pre-proline 0 CA--C 1.568 1.642 0 N-CA-C 115.558 1.688 . . . . 63.55 115.558 -168.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -74.8 -33.98 4.45 Favored 'Trans proline' 0 C--N 1.388 2.608 0 CA-C-N 121.232 1.476 . . . . 74.41 112.505 176.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.405 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 69.1 m80 -82.99 -22.51 33.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.645 0.778 . . . . 72.45 112.283 -169.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.43 HG11 ' HZ ' ' B' ' 123' ' ' PHE . 4.6 p -67.93 -4.38 3.1 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.344 0 C-N-CA 124.391 1.076 . . . . 70.52 111.963 178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -56.49 -27.49 57.27 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.758 0.823 . . . . 75.34 110.931 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.582 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 11.0 pt20 -76.86 -34.99 57.77 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.65 0.38 . . . . 74.04 110.737 174.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.582 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 98.9 mttt -109.99 77.25 1.04 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.565 0.746 . . . . 72.31 112.313 -176.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.449 ' HB3' HD13 ' H' ' 301' ' ' ILE . 15.2 t70 -117.12 82.76 1.86 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 107.628 -1.249 . . . . 71.15 107.628 163.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -148.62 160.15 43.41 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 107.156 -1.424 . . . . 75.42 107.156 -171.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.435 ' HA ' ' HD3' ' B' ' 38' ' ' PRO . 23.9 pt20 -53.6 102.22 0.3 Allowed Pre-proline 0 CA--C 1.564 1.494 0 O-C-N 124.376 1.047 . . . . 73.41 111.7 -173.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.51 ' HB3' ' HG ' ' B' ' 68' ' ' LEU . 6.1 Cg_endo -85.93 170.21 8.67 Favored 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 122.807 2.338 . . . . 73.43 112.305 -173.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.7 tp10 -80.9 100.65 8.99 Favored 'General case' 0 C--O 1.24 0.571 0 N-CA-C 106.344 -1.724 . . . . 74.22 106.344 165.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 3.6 t -114.74 142.14 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 123.923 0.889 . . . . 74.23 108.72 -175.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.599 ' HE3' ' HB2' ' B' ' 43' ' ' ASP . 27.9 ttpt -136.72 136.63 39.17 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.496 0.718 . . . . 73.15 109.377 177.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.624 HD12 HD11 ' B' ' 128' ' ' LEU . 4.6 tt -85.6 127.46 34.47 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 106.28 -1.748 . . . . 70.53 106.28 165.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.599 ' HB2' ' HE3' ' B' ' 41' ' ' LYS . 12.6 t70 -122.27 110.61 15.9 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.358 -1.349 . . . . 72.2 107.358 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' B' ' 61' ' ' ARG . 3.5 pp -100.22 137.45 38.64 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 123.438 0.695 . . . . 75.23 109.292 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.581 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 32.9 t70 -124.23 135.85 53.72 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 108.972 -0.751 . . . . 64.31 108.972 179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.0 p -109.04 110.15 21.34 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.899 0.879 . . . . 72.12 110.402 -171.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -126.97 140.26 52.44 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.514 0.726 . . . . 25.14 109.213 178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 75.6 m -144.07 165.2 28.47 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.777 0.831 . . . . 53.55 110.199 173.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 65.4 p -152.0 162.23 41.4 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.398 1.079 . . . . 43.23 109.033 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -106.78 112.88 26.06 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 109.346 -0.613 . . . . 74.32 109.346 172.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 89.9 mt -80.99 -40.71 23.89 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 122.827 0.451 . . . . 60.52 110.327 176.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.95 -172.91 4.11 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.27 0.628 . . . . 43.22 110.575 -176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -63.06 116.03 4.98 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 114.442 -1.254 . . . . 75.42 109.774 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 41.3 m-20 71.33 -3.41 2.1 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 125.775 1.63 . . . . 65.1 112.636 -176.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.438 HG22 ' OG ' ' B' ' 85' ' ' SER . 98.6 t -101.52 113.38 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.96 -0.755 . . . . 73.33 108.96 -175.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -119.77 137.8 53.73 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.177 -0.919 . . . . 72.54 109.428 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -100.57 98.16 8.77 Favored 'General case' 0 CA--C 1.539 0.53 0 N-CA-C 106.976 -1.49 . . . . 71.34 106.976 179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.5 t -89.11 128.61 41.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.734 1.214 . . . . 30.23 109.644 -176.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.463 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 36.3 t -119.21 143.06 31.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.722 0 C-N-CA 124.757 1.223 . . . . 75.52 108.957 -179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.435 ' HG ' ' HB3' ' B' ' 103' ' ' PRO . 0.7 OUTLIER -136.7 111.75 8.97 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.727 -1.212 . . . . 64.25 107.727 171.243 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.581 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 36.4 ttm180 -86.12 122.67 30.46 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 109.155 -0.683 . . . . 75.21 109.155 174.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 41.4 t -109.81 103.23 15.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 107.92 -1.141 . . . . 74.54 107.92 173.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 18.7 m -103.79 129.89 51.26 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 109.42 -0.585 . . . . 44.34 109.42 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.459 HG23 HD13 ' B' ' 114' ' ' ILE . 61.3 t -115.0 100.99 11.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 109.248 -0.649 . . . . 74.21 109.248 -179.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.3 m -97.8 138.06 35.73 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.068 -0.969 . . . . 25.43 109.146 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.77 149.76 34.97 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 122.881 0.472 . . . . 63.31 110.347 177.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 42.8 p -149.18 141.92 24.57 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.541 -0.754 . . . . 71.04 110.544 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' B' ' 38' ' ' PRO . 17.0 mt -125.55 110.4 13.81 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 124.685 1.194 . . . . 71.21 108.663 176.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.23 -123.39 6.3 Favored Glycine 0 C--N 1.342 0.891 0 CA-C-N 115.627 -0.715 . . . . 63.02 111.489 -174.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -108.42 2.44 22.4 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.116 0.967 . . . . 73.32 109.983 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -118.23 -179.44 3.77 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.748 0.819 . . . . 74.02 110.344 -176.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 26.5 m -77.09 155.21 32.59 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.744 1.218 . . . . 75.2 110.703 -175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . . . . . . . . . . . -109.08 -50.3 3.02 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 108.611 -0.885 . . . . 74.32 108.611 167.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -166.83 152.79 8.17 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 114.822 -1.081 . . . . 72.24 108.812 167.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 96.0 mt -123.54 124.45 42.86 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 108.165 -1.05 . . . . 72.13 108.165 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 42.2 t -142.08 157.14 45.25 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.219 0.608 . . . . 74.35 109.536 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.573 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.5 tt0 -164.42 141.56 6.53 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.851 0.86 . . . . 74.44 109.121 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' B' ' 113' ' ' CYS . 94.5 t -134.22 143.81 37.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 107.677 -1.231 . . . . 70.23 107.677 170.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -119.5 96.53 5.24 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.952 -1.129 . . . . 71.02 107.952 172.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.419 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 6.5 tp-100 -91.34 101.59 14.28 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.367 -0.975 . . . . 61.14 108.367 -178.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.38 167.55 32.77 Favored Glycine 0 C--N 1.339 0.741 0 CA-C-N 115.143 -0.935 . . . . 60.22 110.881 175.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.16 127.56 1.65 Allowed Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 111.562 -0.615 . . . . 74.22 111.562 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' B' ' 17' ' ' TYR . 46.8 mt -85.61 124.5 40.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 N-CA-C 108.062 -1.088 . . . . 54.4 108.062 174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -130.67 159.14 38.1 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.069 0.948 . . . . 54.52 108.699 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.438 ' OG ' HG22 ' B' ' 55' ' ' VAL . 17.1 m -132.14 120.38 22.2 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.379 -0.971 . . . . 70.31 108.379 172.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 pt -133.75 138.75 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.47 1.108 . . . . 55.43 109.367 -178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' B' ' 9' ' ' MET . . . -151.4 155.65 39.06 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 123.649 0.78 . . . . 71.13 110.158 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 109.32 -71.17 0.2 Allowed Glycine 0 C--N 1.341 0.822 0 O-C-N 123.703 0.627 . . . . 63.14 112.469 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.596 HG23 ' HB3' ' B' ' 9' ' ' MET . 32.6 pt -81.95 159.49 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 122.98 0.512 . . . . 72.5 110.942 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -153.56 156.93 38.94 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.666 -0.697 . . . . 63.23 110.16 -175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.47 -114.76 6.49 Favored Glycine 0 C--N 1.35 1.323 0 C-N-CA 123.329 0.49 . . . . 73.23 113.539 170.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 91.3 m -67.14 -39.0 86.48 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.981 0.912 . . . . 62.23 111.536 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 86.8 mt-30 -64.87 -50.71 65.53 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 115.023 -0.989 . . . . 71.12 110.311 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.431 ' HG3' HD23 ' H' ' 277' ' ' LEU . 0.0 OUTLIER -74.96 -24.92 58.54 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-N 115.545 -0.752 . . . . 74.44 111.638 -175.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.431 ' HB2' HD21 ' H' ' 280' ' ' LEU . . . -58.7 -31.36 68.17 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.729 0.812 . . . . 63.33 111.792 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -69.75 -46.47 65.79 Favored 'General case' 0 CA--C 1.548 0.893 0 CA-C-N 115.941 -0.572 . . . . 70.14 110.689 173.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -73.38 -32.52 64.52 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.327 0.651 . . . . 74.04 112.465 -174.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 6.6 tt -96.6 -39.23 9.62 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.858 0.863 . . . . 73.21 109.447 -173.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -84.31 -25.57 43.18 Favored Glycine 0 C--N 1.346 1.132 0 N-CA-C 114.693 0.637 . . . . 63.53 114.693 -175.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -119.24 -49.45 2.39 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 122.888 0.475 . . . . 33.13 111.334 -174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 32.9 t80 -79.21 -42.43 26.04 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 112.536 0.569 . . . . 74.15 112.536 -169.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 74.0 m -64.17 -45.46 79.17 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 118.416 -0.802 . . . . 52.41 112.016 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.435 ' HB3' ' HG ' ' B' ' 60' ' ' LEU . 47.2 Cg_exo -60.89 -31.44 91.58 Favored 'Trans proline' 0 C--N 1.4 3.252 0 C-N-CA 122.427 2.084 . . . . 63.33 113.148 171.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -62.51 -34.87 77.75 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 123.707 0.803 . . . . 62.13 110.94 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 73.7 mt -71.74 -44.47 68.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 123.431 0.692 . . . . 52.35 110.628 176.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.2 mt -73.96 -24.99 59.71 Favored 'General case' 0 CA--C 1.551 1.01 0 O-C-N 123.607 0.567 . . . . 73.45 111.846 -176.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -56.86 -52.68 72.01 Favored Pre-proline 0 CA--C 1.557 1.233 0 CA-C-O 117.029 -1.463 . . . . 74.05 113.494 -172.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -52.92 -34.61 67.24 Favored 'Trans proline' 0 C--N 1.398 3.166 0 C-N-CA 122.582 2.188 . . . . 52.01 113.976 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.628 ' HE2' HG21 ' D' ' 115' ' ' THR . 80.0 m-85 -72.76 -48.81 35.22 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.44 0.696 . . . . 73.12 110.218 -178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.16 80.99 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 115.749 -0.66 . . . . 54.31 110.439 175.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -63.38 -52.49 61.49 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.831 1.652 . . . . 71.22 110.987 -175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.44 -38.44 89.89 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 123.973 0.796 . . . . 74.13 109.286 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.51 ' O ' ' HG2' ' B' ' 117' ' ' MET . 8.2 t -65.46 -37.63 87.43 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.042 0.537 . . . . 62.33 111.186 -175.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.459 HD13 HG23 ' B' ' 64' ' ' VAL . 76.3 mt -64.08 -49.12 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 C-N-CA 123.387 0.675 . . . . 63.34 109.587 173.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 21.4 m -61.44 -30.16 70.41 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.634 0.773 . . . . 71.33 111.231 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.435 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 34.3 t -69.47 -44.43 71.2 Favored 'General case' 0 C--N 1.351 0.649 0 C-N-CA 123.528 0.731 . . . . 34.21 109.146 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.51 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.9 mmt -68.1 -29.34 68.25 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 122.942 0.497 . . . . 74.22 111.124 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.471 HG21 HD23 ' B' ' 126' ' ' LEU . 78.7 t -69.34 -41.18 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 C-N-CA 124.096 0.959 . . . . 75.25 110.015 173.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 68.0 m -67.66 -28.35 67.63 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.994 0.918 . . . . 30.45 111.724 176.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.454 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 73.5 mtt-85 -79.41 -35.72 40.19 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.52 0.728 . . . . 73.13 110.044 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.35 3.75 71.2 Favored Glycine 0 C--N 1.348 1.195 0 CA-C-N 116.022 -0.536 . . . . 55.14 112.72 171.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 45.7 p 59.67 56.11 3.73 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 125.953 1.701 . . . . 65.4 112.744 171.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.43 ' HZ ' HG11 ' B' ' 31' ' ' VAL . 44.1 m-85 -119.49 157.9 50.48 Favored Pre-proline 0 N--CA 1.48 1.053 0 C-N-CA 124.192 0.997 . . . . 60.31 109.835 176.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.28 -173.83 0.38 Allowed 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 122.78 2.32 . . . . 71.22 113.884 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.515 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 0.0 OUTLIER -59.37 116.59 4.04 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.645 1.178 . . . . 74.12 112.41 -172.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.471 HD23 HG21 ' B' ' 118' ' ' VAL . 43.8 tp -123.06 93.7 4.04 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 123.473 0.709 . . . . 74.22 109.811 173.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -92.09 126.87 37.34 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 108.1 -1.074 . . . . 72.5 108.1 168.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.624 HD11 HD12 ' B' ' 42' ' ' LEU . 0.4 OUTLIER -73.28 129.35 37.84 Favored 'General case' 0 CA--C 1.553 1.077 0 N-CA-C 108.133 -1.062 . . . . 53.15 108.133 177.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -66.53 129.66 94.13 Favored Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 123.353 0.661 . . . . 62.44 111.073 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.58 ' HG3' HD11 ' D' ' 16' ' ' ILE . 68.0 Cg_endo -68.38 130.95 22.12 Favored 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.544 2.163 . . . . 74.41 112.115 -176.371 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.438 HG22 HD11 ' H' ' 291' ' ' LEU . 21.8 t -115.71 114.5 46.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.532 0.733 . . . . 73.04 109.435 -177.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -85.22 98.11 10.31 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 108.927 -0.768 . . . . 74.43 108.927 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -74.52 -34.14 62.95 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.731 0.812 . . . . 65.24 110.811 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -59.42 -51.63 69.09 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.857 1.263 . . . . 73.43 111.194 -174.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.46 -43.76 98.3 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 124.454 1.102 . . . . 62.51 111.466 -176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 5.9 tt -63.11 -43.66 97.83 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.033 0.933 . . . . 64.12 110.238 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -69.41 -24.82 63.89 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 123.964 0.906 . . . . 72.24 111.803 -175.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.45 ' HA ' ' HE2' ' B' ' 138' ' ' MET . 31.3 mmt -67.67 -31.99 72.36 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 122.846 0.458 . . . . 75.03 111.668 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 27.9 m-80 -74.76 -29.02 61.0 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.097 0.559 . . . . 71.13 110.199 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -65.89 -28.58 69.05 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.491 0.716 . . . . 74.14 111.07 176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 66.6 mt -99.95 16.52 23.62 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.477 0.711 . . . . 64.52 111.727 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -73.1 111.73 8.49 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.9 0.48 . . . . 64.04 111.533 -177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -169.12 138.07 2.06 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.45 1.1 . . . . 64.53 108.799 171.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -108.31 -55.68 2.35 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.238 0.615 . . . . 74.34 110.405 177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . 61.55 -175.02 0.13 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.704 1.202 . . . . 62.35 112.819 178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 76.08 92.59 0.2 Allowed Glycine 0 C--N 1.353 1.488 0 N-CA-C 112.109 -0.397 . . . . 52.42 112.109 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -156.78 161.32 39.77 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.693 0.797 . . . . 72.11 110.928 -176.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 104.23 107.55 3.2 Favored Glycine 0 C--N 1.341 0.817 0 CA-C-N 115.359 -0.837 . . . . 42.24 112.234 175.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 3.6 p -133.84 102.47 5.46 Favored 'General case' 0 C--O 1.243 0.757 0 C-N-CA 124.193 0.997 . . . . 61.42 109.406 177.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -80.77 88.68 5.79 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 108.69 -0.856 . . . . 75.11 108.69 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.0 -17.7 59.58 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.242 -0.89 . . . . 75.44 111.1 176.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -64.18 131.21 46.76 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.924 0.89 . . . . 73.43 110.608 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -156.4 116.3 3.58 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 108.279 -1.008 . . . . 74.45 108.279 -179.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -154.29 163.59 39.9 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.483 0.713 . . . . 70.24 109.838 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.886 0 N-CA-C 108.44 -0.948 . . . . 75.32 108.44 178.368 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 54.4 ttm . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.583 -0.525 . . . . 73.43 109.583 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 34.6 p -80.2 94.49 6.06 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 109.122 -0.696 . . . . 72.43 109.122 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -65.55 116.1 6.45 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 115.121 -0.945 . . . . 62.1 110.426 -178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -65.3 152.36 43.96 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.478 0.711 . . . . 50.43 111.185 -178.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -120.42 163.21 18.25 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.449 0.7 . . . . 72.31 109.906 -178.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.555 HD22 ' HG2' ' G' ' 310' ' ' PRO . 9.2 m120 -112.52 97.54 6.67 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.138 -1.06 . . . . 71.31 108.138 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.537 HG21 ' HB1' ' A' ' 135' ' ' ALA . 80.6 p -76.59 -66.09 0.85 Allowed 'General case' 0 C--O 1.243 0.728 0 CA-C-N 115.721 -0.672 . . . . 64.42 109.268 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 177.74 143.11 0.1 Allowed 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.017 1.727 . . . . 75.01 107.72 177.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.613 ' SD ' ' HB2' ' C' ' 11' ' ' PHE . 15.1 tmm? 64.71 115.48 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.175 0 C-N-CA 124.587 1.155 . . . . 64.21 112.701 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.4 m -91.28 98.65 11.84 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.584 0.754 . . . . 75.02 109.926 177.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.613 ' HB2' ' SD ' ' C' ' 9' ' ' MET . 50.0 t80 -97.13 142.14 29.41 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.322 0.649 . . . . 71.33 109.474 176.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -156.81 144.55 19.21 Favored 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 123.267 0.627 . . . . 73.32 109.327 166.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.91 137.57 20.94 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 N-CA-C 108.298 -1.001 . . . . 73.12 108.298 173.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -95.89 -50.15 5.01 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 109.488 -0.56 . . . . 73.01 109.488 171.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 24.8 ttt180 -164.23 124.25 2.05 Favored 'General case' 0 C--N 1.35 0.629 0 CA-C-N 115.889 -0.596 . . . . 70.12 110.72 -169.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.409 ' HB ' ' OE1' ' A' ' 125' ' ' GLN . 64.9 mt -109.7 130.72 62.3 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 N-CA-C 107.532 -1.285 . . . . 64.25 107.532 178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.473 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 20.8 p90 -163.05 149.58 12.46 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-O 121.776 0.798 . . . . 74.04 111.947 -172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 81.2 p -77.93 103.94 8.18 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.933 -1.136 . . . . 71.21 107.933 172.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 15.4 mtmt -70.87 -28.81 64.84 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 109.818 -0.438 . . . . 72.53 109.818 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 30.0 t70 -148.91 143.14 26.03 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.216 -0.902 . . . . 71.41 109.853 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 92.0 mt -138.05 145.17 29.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 C-N-CA 125.631 1.572 . . . . 72.12 106.76 175.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 35.6 t -158.4 152.19 23.59 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-O 121.279 0.562 . . . . 60.13 110.133 175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -148.14 133.29 18.32 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 107.254 -1.388 . . . . 64.22 107.254 173.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.518 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 49.0 mt-10 -125.14 132.84 53.01 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 108.853 -0.795 . . . . 74.42 108.853 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -153.39 77.67 5.94 Favored Pre-proline 0 CA--C 1.544 0.713 0 C-N-CA 124.085 0.954 . . . . 74.12 108.806 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.84 -22.12 17.92 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.096 1.864 . . . . 65.31 111.319 172.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -99.91 28.58 4.7 Favored 'General case' 0 C--O 1.244 0.794 0 C-N-CA 124.51 1.124 . . . . 74.3 110.816 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.62 -47.68 97.12 Favored Pre-proline 0 CA--C 1.569 1.673 0 C-N-CA 123.951 0.9 . . . . 71.33 112.925 176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.97 -25.83 8.5 Favored 'Trans proline' 0 C--N 1.392 2.864 0 C-N-CA 121.433 1.422 . . . . 72.52 112.048 173.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -69.41 -21.37 63.77 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.077 1.351 . . . . 73.04 112.063 -178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 12.0 p -51.4 -29.98 9.99 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.529 0 N-CA-C 113.018 0.748 . . . . 72.23 113.018 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 47.6 m-85 -70.94 -34.53 71.56 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 123.339 0.656 . . . . 73.35 111.842 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -93.62 6.05 49.57 Favored 'General case' 0 N--CA 1.495 1.805 0 C-N-CA 123.448 0.699 . . . . 74.04 111.015 175.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.614 ' HE2' ' HA ' ' C' ' 73' ' ' ALA . 2.9 ttmp? -90.95 147.76 22.89 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.277 0.631 . . . . 75.13 111.486 -175.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -83.77 135.76 34.41 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.795 1.638 . . . . 75.51 110.148 177.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.0 m95 -81.79 79.38 8.36 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 122.122 -0.362 . . . . 74.55 110.182 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.408 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 4.7 tp-100 -153.0 55.66 1.48 Allowed Pre-proline 0 CA--C 1.562 1.427 0 C-N-CA 122.693 0.397 . . . . 64.03 111.216 177.332 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.408 ' HD3' ' N ' ' C' ' 37' ' ' GLN . 17.3 Cg_endo -90.47 144.23 3.85 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.06 1.84 . . . . 73.32 112.226 179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -86.3 83.73 7.63 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 107.227 -1.397 . . . . 73.44 107.227 168.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 2.9 p -76.97 99.42 2.21 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.869 0 CA-C-N 114.882 -1.053 . . . . 71.4 108.693 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -125.21 140.65 52.67 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.66 -1.154 . . . . 62.32 108.652 -175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.582 HD13 HD11 ' C' ' 128' ' ' LEU . 2.6 pt? -87.75 163.47 16.47 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 121.252 0.549 . . . . 74.43 110.089 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.556 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 15.1 t70 -148.18 145.41 28.3 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.36 1.064 . . . . 72.44 108.145 178.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 41.1 tp -130.78 135.51 47.84 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 109.734 -0.469 . . . . 72.4 109.734 -174.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.69 ' HB2' ' HB3' ' C' ' 61' ' ' ARG . 3.9 m-20 -118.61 142.29 47.77 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.918 0.887 . . . . 73.41 108.82 169.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.8 p -114.26 113.98 25.34 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.132 0.973 . . . . 73.44 109.561 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -138.89 141.97 38.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.556 0.742 . . . . 65.55 110.171 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 23.6 p -145.78 154.29 41.87 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.251 0.621 . . . . 55.33 110.547 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.9 p -144.61 131.51 20.29 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.936 0.894 . . . . 62.41 108.644 176.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . 0.443 ' HB3' ' HA ' ' F' ' 271' ' ' ALA . 59.5 tt0 -79.21 116.67 19.62 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 109.268 -0.641 . . . . 65.24 109.268 177.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.536 HD11 ' HB2' ' C' ' 57' ' ' GLU . 32.1 mt -93.3 -32.24 14.39 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 115.387 -0.824 . . . . 72.23 109.684 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.77 -177.03 5.28 Favored 'General case' 0 C--O 1.244 0.783 0 CA-C-N 115.153 -0.93 . . . . 54.44 110.387 177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.98 128.05 34.5 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 114.638 -1.164 . . . . 70.03 108.97 171.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 68.48 -7.1 0.73 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 125.201 1.4 . . . . 73.31 113.183 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 64.4 t -112.94 112.93 42.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 C-N-CA 123.607 0.763 . . . . 72.14 109.462 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -129.28 133.87 47.68 Favored 'General case' 0 C--O 1.243 0.713 0 CA-C-N 114.84 -1.073 . . . . 75.24 108.382 -177.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.536 ' HB2' HD11 ' C' ' 51' ' ' LEU . 37.3 tt0 -83.31 115.67 22.1 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 108.919 -0.771 . . . . 72.05 108.919 173.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 40.8 t -97.52 118.11 43.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 N-CA-C 108.017 -1.105 . . . . 71.14 108.017 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 48.3 t -119.73 127.75 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 C-N-CA 122.867 0.467 . . . . 72.34 110.062 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.533 HD23 HD12 ' C' ' 106' ' ' LEU . 3.6 mm? -120.94 112.62 18.99 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.138 -1.06 . . . . 72.43 108.138 173.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.69 ' HB3' ' HB2' ' C' ' 45' ' ' ASP . 35.4 ttm180 -82.06 110.82 17.64 Favored 'General case' 0 N--CA 1.463 0.177 0 N-CA-C 108.701 -0.851 . . . . 65.14 108.701 173.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 27.7 t -99.94 112.27 31.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 108.048 -1.093 . . . . 65.43 108.048 177.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.556 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 34.2 m -114.67 142.13 46.89 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.791 -1.095 . . . . 35.43 108.114 -175.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.412 HG21 HG21 ' C' ' 114' ' ' ILE . 87.4 t -136.02 108.34 7.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 N-CA-C 107.817 -1.179 . . . . 64.04 107.817 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 11.0 m -108.68 142.31 39.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.287 -0.634 . . . . 73.52 109.287 178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.81 113.12 11.92 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 107.705 -1.22 . . . . 65.4 107.705 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 60.7 m -142.46 150.7 40.9 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.236 0.541 . . . . 63.34 111.076 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 4.4 mp -115.21 19.04 15.89 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.615 1.566 . . . . 74.15 109.849 -174.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.48 -108.73 1.3 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 110.416 -1.074 . . . . 62.43 110.416 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -89.9 -33.09 16.56 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 108.282 -1.007 . . . . 74.52 108.282 171.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -62.85 102.83 0.38 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.975 1.31 . . . . 50.4 109.953 173.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 29.5 m -88.59 129.67 35.44 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 117.923 0.329 . . . . 65.13 110.255 178.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.614 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . . . -73.54 -59.79 2.55 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 109.347 -0.612 . . . . 74.2 109.347 173.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -173.09 174.55 3.42 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.211 0.945 . . . . 75.12 110.534 176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.518 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.3 tm? -134.96 145.27 47.99 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 107.047 -1.464 . . . . 71.14 107.047 172.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.433 ' SG ' HG23 ' C' ' 114' ' ' ILE . 46.3 t -151.71 121.45 7.0 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.884 -1.154 . . . . 73.11 107.884 177.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -145.41 130.3 18.22 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 120.902 0.382 . . . . 65.32 110.141 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.3 t -132.31 115.43 25.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 124.925 1.29 . . . . 63.11 108.716 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.574 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 44.0 mt-30 -89.09 88.78 7.69 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 107.849 -1.167 . . . . 72.23 107.849 174.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -80.49 112.35 17.76 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 114.623 -1.171 . . . . 71.45 109.664 -177.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -112.39 148.32 18.31 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 111.269 -0.733 . . . . 44.5 111.269 178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.44 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -144.3 130.97 4.17 Favored Glycine 0 CA--C 1.509 -0.341 0 N-CA-C 111.398 -0.681 . . . . 74.24 111.398 -177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.512 HD12 HD11 ' C' ' 51' ' ' LEU . 13.7 mm -84.52 120.87 35.95 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.439 -0.949 . . . . 72.3 108.439 174.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -130.98 139.88 50.07 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.402 0.681 . . . . 74.14 109.474 -177.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 24.6 m -110.49 109.03 19.23 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.765 -0.828 . . . . 60.33 108.765 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 3.9 mp -115.33 122.38 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 N-CA-C 108.141 -1.059 . . . . 71.12 108.141 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -126.78 170.32 12.29 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.188 0.995 . . . . 72.14 110.187 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 107.81 -60.61 0.33 Allowed Glycine 0 C--N 1.34 0.793 0 CA-C-N 115.968 -0.56 . . . . 54.51 112.803 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.405 HD12 ' HB2' ' C' ' 9' ' ' MET . 0.1 OUTLIER -122.71 -176.65 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 117.084 0.442 . . . . 72.12 111.446 -176.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -144.93 -171.98 3.75 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 124.144 0.977 . . . . 70.32 109.472 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.36 -148.94 41.44 Favored Glycine 0 C--N 1.345 1.068 0 CA-C-N 116.157 -0.474 . . . . 71.55 113.8 173.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 38.5 p -63.32 -26.98 69.02 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.382 1.073 . . . . 41.11 112.052 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -64.71 -54.29 33.83 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.352 1.061 . . . . 74.42 110.655 178.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -70.0 -38.14 75.87 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.283 -0.872 . . . . 73.32 109.974 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.539 ' HB1' ' HB3' ' F' ' 280' ' ' LEU . . . -67.47 -22.74 65.46 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.17 0.988 . . . . 63.42 112.071 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 56.7 t-80 -71.79 -41.59 68.13 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 109.778 -0.453 . . . . 72.01 109.778 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.6 t -69.65 -31.5 69.62 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.137 0.494 . . . . 70.24 110.657 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.542 ' HG ' ' HG ' ' F' ' 278' ' ' LEU . 1.3 tm? -80.54 -48.73 12.31 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.427 1.091 . . . . 75.55 109.901 -176.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.15 9.53 67.64 Favored Glycine 0 C--N 1.342 0.877 0 CA-C-N 115.355 -0.839 . . . . 53.12 114.283 -169.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -146.13 -51.72 0.24 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.442 0.621 . . . . 74.23 111.607 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 46.8 t80 -74.77 -41.98 59.03 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.534 0.333 . . . . 75.15 111.412 -176.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.441 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 68.8 m -66.93 -45.14 53.57 Favored Pre-proline 0 CA--C 1.569 1.709 0 CA-C-O 118.373 -0.823 . . . . 64.15 111.726 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.404 ' HG3' HD21 ' C' ' 60' ' ' LEU . 92.7 Cg_exo -50.2 -38.93 52.11 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.933 2.422 . . . . 75.53 114.017 168.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -61.74 -34.41 75.77 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 123.294 0.638 . . . . 72.25 111.992 177.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.9 mm -74.34 -42.77 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 109.927 -0.397 . . . . 73.33 109.927 179.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.533 HD12 HD23 ' C' ' 60' ' ' LEU . 85.5 mt -76.03 -26.9 57.06 Favored 'General case' 0 CA--C 1.551 1.002 0 CA-C-N 115.69 -0.686 . . . . 72.5 112.015 -174.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -55.83 -52.75 69.77 Favored Pre-proline 0 CA--C 1.567 1.617 0 CA-C-O 117.703 -1.141 . . . . 74.34 113.493 -173.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -60.61 -32.66 93.63 Favored 'Trans proline' 0 C--N 1.396 3.059 0 C-N-CA 122.177 1.918 . . . . 62.04 113.327 -178.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.528 ' HE2' HG21 ' A' ' 115' ' ' THR . 67.9 m-85 -70.88 -44.44 66.32 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.719 0.808 . . . . 54.42 110.819 -179.003 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.3 -45.6 93.8 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 115.811 -0.631 . . . . 62.11 109.691 174.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 45.6 ttt-85 -56.28 -47.21 79.08 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.055 1.342 . . . . 62.12 111.652 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.9 -36.51 78.12 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 123.668 0.605 . . . . 75.0 109.732 -176.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.7 t -68.2 -35.13 77.51 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 123.391 0.676 . . . . 73.23 111.103 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.433 HG23 ' SG ' ' C' ' 76' ' ' CYS . 60.6 mt -72.15 -47.91 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.673 0.789 . . . . 74.1 109.974 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 57.6 m -64.4 -31.42 72.62 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.468 0.707 . . . . 74.12 110.825 -178.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 39.8 t -66.38 -47.72 72.45 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.413 -0.812 . . . . 73.54 109.462 174.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.52 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.3 -36.61 84.68 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.45 0.7 . . . . 74.55 112.428 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.1 t -64.44 -37.87 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 123.21 0.604 . . . . 61.13 109.786 174.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 32.2 t -68.53 -35.1 76.99 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.437 0.695 . . . . 75.33 111.584 177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 76.3 mtt-85 -70.67 -35.58 72.91 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.731 0.812 . . . . 73.44 110.428 -179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.27 4.61 80.58 Favored Glycine 0 C--N 1.346 1.114 0 CA-C-N 115.893 -0.594 . . . . 73.41 113.046 174.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 32.2 p 60.96 35.19 19.15 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.768 1.627 . . . . 72.52 112.372 173.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -105.01 150.75 39.1 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 124.557 1.143 . . . . 55.31 110.05 178.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.535 ' HG2' ' HA ' ' F' ' 297' ' ' TYR . 76.5 Cg_exo -53.92 110.31 0.49 Allowed 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.397 2.731 . . . . 53.23 113.001 177.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -60.34 144.46 50.63 Favored 'General case' 0 C--O 1.242 0.704 0 O-C-N 124.507 1.13 . . . . 64.24 111.224 -177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -146.99 124.14 11.47 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 106.72 -1.585 . . . . 73.43 106.72 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -90.76 130.41 36.74 Favored 'General case' 0 C--O 1.242 0.7 0 N-CA-C 108.892 -0.781 . . . . 71.04 108.892 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.582 HD11 HD13 ' C' ' 42' ' ' LEU . 0.2 OUTLIER -64.62 131.74 47.82 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 108.427 -0.953 . . . . 74.5 108.427 177.714 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.482 ' HB1' HG13 ' H' ' 306' ' ' VAL . . . -60.06 140.19 90.74 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.971 0.909 . . . . 62.23 111.334 -178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -53.06 103.69 0.09 OUTLIER 'Trans proline' 0 C--N 1.382 2.34 0 C-N-CA 123.18 2.587 . . . . 73.53 112.708 178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 59.8 t -97.28 108.33 21.4 Favored 'Isoleucine or valine' 0 C--N 1.349 0.587 0 N-CA-C 108.319 -0.993 . . . . 72.11 108.319 176.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.442 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 6.2 m120 -96.49 92.2 6.16 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.319 -0.855 . . . . 74.55 109.156 176.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -61.51 -39.19 90.12 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 115.218 -0.901 . . . . 54.3 110.475 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -69.32 -38.85 78.41 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.173 0.989 . . . . 75.42 112.031 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.442 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -77.66 -26.22 50.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.126 -0.943 . . . . 75.42 111.768 -173.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.423 HD12 ' HG3' ' F' ' 286' ' ' MET . 76.2 mt -59.75 -36.96 77.7 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 123.854 0.721 . . . . 74.22 111.837 175.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -62.39 -44.12 97.21 Favored 'General case' 0 N--CA 1.486 1.354 0 C-N-CA 123.033 0.533 . . . . 71.13 111.333 174.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 59.4 mtt -73.61 -29.38 62.34 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.892 0.877 . . . . 74.4 111.032 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 35.6 t30 -68.28 -40.62 81.78 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 125.022 1.329 . . . . 73.34 111.111 -175.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -70.67 -88.23 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.07 0 N-CA-C 109.345 -0.613 . . . . 62.43 109.345 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -108.17 120.27 41.88 Favored 'General case' 0 N--CA 1.482 1.125 0 N-CA-C 109.111 -0.7 . . . . 65.31 109.111 173.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -82.65 172.58 12.78 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.441 0.696 . . . . 74.5 110.832 174.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.2 pm0 -135.41 151.43 50.44 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 123.432 0.693 . . . . 75.22 110.441 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -83.79 157.08 22.21 Favored 'General case' 0 C--O 1.241 0.642 0 CA-C-N 115.481 -0.782 . . . . 63.03 110.187 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.47 166.01 13.64 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.859 0.863 . . . . 53.54 109.597 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 146.32 -179.44 23.32 Favored Glycine 0 N--CA 1.472 1.064 0 CA-C-O 120.151 -0.249 . . . . 64.23 113.048 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 66.99 155.09 0.1 Allowed 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 125.263 1.425 . . . . 60.42 111.567 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -157.15 151.88 23.2 Favored Glycine 0 C--N 1.341 0.837 0 N-CA-C 112.083 -0.407 . . . . 71.44 112.083 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 11.7 t -156.76 154.62 30.26 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.804 0.842 . . . . 73.43 109.334 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -155.65 98.26 1.92 Allowed 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.309 0.643 . . . . 73.43 110.276 -175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.37 130.15 18.13 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 107.586 -1.264 . . . . 73.12 107.586 175.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -160.65 66.81 0.32 Allowed 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.929 -1.137 . . . . 71.02 107.929 -176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -64.44 95.25 0.13 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.581 -0.736 . . . . 61.32 110.145 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -87.44 98.08 11.18 Favored 'General case' 0 C--N 1.344 0.338 0 N-CA-C 109.022 -0.732 . . . . 73.52 109.022 177.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.911 0 N-CA-C 108.17 -1.048 . . . . 52.4 108.17 178.874 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' D' ' 138' ' ' MET . 53.4 ttp . . . . . 0 N--CA 1.482 1.162 0 N-CA-C 109.097 -0.705 . . . . 72.25 109.097 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 69.33 -167.04 0.18 Allowed 'General case' 0 C--O 1.253 1.279 0 C-N-CA 124.891 1.276 . . . . 72.42 110.253 -172.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . 0.48 ' HB3' HE22 ' D' ' 93' ' ' GLN . 44.9 mm-40 64.48 -153.92 0.3 Allowed 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.824 0.85 . . . . 71.34 110.79 -178.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 76.29 0.6 3.27 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 125.096 1.358 . . . . 71.01 110.843 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -82.13 134.63 35.34 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.953 0.901 . . . . 74.43 109.321 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -80.49 95.24 6.41 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.434 0.694 . . . . 75.34 110.637 -174.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 90.6 m -74.07 72.89 1.69 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.532 0.733 . . . . 73.32 109.562 174.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 56.31 12.89 1.1 Allowed 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.662 1.185 . . . . 54.23 112.362 -174.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 4.2 ttp -33.93 126.24 0.43 Allowed 'General case' 0 C--N 1.365 1.242 0 C-N-CA 126.115 1.766 . . . . 61.34 112.968 177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 34.7 m -106.35 136.85 45.37 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.801 -0.814 . . . . 74.15 108.801 173.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.608 ' HE2' ' HG ' ' D' ' 102' ' ' CYS . 23.4 t80 -160.23 110.73 1.85 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 105.592 -2.003 . . . . 73.34 105.592 -174.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -130.98 114.79 15.64 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 108.921 -0.77 . . . . 63.3 108.921 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 40.3 mt -72.77 123.18 26.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-O 120.854 0.359 . . . . 74.05 110.141 -177.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -90.08 -40.4 12.3 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-N 115.346 -0.843 . . . . 73.44 109.712 174.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.496 ' HB3' ' HD1' ' D' ' 17' ' ' TYR . 22.1 mmt-85 -156.87 150.52 24.51 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.408 0.683 . . . . 64.54 112.016 -170.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.58 HD11 ' HG3' ' B' ' 130' ' ' PRO . 0.3 OUTLIER -138.85 118.0 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 N-CA-C 105.072 -2.196 . . . . 72.14 105.072 165.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.496 ' HD1' ' HB3' ' D' ' 15' ' ' ARG . 28.2 p90 -150.39 157.91 43.57 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.866 0.841 . . . . 71.5 111.657 -169.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -93.71 113.65 25.77 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.033 -0.985 . . . . 65.24 108.76 174.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.4 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 35.4 mtpt -81.4 -35.65 30.47 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.171 0.51 . . . . 75.41 109.629 178.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -144.67 141.75 29.57 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.064 -0.971 . . . . 74.43 108.444 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.52 HG21 ' HE2' ' C' ' 117' ' ' MET . 95.7 mt -137.09 143.9 33.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 124.698 1.199 . . . . 75.45 107.845 176.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 99.1 p -147.76 141.9 26.08 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.702 0.801 . . . . 72.04 108.993 172.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 83.2 t80 -146.48 113.81 6.28 Favored 'General case' 0 C--O 1.221 -0.44 0 N-CA-C 105.944 -1.872 . . . . 73.23 105.944 170.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -126.87 109.45 11.98 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 73.24 110.106 -173.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -103.97 91.18 3.45 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 107.412 -1.329 . . . . 62.33 107.412 174.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.02 -43.16 0.34 Allowed 'Trans proline' 0 C--N 1.38 2.196 0 C-N-CA 122.262 1.975 . . . . 72.44 112.416 -173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 55.1 m-20 -97.75 37.63 1.37 Allowed 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 107.916 -1.142 . . . . 64.32 107.916 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.473 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -51.32 -64.6 1.3 Allowed Pre-proline 0 CA--C 1.568 1.654 0 CA-C-O 117.786 -1.102 . . . . 73.52 113.858 -161.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.488 ' HB3' HD11 ' C' ' 83' ' ' ILE . 81.7 Cg_endo -78.21 -14.55 14.87 Favored 'Trans proline' 0 C--N 1.391 2.8 0 CA-C-N 122.195 1.82 . . . . 64.03 113.002 -179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 20.0 t-160 -67.25 -41.47 85.55 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.54 1.136 . . . . 72.53 109.395 175.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 55.0 t -62.41 -41.42 91.72 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 O-C-N 123.962 0.789 . . . . 74.51 110.126 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -69.61 -18.6 63.62 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.377 0.88 . . . . 55.32 113.377 -171.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -84.99 -2.98 58.58 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.623 0.769 . . . . 71.51 111.999 178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.405 ' HB2' ' CH2' ' D' ' 36' ' ' TRP . 47.6 mtpt -124.78 116.04 21.67 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.096 1.358 . . . . 62.14 108.571 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -89.34 97.42 11.19 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 123.877 0.871 . . . . 63.51 112.812 -174.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.559 ' CH2' HD13 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -167.85 -179.39 4.2 Favored 'General case' 0 N--CA 1.497 1.92 0 C-N-CA 124.165 0.986 . . . . 64.2 112.97 173.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.496 ' HB2' ' HB3' ' G' ' 295' ' ' ALA . 11.6 pt20 -93.22 145.48 30.11 Favored Pre-proline 0 N--CA 1.488 1.429 0 C-N-CA 124.484 1.114 . . . . 52.45 112.755 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.509 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 76.9 Cg_endo -79.74 135.57 11.54 Favored 'Trans proline' 0 C--N 1.387 2.601 0 C-N-CA 122.418 2.078 . . . . 73.11 112.765 174.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -71.73 111.61 7.15 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.504 -1.295 . . . . 73.13 107.504 165.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 15.4 m -100.78 144.43 12.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 C-N-CA 123.157 0.583 . . . . 45.31 110.774 -174.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' D' ' 64' ' ' VAL . 85.0 tttt -124.69 127.6 47.52 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.288 1.035 . . . . 74.02 109.109 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -98.15 120.76 39.12 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 107.002 -1.481 . . . . 75.45 107.002 173.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -128.49 143.04 50.91 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.527 -0.916 . . . . 65.53 108.527 179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -127.19 148.76 50.18 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-O 121.097 0.475 . . . . 72.13 110.64 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.519 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 18.4 t70 -139.5 150.03 44.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 108.185 -1.042 . . . . 65.11 108.185 169.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 24.2 p -116.75 143.65 45.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.746 0.818 . . . . 72.52 109.785 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . . . . . . . . . . . -156.88 155.88 32.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.511 1.124 . . . . 73.11 108.246 174.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 27.1 p -169.26 163.96 10.87 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 122.844 0.457 . . . . 53.43 110.733 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 38.4 t -159.57 132.71 6.95 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.668 0.787 . . . . 72.15 110.009 -173.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -77.43 117.47 18.94 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.769 -0.826 . . . . 72.44 108.769 170.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.545 HD11 ' HB2' ' D' ' 57' ' ' GLU . 70.6 mt -90.29 -32.59 16.46 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.858 0.463 . . . . 74.34 110.508 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -169.92 -171.17 1.12 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.645 0.778 . . . . 43.23 110.632 -176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -64.93 114.79 4.78 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.779 -1.101 . . . . 70.25 109.391 175.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 68.3 2.18 3.18 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 125.147 1.379 . . . . 75.35 113.012 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.67 120.93 60.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 N-CA-C 108.409 -0.96 . . . . 74.43 108.409 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -136.51 131.2 33.6 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.558 0.536 . . . . 74.23 109.884 -176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.545 ' HB2' HD11 ' D' ' 51' ' ' LEU . 38.7 tt0 -87.43 126.59 34.98 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.298 -1.001 . . . . 62.2 108.298 169.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.89 112.77 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 107.715 -1.217 . . . . 74.24 107.715 178.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.516 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.7 t -102.65 130.74 52.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 C-N-CA 123.233 0.613 . . . . 73.41 109.618 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.01 109.03 13.02 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 107.143 -1.428 . . . . 75.32 107.143 171.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.519 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 13.0 ttm-85 -84.34 106.66 16.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 115.446 -0.797 . . . . 74.33 109.16 177.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 95.3 t -96.32 129.74 45.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 108.568 -0.901 . . . . 61.41 108.568 170.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 31.3 m -125.87 135.67 52.21 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.573 0.749 . . . . 72.41 109.544 -178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.474 HG23 HD13 ' D' ' 114' ' ' ILE . 91.2 t -124.81 111.99 30.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 124.041 0.936 . . . . 63.34 109.382 175.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 58.7 m -105.39 119.67 39.66 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 109.245 -0.65 . . . . 41.1 109.245 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -115.03 133.24 56.21 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.275 0.63 . . . . 73.45 110.635 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 50.9 m -141.93 125.18 16.44 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.143 0.977 . . . . 61.4 109.649 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.642 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.3 OUTLIER -126.7 138.99 53.48 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.283 1.033 . . . . 62.32 110.841 -178.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.85 -111.91 3.51 Favored Glycine 0 C--N 1.345 1.079 0 N-CA-C 111.8 -0.52 . . . . 54.1 111.8 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -112.15 4.05 17.66 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.202 1.001 . . . . 54.21 110.023 -178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -147.17 168.58 21.3 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 121.212 0.529 . . . . 64.12 112.358 -157.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 88.5 m -84.56 126.58 33.44 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.143 -0.935 . . . . 74.32 110.428 176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.642 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -71.78 -69.45 0.39 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.97 0.908 . . . . 64.45 109.706 173.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -158.67 147.5 18.73 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 113.543 -1.662 . . . . 63.1 109.953 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 56.4 mt -102.92 152.93 20.73 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.194 -1.41 . . . . 70.34 107.194 172.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.599 ' SG ' HG12 ' D' ' 114' ' ' ILE . 48.5 t -154.27 135.78 14.25 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.955 -0.757 . . . . 65.21 108.955 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -153.54 134.44 13.88 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 109.522 -0.547 . . . . 70.21 109.522 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 99.5 t -136.52 116.79 17.23 Favored 'Isoleucine or valine' 0 C--O 1.24 0.58 0 N-CA-C 108.745 -0.835 . . . . 52.04 108.745 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -87.81 86.54 7.17 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 107.843 -1.169 . . . . 60.42 107.843 173.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -80.54 92.89 5.98 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 114.951 -1.022 . . . . 60.45 109.254 -176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.516 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -90.67 148.27 19.43 Favored Glycine 0 C--N 1.341 0.832 0 N-CA-C 111.104 -0.798 . . . . 64.01 111.104 176.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -149.63 131.53 3.69 Favored Glycine 0 CA--C 1.507 -0.407 0 N-CA-C 110.961 -0.856 . . . . 64.2 110.961 -178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.402 HG13 ' HE1' ' D' ' 17' ' ' TYR . 68.2 mt -89.18 122.47 40.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 108.446 -0.946 . . . . 64.13 108.446 178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.3 138.78 52.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.37 1.068 . . . . 72.03 108.996 -175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 19.4 m -90.69 97.34 11.13 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.207 -1.034 . . . . 62.21 108.207 176.04 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 56.3 mt -106.98 123.03 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 109.547 -0.538 . . . . 74.32 109.547 -171.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.23 170.95 20.09 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.56 1.144 . . . . 53.04 109.442 -177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.1 -18.48 51.23 Favored Glycine 0 N--CA 1.47 0.901 0 CA-C-N 116.301 -0.409 . . . . 74.41 113.222 176.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 1.4 pp -134.35 159.05 42.19 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 C-N-CA 124.439 1.095 . . . . 74.22 109.195 178.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -132.59 158.98 40.83 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.142 0.577 . . . . 75.41 110.795 -174.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 41.57 -97.48 0.01 OUTLIER Glycine 0 C--N 1.351 1.377 0 O-C-N 125.165 1.54 . . . . 75.3 115.793 161.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 56.3 p -58.89 -54.53 46.07 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.957 1.303 . . . . 74.13 112.597 -175.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.48 HE22 ' HB3' ' D' ' 3' ' ' GLU . 6.8 tp-100 -82.12 -27.02 33.03 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 116.22 -0.445 . . . . 71.03 110.698 -173.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.538 ' SD ' ' HB3' ' G' ' 277' ' ' LEU . 27.8 ttt -67.46 -35.05 78.44 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.831 -0.433 . . . . 74.43 109.831 173.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.95 -53.87 51.98 Favored 'General case' 0 C--N 1.351 0.666 0 C-N-CA 123.615 0.766 . . . . 63.11 110.61 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -57.24 -45.27 84.07 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 124.229 0.956 . . . . 75.31 110.824 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.8 t -65.39 -33.13 75.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.446 0.699 . . . . 62.5 111.706 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.456 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 20.2 tp -75.41 -32.4 60.72 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.431 0.692 . . . . 70.0 110.994 -175.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -108.85 13.59 34.77 Favored Glycine 0 C--N 1.346 1.087 0 CA-C-N 116.21 -0.45 . . . . 71.32 113.658 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.479 ' HA ' ' HB2' ' D' ' 133' ' ' PHE . . . -129.7 -61.2 1.01 Allowed 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 117.172 0.486 . . . . 74.4 110.345 174.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -75.33 -46.51 32.82 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.4 0.68 . . . . 74.35 111.095 -173.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.608 ' HG ' ' HE2' ' D' ' 11' ' ' PHE . 60.5 m -62.47 -48.94 85.67 Favored Pre-proline 0 CA--C 1.569 1.687 0 CA-C-O 118.306 -0.854 . . . . 54.54 112.114 -178.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.63 -16.19 33.87 Favored 'Trans proline' 0 C--N 1.402 3.376 0 C-N-CA 122.1 1.867 . . . . 70.32 112.735 175.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -71.16 -24.48 62.26 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.833 0.453 . . . . 73.12 110.259 173.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 45.6 mm -82.38 -39.29 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.281 0.632 . . . . 64.43 109.853 173.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.2 mt -74.13 -37.0 64.22 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.765 0.826 . . . . 71.24 112.201 -175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -64.14 -40.9 57.49 Favored Pre-proline 0 N--CA 1.486 1.352 0 CA-C-O 117.787 -1.102 . . . . 75.32 113.515 -170.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -53.93 -39.73 83.58 Favored 'Trans proline' 0 C--N 1.391 2.786 0 C-N-CA 122.377 2.051 . . . . 71.22 113.816 171.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -80.26 -32.81 38.24 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.369 0.667 . . . . 74.33 111.368 -177.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.69 81.3 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 109.168 -0.679 . . . . 44.1 109.168 171.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.515 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 28.4 ttp180 -53.53 -53.55 49.94 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 124.906 1.282 . . . . 74.15 110.771 178.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -65.65 -40.76 92.83 Favored 'General case' 0 CA--C 1.538 0.512 0 O-C-N 124.504 1.128 . . . . 74.13 110.698 -173.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.62 -44.11 96.7 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 123.576 0.548 . . . . 75.24 110.757 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.599 HG12 ' SG ' ' D' ' 76' ' ' CYS . 91.1 mt -63.22 -53.19 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 O-C-N 124.249 0.968 . . . . 64.2 109.884 175.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.628 HG21 ' HE2' ' B' ' 109' ' ' TYR . 95.9 m -52.8 -45.07 67.05 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.085 1.354 . . . . 51.12 111.923 -175.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.4 t -67.39 -44.94 77.66 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 114.944 -1.025 . . . . 71.42 110.151 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.414 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 77.7 mtm -62.55 -37.79 87.48 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.857 0.463 . . . . 72.22 112.0 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.502 HG23 ' O ' ' D' ' 114' ' ' ILE . 85.7 t -61.59 -44.63 98.97 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 O-C-N 124.093 0.871 . . . . 61.33 110.014 178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.2 p -73.57 -27.33 61.26 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.878 0.471 . . . . 62.21 111.718 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 91.0 mtt-85 -72.39 -31.64 65.72 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.347 0.659 . . . . 73.22 110.076 175.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.25 10.81 62.48 Favored Glycine 0 C--N 1.352 1.437 0 CA-C-N 115.445 -0.798 . . . . 61.22 112.368 174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.405 HG23 ' HB3' ' C' ' 17' ' ' TYR . 67.6 p 65.75 15.04 9.88 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 126.964 2.105 . . . . 63.04 113.961 176.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.74 156.97 55.51 Favored Pre-proline 0 CA--C 1.563 1.473 0 N-CA-C 107.437 -1.319 . . . . 63.03 107.437 166.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.699 ' HG2' HG23 ' G' ' 296' ' ' THR . 71.7 Cg_endo -74.02 146.09 36.52 Favored 'Trans proline' 0 C--N 1.366 1.484 0 C-N-CA 122.682 2.255 . . . . 54.32 111.588 -177.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.457 ' HB2' HG23 ' D' ' 115' ' ' THR . 20.2 pt20 -51.3 127.71 20.34 Favored 'General case' 0 CA--C 1.551 0.987 0 O-C-N 124.275 0.985 . . . . 63.53 112.134 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 8.1 tt -107.49 100.77 10.16 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 108.483 -0.932 . . . . 74.34 108.483 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.444 ' ND2' ' HB ' ' B' ' 16' ' ' ILE . 3.1 m-20 -98.89 107.1 19.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.298 1.039 . . . . 73.33 110.18 -166.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.515 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.7 mm? -72.22 116.01 12.14 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.069 0.948 . . . . 62.53 109.908 176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.529 ' HB3' HD11 ' G' ' 291' ' ' LEU . . . -68.57 154.42 94.53 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 122.534 0.334 . . . . 72.32 111.494 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -58.78 123.87 14.5 Favored 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.499 2.133 . . . . 64.11 111.951 175.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 63.4 t -108.41 125.49 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 123.905 0.882 . . . . 63.34 108.773 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -72.17 93.88 1.49 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.171 0.588 . . . . 64.23 109.632 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.479 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 70.7 m-85 -72.82 -21.89 60.89 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 115.583 -0.735 . . . . 74.2 111.352 -179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' D' ' 138' ' ' MET . 12.7 m-20 -56.19 -57.25 12.98 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.585 0.754 . . . . 72.51 111.38 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.9 -40.54 95.25 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.078 0.861 . . . . 54.21 112.493 -174.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 85.6 mt -71.37 -48.82 47.68 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.498 -0.774 . . . . 64.32 111.25 -175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -72.28 -26.92 62.17 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.749 0.82 . . . . 74.24 111.089 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.478 ' HB2' ' O ' ' D' ' 134' ' ' ASP . 33.7 ttm -55.06 -35.76 64.87 Favored 'General case' 0 CA--C 1.556 1.183 0 C-N-CA 124.035 0.934 . . . . 71.32 111.157 175.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -79.53 -13.1 59.78 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.093 0.957 . . . . 75.05 112.071 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -79.03 -37.08 39.97 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.703 0.801 . . . . 71.24 110.201 177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 10.6 mp -64.66 -34.78 79.1 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 123.474 0.71 . . . . 75.55 112.217 -177.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -78.2 0.89 23.33 Favored 'General case' 0 CA--C 1.553 1.078 0 C-N-CA 123.053 0.541 . . . . 71.54 112.072 -176.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -135.05 82.05 1.93 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.641 0.776 . . . . 73.44 109.348 178.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.96 125.29 1.94 Allowed 'General case' 0 N--CA 1.478 0.929 0 N-CA-C 108.524 -0.917 . . . . 65.5 108.524 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -79.97 136.18 36.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.333 0.653 . . . . 62.2 109.835 176.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.38 59.15 5.0 Favored Glycine 0 C--N 1.344 0.997 0 C-N-CA 122.723 0.201 . . . . 63.33 112.683 -177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -97.93 112.63 24.48 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.331 -0.989 . . . . 63.43 108.331 177.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.91 68.03 0.33 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 111.532 -0.627 . . . . 43.22 111.532 -175.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.0 t -117.06 157.6 25.58 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.984 0.914 . . . . 72.34 109.706 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -132.88 133.51 43.38 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.768 0.827 . . . . 72.41 109.808 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -115.87 135.23 54.19 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.651 0.78 . . . . 64.23 110.96 -173.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -136.94 135.01 37.36 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 124.557 1.143 . . . . 74.31 107.946 172.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -130.23 112.65 13.55 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 109.009 -0.737 . . . . 62.41 109.009 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -67.61 146.37 53.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.652 0.781 . . . . 72.23 110.581 178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.738 0 C-N-CA 124.067 0.947 . . . . 75.25 108.76 179.677 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.96 0 N-CA-C 110.018 -0.364 . . . . 74.24 110.018 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -76.07 87.26 2.97 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.336 0.655 . . . . 71.24 109.313 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -82.98 178.53 8.11 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.204 -0.907 . . . . 71.0 109.399 176.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -77.06 82.74 3.57 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.079 -0.712 . . . . 74.34 109.079 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -150.7 139.55 13.09 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 123.384 0.674 . . . . 70.1 111.066 -172.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.19 106.3 1.35 Allowed 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.009 1.806 . . . . 72.12 110.573 163.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 10.2 tt -66.67 -24.6 66.3 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.381 0.672 . . . . 73.54 110.182 173.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . 0.675 HD22 HD21 ' A' ' 98' ' ' LEU . 25.0 mt -84.16 144.62 28.87 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.08 0.952 . . . . 75.2 110.548 -177.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . 175.65 40.24 0.05 OUTLIER Glycine 0 C--N 1.35 1.312 0 N-CA-C 114.109 0.404 . . . . 42.24 114.109 179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.415 HD22 ' HB1' ' A' ' 95' ' ' ALA . 62.5 tp -159.5 107.4 1.76 Allowed 'General case' 0 N--CA 1.484 1.235 0 CA-C-N 117.323 0.562 . . . . 55.24 109.876 172.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -173.75 176.35 2.71 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.558 1.543 . . . . 74.32 110.159 168.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.38 -70.82 0.12 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.625 1.57 . . . . 53.44 111.534 -177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.54 108.67 2.94 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.648 0.779 . . . . 73.34 109.623 177.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 168.65 102.55 0.16 Allowed Glycine 0 CA--C 1.527 0.832 0 O-C-N 123.554 0.534 . . . . 74.03 112.496 -179.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -71.14 92.16 0.97 Allowed 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 107.792 -1.188 . . . . 73.44 107.792 169.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . 0.553 ' HG3' HG23 ' E' ' 288' ' ' VAL . 14.1 tpt -82.23 116.55 64.23 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 123.829 0.852 . . . . 73.1 110.841 -169.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' E' ' 286' ' ' MET . 6.2 Cg_exo -77.07 85.85 1.71 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.133 2.555 . . . . 64.24 111.762 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . 0.57 HG13 HG21 ' A' ' 131' ' ' VAL . 88.7 t -125.52 -83.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 115.603 -0.726 . . . . 64.41 109.053 175.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? 54.89 -165.24 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 124.176 0.991 . . . . 72.01 111.455 -173.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -101.46 121.29 41.67 Favored 'General case' 0 N--CA 1.476 0.841 0 O-C-N 121.678 -0.639 . . . . 75.24 110.077 175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.42 52.8 2.15 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.482 1.113 . . . . 74.11 109.704 -175.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 171.22 -148.65 11.34 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.7 -1.055 . . . . 53.22 111.309 -176.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . 0.416 ' HG3' ' HB2' ' G' ' 304' ' ' PRO . 64.4 Cg_endo -81.41 -172.59 1.53 Allowed 'Trans proline' 0 C--N 1.374 1.894 0 C-N-CA 122.915 2.41 . . . . 74.53 112.62 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . 0.427 ' HA ' HG12 ' A' ' 40' ' ' VAL . 11.7 mptt -78.16 -52.69 8.32 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 115.434 -0.803 . . . . 55.13 108.868 174.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 69.73 -73.33 0.09 Allowed 'General case' 0 CA--C 1.553 1.078 0 O-C-N 125.033 1.458 . . . . 75.11 113.343 168.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 43.7 m -56.69 99.8 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 125.251 1.421 . . . . 73.12 113.103 -174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 51.7 t80 179.83 -60.7 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.069 1.348 . . . . 73.12 108.923 170.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 51.9 p-80 -78.3 135.14 37.46 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 123.615 0.572 . . . . 71.04 110.106 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 163.63 -92.84 0.11 Allowed Glycine 0 C--N 1.339 0.714 0 N-CA-C 111.22 -0.752 . . . . 62.24 111.22 -178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 28.3 m120 -93.36 16.88 12.3 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.127 0.571 . . . . 65.33 110.793 -177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 32' ' ' PHE . 5.6 tt -104.76 142.8 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.714 1.205 . . . . 71.21 110.864 -177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 24.3 t0 -174.0 171.61 3.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.166 . . . . 63.04 108.682 178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -77.05 157.07 81.8 Favored Pre-proline 0 CA--C 1.568 1.664 0 C-N-CA 123.558 0.743 . . . . 75.13 109.546 167.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . 0.578 ' HB3' ' HB3' ' B' ' 14' ' ' GLN . 87.1 Cg_exo -47.63 136.97 20.99 Favored 'Trans proline' 0 C--N 1.387 2.558 0 C-N-CA 123.507 2.804 . . . . 73.23 114.313 177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -147.0 22.17 1.23 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.109 0.564 . . . . 71.34 111.841 -175.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 97.9 t -82.25 114.63 23.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-O 120.934 0.397 . . . . 73.42 110.413 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 14.7 m -65.51 -9.0 22.34 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 125.572 1.549 . . . . 64.43 114.332 -169.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . 0.431 ' SG ' ' NE2' ' B' ' 12' ' ' GLN . 36.3 t 78.14 147.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.107 1.363 . . . . 70.13 112.152 -178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' E' ' 310' ' ' PRO . 40.7 m -65.17 116.14 27.66 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 123.751 0.821 . . . . 73.22 109.826 176.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' E' ' 309' ' ' THR . 5.2 Cg_endo . . . . . 0 C--N 1.374 1.883 0 C-N-CA 122.925 2.417 . . . . 52.32 111.051 -177.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . 0.443 ' HA ' ' HB3' ' C' ' 50' ' ' GLN . . . . . . . . 0 N--CA 1.477 0.925 0 N-CA-C 110.204 -0.295 . . . . 64.3 110.204 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -78.81 80.94 5.14 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.376 0.67 . . . . 60.41 109.361 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 64.08 176.51 0.18 Allowed 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.797 1.239 . . . . 71.22 111.508 -172.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 62.59 104.51 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.525 1.13 . . . . 75.03 111.487 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . 0.587 ' HD2' HD22 ' F' ' 278' ' ' LEU . 46.0 mtmt -105.57 92.69 6.22 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.715 0.806 . . . . 73.31 109.248 178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.88 -36.34 97.1 Favored 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.53 2.82 . . . . 74.2 114.021 -174.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 8.0 mp -83.86 -33.05 24.92 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.904 0.482 . . . . 75.42 111.491 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.587 HD22 ' HD2' ' F' ' 275' ' ' LYS . 8.0 mp -89.34 106.24 18.32 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.543 0.737 . . . . 75.13 110.656 -174.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . 0.489 ' H ' ' HB2' ' C' ' 95' ' ' ALA . . . -97.39 -6.31 57.61 Favored Glycine 0 C--N 1.342 0.899 0 CA-C-N 115.938 -0.574 . . . . 74.43 112.153 169.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . 0.539 ' HB3' ' HB1' ' C' ' 95' ' ' ALA . 9.1 tt -158.23 110.05 2.26 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.754 0.821 . . . . 64.43 109.578 -172.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -175.94 54.8 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.877 1.271 . . . . 63.41 109.172 162.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -167.13 99.71 0.53 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.899 -1.046 . . . . 71.01 108.346 177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 62.95 17.65 10.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 124.659 1.184 . . . . 75.25 111.866 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -95.99 104.64 3.13 Favored Glycine 0 C--N 1.35 1.308 0 CA-C-O 119.558 -0.579 . . . . 22.23 112.39 -172.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 16.2 m120 69.46 176.62 0.27 Allowed 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 124.895 1.278 . . . . 74.25 113.089 173.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . 0.423 ' HG3' HD12 ' C' ' 136' ' ' LEU . 4.9 mpp? 52.73 78.54 0.39 Allowed Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.112 1.365 . . . . 72.44 112.186 -178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -78.52 64.33 8.56 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 122.766 2.31 . . . . 54.41 110.653 172.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 63.6 t -71.85 113.67 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 114.973 -1.012 . . . . 71.14 110.674 -173.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -119.93 160.07 23.44 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.247 -1.02 . . . . 74.23 108.247 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -60.68 137.3 58.2 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.093 0.557 . . . . 71.32 111.875 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.563 HD13 ' H ' ' F' ' 291' ' ' LEU . 0.0 OUTLIER -100.1 155.4 17.75 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.686 1.194 . . . . 70.21 110.634 -174.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . 0.414 ' N ' HG21 ' H' ' 307' ' ' THR . . . 76.7 -167.62 54.53 Favored Glycine 0 CA--C 1.527 0.837 0 CA-C-O 119.203 -0.776 . . . . 52.12 112.573 -176.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -67.26 -72.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.368 1.605 0 C-N-CA 122.213 1.942 . . . . 61.31 110.796 175.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 23.1 mtmt -155.36 -56.2 0.09 Allowed 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.607 1.163 . . . . 64.31 109.035 178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . 63.04 -165.15 0.24 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 123.972 0.909 . . . . 34.15 109.73 -169.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 11.1 m 64.92 150.56 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 124.416 1.086 . . . . 74.14 111.486 -176.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.535 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 3.4 m-30 65.7 14.16 9.37 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 123.906 0.883 . . . . 74.13 112.698 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . 0.46 ' HE1' ' HA ' ' H' ' 302' ' ' ASP . 32.2 p80 -95.33 119.01 33.1 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 107.989 -1.115 . . . . 75.42 107.989 170.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 138.33 163.89 9.75 Favored Glycine 0 N--CA 1.469 0.878 0 N-CA-C 112.086 -0.405 . . . . 52.14 112.086 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.73 88.75 7.74 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.292 0.637 . . . . 70.43 109.89 -178.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 2.8 pp -116.44 18.5 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 124.301 1.041 . . . . 74.51 111.279 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -81.31 -72.41 0.43 Allowed 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 109.145 -0.687 . . . . 65.25 109.145 173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 178.38 91.95 0.15 Allowed Pre-proline 0 N--CA 1.482 1.127 0 C-N-CA 123.924 0.89 . . . . 74.54 109.653 176.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.54 -56.63 0.4 Allowed 'Trans proline' 0 C--N 1.372 1.81 0 C-N-CA 121.939 1.759 . . . . 45.12 110.833 169.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -174.61 128.35 0.33 Allowed 'General case' 0 C--N 1.353 0.76 0 C-N-CA 124.851 1.261 . . . . 71.41 108.354 175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 7.7 p -169.74 -39.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 124.349 1.06 . . . . 61.51 110.383 -178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 23.7 m -75.53 80.64 2.55 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 124.443 1.097 . . . . 75.1 110.437 -176.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 48.9 m -146.71 3.44 0.85 Allowed 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 114.513 -1.221 . . . . 74.33 110.421 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 9.3 t -140.65 149.12 55.8 Favored Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 123.671 0.788 . . . . 73.41 110.468 -170.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo . . . . . 0 C--N 1.372 1.77 0 C-N-CA 122.329 2.019 . . . . 74.34 113.329 167.961 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.492 -0.559 . . . . 65.45 109.492 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -73.3 85.9 1.45 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 108.989 -0.745 . . . . 72.52 108.989 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -56.68 120.05 7.16 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.26 1.024 . . . . 62.43 110.598 -176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -77.22 135.0 38.46 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.109 0.564 . . . . 72.41 110.873 -173.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.77 118.08 7.22 Favored Pre-proline 0 CA--C 1.554 1.127 0 C-N-CA 123.381 0.672 . . . . 74.12 110.21 174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -89.77 101.93 0.33 Allowed 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.721 2.281 . . . . 75.11 111.162 170.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.538 ' HB3' ' SD ' ' D' ' 94' ' ' MET . 5.7 mp -82.0 -17.43 46.89 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 120.827 0.346 . . . . 61.22 110.338 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -100.82 114.79 28.92 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.117 0.967 . . . . 72.14 108.864 -176.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . 0.488 ' H ' HD23 ' G' ' 280' ' ' LEU . . . 164.27 78.91 0.04 OUTLIER Glycine 0 C--N 1.341 0.816 0 N-CA-C 110.852 -0.899 . . . . 41.03 110.852 177.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.488 HD23 ' H ' ' G' ' 279' ' ' GLY . 1.1 pt? -154.62 -38.79 0.09 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.77 0.828 . . . . 52.11 111.304 -175.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 5.9 m-30 -61.97 101.24 0.2 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.332 0.653 . . . . 72.41 110.982 -178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -90.06 -151.36 0.23 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.354 1.062 . . . . 54.4 108.421 168.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -75.45 75.44 2.52 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 108.722 -0.844 . . . . 44.34 108.722 166.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -86.52 58.85 4.66 Favored Glycine 0 C--N 1.343 0.92 0 CA-C-N 115.31 -0.859 . . . . 51.45 113.021 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -78.47 97.04 5.56 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 107.985 -1.117 . . . . 73.21 107.985 172.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 71.5 mtm -78.18 140.79 61.65 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-O 118.815 -0.612 . . . . 61.31 109.396 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.86 83.86 0.32 Allowed 'Trans proline' 0 C--N 1.378 2.099 0 C-N-CA 122.919 2.413 . . . . 64.44 111.964 -178.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 81.7 t -101.38 119.13 49.14 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 123.95 0.9 . . . . 72.3 108.632 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -104.59 153.53 21.08 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.173 0.989 . . . . 74.51 109.503 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.409 ' CH2' HD13 ' D' ' 128' ' ' LEU . 53.1 m95 -65.65 169.26 6.48 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 122.211 1.005 . . . . 74.32 111.89 171.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.529 HD11 ' HB3' ' D' ' 129' ' ' ALA . 5.5 mp -76.21 -41.55 49.01 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 113.706 -1.588 . . . . 65.1 110.333 -176.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -171.97 173.52 45.14 Favored Glycine 0 C--N 1.343 0.925 0 CA-C-N 115.701 -0.681 . . . . 72.01 113.621 -178.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_exo -75.62 -25.75 10.61 Favored 'Trans proline' 0 C--N 1.37 1.706 0 C-N-CA 123.772 2.981 . . . . 61.13 113.332 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -69.04 92.52 0.53 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.919 0.487 . . . . 71.43 109.836 -178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . 0.496 ' HB3' ' HB2' ' D' ' 37' ' ' GLN . . . -75.52 173.67 10.68 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 115.322 -0.854 . . . . 73.53 111.295 -179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . 0.699 HG23 ' HG2' ' D' ' 124' ' ' PRO . 4.4 t -72.16 -14.38 61.8 Favored 'General case' 0 CA--C 1.557 1.246 0 CA-C-N 115.083 -0.962 . . . . 61.34 113.071 -173.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.529 ' HA ' ' HG3' ' D' ' 124' ' ' PRO . 0.1 OUTLIER -84.08 76.85 10.03 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 118.612 0.642 . . . . 74.43 110.793 -177.608 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 50.1 m170 -121.45 143.46 49.23 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.161 0.985 . . . . 74.53 108.447 174.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 122.73 -77.78 0.35 Allowed Glycine 0 C--N 1.341 0.82 0 N-CA-C 110.376 -1.089 . . . . 53.41 110.376 -177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -174.78 160.89 3.01 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.447 1.499 . . . . 72.23 108.114 177.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . . . . . . . . . 6.0 tt -80.97 -25.87 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 O-C-N 121.387 -0.821 . . . . 72.33 111.873 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -155.95 -161.33 1.13 Allowed 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 109.604 -0.517 . . . . 64.15 109.604 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . 0.446 ' HD2' ' HB2' ' A' ' 124' ' ' PRO . 0.9 OUTLIER -124.1 163.96 32.56 Favored Pre-proline 0 CA--C 1.557 1.246 0 C-N-CA 124.627 1.171 . . . . 65.43 108.448 175.203 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . 0.416 ' HB2' ' HG3' ' E' ' 293' ' ' PRO . 31.5 Cg_exo -63.51 132.42 35.57 Favored 'Trans proline' 0 C--N 1.386 2.524 0 C-N-CA 122.38 2.053 . . . . 73.41 112.093 172.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.66 161.56 30.15 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.358 0.663 . . . . 63.44 111.034 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 34.6 m -75.23 166.49 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.099 0.56 . . . . 64.14 111.079 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 65.9 p -77.19 -66.87 0.77 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.739 -0.664 . . . . 73.13 110.728 -175.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 84.0 m -157.28 146.45 20.03 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.637 0.775 . . . . 72.31 110.212 -176.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 40.5 m -140.93 82.24 15.38 Favored Pre-proline 0 CA--C 1.555 1.155 0 N-CA-C 108.777 -0.823 . . . . 52.34 108.777 171.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . 0.555 ' HG2' HD22 ' C' ' 6' ' ' ASN . 21.9 Cg_endo . . . . . 0 C--N 1.38 2.193 0 C-N-CA 123.605 2.87 . . . . 72.35 111.417 171.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.059 -0.348 . . . . 63.21 110.059 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 28.3 p-10 -164.82 -38.82 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.53 1.132 . . . . 73.42 109.226 179.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -142.18 47.76 1.6 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.905 1.282 . . . . 72.21 109.406 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -84.01 18.78 1.95 Allowed 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 124.608 1.163 . . . . 72.3 110.812 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 76.7 mttt -93.37 109.62 41.48 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 125.222 1.409 . . . . 72.43 108.615 -173.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -84.2 173.07 9.15 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 122.079 1.853 . . . . 71.42 111.323 174.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . 0.431 HD23 ' HG3' ' B' ' 94' ' ' MET . 9.7 tt -68.48 -37.82 80.47 Favored 'General case' 0 CA--C 1.548 0.876 0 N-CA-C 108.278 -1.008 . . . . 71.01 108.278 170.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 61.0 tp -79.17 73.9 5.75 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.189 0.996 . . . . 70.41 110.038 172.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -74.55 -33.3 56.31 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 116.266 -0.424 . . . . 72.42 112.256 174.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' B' ' 95' ' ' ALA . 2.2 pt? -154.55 175.11 14.04 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 125.2 1.4 . . . . 63.1 108.455 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -98.18 -88.51 0.31 Allowed 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 107.219 -1.4 . . . . 71.44 107.219 170.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -114.13 -47.26 2.95 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 108.343 -0.984 . . . . 62.44 108.343 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 17.0 t70 65.15 -161.99 0.27 Allowed 'General case' 0 CA--C 1.567 1.626 0 O-C-N 124.6 1.188 . . . . 74.22 110.636 171.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 74.69 -109.43 2.78 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 110.231 -1.148 . . . . 71.13 110.231 -173.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -173.15 133.98 0.53 Allowed 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.119 0.968 . . . . 53.35 108.705 173.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . 0.535 ' HB3' HG23 ' H' ' 288' ' ' VAL . 63.1 mtt -126.69 95.22 38.24 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 123.869 0.867 . . . . 74.2 109.703 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -82.01 53.36 4.54 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.116 2.544 . . . . 65.51 111.577 172.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' H' ' 286' ' ' MET . 87.3 t -71.13 130.39 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.777 0.831 . . . . 63.22 110.638 -174.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -122.83 -88.07 0.62 Allowed 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 108.002 -1.11 . . . . 70.43 108.002 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 55.6 m95 -151.79 162.06 41.65 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.051 0.94 . . . . 72.32 110.328 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.438 HD11 HG22 ' B' ' 131' ' ' VAL . 5.6 mp -90.98 -10.75 41.19 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-N 114.541 -1.209 . . . . 72.32 110.023 174.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 176.46 82.05 0.06 OUTLIER Glycine 0 C--N 1.351 1.401 0 N-CA-C 111.474 -0.65 . . . . 43.02 111.474 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -76.87 80.08 2.93 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.048 2.498 . . . . 74.14 111.371 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -154.24 -29.94 0.12 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 115.655 -0.702 . . . . 73.23 110.996 -176.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -63.78 -37.76 88.58 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.696 0.798 . . . . 55.25 111.38 177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 9.3 m -62.23 114.99 3.77 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.928 0.891 . . . . 71.33 110.012 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 69.28 -69.63 0.16 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.15 1.38 . . . . 72.33 111.439 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 31.1 t60 79.73 -60.25 0.33 Allowed 'General case' 0 C--N 1.358 0.975 0 C-N-CA 126.46 1.904 . . . . 70.44 110.611 175.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 161.54 46.72 0.02 OUTLIER Glycine 0 C--N 1.346 1.109 0 CA-C-O 119.27 -0.739 . . . . 63.5 113.496 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -160.78 117.47 2.33 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-N 118.053 0.926 . . . . 74.42 111.199 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . 0.449 HD13 ' HB3' ' B' ' 35' ' ' ASP . 26.1 mm -64.63 147.76 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.369 0 C-N-CA 124.283 1.033 . . . . 75.52 110.448 177.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . 0.46 ' HA ' ' HE1' ' F' ' 298' ' ' HIS . 14.4 p-10 -58.27 -53.21 60.91 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.115 0.966 . . . . 74.52 110.862 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -153.64 139.23 12.0 Favored Pre-proline 0 N--CA 1.479 1.021 0 C-N-CA 125.839 1.656 . . . . 74.54 106.904 177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -61.08 -25.02 80.57 Favored 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.327 2.018 . . . . 75.31 112.433 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -163.67 177.45 8.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.568 1.147 . . . . 64.4 109.144 175.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . 0.482 HG13 ' HB1' ' C' ' 129' ' ' ALA . 3.6 t -62.99 -31.15 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 C-N-CA 122.995 0.518 . . . . 62.01 110.803 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . 0.414 HG21 ' N ' ' F' ' 292' ' ' GLY . 24.2 m 84.76 141.65 0.06 Allowed 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.326 1.85 . . . . 70.14 110.76 -175.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 15.3 p -66.59 131.31 45.74 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.886 0.874 . . . . 63.33 111.382 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 35.8 p -120.28 88.7 42.32 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 124.461 1.104 . . . . 71.23 109.151 176.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo . . . . . 0 C--N 1.378 2.084 0 C-N-CA 123.23 2.62 . . . . 64.31 112.018 -179.781 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.1 mmm . . . . . 0 C--O 1.243 0.757 0 N-CA-C 109.252 -0.647 . . . . 52.33 109.252 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.5 m -76.06 86.27 2.95 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 123.536 0.734 . . . . 60.31 110.865 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -155.64 -71.34 0.12 Allowed 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 108.961 -0.755 . . . . 72.55 108.961 172.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.705 ' HG2' HE22 ' E' ' 273' ' ' GLN . 82.8 mm-40 -86.67 62.28 7.31 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.723 0.773 . . . . 63.41 109.431 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -85.03 -18.46 34.32 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.017 -0.992 . . . . 74.32 111.05 -178.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -70.73 123.84 22.87 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 109.555 -0.535 . . . . 74.21 109.555 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.0 m -87.8 -3.53 58.94 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.258 1.023 . . . . 64.1 111.368 -171.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -99.1 141.31 32.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.009 0.524 . . . . 72.23 111.188 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 52.2 mtm -88.07 159.66 18.15 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.002 0.921 . . . . 42.1 110.278 178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -147.18 135.94 22.1 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 123.921 0.888 . . . . 65.43 109.602 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.621 ' HA ' HG22 ' A' ' 86' ' ' ILE . 54.1 t80 -136.2 132.16 35.53 Favored 'General case' 0 C--O 1.24 0.584 0 N-CA-C 106.495 -1.668 . . . . 72.03 106.495 164.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.4 tp60 -150.82 120.3 6.91 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.855 -0.424 . . . . 75.1 109.855 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 mt -77.81 128.23 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 107.929 -1.137 . . . . 71.24 107.929 169.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -101.78 -39.9 7.2 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 109.605 -0.517 . . . . 61.21 109.605 176.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 20.7 ttt85 -174.68 127.62 0.31 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 122.672 0.389 . . . . 71.31 109.961 -174.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.548 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -112.48 145.94 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.02 -0.733 . . . . 72.42 109.02 175.74 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -165.39 174.64 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.716 0.807 . . . . 74.42 111.195 -172.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 71.5 p -99.68 122.56 42.88 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.212 -0.662 . . . . 72.35 109.212 172.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.0 mtpt -87.94 -24.6 23.54 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 122.738 0.415 . . . . 62.51 110.042 175.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.47 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 22.3 t70 -152.28 137.36 17.32 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.175 -0.921 . . . . 62.42 109.416 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 64.2 mt -133.77 132.33 56.78 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.319 -1.363 . . . . 61.5 107.319 174.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.9 t -139.57 124.89 19.01 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.641 -0.874 . . . . 72.12 108.641 -176.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 89.9 t80 -135.23 128.49 32.04 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 106.397 -1.705 . . . . 75.01 106.397 170.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -137.32 121.7 18.22 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 122.995 0.518 . . . . 72.23 109.666 -175.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -133.11 77.57 67.07 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 106.599 -1.63 . . . . 71.21 106.599 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -63.77 -46.06 9.64 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.578 2.186 . . . . 71.3 111.36 -175.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -92.22 23.37 3.88 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 114.653 -1.158 . . . . 74.41 109.704 -177.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.527 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -45.03 -55.64 10.7 Favored Pre-proline 0 CA--C 1.573 1.841 0 CA-C-O 118.111 -0.947 . . . . 75.22 112.916 -175.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.527 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 23.8 Cg_exo -61.18 -26.89 83.07 Favored 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.378 2.052 . . . . 71.03 113.305 178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -89.97 -26.7 20.24 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.988 0.915 . . . . 72.42 110.763 -175.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.811 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.2 p -82.52 -17.69 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 C-N-CA 122.744 0.417 . . . . 72.31 111.281 -173.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -79.81 -12.46 59.77 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.271 0.628 . . . . 73.45 111.78 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -101.94 -9.14 20.93 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.174 0.99 . . . . 74.3 110.933 172.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 5.9 mmtp -71.94 158.62 35.68 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.3 0.64 . . . . 75.11 111.663 -176.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -62.59 138.16 58.42 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.048 -0.978 . . . . 73.25 110.19 172.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.4 m95 -94.01 63.23 3.18 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.623 0.725 . . . . 73.01 111.645 -165.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -139.45 83.77 16.9 Favored Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 124.123 0.969 . . . . 72.14 109.188 175.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -86.92 167.04 8.36 Favored 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.643 2.229 . . . . 75.15 111.648 174.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -115.14 99.62 7.56 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.316 -1.364 . . . . 74.42 107.316 167.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 65' ' ' THR . 59.7 t -85.08 129.87 37.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 109.04 -0.726 . . . . 64.01 109.04 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -125.09 120.15 30.63 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.528 1.131 . . . . 72.51 109.296 -179.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.6 tt -96.71 109.07 21.79 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 106.281 -1.748 . . . . 51.33 106.281 170.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -127.1 128.2 45.85 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 107.906 -1.146 . . . . 72.3 107.906 176.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.2 pp -109.73 162.13 14.74 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.269 0.556 . . . . 73.32 110.853 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.573 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 10.1 t70 -131.05 134.51 46.71 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 125.015 1.326 . . . . 64.23 108.081 -178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.493 ' HB ' ' CE1' ' E' ' 281' ' ' PHE . 26.8 p -115.76 125.08 52.3 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.018 0.927 . . . . 74.44 110.695 -171.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -146.38 124.06 11.85 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.23 0.612 . . . . 53.2 111.586 -176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.54 ' HB2' HD11 ' E' ' 278' ' ' LEU . 6.5 p -90.91 155.68 18.56 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.296 0.638 . . . . 70.52 109.568 168.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.8 t -150.58 150.56 31.35 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.223 1.009 . . . . 70.3 109.027 -174.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -115.24 138.84 50.5 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.194 0.598 . . . . 60.23 110.228 174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 65.1 mt -110.04 -34.63 6.35 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.824 0.85 . . . . 71.24 109.856 173.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.519 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -166.75 -176.01 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.707 1.203 . . . . 71.04 109.986 -176.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -73.39 122.07 21.48 Favored 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 108.955 -0.758 . . . . 75.32 108.955 173.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 72.75 -7.02 1.52 Allowed 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 125.36 1.464 . . . . 74.32 112.468 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.519 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 57.5 t -114.86 111.24 35.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 107.506 -1.294 . . . . 51.43 107.506 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -128.68 170.96 12.65 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 123.65 0.78 . . . . 73.34 108.997 -173.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -130.59 147.25 52.25 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 123.978 0.911 . . . . 74.12 109.076 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.424 HG13 ' HE2' ' E' ' 281' ' ' PHE . 96.4 t -125.98 122.33 61.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 N-CA-C 107.923 -1.14 . . . . 71.11 107.923 171.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.453 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 61.2 t -105.35 129.68 57.8 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 N-CA-C 109.239 -0.652 . . . . 75.43 109.239 173.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -118.61 100.41 7.42 Favored 'General case' 0 C--O 1.241 0.612 0 N-CA-C 106.482 -1.673 . . . . 64.22 106.482 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.573 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 22.4 ttp180 -84.96 109.0 17.85 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.764 -0.653 . . . . 61.52 109.276 178.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 15.4 t -92.81 132.59 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 107.966 -1.124 . . . . 73.34 107.966 175.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.6 m -120.27 138.39 53.7 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 109.485 -0.561 . . . . 63.15 109.485 176.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.9 t -129.56 108.98 17.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 C-N-CA 124.874 1.27 . . . . 74.14 107.573 176.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.3 m -105.02 134.72 47.65 Favored 'General case' 0 C--O 1.218 -0.574 0 N-CA-C 109.461 -0.57 . . . . 73.04 109.461 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.77 111.63 15.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 107.232 -1.396 . . . . 71.53 107.232 172.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 18.2 t -138.15 134.99 35.26 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.004 0.522 . . . . 71.01 110.464 -177.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.4 mp -91.42 52.06 2.01 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 125.078 1.351 . . . . 64.32 109.608 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.83 -90.69 1.46 Allowed Glycine 0 C--N 1.341 0.83 0 N-CA-C 111.61 -0.596 . . . . 60.25 111.61 -175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -92.62 -27.59 17.23 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.996 0.518 . . . . 73.04 112.381 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -114.31 125.13 53.54 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 109.662 -0.496 . . . . 70.05 109.662 -177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 43.5 m -81.26 135.3 35.71 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.571 0.748 . . . . 73.31 111.237 -177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.811 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.87 -65.08 0.88 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.466 0.706 . . . . 43.14 110.217 173.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.9 p90 -160.53 163.47 32.8 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 114.988 -1.006 . . . . 74.32 111.366 -178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.7 tp -131.93 124.89 30.36 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.862 1.265 . . . . 61.51 108.371 177.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.411 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 54.7 m -123.88 105.61 9.77 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.115 0.966 . . . . 73.41 109.067 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -129.7 122.16 28.38 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.348 0.659 . . . . 61.32 109.718 -175.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.4 HG11 ' HB3' ' A' ' 113' ' ' CYS . 46.7 t -130.47 112.75 23.64 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 123.915 0.886 . . . . 74.1 109.458 -174.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.522 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 44.4 mt-30 -84.87 89.16 7.49 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.466 0.706 . . . . 74.21 109.506 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.33 98.23 7.35 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 115.136 -0.938 . . . . 73.33 109.023 177.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -101.1 145.25 16.91 Favored Glycine 0 C--N 1.341 0.855 0 N-CA-C 111.426 -0.67 . . . . 63.24 111.426 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -146.98 137.27 6.58 Favored Glycine 0 CA--C 1.509 -0.339 0 N-CA-C 111.639 -0.585 . . . . 71.21 111.639 -175.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 42.6 mt -77.9 126.15 38.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.686 0 N-CA-C 108.843 -0.799 . . . . 55.41 108.843 175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -129.52 118.98 22.93 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 108.621 -0.881 . . . . 72.4 108.621 174.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 43.0 t -86.25 99.11 11.33 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 108.778 -0.823 . . . . 71.5 108.778 172.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.621 HG22 ' HA ' ' A' ' 11' ' ' PHE . 0.2 OUTLIER -119.88 157.32 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 123.313 0.645 . . . . 73.25 110.512 -179.177 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.467 ' HA ' HD21 ' E' ' 277' ' ' LEU . . . -166.88 161.6 15.33 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.941 -1.027 . . . . 65.14 110.476 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.3 8.04 83.09 Favored Glycine 0 C--N 1.35 1.327 0 O-C-N 123.287 0.367 . . . . 73.33 113.797 170.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 40.0 pt -111.45 143.69 20.8 Favored 'Isoleucine or valine' 0 C--O 1.243 0.748 0 C-N-CA 123.956 0.902 . . . . 71.14 108.901 -176.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' HG2' ' H ' ' A' ' 91' ' ' GLY . 17.7 tt0 -159.13 174.92 14.14 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 122.834 0.454 . . . . 74.41 109.879 -174.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.469 ' H ' ' HG2' ' A' ' 90' ' ' GLU . . . 58.87 -127.91 46.41 Favored Glycine 0 C--N 1.347 1.174 0 C-N-CA 123.904 0.764 . . . . 72.23 114.274 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.9 t -82.66 -15.19 52.98 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 123.296 0.638 . . . . 70.0 111.527 178.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -74.53 -40.31 61.81 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.353 0.661 . . . . 74.14 110.097 -179.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.8 ptm -71.01 -29.5 65.47 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 116.272 -0.422 . . . . 72.41 110.065 173.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.14 -28.85 63.53 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.561 0.745 . . . . 64.41 111.131 175.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -81.6 -31.49 32.48 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.419 0.687 . . . . 73.01 110.494 176.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -69.12 -57.57 5.23 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 122.965 0.506 . . . . 74.32 109.925 176.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 60.5 mt -67.8 -51.83 44.2 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.284 -0.871 . . . . 61.4 111.001 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -78.57 -6.09 88.16 Favored Glycine 0 N--CA 1.471 0.973 0 N-CA-C 115.147 0.819 . . . . 62.33 115.147 -167.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.644 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.39 -54.14 0.19 Allowed 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 113.254 0.835 . . . . 74.33 113.254 -170.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -69.39 -46.91 65.78 Favored 'General case' 0 CA--C 1.559 1.301 0 C-N-CA 122.611 0.365 . . . . 64.13 111.575 -171.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 63.9 m -67.98 -43.56 37.02 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.003 0.921 . . . . 64.33 112.609 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -49.69 -43.26 40.72 Favored 'Trans proline' 0 C--N 1.403 3.402 0 C-N-CA 123.096 2.531 . . . . 72.43 113.148 168.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 40.1 t-20 -63.25 -37.14 86.07 Favored 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.089 0.868 . . . . 70.34 110.837 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -67.0 -45.53 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 C-N-CA 123.326 0.65 . . . . 74.43 111.015 177.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 94.9 mt -82.33 -24.49 34.55 Favored 'General case' 0 CA--C 1.548 0.89 0 CA-C-N 115.566 -0.743 . . . . 74.14 112.292 -170.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -61.29 -42.49 85.64 Favored Pre-proline 0 CA--C 1.564 1.507 0 N-CA-C 113.824 1.046 . . . . 54.42 113.824 -172.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.427 ' HA ' HH11 ' A' ' 111' ' ' ARG . 76.6 Cg_exo -55.04 -41.8 75.26 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.47 2.114 . . . . 74.31 114.399 172.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -71.53 -43.5 66.32 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.148 0.579 . . . . 62.31 111.62 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.87 97.55 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.032 0.533 . . . . 71.0 110.657 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.505 ' NH1' HD12 ' C' ' 105' ' ' ILE . 31.1 ttm105 -50.69 -57.67 7.73 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.776 1.298 . . . . 64.41 110.825 176.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -64.88 -40.76 95.62 Favored 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.991 0.807 . . . . 74.1 110.802 -175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.571 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 43.2 t -60.76 -33.21 72.6 Favored 'General case' 0 N--CA 1.477 0.888 0 O-C-N 123.659 0.599 . . . . 73.43 111.786 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.522 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 96.1 mt -74.01 -55.74 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 123.623 0.769 . . . . 64.33 109.843 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.448 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.2 m -51.41 -44.3 62.2 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.246 1.418 . . . . 62.21 112.64 -173.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 34.3 t -65.3 -42.75 92.77 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 114.93 -1.032 . . . . 74.14 110.106 -177.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.522 ' HE2' ' HA ' ' A' ' 114' ' ' ILE . 51.4 mtm -64.63 -40.39 95.38 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 122.84 0.456 . . . . 72.21 111.05 178.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 114' ' ' ILE . 95.1 t -57.27 -48.29 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.025 0 C-N-CA 123.576 0.75 . . . . 65.5 109.945 178.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 95.6 p -71.16 -31.89 68.24 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-N 115.737 -0.665 . . . . 75.41 111.765 -176.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 116' ' ' SER . 73.1 mtt-85 -67.58 -28.74 68.03 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.85 0.86 . . . . 71.42 110.885 177.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.87 23.85 8.61 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-O 119.627 -0.54 . . . . 74.24 113.972 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.415 HG23 ' HB3' ' B' ' 17' ' ' TYR . 75.4 p 50.13 26.08 1.99 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 125.809 1.644 . . . . 44.35 113.625 -173.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 63.2 m-85 -94.36 149.17 36.26 Favored Pre-proline 0 N--CA 1.477 0.905 0 N-CA-C 108.83 -0.804 . . . . 63.22 108.83 174.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.541 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 50.3 Cg_exo -56.02 139.3 84.76 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 122.818 2.346 . . . . 60.12 111.488 174.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.448 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.1 tt0 -54.71 132.6 46.06 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 124.13 0.894 . . . . 70.42 111.092 -179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 38.1 tp -111.92 118.3 35.11 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 108.85 -0.796 . . . . 72.5 108.85 176.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.595 ' HB2' HD13 ' C' ' 13' ' ' ILE . 89.9 m-20 -110.0 110.36 21.25 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.995 -1.113 . . . . 70.1 107.995 177.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.419 ' H ' HD22 ' A' ' 128' ' ' LEU . 2.1 mm? -73.15 117.33 14.76 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 107.932 -1.136 . . . . 54.22 107.932 177.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -60.12 140.27 90.93 Favored Pre-proline 0 N--CA 1.476 0.856 0 CA-C-N 118.406 0.548 . . . . 45.44 110.996 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.422 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 1.7 Cg_endo -74.03 109.84 2.96 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.027 1.818 . . . . 43.32 110.645 -178.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.9 p -99.36 123.74 52.24 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.501 -0.925 . . . . 73.45 108.501 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -73.75 99.73 3.24 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.807 0.843 . . . . 73.54 109.929 -173.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -72.15 -46.31 56.98 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.475 0.71 . . . . 73.34 111.85 -178.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.644 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.9 p-10 -63.25 -41.63 99.09 Favored 'General case' 0 N--CA 1.479 1.007 0 O-C-N 123.425 0.453 . . . . 64.31 111.441 -173.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.33 -51.98 60.73 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 123.449 0.468 . . . . 52.45 109.991 175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -53.37 -42.62 67.04 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 124.988 1.43 . . . . 74.33 110.969 -173.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -61.28 -44.87 96.51 Favored 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.22 0.95 . . . . 73.34 110.198 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.402 ' HG2' ' O ' ' A' ' 134' ' ' ASP . 84.1 mmm -71.38 -42.71 68.06 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.058 0.543 . . . . 71.35 112.22 -173.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 7.8 p30 -71.05 -26.43 63.08 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 117.69 0.223 . . . . 53.21 111.096 178.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -76.36 -35.25 58.8 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 122.986 0.514 . . . . 72.52 110.423 172.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 58.8 tp -68.73 -51.76 37.97 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.695 0.798 . . . . 74.33 112.059 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -169.78 19.33 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.716 -0.674 . . . . 74.21 110.615 -168.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.566 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 62.0 mm-40 64.98 -80.24 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 124.414 1.086 . . . . 61.33 110.828 -174.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -88.72 131.72 34.91 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.491 1.116 . . . . 73.53 111.08 -175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -82.42 165.03 20.6 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.021 0.928 . . . . 73.41 111.463 174.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.66 170.46 48.23 Favored Glycine 0 C--N 1.349 1.298 0 CA-C-N 116.169 -0.469 . . . . 74.44 113.805 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -113.46 130.45 56.32 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.211 1.005 . . . . 64.44 110.445 -177.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.9 69.73 2.83 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 111.493 -0.643 . . . . 73.42 111.493 179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 38.6 p -89.31 129.9 35.78 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 123.706 0.802 . . . . 63.51 111.865 -174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -89.77 145.65 25.03 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 107.909 -1.145 . . . . 65.1 107.909 175.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -136.22 -12.98 1.86 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 122.745 0.418 . . . . 73.03 111.67 -169.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 93.6 m-70 -86.24 109.48 18.96 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 121.785 -0.572 . . . . 65.14 111.818 -173.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -80.09 118.53 21.89 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.379 1.072 . . . . 74.33 108.682 171.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -57.07 -49.14 76.76 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.957 0.903 . . . . 75.04 111.693 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.973 0 N-CA-C 108.782 -0.821 . . . . 73.31 108.782 177.385 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 109.736 -0.468 . . . . 62.23 109.736 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -141.32 97.78 3.23 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.889 0.875 . . . . 51.03 109.898 -177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -107.72 159.87 16.14 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.741 0.816 . . . . 73.31 109.76 -175.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -142.01 171.41 14.1 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 124.748 1.219 . . . . 73.14 109.501 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -68.94 157.99 35.55 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.232 0.613 . . . . 61.41 110.772 -179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -67.96 145.07 54.88 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.478 0.711 . . . . 70.43 112.123 -175.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.427 HG22 ' HB2' ' E' ' 310' ' ' PRO . 14.9 t -133.62 -160.09 1.02 Allowed 'General case' 0 C--O 1.246 0.904 0 C-N-CA 124.528 1.131 . . . . 72.52 108.504 -178.027 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -55.6 115.65 2.45 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.07 0.548 . . . . 71.2 110.298 174.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.565 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 15.2 ptm 58.46 177.79 0.07 Allowed 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 126.472 1.909 . . . . 72.13 114.267 -179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 33.5 m -152.48 130.32 11.69 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 124.797 1.239 . . . . 75.35 108.012 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -151.68 128.6 11.0 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 122.936 0.494 . . . . 73.23 110.104 175.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -159.67 144.27 15.09 Favored 'General case' 0 C--O 1.245 0.827 0 C-N-CA 123.678 0.791 . . . . 64.44 108.942 161.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.561 HG22 ' HE2' ' B' ' 84' ' ' PHE . 2.7 pp -59.13 138.4 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-N 115.498 -0.774 . . . . 73.24 109.957 168.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.435 ' HB2' ' HB ' ' B' ' 83' ' ' ILE . 9.7 mm100 -100.47 -45.98 5.38 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 108.575 -0.898 . . . . 75.34 108.575 172.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.1 ttt180 -164.84 129.93 2.64 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.99 -1.004 . . . . 75.14 108.882 -175.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 98.2 mt -115.03 135.98 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 106.667 -1.605 . . . . 62.54 106.667 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.415 ' HB3' HG23 ' A' ' 122' ' ' THR . 26.5 p90 -166.5 158.44 13.52 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.482 0.658 . . . . 73.2 111.331 -173.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 78.2 m -85.46 119.71 26.12 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.162 -0.926 . . . . 74.04 108.962 173.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.524 ' HE3' ' HB3' ' A' ' 28' ' ' ALA . 44.3 mtpt -88.32 -34.68 17.57 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.273 0.629 . . . . 73.14 110.177 176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.58 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 20.2 t70 -153.79 147.16 24.87 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 116.177 -0.465 . . . . 71.13 110.568 -170.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 41.0 mm -139.76 142.94 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 125.86 1.664 . . . . 53.31 107.573 177.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 33.6 t -148.43 138.17 22.22 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.665 -0.865 . . . . 62.02 108.665 174.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 92.2 t80 -151.18 123.3 8.22 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.239 -1.393 . . . . 75.44 107.239 173.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -120.89 149.52 42.49 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 123.081 0.552 . . . . 75.31 109.542 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.565 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -143.72 80.26 12.92 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.11 -1.07 . . . . 40.54 108.11 173.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.41 -17.66 39.03 Favored 'Trans proline' 0 C--N 1.384 2.436 0 C-N-CA 123.057 2.505 . . . . 73.01 111.872 178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -122.87 27.84 7.53 Favored 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.501 1.121 . . . . 72.22 109.439 176.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.565 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -47.05 -50.05 47.87 Favored Pre-proline 0 N--CA 1.498 1.951 0 C-N-CA 124.275 1.03 . . . . 75.32 112.836 172.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 1.0 OUTLIER -85.21 -35.29 0.16 Allowed 'Trans proline' 0 C--N 1.385 2.45 0 C-N-CA 122.504 2.136 . . . . 62.34 112.709 178.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 52.1 m80 -90.84 2.35 56.2 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.702 0.801 . . . . 75.31 112.908 -170.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.83 -28.59 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 C-N-CA 125.075 1.35 . . . . 71.0 111.898 173.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -66.62 -13.82 61.62 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 124.753 1.221 . . . . 73.42 112.381 -173.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.617 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 10.3 pt20 -73.34 -32.45 64.56 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-O 121.427 0.632 . . . . 74.3 110.253 174.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.617 ' HG2' ' HG3' ' B' ' 33' ' ' GLN . 29.3 mmtp -107.03 81.81 1.6 Allowed 'General case' 0 C--O 1.239 0.546 0 C-N-CA 125.04 1.336 . . . . 51.25 108.922 -178.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -81.39 77.17 8.29 Favored 'General case' 0 CA--C 1.553 1.086 0 CA-C-N 115.547 -0.751 . . . . 71.13 111.644 -172.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.6 ' HA ' ' CE3' ' B' ' 36' ' ' TRP 0.258 0.0 OUTLIER 160.56 -171.09 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 127.084 2.153 . . . . 71.33 111.141 156.19 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.59 ' HA ' ' HB3' ' H' ' 297' ' ' TYR . 12.4 pt20 -59.02 132.2 87.11 Favored Pre-proline 0 C--N 1.361 1.068 0 C-N-CA 124.755 1.222 . . . . 72.2 113.278 -168.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -79.42 171.77 15.48 Favored 'Trans proline' 0 C--N 1.37 1.683 0 C-N-CA 123.418 2.746 . . . . 74.23 112.784 174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -69.39 109.41 4.17 Favored 'General case' 0 C--N 1.352 0.694 0 N-CA-C 108.596 -0.89 . . . . 50.51 108.596 167.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' H' ' 295' ' ' ALA . 9.3 m -95.16 135.0 30.57 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 115.407 -0.815 . . . . 61.21 109.931 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -141.65 124.28 15.93 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.329 1.052 . . . . 65.41 108.294 -174.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.65 HD22 HD21 ' B' ' 128' ' ' LEU . 64.7 tp -97.41 145.49 26.12 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.454 -0.573 . . . . 65.02 109.454 174.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -146.66 154.25 41.24 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.999 -1.112 . . . . 63.4 107.999 172.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -138.38 141.97 39.63 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 108.484 -0.932 . . . . 73.04 108.484 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.692 ' HB3' ' HD3' ' B' ' 61' ' ' ARG . 15.1 t70 -124.34 144.02 50.25 Favored 'General case' 0 C--O 1.243 0.721 0 C-N-CA 123.966 0.906 . . . . 61.31 108.699 176.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 71.3 p -112.23 112.08 23.43 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 115.423 -0.808 . . . . 74.3 110.225 -170.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.96 125.36 31.4 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 108.314 -0.995 . . . . 71.35 108.314 176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 24.6 p -142.82 168.17 20.34 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.36 0.664 . . . . 64.32 109.621 176.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 57.8 p -150.99 141.06 22.11 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 123.129 0.572 . . . . 74.25 109.909 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -82.02 109.74 16.63 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 108.826 -0.805 . . . . 62.11 108.826 174.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.507 HD11 ' HB2' ' B' ' 57' ' ' GLU . 55.1 mt -75.83 -41.03 53.7 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 122.811 0.445 . . . . 75.54 110.245 179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.75 -171.77 3.55 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 124.184 0.994 . . . . 65.23 110.062 -177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -59.88 111.37 1.44 Allowed 'General case' 0 N--CA 1.482 1.136 0 CA-C-N 115.555 -0.748 . . . . 63.11 110.446 -179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 65.55 12.53 8.27 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 124.637 1.175 . . . . 75.54 112.516 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 79.0 t -107.06 115.14 47.86 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 108.094 -1.076 . . . . 72.42 108.094 175.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.41 ' CE1' ' HB2' ' H' ' 278' ' ' LEU . 78.7 m-85 -124.14 138.49 54.42 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.225 -0.657 . . . . 72.44 109.225 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.507 ' HB2' HD11 ' B' ' 51' ' ' LEU . 7.8 tm-20 -107.08 106.92 17.66 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.278 -1.379 . . . . 73.32 107.278 177.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 78.1 t -96.4 121.57 47.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 125.088 1.355 . . . . 74.34 110.04 -174.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.494 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 30.0 t -105.39 120.19 55.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 C-N-CA 123.437 0.695 . . . . 54.11 109.149 178.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.438 HD22 ' HA ' ' B' ' 103' ' ' PRO . 50.2 tp -95.16 99.16 11.18 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.605 -0.887 . . . . 73.24 108.605 172.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.692 ' HD3' ' HB3' ' B' ' 45' ' ' ASP . 65.2 ttt180 -88.48 107.94 19.13 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.813 -0.81 . . . . 71.53 108.813 177.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 77.2 t -104.9 102.87 14.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.177 0.991 . . . . 65.24 108.934 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 14.1 m -100.93 128.47 46.95 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.376 0.67 . . . . 72.43 109.836 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 75.1 t -119.43 135.29 60.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.333 1.053 . . . . 72.44 108.932 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 78.9 m -124.83 143.59 50.74 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 123.528 0.731 . . . . 30.32 109.571 174.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.74 130.25 24.0 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.915 -1.142 . . . . 64.22 107.915 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.411 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 8.4 m -135.14 126.53 28.47 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 120.81 0.338 . . . . 53.23 111.586 -176.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 56.9 mt -93.9 109.75 21.45 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.409 1.084 . . . . 73.24 108.467 177.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.9 -111.17 3.86 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 111.051 -0.82 . . . . 53.41 111.051 -174.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -121.97 18.42 10.91 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.657 0.742 . . . . 73.22 110.214 178.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 12.8 pt-20 -122.2 142.79 50.06 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 121.529 -0.732 . . . . 75.21 109.132 178.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 90.7 m -66.78 118.45 10.32 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.909 0.484 . . . . 75.4 110.983 -179.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.563 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -68.03 -55.46 12.51 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.973 -0.751 . . . . 71.4 108.973 177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . 0.43 ' CZ ' HG21 ' H' ' 296' ' ' THR . 50.4 p90 -164.4 164.98 21.96 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.203 -1.362 . . . . 75.24 109.214 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 84.2 mt -123.76 151.91 42.75 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.439 1.096 . . . . 64.45 108.514 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 38.4 t -155.52 115.66 3.75 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 109.221 -0.659 . . . . 74.43 109.221 170.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -123.62 127.04 47.69 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 108.143 -1.058 . . . . 74.15 108.143 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.414 HG13 HD13 ' B' ' 21' ' ' ILE . 57.3 t -122.55 148.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.875 -0.787 . . . . 74.05 108.875 176.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.58 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 24.5 mt-30 -123.4 99.46 6.34 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.218 -1.031 . . . . 55.24 108.218 173.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.518 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -93.71 100.45 12.67 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.35 -0.981 . . . . 72.23 108.35 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.94 162.0 29.7 Favored Glycine 0 C--N 1.339 0.722 0 O-C-N 123.677 0.61 . . . . 45.15 111.912 179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -162.89 127.13 1.64 Allowed Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 111.226 -0.75 . . . . 71.53 111.226 -178.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' B' ' 14' ' ' GLN . 33.9 mt -83.98 133.81 28.37 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.575 0 N-CA-C 108.057 -1.09 . . . . 64.25 108.057 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.561 ' HE2' HG22 ' B' ' 13' ' ' ILE . 49.2 m-85 -135.42 138.61 43.41 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.454 0.702 . . . . 75.13 109.45 177.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 44.1 m -91.86 103.74 16.25 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.791 -0.818 . . . . 74.33 108.791 169.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.475 ' HB ' HD11 ' B' ' 89' ' ' ILE . 26.1 pt -120.21 122.04 67.31 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 123.879 0.872 . . . . 72.2 110.007 -176.024 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.87 21.1 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.839 0.855 . . . . 54.23 109.876 179.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 84.36 -45.32 3.48 Favored Glycine 0 C--N 1.349 1.279 0 O-C-N 123.525 0.516 . . . . 74.13 113.108 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.475 HD11 ' HB ' ' B' ' 86' ' ' ILE . 20.9 pt -64.03 158.88 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.655 1.182 . . . . 61.45 112.439 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.418 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 11.1 pt-20 -170.21 166.57 8.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.581 1.152 . . . . 74.3 109.8 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -119.1 16.6 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-N 116.297 -0.411 . . . . 71.35 113.881 -179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.3 m -80.27 -18.87 48.12 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 123.302 0.641 . . . . 71.42 111.345 -179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.418 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 94.5 mt-30 -60.89 -44.35 97.24 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.185 0.594 . . . . 73.42 110.954 177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.414 ' HE3' ' O ' ' H' ' 277' ' ' LEU . 3.3 ppp? -73.24 -32.7 64.88 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 122.661 0.384 . . . . 71.14 110.612 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.57 -33.7 76.52 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.721 0.808 . . . . 63.33 111.406 176.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -85.24 -26.64 26.57 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.667 0.787 . . . . 52.21 110.488 176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -70.97 -67.18 0.53 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 122.562 0.345 . . . . 72.15 110.569 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.433 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.1 pp -95.14 -6.48 41.74 Favored 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 112.517 0.562 . . . . 74.0 112.517 -176.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.8 2.38 45.19 Favored Glycine 0 C--N 1.351 1.388 0 O-C-N 123.216 0.322 . . . . 71.5 113.036 178.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -145.76 -58.36 0.32 Allowed 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.094 0.558 . . . . 63.43 111.037 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 58.7 t80 -73.41 -46.8 46.57 Favored 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 123.198 0.599 . . . . 73.2 111.963 -171.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 68.8 m -66.04 -42.46 51.67 Favored Pre-proline 0 CA--C 1.559 1.297 0 C-N-CA 123.546 0.738 . . . . 53.02 111.781 179.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.438 ' HA ' HD22 ' B' ' 60' ' ' LEU . 89.9 Cg_exo -50.87 -43.72 45.46 Favored 'Trans proline' 0 C--N 1.397 3.08 0 C-N-CA 122.628 2.218 . . . . 74.11 112.893 166.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.87 -25.04 67.0 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 123.183 0.593 . . . . 71.44 112.523 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 47.7 mt -76.8 -50.55 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 123.407 0.683 . . . . 64.1 110.346 174.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 80.5 mt -79.36 -15.95 57.07 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.562 0.745 . . . . 70.43 111.521 -172.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.466 ' HE1' HD13 ' B' ' 128' ' ' LEU . 37.8 t80 -62.5 -53.33 58.45 Favored Pre-proline 0 N--CA 1.479 1.024 0 CA-C-O 117.609 -1.186 . . . . 75.3 112.799 -175.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' B' ' 107' ' ' PHE . 71.4 Cg_exo -54.26 -37.76 88.31 Favored 'Trans proline' 0 C--N 1.383 2.384 0 C-N-CA 122.187 1.925 . . . . 75.15 113.59 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.518 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 80.0 m-85 -68.33 -51.38 45.22 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 123.737 0.815 . . . . 72.02 110.947 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.38 -38.72 81.23 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.959 0.904 . . . . 61.02 111.33 177.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 40.3 ttt-85 -64.95 -52.71 54.82 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.457 1.503 . . . . 73.21 110.296 -178.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.99 -34.84 78.4 Favored 'General case' 0 N--CA 1.484 1.246 0 O-C-N 123.903 0.752 . . . . 55.12 109.776 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.523 ' O ' ' HG2' ' B' ' 117' ' ' MET . 1.8 t -68.66 -43.29 76.53 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 122.904 0.482 . . . . 75.15 111.363 -177.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 86.4 mt -61.85 -43.78 97.87 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 C-N-CA 123.445 0.698 . . . . 75.14 110.338 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.723 HG23 ' HB2' ' B' ' 125' ' ' GLN . 44.5 m -64.02 -27.7 69.29 Favored 'General case' 0 CA--C 1.554 1.132 0 CA-C-N 115.203 -0.908 . . . . 74.35 111.052 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.451 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 37.8 t -73.59 -45.01 55.71 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.458 0.703 . . . . 71.31 110.122 176.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.9 mmt -72.5 -37.78 68.3 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 122.991 0.517 . . . . 72.33 112.025 -171.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 13.4 p -67.59 -31.07 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 CA-C-O 121.002 0.43 . . . . 73.43 110.46 174.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.461 ' OG ' HG21 ' C' ' 115' ' ' THR . 21.5 t -70.98 -30.54 66.84 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.925 0.89 . . . . 72.01 111.611 177.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.571 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 82.7 mtt-85 -74.03 -31.16 62.78 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 115.213 -0.903 . . . . 75.11 109.683 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -77.4 0.7 68.09 Favored Glycine 0 C--N 1.362 2.027 0 O-C-N 123.911 0.757 . . . . 53.34 112.203 169.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.563 HG22 HH22 ' C' ' 111' ' ' ARG . 29.3 p 65.5 23.62 11.85 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 126.93 2.092 . . . . 75.44 113.244 173.065 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -105.59 150.85 39.53 Favored Pre-proline 0 N--CA 1.471 0.607 0 C-N-CA 122.893 0.477 . . . . 74.55 110.079 177.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.521 ' O ' HG22 ' H' ' 296' ' ' THR . 91.9 Cg_exo -42.0 137.76 3.07 Favored 'Trans proline' 0 C--N 1.386 2.534 0 C-N-CA 124.381 3.387 . . . . 72.14 113.226 173.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.723 ' HB2' HG23 ' B' ' 115' ' ' THR . 18.0 pt20 -66.57 157.33 32.6 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.267 1.21 . . . . 75.51 114.267 -174.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.48 ' HB2' HG23 ' H' ' 296' ' ' THR . 2.1 tt -110.77 95.86 5.82 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 106.521 -1.659 . . . . 73.01 106.521 165.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.407 HD22 ' HG3' ' B' ' 125' ' ' GLN . 3.5 p30 -88.33 92.6 9.23 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 106.923 -1.51 . . . . 72.14 106.923 173.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.65 HD21 HD22 ' B' ' 42' ' ' LEU . 1.2 tt -63.44 133.91 54.76 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 114.785 -1.098 . . . . 72.42 110.892 -165.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.561 ' HB3' HD22 ' H' ' 291' ' ' LEU . . . -62.99 146.6 95.48 Favored Pre-proline 0 CA--C 1.557 1.213 0 C-N-CA 124.155 0.982 . . . . 74.04 111.051 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -59.77 116.16 3.11 Favored 'Trans proline' 0 C--N 1.379 2.173 0 C-N-CA 122.682 2.254 . . . . 72.24 111.516 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.568 HG22 HD21 ' H' ' 291' ' ' LEU . 12.7 t -90.76 118.92 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 N-CA-C 109.226 -0.657 . . . . 73.03 109.226 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.533 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 59.7 t30 -96.74 103.67 15.6 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.578 0.751 . . . . 71.5 109.823 -178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -87.08 -23.31 24.96 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.625 0.77 . . . . 73.11 110.707 177.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -60.25 -34.86 74.29 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 115.509 -0.768 . . . . 74.31 110.685 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.533 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -51.52 -40.19 59.13 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.087 0.955 . . . . 75.32 113.193 -176.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 57.0 tp -72.08 -52.26 17.7 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.74 0.416 . . . . 54.3 110.835 179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -69.37 -29.52 67.32 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 123.274 0.63 . . . . 73.4 112.682 -173.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -72.7 -41.52 65.19 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.521 0.728 . . . . 63.32 109.438 -179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -78.73 -25.08 44.54 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 114.231 -1.35 . . . . 41.31 110.112 -173.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -65.52 -38.38 89.52 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.215 -0.902 . . . . 74.14 110.358 174.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.1 mt -91.01 3.09 55.64 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.301 -0.863 . . . . 63.35 111.51 -177.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 51.1 tp60 -81.02 98.05 7.78 Favored 'General case' 0 C--N 1.353 0.758 0 CA-C-O 121.304 0.573 . . . . 75.35 109.986 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -139.46 -31.56 0.68 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.505 1.122 . . . . 75.35 110.137 177.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 83.8 mm-40 -92.23 163.53 13.88 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.687 0.795 . . . . 75.0 110.456 177.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.1 111.14 8.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.621 0.768 . . . . 71.13 110.361 -179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -175.49 39.83 0.11 Allowed Glycine 0 N--CA 1.467 0.756 0 N-CA-C 111.347 -0.701 . . . . 35.44 111.347 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -114.54 -153.6 0.53 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.242 1.017 . . . . 74.45 109.358 -174.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 92.96 55.1 1.66 Allowed Glycine 0 C--N 1.35 1.35 0 N-CA-C 110.289 -1.124 . . . . 31.54 110.289 -173.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 8.8 t -152.19 166.65 31.05 Favored 'General case' 0 C--O 1.244 0.783 0 C-N-CA 124.364 1.066 . . . . 70.41 109.727 -174.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 67.8 tt0 -68.93 115.87 8.74 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 123.71 0.804 . . . . 72.32 109.597 179.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -75.75 73.44 2.7 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.294 -1.002 . . . . 70.12 108.294 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -69.25 129.42 39.77 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.862 -1.063 . . . . 71.41 111.051 -171.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -173.93 166.82 4.35 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.233 1.413 . . . . 73.52 109.646 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -157.49 76.09 0.81 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 108.977 -0.749 . . . . 70.45 108.977 170.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.046 0 CA-C-N 114.836 -1.074 . . . . 74.15 109.024 177.107 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.7 mpp? . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 109.193 -0.669 . . . . 73.3 109.193 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 23.5 t 63.0 81.44 0.2 Allowed 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.95 1.3 . . . . 61.54 110.945 -178.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.72 16.98 5.06 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.212 1.005 . . . . 71.44 112.439 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 66.32 125.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 125.33 1.452 . . . . 74.34 112.082 175.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -155.68 142.29 18.74 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.273 0.629 . . . . 74.42 110.218 -176.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -151.21 172.74 15.35 Favored 'General case' 0 C--O 1.242 0.672 0 C-N-CA 124.24 1.016 . . . . 43.3 108.637 173.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 87.0 m -129.29 -71.81 0.61 Allowed 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 108.295 -1.002 . . . . 73.43 108.295 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 50.18 64.89 1.61 Allowed 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 124.745 1.218 . . . . 63.54 109.904 -178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.524 ' SD ' ' SG ' ' C' ' 97' ' ' CYS . 57.9 ttp 65.89 144.43 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 125.001 1.32 . . . . 64.01 112.704 -170.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 67.6 m -119.11 97.17 5.55 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.894 -1.521 . . . . 70.23 106.894 169.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -111.92 121.68 45.68 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.338 0.655 . . . . 65.43 109.633 -173.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.413 ' HB3' ' HB3' ' G' ' 310' ' ' PRO . 4.1 pt20 -137.84 145.13 41.87 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 123.363 0.665 . . . . 71.5 109.748 177.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 127' ' ' ASN . 2.6 pp -82.42 142.68 13.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 108.615 -0.883 . . . . 72.13 108.615 171.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -110.09 -50.19 3.0 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 109.855 -0.424 . . . . 75.14 109.855 173.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.643 HH12 HD11 ' G' ' 301' ' ' ILE . 62.7 ttt180 -169.71 130.95 1.06 Allowed 'General case' 0 N--CA 1.484 1.241 0 O-C-N 123.245 0.341 . . . . 72.51 110.464 -177.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . 0.435 ' H ' HD21 ' A' ' 127' ' ' ASN . 65.6 mt -109.61 140.29 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 124.826 1.25 . . . . 73.2 107.92 178.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG12 ' C' ' 83' ' ' ILE . 12.8 p90 -171.89 154.5 3.56 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.018 0.826 . . . . 74.42 112.212 -175.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 79.3 p -80.44 106.44 12.45 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 114.661 -1.154 . . . . 55.03 107.974 170.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -68.73 -48.16 64.51 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-O 121.872 0.844 . . . . 55.44 109.205 178.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.8 t70 -134.65 141.81 46.68 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 114.237 -1.347 . . . . 74.02 109.244 -177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.3 mt -135.63 145.33 31.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.485 0 C-N-CA 125.353 1.461 . . . . 75.24 107.219 175.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 37.3 t -155.59 152.01 28.24 Favored 'General case' 0 C--O 1.24 0.59 0 CA-C-O 121.212 0.529 . . . . 53.14 110.355 176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' D' ' 20' ' ' ASP . 86.3 t80 -147.94 119.11 7.74 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.298 -1.371 . . . . 72.04 107.298 174.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.513 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 41.4 mt-10 -118.7 118.23 31.06 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.163 0.585 . . . . 72.24 109.628 -179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . 0.466 ' CB ' ' HB2' ' C' ' 28' ' ' ALA . . . -134.54 86.0 35.71 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 123.627 0.771 . . . . 72.02 109.313 175.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -71.25 -28.71 18.17 Favored 'Trans proline' 0 C--N 1.381 2.238 0 C-N-CA 122.954 2.436 . . . . 65.24 111.781 170.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -96.99 19.81 12.2 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.397 1.079 . . . . 64.42 110.465 -179.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.466 ' HB2' ' CB ' ' C' ' 25' ' ' ALA . . . -59.11 -47.0 99.34 Favored Pre-proline 0 CA--C 1.567 1.596 0 C-N-CA 124.812 1.245 . . . . 62.33 113.953 -177.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.94 -31.06 6.62 Favored 'Trans proline' 0 C--N 1.391 2.774 0 C-N-CA 121.775 1.65 . . . . 65.52 111.875 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 27.0 t60 -66.68 -21.84 66.09 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 124.896 1.278 . . . . 72.32 112.744 -177.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.51 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 8.3 p -50.92 -33.33 12.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.349 0 N-CA-C 113.856 1.058 . . . . 73.32 113.856 -178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -58.35 -30.8 67.02 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 123.569 0.748 . . . . 71.42 112.624 -177.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 1.1 pm0 -114.25 28.06 9.03 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.232 1.013 . . . . 73.33 110.593 179.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.635 ' HE3' ' HA ' ' C' ' 73' ' ' ALA . 14.1 ttmm -104.15 147.27 27.63 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.242 0.617 . . . . 64.35 109.739 177.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -70.25 130.74 42.83 Favored 'General case' 0 C--O 1.243 0.727 0 C-N-CA 123.347 0.659 . . . . 74.11 109.836 177.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -84.7 62.81 7.59 Favored 'General case' 0 CA--C 1.55 0.955 0 O-C-N 123.731 0.644 . . . . 72.35 111.246 -174.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -156.28 77.66 4.33 Favored Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 124.361 1.065 . . . . 74.24 108.348 173.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.485 ' HB2' ' HB1' ' C' ' 66' ' ' ALA . 72.5 Cg_endo -88.45 140.2 4.4 Favored 'Trans proline' 0 C--N 1.367 1.526 0 C-N-CA 122.454 2.103 . . . . 73.41 111.608 175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -87.03 115.52 24.47 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 108.249 -1.019 . . . . 73.32 108.249 174.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 45.8 t -84.85 106.22 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 108.86 -0.793 . . . . 74.52 108.86 -176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 ttpp -92.11 108.31 19.84 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 108.641 -0.874 . . . . 73.51 108.641 174.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.18 122.85 32.21 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 107.281 -1.377 . . . . 75.41 107.281 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.77 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.0 m-20 -119.88 118.27 30.31 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.769 0.827 . . . . 74.34 109.05 -179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 5.1 mp -109.45 126.34 53.39 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 108.908 -0.775 . . . . 75.52 108.908 177.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.608 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 19.8 t70 -128.53 135.68 49.73 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.719 1.208 . . . . 75.03 108.107 176.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 74.0 p -113.73 126.58 55.39 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 122.946 0.498 . . . . 44.12 110.358 -171.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.532 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -126.58 145.66 50.45 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.951 0.9 . . . . 74.15 110.081 -178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 65.4 p -144.04 148.68 35.54 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.256 0.622 . . . . 53.11 109.458 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 82.3 p -145.38 140.28 27.56 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 108.564 -0.902 . . . . 63.15 108.564 175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -94.29 115.82 28.12 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.044 -1.095 . . . . 73.21 108.044 171.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.577 HD11 HD12 ' C' ' 83' ' ' ILE . 35.1 mt -87.92 -40.83 13.62 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.745 0.818 . . . . 71.43 109.618 -175.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -150.81 -175.77 5.26 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.085 1.354 . . . . 63.14 108.371 175.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -62.45 122.94 16.99 Favored 'General case' 0 N--CA 1.482 1.131 0 O-C-N 123.389 0.431 . . . . 55.55 109.943 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 68.93 -7.09 0.8 Allowed 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 125.67 1.588 . . . . 61.41 113.604 -177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 59.0 t -92.22 107.05 18.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.837 -1.171 . . . . 73.35 107.837 -178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.424 ' HB2' HD13 ' C' ' 86' ' ' ILE . 72.9 m-85 -118.18 122.87 44.12 Favored 'General case' 0 C--O 1.241 0.614 0 N-CA-C 107.927 -1.138 . . . . 74.11 107.927 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -83.22 120.77 26.22 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.158 0.983 . . . . 72.32 109.141 172.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 66.2 t -97.05 116.07 38.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 C-N-CA 124.625 1.17 . . . . 72.21 108.375 176.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.532 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 59.6 t -117.82 134.31 61.84 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.643 0.777 . . . . 63.34 109.132 178.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.91 111.02 19.06 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 108.226 -1.027 . . . . 73.21 108.226 172.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.608 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.2 ttm180 -79.96 105.83 11.54 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.041 -1.466 . . . . 62.41 107.041 167.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.25 114.07 45.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 108.09 -1.078 . . . . 75.13 108.09 -178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.77 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 64.2 m -114.71 137.73 51.57 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.715 0.806 . . . . 72.43 108.882 -174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.48 HG21 HG21 ' C' ' 114' ' ' ILE . 61.0 t -128.23 112.04 25.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 107.667 -1.234 . . . . 62.25 107.667 174.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 5.4 m -106.24 139.89 40.04 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.613 -0.884 . . . . 72.45 108.613 169.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' C' ' 38' ' ' PRO . . . -121.34 112.89 19.14 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 106.881 -1.526 . . . . 74.32 106.881 171.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.0 m -148.12 137.44 22.14 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.116 0.566 . . . . 72.05 110.354 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.5 58.79 0.67 Allowed 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.391 1.076 . . . . 65.41 109.347 175.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.6 -117.78 5.3 Favored Glycine 0 C--N 1.345 1.034 0 CA-C-N 114.808 -1.087 . . . . 73.2 110.464 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -89.53 -30.25 18.36 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 108.925 -0.769 . . . . 70.15 108.925 171.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 12.3 tp10 -63.61 100.05 0.25 Allowed 'General case' 0 C--N 1.353 0.743 0 O-C-N 124.236 0.96 . . . . 63.24 109.476 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 33.0 m -85.56 134.96 34.0 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.053 0.541 . . . . 73.41 109.856 -178.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.635 ' HA ' ' HE3' ' C' ' 34' ' ' LYS . . . -80.83 -61.05 2.08 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.995 0.918 . . . . 42.13 109.173 174.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.6 p90 -167.59 178.0 5.6 Favored 'General case' 0 N--CA 1.481 1.08 0 O-C-N 123.952 0.782 . . . . 74.31 110.934 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.2 tm? -138.49 144.85 40.2 Favored 'General case' 0 CA--C 1.546 0.819 0 N-CA-C 107.548 -1.279 . . . . 75.01 107.548 175.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.465 ' N ' HD13 ' C' ' 75' ' ' LEU . 49.0 t -148.98 142.92 25.78 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 107.792 -1.188 . . . . 74.2 107.792 174.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -156.64 134.54 11.05 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 117.896 0.316 . . . . 60.44 110.722 -175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -138.48 116.08 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 124.458 1.103 . . . . 43.55 110.027 -175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.505 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 2.2 mp0 -89.99 88.4 7.29 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.179 0.992 . . . . 71.34 108.426 174.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.4 tp-100 -79.39 103.41 9.29 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.061 -0.972 . . . . 62.41 110.081 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.54 153.11 20.86 Favored Glycine 0 C--N 1.336 0.576 0 CA-C-N 115.784 -0.644 . . . . 63.21 111.763 176.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.08 117.37 0.82 Allowed Glycine 0 CA--C 1.501 -0.816 0 N-CA-C 110.225 -1.15 . . . . 54.41 110.225 179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.577 HD12 HD11 ' C' ' 51' ' ' LEU . 12.9 mm -81.2 122.31 36.11 Favored 'Isoleucine or valine' 0 C--O 1.239 0.545 0 N-CA-C 109.11 -0.7 . . . . 54.23 109.11 176.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.447 ' HB2' HD11 ' C' ' 86' ' ' ILE . 60.3 m-85 -132.07 152.82 50.98 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 108.534 -0.914 . . . . 64.53 108.534 176.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 23.2 m -110.27 113.15 25.6 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 108.542 -0.91 . . . . 50.42 108.542 169.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' C' ' 84' ' ' PHE . 2.9 mp -115.75 103.15 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 107.204 -1.406 . . . . 45.03 107.204 -176.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -122.52 169.83 10.61 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.339 0.656 . . . . 72.45 110.903 -174.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.06 -50.69 2.8 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.913 -0.585 . . . . 43.21 112.484 177.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 170.32 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 C-N-CA 123.002 0.521 . . . . 72.25 111.769 -171.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -151.22 -173.99 4.67 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.767 0.827 . . . . 71.3 109.823 176.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.2 -138.63 39.12 Favored Glycine 0 C--N 1.352 1.466 0 CA-C-O 119.738 -0.479 . . . . 53.4 113.627 174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . 0.527 ' HA ' ' HB3' ' C' ' 95' ' ' ALA . 35.7 p -68.54 -22.3 64.51 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 123.915 0.886 . . . . 52.43 111.818 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -67.41 -50.07 61.08 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.767 0.827 . . . . 74.42 110.041 176.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 50.5 ttm -66.83 -38.21 85.98 Favored 'General case' 0 N--CA 1.48 1.055 0 CA-C-N 115.871 -0.604 . . . . 64.34 109.985 172.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' C' ' 92' ' ' THR . . . -60.88 -27.69 68.33 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.874 0.87 . . . . 62.44 112.331 -175.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 37.1 t-80 -74.91 -47.88 27.59 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 110.007 -0.368 . . . . 63.11 110.007 172.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.524 ' SG ' ' SD ' ' C' ' 9' ' ' MET . 18.7 t -70.73 -22.3 62.45 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 111.984 0.364 . . . . 71.2 111.984 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.24 -43.48 5.7 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.084 0.954 . . . . 74.01 109.521 -174.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.66 -5.36 64.85 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 115.56 -0.746 . . . . 73.24 114.139 -173.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.446 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -133.87 -54.7 0.87 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 117.192 0.496 . . . . 54.31 111.361 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.422 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 33.4 t80 -67.13 -55.92 12.15 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 124.156 0.983 . . . . 71.35 112.079 -172.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 79.6 m -62.83 -45.49 87.59 Favored Pre-proline 0 CA--C 1.573 1.837 0 N-CA-C 113.044 0.757 . . . . 72.31 113.044 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -56.61 -39.89 88.24 Favored 'Trans proline' 0 C--N 1.392 2.866 0 C-N-CA 122.715 2.277 . . . . 70.11 113.72 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -65.69 -28.7 69.26 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.937 0.895 . . . . 64.34 110.982 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.505 HD12 ' NH1' ' A' ' 111' ' ' ARG . 24.0 mm -72.79 -44.87 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.449 0.7 . . . . 72.21 110.592 173.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 89.4 mt -82.08 -15.01 54.96 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 115.635 -0.711 . . . . 53.31 112.134 -173.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.471 ' HB3' ' HD3' ' C' ' 108' ' ' PRO . 78.1 t80 -57.11 -50.57 87.44 Favored Pre-proline 0 CA--C 1.564 1.501 0 C-N-CA 124.837 1.255 . . . . 71.52 113.139 -175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' C' ' 107' ' ' PHE . 34.4 Cg_exo -62.85 -32.79 77.2 Favored 'Trans proline' 0 C--N 1.387 2.564 0 C-N-CA 122.129 1.886 . . . . 72.42 113.428 177.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -65.34 -44.88 86.32 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.688 0.795 . . . . 73.44 111.626 178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.72 -41.64 95.84 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.001 -0.545 . . . . 73.43 110.117 175.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.563 HH22 HG22 ' B' ' 122' ' ' THR . 48.2 ttt180 -56.44 -55.1 37.91 Favored 'General case' 0 C--N 1.358 0.963 0 O-C-N 124.224 0.952 . . . . 72.2 111.255 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -65.41 -30.7 71.54 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.294 0.638 . . . . 71.4 110.69 -173.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 12.1 t -73.74 -39.82 63.99 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 122.812 0.445 . . . . 55.33 111.34 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.48 HG21 HG21 ' C' ' 64' ' ' VAL . 66.5 mt -62.62 -47.0 95.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 123.958 0.903 . . . . 65.03 109.87 172.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . 0.461 HG21 ' OG ' ' B' ' 119' ' ' SER . 86.8 m -67.62 -29.33 68.63 Favored 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 114.088 -1.414 . . . . 74.44 110.846 -174.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -68.33 -46.26 70.67 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.384 0.674 . . . . 61.13 109.592 174.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.574 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -64.46 -42.71 95.79 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 124.302 1.041 . . . . 73.21 113.248 -176.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 22.8 m -66.65 -32.98 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.05 0 CA-C-O 120.576 0.227 . . . . 64.32 110.438 177.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 29.7 t -67.53 -34.42 77.06 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.111 0.964 . . . . 74.11 111.473 174.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.448 ' HG3' ' O ' ' C' ' 116' ' ' SER . 74.4 mtt-85 -72.77 -33.25 66.19 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.743 0.817 . . . . 73.45 110.498 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.23 9.26 64.46 Favored Glycine 0 C--N 1.357 1.715 0 O-C-N 123.661 0.601 . . . . 45.13 112.465 173.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.409 ' OG1' ' HD3' ' D' ' 15' ' ' ARG . 69.3 p 58.04 31.36 20.56 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 126.152 1.781 . . . . 44.52 112.943 174.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -105.42 148.41 36.27 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.539 1.135 . . . . 65.42 108.771 174.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.403 ' HG2' ' HA ' ' F' ' 297' ' ' TYR . 77.6 Cg_exo -51.46 138.58 47.5 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 123.416 2.744 . . . . 75.34 112.821 176.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.41 ' HB3' HG23 ' C' ' 115' ' ' THR . 95.9 mt-30 -63.36 149.3 46.15 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 113.865 1.061 . . . . 75.33 113.865 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -118.7 98.24 6.13 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 106.863 -1.532 . . . . 75.04 106.863 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -92.38 130.44 38.06 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.313 0.645 . . . . 72.25 109.603 178.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.05 136.64 37.23 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 123.594 0.758 . . . . 54.11 110.495 -179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.531 ' HB3' HD11 ' F' ' 291' ' ' LEU . . . -80.02 157.8 73.24 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 124.263 1.025 . . . . 61.15 109.963 177.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.76 98.9 0.31 Allowed 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 122.358 2.038 . . . . 53.23 113.075 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.425 HG11 HG21 ' F' ' 288' ' ' VAL . 56.0 t -99.57 109.28 24.24 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.524 0 N-CA-C 107.482 -1.303 . . . . 74.13 107.482 170.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -110.45 101.35 10.05 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 108.221 -1.029 . . . . 44.11 108.221 -175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.446 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 64.0 m-85 -69.72 -30.09 67.63 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 115.454 -0.794 . . . . 72.41 110.923 -175.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -60.39 -52.0 67.1 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.671 0.788 . . . . 74.41 110.7 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -58.24 -36.19 72.83 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.007 1.323 . . . . 53.21 111.734 -175.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.9 tt -51.65 -57.84 8.05 Favored 'General case' 0 N--CA 1.483 1.214 0 O-C-N 124.53 1.144 . . . . 74.11 110.275 174.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -80.37 -18.34 49.26 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.076 0.55 . . . . 74.33 111.77 -177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 27.8 ttt -75.79 -26.59 57.46 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.587 1.155 . . . . 63.11 111.024 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -51.47 -45.87 62.91 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.446 0.698 . . . . 64.4 110.688 172.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -71.15 -87.08 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.017 0 N-CA-C 108.868 -0.79 . . . . 73.15 108.868 169.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 56.1 tp 53.22 120.41 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 125.838 1.655 . . . . 65.44 113.85 178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -140.45 11.79 2.33 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.354 0.597 . . . . 63.14 110.062 174.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -89.18 -79.72 0.32 Allowed 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 107.921 -1.14 . . . . 72.43 107.921 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 49.86 85.82 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.118 1.367 . . . . 71.0 112.791 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.95 -54.73 2.47 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 108.839 -0.8 . . . . 54.45 108.839 173.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 69.28 30.08 71.71 Favored Glycine 0 C--N 1.349 1.269 0 CA-C-N 115.1 -0.955 . . . . 65.43 113.593 175.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -98.24 -165.69 1.28 Allowed 'General case' 0 C--O 1.246 0.874 0 C-N-CA 123.954 0.902 . . . . 63.12 108.939 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 149.41 98.38 0.19 Allowed Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.738 -0.945 . . . . 51.31 110.738 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 98.3 m -139.97 137.35 34.65 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.427 0.691 . . . . 61.15 109.789 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -146.12 139.71 26.17 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 107.664 -1.236 . . . . 64.54 107.664 171.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.427 ' HG2' ' HB2' ' C' ' 153' ' ' GLN . 40.9 tt0 -95.81 110.45 22.61 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 108.522 -0.918 . . . . 74.42 108.522 176.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -87.72 73.69 9.28 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.765 0.793 . . . . 71.1 109.009 174.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.427 ' HB2' ' HG2' ' C' ' 151' ' ' GLU . 17.6 tm0? -113.16 100.93 8.96 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.623 -1.251 . . . . 74.11 107.623 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -135.08 177.77 7.55 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.061 0.945 . . . . 74.33 109.727 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.011 0 C-N-CA 123.71 0.804 . . . . 60.11 109.226 -179.565 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 N-CA-C 108.776 -0.824 . . . . 74.43 108.776 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 16.9 m -88.27 -65.65 1.0 Allowed 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 109.136 -0.69 . . . . 62.23 109.136 179.278 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -175.94 99.02 0.07 Allowed 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.437 1.095 . . . . 74.42 109.39 176.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.476 HE22 ' HB2' ' D' ' 8' ' ' GLU . 24.8 tp60 -78.38 89.59 4.39 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 109.543 -0.54 . . . . 73.21 109.543 177.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -91.22 -64.41 1.13 Allowed 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.259 1.024 . . . . 72.2 110.685 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -134.26 -156.61 0.75 Allowed 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.648 0.779 . . . . 72.33 110.431 -168.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 38.0 p -55.03 102.2 0.06 Allowed 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 123.948 0.899 . . . . 65.51 111.35 176.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.476 ' HB2' HE22 ' D' ' 4' ' ' GLN . 50.6 mt-10 -132.98 -140.97 0.2 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.077 1.351 . . . . 63.41 108.419 -176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.414 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 1.2 tmt? -29.69 129.7 0.09 Allowed 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 125.828 1.651 . . . . 72.23 114.518 173.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 92.0 m -148.44 139.58 23.23 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.384 1.474 . . . . 72.14 108.436 -179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.587 ' HZ ' ' HG ' ' D' ' 102' ' ' CYS . 41.3 t80 -149.76 94.95 2.25 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 107.947 -1.131 . . . . 75.43 107.947 172.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -117.94 125.87 51.26 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.314 0.645 . . . . 65.22 109.421 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 47.0 mt -68.37 124.89 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 N-CA-C 108.713 -0.847 . . . . 51.31 108.713 173.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.585 ' HA ' ' HA ' ' F' ' 305' ' ' ALA . 56.2 mt-30 -87.42 -34.96 18.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 109.287 -0.634 . . . . 43.11 109.287 175.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.78 HH22 HD12 ' F' ' 301' ' ' ILE . 17.7 ttm180 -175.64 144.37 0.65 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 115.102 -0.953 . . . . 74.42 109.357 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.417 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -131.11 130.13 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 N-CA-C 106.455 -1.683 . . . . 74.14 106.455 171.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.447 ' CE2' ' HG2' ' D' ' 19' ' ' LYS . 27.5 p90 -164.52 173.42 12.07 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 121.834 0.826 . . . . 72.15 111.249 -165.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 70.3 p -99.26 121.62 41.31 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 114.694 -1.139 . . . . 34.44 108.896 175.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.447 ' HG2' ' CE2' ' D' ' 17' ' ' TYR . 35.2 mtpt -85.46 -39.86 17.04 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.3 0.571 . . . . 61.41 109.732 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.408 ' HA ' ' O ' ' C' ' 23' ' ' PHE . 19.9 t70 -149.78 126.76 11.19 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-N 114.67 -1.15 . . . . 70.04 108.984 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.574 HG21 ' HE2' ' C' ' 117' ' ' MET . 70.0 mt -118.87 147.1 22.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 108.429 -0.952 . . . . 64.33 108.429 175.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 48.1 t -143.77 136.01 26.77 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.21 1.004 . . . . 72.41 109.097 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.509 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 87.3 t80 -140.28 117.63 11.38 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 106.126 -1.805 . . . . 74.54 106.126 168.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -123.71 122.35 37.87 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.269 0.628 . . . . 74.44 109.811 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -112.38 81.26 3.9 Favored Pre-proline 0 CA--C 1.543 0.677 0 N-CA-C 107.181 -1.415 . . . . 74.13 107.181 168.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.2 -33.47 18.64 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 122.734 2.289 . . . . 43.23 112.116 -169.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.425 ' HB2' HG23 ' D' ' 31' ' ' VAL . 3.7 m-80 -111.66 29.76 7.57 Favored 'General case' 0 C--O 1.213 -0.833 0 N-CA-C 108.768 -0.827 . . . . 63.0 108.768 -176.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -46.39 -61.52 2.57 Favored Pre-proline 0 CA--C 1.566 1.564 0 N-CA-C 114.989 1.477 . . . . 71.24 114.989 -166.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.421 ' HB3' HD11 ' C' ' 83' ' ' ILE . 43.1 Cg_endo -81.81 -13.03 10.73 Favored 'Trans proline' 0 C--N 1.378 2.089 0 CA-C-N 121.54 1.586 . . . . 74.51 113.329 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.44 ' HA ' HE21 ' D' ' 33' ' ' GLN . 17.7 t-160 -69.35 -41.38 76.68 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.859 0.864 . . . . 72.42 109.249 170.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.509 HG12 ' HB2' ' D' ' 35' ' ' ASP . 36.1 t -70.8 -35.0 58.46 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.11 0 CA-C-N 114.909 -1.041 . . . . 65.42 109.98 -178.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 -64.36 -6.79 7.75 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.969 1.1 . . . . 73.1 113.969 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.44 HE21 ' HA ' ' D' ' 30' ' ' HIS . 42.7 mt-30 -84.62 -35.46 22.67 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.027 0.531 . . . . 74.12 109.915 170.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -128.7 60.09 1.53 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.114 0.966 . . . . 61.1 110.352 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.623 ' HB3' HD12 ' G' ' 301' ' ' ILE . 5.7 t0 -110.08 94.56 5.08 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.52 -0.737 . . . . 74.31 109.463 -174.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.531 ' H ' HD22 ' D' ' 68' ' ' LEU . 10.8 m95 -124.4 -159.5 0.88 Allowed 'General case' 0 CA--C 1.548 0.883 0 N-CA-C 106.927 -1.508 . . . . 73.2 106.927 -177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -63.35 112.32 6.79 Favored Pre-proline 0 N--CA 1.482 1.15 0 CA-C-N 118.374 0.534 . . . . 73.32 111.558 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -83.54 151.78 13.36 Favored 'Trans proline' 0 C--N 1.375 1.954 0 C-N-CA 123.111 2.541 . . . . 61.23 112.313 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -82.89 113.68 20.67 Favored 'General case' 0 N--CA 1.467 0.403 0 N-CA-C 108.996 -0.742 . . . . 73.43 108.996 166.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.54 HG23 ' NE1' ' G' ' 290' ' ' TRP . 3.6 m -99.28 106.37 18.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.074 0.95 . . . . 61.32 109.602 -176.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.44 ' HB2' ' HB ' ' D' ' 65' ' ' THR . 73.0 mmtt -88.31 128.76 35.49 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.349 1.06 . . . . 74.23 108.952 -175.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 51.2 mt -98.05 113.05 24.8 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 109.532 -0.544 . . . . 75.51 109.532 -173.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -122.94 115.75 22.45 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.892 -0.781 . . . . 63.24 108.892 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.8 mp -106.96 145.75 31.88 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 123.28 0.632 . . . . 72.31 109.973 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.562 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -137.15 131.31 32.39 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 124.364 1.066 . . . . 73.31 108.511 173.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 56.6 p -105.71 144.67 32.13 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.469 0.708 . . . . 73.14 110.195 -179.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.593 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.22 155.03 35.86 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.498 0.719 . . . . 43.13 109.885 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 40.9 p -164.07 153.27 13.88 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.781 0.832 . . . . 33.45 109.883 178.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 81.9 p -160.47 151.77 19.31 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 123.333 0.653 . . . . 70.32 110.101 176.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -81.8 118.57 22.99 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 123.078 0.551 . . . . 71.03 109.688 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 77.3 mt -92.34 -31.3 15.41 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.339 0.656 . . . . 74.35 110.488 177.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.02 -179.34 7.7 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.277 0.631 . . . . 61.05 110.707 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -62.58 116.92 5.57 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.702 -1.135 . . . . 74.51 110.117 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.597 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 11.7 m-20 60.47 24.66 14.27 Favored 'General case' 0 N--CA 1.483 1.225 0 O-C-N 124.258 0.974 . . . . 65.41 111.539 -178.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 70.0 t -127.48 116.54 44.01 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 N-CA-C 108.053 -1.092 . . . . 75.45 108.053 176.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.544 ' HB2' HD12 ' D' ' 86' ' ' ILE . 96.8 m-85 -129.82 129.03 43.51 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.335 1.054 . . . . 74.32 108.738 -174.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -90.32 139.1 30.99 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 123.989 0.915 . . . . 70.52 109.744 175.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -116.45 117.28 54.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 107.354 -1.35 . . . . 64.11 107.354 170.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.593 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.7 t -100.18 128.82 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.575 0 N-CA-C 108.279 -1.008 . . . . 64.32 108.279 172.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -120.65 107.23 12.55 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 107.769 -1.197 . . . . 70.34 107.769 176.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.584 ' HG3' ' HG2' ' D' ' 79' ' ' GLN . 16.1 ttm-85 -87.17 105.71 17.38 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.218 -0.901 . . . . 75.21 109.566 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 90.5 t -97.22 120.47 46.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 108.685 -0.857 . . . . 73.44 108.685 173.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 18.3 m -125.84 135.85 52.43 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.705 0.802 . . . . 74.44 109.137 -176.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.587 HG11 HD11 ' D' ' 126' ' ' LEU . 44.0 t -129.95 117.95 42.71 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 124.436 1.094 . . . . 55.31 109.68 -177.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' D' ' 41' ' ' LYS . 57.0 m -105.57 100.6 10.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.135 0.974 . . . . 54.21 110.093 179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.459 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -96.71 125.15 40.97 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 122.234 -0.291 . . . . 41.34 110.773 -178.15 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 51.5 m -138.94 123.32 18.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.841 0.856 . . . . 53.24 109.611 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.6 OUTLIER -103.07 128.09 50.09 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.354 0.662 . . . . 61.13 109.852 177.054 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.24 -111.73 3.95 Favored Glycine 0 C--N 1.342 0.89 0 N-CA-C 110.95 -0.86 . . . . 71.05 110.95 -173.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.81 5.68 11.49 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.56 0.744 . . . . 73.42 110.877 175.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -119.04 140.28 50.3 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 123.1 0.56 . . . . 61.55 110.449 -172.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 93.8 m -71.98 117.38 13.52 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 123.607 0.763 . . . . 73.14 111.115 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.601 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -68.45 -65.64 0.67 Allowed 'General case' 0 N--CA 1.469 0.51 0 O-C-N 124.279 0.987 . . . . 70.44 109.914 175.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -154.51 156.64 37.04 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 114.408 -1.269 . . . . 75.52 110.406 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 81.3 mt -121.84 145.93 47.59 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.747 1.219 . . . . 72.15 107.714 177.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.62 ' SG ' HG23 ' D' ' 114' ' ' ILE . 49.6 t -150.75 142.11 23.35 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.622 -0.51 . . . . 62.35 109.622 -176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -156.04 138.31 14.75 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 108.988 -0.745 . . . . 74.4 108.988 176.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 57.6 t -139.64 115.57 8.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 108.331 -0.989 . . . . 74.2 108.331 177.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.584 ' HG2' ' HG3' ' D' ' 61' ' ' ARG . 66.4 mt-30 -88.97 84.49 6.62 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.099 -1.074 . . . . 70.43 108.099 173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.52 93.45 5.43 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.208 -0.906 . . . . 70.51 109.031 -177.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -89.69 142.29 16.55 Favored Glycine 0 C--N 1.341 0.822 0 N-CA-C 110.802 -0.919 . . . . 65.13 110.802 177.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.414 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -142.99 128.59 3.48 Favored Glycine 0 CA--C 1.499 -0.919 0 N-CA-C 110.327 -1.109 . . . . 62.1 110.327 -178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 39.7 mt -90.93 132.3 35.83 Favored 'Isoleucine or valine' 0 C--O 1.241 0.654 0 C-N-CA 123.701 0.801 . . . . 61.52 109.061 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -134.01 133.43 41.26 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 122.88 0.472 . . . . 73.33 110.157 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 37.8 m -79.11 98.88 6.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.486 0.714 . . . . 64.34 109.27 170.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.544 HD12 ' HB2' ' D' ' 56' ' ' TYR . 48.2 mt -109.08 106.99 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.967 0 C-N-CA 123.907 0.883 . . . . 70.03 109.506 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.597 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -144.07 148.54 35.31 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.048 0.939 . . . . 33.32 110.092 -179.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.414 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 93.48 -20.82 44.28 Favored Glycine 0 N--CA 1.471 1.026 0 CA-C-O 119.842 -0.421 . . . . 40.2 113.438 177.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.493 ' HB ' ' HG3' ' D' ' 94' ' ' MET . 0.4 OUTLIER -106.39 139.76 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.675 -1.231 . . . . 62.11 107.675 179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -130.77 157.85 41.72 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.15 0.58 . . . . 72.52 111.425 -176.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.33 -134.96 51.81 Favored Glycine 0 C--N 1.351 1.41 0 O-C-N 124.597 1.186 . . . . 63.13 115.782 166.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 10.0 t -63.82 -29.17 70.39 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.235 1.014 . . . . 74.25 111.841 -178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.4 -40.5 77.32 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.624 0.77 . . . . 33.11 109.216 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.493 ' HG3' ' HB ' ' D' ' 89' ' ' ILE . 9.9 ttp -75.92 -41.99 50.21 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 115.813 -0.631 . . . . 73.44 110.773 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.55 -28.21 69.0 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.884 0.874 . . . . 63.55 111.2 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -66.23 -46.63 76.52 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 116.143 -0.48 . . . . 64.02 109.996 173.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.6 t -68.62 -36.61 78.88 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.017 0.527 . . . . 63.33 111.276 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.569 ' HA ' ' SG ' ' D' ' 102' ' ' CYS . 7.1 tt -77.45 -30.75 53.45 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.394 0.678 . . . . 70.35 110.02 -177.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.06 -16.44 55.96 Favored Glycine 0 C--N 1.349 1.251 0 CA-C-N 116.127 -0.488 . . . . 72.12 113.663 -178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -117.09 -64.32 1.32 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 117.398 0.599 . . . . 72.22 111.289 -175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -66.03 -47.27 74.96 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.151 0.58 . . . . 63.45 111.414 -172.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.587 ' HG ' ' HZ ' ' D' ' 11' ' ' PHE . 58.0 m -61.43 -48.47 90.72 Favored Pre-proline 0 CA--C 1.569 1.679 0 CA-C-O 118.348 -0.834 . . . . 65.44 112.731 -176.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 86.2 Cg_exo -54.9 -39.41 90.45 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 122.76 2.306 . . . . 73.1 113.91 170.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -72.47 -14.04 61.58 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.298 0.639 . . . . 62.34 112.541 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 44.6 mm -81.09 -40.95 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 CA-C-O 121.597 0.713 . . . . 73.53 109.864 170.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.414 HD21 ' HA3' ' D' ' 82' ' ' GLY . 71.9 mt -78.46 -31.75 48.08 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 114.909 -1.041 . . . . 75.43 111.802 -174.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -63.72 -42.1 69.39 Favored Pre-proline 0 CA--C 1.56 1.361 0 N-CA-C 114.146 1.165 . . . . 75.33 114.146 -170.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.45 -43.67 55.57 Favored 'Trans proline' 0 C--N 1.382 2.331 0 C-N-CA 122.152 1.901 . . . . 70.01 113.132 172.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -74.98 -31.71 61.51 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.662 0.785 . . . . 71.34 111.891 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.62 -54.53 34.37 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.068 0.547 . . . . 51.14 109.797 175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -56.73 -46.57 81.24 Favored 'General case' 0 C--N 1.352 0.71 0 CA-C-N 114.091 -1.413 . . . . 62.44 110.899 -179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -64.63 -44.49 90.36 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 124.104 0.878 . . . . 72.33 111.214 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . 0.43 ' SG ' ' HD3' ' C' ' 120' ' ' ARG . 42.5 t -58.61 -41.36 85.69 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.533 0.52 . . . . 74.05 110.947 178.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.62 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.0 mt -62.32 -53.78 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 123.939 0.896 . . . . 73.23 110.369 174.071 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 46.2 m -53.84 -42.95 69.05 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.725 1.21 . . . . 71.02 111.426 -175.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 31.1 t -66.97 -44.65 79.96 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 114.754 -1.112 . . . . 64.42 110.654 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.1 mtm -66.32 -33.76 76.46 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 122.863 0.465 . . . . 73.35 111.656 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 89.3 t -67.78 -43.3 86.43 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 CA-C-N 115.545 -0.752 . . . . 73.31 109.919 177.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 80.0 p -71.35 -28.9 64.39 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 122.751 0.42 . . . . 73.44 111.699 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.4 mtt-85 -75.04 -32.06 61.46 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.924 0.89 . . . . 75.22 110.085 175.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.14 5.66 75.48 Favored Glycine 0 C--N 1.356 1.676 0 CA-C-N 115.586 -0.734 . . . . 62.43 111.853 172.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 43.2 p 65.54 14.15 9.31 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.488 2.315 . . . . 43.34 114.257 173.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -84.89 158.28 59.24 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.207 1.003 . . . . 74.1 108.867 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.525 ' HG3' ' HB2' ' G' ' 297' ' ' TYR . 55.4 Cg_endo -65.11 136.74 49.26 Favored 'Trans proline' 0 C--N 1.371 1.756 0 C-N-CA 122.871 2.381 . . . . 72.2 112.175 -177.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -47.19 129.92 12.67 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.488 1.115 . . . . 74.05 112.135 -178.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.587 HD11 HG11 ' D' ' 64' ' ' VAL . 5.1 tt -107.22 93.93 4.82 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 108.234 -1.024 . . . . 33.22 108.234 -170.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -105.09 100.47 10.07 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 107.9 -1.148 . . . . 73.22 107.9 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.413 HD12 ' H ' ' D' ' 129' ' ' ALA . 20.5 tp -75.86 141.46 42.4 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 123.004 0.522 . . . . 64.21 110.814 177.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.413 ' H ' HD12 ' D' ' 128' ' ' LEU . . . -56.24 132.84 75.5 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.447 1.099 . . . . 73.24 111.326 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -73.0 116.65 4.8 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 122.448 2.099 . . . . 75.32 110.363 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 86.7 t -107.48 138.44 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.477 0.711 . . . . 63.34 109.577 -174.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -79.97 103.55 9.94 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.602 0.761 . . . . 72.24 110.02 178.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -77.25 -20.99 54.41 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 123.33 0.652 . . . . 74.23 111.406 177.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -59.46 -46.38 88.95 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.611 0.764 . . . . 62.35 110.577 -177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.78 -42.28 99.63 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.269 0.981 . . . . 74.43 111.804 -179.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 69.7 mt -61.12 -39.96 91.98 Favored 'General case' 0 CA--C 1.549 0.907 0 O-C-N 124.375 1.047 . . . . 53.41 111.121 -178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.464 ' O ' HD13 ' D' ' 141' ' ' LEU . 27.9 m-85 -78.71 -34.75 45.79 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.592 0.757 . . . . 63.33 111.543 176.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 67.3 mtm -63.21 -30.0 71.23 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 122.984 0.514 . . . . 71.24 111.273 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -57.43 -43.31 83.74 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.771 0.828 . . . . 73.41 110.616 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -69.65 -33.74 73.03 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.834 0.854 . . . . 71.21 111.447 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.464 HD13 ' O ' ' D' ' 137' ' ' PHE . 7.6 mp -62.98 -29.16 70.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.751 0.82 . . . . 71.42 111.135 177.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -87.6 10.28 18.46 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.965 0.906 . . . . 74.45 111.813 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 -120.69 52.06 1.2 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 123.919 0.888 . . . . 71.51 110.433 -173.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -151.53 141.01 21.59 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.253 -0.885 . . . . 73.32 109.651 176.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -119.13 162.55 18.44 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.984 0.913 . . . . 70.33 110.058 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -171.56 178.58 43.8 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.192 -0.458 . . . . 43.02 112.314 -178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -117.48 168.84 10.02 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.15 0.98 . . . . 70.23 110.503 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -150.74 75.18 0.25 Allowed Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.492 -0.643 . . . . 71.14 111.492 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 9.5 t -78.06 128.1 33.32 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 123.212 0.605 . . . . 73.02 109.672 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.54 87.33 5.13 Favored 'General case' 0 C--N 1.346 0.431 0 N-CA-C 106.888 -1.523 . . . . 71.31 106.888 174.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -76.18 114.15 14.51 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.831 -0.622 . . . . 70.14 110.092 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -122.4 80.82 1.77 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 108.582 -0.896 . . . . 75.3 108.582 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -127.33 133.16 50.12 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 124.151 0.98 . . . . 73.33 108.883 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.7 167.4 12.54 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.148 0.579 . . . . 73.35 110.948 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.045 0 N-CA-C 109.192 -0.67 . . . . 71.14 109.192 177.687 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 N-CA-C 110.525 -0.176 . . . . 64.13 110.525 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 21.5 p-10 -76.39 142.3 41.18 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 109.533 -0.543 . . . . 75.1 109.533 173.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . 0.705 HE22 ' HG2' ' A' ' 4' ' ' GLN . 25.1 tt0 -83.24 107.35 15.72 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.656 -0.868 . . . . 75.23 108.656 177.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -67.01 -24.65 66.04 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 124.086 0.954 . . . . 73.31 111.728 -170.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 13.9 mptt -107.65 91.45 7.32 Favored Pre-proline 0 N--CA 1.475 0.794 0 N-CA-C 107.221 -1.4 . . . . 73.42 107.221 166.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_exo -57.96 -57.37 1.17 Allowed 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 122.671 2.247 . . . . 70.51 110.463 176.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . 0.467 HD21 ' HA ' ' A' ' 87' ' ' ALA . 5.5 tt -179.45 -46.5 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 105.054 -2.202 . . . . 75.24 105.054 -178.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . 0.54 HD11 ' HB2' ' A' ' 48' ' ' SER . 20.1 tp -86.57 147.22 26.03 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 114.559 -1.201 . . . . 45.33 108.593 170.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -178.46 160.32 26.22 Favored Glycine 0 N--CA 1.464 0.528 0 N-CA-C 110.612 -0.995 . . . . 62.14 110.612 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 45.59 -167.76 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 125.87 1.668 . . . . 74.12 112.432 -172.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . 0.493 ' CE1' ' HB ' ' A' ' 46' ' ' THR . 56.4 t80 68.37 19.69 8.84 Favored 'General case' 0 CA--C 1.562 1.435 0 C-N-CA 123.997 0.919 . . . . 61.43 111.867 171.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -72.8 -33.53 66.31 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 108.437 -0.949 . . . . 60.11 108.437 168.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -122.68 -170.75 2.15 Favored 'General case' 0 C--O 1.244 0.789 0 CA-C-N 114.66 -1.155 . . . . 73.41 108.93 172.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 154.89 -80.25 0.18 Allowed Glycine 0 C--N 1.339 0.739 0 N-CA-C 111.663 -0.575 . . . . 63.41 111.663 175.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 59.95 85.48 0.11 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 124.26 1.024 . . . . 75.02 109.488 -173.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 96.2 mmm -57.42 130.93 81.31 Favored Pre-proline 0 N--CA 1.482 1.173 0 C-N-CA 123.556 0.743 . . . . 74.43 110.408 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -69.19 78.17 0.83 Allowed 'Trans proline' 0 C--N 1.381 2.255 0 C-N-CA 123.199 2.599 . . . . 74.3 111.847 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 92.2 t -98.75 101.93 12.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 N-CA-C 108.137 -1.06 . . . . 54.13 108.137 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -70.82 125.79 27.8 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-N 115.282 -0.872 . . . . 75.51 109.242 176.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 31.5 t-105 -64.56 131.53 47.31 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 122.024 0.916 . . . . 75.33 110.733 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.655 ' HB3' ' HB ' ' G' ' 309' ' ' THR . 0.0 OUTLIER -100.82 4.7 43.07 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 113.972 -1.467 . . . . 64.14 112.005 -169.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -59.91 127.24 43.8 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-O 118.203 -1.332 . . . . 75.44 111.924 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -55.94 -70.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.934 2.423 . . . . 72.25 113.144 -171.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -147.0 -46.97 0.18 Allowed 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.349 1.06 . . . . 73.42 108.905 -173.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -144.22 166.95 23.6 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.249 -0.887 . . . . 62.4 110.143 178.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 47.7 m -114.35 -30.8 6.47 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.061 0.945 . . . . 65.43 110.423 177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.541 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 22.8 m-85 -72.18 125.98 28.65 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.123 -0.49 . . . . 73.33 109.89 174.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . 0.435 ' HA ' ' HB2' ' G' ' 302' ' ' ASP . 32.9 p80 -82.11 57.25 3.46 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 121.549 0.69 . . . . 74.1 109.773 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 62.2 -136.01 45.59 Favored Glycine 0 C--N 1.341 0.811 0 N-CA-C 110.208 -1.157 . . . . 62.34 110.208 -168.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . 0.412 ' HB2' ' ND1' ' G' ' 298' ' ' HIS . 0.8 OUTLIER -68.82 125.49 26.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 117.489 0.645 . . . . 61.2 109.552 175.273 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 122' ' ' THR . 65.2 mt -61.61 -57.95 9.8 Favored 'Isoleucine or valine' 0 C--O 1.245 0.823 0 N-CA-C 108.113 -1.069 . . . . 64.15 108.113 170.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -146.79 167.73 23.15 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-N 113.677 -1.601 . . . . 75.42 108.469 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . 0.614 ' H ' ' HD2' ' E' ' 304' ' ' PRO . 13.3 tmtt? -154.26 -52.69 0.02 OUTLIER Pre-proline 0 CA--C 1.56 1.342 0 CA-C-O 117.901 -1.047 . . . . 73.04 110.061 -178.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . 0.614 ' HD2' ' H ' ' E' ' 303' ' ' LYS . 55.5 Cg_endo -65.62 89.43 0.22 Allowed 'Trans proline' 0 C--N 1.4 3.272 0 C-N-CA 121.642 1.562 . . . . 74.01 112.385 -178.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -75.9 154.45 36.0 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-N 114.89 -1.05 . . . . 22.42 110.557 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.35 163.51 3.97 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 CA-C-N 115.936 -0.574 . . . . 74.1 111.466 -174.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 34.6 p -92.99 -164.54 1.19 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.045 0.938 . . . . 75.03 111.057 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 10.9 p -59.23 -55.18 38.2 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 124.492 1.117 . . . . 75.22 112.075 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 95.8 m 56.14 80.55 0.29 Allowed Pre-proline 0 CA--C 1.553 1.077 0 O-C-N 124.477 1.111 . . . . 62.55 110.965 -174.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . 0.427 ' HB2' HG22 ' B' ' 7' ' ' THR . 29.5 Cg_endo . . . . . 0 CA--C 1.555 1.566 0 C-N-CA 123.505 2.803 . . . . 62.15 111.717 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 119.569 -0.253 . . . . 72.23 111.403 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 69.07 -74.16 0.08 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 124.785 1.234 . . . . 73.12 111.315 -177.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -79.59 -178.2 6.22 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.336 0.655 . . . . 71.31 110.37 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -64.54 170.27 4.14 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 121.473 0.654 . . . . 64.31 111.222 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . 0.776 ' HB2' ' HB3' ' F' ' 278' ' ' LEU . 17.7 mmtp -90.54 131.56 37.75 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 107.302 -1.37 . . . . 74.3 107.302 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -36.66 -64.68 0.17 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 124.783 3.655 . . . . 73.23 115.988 -177.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.17 -3.59 44.15 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 122.865 0.466 . . . . 63.42 111.795 -175.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.776 ' HB3' ' HB2' ' F' ' 275' ' ' LYS . 6.9 tt -118.78 102.66 8.99 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 123.98 0.912 . . . . 71.1 108.802 -169.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -112.94 16.75 22.93 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 116.084 -0.507 . . . . 54.15 112.795 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 10.3 tt -154.25 146.16 23.51 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 108.109 -1.071 . . . . 70.32 108.109 -177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 67.9 t80 88.94 -22.44 0.12 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 126.982 2.113 . . . . 64.21 111.05 -174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -64.2 -25.55 68.12 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 123.115 0.566 . . . . 73.12 111.18 179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -111.31 148.51 32.78 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.55 1.14 . . . . 51.13 109.358 173.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -73.21 73.26 1.1 Allowed Glycine 0 C--N 1.355 1.639 0 O-C-N 123.764 0.665 . . . . 64.0 112.457 177.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -99.24 3.73 46.38 Favored 'General case' 0 CA--C 1.555 1.154 0 C-N-CA 124.358 1.063 . . . . 65.44 110.515 -174.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 97.7 mmm -120.85 83.9 37.39 Favored Pre-proline 0 N--CA 1.483 1.217 0 C-N-CA 123.578 0.751 . . . . 54.44 109.799 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -97.26 92.15 0.07 OUTLIER 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 123.326 2.684 . . . . 61.54 112.92 -179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . 0.425 HG21 HG11 ' C' ' 131' ' ' VAL . 96.0 t -81.83 96.43 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 CA-C-O 121.243 0.544 . . . . 64.2 109.819 178.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 37.2 mmt180 -89.43 60.76 5.34 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.349 0.66 . . . . 65.22 109.684 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 44.0 m95 63.12 -172.9 0.16 Allowed 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.65 -1.159 . . . . 73.44 112.544 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.531 HD11 ' HB3' ' C' ' 129' ' ' ALA . 0.0 OUTLIER -130.15 16.77 5.59 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.409 -1.269 . . . . 62.42 109.842 178.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 147.64 -147.15 17.62 Favored Glycine 0 C--N 1.346 1.092 0 CA-C-O 118.989 -0.895 . . . . 63.13 110.927 -176.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.23 174.26 13.06 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.982 2.455 . . . . 73.34 111.277 174.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 10.8 tptp -159.22 -63.58 0.08 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 109.279 -0.638 . . . . 70.11 109.279 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . 65.11 -178.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.781 1.233 . . . . 74.32 111.407 -174.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 96.0 m -142.94 -67.38 0.37 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 122.956 0.502 . . . . 73.23 109.747 178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.403 ' HA ' ' HG2' ' C' ' 124' ' ' PRO . 22.8 m-30 -66.09 109.29 2.53 Favored 'General case' 0 C--N 1.355 0.832 0 C-N-CA 122.769 0.428 . . . . 74.24 110.295 -178.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 35.5 t60 -143.31 148.82 36.91 Favored 'General case' 0 C--O 1.242 0.667 0 N-CA-C 107.868 -1.16 . . . . 73.05 107.868 175.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.28 -144.86 22.77 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 123.631 0.582 . . . . 60.53 112.116 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -137.71 128.91 27.67 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 122.787 0.435 . . . . 72.34 110.899 -172.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.78 HD12 HH22 ' D' ' 15' ' ' ARG . 41.0 pt -129.19 15.33 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.385 1.074 . . . . 71.14 108.935 167.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -78.07 90.13 4.22 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 124.664 1.186 . . . . 71.53 109.167 -174.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -150.97 130.04 6.37 Favored Pre-proline 0 CA--C 1.544 0.722 0 N-CA-C 108.374 -0.973 . . . . 55.32 108.374 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.42 -32.18 71.65 Favored 'Trans proline' 0 C--N 1.384 2.439 0 C-N-CA 123.148 2.566 . . . . 73.43 113.672 -173.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . 0.585 ' HA ' ' HA ' ' D' ' 14' ' ' GLN . . . -162.01 167.65 24.09 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.358 0.663 . . . . 71.45 110.183 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 36.4 t -79.17 71.09 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.07 0 N-CA-C 108.3 -1.0 . . . . 71.32 108.3 172.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 5.7 m -93.71 73.02 4.28 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 107.462 -1.31 . . . . 70.22 107.462 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . 0.597 ' SG ' ' HD2' ' H' ' 293' ' ' PRO . 85.5 m -149.56 -55.08 0.17 Allowed 'General case' 0 C--O 1.237 0.435 0 CA-C-N 114.667 -1.152 . . . . 75.11 108.608 -173.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . 0.417 ' OG1' HD23 ' H' ' 291' ' ' LEU . 7.8 m -67.47 137.58 93.54 Favored Pre-proline 0 CA--C 1.545 0.777 0 CA-C-N 114.779 -1.1 . . . . 64.34 110.805 177.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo . . . . . 0 CA--C 1.556 1.608 0 C-N-CA 122.741 2.294 . . . . 63.33 111.038 164.373 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.917 0 N-CA-C 110.039 -0.356 . . . . 71.05 110.039 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -86.84 138.81 31.26 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.594 0.757 . . . . 73.01 109.326 179.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -124.81 82.02 2.01 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.298 0.639 . . . . 51.24 109.862 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -73.07 109.93 6.97 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 108.67 -0.863 . . . . 63.35 108.67 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -136.56 154.82 77.01 Favored Pre-proline 0 CA--C 1.552 1.04 0 N-CA-C 109.947 -0.39 . . . . 74.23 109.947 -172.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -65.54 159.34 48.45 Favored 'Trans proline' 0 C--N 1.38 2.201 0 C-N-CA 123.003 2.469 . . . . 64.01 112.759 -179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 68.9 mt -91.9 -77.56 0.43 Allowed 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.286 -0.635 . . . . 73.31 109.286 177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 45.9 tp -78.66 119.51 22.01 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.68 0.792 . . . . 74.11 109.939 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -169.11 61.68 0.19 Allowed Glycine 0 C--N 1.348 1.23 0 O-C-N 123.359 0.412 . . . . 72.31 112.352 -178.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.461 HD21 HD22 ' D' ' 98' ' ' LEU . 2.2 pt? -156.28 -172.06 3.95 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.605 0.762 . . . . 71.32 110.017 -179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 20.1 m-30 66.09 81.93 0.19 Allowed 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.633 1.173 . . . . 63.23 111.279 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -154.6 -52.94 0.09 Allowed 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 108.398 -0.964 . . . . 62.31 108.398 177.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -146.7 173.47 12.33 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-N 114.695 -1.139 . . . . 74.44 109.334 175.236 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 157.23 143.78 3.75 Favored Glycine 0 C--N 1.334 0.425 0 N-CA-C 110.59 -1.004 . . . . 55.44 110.59 -175.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -71.59 91.21 1.06 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.157 0.583 . . . . 71.24 109.662 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 26.5 mmt -100.5 99.16 9.25 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.378 1.071 . . . . 62.2 109.762 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . 0.439 ' HA ' ' NH1' ' G' ' 289' ' ' ARG . 43.5 Cg_endo -94.1 35.05 0.19 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.469 2.779 . . . . 72.11 111.772 177.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.17 79.64 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.887 0 CA-C-O 121.759 0.79 . . . . 72.13 110.371 -172.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . 0.439 ' NH1' ' HA ' ' G' ' 287' ' ' PRO . 1.4 mpt_? -121.12 178.27 4.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 107.507 -1.294 . . . . 72.03 107.507 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.54 ' NE1' HG23 ' D' ' 40' ' ' VAL . 85.9 m95 -70.71 123.48 22.01 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 110.177 -0.305 . . . . 73.42 110.177 176.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 4.1 mp -87.35 -60.86 1.86 Allowed 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.688 0.795 . . . . 71.23 108.95 -178.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -86.84 -178.03 49.17 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-N 115.289 -0.869 . . . . 34.21 112.447 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.68 175.35 1.25 Allowed 'Trans proline' 0 C--N 1.374 1.87 0 C-N-CA 123.575 2.85 . . . . 70.1 113.712 174.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -107.49 103.55 12.9 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.321 0.648 . . . . 73.13 110.235 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -87.08 98.31 11.21 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 108.957 -0.757 . . . . 44.24 108.957 173.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 1.3 p -150.26 -70.36 0.19 Allowed 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 124.277 1.031 . . . . 75.2 110.085 -176.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.525 ' HB2' ' HG3' ' D' ' 124' ' ' PRO . 0.3 OUTLIER -130.82 123.49 29.21 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 108.349 -0.982 . . . . 74.03 108.349 -169.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . 0.412 ' ND1' ' HB2' ' E' ' 300' ' ' ASN . 50.5 t-80 -83.16 -50.68 8.21 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 109.849 -0.426 . . . . 62.24 109.849 174.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 153.66 -177.95 30.89 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-N 115.475 -0.784 . . . . 44.44 112.148 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 64.35 148.7 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 125.572 1.549 . . . . 54.12 111.596 -175.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.643 HD11 HH12 ' C' ' 15' ' ' ARG . 15.2 tt -141.24 29.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-O 122.13 0.967 . . . . 60.33 110.116 -171.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . 0.435 ' HB2' ' HA ' ' E' ' 298' ' ' HIS . 7.8 m-20 -61.88 104.73 0.48 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 114.589 -1.187 . . . . 63.24 110.371 178.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 51.3 pttt -98.44 163.7 18.59 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 125.28 1.432 . . . . 71.24 109.895 -174.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -63.84 81.09 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.473 2.115 . . . . 75.32 111.729 171.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -78.09 97.33 5.39 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 108.766 -0.827 . . . . 72.05 108.766 177.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.574 HG22 HD23 ' E' ' 291' ' ' LEU . 98.9 t -69.33 82.05 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.991 0.916 . . . . 55.04 110.319 -176.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 43.5 p -106.91 -26.27 11.29 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 114.893 -1.049 . . . . 74.4 110.125 -178.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 58.9 m -68.24 -38.02 81.4 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 123.76 0.824 . . . . 72.02 111.48 -178.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . 0.655 ' HB ' ' HB3' ' E' ' 291' ' ' LEU . 96.8 m -147.05 78.58 10.37 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.473 0.709 . . . . 65.22 109.737 177.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . 0.413 ' HB3' ' HB3' ' C' ' 12' ' ' GLN . 37.1 Cg_endo . . . . . 0 CA--C 1.564 2.011 0 C-N-CA 123.362 2.708 . . . . 72.44 112.293 174.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 110.256 -0.276 . . . . 52.01 110.256 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -75.43 85.32 2.55 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.592 0.757 . . . . 71.1 109.296 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -165.52 175.57 8.89 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.308 1.043 . . . . 64.12 110.238 -177.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 34.4 mm-40 -120.45 29.28 7.53 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.18 0.992 . . . . 75.03 110.044 176.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 14.2 mptt 73.46 166.94 0.12 Allowed Pre-proline 0 N--CA 1.497 1.894 0 C-N-CA 124.347 1.059 . . . . 73.52 111.369 -177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.28 -152.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.391 2.796 0 C-N-CA 122.202 1.935 . . . . 71.22 111.543 171.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . 0.454 HD11 HG13 ' B' ' 89' ' ' ILE . 45.1 tp -59.94 -37.25 78.97 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 110.316 -0.253 . . . . 43.44 110.316 177.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . 0.41 ' HB2' ' CE1' ' B' ' 56' ' ' TYR . 31.3 tp -80.2 81.9 6.36 Favored 'General case' 0 CA--C 1.55 0.942 0 C-N-CA 123.074 0.55 . . . . 74.51 110.078 176.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -93.37 -40.79 4.69 Favored Glycine 0 C--N 1.346 1.102 0 CA-C-N 115.149 -0.932 . . . . 32.45 111.56 174.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -94.81 -175.31 3.53 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.75 0.82 . . . . 74.42 109.178 177.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 12.4 t80 70.27 63.99 0.22 Allowed 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.111 0.964 . . . . 74.23 110.894 169.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -149.49 115.78 5.78 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.61 -1.177 . . . . 71.12 108.78 177.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 67.84 8.65 6.58 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.736 1.214 . . . . 63.43 113.444 172.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 167.45 155.33 9.13 Favored Glycine 0 C--N 1.344 1.016 0 N-CA-C 112.116 -0.394 . . . . 72.2 112.116 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.48 -57.82 2.1 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.199 1.0 . . . . 65.43 108.361 178.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . 0.441 ' HE2' ' HB3' ' H' ' 286' ' ' MET . 22.6 ptp -171.77 145.02 1.61 Allowed Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 124.07 0.948 . . . . 75.13 110.061 -176.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.81 105.61 0.67 Allowed 'Trans proline' 0 C--N 1.38 2.217 0 C-N-CA 123.149 2.566 . . . . 71.2 111.625 178.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 89.5 t -100.44 -43.71 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.238 0.615 . . . . 63.12 109.916 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 66.16 -74.19 0.06 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 125.552 1.541 . . . . 74.3 110.558 -174.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . 0.556 ' NE1' HG23 ' B' ' 40' ' ' VAL . 1.5 t-105 -170.13 139.64 1.83 Allowed 'General case' 0 C--O 1.241 0.637 0 C-N-CA 124.983 1.313 . . . . 72.12 107.523 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.568 HD21 HG22 ' B' ' 131' ' ' VAL . 6.5 mp -69.17 -41.94 76.56 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.679 0.792 . . . . 64.25 110.725 -173.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 150.38 -149.67 21.58 Favored Glycine 0 C--N 1.347 1.182 0 CA-C-O 119.049 -0.861 . . . . 52.51 112.926 176.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . 0.597 ' HD2' ' SG ' ' F' ' 308' ' ' CYS . 75.2 Cg_exo -51.56 95.83 0.04 OUTLIER 'Trans proline' 0 C--N 1.382 2.327 0 C-N-CA 124.246 3.297 . . . . 72.24 113.761 178.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . 0.519 ' HA ' ' HE3' ' H' ' 294' ' ' LYS . 0.5 OUTLIER -167.1 33.68 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 123.549 0.74 . . . . 70.21 109.851 -175.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . 0.615 ' HA ' HG21 ' B' ' 40' ' ' VAL . . . -60.23 142.29 54.75 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-O 120.894 0.378 . . . . 65.43 111.869 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . 0.521 HG22 ' O ' ' B' ' 124' ' ' PRO . 5.2 m -58.06 -49.81 75.61 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.333 -1.303 . . . . 55.51 111.672 -178.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.59 ' HB3' ' HA ' ' B' ' 37' ' ' GLN . 10.8 t80 -90.37 41.98 1.08 Allowed 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.407 -1.269 . . . . 73.53 111.546 -165.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . 0.418 ' CE1' ' HB3' ' H' ' 295' ' ' ALA . 11.8 m80 -87.63 -37.14 17.04 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.254 0.622 . . . . 72.03 110.178 172.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -68.59 -165.74 3.8 Favored Glycine 0 C--N 1.35 1.339 0 O-C-N 123.644 0.59 . . . . 61.11 113.9 -175.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 61.8 t30 -73.17 120.39 18.72 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 122.664 -0.315 . . . . 72.35 110.658 -175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 9.1 tt -61.28 -31.03 49.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 123.391 0.676 . . . . 65.2 109.903 172.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 28.0 t70 73.28 115.01 0.06 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.986 1.714 . . . . 72.24 111.232 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -138.97 80.67 23.56 Favored Pre-proline 0 CA--C 1.55 0.965 0 N-CA-C 106.661 -1.607 . . . . 74.11 106.661 178.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -90.06 -7.14 4.54 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 123.174 2.583 . . . . 74.53 112.05 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 49.35 77.73 0.1 Allowed 'General case' 0 C--N 1.368 1.401 0 C-N-CA 125.557 1.543 . . . . 60.31 110.572 -172.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 59.5 t -64.42 105.19 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 123.9 0.75 . . . . 43.34 109.997 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 11.3 t -110.54 176.24 5.12 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 124.168 0.987 . . . . 63.53 108.816 176.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 49.0 t -68.32 83.95 0.25 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.002 0.921 . . . . 74.23 110.61 -176.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 4.7 t -94.32 120.91 64.71 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 123.996 0.919 . . . . 73.21 110.664 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo . . . . . 0 C--N 1.378 2.097 0 C-N-CA 122.932 2.421 . . . . 73.53 110.494 171.933 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 mmt . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 109.679 -0.489 . . . . 73.33 109.679 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.3 p -95.28 3.8 54.15 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.25 0.62 . . . . 73.21 111.592 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.0 tt0 -65.23 124.91 23.42 Favored 'General case' 0 C--N 1.354 0.762 0 C-N-CA 123.6 0.76 . . . . 73.32 110.215 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -166.3 170.94 12.63 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.59 0.756 . . . . 74.41 109.565 -173.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -117.84 106.84 13.42 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 107.125 -1.435 . . . . 73.42 107.125 170.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -172.65 169.78 4.93 Favored 'General case' 0 N--CA 1.483 1.212 0 O-C-N 124.3 1.0 . . . . 72.02 108.771 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 32.6 m 82.95 -63.27 0.12 Allowed 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.723 1.609 . . . . 71.31 112.291 167.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.78 79.16 1.12 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.451 0.7 . . . . 73.42 110.049 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.447 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 23.9 ptm -87.98 153.14 21.53 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.49 -0.777 . . . . 71.13 111.252 -173.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 86' ' ' ILE . 86.9 m -142.95 139.01 30.52 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.745 -1.116 . . . . 73.34 109.104 178.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.466 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 35.4 t80 -137.2 122.84 19.79 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.623 -1.251 . . . . 72.42 107.623 166.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -146.74 129.61 16.27 Favored 'General case' 0 C--N 1.333 -0.122 0 N-CA-C 109.161 -0.681 . . . . 60.55 109.161 173.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.661 HG12 ' HD2' ' A' ' 84' ' ' PHE . 42.7 mt -86.24 119.85 35.08 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 N-CA-C 109.437 -0.579 . . . . 71.11 109.437 175.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.5 -40.38 13.48 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.062 0.945 . . . . 74.51 109.281 -179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.9 ttt180 -166.42 141.7 4.51 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 116.203 -0.453 . . . . 63.14 110.533 -166.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 16' ' ' ILE . 0.8 OUTLIER -131.87 126.31 56.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.032 -1.47 . . . . 73.41 107.032 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 24.6 p90 -161.08 152.55 19.16 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-O 121.512 0.672 . . . . 70.25 111.491 -173.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.4 p -76.57 107.87 9.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 114.614 -1.176 . . . . 71.52 108.161 169.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 31.5 mtpt -67.26 -33.15 74.72 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.198 0.523 . . . . 63.33 109.603 174.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 79' ' ' GLN . 26.4 t70 -153.12 144.16 22.99 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 114.193 -1.367 . . . . 74.22 109.682 -178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 74.0 mt -133.06 143.64 38.79 Favored 'Isoleucine or valine' 0 C--O 1.242 0.698 0 C-N-CA 124.941 1.296 . . . . 53.42 107.863 176.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.422 ' HB3' ' HB3' ' A' ' 77' ' ' GLU . 44.0 t -147.21 126.89 13.37 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 123.855 0.862 . . . . 54.13 109.171 174.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 87.2 t80 -127.93 126.68 41.95 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 105.892 -1.892 . . . . 73.54 105.892 168.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -133.95 116.6 15.77 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.016 -0.735 . . . . 71.42 109.016 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.502 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -127.55 74.45 77.96 Favored Pre-proline 0 CA--C 1.544 0.731 0 N-CA-C 107.573 -1.269 . . . . 54.52 107.573 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -70.13 -43.63 2.25 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.553 2.169 . . . . 74.21 111.127 -175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -89.4 12.15 17.14 Favored 'General case' 0 C--N 1.351 0.653 0 CA-C-O 118.057 -0.973 . . . . 75.23 111.414 -177.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.522 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -44.76 -56.26 9.0 Favored Pre-proline 0 CA--C 1.567 1.614 0 CA-C-O 118.136 -0.935 . . . . 62.05 112.372 -177.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 35.3 Cg_exo -58.75 -22.97 64.15 Favored 'Trans proline' 0 C--N 1.395 2.977 0 C-N-CA 122.579 2.186 . . . . 74.21 113.888 -179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.83 -31.58 12.15 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 123.746 0.818 . . . . 75.14 110.503 -175.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.704 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.58 -17.02 14.25 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.815 0 CA-C-O 120.895 0.379 . . . . 72.22 110.165 -170.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.437 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 21.9 m-85 -73.86 -30.4 62.63 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.61 0.764 . . . . 55.24 111.807 178.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -85.37 -12.86 51.15 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 122.485 0.314 . . . . 74.54 111.364 177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.543 ' HG3' ' HG2' ' A' ' 71' ' ' GLU . 31.4 mmtp -79.16 152.24 30.83 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.311 0.644 . . . . 73.13 110.872 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.05 140.18 58.81 Favored 'General case' 0 N--CA 1.48 1.035 0 O-C-N 124.22 0.95 . . . . 63.12 109.623 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.764 ' HB3' ' HB3' ' E' ' 297' ' ' TYR . 32.2 m95 -74.28 83.47 1.89 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 123.689 0.796 . . . . 71.35 110.912 -173.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -134.56 71.23 71.45 Favored Pre-proline 0 CA--C 1.555 1.16 0 C-N-CA 124.575 1.15 . . . . 71.45 109.609 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -82.32 127.76 5.3 Favored 'Trans proline' 0 C--N 1.374 1.9 0 C-N-CA 122.009 1.806 . . . . 75.43 112.174 -177.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.9 88.82 5.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 106.423 -1.695 . . . . 64.12 106.423 172.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.1 m -82.22 114.72 23.55 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.819 0 CA-C-N 114.761 -1.109 . . . . 73.11 111.11 -171.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 65' ' ' THR . 88.3 mttt -80.18 152.86 28.95 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 124.454 1.102 . . . . 73.41 110.84 167.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 6.1 tt -122.72 109.61 14.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.539 -2.022 . . . . 50.1 105.539 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.688 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 13.7 m-20 -117.77 107.73 14.51 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.793 -0.817 . . . . 64.31 108.793 -177.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.9 pp -99.06 150.45 21.99 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 109.321 -0.622 . . . . 74.01 109.321 174.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 30.1 t70 -145.5 136.6 24.76 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.678 0.791 . . . . 63.3 109.39 -178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.5 p -121.76 126.76 49.61 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.684 0.794 . . . . 54.11 110.942 -169.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -151.3 113.56 4.57 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.366 0.667 . . . . 64.41 110.193 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.9 p -98.77 162.3 13.18 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 109.683 -0.488 . . . . 71.24 109.683 173.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 41.2 t -152.94 158.07 41.55 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.321 1.048 . . . . 71.4 109.196 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -114.07 126.3 54.96 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 107.944 -1.132 . . . . 64.42 107.944 166.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -93.5 -41.53 9.73 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.011 0.525 . . . . 75.53 110.25 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -152.25 178.75 9.18 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 123.866 0.866 . . . . 74.42 109.702 -178.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -64.85 123.13 18.61 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 108.991 -0.744 . . . . 73.14 108.991 171.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 73.02 -7.23 1.53 Allowed 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 125.796 1.638 . . . . 64.3 112.237 -177.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 44.9 t -106.7 111.45 35.52 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 N-CA-C 108.286 -1.005 . . . . 64.24 108.286 -177.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -123.38 161.06 25.47 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.274 -0.639 . . . . 65.43 109.274 -175.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -131.56 138.99 49.11 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.859 -1.064 . . . . 74.54 108.784 -179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.9 t -126.22 117.02 47.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 106.849 -1.538 . . . . 55.21 106.849 169.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 24.6 t -101.23 130.45 50.68 Favored 'Isoleucine or valine' 0 C--O 1.243 0.741 0 N-CA-C 108.986 -0.746 . . . . 72.43 108.986 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.617 HD23 HD12 ' A' ' 106' ' ' LEU . 3.8 mm? -117.57 109.78 17.12 Favored 'General case' 0 C--O 1.241 0.64 0 N-CA-C 108.212 -1.032 . . . . 75.12 108.212 170.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.637 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 13.2 ttp180 -85.57 112.64 21.14 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 109.108 -0.701 . . . . 74.31 109.108 172.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.0 t -94.2 128.62 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.156 0 N-CA-C 107.359 -1.348 . . . . 74.44 107.359 170.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.688 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 47.3 m -127.05 126.5 43.16 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.213 -1.032 . . . . 74.3 108.213 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.826 HG11 HD21 ' A' ' 126' ' ' LEU . 44.9 t -118.75 109.79 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 N-CA-C 108.46 -0.941 . . . . 73.3 108.46 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 41' ' ' LYS . 3.3 m -103.71 133.28 48.98 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.292 -0.632 . . . . 51.14 109.292 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.63 119.37 31.65 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 107.439 -1.319 . . . . 72.22 107.439 174.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.58 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 55.6 m -135.93 127.91 29.56 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 122.819 0.447 . . . . 71.23 110.479 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.0 mp -88.83 72.28 8.56 Favored 'General case' 0 C--O 1.244 0.803 0 N-CA-C 107.917 -1.142 . . . . 74.3 107.917 179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.24 -84.46 0.83 Allowed Glycine 0 C--N 1.35 1.333 0 CA-C-N 114.934 -1.03 . . . . 45.25 110.713 -173.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.9 tm-20 -110.88 -29.22 8.03 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.394 1.078 . . . . 74.01 109.86 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.543 ' HG2' ' HG3' ' A' ' 34' ' ' LYS . 3.3 tp10 -82.89 91.48 7.11 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.721 0.809 . . . . 74.14 110.322 -173.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 86.5 m -64.71 130.89 45.26 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-O 121.284 0.564 . . . . 54.32 111.495 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.704 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -78.29 -63.36 1.42 Allowed 'General case' 0 C--O 1.238 0.477 0 CA-C-N 114.91 -1.041 . . . . 73.42 110.011 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -162.04 170.94 18.37 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 114.467 -1.242 . . . . 73.04 110.97 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 48.4 tp -142.62 113.77 7.69 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.551 -1.204 . . . . 72.01 108.284 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.439 ' SG ' HG22 ' A' ' 118' ' ' VAL . 76.4 m -113.42 100.87 8.86 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.387 0.675 . . . . 71.34 110.77 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.422 ' HB3' ' HB3' ' A' ' 22' ' ' SER . 31.4 tt0 -119.16 118.65 31.92 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.285 1.034 . . . . 71.04 109.617 -174.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.5 t -133.12 112.79 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 124.236 1.015 . . . . 72.23 109.224 -174.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.637 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 49.7 mt-30 -84.24 84.47 7.61 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 108.686 -0.857 . . . . 71.41 108.686 172.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.85 97.89 7.59 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 114.775 -1.102 . . . . 71.21 108.592 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.426 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -96.22 146.64 18.34 Favored Glycine 0 C--N 1.338 0.678 0 CA-C-N 115.723 -0.671 . . . . 71.14 111.524 178.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.23 137.87 9.11 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 110.716 -0.954 . . . . 61.11 110.716 179.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 46.2 mt -93.02 123.72 45.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 N-CA-C 108.806 -0.813 . . . . 61.22 108.806 175.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.661 ' HD2' HG12 ' A' ' 13' ' ' ILE . 6.8 m-85 -132.56 118.64 19.48 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 107.71 -1.219 . . . . 74.3 107.71 -178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 24.3 p -81.68 98.52 8.43 Favored 'General case' 0 C--O 1.242 0.665 0 N-CA-C 109.327 -0.62 . . . . 71.04 109.327 174.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.435 ' HA ' ' O ' ' A' ' 10' ' ' THR . 2.8 pp -113.24 160.64 12.66 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 C-N-CA 123.417 0.687 . . . . 74.15 111.258 -175.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.37 174.58 2.32 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 125.001 1.32 . . . . 63.33 109.495 175.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.447 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 78.08 -6.48 49.36 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 115.514 0.966 . . . . 75.11 115.514 169.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 15.5 pt -126.18 134.35 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 N-CA-C 108.216 -1.031 . . . . 65.11 108.216 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.567 ' HB3' ' HG2' ' E' ' 276' ' ' PRO . 19.2 mp0 -133.16 173.74 11.12 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.692 0.797 . . . . 75.34 109.461 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.34 -139.45 47.4 Favored Glycine 0 C--N 1.35 1.318 0 O-C-N 123.702 0.626 . . . . 43.32 113.737 178.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.431 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 15.1 t -72.9 -18.63 61.39 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.595 0.758 . . . . 54.31 111.208 177.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -69.47 -36.63 76.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 123.599 0.76 . . . . 64.52 110.323 176.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -76.78 -42.19 41.73 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 122.943 0.497 . . . . 74.24 109.777 173.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -68.09 -16.88 64.2 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.431 -0.804 . . . . 73.11 112.682 -178.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.425 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.9 t-80 -68.9 -28.72 66.93 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 122.953 0.501 . . . . 73.5 110.15 171.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.513 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.2 t -78.01 -39.2 42.95 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.064 0.546 . . . . 60.34 110.008 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.7 mt -65.66 -51.77 56.87 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 123.354 0.662 . . . . 73.11 112.081 179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.56 4.91 47.46 Favored Glycine 0 C--N 1.345 1.037 0 CA-C-N 115.424 -0.807 . . . . 74.31 114.33 -164.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -144.91 -63.8 0.35 Allowed 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 117.281 0.541 . . . . 42.4 112.388 -175.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.513 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 82.0 t80 -71.05 -57.1 4.86 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 112.901 0.704 . . . . 75.35 112.901 -169.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 97' ' ' CYS . 88.5 m -67.4 -32.28 4.4 Favored Pre-proline 0 CA--C 1.56 1.355 0 CA-C-O 118.189 -0.91 . . . . 73.11 112.882 179.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -48.28 -50.12 12.79 Favored 'Trans proline' 0 C--N 1.388 2.65 0 C-N-CA 122.413 2.075 . . . . 60.3 112.876 159.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -61.35 -25.01 66.87 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 123.656 0.782 . . . . 73.02 111.957 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.473 HG21 HD11 ' A' ' 13' ' ' ILE . 49.1 mm -76.68 -48.92 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 72.23 110.111 174.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.617 HD12 HD23 ' A' ' 60' ' ' LEU . 95.8 mt -81.18 -23.01 38.48 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.446 0.698 . . . . 73.43 112.214 -170.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.4 ' HZ ' HD22 ' A' ' 128' ' ' LEU . 55.3 t80 -65.34 -42.57 59.47 Favored Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 124.216 1.006 . . . . 73.24 112.957 -171.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -61.84 -32.11 85.47 Favored 'Trans proline' 0 C--N 1.388 2.609 0 C-N-CA 121.83 1.687 . . . . 63.11 113.077 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -74.22 -39.65 62.96 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.209 0.603 . . . . 74.41 111.618 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.87 -46.47 78.32 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 109.419 -0.586 . . . . 72.13 109.419 176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.9 ttm180 -54.37 -46.27 72.98 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.777 1.298 . . . . 71.11 110.728 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.54 -48.47 77.36 Favored 'General case' 0 N--CA 1.476 0.845 0 O-C-N 124.295 0.997 . . . . 72.43 110.552 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 42.5 t -57.54 -45.25 85.29 Favored 'General case' 0 N--CA 1.479 1.013 0 O-C-N 123.772 0.67 . . . . 40.33 110.697 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 118' ' ' VAL . 91.8 mt -60.29 -52.58 59.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 CA-C-N 114.855 -1.066 . . . . 71.4 110.05 176.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 125' ' ' GLN . 78.4 m -53.19 -46.22 68.91 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.919 0.888 . . . . 74.21 111.515 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.0 t -64.88 -47.51 77.57 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 115.179 -0.919 . . . . 71.45 110.034 -177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.42 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 13.4 mtp -54.58 -43.7 72.34 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 124.09 0.956 . . . . 72.1 111.449 175.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 114' ' ' ILE . 67.5 t -65.9 -47.16 86.42 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 C-N-CA 124.862 1.265 . . . . 72.25 111.312 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 76.5 p -66.69 -32.66 74.11 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.095 0.558 . . . . 75.44 111.264 -177.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 80.8 mtt-85 -67.17 -33.08 74.63 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.753 0.821 . . . . 62.24 110.49 176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.58 20.43 18.61 Favored Glycine 0 C--N 1.354 1.566 0 CA-C-O 119.08 -0.845 . . . . 72.31 114.28 -178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 65.0 p 48.39 47.35 20.04 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.366 1.466 . . . . 73.3 112.352 -174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.482 ' HA ' HD13 ' E' ' 301' ' ' ILE . 61.8 m-85 -117.05 149.84 44.95 Favored Pre-proline 0 C--O 1.243 0.759 0 N-CA-C 107.777 -1.194 . . . . 65.53 107.777 169.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.567 ' HB3' ' HB2' ' E' ' 300' ' ' ASN . 44.8 Cg_endo -65.48 153.68 77.1 Favored 'Trans proline' 0 C--N 1.377 2.059 0 C-N-CA 122.189 1.926 . . . . 72.41 110.392 178.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.625 ' HG3' HG23 ' A' ' 115' ' ' THR . 31.8 tt0 -51.1 126.9 17.68 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 124.332 1.02 . . . . 75.14 111.995 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.826 HD21 HG11 ' A' ' 64' ' ' VAL . 33.3 tp -110.19 94.66 5.13 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-N 115.205 -0.907 . . . . 75.03 109.216 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -111.91 104.32 12.6 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.405 -1.27 . . . . 72.5 107.968 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.4 HD22 ' HZ ' ' A' ' 107' ' ' PHE . 3.3 tt -63.74 128.04 34.06 Favored 'General case' 0 CA--C 1.551 0.986 0 N-CA-C 107.943 -1.132 . . . . 64.23 107.943 179.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -49.26 144.13 8.7 Favored Pre-proline 0 N--CA 1.486 1.351 0 C-N-CA 124.208 1.003 . . . . 51.23 111.709 -178.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.421 ' HG2' ' HE2' ' C' ' 11' ' ' PHE . 40.9 Cg_exo -58.52 110.0 0.59 Allowed 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.644 2.229 . . . . 73.51 112.064 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 35.4 t -101.07 112.95 35.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 108.737 -0.838 . . . . 73.32 108.737 -179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.98 85.21 5.61 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.662 0.785 . . . . 64.52 109.537 174.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -59.48 -32.86 70.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.666 0.787 . . . . 73.3 111.366 -178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -67.03 -40.72 87.28 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.125 0.97 . . . . 53.31 111.184 177.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -72.73 -37.44 67.75 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 123.758 0.661 . . . . 64.23 111.173 -178.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 85.9 mt -67.51 -42.99 81.94 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 123.061 0.545 . . . . 65.35 110.906 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -62.02 -38.18 87.69 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.27 -0.877 . . . . 73.4 109.97 174.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.531 ' SD ' ' HG2' ' A' ' 144' ' ' GLN . 36.7 tpp -68.5 -38.64 81.13 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.886 0.874 . . . . 64.24 111.073 178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -58.84 -35.25 72.61 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.161 0.585 . . . . 72.1 110.756 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -81.08 -36.14 30.82 Favored 'General case' 0 CA--C 1.55 0.966 0 C-N-CA 123.271 0.628 . . . . 71.11 110.952 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 10.1 tt -60.91 -51.62 68.52 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.006 0.923 . . . . 74.45 110.827 -173.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 178.7 -19.01 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 124.883 1.273 . . . . 61.32 109.471 174.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.46 ' HA ' ' HG3' ' A' ' 138' ' ' MET . 0.0 OUTLIER 69.9 118.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 126.042 1.737 . . . . 74.32 110.668 178.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.531 ' HG2' ' SD ' ' A' ' 138' ' ' MET . 2.4 pt20 -133.0 107.51 8.31 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.278 1.031 . . . . 62.24 109.162 178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -156.23 172.24 18.81 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.743 0.817 . . . . 72.1 110.568 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -117.81 169.25 13.21 Favored Glycine 0 C--N 1.342 0.867 0 CA-C-N 115.648 -0.705 . . . . 55.35 112.045 178.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -140.08 142.53 36.12 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.083 0.553 . . . . 74.51 110.69 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 70.81 41.75 62.48 Favored Glycine 0 C--N 1.343 0.949 0 CA-C-N 115.945 -0.571 . . . . 62.42 111.744 -177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 58.1 p -62.42 -56.32 19.36 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.713 0.805 . . . . 63.42 109.772 -177.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -172.46 129.45 0.55 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 106.557 -1.646 . . . . 74.45 106.557 165.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -77.89 -67.03 0.77 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.222 1.009 . . . . 71.04 110.072 -172.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 14.2 t-80 -178.26 111.01 0.06 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.642 0.777 . . . . 64.02 110.862 -172.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.41 ' H ' ' HG2' ' C' ' 90' ' ' GLU . 0.2 OUTLIER -143.51 92.57 2.38 Favored 'General case' 0 CA--C 1.55 0.956 0 CA-C-O 121.991 0.9 . . . . 71.52 109.8 167.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -79.2 78.4 5.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.787 0.804 . . . . 75.34 109.992 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.318 0 CA-C-N 115.219 -0.901 . . . . 62.04 110.558 -176.353 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 109.237 -0.653 . . . . 64.51 109.237 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 47.2 m -101.27 -176.02 3.03 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.159 0.984 . . . . 51.24 110.732 178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -84.43 4.02 33.49 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.106 0.962 . . . . 73.45 112.314 -178.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 63.52 -78.42 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.559 1.143 . . . . 70.52 110.896 -174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 51.0 t30 64.25 106.68 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.418 1.487 . . . . 63.33 111.292 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -127.11 79.66 1.9 Allowed 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 108.964 -0.754 . . . . 73.04 108.964 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 39.6 p -134.56 135.82 42.56 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.412 0.685 . . . . 73.05 110.498 -176.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -82.05 -63.4 1.39 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.441 -0.948 . . . . 72.45 108.441 169.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 25.7 ptm 49.36 171.24 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 127.144 2.178 . . . . 74.44 115.08 -179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.555 HG22 HE22 ' B' ' 12' ' ' GLN . 82.2 m -155.3 111.15 3.11 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 107.858 -1.164 . . . . 61.45 107.858 173.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -132.94 136.74 46.29 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 109.558 -0.534 . . . . 65.24 109.558 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.635 ' HB3' HG23 ' E' ' 309' ' ' THR . 0.2 OUTLIER -152.05 139.52 19.57 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.281 1.032 . . . . 74.55 108.954 171.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 2.5 pp -83.42 144.55 9.83 Favored 'Isoleucine or valine' 0 C--O 1.239 0.533 0 N-CA-C 108.738 -0.838 . . . . 74.1 108.738 172.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' E' ' 306' ' ' VAL . 69.3 mt-30 -103.63 -43.35 5.39 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 123.17 0.588 . . . . 62.35 110.194 173.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -166.99 134.88 2.57 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 115.866 -0.606 . . . . 54.43 109.673 -171.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 90.5 mt -118.52 133.78 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 N-CA-C 106.831 -1.544 . . . . 73.24 106.831 175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 18.3 p90 -164.64 147.13 8.57 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.65 0.593 . . . . 73.53 112.098 -175.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 74.8 m -73.25 124.47 25.72 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 115.343 -0.844 . . . . 73.1 108.879 170.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 40.4 mtpt -97.95 -32.93 11.41 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 122.923 0.489 . . . . 73.42 110.89 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.476 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 12.8 t70 -152.81 140.99 20.44 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.338 -0.392 . . . . 72.42 110.361 -171.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.3 mm -132.88 137.33 54.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 124.212 1.005 . . . . 74.43 109.292 176.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.667 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 69.4 m -133.69 112.04 11.08 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 124.986 1.315 . . . . 74.42 108.444 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.407 ' O ' ' HA ' ' A' ' 20' ' ' ASP . 87.7 t80 -130.5 110.02 11.13 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 107.053 -1.462 . . . . 73.13 107.053 167.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -119.66 111.9 18.62 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 108.431 -0.952 . . . . 64.11 108.431 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.524 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -115.92 85.56 14.96 Favored Pre-proline 0 C--O 1.239 0.547 0 N-CA-C 108.296 -1.002 . . . . 63.01 108.296 172.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -68.91 -22.9 35.45 Favored 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.515 2.144 . . . . 70.2 111.388 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -107.83 13.84 25.99 Favored 'General case' 0 C--O 1.214 -0.789 0 C-N-CA 124.653 1.181 . . . . 61.14 110.656 -177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.524 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -45.21 -51.62 24.16 Favored Pre-proline 0 CA--C 1.57 1.732 0 N-CA-C 114.3 1.222 . . . . 73.22 114.3 -175.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -76.5 -46.37 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.55 0 CA-C-N 121.511 1.575 . . . . 73.54 112.965 171.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -77.66 3.34 14.15 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 113.814 1.042 . . . . 70.4 113.814 -171.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.576 HG23 HD11 ' B' ' 68' ' ' LEU . 14.7 p -73.62 -30.64 29.91 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 109.63 -0.507 . . . . 63.32 109.63 171.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -55.54 -31.27 61.99 Favored 'General case' 0 C--N 1.361 1.084 0 C-N-CA 125.145 1.378 . . . . 75.3 112.993 -171.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.42 ' HG3' ' HG2' ' B' ' 34' ' ' LYS . 25.5 pt20 -63.76 -50.37 69.32 Favored 'General case' 0 CA--C 1.552 1.057 0 O-C-N 123.367 0.417 . . . . 73.5 110.886 178.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.487 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 54.1 pttt -116.48 60.31 0.73 Allowed 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.943 0.897 . . . . 75.45 110.501 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -101.27 119.74 39.21 Favored 'General case' 0 N--CA 1.477 0.9 0 O-C-N 121.762 -0.586 . . . . 74.12 109.648 -175.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -178.35 -167.93 0.14 Allowed 'General case' 0 N--CA 1.475 0.813 0 O-C-N 125.071 1.482 . . . . 75.42 108.984 163.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -47.91 105.45 0.49 Allowed Pre-proline 0 CA--C 1.566 1.581 0 C-N-CA 124.421 1.089 . . . . 65.22 112.783 -173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -92.02 169.66 2.89 Favored 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.526 2.818 . . . . 53.52 113.066 -173.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -72.86 107.84 5.49 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 115.154 -0.93 . . . . 45.41 108.652 172.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.417 ' HA ' ' O ' ' B' ' 65' ' ' THR . 16.2 m -105.71 141.01 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 115.678 -0.692 . . . . 75.11 110.77 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -126.79 121.96 33.44 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.984 0.914 . . . . 45.43 109.06 -177.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 47.7 tp -98.44 124.59 43.22 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.683 0.793 . . . . 61.11 108.984 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.742 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 6.7 m-20 -125.47 118.73 26.44 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.982 0.913 . . . . 72.2 108.626 177.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.2 126.44 46.48 Favored 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.405 -1.331 . . . . 75.55 107.405 172.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -133.83 139.4 46.23 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.882 0.873 . . . . 74.24 109.216 -173.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.9 p -117.74 113.74 22.29 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.279 0.632 . . . . 70.11 110.787 -172.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.61 147.78 42.53 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.39 1.076 . . . . 52.14 108.23 172.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 49.5 p -145.95 174.33 11.36 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 118.064 0.393 . . . . 60.34 111.546 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 61.9 p -153.32 145.11 23.51 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.385 1.074 . . . . 54.14 109.248 173.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -97.28 104.2 16.2 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 109.502 -0.555 . . . . 71.14 109.502 -178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 77.7 mt -75.64 -42.49 51.38 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.16 0.584 . . . . 74.1 110.943 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -162.12 -179.95 7.47 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.111 0.965 . . . . 51.3 109.306 178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -70.23 123.41 21.59 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 115.514 -0.766 . . . . 61.44 109.31 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 74.33 -3.1 2.63 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 125.82 1.648 . . . . 70.35 112.838 -176.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 89.1 t -106.34 114.1 44.72 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 108.498 -0.927 . . . . 73.01 108.498 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -116.29 139.87 49.93 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 108.793 -0.818 . . . . 63.13 108.793 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 6.1 tm-20 -111.87 99.92 8.5 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 107.418 -1.327 . . . . 72.11 107.418 177.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.41 127.87 48.13 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.908 0.883 . . . . 43.45 110.277 -174.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.557 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 38.6 t -111.97 112.37 40.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.644 0 C-N-CA 124.912 1.285 . . . . 75.42 108.738 178.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.08 106.0 18.17 Favored 'General case' 0 CA--C 1.54 0.582 0 N-CA-C 108.667 -0.864 . . . . 63.33 108.667 178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 19.6 ttm180 -86.03 123.85 31.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.576 -0.738 . . . . 70.11 109.535 174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -111.44 105.76 19.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.598 0 N-CA-C 107.709 -1.219 . . . . 52.5 107.709 168.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.742 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 32.4 m -94.42 137.49 33.49 Favored 'General case' 0 C--O 1.24 0.568 0 N-CA-C 108.659 -0.867 . . . . 74.23 108.659 176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 96.8 t -131.94 130.14 61.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.429 -1.323 . . . . 71.14 107.429 174.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' B' ' 40' ' ' VAL . 97.1 m -120.04 144.93 47.29 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 108.528 -0.915 . . . . 75.1 108.528 173.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.61 134.11 40.9 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 107.806 -1.183 . . . . 53.23 107.806 173.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 61.2 p -147.36 133.91 19.82 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 123.297 0.639 . . . . 74.45 109.976 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.689 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -125.48 138.27 53.99 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.564 0.746 . . . . 74.23 110.016 177.848 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.05 -127.69 9.03 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.213 -0.903 . . . . 72.13 111.444 -173.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -106.98 11.35 29.89 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.129 0.972 . . . . 74.35 111.932 -176.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.487 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 17.0 pt-20 -154.88 -179.49 8.08 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 122.585 0.354 . . . . 75.24 110.986 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 5.2 m -64.18 154.39 34.94 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.636 1.174 . . . . 72.23 112.424 -174.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.689 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -103.91 -60.35 1.59 Allowed 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 107.774 -1.195 . . . . 73.01 107.774 166.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -166.34 164.39 17.51 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 114.346 -1.297 . . . . 72.55 109.161 173.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 29.4 mt -123.65 135.84 54.15 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 107.129 -1.434 . . . . 74.1 107.129 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 48.7 t -144.96 131.58 19.91 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 109.083 -0.71 . . . . 53.2 109.083 178.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 32.7 tt0 -156.22 143.65 19.23 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 108.615 -0.883 . . . . 64.53 108.615 -170.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.452 HG21 ' HB3' ' B' ' 113' ' ' CYS . 93.3 t -135.69 146.9 28.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 108.555 -0.905 . . . . 64.12 108.555 179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -121.58 95.61 4.74 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.628 -1.249 . . . . 73.13 107.628 171.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.468 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.3 tp-100 -89.0 101.05 13.71 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.642 -0.873 . . . . 62.55 108.642 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.45 168.74 36.81 Favored Glycine 0 C--N 1.341 0.812 0 O-C-N 123.749 0.656 . . . . 64.45 111.874 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -171.54 127.74 1.48 Allowed Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.574 -0.611 . . . . 71.14 111.574 -175.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 48.4 mt -84.46 128.86 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 108.053 -1.091 . . . . 71.03 108.053 174.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 51.7 m-85 -134.64 163.51 29.59 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 124.835 1.254 . . . . 72.13 108.853 -176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -131.87 113.11 13.07 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 108.66 -0.867 . . . . 72.33 108.66 173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 4.0 mp -113.39 129.23 69.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.7 -0.852 . . . . 74.12 108.7 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -147.28 170.1 18.01 Favored 'General case' 0 C--O 1.245 0.839 0 C-N-CA 124.582 1.153 . . . . 63.43 108.857 176.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.39 -70.8 3.02 Favored Glycine 0 C--N 1.344 0.976 0 N-CA-C 111.803 -0.519 . . . . 52.53 111.803 179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.9 pp -87.55 152.22 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 123.166 0.586 . . . . 64.13 110.553 178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.499 ' HA ' ' HB2' ' B' ' 94' ' ' MET . 14.4 pt-20 -158.69 175.86 13.1 Favored 'General case' 0 CA--C 1.544 0.734 0 O-C-N 123.696 0.623 . . . . 74.02 111.822 -173.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 67.69 -130.09 28.04 Favored Glycine 0 C--N 1.351 1.41 0 CA-C-N 115.006 -0.997 . . . . 74.44 113.857 174.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.432 ' HA ' HD21 ' H' ' 280' ' ' LEU . 17.7 m -65.52 -32.9 74.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.158 0.983 . . . . 75.11 110.833 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -75.41 -31.09 60.29 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.922 -1.035 . . . . 75.12 109.933 -177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.506 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 26.3 ttt -70.13 -32.4 70.39 Favored 'General case' 0 C--N 1.351 0.66 0 N-CA-C 109.908 -0.405 . . . . 61.42 109.908 174.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.413 ' HA ' HD11 ' B' ' 98' ' ' LEU . . . -58.33 -25.42 61.93 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.059 0.543 . . . . 61.33 112.133 175.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.51 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 55.5 t-80 -79.56 -26.49 41.35 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.481 0.713 . . . . 75.12 111.157 173.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 41.9 t -79.15 -65.66 0.97 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 122.755 0.422 . . . . 65.35 110.407 177.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' B' ' 94' ' ' MET . 2.7 pp -63.53 -21.4 66.31 Favored 'General case' 0 N--CA 1.489 1.501 0 C-N-CA 123.622 0.769 . . . . 73.45 112.776 -178.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.49 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -107.06 3.62 35.53 Favored Glycine 0 C--N 1.35 1.326 0 N-CA-C 114.431 0.532 . . . . 61.14 114.431 -172.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -151.32 -51.92 0.13 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.903 0.352 . . . . 73.2 111.725 -177.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -68.65 -48.49 63.88 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 123.763 0.825 . . . . 74.3 110.646 -177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.468 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 56.1 m -68.89 -46.51 31.94 Favored Pre-proline 0 CA--C 1.563 1.459 0 C-N-CA 123.186 0.594 . . . . 65.14 111.466 179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 89.0 Cg_exo -55.38 -35.16 91.18 Favored 'Trans proline' 0 C--N 1.395 2.985 0 C-N-CA 122.686 2.257 . . . . 54.21 114.003 168.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -59.64 -35.32 74.16 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 123.357 0.663 . . . . 73.31 110.881 177.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 65.1 mt -73.6 -51.13 26.25 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-N 115.303 -0.862 . . . . 74.33 110.146 177.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 94.5 mt -76.31 -23.94 54.33 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 123.564 0.746 . . . . 73.1 112.667 -170.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 56.2 t80 -61.93 -50.71 79.84 Favored Pre-proline 0 N--CA 1.487 1.418 0 CA-C-O 117.567 -1.206 . . . . 65.33 113.125 -172.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -52.77 -40.5 74.21 Favored 'Trans proline' 0 C--N 1.39 2.726 0 C-N-CA 122.643 2.229 . . . . 71.51 113.911 178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.468 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 74.5 m-85 -69.86 -45.58 67.43 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.411 0.684 . . . . 75.44 110.591 -179.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.97 -38.48 86.06 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.547 0.739 . . . . 65.31 110.859 176.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.647 ' HG3' ' HB2' ' B' ' 128' ' ' LEU . 32.1 ttt180 -63.28 -54.63 34.22 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.758 1.623 . . . . 65.23 110.994 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.33 -36.98 81.66 Favored 'General case' 0 N--CA 1.479 1.003 0 O-C-N 124.226 0.954 . . . . 72.44 109.663 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.507 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.9 t -69.0 -38.95 79.57 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 115.756 -0.656 . . . . 72.02 111.951 -176.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.41 HG23 ' SG ' ' B' ' 76' ' ' CYS . 58.3 mt -63.27 -51.94 64.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 C-N-CA 123.129 0.572 . . . . 74.4 109.463 174.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.615 HG23 ' HB2' ' B' ' 125' ' ' GLN . 29.6 m -61.37 -28.25 69.1 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 115.323 -0.853 . . . . 74.11 111.498 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.4 t -69.47 -43.29 73.52 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 123.514 0.726 . . . . 65.33 110.22 176.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.507 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.5 mmt -73.27 -30.68 63.6 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 122.582 0.353 . . . . 74.24 111.129 -176.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 114' ' ' ILE . 58.8 t -66.77 -39.38 83.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.293 0.637 . . . . 64.23 109.704 172.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.4 t -62.99 -35.72 81.15 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.374 1.07 . . . . 73.5 111.294 174.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.43 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 82.3 mtt-85 -75.99 -31.04 58.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.831 0.852 . . . . 74.11 110.716 179.125 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.05 -0.77 86.58 Favored Glycine 0 C--N 1.353 1.501 0 O-C-N 123.572 0.545 . . . . 54.13 112.469 171.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 48.9 p 62.57 32.68 16.34 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 126.512 1.925 . . . . 71.4 112.512 173.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.468 ' CE1' HG11 ' B' ' 31' ' ' VAL . 40.6 m-85 -101.71 151.94 38.0 Favored Pre-proline 0 N--CA 1.473 0.682 0 CA-C-N 115.095 -0.957 . . . . 74.31 110.479 177.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.641 ' HB2' ' HA ' ' H' ' 297' ' ' TYR . 36.3 Cg_exo -57.55 119.0 5.97 Favored 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 122.67 2.247 . . . . 75.22 110.635 172.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.615 ' HB2' HG23 ' B' ' 115' ' ' THR . 19.9 pt20 -60.42 152.26 26.0 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.231 1.012 . . . . 74.24 113.175 -168.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.526 ' HB3' HG23 ' H' ' 296' ' ' THR . 3.4 pp -112.26 120.81 43.01 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 107.544 -1.28 . . . . 72.21 107.544 179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -93.33 104.37 16.53 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 108.469 -0.938 . . . . 72.44 108.469 -175.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.647 ' HB2' ' HG3' ' B' ' 111' ' ' ARG . 3.1 mm? -58.25 118.41 5.46 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 108.67 -0.863 . . . . 63.55 108.67 175.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.656 ' HB3' ' HB2' ' H' ' 291' ' ' LEU . . . -80.03 144.89 59.95 Favored Pre-proline 0 CA--C 1.549 0.936 0 N-CA-C 109.837 -0.431 . . . . 71.0 109.837 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.446 ' HD2' HG21 ' F' ' 309' ' ' THR . 14.4 Cg_exo -64.12 110.36 1.33 Allowed 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.954 2.436 . . . . 64.14 112.381 -173.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.68 112.79 24.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 107.421 -1.326 . . . . 71.31 107.421 177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.22 75.45 4.75 Favored 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 108.191 -1.04 . . . . 73.02 108.191 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -54.9 -47.21 74.64 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.058 1.343 . . . . 74.54 111.581 -172.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -62.31 -49.86 73.94 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 113.944 -1.48 . . . . 74.41 112.395 -174.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.61 -40.86 96.26 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.871 0.732 . . . . 71.54 110.959 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.528 HD12 ' SD ' ' H' ' 286' ' ' MET . 2.1 tm? -65.08 -43.86 90.8 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.927 0.891 . . . . 64.54 110.034 -177.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 54.7 t80 -67.04 -27.52 67.46 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.416 0.686 . . . . 73.44 111.536 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 94.2 mtp -66.94 -29.92 69.92 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.857 0.463 . . . . 73.32 111.204 176.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -77.63 -20.24 54.17 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.392 0.677 . . . . 61.23 111.177 176.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.78 -34.94 79.04 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 109.936 -0.394 . . . . 75.11 109.936 173.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 58.9 mt -90.77 33.91 0.92 Allowed 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.059 0.944 . . . . 74.43 109.973 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? 63.24 -82.94 0.02 OUTLIER 'General case' 0 C--N 1.36 1.057 0 C-N-CA 125.159 1.383 . . . . 61.42 108.792 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -169.15 141.47 2.59 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.189 0.995 . . . . 73.21 109.842 164.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -177.85 145.14 0.38 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.884 1.274 . . . . 74.33 108.643 173.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -150.94 109.84 3.88 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.777 0.831 . . . . 74.32 108.941 178.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 79.34 150.93 5.95 Favored Glycine 0 C--N 1.351 1.4 0 N-CA-C 111.754 -0.538 . . . . 54.34 111.754 -176.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -92.27 -3.46 55.43 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.109 0.564 . . . . 64.03 112.226 -178.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 69.53 44.98 61.65 Favored Glycine 0 C--N 1.353 1.487 0 O-C-N 123.643 0.589 . . . . 51.35 112.574 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 27.3 m -140.82 85.03 1.97 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.454 0.701 . . . . 73.24 109.327 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -174.17 117.18 0.22 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.473 1.109 . . . . 74.5 109.297 171.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -141.16 118.97 11.75 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.777 0.831 . . . . 61.45 110.436 177.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.2 m80 -137.01 164.87 27.34 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.988 1.315 . . . . 73.21 107.635 163.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -68.66 112.51 5.46 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 121.667 0.746 . . . . 75.13 110.679 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -64.54 118.11 8.34 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-N 115.149 -0.932 . . . . 63.41 109.603 174.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.135 0 C-N-CA 123.096 0.559 . . . . 75.03 110.316 -173.369 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.2 ptm . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.487 -0.56 . . . . 64.25 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 25.1 t -150.27 -52.62 0.14 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 108.565 -0.902 . . . . 44.34 108.565 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -156.35 92.79 1.35 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 106.417 -1.698 . . . . 65.54 106.417 170.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -165.77 122.77 1.42 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 122.488 0.315 . . . . 61.14 110.878 -173.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 51.6 t-20 -86.68 -68.06 0.77 Allowed 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 107.199 -1.408 . . . . 55.1 107.199 167.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -149.79 160.35 43.62 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.659 1.184 . . . . 74.2 109.083 177.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 86.4 m -152.03 95.81 2.12 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 122.502 0.321 . . . . 64.05 111.309 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 67.93 155.42 0.11 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 124.804 1.241 . . . . 63.43 113.43 165.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ttt 65.09 121.72 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.132 1.373 . . . . 75.13 112.129 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 88.3 m -125.68 107.91 11.02 Favored 'General case' 0 C--O 1.237 0.444 0 N-CA-C 108.883 -0.784 . . . . 53.23 108.883 177.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.421 ' HE2' ' HG2' ' A' ' 130' ' ' PRO . 61.1 t80 -123.18 133.84 54.21 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.079 0.952 . . . . 74.14 108.432 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.18 144.49 21.08 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.42 0.688 . . . . 73.31 110.036 166.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.543 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.9 pp -65.23 141.35 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 115.073 -0.967 . . . . 73.53 109.313 171.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.534 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 84.3 mm-40 -112.07 -50.62 2.9 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.681 -0.489 . . . . 73.43 109.681 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 34.5 ttt180 -168.24 123.7 0.99 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.175 -0.676 . . . . 71.41 109.175 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 82.4 mt -108.28 145.61 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 N-CA-C 107.262 -1.385 . . . . 72.21 107.262 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.401 ' HB3' HG23 ' D' ' 122' ' ' THR . 35.0 p90 -176.88 168.49 2.49 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 121.842 0.83 . . . . 75.02 111.242 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 74.4 p -90.12 113.41 25.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.532 -1.213 . . . . 71.32 108.725 174.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -65.66 -38.61 89.8 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.354 0.662 . . . . 61.44 109.793 174.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -149.57 144.48 26.25 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.812 -1.086 . . . . 71.44 109.257 -177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 75.1 mt -134.83 137.89 50.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 N-CA-C 107.006 -1.479 . . . . 62.24 107.006 172.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 38.4 t -149.5 150.73 32.77 Favored 'General case' 0 C--O 1.244 0.799 0 C-N-CA 123.31 0.644 . . . . 73.53 109.495 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -154.23 135.31 13.91 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.74 -1.207 . . . . 74.21 107.74 176.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.543 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.7 mt-10 -131.43 117.74 19.26 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.044 -0.724 . . . . 51.02 109.044 -178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.8 72.46 55.53 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 108.352 -0.981 . . . . 73.1 108.352 169.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -73.06 -15.68 25.83 Favored 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 122.576 2.184 . . . . 61.04 111.912 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . 0.457 ' O ' HG23 ' C' ' 31' ' ' VAL . 2.0 m-20 -105.18 18.4 22.39 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 124.356 1.062 . . . . 52.41 110.093 178.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -47.24 -48.82 54.67 Favored Pre-proline 0 N--CA 1.496 1.856 0 N-CA-C 114.356 1.243 . . . . 65.11 114.356 -171.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.428 ' HB3' HD13 ' D' ' 51' ' ' LEU . 13.5 Cg_exo -68.59 -38.35 11.05 Favored 'Trans proline' 0 C--N 1.393 2.921 0 C-N-CA 121.818 1.679 . . . . 44.41 111.815 174.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 60.2 t60 -67.66 -22.68 65.29 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.406 1.482 . . . . 74.31 112.381 -177.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.457 HG23 ' O ' ' C' ' 27' ' ' ASN . 78.2 t -65.91 -37.28 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 122.813 0.445 . . . . 61.1 111.952 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -69.65 -28.67 66.08 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 111.976 0.361 . . . . 72.2 111.976 -173.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -87.8 12.92 11.73 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.208 0.603 . . . . 74.32 111.656 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.535 ' HD2' HD21 ' C' ' 68' ' ' LEU . 5.4 ttpm? -112.93 148.98 33.86 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.822 0.849 . . . . 65.44 110.915 -175.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -72.97 130.24 39.92 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.147 0.979 . . . . 64.43 109.88 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 19.0 m95 -85.44 80.85 8.96 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.104 0.962 . . . . 75.12 111.721 -165.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . 0.488 ' N ' ' HD3' ' C' ' 38' ' ' PRO . 1.0 OUTLIER -152.94 44.74 0.26 Allowed Pre-proline 0 CA--C 1.571 1.765 0 N-CA-C 114.0 1.111 . . . . 74.31 114.0 173.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.617 ' HA ' ' HB3' ' C' ' 68' ' ' LEU . 22.7 Cg_exo -67.0 149.0 82.75 Favored 'Trans proline' 0 C--N 1.39 2.716 0 C-N-CA 122.253 1.968 . . . . 45.41 111.1 174.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -85.48 118.73 25.19 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 170.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.68 HG21 HD11 ' C' ' 126' ' ' LEU . 14.2 p -82.1 142.89 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 CA-C-N 114.992 -1.004 . . . . 75.3 109.537 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -131.8 124.46 29.7 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 123.933 0.893 . . . . 50.43 108.934 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 4.0 tt -88.77 129.98 35.45 Favored 'General case' 0 CA--C 1.552 1.053 0 N-CA-C 105.764 -1.939 . . . . 75.52 105.764 164.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.411 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 12.8 t70 -130.01 108.43 10.09 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 107.933 -1.136 . . . . 70.42 107.933 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 43.5 tp -96.6 151.96 19.1 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.124 0.57 . . . . 44.51 110.265 -178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.54 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 5.9 t0 -131.15 154.44 48.35 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.908 0.883 . . . . 62.44 108.642 177.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 29.5 p -119.64 111.77 18.47 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.813 0.845 . . . . 61.55 109.586 179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -137.81 146.5 43.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.966 0.906 . . . . 72.22 109.436 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 41.4 p -161.76 152.94 18.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.055 0.542 . . . . 75.22 110.505 -178.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 76.7 p -149.52 146.03 27.17 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.196 0.598 . . . . 32.43 110.394 -179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -86.26 124.73 32.97 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 109.443 -0.576 . . . . 72.33 109.443 173.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.551 HD11 HD12 ' C' ' 83' ' ' ILE . 70.2 mt -96.53 -44.89 6.96 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.731 0.813 . . . . 74.44 109.78 177.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.38 -177.19 5.71 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-N 115.115 -0.948 . . . . 75.21 109.644 -178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -59.83 115.82 3.65 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.301 0.64 . . . . 64.14 109.886 178.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 64.48 0.96 1.19 Allowed 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.205 1.402 . . . . 63.45 113.206 -178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 94.5 t -94.17 111.09 24.61 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 107.885 -1.154 . . . . 72.23 107.885 175.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -126.86 125.72 42.1 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.182 0.993 . . . . 71.43 109.112 -176.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -84.65 122.62 29.33 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.318 -0.855 . . . . 73.12 109.193 173.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 45.2 t -99.13 124.59 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 107.993 -1.114 . . . . 52.11 107.993 173.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 58.0 t -118.64 131.16 72.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.963 0.905 . . . . 74.54 109.236 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -118.12 105.74 12.14 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 107.693 -1.225 . . . . 54.15 107.693 170.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.54 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 5.8 tmm_? -82.64 108.28 15.9 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.433 -1.321 . . . . 71.34 107.433 174.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.418 ' HB ' HD11 ' C' ' 114' ' ' ILE . 3.4 t -100.23 136.54 31.17 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 N-CA-C 108.247 -1.02 . . . . 53.31 108.247 178.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.411 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 59.9 m -134.85 121.32 20.46 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 109.168 -0.679 . . . . 42.21 109.168 178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.411 HG23 HD13 ' C' ' 114' ' ' ILE . 76.7 t -103.75 109.27 26.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 108.434 -0.951 . . . . 61.52 108.434 174.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.451 HG23 HD23 ' C' ' 75' ' ' LEU . 6.2 m -99.28 150.21 22.34 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.2 -0.909 . . . . 64.32 109.792 -179.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.97 110.09 8.32 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.419 0.688 . . . . 62.31 109.17 178.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.0 m -148.0 138.64 23.05 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.924 0.49 . . . . 61.45 110.32 177.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.617 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.7 OUTLIER -112.41 56.11 0.67 Allowed 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.405 1.082 . . . . 74.12 108.764 178.01 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.44 -116.56 4.4 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 114.27 -1.332 . . . . 54.22 110.519 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -88.79 -29.03 20.06 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.195 0.598 . . . . 75.23 110.146 178.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -79.18 106.14 11.0 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 123.999 0.919 . . . . 75.52 110.056 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 55.8 m -78.74 126.01 30.14 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.715 -0.675 . . . . 72.22 109.778 171.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.32 -56.55 4.92 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 114.666 -1.152 . . . . 72.04 109.437 177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -167.75 178.71 5.13 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.645 0.778 . . . . 72.11 110.691 173.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.543 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 2.5 tm? -138.38 143.76 39.95 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.613 1.165 . . . . 75.41 107.956 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.416 ' N ' HD13 ' C' ' 75' ' ' LEU . 50.2 t -140.2 137.51 34.39 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 107.612 -1.255 . . . . 73.21 107.612 173.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -152.88 134.55 14.55 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.667 0.387 . . . . 75.34 110.601 -173.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 47.7 t -141.05 120.76 12.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 C-N-CA 124.684 1.194 . . . . 70.24 108.735 -177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.42 ' HA ' ' HA ' ' C' ' 61' ' ' ARG . 72.4 mt-30 -88.42 100.18 12.85 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 107.455 -1.313 . . . . 72.42 107.455 169.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -87.95 112.23 22.33 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.674 -0.491 . . . . 74.02 109.674 178.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -104.08 154.11 17.7 Favored Glycine 0 C--N 1.336 0.58 0 N-CA-C 111.851 -0.5 . . . . 71.35 111.851 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.452 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.11 123.97 1.48 Allowed Glycine 0 CA--C 1.505 -0.571 0 N-CA-C 110.69 -0.964 . . . . 52.33 110.69 177.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.551 HD12 HD11 ' C' ' 51' ' ' LEU . 9.4 mm -81.38 129.51 37.4 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 108.452 -0.944 . . . . 74.23 108.452 177.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.543 ' HE2' HG22 ' C' ' 13' ' ' ILE . 50.4 m-85 -138.02 151.73 48.17 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 109.399 -0.593 . . . . 62.24 109.399 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 29.9 p -110.36 117.08 32.66 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.364 -0.976 . . . . 71.53 108.364 171.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 10.6 pt -121.99 116.71 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.157 0.983 . . . . 63.55 109.597 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.4 163.52 34.36 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 123.35 0.66 . . . . 54.3 111.439 -174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.77 -29.58 7.8 Favored Glycine 0 C--N 1.35 1.355 0 CA-C-N 115.401 -0.818 . . . . 50.22 113.977 172.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 1.3 pp -124.14 157.11 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.166 0.987 . . . . 70.22 111.013 -177.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.41 ' HG2' ' H ' ' A' ' 153' ' ' GLN . 7.3 tp10 -149.91 159.67 44.19 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 124.134 0.974 . . . . 73.25 109.582 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.34 -144.58 17.98 Favored Glycine 0 C--N 1.348 1.246 0 C-N-CA 123.279 0.466 . . . . 71.05 112.458 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 39.4 p -64.5 -21.29 66.63 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.708 0.803 . . . . 71.52 111.677 178.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 7.3 mt-30 -65.8 -52.24 52.32 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.915 1.286 . . . . 71.2 109.747 178.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' F' ' 279' ' ' GLY . 3.5 ppp? -77.76 -21.6 51.53 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 115.612 -0.722 . . . . 71.43 110.515 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.64 -30.67 70.29 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.87 0.868 . . . . 73.02 111.82 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.431 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 40.3 t-80 -69.85 -34.28 73.4 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 116.224 -0.444 . . . . 73.31 110.058 170.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.5 t -69.59 -43.05 73.58 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 122.695 0.398 . . . . 62.51 110.73 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.503 HD11 HD22 ' F' ' 278' ' ' LEU . 0.8 OUTLIER -79.79 -55.09 5.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.969 0.907 . . . . 74.24 110.06 -174.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.03 11.46 69.43 Favored Glycine 0 C--N 1.345 1.029 0 CA-C-N 115.519 -0.764 . . . . 75.42 114.639 -167.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.577 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -148.23 -52.02 0.18 Allowed 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 117.457 0.628 . . . . 21.34 111.84 -176.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -76.27 -41.95 47.18 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 123.541 0.736 . . . . 74.53 111.203 -173.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.406 ' HB2' ' HD3' ' C' ' 103' ' ' PRO . 86.6 m -67.36 -47.71 48.01 Favored Pre-proline 0 CA--C 1.565 1.55 0 CA-C-O 118.517 -0.754 . . . . 64.03 111.478 177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.406 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 85.6 Cg_exo -53.68 -35.8 79.3 Favored 'Trans proline' 0 C--N 1.403 3.427 0 C-N-CA 122.756 2.304 . . . . 54.31 113.715 169.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -58.28 -40.23 81.37 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.672 0.789 . . . . 53.42 110.912 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 49.1 mm -72.59 -46.25 55.56 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 123.632 0.773 . . . . 72.23 110.901 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.452 HD21 ' HA3' ' C' ' 82' ' ' GLY . 92.8 mt -82.46 -23.33 34.81 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.163 0.801 . . . . 62.12 113.163 -168.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -57.06 -49.39 94.22 Favored Pre-proline 0 N--CA 1.486 1.372 0 C-N-CA 124.162 0.985 . . . . 73.35 112.842 -174.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -58.21 -33.72 97.83 Favored 'Trans proline' 0 C--N 1.393 2.918 0 C-N-CA 122.504 2.136 . . . . 71.2 113.982 178.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.457 ' HE2' HG21 ' A' ' 115' ' ' THR . 95.9 m-85 -70.66 -48.39 55.11 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.387 0.675 . . . . 64.14 111.285 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -58.7 -43.13 89.95 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 123.472 0.482 . . . . 71.43 109.86 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.534 ' HA ' HD23 ' C' ' 128' ' ' LEU . 31.1 ttt-85 -52.64 -55.98 18.64 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.251 1.421 . . . . 72.22 111.78 179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -69.11 -32.79 72.45 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 123.476 0.485 . . . . 71.21 110.546 -174.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 4.7 t -69.39 -33.51 73.13 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 122.996 0.518 . . . . 74.14 111.257 -179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.418 HD11 ' HB ' ' C' ' 62' ' ' VAL . 90.1 mt -69.22 -52.29 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 123.73 0.812 . . . . 62.2 109.283 172.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 32.1 m -59.11 -33.79 71.25 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 124.272 1.029 . . . . 73.34 111.478 -176.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 27.7 t -64.14 -48.72 74.95 Favored 'General case' 0 C--N 1.35 0.629 0 C-N-CA 123.614 0.766 . . . . 42.24 109.41 177.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -63.0 -38.24 90.39 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.392 1.077 . . . . 64.21 112.404 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 63.6 t -63.59 -42.37 95.88 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 O-C-N 123.559 0.537 . . . . 74.5 109.715 176.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -66.79 -32.99 74.63 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.034 0.934 . . . . 74.14 111.68 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.401 ' HG3' ' O ' ' C' ' 116' ' ' SER . 80.6 mtt-85 -72.12 -31.68 66.25 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.781 0.832 . . . . 73.41 110.76 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.03 8.48 70.12 Favored Glycine 0 C--N 1.353 1.497 0 CA-C-O 119.521 -0.599 . . . . 71.23 112.715 174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 43.7 p 62.02 34.05 16.84 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 125.772 1.629 . . . . 65.2 112.408 175.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.438 ' HB3' ' HD2' ' C' ' 124' ' ' PRO . 29.1 m-85 -104.84 163.05 17.98 Favored Pre-proline 0 CA--C 1.562 1.416 0 C-N-CA 124.803 1.241 . . . . 64.2 109.486 178.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' C' ' 123' ' ' PHE . 63.1 Cg_endo -68.51 162.57 40.24 Favored 'Trans proline' 0 C--N 1.394 2.958 0 C-N-CA 123.015 2.477 . . . . 64.14 113.502 -173.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.513 HE21 ' HB3' ' B' ' 125' ' ' GLN . 64.9 mm-40 -60.85 128.05 34.59 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 115.116 -0.947 . . . . 75.21 112.721 -179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.68 HD11 HG21 ' C' ' 40' ' ' VAL . 6.3 tt -140.65 89.28 2.26 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 107.731 -1.211 . . . . 74.02 107.731 179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -97.47 131.31 44.23 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.706 0.802 . . . . 74.25 109.128 175.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.534 HD23 ' HA ' ' C' ' 111' ' ' ARG . 3.5 mm? -70.88 135.59 48.11 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.743 0.817 . . . . 73.14 111.123 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.447 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -85.97 160.29 52.7 Favored Pre-proline 0 CA--C 1.562 1.425 0 C-N-CA 124.925 1.29 . . . . 73.32 112.156 -173.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -67.88 102.57 0.77 Allowed 'Trans proline' 0 C--N 1.391 2.806 0 C-N-CA 123.304 2.669 . . . . 63.32 112.343 -175.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 60.2 t -99.4 110.24 26.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.303 -0.999 . . . . 74.24 108.303 171.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -81.39 88.34 6.12 Favored 'General case' 0 C--O 1.241 0.623 0 C-N-CA 123.422 0.689 . . . . 75.33 110.613 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -65.26 -34.86 79.34 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.007 -0.997 . . . . 65.44 109.344 169.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.577 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.7 p-10 -65.38 -46.78 78.77 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.417 -1.265 . . . . 62.21 111.701 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.82 -31.21 71.68 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 123.567 0.747 . . . . 72.54 111.623 179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 6.4 tt -54.34 -52.02 62.89 Favored 'General case' 0 N--CA 1.478 0.931 0 O-C-N 124.322 1.014 . . . . 71.32 109.288 173.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 m-85 -73.07 -16.44 61.48 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.795 0.838 . . . . 74.23 112.365 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 32.2 mmt -75.48 -27.37 58.8 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 122.987 0.515 . . . . 72.42 111.704 176.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -54.15 -34.16 59.7 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 123.525 0.73 . . . . 73.44 111.71 172.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -57.84 -85.47 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 124.309 1.044 . . . . 75.34 111.323 171.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.539 HD13 HE22 ' C' ' 143' ' ' GLN . 1.3 pp -76.28 159.3 30.72 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 112.684 0.624 . . . . 74.51 112.684 -168.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -148.37 108.21 4.02 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.287 1.035 . . . . 63.42 109.188 -179.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.539 HE22 HD13 ' C' ' 141' ' ' LEU . 1.7 mp0 -94.62 83.47 4.1 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 109.686 -0.487 . . . . 74.32 109.686 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -85.84 86.09 7.37 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 109.14 -0.689 . . . . 74.24 109.14 174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -165.46 -174.77 3.29 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.006 0.922 . . . . 75.14 109.731 -176.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.03 -126.19 22.99 Favored Glycine 0 C--N 1.347 1.19 0 CA-C-O 118.952 -0.915 . . . . 53.32 112.45 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 62.84 102.38 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 124.972 1.309 . . . . 75.55 111.726 178.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 173.97 120.91 0.6 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-O 119.816 -0.435 . . . . 71.24 112.698 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 15.7 p -137.46 164.46 28.62 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 124.056 0.942 . . . . 70.12 110.444 175.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 69.72 117.14 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 125.544 1.538 . . . . 74.43 110.681 170.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -98.62 9.31 43.55 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.155 0.982 . . . . 72.11 111.65 -170.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 59.47 67.2 0.92 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.969 1.308 . . . . 71.2 109.155 -168.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -72.08 108.72 5.43 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.311 -0.859 . . . . 62.53 110.653 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -159.93 150.01 18.47 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 123.727 0.811 . . . . 75.34 109.453 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.132 0 N-CA-C 108.549 -0.908 . . . . 55.45 108.549 176.056 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.226 -0.657 . . . . 74.11 109.226 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 13.4 m -134.59 -165.01 1.59 Allowed 'General case' 0 C--O 1.241 0.649 0 N-CA-C 108.568 -0.901 . . . . 54.53 108.568 177.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -150.43 159.81 44.21 Favored 'General case' 0 C--O 1.241 0.63 0 C-N-CA 123.897 0.879 . . . . 74.35 109.027 169.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . 0.402 ' NE2' HD21 ' D' ' 6' ' ' ASN . 55.4 tt0 -170.73 129.44 0.8 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.276 -0.638 . . . . 74.33 109.276 179.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -127.5 78.63 1.83 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 108.984 -0.747 . . . . 62.32 108.984 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.402 HD21 ' NE2' ' D' ' 4' ' ' GLN . 82.5 m-20 -93.5 134.01 36.21 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 109.788 -0.449 . . . . 73.13 109.788 -179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 27.0 m -63.18 -35.5 80.5 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 109.025 -0.731 . . . . 72.34 109.025 164.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -66.07 175.5 2.05 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 114.896 -1.047 . . . . 63.45 111.133 171.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.0 ttp -33.3 124.6 0.4 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.902 1.281 . . . . 62.22 113.403 178.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 96.0 m -132.18 141.91 49.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 107.612 -1.255 . . . . 72.23 107.612 175.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -152.37 91.35 1.58 Allowed 'General case' 0 C--O 1.237 0.396 0 N-CA-C 107.646 -1.242 . . . . 71.31 107.646 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.441 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 77.0 mt-30 -114.44 115.77 27.8 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.48 -0.933 . . . . 74.3 108.48 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 36.9 mt -72.69 115.86 13.96 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.298 -1.001 . . . . 63.45 108.298 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 64.1 mt-30 -83.14 -50.06 8.85 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 110.062 -0.347 . . . . 64.22 110.062 -178.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -172.83 151.28 2.22 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 120.792 0.33 . . . . 73.45 111.879 -171.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.407 HD12 ' N ' ' D' ' 16' ' ' ILE . 3.3 mp -128.85 126.89 65.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 106.896 -1.52 . . . . 62.5 106.896 178.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -144.6 150.28 37.17 Favored 'General case' 0 C--O 1.242 0.677 0 C-N-CA 124.246 1.019 . . . . 73.24 109.645 -175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 45.5 p -83.97 109.03 17.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.839 -1.073 . . . . 74.22 108.909 175.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.3 mtpt -76.28 -23.52 54.41 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 115.727 -0.67 . . . . 60.55 110.48 179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -163.33 140.18 7.27 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-N 114.968 -1.014 . . . . 70.31 108.823 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.564 HD13 ' HE3' ' C' ' 117' ' ' MET . 85.2 mt -135.11 148.02 29.05 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 108.127 -1.064 . . . . 73.14 108.127 174.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.0 t -147.47 143.22 27.72 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.893 0.877 . . . . 44.35 109.769 175.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.463 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 81.8 t80 -153.56 126.77 8.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 105.969 -1.863 . . . . 71.24 105.969 169.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -126.65 153.66 45.06 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.326 0.651 . . . . 75.02 109.361 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.623 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -145.95 77.02 12.33 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.506 -0.924 . . . . 74.14 108.506 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -69.28 -31.18 23.19 Favored 'Trans proline' 0 C--N 1.379 2.181 0 C-N-CA 122.922 2.415 . . . . 73.11 113.322 -172.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -116.06 36.32 4.11 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.473 0.709 . . . . 51.05 109.621 176.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.623 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.84 -64.12 1.4 Allowed Pre-proline 0 CA--C 1.568 1.646 0 N-CA-C 113.418 0.896 . . . . 72.21 113.418 -172.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.416 ' HB3' HD11 ' C' ' 83' ' ' ILE . 55.1 Cg_endo -78.39 -9.96 16.17 Favored 'Trans proline' 0 C--N 1.385 2.48 0 CA-C-N 121.73 1.654 . . . . 75.53 112.618 -175.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -82.9 -38.69 22.54 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.896 1.679 . . . . 73.35 109.615 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.515 HG22 ' CZ2' ' D' ' 36' ' ' TRP . 2.0 p -85.56 -19.61 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.061 0 C-N-CA 123.791 0.836 . . . . 74.51 110.886 -174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.421 ' HA ' HD12 ' G' ' 301' ' ' ILE . 20.1 m-85 -68.85 -10.57 57.64 Favored 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 123.5 0.72 . . . . 64.42 112.33 176.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -83.62 3.07 34.4 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.065 0.946 . . . . 63.25 111.505 178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -126.23 112.7 16.06 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.012 0.925 . . . . 71.05 109.347 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -90.51 97.6 11.28 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.666 0.786 . . . . 62.14 111.72 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.515 ' CZ2' HG22 ' D' ' 31' ' ' VAL . 0.0 OUTLIER -150.62 -173.93 4.61 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.805 0.842 . . . . 75.42 112.222 -177.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.1 115.93 65.68 Favored Pre-proline 0 CA--C 1.561 1.366 0 CA-C-N 114.974 -1.012 . . . . 71.01 110.1 165.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.652 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.0 Cg_exo -63.3 131.04 30.56 Favored 'Trans proline' 0 C--N 1.374 1.898 0 C-N-CA 123.164 2.576 . . . . 73.2 111.746 163.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -84.6 112.28 20.29 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 106.163 -1.791 . . . . 72.25 106.163 163.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.845 HG12 ' HB2' ' D' ' 66' ' ' ALA . 26.8 m -98.29 112.29 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 107.635 -1.246 . . . . 60.13 107.635 177.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -84.2 124.33 31.07 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.45 -0.945 . . . . 50.15 108.45 -172.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 49.1 mt -97.21 112.77 24.42 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 114.284 -1.326 . . . . 73.53 109.145 -170.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.468 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 31.2 t70 -114.0 130.69 56.52 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 108.257 -1.016 . . . . 74.42 108.257 173.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -107.62 136.5 47.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.706 -0.85 . . . . 64.21 108.706 177.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.508 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.2 t70 -132.64 127.94 35.98 Favored 'General case' 0 N--CA 1.468 0.461 0 N-CA-C 107.865 -1.161 . . . . 73.52 107.865 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 39.2 p -105.54 151.96 23.66 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 123.249 0.62 . . . . 74.04 110.302 -177.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.663 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -151.03 160.53 43.86 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.29 -0.868 . . . . 75.45 109.331 174.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 66.1 p -155.33 156.79 36.1 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.649 0.78 . . . . 75.34 109.535 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 22.6 m -150.63 146.85 26.77 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.419 -1.326 . . . . 74.41 107.419 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -100.34 116.56 32.61 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 107.207 -1.405 . . . . 72.55 107.207 162.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' C' ' 29' ' ' PRO . 40.9 mt -92.23 -29.55 16.37 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 122.801 0.441 . . . . 64.54 110.263 -176.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.46 -178.73 7.49 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.647 0.779 . . . . 52.1 110.083 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -66.76 123.67 20.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.174 -0.921 . . . . 73.21 109.645 178.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 64.25 9.71 5.02 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 124.586 1.154 . . . . 54.22 112.656 -175.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 96.7 t -118.63 117.29 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 N-CA-C 109.305 -0.628 . . . . 72.12 109.305 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -128.36 128.33 44.34 Favored 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.118 0.967 . . . . 70.43 108.685 -175.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.81 132.13 35.4 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.886 0.874 . . . . 62.53 108.795 170.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.577 HG13 ' HZ ' ' G' ' 281' ' ' PHE . 97.9 t -117.03 122.26 69.65 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 N-CA-C 107.047 -1.464 . . . . 65.11 107.047 176.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.663 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 25.9 t -112.86 129.01 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 N-CA-C 109.317 -0.624 . . . . 74.34 109.317 -179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.493 HD23 HD12 ' D' ' 106' ' ' LEU . 3.8 mm? -116.76 107.52 14.75 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.772 0.829 . . . . 64.12 108.994 176.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 16.1 ttm-85 -88.29 112.35 22.72 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 115.489 -0.778 . . . . 74.13 109.071 173.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 86.6 t -99.88 120.65 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 N-CA-C 108.038 -1.097 . . . . 75.13 108.038 170.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 33.6 m -115.4 140.01 49.51 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.792 0.837 . . . . 73.23 109.595 -175.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.598 HG13 ' HB ' ' D' ' 40' ' ' VAL . 88.1 t -137.15 127.81 39.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 C-N-CA 124.754 1.222 . . . . 54.21 108.764 -172.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 91.3 m -133.91 103.8 5.99 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.178 0.591 . . . . 73.51 109.648 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.845 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -102.06 130.42 48.64 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.577 0.751 . . . . 75.23 109.976 177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 16.2 p -154.43 124.37 6.73 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 108.996 -0.742 . . . . 70.22 108.996 177.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.652 HD11 ' HA ' ' D' ' 38' ' ' PRO . 3.0 mm? -114.85 134.07 55.44 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 122.971 0.508 . . . . 70.31 110.083 177.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 73.5 -110.24 3.06 Favored Glycine 0 C--N 1.345 1.047 0 O-C-N 123.902 0.751 . . . . 73.13 112.037 178.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.4 7.68 10.15 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.231 1.012 . . . . 70.14 110.85 -175.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -137.55 154.87 49.75 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 122.874 0.47 . . . . 74.25 110.697 -173.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 99.9 m -83.26 124.94 31.07 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 115.744 -0.662 . . . . 64.33 110.309 177.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.446 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -71.03 -65.73 0.7 Allowed 'General case' 0 C--O 1.24 0.561 0 O-C-N 123.897 0.748 . . . . 64.1 109.555 176.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 47.2 p90 -156.34 158.49 37.51 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 114.962 -1.017 . . . . 72.14 110.765 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 82.5 mt -120.69 151.94 38.87 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 107.502 -1.295 . . . . 62.23 107.502 174.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.651 ' SG ' HG23 ' D' ' 114' ' ' ILE . 33.7 t -159.52 136.12 9.21 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 109.978 -0.379 . . . . 72.04 109.978 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -156.66 139.86 15.55 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 122.746 0.418 . . . . 73.44 110.046 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.8 120.45 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 123.177 0.591 . . . . 74.33 110.087 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -89.03 88.27 7.52 Favored 'General case' 0 C--O 1.239 0.504 0 N-CA-C 108.658 -0.868 . . . . 72.41 108.658 168.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -84.36 92.21 7.97 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 115.019 -0.991 . . . . 64.51 108.738 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.24 143.93 18.97 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 110.946 -0.861 . . . . 62.22 110.946 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -147.86 129.59 3.23 Favored Glycine 0 CA--C 1.508 -0.367 0 N-CA-C 110.808 -0.917 . . . . 54.34 110.808 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 65.7 mt -89.56 134.1 29.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 123.22 0.608 . . . . 72.44 109.505 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -132.0 129.59 40.31 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.177 0.991 . . . . 74.22 109.291 176.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 50.0 m -75.77 94.35 3.28 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.896 -0.779 . . . . 63.31 108.896 166.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 19.5 mt -107.05 123.32 62.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 N-CA-C 107.824 -1.176 . . . . 64.04 107.824 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -148.22 161.98 40.4 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.759 0.824 . . . . 71.0 110.297 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 70.02 19.68 75.66 Favored Glycine 0 C--N 1.35 1.343 0 O-C-N 123.761 0.663 . . . . 43.21 113.875 166.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.516 HD11 ' HG3' ' D' ' 93' ' ' GLN . 16.2 tt -135.45 149.91 28.79 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.844 0 N-CA-C 108.817 -0.808 . . . . 73.43 108.817 -169.489 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.03 156.96 44.27 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 123.068 0.547 . . . . 72.22 111.689 -170.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 33.87 -96.17 0.01 OUTLIER Glycine 0 C--N 1.357 1.73 0 N-CA-C 117.094 1.598 . . . . 61.52 117.094 153.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 44.0 p -64.89 -50.63 65.77 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.98 0.912 . . . . 74.3 112.529 -173.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.516 ' HG3' HD11 ' D' ' 89' ' ' ILE . 52.9 tp60 -79.78 -28.91 40.29 Favored 'General case' 0 C--O 1.245 0.841 0 N-CA-C 111.803 0.298 . . . . 73.5 111.803 -172.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.487 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -70.65 -34.02 71.59 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.746 -0.465 . . . . 74.31 109.746 176.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.47 ' HB1' HD22 ' G' ' 280' ' ' LEU . . . -59.92 -35.99 76.06 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.634 0.774 . . . . 55.34 110.727 176.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -71.14 -36.57 72.13 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 114.873 -1.058 . . . . 75.02 110.712 173.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -73.02 -52.22 15.22 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.006 0.522 . . . . 52.21 112.366 -173.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' D' ' 94' ' ' MET . 4.0 pp -94.84 -20.47 19.43 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 123.04 0.536 . . . . 74.42 111.912 -173.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.45 -6.84 60.91 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-O 119.72 -0.489 . . . . 62.33 113.721 -178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -141.85 -58.66 0.47 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.161 0.48 . . . . 41.15 111.402 -176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 66.2 t80 -69.5 -45.47 68.84 Favored 'General case' 0 CA--C 1.556 1.191 0 C-N-CA 123.221 0.608 . . . . 75.15 112.547 -171.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.2 m -65.87 -43.06 57.26 Favored Pre-proline 0 N--CA 1.487 1.419 0 C-N-CA 123.56 0.744 . . . . 64.33 111.426 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -48.88 -43.47 35.1 Favored 'Trans proline' 0 C--N 1.395 3.022 0 C-N-CA 122.831 2.354 . . . . 71.31 113.906 163.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -67.28 -21.19 65.71 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 123.402 0.681 . . . . 70.34 112.285 178.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 47.4 mm -81.78 -42.2 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.157 0 C-N-CA 122.948 0.499 . . . . 72.22 110.532 176.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.493 HD12 HD23 ' D' ' 60' ' ' LEU . 74.3 mt -91.13 -20.92 21.49 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 112.888 0.699 . . . . 70.05 112.888 -170.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -65.85 -41.67 48.12 Favored Pre-proline 0 CA--C 1.56 1.337 0 CA-C-O 118.152 -0.927 . . . . 65.11 112.715 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -52.19 -40.35 69.41 Favored 'Trans proline' 0 C--N 1.387 2.572 0 C-N-CA 122.383 2.055 . . . . 50.14 113.399 170.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -73.97 -36.39 64.56 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.748 0.819 . . . . 74.42 111.586 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.95 -45.09 83.05 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 123.003 0.521 . . . . 61.55 110.219 176.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 40.6 ttp180 -60.75 -46.05 91.94 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.575 -1.193 . . . . 72.32 110.46 178.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -60.92 -47.23 87.37 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.238 0.961 . . . . 74.14 110.779 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.9 t -58.99 -41.06 86.69 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 123.682 0.614 . . . . 65.32 110.945 -178.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.651 HG23 ' SG ' ' D' ' 76' ' ' CYS . 64.8 mt -66.3 -47.95 82.62 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.496 0.718 . . . . 63.44 110.243 175.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.47 HG23 ' HB3' ' D' ' 125' ' ' GLN . 99.4 m -53.17 -46.82 69.08 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.489 1.116 . . . . 74.35 111.229 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.5 t -66.84 -41.7 86.99 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 115.071 -0.968 . . . . 63.04 110.731 -176.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.479 ' HE3' ' HA ' ' D' ' 114' ' ' ILE . 77.2 mtm -67.8 -45.26 75.28 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 122.86 0.464 . . . . 65.53 112.185 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.87 -32.03 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 115.313 -0.858 . . . . 52.31 110.082 -175.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 99.9 p -72.22 -33.67 67.76 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 122.917 0.487 . . . . 64.33 110.819 174.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 69.5 mtt-85 -68.26 -26.68 65.79 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.744 0.817 . . . . 72.02 110.917 174.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.0 10.46 65.63 Favored Glycine 0 C--N 1.354 1.538 0 O-C-N 123.615 0.572 . . . . 63.41 112.889 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.401 HG23 ' HB3' ' C' ' 17' ' ' TYR . 58.1 p 57.57 19.85 5.71 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 126.524 1.929 . . . . 75.2 113.248 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.603 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 63.7 m-85 -91.4 178.06 1.95 Allowed Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 125.487 1.515 . . . . 73.44 107.688 168.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.603 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 83.1 Cg_endo -74.82 160.79 40.22 Favored 'Trans proline' 0 C--N 1.39 2.75 0 CA-C-N 121.843 1.694 . . . . 74.33 112.434 -174.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.47 ' HB3' HG23 ' D' ' 115' ' ' THR . 15.9 mt-30 -66.34 128.12 34.91 Favored 'General case' 0 C--O 1.243 0.754 0 N-CA-C 108.287 -1.005 . . . . 65.41 108.287 166.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -102.99 91.55 4.17 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 107.433 -1.321 . . . . 74.05 107.433 -171.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -103.88 93.31 4.82 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.089 -1.414 . . . . 65.12 108.323 -176.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -66.87 127.89 34.22 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 109.196 -0.668 . . . . 73.31 109.196 174.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -56.24 134.32 75.42 Favored Pre-proline 0 CA--C 1.548 0.872 0 O-C-N 124.269 0.981 . . . . 73.13 110.554 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' D' ' 129' ' ' ALA . 5.8 Cg_exo -73.63 96.67 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.751 0 C-N-CA 122.702 2.268 . . . . 61.55 109.876 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 47.6 t -107.69 110.06 30.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 107.712 -1.218 . . . . 60.24 107.712 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -68.99 114.76 7.58 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.048 -0.978 . . . . 34.23 109.94 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -63.2 -36.63 84.26 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.039 0.936 . . . . 74.01 111.356 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.14 -44.02 92.04 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.121 0.968 . . . . 70.25 110.217 175.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.98 -51.88 67.36 Favored 'General case' 0 C--O 1.214 -0.765 0 CA-C-N 114.961 -1.018 . . . . 74.45 110.313 -178.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 79.8 mt -57.66 -40.23 78.85 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 122.758 0.423 . . . . 73.02 111.929 -178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -63.29 -52.6 61.32 Favored 'General case' 0 CA--C 1.546 0.798 0 CA-C-N 114.895 -1.048 . . . . 70.2 110.728 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 22.6 ptp -73.64 -32.85 64.24 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.022 0.529 . . . . 70.43 111.007 -178.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.664 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 4.7 m-80 -66.44 -32.5 73.91 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.776 0.83 . . . . 75.34 111.043 -178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -61.07 -39.24 89.13 Favored 'General case' 0 CA--C 1.546 0.793 0 O-C-N 123.452 0.47 . . . . 63.41 110.964 178.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -80.45 -37.64 31.56 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.173 0.589 . . . . 51.44 111.104 -177.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.664 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 12.0 pt20 -89.6 0.58 56.83 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 112.758 0.651 . . . . 64.42 112.758 -171.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -119.29 87.56 2.76 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.426 -0.953 . . . . 72.44 108.426 179.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -145.48 103.27 3.8 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 114.439 -1.255 . . . . 72.31 107.99 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -154.37 141.68 19.58 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.012 0.925 . . . . 74.14 110.252 -174.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -90.61 -157.7 33.85 Favored Glycine 0 C--N 1.343 0.968 0 O-C-N 123.376 0.423 . . . . 61.13 112.31 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -163.24 122.78 2.15 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.954 -1.128 . . . . 64.43 107.954 176.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -92.69 82.0 1.12 Allowed Glycine 0 C--N 1.345 1.072 0 N-CA-C 111.691 -0.564 . . . . 54.03 111.691 -178.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 49.4 m -58.75 129.38 41.84 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.623 0.769 . . . . 74.31 110.573 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -127.5 147.15 50.31 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 123.962 0.905 . . . . 74.43 108.568 178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -137.67 -172.4 3.23 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 124.057 0.943 . . . . 75.31 110.255 -175.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -134.76 105.28 6.37 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.735 -0.839 . . . . 74.54 108.735 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -62.51 111.65 2.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.302 0.641 . . . . 74.3 110.125 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -97.19 123.35 40.94 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.42 -0.956 . . . . 74.11 108.42 174.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.946 0 CA-C-O 118.484 -0.769 . . . . 44.04 109.632 -178.757 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.127 0 N-CA-C 109.888 -0.412 . . . . 64.25 109.888 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -68.76 137.27 53.9 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.58 0.752 . . . . 74.23 109.758 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 -77.59 74.63 4.15 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-O 121.632 0.73 . . . . 74.13 110.073 -176.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -151.32 -0.38 0.36 Allowed 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.778 -1.101 . . . . 55.14 109.472 -175.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 56.6 84.03 0.21 Allowed Pre-proline 0 C--N 1.361 1.069 0 C-N-CA 124.7 1.2 . . . . 72.23 109.744 -170.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . 0.567 ' HG2' ' HB3' ' A' ' 90' ' ' GLU . 38.9 Cg_endo -66.6 77.91 0.36 Allowed 'Trans proline' 0 C--N 1.377 2.067 0 C-N-CA 123.003 2.469 . . . . 63.12 112.334 -178.137 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . 0.42 ' HB2' HD22 ' E' ' 278' ' ' LEU . 62.2 mt -103.16 -63.46 1.17 Allowed 'General case' 0 C--O 1.225 -0.204 0 N-CA-C 108.022 -1.103 . . . . 73.02 108.022 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . 0.42 HD22 ' HB2' ' E' ' 277' ' ' LEU . 0.8 OUTLIER -96.5 87.2 4.34 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 108.316 -0.994 . . . . 53.42 108.316 176.482 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.98 -60.5 0.02 OUTLIER Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.309 -0.717 . . . . 72.32 111.309 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 56.0 tp -88.29 61.66 6.31 Favored 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 123.838 0.855 . . . . 73.44 109.901 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -176.58 91.5 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 115.241 -0.89 . . . . 71.24 109.89 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -160.55 -55.64 0.05 Allowed 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.261 -1.014 . . . . 64.12 108.261 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -102.4 125.45 49.12 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 115.26 -0.882 . . . . 71.31 109.511 175.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -120.1 81.81 0.34 Allowed Glycine 0 C--N 1.334 0.472 0 N-CA-C 110.413 -1.075 . . . . 51.14 110.413 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -77.87 71.55 4.35 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 121.592 0.711 . . . . 71.11 109.227 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 90.6 mtp -131.14 84.57 56.97 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 124.56 1.144 . . . . 70.31 108.757 -175.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -74.36 90.83 0.99 Allowed 'Trans proline' 0 C--N 1.378 2.083 0 C-N-CA 122.801 2.334 . . . . 64.13 111.003 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 48.9 t -71.4 -46.82 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 123.69 0.796 . . . . 74.44 110.175 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 10.0 ttp180 61.07 31.75 19.78 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.1 0.96 . . . . 74.44 111.075 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 69.4 m95 67.02 170.87 0.25 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.371 1.081 . . . . 74.41 112.618 -174.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 3.1 mp -117.35 1.58 12.41 Favored 'General case' 0 CA--C 1.543 0.711 0 CA-C-N 114.061 -1.427 . . . . 74.44 109.959 -178.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -147.47 167.6 28.57 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 118.972 -0.904 . . . . 70.25 112.06 -178.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -59.58 -75.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.385 2.464 0 C-N-CA 123.371 2.714 . . . . 64.1 113.237 -175.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -123.77 -63.2 1.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 108.883 -0.784 . . . . 63.45 108.883 178.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 73.73 -55.5 0.67 Allowed 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.373 1.469 . . . . 70.32 111.108 -175.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 23.7 m -65.12 143.09 58.11 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.758 0.823 . . . . 53.34 110.18 171.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.764 ' HB3' ' HB3' ' A' ' 36' ' ' TRP . 16.7 m-30 68.97 26.4 5.72 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.097 1.359 . . . . 72.11 111.964 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -91.07 63.12 5.02 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 108.277 -1.008 . . . . 64.23 108.277 171.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 86.4 -151.59 24.56 Favored Glycine 0 C--N 1.338 0.654 0 CA-C-N 114.454 -1.248 . . . . 72.33 113.372 -176.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . 0.567 ' HB2' ' HB3' ' A' ' 124' ' ' PRO . 3.3 m-20 73.14 -63.52 0.43 Allowed 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 126.213 1.805 . . . . 74.23 111.742 -177.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 123' ' ' PHE . 20.0 pt -105.42 154.49 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 CA-C-O 121.375 0.607 . . . . 63.13 111.608 -177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . 0.529 ' HA ' ' HZ2' ' A' ' 36' ' ' TRP . 21.7 t70 -157.54 -176.87 6.19 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 114.527 -1.215 . . . . 71.44 107.867 167.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 54.1 mtpt -48.52 150.49 2.38 Favored Pre-proline 0 N--CA 1.487 1.4 0 C-N-CA 125.228 1.411 . . . . 72.33 113.023 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -53.18 124.08 14.76 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.403 2.735 . . . . 65.12 113.423 -178.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . 0.537 ' HB1' ' HB3' ' G' ' 295' ' ' ALA . . . -80.28 -64.53 1.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.034 0.934 . . . . 74.42 110.97 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' B' ' 14' ' ' GLN . 16.7 m -66.86 133.58 31.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.763 0 CA-C-N 115.709 -0.678 . . . . 62.34 109.735 174.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 13.6 t -166.03 7.0 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.219 0.607 . . . . 63.51 110.95 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . 0.479 ' HB2' ' HG3' ' G' ' 293' ' ' PRO . 66.7 m -144.41 152.42 40.64 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 122.989 0.515 . . . . 71.43 111.074 -173.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . 0.635 HG23 ' HB3' ' B' ' 12' ' ' GLN . 16.2 p -126.69 130.59 23.81 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.407 1.083 . . . . 54.25 109.614 176.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--N 1.376 1.983 0 C-N-CA 122.784 2.323 . . . . 72.24 111.451 177.031 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.924 0.392 . . . . 72.12 110.219 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -86.06 149.82 24.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.344 0.658 . . . . 74.13 109.289 175.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -88.8 -29.91 19.38 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.682 0.793 . . . . 71.53 111.887 -171.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 66.55 -74.18 0.07 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.432 1.493 . . . . 63.24 111.044 -171.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 86.2 mttt 63.32 73.76 0.48 Allowed Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.191 1.396 . . . . 70.32 110.267 -170.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -66.72 -38.47 17.98 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.819 2.346 . . . . 73.03 112.111 175.589 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 2.5 tt -149.36 69.43 1.05 Allowed 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 107.468 -1.308 . . . . 74.44 107.468 176.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.503 HD22 HD11 ' C' ' 98' ' ' LEU . 96.4 mt -140.54 122.95 16.0 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.22 1.008 . . . . 61.43 109.249 178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . 0.45 ' N ' ' SD ' ' C' ' 94' ' ' MET . . . -112.0 132.89 11.08 Favored Glycine 0 C--N 1.343 0.968 0 CA-C-O 119.148 -0.807 . . . . 61.34 111.219 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . 0.28 2.3 pp 40.07 -127.32 0.4 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 126.229 1.812 . . . . 73.42 113.388 -175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 34.0 t80 72.41 31.81 1.73 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.917 1.287 . . . . 75.51 109.84 174.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -139.68 -86.22 0.22 Allowed 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.799 -1.091 . . . . 41.42 108.237 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 54.91 26.88 8.35 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 124.524 1.129 . . . . 53.35 111.591 177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 85.21 -73.27 2.64 Favored Glycine 0 C--N 1.346 1.09 0 N-CA-C 109.824 -1.31 . . . . 62.51 109.824 -167.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -176.29 147.91 0.73 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.863 1.265 . . . . 73.52 108.512 177.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 53.7 ttm -93.91 100.91 5.29 Favored Pre-proline 0 CA--C 1.553 1.074 0 N-CA-C 108.65 -0.87 . . . . 72.51 108.65 171.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.66 91.15 1.21 Allowed 'Trans proline' 0 C--N 1.381 2.273 0 C-N-CA 122.525 2.15 . . . . 54.01 111.995 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 68.5 t -97.95 104.05 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 108.491 -0.929 . . . . 65.23 108.491 173.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 31.1 ttt180 -92.15 -90.44 0.17 Allowed 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 108.984 -0.747 . . . . 74.13 108.984 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -140.18 155.91 46.74 Favored 'General case' 0 N--CA 1.486 1.338 0 CA-C-O 121.401 0.62 . . . . 73.53 111.799 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.447 HD13 ' HB3' ' C' ' 129' ' ' ALA . 3.9 mp -92.81 -43.84 8.81 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 114.193 -1.367 . . . . 65.32 110.346 -173.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -151.31 -96.17 0.14 Allowed Glycine 0 C--N 1.349 1.251 0 CA-C-O 118.871 -0.96 . . . . 70.51 111.747 -178.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -65.37 129.22 22.11 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.705 2.27 . . . . 73.21 112.46 -178.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -115.34 -150.63 0.47 Allowed 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.423 1.089 . . . . 74.15 109.12 178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . 71.08 128.28 0.03 OUTLIER 'General case' 0 C--N 1.369 1.446 0 C-N-CA 125.053 1.341 . . . . 72.01 110.766 -176.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 9.3 m -71.43 -53.32 14.41 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.332 0.587 . . . . 73.11 111.09 -178.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -91.63 52.41 2.04 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.943 0.878 . . . . 73.42 108.657 176.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -65.65 -32.27 73.74 Favored 'General case' 0 C--N 1.349 0.585 0 CA-C-N 113.295 -1.775 . . . . 60.2 109.37 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -93.24 115.32 4.88 Favored Glycine 0 C--N 1.347 1.145 0 CA-C-N 114.624 -1.171 . . . . 62.21 110.386 165.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -71.35 94.31 1.21 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.306 0.642 . . . . 43.44 110.354 -175.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.405 HD13 ' HD3' ' C' ' 124' ' ' PRO . 46.7 pt -81.14 15.65 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.15 0.58 . . . . 72.02 111.545 176.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -69.77 76.78 0.45 Allowed 'General case' 0 C--N 1.356 0.852 0 C-N-CA 124.546 1.138 . . . . 74.34 110.902 177.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -153.41 139.84 12.58 Favored Pre-proline 0 C--O 1.243 0.74 0 C-N-CA 126.065 1.746 . . . . 71.1 106.63 175.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_exo -48.39 -42.58 34.24 Favored 'Trans proline' 0 C--N 1.373 1.864 0 C-N-CA 122.914 2.409 . . . . 74.25 112.181 169.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 54.92 -91.83 0.03 OUTLIER 'General case' 0 C--N 1.361 1.099 0 C-N-CA 125.514 1.526 . . . . 64.35 112.383 171.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 15.9 m -92.37 110.35 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 N-CA-C 108.49 -0.93 . . . . 73.55 108.49 174.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 9.6 t -179.62 -35.27 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.154 1.382 . . . . 72.22 108.443 177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 71.9 m -92.51 42.07 1.09 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.332 1.053 . . . . 70.34 109.575 171.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . 0.446 HG21 ' HD2' ' B' ' 130' ' ' PRO . 92.5 m -69.48 -51.74 16.05 Favored Pre-proline 0 CA--C 1.568 1.644 0 CA-C-N 114.21 -1.359 . . . . 75.43 112.182 -177.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . 0.43 ' HD3' ' HB ' ' F' ' 309' ' ' THR . 13.2 Cg_exo . . . . . 0 C--N 1.394 2.96 0 C-N-CA 121.866 1.711 . . . . 72.31 111.284 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 109.244 -0.65 . . . . 75.51 109.244 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 -68.71 94.29 0.58 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.667 -0.864 . . . . 71.24 108.667 172.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -95.51 43.26 1.09 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-O 122.451 1.119 . . . . 62.51 109.152 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -71.18 -33.69 70.23 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.503 -1.226 . . . . 74.14 110.514 177.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -88.15 127.48 57.17 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 109.08 -0.711 . . . . 73.44 109.08 176.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.22 -176.44 0.22 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 123.335 2.69 . . . . 74.44 113.508 175.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.438 HD23 ' O ' ' G' ' 277' ' ' LEU . 6.1 tt -74.47 -32.21 62.5 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 115.606 -0.724 . . . . 64.2 110.372 -177.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 27.4 tp -112.01 111.02 21.64 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 121.693 -0.63 . . . . 73.44 109.381 179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -150.9 -96.33 0.14 Allowed Glycine 0 C--N 1.351 1.384 0 N-CA-C 111.467 -0.653 . . . . 72.23 111.467 -177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.47 HD22 ' HB1' ' D' ' 95' ' ' ALA . 7.5 tt -65.38 115.87 6.1 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.589 -0.893 . . . . 73.23 108.589 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . 0.577 ' HZ ' HG13 ' D' ' 58' ' ' VAL . 2.9 t80 -125.53 102.44 7.38 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.327 -0.99 . . . . 65.33 108.327 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . 66.04 103.43 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.61 1.164 . . . . 62.44 111.528 176.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -132.2 161.35 33.61 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.384 0.673 . . . . 71.3 109.729 -178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 108.23 -23.14 25.73 Favored Glycine 0 C--N 1.344 1.005 0 CA-C-O 119.38 -0.678 . . . . 73.23 112.18 -178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 50.37 80.61 0.07 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.92 1.288 . . . . 55.52 111.723 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 38.0 mtm -89.46 126.33 58.65 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.431 0.693 . . . . 71.43 109.527 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -66.04 -29.85 48.13 Favored 'Trans proline' 0 C--N 1.385 2.485 0 C-N-CA 123.109 2.54 . . . . 74.15 113.004 -175.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 86.6 t 70.76 -66.01 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 125.646 1.578 . . . . 60.53 110.963 -176.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 65.92 -93.59 0.03 OUTLIER 'General case' 0 C--N 1.357 0.897 0 C-N-CA 125.02 1.328 . . . . 74.01 109.15 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.464 ' HE1' HG23 ' D' ' 40' ' ' VAL . 0.0 OUTLIER 178.4 28.65 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.629 1.171 . . . . 74.41 108.86 179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.411 HD23 HG22 ' E' ' 309' ' ' THR . 6.3 mp 63.03 -83.75 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 124.375 1.07 . . . . 63.34 109.706 -171.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -170.75 -77.37 0.04 OUTLIER Glycine 0 C--N 1.348 1.243 0 N-CA-C 111.342 -0.703 . . . . 44.41 111.342 -178.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . 0.479 ' HG3' ' HB2' ' E' ' 308' ' ' CYS . 91.0 Cg_endo -78.43 71.19 6.92 Favored 'Trans proline' 0 C--N 1.381 2.286 0 C-N-CA 123.267 2.644 . . . . 74.42 111.791 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . 0.496 ' HG3' ' H ' ' G' ' 295' ' ' ALA . 35.0 pttt -67.52 -82.07 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.13 0 C-N-CA 124.239 1.016 . . . . 74.45 110.998 -178.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . 0.537 ' HB3' ' HB1' ' E' ' 305' ' ' ALA . . . 52.58 39.63 28.48 Favored 'General case' 0 C--N 1.365 1.271 0 C-N-CA 124.474 1.11 . . . . 65.21 112.887 173.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 18.4 m -47.37 -42.9 22.69 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 125.429 1.492 . . . . 65.21 114.012 -167.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.648 ' HB2' ' HD2' ' D' ' 38' ' ' PRO . 0.3 OUTLIER -87.29 -69.29 0.69 Allowed 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 109.069 -0.715 . . . . 74.41 109.069 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . 0.505 ' HD2' ' HB3' ' E' ' 302' ' ' ASP . 76.8 t60 55.48 24.11 6.49 Favored 'General case' 0 CA--C 1.569 1.674 0 O-C-N 124.74 1.275 . . . . 71.44 110.143 -168.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -81.57 119.07 4.76 Favored Glycine 0 C--N 1.35 1.328 0 CA-C-N 114.917 -1.038 . . . . 74.52 111.836 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -81.15 52.44 1.8 Allowed 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 124.092 0.957 . . . . 74.13 110.454 176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' D' ' 32' ' ' PHE . 22.2 pt -72.45 152.42 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 124.194 0.998 . . . . 70.32 111.478 -174.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -154.28 169.09 24.48 Favored 'General case' 0 C--O 1.244 0.8 0 C-N-CA 123.689 0.795 . . . . 74.11 109.042 -174.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 66.1 pttt -57.86 144.36 74.68 Favored Pre-proline 0 CA--C 1.553 1.081 0 C-N-CA 123.437 0.695 . . . . 53.35 110.444 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . 0.468 ' HG2' ' HB3' ' C' ' 14' ' ' GLN . 24.1 Cg_exo -65.41 122.46 10.16 Favored 'Trans proline' 0 C--N 1.365 1.406 0 C-N-CA 122.427 2.084 . . . . 73.12 111.311 177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -87.29 9.31 20.77 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.604 0.761 . . . . 71.25 111.438 -179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 20.1 t -77.19 95.02 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 108.073 -1.084 . . . . 72.15 108.073 177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 10.4 t -124.64 0.43 8.15 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.471 0.708 . . . . 72.5 110.5 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 19.2 p -124.95 99.65 6.23 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.557 0.743 . . . . 71.12 110.388 -173.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . 0.435 ' N ' ' HD3' ' G' ' 310' ' ' PRO . 21.7 m -150.59 62.97 5.66 Favored Pre-proline 0 CA--C 1.564 1.51 0 N-CA-C 108.7 -0.852 . . . . 62.13 108.7 165.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . 0.435 ' HD3' ' N ' ' G' ' 309' ' ' THR . 58.9 Cg_endo . . . . . 0 C--N 1.385 2.473 0 C-N-CA 123.472 2.781 . . . . 72.34 111.981 172.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.067 0 N-CA-C 109.796 -0.446 . . . . 64.2 109.796 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -75.28 144.56 42.42 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.591 0.756 . . . . 73.53 109.919 178.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 25.2 mp0 -81.57 146.8 29.95 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.595 0.758 . . . . 62.5 110.805 -178.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -74.44 133.98 42.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.558 0.743 . . . . 74.34 110.055 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 56.2 tptt -151.1 110.88 3.06 Favored Pre-proline 0 CA--C 1.548 0.876 0 O-C-N 123.482 0.489 . . . . 52.41 109.97 179.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.72 -164.79 0.2 Allowed 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.555 2.17 . . . . 63.32 110.168 162.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . 0.407 ' HG ' ' HB3' ' B' ' 90' ' ' GLU . 6.5 tt 78.34 -47.97 0.45 Allowed 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 124.409 1.084 . . . . 73.2 110.067 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . 0.482 ' HA ' ' SD ' ' B' ' 94' ' ' MET . 1.6 tm? -50.04 -59.39 3.94 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 125.156 1.382 . . . . 71.34 109.748 172.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . 75.43 -79.1 1.09 Allowed Glycine 0 C--N 1.352 1.417 0 CA-C-N 115.267 -0.879 . . . . 71.43 112.27 179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' B' ' 92' ' ' THR . 2.3 pt? -143.83 146.55 33.15 Favored 'General case' 0 C--O 1.244 0.776 0 C-N-CA 124.291 1.036 . . . . 71.34 109.193 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -96.58 -178.11 4.15 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-N 115.478 -0.783 . . . . 71.21 109.229 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.9 81.99 0.2 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.881 0.872 . . . . 75.33 110.906 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -123.33 154.21 39.23 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 124.021 0.928 . . . . 71.54 108.59 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 133.61 -22.92 3.84 Favored Glycine 0 N--CA 1.466 0.661 0 N-CA-C 111.299 -0.72 . . . . 35.1 111.299 -173.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 53.6 m-20 60.57 88.7 0.08 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.749 1.22 . . . . 53.33 111.012 177.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . 0.528 ' SD ' HD12 ' B' ' 136' ' ' LEU . 62.6 mtm -81.1 109.76 15.08 Favored Pre-proline 0 N--CA 1.477 0.919 0 N-CA-C 109.284 -0.635 . . . . 71.45 109.284 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.41 87.57 1.07 Allowed 'Trans proline' 0 C--N 1.379 2.164 0 C-N-CA 122.905 2.404 . . . . 74.43 111.241 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 47.7 t -72.21 -38.44 62.29 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.892 0 CA-C-N 115.716 -0.674 . . . . 72.25 109.641 178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 59.08 33.14 22.74 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 125.172 1.389 . . . . 75.03 111.207 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 43.0 m95 65.53 162.45 0.14 Allowed 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.075 1.35 . . . . 75.14 112.163 -170.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' B' ' 129' ' ' ALA . 0.5 OUTLIER -117.88 11.81 13.61 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 114.969 -1.014 . . . . 74.22 109.091 -179.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 169.75 70.65 0.04 OUTLIER Glycine 0 C--N 1.342 0.893 0 N-CA-C 109.74 -1.344 . . . . 73.42 109.74 -175.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -65.58 -21.77 59.14 Favored 'Trans proline' 0 C--N 1.384 2.403 0 C-N-CA 123.185 2.59 . . . . 73.11 113.092 -174.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -95.23 0.8 54.31 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.89 1.276 . . . . 73.45 112.299 -176.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -90.48 12.51 18.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.72 0.808 . . . . 74.22 111.567 -179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . 0.526 HG23 ' HB3' ' B' ' 126' ' ' LEU . 20.6 m -78.1 -82.44 0.09 Allowed 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 123.557 0.743 . . . . 64.41 110.65 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.641 ' HA ' ' HB2' ' B' ' 124' ' ' PRO . 3.3 m-30 -84.09 102.0 12.21 Favored 'General case' 0 C--N 1.349 0.565 0 O-C-N 121.758 -0.589 . . . . 74.35 109.547 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 69.5 m-70 -77.88 -11.31 59.88 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.527 -1.215 . . . . 72.23 109.904 170.315 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 91.94 169.77 41.26 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.673 -0.694 . . . . 24.31 111.559 -175.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 66.0 t30 173.81 -27.11 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 125.275 1.43 . . . . 75.53 108.844 177.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 64.7 mt -65.9 104.99 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 C-N-CA 124.113 0.965 . . . . 64.22 110.444 -179.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -168.39 98.21 0.42 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 106.102 -1.814 . . . . 73.15 106.102 -177.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt 61.52 74.17 0.52 Allowed Pre-proline 0 CA--C 1.558 1.275 0 N-CA-C 107.677 -1.231 . . . . 72.13 107.677 -162.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -79.78 4.46 6.69 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.634 2.89 . . . . 72.05 113.624 -168.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -127.09 138.39 53.19 Favored 'General case' 0 C--O 1.244 0.78 0 C-N-CA 123.797 0.839 . . . . 74.44 109.234 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 15.5 m -71.27 119.92 18.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.622 0 N-CA-C 108.811 -0.811 . . . . 73.44 108.811 171.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 40.5 p -74.23 89.84 2.05 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.342 -0.845 . . . . 74.4 109.839 -176.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 63.4 m 71.35 108.32 0.06 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.378 1.471 . . . . 73.41 112.153 175.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 4.7 p -79.92 157.79 73.49 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 124.593 1.157 . . . . 62.14 110.073 171.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo . . . . . 0 C--N 1.387 2.595 0 C-N-CA 123.667 2.912 . . . . 71.41 114.111 179.97 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.477 0.923 0 N-CA-C 109.402 -0.592 . . . . 75.12 109.402 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.8 m -81.9 145.97 30.06 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.999 0.92 . . . . 73.34 110.302 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 76.97 -4.02 2.42 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.441 1.496 . . . . 74.41 112.647 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -86.8 68.59 10.16 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 122.944 0.498 . . . . 75.24 110.841 -179.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 34.4 p30 -103.93 177.32 4.88 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.9 0.88 . . . . 71.02 110.441 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 66.8 t30 62.27 14.86 7.1 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 124.608 1.163 . . . . 73.33 111.558 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.8 t -100.89 23.67 10.31 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 124.605 1.162 . . . . 72.55 109.038 179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.76 -160.4 0.84 Allowed 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.078 1.351 . . . . 63.43 109.637 -167.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.551 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 4.5 ppp? -71.43 158.5 36.19 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.011 0.524 . . . . 74.24 111.017 174.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.0 m -142.03 135.78 29.58 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.089 0.556 . . . . 74.31 110.163 179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.7 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 7.1 t80 -120.09 134.71 55.18 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.457 1.103 . . . . 72.45 108.488 177.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tp60 -155.28 117.17 4.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.978 -0.749 . . . . 61.42 108.978 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.57 HG21 ' HG2' ' C' ' 130' ' ' PRO . 24.4 mt -76.8 124.17 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 109.892 -0.41 . . . . 74.35 109.892 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -81.68 -43.65 18.21 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.775 0.83 . . . . 71.32 110.858 -177.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 69.7 ttt180 -173.4 131.57 0.46 Allowed 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 110.248 -0.278 . . . . 53.24 110.248 -169.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -116.75 138.31 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.716 0.806 . . . . 71.22 108.867 174.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -171.19 166.48 7.21 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.775 0.798 . . . . 73.33 111.082 -172.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.5 p -95.51 119.43 34.0 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 114.947 -1.024 . . . . 73.31 108.895 174.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.507 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 38.6 mtpt -82.71 -28.38 30.56 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 122.642 0.377 . . . . 54.51 110.125 176.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -156.21 145.95 21.05 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 115.062 -0.972 . . . . 52.54 109.631 177.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 69.9 mt -134.65 134.84 54.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 124.981 1.312 . . . . 64.22 107.652 176.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -136.18 123.84 22.38 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.49 -1.3 . . . . 71.01 107.49 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.538 ' HB3' ' HB ' ' B' ' 21' ' ' ILE . 84.5 t80 -136.85 126.5 25.39 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 106.896 -1.52 . . . . 74.04 106.896 173.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -135.4 139.12 43.93 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.824 -0.435 . . . . 74.24 109.824 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.589 ' HB1' ' HB2' ' A' ' 28' ' ' ALA . . . -149.22 70.59 9.98 Favored Pre-proline 0 C--O 1.245 0.833 0 N-CA-C 107.777 -1.194 . . . . 41.34 107.777 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.59 -21.98 38.79 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.226 1.95 . . . . 73.04 111.744 -173.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.474 ' ND2' ' HG3' ' A' ' 71' ' ' GLU . 16.5 m-20 -118.33 23.42 11.57 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.825 0.85 . . . . 63.21 109.77 -177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.589 ' HB2' ' HB1' ' A' ' 25' ' ' ALA . . . -48.22 -54.56 24.21 Favored Pre-proline 0 N--CA 1.489 1.485 0 CA-C-O 118.318 -0.849 . . . . 62.15 113.222 -175.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HG2' ' HD2' ' A' ' 30' ' ' HIS . 17.9 Cg_endo -59.28 -34.25 97.98 Favored 'Trans proline' 0 C--N 1.395 3.008 0 C-N-CA 122.536 2.157 . . . . 55.21 112.716 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.403 ' HD2' ' HG2' ' A' ' 29' ' ' PRO . 15.7 m-70 -70.8 -42.02 70.84 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.456 -0.793 . . . . 73.33 110.148 -179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.87 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.0 OUTLIER -76.78 -28.56 17.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.837 0 CA-C-N 115.364 -0.835 . . . . 72.32 111.596 -170.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -60.85 -33.31 72.86 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 123.472 0.483 . . . . 64.03 112.019 175.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -88.83 -15.89 33.42 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 122.596 0.358 . . . . 74.32 111.541 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -68.01 163.89 21.25 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.328 0.585 . . . . 75.34 111.408 178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -67.96 149.01 50.3 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.085 -0.961 . . . . 75.42 109.973 176.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 37.7 m95 -83.36 63.76 7.44 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.319 0.648 . . . . 75.04 109.955 -174.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -148.05 70.19 11.0 Favored Pre-proline 0 CA--C 1.559 1.291 0 C-N-CA 123.597 0.759 . . . . 75.0 109.986 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -92.35 166.92 2.91 Favored 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.269 1.979 . . . . 65.23 111.585 163.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.5 104.4 16.44 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 107.336 -1.357 . . . . 73.1 107.336 167.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 66' ' ' ALA . 85.1 t -85.06 95.36 4.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 108.937 -0.764 . . . . 63.45 108.937 175.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 50.3 tttm -87.8 115.24 25.12 Favored 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 108.897 -0.779 . . . . 70.42 108.897 176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.4 mp -103.09 120.72 41.2 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 109.417 -0.586 . . . . 62.13 109.417 179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.01 136.5 42.71 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.376 1.071 . . . . 73.12 108.583 179.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.448 ' HB3' ' O ' ' E' ' 286' ' ' MET . 34.0 tp -114.56 118.83 34.84 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.108 -1.071 . . . . 72.23 108.108 -179.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.441 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 29.5 t70 -128.73 147.5 50.77 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 123.979 0.912 . . . . 71.1 108.969 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.1 m -149.15 136.92 20.45 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 108.242 -1.021 . . . . 71.34 108.242 -176.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -136.25 134.5 38.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.303 1.041 . . . . 63.41 109.01 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 80.1 p -129.26 151.44 49.91 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-N 118.616 0.644 . . . . 75.21 110.874 178.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 44.2 t -164.92 133.02 3.25 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.765 0.826 . . . . 73.14 109.767 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 48.3 tt0 -79.01 119.49 22.23 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.692 0.397 . . . . 72.52 110.933 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.405 HD11 ' HB2' ' A' ' 57' ' ' GLU . 79.6 mt -84.07 -43.12 15.4 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 123.725 0.81 . . . . 60.12 111.281 -178.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.9 -179.76 7.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.609 0.764 . . . . 65.42 110.012 -177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.24 116.73 5.25 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.252 -0.647 . . . . 73.31 109.252 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 68.25 19.36 9.07 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.564 1.145 . . . . 74.31 111.991 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.6 t -129.51 120.87 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.152 0.981 . . . . 50.44 108.758 179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.526 ' HE2' HD12 ' A' ' 86' ' ' ILE . 0.8 OUTLIER -128.46 171.13 12.37 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 109.328 -0.619 . . . . 71.01 109.328 169.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.405 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.2 tt0 -127.89 133.28 49.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 124.37 1.068 . . . . 75.05 108.253 176.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.1 t -117.4 121.4 67.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.031 -1.099 . . . . 73.35 108.031 169.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.523 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 56.2 t -97.85 136.85 27.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 124.503 1.121 . . . . 71.53 108.86 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HB2' HD13 ' A' ' 106' ' ' LEU . 0.3 OUTLIER -116.03 99.71 7.45 Favored 'General case' 0 C--O 1.241 0.645 0 N-CA-C 107.327 -1.36 . . . . 72.33 107.327 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.441 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 16.3 ttp180 -89.05 101.83 14.48 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 109.106 -0.701 . . . . 72.5 109.106 174.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.48 ' HB ' HD11 ' A' ' 114' ' ' ILE . 14.2 t -93.6 127.76 45.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.54 0 N-CA-C 106.8 -1.556 . . . . 72.41 106.8 170.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.49 HG23 ' HB2' ' A' ' 77' ' ' GLU . 11.1 m -117.46 130.84 56.71 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.147 -0.686 . . . . 71.55 109.147 176.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 90.8 t -120.37 107.28 20.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.745 -1.206 . . . . 71.23 107.745 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 18.7 m -111.68 134.45 53.24 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 108.846 -0.798 . . . . 71.21 108.846 175.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.425 ' HB2' HG22 ' A' ' 40' ' ' VAL . . . -124.88 126.64 45.86 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 107.663 -1.236 . . . . 44.14 107.663 173.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 49.7 m -141.32 128.49 20.91 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 109.313 -0.625 . . . . 74.34 109.313 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -102.05 86.03 2.79 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 107.804 -1.184 . . . . 52.34 107.804 173.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.64 -126.12 7.49 Favored Glycine 0 C--N 1.343 0.939 0 CA-C-N 114.92 -1.036 . . . . 63.15 110.825 -171.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -88.36 -26.51 22.16 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.274 0.63 . . . . 71.31 110.452 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.474 ' HG3' ' ND2' ' A' ' 27' ' ' ASN . 29.9 tt0 -77.78 120.16 22.3 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 122.584 0.353 . . . . 61.33 110.303 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -79.66 130.5 35.42 Favored 'General case' 0 C--O 1.24 0.572 0 C-N-CA 123.47 0.708 . . . . 72.14 110.163 177.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.87 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -73.96 -62.14 1.6 Allowed 'General case' 0 C--O 1.24 0.556 0 C-N-CA 123.609 0.764 . . . . 62.33 110.485 173.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.479 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 39.0 p90 -160.25 171.03 19.91 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 115.127 -0.942 . . . . 63.32 111.332 178.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 57.5 tp -138.14 131.88 31.11 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 113.995 -1.457 . . . . 72.5 107.443 176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.8 m -135.51 97.95 3.81 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.748 0.819 . . . . 75.32 109.196 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.49 ' HB2' HG23 ' A' ' 63' ' ' THR . 42.0 tt0 -123.26 116.34 23.19 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.264 -1.014 . . . . 73.42 108.264 -176.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.5 t -128.21 121.68 56.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 109.195 -0.669 . . . . 52.13 109.195 -175.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.1 84.41 6.13 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 108.512 -0.922 . . . . 64.41 108.512 173.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -79.01 94.24 5.25 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-N 115.051 -0.977 . . . . 75.2 109.207 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -84.62 142.37 20.16 Favored Glycine 0 C--N 1.343 0.949 0 N-CA-C 111.465 -0.654 . . . . 73.44 111.465 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.03 120.82 1.52 Allowed Glycine 0 CA--C 1.502 -0.736 0 N-CA-C 109.929 -1.269 . . . . 74.32 109.929 179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 41.8 mt -83.14 125.35 40.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 108.671 -0.863 . . . . 65.04 108.671 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.7 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 37.8 m-85 -124.63 127.39 47.26 Favored 'General case' 0 C--O 1.241 0.61 0 N-CA-C 109.297 -0.631 . . . . 63.53 109.297 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.9 t -83.82 119.1 24.43 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.394 0.678 . . . . 73.3 109.344 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.526 HD12 ' HE2' ' A' ' 56' ' ' TYR . 12.9 tt -103.4 146.59 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 124.194 0.997 . . . . 75.4 109.486 -179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.07 157.47 18.29 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.414 0.686 . . . . 74.12 109.892 174.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.551 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 84.29 -33.25 3.2 Favored Glycine 0 C--N 1.346 1.132 0 O-C-N 123.846 0.716 . . . . 61.45 114.413 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.449 HG23 ' HB3' ' A' ' 9' ' ' MET . 2.8 pp -128.78 164.83 29.94 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.165 0 CA-C-N 117.571 0.685 . . . . 71.41 112.469 -172.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -164.48 -179.97 6.34 Favored 'General case' 0 CA--C 1.562 1.431 0 C-N-CA 124.015 0.926 . . . . 72.25 109.545 -176.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 65.73 -122.47 22.36 Favored Glycine 0 N--CA 1.478 1.476 0 C-N-CA 123.116 0.389 . . . . 60.1 113.829 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.5 p -66.94 -28.24 68.12 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.947 1.299 . . . . 73.21 111.659 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -64.11 -51.31 64.58 Favored 'General case' 0 C--O 1.239 0.531 0 CA-C-N 115.35 -0.841 . . . . 63.04 110.322 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -73.93 -28.28 61.44 Favored 'General case' 0 C--O 1.205 -1.282 0 CA-C-N 115.222 -0.899 . . . . 74.53 110.666 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -38.78 92.37 Favored 'General case' 0 N--CA 1.486 1.325 0 CA-C-O 121.282 0.563 . . . . 73.32 111.0 176.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 39.2 t-80 -69.57 -36.49 76.32 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.154 -0.93 . . . . 72.32 110.036 173.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 23.7 t -73.68 -27.17 61.09 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 122.88 0.472 . . . . 74.12 111.276 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 83.9 mt -86.06 -42.19 14.16 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.989 0.916 . . . . 74.32 110.988 -178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -102.09 4.78 52.49 Favored Glycine 0 C--N 1.346 1.112 0 O-C-N 123.59 0.556 . . . . 50.32 114.132 -168.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.819 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.51 -60.13 0.24 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 117.627 0.714 . . . . 63.22 112.493 -174.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.588 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.6 t80 -68.2 -62.12 1.54 Allowed 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.154 0.981 . . . . 53.12 112.125 -170.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 97.8 m -69.06 -32.85 3.61 Favored Pre-proline 0 CA--C 1.567 1.627 0 N-CA-C 114.315 1.228 . . . . 60.25 114.315 -177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -45.92 -42.74 20.22 Favored 'Trans proline' 0 C--N 1.395 3.0 0 C-N-CA 122.985 2.456 . . . . 71.15 113.713 164.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -69.44 -26.19 64.48 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.762 0.825 . . . . 72.04 111.485 -177.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 39.5 mm -72.39 -45.34 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 C-N-CA 123.599 0.76 . . . . 74.53 109.743 174.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.527 HD13 ' HB2' ' A' ' 60' ' ' LEU . 48.9 mt -70.85 -35.68 72.53 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 114.409 -1.269 . . . . 71.11 112.394 -173.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -59.75 -43.05 94.34 Favored Pre-proline 0 CA--C 1.572 1.791 0 C-N-CA 124.701 1.2 . . . . 74.01 114.227 -167.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_exo -59.41 -37.34 90.51 Favored 'Trans proline' 0 C--N 1.389 2.697 0 C-N-CA 122.27 1.98 . . . . 73.44 113.487 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -72.47 -35.92 68.34 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 123.294 0.638 . . . . 75.43 111.863 179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.99 -42.97 94.05 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.515 -0.55 . . . . 60.43 109.515 174.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.6 ttm105 -63.05 -35.83 81.54 Favored 'General case' 0 CA--C 1.549 0.912 0 O-C-N 124.287 0.992 . . . . 71.43 110.309 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' C' ' 108' ' ' PRO . 22.2 tt0 -56.64 -56.37 22.21 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 123.624 0.77 . . . . 75.15 110.91 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 37.6 t -63.35 -45.02 93.12 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 114.397 -1.274 . . . . 64.44 110.766 -175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.498 ' O ' HG23 ' A' ' 118' ' ' VAL . 66.2 mt -62.93 -59.88 3.67 Favored 'Isoleucine or valine' 0 C--N 1.355 0.837 0 O-C-N 123.987 0.804 . . . . 72.14 110.775 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 22.4 m -56.77 -32.8 65.98 Favored 'General case' 0 CA--C 1.555 1.136 0 C-N-CA 123.181 0.593 . . . . 53.23 111.966 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 33.0 t -68.52 -46.45 69.54 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.86 -0.609 . . . . 52.4 110.529 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.402 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 12.7 mtp -58.37 -42.87 87.95 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 123.573 0.749 . . . . 75.33 111.049 175.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 114' ' ' ILE . 94.3 t -62.3 -44.64 99.38 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.823 0 C-N-CA 124.419 1.087 . . . . 74.1 110.225 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 94.0 p -73.56 -29.96 62.76 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.355 -0.384 . . . . 74.03 111.3 -178.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -68.3 -37.12 80.32 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 123.418 0.687 . . . . 74.13 109.815 174.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.97 -3.42 89.39 Favored Glycine 0 C--N 1.348 1.242 0 CA-C-N 115.811 -0.631 . . . . 72.21 113.033 176.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.78 HG21 HE21 ' D' ' 125' ' ' GLN . 24.3 p 54.56 48.8 19.62 Favored 'General case' 0 C--N 1.349 0.552 0 C-N-CA 126.167 1.787 . . . . 75.05 111.572 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.599 ' HA ' HD13 ' E' ' 301' ' ' ILE . 74.5 m-85 -104.56 154.41 38.47 Favored Pre-proline 0 N--CA 1.472 0.66 0 CA-C-N 113.807 -1.542 . . . . 74.23 108.43 169.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.5 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 26.4 Cg_exo -59.75 131.32 39.28 Favored 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 122.335 2.023 . . . . 75.14 110.615 -172.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -47.84 133.69 13.91 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 124.472 1.108 . . . . 62.51 111.785 -174.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 31.8 tp -107.17 110.31 22.35 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.296 -0.631 . . . . 71.51 109.296 -177.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -113.67 84.02 1.95 Allowed 'General case' 0 C--O 1.239 0.52 0 N-CA-C 106.851 -1.537 . . . . 71.42 106.851 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 26.5 tp -71.7 128.81 36.99 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 115.092 -0.958 . . . . 72.32 109.623 -178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -52.97 131.57 49.43 Favored Pre-proline 0 CA--C 1.548 0.897 0 O-C-N 124.689 1.243 . . . . 54.14 111.517 -178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 3.4 Cg_endo -77.47 116.25 4.06 Favored 'Trans proline' 0 C--N 1.374 1.893 0 C-N-CA 122.265 1.977 . . . . 65.53 109.866 179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.8 t -100.41 123.96 53.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.643 -0.873 . . . . 63.21 108.643 -175.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.8 t-20 -76.79 86.83 3.39 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 108.211 -1.033 . . . . 71.03 108.211 177.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -61.84 -30.66 70.99 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 124.184 0.994 . . . . 73.34 110.662 -178.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.819 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.7 t70 -65.42 -44.21 88.13 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 114.984 -1.007 . . . . 74.42 110.426 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.99 -43.79 94.64 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.357 -0.838 . . . . 63.15 111.182 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 86.2 mt -62.28 -48.3 80.49 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.236 0.614 . . . . 53.23 111.223 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -67.37 -31.18 71.24 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 115.161 -0.927 . . . . 71.31 110.427 -179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 52.4 tpp -69.45 -41.95 75.58 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.055 0.542 . . . . 65.44 110.506 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -62.57 -26.5 68.62 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.724 0.809 . . . . 70.31 110.933 178.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -90.87 -31.83 16.28 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 123.776 0.83 . . . . 53.25 111.457 176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.18 -45.58 92.77 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.112 0.965 . . . . 75.44 110.528 -172.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . 0.46 HE21 ' HA2' ' C' ' 146' ' ' GLY . 8.0 pt20 173.57 -13.48 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 125.942 1.697 . . . . 54.04 110.122 167.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 63.05 31.18 16.1 Favored 'General case' 0 C--N 1.366 1.312 0 C-N-CA 124.269 1.027 . . . . 74.41 110.387 178.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 34.1 tt0 -149.97 144.83 26.1 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-N 115.921 -0.581 . . . . 73.13 109.724 -170.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -101.93 143.65 31.54 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.511 0.724 . . . . 33.42 110.461 -177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -94.34 118.69 5.85 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.147 -0.781 . . . . 35.22 111.147 177.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -80.51 134.58 35.97 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 117.17 0.485 . . . . 70.11 110.726 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -97.8 121.46 7.12 Favored Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.662 -0.575 . . . . 75.42 111.662 178.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.0 m -82.8 135.44 34.96 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.63 0.772 . . . . 72.32 110.459 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -75.06 178.59 5.55 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.634 0.773 . . . . 72.3 110.932 174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -153.59 110.18 3.37 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.054 -0.721 . . . . 63.31 109.054 171.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -112.63 131.19 55.75 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 109.16 -0.682 . . . . 72.14 109.16 175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -106.39 120.51 42.08 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 107.988 -1.116 . . . . 51.51 107.988 173.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -78.49 134.88 37.26 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 122.934 0.494 . . . . 72.25 109.754 178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.927 0 C-N-CA 123.137 0.575 . . . . 44.2 110.401 -177.251 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 12.9 tmm? . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.472 -0.566 . . . . 72.23 109.472 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.0 t -153.83 130.58 10.82 Favored 'General case' 0 C--O 1.241 0.644 0 C-N-CA 123.34 0.656 . . . . 73.02 109.735 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -95.29 100.72 12.46 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.602 -0.888 . . . . 72.42 108.602 173.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -84.41 171.58 12.48 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 109.714 -0.476 . . . . 72.1 109.714 175.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -64.63 131.12 46.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 122.951 0.501 . . . . 71.11 110.613 -177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -65.14 156.74 30.71 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.406 0.682 . . . . 70.15 111.027 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 61.4 m -72.28 151.14 43.0 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 123.61 0.764 . . . . 63.02 110.023 176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.416 ' O ' ' HG3' ' B' ' 9' ' ' MET . 35.1 mt-10 -64.64 -175.06 0.16 Allowed 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.083 0.953 . . . . 73.42 111.655 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.591 ' SD ' ' N ' ' B' ' 10' ' ' THR . 0.0 OUTLIER 51.38 -150.98 0.26 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 125.145 1.378 . . . . 63.23 110.146 -171.05 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.591 ' N ' ' SD ' ' B' ' 9' ' ' MET . 90.7 m -152.78 128.6 10.22 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 119.922 1.237 . . . . 72.25 110.11 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.548 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 47.9 t80 -151.06 113.76 4.69 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 108.905 -0.776 . . . . 74.23 108.905 172.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 10.5 mm-40 -142.11 137.63 31.09 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.37 0.668 . . . . 72.3 109.935 170.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.508 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -82.3 128.0 39.13 Favored 'Isoleucine or valine' 0 C--O 1.244 0.786 0 N-CA-C 108.825 -0.805 . . . . 74.24 108.825 174.182 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' E' ' 305' ' ' ALA . 11.9 mm-40 -98.39 -43.62 6.85 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.015 -0.539 . . . . 74.53 110.075 179.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.535 HH22 ' HB ' ' E' ' 301' ' ' ILE . 23.2 ttt180 -164.33 130.93 3.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 116.517 -0.31 . . . . 72.43 110.574 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 58.3 mt -115.86 127.9 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 124.545 1.138 . . . . 72.32 108.902 178.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -162.49 147.59 12.33 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 120.982 0.42 . . . . 72.25 111.869 -171.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 97.6 m -73.95 123.42 24.25 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.984 0.913 . . . . 70.34 109.367 173.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 43.5 mtpt -98.96 -27.56 13.82 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.098 0.559 . . . . 71.03 111.506 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.578 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 23.2 t70 -156.67 144.53 19.36 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 122.316 0.246 . . . . 72.13 110.641 -170.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.538 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 36.2 mm -144.66 141.43 23.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.775 0 C-N-CA 125.326 1.451 . . . . 72.14 108.251 -178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 43.4 t -145.61 109.36 4.77 Favored 'General case' 0 N--CA 1.448 -0.561 0 O-C-N 124.103 0.877 . . . . 74.45 108.699 170.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.415 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 83.0 t80 -118.0 117.48 29.34 Favored 'General case' 0 C--O 1.221 -0.433 0 N-CA-C 107.186 -1.413 . . . . 75.24 107.186 170.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 39.3 mt-10 -119.95 133.01 55.69 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.372 0.669 . . . . 63.22 109.404 177.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . . . . . . . . . . . -128.41 83.33 66.46 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 107.664 -1.236 . . . . 32.22 107.664 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . 0.435 ' HG2' HD22 ' B' ' 27' ' ' ASN . 44.9 Cg_endo -66.23 -29.53 46.88 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 122.902 2.402 . . . . 71.14 112.167 -174.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.435 HD22 ' HG2' ' B' ' 26' ' ' PRO . 27.6 m-80 -108.43 21.06 17.83 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.053 0.941 . . . . 74.53 110.877 -177.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.453 ' HB3' ' HD3' ' B' ' 29' ' ' PRO . . . -44.44 -57.67 6.21 Favored Pre-proline 0 CA--C 1.582 2.193 0 N-CA-C 114.743 1.386 . . . . 74.35 114.743 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.507 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 71.0 Cg_endo -80.24 -26.92 3.89 Favored 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 122.302 2.001 . . . . 64.34 113.11 177.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.437 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 2.3 m-70 -93.99 1.13 56.32 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.545 0.738 . . . . 71.44 112.344 -171.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.67 -28.1 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.036 0.534 . . . . 72.23 111.686 -173.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -53.69 -26.02 20.91 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.589 1.156 . . . . 61.3 113.365 -171.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 25.0 pt20 -66.6 -52.45 45.19 Favored 'General case' 0 CA--C 1.557 1.216 0 C-N-CA 122.338 0.255 . . . . 72.35 110.781 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 57.5 pttt -118.13 68.15 0.77 Allowed 'General case' 0 C--N 1.354 0.795 0 C-N-CA 123.552 0.741 . . . . 44.42 110.167 167.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.44 ' O ' ' HE3' ' B' ' 36' ' ' TRP . 11.0 t70 -98.53 118.16 34.6 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 106.932 -1.507 . . . . 75.22 106.932 173.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.44 ' HE3' ' O ' ' B' ' 35' ' ' ASP . 2.2 t-105 -176.1 175.29 1.93 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 107.832 -1.173 . . . . 72.14 107.832 175.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.55 112.07 3.81 Favored Pre-proline 0 CA--C 1.56 1.359 0 O-C-N 123.582 0.552 . . . . 73.53 110.996 -175.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -82.77 164.84 15.85 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.62 2.213 . . . . 72.32 112.388 -174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -74.09 101.94 4.07 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.185 -1.042 . . . . 71.32 108.185 172.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 38.9 t -88.09 146.43 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-N 115.407 -0.815 . . . . 72.03 108.931 -177.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -138.57 133.07 32.06 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.121 0.969 . . . . 74.04 109.307 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.482 HD21 HD11 ' B' ' 128' ' ' LEU . 4.6 mp -90.97 150.1 21.6 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 115.346 -0.843 . . . . 61.43 108.953 176.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.592 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 26.3 t70 -158.99 154.58 26.04 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 108.419 -0.956 . . . . 74.03 108.419 172.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 3.4 pp -139.2 154.55 48.06 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.002 0.521 . . . . 74.24 110.582 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.583 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 15.5 t70 -140.02 124.62 18.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.419 -1.326 . . . . 53.12 107.419 174.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -110.21 104.76 13.62 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.023 0.929 . . . . 74.41 109.741 -173.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -129.24 155.39 45.64 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.97 0.908 . . . . 41.44 109.984 -175.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 70.6 m -144.11 172.64 12.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.296 0.639 . . . . 62.44 110.678 176.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 72.0 p -151.76 134.88 15.85 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.11 0.964 . . . . 63.11 108.647 173.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -84.47 114.68 22.1 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 109.86 -0.422 . . . . 74.33 109.86 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 69.4 mt -80.49 -45.72 17.05 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.447 -0.575 . . . . 72.43 109.447 173.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.48 -173.43 4.29 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 115.06 -0.973 . . . . 73.13 110.666 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.14 119.43 18.34 Favored 'General case' 0 N--CA 1.48 1.027 0 CA-C-N 115.281 -0.872 . . . . 75.05 109.968 -177.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 71.45 -6.4 1.39 Allowed 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 125.965 1.706 . . . . 75.12 112.668 -171.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 87.5 t -104.99 104.98 17.78 Favored 'Isoleucine or valine' 0 C--N 1.351 0.65 0 N-CA-C 108.08 -1.082 . . . . 73.32 108.08 176.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -122.82 137.96 54.78 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.171 -0.677 . . . . 75.14 109.171 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -101.16 101.51 12.25 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 107.017 -1.475 . . . . 70.23 107.017 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 84.5 t -94.33 123.18 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 124.074 0.949 . . . . 33.24 109.879 -177.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.446 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.0 t -102.95 144.4 13.81 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 C-N-CA 124.085 0.954 . . . . 54.12 109.417 175.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' B' ' 103' ' ' PRO . 61.0 tp -129.77 115.02 16.68 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.555 -0.905 . . . . 55.12 108.555 170.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.583 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 37.3 ttm180 -92.85 125.86 37.65 Favored 'General case' 0 C--O 1.232 0.168 0 N-CA-C 109.373 -0.603 . . . . 70.33 109.373 173.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 92.9 t -111.25 104.55 17.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.629 0 N-CA-C 107.305 -1.369 . . . . 64.44 107.305 171.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 36.4 m -97.0 136.96 36.82 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-N 115.481 -0.781 . . . . 65.21 109.437 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 70.7 t -129.11 129.32 67.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-N 114.947 -1.024 . . . . 73.54 108.476 177.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 59.5 m -124.82 137.87 54.29 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 123.406 0.682 . . . . 71.11 109.408 176.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.51 143.4 35.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 123.034 0.534 . . . . 65.22 109.63 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 15.6 p -158.09 140.37 14.31 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 123.698 0.624 . . . . 71.32 111.362 -175.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.605 HD12 ' HB2' ' B' ' 73' ' ' ALA . 5.2 mp -103.24 118.92 37.87 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 108.45 -0.944 . . . . 33.44 108.45 167.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 67.63 -141.77 39.18 Favored Glycine 0 C--N 1.341 0.848 0 O-C-N 123.587 0.554 . . . . 75.31 112.882 -176.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.19 9.43 12.83 Favored 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 124.327 1.051 . . . . 74.02 111.875 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -127.41 143.35 51.22 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.545 0.738 . . . . 73.31 110.147 -174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 37.2 m -70.78 140.47 51.29 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.574 0.75 . . . . 70.35 110.855 -176.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.605 ' HB2' HD12 ' B' ' 68' ' ' LEU . . . -90.99 -62.58 1.42 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.97 0.908 . . . . 61.54 108.744 176.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 33.9 p90 -156.29 167.02 31.73 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-N 114.572 -1.195 . . . . 64.43 109.144 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.431 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 83.3 mt -137.08 131.03 32.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.802 -1.555 . . . . 62.42 106.802 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.527 ' SG ' ' HA ' ' B' ' 114' ' ' ILE . 37.7 t -141.33 132.7 26.69 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 108.759 -0.83 . . . . 53.1 108.759 176.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -154.19 135.37 13.99 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.009 -0.737 . . . . 72.2 109.009 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.434 HG21 ' HB3' ' B' ' 113' ' ' CYS . 61.9 t -133.33 146.44 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 C-N-CA 123.637 0.775 . . . . 63.41 109.019 -178.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.578 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 23.8 mt-30 -119.48 95.93 4.99 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.405 -1.331 . . . . 71.41 107.405 168.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -85.19 104.57 15.19 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.69 -0.855 . . . . 75.11 108.69 176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.446 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.68 159.85 29.66 Favored Glycine 0 C--O 1.244 0.753 0 O-C-N 123.927 0.767 . . . . 75.33 111.186 176.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -161.29 126.34 1.57 Allowed Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.922 -0.871 . . . . 64.31 110.922 -178.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 54.2 mt -84.26 119.11 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 108.12 -1.067 . . . . 75.22 108.12 175.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.11 134.26 54.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.752 0.821 . . . . 74.42 108.892 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 72.8 m -92.36 97.17 10.7 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.4 -0.963 . . . . 64.22 108.4 168.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 37.3 pt -113.16 139.7 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-N 115.194 -0.912 . . . . 62.45 110.421 -175.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.456 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -157.1 160.92 39.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.014 0.926 . . . . 71.23 109.555 178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.95 -31.9 4.2 Favored Glycine 0 C--N 1.347 1.167 0 O-C-N 123.398 0.436 . . . . 72.12 114.072 174.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.405 HD13 ' H ' ' B' ' 89' ' ' ILE . 0.2 OUTLIER -75.63 136.5 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.912 0 C-N-CA 123.296 0.638 . . . . 72.2 111.048 -178.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.91 151.62 16.45 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.717 0.807 . . . . 63.51 109.695 -177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.54 -110.37 3.32 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 123.614 0.626 . . . . 44.43 113.189 173.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 5.3 m -74.59 -42.9 57.87 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.826 0.822 . . . . 72.22 110.088 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -67.64 -32.6 73.42 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 113.977 -1.465 . . . . 74.24 111.206 -171.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 8.3 ptm -68.47 -37.37 80.1 Favored 'General case' 0 N--CA 1.478 0.963 0 CA-C-N 115.957 -0.565 . . . . 74.23 110.748 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -69.88 -26.73 64.32 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 123.522 0.729 . . . . 63.42 110.721 -178.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.416 ' HD2' ' HB2' ' B' ' 137' ' ' PHE . 41.9 t-80 -89.39 -19.3 25.37 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.354 0.662 . . . . 54.45 110.839 175.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 50.5 t -86.69 -70.17 0.63 Allowed 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 122.497 0.319 . . . . 33.43 111.436 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.516 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.2 pp -80.43 -24.83 39.32 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 122.431 0.292 . . . . 64.13 111.478 -175.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.29 1.82 56.18 Favored Glycine 0 C--N 1.352 1.451 0 CA-C-O 119.66 -0.522 . . . . 64.13 114.153 -175.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.739 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -143.03 -53.08 0.38 Allowed 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 117.548 0.674 . . . . 52.11 111.827 -177.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 63.4 t80 -75.34 -45.17 41.11 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.086 0.554 . . . . 74.25 112.075 -174.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.548 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 56.0 m -65.97 -43.71 58.7 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.161 0.584 . . . . 65.11 111.82 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.52 ' HA ' HD22 ' B' ' 60' ' ' LEU . 65.2 Cg_exo -48.42 -42.97 33.89 Favored 'Trans proline' 0 C--N 1.396 3.072 0 C-N-CA 122.868 2.378 . . . . 75.54 114.295 167.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -61.31 -30.24 70.37 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 123.552 0.741 . . . . 75.24 112.64 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.89 -43.79 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 C-N-CA 123.152 0.581 . . . . 72.52 110.635 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 98.1 mt -79.42 -20.5 47.4 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 116.062 -0.517 . . . . 64.43 111.571 -174.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -61.15 -49.35 88.81 Favored Pre-proline 0 CA--C 1.564 1.499 0 CA-C-O 117.892 -1.052 . . . . 61.35 113.275 -175.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.9 -46.38 30.89 Favored 'Trans proline' 0 C--N 1.391 2.787 0 C-N-CA 122.938 2.426 . . . . 63.54 113.841 176.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -67.16 -44.88 78.61 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.706 0.802 . . . . 71.43 111.32 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.15 -40.58 96.45 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.284 0.634 . . . . 74.41 110.979 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 8.7 ttp-105 -71.75 -44.86 63.36 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 115.086 -0.961 . . . . 71.45 110.743 -174.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.97 -34.04 77.47 Favored 'General case' 0 N--CA 1.48 1.025 0 O-C-N 123.872 0.732 . . . . 74.42 110.166 178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.493 ' O ' ' HG2' ' B' ' 117' ' ' MET . 12.5 t -68.79 -36.5 78.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 122.877 0.471 . . . . 73.13 110.86 177.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.527 ' HA ' ' SG ' ' B' ' 76' ' ' CYS . 62.0 mt -62.84 -48.92 85.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 C-N-CA 123.255 0.622 . . . . 74.41 109.773 172.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 18.0 m -62.03 -32.17 72.65 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 123.678 0.791 . . . . 74.13 111.527 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 30.9 t -65.78 -46.55 78.31 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 115.633 -0.712 . . . . 44.02 110.238 178.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.493 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.7 mmt -72.94 -38.1 66.91 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 122.802 0.441 . . . . 75.51 111.329 -173.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 93.5 t -62.45 -38.49 81.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 123.396 0.678 . . . . 62.35 110.339 174.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 32.8 t -68.05 -34.58 76.72 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 114.892 -1.049 . . . . 63.24 111.19 177.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' B' ' 116' ' ' SER . 86.7 mtt-85 -71.27 -26.79 63.04 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 122.914 0.486 . . . . 73.12 110.458 176.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.92 1.39 63.17 Favored Glycine 0 C--N 1.358 1.796 0 O-C-N 123.446 0.467 . . . . 53.54 112.59 169.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 41.5 p 62.73 49.54 3.73 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 126.915 2.086 . . . . 74.12 112.22 172.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -119.98 154.46 55.53 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-N 114.393 -1.276 . . . . 75.25 109.924 171.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -64.37 -169.96 0.12 Allowed 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.581 2.854 . . . . 74.33 114.143 -176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.464 ' OE1' ' HA ' ' C' ' 119' ' ' SER . 15.4 tp60 -57.34 124.26 18.27 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.448 1.099 . . . . 72.22 112.771 -167.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -141.49 83.35 1.86 Allowed 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 108.864 -0.791 . . . . 71.25 108.864 173.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -104.5 131.42 51.91 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 107.385 -1.339 . . . . 72.14 107.385 165.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.482 HD11 HD21 ' B' ' 42' ' ' LEU . 33.1 tp -70.74 149.74 46.62 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.091 0.557 . . . . 43.41 110.253 178.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.2 149.4 87.05 Favored Pre-proline 0 CA--C 1.555 1.153 0 C-N-CA 123.894 0.878 . . . . 54.33 111.898 -176.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.447 ' HG3' HD12 ' D' ' 16' ' ' ILE . 20.4 Cg_exo -63.45 93.51 0.17 Allowed 'Trans proline' 0 C--N 1.381 2.268 0 C-N-CA 122.925 2.417 . . . . 72.42 111.825 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 25.8 t -92.0 110.07 22.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 108.301 -1.0 . . . . 71.34 108.301 175.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 44.1 t-20 -92.75 88.25 6.17 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.026 -1.101 . . . . 74.04 108.026 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -61.36 -37.32 82.95 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 115.037 -0.983 . . . . 73.14 110.298 -177.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.739 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 15.5 t70 -59.67 -44.75 93.46 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 114.794 -1.093 . . . . 60.23 111.768 177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.27 -33.0 72.55 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.173 0.589 . . . . 60.21 111.446 -178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 8.7 tt -57.23 -55.03 39.97 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 123.327 0.651 . . . . 62.13 109.806 178.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . 0.416 ' HB2' ' HD2' ' B' ' 96' ' ' HIS . 89.1 m-85 -68.31 -31.76 71.42 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 115.732 -0.667 . . . . 73.3 111.343 176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 55.2 ttm -64.78 -37.76 88.68 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.493 0.317 . . . . 42.25 111.184 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -75.22 -28.16 59.82 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.812 0.445 . . . . 75.12 110.779 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -69.11 -36.3 77.37 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.037 0.446 . . . . 70.14 110.196 174.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 62.6 mt -93.86 -5.35 48.24 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 123.555 0.742 . . . . 61.35 111.304 -178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 25.6 tp60 -77.0 93.1 3.77 Favored 'General case' 0 C--N 1.352 0.714 0 C-N-CA 123.098 0.559 . . . . 54.41 109.797 178.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -138.74 -28.87 0.8 Allowed 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 124.108 0.963 . . . . 75.4 109.059 173.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -83.35 126.46 32.74 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-N 115.775 -0.648 . . . . 73.4 110.431 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.78 3.55 54.88 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.255 1.022 . . . . 65.32 111.324 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 100.92 153.87 26.61 Favored Glycine 0 C--N 1.351 1.367 0 N-CA-C 111.819 -0.512 . . . . 44.53 111.819 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -70.85 139.59 50.9 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 122.762 0.425 . . . . 71.23 110.153 175.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -96.72 147.6 18.73 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 123.807 0.692 . . . . 72.4 112.282 178.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 72.8 p -93.71 -159.97 0.73 Allowed 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.216 1.006 . . . . 74.24 109.227 172.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -98.29 177.58 5.33 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 108.496 -0.927 . . . . 73.22 108.496 163.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -165.24 157.28 15.25 Favored 'General case' 0 N--CA 1.482 1.133 0 CA-C-O 121.308 0.575 . . . . 74.23 111.691 172.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 33.6 m80 -147.91 92.99 2.12 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 107.203 -1.406 . . . . 64.44 107.203 165.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -78.36 110.3 13.27 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.132 0.573 . . . . 61.5 109.704 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -102.68 169.65 8.5 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.884 0.874 . . . . 62.53 110.539 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.131 0 C-N-CA 124.907 1.283 . . . . 73.44 111.131 174.581 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 24.3 ptt? . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 109.738 -0.468 . . . . 64.41 109.738 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 60.2 m -156.29 169.47 24.48 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.202 1.001 . . . . 60.43 109.748 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.32 73.39 8.36 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 122.12 0.962 . . . . 72.11 109.119 170.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -77.22 126.7 31.36 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.228 -0.896 . . . . 71.22 109.042 -177.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -71.78 96.63 1.66 Allowed 'General case' 0 C--O 1.241 0.636 0 N-CA-C 108.767 -0.827 . . . . 63.24 108.767 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -66.83 160.19 26.56 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.354 0.662 . . . . 73.31 110.049 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 66.3 p -58.15 126.48 27.68 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.383 0.673 . . . . 62.33 110.388 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -66.76 -76.11 0.09 Allowed 'General case' 0 CA--C 1.549 0.904 0 O-C-N 123.84 0.713 . . . . 73.3 109.45 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.412 ' HA ' HG13 ' C' ' 89' ' ' ILE . 56.3 ttp 57.95 111.22 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 125.326 1.45 . . . . 53.54 112.45 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.721 HG22 HE22 ' C' ' 12' ' ' GLN . 7.0 m -97.22 105.57 17.74 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.172 -1.047 . . . . 62.02 108.172 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.6 ' HE1' ' SG ' ' C' ' 102' ' ' CYS . 75.4 t80 -124.27 119.38 29.15 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 109.529 -0.545 . . . . 63.24 109.529 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.721 HE22 HG22 ' C' ' 10' ' ' THR . 1.6 mp0 -136.92 142.26 42.69 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.486 -0.931 . . . . 71.25 108.486 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 53.6 mt -89.14 97.29 6.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 108.542 -0.91 . . . . 75.33 108.542 175.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 19.0 mm100 -74.19 -28.25 61.19 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 122.423 0.289 . . . . 51.41 110.649 -178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' C' ' 15' ' ' ARG . 10.0 ttt180 -172.55 152.76 2.68 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 123.727 0.642 . . . . 62.51 110.94 177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 89.3 mt -133.6 137.08 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 N-CA-C 107.269 -1.382 . . . . 62.05 107.269 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.493 ' HB3' HG23 ' D' ' 122' ' ' THR . 18.6 p90 -175.52 166.24 3.24 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 122.88 0.472 . . . . 75.31 110.052 179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 60.2 p -89.26 120.24 30.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.267 -0.642 . . . . 75.23 109.267 176.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.541 ' HE3' ' HB3' ' D' ' 28' ' ' ALA . 13.6 mmmm -66.49 -44.55 82.31 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.614 -0.884 . . . . 71.24 108.614 170.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.403 ' HA ' ' O ' ' D' ' 23' ' ' PHE . 19.2 t70 -139.79 145.71 38.54 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.112 -0.949 . . . . 73.33 110.598 -177.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.488 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.9 mt -135.53 142.83 38.39 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 C-N-CA 125.587 1.555 . . . . 71.02 107.038 170.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 36.0 t -156.84 151.34 25.48 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-O 121.129 0.49 . . . . 72.42 110.702 177.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -149.36 112.14 4.81 Favored 'General case' 0 N--CA 1.462 0.171 0 N-CA-C 106.895 -1.52 . . . . 72.14 106.895 173.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -116.24 125.71 52.6 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.286 0.634 . . . . 62.52 109.855 -176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.64 82.08 18.82 Favored Pre-proline 0 CA--C 1.541 0.615 0 N-CA-C 108.086 -1.079 . . . . 62.53 108.086 175.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -62.86 -28.16 75.46 Favored 'Trans proline' 0 C--N 1.38 2.226 0 C-N-CA 122.522 2.148 . . . . 72.55 111.646 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.86 31.87 2.53 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.519 1.128 . . . . 54.53 110.47 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.511 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -58.13 -54.04 59.77 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 114.441 1.275 . . . . 63.44 114.441 -171.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.481 ' HD3' ' HE3' ' D' ' 19' ' ' LYS . 58.8 Cg_endo -79.83 -25.99 4.86 Favored 'Trans proline' 0 C--N 1.385 2.464 0 CA-C-N 122.072 1.776 . . . . 61.04 112.654 172.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -63.06 -23.32 67.39 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 125.044 1.338 . . . . 65.52 111.997 174.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.12 -18.75 20.45 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.309 0 C-N-CA 124.88 1.272 . . . . 61.52 112.022 -174.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -70.04 -38.55 75.88 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 122.676 0.39 . . . . 73.34 111.461 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -92.99 34.42 1.1 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.424 0.69 . . . . 75.42 110.912 -177.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.432 ' HD2' HD13 ' C' ' 68' ' ' LEU . 0.1 OUTLIER -98.0 150.9 20.88 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.181 0.992 . . . . 73.41 111.012 -175.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -65.81 138.95 58.25 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 124.952 1.301 . . . . 73.32 111.533 172.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -85.24 67.21 10.08 Favored 'General case' 0 CA--C 1.557 1.228 0 C-N-CA 123.864 0.866 . . . . 72.11 110.784 -175.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -162.94 71.0 2.01 Favored Pre-proline 0 N--CA 1.49 1.563 0 C-N-CA 123.118 0.567 . . . . 71.04 110.81 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -87.05 115.9 1.2 Allowed 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.315 2.677 . . . . 71.15 112.015 -178.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -86.87 112.77 22.08 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 108.352 -0.981 . . . . 65.52 108.352 175.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.89 104.51 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 115.726 -0.67 . . . . 73.34 109.355 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.416 ' HB3' ' HB ' ' C' ' 65' ' ' THR . 58.7 tttm -95.03 103.25 15.09 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 108.616 -0.883 . . . . 65.12 108.616 173.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.78 138.05 31.87 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 108.153 -1.054 . . . . 72.41 108.153 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.458 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 29.4 t70 -128.89 141.55 51.24 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.42 1.088 . . . . 75.02 109.042 -178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' C' ' 61' ' ' ARG . 61.7 tp -134.29 132.01 39.07 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 109.111 -0.7 . . . . 72.05 109.111 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.777 ' HB3' ' HB2' ' C' ' 61' ' ' ARG . 17.1 t70 -123.27 141.76 51.65 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.106 0.963 . . . . 75.31 109.133 174.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 37.2 p -114.51 111.08 20.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.993 -0.743 . . . . 62.23 108.993 176.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.437 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -117.03 164.29 14.94 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.341 1.056 . . . . 42.02 110.09 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -146.83 155.49 42.38 Favored 'General case' 0 C--O 1.242 0.67 0 C-N-CA 123.391 0.676 . . . . 71.14 109.884 176.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 46.0 t -145.51 126.84 14.89 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.598 -0.89 . . . . 65.32 108.598 177.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.3 tt0 -82.72 117.76 22.87 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 108.447 -0.946 . . . . 73.35 108.447 172.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.591 HD11 HD12 ' C' ' 83' ' ' ILE . 83.1 mt -90.89 -42.51 10.56 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.621 -0.718 . . . . 55.12 109.463 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.45 -177.85 6.84 Favored 'General case' 0 C--O 1.242 0.709 0 CA-C-N 114.802 -1.09 . . . . 71.41 109.728 177.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.4 126.62 30.18 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 114.991 -1.004 . . . . 75.43 109.182 175.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 68.7 10.51 7.93 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.622 1.169 . . . . 60.32 111.732 -179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 91.2 t -126.22 112.96 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 C-N-CA 123.918 0.887 . . . . 72.11 109.206 177.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -131.14 125.54 33.34 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.889 0.876 . . . . 73.3 109.11 -175.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -83.61 124.48 30.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.279 1.031 . . . . 75.12 109.66 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 89.1 t -96.49 130.09 45.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 N-CA-C 107.572 -1.27 . . . . 51.43 107.572 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 86.0 t -123.44 139.91 48.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.505 0.722 . . . . 71.11 109.978 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.575 HD11 ' HA ' ' C' ' 103' ' ' PRO . 69.5 mt -128.76 118.72 23.27 Favored 'General case' 0 C--N 1.345 0.413 0 C-N-CA 124.283 1.033 . . . . 61.02 109.315 176.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.777 ' HB2' ' HB3' ' C' ' 45' ' ' ASP . 45.0 mtt180 -82.96 108.55 16.37 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 108.689 -0.856 . . . . 75.44 108.689 166.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 14.4 t -103.92 116.38 47.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.456 -1.313 . . . . 62.24 107.456 171.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.458 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 20.2 m -130.12 118.24 21.18 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.056 0.542 . . . . 50.23 109.594 -170.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.596 HG23 HD13 ' C' ' 114' ' ' ILE . 67.0 t -104.0 118.18 50.75 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 N-CA-C 108.586 -0.894 . . . . 70.21 108.586 178.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.416 ' HB ' ' HB3' ' C' ' 41' ' ' LYS . 22.4 m -110.77 141.45 44.08 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.463 -0.94 . . . . 72.34 108.463 174.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -127.76 106.61 9.24 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 105.963 -1.865 . . . . 61.33 105.963 170.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 67.5 m -138.91 152.28 47.63 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.338 0.59 . . . . 74.44 109.71 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.432 HD13 ' HD2' ' C' ' 34' ' ' LYS . 4.3 mp -116.32 31.48 6.7 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 114.462 -1.244 . . . . 73.51 108.635 -177.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.54 -117.63 4.02 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 109.802 -1.319 . . . . 75.13 109.802 -170.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -88.85 -30.61 18.8 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 109.433 -0.58 . . . . 63.24 109.433 174.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 15.0 tp10 -70.68 95.12 1.07 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.223 1.009 . . . . 60.14 109.227 173.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 64.3 m -87.49 139.65 30.33 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.219 0.608 . . . . 72.11 110.737 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.6 -65.02 1.01 Allowed 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.098 -0.955 . . . . 73.44 109.395 173.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . 0.603 ' HE1' ' HB2' ' F' ' 297' ' ' TYR . 40.7 p90 -157.91 176.19 12.87 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.167 0.587 . . . . 75.13 110.784 176.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.456 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.6 tm? -140.79 147.47 39.12 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.671 1.188 . . . . 72.34 108.162 179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.456 ' N ' HD13 ' C' ' 75' ' ' LEU . 51.0 t -151.08 129.36 11.98 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.129 0.971 . . . . 50.13 108.596 175.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -136.86 134.58 37.06 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 122.976 0.51 . . . . 74.1 110.025 178.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.466 HG11 ' HA ' ' C' ' 110' ' ' ALA . 36.5 t -131.39 115.6 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 C-N-CA 124.454 1.102 . . . . 52.34 109.021 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.617 ' HG2' ' HG2' ' C' ' 61' ' ' ARG . 27.2 mt-30 -89.48 96.39 10.68 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 108.25 -1.018 . . . . 63.15 108.25 169.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.649 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 8.7 tp-100 -80.07 125.45 29.81 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.273 0.629 . . . . 64.34 109.86 176.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -111.23 154.19 16.81 Favored Glycine 0 N--CA 1.469 0.899 0 N-CA-C 111.831 -0.507 . . . . 40.14 111.831 175.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.494 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.25 120.24 1.05 Allowed Glycine 0 CA--C 1.504 -0.65 0 N-CA-C 111.865 -0.494 . . . . 71.13 111.865 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.591 HD12 HD11 ' C' ' 51' ' ' LEU . 9.0 mm -87.92 122.6 39.76 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.371 -0.974 . . . . 60.51 108.371 -179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -133.75 127.33 32.55 Favored 'General case' 0 C--O 1.243 0.758 0 N-CA-C 108.933 -0.766 . . . . 74.31 108.933 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 30.2 p -87.91 104.28 16.47 Favored 'General case' 0 CA--C 1.544 0.74 0 N-CA-C 108.659 -0.867 . . . . 73.23 108.659 172.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' C' ' 10' ' ' THR . 21.9 pt -115.54 134.36 58.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.857 0 C-N-CA 124.352 1.061 . . . . 73.1 110.234 -173.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.34 172.2 14.98 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.577 0.751 . . . . 74.12 111.272 -170.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 93.68 -49.15 2.3 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-N 115.648 -0.705 . . . . 72.21 113.054 171.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.412 HG13 ' HA ' ' C' ' 9' ' ' MET . 1.8 pp -119.94 172.93 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 C-N-CA 123.567 0.747 . . . . 73.12 110.828 179.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.81 -172.91 4.27 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 115.776 -0.647 . . . . 61.51 110.186 -171.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 54.85 -129.01 44.47 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.736 0.647 . . . . 62.25 113.835 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.4 p -69.75 -28.03 65.44 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.319 1.048 . . . . 64.13 111.916 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -61.8 -47.83 83.37 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.745 0.818 . . . . 73.22 109.838 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . . . . . . . . . 36.6 ttp -83.38 -29.18 28.38 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 115.449 -0.796 . . . . 72.35 110.829 179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . 0.495 ' HB1' ' HB3' ' F' ' 280' ' ' LEU . . . -65.33 -30.86 71.74 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.981 0.513 . . . . 72.05 111.368 179.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 -68.77 -34.53 75.71 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 123.285 0.634 . . . . 75.05 110.434 172.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 45.3 t -70.3 -61.86 1.61 Allowed 'General case' 0 CA--C 1.545 0.751 0 CA-C-N 116.159 -0.473 . . . . 65.43 110.761 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.542 ' HA ' ' SG ' ' C' ' 102' ' ' CYS . 0.9 OUTLIER -77.83 -13.5 59.87 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 112.819 0.674 . . . . 40.1 112.819 -176.009 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.17 -7.35 49.9 Favored Glycine 0 N--CA 1.477 1.375 0 CA-C-O 119.757 -0.468 . . . . 41.02 113.875 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.56 -58.28 0.63 Allowed 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 117.311 0.555 . . . . 73.33 110.951 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -70.99 -45.04 64.72 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.271 1.028 . . . . 74.34 112.089 -169.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.6 ' SG ' ' HE1' ' C' ' 11' ' ' PHE . 33.4 m -70.45 -44.13 17.79 Favored Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 123.549 0.739 . . . . 73.21 111.739 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.575 ' HA ' HD11 ' C' ' 60' ' ' LEU . 86.9 Cg_exo -50.5 -41.57 51.94 Favored 'Trans proline' 0 C--N 1.394 2.965 0 C-N-CA 122.459 2.106 . . . . 73.11 113.91 168.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -62.41 -26.81 68.68 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 123.64 0.776 . . . . 72.23 112.289 178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 30.3 mm -80.95 -45.8 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.139 0.576 . . . . 74.52 110.86 179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.494 HD21 ' HA3' ' C' ' 82' ' ' GLY . 87.3 mt -78.12 -33.13 50.69 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.735 -0.666 . . . . 75.11 112.124 -171.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.557 ' HE1' HD23 ' C' ' 128' ' ' LEU . 25.0 t80 -51.36 -52.03 63.3 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 117.692 -1.147 . . . . 73.02 113.708 -174.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.457 ' HB3' ' HB2' ' A' ' 112' ' ' GLU . 93.6 Cg_exo -48.89 -36.49 34.2 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 122.938 2.425 . . . . 72.33 114.685 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -72.9 -43.9 61.9 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.88 -0.6 . . . . 70.32 111.622 -176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.649 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -64.87 -39.4 93.49 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.744 0.418 . . . . 40.41 110.645 176.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttt-85 -55.8 -57.06 13.64 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 125.481 1.513 . . . . 70.23 111.275 177.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -68.09 -31.73 71.56 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.514 0.725 . . . . 74.41 110.913 -177.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.422 ' SG ' ' HD3' ' D' ' 120' ' ' ARG . 14.0 t -67.91 -37.93 82.32 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.255 0.622 . . . . 60.55 111.199 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.596 HD13 HG23 ' C' ' 64' ' ' VAL . 70.1 mt -64.78 -49.29 80.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 CA-C-N 115.497 -0.774 . . . . 71.42 109.729 172.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 27.7 m -60.16 -34.45 73.59 Favored 'General case' 0 CA--C 1.557 1.234 0 O-C-N 123.882 0.739 . . . . 75.1 111.534 -176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.405 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 32.7 t -67.78 -38.84 83.9 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.256 -0.884 . . . . 75.22 110.083 176.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.618 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -69.43 -37.87 77.61 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 124.101 0.96 . . . . 73.22 112.273 178.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 61.5 t -65.06 -34.16 68.67 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 123.14 0.576 . . . . 73.23 109.498 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.464 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 39.5 t -65.19 -38.81 91.66 Favored 'General case' 0 C--N 1.356 0.855 0 CA-C-N 115.381 -0.827 . . . . 71.14 111.727 175.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.436 HH12 ' HG2' ' D' ' 112' ' ' GLU . 61.5 mtt-85 -72.21 -23.81 61.31 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.19 -0.914 . . . . 53.34 111.18 -178.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.43 6.42 83.29 Favored Glycine 0 C--N 1.356 1.664 0 CA-C-O 119.865 -0.408 . . . . 54.14 113.146 174.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.439 HG23 ' HB3' ' D' ' 17' ' ' TYR . 38.0 p 60.75 35.64 19.56 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 126.014 1.726 . . . . 54.41 112.18 179.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -115.06 148.12 39.88 Favored Pre-proline 0 N--CA 1.483 1.207 0 C-N-CA 123.534 0.734 . . . . 75.34 110.89 -177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -45.89 109.03 0.17 Allowed 'Trans proline' 0 C--N 1.386 2.539 0 C-N-CA 124.295 3.33 . . . . 42.44 112.822 174.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -60.06 131.55 51.18 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 114.304 -1.316 . . . . 70.53 111.967 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 42.3 tp -108.58 102.16 11.25 Favored 'General case' 0 C--O 1.242 0.684 0 C-N-CA 123.401 0.68 . . . . 74.24 109.443 -178.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -90.97 111.89 23.54 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 107.952 -1.129 . . . . 64.13 107.952 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.557 HD23 ' HE1' ' C' ' 107' ' ' PHE . 16.9 tp -73.43 149.05 42.69 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 113.113 0.782 . . . . 71.14 113.113 -164.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.552 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -65.9 157.92 77.85 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 125.611 1.565 . . . . 74.31 112.784 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.57 ' HG2' HG21 ' A' ' 13' ' ' ILE . 8.2 Cg_exo -73.73 129.49 13.6 Favored 'Trans proline' 0 C--N 1.379 2.133 0 C-N-CA 123.059 2.506 . . . . 74.41 112.56 175.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 54.7 t -126.53 107.66 17.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 106.751 -1.574 . . . . 53.05 106.751 168.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -102.78 103.64 13.87 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 108.234 -1.025 . . . . 73.33 108.234 177.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.468 ' HD1' ' SD ' ' F' ' 286' ' ' MET . 65.8 m-85 -62.25 -35.83 80.15 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 115.781 -0.645 . . . . 63.22 110.523 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.44 ' O ' ' HG3' ' C' ' 138' ' ' MET . 14.0 m-20 -66.17 -35.28 80.04 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.578 0.751 . . . . 73.54 112.092 176.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -62.06 -30.46 71.01 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 122.925 0.49 . . . . 64.41 111.405 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 90.5 mt -63.92 -42.79 97.29 Favored 'General case' 0 CA--C 1.552 1.031 0 CA-C-N 115.194 -0.912 . . . . 74.13 110.868 171.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -73.65 -23.68 59.89 Favored 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 123.538 0.735 . . . . 65.31 112.064 177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . 0.44 ' HG3' ' O ' ' C' ' 134' ' ' ASP . 64.5 mtt -69.01 -29.42 67.6 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.584 0.754 . . . . 72.02 110.605 177.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 -60.18 -36.32 77.34 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.417 1.087 . . . . 74.12 111.219 175.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -57.48 -83.15 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 124.346 1.058 . . . . 74.32 110.959 177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.43 ' O ' HD12 ' C' ' 141' ' ' LEU . 1.8 pp -132.47 122.8 25.47 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 118.075 0.398 . . . . 54.1 110.678 174.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -179.2 89.28 0.02 OUTLIER 'General case' 0 C--N 1.353 0.758 0 C-N-CA 125.041 1.337 . . . . 70.24 107.654 173.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -93.78 142.48 27.31 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.863 -0.608 . . . . 73.02 110.534 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -99.83 104.37 16.04 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 108.176 -1.046 . . . . 61.03 108.176 173.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -145.63 112.25 5.89 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.187 0.595 . . . . 74.42 109.535 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . 0.46 ' HA2' HE21 ' A' ' 142' ' ' GLN . . . 148.4 -172.76 28.57 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 123.308 0.38 . . . . 44.13 113.971 176.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -137.91 168.34 19.9 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.934 1.293 . . . . 72.14 109.43 -179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -175.05 146.65 8.52 Favored Glycine 0 C--N 1.35 1.311 0 CA-C-O 120.139 -0.256 . . . . 72.33 112.694 179.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 12.8 t -159.43 129.7 5.71 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 123.688 0.795 . . . . 74.43 109.89 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -121.47 178.23 4.89 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.054 0.542 . . . . 73.41 111.06 -177.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -155.68 81.12 1.02 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.429 0.691 . . . . 74.12 109.314 174.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -154.06 121.48 5.8 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 108.169 -1.049 . . . . 65.51 108.169 172.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -111.93 91.56 3.7 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 108.71 -0.848 . . . . 64.04 108.71 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -161.26 159.73 29.01 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.753 0.821 . . . . 73.51 110.195 -177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 C-N-CA 124.687 1.195 . . . . 73.02 108.585 179.706 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 62.7 mtt . . . . . 0 N--CA 1.488 1.427 0 N-CA-C 109.58 -0.526 . . . . 62.44 109.58 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 20.8 m -114.59 100.26 8.14 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.519 0.728 . . . . 73.53 109.682 -177.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -81.89 97.97 8.3 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-O 121.383 0.611 . . . . 72.2 109.42 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 18.5 tm0? -80.68 136.29 36.17 Favored 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 108.603 -0.888 . . . . 64.15 108.603 -179.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -125.71 145.39 50.2 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.908 0.883 . . . . 65.33 109.479 177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -83.8 6.89 19.67 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.145 0.578 . . . . 64.34 111.133 175.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 41.7 p -65.69 86.5 0.08 Allowed 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 123.559 0.744 . . . . 62.23 109.947 170.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -77.46 178.63 7.05 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.71 0.804 . . . . 64.54 110.171 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 10.6 ttp -32.75 124.61 0.35 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 124.763 1.225 . . . . 72.34 113.61 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.466 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 57.5 m -108.69 140.81 41.56 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.031 -1.1 . . . . 72.43 108.031 165.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -157.59 93.32 1.28 Allowed 'General case' 0 C--O 1.235 0.319 0 N-CA-C 107.728 -1.212 . . . . 74.0 107.728 174.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -117.56 115.88 26.0 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.87 -0.789 . . . . 63.25 108.87 179.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.402 HG12 ' HD2' ' D' ' 84' ' ' PHE . 22.0 mt -68.41 127.67 30.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 108.135 -1.061 . . . . 55.42 108.135 172.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -84.95 -42.47 14.91 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 108.65 -0.87 . . . . 72.11 108.65 173.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 16.5 ptt180 178.92 150.6 0.28 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.312 1.045 . . . . 73.4 109.759 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.545 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -116.1 144.07 24.62 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 107.466 -1.309 . . . . 63.13 107.466 169.245 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.511 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 13.6 p90 -165.53 150.46 8.84 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.669 0.747 . . . . 74.2 111.108 -170.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 67.4 p -78.02 109.76 12.37 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 114.623 -1.171 . . . . 62.33 109.228 173.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.579 ' HD2' ' HA3' ' D' ' 81' ' ' GLY . 46.6 mtpt -75.83 -32.86 59.99 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 115.819 -0.628 . . . . 73.34 109.435 175.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.427 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.4 t70 -149.23 137.42 20.73 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 114.697 -1.138 . . . . 64.43 109.452 -177.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.618 HG21 ' HE2' ' C' ' 117' ' ' MET . 81.0 mt -135.73 146.82 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.321 1.048 . . . . 71.41 108.674 177.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.8 m -147.66 138.3 23.25 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 124.161 0.984 . . . . 73.45 110.494 173.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.488 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 80.6 t80 -142.62 111.67 6.48 Favored 'General case' 0 C--O 1.222 -0.389 0 N-CA-C 105.516 -2.031 . . . . 75.42 105.516 166.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 37.1 mt-10 -123.08 110.89 15.89 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.897 -0.779 . . . . 74.13 108.897 -173.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.821 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -113.64 83.25 6.99 Favored Pre-proline 0 CA--C 1.546 0.801 0 C-N-CA 123.477 0.711 . . . . 71.35 109.336 177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -71.27 -36.9 6.45 Favored 'Trans proline' 0 C--N 1.379 2.155 0 C-N-CA 122.505 2.137 . . . . 71.24 111.807 -175.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.428 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 30.8 m-20 -112.41 22.77 14.32 Favored 'General case' 0 C--O 1.219 -0.518 0 C-N-CA 124.041 0.936 . . . . 75.52 109.891 -172.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.821 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.82 -60.48 4.99 Favored Pre-proline 0 N--CA 1.489 1.512 0 N-CA-C 114.394 1.257 . . . . 41.33 114.394 -168.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HE3' ' C' ' 19' ' ' LYS . 82.7 Cg_endo -75.12 -8.76 20.21 Favored 'Trans proline' 0 C--N 1.387 2.585 0 CA-C-N 121.751 1.661 . . . . 73.13 112.845 -175.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.428 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.3 t-160 -83.5 -37.17 23.43 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.43 1.492 . . . . 64.31 109.427 176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.554 HG21 ' HA ' ' D' ' 73' ' ' ALA . 96.3 t -72.42 -32.49 42.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.641 0.777 . . . . 71.13 110.357 175.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.465 ' HA ' HG12 ' G' ' 301' ' ' ILE . 21.9 m-85 -69.07 -3.1 11.87 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 113.528 0.936 . . . . 73.51 113.528 -176.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -83.94 -9.92 58.34 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 123.57 0.748 . . . . 72.23 111.306 174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -110.4 114.29 27.61 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.672 1.189 . . . . 74.15 109.677 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' G' ' 300' ' ' ASN . 12.1 p-10 -100.11 93.9 5.96 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.826 0.85 . . . . 73.21 112.106 -177.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.444 ' CH2' ' HB3' ' D' ' 68' ' ' LEU . 0.0 OUTLIER -168.78 -164.48 0.49 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.684 0.794 . . . . 73.33 111.262 -177.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -89.12 122.08 69.05 Favored Pre-proline 0 N--CA 1.483 1.191 0 C-N-CA 124.193 0.997 . . . . 74.4 111.544 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.743 ' HB3' HD11 ' D' ' 68' ' ' LEU . 74.2 Cg_exo -56.43 134.52 64.79 Favored 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.51 2.807 . . . . 73.51 114.531 165.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.11 114.0 24.29 Favored 'General case' 0 CA--C 1.542 0.65 0 N-CA-C 106.553 -1.647 . . . . 74.4 106.553 166.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 45.5 t -131.18 138.95 52.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 123.554 0.742 . . . . 55.22 109.852 -172.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -130.92 153.18 49.43 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.424 1.09 . . . . 71.0 111.134 -178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.6 tt -97.6 120.0 37.18 Favored 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 107.847 -1.168 . . . . 62.3 107.847 178.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.582 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 5.2 m-20 -105.66 145.38 31.13 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 108.105 -1.072 . . . . 74.12 108.105 171.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.7 pp -137.68 147.34 44.79 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 121.489 0.661 . . . . 63.51 111.93 -175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -149.67 146.85 27.48 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.328 1.451 . . . . 62.41 107.705 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.6 p -123.62 155.76 37.08 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 123.411 0.684 . . . . 73.22 110.757 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.592 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -159.25 158.37 32.41 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.506 0.722 . . . . 70.13 110.312 -179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 60.7 p -160.25 153.22 21.52 Favored 'General case' 0 C--O 1.242 0.674 0 C-N-CA 123.395 0.678 . . . . 74.11 109.434 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 26.7 p -157.56 123.31 4.66 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 123.521 0.728 . . . . 71.21 109.582 -178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -70.36 120.46 16.05 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.434 -0.58 . . . . 72.12 109.434 174.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 50.3 mt -89.88 -38.35 13.78 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 122.705 0.402 . . . . 71.33 110.138 -179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.0 -175.95 5.69 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.597 0.759 . . . . 75.12 110.262 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -67.19 128.26 35.71 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 115.671 -0.695 . . . . 71.32 109.291 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.407 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 45.5 m-20 63.13 13.99 7.3 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.349 1.06 . . . . 75.22 112.135 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 89.6 t -125.28 119.9 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.238 1.015 . . . . 71.44 108.483 176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 81.3 m-85 -132.86 128.61 37.01 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 108.185 -1.043 . . . . 53.13 108.185 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -94.71 130.97 41.01 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 109.367 -0.605 . . . . 65.21 109.367 173.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 59.6 t -106.87 119.08 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 107.839 -1.171 . . . . 73.44 107.839 174.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.592 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 44.9 t -106.28 129.42 59.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 N-CA-C 108.85 -0.796 . . . . 75.44 108.85 175.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.29 113.1 20.32 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.115 -1.069 . . . . 60.22 108.115 176.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . . . . . . . . . 17.3 ttm-85 -86.87 98.26 11.11 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 108.884 -0.784 . . . . 71.13 108.884 172.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 99.3 t -91.48 127.32 43.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 N-CA-C 108.008 -1.108 . . . . 74.55 108.008 169.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 16.9 m -126.62 148.33 49.8 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 108.988 -0.745 . . . . 51.02 108.988 -178.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 37.1 t -136.42 109.49 8.54 Favored 'Isoleucine or valine' 0 C--O 1.241 0.642 0 C-N-CA 125.317 1.447 . . . . 72.43 108.192 -176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 85.8 m -103.82 122.27 44.78 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 122.994 0.518 . . . . 72.43 109.633 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' HB3' ' D' ' 73' ' ' ALA . . . -107.63 135.14 49.57 Favored 'General case' 0 C--O 1.242 0.686 0 N-CA-C 108.78 -0.822 . . . . 71.51 108.78 172.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 10.9 p -135.39 116.22 14.05 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 107.031 -1.47 . . . . 62.54 107.031 177.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' D' ' 38' ' ' PRO . 9.9 mp -122.42 115.45 22.28 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.555 -0.748 . . . . 64.41 110.662 -167.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.79 -111.32 3.27 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 110.799 -0.92 . . . . 53.35 110.799 -173.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -123.59 6.61 8.88 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.067 0.947 . . . . 72.21 109.172 174.337 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -124.5 174.92 7.48 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 123.846 0.858 . . . . 72.21 110.035 -173.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.9 m -84.18 135.29 34.43 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 123.249 0.619 . . . . 63.14 110.793 178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.638 ' HB2' HD13 ' D' ' 68' ' ' LEU . . . -81.19 -73.58 0.37 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.624 0.725 . . . . 73.3 109.374 169.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -153.6 155.55 36.31 Favored 'General case' 0 C--O 1.245 0.868 0 CA-C-N 114.272 -1.331 . . . . 74.44 109.947 -178.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.455 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 64.2 mt -123.08 110.93 15.94 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 107.928 -1.138 . . . . 53.24 107.928 -178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.444 ' SG ' HG12 ' D' ' 114' ' ' ILE . 52.4 t -115.78 133.74 55.73 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.966 -0.753 . . . . 62.15 108.966 -175.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -153.86 132.87 12.49 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.637 0.375 . . . . 72.12 110.252 179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 60.4 t -136.58 115.69 15.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.593 0 C-N-CA 123.901 0.881 . . . . 74.13 109.327 -177.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 47.3 mt-30 -88.7 86.82 7.06 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 108.723 -0.843 . . . . 71.31 108.723 170.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.21 95.13 6.19 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 114.704 -1.135 . . . . 73.43 109.468 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.579 ' HA3' ' HD2' ' D' ' 19' ' ' LYS . . . -91.96 143.35 16.5 Favored Glycine 0 C--N 1.341 0.852 0 N-CA-C 111.208 -0.757 . . . . 61.43 111.208 175.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -143.57 130.03 3.92 Favored Glycine 0 CA--C 1.505 -0.588 0 N-CA-C 110.274 -1.13 . . . . 74.34 110.274 -178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 51.7 mt -89.8 127.1 42.62 Favored 'Isoleucine or valine' 0 C--O 1.24 0.604 0 N-CA-C 108.795 -0.816 . . . . 74.23 108.795 -178.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.402 ' HD2' HG12 ' D' ' 13' ' ' ILE . 36.6 m-85 -130.21 125.41 34.85 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 109.602 -0.518 . . . . 75.51 109.602 178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 50.3 m -79.33 95.24 5.65 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 123.471 0.709 . . . . 73.12 109.304 172.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 38.1 mt -108.4 123.32 63.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 C-N-CA 123.721 0.808 . . . . 52.31 109.625 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.466 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -152.64 169.84 21.72 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 124.278 1.031 . . . . 62.33 109.711 -177.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 76.63 2.01 73.79 Favored Glycine 0 C--N 1.346 1.13 0 N-CA-C 114.9 0.72 . . . . 62.24 114.9 169.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 19.5 pt -135.93 148.5 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.005 0.922 . . . . 73.21 109.517 179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -137.86 159.71 41.27 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.566 0.746 . . . . 63.21 110.813 -174.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.82 -115.53 7.38 Favored Glycine 0 C--N 1.353 1.516 0 O-C-N 124.279 0.987 . . . . 63.43 115.372 167.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 33.4 m -68.68 -33.04 73.3 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 124.063 0.945 . . . . 64.44 111.891 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -72.08 -44.74 62.78 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.762 0.425 . . . . 72.35 111.025 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.37 -29.82 67.68 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 109.979 -0.378 . . . . 51.42 109.979 177.093 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.417 ' HB1' HD22 ' G' ' 280' ' ' LEU . . . -68.24 -39.19 82.35 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 123.547 0.739 . . . . 54.21 110.649 176.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -63.61 -42.27 98.24 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.849 0.46 . . . . 73.44 110.034 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.4 -47.77 80.6 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 122.848 0.459 . . . . 74.41 110.955 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.58 -34.36 46.92 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.452 0.701 . . . . 63.14 110.576 -176.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -82.82 -15.57 72.57 Favored Glycine 0 N--CA 1.466 0.677 0 CA-C-N 116.271 -0.422 . . . . 61.1 113.47 -175.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -131.17 -63.89 0.83 Allowed 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 112.618 0.599 . . . . 73.22 112.618 -172.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -72.46 -48.02 44.21 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 112.634 0.605 . . . . 65.1 112.634 -169.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.2 m -62.35 -46.23 90.13 Favored Pre-proline 0 CA--C 1.564 1.503 0 C-N-CA 123.556 0.742 . . . . 70.54 112.855 -176.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.16 -31.19 54.7 Favored 'Trans proline' 0 C--N 1.392 2.823 0 C-N-CA 122.043 1.828 . . . . 72.24 112.182 173.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -72.09 -17.99 61.95 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.703 0.801 . . . . 72.25 111.024 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 33.0 mm -80.2 -43.81 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 123.478 0.711 . . . . 50.12 110.051 171.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 87.1 mt -76.81 -32.62 57.75 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.545 0.738 . . . . 71.11 112.571 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -61.06 -44.79 95.47 Favored Pre-proline 0 CA--C 1.565 1.549 0 C-N-CA 124.154 0.981 . . . . 54.01 113.095 -171.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -56.85 -37.24 98.6 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.536 2.157 . . . . 74.25 114.075 172.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -79.91 -25.96 40.35 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 123.087 0.555 . . . . 62.13 111.838 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.22 -50.07 62.14 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 109.105 -0.702 . . . . 41.04 109.105 170.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -60.5 -35.59 76.29 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.564 1.165 . . . . 52.42 111.301 179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . 0.436 ' HG2' HH12 ' C' ' 120' ' ' ARG . 26.8 tt0 -56.35 -52.13 65.72 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.151 0.98 . . . . 71.03 110.865 175.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 47.9 t -67.17 -42.46 84.22 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 114.915 -1.039 . . . . 73.3 111.132 -177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.444 HG12 ' SG ' ' D' ' 76' ' ' CYS . 87.7 mt -58.74 -63.59 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 124.185 0.994 . . . . 64.51 110.508 178.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 34.9 m -52.03 -38.17 56.0 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.467 1.107 . . . . 75.21 112.206 -176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 25.9 t -66.41 -45.21 80.68 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.52 0.728 . . . . 73.34 111.04 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 72.9 mtm -67.95 -36.71 80.57 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 122.886 0.475 . . . . 70.33 111.554 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.438 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.9 t -64.4 -40.27 88.48 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.096 0 CA-C-N 115.306 -0.861 . . . . 64.35 110.224 178.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 88.7 p -72.08 -31.33 65.99 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 122.601 0.36 . . . . 73.35 111.202 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.422 ' HD3' ' SG ' ' C' ' 113' ' ' CYS . 93.8 mtt-85 -73.16 -23.52 60.46 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 123.286 0.634 . . . . 62.03 110.994 176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -94.31 12.41 69.01 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.743 0.652 . . . . 60.51 112.861 174.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.493 HG23 ' HB3' ' C' ' 17' ' ' TYR . 54.3 p 59.78 22.21 11.07 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 126.277 1.831 . . . . 71.11 113.619 176.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -93.23 161.64 30.45 Favored Pre-proline 0 CA--C 1.556 1.203 0 C-N-CA 124.423 1.089 . . . . 70.52 109.387 171.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -74.9 144.34 30.5 Favored 'Trans proline' 0 C--N 1.382 2.301 0 C-N-CA 122.256 1.971 . . . . 62.33 111.172 -176.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.78 HE21 HG21 ' A' ' 122' ' ' THR . 5.0 pt20 -44.84 121.78 2.91 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.666 1.186 . . . . 73.34 111.934 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -106.78 95.42 5.72 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.616 -1.253 . . . . 74.15 107.616 -175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -103.77 109.26 20.91 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-N 115.303 -0.862 . . . . 72.3 109.134 -178.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -67.83 118.97 11.77 Favored 'General case' 0 C--O 1.243 0.723 0 CA-C-N 115.614 -0.721 . . . . 35.44 109.057 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.416 ' HB2' HG11 ' E' ' 306' ' ' VAL . . . -64.2 138.66 97.49 Favored Pre-proline 0 CA--C 1.55 0.953 0 O-C-N 123.963 0.789 . . . . 53.25 111.15 -178.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.45 132.12 10.97 Favored 'Trans proline' 0 C--N 1.375 1.965 0 C-N-CA 122.429 2.086 . . . . 73.54 112.882 -172.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.4 t -109.71 121.96 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 N-CA-C 108.366 -0.976 . . . . 73.41 108.366 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 53.9 t30 -77.27 97.54 4.87 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 109.084 -0.71 . . . . 70.32 109.084 175.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -71.1 -32.9 69.62 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.48 -0.782 . . . . 62.01 111.156 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -56.21 -38.8 71.5 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.101 0.96 . . . . 71.52 112.135 -177.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.42 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -73.38 -27.89 61.72 Favored 'General case' 0 N--CA 1.475 0.784 0 O-C-N 123.825 0.703 . . . . 74.34 112.086 -177.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' G' ' 287' ' ' PRO . 74.7 mt -67.29 -43.9 80.61 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 123.62 0.768 . . . . 75.52 110.244 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -75.58 -32.05 60.22 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.634 0.774 . . . . 75.12 111.191 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 34.8 ttm -59.02 -32.35 69.65 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.415 1.086 . . . . 54.13 111.819 -178.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -58.59 -39.0 79.17 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 115.291 -0.868 . . . . 71.43 111.18 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -65.79 -39.51 91.02 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.138 0.575 . . . . 75.31 111.411 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.98 -34.53 78.65 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 123.896 0.878 . . . . 62.42 112.376 -174.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -90.07 25.29 2.19 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.146 0.579 . . . . 73.11 112.223 -177.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 86.9 mt-30 -116.79 48.13 1.35 Allowed 'General case' 0 N--CA 1.484 1.273 0 CA-C-O 122.271 1.034 . . . . 32.33 108.215 178.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -151.52 151.04 31.07 Favored 'General case' 0 C--O 1.242 0.71 0 CA-C-N 114.049 -1.432 . . . . 61.21 107.796 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.71 146.77 54.29 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 122.842 0.457 . . . . 73.43 111.433 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -151.42 70.98 0.3 Allowed Glycine 0 C--N 1.336 0.565 0 N-CA-C 110.578 -1.009 . . . . 33.43 110.578 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -58.73 109.79 0.88 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.515 1.126 . . . . 62.43 110.684 179.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -106.65 68.64 0.23 Allowed Glycine 0 C--N 1.342 0.884 0 N-CA-C 110.815 -0.914 . . . . 43.43 110.815 179.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 26.9 m -60.56 112.96 2.19 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 123.521 0.728 . . . . 60.34 111.066 -177.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.96 155.41 40.39 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.22 1.008 . . . . 52.13 110.89 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -151.77 141.19 21.55 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 123.454 0.702 . . . . 74.45 110.061 179.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -149.81 166.13 30.42 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.091 1.356 . . . . 71.2 108.8 170.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -152.53 149.53 28.61 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.894 0.877 . . . . 60.11 109.611 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -105.59 117.99 35.44 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.133 -1.062 . . . . 75.2 108.133 172.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.187 0 N-CA-C 109.094 -0.706 . . . . 52.32 109.094 179.13 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 109.525 -0.546 . . . . 74.34 109.525 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 -70.27 103.15 2.29 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 108.966 -0.753 . . . . 75.3 108.966 177.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -77.62 -9.24 58.84 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.512 0.725 . . . . 72.41 112.207 -174.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . 0.635 ' HG3' ' HA3' ' E' ' 279' ' ' GLY . 34.3 tt0 -85.52 53.88 2.92 Favored 'General case' 0 CA--C 1.555 1.16 0 CA-C-O 121.924 0.869 . . . . 74.34 109.745 179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -89.0 -46.16 0.43 Allowed Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 123.703 0.801 . . . . 74.41 110.445 172.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -76.15 176.92 9.43 Favored 'Trans proline' 0 C--N 1.393 2.871 0 C-N-CA 121.53 1.487 . . . . 74.41 111.79 171.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 5.6 mp -86.05 66.08 9.41 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.736 0.814 . . . . 75.42 109.844 177.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -169.81 97.27 0.3 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 105.961 -1.866 . . . . 51.33 105.961 175.318 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . 0.635 ' HA3' ' HG3' ' E' ' 274' ' ' GLN . . . -153.49 17.41 0.67 Allowed Glycine 0 C--N 1.348 1.232 0 N-CA-C 114.302 0.481 . . . . 72.31 114.302 -174.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 5.0 tt -163.59 100.49 0.91 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 106.893 -1.521 . . . . 71.02 106.893 176.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -166.98 131.31 1.97 Allowed 'General case' 0 CA--C 1.542 0.672 0 O-C-N 123.797 0.686 . . . . 64.12 110.263 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -98.76 151.42 20.8 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.624 0.769 . . . . 74.23 109.461 175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -76.79 91.53 3.52 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 123.416 0.687 . . . . 73.31 110.067 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 74.24 -81.49 0.81 Allowed Glycine 0 C--N 1.345 1.069 0 CA-C-N 115.833 -0.621 . . . . 50.23 111.743 -175.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 74.8 -62.33 0.46 Allowed 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.946 1.698 . . . . 64.55 113.109 171.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 44' ' ' LEU . 43.2 ttm -67.63 113.29 13.48 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 123.831 0.852 . . . . 54.41 110.617 -177.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -91.52 108.72 0.29 Allowed 'Trans proline' 0 C--N 1.368 1.585 0 C-N-CA 122.501 2.134 . . . . 72.2 110.269 171.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 9.9 p -68.51 -27.06 35.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.348 0 C-N-CA 122.276 0.23 . . . . 64.12 110.794 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 61.95 -88.36 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.023 1.329 . . . . 75.43 111.77 172.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . 0.54 ' HE3' ' H ' ' E' ' 291' ' ' LEU . 0.0 OUTLIER -167.24 146.94 5.28 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.515 1.126 . . . . 72.23 109.468 179.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.54 ' H ' ' HE3' ' E' ' 290' ' ' TRP . 3.1 mp -126.76 82.68 2.1 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 108.516 -0.92 . . . . 74.31 108.516 174.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 114.14 -94.86 0.71 Allowed Glycine 0 CA--C 1.534 1.221 0 CA-C-O 118.974 -0.903 . . . . 62.14 112.758 176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -70.0 175.05 8.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.03 2.486 . . . . 74.45 113.012 -177.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 38.7 mtmt -106.18 -16.63 14.54 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.225 1.01 . . . . 64.32 110.483 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -156.23 163.75 39.19 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-O 121.242 0.544 . . . . 71.13 111.527 -172.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 12.1 t -90.64 -19.56 23.51 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 115.098 -0.956 . . . . 71.41 109.967 171.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.5 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 6.2 m-85 -72.54 139.51 47.59 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.488 0.715 . . . . 73.41 111.92 -179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . 0.784 ' HB3' ' HB3' ' G' ' 303' ' ' LYS . 80.6 t60 -175.7 -41.08 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 O-C-N 125.058 1.473 . . . . 73.31 107.16 174.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -172.44 -140.86 3.24 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.354 -0.839 . . . . 75.35 112.075 174.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . 0.491 ' HB2' ' HA ' ' G' ' 302' ' ' ASP . 3.3 t-20 82.59 -16.08 0.62 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 125.938 1.695 . . . . 65.35 113.576 170.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.599 HD13 ' HA ' ' A' ' 123' ' ' PHE . 9.3 pt -137.03 48.48 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 N-CA-C 113.309 0.855 . . . . 73.51 113.309 -170.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . 0.777 ' HB2' ' HA ' ' G' ' 297' ' ' TYR . 76.6 m-20 -68.93 144.97 54.03 Favored 'General case' 0 N--CA 1.481 1.099 0 O-C-N 121.557 -0.714 . . . . 62.14 109.876 170.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . 0.582 ' H ' ' HD3' ' E' ' 303' ' ' LYS . 0.0 OUTLIER -70.44 137.04 86.17 Favored Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 123.329 0.651 . . . . 75.12 111.142 -178.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.15 -57.88 0.45 Allowed 'Trans proline' 0 C--N 1.381 2.249 0 C-N-CA 123.127 2.551 . . . . 54.3 112.806 177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . 0.417 ' HA ' ' HA ' ' B' ' 14' ' ' GLN . . . 55.29 85.04 0.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.821 1.248 . . . . 71.24 111.658 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' D' ' 129' ' ' ALA . 57.6 t -73.18 122.45 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 122.965 0.506 . . . . 72.23 110.2 -176.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 15.2 t -70.27 154.67 41.64 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 123.784 0.833 . . . . 74.12 111.2 -174.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 28.1 p -66.42 138.36 57.5 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.313 0.645 . . . . 60.54 111.11 -175.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 17.7 p -65.55 152.46 92.46 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.841 1.256 . . . . 62.14 112.022 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo . . . . . 0 C--N 1.387 2.59 0 C-N-CA 123.768 2.979 . . . . 71.44 113.48 -175.021 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 109.864 -0.421 . . . . 71.24 109.864 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -77.36 -13.27 59.96 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 123.359 0.664 . . . . 71.54 111.306 176.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . 0.619 ' HG2' ' HG3' ' F' ' 274' ' ' GLN . 53.7 tt0 -67.26 130.34 42.79 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.04 0.936 . . . . 73.1 111.999 -178.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . 0.619 ' HG3' ' HG2' ' F' ' 273' ' ' GLN . 92.5 mt-30 65.59 111.99 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.498 1.519 . . . . 64.31 111.94 175.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -104.86 98.92 16.55 Favored Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 108.19 -1.041 . . . . 75.04 108.19 170.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -65.16 -67.66 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.061 0 C-N-CA 122.852 2.368 . . . . 75.24 112.995 -171.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 62.2 mt -102.05 123.31 45.72 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 109.828 -0.434 . . . . 70.52 109.828 -178.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 70.65 81.52 0.16 Allowed 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 125.519 1.528 . . . . 75.02 109.511 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -114.17 -84.99 1.31 Allowed Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.008 -0.997 . . . . 43.42 110.648 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . 0.495 ' HB3' ' HB1' ' C' ' 95' ' ' ALA . 2.4 tt -78.92 78.33 5.37 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 108.444 -0.947 . . . . 72.43 108.444 178.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -179.89 84.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.093 0.957 . . . . 70.43 109.771 176.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -167.62 106.2 0.54 Allowed 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.183 -1.043 . . . . 73.24 108.183 179.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 37.3 t70 63.77 23.59 13.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 124.097 0.873 . . . . 74.3 110.481 -177.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -70.9 89.34 0.39 Allowed Glycine 0 C--N 1.354 1.571 0 CA-C-N 115.37 -0.832 . . . . 44.43 113.159 -171.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -98.78 106.22 18.46 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 123.739 0.816 . . . . 65.34 109.135 177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . 0.468 ' SD ' ' HD1' ' C' ' 133' ' ' PHE . 58.9 mtt -73.7 157.12 87.92 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-O 118.907 -0.568 . . . . 64.45 109.476 171.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -65.48 79.77 0.24 Allowed 'Trans proline' 0 C--N 1.381 2.254 0 C-N-CA 122.592 2.194 . . . . 72.14 112.609 178.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 56.7 t -101.16 84.54 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.614 0 N-CA-C 107.853 -1.165 . . . . 73.31 107.853 177.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.13 130.46 40.94 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 107.787 -1.19 . . . . 72.52 107.787 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . 0.404 ' HE1' ' HG3' ' F' ' 294' ' ' LYS . 15.1 t-105 -62.73 129.12 39.1 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 123.639 0.587 . . . . 62.3 110.542 -177.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.86 -175.06 3.07 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.012 1.325 . . . . 52.32 111.268 -167.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 73.25 173.96 26.81 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 114.995 -1.002 . . . . 51.23 113.672 173.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -75.81 133.5 15.48 Favored 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 122.682 2.255 . . . . 75.5 110.964 169.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . 0.404 ' HG3' ' HE1' ' F' ' 290' ' ' TRP . 0.0 OUTLIER -88.97 30.85 0.9 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.102 0.961 . . . . 72.33 110.93 -177.692 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -76.22 78.5 3.01 Favored 'General case' 0 CA--C 1.547 0.841 0 CA-C-O 121.994 0.902 . . . . 73.44 108.9 173.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 31.5 m -136.78 149.43 47.78 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.404 1.481 . . . . 64.23 107.14 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.603 ' HB2' ' HE1' ' C' ' 74' ' ' PHE . 18.9 t80 68.33 -73.61 0.08 Allowed 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 124.298 1.039 . . . . 71.32 111.303 -177.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -103.41 26.95 7.78 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.09 0.556 . . . . 65.12 110.147 174.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -78.95 70.82 2.69 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 111.046 -0.822 . . . . 34.4 111.046 167.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . 0.61 ' HB2' ' HA2' ' H' ' 299' ' ' GLY . 40.6 m-80 61.97 82.16 0.18 Allowed 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.605 1.562 . . . . 71.53 112.282 178.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 36.5 pt -102.73 170.65 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 CA-C-O 121.67 0.748 . . . . 74.13 110.257 170.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -151.44 -179.81 7.7 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 107.255 -1.387 . . . . 55.33 107.255 176.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -64.84 133.35 95.72 Favored Pre-proline 0 CA--C 1.548 0.901 0 N-CA-C 108.428 -0.953 . . . . 73.42 108.428 173.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.33 11.58 0.45 Allowed 'Trans proline' 0 C--N 1.378 2.131 0 C-N-CA 123.49 2.793 . . . . 73.12 115.226 -168.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.03 27.13 8.83 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.57 1.148 . . . . 74.11 111.539 174.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . 0.416 HG13 ' HD2' ' B' ' 130' ' ' PRO . 55.8 t -102.53 122.38 54.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 123.569 0.748 . . . . 64.04 109.189 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 62.4 m -142.02 155.09 45.41 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.004 0.921 . . . . 54.11 108.557 178.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 53.2 t -63.05 126.58 27.82 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 122.817 0.447 . . . . 73.3 110.461 175.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 3.6 t -134.05 103.44 11.79 Favored Pre-proline 0 CA--C 1.553 1.094 0 C-N-CA 123.937 0.895 . . . . 55.3 108.678 179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo . . . . . 0 CA--C 1.564 1.981 0 C-N-CA 122.419 2.079 . . . . 73.23 112.375 174.028 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 N-CA-C 110.599 -0.149 . . . . 72.25 110.599 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 65.44 30.01 11.04 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 124.832 1.253 . . . . 61.23 111.697 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -78.95 102.15 8.13 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.776 0.831 . . . . 60.34 109.343 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -115.22 -54.45 2.55 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 124.194 0.998 . . . . 74.24 112.061 -168.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -69.92 154.17 94.88 Favored Pre-proline 0 N--CA 1.485 1.287 0 CA-C-O 119.092 -0.48 . . . . 61.03 111.202 -168.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -37.38 116.65 0.19 Allowed 'Trans proline' 0 C--N 1.392 2.836 0 C-N-CA 124.473 3.449 . . . . 70.34 115.666 -175.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.07 -11.09 48.16 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 114.584 -1.189 . . . . 64.32 108.59 169.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 34.2 tp -135.7 118.75 16.42 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.4 1.08 . . . . 54.52 108.194 -179.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 167.27 65.66 0.03 OUTLIER Glycine 0 C--N 1.35 1.315 0 O-C-N 123.074 0.234 . . . . 74.12 113.554 -178.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' G' ' 281' ' ' PHE . 13.4 tp -166.74 -162.84 0.52 Allowed 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.864 -1.162 . . . . 75.24 107.864 170.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . 0.673 ' H ' ' HG ' ' G' ' 280' ' ' LEU . 9.4 t80 87.77 -48.84 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 125.969 1.708 . . . . 75.42 111.925 163.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -75.28 77.33 2.39 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.075 0.55 . . . . 74.4 109.905 173.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -159.87 -52.67 0.06 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.658 0.783 . . . . 75.13 110.833 -176.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 67.25 40.43 92.22 Favored Glycine 0 C--N 1.348 1.244 0 N-CA-C 111.629 -0.588 . . . . 71.21 111.629 -172.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -71.06 -32.94 69.75 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.267 1.027 . . . . 75.02 110.939 -176.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -60.73 125.99 84.18 Favored Pre-proline 0 CA--C 1.552 1.051 0 CA-C-N 115.533 -0.758 . . . . 75.43 109.73 171.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' D' ' 136' ' ' LEU . 14.8 Cg_endo -54.44 -63.69 0.2 Allowed 'Trans proline' 0 C--N 1.38 2.211 0 C-N-CA 123.185 2.59 . . . . 64.31 112.859 -173.525 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 60.0 t 60.84 -75.74 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 124.638 1.175 . . . . 62.31 110.958 -175.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 74.23 -12.07 0.93 Allowed 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 125.433 1.493 . . . . 75.41 112.553 172.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 9.8 t-105 73.91 123.8 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 125.72 1.608 . . . . 65.34 109.705 -164.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 3.3 mp -88.68 19.21 4.1 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.491 1.116 . . . . 71.41 112.288 -161.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 141.51 101.65 0.44 Allowed Glycine 0 C--N 1.346 1.088 0 CA-C-O 119.123 -0.821 . . . . 61.02 112.09 175.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -72.95 168.6 24.26 Favored 'Trans proline' 0 C--N 1.377 2.068 0 C-N-CA 122.595 2.197 . . . . 74.1 111.835 172.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' D' ' 38' ' ' PRO . 6.9 mtmp? 67.71 11.63 8.47 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.322 1.049 . . . . 74.04 112.532 179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.35 60.46 6.01 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.75 0.82 . . . . 74.0 109.96 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -159.63 132.4 6.74 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.502 1.521 . . . . 73.11 107.992 -174.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.777 ' HA ' ' HB2' ' E' ' 302' ' ' ASP . 5.2 m-85 57.11 -175.37 0.07 Allowed 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.352 1.061 . . . . 42.12 113.374 -176.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -143.89 -56.5 0.38 Allowed 'General case' 0 C--O 1.24 0.57 0 CA-C-N 115.08 -0.963 . . . . 71.24 109.087 174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -164.91 30.44 0.23 Allowed Glycine 0 C--N 1.35 1.327 0 N-CA-C 114.48 0.552 . . . . 62.34 114.48 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . 0.427 ' HA ' ' HB2' ' D' ' 35' ' ' ASP . 12.1 p30 -148.67 155.78 41.5 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 117.266 0.533 . . . . 74.22 109.837 168.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.465 HG12 ' HA ' ' D' ' 32' ' ' PHE . 6.9 tp -113.27 -39.91 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 123.847 0.859 . . . . 72.23 110.886 -175.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' E' ' 300' ' ' ASN . 3.5 p30 -166.77 -165.19 0.71 Allowed 'General case' 0 N--CA 1.481 1.086 0 CA-C-O 121.965 0.888 . . . . 71.42 113.115 -175.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . 0.784 ' HB3' ' HB3' ' E' ' 298' ' ' HIS . 0.0 OUTLIER -136.62 125.15 15.12 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 126.025 1.73 . . . . 74.52 108.375 172.239 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.9 -42.11 12.28 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 122.3 2.0 . . . . 71.42 111.171 168.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . 60.37 -84.84 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.425 1.49 . . . . 41.14 112.089 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 20.2 m -90.17 113.41 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 CA-C-O 121.371 0.605 . . . . 74.35 109.646 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 33.0 m -142.18 -32.4 0.51 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.19 0.996 . . . . 55.21 108.801 177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 73.8 m -116.1 76.38 1.01 Allowed 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.92 0.888 . . . . 73.42 108.739 168.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 90.6 m -65.07 -53.58 40.27 Favored Pre-proline 0 CA--C 1.563 1.461 0 CA-C-N 115.487 -0.779 . . . . 65.2 112.098 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo . . . . . 0 C--N 1.396 3.032 0 C-N-CA 122.356 2.038 . . . . 74.53 111.407 -178.19 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.5 0.19 . . . . 55.41 110.575 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -81.37 -14.51 57.12 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.244 0.618 . . . . 72.04 111.408 178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.69 158.01 34.24 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.721 0.808 . . . . 71.05 109.634 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 26.8 mp0 -123.97 144.55 49.74 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.69 0.796 . . . . 71.33 109.249 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.48 -51.43 51.57 Favored Pre-proline 0 CA--C 1.565 1.523 0 C-N-CA 123.7 0.8 . . . . 63.12 111.07 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -83.68 172.97 9.76 Favored 'Trans proline' 0 C--N 1.385 2.483 0 C-N-CA 121.519 1.479 . . . . 74.43 112.238 176.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 85.8 mt 64.99 175.13 0.2 Allowed 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.739 1.216 . . . . 64.15 112.343 176.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 62.51 18.87 10.79 Favored 'General case' 0 N--CA 1.498 1.969 0 C-N-CA 124.257 1.023 . . . . 74.43 112.535 -178.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -79.39 129.49 9.2 Favored Glycine 0 C--N 1.351 1.402 0 CA-C-O 119.477 -0.624 . . . . 70.22 112.651 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 2.2 tt 56.46 75.94 0.32 Allowed 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 125.166 1.386 . . . . 74.34 109.645 -175.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -167.18 -43.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 115.775 -0.648 . . . . 71.35 110.482 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -61.66 -27.37 68.63 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.156 0.582 . . . . 63.21 111.272 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -78.64 -82.72 0.09 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 123.844 0.857 . . . . 54.22 110.249 174.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 73.79 108.81 0.07 OUTLIER Glycine 0 CA--C 1.54 1.639 0 CA-C-N 118.304 0.502 . . . . 72.42 113.999 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -136.22 -101.05 0.21 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 108.193 -1.04 . . . . 44.13 108.193 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 44.8 ttp 46.62 84.8 0.19 Allowed Pre-proline 0 CA--C 1.565 1.527 0 C-N-CA 124.93 1.292 . . . . 73.24 112.797 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.57 111.86 2.46 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 122.858 2.372 . . . . 64.31 111.466 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 98.6 t -70.71 -33.98 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.662 0.785 . . . . 61.03 110.633 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 65.59 -170.01 0.2 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.792 1.237 . . . . 73.42 110.876 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 1.5 m95 -102.69 138.97 38.88 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.237 0.541 . . . . 72.12 110.49 171.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.43 -14.54 30.39 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 114.584 -1.189 . . . . 54.21 109.887 177.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.23 177.57 41.83 Favored Glycine 0 C--N 1.35 1.352 0 CA-C-N 116.007 -0.542 . . . . 31.12 112.656 178.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -76.94 145.59 25.21 Favored 'Trans proline' 0 C--N 1.373 1.818 0 C-N-CA 123.278 2.652 . . . . 73.22 112.578 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -104.82 130.01 53.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 123.229 0.611 . . . . 73.12 111.5 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -88.64 101.19 13.73 Favored 'General case' 0 C--N 1.347 0.483 0 N-CA-C 108.423 -0.955 . . . . 74.13 108.423 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . 0.411 HG22 ' HD1' ' H' ' 297' ' ' TYR . 3.0 m -132.52 160.8 35.48 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 107.946 -1.131 . . . . 72.23 107.946 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.411 ' HD1' HG22 ' H' ' 296' ' ' THR . 2.8 m-85 70.84 -67.26 0.26 Allowed 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 124.614 1.166 . . . . 73.22 111.007 -179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 64.0 t60 -63.26 94.09 0.07 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 123.438 0.695 . . . . 73.54 110.517 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . 0.61 ' HA2' ' HB2' ' F' ' 300' ' ' ASN . . . -154.45 -64.57 0.01 OUTLIER Glycine 0 C--N 1.337 0.638 0 N-CA-C 109.909 -1.276 . . . . 51.03 109.909 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -125.62 79.95 1.86 Allowed 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 107.493 -1.299 . . . . 73.43 107.493 172.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 10.1 tt -139.84 108.41 3.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 115.271 -0.877 . . . . 74.43 110.156 -177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -169.53 -67.15 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 107.465 -1.309 . . . . 70.54 107.465 173.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -123.56 87.72 52.07 Favored Pre-proline 0 N--CA 1.471 0.597 0 N-CA-C 108.027 -1.101 . . . . 64.43 108.027 170.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.46 3.03 7.15 Favored 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.581 2.187 . . . . 75.22 112.511 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -70.61 121.26 17.56 Favored 'General case' 0 C--O 1.241 0.635 0 C-N-CA 124.425 1.09 . . . . 73.45 111.001 178.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 13' ' ' ILE . 58.1 t -77.4 86.83 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 107.923 -1.14 . . . . 74.14 107.923 168.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 32.4 p -86.9 135.8 33.18 Favored 'General case' 0 C--O 1.241 0.632 0 CA-C-N 115.294 -0.866 . . . . 55.24 109.327 177.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 63.7 m 71.42 142.62 0.06 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.555 1.542 . . . . 64.3 111.059 -173.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 94.0 m 67.99 109.53 0.03 OUTLIER Pre-proline 0 CA--C 1.558 1.254 0 C-N-CA 124.883 1.273 . . . . 72.5 111.303 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.377 2.066 0 C-N-CA 122.311 2.007 . . . . 74.32 111.494 173.326 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.5 mtm . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 108.791 -0.818 . . . . 73.4 108.791 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.4 t -121.36 153.72 37.4 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 109.268 -0.641 . . . . 73.14 109.268 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -72.52 102.56 3.27 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 109.139 -0.689 . . . . 73.04 109.139 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -73.76 85.5 1.67 Allowed 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.577 0.703 . . . . 64.31 111.977 -171.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -78.68 128.59 33.66 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 114.912 -1.04 . . . . 63.12 109.661 173.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -73.89 -27.17 60.92 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.534 0.734 . . . . 73.24 110.864 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.5 p 54.18 -170.64 0.05 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 125.491 1.516 . . . . 62.2 112.802 -179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -100.21 168.81 9.56 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.213 0.605 . . . . 70.31 109.721 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -59.63 133.52 56.17 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.611 0.764 . . . . 75.4 110.733 179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 62.9 m -144.52 142.35 30.16 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.62 0.768 . . . . 63.31 109.665 -176.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.557 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 14.7 t80 -135.89 122.33 20.67 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 107.908 -1.145 . . . . 73.55 107.908 171.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.698 HE22 HG12 ' H' ' 306' ' ' VAL . 61.2 tp60 -144.78 102.71 3.82 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 110.099 -0.334 . . . . 72.52 110.099 -177.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.706 HG21 ' HG2' ' C' ' 130' ' ' PRO . 58.2 mt -71.93 128.34 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 N-CA-C 109.101 -0.703 . . . . 71.34 109.101 176.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -103.68 -37.55 7.46 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.917 0.487 . . . . 42.23 110.011 -177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -165.53 138.73 4.42 Favored 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 110.209 -0.293 . . . . 74.22 110.209 -170.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.471 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -128.4 134.01 65.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.57 -0.9 . . . . 74.21 108.57 172.851 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.412 ' HB3' HG23 ' B' ' 122' ' ' THR . 22.9 p90 -165.07 147.02 7.87 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.057 0.543 . . . . 65.43 110.961 -172.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.5 p -76.44 110.48 11.02 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.79 -0.819 . . . . 75.3 108.79 172.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.432 ' HE3' ' HD3' ' B' ' 29' ' ' PRO . 37.2 mtpt -76.05 -22.52 55.6 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 116.025 -0.534 . . . . 74.23 110.511 178.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -156.87 142.16 17.35 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 114.797 -1.092 . . . . 71.43 109.441 179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.7 140.2 41.67 Favored 'Isoleucine or valine' 0 C--O 1.244 0.772 0 N-CA-C 106.732 -1.581 . . . . 73.03 106.732 175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.419 ' HB3' ' HB2' ' A' ' 77' ' ' GLU . 31.1 t -150.85 141.75 22.91 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.8 -0.815 . . . . 73.02 108.8 175.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 86.8 t80 -151.78 110.78 3.87 Favored 'General case' 0 C--O 1.21 -0.982 0 N-CA-C 105.955 -1.869 . . . . 62.25 105.955 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -122.35 118.15 27.77 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 109.356 -0.609 . . . . 74.23 109.356 177.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -105.89 83.73 1.11 Allowed Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 107.802 -1.185 . . . . 55.53 107.802 172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -60.88 -42.64 36.19 Favored 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 122.859 2.372 . . . . 71.4 112.929 -166.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.435 HD22 ' HG2' ' A' ' 71' ' ' GLU . 14.3 m-20 -109.64 29.89 7.17 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 118.415 -0.803 . . . . 64.32 109.815 -175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.429 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -42.89 -57.06 5.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 CA-C-O 117.583 -1.199 . . . . 70.32 113.669 -173.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 11.7 Cg_exo -64.42 -29.33 62.52 Favored 'Trans proline' 0 C--N 1.394 2.938 0 CA-C-N 121.618 1.614 . . . . 62.31 112.348 -178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -79.8 -35.75 38.0 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 114.853 -1.067 . . . . 72.22 110.883 -176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.577 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.1 p -80.88 -13.49 12.77 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 CA-C-N 115.749 -0.66 . . . . 73.05 111.879 -168.205 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -76.57 -11.72 59.91 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.174 0.59 . . . . 72.34 110.781 171.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -91.25 -12.5 35.03 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.495 1.118 . . . . 64.13 110.913 177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HG2' ' HA ' ' A' ' 31' ' ' VAL . 27.9 mmmt -81.62 166.2 20.4 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.671 0.788 . . . . 74.21 112.103 -173.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -77.14 139.18 39.88 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 114.254 -1.339 . . . . 75.3 108.576 174.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.2 m95 -81.31 69.35 7.92 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-O 121.579 0.704 . . . . 74.43 111.16 -171.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -134.35 71.48 72.01 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 123.871 0.868 . . . . 54.12 108.93 177.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HG2' ' HA ' ' E' ' 295' ' ' ALA . 92.4 Cg_endo -81.91 143.18 12.92 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 122.28 1.987 . . . . 62.34 111.704 176.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -104.65 102.37 11.97 Favored 'General case' 0 C--O 1.243 0.756 0 N-CA-C 107.79 -1.189 . . . . 65.35 107.79 164.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 65' ' ' THR . 42.4 t -74.43 94.63 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 N-CA-C 108.897 -0.779 . . . . 74.42 108.897 179.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.503 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 60.1 tttm -80.85 113.84 19.33 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.129 0.972 . . . . 75.53 109.519 176.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.2 tt -99.13 125.67 44.72 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 108.121 -1.066 . . . . 53.2 108.121 -176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.635 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -120.01 129.65 54.36 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.334 -0.987 . . . . 75.11 108.334 176.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.2 mp -105.43 117.56 34.34 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 109.15 -0.685 . . . . 72.41 109.15 179.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -121.73 139.64 53.32 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 108.079 -1.082 . . . . 75.45 108.079 172.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.5 t -152.14 163.46 39.32 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 122.834 0.454 . . . . 75.05 111.15 -174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -160.91 153.23 20.34 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.099 0.96 . . . . 44.34 109.974 -178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 p -131.23 151.45 51.46 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.814 -0.81 . . . . 54.2 108.814 167.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.8 t -158.21 145.5 18.01 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.859 0.464 . . . . 73.24 110.675 -171.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -88.19 113.62 23.99 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.504 0.722 . . . . 51.41 109.585 174.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 76.7 mt -83.46 -35.81 24.65 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.836 0.455 . . . . 73.23 110.269 177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -159.74 -174.61 4.7 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.364 1.066 . . . . 70.14 109.839 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -71.64 130.09 40.31 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 109.225 -0.658 . . . . 74.42 109.225 175.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 69.37 -9.89 0.6 Allowed 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 125.819 1.648 . . . . 63.02 112.813 -170.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 65.5 t -108.57 109.41 28.22 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 C-N-CA 123.649 0.78 . . . . 74.22 109.188 -170.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -126.81 157.2 39.88 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.039 -1.097 . . . . 73.34 108.039 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -132.51 146.08 51.65 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 124.027 0.931 . . . . 64.25 109.355 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -119.92 132.87 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 107.853 -1.166 . . . . 53.53 107.853 167.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 95.0 t -113.22 133.63 58.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 N-CA-C 108.774 -0.824 . . . . 72.54 108.774 172.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 103' ' ' PRO . 75.5 mt -116.69 100.55 7.89 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 107.969 -1.122 . . . . 73.5 107.969 173.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 33.6 ttp180 -85.32 102.31 13.28 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.647 -0.871 . . . . 71.22 108.647 171.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.531 ' HB ' HD11 ' A' ' 114' ' ' ILE . 15.9 t -92.13 119.78 40.18 Favored 'Isoleucine or valine' 0 C--O 1.242 0.707 0 N-CA-C 108.133 -1.062 . . . . 73.11 108.133 179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.635 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 34.0 m -103.7 135.08 45.93 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.391 0.615 . . . . 71.54 110.207 177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 72.9 t -131.12 114.17 25.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 CA-C-N 114.589 -1.187 . . . . 74.13 108.738 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.503 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 1.1 m -115.35 138.72 50.68 Favored 'General case' 0 C--O 1.214 -0.79 0 N-CA-C 108.627 -0.879 . . . . 53.43 108.627 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.27 129.08 42.82 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.105 -0.702 . . . . 73.54 109.105 177.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 64.1 m -134.18 124.34 25.86 Favored 'General case' 0 N--CA 1.476 0.85 0 N-CA-C 109.589 -0.523 . . . . 72.32 109.589 173.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 73' ' ' ALA . 9.5 mp -88.4 85.14 6.82 Favored 'General case' 0 C--O 1.239 0.537 0 N-CA-C 108.398 -0.964 . . . . 75.22 108.398 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.34 -82.59 1.64 Allowed Glycine 0 C--N 1.349 1.274 0 CA-C-N 115.011 -0.995 . . . . 70.14 110.711 -176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.3 -27.15 3.24 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.122 0.969 . . . . 72.21 111.612 -178.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.435 ' HG2' HD22 ' A' ' 27' ' ' ASN . 36.9 tt0 -99.32 127.18 45.3 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.086 0.555 . . . . 72.14 110.239 -172.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 65.8 m -74.05 138.36 43.98 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.471 0.709 . . . . 63.12 111.909 -175.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.577 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -87.3 -64.06 1.21 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 124.63 1.172 . . . . 72.13 110.56 175.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -153.76 172.56 17.12 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.264 -0.88 . . . . 64.02 111.781 -176.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 51.0 tp -141.53 137.95 32.38 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 113.813 -1.539 . . . . 35.12 107.799 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 79.9 m -121.86 139.62 53.4 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.702 0.801 . . . . 52.15 109.864 177.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 22' ' ' SER . 22.3 mp0 -137.25 122.78 19.66 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 124.614 1.166 . . . . 65.14 108.068 169.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.0 t -131.95 108.03 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.529 0 N-CA-C 108.184 -1.043 . . . . 63.52 108.184 176.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mt-30 -86.01 81.76 8.37 Favored 'General case' 0 C--O 1.24 0.584 0 O-C-N 124.296 0.998 . . . . 74.11 108.314 174.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -76.06 93.84 3.36 Favored 'General case' 0 C--O 1.239 0.501 0 N-CA-C 108.309 -0.997 . . . . 72.44 108.309 179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -85.93 153.58 27.07 Favored Glycine 0 C--N 1.336 0.581 0 CA-C-N 115.407 -0.815 . . . . 65.44 111.376 177.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.55 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -155.29 122.17 1.19 Allowed Glycine 0 CA--C 1.509 -0.329 0 N-CA-C 111.083 -0.807 . . . . 43.43 111.083 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 44.9 mt -82.78 116.3 26.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.554 0 C-N-CA 123.397 0.679 . . . . 63.42 109.431 178.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.608 ' HD2' HG12 ' A' ' 13' ' ' ILE . 31.6 m-85 -120.63 118.7 30.81 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.267 -1.012 . . . . 73.01 108.267 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.7 t -91.33 99.71 12.63 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 108.583 -0.895 . . . . 53.41 108.583 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.529 HD13 ' H ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -121.14 152.84 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 C-N-CA 123.255 0.622 . . . . 40.4 111.191 -173.788 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -160.32 162.89 33.63 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.117 0.967 . . . . 72.14 109.843 177.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.61 -14.38 47.25 Favored Glycine 0 C--N 1.346 1.129 0 CA-C-O 119.793 -0.448 . . . . 71.41 114.013 175.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.545 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -112.76 136.3 49.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 117.618 0.709 . . . . 74.12 109.676 177.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -145.56 175.28 10.46 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.99 1.316 . . . . 72.14 108.467 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.52 -121.45 26.63 Favored Glycine 0 C--N 1.347 1.148 0 O-C-N 123.439 0.462 . . . . 52.11 113.798 175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -73.07 -25.7 61.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.285 0.634 . . . . 73.32 111.416 -176.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -67.67 -47.11 70.45 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 123.446 0.698 . . . . 73.55 110.057 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.458 ' HA ' ' HB3' ' A' ' 97' ' ' CYS . 21.7 ttt -81.93 -19.47 40.68 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.571 -0.741 . . . . 75.45 110.518 179.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.61 -33.22 73.67 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.599 0.36 . . . . 62.12 110.395 171.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -79.46 -37.56 36.61 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 123.357 0.663 . . . . 74.13 110.503 173.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.479 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 52.6 t -63.91 -44.76 92.0 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.228 0.611 . . . . 42.31 110.752 -178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.615 HD12 ' H ' ' E' ' 279' ' ' GLY . 15.9 mt -92.39 -9.42 41.77 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.53 0.332 . . . . 54.2 111.049 178.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.558 ' HA2' HD11 ' E' ' 280' ' ' LEU . . . -89.65 -29.04 17.27 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 114.28 0.472 . . . . 64.42 114.28 -177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.42 -46.14 0.14 Allowed 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 112.485 0.55 . . . . 75.2 112.485 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.479 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 66.0 t80 -60.88 -65.63 0.66 Allowed 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.053 0.941 . . . . 73.42 112.699 -171.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 77.4 m -70.75 -34.04 3.42 Favored Pre-proline 0 CA--C 1.565 1.52 0 C-N-CA 123.72 0.808 . . . . 71.44 112.647 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.524 ' HA ' HD11 ' A' ' 60' ' ' LEU . 98.0 Cg_exo -49.5 -39.85 45.31 Favored 'Trans proline' 0 C--N 1.39 2.734 0 C-N-CA 122.263 1.975 . . . . 71.35 113.874 162.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -71.28 -12.79 61.64 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.364 0.665 . . . . 70.32 111.802 -178.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.0 mm -78.11 -48.38 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 109.285 -0.635 . . . . 75.41 109.285 171.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.55 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.0 mt -82.31 -28.43 31.69 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.917 0.887 . . . . 72.42 113.103 -170.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -63.23 -41.5 69.35 Favored Pre-proline 0 CA--C 1.565 1.533 0 CA-C-O 118.169 -0.92 . . . . 75.0 113.425 -172.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -60.33 -36.51 87.18 Favored 'Trans proline' 0 C--N 1.386 2.543 0 C-N-CA 121.93 1.753 . . . . 74.15 113.138 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -69.89 -42.38 73.49 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.062 0.545 . . . . 75.0 111.452 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.0 94.29 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.176 0.591 . . . . 42.41 109.846 177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.9 ttm180 -54.02 -51.86 62.64 Favored 'General case' 0 C--N 1.352 0.706 0 O-C-N 124.676 1.235 . . . . 71.14 110.425 177.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -62.12 -47.04 86.36 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.395 1.06 . . . . 72.54 110.979 -177.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.406 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 36.4 t -57.61 -43.56 84.8 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.082 0.864 . . . . 72.43 110.763 -177.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.531 HD11 ' HB ' ' A' ' 62' ' ' VAL . 81.2 mt -65.81 -51.19 64.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 O-C-N 124.074 0.859 . . . . 64.43 110.303 176.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.453 HG21 ' HE2' ' C' ' 109' ' ' TYR . 87.4 m -53.96 -41.88 68.31 Favored 'General case' 0 N--CA 1.474 0.773 0 O-C-N 124.094 0.871 . . . . 73.51 111.096 -176.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.9 t -68.93 -45.82 69.84 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 114.63 -1.168 . . . . 71.13 110.471 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.469 ' HE3' ' HB2' ' A' ' 23' ' ' PHE . 17.2 mtp -56.76 -41.86 78.34 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.648 0.779 . . . . 52.03 111.428 175.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.498 HG21 HD23 ' A' ' 126' ' ' LEU . 73.5 t -66.1 -45.32 90.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 C-N-CA 124.655 1.182 . . . . 64.21 110.544 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 82.4 p -73.52 -26.72 61.0 Favored 'General case' 0 CA--C 1.55 0.944 0 CA-C-N 116.331 -0.395 . . . . 44.11 111.181 -177.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.465 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 89.7 mtt-85 -73.81 -33.12 64.05 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.668 0.787 . . . . 52.31 109.399 172.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' B' ' 18' ' ' THR . . . -74.95 -1.38 62.57 Favored Glycine 0 C--N 1.355 1.589 0 CA-C-N 115.437 -0.801 . . . . 73.41 112.686 170.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p 62.34 31.98 17.14 Favored 'General case' 0 C--N 1.358 0.937 0 C-N-CA 126.744 2.018 . . . . 74.32 112.433 174.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -94.01 154.91 40.63 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 107.758 -1.201 . . . . 53.51 107.758 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.595 ' HG2' ' HA ' ' E' ' 297' ' ' TYR . 70.5 Cg_exo -51.78 142.19 42.45 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.776 2.318 . . . . 72.12 112.161 177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -55.24 127.26 28.5 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 123.878 0.736 . . . . 73.12 111.516 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.498 HD23 HG21 ' A' ' 118' ' ' VAL . 32.9 tp -111.05 95.18 5.38 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 114.608 -1.178 . . . . 64.4 109.294 -176.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -103.04 107.53 18.37 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.843 -1.169 . . . . 51.41 107.843 171.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 33.2 tp -72.39 134.15 45.28 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 109.381 -0.6 . . . . 65.32 109.381 178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.475 ' HB2' HG21 ' G' ' 306' ' ' VAL . . . -63.63 141.24 97.9 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 123.578 0.751 . . . . 73.32 111.861 -176.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 21.0 Cg_endo -87.21 110.91 0.81 Allowed 'Trans proline' 0 C--N 1.379 2.174 0 C-N-CA 122.562 2.174 . . . . 71.52 111.838 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.6 t -100.7 125.05 54.63 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.422 -0.955 . . . . 72.13 108.422 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -80.73 79.93 7.28 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 108.211 -1.033 . . . . 74.12 108.211 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -61.85 -34.21 75.57 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 115.6 -0.727 . . . . 73.23 110.041 174.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -59.08 -34.66 72.24 Favored 'General case' 0 C--N 1.351 0.655 0 CA-C-N 114.549 -1.205 . . . . 75.24 111.094 179.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.79 -57.45 11.82 Favored 'General case' 0 C--N 1.352 0.68 0 O-C-N 123.894 0.746 . . . . 75.44 111.245 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.5 tt -63.99 -41.64 97.44 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.315 0.646 . . . . 73.11 110.281 -178.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -59.3 -43.12 92.65 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.272 1.029 . . . . 74.11 110.31 -178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.5 mmt -68.68 -48.69 63.28 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 115.058 -0.974 . . . . 61.24 111.015 177.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -57.97 -44.5 87.12 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 123.921 0.763 . . . . 70.42 111.573 -174.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 51.6 t80 -65.8 -37.06 85.26 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 124.14 0.9 . . . . 72.21 110.87 178.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 38.0 tp -67.31 -45.84 75.33 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 123.466 0.479 . . . . 73.11 111.472 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 179.53 -13.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.919 0.711 . . . . 73.33 112.919 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -76.02 146.56 39.39 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 112.196 0.443 . . . . 52.41 112.196 -168.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -168.53 -179.83 4.04 Favored 'General case' 0 C--O 1.244 0.774 0 C-N-CA 124.724 1.21 . . . . 73.22 109.476 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.13 97.06 0.08 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.196 0.598 . . . . 74.44 110.459 175.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -168.6 64.94 0.18 Allowed Glycine 0 C--N 1.339 0.747 0 N-CA-C 110.345 -1.102 . . . . 65.12 110.345 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.608 ' HG2' ' H ' ' C' ' 144' ' ' GLN . 36.6 mt-10 -60.34 125.41 23.58 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.113 0.965 . . . . 75.3 110.856 -176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -86.33 60.38 4.56 Favored Glycine 0 C--N 1.351 1.379 0 N-CA-C 111.765 -0.534 . . . . 72.33 111.765 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.2 p -75.68 98.48 4.08 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.642 0.777 . . . . 60.43 110.656 -176.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -147.96 136.86 21.95 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 123.872 0.869 . . . . 73.33 108.717 173.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.506 ' HG2' ' H ' ' A' ' 153' ' ' GLN . 30.3 tt0 -84.21 -67.16 0.82 Allowed 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 123.726 0.81 . . . . 70.52 109.278 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 82.6 t60 57.0 16.85 3.04 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 124.483 1.113 . . . . 65.25 112.097 -174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.506 ' H ' ' HG2' ' A' ' 151' ' ' GLU . 0.4 OUTLIER -96.43 82.74 3.42 Favored 'General case' 0 N--CA 1.47 0.54 0 N-CA-C 107.499 -1.297 . . . . 73.13 107.499 -176.209 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -99.73 141.68 32.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.699 -1.137 . . . . 64.33 109.393 173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 C-N-CA 123.632 0.773 . . . . 75.23 110.024 -174.306 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.465 ' HB3' ' SD ' ' B' ' 138' ' ' MET . 25.1 mmt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.48 -0.563 . . . . 73.32 109.48 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 40.2 m -74.15 102.83 4.38 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.225 -0.898 . . . . 64.42 110.855 -178.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -112.17 148.78 33.3 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 109.613 -0.514 . . . . 72.45 109.613 175.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -148.82 124.85 10.69 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 124.31 1.044 . . . . 72.41 108.69 178.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -105.27 70.71 0.9 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.782 0.801 . . . . 72.34 109.068 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 15.8 p-10 -73.51 77.9 1.44 Allowed 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 114.427 -1.26 . . . . 74.11 109.771 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . 0.448 HG22 ' HB3' ' B' ' 9' ' ' MET . 36.3 m -154.55 124.22 6.59 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.177 0.991 . . . . 74.25 108.332 -177.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -60.76 -48.76 80.33 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.987 0.915 . . . . 75.11 109.771 176.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.448 ' HB3' HG22 ' B' ' 7' ' ' THR . 21.5 ptm 47.87 -169.25 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 126.57 1.948 . . . . 71.11 114.529 175.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.687 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 19.9 m -140.22 123.25 16.65 Favored 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.948 -1.13 . . . . 71.43 107.948 173.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -146.67 113.71 6.17 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 109.175 -0.676 . . . . 72.25 109.175 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -145.66 140.12 27.08 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.885 -0.783 . . . . 74.11 108.885 165.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.683 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -90.66 126.81 43.41 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.679 0 CA-C-N 115.275 -0.875 . . . . 70.54 108.816 -179.772 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -87.69 -52.6 5.23 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.52 0.676 . . . . 73.0 109.988 176.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 -151.07 132.9 15.02 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 121.944 -0.472 . . . . 73.12 110.878 -169.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.683 HG13 HD11 ' B' ' 13' ' ' ILE . 96.5 mt -114.36 140.73 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.214 -1.773 . . . . 63.04 106.214 166.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.427 ' HE1' HG13 ' B' ' 83' ' ' ILE . 34.9 p90 -164.09 150.73 11.47 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 121.416 0.627 . . . . 75.12 111.333 -177.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.424 ' O ' ' HA2' ' A' ' 121' ' ' GLY . 96.3 m -74.18 126.83 31.45 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.589 -1.187 . . . . 71.1 108.246 167.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -91.91 -48.04 6.98 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.769 -1.197 . . . . 71.41 107.769 172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.569 ' HB2' ' HB2' ' B' ' 79' ' ' GLN . 21.5 m-20 -138.88 143.0 38.55 Favored 'General case' 0 C--N 1.35 0.61 0 CA-C-N 115.091 -0.959 . . . . 75.22 110.471 -165.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.466 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 43.5 mm -136.23 144.44 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 124.939 1.296 . . . . 72.53 109.164 177.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.523 ' HB2' ' HB3' ' B' ' 77' ' ' GLU . 60.3 m -142.83 135.29 27.62 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 125.201 1.4 . . . . 73.14 108.166 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -151.36 107.95 3.49 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.364 -1.717 . . . . 74.44 106.364 165.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -117.73 124.02 47.45 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 108.993 -0.743 . . . . 75.12 108.993 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.454 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -125.02 82.11 61.92 Favored Pre-proline 0 CA--C 1.544 0.748 0 N-CA-C 106.917 -1.512 . . . . 61.24 106.917 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -69.33 -22.11 34.5 Favored 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 123.317 2.678 . . . . 75.22 112.164 -172.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 23.6 p-10 -122.64 29.77 6.75 Favored 'General case' 0 C--O 1.209 -1.068 0 C-N-CA 124.751 1.22 . . . . 52.24 109.392 179.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.454 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -46.3 -45.42 42.8 Favored Pre-proline 0 CA--C 1.576 1.944 0 N-CA-C 115.819 1.785 . . . . 72.42 115.819 -173.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.432 ' HD3' ' HE3' ' A' ' 19' ' ' LYS . 59.8 Cg_endo -75.51 -30.12 6.79 Favored 'Trans proline' 0 C--N 1.386 2.514 0 C-N-CA 121.543 1.496 . . . . 42.35 113.137 172.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.406 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 71.0 m80 -90.92 -15.2 30.22 Favored 'General case' 0 N--CA 1.485 1.275 0 N-CA-C 113.322 0.86 . . . . 72.32 113.322 -170.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 9.7 p -62.44 -19.78 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 123.927 0.891 . . . . 70.24 111.819 177.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.26 -19.11 64.69 Favored 'General case' 0 CA--C 1.554 1.128 0 C-N-CA 124.977 1.311 . . . . 71.14 112.295 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.406 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 23.8 pt20 -64.36 -36.92 85.71 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 122.811 0.444 . . . . 62.32 110.442 175.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.476 ' HB2' HD13 ' B' ' 68' ' ' LEU . 90.5 mttt -106.34 65.48 0.68 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.671 -0.863 . . . . 72.03 108.671 174.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -76.28 100.43 5.1 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.322 -0.399 . . . . 73.32 110.045 -178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.475 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 163.41 -177.36 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 C-N-CA 127.643 2.377 . . . . 75.32 109.731 156.5 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.547 ' HA ' ' HB3' ' H' ' 297' ' ' TYR . 0.0 OUTLIER -54.15 121.15 28.91 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 124.984 1.314 . . . . 61.51 114.175 -170.811 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -82.06 174.55 10.0 Favored 'Trans proline' 0 C--N 1.364 1.37 0 C-N-CA 122.413 2.075 . . . . 75.34 110.816 163.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -76.57 103.23 6.45 Favored 'General case' 0 C--O 1.243 0.722 0 N-CA-C 107.481 -1.303 . . . . 73.53 107.481 166.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 32.7 m -90.72 141.13 14.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.597 0 N-CA-C 108.864 -0.791 . . . . 72.31 108.864 176.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -132.65 130.85 40.7 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 109.355 -0.609 . . . . 72.12 109.355 174.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.409 HD22 HD11 ' B' ' 128' ' ' LEU . 4.4 pp -86.22 140.6 29.99 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 108.02 -1.104 . . . . 73.22 108.02 165.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -139.38 151.52 46.39 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 107.671 -1.233 . . . . 65.02 107.671 -178.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.8 mp -134.84 134.1 40.43 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.147 0.431 . . . . 73.35 110.171 -175.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.455 ' HB2' ' HD2' ' B' ' 61' ' ' ARG . 7.8 m-20 -123.4 138.2 54.65 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.973 0.909 . . . . 63.31 109.06 173.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 40.2 p -109.62 146.75 34.23 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.207 0.603 . . . . 61.0 110.315 -174.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -158.76 143.51 15.94 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.958 0.903 . . . . 70.35 108.933 174.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 52.2 p -141.75 160.93 39.18 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 117.895 0.316 . . . . 65.54 110.626 175.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 66.0 p -152.19 141.83 21.81 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.53 0.732 . . . . 64.43 110.446 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -87.44 121.83 30.39 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.438 0.695 . . . . 71.42 109.927 176.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 48.5 mt -94.17 -40.12 10.2 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.546 0.739 . . . . 34.32 110.435 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . 0.71 ' HB3' ' HB ' ' B' ' 55' ' ' VAL . . . -162.69 -168.33 1.78 Allowed 'General case' 0 C--O 1.243 0.759 0 CA-C-N 114.728 -1.124 . . . . 71.24 109.716 -168.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -77.66 112.77 14.82 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.164 -0.925 . . . . 60.02 109.387 -177.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 79.3 m-20 65.26 3.95 2.45 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 125.184 1.394 . . . . 73.43 112.745 -173.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' B' ' 52' ' ' ALA . 92.8 t -104.73 113.64 42.26 Favored 'Isoleucine or valine' 0 C--O 1.245 0.831 0 N-CA-C 107.902 -1.148 . . . . 53.14 107.902 178.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -127.14 169.81 13.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.441 -0.8 . . . . 65.01 109.101 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -138.5 107.77 6.1 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.783 -0.821 . . . . 73.04 108.783 -171.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 87.6 t -97.09 127.75 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.343 1.457 . . . . 62.21 109.577 -174.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 25.2 t -119.69 132.29 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.888 0.875 . . . . 75.21 109.631 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.472 HD22 ' HB2' ' B' ' 103' ' ' PRO . 50.0 tp -124.5 118.3 26.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 108.942 -0.762 . . . . 75.54 108.942 171.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.455 ' HD2' ' HB2' ' B' ' 45' ' ' ASP . 28.9 ttm180 -84.17 133.22 34.61 Favored 'General case' 0 C--O 1.232 0.182 0 N-CA-C 108.127 -1.064 . . . . 74.11 108.127 169.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 25.5 t -122.97 116.58 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 N-CA-C 108.193 -1.04 . . . . 74.34 108.193 169.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 28.1 m -104.98 146.43 29.05 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 124.808 1.243 . . . . 74.31 109.017 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.75 97.8 3.87 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 107.907 -1.146 . . . . 74.23 107.907 171.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 54.0 m -93.89 135.32 35.34 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 109.21 -0.663 . . . . 71.22 109.21 175.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -145.1 136.64 25.29 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.751 0.821 . . . . 51.13 108.887 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 15.1 p -147.66 130.3 15.95 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.154 0.582 . . . . 53.31 111.067 -174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.535 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 57.8 mt -98.99 104.85 16.93 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 124.374 1.069 . . . . 53.33 109.651 178.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.44 -110.23 3.2 Favored Glycine 0 C--N 1.342 0.913 0 CA-C-N 115.908 -0.587 . . . . 71.32 111.643 -176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -114.94 4.71 14.86 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.73 0.812 . . . . 72.12 111.121 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.17 176.17 5.18 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 109.462 -0.569 . . . . 71.52 109.462 175.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 7.4 m -75.72 157.25 33.82 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.702 0.801 . . . . 65.52 110.34 -178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.535 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -110.18 -61.73 1.62 Allowed 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.034 -0.728 . . . . 65.14 109.034 166.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -166.04 141.09 4.67 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 114.738 -1.119 . . . . 74.43 108.644 176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 69.2 mt -121.26 132.55 54.87 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 108.381 -0.97 . . . . 74.21 108.381 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.429 ' SG ' HG23 ' B' ' 114' ' ' ILE . 48.4 t -140.74 153.59 45.96 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 108.591 -0.892 . . . . 50.44 108.591 175.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.523 ' HB3' ' HB2' ' B' ' 22' ' ' SER . 36.3 tt0 -166.18 141.59 4.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.134 -0.691 . . . . 75.54 109.134 179.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.4 HG21 ' HB3' ' B' ' 113' ' ' CYS . 86.2 t -129.45 146.29 34.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 108.257 -1.016 . . . . 75.4 108.257 173.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.569 ' HB2' ' HB2' ' B' ' 20' ' ' ASP . 49.2 mt-30 -122.54 96.93 5.23 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 107.96 -1.126 . . . . 72.03 107.96 171.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -92.85 106.85 18.75 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.877 -1.056 . . . . 72.04 108.811 -175.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -91.34 171.58 35.34 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.632 -0.587 . . . . 73.02 111.632 174.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.83 126.99 1.54 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 112.056 -0.418 . . . . 70.02 112.056 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.427 HG13 ' HE1' ' B' ' 17' ' ' TYR . 61.8 mt -84.68 116.69 28.74 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 123.877 0.871 . . . . 73.2 109.038 172.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -124.0 146.83 48.26 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.467 1.107 . . . . 63.3 108.609 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 61.3 m -106.86 104.61 14.34 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 109.153 -0.684 . . . . 50.32 109.153 171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 2.6 pp -114.03 134.67 56.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 C-N-CA 123.828 0.851 . . . . 73.14 109.693 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.687 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -156.5 167.9 29.01 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.522 1.129 . . . . 73.14 109.317 -179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.66 -50.21 4.32 Favored Glycine 0 C--N 1.35 1.34 0 O-C-N 123.323 0.389 . . . . 65.54 112.9 178.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -62.68 146.39 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 123.403 0.681 . . . . 72.12 111.504 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.3 178.46 6.21 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.731 0.813 . . . . 72.21 110.627 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.08 -122.05 27.41 Favored Glycine 0 C--N 1.351 1.402 0 O-C-N 123.845 0.715 . . . . 63.05 113.536 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . 0.482 HG22 HD13 ' B' ' 141' ' ' LEU . 4.7 m -78.3 -37.38 44.94 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.023 0.929 . . . . 72.12 110.569 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -76.03 -26.97 57.13 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.561 -0.745 . . . . 65.32 111.987 -166.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -66.11 -30.85 71.43 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 120.479 0.181 . . . . 74.14 110.693 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.03 -33.52 75.72 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 123.868 0.73 . . . . 72.53 110.515 177.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.422 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 62.9 t-80 -76.01 -32.4 59.39 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 122.451 0.3 . . . . 73.0 110.896 177.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -69.47 -55.65 9.66 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 122.946 0.498 . . . . 72.44 110.629 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 4.4 tt -78.75 -38.43 38.77 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.806 0.842 . . . . 72.52 110.0 -176.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.48 ' HA2' ' CD1' ' H' ' 281' ' ' PHE . . . -86.68 -1.62 85.24 Favored Glycine 0 C--N 1.344 1.003 0 N-CA-C 115.084 0.794 . . . . 55.25 115.084 -171.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -142.02 -56.88 0.46 Allowed 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 117.909 0.855 . . . . 52.5 111.524 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -73.87 -46.03 47.27 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 112.451 0.537 . . . . 71.04 112.451 -170.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.3 m -62.04 -46.34 91.68 Favored Pre-proline 0 CA--C 1.571 1.766 0 CA-C-O 118.503 -0.761 . . . . 50.11 112.988 -176.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.472 ' HB2' HD22 ' B' ' 60' ' ' LEU . 59.4 Cg_endo -68.9 -22.2 36.54 Favored 'Trans proline' 0 C--N 1.393 2.869 0 C-N-CA 121.889 1.726 . . . . 74.23 112.849 173.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -71.76 -30.49 65.63 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 123.407 0.683 . . . . 71.41 111.13 179.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 71.2 mt -67.52 -48.16 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.33 0.652 . . . . 65.23 110.986 177.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 3.9 pp -84.63 -10.78 57.03 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 115.866 -0.606 . . . . 72.22 111.941 -174.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -56.5 -47.6 98.64 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-O 117.895 -1.05 . . . . 73.31 113.656 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -53.03 -31.3 53.03 Favored 'Trans proline' 0 C--N 1.393 2.914 0 C-N-CA 122.531 2.154 . . . . 70.14 114.323 176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -74.06 -43.64 57.08 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.12 0.568 . . . . 53.14 110.515 -179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.02 -44.92 91.79 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.105 0.562 . . . . 62.04 110.4 174.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.701 ' HG3' ' HB3' ' B' ' 128' ' ' LEU . 52.7 ttt-85 -51.35 -53.72 33.44 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.081 1.752 . . . . 74.43 112.215 176.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -70.59 -34.01 71.7 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.308 0.643 . . . . 75.31 110.703 -176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.465 ' SG ' ' HD3' ' A' ' 120' ' ' ARG . 7.6 t -71.13 -30.41 66.45 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 123.04 0.536 . . . . 62.45 111.446 -177.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.429 HG23 ' SG ' ' B' ' 76' ' ' CYS . 63.7 mt -65.28 -52.18 55.61 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 109.525 -0.546 . . . . 75.0 109.525 173.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 7.5 m -60.06 -34.08 72.93 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 123.926 0.89 . . . . 75.24 111.854 -175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.446 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 33.0 t -57.98 -49.8 75.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.549 0.74 . . . . 75.32 110.493 176.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.0 mmt -72.22 -34.32 68.25 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.665 0.786 . . . . 74.24 111.563 -173.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 71.6 t -63.88 -37.19 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 123.776 0.83 . . . . 73.1 110.798 175.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . 0.422 ' HB2' ' OE1' ' C' ' 125' ' ' GLN . 3.6 t -74.18 -30.85 62.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 123.628 0.771 . . . . 52.21 111.092 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.446 ' HG3' ' O ' ' B' ' 116' ' ' SER . 87.6 mtt-85 -67.02 -30.09 70.09 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.326 0.65 . . . . 74.22 110.295 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.41 12.99 59.32 Favored Glycine 0 C--N 1.355 1.613 0 CA-C-O 119.468 -0.629 . . . . 55.11 113.554 174.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 17' ' ' TYR . 60.3 p 58.23 27.08 14.65 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 125.843 1.657 . . . . 75.25 113.364 177.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -91.8 165.26 21.0 Favored Pre-proline 0 CA--C 1.56 1.344 0 C-N-CA 124.07 0.948 . . . . 71.3 110.736 -179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.683 ' HG2' ' HA ' ' H' ' 297' ' ' TYR . 51.2 Cg_exo -59.55 177.48 0.44 Allowed 'Trans proline' 0 C--N 1.389 2.695 0 C-N-CA 123.436 2.757 . . . . 70.15 115.696 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.757 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 67.3 tp60 -64.44 143.57 57.81 Favored 'General case' 0 C--N 1.349 0.587 0 CA-C-N 114.565 -1.198 . . . . 71.41 111.806 178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 30.7 tp -134.77 93.02 2.97 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 108.998 -0.742 . . . . 74.41 108.998 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.425 HD21 ' HA ' ' C' ' 122' ' ' THR . 17.1 m120 -92.86 98.89 11.67 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 108.46 -0.941 . . . . 74.22 108.46 173.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.701 ' HB3' ' HG3' ' B' ' 111' ' ' ARG . 42.8 tp -71.93 131.17 42.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.216 0.606 . . . . 60.51 109.764 178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.25 151.5 56.76 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 123.835 0.854 . . . . 52.42 112.199 -170.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -54.93 124.58 16.64 Favored 'Trans proline' 0 C--N 1.385 2.477 0 C-N-CA 123.505 2.803 . . . . 75.12 113.297 171.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.61 112.64 40.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 N-CA-C 107.633 -1.247 . . . . 65.21 107.633 173.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -79.94 83.44 5.85 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 108.657 -0.868 . . . . 70.23 108.657 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -62.05 -37.52 85.27 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.979 0.911 . . . . 63.43 111.125 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -61.42 -40.65 95.2 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.278 1.031 . . . . 72.11 111.649 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.37 -50.88 63.87 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.009 0.524 . . . . 42.44 111.223 177.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -66.32 -45.0 81.78 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.96 0.904 . . . . 72.34 110.934 -173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -71.14 -27.31 63.47 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.3 0.64 . . . . 71.31 111.226 -174.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.465 ' SD ' ' HB3' ' B' ' 1' ' ' MET . 1.2 tmt? -62.89 -35.8 81.21 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.106 0.562 . . . . 53.31 110.518 174.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.445 ' N ' HD22 ' B' ' 139' ' ' ASN . 0.9 OUTLIER -75.78 -20.02 58.55 Favored 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 123.207 0.603 . . . . 75.04 111.023 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -75.22 -30.16 60.5 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 109.787 -0.449 . . . . 75.3 109.787 172.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . 0.482 HD13 HG22 ' B' ' 92' ' ' THR . 61.7 mt -99.92 31.41 3.29 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.704 0.802 . . . . 65.54 110.311 179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 28.3 pt20 -61.54 120.76 11.18 Favored 'General case' 0 CA--C 1.552 1.037 0 CA-C-O 121.364 0.602 . . . . 74.11 111.515 -175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -161.85 171.83 17.11 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.115 1.366 . . . . 73.12 108.836 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -124.06 136.88 54.56 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 122.732 0.413 . . . . 62.24 110.262 -176.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.82 157.31 25.76 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.761 0.825 . . . . 50.21 111.458 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 179.72 -147.96 7.8 Favored Glycine 0 C--N 1.342 0.865 0 N-CA-C 111.243 -0.743 . . . . 74.43 111.243 -179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.22 165.26 31.82 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-N 117.481 0.641 . . . . 70.22 111.109 177.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -128.4 43.31 1.33 Allowed Glycine 0 C--N 1.341 0.833 0 N-CA-C 110.915 -0.874 . . . . 72.44 110.915 175.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 13.1 t -76.63 158.57 30.98 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 123.445 0.698 . . . . 72.3 110.807 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -105.59 148.74 26.98 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.459 0.704 . . . . 74.4 110.379 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.512 ' HG2' ' H ' ' B' ' 152' ' ' HIS . 23.6 tt0 -164.19 176.32 9.33 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 108.582 -0.896 . . . . 73.45 108.582 175.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . 0.512 ' H ' ' HG2' ' B' ' 151' ' ' GLU . 55.4 p-80 -62.88 106.62 0.84 Allowed 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 123.446 0.698 . . . . 64.02 111.075 176.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 50.3 mt-30 -80.35 74.98 7.18 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.25 -1.018 . . . . 64.03 108.25 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -66.14 130.17 42.31 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.917 -1.038 . . . . 72.4 110.601 -173.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.939 0 C-N-CA 123.956 0.902 . . . . 73.11 109.06 -175.819 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.519 -0.548 . . . . 72.1 109.519 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 40.3 m 59.78 -170.44 0.14 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.281 1.032 . . . . 61.15 112.565 177.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.8 149.74 30.97 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.889 0.876 . . . . 72.54 109.078 176.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . 0.427 HE21 ' HG2' ' C' ' 8' ' ' GLU . 8.4 tt0 -84.76 110.97 19.19 Favored 'General case' 0 C--O 1.246 0.885 0 C-N-CA 122.475 0.31 . . . . 74.31 110.181 179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -62.01 -46.98 86.84 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 115.384 -0.826 . . . . 55.23 109.578 164.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . 0.401 ' H ' ' H ' ' C' ' 7' ' ' THR . 8.7 p30 179.19 -17.8 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.599 1.159 . . . . 71.12 110.153 -178.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . 0.401 ' H ' ' H ' ' C' ' 6' ' ' ASN . 23.7 p -90.19 123.45 34.02 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 124.846 1.258 . . . . 75.15 111.76 -171.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' C' ' 149' ' ' THR . 7.0 pt-20 -161.39 -45.38 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 122.962 0.505 . . . . 74.1 111.859 175.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.445 ' N ' ' HG3' ' C' ' 8' ' ' GLU . 56.8 ttp 63.81 112.63 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 125.565 1.546 . . . . 73.33 111.508 -164.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.442 ' HB ' ' HB3' ' C' ' 87' ' ' ALA . 28.6 m -87.6 97.65 10.98 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 108.253 -1.017 . . . . 45.0 108.253 172.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -124.51 140.58 52.82 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.623 -0.717 . . . . 65.14 109.971 -178.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.544 ' NE2' ' HB2' ' C' ' 85' ' ' SER . 0.1 OUTLIER -161.05 140.63 10.61 Favored 'General case' 0 C--O 1.249 1.049 0 C-N-CA 125.174 1.39 . . . . 75.34 107.491 172.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.423 HG22 ' HE2' ' C' ' 84' ' ' PHE . 2.8 pp -74.59 130.25 36.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 N-CA-C 109.249 -0.649 . . . . 64.43 109.249 176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -95.24 -46.52 6.72 Favored 'General case' 0 C--O 1.241 0.65 0 N-CA-C 109.314 -0.624 . . . . 64.52 109.314 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.488 ' NH1' ' HA ' ' G' ' 302' ' ' ASP . 28.4 ttt85 -169.78 151.47 4.23 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 123.666 0.604 . . . . 64.1 110.741 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 81.8 mt -133.74 133.91 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 C-N-CA 124.949 1.3 . . . . 70.24 107.546 176.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -171.0 157.05 5.1 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 121.433 0.635 . . . . 75.02 111.693 -172.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 73.0 p -85.8 108.37 18.07 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-N 115.469 -0.787 . . . . 65.51 109.433 176.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . 0.423 ' HG3' ' HA3' ' C' ' 81' ' ' GLY . 13.0 mtmt -76.58 -35.95 57.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.441 0.639 . . . . 70.41 109.709 176.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.624 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.9 t70 -142.14 122.63 14.1 Favored 'General case' 0 N--CA 1.456 -0.13 0 CA-C-N 114.777 -1.102 . . . . 72.52 109.048 -178.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.547 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -116.57 140.91 36.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 106.775 -1.565 . . . . 72.44 106.775 166.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 46.7 t -150.9 146.26 26.18 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-O 121.224 0.535 . . . . 72.21 110.203 177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -152.43 109.8 3.57 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.491 -1.299 . . . . 74.43 107.491 174.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -116.7 116.27 27.21 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.551 -0.907 . . . . 74.52 108.551 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.01 89.78 10.16 Favored Pre-proline 0 CA--C 1.542 0.64 0 N-CA-C 106.914 -1.513 . . . . 73.24 106.914 171.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -49.99 0.92 Allowed 'Trans proline' 0 C--N 1.379 2.139 0 C-N-CA 122.595 2.196 . . . . 63.23 111.605 -175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -89.96 22.7 3.07 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-O 118.619 -0.705 . . . . 75.11 110.339 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.52 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -38.94 -53.3 3.58 Favored Pre-proline 0 CA--C 1.571 1.759 0 N-CA-C 115.524 1.676 . . . . 71.25 115.524 -171.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 2.7 Cg_exo -75.49 -39.41 1.06 Allowed 'Trans proline' 0 C--N 1.393 2.91 0 CA-C-N 121.472 1.561 . . . . 72.02 112.23 176.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.402 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 83.9 t60 -70.08 -26.23 63.9 Favored 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 124.643 1.177 . . . . 74.51 112.884 -173.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.43 HG21 ' HA ' ' C' ' 73' ' ' ALA . 7.9 p -80.72 -22.71 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.754 0.422 . . . . 71.35 110.82 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.494 ' HA ' ' CH2' ' C' ' 36' ' ' TRP . 19.0 m-30 -62.87 -32.87 74.21 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 122.759 0.424 . . . . 71.41 111.38 177.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 12.2 pt20 -86.24 6.28 30.34 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 123.052 0.541 . . . . 73.3 111.415 179.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.503 ' HZ3' ' HB2' ' C' ' 34' ' ' LYS . 0.0 OUTLIER -100.4 144.08 29.82 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.39 0.676 . . . . 65.31 110.505 -179.041 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -60.62 122.59 15.08 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.921 0.888 . . . . 62.41 110.011 171.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.494 ' CH2' ' HA ' ' C' ' 32' ' ' PHE . 47.9 m95 -67.96 96.32 0.59 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.947 0.899 . . . . 71.23 112.147 -172.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -145.69 73.43 13.84 Favored Pre-proline 0 CA--C 1.547 0.845 0 CA-C-N 115.996 -0.547 . . . . 75.12 109.811 172.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -83.24 133.7 6.54 Favored 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.986 2.457 . . . . 72.54 112.41 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -85.7 91.66 8.36 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 107.253 -1.388 . . . . 73.44 107.253 167.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' C' ' 65' ' ' THR . 58.3 t -76.3 111.84 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 115.331 -0.849 . . . . 74.55 109.303 179.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.519 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 59.2 mttm -99.98 117.54 34.48 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.562 -0.903 . . . . 72.44 108.562 -176.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.502 HD11 HD11 ' C' ' 128' ' ' LEU . 3.7 tt -86.6 122.34 30.38 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 107.333 -1.358 . . . . 73.43 107.333 -179.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.514 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 18.9 m-20 -127.02 132.28 50.78 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 124.524 1.13 . . . . 64.12 109.13 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . 0.405 HD12 ' HB ' ' F' ' 288' ' ' VAL . 33.5 mt -128.45 124.47 36.28 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.943 0.897 . . . . 73.05 109.37 174.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.465 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 16.6 t70 -116.31 150.86 36.97 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.647 1.179 . . . . 70.43 108.902 172.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 41.7 p -130.78 118.38 20.74 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.834 0.854 . . . . 62.01 109.649 -172.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -125.69 149.1 48.77 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.834 0.854 . . . . 72.34 110.206 -177.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -154.38 153.46 31.64 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.237 0.615 . . . . 61.44 110.802 179.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 71.6 p -157.37 152.31 25.74 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.252 0.621 . . . . 62.03 110.573 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -89.36 119.53 29.91 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.647 0.779 . . . . 71.0 109.265 174.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.6 HD11 ' HB2' ' C' ' 57' ' ' GLU . 40.1 mt -95.87 -31.61 13.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.114 0.566 . . . . 71.52 110.342 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -162.49 -172.87 3.32 Favored 'General case' 0 C--O 1.242 0.659 0 C-N-CA 124.083 0.953 . . . . 53.43 109.687 -173.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -77.23 119.33 20.75 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.594 0.757 . . . . 63.23 109.265 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 69.89 -3.17 1.79 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 125.714 1.605 . . . . 73.13 112.556 -172.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 81.5 t -104.34 115.2 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 123.631 0.772 . . . . 61.41 109.536 -176.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -130.8 125.53 33.97 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.805 0.842 . . . . 71.21 108.878 -177.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.6 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.2 tt0 -81.77 123.84 29.12 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 109.392 -0.596 . . . . 74.02 109.392 176.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 49.4 t -102.65 115.74 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 107.881 -1.155 . . . . 62.13 107.881 173.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 61.2 t -104.8 132.19 52.1 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 N-CA-C 108.845 -0.798 . . . . 60.34 108.845 172.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -113.7 102.34 10.16 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.936 -1.505 . . . . 74.14 106.936 172.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.465 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 30.0 ttm180 -83.34 125.7 31.93 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 108.788 -0.819 . . . . 74.42 108.788 174.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.532 ' HB ' HD11 ' C' ' 114' ' ' ILE . 13.4 t -115.52 131.41 67.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 N-CA-C 107.442 -1.318 . . . . 73.41 107.442 172.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.514 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 24.1 m -127.85 125.45 39.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.292 -1.003 . . . . 72.45 108.292 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.427 HG21 HG21 ' C' ' 114' ' ' ILE . 50.3 t -120.37 115.1 46.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 109.026 -0.731 . . . . 72.3 109.026 -176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 7.1 m -99.29 148.39 24.2 Favored 'General case' 0 C--O 1.225 -0.222 0 N-CA-C 109.425 -0.583 . . . . 72.24 109.425 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.09 106.81 4.63 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 108.071 -1.085 . . . . 64.23 108.071 171.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 50.8 m -135.9 127.49 28.85 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 110.081 -0.34 . . . . 72.15 110.081 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.429 HD12 ' N ' ' C' ' 68' ' ' LEU . 4.2 mp -86.78 56.43 4.0 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.365 1.466 . . . . 43.41 108.238 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 100.34 -108.19 3.45 Favored Glycine 0 C--N 1.346 1.085 0 N-CA-C 109.728 -1.349 . . . . 74.41 109.728 -173.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -93.72 -25.61 17.37 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.193 0.997 . . . . 71.43 109.318 168.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 18.6 tp10 -68.03 83.85 0.22 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 125.416 1.486 . . . . 60.2 110.884 -176.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 41.1 m -73.55 120.35 19.03 Favored 'General case' 0 C--N 1.345 0.398 0 CA-C-O 121.083 0.468 . . . . 73.01 111.136 -173.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.43 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -70.79 -55.72 7.93 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.536 -1.211 . . . . 74.2 108.847 175.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -167.16 169.36 12.75 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 114.789 -1.096 . . . . 71.02 111.477 178.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -130.85 138.51 49.88 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 105.232 -2.136 . . . . 51.15 105.232 165.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 51.6 t -139.88 111.99 7.58 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.888 -0.782 . . . . 70.22 108.888 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -120.45 128.12 52.87 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.019 0.527 . . . . 72.03 109.907 -178.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 62.0 t -123.84 114.5 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.836 0.854 . . . . 73.13 108.75 172.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.624 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.8 mt-30 -88.73 91.05 8.66 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 107.911 -1.144 . . . . 70.52 107.911 170.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -78.95 97.72 6.14 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 114.806 -1.088 . . . . 75.14 109.146 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.423 ' HA3' ' HG3' ' C' ' 19' ' ' LYS . . . -84.49 151.47 26.73 Favored Glycine 0 C--N 1.338 0.68 0 CA-C-N 115.731 -0.668 . . . . 71.1 111.832 177.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.449 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -152.81 120.89 1.1 Allowed Glycine 0 CA--C 1.503 -0.696 0 N-CA-C 110.823 -0.911 . . . . 53.52 110.823 -179.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.452 HD12 HD11 ' C' ' 51' ' ' LEU . 17.7 mm -81.72 128.56 38.61 Favored 'Isoleucine or valine' 0 C--O 1.243 0.756 0 N-CA-C 108.616 -0.883 . . . . 74.25 108.616 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.423 ' HE2' HG22 ' C' ' 13' ' ' ILE . 58.7 m-85 -137.62 151.62 48.5 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.38 -0.97 . . . . 44.41 108.38 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.544 ' HB2' ' NE2' ' C' ' 12' ' ' GLN . 34.9 m -111.31 121.49 45.39 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 108.824 -0.806 . . . . 53.53 108.824 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.555 HG21 ' HG2' ' C' ' 94' ' ' MET . 3.9 mp -113.5 120.88 64.53 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 N-CA-C 107.224 -1.399 . . . . 72.5 107.224 -178.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . 0.442 ' HB3' ' HB ' ' C' ' 10' ' ' THR . . . -149.21 171.07 17.07 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.707 0.803 . . . . 61.44 110.326 -174.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.51 -57.4 3.07 Favored Glycine 0 C--N 1.344 1.008 0 CA-C-N 115.807 -0.633 . . . . 72.13 112.675 173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.408 HG13 ' HA ' ' C' ' 9' ' ' MET . 2.6 pp -113.94 179.84 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.054 0.941 . . . . 71.3 111.013 -175.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -154.44 -169.42 3.22 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.825 0.85 . . . . 75.24 109.706 175.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.73 -135.17 20.09 Favored Glycine 0 C--N 1.351 1.389 0 CA-C-O 119.964 -0.353 . . . . 72.13 113.539 171.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 22.8 p -66.83 -28.6 68.49 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 123.767 0.827 . . . . 40.42 111.489 179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -64.49 -43.13 95.11 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.202 0.601 . . . . 75.34 110.44 175.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.555 ' HG2' HG21 ' C' ' 86' ' ' ILE . 0.3 OUTLIER -72.73 -43.8 62.48 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 115.961 -0.563 . . . . 71.52 110.317 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.03 -30.94 71.97 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.433 0.693 . . . . 74.41 111.671 -178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -71.5 -41.81 68.81 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.657 0.783 . . . . 75.12 110.275 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 50.3 t -65.84 -40.63 91.94 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 122.83 0.452 . . . . 34.33 111.024 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 37.5 tp -73.67 -37.66 65.2 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.302 1.041 . . . . 60.34 110.875 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -98.9 -3.85 56.91 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 115.117 0.807 . . . . 70.44 115.117 -172.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -138.3 -54.36 0.63 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 117.903 0.851 . . . . 52.21 112.052 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -71.84 -49.21 40.33 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 122.635 0.374 . . . . 72.13 111.978 -171.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 62.1 m -68.8 -44.06 29.81 Favored Pre-proline 0 CA--C 1.569 1.674 0 CA-C-O 118.726 -0.654 . . . . 74.14 112.041 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.489 ' HG3' ' HZ ' ' F' ' 281' ' ' PHE . 61.3 Cg_exo -56.85 -37.65 97.65 Favored 'Trans proline' 0 C--N 1.394 2.964 0 C-N-CA 122.703 2.269 . . . . 65.02 113.865 170.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -56.84 -38.69 72.99 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 123.892 0.877 . . . . 74.44 110.927 177.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 43.2 mm -73.16 -47.16 48.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.177 -0.919 . . . . 74.33 111.2 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.449 HD21 ' HA3' ' C' ' 82' ' ' GLY . 98.0 mt -79.11 -24.33 43.47 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 112.923 0.712 . . . . 74.21 112.923 -170.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -55.68 -53.13 66.03 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 124.244 1.018 . . . . 71.24 113.568 -174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -65.7 -31.15 49.83 Favored 'Trans proline' 0 C--N 1.388 2.638 0 C-N-CA 121.788 1.659 . . . . 62.34 112.809 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.453 ' HE2' HG21 ' A' ' 115' ' ' THR . 79.8 m-85 -68.5 -38.52 81.04 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.241 0.616 . . . . 50.15 111.317 179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.94 -40.77 91.65 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 116.231 -0.441 . . . . 63.41 110.154 173.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 56.3 ttt180 -53.34 -59.89 3.99 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.084 0.954 . . . . 75.22 111.906 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . 0.44 ' HG3' ' NH2' ' B' ' 120' ' ' ARG . 2.5 tm-20 -65.27 -31.33 72.42 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.922 0.489 . . . . 73.13 110.837 -172.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.482 ' SG ' HG12 ' C' ' 21' ' ' ILE . 47.5 t -69.09 -36.83 78.02 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 123.1 0.56 . . . . 71.32 111.457 179.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.532 HD11 ' HB ' ' C' ' 62' ' ' VAL . 96.7 mt -70.7 -50.15 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.638 0.775 . . . . 62.52 110.174 175.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.1 m -64.4 -29.14 70.21 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 123.574 0.749 . . . . 71.03 111.052 -174.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 24.1 t -63.53 -49.94 71.53 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 123.596 0.758 . . . . 64.24 109.316 171.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.564 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -58.39 -40.34 82.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.569 1.148 . . . . 71.53 112.315 178.377 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.405 HG23 ' O ' ' C' ' 114' ' ' ILE . 94.1 t -61.61 -44.39 98.58 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.084 0 C-N-CA 123.697 0.799 . . . . 72.52 109.852 176.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.455 ' HB2' ' NE2' ' C' ' 125' ' ' GLN . 41.4 t -65.92 -31.75 72.85 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.992 0.917 . . . . 62.3 112.188 176.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' C' ' 116' ' ' SER . 79.9 mtt-85 -73.98 -37.43 64.46 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.599 0.76 . . . . 73.53 110.817 -177.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -81.18 6.08 64.77 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.469 0.481 . . . . 74.11 112.591 170.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.425 ' HA ' HD21 ' B' ' 127' ' ' ASN . 46.2 p 63.98 20.11 12.05 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 126.865 2.066 . . . . 73.23 113.145 174.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . 0.465 ' HA ' HD12 ' F' ' 301' ' ' ILE . 71.1 m-85 -84.82 141.2 38.01 Favored Pre-proline 0 CA--C 1.555 1.169 0 C-N-CA 124.292 1.037 . . . . 54.22 108.987 173.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.757 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 84.3 Cg_exo -53.07 140.16 60.56 Favored 'Trans proline' 0 C--N 1.374 1.881 0 C-N-CA 123.811 3.008 . . . . 70.41 116.854 -176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.455 ' NE2' ' HB2' ' C' ' 119' ' ' SER . 9.1 mm-40 -56.45 117.06 3.47 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 125.601 1.56 . . . . 72.41 113.175 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 66.6 tp -119.57 125.41 48.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.996 0.918 . . . . 52.1 108.91 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 62.6 m-80 -121.55 132.58 54.77 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.908 0.883 . . . . 71.35 109.388 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.502 HD11 HD11 ' C' ' 42' ' ' LEU . 0.1 OUTLIER -71.5 138.43 48.93 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.581 0.753 . . . . 74.11 109.808 179.019 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -70.54 161.02 79.41 Favored Pre-proline 0 CA--C 1.558 1.275 0 C-N-CA 124.25 1.02 . . . . 62.45 110.833 174.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.706 ' HG2' HG21 ' A' ' 13' ' ' ILE . 35.0 Cg_exo -59.58 108.64 0.48 Allowed 'Trans proline' 0 C--N 1.384 2.4 0 C-N-CA 122.275 1.983 . . . . 72.11 112.563 177.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 98.5 t -96.48 108.52 21.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.592 0 N-CA-C 107.526 -1.287 . . . . 74.12 107.526 173.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -91.34 99.37 12.35 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.004 -1.11 . . . . 74.3 108.004 179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -64.36 -38.54 91.38 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.546 -0.752 . . . . 75.24 110.393 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -57.8 -40.75 80.66 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.803 0.841 . . . . 70.35 112.0 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -60.45 -42.28 95.8 Favored 'General case' 0 N--CA 1.48 1.027 0 O-C-N 123.886 0.741 . . . . 63.55 111.562 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.03 -46.01 92.47 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.154 0.982 . . . . 73.4 110.226 179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -75.79 -22.58 56.24 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 123.393 0.677 . . . . 74.34 111.888 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 27.0 ttt -76.36 -32.79 58.82 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.832 0.853 . . . . 72.52 110.254 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 -56.87 -38.52 72.85 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 123.602 0.761 . . . . 64.24 110.281 174.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -70.04 -87.2 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.093 0.957 . . . . 75.33 110.798 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -127.18 141.44 51.74 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.097 0.959 . . . . 64.51 108.985 177.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -107.98 110.17 21.82 Favored 'General case' 0 C--O 1.242 0.673 0 C-N-CA 123.845 0.858 . . . . 73.25 110.219 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -85.1 137.87 32.76 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.408 -0.814 . . . . 51.12 109.914 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.608 ' H ' ' HG2' ' A' ' 147' ' ' GLU . 43.3 mt-30 -125.17 100.27 6.47 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.037 0.935 . . . . 72.54 108.598 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -173.92 158.42 3.18 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.944 1.298 . . . . 53.34 109.359 176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 137.96 53.99 0.05 OUTLIER Glycine 0 N--CA 1.47 0.918 0 N-CA-C 111.242 -0.743 . . . . 61.23 111.242 177.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.11 -38.26 85.7 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.665 1.186 . . . . 72.42 111.551 -171.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 159.66 159.79 10.02 Favored Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.294 -0.867 . . . . 74.0 111.389 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.492 ' HA ' ' HB2' ' C' ' 8' ' ' GLU . 9.3 t -78.08 133.62 37.87 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.047 0.539 . . . . 73.44 109.71 177.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -175.79 104.49 0.08 Allowed 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 107.768 -1.197 . . . . 52.32 107.768 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.13 96.19 0.8 Allowed 'General case' 0 CA--C 1.552 1.045 0 N-CA-C 108.477 -0.934 . . . . 74.41 108.477 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -146.02 -69.39 0.27 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.481 0.712 . . . . 74.3 109.561 -171.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 58.46 89.58 0.05 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.219 1.407 . . . . 55.42 112.002 179.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -86.15 -49.41 7.78 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 116.043 -0.526 . . . . 74.53 110.458 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 C-N-CA 123.52 0.728 . . . . 74.23 109.704 -175.66 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 25.9 ptm . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 109.906 -0.405 . . . . 71.23 109.906 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 16.2 p -167.78 144.78 4.27 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.088 0.955 . . . . 54.44 109.135 -178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -81.76 72.28 8.8 Favored 'General case' 0 CA--C 1.553 1.085 0 CA-C-O 121.647 0.737 . . . . 74.3 111.775 -176.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 23.6 pt20 -71.04 91.92 0.92 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-O 121.494 0.664 . . . . 70.04 109.944 173.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -67.99 86.3 0.24 Allowed 'General case' 0 C--N 1.355 0.838 0 N-CA-C 108.53 -0.915 . . . . 54.25 108.53 177.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -158.55 171.41 20.18 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 125.267 1.427 . . . . 53.42 107.443 -171.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 75.9 p -79.53 68.44 5.57 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-O 121.55 0.69 . . . . 53.24 110.023 174.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -69.44 -54.51 13.98 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.285 1.034 . . . . 44.35 108.802 179.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 7.6 ttp 18.65 121.36 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 128.187 2.595 . . . . 72.51 116.14 -171.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.565 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 21.4 m -118.44 139.32 51.6 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 109.192 -0.67 . . . . 72.22 109.192 169.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -161.75 94.38 0.95 Allowed 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 107.447 -1.316 . . . . 72.43 107.447 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -126.56 123.24 37.26 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 108.854 -0.795 . . . . 64.53 108.854 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.582 HD13 HG21 ' D' ' 105' ' ' ILE . 5.8 mt -82.16 119.32 31.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 109.206 -0.665 . . . . 60.45 109.206 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' F' ' 304' ' ' PRO . 74.8 mt-30 -86.3 -34.21 20.4 Favored 'General case' 0 C--O 1.244 0.792 0 CA-C-N 116.374 -0.376 . . . . 75.32 111.104 -173.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.6 tpp180 -179.74 133.61 0.11 Allowed 'General case' 0 N--CA 1.478 0.956 0 O-C-N 123.672 0.607 . . . . 61.34 110.094 -173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.475 HD12 ' N ' ' D' ' 16' ' ' ILE . 2.2 mp -114.21 119.39 61.15 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 N-CA-C 106.205 -1.776 . . . . 73.52 106.205 174.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.52 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 27.2 p90 -144.3 153.45 42.02 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 122.073 0.939 . . . . 74.22 110.16 -173.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 82.5 p -85.27 113.69 21.8 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.235 -1.348 . . . . 71.35 108.766 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -78.79 -30.95 45.82 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.156 0.503 . . . . 74.55 109.769 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -150.0 142.3 24.21 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 114.482 -1.236 . . . . 54.53 109.89 176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.564 HG21 ' HE2' ' C' ' 117' ' ' MET . 69.3 mt -137.73 138.31 44.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.574 0 C-N-CA 125.072 1.349 . . . . 74.01 107.96 173.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 45.2 t -139.4 136.82 35.11 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.301 1.04 . . . . 73.54 108.297 171.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.547 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 88.9 t80 -140.67 117.83 11.27 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 106.38 -1.711 . . . . 75.23 106.38 167.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . 0.413 ' HB2' ' HB2' ' D' ' 75' ' ' LEU . 47.7 mt-10 -122.36 139.42 53.85 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.485 0.714 . . . . 65.51 109.158 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.425 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -127.29 79.91 72.48 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 106.906 -1.516 . . . . 73.21 106.906 173.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.25 -38.87 8.28 Favored 'Trans proline' 0 C--N 1.375 1.939 0 C-N-CA 122.947 2.431 . . . . 41.21 113.036 -169.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -110.67 35.09 3.62 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 108.336 -0.987 . . . . 70.12 108.336 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.425 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -49.71 -66.53 0.6 Allowed Pre-proline 0 CA--C 1.559 1.295 0 N-CA-C 113.845 1.054 . . . . 24.13 113.845 -166.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' D' ' 28' ' ' ALA . 84.0 Cg_endo -74.69 -16.47 21.02 Favored 'Trans proline' 0 C--N 1.384 2.407 0 CA-C-N 121.852 1.697 . . . . 71.21 112.653 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.419 ' HA ' HE21 ' D' ' 33' ' ' GLN . 13.6 t-160 -66.46 -42.3 87.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.925 1.29 . . . . 64.13 110.26 172.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . . . . . . . . . 42.1 t -66.06 -41.48 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.492 0.717 . . . . 73.21 110.594 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -67.25 -15.38 63.66 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 124.02 0.825 . . . . 65.24 112.571 -171.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.419 HE21 ' HA ' ' D' ' 30' ' ' HIS . 48.2 mt-30 -86.09 -7.57 58.51 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 124.506 1.122 . . . . 75.13 112.703 177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 29.6 mtpt -127.31 114.62 17.82 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 124.678 1.191 . . . . 75.03 108.605 -172.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -98.42 95.26 7.21 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 119.428 1.013 . . . . 73.23 112.68 -169.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.442 ' CH2' HD13 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -157.65 -179.54 8.26 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.859 0.864 . . . . 73.35 112.935 178.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 14.2 mt-30 -91.51 141.98 26.44 Favored Pre-proline 0 CA--C 1.56 1.361 0 C-N-CA 124.693 1.197 . . . . 54.5 112.185 -169.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -91.74 124.5 0.8 Allowed 'Trans proline' 0 C--N 1.387 2.566 0 C-N-CA 123.578 2.852 . . . . 75.43 113.389 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -74.61 113.08 11.46 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 108.316 -0.994 . . . . 73.53 108.316 171.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 12.3 m -101.06 125.17 55.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 123.517 0.727 . . . . 74.1 110.498 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -109.56 144.33 38.01 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.1 0.96 . . . . 72.41 108.851 172.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.418 HD13 HG11 ' G' ' 288' ' ' VAL . 3.7 tt -119.59 124.45 46.38 Favored 'General case' 0 C--O 1.241 0.613 0 N-CA-C 108.49 -0.93 . . . . 64.24 108.49 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.664 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 9.4 m-20 -108.82 133.43 52.87 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.516 1.126 . . . . 75.03 108.805 175.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.62 130.95 55.59 Favored 'General case' 0 N--CA 1.475 0.824 0 N-CA-C 108.973 -0.751 . . . . 52.31 108.973 -178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 22.2 t70 -137.69 146.44 43.78 Favored 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 123.815 0.846 . . . . 62.04 108.943 174.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 38.7 p -125.45 147.3 49.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.364 0.665 . . . . 70.22 110.651 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.443 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.42 164.02 36.93 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.745 1.218 . . . . 63.24 108.872 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 55.4 p -175.6 154.33 1.59 Allowed 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.745 0.818 . . . . 63.23 110.708 -177.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 59.9 p -165.76 138.79 4.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.368 0.667 . . . . 63.24 110.462 -178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -72.95 123.82 24.23 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.896 0.479 . . . . 72.53 109.926 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.47 HD11 ' HB2' ' D' ' 57' ' ' GLU . 60.1 mt -91.32 -41.61 10.82 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.158 0.583 . . . . 64.35 110.593 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . 0.4 ' HB3' ' HB ' ' D' ' 55' ' ' VAL . . . -152.22 -174.92 5.05 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.276 0.63 . . . . 65.01 110.541 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.59 111.4 3.6 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 115.209 -0.905 . . . . 71.45 109.87 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 67.37 21.61 9.7 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 124.415 1.086 . . . . 63.23 110.956 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . 0.4 ' HB ' ' HB3' ' D' ' 52' ' ' ALA . 81.8 t -126.52 117.51 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.398 1.079 . . . . 70.24 108.614 176.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.61 ' HB2' HD12 ' D' ' 86' ' ' ILE . 54.1 m-85 -131.0 137.25 49.13 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.206 1.002 . . . . 74.02 108.503 -174.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.47 ' HB2' HD11 ' D' ' 51' ' ' LEU . 32.0 tt0 -92.24 136.24 33.35 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 123.832 0.853 . . . . 71.24 109.362 173.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 67.3 t -118.65 118.66 58.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 N-CA-C 107.373 -1.343 . . . . 75.45 107.373 170.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 40.1 t -103.13 130.81 52.71 Favored 'Isoleucine or valine' 0 C--O 1.24 0.576 0 N-CA-C 108.613 -0.884 . . . . 72.21 108.613 173.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -124.15 108.28 12.14 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 107.846 -1.168 . . . . 62.2 107.846 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.9 ttm180 -86.26 117.88 25.35 Favored 'General case' 0 C--O 1.241 0.637 0 CA-C-N 115.977 -0.556 . . . . 73.02 109.79 178.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 79.1 t -104.62 121.55 56.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 107.887 -1.153 . . . . 71.2 107.887 169.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.664 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 21.9 m -120.32 139.44 52.75 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 109.566 -0.531 . . . . 64.15 109.566 -177.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 83.8 t -128.33 102.26 8.13 Favored 'Isoleucine or valine' 0 C--O 1.241 0.61 0 C-N-CA 124.29 1.036 . . . . 65.3 108.451 -176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 7.4 p -98.49 93.71 6.31 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.231 -1.026 . . . . 71.13 108.231 174.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -100.57 142.07 32.56 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 114.513 -1.221 . . . . 71.54 109.684 -176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 52.1 p -155.52 130.43 9.31 Favored 'General case' 0 C--N 1.347 0.498 0 C-N-CA 122.931 0.492 . . . . 54.51 110.717 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.672 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.2 OUTLIER -121.79 137.83 54.61 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.655 1.182 . . . . 54.1 109.461 177.214 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.88 -113.43 4.0 Favored Glycine 0 C--N 1.344 1.001 0 O-C-N 123.392 0.433 . . . . 73.44 112.855 176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -120.84 3.84 10.55 Favored 'General case' 0 CA--C 1.55 0.98 0 C-N-CA 123.606 0.763 . . . . 74.45 110.288 -176.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -130.69 173.5 10.85 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.144 0.578 . . . . 75.22 111.917 -176.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 68.6 m -74.31 139.42 44.18 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-N 115.069 -0.969 . . . . 74.04 109.958 170.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.672 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -81.85 -70.66 0.53 Allowed 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.802 -0.814 . . . . 44.32 108.802 174.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -153.54 139.78 18.48 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-N 115.155 -0.93 . . . . 72.23 109.552 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . 0.413 ' HB2' ' HB2' ' D' ' 24' ' ' GLU . 96.3 mt -105.82 109.0 20.81 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 108.065 -1.087 . . . . 74.32 108.065 174.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.67 ' SG ' HG23 ' D' ' 114' ' ' ILE . 48.9 t -125.36 114.4 18.83 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.311 -0.626 . . . . 60.41 109.311 -174.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -138.17 122.24 17.94 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 109.14 -0.689 . . . . 53.34 109.14 -175.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 69.7 t -126.86 117.61 48.31 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 C-N-CA 123.836 0.854 . . . . 63.22 109.215 -177.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -89.29 86.72 6.9 Favored 'General case' 0 C--O 1.24 0.557 0 N-CA-C 108.239 -1.023 . . . . 72.11 108.239 173.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -80.97 94.88 6.62 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.667 -1.151 . . . . 70.42 109.32 -174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.475 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -87.77 146.43 19.93 Favored Glycine 0 C--N 1.343 0.961 0 N-CA-C 111.431 -0.668 . . . . 62.45 111.431 178.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.43 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -145.47 131.82 4.36 Favored Glycine 0 C--N 1.332 0.344 0 N-CA-C 110.912 -0.875 . . . . 52.55 110.912 -178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 42.5 mt -90.24 131.49 37.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.497 0 N-CA-C 108.897 -0.779 . . . . 62.33 108.897 179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -132.51 139.93 48.12 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.24 0.616 . . . . 75.14 110.162 178.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.4 m -80.14 102.1 9.19 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 107.912 -1.144 . . . . 71.05 107.912 168.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.61 HD12 ' HB2' ' D' ' 56' ' ' TYR . 58.2 mt -106.6 110.31 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 N-CA-C 109.378 -0.601 . . . . 63.33 109.378 -175.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.565 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -152.73 165.1 36.37 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.285 1.034 . . . . 72.13 110.18 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 73.54 -1.33 44.83 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 114.733 0.653 . . . . 71.11 114.733 173.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.477 HD11 HG23 ' D' ' 86' ' ' ILE . 28.8 pt -124.94 147.65 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 124.907 1.283 . . . . 61.21 108.503 178.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.37 177.55 11.32 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.349 0.659 . . . . 71.32 110.95 -177.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 61.95 -137.44 46.12 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 123.596 0.56 . . . . 63.42 113.782 175.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 22.6 p -80.21 -15.77 56.28 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.515 0.726 . . . . 52.44 111.655 179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 50.1 tt0 -63.85 -51.13 66.08 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.303 0.641 . . . . 72.44 109.802 173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -73.32 -28.79 62.27 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.612 -0.722 . . . . 63.15 110.303 -178.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.49 ' HA ' ' HA2' ' G' ' 279' ' ' GLY . . . -68.81 -32.66 72.53 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 122.831 0.453 . . . . 74.34 111.017 175.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -72.97 -40.68 65.09 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.807 0.843 . . . . 73.22 110.552 175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 51.3 t -65.63 -44.66 85.76 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.267 0.627 . . . . 61.02 110.606 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.481 ' HB3' ' HE1' ' G' ' 281' ' ' PHE . 3.8 mm? -77.73 -20.18 53.95 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.078 0.951 . . . . 75.34 111.403 -178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.72 13.93 57.74 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-O 119.73 -0.483 . . . . 65.13 113.456 179.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -157.59 -64.04 0.09 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.031 0.416 . . . . 63.11 111.978 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -72.53 -48.96 36.12 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.418 0.687 . . . . 72.14 112.654 -167.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.428 ' HB2' ' HD3' ' D' ' 103' ' ' PRO . 59.9 m -63.58 -45.57 83.03 Favored Pre-proline 0 CA--C 1.565 1.552 0 C-N-CA 123.578 0.751 . . . . 43.24 112.506 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' D' ' 102' ' ' CYS . 43.7 Cg_exo -61.88 -30.97 84.74 Favored 'Trans proline' 0 C--N 1.397 3.086 0 C-N-CA 122.261 1.974 . . . . 73.02 113.439 171.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 38.1 t-20 -66.54 -28.24 68.39 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.768 0.827 . . . . 74.05 110.755 -178.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.582 HG21 HD13 ' D' ' 13' ' ' ILE . 40.9 mm -67.82 -46.4 82.38 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.222 0.609 . . . . 75.23 110.478 174.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.43 HD21 ' HA3' ' D' ' 82' ' ' GLY . 64.9 mt -76.99 -23.37 52.27 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 115.231 -0.895 . . . . 74.03 111.734 -170.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 34.0 t80 -66.08 -44.22 59.42 Favored Pre-proline 0 CA--C 1.569 1.7 0 N-CA-C 113.572 0.953 . . . . 73.13 113.572 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -59.85 -32.46 95.37 Favored 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 122.42 2.08 . . . . 72.03 113.725 172.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -78.09 -31.68 50.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.206 0.602 . . . . 74.25 111.232 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.64 -51.6 58.29 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 109.333 -0.618 . . . . 50.44 109.333 172.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 34.9 ttp180 -54.15 -49.42 69.29 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 124.752 1.282 . . . . 64.11 111.069 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -62.53 -45.86 91.04 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.196 0.935 . . . . 75.32 110.783 -177.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 49.6 t -58.1 -45.13 87.75 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.801 0.688 . . . . 73.3 110.997 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.67 HG23 ' SG ' ' D' ' 76' ' ' CYS . 73.5 mt -64.57 -53.41 42.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.021 0.928 . . . . 72.12 110.786 178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 29.5 m -53.91 -42.97 69.33 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 124.347 1.059 . . . . 64.24 111.564 -175.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 47.8 t -67.77 -32.07 72.4 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 115.275 -0.875 . . . . 64.32 111.666 -178.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 75.0 mtm -80.04 -36.05 36.28 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 122.668 0.387 . . . . 65.32 111.999 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.506 HG23 ' O ' ' D' ' 114' ' ' ILE . 47.4 t -67.14 -34.99 73.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 C-N-CA 122.979 0.511 . . . . 61.05 110.025 -178.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 89.2 p -69.42 -33.89 73.66 Favored 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 123.363 0.665 . . . . 72.14 111.27 174.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' D' ' 116' ' ' SER . 91.8 mtt-85 -68.96 -34.14 74.86 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.282 0.633 . . . . 75.22 110.994 177.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.01 8.76 65.48 Favored Glycine 0 C--N 1.354 1.571 0 CA-C-N 116.209 -0.45 . . . . 74.14 113.196 176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 30.4 p 61.93 20.86 11.86 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 126.616 1.966 . . . . 74.23 113.567 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.428 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 47.9 m-85 -87.83 167.16 21.17 Favored Pre-proline 0 CA--C 1.561 1.381 0 C-N-CA 124.653 1.181 . . . . 71.5 107.862 165.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.561 ' HB3' ' HB3' ' G' ' 297' ' ' TYR . 72.9 Cg_endo -67.82 -166.5 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.614 2.209 . . . . 70.15 113.875 -176.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -75.24 156.6 35.57 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.679 -0.691 . . . . 70.21 110.851 170.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 32.6 tp -127.61 95.23 4.18 Favored 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.456 -1.313 . . . . 70.43 107.456 164.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.667 ' HB3' HD12 ' B' ' 13' ' ' ILE . 78.6 m-20 -99.2 89.55 4.27 Favored 'General case' 0 C--O 1.237 0.435 0 N-CA-C 108.187 -1.042 . . . . 74.23 108.187 -175.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 123.06 17.32 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-N 115.172 -0.922 . . . . 73.5 110.687 -173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -65.67 124.04 86.31 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 123.641 0.776 . . . . 71.22 110.405 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -73.31 127.36 11.84 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 122.284 1.99 . . . . 34.11 111.692 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 44.7 t -109.49 133.85 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 123.801 0.84 . . . . 72.12 109.165 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -76.64 85.18 3.3 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 108.966 -0.753 . . . . 53.41 108.966 176.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -65.09 -33.45 76.06 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.744 -0.662 . . . . 63.34 110.791 178.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' D' ' 138' ' ' MET . 3.7 t70 -60.21 -57.63 11.98 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.604 1.161 . . . . 64.25 110.856 -173.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -64.59 -41.33 96.31 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 124.292 1.037 . . . . 53.03 112.657 -174.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 91.9 mt -70.17 -34.09 72.56 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.361 0.664 . . . . 73.44 111.704 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 42.1 t80 -65.77 -32.27 73.71 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 124.089 0.956 . . . . 71.55 111.027 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.422 ' HG3' ' O ' ' D' ' 134' ' ' ASP . 48.3 mtt -61.27 -42.63 98.97 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.037 0.935 . . . . 71.35 111.032 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -67.58 -31.28 71.23 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 123.889 0.876 . . . . 71.1 111.759 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 77.5 t80 -69.71 -36.22 75.74 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 115.54 -0.755 . . . . 71.25 111.053 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.7 mp -68.86 -24.51 64.35 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.197 0.999 . . . . 71.43 112.205 178.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 14.7 mt-30 -71.29 2.56 4.59 Favored 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 123.984 0.914 . . . . 72.24 112.337 175.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 62.1 mt-30 -116.7 92.49 3.88 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 107.874 -1.158 . . . . 74.35 107.874 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 27.8 pt20 -143.54 165.87 26.38 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.555 0.742 . . . . 72.2 110.203 -178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -147.14 145.4 29.55 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 123.089 0.555 . . . . 72.34 109.524 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -79.93 64.33 3.92 Favored Glycine 0 C--N 1.347 1.142 0 O-C-N 123.544 0.528 . . . . 40.22 111.923 175.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -96.1 130.73 43.06 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 107.17 -1.419 . . . . 72.31 107.17 177.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -151.72 58.58 0.43 Allowed Glycine 0 C--N 1.344 1.004 0 O-C-N 123.081 0.238 . . . . 44.22 112.802 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 7.0 p -66.63 96.85 0.41 Allowed 'General case' 0 CA--C 1.551 0.983 0 CA-C-O 120.909 0.385 . . . . 74.12 110.368 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.51 -39.96 9.3 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.76 0.824 . . . . 72.43 109.862 178.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 64.62 131.8 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 125.898 1.679 . . . . 73.55 113.867 170.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 15.1 m80 -117.38 147.12 42.94 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.484 1.113 . . . . 64.22 109.801 175.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -156.77 159.58 38.43 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.522 0.729 . . . . 71.01 110.618 178.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -116.21 164.68 14.14 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.049 0.94 . . . . 54.25 111.57 -174.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.995 0 C-N-CA 124.57 1.148 . . . . 44.24 108.572 173.849 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.915 0 N-CA-C 109.965 -0.383 . . . . 74.24 109.965 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -84.4 132.46 34.58 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.24 0.616 . . . . 73.11 109.808 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -79.75 -58.44 3.18 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.078 -0.712 . . . . 74.31 109.078 170.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 58.38 -171.81 0.1 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.75 1.22 . . . . 72.25 111.757 -176.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 39.6 ttmt 52.89 84.23 0.21 Allowed Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 124.751 1.22 . . . . 70.44 111.401 178.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -63.63 103.05 0.37 Allowed 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 121.755 1.637 . . . . 75.53 109.761 174.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 2.2 tt -75.9 73.05 2.81 Favored 'General case' 0 CA--C 1.546 0.822 0 N-CA-C 107.578 -1.267 . . . . 73.14 107.578 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 90.4 mt -142.64 -170.03 3.12 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 125.689 1.596 . . . . 72.45 108.17 -175.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . 0.615 ' H ' HD12 ' A' ' 98' ' ' LEU . . . -106.35 -120.68 4.68 Favored Glycine 0 C--N 1.34 0.767 0 N-CA-C 111.596 -0.602 . . . . 75.13 111.596 178.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.558 HD11 ' HA2' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -95.53 -117.59 0.11 Allowed 'General case' 0 CA--C 1.553 1.077 0 CA-C-O 118.414 -0.803 . . . . 33.41 110.77 177.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 22.2 m-30 76.93 -43.65 0.45 Allowed 'General case' 0 C--N 1.37 1.484 0 C-N-CA 125.946 1.699 . . . . 71.13 111.13 -176.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -65.64 -37.26 86.05 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.509 0.723 . . . . 74.34 110.686 168.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -125.72 173.22 9.18 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.007 0.923 . . . . 74.01 110.434 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 72.79 83.17 0.28 Allowed Glycine 0 C--N 1.349 1.257 0 O-C-N 123.919 0.762 . . . . 42.21 112.247 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.13 -39.77 87.45 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 124.157 0.983 . . . . 50.23 110.862 -178.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 5.8 tpt 64.68 93.73 0.06 OUTLIER Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 124.642 1.177 . . . . 74.15 110.577 -179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -63.34 101.13 0.29 Allowed 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.726 2.284 . . . . 71.22 111.806 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 90.7 t -82.73 -63.49 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.623 0 C-N-CA 123.889 0.875 . . . . 74.11 110.32 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 66.05 145.88 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 125.224 1.41 . . . . 75.41 111.616 -173.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.6 135.31 37.22 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 109.413 -0.588 . . . . 73.5 109.413 173.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . . . . . . . . . 5.3 mp -87.5 109.45 19.62 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.483 0.713 . . . . 74.4 109.716 -175.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.35 -167.99 54.33 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 115.569 -0.742 . . . . 63.22 112.619 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.05 120.41 7.39 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.326 2.018 . . . . 72.11 111.471 173.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . 0.599 ' HD3' ' H ' ' E' ' 294' ' ' LYS . 0.0 OUTLIER -84.44 68.68 10.36 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.551 0.741 . . . . 71.03 110.783 -177.515 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . 0.563 ' HA ' ' HG2' ' A' ' 38' ' ' PRO . . . -134.57 86.71 2.29 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.195 0.598 . . . . 74.43 110.946 -174.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . 0.414 HG22 ' HB2' ' A' ' 124' ' ' PRO . 25.7 m -66.35 -42.15 88.52 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.993 0.917 . . . . 73.14 112.447 -175.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.595 ' HA ' ' HG2' ' A' ' 124' ' ' PRO . 0.7 OUTLIER -75.66 140.16 42.38 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.617 0.767 . . . . 75.33 110.051 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -163.42 23.73 0.08 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.707 0.803 . . . . 74.25 110.143 -178.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . 110.23 -136.29 13.48 Favored Glycine 0 C--N 1.34 0.78 0 CA-C-O 119.039 -0.867 . . . . 52.0 111.353 -170.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 8.3 t30 68.65 -67.79 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 125.685 1.594 . . . . 64.31 110.613 -175.092 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 40.8 pt -78.87 23.5 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 123.913 0.885 . . . . 71.12 112.658 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -58.42 -65.85 0.59 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.682 1.593 . . . . 43.13 112.109 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -110.41 101.71 49.28 Favored Pre-proline 0 N--CA 1.478 0.931 0 C-N-CA 123.169 0.588 . . . . 75.42 110.372 -174.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -91.9 5.92 3.55 Favored 'Trans proline' 0 C--N 1.379 2.158 0 C-N-CA 123.1 2.533 . . . . 72.11 113.593 178.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -73.6 76.36 1.5 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 122.871 0.469 . . . . 73.31 110.419 -178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 89.2 t -63.42 -36.17 75.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.913 0.885 . . . . 71.43 111.826 -171.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 41.0 m -145.33 135.73 24.13 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.067 0.547 . . . . 75.3 110.536 179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 77.2 m -104.04 85.47 2.4 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 123.906 0.882 . . . . 73.42 109.833 176.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 68.5 p -78.19 169.55 20.35 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 123.638 0.775 . . . . 71.15 110.206 175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo . . . . . 0 C--N 1.381 2.286 0 C-N-CA 122.171 1.914 . . . . 74.43 112.468 167.659 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 110.466 -0.198 . . . . 51.4 110.466 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -101.52 -173.87 2.46 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.83 0.852 . . . . 62.34 110.133 174.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . 0.491 ' HG2' HE21 ' F' ' 274' ' ' GLN . 51.5 tt0 -159.86 -57.93 0.06 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.724 0.81 . . . . 73.44 109.039 176.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . 0.491 HE21 ' HG2' ' F' ' 273' ' ' GLN . 30.3 mm-40 -111.14 152.36 27.09 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.931 0.893 . . . . 55.31 110.263 -177.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . 0.532 ' HE2' ' HB3' ' F' ' 278' ' ' LEU . 5.8 ttpm? -151.12 79.52 6.84 Favored Pre-proline 0 CA--C 1.551 0.994 0 N-CA-C 108.465 -0.939 . . . . 52.12 108.465 175.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.12 -16.46 17.79 Favored 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.137 2.558 . . . . 60.02 112.92 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . 0.521 ' HA ' ' HG3' ' C' ' 94' ' ' MET . 49.8 mt -96.96 42.77 1.08 Allowed 'General case' 0 C--O 1.24 0.565 0 C-N-CA 123.526 0.731 . . . . 74.44 110.707 -175.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.532 ' HB3' ' HE2' ' F' ' 275' ' ' LYS . 0.3 OUTLIER -172.29 92.44 0.12 Allowed 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 106.791 -1.559 . . . . 53.24 106.791 175.337 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -133.15 25.77 3.63 Favored Glycine 0 N--CA 1.478 1.444 0 CA-C-N 116.392 -0.367 . . . . 70.53 112.367 -178.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 22.0 tp -163.82 167.5 20.74 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 108.051 -1.092 . . . . 71.1 108.051 -177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . 0.489 ' HZ ' ' HG3' ' C' ' 103' ' ' PRO . 2.6 m-85 67.74 -168.65 0.19 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.925 0.89 . . . . 73.13 111.004 -176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 64.91 97.78 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 124.705 1.202 . . . . 64.31 111.448 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 28.2 t70 63.61 42.01 6.76 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 124.665 1.186 . . . . 75.24 110.755 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -138.45 156.22 23.95 Favored Glycine 0 C--N 1.345 1.056 0 CA-C-N 114.863 -1.062 . . . . 73.12 111.383 177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -122.36 171.49 9.02 Favored 'General case' 0 N--CA 1.488 1.425 0 C-N-CA 123.917 0.887 . . . . 74.55 110.061 177.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 90.7 mtp -125.6 136.9 28.96 Favored Pre-proline 0 N--CA 1.474 0.773 0 N-CA-C 108.57 -0.9 . . . . 70.24 108.57 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -82.62 44.93 1.79 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.397 2.731 . . . . 74.41 112.582 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . 0.405 ' HB ' HD12 ' C' ' 44' ' ' LEU . 97.5 t -77.48 103.18 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 108.479 -0.934 . . . . 74.01 108.479 174.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 65.1 mtt-85 -98.0 -179.45 4.41 Favored 'General case' 0 C--O 1.245 0.853 0 C-N-CA 123.95 0.9 . . . . 72.23 109.463 -177.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -69.22 155.44 40.39 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 121.343 0.592 . . . . 70.41 110.699 173.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -87.87 -7.32 57.36 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 114.882 -1.054 . . . . 61.14 110.305 -174.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -140.28 -174.42 13.86 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 110.681 -0.968 . . . . 70.53 110.681 173.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.6 -61.62 0.12 Allowed 'Trans proline' 0 C--N 1.376 2.023 0 C-N-CA 122.828 2.352 . . . . 73.45 112.026 176.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -173.84 150.77 1.7 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.167 0.987 . . . . 63.35 109.543 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -173.78 87.86 0.06 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.768 0.827 . . . . 71.21 109.405 178.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . 0.538 HG22 ' HD2' ' F' ' 297' ' ' TYR . 3.5 m -149.6 162.26 40.55 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.113 -0.699 . . . . 71.31 109.113 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.538 ' HD2' HG22 ' F' ' 296' ' ' THR . 2.2 m-85 71.02 -159.92 0.13 Allowed 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.782 1.233 . . . . 72.24 110.786 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 9.4 t-160 71.15 17.03 6.17 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 124.192 0.997 . . . . 71.22 110.778 -176.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -108.1 -127.81 5.7 Favored Glycine 0 C--N 1.347 1.178 0 CA-C-N 115.966 -0.561 . . . . 35.24 112.577 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -106.34 110.49 22.74 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.783 0.833 . . . . 72.42 109.598 -175.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.465 HD12 ' HA ' ' C' ' 123' ' ' PHE . 16.7 tt -162.71 152.45 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 C-N-CA 124.244 1.018 . . . . 72.44 108.969 177.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 36.5 t70 70.31 -174.99 0.19 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 124.266 1.026 . . . . 55.55 110.283 176.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 80.15 137.2 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 126.098 1.759 . . . . 71.54 111.159 174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' D' ' 14' ' ' GLN . 55.3 Cg_endo -71.03 101.03 1.03 Allowed 'Trans proline' 0 C--N 1.389 2.708 0 C-N-CA 122.97 2.447 . . . . 71.13 111.578 176.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.4 -53.44 8.15 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.596 0.758 . . . . 63.44 111.603 -176.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . 0.661 HG13 HG23 ' F' ' 309' ' ' THR . 91.5 t -72.84 96.46 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 123.695 0.798 . . . . 64.13 109.762 -177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 40.2 p -129.67 -36.36 1.63 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.859 1.264 . . . . 65.21 110.252 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 43.6 t -88.54 -2.78 58.78 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 124.056 0.943 . . . . 73.5 112.059 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . 0.661 HG23 HG13 ' F' ' 306' ' ' VAL . 6.2 t -141.14 149.92 57.05 Favored Pre-proline 0 N--CA 1.478 0.969 0 C-N-CA 123.989 0.916 . . . . 73.14 108.835 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo . . . . . 0 C--N 1.379 2.14 0 C-N-CA 122.182 1.921 . . . . 75.44 111.542 171.137 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.075 0 N-CA-C 109.975 -0.38 . . . . 61.04 109.975 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -85.62 -57.37 3.08 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.615 0.766 . . . . 74.31 109.408 177.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 -167.53 108.14 0.59 Allowed 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.458 1.103 . . . . 72.43 108.972 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -169.74 150.29 3.97 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 123.528 0.731 . . . . 72.51 109.46 174.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . 0.456 ' HD2' ' N ' ' G' ' 275' ' ' LYS . 0.1 OUTLIER -76.45 107.92 5.45 Favored Pre-proline 0 CA--C 1.548 0.877 0 N-CA-C 108.322 -0.992 . . . . 73.32 108.322 176.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.77 -39.77 24.79 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 123.14 2.56 . . . . 63.53 112.727 -171.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 97.2 mt -128.78 84.71 2.25 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.467 0.707 . . . . 71.33 110.704 -177.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -169.34 17.45 0.02 OUTLIER 'General case' 0 CA--C 1.564 1.482 0 C-N-CA 123.939 0.896 . . . . 71.41 109.476 168.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' D' ' 95' ' ' ALA . . . 62.86 -106.92 1.43 Allowed Glycine 0 C--N 1.352 1.462 0 CA-C-N 116.182 -0.463 . . . . 44.31 113.366 177.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -156.31 17.74 0.34 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.74 0.816 . . . . 72.21 110.684 -176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . 0.481 ' HE1' ' HB3' ' D' ' 98' ' ' LEU . 77.6 m-85 -64.45 -18.2 64.53 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.571 0.748 . . . . 64.11 112.274 -176.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -57.32 -40.95 79.0 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.899 0.88 . . . . 50.12 111.479 176.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -157.24 99.53 1.79 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.44 0.696 . . . . 63.12 109.296 176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 166.19 111.41 0.24 Allowed Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.39 -0.368 . . . . 64.54 112.816 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -139.28 162.8 34.11 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 125.219 1.408 . . . . 60.43 108.715 172.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 18.1 ptm -143.2 103.5 5.13 Favored Pre-proline 0 CA--C 1.551 1.016 0 C-N-CA 122.928 0.491 . . . . 72.44 109.948 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.55 108.48 1.85 Allowed 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.651 2.234 . . . . 73.01 110.458 173.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . 0.418 HG11 HD13 ' D' ' 42' ' ' LEU . 13.9 p -62.55 -31.16 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 123.318 0.647 . . . . 72.0 111.218 -179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 67.24 3.08 3.07 Favored 'General case' 0 CA--C 1.568 1.662 0 C-N-CA 124.414 1.086 . . . . 74.54 112.196 175.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.418 ' H ' HG13 ' G' ' 288' ' ' VAL . 87.6 m95 70.45 153.81 0.12 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 125.29 1.436 . . . . 65.31 111.459 -163.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.407 ' N ' HD12 ' G' ' 291' ' ' LEU . 3.0 mp -97.44 28.9 3.48 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.546 0.738 . . . . 75.51 109.795 -178.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 89.34 83.53 1.31 Allowed Glycine 0 C--N 1.35 1.347 0 CA-C-O 119.311 -0.716 . . . . 70.05 112.423 -176.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.14 153.34 46.29 Favored 'Trans proline' 0 C--N 1.372 1.811 0 C-N-CA 122.626 2.217 . . . . 73.34 112.661 177.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -130.92 84.76 2.21 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.402 0.681 . . . . 64.3 109.217 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . 62.02 -172.32 0.15 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.916 0.887 . . . . 70.22 110.825 -172.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 2.0 m -146.94 -32.18 0.31 Allowed 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 108.284 -1.006 . . . . 70.23 108.284 172.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.564 ' HE1' HG12 ' G' ' 301' ' ' ILE . 3.5 p90 -153.61 169.38 23.4 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.671 0.789 . . . . 74.43 110.228 169.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -154.63 138.46 16.23 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.827 0.851 . . . . 75.24 108.823 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 121.83 -172.38 15.46 Favored Glycine 0 N--CA 1.47 0.915 0 N-CA-C 110.46 -1.056 . . . . 71.21 110.46 -174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -76.02 138.0 40.61 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 109.926 -0.398 . . . . 63.34 109.926 176.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.564 HG12 ' HE1' ' G' ' 297' ' ' TYR . 7.5 mt -78.55 -47.4 23.85 Favored 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 108.697 -0.853 . . . . 73.01 108.697 177.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . 0.488 ' HA ' ' NH1' ' C' ' 15' ' ' ARG . 7.0 p-10 -72.82 172.58 10.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.024 -1.443 . . . . 71.1 110.744 -178.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 8.0 tmtm? -147.68 103.17 3.68 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 109.143 -0.688 . . . . 74.25 109.143 -175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -83.99 139.58 8.52 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.868 2.379 . . . . 75.25 112.171 169.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -170.12 -60.16 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.778 0.831 . . . . 71.34 110.154 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.475 HG21 ' HB2' ' A' ' 129' ' ' ALA . 42.1 t -95.92 108.58 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 123.406 0.682 . . . . 73.21 110.19 -174.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 6.2 p -111.96 121.06 43.98 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 108.362 -0.977 . . . . 52.52 108.362 171.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 22.8 t 59.63 -164.73 0.21 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.977 1.311 . . . . 54.02 110.42 -172.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 51.4 m -132.35 72.82 78.03 Favored Pre-proline 0 CA--C 1.555 1.15 0 N-CA-C 108.148 -1.056 . . . . 60.32 108.148 166.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo . . . . . 0 C--N 1.384 2.434 0 C-N-CA 123.321 2.681 . . . . 73.42 111.74 177.86 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.964 0 N-CA-C 109.451 -0.574 . . . . 61.05 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 66.8 156.21 0.1 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 125.105 1.362 . . . . 62.04 113.445 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 9.1 pt20 -103.72 124.04 48.14 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 114.724 -1.126 . . . . 74.13 109.098 173.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -114.89 129.73 56.76 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 108.764 -0.828 . . . . 74.2 108.764 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -124.49 86.04 55.56 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 123.87 0.868 . . . . 61.12 109.905 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . 0.41 ' HG2' ' O ' ' H' ' 278' ' ' LEU . 92.0 Cg_endo -88.67 -174.76 1.1 Allowed 'Trans proline' 0 C--N 1.367 1.543 0 C-N-CA 122.269 1.979 . . . . 73.33 111.129 165.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 79.5 mt -94.77 32.63 1.59 Allowed 'General case' 0 CA--C 1.553 1.078 0 CA-C-O 121.456 0.646 . . . . 73.33 109.822 175.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . 0.607 HD13 ' H ' ' H' ' 279' ' ' GLY . 0.4 OUTLIER -153.9 156.36 37.4 Favored 'General case' 0 CA--C 1.551 1.018 0 N-CA-C 106.971 -1.492 . . . . 74.35 106.971 -179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . 0.607 ' H ' HD13 ' H' ' 278' ' ' LEU . . . 122.9 6.55 7.69 Favored Glycine 0 N--CA 1.478 1.453 0 N-CA-C 111.535 -0.626 . . . . 72.55 111.535 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 6.8 tt -138.86 161.88 36.18 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 107.332 -1.358 . . . . 52.43 107.332 177.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . 0.48 ' CD1' ' HA2' ' B' ' 99' ' ' GLY . 57.1 t80 74.24 75.6 0.12 Allowed 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 124.072 0.949 . . . . 72.54 109.245 178.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -152.97 3.39 0.32 Allowed 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.889 -1.05 . . . . 65.24 111.256 -178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -127.37 123.6 36.63 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.812 -0.81 . . . . 75.51 108.812 -178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.42 -84.49 0.11 Allowed Glycine 0 C--N 1.347 1.147 0 O-C-N 123.598 0.561 . . . . 73.15 112.045 177.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 71.69 -15.65 0.43 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 124.613 1.165 . . . . 75.35 113.452 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 63.9 mtt -61.72 107.41 1.12 Allowed Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 124.007 0.923 . . . . 63.21 111.366 -167.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -89.23 61.44 2.37 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.174 2.583 . . . . 53.22 110.962 -176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 21.8 t -84.22 117.71 30.22 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 108.735 -0.839 . . . . 65.03 108.735 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -87.36 43.65 1.12 Allowed 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.923 0.889 . . . . 73.41 109.757 179.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 4.2 m95 64.36 175.16 0.19 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.702 1.201 . . . . 61.21 112.546 -171.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 78.3 mt -130.53 43.43 3.11 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.732 -1.577 . . . . 74.4 107.546 172.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -170.11 -172.25 36.39 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-N 115.242 -0.89 . . . . 72.23 113.501 -176.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -65.34 -10.79 27.35 Favored 'Trans proline' 0 C--N 1.38 2.235 0 C-N-CA 123.666 2.911 . . . . 41.4 114.853 -175.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? 59.32 22.84 11.23 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.583 1.153 . . . . 73.55 111.477 -175.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -131.36 65.43 1.56 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.627 1.171 . . . . 63.23 108.831 -176.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 84.2 m -63.53 -45.57 89.95 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.19 0.996 . . . . 73.15 111.862 -178.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.683 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 0.8 OUTLIER -84.49 69.3 10.54 Favored 'General case' 0 CA--C 1.551 0.998 0 C-N-CA 124.78 1.232 . . . . 71.43 109.796 -175.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 23.2 m170 -72.4 -82.2 0.05 OUTLIER 'General case' 0 N--CA 1.479 0.996 0 CA-C-N 115.908 -0.587 . . . . 54.42 109.89 176.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -158.58 19.5 0.31 Allowed Glycine 0 C--N 1.349 1.264 0 CA-C-O 119.536 -0.591 . . . . 25.23 113.791 -177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -87.59 63.61 7.67 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-O 122.291 1.043 . . . . 71.12 108.52 170.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 14.4 tt -116.16 -24.32 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 124.924 1.29 . . . . 74.41 107.66 177.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -73.55 91.93 1.87 Allowed 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 114.463 -1.244 . . . . 73.44 108.925 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -97.21 144.21 27.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 N-CA-C 107.317 -1.364 . . . . 64.42 107.317 165.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.1 79.13 2.09 Favored 'Trans proline' 0 C--N 1.371 1.759 0 C-N-CA 122.177 1.918 . . . . 51.34 110.356 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -71.83 172.76 9.27 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-N 114.555 -1.202 . . . . 73.43 110.365 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . 0.698 HG12 HE22 ' A' ' 12' ' ' GLN . 48.7 t -64.96 97.76 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 109.32 -0.622 . . . . 71.04 109.32 178.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 25.0 m -72.85 -49.18 31.7 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.31 -0.996 . . . . 60.0 108.31 169.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 42.2 t -172.61 119.69 0.38 Allowed 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 114.215 -1.357 . . . . 71.54 108.472 172.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . 0.563 HG23 HG13 ' H' ' 306' ' ' VAL . 11.7 p -78.99 149.62 73.78 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 123.19 0.596 . . . . 73.12 110.019 174.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo . . . . . 0 C--N 1.378 2.101 0 C-N-CA 123.037 2.492 . . . . 55.01 111.455 173.763 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.2 mtt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 108.608 -0.886 . . . . 74.43 108.608 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 m 61.0 78.68 0.28 Allowed 'General case' 0 CA--C 1.553 1.059 0 O-C-N 124.257 0.973 . . . . 65.12 111.395 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -82.31 67.42 8.32 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.259 0.624 . . . . 74.13 110.082 177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -156.7 113.3 3.06 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 107.752 -1.203 . . . . 33.31 107.752 171.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 93' ' ' GLN . 29.9 p30 -166.43 -12.14 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.915 0 CA-C-N 115.472 -0.786 . . . . 75.44 111.416 -169.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -101.28 97.59 8.08 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.962 0.905 . . . . 54.23 110.759 -175.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -120.2 -71.26 0.74 Allowed 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 123.79 0.836 . . . . 72.43 108.957 178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -164.18 175.06 10.51 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.567 1.147 . . . . 72.42 108.987 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 90.6 mtp -136.33 150.44 48.86 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.891 0.477 . . . . 74.14 110.643 -174.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.547 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 96.8 m -142.25 126.32 17.37 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.291 1.036 . . . . 62.23 108.483 171.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.663 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 5.1 t80 -139.63 135.56 33.43 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.717 0.636 . . . . 63.52 110.511 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 58.3 tp60 -154.44 126.16 7.58 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 108.465 -0.939 . . . . 74.41 108.465 169.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.536 HG12 ' HD2' ' A' ' 84' ' ' PHE . 27.9 mt -81.32 113.57 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 108.604 -0.887 . . . . 74.2 108.604 176.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -79.13 -31.05 43.98 Favored 'General case' 0 CA--C 1.544 0.728 0 O-C-N 124.16 0.913 . . . . 64.43 109.771 -178.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 57.3 ttt180 -173.25 143.64 1.12 Allowed 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 123.361 0.664 . . . . 72.1 110.293 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 1.8 pp -135.63 140.2 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 C-N-CA 123.788 0.835 . . . . 74.3 109.161 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -173.63 175.68 2.91 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.955 0.902 . . . . 70.33 110.495 -169.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.1 p -100.15 119.54 38.5 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.725 0.81 . . . . 44.11 109.009 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.3 mtpt -84.48 -32.75 23.82 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.5 0.32 . . . . 64.25 110.405 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -148.93 139.44 22.56 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.695 -0.684 . . . . 73.41 109.641 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.447 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 89.2 mt -138.42 139.5 41.46 Favored 'Isoleucine or valine' 0 C--O 1.241 0.64 0 N-CA-C 106.398 -1.704 . . . . 71.53 106.398 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 46.0 t -154.85 110.21 3.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 123.711 0.632 . . . . 71.44 109.636 174.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.666 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 74.1 t80 -110.54 113.65 26.45 Favored 'General case' 0 C--O 1.218 -0.594 0 N-CA-C 107.268 -1.382 . . . . 73.32 107.268 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -117.44 118.27 31.74 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 123.21 0.604 . . . . 64.11 109.748 -178.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -108.61 78.77 0.93 Allowed Pre-proline 0 N--CA 1.474 0.775 0 N-CA-C 107.271 -1.381 . . . . 74.34 107.271 168.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.0 -39.03 34.24 Favored 'Trans proline' 0 C--N 1.381 2.265 0 C-N-CA 122.814 2.343 . . . . 70.11 112.464 -166.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.43 ' HB3' ' HB3' ' A' ' 30' ' ' HIS . 7.2 m-20 -106.85 48.32 0.84 Allowed 'General case' 0 C--O 1.212 -0.873 0 N-CA-C 106.998 -1.482 . . . . 74.54 106.998 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.514 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -54.39 -62.13 4.47 Favored Pre-proline 0 N--CA 1.491 1.607 0 CA-C-O 117.503 -1.237 . . . . 61.43 111.499 -176.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 16.7 Cg_exo -64.59 -21.95 65.2 Favored 'Trans proline' 0 C--N 1.393 2.869 0 CA-C-N 121.578 1.599 . . . . 52.41 113.23 -179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 27' ' ' ASN . 1.9 t60 -81.44 -55.78 4.47 Favored 'General case' 0 C--O 1.216 -0.701 0 C-N-CA 123.489 0.715 . . . . 73.42 110.118 -173.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG11 ' HA ' ' A' ' 73' ' ' ALA . 5.0 p -67.99 -18.22 23.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 123.85 0.86 . . . . 71.14 111.626 -165.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.406 ' HA ' ' HH2' ' A' ' 36' ' ' TRP . 20.1 m-30 -62.87 -27.03 69.07 Favored 'General case' 0 CA--C 1.556 1.203 0 C-N-CA 124.281 1.032 . . . . 74.23 112.718 176.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -96.83 -12.93 22.94 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 112.085 0.402 . . . . 74.11 112.085 173.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' ' N ' ' A' ' 35' ' ' ASP . 3.4 tmtp? -74.59 141.62 44.72 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.213 0.605 . . . . 70.14 109.838 -173.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.512 ' N ' ' HD3' ' A' ' 34' ' ' LYS . 25.1 t70 -51.03 128.16 20.79 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 125.408 1.483 . . . . 60.3 112.348 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.406 ' HH2' ' HA ' ' A' ' 32' ' ' PHE . 51.8 m95 -78.11 90.4 4.24 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 124.019 0.825 . . . . 74.22 111.262 -171.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -139.94 78.22 25.04 Favored Pre-proline 0 CA--C 1.547 0.832 0 CA-C-N 114.651 -1.159 . . . . 64.45 108.446 172.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -82.52 121.36 3.36 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 122.828 2.352 . . . . 63.35 112.662 -176.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -96.39 95.39 8.02 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 107.006 -1.479 . . . . 72.3 107.006 171.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' THR . 20.0 t -84.27 97.94 5.43 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 CA-C-N 115.318 -0.855 . . . . 74.42 110.075 -170.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.475 ' HB3' ' HB ' ' A' ' 65' ' ' THR . 55.8 tttm -82.53 125.83 31.58 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 123.626 0.77 . . . . 73.34 110.418 -177.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.3 tt -111.43 115.59 29.51 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 108.596 -0.89 . . . . 72.25 108.596 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.694 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 4.8 m-20 -106.75 129.67 54.59 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.864 0.866 . . . . 74.4 109.165 173.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 43.6 tp -113.96 116.31 29.02 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 108.967 -0.753 . . . . 64.55 108.967 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -132.99 153.93 51.0 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.81 0.844 . . . . 75.44 109.292 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 10.1 t -151.43 163.47 38.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.322 0.649 . . . . 55.03 110.883 -176.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -164.26 154.42 14.6 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 124.154 0.982 . . . . 42.13 109.838 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 81.5 p -131.16 159.85 36.49 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 117.97 0.35 . . . . 73.53 111.21 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.6 t -150.53 128.51 11.81 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.736 0.815 . . . . 44.34 109.46 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -77.54 110.74 12.58 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 109.05 -0.722 . . . . 72.23 109.05 175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.529 HD12 HG23 ' A' ' 83' ' ' ILE . 74.1 mt -94.54 -38.67 10.78 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 115.78 -0.646 . . . . 64.11 109.571 178.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.575 ' HB3' ' HB ' ' A' ' 55' ' ' VAL . . . -151.62 -179.51 7.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.733 0.813 . . . . 53.01 110.042 178.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -73.3 126.52 30.31 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.846 -0.798 . . . . 45.23 108.846 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 68.78 1.78 3.22 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 125.318 1.447 . . . . 44.54 112.258 -173.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.575 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 94.5 t -115.68 107.33 22.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.883 -0.784 . . . . 72.14 108.883 -178.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.65 ' HB2' HD13 ' A' ' 86' ' ' ILE . 76.0 m-85 -126.85 126.87 44.06 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 107.184 -1.414 . . . . 74.53 107.184 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -84.47 133.1 34.49 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.191 -1.04 . . . . 75.34 108.191 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.8 t -113.06 127.06 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 107.343 -1.354 . . . . 73.43 107.343 168.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 47.2 t -100.65 138.02 26.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 107.893 -1.151 . . . . 73.32 107.893 172.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -126.63 109.35 12.0 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.635 -1.246 . . . . 75.34 107.635 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 24.6 ttp180 -95.31 124.02 39.13 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.331 1.052 . . . . 73.1 110.326 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.5 t -108.74 132.14 57.5 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 107.409 -1.33 . . . . 74.24 107.409 169.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.694 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 18.9 m -120.29 121.46 38.7 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.037 -0.727 . . . . 64.04 109.037 177.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 114' ' ' ILE . 50.1 t -114.72 106.65 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 124.532 1.133 . . . . 72.31 108.679 -174.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.475 ' HB ' ' HB3' ' A' ' 41' ' ' LYS . 11.6 m -105.94 145.52 31.2 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 108.04 -1.096 . . . . 63.02 108.04 173.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.87 103.88 7.29 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 107.252 -1.388 . . . . 74.2 107.252 168.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.524 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 36.0 m -108.09 124.16 49.79 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 120.98 0.419 . . . . 71.0 109.992 -178.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.8 mp -100.52 80.54 2.23 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 106.658 -1.608 . . . . 74.43 106.658 175.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.98 -117.81 5.46 Favored Glycine 0 C--N 1.345 1.071 0 N-CA-C 110.212 -1.155 . . . . 55.41 110.212 -173.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -88.09 -26.31 22.58 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.397 0.679 . . . . 73.33 109.972 174.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -84.1 100.35 11.07 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.24 0.616 . . . . 62.44 111.061 -177.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 85.3 m -72.53 133.85 44.96 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 120.923 0.392 . . . . 73.25 110.298 172.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' HA ' HG11 ' A' ' 31' ' ' VAL . . . -77.5 -63.48 1.37 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 124.645 1.178 . . . . 73.02 110.183 177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -149.2 162.96 38.97 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 114.591 -1.186 . . . . 64.53 110.689 -179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 14.0 tp -141.29 140.6 33.88 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.613 -1.625 . . . . 63.41 106.613 179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.666 ' HG ' ' HD1' ' A' ' 23' ' ' PHE . 16.3 m -145.51 99.08 3.24 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 109.186 -0.672 . . . . 64.3 109.186 -175.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -114.01 116.68 29.58 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.661 -0.866 . . . . 74.12 108.661 -179.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.5 t -129.49 110.39 20.04 Favored 'Isoleucine or valine' 0 C--O 1.238 0.476 0 C-N-CA 123.715 0.806 . . . . 71.34 109.392 -174.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 61.5 mt-30 -84.85 89.21 7.5 Favored 'General case' 0 C--O 1.237 0.395 0 N-CA-C 108.302 -0.999 . . . . 73.11 108.302 173.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -76.71 97.21 4.4 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.118 -0.697 . . . . 75.52 109.118 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.499 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -90.3 143.25 16.81 Favored Glycine 0 C--N 1.339 0.699 0 N-CA-C 111.552 -0.619 . . . . 73.21 111.552 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -141.47 122.91 2.15 Favored Glycine 0 CA--C 1.502 -0.741 0 N-CA-C 110.44 -1.064 . . . . 73.21 110.44 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.529 HG23 HD12 ' A' ' 51' ' ' LEU . 43.5 mt -80.12 116.33 24.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 107.656 -1.238 . . . . 71.24 107.656 174.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.663 ' HB3' ' HE2' ' A' ' 11' ' ' PHE . 44.6 m-85 -122.38 158.57 29.36 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.281 0.632 . . . . 63.11 109.416 -177.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' PHE . 42.8 m -104.57 98.76 8.48 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 108.226 -1.028 . . . . 65.24 108.226 172.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.65 HD13 ' HB2' ' A' ' 56' ' ' TYR . 3.9 mp -97.46 124.26 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 N-CA-C 107.739 -1.208 . . . . 71.23 107.739 176.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.547 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -162.04 151.93 16.55 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.772 0.67 . . . . 42.43 110.714 179.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 105.55 -33.24 6.67 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 115.334 -0.848 . . . . 53.44 113.081 174.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 89' ' ' ILE . 0.2 OUTLIER -116.67 147.5 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.339 0.656 . . . . 53.11 111.467 -168.486 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.52 173.88 10.85 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.226 -0.897 . . . . 41.15 110.708 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.07 -114.46 5.79 Favored Glycine 0 C--N 1.35 1.317 0 O-C-N 124.639 1.212 . . . . 52.43 115.011 173.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 76.6 p -65.42 -42.54 92.38 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.019 0.928 . . . . 61.0 111.551 -176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.459 ' HG2' ' HB2' ' A' ' 5' ' ' ASN . 82.9 mm-40 -70.39 -36.91 74.37 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.226 0.611 . . . . 53.52 111.042 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 15.8 tmm? -65.19 -44.03 89.7 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.368 0.667 . . . . 62.12 109.799 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.83 88.74 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.044 0.938 . . . . 51.4 111.243 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -74.07 -31.09 62.7 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.694 -0.685 . . . . 65.14 110.79 177.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 44.7 t -69.76 -44.36 70.34 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.336 0.589 . . . . 74.51 110.055 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.4 mt -76.34 -44.28 37.36 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.876 -1.056 . . . . 63.15 111.403 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -96.91 3.36 62.42 Favored Glycine 0 C--N 1.349 1.298 0 N-CA-C 115.434 0.933 . . . . 72.12 115.434 -167.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.652 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.63 -61.23 0.21 Allowed 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 117.708 0.754 . . . . 75.41 112.055 -175.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.453 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 67.1 t80 -61.75 -59.33 5.32 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.974 1.31 . . . . 74.21 112.625 -171.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 86.1 m -71.41 -36.5 4.75 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 118.557 -0.735 . . . . 42.34 112.951 -179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.48 -40.96 45.1 Favored 'Trans proline' 0 C--N 1.387 2.59 0 C-N-CA 123.089 2.526 . . . . 74.42 114.287 164.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -60.04 -35.33 74.87 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.942 0.897 . . . . 74.44 111.108 177.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' A' ' 13' ' ' ILE . 43.8 mm -68.15 -42.34 84.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 C-N-CA 123.638 0.775 . . . . 65.14 110.145 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 50.0 mt -75.61 -33.09 60.51 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 114.582 -1.19 . . . . 52.02 112.547 -172.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -59.65 -43.76 96.14 Favored Pre-proline 0 CA--C 1.569 1.71 0 N-CA-C 114.032 1.123 . . . . 70.12 114.032 -170.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.06 -38.23 96.34 Favored 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.483 2.122 . . . . 72.1 113.73 173.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -72.83 -40.48 65.73 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.494 0.718 . . . . 73.32 111.845 -179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.02 -40.52 87.28 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 122.728 0.411 . . . . 75.03 110.16 176.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 -54.07 -52.43 60.97 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.637 1.175 . . . . 73.13 110.477 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -62.98 -46.13 89.17 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.809 0.844 . . . . 71.34 111.141 -177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 40.5 t -55.16 -47.12 75.59 Favored 'General case' 0 N--CA 1.478 0.936 0 O-C-N 123.855 0.722 . . . . 63.14 110.469 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.489 ' O ' HG23 ' A' ' 118' ' ' VAL . 95.2 mt -60.69 -51.64 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 114.918 -1.037 . . . . 63.24 110.371 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.611 HG23 ' HG3' ' A' ' 125' ' ' GLN . 99.3 m -52.41 -46.66 66.41 Favored 'General case' 0 C--O 1.247 0.964 0 C-N-CA 124.248 1.019 . . . . 62.13 112.18 -175.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 35.3 t -66.04 -44.04 85.79 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-N 115.061 -0.972 . . . . 74.41 109.848 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 mtp -58.87 -42.08 88.61 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.785 0.834 . . . . 62.32 111.206 177.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 114' ' ' ILE . 89.4 t -59.96 -49.65 83.15 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.045 0 C-N-CA 123.788 0.835 . . . . 75.33 110.307 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 93.0 p -69.25 -28.97 66.79 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 122.866 0.467 . . . . 64.12 112.135 -174.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 83.9 mtt-85 -66.49 -28.34 68.49 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.813 0.845 . . . . 74.12 111.235 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.04 11.85 61.56 Favored Glycine 0 C--N 1.354 1.574 0 CA-C-O 119.478 -0.623 . . . . 62.04 114.053 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.408 ' HB ' HH21 ' B' ' 15' ' ' ARG . 3.8 m 65.62 16.11 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 125.0 1.32 . . . . 45.1 111.192 -175.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -88.21 141.23 30.81 Favored Pre-proline 0 CA--C 1.548 0.873 0 N-CA-C 108.736 -0.838 . . . . 74.44 108.736 175.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.53 144.4 84.71 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 123.14 2.56 . . . . 50.21 112.71 178.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.611 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.8 tt0 -53.71 138.85 34.21 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 124.352 1.033 . . . . 64.44 111.958 -176.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 40.7 tp -127.46 114.92 18.11 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.632 -0.713 . . . . 74.4 109.398 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -112.0 118.89 36.69 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.462 -1.31 . . . . 74.3 107.462 172.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -71.36 122.64 20.69 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 109.274 -0.639 . . . . 65.54 109.274 177.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -62.18 134.91 94.75 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 123.399 0.437 . . . . 72.41 110.913 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -65.0 106.62 0.8 Allowed 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.783 2.322 . . . . 64.24 111.975 -176.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 90.2 t -100.15 117.77 45.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 107.716 -1.216 . . . . 63.23 107.716 175.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.541 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 12.2 m120 -80.98 73.22 8.03 Favored 'General case' 0 C--O 1.241 0.634 0 CA-C-O 121.668 0.747 . . . . 72.22 110.628 177.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -67.2 -33.75 76.03 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 114.78 -1.1 . . . . 74.52 108.997 169.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.652 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 4.4 p-10 -60.19 -43.16 96.11 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.328 -1.306 . . . . 60.1 111.654 176.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -72.75 -38.73 67.27 Favored 'General case' 0 C--N 1.348 0.514 0 C-N-CA 123.474 0.71 . . . . 51.13 110.594 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.496 HD22 ' HG2' ' E' ' 286' ' ' MET . 8.9 tt -55.25 -52.86 62.03 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 124.398 1.061 . . . . 50.41 109.988 176.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . 0.464 ' HB2' ' SD ' ' E' ' 286' ' ' MET . 10.9 t80 -69.04 -23.45 64.06 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 114.607 -1.178 . . . . 73.35 110.883 -177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.61 -46.4 19.37 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.681 0.792 . . . . 72.24 111.291 -178.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -71.06 -19.77 62.45 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 120.879 0.371 . . . . 62.13 111.206 179.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -82.98 -30.59 28.09 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 123.531 0.732 . . . . 72.23 110.345 170.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 137' ' ' PHE . 26.5 tp -63.48 -51.27 66.32 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 124.318 1.047 . . . . 70.35 112.848 -173.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -158.29 22.06 0.24 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 123.385 0.674 . . . . 45.5 109.563 -173.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' C' ' 144' ' ' GLN . 18.6 tp60 68.69 -70.52 0.13 Allowed 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 124.875 1.27 . . . . 73.02 110.354 -175.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.416 ' HB2' ' HG2' ' C' ' 144' ' ' GLN . 1.1 mm-40 -171.79 168.34 6.15 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 125.982 1.713 . . . . 70.04 108.547 170.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.16 -59.79 0.31 Allowed 'General case' 0 C--O 1.241 0.656 0 N-CA-C 108.381 -0.97 . . . . 71.25 108.381 176.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 64.42 -146.3 50.22 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 114.954 -1.021 . . . . 73.21 112.866 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 63.61 109.06 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 125.451 1.501 . . . . 70.33 110.412 178.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -142.11 60.53 0.54 Allowed Glycine 0 C--N 1.341 0.817 0 N-CA-C 110.869 -0.892 . . . . 61.15 110.869 177.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 24.6 m -77.71 -59.17 2.89 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.6 0.76 . . . . 74.41 110.546 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 57.49 87.61 0.06 Allowed 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.509 1.123 . . . . 71.13 111.598 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -158.62 120.98 3.62 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.695 -0.854 . . . . 74.11 108.695 176.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -166.21 28.7 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 123.72 0.808 . . . . 71.01 110.14 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -67.78 107.76 2.71 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 121.297 0.57 . . . . 64.35 110.521 -178.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -110.28 141.98 42.52 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.41 1.084 . . . . 64.0 109.773 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.5 0 O-C-N 124.068 0.855 . . . . 64.5 110.541 178.33 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.668 ' HG2' ' HA ' ' D' ' 141' ' ' LEU . 66.0 mtm . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 108.501 -0.926 . . . . 72.54 108.501 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.555 ' HB3' ' HG2' ' B' ' 4' ' ' GLN . 23.1 t -165.18 175.76 9.03 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.977 -0.749 . . . . 71.31 108.977 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.05 -16.03 61.5 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 122.859 0.464 . . . . 73.21 111.21 -179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.555 ' HG2' ' HB3' ' B' ' 2' ' ' SER . 20.9 pt20 -74.35 164.45 26.58 Favored 'General case' 0 C--O 1.245 0.823 0 C-N-CA 124.489 1.115 . . . . 72.23 111.993 -178.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 30.6 p-10 -137.42 178.96 6.7 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 115.364 -0.835 . . . . 74.52 108.913 169.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -147.95 177.88 8.98 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.224 0.61 . . . . 74.41 109.698 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 53.6 p -63.45 118.81 8.64 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 109.416 -0.587 . . . . 63.13 109.416 173.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -86.69 34.25 0.65 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.574 1.15 . . . . 61.21 110.256 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.572 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 10.1 ptt? 51.48 -170.05 0.03 OUTLIER 'General case' 0 CA--C 1.554 1.127 0 C-N-CA 126.811 2.044 . . . . 75.41 113.347 -172.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.609 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 99.6 m -155.39 108.64 2.78 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 107.185 -1.413 . . . . 52.35 107.185 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 22.6 t80 -121.69 143.46 49.33 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 109.298 -0.63 . . . . 74.15 109.298 -177.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.6 ' NE2' ' HB ' ' E' ' 306' ' ' VAL . 0.0 OUTLIER -156.15 132.18 9.88 Favored 'General case' 0 C--O 1.244 0.815 0 N-CA-C 108.6 -0.889 . . . . 72.03 108.6 175.577 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.475 HG22 ' HE2' ' B' ' 84' ' ' PHE . 1.8 pp -76.4 104.33 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 CA-C-O 122.112 0.958 . . . . 73.01 108.842 173.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . 0.418 ' HG3' ' OG ' ' B' ' 85' ' ' SER . 1.4 tm0? -76.71 -36.37 57.24 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.963 -0.754 . . . . 55.41 108.963 -170.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.408 HH21 ' HB ' ' A' ' 122' ' ' THR . 21.8 ttt180 -168.06 140.08 2.97 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 124.036 0.835 . . . . 74.43 109.199 173.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 89.0 mt -124.82 134.38 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 107.597 -1.26 . . . . 32.31 107.597 172.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -166.27 157.39 13.11 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.576 0.547 . . . . 70.24 111.813 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.3 m -83.0 127.9 33.98 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.407 -0.815 . . . . 54.52 109.039 171.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.564 ' HD2' ' HA3' ' B' ' 81' ' ' GLY . 25.4 mtpp -93.51 -41.05 9.99 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.549 -0.75 . . . . 75.33 110.095 177.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 14.5 t70 -152.4 145.63 24.69 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 115.827 -0.624 . . . . 74.34 111.4 -168.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 23' ' ' PHE . 46.8 mm -140.02 143.22 30.38 Favored 'Isoleucine or valine' 0 C--N 1.352 0.681 0 C-N-CA 125.291 1.437 . . . . 73.23 108.411 -177.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.486 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 40.4 t -146.22 134.9 22.24 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 124.454 1.101 . . . . 73.4 108.325 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.447 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 87.2 t80 -148.2 120.14 8.2 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 107.061 -1.459 . . . . 73.23 107.061 170.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -119.08 142.91 47.46 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.153 -1.055 . . . . 71.33 108.153 179.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.976 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -139.25 77.59 29.82 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 107.635 -1.246 . . . . 72.42 107.635 176.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -67.62 -40.4 10.22 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.902 2.401 . . . . 64.33 112.509 -172.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -109.03 21.06 17.69 Favored 'General case' 0 C--O 1.204 -1.337 0 CA-C-N 115.255 -0.884 . . . . 71.22 110.072 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.976 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -45.44 -48.88 35.24 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 115.524 1.676 . . . . 72.01 115.524 -175.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.437 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 4.1 Cg_exo -74.93 -38.44 1.63 Allowed 'Trans proline' 0 C--N 1.383 2.348 0 C-N-CA 122.539 2.16 . . . . 74.1 112.256 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.46 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 37.8 m80 -90.09 -4.98 57.02 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.147 0.795 . . . . 65.31 113.147 -171.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.466 HG23 HD11 ' B' ' 68' ' ' LEU . 7.6 p -69.99 -18.45 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 C-N-CA 123.115 0.566 . . . . 64.43 111.082 -175.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.4 ' HA ' ' HB3' ' B' ' 35' ' ' ASP . 55.2 t80 -66.47 -14.95 62.94 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.645 0.778 . . . . 73.31 111.865 -178.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.539 ' HG3' ' HG3' ' B' ' 34' ' ' LYS . 10.2 pt20 -69.15 -37.3 78.18 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.602 -0.518 . . . . 75.41 109.602 172.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.539 ' HG3' ' HG3' ' B' ' 33' ' ' GLN . 86.6 mttt -110.75 62.46 0.61 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 108.615 -0.883 . . . . 52.2 108.615 172.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.4 ' HB3' ' HA ' ' B' ' 32' ' ' PHE . 11.1 p-10 -88.17 98.44 11.56 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 122.03 -0.419 . . . . 73.24 110.662 -173.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER 172.36 -174.96 0.05 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 125.244 1.417 . . . . 63.04 111.429 163.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.535 ' HA ' ' HB2' ' H' ' 297' ' ' TYR . 29.4 pt20 -49.03 110.1 1.41 Allowed Pre-proline 0 CA--C 1.558 1.263 0 C-N-CA 125.464 1.506 . . . . 65.35 113.494 -169.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -82.51 165.84 16.0 Favored 'Trans proline' 0 C--N 1.373 1.831 0 C-N-CA 122.688 2.259 . . . . 71.54 110.836 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -72.86 104.46 4.03 Favored 'General case' 0 C--O 1.241 0.648 0 N-CA-C 107.205 -1.406 . . . . 75.22 107.205 169.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.65 143.53 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 108.164 -1.05 . . . . 71.02 108.164 -179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttm -138.96 116.75 11.5 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.231 0.612 . . . . 54.02 109.909 -170.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 66.1 mt -86.78 125.72 34.13 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 108.55 -0.907 . . . . 74.44 108.55 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 17.8 t70 -133.83 107.41 7.85 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 107.814 -1.18 . . . . 64.35 107.814 177.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.39 127.37 53.52 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 108.72 -0.844 . . . . 63.21 108.72 -178.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.498 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 12.1 t70 -123.14 136.91 54.98 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 107.801 -1.185 . . . . 73.11 107.801 -172.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 32.2 p -109.19 115.05 29.27 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.325 0.65 . . . . 74.22 110.998 -168.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -119.63 144.57 47.07 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.909 0.884 . . . . 63.33 109.161 174.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 58.8 p -145.14 163.21 35.04 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.375 0.67 . . . . 75.51 109.894 174.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -151.26 167.28 28.33 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.525 0.73 . . . . 74.53 109.804 174.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -113.42 112.61 23.91 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 108.885 -0.783 . . . . 73.12 108.885 175.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -81.49 -40.21 23.58 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 122.894 0.477 . . . . 71.21 110.035 176.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.78 -173.32 4.32 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 115.28 -0.873 . . . . 74.32 110.706 -177.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.2 106.62 0.45 Allowed 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.645 -1.162 . . . . 75.35 109.73 175.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 73.49 5.22 4.94 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.197 1.399 . . . . 71.12 112.209 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.9 t -103.81 113.07 39.68 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 N-CA-C 107.958 -1.127 . . . . 73.45 107.958 175.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -122.5 140.76 52.38 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.22 0.608 . . . . 71.15 110.119 -177.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.629 ' HG2' HG12 ' B' ' 83' ' ' ILE . 3.9 tm-20 -108.15 98.31 7.88 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.58 -1.267 . . . . 71.42 107.58 -179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -93.96 119.87 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.703 1.201 . . . . 62.41 110.236 -175.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.538 ' HB ' ' HB3' ' B' ' 47' ' ' ALA . 21.8 t -107.13 139.21 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 124.204 1.002 . . . . 53.13 109.981 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.815 HD11 ' HA ' ' B' ' 103' ' ' PRO . 84.9 mt -121.56 112.85 18.99 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.373 0.669 . . . . 74.24 109.376 174.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 40.2 ttm-85 -86.89 107.6 18.41 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 108.185 -1.043 . . . . 72.34 108.185 170.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 45.1 t -103.83 101.88 12.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 N-CA-C 107.075 -1.454 . . . . 74.25 107.075 174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 32.3 m -97.31 139.12 33.74 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 113.931 -1.486 . . . . 54.41 108.443 -179.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 60.4 t -133.61 114.08 19.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 N-CA-C 108.203 -1.036 . . . . 71.23 108.203 176.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 88.4 m -101.38 140.58 35.47 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.371 -0.974 . . . . 71.11 108.371 178.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.95 126.38 23.34 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 108.314 -0.995 . . . . 41.11 108.314 175.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 41.4 p -146.27 140.03 26.2 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 123.357 0.663 . . . . 74.21 110.514 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.628 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -133.36 140.87 47.63 Favored 'General case' 0 C--O 1.242 0.683 0 C-N-CA 123.992 0.917 . . . . 74.4 109.655 -178.642 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 72.84 -111.75 3.66 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-N 115.434 -0.803 . . . . 30.12 111.429 -172.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -121.6 2.5 10.13 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.596 0.758 . . . . 74.1 109.885 -179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -135.63 171.95 13.72 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.949 0.5 . . . . 70.2 110.877 -169.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 24.7 m -75.03 140.37 43.5 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 115.493 -0.776 . . . . 73.23 111.352 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.628 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -86.04 -62.2 1.57 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.247 -1.02 . . . . 71.51 108.247 172.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -163.07 167.08 22.83 Favored 'General case' 0 CA--C 1.548 0.872 0 CA-C-N 113.475 -1.693 . . . . 74.25 107.917 175.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 94.3 mt -132.63 143.31 49.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.54 1.136 . . . . 71.33 108.013 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 49.7 t -143.33 144.34 32.05 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 108.372 -0.973 . . . . 62.13 108.372 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.486 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 40.5 tt0 -160.12 139.01 10.62 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 108.97 -0.752 . . . . 60.43 108.97 -175.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.441 HG21 ' HB3' ' B' ' 113' ' ' CYS . 69.7 t -135.43 145.69 31.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 107.547 -1.279 . . . . 72.22 107.547 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.44 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 25.0 mt-30 -124.88 92.78 3.72 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.939 -1.134 . . . . 64.02 107.939 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -89.38 104.42 16.97 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 114.956 -1.02 . . . . 61.41 108.848 -176.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.564 ' HA3' ' HD2' ' B' ' 19' ' ' LYS . . . -90.21 156.65 25.3 Favored Glycine 0 C--O 1.244 0.767 0 N-CA-C 111.131 -0.788 . . . . 74.14 111.131 176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -159.29 124.18 1.33 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 111.072 -0.811 . . . . 73.11 111.072 -178.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.629 HG12 ' HG2' ' B' ' 57' ' ' GLU . 26.0 mt -85.99 134.55 27.02 Favored 'Isoleucine or valine' 0 C--O 1.242 0.676 0 N-CA-C 108.076 -1.083 . . . . 60.32 108.076 175.677 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . 0.475 ' HE2' HG22 ' B' ' 13' ' ' ILE . 65.4 m-85 -133.64 135.08 43.94 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.343 -0.984 . . . . 71.34 108.343 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.418 ' OG ' ' HG3' ' B' ' 14' ' ' GLN . 65.5 m -107.61 91.85 3.82 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 107.369 -1.345 . . . . 71.43 107.369 172.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.555 ' HB ' HD11 ' B' ' 89' ' ' ILE . 35.2 pt -98.11 138.21 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 115.386 -0.825 . . . . 65.33 110.974 -169.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.609 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -145.01 167.77 21.87 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.28 1.032 . . . . 65.35 109.945 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 82.79 -63.72 4.42 Favored Glycine 0 C--N 1.342 0.915 0 CA-C-N 115.696 -0.684 . . . . 75.42 112.006 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.555 HD11 ' HB ' ' B' ' 86' ' ' ILE . 2.3 pp -61.35 138.1 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 123.618 0.767 . . . . 73.13 112.123 178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -161.12 149.66 16.08 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.477 -0.783 . . . . 73.41 109.197 177.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.08 -124.9 14.69 Favored Glycine 0 C--N 1.348 1.228 0 O-C-N 123.68 0.613 . . . . 42.33 112.793 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 30.0 m -67.19 -33.37 75.25 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.402 0.681 . . . . 62.11 110.964 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 42.5 mt-30 -69.88 -33.24 71.97 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 115.763 -0.653 . . . . 71.21 110.468 178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 1.2 tmt? -65.57 -45.57 82.8 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.024 0.53 . . . . 62.33 110.138 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.14 -31.87 70.5 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.812 0.845 . . . . 62.34 112.09 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 49.2 t-80 -77.71 -43.92 29.49 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.168 0.587 . . . . 74.55 111.2 177.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -71.46 -47.26 56.82 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.37 0.605 . . . . 54.33 111.909 -172.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.564 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 3.1 tm? -89.38 -37.61 14.73 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.112 0.965 . . . . 73.43 110.202 -174.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -79.28 -26.32 57.68 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 123.34 0.4 . . . . 54.04 114.015 -174.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.615 ' HB1' ' HA ' ' B' ' 134' ' ' ASP . . . -120.91 -48.99 2.23 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 122.985 0.514 . . . . 70.43 112.203 -173.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.512 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 67.2 t80 -77.84 -45.71 23.57 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 112.51 0.559 . . . . 73.51 112.51 -172.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.564 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 78.5 m -59.48 -42.55 92.82 Favored Pre-proline 0 CA--C 1.565 1.526 0 N-CA-C 112.981 0.734 . . . . 62.04 112.981 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.815 ' HA ' HD11 ' B' ' 60' ' ' LEU . 83.6 Cg_exo -52.08 -39.61 70.0 Favored 'Trans proline' 0 C--N 1.389 2.674 0 C-N-CA 122.529 2.153 . . . . 73.31 114.818 168.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -67.54 -24.05 65.5 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.114 0.566 . . . . 61.42 112.062 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.534 HG23 ' NH2' ' D' ' 111' ' ' ARG . 92.8 mt -73.15 -47.39 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 123.778 0.831 . . . . 71.33 111.348 179.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.513 ' HB2' HD12 ' B' ' 60' ' ' LEU . 75.1 mt -79.72 -18.79 50.38 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 115.871 -0.604 . . . . 63.45 110.987 -175.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 43.4 t80 -55.76 -50.55 86.42 Favored Pre-proline 0 CA--C 1.569 1.703 0 CA-C-O 117.699 -1.143 . . . . 73.53 113.733 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -59.1 -35.86 97.18 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 122.552 2.168 . . . . 71.2 113.959 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -69.44 -46.73 66.07 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.481 0.712 . . . . 73.53 110.575 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.417 ' HA ' HG11 ' B' ' 78' ' ' VAL . . . -59.3 -41.28 88.63 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 115.398 -0.819 . . . . 75.33 110.616 175.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -63.14 -50.43 70.45 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.557 1.543 . . . . 74.32 111.268 -177.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -64.85 -37.99 89.47 Favored 'General case' 0 N--CA 1.482 1.142 0 O-C-N 123.95 0.781 . . . . 64.51 109.998 -177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.545 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.7 t -68.62 -39.21 80.91 Favored 'General case' 0 CA--C 1.549 0.925 0 O-C-N 123.508 0.505 . . . . 64.4 111.169 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 60.8 mt -61.2 -49.69 83.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 123.062 0.545 . . . . 43.45 110.014 172.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 84.1 m -56.53 -39.37 73.25 Favored 'General case' 0 C--O 1.244 0.799 0 CA-C-N 115.301 -0.863 . . . . 71.14 111.168 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 35.0 t -68.05 -46.53 70.86 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.123 -0.944 . . . . 65.4 110.394 -177.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.545 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 14.4 mmt -66.74 -39.48 87.95 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.006 0.523 . . . . 73.21 111.349 -174.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.28 -39.47 85.65 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 122.867 0.467 . . . . 75.13 110.251 175.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 43.4 t -68.5 -28.57 67.12 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.071 0.948 . . . . 61.13 111.761 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.431 ' HG3' ' O ' ' B' ' 116' ' ' SER . 91.0 mtt-85 -73.58 -35.79 65.47 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.744 0.818 . . . . 73.14 110.101 177.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -76.57 3.4 55.0 Favored Glycine 0 C--N 1.355 1.626 0 O-C-N 123.757 0.661 . . . . 73.44 112.673 170.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 49.1 p 58.81 28.87 18.01 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 126.516 1.926 . . . . 61.21 112.304 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -98.77 153.03 38.07 Favored Pre-proline 0 N--CA 1.468 0.464 0 CA-C-N 114.849 -1.069 . . . . 75.45 109.645 175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.61 ' HG2' ' HA ' ' H' ' 297' ' ' TYR . 54.0 Cg_exo -51.2 102.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.379 2.184 0 C-N-CA 123.13 2.553 . . . . 74.23 111.523 178.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.408 ' NE2' ' HB3' ' C' ' 119' ' ' SER . 4.6 pt20 -62.38 155.41 25.32 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.604 -1.18 . . . . 75.35 111.527 -171.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 55.6 tp -109.29 100.82 9.89 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.459 -0.791 . . . . 73.22 109.612 -168.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.471 HD21 ' HB2' ' C' ' 119' ' ' SER . 10.0 m120 -89.37 92.85 9.31 Favored 'General case' 0 C--N 1.348 0.527 0 N-CA-C 106.44 -1.689 . . . . 73.14 106.44 176.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 19.3 tp -70.25 150.1 46.76 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.959 -1.473 . . . . 63.51 111.19 -168.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 132.26 74.16 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 122.97 0.508 . . . . 71.1 110.779 -178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -51.08 111.8 0.64 Allowed 'Trans proline' 0 C--N 1.378 2.13 0 C-N-CA 122.942 2.428 . . . . 75.11 112.233 168.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 23.4 t -100.64 113.85 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.479 -0.934 . . . . 61.12 108.479 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.1 t-20 -88.38 80.11 7.56 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.279 0.632 . . . . 74.11 109.375 -177.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -59.64 -34.68 73.11 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.653 0.781 . . . . 72.41 111.303 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.615 ' HA ' ' HB1' ' B' ' 100' ' ' ALA . 12.3 t70 -63.0 -44.72 95.23 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 114.781 -1.099 . . . . 74.11 111.671 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -69.92 -36.73 75.59 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.295 0.638 . . . . 74.05 111.276 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 95.8 mt -63.82 -30.87 71.92 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.007 0.523 . . . . 44.33 110.737 177.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 17.4 t80 -76.76 -32.09 57.51 Favored 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 123.397 0.679 . . . . 72.2 110.077 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 63.2 mtt -67.49 -25.43 65.86 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.336 0.654 . . . . 72.35 110.951 173.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -74.76 -29.86 61.28 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.381 0.672 . . . . 53.55 110.532 175.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -72.7 -36.43 67.85 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.244 0.617 . . . . 73.33 109.71 174.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 53.7 mt -100.08 22.16 11.74 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.705 0.802 . . . . 73.42 110.868 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -70.74 100.14 1.83 Allowed 'General case' 0 C--N 1.351 0.64 0 CA-C-O 121.2 0.524 . . . . 72.02 110.675 -176.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -151.23 96.44 2.3 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 106.568 -1.642 . . . . 74.33 106.568 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 4.5 pp0? -138.97 151.37 46.81 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.681 0.793 . . . . 45.42 110.059 -173.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -74.39 -44.98 49.71 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.878 0.871 . . . . 71.41 111.372 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 85.13 88.16 0.9 Allowed Glycine 0 C--N 1.343 0.97 0 CA-C-N 115.892 -0.595 . . . . 51.04 112.517 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -139.32 138.73 36.94 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.831 0.852 . . . . 74.23 109.346 177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . 176.23 101.51 0.15 Allowed Glycine 0 C--N 1.337 0.624 0 N-CA-C 109.761 -1.336 . . . . 75.52 109.761 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 72.6 p -64.57 169.54 4.79 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.37 0.668 . . . . 65.45 111.443 -178.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -119.64 44.23 2.44 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.6 0.76 . . . . 63.53 109.423 173.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -59.91 102.91 0.18 Allowed 'General case' 0 CA--C 1.548 0.884 0 CA-C-O 121.966 0.888 . . . . 74.25 109.862 178.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 37.6 t60 -128.62 58.56 1.56 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-N 114.869 -1.06 . . . . 65.24 109.661 -172.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 53.9 tp60 -72.78 -46.74 51.69 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.338 -1.356 . . . . 74.51 107.338 158.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 30.0 t70 68.5 -68.24 0.18 Allowed 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 125.552 1.541 . . . . 73.24 111.971 174.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.255 1.364 0 C-N-CA 124.175 0.99 . . . . 72.33 108.576 174.782 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 3.0 mpp? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.568 -0.53 . . . . 55.25 109.568 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 26.5 t -151.83 101.84 2.79 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.664 -0.495 . . . . 63.54 109.664 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -160.5 104.64 1.42 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 108.296 -1.001 . . . . 63.21 108.296 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.42 109.43 4.47 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.625 0.77 . . . . 64.05 109.82 -176.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -155.73 69.51 0.68 Allowed 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 107.611 -1.255 . . . . 74.01 107.611 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -154.03 147.92 25.5 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.013 -0.994 . . . . 63.13 110.493 -170.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 17.9 p -80.89 120.54 24.85 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 108.769 -0.826 . . . . 73.11 108.769 174.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -58.44 -25.57 62.35 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 124.13 0.972 . . . . 74.42 112.412 -176.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.531 ' HB2' HG21 ' C' ' 89' ' ' ILE . 46.9 ttp 67.29 115.93 0.03 OUTLIER 'General case' 0 C--N 1.358 0.947 0 C-N-CA 125.385 1.474 . . . . 74.03 111.088 -172.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 25.2 m -85.77 88.38 7.54 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.975 -1.12 . . . . 72.42 107.975 175.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.546 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 52.1 t80 -96.62 122.31 39.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 108.784 -0.821 . . . . 54.52 108.784 178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -138.57 139.11 38.51 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.465 0.706 . . . . 73.35 110.472 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 1.4 pp -89.58 96.79 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 N-CA-C 108.764 -0.828 . . . . 73.41 108.764 171.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.452 ' HB2' ' HB ' ' C' ' 83' ' ' ILE . 12.5 mm100 -75.98 -43.47 44.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 116.207 -0.451 . . . . 72.23 110.69 -174.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.418 ' NH1' ' H ' ' G' ' 302' ' ' ASP . 24.4 ttt85 -169.84 122.99 0.73 Allowed 'General case' 0 C--N 1.352 0.674 0 O-C-N 123.894 0.746 . . . . 72.52 109.892 178.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 74.9 mt -110.84 133.54 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 108.347 -0.983 . . . . 44.12 108.347 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.463 ' HB3' HG23 ' D' ' 122' ' ' THR . 28.0 p90 -169.67 158.72 7.78 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 121.697 0.761 . . . . 72.31 112.267 -173.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 76.2 p -81.56 110.37 16.88 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 114.518 -1.219 . . . . 70.41 108.864 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mtmt -79.47 -23.92 42.71 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 122.277 -0.264 . . . . 71.33 110.605 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 28.3 t70 -150.06 142.08 23.94 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 123.954 0.783 . . . . 74.34 109.467 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 85.5 mt -137.26 144.26 32.28 Favored 'Isoleucine or valine' 0 C--O 1.244 0.811 0 N-CA-C 106.916 -1.513 . . . . 74.21 106.916 174.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . 0.551 ' HB3' ' HB3' ' C' ' 77' ' ' GLU . 40.3 t -151.82 147.71 26.97 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.482 0.713 . . . . 73.21 110.125 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -154.87 119.93 4.93 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.342 -1.355 . . . . 74.5 107.342 168.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.48 130.14 54.16 Favored 'General case' 0 C--O 1.238 0.491 0 C-N-CA 123.489 0.716 . . . . 75.54 109.236 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.31 77.36 76.3 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.652 -1.24 . . . . 72.33 107.652 171.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_exo -68.02 -27.72 35.91 Favored 'Trans proline' 0 C--N 1.379 2.148 0 C-N-CA 123.037 2.491 . . . . 62.44 112.051 -177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -109.91 41.96 1.61 Allowed 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.496 1.118 . . . . 35.21 109.457 177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.617 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -60.64 -54.94 49.83 Favored Pre-proline 0 CA--C 1.571 1.753 0 N-CA-C 114.47 1.285 . . . . 54.42 114.47 -175.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 12.5 Cg_exo -72.66 -28.42 14.11 Favored 'Trans proline' 0 C--N 1.386 2.533 0 CA-C-N 121.891 1.711 . . . . 73.41 111.775 173.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 81.3 t60 -68.7 -22.08 64.38 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 125.04 1.336 . . . . 74.0 111.953 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.473 ' HA ' ' HB2' ' C' ' 34' ' ' LYS . 0.5 OUTLIER -72.2 -18.84 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 123.539 0.736 . . . . 72.23 111.497 -177.025 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -68.79 -23.48 64.3 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 122.623 0.369 . . . . 65.05 111.201 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -109.52 24.04 13.62 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.51 0.724 . . . . 71.35 110.722 175.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.681 ' HD2' HD21 ' C' ' 68' ' ' LEU . 0.6 OUTLIER -81.08 148.05 29.83 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.35 0.66 . . . . 73.43 110.046 -176.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' C' ' 68' ' ' LEU . 12.7 t70 -69.37 125.01 25.37 Favored 'General case' 0 C--O 1.242 0.708 0 N-CA-C 108.315 -0.994 . . . . 75.04 108.315 169.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -86.76 63.12 7.79 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 123.882 0.738 . . . . 74.24 110.372 -168.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -164.95 77.4 1.39 Allowed Pre-proline 0 CA--C 1.557 1.229 0 C-N-CA 124.227 1.011 . . . . 61.25 108.403 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.97 156.11 26.62 Favored 'Trans proline' 0 C--N 1.372 1.767 0 C-N-CA 122.77 2.313 . . . . 71.13 111.371 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -86.37 86.85 7.35 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 107.132 -1.433 . . . . 73.51 107.132 170.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 15.0 m -69.42 112.43 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 114.427 -1.26 . . . . 62.21 109.835 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -134.29 127.12 31.14 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.749 0.82 . . . . 74.31 109.852 177.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . 0.409 HD23 ' N ' ' C' ' 43' ' ' ASP . 6.1 tt -86.41 139.14 31.21 Favored 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 107.648 -1.241 . . . . 70.45 107.648 173.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.584 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 20.4 t70 -119.61 107.5 13.33 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 107.577 -1.268 . . . . 61.15 107.577 178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 59.1 tp -94.17 116.16 28.53 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.268 1.027 . . . . 74.42 109.059 -178.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.602 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 18.9 t70 -115.08 143.94 44.41 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 108.606 -0.887 . . . . 64.42 108.606 172.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 31.9 p -131.19 134.96 47.0 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.614 0.766 . . . . 64.11 109.789 -172.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.436 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -148.21 157.34 43.44 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 123.138 0.575 . . . . 54.35 110.628 -175.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.419 ' HB3' ' HE2' ' F' ' 281' ' ' PHE . 57.6 p -161.28 145.75 13.42 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.87 0.868 . . . . 52.51 110.413 178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 57.9 p -156.06 140.85 17.09 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.465 0.706 . . . . 73.03 109.898 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -72.55 127.87 33.87 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 109.062 -0.718 . . . . 72.33 109.062 171.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.667 HD11 ' HB2' ' C' ' 57' ' ' GLU . 34.9 mt -96.06 -39.67 9.62 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.721 0.809 . . . . 64.45 109.581 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.32 176.59 12.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 113.919 -1.491 . . . . 45.21 108.964 175.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -68.31 121.98 17.41 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 115.673 -0.694 . . . . 71.11 109.595 179.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 76.51 -8.37 1.67 Allowed 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 126.401 1.881 . . . . 72.15 112.632 -175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 60.4 t -109.81 96.15 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 123.927 0.891 . . . . 70.22 108.879 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -104.8 161.97 13.72 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.493 0.717 . . . . 74.34 109.378 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.667 ' HB2' HD11 ' C' ' 51' ' ' LEU . 42.0 tt0 -124.73 133.61 53.11 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.14 0.576 . . . . 73.52 109.768 176.045 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.426 HG22 HD12 ' C' ' 98' ' ' LEU . 77.2 t -110.69 129.22 66.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.402 -1.333 . . . . 52.04 107.402 169.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 96.7 t -114.18 136.76 49.68 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 108.257 -1.016 . . . . 74.53 108.257 173.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -130.13 101.76 5.95 Favored 'General case' 0 C--O 1.238 0.485 0 N-CA-C 107.324 -1.361 . . . . 74.25 107.324 179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.602 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 8.1 ttm180 -87.29 135.13 33.44 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 123.262 0.625 . . . . 73.41 109.687 177.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.539 ' HB ' HD11 ' C' ' 114' ' ' ILE . 6.5 t -125.81 121.89 60.84 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 N-CA-C 107.137 -1.431 . . . . 55.45 107.137 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 30.7 m -124.7 119.56 29.32 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.423 -0.584 . . . . 64.2 109.423 179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.408 HG21 HG21 ' C' ' 114' ' ' ILE . 59.1 t -100.35 116.43 43.73 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 108.635 -0.876 . . . . 74.33 108.635 179.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 6.5 m -106.21 137.71 43.68 Favored 'General case' 0 C--O 1.243 0.735 0 O-C-N 123.688 0.618 . . . . 62.23 109.511 175.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.64 94.49 3.2 Favored 'General case' 0 C--O 1.231 0.129 0 N-CA-C 107.516 -1.291 . . . . 74.24 107.516 175.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 19.7 m -143.57 139.15 29.57 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 108.392 -0.966 . . . . 64.24 108.392 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.681 HD21 ' HD2' ' C' ' 34' ' ' LYS . 0.1 OUTLIER -99.02 23.65 8.74 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 123.506 0.722 . . . . 74.02 110.329 -179.955 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 144.94 -120.57 1.4 Allowed Glycine 0 C--N 1.344 1.025 0 N-CA-C 109.827 -1.309 . . . . 72.44 109.827 -177.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -87.79 -28.47 21.66 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.56 -0.904 . . . . 75.31 108.56 172.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -67.0 99.2 0.62 Allowed 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 124.466 1.106 . . . . 64.54 109.608 173.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 57.1 m -87.75 130.24 34.9 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.058 0.543 . . . . 64.0 110.644 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -79.23 -54.66 5.75 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 115.495 -0.775 . . . . 72.24 109.256 174.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -167.21 169.75 12.33 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.827 0.851 . . . . 70.32 110.768 175.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.411 HD13 ' N ' ' C' ' 76' ' ' CYS . 3.0 tm? -142.87 144.67 32.57 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 107.939 -1.134 . . . . 62.4 107.939 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.411 ' N ' HD13 ' C' ' 75' ' ' LEU . 53.6 t -146.68 146.28 30.3 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 108.353 -0.98 . . . . 61.44 108.353 176.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . 0.551 ' HB3' ' HB3' ' C' ' 22' ' ' SER . 38.4 tt0 -153.76 137.49 16.1 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.25 0.62 . . . . 71.44 110.218 -177.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' C' ' 110' ' ' ALA . 54.4 t -141.9 115.02 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 C-N-CA 124.305 1.042 . . . . 74.33 108.615 -178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.481 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 73.2 mt-30 -95.03 97.69 10.14 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 108.889 -0.782 . . . . 64.12 108.889 171.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.0 tp-100 -87.1 102.32 14.32 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.32 0.648 . . . . 44.25 110.009 -178.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.16 151.82 21.8 Favored Glycine 0 C--N 1.338 0.661 0 N-CA-C 111.918 -0.473 . . . . 73.43 111.918 175.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.573 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -148.97 128.59 2.82 Favored Glycine 0 CA--C 1.506 -0.513 0 N-CA-C 111.645 -0.582 . . . . 32.03 111.645 -178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' D' ' 29' ' ' PRO . 8.3 mm -90.14 130.38 39.5 Favored 'Isoleucine or valine' 0 C--O 1.242 0.669 0 N-CA-C 108.491 -0.929 . . . . 73.33 108.491 178.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -135.98 119.91 17.48 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.316 -0.624 . . . . 71.54 109.316 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 66.0 p -85.93 99.9 11.74 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.212 -1.033 . . . . 22.42 108.212 172.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 30.3 pt -124.63 124.7 68.7 Favored 'Isoleucine or valine' 0 C--O 1.242 0.708 0 C-N-CA 123.472 0.709 . . . . 62.13 109.645 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.76 169.06 25.23 Favored 'General case' 0 C--O 1.244 0.81 0 CA-C-N 115.029 -0.987 . . . . 72.22 110.228 -178.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 95.69 -28.58 11.9 Favored Glycine 0 C--N 1.342 0.897 0 CA-C-N 115.033 -0.985 . . . . 63.02 111.045 -173.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.553 HG12 ' HB3' ' C' ' 94' ' ' MET . 0.2 OUTLIER -119.14 167.51 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 123.943 0.897 . . . . 64.41 110.903 -173.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -160.1 -171.76 3.34 Favored 'General case' 0 C--O 1.243 0.729 0 CA-C-N 114.799 -1.092 . . . . 75.55 108.954 173.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 55.52 -124.44 33.43 Favored Glycine 0 C--N 1.352 1.448 0 O-C-N 123.824 0.703 . . . . 63.43 114.109 174.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 8.6 t -63.62 -32.19 73.59 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.103 0.961 . . . . 75.01 112.789 -175.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -68.28 -57.52 5.83 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 123.249 0.62 . . . . 73.24 111.218 -175.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.553 ' HB3' HG12 ' C' ' 89' ' ' ILE . 3.3 ppp? -73.92 -21.19 60.14 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.698 -0.683 . . . . 61.52 110.739 -178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.77 -43.4 96.49 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.946 0.498 . . . . 73.45 110.414 173.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 29.4 t-80 -57.29 -39.18 75.22 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 116.007 -0.542 . . . . 72.12 110.844 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . 0.515 ' HA ' ' HB3' ' C' ' 101' ' ' TYR . 94.2 m -67.49 -52.98 32.73 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.028 -0.533 . . . . 63.43 110.232 175.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.426 HD12 HG22 ' C' ' 58' ' ' VAL . 52.2 tp -60.38 -53.98 51.16 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.072 0.949 . . . . 70.43 111.546 -168.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.441 ' HA3' HD23 ' F' ' 280' ' ' LEU . . . -100.53 11.29 59.64 Favored Glycine 0 C--N 1.343 0.929 0 CA-C-O 119.433 -0.648 . . . . 75.23 114.687 -170.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.23 -63.79 0.23 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 117.837 0.818 . . . . 74.31 112.477 -176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.515 ' HB3' ' HA ' ' C' ' 97' ' ' CYS . 38.5 t80 -72.76 -53.25 12.12 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.823 0.449 . . . . 62.54 111.919 -168.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.546 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 44.1 m -59.11 -47.39 98.58 Favored Pre-proline 0 CA--C 1.569 1.675 0 C-N-CA 123.969 0.908 . . . . 72.5 112.352 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' C' ' 102' ' ' CYS . 86.5 Cg_exo -54.55 -37.28 90.4 Favored 'Trans proline' 0 C--N 1.399 3.215 0 C-N-CA 122.96 2.44 . . . . 64.35 113.711 170.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 46.3 t-20 -66.58 -38.49 87.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 123.886 0.741 . . . . 61.33 110.286 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 41.1 mm -61.53 -44.6 98.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.05 0.54 . . . . 74.13 110.324 175.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.573 HD21 ' HA3' ' C' ' 82' ' ' GLY . 97.0 mt -75.31 -30.85 60.46 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-N 115.291 -0.868 . . . . 74.23 112.302 -173.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . 0.407 ' HZ ' ' HB3' ' C' ' 128' ' ' LEU . 61.5 t80 -53.94 -49.77 87.73 Favored Pre-proline 0 CA--C 1.565 1.531 0 N-CA-C 114.298 1.221 . . . . 73.34 114.298 -171.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.09 -31.85 94.12 Favored 'Trans proline' 0 C--N 1.387 2.556 0 C-N-CA 122.299 1.999 . . . . 72.35 113.841 179.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.468 ' HE2' HG21 ' A' ' 115' ' ' THR . 68.5 m-85 -71.98 -43.15 65.61 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.238 0.615 . . . . 64.25 110.64 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.544 ' HA ' HG11 ' C' ' 78' ' ' VAL . . . -65.3 -38.33 89.89 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 116.038 -0.528 . . . . 60.4 110.484 174.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.516 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 39.2 ttt-85 -56.66 -53.48 57.16 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 125.556 1.542 . . . . 64.41 111.797 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.35 -32.91 74.16 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 122.825 0.45 . . . . 71.21 110.307 -178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.2 t -69.13 -32.38 71.72 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 123.065 0.546 . . . . 73.14 111.269 -179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' C' ' 62' ' ' VAL . 59.3 mt -70.29 -56.06 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 C-N-CA 123.408 0.683 . . . . 72.4 109.739 174.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 6.6 m -63.33 -27.14 69.12 Favored 'General case' 0 CA--C 1.559 1.314 0 C-N-CA 123.563 0.745 . . . . 72.3 111.276 -174.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 32.5 t -66.36 -48.83 68.92 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.422 0.689 . . . . 50.35 109.544 171.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.88 -32.79 74.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.482 0.713 . . . . 72.34 112.16 178.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 71.1 t -62.65 -46.97 95.08 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 C-N-CA 123.473 0.709 . . . . 65.33 109.549 174.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.471 ' HB2' HD21 ' B' ' 127' ' ' ASN . 58.9 p -73.73 -23.78 59.81 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 123.275 0.63 . . . . 72.14 112.185 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -72.76 -37.8 67.56 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.575 0.75 . . . . 74.34 110.192 176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.16 1.86 73.26 Favored Glycine 0 C--N 1.354 1.53 0 O-C-N 123.524 0.515 . . . . 45.41 112.43 169.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 19.1 p 62.42 36.97 13.94 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.93 2.092 . . . . 70.34 112.665 174.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -94.94 154.15 39.77 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-N 114.781 -1.1 . . . . 73.42 109.44 173.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -68.15 -177.78 1.49 Allowed 'Trans proline' 0 C--N 1.382 2.319 0 C-N-CA 123.032 2.488 . . . . 43.25 113.591 178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -58.71 133.9 56.33 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.133 1.16 . . . . 62.34 114.133 -169.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 6.3 tt -138.7 85.31 2.07 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 106.079 -1.822 . . . . 73.13 106.079 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -96.7 129.88 44.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.787 0.835 . . . . 55.03 109.493 -176.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.516 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.6 mm? -80.47 143.89 33.0 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 123.642 0.589 . . . . 73.54 110.472 177.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.575 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -86.72 150.23 50.24 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.951 0.9 . . . . 72.22 111.376 -178.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -81.06 130.08 7.19 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 123.174 2.583 . . . . 61.22 112.297 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.535 HG22 HD21 ' F' ' 291' ' ' LEU . 9.4 t -135.08 112.97 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 109.067 -0.716 . . . . 74.32 109.067 173.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -97.34 90.75 5.2 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.438 0.695 . . . . 73.11 110.128 178.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -69.63 -39.07 77.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-O 121.778 0.799 . . . . 73.15 109.705 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -65.21 -42.46 93.49 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 113.984 -1.462 . . . . 75.23 112.193 -176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.4 -42.54 92.48 Favored 'General case' 0 C--N 1.349 0.555 0 C-N-CA 123.685 0.794 . . . . 62.31 110.551 -177.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 10.4 tt -64.66 -38.27 90.42 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 124.297 0.998 . . . . 63.42 110.817 176.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -70.93 -30.06 66.28 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 123.532 0.733 . . . . 74.12 110.734 -177.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 72.5 mtm -81.44 -30.05 33.61 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.099 0.56 . . . . 74.24 111.274 170.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -64.77 -39.62 93.92 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.223 1.009 . . . . 72.54 111.817 -174.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 3.8 p90 -68.16 -85.93 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.644 0 CA-C-O 117.696 -1.145 . . . . 73.44 108.083 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . 0.664 ' HG ' ' H ' ' C' ' 143' ' ' GLN . 15.6 tp 48.41 -179.16 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 125.281 1.432 . . . . 53.23 114.073 173.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -164.49 15.77 0.05 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.654 0.782 . . . . 71.21 110.114 163.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.664 ' H ' ' HG ' ' C' ' 141' ' ' LEU . 78.3 mt-30 -111.32 178.43 4.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.406 1.082 . . . . 73.41 110.997 -176.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.472 ' HG3' ' HG3' ' A' ' 143' ' ' GLN . 7.3 tm0? -135.42 143.68 46.08 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 108.068 -1.086 . . . . 73.11 108.068 177.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -139.91 138.11 35.36 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.946 0.899 . . . . 73.43 109.899 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -100.24 173.49 25.29 Favored Glycine 0 C--N 1.346 1.119 0 O-C-N 123.654 0.596 . . . . 74.42 113.069 -179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -84.9 145.85 27.58 Favored 'General case' 0 N--CA 1.483 1.184 0 C-N-CA 123.738 0.815 . . . . 72.11 109.643 178.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -120.3 -167.23 13.4 Favored Glycine 0 C--N 1.343 0.957 0 N-CA-C 112.012 -0.435 . . . . 75.55 112.012 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 37.8 m -152.06 142.58 22.66 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.492 0.717 . . . . 71.43 110.067 174.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . 0.564 ' H ' ' HG2' ' G' ' 310' ' ' PRO . 2.3 mm-40 -130.4 84.17 2.18 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.026 1.33 . . . . 71.4 107.591 177.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -121.75 103.55 8.95 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.677 -0.692 . . . . 74.13 109.685 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -167.44 138.26 2.99 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.928 0.891 . . . . 63.15 109.318 173.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -153.06 108.53 3.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.973 0.909 . . . . 52.33 108.814 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -154.0 105.81 2.77 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 108.1 -1.074 . . . . 60.23 108.1 179.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.938 0 N-CA-C 108.813 -0.81 . . . . 74.34 108.813 176.441 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 20.9 mmt . . . . . 0 N--CA 1.485 1.301 0 N-CA-C 110.111 -0.329 . . . . 75.24 110.111 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 24.3 t -141.32 21.61 2.22 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 123.69 0.796 . . . . 63.15 108.945 175.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -73.65 105.95 5.19 Favored 'General case' 0 C--N 1.353 0.751 0 CA-C-N 115.772 -0.649 . . . . 64.41 109.658 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -71.18 86.65 0.78 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 108.195 -1.039 . . . . 62.54 108.195 168.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -68.31 176.23 2.9 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-N 114.696 -1.138 . . . . 74.43 109.787 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -48.77 96.51 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.73 0.812 . . . . 72.01 110.549 177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 8.9 m -84.71 69.66 10.7 Favored 'General case' 0 C--N 1.354 0.798 0 CA-C-O 122.439 1.114 . . . . 73.24 108.487 -178.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -83.27 -10.89 58.27 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 113.995 -1.457 . . . . 74.32 109.917 176.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.503 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 5.4 ttp -29.86 126.0 0.14 Allowed 'General case' 0 C--N 1.375 1.695 0 C-N-CA 126.039 1.736 . . . . 61.42 113.117 172.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 9.0 m -114.09 146.36 40.35 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.897 -0.779 . . . . 65.33 108.897 175.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -171.87 104.46 0.19 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 106.164 -1.791 . . . . 71.41 106.164 175.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -156.07 138.39 14.78 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.826 0.851 . . . . 63.42 108.844 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.426 HG21 HD13 ' D' ' 16' ' ' ILE . 10.1 mt -76.4 137.28 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 O-C-N 123.536 0.522 . . . . 73.52 110.368 -175.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -99.93 -40.56 7.61 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.64 0.776 . . . . 71.3 110.257 174.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -167.15 125.9 1.35 Allowed 'General case' 0 CA--C 1.547 0.856 0 CA-C-N 116.474 -0.33 . . . . 61.23 111.207 -170.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.426 HD13 HG21 ' D' ' 13' ' ' ILE . 1.3 mp -103.91 132.56 50.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 107.13 -1.433 . . . . 55.25 107.13 165.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.617 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 26.0 p90 -166.09 154.95 11.27 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 123.954 0.784 . . . . 74.53 110.475 -177.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 73.2 p -80.22 121.31 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 115.218 -0.901 . . . . 70.32 109.05 173.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.516 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 42.4 mtpt -87.28 -30.51 20.84 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 109.767 -0.457 . . . . 71.32 109.767 175.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.474 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 20.6 t70 -150.17 135.33 17.92 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.891 -1.049 . . . . 62.45 109.018 -177.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.676 HG23 HG22 ' D' ' 78' ' ' VAL . 48.7 mt -134.84 144.26 35.19 Favored 'Isoleucine or valine' 0 C--O 1.245 0.827 0 N-CA-C 107.991 -1.114 . . . . 74.43 107.991 174.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 38.9 t -151.82 137.78 18.14 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 123.359 0.664 . . . . 73.41 110.313 173.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.595 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 55.2 t80 -143.88 115.66 8.24 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 106.767 -1.568 . . . . 71.12 106.767 171.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -121.56 126.19 48.56 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.13 0.572 . . . . 75.42 109.601 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -119.56 80.35 22.8 Favored Pre-proline 0 CA--C 1.542 0.67 0 N-CA-C 107.578 -1.267 . . . . 64.23 107.578 174.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.24 -31.91 17.54 Favored 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.017 2.478 . . . . 65.15 112.672 -170.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 46.9 m-20 -114.95 36.49 3.84 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.45 -0.944 . . . . 73.3 108.45 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.443 ' O ' HG12 ' D' ' 31' ' ' VAL . . . -56.38 -62.48 4.8 Favored Pre-proline 0 CA--C 1.559 1.321 0 N-CA-C 113.919 1.081 . . . . 74.44 113.919 -167.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.509 ' HB3' HD11 ' C' ' 83' ' ' ILE . 93.7 Cg_endo -78.07 -2.21 12.33 Favored 'Trans proline' 0 C--N 1.382 2.309 0 CA-C-N 122.796 2.034 . . . . 64.1 113.318 -178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -84.35 -42.17 16.01 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.758 1.223 . . . . 71.15 109.75 174.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' D' ' 73' ' ' ALA . 11.0 p -76.6 -27.26 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 123.102 0.561 . . . . 72.14 111.049 -174.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.533 ' HA ' HG13 ' G' ' 301' ' ' ILE . 21.5 m-85 -68.2 -7.95 34.69 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 113.247 0.832 . . . . 72.21 113.247 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -82.72 -18.79 39.57 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.799 0.84 . . . . 74.31 111.19 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -109.99 99.46 8.56 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.101 0.96 . . . . 64.21 110.954 -175.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -75.52 94.63 3.17 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 123.861 0.865 . . . . 74.21 111.743 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.481 ' CE3' HD23 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -155.84 175.02 14.48 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 123.71 0.804 . . . . 75.13 111.961 174.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.615 ' HA ' ' HB2' ' G' ' 297' ' ' TYR . 1.9 mp0 -94.92 109.56 44.81 Favored Pre-proline 0 N--CA 1.484 1.269 0 C-N-CA 124.299 1.04 . . . . 70.41 110.942 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.542 ' HD3' ' HD2' ' G' ' 297' ' ' TYR . 19.0 Cg_exo -65.3 146.13 85.26 Favored 'Trans proline' 0 C--N 1.382 2.334 0 C-N-CA 123.231 2.62 . . . . 33.04 111.85 -177.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -68.27 156.17 38.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 108.903 -0.777 . . . . 65.14 108.903 164.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.526 HG23 HG13 ' D' ' 64' ' ' VAL . 1.3 p -136.3 118.23 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 107.775 -1.194 . . . . 75.34 107.775 177.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -106.1 125.69 51.3 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 124.104 0.962 . . . . 61.11 108.514 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 8.5 tt -95.89 126.54 41.21 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.277 -1.008 . . . . 75.2 108.277 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.44 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 23.9 t70 -114.95 125.87 54.12 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 107.879 -1.156 . . . . 64.45 107.879 169.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 51.7 tp -100.06 130.85 46.26 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 109.1 -0.704 . . . . 63.23 109.1 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.527 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 19.8 t70 -134.01 143.29 48.01 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 108.723 -0.843 . . . . 73.21 108.723 173.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 47.4 p -121.47 147.74 45.36 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.139 0.976 . . . . 65.25 110.019 -173.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.448 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -156.07 142.74 18.71 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.785 0.834 . . . . 63.44 109.261 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 44.3 p -160.64 153.4 21.08 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.889 0.476 . . . . 61.22 109.98 178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 60.1 p -164.08 147.17 9.5 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.33 0.652 . . . . 63.04 109.948 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -78.8 122.13 25.67 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.162 -0.681 . . . . 72.55 109.162 172.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.494 HD13 ' HB3' ' C' ' 29' ' ' PRO . 71.6 mt -89.95 -34.61 15.96 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.549 0.74 . . . . 75.12 110.524 -178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.66 -177.8 6.43 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.349 -0.841 . . . . 71.55 109.667 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -64.43 116.25 5.92 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.75 -0.659 . . . . 72.32 110.495 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 61.6 m-20 62.4 24.59 14.64 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.435 1.094 . . . . 71.25 111.899 -176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 97.2 t -125.08 116.82 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.396 -0.964 . . . . 75.45 108.396 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.485 ' HB2' HD12 ' D' ' 86' ' ' ILE . 82.3 m-85 -131.91 129.05 39.8 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 124.745 1.218 . . . . 61.41 108.036 -173.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.401 ' HB2' HD11 ' D' ' 51' ' ' LEU . 34.6 tt0 -102.52 139.7 37.77 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 123.599 0.76 . . . . 73.02 109.803 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.476 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 96.6 t -118.72 122.82 70.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 N-CA-C 107.617 -1.253 . . . . 72.35 107.617 173.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.448 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 39.1 t -108.55 131.99 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 N-CA-C 108.329 -0.989 . . . . 64.15 108.329 174.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tt -116.43 116.96 28.64 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 107.373 -1.343 . . . . 64.14 107.373 178.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.527 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.2 ttm180 -97.63 108.69 21.47 Favored 'General case' 0 C--O 1.24 0.592 0 N-CA-C 109.116 -0.698 . . . . 73.22 109.116 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 60.6 t -91.92 129.09 43.11 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 107.645 -1.243 . . . . 72.13 107.645 166.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.44 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.0 m -120.41 134.06 55.33 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.243 0.544 . . . . 73.21 109.701 177.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.647 ' HB ' ' HB2' ' D' ' 76' ' ' CYS . 78.5 t -125.62 106.81 16.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 125.128 1.371 . . . . 71.42 108.199 -177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 26.2 m -113.21 106.75 15.01 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 109.465 -0.568 . . . . 75.51 109.465 -179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -105.87 123.93 48.75 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 123.209 0.604 . . . . 51.55 109.679 176.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 66.7 m -147.31 121.54 9.56 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 108.304 -0.998 . . . . 50.12 108.304 175.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.481 HD23 ' CE3' ' D' ' 36' ' ' TRP . 17.3 tp -137.55 136.85 38.01 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 122.808 0.443 . . . . 51.31 110.013 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . 0.417 ' H ' HD12 ' D' ' 68' ' ' LEU . . . 91.75 -136.11 13.11 Favored Glycine 0 C--N 1.345 1.038 0 N-CA-C 110.336 -1.106 . . . . 74.54 110.336 -172.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.75 16.4 23.65 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 117.316 0.558 . . . . 73.31 110.881 174.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -136.21 164.66 27.55 Favored 'General case' 0 C--O 1.243 0.728 0 C-N-CA 123.071 0.548 . . . . 65.11 111.562 -175.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -79.85 129.74 34.73 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 114.874 -1.057 . . . . 64.44 109.764 170.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.526 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -77.91 -66.15 0.88 Allowed 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.178 -0.675 . . . . 74.44 109.178 176.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -159.35 165.88 32.36 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.061 -0.972 . . . . 72.5 111.191 174.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 74.1 mt -129.07 146.54 51.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.888 1.275 . . . . 74.12 108.481 -176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.647 ' HB2' ' HB ' ' D' ' 64' ' ' VAL . 5.4 m -148.66 138.23 21.98 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.015 0.926 . . . . 62.15 109.661 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.57 122.31 5.32 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 108.332 -0.988 . . . . 70.53 108.332 173.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.676 HG22 HG23 ' D' ' 21' ' ' ILE . 91.6 t -130.54 118.49 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 N-CA-C 109.448 -0.575 . . . . 54.53 109.448 173.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.474 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 76.6 mt-30 -90.02 90.81 8.3 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.132 -0.94 . . . . 74.42 108.651 174.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -80.28 103.66 10.3 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.427 -0.806 . . . . 75.12 109.401 179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -94.24 143.37 16.51 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 111.519 -0.633 . . . . 34.33 111.519 177.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -138.43 128.47 4.16 Favored Glycine 0 CA--C 1.506 -0.515 0 N-CA-C 109.942 -1.263 . . . . 52.13 109.942 177.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -90.27 131.68 36.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.659 0 N-CA-C 108.12 -1.067 . . . . 71.2 108.12 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.476 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 18.7 m-85 -130.65 139.72 50.36 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 109.428 -0.582 . . . . 73.43 109.428 176.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 14.7 m -82.65 100.9 10.47 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 108.084 -1.08 . . . . 34.04 108.084 169.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' D' ' 56' ' ' TYR . 36.3 mt -117.28 138.65 47.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 C-N-CA 123.294 0.638 . . . . 72.31 110.218 -174.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -166.6 167.52 15.34 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.804 0.841 . . . . 65.54 110.456 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.503 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 82.8 -19.78 10.95 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 114.914 0.726 . . . . 53.41 114.914 169.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.446 HG23 ' HG3' ' D' ' 9' ' ' MET . 13.1 pt -121.67 138.31 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 N-CA-C 107.969 -1.122 . . . . 74.34 107.969 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . 0.591 ' HB2' ' HA ' ' G' ' 272' ' ' ASN . 40.9 mt-10 -141.87 167.67 21.57 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.681 0.792 . . . . 64.3 110.809 -176.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 63.87 -135.19 40.76 Favored Glycine 0 C--N 1.352 1.421 0 O-C-N 123.849 0.718 . . . . 44.32 113.054 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 24.5 m -66.08 -29.86 70.27 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.265 0.626 . . . . 64.04 111.324 177.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.522 ' HA ' HE21 ' D' ' 93' ' ' GLN . 0.0 OUTLIER -63.77 -40.96 97.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.371 0.669 . . . . 74.32 110.728 -178.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 1.3 tmt? -81.34 -34.6 31.69 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.301 176.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' G' ' 280' ' ' LEU . . . -63.21 -23.92 67.65 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.64 0.776 . . . . 73.15 112.545 -177.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . 0.565 ' O ' ' HB3' ' D' ' 100' ' ' ALA . 49.6 t-80 -69.91 -38.55 76.31 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 122.695 0.398 . . . . 73.02 110.506 171.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -74.18 -33.67 63.53 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 110.338 -0.245 . . . . 44.3 110.338 177.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 1.3 tt -71.52 -54.16 11.47 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.475 1.11 . . . . 74.34 109.877 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.92 14.31 64.86 Favored Glycine 0 C--N 1.344 1.025 0 CA-C-N 115.562 -0.745 . . . . 61.43 114.405 -170.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' D' ' 96' ' ' HIS . . . -145.23 -56.42 0.32 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 117.405 0.603 . . . . 54.41 112.333 -175.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 t80 -75.63 -51.6 12.45 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 112.532 0.567 . . . . 72.42 112.532 -176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 73.9 m -59.14 -48.61 96.11 Favored Pre-proline 0 CA--C 1.568 1.653 0 C-N-CA 124.206 1.002 . . . . 72.1 112.93 -176.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -62.81 -30.79 78.09 Favored 'Trans proline' 0 C--N 1.399 3.205 0 C-N-CA 122.265 1.976 . . . . 70.03 112.852 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -62.94 -32.2 73.45 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.298 0.639 . . . . 74.44 111.126 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.407 HG21 HD11 ' D' ' 13' ' ' ILE . 49.5 mm -74.21 -42.01 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 123.584 0.754 . . . . 64.21 110.678 178.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 79.4 mt -78.16 -30.25 49.04 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-N 115.325 -0.852 . . . . 73.31 111.997 -171.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -59.51 -44.4 97.71 Favored Pre-proline 0 CA--C 1.563 1.476 0 N-CA-C 114.187 1.18 . . . . 62.44 114.187 -170.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -50.42 -41.59 51.22 Favored 'Trans proline' 0 C--N 1.384 2.421 0 C-N-CA 122.452 2.101 . . . . 63.12 114.159 173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -75.92 -38.62 57.49 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.726 0.811 . . . . 75.3 111.756 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.68 -42.67 99.75 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.476 0.71 . . . . 51.05 110.753 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.536 HH12 ' HB3' ' D' ' 130' ' ' PRO . 36.7 ttp180 -62.56 -49.91 73.42 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 114.542 -1.208 . . . . 72.22 110.59 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -58.4 -48.47 80.56 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.379 1.072 . . . . 71.35 111.531 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 44.6 t -56.69 -40.12 75.03 Favored 'General case' 0 N--CA 1.481 1.103 0 O-C-N 123.811 0.694 . . . . 73.35 111.224 -178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.492 HG21 HG21 ' D' ' 64' ' ' VAL . 93.7 mt -65.98 -50.55 68.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 115.132 -0.94 . . . . 74.43 110.582 174.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 23.6 m -53.9 -38.88 65.26 Favored 'General case' 0 CA--C 1.555 1.168 0 C-N-CA 124.507 1.123 . . . . 75.42 111.759 -178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 23.2 t -70.54 -50.24 39.68 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 115.079 -0.964 . . . . 74.01 110.316 -178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.434 ' SD ' ' HB2' ' D' ' 23' ' ' PHE . 75.1 mtm -56.62 -43.16 79.95 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 123.453 0.701 . . . . 73.33 111.948 -179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.553 HG11 HD23 ' D' ' 126' ' ' LEU . 82.3 t -63.73 -42.28 95.45 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 CA-C-N 114.441 -1.254 . . . . 64.22 110.814 -177.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 59.6 p -68.8 -30.79 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 120.817 0.341 . . . . 61.11 110.965 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -69.63 -29.45 66.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.072 0.949 . . . . 73.44 110.525 175.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . 0.411 ' HA2' ' HB2' ' C' ' 17' ' ' TYR . . . -89.45 11.42 69.97 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-N 115.579 -0.737 . . . . 71.12 112.905 177.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.463 HG23 ' HB3' ' C' ' 17' ' ' TYR . 81.7 p 61.31 16.04 7.02 Favored 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 126.771 2.028 . . . . 70.44 113.721 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -90.41 164.66 26.21 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.237 1.015 . . . . 75.23 108.359 170.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.643 ' HG3' ' HA ' ' G' ' 297' ' ' TYR . 37.8 Cg_endo -86.65 150.77 8.77 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 122.655 2.237 . . . . 74.42 112.466 -172.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -51.17 133.21 28.35 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.949 0.9 . . . . 62.43 112.749 -176.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.553 HD23 HG11 ' D' ' 118' ' ' VAL . 3.8 mm? -105.82 95.0 5.49 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 108.533 -0.914 . . . . 75.13 108.533 177.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -98.87 98.79 9.83 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 107.737 -1.208 . . . . 74.32 107.737 176.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 3.9 mm? -76.08 135.15 39.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.3 -0.864 . . . . 61.32 109.625 172.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.483 ' HB3' HD11 ' G' ' 291' ' ' LEU . . . -68.88 128.69 92.74 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-O 119.56 -0.257 . . . . 75.32 110.989 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.536 ' HB3' HH12 ' D' ' 111' ' ' ARG . 65.6 Cg_endo -74.65 117.48 4.96 Favored 'Trans proline' 0 C--N 1.373 1.856 0 C-N-CA 122.508 2.139 . . . . 61.41 111.299 -179.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -108.76 110.3 31.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 N-CA-C 108.534 -0.913 . . . . 71.4 108.534 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.538 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 32.9 t30 -78.4 98.8 6.13 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.859 -0.793 . . . . 73.3 108.859 174.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . 0.518 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 62.8 m-85 -70.09 -28.54 65.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 115.102 -0.953 . . . . 74.04 111.267 -177.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . 0.425 ' HA ' ' HB1' ' D' ' 100' ' ' ALA . 1.9 t70 -63.95 -38.12 89.9 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.272 0.629 . . . . 71.04 110.52 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.538 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -61.76 -40.94 96.92 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.544 1.152 . . . . 31.24 112.181 178.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 82.3 mt -55.31 -48.38 74.21 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 124.01 0.924 . . . . 63.51 112.312 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -75.72 -36.4 59.98 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.353 0.661 . . . . 72.51 110.631 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.422 ' O ' ' HG2' ' D' ' 142' ' ' GLN . 32.2 ttm -58.96 -33.16 70.32 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 124.717 1.207 . . . . 74.32 111.417 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.466 ' O ' ' HG2' ' D' ' 143' ' ' GLN . 85.2 m-20 -57.51 -35.2 69.95 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.424 1.09 . . . . 72.11 111.669 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -64.55 -40.67 96.0 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.375 0.67 . . . . 75.02 110.695 175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.668 ' HA ' ' HG2' ' B' ' 1' ' ' MET . 8.6 mp -70.73 -42.81 70.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.624 0.77 . . . . 75.53 111.674 -176.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.422 ' HG2' ' O ' ' D' ' 138' ' ' MET . 13.6 pt20 -89.91 43.95 1.18 Allowed 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.917 0.887 . . . . 73.1 111.684 -176.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.466 ' HG2' ' O ' ' D' ' 139' ' ' ASN . 19.6 mm-40 -125.76 93.76 3.93 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.595 0.758 . . . . 74.34 111.496 179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -162.22 -77.77 0.04 OUTLIER 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.037 1.335 . . . . 65.41 108.181 172.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -179.62 103.31 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.403 1.081 . . . . 61.43 108.516 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -134.9 82.27 0.29 Allowed Glycine 0 C--N 1.342 0.874 0 O-C-N 123.295 0.372 . . . . 75.03 112.404 -174.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -164.38 123.26 1.86 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.789 0.836 . . . . 62.52 109.34 177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.1 151.58 19.44 Favored Glycine 0 C--N 1.344 0.984 0 N-CA-C 110.904 -0.878 . . . . 73.24 110.904 179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 31.8 p -78.61 97.74 5.91 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.027 0.531 . . . . 63.33 110.856 -177.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -86.81 116.56 24.98 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.98 0.512 . . . . 72.33 109.941 176.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -122.34 140.9 52.13 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 107.667 -1.234 . . . . 70.3 107.667 174.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 65.0 m-70 -71.31 144.44 49.95 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 122.743 0.417 . . . . 63.44 110.492 -177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -74.47 132.65 42.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.551 0.741 . . . . 73.44 109.32 175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 11.5 p-10 -49.89 121.98 6.01 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.979 1.312 . . . . 74.32 111.645 -174.302 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.268 0 C-N-CA 123.733 0.813 . . . . 72.22 110.247 -176.143 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.226 -0.657 . . . . 52.13 109.226 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 -71.93 -64.09 1.0 Allowed 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.002 0.814 . . . . 71.02 109.042 177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -168.71 172.9 7.6 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.762 0.825 . . . . 61.21 110.728 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -174.22 118.37 0.24 Allowed 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.382 1.073 . . . . 74.44 108.223 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.57 104.79 50.01 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 123.598 0.759 . . . . 63.12 109.97 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -77.75 89.35 1.34 Allowed 'Trans proline' 0 C--N 1.376 2.013 0 C-N-CA 122.241 1.961 . . . . 55.43 110.934 175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 7.2 tt -67.52 -45.33 76.07 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 108.151 -1.055 . . . . 71.23 108.151 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 17.7 tp -83.46 91.57 7.4 Favored 'General case' 0 CA--C 1.55 0.955 0 CA-C-N 114.23 -1.35 . . . . 72.43 107.666 173.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -131.12 -78.96 0.18 Allowed Glycine 0 C--N 1.35 1.34 0 N-CA-C 112.652 -0.179 . . . . 50.45 112.652 -172.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -72.57 100.93 2.88 Favored 'General case' 0 C--O 1.242 0.703 0 N-CA-C 108.88 -0.785 . . . . 54.3 108.88 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -170.47 120.9 0.6 Allowed 'General case' 0 C--N 1.35 0.616 0 O-C-N 124.122 0.889 . . . . 72.23 110.481 175.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -151.4 -65.88 0.18 Allowed 'General case' 0 CA--C 1.536 0.435 0 O-C-N 124.201 0.938 . . . . 60.04 108.897 174.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -157.97 -163.02 1.24 Allowed 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.926 0.89 . . . . 63.11 109.085 -176.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -151.85 176.67 30.1 Favored Glycine 0 C--N 1.344 0.995 0 N-CA-C 111.728 -0.549 . . . . 74.34 111.728 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . 0.461 ' N ' HD22 ' E' ' 285' ' ' ASN . 0.8 OUTLIER -87.13 25.91 1.27 Allowed 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 123.712 0.805 . . . . 43.12 110.817 176.474 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . 0.496 ' HG2' HD22 ' A' ' 136' ' ' LEU . 32.9 mtm -99.03 106.44 38.08 Favored Pre-proline 0 CA--C 1.545 0.778 0 N-CA-C 107.307 -1.368 . . . . 74.31 107.307 179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.76 -58.82 0.35 Allowed 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 122.992 2.461 . . . . 74.34 112.825 -172.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 12.5 t 54.34 37.33 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 CA-C-O 123.616 1.674 . . . . 71.45 109.512 -176.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -96.03 50.04 1.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 113.834 -1.53 . . . . 64.41 108.372 -173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 53.6 m95 69.25 174.47 0.29 Allowed 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.132 1.373 . . . . 74.43 113.08 -174.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.435 ' N ' HD12 ' E' ' 291' ' ' LEU . 2.2 mp -112.7 -52.8 2.76 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 113.28 -1.782 . . . . 64.2 106.376 175.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -154.31 114.01 0.6 Allowed Glycine 0 CA--C 1.533 1.21 0 CA-C-N 114.316 -1.311 . . . . 74.42 110.257 176.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -69.11 177.17 5.38 Favored 'Trans proline' 0 C--N 1.381 2.239 0 C-N-CA 122.771 2.314 . . . . 33.22 112.443 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? 64.23 103.18 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.156 0 C-N-CA 124.42 1.088 . . . . 74.45 110.36 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -160.26 -34.29 0.06 Allowed 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.606 1.162 . . . . 74.1 108.226 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 11.6 m -66.87 145.34 55.57 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 114.581 -1.19 . . . . 70.11 109.909 171.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 74.38 175.12 0.26 Allowed 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.749 1.619 . . . . 74.32 110.772 -177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 51.2 t-80 -163.4 -50.68 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 122.64 0.376 . . . . 72.41 109.998 176.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -125.49 -81.57 0.44 Allowed Glycine 0 C--N 1.346 1.1 0 N-CA-C 111.494 -0.642 . . . . 71.55 111.494 178.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 28.6 p30 -152.87 132.35 12.96 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.156 0.582 . . . . 72.13 110.498 178.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.659 ' HA ' ' HB3' ' G' ' 298' ' ' HIS . 24.4 pt -96.73 10.02 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 122.419 0.288 . . . . 45.24 111.103 176.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -157.65 165.35 35.7 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.03 0.932 . . . . 73.22 110.633 -173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . 0.561 ' HB3' ' HD3' ' E' ' 304' ' ' PRO 0.268 57.2 tttm 104.3 -68.49 0.0 OUTLIER Pre-proline 0 CA--C 1.568 1.654 0 C-N-CA 128.385 2.674 . . . . 73.33 111.761 174.701 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' E' ' 303' ' ' LYS . 13.7 Cg_exo -72.57 97.6 0.89 Allowed 'Trans proline' 0 C--N 1.391 2.779 0 CA-C-N 122.381 1.886 . . . . 75.3 111.85 175.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -92.04 -170.45 2.54 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.813 0.845 . . . . 64.13 111.474 -177.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . 0.6 ' HB ' ' NE2' ' B' ' 12' ' ' GLN . 21.5 t -86.36 144.94 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 C-N-CA 123.867 0.867 . . . . 65.43 110.393 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 40.2 p -72.28 149.58 44.37 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.378 0.671 . . . . 63.22 110.857 177.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 35.6 m -107.7 163.11 13.37 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.69 0.796 . . . . 75.43 110.642 -175.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 12.1 t -147.62 147.54 27.96 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.194 0.597 . . . . 73.11 109.818 174.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 C--N 1.372 1.788 0 C-N-CA 122.539 2.159 . . . . 72.14 112.855 167.442 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 111.578 0.214 . . . . 74.35 111.578 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -89.1 146.87 24.54 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.267 0.627 . . . . 75.3 110.151 175.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 23.5 mt-30 57.97 85.39 0.09 Allowed 'General case' 0 CA--C 1.544 0.746 0 O-C-N 124.824 1.328 . . . . 74.54 110.52 -175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.74 177.75 10.14 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.281 0.632 . . . . 74.41 111.167 177.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -141.14 164.45 35.57 Favored Pre-proline 0 CA--C 1.553 1.059 0 C-N-CA 125.322 1.449 . . . . 75.42 108.351 174.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -59.57 -7.87 6.27 Favored 'Trans proline' 0 C--N 1.387 2.594 0 C-N-CA 123.301 2.667 . . . . 72.21 114.271 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.4 mp -58.85 -56.3 24.03 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 123.149 0.58 . . . . 62.43 109.487 169.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.66 122.09 17.8 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-N 115.111 -0.95 . . . . 75.15 110.387 -175.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 159.07 94.15 0.1 OUTLIER Glycine 0 C--N 1.348 1.201 0 O-C-N 123.43 0.457 . . . . 43.34 111.999 176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . 0.441 HD23 ' HA3' ' C' ' 99' ' ' GLY . 27.9 tp -163.97 -22.5 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 123.192 0.597 . . . . 61.43 110.658 176.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . 0.419 ' HE2' ' HB3' ' C' ' 48' ' ' SER . 12.1 m-85 -70.23 -49.29 51.61 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.288 0.635 . . . . 73.41 112.37 -177.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . 64.33 -156.85 0.31 Allowed 'General case' 0 N--CA 1.482 1.129 0 O-C-N 124.314 1.009 . . . . 73.23 109.58 -167.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -69.7 -19.7 63.56 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 122.683 0.393 . . . . 64.04 110.266 172.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 164.41 151.96 6.77 Favored Glycine 0 C--N 1.346 1.12 0 N-CA-C 110.352 -1.099 . . . . 62.33 110.352 177.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -148.39 146.88 28.67 Favored 'General case' 0 N--CA 1.483 1.203 0 N-CA-C 108.833 -0.803 . . . . 72.03 108.833 178.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 61.8 mtt 59.15 69.43 1.35 Allowed Pre-proline 0 CA--C 1.556 1.205 0 C-N-CA 124.593 1.157 . . . . 70.35 110.91 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -69.89 94.81 0.55 Allowed 'Trans proline' 0 C--N 1.382 2.312 0 C-N-CA 122.457 2.105 . . . . 54.2 110.859 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.52 107.57 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 115.183 -0.917 . . . . 72.23 109.826 -178.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -88.51 37.6 0.83 Allowed 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.391 1.077 . . . . 72.43 110.677 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 94.6 m95 68.32 164.91 0.24 Allowed 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.221 1.408 . . . . 75.22 112.1 -169.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.575 HD13 ' HB3' ' C' ' 129' ' ' ALA . 4.5 mp -107.33 64.86 0.64 Allowed 'General case' 0 C--O 1.242 0.681 0 N-CA-C 107.168 -1.419 . . . . 70.22 107.168 176.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . 83.58 88.65 0.77 Allowed Glycine 0 C--N 1.347 1.18 0 CA-C-N 114.716 -1.129 . . . . 53.22 110.623 -167.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.38 115.54 1.62 Allowed 'Trans proline' 0 C--N 1.385 2.471 0 C-N-CA 123.914 3.076 . . . . 71.11 113.226 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -82.32 142.35 32.12 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.695 -0.684 . . . . 72.22 110.548 -174.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.8 72.55 7.78 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.338 -0.616 . . . . 64.3 109.338 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 86.7 m -60.67 -53.87 52.17 Favored 'General case' 0 C--N 1.353 0.738 0 CA-C-N 114.999 -1.0 . . . . 74.11 110.352 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -82.3 74.88 9.25 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.916 0.865 . . . . 75.45 109.364 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -78.28 -37.31 45.26 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 113.891 -1.504 . . . . 71.13 111.131 -172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 120.09 -141.77 15.59 Favored Glycine 0 C--N 1.34 0.761 0 N-CA-C 111.019 -0.832 . . . . 74.33 111.019 -176.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 14.2 m120 71.7 -2.55 2.44 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 125.286 1.434 . . . . 75.3 112.666 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 35.9 pt -102.7 22.85 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 124.584 1.153 . . . . 74.32 109.232 174.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.73 2.51 11.9 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.705 1.202 . . . . 64.41 112.394 -176.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -134.49 148.51 67.78 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 124.052 0.941 . . . . 32.32 110.021 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.24 147.58 29.62 Favored 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.878 2.385 . . . . 65.12 111.32 175.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -124.44 -167.21 1.62 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.618 0.767 . . . . 63.2 108.988 178.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 4.3 t 67.58 3.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 C-N-CA 124.738 1.215 . . . . 75.04 111.953 174.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 37.1 p -77.52 11.98 1.8 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.24 1.016 . . . . 52.42 112.836 -172.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . 0.453 ' HB2' ' HG ' ' H' ' 291' ' ' LEU . 60.9 m -97.66 1.53 48.77 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 124.105 0.962 . . . . 51.53 111.129 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 14.5 t -139.29 134.52 16.62 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 122.675 0.39 . . . . 74.4 110.455 175.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo . . . . . 0 CA--C 1.564 2.017 0 C-N-CA 123.417 2.745 . . . . 73.33 111.707 170.644 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 110.481 -0.192 . . . . 61.44 110.481 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . 0.591 ' HA ' ' HB2' ' D' ' 90' ' ' GLU . 26.1 t-20 -86.67 146.84 26.14 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 122.833 0.453 . . . . 73.01 110.655 -177.302 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -153.02 78.26 1.17 Allowed 'General case' 0 C--O 1.24 0.563 0 N-CA-C 108.463 -0.94 . . . . 65.3 108.463 172.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 65.92 126.17 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.936 1.294 . . . . 73.32 112.162 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . 0.458 ' HB3' ' HD2' ' G' ' 276' ' ' PRO . 0.1 OUTLIER 68.83 168.58 0.12 Allowed Pre-proline 0 N--CA 1.49 1.566 0 C-N-CA 124.048 0.939 . . . . 54.23 112.068 177.282 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' G' ' 275' ' ' LYS . 46.0 Cg_endo -65.57 -164.81 0.07 OUTLIER 'Trans proline' 0 C--N 1.388 2.61 0 C-N-CA 122.278 1.986 . . . . 60.03 113.643 173.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 6.1 mp -67.27 -37.17 83.02 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.893 0.877 . . . . 75.12 112.057 -175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -79.17 107.4 11.9 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 109.147 -0.686 . . . . 75.0 109.147 -177.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -137.59 -101.57 0.57 Allowed Glycine 0 C--N 1.344 1.023 0 O-C-N 123.534 0.521 . . . . 62.25 112.137 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.578 ' HB3' ' HB1' ' D' ' 95' ' ' ALA . 6.7 tt -72.09 122.25 20.63 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.937 0.895 . . . . 61.45 109.079 178.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -163.26 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.607 0 O-C-N 124.502 1.126 . . . . 74.04 109.349 170.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -79.66 -18.69 50.86 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 116.104 -0.498 . . . . 63.32 110.763 175.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . 0.543 ' HB3' ' HG ' ' G' ' 280' ' ' LEU . 25.5 t70 -66.94 99.96 0.69 Allowed 'General case' 0 C--N 1.353 0.758 0 C-N-CA 123.528 0.731 . . . . 64.34 109.487 174.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.36 73.92 2.3 Favored Glycine 0 C--N 1.344 0.985 0 CA-C-N 115.562 -0.745 . . . . 63.11 111.504 176.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -57.0 -36.75 70.77 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.85 0.86 . . . . 63.34 110.697 177.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . 0.449 ' SD ' ' N ' ' G' ' 286' ' ' MET . 0.0 OUTLIER -122.9 101.58 38.98 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.192 0.997 . . . . 71.22 109.698 177.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.48 85.68 1.25 Allowed 'Trans proline' 0 C--N 1.381 2.242 0 C-N-CA 122.303 2.002 . . . . 62.4 110.418 173.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 95.4 t -65.44 -52.38 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 CA-C-N 115.153 -0.93 . . . . 70.31 110.283 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 63.7 -77.39 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 124.8 1.24 . . . . 73.15 111.226 179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.527 ' HE3' ' H ' ' G' ' 291' ' ' LEU . 3.6 m95 -150.98 175.79 11.74 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.726 1.21 . . . . 64.23 109.681 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.527 ' H ' ' HE3' ' G' ' 290' ' ' TRP . 5.1 mp -93.71 -32.93 13.83 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.313 1.045 . . . . 73.25 108.894 171.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 155.36 -161.25 30.38 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 114.842 -1.072 . . . . 55.43 111.496 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -77.0 167.03 25.83 Favored 'Trans proline' 0 C--N 1.369 1.623 0 C-N-CA 122.629 2.219 . . . . 72.5 112.147 178.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . 0.468 ' HE3' HG11 ' D' ' 40' ' ' VAL . 22.1 pttp -160.24 149.7 17.66 Favored 'General case' 0 C--O 1.244 0.789 0 C-N-CA 122.911 0.485 . . . . 73.15 109.919 174.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -74.53 96.32 2.92 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.295 -1.002 . . . . 74.44 108.295 170.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . 0.508 HG22 ' HG2' ' D' ' 124' ' ' PRO . 78.7 m -73.3 -58.95 2.95 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-N 115.801 -0.636 . . . . 73.24 110.967 -173.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.643 ' HA ' ' HG3' ' D' ' 124' ' ' PRO . 0.2 OUTLIER -71.09 135.51 47.75 Favored 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.004 0.431 . . . . 74.23 111.22 -178.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . 0.659 ' HB3' ' HA ' ' E' ' 301' ' ' ILE . 42.1 m-70 -151.36 -41.62 0.12 Allowed 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 114.728 -1.124 . . . . 61.34 110.295 -177.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -59.02 -89.43 0.02 OUTLIER Glycine 0 CA--C 1.533 1.206 0 O-C-N 123.792 0.682 . . . . 74.4 113.144 -179.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -160.57 143.8 13.39 Favored 'General case' 0 N--CA 1.47 0.541 0 N-CA-C 108.79 -0.818 . . . . 45.25 108.79 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' D' ' 32' ' ' PHE . 9.9 tt -148.23 102.55 0.42 Allowed 'Isoleucine or valine' 0 C--O 1.243 0.726 0 C-N-CA 124.928 1.291 . . . . 74.1 108.059 174.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . 0.418 ' H ' ' NH1' ' C' ' 15' ' ' ARG . 0.7 OUTLIER -159.92 159.19 32.05 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.378 -0.971 . . . . 53.32 108.378 -175.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 5.8 tmtp? -95.89 -54.11 0.22 Allowed Pre-proline 0 CA--C 1.57 1.732 0 CA-C-O 118.821 -0.609 . . . . 71.33 110.761 -171.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -90.22 159.56 4.69 Favored 'Trans proline' 0 C--N 1.393 2.907 0 C-N-CA 122.077 1.851 . . . . 73.52 112.88 172.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -100.18 -70.39 0.74 Allowed 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.37 0.668 . . . . 55.41 109.993 177.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.02 176.98 3.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 123.734 0.813 . . . . 74.25 110.345 -179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 27.0 m -87.09 -60.04 2.09 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.497 0.719 . . . . 75.04 111.18 -176.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 60.1 m -127.28 158.08 38.16 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.195 0.998 . . . . 72.32 110.047 -176.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . 0.488 ' HB ' ' HD3' ' G' ' 310' ' ' PRO . 28.1 m -73.4 -52.04 5.35 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-O 118.877 -0.583 . . . . 75.14 109.604 167.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . 0.564 ' HG2' ' H ' ' C' ' 150' ' ' GLU . 98.3 Cg_endo . . . . . 0 C--N 1.394 2.962 0 C-N-CA 122.221 1.947 . . . . 53.54 111.504 172.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.165 0 N-CA-C 110.062 -0.347 . . . . 70.41 110.062 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 9.6 p30 -132.47 145.41 51.16 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 108.938 -0.764 . . . . 71.44 108.938 174.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -104.38 32.19 4.19 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.48 0.712 . . . . 61.0 109.978 -176.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -60.84 -36.09 78.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.932 0.893 . . . . 74.04 110.815 -178.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . 0.439 ' N ' ' HD2' ' H' ' 275' ' ' LYS . 0.0 OUTLIER -98.98 130.95 26.36 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 107.521 -1.289 . . . . 71.52 107.521 171.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -51.26 -58.41 1.65 Allowed 'Trans proline' 0 C--N 1.38 2.231 0 C-N-CA 123.945 3.096 . . . . 74.01 114.556 -171.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 7.1 mp -86.97 -46.41 9.88 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.283 -0.636 . . . . 74.33 109.283 178.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' H' ' 275' ' ' LYS . 39.0 tp -76.99 74.67 3.57 Favored 'General case' 0 CA--C 1.552 1.056 0 CA-C-O 122.098 0.951 . . . . 71.2 111.05 -176.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -111.98 -4.77 25.79 Favored Glycine 0 N--CA 1.467 0.757 0 CA-C-N 114.767 -1.106 . . . . 70.02 111.669 174.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 7.7 tt -150.65 129.76 12.68 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.017 0.927 . . . . 72.22 108.944 -177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -158.94 22.19 0.21 Allowed 'General case' 0 CA--C 1.559 1.311 0 O-C-N 124.245 0.966 . . . . 73.12 109.179 171.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -148.54 131.56 16.26 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.305 0.642 . . . . 74.41 110.213 -178.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -85.11 -74.65 0.39 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.283 0.633 . . . . 75.24 110.331 176.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 159.48 -54.27 0.36 Allowed Glycine 0 C--N 1.348 1.219 0 N-CA-C 111.577 -0.609 . . . . 73.11 111.577 -178.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -148.62 109.01 4.14 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.018 0.527 . . . . 65.53 109.841 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 55.6 ttp -169.69 89.17 0.56 Allowed Pre-proline 0 CA--C 1.553 1.083 0 N-CA-C 108.165 -1.05 . . . . 73.42 108.165 172.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_exo -73.62 148.64 42.37 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.746 2.298 . . . . 60.32 111.96 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 61.9 t -77.1 89.98 0.97 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.652 -0.87 . . . . 54.2 108.652 175.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -75.23 148.49 39.44 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.769 -1.105 . . . . 61.42 109.78 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -66.13 131.54 46.41 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 121.259 0.552 . . . . 73.1 111.947 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.453 ' HG ' ' HB2' ' F' ' 308' ' ' CYS . 4.5 mp -88.65 1.24 55.4 Favored 'General case' 0 CA--C 1.552 1.048 0 CA-C-N 114.513 -1.221 . . . . 75.21 109.917 171.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -178.27 95.47 0.1 OUTLIER Glycine 0 C--N 1.345 1.056 0 N-CA-C 109.255 -1.538 . . . . 63.02 109.255 176.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -58.59 -28.89 87.44 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 123.11 2.54 . . . . 52.43 112.945 -173.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 66.9 mttm -93.05 116.02 28.65 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 108.669 -0.863 . . . . 65.43 108.669 173.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -148.74 -59.94 0.23 Allowed 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 122.911 0.485 . . . . 74.32 110.616 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . 0.542 HG22 ' HD2' ' H' ' 297' ' ' TYR . 7.8 m -84.09 145.04 28.66 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.196 0.598 . . . . 71.53 110.534 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.61 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 27.2 m-85 59.99 103.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 125.081 1.352 . . . . 73.14 112.161 -174.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -148.4 -50.82 0.17 Allowed 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.427 -0.806 . . . . 61.54 110.252 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -165.94 123.85 1.19 Allowed Glycine 0 C--N 1.347 1.144 0 C-N-CA 120.732 -0.747 . . . . 54.42 113.965 -178.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . 0.48 ' OD1' ' HG3' ' B' ' 124' ' ' PRO . 28.7 p-10 171.44 -40.57 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 125.807 1.643 . . . . 72.14 108.861 174.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 33.3 pt -94.35 18.32 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 C-N-CA 124.093 0.957 . . . . 61.03 111.568 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.47 -43.31 77.25 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.951 0.9 . . . . 44.15 108.983 172.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -126.14 85.01 60.47 Favored Pre-proline 0 CA--C 1.543 0.706 0 N-CA-C 107.88 -1.156 . . . . 75.23 107.88 165.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -87.65 -161.77 0.13 Allowed 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 123.266 2.644 . . . . 71.43 111.434 -179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 70.46 157.33 0.16 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.655 1.182 . . . . 72.53 113.188 171.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 83.9 t -116.35 120.5 65.1 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 N-CA-C 107.361 -1.348 . . . . 72.5 107.361 173.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 13.4 t -160.28 168.66 24.84 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.256 0.622 . . . . 71.42 110.067 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 43.9 t 61.55 34.17 18.01 Favored 'General case' 0 C--N 1.357 0.924 0 C-N-CA 124.455 1.102 . . . . 72.51 110.335 -176.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 47.6 m -64.69 111.95 6.85 Favored Pre-proline 0 CA--C 1.549 0.931 0 CA-C-N 114.986 -1.007 . . . . 54.03 109.989 178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo . . . . . 0 C--N 1.375 1.922 0 C-N-CA 122.465 2.11 . . . . 64.44 111.325 178.564 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 109.062 -0.718 . . . . 72.2 109.062 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.3 m -147.74 39.67 0.96 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 124.446 1.098 . . . . 34.23 109.102 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -81.32 95.86 7.13 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 122.912 0.485 . . . . 72.02 110.839 -177.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.681 HE21 ' HB3' ' A' ' 90' ' ' GLU . 2.0 mp0 -80.99 124.24 28.99 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 108.78 -0.822 . . . . 73.1 108.78 168.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -89.68 157.57 17.94 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.51 0.724 . . . . 75.54 109.876 -178.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -69.4 90.34 0.52 Allowed 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 123.864 0.866 . . . . 63.34 109.765 174.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.3 p -141.89 164.47 30.1 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 124.672 1.189 . . . . 65.34 110.411 -171.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -88.63 122.63 32.27 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.478 0.711 . . . . 61.33 109.316 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.411 ' N ' ' SD ' ' A' ' 9' ' ' MET . 1.4 mpt? -67.76 134.01 50.26 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 108.982 -0.747 . . . . 55.23 108.982 172.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 37.6 m -140.69 137.4 33.5 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.294 0.638 . . . . 72.12 110.181 -173.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.475 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 28.1 t80 -138.83 127.59 23.48 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 109.005 -0.739 . . . . 71.44 109.005 171.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.4 tp60 -159.17 110.91 2.11 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 123.466 0.479 . . . . 71.52 110.143 176.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.688 HG12 ' HD2' ' A' ' 84' ' ' PHE . 56.6 mt -69.5 116.02 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 C-N-CA 123.057 0.543 . . . . 60.22 110.329 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' H' ' 307' ' ' THR . 22.7 tm0? -81.43 -36.04 29.91 Favored 'General case' 0 C--O 1.248 0.996 0 O-C-N 124.159 0.912 . . . . 65.41 110.007 178.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -176.28 123.01 0.17 Allowed 'General case' 0 C--N 1.363 1.195 0 O-C-N 123.557 0.536 . . . . 64.53 111.025 -173.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.06 142.03 22.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.057 0 C-N-CA 123.614 0.766 . . . . 74.43 109.024 173.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 29.8 p90 -168.44 155.83 7.85 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.674 0.75 . . . . 75.11 111.71 -170.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -86.6 114.99 23.77 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 114.953 -1.021 . . . . 32.45 109.193 175.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.2 mtpt -79.3 -22.07 45.12 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.147 -0.479 . . . . 74.1 111.009 178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -159.84 144.27 14.82 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 123.88 0.872 . . . . 62.11 109.357 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 84.3 mt -141.93 143.88 26.21 Favored 'Isoleucine or valine' 0 C--O 1.242 0.687 0 C-N-CA 125.361 1.464 . . . . 75.22 107.806 179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 41.3 t -145.73 128.29 16.08 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.525 0.73 . . . . 60.21 109.537 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.498 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 89.7 t80 -126.12 117.25 22.76 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 106.082 -1.821 . . . . 71.4 106.082 162.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 74' ' ' PHE . 47.1 mt-10 -118.99 140.56 49.79 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.965 -0.754 . . . . 73.51 108.965 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -134.53 72.96 69.16 Favored Pre-proline 0 C--O 1.242 0.707 0 N-CA-C 105.804 -1.925 . . . . 53.21 105.804 168.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -68.58 -20.27 41.24 Favored 'Trans proline' 0 C--N 1.382 2.294 0 C-N-CA 122.798 2.332 . . . . 73.2 112.042 -169.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' A' ' 71' ' ' GLU . 37.9 m-20 -119.42 23.43 11.24 Favored 'General case' 0 C--O 1.216 -0.694 0 C-N-CA 124.242 1.017 . . . . 64.3 109.434 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.443 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -47.95 -57.45 10.2 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-O 117.625 -1.179 . . . . 24.34 113.485 -170.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 14.1 Cg_exo -65.9 -19.4 58.42 Favored 'Trans proline' 0 C--N 1.4 3.271 0 C-N-CA 121.873 1.715 . . . . 61.11 112.572 -179.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -83.61 -44.62 14.38 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.803 0.841 . . . . 64.41 109.889 -179.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.686 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -78.99 -19.6 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-N 114.824 -1.08 . . . . 70.51 111.943 -160.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -72.61 -6.25 42.88 Favored 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 123.497 0.719 . . . . 71.15 111.301 174.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -102.2 -12.55 17.94 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 124.661 1.185 . . . . 74.15 111.978 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -71.42 168.66 17.0 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 123.719 0.808 . . . . 75.24 113.016 -171.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' O ' HD23 ' A' ' 68' ' ' LEU . 23.3 m-20 -69.97 135.19 49.14 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.182 -0.917 . . . . 64.31 109.368 169.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -82.77 67.18 8.73 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 124.491 1.116 . . . . 73.33 110.617 -169.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -141.75 71.0 25.01 Favored Pre-proline 0 CA--C 1.552 1.036 0 C-N-CA 124.137 0.975 . . . . 55.41 109.086 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.642 ' HG2' ' HB3' ' E' ' 297' ' ' TYR . 2.0 Cg_endo -91.26 129.47 1.27 Allowed 'Trans proline' 0 C--N 1.38 2.236 0 C-N-CA 123.61 2.873 . . . . 75.4 112.217 176.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -96.63 110.5 22.91 Favored 'General case' 0 C--O 1.243 0.727 0 N-CA-C 108.034 -1.098 . . . . 73.24 108.034 170.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 25.3 t -79.22 136.64 23.28 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 123.672 0.789 . . . . 62.25 109.108 177.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -117.04 118.58 32.79 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.486 1.114 . . . . 75.01 108.136 -175.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.702 HD13 HG11 ' E' ' 288' ' ' VAL . 4.0 tt -102.37 107.72 18.83 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 108.109 -1.071 . . . . 61.33 108.109 -177.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.701 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 14.8 m-20 -108.01 151.16 26.2 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.935 0.894 . . . . 73.54 108.982 172.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 6.4 tt -139.0 134.58 33.26 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.202 1.001 . . . . 64.41 108.42 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.541 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 35.0 t70 -135.96 137.27 41.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.076 0.951 . . . . 73.14 109.354 -178.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 36.2 p -124.86 134.9 52.53 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.339 1.056 . . . . 64.24 110.157 -172.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -149.95 143.09 25.0 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.612 0.765 . . . . 61.24 109.77 175.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 78.8 p -132.18 161.1 34.2 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 123.28 0.632 . . . . 74.54 109.338 169.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.5 t -163.49 127.8 2.87 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.499 0.72 . . . . 74.15 109.74 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -74.23 114.06 12.15 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 108.845 -0.798 . . . . 54.4 108.845 174.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 57' ' ' GLU . 39.9 mt -79.42 -43.96 22.33 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.146 0.578 . . . . 63.11 109.629 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.64 -172.69 2.98 Favored 'General case' 0 C--O 1.244 0.791 0 CA-C-N 114.939 -1.028 . . . . 75.52 109.815 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.34 120.99 14.75 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.371 0.668 . . . . 64.35 109.387 175.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 63.37 16.55 9.6 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 124.668 1.187 . . . . 71.45 112.528 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.49 HG12 HD12 ' A' ' 51' ' ' LEU . 28.7 t -127.48 106.32 14.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 108.301 -1.0 . . . . 71.51 108.301 178.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -133.78 127.9 33.68 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.089 0.956 . . . . 74.12 108.479 -171.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.652 ' HB2' HD11 ' A' ' 51' ' ' LEU . 33.7 tt0 -104.65 134.41 47.86 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.36 0.664 . . . . 70.32 109.762 179.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.61 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 97.2 t -122.82 123.79 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 N-CA-C 107.967 -1.123 . . . . 71.43 107.967 169.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.551 ' HA ' ' HA2' ' A' ' 81' ' ' GLY . 44.7 t -99.68 135.48 34.98 Favored 'Isoleucine or valine' 0 C--O 1.242 0.672 0 C-N-CA 124.357 1.063 . . . . 73.13 109.374 175.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -123.14 99.52 6.4 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 107.158 -1.423 . . . . 73.04 107.158 173.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.541 ' HB3' ' HB3' ' A' ' 45' ' ' ASP . 15.7 ttp180 -87.46 113.29 23.03 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.045 0.538 . . . . 73.31 109.806 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.6 t -93.76 143.33 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 N-CA-C 107.498 -1.297 . . . . 74.11 107.498 171.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.701 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 5.5 m -131.56 133.86 45.47 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.42 -0.585 . . . . 62.53 109.42 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.602 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 77.8 t -131.19 111.02 18.77 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 125.1 1.36 . . . . 72.24 108.709 -173.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 35.2 m -120.69 121.64 38.71 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.326 0.512 . . . . 74.41 110.212 173.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -104.37 110.33 22.53 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 107.339 -1.356 . . . . 72.0 107.339 176.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 66.2 m -118.25 126.56 52.42 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.306 0.503 . . . . 73.42 110.485 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.466 HD23 ' O ' ' A' ' 35' ' ' ASP . 5.3 mp -90.22 85.72 6.33 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.879 -1.156 . . . . 74.14 107.879 178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.15 -85.11 1.53 Allowed Glycine 0 C--N 1.343 0.94 0 CA-C-N 114.434 -1.257 . . . . 45.53 110.643 -173.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -126.13 -28.74 3.11 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.482 0.713 . . . . 64.3 110.872 178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HG2' ' ND2' ' A' ' 27' ' ' ASN . 30.4 tt0 -95.73 125.65 40.45 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 120.835 0.35 . . . . 65.15 110.307 -174.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 29.5 m -77.77 142.23 38.78 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 124.783 1.233 . . . . 71.11 112.805 -171.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.686 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.04 -65.98 0.94 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.522 1.129 . . . . 53.32 109.199 169.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.414 ' HD2' ' HG ' ' A' ' 76' ' ' CYS . 50.6 p90 -146.1 148.94 33.15 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.513 -1.221 . . . . 74.35 111.865 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 58.9 tp -109.29 143.08 39.25 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 114.22 -1.355 . . . . 71.32 107.904 167.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.602 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 72.3 m -143.06 109.7 5.45 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.506 -0.924 . . . . 72.31 108.506 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -135.6 119.54 17.44 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.755 -0.461 . . . . 70.45 109.755 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.0 t -129.09 114.37 32.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 124.382 1.073 . . . . 75.22 109.404 -171.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -83.86 84.22 7.65 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 108.38 -0.97 . . . . 72.44 108.38 171.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -79.57 91.7 5.23 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.811 -0.811 . . . . 60.42 108.811 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.551 ' HA2' ' HA ' ' A' ' 59' ' ' VAL . . . -87.09 167.27 37.69 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-N 115.39 -0.823 . . . . 52.43 111.715 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -166.3 124.95 1.28 Allowed Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 112.186 -0.366 . . . . 75.34 112.186 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.1 mt -81.98 115.51 24.65 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 N-CA-C 108.964 -0.754 . . . . 41.32 108.964 171.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.7 m-85 -116.98 120.08 37.31 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 125.17 1.388 . . . . 75.55 107.81 177.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 38.4 t -75.57 94.17 3.14 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 108.797 -0.816 . . . . 71.41 108.797 171.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.681 HD13 HD21 ' A' ' 98' ' ' LEU . 50.8 pt -112.72 155.57 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 123.165 0.586 . . . . 53.5 110.708 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -168.76 167.69 11.03 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 114.456 -1.247 . . . . 71.45 109.111 172.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.33 -11.65 57.6 Favored Glycine 0 C--N 1.341 0.849 0 N-CA-C 114.511 0.564 . . . . 71.24 114.511 173.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 2.0 pp -112.47 144.21 20.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 C-N-CA 123.755 0.822 . . . . 45.14 110.3 -177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.681 ' HB3' HE21 ' A' ' 4' ' ' GLN . 1.3 tm-20 -162.06 173.31 14.55 Favored 'General case' 0 CA--C 1.56 1.328 0 N-CA-C 106.785 -1.561 . . . . 65.31 106.785 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.25 -129.82 48.11 Favored Glycine 0 CA--C 1.536 1.395 0 CA-C-N 117.888 0.313 . . . . 61.04 113.543 177.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.418 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 71.3 p -75.09 -20.98 59.23 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 123.805 0.842 . . . . 74.43 111.826 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -69.82 -44.59 69.66 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.135 0.574 . . . . 74.14 109.619 175.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.712 ' SD ' ' HA ' ' E' ' 278' ' ' LEU . 50.4 ttm -68.95 -34.27 75.08 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 116.01 -0.541 . . . . 72.24 110.066 174.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.513 ' HA ' HD22 ' E' ' 280' ' ' LEU . . . -60.98 -28.34 68.94 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 123.188 0.595 . . . . 62.44 111.777 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.439 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 52.8 t-80 -88.47 -31.13 18.92 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 123.297 0.639 . . . . 71.43 111.065 171.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.8 t -70.11 -64.69 0.84 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 122.582 0.353 . . . . 72.33 111.149 -175.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.681 HD21 HD13 ' A' ' 86' ' ' ILE . 47.2 mt -90.09 -12.74 37.52 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.168 0.433 . . . . 72.52 112.168 -174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.78 -2.45 55.2 Favored Glycine 0 C--N 1.344 1.019 0 CA-C-O 119.768 -0.462 . . . . 61.4 113.347 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.19 -53.17 0.17 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.365 0.582 . . . . 73.33 112.186 -174.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -77.3 -56.94 4.13 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.654 0.782 . . . . 64.34 112.085 -168.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 80.5 m -74.97 -34.48 1.72 Allowed Pre-proline 0 CA--C 1.569 1.681 0 N-CA-C 113.563 0.949 . . . . 73.32 113.563 -174.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 37.6 Cg_endo -67.06 -23.01 46.8 Favored 'Trans proline' 0 C--N 1.392 2.819 0 C-N-CA 121.958 1.772 . . . . 61.1 112.936 168.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 47.2 t-20 -70.19 -33.76 72.11 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.3 0.64 . . . . 62.31 109.487 174.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.556 HG21 HD11 ' A' ' 13' ' ' ILE . 45.3 mm -63.04 -42.17 95.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 C-N-CA 123.799 0.84 . . . . 50.23 110.14 173.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 86.2 mt -70.66 -32.62 69.97 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 114.982 -1.008 . . . . 64.34 111.981 -174.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.27 -39.99 55.75 Favored Pre-proline 0 CA--C 1.575 1.927 0 N-CA-C 114.597 1.332 . . . . 74.41 114.597 -169.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -56.05 -41.75 73.69 Favored 'Trans proline' 0 C--N 1.392 2.835 0 C-N-CA 122.592 2.195 . . . . 73.32 113.489 170.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 85.1 m-85 -71.97 -37.3 69.95 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 122.985 0.514 . . . . 64.25 111.376 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.26 -44.46 88.03 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 122.785 0.434 . . . . 74.24 109.86 175.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -54.97 -53.38 56.44 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 124.726 1.266 . . . . 75.23 110.126 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -64.52 -42.75 95.59 Favored 'General case' 0 N--CA 1.475 0.786 0 O-C-N 124.044 0.84 . . . . 73.41 111.231 -177.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.522 ' SG ' ' HD3' ' B' ' 120' ' ' ARG . 45.4 t -60.64 -34.52 74.39 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 123.504 0.722 . . . . 72.45 111.257 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.459 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 95.5 mt -73.44 -55.51 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 123.593 0.757 . . . . 71.21 109.867 174.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.502 HG23 ' HG3' ' A' ' 125' ' ' GLN . 90.0 m -53.08 -40.33 63.98 Favored 'General case' 0 C--O 1.244 0.813 0 C-N-CA 125.199 1.4 . . . . 54.05 111.952 -173.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -61.49 -50.78 71.33 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 114.92 -1.036 . . . . 60.03 110.303 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 52.6 mtm -61.17 -44.22 97.65 Favored 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 123.461 0.704 . . . . 71.44 111.527 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 114' ' ' ILE . 99.4 t -55.83 -46.81 80.14 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 O-C-N 124.25 0.969 . . . . 63.02 110.299 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.6 t -69.87 -29.58 66.83 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 115.199 -0.91 . . . . 74.43 111.504 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -70.95 -27.67 63.92 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.363 0.665 . . . . 73.34 111.259 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.78 11.77 58.71 Favored Glycine 0 C--N 1.355 1.619 0 CA-C-O 119.93 -0.372 . . . . 62.24 113.339 176.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.524 ' HB ' HH21 ' B' ' 15' ' ' ARG . 2.4 m 61.03 25.62 15.63 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 125.141 1.376 . . . . 71.4 111.022 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -94.01 146.23 31.26 Favored Pre-proline 0 CA--C 1.547 0.838 0 N-CA-C 108.825 -0.806 . . . . 74.24 108.825 171.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -63.73 149.55 90.55 Favored 'Trans proline' 0 C--N 1.378 2.1 0 C-N-CA 122.66 2.24 . . . . 63.51 112.088 -178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.502 ' HG3' HG23 ' A' ' 115' ' ' THR . 33.6 tt0 -58.37 133.16 55.49 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 124.295 0.997 . . . . 60.24 112.003 -176.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 34.7 tp -120.01 103.73 9.54 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.256 1.022 . . . . 55.5 108.783 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -105.97 110.89 23.31 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 108.127 -1.064 . . . . 73.23 108.127 173.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -66.55 135.5 54.27 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 123.404 0.44 . . . . 73.03 110.402 177.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.486 ' HB3' HD12 ' E' ' 291' ' ' LEU . . . -69.38 155.93 92.59 Favored Pre-proline 0 CA--C 1.555 1.171 0 C-N-CA 123.39 0.676 . . . . 63.3 110.312 175.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -64.24 125.33 14.94 Favored 'Trans proline' 0 C--N 1.379 2.144 0 C-N-CA 122.524 2.149 . . . . 73.1 112.181 -177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.5 t -99.8 113.1 34.13 Favored 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 106.717 -1.586 . . . . 63.52 106.717 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.598 ' HB2' ' HB3' ' A' ' 135' ' ' ALA . 2.3 p-10 -72.79 81.33 1.15 Allowed 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 123.617 0.767 . . . . 74.11 110.488 -177.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.09 -44.26 97.64 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.449 0.7 . . . . 63.32 110.951 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.519 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.2 p-10 -71.92 -40.33 68.86 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 114.286 -1.325 . . . . 65.13 111.707 -176.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB3' ' HB2' ' A' ' 132' ' ' ASN . . . -72.44 -41.58 65.97 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 123.61 0.569 . . . . 34.02 111.16 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.3 tt -64.13 -51.09 65.59 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 123.441 0.696 . . . . 74.02 109.794 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -63.98 -36.09 82.83 Favored 'General case' 0 CA--C 1.542 0.66 0 O-C-N 123.699 0.624 . . . . 61.01 110.979 179.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 4.5 tpt -63.26 -43.95 96.51 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 123.573 0.545 . . . . 62.21 110.104 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 43.5 m-80 -62.89 -38.79 92.31 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.786 0.679 . . . . 64.21 111.368 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 69.9 t80 -69.12 -39.33 79.0 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-N 115.944 -0.571 . . . . 71.12 110.852 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 36.0 tp -69.15 -50.87 43.83 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 123.117 0.567 . . . . 72.41 111.72 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 4.9 tp60 -178.43 21.6 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.016 0.526 . . . . 71.5 111.416 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.683 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 40.3 mt-30 58.47 -75.62 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 126.384 1.874 . . . . 65.42 114.66 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -135.2 34.07 3.07 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.803 0.811 . . . . 71.22 109.093 -174.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -152.97 -169.15 3.25 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 115.051 -0.977 . . . . 71.0 110.195 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -137.85 137.38 8.82 Favored Glycine 0 C--N 1.343 0.934 0 N-CA-C 110.854 -0.898 . . . . 52.13 110.854 177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -72.74 129.26 37.8 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 123.083 0.553 . . . . 75.31 110.908 -174.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -83.98 124.63 6.72 Favored Glycine 0 C--N 1.347 1.18 0 CA-C-N 115.981 -0.554 . . . . 55.13 112.354 -176.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 41.5 p -81.75 138.7 35.15 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.885 0.874 . . . . 74.25 111.195 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -107.45 118.0 35.58 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.733 0.813 . . . . 53.5 109.912 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -83.9 128.32 34.46 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.316 0.646 . . . . 73.02 110.293 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -176.53 123.5 0.16 Allowed 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.658 1.183 . . . . 60.32 108.013 168.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -82.39 66.88 8.19 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.855 0.862 . . . . 53.34 110.288 -176.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -87.1 86.9 7.33 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 108.424 -0.954 . . . . 51.11 108.424 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 N-CA-C 108.401 -0.963 . . . . 74.25 108.401 174.998 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.756 -0.461 . . . . 52.53 109.756 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' D' ' 137' ' ' PHE . 47.3 m -74.61 85.43 2.09 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 123.246 0.618 . . . . 61.22 110.181 175.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 56.7 mm-40 -75.51 168.39 20.1 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.292 -0.867 . . . . 71.24 112.15 -173.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 63.03 -161.9 0.29 Allowed 'General case' 0 C--N 1.36 1.054 0 C-N-CA 124.546 1.139 . . . . 62.45 110.555 178.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -157.14 145.06 19.16 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 107.713 -1.217 . . . . 75.15 107.713 167.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -74.47 137.35 42.51 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.818 -0.808 . . . . 72.43 108.818 171.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 23.8 m -72.0 78.35 0.92 Allowed 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.528 -0.916 . . . . 65.32 108.528 173.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -108.64 103.25 12.31 Favored 'General case' 0 C--O 1.238 0.458 0 N-CA-C 107.256 -1.387 . . . . 73.31 107.256 -175.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 21.2 ptm 48.84 -171.77 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 125.729 1.612 . . . . 75.55 113.76 -175.102 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 52.6 m -137.35 116.69 12.71 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.537 0.735 . . . . 70.52 109.381 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.593 ' HE1' ' HG ' ' B' ' 102' ' ' CYS . 31.9 t80 -139.58 131.33 27.46 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.224 -0.658 . . . . 65.24 109.224 176.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.592 ' NE2' ' HB2' ' B' ' 85' ' ' SER . 3.9 pp0? -152.29 140.9 20.81 Favored 'General case' 0 C--O 1.246 0.908 0 C-N-CA 123.055 0.542 . . . . 72.31 109.54 168.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.594 ' H ' HD13 ' B' ' 13' ' ' ILE . 0.2 OUTLIER -69.28 113.8 5.5 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.75 0 CA-C-N 115.247 -0.888 . . . . 72.12 109.344 178.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -88.24 -35.31 17.38 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 109.008 -0.738 . . . . 62.32 109.008 -175.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.524 HH21 ' HB ' ' A' ' 122' ' ' THR . 24.3 ttt180 -168.47 142.0 3.12 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.999 0.92 . . . . 72.32 109.726 173.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 75.6 mt -126.11 137.66 57.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 107.007 -1.479 . . . . 72.04 107.007 172.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.404 ' CE2' ' HG2' ' B' ' 19' ' ' LYS . 36.2 p90 -166.28 159.24 14.75 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.687 0.756 . . . . 75.24 110.96 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 64.9 m -84.63 119.42 25.21 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 108.283 -1.006 . . . . 75.51 108.283 172.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.404 ' HG2' ' CE2' ' B' ' 17' ' ' TYR . 41.8 mtpt -87.03 -34.44 19.2 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.289 0.635 . . . . 75.51 111.142 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -158.84 146.26 17.64 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.322 -0.399 . . . . 73.52 110.746 -169.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 46.7 mm -142.49 138.03 28.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 C-N-CA 125.965 1.706 . . . . 73.22 107.619 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 40.9 t -140.1 118.9 12.44 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.522 -1.288 . . . . 63.31 107.522 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.563 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 78.5 t80 -131.59 136.42 47.77 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 108.08 -1.081 . . . . 73.33 108.08 170.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -139.76 145.28 38.05 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 124.131 0.972 . . . . 65.03 108.696 -178.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.438 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -148.34 72.3 10.93 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 105.9 -1.889 . . . . 74.34 105.9 171.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -71.55 -14.71 30.65 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.79 2.327 . . . . 71.45 112.177 -170.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -127.04 28.53 5.76 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.032 0.933 . . . . 60.14 109.502 178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.438 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -46.69 -59.35 5.25 Favored Pre-proline 0 CA--C 1.565 1.529 0 C-N-CA 124.477 1.111 . . . . 63.2 113.305 -173.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.29 -18.97 34.16 Favored 'Trans proline' 0 C--N 1.39 2.731 0 C-N-CA 121.926 1.751 . . . . 53.33 113.029 -176.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -94.73 -21.81 18.51 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.439 0.696 . . . . 74.1 112.382 -172.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.8 p -81.94 -28.1 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 110.051 -0.351 . . . . 71.44 110.051 178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 m-30 -62.47 -27.03 68.85 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.278 1.031 . . . . 72.04 113.216 -175.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -72.77 -16.18 61.64 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.235 0.614 . . . . 71.11 112.204 -178.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . . . . . . . . . 47.9 mtmt -107.55 113.34 26.59 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.149 0.98 . . . . 73.32 109.227 -177.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -110.38 104.57 13.36 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 118.707 0.685 . . . . 62.15 112.605 -171.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.473 ' HE3' ' N ' ' B' ' 36' ' ' TRP . 0.0 OUTLIER 179.21 -177.38 0.3 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 125.384 1.474 . . . . 73.35 110.898 176.563 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -76.54 133.73 70.45 Favored Pre-proline 0 N--CA 1.485 1.324 0 C-N-CA 124.293 1.037 . . . . 74.41 111.956 -174.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . 0.611 ' HB3' HD21 ' B' ' 68' ' ' LEU . 93.1 Cg_endo -93.43 170.6 2.08 Favored 'Trans proline' 0 C--N 1.378 2.118 0 C-N-CA 123.329 2.686 . . . . 73.34 114.564 178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -80.98 101.69 9.67 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 106.879 -1.526 . . . . 54.31 106.879 164.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.497 ' H ' ' HE3' ' H' ' 294' ' ' LYS . 10.9 t -99.7 134.29 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 N-CA-C 108.343 -0.984 . . . . 63.41 108.343 177.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.424 ' HB3' ' HB ' ' B' ' 65' ' ' THR . 58.3 tttp -125.35 117.17 23.15 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.251 0.62 . . . . 74.33 110.195 -176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 32.1 tp -85.88 136.57 33.24 Favored 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 107.968 -1.123 . . . . 71.53 107.968 169.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 15.4 t70 -145.93 154.72 42.25 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.19 0.596 . . . . 61.33 109.584 -177.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 66.5 tp -135.42 128.32 31.33 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.228 1.011 . . . . 74.43 109.71 -174.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.471 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 18.6 t70 -124.01 130.99 53.49 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.232 -1.025 . . . . 64.31 108.232 170.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.0 p -118.31 104.54 10.85 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.36 0.664 . . . . 74.43 109.947 -176.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -117.27 118.77 33.19 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 108.575 -0.898 . . . . 73.2 108.575 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 41.1 p -129.31 160.58 32.57 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.22 0.608 . . . . 52.41 110.53 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 53.1 p -165.69 138.37 4.21 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 123.972 0.909 . . . . 62.34 110.016 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' B' ' 56' ' ' TYR . 50.3 tt0 -81.16 115.46 20.59 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.477 0.711 . . . . 62.12 109.405 175.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.42 HD11 ' HB2' ' B' ' 57' ' ' GLU . 32.7 mt -75.5 -43.38 49.35 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.67 0.788 . . . . 70.23 110.538 -175.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.65 -171.21 3.59 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.84 0.856 . . . . 53.51 110.481 179.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -59.62 116.49 4.05 Favored 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 123.36 0.664 . . . . 64.31 110.243 178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 67.12 -3.36 0.99 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 125.568 1.547 . . . . 70.23 113.383 -176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 92.8 t -102.92 110.56 29.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 107.822 -1.177 . . . . 74.44 107.822 -178.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.464 ' HA ' ' HA ' ' B' ' 50' ' ' GLN . 45.6 m-85 -111.68 172.04 7.13 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.379 -0.828 . . . . 71.32 108.996 177.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.42 ' HB2' HD11 ' B' ' 51' ' ' LEU . 20.3 tt0 -142.43 129.0 20.26 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.485 -0.931 . . . . 61.43 108.485 172.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 95.4 t -112.51 119.0 59.28 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 N-CA-C 107.504 -1.295 . . . . 71.33 107.504 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 39.9 t -103.09 111.91 34.62 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 N-CA-C 108.965 -0.754 . . . . 72.35 108.965 178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' B' ' 106' ' ' LEU . 0.3 OUTLIER -93.49 101.47 13.67 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 114.993 -1.003 . . . . 64.25 108.772 -176.883 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 14.7 ttm-85 -94.93 121.0 36.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.366 -0.605 . . . . 63.0 109.366 174.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . 0.43 HG11 HD21 ' B' ' 128' ' ' LEU . 41.3 t -115.75 125.48 72.93 Favored 'Isoleucine or valine' 0 C--O 1.241 0.606 0 N-CA-C 108.222 -1.029 . . . . 61.0 108.222 172.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.573 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 27.6 m -111.96 140.34 46.71 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-O 121.616 0.722 . . . . 71.22 110.129 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.554 HG21 HG21 ' B' ' 114' ' ' ILE . 54.5 t -124.72 130.81 73.3 Favored 'Isoleucine or valine' 0 C--O 1.24 0.578 0 CA-C-N 113.818 -1.537 . . . . 61.1 108.161 174.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' B' ' 41' ' ' LYS . 54.1 m -122.23 143.61 49.48 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.127 0.571 . . . . 70.33 109.466 174.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.05 125.77 13.42 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.524 -1.287 . . . . 70.55 107.524 171.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . 0.416 ' HA ' ' H ' ' B' ' 73' ' ' ALA . 55.8 p -140.82 140.08 34.61 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 123.303 0.641 . . . . 62.41 109.566 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.63 HD23 ' HB2' ' B' ' 73' ' ' ALA . 3.2 mm? -124.68 123.0 39.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.59 1.156 . . . . 55.21 109.974 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.89 -113.03 4.75 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.595 0.56 . . . . 63.35 112.057 -179.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -113.02 4.16 16.55 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 123.856 0.863 . . . . 73.54 110.326 178.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' B' ' 68' ' ' LEU . 10.6 pt-20 -123.6 146.51 48.11 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.063 0.545 . . . . 75.53 110.282 -169.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 88.1 m -83.03 124.89 30.85 Favored 'General case' 0 C--O 1.243 0.715 0 C-N-CA 122.469 0.308 . . . . 74.22 110.341 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.63 ' HB2' HD23 ' B' ' 68' ' ' LEU . . . -71.45 -63.98 1.01 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 124.257 0.973 . . . . 63.44 109.262 175.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -157.03 149.44 23.17 Favored 'General case' 0 C--N 1.353 0.741 0 CA-C-O 121.657 0.741 . . . . 73.05 112.511 173.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 83.6 mt -113.89 118.96 35.66 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 106.946 -1.501 . . . . 74.52 106.946 166.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.512 ' SG ' ' HB2' ' B' ' 117' ' ' MET . 34.5 t -125.42 124.8 42.25 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 108.797 -0.816 . . . . 34.45 108.797 176.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -148.55 130.81 15.55 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 108.5 -0.926 . . . . 65.21 108.5 -169.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -124.45 146.4 30.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 C-N-CA 123.953 0.901 . . . . 74.11 109.512 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -121.66 96.49 5.09 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 108.193 -1.04 . . . . 63.25 108.193 170.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.529 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.0 tp-100 -90.99 99.33 12.38 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.292 -1.003 . . . . 70.43 108.292 177.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -93.13 142.66 16.07 Favored Glycine 0 C--N 1.34 0.79 0 N-CA-C 110.788 -0.925 . . . . 55.33 110.788 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -136.27 124.93 3.35 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.43 -1.068 . . . . 42.21 110.43 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -85.69 127.7 39.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 N-CA-C 107.305 -1.369 . . . . 73.24 107.305 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -132.73 133.66 43.77 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 108.402 -0.962 . . . . 75.32 108.402 176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.592 ' HB2' ' NE2' ' B' ' 12' ' ' GLN . 48.4 m -94.04 103.58 15.65 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 107.628 -1.249 . . . . 70.44 107.628 171.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . . . . . . . . . 9.2 mt -114.86 146.16 19.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 C-N-CA 124.405 1.082 . . . . 73.52 110.265 -171.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -151.05 172.22 16.08 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 124.798 1.239 . . . . 40.44 109.198 172.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 92.0 -30.39 6.7 Favored Glycine 0 C--N 1.345 1.069 0 C-N-CA 123.173 0.416 . . . . 71.51 114.003 174.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . . . . . . . . . 27.9 pt -90.36 162.79 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 123.343 0.657 . . . . 61.21 112.135 -176.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -172.09 145.38 1.79 Allowed 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 124.925 1.29 . . . . 62.2 109.04 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.34 -111.3 3.3 Favored Glycine 0 C--N 1.356 1.662 0 N-CA-C 114.74 0.656 . . . . 75.25 114.74 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 7.2 m -65.49 -44.02 88.36 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.833 0.853 . . . . 52.34 110.122 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -69.07 -29.77 67.95 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 113.693 -1.594 . . . . 75.31 110.545 -171.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.468 ' O ' ' HG ' ' B' ' 98' ' ' LEU . 19.9 ptm -81.84 -34.09 30.35 Favored 'General case' 0 C--N 1.349 0.579 0 CA-C-N 116.496 -0.32 . . . . 71.21 111.016 179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.61 -34.75 74.7 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.515 0.726 . . . . 14.44 111.912 -176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 21.3 t-80 -77.83 -34.02 52.09 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.238 0.615 . . . . 74.13 111.05 175.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.0 t -66.92 -65.84 0.63 Allowed 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 122.698 0.399 . . . . 71.35 111.013 -178.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.551 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.4 pp -70.95 -24.1 62.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 122.735 0.414 . . . . 72.21 111.961 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.453 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -84.4 -32.89 21.34 Favored Glycine 0 C--N 1.349 1.301 0 O-C-N 123.661 0.601 . . . . 54.14 113.729 -173.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -126.7 -50.35 1.49 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.007 0.523 . . . . 70.43 111.564 -171.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . 0.42 ' OH ' ' HB2' ' D' ' 130' ' ' PRO . 70.3 t80 -71.22 -40.8 70.9 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 123.361 0.664 . . . . 71.02 111.945 -172.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.593 ' HG ' ' HE1' ' B' ' 11' ' ' PHE . 55.6 m -72.21 -46.99 10.93 Favored Pre-proline 0 CA--C 1.56 1.345 0 CA-C-O 118.803 -0.618 . . . . 74.12 111.121 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 74.1 Cg_exo -57.62 -33.24 96.32 Favored 'Trans proline' 0 C--N 1.396 3.056 0 C-N-CA 122.462 2.108 . . . . 53.41 113.708 168.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.78 -37.57 68.75 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 123.886 0.874 . . . . 54.41 110.919 178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 80.0 mt -71.19 -48.87 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 114.865 -1.062 . . . . 72.22 111.159 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.447 ' HB2' HD12 ' B' ' 60' ' ' LEU . 62.3 mt -77.72 -19.33 55.42 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.538 0.735 . . . . 74.33 112.405 -170.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.26 -45.56 85.12 Favored Pre-proline 0 CA--C 1.56 1.346 0 N-CA-C 114.164 1.172 . . . . 74.32 114.164 -170.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_exo -57.02 -38.94 94.75 Favored 'Trans proline' 0 C--N 1.386 2.532 0 C-N-CA 122.511 2.141 . . . . 55.33 113.351 175.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.529 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 38.1 m-85 -69.14 -40.11 78.45 Favored 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 115.153 -0.93 . . . . 71.24 109.858 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.3 -43.99 93.02 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.523 0.729 . . . . 63.12 110.308 173.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -54.86 -57.59 11.0 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 124.623 1.169 . . . . 64.43 111.373 -179.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.68 -35.43 80.53 Favored 'General case' 0 N--CA 1.481 1.079 0 O-C-N 123.989 0.805 . . . . 74.2 110.244 -175.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.459 ' O ' ' HG2' ' B' ' 117' ' ' MET . 5.1 t -72.37 -32.58 66.56 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 122.868 0.467 . . . . 64.13 111.643 -175.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.554 HG21 HG21 ' B' ' 64' ' ' VAL . 50.9 mt -65.3 -51.81 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.357 -0.979 . . . . 71.23 108.357 171.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . 0.437 HG21 ' OG ' ' C' ' 119' ' ' SER . 24.8 m -61.28 -30.17 70.31 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-N 114.667 -1.152 . . . . 60.41 111.698 -176.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.2 t -64.86 -46.7 80.74 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 123.789 0.836 . . . . 74.21 109.443 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.512 ' HB2' ' SG ' ' B' ' 76' ' ' CYS . 13.3 mmt -72.54 -30.54 64.54 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.217 0.607 . . . . 74.53 110.944 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.497 HG21 HD23 ' B' ' 126' ' ' LEU . 83.3 t -64.46 -41.16 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 123.911 0.884 . . . . 75.02 110.311 172.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 48.0 t -65.65 -35.11 79.85 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.058 0.943 . . . . 72.03 111.452 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.522 ' HD3' ' SG ' ' A' ' 113' ' ' CYS . 77.4 mtt-85 -73.03 -37.21 66.99 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 115.614 -0.721 . . . . 75.1 110.317 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -79.39 1.94 74.14 Favored Glycine 0 C--N 1.351 1.373 0 O-C-N 123.737 0.648 . . . . 71.21 112.59 173.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 67.1 p 63.93 18.32 11.11 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 126.581 1.952 . . . . 73.42 113.544 173.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -77.57 152.79 81.08 Favored Pre-proline 0 CA--C 1.551 1.008 0 C-N-CA 123.47 0.708 . . . . 73.5 109.433 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.444 ' HG2' ' HA ' ' H' ' 297' ' ' TYR . 32.1 Cg_exo -60.54 -178.81 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 123.106 2.538 . . . . 73.43 114.236 -176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.585 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 26.5 tp60 -65.37 113.48 4.11 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 115.753 -0.658 . . . . 63.12 112.445 -170.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.497 HD23 HG21 ' B' ' 118' ' ' VAL . 55.9 tp -114.35 93.78 4.5 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.05 -0.977 . . . . 72.23 108.855 171.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -91.08 128.5 36.93 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 107.591 -1.262 . . . . 74.41 107.591 166.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.43 HD21 HG11 ' B' ' 62' ' ' VAL . 30.2 tp -75.77 145.6 40.64 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 123.377 0.671 . . . . 73.31 110.51 -176.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -76.08 127.49 85.02 Favored Pre-proline 0 CA--C 1.547 0.857 0 C-N-CA 123.817 0.847 . . . . 51.12 111.316 -175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -65.47 122.84 10.62 Favored 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 122.891 2.394 . . . . 54.35 111.594 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.423 HG22 HD11 ' H' ' 291' ' ' LEU . 29.1 t -111.91 116.85 53.68 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 123.409 0.684 . . . . 73.02 109.978 -175.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 38.9 t-20 -86.23 86.47 7.35 Favored 'General case' 0 C--O 1.24 0.601 0 N-CA-C 108.546 -0.909 . . . . 52.34 108.546 176.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -73.31 -32.17 64.45 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.742 -0.663 . . . . 72.12 109.668 178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -58.63 -51.01 71.73 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.55 1.14 . . . . 74.2 111.502 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.74 -39.98 73.02 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.623 0.769 . . . . 70.14 111.364 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -61.34 -47.7 84.7 Favored 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 123.424 0.69 . . . . 73.34 109.514 -179.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -73.79 -24.77 59.87 Favored 'General case' 0 CA--C 1.55 0.961 0 CA-C-N 115.132 -0.94 . . . . 71.1 111.086 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.4 ttt -67.67 -37.98 83.12 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.357 0.663 . . . . 61.44 110.485 176.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -79.49 -26.12 41.69 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 115.906 -0.588 . . . . 71.42 110.739 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 50.3 t80 -63.88 -39.1 93.4 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.918 0.887 . . . . 72.2 110.108 175.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 75.6 mt -90.11 -6.4 55.46 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 115.479 -0.782 . . . . 61.43 112.124 -178.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 68.0 135.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 124.802 1.241 . . . . 64.31 111.629 -175.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -76.6 85.56 3.27 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.184 0.516 . . . . 50.41 111.166 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -167.36 115.05 0.78 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.269 1.028 . . . . 64.11 108.265 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.41 97.55 1.35 Allowed 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.185 -0.672 . . . . 64.41 109.185 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -83.56 66.03 4.0 Favored Glycine 0 C--N 1.345 1.055 0 N-CA-C 111.717 -0.553 . . . . 71.14 111.717 176.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -71.25 139.0 49.88 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.215 1.006 . . . . 75.54 110.757 -177.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -173.85 86.27 0.08 OUTLIER Glycine 0 C--N 1.342 0.882 0 N-CA-C 110.325 -1.11 . . . . 73.15 110.325 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 24.0 p -74.51 84.15 2.01 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 123.659 0.784 . . . . 75.23 111.347 -176.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.26 147.3 32.6 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.551 -0.749 . . . . 73.22 109.265 174.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -156.45 132.38 9.72 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.914 0.388 . . . . 71.31 111.522 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -128.9 105.61 8.34 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.498 1.119 . . . . 75.14 108.795 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -74.31 91.28 2.17 Favored 'General case' 0 CA--C 1.547 0.848 0 N-CA-C 109.088 -0.708 . . . . 62.43 109.088 175.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -100.54 139.92 35.53 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.373 1.069 . . . . 73.42 110.318 -176.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.916 0 C-N-CA 123.64 0.776 . . . . 73.2 109.234 177.582 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 109.373 -0.603 . . . . 75.02 109.373 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 17.6 m -76.24 76.41 3.04 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.395 0.678 . . . . 63.11 109.618 175.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -66.25 -44.88 82.44 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.395 0.617 . . . . 71.52 110.499 -176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -153.19 130.5 11.28 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 114.854 -1.066 . . . . 63.41 109.469 175.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.494 ' HA ' ' OG1' ' C' ' 149' ' ' THR . 19.2 m120 -132.31 127.5 35.71 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 107.66 -1.237 . . . . 54.51 107.66 170.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 42.6 t-20 -153.55 118.71 5.12 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 109.132 -0.692 . . . . 73.53 109.132 -168.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 51.1 m -103.24 101.47 11.41 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.291 1.036 . . . . 72.34 110.337 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.05 117.88 30.93 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.154 -1.054 . . . . 65.13 108.154 167.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 73.5 mtp 64.71 117.33 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 125.364 1.466 . . . . 53.01 112.365 -176.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.497 ' HA ' ' SG ' ' G' ' 308' ' ' CYS . 89.3 m -86.26 99.5 11.61 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.677 -0.86 . . . . 54.03 108.677 169.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -124.33 126.76 46.55 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 107.789 -1.189 . . . . 71.03 107.789 176.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.424 ' HB2' ' O ' ' G' ' 306' ' ' VAL . 13.0 pt20 -151.85 144.09 23.99 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 122.918 0.487 . . . . 71.02 110.257 178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.467 HG13 ' HE2' ' C' ' 84' ' ' PHE . 3.1 mp -82.63 115.73 25.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 108.219 -1.03 . . . . 62.44 108.219 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -80.93 -44.08 18.79 Favored 'General case' 0 C--O 1.242 0.702 0 N-CA-C 109.951 -0.388 . . . . 72.31 109.951 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 17.1 ttt180 -169.11 141.78 2.67 Favored 'General case' 0 N--CA 1.477 0.924 0 O-C-N 123.304 0.378 . . . . 75.11 110.098 -176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 86.2 mt -125.45 135.52 63.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 108.053 -1.091 . . . . 70.2 108.053 173.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.595 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 32.6 p90 -173.77 155.9 2.74 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.914 0.387 . . . . 71.41 111.129 -174.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -77.36 115.59 17.26 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 115.392 -0.822 . . . . 51.15 109.871 178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 16.4 mmtp -65.1 -41.02 95.34 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 108.995 -0.743 . . . . 74.22 108.995 171.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.57 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 12.0 t70 -149.34 150.11 31.96 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.316 -1.311 . . . . 74.14 110.353 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.484 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 90.9 mt -142.14 145.28 24.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.462 0 C-N-CA 126.501 1.92 . . . . 65.34 106.507 176.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 29.0 t -161.87 150.87 15.68 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 122.822 0.449 . . . . 64.25 110.053 176.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -154.86 106.67 2.68 Favored 'General case' 0 C--O 1.222 -0.367 0 N-CA-C 107.436 -1.32 . . . . 62.33 107.436 174.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -118.39 120.22 36.94 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.747 0.819 . . . . 70.33 109.41 -176.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.95 83.34 61.42 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 124.343 1.057 . . . . 70.31 108.496 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.92 -39.21 34.01 Favored 'Trans proline' 0 C--N 1.382 2.33 0 C-N-CA 122.628 2.219 . . . . 73.13 112.081 -178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 45.6 m-20 -97.13 20.9 10.61 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.957 0.903 . . . . 64.11 110.952 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -50.9 -50.15 76.08 Favored Pre-proline 0 CA--C 1.575 1.907 0 N-CA-C 114.419 1.266 . . . . 70.25 114.419 -171.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.75 -26.35 8.32 Favored 'Trans proline' 0 C--N 1.389 2.692 0 CA-C-N 121.235 1.477 . . . . 73.32 112.655 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -71.66 -30.37 65.65 Favored 'General case' 0 CA--C 1.559 1.29 0 C-N-CA 124.336 1.054 . . . . 63.2 112.511 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.617 HG21 ' HA ' ' C' ' 73' ' ' ALA . 99.4 t -80.02 -20.17 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.32 0.648 . . . . 64.21 110.639 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -60.47 -28.97 68.75 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.072 0.549 . . . . 74.24 111.348 176.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -100.42 26.26 6.82 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.558 0.743 . . . . 74.34 110.97 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.25 152.36 37.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.605 0.762 . . . . 74.23 111.084 -174.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -67.62 130.71 43.86 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 123.816 0.847 . . . . 71.5 110.449 176.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.504 ' HE1' ' ND2' ' F' ' 300' ' ' ASN . 18.0 m95 -76.34 98.14 4.43 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.838 0.855 . . . . 73.3 110.889 -172.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -156.59 75.82 4.49 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 108.397 -0.964 . . . . 74.41 108.397 173.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -86.63 130.09 3.17 Favored 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.391 2.06 . . . . 73.11 112.126 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -85.53 80.25 9.13 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 106.582 -1.636 . . . . 74.42 106.582 171.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.442 HG11 HD21 ' C' ' 126' ' ' LEU . 90.2 t -74.45 118.26 19.84 Favored 'Isoleucine or valine' 0 C--N 1.347 0.461 0 CA-C-N 114.226 -1.352 . . . . 75.45 108.617 -179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 34.0 mtmt -128.71 141.34 51.36 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.276 -1.379 . . . . 72.4 107.276 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 pp -88.16 166.39 14.42 Favored 'General case' 0 C--O 1.242 0.707 0 N-CA-C 108.554 -0.906 . . . . 61.33 108.554 167.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 17.1 t70 -140.0 127.91 22.06 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 107.611 -1.255 . . . . 54.44 107.611 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 54.2 tp -104.85 140.62 37.86 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 123.691 0.796 . . . . 63.14 109.991 -176.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.504 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 29.3 t70 -144.84 149.93 36.23 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.17 0.988 . . . . 73.4 108.676 172.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 66.3 p -126.77 141.09 51.93 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.878 0.871 . . . . 62.05 109.928 -172.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.44 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -150.25 139.98 21.73 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 123.055 0.542 . . . . 63.32 110.104 177.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.0 p -148.01 156.07 42.23 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.533 0.733 . . . . 64.51 109.529 176.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 79.8 p -152.68 165.55 34.93 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.282 0.633 . . . . 74.01 109.937 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -105.16 118.08 35.64 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.824 -0.806 . . . . 63.41 108.824 170.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.576 HD11 HD12 ' C' ' 83' ' ' ILE . 76.4 mt -89.04 -35.61 16.26 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.181 0.592 . . . . 73.2 110.366 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.1 -171.3 2.17 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.036 0.934 . . . . 44.21 110.219 179.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -68.43 116.41 8.96 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.278 -0.874 . . . . 75.22 109.423 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.1 m-20 69.57 -0.46 2.61 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.371 1.468 . . . . 75.43 112.601 -178.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 90.6 t -105.32 112.29 38.24 Favored 'Isoleucine or valine' 0 C--O 1.243 0.733 0 N-CA-C 108.146 -1.057 . . . . 63.02 108.146 176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.452 ' HB2' HD11 ' C' ' 86' ' ' ILE . 94.0 m-85 -129.56 144.13 51.13 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.889 0.876 . . . . 72.24 108.856 -177.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -99.73 136.42 39.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.529 1.132 . . . . 74.52 110.021 -178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . 0.431 HG22 HD22 ' C' ' 98' ' ' LEU . 40.8 t -114.95 120.04 63.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 N-CA-C 107.816 -1.179 . . . . 74.42 107.816 173.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.44 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 88.7 t -118.59 129.92 74.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 108.764 -0.828 . . . . 71.02 108.764 170.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -125.01 107.0 10.38 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 106.948 -1.501 . . . . 73.43 106.948 176.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.504 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 25.5 ttm180 -84.06 127.02 33.62 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 115.906 -0.588 . . . . 71.3 109.774 179.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 19.4 t -116.15 121.28 67.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-N 114.52 -1.218 . . . . 73.2 107.881 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.555 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 68.5 m -120.59 142.54 49.29 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.566 -0.902 . . . . 72.15 108.566 -178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.468 HG23 HD13 ' C' ' 114' ' ' ILE . 72.8 t -122.39 115.31 45.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 123.889 0.876 . . . . 74.31 109.421 175.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 28.2 m -99.31 135.79 40.21 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 108.879 -0.786 . . . . 43.35 108.879 169.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.29 107.29 7.11 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.082 -1.451 . . . . 60.52 107.082 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' C' ' 72' ' ' THR . 49.3 m -143.44 128.36 18.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.286 0.634 . . . . 73.3 109.468 -178.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.424 ' CD1' ' HB2' ' C' ' 73' ' ' ALA . 5.3 mp -85.8 56.71 4.09 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.469 1.507 . . . . 74.41 109.313 -178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.0 -82.33 0.44 Allowed Glycine 0 C--N 1.344 0.976 0 N-CA-C 109.893 -1.283 . . . . 71.54 109.893 -176.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -121.12 -30.6 4.31 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.604 1.161 . . . . 71.02 109.104 171.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -64.19 91.79 0.08 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.191 1.397 . . . . 62.11 110.796 179.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' C' ' 67' ' ' SER . 38.6 m -71.98 121.36 19.0 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 120.749 0.309 . . . . 63.05 111.389 -173.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.617 ' HA ' HG21 ' C' ' 31' ' ' VAL . . . -68.72 -62.67 1.29 Allowed 'General case' 0 C--O 1.24 0.557 0 O-C-N 124.722 1.263 . . . . 60.13 109.646 175.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -163.48 175.66 10.52 Favored 'General case' 0 C--O 1.241 0.623 0 CA-C-N 114.442 -1.254 . . . . 73.11 109.794 -178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.431 HD13 ' N ' ' C' ' 76' ' ' CYS . 2.9 tm? -140.41 145.71 37.4 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 106.251 -1.759 . . . . 73.11 106.251 175.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.431 ' N ' HD13 ' C' ' 75' ' ' LEU . 45.0 t -144.92 149.61 35.56 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.325 -0.991 . . . . 64.11 108.325 178.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -157.88 121.03 3.93 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 109.61 -0.515 . . . . 62.42 109.61 176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 73.3 t -119.64 114.41 44.22 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 N-CA-C 108.869 -0.789 . . . . 73.42 108.869 170.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.57 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.1 mt-30 -90.1 96.79 10.84 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.628 -1.249 . . . . 74.51 107.628 172.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.564 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.1 tp-100 -82.75 129.22 34.94 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 122.941 0.496 . . . . 53.44 109.678 -178.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -115.16 154.84 16.72 Favored Glycine 0 N--CA 1.461 0.328 0 O-C-N 123.51 0.506 . . . . 61.43 112.051 176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.462 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -154.47 122.25 1.22 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.147 -0.781 . . . . 73.43 111.147 -178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.576 HD12 HD11 ' C' ' 51' ' ' LEU . 12.0 mm -89.25 127.08 42.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 108.468 -0.938 . . . . 71.32 108.468 177.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.467 ' HE2' HG13 ' C' ' 13' ' ' ILE . 83.8 m-85 -136.59 131.68 34.08 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.32 0.648 . . . . 71.43 109.871 -177.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 44.4 m -81.05 104.09 11.31 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 108.405 -0.961 . . . . 71.44 108.405 169.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.586 HD12 ' SD ' ' C' ' 94' ' ' MET . 10.5 pt -119.45 120.55 63.94 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 123.705 0.802 . . . . 65.44 109.867 -178.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.35 168.05 25.23 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.715 0.806 . . . . 75.53 110.72 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 89.28 -61.17 3.65 Favored Glycine 0 C--N 1.344 1.027 0 CA-C-N 115.048 -0.978 . . . . 71.55 111.411 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 2.3 pp -81.17 142.52 13.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-O 120.789 0.328 . . . . 74.44 110.331 172.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.453 ' HA ' ' HB2' ' C' ' 94' ' ' MET . 12.2 pt-20 -147.91 179.03 8.02 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.797 0.839 . . . . 63.23 109.397 177.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 60.45 -122.43 29.81 Favored Glycine 0 CA--C 1.532 1.108 0 O-C-N 123.687 0.617 . . . . 71.03 113.652 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 11.7 p -78.79 -22.99 45.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.93 0.892 . . . . 73.31 111.595 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -72.86 -31.7 64.93 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.882 0.473 . . . . 74.41 109.913 173.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.586 ' SD ' HD12 ' C' ' 86' ' ' ILE . 51.6 tpp -66.66 -40.52 88.68 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 115.659 -0.7 . . . . 71.34 110.114 170.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -57.08 -36.11 70.2 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.934 0.894 . . . . 73.34 112.767 -176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.538 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 43.7 t-80 -69.27 -39.06 78.61 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 122.737 0.415 . . . . 65.43 111.426 177.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 51.4 t -76.16 -41.47 49.71 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-O 121.168 0.509 . . . . 73.3 110.732 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.431 HD22 HG22 ' C' ' 58' ' ' VAL . 3.4 tm? -82.62 -53.38 5.99 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.995 1.318 . . . . 71.05 110.75 -168.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -92.7 -0.19 69.58 Favored Glycine 0 C--N 1.342 0.863 0 CA-C-N 115.708 -0.678 . . . . 63.4 114.176 -171.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -128.97 -66.81 0.81 Allowed 'General case' 0 C--N 1.35 0.598 0 CA-C-N 117.211 0.506 . . . . 45.2 111.503 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -68.15 -49.01 63.74 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 112.678 0.622 . . . . 73.4 112.678 -169.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 73.4 m -63.12 -42.67 77.87 Favored Pre-proline 0 CA--C 1.57 1.726 0 CA-C-O 118.237 -0.887 . . . . 70.34 112.477 -177.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.57 -41.36 44.99 Favored 'Trans proline' 0 C--N 1.397 3.119 0 C-N-CA 123.129 2.553 . . . . 61.11 113.691 166.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' C' ' 134' ' ' ASP . 89.0 m-20 -67.62 -31.22 71.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.766 0.827 . . . . 75.41 111.467 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 39.6 mm -70.39 -44.23 77.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.16 0.584 . . . . 75.14 109.735 175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.462 HD21 ' HA3' ' C' ' 82' ' ' GLY . 94.4 mt -79.24 -21.56 46.01 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.452 -0.794 . . . . 73.54 111.773 -173.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -55.42 -54.88 46.1 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.788 1.235 . . . . 74.44 113.199 -173.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -62.67 -30.26 78.46 Favored 'Trans proline' 0 C--N 1.392 2.867 0 C-N-CA 122.024 1.816 . . . . 74.04 112.662 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -68.26 -48.75 64.23 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.574 0.75 . . . . 73.33 110.809 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.564 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -63.75 -37.22 86.55 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.426 0.69 . . . . 75.44 110.802 177.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -42.01 72.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.534 1.134 . . . . 74.22 110.568 -174.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -70.66 -36.45 73.36 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.616 0.766 . . . . 53.31 109.581 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 37.8 t -67.04 -35.18 79.3 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.69 0.796 . . . . 74.3 111.256 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.468 HD13 HG23 ' C' ' 64' ' ' VAL . 51.7 mt -68.61 -49.0 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 123.135 0.574 . . . . 62.01 110.083 173.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 30.4 m -61.01 -33.25 72.96 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 123.55 0.74 . . . . 74.41 111.249 -175.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 36.9 t -61.26 -51.81 67.36 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.917 0.887 . . . . 71.53 109.359 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.521 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -56.68 -42.02 78.33 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.716 1.207 . . . . 64.13 112.622 179.285 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' C' ' 126' ' ' LEU . 61.2 t -65.62 -41.7 91.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 123.156 0.582 . . . . 60.44 110.595 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.437 ' OG ' HG21 ' B' ' 115' ' ' THR . 32.1 t -68.16 -33.79 75.11 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.623 0.769 . . . . 73.24 111.218 177.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.3 mtt-85 -64.92 -38.68 91.78 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.417 0.687 . . . . 73.34 110.282 178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.37 7.86 55.58 Favored Glycine 0 C--N 1.353 1.478 0 O-C-N 123.8 0.688 . . . . 72.2 113.059 174.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 41.2 p 60.6 34.15 20.25 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 126.016 1.726 . . . . 62.12 112.195 174.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -108.41 152.82 42.2 Favored Pre-proline 0 CA--C 1.554 1.11 0 C-N-CA 124.808 1.243 . . . . 73.41 109.094 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.631 ' HD3' HG22 ' F' ' 301' ' ' ILE . 34.0 Cg_exo -60.99 158.82 32.23 Favored 'Trans proline' 0 C--N 1.386 2.523 0 C-N-CA 123.684 2.923 . . . . 55.11 114.776 -173.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -51.9 111.0 0.53 Allowed 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.916 1.286 . . . . 63.22 112.477 -175.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.497 HD23 HG23 ' F' ' 296' ' ' THR . 2.8 tm? -112.2 99.16 7.82 Favored 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.594 -1.261 . . . . 74.5 107.594 172.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -122.51 127.61 49.76 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.168 0.987 . . . . 71.41 108.709 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.413 HD23 ' N ' ' C' ' 129' ' ' ALA . 2.2 tt -71.74 143.03 49.75 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.763 0.825 . . . . 74.01 109.677 -174.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.545 ' HB3' HD22 ' F' ' 291' ' ' LEU . . . -72.2 146.9 90.16 Favored Pre-proline 0 CA--C 1.559 1.314 0 C-N-CA 124.278 1.031 . . . . 64.54 111.855 -177.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.0 124.61 16.35 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 123.24 2.627 . . . . 64.21 112.045 175.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.664 ' HB ' HD21 ' F' ' 291' ' ' LEU . 5.8 p -133.64 126.86 52.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 123.631 0.773 . . . . 75.22 109.746 178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -91.98 90.83 7.58 Favored 'General case' 0 C--O 1.243 0.718 0 C-N-CA 123.452 0.701 . . . . 43.24 110.535 -176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -65.42 -30.41 71.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 109.536 -0.542 . . . . 71.2 109.536 169.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.676 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 12.9 t70 -66.28 -47.11 74.74 Favored 'General case' 0 C--N 1.351 0.668 0 CA-C-N 114.755 -1.111 . . . . 71.52 111.28 -177.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -63.9 -35.21 79.91 Favored 'General case' 0 N--CA 1.475 0.818 0 O-C-N 124.099 0.875 . . . . 31.52 111.428 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.62 -51.54 69.46 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.029 0.932 . . . . 71.14 109.621 174.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 24.6 m-85 -73.45 -15.1 61.35 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 123.723 0.809 . . . . 75.55 112.336 177.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 90.3 mmm -81.86 -29.42 32.49 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 123.475 0.71 . . . . 72.44 112.552 172.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -53.22 -35.63 60.14 Favored 'General case' 0 N--CA 1.494 1.738 0 C-N-CA 124.211 1.004 . . . . 73.14 113.351 -174.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -47.62 -88.7 0.0 OUTLIER 'General case' 0 CA--C 1.587 2.392 0 C-N-CA 125.2 1.4 . . . . 70.13 113.507 -170.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -134.95 88.79 2.46 Favored 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 125.792 1.637 . . . . 70.12 106.648 173.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -81.38 89.04 6.08 Favored 'General case' 0 CA--C 1.553 1.059 0 CA-C-O 121.544 0.688 . . . . 71.4 109.379 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -130.03 22.88 5.3 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 124.251 1.02 . . . . 72.1 111.256 -173.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -132.26 115.4 15.61 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.915 0.486 . . . . 64.21 110.435 -178.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -130.48 102.54 6.2 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.429 1.091 . . . . 63.15 108.272 173.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -104.4 -173.44 25.03 Favored Glycine 0 C--N 1.346 1.139 0 CA-C-O 121.457 0.476 . . . . 54.21 114.287 -173.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -107.66 133.25 52.35 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.273 1.029 . . . . 75.22 109.509 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -145.34 99.55 0.21 Allowed Glycine 0 C--N 1.342 0.915 0 N-CA-C 109.998 -1.241 . . . . 72.34 109.998 179.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.494 ' OG1' ' HA ' ' C' ' 5' ' ' ASN . 39.1 p -104.77 -173.51 2.32 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.593 0.757 . . . . 62.02 110.975 -175.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -159.12 168.52 26.4 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 123.511 0.724 . . . . 72.13 110.823 175.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -167.8 -76.45 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 O-C-N 123.912 0.758 . . . . 73.34 109.631 170.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -174.0 32.2 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.415 0.686 . . . . 72.11 110.478 179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.419 HE22 ' ND2' ' C' ' 5' ' ' ASN . 20.6 mp0 -73.43 125.67 28.42 Favored 'General case' 0 N--CA 1.48 1.054 0 O-C-N 122.074 -0.391 . . . . 73.14 110.338 -175.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . 0.629 ' HA ' ' HD3' ' E' ' 293' ' ' PRO . 6.6 m-20 -83.68 95.23 8.32 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.099 -0.955 . . . . 75.25 110.0 -175.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . 0.479 ' HB3' HG23 ' G' ' 307' ' ' THR . . . . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.527 -0.749 . . . . 52.02 109.903 174.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 84.8 mtp . . . . . 0 N--CA 1.477 0.892 0 N-CA-C 109.513 -0.551 . . . . 70.35 109.513 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 33.9 m -80.57 75.78 7.44 Favored 'General case' 0 C--O 1.24 0.575 0 C-N-CA 123.669 0.788 . . . . 73.45 109.435 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.49 115.4 18.18 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 114.643 -1.162 . . . . 55.44 108.296 177.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 15.8 tm0? -126.46 99.3 5.77 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 107.951 -1.129 . . . . 73.32 107.951 -169.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -85.18 -21.14 29.29 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.012 0.525 . . . . 75.4 111.23 -174.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -79.62 77.56 6.22 Favored 'General case' 0 CA--C 1.553 1.06 0 CA-C-O 121.747 0.784 . . . . 74.33 110.413 -177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 22.4 m -138.82 113.99 9.47 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 107.787 -1.19 . . . . 44.5 107.787 177.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -61.36 116.56 4.74 Favored 'General case' 0 C--O 1.244 0.803 0 C-N-CA 123.977 0.911 . . . . 71.55 111.165 -176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -32.76 127.61 0.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.694 1.197 . . . . 74.14 113.093 168.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.463 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 23.5 m -144.48 140.59 29.01 Favored 'General case' 0 C--O 1.24 0.559 0 C-N-CA 123.054 0.541 . . . . 64.25 110.17 173.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' D' ' 85' ' ' SER . 30.1 t80 -158.57 114.02 2.62 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.213 1.005 . . . . 71.15 108.474 172.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -135.07 131.14 36.62 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.905 -0.776 . . . . 73.53 108.905 175.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 59.3 mt -74.48 132.95 32.54 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 N-CA-C 109.238 -0.652 . . . . 72.21 109.238 175.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.405 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 40.9 mt-30 -95.48 -35.04 11.85 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 122.562 0.345 . . . . 54.34 110.446 174.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 15.6 ptp180 178.79 160.92 0.66 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.187 0.995 . . . . 75.11 110.766 176.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.24 118.61 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 N-CA-C 106.542 -1.651 . . . . 54.22 106.542 166.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.438 ' HE1' HG13 ' D' ' 83' ' ' ILE . 9.9 p90 -140.7 141.88 34.91 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 123.298 0.639 . . . . 54.04 110.503 -173.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 41.1 p -76.85 119.68 20.94 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.658 -0.497 . . . . 72.33 109.658 177.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -93.84 -21.82 19.03 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.094 0.558 . . . . 62.11 109.928 176.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.72 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 3.4 t70 -153.91 137.06 15.6 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.378 1.071 . . . . 72.44 109.343 177.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.521 HD13 ' HE3' ' C' ' 117' ' ' MET . 30.1 mt -139.36 146.76 25.15 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 C-N-CA 124.857 1.263 . . . . 74.54 107.682 174.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 41.4 t -154.13 137.9 16.16 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.328 0.651 . . . . 73.12 109.849 168.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.484 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 78.9 t80 -133.93 121.49 21.75 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 105.798 -1.927 . . . . 71.52 105.798 165.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -122.4 131.24 53.78 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.188 -0.671 . . . . 73.05 109.188 176.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -114.8 83.52 9.32 Favored Pre-proline 0 C--O 1.241 0.649 0 N-CA-C 106.34 -1.726 . . . . 72.53 106.34 169.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -61.5 -37.54 69.93 Favored 'Trans proline' 0 C--N 1.379 2.138 0 C-N-CA 122.732 2.288 . . . . 51.25 112.614 -167.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.445 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 0.5 OUTLIER -117.82 25.48 10.35 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 123.893 0.877 . . . . 74.21 109.247 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.595 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -23.42 -68.58 0.05 OUTLIER Pre-proline 0 CA--C 1.581 2.164 0 N-CA-C 117.413 2.375 . . . . 73.42 117.413 -167.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.74 -24.84 15.26 Favored 'Trans proline' 0 C--N 1.395 2.979 0 CA-C-N 122.777 2.028 . . . . 54.33 112.976 -174.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 16.9 t-160 -66.25 -35.11 79.57 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.894 1.277 . . . . 64.51 109.725 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' D' ' 73' ' ' ALA . 94.1 t -70.98 -39.9 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.853 0 CA-C-N 115.707 -0.679 . . . . 73.24 111.604 -176.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -65.71 -15.0 62.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 113.706 1.002 . . . . 64.35 113.706 -174.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.73 -33.08 74.84 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.131 0.572 . . . . 74.41 110.581 176.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.459 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 44.9 mtpt -87.42 111.18 20.87 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.933 0.893 . . . . 65.21 108.594 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.561 ' HB2' ' H ' ' G' ' 301' ' ' ILE . 11.9 p-10 -99.7 99.32 10.13 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 124.256 1.023 . . . . 73.21 111.374 -173.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.595 ' CD2' HD22 ' D' ' 68' ' ' LEU . 0.0 OUTLIER -156.7 -176.65 6.09 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 113.758 1.021 . . . . 74.35 113.758 -170.004 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.448 ' HA ' ' HB2' ' G' ' 297' ' ' TYR . 51.5 tt0 -97.43 102.94 14.07 Favored Pre-proline 0 N--CA 1.499 2.011 0 C-N-CA 124.761 1.224 . . . . 75.31 112.975 175.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.536 ' HA ' HD21 ' D' ' 68' ' ' LEU . 75.2 Cg_exo -53.2 131.84 45.06 Favored 'Trans proline' 0 C--N 1.391 2.797 0 C-N-CA 124.059 3.173 . . . . 73.24 115.32 176.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.689 ' HG2' ' HG2' ' G' ' 294' ' ' LYS . 36.7 mt-10 -98.15 115.44 28.29 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-N 114.048 -1.433 . . . . 62.54 107.177 170.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.572 HG12 ' HB2' ' D' ' 66' ' ' ALA . 31.9 m -98.64 143.77 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.605 0.762 . . . . 73.41 110.073 -176.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.49 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 83.1 tttt -107.22 130.54 54.72 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.168 0.987 . . . . 73.54 109.243 177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -96.61 128.77 43.87 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 107.316 -1.364 . . . . 71.44 107.316 175.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' D' ' 63' ' ' THR . 29.4 t70 -132.59 126.6 33.15 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 107.571 -1.27 . . . . 61.15 107.571 172.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 63.9 tp -107.36 139.91 41.11 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.558 0.743 . . . . 64.03 110.764 -172.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 27.4 t70 -138.88 139.63 38.15 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.588 0.755 . . . . 63.43 109.003 172.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . 0.48 ' HB ' ' HD1' ' G' ' 281' ' ' PHE . 46.6 p -108.11 144.07 35.98 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 123.691 0.796 . . . . 74.13 110.76 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.641 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -152.8 161.99 41.85 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.688 0.795 . . . . 61.43 109.653 176.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 57.6 p -170.9 156.41 4.97 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.113 0.965 . . . . 62.12 109.499 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 64.7 p -149.53 120.35 7.6 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.532 0.733 . . . . 44.55 109.154 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -69.99 118.35 12.72 Favored 'General case' 0 C--O 1.239 0.52 0 N-CA-C 109.389 -0.597 . . . . 75.23 109.389 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 46.5 mt -90.31 -30.02 17.74 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.941 -0.572 . . . . 75.31 110.211 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -165.13 -179.89 5.93 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 115.6 -0.727 . . . . 53.42 110.601 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -72.35 130.44 40.74 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.926 -1.033 . . . . 63.45 108.538 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 69.21 2.24 3.57 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 125.395 1.478 . . . . 74.03 112.23 -174.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 63.2 t -123.26 117.65 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 109.284 -0.636 . . . . 74.22 109.284 179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.672 ' HB2' HD13 ' D' ' 86' ' ' ILE . 97.6 m-85 -128.37 130.13 47.26 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 108.036 -1.098 . . . . 74.11 108.036 176.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 12.0 tm-20 -90.91 135.85 33.46 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 106.68 -1.6 . . . . 41.44 106.68 173.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 93.4 t -123.95 131.67 72.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 C-N-CA 124.042 0.937 . . . . 75.44 108.637 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 17.5 t -115.16 135.85 53.77 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 N-CA-C 109.068 -0.716 . . . . 71.41 109.068 176.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -124.21 114.84 20.16 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.873 -1.158 . . . . 72.21 107.873 177.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.505 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 8.8 ttm180 -96.57 114.9 26.59 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.136 0.574 . . . . 73.31 110.01 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 98.7 t -103.49 122.26 55.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.638 -0.875 . . . . 73.44 108.638 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' D' ' 43' ' ' ASP . 26.8 m -115.32 128.65 56.24 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 123.276 0.631 . . . . 65.22 109.434 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 76' ' ' CYS . 78.4 t -115.8 117.64 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 C-N-CA 125.069 1.348 . . . . 73.21 109.342 -178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 31.5 m -119.03 95.21 4.72 Favored 'General case' 0 CA--C 1.542 0.655 0 N-CA-C 108.741 -0.837 . . . . 74.4 108.741 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.572 ' HB2' HG12 ' D' ' 40' ' ' VAL . . . -98.05 135.0 40.37 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 108.998 -0.741 . . . . 75.45 108.998 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 39.9 p -163.82 135.73 4.88 Favored 'General case' 0 N--CA 1.469 0.495 0 O-C-N 123.869 0.731 . . . . 64.1 109.704 -173.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.595 HD22 ' CD2' ' D' ' 36' ' ' TRP . 4.7 mp -134.74 136.44 42.65 Favored 'General case' 0 C--O 1.247 0.922 0 C-N-CA 123.54 0.736 . . . . 72.03 110.701 -177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.66 -111.6 3.35 Favored Glycine 0 C--N 1.335 0.476 0 N-CA-C 111.238 -0.745 . . . . 42.31 111.238 175.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.15 4.55 11.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.231 1.012 . . . . 75.5 109.588 178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -139.82 144.11 37.17 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.04 0.536 . . . . 71.24 111.409 -163.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 81.1 m -67.53 140.54 57.0 Favored 'General case' 0 C--N 1.348 0.523 0 C-N-CA 124.298 1.039 . . . . 63.14 110.633 176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.478 ' HA ' HG11 ' D' ' 31' ' ' VAL . . . -84.96 -69.48 0.65 Allowed 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 108.748 -0.834 . . . . 72.35 108.748 173.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -154.91 148.45 25.27 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 114.623 -1.171 . . . . 73.51 109.074 178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 67.2 mt -108.24 152.94 23.92 Favored 'General case' 0 C--N 1.32 -0.703 0 C-N-CA 124.853 1.261 . . . . 55.13 108.979 172.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.59 ' SG ' HG12 ' D' ' 114' ' ' ILE . 51.3 t -158.87 144.02 16.14 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 123.659 0.784 . . . . 52.33 109.002 178.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -155.68 121.37 4.98 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 108.857 -0.794 . . . . 44.22 108.857 173.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . 0.462 HG22 HG23 ' D' ' 21' ' ' ILE . 51.1 t -125.94 119.71 55.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 122.819 0.448 . . . . 74.3 110.054 178.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.72 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 16.0 mt-30 -89.5 91.79 8.85 Favored 'General case' 0 C--O 1.245 0.821 0 N-CA-C 109.02 -0.733 . . . . 75.21 109.02 166.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 tp-100 -81.1 101.64 9.74 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-N 114.889 -1.051 . . . . 63.41 108.391 176.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.2 171.39 44.16 Favored Glycine 0 C--O 1.244 0.73 0 N-CA-C 111.442 -0.663 . . . . 41.03 111.442 175.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -175.56 131.59 1.96 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 111.433 -0.667 . . . . 71.11 111.433 176.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.438 HG13 ' HE1' ' D' ' 17' ' ' TYR . 32.7 mt -89.43 134.19 29.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 N-CA-C 109.151 -0.685 . . . . 74.41 109.151 -177.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.492 ' HB2' HD11 ' D' ' 86' ' ' ILE . 32.8 m-85 -133.63 162.29 32.33 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 123.3 0.64 . . . . 74.32 109.687 174.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.487 ' O ' ' HA ' ' D' ' 11' ' ' PHE . 36.2 m -109.61 103.23 12.06 Favored 'General case' 0 CA--C 1.546 0.791 0 N-CA-C 108.409 -0.96 . . . . 54.53 108.409 171.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.672 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.1 mp -107.15 117.57 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 123.999 0.92 . . . . 65.15 108.837 -176.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.463 ' HB3' ' HB ' ' D' ' 10' ' ' THR . . . -149.8 164.55 35.01 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.738 0.815 . . . . 72.25 110.336 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 75.51 -0.98 59.11 Favored Glycine 0 C--N 1.347 1.163 0 N-CA-C 116.103 1.201 . . . . 42.14 116.103 168.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 25.9 pt -125.67 133.47 69.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.58 0.752 . . . . 73.11 109.737 -177.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -133.61 154.23 51.05 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.866 0.866 . . . . 74.41 110.299 -173.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.02 -110.59 2.75 Favored Glycine 0 C--N 1.346 1.102 0 O-C-N 124.23 0.956 . . . . 50.22 114.489 173.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 57.8 m -65.82 -41.04 92.32 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.359 1.064 . . . . 63.04 112.298 -173.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -72.78 -36.73 67.7 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.781 0.432 . . . . 65.4 111.106 -174.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.807 ' SD ' ' HB2' ' G' ' 277' ' ' LEU . 20.4 ptt? -79.92 -23.93 41.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-O 120.531 0.205 . . . . 53.52 110.602 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.2 -32.38 68.78 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 109.79 -0.448 . . . . 63.33 109.79 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -74.04 -45.45 49.52 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.546 0.738 . . . . 74.32 110.6 173.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 52.3 t -66.58 -51.6 54.67 Favored 'General case' 0 C--O 1.216 -0.665 0 C-N-CA 122.743 0.417 . . . . 63.14 110.285 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.667 ' HG ' HD13 ' G' ' 278' ' ' LEU . 3.8 mm? -78.98 -19.11 52.44 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 122.959 0.503 . . . . 63.45 110.87 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.11 -1.98 64.59 Favored Glycine 0 C--N 1.354 1.539 0 CA-C-O 119.775 -0.459 . . . . 74.22 114.154 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.82 -61.31 0.23 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 117.345 0.573 . . . . 73.51 111.135 -178.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -68.41 -50.59 51.76 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 124.195 0.998 . . . . 74.24 113.278 -166.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . 0.447 ' SG ' HD13 ' D' ' 98' ' ' LEU . 22.1 m -68.1 -45.78 40.69 Favored Pre-proline 0 CA--C 1.558 1.278 0 C-N-CA 123.797 0.839 . . . . 63.11 112.202 -175.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.02 -24.28 45.51 Favored 'Trans proline' 0 C--N 1.394 2.968 0 C-N-CA 121.54 1.494 . . . . 73.23 112.847 172.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 48.3 t-20 -66.36 -32.62 74.12 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 123.457 0.703 . . . . 64.3 110.285 177.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 50.5 mm -65.16 -46.42 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 123.185 0.594 . . . . 54.04 110.193 176.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 78.4 mt -75.9 -32.72 59.78 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.271 -0.877 . . . . 72.45 111.987 -172.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.629 ' HZ ' HD12 ' D' ' 128' ' ' LEU . 75.7 t80 -59.76 -46.01 98.43 Favored Pre-proline 0 CA--C 1.567 1.628 0 N-CA-C 114.81 1.411 . . . . 65.31 114.81 -167.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.18 -33.11 91.15 Favored 'Trans proline' 0 C--N 1.389 2.687 0 C-N-CA 121.919 1.746 . . . . 72.41 112.618 177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -75.67 -34.91 60.5 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.645 0.778 . . . . 73.12 110.993 178.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.3 -46.9 84.61 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.479 0.711 . . . . 61.51 110.06 175.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 38.3 ttp180 -60.66 -46.64 89.57 Favored 'General case' 0 C--N 1.349 0.565 0 CA-C-N 114.585 -1.189 . . . . 74.2 110.956 177.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -67.67 -38.33 83.6 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 123.614 0.766 . . . . 62.24 111.117 -175.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.7 t -60.49 -41.86 95.14 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 123.715 0.635 . . . . 62.4 110.14 178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.59 HG12 ' SG ' ' D' ' 76' ' ' CYS . 97.5 mt -63.05 -56.19 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 124.21 0.944 . . . . 64.33 110.061 173.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.467 HG21 ' HE2' ' B' ' 109' ' ' TYR . 88.9 m -51.76 -45.13 63.6 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.971 1.308 . . . . 74.33 112.003 -172.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.6 t -66.4 -43.14 86.62 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 114.832 -1.076 . . . . 72.4 110.724 -177.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 62.7 mtm -66.12 -34.61 78.44 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 122.945 0.498 . . . . 72.42 111.812 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' D' ' 114' ' ' ILE . 97.3 t -66.11 -42.75 91.94 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-N 115.155 -0.93 . . . . 71.43 109.913 178.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 98.9 p -72.49 -30.76 64.81 Favored 'General case' 0 N--CA 1.481 1.1 0 C-N-CA 122.834 0.454 . . . . 74.45 111.392 178.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -69.83 -30.89 68.51 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 123.345 0.658 . . . . 63.54 110.167 174.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.06 11.16 65.79 Favored Glycine 0 C--N 1.354 1.532 0 CA-C-N 115.492 -0.777 . . . . 64.14 112.613 174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.409 HG23 ' HB3' ' C' ' 17' ' ' TYR . 75.7 p 59.27 13.98 3.38 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 126.865 2.066 . . . . 63.51 114.424 178.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -82.15 162.67 56.06 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 107.417 -1.327 . . . . 72.31 107.417 164.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.535 ' HG2' ' HB ' ' G' ' 296' ' ' THR . 62.1 Cg_endo -82.34 152.74 15.91 Favored 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 122.017 1.811 . . . . 74.12 112.444 -171.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -54.02 120.46 6.43 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.372 0.669 . . . . 51.52 110.906 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 48.7 tp -104.58 108.59 20.11 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 108.281 -1.007 . . . . 73.23 108.281 -178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.465 ' HB3' HG13 ' B' ' 13' ' ' ILE . 57.9 m-20 -100.28 93.09 5.5 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 108.463 -0.94 . . . . 74.41 108.463 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.629 HD12 ' HZ ' ' D' ' 107' ' ' PHE . 0.3 OUTLIER -61.61 137.48 58.25 Favored 'General case' 0 CA--C 1.561 1.38 0 C-N-CA 125.079 1.352 . . . . 75.23 109.785 -178.545 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -58.28 129.3 83.23 Favored Pre-proline 0 N--CA 1.483 1.219 0 C-N-CA 123.902 0.881 . . . . 64.11 112.295 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.457 ' HD3' HD12 ' B' ' 13' ' ' ILE . 59.3 Cg_endo -76.13 117.63 4.72 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 121.717 1.612 . . . . 71.32 109.841 168.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 95.4 t -106.1 110.81 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 N-CA-C 108.679 -0.86 . . . . 74.14 108.679 -174.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.403 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 44.2 t30 -70.33 99.43 1.55 Allowed 'General case' 0 C--O 1.243 0.748 0 CA-C-N 115.336 -0.847 . . . . 74.14 109.665 178.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -71.36 -21.85 61.98 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.484 -0.78 . . . . 72.13 111.249 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.68 -51.27 70.08 Favored 'General case' 0 C--O 1.211 -0.952 0 C-N-CA 123.083 0.553 . . . . 73.01 111.042 177.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.403 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -52.75 -53.76 43.42 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.831 0.852 . . . . 65.41 112.002 -176.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 2.7 pp -75.45 -25.74 57.7 Favored 'General case' 0 CA--C 1.548 0.895 0 CA-C-N 115.964 -0.562 . . . . 60.21 112.335 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' B' ' 2' ' ' SER . 44.0 t80 -74.83 -53.93 8.22 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 109.772 -0.455 . . . . 62.32 109.772 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 69.6 mtm -58.5 -25.95 62.92 Favored 'General case' 0 C--O 1.218 -0.605 0 C-N-CA 124.144 0.978 . . . . 63.54 111.115 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -57.46 -36.24 71.18 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.639 0.776 . . . . 74.33 111.25 177.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 72.0 t80 -73.35 -38.12 65.85 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 123.711 0.804 . . . . 75.3 110.528 174.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . 0.408 HD13 ' O ' ' D' ' 137' ' ' PHE . 7.6 mp -76.23 -30.13 57.82 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 124.023 0.929 . . . . 73.14 112.985 -174.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 5.0 pp0? -83.91 25.68 0.79 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 123.066 0.546 . . . . 50.44 112.155 -170.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -113.96 46.64 1.29 Allowed 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 122.384 1.088 . . . . 75.12 108.772 -170.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -147.12 146.2 29.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 113.64 -1.618 . . . . 74.41 107.277 168.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.83 102.72 1.29 Allowed 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 109.471 -0.566 . . . . 72.54 109.471 179.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -82.89 57.08 5.07 Favored Glycine 0 C--N 1.348 1.243 0 C-N-CA 123.151 0.405 . . . . 63.34 112.112 -176.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -68.81 102.99 1.66 Allowed 'General case' 0 C--N 1.351 0.659 0 C-N-CA 123.928 0.891 . . . . 73.44 109.651 -178.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -164.64 41.32 0.3 Allowed Glycine 0 C--O 1.238 0.399 0 N-CA-C 109.963 -1.255 . . . . 53.43 109.963 179.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 48.3 p -64.73 97.62 0.23 Allowed 'General case' 0 C--N 1.352 0.706 0 C-N-CA 123.825 0.85 . . . . 54.31 110.154 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -86.79 148.88 25.21 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 123.514 0.726 . . . . 73.34 109.811 174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -146.52 124.58 12.1 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 108.702 -0.851 . . . . 73.45 108.702 176.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -157.65 80.52 0.88 Allowed 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 122.24 1.019 . . . . 72.35 109.298 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -119.77 121.02 38.22 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.86 -1.163 . . . . 73.54 107.86 175.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -149.7 166.72 28.51 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.096 0.958 . . . . 74.44 109.009 -177.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 C-N-CA 123.484 0.714 . . . . 74.3 109.636 176.256 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.804 -0.443 . . . . 62.21 109.804 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -67.81 139.82 56.6 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.938 0.895 . . . . 73.23 110.063 176.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -74.68 143.45 44.22 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.318 0.647 . . . . 73.22 110.461 176.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -122.45 77.21 1.39 Allowed 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.584 0.753 . . . . 64.24 109.524 176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -145.15 113.49 4.85 Favored Pre-proline 0 CA--C 1.541 0.627 0 CA-C-N 115.052 -0.976 . . . . 73.41 108.628 178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -82.14 174.45 10.02 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.154 1.903 . . . . 60.2 111.941 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 4.9 tt -155.01 -58.29 0.1 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 106.689 -1.597 . . . . 71.43 106.689 174.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . 0.712 ' HA ' ' SD ' ' A' ' 94' ' ' MET . 5.6 mp -81.15 78.3 7.96 Favored 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 108.882 -0.784 . . . . 63.13 108.882 175.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -84.95 61.48 4.67 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-N 115.598 -0.728 . . . . 50.13 112.177 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.513 HD22 ' HA ' ' A' ' 95' ' ' ALA . 42.7 tp -168.79 170.45 9.25 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 124.101 0.961 . . . . 72.43 109.035 -172.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 70.76 -177.35 0.21 Allowed 'General case' 0 C--N 1.367 1.334 0 C-N-CA 125.205 1.402 . . . . 72.42 110.158 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 68.27 -69.78 0.14 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.496 1.118 . . . . 63.42 109.554 -171.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -80.04 94.68 5.99 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 108.385 -0.969 . . . . 73.01 108.385 166.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 171.02 125.66 0.83 Allowed Glycine 0 C--N 1.343 0.957 0 CA-C-N 115.731 -0.668 . . . . 71.3 111.689 -177.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -111.07 -52.74 2.77 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.539 0.736 . . . . 74.44 111.358 -175.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 20.7 mmt 60.12 77.94 0.35 Allowed Pre-proline 0 N--CA 1.487 1.425 0 C-N-CA 124.058 0.943 . . . . 73.01 110.489 -166.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.49 129.12 9.97 Favored 'Trans proline' 0 C--N 1.38 2.209 0 C-N-CA 123.221 2.614 . . . . 65.23 112.199 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . 0.702 HG11 HD13 ' A' ' 42' ' ' LEU . 50.3 t -116.45 124.86 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 108.696 -0.853 . . . . 74.21 108.696 173.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 19.5 mmt85 -103.82 -3.27 25.11 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.434 1.094 . . . . 73.52 111.429 -179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 64.7 m95 78.04 149.6 0.1 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.67 1.588 . . . . 75.34 111.414 -167.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.486 HD12 ' HB3' ' A' ' 129' ' ' ALA . 29.9 mt -90.69 -7.49 52.43 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 113.518 -1.674 . . . . 71.34 111.151 -172.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 169.87 -150.93 15.73 Favored Glycine 0 C--N 1.347 1.183 0 CA-C-O 119.221 -0.766 . . . . 53.22 112.737 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . 0.629 ' HD3' ' HA ' ' C' ' 154' ' ' ASP . 88.5 Cg_endo -77.17 173.06 14.98 Favored 'Trans proline' 0 C--N 1.378 2.079 0 C-N-CA 123.399 2.733 . . . . 73.21 113.561 -177.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 22.3 pttm -83.2 176.95 8.78 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.412 1.085 . . . . 75.34 110.621 176.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -175.92 -25.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 124.636 1.174 . . . . 71.13 110.007 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 19.8 m -60.8 124.89 21.78 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 124.641 1.177 . . . . 50.53 111.157 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.642 ' HB3' ' HG2' ' A' ' 38' ' ' PRO . 22.8 t80 71.31 10.54 6.68 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.292 1.437 . . . . 75.55 112.7 173.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 -80.35 101.08 8.75 Favored 'General case' 0 C--O 1.241 0.625 0 N-CA-C 107.04 -1.467 . . . . 75.2 107.04 166.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -169.36 -141.92 3.38 Favored Glycine 0 C--N 1.339 0.73 0 CA-C-O 119.872 -0.404 . . . . 74.32 112.268 -175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -143.64 125.45 15.13 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.359 0.664 . . . . 74.04 110.015 -176.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 74.1 mt -122.79 100.85 8.7 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 N-CA-C 108.2 -1.037 . . . . 75.44 108.2 169.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -133.59 -179.77 5.73 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.557 1.143 . . . . 42.42 108.53 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 65.03 134.31 0.04 OUTLIER Pre-proline 0 CA--C 1.563 1.454 0 C-N-CA 125.283 1.433 . . . . 60.2 113.556 168.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.71 -177.67 3.55 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.966 1.777 . . . . 74.35 111.395 170.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -131.38 144.52 51.28 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 123.108 0.563 . . . . 42.44 110.185 -178.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 17.9 t 60.76 29.53 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 124.458 1.103 . . . . 75.24 111.528 173.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 3.0 m -87.71 37.76 0.81 Allowed 'General case' 0 CA--C 1.567 1.605 0 O-C-N 120.995 -1.066 . . . . 74.44 110.842 -176.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 70.7 m -112.23 -0.81 15.38 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.577 1.151 . . . . 72.03 110.468 172.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 24.2 m -75.1 133.64 75.18 Favored Pre-proline 0 CA--C 1.559 1.316 0 C-N-CA 123.574 0.749 . . . . 71.24 110.512 -177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo . . . . . 0 C--N 1.394 2.97 0 C-N-CA 124.383 3.389 . . . . 71.5 114.776 177.301 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.533 0.206 . . . . 74.41 110.496 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -70.9 -47.48 58.9 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.95 0.9 . . . . 60.42 109.953 178.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 29.5 pt20 -115.97 171.21 7.93 Favored 'General case' 0 C--O 1.244 0.763 0 C-N-CA 124.24 1.016 . . . . 72.22 109.734 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.94 -64.5 1.17 Allowed 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 108.038 -1.097 . . . . 74.53 108.038 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -143.08 140.39 17.85 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 107.708 -1.219 . . . . 75.01 107.708 174.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -58.46 131.12 40.81 Favored 'Trans proline' 0 C--N 1.377 2.072 0 C-N-CA 122.72 2.28 . . . . 72.51 112.804 177.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 10.5 tt -58.54 -36.54 74.02 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.979 0.912 . . . . 74.22 109.955 175.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 6.3 tt -122.73 117.68 26.29 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 106.919 -1.511 . . . . 75.41 106.919 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -146.22 33.46 1.47 Allowed Glycine 0 C--N 1.343 0.926 0 O-C-N 123.355 0.41 . . . . 32.31 112.897 -174.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 4.1 pp -161.23 -172.73 3.53 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.011 0.924 . . . . 64.52 109.878 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -145.43 -90.06 0.1 Allowed 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 108.101 -1.074 . . . . 71.13 108.101 169.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -94.32 176.82 6.16 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.498 0.719 . . . . 74.51 110.074 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -63.56 -35.47 80.58 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.72 0.808 . . . . 73.24 110.968 175.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 92.98 -43.12 2.59 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.928 -0.578 . . . . 73.34 112.243 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -93.46 47.39 1.24 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.947 0.899 . . . . 74.44 110.001 -175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 90.6 mtp -125.89 87.68 55.56 Favored Pre-proline 0 N--CA 1.481 1.093 0 C-N-CA 124.116 0.966 . . . . 44.51 109.238 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.8 100.73 1.3 Allowed 'Trans proline' 0 C--N 1.378 2.115 0 C-N-CA 122.84 2.36 . . . . 73.44 111.101 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 40.5 t -72.04 -42.01 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 C-N-CA 123.089 0.556 . . . . 65.13 110.074 -178.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 29.6 mmm180 62.94 -81.43 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 125.515 1.526 . . . . 73.04 111.657 176.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -173.57 125.7 0.39 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 107.35 -1.352 . . . . 73.33 107.35 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.664 HD21 ' HB ' ' C' ' 131' ' ' VAL . 7.4 mp -65.96 -23.71 66.65 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 123.961 0.905 . . . . 63.22 113.145 -166.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -162.99 -175.95 34.55 Favored Glycine 0 CA--C 1.522 0.506 0 CA-C-O 119.291 -0.727 . . . . 71.42 111.835 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -83.38 46.68 2.16 Favored 'Trans proline' 0 C--N 1.367 1.525 0 C-N-CA 123.309 2.673 . . . . 52.23 111.613 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -91.31 83.77 5.53 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.452 0.701 . . . . 74.11 109.574 -173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -100.06 154.23 18.58 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.581 -0.736 . . . . 71.31 110.365 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . 0.497 HG23 HD23 ' C' ' 126' ' ' LEU . 14.2 p -88.59 -165.72 1.41 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 123.872 0.869 . . . . 74.11 110.512 174.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.494 ' OH ' ' HB1' ' C' ' 73' ' ' ALA . 50.0 m-85 62.76 14.31 7.18 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 124.802 1.241 . . . . 71.32 112.567 178.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -72.64 130.13 39.86 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.664 0.786 . . . . 72.31 109.822 177.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . 0.595 ' HA3' ' HB3' ' H' ' 298' ' ' HIS . . . 85.54 -83.34 1.63 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.347 -1.101 . . . . 73.32 110.347 -169.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . 0.504 ' ND2' ' HE1' ' C' ' 36' ' ' TRP . 3.9 t-20 -177.38 163.39 2.0 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.12 0.968 . . . . 64.22 108.867 177.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.631 HG22 ' HD3' ' C' ' 124' ' ' PRO . 30.4 pt -104.29 24.17 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 123.428 0.691 . . . . 62.42 109.965 171.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -48.51 -43.99 35.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.598 1.959 . . . . 74.53 114.713 -168.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 51.33 76.87 0.5 Allowed Pre-proline 0 CA--C 1.561 1.368 0 O-C-N 124.348 1.03 . . . . 63.2 109.53 -174.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . 0.527 ' HB2' ' HD2' ' H' ' 293' ' ' PRO . 75.0 Cg_endo -86.38 -31.13 0.31 Allowed 'Trans proline' 0 C--N 1.379 2.169 0 C-N-CA 122.668 2.245 . . . . 74.45 114.149 -173.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -77.66 86.71 3.95 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.196 0.598 . . . . 74.31 109.548 176.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 7.6 p 168.1 -24.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 125.785 1.634 . . . . 75.42 109.076 -174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 75.5 p -75.12 12.69 0.84 Allowed 'General case' 0 CA--C 1.553 1.067 0 N-CA-C 113.55 0.945 . . . . 53.53 113.55 -170.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 36.9 t -144.7 37.14 1.18 Allowed 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.568 0.747 . . . . 70.43 110.199 176.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 17.4 p -69.74 128.88 91.69 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 123.12 0.568 . . . . 72.41 110.642 175.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--N 1.382 2.295 0 C-N-CA 122.801 2.334 . . . . 74.23 111.844 176.613 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 109.835 -0.432 . . . . 61.44 109.835 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -77.17 -58.81 3.07 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 109.341 -0.614 . . . . 63.03 109.341 177.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -122.23 -70.7 0.76 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 108.428 -0.952 . . . . 61.33 108.428 169.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . 0.455 ' HG2' ' H ' ' G' ' 275' ' ' LYS . 62.1 tt0 64.79 179.09 0.18 Allowed 'General case' 0 CA--C 1.56 1.363 0 C-N-CA 124.899 1.28 . . . . 73.14 111.032 -178.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . 0.455 ' H ' ' HG2' ' G' ' 274' ' ' GLN . 32.1 mtmt 71.72 83.08 0.15 Allowed Pre-proline 0 C--N 1.362 1.126 0 C-N-CA 125.11 1.364 . . . . 64.01 109.251 170.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.74 89.88 0.18 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 122.421 2.081 . . . . 64.1 111.063 176.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.807 ' HB2' ' SD ' ' D' ' 94' ' ' MET . 2.7 pt? -79.6 -174.86 4.5 Favored 'General case' 0 CA--C 1.551 1.0 0 CA-C-N 115.357 -0.838 . . . . 75.13 110.005 176.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . 0.667 HD13 ' HG ' ' D' ' 98' ' ' LEU . 40.1 tp 66.4 94.45 0.06 Allowed 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.368 1.067 . . . . 74.12 110.426 -171.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -102.66 4.64 50.48 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.588 -0.733 . . . . 73.23 112.389 173.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . 0.42 ' H ' HD12 ' G' ' 278' ' ' LEU . 78.0 mt -101.83 175.88 5.4 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.943 0.897 . . . . 75.42 111.257 -175.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . 0.48 ' HD1' ' HB ' ' D' ' 46' ' ' THR . 90.3 m-85 65.16 6.19 3.41 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 125.292 1.437 . . . . 54.41 112.208 -175.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -105.96 86.9 2.46 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.232 1.013 . . . . 74.33 108.781 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 62.55 19.33 11.17 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 124.458 1.103 . . . . 71.23 112.573 175.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -89.94 91.25 1.68 Allowed Glycine 0 C--N 1.351 1.384 0 CA-C-N 116.314 -0.403 . . . . 64.23 112.25 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -70.45 109.16 4.63 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.517 0.727 . . . . 75.54 110.031 176.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . 0.429 ' SD ' ' HD2' ' G' ' 287' ' ' PRO . 16.0 tpt -91.34 123.88 62.82 Favored Pre-proline 0 CA--C 1.546 0.811 0 N-CA-C 108.575 -0.898 . . . . 60.41 108.575 172.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . 0.429 ' HD2' ' SD ' ' G' ' 286' ' ' MET . 72.7 Cg_endo -74.25 72.09 4.24 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.5 2.133 . . . . 75.42 112.442 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 57.0 t -82.44 95.34 3.22 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 N-CA-C 108.94 -0.763 . . . . 63.22 108.94 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 10.6 ptt180 -71.46 135.55 47.23 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.306 -0.861 . . . . 73.22 110.374 176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.472 ' NE1' ' HA ' ' G' ' 293' ' ' PRO . 1.3 t-105 -82.07 120.03 24.77 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.625 0.77 . . . . 72.5 110.486 -176.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.441 ' H ' HD12 ' G' ' 291' ' ' LEU . 1.8 mp -88.01 91.08 8.63 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.456 1.102 . . . . 64.13 109.903 -173.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 81.03 86.91 0.64 Allowed Glycine 0 C--N 1.347 1.177 0 CA-C-O 119.269 -0.74 . . . . 75.53 112.838 177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . 0.472 ' HA ' ' NE1' ' G' ' 290' ' ' TRP . 34.8 Cg_endo -63.21 -27.62 72.62 Favored 'Trans proline' 0 C--N 1.381 2.252 0 C-N-CA 123.034 2.489 . . . . 64.13 113.148 176.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . 0.689 ' HG2' ' HG2' ' D' ' 39' ' ' GLU . 42.8 mtmt -88.66 92.51 9.23 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 123.291 0.636 . . . . 74.04 109.621 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -162.05 65.94 0.24 Allowed 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 121.291 0.567 . . . . 70.43 110.822 -179.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . 0.535 ' HB ' ' HG2' ' D' ' 124' ' ' PRO . 7.9 p -142.04 -97.79 0.13 Allowed 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 123.962 0.905 . . . . 63.03 109.973 -177.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.448 ' HB2' ' HA ' ' D' ' 37' ' ' GLN . 31.6 m-85 -73.42 166.37 23.33 Favored 'General case' 0 C--N 1.371 1.542 0 N-CA-C 108.767 -0.827 . . . . 73.24 108.767 170.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -143.97 14.66 1.7 Allowed 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 108.428 -0.953 . . . . 72.34 108.428 165.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -155.24 -172.38 22.83 Favored Glycine 0 C--N 1.349 1.275 0 CA-C-N 115.321 -0.854 . . . . 64.1 111.745 -172.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 24.2 p-10 -82.31 154.06 25.5 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.703 0.801 . . . . 73.34 112.233 -174.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.561 ' H ' ' HB2' ' D' ' 35' ' ' ASP . 41.3 mt -90.74 -5.73 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.42 0 C-N-CA 125.1 1.36 . . . . 75.21 110.452 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -57.37 97.42 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.83 1.252 . . . . 70.21 112.658 -170.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 31.8 mtmm -143.5 96.62 5.68 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 106.671 -1.603 . . . . 72.23 106.671 172.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -59.94 -63.04 0.13 Allowed 'Trans proline' 0 C--N 1.377 2.04 0 C-N-CA 122.562 2.175 . . . . 74.11 113.092 -172.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -175.06 164.76 3.38 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.086 0.955 . . . . 55.13 109.779 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' C' ' 12' ' ' GLN . 10.4 p -80.24 143.48 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 107.357 -1.349 . . . . 74.24 107.357 162.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . 0.479 HG23 ' HB3' ' C' ' 155' ' ' ALA . 14.0 m -74.43 138.36 43.25 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 122.841 0.456 . . . . 55.33 111.259 -173.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . 0.497 ' SG ' ' HA ' ' C' ' 10' ' ' THR . 41.5 t -68.48 162.05 26.43 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.819 0.848 . . . . 63.23 111.094 174.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 36.0 p -65.42 113.57 12.1 Favored Pre-proline 0 CA--C 1.555 1.136 0 C-N-CA 124.149 0.98 . . . . 73.21 111.061 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo . . . . . 0 C--N 1.377 2.034 0 C-N-CA 123.212 2.608 . . . . 72.51 112.066 175.77 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.878 0 N-CA-C 109.697 -0.483 . . . . 71.34 109.697 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . 0.466 ' ND2' HE22 ' H' ' 274' ' ' GLN . 28.4 p-10 -168.19 154.54 7.4 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.581 0.753 . . . . 73.41 110.404 -177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -140.75 -35.64 0.48 Allowed 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.524 0.73 . . . . 54.34 111.112 -178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . 0.466 HE22 ' ND2' ' H' ' 272' ' ' ASN . 1.8 mp0 55.28 88.37 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.633 1.173 . . . . 73.52 110.65 -175.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -66.93 135.55 94.17 Favored Pre-proline 0 CA--C 1.554 1.131 0 CA-C-N 115.591 -0.731 . . . . 74.14 109.994 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -62.51 158.31 41.87 Favored 'Trans proline' 0 C--N 1.377 2.063 0 C-N-CA 123.104 2.536 . . . . 61.23 112.46 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 6.6 tt -67.44 -32.95 74.17 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 109.116 -0.698 . . . . 63.13 109.116 176.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . 0.419 ' HA ' ' HE1' ' B' ' 94' ' ' MET . 39.3 tp -58.99 127.04 30.21 Favored 'General case' 0 C--N 1.36 1.047 0 O-C-N 123.8 0.687 . . . . 65.52 111.432 -177.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -170.89 148.96 11.77 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 111.13 -0.788 . . . . 54.54 111.13 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 46.6 mt 67.08 161.91 0.17 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 125.191 1.396 . . . . 75.33 112.298 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -165.67 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 108.436 -0.95 . . . . 73.21 108.436 172.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -173.92 127.36 0.38 Allowed 'General case' 0 C--N 1.353 0.732 0 C-N-CA 124.362 1.065 . . . . 72.15 109.962 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -98.95 163.82 12.44 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 108.595 -0.891 . . . . 73.41 108.595 173.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . -75.22 26.12 1.25 Allowed Glycine 0 CA--C 1.54 1.651 0 N-CA-C 115.996 1.159 . . . . 74.53 115.996 -171.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -68.39 -20.18 64.67 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 117.727 0.764 . . . . 64.42 111.212 173.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 16.3 ptt? -128.47 90.84 45.49 Favored Pre-proline 0 CA--C 1.557 1.227 0 C-N-CA 124.43 1.092 . . . . 64.34 109.29 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.3 121.55 7.28 Favored 'Trans proline' 0 C--N 1.382 2.338 0 C-N-CA 122.87 2.38 . . . . 62.41 112.994 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 85.3 t -86.33 91.96 3.47 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.845 0 CA-C-O 121.812 0.815 . . . . 73.25 109.635 176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -117.22 -173.91 2.5 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.156 1.382 . . . . 61.43 108.312 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 76.9 m95 -59.83 134.78 57.36 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.519 0.6 . . . . 74.24 112.167 -175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.423 HD11 HG22 ' B' ' 131' ' ' VAL . 5.1 mp -93.88 41.45 1.09 Allowed 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.256 1.023 . . . . 61.54 110.091 -175.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 158.93 -173.56 35.84 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-N 114.293 -1.321 . . . . 41.34 110.612 -173.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . 0.527 ' HD2' ' HB2' ' F' ' 304' ' ' PRO . 80.3 Cg_endo -81.64 68.87 7.92 Favored 'Trans proline' 0 C--N 1.367 1.516 0 C-N-CA 122.672 2.248 . . . . 73.31 112.584 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . 0.497 ' HE3' ' H ' ' B' ' 40' ' ' VAL . 50.2 mttp 60.6 -158.43 0.33 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.087 0.955 . . . . 73.31 112.297 173.332 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -158.54 -173.71 4.42 Favored 'General case' 0 C--O 1.245 0.822 0 C-N-CA 125.199 1.4 . . . . 72.01 107.975 168.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 1.4 m 72.06 164.64 0.28 Allowed 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.308 1.043 . . . . 72.41 112.346 168.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.444 ' HA ' ' HG2' ' B' ' 124' ' ' PRO . 5.9 m-85 60.51 29.75 19.25 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 125.146 1.378 . . . . 72.43 113.126 176.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . 0.595 ' HB3' ' HA3' ' F' ' 299' ' ' GLY . 2.2 m80 -73.46 88.6 1.62 Allowed 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.074 0.55 . . . . 74.25 110.856 178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 70.3 23.87 77.07 Favored Glycine 0 C--N 1.355 1.611 0 CA-C-N 115.359 -0.837 . . . . 64.41 113.583 175.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -166.4 136.75 3.32 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-O 120.908 0.385 . . . . 65.1 111.36 -176.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 15.3 tt -134.45 -33.03 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 124.86 1.264 . . . . 74.0 108.27 165.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -157.37 -170.78 3.35 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 125.939 1.696 . . . . 74.41 107.48 -177.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . 0.415 ' HB2' ' HD3' ' H' ' 304' ' ' PRO 0.266 42.9 mtmt 108.61 -57.26 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.204 0 C-N-CA 127.706 2.403 . . . . 71.02 112.392 171.083 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . 0.415 ' HD3' ' HB2' ' H' ' 303' ' ' LYS . 8.2 Cg_exo -74.88 -53.52 0.1 OUTLIER 'Trans proline' 0 C--N 1.395 2.987 0 CA-C-N 122.034 1.762 . . . . 55.13 110.656 166.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 41.51 -106.53 0.07 Allowed 'General case' 0 CA--C 1.558 1.279 0 C-N-CA 125.377 1.471 . . . . 75.54 111.82 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 34.6 m -144.6 29.21 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 124.559 1.144 . . . . 74.53 108.428 168.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . 0.549 ' HA ' ' HA ' ' A' ' 14' ' ' GLN . 29.4 p -39.25 -66.56 0.28 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 126.577 1.951 . . . . 64.44 114.922 -162.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 27.2 p -154.2 151.4 29.15 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.921 0.391 . . . . 71.24 111.61 -177.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 3.8 t -144.07 110.35 5.1 Favored Pre-proline 0 CA--C 1.552 1.054 0 C-N-CA 124.286 1.034 . . . . 74.53 108.473 177.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo . . . . . 0 C--N 1.379 2.154 0 C-N-CA 122.453 2.102 . . . . 53.12 111.21 175.42 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.513 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.484 1.238 0 N-CA-C 110.331 -0.248 . . . . 65.33 110.331 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.3 t 68.42 173.94 0.28 Allowed 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 125.001 1.32 . . . . 51.44 111.972 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -71.84 124.29 24.51 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 123.414 0.685 . . . . 72.52 110.651 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -79.15 120.13 23.23 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 123.26 0.624 . . . . 72.04 110.759 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.58 ' H ' ' HB1' ' C' ' 145' ' ' ALA . 21.8 m120 -93.53 163.86 13.4 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.103 0.961 . . . . 62.34 110.819 175.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -136.59 -71.41 0.45 Allowed 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.431 0.692 . . . . 70.14 110.987 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.9 m -79.24 -12.82 59.96 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.646 0.778 . . . . 74.22 111.687 -171.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 33.9 mp0 -85.05 69.2 10.77 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.425 0.69 . . . . 75.0 109.789 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 73.7 mtm -149.58 133.56 17.08 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 108.063 -1.088 . . . . 71.52 108.063 170.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.627 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 90.4 m -149.05 130.26 14.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.345 0.658 . . . . 64.42 109.458 172.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.496 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 29.1 t80 -140.16 129.4 23.8 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.214 -1.032 . . . . 74.21 108.214 172.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 29.1 tp60 -148.77 109.44 4.23 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 120.706 0.289 . . . . 75.54 110.744 177.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.669 HG12 ' HD2' ' A' ' 84' ' ' PHE . 60.2 mt -73.0 111.42 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 N-CA-C 109.237 -0.653 . . . . 63.52 109.237 172.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -91.7 -27.46 18.07 Favored 'General case' 0 C--O 1.241 0.633 0 O-C-N 123.82 0.7 . . . . 64.4 110.209 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 41.9 ttt180 -164.27 144.29 7.89 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 121.382 -0.127 . . . . 74.43 110.924 -171.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.421 ' N ' HD13 ' A' ' 16' ' ' ILE . 0.1 OUTLIER -143.51 118.27 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 125.074 1.349 . . . . 71.14 108.72 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 32.8 p90 -166.63 176.66 7.09 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.864 0.84 . . . . 75.52 111.821 -163.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -103.55 112.36 25.25 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 114.712 -1.131 . . . . 62.22 108.582 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.503 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 34.8 mtpt -76.83 -19.63 57.3 Favored 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 110.103 -0.332 . . . . 54.55 110.103 175.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -158.14 144.88 17.68 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 123.716 0.806 . . . . 65.45 109.646 175.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 66.1 mt -135.22 145.47 31.9 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 C-N-CA 124.993 1.317 . . . . 72.45 107.742 173.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 81.9 p -147.9 138.95 23.37 Favored 'General case' 0 N--CA 1.457 -0.12 0 N-CA-C 109.039 -0.726 . . . . 51.14 109.039 166.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' B' ' 20' ' ' ASP . 93.6 t80 -136.06 111.17 8.94 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 105.831 -1.914 . . . . 73.54 105.831 170.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -119.25 107.24 13.17 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 109.292 -0.633 . . . . 75.42 109.292 -177.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -117.29 78.41 10.55 Favored Pre-proline 0 N--CA 1.478 0.969 0 N-CA-C 107.477 -1.305 . . . . 71.52 107.477 171.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.47 -34.74 5.48 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 122.155 1.903 . . . . 71.24 111.737 -174.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -89.41 10.67 21.7 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 115.69 -0.686 . . . . 71.23 110.879 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.484 ' HA ' HG12 ' A' ' 31' ' ' VAL . . . -47.98 -57.59 9.9 Favored Pre-proline 0 CA--C 1.566 1.573 0 CA-C-O 117.455 -1.259 . . . . 73.32 113.426 -166.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -47.8 -41.88 31.24 Favored 'Trans proline' 0 C--N 1.403 3.411 0 C-N-CA 123.381 2.721 . . . . 63.33 113.885 -176.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -100.95 -14.04 18.05 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.145 0.794 . . . . 74.22 113.145 -175.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.529 HG21 ' HA ' ' A' ' 73' ' ' ALA . 1.7 p -77.6 -18.43 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 CA-C-N 118.29 0.495 . . . . 73.52 110.582 -177.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -74.25 -5.37 41.61 Favored 'General case' 0 CA--C 1.553 1.064 0 C-N-CA 123.767 0.827 . . . . 72.44 111.689 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -99.95 -18.79 16.9 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.203 1.001 . . . . 71.41 111.18 176.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -67.57 150.19 49.13 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.427 0.691 . . . . 75.21 111.912 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.39 134.83 55.38 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.581 0.753 . . . . 75.31 110.139 175.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 20.2 m95 -78.82 75.91 5.33 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 123.273 0.629 . . . . 75.01 112.101 -169.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -132.91 74.86 73.44 Favored Pre-proline 0 N--CA 1.48 1.033 0 N-CA-C 108.324 -0.991 . . . . 72.12 108.324 170.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -86.75 128.09 2.8 Favored 'Trans proline' 0 C--N 1.374 1.886 0 C-N-CA 123.102 2.535 . . . . 74.43 112.113 -177.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.72 98.47 11.43 Favored 'General case' 0 C--O 1.239 0.529 0 N-CA-C 105.312 -2.107 . . . . 72.1 105.312 169.135 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.618 ' H ' ' HD3' ' E' ' 294' ' ' LYS . 39.8 t -91.78 102.04 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 CA-C-N 114.312 -1.313 . . . . 75.52 108.997 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -78.91 148.08 32.84 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 123.572 0.749 . . . . 74.32 111.048 177.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.51 111.53 18.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 107.617 -1.253 . . . . 75.44 107.617 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.778 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 5.6 m-20 -107.3 144.06 34.67 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 108.277 -1.008 . . . . 73.11 108.277 170.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 60.1 tp -139.68 129.45 24.65 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 122.903 0.481 . . . . 54.54 109.918 -174.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.65 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 7.1 m-20 -127.22 127.4 44.39 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.194 0.998 . . . . 74.45 109.317 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.419 ' HB ' ' CE1' ' E' ' 281' ' ' PHE . 44.9 p -118.17 122.83 44.02 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.56 1.144 . . . . 75.4 109.522 -175.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.97 147.28 31.52 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.082 0.553 . . . . 51.11 110.938 -175.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 p -119.42 167.12 12.24 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.76 0.824 . . . . 74.35 110.014 170.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 43.2 t -156.07 153.16 28.96 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.617 1.167 . . . . 73.4 108.355 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.7 tt0 -113.44 127.04 55.97 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 122.488 0.315 . . . . 64.03 110.349 177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.51 HD11 ' HB2' ' A' ' 57' ' ' GLU . 41.6 mt -93.65 -44.33 8.23 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.604 0.762 . . . . 64.34 110.495 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.636 ' HB1' ' HA ' ' C' ' 155' ' ' ALA . . . -150.1 -179.01 6.82 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 114.482 -1.235 . . . . 75.44 108.914 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -63.39 118.87 8.68 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 109.483 -0.562 . . . . 71.42 109.483 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 71.96 -4.61 1.91 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 125.707 1.603 . . . . 72.03 113.312 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.464 ' HB ' ' HB3' ' A' ' 52' ' ' ALA . 42.1 t -104.86 118.62 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 N-CA-C 108.915 -0.772 . . . . 71.21 108.915 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -122.3 160.43 25.34 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 123.488 0.715 . . . . 73.14 110.676 -177.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' HB2' HD11 ' A' ' 51' ' ' LEU . 8.1 tm-20 -132.71 136.87 46.68 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 107.318 -1.364 . . . . 73.51 107.318 168.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.418 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 86.3 t -126.49 125.88 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.106 0 N-CA-C 108.449 -0.945 . . . . 73.3 108.449 -177.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 32.4 t -101.71 136.94 31.27 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 C-N-CA 123.159 0.584 . . . . 61.44 110.025 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -122.3 97.68 5.58 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 106.67 -1.604 . . . . 54.04 106.67 175.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.65 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 47.2 ttp180 -86.53 109.81 19.36 Favored 'General case' 0 C--N 1.349 0.557 0 N-CA-C 109.319 -0.622 . . . . 74.1 109.319 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.8 t -93.8 139.49 18.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.295 -1.372 . . . . 61.41 107.295 169.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.778 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 40.3 m -132.27 136.03 46.66 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.611 -0.885 . . . . 51.23 108.611 173.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.705 HG11 HD21 ' A' ' 126' ' ' LEU . 92.5 t -134.85 109.07 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 124.464 1.106 . . . . 72.44 108.421 -173.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 8.3 m -106.05 137.22 44.35 Favored 'General case' 0 C--O 1.207 -1.149 0 N-CA-C 108.684 -0.858 . . . . 75.55 108.684 174.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.39 123.57 38.24 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.021 -0.733 . . . . 63.11 109.021 176.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 63.8 m -132.14 125.45 31.29 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 122.768 0.427 . . . . 72.13 110.143 175.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.6 mp -89.39 84.41 6.44 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.239 -1.393 . . . . 75.01 107.239 176.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.98 -98.86 1.23 Allowed Glycine 0 C--N 1.344 1.011 0 CA-C-N 114.245 -1.343 . . . . 35.22 110.93 -170.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -104.88 -25.87 12.44 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.299 1.04 . . . . 64.51 110.253 -178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -87.88 106.13 17.89 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 75.14 110.277 -171.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 48.7 m -68.77 130.31 42.46 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 121.506 0.669 . . . . 70.31 111.248 177.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -80.53 -60.76 2.19 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.898 -1.046 . . . . 73.13 109.724 177.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -155.82 162.98 40.38 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 114.956 -1.02 . . . . 72.4 111.478 -176.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 43.4 tp -135.9 111.32 9.15 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.55 1.14 . . . . 74.03 108.465 172.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 73.9 m -105.43 124.05 48.9 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.25 1.02 . . . . 64.11 109.865 179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -135.54 119.01 16.87 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 109.211 -0.663 . . . . 65.44 109.211 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -127.96 110.36 21.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 C-N-CA 123.912 0.885 . . . . 64.3 109.132 -175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 10.6 mp0 -83.91 82.8 8.18 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 107.396 -1.335 . . . . 75.51 107.396 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.433 ' HG2' ' O ' ' A' ' 106' ' ' LEU . 7.8 tp-100 -76.91 94.51 3.94 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 108.624 -0.88 . . . . 53.25 108.624 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.15 149.79 19.11 Favored Glycine 0 N--CA 1.451 -0.324 0 CA-C-N 115.3 -0.864 . . . . 73.01 111.754 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -148.86 134.76 5.12 Favored Glycine 0 CA--C 1.509 -0.286 0 N-CA-C 111.802 -0.519 . . . . 63.22 111.802 -176.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . 0.512 HD11 ' HA ' ' B' ' 29' ' ' PRO . 63.8 mt -81.72 123.86 38.41 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.941 -0.763 . . . . 63.52 108.941 175.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.669 ' HD2' HG12 ' A' ' 13' ' ' ILE . 10.3 m-85 -132.78 117.14 17.43 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 107.792 -1.188 . . . . 75.52 107.792 175.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 31.8 t -77.93 93.84 4.48 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 108.565 -0.902 . . . . 71.45 108.565 173.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 50.5 mt -104.34 131.61 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 N-CA-C 108.862 -0.792 . . . . 75.11 108.862 -176.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.627 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -153.34 162.65 41.07 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 123.721 0.808 . . . . 63.25 110.133 -177.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' C' ' 147' ' ' GLU . . . 92.2 -28.92 8.12 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-N 115.938 -0.573 . . . . 73.12 114.521 168.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 12.2 pt -115.79 140.9 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 C-N-CA 123.448 0.699 . . . . 70.21 111.636 -167.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.677 ' HB2' ' HA3' ' C' ' 148' ' ' GLY . 0.4 OUTLIER -147.19 176.03 10.28 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.15 0.98 . . . . 63.24 108.6 177.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.59 -135.82 23.93 Favored Glycine 0 C--N 1.348 1.23 0 CA-C-O 119.561 -0.577 . . . . 33.54 112.055 -179.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.427 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 48.1 p -71.85 -14.99 62.11 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.416 0.687 . . . . 72.21 111.729 179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.706 ' HG3' ' HB3' ' C' ' 144' ' ' GLN . 23.2 mp0 -74.25 -57.43 3.95 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 124.173 0.989 . . . . 75.52 110.253 -176.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.567 ' SD ' ' HB3' ' E' ' 277' ' ' LEU . 25.7 ttt -80.27 -15.32 57.22 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 116.821 -0.172 . . . . 71.42 110.648 175.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.427 ' HB3' ' HA ' ' A' ' 92' ' ' THR . . . -62.57 -39.66 94.4 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-O 120.884 0.373 . . . . 71.15 110.108 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.559 ' O ' ' HB3' ' A' ' 100' ' ' ALA . 60.7 t-80 -77.3 -19.54 56.29 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-N 115.878 -0.601 . . . . 63.54 110.988 176.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 49.3 t -76.6 -61.05 2.09 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 121.813 -0.554 . . . . 74.14 110.278 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.46 -45.5 72.29 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.873 0.869 . . . . 70.4 111.702 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -91.69 6.38 79.92 Favored Glycine 0 C--N 1.34 0.783 0 CA-C-O 119.116 -0.825 . . . . 34.33 114.559 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.683 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -149.37 -61.71 0.22 Allowed 'General case' 0 N--CA 1.478 0.946 0 CA-C-N 118.117 0.958 . . . . 62.13 112.714 -175.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.474 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 87.5 t80 -78.32 -55.46 5.22 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.036 1.124 . . . . 71.54 114.036 -164.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.447 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 75.5 m -70.21 -33.06 3.1 Favored Pre-proline 0 CA--C 1.569 1.69 0 N-CA-C 114.048 1.129 . . . . 74.32 114.048 -175.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 29.4 Cg_endo -63.8 -16.8 56.91 Favored 'Trans proline' 0 C--N 1.39 2.748 0 C-N-CA 122.039 1.826 . . . . 62.43 113.149 167.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 101' ' ' TYR . 26.7 t-20 -71.98 -14.95 62.04 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 123.174 0.59 . . . . 53.21 110.825 174.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.66 HD11 HD21 ' C' ' 132' ' ' ASN . 36.0 mm -84.11 -41.8 16.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 CA-C-O 121.848 0.832 . . . . 72.33 109.855 173.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 80' ' ' GLN . 76.0 mt -76.35 -44.38 36.8 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 114.251 -1.341 . . . . 74.01 111.598 -171.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -59.82 -41.35 85.13 Favored Pre-proline 0 CA--C 1.57 1.747 0 N-CA-C 113.706 1.002 . . . . 74.03 113.706 -172.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.96 -44.73 33.01 Favored 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 122.12 1.88 . . . . 72.44 113.375 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.586 ' CE1' ' HA ' ' C' ' 108' ' ' PRO . 26.7 m-85 -73.7 -24.06 59.88 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.989 0.516 . . . . 72.45 111.997 179.37 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.22 -51.69 23.28 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 108.832 -0.803 . . . . 61.24 108.832 174.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -50.91 -46.78 60.8 Favored 'General case' 0 N--CA 1.476 0.843 0 O-C-N 124.944 1.402 . . . . 73.01 110.488 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -65.36 -42.02 93.22 Favored 'General case' 0 C--O 1.241 0.62 0 O-C-N 124.765 1.291 . . . . 74.04 111.073 -175.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 41.5 t -62.26 -45.43 93.35 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.739 0.649 . . . . 73.15 110.188 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 86.5 mt -63.56 -43.0 98.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.635 0 O-C-N 124.267 0.98 . . . . 74.55 110.105 177.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.592 HG23 ' HG3' ' A' ' 125' ' ' GLN . 91.5 m -57.14 -44.06 83.03 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.824 0.85 . . . . 65.25 110.552 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 14.6 t -67.77 -47.7 68.47 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 115.071 -0.968 . . . . 65.33 110.589 -178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 12.7 mtp -57.11 -48.58 78.27 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 124.28 1.032 . . . . 71.44 111.502 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 50.2 t -59.81 -43.44 91.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.932 0 C-N-CA 125.069 1.348 . . . . 54.15 110.859 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.8 t -67.51 -33.61 75.43 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.795 0.838 . . . . 75.32 111.59 -177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' A' ' 116' ' ' SER . 37.0 mtt180 -72.13 -29.63 64.25 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 123.428 0.691 . . . . 74.33 110.659 178.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.87 14.25 38.6 Favored Glycine 0 C--N 1.351 1.399 0 CA-C-O 119.498 -0.612 . . . . 75.5 113.555 177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 82.4 p 57.51 22.48 8.13 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 126.105 1.762 . . . . 41.33 113.329 -178.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . 0.503 ' HA ' HD11 ' E' ' 301' ' ' ILE . 91.4 m-85 -89.22 156.51 48.68 Favored Pre-proline 0 CA--C 1.554 1.102 0 C-N-CA 123.896 0.878 . . . . 73.43 108.759 171.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.646 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 60.1 Cg_endo -66.71 151.98 81.52 Favored 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.813 2.342 . . . . 53.45 111.755 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.592 ' HG3' HG23 ' A' ' 115' ' ' THR . 32.9 tt0 -53.99 127.74 27.64 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 123.976 0.797 . . . . 53.43 111.569 -177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.705 HD21 HG11 ' A' ' 64' ' ' VAL . 16.5 tp -110.71 101.15 9.81 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-N 115.21 -0.904 . . . . 73.43 109.825 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -107.48 100.07 9.53 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 107.377 -1.342 . . . . 74.12 107.377 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 28.9 tp -64.77 121.38 14.43 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 109.492 -0.558 . . . . 64.12 109.492 -178.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 130' ' ' PRO . . . -50.63 129.82 27.0 Favored Pre-proline 0 CA--C 1.559 1.294 0 C-N-CA 124.119 0.968 . . . . 62.01 112.219 -170.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 46.5 Cg_endo -84.1 115.86 2.05 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.678 2.252 . . . . 61.34 113.07 -175.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -99.65 141.43 16.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.609 0 N-CA-C 108.573 -0.899 . . . . 73.14 108.573 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.34 72.43 4.86 Favored 'General case' 0 CA--C 1.544 0.745 0 N-CA-C 108.37 -0.974 . . . . 71.55 108.37 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -69.46 -35.74 75.92 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.818 1.247 . . . . 72.02 110.586 -172.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.683 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 6.0 p-10 -62.03 -38.87 90.31 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.655 -1.157 . . . . 72.43 111.511 174.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -80.75 -27.55 36.75 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.442 0.697 . . . . 74.35 111.336 177.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 3.3 tt -63.01 -38.35 90.86 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 123.965 0.906 . . . . 75.25 109.946 -177.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -62.82 -31.55 72.57 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 116.214 -0.448 . . . . 65.41 111.051 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 93.5 mmm -74.66 -31.21 61.86 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.719 0.408 . . . . 74.43 111.201 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 50.0 m-80 -65.48 -38.94 91.25 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 116.351 -0.386 . . . . 62.21 110.118 172.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -71.15 -36.91 72.23 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.396 0.679 . . . . 71.33 110.783 174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 tt -63.45 -49.1 75.02 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 123.633 0.773 . . . . 72.45 110.911 -172.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -169.36 18.07 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.497 0.498 . . . . 73.13 110.758 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.614 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 34.3 tt0 59.86 34.82 21.82 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.325 1.05 . . . . 61.25 111.11 -178.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -98.12 116.45 30.37 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 115.435 -0.802 . . . . 63.42 109.69 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -91.78 -49.3 6.34 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 123.123 0.569 . . . . 55.42 109.601 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 68.82 -163.94 49.75 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 115.246 -0.888 . . . . 63.51 113.571 -179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.453 ' HB3' ' ND2' ' C' ' 5' ' ' ASN . 8.2 pt-20 -161.45 165.84 28.15 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.128 0.971 . . . . 63.44 110.012 -179.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 163.63 97.02 0.11 Allowed Glycine 0 C--N 1.346 1.111 0 N-CA-C 112.301 -0.32 . . . . 72.02 112.301 -178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 29.0 p -126.75 150.25 49.19 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.912 0.885 . . . . 71.41 110.576 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -88.85 108.56 19.6 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.746 0.818 . . . . 73.22 110.336 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . 0.409 ' HG2' ' HG3' ' A' ' 153' ' ' GLN . 27.4 tt0 -98.24 78.16 2.45 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 108.266 -1.013 . . . . 73.54 108.266 169.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -83.34 -17.16 43.39 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 116.384 -0.371 . . . . 74.13 111.12 177.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.409 ' HG3' ' HG2' ' A' ' 151' ' ' GLU . 94.4 mt-30 61.59 78.57 0.28 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.807 1.243 . . . . 63.12 112.193 175.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -173.03 -73.15 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 123.778 0.831 . . . . 64.05 108.981 170.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.164 0 C-N-CA 123.787 0.835 . . . . 71.34 109.171 177.704 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.486 1.335 0 N-CA-C 110.258 -0.275 . . . . 64.23 110.258 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 45.7 t -159.58 113.67 2.31 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.354 0.662 . . . . 43.13 109.331 -179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -102.42 107.19 18.09 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 121.343 0.592 . . . . 55.4 109.822 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -82.86 82.6 8.09 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.463 0.705 . . . . 71.41 110.098 -176.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 38.5 t30 -164.67 -172.46 2.66 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 108.389 -0.967 . . . . 64.35 108.389 176.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -49.3 111.8 0.54 Allowed 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.812 0.845 . . . . 72.1 112.748 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 89.8 m -67.15 -50.61 60.58 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.196 0.998 . . . . 75.21 110.341 178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 73.57 -56.99 0.64 Allowed 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 125.698 1.599 . . . . 75.04 112.795 178.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 12.1 ptm 56.83 166.17 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 128.072 2.549 . . . . 73.21 113.564 -168.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 86.1 m -163.87 139.59 6.38 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.377 -1.342 . . . . 51.31 107.377 176.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.86 156.69 44.97 Favored 'General case' 0 CA--C 1.511 -0.53 0 CA-C-O 121.807 0.813 . . . . 74.02 110.957 161.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.604 ' HB2' HG12 ' E' ' 306' ' ' VAL . 17.1 pm0 -126.43 132.67 51.44 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 113.644 -1.616 . . . . 65.33 107.722 176.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.414 ' O ' HG13 ' B' ' 13' ' ' ILE . 35.5 pt -76.89 108.68 10.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 CA-C-N 115.497 -0.774 . . . . 72.13 109.136 177.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -74.93 -46.68 34.04 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 109.611 -0.515 . . . . 73.31 109.611 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.757 HH22 HG23 ' E' ' 301' ' ' ILE . 18.2 ttt85 -162.04 135.62 6.37 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 110.28 -0.267 . . . . 70.45 110.28 -174.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 79.9 mt -116.74 131.74 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 106.147 -1.797 . . . . 73.35 106.147 170.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 11.3 p90 -164.01 141.58 7.07 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 122.644 0.378 . . . . 65.32 110.975 -171.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 45.2 m -72.34 116.89 13.33 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 108.726 -0.842 . . . . 74.13 108.726 170.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 46.5 mtpt -84.99 -40.28 17.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.944 -0.571 . . . . 71.12 110.458 178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 23' ' ' PHE . 11.6 t70 -145.62 144.2 30.31 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 116.108 -0.496 . . . . 63.21 111.081 -169.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.533 HD11 ' SG ' ' B' ' 113' ' ' CYS . 32.2 mm -137.15 145.85 29.06 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.277 1.431 . . . . 65.52 108.487 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.552 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 26.7 t -146.25 138.86 25.39 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.284 -1.326 . . . . 22.52 107.434 176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -155.92 143.12 19.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.024 -1.102 . . . . 73.53 108.024 172.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.3 mt-10 -143.6 155.59 44.32 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.733 1.213 . . . . 70.43 108.716 177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.54 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -151.27 86.09 4.85 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 107.878 -1.156 . . . . 60.01 107.878 172.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -68.5 -43.22 4.31 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.779 2.319 . . . . 71.13 113.006 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' B' ' 71' ' ' GLU . 38.0 m-80 -105.0 29.02 6.66 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.018 0.527 . . . . 70.34 109.893 179.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.54 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -47.55 -54.06 25.42 Favored Pre-proline 0 CA--C 1.56 1.351 0 C-N-CA 124.866 1.266 . . . . 42.44 113.233 175.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.512 ' HA ' HD11 ' A' ' 83' ' ' ILE . 2.5 Cg_endo -80.35 -20.44 8.36 Favored 'Trans proline' 0 C--N 1.387 2.603 0 C-N-CA 121.527 1.485 . . . . 60.22 112.77 -176.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.52 ' HB3' ' NE2' ' B' ' 33' ' ' GLN . 51.5 m-70 -97.41 2.66 50.68 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.405 1.082 . . . . 60.32 112.686 -175.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 6.1 p -68.25 -15.12 19.28 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.39 0 C-N-CA 123.62 0.768 . . . . 75.2 112.08 -174.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -84.94 -27.11 26.78 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.606 0.762 . . . . 73.12 112.836 -175.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.52 ' NE2' ' HB3' ' B' ' 30' ' ' HIS . 23.0 pt20 -75.69 -29.43 59.01 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 122.591 0.356 . . . . 72.45 111.626 -172.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.433 ' HB2' ' CZ2' ' B' ' 36' ' ' TRP . 38.1 mtpt -108.85 117.44 34.2 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.726 1.21 . . . . 52.33 108.707 176.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -89.71 117.41 28.55 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 118.458 0.572 . . . . 75.23 110.857 175.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.472 ' CZ2' HD13 ' B' ' 68' ' ' LEU . 0.0 OUTLIER -171.39 162.5 6.72 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 123.982 0.913 . . . . 71.53 112.916 -178.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -93.24 132.72 29.89 Favored Pre-proline 0 N--CA 1.485 1.322 0 C-N-CA 124.328 1.051 . . . . 64.2 109.997 170.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -74.44 147.39 36.48 Favored 'Trans proline' 0 C--N 1.372 1.779 0 C-N-CA 122.25 1.966 . . . . 73.21 112.83 171.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -82.23 109.65 16.7 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.845 -1.169 . . . . 62.4 107.845 163.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.439 HG12 ' HE1' ' H' ' 290' ' ' TRP . 60.8 t -100.24 123.21 52.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.731 -0.668 . . . . 61.21 109.422 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.3 142.24 35.41 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.776 0.83 . . . . 71.31 109.555 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.601 HD11 HD21 ' B' ' 128' ' ' LEU . 3.7 tt -106.52 134.98 48.83 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 106.962 -1.496 . . . . 61.1 106.962 176.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.749 ' HB2' ' HB ' ' B' ' 63' ' ' THR . 4.7 m-20 -128.42 114.55 16.96 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 108.215 -1.032 . . . . 60.21 108.215 -177.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.17 127.2 46.47 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 107.239 -1.393 . . . . 73.53 107.239 175.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -137.66 147.12 44.62 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 123.453 0.701 . . . . 73.23 109.199 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 69.1 p -121.82 128.85 52.12 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.412 0.685 . . . . 63.41 110.217 -173.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . 0.41 ' HB3' ' HB ' ' B' ' 59' ' ' VAL . . . -131.57 137.3 48.39 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.044 -1.095 . . . . 63.44 108.044 174.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 80.7 p -144.6 163.17 34.72 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 121.132 0.491 . . . . 55.32 110.559 174.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 71.8 p -152.88 173.09 15.79 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 115.065 -0.97 . . . . 75.53 108.845 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -120.51 125.14 47.09 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 122.801 0.44 . . . . 73.51 110.25 175.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 65.1 mt -87.45 -46.56 9.5 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.397 0.679 . . . . 72.43 109.459 176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.25 -174.33 4.93 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 115.209 -0.905 . . . . 54.24 111.059 -174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -64.79 120.72 13.01 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 115.5 -0.773 . . . . 72.22 110.197 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 70.02 -5.48 1.27 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.522 1.529 . . . . 75.21 112.542 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 68.7 t -102.43 111.62 32.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.585 0 N-CA-C 108.728 -0.842 . . . . 73.31 108.728 -175.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.4 ' HE1' HD23 ' H' ' 277' ' ' LEU . 78.3 m-85 -119.79 139.93 51.56 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.597 -0.729 . . . . 64.32 109.861 178.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.581 ' HG2' HG12 ' B' ' 83' ' ' ILE . 2.9 tm-20 -104.05 97.13 7.15 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 106.694 -1.595 . . . . 70.22 106.694 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -92.62 118.72 38.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 123.864 0.866 . . . . 74.02 109.533 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.429 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 21.3 t -103.61 119.23 51.92 Favored 'Isoleucine or valine' 0 C--O 1.241 0.627 0 C-N-CA 123.632 0.773 . . . . 64.31 110.033 176.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.23 109.14 20.97 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.096 -1.076 . . . . 64.34 108.096 172.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . . . . . . . . . 13.0 ttm-85 -90.7 122.95 33.91 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.351 -0.611 . . . . 74.42 109.351 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 18.8 t -120.43 124.99 73.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 107.985 -1.117 . . . . 71.43 107.985 169.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.749 ' HB ' ' HB2' ' B' ' 43' ' ' ASP . 12.4 m -119.7 138.53 53.23 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 123.579 0.752 . . . . 71.45 109.227 -176.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.533 HG23 HD13 ' B' ' 114' ' ' ILE . 51.6 t -122.0 128.78 75.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 123.932 0.893 . . . . 62.13 109.164 175.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 52.1 m -118.84 144.28 46.45 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.576 -0.898 . . . . 75.02 108.576 171.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.81 133.79 30.86 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 108.66 -0.867 . . . . 71.23 108.66 175.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 31.4 p -149.88 140.11 22.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 122.883 0.473 . . . . 74.15 110.321 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.573 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.2 OUTLIER -137.41 144.3 42.33 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.597 1.159 . . . . 71.33 109.228 -171.154 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 62.86 -108.06 1.95 Allowed Glycine 0 C--N 1.347 1.143 0 O-C-N 123.341 0.401 . . . . 74.14 113.81 171.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -116.05 1.17 13.2 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.226 1.01 . . . . 74.34 110.11 -176.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' B' ' 27' ' ' ASN . 0.9 OUTLIER -139.88 177.98 7.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.002 0.742 . . . . 72.24 113.002 -169.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 97.7 m -89.72 140.34 29.68 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 124.419 1.088 . . . . 55.12 109.808 171.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.573 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -80.44 -67.58 0.76 Allowed 'General case' 0 C--O 1.239 0.504 0 C-N-CA 124.106 0.962 . . . . 71.22 109.477 176.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -159.3 157.79 31.19 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 114.146 -1.388 . . . . 62.53 109.472 179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 84.9 mt -125.98 150.51 47.98 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.608 1.163 . . . . 75.54 108.22 178.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 46.5 t -157.96 152.02 24.24 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.44 -0.578 . . . . 71.14 109.44 -179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.552 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 36.7 tt0 -164.85 131.51 2.94 Favored 'General case' 0 CA--C 1.518 -0.264 0 N-CA-C 109.147 -0.686 . . . . 62.41 109.147 179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 94.8 t -124.23 146.39 29.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 108.771 -0.826 . . . . 72.34 108.771 175.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -125.09 98.26 5.59 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 108.463 -0.939 . . . . 75.32 108.463 171.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.412 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 9.1 tp-100 -86.52 102.08 13.78 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.445 -0.798 . . . . 44.12 109.186 178.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.62 148.66 20.61 Favored Glycine 0 C--O 1.24 0.516 0 N-CA-C 111.189 -0.765 . . . . 62.02 111.189 177.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.422 ' HA3' HD21 ' B' ' 106' ' ' LEU . . . -152.38 125.46 1.82 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.889 -0.885 . . . . 71.2 110.889 -177.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.581 HG12 ' HG2' ' B' ' 57' ' ' GLU . 38.0 mt -88.94 117.22 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 109.113 -0.699 . . . . 70.41 109.113 177.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -122.27 131.37 53.88 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.195 -1.409 . . . . 72.22 107.195 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 21.7 m -97.62 88.87 4.47 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 108.216 -1.031 . . . . 73.43 108.216 176.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.451 ' HB ' HD11 ' B' ' 89' ' ' ILE . 4.4 pt -95.67 121.98 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 114.24 -1.346 . . . . 75.42 110.028 -169.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -135.46 159.68 40.85 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.924 0.889 . . . . 45.42 109.89 -177.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.19 -56.55 3.6 Favored Glycine 0 C--N 1.345 1.062 0 CA-C-N 115.989 -0.55 . . . . 62.42 111.957 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.451 HD11 ' HB ' ' B' ' 86' ' ' ILE . 1.3 pp -58.5 153.04 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 124.152 0.981 . . . . 75.25 113.308 178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -169.28 146.5 3.54 Favored 'General case' 0 CA--C 1.549 0.929 0 CA-C-N 114.842 -1.072 . . . . 70.52 108.43 175.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.67 -130.45 13.13 Favored Glycine 0 C--N 1.349 1.293 0 CA-C-O 120.028 -0.318 . . . . 62.12 113.465 177.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 22.7 m -65.8 -33.22 75.35 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.479 1.111 . . . . 35.05 110.883 -179.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -62.83 -40.54 97.74 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 115.202 -0.908 . . . . 74.3 110.561 177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.425 ' SD ' ' O ' ' H' ' 277' ' ' LEU . 23.0 ttt -76.93 -31.73 56.86 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 115.808 -0.633 . . . . 70.11 110.438 179.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.05 -21.3 66.37 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.877 -0.602 . . . . 65.32 111.517 175.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.406 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 33.7 t-80 -84.71 -37.0 21.47 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.22 0.608 . . . . 73.1 110.552 169.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 43.2 t -63.47 -67.2 0.45 Allowed 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 122.482 0.313 . . . . 61.15 111.38 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.24 -12.79 42.7 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 112.383 0.512 . . . . 72.51 112.383 -176.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.03 -4.97 53.9 Favored Glycine 0 C--N 1.348 1.227 0 CA-C-O 119.715 -0.492 . . . . 53.43 113.82 -177.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -141.43 -58.41 0.49 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 117.185 0.493 . . . . 74.31 111.753 -177.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 75.7 t80 -75.28 -44.61 44.73 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 123.2 0.6 . . . . 72.1 111.922 -171.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 82.9 m -67.21 -44.68 49.23 Favored Pre-proline 0 CA--C 1.565 1.546 0 CA-C-O 118.572 -0.728 . . . . 71.03 111.721 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_exo -57.16 -36.27 99.1 Favored 'Trans proline' 0 C--N 1.397 3.088 0 C-N-CA 122.435 2.09 . . . . 64.14 113.143 168.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -61.87 -35.91 79.72 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.389 0.676 . . . . 60.44 110.429 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 64.9 mt -69.6 -48.02 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 123.328 0.651 . . . . 74.1 110.752 174.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.422 HD21 ' HA3' ' B' ' 82' ' ' GLY . 96.5 mt -74.26 -21.12 59.9 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.188 0.595 . . . . 65.02 112.24 -173.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.573 ' HZ ' HD22 ' B' ' 128' ' ' LEU . 50.0 t80 -60.64 -52.32 73.48 Favored Pre-proline 0 CA--C 1.556 1.186 0 CA-C-O 117.143 -1.408 . . . . 65.22 113.578 -171.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -53.88 -35.58 80.34 Favored 'Trans proline' 0 C--N 1.389 2.703 0 C-N-CA 122.204 1.936 . . . . 55.21 113.267 179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 61.5 m-85 -68.81 -49.87 54.9 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 123.683 0.793 . . . . 74.42 110.548 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -60.56 -40.54 92.0 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 123.574 0.749 . . . . 50.41 111.087 176.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 51.2 ttt-85 -57.23 -62.09 2.01 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.236 1.814 . . . . 73.34 111.7 -176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . 0.466 ' HG2' ' NH2' ' C' ' 120' ' ' ARG . 13.7 tp10 -70.34 -23.89 62.89 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.498 0.719 . . . . 72.41 110.709 -176.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.533 ' SG ' HD11 ' B' ' 21' ' ' ILE . 4.1 t -69.97 -35.84 74.77 Favored 'General case' 0 CA--C 1.544 0.721 0 CA-C-O 119.683 -0.199 . . . . 61.43 110.632 178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.533 HD13 HG23 ' B' ' 64' ' ' VAL . 61.7 mt -63.82 -54.86 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 109.048 -0.723 . . . . 72.44 109.048 171.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 17.6 m -56.62 -34.69 67.5 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.382 1.073 . . . . 61.32 112.072 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -66.64 -45.01 80.41 Favored 'General case' 0 C--N 1.347 0.47 0 CA-C-N 115.644 -0.707 . . . . 71.04 110.43 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.531 ' SD ' ' HD2' ' B' ' 120' ' ' ARG . 13.7 mmt -71.2 -33.93 70.4 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 123.498 0.499 . . . . 52.03 111.165 -177.418 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.61 -44.0 98.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.933 0 C-N-CA 123.833 0.853 . . . . 63.22 109.746 173.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 29.2 t -72.0 -25.48 61.85 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-N 115.35 -0.841 . . . . 65.34 111.399 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.531 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 81.7 mtt-85 -72.94 -27.51 61.89 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.877 0.471 . . . . 74.33 109.883 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.36 14.71 38.6 Favored Glycine 0 C--N 1.35 1.341 0 O-C-N 123.837 0.711 . . . . 52.11 112.756 169.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 21.9 p 54.86 46.6 24.13 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 125.888 1.675 . . . . 74.53 112.253 177.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.566 ' HD1' ' HH ' ' H' ' 297' ' ' TYR . 60.9 m-85 -108.8 158.5 33.95 Favored Pre-proline 0 CA--C 1.564 1.5 0 C-N-CA 124.523 1.129 . . . . 63.1 109.099 174.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.407 ' HG2' HG22 ' H' ' 296' ' ' THR . 89.8 Cg_endo -72.93 -163.21 0.15 Allowed 'Trans proline' 0 C--N 1.386 2.546 0 C-N-CA 123.073 2.515 . . . . 71.21 113.696 -174.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.595 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 21.6 tp60 -64.08 130.38 43.78 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.724 0.81 . . . . 65.03 112.098 -174.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.425 ' HB2' HG23 ' H' ' 296' ' ' THR . 29.9 tp -130.5 85.09 2.25 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.141 0.576 . . . . 74.52 109.615 171.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -91.01 115.55 28.1 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.623 -0.88 . . . . 74.34 108.623 174.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.601 HD21 HD11 ' B' ' 42' ' ' LEU . 1.6 tt -77.12 140.22 40.18 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 107.841 -1.17 . . . . 71.44 107.841 173.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.483 ' HB3' HD13 ' H' ' 291' ' ' LEU . . . -76.77 148.31 79.13 Favored Pre-proline 0 CA--C 1.551 0.995 0 C-N-CA 123.143 0.577 . . . . 71.45 111.057 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.87 109.67 0.48 Allowed 'Trans proline' 0 C--N 1.38 2.188 0 C-N-CA 122.576 2.184 . . . . 65.4 112.354 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 59.6 t -89.84 110.37 21.73 Favored 'Isoleucine or valine' 0 C--O 1.239 0.529 0 N-CA-C 108.747 -0.834 . . . . 42.12 108.747 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 -90.31 85.44 6.21 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.724 -0.843 . . . . 64.13 108.724 -177.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -59.05 -36.37 74.91 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.921 0.889 . . . . 74.44 111.525 179.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.459 ' O ' ' HG2' ' B' ' 138' ' ' MET . 4.2 m-20 -61.05 -47.81 84.64 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.874 -1.057 . . . . 73.33 110.391 -179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -66.62 -37.01 83.96 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 123.679 0.612 . . . . 64.54 111.466 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.76 -41.98 98.4 Favored 'General case' 0 N--CA 1.483 1.205 0 O-C-N 123.659 0.6 . . . . 74.0 110.888 177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -74.27 -31.7 62.64 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.704 -0.68 . . . . 72.33 110.486 -179.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' B' ' 134' ' ' ASP . 24.2 mmt -67.48 -38.84 84.99 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.763 -0.458 . . . . 61.32 109.763 173.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' B' ' 142' ' ' GLN . 0.9 OUTLIER -75.04 -8.05 55.42 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.387 0.675 . . . . 55.14 111.567 -175.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -69.3 -38.79 78.46 Favored 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 110.101 -0.333 . . . . 74.44 110.101 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.17 4.57 10.83 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 113.209 0.818 . . . . 73.54 113.209 -176.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' B' ' 139' ' ' ASN . 58.1 tt0 -143.38 141.38 30.88 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 123.028 0.531 . . . . 52.03 110.443 -177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -124.0 171.01 10.07 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.193 0.597 . . . . 74.14 110.078 173.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -115.42 172.65 6.96 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.931 0.892 . . . . 74.14 109.254 172.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -161.46 74.33 0.46 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.325 0.65 . . . . 53.43 109.275 177.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . 0.555 ' HA2' HG23 ' D' ' 7' ' ' THR . . . -95.26 120.11 6.39 Favored Glycine 0 C--N 1.346 1.133 0 N-CA-C 111.731 -0.548 . . . . 73.41 111.731 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -166.4 98.11 0.59 Allowed 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.081 0.552 . . . . 75.04 110.181 -173.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -141.39 -120.22 1.62 Allowed Glycine 0 C--N 1.345 1.073 0 N-CA-C 111.059 -0.817 . . . . 50.4 111.059 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 10.2 t -173.65 129.59 0.42 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.931 0.892 . . . . 43.03 109.076 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -166.17 127.93 1.86 Allowed 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 109.425 -0.583 . . . . 72.34 109.425 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -133.04 105.83 7.29 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.099 -1.445 . . . . 73.3 107.099 175.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -114.55 109.34 18.11 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 122.616 0.367 . . . . 72.42 110.92 -168.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -111.62 100.17 8.76 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 107.869 -1.16 . . . . 63.32 107.869 170.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.95 158.13 29.45 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 122.945 0.498 . . . . 72.1 110.802 -179.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.936 0 C-N-CA 124.073 0.949 . . . . 72.33 108.618 179.926 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.406 ' SD ' ' N ' ' C' ' 1' ' ' MET . 1.4 mpt? . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 108.654 -0.869 . . . . 65.51 108.654 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 54.3 m -151.81 112.19 4.13 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 123.855 0.862 . . . . 51.13 108.985 171.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -83.49 151.04 25.63 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.292 0.637 . . . . 73.04 110.499 177.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -148.83 140.04 23.17 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.192 0.597 . . . . 73.43 109.922 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.453 ' ND2' ' HB3' ' A' ' 147' ' ' GLU . 5.2 p30 -112.08 141.72 45.41 Favored 'General case' 0 C--O 1.242 0.705 0 C-N-CA 124.459 1.103 . . . . 73.55 109.408 175.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -86.51 73.34 10.12 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.639 0.733 . . . . 64.2 109.508 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 39.1 m -120.82 95.2 4.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.057 0.943 . . . . 72.45 108.616 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -80.45 -40.97 25.28 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.874 -0.603 . . . . 72.33 110.737 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . . . . . . . . . 89.3 mtp 59.69 115.39 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.065 1.346 . . . . 72.21 112.379 -173.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 6.7 m -122.45 97.12 5.32 Favored 'General case' 0 C--O 1.239 0.511 0 N-CA-C 107.492 -1.299 . . . . 61.12 107.492 174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 72.4 t80 -105.59 129.3 53.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.742 -0.663 . . . . 74.01 109.446 -176.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.663 ' HB3' ' H ' ' G' ' 308' ' ' CYS . 0.7 OUTLIER -137.71 108.87 6.8 Favored 'General case' 0 C--O 1.241 0.646 0 C-N-CA 123.401 0.681 . . . . 63.14 109.254 173.521 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -66.7 120.07 13.25 Favored 'Isoleucine or valine' 0 C--O 1.241 0.645 0 CA-C-N 115.222 -0.899 . . . . 63.32 108.626 171.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -86.15 -49.91 7.39 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.685 -0.689 . . . . 70.22 109.9 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . 0.635 HH12 HD13 ' G' ' 301' ' ' ILE . 58.7 ttt180 -171.69 129.41 0.66 Allowed 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.174 -0.467 . . . . 65.42 109.893 -176.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 88.1 mt -107.21 143.88 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.179 0 N-CA-C 107.197 -1.409 . . . . 72.33 107.197 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.488 ' HE1' HG12 ' C' ' 83' ' ' ILE . 15.7 p90 -175.73 151.4 1.14 Allowed 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.315 0.579 . . . . 71.55 110.444 -177.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 75.0 p -76.6 107.12 8.67 Favored 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 108.622 -0.881 . . . . 72.12 108.622 171.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 mtmt -70.48 -29.73 66.35 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 109.008 -0.738 . . . . 72.53 109.008 173.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.756 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 14.5 t70 -145.84 140.51 27.11 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 115.26 -0.882 . . . . 53.42 110.687 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 93.4 mt -134.66 144.98 33.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 106.275 -1.75 . . . . 62.32 106.275 170.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 34.0 t -159.68 151.77 20.71 Favored 'General case' 0 C--O 1.239 0.515 0 CA-C-O 121.484 0.659 . . . . 54.34 110.674 178.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.43 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 80.7 t80 -149.36 109.7 4.18 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 107.335 -1.357 . . . . 75.14 107.335 171.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -115.3 119.17 35.41 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 108.98 -0.748 . . . . 64.12 108.98 -174.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -144.07 79.62 12.98 Favored Pre-proline 0 CA--C 1.543 0.693 0 N-CA-C 108.626 -0.879 . . . . 65.53 108.626 178.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.17 -12.53 25.62 Favored 'Trans proline' 0 C--N 1.38 2.223 0 C-N-CA 122.815 2.343 . . . . 72.11 111.409 171.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -103.97 13.25 33.05 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 124.453 1.101 . . . . 51.41 109.357 178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . . . . . . . . . . . -56.55 -49.02 96.0 Favored Pre-proline 0 CA--C 1.563 1.46 0 N-CA-C 114.613 1.338 . . . . 65.12 114.613 -174.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.402 ' HA ' HH21 ' D' ' 15' ' ' ARG . 24.0 Cg_exo -65.24 -39.72 22.09 Favored 'Trans proline' 0 C--N 1.387 2.604 0 C-N-CA 121.624 1.549 . . . . 62.43 112.181 178.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -68.76 -41.59 78.65 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-N 114.977 -1.011 . . . . 71.25 112.359 -176.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.435 ' HA ' ' HE2' ' C' ' 34' ' ' LYS . 13.5 p -70.94 -25.83 26.59 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 N-CA-C 112.065 0.394 . . . . 71.43 112.065 -173.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . 0.434 ' HE2' ' HD3' ' F' ' 304' ' ' PRO . 67.9 t80 -69.63 -12.16 61.42 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.668 0.787 . . . . 75.11 112.173 -176.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -128.47 22.84 5.95 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.584 0.753 . . . . 71.45 110.635 176.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.6 ' HE3' HD21 ' C' ' 68' ' ' LEU . 31.9 ttpt -109.1 168.1 9.62 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.934 0.894 . . . . 75.35 110.626 -174.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -54.67 125.23 19.03 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 124.942 1.297 . . . . 65.02 112.243 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -85.53 68.21 10.36 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 123.955 0.902 . . . . 72.34 111.39 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -149.3 71.65 10.02 Favored Pre-proline 0 N--CA 1.478 0.946 0 N-CA-C 109.379 -0.6 . . . . 75.24 109.379 178.125 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -90.03 143.19 4.0 Favored 'Trans proline' 0 C--N 1.369 1.633 0 C-N-CA 122.673 2.249 . . . . 63.02 112.023 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -88.06 91.6 8.83 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 107.61 -1.256 . . . . 75.53 107.61 170.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.41 129.02 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 N-CA-C 108.662 -0.866 . . . . 55.3 108.662 178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -128.77 118.24 22.46 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.394 0.678 . . . . 71.1 109.222 -174.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 61.7 tp -87.17 119.76 27.74 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 107.423 -1.325 . . . . 65.41 107.423 175.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -123.73 114.35 19.81 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 108.959 -0.756 . . . . 74.42 108.959 -172.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 4.6 mp -103.83 150.11 24.43 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.38 0.672 . . . . 73.32 109.284 -177.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.729 ' HB3' ' HD2' ' C' ' 61' ' ' ARG . 6.5 t70 -148.02 150.93 34.86 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.345 1.058 . . . . 74.42 109.158 176.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 77.2 m -119.34 131.12 55.66 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.886 0.874 . . . . 54.42 110.272 -174.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.549 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -134.57 145.77 49.01 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 64.13 109.509 174.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 68.0 m -151.89 146.05 25.36 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.536 0.734 . . . . 74.14 110.262 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 72.8 p -148.09 137.09 21.96 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.556 0.742 . . . . 75.43 109.93 178.002 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -83.58 116.62 22.67 Favored 'General case' 0 C--N 1.352 0.677 0 N-CA-C 109.096 -0.705 . . . . 70.32 109.096 173.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.593 HD11 ' HB2' ' C' ' 57' ' ' GLU . 43.7 mt -93.91 -34.02 13.27 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.453 0.701 . . . . 54.1 109.933 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -160.71 -173.99 4.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.939 0.896 . . . . 73.54 110.101 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.95 116.39 5.8 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 115.32 -0.854 . . . . 75.15 110.188 178.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 70.28 -5.85 1.26 Allowed 'General case' 0 N--CA 1.496 1.84 0 C-N-CA 125.559 1.543 . . . . 44.3 113.129 -176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 47.7 t -94.76 109.54 22.42 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 108.724 -0.843 . . . . 75.33 108.724 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -124.62 126.18 45.35 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.518 1.127 . . . . 75.53 108.748 -179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.593 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.1 tt0 -82.21 116.17 21.63 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.051 -0.977 . . . . 71.55 108.783 173.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 93.6 t -97.23 122.82 49.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 107.597 -1.26 . . . . 63.21 107.597 171.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.549 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 92.5 t -115.85 132.81 64.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 N-CA-C 108.536 -0.912 . . . . 73.45 108.536 173.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -116.94 102.59 9.49 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 107.343 -1.354 . . . . 60.2 107.343 174.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.729 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 2.2 tmt_? -82.59 110.03 17.31 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 124.226 1.01 . . . . 74.13 108.481 178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.52 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.5 t -102.57 136.88 32.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 N-CA-C 107.92 -1.141 . . . . 64.35 107.92 173.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 90.4 m -140.03 116.54 10.73 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.217 -0.66 . . . . 72.12 109.217 176.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 78.4 t -102.35 109.09 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 114.793 -1.094 . . . . 71.22 108.1 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 12.0 m -98.67 150.68 21.52 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 114.623 -1.171 . . . . 71.34 109.301 -177.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -138.94 111.24 7.44 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.141 -1.429 . . . . 74.24 107.141 173.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 64.2 m -144.39 127.08 16.16 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 109.621 -0.511 . . . . 33.32 109.621 178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.645 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.4 OUTLIER -90.29 60.5 4.76 Favored 'General case' 0 CA--C 1.547 0.844 0 CA-C-O 122.283 1.039 . . . . 71.22 108.798 176.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 110.16 -122.7 6.41 Favored Glycine 0 C--N 1.348 1.236 0 CA-C-N 114.063 -1.426 . . . . 43.15 110.517 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -91.86 -23.93 19.5 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.449 -0.945 . . . . 73.12 108.449 169.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.11 115.89 5.94 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 124.424 1.09 . . . . 72.21 109.722 173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 22.6 m -85.73 140.19 30.71 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 122.766 0.427 . . . . 63.34 111.085 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -87.37 -61.54 1.7 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.962 0.905 . . . . 41.4 109.058 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -164.47 176.42 9.03 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.454 0.702 . . . . 71.12 110.653 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -141.57 143.9 33.96 Favored 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 107.934 -1.135 . . . . 54.14 107.934 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.501 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.7 t -147.17 129.83 16.02 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.558 0.743 . . . . 65.04 109.113 175.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -132.15 139.6 48.47 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.344 0.658 . . . . 71.13 110.407 179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 25.5 t -136.97 114.15 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 124.526 1.13 . . . . 65.44 108.365 172.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.756 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 53.5 mt-30 -92.31 93.62 8.73 Favored 'General case' 0 C--O 1.244 0.777 0 N-CA-C 108.849 -0.797 . . . . 75.43 108.849 171.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.427 ' HB2' ' HB2' ' C' ' 110' ' ' ALA . 9.5 tp-100 -80.04 105.39 11.28 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.407 -0.815 . . . . 75.53 110.073 -179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -87.06 155.0 27.06 Favored Glycine 0 C--N 1.336 0.537 0 CA-C-N 115.917 -0.583 . . . . 73.24 112.08 175.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . 0.487 ' HA3' HD21 ' C' ' 106' ' ' LEU . . . -156.57 116.22 0.71 Allowed Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 110.703 -0.959 . . . . 73.22 110.703 175.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.511 HD12 HD11 ' C' ' 51' ' ' LEU . 15.3 mm -81.41 122.73 36.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.192 -1.04 . . . . 75.03 108.192 175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -132.68 142.07 48.9 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 -178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . 0.622 ' HB2' ' HG2' ' C' ' 12' ' ' GLN . 38.3 m -109.8 121.47 45.3 Favored 'General case' 0 C--O 1.24 0.599 0 N-CA-C 107.633 -1.247 . . . . 72.2 107.633 169.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.505 ' HB ' HD11 ' C' ' 89' ' ' ILE . 1.9 pp -121.49 141.41 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.873 0.869 . . . . 75.44 110.852 -171.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -158.76 164.22 36.04 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 124.003 0.921 . . . . 74.1 109.645 177.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.64 -19.11 34.56 Favored Glycine 0 C--N 1.349 1.269 0 N-CA-C 114.092 0.397 . . . . 71.51 114.092 176.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' C' ' 86' ' ' ILE . 0.8 OUTLIER -101.91 141.88 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 124.76 1.224 . . . . 64.24 110.581 177.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -156.15 148.24 23.28 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.591 0.757 . . . . 74.02 110.068 -178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 74.18 -146.06 35.69 Favored Glycine 0 C--N 1.352 1.443 0 CA-C-N 116.27 -0.423 . . . . 73.32 112.874 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.6 p -67.83 -21.54 65.2 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.481 0.712 . . . . 72.45 111.357 178.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.6 -36.74 84.63 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.588 0.755 . . . . 71.35 110.926 173.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.505 ' HG3' HD13 ' C' ' 89' ' ' ILE . 28.1 ttt -70.42 -29.92 66.65 Favored 'General case' 0 C--N 1.348 0.528 0 CA-C-N 116.288 -0.415 . . . . 62.2 110.883 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.97 -26.82 69.02 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.313 0.645 . . . . 54.44 111.679 176.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.473 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 50.1 t-80 -74.14 -26.93 60.61 Favored 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 123.154 0.582 . . . . 72.52 110.816 174.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -81.18 -60.68 2.19 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 122.511 0.324 . . . . 33.42 110.712 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.638 HD22 HD22 ' F' ' 278' ' ' LEU . 4.6 pp -73.23 -36.96 66.52 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.257 0.623 . . . . 63.12 111.695 -174.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . 0.436 ' N ' HD12 ' C' ' 98' ' ' LEU . . . -90.95 -14.65 57.54 Favored Glycine 0 C--N 1.347 1.181 0 N-CA-C 114.3 0.48 . . . . 72.15 114.3 -170.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' C' ' 96' ' ' HIS . . . -127.09 -58.16 1.29 Allowed 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 122.725 0.41 . . . . 64.12 111.579 -172.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -67.8 -45.24 75.36 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 122.602 0.361 . . . . 44.41 111.935 -174.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 83.3 m -63.94 -45.52 80.65 Favored Pre-proline 0 CA--C 1.567 1.616 0 CA-C-O 118.641 -0.695 . . . . 73.21 112.124 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -53.63 -39.73 81.97 Favored 'Trans proline' 0 C--N 1.394 2.963 0 C-N-CA 122.559 2.173 . . . . 72.43 113.87 165.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -65.9 -18.75 65.55 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 122.826 0.451 . . . . 61.32 112.202 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 28.2 mm -86.66 -45.94 16.51 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 123.254 0.622 . . . . 73.41 110.537 173.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.487 HD21 ' HA3' ' C' ' 82' ' ' GLY . 88.7 mt -79.85 -43.53 22.16 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 112.936 0.717 . . . . 60.31 112.936 -168.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.4 -42.08 89.87 Favored Pre-proline 0 CA--C 1.561 1.391 0 C-N-CA 124.239 1.016 . . . . 73.13 113.041 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . 0.586 ' HA ' ' CE1' ' A' ' 109' ' ' TYR . 69.9 Cg_exo -44.36 -46.97 11.34 Favored 'Trans proline' 0 C--N 1.389 2.678 0 C-N-CA 122.628 2.219 . . . . 54.23 115.091 169.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . 0.417 ' HE2' HG21 ' A' ' 115' ' ' THR . 53.0 m-85 -69.64 -42.21 74.56 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 123.155 0.582 . . . . 72.31 111.252 -177.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . 0.427 ' HB2' ' HB2' ' C' ' 80' ' ' GLN . . . -66.82 -29.8 69.82 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 115.705 -0.679 . . . . 60.12 111.354 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.619 ' HG3' ' HB2' ' C' ' 128' ' ' LEU . 34.7 ttp180 -56.08 -58.27 8.64 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 123.93 0.769 . . . . 74.22 111.179 -178.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -73.5 -32.69 64.41 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.258 0.623 . . . . 75.2 110.338 -176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . 0.495 ' SG ' HG12 ' C' ' 21' ' ' ILE . 36.2 t -62.54 -34.68 77.42 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 123.396 0.678 . . . . 61.44 111.865 -178.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.52 HD11 ' HB ' ' C' ' 62' ' ' VAL . 96.7 mt -71.36 -47.16 61.02 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 C-N-CA 123.608 0.763 . . . . 75.02 110.206 174.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 10.3 m -64.7 -28.32 69.52 Favored 'General case' 0 CA--C 1.557 1.242 0 C-N-CA 123.327 0.651 . . . . 63.52 111.852 -174.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.1 t -68.28 -39.97 81.99 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.581 0.753 . . . . 72.13 110.011 174.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.636 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.06 -41.11 95.41 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.729 0.811 . . . . 73.34 111.105 175.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 99.1 t -65.24 -34.14 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 C-N-CA 123.831 0.852 . . . . 72.32 110.246 177.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . 0.461 ' HA ' ' OE1' ' B' ' 125' ' ' GLN . 42.0 t -65.59 -43.04 90.91 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.57 -0.741 . . . . 52.25 110.98 176.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.466 ' NH2' ' HG2' ' B' ' 112' ' ' GLU . 91.3 mtt-85 -72.28 -21.28 61.38 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.22 -0.9 . . . . 74.02 111.439 -179.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.65 -1.04 87.7 Favored Glycine 0 C--N 1.349 1.304 0 CA-C-O 119.79 -0.45 . . . . 24.51 113.365 174.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.444 HG23 ' HB3' ' D' ' 17' ' ' TYR . 30.2 p 59.66 43.09 16.11 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.507 1.523 . . . . 64.23 111.489 -178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -119.69 141.11 30.48 Favored Pre-proline 0 N--CA 1.484 1.268 0 C-N-CA 123.733 0.813 . . . . 71.41 110.033 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.595 ' HA ' ' HB2' ' B' ' 125' ' ' GLN . 13.1 Cg_endo -53.09 107.16 0.18 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.729 2.953 . . . . 71.21 112.898 -175.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -55.74 143.21 31.63 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.058 1.343 . . . . 73.53 113.52 -170.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tt -134.61 114.65 12.99 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.787 -1.19 . . . . 71.21 107.787 -177.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -92.12 126.24 37.13 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 108.395 -0.965 . . . . 75.52 108.395 174.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.619 ' HB2' ' HG3' ' C' ' 111' ' ' ARG . 3.0 mm? -66.67 148.33 52.05 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.667 0.787 . . . . 72.21 111.447 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.404 ' HB3' ' HB2' ' F' ' 291' ' ' LEU . . . -84.92 153.4 60.33 Favored Pre-proline 0 CA--C 1.557 1.219 0 C-N-CA 123.356 0.663 . . . . 74.42 110.86 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.529 ' HG2' HG21 ' A' ' 13' ' ' ILE . 6.3 Cg_exo -76.9 125.53 8.12 Favored 'Trans proline' 0 C--N 1.384 2.435 0 C-N-CA 123.301 2.668 . . . . 75.24 112.295 -172.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . . . . . . . . . 40.5 t -103.37 110.6 30.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 123.13 0.572 . . . . 65.23 109.493 177.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.66 HD21 HD11 ' A' ' 105' ' ' ILE . 3.4 m-20 -91.3 93.89 9.27 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.312 0.645 . . . . 62.32 109.451 175.341 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 37.7 t80 -76.57 -33.11 58.5 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.36 0.6 . . . . 75.31 109.592 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -70.69 -40.78 72.71 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.885 -1.052 . . . . 51.42 111.503 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -65.48 -36.26 83.35 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.107 0.879 . . . . 63.24 111.842 -175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 92.2 mt -75.32 -23.22 57.27 Favored 'General case' 0 CA--C 1.551 1.011 0 O-C-N 123.937 0.773 . . . . 72.25 111.372 179.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -80.63 -33.61 35.62 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.176 0.59 . . . . 75.4 111.097 173.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 95.0 mmm -74.05 -30.91 62.64 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.698 -0.482 . . . . 75.22 109.698 173.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -53.73 -37.07 62.96 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 125.411 1.484 . . . . 63.43 111.076 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -52.96 -83.75 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.229 0 C-N-CA 125.502 1.521 . . . . 74.21 112.342 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 95.0 mt -95.34 10.63 35.54 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 113.448 0.907 . . . . 63.43 113.448 -171.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -122.94 150.0 43.52 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 118.165 0.439 . . . . 61.51 110.418 176.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -160.46 163.08 33.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.049 0.94 . . . . 74.51 110.634 176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . 0.706 ' HB3' ' HG3' ' A' ' 93' ' ' GLN . 51.3 mt-30 -130.62 147.07 52.26 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.13 0.972 . . . . 71.23 108.711 170.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . 0.58 ' HB1' ' H ' ' A' ' 5' ' ' ASN . . . -132.71 119.71 20.73 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.257 0.623 . . . . 53.24 110.696 -173.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 165.5 98.82 0.13 Allowed Glycine 0 C--N 1.341 0.85 0 N-CA-C 110.36 -1.096 . . . . 62.33 110.36 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 88' ' ' GLY . 15.1 pt-20 -72.96 164.89 26.0 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.446 0.641 . . . . 73.42 112.468 -173.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 90' ' ' GLU . . . -177.27 141.21 5.21 Favored Glycine 0 C--O 1.24 0.513 0 CA-C-N 114.653 -1.158 . . . . 43.44 110.817 175.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 13.7 t -171.33 163.3 6.97 Favored 'General case' 0 C--O 1.242 0.694 0 C-N-CA 123.21 0.604 . . . . 65.32 110.592 -179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -170.13 119.8 0.61 Allowed 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 106.7 -1.592 . . . . 75.35 106.7 177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -67.63 89.06 0.24 Allowed 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.321 0.649 . . . . 54.23 109.436 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -77.36 153.19 33.99 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.731 0.812 . . . . 65.41 112.362 -168.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -61.06 130.79 48.15 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 124.614 1.165 . . . . 75.24 111.105 176.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 22.6 t70 72.04 132.7 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 125.571 1.549 . . . . 75.34 111.576 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . 0.636 ' HA ' ' HB1' ' A' ' 52' ' ' ALA . . . . . . . . 0 C--O 1.25 1.117 0 C-N-CA 123.508 0.723 . . . . 74.31 109.749 -178.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.48 1.05 0 N-CA-C 109.123 -0.695 . . . . 74.02 109.123 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 41.9 t -78.98 105.93 10.66 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.289 0.635 . . . . 72.4 110.691 -176.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -112.38 107.87 16.84 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 107.993 -1.114 . . . . 75.3 107.993 175.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 28.9 tp60 -102.92 173.85 6.13 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 123.93 0.892 . . . . 74.54 109.046 -176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 25.2 p-10 -161.18 93.69 0.97 Allowed 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.576 0.703 . . . . 64.34 110.645 175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . 0.455 ' HB3' ' HG2' ' D' ' 8' ' ' GLU . 61.3 t30 -163.03 175.02 11.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.427 0.691 . . . . 74.21 109.327 177.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . 0.555 HG23 ' HA2' ' B' ' 146' ' ' GLY . 8.1 t -82.78 59.16 4.64 Favored 'General case' 0 CA--C 1.559 1.307 0 CA-C-O 122.411 1.1 . . . . 70.12 110.76 175.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . 0.455 ' HG2' ' HB3' ' D' ' 6' ' ' ASN . 11.1 mm-40 -85.75 -2.01 57.78 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 114.901 -1.045 . . . . 75.23 110.927 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 5.5 ttp -30.65 127.96 0.14 Allowed 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 126.332 1.853 . . . . 72.41 113.698 170.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . 0.457 ' HB ' ' HB3' ' D' ' 87' ' ' ALA . 57.5 m -135.65 138.26 42.67 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 123.608 0.763 . . . . 75.32 109.45 -179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -157.47 105.77 2.09 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 107.492 -1.299 . . . . 53.23 107.492 178.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -125.26 119.19 27.75 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.639 0.776 . . . . 74.12 109.257 -177.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . . . . . . . . . 48.8 mt -73.4 114.93 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 107.837 -1.171 . . . . 65.53 107.837 170.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -80.91 -45.54 16.59 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 109.27 -0.641 . . . . 74.05 109.27 178.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' C' ' 29' ' ' PRO . 16.6 ptt180 -174.04 159.73 3.34 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.025 0.93 . . . . 71.12 109.897 172.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.489 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -130.03 143.2 41.76 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 124.375 1.07 . . . . 65.2 108.128 174.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.444 ' HB3' HG23 ' C' ' 122' ' ' THR . 31.0 p90 -170.26 172.27 6.33 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-O 121.933 0.873 . . . . 75.14 110.988 -169.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.414 HG21 HD11 ' D' ' 21' ' ' ILE . 81.4 p -98.74 115.77 29.49 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 114.507 -1.224 . . . . 73.0 109.56 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 34.2 mtpt -87.69 -23.42 24.19 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.356 -0.609 . . . . 74.15 109.356 176.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 21.1 t70 -151.23 134.56 16.11 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 114.553 -1.203 . . . . 63.11 109.338 175.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.636 HD13 ' HE3' ' C' ' 117' ' ' MET . 72.0 mt -129.45 138.39 54.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 107.562 -1.273 . . . . 64.22 107.562 171.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 35.5 t -143.08 128.47 18.91 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 108.107 -1.071 . . . . 72.23 108.107 174.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.505 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 56.6 t80 -138.0 113.63 9.65 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 105.653 -1.98 . . . . 72.3 105.653 167.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -121.36 138.54 54.21 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.373 -0.603 . . . . 74.31 109.373 -175.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.519 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -143.53 77.06 15.58 Favored Pre-proline 0 CA--C 1.543 0.699 0 N-CA-C 107.436 -1.32 . . . . 55.14 107.436 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.46 -45.44 0.33 Allowed 'Trans proline' 0 C--N 1.38 2.233 0 C-N-CA 122.664 2.243 . . . . 51.02 111.901 -177.41 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -93.48 30.09 1.82 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.442 1.097 . . . . 73.0 108.78 -178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.519 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -59.47 -57.45 26.81 Favored Pre-proline 0 CA--C 1.556 1.184 0 C-N-CA 124.112 0.965 . . . . 65.51 112.702 -172.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -76.88 -12.19 17.97 Favored 'Trans proline' 0 C--N 1.383 2.345 0 CA-C-N 121.468 1.56 . . . . 71.43 112.163 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 22.4 t-160 -78.19 -41.65 33.94 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.02 1.328 . . . . 72.31 109.982 177.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' D' ' 73' ' ' ALA . 8.6 p -79.32 -32.48 14.93 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.572 0 CA-C-O 118.812 -0.613 . . . . 73.03 110.097 -174.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -50.95 -28.67 10.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 124.094 0.872 . . . . 73.43 113.197 -176.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -63.43 -38.01 89.48 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 123.442 0.697 . . . . 71.34 111.141 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.48 ' HD2' ' O ' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -132.5 64.07 1.61 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 123.639 0.776 . . . . 72.15 110.202 168.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.511 ' HB3' HD11 ' G' ' 301' ' ' ILE . 17.5 t70 -112.16 95.98 5.77 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.795 0.807 . . . . 74.22 110.152 -177.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 1.6 m-90 -123.01 -157.45 0.75 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 126.044 1.738 . . . . 63.14 106.804 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . 0.428 ' HA ' ' HD3' ' D' ' 38' ' ' PRO . 15.9 pm0 -50.87 106.28 0.63 Allowed Pre-proline 0 CA--C 1.567 1.618 0 C-N-CA 123.386 0.674 . . . . 75.42 111.915 175.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' D' ' 37' ' ' GLN . 4.7 Cg_exo -78.06 147.32 23.66 Favored 'Trans proline' 0 C--N 1.386 2.517 0 C-N-CA 122.737 2.291 . . . . 51.31 112.295 -174.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -70.4 110.98 5.63 Favored 'General case' 0 C--N 1.347 0.493 0 N-CA-C 107.243 -1.392 . . . . 74.53 107.243 168.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.74 114.81 48.04 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 115.539 -0.755 . . . . 63.3 110.18 -169.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.56 138.49 32.38 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.109 0.964 . . . . 55.22 109.767 173.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . 0.47 HD12 HD21 ' D' ' 128' ' ' LEU . 6.2 tt -98.8 131.91 44.57 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 107.331 -1.359 . . . . 74.14 107.331 170.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -132.33 147.14 52.38 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.865 -0.791 . . . . 75.04 108.865 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 58.9 tp -131.16 139.39 49.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.251 0.62 . . . . 73.45 110.394 -172.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.53 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 12.1 t70 -137.43 135.27 36.74 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 108.109 -1.071 . . . . 75.51 108.109 170.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -113.42 144.4 42.87 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.278 0.631 . . . . 65.13 109.584 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.574 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -150.16 155.1 39.17 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.355 0.662 . . . . 63.32 110.197 -176.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 73.6 p -164.72 153.14 12.34 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.191 0.596 . . . . 74.25 110.649 177.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 62.9 p -154.31 137.06 15.26 Favored 'General case' 0 C--O 1.242 0.71 0 C-N-CA 123.356 0.663 . . . . 51.21 109.449 176.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 -74.19 116.99 15.48 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 108.912 -0.773 . . . . 61.4 108.912 173.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.3 mt -91.89 -32.12 15.42 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.674 0.39 . . . . 65.4 110.358 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.83 -175.25 5.26 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 115.785 -0.643 . . . . 75.21 111.361 -178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.67 118.08 7.16 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.598 -1.183 . . . . 74.21 109.749 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 13.0 m-20 65.09 11.05 6.83 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 124.508 1.123 . . . . 74.5 112.314 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.83 120.21 64.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.611 0 C-N-CA 123.779 0.831 . . . . 75.12 109.239 179.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.614 ' HB2' HD13 ' D' ' 86' ' ' ILE . 73.8 m-85 -129.67 128.88 43.48 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.502 -1.295 . . . . 64.52 107.502 177.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -92.27 128.37 38.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.116 -0.698 . . . . 75.34 109.116 173.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 49.1 t -102.92 118.85 50.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 N-CA-C 107.849 -1.167 . . . . 70.4 107.849 171.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 49.0 t -99.97 133.41 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.365 -0.976 . . . . 73.12 108.365 172.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -125.29 109.74 13.17 Favored 'General case' 0 C--O 1.24 0.58 0 N-CA-C 108.384 -0.969 . . . . 64.33 108.384 -178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.53 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.6 ttm180 -88.53 112.65 23.26 Favored 'General case' 0 C--O 1.239 0.5 0 C-N-CA 123.475 0.71 . . . . 74.41 110.051 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 87.7 t -101.27 126.31 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.088 0.955 . . . . 74.5 108.564 174.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 12.0 m -129.42 134.3 47.77 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 122.97 0.508 . . . . 73.44 110.2 -174.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.659 HG11 HD13 ' D' ' 126' ' ' LEU . 47.6 t -130.72 113.44 24.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 124.425 1.09 . . . . 60.41 108.892 -177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 21.4 m -103.87 101.12 10.93 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.465 0.706 . . . . 63.52 109.415 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -98.47 124.79 43.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 109.827 -0.435 . . . . 72.21 109.827 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.443 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 70.7 m -139.2 124.61 19.24 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 123.694 0.798 . . . . 73.05 108.894 -179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.6 103.36 15.96 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 107.771 -1.196 . . . . 75.44 107.771 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.19 -115.94 4.61 Favored Glycine 0 C--N 1.343 0.94 0 O-C-N 123.885 0.741 . . . . 75.24 112.465 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.47 5.0 51.75 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.741 0.816 . . . . 64.11 110.742 -179.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -135.86 145.83 46.8 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.763 0.825 . . . . 63.34 110.473 -165.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 54.5 m -73.08 130.57 40.59 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 123.298 0.639 . . . . 61.13 111.334 178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.477 ' HA ' HG21 ' D' ' 31' ' ' VAL . . . -85.36 -61.38 1.78 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 124.179 0.991 . . . . 30.21 108.679 175.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . 0.571 ' HE2' HD11 ' D' ' 126' ' ' LEU . 42.9 p90 -159.05 151.69 21.73 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.175 -1.375 . . . . 63.32 110.311 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 84.1 mt -113.65 151.49 31.7 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.489 1.116 . . . . 73.24 109.127 174.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.599 ' SG ' HG23 ' D' ' 114' ' ' ILE . 34.7 t -154.64 134.68 13.07 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 109.722 -0.473 . . . . 65.44 109.722 177.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -154.44 128.95 9.18 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.485 0.714 . . . . 73.31 109.832 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 88.1 t -132.44 121.09 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 123.61 0.764 . . . . 42.15 109.473 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 46.5 mt-30 -89.87 89.84 7.92 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.722 -0.844 . . . . 75.1 108.722 171.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -80.22 93.39 5.86 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 114.821 -1.081 . . . . 70.13 109.107 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -86.6 140.38 17.25 Favored Glycine 0 C--N 1.34 0.755 0 N-CA-C 111.36 -0.696 . . . . 70.12 111.36 177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . 0.406 ' HA3' HD21 ' D' ' 106' ' ' LEU . . . -141.19 128.09 3.58 Favored Glycine 0 CA--C 1.503 -0.712 0 N-CA-C 110.189 -1.164 . . . . 34.24 110.189 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 53.2 mt -90.85 129.23 41.98 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 108.834 -0.802 . . . . 71.12 108.834 -177.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.516 ' HB2' HD11 ' D' ' 86' ' ' ILE . 22.1 m-85 -132.48 158.26 42.53 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 123.353 0.408 . . . . 63.0 110.368 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 25.4 m -107.14 102.29 11.63 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 108.504 -0.924 . . . . 75.32 108.504 172.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' D' ' 56' ' ' TYR . 4.0 mp -107.51 113.28 43.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 107.818 -1.179 . . . . 74.0 107.818 -177.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.608 ' HA ' HD11 ' G' ' 277' ' ' LEU . . . -142.57 124.79 15.45 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.177 0.591 . . . . 71.13 110.492 -177.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 98.19 5.65 57.09 Favored Glycine 0 C--N 1.348 1.237 0 CA-C-O 119.421 -0.655 . . . . 52.13 114.577 175.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.408 HD13 HG23 ' D' ' 86' ' ' ILE . 2.4 mp -114.96 126.39 72.53 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 N-CA-C 108.69 -0.856 . . . . 74.41 108.69 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -135.49 -177.83 4.84 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.776 0.83 . . . . 74.12 110.56 -177.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.59 -141.06 39.83 Favored Glycine 0 C--N 1.354 1.533 0 CA-C-N 115.501 -0.772 . . . . 75.1 113.799 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 34.2 p -84.31 -13.5 52.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.635 0.774 . . . . 73.14 111.656 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -68.96 -43.84 74.17 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 122.89 0.476 . . . . 74.33 110.403 178.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.471 ' O ' ' HG ' ' D' ' 98' ' ' LEU . 0.0 OUTLIER -69.95 -31.84 69.79 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 110.421 -0.214 . . . . 74.24 110.421 175.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -68.09 -29.62 68.6 Favored 'General case' 0 CA--C 1.547 0.829 0 O-C-N 123.866 0.729 . . . . 75.02 111.218 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -72.62 -35.67 67.87 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.224 0.61 . . . . 61.11 110.204 173.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 49.5 t -67.25 -51.45 52.94 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 122.859 0.464 . . . . 74.22 110.908 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' G' ' 281' ' ' PHE . 2.9 pp -75.84 -19.74 58.68 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 122.755 0.422 . . . . 70.34 112.065 -178.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.39 -7.79 60.32 Favored Glycine 0 C--N 1.347 1.15 0 CA-C-O 119.73 -0.483 . . . . 71.21 113.364 -179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.56 -62.6 0.43 Allowed 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 117.342 0.571 . . . . 52.12 111.952 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -68.13 -52.33 36.02 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 112.424 0.527 . . . . 75.22 112.424 -169.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 60.7 m -61.55 -43.81 89.9 Favored Pre-proline 0 CA--C 1.562 1.411 0 C-N-CA 123.673 0.789 . . . . 63.34 111.944 179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -52.13 -46.52 32.08 Favored 'Trans proline' 0 C--N 1.395 2.996 0 C-N-CA 122.13 1.887 . . . . 71.03 112.898 165.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -66.9 -15.79 63.89 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.442 0.697 . . . . 63.5 112.584 -179.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 40.0 mm -80.11 -49.21 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 109.464 -0.569 . . . . 72.42 109.464 171.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.406 HD21 ' HA3' ' D' ' 82' ' ' GLY . 74.3 mt -79.22 -28.91 42.54 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.73 0.812 . . . . 71.34 112.247 -169.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -68.93 -40.43 16.39 Favored Pre-proline 0 CA--C 1.557 1.247 0 CA-C-O 118.035 -0.983 . . . . 72.44 113.07 -169.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_exo -50.91 -43.52 46.83 Favored 'Trans proline' 0 C--N 1.385 2.475 0 C-N-CA 122.282 1.988 . . . . 73.22 113.229 169.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -74.84 -37.08 62.35 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.477 0.711 . . . . 54.05 111.6 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -62.81 -51.3 67.59 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.084 0.553 . . . . 74.22 110.281 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 46.4 ttp180 -56.46 -43.6 79.72 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 124.905 1.378 . . . . 64.14 111.13 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -73.2 -36.48 66.54 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 123.779 0.832 . . . . 75.51 111.236 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 48.6 t -62.92 -44.92 94.77 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 122.893 0.477 . . . . 45.02 110.163 177.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.599 HG23 ' SG ' ' D' ' 76' ' ' CYS . 73.0 mt -61.83 -50.3 80.74 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 124.225 1.01 . . . . 71.52 110.213 176.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.568 HG23 ' HB3' ' D' ' 125' ' ' GLN . 30.4 m -50.84 -46.9 60.3 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 124.494 1.117 . . . . 73.33 111.921 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 43.8 t -73.53 -22.63 60.05 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.065 0.946 . . . . 35.2 112.635 -172.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.45 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 76.8 mtm -87.31 -43.46 12.14 Favored 'General case' 0 N--CA 1.483 1.204 0 CA-C-O 121.062 0.458 . . . . 64.22 111.243 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . . . . . . . . . 75.6 t -62.5 -34.45 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 CA-C-N 114.691 -1.14 . . . . 72.02 110.382 -178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 84.2 p -66.55 -36.81 83.59 Favored 'General case' 0 CA--C 1.556 1.181 0 C-N-CA 123.387 0.675 . . . . 74.23 111.405 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' D' ' 116' ' ' SER . 87.5 mtt-85 -69.65 -26.74 64.54 Favored 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.143 0.577 . . . . 70.41 111.164 177.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -84.81 11.04 60.71 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-O 119.689 -0.506 . . . . 74.43 113.316 176.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.479 HG23 ' HB3' ' C' ' 17' ' ' TYR . 25.6 p 65.42 16.36 10.48 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 126.581 1.952 . . . . 71.13 112.921 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -96.31 165.66 15.79 Favored Pre-proline 0 CA--C 1.562 1.426 0 C-N-CA 124.707 1.203 . . . . 72.44 108.406 174.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.64 150.58 24.59 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.258 1.972 . . . . 74.1 112.628 -174.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . 0.568 ' HB3' HG23 ' D' ' 115' ' ' THR . 21.4 mt-30 -57.54 135.25 56.63 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.144 0.578 . . . . 74.55 111.092 178.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.659 HD13 HG11 ' D' ' 64' ' ' VAL . 88.4 mt -106.33 93.32 4.54 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.367 -0.605 . . . . 62.02 109.367 -177.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -100.43 100.36 11.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 108.474 -0.936 . . . . 71.22 108.474 176.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.47 HD21 HD12 ' D' ' 42' ' ' LEU . 0.2 OUTLIER -67.39 132.79 48.36 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.961 0.904 . . . . 70.44 109.136 178.66 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.21 146.95 87.74 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 123.815 0.846 . . . . 62.13 111.615 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.05 111.54 2.02 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 121.939 1.759 . . . . 65.41 111.393 176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . 0.511 HG22 HD22 ' G' ' 291' ' ' LEU . 77.1 t -106.65 124.99 62.56 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 N-CA-C 108.375 -0.972 . . . . 75.31 108.375 -178.236 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 55.9 t-20 -80.02 92.41 5.59 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.242 0.617 . . . . 73.41 110.036 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -64.01 -33.11 74.99 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.023 0.929 . . . . 74.22 111.202 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -59.68 -54.04 50.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.862 0.865 . . . . 73.44 111.071 -178.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.27 -41.3 88.57 Favored 'General case' 0 N--CA 1.476 0.846 0 O-C-N 124.133 0.896 . . . . 71.42 111.592 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 88.7 mt -62.92 -42.38 99.78 Favored 'General case' 0 N--CA 1.477 0.905 0 O-C-N 124.174 0.921 . . . . 73.42 111.536 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 75.4 t80 -69.74 -52.31 26.49 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.093 0.557 . . . . 75.03 110.272 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.0 mtm -66.2 -19.86 65.96 Favored 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 123.873 0.869 . . . . 73.32 111.825 -175.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 34.1 t-20 -66.27 -42.28 88.69 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.706 0.802 . . . . 52.51 109.877 175.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -63.97 -34.94 79.11 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.329 1.051 . . . . 75.25 111.322 177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.6 mp -62.57 -28.55 69.95 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 123.821 0.848 . . . . 74.52 111.082 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -90.27 9.11 29.97 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.946 0.899 . . . . 62.31 111.63 178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -126.71 45.83 2.61 Favored 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 123.499 0.72 . . . . 74.33 109.682 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 1.4 pp0? -154.49 145.81 22.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.241 0.616 . . . . 71.12 110.138 -178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -138.31 19.66 2.76 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.19 0.596 . . . . 64.22 110.657 175.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -88.82 69.9 2.62 Favored Glycine 0 C--N 1.347 1.151 0 N-CA-C 111.023 -0.831 . . . . 73.42 111.023 175.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -60.9 -48.71 80.56 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.014 0.925 . . . . 70.2 111.087 179.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . 79.78 -49.73 3.73 Favored Glycine 0 C--N 1.35 1.356 0 CA-C-N 116.015 -0.538 . . . . 65.22 114.281 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 79.0 p 55.52 89.2 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.565 1.546 . . . . 75.21 111.976 -175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -143.68 152.61 41.54 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.92 0.888 . . . . 74.45 109.28 178.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -73.19 164.27 26.93 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.414 0.686 . . . . 64.41 111.248 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -166.82 155.07 9.96 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.378 1.071 . . . . 73.22 108.415 -175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -67.62 146.34 53.95 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 109.766 -0.457 . . . . 74.53 109.766 171.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -116.84 154.49 30.66 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 123.496 0.718 . . . . 72.11 109.882 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.158 0 C-N-CA 124.531 1.132 . . . . 72.41 108.422 177.435 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.214 0 CA-C-O 121.327 0.584 . . . . 73.54 110.143 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 31.2 t30 -86.83 123.2 31.71 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 115.315 -0.857 . . . . 71.33 108.997 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -78.18 81.1 4.57 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-O 122.031 0.92 . . . . 63.52 109.259 176.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -106.26 -161.89 0.82 Allowed 'General case' 0 CA--C 1.544 0.743 0 CA-C-N 114.35 -1.295 . . . . 74.04 108.186 173.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . 0.405 ' HG2' ' HA2' ' E' ' 279' ' ' GLY . 11.9 mptt -65.6 124.62 87.82 Favored Pre-proline 0 CA--C 1.558 1.274 0 N-CA-C 108.983 -0.747 . . . . 63.12 108.983 170.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -61.49 -49.73 6.89 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.74 2.294 . . . . 71.43 112.141 -176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . 0.567 ' HB3' ' SD ' ' A' ' 94' ' ' MET . 52.2 mt -154.64 -43.71 0.09 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.067 1.747 . . . . 75.43 107.531 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 77.2 mt -66.26 88.54 0.12 Allowed 'General case' 0 C--N 1.358 0.953 0 C-N-CA 123.525 0.73 . . . . 51.15 110.76 174.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . 0.405 ' HA2' ' HG2' ' E' ' 275' ' ' LYS . . . -96.0 -67.58 0.98 Allowed Glycine 0 C--N 1.338 0.659 0 CA-C-N 115.757 -0.656 . . . . 73.5 111.922 177.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 40.0 tp -91.38 122.08 33.66 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 122.728 0.411 . . . . 63.42 111.865 -175.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . 0.419 ' CE1' ' HB ' ' A' ' 46' ' ' THR . 0.8 OUTLIER -177.74 138.5 0.21 Allowed 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 126.363 1.865 . . . . 65.22 107.906 158.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -152.85 -161.67 1.34 Allowed 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.199 1.0 . . . . 74.54 108.795 -179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -71.19 78.49 0.7 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 108.875 -0.787 . . . . 62.14 108.875 173.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 57.63 -136.85 50.32 Favored Glycine 0 CA--C 1.538 1.476 0 CA-C-N 115.867 -0.606 . . . . 73.22 112.103 -171.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -176.37 -61.2 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 107.036 -1.468 . . . . 72.01 107.036 171.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -83.86 124.22 75.06 Favored Pre-proline 0 CA--C 1.549 0.938 0 N-CA-C 107.933 -1.136 . . . . 64.3 107.933 170.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -64.5 -26.52 62.32 Favored 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 122.55 2.167 . . . . 73.14 112.938 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 58.7 t 64.19 -76.3 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 C-N-CA 125.154 1.382 . . . . 73.43 110.144 -173.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 12.8 tpt180 62.02 33.16 17.4 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 124.17 0.988 . . . . 72.2 110.363 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 72.0 m95 69.18 152.79 0.1 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.419 1.487 . . . . 72.34 111.402 -165.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.43 HD23 HG21 ' G' ' 309' ' ' THR . 9.8 mp -69.78 -40.31 76.11 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 115.313 -0.858 . . . . 75.23 110.826 -178.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 172.58 -70.38 0.11 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 110.657 -0.977 . . . . 71.44 110.657 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . 0.445 ' HB2' HG12 ' G' ' 306' ' ' VAL . 6.6 Cg_exo -75.02 167.79 26.26 Favored 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.658 2.239 . . . . 73.21 111.362 172.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . 0.618 ' HD3' ' H ' ' A' ' 40' ' ' VAL . 22.1 ttmm -138.18 -62.18 0.59 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.774 0.83 . . . . 72.02 108.879 -177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . 57.61 -87.16 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.077 1.351 . . . . 74.0 112.487 177.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . 0.412 HG23 HD13 ' A' ' 126' ' ' LEU . 11.9 m 68.51 -65.17 0.28 Allowed 'General case' 0 CA--C 1.555 1.165 0 C-N-CA 125.552 1.541 . . . . 54.53 112.561 -179.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.646 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 3.1 m-85 -85.7 -84.83 0.16 Allowed 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 113.326 0.861 . . . . 65.04 113.326 -174.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 33.8 m170 70.65 -55.77 0.62 Allowed 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 125.381 1.472 . . . . 73.52 111.22 -164.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . 0.565 ' HA3' ' HB2' ' G' ' 300' ' ' ASN . . . -160.26 -113.24 0.32 Allowed Glycine 0 C--N 1.345 1.067 0 CA-C-O 119.497 -0.613 . . . . 73.4 112.003 173.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 26.8 t30 69.04 -66.36 0.25 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 125.632 1.573 . . . . 74.13 111.522 -173.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.757 HG23 HH22 ' B' ' 15' ' ' ARG . 27.4 mt -74.36 144.91 11.85 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.724 0 C-N-CA 123.622 0.769 . . . . 71.44 111.451 -172.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . 0.415 ' HB2' ' HB2' ' G' ' 298' ' ' HIS . 44.0 t0 -156.93 169.93 23.67 Favored 'General case' 0 C--O 1.24 0.56 0 C-N-CA 124.924 1.29 . . . . 64.34 107.73 169.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? -72.23 117.35 57.72 Favored Pre-proline 0 CA--C 1.559 1.292 0 N-CA-C 108.787 -0.82 . . . . 54.41 108.787 169.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -81.95 91.27 1.06 Allowed 'Trans proline' 0 C--N 1.375 1.932 0 C-N-CA 122.225 1.95 . . . . 71.33 109.99 176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -76.62 76.51 3.3 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 115.41 -0.814 . . . . 63.3 110.79 -176.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . 0.604 HG12 ' HB2' ' B' ' 12' ' ' GLN . 47.6 t -89.73 121.0 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 N-CA-C 108.495 -0.928 . . . . 64.21 108.495 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 72.0 p -103.96 168.16 9.3 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 123.4 0.68 . . . . 75.32 111.325 -176.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 78.8 m -58.65 99.99 0.06 Allowed 'General case' 0 C--N 1.366 1.286 0 C-N-CA 124.17 0.988 . . . . 73.42 110.909 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . 0.408 HG21 ' HB3' ' G' ' 291' ' ' LEU . 91.0 m -68.42 122.29 83.88 Favored Pre-proline 0 CA--C 1.552 1.028 0 CA-C-N 114.403 -1.271 . . . . 72.33 112.069 -171.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo . . . . . 0 C--N 1.38 2.189 0 C-N-CA 122.548 2.165 . . . . 70.44 111.021 166.824 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.131 0 N-CA-C 109.491 -0.559 . . . . 74.41 109.491 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -68.85 -67.56 0.46 Allowed 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 123.329 0.652 . . . . 72.24 109.843 175.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 67.11 -71.71 0.1 Allowed 'General case' 0 CA--C 1.558 1.254 0 C-N-CA 124.924 1.29 . . . . 75.2 112.011 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -131.79 161.9 31.8 Favored 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 124.072 0.949 . . . . 74.45 111.422 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -128.31 169.35 12.92 Favored Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 125.331 1.452 . . . . 63.4 108.808 171.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.68 -156.54 0.05 OUTLIER 'Trans proline' 0 C--N 1.381 2.259 0 C-N-CA 122.124 1.883 . . . . 62.12 111.966 169.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 35.9 tp -77.63 66.23 3.29 Favored 'General case' 0 CA--C 1.557 1.229 0 CA-C-O 122.347 1.07 . . . . 74.12 108.487 173.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.638 HD22 HD22 ' C' ' 98' ' ' LEU . 1.6 tm? -175.35 97.24 0.07 Allowed 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 105.891 -1.892 . . . . 74.42 105.891 -171.212 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -138.19 154.71 23.01 Favored Glycine 0 N--CA 1.47 0.962 0 CA-C-O 119.414 -0.659 . . . . 64.02 111.551 179.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 4.8 tt 57.53 77.27 0.28 Allowed 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 124.108 0.963 . . . . 73.02 108.926 -178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -154.37 43.37 0.52 Allowed 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 115.626 -0.716 . . . . 75.03 109.763 -176.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -129.94 125.32 35.19 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.554 0.742 . . . . 41.24 109.659 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -75.2 157.24 34.85 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 123.219 0.608 . . . . 74.0 109.994 177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . 147.71 -1.36 0.7 Allowed Glycine 0 N--CA 1.469 0.898 0 CA-C-N 116.003 -0.544 . . . . 62.04 112.102 -173.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -124.17 137.43 54.54 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.204 1.002 . . . . 75.54 108.306 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 51.6 ttp 64.24 94.14 0.05 OUTLIER Pre-proline 0 CA--C 1.559 1.317 0 O-C-N 124.299 1.0 . . . . 72.43 110.091 -177.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -64.26 94.32 0.2 Allowed 'Trans proline' 0 C--N 1.383 2.344 0 C-N-CA 122.621 2.214 . . . . 75.1 113.465 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 44.5 t -81.99 78.09 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 N-CA-C 108.246 -1.02 . . . . 61.02 108.246 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 64.6 ttt180 -79.55 -64.58 1.15 Allowed 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.688 -1.142 . . . . 62.12 110.187 -176.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . 0.453 ' HE3' ' H ' ' F' ' 291' ' ' LEU . 0.8 OUTLIER -155.8 155.99 33.97 Favored 'General case' 0 C--N 1.348 0.524 0 CA-C-N 115.424 -0.807 . . . . 74.11 110.297 177.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.453 ' H ' ' HE3' ' F' ' 290' ' ' TRP . 2.4 mp -118.41 26.72 9.4 Favored 'General case' 0 CA--C 1.549 0.908 0 CA-C-N 114.449 -1.25 . . . . 55.42 108.567 174.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -173.47 105.18 0.21 Allowed Glycine 0 C--N 1.349 1.271 0 N-CA-C 110.653 -0.979 . . . . 75.03 110.653 -173.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -85.23 98.62 0.66 Allowed 'Trans proline' 0 C--N 1.372 1.797 0 C-N-CA 122.863 2.375 . . . . 63.13 112.779 -168.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' F' ' 294' ' ' LYS . 35.0 mtmt 63.98 42.92 5.51 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.353 1.061 . . . . 72.32 111.388 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -81.59 41.03 0.61 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 122.905 0.482 . . . . 70.12 111.733 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 37.2 m -134.1 138.8 45.51 Favored 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 124.522 1.129 . . . . 61.11 109.418 -177.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.455 ' H ' ' HG2' ' C' ' 124' ' ' PRO . 22.8 m-30 63.26 -97.16 0.06 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 125.256 1.422 . . . . 63.2 112.282 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 19.2 m170 56.42 -85.65 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.503 1.121 . . . . 74.25 113.156 -177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -91.39 38.33 3.23 Favored Glycine 0 C--N 1.349 1.277 0 CA-C-O 119.477 -0.624 . . . . 73.4 114.086 -171.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 67.74 143.05 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.754 1.221 . . . . 73.05 112.166 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . . . . . . . . . 46.7 mt -71.91 -68.72 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-O 121.258 0.551 . . . . 75.24 109.787 177.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 11.9 t70 176.64 175.11 0.36 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.929 1.692 . . . . 73.14 107.388 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -135.21 148.79 67.92 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 123.48 0.712 . . . . 65.33 109.244 173.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . 0.434 ' HD3' ' HE2' ' C' ' 32' ' ' PHE . 30.1 Cg_endo -61.14 85.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.38 2.222 0 C-N-CA 123.212 2.608 . . . . 71.01 113.448 -176.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -103.11 3.97 36.52 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.148 0.979 . . . . 65.32 110.03 171.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 23.9 m -78.13 12.09 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 124.567 1.147 . . . . 71.34 112.688 -174.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 7.6 t -84.07 29.45 0.56 Allowed 'General case' 0 CA--C 1.562 1.43 0 C-N-CA 125.162 1.385 . . . . 65.1 111.783 -176.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 49.0 t -142.35 94.99 2.72 Favored 'General case' 0 C--N 1.351 0.667 0 O-C-N 121.58 -0.7 . . . . 74.05 109.95 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 17.7 p -91.37 -47.48 0.35 Allowed Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 118.169 -0.919 . . . . 75.45 112.627 175.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo . . . . . 0 C--N 1.397 3.13 0 C-N-CA 122.77 2.313 . . . . 54.24 112.152 -177.135 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.709 0.29 . . . . 70.14 110.933 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -86.62 -4.92 59.24 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.565 0.746 . . . . 60.14 111.617 -176.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -123.59 83.16 2.1 Favored 'General case' 0 C--O 1.241 0.641 0 C-N-CA 123.513 0.725 . . . . 74.34 109.295 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -86.29 140.68 29.87 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 107.895 -1.15 . . . . 61.03 107.895 171.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -120.06 152.97 55.05 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 108.22 -1.03 . . . . 64.41 108.22 177.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -68.71 82.32 0.56 Allowed 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 122.405 2.07 . . . . 74.53 110.649 175.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.608 HD11 ' HA ' ' D' ' 87' ' ' ALA . 5.4 tt 66.26 -84.82 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.161 1.384 . . . . 75.41 110.121 -176.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.9 112.39 25.0 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 107.861 -1.162 . . . . 54.32 107.861 -174.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . -164.1 26.93 0.21 Allowed Glycine 0 C--N 1.345 1.067 0 C-N-CA 121.589 -0.338 . . . . 64.02 113.76 179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -143.49 80.29 1.66 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 107.77 -1.196 . . . . 70.52 107.77 178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . 0.532 ' CD1' HD13 ' D' ' 98' ' ' LEU . 2.3 t80 -147.49 43.22 1.1 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 107.847 -1.168 . . . . 72.01 107.847 174.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -82.36 -166.78 1.36 Allowed 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 113.934 -1.485 . . . . 71.2 110.88 -179.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -53.86 149.05 9.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 123.766 0.826 . . . . 74.32 112.409 178.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 142.34 -54.14 0.61 Allowed Glycine 0 C--N 1.34 0.798 0 CA-C-N 115.809 -0.632 . . . . 65.32 111.678 178.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 15.6 m120 61.79 -169.23 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 124.278 1.031 . . . . 64.35 111.395 -175.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 95.9 mmm -111.85 133.11 21.67 Favored Pre-proline 0 CA--C 1.542 0.655 0 N-CA-C 108.791 -0.818 . . . . 74.44 108.791 173.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.81 79.41 2.86 Favored 'Trans proline' 0 C--N 1.372 1.763 0 C-N-CA 122.29 1.993 . . . . 65.53 111.012 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 14.9 t -73.74 -30.84 29.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 123.405 0.682 . . . . 74.44 110.602 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 64.74 -81.81 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.955 1.302 . . . . 62.02 111.196 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -174.91 -60.11 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 108.482 -0.933 . . . . 74.02 108.482 173.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . 0.511 HD22 HG22 ' D' ' 131' ' ' VAL . 10.2 mp 65.44 22.91 11.93 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 125.082 1.353 . . . . 74.24 113.17 -179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -132.34 140.62 11.97 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.011 -0.883 . . . . 74.43 112.197 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . 0.5 ' HG3' ' HA ' ' E' ' 306' ' ' VAL . 57.0 Cg_endo -71.77 119.97 6.57 Favored 'Trans proline' 0 C--N 1.379 2.135 0 C-N-CA 122.68 2.253 . . . . 70.45 111.087 175.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 46.0 pttt -78.05 73.67 4.61 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.656 1.217 . . . . 75.44 110.904 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -142.24 33.44 1.51 Allowed 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.733 -1.576 . . . . 72.43 107.786 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 8.3 m -63.66 -30.19 71.33 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-N 114.096 -1.411 . . . . 62.11 112.465 -170.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -120.58 142.15 49.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 120.705 0.288 . . . . 74.35 111.087 -174.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . 0.415 ' HB2' ' HB2' ' E' ' 302' ' ' ASP . 70.9 t60 -95.04 -15.39 23.5 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.549 0.739 . . . . 54.43 110.347 175.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 71.36 -132.47 20.83 Favored Glycine 0 C--N 1.348 1.223 0 CA-C-O 119.334 -0.703 . . . . 74.43 112.627 -178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . 0.565 ' HB2' ' HA3' ' E' ' 299' ' ' GLY . 30.6 m-80 61.45 34.02 18.33 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 124.309 1.044 . . . . 75.41 111.322 178.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.635 HD13 HH12 ' C' ' 15' ' ' ARG . 1.9 pp -120.73 10.21 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 CA-C-N 114.684 -1.144 . . . . 74.11 111.015 -176.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.57 -16.25 64.02 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.127 1.371 . . . . 72.32 112.341 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . 0.568 ' HD2' ' H ' ' G' ' 303' ' ' LYS . 0.0 OUTLIER -103.46 151.92 38.72 Favored Pre-proline 0 CA--C 1.558 1.288 0 C-N-CA 124.472 1.109 . . . . 63.44 109.695 178.304 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -77.25 179.78 6.19 Favored 'Trans proline' 0 C--N 1.381 2.269 0 C-N-CA 123.035 2.49 . . . . 64.43 113.854 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -75.44 -56.13 5.01 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.812 0.845 . . . . 64.33 110.199 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.445 HG12 ' HB2' ' E' ' 293' ' ' PRO . 26.9 m -134.91 160.69 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.692 0.797 . . . . 71.13 110.157 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 4.5 t -145.31 95.3 2.65 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 123.663 0.785 . . . . 55.5 109.066 176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . 0.663 ' H ' ' HB3' ' C' ' 12' ' ' GLN . 52.9 t 66.05 160.46 0.13 Allowed 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 125.566 1.546 . . . . 63.51 112.346 -175.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . 0.43 HG21 HD23 ' E' ' 291' ' ' LEU . 6.0 t -159.7 97.66 1.55 Allowed Pre-proline 0 CA--C 1.555 1.138 0 C-N-CA 123.283 0.633 . . . . 60.45 110.556 175.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo . . . . . 0 CA--C 1.562 1.895 0 C-N-CA 122.829 2.353 . . . . 73.35 111.665 168.187 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.67 0.271 . . . . 60.31 110.936 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 36.5 m-80 -72.96 163.73 27.72 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.994 0.918 . . . . 62.41 110.365 173.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 97.2 mt-30 75.36 -33.48 0.23 Allowed 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 125.722 1.609 . . . . 61.14 111.818 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -64.77 156.26 31.16 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 123.852 0.861 . . . . 53.02 110.062 166.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt -65.43 144.14 98.89 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 109.787 -0.449 . . . . 73.41 109.787 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -66.92 172.69 9.32 Favored 'Trans proline' 0 C--N 1.366 1.486 0 C-N-CA 122.025 1.817 . . . . 74.53 110.917 167.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . 0.425 ' O ' ' SD ' ' B' ' 94' ' ' MET . 36.7 tp -58.19 -49.33 77.42 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 109.552 -0.536 . . . . 72.5 109.552 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 6.8 tt -78.71 94.99 5.18 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.154 -1.054 . . . . 65.43 108.154 168.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -72.87 -49.51 17.02 Favored Glycine 0 C--N 1.34 0.795 0 N-CA-C 110.958 -0.857 . . . . 64.12 110.958 172.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 3.8 pp -147.78 163.75 35.77 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.48 1.112 . . . . 64.51 109.234 173.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -82.16 -64.73 1.12 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 109.303 -0.628 . . . . 75.43 109.303 -178.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -165.7 138.64 4.27 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.048 0.939 . . . . 72.41 108.775 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -95.63 125.11 39.99 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 109.369 -0.604 . . . . 75.23 109.369 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 155.84 -115.69 0.68 Allowed Glycine 0 C--N 1.337 0.629 0 N-CA-C 110.087 -1.205 . . . . 54.51 110.087 -177.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -174.59 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 123.994 0.917 . . . . 54.52 108.622 -178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 1.2 mpt? 61.96 76.92 0.37 Allowed Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 124.445 1.098 . . . . 74.05 109.869 -168.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -78.77 65.93 8.69 Favored 'Trans proline' 0 C--N 1.378 2.091 0 C-N-CA 122.914 2.409 . . . . 64.01 110.806 176.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 60.6 t -79.24 89.0 1.32 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 115.041 -0.981 . . . . 65.33 109.415 -175.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 50.5 ttt180 -94.89 173.71 7.45 Favored 'General case' 0 CA--C 1.548 0.888 0 CA-C-N 114.148 -1.387 . . . . 75.42 107.669 170.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . 0.509 ' HZ3' ' HA ' ' B' ' 128' ' ' LEU . 94.9 m95 -58.02 113.73 2.03 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.421 0.629 . . . . 72.52 111.932 176.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.483 HD13 ' HB3' ' B' ' 129' ' ' ALA . 3.0 mp -77.34 -13.01 60.02 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 114.321 -1.308 . . . . 73.45 110.884 -173.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . -156.13 -82.0 0.04 OUTLIER Glycine 0 C--N 1.353 1.506 0 CA-C-O 118.921 -0.933 . . . . 61.51 112.888 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -58.51 129.58 33.22 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.629 2.886 . . . . 64.14 113.366 -177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.1 99.91 12.83 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 108.72 -0.845 . . . . 65.34 108.72 176.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 72.07 172.57 0.31 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.3 1.44 . . . . 72.34 113.232 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . 0.425 HG23 ' HB2' ' B' ' 126' ' ' LEU . 8.8 m -71.85 -39.97 69.36 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 114.971 -1.013 . . . . 63.33 110.382 177.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.566 ' HH ' ' HD1' ' B' ' 123' ' ' PHE . 87.1 m-85 -87.21 91.71 8.81 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 115.006 -0.997 . . . . 72.1 110.523 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 40.4 t60 -82.53 -54.86 4.84 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.677 -0.692 . . . . 53.31 109.59 174.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . -97.29 49.97 1.48 Allowed Glycine 0 C--N 1.349 1.263 0 CA-C-N 116.235 -0.439 . . . . 63.52 112.761 -178.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 64.27 178.11 0.18 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 124.928 1.291 . . . . 54.24 112.881 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . . . . . . . . . 20.2 tt -82.06 -12.9 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 CA-C-N 115.57 -0.741 . . . . 71.12 110.632 171.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.66 93.76 0.39 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 123.765 0.826 . . . . 73.3 112.213 -174.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -115.7 148.75 41.81 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 107.231 -1.396 . . . . 70.43 107.231 158.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -65.82 -1.52 5.18 Favored 'Trans proline' 0 C--N 1.374 1.883 0 C-N-CA 122.752 2.301 . . . . 64.11 114.686 -175.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . 68.26 -172.58 0.19 Allowed 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 124.961 1.304 . . . . 55.22 111.337 177.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . . . . . . . . . 20.4 m -84.55 133.8 28.45 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 121.224 0.535 . . . . 71.01 110.034 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 54.4 m -82.34 143.66 31.1 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 123.864 0.866 . . . . 73.1 110.865 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 26.5 p -66.01 111.89 3.57 Favored 'General case' 0 C--N 1.35 0.613 0 N-CA-C 108.392 -0.966 . . . . 70.52 108.392 166.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 33.1 p -62.41 117.34 29.74 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 123.221 0.608 . . . . 74.5 110.456 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 C--N 1.381 2.259 0 C-N-CA 122.683 2.256 . . . . 71.33 112.394 -177.216 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 120.062 -0.018 . . . . 74.32 110.999 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.477 ' HA ' HE21 ' E' ' 274' ' ' GLN . 21.8 p -62.39 115.16 3.96 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.342 0.657 . . . . 74.4 110.389 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.566 ' HG3' ' H ' ' A' ' 5' ' ' ASN . 10.5 tp10 -80.72 143.27 33.09 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.685 0.794 . . . . 75.52 112.983 -166.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -79.41 1.37 25.64 Favored 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.681 1.192 . . . . 70.22 111.553 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . 0.566 ' H ' ' HG3' ' A' ' 3' ' ' GLU . 45.7 t-20 -67.76 112.81 5.05 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.266 0.626 . . . . 64.51 110.115 177.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 61.4 t30 -91.79 132.95 36.05 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.533 -0.758 . . . . 44.33 109.092 177.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.2 m -76.33 82.28 3.08 Favored 'General case' 0 CA--C 1.545 0.756 0 CA-C-O 121.473 0.654 . . . . 54.15 110.804 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -124.04 101.02 7.01 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 107.358 -1.349 . . . . 73.22 107.358 173.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.448 ' N ' ' SD ' ' A' ' 9' ' ' MET . 2.0 mpp? -64.47 133.89 53.38 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 123.45 0.468 . . . . 55.14 110.592 -171.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.576 ' HB ' ' HB3' ' A' ' 87' ' ' ALA . 79.2 m -140.22 124.02 17.34 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 109.088 -0.708 . . . . 74.35 109.088 -179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.481 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 20.4 t80 -136.76 120.83 17.73 Favored 'General case' 0 C--O 1.234 0.267 0 N-CA-C 107.824 -1.176 . . . . 74.4 107.824 171.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 85' ' ' SER . 45.9 tp60 -142.83 108.25 5.04 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.087 -0.708 . . . . 71.11 109.087 -179.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.521 HG12 ' HD2' ' A' ' 84' ' ' PHE . 20.0 mt -71.03 125.2 28.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 116.2 -0.455 . . . . 63.13 109.91 177.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -101.23 -31.89 10.78 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 115.073 -0.967 . . . . 71.22 110.975 -177.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -179.27 132.48 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 119.369 -0.348 . . . . 72.35 110.996 -167.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.418 HD13 ' HG3' ' C' ' 130' ' ' PRO . 3.6 mp -120.41 133.87 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.265 0 N-CA-C 107.417 -1.327 . . . . 61.31 107.417 168.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' CE2' ' HG2' ' A' ' 19' ' ' LYS . 23.5 p90 -164.06 167.53 20.22 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 122.218 1.009 . . . . 62.33 111.299 -174.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.7 p -97.5 109.09 21.92 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.038 -1.437 . . . . 65.22 108.674 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.444 ' HG2' ' CE2' ' A' ' 17' ' ' TYR . 29.9 mtpt -78.26 -29.97 48.33 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.105 0.479 . . . . 62.13 109.791 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -146.33 141.4 27.23 Favored 'General case' 0 C--O 1.239 0.503 0 CA-C-N 114.902 -1.045 . . . . 75.35 109.616 177.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 61.8 mt -137.54 136.68 46.15 Favored 'Isoleucine or valine' 0 C--O 1.242 0.682 0 N-CA-C 106.077 -1.823 . . . . 73.22 106.077 176.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 44.3 t -148.08 125.59 11.7 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.66 -0.867 . . . . 75.02 108.66 176.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 84.0 t80 -127.18 140.15 52.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 107.18 -1.415 . . . . 71.31 107.18 169.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -134.74 151.58 51.09 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.752 -0.832 . . . . 65.11 108.752 173.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -147.24 73.96 11.87 Favored Pre-proline 0 C--O 1.241 0.654 0 N-CA-C 105.682 -1.97 . . . . 73.31 105.682 167.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -65.66 -43.02 10.78 Favored 'Trans proline' 0 C--N 1.381 2.245 0 C-N-CA 122.893 2.396 . . . . 75.32 113.197 -165.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -104.34 30.19 5.49 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.971 -0.751 . . . . 61.13 108.971 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.529 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.38 -57.92 7.62 Favored Pre-proline 0 CA--C 1.567 1.627 0 CA-C-O 117.595 -1.193 . . . . 75.14 113.052 -174.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 45.0 Cg_exo -55.74 -20.31 27.8 Favored 'Trans proline' 0 C--N 1.393 2.893 0 C-N-CA 122.979 2.453 . . . . 75.12 113.722 179.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -98.96 -38.14 9.11 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.018 0.927 . . . . 73.13 110.798 -175.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.54 HG21 ' HA ' ' A' ' 73' ' ' ALA . 2.4 p -78.85 -15.4 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.074 0.549 . . . . 72.45 111.444 -164.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -64.73 -30.95 71.97 Favored 'General case' 0 CA--C 1.556 1.189 0 C-N-CA 123.081 0.553 . . . . 53.52 111.193 176.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -90.93 -7.12 52.99 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 112.363 0.505 . . . . 73.05 112.363 -179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 19.9 mmtp -64.01 173.05 2.02 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.016 1.117 . . . . 72.11 114.016 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -76.45 159.12 30.71 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 124.928 1.291 . . . . 74.31 111.691 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.8 m95 -94.14 64.46 3.27 Favored 'General case' 0 N--CA 1.478 0.952 0 CA-C-O 121.063 0.459 . . . . 74.32 110.166 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -142.81 82.84 11.95 Favored Pre-proline 0 N--CA 1.479 1.011 0 C-N-CA 123.918 0.887 . . . . 61.12 109.241 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.57 138.44 13.64 Favored 'Trans proline' 0 C--N 1.368 1.568 0 C-N-CA 121.735 1.623 . . . . 64.42 110.891 173.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -92.57 82.58 4.83 Favored 'General case' 0 C--O 1.239 0.531 0 N-CA-C 105.978 -1.86 . . . . 71.25 105.978 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 65' ' ' THR . 10.2 m -82.53 114.65 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-N 113.993 -1.458 . . . . 42.32 109.382 -176.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.8 tttp -121.48 143.95 48.97 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.753 0.821 . . . . 74.21 109.96 177.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 97.3 mt -112.97 118.91 36.15 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 123.865 0.866 . . . . 73.21 109.786 177.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 3.8 m-20 -107.41 143.13 36.19 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 107.594 -1.261 . . . . 64.25 107.594 170.387 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.59 129.24 32.61 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 108.728 -0.842 . . . . 54.33 108.728 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.594 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 3.3 m-20 -117.74 120.81 39.09 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.738 -1.208 . . . . 74.52 107.738 179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 73.5 p -107.29 121.81 45.31 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.347 1.059 . . . . 75.33 108.627 -175.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.0 140.33 28.1 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 122.991 0.517 . . . . 62.44 110.377 -173.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.1 p -130.35 158.79 38.87 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.415 0.686 . . . . 74.22 110.616 176.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.5 t -149.48 154.98 39.64 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.336 1.054 . . . . 73.14 109.534 -178.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -103.76 105.61 15.87 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.693 -0.855 . . . . 75.41 108.693 172.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.419 HD11 ' HB2' ' A' ' 57' ' ' GLU . 52.0 mt -79.22 -38.2 36.29 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.221 0.609 . . . . 74.23 110.55 -179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -153.62 -178.19 6.86 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 124.333 1.053 . . . . 63.23 109.246 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -65.47 123.15 18.89 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 109.0 -0.741 . . . . 73.4 109.0 173.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 71.18 -9.81 0.84 Allowed 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 126.019 1.728 . . . . 75.53 112.771 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.9 t -100.67 110.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 N-CA-C 108.385 -0.969 . . . . 71.24 108.385 -178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -125.3 164.13 21.02 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 123.703 0.801 . . . . 70.14 109.536 -176.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HB2' HD11 ' A' ' 51' ' ' LEU . 38.0 tt0 -131.69 142.73 49.89 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 123.693 0.797 . . . . 65.15 109.449 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 58.2 t -124.36 132.52 71.22 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 107.601 -1.259 . . . . 74.24 107.601 172.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 40.2 t -125.08 131.36 72.61 Favored 'Isoleucine or valine' 0 C--O 1.241 0.641 0 C-N-CA 123.625 0.77 . . . . 74.4 108.934 179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.463 HD23 HD12 ' A' ' 106' ' ' LEU . 3.9 mm? -117.99 106.0 12.47 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 108.106 -1.072 . . . . 73.12 108.106 177.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.594 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 23.9 ttp180 -83.82 102.63 12.48 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 108.151 -1.055 . . . . 54.44 108.151 173.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 17.7 t -91.31 119.75 39.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 N-CA-C 106.995 -1.483 . . . . 70.41 106.995 175.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 44.0 m -118.97 122.64 42.67 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.344 -0.613 . . . . 72.11 109.344 -178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.85 HG11 HD21 ' A' ' 126' ' ' LEU . 28.9 t -118.52 108.99 25.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.652 -0.87 . . . . 62.53 108.652 -179.162 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.51 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 7.0 m -107.63 137.4 45.73 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.537 -0.542 . . . . 71.02 109.537 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -125.95 105.25 8.78 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 108.362 -0.977 . . . . 63.41 108.362 174.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.563 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 50.2 m -114.2 127.56 55.95 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 122.996 0.519 . . . . 72.24 110.796 -177.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.5 mp -107.12 85.19 2.09 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 107.91 -1.145 . . . . 65.43 107.91 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.16 -111.29 3.23 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 110.562 -1.015 . . . . 73.15 110.562 -171.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 44.9 mm-40 -100.8 -8.49 22.62 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.058 0.543 . . . . 74.44 110.512 174.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -102.26 97.71 7.95 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 123.753 0.821 . . . . 60.43 110.383 -171.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 46.9 m -66.86 124.29 22.56 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 122.911 0.484 . . . . 73.42 110.823 175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -67.64 -57.3 6.65 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 124.203 1.001 . . . . 54.13 109.974 175.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -157.48 158.85 36.53 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 114.528 -1.215 . . . . 62.44 112.204 178.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.4 ' O ' ' HA ' ' A' ' 23' ' ' PHE . 55.6 tp -126.89 135.17 50.57 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.95 1.3 . . . . 64.14 108.035 171.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.414 ' SG ' HG22 ' A' ' 118' ' ' VAL . 51.2 m -130.64 97.75 4.45 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.404 -0.591 . . . . 71.33 109.404 175.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -116.9 116.28 27.12 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.021 0.929 . . . . 74.43 109.392 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.8 t -133.94 110.94 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 C-N-CA 123.784 0.834 . . . . 70.42 109.215 -171.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 70.2 mt-30 -84.93 89.31 7.55 Favored 'General case' 0 C--O 1.243 0.721 0 N-CA-C 108.684 -0.858 . . . . 74.45 108.684 173.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.86 96.69 7.09 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.506 -0.77 . . . . 70.32 109.048 179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -88.99 151.52 22.21 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 115.48 -0.782 . . . . 72.45 111.92 178.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.58 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -153.19 124.55 1.61 Allowed Glycine 0 CA--C 1.509 -0.309 0 N-CA-C 111.302 -0.719 . . . . 44.45 111.302 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 38.1 mt -85.14 124.59 40.1 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 123.208 0.603 . . . . 70.31 109.763 178.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.521 ' HD2' HG12 ' A' ' 13' ' ' ILE . 37.9 m-85 -132.94 119.87 20.71 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 107.764 -1.198 . . . . 63.0 107.764 -178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 12' ' ' GLN . 25.8 t -82.19 98.61 8.82 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 109.493 -0.558 . . . . 65.52 109.493 176.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.55 HD13 HD21 ' A' ' 98' ' ' LEU . 45.3 pt -103.49 147.46 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.999 0.919 . . . . 74.35 110.411 -177.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.576 ' HB3' ' HB ' ' A' ' 10' ' ' THR . . . -169.68 161.08 9.19 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.228 0.611 . . . . 41.11 111.863 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.31 -33.96 3.54 Favored Glycine 0 C--N 1.356 1.655 0 CA-C-N 115.605 -0.725 . . . . 75.24 113.964 173.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.422 ' O ' HD12 ' A' ' 89' ' ' ILE . 2.1 pp -117.04 135.56 57.03 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.877 0.871 . . . . 64.34 109.432 -176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 62.1 mt-10 -139.56 175.86 9.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 123.376 0.67 . . . . 71.43 110.326 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.406 ' HA2' ' HD3' ' E' ' 275' ' ' LYS . . . 62.59 -115.32 7.85 Favored Glycine 0 C--N 1.351 1.362 0 O-C-N 123.77 0.669 . . . . 65.3 112.831 177.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.1 t -74.58 -30.46 61.72 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.54 0.736 . . . . 74.33 111.567 179.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -67.32 -37.5 83.42 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.536 -0.757 . . . . 73.14 109.562 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.431 ' HG2' ' HG ' ' A' ' 98' ' ' LEU . 3.4 ttp -82.3 -24.45 34.65 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-N 115.311 -0.859 . . . . 74.45 110.833 172.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.731 ' HA ' HD22 ' E' ' 280' ' ' LEU . . . -66.48 -34.74 78.6 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.086 0.402 . . . . 75.44 112.086 -177.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.6 t-80 -77.28 -30.77 54.42 Favored 'General case' 0 CA--C 1.544 0.732 0 CA-C-N 116.559 -0.292 . . . . 74.24 110.34 174.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 53.5 t -69.39 -65.05 0.76 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 122.582 0.353 . . . . 70.2 110.951 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.55 HD21 HD13 ' A' ' 86' ' ' ILE . 14.7 mt -75.66 -23.81 56.3 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 122.742 0.417 . . . . 65.41 111.739 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -95.94 -5.97 59.44 Favored Glycine 0 C--N 1.345 1.039 0 CA-C-O 119.313 -0.715 . . . . 34.51 114.751 -172.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -148.41 -57.78 0.23 Allowed 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 117.992 0.896 . . . . 72.13 112.319 -175.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.481 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 89.8 t80 -68.4 -54.89 14.15 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 123.245 0.618 . . . . 73.42 112.066 -171.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 71.0 m -71.01 -33.16 2.71 Favored Pre-proline 0 CA--C 1.569 1.674 0 C-N-CA 123.673 0.789 . . . . 64.25 112.876 -178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -51.96 -41.96 60.87 Favored 'Trans proline' 0 C--N 1.388 2.633 0 C-N-CA 122.493 2.128 . . . . 64.13 113.154 160.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.1 m-20 -70.87 -14.03 62.24 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.384 0.674 . . . . 64.11 111.766 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 49.2 mm -78.86 -41.39 23.84 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.036 0 N-CA-C 108.98 -0.748 . . . . 75.32 108.98 169.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.58 HD21 ' HA3' ' A' ' 82' ' ' GLY . 95.9 mt -84.33 -30.21 25.69 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.059 0.944 . . . . 72.44 113.189 -172.047 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -64.94 -38.63 30.97 Favored Pre-proline 0 CA--C 1.565 1.543 0 CA-C-O 118.037 -0.983 . . . . 75.43 113.537 -171.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.54 -38.45 93.8 Favored 'Trans proline' 0 C--N 1.386 2.51 0 C-N-CA 121.923 1.749 . . . . 74.24 113.25 171.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -73.84 -37.45 64.81 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.985 0.514 . . . . 75.45 111.141 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.17 -44.6 91.55 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 109.777 -0.453 . . . . 45.12 109.777 175.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -52.51 -53.58 44.09 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 124.777 1.298 . . . . 74.11 110.72 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -68.19 -38.92 82.52 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 124.242 0.964 . . . . 73.4 111.374 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 38.5 t -61.79 -32.25 72.53 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 122.978 0.511 . . . . 74.1 110.648 178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.457 ' O ' HG23 ' A' ' 118' ' ' VAL . 84.9 mt -74.34 -52.94 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 CA-C-N 115.287 -0.869 . . . . 74.22 110.323 174.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 13.7 m -55.28 -41.56 72.41 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.223 1.009 . . . . 72.22 111.297 -172.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 27.8 t -64.96 -44.86 88.0 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.72 -1.127 . . . . 72.34 110.776 -178.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 64.4 mtm -64.52 -38.59 91.56 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 122.689 0.395 . . . . 75.15 111.492 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 114' ' ' ILE . 93.2 t -64.36 -42.01 94.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.893 0 C-N-CA 123.664 0.785 . . . . 74.52 110.704 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 88.3 p -72.4 -30.73 64.92 Favored 'General case' 0 CA--C 1.551 0.999 0 CA-C-N 116.09 -0.505 . . . . 73.35 110.907 -179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 71.0 mtt-85 -68.3 -25.32 65.08 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.594 0.758 . . . . 70.33 110.882 175.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.7 7.51 65.36 Favored Glycine 0 C--N 1.357 1.732 0 CA-C-O 120.004 -0.331 . . . . 73.22 113.595 176.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.4 m 61.86 35.49 16.45 Favored 'General case' 0 CA--C 1.558 1.275 0 C-N-CA 125.255 1.422 . . . . 73.01 110.945 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -107.31 160.89 24.87 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 124.064 0.946 . . . . 65.2 109.723 171.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -55.25 146.22 61.91 Favored 'Trans proline' 0 C--N 1.387 2.584 0 C-N-CA 122.242 1.961 . . . . 73.13 111.522 168.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -63.11 148.19 48.63 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-O 120.775 0.322 . . . . 74.32 110.3 -175.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.85 HD21 HG11 ' A' ' 64' ' ' VAL . 48.7 tp -113.72 113.48 25.04 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 123.004 0.522 . . . . 65.43 110.127 -177.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 83.8 m-20 -114.17 114.19 25.7 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 107.653 -1.24 . . . . 71.23 107.653 -178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 128' ' ' LEU . 3.9 mm? -74.4 135.14 42.41 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.92 0.391 . . . . 70.34 110.152 174.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . 0.596 ' HB3' HD13 ' E' ' 291' ' ' LEU . . . -71.87 132.23 85.09 Favored Pre-proline 0 CA--C 1.55 0.971 0 CA-C-N 115.935 -0.575 . . . . 51.24 110.368 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 129' ' ' ALA . 0.9 OUTLIER -77.54 116.95 4.17 Favored 'Trans proline' 0 C--N 1.375 1.959 0 C-N-CA 122.505 2.136 . . . . 74.02 111.515 -177.012 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.512 HG22 HD21 ' E' ' 291' ' ' LEU . 48.3 t -101.76 135.36 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 123.189 0.596 . . . . 72.54 109.953 -178.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.53 HD22 ' HB3' ' A' ' 135' ' ' ALA . 1.2 p-10 -76.78 69.94 3.19 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.334 1.054 . . . . 74.54 110.605 172.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -56.08 -38.74 71.09 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.247 1.019 . . . . 75.1 111.749 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -65.51 -35.36 80.66 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 114.487 -1.233 . . . . 53.53 111.917 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.53 ' HB3' HD22 ' A' ' 132' ' ' ASN . . . -71.19 -34.17 70.63 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.049 0.54 . . . . 34.14 111.307 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 11.3 mp -61.72 -42.89 99.55 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.81 0.444 . . . . 75.43 110.204 173.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -63.04 -31.55 72.72 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 124.038 0.935 . . . . 73.03 110.345 176.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 33.3 mmt -75.93 -35.25 59.8 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-N 116.009 -0.541 . . . . 72.54 111.398 175.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 30.2 m-80 -61.31 -39.68 91.37 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 122.506 0.322 . . . . 73.33 110.933 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . 0.437 ' CE2' ' HB ' ' C' ' 149' ' ' THR . 83.9 t80 -67.3 -43.98 80.34 Favored 'General case' 0 CA--C 1.544 0.73 0 O-C-N 123.377 0.423 . . . . 62.23 110.406 171.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 20.4 tp -57.67 -51.57 69.0 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 124.106 0.879 . . . . 71.11 111.569 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 175.31 30.0 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 125.259 1.423 . . . . 72.31 109.843 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 0.5 OUTLIER 65.41 -83.96 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.713 1.205 . . . . 64.1 108.238 -169.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -158.83 164.45 35.74 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.948 1.299 . . . . 74.41 109.155 173.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.5 114.97 17.43 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.956 0.903 . . . . 74.43 108.785 171.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -80.5 156.08 38.5 Favored Glycine 0 C--N 1.346 1.089 0 N-CA-C 111.766 -0.533 . . . . 61.24 111.766 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.17 -74.92 0.08 Allowed 'General case' 0 CA--C 1.556 1.196 0 C-N-CA 122.973 0.509 . . . . 74.12 110.258 177.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 56.46 29.39 57.17 Favored Glycine 0 C--N 1.361 1.962 0 N-CA-C 113.972 0.349 . . . . 72.31 113.972 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.9 t -119.25 102.6 8.82 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.497 1.119 . . . . 53.42 110.111 -171.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -95.36 132.33 40.51 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.309 0.644 . . . . 75.21 109.422 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -122.97 150.22 43.27 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.761 0.824 . . . . 61.21 109.534 -178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -85.09 125.2 32.57 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 122.824 0.45 . . . . 65.21 109.865 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -66.03 -61.29 2.12 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.99 0.916 . . . . 72.22 112.394 -173.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -157.52 141.91 16.33 Favored 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 122.97 0.508 . . . . 73.43 109.885 -178.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.954 0 C-N-CA 123.454 0.702 . . . . 61.34 109.652 179.66 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.474 0.742 0 N-CA-C 109.765 -0.457 . . . . 74.24 109.765 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 60.3 p -167.19 142.86 4.16 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 124.39 1.076 . . . . 72.13 109.178 176.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -167.39 153.68 7.97 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.97 0.908 . . . . 73.45 109.786 176.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.417 ' H ' ' HD1' ' D' ' 140' ' ' TYR . 28.0 mt-30 -79.31 77.12 5.85 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 107.998 -1.112 . . . . 64.31 107.998 169.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -69.52 115.13 8.41 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.014 -0.993 . . . . 70.31 111.202 -169.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -163.21 142.54 8.59 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.383 1.073 . . . . 70.42 108.306 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 27.7 m -110.06 143.25 40.37 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.1 0.56 . . . . 70.4 109.61 -178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.3 176.87 7.73 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.862 0.865 . . . . 71.22 110.446 177.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . . . . . . . . . 21.9 ptm 43.86 -153.04 0.03 OUTLIER 'General case' 0 N--CA 1.509 2.505 0 C-N-CA 125.575 1.55 . . . . 73.04 111.969 -176.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.617 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 87.9 m -143.52 114.94 8.02 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 108.536 -0.913 . . . . 72.53 108.536 167.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . 0.41 ' HE2' ' HG2' ' D' ' 130' ' ' PRO . 49.4 t80 -135.32 132.8 38.13 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.828 0.851 . . . . 74.35 109.492 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.583 ' HB3' ' HB ' ' E' ' 309' ' ' THR . 9.3 pt20 -156.41 140.17 16.11 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.942 0.897 . . . . 71.44 109.022 173.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . . . . . . . . . 28.5 pt -90.71 135.42 26.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 N-CA-C 107.834 -1.173 . . . . 61.15 107.834 169.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -93.19 -53.84 3.95 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 109.858 -0.423 . . . . 61.23 109.858 174.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.525 ' HB2' ' HB3' ' E' ' 304' ' ' PRO . 20.9 ttt180 -155.49 131.52 10.06 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 109.914 -0.402 . . . . 73.12 109.914 -172.037 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.51 ' H ' ' ND2' ' D' ' 127' ' ' ASN . 83.7 mt -114.97 136.96 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 N-CA-C 106.287 -1.746 . . . . 63.45 106.287 174.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -165.45 140.44 4.99 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.881 0.472 . . . . 74.25 111.142 -171.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 92.0 m -73.47 117.85 15.72 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.873 0.869 . . . . 54.42 109.24 173.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 44.1 mtpt -94.59 -22.41 18.21 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.471 0.708 . . . . 72.13 111.58 -177.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' B' ' 79' ' ' GLN . 26.1 t70 -163.1 142.48 8.69 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 123.337 0.398 . . . . 65.05 110.473 -172.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.448 HD11 ' SG ' ' B' ' 113' ' ' CYS . 33.1 mm -137.27 141.59 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 C-N-CA 124.975 1.31 . . . . 40.24 108.467 176.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.516 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 27.5 t -142.8 124.09 14.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.785 -1.191 . . . . 74.13 107.785 177.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.553 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 90.6 t80 -146.56 115.73 7.0 Favored 'General case' 0 C--O 1.217 -0.616 0 N-CA-C 107.274 -1.38 . . . . 72.52 107.274 172.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -119.91 158.81 25.91 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 123.448 0.699 . . . . 64.55 109.513 176.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.647 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -149.99 78.19 8.15 Favored Pre-proline 0 CA--C 1.54 0.573 0 N-CA-C 107.664 -1.235 . . . . 70.33 107.664 175.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -67.88 -22.65 42.19 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.936 2.424 . . . . 53.31 112.675 -170.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -122.97 24.55 8.92 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.096 0.959 . . . . 73.1 109.663 -178.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.647 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -48.42 -50.16 59.26 Favored Pre-proline 0 CA--C 1.573 1.853 0 N-CA-C 114.744 1.387 . . . . 71.3 114.744 -178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -80.41 -28.7 2.77 Favored 'Trans proline' 0 C--N 1.388 2.637 0 C-N-CA 121.849 1.7 . . . . 54.54 112.789 177.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.45 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 51.5 m80 -96.18 4.67 52.27 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.354 1.061 . . . . 71.14 112.09 -172.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 11.6 p -62.31 -26.25 39.82 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 123.632 0.773 . . . . 75.42 110.788 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.57 ' HA ' ' HB2' ' B' ' 35' ' ' ASP . 30.2 t80 -69.0 -16.09 63.64 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 113.104 0.779 . . . . 72.31 113.104 -170.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 27.2 pt20 -73.16 -47.08 46.87 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 118.065 0.393 . . . . 75.53 110.73 176.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.52 ' NZ ' ' HG2' ' B' ' 71' ' ' GLU . 45.4 pttt -112.62 66.79 0.65 Allowed 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 107.548 -1.279 . . . . 75.21 107.548 174.094 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.57 ' HB2' ' HA ' ' B' ' 32' ' ' PHE . 39.1 t70 -96.86 108.47 21.16 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 115.275 -0.875 . . . . 73.51 111.563 -164.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.514 ' HA ' ' CE3' ' B' ' 36' ' ' TRP . 0.8 OUTLIER 177.74 -170.86 0.1 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 124.597 1.186 . . . . 73.03 109.437 163.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -50.89 116.77 7.59 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 124.096 0.958 . . . . 73.3 111.995 177.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -81.65 156.73 18.68 Favored 'Trans proline' 0 C--N 1.369 1.651 0 C-N-CA 122.651 2.234 . . . . 72.43 111.464 178.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -64.03 102.19 0.47 Allowed 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 108.123 -1.066 . . . . 73.13 108.123 170.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 11.8 p -97.4 151.16 4.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.066 -0.97 . . . . 61.22 109.632 -176.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -139.12 137.42 36.13 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.34 0.656 . . . . 74.2 109.621 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.511 HD12 HD11 ' B' ' 128' ' ' LEU . 2.4 tt -93.18 126.11 38.12 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 107.148 -1.427 . . . . 62.43 107.148 167.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . 0.59 ' HB3' ' HB ' ' B' ' 63' ' ' THR . 8.4 t0 -131.34 145.21 51.75 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 106.547 -1.649 . . . . 73.3 106.547 174.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 10.3 tt -140.62 133.27 28.77 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.667 -0.864 . . . . 73.31 108.667 -174.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.585 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 14.7 t70 -124.3 134.38 53.22 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 124.694 1.198 . . . . 74.44 108.701 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.1 p -107.9 108.25 19.33 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.455 0.702 . . . . 64.42 109.759 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -120.91 119.3 32.22 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 108.538 -0.912 . . . . 72.21 108.538 176.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 64.2 p -139.15 166.08 25.45 Favored 'General case' 0 C--O 1.24 0.574 0 C-N-CA 123.141 0.577 . . . . 73.13 110.688 -178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 74.2 p -151.16 165.99 32.22 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.136 0.974 . . . . 72.35 109.146 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -115.07 107.74 15.74 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 108.454 -0.943 . . . . 72.21 108.454 173.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 95.1 mt -67.11 -42.52 84.39 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.585 0.754 . . . . 75.11 110.892 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -157.77 -170.98 3.37 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.667 0.787 . . . . 43.43 110.363 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.41 114.39 5.4 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.226 -0.897 . . . . 75.21 109.517 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 73.22 -6.69 1.67 Allowed 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 126.332 1.853 . . . . 70.41 113.202 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 58.9 t -102.74 120.59 52.75 Favored 'Isoleucine or valine' 0 C--N 1.35 0.594 0 N-CA-C 109.151 -0.685 . . . . 73.31 109.151 -174.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . 0.528 ' HE2' ' HB2' ' H' ' 278' ' ' LEU . 36.9 m-85 -114.11 173.11 6.6 Favored 'General case' 0 C--O 1.238 0.477 0 CA-C-N 115.605 -0.725 . . . . 73.21 110.945 177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -142.17 95.19 2.76 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 105.541 -2.022 . . . . 74.52 105.541 172.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.35 122.32 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 124.03 0.932 . . . . 62.12 109.09 -175.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . . . . . . . . . 16.5 t -111.7 143.47 21.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.711 0 C-N-CA 123.57 0.748 . . . . 75.31 109.454 178.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' B' ' 103' ' ' PRO . 93.6 mt -120.1 112.43 19.11 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.753 -0.462 . . . . 43.21 109.753 174.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.585 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 55.7 ttm-85 -86.6 107.24 18.07 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 108.155 -1.054 . . . . 73.43 108.155 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 94.0 t -101.66 105.54 18.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 107.27 -1.382 . . . . 75.01 107.27 177.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . 0.59 ' HB ' ' HB3' ' B' ' 43' ' ' ASP . 28.6 m -96.48 137.79 35.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.447 -0.797 . . . . 74.43 108.994 178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . . . . . . . . . 77.4 t -134.62 101.43 3.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.505 0 N-CA-C 107.887 -1.153 . . . . 64.23 107.887 177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.5 m -98.08 141.58 30.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.272 -0.876 . . . . 72.1 109.516 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.73 148.44 52.58 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 109.02 -0.733 . . . . 75.31 109.02 174.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -157.39 128.61 6.76 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 123.368 0.417 . . . . 52.34 111.238 -175.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.671 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -127.84 143.19 51.12 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 123.552 0.741 . . . . 63.31 109.917 175.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.25 -112.24 3.51 Favored Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.929 -0.869 . . . . 53.12 110.929 -173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -123.86 6.1 8.71 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.966 0.906 . . . . 73.34 109.922 178.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . 0.52 ' HG2' ' NZ ' ' B' ' 34' ' ' LYS . 8.8 pt-20 -149.28 -178.98 6.71 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 122.625 0.37 . . . . 74.41 111.209 -171.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 89.8 m -64.6 147.69 52.4 Favored 'General case' 0 CA--C 1.551 1.008 0 C-N-CA 124.685 1.194 . . . . 72.33 111.674 -174.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.671 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -96.34 -63.49 1.14 Allowed 'General case' 0 N--CA 1.475 0.79 0 N-CA-C 108.111 -1.07 . . . . 75.43 108.111 171.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 27.3 p90 -152.78 163.66 39.28 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.622 -1.626 . . . . 73.41 108.041 173.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . . . . . . . . . 87.6 mt -125.84 144.69 50.55 Favored 'General case' 0 C--N 1.322 -0.601 0 C-N-CA 124.736 1.215 . . . . 75.4 108.543 178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . 0.492 ' SG ' HG23 ' B' ' 114' ' ' ILE . 33.8 t -147.44 144.08 28.37 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 108.53 -0.915 . . . . 61.31 108.53 173.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.516 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 33.1 tt0 -164.95 138.98 4.95 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.171 -0.677 . . . . 71.43 109.171 -174.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.405 HG21 ' HB3' ' B' ' 113' ' ' CYS . 97.4 t -132.07 148.07 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 123.675 0.79 . . . . 73.5 109.257 179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . 0.492 ' HB2' ' HB3' ' B' ' 20' ' ' ASP . 41.5 mt-30 -122.6 103.17 8.51 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.407 -0.96 . . . . 70.11 108.407 168.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -94.05 105.29 17.3 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 108.14 -1.059 . . . . 51.41 108.14 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 155.0 24.18 Favored Glycine 0 C--O 1.243 0.69 0 N-CA-C 111.205 -0.758 . . . . 61.55 111.205 176.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.75 125.29 1.72 Allowed Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.566 -0.614 . . . . 65.13 111.566 -178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 66.5 mt -84.28 126.36 40.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 N-CA-C 108.055 -1.091 . . . . 73.42 108.055 172.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -129.74 162.57 28.12 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.066 0.946 . . . . 74.53 108.988 -176.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 48.7 m -132.5 113.26 12.89 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.083 -0.71 . . . . 71.1 109.083 168.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.462 ' HB ' HD11 ' B' ' 89' ' ' ILE . 32.9 pt -119.17 137.85 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 123.919 0.888 . . . . 63.33 110.084 -177.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.617 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.23 164.0 39.41 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.918 0.887 . . . . 71.44 109.743 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 87.63 -47.46 3.6 Favored Glycine 0 C--N 1.347 1.167 0 CA-C-N 116.242 -0.435 . . . . 73.31 112.493 -178.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.558 HD12 ' HA ' ' B' ' 94' ' ' MET . 19.9 pt -64.04 148.89 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.523 1.129 . . . . 74.42 113.211 -177.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.41 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 15.4 pt-20 -157.36 162.7 39.07 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.306 1.042 . . . . 72.4 109.704 172.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 58.57 -115.07 6.61 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.398 0.436 . . . . 54.24 113.614 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 17.9 m -77.77 -28.88 50.71 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.413 0.685 . . . . 55.5 110.79 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.41 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 97.0 mt-30 -58.56 -42.15 87.26 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.053 0.541 . . . . 71.52 110.588 177.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.558 ' HA ' HD12 ' B' ' 89' ' ' ILE . 23.9 ttt -71.87 -41.54 67.92 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.726 -0.67 . . . . 74.43 110.767 -178.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -59.09 -39.55 82.54 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 123.783 0.677 . . . . 74.23 111.29 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.416 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 57.9 t-80 -79.54 -20.15 47.82 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 114.963 -1.017 . . . . 71.32 110.916 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 53.2 t -83.29 -67.05 0.82 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 122.293 0.237 . . . . 41.32 111.009 178.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.451 ' HA ' ' SG ' ' B' ' 102' ' ' CYS . 2.5 pp -83.92 -15.0 49.58 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 112.64 0.608 . . . . 75.12 112.64 -174.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.64 -27.75 11.15 Favored Glycine 0 C--N 1.347 1.159 0 CA-C-O 119.986 -0.341 . . . . 55.14 112.929 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.416 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -114.93 -60.24 1.91 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.252 0.621 . . . . 65.05 111.391 -177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -69.87 -46.0 66.46 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 123.195 0.598 . . . . 73.11 112.133 -170.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' B' ' 98' ' ' LEU . 62.6 m -68.38 -40.86 21.72 Favored Pre-proline 0 CA--C 1.564 1.502 0 CA-C-O 118.851 -0.595 . . . . 74.55 112.299 -177.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.561 ' HA ' HD11 ' B' ' 60' ' ' LEU . 76.0 Cg_exo -52.91 -39.9 77.16 Favored 'Trans proline' 0 C--N 1.388 2.635 0 C-N-CA 122.273 1.982 . . . . 64.33 113.961 165.744 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -65.91 -16.43 63.85 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 111.715 0.265 . . . . 63.54 111.715 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 79.4 mt -82.67 -55.76 7.0 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.795 0 C-N-CA 123.368 0.667 . . . . 65.04 110.526 173.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . 0.435 ' HB2' HD12 ' B' ' 60' ' ' LEU . 91.0 mt -76.83 -25.32 53.09 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.265 0.626 . . . . 73.55 112.681 -169.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -61.7 -48.98 88.41 Favored Pre-proline 0 N--CA 1.489 1.504 0 CA-C-O 117.72 -1.134 . . . . 70.41 113.628 -173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -53.92 -38.47 86.18 Favored 'Trans proline' 0 C--N 1.387 2.602 0 C-N-CA 122.052 1.835 . . . . 51.44 113.374 176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.469 ' HE2' HG21 ' D' ' 115' ' ' THR . 29.3 m-85 -65.3 -45.33 84.8 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.596 0.759 . . . . 74.02 110.296 178.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.17 -35.19 79.82 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.791 -0.641 . . . . 65.21 111.044 178.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.9 ttt-85 -61.2 -56.23 23.1 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.331 1.052 . . . . 55.15 111.106 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.17 -36.86 85.03 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.517 0.511 . . . . 63.45 110.087 -176.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.535 ' O ' ' HG2' ' B' ' 117' ' ' MET . 4.0 t -69.44 -26.9 64.83 Favored 'General case' 0 CA--C 1.553 1.067 0 O-C-N 123.684 0.615 . . . . 74.42 111.503 -178.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.492 HG23 ' SG ' ' B' ' 76' ' ' CYS . 81.7 mt -74.56 -52.35 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 122.889 0.475 . . . . 73.33 109.846 170.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 28.9 m -60.26 -27.74 67.49 Favored 'General case' 0 CA--C 1.56 1.335 0 C-N-CA 124.053 0.941 . . . . 71.44 111.665 -176.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.7 t -68.16 -48.73 64.53 Favored 'General case' 0 C--N 1.351 0.662 0 C-N-CA 123.632 0.773 . . . . 65.12 109.769 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.535 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 12.8 mmt -71.72 -32.2 67.52 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 122.921 0.488 . . . . 75.12 111.484 -174.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.33 -38.94 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 C-N-CA 123.228 0.611 . . . . 64.31 110.139 175.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 46.5 t -65.66 -38.99 90.87 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.599 0.759 . . . . 71.33 111.166 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.435 ' HD2' ' SD ' ' B' ' 117' ' ' MET . 94.5 mtt-85 -67.66 -33.76 75.59 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.608 0.763 . . . . 62.33 110.356 178.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.82 11.66 61.59 Favored Glycine 0 C--N 1.353 1.508 0 CA-C-N 115.875 -0.602 . . . . 73.13 112.963 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 76.2 p 56.97 29.69 16.81 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.735 1.614 . . . . 52.43 113.847 171.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -109.72 145.47 32.04 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.106 0.962 . . . . 74.12 109.045 172.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.571 ' HA ' ' HG3' ' C' ' 125' ' ' GLN . 61.6 Cg_exo -57.21 140.34 92.56 Favored 'Trans proline' 0 C--N 1.376 2.017 0 C-N-CA 122.838 2.358 . . . . 65.12 113.843 178.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.495 ' NE2' HD21 ' B' ' 127' ' ' ASN . 20.3 pt20 -65.43 160.01 22.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 113.476 -1.693 . . . . 74.21 112.695 -174.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -134.4 116.38 15.11 Favored 'General case' 0 C--O 1.243 0.711 0 N-CA-C 107.574 -1.269 . . . . 62.34 107.574 168.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . 0.495 HD21 ' NE2' ' B' ' 125' ' ' GLN . 54.8 m-80 -89.97 104.08 16.68 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 106.924 -1.51 . . . . 71.04 106.924 177.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . 0.511 HD11 HD12 ' B' ' 42' ' ' LEU . 16.0 tp -66.46 134.85 53.3 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 115.846 -0.616 . . . . 75.11 110.874 -172.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.14 137.97 94.29 Favored Pre-proline 0 CA--C 1.551 1.004 0 C-N-CA 124.228 1.011 . . . . 73.51 111.745 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -48.46 111.72 0.5 Allowed 'Trans proline' 0 C--N 1.383 2.342 0 C-N-CA 123.143 2.562 . . . . 72.34 112.013 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -88.15 108.13 18.27 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 108.14 -1.059 . . . . 61.24 108.14 -179.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -97.47 77.24 2.6 Favored 'General case' 0 C--O 1.239 0.543 0 N-CA-C 108.436 -0.95 . . . . 61.42 108.436 -177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -70.74 -21.41 62.53 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.862 -1.063 . . . . 74.31 109.917 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -63.79 -46.07 86.87 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.815 0.846 . . . . 73.44 109.087 174.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.84 -32.59 70.81 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-N 114.838 -1.074 . . . . 74.23 112.011 177.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . 0.478 HD21 ' SD ' ' H' ' 286' ' ' MET . 7.3 tt -57.07 -50.43 72.78 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 123.544 0.737 . . . . 73.1 110.31 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -67.4 -33.56 75.44 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.278 0.631 . . . . 61.43 111.758 177.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.2 mmt -69.51 -33.77 73.31 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.139 0.576 . . . . 75.52 111.44 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -82.85 -14.81 53.62 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.453 0.701 . . . . 74.01 110.896 178.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -72.95 -29.71 63.3 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 109.247 -0.649 . . . . 74.51 109.247 168.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 58.2 mt -104.86 33.69 3.5 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.186 0.994 . . . . 74.21 109.957 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -72.72 93.71 1.68 Allowed 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.077 0.951 . . . . 70.13 111.85 -174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -166.47 109.88 0.75 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 123.59 0.756 . . . . 65.24 109.35 171.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -156.66 130.67 8.44 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.361 0.665 . . . . 63.42 109.658 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -80.07 145.36 32.48 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.08 0.552 . . . . 52.54 110.76 173.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -99.41 139.71 14.58 Favored Glycine 0 C--N 1.343 0.932 0 N-CA-C 111.487 -0.645 . . . . 73.13 111.487 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -97.8 130.84 44.71 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.465 0.706 . . . . 73.34 110.242 -178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -81.8 160.35 41.02 Favored Glycine 0 C--N 1.351 1.374 0 O-C-N 123.515 0.509 . . . . 71.41 112.189 177.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 50.2 m -103.04 108.8 20.11 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 108.477 -0.934 . . . . 74.45 108.477 172.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -70.6 104.83 2.92 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 108.822 -0.807 . . . . 61.13 108.822 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -65.33 90.16 0.1 Allowed 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.821 -0.807 . . . . 51.41 108.821 175.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -68.24 102.45 1.37 Allowed 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 115.52 -0.764 . . . . 72.11 109.933 -179.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.99 115.92 8.85 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 106.635 -1.617 . . . . 64.12 106.635 168.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -68.76 137.42 54.01 Favored 'General case' 0 N--CA 1.473 0.714 0 O-C-N 123.514 0.509 . . . . 73.11 110.522 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.923 0 C-N-CA 123.429 0.692 . . . . 63.54 110.548 -178.023 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . 0.45 ' SD ' ' N ' ' C' ' 1' ' ' MET . 2.7 mpp? . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 109.023 -0.732 . . . . 70.22 109.023 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 47.6 t -67.63 126.28 28.86 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 122.991 0.516 . . . . 53.45 110.244 -179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -73.38 79.42 1.38 Allowed 'General case' 0 CA--C 1.554 1.099 0 C-N-CA 123.731 0.812 . . . . 71.0 110.079 175.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -80.18 89.59 5.46 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 108.828 -0.804 . . . . 73.22 108.828 -178.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . 0.431 HD22 ' N ' ' C' ' 5' ' ' ASN . 0.0 OUTLIER -168.03 126.32 1.19 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 124.556 1.142 . . . . 75.42 108.726 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -161.81 125.68 3.22 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.982 0.913 . . . . 72.4 109.178 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 16.9 p -142.46 179.29 7.04 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.237 1.015 . . . . 72.11 110.101 -176.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.47 159.37 34.61 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.13 0.572 . . . . 64.34 109.527 167.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.423 ' HB2' HG23 ' C' ' 89' ' ' ILE . 23.7 ttt 64.25 114.84 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.319 1.047 . . . . 70.15 111.651 -174.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . 0.419 ' O ' ' HA ' ' C' ' 86' ' ' ILE . 91.0 m -98.58 96.36 7.91 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 108.836 -0.801 . . . . 61.45 108.836 174.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . 0.596 ' HE1' ' HG ' ' C' ' 102' ' ' CYS . 57.1 t80 -99.38 128.38 45.49 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 108.652 -0.87 . . . . 74.35 108.652 174.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -152.79 136.74 16.31 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 109.262 -0.644 . . . . 60.35 109.262 175.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.409 ' HB ' HG21 ' G' ' 306' ' ' VAL . 66.7 mt -90.07 104.39 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 C-N-CA 124.069 0.947 . . . . 74.14 109.745 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -73.56 -50.51 20.96 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 110.309 -0.256 . . . . 71.33 110.309 -177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 18.9 ttt85 -169.48 123.83 0.8 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 109.734 -0.469 . . . . 74.33 109.734 -174.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 72.0 mt -107.98 137.3 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.388 -0.967 . . . . 74.32 108.388 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.491 ' HE2' ' HB1' ' D' ' 28' ' ' ALA . 33.6 p90 -168.56 159.54 10.24 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.815 0.817 . . . . 72.35 111.09 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 71.1 p -77.5 114.32 16.21 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 114.138 -1.392 . . . . 72.33 108.763 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 19.0 mmmt -68.89 -41.59 78.1 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-O 121.864 0.84 . . . . 61.24 109.469 173.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -145.23 140.85 28.16 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 114.033 -1.439 . . . . 75.53 109.058 -176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.48 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 65.6 mt -134.63 141.51 43.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 N-CA-C 107.333 -1.358 . . . . 74.14 107.333 172.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 47.4 t -161.74 150.7 15.79 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.397 0.618 . . . . 72.41 111.276 177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' C' ' 117' ' ' MET . 88.4 t80 -141.86 131.0 23.32 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 107.584 -1.265 . . . . 53.41 107.584 173.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . 0.427 ' HB2' ' HB3' ' C' ' 75' ' ' LEU . 44.2 mt-10 -123.73 123.73 41.16 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.351 0.66 . . . . 73.31 109.266 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -130.8 83.21 62.19 Favored Pre-proline 0 C--O 1.24 0.595 0 N-CA-C 107.432 -1.321 . . . . 33.31 107.432 170.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -63.28 -35.45 62.69 Favored 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.708 2.272 . . . . 72.51 111.875 -176.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -110.66 33.39 4.57 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.811 -1.086 . . . . 75.02 109.223 -177.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.425 ' HB3' ' HD3' ' C' ' 29' ' ' PRO . . . -47.23 -50.19 48.8 Favored Pre-proline 0 N--CA 1.491 1.599 0 N-CA-C 114.299 1.222 . . . . 71.34 114.299 -175.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.425 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 15.2 Cg_exo -66.47 -39.51 16.48 Favored 'Trans proline' 0 C--N 1.389 2.694 0 C-N-CA 121.788 1.659 . . . . 75.33 112.971 174.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -67.2 -57.58 6.45 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.313 1.045 . . . . 62.2 112.333 -172.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . 0.419 HG11 ' HA ' ' C' ' 73' ' ' ALA . 46.0 t -54.91 -24.03 13.48 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 C-N-CA 125.176 1.39 . . . . 73.12 112.877 -177.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -51.95 -35.11 44.98 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.113 0.565 . . . . 62.32 112.05 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -106.48 45.9 0.95 Allowed 'General case' 0 CA--C 1.556 1.2 0 C-N-CA 123.666 0.787 . . . . 70.25 110.749 179.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . . . . . . . . . 1.6 tppp? -124.53 151.86 44.16 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 124.011 0.924 . . . . 71.13 110.82 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -52.37 131.84 33.72 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 124.384 1.074 . . . . 72.34 112.636 179.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 41.1 m95 -86.39 69.31 10.41 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.082 0.953 . . . . 74.22 111.253 -174.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -158.13 77.87 3.44 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.313 0.645 . . . . 71.32 109.679 178.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.754 ' HG3' ' HB3' ' F' ' 297' ' ' TYR . 95.7 Cg_endo -90.83 154.13 4.06 Favored 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.814 2.342 . . . . 71.13 113.122 178.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -87.05 95.2 9.86 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 107.455 -1.313 . . . . 73.45 107.455 168.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 21.2 t -76.4 114.3 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 114.938 -1.028 . . . . 72.2 109.461 -176.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.474 ' HB2' ' HB ' ' C' ' 65' ' ' THR . 89.6 mttt -102.24 146.51 27.89 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 123.757 0.823 . . . . 61.13 109.752 -177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.5 tt -125.34 123.42 39.36 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 106.836 -1.542 . . . . 72.34 106.836 171.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -130.53 104.19 7.08 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.832 -1.173 . . . . 74.25 107.832 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 pp -95.42 154.5 17.17 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.036 0.534 . . . . 64.03 110.224 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.577 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 10.6 t70 -146.79 151.91 37.91 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.774 0.83 . . . . 75.25 109.036 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 72.8 p -121.52 122.01 38.77 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.296 0.638 . . . . 73.05 110.093 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -131.76 138.7 48.7 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.503 -0.925 . . . . 75.3 108.503 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . 0.58 ' HB3' ' HE1' ' C' ' 56' ' ' TYR . 71.2 m -155.06 151.54 28.51 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.038 0.535 . . . . 72.43 110.692 -174.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 78.2 p -152.91 138.07 17.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.077 0.551 . . . . 72.34 110.498 -176.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -79.53 122.92 27.07 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 109.671 -0.492 . . . . 75.2 109.671 176.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' C' ' 57' ' ' GLU . 41.1 mt -95.44 -43.32 8.04 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.767 0.827 . . . . 73.12 111.103 -172.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.429 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -158.83 -168.1 2.3 Favored 'General case' 0 C--O 1.243 0.742 0 C-N-CA 123.676 0.79 . . . . 75.41 110.066 -176.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -64.91 103.63 0.74 Allowed 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 115.093 -0.958 . . . . 74.22 110.066 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 72.77 -6.35 1.67 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 126.126 1.77 . . . . 64.31 113.024 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 60.2 t -91.85 107.49 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 107.792 -1.188 . . . . 65.24 107.792 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . 0.58 ' HE1' ' HB3' ' C' ' 48' ' ' SER . 2.1 t80 -128.59 141.0 51.5 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 108.11 -1.07 . . . . 62.31 108.11 -173.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.548 ' HB2' HD11 ' C' ' 51' ' ' LEU . 44.2 tt0 -98.05 129.33 44.9 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.348 0.659 . . . . 70.14 110.829 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 79.6 t -110.35 114.69 47.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 108.08 -1.081 . . . . 74.44 108.08 171.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 44.1 t -114.21 135.84 52.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 N-CA-C 108.831 -0.803 . . . . 55.43 108.831 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -125.16 109.38 12.81 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 106.945 -1.502 . . . . 74.52 106.945 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.577 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 11.2 ttm-85 -80.55 125.0 29.44 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 109.102 -0.703 . . . . 63.1 109.102 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.405 ' HB ' HD11 ' C' ' 114' ' ' ILE . 43.9 t -116.11 105.75 19.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 N-CA-C 107.468 -1.308 . . . . 73.1 107.468 175.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . . . . . . . . . 7.8 m -108.57 119.17 38.74 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 108.741 -0.837 . . . . 62.2 108.741 177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 5.0 t -120.52 130.44 74.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 N-CA-C 108.742 -0.836 . . . . 61.55 108.742 -176.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . 0.474 ' HB ' ' HB2' ' C' ' 41' ' ' LYS . 9.7 m -121.22 152.11 39.21 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.245 1.018 . . . . 61.51 109.309 -171.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.67 112.83 10.45 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 107.476 -1.305 . . . . 73.31 107.476 167.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 36.8 m -145.02 135.06 23.83 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 109.329 -0.619 . . . . 74.25 109.329 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.501 ' HB3' ' HA ' ' C' ' 38' ' ' PRO . 0.5 OUTLIER -120.23 57.01 0.95 Allowed 'General case' 0 N--CA 1.479 1.015 0 CA-C-O 122.216 1.008 . . . . 53.44 110.49 -173.76 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.29 -119.94 4.47 Favored Glycine 0 C--N 1.341 0.839 0 CA-C-N 113.692 -1.594 . . . . 54.24 110.285 -176.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -88.92 -30.59 18.73 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 108.855 -0.794 . . . . 65.25 108.855 172.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.436 ' HB3' HD12 ' C' ' 68' ' ' LEU . 11.7 tp10 -72.72 109.72 6.54 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 114.743 -1.117 . . . . 64.04 109.984 -175.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 24.9 m -83.41 122.76 28.93 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.975 -0.75 . . . . 65.54 108.975 176.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.419 ' HA ' HG11 ' C' ' 31' ' ' VAL . . . -72.64 -54.77 8.15 Favored 'General case' 0 N--CA 1.469 0.5 0 O-C-N 124.407 1.067 . . . . 65.11 109.264 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -165.82 171.65 12.56 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.476 -0.784 . . . . 71.42 111.45 171.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . 0.427 ' HB3' ' HB2' ' C' ' 24' ' ' GLU . 3.0 tm? -137.86 145.97 42.84 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.185 1.394 . . . . 74.53 107.242 176.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.431 ' SG ' HG23 ' C' ' 114' ' ' ILE . 42.0 t -152.85 121.39 6.37 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.044 0.537 . . . . 73.22 109.671 176.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -125.45 127.98 47.35 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 122.963 0.505 . . . . 73.3 110.285 177.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -126.91 124.46 64.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 N-CA-C 108.895 -0.78 . . . . 74.2 108.895 169.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.551 ' HG2' ' HG3' ' C' ' 61' ' ' ARG . 23.3 mt-30 -96.62 105.52 17.63 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 107.988 -1.116 . . . . 71.33 107.988 174.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 9.5 tp-100 -92.24 112.05 23.84 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 122.724 0.41 . . . . 72.31 110.656 -175.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.97 155.5 23.75 Favored Glycine 0 C--N 1.334 0.447 0 CA-C-N 115.93 -0.577 . . . . 60.32 111.92 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -153.95 116.62 0.74 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 109.825 -1.31 . . . . 41.44 109.825 173.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.516 HD12 HD11 ' C' ' 51' ' ' LEU . 19.4 mm -81.71 119.51 31.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.322 -0.992 . . . . 70.55 108.322 178.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -126.93 119.18 26.11 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.661 -1.237 . . . . 74.24 107.661 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 32.5 t -84.65 98.61 10.29 Favored 'General case' 0 C--O 1.241 0.639 0 N-CA-C 107.505 -1.294 . . . . 74.14 107.505 173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' C' ' 10' ' ' THR . 0.2 OUTLIER -121.34 142.29 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-O 121.169 0.509 . . . . 74.43 111.242 -175.439 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -157.58 168.38 27.43 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.547 1.139 . . . . 62.1 109.416 178.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.77 -45.67 2.71 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 111.939 -0.464 . . . . 61.12 111.939 -177.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.6 HG22 ' HB3' ' C' ' 93' ' ' GLN . 1.6 pp -80.93 145.66 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 123.482 0.713 . . . . 75.21 111.021 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -162.04 148.32 13.5 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.791 0.837 . . . . 71.0 109.081 177.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.52 -117.22 10.79 Favored Glycine 0 C--N 1.35 1.307 0 O-C-N 123.603 0.564 . . . . 52.12 113.328 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 56.6 p -65.12 -35.66 81.82 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.889 0.875 . . . . 74.3 111.532 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . 0.6 ' HB3' HG22 ' C' ' 89' ' ' ILE . 26.4 mt-30 -67.64 -43.3 80.64 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.92 -0.582 . . . . 61.24 110.623 178.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.491 ' O ' ' HG ' ' C' ' 98' ' ' LEU . 23.5 ttt -75.78 -23.51 55.91 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.159 -0.473 . . . . 62.32 110.801 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.75 -40.49 96.84 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.038 0.535 . . . . 74.53 110.674 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -69.25 -34.19 74.41 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 115.433 -0.803 . . . . 71.44 110.745 175.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 41.7 t -65.74 -61.26 2.17 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 115.797 -0.638 . . . . 71.43 111.317 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' C' ' 94' ' ' MET . 4.2 pp -87.08 -12.97 45.62 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 112.502 0.556 . . . . 72.35 112.502 -174.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.15 8.02 60.62 Favored Glycine 0 N--CA 1.469 0.897 0 CA-C-O 119.584 -0.564 . . . . 60.32 113.36 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.419 ' HB1' ' HB2' ' C' ' 134' ' ' ASP . . . -154.79 -59.95 0.11 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 122.93 0.492 . . . . 64.22 111.273 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -74.53 -49.59 21.4 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 123.556 0.742 . . . . 75.13 112.094 -168.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . 0.596 ' HG ' ' HE1' ' C' ' 11' ' ' PHE . 57.6 m -69.86 -44.52 22.68 Favored Pre-proline 0 CA--C 1.561 1.401 0 CA-C-O 118.156 -0.926 . . . . 73.11 113.223 -176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' C' ' 102' ' ' CYS . 28.7 Cg_endo -61.59 -38.42 62.26 Favored 'Trans proline' 0 C--N 1.396 3.078 0 C-N-CA 121.722 1.615 . . . . 74.05 111.259 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -62.95 -22.74 67.01 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.591 0.756 . . . . 75.04 112.392 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 45.5 mm -73.32 -54.46 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 N-CA-C 110.224 -0.287 . . . . 74.13 110.224 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 2.9 pp -87.16 -8.51 56.86 Favored 'General case' 0 CA--C 1.554 1.106 0 CA-C-N 115.955 -0.566 . . . . 62.12 112.517 -170.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -58.44 -50.67 86.77 Favored Pre-proline 0 N--CA 1.484 1.256 0 C-N-CA 124.421 1.088 . . . . 64.24 113.303 -177.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.51 -29.94 89.67 Favored 'Trans proline' 0 C--N 1.39 2.752 0 C-N-CA 121.654 1.57 . . . . 63.15 113.189 179.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -69.68 -45.78 67.55 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.223 0.609 . . . . 74.32 110.462 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -59.1 -44.63 91.95 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 123.547 0.739 . . . . 73.13 110.631 174.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . 0.533 ' HG3' ' HB3' ' C' ' 128' ' ' LEU . 36.1 ttt180 -61.78 -53.74 51.87 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 113.431 -1.713 . . . . 75.32 111.927 -172.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -67.08 -33.19 74.96 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.322 0.649 . . . . 71.1 110.315 -177.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 7.9 t -67.91 -31.35 71.07 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.2 0.6 . . . . 73.43 111.449 -177.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.431 HG23 ' SG ' ' C' ' 76' ' ' CYS . 83.2 mt -75.4 -49.97 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 C-N-CA 123.617 0.767 . . . . 72.11 110.526 174.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 13.5 m -62.2 -29.37 70.33 Favored 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 123.515 0.726 . . . . 74.33 111.457 -177.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 34.4 t -67.26 -49.69 63.41 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 115.56 -0.745 . . . . 74.14 109.622 174.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.672 ' HE3' HD13 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -59.04 -36.59 75.27 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.055 0.942 . . . . 63.43 112.615 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . 0.407 HG23 ' O ' ' C' ' 114' ' ' ILE . 93.4 t -64.88 -41.74 92.96 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.588 0.755 . . . . 75.01 110.346 177.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 27.1 p -74.91 -27.01 60.05 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 116.031 -0.532 . . . . 72.31 111.349 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . . . . . . . . . 78.6 mtt-85 -70.3 -39.44 74.82 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.835 0.854 . . . . 74.21 110.742 177.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . 0.491 ' HA2' ' H ' ' D' ' 18' ' ' THR . . . -83.89 10.06 61.23 Favored Glycine 0 C--N 1.351 1.415 0 CA-C-N 116.045 -0.525 . . . . 61.43 113.461 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . . . . . . . . . 54.4 p 55.12 62.28 2.57 Favored 'General case' 0 C--N 1.35 0.625 0 C-N-CA 125.482 1.513 . . . . 73.35 111.718 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 69.8 m-85 -126.59 154.39 75.42 Favored Pre-proline 0 CA--C 1.555 1.17 0 C-N-CA 124.867 1.267 . . . . 74.35 109.139 170.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.435 ' HD3' HD13 ' F' ' 301' ' ' ILE . 23.4 Cg_exo -64.32 167.8 13.99 Favored 'Trans proline' 0 C--N 1.382 2.31 0 C-N-CA 123.276 2.651 . . . . 72.01 113.759 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . 0.571 ' HG3' ' HA ' ' B' ' 124' ' ' PRO . 17.3 mm-40 -56.26 123.64 15.28 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.571 1.148 . . . . 74.14 113.912 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -107.97 84.18 1.91 Allowed 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.117 -1.438 . . . . 70.12 107.117 169.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . 0.476 ' HB2' ' HD3' ' F' ' 294' ' ' LYS . 13.7 m120 -91.77 102.11 14.71 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 108.248 -1.019 . . . . 63.05 108.248 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . 0.533 ' HB3' ' HG3' ' C' ' 111' ' ' ARG . 14.8 tp -68.08 137.15 54.76 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 122.693 0.397 . . . . 64.53 110.382 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.417 ' H ' HD12 ' C' ' 128' ' ' LEU . . . -81.08 152.19 70.99 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.035 0.934 . . . . 64.03 111.146 -176.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.467 ' O ' HG11 ' H' ' 306' ' ' VAL . 41.3 Cg_exo -50.11 142.19 28.43 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.16 2.573 . . . . 74.21 113.111 171.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.552 ' HA ' HG21 ' H' ' 309' ' ' THR . 22.0 t -123.11 110.29 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.025 0 N-CA-C 108.779 -0.823 . . . . 72.14 108.779 172.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.615 ' HB3' ' HB3' ' C' ' 135' ' ' ALA . 3.5 m-20 -97.98 85.65 3.55 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 123.389 0.676 . . . . 71.43 109.922 -176.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.408 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 91.0 m-85 -69.59 -46.65 65.84 Favored 'General case' 0 N--CA 1.477 0.904 0 CA-C-N 116.264 -0.426 . . . . 75.23 110.866 178.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.419 ' HB2' ' HB1' ' C' ' 100' ' ' ALA . 29.8 t70 -65.98 -48.35 71.53 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.72 -0.673 . . . . 72.45 110.801 -176.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . 0.615 ' HB3' ' HB3' ' C' ' 132' ' ' ASN . . . -58.39 -21.02 48.87 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 124.147 0.904 . . . . 73.14 112.958 -178.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.11 -56.66 4.65 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.913 0.885 . . . . 42.34 109.638 175.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -72.53 -47.31 49.37 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 113.041 0.756 . . . . 73.44 113.041 -171.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.63 -25.75 60.6 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.911 0.885 . . . . 71.03 113.224 -170.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -50.79 -37.52 42.9 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 124.488 1.115 . . . . 74.22 113.767 176.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -34.09 -80.5 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.675 0 C-N-CA 126.262 1.825 . . . . 61.34 114.365 -168.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -147.25 117.36 7.29 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 106.816 -1.55 . . . . 73.13 106.816 178.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.15 177.98 10.72 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.286 1.034 . . . . 63.13 109.617 178.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -152.65 150.66 29.72 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.171 0.588 . . . . 73.15 109.821 176.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -155.04 136.55 14.22 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 109.032 -0.729 . . . . 70.31 109.032 -177.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -90.69 -167.94 1.96 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.342 0.657 . . . . 63.34 110.929 179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . -144.43 121.32 1.57 Allowed Glycine 0 C--N 1.35 1.324 0 C-N-CA 121.457 -0.402 . . . . 75.03 113.928 -174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -173.61 104.54 0.12 Allowed 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.256 1.422 . . . . 75.31 107.965 169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -87.46 75.42 2.14 Favored Glycine 0 C--N 1.351 1.373 0 CA-C-N 115.968 -0.56 . . . . 70.54 113.706 -168.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . 0.437 ' HB ' ' CE2' ' A' ' 140' ' ' TYR . 47.2 m -147.0 153.91 40.61 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.95 0.9 . . . . 62.53 108.572 176.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -158.48 179.2 9.35 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.851 0.86 . . . . 73.12 108.831 173.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -109.99 133.4 53.23 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 120.909 0.385 . . . . 54.33 110.456 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 28.9 p-80 -89.92 134.59 34.13 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.6 0.76 . . . . 75.21 109.697 175.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.594 ' HB3' ' HB3' ' E' ' 287' ' ' PRO . 59.5 tt0 -123.66 93.41 3.93 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.477 -0.934 . . . . 42.44 108.477 174.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -75.67 96.27 3.56 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 114.951 -1.022 . . . . 71.24 109.741 179.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.03 0 CA-C-N 115.649 -0.705 . . . . 54.42 109.68 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptp . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 109.92 -0.4 . . . . 62.45 109.92 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 46.7 m -64.08 92.25 0.08 Allowed 'General case' 0 C--N 1.354 0.801 0 C-N-CA 123.567 0.747 . . . . 72.34 111.304 -175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -81.57 74.22 8.58 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.682 -1.229 . . . . 72.43 107.682 177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -176.76 150.59 0.83 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.987 -1.46 . . . . 51.55 108.772 -172.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 49.6 t30 -71.08 84.58 0.72 Allowed 'General case' 0 N--CA 1.483 1.191 0 CA-C-O 121.381 0.61 . . . . 70.42 110.223 -178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -146.61 -165.48 2.24 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.554 1.142 . . . . 63.05 109.616 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 5.0 t -78.17 70.62 4.56 Favored 'General case' 0 CA--C 1.566 1.572 0 CA-C-O 121.88 0.848 . . . . 74.34 111.724 -177.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -169.63 -166.31 0.58 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.965 1.706 . . . . 73.54 108.414 174.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -32.43 123.58 0.33 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.674 1.19 . . . . 71.23 113.383 168.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 40.6 m -149.39 141.53 23.98 Favored 'General case' 0 C--O 1.242 0.707 0 C-N-CA 123.841 0.857 . . . . 73.53 108.924 175.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -157.15 100.66 1.87 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 107.945 -1.131 . . . . 61.52 107.945 174.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -128.3 143.53 51.03 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.842 0.857 . . . . 71.33 109.221 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.403 HG12 ' CD2' ' D' ' 84' ' ' PHE . 47.7 mt -96.11 136.22 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 123.016 0.526 . . . . 51.15 109.754 175.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . 0.426 ' HB2' ' HB ' ' D' ' 83' ' ' ILE . 79.6 mt-30 -89.13 -42.1 11.89 Favored 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 109.978 -0.379 . . . . 62.15 109.978 172.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 14.3 ptt180 -176.03 153.64 1.34 Allowed 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.637 0.775 . . . . 65.31 110.919 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . . . . . . . . . 40.7 mm -114.86 125.03 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 106.842 -1.54 . . . . 73.32 106.842 174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -149.43 170.81 17.73 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 122.173 0.987 . . . . 64.43 111.613 -169.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . 0.491 ' H ' ' HA2' ' C' ' 121' ' ' GLY . 68.4 p -105.09 117.65 34.54 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.312 -1.313 . . . . 71.11 109.726 177.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 mtpt -85.6 -29.29 24.21 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 115.889 -0.596 . . . . 72.54 109.458 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.421 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 24.5 t70 -151.03 139.1 20.08 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-N 114.338 -1.301 . . . . 72.55 108.924 177.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.672 HD13 ' HE3' ' C' ' 117' ' ' MET . 92.1 mt -132.49 146.84 32.28 Favored 'Isoleucine or valine' 0 C--O 1.241 0.646 0 N-CA-C 107.729 -1.211 . . . . 74.44 107.729 173.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 44.8 t -148.75 140.0 23.23 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 123.65 0.78 . . . . 53.11 109.715 175.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.48 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 77.1 t80 -149.35 117.67 6.45 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 105.372 -2.084 . . . . 74.23 105.372 167.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -121.88 135.64 54.9 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.966 -0.753 . . . . 70.21 108.966 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.04 83.45 55.66 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 107.371 -1.344 . . . . 72.11 107.371 173.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -73.38 -29.82 10.84 Favored 'Trans proline' 0 C--N 1.378 2.102 0 C-N-CA 122.89 2.393 . . . . 63.01 113.558 -169.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -114.71 33.22 5.49 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 109.03 -0.73 . . . . 64.5 109.03 176.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.491 ' HB1' ' HE2' ' C' ' 17' ' ' TYR . . . -43.15 -62.33 1.39 Allowed Pre-proline 0 CA--C 1.57 1.735 0 N-CA-C 115.433 1.642 . . . . 61.33 115.433 -163.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -83.21 -15.61 7.69 Favored 'Trans proline' 0 C--N 1.381 2.239 0 CA-C-N 121.794 1.676 . . . . 61.15 112.888 -178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.478 ' HA ' HE21 ' D' ' 33' ' ' GLN . 18.6 t-160 -68.18 -34.29 76.01 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.815 1.246 . . . . 63.42 109.079 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.565 HG13 ' HH2' ' D' ' 36' ' ' TRP . 55.8 t -68.44 -38.97 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 C-N-CA 123.81 0.844 . . . . 71.24 110.398 175.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.416 ' HD1' HG12 ' G' ' 301' ' ' ILE . 24.5 m-85 -74.04 4.69 5.12 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 112.831 0.678 . . . . 72.42 112.831 -179.492 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . 0.478 HE21 ' HA ' ' D' ' 30' ' ' HIS . 38.1 mt-30 -87.04 -17.75 32.21 Favored 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 123.058 0.543 . . . . 73.03 111.181 167.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.648 ' HE2' ' HE1' ' D' ' 36' ' ' TRP . 29.5 mtpt -126.34 107.3 10.18 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.336 1.054 . . . . 73.54 110.656 -167.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -96.47 97.6 9.56 Favored 'General case' 0 N--CA 1.502 2.145 0 CA-C-N 118.905 0.775 . . . . 65.33 111.295 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.648 ' HE1' ' HE2' ' D' ' 34' ' ' LYS . 0.0 OUTLIER -136.4 176.67 8.48 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 124.317 1.047 . . . . 71.02 110.4 175.397 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -85.43 111.82 39.63 Favored Pre-proline 0 CA--C 1.555 1.143 0 C-N-CA 124.046 0.938 . . . . 74.05 110.336 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.616 ' HA ' HD11 ' D' ' 68' ' ' LEU . 32.1 Cg_exo -64.35 140.07 68.47 Favored 'Trans proline' 0 C--N 1.381 2.279 0 C-N-CA 123.049 2.499 . . . . 52.4 113.871 173.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . 0.45 ' H ' HD11 ' D' ' 68' ' ' LEU . 14.4 pt-20 -82.77 130.15 35.09 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.042 -1.095 . . . . 75.1 108.042 162.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.503 HG13 HG13 ' D' ' 64' ' ' VAL . 77.2 t -105.57 104.74 17.45 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.401 0 N-CA-C 107.694 -1.224 . . . . 42.34 107.694 177.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -91.16 127.86 36.75 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 110.17 -0.307 . . . . 74.02 110.17 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 4.7 tt -95.89 124.43 39.9 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 107.621 -1.251 . . . . 61.33 107.621 178.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -137.59 138.26 39.37 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 108.36 -0.978 . . . . 74.12 108.36 175.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 95.3 mt -121.88 147.36 46.1 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.417 0.627 . . . . 75.2 110.945 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.478 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 17.4 t70 -133.07 137.52 46.42 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 107.823 -1.177 . . . . 72.52 107.823 170.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 37.1 p -105.16 144.16 32.34 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 115.437 -0.801 . . . . 51.23 110.205 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.615 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.33 145.08 23.46 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.462 0.705 . . . . 62.34 109.32 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 36.9 p -151.22 157.46 42.65 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 122.873 0.469 . . . . 74.24 109.973 178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 6.4 m -147.82 149.62 32.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 107.98 -1.118 . . . . 71.22 107.98 -177.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -101.1 118.03 36.18 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.56 -1.274 . . . . 55.11 107.56 161.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 29.4 mt -89.68 -34.02 16.41 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.805 -0.442 . . . . 62.41 109.805 -177.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -158.68 -177.8 6.79 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.599 -0.728 . . . . 73.15 110.679 -175.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -64.34 130.94 45.77 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 115.252 -0.885 . . . . 71.43 109.126 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 66.33 5.64 3.82 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 124.63 1.172 . . . . 72.52 112.4 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 86.5 t -118.86 123.32 71.3 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 C-N-CA 123.381 0.672 . . . . 63.44 109.937 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -128.11 127.34 42.86 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 108.316 -0.994 . . . . 61.21 108.316 172.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -88.15 143.0 27.31 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 123.776 0.831 . . . . 64.43 109.114 172.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HE1' ' D' ' 84' ' ' PHE . 48.6 t -125.32 123.69 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.179 0 N-CA-C 108.268 -1.012 . . . . 74.41 108.268 176.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.615 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 43.4 t -109.83 131.33 61.07 Favored 'Isoleucine or valine' 0 C--O 1.241 0.608 0 N-CA-C 108.167 -1.049 . . . . 61.21 108.167 177.114 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -126.38 117.66 23.42 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.588 -0.893 . . . . 75.24 108.588 178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.478 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 22.1 ttm-85 -95.64 106.93 19.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.78 0.832 . . . . 71.11 109.938 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 96.5 t -94.46 112.29 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 N-CA-C 108.778 -0.823 . . . . 73.31 108.778 173.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . . . . . . . . . 15.8 m -112.15 128.59 56.27 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.485 0.66 . . . . 70.44 109.868 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . 0.503 HG13 HG13 ' D' ' 40' ' ' VAL . 42.2 t -124.8 107.42 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 C-N-CA 125.458 1.503 . . . . 72.14 108.649 -173.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.9 m -106.02 117.46 34.09 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 123.904 0.881 . . . . 74.44 110.375 -174.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -116.48 126.55 53.53 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 109.307 -0.627 . . . . 72.23 109.307 172.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . 0.482 ' HA ' ' H ' ' D' ' 73' ' ' ALA . 58.2 m -153.76 122.83 6.46 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.304 0.641 . . . . 52.11 109.344 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.616 HD11 ' HA ' ' D' ' 38' ' ' PRO . 2.5 mm? -130.49 135.46 47.98 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.795 0.838 . . . . 63.13 109.448 -173.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 91.35 -116.39 4.93 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 110.972 -0.851 . . . . 45.12 110.972 -178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.03 8.3 8.64 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.998 -0.742 . . . . 63.01 108.998 167.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -121.46 155.87 33.98 Favored 'General case' 0 C--N 1.356 0.859 0 C-N-CA 123.651 0.78 . . . . 61.02 110.793 -173.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 97.3 m -82.64 129.14 34.9 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 116.04 -0.527 . . . . 72.23 110.529 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.482 ' H ' ' HA ' ' D' ' 67' ' ' SER . . . -69.33 -68.61 0.39 Allowed 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 108.093 -1.077 . . . . 55.45 108.093 173.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 38.0 p90 -155.88 152.61 28.54 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 115.388 -0.824 . . . . 73.43 109.596 175.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 77.1 mt -110.64 150.27 29.23 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 124.426 1.09 . . . . 71.34 108.243 167.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.484 ' SG ' HG23 ' D' ' 114' ' ' ILE . 38.1 t -150.9 136.23 17.75 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.432 -0.951 . . . . 71.22 108.432 177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -155.53 129.56 8.73 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.644 0.378 . . . . 74.13 110.313 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 67.5 t -134.43 120.1 32.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 123.049 0.539 . . . . 74.54 110.07 -178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 7.1 mt-30 -87.7 91.25 8.68 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.607 -0.886 . . . . 62.52 108.607 167.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -80.72 95.54 6.65 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.383 -0.969 . . . . 63.34 108.383 177.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.41 144.18 16.95 Favored Glycine 0 C--N 1.337 0.606 0 CA-C-N 115.83 -0.623 . . . . 61.14 111.562 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -144.39 136.22 6.61 Favored Glycine 0 CA--C 1.507 -0.43 0 N-CA-C 110.515 -1.034 . . . . 50.12 110.515 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.426 ' HB ' ' HB2' ' D' ' 14' ' ' GLN . 56.8 mt -88.42 126.54 41.69 Favored 'Isoleucine or valine' 0 C--O 1.24 0.564 0 N-CA-C 108.6 -0.889 . . . . 65.01 108.6 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . 0.404 ' HE1' ' HB ' ' D' ' 58' ' ' VAL . 52.6 m-85 -123.92 148.65 46.69 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.565 -0.532 . . . . 72.55 109.565 175.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 27.0 m -103.57 94.22 5.35 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 107.671 -1.233 . . . . 63.33 107.671 174.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . . . . . . . . . 43.8 mt -110.17 116.34 52.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.999 0.919 . . . . 74.33 108.72 -172.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.45 153.5 15.47 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.145 0.578 . . . . 75.11 110.33 178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 94.81 -17.05 59.97 Favored Glycine 0 C--N 1.341 0.855 0 CA-C-N 116.127 -0.488 . . . . 71.45 112.738 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . . . . . . . . . 3.9 mp -113.65 129.1 70.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 N-CA-C 108.736 -0.839 . . . . 53.35 108.736 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -134.5 168.07 19.62 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.883 0.873 . . . . 73.14 110.362 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . 0.411 ' HA2' ' HD2' ' G' ' 276' ' ' PRO . . . 71.42 -135.61 23.95 Favored Glycine 0 C--N 1.348 1.2 0 CA-C-N 115.855 -0.611 . . . . 70.24 114.177 174.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 42.9 p -70.61 -34.63 72.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.166 0.987 . . . . 55.11 112.056 -173.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -67.98 -38.76 83.08 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.971 0.508 . . . . 62.01 110.726 -179.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -68.17 -44.11 76.66 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 109.5 -0.555 . . . . 73.0 109.5 176.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -60.6 -32.54 71.66 Favored 'General case' 0 CA--C 1.546 0.81 0 O-C-N 124.204 0.94 . . . . 71.33 111.508 177.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -72.01 -45.0 62.55 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.572 0.749 . . . . 64.45 110.646 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.0 t -65.44 -37.9 88.27 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 122.807 0.443 . . . . 61.22 110.907 -179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.524 ' HG ' ' HB2' ' G' ' 281' ' ' PHE . 41.3 tp -79.32 -37.77 36.81 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.262 1.025 . . . . 53.22 111.301 -178.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -87.25 -7.79 76.09 Favored Glycine 0 C--N 1.338 0.681 0 CA-C-O 119.657 -0.524 . . . . 74.24 113.769 -174.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -136.64 -54.98 0.73 Allowed 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 117.763 0.782 . . . . 73.31 112.211 -175.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -72.37 -49.02 37.16 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 118.064 0.393 . . . . 75.22 111.573 -172.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 82.0 m -60.78 -48.47 92.89 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-O 118.252 -0.88 . . . . 75.34 112.531 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -66.24 -27.75 48.22 Favored 'Trans proline' 0 C--N 1.398 3.135 0 C-N-CA 121.636 1.557 . . . . 74.31 112.604 173.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -71.99 -24.09 61.52 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 123.066 0.546 . . . . 74.11 111.099 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . . . . . . . . . 31.7 mm -80.64 -41.68 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 C-N-CA 123.607 0.763 . . . . 62.54 110.455 174.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 85.3 mt -73.77 -30.57 62.84 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.202 0.601 . . . . 64.04 111.547 -177.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -63.87 -42.36 70.09 Favored Pre-proline 0 CA--C 1.564 1.508 0 N-CA-C 114.187 1.18 . . . . 75.31 114.187 -170.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.57 -45.09 32.69 Favored 'Trans proline' 0 C--N 1.382 2.314 0 C-N-CA 122.413 2.076 . . . . 75.42 113.821 172.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -79.63 -30.98 41.56 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.357 0.663 . . . . 74.13 111.798 -177.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.12 -48.91 74.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 122.912 0.485 . . . . 73.42 109.863 174.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -58.85 -51.27 70.72 Favored 'General case' 0 C--N 1.35 0.615 0 CA-C-N 114.293 -1.321 . . . . 55.23 110.352 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.54 -42.17 91.72 Favored 'General case' 0 N--CA 1.477 0.896 0 O-C-N 124.218 0.949 . . . . 73.11 111.385 -174.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 42.2 t -59.94 -44.56 94.29 Favored 'General case' 0 CA--C 1.542 0.664 0 O-C-N 123.754 0.659 . . . . 65.21 110.793 178.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.484 HG23 ' SG ' ' D' ' 76' ' ' CYS . 59.3 mt -62.46 -52.38 60.59 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 124.073 0.949 . . . . 73.11 110.697 175.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.469 HG21 ' HE2' ' B' ' 109' ' ' TYR . 32.0 m -56.36 -41.25 75.86 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.824 1.249 . . . . 63.25 111.135 -171.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 22.6 t -67.93 -43.58 78.84 Favored 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.549 -1.205 . . . . 74.12 110.507 178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . . . . . . . . . 76.9 mtm -66.64 -31.55 72.31 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 112.371 0.508 . . . . 62.05 112.371 -179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.48 HG23 ' O ' ' D' ' 114' ' ' ILE . 94.5 t -68.34 -44.83 83.35 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 123.27 0.628 . . . . 73.12 109.712 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 92.0 p -70.37 -28.96 65.52 Favored 'General case' 0 CA--C 1.553 1.076 0 C-N-CA 122.994 0.518 . . . . 74.02 111.45 178.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 72.8 mtt-85 -73.38 -31.71 64.07 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.337 0.655 . . . . 74.52 110.186 175.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.24 3.0 86.12 Favored Glycine 0 C--N 1.354 1.569 0 CA-C-N 115.959 -0.564 . . . . 73.32 112.851 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . 0.406 HG23 ' HB3' ' C' ' 17' ' ' TYR . 69.3 p 63.29 14.43 7.81 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 126.794 2.038 . . . . 73.34 113.672 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.447 ' HE1' HG11 ' D' ' 31' ' ' VAL . 87.8 m-85 -80.29 158.83 71.34 Favored Pre-proline 0 CA--C 1.558 1.272 0 N-CA-C 107.266 -1.383 . . . . 75.43 107.266 165.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -70.88 134.29 25.32 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 121.61 1.54 . . . . 73.32 110.878 -168.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -48.72 116.94 1.81 Allowed 'General case' 0 N--CA 1.48 1.04 0 O-C-N 124.333 1.021 . . . . 54.2 110.349 -176.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -105.5 104.79 14.58 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 109.039 -0.726 . . . . 64.43 109.039 -164.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . 0.51 ' ND2' ' H ' ' B' ' 16' ' ' ILE . 78.6 m-20 -99.0 94.24 6.44 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 114.513 -1.221 . . . . 74.23 107.998 -177.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.36 127.48 32.43 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 124.121 0.969 . . . . 71.01 109.368 -175.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' D' ' 130' ' ' PRO . . . -59.88 128.63 87.1 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 123.58 0.752 . . . . 72.42 111.235 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . 0.41 ' HG2' ' HE2' ' B' ' 11' ' ' PHE . 1.2 Cg_endo -79.73 122.61 5.0 Favored 'Trans proline' 0 C--N 1.379 2.157 0 C-N-CA 122.852 2.368 . . . . 73.03 111.391 -177.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 59.0 t -108.36 115.72 49.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.273 0.629 . . . . 74.53 109.448 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' D' ' 135' ' ' ALA . 28.1 t30 -76.55 105.28 7.52 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 109.143 -0.688 . . . . 65.44 109.143 174.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -68.21 -37.75 81.2 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.798 0.839 . . . . 70.35 110.571 -177.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -55.73 -46.52 77.77 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.998 0.919 . . . . 72.23 111.282 -178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . 0.52 ' HB2' ' ND2' ' D' ' 132' ' ' ASN . . . -53.45 -48.21 69.02 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 124.985 1.428 . . . . 70.32 111.006 178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . . . . . . . . . 66.0 mt -55.99 -49.37 73.79 Favored 'General case' 0 N--CA 1.482 1.175 0 O-C-N 124.719 1.262 . . . . 53.42 112.206 -176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -72.43 -42.24 65.28 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 115.267 -0.879 . . . . 75.11 112.127 -176.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 24.4 ptp -73.13 -25.85 60.99 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-O 120.619 0.247 . . . . 73.0 110.813 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' D' ' 143' ' ' GLN . 0.4 OUTLIER -68.9 -35.72 77.18 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.258 1.023 . . . . 73.33 111.398 178.787 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . 0.417 ' HD1' ' H ' ' B' ' 4' ' ' GLN . 75.3 t80 -48.68 -36.87 17.03 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 123.613 0.765 . . . . 73.55 111.27 177.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 7.1 mp -74.24 -57.88 3.66 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 115.318 -0.856 . . . . 61.24 110.39 177.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.4 ' HG2' ' HA ' ' D' ' 139' ' ' ASN . 30.1 pt20 -88.38 38.86 0.88 Allowed 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.185 0.994 . . . . 63.04 112.409 -169.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' D' ' 139' ' ' ASN . 22.7 tt0 -116.18 91.52 3.62 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 108.927 -0.768 . . . . 53.13 108.927 -174.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -155.73 26.2 0.39 Allowed 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 114.893 -1.049 . . . . 72.1 109.828 -178.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -131.8 169.04 16.79 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.709 0.804 . . . . 71.13 110.695 -174.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . 144.62 118.91 1.26 Allowed Glycine 0 C--N 1.343 0.965 0 N-CA-C 110.422 -1.071 . . . . 62.23 110.422 -178.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -87.46 148.86 24.77 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.316 0.646 . . . . 71.31 111.045 -176.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -69.16 81.12 0.26 Allowed Glycine 0 C--N 1.352 1.459 0 O-C-N 124.345 1.028 . . . . 54.13 113.6 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 44.3 m -84.05 98.71 10.01 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.793 0.837 . . . . 61.54 109.947 -179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -100.25 139.62 35.66 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.065 0.546 . . . . 75.14 109.595 172.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . 0.436 ' HB3' HE22 ' D' ' 153' ' ' GLN . 0.3 OUTLIER -141.28 134.73 29.79 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 108.124 -1.065 . . . . 63.42 108.124 -178.456 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -99.73 103.51 15.17 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 122.816 0.446 . . . . 74.14 111.076 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . 0.436 HE22 ' HB3' ' D' ' 151' ' ' GLU . 0.0 OUTLIER -139.35 139.23 37.17 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 108.304 -0.999 . . . . 75.34 108.304 171.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -107.71 108.75 20.12 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 109.131 -0.692 . . . . 74.44 109.131 175.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.081 0 C-N-CA 123.893 0.877 . . . . 65.11 108.782 172.77 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 109.341 -0.614 . . . . 61.14 109.341 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -170.66 46.53 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.76 1.224 . . . . 70.23 107.767 -174.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 19.9 mp0 -68.75 96.23 0.72 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 115.575 -0.739 . . . . 61.32 109.783 -179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . 0.477 HE21 ' HA ' ' A' ' 2' ' ' SER . 93.3 mt-30 -102.76 37.4 1.94 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.277 1.031 . . . . 70.31 111.466 -173.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . 0.449 ' HE3' ' HA3' ' E' ' 279' ' ' GLY . 61.4 tttp -144.73 86.17 8.05 Favored Pre-proline 0 CA--C 1.544 0.746 0 N-CA-C 108.604 -0.888 . . . . 72.14 108.604 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.34 79.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.384 2.399 0 C-N-CA 124.684 3.59 . . . . 74.11 115.489 -165.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 61.4 mt 50.21 -82.38 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.405 1.882 . . . . 75.35 113.181 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 55.5 mt -67.44 90.73 0.25 Allowed 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.451 0.7 . . . . 71.31 111.894 -172.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . 0.449 ' HA3' ' HE3' ' E' ' 275' ' ' LYS . . . -135.05 34.36 2.33 Favored Glycine 0 C--N 1.34 0.782 0 N-CA-C 109.859 -1.297 . . . . 71.22 109.859 169.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.731 HD22 ' HA ' ' A' ' 95' ' ' ALA . 39.5 tp -134.69 167.97 19.87 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.85 1.26 . . . . 45.43 108.91 -173.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . 0.425 ' N ' ' HG ' ' E' ' 280' ' ' LEU . 21.8 m-30 79.11 -26.71 0.17 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 125.534 1.534 . . . . 75.41 111.87 176.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . -47.24 -43.84 22.22 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 124.188 0.995 . . . . 72.22 110.763 168.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -130.92 102.68 6.16 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 107.716 -1.216 . . . . 72.1 107.716 164.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -163.59 38.06 0.32 Allowed Glycine 0 C--N 1.344 1.018 0 CA-C-N 115.667 -0.697 . . . . 74.14 112.663 -177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -75.9 102.55 5.59 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 108.726 -0.842 . . . . 71.31 108.726 170.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 13.0 mmt -65.14 143.73 98.9 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-N 116.119 -0.491 . . . . 73.53 111.461 177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . 0.594 ' HB3' ' HB3' ' C' ' 153' ' ' GLN . 22.3 Cg_exo -66.98 77.82 0.4 Allowed 'Trans proline' 0 C--N 1.372 1.803 0 C-N-CA 122.571 2.181 . . . . 74.14 111.347 168.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 11.2 t -89.83 65.23 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-O 122.665 1.221 . . . . 64.43 108.689 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -88.2 128.96 35.46 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 113.706 -1.588 . . . . 74.42 107.135 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 18.3 m95 -53.2 124.53 14.76 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 123.449 0.7 . . . . 72.4 111.785 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 129' ' ' ALA . 3.2 mp -83.82 76.51 10.01 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 107.134 -1.432 . . . . 74.25 107.134 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . 0.489 ' HA3' ' HB ' ' G' ' 307' ' ' THR . . . 80.44 90.29 0.51 Allowed Glycine 0 C--N 1.347 1.151 0 CA-C-N 114.459 -1.246 . . . . 33.34 111.552 -165.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -73.9 27.67 0.32 Allowed 'Trans proline' 0 C--N 1.379 2.142 0 C-N-CA 123.57 2.847 . . . . 75.42 114.162 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 4.9 ttmp? -133.92 91.9 2.89 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 108.647 -0.872 . . . . 55.31 108.647 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . 0.594 ' HB1' ' HA ' ' G' ' 305' ' ' ALA . . . -164.92 174.1 10.92 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.214 1.006 . . . . 64.34 109.112 179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 83.9 m 64.98 -86.62 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.151 0 O-C-N 123.774 0.671 . . . . 65.5 110.615 177.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -97.83 92.55 5.89 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.227 -0.657 . . . . 62.44 109.227 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 28.8 t-80 -157.58 10.69 0.19 Allowed 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.589 -0.522 . . . . 73.0 109.589 170.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -101.68 174.81 24.96 Favored Glycine 0 C--N 1.345 1.076 0 CA-C-N 115.762 -0.654 . . . . 62.02 112.137 178.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -70.42 117.54 12.09 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 108.827 -0.805 . . . . 71.54 108.827 176.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 10.4 tp -52.63 134.12 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 124.139 0.976 . . . . 71.34 111.583 -169.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -65.16 126.41 28.01 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 109.992 -0.373 . . . . 73.23 109.992 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -78.95 139.65 57.47 Favored Pre-proline 0 CA--C 1.546 0.817 0 CA-C-N 114.787 -1.097 . . . . 72.42 110.054 -174.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' B' ' 15' ' ' ARG . 4.8 Cg_endo -46.5 -25.56 3.5 Favored 'Trans proline' 0 C--N 1.384 2.412 0 C-N-CA 124.042 3.162 . . . . 23.52 114.692 174.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . 74.3 -66.0 0.32 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 125.332 1.453 . . . . 43.4 112.314 172.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . 0.561 ' HA ' ' HD2' ' G' ' 293' ' ' PRO . 20.9 m -79.22 40.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 124.491 1.116 . . . . 72.42 111.915 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 2.5 m -79.59 1.23 26.82 Favored 'General case' 0 CA--C 1.557 1.223 0 C-N-CA 124.382 1.073 . . . . 73.31 111.178 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 80.0 m -144.57 118.78 9.51 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.189 0.996 . . . . 73.22 109.396 175.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' B' ' 12' ' ' GLN . 94.7 m -141.08 94.72 7.74 Favored Pre-proline 0 CA--C 1.551 1.006 0 N-CA-C 107.503 -1.295 . . . . 52.52 107.503 170.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo . . . . . 0 C--N 1.379 2.158 0 C-N-CA 123.335 2.69 . . . . 73.44 113.461 -172.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.944 0 N-CA-C 109.549 -0.537 . . . . 74.03 109.549 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 19.5 p30 -79.17 80.75 5.5 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-O 121.551 0.691 . . . . 74.51 111.42 -178.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -79.2 70.06 5.51 Favored 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.06 -0.719 . . . . 75.33 109.06 175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -82.77 147.16 28.58 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 115.4 -0.818 . . . . 74.43 110.122 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.92 77.09 30.24 Favored Pre-proline 0 CA--C 1.551 0.996 0 N-CA-C 108.571 -0.9 . . . . 74.14 108.571 176.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -78.27 178.23 7.83 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.455 2.103 . . . . 63.53 111.401 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 7.3 mp -67.61 109.63 3.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 109.238 -0.653 . . . . 73.15 109.238 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.432 HD12 HD22 ' C' ' 98' ' ' LEU . 13.7 tp -161.36 -81.9 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.853 0 N-CA-C 109.842 -0.429 . . . . 73.44 109.842 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 87.16 -82.3 1.62 Allowed Glycine 0 C--N 1.352 1.435 0 N-CA-C 114.995 0.758 . . . . 52.43 114.995 171.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' C' ' 98' ' ' LEU . 9.8 tt -62.1 -28.52 69.68 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.482 0.713 . . . . 70.01 112.405 -169.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -73.53 79.51 1.45 Allowed 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 121.676 0.751 . . . . 75.25 109.891 173.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -170.12 35.36 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.355 1.462 . . . . 72.43 108.478 -176.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 27.4 t70 77.18 131.78 0.05 Allowed 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.752 1.621 . . . . 71.41 111.727 -176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -128.75 157.27 21.43 Favored Glycine 0 N--CA 1.477 1.422 0 C-N-CA 123.161 0.41 . . . . 72.13 112.307 -177.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -85.62 77.4 9.84 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.283 0.633 . . . . 55.54 110.259 -178.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 17.2 ptp -156.49 89.26 2.72 Favored Pre-proline 0 CA--C 1.549 0.923 0 CA-C-N 115.232 -0.894 . . . . 75.12 109.588 178.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -46.72 -60.07 1.0 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 123.3 2.666 . . . . 72.45 113.621 171.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 46.4 t 50.55 -83.72 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 124.852 1.261 . . . . 70.24 112.176 -174.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 14.5 ttp180 57.75 -88.15 0.02 OUTLIER 'General case' 0 C--N 1.36 1.055 0 C-N-CA 125.429 1.492 . . . . 64.23 111.282 -176.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -137.07 157.29 47.03 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-O 121.461 0.648 . . . . 62.44 111.523 179.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.472 HD22 HG12 ' H' ' 306' ' ' VAL . 5.3 mp -118.93 -4.44 10.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 114.685 -1.143 . . . . 70.15 110.173 179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -170.37 154.62 23.47 Favored Glycine 0 C--N 1.351 1.385 0 CA-C-O 119.45 -0.639 . . . . 71.24 112.341 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -61.88 -39.95 47.81 Favored 'Trans proline' 0 C--N 1.378 2.113 0 C-N-CA 123.61 2.873 . . . . 41.22 114.163 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . 0.497 ' HA ' ' HE3' ' F' ' 294' ' ' LYS . 0.1 OUTLIER 70.28 173.19 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 124.914 1.286 . . . . 73.33 111.271 178.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . 0.423 ' H ' ' HG3' ' F' ' 294' ' ' LYS . . . -78.29 6.69 7.72 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.169 0.988 . . . . 74.52 112.761 177.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 34.0 m -60.67 105.23 0.42 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.685 1.194 . . . . 62.34 111.483 -176.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.754 ' HB3' ' HG3' ' C' ' 38' ' ' PRO . 68.7 t80 55.73 38.91 30.69 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.75 1.22 . . . . 71.52 111.215 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -118.79 143.59 46.83 Favored 'General case' 0 N--CA 1.477 0.904 0 O-C-N 121.696 -0.628 . . . . 73.53 109.564 176.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . 83.02 -81.37 1.74 Allowed Glycine 0 C--N 1.35 1.313 0 N-CA-C 111.69 -0.564 . . . . 70.1 111.69 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -170.01 164.53 9.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 124.445 1.098 . . . . 64.04 109.629 -178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.435 HD13 ' HD3' ' C' ' 124' ' ' PRO . 40.4 mm -62.18 -70.84 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.274 0 C-N-CA 123.634 0.774 . . . . 71.22 109.92 178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 174.79 -40.23 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.826 1.651 . . . . 74.13 107.803 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.36 140.69 29.45 Favored Pre-proline 0 N--CA 1.48 1.064 0 N-CA-C 109.497 -0.557 . . . . 62.22 109.497 174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -76.4 -32.58 3.79 Favored 'Trans proline' 0 C--N 1.37 1.695 0 C-N-CA 122.724 2.283 . . . . 65.31 111.509 166.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -164.29 169.56 17.35 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.505 1.122 . . . . 62.23 109.36 176.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 46.0 t -72.47 129.41 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 N-CA-C 108.444 -0.947 . . . . 52.12 108.444 173.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . 0.545 HG21 ' HA3' ' H' ' 292' ' ' GLY . 18.5 m -82.27 100.13 9.73 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 123.458 0.703 . . . . 74.23 111.516 -168.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 75.3 m 75.46 -63.71 0.4 Allowed 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 125.702 1.601 . . . . 70.25 113.107 172.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . 0.718 HG21 HD23 ' H' ' 291' ' ' LEU . 10.1 t -61.91 145.51 92.54 Favored Pre-proline 0 N--CA 1.474 0.749 0 C-N-CA 123.427 0.691 . . . . 75.14 110.732 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo . . . . . 0 CA--C 1.561 1.863 0 C-N-CA 121.613 1.542 . . . . 62.14 110.301 168.391 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 120.795 0.331 . . . . 71.52 110.59 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -146.07 156.92 43.79 Favored 'General case' 0 C--O 1.24 0.584 0 C-N-CA 123.905 0.882 . . . . 64.13 109.891 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -29.86 70.38 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.121 -0.945 . . . . 55.14 111.51 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -75.99 -60.84 2.15 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.327 0.651 . . . . 71.11 111.866 -174.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . . . . . . . . . 97.2 mttt 56.35 84.99 0.2 Allowed Pre-proline 0 N--CA 1.488 1.468 0 C-N-CA 123.984 0.914 . . . . 74.22 111.276 -174.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . 0.411 ' HD2' ' HA2' ' D' ' 91' ' ' GLY . 91.8 Cg_endo -80.77 150.29 18.56 Favored 'Trans proline' 0 C--N 1.366 1.496 0 C-N-CA 122.54 2.16 . . . . 74.31 113.582 -173.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -94.24 21.45 6.94 Favored 'General case' 0 CA--C 1.564 1.515 0 C-N-CA 124.021 0.928 . . . . 64.31 108.993 173.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 43.4 tp -168.85 118.07 0.7 Allowed 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 125.189 1.396 . . . . 74.24 107.396 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 178.06 169.63 39.2 Favored Glycine 0 N--CA 1.479 1.539 0 N-CA-C 114.199 0.44 . . . . 55.33 114.199 -178.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 67.7 tp 78.07 -48.11 0.47 Allowed 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 126.378 1.871 . . . . 60.13 112.18 -178.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . 0.524 ' HB2' ' HG ' ' D' ' 98' ' ' LEU . 16.3 t80 -59.58 -30.31 68.56 Favored 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.446 1.098 . . . . 65.3 112.344 -172.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.32 88.36 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.319 0.647 . . . . 75.12 111.078 177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -77.98 -40.38 39.41 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.739 0.816 . . . . 74.23 109.847 172.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 87.59 -60.66 4.23 Favored Glycine 0 C--N 1.345 1.042 0 CA-C-N 115.592 -0.731 . . . . 70.34 112.511 -175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 5.4 t30 53.14 68.07 0.9 Allowed 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.744 1.218 . . . . 75.43 110.154 -170.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . . . . . . . . . 21.9 mmt -133.24 89.85 31.84 Favored Pre-proline 0 N--CA 1.477 0.885 0 C-N-CA 123.79 0.836 . . . . 63.33 110.143 -176.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -93.06 50.38 0.4 Allowed 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 123.629 2.886 . . . . 70.3 111.1 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.16 -39.61 85.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 C-N-CA 124.855 1.262 . . . . 71.33 112.762 -169.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 61.68 -155.9 0.35 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.304 1.042 . . . . 71.54 110.61 -174.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . . . . . . . . . 48.5 t-105 -128.21 132.08 48.82 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 108.417 -0.957 . . . . 72.53 108.417 165.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.96 3.11 11.54 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.705 0.802 . . . . 73.12 111.79 -175.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -87.62 124.64 7.19 Favored Glycine 0 C--N 1.348 1.208 0 CA-C-O 119.045 -0.864 . . . . 53.53 112.181 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . 0.561 ' HD2' ' HA ' ' E' ' 306' ' ' VAL . 52.4 Cg_exo -57.22 127.82 27.2 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 122.672 2.248 . . . . 51.3 112.388 174.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -73.72 84.49 1.63 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.258 1.023 . . . . 71.12 109.91 -175.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -147.03 34.74 0.9 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.953 0.901 . . . . 71.01 110.187 -174.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . 0.524 ' HB ' ' HD2' ' D' ' 38' ' ' PRO . 2.4 m -66.28 -63.7 1.02 Allowed 'General case' 0 CA--C 1.56 1.34 0 C-N-CA 123.921 0.888 . . . . 63.0 111.588 -169.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.567 ' H ' ' HD2' ' D' ' 38' ' ' PRO . 16.7 m-85 -73.28 162.87 28.87 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.943 -0.762 . . . . 62.13 108.943 165.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -153.84 -20.28 0.14 Allowed 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 116.084 -0.507 . . . . 72.4 109.976 173.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 166.44 65.1 0.03 OUTLIER Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.999 -0.44 . . . . 73.35 111.999 173.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -118.01 -40.74 2.95 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.728 0.811 . . . . 74.03 110.158 -175.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.416 HG12 ' HD1' ' D' ' 32' ' ' PHE . 18.2 mt -65.22 -36.9 78.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.211 1.004 . . . . 53.43 110.963 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -80.46 15.55 1.61 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 112.873 0.694 . . . . 73.24 112.873 179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . 0.703 ' HA ' ' HE3' ' G' ' 303' ' ' LYS . 0.6 OUTLIER -143.11 103.05 5.17 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 110.003 -0.369 . . . . 62.54 110.003 165.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -76.79 -174.28 2.09 Favored 'Trans proline' 0 C--N 1.377 2.03 0 C-N-CA 122.942 2.428 . . . . 63.12 112.388 170.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . 0.594 ' HA ' ' HB1' ' E' ' 295' ' ' ALA . . . -113.39 167.82 10.26 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.778 0.831 . . . . 74.33 109.773 174.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.409 HG21 ' HB ' ' C' ' 13' ' ' ILE . 58.6 t 53.31 98.05 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 C-N-CA 124.725 1.21 . . . . 61.22 112.371 -177.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . 0.489 ' HB ' ' HA3' ' E' ' 292' ' ' GLY . 18.2 m -68.39 156.73 37.23 Favored 'General case' 0 CA--C 1.557 1.222 0 CA-C-N 115.546 -0.752 . . . . 73.21 109.924 177.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 28.5 p -51.4 114.31 1.2 Allowed 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.573 1.149 . . . . 62.53 112.933 -174.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 60.3 m -118.07 96.17 49.28 Favored Pre-proline 0 CA--C 1.555 1.149 0 C-N-CA 124.087 0.955 . . . . 73.54 109.871 -179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.378 2.114 0 C-N-CA 123.448 2.765 . . . . 74.43 112.259 171.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.366 0 N-CA-C 109.799 -0.445 . . . . 61.41 109.799 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -163.21 147.79 11.18 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 123.827 0.851 . . . . 71.54 109.5 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 41.5 tp60 -73.29 86.29 1.45 Allowed 'General case' 0 CA--C 1.543 0.705 0 N-CA-C 108.113 -1.069 . . . . 74.34 108.113 174.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -85.69 32.99 0.57 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.686 1.194 . . . . 74.41 113.497 -162.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -159.8 102.76 1.45 Allowed Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 123.316 0.646 . . . . 64.14 109.405 176.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.99 128.61 9.26 Favored 'Trans proline' 0 C--N 1.372 1.799 0 C-N-CA 122.755 2.303 . . . . 62.33 110.067 168.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 54.6 tp -66.09 -28.65 68.98 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 109.916 -0.402 . . . . 75.03 109.916 177.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . 0.528 ' HB2' ' HE2' ' B' ' 56' ' ' TYR . 32.9 tp -65.48 96.38 0.25 Allowed 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.588 0.755 . . . . 70.44 110.014 175.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -92.38 -17.06 47.56 Favored Glycine 0 C--N 1.347 1.172 0 CA-C-N 115.733 -0.667 . . . . 65.24 113.494 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 92.7 mt -131.2 -169.73 2.23 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 124.273 1.029 . . . . 73.42 109.93 -179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . . . . . . . . . 28.2 t80 80.5 -29.4 0.13 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 125.091 1.357 . . . . 74.44 113.599 167.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -67.98 -26.5 65.95 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.305 0.642 . . . . 42.12 112.534 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -82.4 -24.74 34.24 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.516 0.726 . . . . 73.33 110.46 175.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 73.53 -92.51 0.69 Allowed Glycine 0 C--N 1.352 1.428 0 N-CA-C 111.435 -0.666 . . . . 72.04 111.435 -174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 69.09 163.05 0.23 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.278 1.431 . . . . 64.23 112.236 175.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . 0.478 ' SD ' HD21 ' B' ' 136' ' ' LEU . 66.6 mtm 64.23 77.95 0.29 Allowed Pre-proline 0 N--CA 1.48 1.062 0 C-N-CA 125.072 1.349 . . . . 53.3 110.358 -177.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -54.2 131.77 46.76 Favored 'Trans proline' 0 C--N 1.383 2.375 0 C-N-CA 123.385 2.723 . . . . 70.42 113.293 -179.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 58.7 t -68.08 -45.99 82.36 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 O-C-N 123.848 0.718 . . . . 70.23 110.2 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 65.94 -78.42 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.956 1.302 . . . . 72.41 111.267 175.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -171.26 142.47 1.74 Allowed 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.366 1.066 . . . . 72.24 108.559 175.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.718 HD23 HG21 ' F' ' 309' ' ' THR . 5.6 mp -93.85 56.48 2.31 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 107.983 -1.117 . . . . 61.42 107.983 172.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . 0.545 ' HA3' HG21 ' F' ' 307' ' ' THR . . . 74.0 165.37 11.67 Favored Glycine 0 C--N 1.353 1.484 0 CA-C-N 115.351 -0.84 . . . . 64.24 113.318 -174.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -77.24 151.54 30.04 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 122.525 2.15 . . . . 61.12 112.215 177.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -124.42 158.72 32.09 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 108.898 -0.779 . . . . 71.22 108.898 169.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -80.63 72.25 7.55 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 124.515 1.126 . . . . 70.14 111.282 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 17.0 m -85.17 148.21 26.22 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 124.28 1.032 . . . . 74.31 109.311 177.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 64.14 30.55 13.72 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.979 0.912 . . . . 72.54 111.666 -173.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 13.1 m170 -100.83 162.88 12.6 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 120.726 0.298 . . . . 63.14 110.265 173.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 90.15 -160.74 28.56 Favored Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.693 -0.685 . . . . 73.25 111.694 -171.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 9.6 m120 -89.57 88.93 7.61 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 109.022 -0.733 . . . . 74.42 109.022 176.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . 0.545 HG22 ' HG2' ' B' ' 124' ' ' PRO . 8.8 pt -71.1 -18.22 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 CA-C-O 121.298 0.57 . . . . 71.45 111.091 -175.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -86.17 -159.85 0.5 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.558 1.143 . . . . 72.54 110.334 174.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' H' ' 304' ' ' PRO . 39.8 mttp 63.12 50.79 1.32 Allowed Pre-proline 0 CA--C 1.577 1.997 0 C-N-CA 124.639 1.175 . . . . 73.01 111.84 -177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' H' ' 303' ' ' LYS . 64.8 Cg_endo -101.95 6.22 0.51 Allowed 'Trans proline' 0 C--N 1.387 2.571 0 C-N-CA 123.167 2.578 . . . . 75.43 112.813 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -98.78 157.16 16.47 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.246 1.018 . . . . 72.3 111.772 -170.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . 0.472 HG12 HD22 ' F' ' 291' ' ' LEU . 13.9 m -124.98 110.33 24.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 CA-C-N 115.593 -0.731 . . . . 74.22 109.557 173.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 14.8 p -66.09 -53.53 37.03 Favored 'General case' 0 CA--C 1.547 0.831 0 CA-C-N 115.012 -0.994 . . . . 73.14 110.092 176.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . 0.434 ' O ' ' HD3' ' H' ' 310' ' ' PRO . 47.5 t -172.05 150.28 2.49 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.531 1.133 . . . . 74.32 108.656 172.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . 0.552 HG21 ' HA ' ' C' ' 131' ' ' VAL . 29.5 p -109.58 85.0 3.46 Favored Pre-proline 0 CA--C 1.553 1.09 0 C-N-CA 123.636 0.774 . . . . 44.2 109.961 175.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' H' ' 308' ' ' CYS . 37.8 Cg_endo . . . . . 0 C--N 1.38 2.219 0 C-N-CA 123.697 2.932 . . . . 61.3 111.359 174.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.924 -0.398 . . . . 63.35 109.924 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.7 p -164.83 97.14 0.74 Allowed 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.496 1.118 . . . . 63.33 108.179 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -116.1 158.23 23.52 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.069 0.947 . . . . 74.34 111.402 -172.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 64.11 32.86 12.43 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 124.317 1.047 . . . . 72.12 112.703 171.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -151.45 91.15 1.64 Allowed 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 122.945 0.498 . . . . 62.12 110.129 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -167.92 33.5 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 123.596 0.758 . . . . 53.12 110.027 -179.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.557 ' HA ' ' HG2' ' C' ' 143' ' ' GLN . 73.3 m -142.86 -57.34 0.43 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 109.139 -0.689 . . . . 43.33 109.139 174.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -172.86 4.38 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 114.992 -1.004 . . . . 74.25 109.891 173.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.488 ' HG3' HG23 ' A' ' 89' ' ' ILE . 54.8 ttm 68.86 133.31 0.03 OUTLIER 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.319 1.447 . . . . 74.4 111.511 -176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 97.8 m -148.85 131.22 15.64 Favored 'General case' 0 C--O 1.24 0.562 0 C-N-CA 124.164 0.986 . . . . 52.22 108.382 -179.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.482 ' CE1' ' HE2' ' A' ' 101' ' ' TYR . 47.5 t80 -137.08 129.07 29.27 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 107.818 -1.178 . . . . 74.15 107.818 172.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -153.02 119.29 5.52 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.074 -0.713 . . . . 71.35 109.074 173.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.623 HG21 ' HG2' ' C' ' 130' ' ' PRO . 52.8 mt -65.69 133.24 31.01 Favored 'Isoleucine or valine' 0 C--N 1.335 -0.058 0 CA-C-N 114.922 -1.036 . . . . 73.44 110.026 175.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -115.66 -22.32 9.24 Favored 'General case' 0 C--O 1.243 0.753 0 C-N-CA 123.568 0.747 . . . . 74.23 112.447 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.558 ' HD2' ' HG3' ' H' ' 304' ' ' PRO . 24.6 ttt85 -176.12 122.81 0.18 Allowed 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 118.192 0.451 . . . . 74.31 111.628 -175.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.524 HD13 ' HG2' ' C' ' 130' ' ' PRO . 1.4 mp -110.11 127.45 67.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 108.209 -1.034 . . . . 55.42 108.209 169.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.504 ' HB3' HG23 ' B' ' 122' ' ' THR . 27.2 p90 -158.44 150.69 21.76 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.014 0.926 . . . . 74.21 110.284 -178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.422 HG21 ' SG ' ' A' ' 113' ' ' CYS . 82.2 p -76.81 119.02 20.01 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.834 -0.802 . . . . 73.55 108.834 171.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 38.1 mtpt -81.68 -42.36 20.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.392 0.615 . . . . 53.33 109.568 176.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.69 ' HB2' ' HB2' ' A' ' 79' ' ' GLN . 15.3 m-20 -136.26 137.31 40.64 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 114.724 -1.125 . . . . 64.43 109.053 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 57.3 mt -133.74 142.53 41.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.458 -1.312 . . . . 75.45 107.458 175.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 34.8 t -150.49 133.93 16.41 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.849 -0.797 . . . . 70.51 108.849 171.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.539 ' HB2' ' SD ' ' A' ' 117' ' ' MET . 82.9 t80 -136.22 132.65 36.16 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 106.564 -1.643 . . . . 62.41 106.564 172.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -135.42 138.09 42.91 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 108.622 -0.881 . . . . 74.21 108.622 177.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -124.82 79.83 63.53 Favored Pre-proline 0 CA--C 1.542 0.649 0 N-CA-C 106.356 -1.72 . . . . 51.2 106.356 171.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -57.68 -40.81 76.69 Favored 'Trans proline' 0 C--N 1.386 2.551 0 C-N-CA 123.297 2.664 . . . . 70.23 113.049 -164.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -120.37 38.5 3.97 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 108.748 -0.834 . . . . 54.51 108.748 -177.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.494 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -46.06 -57.63 7.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-O 117.935 -1.031 . . . . 50.31 113.262 -175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 28' ' ' ALA . 22.5 Cg_exo -62.79 -20.25 70.67 Favored 'Trans proline' 0 C--N 1.393 2.882 0 C-N-CA 122.073 1.849 . . . . 34.2 113.383 -178.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -94.24 -31.87 13.91 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.178 0.991 . . . . 63.42 111.049 -175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.776 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.1 p -78.33 -19.45 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 C-N-CA 123.716 0.807 . . . . 54.54 111.025 -169.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -73.78 -7.52 52.46 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 123.744 0.818 . . . . 73.44 111.397 174.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -98.33 -19.8 17.56 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.588 1.155 . . . . 60.44 111.003 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -82.03 166.61 19.63 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.659 0.783 . . . . 72.44 111.546 -172.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.94 149.18 49.14 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.996 0.918 . . . . 70.1 110.02 178.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 10.1 m95 -86.77 62.35 7.35 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-O 121.266 0.555 . . . . 74.3 111.948 -168.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -134.34 66.71 71.4 Favored Pre-proline 0 N--CA 1.484 1.261 0 C-N-CA 123.007 0.523 . . . . 75.02 111.298 173.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -86.18 126.65 2.81 Favored 'Trans proline' 0 C--N 1.374 1.915 0 C-N-CA 122.008 1.805 . . . . 61.22 110.615 167.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -95.54 105.31 17.27 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 108.459 -0.941 . . . . 72.23 108.459 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.614 HG23 HG13 ' A' ' 64' ' ' VAL . 2.1 p -75.52 129.64 36.8 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 CA-C-N 114.278 -1.328 . . . . 74.31 110.218 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -99.92 141.17 33.09 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.56 1.144 . . . . 74.21 110.089 -177.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.458 ' HG ' HD11 ' A' ' 128' ' ' LEU . 0.8 OUTLIER -100.65 118.67 37.26 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 107.954 -1.128 . . . . 64.5 107.954 173.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -142.54 145.05 33.23 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.012 0.525 . . . . 64.13 110.068 170.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 4.1 mp -128.87 141.49 51.27 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 108.355 -0.979 . . . . 65.12 108.355 171.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 61' ' ' ARG . 17.9 t70 -119.37 138.0 53.36 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 107.583 -1.266 . . . . 63.24 107.583 175.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' E' ' 282' ' ' ALA . 72.4 p -106.66 138.21 43.26 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.374 0.669 . . . . 75.41 110.629 -167.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -165.16 110.45 0.91 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.17 0.588 . . . . 54.34 110.492 175.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.0 p -112.76 159.76 18.64 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 109.019 -0.734 . . . . 73.33 109.019 170.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.5 t -154.14 150.42 28.12 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.536 0.734 . . . . 53.12 109.716 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -83.46 143.45 30.23 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.403 -0.962 . . . . 65.31 108.403 171.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 57' ' ' GLU . 28.6 mt -115.94 -43.88 2.96 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.396 0.679 . . . . 75.14 109.719 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.86 -167.94 2.96 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.108 -0.951 . . . . 74.31 110.073 -174.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -62.76 106.41 0.8 Allowed 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.553 0.741 . . . . 73.51 110.132 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 87' ' ' ALA . 23.9 m-20 67.34 13.87 9.5 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.727 1.211 . . . . 73.45 113.095 177.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.25 117.14 45.01 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 N-CA-C 108.379 -0.971 . . . . 63.21 108.379 174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.505 ' HB2' ' HB ' ' A' ' 86' ' ' ILE . 64.0 m-85 -125.06 123.39 39.68 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 108.512 -0.921 . . . . 64.54 108.512 175.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.589 ' HB2' HD11 ' A' ' 51' ' ' LEU . 27.4 tt0 -88.88 143.11 27.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.094 -0.957 . . . . 75.2 108.761 173.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.441 ' HB ' ' HE1' ' A' ' 84' ' ' PHE . 21.7 t -119.08 136.03 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 N-CA-C 107.815 -1.18 . . . . 63.2 107.815 172.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.8 t -127.13 132.38 69.82 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 C-N-CA 124.065 0.946 . . . . 74.4 108.762 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.53 HD23 HD12 ' A' ' 106' ' ' LEU . 4.5 mm? -119.67 110.09 16.42 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 124.336 1.055 . . . . 73.25 108.344 175.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.727 ' HB2' ' HG2' ' A' ' 79' ' ' GLN . 26.3 ttp180 -83.81 99.55 10.37 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 109.012 -0.736 . . . . 62.44 109.012 173.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.1 t -91.16 117.35 34.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.594 0 N-CA-C 107.313 -1.365 . . . . 72.43 107.313 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.8 m -116.03 122.24 44.6 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-O 121.911 0.862 . . . . 74.45 109.544 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.614 HG13 HG23 ' A' ' 40' ' ' VAL . 49.1 t -112.98 120.93 64.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 113.492 -1.685 . . . . 72.13 108.181 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.5 m -121.45 125.95 48.12 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.934 -0.765 . . . . 73.43 108.934 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.94 121.63 38.44 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 107.97 -1.122 . . . . 75.03 107.97 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 70.9 m -136.93 132.86 35.02 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.095 0.558 . . . . 70.15 110.344 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.24 85.18 3.63 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.003 0.921 . . . . 72.43 109.166 174.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 92.06 -90.98 1.54 Allowed Glycine 0 C--N 1.344 0.978 0 CA-C-N 114.45 -1.25 . . . . 71.32 110.889 -177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -122.36 -30.2 4.01 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.637 0.775 . . . . 73.21 110.423 177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -80.01 131.35 35.78 Favored 'General case' 0 C--N 1.347 0.499 0 N-CA-C 109.333 -0.617 . . . . 61.11 109.333 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 34.3 m -87.01 136.23 32.99 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.232 0.539 . . . . 53.03 111.156 -177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.776 ' HA ' HG21 ' A' ' 31' ' ' VAL . . . -75.61 -65.22 0.93 Allowed 'General case' 0 C--O 1.239 0.502 0 CA-C-N 114.893 -1.049 . . . . 70.32 109.323 172.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -150.69 159.28 44.62 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 114.511 -1.222 . . . . 74.21 111.319 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 49.9 tp -132.14 115.4 15.69 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.173 1.389 . . . . 74.23 107.964 176.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.603 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 67.7 m -105.76 138.28 42.21 Favored 'General case' 0 N--CA 1.466 0.341 0 N-CA-C 108.26 -1.015 . . . . 60.33 108.26 175.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -146.81 115.39 6.75 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 108.28 -1.007 . . . . 65.24 108.28 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.9 t -129.39 110.14 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.448 0.699 . . . . 45.32 109.501 -175.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.727 ' HG2' ' HB2' ' A' ' 61' ' ' ARG . 39.5 mt-30 -84.64 83.19 8.1 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.894 -1.15 . . . . 52.34 107.894 169.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -76.22 102.22 5.73 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-N 114.443 -1.253 . . . . 41.33 107.884 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.5 156.31 24.77 Favored Glycine 0 C--O 1.243 0.685 0 CA-C-N 115.939 -0.573 . . . . 64.14 111.882 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . -152.3 120.61 1.09 Allowed Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 110.503 -1.039 . . . . 71.21 110.503 176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 68.3 mt -80.75 125.99 39.51 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 N-CA-C 108.267 -1.012 . . . . 34.42 108.267 173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.553 ' HD2' HG12 ' A' ' 13' ' ' ILE . 4.7 m-85 -135.65 144.75 46.22 Favored 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 107.642 -1.244 . . . . 74.13 107.642 176.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 39.1 t -84.47 93.53 8.33 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 107.907 -1.145 . . . . 53.23 107.907 169.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 56' ' ' TYR . 55.3 mt -100.08 117.92 45.98 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 N-CA-C 108.56 -0.904 . . . . 62.2 108.56 -176.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.465 ' HB2' ' HB3' ' A' ' 54' ' ' ASP . . . -151.03 158.33 43.96 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 123.679 0.791 . . . . 64.04 110.38 -172.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.404 ' HA3' ' H ' ' A' ' 9' ' ' MET . . . 76.75 10.13 86.11 Favored Glycine 0 C--N 1.352 1.446 0 O-C-N 123.339 0.399 . . . . 65.13 113.788 171.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.488 HG23 ' HG3' ' A' ' 9' ' ' MET . 1.2 pp -113.26 163.05 10.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.967 1.307 . . . . 73.44 110.299 -173.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -170.56 170.64 6.75 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 108.296 -1.001 . . . . 72.1 108.296 172.264 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 51.05 -126.53 26.88 Favored Glycine 0 C--N 1.346 1.129 0 C-N-CA 124.07 0.843 . . . . 74.4 114.947 174.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 41.6 p -72.97 -22.47 60.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.086 0.955 . . . . 71.53 111.639 -177.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -71.6 -43.96 65.31 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 122.926 0.491 . . . . 75.11 110.3 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . . . . . . . . . 23.4 ttt -71.42 -38.52 71.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 115.759 -0.655 . . . . 64.14 109.358 177.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.7 -31.93 72.93 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 115.49 -0.777 . . . . 65.35 111.233 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 -78.98 -27.03 43.38 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 122.861 0.464 . . . . 74.0 110.695 175.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . . . . . . . . . 52.1 t -73.95 -66.03 0.76 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 122.161 0.184 . . . . 54.33 110.519 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 1.2 pp -85.65 -17.26 36.58 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 112.445 0.535 . . . . 73.32 112.445 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.85 1.33 44.97 Favored Glycine 0 C--N 1.347 1.191 0 CA-C-O 119.43 -0.65 . . . . 50.42 114.265 -176.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.646 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.96 -56.8 0.2 Allowed 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 117.885 0.842 . . . . 44.24 113.25 -175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.482 ' HE2' ' CE1' ' A' ' 11' ' ' PHE . 91.6 t80 -76.04 -59.05 2.93 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.477 0.711 . . . . 75.13 111.221 -171.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . . . . . . . . . 81.5 m -66.82 -31.99 4.57 Favored Pre-proline 0 CA--C 1.564 1.482 0 C-N-CA 123.913 0.885 . . . . 62.42 113.105 -178.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_exo -47.54 -49.06 14.01 Favored 'Trans proline' 0 C--N 1.394 2.948 0 C-N-CA 122.647 2.231 . . . . 74.13 113.192 160.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -68.67 -26.53 65.36 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.574 0.75 . . . . 74.23 110.437 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 35.9 mm -69.62 -42.94 80.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 123.194 0.597 . . . . 73.25 110.196 172.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.53 HD12 HD23 ' A' ' 60' ' ' LEU . 96.7 mt -80.75 -17.42 51.02 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.733 0.813 . . . . 75.41 111.568 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.8 t80 -65.85 -45.8 65.17 Favored Pre-proline 0 CA--C 1.555 1.169 0 CA-C-O 118.075 -0.964 . . . . 72.44 113.277 -169.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_exo -64.25 -30.91 64.21 Favored 'Trans proline' 0 C--N 1.391 2.772 0 C-N-CA 121.986 1.791 . . . . 65.41 112.616 176.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -78.89 -36.46 42.07 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.423 0.689 . . . . 73.1 111.356 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.53 74.67 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.853 -0.795 . . . . 72.22 108.853 172.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -51.25 -50.31 59.46 Favored 'General case' 0 N--CA 1.477 0.88 0 O-C-N 125.098 1.499 . . . . 70.23 110.757 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -72.81 -37.63 67.44 Favored 'General case' 0 N--CA 1.475 0.779 0 O-C-N 124.197 0.936 . . . . 63.4 111.106 -174.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.422 ' SG ' HG21 ' A' ' 18' ' ' THR . 41.8 t -62.9 -35.89 81.52 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 121.08 0.467 . . . . 71.55 110.651 176.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.467 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 97.0 mt -68.13 -52.06 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 CA-C-N 115.333 -0.849 . . . . 71.33 109.527 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.481 HG23 ' HG3' ' A' ' 125' ' ' GLN . 92.6 m -52.25 -44.8 65.08 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 124.775 1.23 . . . . 71.0 111.422 -174.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 32.1 t -66.42 -45.8 78.69 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 114.412 -1.267 . . . . 71.24 110.546 -175.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.539 ' SD ' ' HB2' ' A' ' 23' ' ' PHE . 47.3 mtm -61.91 -41.16 97.59 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 122.789 0.436 . . . . 72.53 111.147 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 114' ' ' ILE . 72.4 t -58.5 -49.46 82.19 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 C-N-CA 124.227 1.011 . . . . 44.34 110.334 177.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 84.9 p -69.14 -27.45 65.56 Favored 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 122.847 0.459 . . . . 55.34 111.383 -179.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.467 ' HD3' ' SG ' ' B' ' 113' ' ' CYS . 86.1 mtt-85 -73.61 -20.75 60.51 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 123.717 0.807 . . . . 74.44 110.837 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.95 10.83 64.18 Favored Glycine 0 C--N 1.354 1.568 0 CA-C-O 119.676 -0.513 . . . . 61.41 113.539 173.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.7 m 56.94 32.74 22.08 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 125.171 1.389 . . . . 73.11 110.646 -173.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -99.09 153.85 37.59 Favored Pre-proline 0 C--O 1.243 0.743 0 CA-C-N 114.897 -1.047 . . . . 75.13 109.097 173.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' E' ' 297' ' ' TYR . 36.4 Cg_endo -62.47 144.97 95.54 Favored 'Trans proline' 0 C--N 1.375 1.921 0 C-N-CA 122.365 2.043 . . . . 72.31 110.944 177.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.481 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.1 tt0 -55.05 130.13 40.64 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 123.864 0.728 . . . . 73.14 111.298 -176.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 51.4 tp -111.51 102.71 11.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.03 0.932 . . . . 63.4 109.516 179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -97.36 102.63 14.45 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 107.753 -1.203 . . . . 64.31 107.753 173.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.458 HD11 ' HG ' ' A' ' 42' ' ' LEU . 0.5 OUTLIER -63.65 116.97 6.17 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 107.765 -1.198 . . . . 62.5 107.765 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -61.61 135.92 94.34 Favored Pre-proline 0 CA--C 1.553 1.058 0 C-N-CA 123.428 0.691 . . . . 70.2 112.241 -172.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.24 137.81 49.01 Favored 'Trans proline' 0 C--N 1.382 2.3 0 C-N-CA 122.763 2.308 . . . . 64.41 112.983 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.94 134.7 65.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.033 0.933 . . . . 71.4 109.258 178.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 135' ' ' ALA . 15.9 p-10 -84.01 77.61 9.9 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.201 1.0 . . . . 71.3 110.908 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -66.59 -40.79 89.06 Favored 'General case' 0 N--CA 1.485 1.299 0 CA-C-O 121.45 0.643 . . . . 72.43 109.932 174.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.646 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.3 p-10 -61.28 -40.75 95.26 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.036 1.334 . . . . 71.54 111.69 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 132' ' ' ASN . . . -79.11 -34.64 43.25 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.844 0.858 . . . . 74.1 110.582 -178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 8.3 tt -53.12 -48.47 67.84 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 123.962 0.905 . . . . 75.31 110.285 179.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -60.36 -42.76 96.42 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.095 -0.957 . . . . 75.23 111.734 177.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 mmt -73.07 -33.76 65.84 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 112.691 0.626 . . . . 71.42 112.691 -175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -61.82 -31.41 71.64 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 123.462 0.705 . . . . 74.1 110.247 178.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -88.43 -37.44 15.85 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.029 -0.987 . . . . 74.31 110.814 176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 30.6 tp -68.84 -49.68 56.35 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.277 0.631 . . . . 72.2 111.927 -171.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 28.7 pt20 -157.52 14.39 0.24 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 115.902 -0.59 . . . . 70.13 111.55 -172.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 68.75 -72.75 0.1 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.866 1.266 . . . . 72.14 110.211 -169.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? 71.99 127.0 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.835 1.254 . . . . 74.1 110.298 178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.9 143.5 14.24 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.158 0.583 . . . . 60.5 109.804 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 109.34 153.99 15.43 Favored Glycine 0 C--N 1.345 1.064 0 N-CA-C 111.942 -0.463 . . . . 71.21 111.942 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -123.42 -172.44 2.51 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 124.217 1.007 . . . . 61.11 110.629 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . -139.66 93.09 0.19 Allowed Glycine 0 C--N 1.348 1.213 0 N-CA-C 110.332 -1.107 . . . . 64.3 110.332 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 13.3 p -139.07 107.41 5.8 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.175 0.99 . . . . 73.23 110.502 -176.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -74.02 -36.21 64.42 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.684 0.794 . . . . 74.53 109.981 170.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 75.67 15.18 2.67 Favored 'General case' 0 C--N 1.367 1.369 0 O-C-N 125.35 1.656 . . . . 72.22 110.338 -172.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -87.7 85.66 7.09 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 124.058 0.943 . . . . 64.25 110.42 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -174.96 99.37 0.08 Allowed 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.582 1.153 . . . . 51.45 108.956 173.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -82.63 132.01 35.2 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.17 0.988 . . . . 61.44 110.161 -177.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.472 ' HA ' HD22 ' F' ' 285' ' ' ASN . . . . . . . . 0 C--O 1.249 1.053 0 C-N-CA 123.461 0.704 . . . . 75.43 110.363 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 48.9 ttm . . . . . 0 N--CA 1.478 0.927 0 N-CA-C 109.795 -0.446 . . . . 75.14 109.795 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 33.2 t -166.18 94.5 0.55 Allowed 'General case' 0 C--O 1.245 0.828 0 N-CA-C 108.114 -1.069 . . . . 63.3 108.114 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -77.65 78.82 4.16 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-O 121.746 0.784 . . . . 73.23 109.237 177.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -135.09 28.74 3.44 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 114.88 -1.055 . . . . 74.33 110.109 -179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -77.1 83.23 3.6 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.985 -0.746 . . . . 71.03 108.985 175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 -175.51 98.66 0.07 Allowed 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.093 -1.077 . . . . 74.25 108.093 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 5.2 t -146.15 94.38 2.46 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.869 0.842 . . . . 44.4 110.683 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -167.69 -59.35 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 107.845 -1.168 . . . . 71.41 107.845 173.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.465 ' HA ' ' HA3' ' B' ' 88' ' ' GLY . 5.0 ptt? 53.62 -171.67 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.286 0 C-N-CA 126.239 1.816 . . . . 74.3 113.352 177.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . . . . . . . . . 87.4 m -154.97 132.15 11.0 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 107.394 -1.336 . . . . 53.35 107.394 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -140.62 135.72 32.01 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.314 0.646 . . . . 70.11 109.314 -178.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.572 ' HG3' ' HA ' ' E' ' 308' ' ' CYS . 3.1 mm-40 -152.99 140.59 19.86 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 124.146 0.903 . . . . 72.24 109.708 167.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.453 ' O ' ' HB ' ' E' ' 306' ' ' VAL . 2.4 pp -80.51 140.21 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 N-CA-C 107.333 -1.358 . . . . 75.24 107.333 169.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 63.2 mt-30 -98.02 -44.32 6.7 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 109.071 -0.714 . . . . 62.01 109.071 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -164.41 138.67 5.42 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 115.331 -0.85 . . . . 71.23 109.28 -173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . . . . . . . . . 95.8 mt -119.77 137.22 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 106.344 -1.724 . . . . 75.12 106.344 172.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . . . . . . . . . 27.9 p90 -166.08 161.64 17.31 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.414 0.626 . . . . 74.44 111.88 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 98.9 m -90.24 117.66 29.16 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 115.017 -0.992 . . . . 71.31 108.818 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . . . . . . . . . 45.0 mtpt -87.67 -27.91 22.15 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.453 -0.794 . . . . 74.42 111.056 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -159.81 143.69 14.51 Favored 'General case' 0 N--CA 1.475 0.789 0 O-C-N 123.411 0.444 . . . . 70.42 111.928 -174.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . 0.474 HD11 ' SG ' ' B' ' 113' ' ' CYS . 44.9 mm -134.63 143.46 37.68 Favored 'Isoleucine or valine' 0 C--N 1.352 0.692 0 C-N-CA 125.286 1.435 . . . . 74.13 109.055 174.402 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . 0.521 ' HB3' ' HB3' ' B' ' 77' ' ' GLU . 32.7 t -144.37 130.53 19.59 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 107.757 -1.201 . . . . 53.43 107.757 173.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -145.59 114.45 6.9 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 107.352 -1.351 . . . . 71.03 107.352 171.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 40.1 mt-10 -118.78 137.51 53.33 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.131 0.572 . . . . 72.41 109.673 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.931 ' HB1' ' HB2' ' B' ' 28' ' ' ALA . . . -129.34 78.69 75.43 Favored Pre-proline 0 CA--C 1.544 0.73 0 N-CA-C 107.814 -1.18 . . . . 73.42 107.814 173.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.4 -18.24 38.78 Favored 'Trans proline' 0 C--N 1.383 2.343 0 C-N-CA 123.471 2.781 . . . . 65.44 113.448 -170.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 11.3 p-10 -126.81 12.88 7.36 Favored 'General case' 0 C--O 1.22 -0.491 0 C-N-CA 125.315 1.446 . . . . 71.0 110.739 -176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.931 ' HB2' ' HB1' ' B' ' 25' ' ' ALA . . . -44.71 -57.18 7.19 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 115.817 1.784 . . . . 71.22 115.817 -165.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.484 ' HD3' ' HB3' ' B' ' 28' ' ' ALA . 16.0 Cg_exo -66.01 -26.8 50.63 Favored 'Trans proline' 0 C--N 1.377 2.05 0 C-N-CA 122.528 2.152 . . . . 62.21 112.336 -173.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.459 ' O ' ' HG2' ' B' ' 33' ' ' GLN . 80.9 m80 -91.46 -43.79 9.5 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-N 115.129 -0.941 . . . . 71.32 111.465 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -55.7 -26.37 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 C-N-CA 123.244 0.618 . . . . 73.03 112.389 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . 0.513 ' HA ' HG21 ' H' ' 301' ' ' ILE . 21.9 m-30 -58.8 -24.01 61.23 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.026 0.93 . . . . 71.32 113.029 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.651 ' HA ' ' HE2' ' H' ' 303' ' ' LYS . 24.2 pt20 -76.47 -6.52 52.12 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.224 0.61 . . . . 71.2 112.424 -176.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.687 ' HG2' ' HB2' ' C' ' 153' ' ' GLN . 31.0 mtpt -103.93 109.49 21.26 Favored 'General case' 0 CA--C 1.553 1.085 0 N-CA-C 109.162 -0.681 . . . . 74.44 109.162 -177.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -95.46 96.93 9.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 112.266 0.469 . . . . 74.55 112.266 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -176.18 177.0 1.62 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.18 1.392 . . . . 74.23 110.511 162.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? -78.7 138.03 58.36 Favored Pre-proline 0 CA--C 1.554 1.119 0 C-N-CA 124.121 0.968 . . . . 75.14 112.082 -177.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -84.41 158.3 12.72 Favored 'Trans proline' 0 C--N 1.37 1.671 0 C-N-CA 122.796 2.33 . . . . 73.01 112.881 167.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -87.49 128.2 35.23 Favored 'General case' 0 C--O 1.241 0.646 0 N-CA-C 107.813 -1.18 . . . . 74.22 107.813 162.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 51.9 t -108.48 131.72 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 123.302 0.641 . . . . 74.25 109.891 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -105.74 135.6 46.87 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.603 1.161 . . . . 72.51 109.194 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . . . . . . . . . 75.4 mt -109.16 125.62 52.38 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 124.222 1.009 . . . . 72.54 108.331 176.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -141.01 118.55 11.55 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.217 0.607 . . . . 61.12 109.368 -177.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 4.7 pp -99.75 165.31 11.65 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.789 -0.449 . . . . 60.14 109.789 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.559 ' HB3' ' HB3' ' B' ' 61' ' ' ARG . 9.8 t70 -146.82 136.52 23.1 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.805 1.242 . . . . 71.13 108.095 179.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.8 p -120.93 105.54 10.77 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.609 0.764 . . . . 62.45 111.189 -167.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -119.19 155.27 31.96 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.861 0.864 . . . . 72.21 109.984 176.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 26.2 p -146.85 169.04 19.95 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 124.272 1.029 . . . . 53.45 109.885 171.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 59.5 p -153.46 137.63 16.5 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.308 0.643 . . . . 62.0 109.523 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -83.54 111.69 19.31 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 109.716 -0.476 . . . . 71.45 109.716 177.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 76.3 mt -83.24 -45.78 13.43 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 123.689 0.618 . . . . 74.23 110.257 176.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -156.86 -168.01 2.53 Favored 'General case' 0 C--O 1.243 0.754 0 CA-C-N 115.218 -0.901 . . . . 60.32 110.701 -174.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.01 108.32 3.03 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.997 -1.001 . . . . 72.43 109.883 -178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 65.8 11.11 7.37 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.945 1.298 . . . . 72.14 112.641 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 74.5 t -106.42 113.63 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 108.646 -0.872 . . . . 51.52 108.646 173.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 82.1 m-85 -125.92 139.87 53.1 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.438 0.695 . . . . 74.02 109.522 178.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . . . . . . . . . 7.9 tm-20 -101.78 106.39 17.39 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 107.528 -1.286 . . . . 54.3 107.528 178.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.19 123.6 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 C-N-CA 124.256 1.022 . . . . 64.25 110.213 -176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 22.4 t -103.39 113.47 40.28 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 C-N-CA 124.003 0.921 . . . . 74.21 109.496 176.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.61 100.02 10.68 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 107.614 -1.254 . . . . 75.52 107.614 173.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 11.7 ttm180 -85.3 128.18 34.6 Favored 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 109.116 -0.698 . . . . 71.35 109.116 176.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 52.8 t -119.26 106.13 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 108.1 -1.074 . . . . 71.4 108.1 172.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 19.6 m -98.55 126.72 44.21 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.522 0.729 . . . . 75.52 109.375 177.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.621 HG21 HG21 ' B' ' 114' ' ' ILE . 93.7 t -118.33 116.71 52.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 114.889 -1.05 . . . . 64.15 108.575 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 97.7 m -116.32 140.48 49.28 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.653 -0.869 . . . . 75.23 108.653 173.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.92 142.73 49.05 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 107.81 -1.181 . . . . 52.0 107.81 176.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 38.9 p -150.31 141.96 23.59 Favored 'General case' 0 C--O 1.241 0.632 0 C-N-CA 123.074 0.55 . . . . 74.15 110.64 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' B' ' 73' ' ' ALA . 0.5 OUTLIER -138.1 136.53 36.84 Favored 'General case' 0 C--O 1.243 0.713 0 C-N-CA 124.223 1.009 . . . . 62.23 110.534 -177.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 65.4 -124.1 26.68 Favored Glycine 0 C--N 1.34 0.753 0 CA-C-N 115.766 -0.652 . . . . 31.21 112.455 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -96.98 2.91 52.11 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 124.328 1.051 . . . . 73.42 111.066 -176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -149.65 -179.87 7.45 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 112.469 0.544 . . . . 63.33 112.469 -167.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 18.3 m -73.29 154.67 40.06 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 124.518 1.127 . . . . 53.2 111.235 -177.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.533 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -97.77 -57.8 2.15 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 108.052 -1.092 . . . . 51.42 108.052 167.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -160.28 161.41 33.36 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.492 -1.231 . . . . 71.33 109.674 169.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 50.7 mt -116.95 131.34 56.98 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 107.273 -1.38 . . . . 72.31 107.273 171.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 48.5 t -143.09 150.46 39.54 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 109.09 -0.707 . . . . 75.35 109.09 177.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . 0.521 ' HB3' ' HB3' ' B' ' 22' ' ' SER . 45.0 tt0 -164.55 133.71 3.68 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.66 0.784 . . . . 63.32 108.975 -177.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . . . . . . . . . 69.3 t -130.61 145.7 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 C-N-CA 124.276 1.03 . . . . 71.34 108.289 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -121.87 95.68 4.76 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 107.668 -1.234 . . . . 74.23 107.668 170.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.469 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 7.6 tp-100 -90.4 99.69 12.67 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 108.28 -1.007 . . . . 74.25 108.28 177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.48 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -89.75 165.49 32.14 Favored Glycine 0 C--O 1.242 0.631 0 N-CA-C 111.165 -0.774 . . . . 72.42 111.165 178.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -165.51 127.18 1.58 Allowed Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 111.025 -0.83 . . . . 10.43 111.025 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 56.0 mt -83.58 129.09 38.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 107.961 -1.125 . . . . 63.41 107.961 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -133.02 134.79 44.89 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.074 0.95 . . . . 75.03 109.084 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . . . . . . . . . 50.8 m -99.36 105.15 17.09 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 107.75 -1.204 . . . . 61.3 107.75 168.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.463 HD12 HD11 ' B' ' 89' ' ' ILE . 29.9 pt -119.75 142.88 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.631 0.772 . . . . 71.54 110.065 -176.084 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . . . . . . . . . . . -154.58 161.12 41.76 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.757 0.823 . . . . 44.21 109.984 -178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' B' ' 9' ' ' MET . . . 89.49 -54.43 3.83 Favored Glycine 0 C--N 1.347 1.169 0 O-C-N 123.647 0.592 . . . . 71.23 112.13 177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.463 HD11 HD12 ' B' ' 86' ' ' ILE . 28.6 pt -54.44 145.7 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 C-N-CA 124.531 1.132 . . . . 53.43 112.026 178.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -165.99 152.5 9.47 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 123.553 0.533 . . . . 70.3 110.485 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 64.95 -128.29 34.19 Favored Glycine 0 C--N 1.35 1.329 0 O-C-N 123.869 0.73 . . . . 44.35 114.058 173.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 12.6 m -69.25 -29.94 67.96 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 123.726 0.811 . . . . 74.32 110.77 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -75.65 -26.81 58.04 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.919 0.888 . . . . 63.21 110.392 -178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . . . . . . . . . 35.3 ttm -62.71 -32.96 74.16 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 123.826 0.85 . . . . 71.54 110.422 174.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' H' ' 280' ' ' LEU . . . -64.77 -29.01 69.97 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.96 0.904 . . . . 33.21 112.608 -176.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . 0.476 ' O ' ' HB3' ' B' ' 100' ' ' ALA . 51.4 t-80 -69.07 -26.55 65.01 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 122.522 0.329 . . . . 74.34 110.773 175.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 46.6 t -80.94 -63.17 1.46 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 110.179 -0.304 . . . . 64.33 110.179 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.491 HD13 ' CD1' ' H' ' 281' ' ' PHE . 3.5 pp -67.12 -31.66 72.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.656 0.613 . . . . 74.3 112.656 -172.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . 0.481 ' N ' HD12 ' B' ' 98' ' ' LEU . . . -108.32 3.08 32.94 Favored Glycine 0 N--CA 1.474 1.229 0 CA-C-O 119.718 -0.49 . . . . 61.42 114.284 -171.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.476 ' HB3' ' O ' ' B' ' 96' ' ' HIS . . . -144.16 -57.64 0.38 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 117.377 0.588 . . . . 52.32 111.7 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -72.38 -53.75 11.37 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.312 0.645 . . . . 73.43 111.459 -170.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . 0.425 ' HB2' ' HD3' ' B' ' 103' ' ' PRO . 68.0 m -64.28 -45.05 78.27 Favored Pre-proline 0 CA--C 1.565 1.522 0 C-N-CA 123.956 0.903 . . . . 64.33 111.601 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . 0.425 ' HD3' ' HB2' ' B' ' 102' ' ' CYS . 71.7 Cg_exo -55.6 -39.96 88.09 Favored 'Trans proline' 0 C--N 1.402 3.348 0 C-N-CA 122.649 2.233 . . . . 64.02 113.236 168.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -58.4 -29.17 65.86 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 123.579 0.752 . . . . 61.44 111.29 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . 0.403 ' O ' ' HD2' ' B' ' 108' ' ' PRO . 73.1 mt -80.54 -53.42 12.68 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.95 0 C-N-CA 123.786 0.834 . . . . 73.31 110.886 176.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 97.3 mt -75.48 -24.54 56.95 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 123.367 0.667 . . . . 72.31 112.545 -170.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -63.53 -48.15 81.71 Favored Pre-proline 0 N--CA 1.485 1.293 0 CA-C-O 117.913 -1.041 . . . . 65.13 112.893 -172.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.403 ' HD2' ' O ' ' B' ' 105' ' ' ILE . 84.7 Cg_exo -51.9 -43.09 54.3 Favored 'Trans proline' 0 C--N 1.385 2.465 0 C-N-CA 122.455 2.103 . . . . 53.42 113.966 174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.505 ' HE2' HG21 ' D' ' 115' ' ' THR . 86.7 m-85 -67.1 -47.43 71.2 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.348 0.659 . . . . 75.25 110.888 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . 0.536 ' O ' HG13 ' B' ' 114' ' ' ILE . . . -58.09 -48.27 80.67 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 123.813 0.696 . . . . 72.11 110.127 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 19.7 ttt-85 -51.85 -52.27 50.73 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 125.806 1.642 . . . . 73.44 111.628 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.39 -35.0 78.43 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 123.657 0.598 . . . . 63.03 109.727 -178.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.474 ' SG ' HD11 ' B' ' 21' ' ' ILE . 1.8 t -68.08 -31.0 70.32 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 122.93 0.492 . . . . 53.52 111.527 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.621 HG21 HG21 ' B' ' 64' ' ' VAL . 53.7 mt -70.14 -55.25 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 N-CA-C 108.562 -0.903 . . . . 73.31 108.562 173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 77.1 m -54.93 -33.91 62.65 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.88 1.363 . . . . 64.42 111.628 -177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' B' ' 120' ' ' ARG . 32.6 t -63.35 -51.56 65.4 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 115.398 -0.819 . . . . 62.13 109.552 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 11.4 mmt -71.76 -34.17 69.26 Favored 'General case' 0 N--CA 1.484 1.257 0 O-C-N 123.786 0.679 . . . . 75.2 111.318 -174.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . 0.422 HG21 HD23 ' B' ' 126' ' ' LEU . 85.0 t -62.64 -44.73 99.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.879 0.872 . . . . 72.5 110.011 175.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 37.8 t -68.6 -35.28 77.13 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 115.179 -0.919 . . . . 71.21 110.634 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . 0.415 ' HG3' ' O ' ' B' ' 116' ' ' SER . 93.2 mtt-85 -66.59 -29.42 69.47 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.026 0.53 . . . . 65.24 110.326 177.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.7 18.28 35.38 Favored Glycine 0 C--N 1.354 1.543 0 O-C-N 123.967 0.792 . . . . 54.35 112.629 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.504 HG23 ' HB3' ' A' ' 17' ' ' TYR . 35.5 p 54.51 44.98 27.94 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.876 1.67 . . . . 65.23 112.881 176.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . 0.407 ' HA ' ' HD3' ' B' ' 124' ' ' PRO . 41.4 m-85 -112.78 147.32 36.92 Favored Pre-proline 0 N--CA 1.481 1.085 0 C-N-CA 123.403 0.681 . . . . 71.43 109.709 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' B' ' 123' ' ' PHE . 10.6 Cg_exo -70.01 -165.63 0.17 Allowed 'Trans proline' 0 C--N 1.383 2.38 0 C-N-CA 123.41 2.74 . . . . 43.24 113.954 -175.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.421 HE21 ' N ' ' B' ' 126' ' ' LEU . 22.9 tp60 -61.27 129.56 41.85 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.967 1.099 . . . . 71.11 113.967 -163.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' H' ' 296' ' ' THR . 27.5 tp -136.3 118.35 15.37 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 124.609 1.163 . . . . 62.11 108.951 168.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -134.5 134.48 41.52 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.157 -1.053 . . . . 72.44 108.157 166.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -87.58 148.17 24.98 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.928 0.394 . . . . 74.34 111.342 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . . . . . . . . . . . -83.07 147.94 55.34 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.204 1.002 . . . . 52.24 112.352 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . 0.454 ' HG3' ' CD1' ' D' ' 16' ' ' ILE . 85.0 Cg_endo -75.82 79.78 2.77 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.53 2.82 . . . . 75.13 111.306 175.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . . . . . . . . . 58.4 t -88.99 111.49 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 N-CA-C 107.781 -1.192 . . . . 74.21 107.781 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.447 ' ND2' ' HB2' ' B' ' 134' ' ' ASP . 5.8 t30 -71.54 94.52 1.31 Allowed 'General case' 0 CA--C 1.541 0.634 0 O-C-N 124.162 0.914 . . . . 75.05 109.341 -171.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -62.65 -27.46 69.24 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.091 0.956 . . . . 74.03 111.391 -177.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . 0.447 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . 2.6 m-20 -58.45 -44.26 89.15 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.624 1.169 . . . . 53.31 109.683 175.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.444 ' H ' HD22 ' B' ' 132' ' ' ASN . . . -68.79 -42.92 76.72 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.737 -1.119 . . . . 75.23 110.658 -178.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 82.9 mt -60.81 -36.92 80.29 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.535 0.734 . . . . 73.41 111.772 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -85.32 -46.82 10.62 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 116.221 -0.445 . . . . 71.1 111.04 -175.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.92 -33.24 75.37 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.711 0.404 . . . . 53.44 111.971 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -75.81 -22.31 56.48 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.359 0.663 . . . . 72.1 111.779 -178.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 44.4 t80 -65.63 -37.46 86.63 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-O 121.785 0.802 . . . . 65.34 109.535 174.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 9.5 mt -94.11 6.48 48.43 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 114.345 -1.298 . . . . 65.15 110.414 -175.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 69.58 112.34 0.05 OUTLIER 'General case' 0 C--N 1.363 1.163 0 C-N-CA 125.107 1.363 . . . . 72.33 109.569 -168.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -67.49 124.94 24.6 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.143 0.577 . . . . 72.03 110.936 -178.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -104.46 130.02 52.4 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 108.195 -1.039 . . . . 62.43 108.195 167.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -94.52 -73.92 0.56 Allowed 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 122.983 0.513 . . . . 75.51 109.752 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.91 61.64 3.94 Favored Glycine 0 C--N 1.347 1.177 0 N-CA-C 111.477 -0.649 . . . . 75.21 111.477 -173.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -71.84 117.85 13.94 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.525 0.73 . . . . 73.33 109.74 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -130.75 121.96 3.41 Favored Glycine 0 C--N 1.344 0.985 0 N-CA-C 111.904 -0.479 . . . . 75.24 111.904 -177.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 31.6 p -107.05 95.87 6.03 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.579 0.752 . . . . 74.44 109.708 177.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -83.39 146.56 28.39 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 115.806 -0.633 . . . . 71.04 110.179 176.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . 0.727 ' HA ' ' HG2' ' D' ' 142' ' ' GLN . 47.2 mt-10 -140.77 95.94 2.93 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.109 0.964 . . . . 63.31 108.897 174.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -104.69 130.93 52.65 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.065 0.546 . . . . 73.31 109.675 177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -99.91 84.04 2.82 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.453 0.701 . . . . 72.45 109.825 -175.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -163.78 -170.23 2.12 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.707 0.803 . . . . 72.11 109.717 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.303 0 C-N-CA 123.595 0.758 . . . . 50.35 109.187 -178.486 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 111.744 0.275 . . . . 63.15 111.744 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 19.7 m -63.98 111.02 2.32 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 123.126 0.571 . . . . 54.43 109.635 177.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -130.63 151.16 51.39 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.586 0.754 . . . . 62.02 109.673 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -60.12 135.86 57.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 123.616 0.766 . . . . 63.0 110.659 175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -148.34 -66.45 0.24 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.207 0.603 . . . . 73.45 109.65 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -87.48 67.45 9.39 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 121.826 0.822 . . . . 63.35 110.219 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 5.6 t -156.1 81.82 1.0 Allowed 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 107.332 -1.359 . . . . 70.51 107.332 175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -108.72 150.31 27.77 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.253 -0.885 . . . . 74.33 109.235 -178.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.445 ' HG3' HD13 ' C' ' 89' ' ' ILE . 41.0 ttm 65.24 113.52 0.03 OUTLIER 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 124.977 1.311 . . . . 72.12 111.703 -178.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 33.2 m -89.82 79.57 6.66 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 108.486 -0.931 . . . . 71.15 108.486 175.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -90.78 120.88 32.18 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 108.635 -0.876 . . . . 74.31 108.635 176.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . 0.632 ' HB2' ' HB ' ' G' ' 306' ' ' VAL . 12.5 pt20 -146.14 125.7 13.28 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.292 0.637 . . . . 74.22 109.594 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . . . . . . . . . 2.7 pp -81.29 138.3 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 115.433 -0.803 . . . . 72.3 110.395 -175.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -103.86 -51.65 3.12 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 110.02 -0.363 . . . . 73.54 110.02 176.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -172.22 129.81 0.59 Allowed 'General case' 0 N--CA 1.484 1.27 0 O-C-N 123.276 0.36 . . . . 74.52 110.466 -175.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.9 mt -110.31 145.69 16.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.347 -0.982 . . . . 63.32 108.347 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . 0.41 ' HE1' HG12 ' C' ' 83' ' ' ILE . 39.9 p90 -173.32 172.5 3.76 Favored 'General case' 0 N--CA 1.483 1.181 0 CA-C-O 121.428 0.632 . . . . 74.34 111.417 -172.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . . . . . . . . . 38.5 p -92.16 114.95 27.63 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.647 -0.706 . . . . 61.24 110.103 171.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 24.8 mmmt -64.48 -38.41 90.94 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 109.033 -0.728 . . . . 74.41 109.033 167.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.443 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 22.7 t70 -153.73 148.14 26.04 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 114.571 -1.195 . . . . 74.23 110.043 -177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.537 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 86.5 mt -136.15 143.26 36.43 Favored 'Isoleucine or valine' 0 C--O 1.244 0.797 0 N-CA-C 105.606 -1.998 . . . . 73.25 105.606 171.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 23.3 t -156.18 150.1 25.16 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.391 0.615 . . . . 62.32 109.868 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -152.59 118.19 5.34 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.481 -1.303 . . . . 71.45 107.481 173.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -115.44 139.43 50.04 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.655 -1.239 . . . . 75.42 107.655 177.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.12 84.25 53.48 Favored Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 107.66 -1.237 . . . . 75.1 107.66 174.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -59.32 -45.09 28.77 Favored 'Trans proline' 0 C--N 1.384 2.441 0 C-N-CA 123.101 2.534 . . . . 72.23 112.226 -176.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 43.1 m-80 -110.27 50.73 0.79 Allowed 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 108.591 -0.892 . . . . 72.21 108.591 178.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.59 ' HB1' ' HE2' ' D' ' 17' ' ' TYR . . . -55.73 -48.15 97.17 Favored Pre-proline 0 CA--C 1.562 1.423 0 CA-C-N 115.518 -0.764 . . . . 73.23 112.832 -175.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' C' ' 28' ' ' ALA . 1.9 Cg_endo -85.91 -33.7 0.2 Allowed 'Trans proline' 0 C--N 1.386 2.53 0 C-N-CA 121.929 1.752 . . . . 74.02 112.836 169.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . 0.416 ' O ' ' HG2' ' C' ' 33' ' ' GLN . 55.8 t60 -70.23 -33.52 71.75 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 113.657 0.984 . . . . 72.05 113.657 -167.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 5.1 p -79.44 -14.14 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 122.815 0.446 . . . . 75.02 111.224 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -71.31 -14.91 62.36 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 123.624 0.77 . . . . 74.04 111.601 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . 0.416 ' HG2' ' O ' ' C' ' 30' ' ' HIS . 14.1 pt20 -105.14 12.51 31.94 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.525 0.73 . . . . 62.23 110.824 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.443 ' HZ3' ' HG2' ' C' ' 71' ' ' GLU . 1.1 mptm? -97.45 176.71 5.77 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.021 0.915 . . . . 63.51 112.994 -170.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -87.91 128.5 35.36 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 113.384 -1.735 . . . . 72.03 108.938 178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . . . . . . . . . 8.7 m95 -79.49 97.47 6.43 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 123.648 0.592 . . . . 73.44 111.206 -168.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -148.24 58.89 4.06 Favored Pre-proline 0 CA--C 1.563 1.48 0 C-N-CA 123.247 0.619 . . . . 52.31 110.319 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -69.37 123.31 10.1 Favored 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 122.767 2.311 . . . . 64.54 112.387 -170.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.98 77.57 8.42 Favored 'General case' 0 C--O 1.239 0.551 0 N-CA-C 106.551 -1.648 . . . . 64.43 106.551 173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . . . . . . . . . 26.0 t -73.83 97.85 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.485 0 CA-C-N 114.838 -1.074 . . . . 65.32 108.4 -177.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -93.49 122.08 35.55 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 114.95 -1.023 . . . . 74.31 109.01 -179.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 5.1 mp -86.31 121.51 28.98 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 107.308 -1.368 . . . . 64.03 107.308 174.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.541 ' HB3' ' HB ' ' C' ' 63' ' ' THR . 18.0 t70 -121.85 135.43 54.9 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 107.691 -1.225 . . . . 74.03 107.691 176.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 9.3 tt -137.21 120.12 16.43 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.335 -0.987 . . . . 71.23 108.335 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.557 ' HA ' ' HA2' ' F' ' 284' ' ' GLY . 5.6 t70 -113.46 148.11 36.57 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.056 0.942 . . . . 62.44 108.71 174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . 0.48 ' HB ' ' CG ' ' F' ' 281' ' ' PHE . 62.0 p -117.19 118.85 33.46 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 115.212 -0.904 . . . . 75.45 109.753 -173.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . 0.492 ' HB3' ' HB ' ' C' ' 59' ' ' VAL . . . -124.37 146.6 48.76 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.0 0.92 . . . . 34.42 109.5 -179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 75.6 p -151.48 157.4 42.27 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 122.687 0.395 . . . . 75.21 110.584 177.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' C' ' 57' ' ' GLU . 20.0 m -143.81 147.53 34.25 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.133 0.973 . . . . 71.14 108.635 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -101.93 115.76 31.23 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 107.953 -1.129 . . . . 74.34 107.953 168.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' C' ' 57' ' ' GLU . 28.5 mt -98.18 -27.6 14.1 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.324 0.65 . . . . 63.12 110.034 -175.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . . . . . . . . . . . -166.72 -171.38 1.83 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.242 1.017 . . . . 70.32 110.334 177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -72.51 124.76 25.87 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.254 -0.884 . . . . 71.14 109.237 177.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 37.0 m-20 69.85 -8.88 0.75 Allowed 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 125.878 1.671 . . . . 74.41 112.728 -173.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . . . . . . . . . 58.5 t -101.91 112.58 35.53 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 N-CA-C 109.407 -0.59 . . . . 64.31 109.407 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -127.54 126.08 41.52 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 124.476 1.11 . . . . 63.44 108.685 -178.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.603 ' HB2' HD11 ' C' ' 51' ' ' LEU . 38.4 tt0 -82.52 118.53 23.33 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.809 0.843 . . . . 75.33 108.745 173.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.15 114.75 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.952 -1.129 . . . . 53.43 107.952 174.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . 0.492 ' HB ' ' HB3' ' C' ' 47' ' ' ALA . 43.6 t -110.64 131.38 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 N-CA-C 109.071 -0.714 . . . . 63.04 109.071 176.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.436 HD13 ' HB3' ' C' ' 103' ' ' PRO . 36.2 tp -111.97 103.14 11.34 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.971 -1.122 . . . . 64.12 107.971 178.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.547 ' HD2' ' HB3' ' C' ' 45' ' ' ASP . 55.1 ttm-85 -81.32 115.36 20.65 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 107.883 -1.154 . . . . 64.4 107.883 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . 0.455 ' HB ' HD11 ' C' ' 114' ' ' ILE . 4.2 t -116.73 108.74 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 107.905 -1.146 . . . . 75.43 107.905 -179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' C' ' 43' ' ' ASP . 32.1 m -116.02 124.37 50.29 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.834 0.854 . . . . 71.11 108.755 -174.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . . . . . . . . . 56.2 t -117.8 113.71 43.18 Favored 'Isoleucine or valine' 0 C--O 1.24 0.565 0 N-CA-C 108.846 -0.798 . . . . 73.31 108.846 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 3.1 m -100.88 146.84 26.83 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.595 -0.73 . . . . 72.13 109.343 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.4 121.66 13.06 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 109.132 -0.692 . . . . 74.24 109.132 170.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 46.2 m -131.63 126.28 34.32 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.841 -0.799 . . . . 70.14 108.841 173.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' C' ' 73' ' ' ALA . 9.2 mp -84.56 57.32 4.26 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.894 0.878 . . . . 63.25 109.399 -177.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 107.1 -114.03 4.2 Favored Glycine 0 C--N 1.35 1.311 0 N-CA-C 110.072 -1.211 . . . . 73.52 110.072 -174.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -90.8 -22.83 20.83 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.87 0.868 . . . . 62.15 110.322 177.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . 0.443 ' HG2' ' HZ3' ' C' ' 34' ' ' LYS . 7.3 tp10 -87.87 117.83 26.98 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 123.433 0.693 . . . . 70.12 110.844 -177.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 59.4 m -76.23 128.05 34.13 Favored 'General case' 0 C--O 1.242 0.663 0 CA-C-O 121.006 0.431 . . . . 73.33 110.647 175.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . 0.514 ' HB2' HD13 ' C' ' 68' ' ' LEU . . . -77.32 -60.45 2.36 Favored 'General case' 0 C--O 1.242 0.665 0 CA-C-N 114.792 -1.094 . . . . 60.42 109.422 178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -159.11 176.47 12.21 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-N 114.88 -1.055 . . . . 72.32 110.58 -176.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -140.98 120.86 13.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 106.357 -1.72 . . . . 71.13 106.357 171.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . 0.449 ' SG ' HG23 ' C' ' 114' ' ' ILE . 48.9 t -117.01 119.89 36.7 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 108.439 -0.949 . . . . 72.02 108.439 177.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -127.69 141.71 51.53 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 108.72 -0.844 . . . . 70.31 108.72 -174.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 70.9 t -147.41 115.14 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.342 0 C-N-CA 124.444 1.098 . . . . 73.41 108.823 175.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.443 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 50.1 mt-30 -89.41 97.84 11.43 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 107.988 -1.115 . . . . 71.15 107.988 169.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . . . . . . . . . 8.8 tp-100 -88.97 100.86 13.54 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 115.719 -0.673 . . . . 52.33 109.328 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' C' ' 59' ' ' VAL . . . -98.21 147.24 18.5 Favored Glycine 0 C--N 1.343 0.97 0 CA-C-N 116.146 -0.479 . . . . 64.21 112.366 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -145.38 125.57 2.37 Favored Glycine 0 CA--C 1.51 -0.242 0 N-CA-C 111.008 -0.837 . . . . 75.21 111.008 -177.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' D' ' 29' ' ' PRO . 13.4 mm -81.76 122.66 37.0 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 108.765 -0.828 . . . . 61.1 108.765 175.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 65.1 m-85 -133.54 138.17 45.93 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 108.414 -0.958 . . . . 75.24 108.414 179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 11.3 p -109.34 106.17 15.86 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.933 -0.765 . . . . 71.21 108.933 173.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . . . . . . . . . 34.7 pt -116.46 142.24 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 123.856 0.863 . . . . 72.42 110.709 -175.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -145.8 163.18 35.83 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.942 0.897 . . . . 43.01 110.406 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 90.82 -21.13 34.96 Favored Glycine 0 C--N 1.352 1.419 0 CA-C-N 115.833 -0.621 . . . . 64.51 113.406 177.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . 0.445 HD13 ' HG3' ' C' ' 9' ' ' MET . 36.4 pt -114.18 148.16 17.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 124.063 0.945 . . . . 54.35 109.914 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . 0.547 ' HG3' ' HA ' ' F' ' 277' ' ' LEU . 35.6 tt0 -160.22 148.19 16.61 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 123.494 0.497 . . . . 61.03 110.099 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 59.51 -112.66 4.49 Favored Glycine 0 C--N 1.35 1.331 0 O-C-N 124.293 0.996 . . . . 72.22 113.543 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 37.0 p -64.69 -37.22 86.85 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.062 0.945 . . . . 65.12 111.775 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -65.88 -46.73 77.32 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 123.135 0.574 . . . . 72.25 110.937 178.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.437 ' HA ' HD12 ' C' ' 89' ' ' ILE . 3.1 ppp? -74.53 -20.97 59.76 Favored 'General case' 0 C--O 1.214 -0.773 0 CA-C-N 115.509 -0.769 . . . . 63.55 110.146 -178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.66 72.64 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.408 0.683 . . . . 64.12 111.074 175.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 53.1 t-80 -68.18 -46.86 69.53 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.247 -0.433 . . . . 74.32 110.596 176.217 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 42.1 t -66.98 -56.56 9.62 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 116.141 -0.481 . . . . 64.02 110.376 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 54.7 tp -64.02 -40.43 96.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 124.449 1.1 . . . . 63.14 111.894 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -94.72 10.93 70.42 Favored Glycine 0 C--N 1.347 1.163 0 CA-C-O 119.481 -0.622 . . . . 70.04 114.415 -173.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' C' ' 133' ' ' PHE . . . -149.87 -59.76 0.2 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 117.808 0.804 . . . . 73.12 111.988 -177.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . . . . . . . . . 62.4 t80 -75.0 -50.93 14.91 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-N 116.244 -0.435 . . . . 72.15 112.008 -171.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 65.8 m -60.66 -45.76 97.09 Favored Pre-proline 0 CA--C 1.567 1.616 0 C-N-CA 123.577 0.751 . . . . 63.45 112.95 -177.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . 0.436 ' HB3' HD13 ' C' ' 60' ' ' LEU . 44.2 Cg_endo -67.65 -24.72 41.11 Favored 'Trans proline' 0 C--N 1.393 2.875 0 C-N-CA 121.983 1.788 . . . . 74.32 112.882 174.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 56.9 t-20 -65.47 -40.49 93.21 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 123.257 0.623 . . . . 71.24 109.392 175.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . . . . . . . . . 51.2 mm -61.08 -46.76 96.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-N 115.634 -0.712 . . . . 71.41 110.195 176.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . . . . . . . . . 88.1 mt -80.07 -20.84 44.23 Favored 'General case' 0 CA--C 1.551 0.995 0 CA-C-N 115.27 -0.877 . . . . 70.41 112.226 -172.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -55.9 -54.74 48.78 Favored Pre-proline 0 CA--C 1.56 1.351 0 CA-C-O 118.109 -0.948 . . . . 73.55 113.538 -173.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -63.49 -31.52 71.53 Favored 'Trans proline' 0 C--N 1.389 2.707 0 C-N-CA 121.994 1.796 . . . . 53.44 112.972 -176.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -66.1 -45.38 81.38 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 123.524 0.73 . . . . 63.21 110.756 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -66.13 -37.78 86.54 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 115.852 -0.613 . . . . 74.04 110.439 175.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 53.6 ttt180 -60.56 -54.11 49.36 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 125.298 1.439 . . . . 70.32 111.425 -172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.28 -35.39 80.28 Favored 'General case' 0 N--CA 1.485 1.301 0 O-C-N 123.608 0.568 . . . . 74.12 110.172 -177.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 49.0 t -67.09 -38.87 86.46 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.079 0.552 . . . . 71.44 111.822 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' C' ' 62' ' ' VAL . 77.1 mt -67.76 -50.94 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.436 0.694 . . . . 61.53 110.169 175.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.4 m -63.14 -28.79 70.3 Favored 'General case' 0 CA--C 1.557 1.233 0 C-N-CA 123.368 0.667 . . . . 61.11 111.311 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . . . . . . . . . 37.6 t -67.58 -47.85 68.58 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.18 -0.674 . . . . 61.53 109.18 174.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.555 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -62.45 -37.67 86.82 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.961 0.904 . . . . 75.41 112.325 179.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 96.0 t -64.52 -40.58 89.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 C-N-CA 123.049 0.539 . . . . 61.32 109.918 175.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 35.3 t -66.33 -33.96 76.9 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 123.651 0.78 . . . . 75.24 111.229 176.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.474 ' HD2' ' HA ' ' C' ' 117' ' ' MET . 71.4 mtt-85 -70.48 -27.11 63.96 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 123.9 0.88 . . . . 73.12 110.901 -179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -91.24 15.01 62.13 Favored Glycine 0 C--N 1.352 1.45 0 O-C-N 123.63 0.581 . . . . 44.24 112.817 174.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.534 HG23 ' HB3' ' D' ' 17' ' ' TYR . 49.6 p 55.0 26.39 7.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 125.901 1.681 . . . . 65.21 112.638 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -103.46 141.86 23.38 Favored Pre-proline 0 CA--C 1.556 1.174 0 C-N-CA 124.425 1.09 . . . . 72.21 108.887 -174.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_exo -40.6 111.77 0.16 Allowed 'Trans proline' 0 C--N 1.391 2.795 0 C-N-CA 124.148 3.232 . . . . 75.15 113.893 176.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -57.23 123.67 16.13 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.148 0.905 . . . . 74.13 111.268 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . 0.487 HD11 ' HH2' ' F' ' 290' ' ' TRP . 3.1 tm? -112.36 110.75 21.15 Favored 'General case' 0 C--O 1.243 0.736 0 N-CA-C 108.128 -1.064 . . . . 73.54 108.128 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -94.97 117.38 30.04 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.635 -0.876 . . . . 71.33 108.635 175.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.55 142.25 53.66 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.516 0.51 . . . . 61.32 110.268 175.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . . . . . . . . . . . -73.2 160.84 81.73 Favored Pre-proline 0 CA--C 1.553 1.075 0 CA-C-N 115.099 -0.955 . . . . 63.32 111.065 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.623 ' HG2' HG21 ' A' ' 13' ' ' ILE . 26.0 Cg_exo -59.76 100.73 0.14 Allowed 'Trans proline' 0 C--N 1.377 2.037 0 C-N-CA 122.65 2.233 . . . . 63.42 112.455 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.452 HG11 HG21 ' F' ' 288' ' ' VAL . 61.2 t -98.85 107.12 19.9 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 N-CA-C 108.399 -0.963 . . . . 74.01 108.399 175.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . . . . . . . . . 40.8 t30 -114.34 106.25 14.09 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.232 1.013 . . . . 64.31 108.559 176.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . 0.559 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 51.1 m-85 -63.91 -30.64 71.7 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.731 0.812 . . . . 72.43 111.429 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -59.43 -50.57 73.42 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 123.849 0.86 . . . . 63.22 110.515 173.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -61.59 -38.46 87.64 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 115.213 -0.903 . . . . 53.34 110.693 177.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . . . . . . . . . 7.0 tt -61.12 -41.37 96.58 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 124.199 1.0 . . . . 74.3 110.401 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -64.05 -33.4 75.67 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 123.352 0.661 . . . . 73.21 111.333 178.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 62.3 mtt -77.71 -45.37 24.97 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.228 0.611 . . . . 74.15 111.046 179.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -59.69 -33.74 71.97 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 124.198 0.999 . . . . 54.2 111.766 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -29.54 -82.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 126.112 1.765 . . . . 65.12 112.548 177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 50.1 tp -107.21 87.47 2.51 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 109.417 -0.586 . . . . 71.11 109.417 177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -145.73 -168.85 3.09 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.7 1.2 . . . . 71.51 109.261 172.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . 0.557 ' HG2' ' HA ' ' A' ' 7' ' ' THR . 30.1 tp60 -117.34 131.29 56.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 124.062 0.945 . . . . 73.51 109.66 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -118.97 127.34 53.38 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.953 0.901 . . . . 63.53 109.577 175.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -88.85 -70.82 0.63 Allowed 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.184 0.593 . . . . 70.52 109.797 178.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 171.15 176.94 40.65 Favored Glycine 0 C--N 1.34 0.8 0 CA-C-N 116.153 -0.476 . . . . 43.04 112.117 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.96 -65.67 1.12 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.529 0.732 . . . . 73.42 111.386 -172.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . 142.62 -145.97 16.47 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 115.335 -0.848 . . . . 64.51 111.327 -173.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 99.8 m -148.96 150.13 32.35 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.398 1.079 . . . . 73.32 108.464 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.33 -172.86 0.99 Allowed 'General case' 0 CA--C 1.558 1.274 0 C-N-CA 122.98 0.512 . . . . 63.34 110.723 174.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' C' ' 152' ' ' HIS . 23.0 tt0 -133.44 -174.96 3.65 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.887 -0.783 . . . . 72.23 108.887 -177.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . 0.453 ' H ' ' HG2' ' C' ' 151' ' ' GLU . 8.2 p80 -152.04 138.41 18.5 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 118.12 0.418 . . . . 55.23 111.642 -177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . 0.687 ' HB2' ' HG2' ' B' ' 34' ' ' LYS . 90.2 mt-30 -114.76 118.54 33.88 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 108.021 -1.103 . . . . 75.21 108.021 169.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -97.84 120.67 38.64 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.627 0.771 . . . . 73.25 109.646 -176.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.236 0 C-N-CA 123.505 0.722 . . . . 72.51 109.227 176.124 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 109.951 -0.389 . . . . 55.3 109.951 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -163.86 86.76 0.5 Allowed 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 108.273 -1.01 . . . . 72.15 108.273 174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -82.98 63.21 6.95 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-O 122.171 0.986 . . . . 54.33 111.192 -175.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -138.71 118.04 12.78 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.335 1.054 . . . . 74.21 109.044 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -149.68 84.02 1.41 Allowed 'General case' 0 C--O 1.24 0.59 0 N-CA-C 107.337 -1.357 . . . . 65.41 107.337 176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -84.29 161.03 20.6 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.075 -0.966 . . . . 72.34 111.31 -175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 4.7 t -155.4 151.8 28.28 Favored 'General case' 0 C--O 1.239 0.524 0 C-N-CA 124.104 0.962 . . . . 72.32 109.77 177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -139.7 71.5 1.38 Allowed 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.635 -1.246 . . . . 74.32 107.635 164.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . . . . . . . . . 6.8 ttp -34.58 126.34 0.5 Allowed 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 114.67 -1.15 . . . . 74.34 111.713 166.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.5 m -136.79 139.87 42.11 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 107.735 -1.209 . . . . 54.42 107.735 169.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -156.8 92.93 1.32 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.05 -1.463 . . . . 55.25 107.05 -178.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -122.02 156.44 33.49 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.674 0.79 . . . . 63.13 109.363 178.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.507 HD13 HG21 ' D' ' 105' ' ' ILE . 11.3 mt -102.0 122.48 54.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.983 -0.747 . . . . 42.15 108.983 -177.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 74.7 mt-30 -81.25 -49.57 10.6 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 109.433 -0.58 . . . . 74.11 109.433 171.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . 0.513 ' HE ' HD12 ' D' ' 83' ' ' ILE . 19.4 ptt180 -173.65 152.67 2.11 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 112.171 0.434 . . . . 72.14 112.171 178.266 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.454 ' CD1' ' HG3' ' B' ' 130' ' ' PRO . 4.0 mp -114.36 139.35 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 N-CA-C 106.621 -1.622 . . . . 72.42 106.621 167.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.59 ' HE2' ' HB1' ' C' ' 28' ' ' ALA . 41.2 p90 -162.56 157.67 22.43 Favored 'General case' 0 C--O 1.239 0.53 0 C-N-CA 123.833 0.853 . . . . 64.22 109.691 -177.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 80.6 p -81.42 113.55 19.57 Favored 'General case' 0 N--CA 1.441 -0.919 0 CA-C-N 114.459 -1.246 . . . . 72.45 109.175 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 33.9 mtpt -83.33 -33.2 25.94 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.098 0.475 . . . . 63.14 109.812 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 27.6 t70 -144.93 135.54 24.45 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 114.537 -1.21 . . . . 71.34 109.038 178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.555 HG21 ' HE2' ' C' ' 117' ' ' MET . 53.4 mt -133.43 140.89 45.84 Favored 'Isoleucine or valine' 0 C--O 1.242 0.665 0 N-CA-C 107.351 -1.351 . . . . 64.05 107.351 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 47.5 t -154.44 102.32 2.41 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.675 0.79 . . . . 62.55 109.466 178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 70.0 t80 -108.39 115.49 30.2 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 105.783 -1.932 . . . . 73.32 105.783 167.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -121.01 131.78 54.5 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 109.149 -0.686 . . . . 74.23 109.149 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . . . . . . . . . . . -122.45 78.26 45.77 Favored Pre-proline 0 CA--C 1.54 0.57 0 N-CA-C 107.284 -1.376 . . . . 75.13 107.284 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -65.9 -35.15 36.49 Favored 'Trans proline' 0 C--N 1.383 2.391 0 C-N-CA 122.675 2.25 . . . . 62.42 111.522 -172.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.4 ' O ' ' HB3' ' D' ' 30' ' ' HIS . 6.5 m-80 -109.91 22.29 15.82 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.775 0.83 . . . . 72.01 109.99 -177.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . . . . . . . . . . . -35.43 -64.82 0.31 Allowed Pre-proline 0 CA--C 1.571 1.773 0 N-CA-C 116.13 1.9 . . . . 74.13 116.13 -171.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.508 ' HB3' HD11 ' C' ' 83' ' ' ILE . 40.0 Cg_endo -81.03 -14.5 10.91 Favored 'Trans proline' 0 C--N 1.39 2.744 0 CA-C-N 122.023 1.758 . . . . 74.41 113.339 -174.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' D' ' 27' ' ' ASN . 17.0 t-160 -71.35 -37.43 71.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.901 1.28 . . . . 71.44 109.06 172.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.633 HG13 HD11 ' D' ' 68' ' ' LEU . 76.1 t -74.12 -30.98 28.4 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.575 0 CA-C-N 115.131 -0.94 . . . . 74.32 109.95 175.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -70.84 6.76 1.37 Allowed 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.644 0.979 . . . . 73.21 113.644 179.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -84.48 -37.84 20.84 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 109.367 -0.605 . . . . 75.24 109.367 163.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . 0.426 ' HA ' ' HZ3' ' D' ' 36' ' ' TRP . 30.4 pttt -132.45 95.87 3.72 Favored 'General case' 0 CA--C 1.568 1.663 0 C-N-CA 124.23 1.012 . . . . 74.12 112.319 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.427 ' CG ' HD11 ' G' ' 301' ' ' ILE . 92.2 m-20 -108.72 92.74 4.18 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.202 -0.936 . . . . 72.42 109.522 170.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . 0.426 ' HZ3' ' HA ' ' D' ' 34' ' ' LYS . 12.3 m-90 -125.86 -179.99 4.93 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 107.364 -1.347 . . . . 75.13 107.364 169.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.05 104.65 0.44 Allowed Pre-proline 0 N--CA 1.489 1.517 0 C-N-CA 123.476 0.71 . . . . 73.03 112.055 -163.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -76.69 109.72 2.91 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 122.958 2.438 . . . . 70.41 109.464 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -64.62 113.9 4.04 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 108.589 -0.893 . . . . 74.54 108.589 175.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.418 HG11 HD11 ' D' ' 126' ' ' LEU . 1.2 m -104.78 114.2 43.77 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 CA-C-N 114.436 -1.256 . . . . 45.44 110.64 -166.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . 0.418 ' HB3' ' HB ' ' D' ' 65' ' ' THR . 81.1 tttt -87.54 128.65 35.25 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 125.198 1.399 . . . . 73.4 108.945 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 76.8 mt -101.77 114.17 27.99 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.382 0.673 . . . . 75.55 109.828 -178.091 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.646 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.9 m-20 -106.84 109.43 21.33 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 107.256 -1.387 . . . . 73.41 107.256 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . 0.419 ' HG ' ' HG2' ' G' ' 286' ' ' MET . 3.0 mm? -97.5 130.88 44.54 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.245 -1.02 . . . . 74.44 108.245 177.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.611 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 20.7 t70 -133.49 130.39 38.48 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 108.149 -1.056 . . . . 72.23 108.149 -178.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 36.4 p -103.88 142.4 34.47 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.6 0.76 . . . . 63.14 109.781 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.422 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -155.24 150.65 27.19 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.549 0.74 . . . . 71.22 109.251 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . . . . . . . . . 76.5 p -164.63 153.32 12.72 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 123.393 0.677 . . . . 41.53 109.332 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 79.3 p -158.65 142.55 15.39 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.063 0.545 . . . . 63.35 110.054 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -73.05 128.47 35.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.356 0.662 . . . . 71.22 109.393 174.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . . . . . . . . . 37.0 mt -100.88 -26.32 13.79 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.884 0.474 . . . . 73.32 110.552 176.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -167.52 -179.09 4.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.753 0.821 . . . . 61.21 110.82 177.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -66.04 119.82 12.06 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 114.852 -1.067 . . . . 62.51 108.858 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' D' ' 87' ' ' ALA . 40.5 m-20 66.39 16.79 10.53 Favored 'General case' 0 N--CA 1.484 1.229 0 C-N-CA 125.044 1.338 . . . . 75.03 111.891 -178.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 88.9 t -126.81 114.81 39.23 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.934 0.894 . . . . 72.23 108.969 175.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . 0.448 ' HB2' HD12 ' D' ' 86' ' ' ILE . 90.4 m-85 -132.81 129.45 38.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.352 1.061 . . . . 73.22 108.489 -173.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -100.27 139.73 35.54 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.384 1.074 . . . . 50.5 109.789 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.58 118.8 59.15 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.375 1.07 . . . . 73.45 108.305 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA2' ' D' ' 81' ' ' GLY . 25.5 t -104.99 131.4 54.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.729 0 N-CA-C 108.442 -0.947 . . . . 72.51 108.442 174.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -125.93 109.76 12.84 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.991 -1.115 . . . . 70.24 107.991 -178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.611 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 18.2 ttm-85 -87.05 109.36 19.35 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 123.537 0.735 . . . . 74.12 109.838 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 89.1 t -97.56 104.25 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 N-CA-C 107.591 -1.263 . . . . 50.22 107.591 166.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.646 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 24.8 m -100.0 136.51 39.8 Favored 'General case' 0 C--O 1.238 0.449 0 N-CA-C 109.433 -0.58 . . . . 65.31 109.433 175.582 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 55.7 t -125.06 110.12 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 C-N-CA 124.46 1.104 . . . . 63.24 108.255 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . 0.418 ' HB ' ' HB3' ' D' ' 41' ' ' LYS . 39.6 m -102.97 103.08 13.17 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.597 0.759 . . . . 63.5 109.244 175.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -95.59 135.99 36.55 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 109.855 -0.424 . . . . 73.23 109.855 -175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 29.5 p -148.36 124.28 10.64 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 123.641 0.588 . . . . 63.33 110.433 -177.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.634 ' HG ' ' HB2' ' D' ' 73' ' ' ALA . 0.5 OUTLIER -113.04 126.7 55.78 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 108.422 -0.955 . . . . 54.01 108.422 172.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 68.54 -134.03 28.11 Favored Glycine 0 C--N 1.344 1.006 0 N-CA-C 111.474 -0.65 . . . . 65.32 111.474 -172.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -93.26 4.2 54.38 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 122.979 0.512 . . . . 73.33 110.874 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -119.07 144.18 46.72 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.936 0.494 . . . . 75.41 111.337 -168.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 40.8 m -74.72 120.1 19.81 Favored 'General case' 0 C--N 1.349 0.574 0 C-N-CA 123.469 0.708 . . . . 75.13 109.895 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.634 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -67.94 -61.53 1.82 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 124.252 0.97 . . . . 72.42 110.191 176.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -154.37 168.56 26.24 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 114.247 -1.342 . . . . 63.54 110.454 177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 90.7 mt -127.45 139.57 52.73 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.65 -1.611 . . . . 72.31 106.65 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.578 ' SG ' HG23 ' D' ' 114' ' ' ILE . 36.2 t -153.38 110.21 3.42 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.415 -0.587 . . . . 70.32 109.415 -175.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -136.45 132.18 35.05 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 124.45 1.1 . . . . 71.43 108.998 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.39 121.79 20.08 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 C-N-CA 123.117 0.567 . . . . 65.31 109.614 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.521 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 49.4 mt-30 -88.74 88.83 7.74 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.321 -0.992 . . . . 61.42 108.321 169.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -81.11 96.63 7.24 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 114.565 -1.198 . . . . 65.15 108.958 -177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -92.09 144.24 17.01 Favored Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.579 -0.608 . . . . 64.45 111.579 -179.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -142.74 130.0 4.03 Favored Glycine 0 CA--C 1.507 -0.432 0 N-CA-C 110.834 -0.906 . . . . 74.33 110.834 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . 0.513 HD12 ' HE ' ' D' ' 15' ' ' ARG . 48.0 mt -89.82 127.04 42.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 N-CA-C 108.527 -0.916 . . . . 64.4 108.527 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -129.12 133.51 47.67 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.724 0.809 . . . . 74.24 109.759 -178.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . . . . . . . . . 42.1 m -80.92 94.98 6.61 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 108.901 -0.777 . . . . 55.11 108.901 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' D' ' 56' ' ' TYR . 40.1 mt -111.34 123.63 67.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.302 0 C-N-CA 123.444 0.698 . . . . 62.13 110.202 -174.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' D' ' 54' ' ' ASP . . . -149.67 165.01 33.63 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.767 0.827 . . . . 52.53 110.671 -177.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . . . . . . . . . . . 85.71 -19.44 24.73 Favored Glycine 0 C--N 1.347 1.143 0 N-CA-C 115.411 0.925 . . . . 52.12 115.411 169.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.552 ' O ' HD23 ' G' ' 277' ' ' LEU . 19.7 pt -129.2 134.73 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.16 0 CA-C-N 117.835 0.817 . . . . 40.31 111.879 -170.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.33 -171.26 3.08 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.617 0.767 . . . . 63.04 110.061 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 68.88 -140.41 34.5 Favored Glycine 0 C--N 1.349 1.262 0 O-C-N 123.622 0.576 . . . . 61.04 112.18 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 52.5 p -78.19 -20.87 51.04 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.381 0.672 . . . . 70.31 111.57 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . 0.446 HE21 ' HA ' ' D' ' 93' ' ' GLN . 0.0 OUTLIER -60.44 -52.96 63.01 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.759 0.823 . . . . 75.21 110.17 177.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -71.27 -41.56 69.87 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 114.86 -1.063 . . . . 55.45 109.923 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.38 -26.92 68.68 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.476 0.71 . . . . 75.11 112.36 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -79.88 -42.04 25.0 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.347 0.659 . . . . 73.44 109.694 176.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.39 -31.03 71.92 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.068 0.547 . . . . 63.42 110.836 177.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.78 -46.59 18.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.542 1.137 . . . . 71.3 108.611 178.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.14 -20.05 79.41 Favored Glycine 0 C--N 1.348 1.206 0 CA-C-N 114.97 -1.013 . . . . 75.2 114.377 -173.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -125.98 -61.71 1.22 Allowed 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 117.17 0.485 . . . . 72.35 111.805 -173.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -67.11 -40.89 86.95 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 112.677 0.621 . . . . 75.44 112.677 -170.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 72.5 m -63.76 -47.48 81.52 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-O 118.72 -0.657 . . . . 65.33 111.742 -178.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.3 -40.2 35.43 Favored 'Trans proline' 0 C--N 1.4 3.269 0 C-N-CA 123.045 2.497 . . . . 63.11 114.196 167.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -59.78 -27.0 66.17 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 112.764 0.653 . . . . 64.11 112.764 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.507 HG21 HD13 ' D' ' 13' ' ' ILE . 41.6 mm -82.42 -44.91 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.12 0 CA-C-O 121.157 0.503 . . . . 53.02 110.572 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . . . . . . . . . 65.1 mt -76.29 -32.2 58.66 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 114.97 -1.014 . . . . 72.25 111.722 -171.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . 0.408 ' HZ ' ' HG ' ' D' ' 128' ' ' LEU . 62.8 t80 -63.48 -42.86 76.36 Favored Pre-proline 0 CA--C 1.559 1.301 0 C-N-CA 124.566 1.146 . . . . 75.44 113.872 -169.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_exo -50.08 -42.65 45.37 Favored 'Trans proline' 0 C--N 1.385 2.474 0 C-N-CA 122.386 2.058 . . . . 61.04 113.19 171.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -81.26 -27.67 35.07 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.58 0.752 . . . . 75.21 111.858 -177.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.61 -53.54 49.97 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 109.317 -0.623 . . . . 72.44 109.317 173.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.414 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 39.1 ttp180 -58.74 -42.08 87.98 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 113.837 -1.529 . . . . 61.11 110.99 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -61.74 -49.92 74.5 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.771 0.828 . . . . 72.0 110.708 -178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 46.6 t -60.19 -44.2 95.28 Favored 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.843 0.714 . . . . 52.51 111.176 -178.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.578 HG23 ' SG ' ' D' ' 76' ' ' CYS . 49.8 mt -58.57 -55.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.175 0.99 . . . . 72.42 111.07 174.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . 0.505 HG21 ' HE2' ' B' ' 109' ' ' TYR . 63.2 m -53.24 -47.46 69.01 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 124.239 1.016 . . . . 72.43 111.758 -174.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' D' ' 120' ' ' ARG . 46.7 t -62.14 -37.8 86.54 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 114.655 -1.157 . . . . 63.12 111.204 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.407 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 72.6 mtm -75.17 -32.14 61.19 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 122.871 0.469 . . . . 74.22 111.998 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.516 HG23 ' O ' ' D' ' 114' ' ' ILE . 61.0 t -68.07 -36.93 77.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 CA-C-N 116.066 -0.515 . . . . 54.41 109.733 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 90.2 p -72.54 -28.44 62.84 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.874 0.47 . . . . 65.24 111.085 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' D' ' 116' ' ' SER . 77.4 mtt-85 -73.06 -27.23 61.62 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 123.673 0.789 . . . . 71.24 110.635 174.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -86.95 8.42 76.31 Favored Glycine 0 C--N 1.354 1.554 0 CA-C-N 116.015 -0.538 . . . . 74.43 112.395 172.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 27.7 p 66.54 13.67 9.39 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 127.084 2.154 . . . . 51.32 114.02 175.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . 0.489 ' HB3' ' HD2' ' D' ' 124' ' ' PRO . 76.5 m-85 -90.99 169.19 12.12 Favored Pre-proline 0 CA--C 1.568 1.647 0 C-N-CA 124.536 1.135 . . . . 70.02 107.964 169.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' D' ' 123' ' ' PHE . 93.0 Cg_endo -74.47 166.94 28.29 Favored 'Trans proline' 0 C--N 1.377 2.077 0 C-N-CA 122.532 2.155 . . . . 61.45 112.92 -172.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -60.9 121.69 13.02 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-N 116.114 -0.494 . . . . 70.45 109.757 171.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . 0.418 HD11 HG11 ' D' ' 40' ' ' VAL . 7.5 tt -104.24 93.53 4.88 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 107.16 -1.422 . . . . 65.21 107.16 -173.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 56.5 m-20 -103.25 89.82 3.52 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 114.011 -1.45 . . . . 73.22 108.596 -171.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 23.1 tp -71.96 122.78 21.42 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 115.854 -0.612 . . . . 71.21 110.514 -179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.91 140.31 61.04 Favored Pre-proline 0 CA--C 1.554 1.12 0 C-N-CA 124.492 1.117 . . . . 44.15 112.223 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.67 114.42 3.67 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.661 2.241 . . . . 73.35 110.371 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 41.3 t -108.56 143.56 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.555 0.742 . . . . 34.44 109.682 -172.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 57.9 t-20 -69.67 101.72 1.72 Allowed 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.189 0.996 . . . . 73.34 110.302 -176.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 72.7 m-85 -71.24 -33.31 69.73 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.262 0.625 . . . . 73.22 111.175 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.07 -57.57 12.01 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.467 0.707 . . . . 74.24 111.799 -178.507 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.91 89.86 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 123.911 0.757 . . . . 52.45 111.674 -174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.504 HD13 ' HD2' ' G' ' 287' ' ' PRO . 87.5 mt -64.78 -36.47 84.42 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 115.57 -0.741 . . . . 73.52 111.246 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -71.63 -41.43 68.87 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 115.701 -0.681 . . . . 70.14 110.579 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . 0.412 ' O ' ' HG3' ' D' ' 142' ' ' GLN . 78.3 mtm -69.51 -31.68 70.06 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.015 0.526 . . . . 73.35 110.852 -178.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . 0.562 ' HA ' HE21 ' D' ' 142' ' ' GLN . 32.0 m-80 -75.68 -25.4 56.72 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 119.083 -0.484 . . . . 72.24 111.82 174.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 67.0 t80 -59.9 -43.37 94.87 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-O 120.896 0.379 . . . . 71.23 110.735 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.3 mp -62.57 -31.06 71.81 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.891 0.876 . . . . 75.33 111.32 178.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . 0.727 ' HG2' ' HA ' ' B' ' 151' ' ' GLU . 42.0 mt-30 -83.08 3.26 31.24 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.688 0.795 . . . . 74.4 112.311 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -117.27 53.48 0.92 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.917 0.865 . . . . 74.34 108.779 -175.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -159.54 151.41 20.51 Favored 'General case' 0 C--O 1.242 0.707 0 CA-C-N 113.859 -1.519 . . . . 65.41 109.073 173.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -76.31 150.64 36.89 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.492 -0.558 . . . . 64.21 109.492 173.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -81.88 56.55 4.94 Favored Glycine 0 C--N 1.345 1.064 0 O-C-N 123.35 0.406 . . . . 40.31 112.113 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -73.21 112.97 9.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.542 0.737 . . . . 74.53 109.051 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -66.94 127.49 27.83 Favored Glycine 0 C--N 1.342 0.866 0 O-C-N 123.795 0.684 . . . . 74.13 112.903 -178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . 0.428 HG22 ' HG3' ' D' ' 151' ' ' GLU . 38.8 m -106.82 111.89 24.61 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.253 1.021 . . . . 73.41 108.559 175.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -98.82 94.33 6.54 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 109.325 -0.62 . . . . 74.04 109.325 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . 0.428 ' HG3' HG22 ' D' ' 149' ' ' THR . 46.1 mt-10 -112.1 154.75 24.97 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.929 0.892 . . . . 74.21 109.673 172.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 5.0 p80 -158.55 126.01 5.01 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.236 1.014 . . . . 75.32 109.083 178.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -65.29 -53.26 46.6 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.962 0.905 . . . . 73.34 111.304 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 73.42 177.07 0.25 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 125.229 1.412 . . . . 62.01 111.482 -175.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.327 0 C-N-CA 123.843 0.857 . . . . 70.45 109.036 176.962 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 120.768 0.318 . . . . 73.11 110.898 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -104.16 126.14 51.04 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 108.684 -0.858 . . . . 74.42 108.684 173.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 57.4 tt0 -70.13 98.31 1.31 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 123.128 0.571 . . . . 73.45 109.963 -179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 45.3 tt0 -163.55 166.02 22.95 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.643 1.177 . . . . 72.02 108.164 176.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.77 68.88 0.94 Allowed Pre-proline 0 N--CA 1.488 1.45 0 C-N-CA 124.474 1.11 . . . . 72.22 109.765 -172.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -81.19 110.58 2.29 Favored 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.662 2.241 . . . . 72.05 110.902 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 60.0 tp -54.47 -39.79 67.81 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.962 0.905 . . . . 63.44 110.374 175.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 19.1 tp -85.89 107.23 17.61 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 114.839 -1.073 . . . . 72.45 109.721 173.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -148.92 26.37 1.29 Allowed Glycine 0 C--N 1.347 1.155 0 O-C-N 123.701 0.625 . . . . 65.22 112.356 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -153.14 76.17 1.1 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 108.532 -0.914 . . . . 74.32 108.532 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 5.0 t80 176.42 -176.26 0.12 Allowed 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 125.042 1.337 . . . . 73.45 108.107 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 46' ' ' THR . . . 72.29 105.97 0.07 Allowed 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.665 1.186 . . . . 60.21 110.741 171.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 16.8 t70 72.92 136.49 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.275 0 C-N-CA 125.043 1.337 . . . . 62.15 110.451 -174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . 110.48 80.63 1.15 Allowed Glycine 0 C--N 1.343 0.925 0 N-CA-C 111.149 -0.78 . . . . 71.31 111.149 -177.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -75.97 153.44 36.57 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.337 0.655 . . . . 65.11 110.875 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 62.5 mtt -88.85 141.27 29.67 Favored Pre-proline 0 CA--C 1.547 0.842 0 CA-C-N 115.777 -0.647 . . . . 71.31 109.429 178.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -75.7 70.7 5.69 Favored 'Trans proline' 0 C--N 1.377 2.057 0 C-N-CA 122.85 2.367 . . . . 70.11 110.925 172.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . . . . . . . . . 62.3 t -76.54 134.31 29.15 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 114.787 -1.097 . . . . 73.35 109.859 -176.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 6.4 ptp180 -62.49 142.61 57.84 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 123.835 0.709 . . . . 63.04 109.907 172.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . 0.485 ' HE1' HG13 ' A' ' 40' ' ' VAL . 1.7 t-105 -92.27 109.08 20.45 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 107.831 -1.174 . . . . 72.32 107.831 170.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.516 ' HB3' HG13 ' G' ' 306' ' ' VAL . 4.9 mp -74.12 -16.33 61.01 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 114.818 -1.083 . . . . 54.55 111.769 -172.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . -118.75 82.12 0.33 Allowed Glycine 0 C--N 1.343 0.956 0 CA-C-O 119.183 -0.787 . . . . 62.4 111.925 -178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.57 46.44 2.26 Favored 'Trans proline' 0 C--N 1.381 2.267 0 C-N-CA 123.316 2.677 . . . . 71.42 111.14 178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 15.4 tppt? -111.71 132.99 54.24 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.258 1.423 . . . . 71.2 108.0 -172.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -64.14 123.29 18.69 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 109.026 -0.731 . . . . 64.24 109.026 175.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 20.9 m -55.29 -49.37 72.3 Favored 'General case' 0 CA--C 1.548 0.897 0 O-C-N 124.179 0.924 . . . . 72.13 111.611 -172.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.458 ' HA ' ' HG3' ' A' ' 124' ' ' PRO . 21.6 m-85 -68.19 87.31 0.28 Allowed 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.437 0.636 . . . . 73.21 110.719 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -136.86 -42.61 0.59 Allowed 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 124.642 1.177 . . . . 75.02 108.327 171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . . . . . . . . . . . -72.69 -132.37 0.16 Allowed Glycine 0 C--N 1.35 1.33 0 CA-C-N 115.549 -0.75 . . . . 55.33 113.15 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' D' ' 124' ' ' PRO . 9.9 p30 -72.21 120.89 18.46 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 117.136 0.468 . . . . 63.15 110.472 -174.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . . . . . . . . . 9.4 tp -153.69 -45.01 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 122.604 0.362 . . . . 72.43 110.453 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . 0.434 ' HA ' ' HB3' ' G' ' 298' ' ' HIS . 9.0 t70 63.6 -178.83 0.15 Allowed 'General case' 0 CA--C 1.563 1.481 0 C-N-CA 124.727 1.211 . . . . 62.15 112.07 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . 0.595 ' H ' ' HD2' ' E' ' 304' ' ' PRO . 39.8 ttmt -162.72 -48.66 0.0 OUTLIER Pre-proline 0 CA--C 1.562 1.417 0 C-N-CA 124.57 1.148 . . . . 73.1 111.241 175.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . 0.595 ' HD2' ' H ' ' E' ' 303' ' ' LYS . 4.6 Cg_endo -45.52 -39.3 17.13 Favored 'Trans proline' 0 C--N 1.406 3.563 0 C-N-CA 123.51 2.806 . . . . 63.11 115.064 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . 67.32 162.7 0.18 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 124.719 1.208 . . . . 73.22 111.855 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' B' ' 13' ' ' ILE . 58.5 t -74.34 127.75 36.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 122.879 0.472 . . . . 62.2 110.114 -174.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 24.4 m -74.7 141.35 44.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.761 0.824 . . . . 64.34 111.11 -175.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . 0.572 ' HA ' ' HG3' ' B' ' 12' ' ' GLN . 67.3 m -64.48 152.29 42.08 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 124.311 1.044 . . . . 62.14 111.731 -179.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' E' ' 310' ' ' PRO . 9.0 t -144.62 140.01 16.07 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 123.145 0.578 . . . . 74.44 110.454 -178.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' E' ' 309' ' ' THR . 7.9 Cg_exo . . . . . 0 C--N 1.373 1.834 0 C-N-CA 122.978 2.452 . . . . 61.04 111.155 172.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 110.882 -0.044 . . . . 74.33 110.882 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 65.97 -169.44 0.2 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.678 1.191 . . . . 72.02 110.268 -171.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 61.71 35.05 17.12 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.091 0.956 . . . . 75.12 110.435 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -87.56 59.88 5.7 Favored 'General case' 0 CA--C 1.552 1.05 0 CA-C-O 121.997 0.904 . . . . 74.42 109.733 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -121.25 79.56 35.66 Favored Pre-proline 0 N--CA 1.48 1.028 0 C-N-CA 124.306 1.042 . . . . 73.33 108.682 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -92.38 -84.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.373 1.826 0 C-N-CA 123.021 2.48 . . . . 71.34 110.894 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . 0.547 ' HA ' ' HG3' ' C' ' 90' ' ' GLU . 7.9 tt -88.56 -41.11 12.9 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.616 -1.253 . . . . 72.11 107.616 168.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . 0.409 HD12 ' HE1' ' C' ' 94' ' ' MET . 45.8 tp -67.01 112.02 4.14 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.66 1.184 . . . . 75.11 110.248 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . -97.49 -80.72 1.55 Allowed Glycine 0 C--N 1.349 1.252 0 CA-C-N 116.237 -0.438 . . . . 73.31 113.216 -175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 82.7 mt -73.12 -172.41 1.08 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 123.581 0.752 . . . . 65.35 111.755 -177.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . 0.48 ' CG ' ' HB ' ' C' ' 46' ' ' THR . 4.1 m-85 67.85 93.13 0.08 Allowed 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.477 1.111 . . . . 74.1 111.22 177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -161.4 -34.29 0.05 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.452 0.701 . . . . 72.14 111.432 -176.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -132.71 -171.84 2.76 Favored 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 123.787 0.835 . . . . 74.33 109.957 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . 0.557 ' HA2' ' HA ' ' C' ' 45' ' ' ASP . . . -95.24 124.15 7.88 Favored Glycine 0 C--N 1.344 0.979 0 CA-C-O 119.897 -0.39 . . . . 73.42 112.316 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . 0.472 HD22 ' HA ' ' A' ' 155' ' ' ALA . 10.5 t-20 -163.5 177.85 8.51 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 124.243 1.017 . . . . 60.5 108.263 174.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . 0.452 ' N ' ' HD3' ' F' ' 287' ' ' PRO . 17.8 mmt 62.74 47.29 0.9 Allowed Pre-proline 0 N--CA 1.489 1.516 0 C-N-CA 124.455 1.102 . . . . 75.15 111.094 -170.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' F' ' 286' ' ' MET . 20.3 Cg_exo -65.29 -34.95 42.86 Favored 'Trans proline' 0 C--N 1.394 2.949 0 C-N-CA 122.083 1.855 . . . . 72.32 112.244 -174.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . 0.452 HG21 HG11 ' C' ' 131' ' ' VAL . 60.6 t 70.53 124.59 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 125.131 1.373 . . . . 74.25 110.371 -176.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 64.5 mtp85 -72.34 -81.44 0.05 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.736 0.414 . . . . 73.42 110.62 -174.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . 0.487 ' HH2' HD11 ' C' ' 126' ' ' LEU . 0.5 OUTLIER -175.62 148.81 0.93 Allowed 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.987 1.315 . . . . 73.42 108.157 179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' H' ' 306' ' ' VAL . 0.0 OUTLIER -103.44 -3.82 24.9 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.13 0.972 . . . . 71.23 110.725 179.505 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -163.92 168.32 38.38 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-N 115.439 -0.8 . . . . 72.43 111.303 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -80.05 42.8 1.38 Allowed 'Trans proline' 0 C--N 1.369 1.607 0 C-N-CA 123.855 3.037 . . . . 75.3 112.791 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 90.6 mttt 69.86 115.28 0.04 OUTLIER 'General case' 0 C--N 1.364 1.235 0 C-N-CA 125.385 1.474 . . . . 65.04 112.187 174.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . . . . . . . . . . . -84.84 -10.48 57.11 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.554 0.741 . . . . 25.25 111.133 175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . . . . . . . . . 3.7 m -68.68 121.41 16.4 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.809 0.844 . . . . 55.4 109.654 -179.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 64.28 48.31 2.89 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 124.539 1.136 . . . . 71.2 111.687 -173.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -67.85 -27.43 66.68 Favored 'General case' 0 CA--C 1.558 1.286 0 N-CA-C 107.912 -1.144 . . . . 71.22 107.912 165.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -129.06 149.54 18.55 Favored Glycine 0 C--N 1.346 1.095 0 N-CA-C 110.316 -1.114 . . . . 73.34 110.316 166.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -75.48 151.03 38.08 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.551 0.74 . . . . 74.3 110.236 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.456 ' HB ' ' HG3' ' F' ' 304' ' ' PRO . 36.1 pt -90.57 43.23 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.547 0.689 . . . . 64.51 111.883 -177.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -74.91 86.86 2.28 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 108.468 -0.938 . . . . 72.42 108.468 169.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . 0.56 ' HE2' ' SG ' ' F' ' 308' ' ' CYS . 0.1 OUTLIER 64.88 70.39 0.61 Allowed Pre-proline 0 CA--C 1.557 1.217 0 C-N-CA 125.598 1.559 . . . . 64.41 111.05 -178.526 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . 0.462 ' HD2' ' OG1' ' F' ' 307' ' ' THR . 24.0 Cg_exo -60.36 -40.39 58.72 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 123.256 2.637 . . . . 75.05 112.36 -177.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -169.07 -76.6 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 O-C-N 124.647 1.217 . . . . 40.31 109.372 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' D' ' 15' ' ' ARG . 5.6 t -93.44 97.2 6.83 Favored 'Isoleucine or valine' 0 C--O 1.242 0.692 0 N-CA-C 108.098 -1.075 . . . . 73.31 108.098 179.275 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . 0.462 ' OG1' ' HD2' ' F' ' 304' ' ' PRO . 82.0 m -149.82 -46.74 0.13 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.729 0.411 . . . . 65.35 111.517 -178.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . 0.56 ' SG ' ' HE2' ' F' ' 303' ' ' LYS . 85.2 m -136.11 104.08 5.55 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-O 120.787 0.327 . . . . 75.4 111.443 -172.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 48.7 p -88.37 117.95 68.94 Favored Pre-proline 0 CA--C 1.552 1.028 0 N-CA-C 107.346 -1.353 . . . . 74.03 107.346 162.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo . . . . . 0 C--N 1.377 2.03 0 C-N-CA 123.389 2.726 . . . . 70.42 113.189 -176.535 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.14 0 CA-C-O 121.018 0.437 . . . . 32.32 110.286 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -88.59 109.64 20.25 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 109.131 -0.692 . . . . 64.11 109.131 173.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -111.5 70.49 0.71 Allowed 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 108.719 -0.845 . . . . 71.01 108.719 173.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 26.4 mm-40 -116.16 178.12 4.44 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 114.695 -1.139 . . . . 53.55 110.203 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . 0.548 ' H ' ' HD3' ' G' ' 275' ' ' LYS . 0.3 OUTLIER -121.38 149.04 51.31 Favored Pre-proline 0 C--O 1.247 0.935 0 CA-C-N 115.241 -0.89 . . . . 72.31 109.539 -174.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.37 -178.85 3.18 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 122.635 2.223 . . . . 74.1 111.945 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.552 HD23 ' O ' ' D' ' 89' ' ' ILE . 56.5 mt 62.62 22.49 13.35 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.792 0.837 . . . . 72.13 111.304 -176.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . . . . . . . . . 29.2 tp -161.33 -66.04 0.06 Allowed 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.014 -1.106 . . . . 65.25 108.014 178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . . . . . . . . . . . 72.34 -83.47 0.54 Allowed Glycine 0 C--N 1.348 1.198 0 CA-C-N 115.606 -0.724 . . . . 75.24 112.781 178.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 2.9 pp -158.17 157.1 32.04 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.723 0.809 . . . . 65.01 110.977 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -159.81 86.82 0.79 Allowed 'General case' 0 C--O 1.24 0.598 0 N-CA-C 107.509 -1.293 . . . . 60.23 107.509 174.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . . . . . . . . . . . -148.67 -160.44 1.17 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 114.957 -1.02 . . . . 73.35 109.406 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 22.6 t70 76.75 148.2 0.1 Allowed 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.455 1.502 . . . . 74.01 111.455 175.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . -114.98 12.98 19.89 Favored Glycine 0 C--N 1.35 1.351 0 CA-C-O 118.935 -0.925 . . . . 72.14 114.615 -170.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -79.21 92.64 5.11 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 118.26 1.03 . . . . 75.01 109.303 175.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . 0.419 ' HG2' ' HG ' ' D' ' 44' ' ' LEU . 0.3 OUTLIER -134.98 94.33 16.36 Favored Pre-proline 0 CA--C 1.546 0.81 0 N-CA-C 108.102 -1.074 . . . . 72.0 108.102 176.301 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . 0.504 ' HD2' HD13 ' D' ' 136' ' ' LEU . 32.1 Cg_exo -63.79 15.91 0.07 OUTLIER 'Trans proline' 0 C--N 1.378 2.097 0 C-N-CA 124.113 3.209 . . . . 72.25 116.227 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.09 86.56 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 108.874 -0.787 . . . . 73.43 108.874 172.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 26.2 ttm180 -121.07 29.24 7.44 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.191 0.996 . . . . 75.13 108.631 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.414 ' NE1' HG23 ' D' ' 40' ' ' VAL . 94.7 m95 67.97 113.11 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.087 1.355 . . . . 75.41 110.961 -168.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 6.4 mp -89.41 7.06 37.82 Favored 'General case' 0 CA--C 1.555 1.162 0 CA-C-N 114.858 -1.065 . . . . 61.0 110.661 -179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . -179.26 68.45 0.07 OUTLIER Glycine 0 CA--C 1.534 1.252 0 N-CA-C 111.387 -0.685 . . . . 63.12 111.387 176.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -80.65 -142.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.382 2.323 0 C-N-CA 123.327 2.684 . . . . 71.13 111.719 -178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt 65.22 28.3 12.08 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 124.211 1.005 . . . . 65.02 111.61 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -160.33 112.37 1.98 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.927 -1.033 . . . . 74.55 109.948 -178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -161.73 -68.0 0.06 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.003 1.321 . . . . 73.15 107.667 173.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . 0.471 ' CD2' ' HD3' ' D' ' 124' ' ' PRO . 0.3 OUTLIER -122.35 71.69 1.02 Allowed 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 109.856 -0.424 . . . . 73.33 109.856 -173.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . 0.434 ' HB3' ' HA ' ' E' ' 302' ' ' ASP . 71.6 t60 -88.35 74.26 8.68 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 107.492 -1.299 . . . . 73.4 107.492 164.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . -115.39 -140.26 7.05 Favored Glycine 0 C--N 1.343 0.935 0 CA-C-N 114.997 -1.001 . . . . 72.41 111.145 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . 0.426 ' ND2' ' HB2' ' G' ' 302' ' ' ASP . 56.7 t30 -156.26 -37.71 0.08 Allowed 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.663 0.385 . . . . 71.12 111.046 -176.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.427 HD11 ' CG ' ' D' ' 35' ' ' ASP . 97.0 mt 73.37 -71.64 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 C-N-CA 125.148 1.379 . . . . 71.41 110.188 -166.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . 0.426 ' HB2' ' ND2' ' G' ' 300' ' ' ASN . 35.7 t70 62.99 118.48 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.949 1.3 . . . . 72.3 110.363 -174.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -49.98 122.25 14.02 Favored Pre-proline 0 N--CA 1.483 1.212 0 C-N-CA 123.517 0.727 . . . . 71.24 112.477 -173.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -81.61 170.34 14.44 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 123.02 2.48 . . . . 60.22 110.892 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -163.48 -37.68 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.014 0.525 . . . . 52.34 111.287 178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.632 ' HB ' ' HB2' ' C' ' 12' ' ' GLN . 62.2 t 68.46 147.22 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 C-N-CA 124.092 0.957 . . . . 73.42 110.517 -172.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . . . . . . . . . 44.8 p -64.1 -70.99 0.19 Allowed 'General case' 0 CA--C 1.553 1.066 0 N-CA-C 109.569 -0.53 . . . . 70.42 109.569 177.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 49.3 t 169.33 158.29 0.05 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.352 1.461 . . . . 72.22 109.199 175.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 21.8 p -77.92 141.87 64.1 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 123.417 0.687 . . . . 44.33 109.869 172.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo . . . . . 0 C--N 1.38 2.206 0 C-N-CA 123.651 2.901 . . . . 73.12 113.434 -179.121 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 110.39 -0.226 . . . . 65.25 110.39 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -71.41 -57.45 4.43 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.967 0.507 . . . . 61.24 109.901 176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 60.34 90.76 0.06 Allowed 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 124.216 1.007 . . . . 72.33 111.099 175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 23.2 pt20 -73.27 82.76 1.37 Allowed 'General case' 0 CA--C 1.551 1.019 0 CA-C-O 121.978 0.894 . . . . 73.21 111.736 -175.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -91.79 134.49 28.95 Favored Pre-proline 0 N--CA 1.472 0.645 0 CA-C-N 115.224 -0.898 . . . . 75.53 109.171 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.79 -42.66 24.09 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 123.185 2.59 . . . . 63.01 113.229 -175.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 58.3 mt -118.52 167.14 11.89 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 123.121 0.569 . . . . 63.21 110.54 -177.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 4.0 mm? 68.12 19.58 9.18 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 125.416 1.486 . . . . 64.25 112.458 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -87.49 39.14 3.11 Favored Glycine 0 C--N 1.353 1.472 0 C-N-CA 122.676 0.179 . . . . 42.03 112.789 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' B' ' 95' ' ' ALA . 18.1 tp -165.17 33.67 0.06 Allowed 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.852 1.261 . . . . 61.34 107.833 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . 0.491 ' CD1' HD13 ' B' ' 98' ' ' LEU . 6.6 t80 -147.23 113.99 6.07 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.045 -0.979 . . . . 70.45 109.574 -169.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -166.53 -54.4 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 O-C-N 123.724 0.64 . . . . 32.41 110.541 -178.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -148.77 147.53 28.91 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.077 0.951 . . . . 63.41 109.304 -174.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . . . . . . . . . . . 153.06 61.06 0.01 OUTLIER Glycine 0 C--N 1.346 1.133 0 O-C-N 123.077 0.236 . . . . 61.22 112.628 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -73.06 128.9 36.8 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 109.584 -0.524 . . . . 75.32 109.584 172.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . 0.402 ' N ' ' SD ' ' H' ' 286' ' ' MET . 1.5 mpt? -71.47 135.88 83.89 Favored Pre-proline 0 CA--C 1.549 0.937 0 N-CA-C 108.211 -1.033 . . . . 65.52 108.211 172.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -70.45 80.25 1.09 Allowed 'Trans proline' 0 C--N 1.371 1.742 0 C-N-CA 122.415 2.077 . . . . 71.15 110.857 177.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . . . . . . . . . 45.9 t -78.4 102.91 4.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 CA-C-N 115.448 -0.796 . . . . 74.43 109.427 -175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 73.3 mtt-85 -95.27 24.31 5.12 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 124.414 1.086 . . . . 71.13 109.505 178.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 97.4 m95 69.95 -175.41 0.19 Allowed 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.492 1.517 . . . . 74.54 111.758 -172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . . . . . . . . . 5.5 mp -71.13 -18.79 62.5 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 124.016 0.926 . . . . 74.42 111.563 -175.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 152.69 -66.87 0.33 Allowed Glycine 0 C--N 1.34 0.755 0 N-CA-C 109.555 -1.418 . . . . 64.32 109.555 -176.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -77.16 144.88 23.92 Favored 'Trans proline' 0 C--N 1.371 1.741 0 C-N-CA 122.456 2.104 . . . . 52.54 110.909 167.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 132.73 49.86 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 115.603 -0.726 . . . . 74.01 110.384 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . -107.36 -176.7 3.14 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.595 0.758 . . . . 71.32 111.365 -175.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . 0.58 HG22 ' HD1' ' H' ' 297' ' ' TYR . 3.8 m 74.71 146.26 0.09 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 125.415 1.486 . . . . 62.42 111.135 177.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . 0.58 ' HD1' HG22 ' H' ' 296' ' ' THR . 2.7 m-85 64.16 -82.73 0.03 OUTLIER 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.612 1.165 . . . . 72.32 110.617 -173.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 61.18 99.98 0.03 OUTLIER 'General case' 0 C--N 1.359 0.981 0 C-N-CA 124.913 1.285 . . . . 73.13 110.353 -168.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 125.77 -96.76 0.5 Allowed Glycine 0 C--N 1.339 0.701 0 CA-C-N 114.521 -1.218 . . . . 62.31 110.081 -173.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -171.31 -175.44 1.66 Allowed 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.235 1.014 . . . . 74.3 109.239 -176.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . 0.513 HG21 ' HA ' ' B' ' 32' ' ' PHE . 37.7 mt -78.87 108.34 12.32 Favored 'Isoleucine or valine' 0 C--N 1.346 0.431 0 N-CA-C 108.197 -1.038 . . . . 64.54 108.197 170.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -64.39 128.77 37.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 109.016 -0.735 . . . . 64.35 109.016 176.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . 0.651 ' HE2' ' HA ' ' B' ' 33' ' ' GLN . 98.5 mttt -88.01 157.56 51.15 Favored Pre-proline 0 N--CA 1.482 1.154 0 C-N-CA 123.92 0.888 . . . . 71.11 112.23 -173.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . 0.558 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 52.1 Cg_exo -54.98 123.23 13.28 Favored 'Trans proline' 0 C--N 1.388 2.63 0 C-N-CA 123.46 2.773 . . . . 74.23 113.009 176.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -156.41 79.91 0.96 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.519 0.728 . . . . 72.42 110.325 178.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . 0.506 ' HA ' ' HB2' ' F' ' 291' ' ' LEU . 81.6 t -114.35 98.35 6.83 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 N-CA-C 108.336 -0.987 . . . . 62.33 108.336 173.185 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 8.7 m -93.12 158.51 15.73 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.484 0.713 . . . . 52.32 110.036 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 56.0 m -55.27 104.3 0.12 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 124.384 1.074 . . . . 74.33 110.694 176.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . . . . . . . . . 4.3 t -118.23 103.45 49.52 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.504 0.722 . . . . 61.23 111.038 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo . . . . . 0 CA--C 1.559 1.765 0 C-N-CA 122.861 2.374 . . . . 65.32 109.594 162.931 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.478 0.953 0 N-CA-C 108.955 -0.757 . . . . 63.03 108.955 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.4 p -152.89 121.28 6.31 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.566 0.746 . . . . 73.22 109.252 179.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -86.72 83.68 7.53 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 109.273 -0.64 . . . . 71.15 109.273 178.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 -75.37 83.66 2.49 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.603 0.761 . . . . 63.13 109.012 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -100.55 91.34 4.62 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 114.977 -1.011 . . . . 64.11 110.328 -174.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -130.12 64.18 1.53 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 106.853 -1.536 . . . . 74.23 106.853 168.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.5 p -83.55 105.43 14.47 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 114.02 -1.446 . . . . 71.33 110.191 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -69.81 85.5 0.49 Allowed 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.992 -0.744 . . . . 72.12 108.992 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.593 ' HA ' ' HA3' ' A' ' 88' ' ' GLY . 25.5 ptp -90.82 153.28 20.35 Favored 'General case' 0 C--O 1.24 0.556 0 CA-C-N 115.679 -0.691 . . . . 54.33 110.774 -175.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.3 m -144.29 131.46 20.64 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.045 0.938 . . . . 75.05 108.7 175.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.627 ' HE2' ' HB3' ' A' ' 84' ' ' PHE . 24.8 t80 -126.34 123.47 38.08 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.079 0.952 . . . . 65.43 108.646 178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -143.3 103.5 4.13 Favored 'General case' 0 CA--C 1.534 0.349 0 O-C-N 123.423 0.452 . . . . 73.12 109.878 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.642 HG12 ' HD2' ' A' ' 84' ' ' PHE . 59.4 mt -64.9 121.57 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 N-CA-C 109.041 -0.725 . . . . 72.04 109.041 174.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -87.61 -41.39 13.46 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.677 0.611 . . . . 75.43 109.656 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.47 ' HG2' ' HD1' ' A' ' 17' ' ' TYR . 59.0 ttt180 -168.28 144.01 3.71 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 120.996 -0.281 . . . . 74.42 111.428 -162.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.459 HD13 ' H ' ' A' ' 16' ' ' ILE . 0.2 OUTLIER -129.67 137.29 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 N-CA-C 108.09 -1.078 . . . . 60.31 108.09 172.452 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.47 ' HD1' ' HG2' ' A' ' 15' ' ' ARG . 21.4 p90 -160.96 165.97 29.09 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.453 0.701 . . . . 71.21 110.996 -173.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 69.3 p -100.24 117.57 34.74 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 108.651 -0.87 . . . . 43.45 108.651 171.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 43.2 mtpt -77.83 -26.69 49.64 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.111 -0.495 . . . . 75.32 110.382 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -157.35 142.39 16.93 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 123.912 0.757 . . . . 70.31 109.223 178.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' B' ' 23' ' ' PHE . 95.9 mt -134.75 142.38 40.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.532 0 N-CA-C 106.612 -1.625 . . . . 74.23 106.612 175.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 32.5 t -155.14 114.0 3.57 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.413 0.446 . . . . 34.52 110.045 171.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -109.08 117.89 35.36 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 106.766 -1.568 . . . . 73.34 106.766 171.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.81 137.1 52.44 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.273 -0.64 . . . . 65.03 109.273 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -146.45 72.2 12.95 Favored Pre-proline 0 C--O 1.24 0.599 0 N-CA-C 106.818 -1.549 . . . . 73.22 106.818 168.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -67.16 -30.98 37.27 Favored 'Trans proline' 0 C--N 1.377 2.043 0 C-N-CA 122.772 2.315 . . . . 64.24 111.577 -173.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -109.04 28.31 8.62 Favored 'General case' 0 C--O 1.213 -0.842 0 C-N-CA 124.207 1.003 . . . . 53.35 108.381 -177.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.418 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . . . -50.29 -53.5 43.9 Favored Pre-proline 0 CA--C 1.564 1.508 0 CA-C-O 118.272 -0.871 . . . . 53.1 112.486 -176.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.441 ' HD3' ' HE3' ' B' ' 19' ' ' LYS . 16.0 Cg_exo -66.63 -17.53 52.86 Favored 'Trans proline' 0 C--N 1.396 3.034 0 C-N-CA 121.882 1.721 . . . . 73.44 112.696 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -95.9 -29.16 14.34 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.745 0.818 . . . . 72.32 111.285 -173.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.68 HG21 ' HA ' ' A' ' 73' ' ' ALA . 3.0 p -82.94 -25.39 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 122.791 0.436 . . . . 72.35 111.652 -172.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . 0.444 ' O ' HG12 ' E' ' 301' ' ' ILE . 23.5 m-85 -72.49 -9.6 58.75 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.516 0.726 . . . . 71.15 112.277 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -102.71 -10.78 18.89 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.651 0.78 . . . . 54.31 111.472 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -77.73 165.44 24.2 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.152 0.581 . . . . 62.34 111.965 -175.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.74 145.15 55.01 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.376 1.07 . . . . 72.52 110.922 -176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 14.1 m95 -81.13 90.3 6.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.516 0.726 . . . . 75.35 110.183 -173.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.411 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 56.5 tp60 -141.8 50.04 1.62 Allowed Pre-proline 0 CA--C 1.563 1.455 0 CA-C-N 114.729 -1.123 . . . . 71.11 109.261 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.595 ' HG2' ' HB2' ' E' ' 297' ' ' TYR . 6.9 Cg_exo -74.99 96.43 1.02 Allowed 'Trans proline' 0 C--N 1.394 2.932 0 C-N-CA 122.539 2.159 . . . . 63.32 111.624 -172.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.14 98.0 10.67 Favored 'General case' 0 C--O 1.239 0.526 0 N-CA-C 108.279 -1.008 . . . . 64.34 108.279 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 65' ' ' THR . 2.6 p -93.33 104.94 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.136 0 CA-C-N 114.055 -1.429 . . . . 72.21 110.616 -175.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -83.17 137.98 33.83 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.007 1.323 . . . . 74.24 110.15 177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.566 HD22 ' HB ' ' E' ' 288' ' ' VAL . 4.6 tt -105.72 127.56 53.15 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 108.122 -1.066 . . . . 74.34 108.122 174.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.739 ' HB2' ' HB ' ' A' ' 63' ' ' THR . 12.8 m-20 -120.34 144.21 47.98 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.095 -1.076 . . . . 72.33 108.095 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.566 HD11 HD12 ' A' ' 60' ' ' LEU . 27.1 tp -139.31 124.61 19.1 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 109.73 -0.47 . . . . 62.54 109.73 -178.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.604 ' HB2' ' HB3' ' A' ' 61' ' ' ARG . 5.3 m-20 -119.3 127.09 52.88 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.763 0.825 . . . . 74.12 109.042 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.7 p -106.33 121.42 44.18 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.053 0.941 . . . . 55.13 109.485 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -140.88 147.08 38.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.975 0.91 . . . . 72.31 109.544 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 33.9 p -133.08 168.57 18.26 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.693 0.797 . . . . 55.25 110.271 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 37.8 t -161.71 154.44 20.3 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.385 1.074 . . . . 74.42 109.506 -178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -111.25 121.87 46.38 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 108.152 -1.055 . . . . 54.21 108.152 172.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 57' ' ' GLU . 26.9 mt -97.43 -33.88 11.23 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.338 0.655 . . . . 74.22 110.599 -178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -164.14 -173.13 3.02 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.266 0.626 . . . . 72.23 110.729 -175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -65.04 112.35 3.3 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.229 1.012 . . . . 64.41 110.093 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 85' ' ' SER . 62.0 m-20 70.45 1.69 3.74 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 125.579 1.552 . . . . 75.53 113.323 -175.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.5 t -100.86 115.82 43.2 Favored 'Isoleucine or valine' 0 C--O 1.244 0.765 0 C-N-CA 123.508 0.723 . . . . 64.32 109.382 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 -131.64 124.76 30.57 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 109.175 -0.676 . . . . 74.31 109.175 -177.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.535 ' HB2' HD11 ' A' ' 51' ' ' LEU . 26.4 tt0 -95.59 116.54 28.99 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.261 1.025 . . . . 64.04 109.408 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 23.0 t -102.1 124.11 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 N-CA-C 107.418 -1.327 . . . . 73.04 107.418 173.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.0 t -112.7 129.84 67.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.595 0.758 . . . . 71.45 109.195 179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.566 HD12 HD11 ' A' ' 44' ' ' LEU . 3.9 mm? -120.86 104.27 9.72 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.708 1.203 . . . . 73.22 108.443 179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.604 ' HB3' ' HB2' ' A' ' 45' ' ' ASP . 30.4 ttp180 -84.49 104.55 14.59 Favored 'General case' 0 C--N 1.349 0.567 0 N-CA-C 108.743 -0.836 . . . . 74.2 108.743 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -93.9 120.48 43.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 107.393 -1.336 . . . . 74.0 107.393 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.739 ' HB ' ' HB2' ' A' ' 43' ' ' ASP . 36.9 m -122.07 130.6 53.41 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.225 -0.657 . . . . 71.52 109.225 -175.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.689 ' HB ' ' HB2' ' A' ' 76' ' ' CYS . 55.6 t -123.47 116.46 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 124.932 1.293 . . . . 72.15 108.777 -174.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 40' ' ' VAL . 23.9 m -118.61 130.15 55.71 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 118.249 0.477 . . . . 73.42 110.12 174.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.36 130.28 54.33 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 108.556 -0.905 . . . . 44.2 108.556 175.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.416 ' HA ' ' HA ' ' A' ' 72' ' ' THR . 46.9 m -127.35 126.82 43.21 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.125 0.57 . . . . 61.35 109.704 176.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.685 HD13 ' HB2' ' A' ' 73' ' ' ALA . 11.0 mp -88.65 85.89 6.89 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 107.97 -1.122 . . . . 72.22 107.97 174.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.94 -88.29 1.17 Allowed Glycine 0 C--N 1.346 1.091 0 CA-C-N 114.924 -1.034 . . . . 50.14 111.488 -175.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -115.21 -27.78 7.16 Favored 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 123.472 0.709 . . . . 71.14 111.357 -174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.8 tt0 -102.75 132.93 48.57 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.188 0.595 . . . . 64.03 110.629 -173.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 67' ' ' SER . 47.2 m -69.03 130.61 43.24 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.077 0.951 . . . . 74.32 111.315 178.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.685 ' HB2' HD13 ' A' ' 68' ' ' LEU . . . -74.63 -61.51 1.85 Allowed 'General case' 0 C--O 1.241 0.61 0 C-N-CA 123.998 0.919 . . . . 74.51 109.504 171.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.459 ' HD1' ' HG ' ' A' ' 76' ' ' CYS . 40.3 p90 -152.9 163.26 40.12 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 114.564 -1.198 . . . . 73.25 111.38 -178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 16.5 tp -130.67 137.5 49.6 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 114.149 -1.387 . . . . 75.11 107.274 174.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.689 ' HB2' ' HB ' ' A' ' 64' ' ' VAL . 74.2 m -137.03 98.99 3.88 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 123.557 0.743 . . . . 75.43 109.306 -176.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -119.13 117.83 29.75 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.23 -1.026 . . . . 72.34 108.23 -175.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -131.54 109.22 15.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 C-N-CA 123.985 0.914 . . . . 72.41 109.148 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 mp0 -84.59 81.24 8.94 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 107.593 -1.262 . . . . 70.33 107.593 174.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.0 tp-100 -76.63 93.56 3.64 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 108.718 -0.845 . . . . 74.14 108.718 -177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -86.16 147.26 21.56 Favored Glycine 0 C--N 1.345 1.052 0 N-CA-C 111.073 -0.811 . . . . 71.32 111.073 177.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.635 ' HA3' HD21 ' A' ' 106' ' ' LEU . . . -151.68 122.97 1.41 Allowed Glycine 0 CA--C 1.502 -0.744 0 N-CA-C 111.783 -0.527 . . . . 43.53 111.783 -176.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ILE . . . . . . . . . . . . . 59.8 mt -82.79 125.62 39.99 Favored 'Isoleucine or valine' 0 C--O 1.245 0.834 0 N-CA-C 109.233 -0.654 . . . . 71.42 109.233 175.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.642 ' HD2' HG12 ' A' ' 13' ' ' ILE . 20.0 m-85 -132.17 148.76 52.48 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.767 -1.197 . . . . 71.21 107.767 175.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.442 ' HA ' ' O ' ' A' ' 54' ' ' ASP . 41.9 t -102.51 110.84 22.9 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.425 -0.954 . . . . 63.25 108.425 176.307 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.55 HG21 ' HG2' ' A' ' 94' ' ' MET . 4.2 mp -112.95 125.27 70.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 109.162 -0.681 . . . . 65.24 109.162 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.61 158.97 44.77 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 123.559 0.744 . . . . 52.41 109.644 175.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.593 ' HA3' ' HA ' ' A' ' 9' ' ' MET . . . 101.26 -32.55 7.34 Favored Glycine 0 C--N 1.343 0.962 0 O-C-N 123.72 0.637 . . . . 73.34 113.667 175.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.522 HD13 ' H ' ' A' ' 89' ' ' ILE . 0.2 OUTLIER -125.82 147.75 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 123.435 0.694 . . . . 73.25 110.287 -175.135 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' E' ' 275' ' ' LYS . 32.4 mt-10 -138.82 -179.08 5.62 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.706 0.802 . . . . 74.34 109.38 176.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 66.61 -132.88 32.35 Favored Glycine 0 C--N 1.353 1.479 0 CA-C-O 119.623 -0.543 . . . . 62.24 112.897 179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.522 ' HA ' ' HB3' ' A' ' 95' ' ' ALA . 18.6 p -74.96 -17.54 60.53 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.64 0.776 . . . . 55.55 111.977 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 -72.01 -42.67 66.13 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.999 0.52 . . . . 71.51 109.668 176.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' MET . . . . . 0.55 ' HG2' HG21 ' A' ' 86' ' ' ILE . 1.1 tmt? -81.7 -24.84 35.94 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.637 0.775 . . . . 73.24 110.043 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.529 ' HB1' HD13 ' E' ' 280' ' ' LEU . . . -68.65 -37.18 79.46 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 123.368 0.667 . . . . 64.23 110.135 172.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -62.71 -34.47 77.22 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.357 0.663 . . . . 74.13 110.11 172.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 101' ' ' TYR . 48.5 t -67.89 -42.42 81.24 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.016 -0.538 . . . . 64.24 110.999 178.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 28.0 mt -86.15 -29.19 23.46 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 112.912 0.708 . . . . 72.41 112.912 -175.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -107.78 3.89 34.2 Favored Glycine 0 N--CA 1.477 1.405 0 N-CA-C 114.597 0.599 . . . . 50.14 114.597 -170.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 134' ' ' ASP . . . -148.72 -51.22 0.16 Allowed 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 117.42 0.61 . . . . 71.02 111.745 -174.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.403 ' HB3' ' HA ' ' A' ' 97' ' ' CYS . 60.0 t80 -79.46 -66.84 0.82 Allowed 'General case' 0 CA--C 1.557 1.247 0 C-N-CA 124.445 1.098 . . . . 74.2 112.23 -169.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' CYS . . . . . 0.471 ' N ' ' HD2' ' A' ' 103' ' ' PRO . 67.2 m -70.72 -32.17 2.42 Favored Pre-proline 0 CA--C 1.566 1.584 0 N-CA-C 114.78 1.4 . . . . 70.44 114.78 -176.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 102' ' ' CYS . 36.3 Cg_endo -63.99 -20.66 68.13 Favored 'Trans proline' 0 C--N 1.384 2.436 0 CA-C-N 122.055 1.77 . . . . 65.43 112.775 171.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 30.0 t-20 -76.14 -17.75 59.43 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 123.227 0.611 . . . . 74.04 109.981 175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.532 HG21 HD13 ' A' ' 13' ' ' ILE . 42.2 mm -75.41 -39.5 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 108.961 -0.755 . . . . 72.52 108.961 170.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.635 HD21 ' HA3' ' A' ' 82' ' ' GLY . 94.5 mt -78.47 -33.02 48.6 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.953 0.901 . . . . 74.32 112.959 -175.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -62.16 -43.75 86.88 Favored Pre-proline 0 CA--C 1.572 1.789 0 N-CA-C 113.758 1.022 . . . . 75.24 113.758 -171.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -70.53 -28.08 22.01 Favored 'Trans proline' 0 C--N 1.388 2.614 0 C-N-CA 122.113 1.875 . . . . 75.02 113.157 177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -76.02 -34.56 59.68 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.084 0.553 . . . . 75.51 111.156 175.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.69 -44.27 78.16 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 109.111 -0.699 . . . . 42.41 109.111 173.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.436 ' NH1' HG23 ' C' ' 105' ' ' ILE . 35.7 ttm180 -55.18 -49.86 70.83 Favored 'General case' 0 N--CA 1.477 0.892 0 O-C-N 124.594 1.184 . . . . 75.1 109.845 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -61.16 -46.86 88.79 Favored 'General case' 0 N--CA 1.473 0.716 0 O-C-N 124.266 0.979 . . . . 71.34 110.738 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 28.3 t -59.51 -44.25 93.17 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 123.386 0.674 . . . . 44.32 110.558 -178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.451 ' O ' HG23 ' A' ' 118' ' ' VAL . 96.4 mt -64.41 -54.13 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.818 0.847 . . . . 65.44 109.965 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 125' ' ' GLN . 58.2 m -55.22 -39.77 70.05 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.126 0.97 . . . . 75.15 111.212 -176.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 26.4 t -64.22 -51.35 64.12 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 114.824 -1.08 . . . . 60.14 109.793 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 21' ' ' ILE . 16.0 mtp -56.83 -44.49 82.12 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 124.376 1.07 . . . . 73.1 111.646 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 114' ' ' ILE . 75.9 t -62.5 -45.82 97.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.324 1.05 . . . . 74.24 110.436 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 33.4 t -68.77 -31.68 70.88 Favored 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.402 -0.817 . . . . 62.4 110.881 -178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 89.8 mtt-85 -70.63 -31.98 69.13 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.807 0.843 . . . . 74.51 110.11 176.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -80.68 2.68 78.11 Favored Glycine 0 C--N 1.355 1.629 0 O-C-N 123.858 0.724 . . . . 60.33 113.181 175.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.2 m 65.69 32.86 8.75 Favored 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 124.824 1.25 . . . . 73.54 111.159 174.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -101.09 140.63 21.45 Favored Pre-proline 0 C--O 1.244 0.793 0 N-CA-C 106.723 -1.584 . . . . 64.13 106.723 168.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.551 ' HG3' ' H ' ' E' ' 299' ' ' GLY . 25.0 Cg_endo -56.94 149.79 59.44 Favored 'Trans proline' 0 C--N 1.386 2.513 0 C-N-CA 122.562 2.174 . . . . 41.22 111.672 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 115' ' ' THR . 35.5 tt0 -51.53 136.47 26.18 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 124.349 1.03 . . . . 73.11 113.202 -168.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.517 HD21 HG11 ' A' ' 64' ' ' VAL . 10.3 tp -125.69 120.65 31.27 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 114.306 -1.315 . . . . 73.1 108.064 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -123.01 120.18 32.58 Favored 'General case' 0 N--CA 1.473 0.71 0 N-CA-C 108.44 -0.948 . . . . 71.23 108.44 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -73.06 118.32 15.86 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 108.935 -0.765 . . . . 74.03 108.935 177.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.66 139.67 59.76 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 124.209 1.004 . . . . 74.14 111.98 -174.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.417 ' HB2' ' OH ' ' C' ' 101' ' ' TYR . 4.6 Cg_exo -72.25 110.17 2.89 Favored 'Trans proline' 0 C--N 1.379 2.168 0 C-N-CA 121.835 1.69 . . . . 61.25 110.208 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 97.8 t -99.84 123.75 52.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 108.068 -1.086 . . . . 72.41 108.068 -177.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.644 ' HB3' ' HB3' ' A' ' 135' ' ' ALA . 7.1 m-20 -65.54 97.3 0.3 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.409 1.084 . . . . 63.33 110.835 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -88.2 -50.27 6.47 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 123.256 0.623 . . . . 74.31 109.556 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . 0.658 ' HA ' ' HB1' ' A' ' 100' ' ' ALA . 11.0 p-10 -61.59 -45.22 95.03 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.704 1.201 . . . . 74.53 111.312 -177.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.644 ' HB3' ' HB3' ' A' ' 132' ' ' ASN . . . -66.07 -52.73 46.15 Favored 'General case' 0 C--N 1.351 0.653 0 O-C-N 124.07 0.856 . . . . 52.24 110.545 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 tt -53.71 -50.61 65.53 Favored 'General case' 0 N--CA 1.48 1.028 0 O-C-N 124.687 1.242 . . . . 62.33 110.449 -174.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PHE . . . . . . . . . . . . . 26.7 t80 -58.14 -37.16 74.09 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 124.073 0.858 . . . . 72.42 110.848 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . 0.485 ' HB3' ' HB3' ' A' ' 144' ' ' GLN . 17.2 mmt -73.86 -50.58 19.64 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.108 0.563 . . . . 71.35 111.909 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 143' ' ' GLN . 12.1 p30 -69.94 -24.19 63.31 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 111.54 0.2 . . . . 65.11 111.54 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -79.61 -44.33 21.21 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.559 0.744 . . . . 62.13 110.913 176.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.13 -49.74 66.42 Favored 'General case' 0 N--CA 1.482 1.172 0 O-C-N 123.523 0.515 . . . . 62.32 111.259 -172.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLN . . . . . . . . . . . . . 43.7 tp60 -162.69 27.14 0.1 Allowed 'General case' 0 N--CA 1.478 0.943 0 O-C-N 123.384 0.428 . . . . 65.11 111.156 -174.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.495 ' HA ' ' HA ' ' A' ' 139' ' ' ASN . 41.1 mt-30 56.95 34.58 25.12 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.595 0.758 . . . . 60.3 110.862 176.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLN . . . . . 0.485 ' HB3' ' HB3' ' A' ' 138' ' ' MET . 6.0 tp-100 -60.87 116.15 4.24 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 124.006 0.922 . . . . 71.24 111.664 -172.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.36 137.76 24.58 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 124.407 1.083 . . . . 73.01 109.243 -178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 75.42 -97.32 1.06 Allowed Glycine 0 C--N 1.341 0.86 0 N-CA-C 111.522 -0.631 . . . . 62.24 111.522 -178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 66.21 137.16 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 125.291 1.436 . . . . 64.11 111.964 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 136.27 -170.64 23.19 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 116.394 -0.366 . . . . 71.31 112.203 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 12.3 t -164.64 162.59 21.56 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.036 0.934 . . . . 70.13 109.703 -179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -129.26 153.83 47.41 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 123.478 0.711 . . . . 74.1 109.967 175.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -178.06 97.85 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 124.44 1.096 . . . . 73.11 108.518 175.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -147.33 103.53 3.57 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 122.883 0.473 . . . . 63.34 110.17 -174.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -93.75 150.33 20.49 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.155 0.982 . . . . 73.21 109.428 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -74.97 -63.31 1.29 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.692 0.797 . . . . 53.3 109.72 176.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.213 0 C-N-CA 124.272 1.029 . . . . 73.23 108.477 -179.916 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.443 ' SD ' ' N ' ' B' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.534 0.207 . . . . 75.13 111.521 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 40.8 m -74.25 77.31 1.82 Allowed 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 121.595 0.712 . . . . 75.4 109.822 174.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' GLU . . . . . 0.499 ' HG3' ' HG2' ' B' ' 4' ' ' GLN . 8.5 pt-20 -158.14 -28.69 0.08 Allowed 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.98 0.912 . . . . 62.22 110.544 -172.88 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLN . . . . . 0.499 ' HG2' ' HG3' ' B' ' 3' ' ' GLU . 9.2 pt20 -134.19 88.92 2.5 Favored 'General case' 0 C--N 1.352 0.702 0 C-N-CA 123.513 0.725 . . . . 71.24 110.32 -177.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -168.81 175.26 6.06 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.197 0.999 . . . . 74.25 108.627 175.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -66.26 95.52 0.3 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.845 0.858 . . . . 71.04 109.748 174.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' THR . . . . . . . . . . . . . 22.7 p -66.89 141.42 57.66 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.796 0.839 . . . . 62.11 111.269 -177.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 76.23 -44.57 0.49 Allowed 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 126.173 1.789 . . . . 64.04 113.512 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' MET . . . . . 0.679 ' SD ' HG23 ' B' ' 89' ' ' ILE . 1.9 ptt? 51.68 -159.12 0.11 Allowed 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 125.613 1.565 . . . . 70.14 112.341 179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' THR . . . . . 0.658 ' HB ' ' HB3' ' B' ' 87' ' ' ALA . 39.2 m -146.04 124.71 12.54 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.303 0.641 . . . . 73.45 109.694 177.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -134.7 139.89 45.56 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 107.724 -1.213 . . . . 74.45 107.724 168.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' GLN . . . . . 0.448 ' HG3' ' HB2' ' B' ' 85' ' ' SER . 2.7 pp0? -163.39 139.61 6.93 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.057 -0.72 . . . . 71.4 109.057 168.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ILE . . . . . 0.624 HD11 HG13 ' B' ' 16' ' ' ILE . 0.0 OUTLIER -91.79 134.86 28.77 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 N-CA-C 108.378 -0.971 . . . . 64.15 108.378 177.128 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -97.97 -52.67 3.63 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.164 0.586 . . . . 65.14 110.566 176.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . . . . . . . . . 20.2 ttt180 -151.3 134.52 16.02 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 116.609 -0.269 . . . . 75.13 110.45 -173.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' ILE . . . . . 0.624 HG13 HD11 ' B' ' 13' ' ' ILE . 98.5 mt -114.4 136.12 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 107.072 -1.455 . . . . 71.02 107.072 167.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' TYR . . . . . 0.472 ' HE1' HG13 ' B' ' 83' ' ' ILE . 12.2 p90 -166.21 144.98 5.77 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 122.943 0.497 . . . . 73.4 110.882 -172.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . . . . . . . . . 99.5 m -76.67 120.52 21.97 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 115.484 -0.78 . . . . 72.33 109.295 174.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' LYS . . . . . 0.441 ' HE3' ' HD3' ' A' ' 29' ' ' PRO . 44.5 mtpt -92.1 -30.82 15.79 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.451 0.7 . . . . 63.14 111.34 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -156.6 142.18 17.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 120.59 0.233 . . . . 75.02 110.636 -173.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' ILE . . . . . . . . . . . . . 43.8 mm -141.1 139.35 33.5 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.633 1.573 . . . . 65.12 108.02 178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 23.4 t -143.0 130.61 21.3 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.486 -1.302 . . . . 71.24 107.486 172.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' PHE . . . . . 0.518 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 79.2 t80 -137.45 119.23 15.13 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 106.708 -1.589 . . . . 72.2 106.708 170.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 75' ' ' LEU . 41.4 mt-10 -117.38 122.49 43.98 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 108.402 -0.962 . . . . 75.14 108.402 175.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ALA . . . . . 0.465 ' CB ' ' HB2' ' B' ' 28' ' ' ALA . . . -119.49 79.84 21.74 Favored Pre-proline 0 C--O 1.243 0.745 0 N-CA-C 107.302 -1.369 . . . . 73.14 107.302 165.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.26 -18.25 34.76 Favored 'Trans proline' 0 C--N 1.379 2.172 0 C-N-CA 122.207 1.938 . . . . 61.42 110.419 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -111.59 15.67 21.0 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 124.984 1.314 . . . . 73.31 110.821 -179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' ALA . . . . . 0.465 ' HB2' ' CB ' ' B' ' 25' ' ' ALA . . . -42.1 -54.5 7.35 Favored Pre-proline 0 N--CA 1.504 2.267 0 N-CA-C 114.396 1.258 . . . . 64.52 114.396 -174.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PRO . . . . . 0.465 ' HG2' ' ND1' ' B' ' 30' ' ' HIS . 95.0 Cg_endo -78.76 -31.75 2.32 Favored 'Trans proline' 0 C--N 1.385 2.449 0 C-N-CA 121.765 1.643 . . . . 74.32 113.274 174.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' HIS . . . . . 0.465 ' ND1' ' HG2' ' B' ' 29' ' ' PRO . 77.0 m80 -92.35 4.11 54.05 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 124.096 0.959 . . . . 74.13 113.303 -169.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' VAL . . . . . 0.407 ' O ' ' HB2' ' B' ' 35' ' ' ASP . 7.7 p -79.06 -6.96 10.03 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.156 0 C-N-CA 123.516 0.726 . . . . 72.44 110.061 174.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -67.14 -33.04 74.57 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 122.797 0.439 . . . . 71.43 111.141 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' B' ' 30' ' ' HIS . 29.8 pt20 -76.03 -41.85 49.66 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.358 0.663 . . . . 72.22 109.931 175.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' LYS . . . . . 0.618 ' HB3' HD13 ' B' ' 68' ' ' LEU . 30.3 mmtp -108.42 64.34 0.62 Allowed 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.584 1.154 . . . . 75.32 109.168 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 31' ' ' VAL . 13.6 t70 -118.82 118.55 31.88 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 109.565 -0.531 . . . . 73.34 109.565 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -179.81 179.43 0.57 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.029 1.732 . . . . 73.34 107.883 155.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -47.35 106.43 0.59 Allowed Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 124.011 0.925 . . . . 74.2 110.92 -174.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -87.23 169.1 7.42 Favored 'Trans proline' 0 C--N 1.374 1.875 0 C-N-CA 122.723 2.282 . . . . 73.5 110.667 -177.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -73.26 100.69 3.19 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 106.907 -1.516 . . . . 72.32 106.907 170.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 4.4 m -96.25 126.66 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 114.68 -1.145 . . . . 72.23 109.401 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -128.05 135.09 49.38 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.738 0.815 . . . . 74.23 109.477 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' LEU . . . . . 0.542 ' HB2' ' O ' ' H' ' 288' ' ' VAL . 22.5 mt -97.41 151.79 19.6 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.337 -0.986 . . . . 73.11 108.337 172.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -148.2 109.9 4.46 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.419 -1.326 . . . . 75.01 107.419 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . . . . . . . . . 11.0 mp -103.72 129.63 51.11 Favored 'General case' 0 C--O 1.24 0.581 0 C-N-CA 123.136 0.574 . . . . 72.0 109.478 -174.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ASP . . . . . 0.723 ' HA ' ' HA3' ' H' ' 284' ' ' GLY . 9.2 t70 -122.62 149.92 43.35 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.335 1.054 . . . . 74.02 110.192 -173.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 68.3 p -118.07 128.57 54.89 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 114.631 -1.168 . . . . 74.22 109.438 -170.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' ALA . . . . . . . . . . . . . . . -145.13 126.74 15.14 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.038 0.535 . . . . 72.04 110.175 179.189 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' SER . . . . . . . . . . . . . 56.5 p -136.49 160.78 37.75 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 120.83 0.348 . . . . 72.43 110.795 177.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' SER . . . . . . . . . . . . . 78.8 p -157.64 137.66 12.48 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.723 -0.671 . . . . 63.54 110.045 -178.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -81.93 114.69 20.7 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.197 0.599 . . . . 74.42 110.263 178.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . 0.438 HD11 ' HB2' ' B' ' 57' ' ' GLU . 23.5 mt -88.41 -34.55 17.5 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 123.603 0.761 . . . . 63.01 110.461 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' ALA . . . . . . . . . . . . . . . -163.83 -167.93 1.5 Allowed 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.654 0.782 . . . . 73.4 110.573 -175.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -63.86 106.24 0.98 Allowed 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 114.576 -1.193 . . . . 61.04 110.166 -179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 66.29 9.16 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.954 1.301 . . . . 72.3 113.044 -178.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' VAL . . . . . . . . . . . . . 93.0 t -103.89 108.46 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 N-CA-C 108.262 -1.014 . . . . 71.32 108.262 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -120.14 140.13 51.55 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.168 0.987 . . . . 71.44 109.239 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' GLU . . . . . 0.438 ' HB2' HD11 ' B' ' 51' ' ' LEU . 5.8 tm-20 -103.6 99.96 9.78 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 108.234 -1.024 . . . . 74.12 108.234 -174.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' VAL . . . . . 0.424 HG13 ' CZ ' ' H' ' 281' ' ' PHE . 77.0 t -88.68 125.93 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.354 1.462 . . . . 62.3 109.925 -175.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.406 ' HA ' ' HA2' ' B' ' 81' ' ' GLY . 25.3 t -118.7 131.26 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 123.874 0.869 . . . . 74.14 109.543 179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -110.33 108.12 18.09 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 107.762 -1.199 . . . . 71.02 107.762 173.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' ARG . . . . . 0.526 ' HB3' ' HB3' ' B' ' 45' ' ' ASP . 12.5 ttm180 -88.21 113.79 24.19 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.622 -0.881 . . . . 64.54 108.622 171.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' VAL . . . . . . . . . . . . . 62.8 t -105.7 104.17 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 107.891 -1.151 . . . . 71.23 107.891 169.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' THR . . . . . . . . . . . . . 9.0 m -98.7 132.99 43.65 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.589 -0.522 . . . . 44.04 109.589 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' VAL . . . . . 0.403 HG21 HG21 ' B' ' 114' ' ' ILE . 95.8 t -122.09 120.22 60.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 124.347 1.059 . . . . 72.43 108.933 178.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' THR . . . . . . . . . . . . . 95.2 m -115.11 143.03 45.84 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.354 0.661 . . . . 70.42 109.305 173.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.3 136.58 38.14 Favored 'General case' 0 C--O 1.245 0.845 0 N-CA-C 108.75 -0.833 . . . . 74.34 108.75 175.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' SER . . . . . . . . . . . . . 52.1 p -147.1 139.01 24.36 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 122.879 0.472 . . . . 75.41 110.672 178.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' LEU . . . . . 0.618 HD13 ' HB3' ' B' ' 34' ' ' LYS . 0.4 OUTLIER -136.45 139.67 42.55 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.905 1.282 . . . . 73.51 108.615 178.546 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . 69.09 -115.95 6.84 Favored Glycine 0 CA--C 1.527 0.801 0 N-CA-C 111.016 -0.834 . . . . 72.44 111.016 -169.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -122.94 3.01 9.41 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.061 0.944 . . . . 72.13 108.853 173.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -115.1 168.96 9.47 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.338 0.59 . . . . 74.32 111.342 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' THR . . . . . . . . . . . . . 14.8 m -71.04 143.77 50.61 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 114.651 -1.158 . . . . 63.22 111.028 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ALA . . . . . 0.569 ' HB2' ' HG ' ' B' ' 68' ' ' LEU . . . -95.32 -60.02 1.76 Allowed 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 108.27 -1.011 . . . . 64.05 108.27 169.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -164.68 155.52 14.76 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-N 114.339 -1.3 . . . . 74.14 108.401 173.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.545 ' HB2' ' HB2' ' B' ' 24' ' ' GLU . 62.9 mt -128.23 136.52 51.18 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 107.663 -1.236 . . . . 74.14 107.663 178.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' CYS . . . . . . . . . . . . . 47.7 t -148.69 152.71 37.12 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 123.235 0.614 . . . . 71.12 109.357 175.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -160.39 129.19 4.84 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 107.952 -1.129 . . . . 63.33 107.952 179.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.406 HG21 ' HB3' ' B' ' 113' ' ' CYS . 92.9 t -124.04 142.37 41.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 N-CA-C 108.676 -0.861 . . . . 52.42 108.676 176.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 79' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -125.32 93.23 3.81 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.138 -1.06 . . . . 71.23 108.138 172.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 80' ' ' GLN . . . . . 0.403 ' HG2' ' HB2' ' B' ' 109' ' ' TYR . 8.7 tp-100 -83.52 102.8 12.37 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.23 -1.026 . . . . 41.2 108.23 176.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 81' ' ' GLY . . . . . 0.406 ' HA2' ' HA ' ' B' ' 59' ' ' VAL . . . -88.29 166.85 35.25 Favored Glycine 0 C--O 1.244 0.724 0 N-CA-C 111.02 -0.832 . . . . 23.35 111.02 176.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -164.33 126.91 1.57 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 111.15 -0.78 . . . . 71.23 111.15 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.472 HG13 ' HE1' ' B' ' 17' ' ' TYR . 69.1 mt -83.68 118.51 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 N-CA-C 107.67 -1.233 . . . . 64.35 107.67 172.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -124.34 166.84 15.23 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.358 1.063 . . . . 72.42 108.68 178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 85' ' ' SER . . . . . 0.448 ' HB2' ' HG3' ' B' ' 12' ' ' GLN . 40.9 m -130.53 112.69 13.42 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 108.466 -0.939 . . . . 64.14 108.466 172.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 86' ' ' ILE . . . . . 0.712 ' HB ' HD11 ' B' ' 89' ' ' ILE . 2.6 pp -117.36 133.77 63.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 123.985 0.914 . . . . 51.44 109.743 -177.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 87' ' ' ALA . . . . . 0.658 ' HB3' ' HB ' ' B' ' 10' ' ' THR . . . -155.37 158.35 38.54 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.107 0.963 . . . . 52.5 109.399 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 88' ' ' GLY . . . . . . . . . . . . . . . 86.82 -41.71 3.11 Favored Glycine 0 C--N 1.344 0.999 0 CA-C-N 116.302 -0.408 . . . . 73.44 112.526 -177.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 89' ' ' ILE . . . . . 0.712 HD11 ' HB ' ' B' ' 86' ' ' ILE . 20.5 pt -68.5 150.12 10.94 Favored 'Isoleucine or valine' 0 C--O 1.242 0.702 0 C-N-CA 123.041 0.536 . . . . 63.42 110.297 169.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 90' ' ' GLU . . . . . 0.45 ' H ' ' HB2' ' B' ' 93' ' ' GLN . 39.8 tt0 -164.31 146.32 8.74 Favored 'General case' 0 CA--C 1.546 0.819 0 CA-C-N 115.537 -0.756 . . . . 61.03 109.818 -174.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . 73.76 -103.75 1.5 Allowed Glycine 0 C--N 1.349 1.298 0 O-C-N 123.332 0.395 . . . . 45.21 113.109 175.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 92' ' ' THR . . . . . . . . . . . . . 82.4 m -88.3 -29.28 20.48 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.486 0.714 . . . . 50.43 110.947 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 93' ' ' GLN . . . . . 0.45 ' HB2' ' H ' ' B' ' 90' ' ' GLU . 47.9 mt-30 -58.66 -45.21 89.85 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.787 0.835 . . . . 73.13 110.986 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 94' ' ' MET . . . . . 0.637 ' HA ' HD12 ' B' ' 89' ' ' ILE . 26.8 ptt? -65.1 -39.56 93.33 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.214 -0.903 . . . . 63.24 110.864 178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.33 82.9 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.738 0.815 . . . . 75.33 110.884 -178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 96' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -76.57 -33.56 58.48 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 123.591 0.757 . . . . 64.43 110.837 176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 97' ' ' CYS . . . . . . . . . . . . . 54.1 t -62.46 -63.11 1.33 Allowed 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 122.89 0.476 . . . . 75.02 110.531 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.86 -3.43 54.08 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 112.102 0.408 . . . . 71.25 112.102 177.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.21 -1.78 56.9 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-O 119.648 -0.529 . . . . 63.04 113.49 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -149.38 -55.26 0.18 Allowed 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 117.477 0.639 . . . . 44.52 111.585 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -72.02 -55.54 7.22 Favored 'General case' 0 CA--C 1.555 1.149 0 C-N-CA 123.377 0.671 . . . . 71.51 111.547 -170.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' CYS . . . . . . . . . . . . . 58.9 m -65.43 -37.65 21.09 Favored Pre-proline 0 CA--C 1.566 1.574 0 C-N-CA 123.875 0.87 . . . . 72.21 112.583 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_exo -49.6 -48.79 17.72 Favored 'Trans proline' 0 C--N 1.397 3.117 0 C-N-CA 122.885 2.39 . . . . 72.53 113.052 164.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -64.89 -15.89 62.54 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 112.52 0.563 . . . . 74.24 112.52 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' ILE . . . . . . . . . . . . . 67.3 mt -80.02 -49.86 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 122.92 0.488 . . . . 73.2 110.264 171.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.15 -19.52 39.8 Favored 'General case' 0 CA--C 1.557 1.224 0 C-N-CA 123.396 0.678 . . . . 53.1 112.784 -171.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' PHE . . . . . 0.41 ' N ' ' HD2' ' B' ' 108' ' ' PRO . 84.3 t80 -66.49 -45.53 58.34 Favored Pre-proline 0 N--CA 1.487 1.412 0 C-N-CA 124.54 1.136 . . . . 72.33 113.423 -172.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' PRO . . . . . 0.41 ' HD2' ' N ' ' B' ' 107' ' ' PHE . 18.6 Cg_endo -57.58 -35.7 98.77 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 122.105 1.87 . . . . 64.32 113.256 176.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' TYR . . . . . 0.403 ' HB2' ' HG2' ' B' ' 80' ' ' GLN . 82.9 m-85 -68.05 -45.13 74.77 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.292 0.637 . . . . 73.05 110.418 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.09 -36.57 84.47 Favored 'General case' 0 N--CA 1.481 1.12 0 CA-C-N 115.925 -0.58 . . . . 71.43 110.813 177.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 48.6 ttt180 -59.84 -57.55 12.4 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.482 1.113 . . . . 64.35 110.254 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.67 -31.69 71.83 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 123.697 0.799 . . . . 62.31 110.831 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.47 ' O ' ' HG2' ' B' ' 117' ' ' MET . 6.2 t -72.04 -43.56 64.77 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 122.931 0.492 . . . . 75.1 111.269 -178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . 0.403 HG21 HG21 ' B' ' 64' ' ' VAL . 87.4 mt -62.99 -44.74 99.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 C-N-CA 123.347 0.659 . . . . 50.01 109.671 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' THR . . . . . . . . . . . . . 41.5 m -61.56 -30.83 70.91 Favored 'General case' 0 CA--C 1.554 1.11 0 CA-C-N 114.995 -1.002 . . . . 75.52 111.344 179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' SER . . . . . . . . . . . . . 32.3 t -73.58 -52.95 11.7 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.317 0.647 . . . . 73.32 110.07 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 117' ' ' MET . . . . . 0.47 ' HG2' ' O ' ' B' ' 113' ' ' CYS . 36.4 mmt -59.31 -46.94 87.22 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 123.903 0.881 . . . . 75.34 111.641 -173.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 118' ' ' VAL . . . . . . . . . . . . . 94.7 t -69.65 -34.9 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 C-N-CA 123.728 0.811 . . . . 72.25 110.879 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 17.8 t -67.99 -30.76 70.1 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.357 -0.383 . . . . 74.32 110.74 176.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 120' ' ' ARG . . . . . . . . . . . . . 90.1 mtt-85 -68.76 -18.93 64.29 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 123.435 0.694 . . . . 73.13 110.823 175.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLY . . . . . . . . . . . . . . . -85.1 15.71 42.42 Favored Glycine 0 C--N 1.355 1.624 0 CA-C-O 119.533 -0.593 . . . . 74.41 112.488 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 17' ' ' TYR . 57.6 p 62.14 28.8 17.32 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 126.856 2.063 . . . . 70.25 112.809 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -97.16 150.93 37.36 Favored Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 122.817 0.447 . . . . 73.34 110.938 -176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -67.86 -165.06 0.11 Allowed 'Trans proline' 0 C--N 1.392 2.817 0 C-N-CA 123.751 2.967 . . . . 72.1 113.579 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . 0.413 ' HB2' ' HA ' ' C' ' 124' ' ' PRO . 18.3 tp60 -63.78 115.79 5.13 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.753 -0.658 . . . . 72.2 112.565 -170.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 126' ' ' LEU . . . . . . . . . . . . . 47.6 tp -119.43 100.92 7.59 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 107.899 -1.148 . . . . 74.53 107.899 168.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 127' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -119.49 135.19 54.88 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.993 0.917 . . . . 65.01 109.766 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 128' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -83.09 139.26 33.32 Favored 'General case' 0 C--O 1.241 0.648 0 O-C-N 124.255 0.972 . . . . 72.24 110.39 177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 129' ' ' ALA . . . . . 0.523 ' HB3' HD13 ' H' ' 291' ' ' LEU . . . -83.37 147.26 52.68 Favored Pre-proline 0 CA--C 1.546 0.824 0 C-N-CA 124.101 0.961 . . . . 73.22 110.35 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 130' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.13 109.37 1.31 Allowed 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 122.939 2.426 . . . . 74.4 111.489 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 131' ' ' VAL . . . . . 0.479 HG22 HD11 ' H' ' 291' ' ' LEU . 56.0 t -95.24 131.5 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 C-N-CA 123.896 0.879 . . . . 72.04 109.897 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 132' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' B' ' 135' ' ' ALA . 57.1 t30 -82.12 90.3 6.54 Favored 'General case' 0 CA--C 1.543 0.702 0 CA-C-O 121.33 0.586 . . . . 60.04 109.771 177.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 133' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -69.83 -25.01 63.55 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.993 -1.003 . . . . 64.32 111.363 177.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 134' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -59.95 -38.62 82.97 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.852 0.861 . . . . 55.34 110.727 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 135' ' ' ALA . . . . . 0.459 ' HB2' ' ND2' ' B' ' 132' ' ' ASN . . . -63.55 -38.49 91.32 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.725 0.81 . . . . 62.12 112.289 -178.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 136' ' ' LEU . . . . . . . . . . . . . 79.0 mt -57.2 -42.64 81.66 Favored 'General case' 0 N--CA 1.485 1.298 0 O-C-N 123.955 0.784 . . . . 70.53 110.596 -179.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 137' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -77.34 -42.23 37.41 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 114.584 -1.189 . . . . 70.3 111.462 174.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 138' ' ' MET . . . . . . . . . . . . . 13.2 tmm? -58.97 -35.71 73.64 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.423 1.089 . . . . 71.05 112.292 -170.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 139' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -73.29 -38.75 65.76 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 116.338 -0.392 . . . . 74.0 110.284 178.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 140' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -70.4 -30.68 67.63 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-O 121.07 0.462 . . . . 73.52 111.17 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 141' ' ' LEU . . . . . . . . . . . . . 42.2 mt -99.58 9.3 43.43 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 124.125 0.97 . . . . 73.43 111.261 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 142' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -68.29 114.92 7.17 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.491 0.717 . . . . 74.1 110.734 -176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 143' ' ' GLN . . . . . . . . . . . . . 84.9 mm-40 -122.71 131.98 54.04 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.676 0.79 . . . . 75.14 110.592 -177.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 144' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -99.93 140.76 33.68 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.777 0.831 . . . . 63.51 110.02 178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -146.84 152.29 38.49 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.439 1.096 . . . . 61.21 109.458 178.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 146' ' ' GLY . . . . . . . . . . . . . . . -130.89 -159.38 9.58 Favored Glycine 0 C--N 1.348 1.243 0 CA-C-N 116.472 -0.331 . . . . 64.12 112.995 -176.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -112.93 -173.63 2.29 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.797 0.839 . . . . 73.21 109.891 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 148' ' ' GLY . . . . . . . . . . . . . . . -88.96 135.88 13.28 Favored Glycine 0 C--N 1.343 0.952 0 CA-C-O 119.475 -0.625 . . . . 62.13 111.573 173.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 149' ' ' THR . . . . . . . . . . . . . 38.7 p -65.32 106.88 1.46 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.558 0.743 . . . . 64.42 110.542 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -88.84 121.74 31.51 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 122.983 0.513 . . . . 70.43 110.52 -174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 151' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -81.73 174.93 10.88 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.24 0.616 . . . . 73.44 110.583 175.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 152' ' ' HIS . . . . . . . . . . . . . 43.2 p-80 -131.22 147.91 52.64 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.226 0.61 . . . . 71.41 110.104 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 153' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -80.6 121.48 25.88 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 109.245 -0.65 . . . . 71.31 109.245 172.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 154' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -129.35 119.67 24.28 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 107.572 -1.27 . . . . 71.13 107.572 172.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 C-N-CA 124.004 0.922 . . . . 74.44 110.001 -172.062 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.484 1.225 0 CA-C-O 120.788 0.328 . . . . 71.04 110.127 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' C' C ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -162.38 151.99 15.98 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 123.55 0.74 . . . . 73.14 109.374 -173.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 3' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -104.75 114.45 28.67 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 109.097 -0.705 . . . . 73.05 109.097 178.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.25 172.2 13.64 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.407 0.623 . . . . 73.01 111.497 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -144.73 151.23 38.57 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.824 1.25 . . . . 72.53 108.817 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 6' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -167.85 158.13 10.54 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.334 0.654 . . . . 73.55 109.438 -173.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 7' ' ' THR . . . . . . . . . . . . . 73.4 p -117.76 72.9 0.86 Allowed 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 123.235 0.614 . . . . 71.51 111.871 -170.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 8' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -138.59 89.68 2.39 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 123.736 0.814 . . . . 73.41 109.667 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 9' ' ' MET . . . . . 0.423 ' SD ' HG23 ' C' ' 86' ' ' ILE . 48.6 ttp 65.28 119.35 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.91 1.284 . . . . 74.21 113.039 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 10' ' ' THR . . . . . . . . . . . . . 3.8 m -84.77 85.12 7.48 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 107.333 -1.358 . . . . 71.3 107.333 170.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 11' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -93.77 120.17 33.69 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.635 -0.712 . . . . 72.23 109.875 -175.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -138.79 142.64 38.75 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 123.464 0.706 . . . . 64.32 110.144 172.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 13' ' ' ILE . . . . . 0.406 HG22 ' CE2' ' C' ' 84' ' ' PHE . 2.7 pp -77.96 137.79 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.688 0 O-C-N 123.945 0.778 . . . . 52.12 109.279 174.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 14' ' ' GLN . . . . . 0.431 ' HA ' ' HB3' ' G' ' 304' ' ' PRO . 15.3 mm100 -101.78 -51.17 3.49 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 109.802 -0.444 . . . . 63.04 109.802 177.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 15' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -167.86 124.77 1.12 Allowed 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 115.954 -0.566 . . . . 74.24 110.092 -174.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 16' ' ' ILE . . . . . . . . . . . . . 80.5 mt -106.73 147.14 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 N-CA-C 107.616 -1.253 . . . . 73.12 107.616 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 17' ' ' TYR . . . . . . . . . . . . . 22.9 p90 -175.15 160.77 2.76 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.142 0.496 . . . . 73.23 110.807 -177.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 18' ' ' THR . . . . . 0.411 HG22 HE22 ' C' ' 80' ' ' GLN . 60.8 p -78.87 115.03 18.3 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.005 -0.998 . . . . 75.14 108.534 173.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 19' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -66.6 -43.68 84.17 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-O 121.904 0.859 . . . . 71.14 109.415 172.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 20' ' ' ASP . . . . . 0.544 ' HB3' ' HB2' ' C' ' 79' ' ' GLN . 23.1 t70 -150.52 145.94 26.28 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 113.959 -1.473 . . . . 75.42 109.211 -172.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 21' ' ' ILE . . . . . 0.436 ' HB ' ' HB3' ' D' ' 23' ' ' PHE . 67.2 mt -140.25 141.27 33.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 106.6 -1.629 . . . . 61.24 106.6 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 24.3 t -153.16 150.62 29.24 Favored 'General case' 0 C--O 1.245 0.82 0 CA-C-O 121.111 0.481 . . . . 54.41 110.116 176.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 23' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -151.14 115.42 5.07 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 107.579 -1.267 . . . . 72.13 107.579 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 24' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -116.22 116.1 27.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 107.966 -1.124 . . . . 63.21 107.966 178.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 25' ' ' ALA . . . . . . . . . . . . . . . -111.19 85.53 5.5 Favored Pre-proline 0 C--O 1.242 0.659 0 N-CA-C 107.285 -1.376 . . . . 73.01 107.285 170.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.31 -26.11 30.0 Favored 'Trans proline' 0 C--N 1.38 2.193 0 C-N-CA 122.635 2.223 . . . . 64.31 112.025 -173.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 27' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -117.31 36.83 4.08 Favored 'General case' 0 C--O 1.21 -1.018 0 C-N-CA 124.142 0.977 . . . . 54.12 109.081 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 28' ' ' ALA . . . . . 0.404 ' HB3' ' HE3' ' D' ' 19' ' ' LYS . . . -45.31 -52.77 20.25 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 124.613 1.165 . . . . 73.53 114.012 -177.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 29' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -82.22 -32.81 0.65 Allowed 'Trans proline' 0 C--N 1.384 2.398 0 C-N-CA 121.563 1.509 . . . . 72.54 113.345 173.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 30' ' ' HIS . . . . . . . . . . . . . 76.2 t60 -70.06 -27.1 64.36 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 123.887 0.875 . . . . 63.31 113.071 -174.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 31' ' ' VAL . . . . . . . . . . . . . 9.4 p -79.22 -15.15 13.45 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 C-N-CA 123.542 0.737 . . . . 65.23 110.271 -177.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 32' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -64.06 -34.9 79.07 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.102 0.561 . . . . 74.55 111.3 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 33' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -89.75 7.49 36.62 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.964 0.906 . . . . 62.2 111.889 176.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 34' ' ' LYS . . . . . 0.442 ' HD2' HD11 ' C' ' 68' ' ' LEU . 1.0 OUTLIER -98.73 147.25 25.06 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.604 0.762 . . . . 63.21 111.202 -171.142 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 35' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -67.74 131.09 44.9 Favored 'General case' 0 C--O 1.242 0.678 0 C-N-CA 124.414 1.085 . . . . 52.51 109.832 175.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 36' ' ' TRP . . . . . 0.605 ' HB3' ' HB3' ' F' ' 297' ' ' TYR . 26.7 m95 -80.06 71.33 6.78 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 123.737 0.815 . . . . 75.24 110.786 -174.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 37' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -143.98 72.53 16.69 Favored Pre-proline 0 N--CA 1.476 0.845 0 N-CA-C 108.179 -1.045 . . . . 71.4 108.179 -178.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 38' ' ' PRO . . . . . 0.716 ' HG3' ' HD2' ' F' ' 297' ' ' TYR . 69.4 Cg_endo -90.97 155.84 3.94 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.795 2.33 . . . . 75.22 111.18 176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 39' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -87.1 81.39 8.05 Favored 'General case' 0 C--O 1.243 0.752 0 N-CA-C 106.893 -1.521 . . . . 71.32 106.893 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 40' ' ' VAL . . . . . 0.613 HG13 ' HG2' ' C' ' 38' ' ' PRO . 12.6 m -68.35 123.99 22.93 Favored 'Isoleucine or valine' 0 C--N 1.35 0.625 0 CA-C-N 114.517 -1.219 . . . . 71.13 109.383 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 41' ' ' LYS . . . . . 0.422 ' HZ2' ' HB3' ' C' ' 41' ' ' LYS . 0.0 OUTLIER -136.86 126.73 25.74 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 108.528 -0.916 . . . . 74.21 108.528 179.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 42' ' ' LEU . . . . . . . . . . . . . 56.3 tp -86.56 138.41 31.73 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 124.121 0.968 . . . . 74.33 108.637 -179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 43' ' ' ASP . . . . . 0.828 ' HB2' ' HB ' ' C' ' 63' ' ' THR . 5.2 m-20 -119.01 119.1 33.28 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.114 0.965 . . . . 41.21 109.177 -175.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 44' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.02 125.54 52.6 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 108.125 -1.065 . . . . 70.52 108.125 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 45' ' ' ASP . . . . . 0.64 ' HB3' ' HB3' ' C' ' 61' ' ' ARG . 7.3 t70 -137.12 142.67 42.29 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.698 0.799 . . . . 62.24 109.583 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 46' ' ' THR . . . . . . . . . . . . . 33.9 p -115.4 116.73 28.74 Favored 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 123.962 0.905 . . . . 62.31 110.836 -171.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 47' ' ' ALA . . . . . . . . . . . . . . . -128.03 153.01 47.25 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.371 1.068 . . . . 72.34 110.072 179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 48' ' ' SER . . . . . . . . . . . . . 34.3 p -166.13 159.05 14.92 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 122.985 0.514 . . . . 74.0 111.732 178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 49' ' ' SER . . . . . . . . . . . . . 77.1 p -149.88 153.88 37.43 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.556 0.742 . . . . 63.42 111.08 -178.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 50' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -90.2 122.75 33.42 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 108.991 -0.744 . . . . 73.1 108.991 169.298 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 51' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' C' ' 57' ' ' GLU . 37.7 mt -96.58 -44.17 7.26 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.717 0.807 . . . . 54.1 110.205 -176.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 52' ' ' ALA . . . . . 0.467 ' HB3' ' HB ' ' C' ' 55' ' ' VAL . . . -157.94 -165.31 1.71 Allowed 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.139 -0.937 . . . . 75.21 109.952 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 53' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -70.4 102.78 2.26 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.725 0.81 . . . . 74.03 109.601 179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 54' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 71.62 -3.24 2.2 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 125.726 1.61 . . . . 42.03 113.444 -178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 55' ' ' VAL . . . . . 0.467 ' HB ' ' HB3' ' C' ' 52' ' ' ALA . 95.5 t -92.09 113.48 27.46 Favored 'Isoleucine or valine' 0 C--O 1.242 0.666 0 N-CA-C 107.242 -1.392 . . . . 35.11 107.242 173.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 56' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -126.34 149.17 49.36 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 124.074 0.95 . . . . 72.44 108.945 -175.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 57' ' ' GLU . . . . . 0.637 ' HB2' HD11 ' C' ' 51' ' ' LEU . 45.9 tt0 -104.41 136.23 44.37 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.112 -0.699 . . . . 62.55 109.112 172.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 58' ' ' VAL . . . . . . . . . . . . . 77.2 t -119.43 120.84 64.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 106.442 -1.688 . . . . 63.51 106.442 171.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 59' ' ' VAL . . . . . . . . . . . . . 57.5 t -116.53 135.56 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.078 0.951 . . . . 33.31 109.048 177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 60' ' ' LEU . . . . . 0.43 HD23 HD12 ' C' ' 106' ' ' LEU . 3.8 mm? -120.34 114.0 21.2 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 123.698 0.799 . . . . 73.45 109.072 172.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 61' ' ' ARG . . . . . 0.64 ' HB3' ' HB3' ' C' ' 45' ' ' ASP . 17.2 ttm-85 -81.84 106.15 13.53 Favored 'General case' 0 C--O 1.241 0.615 0 N-CA-C 108.443 -0.947 . . . . 64.45 108.443 173.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 62' ' ' VAL . . . . . . . . . . . . . 40.6 t -107.85 120.4 59.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 107.92 -1.141 . . . . 62.43 107.92 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 63' ' ' THR . . . . . 0.828 ' HB ' ' HB2' ' C' ' 43' ' ' ASP . 48.0 m -133.26 145.77 50.8 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 124.242 1.017 . . . . 74.2 108.405 -173.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 64' ' ' VAL . . . . . 0.403 HG23 HD13 ' C' ' 114' ' ' ILE . 98.9 t -127.08 121.23 57.39 Favored 'Isoleucine or valine' 0 C--O 1.244 0.793 0 N-CA-C 108.9 -0.778 . . . . 72.33 108.9 174.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 65' ' ' THR . . . . . . . . . . . . . 10.6 m -104.58 142.5 34.54 Favored 'General case' 0 C--O 1.24 0.592 0 O-C-N 124.007 0.817 . . . . 74.43 109.514 176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.87 100.42 4.44 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 108.137 -1.06 . . . . 63.2 108.137 172.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 67' ' ' SER . . . . . . . . . . . . . 25.0 m -139.23 126.59 21.51 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 109.888 -0.412 . . . . 71.14 109.888 -176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 68' ' ' LEU . . . . . 0.462 ' H ' HD23 ' C' ' 68' ' ' LEU . 0.3 OUTLIER -100.82 60.04 0.95 Allowed 'General case' 0 CA--C 1.547 0.846 0 CA-C-O 122.172 0.987 . . . . 74.15 109.416 176.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 69' ' ' GLY . . . . . . . . . . . . . . . 104.64 -122.05 7.18 Favored Glycine 0 C--N 1.345 1.052 0 CA-C-N 113.979 -1.464 . . . . 73.31 110.4 -179.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 70' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -89.65 -16.96 29.32 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 123.498 0.719 . . . . 65.15 109.891 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 71' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -75.92 92.49 3.12 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 124.249 1.019 . . . . 73.11 109.091 170.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 72' ' ' THR . . . . . . . . . . . . . 84.9 m -83.35 121.7 27.49 Favored 'General case' 0 C--N 1.347 0.475 0 N-CA-C 109.036 -0.727 . . . . 73.31 109.036 173.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 73' ' ' ALA . . . . . . . . . . . . . . . -77.7 -51.48 10.51 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.45 -1.25 . . . . 71.53 109.478 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 74' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -161.08 175.64 12.2 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.663 0.745 . . . . 62.23 110.976 168.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 75' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -145.12 144.36 30.87 Favored 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 106.403 -1.702 . . . . 62.13 106.403 175.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 76' ' ' CYS . . . . . . . . . . . . . 46.3 t -146.21 112.03 5.64 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 109.158 -0.682 . . . . 75.05 109.158 175.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 77' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -118.38 117.39 28.95 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 123.06 0.544 . . . . 72.2 110.459 -178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 78' ' ' VAL . . . . . . . . . . . . . 56.0 t -120.44 122.01 67.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.598 0 C-N-CA 123.129 0.572 . . . . 73.25 109.554 172.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 79' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' C' ' 20' ' ' ASP . 51.2 mt-30 -99.68 105.04 16.82 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 107.956 -1.127 . . . . 75.23 107.956 174.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 80' ' ' GLN . . . . . 0.411 HE22 HG22 ' C' ' 18' ' ' THR . 8.9 tp-100 -93.2 112.96 25.05 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.516 0.727 . . . . 72.34 110.234 -176.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.58 161.57 25.06 Favored Glycine 0 C--N 1.337 0.627 0 O-C-N 123.473 0.483 . . . . 62.21 112.782 177.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 82' ' ' GLY . . . . . . . . . . . . . . . -158.81 120.58 0.98 Allowed Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.253 -0.739 . . . . 73.45 111.253 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 83' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' C' ' 14' ' ' GLN . 12.6 mm -84.31 122.76 38.34 Favored 'Isoleucine or valine' 0 C--O 1.24 0.582 0 N-CA-C 108.207 -1.034 . . . . 65.52 108.207 176.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . 0.406 ' CE2' HG22 ' C' ' 13' ' ' ILE . 70.6 m-85 -133.49 130.59 38.75 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.283 1.033 . . . . 72.35 109.062 -176.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -85.96 106.58 17.24 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.892 -0.781 . . . . 70.23 108.892 171.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 86' ' ' ILE . . . . . 0.423 HG23 ' SD ' ' C' ' 9' ' ' MET . 66.7 mt -116.32 107.93 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 123.954 0.902 . . . . 75.03 108.987 -176.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 87' ' ' ALA . . . . . . . . . . . . . . . -150.15 138.32 20.34 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.786 0.835 . . . . 73.31 109.458 178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 88' ' ' GLY . . . . . . . . . . . . . . . 130.33 -47.74 1.0 Allowed Glycine 0 C--N 1.343 0.952 0 O-C-N 123.641 0.588 . . . . 75.1 112.366 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 89' ' ' ILE . . . . . . . . . . . . . 27.4 pt -101.89 172.68 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 C-N-CA 123.147 0.579 . . . . 64.53 111.526 -179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 90' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -161.28 151.31 17.26 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.594 0.758 . . . . 75.42 110.585 -179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . 70.11 -112.62 4.47 Favored Glycine 0 C--N 1.356 1.669 0 O-C-N 123.731 0.644 . . . . 52.21 114.191 168.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 92' ' ' THR . . . . . . . . . . . . . 45.3 p -64.3 -35.03 79.54 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 123.982 0.913 . . . . 71.24 111.842 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 93' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -77.86 -35.69 50.69 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.914 -0.585 . . . . 74.0 111.41 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 94' ' ' MET . . . . . 0.645 ' SD ' ' HA ' ' F' ' 277' ' ' LEU . 12.6 ptt? -70.66 -23.66 62.55 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 110.333 -0.247 . . . . 63.54 110.333 175.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.57 -38.75 92.33 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 122.762 0.425 . . . . 51.1 110.878 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 96' ' ' HIS . . . . . 0.485 ' O ' ' HB3' ' C' ' 100' ' ' ALA . 57.3 t-80 -73.7 -32.45 63.93 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 116.203 -0.453 . . . . 51.21 111.305 178.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 97' ' ' CYS . . . . . . . . . . . . . 52.4 t -81.81 -62.55 1.61 Allowed 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 121.157 0.503 . . . . 65.41 110.628 -178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 58.8 tp -60.42 -43.83 96.37 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.484 1.113 . . . . 70.52 111.817 -176.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 99' ' ' GLY . . . . . . . . . . . . . . . -90.57 5.27 82.48 Favored Glycine 0 C--N 1.349 1.302 0 CA-C-O 119.295 -0.725 . . . . 72.12 114.876 -172.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.589 ' HB1' ' HA ' ' C' ' 134' ' ' ASP . . . -149.39 -56.35 0.19 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 118.306 1.053 . . . . 64.13 112.908 -173.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 101' ' ' TYR . . . . . 0.417 ' OH ' ' HB2' ' A' ' 130' ' ' PRO . 89.3 t80 -71.13 -49.43 44.14 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 124.349 1.06 . . . . 75.44 111.543 -173.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 102' ' ' CYS . . . . . . . . . . . . . 56.9 m -65.53 -44.42 65.83 Favored Pre-proline 0 CA--C 1.571 1.788 0 C-N-CA 124.144 0.977 . . . . 65.23 112.249 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 103' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -52.06 -40.64 67.73 Favored 'Trans proline' 0 C--N 1.398 3.145 0 C-N-CA 122.948 2.432 . . . . 51.02 114.196 169.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 104' ' ' ASN . . . . . . . . . . . . . 44.3 t-20 -64.14 -31.64 72.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 123.787 0.679 . . . . 63.22 110.825 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 105' ' ' ILE . . . . . 0.436 HG23 ' NH1' ' A' ' 111' ' ' ARG . 39.9 mm -68.2 -41.55 84.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.161 0 C-N-CA 122.82 0.448 . . . . 72.51 110.856 178.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 106' ' ' LEU . . . . . 0.43 HD12 HD23 ' C' ' 60' ' ' LEU . 86.4 mt -88.88 -22.22 23.25 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.701 0.8 . . . . 54.41 113.014 -172.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 107' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -56.36 -48.54 96.79 Favored Pre-proline 0 CA--C 1.568 1.649 0 N-CA-C 113.947 1.092 . . . . 52.44 113.947 -173.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 108' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_exo -62.8 -33.27 76.6 Favored 'Trans proline' 0 C--N 1.385 2.492 0 C-N-CA 121.912 1.741 . . . . 60.13 113.64 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 109' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -48.04 69.4 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.432 0.693 . . . . 73.34 110.359 178.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.65 -44.36 81.25 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 114.948 -1.023 . . . . 71.05 110.597 176.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 111' ' ' ARG . . . . . . . . . . . . . 18.6 ttt-85 -56.48 -52.47 64.6 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 113.938 -1.483 . . . . 75.45 112.003 177.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 112' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -68.44 -33.27 73.91 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 122.607 0.363 . . . . 71.44 110.568 -173.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 113' ' ' CYS . . . . . . . . . . . . . 11.4 t -70.46 -29.44 66.0 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 122.999 0.519 . . . . 75.43 110.839 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 114' ' ' ILE . . . . . 0.403 HD13 HG23 ' C' ' 64' ' ' VAL . 73.3 mt -72.04 -44.16 66.28 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 123.599 0.76 . . . . 74.24 109.768 170.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 115' ' ' THR . . . . . . . . . . . . . 28.5 m -64.34 -30.13 71.18 Favored 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 123.47 0.708 . . . . 72.21 111.174 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 116' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' C' ' 120' ' ' ARG . 30.9 t -71.76 -49.57 37.85 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.824 0.85 . . . . 74.1 109.002 176.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 117' ' ' MET . . . . . 0.528 ' HE2' HG21 ' D' ' 21' ' ' ILE . 0.0 OUTLIER -65.0 -39.88 94.12 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 124.097 0.959 . . . . 74.05 113.041 -175.24 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' C' C ' 118' ' ' VAL . . . . . . . . . . . . . 13.9 p -65.7 -34.78 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 N-CA-C 109.944 -0.391 . . . . 60.41 109.944 177.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 47.4 t -72.71 -32.07 65.47 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.559 0.744 . . . . 60.54 111.587 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 120' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' C' ' 116' ' ' SER . 88.7 mtt-85 -68.16 -26.76 65.92 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.21 0.604 . . . . 60.12 110.42 177.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.7 11.52 68.35 Favored Glycine 0 C--N 1.354 1.534 0 CA-C-O 119.246 -0.752 . . . . 74.03 113.271 173.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 122' ' ' THR . . . . . 0.495 HG23 ' HB3' ' D' ' 17' ' ' TYR . 52.7 p 58.76 26.86 15.21 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 125.91 1.684 . . . . 71.51 112.82 -179.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 123' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -102.05 151.64 38.07 Favored Pre-proline 0 N--CA 1.483 1.205 0 C-N-CA 123.706 0.802 . . . . 75.31 109.922 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 124' ' ' PRO . . . . . 0.542 ' HD3' HD11 ' F' ' 301' ' ' ILE . 35.3 Cg_exo -59.87 121.55 10.01 Favored 'Trans proline' 0 C--N 1.39 2.735 0 C-N-CA 123.016 2.477 . . . . 71.53 113.108 -171.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -60.33 146.37 44.32 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 124.111 0.882 . . . . 73.43 112.496 -177.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 126' ' ' LEU . . . . . . . . . . . . . 10.3 tt -141.66 127.58 19.41 Favored 'General case' 0 CA--C 1.541 0.635 0 N-CA-C 108.316 -0.994 . . . . 65.34 108.316 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -88.13 114.88 25.18 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 107.587 -1.264 . . . . 70.24 107.587 172.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 128' ' ' LEU . . . . . . . . . . . . . 29.9 tp -64.86 129.01 38.14 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 123.86 0.725 . . . . 60.21 110.532 -175.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 129' ' ' ALA . . . . . 0.405 ' HB3' HD13 ' F' ' 291' ' ' LEU . . . -68.2 151.09 97.46 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 124.98 1.312 . . . . 74.11 112.039 -171.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 130' ' ' PRO . . . . . 0.474 ' HG2' HG21 ' A' ' 13' ' ' ILE . 23.1 Cg_exo -64.02 109.88 1.21 Allowed 'Trans proline' 0 C--N 1.384 2.432 0 C-N-CA 122.979 2.453 . . . . 60.05 112.28 -177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 131' ' ' VAL . . . . . 0.429 HG22 HD21 ' F' ' 291' ' ' LEU . 61.3 t -97.16 108.67 21.9 Favored 'Isoleucine or valine' 0 C--O 1.242 0.667 0 N-CA-C 107.619 -1.252 . . . . 42.24 107.619 175.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 132' ' ' ASN . . . . . 0.443 ' O ' HD23 ' C' ' 136' ' ' LEU . 14.7 m120 -82.23 101.39 10.46 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 115.557 -0.747 . . . . 75.14 110.239 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 133' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -80.02 -38.46 31.98 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 108.332 -0.988 . . . . 73.42 108.332 168.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 134' ' ' ASP . . . . . 0.589 ' HA ' ' HB1' ' C' ' 100' ' ' ALA . 6.1 p-10 -55.71 -44.74 77.7 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 126.118 1.767 . . . . 52.15 112.856 -178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 135' ' ' ALA . . . . . . . . . . . . . . . -70.04 -37.85 75.69 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 124.013 0.925 . . . . 73.05 111.798 -174.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 136' ' ' LEU . . . . . 0.443 HD23 ' O ' ' C' ' 132' ' ' ASN . 4.5 mm? -66.51 -46.38 76.4 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 115.548 -0.751 . . . . 63.25 110.953 177.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 137' ' ' PHE . . . . . . . . . . . . . 28.5 m-85 -74.4 -18.65 60.63 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.414 0.686 . . . . 73.51 112.433 177.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 138' ' ' MET . . . . . . . . . . . . . 55.6 ttp -66.75 -38.41 86.55 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.478 0.711 . . . . 73.33 109.926 176.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 139' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.75 -37.33 86.95 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 115.025 -0.989 . . . . 43.33 110.594 175.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 140' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -69.78 -84.94 0.03 OUTLIER 'General case' 0 CA--C 1.559 1.297 0 C-N-CA 124.079 0.952 . . . . 75.44 110.218 174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 141' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -105.5 90.64 3.47 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 123.736 0.814 . . . . 63.11 109.966 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 142' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.36 97.23 6.25 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 107.73 -1.211 . . . . 74.24 107.73 169.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 143' ' ' GLN . . . . . . . . . . . . . 27.1 tp60 -161.29 132.51 5.41 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 108.454 -0.943 . . . . 75.43 108.454 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.65 150.92 45.51 Favored 'General case' 0 CA--C 1.547 0.863 0 O-C-N 123.619 0.574 . . . . 65.1 111.365 178.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -167.46 130.63 1.71 Allowed 'General case' 0 C--O 1.243 0.763 0 C-N-CA 124.668 1.187 . . . . 64.32 108.717 176.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 146' ' ' GLY . . . . . . . . . . . . . . . 157.31 -39.47 0.55 Allowed Glycine 0 C--N 1.34 0.776 0 N-CA-C 111.082 -0.807 . . . . 72.44 111.082 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -79.82 134.95 36.36 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.016 -1.105 . . . . 72.31 108.016 176.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 148' ' ' GLY . . . . . . . . . . . . . . . -148.21 66.36 0.39 Allowed Glycine 0 N--CA 1.476 1.343 0 CA-C-N 118.686 0.675 . . . . 75.03 112.516 -175.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 149' ' ' THR . . . . . . . . . . . . . 4.0 m -83.41 73.34 10.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 123.611 0.764 . . . . 75.12 111.445 -174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -136.83 140.07 42.17 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.611 0.764 . . . . 71.45 110.137 178.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 151' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -135.9 179.26 6.45 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.187 1.395 . . . . 73.13 109.46 -177.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 152' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 63.7 112.24 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.907 1.283 . . . . 72.44 111.642 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 153' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -97.92 173.82 6.88 Favored 'General case' 0 C--O 1.242 0.674 0 CA-C-N 116.099 -0.5 . . . . 71.54 110.158 174.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 154' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -136.15 125.71 25.26 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.133 0.973 . . . . 74.33 109.116 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' C' C ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.122 0 C-N-CA 123.523 0.729 . . . . 72.43 109.152 178.199 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 87.8 mtp . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 110.441 -0.207 . . . . 75.3 110.441 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' D' D ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -63.82 138.09 58.33 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.651 0.78 . . . . 71.54 111.056 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 3' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -74.57 -72.82 0.26 Allowed 'General case' 0 CA--C 1.551 1.006 0 O-C-N 123.869 0.731 . . . . 74.44 110.768 -174.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 4' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 73.08 -36.26 0.35 Allowed 'General case' 0 N--CA 1.51 2.574 0 C-N-CA 125.413 1.485 . . . . 71.12 111.966 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 73.58 -84.85 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 126.329 1.852 . . . . 73.14 110.132 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 6' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 178.5 15.22 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 124.859 1.264 . . . . 71.25 109.844 -172.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 7' ' ' THR . . . . . . . . . . . . . 55.8 p -73.27 -16.52 61.39 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 123.447 0.699 . . . . 73.33 111.926 -170.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 8' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -99.25 -66.19 0.92 Allowed 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 108.356 -0.979 . . . . 74.34 108.356 166.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 9' ' ' MET . . . . . 0.559 ' HA ' ' HA3' ' D' ' 88' ' ' GLY . 0.0 OUTLIER 23.11 170.91 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 C-N-CA 129.178 2.991 . . . . 60.22 118.858 -170.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 10' ' ' THR . . . . . . . . . . . . . 73.7 m -141.92 136.64 30.63 Favored 'General case' 0 C--O 1.245 0.863 0 CA-C-N 114.631 -1.168 . . . . 72.1 109.611 172.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 11' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -143.87 112.11 6.34 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 108.233 -1.025 . . . . 54.41 108.233 179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 12' ' ' GLN . . . . . 0.541 ' HB2' ' HB2' ' D' ' 85' ' ' SER . 71.3 mt-30 -131.59 154.54 48.76 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.467 -0.938 . . . . 75.32 108.467 176.056 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 13' ' ' ILE . . . . . 0.44 HD11 HG21 ' D' ' 105' ' ' ILE . 35.6 mt -104.02 132.94 49.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.913 -1.143 . . . . 53.13 107.913 168.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 14' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -87.36 -48.14 8.23 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 109.627 -0.509 . . . . 71.03 109.627 171.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 15' ' ' ARG . . . . . . . . . . . . . 57.7 mtm180 -155.64 148.29 24.08 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.32 0.648 . . . . 70.15 109.873 -176.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 16' ' ' ILE . . . . . 0.463 HD13 ' H ' ' D' ' 16' ' ' ILE . 0.2 OUTLIER -124.05 111.21 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 N-CA-C 107.345 -1.354 . . . . 71.21 107.345 168.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 17' ' ' TYR . . . . . 0.495 ' HB3' HG23 ' C' ' 122' ' ' THR . 31.8 p90 -140.56 170.2 16.23 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.82 0.819 . . . . 73.51 111.764 -172.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 18' ' ' THR . . . . . . . . . . . . . 61.4 p -101.2 121.31 41.61 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.556 -1.202 . . . . 65.03 108.883 175.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 19' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' C' ' 28' ' ' ALA . 40.0 mtpt -88.23 -30.62 19.56 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 122.984 0.513 . . . . 73.43 110.346 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 20' ' ' ASP . . . . . 0.423 ' HB3' ' HB2' ' D' ' 79' ' ' GLN . 28.6 t70 -152.86 127.02 9.11 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.142 -0.935 . . . . 73.22 108.573 178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 21' ' ' ILE . . . . . 0.528 HG21 ' HE2' ' C' ' 117' ' ' MET . 82.7 mt -123.93 144.07 34.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 107.335 -1.357 . . . . 72.03 107.335 173.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 37.8 t -152.49 110.67 3.69 Favored 'General case' 0 N--CA 1.451 -0.397 0 O-C-N 124.188 0.93 . . . . 62.21 109.494 172.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 23' ' ' PHE . . . . . 0.436 ' HB3' ' HB ' ' C' ' 21' ' ' ILE . 75.1 t80 -108.39 128.75 55.04 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 106.109 -1.812 . . . . 63.32 106.109 162.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 24' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -123.86 151.01 43.91 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.851 -0.796 . . . . 75.03 108.851 174.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 25' ' ' ALA . . . . . 0.778 ' HB1' ' HB2' ' D' ' 28' ' ' ALA . . . -132.82 76.59 70.55 Favored Pre-proline 0 C--O 1.243 0.729 0 N-CA-C 106.616 -1.624 . . . . 74.21 106.616 170.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 26' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.5 -45.23 31.47 Favored 'Trans proline' 0 C--N 1.381 2.28 0 C-N-CA 123.561 2.841 . . . . 71.43 113.113 -166.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 27' ' ' ASN . . . . . 0.458 ' HB2' HG23 ' D' ' 31' ' ' VAL . 20.3 m-80 -114.59 25.99 10.57 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-N 115.232 -0.895 . . . . 63.42 110.101 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 28' ' ' ALA . . . . . 0.778 ' HB2' ' HB1' ' D' ' 25' ' ' ALA . . . -39.01 -60.02 1.27 Allowed Pre-proline 0 N--CA 1.499 1.989 0 N-CA-C 115.798 1.777 . . . . 63.11 115.798 -163.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 29' ' ' PRO . . . . . 0.422 ' HA ' ' CD2' ' D' ' 32' ' ' PHE . 31.3 Cg_endo -81.94 -14.47 9.85 Favored 'Trans proline' 0 C--N 1.379 2.173 0 CA-C-N 122.282 1.851 . . . . 74.44 113.542 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 30' ' ' HIS . . . . . . . . . . . . . 14.6 t-160 -72.02 -38.77 69.51 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.36 1.064 . . . . 74.33 109.301 169.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 31' ' ' VAL . . . . . 0.607 HG13 HD11 ' D' ' 68' ' ' LEU . 52.8 t -63.35 -39.04 83.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 123.914 0.886 . . . . 61.42 109.991 178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 32' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' D' ' 29' ' ' PRO . 21.9 m-30 -60.12 -9.22 2.99 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 114.378 1.251 . . . . 74.05 114.378 -173.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 33' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -77.77 -37.67 48.44 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.974 0.51 . . . . 75.34 111.108 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 34' ' ' LYS . . . . . . . . . . . . . 21.4 pttp -132.8 62.83 1.65 Allowed 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 123.847 0.859 . . . . 75.3 109.979 173.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 35' ' ' ASP . . . . . 0.527 ' HB3' HD12 ' G' ' 301' ' ' ILE . 42.5 t0 -107.79 83.28 1.77 Allowed 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.847 0.832 . . . . 65.31 110.706 -169.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 36' ' ' TRP . . . . . . . . . . . . . 47.5 m95 -126.5 -178.53 4.39 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.713 -1.131 . . . . 71.44 108.062 -177.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 37' ' ' GLN . . . . . . . . . . . . . 18.2 pm0 -48.56 100.59 0.24 Allowed Pre-proline 0 N--CA 1.493 1.703 0 C-N-CA 123.571 0.749 . . . . 60.23 112.728 -162.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 38' ' ' PRO . . . . . 0.475 ' HB2' ' HB1' ' D' ' 66' ' ' ALA . 59.9 Cg_endo -71.62 149.09 54.65 Favored 'Trans proline' 0 C--N 1.387 2.582 0 C-N-CA 122.601 2.201 . . . . 62.13 111.107 -173.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -68.63 111.45 4.79 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 107.873 -1.158 . . . . 73.42 107.873 173.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 40' ' ' VAL . . . . . 0.452 HG23 ' NE1' ' G' ' 290' ' ' TRP . 2.8 m -103.54 106.27 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 123.919 0.888 . . . . 74.22 109.164 -172.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 41' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -100.95 129.98 46.88 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 124.069 0.948 . . . . 63.23 109.952 -172.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 42' ' ' LEU . . . . . . . . . . . . . 54.5 tp -97.09 119.53 35.76 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 109.05 -0.722 . . . . 55.45 109.05 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 43' ' ' ASP . . . . . 0.625 ' HB2' ' HB ' ' D' ' 63' ' ' THR . 4.2 m-20 -120.32 130.82 54.61 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.782 0.833 . . . . 75.0 109.15 176.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 44' ' ' LEU . . . . . . . . . . . . . 5.3 mp -110.02 137.42 47.81 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.831 0.853 . . . . 54.13 109.155 178.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 45' ' ' ASP . . . . . 0.609 ' HB3' ' HB3' ' D' ' 61' ' ' ARG . 6.3 t70 -135.83 132.27 36.44 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 108.687 -0.857 . . . . 73.42 108.687 170.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 46' ' ' THR . . . . . . . . . . . . . 44.4 p -104.94 143.61 32.93 Favored 'General case' 0 C--O 1.24 0.579 0 C-N-CA 123.717 0.807 . . . . 62.32 109.773 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 47' ' ' ALA . . . . . 0.554 ' HB3' ' HB ' ' D' ' 59' ' ' VAL . . . -153.18 155.47 36.73 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.892 0.877 . . . . 71.03 110.025 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 48' ' ' SER . . . . . 0.426 ' HB2' HD21 ' G' ' 278' ' ' LEU . 28.6 p -158.99 162.8 36.82 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.219 0.533 . . . . 65.0 111.228 178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 49' ' ' SER . . . . . . . . . . . . . 15.7 m -150.01 150.02 31.19 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 114.649 -1.16 . . . . 74.4 109.462 -177.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 50' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -100.71 122.52 43.49 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 107.335 -1.358 . . . . 74.42 107.335 159.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 51' ' ' LEU . . . . . 0.494 HD11 ' HB2' ' D' ' 57' ' ' GLU . 23.0 mt -96.3 -26.36 15.42 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.453 0.701 . . . . 52.11 109.38 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 52' ' ' ALA . . . . . . . . . . . . . . . -170.33 173.46 5.69 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.758 1.223 . . . . 52.23 109.532 177.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 53' ' ' ASP . . . . . . . . . . . . . 28.5 t0 -65.93 131.47 46.33 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 108.623 -0.88 . . . . 71.53 108.623 171.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 54' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 70.15 -2.05 2.23 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 125.112 1.365 . . . . 61.11 113.086 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 55' ' ' VAL . . . . . . . . . . . . . 58.3 t -119.65 116.34 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 123.35 0.66 . . . . 72.04 109.29 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 56' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -132.01 162.13 31.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.979 -0.749 . . . . 72.51 108.979 -178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 57' ' ' GLU . . . . . 0.494 ' HB2' HD11 ' D' ' 51' ' ' LEU . 28.4 tt0 -130.42 118.31 21.0 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 124.084 0.954 . . . . 74.11 108.604 -177.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 58' ' ' VAL . . . . . 0.52 HG13 ' HZ ' ' G' ' 281' ' ' PHE . 77.3 t -100.48 113.31 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 107.387 -1.338 . . . . 64.31 107.387 175.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 59' ' ' VAL . . . . . 0.554 ' HB ' ' HB3' ' D' ' 47' ' ' ALA . 22.9 t -107.01 127.72 62.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 107.997 -1.112 . . . . 73.25 107.997 176.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 60' ' ' LEU . . . . . 0.481 ' HB3' HD22 ' D' ' 106' ' ' LEU . 0.9 OUTLIER -128.94 112.65 14.3 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 107.762 -1.199 . . . . 63.0 107.762 -178.406 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 61' ' ' ARG . . . . . 0.609 ' HB3' ' HB3' ' D' ' 45' ' ' ASP . 10.3 ttm180 -85.18 118.4 24.71 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 123.733 0.813 . . . . 75.41 109.459 176.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 62' ' ' VAL . . . . . . . . . . . . . 76.0 t -108.59 122.0 62.48 Favored 'Isoleucine or valine' 0 C--O 1.241 0.624 0 N-CA-C 107.943 -1.132 . . . . 74.1 107.943 170.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 63' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' D' ' 43' ' ' ASP . 23.4 m -119.36 137.27 53.83 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.561 0.745 . . . . 65.11 109.92 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 64' ' ' VAL . . . . . . . . . . . . . 71.5 t -128.24 103.73 10.52 Favored 'Isoleucine or valine' 0 C--O 1.246 0.872 0 C-N-CA 125.146 1.378 . . . . 70.53 107.729 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 65' ' ' THR . . . . . . . . . . . . . 40.2 m -101.91 105.24 16.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.515 0.726 . . . . 61.25 109.454 -178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . 0.475 ' HB1' ' HB2' ' D' ' 38' ' ' PRO . . . -99.28 128.5 45.41 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.276 0.63 . . . . 74.05 110.633 -178.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 67' ' ' SER . . . . . . . . . . . . . 23.5 p -144.81 126.06 14.74 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 123.174 0.589 . . . . 65.41 110.443 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 68' ' ' LEU . . . . . 0.607 HD11 HG13 ' D' ' 31' ' ' VAL . 3.4 pp -124.96 139.81 53.49 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.723 0.809 . . . . 63.42 111.187 178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.57 -111.47 3.34 Favored Glycine 0 C--N 1.346 1.097 0 N-CA-C 110.479 -1.049 . . . . 32.21 110.479 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.94 3.35 8.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.723 0.809 . . . . 75.02 110.446 175.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 71' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -125.78 167.76 14.73 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.109 0.564 . . . . 53.55 110.082 -173.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 72' ' ' THR . . . . . . . . . . . . . 95.0 m -84.65 126.47 33.39 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.492 -0.777 . . . . 54.53 110.593 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 73' ' ' ALA . . . . . 0.403 ' HB2' ' HG ' ' D' ' 68' ' ' LEU . . . -69.7 -64.95 0.78 Allowed 'General case' 0 C--O 1.242 0.668 0 O-C-N 124.259 0.974 . . . . 55.11 109.299 174.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 74' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -157.1 162.2 39.43 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 114.559 -1.201 . . . . 74.31 110.432 176.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 75' ' ' LEU . . . . . . . . . . . . . 75.1 mt -124.12 141.42 52.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.898 1.279 . . . . 72.03 108.012 178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 76' ' ' CYS . . . . . 0.605 ' SG ' HG23 ' D' ' 114' ' ' ILE . 21.8 t -152.27 109.5 3.55 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 109.652 -0.499 . . . . 72.14 109.652 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 77' ' ' GLU . . . . . 0.411 ' HB2' HG23 ' D' ' 63' ' ' THR . 38.7 tt0 -140.41 130.65 25.07 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.404 1.082 . . . . 74.53 108.848 -171.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 78' ' ' VAL . . . . . . . . . . . . . 58.0 t -133.68 116.36 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 C-N-CA 123.428 0.691 . . . . 73.53 109.788 -177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 79' ' ' GLN . . . . . 0.423 ' HB2' ' HB3' ' D' ' 20' ' ' ASP . 50.7 mt-30 -88.04 83.93 6.99 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 107.851 -1.166 . . . . 74.15 107.851 166.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 80' ' ' GLN . . . . . 0.483 ' HB3' HD21 ' D' ' 106' ' ' LEU . 4.4 tp-100 -79.84 114.82 19.05 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 107.44 -1.318 . . . . 71.15 107.44 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 81' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' D' ' 59' ' ' VAL . . . -109.16 142.03 16.11 Favored Glycine 0 C--N 1.34 0.788 0 N-CA-C 111.194 -0.762 . . . . 61.23 111.194 178.66 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 82' ' ' GLY . . . . . . . . . . . . . . . -135.89 131.9 5.92 Favored Glycine 0 C--N 1.333 0.368 0 N-CA-C 111.058 -0.817 . . . . 65.33 111.058 -176.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 83' ' ' ILE . . . . . . . . . . . . . 56.7 mt -89.31 126.06 42.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 108.062 -1.088 . . . . 72.32 108.062 175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -123.65 127.96 48.97 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 124.593 1.157 . . . . 75.11 109.229 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 85' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' D' ' 12' ' ' GLN . 43.8 m -78.63 101.16 7.32 Favored 'General case' 0 C--O 1.242 0.691 0 N-CA-C 108.301 -1.0 . . . . 72.04 108.301 169.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 86' ' ' ILE . . . . . 0.509 HG22 HD22 ' G' ' 277' ' ' LEU . 61.4 mt -108.59 128.99 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 123.914 0.886 . . . . 63.13 109.725 -172.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 87' ' ' ALA . . . . . . . . . . . . . . . -162.24 159.15 25.34 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.973 0.909 . . . . 72.22 110.328 175.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 88' ' ' GLY . . . . . 0.559 ' HA3' ' HA ' ' D' ' 9' ' ' MET . . . 80.79 14.96 78.79 Favored Glycine 0 C--N 1.348 1.198 0 N-CA-C 115.011 0.765 . . . . 71.35 115.011 169.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 89' ' ' ILE . . . . . 0.469 HD12 ' HA ' ' D' ' 94' ' ' MET . 18.3 pt -136.67 134.93 48.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 N-CA-C 108.355 -0.979 . . . . 52.12 108.355 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 90' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.98 157.66 45.93 Favored 'General case' 0 N--CA 1.485 1.293 0 O-C-N 121.949 -0.47 . . . . 73.51 111.202 -179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.5 -118.51 14.5 Favored Glycine 0 C--N 1.355 1.605 0 O-C-N 124.658 1.224 . . . . 74.43 113.565 174.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 92' ' ' THR . . . . . . . . . . . . . 17.4 m -69.6 -31.36 69.45 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.738 0.815 . . . . 75.23 111.985 -174.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 93' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -72.99 -42.33 63.39 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.828 0.451 . . . . 65.43 110.871 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 94' ' ' MET . . . . . 0.469 ' HA ' HD12 ' D' ' 89' ' ' ILE . 0.0 OUTLIER -72.04 -34.37 68.73 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 110.234 -0.284 . . . . 62.45 110.234 178.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' D' D ' 95' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.84 92.54 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.782 0.833 . . . . 54.22 110.893 175.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 96' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -67.7 -36.42 80.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.027 0.931 . . . . 72.53 110.953 174.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 97' ' ' CYS . . . . . . . . . . . . . 44.6 t -69.8 -51.41 34.05 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 122.582 0.353 . . . . 70.43 110.85 -177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.429 HD21 ' H ' ' G' ' 279' ' ' GLY . 4.5 pp -80.19 -20.48 44.66 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 122.649 0.379 . . . . 71.04 111.652 -177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 99' ' ' GLY . . . . . . . . . . . . . . . -100.39 -2.98 55.59 Favored Glycine 0 C--N 1.354 1.528 0 CA-C-O 119.608 -0.551 . . . . 63.21 114.007 -176.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -142.82 -64.48 0.41 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 117.69 0.745 . . . . 65.41 111.251 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 101' ' ' TYR . . . . . . . . . . . . . 51.9 t80 -64.23 -56.11 16.92 Favored 'General case' 0 CA--C 1.557 1.237 0 N-CA-C 112.812 0.671 . . . . 72.52 112.812 -170.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 102' ' ' CYS . . . . . . . . . . . . . 61.3 m -60.2 -45.41 97.76 Favored Pre-proline 0 CA--C 1.56 1.343 0 C-N-CA 124.31 1.044 . . . . 73.45 112.417 -177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 103' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -53.76 -40.2 80.91 Favored 'Trans proline' 0 C--N 1.397 3.123 0 C-N-CA 122.65 2.234 . . . . 71.34 113.254 168.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 104' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -75.33 -22.81 57.35 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.465 0.706 . . . . 71.1 112.406 -177.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 105' ' ' ILE . . . . . 0.44 HG21 HD11 ' D' ' 13' ' ' ILE . 29.0 mm -71.74 -42.77 70.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 CA-C-O 122.302 1.048 . . . . 74.35 109.166 169.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 106' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' D' ' 80' ' ' GLN . 8.6 tt -76.55 -27.82 56.06 Favored 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 113.562 -1.653 . . . . 72.42 111.171 -173.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 107' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -61.91 -40.83 72.52 Favored Pre-proline 0 CA--C 1.566 1.596 0 C-N-CA 125.254 1.422 . . . . 61.41 113.905 -170.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 108' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_exo -55.38 -34.42 88.87 Favored 'Trans proline' 0 C--N 1.387 2.559 0 C-N-CA 122.477 2.118 . . . . 41.05 114.272 170.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 109' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -79.55 -30.9 41.88 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.185 0.594 . . . . 72.52 111.055 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.02 -48.35 79.14 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 109.363 -0.606 . . . . 74.13 109.363 169.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 111' ' ' ARG . . . . . 0.411 ' HD3' ' O ' ' D' ' 128' ' ' LEU . 25.2 ttp180 -54.52 -55.41 29.42 Favored 'General case' 0 C--N 1.355 0.832 0 CA-C-N 114.098 -1.41 . . . . 71.44 111.158 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 112' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -60.16 -43.93 95.39 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 124.027 0.829 . . . . 71.04 111.177 -173.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 113' ' ' CYS . . . . . . . . . . . . . 40.2 t -63.26 -45.44 91.5 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.804 0.442 . . . . 74.21 111.318 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 114' ' ' ILE . . . . . 0.605 HG23 ' SG ' ' D' ' 76' ' ' CYS . 69.2 mt -58.06 -59.39 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 123.877 0.871 . . . . 55.1 110.555 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 115' ' ' THR . . . . . . . . . . . . . 94.9 m -51.64 -43.57 62.67 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.569 1.548 . . . . 64.31 112.426 -175.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 116' ' ' SER . . . . . . . . . . . . . 43.2 t -68.9 -39.33 79.79 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.204 -0.907 . . . . 74.33 110.741 -175.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 117' ' ' MET . . . . . 0.422 ' SD ' ' CG2' ' D' ' 21' ' ' ILE . 70.8 mtm -71.33 -32.33 68.44 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.0 0.52 . . . . 60.41 111.721 -178.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 118' ' ' VAL . . . . . 0.424 HG23 ' O ' ' D' ' 114' ' ' ILE . 90.1 t -63.65 -44.98 98.68 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.847 0 O-C-N 123.683 0.614 . . . . 74.12 109.432 175.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 86.2 p -73.02 -27.84 62.0 Favored 'General case' 0 CA--C 1.557 1.235 0 C-N-CA 123.171 0.588 . . . . 44.42 111.808 179.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 120' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -73.4 -31.4 63.85 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 123.6 0.76 . . . . 74.21 110.499 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 121' ' ' GLY . . . . . . . . . . . . . . . -82.94 5.44 75.85 Favored Glycine 0 C--N 1.352 1.447 0 O-C-N 123.599 0.562 . . . . 61.33 111.933 171.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 122' ' ' THR . . . . . . . . . . . . . 39.3 p 61.5 14.67 6.07 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 127.128 2.171 . . . . 75.21 113.333 178.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 123' ' ' PHE . . . . . . . . . . . . . 59.9 m-85 -80.01 158.81 72.04 Favored Pre-proline 0 CA--C 1.555 1.148 0 C-N-CA 124.483 1.113 . . . . 72.43 108.585 169.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 124' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -67.42 124.5 12.13 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.746 2.297 . . . . 75.2 111.419 -168.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -53.3 116.8 2.61 Favored 'General case' 0 CA--C 1.547 0.857 0 O-C-N 124.298 0.999 . . . . 63.02 110.282 -179.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 126' ' ' LEU . . . . . . . . . . . . . 4.6 pp -109.13 131.45 55.06 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 107.831 -1.174 . . . . 74.11 107.831 -174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 127' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -107.34 98.2 7.86 Favored 'General case' 0 C--O 1.239 0.53 0 N-CA-C 108.37 -0.974 . . . . 71.12 108.37 -173.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 128' ' ' LEU . . . . . 0.411 ' O ' ' HD3' ' D' ' 111' ' ' ARG . 65.3 tp -56.73 115.7 2.71 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.874 1.27 . . . . 73.14 111.053 -176.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 129' ' ' ALA . . . . . . . . . . . . . . . -64.14 134.13 95.85 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.933 0.893 . . . . 44.43 110.895 -176.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 130' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.26 139.05 25.87 Favored 'Trans proline' 0 C--N 1.374 1.901 0 C-N-CA 122.104 1.869 . . . . 62.24 111.719 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 131' ' ' VAL . . . . . . . . . . . . . 57.6 t -109.48 111.27 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 N-CA-C 108.727 -0.842 . . . . 74.31 108.727 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 132' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -78.41 81.39 4.76 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 108.402 -0.962 . . . . 72.33 108.402 175.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 133' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -77.04 -29.28 55.14 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 114.862 -1.063 . . . . 75.41 111.44 -173.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 134' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.84 -46.45 74.63 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 122.813 0.445 . . . . 75.43 111.497 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.98 -60.77 2.9 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.014 0.926 . . . . 63.13 112.367 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 136' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' G' ' 285' ' ' ASN . 3.3 pp -64.97 -27.04 68.56 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 115.404 -0.816 . . . . 63.42 112.197 -175.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 137' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -78.67 -40.6 33.54 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.402 0.681 . . . . 63.22 110.565 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 138' ' ' MET . . . . . . . . . . . . . 70.0 mtm -72.7 -26.85 61.75 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 123.486 0.714 . . . . 73.54 111.297 -176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 139' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -56.15 -40.02 73.2 Favored 'General case' 0 N--CA 1.485 1.3 0 O-C-N 123.679 0.612 . . . . 74.32 110.666 175.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 140' ' ' TYR . . . . . . . . . . . . . 90.3 t80 -60.46 -43.72 96.59 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.312 1.045 . . . . 73.33 111.179 175.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 141' ' ' LEU . . . . . . . . . . . . . 9.1 mp -64.94 -29.29 70.22 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.264 1.026 . . . . 73.53 111.561 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 142' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 -83.06 4.54 25.79 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.757 0.823 . . . . 72.34 112.419 -177.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 143' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -118.63 88.55 2.95 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 109.173 -0.677 . . . . 75.24 109.173 -174.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 144' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.58 112.95 1.73 Allowed 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 114.685 -1.143 . . . . 73.54 107.997 -178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -128.48 101.5 6.21 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 123.43 0.692 . . . . 63.22 109.312 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 146' ' ' GLY . . . . . . . . . . . . . . . -127.28 76.43 0.4 Allowed Glycine 0 C--N 1.343 0.921 0 N-CA-C 110.492 -1.043 . . . . 62.15 110.492 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 147' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -123.68 142.9 50.62 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.493 0.717 . . . . 74.22 110.628 -172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 148' ' ' GLY . . . . . . . . . . . . . . . -178.92 152.49 11.29 Favored Glycine 0 C--N 1.342 0.907 0 CA-C-N 115.573 -0.74 . . . . 65.24 111.85 178.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 149' ' ' THR . . . . . . . . . . . . . 13.0 t -146.61 174.86 11.05 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.227 0.611 . . . . 35.34 110.14 178.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -151.99 -77.89 0.12 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 105.219 -2.141 . . . . 65.04 105.219 169.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 151' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -174.26 94.87 0.09 Allowed 'General case' 0 C--O 1.241 0.644 0 N-CA-C 107.957 -1.127 . . . . 62.42 107.957 173.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 152' ' ' HIS . . . . . . . . . . . . . 62.3 t-80 -159.35 66.76 0.4 Allowed 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 108.413 -0.958 . . . . 73.34 108.413 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 153' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -18.83 57.87 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-N 114.866 -1.061 . . . . 74.51 111.303 176.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' D' D ' 154' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -76.16 167.22 22.25 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.037 0.935 . . . . 74.24 110.097 176.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' D' D ' 155' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.957 0 C-N-CA 123.731 0.812 . . . . 74.21 109.01 176.373 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.21 0 N-CA-C 109.66 -0.496 . . . . 53.53 109.66 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' E' E ' 272' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -81.0 156.01 26.11 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 109.286 -0.635 . . . . 64.24 109.286 177.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 273' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -60.03 113.05 2.12 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.03 0.932 . . . . 63.22 108.746 175.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 274' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -69.45 -66.86 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 123.882 0.739 . . . . 62.53 110.069 -168.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 275' ' ' LYS . . . . . 0.445 ' O ' ' HB3' ' A' ' 90' ' ' GLU . 26.9 mtmt -161.1 148.52 12.16 Favored Pre-proline 0 N--CA 1.487 1.416 0 C-N-CA 124.408 1.083 . . . . 65.12 108.936 176.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 276' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -43.21 129.7 6.13 Favored 'Trans proline' 0 C--N 1.383 2.354 0 C-N-CA 124.421 3.414 . . . . 64.53 114.763 -173.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 67.0 mt -54.43 140.53 33.72 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 124.858 1.263 . . . . 74.42 110.666 177.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 278' ' ' LEU . . . . . . . . . . . . . 7.3 mp 76.61 2.18 3.38 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 125.04 1.336 . . . . 64.24 112.003 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 279' ' ' GLY . . . . . . . . . . . . . . . -76.72 89.86 0.95 Allowed Glycine 0 C--N 1.349 1.264 0 N-CA-C 111.872 -0.491 . . . . 71.24 111.872 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . 0.529 HD13 ' HB1' ' A' ' 95' ' ' ALA . 47.9 tp -159.98 -67.34 0.07 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.494 0.718 . . . . 53.53 110.174 174.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 281' ' ' PHE . . . . . . . . . . . . . 21.1 m-85 -53.78 -70.17 0.1 Allowed 'General case' 0 C--N 1.359 0.994 0 O-C-N 124.376 1.047 . . . . 65.42 112.641 -163.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 282' ' ' ALA . . . . . . . . . . . . . . . 57.77 -82.83 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 124.158 0.983 . . . . 70.05 110.52 -171.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 283' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -113.91 148.01 37.51 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.391 1.076 . . . . 72.1 109.141 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 284' ' ' GLY . . . . . . . . . . . . . . . -79.59 68.48 3.18 Favored Glycine 0 C--N 1.351 1.366 0 N-CA-C 111.461 -0.656 . . . . 74.42 111.461 176.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 285' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -80.56 -8.34 59.56 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.848 0.859 . . . . 74.02 112.029 -169.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 286' ' ' MET . . . . . . . . . . . . . 52.3 mtm -118.73 87.96 33.87 Favored Pre-proline 0 N--CA 1.48 1.061 0 C-N-CA 123.129 0.572 . . . . 74.32 109.674 174.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -86.27 135.62 4.56 Favored 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 122.787 2.325 . . . . 73.23 110.058 169.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 288' ' ' VAL . . . . . 0.566 ' HB ' HD22 ' A' ' 42' ' ' LEU . 80.4 t -69.25 103.63 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.556 0 N-CA-C 109.597 -0.52 . . . . 60.44 109.597 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 289' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -58.07 137.4 56.93 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 108.26 -1.015 . . . . 71.4 108.26 170.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 290' ' ' TRP . . . . . . . . . . . . . 70.4 t-105 -74.28 74.93 1.84 Allowed 'General case' 0 CA--C 1.548 0.878 0 O-C-N 123.708 0.63 . . . . 74.02 111.536 -173.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 291' ' ' LEU . . . . . 0.445 HD13 ' HB ' ' G' ' 306' ' ' VAL . 24.0 mt 51.7 25.69 3.01 Favored 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 125.732 1.613 . . . . 74.21 113.824 163.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 292' ' ' GLY . . . . . . . . . . . . . . . 77.06 -137.23 20.27 Favored Glycine 0 C--N 1.352 1.46 0 CA-C-O 119.173 -0.793 . . . . 51.32 112.428 -175.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 293' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -81.45 87.76 1.43 Allowed 'Trans proline' 0 C--N 1.374 1.895 0 C-N-CA 122.69 2.26 . . . . 75.31 112.45 175.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 294' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -143.17 167.21 22.65 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.778 0.831 . . . . 71.53 110.997 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 295' ' ' ALA . . . . . . . . . . . . . . . -149.16 175.89 10.97 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 124.296 1.038 . . . . 72.25 110.653 -178.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 296' ' ' THR . . . . . . . . . . . . . 99.0 m -133.69 113.08 11.96 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 123.475 0.71 . . . . 65.24 110.22 176.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 297' ' ' TYR . . . . . 0.595 ' HB2' ' HG2' ' A' ' 38' ' ' PRO . 58.3 t80 -167.34 146.56 5.09 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 107.438 -1.319 . . . . 75.24 107.438 171.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 298' ' ' HIS . . . . . . . . . . . . . 70.9 m80 -134.68 -49.26 0.76 Allowed 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.145 -1.057 . . . . 72.54 108.145 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 299' ' ' GLY . . . . . 0.551 ' H ' ' HG3' ' A' ' 124' ' ' PRO . . . 148.44 129.86 1.88 Allowed Glycine 0 C--N 1.342 0.894 0 CA-C-N 115.669 -0.696 . . . . 60.21 111.603 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 300' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -152.55 7.74 0.44 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.326 1.05 . . . . 63.52 110.221 175.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 301' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 32' ' ' PHE . 4.1 mp -117.31 137.68 50.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 123.522 0.729 . . . . 72.13 109.652 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' E' E ' 302' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -169.42 -89.79 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 107.646 -1.242 . . . . 73.42 107.646 174.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 303' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -175.15 75.29 0.3 Allowed Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 105.993 -1.855 . . . . 71.2 105.993 174.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 304' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.35 121.05 6.55 Favored 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 121.596 1.53 . . . . 73.25 109.285 174.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 305' ' ' ALA . . . . . . . . . . . . . . . -160.1 137.9 9.86 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.914 0.486 . . . . 63.24 109.98 -176.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 306' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.59 1.07 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.552 0 C-N-CA 124.146 0.978 . . . . 74.0 110.001 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 307' ' ' THR . . . . . . . . . . . . . 71.6 p 67.05 -69.85 0.12 Allowed 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 126.715 2.006 . . . . 62.24 111.459 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 308' ' ' CYS . . . . . . . . . . . . . 74.3 m -154.6 136.07 14.2 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.419 1.087 . . . . 74.45 109.051 171.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 309' ' ' THR . . . . . . . . . . . . . 63.3 m -74.26 -41.03 4.84 Favored Pre-proline 0 CA--C 1.568 1.635 0 C-N-CA 124.528 1.131 . . . . 74.14 110.992 173.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' E' E ' 310' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo . . . . . 0 C--N 1.402 3.366 0 C-N-CA 122.057 1.838 . . . . 53.3 111.167 166.842 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.991 0 CA-C-O 121.022 0.439 . . . . 55.2 110.154 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' F' F ' 272' ' ' ASN . . . . . 0.45 ' ND2' ' HB3' ' F' ' 274' ' ' GLN . 52.2 t30 -96.85 120.78 37.81 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 108.2 -1.037 . . . . 71.02 108.2 175.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 273' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -71.62 -14.74 62.15 Favored 'General case' 0 N--CA 1.481 1.125 0 O-C-N 123.72 0.638 . . . . 53.21 111.935 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 274' ' ' GLN . . . . . 0.45 ' HB3' ' ND2' ' F' ' 272' ' ' ASN . 1.1 tm0? -57.55 -32.58 67.25 Favored 'General case' 0 N--CA 1.484 1.267 0 C-N-CA 123.184 0.594 . . . . 73.25 110.65 171.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 275' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -73.47 113.47 22.74 Favored Pre-proline 0 CA--C 1.55 0.944 0 N-CA-C 109.051 -0.722 . . . . 45.42 109.051 173.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 276' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -86.44 -151.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.374 1.916 0 C-N-CA 123.238 2.625 . . . . 71.13 110.706 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . 0.645 ' HA ' ' SD ' ' C' ' 94' ' ' MET . 59.1 mt -50.14 137.67 17.34 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 123.586 0.754 . . . . 43.44 111.987 176.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 278' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 77.65 -173.02 0.08 Allowed 'General case' 0 N--CA 1.483 1.222 0 O-C-N 125.05 1.469 . . . . 53.22 110.816 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 279' ' ' GLY . . . . . . . . . . . . . . . 87.69 -57.59 4.4 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 111.473 -0.651 . . . . 73.41 111.473 -177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -75.71 77.01 2.68 Favored 'General case' 0 CA--C 1.554 1.108 0 N-CA-C 108.193 -1.04 . . . . 74.43 108.193 175.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 281' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -165.82 33.66 0.05 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.698 1.199 . . . . 73.24 108.332 176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 282' ' ' ALA . . . . . . . . . . . . . . . -141.42 89.97 2.26 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 108.988 -0.745 . . . . 64.03 108.988 177.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 283' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -168.56 151.17 5.2 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 108.297 -1.001 . . . . 74.21 108.297 176.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 284' ' ' GLY . . . . . . . . . . . . . . . -84.93 57.84 4.99 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 123.588 0.555 . . . . 65.11 112.744 -179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 285' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -69.34 127.09 31.82 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 123.986 0.915 . . . . 74.04 109.929 177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 286' ' ' MET . . . . . . . . . . . . . 4.4 mpp? 55.27 88.66 0.12 Allowed Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 124.75 1.22 . . . . 51.21 111.11 -176.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.62 -42.71 18.77 Favored 'Trans proline' 0 C--N 1.38 2.212 0 C-N-CA 123.92 3.08 . . . . 75.24 114.493 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 288' ' ' VAL . . . . . . . . . . . . . 48.7 t 46.31 84.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 C-N-CA 124.957 1.303 . . . . 53.43 111.772 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 289' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.94 -59.27 2.83 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 106.956 -1.498 . . . . 73.33 106.956 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 290' ' ' TRP . . . . . . . . . . . . . 45.7 m95 -152.21 178.15 9.79 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.953 1.301 . . . . 73.44 109.234 165.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 291' ' ' LEU . . . . . 0.593 ' HG ' HG23 ' H' ' 309' ' ' THR . 4.7 mp -114.64 16.07 17.58 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.745 0.818 . . . . 73.13 110.973 -178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 292' ' ' GLY . . . . . . . . . . . . . . . -166.32 162.09 35.72 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 119.275 -0.736 . . . . 73.25 111.898 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 293' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -75.82 1.4 8.15 Favored 'Trans proline' 0 C--N 1.378 2.105 0 C-N-CA 123.347 2.698 . . . . 71.01 113.244 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 294' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -87.66 -178.86 6.19 Favored 'General case' 0 CA--C 1.55 0.957 0 C-N-CA 124.933 1.293 . . . . 62.53 112.524 -175.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 295' ' ' ALA . . . . . 0.524 ' HA ' HG21 ' C' ' 40' ' ' VAL . . . -143.65 155.95 44.4 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 124.171 0.988 . . . . 53.22 110.313 -175.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 296' ' ' THR . . . . . 0.577 ' H ' HG11 ' C' ' 40' ' ' VAL . 7.5 m -63.31 -33.6 75.86 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.512 0.725 . . . . 73.34 111.064 -179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 297' ' ' TYR . . . . . 0.716 ' HD2' ' HG3' ' C' ' 38' ' ' PRO . 42.3 m-85 -87.39 60.79 6.26 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.65 0.738 . . . . 65.32 110.455 169.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 298' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -67.43 109.92 3.39 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 106.776 -1.564 . . . . 63.31 106.776 158.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 299' ' ' GLY . . . . . . . . . . . . . . . -61.73 79.78 0.02 OUTLIER Glycine 0 C--N 1.353 1.485 0 O-C-N 124.788 1.305 . . . . 61.11 115.348 -165.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 300' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -100.0 -21.73 15.52 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.216 1.006 . . . . 64.31 109.493 173.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 301' ' ' ILE . . . . . 0.542 HD11 ' HD3' ' C' ' 124' ' ' PRO . 46.9 mt -69.35 96.83 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.119 0 N-CA-C 109.035 -0.728 . . . . 75.11 109.035 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' F' F ' 302' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -155.92 -42.35 0.08 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 114.955 -1.021 . . . . 74.33 108.669 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 303' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -96.92 127.33 39.4 Favored Pre-proline 0 N--CA 1.476 0.838 0 N-CA-C 108.783 -0.821 . . . . 71.51 108.783 171.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 304' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.27 163.08 39.75 Favored 'Trans proline' 0 C--N 1.379 2.153 0 C-N-CA 122.914 2.41 . . . . 72.14 112.317 176.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 305' ' ' ALA . . . . . . . . . . . . . . . -95.61 -32.63 12.71 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 123.371 0.668 . . . . 70.21 110.893 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 306' ' ' VAL . . . . . . . . . . . . . 2.8 t -116.98 116.53 52.45 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 C-N-CA 123.956 0.902 . . . . 71.03 108.989 -175.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 307' ' ' THR . . . . . . . . . . . . . 91.5 m -133.66 93.82 3.19 Favored 'General case' 0 C--O 1.243 0.737 0 N-CA-C 107.676 -1.231 . . . . 64.34 107.676 171.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 308' ' ' CYS . . . . . . . . . . . . . 56.0 m 65.63 175.02 0.22 Allowed 'General case' 0 CA--C 1.558 1.272 0 C-N-CA 124.985 1.314 . . . . 35.21 111.783 -173.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 309' ' ' THR . . . . . . . . . . . . . 16.3 p -132.69 156.97 79.49 Favored Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.832 1.253 . . . . 61.33 109.029 174.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' F' F ' 310' ' ' PRO . . . . . 0.401 ' HG2' ' HB3' ' B' ' 132' ' ' ASN . 9.5 Cg_endo . . . . . 0 C--N 1.387 2.587 0 C-N-CA 123.014 2.476 . . . . 74.41 112.331 174.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 109.743 -0.466 . . . . 65.11 109.743 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' G' G ' 272' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -158.38 177.12 11.6 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 123.152 0.581 . . . . 72.12 109.961 -178.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 273' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -67.5 106.14 2.05 Favored 'General case' 0 CA--C 1.552 1.036 0 CA-C-O 121.469 0.652 . . . . 41.45 109.736 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 274' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -160.71 -175.29 4.88 Favored 'General case' 0 C--O 1.242 0.671 0 C-N-CA 123.666 0.786 . . . . 61.13 109.36 179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 275' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' G' ' 278' ' ' LEU . 2.4 mppt? -110.65 89.47 9.13 Favored Pre-proline 0 CA--C 1.546 0.815 0 N-CA-C 107.898 -1.149 . . . . 55.21 107.898 174.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 276' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' D' ' 94' ' ' MET . 88.8 Cg_endo -78.41 -2.66 12.7 Favored 'Trans proline' 0 C--N 1.38 2.198 0 C-N-CA 122.579 2.186 . . . . 73.42 112.119 -177.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . 0.509 HD22 HG22 ' D' ' 86' ' ' ILE . 96.1 mt -131.16 17.85 4.99 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 124.858 1.263 . . . . 75.11 110.832 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 278' ' ' LEU . . . . . 0.439 ' HB3' ' HB3' ' G' ' 275' ' ' LYS . 0.4 OUTLIER -153.69 101.38 2.46 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 109.803 -0.443 . . . . 72.35 109.803 -179.241 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' G' G ' 279' ' ' GLY . . . . . 0.429 ' H ' HD21 ' D' ' 98' ' ' LEU . . . -173.58 143.93 7.41 Favored Glycine 0 C--N 1.343 0.959 0 CA-C-O 119.008 -0.885 . . . . 73.44 111.4 178.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 65.5 tp 62.29 106.95 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.185 0 C-N-CA 125.038 1.335 . . . . 74.02 111.77 178.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 281' ' ' PHE . . . . . 0.52 ' HZ ' HG13 ' D' ' 58' ' ' VAL . 0.1 OUTLIER -134.31 -45.42 0.77 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.664 0.385 . . . . 75.33 110.209 -174.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' G' G ' 282' ' ' ALA . . . . . 0.648 ' HA ' ' HG2' ' G' ' 286' ' ' MET . . . -123.87 72.32 1.15 Allowed 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.255 0.622 . . . . 73.44 111.499 -177.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 283' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -171.12 116.48 0.44 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 124.167 0.987 . . . . 70.13 109.343 174.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 284' ' ' GLY . . . . . . . . . . . . . . . 151.02 -75.86 0.24 Allowed Glycine 0 C--N 1.346 1.089 0 N-CA-C 110.721 -0.951 . . . . 74.41 110.721 -175.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 285' ' ' ASN . . . . . 0.516 ' HB3' HD13 ' D' ' 136' ' ' LEU . 17.0 t-20 -159.93 31.68 0.18 Allowed 'General case' 0 CA--C 1.559 1.3 0 CA-C-O 122.37 1.081 . . . . 72.31 109.192 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 286' ' ' MET . . . . . 0.648 ' HG2' ' HA ' ' G' ' 282' ' ' ALA . 1.5 mpt? -69.18 -31.77 2.92 Favored Pre-proline 0 CA--C 1.568 1.643 0 N-CA-C 115.478 1.658 . . . . 75.54 115.478 -172.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.23 77.2 0.33 Allowed 'Trans proline' 0 C--N 1.4 3.251 0 CA-C-N 122.424 1.901 . . . . 74.53 112.541 170.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 288' ' ' VAL . . . . . . . . . . . . . 74.8 t -81.19 121.14 34.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 123.457 0.703 . . . . 70.02 109.42 -179.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 289' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -69.36 165.48 20.65 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.322 1.049 . . . . 72.24 110.753 179.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 290' ' ' TRP . . . . . 0.452 ' NE1' HG23 ' D' ' 40' ' ' VAL . 20.2 t-105 -73.82 123.99 25.22 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 122.844 0.458 . . . . 71.41 110.161 178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 291' ' ' LEU . . . . . . . . . . . . . 3.7 mp -88.74 129.19 35.6 Favored 'General case' 0 C--O 1.243 0.722 0 C-N-CA 123.585 0.754 . . . . 64.52 109.935 -176.154 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 292' ' ' GLY . . . . . . . . . . . . . . . 86.12 166.02 41.62 Favored Glycine 0 C--N 1.347 1.15 0 O-C-N 123.62 0.575 . . . . 61.14 114.028 175.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 293' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -81.57 162.59 19.21 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 123.239 2.626 . . . . 74.32 112.513 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 294' ' ' LYS . . . . . . . . . . . . . 54.3 pttt -80.39 74.79 7.24 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-O 122.472 1.13 . . . . 71.14 109.364 173.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 295' ' ' ALA . . . . . . . . . . . . . . . -92.71 24.77 3.4 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 114.726 -1.124 . . . . 73.25 110.636 177.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 296' ' ' THR . . . . . . . . . . . . . 16.0 p -68.27 -76.8 0.08 Allowed 'General case' 0 CA--C 1.55 0.981 0 C-N-CA 124.444 1.098 . . . . 74.24 112.186 -173.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 297' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -87.52 111.35 21.1 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 122.509 0.324 . . . . 61.34 111.218 -167.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 298' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -145.68 107.14 4.22 Favored 'General case' 0 C--O 1.239 0.529 0 C-N-CA 123.857 0.863 . . . . 72.23 109.155 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 299' ' ' GLY . . . . . . . . . . . . . . . 177.12 -141.15 5.23 Favored Glycine 0 C--N 1.337 0.607 0 O-C-N 123.835 0.71 . . . . 64.21 111.693 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 300' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -150.5 109.21 3.84 Favored 'General case' 0 C--O 1.244 0.801 0 C-N-CA 124.193 0.997 . . . . 74.25 109.047 -174.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 301' ' ' ILE . . . . . 0.527 HD12 ' HB3' ' D' ' 35' ' ' ASP . 50.3 mt -93.12 61.8 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.216 0 CA-C-O 122.52 1.152 . . . . 72.43 109.446 -178.368 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 302' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -165.47 72.48 0.18 Allowed 'General case' 0 C--O 1.233 0.22 0 N-CA-C 106.731 -1.581 . . . . 62.14 106.731 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 303' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -168.11 74.95 0.89 Allowed Pre-proline 0 CA--C 1.551 0.998 0 CA-C-N 115.557 -0.747 . . . . 74.21 110.36 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 304' ' ' PRO . . . . . 0.453 ' HG2' ' HA ' ' G' ' 307' ' ' THR . 37.3 Cg_endo -70.29 133.74 25.28 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 121.835 1.69 . . . . 62.14 110.972 171.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 305' ' ' ALA . . . . . . . . . . . . . . . -57.72 -33.65 68.65 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.833 0.853 . . . . 70.13 110.801 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 306' ' ' VAL . . . . . 0.445 ' HB ' HD13 ' E' ' 291' ' ' LEU . 5.1 p -114.04 100.56 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.83 0 N-CA-C 108.43 -0.952 . . . . 72.41 108.43 164.397 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 307' ' ' THR . . . . . 0.453 ' HA ' ' HG2' ' G' ' 304' ' ' PRO . 9.4 m -73.18 -32.21 64.69 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.531 -0.759 . . . . 73.04 110.538 177.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' G' G ' 308' ' ' CYS . . . . . . . . . . . . . 19.3 p -162.17 125.5 3.03 Favored 'General case' 0 C--N 1.346 0.438 0 C-N-CA 124.539 1.136 . . . . 73.43 108.735 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 309' ' ' THR . . . . . . . . . . . . . 61.7 m -76.46 130.18 77.74 Favored Pre-proline 0 CA--C 1.553 1.091 0 CA-C-O 118.101 -0.952 . . . . 75.21 109.222 173.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' G' G ' 310' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo . . . . . 0 C--N 1.398 3.134 1 C-N-CA 125.406 4.07 . . . . 53.43 115.892 -176.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 271' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 110.432 -0.21 . . . . 50.02 110.432 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' H' H ' 272' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -115.4 -48.95 2.77 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 124.483 1.113 . . . . 75.02 108.524 174.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 273' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -87.94 78.38 8.28 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 115.205 -0.907 . . . . 71.34 109.149 175.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 274' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -68.58 -33.8 74.69 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 115.774 -0.648 . . . . 60.11 110.747 -178.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 275' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -114.14 87.34 13.0 Favored Pre-proline 0 CA--C 1.554 1.117 0 N-CA-C 109.165 -0.68 . . . . 65.13 109.165 172.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 276' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -88.2 128.33 2.23 Favored 'Trans proline' 0 C--N 1.381 2.256 0 C-N-CA 122.545 2.163 . . . . 44.15 111.328 172.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . 0.508 HD23 ' SD ' ' B' ' 94' ' ' MET . 1.2 tt -81.31 65.97 6.66 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 107.755 -1.202 . . . . 64.24 107.755 175.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 278' ' ' LEU . . . . . . . . . . . . . 47.8 tp -175.59 136.6 0.34 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.131 1.372 . . . . 74.3 107.98 -174.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 279' ' ' GLY . . . . . . . . . . . . . . . -142.55 -69.11 0.03 OUTLIER Glycine 0 C--N 1.342 0.915 0 N-CA-C 110.517 -1.033 . . . . 61.33 110.517 -179.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 mp -83.74 -176.92 6.52 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.476 0.711 . . . . 72.22 109.633 173.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 281' ' ' PHE . . . . . 0.424 ' CZ ' HG13 ' B' ' 58' ' ' VAL . 38.4 t80 69.39 85.09 0.14 Allowed 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.26 1.024 . . . . 63.14 110.203 176.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 282' ' ' ALA . . . . . . . . . . . . . . . -174.09 -35.83 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.585 1.154 . . . . 63.41 108.97 -174.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 283' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -112.71 100.17 8.49 Favored 'General case' 0 N--CA 1.473 0.717 0 N-CA-C 108.237 -1.023 . . . . 70.42 108.237 172.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 284' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' B' ' 45' ' ' ASP . . . -81.84 91.36 1.49 Allowed Glycine 0 C--N 1.342 0.916 0 N-CA-C 111.812 -0.515 . . . . 62.32 111.812 -179.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 285' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -117.61 28.24 8.57 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.068 0.947 . . . . 60.2 110.552 -174.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 286' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -105.54 96.74 12.59 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 109.312 -0.625 . . . . 72.32 109.312 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -80.62 94.26 1.0 Allowed 'Trans proline' 0 C--N 1.378 2.121 0 C-N-CA 122.674 2.25 . . . . 64.52 110.208 176.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 288' ' ' VAL . . . . . 0.542 ' O ' ' HB2' ' B' ' 42' ' ' LEU . 57.3 t -61.03 111.4 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.814 0 CA-C-N 115.728 -0.669 . . . . 64.32 110.32 178.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 289' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -82.28 150.15 27.42 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 108.796 -0.816 . . . . 75.1 108.796 172.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 290' ' ' TRP . . . . . . . . . . . . . 94.4 m95 -61.03 142.98 56.22 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 123.165 0.586 . . . . 74.53 111.225 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 291' ' ' LEU . . . . . 0.523 HD13 ' HB3' ' B' ' 129' ' ' ALA . 5.6 mp -82.23 81.26 8.19 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.206 1.002 . . . . 71.03 108.949 -174.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 292' ' ' GLY . . . . . . . . . . . . . . . 80.19 -130.53 9.85 Favored Glycine 0 CA--C 1.534 1.253 0 CA-C-O 118.834 -0.981 . . . . 72.4 111.19 -172.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 293' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -84.82 179.24 4.39 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.812 2.341 . . . . 75.24 113.013 174.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 294' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -155.48 -65.16 0.12 Allowed 'General case' 0 N--CA 1.479 1.01 0 CA-C-N 115.064 -0.971 . . . . 73.51 109.46 172.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 295' ' ' ALA . . . . . . . . . . . . . . . 63.91 109.93 0.03 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 125.07 1.348 . . . . 71.54 111.794 -172.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 296' ' ' THR . . . . . . . . . . . . . 25.9 m -77.68 -59.76 2.65 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 122.879 0.472 . . . . 72.24 109.861 177.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 297' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -109.05 111.05 22.49 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 108.27 -1.011 . . . . 74.34 108.27 176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 298' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -154.92 150.02 26.96 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 122.784 0.433 . . . . 63.02 110.166 -176.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 299' ' ' GLY . . . . . . . . . . . . . . . 69.35 -95.97 0.46 Allowed Glycine 0 C--N 1.35 1.343 0 O-C-N 124.068 0.855 . . . . 62.3 111.912 178.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 300' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -120.53 111.02 17.17 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 108.1 -1.074 . . . . 73.12 108.1 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 301' ' ' ILE . . . . . 0.506 HG23 ' O ' ' H' ' 302' ' ' ASP . 1.2 tt -68.36 -24.35 29.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 124.357 1.063 . . . . 75.22 111.612 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 302' ' ' ASP . . . . . 0.506 ' O ' HG23 ' H' ' 301' ' ' ILE . 2.5 t70 85.82 -161.09 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 126.573 1.949 . . . . 71.23 107.162 -163.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 303' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -158.12 101.39 1.75 Allowed Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 108.301 -1.0 . . . . 73.24 108.301 165.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 304' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -68.96 77.92 0.77 Allowed 'Trans proline' 0 C--N 1.381 2.289 0 C-N-CA 122.556 2.17 . . . . 73.55 110.628 172.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 305' ' ' ALA . . . . . . . . . . . . . . . -144.28 81.05 1.66 Allowed 'General case' 0 C--O 1.241 0.656 0 CA-C-N 114.441 -1.254 . . . . 75.45 108.976 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 306' ' ' VAL . . . . . 0.488 ' HB ' ' O ' ' A' ' 13' ' ' ILE . 45.3 t -65.29 114.1 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 115.42 -0.809 . . . . 74.43 109.023 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 307' ' ' THR . . . . . . . . . . . . . 5.0 m -123.62 6.16 8.87 Favored 'General case' 0 CA--C 1.553 1.063 0 C-N-CA 123.57 0.748 . . . . 73.44 109.815 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 308' ' ' CYS . . . . . . . . . . . . . 24.6 p -168.04 164.71 13.66 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.246 1.019 . . . . 63.22 109.727 -174.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' H' H ' 309' ' ' THR . . . . . 0.593 HG23 ' HG ' ' F' ' 291' ' ' LEU . 17.5 m -145.64 61.79 7.93 Favored Pre-proline 0 CA--C 1.565 1.542 0 C-N-CA 123.507 0.723 . . . . 71.43 109.302 170.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' H' H ' 310' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_endo . . . . . 0 C--N 1.38 2.192 0 C-N-CA 122.3 2.0 . . . . 71.11 111.102 178.753 . . . . . . . . 0 0 . 1 stop_ save_